PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Gimenez-Mascarell, P; Oyenarte, I; Hardy, S; Breiderhoff, T; Stuiver, M; Kostantin, E; Diercks, T; Pey, AL; Ereno-Orbea, J; Martinez-Chantar, ML; Khalaf-Nazzal, R; Claverie-Martin, F; Muller, D; Tremblay, ML; Martinez-Cruz, LA				Gimenez-Mascarell, Paula; Oyenarte, Iker; Hardy, Serge; Breiderhoff, Tilman; Stuiver, Marchel; Kostantin, Elie; Diercks, Tammo; Pey, Angel L.; Ereno-Orbea, June; Luz Martinez-Chantar, Maria; Khalaf-Nazzal, Reham; Claverie-Martin, Felix; Mueller, Dominik; Tremblay, Michel L.; Alfonso Martinez-Cruz, Luis			Structural Basis of the Oncogenic Interaction of Phosphatase PRL-1 with the Magnesium Transporter CNNM2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; CYSTATHIONINE-BETA-SYNTHASE; CONE-ROD DYSTROPHY; CELL-GROWTH; CBS DOMAINS; CANCER; EXPRESSION; MUTATIONS; INVASION; TARGET	Phosphatases of regenerating liver (PRLs), the most oncogenic of all protein-tyrosine phosphatases (PTPs), play a critical role in metastatic progression of cancers. Recent findings established a new paradigm by uncovering that their association with magnesium transporters of the cyclinM(CNNM) family causes a rise in intracellular magnesium levels that promote oncogenic transformation. Recently, however, essential roles for regulation of the circadian rhythm and reproduction of the CNNM family have been highlighted. Here, we describe the crystal structure of PRL-1 in complex with the Bateman module of CNNM2 (CNNM2BAT), which consists of two cystathionine beta-synthase (CBS) domains (IPR000664) and represents an intracellular regulatory module of the transporter. The structure reveals a heterotetrameric association, consisting of a disclike homodimer of CNNM2(BAT) bound to two independent PRL-1 molecules, each one located at opposite tips of the disc. The structure highlights the key role played by Asp-558 at the extended loop of the CBS2 motif of CNNM2 in maintaining the association between the two proteins and proves that the interaction between CNNM2 and PRL-1 occurs via the catalytic domain of the phosphatase. Our data shed new light on the structural basis underlying the interaction between PRL phosphatases and CNNM transporters and provides a hypothesis about the molecular mechanism by which PRL-1, upon binding to CNNM2, might increase the intracellular concentration of Mg2+ thereby contributing to tumor progression and metastasis. The availability of this structure sets the basis for the rational design of compounds modulating PRL-1 andCNNM2activities.	[Gimenez-Mascarell, Paula; Oyenarte, Iker; Diercks, Tammo; Ereno-Orbea, June; Alfonso Martinez-Cruz, Luis] Ctr Cooperat Res Biosci CIC bioGUNE, Struct Biol Unit, Technol Pk Bizkaia, Derio 48160, Bizkaia, Spain; [Hardy, Serge; Kostantin, Elie; Tremblay, Michel L.] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada; [Kostantin, Elie; Tremblay, Michel L.] McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada; [Tremblay, Michel L.] McGill Univ, Dept Med, Div Expt Med, Montreal, PQ H3A 1A3, Canada; [Breiderhoff, Tilman; Mueller, Dominik] Charite, Dept Pediat Nephrol, D-13353 Berlin, Germany; [Breiderhoff, Tilman] Berlin Inst Hlth, Berlin, Germany; [Stuiver, Marchel] Leibniz Inst Mol Pharmacol FMP Berlin, Dept NMR Supported Struct Biol, In Cell NMR Lab, Robert Rossle Str 10, D-13125 Berlin, Germany; [Pey, Angel L.] Univ Granada, Fac Sci, Dept Phys Chem, Av Fuentenueva S-N, E-18071 Granada, Spain; [Luz Martinez-Chantar, Maria] Ctr Cooperat Res Biosci CIC bioGUNE, Metabol Unit, Technol Pk Bizkaia, Derio 48160, Bizkaia, Spain; [Khalaf-Nazzal, Reham] An Najah Natl Univ, Dept Biomed Sci, POB 7, Nablus, Palestine; [Claverie-Martin, Felix] Nuestra Senora de Candelaria Univ Hosp, Res Unit, Santa Cruz De Tenerife 38010, Spain	CIC bioGUNE; McGill University; McGill University; McGill University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); University of Granada; CIC bioGUNE; An Najah National University	Tremblay, ML (corresponding author), McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada.; Tremblay, ML (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada.; Tremblay, ML (corresponding author), McGill Univ, Dept Med, Div Expt Med, Montreal, PQ H3A 1A3, Canada.; Muller, D (corresponding author), Charite, Dept Pediat Nephrol, D-13353 Berlin, Germany.; Martinez-Cruz, LA (corresponding author), Ctr Cooperat Res Biosci CIC bioGUNE, Struct Biol Unit, Bizkaia Sci & Technol Pk Bldg 800, Derio 48160, Bizkaia, Spain.	Dominik.Mueller@charite.de; Michel.tremblay@mcgill.ca; amartinez@cicbiogune.es	Breiderhoff, Tilman/X-9364-2019; Chantar, Maria Luz Martinez/F-5190-2011; Diercks, Tammo/G-1167-2011; Diercks, Tammo/AAT-3731-2021; Martinez-Cruz, Luis Alfonso/G-2285-2011	Breiderhoff, Tilman/0000-0002-1676-7498; Chantar, Maria Luz Martinez/0000-0002-6446-9911; Diercks, Tammo/0000-0002-5200-0905; Diercks, Tammo/0000-0002-5200-0905; Claverie-Martin, Felix/0000-0003-2468-3267; Stuiver, Marchel/0000-0003-3437-4468; ereno orbea, june/0000-0002-5076-2105; Martinez-Cruz, Luis Alfonso/0000-0002-5856-9377; Pey, Angel Luis/0000-0001-7706-3243; OYENARTE, IKER/0000-0002-2870-3344; Gimenez Mascarell, Paula/0000-0002-7775-9440	Departamento de Educacion, Universidades e Investigacion del Gobierno Vasco [PI2010-17]; Departamento de Industria, Innovacion, Comercio y Turismo del Gobierno Vasco [ETORTEK IE05-14, IE07-202]; Diputacion Foral de Bizkaia [7/13/08/2006/11, 7/13/08/2005/14]; Spanish Ministerio de Ciencia e Innovacion (MICINN) [BFU2010-17857]; Spanish Ministry of Economy and Competitiveness [BFU2013-47531-R]; Ministerio de Ciencia e Innovacion CONSOLIDER-INGENIO [CSD2008-00005]	Departamento de Educacion, Universidades e Investigacion del Gobierno Vasco; Departamento de Industria, Innovacion, Comercio y Turismo del Gobierno Vasco; Diputacion Foral de Bizkaia; Spanish Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Economy and Competitiveness(Spanish Government); Ministerio de Ciencia e Innovacion CONSOLIDER-INGENIO	This work was supported in part by Departamento de Educacion, Universidades e Investigacion del Gobierno Vasco Grant PI2010-17, Departamento de Industria, Innovacion, Comercio y Turismo del Gobierno Vasco Grants ETORTEK IE05-14 and IE07-202], Diputacion Foral de Bizkaia Grants 7/13/08/2006/11 and 7/13/08/2005/14, Spanish Ministerio de Ciencia e Innovacion (MICINN) Grant BFU2010-17857, Spanish Ministry of Economy and Competitiveness Grant BFU2013-47531-R, and Ministerio de Ciencia e Innovacion CONSOLIDER-INGENIO 2010 Program Grant CSD2008-00005 (to L. A. M.-C.). The authors declare that they have no conflicts of interest with the contents of this article.	Achiwa H, 2007, CANCER RES, V67, P643, DOI 10.1158/0008-5472.CAN-06-2436; Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Corral-Rodriguez MA, 2014, BIOCHEM J, V464, P23, DOI 10.1042/BJ20140409; Arjona FJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004267; Bai YP, 2011, J BIOL CHEM, V286, P42316, DOI 10.1074/jbc.M111.286302; Bateman A, 1997, TRENDS BIOCHEM SCI, V22, P12, DOI 10.1016/S0968-0004(96)30046-7; Baykov AA, 2011, ACS CHEM BIOL, V6, P1156, DOI 10.1021/cb200231c; Bessette DC, 2008, CANCER METAST REV, V27, P231, DOI 10.1007/s10555-008-9121-3; de Baaij JHF, 2015, PHYSIOL REV, V95, P1, DOI 10.1152/physrev.00012.2014; Denu JM, 1996, P NATL ACAD SCI USA, V93, P2493, DOI 10.1073/pnas.93.6.2493; DIAMOND RH, 1994, MOL CELL BIOL, V14, P3752, DOI 10.1128/MCB.14.6.3752; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ereno-Orbea J, 2013, ARCH BIOCHEM BIOPHYS, V540, P70, DOI 10.1016/j.abb.2013.10.008; Ereno-Orbea J, 2013, P NATL ACAD SCI USA, V110, pE3790, DOI 10.1073/pnas.1313683110; ERNST RR, 1966, REV SCI INSTRUM, V37, P93, DOI 10.1063/1.1719961; Feeney KA, 2016, NATURE, V532, P375, DOI 10.1038/nature17407; Gomez-Garcia I, 2012, ACTA CRYSTALLOGR F, V68, P1198, DOI 10.1107/S1744309112035348; Goytain A, 2005, PHYSIOL GENOMICS, V22, P382, DOI 10.1152/physiolgenomics.00058.2005; Hardy S, 2015, ONCOGENE, V34, P986, DOI 10.1038/onc.2014.33; Hirata Y, 2014, J BIOL CHEM, V289, P14731, DOI 10.1074/jbc.M114.551176; Jeong DG, 2005, J MOL BIOL, V345, P401, DOI 10.1016/j.jmb.2004.10.061; Jiao Y, 2015, AM J PHYSIOL-GASTR L, V308, pG85, DOI 10.1152/ajpgi.00084.2014; Jin SW, 2014, ONCOTARGET, V5, P3685, DOI 10.18632/oncotarget.1986; Julien SG, 2011, NAT REV CANCER, V11, P35, DOI 10.1038/nrc2980; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kleywegt GJ, 2002, STRUCTURE, V10, P465, DOI 10.1016/S0969-2126(02)00743-8; Kostantin E, 2016, J BIOL CHEM, V291, P10716, DOI 10.1074/jbc.M115.705863; Kozlov G, 2004, J BIOL CHEM, V279, P11882, DOI 10.1074/jbc.M312905200; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lotan A, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00331; Lu JW, 2012, CLIN TRANSL ONCOL, V14, P287, DOI 10.1007/s12094-012-0797-z; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McKusick V.A., 1998, MENDELIAN INHERITANC; Min SH, 2009, ONCOGENE, V28, P545, DOI 10.1038/onc.2008.409; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Parry DA, 2009, AM J HUM GENET, V84, P266, DOI 10.1016/j.ajhg.2009.01.009; Polok B, 2009, AM J HUM GENET, V84, P259, DOI 10.1016/j.ajhg.2009.01.006; Quamme G. A., 2010, AM J PHYSIOL-CELL PH, V298; Rios P, 2013, FEBS J, V280, P505, DOI 10.1111/j.1742-4658.2012.08565.x; SHABB JB, 1992, J BIOL CHEM, V267, P5723; Shinmei S, 2014, UROL ONCOL-SEMIN ORI, V32, P769, DOI 10.1016/j.urolonc.2014.03.007; Sponder G, 2016, PFLUG ARCH EUR J PHY, V468, P1223, DOI 10.1007/s00424-016-1816-7; Stuiver M, 2011, AM J HUM GENET, V88, P333, DOI 10.1016/j.ajhg.2011.02.005; Sun JP, 2007, J BIOL CHEM, V282, P29043, DOI 10.1074/jbc.M703537200; Sun JP, 2005, BIOCHEMISTRY-US, V44, P12009, DOI 10.1021/bi0509191; Wang CY, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-7; Wang CY, 2003, GENE, V306, P37, DOI 10.1016/S0378-1119(02)01210-6; Yamazaki D, 2016, J CELL SCI, V129, P1940, DOI 10.1242/jcs.182220; Yamazaki D, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003983; Yu L, 2007, BBA-MOL CELL RES, V1773, P1473, DOI 10.1016/j.bbamcr.2007.06.005; Zeng Q, 2000, J BIOL CHEM, V275, P21444, DOI 10.1074/jbc.M000453200; Zeng Q, 2003, CANCER RES, V63, P2716; Zeng Q, 1998, BIOCHEM BIOPH RES CO, V244, P421, DOI 10.1006/bbrc.1998.8291	53	36	37	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2017	292	3					786	801		10.1074/jbc.M116.759944	http://dx.doi.org/10.1074/jbc.M116.759944			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2LL	27899452	Green Published, hybrid			2022-12-26	WOS:000392318700003
J	Kaur, A; Gautam, R; Srivastava, R; Chandel, A; Kumar, A; Karthikeyan, S; Bachhawat, AK				Kaur, Amandeep; Gautam, Ruchi; Srivastava, Ritika; Chandel, Avinash; Kumar, Akhilesh; Karthikeyan, Subramanian; Bachhawat, Anand Kumar			ChaC2, an Enzyme for Slow Turnover of Cytosolic Glutathione	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-GLUTAMYL CYCLOTRANSFERASES; CRYSTAL-STRUCTURE; PROTEIN; DEGRADATION; IDENTIFICATION; METABOLISM; PATHWAY; FAMILY	Glutathione degradation plays an important role in glutathione and redox homeostasis, and thus it is imperative to understand the enzymes and the mechanisms involved in glutathione degradation in detail. We describe here ChaC2, a member of the ChaC family of gamma-glutamylcyclotransferases, as an enzyme that degrades glutathione in the cytosol of mammalian cells. ChaC2 is distinct from the previously described ChaC1, to which ChaC2 shows similar to 50% sequence identity. Human and mouse ChaC2 proteins purified in vitro show 10 -20-fold lower catalytic efficiency than ChaC1, although they showed comparable K-m values (K-m of 3.7 +/- 0.4 mM and k(cat) of 15.9 +/- 1.0 min(-1) toward glutathione for human ChaC2; K-m of 2.2 +/- 0.4 mM and k(cat) of 225.2 +/- 15 min(-1) toward glutathione for human ChaC1). The ChaC1 and ChaC2 proteins also shared the same specificity for reduced glutathione, with no activity against either gamma-glutamyl amino acids or oxidized glutathione. The ChaC2 proteins were found to be expressed constitutively in cells, unlike the tightly regulated ChaC1. Moreover, lower eukaryotes have a single member of the ChaC family that appears to be orthologous to ChaC2. In addition, we determined the crystal structure of yeast ChaC2 homologue, GCG1, at 1.34 angstrom resolution, which represents the first structure of the ChaC family of proteins. The catalytic site is defined by a fortuitous benzoic acid molecule bound to the crystal structure. The mechanism for binding and catalytic activity of this new enzyme of glutathione degradation, which is involved in continuous but basal turnover of cytosolic glutathione, is proposed.	[Kaur, Amandeep; Chandel, Avinash; Kumar, Akhilesh; Bachhawat, Anand Kumar] Indian Inst Sci Educ & Res, Dept Biol Sci, Sas Nagar 140306, Punjab, India; [Gautam, Ruchi; Srivastava, Ritika; Karthikeyan, Subramanian] Council Sci & Ind Res CSIR, CSIR Inst Microbial Technol, Sect 39A, Chandigarh 160036, India; [Kumar, Akhilesh] Univ Miami, Miller Sch Med, Miami, FL 33136 USA	Indian Institute of Science Education & Research (IISER) - Mohali; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); University of Miami	Bachhawat, AK (corresponding author), Indian Inst Sci Educ & Res, Dept Biol Sci, Sas Nagar 140306, Punjab, India.; Karthikeyan, S (corresponding author), Council Sci & Ind Res CSIR, CSIR Inst Microbial Technol, Sect 39A, Chandigarh 160036, India.	skarthik@imtech.res.in; anand@iisermohali.ac.in		KAUR, AMANDEEP/0000-0002-2382-9327	Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	We thank the EMBL staff Dr. Hassan Belrhali and Dr. Babu A. Manjasetty for providing support on the beamline and EMBL-DBT for providing access to the BM14 beamline at the ESRF. We also thank the Department of Biotechnology, Government of India for providing financial assistance to R. G. for collecting data at BM14.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arthur JR, 2000, CELL MOL LIFE SCI, V57, P1825; Baudouin-Cornu P, 2012, J BIOL CHEM, V287, P4552, DOI 10.1074/jbc.M111.315705; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Chi ZK, 2014, CELL REP, V7, P681, DOI 10.1016/j.celrep.2014.03.048; Crawford RR, 2015, J BIOL CHEM, V290, P15878, DOI 10.1074/jbc.M114.635144; Dalle-Donne I, 2009, TRENDS BIOCHEM SCI, V34, P85, DOI 10.1016/j.tibs.2008.11.002; DeLano WL., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FAHEY RC, 1984, SCIENCE, V224, P70, DOI 10.1126/science.6322306; Franco R, 2009, CELL DEATH DIFFER, V16, P1303, DOI 10.1038/cdd.2009.107; Fujiwara S, 2016, J BIOL CHEM, V291, P6813, DOI 10.1074/jbc.M115.678953; GAITONDE MK, 1967, BIOCHEM J, V104, P627, DOI 10.1042/bj1040627; Ganguli D, 2007, GENETICS, V175, P1137, DOI 10.1534/genetics.106.066944; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Hwang J, 2015, BIOCHEM BIOPH RES CO, V467, P218, DOI 10.1016/j.bbrc.2015.10.003; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Kantardjieff KA, 2003, PROTEIN SCI, V12, P1865, DOI 10.1110/ps.0350503; Kaur H, 2009, J BIOL CHEM, V284, P14493, DOI 10.1074/jbc.M808952200; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kumar A, 2012, EMBO REP, V13, P1095, DOI 10.1038/embor.2012.156; Kumar C, 2011, EMBO J, V30, P2044, DOI 10.1038/emboj.2011.105; Kumar S, 2015, BIOCHEM J, V468, P73, DOI 10.1042/BJ20141154; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Mungrue IN, 2009, J IMMUNOL, V182, P466, DOI 10.4049/jimmunol.182.1.466; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Oakley AJ, 2008, J BIOL CHEM, V283, P22031, DOI 10.1074/jbc.M803623200; Oakley AJ, 2010, J BIOL CHEM, V285, P9642, DOI 10.1074/jbc.M109.082099; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PENNINCKX MJ, 1993, ADV MICROB PHYSIOL, V34, P239, DOI 10.1016/S0065-2911(08)60031-4; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; Rajasekaran NS, 2007, CELL, V130, P427, DOI 10.1016/j.cell.2007.06.044; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Srikanth CV, 2005, CURR GENET, V47, P345, DOI 10.1007/s00294-005-0571-7; Steegborn C, 2001, STRUCTURE, V9, P1051, DOI 10.1016/S0969-2126(01)00665-7; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TATE SS, 1981, MOL CELL BIOCHEM, V39, P357, DOI 10.1007/BF00232585; Townsend DM, 2003, BIOMED PHARMACOTHER, V57, P145, DOI 10.1016/S0753-3322(03)00043-X; Winkler A, 2011, BIOCHEM BIOPH RES CO, V412, P121, DOI 10.1016/j.bbrc.2011.07.056; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	44	28	33	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2017	292	2					638	651		10.1074/jbc.M116.727479	http://dx.doi.org/10.1074/jbc.M116.727479			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2KN	27913623	Green Published, hybrid			2022-12-26	WOS:000392316100019
J	Menasria, R; Canivet, C; Piret, J; Gosselin, J; Boivin, G				Menasria, Rafik; Canivet, Coraline; Piret, Jocelyne; Gosselin, Jean; Boivin, Guy			Both Cerebral and Hematopoietic Deficiencies in CCR2 Result in Uncontrolled Herpes Simplex Virus Infection of the Central Nervous System in Mice	PLOS ONE			English	Article							INFLAMMATORY MONOCYTES; BONE-MARROW; ALZHEIMERS-DISEASE; IMMUNE-RESPONSE; INTRAVITAL MICROSCOPY; VIRAL ENCEPHALITIS; RECRUITMENT; MICROGLIA; BRAIN; EXPRESSION	CCR2 is a chemokine receptor expressed on the surface of blood leukocytes, particularly "Ly6C(hi)" inflammatory monocytes and microglia. Signaling through this receptor is thought to influence the immune activity of microglia as well as monocytes egress from the bone marrow (BM) and their trafficking into the central nervous system (CNS) in several neurological diseases. During experimental herpes simplex virus 1 (HSV-1) encephalitis (HSE), CCR2 deficiency has been reported to exacerbate the outcome of the disease. However, the precise contribution of CCR2 expressed in cells of the CNS or peripheral monocytes in the protection against HSE remains unclear. To dissect the differential role of CCR2 during HSE, chimeric mice with receptor deficiency in the brain or blood cells were generated by transplanting wild-type (WT) C57BL/6 or CCR2(-/-) BM-derived cells in CCR2(-/-)(WT -> CCR2(-/-)) and WT (CCR2(-/-)-> WT) mice, respectively. Our results indicate that following intranasal infection with 1.2x10(6) plaque forming units of HSV-1, CCR2 deficiency in hematopoietic cells and, to a lesser extent, in CNS exacerbates the outcome of HSE. Mortality rates of CCR2(-/-) (71.4%) and CCR2(-/-)-> WT (57.1%) mice were significantly higher than that of WT (15.3%; P<0.01 and P<0.05, respectively) but the difference did not reach statistical significance for WT -> CCR2(-/-) animals (42.8%; P = 0.16). Both peripheral and CNS deficiencies in CCR2 resulted in increased infectious viral titers and wider dissemination of HSV antigens in the brain as well as an overproduction of inflammatory cytokines and chemokines including IL-1 beta, IL-6, CCL2, CCL3 and CCL5. Furthermore, CCR2 deficiency in the hematopoietic system altered monocytes egress from the BM and their recruitment to the CNS, which may contribute to the failure in HSV-1 containment. Collectively, these data suggest that CCR2 expressed on cells of CNS and especially on peripheral monocytes is important for the control of HSV-1 replication and inflammatory environment during experimental HSE.	[Menasria, Rafik; Canivet, Coraline; Piret, Jocelyne; Boivin, Guy] Univ Laval, Fac Med, Dept Microbiol Immunol & Infect Dis, Res Ctr Infect Dis,CHU Quebec Res Ctr, Quebec City, PQ, Canada; [Gosselin, Jean] Univ Laval, Dept Mol Med, CHU Quebec Res Ctr, Lab Innate Immun,Fac Med, Quebec City, PQ, Canada	Laval University; Laval University	Boivin, G (corresponding author), Univ Laval, Fac Med, Dept Microbiol Immunol & Infect Dis, Res Ctr Infect Dis,CHU Quebec Res Ctr, Quebec City, PQ, Canada.	Guy.Boivin@crchudequebec.ulaval.ca		Piret, Jocelyne/0000-0003-4102-0094; Boivin, Guy/0000-0003-3027-4662	Canadian Institutes of Health Research [MOP-133481]; Fonds de Recherche du Quebec-Sante	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec)	This study was supported by a grant from the Canadian Institutes of Health Research (grant MOP-133481 to G.B.). G.B. is the holder of the Canada research chair on emerging viruses and antiviral resistance. R.M. has a PhD scholarship from the "Fonds de Recherche du Quebec-Sante". The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ashhurst TM, 2014, CELL IMMUNOL, V291, P49, DOI 10.1016/j.cellimm.2014.07.002; Bao Y, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-92; Boivin N, 2012, J GEN VIROL, V93, P1294, DOI 10.1099/vir.0.041046-0; Bradshaw MJ, 2016, NEUROTHERAPEUTICS TH; Cazareth J, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-132; Chen BP, 2001, J IMMUNOL, V167, P4585, DOI 10.4049/jimmunol.167.8.4585; Chu HX, 2014, J CEREBR BLOOD F MET, V34, P1425, DOI 10.1038/jcbfm.2014.120; Conrady CD, 2013, J IMMUNOL, V190, P2807, DOI 10.4049/jimmunol.1203265; Conrady CD, 2010, J NEUROIMMUNOL, V220, P1, DOI 10.1016/j.jneuroim.2009.09.013; Deng YY, 2009, GLIA, V57, P604, DOI 10.1002/glia.20790; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Getts DR, 2008, J EXP MED, V205, P2319, DOI 10.1084/jem.20080421; Hickman SE, 2010, CNS NEUROL DISORD-DR, V9, P168, DOI 10.2174/187152710791011982; Howe CL, 2012, SCI REP-UK, V2, DOI 10.1038/srep00545; Hu SX, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-123; Iijima N, 2011, P NATL ACAD SCI USA, V108, P284, DOI 10.1073/pnas.1005201108; Inose Y, 2015, NEUROPATHOLOGY, V35, P209, DOI 10.1111/neup.12182; Jia T, 2008, J IMMUNOL, V180, P6846, DOI 10.4049/jimmunol.180.10.6846; Kaewpoowat Q, 2016, INFECTION, V44, P337, DOI 10.1007/s15010-015-0867-6; Lampron A, 2012, CELL TRANSPLANT, V21, P1149, DOI 10.3727/096368911X593154; Lim JK, 2011, J IMMUNOL, V186, P471, DOI 10.4049/jimmunol.1003003; Luhmann UFO, 2012, ADV EXP MED BIOL, V723, P17, DOI 10.1007/978-1-4614-0631-0_3; Lundberg P, 2008, J VIROL, V82, P7078, DOI 10.1128/JVI.00619-08; Marques CP, 2006, VIRUS RES, V121, P1, DOI 10.1016/j.virusres.2006.03.009; Mathur M, 2014, HAND CLINIC, V123, P149, DOI 10.1016/B978-0-444-53488-0.00006-7; McMillin M, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-121; Menasria R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145773; Mildner A, 2011, J NEUROSCI, V31, P11159, DOI 10.1523/JNEUROSCI.6209-10.2011; Mildner A, 2009, BRAIN, V132, P2487, DOI 10.1093/brain/awp144; Naert G, 2013, J MOL CELL BIOL, V5, P284, DOI 10.1093/jmcb/mjt028; O'Connor T, 2015, ENDOCR METAB IMMUNE, V15, P105, DOI 10.2174/1871530315666150316120920; Piret J, 2015, REV MED VIROL, V25, P300, DOI 10.1002/rmv.1848; Prinz M, 2011, NAT NEUROSCI, V14, P1227, DOI 10.1038/nn.2923; Prinz M, 2010, J NEUROIMMUNOL, V224, P80, DOI 10.1016/j.jneuroim.2010.05.015; Raber J, 2013, BEHAV BRAIN RES, V246, P69, DOI 10.1016/j.bbr.2013.03.003; Rebenko-Moll NM, 2006, CURR OPIN IMMUNOL, V18, P683, DOI 10.1016/j.coi.2006.09.005; Riancho J, 2013, NEUROL SCI, V34, P1879, DOI 10.1007/s10072-013-1475-9; Rozenberg Flore, 2011, Infectious Disorders - Drug Targets, V11, P235; Saederup N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013693; Savarin C, 2010, J VIROL, V84, P4878, DOI 10.1128/JVI.00051-10; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Sergerie Y, 2007, J INFECT DIS, V195, P817, DOI 10.1086/511987; Sheahan T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000240; Shechter R, 2013, IMMUNITY, V38, P555, DOI 10.1016/j.immuni.2013.02.012; Shechter R, 2013, NAT REV IMMUNOL, V13, P206, DOI 10.1038/nri3391; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Steiner I, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0414-8; Tacke F, 2006, IMMUNOBIOLOGY, V211, P609, DOI 10.1016/j.imbio.2006.05.025; Teixeira MM, 2010, J NEUROIMMUNOL, V224, P62, DOI 10.1016/j.jneuroim.2010.05.018; Terry RL, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-270; Trujillo JA, 2013, J VIROL, V87, P2376, DOI 10.1128/JVI.03089-12; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Tuppeny M, 2013, CRIT CARE NURS CLIN, V25, P363, DOI 10.1016/j.ccell.2013.04.003; Vilela MC, 2008, NEUROSCI LETT, V445, P18, DOI 10.1016/j.neulet.2008.08.072; Vilela MC, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-19; Whitley RJ, 2006, ANTIVIR RES, V71, P141, DOI 10.1016/j.antiviral.2006.04.002; Wickham S, 2005, J NEUROIMMUNOL, V162, P51, DOI 10.1016/j.jneuroim.2005.01.001; Wuest TR, 2008, FRONT BIOSCI-LANDMRK, V13, P4862, DOI 10.2741/3045; Yao Y, 2014, INT J BIOCHEM CELL B, V55, P51, DOI 10.1016/j.biocel.2014.08.002; Zhang J, 2007, J NEUROSCI, V27, P12396, DOI 10.1523/JNEUROSCI.3016-07.2007	60	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0168034	10.1371/journal.pone.0168034	http://dx.doi.org/10.1371/journal.pone.0168034			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930721	gold, Green Published, Green Submitted			2022-12-26	WOS:000389580900072
J	Patton, TG; Blamer, SL; Horak, KE				Patton, Toni G.; Blamer, Stephen L.; Horak, Katherine E.			Detecting Methemoglobinemia in Animals with a Drop of Blood	PLOS ONE			English	Article							NITRITE-INDUCED METHEMOGLOBINEMIA; ACUTE ORAL TOXICITY; P-AMINOPROPIOPHENONE; BEDSIDE TEST; HUMANE RODENTICIDES; SODIUM-NITRITE; OXYHEMOGLOBIN; INVASIONS; RAT	A major concern during pesticide development and use is the impact on non-target species, such as raptors or domestic cats and dogs. Sodium nitrite and para-aminopropiophenone (PAPP) are two toxicants currently being studied for the control of invasive species, such as starlings and feral swine. When given to an animal these compounds oxidize hemoglobin, which renders it unable to carry oxygen resulting in methemoglobinemia. This study developed a method to estimate methemoglobin levels in mammals and birds by examining the efficacy of sodium nitrite to induce the conversion of hemoglobin to methemoglobin. Varying concentrations of sodium nitrite were added to aliquots of coyote, vole, feral swine, starling, and duck blood, collected from captive animals. The blood samples were analyzed spectrophotometrically to determine percent methemoglobin and digitally to determine red color values (RCV) associated with different methemoglobin levels. The avian and mammalian blood reached 100% methemoglobin levels at 200 mM and 15 mM sodium nitrite, respectively. All animals had similar RCV for a given percent methemoglobin. In conclusion, this study developed a procedure to quickly determine methemoglobin levels in mammals and birds. Furthermore, percent methemoglobin can be estimated with one standard curve from any animal species and an image of a blood spot. The technique will be useful during field studies, in agricultural areas, or in a veterinarian's office for the rapid diagnosis of methemoglobinemia in non-target animals that have eaten toxicants/baits or baited animals.	[Patton, Toni G.; Horak, Katherine E.] USDA, Fertil Control Project 1, Natl Wildlife Res Ctr, Anim & Plant Hlth Inspect Serv, Ft Collins, CO 80524 USA; [Blamer, Stephen L.] USDA, Chem Lab Unit 2, Natl Wildlife Res Ctr, Anim & Plant Hlth Inspect Serv, Ft Collins, CO USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Horak, KE (corresponding author), USDA, Fertil Control Project 1, Natl Wildlife Res Ctr, Anim & Plant Hlth Inspect Serv, Ft Collins, CO 80524 USA.	Katherine.E.Horak@aphis.usda.gov						Ajloo D, 2002, ACTA BIOCHIM POL, V49, P459; Blackie HM, 2014, PEST MANAG SCI, V70, P345, DOI 10.1002/ps.3627; BRUNINGFANN CS, 1993, VET HUM TOXICOL, V35, P237; Conole D, 2014, BIOORGAN MED CHEM, V22, P2220, DOI 10.1016/j.bmc.2014.02.013; Courchamp F, 2003, BIOL REV, V78, P347, DOI 10.1017/S1464793102006061; DEFEO FG, 1972, J MED CHEM, V15, P1185, DOI 10.1021/jm00281a027; Eason CT, 2010, INT J PEST MANAGE, V56, P109, DOI 10.1080/09670870903243463; Eason CT, 2002, ECOTOXICOLOGY, V11, P35, DOI 10.1023/A:1013793029831; Elliott JE, 2013, ENV MONIT ASSESS; Evelyn KA, 1938, J BIOL CHEM, V126, P655; Fisher P, 2008, J WILDLIFE DIS, V44, P655, DOI 10.7589/0090-3558-44.3.655; Fisher P, 2007, WILDLIFE RES, V34, P19, DOI 10.1071/WR06125; Fisher PM, 2005, NEW ZEAL J ZOOL, V32, P163, DOI 10.1080/03014223.2005.9518409; Hulse E, 2016, CLIN TOXICOL, V54, P826, DOI 10.1080/15563650.2016.1217421; IMAIZUMI K, 1980, INT ARCH OCC ENV HEA, V45, P97, DOI 10.1007/BF01274129; Kohn MC, 2002, DRUG METAB DISPOS, V30, P676, DOI 10.1124/dmd.30.6.676; KOSAKA H, 1979, BIOCHIM BIOPHYS ACTA, V581, P184, DOI 10.1016/0005-2795(79)90235-6; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Marks CA, 2004, ANIM WELFARE, V13, P401; Martinez-Haro M, 2008, VET J, V176, P405, DOI 10.1016/j.tvjl.2007.02.021; PAN HP, 1983, GEN PHARMACOL, V14, P465, DOI 10.1016/0306-3623(83)90032-0; Pejchar L, 2009, TRENDS ECOL EVOL, V24, P497, DOI 10.1016/j.tree.2009.03.016; Rennison D, 2013, BIOORG MED CHEM LETT, V23, P6629, DOI 10.1016/j.bmcl.2013.10.046; Shihana F, 2016, B WORLD HEALTH ORGAN, V94, P622, DOI 10.2471/BLT.15.158147; Shihana F, 2016, CLIN TOXICOL, V54, P576, DOI 10.1080/15563650.2016.1177651; Shihana F, 2010, ANN EMERG MED, V55, P184, DOI 10.1016/j.annemergmed.2009.07.022; Simberloff D, 2013, TRENDS ECOL EVOL, V28, P58, DOI 10.1016/j.tree.2012.07.013; SMITH RP, 1967, BIOCHEM PHARMACOL, V16, P317, DOI 10.1016/0006-2952(67)90033-0; Titov VY, 2005, BIOCHEMISTRY-MOSCOW+, V70, P473, DOI 10.1007/s10541-005-0139-7; Umbreit J, 2007, AM J HEMATOL, V82, P134, DOI 10.1002/ajh.20738; Wright RO, 1999, ANN EMERG MED, V34, P646, DOI 10.1016/S0196-0644(99)70167-8; ZIJLSTRA WG, 1994, COMP BIOCHEM PHYS B, V107, P161, DOI 10.1016/0305-0491(94)90238-0	32	5	5	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167942	10.1371/journal.pone.0167942	http://dx.doi.org/10.1371/journal.pone.0167942			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930713	Green Published, gold, Green Submitted			2022-12-26	WOS:000389580900062
J	Yamamoto, W; Asakura, K; Ando, H; Taniguchi, T; Ojima, A; Uda, T; Osada, T; Hayashi, S; Kasai, C; Miyamoto, N; Tashibu, H; Yoshinaga, T; Yamazaki, D; Sugiyama, A; Kanda, Y; Sawada, K; Sekino, Y				Yamamoto, Wataru; Asakura, Keiichi; Ando, Hiroyuki; Taniguchi, Tomohiko; Ojima, Atsuko; Uda, Takaaki; Osada, Tomoharu; Hayashi, Seiji; Kasai, Chieko; Miyamoto, Norimasa; Tashibu, Hiroyuki; Yoshinaga, Takashi; Yamazaki, Daiju; Sugiyama, Atsushi; Kanda, Yasunari; Sawada, Kohei; Sekino, Yuko			Electrophysiological Characteristics of Human iPSC-Derived Cardiomyocytes for the Assessment of Drug-Induced Proarrhythmic Potential	PLOS ONE			English	Article							QT INTERVAL; CHROMANOL 293B; DE-POINTES; PROLONGATION; HEART; REPOLARIZATION	The aims of this study were to (1) characterize basic electrophysiological elements of human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) that correspond to clinical properties such as QT-RR relationship, (2) determine the applicability of QT correction and analysis methods, and (3) determine if and how these in-vitro parameters could be used in risk assessment for adverse drug-induced effects such as Torsades de pointes (TdP). Field potential recordings were obtained from commercially available hiPSC-CMs using multi-electrode array (MEA) platform with and without ion channel antagonists in the recording solution. Under control conditions, MEA-measured interspike interval and field potential duration (FPD) ranged widely from 1049 to 1635 ms and from 334 to 527 ms, respectively and provided positive linear regression coefficients similar to native QT-RR plots obtained from human electrocardiogram (ECG) analyses in the ongoing cardiovascular-based Framingham Heart Study. Similar to minimizing the effect of heart rate on the QT interval, Fridericia's and Bazett's corrections reduced the influence of beat rate on hiPSC-CM FPD. In the presence of E-4031 and cisapride, inhibitors of the rapid delayed rectifier potassium current, hiPSC-CMs showed reverse use-dependent FPD prolongation. Categorical analysis, which is usually applied to clinical QT studies, was applicable to hiPSC-CMs for evaluating torsadogenic risks with FPD and/or corrected FPD. Together, this results of this study links hiPSC-CM electrophysiological endpoints to native ECG endpoints, demonstrates the appropriateness of clinical analytical practices as applied to hiPSC-CMs, and suggests that hiPSC-CMs are a reliable models for assessing the arrhythmogenic potential of drug candidates in human.	[Yamamoto, Wataru; Asakura, Keiichi; Ando, Hiroyuki; Taniguchi, Tomohiko; Ojima, Atsuko; Uda, Takaaki; Osada, Tomoharu; Hayashi, Seiji; Kasai, Chieko; Miyamoto, Norimasa; Tashibu, Hiroyuki; Yoshinaga, Takashi; Yamazaki, Daiju; Sugiyama, Atsushi; Kanda, Yasunari; Sawada, Kohei; Sekino, Yuko] Japan iPS Cardiac Safety Assessment JiCSA, Setagaya Ku, Tokyo, Japan; [Asakura, Keiichi; Ando, Hiroyuki; Osada, Tomoharu; Hayashi, Seiji; Kasai, Chieko; Tashibu, Hiroyuki; Yoshinaga, Takashi; Sugiyama, Atsushi; Sawada, Kohei; Sekino, Yuko] Japanese Safety Pharmacol Soc, Setagaya Ku, Showa Machi, Maebashi, Gunma, Japan; [Yamamoto, Wataru] Teijin Pharma Ltd, Hino, Tokyo, Japan; [Asakura, Keiichi; Hayashi, Seiji] Nippon Shinyaku Co Ltd, Minami Ku, Nishinosho Monguchi Cho, Kyoto, Japan; [Ando, Hiroyuki; Uda, Takaaki] Ono Pharmaceut Co Ltd, Mikuni Cho, Sakai, Fukui, Japan; [Taniguchi, Tomohiko; Ojima, Atsuko; Miyamoto, Norimasa; Yoshinaga, Takashi; Sawada, Kohei] Eisai & Co Ltd, Tsukuba, Ibaraki, Japan; [Osada, Tomoharu] LSI Medience Corp, Chiyoda Ku, Uchikanda 1 Chome, Tokyo, Japan; [Kasai, Chieko] Astellas Pharma Inc, Tsukuba, Ibaraki, Japan; [Tashibu, Hiroyuki] Ina Res Inc, Ina, Nagano, Japan; [Sugiyama, Atsushi] Toho Univ, Dept Pharmacol, Fac Med, Ota Ku, Tokyo, Japan; [Yamazaki, Daiju; Kanda, Yasunari; Sekino, Yuko] Natl Inst Hlth Sci, Setagaya Ku, Tokyo, Japan	Teijin Pharma Limited; Nippon Shinyaku Co Ltd; Ono Pharmaceutical Co Ltd; Eisai Co Ltd; Astellas Pharmaceuticals; Ina Research Inc.; National Institute of Health Sciences - Japan	Yamamoto, W; Osada, T (corresponding author), Japan iPS Cardiac Safety Assessment JiCSA, Setagaya Ku, Tokyo, Japan.; Osada, T (corresponding author), Japanese Safety Pharmacol Soc, Setagaya Ku, Showa Machi, Maebashi, Gunma, Japan.; Yamamoto, W (corresponding author), Teijin Pharma Ltd, Hino, Tokyo, Japan.; Osada, T (corresponding author), LSI Medience Corp, Chiyoda Ku, Uchikanda 1 Chome, Tokyo, Japan.	w.yamamoto@teijin.co.jp; osada.tomoharu@mg.medience.co.jp	Kanda, Yasunari/AAD-7514-2019	Kanda, Yasunari/0000-0003-2527-3526	Ministry of Health Labour and Welfare (MLHW) [H24-lyaku-Shitei-030]; Research on Regulatory Harmonization and Evaluation of Pharmaceuticals, Medical Devices, Regenerative and Cellular Therapy Products, Gene Therapy Products, and Cosmetics from Japan Agency for Medical Research and development (AMED) [15mk0104053h0101, 16mk0104027j0002]; Teijin Pharma Limited; Nippon Shinyaku Co., Ltd; Ono Pharmaceutical Co., Ltd.; Eisai Co., Ltd; LSI Medience Corporation; Astellas Pharma Inc.; Ina Research Inc.	Ministry of Health Labour and Welfare (MLHW); Research on Regulatory Harmonization and Evaluation of Pharmaceuticals, Medical Devices, Regenerative and Cellular Therapy Products, Gene Therapy Products, and Cosmetics from Japan Agency for Medical Research and development (AMED)(Japan Agency for Medical Research and Development (AMED)); Teijin Pharma Limited(Teijin Pharma Limited); Nippon Shinyaku Co., Ltd(Nippon Shinyaku Co Ltd); Ono Pharmaceutical Co., Ltd.(Ono Pharmaceutical Co Ltd); Eisai Co., Ltd(Eisai Co Ltd); LSI Medience Corporation; Astellas Pharma Inc.(Astellas Pharmaceuticals); Ina Research Inc.	This research was supported by the Regulatory Science Research Grant from the Ministry of Health Labour and Welfare (MLHW) to YS (H24-lyaku-Shitei-030 from 2012 to 2014), and the Research on Regulatory Harmonization and Evaluation of Pharmaceuticals, Medical Devices, Regenerative and Cellular Therapy Products, Gene Therapy Products, and Cosmetics from Japan Agency for Medical Research and development (AMED) to YS (15mk0104053h0101 for 2015, 16mk0104027j0002 for 2016). The funding organizations (MLHW and AMED) did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Teijin Pharma Limited, Nippon Shinyaku Co., Ltd, Ono Pharmaceutical Co., Ltd., Eisai Co., Ltd, LSI Medience Corporation, Astellas Pharma Inc. and Ina Research Inc., provided support in the form of salaries for authors [Teijin Pharma Limited - WY, Nippon Shinyaku Co., Ltd - KA, SH, Ono Pharmaceutical Co., Ltd. -HA, TU, Eisai Co., Ltd - TT, AO, NM, TY, KS, LSI Medience Corporation - TO, Astellas Pharma Inc. - CK, Ina Research Inc. - HT], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakura K, 2015, J PHARMACOL TOX MET, V75, P17, DOI 10.1016/j.vascn.2015.04.002; Barandi L, 2010, BASIC RES CARDIOL, V105, P315, DOI 10.1007/s00395-009-0082-7; Bauer A, 2000, BASIC RES CARDIOL, V95, P324, DOI 10.1007/s003950070052; Bazett HC, 1920, HEART-J STUD CIRC, V7, P353; Benatar A, 2015, ANN NONINVAS ELECTRO, V20, P119, DOI 10.1111/anec.12200; Bosch RF, 1998, CARDIOVASC RES, V38, P441, DOI 10.1016/S0008-6363(98)00021-2; Cavero I, 2014, EXPERT OPIN DRUG SAF, V13, P745, DOI 10.1517/14740338.2014.915311; Clements M, 2014, TOXICOL SCI, V140, P445, DOI 10.1093/toxsci/kfu084; Fridericia L, 1920, ACTA MED SCAND, V57, P469, DOI DOI 10.1111/J.0954-6820.1920.TB18266.X; Gilchrist KH, 2015, TOXICOL APPL PHARM, V288, P249, DOI 10.1016/j.taap.2015.07.024; Gilmour RF, 1997, J AM COLL CARDIOL, V30, P209, DOI 10.1016/S0735-1097(97)00105-8; Gintant GA, 2001, J CARDIOVASC PHARM, V37, P607, DOI 10.1097/00005344-200105000-00012; Harris K, 2013, TOXICOL SCI, V134, P412, DOI 10.1093/toxsci/kft113; ICH. International Conference on Harmonisation, 2005, FED REGISTER, V70, P61134; KARJALAINEN J, 1994, J AM COLL CARDIOL, V23, P1547, DOI 10.1016/0735-1097(94)90654-8; Kitaguchi T, 2016, J PHARMACOL TOX MET, V78, P93, DOI 10.1016/j.vascn.2015.12.002; Naitoh N, 1998, JPN HEART J, V39, P457; Nakamura Y, 2014, J PHARMACOL SCI, V124, P494, DOI 10.1254/jphs.13248FP; Okada Y, 1996, J AM COLL CARDIOL, V27, P84, DOI 10.1016/0735-1097(95)00424-6; Puisieux FL, 1996, BRIT J PHARMACOL, V117, P1377, DOI 10.1111/j.1476-5381.1996.tb15295.x; Sager PT, 2014, AM HEART J, V167, P292, DOI 10.1016/j.ahj.2013.11.004; SAGIE A, 1992, AM J CARDIOL, V70, P797, DOI 10.1016/0002-9149(92)90562-D; Sides GD, 2002, DIS MARKERS, V18, P57, DOI 10.1155/2002/482953; Spira ME, 2013, NAT NANOTECHNOL, V8, P83, DOI [10.1038/nnano.2012.265, 10.1038/NNANO.2012.265]; Sugrue A, 2015, CARDIOVASC DRUG THER, V29, P433, DOI 10.1007/s10557-015-6619-0	25	48	49	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2016	11	12							e0167348	10.1371/journal.pone.0167348	http://dx.doi.org/10.1371/journal.pone.0167348			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4MY	27923051	Green Published, gold, Green Submitted			2022-12-26	WOS:000389577900003
J	Wu, RD; Tang, S; Wang, M; Xu, XD; Yao, C; Wang, SM				Wu, Ridong; Tang, Shi; Wang, Mian; Xu, Xiangdong; Yao, Chen; Wang, Shenming			MicroRNA-497 Induces Apoptosis and Suppresses Proliferation via the Bcl-2/Bax-Caspase9-Caspase3 Pathway and Cyclin D2 Protein in HUVECs	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; BREAST-CANCER; OX-LDL; ATHEROSCLEROSIS; EXPRESSION; CASPASE-3	Introduction MicroRNAs play crucial roles in various types of diseases. However, to date, no information about the role of miR-497 in the development of atherosclerosis has been reported. This study investigated the possible role of miR-497 in vascular endothelial cell injury during the early stage of atherosclerosis. Materials and Methods The expression level of miR-497 in human umbilical vein endothelial cells (HUVECs) exposed to ox-LDL was detected using qRT-PCR. To perform gain of function and loss of function analyses, miR-497 mimics were transfected into HUVECs, and miR-497 inhibitors were transfected into HUVECs stimulated with ox-LDL. Flow cytometry was used to analyze cell cycle progression and apoptosis. EdU and CCK-8 assays were employed to detect DNA synthesis and cell proliferation, respectively. After bioinformatics prediction, a dual Luciferase Reporter assay was used to analyze the direct target genes of miR-497. The mRNA and protein levels of the target genes were detected using qRT-PCR and western blot analyses, respectively. Caspase-9/3 activity was analyzed to determine the mechanism of endothelial dysfunction. Results We showed that miR-497 was significantly upregulated in HUVECs stimulated with ox-LDL. Ectopic expression of miR-497 suppressed cell proliferation, induced apoptosis and increased the activity of caspase-9/3. After verification, Bcl2 and CCND2 were shown to be direct target genes of miR-497 in HUVECs. MiR-497 significantly suppressed cell proliferation by arresting the cell cycle through the CCND2 protein and induced apoptosis through the Bcl2/Bax-caspase9-caspase3 pathway. Conclusion Overall, our study shows that miR-497 might play a role in the development of atherosclerosis by inducing apoptosis and suppressing the proliferation of vascular endothelial cells. Therefore, miR-497 could be a potential therapeutic target for the treatment of atherosclerosis.	[Wu, Ridong; Wang, Mian; Xu, Xiangdong; Yao, Chen; Wang, Shenming] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Vasc Surg, Guangzhou, Guangdong, Peoples R China; [Tang, Shi] Dongguan Maternal & Children Hlth Hosp, Dept Breast Surg, Dongguan, Peoples R China	Sun Yat Sen University	Yao, C; Wang, SM (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Vasc Surg, Guangzhou, Guangdong, Peoples R China.	skywalker_chenyao@yahoo.com.cn; shenmingwang@hotmail.com						Cain K, 2002, BIOCHIMIE, V84, P203, DOI 10.1016/S0300-9084(02)01376-7; Caporali A, 2011, CIRCULATION, V123, P282, DOI 10.1161/CIRCULATIONAHA.110.952325; Chehrehasa F, 2009, J NEUROSCI METH, V177, P122, DOI 10.1016/j.jneumeth.2008.10.006; Chen K, 2012, BIOCHEM BIOPH RES CO, V427, P138, DOI 10.1016/j.bbrc.2012.09.026; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Dong Q, 2013, BRAZ J MED BIOL RES, V46, P765, DOI 10.1590/1414-431X20132733; Dong QC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010147; Fu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043204; Gui DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039824; Guo ST, 2012, ONCOGENE, DOI DOI 10.3892/ETM.2011.428; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Kaufmann SH, 2008, METHODS, V44, P262, DOI 10.1016/j.ymeth.2007.11.005; Li HY, 2013, CELL PHYSIOL BIOCHEM, V32, P1354, DOI 10.1159/000356574; Li L, 2012, LAB INVEST, V92, P571, DOI 10.1038/labinvest.2012.10; Lia D, 2010, J HYPERTENS, V28, P1646, DOI 10.1097/HJH.0b013e32833a4922; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Liuzzo G, 2001, Rays, V26, P221; Luo QF, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-95; Maiolino G, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/714653; Marsden VS, 2002, NATURE, V419, P634, DOI 10.1038/nature01101; McNutt MC, 2007, J BIOL CHEM, V282, P20799, DOI 10.1074/jbc.C700095200; Menghini R, 2009, CIRCULATION, V120, P1524, DOI 10.1161/CIRCULATIONAHA.109.864629; Mermelshtein A, 2005, BRIT J CANCER, V93, P338, DOI 10.1038/sj.bjc.6602709; Mudau M, 2012, CARDIOVASC J AFR, V23, DOI 10.5830/CVJA-2011-068; Olejarz W, 2013, EUR J CLIN INVEST; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Puissant C, 2013, J MAL VASC; Qin B, 2012, MOL BIOL REP, V39, P4509, DOI 10.1007/s11033-011-1241-0; Rahman M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026390; Rodriguez J, 1999, GENE DEV, V13, P3179, DOI 10.1101/gad.13.24.3179; Samson S, 2012, CHOLESTEROL, DOI 10.1155/2012/571846; Shan Z, 2013, CHINESE MED J-PEKING, V126, P515, DOI 10.3760/cma.j.issn.0366-6999.20122289; Shen L, 2012, EXP THER MED, V3, P475, DOI 10.3892/etm.2011.428; Sun XH, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0372-2; Tu YF, 2015, SCI REP-UK, V5, DOI 10.1038/srep13827; Vasa-Nicotera M, 2011, ATHEROSCLEROSIS, V217, P326, DOI 10.1016/j.atherosclerosis.2011.03.034; Vegran F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029058; Wang M, 2011, ARTERIOSCL THROM VAS, V31, P2046, DOI 10.1161/ATVBAHA.111.229559; Westhorpe CLV, 2012, EXP MOL PATHOL, V93, P220, DOI 10.1016/j.yexmp.2012.03.014; Zhang YF, 2013, INT J MOL SCI, V14, P22708, DOI 10.3390/ijms141122708; Zhou J, 2011, P NATL ACAD SCI USA, V108, P10355, DOI 10.1073/pnas.1107052108	41	62	75	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2016	11	12							e0167052	10.1371/journal.pone.0167052	http://dx.doi.org/10.1371/journal.pone.0167052			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4MR	27918592	gold, Green Submitted, Green Published			2022-12-26	WOS:000389577100007
J	Bai, X; Liu, Y				Bai, Xu; Liu, Yun			International Collaboration Patterns and Effecting Factors of Emerging Technologies	PLOS ONE			English	Article							NETWORK; VISUALIZATION; CHALLENGES; INNOVATION; COUNTRY	With the globalization of the world economy, international innovation collaboration has taken place all over the world. This study selects three emerging technologies (3D printing, big data and carbon nanotubes and graphene technology) among 20 countries as the research objects, using three patent-based indicators and network relationship analysis to reflect international collaboration patterns. Then we integrate empirical analyses to show effecting factors of international collaboration degrees by using panel data. The results indicate that while 3D printing technology is associated with a "balanced collaboration" mode, big data technology is more accurately described by a radial pattern, centered on the United States, and carbon nanotubes and graphene technology exhibits "small-world" characteristics in this respect. It also shows that the factors GDP per capita (GPC), R&D expenditure (RDE) and the export of global trade value (ETV) negatively affect the level of international collaboration. It could be useful for China and other developing countries to make international scientific and technological collaboration strategies and policies in the future.	[Bai, Xu; Liu, Yun] Beijing Inst Technol, Sch Management & Econ, Beijing, Peoples R China	Beijing Institute of Technology	Bai, X (corresponding author), Beijing Inst Technol, Sch Management & Econ, Beijing, Peoples R China.	bx0723@126.com						Axelsson R, 2013, AMBIO, V42, P215, DOI 10.1007/s13280-012-0376-0; Baccarelli E, 2016, IEEE NETWORK, V30, P54, DOI 10.1109/MNET.2016.7437025; Boekholt P, 2009, DRIVERS INT COLLABOR, V40; Boutellier R., 2008, MANAGING GLOBAL INNO; Bozeman B, 2013, J TECHNOL TRANSFER, V38, P1, DOI 10.1007/s10961-012-9281-8; Bridges DR, 2011, MED EDUC ONLINE, V16, DOI 10.3402/meo.v16i0.6035; Butun I, 2016, IEEE COMMUN MAG, V54, P47, DOI 10.1109/MCOM.2016.7452265; Castellani D, 2013, J INT BUS STUD, V44, P649, DOI 10.1057/jibs.2013.30; Chen YS, 2010, TECHNOL ANAL STRATEG, V22, P153, DOI 10.1080/09537320903498496; Cimoli M, 2009, GCG REV GLOBALIZATIO, V3; Cordeschi N, 2015, EMERGING RES CLOUD D, V122; De Prato G, 2012, INT J TECHNOL MANAGE, P2; Dunning JH, 2015, ECLECTIC PARADIGM: A FRAMEWORK FOR SYNTHESIZING AND COMPARING THEORIES OF INTERNATIONAL BUSINESS FROM DIFFERENT DISCIPLINES OR PERSPECTIVES, P111; Fernhaber SA, 2013, J BUS VENTURING, V28, P316, DOI 10.1016/j.jbusvent.2012.05.002; Freeman L C., 2012, VISUALIZING SOCIAL N; Frost TS, 2005, J INT BUS STUD, V36, P676, DOI 10.1057/palgrave.jibs.8400168; Gassler H, 2008, J TECHNOL TRANSFER, V33, P407, DOI 10.1007/s10961-007-9048-9; Gazni A, 2012, J AM SOC INF SCI TEC, V63, P323, DOI 10.1002/asi.21688; Goryawala M, 2015, BIOMED PHYS ENG EXPR, V1, DOI 10.1088/2057-1976/1/1/015001; Grieneisen ML, 2014, BIOSCIENCE, V64, P322, DOI 10.1093/biosci/biu035; Guan JC, 2016, RES POLICY, V45, P770, DOI 10.1016/j.respol.2016.01.003; Guan JC, 2013, TECHNOL FORECAST SOC, V80, P1271, DOI 10.1016/j.techfore.2012.11.013; Guellec D, 2000, ECON LETT, V69, P109, DOI 10.1016/S0165-1765(00)00265-2; Hennemann S, 2012, J INFORMETR, V6, P217, DOI 10.1016/j.joi.2011.12.002; Ito D., 2016, ASS POLICY PROMOTION, P51; Jayasinghe M, 2016, ACAD MANAGE J, V59, P658, DOI 10.5465/amj.2014.0478; Jones B., 2012, NESTA COMPENDIUM EVI; Kim YG, 2008, EXPERT SYST APPL, V34, P1804, DOI 10.1016/j.eswa.2007.01.033; Knack S, 1997, Q J ECON, V112, P1251, DOI 10.1162/003355300555475; Liu YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044459; Ma J, 2015, INT J TECHNOL MANAGE, V69, P210, DOI 10.1504/IJTM.2015.072972; Ma ZZ, 2009, TECHNOL FORECAST SOC, V76, P787, DOI 10.1016/j.techfore.2008.11.003; Mazor T, 2013, DIVERS DISTRIB, V19, P1380, DOI 10.1111/ddi.12095; Meijer I C., 2012, JOURNALISM, V8, P1; Mittal G, 2015, J IND ENG CHEM, V21, P11, DOI 10.1016/j.jiec.2014.03.022; Montobbio F, 2013, WORLD DEV, V44, P281, DOI 10.1016/j.worlddev.2012.11.017; Myers SA, 2014, WWW'14 COMPANION: PROCEEDINGS OF THE 23RD INTERNATIONAL CONFERENCE ON WORLD WIDE WEB, P493, DOI 10.1145/2567948.2576939; Narula R., 2014, GLOBALIZATION TECHNO; Nepelski D, 2015, TECHNOVATION, V35, P12, DOI 10.1016/j.technovation.2014.07.007; Peters B, 2011, 11002 ZEW CTR EUR EC, P11; Phaal R, 2011, TECHNOL FORECAST SOC, V78, P217, DOI 10.1016/j.techfore.2010.06.018; RAMSEY JB, 1969, J ROY STAT SOC B, V31, P350; Ruigrok W., 2013, LOGIC INT RESTRUCTUR; Santos M.E.R., 2013, INT J TECHNOLOGY MAN, V12, P89, DOI DOI 10.1386/tmsd.12.1.89_1; Schwab Klaus, 2015, 4 IND REVOLUTION WHA; Shapira P, 2015, GRAPHENE RES ENTERPR; Sun YC, 2016, IEEE ACCESS, V4, P766, DOI 10.1109/ACCESS.2016.2529723; Trench B, 2014, ROUT INT HANDB, P214; Trifilova A, 2013, CRIT PERSPECT INT BU, V9, P40, DOI 10.1108/17422041311299932; Tseng CY, 2009, TECHNOL FORECAST SOC, V76, P654, DOI 10.1016/j.techfore.2008.03.007; Vessuri H, 2013, CURR SOCIOL, P1; Wang CQ, 2012, INT BUS REV, V21, P425, DOI 10.1016/j.ibusrev.2011.05.004; Wang XF, 2014, J INFORMETR, V8, P854, DOI 10.1016/j.joi.2014.08.004; Wang YAD, 2013, INT BUS REV, V22, P1079, DOI 10.1016/j.ibusrev.2013.02.009; Wilson J, 2008, INFECT CONT HOSP EP, V29, P219, DOI 10.1086/527511; Wohlers T., 2014, 3D PRINTING ADDITIVE; Yoon B, 2010, TECHNOL ANAL STRATEG, V22, P377, DOI 10.1080/09537321003647438; Zheng J, 2014, SCIENTOMETRICS, V98, P683, DOI 10.1007/s11192-013-1081-x; Zheng J, 2012, SCIENTOMETRICS, V91, P65, DOI 10.1007/s11192-011-0529-0	59	22	23	9	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0167772	10.1371/journal.pone.0167772	http://dx.doi.org/10.1371/journal.pone.0167772			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3TF	27911926	gold, Green Published, Green Submitted			2022-12-26	WOS:000389520600052
J	de Vries, S; Gerrits, WJJ; Kabel, MA; Vasanthan, T; Zijlstra, RT				de Vries, Sonja; Gerrits, Walter J. J.; Kabel, Mirjam A.; Vasanthan, Thava; Zijlstra, Ruurd T.			beta-Glucans and Resistant Starch Alter the Fermentation of Recalcitrant Fibers in Growing Pigs	PLOS ONE			English	Article							DIETARY FIBER; NONSTARCH POLYSACCHARIDES; GASTROINTESTINAL IMPLICATIONS; ENDOGENOUS NITROGEN; OAT FRACTIONS; DIGESTIBILITY; ILEAL; WHEAT; APPARENT; PROTEIN	Interactions among dietary ingredients are often assumed non-existent when evaluating the nutritive value and health effects of dietary fiber. Specific fibers can distinctly affect digestive processes; therefore, digestibility and fermentability of the complete diet may depend on fiber types present. This study aimed to evaluate the effects of readily fermentable fibers (beta-lucans and resistant starch) on the degradation of feed ingredients containing more persistent, recalcitrant, fibers. Six semi-synthetic diets with recalcitrant fibers from rapeseed meal (pectic polysaccharides, xyloglucans, and cellulose) or corn distillers dried grain with solubles (DDGS; (glucurono) arabinoxylans and cellulose) with or without inclusion of beta-glucans (6%) or retrograded tapioca (40%) substituted for corn starch were formulated. Six ileal-cannulated pigs (BW 28 +/- 1.4 kg) were assigned to the diets according to a 6x6 Latin square. beta-glucan- extract increased apparent total tract digestibility (ATTD) of non-glucosyl polysaccharides (accounting for similar to 40% of the fiber-fraction) from rapeseed meal (6%-units, P<0.001), but did not affect non-glucosyl polysaccharides from DDGS. Retrograded tapioca reduced ATTD of non-glucosyl polysaccharides from rapeseed meal and DDGS (>10%units, P<0.001), indicating that the large amount of resistant starch entering the hindgut was preferentially degraded over recalcitrant fibers from rapeseed meal and DDGS, possibly related to reduced hindgut-retention time following the increased intestinal bulk. Fermentation of fiber sources was not only dependent on fiber characteristics, but also on the presence of other fibers in the diet. Hence, interactions in the gastrointestinal tract among fibrous feed ingredients should be considered when evaluating their nutritive value.	[de Vries, Sonja; Gerrits, Walter J. J.] Wageningen Univ, Anim Nutr Grp, Wageningen, Netherlands; [Kabel, Mirjam A.] Wageningen Univ, Food Chem Lab, Wageningen, Netherlands; [Vasanthan, Thava; Zijlstra, Ruurd T.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada	Wageningen University & Research; Wageningen University & Research; University of Alberta	de Vries, S (corresponding author), Wageningen Univ, Anim Nutr Grp, Wageningen, Netherlands.	sonja.devries@wur.nl	de Vries, Sonja/M-1211-2019; Kabel, Mirjam/M-1051-2016	de Vries, Sonja/0000-0002-3842-8411; Kabel, Mirjam/0000-0002-2787-7852	European Union; European Regional Development Fund; Ministry of Economic Affairs, Agriculture and Innovation; Pieken in the Delta; Municipality of Groningen; Province of Groningen; Dutch Carbohydrate Competence Center (CCC WP7) - Agrifirm Group; Duynie Holding; Nutreco Nederland B.V.; University of Alberta; Wageningen University	European Union(European Commission); European Regional Development Fund(European Commission); Ministry of Economic Affairs, Agriculture and Innovation; Pieken in the Delta; Municipality of Groningen; Province of Groningen; Dutch Carbohydrate Competence Center (CCC WP7) - Agrifirm Group; Duynie Holding; Nutreco Nederland B.V.; University of Alberta(University of Alberta); Wageningen University(European Commission)	This work was jointly financed by the European Union (europa.eu), European Regional Development Fund (ec.europa.eu/regional_policy/en/funding/erdf/) and The Ministry of Economic Affairs, Agriculture and Innovation (https://www.rijksoverheid.nl/ministeries/ministerie-van-economische-zaken), Pieken in the Delta (www.rvo.nl/subsidies-regelingen/pieken-de-delta), the Municipality of Groningen (https://gemeentegroningen.nl), the Province of Groningen (www.provinciegroningen.nl) as well as the Dutch Carbohydrate Competence Center (CCC WP7, www.cccresearch.nl), supported by Agrifirm Group (www.agrifirm.com), Duynie Holding (www.duynie.nl), Nutreco Nederland B.V. (www.nutreco.com), University of Alberta (https://ualberta.ca), and Wageningen University (www.wageningenur.nl). Except for the University of Alberta and Wageningen University, funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1994, APPL ENVIRON MICROB, V60, P1897; [Anonymous], 2004, NUTR REV, V62, P105; AOAC, 2005, OFF METH AN, V18th; Appeldoorn MM, 2010, J AGR FOOD CHEM, V58, P11294, DOI 10.1021/jf102849x; Bach Knudsen KE, BR J NUTR; Bartelt J, 2002, ARCH ANIM NUTR, V56, P93, DOI 10.1080/00039420214182; Beg QK, 2001, APPL MICROBIOL BIOT, V56, P326, DOI 10.1007/s002530100704; Buttriss JL, 2008, NUTR BULL, V33, P186, DOI 10.1111/j.1467-3010.2008.00705.x; Canibe N, 1997, ANIM FEED SCI TECH, V64, P293, DOI 10.1016/S0377-8401(96)01032-2; Chan HT, 2011, FOOD CHEM, V126, P1019, DOI 10.1016/j.foodchem.2010.11.113; Collins T, 2005, FEMS MICROBIOL REV, V29, P3, DOI 10.1016/j.femsre.2004.06.005; CVB, 2011, FEED TABL; da Silva CS, 2014, ANIMAL, V8, P1917, DOI 10.1017/S1751731114001840; de Vries S, 2014, J ANIM SCI, V92, P5496, DOI 10.2527/jas.2014-7596; de Vries S, 2014, POULTRY SCI, V93, P589, DOI 10.3382/ps.2013-03476; de Vries S, 2012, ANIM FEED SCI TECH, V178, P123, DOI 10.1016/j.anifeedsci.2012.10.004; DeVries JW, 2004, J AOAC INT, V87, P682; Elia M, 2007, EUR J CLIN NUTR, V61, pS40, DOI 10.1038/sj.ejcn.1602938; ENGLYST HN, 1994, ANALYST, V119, P1497, DOI 10.1039/an9941901497; ENGLYST HN, 1984, ANALYST, V109, P937, DOI 10.1039/an9840900937; FADEL JG, 1989, J NUTR, V119, P722, DOI 10.1093/jn/119.5.722; FADEL JG, 1988, CAN J ANIM SCI, V68, P891, DOI 10.4141/cjas88-098; Fledderus J, 2007, LIVEST SCI, V109, P89, DOI 10.1016/j.livsci.2007.01.086; GRAHAM H, 1989, J ANIM SCI, V67, P1293; Grala W, 1998, J ANIM SCI, V76, P557; Heijnen MLA, 1997, J NUTR, V127, P1828, DOI 10.1093/jn/127.9.1828; Huisman MMH, 2000, CARBOHYD POLYM, V43, P269, DOI 10.1016/S0144-8617(00)00154-5; ISO, 2009, 5983 ISO; Johansen HN, 1996, BRIT J NUTR, V75, P339, DOI 10.1079/BJN19960138; Johansen HN, 1997, J SCI FOOD AGR, V73, P81, DOI 10.1002/(SICI)1097-0010(199701)73:1&lt;81::AID-JSFA695&gt;3.0.CO;2-Z; Jonathan MC, 2013, CARBOHYD POLYM, V93, P232, DOI 10.1016/j.carbpol.2012.06.057; Jorgensen H, 1996, BRIT J NUTR, V75, P365, DOI 10.1079/BJN19960140; Kil DY, 2010, J ANIM SCI, V88, P2959, DOI 10.2527/jas.2009-2216; Kim Y, 2008, BIORESOURCE TECHNOL, V99, P5165, DOI 10.1016/j.biortech.2007.09.028; Knudsen KEB, 2000, J SCI FOOD AGR, V80, P1253, DOI 10.1002/1097-0010(200006)80:8&lt;1253::AID-JSFA632&gt;3.0.CO;2-0; KNUDSEN KEB, 1991, BRIT J NUTR, V65, P233, DOI 10.1079/BJN19910083; KNUDSEN KEB, 1991, BRIT J NUTR, V65, P217, DOI 10.1079/BJN19910082; Knudsen KEB, 1997, ANIM FEED SCI TECH, V67, P319, DOI 10.1016/S0377-8401(97)00009-6; Knudsen KEB, 2001, ANIM FEED SCI TECH, V90, P3, DOI 10.1016/S0377-8401(01)00193-6; Knudsen KEB, 2007, J SCI FOOD AGR, V87, P2399, DOI 10.1002/jsfa.2893; KOHLER T, 1990, J SCI FOOD AGR, V53, P465, DOI 10.1002/jsfa.2740530405; Kotb A R, 1972, Nutr Abstr Rev, V42, P813; MANTLE M, 1981, BIOCHEM J, V195, P267, DOI 10.1042/bj1950267; Martinez-Puig D, 2003, J NUTR, V133, P134, DOI 10.1093/jn/133.1.134; McDonald DE, 2001, BRIT J NUTR, V86, P487, DOI 10.1079/BJN2001416; MERRY RJ, 1983, BRIT J NUTR, V50, P701, DOI 10.1079/BJN19830142; Metzler-Zebeli BU, 2010, LIVEST SCI, V133, P95, DOI 10.1016/j.livsci.2010.06.033; Montagne L, 2003, ANIM FEED SCI TECH, V108, P95, DOI 10.1016/S0377-8401(03)00163-9; Montoya CA, 2016, NUTR REV, V74, P517, DOI 10.1093/nutrit/nuw014; Neidhardt FC, 1990, PHYSL BACTERIAL CELL; Nindjin C, 2011, CARBOHYD POLYM, V86, P1637, DOI 10.1016/j.carbpol.2011.06.076; Nugent AP, 2005, NUTR BULL, V30, P27, DOI 10.1111/j.1467-3010.2005.00481.x; Olfert E, 1993, GUID CAR US EXP AN; Owusu-Asiedu A, 2006, J ANIM SCI, V84, P843, DOI 10.2527/2006.844843x; Pustjens AM, 2014, IND CROP PROD, V58, P271, DOI 10.1016/j.indcrop.2014.04.036; Pustjens AM, 2013, CARBOHYD POLYM, V98, P1650, DOI 10.1016/j.carbpol.2013.07.059; Pustjens AM, 2012, J AGR FOOD CHEM, V60, P8257, DOI 10.1021/jf301160m; Richards JD, 2005, CAN J ANIM SCI, V85, P421, DOI 10.4141/A05-049; Sandstrom B, 1998, BR J NUTR, V80, P457; Slavin J, 2013, NUTRIENTS, V5, P1417, DOI 10.3390/nu5041417; Theil PK, 2009, BR J NUTR, V102, P1590, DOI 10.1017/S0007114509980824; THIBAULT JF, 1979, LEBENSM WISS TECHNOL, V12, P247; Urriola PE, 2010, J ANIM SCI, V88, P2373, DOI 10.2527/jas.2009-2227; Widmer MR, 2007, J ANIM SCI, V85, P2994, DOI 10.2527/jas.2006-840; Wilfart A, 2007, BRIT J NUTR, V98, P54, DOI 10.1017/S0007114507682981; WILLIAMS CH, 1962, J AGR SCI, V59, P381, DOI 10.1017/S002185960001546X	66	22	22	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0167624	10.1371/journal.pone.0167624	http://dx.doi.org/10.1371/journal.pone.0167624			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3TF	27911928	Green Published, gold, Green Submitted			2022-12-26	WOS:000389520600048
J	Klein, M; Teixeira, S; Assis, J; Serrao, EA; Goncalves, EJ; Borges, R				Klein, Maria; Teixeira, Sara; Assis, Jorge; Serrao, Ester A.; Goncalves, Emanuel J.; Borges, Rita			High Interannual Variability in Connectivity and Genetic Pool of a Temperate Clingfish Matches Oceanographic Transport Predictions	PLOS ONE			English	Article							CORAL-REEF FISH; MICROSATELLITE NULL ALLELES; PELAGIC LARVAL DURATION; SELF-RECRUITMENT; POPULATION CONNECTIVITY; MARINE POPULATIONS; PARENTAGE ANALYSIS; LEPADOGASTER-LEPADOGASTER; ASSIGNMENT METHODS; TELL US	Adults of most marine benthic and demersal fish are site-attached, with the dispersal of their larval stages ensuring connectivity among populations. In this study we aimed to infer spatial and temporal variation in population connectivity and dispersal of a marine fish species, using genetic tools and comparing these with oceanographic transport. We focused on an intertidal rocky reef fish species, the shore clingfish Lepadogaster lepadogaster, along the southwest Iberian Peninsula, in 2011 and 2012. We predicted high levels of self-recruitment and distinct populations, due to short pelagic larval duration and because all its developmental stages have previously been found near adult habitats. Genetic analyses based on microsatellites countered our prediction and a biophysical dispersal model showed that oceanographic transport was a good explanation for the patterns observed. Adult sub-populations separated by up to 300 km of coastline displayed no genetic differentiation, revealing a single connected population with larvae potentially dispersing long distances over hundreds of km. Despite this, parentage analysis performed on recruits from one focal site within the Marine Park of Arrabida (Portugal), revealed self-recruitment levels of 2.5% and 7.7% in 2011 and 2012, respectively, suggesting that both long-and short-distance dispersal play an important role in the replenishment of these populations. Population differentiation and patterns of dispersal, which were highly variable between years, could be linked to the variability inherent in local oceanographic processes. Overall, our measures of connectivity based on genetic and oceanographic data highlight the relevance of long-distance dispersal in determining the degree of connectivity, even in species with short pelagic larval durations.	[Klein, Maria; Teixeira, Sara; Assis, Jorge; Serrao, Ester A.; Borges, Rita] Univ Algarve, CCMAR Ctr Marine Sci, Campus Gambelas, P-8005 ~139 Faro, Portugal; [Klein, Maria; Goncalves, Emanuel J.; Borges, Rita] ISPA Inst Univ, MARE Marine & Environm Sci Ctr, R Jardim do Tabaco 34, P-1149 ~041 Lisbon, Portugal	Universidade do Algarve; Instituto Superior Psicologia Aplicada (ISPA)	Borges, R (corresponding author), Univ Algarve, CCMAR Ctr Marine Sci, Campus Gambelas, P-8005 ~139 Faro, Portugal.; Borges, R (corresponding author), ISPA Inst Univ, MARE Marine & Environm Sci Ctr, R Jardim do Tabaco 34, P-1149 ~041 Lisbon, Portugal.	rborges@ispa.pt	Serrao, Ester A/C-6686-2012; Assis, Jorge/AAC-6524-2019; Klein, Maria/M-4170-2013	Serrao, Ester A/0000-0003-1316-658X; Assis, Jorge/0000-0002-6624-4820; Goncalves, Emanuel/0000-0002-3918-6215; Borges, Rita/0000-0001-6887-6605; Klein, Maria/0000-0003-0818-7191	Portuguese Foundation for Science and Technology (FCT) [SFRH/BD/72970/2010]; FCT project [EXPL/MAR-PRO/0933/2013, EXCL/AAG-GLO/0661/2012, SFRH/BPD/111003/2015]; FCT postdoctoral fellowship [SFRH/ BPD / 23743 / 2005]; FCT [PTDC/MAR/115226/2009, CCMAR/Multi/04326/2013, PEst-OE/MAR/U10331/2011, UID/MAR/04292/2013]; Fundação para a Ciência e a Tecnologia [EXPL/MAR-PRO/0933/2013, PTDC/MAR/115226/2009] Funding Source: FCT	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); FCT project(Portuguese Foundation for Science and Technology); FCT postdoctoral fellowship(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundação para a Ciência e a Tecnologia	MK was supported by a PhD grant (SFRH/BD/72970/2010) from the Portuguese Foundation for Science and Technology (FCT). ST was supported by the FCT project EXPL/MAR-PRO/0933/2013. JA was supported by the FCT project EXCL/AAG-GLO/0661/2012 and a postdoctoral fellowship SFRH/BPD/111003/2015. RB was supported by a FCT postdoctoral fellowship (SFRH/ BPD / 23743 / 2005). Field and lab work were financed by the following FCT funded projects: Matrix (PTDC/MAR/115226/2009), CCMAR/Multi/04326/2013, and PEst-OE/MAR/U10331/2011 and UID/MAR/04292/2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberto F., 2006, STANDARICH V1 00 R P; [Anonymous], 2009, R LANG ENV STAT COMP; [Anonymous], 1996, 5000 CNRS UMR; [Anonymous], 2015, OC DAT; Assis J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128124; Assis J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068646; Beldade R, 2007, J FISH BIOL, V71, P376, DOI 10.1111/j.1095-8649.2007.01491.x; Beldade R, 2006, J MAR BIOL ASSOC UK, V86, P1221, DOI 10.1017/S0025315406014226; Beldade R, 2012, P ROY SOC B-BIOL SCI, V279, P2116, DOI 10.1098/rspb.2011.2433; Beldade R, 2006, J PLANKTON RES, V28, P1003, DOI 10.1093/plankt/fbl035; BLAXTER JHS, 1986, T AM FISH SOC, V115, P98; Borges R, 2007, MAR BIOL, V151, P1349, DOI 10.1007/s00227-006-0574-z; Borges R, 2007, ESTUAR COAST SHELF S, V71, P412, DOI 10.1016/j.ecss.2006.08.020; Botsford LW, 2009, CORAL REEFS, V28, P327, DOI 10.1007/s00338-009-0466-z; Burgess SC, 2014, ECOL APPL, V24, P257, DOI 10.1890/13-0710.1; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Chassignet EP, 2007, J MARINE SYST, V65, P60, DOI 10.1016/j.jmarsys.2005.09.016; Christie MR, 2010, MOL ECOL, V19, P1042, DOI 10.1111/j.1365-294X.2010.04524.x; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Dakin EE, 2004, HEREDITY, V93, P504, DOI 10.1038/sj.hdy.6800545; Earl DA, 2011, CONSERV GENET RESOUR, V4, P359, DOI DOI 10.1007/S12686-011-9548-7; Eckert GL, 2003, ECOLOGY, V84, P372, DOI 10.1890/0012-9658(2003)084[0372:EOTPPO]2.0.CO;2; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Faria AM, 2010, MAR ECOL PROG SER, V414, P237, DOI 10.3354/meps08692; Felix-Hackradt FC, 2013, MAR ENVIRON RES, V92, P23, DOI 10.1016/j.marenvres.2013.08.008; Fisher R, 2005, MAR ECOL PROG SER, V285, P223, DOI 10.3354/meps285223; Fontes J, 2009, MAR ECOL PROG SER, V387, P51, DOI 10.3354/meps08116; Fossette S, 2012, MAR ECOL PROG SER, V457, P285, DOI 10.3354/meps09581; Galarza JA, 2009, P NATL ACAD SCI USA, V106, P1473, DOI 10.1073/pnas.0806804106; Gawarkiewicz G, 2007, OCEANOGRAPHY, V20, P40, DOI 10.5670/oceanog.2007.28; Gerlach G, 2007, P NATL ACAD SCI USA, V104, P858, DOI 10.1073/pnas.0606777104; Gerlach G, 2010, MOL ECOL, V19, P3845, DOI 10.1111/j.1365-294X.2010.04784.x; Goncalves DM, 1998, J FISH BIOL, V53, P447, DOI 10.1111/j.1095-8649.1998.tb00992.x; HEDGECOCK D, 1994, CAL COOP OCEAN FISH, V35, P73; Henriques M, 2002, BIOL J LINN SOC, V76, P327, DOI 10.1111/j.1095-8312.2002.tb01700.x; Hofrichter R., 1995, THESIS; Hogan JD, 2012, OECOLOGIA, V168, P61, DOI 10.1007/s00442-011-2058-1; Hogan JD, 2010, MAR ECOL PROG SER, V417, P263, DOI 10.3354/meps08793; Horne JB, 2011, MOL ECOL, V20, P2291, DOI 10.1111/j.1365-294X.2011.05097.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jenkins GP, 1999, MAR ECOL PROG SER, V184, P259, DOI 10.3354/meps184259; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jones AG, 2003, MOL ECOL, V12, P2511, DOI 10.1046/j.1365-294X.2003.01928.x; Jones DB, 2010, CORAL REEFS, V29, P455, DOI 10.1007/s00338-010-0591-8; Jones GP, 2005, CURR BIOL, V15, P1314, DOI 10.1016/j.cub.2005.06.061; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Keenan K, 2013, METHODS ECOL EVOL, V4, P782, DOI 10.1111/2041-210X.12067; Keough Michael J., 2007, P19; Kingsford MJ, 2002, B MAR SCI, V70, P309; Largier JL, 2003, ECOL APPL, V13, pS71; Leis JM, 2003, MAR ECOL PROG SER, V252, P239, DOI 10.3354/meps252239; Leis JM, 2011, OCEANOGRAPHY MARINE; Lett C, 2008, ENVIRON MODELL SOFTW, V23, P1210, DOI 10.1016/j.envsoft.2008.02.005; Lowe WH, 2010, MOL ECOL, V19, P3038, DOI 10.1111/j.1365-294X.2010.04688.x; Manel S, 2005, TRENDS ECOL EVOL, V20, P136, DOI 10.1016/j.tree.2004.12.004; MILLER TJ, 1988, CAN J FISH AQUAT SCI, V45, P1657, DOI 10.1139/f88-197; Nanninga GB, 2015, CORAL REEFS, V34, P383, DOI 10.1007/s00338-015-1266-2; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Palsboll PJ, 2007, TRENDS ECOL EVOL, V22, P11, DOI 10.1016/j.tree.2006.09.003; Paris CB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072808; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Pritchard JK, 2000, GENETICS, V155, P945; Purcell JFH, 2006, P ROY SOC B-BIOL SCI, V273, P1483, DOI 10.1098/rspb.2006.3470; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Raventos N, 2001, MAR BIOL, V138, P1115; Relvas P, 2007, PROG OCEANOGR, V74, P149, DOI 10.1016/j.pocean.2007.04.021; Roberts CM, 1997, SCIENCE, V278, P1454, DOI 10.1126/science.278.5342.1454; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Saenz-Agudelo P, 2009, MOL ECOL, V18, P1765, DOI 10.1111/j.1365-294X.2009.04109.x; Saenz-Agudelo P, 2012, MOL ECOL, V21, P4695, DOI 10.1111/j.1365-294X.2012.05726.x; Schunter C, 2011, MOL ECOL, V20, P5167, DOI 10.1111/j.1365-294X.2011.05355.x; Selkoe KA, 2006, ECOLOGY, V87, P3082, DOI 10.1890/0012-9658(2006)87[3082:CSAKAE]2.0.CO;2; Selkoe KA, 2010, MOL ECOL, V19, P3708, DOI 10.1111/j.1365-294X.2010.04658.x; Shanks AL, 2009, BIOL BULL-US, V216, P373; Siegel DA, 2008, P NATL ACAD SCI USA, V105, P8974, DOI 10.1073/pnas.0802544105; Siegel DA, 2003, MAR ECOL PROG SER, V260, P83, DOI 10.3354/meps260083; Silva G, 2014, J BIOGEOGR, V41, P1171, DOI 10.1111/jbi.12275; Simpson SD, 2014, PLOS ONE, DOI [10.1371/journal.pone.0107610ER, DOI 10.1371/JOURNAL.PONE.0107610ER]; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Swearer SE, 1999, NATURE, V402, P799, DOI 10.1038/45533; Swearer SE, 2010, MAR ECOL PROG SER, V417, P229, DOI 10.3354/meps08801; Taylor MS, 2003, SCIENCE, V299, P107, DOI 10.1126/science.1079365; Teixeira S, 2013, CONSERV GENET RESOUR, V5, P55, DOI 10.1007/s12686-012-9732-4; Thorrold SR, 2006, CAN J FISH AQUAT SCI, V63, P1193, DOI 10.1139/F06-048; Tojeira I, 2012, ENVIRON BIOL FISH, V93, P449, DOI 10.1007/s10641-011-9935-7; Underwood JN, 2012, ECOL EVOL, V2, P666, DOI 10.1002/ece3.80; Van Etten J, 2014, GDISTANCE DISTANCES; Wang JL, 2010, MOL ECOL, V19, P5061, DOI 10.1111/j.1365-294X.2010.04865.x; Wang JL, 2004, GENETICS, V166, P1963, DOI 10.1534/genetics.166.4.1963; Waser PM, 2011, MOL ECOL, V20, P1277, DOI 10.1111/j.1365-294X.2011.05002.x; Weersing K, 2009, MAR ECOL PROG SER, V393, P1, DOI 10.3354/meps08287; White C, 2010, P ROY SOC B-BIOL SCI, V277, P1685, DOI 10.1098/rspb.2009.2214; WILLIAMS DM, 1984, CORAL REEFS, V3, P229, DOI 10.1007/BF00288259	93	13	13	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0165881	10.1371/journal.pone.0165881	http://dx.doi.org/10.1371/journal.pone.0165881			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3TF	27911952	gold, Green Published			2022-12-26	WOS:000389520600004
J	Bentivenha, JPF; Paula-Moraes, SV; Baldin, ELL; Specht, A; da Silva, IF; Hunt, TE				Bentivenha, Jose P. F.; Paula-Moraes, Silvana V.; Baldin, Edson L. L.; Specht, Alexandre; da Silva, Ivana F.; Hunt, Thomas E.			Battle in the New World: Helicoverpa armigera versus Helicoverpa zea (Lepidoptera: Noctuidae)	PLOS ONE			English	Article							PUNCTIGERA WALLENGREN LEPIDOPTERA; HUBNER LEPIDOPTERA; HELIOTHIS-ZEA; RESISTANCE MANAGEMENT; PYRETHROID RESISTANCE; TRANSGENIC CORN; COTTON BOLLWORM; BT-COTTON; CANNIBALISM; AUSTRALIA	The corn earworm Helicoverpa zea (Boddie) and the old world bollworm Helicoverpa armigera (Hubner) (Lepidoptera: Noctuidae) are allopatric species and occur in important agricultural crops. In maize, both species tend to infest the ear. The introduction of H. armigera in Brazil has created a new scenario, where these Helicoverpa species might cohabit and interact with one another, affecting the prevalence of each species in the agroecosystem, integrated pest management, and insect resistance management. In this study, larval occurrence and proportion of these species in maize was assessed in three regions of Brazil during three crop seasons. Interaction between the species was evaluated in interspecific and intraspecific scenarios under laboratory and field conditions. Helicoverpa zea was predominant in Rio Grande do Sul and the Planaltina, DF (central Brazil). In western Bahia, H. zea was predominant in the first collection, but approximately equal in number to H armigera in the second crop season. Both species exhibit high cannibalism/predation rates, and larval size was the primary factor for larval survival in the interaction studies. Larva of H. zea had higher survival when interacting with H. armigera, indicating that H. zea has an advantage in intraguild interactions with H. armigera in maize. Overall, the results from this study indicate that maize might play a role as a source of infestation or a sink of insecticide or Bt protein unselected H. armigera populations, depending on the H. zea:H. armigera intraguild competition and adult movement in the landscape.	[Bentivenha, Jose P. F.] Univ Sao Paulo, Dept Entomol & Acarol, Luiz de Queiroz Coll Agr, Piracicaba, SP, Brazil; [Paula-Moraes, Silvana V.] Univ Florida, Dept Entomol & Nematol, WFREC, Jay, FL USA; [Baldin, Edson L. L.; da Silva, Ivana F.] Sao Paulo State Univ, Dept Crop Protect, Coll Agron Sci, Botucatu, SP, Brazil; [Specht, Alexandre] Embrapa Cerrados, Planaltina, DF, Brazil; [Hunt, Thomas E.] Univ Nebraska, Haskell Agr Lab, Concord, NE USA	Universidade de Sao Paulo; State University System of Florida; University of Florida; Universidade Estadual Paulista; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); University of Nebraska System	Bentivenha, JPF (corresponding author), Univ Sao Paulo, Dept Entomol & Acarol, Luiz de Queiroz Coll Agr, Piracicaba, SP, Brazil.	jpgfdsilva@gmail.com	Specht, Alexandre/G-6007-2012; Bentivenha, José Paulo Franco/G-4015-2017; da Silva, Ivana Fernandes IFS/C-4605-2017; Baldin, Edson L L/F-3009-2013; Specht, Alexandre/P-8435-2019	Specht, Alexandre/0000-0002-8921-0340; Bentivenha, José Paulo Franco/0000-0002-6524-4714; da Silva, Ivana Fernandes IFS/0000-0003-3533-5508; Specht, Alexandre/0000-0002-8921-0340	National Council for Scientific and Technological Development (CNPq) [403376/2013-0]; Embrapa Project, MP2 [02.13.14.606.00.00 / 02.13.14.606.00.02]; Coordination for the Improvement of Higher Education Personnel (CAPES) [99999.002564/2014-09]	National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Embrapa Project, MP2(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)); Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by the National Council for Scientific and Technological Development (CNPq: 403376/2013-0): AS, SVP; Embrapa Project, MP2 (PA: 02.13.14.606.00.00 / 02.13.14.606.00.02): AS, SVP; Coordination for the Improvement of Higher Education Personnel (CAPES: 99999.002564/2014-09): JPFB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, 28 C BRAS ENT 9 C LA; Bird LJ, 2007, J INVERTEBR PATHOL, V94, P84, DOI 10.1016/j.jip.2006.08.005; Burkness EC, 2012, J ECON ENTOMOL, V105, P1773, DOI 10.1603/EC12128; Burkness Eric C, 2010, GM Crops, V1, P337, DOI 10.4161/gmcr.1.5.14765; BUTLER GD, 1976, ENVIRON ENTOMOL, V5, P520, DOI 10.1093/ee/5.3.520; Carvalho RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062268; Chapman JW, 1999, BEHAV ECOL, V10, P298, DOI 10.1093/beheco/10.3.298; Chapman JW, 2000, BEHAV ECOL SOCIOBIOL, V48, P321, DOI 10.1007/s002650000237; Chapman JW, 1999, ECOL ENTOMOL, V24, P268, DOI 10.1046/j.1365-2311.1999.00224.x; Chilcutt CF, 2006, J ECON ENTOMOL, V99, P728, DOI 10.1603/0022-0493-99.3.728; Chilcutt CF, 2004, P NATL ACAD SCI USA, V101, P7526, DOI 10.1073/pnas.0400546101; Cho S, 2008, SYST ENTOMOL, V33, P581, DOI 10.1111/j.1365-3113.2008.00427.x; Cunningham JP, 2014, J ECON ENTOMOL, V107, P881, DOI 10.1603/EC14036; Czepak Cecília, 2013, Pesqui. Agropecu. Trop., V43, P110, DOI 10.1590/S1983-40632013000100015; DIAL CI, 1990, ANN ENTOMOL SOC AM, V83, P258, DOI 10.1093/aesa/83.2.258; Dorhout DL, 2010, J ECON ENTOMOL, V103, P54, DOI 10.1603/EC09247; Downes S, 2007, J INVERTEBR PATHOL, V95, P208, DOI 10.1016/j.jip.2007.03.010; Duffield SJ, 2001, AUST J ENTOMOL, V40, P151, DOI 10.1046/j.1440-6055.2001.00213.x; Embrapa, 2013, NOT TECN RES TRAB IN; FIREMPONG S, 1990, AUST J ZOOL, V37, P665, DOI 10.1071/ZO9890665; FITT GP, 1989, ANNU REV ENTOMOL, V34, P17, DOI 10.1146/annurev.en.34.010189.000313; FOX LR, 1975, ANNU REV ECOL SYST, V6, P87, DOI 10.1146/annurev.es.06.110175.000511; Murua MG, 2014, FLA ENTOMOL, V97, P854, DOI 10.1653/024.097.0279; Gouffon C, 2011, APPL ENVIRON MICROB, V77, P3182, DOI 10.1128/AEM.02791-10; Hardwick D. F., 1965, Mem ent Soc Canada Ottawa, Vno. 40, P1; HARDWICK DF, 1970, MEM ENTOMOL SOC CAN, P5; Hayden J. E, 2015, FDACS02039 DIV PLANT; Horner TA, 2003, J ECON ENTOMOL, V96, P914, DOI 10.1603/0022-0493-96.3.914; Hutchison W.D., 2007, PLANT HLTH PROGR; Jacobson A, 2009, J ECON ENTOMOL, V102, P2289, DOI 10.1603/029.102.0634; Jha RK, 2012, ENVIRON ENTOMOL, V41, P30, DOI 10.1603/EN11206; JOYNER K, 1985, ANN ENTOMOL SOC AM, V78, P24, DOI 10.1093/aesa/78.1.24; Kakimoto T, 2003, ANN ENTOMOL SOC AM, V96, P793, DOI 10.1603/0013-8746(2003)096[0793:ELPLDA]2.0.CO;2; Kao S. S, 1995, B TAIWAN AGR CHEM TO, V37, P1; Keszthelyi S, 2011, BIOLOGIA, V66, P340, DOI 10.2478/s11756-011-0013-6; Kitching IJ, 1998, HDB ZOOLOGY ARTHROPO, VIV, P355, DOI DOI 10.1515/9783110804744.355; Kranthi KR, 2001, J ECON ENTOMOL, V94, P253, DOI 10.1603/0022-0493-94.1.253; Kriticos DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119618; LASTER ML, 1995, J ECON ENTOMOL, V88, P1288, DOI 10.1093/jee/88.5.1288; LASTER ML, 1995, J ECON ENTOMOL, V88, P77, DOI 10.1093/jee/88.1.77; Liu ZD, 2004, APPL ENTOMOL ZOOL, V39, P373, DOI 10.1303/aez.2004.373; Luo SD, 2007, J ECON ENTOMOL, V100, P909, DOI 10.1603/0022-0493(2007)100[909:CSOCSO]2.0.CO;2; Luz PMC, 1809, OCORRENCIA PARASITOI; Mally F. W., 1892, Bull Dept Agric Ent, Vxxvi, P45; Matthews M, 1991, 44 NAT RES I; Matthews M, 1999, HELIOTHINE MOTHS AUS; Mironidis GK, 2008, ENVIRON ENTOMOL, V37, P16, DOI 10.1603/0046-225X(2008)37[16:DSAROH]2.0.CO;2; MITTER C, 1993, ANNU REV ENTOMOL, V38, P207, DOI 10.1146/annurev.en.38.010193.001231; Montezano DG, 2013, AN ACAD BRAS CIENC, V85, P271, DOI 10.1590/S0001-37652013000100013; Barbosa TAN, 2016, FLA ENTOMOL, V99, P72, DOI 10.1653/024.099.0113; Pannuti LER, 2016, ENVIRON ENTOMOL, V45, P192, DOI 10.1093/ee/nvv159; Paula-Moraes S, 2013, J ECON ENTOMOL, V106, P1274, DOI 10.1603/EC12436; Paula-Moraes SV, 2012, ENVIRON ENTOMOL, V41, P1494, DOI 10.1603/EN12149; Perkins LE, 2008, ARTHROPOD-PLANT INTE, V2, P197, DOI 10.1007/s11829-008-9047-2; PFENNIG DW, 1993, ANIM BEHAV, V46, P87, DOI 10.1006/anbe.1993.1164; Pierce Naomi E., 1995, Journal of the Lepidopterists' Society, V49, P412; Pimentel D., 2002, BIOL INVASIONS EC EN; Pogue MG, 2004, ANN ENTOMOL SOC AM, V97, P1222, DOI 10.1603/0013-8746(2004)097[1222:ANSOHZ]2.0.CO;2; POLIS GA, 1981, ANNU REV ECOL SYST, V12, P225, DOI 10.1146/annurev.es.12.110181.001301; Pratissoli D, 2015, HORTIC BRAS, V33, P101, DOI 10.1590/S0102-053620150000100016; Reisig DD, 2015, ENVIRON ENTOMOL, V44, P1275, DOI 10.1093/ee/nvv076; Ritchie S.W., 1993, IOWA STATE U COOPERA, V48, P21; Rudolf VHW, 2007, P R SOC B, V274, P1205, DOI 10.1098/rspb.2006.0449; SAS Institute, 2001, SAS STAT US GGGUID V; Sharma H. C., 2001, CROP PROTECTION COMP; Siebert MW, 2012, J ECON ENTOMOL, V105, P1825, DOI 10.1603/EC12155; Sosa-Gomez DR, 2016, REV BRAS ENTOMOL, V60, P101, DOI 10.1016/j.rbe.2015.09.008; Specht A, 2013, PESQUI AGROPECU BRAS, V48, P689, DOI 10.1590/S0100-204X2013000600015; Torres-Vila LM, 2002, AGR ECOSYST ENVIRON, V93, P55, DOI 10.1016/S0167-8809(02)00003-8; Yang YH, 2013, J ECON ENTOMOL, V106, P375, DOI 10.1603/EC12286; ZALUCKI MP, 1986, AUST J ZOOL, V34, P779, DOI 10.1071/ZO9860779; Zalucki MP, 2002, ANNU REV ENTOMOL, V47, P361, DOI 10.1146/annurev.ento.47.091201.145220; Zhao XC, 2010, CHEM SENSES, V35, P511, DOI 10.1093/chemse/bjq043	73	22	23	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167182	10.1371/journal.pone.0167182	http://dx.doi.org/10.1371/journal.pone.0167182			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907051	Green Published, Green Submitted, gold			2022-12-26	WOS:000389482700088
J	Fischer, A; Onur, S; Niklowitz, P; Menke, T; Laudes, M; Rimbach, G; Doring, F				Fischer, Alexandra; Onur, Simone; Niklowitz, Petra; Menke, Thomas; Laudes, Matthias; Rimbach, Gerald; Doering, Frank			Coenzyme Q(10) Status as a Determinant of Muscular Strength in Two Independent Cohorts	PLOS ONE			English	Article							SKELETAL-MUSCLE STRENGTH; BODY-MASS INDEX; GENE-EXPRESSION; PHYSICAL-DISABILITY; LIFELONG EXERCISE; OXIDATIVE DAMAGE; GRIP STRENGTH; SARCOPENIA; MEN; SUPPLEMENTATION	Aging is associated with sarcopenia, which is a loss of skeletal muscle mass and function. Coenzyme Q(10) (CoQ(10)) is involved in several important functions that are related to bioenergetics and protection against oxidative damage; however, the role of CoQ(10) as a determinant of muscular strength is not well documented. The aim of the present study was to evaluate the determinants of muscular strength by examining hand grip force in relation to CoQ(10) status, gender, age and body mass index (BMI) in two independent cohorts (n = 334, n = 967). Furthermore, peak flow as a function of respiratory muscle force was assessed. Spearman's correlation revealed a significant positive association between CoQ(10)/cholesterol level and hand grip in the basic study population (p<0.01) as well as in the validation population (p<0.001). In the latter, we also found a negative correlation with the CoQ(10) redox state (p<0.01), which represents a lower percentage of the reduced form of CoQ10 (ubiquinol) in subjects who exhibit a lower muscular strength. Furthermore, the age of the subjects showed a negative correlation with hand grip (p<0.001), whereas BMI was positively correlated with hand grip (p<0.01), although only in the normal weight subgroup (BMI <25 kg/m(2)). Analysis of the covariance (ANCOVA) with hand grip as the dependent variable revealed CoQ(10)/cholesterol as a determinant of muscular strength and gender as the strongest effector of hand grip. In conclusion, our data suggest that both a low CoQ(10)/cholesterol level and a low percentage of the reduced form of CoQ(10) could be an indicator of an increased risk of sarcopenia in humans due to their negative associations to upper body muscle strength, peak flow and muscle mass.	[Fischer, Alexandra; Onur, Simone; Doering, Frank] Christian Albrechts Univ Kiel, Inst Human Nutr & Food Sci, Dept Mol Prevent, Kiel, Germany; [Niklowitz, Petra; Menke, Thomas] Univ Witten Herdecke, Childrens Hosp Datteln, Datteln, Germany; [Laudes, Matthias] Univ Hosp Schleswig Holstein, Dept Internal Med, Campus Kiel, Kiel, Germany; [Rimbach, Gerald] Christian Albrechts Univ Kiel, Inst Human Nutr & Food Sci, Dept Food Sci, Kiel, Germany	University of Kiel; Witten Herdecke University; University of Kiel; Schleswig Holstein University Hospital; University of Kiel	Doring, F (corresponding author), Christian Albrechts Univ Kiel, Inst Human Nutr & Food Sci, Dept Mol Prevent, Kiel, Germany.	sek@molprev.uni-kiel.de	Laudes, Matthias/C-8885-2011; Rimbach, Gerald/A-7178-2011	Rimbach, Gerald/0000-0001-7888-4684	Federal Ministry for Education and Research [01EY1103]; grant of the Federal Ministry for Education and Research [0315540A]; Kaneka Corporation, Japan	Federal Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); grant of the Federal Ministry for Education and Research; Kaneka Corporation, Japan	Data from the basic study population presented in this paper derived from the PopGen control cohort, a population-based sample of mainly Caucasian individuals, identified through official population registries in Kiel (Germany). Participants were recruited into the PopGen biobank between June 2005 and February 2006. The study was funded by the Federal Ministry for Education and Research (01EY1103). Subjects of the validation population were randomly recruited via registry office of Kiel, Germany or via the adiposity ambulance of UKSH, Kiel, Germany. Members are part of the Focus Cohort, which was supported by a grant of the Federal Ministry for Education and Research (0315540A). Determining and analyzing the CoQ10 status was financially supported by Kaneka Corporation, Japan. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Acosta MJ, 2016, BIOCH BIOPHYSICA ACT; Alf D, 2013, J INT SOC SPORT NUTR, V10, DOI 10.1186/1550-2783-10-24; Bahat G, 2014, AGING MALE, V17, P136, DOI 10.3109/13685538.2014.936001; Banerjee AK, 2003, MOL CELL BIOCHEM, V253, P307, DOI 10.1023/A:1026032404105; Bello RI, 2006, EXP GERONTOL, V41, P1174, DOI 10.1016/j.exger.2006.08.012; Bentinger M, 2010, BIOCHEM BIOPH RES CO, V396, P74, DOI 10.1016/j.bbrc.2010.02.147; Buchman AS, 2008, MECH AGEING DEV, V129, P625, DOI 10.1016/j.mad.2008.07.003; Chai WW, 2014, J AM COLL NUTR, V33, P192, DOI 10.1080/07315724.2013.862490; Corbi G, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/728547; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Del Pozo-Cruz J, 2014, EXP GERONTOL, V52, P46, DOI 10.1016/j.exger.2014.01.026; Delmonico MJ, 2007, J AM GERIATR SOC, V55, P769, DOI 10.1111/j.1532-5415.2007.01140.x; ERNSTER L, 1995, BBA-MOL BASIS DIS, V1271, P195, DOI 10.1016/0925-4439(95)00028-3; Fischer A, 2015, BIOFACTORS, V41, P166, DOI 10.1002/biof.1210; Goodpaster BH, 2006, J GERONTOL A-BIOL, V61, P1059, DOI 10.1093/gerona/61.10.1059; Hairi NN, 2010, J AM GERIATR SOC, V58, P2055, DOI 10.1111/j.1532-5415.2010.03145.x; Hardy R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056483; Hosoe K, 2007, REGUL TOXICOL PHARM, V47, P19, DOI 10.1016/j.yrtph.2006.07.001; Kalyan S, 2014, J CLIN ENDOCR METAB, V99, P1307, DOI 10.1210/jc.2013-3648; Kim JH, 2008, EXP GERONTOL, V43, P317, DOI 10.1016/j.exger.2007.12.012; King MS, 2009, BIOCHEMISTRY-US, V48, P2053, DOI 10.1021/bi802282h; Krawczak M, 2006, COMMUNITY GENET, V9, P55, DOI 10.1159/000090694; Leong DP, 2015, LANCET, V386, P266, DOI 10.1016/S0140-6736(14)62000-6; Littarru GP, 2007, MOL BIOTECHNOL, V37, P31, DOI 10.1007/s12033-007-0052-y; LUKASKI HC, 1987, AM J CLIN NUTR, V46, P537, DOI 10.1093/ajcn/46.4.537; Marzetti E, 2009, MECH AGEING DEV, V130, P272, DOI 10.1016/j.mad.2008.12.008; Menke T, 2000, ANAL BIOCHEM, V282, P209, DOI 10.1006/abio.2000.4579; Metter EJ, 2002, J GERONTOL A-BIOL, V57, pB359, DOI 10.1093/gerona/57.10.B359; Muller N, 2015, J LIPID RES, V56, P1034, DOI 10.1194/jlr.P052209; Navas P, 2004, METHOD ENZYMOL, V378, P200; Navas P, 2007, MITOCHONDRION, V7, pS34, DOI 10.1016/j.mito.2007.02.010; Nothlings U, 2012, BUNDESGESUNDHEITSBLA, V55, P831, DOI 10.1007/s00103-012-1487-2; Onur S, 2015, BIOFACTORS, V41, P211, DOI 10.1002/biof.1216; Onur S, 2014, BIOFACTORS, V40, P346, DOI 10.1002/biof.1160; PORTER DA, 1995, INT J SPORTS MED, V16, P421, DOI 10.1055/s-2007-973031; Ristow M, 2009, P NATL ACAD SCI USA, V106, P8665, DOI 10.1073/pnas.0903485106; Rosenfeldt RL, 2002, ANN NY ACAD SCI, V959, P355, DOI 10.1111/j.1749-6632.2002.tb02106.x; Sarmiento A, 2016, CURR DRUG METAB, V17, P345, DOI 10.2174/1389200216666151103115654; Schmelzer C, 2011, IUBMB LIFE, V63, P42, DOI 10.1002/iub.413; Schmelzer C, 2010, MOL NUTR FOOD RES, V54, P805, DOI 10.1002/mnfr.200900155; Schmelzer C, 2010, BIOFACTORS, V36, P222, DOI 10.1002/biof.93; SCHUTTE JE, 1981, J APPL PHYSIOL, V51, P762, DOI 10.1152/jappl.1981.51.3.762; Sprenger K B, 1987, J Clin Apher, V3, P185, DOI 10.1002/jca.2920030313; Tian G, 2014, ANTIOXID REDOX SIGN, V20, P2606, DOI 10.1089/ars.2013.5406; TRAUT TW, 1980, BIOCHEMISTRY-US, V19, P6062, DOI 10.1021/bi00567a018; Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106; Wohlgemuth SE, 2010, EXP GERONTOL, V45, P138, DOI 10.1016/j.exger.2009.11.002; Yoritaka A, 2015, PARKINSONISM RELAT D, V21, P911, DOI 10.1016/j.parkreldis.2015.05.022; Zoico E, 2004, INT J OBESITY, V28, P234, DOI 10.1038/sj.ijo.0802552	49	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167124	10.1371/journal.pone.0167124	http://dx.doi.org/10.1371/journal.pone.0167124			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3JC	27907044	Green Submitted, Green Published, gold			2022-12-26	WOS:000389482700078
J	Kim, JS; Kwon, SH				Kim, Jong Seung; Kwon, Sam Hyun			Mupirocin in the Treatment of Staphylococcal Infections in Chronic Rhinosinusitis: A Meta-Analysis	PLOS ONE			English	Article							BACTERIAL BIOFILMS; CONFIDENCE-INTERVALS; PUBLICATION BIAS; SINUS SURGERY; AUREUS; SUPERANTIGENS; IRRIGATION; EFFICACY; AGENTS; SALINE	Background Saline irrigation of the nasal cavity is a classic and effective treatment for acute or chronic rhinosinusitis. Topical antibiotics such as mupirocin have been widely used for recalcitrant chronic rhinosinusitis. Therefore, the purpose of this study was to evaluate the effect of saline irrigation using mupirocin. Methods A systematic literature review and meta-analysis of mupirocin saline irrigation were performed using EMBASE, MEDLINE, and Cochrane library through December 2015. Data were analyzed with R 3.2.2 software. A random effects model was used because of the diversity of included studies. Sensitivity analysis of particular tested groups and single proportion tests were also performed. The main outcome measure was residual staphylococcal infection, as confirmed by culture or PCR. Results Two RCTs, two prospective studies and two retrospective studies were included. A random effects model meta-analysis of the pooled data identified a relative risk of residual infection of 0.13 (95% CI: 0.06-0.26, p<0.05) with low heterogeneity (I-2 = 0%). The proportion of residual staphylococcal infections after 1 month was 0.08 (95% Cl: 0.04-0.16). However, this proportion increased to 0.53 at 6 months (95% Cl: 0.27-0.78). Conclusions The short-term use of mupirocin has a strongly reductive effect on staphylococcal infection in chronic rhinosinusitis. Although there is currently a lack of clear evidence, future studies with well-designed inclusion criteria and randomized controlled trials are needed to examine mupirocin's long-term effect on chronic rhinosinusitis.	[Kim, Jong Seung; Kwon, Sam Hyun] Chonbuk Natl Univ, Coll Med, Dept Otolaryngol Head & Neck Surg, Jeonju, South Korea; [Kim, Jong Seung; Kwon, Sam Hyun] Chonbuk Natl Univ, Res Inst Clin Med, Biomed Res Inst, Chonbuk Natl Univ Hosp, Jeonju, South Korea	Jeonbuk National University; Jeonbuk National University; Jeonbuk National University Hospital	Kwon, SH (corresponding author), Chonbuk Natl Univ, Coll Med, Dept Otolaryngol Head & Neck Surg, Jeonju, South Korea.; Kwon, SH (corresponding author), Chonbuk Natl Univ, Res Inst Clin Med, Biomed Res Inst, Chonbuk Natl Univ Hosp, Jeonju, South Korea.	shkwon@jbnu.ac.kr	Kim, Jong Seung/N-4504-2015	Kim, Jong Seung/0000-0003-3477-1172; Kim, Jong Seung/0000-0002-1384-6799	Biomedical Research Institute at Chonbuk National University Hospital	Biomedical Research Institute at Chonbuk National University Hospital	This paper was supported by a fund of the Biomedical Research Institute at Chonbuk National University Hospital.	Agresti A, 2005, STAT MED, V24, P729, DOI 10.1002/sim.1781; Al-Mutairi D, 2011, CURR OPIN ALLERGY CL, V11, P18, DOI 10.1097/ACI.0b013e3283423376; Bachert C, 2008, CURR OPIN ALLERGY CL, V8, P34, DOI 10.1097/ACI.0b013e3282f4178f; Barham HP, 2015, BRAZ J OTORHINOLAR, V81, P457, DOI 10.1016/j.bjorl.2015.07.002; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Borenstein M., 2009, INTRO META ANAL, V77, P85, DOI [10.1002/9780470743386.ch13, DOI 10.1002/9780470743386.CH13]; Brown Christopher L, 2004, Curr Opin Otolaryngol Head Neck Surg, V12, P9, DOI 10.1097/00020840-200402000-00004; Brown CL, 2004, LARYNGOSCOPE, V114, P2021, DOI 10.1097/01.mlg.0000147939.90249.47; Conley DB, 2006, AM J RHINOL, V20, P451, DOI 10.2500/ajr.2006.20.2880; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DOEBBELING BN, 1994, ARCH INTERN MED, V154, P1505, DOI 10.1001/archinte.154.13.1505; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Edmundson SP, 2011, EUR J CLIN MICROBIOL, V30, P1063, DOI 10.1007/s10096-011-1192-3; Ezzat WF, 2015, EUR ARCH OTO-RHINO-L, V272, P2355, DOI 10.1007/s00405-014-3301-2; Grossman EM, 2012, J DRUGS DERMATOL, V11, P1490; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Jervis-Bardy J, 2012, LARYNGOSCOPE, V122, P2148, DOI 10.1002/lary.23486; Jervis-Bardy J, 2012, INT FORUM ALLERGY RH, V2, P111, DOI 10.1002/alr.20106; Khalil Yaser, 2011, Ear Nose Throat J, V90, pE1; Knapp G, 2003, STAT MED, V22, P2693, DOI 10.1002/sim.1482; Lanza DC, 1997, OTOLARYNG HEAD NECK, V117, pS1, DOI 10.1016/S0194-5998(97)70001-9; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Matthijs S, 2014, RES MICROBIOL, V165, P695, DOI 10.1016/j.resmic.2014.09.009; McConeghy KW, 2009, PHARMACOTHERAPY, V29, P263, DOI 10.1592/phco.29.3.263; Moore EJ, 2001, AM J RHINOL, V15, P355, DOI 10.1177/194589240101500601; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Nikfar R, 2015, IRAN J MICROBIOL, V7, P67; Ou J, 2016, INT FORUM ALLERGY RH, V6, P792, DOI 10.1002/alr.21758; Park SH, 2015, ANN DERMATOL, V27, P551, DOI 10.5021/ad.2015.27.5.551; Psaltis AJ, 2008, AM J RHINOL, V22, P1, DOI 10.2500/ajr.2008.22.3119; Rezai MS, 2016, CASP J INTERN MED, V7, P114; Riley RD, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d549; Rohrer JW, 2012, AM J RHINOL ALLERGY, V26, P197, DOI 10.2500/ajra.2012.26.3761; Rotenberg BW, 2011, LARYNGOSCOPE, V121, P2702, DOI 10.1002/lary.22396; Seiberling KA, 2013, INT FORUM ALLERGY RH, V3, P94, DOI 10.1002/alr.21076; Solares CA, 2006, AM J OTOLARYNG, V27, P161, DOI 10.1016/j.amjoto.2005.09.006; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; SUTHERLAND R, 1985, ANTIMICROB AGENTS CH, V27, P495, DOI 10.1128/AAC.27.4.495; Sutton AJ, 2000, BMJ-BRIT MED J, V320, P1574, DOI 10.1136/bmj.320.7249.1574; Uren B, 2008, LARYNGOSCOPE, V118, P1677, DOI 10.1097/MLG.0b013e31817aec47; Xie S, 2015, CANCER MED-US, V4, P1639, DOI 10.1002/cam4.504; Zabner J, 2000, P NATL ACAD SCI USA, V97, P11614, DOI 10.1073/pnas.97.21.11614; Zhang N, 2005, RHINOLOGY, V43, P162	43	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167369	10.1371/journal.pone.0167369	http://dx.doi.org/10.1371/journal.pone.0167369			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907108	gold, Green Published, Green Submitted			2022-12-26	WOS:000389482700132
J	Kong, F; Li, YG; Hu, EZ; Wang, R; Wang, JH; Liu, J; Zhang, JS; He, DC; Xiao, XY				Kong, Fei; Li, Yunguang; Hu, Enze; Wang, Rui; Wang, Junhao; Liu, Jin; Zhang, Jinsan; He, Dacheng; Xiao, Xueyuan			The Characteristic of S100A7 Induction by the Hippo-YAP Pathway in Cervical and Glossopharyngeal Squamous Cell Carcinoma	PLOS ONE			English	Article							YES-ASSOCIATED PROTEIN; CONTACT INHIBITION; GROWTH-CONTROL; PSORIASIN; PROLIFERATION; TRANSCRIPTION; DOMAIN; ACTS; TAZ; DIFFERENTIATION	S100A7 is expressed in many squamous cell carcinomas (SCCs). Our previous study revealed that S100A7 was dramatically induced in several SCC cells and activation of the Hippo pathway significantly promoted S100A7 in epidermoid carcinoma cells. However, whether the Hippo pathway regulates S100A7 expression in SCCs remains largely unknown. Here, we uncover that S100A7 induction by the Hippo-YAP pathway displays different characteristic in cervical and glossopharyngeal SCC. In well differentiated HCC94 cervical cells and FaDu pharyngeal cells, S100A7 is easily induced by both suspension and dense culture, which is accompanied by an increase in YAP phosphorylation and a decrease in nuclear YAP. Strikingly, these correlations of S100A7 and YAP reverse after recovery of cell attachment or relief from dense culture. Further examination finds that S100A7 induction is significantly repressed by nuclear YAP, which is validated by activation or inhibition of the Hippo pathway via loss-and/or gain-of-LATS1 and MST1 function. Subsequently, we prove that TEAD1 is required for YAP transcriptional repression of S100A7. However, S100A7 is hardly induced in poorly differentiated SiHa cervical cells and NCI-H226 pulmonary cells even in suspension or activation of the Hippo pathway. More importantly, cervical and lingual SCC tissues array analyses show that S100A7 expression displays the positive correlation with pYAP-S127 and the negative correlation with nuclear YAP in the majority of well differentiated but not in poorly differentiated tissues. Collectively, our findings demonstrate that the different induction of S100A7 toward activation of the Hippo pathway mainly depends on the degree of cell differentiation in cervical and glossopharyngeal SCC.	[Kong, Fei; Li, Yunguang; Hu, Enze; Wang, Rui; Wang, Junhao; Liu, Jin; He, Dacheng; Xiao, Xueyuan] Beijing Normal Univ, Key Lab Cell Proliferat & Regulat Biol, Minist Educ, Beijing, Peoples R China; [Zhang, Jinsan] Wenzhou Med Univ, Sch Pharmaceut Sci, Wenzhou, Zhejiang, Peoples R China; [Zhang, Jinsan] Wenzhou Med Univ, Key Lab Biotechnol & Pharmaceut Engn, Wenzhou, Zhejiang, Peoples R China	Beijing Normal University; Wenzhou Medical University; Wenzhou Medical University	Xiao, XY (corresponding author), Beijing Normal Univ, Key Lab Cell Proliferat & Regulat Biol, Minist Educ, Beijing, Peoples R China.	xyxiao@bnu.edu.cn			National Natural Science Foundation of China [81172216, 81272604]; Ministry of Science and Technology of China [2011CB915504]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by the National Natural Science Foundation of China (81172216, 81272604), of the Ministry of Science and Technology of China (2011CB915504). The funder's website is www.nsfc.gov.cn. X.Y. Xiao and D.C. He are the authors who received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alowami Salem, 2003, BMC Dermatol, V3, P1, DOI 10.1186/1471-5945-3-1; Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042; Barbieri M, 2011, BIOSEMIOTICS-NETH, V4, P1, DOI 10.1007/s12304-010-9103-z; Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; Callus BA, 2006, FEBS J, V273, P4264, DOI 10.1111/j.1742-4658.2006.05427.x; Celis JE, 1996, J UROLOGY, V155, P2105, DOI 10.1016/S0022-5347(01)66118-4; Chan EH, 2005, ONCOGENE, V24, P2076, DOI 10.1038/sj.onc.1208445; Dey KK, 2015, CANCER CELL INT, V15, P1; Halder G, 2012, NAT REV MOL CELL BIO, V13, P591, DOI 10.1038/nrm3416; Han XK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4261; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Kesting MR, 2009, ORAL ONCOL, V45, P731, DOI 10.1016/j.oraloncology.2008.11.012; Kim M, 2015, CELL REP, V11, P270, DOI 10.1016/j.celrep.2015.03.015; Kim NG, 2011, P NATL ACAD SCI USA, V108, P11930, DOI 10.1073/pnas.1103345108; Komuro A, 2003, J BIOL CHEM, V278, P33334, DOI 10.1074/jbc.M305597200; Kulski JK, 2003, J MOL EVOL, V56, P397, DOI 10.1007/s00239-002-2410-5; Li T, 2015, EXP DERMATOL, V24, P342, DOI 10.1111/exd.12645; Li YJ, 2016, ONCOTARGET; Mandal S, 2007, EXP CELL RES, V313, P3016, DOI 10.1016/j.yexcr.2007.03.020; Martinsson H, 2005, EXP DERMATOL, V14, P161, DOI 10.1111/j.0906-6705.2005.00239.x; Meng ZP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9357; Mo JS, 2012, GENE DEV, V26, P2138, DOI 10.1101/gad.197582.112; Moubayed N, 2007, J CANCER RES CLIN, V133, P253, DOI 10.1007/s00432-006-0164-y; Mullen AC, 2014, CELL STEM CELL, V14, P6, DOI 10.1016/j.stem.2013.12.009; Oh H, 2014, CELL REP, V8, P448, DOI 10.1016/j.celrep.2014.06.017; Peder M, 1991, J INVEST DERMATOL, V97, P701; Qi Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128887; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Tripathi SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011939; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Wada KI, 2011, DEVELOPMENT, V138, P3907, DOI 10.1242/dev.070987; Yagi R, 1999, EMBO J, V18, P2551, DOI 10.1093/emboj/18.9.2551; Zhang K, 2015, BIOCHEMISTRY-US, V54, P6555, DOI 10.1021/acs.biochem.5b01014; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2012, GENE DEV, V26, P54, DOI 10.1101/gad.173435.111; Zhu Y, 2015, CELL SIGNAL, V27, P606, DOI 10.1016/j.cellsig.2014.12.002	37	6	8	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167080	10.1371/journal.pone.0167080	http://dx.doi.org/10.1371/journal.pone.0167080			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907036	Green Submitted, Green Published, gold			2022-12-26	WOS:000389482700073
J	Zhou, W; Gao, J; Liao, J; Shi, RG; Li, T; Guo, YJ; Long, AM				Zhou, Weihua; Gao, Jie; Liao, Jianzu; Shi, Ronggui; Li, Tao; Guo, Yajuan; Long, Aimin			Characteristics of Phytoplankton Biomass, Primary Production and Community Structure in the Modaomen Channel, Pearl River Estuary, with Special Reference to the Influence of Saltwater Intrusion during Neap and Spring Tides	PLOS ONE			English	Article							SWAN-CANNING ESTUARY; SALT WEDGE ESTUARY; HONG-KONG; DYNAMICS; WATERS; NUTRIENTS; DIVERSITY	In recent decades, increasing frequency and intensity of saltwater intrusion in the Modaomen Channel has threatened the freshwater supply in the surrounding cities of the Pearl River Estuary, and ulteriorly changed the environmental conditions of the estuarine waters. Phytoplankton biomass, primary production (PP) and species composition, as well as hydrological and chemical parameters were examined along a downstream transect in the Modaomen Channel during neap tide (NT) and spring tide (ST), when a strong saltwater intrusion event occurred in late September, 2011. A total of 46 species phytoplankton were identified, including Bacillariophyta (25 species), Dinoflagellate (14 species), Chlorophyta (4 species), Cyanophyta (2 species) and Euglenozoa (1 species). The dominant species were shifted from freshwater diatoms (e.g., Melosira granulata and Melosira granulata var. angustissima) in the upper reaches to saline water diatoms (e.g., Skeletonema costatum and Coscinodiscus sp.) in the river mouth. Generally, phytoplankton density, biomass (chla) and PP decreased from the upper to lower reaches along the channel, and were significantly higher in NT than those of ST. There was a shift from large-sized phytoplankton (>20 mu m) in the upper reaches to relative small-sized cells (5-20 mu m) in the lower reaches. Compared to NT, low discharge and flow velocity, coupled with strong easterly winds during ST specially aggravated saltwater intrusion further to the upstream (similar to 50 km from the estuary). The intruded saltwater diluted nutrients, N/P ratios, chl-a, and phytoplankton abundances, and thereby led to a decline in PP during ST.	[Zhou, Weihua; Liao, Jianzu; Li, Tao; Guo, Yajuan; Long, Aimin] Chinese Acad Sci, South China Sea Inst Oceanol, Key Lab Trop Marine Bioresources & Ecol, Guangzhou, Guangdong, Peoples R China; [Zhou, Weihua; Liao, Jianzu; Li, Tao; Guo, Yajuan; Long, Aimin] Chinese Acad Sci, South China Sea Inst Oceanol, Guangdong Prov Key Lab Appl Marine Biol, Guangzhou, Guangdong, Peoples R China; [Zhou, Weihua; Liao, Jianzu; Li, Tao; Guo, Yajuan] Chinese Acad Sci, South China Sea Inst Oceanol, Trop Marine Biol Res Stn Hainan, Sanya, Peoples R China; [Gao, Jie] Guangdong Univ Foreign Studies, South China Business Coll, Guangzhou, Guangdong, Peoples R China; [Shi, Ronggui] State Ocean Adm, South China Sea Environm Monitoring Ctr, Guangzhou, Guangdong, Peoples R China; [Liao, Jianzu; Guo, Yajuan] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Guangdong University of Foreign Studies; State Oceanic Administration; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhou, W; Long, AM (corresponding author), Chinese Acad Sci, South China Sea Inst Oceanol, Key Lab Trop Marine Bioresources & Ecol, Guangzhou, Guangdong, Peoples R China.; Zhou, W; Long, AM (corresponding author), Chinese Acad Sci, South China Sea Inst Oceanol, Guangdong Prov Key Lab Appl Marine Biol, Guangzhou, Guangdong, Peoples R China.; Zhou, W (corresponding author), Chinese Acad Sci, South China Sea Inst Oceanol, Trop Marine Biol Res Stn Hainan, Sanya, Peoples R China.	whzhou@scsio.ac.en; longam@sciso.ac.en			Global Change Scientific Research Program of China [2010CB951201]; National Natural Science Fundiation of China [31370500, 31370499]	Global Change Scientific Research Program of China; National Natural Science Fundiation of China(National Natural Science Foundation of China (NSFC))	This study was financially supported by the Global Change Scientific Research Program of China through grant No. 2010CB951201 (http://program.most.gov.ch/), and the National Natural Science Fundiation of China through grants No. 31370500 and 31370499 (http:// www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao Y., 2008, SHIP BUILD, V49, P441; [包芸 Bao Yun], 2009, [中国科学. G辑, 物理学，力学，天文学, Science in China. Series G, Physics, Mechanics & Astronomy], V39, P1527; Behbehani, 1986, COASTAL EUTROPHICATI, P97; Brockway R, 2006, ESTUAR COAST SHELF S, V66, P1, DOI 10.1016/j.ecss.2005.07.014; [陈荣力 CHEN Rongli], 2011, [水动力学研究与进展. A辑, Journal of Hydrodynomics], V26, P312; Gong WP, 2011, CONT SHELF RES, V31, P769, DOI 10.1016/j.csr.2011.01.011; Haralambidou K, 2010, ESTUAR COAST SHELF S, V90, P174, DOI 10.1016/j.ecss.2010.08.010; Harrison PJ, 2008, CONT SHELF RES, V28, P1405, DOI 10.1016/j.csr.2007.02.011; HAYWARD D, 1982, SCIENCE, V216, P1413, DOI 10.1126/science.216.4553.1413; Ho AYT, 2010, ESTUAR COAST, V33, P170, DOI 10.1007/s12237-009-9247-8; Hu X., 2010, THESIS; Huang Liangmin, 1997, Marine Environmental Science, V16, P1; Huang LM, 2004, MAR POLLUT BULL, V49, P588, DOI 10.1016/j.marpolbul.2004.03.015; Jing ZY, 2013, EVOLUTION CAUSE ANAL, P118; JUSTIC D, 1995, ESTUAR COAST SHELF S, V40, P339, DOI 10.1016/S0272-7714(05)80014-9; Kasai A, 2010, ESTUAR COAST SHELF S, V86, P408, DOI 10.1016/j.ecss.2009.06.001; Knap A., 1996, PROTOCOLS JOINT GLOB, V1994, P19; Lai YS, 2011, ZHONGSHAN DAILY 0926; Li Kai-zhi, 2010, JOURNAL OF TROPICAL OCEANOGRAPHY, V29, P62; Liu JB., 2008, ACTA SCIENTIARUMNATU, V47, P122; Liu XF, 2010, GUANGDONG METEOROL, V32, P11; Long AM, 2013, J COASTAL RES, V29, P1158, DOI 10.2112/JCOASTRES-D-12-00182.1; Lu A., 2006, GUANGDONG WATER RESO, V2006, P50; Luo Lin, 2010, Journal of Tropical Oceanography, V29, P22; Nassar M. Z., 2000, THESIS; Paerl HW, 2007, ECOL APPL, V17, pS88, DOI 10.1890/05-0840.1; PIELOU EC, 1966, J THEOR BIOL, V10, P370, DOI 10.1016/0022-5193(66)90133-0; Qiu DJ, 2010, CONT SHELF RES, V30, P177, DOI 10.1016/j.csr.2009.10.015; Scully ME, 2005, ESTUARIES, V28, P321, DOI 10.1007/BF02693915; SEKI H, 1980, Journal of the Oceanographical Society of Japan, V36, P30, DOI 10.1007/BF02209352; Shannon C. E., 1949, MATH THEORY COMMUNIC; Shen PP, 2011, CONT SHELF RES, V31, P1672, DOI 10.1016/j.csr.2011.07.002; [石荣贵 Shi Ronggui], 2012, [海洋科学, Marine Sciences], V36, P86; Short FT, 1999, AQUAT BOT, V63, P169, DOI 10.1016/S0304-3770(98)00117-X; Sierra JP, 2002, CONT SHELF RES, V22, P361, DOI 10.1016/S0278-4343(01)00061-9; Specification for Oceanographic Survey, 2007, GB1276342007; Stephens R, 1996, MAR FRESHWATER RES, V47, P517, DOI 10.1071/MF9960517; Thompson PA, 2001, HYDROL PROCESS, V15, P2617, DOI 10.1002/hyp.289; Thompson PA, 1998, ESTUARIES, V21, P801, DOI 10.2307/1353282; Thomson DM, 2001, GLOBAL PLANET CHANGE, V32, P49, DOI 10.1016/S0921-8181(01)00149-7; Twomey L, 2001, HYDROL PROCESS, V15, P2655, DOI 10.1002/hyp.287; Utermohl H., 1958, MITT INT VER THEOR, V9, P1, DOI DOI 10.1080/05384680.1958.11904091; Wang B, 2012, SCI CHINA EARTH SCI, V55, P1901, DOI 10.1007/s11430-012-4371-x; WELSCHMEYER NA, 1994, LIMNOL OCEANOGR, V39, P1985, DOI 10.4319/lo.1994.39.8.1985; Wen P., 2007, J CHINA HYDROL, V27, P65; Wong MW, 1999, MAR ECOL PROG SER, V178, P133, DOI 10.3354/meps178133; Xu Z.L., 1989, J ECOL, V8, P13; Yin KD, 2004, CONT SHELF RES, V24, P1909, DOI 10.1016/j.csr.2004.06.015; YIN KD, 1995, ESTUAR COAST SHELF S, V40, P505, DOI 10.1006/ecss.1995.0035; Yin KD, 2000, MAR ECOL PROG SER, V194, P295, DOI 10.3354/meps194295; Yin KD, 2001, MAR ECOL PROG SER, V221, P17, DOI 10.3354/meps221017; Zhang X, 2014, J OCEAN U CHINA, V13, P73, DOI 10.1007/s11802-014-1972-3; Zhou MR, 2006, ENVIRONMENT IN ASIA PACIFIC HARBOURS, P113, DOI 10.1007/1-4020-3655-8_8	53	23	24	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167630	10.1371/journal.pone.0167630	http://dx.doi.org/10.1371/journal.pone.0167630			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907178	gold, Green Published, Green Submitted			2022-12-26	WOS:000389482700215
J	Huo, MY; Huang, YH; Qu, D; Zhang, HS; Wong, WT; Chawla, A; Huang, Y; Tian, XY				Huo, Mingyu; Huang, Yuhong; Qu, Dan; Zhang, Hongsong; Wong, Wing Tak; Chawla, Ajay; Huang, Yu; Tian, Xiao Yu			Myeloid Bmal1 deletion increases monocyte recruitment and worsens atherosclerosis	FASEB JOURNAL			English	Article						molecular clock; chronic inflammation; macrophage	CIRCADIAN CLOCK; MYOCARDIAL-INFARCTION; INNATE IMMUNITY; BONE-MARROW; MACROPHAGES; TISSUE; CELLS; INFLAMMATION; METABOLISM; MICE	BMAL1, the nonredundant transcription factor in the core molecular clock, has been implicated in cardiometabolic diseases in mice and humans. BMAL1 controls the cyclic trafficking of Ly6c(hi) monocytes to sites of acute inflammation. Myeloid deficiency of Bmal1 also worsens chronic inflammation in diet-induced obesity. We studied whether myeloid Bmal1 deletion promotes atherosclerosis by enhancing monocyte recruitment to atherosclerotic lesions. By generating Bmal1(FloxP/Floxp) ; LysM(Cre) mice on the Apoe(-/-) background, we showed that Bmal1 deletion in myeloid cells increased the size of atherosclerotic lesions. Bmal1 deficiency in monocytes and macrophages resulted in an increased total number of lesional macrophages in general and Ly6c(hi) infiltrating monocyte-macrophages in particular, accompanied by skewed M2 to M1 macrophage phenotype. Ly6c(hi) and/or Ly6c(lo) monocyte subsets in blood, spleen, and bone marrow were not altered. Cell tracking and adoptive transfer of Ly6c(hi) monocytes showed Bmal1 deficiency induced more trafficking of Ly6c(hi) monocytes to atherosclerotic lesions, preferential differentiation of Ly6c(hi) monocytes into M1 macrophages, and increased macrophage content and lesion size in the carotid arteries. We demonstrated that Bmal1 deficiency in macrophages promotes atherosclerosis by enhancing recruitment of Ly6c(hi) monocytes to atherosclerotic lesions.	[Huo, Mingyu; Huang, Yuhong; Qu, Dan; Zhang, Hongsong; Huang, Yu; Tian, Xiao Yu] Chinese Univ Hong Kong, Inst Vasc Med, Hong Kong, Peoples R China; [Huo, Mingyu; Huang, Yuhong; Qu, Dan; Zhang, Hongsong; Huang, Yu; Tian, Xiao Yu] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Peoples R China; [Huo, Mingyu; Huang, Yuhong; Qu, Dan; Zhang, Hongsong; Huang, Yu; Tian, Xiao Yu] Chinese Univ Hong Kong, Sch Biomed Sci, Room 223A,LIBSB, Hong Kong, Peoples R China; [Wong, Wing Tak] Chinese Univ Hong Kong, Sch Life Sci, Hong Kong, Peoples R China; [Chawla, Ajay] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Chawla, Ajay] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Chawla, Ajay] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Tian, XY (corresponding author), Chinese Univ Hong Kong, Sch Biomed Sci, Room 223A,LIBSB, Hong Kong, Peoples R China.	xytian@cuhk.edu.hk	Huang, Yu/K-2866-2017; Tian, Xiao Yu/P-1092-2016; Wong, Wing Tak Jack/Q-4512-2018; Zhang, Hongsong/AGH-4158-2022; Huo, Mingyu/AAK-5990-2021	Huang, Yu/0000-0002-1277-6784; Tian, Xiao Yu/0000-0003-3472-9898; Wong, Wing Tak Jack/0000-0002-4514-3780; Zhang, Hongsong/0000-0003-4251-7609; 	Chinese University of Hong Kong (CUHK) [4054321]; CUHK ViceChancellor's Discretionary Fund; Hong Kong Research Grants Council [GRF464712]; Hong Kong Food and Health Bureau [Health and Medical Research Fund (HMRF) Research Fellowship Scheme] [01150057]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK094641, R01DK101064] Funding Source: NIH RePORTER	Chinese University of Hong Kong (CUHK)(Chinese University of Hong Kong); CUHK ViceChancellor's Discretionary Fund; Hong Kong Research Grants Council(Hong Kong Research Grants Council); Hong Kong Food and Health Bureau [Health and Medical Research Fund (HMRF) Research Fellowship Scheme]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by Chinese University of Hong Kong (CUHK) Direct Grant 4054321 (to X.Y.T.), CUHK ViceChancellor's Discretionary Fund (to Y.H. and X.Y.T.), the Hong Kong Research Grants Council Grant GRF464712 (to Y.H.), and Hong Kong Food and Health Bureau [Health and Medical Research Fund (HMRF) Research Fellowship Scheme 01150057] (to X.Y.T.). The authors thank Dr. Khoa Nguyen (Stanford University Blood Center, Stanford, CA, USA) for advice on flow cytometry experiments; Dr. D. Rowlands and C. Cheng (CUHK) for animal care; and Dr. X. Cui, Francis Chen, and J. Park (University of California, San Francisco) for technical assistance.	Akhtar S, 2013, ARTERIOSCL THROM VAS, V33, P679, DOI 10.1161/ATVBAHA.112.301162; Aldridge JR, 2009, P NATL ACAD SCI USA, V106, P5306, DOI 10.1073/pnas.0900655106; Ammirati E, 2013, CIRC RES, V112, pE110, DOI 10.1161/CIRCRESAHA.112.300778; Asher G, 2015, CELL, V161, P84, DOI 10.1016/j.cell.2015.03.015; Bellet MM, 2013, P NATL ACAD SCI USA, V110, P9897, DOI 10.1073/pnas.1120636110; Belliere J, 2015, J AM SOC NEPHROL, V26, P1363, DOI 10.1681/ASN.2014040320; Butcher MJ, 2011, JOVE-J VIS EXP, DOI 10.3791/2848; Carter SJ, 2016, J LEUKOCYTE BIOL, V99, P549, DOI 10.1189/jlb.3RU1015-451R; Cheng B, 2011, P NATL ACAD SCI USA, V108, P17147, DOI 10.1073/pnas.1112998108; Curtis AM, 2015, P NATL ACAD SCI USA, V112, P7231, DOI 10.1073/pnas.1501327112; Davies LC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2877; Dutta P, 2012, NATURE, V487, P325, DOI 10.1038/nature11260; Fink LN, 2014, OBESITY, V22, P747, DOI 10.1002/oby.20615; Gibbs JE, 2012, P NATL ACAD SCI USA, V109, P582, DOI 10.1073/pnas.1106750109; Gordon S, 2007, J CLIN INVEST, V117, P89, DOI 10.1172/JCI30992; Irvine KM, 2009, J LEUKOCYTE BIOL, V85, P278, DOI 10.1189/jlb.0808497; Li XF, 2014, CIRCULATION, V129, P1244, DOI 10.1161/CIRCULATIONAHA.113.006840; McAlpine CS, 2016, CIRC RES, V119, P131, DOI 10.1161/CIRCRESAHA.116.308034; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Narasimamurthy R, 2012, P NATL ACAD SCI USA, V109, P12662, DOI 10.1073/pnas.1209965109; Nguyen KD, 2013, SCIENCE, V341, P1483, DOI 10.1126/science.1240636; Pan XY, 2013, CIRCULATION, V128, P1758, DOI 10.1161/CIRCULATIONAHA.113.002885; Perez-Rial S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072975; Robbins CS, 2013, NAT MED, V19, P1166, DOI 10.1038/nm.3258; Scheiermann C, 2013, NAT REV IMMUNOL, V13, P190, DOI 10.1038/nri3386; Sitaula S, 2015, BIOCHEM BIOPH RES CO, V460, P566, DOI 10.1016/j.bbrc.2015.03.070; Spengler ML, 2012, P NATL ACAD SCI USA, V109, pE2457, DOI 10.1073/pnas.1206274109; Subramanian M, 2013, J CLIN INVEST, V123, P179, DOI 10.1172/JCI64617; Tabas I, 2016, CIRC RES, V118, P653, DOI 10.1161/CIRCRESAHA.115.306256; Tacke F, 2006, J EXP MED, V203, P583, DOI 10.1084/jem.20052119; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Takahashi JS, 2015, DIABETES OBES METAB, V17, P6, DOI 10.1111/dom.12514; Tian XY, 2016, CELL METAB, V23, P165, DOI 10.1016/j.cmet.2015.10.003; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Yang G, 2016, MATH PROBL ENG, V2016, DOI 10.1155/2016/6581204; Yang GR, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007225; Yang L, 2015, INT IMMUNOPHARMACOL, V28, P525, DOI 10.1016/j.intimp.2015.07.001; Zernecke A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000610; Zhu BK, 2015, MOL CELL, V60, P769, DOI 10.1016/j.molcel.2015.10.024	39	45	46	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2017	31	3					1097	+		10.1096/fj.201601030R	http://dx.doi.org/10.1096/fj.201601030R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EM9ZX	27927724	Green Published			2022-12-26	WOS:000395671200023
J	Diez, MDA; Miah, F; Stevenson, CEM; Lawson, DM; Iglesias, AA; Bornemann, S				Asencion Diez, Matias D.; Miah, Farzana; Stevenson, Clare E. M.; Lawson, David M.; Iglesias, Alberto A.; Bornemann, Stephen			The Production and Utilization of GDP-glucose in the Biosynthesis of Trehalose 6-Phosphate by Streptomyces venezuelae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYCOBACTERIUM-TUBERCULOSIS; ENZYMATIC-SYNTHESIS; COELICOLOR A3(2); ALPHA-GLUCAN; MACROMOLECULAR CRYSTALLOGRAPHY; MANNOSE PYROPHOSPHORYLASE; CARBOHYDRATE-METABOLISM; STRUCTURE VALIDATION; DIPHOSPHATE-GLUCOSE; MOLECULAR-GRAPHICS	Trehalose-6-phosphate synthase OtsA from streptomycetes is unusual in that it uses GDP-glucose as the donor substrate rather than the more commonly used UDP-glucose. We now confirm that OtsA from Streptomyces venezuelae has such a preference for GDP-glucose and can utilize ADP-glucose to some extent too. A crystal structure of the enzyme shows that it shares twin Rossmann-like domains with the UDP-glucose-specific OtsA from Escherichia coli. However, it is structurally more similar to Streptomyces hygroscopicus VldE, a GDP-valienol-dependent pseudoglycosyltransferase enzyme. Comparison of the donor binding sites reveals that the amino acids associated with the binding of diphosphoribose are almost all identical in these three enzymes. By contrast, the amino acids associated with binding guanine in VldE (Asn, Thr, and Val) are similar in S. venezuelae OtsA (Asp, Ser, and Phe, respectively) but not conserved in E. coli OtsA (His, Leu, and Asp, respectively), providing a rationale for the purine base specificity of S. venezuelae OtsA. To establish which donor is used in vivo, we generated an otsA null mutant in S. venezuelae. The mutant had a cell density-dependent growth phenotype and accumulated galactose 1-phosphate, glucose 1-phosphate, and GDP-glucose when grown on galactose. To determine how the GDP-glucose is generated, we characterized three candidate GDP-glucose pyrophosphorylases. SVEN_3027 is a UDP-glucose pyrophosphorylase, SVEN_ 3972 is an unusual ITP-mannose pyrophosphorylase, and SVEN_2781 is a pyrophosphorylase that is capable of generating GDP-glucose as well as GDP-mannose. We have therefore established how S. venezuelae can make and utilize GDP-glucose in the biosynthesis of trehalose 6-phosphate.	[Miah, Farzana; Stevenson, Clare E. M.; Lawson, David M.; Bornemann, Stephen] John Innes Ctr, Dept Biol Chem, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England; [Asencion Diez, Matias D.; Iglesias, Alberto A.] CCT Santa Fe, Lab Enzimol Mol, Inst Agrobiotecnol Litoral UNL CONICET, Fac Bioquim & Ciencias Biol, Colectora Ruta Nac 168 Km 0, RA-3000 Santa Fe, Argentina	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of the Littoral	Bornemann, S (corresponding author), John Innes Ctr, Dept Biol Chem, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	stephen.bornemann@jic.ac.uk	Bornemann, Stephen/K-2938-2012	Bornemann, Stephen/0000-0001-5930-9473; Iglesias, Alberto/0000-0001-9729-7338; Asencion Diez, Matias Damian/0000-0001-6495-387X	United Kingdom Biotechnology and Biological Sciences Research Council [BB/F017294/1]; Institute Strategic Programme Grant [BB/J004561/1]; John Innes Foundation; European Molecular Biology Organization [ASTF537-2014]; CONICET; UNL; ANPCyT [PICT'15 1767]; BBSRC [BBS/E/J/000C0647] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/J/000C0647] Funding Source: researchfish	United Kingdom Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Institute Strategic Programme Grant; John Innes Foundation; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); UNL; ANPCyT(ANPCyT); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by United Kingdom Biotechnology and Biological Sciences Research Council Doctoral Training Grant BB/F017294/1 and Institute Strategic Programme Grant BB/J004561/1, the John Innes Foundation, and the European Molecular Biology Organization (short term fellowship grant ASTF537-2014). The work in Argentina was supported by CONICET, UNL, and ANPCyT (PICT'15 1767). The authors declare that they have no conflicts of interest with the contents of this article.	Diez MDA, 2015, BBA-GEN SUBJECTS, V1850, P13, DOI 10.1016/j.bbagen.2014.09.023; Diez MDA, 2012, J BACTERIOL, V194, P1485, DOI 10.1128/JB.06377-11; Bar-Even A, 2011, BIOCHEMISTRY-US, V50, P4402, DOI 10.1021/bi2002289; Barber G.A., 1966, METHOD ENZYMOL, V8, P266; BRUTON CJ, 1995, MOL MICROBIOL, V18, P89, DOI 10.1111/j.1365-2958.1995.mmi_18010089.x; Bush MJ, 2015, NAT REV MICROBIOL, V13, P749, DOI 10.1038/nrmicro3546; CARLSON DM, 1962, J BIOL CHEM, V237, P1260; Cavalier MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044934; Chandra G, 2011, MICROBIOL-SGM, V157, P1565, DOI 10.1099/mic.0.044263-0; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; ELBEIN AD, 1967, J BACTERIOL, V94, P1520, DOI 10.1128/JB.94.5.1520-1524.1967; ELBEIN AD, 1967, J BIOL CHEM, V242, P403; ELBEIN AD, 1968, J BACTERIOL, V96, P1623, DOI 10.1128/JB.96.5.1623-1631.1968; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Frey PA, 1996, FASEB J, V10, P461, DOI 10.1096/fasebj.10.4.8647345; Fusari C, 2006, ANAL BIOCHEM, V352, P145, DOI 10.1016/j.ab.2006.01.024; Gibson RP, 2004, J BIOL CHEM, V279, P1950, DOI 10.1074/jbc.M307643200; Gibson RP, 2002, CHEM BIOL, V9, P1337, DOI 10.1016/S1074-5521(02)00292-2; Gregory MA, 2003, J BACTERIOL, V185, P5320, DOI 10.1128/JB.185.17.5320-5323.2003; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Hansen R. G., 1966, METHOD ENZYMOL, V8, P269; HEYFERGU.A, 1973, J BACTERIOL, V116, P1084, DOI 10.1128/JB.116.2.1084-1085.1973; Kalscheuer R, 2010, NAT CHEM BIOL, V6, P376, DOI 10.1038/nchembio.340; KAWAGUCHI K, 1973, AGR BIOL CHEM TOKYO, V37, P75, DOI 10.1080/00021369.1973.10860641; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kleywegt GJ, 1996, STRUCTURE, V4, P897, DOI 10.1016/S0969-2126(96)00097-4; Koliwer-Brandl H, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005768; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LAPP D, 1971, J BIOL CHEM, V246, P4567; LAPP D, 1972, J BACTERIOL, V112, P327, DOI 10.1128/JB.112.1.327-336.1972; Lee SS, 2011, NAT CHEM BIOL, V7, P631, DOI [10.1038/NCHEMBIO.628, 10.1038/nchembio.628]; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Ma YF, 2001, ANTIMICROB AGENTS CH, V45, P1407, DOI 10.1128/AAC.45.5.1407-1416.2001; MARTIN MC, 1986, FEMS MICROBIOL LETT, V35, P49; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Miah F, 2016, MICROBIOL-SGM, V162, P1208, DOI 10.1099/mic.0.000296; Miah F, 2013, CHEM BIOL, V20, P487, DOI 10.1016/j.chembiol.2013.02.014; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ning B, 1999, ARCH BIOCHEM BIOPHYS, V362, P339, DOI 10.1006/abbi.1998.1053; Ning BT, 2000, EUR J BIOCHEM, V267, P6866, DOI 10.1046/j.1432-1033.2000.01781.x; Nobre A, 2008, J BACTERIOL, V190, P7939, DOI 10.1128/JB.01055-08; Pan YT, 2002, EUR J BIOCHEM, V269, P6091, DOI 10.1046/j.1432-1033.2002.03327.x; PLASKITT KA, 1995, PHILOS T R SOC B, V347, P105, DOI 10.1098/rstb.1995.0016; Rashid AM, 2016, BIOCHEMISTRY-US, V55, P3270, DOI 10.1021/acs.biochem.6b00209; VERACHTERT H, 1964, BIOCHEM BIOPH RES CO, V15, P158, DOI 10.1016/0006-291X(64)90316-X; VERACHTERT H, 1966, J BIOL CHEM, V241, P2007; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Yeo M, 2005, MICROBIOL-SGM, V151, P855, DOI 10.1099/mic.0.27428-0	58	7	8	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2017	292	3					945	954		10.1074/jbc.M116.758664	http://dx.doi.org/10.1074/jbc.M116.758664			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2LL	27903647	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000392318700016
J	Rudolph, MJ; Vance, DJ; Cassidy, MS; Rong, YH; Mantis, NJ				Rudolph, Michael J.; Vance, David J.; Cassidy, Michael S.; Rong, Yinghui; Mantis, Nicholas J.			Structural Analysis of Single DomainAntibodies Bound to a Second Neutralizing Hot Spot on Ricin Toxin's Enzymatic Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B-CELL EPITOPES; A-CHAIN; VACCINE; BINDING; MECHANISM; ANTIBODIES; GALACTOSE; SITE; STABILITY; LECTINS	Ricin toxin is a heterodimer consisting of RTA, a ribosomeinactivating protein, and RTB, a lectin that facilitates receptormediated uptake into mammalian cells. In previous studies, we demonstrated that toxin- neutralizing antibodies target four spatially distinct hot spots on RTA, which we refer to as epitope clusters I- IV. In this report, we identified and characterized three single domain camelid antibodies (VHH) against cluster II. One of these V(H)Hs, V5E1, ranks as one of the most potent ricinneutralizing antibodies described to date. We solved the X- ray crystal structures of each of the three V(H)Hs (E1, V1C7, and V5E1) in complex with RTA. V5E1 buries a total of 1,133 angstrom(2) of surface area on RTA and makes primary contacts with alpha-helixA (residues 18- 32), alpha-helix F (182- 194), as well as the F- G loop. V5E1, by virtue of complementarity determining region 3 (CDR3), may also engage with RTB and potentially interfere with the high affinity galactose- recognition element that plays a critical role in toxin attachment to cell surfaces and intracellular trafficking. The two other V(H)Hs, E1 and V1C7, bind epitopes adjacent to V5E1 but display only weak toxin neutralizing activity, thereby providing structural insights into specific residues within cluster II that may be critical contact points for toxin inactivation.	[Rudolph, Michael J.; Cassidy, Michael S.] New York Struct Biol Ctr, 89 Convent Ave, New York, NY 10027 USA; [Vance, David J.; Rong, Yinghui; Mantis, Nicholas J.] New York State Dept Hlth, Wadsworth Ctr, Div Infect Dis, 120 New Scotland Ave, Albany, NY 12208 USA; [Mantis, Nicholas J.] Univ Albany, Dept Biomed Sci, Albany, NY 12201 USA	State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Rudolph, MJ (corresponding author), New York Struct Biol Ctr, 89 Convent Ave, New York, NY 10027 USA.; Mantis, NJ (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Div Infect Dis, 120 New Scotland Ave, Albany, NY 12208 USA.	mrudolph@nysbc.org; nicholas.mantis@health.ny.gov	Vance, David/ABF-5998-2020	Vance, David/0000-0002-9913-7722; Mantis, Nicholas/0000-0002-5083-8640	NIAID from the National Institutes of Health [HHSN272201400021C]	NIAID from the National Institutes of Health	This work was supported by NIAID Contract No. HHSN272201400021C from the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Carra JH, 2007, VACCINE, V25, P4149, DOI 10.1016/j.vaccine.2007.03.011; Castelletti D, 2004, CLIN EXP IMMUNOL, V136, P365, DOI 10.1111/j.1365-2249.2004.02442.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ENDO Y, 1987, J BIOL CHEM, V262, P8128; ENDO Y, 1987, J BIOL CHEM, V262, P5908; Herrera C, 2015, J BIOL CHEM, V290, P27880, DOI 10.1074/jbc.M115.658070; Herrera C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099788; Jandhyala DM, 2012, CURR TOP MICROBIOL, V357, P41, DOI 10.1007/82_2011_181; KATZIN BJ, 1991, PROTEINS, V10, P251, DOI 10.1002/prot.340100309; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Li XP, 2013, J BIOL CHEM, V288, P30270, DOI 10.1074/jbc.M113.510966; Li XP, 2009, BIOCHEMISTRY-US, V48, P3853, DOI 10.1021/bi802371h; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McHugh CA, 2004, PROTEIN SCI, V13, P2736, DOI 10.1110/ps.04897904; MONTFORT W, 1987, J BIOL CHEM, V262, P5398; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Muyldermans S, 2001, TRENDS BIOCHEM SCI, V26, P230, DOI 10.1016/S0968-0004(01)01790-X; NEWTON DL, 1992, J BIOL CHEM, V267, P11917; O'Hara JM, 2014, IMMUNOL LETT, V158, P7, DOI 10.1016/j.imlet.2013.11.009; O'Hara JM, 2010, VACCINE, V28, P7035, DOI 10.1016/j.vaccine.2010.08.020; Olson MA, 2004, PROTEIN ENG DES SEL, V17, P391, DOI 10.1093/protein/gzh043; Pincus SH, 2011, TOXINS, V3, P1163, DOI 10.3390/toxins3091163; READY MP, 1991, PROTEINS, V10, P270, DOI 10.1002/prot.340100311; Reisler Ronald B, 2012, Adv Prev Med, V2012, P149737, DOI 10.1155/2012/149737; Roy CJ, 2015, P NATL ACAD SCI USA, V112, P3782, DOI 10.1073/pnas.1502585112; Rudolph MJ, 2016, PROTEINS, V84, P1162, DOI 10.1002/prot.25062; Rudolph MJ, 2014, J MOL BIOL, V426, P3057, DOI 10.1016/j.jmb.2014.05.026; RUTENBER E, 1987, NATURE, V326, P624, DOI 10.1038/326624a0; RUTENBER E, 1991, PROTEINS, V10, P240, DOI 10.1002/prot.340100308; SANDVIG K, 1976, J BIOL CHEM, V251, P3977; Smallshaw JE, 2003, NAT BIOTECHNOL, V21, P387, DOI 10.1038/nbt800; Smallshaw JE, 2002, VACCINE, V20, P3422, DOI 10.1016/S0264-410X(02)00312-2; Spooner RA, 2015, TOXINS, V7, P49, DOI 10.3390/toxins7010049; Vance DJ, 2016, EXPERT REV VACCINES, V15, P1213, DOI 10.1586/14760584.2016.1168701; Vance DJ, 2013, J BIOL CHEM, V288, P36538, DOI 10.1074/jbc.M113.519207; Wahome P.G., 2013, CURR PROTOC TOXICOL, V23, DOI DOI 10.1002/0471140856.TX0223S55; WALES R, 1991, J BIOL CHEM, V266, P19172; Yermakova A, 2014, MBIO, V5, DOI 10.1128/mBio.00995-13; Yermakova A, 2011, VACCINE, V29, P7925, DOI 10.1016/j.vaccine.2011.08.075; ZENTZ C, 1978, BIOCHIM BIOPHYS ACTA, V536, P18, DOI 10.1016/0005-2795(78)90047-8; Zhu YW, 2013, J BIOL CHEM, V288, P25165, DOI 10.1074/jbc.M113.480830	42	17	17	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2017	292	3					872	883		10.1074/jbc.M116.758102	http://dx.doi.org/10.1074/jbc.M116.758102			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2LL	27903650	hybrid, Green Published			2022-12-26	WOS:000392318700010
J	Chien, TL; Wang, JH; Kee, KM; Chen, CH; Hung, CH; Lu, SN				Chien, Tai-Long; Wang, Jing-Houng; Kee, Kwong-Ming; Chen, Chien-Hung; Hung, Chao-Hung; Lu, Sheng-Nan			Factors Predicting HBsAg Seroclearance and Alanine Transaminase Elevation in HBeAg-Negative Hepatitis B Virus-Infected Patients with Persistently Normal Liver Function	PLOS ONE			English	Article							SURFACE-ANTIGEN; NATURAL-HISTORY; DISEASE PROGRESSION; CLINICAL-COURSE; SERUM-LEVELS; LEVELS HELP; NORMAL ALT; CARRIERS; DNA	Background A certain proportion of hepatitis B virus (HBV)-infected patients with persistently normal alanine transaminase (ALT) levels have significant fibrosis. Using liver stiffness measurements (Fibroscan (R)) and laboratory data, including serum ALT, quantitative HBsAg (qHBsAg), and HBV DNA, we attempted to predict the natural histories of these patients. Methods Non-cirrhotic HBeAg-negative chronic hepatitis B patients with persistently normal ALT were followed up prospectively with the end points of HBsAg seroclearance and ALT elevation above the upper limit of normal. The factors that were predictive of the end points were identified. Results A total of 235 patients with an average age of 48.1 +/- 10.7 years were followed up for 7 years. Eight patients (3.4%) lost HBsAg, and 15 patients (6.4%) experienced ALT elevation. The overall cumulative HBsAg seroclearances were 0.4%, 1.3% and 2.3% at years 1, 3 and 5, respectively. Regarding HBsAg seroclearance, the qHBsAg (< 30 IU/ml) cutoff resulted in a hazard ratio (HR) of 19.6 with a 95% confidence interval (CI) of 2.2-166.7 (P = 0.008). The baseline ALT level (odd ratio (OR) 1.075, 95% CI 1.020-1.132, P = 0.006) and a qHBsAg above 1000 IU/ml (3.7, 1.1-12.4, P = 0.032) were associated with ALT elevation. Limited to men, the baseline liver stiffness (1.6, 1.0-2.5, P = 0.031) and a qHBsAg above 1000 IU/ml (10.4, 2.1-52.4, P = 0.004) were factors that were independently associated with ALT elevation. Conclusion A low qHBsAg level predicted HBsAg clearance. Baseline ALT and a qHBsAg above 1000 IU/ml were independent predictive factors for ALT elevation. Among the men, the independent predictive factors for ALT elevation were qHBsAg and liver stiffness.	[Chien, Tai-Long] Antai Med Care Cooperat Antai Tian Sheng Mem Hosp, Div Hepatogastroenterol, Dept Internal Med, Donggang Township, Pingtung County, Taiwan; [Wang, Jing-Houng; Kee, Kwong-Ming; Chen, Chien-Hung; Hung, Chao-Hung; Lu, Sheng-Nan] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Hepatogastroenterol, Kaohsiung, Taiwan; [Wang, Jing-Houng; Kee, Kwong-Ming; Chen, Chien-Hung; Hung, Chao-Hung; Lu, Sheng-Nan] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University	Lu, SN (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Hepatogastroenterol, Kaohsiung, Taiwan.; Lu, SN (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung, Taiwan.	juten@ms17.hinet.net			Chang Gung Memorial Hospital, Taiwan [CMRPG 880881-2]	Chang Gung Memorial Hospital, Taiwan(Chang Gung Memorial Hospital)	This study was supported in part by contract grant (CMRPG 880881-2) from Chang Gung Memorial Hospital, Taiwan, to Dr. Sheng-Nan Lu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank our colleagues Shu-Fen Hung from the research department and Chin-Yun Lin from Biostatistics and Bioinformatics Center, Kaohsiung Chang Gung Memorial Hospital who provided insight and expertise regarding the statistical analyses. This study was supported in part by contract grant (CMRPG 880881-2) from Chang Gung Memorial Hospital, Taiwan to Dr. Sheng-Nan Lu.	Andreani T, 2007, CLIN GASTROENTEROL H, V5, P636, DOI 10.1016/j.cgh.2007.01.005; Arena U, 2008, HEPATOLOGY, V47, P380, DOI 10.1002/hep.22007; Brunetto MR, 2010, GASTROENTEROLOGY, V139, P483, DOI 10.1053/j.gastro.2010.04.052; Chan HLY, 2007, CLIN GASTROENTEROL H, V5, P1462, DOI 10.1016/j.cgh.2007.09.005; Chan HLY, 2010, HEPATOLOGY, V52, P1232, DOI 10.1002/hep.23803; Chen CH, 2004, EUR J GASTROEN HEPAT, V16, P1213, DOI 10.1097/00042737-200411000-00021; Chen CJ, 2011, J GASTROEN HEPATOL, V26, P628, DOI 10.1111/j.1440-1746.2011.06695.x; Chen YC, 2002, GASTROENTEROLOGY, V123, P1084, DOI 10.1053/gast.2002.36026; Chu CM, 2007, HEPATOLOGY, V45, P1187, DOI 10.1002/hep.21612; Feld JJ, 2007, HEPATOLOGY, V46, P1057, DOI 10.1002/hep.21811; Fung J, 2010, HEPATOL INT, V4, P716, DOI 10.1007/s12072-010-9189-z; Hui CK, 2007, HEPATOLOGY, V46, P395, DOI 10.1002/hep.21724; Kumar M, 2008, J GASTROENTEROL, V134, P1376; Kumar M, 2009, GASTROENTEROLOGY, V136, P1272, DOI 10.1053/j.gastro.2009.01.011; Kuo YH, 2015, KAOHSIUNG J MED SCI, V31, P102, DOI 10.1016/j.kjms.2014.11.002; Kwak MS, 2011, DIGESTION, V84, P23, DOI 10.1159/000333211; Lai M, 2007, J HEPATOL, V47, P760, DOI 10.1016/j.jhep.2007.07.022; Liu J, 2010, GASTROENTEROLOGY, V139, P474, DOI 10.1053/j.gastro.2010.04.048; Maimone S, 2016, LIVER INT; Martinot-Peignoux M, 2013, J CLIN VIROL, V58, P401, DOI 10.1016/j.jcv.2013.08.010; McMahon BJ, 2001, ANN INTERN MED, V135, P759, DOI 10.7326/0003-4819-135-9-200111060-00006; Nguyen K, 2015, J VIRAL HEPATITIS, V22, P809, DOI 10.1111/jvh.12388; Park H, 2012, LIVER INT, V32, P796, DOI 10.1111/j.1478-3231.2011.02693.x; Tseng TC, 2013, HEPATOLOGY, V57, P441, DOI 10.1002/hep.26041; Tseng TC, 2012, GASTROENTEROLOGY, V142, P1140, DOI 10.1053/j.gastro.2012.02.007; Tseng TC, 2011, GASTROENTEROLOGY, V141, P517, DOI 10.1053/j.gastro.2011.04.046; Wang JH, 2009, J GASTROENTEROL, V44, P439, DOI 10.1007/s00535-009-0017-y; Xu XR, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/623509	28	1	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0166543	10.1371/journal.pone.0166543	http://dx.doi.org/10.1371/journal.pone.0166543			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935953	Green Published, gold, Green Submitted			2022-12-26	WOS:000389587100033
J	Grove, E; Eckardt, S; McLaughlin, KJ				Grove, Erin; Eckardt, Sigrid; McLaughlin, K. John			High-Speed Mouse Backcrossing Through the Female Germ Line	PLOS ONE			English	Article							GENE-EXPRESSION; SUPEROVULATION; MICE; STRAINS; PERTURBATIONS; METHYLATION; STRATEGIES; MODEL; DNA	Transferring mouse mutations into specific mouse strain backgrounds can be critical for appropriate analysis of phenotypic effects of targeted genomic alterations and quantitative trait loci. Speed congenic breeding strategies incorporating marker-assisted selection of progeny with the highest percentage target background as breeders for the next generation can produce congenic strains within approximately 5 generations. When mating selected donor males to target strain females, this may require more than 1 year, with each generation lasting 10 to 11 weeks including 3 weeks of gestation and 7 to 8 weeks until the males reach sexual maturity. Because ovulation can be induced in female mice as early as 3 weeks of age, superovulation-aided backcrossing of marker-selected females could accelerate the production of congenic animals by approximately 4 weeks per generation, reducing time and cost. Using this approach, we transferred a transgenic strain of undefined genetic background to >99% C57BL/6J within 10 months, with most generations lasting 7 weeks. This involved less than 60 mice in total, with 9 to 18 animals per generation. Our data demonstrate that high-speed backcrossing through the female germline is feasible and practical with small mouse numbers.	[Grove, Erin; Eckardt, Sigrid; McLaughlin, K. John] Nationwide Childrens Hosp, Res Inst, Ctr Mol & Human Genet, Columbus, OH 43205 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital	McLaughlin, KJ (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Mol & Human Genet, Columbus, OH 43205 USA.	John.McLaughlin@nationwidechildrens.org			Research Institute at Nationwide Children's Hospital	Research Institute at Nationwide Children's Hospital(Ohio State University)	This study was funded by The Research Institute at Nationwide Children's Hospital, and there was no additional external funding received for this study.	Ackert-Bicknell CL, 2016, J BONE MINER RES, V31, P270, DOI 10.1002/jbmr.2772; Almind K, 2003, DIABETES, V52, P1535, DOI 10.2337/diabetes.52.6.1535; Armstrong NJ, 2006, MAMM GENOME, V17, P273, DOI 10.1007/s00335-005-0123-y; Behringer R, 1998, NAT GENET, V18, P108, DOI 10.1038/ng0298-108; Behringer RR, 2014, MANIPULATING THE MOU; de Waal E, 2015, HUM MOL GENET, V24, P6975, DOI 10.1093/hmg/ddv400; Denomme MM, 2011, FERTIL STERIL, V96, P734, DOI 10.1016/j.fertnstert.2011.06.055; Fortier AL, 2014, MOL CELL ENDOCRINOL, V388, P51, DOI 10.1016/j.mce.2014.03.003; Gao Z, 2014, J ASSIST REPROD GEN, V31, P1243, DOI 10.1007/s10815-014-0295-z; Huffman SR, 2015, MOL REPROD DEV, V82, P207, DOI 10.1002/mrd.22463; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Landa V, 2010, METHODS MOL BIOL, V597, P267, DOI 10.1007/978-1-60327-389-3_18; Linder CC, 2006, ILAR J, V47, P132, DOI 10.1093/ilar.47.2.132; Luo C, 2011, J AM ASSOC LAB ANIM, V50, P471; Lusis AJ, 2007, ARTERIOSCL THROM VAS, V27, P2100, DOI 10.1161/ATVBAHA.107.147918; Markel P, 1997, NAT GENET, V17, P280, DOI 10.1038/ng1197-280; Market-Velker BA, 2010, BIOL REPROD, V83, P938, DOI 10.1095/biolreprod.110.085480; Market-Velker BA, 2010, HUM MOL GENET, V19, P36, DOI 10.1093/hmg/ddp465; Ogonuki N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004943; Rivera J, 2008, IMMUNITY, V28, P1, DOI 10.1016/j.immuni.2007.12.008; Singh P, 2015, GENETICS, V199, P1, DOI 10.1534/genetics.114.169771; Takeo T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128330; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Vanden Berghe T, 2015, IMMUNITY, V43, P200, DOI 10.1016/j.immuni.2015.06.011; Wei ZT, 2014, J ASSIST REPROD GEN, V31, P555, DOI 10.1007/s10815-014-0191-6; Yoshiki A, 2006, ILAR J, V47, P94, DOI 10.1093/ilar.47.2.94	26	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2016	11	12							e0166822	10.1371/journal.pone.0166822	http://dx.doi.org/10.1371/journal.pone.0166822			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4NG	27926922	Green Published, Green Submitted, gold			2022-12-26	WOS:000389578800007
J	Garge, SS; Nerurkar, AS				Garge, Sneha S.; Nerurkar, Anuradha S.			Attenuation of Quorum Sensing Regulated Virulence of Pectobacterium carotovorum subsp carotovorum through an AHL Lactonase Produced by Lysinibacillus sp Gs50	PLOS ONE			English	Article							N-ACYLHOMOSERINE LACTONASE; SP STRAIN; BACTERIA; ENZYME; GROWTH; SIGNAL; IDENTIFICATION; COMMUNICATION; RHIZOSPHERE; SPECIFICITY	Quorum sensing (QS) is a mechanism in which Gram negative bacterial pathogens sense their population density through acyl homoserine lactones (AHLs) and regulate the expression of virulence factors. Enzymatic degradation of AHLs by lactonases, known as quorum quenching (QQ), is thus a potential strategy for attenuating QS regulated bacterial infections. We characterised the QQ activity of soil isolate Lysinibacillus sp. Gs50 and explored its potential for controlling bacterial soft rot of crop plants. Lysinibacillus sp. Gs50 inactivated AHL, which could be restored upon acidification, suggested that inactivation was due to the lactone ring hydrolysis of AHL. Heterologous expression of cloned gene for putative hydro lase (792 bp) designated adeH from Lysinibacillus sp. Gs50 produced a-29 kDa protein which degraded AHLs of varying chain length. Mass spectrometry analysis of AdeH enzymatic reaction product revealed that AdeH hydrolyses the lactone ring of AHL and hence is an AHL lactonase. Multiple sequence alignment of the amino acid sequence of AdeH showed that it belongs to the metallo-13-lactamase superfamily, has a conserved "HXHXDH" motif typical of AHL lactonases. KM for AdeH for C6HSL was found to be 3.089 mu M and the specific activity was 0.8 picomol min(-1) mu g(-1). AdeH has not so far been reported from any Lysinibacillus sp. and has less than 40% identity with known AHL lactonases. Finally we found that Lysinibacillus sp. Gs50 can degrade AHL produced by Pectobacterium carotovorum subsp. carotovorum (Pcc), a common cause of soft rot. This QQ activity causes a decrease in production of plant cell wall degrading enzymes of Pcc and attenuates symptoms of soft rot in experimental infection of potato, carrot and cucumber. Our results demonstrate the potential of Lysinibacillus sp. Gs50 as a preventive and curative biocontrol agent.	[Nerurkar, Anuradha S.] Maharaja Sayajirao Univ Baroda, Dept Microbiol, Vadodara, Gujarat, India; Maharaja Sayajirao Univ Baroda, Fac Sci, Ctr Biotechnol, Vadodara, Gujarat, India	Maharaja Sayajirao University Baroda; Maharaja Sayajirao University Baroda	Nerurkar, AS (corresponding author), Maharaja Sayajirao Univ Baroda, Dept Microbiol, Vadodara, Gujarat, India.	anuner26@yahoo.com	Nerurkar, Anuradha/AAA-4099-2019		Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India [BT/PR3474/AGR/05/559/2011]	Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India)	ASN acknowledges Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India (BT/PR3474/AGR/05/559/2011), for funding, and SSG for the fellowship in this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed I, 2007, INT J SYST EVOL MICR, V57, P1117, DOI 10.1099/ijs.0.63867-0; Amara N, 2011, CHEM REV, V111, P195, DOI 10.1021/cr100101c; Augustine N, 2010, ARCH MICROBIOL, V192, P1019, DOI 10.1007/s00203-010-0633-1; Barnard AML, 2007, ANAL BIOANAL CHEM, V387, P415, DOI 10.1007/s00216-006-0701-1; Camilli A, 2006, SCIENCE, V311, P1113, DOI 10.1126/science.1121357; Carlier A, 2003, APPL ENVIRON MICROB, V69, P4989, DOI 10.1128/AEM.69.8.4989-4993.2003; Cirou A, 2007, ENVIRON MICROBIOL, V9, P1511, DOI 10.1111/j.1462-2920.2007.01270.x; Czajkowski R, 2009, ACTA BIOCHIM POL, V56, P1; d'Angelo-Picard C, 2005, ENVIRON MICROBIOL, V7, P1796, DOI 10.1111/j.1462-2920.2005.00886.x; Dong YH, 2005, J MICROBIOL, V43, P101; Dong YH, 2004, APPL ENVIRON MICROB, V70, P954, DOI 10.1128/AEM.70.2.954-960.2004; Dong YH, 2000, P NATL ACAD SCI USA, V97, P3526, DOI 10.1073/pnas.060023897; Dong YH, 2002, APPL ENVIRON MICROB, V68, P1754, DOI 10.1128/AEM.68.4.1754-1759.2002; Dong YH, 2001, NATURE, V411, P813, DOI 10.1038/35081101; Faure D, 2007, EUR J PLANT PATHOL, V119, P353, DOI 10.1007/s10658-007-9149-1; Fuqua C, 2001, ANNU REV GENET, V35, P439, DOI 10.1146/annurev.genet.35.102401.090913; Gantner S, 2006, FEMS MICROBIOL ECOL, V56, P188, DOI 10.1111/j.1574-6941.2005.00037.x; Gao A, 2013, ACTA CRYSTALLOGR D, V69, P82, DOI 10.1107/S0907444912042369; Hirakawa H, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00114; Huang JJ, 2003, APPL ENVIRON MICROB, V69, P5941, DOI 10.1128/AEM.69.10.5941-5949.2003; Jafra S, 2006, CAN J MICROBIOL, V52, P1006, DOI 10.1139/W06-062; Kalia VC, 2011, OPEN MICROBIOL J, V5; Kim MH, 2005, BBA-PROTEINS PROTEOM, V1750, P5, DOI 10.1016/j.bbapap.2005.04.004; Leadbetter JR, 2000, J BACTERIOL, V182, P6921, DOI 10.1128/JB.182.24.6921-6926.2000; Lee SJ, 2002, APPL ENVIRON MICROB, V68, P3919, DOI 10.1128/AEM.68.8.3919-3924.2002; Lin YH, 2003, MOL MICROBIOL, V47, P849, DOI 10.1046/j.1365-2958.2003.03351.x; Liu DL, 2007, BIOCHEMISTRY-US, V46, P11789, DOI 10.1021/bi7012849; Liu DL, 2005, P NATL ACAD SCI USA, V102, P11882, DOI 10.1073/pnas.0505255102; Liu H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000093; Maisuria VB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138034; McClean KH, 1997, MICROBIOL-UK, V143, P3703, DOI 10.1099/00221287-143-12-3703; Mei GY, 2010, APPL ENVIRON MICROB, V76, P4933, DOI 10.1128/AEM.00477-10; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Molina L, 2003, FEMS MICROBIOL ECOL, V45, P71, DOI 10.1016/S0168-6496(03)00125-9; Nedjma M, 2001, ANAL BIOCHEM, V291, P290, DOI 10.1006/abio.2001.5032; Pana J, 2008, MICROBIOL RES, V163, P711, DOI 10.1016/j.micres.2007.12.002; Park SY, 2006, FEMS MICROBIOL LETT, V261, P102, DOI 10.1111/j.1574-6968.2006.00336.x; Park SY, 2005, APPL ENVIRON MICROB, V71, P2632, DOI 10.1128/AEM.71.5.2632-2641.2005; Park SY, 2003, MICROBIOL-SGM, V149, P1541, DOI 10.1099/mic.0.26269-0; Seo MJ, 2011, BIOSCI BIOTECH BIOCH, V75, P1789, DOI 10.1271/bbb.110322; Tang KH, 2015, APPL ENVIRON MICROB, V81, P774, DOI 10.1128/AEM.02805-14; Uroz S, 2003, MICROBIOL-SGM, V149, P1981, DOI 10.1099/mic.0.26375-0; Uroz S, 2008, APPL ENVIRON MICROB, V74, P1357, DOI 10.1128/AEM.02014-07; Uroz S, 2007, ARCH MICROBIOL, V187, P249, DOI 10.1007/s00203-006-0186-5; Uroz S, 2009, CHEMBIOCHEM, V10, P205, DOI 10.1002/cbic.200800521; von Bodman SB, 2003, ANNU REV PHYTOPATHOL, V41, P455, DOI 10.1146/annurev.phyto.41.052002.095652; Wang LH, 2004, J BIOL CHEM, V279, P13645, DOI 10.1074/jbc.M311194200; Wang W-Z, 2010, APPL ENVIRON MICROB, V78, P7985; Wang WZ, 2010, APPL ENVIRON MICROB, V76, P2524, DOI 10.1128/AEM.02738-09; Whitehead NA, 2001, FEMS MICROBIOL REV, V25, P365, DOI 10.1111/j.1574-6976.2001.tb00583.x; Yates EA, 2002, INFECT IMMUN, V70, P5635, DOI 10.1128/IAI.70.10.5635-5646.2002; Yin XT, 2010, WORLD J MICROB BIOT, V26, P1361, DOI 10.1007/s11274-010-0308-8; Zhang H, 2007, CURR PROTOC MICROBIO	53	24	27	10	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0167344	10.1371/journal.pone.0167344	http://dx.doi.org/10.1371/journal.pone.0167344			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3TF	27911925	gold, Green Published, Green Submitted			2022-12-26	WOS:000389520600030
J	Alfonso-Gordillo, G; Flores-Ortiz, CM; Morales-Barrera, L; Cristiani-Urbina, E				Alfonso-Gordillo, Guadalupe; Flores-Ortiz, Cesar Mateo; Morales-Barrera, Liliana; Cristiani-Urbina, Eliseo			Biodegradation of Methyl Tertiary Butyl Ether (MTBE) by a Microbial Consortium in a Continuous Up-Flow Packed-Bed Biofilm Reactor: Kinetic Study, Metabolite Identification and Toxicity Bioassays	PLOS ONE			English	Article							SERVICE OIL DISTRIBUTION; PHOTOCATALYTIC DEGRADATION; AEROBIC BIODEGRADATION; STORAGE STATION; WATER; BIOREMEDIATION; OPTIMIZATION; BACTERIA; REMOVAL; WASTE	This study investigated the aerobic biodegradation of methyl tertiary-butyl ether (MTBE) by a microbial consortium in a continuous up-flow packed-bed biofilm reactor using tezontle stone particles as a supporting material for the biofilm. Although MTBE is toxic for microbial communities, the microbial consortium used here was able to resist MTBE loading rates up to 128.3 mg L-1 h(-1), with removal efficiencies of MTBE and chemical oxygen demand (COD) higher than 90%. A linear relationship was observed between the MTBE loading rate and the MTBE removal rate, as well as between the COD loading rate and the COD removal rate, within the interval of MTBE loading rates from 11.98 to 183.71 mg L-1 h(-1). The metabolic intermediate tertiary butyl alcohol (TBA) was not detected in the effluent during all reactor runs, and the intermediate 2-hydroxy butyric acid (2-HIBA) was only detected at MTBE loading rates higher than 128.3 mg L-1 h(-1). The results of toxicity bioassays with organisms from two different trophic levels revealed that the toxicity of the influent was significantly reduced after treatment in the packed-bed reactor. The packed-bed reactor system used in this study was highly effective for the continuous biodegradation of MTBE and is therefore a promising alternative for detoxifying MTBE-laden wastewater and groundwater.	[Alfonso-Gordillo, Guadalupe; Morales-Barrera, Liliana; Cristiani-Urbina, Eliseo] Inst Politecn Nacl, Escuela Nacl Ciencias Biol, Dept Ingn Bioquim, Mexico City, DF, Mexico; [Flores-Ortiz, Cesar Mateo] Univ Nacl Autonoma Mexico, Fac Estudios Super Iztacala, Unidad Biotecnol & Prototipos, Tlalnepantla, Estado De Mexic, Mexico; [Flores-Ortiz, Cesar Mateo] Univ Nacl Autonoma Mexico, Fac Estudios Super Iztacala, Lab Nacl Salud, Tlalnepantla, Estado De Mexic, Mexico	Instituto Politecnico Nacional - Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Cristiani-Urbina, E (corresponding author), Inst Politecn Nacl, Escuela Nacl Ciencias Biol, Dept Ingn Bioquim, Mexico City, DF, Mexico.	ecristianiu@yahoo.com.mx	Morales-Barrera, Liliana/GSD-2373-2022; MORALES-BARRERA, LILIANA/GSD-2320-2022	Cristiani-Urbina, Eliseo/0000-0002-8470-0711; Flores, Cesar M./0000-0002-5837-799X				Abdel-Razek MARS, 2013, J ENVIRON SCI HEAL B, V48, P449, DOI 10.1080/03601234.2013.761863; Acuna-Askar K, 2000, WATER SCI TECHNOL, V42, P153, DOI 10.2166/wst.2000.0509; Aivalioti M, 2012, J HAZARD MATER, V207, P117, DOI 10.1016/j.jhazmat.2011.03.040; Alfonso-Gordillo G, 2016, ELECTRON J BIOTECHN, V23, P12, DOI 10.1016/j.ejbt.2016.06.006; [Anonymous], [No title captured]; Bianchi E, 2009, J CHEM TECHNOL BIOT, V84, P871, DOI 10.1002/jctb.2133; BITTON G, 1992, REV ENVIRON CONTAM T, V125, P1; CALOW P, 1989, HYDROBIOLOGIA, V188, P61, DOI 10.1007/BF00027771; Chen DZ, 2009, J HAZARD MATER, V167, P860, DOI 10.1016/j.jhazmat.2009.01.065; Chen SC, 2011, J HAZARD MATER, V186, P1744, DOI 10.1016/j.jhazmat.2010.12.079; Company Hach, 2008, HACH WAT AN HDB; DEBEER D, 2013, PROKARYOTES, P343; DUTKA BJ, 1982, ENVIRON POLLUT A, V29, P125, DOI 10.1016/0143-1471(82)90116-7; Eixarch H, 2010, PROCESS BIOCHEM, V45, P794, DOI 10.1016/j.procbio.2009.12.015; Ercan D, 2015, CRIT REV BIOTECHNOL, V35, P1, DOI 10.3109/07388551.2013.793170; Gomez-De-Jesus A, 2003, ENG LIFE SCI, V3, P306, DOI 10.1002/elsc.200300052; Guisado IM, 2015, INT BIODETER BIODEGR, V97, P67, DOI 10.1016/j.ibiod.2014.11.008; Gunasekaran V, 2014, PROCESS BIOCHEM, V49, P124, DOI 10.1016/j.procbio.2013.09.028; Hu C, 2004, WATER SCI TECHNOL, V49, P87, DOI 10.2166/wst.2004.0026; Israni SH, 2002, J CHEM TECHNOL BIOT, V77, P1050, DOI 10.1002/jctb.677; Iturbe R, 2003, ENVIRON GEOL, V44, P608, DOI 10.1007/s00254-003-0799-9; Iturbe R, 2003, WATER AIR SOIL POLL, V146, P261, DOI 10.1023/A:1023967325239; Young BJ, 2012, ECOTOX ENVIRON SAFE, V76, P182, DOI 10.1016/j.ecoenv.2011.09.019; Karimi M, 2010, J CHROMATOGR A, V1217, P7017, DOI 10.1016/j.chroma.2010.09.015; Kharoune M, 2001, WATER RES, V35, P1665, DOI 10.1016/S0043-1354(00)00448-6; Kwak Y, 2013, BIOREMEDIAT J, V17, P173, DOI 10.1080/10889868.2013.807773; Lechner U, 2007, INT J SYST EVOL MICR, V57, P1295, DOI 10.1099/ijs.0.64663-0; Lee WM, 2015, CHEMOSPHERE, V128, P191, DOI 10.1016/j.chemosphere.2015.01.023; Levchuk I, 2014, SCI TOTAL ENVIRON, V476, P415, DOI 10.1016/j.scitotenv.2014.01.037; Li SS, 2014, CURR MICROBIOL, V68, P317, DOI 10.1007/s00284-013-0480-9; Li SS, 2015, ENVIRON SCI POLLUT R, V22, P10196, DOI 10.1007/s11356-015-4211-6; Logar R.M., 2007, COMMUN CURR RES ED T, P577; Lopez-Lopez A, 2013, ENVIRON TECHNOL, V34, P1151, DOI 10.1080/09593330.2012.743588; Maciel H, 2008, J MOL MICROB BIOTECH, V15, P190, DOI 10.1159/000121330; Maksimova YG, 2014, APPL BIOCHEM MICRO+, V50, P750, DOI 10.1134/S0003683814080043; Manzanares L, 2001, P 94 ANN C EXH AIR W; Martienssen M, 2006, J CONTAM HYDROL, V87, P37, DOI 10.1016/j.jconhyd.2006.04.007; Muller RH, 2007, APPL ENVIRON MICROB, V73, P1783, DOI 10.1128/AEM.01899-06; Netzahuatl-Munoz AR, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0137086, DOI 10.1371/JOURNAL.PONE.0137086]; Nicolella C, 2000, TRENDS BIOTECHNOL, V18, P312, DOI 10.1016/S0167-7799(00)01461-X; Okeke BC, 2003, MICROBIOL RES, V158, P99, DOI 10.1078/0944-5013-00181; Perez-Lopez H, 2014, BIORESOURCES, V9, P3977; Pimentel-Gonzalez D, 2008, PROCESS BIOCHEM, V43, P1239, DOI 10.1016/j.procbio.2008.07.004; Pourreau DB, 2015, P 3 ANN FOR EXCH TEC; Raynal M, 2008, BIODEGRADATION, V19, P269, DOI 10.1007/s10532-007-9133-7; Razo-Flores E, 2004, STUD SURF SCI CATAL, V151, P513; Reyna G, 2001, P 94 ANN C EXH AIR W; Rodriguez-Medina IC, 2009, J SEP SCI, V32, P3441, DOI 10.1002/jssc.200900298; Rohwerder T, 2006, APPL ENVIRON MICROB, V72, P4128, DOI 10.1128/AEM.00080-06; Rohwerder T, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-13; Roslev P, 2015, CHEMOSPHERE, V120, P284, DOI 10.1016/j.chemosphere.2014.07.003; Seddigi ZS, 2015, PHOTOCHEM PHOTOBIOL, V91, P265, DOI 10.1111/php.12391; Seddigi ZS, 2014, J HAZARD MATER, V264, P71, DOI 10.1016/j.jhazmat.2013.10.070; Siddiqui MN, 2014, J ENVIRON SCI HEAL A, V49, P52, DOI 10.1080/10934529.2013.824298; Tawabini BS, 2015, DESALIN WATER TREAT, V55, P549, DOI 10.1080/19443994.2014.924035; USDA Foreign Agricultural Service, 2009, MEX BIOF REP 2009; van Wezel A, 2009, CHEMOSPHERE, V76, P672, DOI 10.1016/j.chemosphere.2009.03.073; Volpe A, 2009, CHEMOSPHERE, V75, P149, DOI 10.1016/j.chemosphere.2008.12.053; Waul Christopher Kevin, 2007, V5, P213, DOI 10.1007/698_5_087; Wedekind W, 2011, ENVIRON EARTH SCI, V63, P1787, DOI 10.1007/s12665-011-1075-z; Wieczerzak M, 2016, ENVIRON INT, V94, P341, DOI 10.1016/j.envint.2016.05.017; Yanez-Ocampo G, 2011, BIODEGRADATION, V22, P1203, DOI 10.1007/s10532-011-9475-z; Yanez-Ocampo G, 2009, J HAZARD MATER, V168, P1554, DOI 10.1016/j.jhazmat.2009.03.047; ZUCCONI F, 1981, BIOCYCLE, V22, P54	64	15	16	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167494	10.1371/journal.pone.0167494	http://dx.doi.org/10.1371/journal.pone.0167494			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907122	gold, Green Published, Green Submitted			2022-12-26	WOS:000389482700169
J	Bahramali, E; Askari, A; Zakeri, H; Farjam, M; Dehghan, A; Zendehdel, K				Bahramali, Ehsan; Askari, Alireza; Zakeri, Habib; Farjam, Mojtaba; Dehghan, Azizallah; Zendehdel, Kazem			Fasa Registry on Acute Myocardial Infarction (FaRMI): Feasibility Study and Pilot Phase Results	PLOS ONE			English	Article							ACUTE CORONARY SYNDROMES; MORTALITY; TRENDS; EVENTS	Background Myocardial infarction (MI) is the leading cause of death in Iran. Every attempt to improve treatment patterns and patient outcomes needs a surveillance system to both consider the efficacy and safety measures. Fasa Registry on Myocardial Infarction (FaRMI) is the first population-based registry for acute MI in Iran targeted to provide meticulous description of patients' characteristics, to explore the management patterns of these patients, to discover the degree of adherence to the practice guidelines, and to investigate the determinants of poor in-hospital and later outcomes. Methods A diagnosis of acute MI (type I, II and III) was made upon the accepted criteria by the attending cardiologists and types IV and V MI were excluded. Two registrar nurses gathered data on demographics, place of residence and ethnicity, past medical history, risk factors, and the clinical course. Management patterns in the pre-hospital setting, during the hospital stay and at the discharge time were recorded. Routine laboratory results and cardiac biomarkers on three consecutive days were registered. Results pilot phase included the first 95 patients, 63.5% of whom were men and 31.5% were women. With a mean age of 62.89 +/- 13.75 years among participants, the rate of premature MI was 31.8%. ST segment elevation MI accounted for 68.2% cases and inferior wall was the most prevalent region involved followed by anterior and posterior walls. Discussion Obtained data on the characteristics of patients suffering an MI event revealed the major determinants of delay in initiation of therapies and contributors of poor outcome. Completeness of data was guaranteed upon involvement of multiple checkpoints and data quality was secured by means of automatic validation processes in addition to weekly physicians' roundups. Conclusion Execution of FaRMI in the form presented is feasible and it will build up a comprehensive population-based registry for MI in the region.	[Bahramali, Ehsan] Fasa Univ Med Sci, Dept Cardiol, Fasa, Iran; [Bahramali, Ehsan; Zakeri, Habib; Farjam, Mojtaba; Dehghan, Azizallah] Fasa Univ Med Sci, Noncommunicable Dis Res Ctr, Fasa, Iran; [Askari, Alireza] Shiraz Univ Med Sci, Fac Med, Shiraz, Iran; [Farjam, Mojtaba] Fasa Univ Med Sci, Sch Med, Dept Med Pharmacol, Fasa, Iran; [Zendehdel, Kazem] Univ Tehran Med Sci, Canc Inst Iran, Canc Res Ctr, Tehran, Iran	Shiraz University of Medical Science; Tehran University of Medical Sciences	Bahramali, E (corresponding author), Fasa Univ Med Sci, Dept Cardiol, Fasa, Iran.; Bahramali, E (corresponding author), Fasa Univ Med Sci, Noncommunicable Dis Res Ctr, Fasa, Iran.	ebahramali@fums.ac.ir	Dehghan, Azizallah/ABG-3704-2020; Farjam, Mojtaba/O-3475-2017; Dehghan, Azizallah/S-9306-2018; Askari, Alireza/Z-2099-2019; bahramali, ehsan/M-2673-2017; Zakeri, Habib/N-2431-2017	Dehghan, Azizallah/0000-0002-7345-0796; Farjam, Mojtaba/0000-0003-4826-2846; Zakeri, Habib/0000-0003-2495-8507; Bahramali, Ehsan/0000-0001-5454-0406; Zendehdel, Kazem/0000-0002-0269-4945	Iranian ministry of health, national center [1290007/10516]	Iranian ministry of health, national center	This work was funded by Iranian ministry of health, national center for disease registries grant number 1290007/10516 (http://hbi.ir/Forms/Special.aspx?hbsld=774&category=1&templateid=1&hdlld=61). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alnasser SMA, 2015, AM J MED, V128, P766, DOI 10.1016/j.amjmed.2014.12.007; Brown TM, 2015, AM HEART J, V170, P249, DOI 10.1016/j.ahj.2015.04.027; Degano IR, 2015, HEART, V101, P1413, DOI 10.1136/heartjnl-2014-307310; Hanssen M, 2012, HEART, V98, P699, DOI 10.1136/heartjnl-2012-301700; Hasdai D, 2002, EUR HEART J, V23, P1190, DOI 10.1053/euhj.2002.3193; Herrett E, 2010, HEART, V96, P1264, DOI 10.1136/hrt.2009.192328; Khademi H, 2012, OPIUM USE MORTALITY; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Schmidt Morten, 2012, BMJ, V344, pe356, DOI 10.1136/bmj.e356; Smolina Kate, 2012, BMJ, V344, pd8059, DOI 10.1136/bmj.d8059; Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001	11	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167579	10.1371/journal.pone.0167579	http://dx.doi.org/10.1371/journal.pone.0167579			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907128	Green Submitted, Green Published, gold			2022-12-26	WOS:000389482700202
J	Bernardino, T; Tatemoto, P; Morrone, B; Rodrigues, PHM; Zanella, AJ				Bernardino, Thiago; Tatemoto, Patricia; Morrone, Beatrice; Mazza Rodrigues, Paulo Henrique; Zanella, Adroaldo Jose			Piglets Born from Sows Fed High Fibre Diets during Pregnancy Are Less Aggressive Prior to Weaning	PLOS ONE			English	Article							DENDRITIC SPINE DENSITY; PRENATAL STRESS; GROWING PIGS; FOOD RESTRICTION; GENE-EXPRESSION; BLOOD-GLUCOSE; SKIN-LESIONS; DOMESTIC PIG; BEHAVIOR; PERFORMANCE	Aggressive interactions, and their consequences, are the most important causes of poor welfare in piglets. Aggressive behaviour can be modulated by the prenatal and neonatal environment in several species. Commercially kept pregnant sows are often subjected to food restriction, which can compromise their welfare. Limited information is available on the consequences of sow hunger during pregnancy on welfare outcomes for their piglets. High fibre diets can mitigate the feeling of hunger and, consequently, it may improve welfare and productivity measures. The aim of this study was to assess the consequences of feeding pregnant gilts with high fibre diets (HFD) on agonistic behaviour, as manifested by skin lesions, and indicators of fear in their piglets at weaning. Twenty-two pregnant gilts were fed either HFD, 12.86% of crude fibre, 2.4 kg per day (N = 14), or low fibre diet (LFD), 2.53% of crude fibre, 2.0 kg per day (N = 8). During lactation, both treatments received the same diet, ad libitum. We investigated the impact of HFD on behaviour and performance measures (birth weight, average daily gain, weaning weight, see S3 File) in the offspring. Skin lesions were evaluated before and after weaning in 156 piglets (100 HFD and 56 LFD), and 142 piglets were subjected to an open field test and a novel object test (87 HFD and 55 LFD). We found no treatment effect on the performance measures. Piglets born from gilts that received HFD had fewer skin lesions before weaning (D28) than the offspring of LFD gilts, while no difference was found during days 29 and 30. In the open field and novel object tests, there was no treatment effect on the behaviour of piglets. The improved skin health at weaning in piglets of sows fed HFD suggests less agonistic interactions amongst these littermates than in piglets of sows fed LFD.	[Bernardino, Thiago; Tatemoto, Patricia; Morrone, Beatrice; Zanella, Adroaldo Jose] Univ Sao Paulo, Sch Vet Med & Anim Sci, Dept Prevent Vet Med & Anim Hlth, Pirassununga, Brazil; [Mazza Rodrigues, Paulo Henrique] Univ Sao Paulo, Sch Vet Med & Anim Sci, Dept Anim Nutr & Prod, Pirassununga, Brazil; [Bernardino, Thiago; Tatemoto, Patricia; Morrone, Beatrice; Mazza Rodrigues, Paulo Henrique; Zanella, Adroaldo Jose] Univ Sao Paulo, Sch Vet Med & Anim Sci, Pirassununga, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Zanella, AJ (corresponding author), Univ Sao Paulo, Sch Vet Med & Anim Sci, Dept Prevent Vet Med & Anim Hlth, Pirassununga, Brazil.; Zanella, AJ (corresponding author), Univ Sao Paulo, Sch Vet Med & Anim Sci, Pirassununga, Brazil.	adroaldo.zanella@usp.br	Bernardino, Thiago/I-2939-2016; Zanella, Adroaldo J/G-7775-2014; Rodrigues, Paulo HM/O-2689-2017	Bernardino, Thiago/0000-0002-2146-0669; Zanella, Adroaldo J/0000-0002-5505-1679; Rodrigues, Paulo HM/0000-0002-4646-6805	Department of Preventive Veterinary Medicine and Animal Health, School of Veterinary Medicine and Animal Science, University of Sao Paulo; CAPES; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [312985/2013-4]	Department of Preventive Veterinary Medicine and Animal Health, School of Veterinary Medicine and Animal Science, University of Sao Paulo; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funds were provided by the Department of Preventive Veterinary Medicine and Animal Health, School of Veterinary Medicine and Animal Science, University of Sao Paulo, with resources from CAPES, and by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (award 312985/2013-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algers B., 2007, EFSA J, V572, P1; Andersen IL, 2000, APPL ANIM BEHAV SCI, V68, P107, DOI 10.1016/S0168-1591(00)00092-7; APPLEBY MC, 1987, ANIM PROD, V45, P103, DOI 10.1017/S0003356100036680; Bolhuis JE, 2010, APPL ANIM BEHAV SCI, V123, P77, DOI 10.1016/j.applanim.2010.01.010; BROUNS F, 1994, APPL ANIM BEHAV SCI, V39, P215, DOI 10.1016/0168-1591(94)90157-0; Brunton PJ, 2013, REPRODUCTION, P146; Camerlink I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113502; Coulon M, 2013, PSYCHONEUROENDOCRINO, V38, P1112, DOI 10.1016/j.psyneuen.2012.10.018; Couret D, 2009, PHYSIOL BEHAV, V98, P498, DOI 10.1016/j.physbeh.2009.08.003; de Leeuw JA, 2005, APPL ANIM BEHAV SCI, V94, P15, DOI 10.1016/j.applanim.2005.02.006; de Leeuw JA, 2004, J NUTR, V134, P1481, DOI 10.1093/jn/134.6.1481; DELL PA, 1987, PHYSIOL BEHAV, V39, P187, DOI 10.1016/0031-9384(87)90008-4; Gentilini FP, CIENCIA RURAL; Guy JH, 2009, ANIM WELFARE, V18, P249; Harris MJ, 2001, APPL ANIM BEHAV SCI, V74, P153, DOI 10.1016/S0168-1591(01)00160-5; Holt JP, 2006, J ANIM SCI, V84, P946, DOI 10.2527/2006.844946x; Janczak AM, 2003, APPL ANIM BEHAV SCI, V81, P13, DOI 10.1016/S0168-1591(02)00252-6; Jarvis S, 2006, HORM BEHAV, V49, P68, DOI 10.1016/j.yhbeh.2005.05.004; LAWRENCE AB, 1993, J ANIM SCI, V71, P2815, DOI 10.2527/1993.71102815x; LAWRENCE AB, 1988, ANIM PROD, V47, P131, DOI 10.1017/S0003356100037132; Lepionka L, 1997, REPROD NUTR DEV, V37, P449, DOI 10.1051/rnd:19970406; Meunier-Salaun MC, 2001, ANIM FEED SCI TECH, V90, P53, DOI 10.1016/S0377-8401(01)00196-1; Morgan CA, 1998, APPL ANIM BEHAV SCI, V58, P23, DOI 10.1016/S0168-1591(97)00141-X; PETHERICK JC, 1987, AUST J EXP AGR, V27, P605, DOI 10.1071/EA9870605; Petit B, 2015, BEHAV BRAIN RES, V291, P155, DOI 10.1016/j.bbr.2015.05.025; Poltyrev T, 1996, DEV PSYCHOBIOL, V29, P453, DOI 10.1002/(SICI)1098-2302(199607)29:5<453::AID-DEV4>3.0.CO;2-N; Puppe B, 2007, APPL ANIM BEHAV SCI, V105, P75, DOI 10.1016/j.applanim.2006.05.016; Rerat A, 1996, REPROD NUTR DEV, V36, P3, DOI 10.1051/rnd:19960101; ROBERT S, 1993, APPL ANIM BEHAV SCI, V37, P297, DOI 10.1016/0168-1591(93)90119-A; Rutherford KMD, 2014, PHYSIOL BEHAV, V129, P255, DOI 10.1016/j.physbeh.2014.02.052; Souza AS, 2006, APPL ANIM BEHAV SCI, V99, P77, DOI 10.1016/j.applanim.2005.09.008; Tuchscherer M, 2002, VET IMMUNOL IMMUNOP, V86, P195, DOI 10.1016/S0165-2427(02)00035-1; Turner SP, 2000, LIVEST PROD SCI, V66, P47, DOI 10.1016/S0301-6226(00)00159-7; Turner SP, 2006, APPL ANIM BEHAV SCI, V96, P245, DOI 10.1016/j.applanim.2005.06.009; Veum TL, 2009, J ANIM SCI, V87, P1003, DOI 10.2527/jas.2008-1119; Yuan Y, 2004, APPL ANIM BEHAV SCI, V88, P39, DOI 10.1016/j.applanim.2004.01.012; Zonderland JJ, 2004, APPL ANIM BEHAV SCI, V87, P15, DOI 10.1016/j.applanim.2003.12.009	37	18	18	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167363	10.1371/journal.pone.0167363	http://dx.doi.org/10.1371/journal.pone.0167363			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907173	Green Submitted, Green Published, gold			2022-12-26	WOS:000389482700129
J	Cheng, Y; Zhao, G; Zhang, SW; Nigim, F; Zhou, GT; Yu, ZY; Song, Y; Chen, Y; Li, YQ				Cheng, Ye; Zhao, Gang; Zhang, Siwen; Nigim, Fares; Zhou, Guangtong; Yu, Zhiyun; Song, Yang; Chen, Yong; Li, Yunqian			AS1411-Induced Growth Inhibition of Glioma Cells by Up-Regulation of p53 and Down-Regulation of Bcl-2 and Akt1 via Nucleolin	PLOS ONE			English	Article							MESSENGER-RNA; ADJUVANT TEMOZOLOMIDE; TUMOR-GROWTH; CANCER; PROTEIN; AS1411; DNA; APTAMER; GLIOBLASTOMA; EXPRESSION	AS1411 binds nucleolin (NCL) and is the first oligodeoxynucleotide aptamer to reach phase I and II clinical trials for the treatment of several cancers. However, the mechanisms by which AS1411 targets and kills glioma cells and tissues remain unclear. Here we report that AS1411 induces cell apoptosis and cycle arrest, and inhibits cell viability by up-regulation of p53 and down-regulation of Bcl-2 and Akt1 in human glioma cells. NCL was overexpressed in both nucleus and cytoplasm in human glioma U87, U251 and SHG44 cells compared to normal human astrocytes (NHA). AS1411 bound NCL and inhibited the proliferation of glioma cells but not NHA, which was accompanied with up-regulation of p53 and down-regulation of Bcl-2 and Akt1. Moreover, AS1411 treatment resulted in the G2/M cell cycle arrest in glioma cells, which was however abolished by overexpression of NCL. Further, AS1411 induced cell apoptosis, which was prevented by silencing of p53 and overexpression of Bcl-2. In addition, AS1411 inhibited the migration and invasion of glioma cells in an Akt1-dependent manner. Importantly, AS1411 inhibited the growth of glioma xenograft and prolonged the survival time of glioma tumor-bearing mice. These results revealed a promising treatment of glioma by oligodeoxynucleotide aptamer.	[Cheng, Ye; Zhao, Gang; Zhou, Guangtong; Yu, Zhiyun; Song, Yang; Chen, Yong; Li, Yunqian] Jilin Univ, Hosp 1, Dept Neurosurg, Changchun, Peoples R China; [Zhang, Siwen] Jilin Univ, Hosp 1, Dept Endocrine, Changchun, Peoples R China; [Cheng, Ye; Nigim, Fares] Harvard Med Sch, Dept Neurosurg, Boston, MA USA	Jilin University; Jilin University; Harvard University; Harvard Medical School	Chen, Y; Li, YQ (corresponding author), Jilin Univ, Hosp 1, Dept Neurosurg, Changchun, Peoples R China.	chenyong_jdyy@163.com; liyunqian_jdyy@163.com		yu, zhiyun/0000-0002-9773-4769	National Natural Science Foundation of China [21401072, 81672505]; China Scholarship Council	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council)	This work was supported by grants from National Natural Science Foundation of China (Nos. 21401072 and 81672505). This work was supported by China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Young Scientists Fund of the National Natural Science Foundation of China (No.21401072); This work was supported by China Scholarship Council.	Abdelmohsen K, 2012, RNA BIOL, V9, P799, DOI 10.4161/rna.19718; Abdelmohsen K, 2011, NUCLEIC ACIDS RES, V39, P8513, DOI 10.1093/nar/gkr488; Bates PJ, 2009, EXP MOL PATHOL, V86, P151, DOI 10.1016/j.yexmp.2009.01.004; Benedetti E, 2015, ONCOTARGET, V6, P42091, DOI 10.18632/oncotarget.5990; Bouvet P, 1998, J BIOL CHEM, V273, P19025, DOI 10.1074/jbc.273.30.19025; Brazda V, 2014, INT J MOL SCI, V15, P17493, DOI 10.3390/ijms151017493; Chen Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2091; Cheng Y, 2016, ONCOTARGET, V7, P12682, DOI 10.18632/oncotarget.7259; Galzio R, 2012, J CELL BIOCHEM, V113, P571, DOI 10.1002/jcb.23381; Gao HL, 2014, ACTA BIOMATER, V10, P858, DOI 10.1016/j.actbio.2013.11.003; GHISOLFI L, 1992, EUR J BIOCHEM, V209, P541, DOI 10.1111/j.1432-1033.1992.tb17318.x; Gimenez M, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1473-9; Ginisty H, 1999, J CELL SCI, V112, P761; Gleave ME, 2005, NAT REV CANCER, V5, P468, DOI 10.1038/nrc1631; Goldshmit Y, 2014, ONCOTARGET, V5, P8602, DOI 10.18632/oncotarget.2343; Griffin SV, 2006, J BIOL CHEM, V281, P28048, DOI 10.1074/jbc.M513336200; Hers I, 2011, CELL SIGNAL, V23, P1515, DOI 10.1016/j.cellsig.2011.05.004; Huang PH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.287re6; Huwiler A, 2003, J BIOL CHEM, V278, P51758, DOI 10.1074/jbc.M305722200; Ireson CR, 2006, MOL CANCER THER, V5, P2957, DOI 10.1158/1535-7163.MCT-06-0172; Ishimaru D, 2010, J BIOL CHEM, V285, P27182, DOI 10.1074/jbc.M109.098830; Koutsioumpa M, 2014, RECENT PAT ANTI-CANC, V9, DOI 10.2174/1574892808666131119095953; Luan SH, 2010, ARCH MED RES, V41, P67, DOI 10.1016/j.arcmed.2010.02.007; Ma HW, 2014, BIOCHEM BIOPH RES CO, V449, P44, DOI 10.1016/j.bbrc.2014.04.148; Mongelard F, 2007, TRENDS CELL BIOL, V17, P80, DOI 10.1016/j.tcb.2006.11.010; Mongelard F, 2010, CURR OPIN MOL THER, V12, P107; Mu QC, 2015, CANCER BIOL THER, V16, P623, DOI 10.1080/15384047.2015.1019185; Opalinska JB, 2002, NAT REV DRUG DISCOV, V1, P503, DOI 10.1038/nrd837; Otake Y, 2007, BLOOD, V109, P3069, DOI 10.1182/blood-2006-08-043257; Perrone R, 2016, INT J ANTIMICROB AG, V47, P311, DOI 10.1016/j.ijantimicag.2016.01.016; Pich A, 2000, MICRON, V31, P133, DOI 10.1016/S0968-4328(99)00070-0; Pichiorri F, 2013, J EXP MED, V210, P951, DOI 10.1084/jem.20120950; Roos WP, 2007, ONCOGENE, V26, P186, DOI 10.1038/sj.onc.1209785; Rosenberg JE, 2014, INVEST NEW DRUG, V32, P178, DOI 10.1007/s10637-013-0045-6; Seinsoth S, 2003, EMBO REP, V4, P263, DOI 10.1038/sj.embor.embor770; Sengupta TK, 2004, J BIOL CHEM, V279, P10855, DOI 10.1074/jbc.M309111200; Soundararajan S, 2008, CANCER RES, V68, P2358, DOI 10.1158/0008-5472.CAN-07-5723; Srivastava M, 1999, FASEB J, V13, P1911, DOI 10.1096/fasebj.13.14.1911; Storck Sebastien, 2007, Subcell Biochem, V41, P125; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; Teng Y, 2007, CANCER RES, V67, P10491, DOI 10.1158/0008-5472.CAN-06-4206; Ugrinova I, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-66; Vlatkovic N, 2014, CELL MOL LIFE SCI, V71, P771, DOI 10.1007/s00018-013-1361-x; Watanabe T, 2010, BIOL PHARM BULL, V33, P796, DOI 10.1248/bpb.33.796; Willimott S, 2010, BIOCHEM SOC T, V38, P1571, DOI 10.1042/BST0381571; Wu YL, 2001, ONCOGENE, V20, P240, DOI 10.1038/sj.onc.1204067; Xu ZQ, 2012, J NEURO-ONCOL, V108, P59, DOI 10.1007/s11060-012-0827-2; Zhang GQ, 2016, BIOCHEM BIOPH RES CO, V469, P189, DOI 10.1016/j.bbrc.2015.11.099; Zhang HJ, 2013, CURR PHARM BIOTECHNO, V14, P1105, DOI 10.2174/1389201015666140408123710	51	25	28	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167094	10.1371/journal.pone.0167094	http://dx.doi.org/10.1371/journal.pone.0167094			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907160	Green Submitted, Green Published, gold			2022-12-26	WOS:000389482700076
J	Cortese, G; Gandasi, NR; Barge, S; Pedersen, MG				Cortese, Giuliana; Gandasi, Nikhil R.; Barge, Sebastian; Pedersen, Morten Gram			Statistical Frailty Modeling for Quantitative Analysis of Exocytotic Events Recorded by Live Cell Imaging: Rapid Release of Insulin-Containing Granules Is Impaired in Human Diabetic beta-cells	PLOS ONE			English	Article							SECRETORY GRANULES; CHROMAFFIN CELLS; CA2+ CHANNELS; PEPTIDE SECRETION; CALCIUM; DYNAMICS; DISSOCIATION; VESICLES; SYNTAXIN; DOCKING	Hormones and neurotransmitters are released when secretory granules or synaptic vesicles fuse with the cell membrane, a process denoted exocytosis. Modern imaging techniques, in particular total internal reflection fluorescence (TIRF) microscopy, allow the investigator to monitor secretory granules at the plasma membrane before and when they undergo exocytosis. However, rigorous statistical approaches for temporal analysis of such exocytosis data are still lacking. We propose here that statistical methods from time-to-event (also known as survival) analysis are well suited for the problem. These methods are typically used in clinical settings when individuals are followed over time to the occurrence of an event such as death, remission or conception. We model the rate of exocytosis in response to pulses of stimuli in insulin-secreting pancreatic beta-cell from healthy and diabetic human donors using piecewise-constant hazard modeling. To study heterogeneity in the granule population we exploit frailty modeling, which describe unobserved differences in the propensity to exocytosis. In particular, we insert a discrete frailty in our statistical model to account for the higher rate of exocytosis in an immediately releasable pool (IRP) of insulin-containing granules. Estimates of parameters are obtained from maximum-likelihood methods. Since granules within the same cell are correlated, i.e., the data are clustered, a modified likelihood function is used for log-likelihood ratio tests in order to perform valid inference. Our approach allows us for example to estimate the size of the IRP in the cells, and we find that the IRP is deficient in diabetic cells. This novel application of time-to-event analysis and frailty modeling should be useful also for the study of other well-defined temporal events at the cellular level.	[Cortese, Giuliana] Univ Padua, Dept Stat Sci, Padua, Italy; [Gandasi, Nikhil R.; Barge, Sebastian] Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden; [Pedersen, Morten Gram] Univ Padua, Dept Informat Engn, Padua, Italy	University of Padua; Uppsala University; University of Padua	Pedersen, MG (corresponding author), Univ Padua, Dept Informat Engn, Padua, Italy.	pedersen@dei.unipd.it	Cortese, Giuliana/AAA-1603-2020; Pedersen, Morten Gram/P-5247-2019; Barg, Sebastian/F-9523-2010; Pedersen, Morten/F-4134-2012; Gandasi, Nikhil R/F-2164-2018	Pedersen, Morten Gram/0000-0002-2639-2394; Barg, Sebastian/0000-0003-4661-5724; Pedersen, Morten/0000-0002-2639-2394; Gandasi, Nikhil R/0000-0001-9400-6494	University of Padova; Swedish Society for Medical Research; European Foundation for the Study of Diabetes; Swedish Science Council; Diabetes Wellness Network Sweden; Swedish Diabetes Society; Barndiabetesfonden; Hjarnfonden; NovoNordisk-foundation; Goran Gustafsson-foundation; Family Ernfors-foundation; OE&E Johanssons-foundation; European Foundation for the Study of Diabetes via the EFSD/Boehringer Ingelheim Basic Programme; University of Padua via the Strategic Project 'DYCENDI'; Novo Nordisk Fonden [NNF15OC0016260, NNF14OC0010001] Funding Source: researchfish; European Foundation for the Study of Diabetes [Lilly FS 2016_9, BI 2014_5] Funding Source: researchfish	University of Padova; Swedish Society for Medical Research; European Foundation for the Study of Diabetes; Swedish Science Council; Diabetes Wellness Network Sweden; Swedish Diabetes Society; Barndiabetesfonden; Hjarnfonden; NovoNordisk-foundation(Novo Nordisk Foundation); Goran Gustafsson-foundation; Family Ernfors-foundation; OE&E Johanssons-foundation; European Foundation for the Study of Diabetes via the EFSD/Boehringer Ingelheim Basic Programme; University of Padua via the Strategic Project 'DYCENDI'; Novo Nordisk Fonden(Novo Nordisk Foundation); European Foundation for the Study of Diabetes	This work was supported by the University of Padova to GC. NG received support from the Swedish Society for Medical Research and the European Foundation for the Study of Diabetes. SB acknowledges support from the Swedish Science Council, Diabetes Wellness Network Sweden, the Swedish Diabetes Society, the European Foundation for the Study of Diabetes, Barndiabetesfonden, Hjarnfonden, and the NovoNordisk-, Goran Gustafsson-, Family Ernfors-, and OE&E Johanssons-foundations. MGP was supported by the European Foundation for the Study of Diabetes via the EFSD/Boehringer Ingelheim Basic Programme, and the University of Padua via the Strategic Project 'DYCENDI'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2021, LANG ENV STAT COMP; Arai Mahmood, 2015, CLUSTER ROBUST STAND; Ashcroft FM, 2012, CELL, V148, P1160, DOI 10.1016/j.cell.2012.02.010; Barg S, 2010, P NATL ACAD SCI USA, V107, P20804, DOI 10.1073/pnas.1014823107; Barg S, 2001, BIOPHYS J, V81, P3308, DOI 10.1016/S0006-3495(01)75964-4; Becherer U, 2003, NAT NEUROSCI, V6, P846, DOI 10.1038/nn1087; Bertuzzi A, 2007, AM J PHYSIOL-ENDOC M, V293, pE396, DOI 10.1152/ajpendo.00647.2006; Braun M, 2008, DIABETES, V57, P1618, DOI 10.2337/db07-0991; Burgoyne RD, 2003, PHYSIOL REV, V83, P581, DOI 10.1152/physrev.00031.2002; Chandler RE, 2007, BIOMETRIKA, V94, P167, DOI 10.1093/biomet/asm015; Claeskens G, 2008, TEST, V17, P69, DOI 10.1007/s11749-006-0023-9; Collins SC, 2010, DIABETES, V59, P1192, DOI 10.2337/db09-0791; Corkey BE, 2012, DIABETES, V61, P4, DOI 10.2337/db11-1483; Cortese G, 2010, BIOMETRICAL J, V52, P138, DOI 10.1002/bimj.200900076; Cortese G, 2010, STAT METHODS MED RES, V19, P5, DOI 10.1177/0962280209105022; CURRY DL, 1968, ENDOCRINOLOGY, V83, P572, DOI 10.1210/endo-83-3-572; Dalgaard P, 2008, STAT COMPUT SER, P1, DOI 10.1007/978-0-387-79054-1_1; Daniel S, 1999, DIABETES, V48, P1686, DOI 10.2337/diabetes.48.9.1686; Davison A., 2003, STAT MODELS; Del Guerra S, 2005, DIABETES, V54, P727, DOI 10.2337/diabetes.54.3.727; Del Prato S, 2002, DIABETES, V51, pS109, DOI 10.2337/diabetes.51.2007.S109; Edlund A, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-87; Eliasson L, 2008, J PHYSIOL-LONDON, V586, P3313, DOI 10.1113/jphysiol.2008.155317; Gandasi NR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127801; Gandasi NR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4914; Gilbert P., 2016, NUMDERIV ACCURATE NU; GRODSKY GM, 1972, J CLIN INVEST, V51, P2047, DOI 10.1172/JCI107011; HEINEMANN C, 1994, BIOPHYS J, V67, P2546, DOI 10.1016/S0006-3495(94)80744-1; Hoppa MB, 2009, CELL METAB, V10, P455, DOI 10.1016/j.cmet.2009.09.011; Kahn SE, 2003, DIABETOLOGIA, V46, P3, DOI 10.1007/s00125-002-1009-0; Karatekin E, 2008, BIOPHYS J, V94, P2891, DOI 10.1529/biophysj.107.116756; Klein JP, 2005, SURVIVAL ANAL TECHNI; Lang T, 1997, NEURON, V18, P857, DOI 10.1016/S0896-6273(00)80325-6; Lizunov VA, 2013, DIABETES, V62, P3114, DOI 10.2337/db12-1741; Michael DJ, 2007, DIABETES, V56, P1277, DOI 10.2337/db06-0367; Midorikawa M, 2015, NEURON, V88, P492, DOI 10.1016/j.neuron.2015.09.047; Montefusco F, 2015, J PHYSIOL-LONDON, V593, P4519, DOI 10.1113/JP270777; Moser T, 1997, J NEUROSCI, V17, P2314; Ohara-Imaizumi M, 2002, J BIOL CHEM, V277, P3805, DOI 10.1074/jbc.C100712200; Pedersen MG, 2010, J NEUROENDOCRINOL, V22, P1315, DOI 10.1111/j.1365-2826.2010.02056.x; Pedersen MG, 2008, PHILOS T R SOC A, V366, P3525, DOI 10.1098/rsta.2008.0120; Pedersen MG, 2011, BIOPHYS J, V101, P793, DOI 10.1016/j.bpj.2011.06.061; Pedersen MG, 2009, P NATL ACAD SCI USA, V106, P7432, DOI 10.1073/pnas.0901202106; Pories WJ, 2012, DIABETES CARE, V35, P2438, DOI 10.2337/dc12-0684; Rorsman P, 2003, DIABETOLOGIA, V46, P1029, DOI 10.1007/s00125-003-1153-1; Rorsman P, 2013, ANNU REV PHYSIOL, V75, P155, DOI 10.1146/annurev-physiol-030212-183754; Rorsman P, 2011, PROG BIOPHYS MOL BIO, V107, P224, DOI 10.1016/j.pbiomolbio.2011.06.009; Rua SMH, 2016, STAT METHODS MED RES, V25, P167, DOI 10.1177/0962280212445658; Stabley DR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9307; Stenkula KG, 2010, CELL METAB, V12, P250, DOI 10.1016/j.cmet.2010.08.005; Steyer JA, 1997, NATURE, V388, P474, DOI 10.1038/41329; THOMAS P, 1993, NEURON, V11, P93, DOI 10.1016/0896-6273(93)90274-U; Toomre Derek, 2012, Cold Spring Harb Protoc, V2012, P439, DOI 10.1101/pdb.ip068676; Trexler AJ, 2016, MOL BIOL CELL, V27, P2423, DOI 10.1091/mbc.E16-01-0057; VAUPEL JW, 1979, DEMOGRAPHY, V16, P439, DOI 10.2307/2061224; Voets T, 2000, NEURON, V28, P537, DOI 10.1016/S0896-6273(00)00131-8; Wienke A., 2010, FRAILTY MODELS SURVI, DOI [10.1201/9781420073911, DOI 10.1201/9781420073911]; Yu BB, 2008, COMPUT STAT DATA AN, V52, P1524, DOI 10.1016/j.csda.2007.04.018	58	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167282	10.1371/journal.pone.0167282	http://dx.doi.org/10.1371/journal.pone.0167282			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907065	Green Published, Green Submitted, gold			2022-12-26	WOS:000389482700110
J	Ferraro, M; Masetti, M; Recanatini, M; Cavalli, A; Bottegoni, G				Ferraro, Mariarosaria; Masetti, Matteo; Recanatini, Maurizio; Cavalli, Andrea; Bottegoni, Giovanni			Mapping Cholesterol Interaction Sites on Serotonin Transporter through Coarse Grained Molecular Dynamics	PLOS ONE			English	Article							X-RAY STRUCTURES; NEUROTRANSMITTER TRANSPORTERS; DOPAMINE TRANSPORTER; BINDING-SITE; SUBSTRATE-BINDING; BACTERIAL HOMOLOG; MEMBRANE-PROTEINS; LIPID RAFTS; MECHANISM; SIMULATIONS	Serotonin transporter (SERT) modulates serotonergic signaling via re-uptake of serotonin in pre-synaptic cells. The inclusion in cholesterol-enriched membrane domains is crucial for SERT activity, suggesting a cross-talk between the protein and the sterol. Here, we develop a protocol to identify potential cholesterol interaction sites coupling statistical analysis to multi-microsecond coarse-grained molecular dynamics simulations of SERT in a previously validated raft-like membrane model. Six putative sites were found, including a putative CRAC motif on TM4 and a CARC motif on TM10. Among them, four hot-spots near regions related to ion binding, transport, and inhibition were detected. Our results encourage prospective studies to unravel mechanistic features of the transporter and related drug discovery implications.	[Ferraro, Mariarosaria; Cavalli, Andrea; Bottegoni, Giovanni] Ist Italiano Tecnol, CompuNet, Genoa, Italy; [Masetti, Matteo; Recanatini, Maurizio; Cavalli, Andrea] Alma Mater Studiorum Univ Bologna, Dept Pharm & Biotechnol FaBiT, Bologna, Italy; [Bottegoni, Giovanni] BiKi Technol Srl, Genoa, Italy	Istituto Italiano di Tecnologia - IIT; University of Bologna	Bottegoni, G (corresponding author), Ist Italiano Tecnol, CompuNet, Genoa, Italy.; Masetti, M (corresponding author), Alma Mater Studiorum Univ Bologna, Dept Pharm & Biotechnol FaBiT, Bologna, Italy.; Bottegoni, G (corresponding author), BiKi Technol Srl, Genoa, Italy.	matteo.masetti4@unibo.it; giovanni.bottegoni@iit.it	Recanatini, Maurizio/AAU-3319-2021; Recanatini, Maurizio/GXH-1338-2022	Recanatini, Maurizio/0000-0002-0039-0518; Bottegoni, Giovanni/0000-0003-1251-583X; CAVALLI, ANDREA/0000-0002-6370-1176				Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Bjerregaard H, 2015, J BIOL CHEM, V290, P7747, DOI 10.1074/jbc.M114.573477; Bray D, 1998, ANNU REV BIOPH BIOM, V27, P59, DOI 10.1146/annurev.biophys.27.1.59; Buchmayer F, 2013, P NATL ACAD SCI USA, V110, P11642, DOI 10.1073/pnas.1220552110; Cang XH, 2014, PROTEINS, V82, P760, DOI 10.1002/prot.24456; Cang XH, 2013, J PHYS CHEM B, V117, P1085, DOI 10.1021/jp3118192; Celik L, 2008, J AM CHEM SOC, V130, P3853, DOI 10.1021/ja076403h; Celik L, 2008, BIOPHYS J, V94, P1600, DOI 10.1529/biophysj.107.117580; Chen FH, 2005, J NEUROCHEM, V92, P21, DOI 10.1111/j.1471-4159.2004.02835.x; Coleman JA, 2016, NATURE, V532, P334, DOI 10.1038/nature17629; de Jong DH, 2013, J CHEM THEORY COMPUT, V9, P687, DOI 10.1021/ct300646g; de Jong DH, 2012, J CHEM THEORY COMPUT, V8, P1003, DOI 10.1021/ct200599d; Divito CB, 2009, MOL INTERV, V9, P252, DOI 10.1124/mi.9.5.8; Fantini J, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00031; Ferraro M, 2015, RSC ADV, V5, P37102, DOI 10.1039/c5ra02196k; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Forrest LR, 2006, BIOPHYS J, V91, P508, DOI 10.1529/biophysj.106.082313; Forrest LR, 2009, PHYSIOLOGY, V24, P377, DOI 10.1152/physiol.00030.2009; Grouleff J, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00235; Grouleff J, 2015, BBA-BIOMEMBRANES, V1848, P1783, DOI 10.1016/j.bbamem.2015.03.029; Hamilton PJ, 2014, NAT CHEM BIOL, V10, P582, DOI [10.1038/NCHEMBIO.1545, 10.1038/nchembio.1545]; Hansen FH, 2014, J CLIN INVEST, V124, P3107, DOI 10.1172/JCI73778; Hedger G., 2016, BIOCH BIOPHYS ACTA; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hong WC, 2010, J BIOL CHEM, V285, P32616, DOI 10.1074/jbc.M110.150565; Jafurulla M, 2011, BIOCHEM BIOPH RES CO, V404, P569, DOI 10.1016/j.bbrc.2010.12.031; Jess U, 1996, FEBS LETT, V394, P44, DOI 10.1016/0014-5793(96)00916-7; Just H, 2004, J BIOL CHEM, V279, P6650, DOI 10.1074/jbc.M306092200; Kantcheva AK, 2013, P NATL ACAD SCI USA, V110, P8489, DOI 10.1073/pnas.1221279110; Khelashvili G, 2015, ACS CHEM NEUROSCI, V6, P1825, DOI 10.1021/acschemneuro.5b00179; Khelashvili G, 2015, BBA-BIOMEMBRANES, V1848, P1765, DOI 10.1016/j.bbamem.2015.03.025; Koldso H, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00208; Koldso H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063635; Koldso H, 2013, ACS CHEM NEUROSCI, V4, P295, DOI 10.1021/cn300148r; Koldso H, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002246; Kortagere S, 2013, NEUROPHARMACOLOGY, V72, P282, DOI 10.1016/j.neuropharm.2013.04.026; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; Kufareva I, 2014, STRUCTURE, V22, P1120, DOI 10.1016/j.str.2014.06.012; Lee JY, 2012, J AM CHEM SOC, V134, P16512, DOI 10.1021/ja307532d; Loland CJ, 2015, BBA-GEN SUBJECTS, V1850, P500, DOI 10.1016/j.bbagen.2014.04.011; Magnani F, 2004, J BIOL CHEM, V279, P38770, DOI 10.1074/jbc.M400831200; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Midzak AS, 2015, PHARMACOL RES, V99, P393, DOI 10.1016/j.phrs.2015.03.023; Mortensen OV, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00223; Neubauer HA, 2006, MOL PHARMACOL, V69, P1242, DOI 10.1124/mol.105.018507; Paila YD, 2009, BBA-BIOMEMBRANES, V1788, P295, DOI 10.1016/j.bbamem.2008.11.020; Penmatsa A, 2015, NAT STRUCT MOL BIOL, V22, P506, DOI 10.1038/nsmb.3029; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Pike LJ, 2009, J LIPID RES, V50, pS323, DOI 10.1194/jlr.R800040-JLR200; Pike LJ, 2004, BIOCHEM J, V378, P281, DOI 10.1042/BJ20031672; Plenge P, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.371765; Saliba AE, 2015, NAT REV MOL CELL BIO, V16, P753, DOI 10.1038/nrm4080; Sandtner W, 2016, MOL PHARMACOL, V89, P165, DOI 10.1124/mol.115.101394; Scanlon SM, 2001, BIOCHEMISTRY-US, V40, P10507, DOI 10.1021/bi010730z; Schmid JA, 2001, J BIOL CHEM, V276, P3805, DOI 10.1074/jbc.M007357200; Sengupta D, 2015, BBA-BIOMEMBRANES, V1848, P1775, DOI 10.1016/j.bbamem.2015.03.018; Sengupta D, 2012, J PHYS CHEM B, V116, P12991, DOI 10.1021/jp309888u; Shan JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016350; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Sinning S, 2010, J BIOL CHEM, V285, P8363, DOI 10.1074/jbc.M109.045401; Sonnino S, 2013, CURR MED CHEM, V20, P4; Stockner T, 2014, SPRINGER SER BIOPHYS, V17, P99, DOI 10.1007/978-3-642-53839-1_5; Stockner T, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002909; Wang KH, 2015, NATURE, V521, P322, DOI 10.1038/nature14431; Wenthur CJ, 2010, BIOCHEM PHARMACOL, V80, P1418, DOI 10.1016/j.bcp.2010.07.005; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhao YF, 2011, NATURE, V474, P109, DOI 10.1038/nature09971; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614; Zhou Z, 2009, NAT STRUCT MOL BIOL, V16, P652, DOI 10.1038/nsmb.1602	72	15	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166196	10.1371/journal.pone.0166196	http://dx.doi.org/10.1371/journal.pone.0166196			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907003	Green Published, Green Submitted, gold			2022-12-26	WOS:000389482700019
J	Koopman, C; Vaartjes, I; van Dis, I; Verschuren, WMM; Engelfriet, P; Heintjes, EM; Blokstra, A; Deeg, DJH; Visser, M; Bots, ML; O'Flaherty, M; Capewell, S				Koopman, Carla; Vaartjes, Ilonca; van Dis, Ineke; Verschuren, W. M. Monique; Engelfriet, Peter; Heintjes, Edith M.; Blokstra, Anneke; Deeg, Dorly J. H.; Visser, Marjolein; Bots, Michiel L.; O'Flaherty, Martin; Capewell, Simon			Explaining the Decline in Coronary Heart Disease Mortality in the Netherlands between 1997 and 2007	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; COHORT PROFILE; RISK-FACTORS; DECREASE; IRELAND; RATES	Objective We set out to determine what proportion of the mortality decline from 1997 to 2007 in coronary heart disease (CHD) in the Netherlands could be attributed to advances in medical treatment and to improvements in population-wide cardiovascular risk factors. Methods We used the IMPACT-SEC model. Nationwide information was obtained on changes between 1997 and 2007 in the use of 42 treatments and in cardiovascular risk factor levels in adults, aged 25 or over. The primary outcome was the number of CHD deaths prevented or postponed. Results The age-standardized CHD mortality fell by 48% from 269 to 141 per 100.000, with remarkably similar relative declines across socioeconomic groups. This resulted in 11,200 fewer CHD deaths in 2007 than expected. The model was able to explain 72% of the mortality decline. Approximately 37% (95% CI: 10%-80%) of the decline was attributable to changes in acute phase and secondary prevention treatments: the largest contributions came from treating patients in the community with heart failure (11%) or chronic angina (9%). Approximately 36% (24%-67%) was attributable to decreases in risk factors: blood pressure (30%), total cholesterol levels (10%), smoking (5%) and physical inactivity (1%). Ten% more deaths could have been prevented if body mass index and diabetes would not have increased. Overall, these findings did not vary across socioeconomic groups, although within socioeconomic groups the contribution of risk factors differed. Conclusion CHD mortality has recently halved in The Netherlands. Equally large contributions have come from the increased use of acute and secondary prevention treatments and from improvements in population risk factors (including primary prevention treatments). Increases in obesity and diabetes represent a major challenge for future prevention policies.	[Koopman, Carla; Vaartjes, Ilonca; Verschuren, W. M. Monique; Bots, Michiel L.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Koopman, Carla; Vaartjes, Ilonca; van Dis, Ineke] Dutch Heart Fdn, The Hague, Netherlands; [Verschuren, W. M. Monique; Engelfriet, Peter; Blokstra, Anneke] Natl Inst Publ Hlth & Environm, Bilthoven, Netherlands; [Heintjes, Edith M.] PHARMO Inst Drug Res, Utrecht, Netherlands; [Deeg, Dorly J. H.; Visser, Marjolein] Vrije Univ Amsterdam Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Visser, Marjolein] Vrije Univ Amsterdam, Dept Hlth Sci, Amsterdam, Netherlands; [Visser, Marjolein] Vrije Univ Amsterdam Med Ctr, Dept Dietet & Nutr Sci, Internal Med, Amsterdam, Netherlands; [O'Flaherty, Martin; Capewell, Simon] Univ Liverpool, Inst Psychol Hlth & Soc, Dept Publ Hlth & Policy, Liverpool, Merseyside, England	Utrecht University; Utrecht University Medical Center; Netherlands National Institute for Public Health & the Environment; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Liverpool	Vaartjes, I (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.; Vaartjes, I (corresponding author), Dutch Heart Fdn, The Hague, Netherlands.	C.H.Vaartjes@umcutrecht.nl	Visser, Marjolein/AAP-3224-2020	Visser, Marjolein/0000-0002-5136-298X	Dutch Heart Foundation [2008T111]; MRC [G0500920] Funding Source: UKRI; Medical Research Council [G0500920] Funding Source: researchfish	Dutch Heart Foundation(Netherlands Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	CK and IV are supported by a grant from the Dutch Heart Foundation (grant 2008T111, http://www.hartstichting.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Rmeileh NM, 2012, BMJ OPEN, P2; Aspelund T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013957; Bajekal M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001237; Bandosz P, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8136; Bennett K, 2006, J EPIDEMIOL COMMUN H, V60, P322, DOI 10.1136/jech.2005.038638; Bjorck L, 2009, EUR HEART J, V30, P1046, DOI 10.1093/eurheartj/ehn554; Bruggink JW, 2009, BEVOLK INGSTRENDS 4E; Bruthans J, 2014, EUR J PREV CARDIOL, V21, P829, DOI 10.1177/2047487312469476; Capewell S, 2000, CIRCULATION, V102, P1511, DOI 10.1161/01.CIR.102.13.1511; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Herings R., 2012, PHARMACOEPIDEM DR S, P270, DOI [10.1002/9781119959946.ch18, DOI 10.1002/9781119959946.CH18]; Hotchkiss JW, 2014, BMJ-BRIT MED J, V348, P1088; Hughes J, 2013, EUR J PREV CARDIOL, V20, P310, DOI 10.1177/2047487312441725; Huisman M, 2011, INT J EPIDEMIOL, V40, P868, DOI 10.1093/ije/dyq219; Kabir Z, 2013, INT J CARDIOL, V168, P2462, DOI 10.1016/j.ijcard.2013.03.007; Knol F, 1998, HIGH LOW LOW HIGH DE; Knol FA, 1998, HIGH LOW LOW HIGH DE; Koopman C, 2013, EUR HEART J, V34, P3198, DOI 10.1093/eurheartj/eht368; Koopman C, 2013, INT J CARDIOL, V168, P993, DOI 10.1016/j.ijcard.2012.10.036; Laatikainen T, 2005, AM J EPIDEMIOL, V162, P764, DOI 10.1093/aje/kwi274; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; MANT J, 1995, BMJ-BRIT MED J, V311, P793, DOI 10.1136/bmj.311.7008.793; Nichol G, 1999, ACAD EMERG MED, V6, P95, DOI 10.1111/j.1553-2712.1999.tb01044.x; Palmieri L, 2010, AM J PUBLIC HEALTH, V100, P684, DOI 10.2105/AJPH.2008.147173; Pereira M, 2013, CIRC-CARDIOVASC QUAL, V6, P634, DOI 10.1161/CIRCOUTCOMES.113.000264; Stjarne MK, 2006, EPIDEMIOLOGY, V17, P14, DOI 10.1097/01.ede.0000187178.51024.a7; Sundquist K, 2004, J EPIDEMIOL COMMUN H, V58, P71, DOI 10.1136/jech.58.1.71; Unal B, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1135; van Herk-Sukel MPP, 2010, EUR J CANCER, V46, P395, DOI 10.1016/j.ejca.2009.09.010; Verschuren WMM, 2008, INT J EPIDEMIOL, V37, P1236, DOI 10.1093/ije/dym292; *VOED, 1998, ZO EET NED RES VOEDS; Wijeysundera HC, 2010, JAMA-J AM MED ASSOC, V303, P1841, DOI 10.1001/jama.2010.580; World Health Organization, TOP 10 CAUS DEATH; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	34	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166139	10.1371/journal.pone.0166139	http://dx.doi.org/10.1371/journal.pone.0166139			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27906998	gold, Green Published			2022-12-26	WOS:000389482700017
J	Stroman, PW; Bosma, RL; Cotoi, AI; Leung, RH; Kornelsen, J; Lawrence-Dewar, JM; Pukall, CF; Staud, R				Stroman, Patrick W.; Bosma, Rachael L.; Cotoi, Andreea I.; Leung, Roxanne H.; Kornelsen, Jennifer; Lawrence-Dewar, Jane M.; Pukall, Caroline F.; Staud, Roland			Continuous Descending Modulation of the Spinal Cord Revealed by Functional MRI	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; TEMPORAL SUMMATION; BRAIN-STEM; 2ND PAIN; EFFECTIVE CONNECTIVITY; IMAGE REGISTRATION; FMRI; ANTICIPATION; ACTIVATION; INTENSITY	Spontaneous variations in spinal cord activity may arise from regulation of any of a number of functions including sensory, motor, and autonomic control. Here, we use functional MRI (fMRI) of healthy participants to identify properties of blood oxygenation-level dependent (BOLD) variations in the spinal cord in response to knowledge that either a noxious stimulus is impending, or that no stimulus is to be expected. Expectation of a noxious stimulus, or no stimulus, is shown to have a significant effect on wide-spread BOLD signal variations in the spinal cord over the entire time period of the fMRI acquisition. Coordination of BOLD responses between/within spinal cord and brainstem regions are also influenced by this knowledge. We provide evidence that such signal variations are the result of continuous descending modulation of spinal cord function. BOLD signal variations in response to noxious stimulation of the hand are also shown, as in previous studies. The observation of both continuous and reactive BOLD responses to emotional/cognitive factors and noxious peripheral stimulation may have important implications, not only for our understanding of endogenous pain modulation, but also in showing that spinal cord activity is under continuous regulatory control.	[Stroman, Patrick W.; Bosma, Rachael L.; Cotoi, Andreea I.; Leung, Roxanne H.; Pukall, Caroline F.] Queens Univ, Ctr Neurosci Studies, Kingston, ON, Canada; [Stroman, Patrick W.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Stroman, Patrick W.] Queens Univ, Dept Phys, Kingston, ON, Canada; [Kornelsen, Jennifer] Univ Manitoba, Dept Radiol, Winnipeg, MB, Canada; [Lawrence-Dewar, Jane M.] Thunder Bay Reg Res Inst, Thunder Bay, ON, Canada; [Pukall, Caroline F.] Queens Univ, Dept Psychol, Kingston, ON, Canada; [Staud, Roland] Univ Florida, Dept Med, Gainesville, FL USA	Queens University - Canada; Queens University - Canada; Queens University - Canada; University of Manitoba; Northern Ontario School of Medicine; Queens University - Canada; State University System of Florida; University of Florida	Stroman, PW (corresponding author), Queens Univ, Ctr Neurosci Studies, Kingston, ON, Canada.; Stroman, PW (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada.; Stroman, PW (corresponding author), Queens Univ, Dept Phys, Kingston, ON, Canada.	stromanp@queensu.ca	Staud, Roland/A-8442-2008	Stroman, Patrick/0000-0002-9814-260X; Lawrence-Dewar, Jane/0000-0003-1529-5748; Kornelsen, Jennifer/0000-0003-0658-5321	NIH [NR014049-01]; Harry S. Botterell Foundation; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR014049] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harry S. Botterell Foundation; NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	Funding was provided by the Harry S. Botterell Foundation. Dr. Staud's effort was partially funded by NIH grant NR014049-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Harry S. Botterell Foundation for project funding support. We would also like to thank Don Brien for his help with acquiring the data, and Janet Mirtle-Stroman for her help with participant recruitment. Dr. Staud's effort was partially funded by NIH grant NR014049-01. All authors confirm that they have no conflicts of interest to declare.	Barry RL, 2014, ELIFE, V3, DOI 10.7554/eLife.02812; Beynon M, 2013, 4 INT C NEUR PAIN MA; Bollen KA, 1989, STRUCTURAL EQUATIONS; Bosma RL, 2014, MAGN RESON IMAGING, V32, P473, DOI 10.1016/j.mri.2014.01.007; Bosma R.L., 2015, HUM BRAIN MAPP; Bosma RL, 2016, HUM BRAIN MAPP, V37, P1349, DOI 10.1002/hbm.23106; Bosma RL, 2015, HUM BRAIN MAPP, V36, P5038, DOI 10.1002/hbm.22993; Bosma RL, 2014, J MAGN RESON IMAGING; Bosma RL, 2014, SOC NEUROSCIENCE; Craggs JG, 2012, J PAIN, V13, P390, DOI 10.1016/j.jpain.2012.01.002; Dobek CE, 2014, J PAIN, V15, P1057, DOI 10.1016/j.jpain.2014.07.006; Dunckley P, 2007, NEUROGASTROENT MOTIL, V19, P569, DOI 10.1111/j.1365-2982.2007.00908.x; Eippert F, 2009, SCIENCE, V326, P404, DOI 10.1126/science.1180142; Fairhurst M, 2007, PAIN, V128, P101, DOI 10.1016/j.pain.2006.09.001; Figley CR, 2009, NEUROIMAGE, V44, P421, DOI 10.1016/j.neuroimage.2008.08.040; Figley CR, 2006, P INT SOC MAGN RES M; Heinricher M.M., 2013, WALL MELZACKS TXB PA, P129; Ikeda H, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-14; Khan HS, 2015, NEUROSCIENCE, V307, P231, DOI 10.1016/j.neuroscience.2015.08.059; Khan HS, 2015, NEUROSCIENC IN PRESS; Kong YZ, 2014, P NATL ACAD SCI USA, V111, P18067, DOI 10.1073/pnas.1414293111; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; MCARDLE JJ, 1984, BRIT J MATH STAT PSY, V37, P234, DOI 10.1111/j.2044-8317.1984.tb00802.x; McIver TA, 2014, SOC NEUROSCIENCE; Millan MJ, 2002, PROG NEUROBIOL, V66, P355, DOI 10.1016/S0301-0082(02)00009-6; Murphy K, 2007, NEUROIMAGE, V34, P565, DOI 10.1016/j.neuroimage.2006.09.032; Myronenko A, 2010, IEEE T MED IMAGING, V29, P1882, DOI 10.1109/TMI.2010.2053043; Myronenko A, 2009, PROC CVPR IEEE, P49, DOI 10.1109/CVPRW.2009.5206571; Palermo S, 2015, HUM BRAIN MAPP, V36, P1648, DOI 10.1002/hbm.22727; Ploghaus A, 1999, SCIENCE, V284, P1979, DOI 10.1126/science.284.5422.1979; PRICE DD, 1977, PAIN, V3, P57, DOI 10.1016/0304-3959(77)90035-5; Rainville P, 2002, CURR OPIN NEUROBIOL, V12, P195, DOI 10.1016/S0959-4388(02)00313-6; Rempe T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112325; Rhudy JL, 2003, PAIN MED, V4, P244, DOI 10.1046/j.1526-4637.2003.03028.x; Schlosser R, 2003, NEUROIMAGE, V19, P751, DOI 10.1016/S1053-8119(03)00106-X; Smith SD, 2011, NEUROIMAGE, V58, P269, DOI 10.1016/j.neuroimage.2011.06.004; Sousa MAS, 2014, B REAL SOC IN PRESS, V1, P1, DOI DOI 10.1152/JN.00440.2013; Sprenger C, 2015, J NEUROSCI, V35, P4248, DOI 10.1523/JNEUROSCI.4897-14.2015; Sprenger C, 2012, CURR BIOL, V22, P1019, DOI 10.1016/j.cub.2012.04.006; Staud R, 2007, PAIN, V129, P130, DOI 10.1016/j.pain.2006.10.010; Staud R, 2006, J PAIN, V7, P575, DOI 10.1016/j.jpain.2006.02.005; Strigo IA, 2013, INT J EAT DISORDER, V46, P23, DOI 10.1002/eat.22045; Stroman PW, 2016, J NEUROTRAUMA; Vierck CJ, 1997, J NEUROPHYSIOL, V78, P992, DOI 10.1152/jn.1997.78.2.992; Wager TD, 2013, NEW ENGL J MED, V368, P1388, DOI 10.1056/NEJMoa1204471; Watkins LR, 1998, BEHAV NEUROSCI, V112, P360; Zhang L, 2005, EUR J NEUROSCI, V22, P1141, DOI 10.1111/j.1460-9568.2005.04302.x	47	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167317	10.1371/journal.pone.0167317	http://dx.doi.org/10.1371/journal.pone.0167317			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907094	Green Published, Green Submitted, gold			2022-12-26	WOS:000389482700118
J	Yin, CM; Xiang, L; Wang, GS; Wang, YF; Shen, X; Chen, XS; Mao, ZQ				Yin, Chengmiao; Xiang, Li; Wang, Gongshuai; Wang, Yanfang; Shen, Xiang; Chen, Xuesen; Mao, Zhiquan			How to Plant Apple Trees to Reduce Replant Disease in Apple Orchard: A Study on the Phenolic Acid of the Replanted Apple Orchard	PLOS ONE			English	Article							SOIL; GROWTH; SEEDLINGS; CUCUMBER	Apple replant disease (ARD) is an important problem in the production of apple. The phenolic acid is one of the causes of ARD. How phenolic acid affects the ARD was not well known. In this study, we analyzed the type, concentration and annual dynamic variation of phenolic acid in soil from three replanted apple orchards using an accelerated solvent extraction system with high performance liquid chromatography (ASE-HPLC). We found that the type and concentration of phenolic acid were significantly differed among different seasons, different sampling positions and different soil layers. Major types of phenolic acid in three replanted apple orchards were phlorizin, benzoic acid and vanillic aldehyde. The concentration of phenolic acid was highest in the soil of the previous tree holes and it was increased from the spring to autumn. Moreover, phenolic acid was primarily distributed in 30-60 cm soil layer in the autumn, while it was most abundant in 0-30 cm soil layer in the spring. Our results suggest that phlorizin, benzoic acid and vanillic aldehyde may be the key phenolic acid that brought about ARD in the replanted apple orchard.	[Yin, Chengmiao; Xiang, Li; Wang, Gongshuai; Wang, Yanfang; Shen, Xiang; Chen, Xuesen; Mao, Zhiquan] Shandong Agr Univ, Coll Hort Sci & Engn, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China; [Wang, Yanfang] Shandong Agr Univ, Coll Chem & Mat Sci, Tai An, Shandong, Peoples R China	Shandong Agricultural University; Shandong Agricultural University	Mao, ZQ (corresponding author), Shandong Agr Univ, Coll Hort Sci & Engn, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China.	mzhiquan@sdau.edu.cn			earmarked fund for National Modern Agro-industry Technology Research System [CARS-28]; National Natural Science Foundation of China [31501720]; Shandong Province, China [SDAIT-06-07]; Shandong Natural Science Foundation, China [ZR2014CL024]	earmarked fund for National Modern Agro-industry Technology Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Province, China; Shandong Natural Science Foundation, China	The research was supported by the earmarked fund for National Modern Agro-industry Technology Research System (CARS-28), the National Natural Science Foundation of China (31501720), Fruit innovation team in Shandong Province, China (SDAIT-06-07), and joint project of Shandong Natural Science Foundation, China (ZR2014CL024).; The research was supported by the earmarked fund for National Modern Agro-industry Technology Research System (CARS-28), the National Natural Science Foundation of China (31501720), Fruit innovation team in Shandong Province, China (SDAIT-06-07), and joint project of Shandong Natural Science Foundation, China (ZR2014CL024).	Baerson SR, 2008, J BIOL CHEM, V283, P3231, DOI 10.1074/jbc.M706587200; Bai R, 2009, J CHEM ECOL, V35, P488, DOI 10.1007/s10886-009-9615-7; Chen LiXin, 2005, Agricultural Sciences in China, V4, P747; David I., 2005, Novenyvdelem, V41, P397; Ding J, 2007, J EXP BOT, V58, P3765, DOI 10.1093/jxb/erm227; Gao XB, 2010, AGR SCI CHINA, V9, P833, DOI 10.1016/S1671-2927(09)60161-9; Han CM, 2008, SCI HORTIC-AMSTERDAM, V116, P330, DOI 10.1016/j.scienta.2008.01.005; Hiradate S, 2005, J CHEM ECOL, V31, P591, DOI 10.1007/s10886-005-2047-0; Hofmann A, 2009, J APPL BOT FOOD QUAL, V82, P193; Jilani G, 2008, ANN MICROBIOL, V58, P351, DOI 10.1007/BF03175528; KUITERS AT, 1990, ACTA BOT NEERL, V39, P329, DOI 10.1111/j.1438-8677.1990.tb01412.x; Kummeler M., 1981, Erwerbsobstbau, V23; 24, P162; Laurent AS, 2008, PLANT SOIL, V304, P209, DOI 10.1007/s11104-008-9541-4; Macias FA, 2000, PHYTOCHEMISTRY, V54, P165, DOI 10.1016/S0031-9422(00)00070-4; Manici LM, 2003, PLANT SOIL, V256, P315, DOI 10.1023/A:1026103001592; Mazzola M, 1998, PHYTOPATHOLOGY, V88, P930, DOI 10.1094/PHYTO.1998.88.9.930; Mazzola M, 2012, ANNU REV PHYTOPATHOL, V50, P45, DOI 10.1146/annurev-phyto-081211-173005; Narwal SS, 2010, ALLELOPATHY J, V25, P51; Ogweno JO, 2006, ALLELOPATHY J, V18, P93; Politycka B, 2003, POL J ENVIRON STUD, V12, P95; Rumberger A, 2004, PLANT SOIL, V264, P247, DOI 10.1023/B:PLSO.0000047760.13004.94; Tewoldemedhin YT, 2011, SOIL BIOL BIOCHEM, V43, P1917, DOI 10.1016/j.soilbio.2011.05.014; Tewoldemedhin YT, 2011, EUR J PLANT PATHOL, V130, P215, DOI 10.1007/s10658-011-9747-9; van Schoor L, 2009, SCI HORTIC-AMSTERDAM, V119, P153, DOI 10.1016/j.scienta.2008.07.032; Wu FZ, 2006, ALLELOPATHY J, V18, P287; Wu HW, 2001, J CHEM ECOL, V27, P125, DOI 10.1023/A:1005676218582; Yang CM, 2004, BOT BULL ACAD SINICA, V45, P119; [尹承苗 Yin Chengmiao], 2013, [中国农业科学, Scientia Agricultura Sinica], V46, P4612; Zhang JH, 2007, J INTEGR PLANT BIOL, V49, P257, DOI 10.1111/j.1744-7909.2007.00307.x	29	31	36	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167347	10.1371/journal.pone.0167347	http://dx.doi.org/10.1371/journal.pone.0167347			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907081	Green Published, gold, Green Submitted			2022-12-26	WOS:000389482700125
J	Qiao, PP; Liu, HY; Yan, XP; Jia, ZR; Pi, XT				Qiao, Panpan; Liu, Hongying; Yan, Xueping; Jia, Ziru; Pi, Xitian			A Smart Capsule System for Automated Detection of Intestinal Bleeding Using HSL Color Recognition	PLOS ONE			English	Article							DIGITAL-SUBTRACTION-ANGIOGRAPHY; WIRELESS CAPSULE; PUSH ENTEROSCOPY; DIAGNOSTIC YIELD; ENDOSCOPY; HEMOGLOBIN; FUSION; BOVINE; IMAGES	There are no ideal means for the diagnosis of intestinal bleeding diseases as of now, particularly in the small intestine. This study investigated an intelligent intestinal bleeding detection capsule system based on color recognition. After the capsule is swallowed, the bleeding detection module (containing a color-sensitive adsorptive film that changes color when absorbing intestinal juice,) is used to identify intestinal bleeding features. A hue-saturation-light color space method can be applied to detect bleeding according to the range of H and S values of the film color. Once bleeding features are recognized, a wireless transmission module is activated immediately to send an alarm signal to the outside; an in vitro module receives the signal and sends an alarm. The average power consumption of the entire capsule system is estimated to be about 2.1mW. Owing to its simplicity, reliability, and effectiveness, this system represents a new approach to the clinical diagnosis of intestinal bleeding diseases.	[Qiao, Panpan; Liu, Hongying; Yan, Xueping; Jia, Ziru; Pi, Xitian] Chongqing Univ, Bioengn Coll, Minist Educ, Key Lab Biorheol Sci & Technol, Chongqing, Peoples R China; [Pi, Xitian] Chongqing Univ, Key Labs Natl Def Sci & Technol Innovat Micronano, Chongqing, Peoples R China; [Liu, Hongying] Chongqing Engn Res Ctr Med Elect, Chongqing, Peoples R China	Chongqing University; Chongqing University	Liu, HY; Pi, XT (corresponding author), Chongqing Univ, Bioengn Coll, Minist Educ, Key Lab Biorheol Sci & Technol, Chongqing, Peoples R China.; Pi, XT (corresponding author), Chongqing Univ, Key Labs Natl Def Sci & Technol Innovat Micronano, Chongqing, Peoples R China.; Liu, HY (corresponding author), Chongqing Engn Res Ctr Med Elect, Chongqing, Peoples R China.	liuhongying@cqu.edu.cn; pixitian@cqu.edu.cn			National Key Technology Support Program [2015BA101613]; Medical Instrument Key Project of Chongqing [cstc2015zdcy-zta10002]; National Natural Science Foundation of China [81671850]; Fundamental Research Funds for the Central Universities [106112016CDJXY230004]	National Key Technology Support Program(National Key Technology R&D Program); Medical Instrument Key Project of Chongqing; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Key Technology Support Program (2015BA101613), http://program.most.gov.cn/; The Medical Instrument Key Project of Chongqing (No. cstc2015zdcy-zta10002), http://www.cstc.gov.cn/; National Natural Science Foundation of China (81671850, http://www.nsfc.gov.cn/; and the Fundamental Research Funds for the Central Universities (106112016CDJXY230004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi A, 2014, J SUPERCOMPUT, V68, P599, DOI 10.1007/s11227-013-1054-0; Al-Rawhani MA, 2013, SENSOR ACTUAT B-CHEM, V189, P203, DOI 10.1016/j.snb.2013.03.037; Amin U., DETECTION DISTINCTIO; Appleyard M, 2000, GASTROENTEROLOGY, V119, P1431, DOI 10.1053/gast.2000.20844; Chen YT, 2014, WORLD J GASTROENTERO, V20, P17955, DOI 10.3748/wjg.v20.i47.17955; Chien CL, 2014, IEEE T GEOSCI REMOTE, V52, P651, DOI 10.1109/TGRS.2013.2243157; Chou PH, 2005, IEEE IC CAD, P913, DOI 10.1109/ICCAD.2005.1560192; COOK DJ, 1994, NEW ENGL J MED, V330, P377, DOI 10.1056/NEJM199402103300601; Dimino ML, 2007, J CHROMATOGR B, V856, P353, DOI 10.1016/j.jchromb.2007.05.040; Du H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089740; Eliakim R, 2004, ALIMENT PHARM THER, V20, P1083, DOI 10.1111/j.1365-2036.2004.02206.x; Ell C, 2002, ENDOSCOPY, V34, P685, DOI 10.1055/s-2002-33446; Erenas MM, 2012, SENSOR ACTUAT B-CHEM, V174, P10, DOI 10.1016/j.snb.2012.07.100; Haase S, 2013, CURR MED IMAGING, V9, P113, DOI 10.2174/1573405611309020006; Hayat M, 2000, ENDOSCOPY, V32, P369, DOI 10.1055/s-2000-9003; Herzig SJ, 2013, J GEN INTERN MED, V28, P978, DOI 10.1007/s11606-013-2425-1; Houbing Song CB., 2016, CYBER PHYS SYSTEMS F; Iddan G, 2000, NATURE, V405, P417, DOI 10.1038/35013140; Jiang Y, 2017, IEEE T IND INFORM, V13, P1900, DOI 10.1109/TII.2016.2573762; Kapsoritakis AN, 2001, AM J GASTROENTEROL, V96, P776; Li BP, 2009, IMAGE VISION COMPUT, V27, P1336, DOI 10.1016/j.imavis.2008.12.003; Li BP, 2009, COMPUT BIOL MED, V39, P141, DOI 10.1016/j.compbiomed.2008.11.007; Lin TF, 2015, 2015 8TH INTERNATIONAL CONFERENCE ON UBI-MEDIA COMPUTING (UMEDIA) CONFERENCE PROCEEDINGS, P268, DOI 10.1109/UMEDIA.2015.7297467; Liu HY, 2010, J ZHEJIANG UNIV-SC B, V11, P937, DOI 10.1631/jzus.B1000047; Liu HY, 2013, INT J BIOMED ENG TEC, V13, P105, DOI 10.1504/IJBET.2013.057925; Longacre AV, 2003, AM J GASTROENTEROL, V98, P59; Meng M. Q.-H., 2004, Fifth World Congress on Intelligent Control and Automation (IEEE Cat. No.04EX788), P5561; Miraglia R, 2015, ABDOM IMAGING, V40, P1808, DOI 10.1007/s00261-014-0313-8; Peery AF, 2015, GASTROENTEROLOGY, V149, P1731, DOI 10.1053/j.gastro.2015.08.045; Ramaswamy RS, 2014, WORLD J RADIOL, V6, P82, DOI 10.4329/wjr.v6.i4.82; Shovlin CL, 2000, AM J MED GENET, V91, P66, DOI 10.1002/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P; Sun B, 2006, AM J GASTROENTEROL, V101, P2011, DOI 10.1111/j.1572-0241.2006.00664.x; Sun GY, 2008, J CHROMATOGR B, V867, P1, DOI 10.1016/j.jchromb.2008.02.014; WEEKS AR, 1995, P SOC PHOTO-OPT INS, V2424, P291, DOI 10.1117/12.205231; Xie ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090286; Zhang YG, 2014, EURASIP J ADV SIG PR, DOI 10.1186/1687-6180-2014-17	36	14	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0166488	10.1371/journal.pone.0166488	http://dx.doi.org/10.1371/journal.pone.0166488			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902728	Green Submitted, gold, Green Published			2022-12-26	WOS:000389474100026
J	Singh, AB; Liu, JW				Singh, Amar Bahadur; Liu, Jingwen			Identification of Hepatic Lysophosphatidylcholine Acyltransferase 3 as a Novel Target Gene Regulated by Peroxisome Proliferator-activated Receptor delta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYL-COA SYNTHETASE; ENDOPLASMIC-RETICULUM STRESS; EXPRESSION IN-VIVO; LIVER X RECEPTOR; PPAR-DELTA; FATTY-ACIDS; DEPENDENT MECHANISM; INSULIN-RESISTANCE; METABOLISM; INFLAMMATION	Peroxisome proliferator- activated receptor delta (PPAR delta) regulates many genes involved in lipid metabolism. Hepatic lysophosphatidylcholine acyltransferase 3 ( LPCAT3) has critical functions in triglycerides transport and endoplasmic reticulum stress response due to its unique ability to catalyze the incorporation of polyunsaturated fatty acids into phospholipids. Previous studies identified liverXreceptor as the transcription factor controlling LPCAT3 expression in mouse liver tissue. Here we show that the hepatic LPCAT3 gene is transcriptionally regulated by PPAR delta. Adenovirus-mediated knockdown of PPAR delta in cultured hepatic cells and liver tissue reduced LPCAT3 mRNA levels, and exogenous overexpression of PPAR delta increased LPCAT3 mRNA expression. Activation of PPAR delta in HepG2, Huh7, and Hepa 1- 6 cells with its specific agonists increased LPCAT3 mRNA levels in all three hepatic cell lines. Through conducting sequence analysis, LPCAT3 promoter assays, and direct DNA binding assays, we have mapped the functional PPAR- responsive element to a proximal region from - 135 to - 123 of the LPCAT3 promoter that plays an essential role in mediating PPAR delta-induced transactivation of the LPCAT3 gene. Finally, we have provided in vivo evidence showing that activation of PPAR delta by agonist L165041 in mice increased hepatic LPCAT3 mRNA abundance and LPCAT enzymatic activity, which is associated with increased incorporations of arachidonate into liver phosphatidylcholine and phosphatidylethanolamine. Furthermore, transient liver- specific knockdown of LPCAT3 in mice affected PPAR delta-mediated activation of several hepatic genes involving in FA metabolism. Altogether, our new findings identify LPCAT3 as a direct PPAR delta target gene and suggest a novel function of PPAR delta in regulation of phospholipid metabolism through LPCAT3.	[Singh, Amar Bahadur; Liu, Jingwen] Dept Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Liu, JW (corresponding author), VA Palo Alto Hlth Care System, 3801 Miranda Ave, Palo Alto, CA 94304 USA.	Jingwen.Liu@va.gov	Singh, Amar B/I-2253-2014	Singh, Amar B/0000-0002-7677-2424	Department of Veterans Affairs (Office of Research and Development, Medical Research Service); NCCIH, National Institutes of Health [1R01AT006336-01A1]; National Center for Complementary & Integrative Health [R01AT006336] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001419] Funding Source: NIH RePORTER	Department of Veterans Affairs (Office of Research and Development, Medical Research Service)(US Department of Veterans Affairs); NCCIH, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the Department of Veterans Affairs (Office of Research and Development, Medical Research Service) and by NCCIH, National Institutes of Health, Grant 1R01AT006336-01A1. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bojic LA, 2014, J LIPID RES, V55, P1254, DOI 10.1194/jlr.M046037; Cao AQ, 2010, J BIOL CHEM, V285, P16664, DOI 10.1074/jbc.M110.112805; Cash JG, 2016, NUTR DIABETES, V6, DOI 10.1038/nutd.2016.12; Chehaibi K, 2015, BIOCHEM PHARMACOL, V94, P101, DOI 10.1016/j.bcp.2015.01.016; Coll Teresa, 2009, Curr Mol Pharmacol, V2, P46; Dong B, 2014, ATHEROSCLEROSIS, V235, P449, DOI 10.1016/j.atherosclerosis.2014.05.931; Dong B, 2013, J LIPID RES, V54, P1241, DOI 10.1194/jlr.M032599; Gao SY, 2012, HEPATOL RES, V42, P686, DOI 10.1111/j.1872-034X.2011.00961.x; Grevengoed TJ, 2014, ANNU REV NUTR, V34, P1, DOI 10.1146/annurev-nutr-071813-105541; Hashidate-Yoshida T, 2015, ELIFE, V4, DOI 10.7554/eLife.06328; Ishibashi M, 2013, ARTERIOSCL THROM VAS, V33, P1171, DOI 10.1161/ATVBAHA.112.300812; Kan CFK, 2015, BBA-MOL CELL BIOL L, V1851, P577, DOI 10.1016/j.bbalip.2015.01.008; Kang MJ, 1997, P NATL ACAD SCI USA, V94, P2880, DOI 10.1073/pnas.94.7.2880; Kuch EM, 2014, BBA-MOL CELL BIOL L, V1841, P227, DOI 10.1016/j.bbalip.2013.10.018; Kuwata H, 2014, BBA-MOL CELL BIOL L, V1841, P44, DOI 10.1016/j.bbalip.2013.09.015; Lee CH, 2003, ENDOCRINOLOGY, V144, P2201, DOI 10.1210/en.2003-0288; Liu SH, 2013, NATURE, V502, P550, DOI 10.1038/nature12710; Liu SH, 2011, J BIOL CHEM, V286, P1237, DOI 10.1074/jbc.M110.138115; Lopes-Marques M, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-271; Mashek DG, 2007, FUTURE LIPIDOL, V2, P465, DOI 10.2217/17460875.2.4.465; Michalik L, 2006, PHARMACOL REV, V58, P726, DOI 10.1124/pr.58.4.5; Ramirez T, 2013, J GASTROEN HEPATOL, V28, P179, DOI 10.1111/j.1440-1746.2012.07256.x; Rong X, 2015, ELIFE, V4, DOI 10.7554/eLife.06557; Rong X, 2013, CELL METAB, V18, P685, DOI 10.1016/j.cmet.2013.10.002; Salvado L, 2014, DIABETOLOGIA, V57, P2126, DOI 10.1007/s00125-014-3331-8; Salvado L, 2012, EXPERT OPIN THER TAR, V16, P209, DOI 10.1517/14728222.2012.658370; SCHMIDT A, 1992, MOL ENDOCRINOL, V6, P1634, DOI 10.1210/me.6.10.1634; Shende VR, 2015, BIOCHEM J, V472, P275, DOI 10.1042/BJ20150666; Singh AB, 2016, J BIOL CHEM, V291, P5373, DOI 10.1074/jbc.M115.696872; Soupene E, 2008, EXP BIOL MED, V233, P507, DOI 10.3181/0710-MR-287; Sun XW, 2016, J BIOL CHEM, V291, P1115, DOI 10.1074/jbc.M115.668269; Sznaidman ML, 2003, BIOORG MED CHEM LETT, V13, P1517, DOI 10.1016/S0960-894X(03)00207-5; Wagner KD, 2010, PHARMACOL THERAPEUT, V125, P423, DOI 10.1016/j.pharmthera.2009.12.001; Wierzbicki AS, 2009, CURR VASC PHARMACOL, V7, P277, DOI 10.2174/157016109788340703; Yamashita A, 2014, PROG LIPID RES, V53, P18, DOI 10.1016/j.plipres.2013.10.001; Yang J, 2013, J TOXICOL SCI, V38, P833; Zhao Y, 2008, J BIOL CHEM, V283, P8258, DOI 10.1074/jbc.M710422200	37	18	18	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2017	292	3					884	897		10.1074/jbc.M116.743575	http://dx.doi.org/10.1074/jbc.M116.743575			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2LL	27913621	hybrid, Green Published			2022-12-26	WOS:000392318700011
J	Barnhart, PR; Gillam, EH				Barnhart, Paul R.; Gillam, Erin H.			Understanding Peripheral Bat Populations Using Maximum-Entropy Suitability Modeling	PLOS ONE			English	Article							BIG-EARED BAT; HABITAT USE; SPECIES DISTRIBUTIONS; SAMPLE-SIZE; RANGE SIZE; CONSERVATION; MYOTIS; PERFORMANCE; SELECTION; PATTERNS	Individuals along the periphery of a species distribution regularly encounter more challenging environmental and climatic conditions than conspecifics near the center of the distribution. Due to these potential constraints, individuals in peripheral margins are expected to change their habitat and behavioral characteristics. Managers typically rely on species distribution maps when developing adequate management practices. However, these range maps are often too simplistic and do not provide adequate information as to what fine-scale biotic and abiotic factors are driving a species occurrence. In the last decade, habitat suitability modelling has become widely used as a substitute for simplistic distribution mapping which allows regional managers the ability to fine-tune management resources. The objectives of this study were to use maximum-entropy modeling to produce habitat suitability models for seven species that have a peripheral margin intersecting the state of North Dakota, according to current IUCN distributions, and determine the vegetative and climatic characteristics driving these models. Mistnetting resulted in the documentation of five species outside the IUCN distribution in North Dakota, indicating that current range maps for North Dakota, and potentially the northern Great Plains, are in need of update. Maximum-entropy modeling showed that temperature and not precipitation were the variables most important for model production. This fine-scale result highlights the importance of habitat suitability modelling as this information cannot be extracted from distribution maps. Our results provide baseline information needed for future research about how and why individuals residing in the peripheral margins of a species' distribution may show marked differences in habitat use as a result of urban expansion, habitat loss, and climate change compared to more centralized populations.	[Barnhart, Paul R.] Dickinson State Univ, Dickinson, ND 58601 USA; [Gillam, Erin H.] North Dakota State Univ, Fargo, ND 58105 USA	North Dakota State University Fargo	Barnhart, PR (corresponding author), Dickinson State Univ, Dickinson, ND 58601 USA.	Paul.Barnhart@dickinsonstate.edu			North Dakota Game and Fish Department under their State Wildlife Grant program [T-2-5-R-1]	North Dakota Game and Fish Department under their State Wildlife Grant program	Funding was provided by the North Dakota Game and Fish Department under their State Wildlife Grant program (Grant number:T-2-5-R-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the North Dakota Game and Fish Department for funding this research through a State Wildlife Grant. We would like to thank J.J. Nelson for his assistance with data collection in the field and Liam McGuire for guidance and objective input during manuscript development.	ADAM MD, 1994, J WILDLIFE MANAGE, V58, P462, DOI 10.2307/3809317; [Anonymous], 1988, CONSERVATION EUROPEA; Baker MD, 2006, J WILDLIFE MANAGE, V70, P207, DOI 10.2193/0022-541X(2006)70[207:DHOFLM]2.0.CO;2; Brown JH, 1996, ANNU REV ECOL SYST, V27, P597, DOI 10.1146/annurev.ecolsys.27.1.597; BRUSSARD PF, 1984, ANNU REV ECOL SYST, V15, P25, DOI 10.1146/annurev.es.15.110184.000325; BURLEY TM, 1961, PROF GEOGR, V13, P18, DOI 10.1111/j.0033-0124.1961.136_18.x; Caceres M.C., 2000, MAMMAL SPECIES, V634, P1; Carvalho SB, 2011, BIOL CONSERV, V144, P2020, DOI 10.1016/j.biocon.2011.04.024; Chruszcz BJ, 2002, FUNCT ECOL, V16, P18, DOI 10.1046/j.0269-8463.2001.00602.x; Dodd LE, 2008, FOREST ECOL MANAG, V255, P3866, DOI 10.1016/j.foreco.2008.03.034; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Elmore LW, 2004, FOREST ECOL MANAG, V199, P11, DOI 10.1016/j.foreco.2004.03.045; Farrow LJ, 2011, MAMM BIOL, V76, P172, DOI 10.1016/j.mambio.2010.04.004; Fellers GM, 2002, J MAMMAL, V83, P167, DOI 10.1644/1545-1542(2002)083<0167:HUAFBO>2.0.CO;2; Foster RW, 1999, J MAMMAL, V80, P659, DOI 10.2307/1383310; Franklin J, 2009, MAPPING SPECIES DIST; Fry J, 2011, PHOTOGRAMM ENG REMOT, V77, P858; Garner TWJ, 2004, MOL ECOL, V13, P1047, DOI 10.1111/j.1365-294X.2004.02119.x; Genoways H, 1972, MAMMALS SW N DAKOTA; Genoways H. H., 1966, Transactions of the Kansas Academy of Science, V69, P355, DOI 10.2307/3627432; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Holloway Gillian L., 2001, Mammalian Species, V670, P1, DOI 10.1644/1545-1410(2001)670<0001:MC>2.0.CO;2; Jones B, 2001, BIOL CONSERV, V101, P147, DOI 10.1016/S0006-3207(01)00055-6; Jones Jr JK, 1962, J MAMMAL, V43, P263; Kennedy JP, 2014, ACTA CHIROPTEROL, V16, P53, DOI 10.3161/150811014X683264; Kirkpatrick M, 1997, AM NAT, V150, P1, DOI 10.1086/286054; Kluth C, 2005, J ECOL, V93, P584, DOI 10.1111/j.1365-2745.2005.00997.x; Knox Jones J., 1966, Transactions of the Kansas Academy of Science, V69, P88; Knox Jones J. Jr, 1978, Prairie Naturalist, V10, P49; Kramer-Schadt S, 2013, DIVERS DISTRIB, V19, P1366, DOI 10.1111/ddi.12096; Krusic RA, 1996, J WILDLIFE MANAGE, V60, P625, DOI 10.2307/3802081; Kuenzi AJ, 1998, WILDLIFE SOC B, V26, P307; Lenard S, 2010, SUMMARY 2009 BAT SUR; LESICA P, 1995, CONSERV BIOL, V9, P753, DOI 10.1046/j.1523-1739.1995.09040753.x; Loeb SC, 2006, J WILDLIFE MANAGE, V70, P1210, DOI 10.2193/0022-541X(2006)70[1210:HUBFBI]2.0.CO;2; Mackie LJ, 2007, BIOL CONSERV, V140, P70, DOI 10.1016/j.biocon.2007.07.031; Martin RA., 1982, MAMMAL SPECIES, V175, P1; Owen SF, 2003, AM MIDL NAT, V150, P352, DOI 10.1674/0003-0031(2003)150[0352:HSAHUB]2.0.CO;2; Peterman WE, 2013, BIOL CONSERV, V158, P351, DOI 10.1016/j.biocon.2012.07.028; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; POTTER LD, 1961, ECOLOGY, V42, P468, DOI 10.2307/1932232; Razgour O, 2011, BIOL CONSERV, V144, P2922, DOI 10.1016/j.biocon.2011.08.010; Russo D, 2002, BIOL CONSERV, V107, P71, DOI 10.1016/S0006-3207(02)00047-2; SEABLOOM RW, 1978, VERTEBRATES SW N DAK; Tigner J., 2006, BAT SURVEYS 2006 LIT; Tingley MW, 2009, P NATL ACAD SCI USA, V106, P19637, DOI 10.1073/pnas.0901562106; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Young N., 2011, MAXENT MODEL V3 3 3E, DOI DOI 10.1145/1015330.1015412; Zhang ZH, 2008, AQUAT BOT, V89, P57, DOI 10.1016/j.aquabot.2008.03.002	53	1	1	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0152508	10.1371/journal.pone.0152508	http://dx.doi.org/10.1371/journal.pone.0152508			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935936	gold, Green Published, Green Submitted			2022-12-26	WOS:000389587100002
J	Anwar, T; Gourinath, S				Anwar, Tamanna; Gourinath, Samudrala			Deep Insight into the Phosphatomes of Parasitic Protozoa and a Web Resource ProtozPhosDB	PLOS ONE			English	Article							EUKARYOTIC PROTEIN-KINASES; TRYPANOSOMA-BRUCEI; ACID-PHOSPHATASE; LEISHMANIA-AMAZONENSIS; PLASMODIUM-FALCIPARUM; TYROSINE PHOSPHATASES; ENTAMOEBA-HISTOLYTICA; SURFACE-MEMBRANE; PROCYCLIC FORMS; CELL-SURFACE	Phosphorylation dynamically regulates the function of proteins by maintaining a balance between protein kinase and phosphatase activity. A comprehensive understanding of the role phosphatases in cellular signaling is lacking in case of protozoans of medical and veterinary importance worldwide. The drugs used to treat protozoal diseases have many undesired effects and the development of resistance, highlights the need for new effective and safer antiprotozoal agents. In the present study we have analyzed phosphatomes of 15 protozoans of medical significance. We identified similar to 2000 phosphatases, out of which 21% are uncharacterized proteins. A significant positive correlation between phosphatome and proteome size was observed except for E. histolytica, having highest density of phosphatases irrespective of its proteome size. A difference in the number of phosphatases among different genera shows the variation in the signaling pathways they are involved in. The phosphatome of parasites is dominated by ser/thr phosphatases contrary to the vertebrate host dominated by tyrosine phosphatases. Phosphatases were widely distributed throughout the cell suggesting physiological adaptation of the parasite to regulate its host. 20% to 45% phosphatome of different protozoa consists of ectophosphatases, i.e. crucial for the survival of parasites. A database and a webserver "ProtozPhosDB" can be used to explore the phosphatomes of protozoans of medical significance.	[Anwar, Tamanna; Gourinath, Samudrala] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi, India	Jawaharlal Nehru University, New Delhi	Gourinath, S (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, New Delhi, India.	sgourinath@mail.jnu.ac.in			University Grants Commission (Government of India) [F.4-2/2006(BSR)/13-739/2012(BSR)]	University Grants Commission (Government of India)(University Grants Commission, India)	The authors are thankful to University Grants Commission (Government of India) for providing the funds for this project under Dr. D. S. Kothari postdoctoral fellowship scheme. Grant No. F.4-2/2006(BSR)/13-739/2012(BSR).	Pinheiro AAD, 2007, EXP PARASITOL, V115, P352, DOI 10.1016/j.exppara.2006.09.019; Aguirre-Garcia MM, 2003, PARASITOLOGY, V126, P195, DOI 10.1017/S0031182002002767; Amazonas JN, 2009, EXP PARASITOL, V121, P15, DOI 10.1016/j.exppara.2008.09.010; Andrade LO, 2005, NAT REV MICROBIOL, V3, P819, DOI 10.1038/nrmicro1249; Andreeva AV, 2008, INT J PARASITOL, V38, P1279, DOI 10.1016/j.ijpara.2008.04.003; Andrews KT, 2014, INT J PARASITOL-DRUG, V4, P95, DOI 10.1016/j.ijpddr.2014.02.002; Andrews PD, 2000, J CELL SCI, V113, P2685; Anwar T, 2016, IJBRA138978; Anwar T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078714; Atwood JA, 2005, SCIENCE, V309, P473, DOI 10.1126/science.1110289; Bakalara N, 2000, J BIOL CHEM, V275, P8863, DOI 10.1074/jbc.275.12.8863; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Cosentino-Gomes D, 2011, J BIOENERG BIOMEMBR, V43, P89, DOI 10.1007/s10863-011-9334-y; de Almeida-Amaral EE, 2006, EXP PARASITOL, V114, P334, DOI 10.1016/j.exppara.2006.04.011; de Jesus JB, 2002, PARASITOL RES, V88, P991, DOI 10.1007/s00436-001-0583-2; De Jesus JB, 2006, PARASITOL INT, V55, P285, DOI 10.1016/j.parint.2006.08.002; DELL KR, 1994, MOL BIOCHEM PARASIT, V64, P283, DOI 10.1016/0166-6851(94)00030-1; DICK CF, 2011, ENZYME RES, V2011, DOI DOI 10.4061/2011/103980; Doerig C, 2002, TRENDS PARASITOL, V18, P366, DOI 10.1016/S1471-4922(02)02321-8; Dutra PML, 2006, ACTA TROP, V100, P88, DOI 10.1016/j.actatropica.2006.05.014; Fernandes ACS, 2013, FEMS MICROBIOL LETT, V340, P117, DOI 10.1111/1574-6968.12080; Fernandes EC, 1997, Z NATURFORSCH C, V52, P351; Fernandes EC, 2003, FEMS MICROBIOL LETT, V220, P197, DOI 10.1016/S0378-1097(03)00091-0; Fernandes EC, 2003, VET PARASITOL, V118, P19, DOI 10.1016/j.vetpar.2003.09.012; Furuya T, 1998, MOL BIOCHEM PARASIT, V92, P339, DOI 10.1016/S0166-6851(97)00246-6; Gomes Marta T., 2011, Journal of Parasitology Research, P479146, DOI 10.1155/2011/479146; Gomes SAO, 2006, EXP PARASITOL, V112, P253, DOI 10.1016/j.exppara.2005.11.015; GOTTLIEB M, 1981, SCIENCE, V212, P939, DOI 10.1126/science.7233189; Heberle H, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0611-3; Herrera L, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00259; Hotez PJ, 2009, LANCET, V373, P1570, DOI 10.1016/S0140-6736(09)60233-6; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kellosalo J, 2012, SCIENCE, V337, P473, DOI 10.1126/science.1222505; Kutuzov MA, 2008, MOL BIOCHEM PARASIT, V161, P81, DOI 10.1016/j.molbiopara.2008.06.008; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liberti S, 2013, FEBS J, V280, P379, DOI 10.1111/j.1742-4658.2012.08712.x; Manning G, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r66; Martin DMA, 2009, NUCLEIC ACIDS RES, V37, pD244, DOI 10.1093/nar/gkn834; Matthews KR, 2005, J CELL SCI, V118, P283, DOI 10.1242/jcs.01649; Meyer-Fernandes JR, 1999, Z NATURFORSCH C, V54, P977; Meyer-Fernandes JR, 2002, PARASITOL INT, V51, P299, DOI 10.1016/S1383-5769(02)00017-X; Mi HY, 2016, NUCLEIC ACIDS RES, V44, pD336, DOI 10.1093/nar/gkv1194; Miranda-Saavedra D, 2007, PROTEINS, V68, P893, DOI 10.1002/prot.21444; Neves RFC, 2014, PARASITOL RES, V113, P2961, DOI 10.1007/s00436-014-3958-x; Pandey R, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1024; Parsons M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-127; PARSONS M, 1991, MOL BIOCHEM PARASIT, V45, P241, DOI 10.1016/0166-6851(91)90091-J; Shakarian AM, 2002, J BIOL CHEM, V277, P17994, DOI 10.1074/jbc.M200114200; Stefani M, 1995, LIFE CHEM REPORTS, V12, P271; Szoor B, 2010, MOL BIOCHEM PARASIT, V173, P53, DOI 10.1016/j.molbiopara.2010.05.017; Veeramani S, 2009, TRENDS BIOCHEM SCI, V34, P273, DOI 10.1016/j.tibs.2009.03.002; Wilkes JM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-412; Yu CS, 2004, PROTEIN SCI, V13, P1402, DOI 10.1110/ps.03479604	54	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167594	10.1371/journal.pone.0167594	http://dx.doi.org/10.1371/journal.pone.0167594			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930683	Green Submitted, Green Published, gold			2022-12-26	WOS:000389580900029
J	Guido, NJ; Handerson, S; Joseph, EM; Leake, D; Kung, LA				Guido, Nicholas J.; Handerson, Steven; Joseph, Elaine M.; Leake, Devin; Kung, Li A.			Determination of a Screening Metric for High Diversity DNA Libraries	PLOS ONE			English	Article							GENE SYNTHESIS; ERROR-CORRECTION; SEQUENCES; ALIGNMENT; GAP	The fields of antibody engineering, enzyme optimization and pathway construction rely increasingly on screening complex variant DNA libraries. These highly diverse libraries allow researchers to sample a maximized sequence space; and therefore, more rapidly identify proteins with significantly improved activity. The current state of the art in synthetic biology allows for libraries with billions of variants, pushing the limits of researchers' ability to qualify libraries for screening by measuring the traditional quality metrics of fidelity and diversity of variants. Instead, when screening variant libraries, researchers typically use a generic, and often insufficient, oversampling rate based on a common rule-of-thumb. We have developed methods to calculate a library-specific oversampling metric, based on fidelity, diversity, and representation of variants, which informs researchers, prior to screening the library, of the amount of oversampling required to ensure that the desired fraction of variant molecules will be sampled. To derive this oversampling metric, we developed a novel alignment tool to efficiently measure frequency counts of individual nucleotide variant positions using next-generation sequencing data. Next, we apply a method based on the "coupon collector" probability theory to construct a curve of upper bound estimates of the sampling size required for any desired variant coverage. The calculated oversampling metric will guide researchers to maximize their efficiency in using highly variant libraries.	[Guido, Nicholas J.; Handerson, Steven; Joseph, Elaine M.; Leake, Devin; Kung, Li A.] Gen9 Inc, Cambridge, MA 02139 USA		Guido, NJ (corresponding author), Gen9 Inc, Cambridge, MA 02139 USA.	nguido@gen9bio.com		Joseph, Elaine/0000-0002-9632-4207	Gen9	Gen9	Gen9 provided support in the form of salaries for authors NJG, SH, EMJ, DL, LAK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ALTSCHUL SF, 1986, B MATH BIOL, V48, P603, DOI 10.1016/S0092-8240(86)90010-8; Arndt KM, 2007, PROTEIN ENG PROTOCOL, pxi; Boneh A, 1996, COMMUNICATIONS STA C, V13, P39; Bradley LH, 2014, METHODS MOL BIOL, V1216, P117, DOI 10.1007/978-1-4939-1486-9_6; Carr PA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh160; Davis PJ, 1975, METHODS NUMERICAL IN, pxii; Ferragina P, 2000, ANN IEEE SYMP FOUND, P390, DOI 10.1109/SFCS.2000.892127; Ferrante M, 2014, MAT MATEMATICS, V2, P1; FLAJOLET P, 1992, DISCRETE APPL MATH, V39, P207, DOI 10.1016/0166-218X(92)90177-C; Gan R., 2016, BIOTECHNOL BIOENG; GOTOH O, 1982, J MOL BIOL, V162, P705, DOI 10.1016/0022-2836(82)90398-9; Hoebenreich S, 2015, ACS SYNTH BIOL, V4, P317, DOI 10.1021/sb5002399; Kosuri S, 2013, P NATL ACAD SCI USA, V110, P14024, DOI 10.1073/pnas.1301301110; Kosuri S, 2010, NAT BIOTECHNOL, V28, P1295, DOI 10.1038/nbt.1716; Langmead B., BOWTIE 2 MANUAL 2016; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; LeProust EM, 2010, NUCLEIC ACIDS RES, V38, P2522, DOI 10.1093/nar/gkq163; Ma SY, 2012, TRENDS BIOTECHNOL, V30, P147, DOI 10.1016/j.tibtech.2011.10.002; Motwani R, 1995, RANDOMIZED ALGORITHM, pxiv; Patwardhan RP, 2009, NAT BIOTECHNOL, V27, P1173, DOI 10.1038/nbt.1589; Poust S, 2014, CURR OPIN BIOTECH, V30, P32, DOI 10.1016/j.copbio.2014.04.011; Quan JY, 2011, NAT BIOTECHNOL, V29, P449, DOI 10.1038/nbt.1847; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Townsend S, 2015, P NATL ACAD SCI USA, V112, P15354, DOI 10.1073/pnas.1510944112; Vidal E, 2005, IEEE T PATTERN ANAL, V27, P1013, DOI 10.1109/TPAMI.2005.147	25	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167088	10.1371/journal.pone.0167088	http://dx.doi.org/10.1371/journal.pone.0167088			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930689	Green Submitted, Green Published, gold			2022-12-26	WOS:000389580900020
J	Leonard, SR; Mammel, MK; Lacher, DW; Elkins, CA				Leonard, Susan R.; Mammel, Mark K.; Lacher, David W.; Elkins, Christopher A.			Strain-Level Discrimination of Shiga Toxin-Producing Escherichia coli in Spinach Using Metagenomic Sequencing	PLOS ONE			English	Article							FLAGELLIN GENES; OUTBREAK; INFECTIONS; O157-H7	Consumption of fresh bagged spinach contaminated with Shiga toxin-producing Escherichia coli (STEC) has led to severe illness and death; however current culture-based methods to detect foodborne STEC are time consuming. Since not all STEC strains are considered pathogenic to humans, it is crucial to incorporate virulence characterization of STEC in the detection method. In this study, we assess the comprehensiveness of utilizing a shotgun metagenomics approach for detection and strain-level identification by spiking spinach with a variety of genomically disparate STEC strains at a low contamination level of 0.1 CFU/g. Molecular serotyping, virulence gene characterization, microbial community analysis, and E. coli core gene single nucleotide polymorphism (SNP) analysis were performed on metagenomic sequence data from enriched samples. It was determined from bacterial community analysis that E. coli, which was classified at the phylogroup level, was a major component of the population in most samples. However, in over half the samples, molecular serotyping revealed the presence of indigenous E. coli which also contributed to the percent abundance of E. coli. Despite the presence of additional E. coli strains, the serotype and virulence genes of the spiked STEC, including correct Shiga toxin subtype, were detected in 94% of the samples with a total number of reads per sample averaging 2.4 million. Variation in STEC abundance and/or detection was observed in replicate spiked samples, indicating an effect from the indigenous microbiota during enrichment. SNP analysis of the metagenomic data correctly placed the spiked STEC in a phylogeny of related strains in cases where the indigenous E. coli did not predominate in the enriched sample. Also, for these samples, our analysis demonstrates that strain-level phylogenetic resolution is possible using shotgun metagenomic data for determining the genomic relatedness of a contaminating STEC strain to other closely related E. coli.	[Leonard, Susan R.; Mammel, Mark K.; Lacher, David W.; Elkins, Christopher A.] US FDA, Div Mol Biol, Ctr Food Safety & Appl Nutr, Laurel, MD 20708 USA	US Food & Drug Administration (FDA)	Leonard, SR (corresponding author), US FDA, Div Mol Biol, Ctr Food Safety & Appl Nutr, Laurel, MD 20708 USA.	Susan.Leonard@fda.hhs.gov		Elkins, Christopher/0000-0002-6029-9812	Oak Ridge Institute for Science and Education	Oak Ridge Institute for Science and Education(General Electric)	SRL was supported by a fellowship appointment administered by Oak Ridge Institute for Science and Education.	Baylis CL, 2008, J APPL MICROBIOL, V105, P1259, DOI 10.1111/j.1365-2672.2008.03859.x; Bielaszewska M, 2014, EMBO MOL MED, V6, P347, DOI 10.1002/emmm.201303133; Doyle MP, 2008, J APPL MICROBIOL, V105, P317, DOI 10.1111/j.1365-2672.2008.03746.x; Feng P., 2013, BACTERIOLOGICAL ANAL; Feng P, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.EHEC-0010-2013; Feng PCH, 2013, APPL ENVIRON MICROB, V79, P6917, DOI 10.1128/AEM.02455-13; Gould LH, 2013, FOODBORNE PATHOG DIS, V10, P453, DOI 10.1089/fpd.2012.1401; Herman KM, 2015, EPIDEMIOL INFECT, P1; Iguchi A, 2015, DNA RES, V22, P101, DOI 10.1093/dnares/dsu043; Ilic S, 2008, J FOOD PROTECT, V71, P2398, DOI 10.4315/0362-028X-71.12.2398; Jackson BR, 2016, CLIN INFECT DIS, V63, P380, DOI 10.1093/cid/ciw242; Jarvis KG, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0497-2; Jensen AK, 2016, CLIN INFECT DIS, V63, P64, DOI 10.1093/cid/ciw192; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leonard SR, 2016, APPL ENVIRON MICROB, V82, P4309, DOI 10.1128/AEM.01129-16; Leonard SR, 2015, APPL ENVIRON MICROB, V81, P8183, DOI 10.1128/AEM.02601-15; Mariani-Kurkdjian P, 2014, New Microbes New Infect, V2, P127, DOI 10.1002/nmi2.49; Melton-Celsa AR, 2014, MICROBIOLOGY SPECTRU, V2; Ottesen AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073079; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; Ratiner YA, 2010, ARCH MICROBIOL, V192, P267, DOI 10.1007/s00203-010-0556-x; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; Taylor AJ, 2015, J CLIN MICROBIOL, V53, P3334, DOI 10.1128/JCM.01280-15; Teunis PFM, 2008, EPIDEMIOL INFECT, V136, P761, DOI 10.1017/S0950268807008771; Tilden J, 1996, AM J PUBLIC HEALTH, V86, P1142, DOI 10.2105/AJPH.86.8_Pt_1.1142; Tominaga A, 2004, GENES GENET SYST, V79, P1, DOI 10.1266/ggs.79.1; Tominaga A, 2007, GENES GENET SYST, V82, P1, DOI 10.1266/ggs.82.1; Tuttle J, 1999, EPIDEMIOL INFECT, V122, P185, DOI 10.1017/S0950268898001976; Valentin-Bon I, 2008, APPL ENVIRON MICROB, V74, P1240, DOI 10.1128/AEM.02258-07; Wang F, 2013, FOODBORNE PATHOG DIS, V10, P665, DOI 10.1089/fpd.2012.1448; Wang L, 2003, J BACTERIOL, V185, P2936, DOI 10.1128/JB.185.9.2936-2943.2003; Wang W, 2007, MICROBIOL-SGM, V153, P2159, DOI 10.1099/mic.0.2007/004192-0; Wilson MR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146929	35	44	44	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167870	10.1371/journal.pone.0167870	http://dx.doi.org/10.1371/journal.pone.0167870			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930729	Green Submitted, gold, Green Published			2022-12-26	WOS:000389580900053
J	Oren, DA; Wei, Y; Skrabanek, L; Chow, BKC; Mommsen, T; Mojsov, S				Oren, Deena A.; Wei, Yang; Skrabanek, Luce; Chow, Billy K. C.; Mommsen, Thomas; Mojsov, Svetlana			Structural Mapping and Functional Characterization of Zebrafish Class B G-Protein Coupled Receptor (GPCR) with Dual Ligand Selectivity towards GLP-1 and Glucagon	PLOS ONE			English	Article							TERMINAL EXTRACELLULAR DOMAIN; TISSUE-SPECIFIC EXPRESSION; AMINO-ACID-SEQUENCES; PEPTIDE-I; CRYSTAL-STRUCTURE; RAT-LIVER; BIOLOGICAL-ACTIVITY; BINDING; PANCREAS; RESIDUES	GLP-1 and glucagon regulate glucose metabolism through a network of metabolic pathways initiated upon binding to their specific receptors that belong to class B G-protein coupled receptors (GPCRs). The therapeutic potential of glucagon is currently being evaluated, while GLP-1 is already used in the treatment of type 2 diabetes and obesity. Development of a second generation of GLP-1 based therapeutics depends on a molecular and structural understanding of the interactions between the GLP-1 receptor (GLP-1R) and its ligand GLP-1. There is considerable sequence conservation between GLP-1 and glucagon and between the hGLP-1R and human glucagon receptor (hGCGR), yet each receptor recognizes only its own specific ligand. Glucagon receptors in fish and frogs also exhibit ligand selectivity only towards glucagon and not GLP-1. Based on competitive binding experiments and assays of increase in intracellular cAMP, we demonstrate here that a GPCR in zebrafish (Danio rerio) exhibits dual ligand selectivity towards GLP-1 and glucagon, a characteristic not found in mammals. Further, many structural features found in hGLP-1R and hGCGR are also found in this zebrafish GPCR (zfGPCR). We show this by mapping of its sequence and structural features onto the hGLP-1R and hGCGR based on their partial and complementary crystal structures. Thus, we propose that zfGPCR represents a dual GLP-1R/GCGR. The main differences between the three receptors are in their stalk regions that connect their N-terminal extracellular domains (NECDs) with their transmembrane domains and the absence of loop 3 in the NECD in zfGLP-1R/GCGR. These observations suggest that the interactions between GLP-1 and glucagon with loop 3 and the stalk regions may induce different conformational changes in hGLP-1R and hGCGR upon ligand binding and activation that lead to selective recognition of their native ligands.	[Oren, Deena A.; Wei, Yang; Mojsov, Svetlana] Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA; [Skrabanek, Luce] Weill Cornell Med Coll, Appl Bioinformat Core, New York, NY USA; [Chow, Billy K. C.] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China; [Mommsen, Thomas] Univ Victoria, Dept Biochem, Victoria, BC, Canada; [Wei, Yang] Regeneron Pharmaceut, Tarrytown, NY USA	Rockefeller University; Cornell University; University of Hong Kong; University of Victoria; Regeneron	Mojsov, S (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.	mojsov@rockefeller.edu	Chow, Billy/D-3064-2009	Chow, Billy/0000-0003-3390-0307	National Science Foundation (NSF) [IBN-9904506]	National Science Foundation (NSF)(National Science Foundation (NSF))	Support was provided by the National Science Foundation (NSF) Grant No. IBN-9904506 to SM.	Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; BROMER WW, 1976, METABOLISM, V25, P1315, DOI 10.1016/S0026-0495(76)80130-8; Chen QA, 2010, J BIOL CHEM, V285, P24508, DOI 10.1074/jbc.M110.135749; Chen Q, 2009, J BIOL CHEM, V284, P34135, DOI 10.1074/jbc.M109.038109; Chow BKC, 2004, ENDOCRINOLOGY, V145, P3273, DOI 10.1210/en.2003-0597; Coin I, 2013, CELL, V155, P1258, DOI 10.1016/j.cell.2013.11.008; Cooke RM, 2015, DRUG DISCOV TODAY, V20, P1355, DOI 10.1016/j.drudis.2015.08.003; Coopman K, 2011, MOL ENDOCRINOL, V25, P1804, DOI 10.1210/me.2011-1160; Delano W.L, 2002, PYMOL USERS MANUAL; ENG J, 1992, J BIOL CHEM, V267, P7402; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; GARRISON JC, 1973, J BIOL CHEM, V248, P5333; GEFEL D, 1990, ENDOCRINOLOGY, V126, P2164, DOI 10.1210/endo-126-4-2164; GOKE R, 1993, J BIOL CHEM, V268, P19650; HARMAR T, 1994, TRENDS PHARMACOL SCI, V15, P97, DOI 10.1016/0165-6147(94)90042-6; HEINRICH G, 1984, ENDOCRINOLOGY, V115, P2176, DOI 10.1210/endo-115-6-2176; Hoare SRJ, 2005, DRUG DISCOV TODAY, V10, P417, DOI 10.1016/S1359-6446(05)03370-2; Hollenstein K, 2014, TRENDS PHARMACOL SCI, V35, P12, DOI 10.1016/j.tips.2013.11.001; Hollenstein K, 2013, NATURE, V499, P438, DOI 10.1038/nature12357; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Irwin DM, 2014, GEN COMP ENDOCR, V209, P50, DOI 10.1016/j.ygcen.2014.03.002; JELINEK LJ, 1993, SCIENCE, V259, P1614, DOI 10.1126/science.8384375; Kirkpatrick A, 2012, P NATL ACAD SCI USA, V109, P19988, DOI [10.1073/pnas.1218051109, 10.1073/pnas.12180511091]; Koth CM, 2012, P NATL ACAD SCI USA, V109, P14393, DOI 10.1073/pnas.1206734109; Kumar S., 2011, J PHARM ALLIED HLTH, V1, P1, DOI [10.3923/jpahs.2011.1.15, DOI 10.3923/JPAHS.2011.1.15]; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Li MY, 2015, J ENDOCRINOL, V227, P93, DOI 10.1530/JOE-15-0284; LOK S, 1994, GENE, V140, P203, DOI 10.1016/0378-1119(94)90545-2; MACNEIL DJ, 1994, BIOCHEM BIOPH RES CO, V198, P328, DOI 10.1006/bbrc.1994.1046; Miller JR, 2003, GRAPHPAD PRISM STEP; Miller LJ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.217901; Mojsov S, 2000, AM ZOOL, V40, P246, DOI 10.1668/0003-1569(2000)040[0246:GLPGAT]2.0.CO;2; MOJSOV S, 1986, J BIOL CHEM, V261, P1880; MOJSOV S, 1987, J CLIN INVEST, V79, P616, DOI 10.1172/JCI112855; MOJSOV S, 1992, INT J PEPT PROT RES, V40, P333; MOMMSEN TP, 1987, FEBS LETT, V219, P227, DOI 10.1016/0014-5793(87)81222-X; MOMMSEN TP, 1990, J ENDOCRINOL, V126, P109, DOI 10.1677/joe.0.1260109; Moon MJ, 2015, J BIOL CHEM, V290, P5696, DOI 10.1074/jbc.M114.612606; MOTULSKI HJ, 2003, FITTING MODELS BIOL; Ngan ESW, 1999, FEBS LETT, V457, P499, DOI 10.1016/S0014-5793(99)01112-6; ORSKOV C, 1986, ENDOCRINOLOGY, V119, P1467, DOI 10.1210/endo-119-4-1467; Parthier C, 2007, P NATL ACAD SCI USA, V104, P13942, DOI 10.1073/pnas.0706404104; Parthier C, 2009, TRENDS BIOCHEM SCI, V34, P303, DOI 10.1016/j.tibs.2009.02.004; Patterson JT, 2013, MOL METAB, V2, P86, DOI 10.1016/j.molmet.2013.01.003; Perrin MH, 1999, ANN NY ACAD SCI, V885, P312, DOI 10.1111/j.1749-6632.1999.tb08687.x; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Plisetskaya EM, 1996, INT REV CYTOL, V168, P187, DOI 10.1016/S0074-7696(08)60885-2; Poudyal H, 2016, ACTA PHYSIOL, V216, P277, DOI 10.1111/apha.12604; Roch GJ, 2009, GEN COMP ENDOCR, V161, P3, DOI 10.1016/j.ygcen.2008.10.017; RODBELL M, 1971, J BIOL CHEM, V246, P1861; Runge S, 2008, J BIOL CHEM, V283, P11340, DOI 10.1074/jbc.M708740200; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Skrabanek L, 2003, NUCLEIC ACIDS RES, V31, P3856, DOI 10.1093/nar/gkg552; SONNE O, 1978, J BIOL CHEM, V253, P3203; Stalmans W., 1983, GLUCAGON LIVER GLYCO; ter Haar E, 2010, STRUCTURE, V18, P1083, DOI 10.1016/j.str.2010.05.014; THORENS B, 1993, DIABETES, V42, P1678, DOI 10.2337/diabetes.42.11.1678; THORENS B, 1992, P NATL ACAD SCI USA, V89, P8641, DOI 10.1073/pnas.89.18.8641; Underwood CR, 2010, J BIOL CHEM, V285, P723, DOI 10.1074/jbc.M109.033829; VanEyll B, 1996, PEPTIDES, V17, P565, DOI 10.1016/0196-9781(96)00019-8; WAGLE SR, 1973, BIOCHEM BIOPH RES CO, V52, P125, DOI 10.1016/0006-291X(73)90963-7; Wei Y, 1996, J NEUROENDOCRINOL, V8, P811, DOI 10.1046/j.1365-2826.1996.05191.x; WEI Y, 1995, FEBS LETT, V358, P219, DOI 10.1016/0014-5793(94)01430-9; Wei Y, 1998, ANN NY ACAD SCI; Wilmen A, 1997, PEPTIDES, V18, P301, DOI 10.1016/S0196-9781(96)00321-X; Wootten D, 2013, P NATL ACAD SCI USA, V110, P5211, DOI 10.1073/pnas.1221585110; Zhou L, 2004, COMP BIOCHEM PHYS B, V137, P255, DOI 10.1016/j.cbpc.2003.11.009; Zidovetzki R, 2003, BIOPHYS CHEM, V100, P555, DOI 10.1016/S0301-4622(02)00306-X	68	9	9	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167718	10.1371/journal.pone.0167718	http://dx.doi.org/10.1371/journal.pone.0167718			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930690	Green Submitted, gold, Green Published			2022-12-26	WOS:000389580900040
J	Sardarinia, M; Akbarpour, S; Lotfaliany, M; Bagherzadeh-Khiabani, F; Bozorgmanesh, M; Sheikholeslami, F; Azizi, F; Hadaegh, F				Sardarinia, Mahsa; Akbarpour, Samaneh; Lotfaliany, Mojtaba; Bagherzadeh-Khiabani, Farideh; Bozorgmanesh, Mohammadreza; Sheikholeslami, Farhad; Azizi, Fereidoun; Hadaegh, Farzad			Risk Factors for Incidence of Cardiovascular Diseases and All-Cause Mortality in a Middle Eastern Population over a Decade Follow-up: Tehran Lipid and Glucose Study	PLOS ONE			English	Article							BODY-MASS INDEX; CHRONIC KIDNEY-DISEASE; WAIST CIRCUMFERENCE; MYOCARDIAL-INFARCTION; DIABETES-MELLITUS; OBESITY PARADOX; POOLED ANALYSIS; 52 COUNTRIES; HYPERTENSION; PREVALENCE	Background To examine the association between potentially modifiable risk factors with cardiovascular disease (CVD) and all-cause mortality and to quantify their population attributable fractions (PAFs) among a sample of Tehran residents. Methods Overall, 8108 participants (3686 men) aged >= 30 years, were investigated. To examine the association between risk factors and outcomes, multivariate sex-adjusted Cox proportional hazard regression analysis were conducted, using age as time-scale in two models including general/central adiposity: 1) adjusted for different independent variables including smoking, education, family history of CVD and sex for both outcomes and additionally adjusted for prevalent CVD for all-cause mortality 2) further adjusted for obesity mediators (hypertension, diabetes, lipid profile and chronic kidney disease). Separate models were used including either general or central adiposity. Results During median follow-up of >10 years, 827 first CVD events and 551 deaths occurred. Both being overweight (hazard ratio (HR), 95% CI: 1.41, 1.18-1.66, PAF 13.66) and obese (1.51, 1.24-1.84, PAF 9.79) played significant roles for incident CVD in the absence of obesity mediators. Predicting CVD, in the presence of general adiposity and its mediators, significant positive associations were found for hypercholesterolemia (1.59, 1.36-1.85, PAF 16.69), low HDL-C (1.21, 1.03-1.41, PAF 12.32), diabetes (1.86, 1.57-2.27, PAF 13.87), hypertension (1.79, 1.46-2.19, PAF 21.62) and current smoking (1.61, 1.34-1.94, PAF 7.57). Central adiposity remained a significant positive predictor, even after controlling for mediators (1.17, 1.01-1.35, PAF 7.55). For all-cause mortality, general/central obesity did not have any risk even in the absence of obesity mediators. Predictors including diabetes (2.56, 2.08-3.16, PAF 24.37), hypertension (1.43, 1.11-1.84, PAF 17.13), current smoking (1.75, 1.38-2.22, PAF 7.71), and low education level (1.59, 1.01-2.51, PAF 27.08) were associated with higher risk, however, hypertriglyceridemia (0.83, 0.68-1.01) and being overweight (0.71, 0.58-0.87) were associated with lower risk. Conclusions Modifiable risk factors account for more than 70% risk for both CVD and mortality events.	[Sardarinia, Mahsa; Akbarpour, Samaneh; Lotfaliany, Mojtaba; Bagherzadeh-Khiabani, Farideh; Bozorgmanesh, Mohammadreza; Sheikholeslami, Farhad; Hadaegh, Farzad] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Prevent Metab Disorders Res Ctr, Tehran, Iran; [Akbarpour, Samaneh] Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Tehran, Iran; [Lotfaliany, Mojtaba] Univ Melbourne, Sch Populat & Global Hlth, Noncommunicable Dis Control, Melbourne, Vic, Australia; [Azizi, Fereidoun] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Endocrine Res Ctr, Tehran, Iran	Shahid Beheshti University Medical Sciences; Tehran University of Medical Sciences; University of Melbourne; Shahid Beheshti University Medical Sciences	Hadaegh, F (corresponding author), Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Prevent Metab Disorders Res Ctr, Tehran, Iran.	fzhadaegh@endocrine.ac.ir	Lotfaliany, Mojtaba/ABB-6325-2020; bozorgmanesh, mohammadreza/AAE-1001-2022; Azizi, Fereidoun/ABD-4136-2021; hadaegh, farzad/K-2460-2017	Azizi, Fereidoun/0000-0002-6470-2517; Hajsheikholeslami, Farhad/0000-0001-6016-1867; hadaegh, farzad/0000-0002-0352-8666; Lotfaliany Abrand Abadi, Mojtaba/0000-0001-6594-9004; Hadaegh, Farzad/0000-0002-8935-2744	National Research Council of the Islamic Republic of Iran [121]	National Research Council of the Islamic Republic of Iran	This study was supported by Grant No.121 from the National Research Council of the Islamic Republic of Iran. Funding source had no role in design, in the collection, analysis, and interpretation of data; in the writing of the manuscript; and in the decision to submit the manuscript for publication.	Akbarpour S, 2015, IRANIAN J EPIDEMIOLO, V11, P23; Alwan A, 2011, GLOBAL STATUS REPORT ON NONCOMMUNICABLE DISEASES 2010, P9; American Diabetes Association, 2015, Clin Diabetes, V33, P97, DOI 10.2337/diaclin.33.2.97; Azizi F, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-5; Balkau B, 2007, CIRCULATION, V116, P1942, DOI 10.1161/CIRCULATIONAHA.106.676379; Barr ELM, 2007, CIRCULATION, V116, P151, DOI 10.1161/CIRCULATIONAHA.106.685628; Boshtam M, 2005, PAK J CARDIOL, V16, P23; Bozorgmanesh M, 2012, ACTA DIABETOL, V49, P341, DOI 10.1007/s00592-011-0298-5; Bucholz EM, 2012, AM J MED, V125, P796, DOI 10.1016/j.amjmed.2012.01.018; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Carl J., 2012, J GLYCOMICS LIPIDOMI; Cerhan JR, 2014, MAYO CLIN PROC, V89, P335, DOI 10.1016/j.mayocp.2013.11.011; Chang Y, 2016, ANN INTERN MED, V164, P305, DOI 10.7326/M15-1323; Cvetkovic Z, 2009, J BUON, V14, P501; Derakhshan A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102563; DEWYS WD, 1980, AM J MED, V69, P491, DOI 10.1016/S0149-2918(05)80001-3; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Foster MC, 2008, AM J KIDNEY DIS, V52, P39, DOI 10.1053/j.ajkd.2008.03.003; Gellert C, 2012, ARCH INTERN MED, V172, P837, DOI 10.1001/archinternmed.2012.1397; Ghasemzadeh Z, 2016, NUTR METAB, V13, P1; Gray L, 2011, J AM COLL CARDIOL, V58, P2396, DOI 10.1016/j.jacc.2011.07.045; GREENLAND S, 1988, AM J EPIDEMIOL, V128, P1185, DOI 10.1093/oxfordjournals.aje.a115073; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hadaegh F, 2009, INT J OBESITY, V33, P1437, DOI 10.1038/ijo.2009.180; Hadaegh F, 2015, DIABETIC MED; Hadaegh F, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-176; Hadaegh F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139412; Hadaegh F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076304; Hadaegh F, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-84; Hainer V, 2013, DIABETES CARE, V36, pS276, DOI 10.2337/dcS13-2023; Hastie CE, 2010, EUR HEART J, V31, P222, DOI 10.1093/eurheartj/ehp317; Hong YL, 2009, CLIN CHEM, V55, P1450, DOI 10.1373/clinchem.2009.125369; Jackson C, 2004, ARCH PEDIAT ADOL MED, V158, P1050, DOI 10.1001/archpedi.158.11.1050; Jahangiri-Noudeh Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112639; James PA, 2014, JAMA-J AM MED ASSOC, V311, P507, DOI 10.1001/jama.2013.284427; Karimy M, 2013, IRAN RED CRESCENT ME, V15, P187, DOI 10.5812/ircmj.3378; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Kheirandish M, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-20; Kutner M., 2005, APPL LINEAR STAT MOD; Levey A, 2000, SIMPLIFIED EQUATION; Liu J, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-159; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Lotfaliany M, 2015, J HYPERTENS, V33, P1153, DOI 10.1097/HJH.0000000000000540; Lu Y, 2015, EPIDEMIOLOGY, V26, P153, DOI 10.1097/EDE.0000000000000234; Lu Y, 2014, LANCET, V383, P970, DOI 10.1016/S0140-6736(13)61836-X; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; MCKEIGUE PM, 1991, LANCET, V337, P382, DOI 10.1016/0140-6736(91)91164-P; McMahon K, 1998, SEMINARS ONCOLOGY; Moghaddam MM, 2014, ANN SAUDI MED, V34, P134, DOI 10.5144/0256-4947.2014.134; Morgan CL, 2000, DIABETES CARE, V23, P1103, DOI 10.2337/diacare.23.8.1103; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Norman K, 2008, CLIN NUTR, V27, P5, DOI 10.1016/j.clnu.2007.10.007; Organization WH, 2010, MORT BURD DIS EST WH; Organization WH, 2009, GLOB HLTH RISKS MORT; Parikh NI, 2008, AM J CARDIOL, V102, P47, DOI 10.1016/j.amjcard.2008.02.095; Pednekar MS, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-567; Pencina MJ, 2007, STAT MED, V26, P1343, DOI 10.1002/sim.2699; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; Samadi S, 2013, INT J CARDIOL, V165, P260, DOI 10.1016/j.ijcard.2011.08.049; Schulze MB, 2006, DIABETES CARE, V29, P1921, DOI 10.2337/dc06-0895; Shankar A, 2007, ATHEROSCLEROSIS, V192, P177, DOI 10.1016/j.atherosclerosis.2006.04.029; Smith DG, 2007, AM J MANAG CARE, V13, pS68; Staiano AE, 2012, INT J OBESITY, V36, P1450, DOI 10.1038/ijo.2011.268; Taylor KS, 2013, DIABETES CARE, V36, P2366, DOI 10.2337/dc12-1513; Thorogood M, 2003, J EPIDEMIOL COMMUN H, V57, P130, DOI 10.1136/jech.57.2.130; van Buuren S, 2011, J STAT SOFTW, V45, P1; Visscher TLS, 2001, INT J OBESITY, V25, P1730, DOI 10.1038/sj.ijo.0801787; Weiner DE, 2004, J AM SOC NEPHROL, V15, P1307, DOI 10.1097/01.ASN.0000123691.46138.E2; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	72	54	55	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167623	10.1371/journal.pone.0167623	http://dx.doi.org/10.1371/journal.pone.0167623			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930696	gold, Green Published, Green Submitted			2022-12-26	WOS:000389580900031
J	Hu, C; Li, Z; Zhou, T; Zhu, AJ; Xu, CP				Hu, Cong; Li, Zhi; Zhou, Tian; Zhu, Aijun; Xu, Chuanpei			A Multi-Verse Optimizer with Levy Flights for Numerical Optimization and Its Application in Test Scheduling for Network-on-Chip	PLOS ONE			English	Article							GLOBAL OPTIMIZATION; PARTICLE SWARM; TEST ACCESS; ALGORITHM; SEARCH	We propose a new meta-heuristic algorithm named Levy flights multi-verse optimizer (LFMVO), which incorporates Levy flights into multi-verse optimizer (MVO) algorithm to solve numerical and engineering optimization problems. The Original MVO easily falls into stagnation when wormholes stochastically re-span a number of universes (solutions) around the best universe achieved over the course of iterations. Since Levy flights are superior in exploring unknown, large-scale search space, they are integrated into the previous best universe to force MVO out of stagnation. We test this method on three sets of 23 well-known benchmark test functions and an NP complete problem of test scheduling for Network-on-Chip (NoC). Experimental results prove that the proposed LFMVO is more competitive than its peers in both the quality of the resulting solutions and convergence speed.	[Hu, Cong; Li, Zhi] Xidian Univ, Sch Mechanoelect Engn, Xian, Shaanxi, Peoples R China; [Hu, Cong; Zhou, Tian; Zhu, Aijun; Xu, Chuanpei] Guilin Univ Elect Technol, Sch Elect Engn & Automat, Guilin, Guangxi, Peoples R China; [Li, Zhi] Guilin Univ Aerosp Technol, Guilin, Guangxi, Peoples R China	Xidian University; Guilin University of Electronic Technology; Guilin University of Aerospace Technology	Xu, CP (corresponding author), Guilin Univ Elect Technol, Sch Elect Engn & Automat, Guilin, Guangxi, Peoples R China.	mataaedu@outlook.com	Zhu, Aijun/AGO-3276-2022	Zhu, Aijun/0000-0003-3112-4172	National Natural Science Foundation of China [61561012]; Guangxi Natural Science Foundation of China [2014GXNSFAA118393]; Guangxi Key Laboratory of Automatic Detecting Technology and Instruments [YQ16106]; Science and Technology Research Project of Guangxi Department of Education [KY2015Y13110]; National Natural Science Foundation of China [61561012]; Guangxi Natural Science Foundation of China [2014GXNSFAA118393]; Guangxi Key Laboratory of Automatic Detecting Technology and Instruments [YQ16106]; Science and Technology Research Project of Guangxi Department of Education [KY2015Y13110]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangxi Natural Science Foundation of China; Guangxi Key Laboratory of Automatic Detecting Technology and Instruments; Science and Technology Research Project of Guangxi Department of Education; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangxi Natural Science Foundation of China; Guangxi Key Laboratory of Automatic Detecting Technology and Instruments; Science and Technology Research Project of Guangxi Department of Education	This work is supported by the National Natural Science Foundation of China (Grant No. 61561012), the Guangxi Natural Science Foundation of China (Grant No. 2014GXNSFAA118393), the Guangxi Key Laboratory of Automatic Detecting Technology and Instruments (Grant No. YQ16106), and the Science and Technology Research Project of Guangxi Department of Education (Grant No. KY2015Y13110). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdechiri M, 2013, APPL SOFT COMPUT, V13, P2932, DOI 10.1016/j.asoc.2012.03.068; Ahmed SH, 2016, IEEE T VEH TECHNOL, V65, P3954, DOI 10.1109/TVT.2016.2558650; Al-Temeemy AA, 2010, 2010 IEEE INT C IM S; Butun I, 2016, IEEE COMMUN MAG, V54, P47, DOI 10.1109/MCOM.2016.7452265; Candela R, 2010, LECT NOTES ARTIF INT, V6097, P288, DOI 10.1007/978-3-642-13025-0_31; Chen Y, 2010, J OCCUPATIONAL SAFET, V18, P1, DOI DOI 10.1109/GE0INF0RMATICS.2010.5; Cheng MY, 2014, COMPUT STRUCT, V139, P98, DOI 10.1016/j.compstruc.2014.03.007; Clerc M, 2002, IEEE T EVOLUT COMPUT, V6, P58, DOI 10.1109/4235.985692; COLORNI A, 1992, FROM ANIM ANIMAT, P134; Cordeschi N, 2015, J SUPERCOMPUT, V71, P448, DOI 10.1007/s11227-014-1305-8; Cordeschi N, 2013, COMPUT NETW, V57, P3479, DOI 10.1016/j.comnet.2013.08.002; Gandomi AH, 2014, J COMPUT SCI-NETH, V5, P224, DOI 10.1016/j.jocs.2013.10.002; Geem ZW, 2001, SIMULATION, V76, P60, DOI 10.1177/003754970107600201; Hakli H, 2014, APPL SOFT COMPUT, V23, P333, DOI 10.1016/j.asoc.2014.06.034; Holland J.H., 1975, ADAPTATION NATURAL A; Houbing Song CB., 2016, CYBER PHYS SYSTEMS F; Hu C, 2016, J ELECTRON TEST, V32, P31, DOI 10.1007/s10836-016-5565-5; Iyengar V, 2002, J ELECTRON TEST, V18, P213, DOI 10.1023/A:1014916913577; Jordehi AR, 2014, NEURAL COMPUT APPL, V25, P1329, DOI 10.1007/s00521-014-1613-1; Karaboga D, 2007, J GLOBAL OPTIM, V39, P459, DOI 10.1007/s10898-007-9149-x; Kennedy J., 1995, 1995 IEEE International Conference on Neural Networks Proceedings (Cat. No.95CH35828), P1942, DOI 10.1109/ICNN.1995.488968; Lee CY, 2001, IEEE C EVOL COMPUTAT, P568, DOI 10.1109/CEC.2001.934442; Li W, 2016, FUTURE GENE IN PRESS; Liu C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097822; Liu CS, 2006, IEEE VLSI TEST SYMP, P46; Lo Ai A., 2016, 2016 IEEE 1 INT C CO; Lv ZH, 2016, IEEE INTERNET THINGS, V3, P1015, DOI 10.1109/JIOT.2016.2546307; MANTEGNA RN, 1994, PHYS REV E, V49, P4677, DOI 10.1103/PhysRevE.49.4677; Marinissen EJ, 2002, INT TEST CONF P, P519, DOI 10.1109/TEST.2002.1041802; Mirjalili S, 2015, KNOWL-BASED SYST, V89, P228, DOI 10.1016/j.knosys.2015.07.006; Mirjalili S, 2016, NEURAL COMPUT APPL, V27, P495, DOI 10.1007/s00521-015-1870-7; Nurzaman SG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016168; Pan WT, 2012, KNOWL-BASED SYST, V26, P69, DOI 10.1016/j.knosys.2011.07.001; Rashedi E, 2009, INFORM SCIENCES, V179, P2232, DOI 10.1016/j.ins.2009.03.004; Richter M, 2014, IEEE T COMPUT, V63, P691, DOI 10.1109/TC.2013.82; Saadi Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144371; Shojafar M, 2019, IEEE T CLOUD COMPUT, V7, P196, DOI 10.1109/TCC.2016.2551747; Storn R, 1997, J GLOBAL OPTIM, V11, P341, DOI 10.1023/A:1008202821328; Tegmark M., 2004, SCI ULTIMATE REALITY, P459; Wei W, 2018, IEEE T SERV COMPUT, V11, P78, DOI 10.1109/TSC.2016.2528246; Yang XS, 2009, WOR CONG NAT BIOL, P210, DOI 10.1109/nabic.2009.5393690; Yang XS, 2013, COMPUT OPER RES, V40, P1616, DOI 10.1016/j.cor.2011.09.026; Yang XS, 2010, RESEARCH AND DEVELOPMENT IN INTELLIGENT SYSTEMS XXVI, P209, DOI 10.1007/978-1-84882-983-1_15; Zhang YY, 2015, 2015 INTERNATIONAL CONFERENCE ON IDENTIFICATION, INFORMATION, AND KNOWLEDGE IN THE INTERNET OF THINGS (IIKI), P197, DOI 10.1109/IIKI.2015.49	44	24	24	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2016	11	12							e0167341	10.1371/journal.pone.0167341	http://dx.doi.org/10.1371/journal.pone.0167341			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4NG	27926946	Green Submitted, Green Published, gold			2022-12-26	WOS:000389578800010
J	Sengupta, S; Roebroeck, A; Kemper, VG; Poser, BA; Zimmermann, J; Goebel, R; Adriany, G				Sengupta, Shubharthi; Roebroeck, Alard; Kemper, Valentin G.; Poser, Benedikt A.; Zimmermann, Jan; Goebel, Rainer; Adriany, Gregor			A Specialized Multi-Transmit Head Coil for High Resolution fMRI of the Human Visual Cortex at 7T	PLOS ONE			English	Article							TO-NOISE RATIO; PHASED-ARRAY; HUMAN BRAIN; FAST MRI; DESIGN; TESLA; SENSE; FIELD; NMR	Purpose To design, construct and validate radiofrequency (RF) transmit and receive phased array coils for high-resolution visual cortex imaging at 7 Tesla. Methods A 4 channel transmit and 16 channel receive array was constructed on a conformal polycarbonate former. Transmit field efficiency and homogeneity were simulated and validated, along with the Specific Absorption Rate, using B-1(+) mapping techniques and electromagnetic simulations. Receiver signal-to-noise ratio (SNR), temporal SNR (tSNR) across EPI time series, g-factors for accelerated imaging and noise correlations were evaluated and compared with a commercial 32 channel whole head coil. The performance of the coil was further evaluated with human subjects through functional MRI (fMRI) studies at standard and submillimeter resolutions of upto 0.8mm isotropic. Results The transmit and receive sections were characterized using bench tests and showed good interelement decoupling, preamplifier decoupling and sample loading. SNR for the 16 channel coil was similar to 1.5 times that of the commercial coil in the human occipital lobe, and showed better g-factor values for accelerated imaging. fMRI tests conducted showed better response to Blood Oxygen Level Dependent (BOLD) activation, at resolutions of 1.2mm and 0.8mm isotropic. Conclusion The 4 channel phased array transmit coil provides homogeneous excitation across the visual cortex, which, in combination with the dual row 16 channel receive array, makes for a valuable research tool for high resolution anatomical and functional imaging of the visual cortex at 7T.	[Sengupta, Shubharthi; Roebroeck, Alard; Kemper, Valentin G.; Poser, Benedikt A.; Goebel, Rainer] Maastricht Univ, Fac Psychol & Neurosci, Dept Cognit Neurosci, Maastricht, Netherlands; [Sengupta, Shubharthi; Roebroeck, Alard; Kemper, Valentin G.; Poser, Benedikt A.; Goebel, Rainer] Maastricht Univ, Fac Psychol & Neurosci, Maastricht Brain Imaging Ctr, Maastricht, Netherlands; [Adriany, Gregor] Univ Minnesota, Sch Med, Dept Radiol, Ctr Magnet Resonance Res, Minneapolis, MN 55455 USA; [Zimmermann, Jan] NYU, Ctr Neural Sci, New York, NY 10003 USA	Maastricht University; Maastricht University; University of Minnesota System; University of Minnesota Twin Cities; New York University	Sengupta, S (corresponding author), Maastricht Univ, Fac Psychol & Neurosci, Dept Cognit Neurosci, Maastricht, Netherlands.; Sengupta, S (corresponding author), Maastricht Univ, Fac Psychol & Neurosci, Maastricht Brain Imaging Ctr, Maastricht, Netherlands.	shubharthi.sengupta@maastrichtuniversity.nl	Sengupta, Shubharthi/AAZ-2649-2020; Adriany, Gregor/AAK-1323-2020; Poser, Benedikt A/F-4992-2010	Sengupta, Shubharthi/0000-0001-5033-0110; Zimmermann, Jan/0000-0003-3345-6074; Poser, Benedikt A/0000-0001-8190-4367; Goebel, Rainer/0000-0003-1780-2467	NWO Middelgroot Grant [36020201N]; ERC Starting Grant (MULTICONNECT) [639938]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015894] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R41MH111541] Funding Source: NIH RePORTER	NWO Middelgroot Grant; ERC Starting Grant (MULTICONNECT); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the NWO Middelgroot Grant (#36020201N) to RG [http://www.nwo.ni/en]. AR was supported by an ERC Starting Grant (MULTICONNECT, #639938) [https://erc.europa.eu/projects-and-results/erc-funded-projects/multiconnect]. The funders had no role in study design, data collection and analysis,; We would like to thank Christopher J. Wiggins for his help with the project. This work was supported by the NWO Middelgroot Grant (#36020201N). Alard Roebroeck was supported by an ERC Starting Grant (MULTICONNECT, #639938).	Adriany G, 2005, MAGN RESON MED, V53, P434, DOI 10.1002/mrm.20321; Adriany G., 2012, INT SOC MAGN RESON M, V20, P429; Avdievich NI, 2015, P 23 ISMRM ANN M TOR, P3177; de Zwart JA, 2002, MAGNET RESON MED, V47, P1218, DOI 10.1002/mrm.10169; GLOVER GH, 1985, J MAGN RESON, V64, P255, DOI 10.1016/0022-2364(85)90349-X; Hoult DI, 2000, CONCEPT MAGNETIC RES, V12, P173, DOI 10.1002/1099-0534(2000)12:4<173::AID-CMR1>3.0.CO;2-Q; Keil B, 2011, MAGN RESON MED, V66, P1777, DOI 10.1002/mrm.22961; KELTNER JR, 1991, MAGNET RESON MED, V22, P467, DOI 10.1002/mrm.1910220254; Kozlov M, 2009, J MAGN RESON, V200, P147, DOI 10.1016/j.jmr.2009.06.005; Lattanzi R, 2012, MAGN RESON MED, V68, P286, DOI 10.1002/mrm.23198; Ledden PJ., 2007, P INT SOC MAGN RESON, P242; Moeller S., 2008, P INT SOC MAG RESON, V16, P2366; Oezerdem C., 2015, MAGN RESON MED; Orzada S, 2010, MED PHYS, V37, P2225, DOI 10.1118/1.3378478; Petridou N, 2013, NMR BIOMED, V26, P65, DOI 10.1002/nbm.2820; Possanzini C, 2008, P 16 ANN M INT SOC M, V16, P1123; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; REYKOWSKI A, 1995, MAGNET RESON MED, V33, P848, DOI 10.1002/mrm.1910330617; Robson PM, 2008, MAGN RESON MED, V60, P895, DOI 10.1002/mrm.21728; ROEMER PB, 1990, MAGNET RESON MED, V16, P192, DOI 10.1002/mrm.1910160203; Sengupta S, 2015, P 23 ISMRM ANN M TOR, P1777; Shajan G, 2016, MAGN RESON MED, V75, P906, DOI 10.1002/mrm.25666; Shajan G, 2014, MAGN RESON MED, V71, P870, DOI 10.1002/mrm.24726; Shmuel A, 2006, NAT NEUROSCI, V9, P569, DOI 10.1038/nn1675; Van de Moortele P-F, 2007, P 15 ANN M ISMRM BER, P1676; Vaughan JT, 2001, MAGN RESON MED, V46, P24, DOI 10.1002/mrm.1156; WALD LL, 1995, MAGNET RESON MED, V34, P433, DOI 10.1002/mrm.1910340321; Walsh DO, 2000, MAGNET RESON MED, V43, P682, DOI 10.1002/(SICI)1522-2594(200005)43:5<682::AID-MRM10>3.0.CO;2-G; Wandell BA, 2007, NEURON, V56, P366, DOI 10.1016/j.neuron.2007.10.012; Wiggins G., 2009, P 17 ISMRM ANN M HON, P394; Wiggins GC, 2006, MAGN RESON MED, V56, P216, DOI 10.1002/mrm.20925; Wiggins GC, 2009, MAGN RESON MED, V62, P754, DOI 10.1002/mrm.22028; Wright SM, 1997, NMR BIOMED, V10, P394, DOI 10.1002/(SICI)1099-1492(199712)10:8<394::AID-NBM494>3.0.CO;2-0; Yarnykh VL, 2007, MAGN RESON MED, V57, P192, DOI 10.1002/mrm.21120	34	18	18	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0165418	10.1371/journal.pone.0165418	http://dx.doi.org/10.1371/journal.pone.0165418			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3TF	27911950	Green Published, gold, Green Submitted			2022-12-26	WOS:000389520600003
J	Weyandt, JD; Carney, JM; Pavlisko, EN; Xu, MM; Counter, CM				Weyandt, Jamie D.; Carney, John M.; Pavlisko, Elizabeth N.; Xu, MengMeng; Counter, Christopher M.			Isoform-Specific Effects of Wild-Type Ras Genes on Carcinogen-Induced Lung Tumorigenesis in Mice	PLOS ONE			English	Article							N-RAS; H-RAS; ACTIVATION; PROTOONCOGENE; ONCOGENES; TUMORS; MOUSE	The gene KRAS is commonly mutated in lung cancer to encode a constitutively active and oncogenic protein that is well established to initiate and maintain lung tumorigenesis. However, the remaining wild-type KRAS protein, or the other family members HRAS and NRAS, can still be activated in the presence of oncogenic KRAS. Moreover, loss of any one of these three genes has been shown to increase the sensitivity of mice to the carcinogen urethane, which induces Kras mutation-positive early lung lesions. To determine the contribution of progressively disrupting Hras and Nras genes on urethane lung tumorigenesis, mice with different combinations of wild-type and null alleles of Hras and Nras were exposed with urethane and tumor burden was assessed. As previously reported, loss of one allele of Hras increased the sensitivity of mice to this carcinogen, and this effect was further exacerbated by the loss of the second Hras allele. However, loss of one or both alleles of Nras failed to alter tumor burden, either in the absence or presence of Hras, after exposure to urethane. Additionally, no obvious difference between lung lesions in mice with wild-type versus null alleles was detected, suggesting that wild-type Ras proteins may exert a tumor suppressive effects at the time of initiation, although other interpretations are certainly possible. In summary, these data suggest that in some genetic backgrounds inactivation of different wild type Ras genes can have different effects on urethane-induced lung tumorigenesis.	[Weyandt, Jamie D.; Xu, MengMeng; Counter, Christopher M.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA; [Carney, John M.; Pavlisko, Elizabeth N.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Counter, Christopher M.] Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC 27708 USA	Duke University; Duke University; Duke University	Counter, CM (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA.; Counter, CM (corresponding author), Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC 27708 USA.	count004@mc.duke.edu		Counter, Christopher M/0000-0003-0748-3079	National Cancer Institute [R01CA123031]; NATIONAL CANCER INSTITUTE [R01CA123031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007171] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the National Cancer Institute, Grant Number: R01CA123031. Grant Recipient: Christopher M. Counter. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aviel-Ronen S, 2006, CLIN LUNG CANCER, V8, P30, DOI 10.3816/CLC.2006.n.030; Brambilla E, 2016, J CLIN ONCOL, V34, P1223, DOI 10.1200/JCO.2015.63.0970; Castellano E, 2007, ONCOGENE, V26, P917, DOI 10.1038/sj.onc.1209845; Diaz R, 2002, CANCER RES, V62, P4514; Esteban LM, 2001, MOL CELL BIOL, V21, P1444, DOI 10.1128/MCB.21.5.1444-1452.2001; Grabocka E, 2014, CANCER CELL, V25, P243, DOI 10.1016/j.ccr.2014.01.005; Huang L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123918; Iborra S, 2011, BLOOD, V117, P5102, DOI 10.1182/blood-2010-10-315770; Jeng HH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2173; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Lim KH, 2008, NATURE, V452, P646, DOI 10.1038/nature06778; Manenti G, 2008, ONCOGENE, V27, P5753, DOI 10.1038/onc.2008.194; Miller Mark Steven, 2012, Frontiers in Genetics, V2, P100, DOI 10.3389/fgene.2011.00100; Pershing NLK, 2015, J CLIN INVEST, V125, P222, DOI 10.1172/JCI77627; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; To MD, 2013, ONCOGENE, V32, P4028, DOI 10.1038/onc.2012.404; Weyandt JD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140253; YOU M, 1989, P NATL ACAD SCI USA, V86, P3070, DOI 10.1073/pnas.86.9.3070; Young A, 2013, CANCER DISCOV, V3, P112, DOI 10.1158/2159-8290.CD-12-0231; Zhang ZQ, 2001, NAT GENET, V29, P25, DOI 10.1038/ng721	21	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0167205	10.1371/journal.pone.0167205	http://dx.doi.org/10.1371/journal.pone.0167205			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3TF	27911940	Green Submitted, Green Published, gold			2022-12-26	WOS:000389520600026
J	Chen, JH; Chung, CH; Wang, YC; Hsu, SN; Huang, WY; Chien, WC				Chen, Jia-Hong; Chung, Chi-Hsiang; Wang, Yung-Chih; Hsu, Shun-Neng; Huang, Wen-Yen; Chien, Wu-Chien			Prevalence and Mortality-Related Factors of Multiple Myeloma in Taiwan	PLOS ONE			English	Article							TRANSPLANTATION; EXPERIENCE	In this retrospective cohort study based in Taiwan, we reported the current epidemiology of patients with multiple myeloma and analyzed the factors affecting mortality. We identified 7285 patients with newly diagnosed multiple myeloma (MM) between 1997 and 2013 in Taiwan. Privileges data from the National Health Institute Research Database was used, as it is made readily available to the public in electronic format for research purposes. From 1997 to 2013, the average incidence of MM per 100,000 people was 1.83. The mortality accounted for an average of 0.44 per 100,000 deaths. In all 7285 inpatients with MM, the proportion of male patients was greater than that of female (59.90% vs. 40.10%); the mean age was 68.71 years with the proportion of those >55 years of age was 85.11%; and the proportion of a catastrophic illness was 66.51%. The death risk of the inpatient dialysis group was 3.044 times that of patients without dialysis (P <0.001). Moreover, the risk of death to men in the hospital setting was 1.162 times that of women (P = 0.012), and in the group of patients aged >55 years, the risk of in-hospital death was 1.511 times more than that in those aged <= 55 years (P <0.001). The risk of hospital death due to catastrophic illness was 1.347 times that of a non-catastrophic illness (P <0.001). Male patients and those >55 years of age had the most common prevalence of MM in Taiwan. Hemodialysis treatment, male sex, old age, and catastrophic illness were independent predictors of hospital mortality in patients with MM.	[Chen, Jia-Hong] Triserv Gen Hosp, Natl Def Med Ctr, Dept Med, Div Hematol Oncol, Taipei, Taiwan; [Chen, Jia-Hong] Taipei Med Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan; [Chung, Chi-Hsiang] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Chung, Chi-Hsiang] Natl Def Med Ctr, Taiwanese Injury Prevent & Safety Promot Assoc, Taipei, Taiwan; [Wang, Yung-Chih] Triserv Gen Hosp, Natl Def Med Ctr, Dept Internal Med, Div Infect Dis & Trop Med, Taipei, Taiwan; [Wang, Yung-Chih; Huang, Wen-Yen] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan; [Hsu, Shun-Neng] Triserv Gen Hosp, Natl Def Med Ctr, Dept Med, Div Nephrol, Taipei, Taiwan; [Huang, Wen-Yen] Triserv Gen Hosp, Natl Def Med Ctr, Dept Radiat Oncol, Taipei, Taiwan; [Chien, Wu-Chien] Triserv Gen Hosp, Dept Med Res, Natl Def Med Ctr, Taipei, Taiwan; [Chien, Wu-Chien] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; Taipei Medical University; National Defense Medical Center; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; National Yang Ming Chiao Tung University; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center	Chien, WC (corresponding author), Triserv Gen Hosp, Dept Med Res, Natl Def Med Ctr, Taipei, Taiwan.; Chien, WC (corresponding author), Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan.	chienwu@mail.ndmctsgh.eciu.tw	Chung, Chi-Hsiang/AAY-3386-2021; Wang, Yung-Chih/ABE-9069-2020; huang, wen/GXW-0661-2022; Hsu, Shun-Neng/A-3602-2014	Wang, Yung-Chih/0000-0002-8491-8972; Hsu, Shun-Neng/0000-0002-8014-6311				[Anonymous], 2014, MYEL NCI SURV EP END; Barlogie B, 2006, WILLIAMS HEMATOLOGY, P1501; Bensinger WI, 2009, LEUKEMIA, V23, P442, DOI 10.1038/leu.2008.396; Cartwright RA, 1999, BRIT J HAEMATOL, V106, P281, DOI 10.1046/j.1365-2141.1999.01480.x; Chen YC, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d637; Friese CR, 2009, LEUKEMIA LYMPHOMA, V50, P392, DOI 10.1080/10428190902741471; Huang SY, 2007, CANCER-AM CANCER SOC, V110, P896, DOI 10.1002/cncr.22850; Huang TC, 2015, ANN HEMATOL, V94, P107, DOI 10.1007/s00277-014-2165-2; IGLEHART JK, 1989, NEW ENGL J MED, V320, P329, DOI 10.1056/NEJM198902023200536; Kim K, 2014, AM J HEMATOL, V89, P751, DOI 10.1002/ajh.23731; Kyle RA, 2004, NEW ENGL J MED, V351, P1860, DOI 10.1056/NEJMra041875; Lee JH, 2010, INT J HEMATOL, V92, P52, DOI 10.1007/s12185-010-0617-6; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Palumbo A, 2009, LEUKEMIA, V23, P449, DOI 10.1038/leu.2008.325; Raab MS, 2009, LANCET, V374, P324, DOI 10.1016/S0140-6736(09)60221-X; Rajkumar SV, 2016, AM J HEMATOL, V91, P90, DOI 10.1002/ajh.24236; Yoshimi I, 2004, JPN J CLIN ONCOL, V34, P218	17	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167227	10.1371/journal.pone.0167227	http://dx.doi.org/10.1371/journal.pone.0167227			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907052	Green Published, Green Submitted, gold			2022-12-26	WOS:000389482700095
J	Dreiss, AN; Chatelain, PG; Roulin, A; Richner, H				Dreiss, Amelie N.; Chatelain, Philippe G.; Roulin, Alexandre; Richner, Heinz			Prosody Predicts Contest Outcome in Non-Verbal Dialogs	PLOS ONE			English	Article							CONFLICT; ORGANIZATION; DOMINANCE; EVOLUTION; BEHAVIOR	Non-verbal communication has important implications for inter-individual relationships and negotiation success. However, to what extent humans can spontaneously use rhythm and prosody as a sole communication tool is largely unknown. We analysed human ability to resolve a conflict without verbal dialogs, independently of semantics. We invited pairs of subjects to communicate non-verbally using whistle sounds. Along with the production of more whistles, participants unwittingly used a subtle prosodic feature to compete over a resource (ice-cream scoops). Winners can be identified by their propensity to accentuate the first whistles blown when replying to their partner, compared to the following whistles. Naive listeners correctly identified this prosodic feature as a key determinant of which whistler won the interaction. These results suggest that in the absence of other communication channels, individuals spontaneously use a subtle variation of sound accentuation (prosody), instead of merely producing exuberant sounds, to impose themselves in a conflict of interest. We discuss the biological and cultural bases of this ability and their link with verbal communication. Our results highlight the human ability to use non-verbal communication in a negotiation process.	[Dreiss, Amelie N.; Chatelain, Philippe G.; Roulin, Alexandre] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland; [Dreiss, Amelie N.; Richner, Heinz] Univ Bern, Inst Ecol & Evolut, Bern, Switzerland; [Chatelain, Philippe G.] Univ Tubingen, Ctr Plant Mol Biol, Tubingen, Germany	University of Lausanne; University of Bern; Eberhard Karls University of Tubingen	Dreiss, AN (corresponding author), Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland.; Dreiss, AN (corresponding author), Univ Bern, Inst Ecol & Evolut, Bern, Switzerland.	Amelie.n.dreiss@gmail.com	Richner, Heinz/B-1659-2008	Richner, Heinz/0000-0001-7390-0526; Dreiss, Amelie/0000-0001-7154-4783				AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Bradbury Jack W., 1998, pi; COOPER VW, 1986, J NONVERBAL BEHAV, V10, P134, DOI 10.1007/BF01000009; Curhan JR, 2007, J APPL PSYCHOL, V92, P802, DOI 10.1037/0021-9010.92.3.802; DePaulo B M, 1997, Pers Soc Psychol Rev, V1, P346, DOI 10.1207/s15327957pspr0104_5; DEPAULO BM, 1992, PSYCHOL BULL, V111, P203, DOI 10.1037/0033-2909.111.2.203; Gatica-Perez D, 2009, IMAGE VISION COMPUT, V27, P1775, DOI 10.1016/j.imavis.2009.01.004; GoldinMeadow S, 1996, PSYCHOL REV, V103, P34, DOI 10.1037/0033-295X.103.1.34; GRAFEN A, 1990, J THEOR BIOL, V144, P517, DOI 10.1016/S0022-5193(05)80088-8; Hall JA, 2005, PSYCHOL BULL, V131, P898, DOI 10.1037/0033-2909.131.6.898; HALLE PA, 1991, LANG SPEECH, V34, P299, DOI 10.1177/002383099103400401; Iversen JR, 2008, J ACOUST SOC AM, V124, P2263, DOI 10.1121/1.2973189; Jayagopi DB, 2009, IEEE T AUDIO SPEECH, V17, P501, DOI 10.1109/TASL.2008.2008238; Kim S, 2012, INT CONF ACOUST SPEE, P5089, DOI 10.1109/ICASSP.2012.6289065; Ko SJ, 2015, PSYCHOL SCI, V26, P3, DOI 10.1177/0956797614553009; Kose-Bagci H, 2010, CONNECT SCI, V22, P103, DOI 10.1080/09540090903383189; KRAUSS RM, 1981, J PERS SOC PSYCHOL, V40, P312, DOI 10.1037/0022-3514.40.2.312; LEINONEN L, 1991, LANG COMMUN, V11, P241, DOI 10.1016/0271-5309(91)90031-P; MANDEL DR, 1994, COGNITION, V53, P155, DOI 10.1016/0010-0277(94)90069-8; Nass C, 2004, VOICE ACTIVATED PEOP; PARKER GA, 1974, J THEOR BIOL, V47, P223, DOI 10.1016/0022-5193(74)90111-8; Patterson ML, 2001, J NONVERBAL BEHAV, V25, P207, DOI 10.1023/A:1010675210696; Perlman M, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150152; Pesarin A, 2012, COGN PROCESS, V13, P533, DOI 10.1007/s10339-011-0417-9; Rienks R, 2005, LECT NOTES COMPUT SC, V3869, P76; Saarni T, 2006, LECT NOTES ARTIF INT, V4139, P576; Sanchez-Cortes D, 2012, IEEE T MULTIMEDIA, V14, P816, DOI 10.1109/TMM.2011.2181941; Scheumann M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091192; SILLARS AL, 1982, HUM COMMUN RES, V9, P83, DOI 10.1111/j.1468-2958.1982.tb00685.x; SMITH JM, 1982, J THEOR BIOL, V97, P1, DOI 10.1016/0022-5193(82)90271-5; Soderstrom M, 2003, J MEM LANG, V49, P249, DOI 10.1016/S0749-596X(03)00024-X; Steels L, 2006, TRENDS COGN SCI, V10, P347, DOI 10.1016/j.tics.2006.06.002; Sternglanz RW, 2004, J NONVERBAL BEHAV, V28, P245, DOI 10.1007/s10919-004-4158-7; Tusing KJ, 2000, HUM COMMUN RES, V26, P148, DOI 10.1093/hcr/26.1.148; Vinciarelli A, 2009, IMAGE VISION COMPUT, V27, P1743, DOI 10.1016/j.imavis.2008.11.007; WALL JA, 1995, J MANAGE, V21, P515, DOI 10.1016/0149-2063(95)90018-7; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3	37	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166953	10.1371/journal.pone.0166953	http://dx.doi.org/10.1371/journal.pone.0166953			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3JC	27907039	Green Published, Green Submitted, gold			2022-12-26	WOS:000389482700055
J	Gorski, L; Parker, CT; Liang, AS; Walker, S; Romanolo, KF				Gorski, Lisa; Parker, Craig T.; Liang, Anita S.; Walker, Samarpita; Romanolo, Kelly F.			The Majority of Genotypes of the Virulence Gene inlA Are Intact among Natural Watershed Isolates of Listeria monocytogenes from the Central California Coast	PLOS ONE			English	Article							PREMATURE STOP CODON; TO-EAT FOODS; PHENOTYPIC CHARACTERIZATION; MUTATIONS; EVOLUTION; STRAINS; ENVIRONMENTS; INTERNALIN; IDENTIFICATION; PREVALENCE	Internalin A is an essential virulence gene involved in the uptake of the foodborne pathogen Listeria monocytogenes into host cells. It is intact in clinical strains and often truncated due to Premature Stop Codons (PMSCs) in isolates from processed foods and processing facilities. Less information is known about environmental isolates. We sequenced the inlA alleles and did Multi Locus Variable Number Tandem Repeat Analysis (MLVA) on 112 L. monocytogenes isolates from a 3-year period from naturally contaminated watersheds near a leafy green growing area in Central California. The collection contained 14 serotype 1/2a, 12 serotype 1/2b, and 86 serotype 4b strains. Twenty-seven different inlA alleles were found. Twenty-three of the alleles are predicted to encode intact copies of InlA, while three contain PMSCs. Another allele has a 9-nucleotide deletion, previously described for a clinical strain, indicating that it is still functional. Intact inlA genes were found in 101 isolates, and 8 isolates contained the allele predicted to contain the 3-amino acid deletion. Both allele types were found throughout the 3-year sampling period. Three strains contained inlA alleles with PMSCs, and these were found only during the first 3 months of the study. SNP analysis of the intact alleles indicated clustering of alleles based on serotype and lineage with serotypes 1/2b and 4b (lineage I strains) clustering together, and serotype 1/2a (lineage II strains) clustering separately. The combination of serotype, MLVA types, and inlA allele types indicate that the 112 isolates reflect at least 49 different strains of L. monocytogenes. The finding that 90% of environmental L. monocytogenes isolates contain intact inlA alleles varies significantly from isolates found in processing plants. This information is important to public health labs and growers as to the varieties of L. monocytogenes that could potentially contaminate fresh produce in the field by various means.	[Gorski, Lisa; Parker, Craig T.; Liang, Anita S.; Walker, Samarpita; Romanolo, Kelly F.] ARS, Prod Safety & Microbiol Res Unit, USDA, Albany, CA 94710 USA; [Romanolo, Kelly F.] USDA, Food Safety Inspect Serv, Alameda, CA USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Gorski, L (corresponding author), ARS, Prod Safety & Microbiol Res Unit, USDA, Albany, CA 94710 USA.	lisa.gorski@ars.usda.gov		Gorski, Lisa/0000-0003-2387-1012; Parker, Craig/0000-0002-7719-8882	Agricultural Research Service CRIS project [5325-42000-050-00D]; Food and Drug Administration [224-11-2044]; FDA [224-11-2044]	Agricultural Research Service CRIS project(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Food and Drug Administration(United States Department of Health & Human Services); FDA(United States Department of Health & Human Services)	This work was funded through Agricultural Research Service CRIS project 5325-42000-050-00D and Food and Drug Administration grant #224-11-2044. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank M. Cooley for information and advice. This work was funded through Agricultural Research Service CRIS project 5325-42000-050-00D and FDA grant #224-11-2044.	Association LGM, 2013, COMMODITY SPECIFIC F; Bonazzi M, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003087; Cantinelli T, 2013, J CLIN MICROBIOL, V51, P3770, DOI 10.1128/JCM.01874-13; Chen Y, 2011, J BACTERIOL, V193, P3424, DOI 10.1128/JB.05048-11; Cooley MB, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00030; Doumith M, 2004, INFECT IMMUN, V72, P1072, DOI 10.1128/IAI.72.2.1072-1083.2004; Doumith M, 2004, J CLIN MICROBIOL, V42, P3819, DOI 10.1128/JCM.42.8.3819-3822.2004; Dramsi S, 2005, RES MICROBIOL, V156, P289, DOI 10.1016/j.resmic.2004.10.011; Felicio MTS, 2007, APPL ENVIRON MICROB, V73, P3887, DOI 10.1128/AEM.02912-06; GAILLARD JL, 1991, CELL, V65, P1127, DOI 10.1016/0092-8674(91)90009-N; Gorski L, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00058; Gorski L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092467; Gudmundsdottir S, 2006, J FOOD PROTECT, V69, P2157; Jacquet C, 2004, J INFECT DIS, V189, P2094, DOI 10.1086/420853; Jonquieres R, 1998, INFECT IMMUN, V66, P3420; Kathariou S, 2002, J FOOD PROTECT, V65, P1811, DOI 10.4315/0362-028X-65.11.1811; Kovacevic J, 2013, APPL ENVIRON MICROB, V79, P1915, DOI 10.1128/AEM.03341-12; Lyautey E, 2007, APPL ENVIRON MICROB, V73, P5401, DOI 10.1128/AEM.00354-07; Lynch MF, 2009, EPIDEMIOL INFECT, V137, P307, DOI 10.1017/S0950268808001969; Manuel CS, 2015, APPL ENVIRON MICROB, V81, P8339, DOI 10.1128/AEM.02752-15; MCLAUCHLIN J, 1990, EUR J CLIN MICROBIOL, V9, P210, DOI 10.1007/BF01963840; Nightingale KK, 2008, APPL ENVIRON MICROB, V74, P6570, DOI 10.1128/AEM.00997-08; Nightingale KK, 2005, APPL ENVIRON MICROB, V71, P8764, DOI 10.1128/AEM.71.12.8764-8772.2005; Nightingale KK, 2005, J BACTERIOL, V187, P5537, DOI 10.1128/JB.187.16.5537-5551.2005; Oliveira M, 2011, FOOD MICROBIOL, V28, P590, DOI 10.1016/j.fm.2010.11.004; Orsi RH, 2007, MICROBIOL-SGM, V153, P2666, DOI 10.1099/mic.0.2007/007310-0; Orsi RH, 2011, INT J MED MICROBIOL, V301, P79, DOI 10.1016/j.ijmm.2010.05.002; Palumbo JD, 2003, J CLIN MICROBIOL, V41, P564, DOI 10.1128/JCM.41.2.564-571.2003; Ragon M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000146; Roberts A, 2006, MICROBIOL-SGM, V152, P685, DOI 10.1099/mic.0.28503-0; Roche SM, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-304; Sauders BD, 2006, J FOOD PROTECT, V69, P93, DOI 10.4315/0362-028X-69.1.93; Sauders BD, 2004, J FOOD PROTECT, V67, P1417, DOI 10.4315/0362-028X-67.7.1417; Scallan E, 2011, EMERG INFECT DIS, V17, P7, DOI 10.3201/eid1701.P11101; Sperry KEV, 2008, J CLIN MICROBIOL, V46, P1435, DOI 10.1128/JCM.02207-07; Sperry KEV, 2009, J CLIN MICROBIOL, V47, P1984, DOI 10.1128/JCM.00730-09; Stea EC, 2015, APPL ENVIRON MICROB, V81, P3812, DOI 10.1128/AEM.00416-15; Van Stelten A, 2008, APPL ENVIRON MICROB, V74, P7365, DOI 10.1128/AEM.01138-08; Van Stelten A, 2010, APPL ENVIRON MICROB, V76, P2783, DOI 10.1128/AEM.02651-09; Walters SP, 2011, WATER RES, V45, P1752, DOI 10.1016/j.watres.2010.11.032; Ward TJ, 2004, J BACTERIOL, V186, P4994, DOI 10.1128/jb.186.15.4994-5002.2004; Ward TJ, 2010, J FOOD PROTECT, V73, P861, DOI 10.4315/0362-028X-73.5.861	42	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167566	10.1371/journal.pone.0167566	http://dx.doi.org/10.1371/journal.pone.0167566			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907153	Green Published, gold, Green Submitted			2022-12-26	WOS:000389482700196
J	Llano-Diez, M; Sinclair, J; Yamada, T; Zong, M; Fauconnier, J; Zhang, SJ; Katz, A; Jardemark, K; Westerblad, H; Andersson, DC; Lanner, JT				Llano-Diez, Monica; Sinclair, Jon; Yamada, Takashi; Zong, Mei; Fauconnier, Jeremy; Zhang, Shi-Jin; Katz, Abram; Jardemark, Kent; Westerblad, Hakan; Andersson, Daniel C.; Lanner, Johanna T.			The Role of Reactive Oxygen Species in beta-Adrenergic Signaling in Cardiomyocytes from Mice with the Metabolic Syndrome	PLOS ONE			English	Article							SKELETAL-MUSCLE FIBERS; HEART-FAILURE; OXIDATIVE STRESS; MITOCHONDRIAL DYSFUNCTION; CA2+ CHANNEL; CARDIAC CONTRACTILITY; RECEPTOR STIMULATION; HIGH-FAT; INSULIN; OB/OB	The metabolic syndrome is associated with prolonged stress and hyperactivity of the sympathetic nervous system and afflicted subjects are prone to develop cardiovascular disease. Under normal conditions, the cardiomyocyte response to acute beta-adrenergic stimulation partly depends on increased production of reactive oxygen species (ROS). Here we investigated the interplay between beta-adrenergic signaling, ROS and cardiac contractility using freshly isolated cardiomyocytes and whole hearts from two mouse models with the metabolic syndrome (high-fat diet and ob/ob mice). We hypothesized that cardiomyocytes of mice with the metabolic syndrome would experience excessive ROS levels that trigger cellular dysfunctions. Fluorescent dyes and confocal microscopy were used to assess mitochondrial ROS production, cellular Ca2+ handling and contractile function in freshly isolated adult cardiomyocytes. Immunofluorescence, western blot and enzyme assay were used to study protein biochemistry. Unexpectedly, our results point towards decreased cardiac ROS signaling in a stable, chronic phase of the metabolic syndrome because: beta-adrenergic-induced increases in the amplitude of intracellular Ca2+ signals were insensitive to antioxidant treatment; mitochondrial ROS production showed decreased basal rate and smaller response to beta-adrenergic stimulation. Moreover, control hearts and hearts with the metabolic syndrome showed similar basal levels of ROS-mediated protein modification, but only control hearts showed increases after beta-adrenergic stimulation. In conclusion, in contrast to the situation in control hearts, the cardiomyocyte response to acute beta-adrenergic stimulation does not involve increased mitochondrial ROS production in a stable, chronic phase of the metabolic syndrome. This can be seen as a beneficial adaptation to prevent excessive ROS levels.	[Llano-Diez, Monica; Sinclair, Jon; Yamada, Takashi; Fauconnier, Jeremy; Zhang, Shi-Jin; Katz, Abram; Jardemark, Kent; Westerblad, Hakan; Lanner, Johanna T.] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Zong, Mei] Karolinska Univ Hosp, Rheumatol Unit, CMM, Stockholm, Sweden; [Andersson, Daniel C.] Karolinska Inst, Dept Med, Stockholm, Sweden; [Yamada, Takashi] Sapporo Med Univ, Grad Sch Hlth Sci, Sapporo, Hokkaido, Japan; [Fauconnier, Jeremy] Univ Montpellier, INSERM, U1046, Montpellier, France; [Katz, Abram] Ariel Univ, Sch Hlth Sci, Dept Phys Therapy, Ariel, Israel	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Sapporo Medical University; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Ariel University	Lanner, JT (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden.	Johanna.Lanner@ki.se	Andersson, Daniel/AAE-9968-2019; Katz, Abram/AAL-2244-2020; Yamada, Takashi/U-8443-2019; Yamada, Takashi/AAZ-6212-2021; Jeremy, Jeremy/N-6233-2018	Andersson, Daniel/0000-0003-4548-702X; Yamada, Takashi/0000-0003-1797-3880; Yamada, Takashi/0000-0003-1797-3880; Westerblad, Hakan/0000-0002-8180-3029; Jeremy, Jeremy/0000-0003-2748-0983	Swedish Research Council; Swedish Heart-Lung Foundation; KI fonds; Ake Wiberg foundation; Stockholm County Council; Karolinska Institutet; Lars Hierta foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); KI fonds; Ake Wiberg foundation; Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); Lars Hierta foundation	This study was supported by The Swedish Research Council (JTL, HW), the Swedish Heart-Lung Foundation (DCA, HW), KI fonds (JTL), Ake Wiberg foundation (JTL, DCA), Regional Agreement on Medical Training and Clinical Research (ALF) between Stockholm County Council and Karolinska Institutet (DCA) and Lars Hierta foundation (ML-D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alipio Z, 2010, P NATL ACAD SCI USA, V107, P13426, DOI 10.1073/pnas.1007884107; Andersson DC, 2011, J PHYSIOL-LONDON, V589, P1791, DOI 10.1113/jphysiol.2010.202838; Aydin J, 2009, HUMAN MOL GENET; BASS A, 1969, EUR J BIOCHEM, V10, P198, DOI 10.1111/j.1432-1033.1969.tb00674.x; Blake R, 2014, BBA-GEN SUBJECTS, V1840, P1404, DOI 10.1016/j.bbagen.2013.11.007; Board PG, 2013, BBA-GEN SUBJECTS, V1830, P3267, DOI 10.1016/j.bbagen.2012.11.019; Bovo E, 2012, J PHYSIOL-LONDON, V590, P3291, DOI 10.1113/jphysiol.2012.230748; Bruton JD, 2008, J PHYSIOL-LONDON, V586, P175, DOI 10.1113/jphysiol.2007.147470; Bugger H, 2008, CLIN SCI, V114, P195, DOI 10.1042/CS20070166; Callow AD, 2006, VASC PHARMACOL, V45, P302, DOI 10.1016/j.vph.2006.08.010; Carley AN, 2005, BBA-MOL CELL BIOL L, V1734, P112, DOI 10.1016/j.bbalip.2005.03.005; Cheng AJ, 2015, J PHYSIOL-LONDON, V593, P457, DOI 10.1113/jphysiol.2014.279398; Chu G., 2002, BASIC RES CARDIOL S1, V97, pI43, DOI [10.1007/s003950200028, DOI 10.1007/S003950200028]; Cortassa S, 2014, BBA-BIOENERGETICS, V1837, P287, DOI 10.1016/j.bbabio.2013.11.007; Crocini C, 2014, P NATL ACAD SCI USA, V111, P15196, DOI 10.1073/pnas.1411557111; Diniz YS, 2008, EUR J PHARMACOL, V579, P318, DOI 10.1016/j.ejphar.2007.11.008; Dong F, 2007, DIABETES, V56, P2201, DOI 10.2337/db06-1596; Dugan LL, 2013, J CLIN INVEST, V123, P4888, DOI 10.1172/JCI66218; Fauconnier J, 2005, DIABETES, V54, P2375, DOI 10.2337/diabetes.54.8.2375; Fauconnier J, 2007, DIABETES, V56, P1136, DOI 10.2337/db06-0739; Fauconnier J, 2007, CARDIOVASC RES, V73, P376, DOI 10.1016/j.cardiores.2006.10.018; Findlay I, 2002, J PHYSIOL-LONDON, V541, P731, DOI 10.1113/jphysiol.2002.019729; Fu Q, 2014, DIABETES, V63, P2676, DOI 10.2337/db13-1763; Fu Y, 2014, P NATL ACAD SCI USA, V111, P16598, DOI 10.1073/pnas.1419129111; Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408; Hagemann D, 2002, TRENDS CARDIOVAS MED, V12, P51, DOI 10.1016/S1050-1738(01)00145-1; Halseth AE, 2002, BIOCHEM BIOPH RES CO, V294, P798, DOI 10.1016/S0006-291X(02)00557-0; Harmancey R, 2008, HYPERTENSION, V52, P181, DOI 10.1161/HYPERTENSIONAHA.108.110031; Harper JM, 2005, EXP GERONTOL, V40, P303, DOI 10.1016/j.exger.2005.01.002; Heymes C, 2003, J AM COLL CARDIOL, V41, P2164, DOI 10.1016/S0735-1097(03)00471-6; Hool LC, 2002, CIRC RES, V91, P601, DOI 10.1161/01.RES.0000035528.00678.D5; How OJ, 2006, DIABETES, V55, P466, DOI 10.2337/diabetes.55.02.06.db05-1164; Jeong EM, 2016, J AM HEART ASSOC, P5; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; Kowluru RA, 2000, FREE RADICAL RES, V32, P67, DOI 10.1080/10715760000300071; Kuroda J, 2010, P NATL ACAD SCI USA, V107, P15565, DOI 10.1073/pnas.1002178107; Lanner JT, 2006, DIABETES, V55, P2077, DOI 10.2337/db05-1613; Lanner JT, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003996; Mazumder PK, 2004, DIABETES, V53, P2366, DOI 10.2337/diabetes.53.9.2366; Mellor KM, 2010, CLIN EXP PHARMACOL P, V37, P222, DOI 10.1111/j.1440-1681.2009.05274.x; Mulligan C., 2016, ENVIRON TOXICOL; Nagasaka S, 2007, CIRC J, V71, P429, DOI 10.1253/circj.71.429; Nandhini A. T. A., 2005, SMJ Singapore Medical Journal, V46, P82; Nickel AG, 2015, CELL METAB, V22, P472, DOI 10.1016/j.cmet.2015.07.008; Nicolson GL, 2007, J CELL BIOCHEM, V100, P1352, DOI 10.1002/jcb.21247; Nikolaev VO, 2010, SCIENCE, V327, P1653, DOI 10.1126/science.1185988; Panchenko PE, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0188-3; Patriarchi T, 2016, EMBO J, V35, P1330, DOI 10.15252/embj.201593409; Pironti G, 2016, BASIC RES CARDIOL, V111, DOI 10.1007/s00395-016-0551-8; Powers SK, 2011, COMPR PHYSIOL, V1, P941, DOI 10.1002/cphy.c100054; Roberts CK, 2009, LIFE SCI, V84, P705, DOI 10.1016/j.lfs.2009.02.026; Spooner PM, 2008, DIABETES OBES METAB, V10, P523, DOI 10.1111/j.1463-1326.2007.00723.x; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Sverdlov AL, 2015, J MOL CELL CARDIOL, V78, P165, DOI 10.1016/j.yjmcc.2014.07.018; Takimoto E, 2007, HYPERTENSION, V49, P241, DOI 10.1161/01.HYP.0000254415.31362.a7; Tentolouris N, 2006, ANN NY ACAD SCI, V1083, P129, DOI 10.1196/annals.1367.010; Thirunavukkarasu V, 2004, NUTR METAB CARDIOVAS, V14, P351, DOI 10.1016/S0939-4753(04)80025-5; Toye AA, 2005, DIABETOLOGIA, V48, P675, DOI 10.1007/s00125-005-1680-z; Tu VC, 2002, J PHARMACOL EXP THER, V300, P1101, DOI 10.1124/jpet.300.3.1101; Wibom R, 2002, ANAL BIOCHEM, V311, P139, DOI 10.1016/S0003-2697(02)00424-4; Yamada T, 2015, ANN RHEUM DIS, V74, P1907, DOI 10.1136/annrheumdis-2013-205007; Zhang M, 2013, ANTIOXID REDOX SIGN, V18, P1024, DOI 10.1089/ars.2012.4550; Zhang YX, 2012, FREE RADICAL BIO MED, V53, P1531, DOI 10.1016/j.freeradbiomed.2012.07.010; Zima AV, 2006, CARDIOVASC RES, V71, P310, DOI 10.1016/j.cardiores.2006.02.019	64	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167090	10.1371/journal.pone.0167090	http://dx.doi.org/10.1371/journal.pone.0167090			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907040	Green Published, gold, Green Submitted			2022-12-26	WOS:000389482700075
J	Stankovic, S; Dimkic, I; Vujisic, L; Pavkovic-Lucic, S; Jovanovic, Z; Stevic, T; Sofrenic, I; Mitic, B; Tomic, V				Stankovic, Slavisa; Dimkic, Ivica; Vujisic, Ljubodrag; Pavkovic-Lucic, Sofija; Jovanovic, Zvezdana; Stevic, Tatjana; Sofrenic, Ivana; Mitic, Bojan; Tomic, Vladimir			Chemical Defence in a Millipede: Evaluation and Characterization of Antimicrobial Activity of the Defensive Secretion from Pachyiulus hungaricus (Karsch, 1881) (Diplopoda, Julida, Julidae)	PLOS ONE			English	Article							ANTIFUNGAL ACTIVITY; LABOULBENIALES	The chemical defence of the millipede Pachyiulus hungaricus is reported in the present paper, in which a chemical characterization is given and antimicrobial activity is determined. In total, independently of sex, 44 compounds were identified. All compounds belong to two groups: quinones and pentyl and hexyl esters of long-chain fatty acids. The relative abundances of quinones and non-quinones were 94.7% vs. 5.3% (males) and 87.3% vs. 12.7% (females), respectively. The two dominant quinones in both sexes were 2-methyl-1,4,-benzoquinone and 2-methoxy-3-methyl-1,4-benzoquinone. Antibacterial and antifungal activity of the defensive secretion was evaluated in vitro against seven bacterial strains and eight fungal species. With the aid of a dilution technique, the antimicrobial potential of the secretion and high sensitivity of all tested strains were confirmed. The lowest minimum concentrations of these compounds (0.20-0.25 mg/mL) were sufficient for inhibition of Aeromonas hydrophila, Listeria monocytogenes and Methicillin resistant Staphylococcus aureus (MRSA). The growth of eight tested fungal species was inhibited by slightly lower concentrations of the secretion, with Fusarium equisetias the most sensitive fungus and Aspergillus flavus as the most resistant. Values of MIC and MFC in the employed microdilution assay ranged from 0.10 to above 0.35 mg/m L. The given extract contains antimicrobial components potentially useful as therapeutic agents in the pharmaceutical and agricultural industries.	[Stankovic, Slavisa; Dimkic, Ivica] Univ Belgrade, Dept Microbiol, Fac Biol, Belgrade, Serbia; [Vujisic, Ljubodrag; Sofrenic, Ivana] Univ Belgrade, Dept Organ Chem, Fac Chem, Belgrade, Serbia; [Pavkovic-Lucic, Sofija] Univ Belgrade, Dept Genet & Evolut, Fac Biol, Belgrade, Serbia; [Jovanovic, Zvezdana; Mitic, Bojan; Tomic, Vladimir] Univ Belgrade, Dept Anim Dev, Fac Biol, Belgrade, Serbia; [Stevic, Tatjana] Inst Med Plants Res Dr Josif Pancic, Belgrade, Serbia	University of Belgrade; University of Belgrade; University of Belgrade; University of Belgrade	Stankovic, S (corresponding author), Univ Belgrade, Dept Microbiol, Fac Biol, Belgrade, Serbia.	slavisas@bio.bg.ac.rs	Sofrenić, Ivana/W-2421-2018; Dimkic, Ivica/GWR-2445-2022; Stanković, Slaviša/S-6273-2018; Pavković-Lučić, Sofija/E-7668-2018; Mitic, Bojan/AAD-4235-2019; Dimkić, Ivica/AAE-1508-2019; Vujisic, Ljubodrag/Q-5913-2016	Sofrenić, Ivana/0000-0002-9799-670X; Stanković, Slaviša/0000-0003-0527-8741; Pavković-Lučić, Sofija/0000-0003-2415-7160; Vujisic, Ljubodrag/0000-0001-7625-7484; Dimkic, Ivica/0000-0002-0425-5938; Mitic, Bojan/0000-0003-4507-7629	Ministry of Education, Science and Technological Development of the Republic of Serbia [173026, 173038, 172053]	Ministry of Education, Science and Technological Development of the Republic of Serbia	This work was supported by the Ministry of Education, Science and Technological Development of the Republic of Serbia (Grants Nos. 173026, 173038 and 172053 - http://www./mpn.gov.rs/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0157097, DOI 10.1371/JOURNAL.PONE.0157097]; Arab Alberto, 2003, Entomotropica, V18, P79; Beheshti A, 2012, INT J ELECTROCHEM SC, V7, P4811; Bodner M, 2016, J CHEM ECOL, V42, P249, DOI 10.1007/s10886-016-0680-4; Bodner M, 2012, J CHEM ECOL, V38, P547, DOI 10.1007/s10886-012-0127-5; DAOUK RK, 1995, J FOOD PROTECT, V58, P1147, DOI 10.4315/0362-028X-58.10.1147; Drewes SE, 2005, PHYTOCHEMISTRY, V66, P1812, DOI 10.1016/j.phytochem.2005.05.024; Eisner O, 1978, ARTHROPOD VENOMS, P41; EISNER T, 1963, SCIENCE, V139, P1218, DOI 10.1126/science.139.3560.1218; Enghoff H, 2011, FAUNA EUROPAEA; Enghoff H, 2015, ORG DIVERS EVOL, V15, P249, DOI 10.1007/s13127-015-0208-8; HARRIS LJ, 1989, J FOOD PROTECT, V52, P384, DOI 10.4315/0362-028X-52.6.384; Jayaraman SS, 2014, ARCH BIOL SCI, V66, P385; KUWAHARA Y, 2002, JPN J ENV ENTOMOL ZO, V13, P117; Kuwahara Yasumasa, 2007, Japanese Journal of Environmental Entomology and Zoology, V18, P91; Makarov SE, 2015, THE MYRIAPODA, V2, P69, DOI DOI 10.1163/9789004188273; Makarov SE, 2010, J CHEM ECOL, V36, P978, DOI 10.1007/s10886-010-9847-6; McNicholl BP, 2007, WATER RES, V41, P127, DOI 10.1016/j.watres.2006.10.002; Nazzaro F, 2013, PHARMACEUTICALS, V6, P1451, DOI 10.3390/ph6121451; Rakholiya K, 2014, INDIAN J PHARM SCI, V76, P148; Rocha DFO, 2013, MOLECULES, V18, P11429, DOI 10.3390/molecules180911429; RONCADORI RW, 1985, MYCOLOGIA, V77, P185, DOI 10.2307/3793067; Santamaria S, 2016, PHYTOTAXA, V243, P101, DOI 10.11646/phytotaxa.243.2.1; Sarker SD, 2007, METHODS, V42, P321, DOI 10.1016/j.ymeth.2007.01.006; Savikin K, 2015, BIOL CONTROL, V87, P6; Sekulic TL, 2013, BIOL CONTROL, V65, P312; Sen A., 2012, INT J CURRENT PHARM, V4, P67; Shimizu N, 2012, J CHEM ECOL, V38, P23, DOI 10.1007/s10886-012-0063-4; Stevic T, 2012, ARCH BIOL SCI, V64, P49, DOI 10.2298/ABS1201049S; Tatjana L., 2011, CHEM BIODIVERS, V8, P1284, DOI [10.1002/cbdv.201000377, DOI 10.1002/CBDV.201000377]; Tegos G, 2002, ANTIMICROB AGENTS CH, V46, P3133, DOI 10.1128/AAC.46.10.3133-3141.2002; Vega-Avila Elisa, 2011, Proc West Pharmacol Soc, V54, P10; Vujisic LV, 2011, J CHEM ECOL, V37, P1358, DOI 10.1007/s10886-011-0040-3; WEATHERS.J, 1969, CAN J ZOOLOG, V47, P1389, DOI 10.1139/z69-214; Williams LAD, 1997, NATURWISSENSCHAFTEN, V84, P143, DOI 10.1007/s001140050364; Wu XG, 2007, CHEMOECOLOGY, V17, P131, DOI 10.1007/s00049-007-0372-1; Xylander Willi E. R., 2009, Soil Organisms, V81, P413; Yadav P. R., 2005, IND BIOTECHNOLOGY	38	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167249	10.1371/journal.pone.0167249	http://dx.doi.org/10.1371/journal.pone.0167249			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907048	Green Submitted, Green Published, gold			2022-12-26	WOS:000389482700103
J	Li, QY; Chang, R; Sun, YJ; Li, BS				Li, Qingye; Chang, Rong; Sun, Yijun; Li, Bosheng			iTRAQ-Based Quantitative Proteomic Analysis of Spirulina platensis in Response to Low Temperature Stress	PLOS ONE			English	Article							ACYL-LIPID DESATURASES; SEDOHEPTULOSE-1,7-BISPHOSPHATASE ACTIVITY; PHOTOSYNTHETIC CAPACITY; ARABIDOPSIS-THALIANA; COLD; PROTEINS; GROWTH; EXPRESSION; PLANTS; ACID	Low temperature (LT) is one of the most important abiotic stresses that can significantly reduce crop yield. To gain insight into how Spirulina responds to LT stress, comprehensive physiological and proteomic analyses were conducted in this study. Significant decreases in growth and pigment levels as well as excessive accumulation of compatible osmolytes were observed in response to LT stress. An isobaric tag for relative and absolute quantitation (iTRAQ)-based quantitative proteomics approach was used to identify changes in protein abundance in Spirulina under LT. A total of 3,782 proteins were identified, of which 1,062 showed differential expression. Bioinformatics analysis indicated that differentially expressed proteins that were enriched in photosynthesis, carbohydrate metabolism, amino acid biosynthesis, and translation are important for the maintenance of cellular homeostasis and metabolic balance in Spirulina when subjected to LT stress. The up-regulation of proteins involved in gluconeogenesis, starch and sucrose metabolism, and amino acid biosynthesis served as coping mechanisms of Spirulina in response to LT stress. Moreover, the down-regulated expression of proteins involved in glycolysis, TCA cycle, pentose phosphate pathway, photosynthesis, and translation were associated with reduced energy consumption. The findings of the present study allow a better understanding of the response of Spirulina to LT stress and may facilitate in the elucidation of mechanisms underlying LT tolerance.	[Li, Qingye; Chang, Rong; Li, Bosheng] Beijing Forestry Univ, Coll Biol Sci & Technol, Beijing, Peoples R China; [Sun, Yijun] Beijing Forestry Univ, Coll Nat Conservat, Beijing, Peoples R China; [Li, Bosheng] Beijing Forestry Univ, Inst Spirulina Res, Beijing, Peoples R China	Beijing Forestry University; Beijing Forestry University; Beijing Forestry University	Li, BS (corresponding author), Beijing Forestry Univ, Coll Biol Sci & Technol, Beijing, Peoples R China.; Li, BS (corresponding author), Beijing Forestry Univ, Inst Spirulina Res, Beijing, Peoples R China.	libs3721@bjfu.edu.cn			State Public Forest Research Grant [201304605]	State Public Forest Research Grant	This study is funded by the State Public Forest Research Grant (NO. 201304605) (http://www.forestry.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Daim MM, 2015, IMMUNOPHARM IMMUNOT, V37, P126, DOI 10.3109/08923973.2014.998368; Aleksandrov A, 2014, J PHYS CHEM B, V118, P4505, DOI 10.1021/jp412346g; Aseev L V, 2011, Mol Biol (Mosk), V45, P805; Cai HM, 2009, PLANT CELL REP, V28, P527, DOI 10.1007/s00299-008-0665-z; Casado-Vela J, 2010, PROTEOMICS, V10, P343, DOI 10.1002/pmic.200900509; Chen WP, 2002, PLANT CELL ENVIRON, V25, P955, DOI 10.1046/j.1365-3040.2002.00874.x; Chien L.-F., 2000, Journal of Phycology, V36, P12, DOI 10.1046/j.1529-8817.1999.00001-36.x; Chien LF, 2011, J APPL PHYCOL, V23, P887, DOI 10.1007/s10811-010-9607-6; Claussen W, 2005, PLANT SCI, V168, P241, DOI 10.1016/j.plantsci.2004.07.039; COSSINS AR, 1994, PORTL PR P, P63; COSTA G, 1994, PLANT PHYSIOL BIOCH, V32, P561; Crosatti C, 2008, ENVIRON EXP BOT, V62, P93, DOI 10.1016/j.envexpbot.2007.07.008; Deshnium P, 2000, FEMS MICROBIOL LETT, V184, P207, DOI 10.1111/j.1574-6968.2000.tb09015.x; Fan PX, 2011, PROTEOMICS, V11, P4346, DOI 10.1002/pmic.201100054; Ge P, 2013, PROTEOMICS, V13, P3046, DOI 10.1002/pmic.201300042; Gharechahi J, 2014, MOL BIOL REP, V41, P3897, DOI 10.1007/s11033-014-3257-8; Gilmour SJ, 2000, PLANT PHYSIOL, V124, P1854, DOI 10.1104/pp.124.4.1854; Gong B, 2014, BIOCHEM BIOPH RES CO, V446, P417, DOI 10.1016/j.bbrc.2014.03.005; Guo ZW, 1996, CHINESE J CHEM, V14, P279; Harris EH., 2009, CHLAMYDOMONAS SOURCE; Harrison EP, 1998, PLANTA, V204, P27, DOI 10.1007/s004250050226; Hashimoto M, 2007, PROTEOMICS, V7, P1293, DOI 10.1002/pmic.200600921; Hongsthong A, 2003, J BIOSCI BIOENG, V96, P519, DOI 10.1016/S1389-1723(04)70143-7; Hongsthong A, 2008, FEMS MICROBIOL LETT, V288, P92, DOI 10.1111/j.1574-6968.2008.01330.x; Hosseini SM, 2013, CURR NUTR FOOD SCI, V9, P189, DOI 10.2174/1573401311309030003; Huang Y, 2015, PLANT BIOTECHNOLOGY, V32, P159; Ibrahem M. D., 2013, Journal of Agricultural Science (Toronto), V5, P109; Kant S, 2014, INDIANAPOLIS BUSINES, V9, P83; Klotke J, 2004, PLANT CELL ENVIRON, V27, P1395, DOI 10.1111/j.1365-3040.2004.01242.x; Korobeinikova AV, 2012, BIOCHEMISTRY-MOSCOW+, V77, P562, DOI 10.1134/S0006297912060028; Kramer U, 1996, NATURE, V379, P635, DOI 10.1038/379635a0; Kulshreshtha A, 2008, CURR PHARM BIOTECHNO, V9, P400, DOI 10.2174/138920108785915111; Kumar D, 2005, BIOTECHNOL ADV, V23, P41, DOI 10.1016/j.biotechadv.2004.08.005; Kurdrid P, 2012, BIOCHEM CELL BIOL, V90, P621, DOI [10.1139/O2012-017, 10.1139/o2012-017]; Kurdrid P, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-39; Lefebvre S, 2005, PLANT PHYSIOL, V138, P451, DOI 10.1104/pp.104.055046; Liu XL, 2012, MOL PLANT, V5, P1082, DOI 10.1093/mp/sss012; Lu C, 1999, J APPL PHYCOL, V11, P355, DOI 10.1023/A:1008195927725; Mackey KRM, 2013, PLANT PHYSIOL, V163, P815, DOI 10.1104/pp.113.221937; Mansour MMF, 2000, BIOL PLANTARUM, V43, P491, DOI 10.1023/A:1002873531707; Martinez-Esteso MJ, 2014, METHODS MOL BIOL, V1072, P155, DOI 10.1007/978-1-62703-631-3_12; MURATA N, 1995, BIOCHEM J, V308, P1; Murata Norio, 1996, P22; Nam MH, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-25; Neilson KA, 2011, PROTEOMICS, V11, P1696, DOI 10.1002/pmic.201000727; Nogueira FCS, 2012, J PROTEOME RES, V11, P3046, DOI 10.1021/pr300192f; Olcer H, 2001, PLANT PHYSIOL, V125, P982, DOI 10.1104/pp.125.2.982; Parry MAJ, 2008, J EXP BOT, V59, P1569, DOI 10.1093/jxb/ern084; Prakash JSS, 2010, MICROBIOL-SGM, V156, P442, DOI 10.1099/mic.0.031823-0; Qian P-Y, 2009, HUMAN GENOMICS PROTE, V2009, P239; Rinalducci S, 2011, ELECTROPHORESIS, V32, P1807, DOI 10.1002/elps.201000663; Rocco M, 2013, MOL BIOSYST, V9, P1257, DOI 10.1039/c3mb70137a; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Schulze WX, 2010, ANNU REV PLANT BIOL, V61, P491, DOI 10.1146/annurev-arplant-042809-112132; Shingaki-Wells RN, 2011, PLANT PHYSIOL, V156, P1706, DOI 10.1104/pp.111.175570; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; Tamoi M, 2006, PLANT CELL PHYSIOL, V47, P380, DOI 10.1093/pcp/pcj004; Tang RS, 2008, PLANT GROWTH REGUL, V54, P37, DOI 10.1007/s10725-007-9225-8; Teets NM, 2013, J COMP PHYSIOL B, V183, P189, DOI 10.1007/s00360-012-0707-2; THEODOROU ME, 1992, J BIOL CHEM, V267, P21901; Vonshak A, 2001, PLANT CELL ENVIRON, V24, P1113, DOI 10.1046/j.0016-8025.2001.00759.x; Vonshak A, 2008, J PHYCOL, V44, P1071, DOI 10.1111/j.1529-8817.2008.00546.x; Walker RP, 2015, PLANT PHYSIOL BIOCH, V97, P62, DOI 10.1016/j.plaphy.2015.09.004; Wang HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083485; Wang LX, 2013, J PROTEOME RES, V12, P5124, DOI 10.1021/pr4006469; Wang XC, 2013, MOL CELL PROTEOMICS, V12, P2174, DOI 10.1074/mcp.M112.022475; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; WARNOCK DW, 1988, J ANTIMICROB CHEMOTH, V21, P93, DOI 10.1093/jac/21.1.93; Wienkoop S, 2006, J EXP BOT, V57, P1529, DOI 10.1093/jxb/erj157; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Xu J, 2013, PLANT BIOLOGY, V15, P292, DOI 10.1111/j.1438-8677.2012.00639.x; Yan SP, 2006, MOL CELL PROTEOMICS, V5, P484, DOI 10.1074/mcp.M500251-MCP200; YEMM EW, 1954, BIOCHEM J, V57, P508, DOI 10.1042/bj0570508; Zhao N, 2014, MOL BIOL REP, V41, P9, DOI 10.1007/s11033-013-2764-3	75	6	6	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0166876	10.1371/journal.pone.0166876	http://dx.doi.org/10.1371/journal.pone.0166876			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902743	gold, Green Submitted, Green Published			2022-12-26	WOS:000389474100040
J	Manhica, H; Gauffin, K; Almqvist, YB; Rostila, M; Hjern, A				Manhica, Helio; Gauffin, Karl; Almqvist, Ylva B.; Rostila, Mikael; Hjern, Anders			Hospital Admission and Criminality Associated with Substance Misuse in Young Refugees - A Swedish National Cohort Study	PLOS ONE			English	Article							MENTAL-HEALTH; USE DISORDERS; DRUG-ABUSE; GENDER-DIFFERENCES; PUBLIC-HEALTH; UNITED-STATES; CHILDREN; CARE; NEIGHBORHOOD; EXPERIENCES	Background High rates of mental health problems have been described in young refugees, but few studies have been conducted on substance misuse. This study aimed to investigate the patterns of hospital care and criminality associated with substance misuse in refugees who settled in Sweden as teenagers. Methods Gender stratified Cox regression models were used to estimate the risks of criminal convictions and hospital care associated with substance misuse from national Swedish data for 2005-2012. We focused on 22,992 accompanied and 5,686 unaccompanied refugees who were aged 13-19 years when they settled in Sweden and compared them with 1 million native Swedish youths from the same birth cohort. Results The risks of criminal conviction associated with substance misuse increased with the length of residency in male refugees, after adjustment for age and domicile. The hazard ratios (HRs) were 5.21 (4.39-6.19) for unaccompanied and 3.85 (3.42-4.18) for accompanied refugees after more than 10 years of residency, compared with the native population. The risks were slightly lower for hospital care, at 2.88 (2.18-3.79) and 2.52(2.01-3.01) respectively. Risks were particularly pronounced for male refugees from the Horn of Africa and Iran. The risks for all male refugees decreased substantially when income was adjusted for. Young female refugees had similar risks to the general population. Conclusion The risks of criminality and hospital care associated with substance misuse in young male refugees increased with time of residency in Sweden and were associated with a low level of income compared with the native Swedish population. Risks were similar in accompanied and unaccompanied refugees.	[Manhica, Helio; Gauffin, Karl; Almqvist, Ylva B.; Rostila, Mikael; Hjern, Anders] Stockholm Univ, Karolinska Inst, Ctr Hlth Equ Studies CHESS, Stockholm, Sweden; [Hjern, Anders] Karolinska Inst, Dept Med, Clin Epidemiol, Stockholm, Sweden	Karolinska Institutet; Stockholm University; Karolinska Institutet	Manhica, H (corresponding author), Stockholm Univ, Karolinska Inst, Ctr Hlth Equ Studies CHESS, Stockholm, Sweden.	helio.manhica@chess.su.se	MANHICA, Helio/ABG-2029-2021	Gauffin, Karl/0000-0001-9349-9936	Swedish Research Council for Health, Working Life and Welfare (Forte); Nordforsk	Swedish Research Council for Health, Working Life and Welfare (Forte); Nordforsk	This work was supported by the Swedish Research Council for Health, Working Life and Welfare (Forte), and Nordforsk.	Bean T, 2007, J NERV MENT DIS, V195, P288, DOI 10.1097/01.nmd.0000243751.49499.93; Becker JB, 2008, FRONT NEUROENDOCRIN, V29, P36, DOI 10.1016/j.yfrne.2007.07.003; Beckett K, 2006, CRIMINOLOGY, V44, P105, DOI 10.1111/j.1745-9125.2006.00044.x; Bhugra D, 2011, WORLD PSYCHIATRY, V10, P2; Brady KT, 1999, PSYCHIAT CLIN N AM, V22, P241, DOI 10.1016/S0193-953X(05)70074-5; Brady KT, 2004, CURR DIR PSYCHOL SCI, V13, P206, DOI 10.1111/j.0963-7214.2004.00309.x; Brama A, 2010, J HOUS BUILT ENVIRON, V25, P331, DOI 10.1007/s10901-010-9179-4; Brendler-Lindqvist M, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/s12939-014-0122-2; Byqvist S, 2006, J PSYCHOACTIVE DRUGS, V38, P427, DOI 10.1080/02791072.2006.10400582; Chilcoat HD, 1998, ADDICT BEHAV, V23, P827, DOI 10.1016/S0306-4603(98)00069-0; Crum RM, 1996, DRUG ALCOHOL DEPEN, V43, P155, DOI 10.1016/S0376-8716(96)01298-7; Dupont HJBHM, 2005, INT J DRUG POLICY, V16, P27, DOI 10.1016/j.drugpo.2004.06.002; Eide K, 2013, ACTA PAEDIATR, V102, P666, DOI 10.1111/apa.12258; Medina-Mora ME, 2008, ISSUES CHILD FAM LIV, P73, DOI 10.1007/978-0-387-78512-7_4; Fazel M, 2005, LANCET, V365, P1309, DOI 10.1016/S0140-6736(05)61027-6; Fazel M, 2012, LANCET, V379, P266, DOI 10.1016/S0140-6736(11)60051-2; Fellner, 2009, STANFORD LAW REV, V20, P257; Gauffin K, 2013, ADDICTION, V108, P1441, DOI 10.1111/add.12169; Grella CE, 1999, AM J DRUG ALCOHOL AB, V25, P385, DOI 10.1081/ADA-100101868; Hjern A, 2000, ACTA PAEDIATR, V89, P722, DOI 10.1080/080352500750044089; Hjern A, 2004, SCAND J PUBLIC HEALT, V32, P40, DOI 10.1080/14034940310001677; Hjern A, 2013, EUROPEAN J PUBLIC HL; Hjern A, 2012, SCAND J PUBLIC HEALT, V40, P255, DOI 10.1177/1403494812459610; Kirmayer LJ, 2011, CAN MED ASSOC J, V183, pE959, DOI 10.1503/cmaj.090292; Lappalainen Paul., 2005, BLAGULA GLASHUSET ST; Lindert J, 2009, SOC SCI MED, V69, P246, DOI 10.1016/j.socscimed.2009.04.032; Little M, 2006, J RES CRIME DELINQ, V43, P357, DOI 10.1177/0022427806291260; Manhica H, EPIDEMIOLOG IN PRESS; Manhica H, 2015, NORD J MIGR RES, V5, P194, DOI 10.1515/njmr-2015-0024; Marshall GN, 2005, JAMA-J AM MED ASSOC, V294, P571, DOI 10.1001/jama.294.5.571; Martinez R, 2008, URBAN AFF REV, V43, P846, DOI 10.1177/1078087408314774; Matheson K, 2008, J IMMIGR MINOR HEALT, V10, P291, DOI 10.1007/s10903-007-9086-2; Momtazi S, 2010, CURR OPIN PSYCHIATR, V23, P221, DOI 10.1097/YCO.0b013e328338630d; Montgomery E, 2011, ACTA PSYCHIAT SCAND, V124, P1, DOI 10.1111/j.1600-0447.2011.01740.x; Norredam ML, 2007, DAN MED BULL, V54, P48; PANTELIS C, 1989, PSYCHOL MED, V19, P657, DOI 10.1017/S0033291700024259; Pfeiffer-Gerschel T, 2013 NATL REPORT 20; Pickering S., 2014, ROUTLEDGE HDB CRIME; Rosen M, 2002, SCAND J PUBLIC HEALT, V30, P81, DOI 10.1080/140349401753683444; Salas-Wright CP, 2014, DRUG ALCOHOL DEPEN, V142, P345, DOI 10.1016/j.drugalcdep.2014.06.008; Samecki J, 2006, AR RETTVISAN RATTVIS; Sellstrom E, 2011, HEALTH PLACE, V17, P551, DOI 10.1016/j.healthplace.2010.12.013; Sellstrom E, 2008, HEALTH PLACE, V14, P155, DOI 10.1016/j.healthplace.2007.05.007; UBA L, 1992, PUBLIC HEALTH REP, V107, P544; Vega WA, 2003, AM J PUBLIC HEALTH, V93, P1057, DOI 10.2105/AJPH.93.7.1057; Weitoft GR, 1999, INT J EPIDEMIOL, V28, P756, DOI 10.1093/ije/28.4.756; YEE BWK, 1987, J PSYCHOACTIVE DRUGS, V19, P77, DOI 10.1080/02791072.1987.10472382; Zanchetta MS, 2006, CAN J PUBLIC HEALTH, V97, pS26	48	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0166066	10.1371/journal.pone.0166066	http://dx.doi.org/10.1371/journal.pone.0166066			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FV	27902694	Green Published, Green Submitted, gold			2022-12-26	WOS:000389474100010
J	Pinar, A; Dowling, JK; Bitto, NJ; Robertson, AAB; Latz, E; Stewart, CR; Drummond, GR; Cooper, MA; McAuley, JL; Tate, MD; Mansell, A				Pinar, Anita; Dowling, Jennifer K.; Bitto, Natalie J.; Robertson, Avril A. B.; Latz, Eicke; Stewart, Cameron R.; Drummond, Grant R.; Cooper, Matthew A.; McAuley, Julie L.; Tate, Michelle D.; Mansell, Ashley			PB1-F2 Peptide Derived from Avian Influenza A Virus H7N9 Induces Inflammation via Activation of the NLRP3 Inflammasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNATE IMMUNITY; INFECTION; PATHOGENESIS; PROTEIN; MACROPHAGES; RESPONSES; HOST; MICE	The emergence of avian H7N9 influenza A virus in humans with associated high mortality has highlighted the threat of a potential pandemic. Fatal H7N9 infections are characterized by hyperinflammation and increased cellular infiltrates in the lung. Currently there are limited therapies to address the pathologies associated with H7N9 infection and the virulence factors that contribute to these pathologies. We have found that PB1-F2 derived from H7N9 activates the NLRP3 inflammasome and induces lung inflammation and cellular recruitment that is NLRP3-dependent. We have also shown that H7N9 and A/ Puerto Rico/ H1N1 (PR8) PB1-F2 peptide treatment induces significant mitochondrial reactive oxygen production, which contributes to NLRP3 activation. Importantly, treatment of cells or mice with the specific NLRP3 inhibitor MCC950 significantly reduces IL-1 beta maturation, lung cellular recruitment, and cytokine production. Together, these results suggest that PB1-F2 from H7N9 avian influenza A virus may be a major contributory factor to disease pathophysiology and excessive inflammation characteristic of clinical infections and that targeting the NLRP3 inflammasome may be an effective means to reduce the inflammatory burden associated with H7N9 infections.	[Pinar, Anita; Dowling, Jennifer K.; Bitto, Natalie J.; Tate, Michelle D.; Mansell, Ashley] Hudson Inst Med Res, Ctr Innate Immun & Infect Dis, Clayton, Vic 3168, Australia; [Pinar, Anita; Dowling, Jennifer K.; Bitto, Natalie J.; Tate, Michelle D.; Mansell, Ashley] Monash Univ, Dept Mol & Translat Sci, Clayton, Vic 3168, Australia; [Drummond, Grant R.] Monash Univ, Dept Pharmacol, Clayton, Vic 3168, Australia; [Robertson, Avril A. B.; Cooper, Matthew A.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4702, Australia; [Latz, Eicke] Univ Bonn, Univ Hosp, Inst Innate Immun, D-53127 Bonn, Germany; [Latz, Eicke] Univ Massachusetts, Sch Med, Dept Infect Dis & Immunol, Worcester, MA 01655 USA; [Latz, Eicke] German Ctr Neurodegenerat Dis, D-53175 Bonn, Germany; [Stewart, Cameron R.] CSIRO, Hlth & Biosecur, Australian Anim Hlth Lab, Geelong, Vic 3220, Australia; [McAuley, Julie L.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia	Hudson Institute of Medical Research; Monash University; Monash University; University of Queensland; University of Bonn; University of Massachusetts System; University of Massachusetts Worcester; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Melbourne	Mansell, A (corresponding author), Hudson Inst Med Res, 27-31 Wright St, Clayton, Vic 3168, Australia.	ashley.mansell@hudson.org.au	Mansell, Ashley/B-9553-2008; Latz, Eicke/H-3951-2014; Stewart, Cameron R/E-6823-2011; Robertson, Avril/A-4043-2012; Cooper, Matthew A./C-7988-2009; Dowling, Jennifer/ABA-6670-2020; McAuley, Julie/W-1272-2019; McAuley, Julie/L-4454-2019	Mansell, Ashley/0000-0002-6540-1281; Latz, Eicke/0000-0003-1488-5666; Robertson, Avril/0000-0002-9652-8357; Cooper, Matthew A./0000-0003-3147-3460; McAuley, Julie/0000-0003-2493-3465; Stewart, Cameron/0000-0002-3395-7859; Tate, Michelle/0000-0002-0587-5514; Dowling, Jennifer/0000-0003-2842-1504; Bitto, Natalie/0000-0003-3533-9824; Pinar, Anita/0000-0001-7779-4986	Victorian State Government Operational Infrastructure Scheme; National Health and Medical Research Council of Australia [GNT1079924, GNT1062721, GNT1062977]; National Health and Medical Research Council Australia [511105]; National Health and Medical Research Council Early Career Fellowship [1035733]	Victorian State Government Operational Infrastructure Scheme; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Victorian State Government Operational Infrastructure Scheme and by National Health and Medical Research Council of Australia Project Grants GNT1079924, GNT1062721, and GNT1062977 (to A. M., J. L. M., and G. D., respectively). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by National Health and Medical Research Council Australia Fellowship 511105.r Supported by National Health and Medical Research Council Early Career Fellowship 1035733.	Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Alymova IV, 2011, J VIROL, V85, P12324, DOI 10.1128/JVI.05872-11; Baroja-Mazo A, 2014, NAT IMMUNOL, V15, P738, DOI 10.1038/ni.2919; Chen CJ, 2010, J VIROL, V84, P10051, DOI 10.1128/JVI.00592-10; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Coleman JR, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-9; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4; Franklin BS, 2014, NAT IMMUNOL, V15, P727, DOI 10.1038/ni.2913; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Grailer JJ, 2014, J IMMUNOL, V192, P5974, DOI 10.4049/jimmunol.1400368; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Ichinohe T, 2010, NAT IMMUNOL, V11, P404, DOI 10.1038/ni.1861; Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667; Iwasaki A, 2014, NAT REV IMMUNOL, V14, P315, DOI 10.1038/nri3665; Kash JC, 2015, AM J PATHOL, V185, P1528, DOI 10.1016/j.ajpath.2014.08.030; Krumbholz A, 2011, MED MICROBIOL IMMUN, V200, P69, DOI 10.1007/s00430-010-0176-8; Lam TTY, 2015, NATURE, V522, P102, DOI 10.1038/nature14348; McAuley JL, 2007, CELL HOST MICROBE, V2, P240, DOI 10.1016/j.chom.2007.09.001; McAuley JL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003392; McAuley JL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001014; Normile D, 2015, SCIENCE, V347, P1188, DOI 10.1126/science.347.6227.1188; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; Schmitz N, 2005, J VIROL, V79, P6441, DOI 10.1128/JVI.79.10.6441-6448.2005; Szretter KJ, 2007, J VIROL, V81, P2736, DOI 10.1128/JVI.02336-06; Tate MD, 2016, SCI REP-UK, V6, DOI 10.1038/srep27912; Tate MD, 2010, J VIROL, V84, P7569, DOI 10.1128/JVI.00291-10; Thomas PG, 2009, IMMUNITY, V30, P566, DOI 10.1016/j.immuni.2009.02.006; Yoshizumi T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5713; Yu L, 2013, CLIN INFECT DIS, V57, P1449, DOI 10.1093/cid/cit541	30	58	59	5	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2017	292	3					826	836		10.1074/jbc.M116.756379	http://dx.doi.org/10.1074/jbc.M116.756379			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2LL	27913620	Green Published, hybrid			2022-12-26	WOS:000392318700006
J	Guilvout, I; Brier, S; Chami, M; Hourdel, V; Francetic, O; Pugsley, AP; Chamot-Rooke, J; Huysmans, GHM				Guilvout, Ingrid; Brier, Sebastien; Chami, Mohamed; Hourdel, Veronique; Francetic, Olivera; Pugsley, Anthony P.; Chamot-Rooke, Julia; Huysmans, Gerard H. M.			Prepore Stability Controls Productive Folding of the BAM-independent Multimeric Outer Membrane Secretin PulD	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-EXCHANGE; ELECTRON-MICROSCOPY; CRYSTAL-STRUCTURE; TERMINAL DOMAIN; PROTEIN; CHAPERONE; INSERTION; ASSOCIATION; PULLULANASE; PROTEOLYSIS	Members of a group of multimeric secretion pores that assemble independently of any known membrane-embedded insertase in Gram-negative bacteria fold into a prepore before membrane-insertion occurs. The mechanisms and the energetics that drive the folding of these proteins are poorly understood. Here, equilibrium unfolding and hydrogen/deuterium exchange monitored by mass spectrometry indicated that a loss of 4-5 kJ/mol/protomer in the N-3 domain that is peripheral to the membrane-spanning C domain in the dodecameric secretin PulD, the founding member of this class, prevents pore formation by destabilizing the prepore into a poorly structured dodecamer as visualized by electron microscopy. Formation of native PulD-multimers by mixing protomers that differ in N-3 domain stability, suggested that the N-3 domain forms a thermodynamic seal onto the prepore. This highlights the role of modest free energy changes in the folding of preintegration forms of a hyperstable outer membrane complex and reveals a key driving force for assembly independently of the beta-barrel assembly machinery.	[Guilvout, Ingrid; Francetic, Olivera; Pugsley, Anthony P.; Huysmans, Gerard H. M.] Inst Pasteur, ERL 3526, CNRS, Mol Genet Unit, F-75724 Paris 15, France; [Guilvout, Ingrid; Francetic, Olivera] Inst Pasteur, Lab Macromol Syst & Signaling, F-75724 Paris 15, France; [Brier, Sebastien; Hourdel, Veronique; Chamot-Rooke, Julia] Inst Pasteur, CNRS, UMR 3528, Struct Mass Spectrometry & Prote Unit, F-75724 Paris 15, France; [Chami, Mohamed] Univ Basel, Biozentrum, BioEM Lab, CH-4058 Basel, Switzerland	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Basel	Chamot-Rooke, J (corresponding author), Inst Pasteur, CNRS, UMR 3528, Struct Mass Spectrometry & Prote Unit, F-75724 Paris 15, France.; Huysmans, GHM (corresponding author), Weill Cornell Med, Dept Phys & Biophys, New York, NY 10021 USA.	julia.chamot-rooke@pasteur.fr; ghh2001@med.cornell.edu	Francetic, Olivera/H-8915-2019; Huysmans, Gerard/AAJ-6285-2020; Brier, Sebastien/L-7787-2019; Brier, Sébastien/E-8558-2019; Chamot-Rooke, Julia/F-3644-2014	Francetic, Olivera/0000-0002-4145-5314; Brier, Sebastien/0000-0003-1758-8237; Chamot-Rooke, Julia/0000-0002-9427-543X	Swiss National Science Foundation (SystemsX.ch RTD CINA); CACSICE Equipex [ANR-11-EQPX-008]	Swiss National Science Foundation (SystemsX.ch RTD CINA)(Swiss National Science Foundation (SNSF)); CACSICE Equipex	We thank Prof. Henning Stahlberg (Biozentrum, University of Basel) for continued support. The EM work was supported in part by the Swiss National Science Foundation (SystemsX.ch RTD CINA). The MS work was supported by the CACSICE Equipex (ANR-11-EQPX-008).	Bai YW, 1995, METHOD ENZYMOL, V259, P344; Chami M, 2005, J BIOL CHEM, V280, P37732, DOI 10.1074/jbc.M504463200; Collin S, 2007, MOL MICROBIOL, V64, P1350, DOI 10.1111/j.1365-2958.2007.05743.x; Collin S, 2013, RES MICROBIOL, V164, P390, DOI 10.1016/j.resmic.2013.03.023; Collin S, 2011, MOL MICROBIOL, V80, P655, DOI 10.1111/j.1365-2958.2011.07596.x; Daefler S, 1997, MOL MICROBIOL, V24, P465, DOI 10.1046/j.1365-2958.1997.3531727.x; Degiacomi MT, 2013, NAT CHEM BIOL, V9, P623, DOI [10.1038/NCHEMBIO.1312, 10.1038/nchembio.1312]; DENFERT C, 1989, J BIOL CHEM, V264, P17462; Dunstan RA, 2015, MOL MICROBIOL, V97, P616, DOI 10.1111/mmi.13055; ENGLANDER SW, 1983, Q REV BIOPHYS, V16, P521, DOI 10.1017/S0033583500005217; Fleming KG, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2015.0026; Goyal P, 2014, NATURE, V516, P250, DOI 10.1038/nature13768; Guilvout I, 1999, J BACTERIOL, V181, P7212, DOI 10.1128/JB.181.23.7212-7220.1999; Guilvout I, 2008, J MOL BIOL, V382, P13, DOI 10.1016/j.jmb.2008.06.055; Guilvout I, 2014, STRUCTURE, V22, P582, DOI 10.1016/j.str.2014.02.009; Guilvout I, 2011, RES MICROBIOL, V162, P180, DOI 10.1016/j.resmic.2011.01.006; Hardie KR, 1996, EMBO J, V15, P978, DOI 10.1002/j.1460-2075.1996.tb00434.x; Hoang HH, 2011, MBIO, V2, DOI 10.1128/mBio.00246-11; Hourdel V, 2016, BIOINFORMATICS, V32, P3413, DOI 10.1093/bioinformatics/btw420; Huyghues-Despointes BMP, 1999, BIOCHEMISTRY-US, V38, P16481, DOI 10.1021/bi9919450; Huyghues-Despointes BMP, 1999, NAT STRUCT BIOL, V6, P910; Huysmans GHM, 2016, BIOCHEM SOC T, V44, P845, DOI 10.1042/BST20160003; Huysmans GHM, 2015, SCI REP-UK, V5, DOI 10.1038/srep15068; Huysmans GHM, 2013, J BIOL CHEM, V288, P30700, DOI 10.1074/jbc.M113.489112; Iacovache I, 2010, CURR OPIN STRUC BIOL, V20, P241, DOI 10.1016/j.sbi.2010.01.013; Konermann L, 2011, CHEM SOC REV, V40, P1224, DOI 10.1039/c0cs00113a; Korotkov KV, 2011, TRENDS BIOCHEM SCI, V36, P433, DOI 10.1016/j.tibs.2011.04.002; Korotkov KV, 2009, STRUCTURE, V17, P255, DOI 10.1016/j.str.2008.11.011; MICHAELIS S, 1985, J BACTERIOL, V164, P633, DOI 10.1128/JB.164.2.633-638.1985; Moon CP, 2013, P NATL ACAD SCI USA, V110, P4285, DOI 10.1073/pnas.1212527110; Nickerson NN, 2011, J BIOL CHEM, V286, P38833, DOI 10.1074/jbc.M111.279851; Nouwen N, 2000, EMBO J, V19, P2229, DOI 10.1093/emboj/19.10.2229; Nouwen N, 1999, P NATL ACAD SCI USA, V96, P8173, DOI 10.1073/pnas.96.14.8173; Sathiyamoorthy K, 2011, BIOCHEMISTRY-US, V50, P5465, DOI 10.1021/bi101869h; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Schulz GE, 2002, BBA-BIOMEMBRANES, V1565, P308, DOI 10.1016/S0005-2736(02)00577-1; Singh J, 2014, J AM CHEM SOC, V136, P16704, DOI 10.1021/ja510964t; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tarry M, 2011, J MOL BIOL, V409, P642, DOI 10.1016/j.jmb.2011.04.034; Tosi T, 2014, STRUCTURE, V22, P1348, DOI 10.1016/j.str.2014.07.005; Wade KR, 2015, P NATL ACAD SCI USA, V112, P2204, DOI 10.1073/pnas.1423754112; Wales TE, 2006, MASS SPECTROM REV, V25, P158, DOI 10.1002/mas.20064; Wales TE, 2008, ANAL CHEM, V80, P6815, DOI 10.1021/ac8008862	43	9	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2017	292	1					328	338		10.1074/jbc.M116.759498	http://dx.doi.org/10.1074/jbc.M116.759498			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2DQ	27903652	Green Published, hybrid			2022-12-26	WOS:000391578000028
J	Jha, JK; Chattoraj, DK				Jha, Jyoti K.; Chattoraj, Dhruba K.			Inactivation of Individual SeqA Binding Sites of the E. coli Origin Reveals Robustness of Replication Initiation Synchrony	PLOS ONE			English	Article							ESCHERICHIA-COLI; DNA-REPLICATION; GATC SITES; COORDINATED REPLICATION; CHROMOSOME-REPLICATION; STRANDED-DNA; PROTEIN; SEQUESTRATION; RESTRICTION; SEQUENCES	The Escherichia coli origin of replication, oriC, comprises mostly binding sites of two proteins: DnaA, a positive regulator, and SeqA, a negative regulator. SeqA, although not essential, is required for timely initiation, and during rapid growth, synchronous initiation from multiple origins. Unlike DnaA, details of SeqA binding to oriC are limited. Here we have determined that SeqA binds to all its sites tested (9/11) and with variable efficiency. Titration of DnaA alters SeqA binding to two sites, both of which have overlapping DnaA sites. The altered SeqA binding, however, does not affect initiation synchrony. Synchrony is also unaffected when individual SeqA sites are mutated. An apparent exception was one mutant where the mutation also changed an overlapping DnaA site. In this mutant, the observed asynchrony could be from altered DnaA binding, as selectively mutating this SeqA site did not cause asynchrony. These results reveal robust initiation synchrony against alterations of individual SeqA binding sites. The redundancy apparently ensures SeqA function in controlling replication in E. coli.	[Jha, Jyoti K.; Chattoraj, Dhruba K.] NCI, Lab Biochem & Mol Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Chattoraj, DK (corresponding author), NCI, Lab Biochem & Mol Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	chattoraj@nih.gov			Intramural Research Program of the Center for Cancer Research, NCI, NIH; NATIONAL CANCER INSTITUTE [ZIABC010277] Funding Source: NIH RePORTER	Intramural Research Program of the Center for Cancer Research, NCI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the Intramural Research Program of the Center for Cancer Research, NCI, NIH.	Bach T, 2005, J MOL BIOL, V350, P7, DOI 10.1016/j.jmb.2005.04.055; Bach T, 2004, MOL MICROBIOL, V51, P1589, DOI 10.1111/j.1365-2958.2003.03943.x; Bach MT, 2008, J MOL BIOL, V384, P1076, DOI 10.1016/j.jmb.2008.09.042; Boye E, 1996, P NATL ACAD SCI USA, V93, P12206, DOI 10.1073/pnas.93.22.12206; Brendler T, 1999, EMBO J, V18, P2304, DOI 10.1093/emboj/18.8.2304; CAMPBELL JL, 1990, CELL, V62, P967, DOI 10.1016/0092-8674(90)90271-F; CHATTORAJ DK, 1977, VIROLOGY, V81, P460, DOI 10.1016/0042-6822(77)90161-1; Court DL, 2003, GENE, V315, P63, DOI 10.1016/S0378-1119(03)00728-5; Duderstadt KE, 2013, CURR OPIN STRUC BIOL, V23, P144, DOI 10.1016/j.sbi.2012.11.012; Han JS, 2004, J BIOL CHEM, V279, P30236, DOI 10.1074/jbc.M402612200; Jha JK, 2016, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00062; Kasho K, 2013, P NATL ACAD SCI USA, V110, P936, DOI 10.1073/pnas.1212070110; Kim MS, 2005, J BACTERIOL, V187, P6998, DOI 10.1128/JB.187.20.6998-7008.2005; KOHIYAMA M, 1966, ANN I PASTEUR PARIS, V110, P465; Kurokawa K, 1999, EMBO J, V18, P6642, DOI 10.1093/emboj/18.23.6642; Langer U, 1996, MOL MICROBIOL, V21, P301, DOI 10.1046/j.1365-2958.1996.6481362.x; Leonard AC, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010116; LOBNEROLESEN A, 1989, CELL, V57, P881, DOI 10.1016/0092-8674(89)90802-7; LU M, 1994, CELL, V77, P413, DOI 10.1016/0092-8674(94)90156-2; McGarry KC, 2004, P NATL ACAD SCI USA, V101, P2811, DOI 10.1073/pnas.0400340101; Morigen, 2003, MOL MICROBIOL, V50, P349, DOI 10.1046/j.1365-2958.2003.03695.x; Nievera C, 2006, MOL CELL, V24, P581, DOI 10.1016/j.molcel.2006.09.016; Ozaki S, 2012, NUCLEIC ACIDS RES, V40, P1648, DOI 10.1093/nar/gkr832; PRITCHARD R H, 1969, Symposium of the Society for General Microbiology, V19, P263; Riber L, 2005, J BACTERIOL, V187, P5605, DOI 10.1128/JB.187.16.5605-5613.2005; Riber L, 2009, MOL MICROBIOL, V71, P107, DOI 10.1111/j.1365-2958.2008.06516.x; Rozgaja TA, 2011, MOL MICROBIOL, V82, P475, DOI 10.1111/j.1365-2958.2011.07827.x; Sanchez-Romero MA, 2010, MBIO, V1, DOI 10.1128/mBio.00012-10; SKARSTAD K, 1988, J BACTERIOL, V170, P852, DOI 10.1128/jb.170.2.852-858.1988; SKARSTAD K, 1986, EMBO J, V5, P1711, DOI 10.1002/j.1460-2075.1986.tb04415.x; Skarstad K, 2003, EMBO J, V22, P140, DOI 10.1093/emboj/cdg003; Skarstad K, 2001, BIOCHIMIE, V83, P49, DOI 10.1016/S0300-9084(00)01207-4; Skarstad K, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012922; SLATER S, 1995, CELL, V82, P927, DOI 10.1016/0092-8674(95)90272-4; SMITH DW, 1985, EMBO J, V4, P1319, DOI 10.1002/j.1460-2075.1985.tb03779.x; Speck C, 2001, EMBO J, V20, P1469, DOI 10.1093/emboj/20.6.1469; Srivastava P, 2006, J BACTERIOL, V188, P1060, DOI 10.1128/JB.188.3.1060-1070.2006; Stepankiw N, 2009, MOL MICROBIOL, V74, P467, DOI 10.1111/j.1365-2958.2009.06877.x; THOMAS M, 1975, J MOL BIOL, V91, P315, DOI 10.1016/0022-2836(75)90383-6; Torheim NK, 1999, EMBO J, V18, P4882, DOI 10.1093/emboj/18.17.4882; VONFREIESLEBEN U, 1994, MOL MICROBIOL, V14, P763; Weigel C, 2001, MOL MICROBIOL, V40, P498, DOI 10.1046/j.1365-2958.2001.02409.x; Wilkinson TG, 2006, J BACTERIOL, V188, P4573, DOI 10.1128/JB.00089-06; Wold S, 1998, EMBO J, V17, P4158, DOI 10.1093/emboj/17.14.4158; ZYSKIND JW, 1986, CELL, V46, P489, DOI 10.1016/0092-8674(86)90873-1	45	4	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0166722	10.1371/journal.pone.0166722	http://dx.doi.org/10.1371/journal.pone.0166722			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930658	gold, Green Published			2022-12-26	WOS:000389580900014
J	Bar-Ephraim, YE; Konijn, T; Gonultas, M; Mebius, RE; Reijmers, RM				Bar-Ephraim, Yotam E.; Konijn, Tanja; Gonultas, Mehmet; Mebius, Reina E.; Reijmers, Rogier M.			A Reproducible Method for Isolation and In Vitro Culture of Functional Human Lymphoid Stromal Cells from Tonsils	PLOS ONE			English	Article							FIBROBLASTIC RETICULAR CELLS; TISSUE-INDUCER CELLS; DENDRITIC CELLS; ENDOTHELIAL-CELLS; T-CELLS; INNATE; NODE; ANTIGEN; LIGANDS; ORGANS	The stromal compartment of secondary lymphoid organs is classicaly known for providing a mechanical scaffold for the complex interactions between hematopoietic cells during immune activation as well as for providing a niche which is favorable for survival of lymphocytes. In recent years, it became increasingly clear that these cells also play an active role during such a response. Currently, knowledge of the interactions between human lymphoid stroma and hematopoietic cells is still lacking and most insight is based on murine systems. Although methods to isolate stromal cells from tonsils have been reported, data on stability in culture, characterization, and functional properties are lacking. Here, we describe a reproducible and easy method for isolation and in vitro culture of functional human lymphoid stromal cells from palatine tonsils. The cells isolated express markers and characteristics of T cell zone fibroblastic reticular cells (FRCs) and react to inflammatory stimuli by upregulating inflammatory cytokines and chemokines as well as adhesion molecules, as previously described for mouse lymphoid stroma. Also, cultured tonsil stromal cells support survival of human innate lymphoid cells, showing that these stromal cells can function as bone fide FRCs, providing a favorable microenvironment for hematopoietic cells.	[Bar-Ephraim, Yotam E.; Konijn, Tanja; Mebius, Reina E.; Reijmers, Rogier M.] Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, Amsterdam, Netherlands; [Gonultas, Mehmet] MC Hosp, Dept Otolaryngol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Reijmers, RM (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, Amsterdam, Netherlands.	r.reijmers@vumc.nl	Reijmers, Rogier/M-2620-2019	Reijmers, Rogier/0000-0001-7471-7715; Mebius, Reina/0000-0003-0451-7464	Netherlands Organization for Scientific Research (NWO), VENI grant [916.13.011]; VUmc/CCA proof-of-concept grant [CCA2015-5-23]; Landsteiner Foundation for Blood Transfusion Research (LSBR) grant	Netherlands Organization for Scientific Research (NWO), VENI grant(Netherlands Organization for Scientific Research (NWO)); VUmc/CCA proof-of-concept grant; Landsteiner Foundation for Blood Transfusion Research (LSBR) grant	This study was supported by the Netherlands Organization for Scientific Research (NWO), VENI grant (916.13.011) to RMR, http://www.nwo.nl/; VUmc/CCA proof-of-concept grant (CCA2015-5-23) to RMR, http://www.vumc.nl; Landsteiner Foundation for Blood Transfusion Research (LSBR) grant to REM, http://www.lsbr.nl/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan DSJ, 2015, MUCOSAL IMMUNOL, V8, P340, DOI 10.1038/mi.2014.71; Ame-Thomas P, 2007, BLOOD, V109, P693, DOI 10.1182/blood-2006-05-020800; Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Asperti-Boursin F, 2007, J EXP MED, V204, P1167, DOI 10.1084/jem.20062079; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Baptista AP, 2014, ELIFE, V3, DOI 10.7554/eLife.04433; Bar-Ephraim YE, 2016, IMMUNOL REV, V271, P185, DOI 10.1111/imr.12407; Barone F, 2015, P NATL ACAD SCI USA, V112, P11024, DOI 10.1073/pnas.1503315112; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Carrega P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9280; Chang JE, 2015, TRENDS IMMUNOL, V36, P30, DOI 10.1016/j.it.2014.11.003; Christensen JR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-215; Cohen JN, 2010, J EXP MED, V207, P681, DOI 10.1084/jem.20092465; Cornelissen F, 2011, CURR OPIN IMMUNOL, V23, P361, DOI 10.1016/j.coi.2011.03.002; Corneth OBJ, 2016, EUR J IMMUNOL, V46, P1404, DOI 10.1002/eji.201546241; Crellin NK, 2010, IMMUNITY, V33, P752, DOI 10.1016/j.immuni.2010.10.012; Cupedo T, 2009, NAT IMMUNOL, V10, P66, DOI 10.1038/ni.1668; Fletcher AL, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00035; Fletcher AL, 2010, J EXP MED, V207, P689, DOI 10.1084/jem.20092642; Friedman AD, 2015, INT J HEMATOL, V101, P330, DOI 10.1007/s12185-015-1764-6; Fujisaka M, 1996, ARCH HISTOL CYTOL, V59, P273, DOI 10.1679/aohc.59.273; Garrafa E, 2006, J CELL PHYSIOL, V207, P107, DOI 10.1002/jcp.20537; Grzywacz B, 2006, BLOOD, V108, P3824, DOI 10.1182/blood-2006-04-020198; Hoorweg K, 2015, J IMMUNOL, V195, P4257, DOI 10.4049/jimmunol.1402584; Hoorweg K, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00072; Hou TZ, 2010, EUR J IMMUNOL, V40, P359, DOI 10.1002/eji.200939776; Katakai T, 2004, INT IMMUNOL, V16, P1133, DOI 10.1093/intimm/dxh113; Kim MY, 2007, BLOOD, V109, P1602, DOI 10.1182/blood-2006-04-018465; Koning JJ, 2012, TRENDS IMMUNOL, V33, P264, DOI 10.1016/j.it.2011.10.006; Lee JW, 2007, NAT IMMUNOL, V8, P181, DOI 10.1038/ni1427; Lee TV, 2000, J INTERF CYTOK RES, V20, P391, DOI 10.1089/107999000312333; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Mackley EC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6862; Magnusson FC, 2008, GASTROENTEROLOGY, V134, P1028, DOI 10.1053/j.gastro.2008.01.070; Malhotra D, 2013, IMMUNOL REV, V251, P160, DOI 10.1111/imr.12023; Malhotra D, 2012, NAT IMMUNOL, V13, P499, DOI 10.1038/ni.2262; Marsland BJ, 2005, IMMUNITY, V22, P493, DOI 10.1016/j.immuni.2005.02.010; Mebius RE, 2003, NAT REV IMMUNOL, V3, P292, DOI 10.1038/nri1054; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Mogoanta CA, 2013, ROM J MORPHOL EMBRYO, V54, P179; MOST J, 1992, J IMMUNOL, V148, P1635; Mueller SN, 2009, NAT REV IMMUNOL, V9, P618, DOI 10.1038/nri2588; Nagasawa T, 1998, SEMIN IMMUNOL, V10, P179, DOI 10.1006/smim.1998.0128; Nichols LA, 2007, J IMMUNOL, V179, P993, DOI 10.4049/jimmunol.179.2.993; Okada T, 2007, J IMMUNOL, V178, P2973, DOI 10.4049/jimmunol.178.5.2973; Pellegrini M, 2011, CELL, V144, P601, DOI 10.1016/j.cell.2011.01.011; Possot C, 2011, NAT IMMUNOL, V12, P949, DOI 10.1038/ni.2105; Qi H, 2014, ANNU REV CELL DEV BI, V30, P141, DOI 10.1146/annurev-cellbio-100913-013254; Roozendaal R, 2011, ANNU REV IMMUNOL, V29, P23, DOI 10.1146/annurev-immunol-031210-101357; Scandella E, 2008, NAT IMMUNOL, V9, P667, DOI 10.1038/ni.1605; Schmutz S, 2009, J IMMUNOL, V183, P2217, DOI 10.4049/jimmunol.0802911; Siegert S, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00285; Siegert S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027618; Stachowiak AN, 2006, J IMMUNOL, V177, P2340, DOI 10.4049/jimmunol.177.4.2340; Tang Q, 2011, BLOOD, V117, P4052, DOI 10.1182/blood-2010-09-303081; Worbs T, 2007, J EXP MED, V204, P489, DOI 10.1084/jem.20061706; Yanagawa Y, 2002, BLOOD, V100, P1948, DOI 10.1182/blood-2002-01-0260; Yanagawa Y, 2003, BLOOD, V101, P4923, DOI 10.1182/blood-2002-11-3474; Yip LD, 2009, NAT IMMUNOL, V10, P1026, DOI 10.1038/ni.1773	61	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167555	10.1371/journal.pone.0167555	http://dx.doi.org/10.1371/journal.pone.0167555			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907202	Green Published, gold, Green Submitted			2022-12-26	WOS:000389482700193
J	Tayi, L; Maku, RV; Patel, HK; Sonti, RV				Tayi, Lavanya; Maku, Roshan V.; Patel, Hitendra Kumar; Sonti, Ramesh V.			Identification of Pectin Degrading Enzymes Secreted by Xanthomonas oryzae pv. oryzae and Determination of Their Role in Virulence on Rice	PLOS ONE			English	Article							PECTATE LYASE GENE; RALSTONIA-SOLANACEARUM; CELL-WALL; CAMPESTRIS; INDUCTION; SEQUENCE; CLONING; ACID; METHYLESTERASE; PATHOGENICITY	Xanthomonas oryzae pv.oryzae (Xoo) causes the serious bacterial blight disease of rice. Xoo secretes a repertoire of plant cell wall degrading enzymes (CWDEs) like cellulases, xylanases, esterases etc., which act on various components of the rice cell wall. The major cellulases and xylanases secreted by Xoo have been identified and their role in virulence has been determined. In this study, we have identified some of the pectin degrading enzymes of Xoo and assessed their role in virulence. Bioinformatics analysis indicated the presence of four pectin homogalacturonan (HG) degrading genes in the genome of Xoo. The four HG degrading genes include one polygalacturonase (pg/A), one pectin methyl esterase (pmt) and two pectate lyases (pel/and pelL). There was no difference in the expression of pg/A, pmtand pe/genes by laboratory wild type Xoo strain (BXO43) grown in either nutrient rich PS medium or in plant mimic XOM2 medium whereas the expression of pelL gene was induced in XOM2 medium as indicated by qRT-PCR experiments. Gene disruption mutations were generated in each of these four genes. The polygalacturonase mutant pglyet-was completely deficient in degrading the substrate Na-polygalacturonicacid (PGA). Strains carrying mutations in the pmt, pe/and pelL genes were as efficient as wild type Xoo (BXO43) in cleaving PGA. These observations clearly indicate that PgIA is the major pectin degrading enzyme produced by Xoo. The pectin methyl esterase, Pmt, is the pectin deesterifying enzyme secreted by Xoo as evident from the enzymatic activity assay performed using pectin as the substrate. Mutations in the pg/A, pmt, pe/and pelL genes have minimal effects on virulence. This suggests that, as compared to cellulases and xylanases, the HG degrading enzymes may not have a major role in the pathogenicity of Xoo.	[Tayi, Lavanya; Maku, Roshan V.; Patel, Hitendra Kumar; Sonti, Ramesh V.] CSIR Ctr Cellular & Mol Biol, Hyderabad, Telangana State, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Sonti, RV (corresponding author), CSIR Ctr Cellular & Mol Biol, Hyderabad, Telangana State, India.	sonti@ccmb.res.in			Indian Council of Medical Research ICMR India; XIIth five year plan project, Plant-Microbe and soil Interactions of the Council of Scientific and Industrial research [BSC0117]; Department of Science and Technology India	Indian Council of Medical Research ICMR India(Indian Council of Medical Research (ICMR)); XIIth five year plan project, Plant-Microbe and soil Interactions of the Council of Scientific and Industrial research; Department of Science and Technology India(Department of Science & Technology (India))	Support was provided by: Fellowship from Indian Council of Medical Research ICMR India [http://www.icmr.nic.in/]to LT; XIIth five year plan project, Plant-Microbe and soil Interactions (BSC0117) of the Council of Scientific and Industrial research [http://www.csir.res.in/] to RVS; and a JC Bose fellowship from the Department of Science and Technology India [www.dst.gov.in/] to RVS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; LT acknowledges a fellowship from the Indian Council of Medical Research (ICMR), India. This work was supported by the XIIth five year plan project, Plant-Microbe and soil Interactions (BSC0117) of the Council of Scientific and Industrial research. RVS is also supported by a JC Bose fellowship from the Department of Science and Technology, Government of India.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Annis SL, 1997, EUR J PLANT PATHOL, V103, P1, DOI 10.1023/A:1008656013255; BEAULIEU C, 1991, MOL PLANT MICROBE IN, V4, P446, DOI 10.1094/MPMI-4-446; da Silva ACR, 2002, NATURE, V417, P459, DOI 10.1038/417459a; DOW JM, 1989, PHYSIOL MOL PLANT P, V35, P113, DOI 10.1016/0885-5765(89)90081-7; Downie B, 1998, ANAL BIOCHEM, V264, P149, DOI 10.1006/abio.1998.2847; DURRANDS PK, 1988, PHYSIOL MOL PLANT P, V32, P363, DOI 10.1016/S0885-5765(88)80030-4; Gonzalez ET, 2003, MOL PLANT MICROBE IN, V16, P536, DOI 10.1094/MPMI.2003.16.6.536; Harholt J, 2010, PLANT PHYSIOL, V153, P384, DOI 10.1104/pp.110.156588; Hsiao YM, 2008, MICROBIOL-SGM, V154, P705, DOI 10.1099/mic.0.2007/012930-0; Hsiao YM, 2009, J AGR FOOD CHEM, V57, P6207, DOI 10.1021/jf900701n; Huang Q, 1997, J BACTERIOL, V179, P7369, DOI 10.1128/jb.179.23.7369-7378.1997; Huang Q, 2000, PHYSIOL MOL PLANT P, V57, P77, DOI 10.1006/pmpp.2000.0283; INNES RW, 1988, J BACTERIOL, V170, P3793, DOI 10.1128/jb.170.9.3793-3802.1988; Jha G, 2007, MOL PLANT MICROBE IN, V20, P31, DOI 10.1094/MPMI-20-0031; Kaewnum S, 2006, PHYTOPATHOLOGY, V96, P1230, DOI 10.1094/PHYTO-96-1230; LEACH JE, 1990, MOL PLANT MICROBE IN, V3, P238, DOI 10.1094/MPMI-3-238; Lee BM, 2005, NUCLEIC ACIDS RES, V33, P577, DOI 10.1093/nar/gki206; Liao CH, 1996, MOL PLANT MICROBE IN, V9, P14, DOI 10.1094/MPMI-9-0014; Lin HC, 2010, J PLANT PATHOL, V92, P149; Liu HL, 2005, MOL PLANT MICROBE IN, V18, P1296, DOI 10.1094/MPMI-18-1296; Qian W, 2005, GENOME RES, V15, P757, DOI 10.1101/gr.3378705; Rajeshwari R, 2005, MOL PLANT MICROBE IN, V18, P830, DOI 10.1094/MPMI-18-0830; Ried J. L., 1988, Molecular Plant-Microbe Interactions, V1, P32, DOI 10.1094/MPMI-1-032; Sambrook J, 1989, MOL CLONING; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Shevchik VE, 1998, MOL MICROBIOL, V29, P1459, DOI 10.1046/j.1365-2958.1998.01028.x; Subramoni S, 2005, MOL PLANT MICROBE IN, V18, P644, DOI 10.1094/MPMI-18-0644; Tans-Kersten J, 1998, APPL ENVIRON MICROB, V64, P4918; Tayi L, 2016, MOL PLANT MICROBE IN; Vidal S, 1998, MOL PLANT MICROBE IN, V11, P23, DOI 10.1094/MPMI.1998.11.1.23; WALTON JD, 1994, PLANT PHYSIOL, V104, P1113, DOI 10.1104/pp.104.4.1113	32	15	15	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166396	10.1371/journal.pone.0166396	http://dx.doi.org/10.1371/journal.pone.0166396			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907079	gold, Green Submitted, Green Published			2022-12-26	WOS:000389482700025
J	Fitzsimmons, CM; Fujimori, DG				Fitzsimmons, Christina M.; Fujimori, Danica Galonic			Determinants of tRNA Recognition by the Radical SAM Enzyme RlmN	PLOS ONE			English	Article							23S RIBOSOMAL-RNA; PSEUDOURIDINE SYNTHASE RLUA; ESCHERICHIA-COLI; M(5)C967 METHYLTRANSFERASE; SACCHAROMYCES-CEREVISIAE; SUBSTRATE SELECTIVITY; CATALYTIC MECHANISM; CRYSTAL-STRUCTURE; NASCENT PEPTIDE; METHYL TRANSFER	RlmN, a bacterial radical SAM methylating enzyme, has the unusual ability to modify two distinct types of RNA: 23S rRNA and tRNA. In rRNA, RlmN installs a methyl group at the C2 position of A2503 of 23S rRNA, while in tRNA the modification occurs at nucleotide A37, immediately adjacent to the anticodon triplet. Intriguingly, only a subset of tRNAs that contain an adenosine at position 37 are substrates for RlmN, suggesting that the enzyme carefully probes the highly conserved tRNA fold and sequence features to identify its targets. Over the past several years, multiple studies have addressed rRNA modification by RlmN, while relatively few investigations have focused on the ability of this enzyme to modify tRNAs. In this study, we utilized in vitro transcribed tRNAs as model substrates to interrogate RNA recognition by RlmN. Using chimeras and point mutations, we probed how the structure and sequence of RNA influences methylation, identifying position 38 of tRNAs as a critical determinant of substrate recognition. We further demonstrate that, analogous to previous mechanistic studies with fragments of 23S rRNA, tRNA methylation requirements are consistent with radical SAM reactivity. Together, our findings provide detailed insight into tRNA recognition by a radical SAM methylating enzyme.	[Fitzsimmons, Christina M.] Univ Calif San Francisco, Chem & Chem Biol Grad Program, San Francisco, CA 94143 USA; [Fujimori, Danica Galonic] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Fujimori, Danica Galonic] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Fujimori, DG (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.; Fujimori, DG (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA.	Danica.Fujimori@ucsf.edu		Fitzsimmons, Christina/0000-0002-6743-2671	National Institutes of Health, NIAID [R01A1095393]; Genentech Predoctoral Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095393] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM064337] Funding Source: NIH RePORTER	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Genentech Predoctoral Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health, NIAID R01A1095393 (DGF); https://www.niaid.nih.gov/, Genentech Predoctoral Fellowship (CMF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwalla S, 2002, J BIOL CHEM, V277, P8835, DOI 10.1074/jbc.M111825200; Alian A, 2008, P NATL ACAD SCI USA, V105, P6876, DOI 10.1073/pnas.0802247105; ARNEZ JG, 1994, BIOCHEMISTRY-US, V33, P7560, DOI 10.1021/bi00190a008; Bauerle MR, 2015, J BIOL CHEM, V290, P3995, DOI 10.1074/jbc.R114.607044; Benitez-Paez A, 2012, RNA, V18, P1783, DOI 10.1261/rna.033266.112; Benitez-Paez A, 2010, RNA, V16, P2131, DOI 10.1261/rna.2245910; Boal AK, 2011, SCIENCE, V332, P1089, DOI 10.1126/science.1205358; CRAIN PF, 1990, METHOD ENZYMOL, V193, P782, DOI 10.1016/0076-6879(90)93450-Y; Czerwoniec A, 2009, NUCLEIC ACIDS RES, V37, pD118, DOI 10.1093/nar/gkn710; Dunin-Horkawicz S, 2006, NUCLEIC ACIDS RES, V34, pD145, DOI 10.1093/nar/gkj084; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; Gao W, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000944; Golovina AY, 2012, RNA, V18, P1725, DOI 10.1261/rna.034207.112; Grove TL, 2013, NAT CHEM BIOL, V9, P422, DOI [10.1038/NCHEMBIO.1251, 10.1038/nchembio.1251]; Grove TL, 2011, J AM CHEM SOC, V133, P19586, DOI 10.1021/ja207327v; Grove TL, 2011, SCIENCE, V332, P604, DOI 10.1126/science.1200877; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; GU XG, 1991, BIOCHEMISTRY-US, V30, P2999, DOI 10.1021/bi00226a003; GU XG, 1994, BIOCHEMISTRY-US, V33, P2255, DOI 10.1021/bi00174a036; Gu XR, 1999, BIOCHEMISTRY-US, V38, P4053, DOI 10.1021/bi982364y; Hamilton CS, 2006, BIOCHEMISTRY-US, V45, P12029, DOI 10.1021/bi061293x; HARTMANN RK, 2005, HANDBOOK OF RNA BIOC; Hoang C, 2006, MOL CELL, V24, P535, DOI 10.1016/j.molcel.2006.09.017; Hur S, 2007, MOL CELL, V26, P189, DOI 10.1016/j.molcel.2007.02.027; KEALEY JT, 1995, BIOCHEMISTRY-US, V34, P2441, DOI 10.1021/bi00008a006; LaMarre JM, 2011, ANTIMICROB AGENTS CH, V55, P2989, DOI 10.1128/AAC.00183-11; Lanz ND, 2012, METHOD ENZYMOL, V516, P125, DOI 10.1016/B978-0-12-394291-3.00030-7; Lee TT, 2005, CELL, V120, P599, DOI 10.1016/j.cell.2004.12.037; Machnicka MA, 2013, NUCLEIC ACIDS RES, V41, pD262, DOI 10.1093/nar/gks1007; McCusker KP, 2012, J AM CHEM SOC, V134, P18074, DOI 10.1021/ja307855d; MILLIGAN JF, 1987, NUCLEIC ACIDS RES, V15, P8783, DOI 10.1093/nar/15.21.8783; Motorin Y, 1999, RNA, V5, P1105, DOI 10.1017/S1355838299982201; Motorin Y, 2010, BIOCHEMISTRY-US, V49, P4934, DOI 10.1021/bi100408z; Motorin Y, 2010, NUCLEIC ACIDS RES, V38, P1415, DOI 10.1093/nar/gkp1117; OHASHI Z, 1972, FEBS LETT, V20, P239, DOI 10.1016/0014-5793(72)80804-4; Purta E, 2009, MOL MICROBIOL, V72, P1147, DOI 10.1111/j.1365-2958.2009.06709.x; Ramu H, 2011, MOL CELL, V41, P321, DOI 10.1016/j.molcel.2010.12.031; Ranaei-Siadat E, 2013, RNA BIOL, V10, P572, DOI 10.4161/rna.24327; Raychaudhuri S, 1999, J BIOL CHEM, V274, P18880, DOI 10.1074/jbc.274.27.18880; Saneyoshi M, 1972, BIOCHIM BIOPHYS ACTA, V1, P1; SANTI DV, 1987, BIOCHEMISTRY-US, V26, P8599, DOI 10.1021/bi00400a016; Schwalm EL, 2016, SCIENCE, V352, P309, DOI 10.1126/science.aad5367; Sharma S, 2013, NUCLEIC ACIDS RES, V41, P5428, DOI 10.1093/nar/gkt195; Silakov A, 2014, J AM CHEM SOC, V136, P8221, DOI 10.1021/ja410560p; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Stojkovic V, 2016, NUCLEIC ACIDS RES, V44, P8897, DOI 10.1093/nar/gkw699; Stojkovic V, 2015, METHOD ENZYMOL, V560, P355, DOI 10.1016/bs.mie.2015.03.002; Toh SM, 2008, RNA, V14, P98, DOI 10.1261/rna.814408; Tscherne JS, 1999, BIOCHEMISTRY-US, V38, P1884, DOI 10.1021/bi981880l; Vazquez-Laslop N, 2010, EMBO J, V29, P3108, DOI 10.1038/emboj.2010.180; Villsen ID, 1999, J MOL BIOL, V286, P365, DOI 10.1006/jmbi.1998.2504; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; WRZESINSKI J, 1995, RNA, V1, P437; Yan F, 2011, P NATL ACAD SCI USA, V108, P3930, DOI 10.1073/pnas.1017781108; Yan F, 2010, J AM CHEM SOC, V132, P3953, DOI 10.1021/ja910850y	55	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167298	10.1371/journal.pone.0167298	http://dx.doi.org/10.1371/journal.pone.0167298			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902775	Green Published, gold, Green Submitted			2022-12-26	WOS:000389474100070
J	Grosset, AA; Poirier, F; Gaboury, L; St-Pierre, Y				Grosset, Andree-Anne; Poirier, Francoise; Gaboury, Louis; St-Pierre, Yves			Galectin-7 Expression Potentiates HER-2-Positive Phenotype in Breast Cancer	PLOS ONE			English	Article							MYOEPITHELIAL CELL; MAMMARY-TUMORS; NEU ONCOGENE; T-CELLS; PROGRESSION; MICE; OVEREXPRESSION; CARCINOMAS; INDUCTION; LECTINS	HER-2 positive tumors are among the most aggressive subtypes of breast cancer and are frequently associated with metastasis and poor outcome. As with other aggressive subtypes of breast cancer, these tumors are associated with abnormally high expression of galectin-7 (gal-7), which confers metastatic breast tumor cells with increased invasive behavior. Although previous studies in the rat model of breast tumorigenesis have shown that gal-7 is also increased in primary breast tumor, its contribution to the development of the primary breast tumors remains unclear. In the present work, we have used genetically-engineered gal-7-deficient mice to examine the role of gal-7 in the development of the mammary gland and of breast cancer. Using histological and immunohistological analysis of whole mammary glands at different stages of development, we detected no significant changes between normal and gal-7-deficient mice. To test the involvement of gal-7 in breast cancer, we next examined the effects of loss of gal-7 on mammary tumor development by crossing gal-7-deficient mice with the mammary tumor transgenic mouse strain FVB-Tg(MMTV-Erbb2) NK1Mul/J. Finally, assessment of mice survival and tumor volume showed a delay of mammary tumor growth in the absence of systemic gal-7. These data suggest that gal-7 could potentiate the phenotype of HER-2 positive primary breast cancer.	[Grosset, Andree-Anne; St-Pierre, Yves] Inst Armand Frappier, INRS, Laval, PQ, Canada; [Grosset, Andree-Anne; Gaboury, Louis] Univ Montreal, IRIC, Montreal, PQ, Canada; [Poirier, Francoise] Univ Paris Diderot, Sorbonne Paris Cite, CNRS, Inst Jacques Monod, Paris, France	University of Quebec; Institut national de la recherche scientifique (INRS); Universite de Montreal; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	St-Pierre, Y (corresponding author), Inst Armand Frappier, INRS, Laval, PQ, Canada.	yves.st-pierre@iaf.inrs.ca		St-Pierre, Yves/0000-0002-1948-2041	Canadian Institutes for Health Research [MOP-89697]; CIHR; FRQS; GEFLUC (groupement des entreprises francaises contre le cancer)	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); FRQS; GEFLUC (groupement des entreprises francaises contre le cancer)	This work was supported by a grant from the Canadian Institutes for Health Research (Grant No. MOP-89697) the CIHR (http://www.cihr-irsc.gc.ca), and FRQS (http://www.frqs.gouv.qc.ca). This work was supported by GEFLUC (groupement des entreprises francaises contre le cancer) (www.gefluc.org/paris-ile-de-france.html).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARONDES SH, 1994, CELL, V76, P597, DOI 10.1016/0092-8674(94)90498-7; BARONDES SH, 1994, J BIOL CHEM, V269, P20807; Bernerd F, 1999, P NATL ACAD SCI USA, V96, P11329, DOI 10.1073/pnas.96.20.11329; Canadian Cancer Society's Advisory Committee on Cancer Statistics, 2014, CAN CANC STAT 2014; Colnot C, 1998, DEV DYNAM, V211, P306, DOI 10.1002/(SICI)1097-0177(199804)211:4<306::AID-AJA2>3.0.CO;2-L; De Oliveira JT, 2014, ANTICANCER RES, V34, P2211; Demers M, 2010, AM J PATHOL, V176, P3023, DOI 10.2353/ajpath.2010.090876; Fernandez-Aguilar S, 2008, APMIS, V116, P33, DOI 10.1111/j.1600-0463.2008.00753.x; Fortuna-Costa A, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00138; Gendronneau G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119031; Gendronneau G, 2008, MOL BIOL CELL, V19, P5541, DOI 10.1091/mbc.E08-02-0166; Grosset A. A, 2016, ONCOTARGET; Jones C, 2004, CANCER RES, V64, P3037, DOI 10.1158/0008-5472.CAN-03-2028; Koo JS, 2011, YONSEI MED J, V52, P89, DOI 10.3349/ymj.2011.52.1.89; Kouo T, 2015, CANCER IMMUNOL RES, V3, P412, DOI 10.1158/2326-6066.CIR-14-0150; Lu CH, 2003, J NATL CANCER I, V95, P1825, DOI 10.1093/jnci/djg117; Lu JX, 1997, MOL CARCINOGEN, V20, P204, DOI 10.1002/(SICI)1098-2744(199710)20:2<204::AID-MC7>3.0.CO;2-M; Miwa HE, 2013, GLYCOBIOLOGY, V23, P1477, DOI 10.1093/glycob/cwt075; Moisa A, 2007, ANTICANCER RES, V27, P2131; Moumen M, 2011, INT J DEV BIOL, V55, P763, DOI 10.1387/ijdb.113385mm; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; Nabi IR, 2015, J CELL SCI, V128, P2213, DOI 10.1242/jcs.151159; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; POIRIER F, 1993, DEVELOPMENT, V119, P1229; Seki M, 2008, CLIN IMMUNOL, V127, P78, DOI 10.1016/j.clim.2008.01.006; Shekhar MPV, 2004, AM J PATHOL, V165, P1931, DOI 10.1016/S0002-9440(10)63245-2; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Ursini-Siegel J, 2007, NAT REV CANCER, V7, P389, DOI 10.1038/nrc2127; Zhang H, 2014, MATH PROBL ENG, V2014, DOI [10.1155/2014/183580, 10.1007/978-3-319-07200-5_1]	30	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0166731	10.1371/journal.pone.0166731	http://dx.doi.org/10.1371/journal.pone.0166731			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902734	Green Published, Green Accepted, gold			2022-12-26	WOS:000389474100036
J	Schibler, J; Tomanek-Chalkley, AM; Reedy, JL; Zhan, FH; Spitz, DR; Schultz, MK; Goel, A				Schibler, Jeanine; Tomanek-Chalkley, Ann M.; Reedy, Jessica L.; Zhan, Fenghuang; Spitz, Douglas R.; Schultz, Michael K.; Goel, Apollina			Mitochondrial-Targeted Decyl-Triphenylphosphonium Enhances 2-Deoxy-D-Glucose Mediated Oxidative Stress and Clonogenic Killing of Multiple Myeloma Cells	PLOS ONE			English	Article							TUMOR-INITIATING CELLS; CANCER STEM-CELLS; THERAPEUTIC TARGET; RETICULUM STRESS; REDOX REGULATION; PROSTATE-CANCER; DRUG-RESISTANCE; PLASMA-CELLS; HYPOXIA; METABOLISM	Therapeutic advances have markedly prolonged overall survival in multiple myeloma (MM) but the disease currently remains incurable. In a panel of MM cell lines (MM. 1S, OPM-2, H929, and U266), using CD138 immunophenotyping, side population staining, and stem cell-related gene expression, we demonstrate the presence of stem-like tumor cells. Hypoxic culture conditions further increased CD138 low stem-like cells with upregulated expression of OCT4 and NANOG. Compared to MM cells, these stem-like cells maintained lower steady-state pro-oxidant levels with increased uptake of the fluorescent deoxyglucose analog. In primary human MM samples, increased glycolytic gene expression correlated with poorer overall and event-free survival outcomes. Notably, stem-like cells showed increased mitochondrial mass, rhodamine 123 accumulation, and orthodox mitochondrial configuration while more condensed mitochondria were noted in the CD138 high cells. Glycolytic inhibitor 2-deoxyglucose (2-DG) induced ER stress as detected by qPCR (BiP, ATF4) and immunoblotting (BiP, CHOP) and increased dihydroethidium probe oxidation both CD138(low) and CD138(high) cells. Treatment with a mitochondrial-targeting agent decyl-triphenylphosphonium (10-TPP) increased intracellular steady-state pro-oxidant levels in stem-like and mature MM cells. Furthermore, 10-TPP mediated increases in mitochondrial oxidant production were suppressed by ectopic expression of manganese superoxide dismutase. Relative to 2-DG or 10-TPP alone, 2-DG plus 10-TPP combination showed increased caspase 3 activation in MM cells with minimal toxicity to the normal hematopoietic progenitor cells. Notably, treatment with polyethylene glycol conjugated catalase significantly reduced 2-DG and/or 10-TPP-induced apoptosis of MM cells. Also, the combination of 2-DG with 10-TPP decreased clonogenic survival of MM cells. Taken together, this study provides a novel strategy of metabolic oxidative stress-induced cytotoxicity of MM cells via 2-DG and 10-TPP combination therapy.	[Schibler, Jeanine; Zhan, Fenghuang; Goel, Apollina] Univ Iowa, Interdisciplinary Grad Program Mol & Cellular Bio, Iowa City, IA 52242 USA; [Tomanek-Chalkley, Ann M.; Reedy, Jessica L.; Spitz, Douglas R.; Schultz, Michael K.; Goel, Apollina] Univ Iowa, Free Radical & Radiat Biol Program, Dept Radiat Oncol, Iowa City, IA 52242 USA; [Zhan, Fenghuang] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Schultz, Michael K.] Univ Iowa, Dept Radiol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa	Goel, A (corresponding author), Univ Iowa, Interdisciplinary Grad Program Mol & Cellular Bio, Iowa City, IA 52242 USA.; Goel, A (corresponding author), Univ Iowa, Free Radical & Radiat Biol Program, Dept Radiat Oncol, Iowa City, IA 52242 USA.	apollina-goel@uiowa.edu	Schultz, Michael/ABC-9890-2020	Schultz, Michael/0000-0002-4554-2212; Zhan, Fenghuang/0000-0001-6208-1676; Spitz, Douglas/0000-0002-1254-8765	NIH [R21-CA186040, R01-CA182804, K25-CA172218]; Cancer Center grant [P30-CA086862]; NATIONAL CANCER INSTITUTE [R21CA186040, P30CA086862, R01CA182804, K25CA172218] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	study was supported by NIH Grants R21-CA186040 (Dr. Apollina Goel), R01-CA182804 (Dr. Douglas R. Spitz), and K25-CA172218 (Dr. Michael K. Schultz). The Holden Comprehensive Cancer Center cores facilities are supported by the Cancer Center grant P30-CA086862.	Asosingh K, 2005, HAEMATOLOGICA, V90, P810; Aykin-Burns N, 2009, BIOCHEM J, V418, P29, DOI 10.1042/BJ20081258; Benard G, 2008, ANTIOXID REDOX SIGN, V10, P1313, DOI 10.1089/ars.2007.2000; Bera S, 2010, NEOPLASIA, V12, P980, DOI 10.1593/neo.101146; Borsi E, 2015, TRANSL RES, V165, P641, DOI 10.1016/j.trsl.2014.12.001; Boutrid H, 2008, INVEST OPHTH VIS SCI, V49, P2799, DOI 10.1167/iovs.08-1751; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Brown CO, 2012, BIOCHEM J, V444, P515, DOI 10.1042/BJ20112019; Calame KL, 2003, ANNU REV IMMUNOL, V21, P205, DOI 10.1146/annurev.immunol.21.120601.141138; Cao SS, 2014, ANTIOXID REDOX SIGN, V21, P396, DOI 10.1089/ars.2014.5851; Challen GA, 2006, STEM CELLS, V24, P3, DOI 10.1634/stemcells.2005-0116; Charruyer A, 2012, J INVEST DERMATOL, V132, P2522, DOI 10.1038/jid.2012.196; Chazotte Brad, 2011, Cold Spring Harb Protoc, V2011, P990, DOI 10.1101/pdb.prot5648; Colla S, 2010, LEUKEMIA, V24, P1967, DOI 10.1038/leu.2010.193; Dela Cruz R, 2011, AM J BLOOD RES, V1, P135; Dezorella N, 2009, EXP CELL RES, V315, P1904, DOI 10.1016/j.yexcr.2009.03.016; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Dong LF, 2011, J BIOL CHEM, V286, P3717, DOI 10.1074/jbc.M110.186643; Elliott BM, 2011, EUR J HAEMATOL, V86, P289, DOI 10.1111/j.1600-0609.2010.01575.x; Fath MA, 2009, CANCER BIOL THER, V8, P1228, DOI 10.4161/cbt.8.13.8631; Feng W, 2014, STEM CELLS; Flavahan WA, 2013, NAT NEUROSCI, V16, P1373, DOI 10.1038/nn.3510; Fuhler GM, 2010, EXP CELL RES, V316, P1816, DOI 10.1016/j.yexcr.2010.03.013; Fujiwara S, 2013, BRIT J CANCER, V108, P170, DOI 10.1038/bjc.2012.527; Gabr MT, 2015, RSC ADV, V5, P90226, DOI 10.1039/c5ra18724a; Gane EJ, 2010, LIVER INT, V30, P1019, DOI 10.1111/j.1478-3231.2010.02250.x; Gao M, 2016, ONCOTARGET; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Goel A, 2005, EXP HEMATOL, V33, P784, DOI 10.1016/j.exphem.2005.04.005; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Goto M, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-76; Green DR, 2010, CELL, V142, P200, DOI 10.1016/j.cell.2010.07.007; Hajek R, 2013, BRIT J HAEMATOL, V163, P551, DOI 10.1111/bjh.12563; Han M, 2014, MOL PHARMACEUT, V11, P2640, DOI 10.1021/mp500038g; Herault O, 2012, J EXP MED, V209, P895, DOI 10.1084/jem.20102386; Hosen N, 2012, LEUKEMIA, V26, P2135, DOI 10.1038/leu.2012.80; Jakubikova J, 2011, BLOOD, V117, P4409, DOI 10.1182/blood-2010-02-267344; Janiszewska M, 2012, GENE DEV, V26, P1926, DOI 10.1101/gad.188292.112; Jara JA, 2014, J MED CHEM, V57, P2440, DOI 10.1021/jm500174v; Katajisto P, 2015, SCIENCE, V348, P340, DOI 10.1126/science.1260384; Kawano Y, 2013, INT J ONCOL, V43, P1809, DOI 10.3892/ijo.2013.2134; Kawano Y, 2012, INT J ONCOL, V41, P876, DOI 10.3892/ijo.2012.1545; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Kim YS, 2013, ANTICANCER RES, V33, P4469; Kurtoglu M, 2007, MOL CANCER THER, V6, P3049, DOI 10.1158/1535-7163.MCT-07-0310; Kurtoglu M, 2010, CANCER CHEMOTH PHARM, V66, P129, DOI 10.1007/s00280-009-1143-1; Lagadec C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034545; Leung CWT, 2013, J AM CHEM SOC, V135, P62, DOI 10.1021/ja310324q; Li L, 2015, REDOX BIOL, V4, P127, DOI 10.1016/j.redox.2014.12.001; LIN JJC, 1981, P NATL ACAD SCI-BIOL, V78, P2335, DOI 10.1073/pnas.78.4.2335; Liu HP, 2002, BIOCHEM PHARMACOL, V64, P1745, DOI 10.1016/S0006-2952(02)01456-9; Liu JH, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/294303; Loureiro R, 2013, RECENT PATENTS ENDOC, V7, P102, DOI 10.2174/18722148113079990006; Maher JC, 2004, CANCER CHEMOTH PHARM, V53, P116, DOI 10.1007/s00280-003-0724-7; Mahindra A, 2012, NAT REV CLIN ONCOL, V9, P135, DOI 10.1038/nrclinonc.2012.15; Majithia N, 2015, AM J HEMATOL, V90, P981, DOI 10.1002/ajh.24131; Matsui W, 2004, BLOOD, V103, P2332, DOI 10.1182/blood-2003-09-3064; Matsui W, 2008, CANCER RES, V68, P190, DOI 10.1158/0008-5472.CAN-07-3096; McBrayer SK, 2012, BLOOD, V119, P4686, DOI 10.1182/blood-2011-09-377846; Minor RK, 2010, TOXICOL APPL PHARM, V243, P332, DOI 10.1016/j.taap.2009.11.025; Mohanti BK, 1996, INT J RADIAT ONCOL, V35, P103, DOI 10.1016/S0360-3016(96)85017-6; Moreno-Sanchez R, 2016, FEBS J, V283, P54, DOI 10.1111/febs.13535; Morfouace M, 2012, J BIOL CHEM, V287, P33664, DOI 10.1074/jbc.M111.320028; Murphy MP, 2008, BBA-BIOENERGETICS, V1777, P1028, DOI 10.1016/j.bbabio.2008.03.029; Muz B, 2014, BLOOD CANCER J, V4, DOI 10.1038/bcj.2014.82; Nakano A, 2012, J BIOENERG BIOMEMBR, V44, P31, DOI 10.1007/s10863-012-9412-9; Nara M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056954; Obeng EA, 2006, BLOOD, V107, P4907, DOI 10.1182/blood-2005-08-3531; Ogasawara MA, 2009, ANTIOXID REDOX SIGN, V11, P1107, DOI [10.1089/ars.2008.2308, 10.1089/ARS.2008.2308]; Orlowski RZ, 2013, CANCER CELL, V24, P275, DOI 10.1016/j.ccr.2013.08.014; Paino T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092378; Pasto A, 2014, ONCOTARGET, V5, P4305, DOI 10.18632/oncotarget.2010; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Raez LE, 2013, CANCER CHEMOTH PHARM, V71, P523, DOI 10.1007/s00280-012-2045-1; Ralph SJ, 2010, MOL ASPECTS MED, V31, P145, DOI 10.1016/j.mam.2010.02.008; Ramani VC, 2014, MATRIX BIOL, V35, P215, DOI 10.1016/j.matbio.2013.10.005; Reedy JL, 2016, BIOCONJUG CHEM; Reid S, 2010, INT J LAB HEMATOL, V32, pE190, DOI 10.1111/j.1751-553X.2010.01222.x; Reily C, 2013, REDOX BIOL, V1, P86, DOI 10.1016/j.redox.2012.11.009; Ria R, 2014, CLIN CANCER RES, V20, P847, DOI 10.1158/1078-0432.CCR-13-1950; Salaun PY, 2008, HAEMATOL-HEMATOL J, V93, P1269, DOI 10.3324/haematol.12654; Salem K, 2015, REDOX BIOL, V4, P23, DOI 10.1016/j.redox.2014.11.002; Sanchez WY, 2013, BRIT J CANCER, V108, P1624, DOI 10.1038/bjc.2013.120; Sancho P, 2015, CELL METAB, V22, P590, DOI 10.1016/j.cmet.2015.08.015; Sattler UGA, 2009, INT J RADIAT BIOL, V85, P963, DOI 10.3109/09553000903258889; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Shanmugam M, 2009, J BIOL CHEM, V284, P26816, DOI 10.1074/jbc.M109.000646; Shaughnessy JD, 2007, BLOOD, V109, P2276, DOI 10.1182/blood-2006-07-038430; Shaughnessy JD, 2011, BLOOD, V118, P3512, DOI 10.1182/blood-2010-12-328252; Shi XK, 2012, ANTIOXID REDOX SIGN, V16, P1215, DOI 10.1089/ars.2012.4529; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Snow BJ, 2010, MOVEMENT DISORD, V25, P1670, DOI 10.1002/mds.23148; Spitz DR, 2000, ANN NY ACAD SCI, V899, P349, DOI 10.1111/j.1749-6632.2000.tb06199.x; Stein M, 2010, PROSTATE, V70, P1388, DOI 10.1002/pros.21172; Suhr ST, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0008124, 10.1371/journal.pone.0014095]; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Van Valckenborgh E, 2012, LEUKEMIA, V26, P1436, DOI 10.1038/leu.2011.373; Varum S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020914; Vayalil PK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120460; Victorino VJ, 2014, CURRENT MED CHEM; Vlashi E, 2014, BREAST CANCER RES TR, V146, P525, DOI 10.1007/s10549-014-3051-2; Wang XH, 2007, ACTA MATER, V55, P5304, DOI 10.1016/j.actamat.2007.04.041; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wen JG, 2015, INT J CANCER, V136, P991, DOI 10.1002/ijc.29078; White-Gilbertson Shai, 2013, Frontiers in Genetics, V4, P109, DOI 10.3389/fgene.2013.00109; WICK AN, 1957, J BIOL CHEM, V224, P963; Xi HB, 2014, IUBMB LIFE, V66, P110, DOI 10.1002/iub.1251; Yan B, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1394-7; Yang Y, 2015, CANCER RES, V75, P594, DOI 10.1158/0008-5472.CAN-14-2362; Yang Y, 2013, BLOOD, V122, P1437, DOI 10.1182/blood-2013-02-482919; Ye F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080397; Ye XQ, 2011, INT J CANCER, V129, P820, DOI 10.1002/ijc.25944; Ye XQ, 2011, STEM CELL REV REP, V7, P153, DOI 10.1007/s12015-010-9122-9; Zamagni E, 2011, BLOOD, V118, P5989, DOI 10.1182/blood-2011-06-361386; Zhang BB, 2015, FAM CANCER, V14, P19, DOI 10.1007/s10689-014-9757-9; Zhang GC, 2013, BBA-REV CANCER, V1836, P49, DOI 10.1016/j.bbcan.2013.03.001; Zhu YM, 2009, FREE RADICAL BIO MED, V47, P1762, DOI 10.1016/j.freeradbiomed.2009.09.024; Zou CH, 2005, J BIOCHEM BIOPH METH, V64, P207, DOI 10.1016/j.jbbm.2005.08.001	119	6	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167323	10.1371/journal.pone.0167323	http://dx.doi.org/10.1371/journal.pone.0167323			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902770	Green Published, Green Submitted, gold			2022-12-26	WOS:000389474100071
J	Leong, KH; Abdul-Rahman, H; Wang, C; Onn, CC; Loo, SC				Leong, Kah Huo; Abdul-Rahman, Hamzah; Wang, Chen; Onn, Chiu Chuen; Loo, Siaw-Chuing			Bee Inspired Novel Optimization Algorithm and Mathematical Model for Effective and Efficient Route Planning in Railway System	PLOS ONE			English	Article							TRANSIT NETWORK DESIGN; COLONY OPTIMIZATION	Railway and metro transport systems (RS) are becoming one of the popular choices of transportation among people, especially those who live in urban cities. Urbanization and increasing population due to rapid development of economy in many cities are leading to a bigger demand for urban rail transit. Despite being a popular variant of Traveling Salesman Problem (TSP), it appears that the universal formula or techniques to solve the problem are yet to be found. This paper aims to develop an optimization algorithm for optimum route selection to multiple destinations in RS before returning to the starting point. Bee foraging behaviour is examined to generate a reliable algorithm in railway TSP. The algorithm is then verified by comparing the results with the exact solutions in 10 test cases, and a numerical case study is designed to demonstrate the application with large size sample. It is tested to be efficient and effective in railway route planning as the tour can be completed within a certain period of time by using minimal resources. The findings further support the reliability of the algorithm and capability to solve the problems with different complexity. This algorithm can be used as a method to assist business practitioners making better decision in route planning.	[Leong, Kah Huo; Abdul-Rahman, Hamzah] Int Univ Malaya Wales, Fac Sci Technol Engn & Math STEM, Kuala Lumpur, Malaysia; [Wang, Chen] Huaqiao Univ, Coll Civil Engn, Xiamen 361021, Peoples R China; [Onn, Chiu Chuen; Loo, Siaw-Chuing] Univ Malaya, Fac Engn, Dept Civil Engn, Kuala Lumpur, Malaysia; Univ Malaya, Fac Built Environm, Ctr Bldg Construct & Trop Architecture, Kuala Lumpur, Malaysia	Universiti Malaya; Huaqiao University; Universiti Malaya; Universiti Malaya	Loo, SC (corresponding author), Univ Malaya, Fac Engn, Dept Civil Engn, Kuala Lumpur, Malaysia.	siawchuing@um.edu.my	wang, chen/GWM-9481-2022; Loo, Siaw-Chuing/AAT-3921-2020; ABDUL RAHMAN, HAMZAH/B-8583-2010; ONN, CHIU CHUEN/B-9460-2010; Loo, Siaw-Chuing/B-3958-2009; Wang, Chen/F-1586-2010; Leong, Kah Huo/R-3769-2017	Loo, Siaw-Chuing/0000-0003-2528-1817; ONN, CHIU CHUEN/0000-0002-5093-5651; Loo, Siaw-Chuing/0000-0003-2528-1817; Wang, Chen/0000-0001-7892-3575; Leong, Kah Huo/0000-0001-7266-631X	University of Malaya; Center of Building, Construction AMP; Tropical Architecture of the Faculty of Built Environment, Center of Transport Research, Department of Civil Engineering, Faculty of Engineering, and University of Malaya (UM), Malaysia;  [LL026-16SUS]	University of Malaya(Universiti Malaya); Center of Building, Construction AMP; Tropical Architecture of the Faculty of Built Environment, Center of Transport Research, Department of Civil Engineering, Faculty of Engineering, and University of Malaya (UM), Malaysia; 	This research was supported by the University of Malaya. We thank the reviewers and associate editor for their comments that greatly improved the manuscript.r The authors wish to thank the Center of Building, Construction & Tropical Architecture of the Faculty of Built Environment, Center of Transport Research, Department of Civil Engineering, Faculty of Engineering, and University of Malaya (UM), Malaysia for their financial support to carry out this research project. The project was funded under the project LL026-16SUS.	Aghazadeh F., 2011, INT C INF INT COMP, P115; Awuni K., 2014, DYNAMIC PROGRAMMING; Baykasoglu A, 2007, SWARM INTELLIGENCE F, P113; Bellizzi C, 2015, ANIM COGN, V18, P1207, DOI 10.1007/s10071-015-0890-0; Beni G, 1993, ROBOTS BIOL SYSTEMS, V102, P703, DOI [DOI 10.1007/978-3-642-58069-7_38, 10.1007/978-3-642-58069-7, DOI 10.1007/978-3-642-58069-7]; Bonabeau E DdRDF, 1999, SWARM INTELLIGENCE N; Ch'ng B., 2014, STAR; Chauhan J. R., 2013, J INFORM KNOWLEDGE R, V2, P616; Cook W. J., 2012, PURSUIT TRAVELING SA; Gandomi AH, 2011, INFORM SCIENCES, V181, P5227, DOI 10.1016/j.ins.2011.07.026; Kennedy J., 1995, P ICNN 95 INT C NEUR, P1942; LAPORTE G, 1992, EUR J OPER RES, V59, P345, DOI 10.1016/0377-2217(92)90192-C; Li R., 2013, MATH PROBLEMS ENG, V2013; MAGNANTI TL, 1984, TRANSPORT SCI, V18, P1, DOI 10.1287/trsc.18.1.1; Matai R., 2010, TRAVELING SALESMAN P; Mittal S., 2014, J ADV COMPUTING COMM, V2; Moghaddam B. F., 2010, INT J RES REV APPL S, V2, P108; Nikolic M, 2014, EXPERT SYST APPL, V41, P7200, DOI 10.1016/j.eswa.2014.05.034; Nikolic M, 2013, EXPERT SYST APPL, V40, P5945, DOI 10.1016/j.eswa.2013.05.002; Nikolic M, 2013, EXPERT SYST APPL, V40, P4609, DOI 10.1016/j.eswa.2013.01.063; Orr J. L., TRAVELING SALESMAN P; Osaba E, 2016, ENG APPL ARTIF INTEL, V48, P59, DOI 10.1016/j.engappai.2015.10.006; Quak C., 2003, THESIS; Sahalot Antima, 2014, INT J RES ENG TECHNO, V2, P59; Sathya N., 2015, INDIAN J SCI TECHNOL, V8, P1; Teodorovic D., 2011, ACM T COMPUT LOG, V1529, P3785; Teodorovic D, 2009, STUD COMPUT INTELL, V248, P39; Todorovic N, 2013, IEEE T SYST MAN CY-S, V43, P467, DOI 10.1109/TSMCA.2012.2210404; Yang XS, 2014, APPL MATH INFORM SCI, V8, P977, DOI 10.12785/amis/080306; Yuce Baris, 2013, Insects, V4, P646, DOI 10.3390/insects4040646	31	3	3	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0166064	10.1371/journal.pone.0166064	http://dx.doi.org/10.1371/journal.pone.0166064			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930659	gold, Green Published, Green Submitted			2022-12-26	WOS:000389580900008
J	Ma, XF; Huang, XL; Ge, Y; Hu, YM; Chen, W; Liu, AL; Liu, HX; Chen, Y; Li, B; Ning, XB				Ma, Xiaofei; Huang, Xiaolin; Ge, Yun; Hu, Yueming; Chen, Wei; Liu, Aili; Liu, Hongxing; Chen, Ying; Li, Bin; Ning, Xinbao			Brain Connectivity Variation Topography Associated with Working Memory	PLOS ONE			English	Article							SYNCHRONIZATION; CORTEX; NETWORKS; PATHWAYS; GAMMA; STATE	Brain connectivity analysis plays an essential role in the research of working memory that involves complex coordination of various brain regions. In this research, we present a comprehensive view of trans-states brain connectivity variation based on continuous scalp EEG, extending beyond traditional stimuli-lock averaging or restriction to short time scales of hundreds of milliseconds after stimulus onset. The scalp EEG was collected under three conditions: quiet, memory, and control. The only difference between the memory and control conditions was that in the memory condition, subjects made an effort to retain information. We started our investigation with calibrations of Pearson correlation in EEG analysis and then derived two indices, link strength and node connectivity, to make comparisons between different states. Finally, we constructed and studied trans-state brain connectivity variation topography. Comparing memory and control states with quiet state, we found that the beta topography highlights links between T5/T6 and O1/O2, which represents the visual ventral stream, and the gamma topography conveys strengthening of inter-hemisphere links and weakening of intra-hemisphere frontal-posterior links, implying parallel inter-hemisphere coordination combined with sequential intra-hemisphere coordination when subjects are confronted with visual stimuli and a motor task. For comparison between memory and control states, we also found that the node connectivity of T6 stands out in gamma topography, which provides strong proof from scalp EEG for the information binding or relational processing function of the temporal lobe in memory formation. To our knowledge, this is the first time for any method to effectively capture brain connectivity variation associated with working memory from a relatively large scale both in time (from a second to a minute) and in space (from the scalp). The method can track brain activity continuously with minimal manual interruptions; therefore, it has promising potential in applications such as brain computer interfaces and brain training.	[Ma, Xiaofei; Huang, Xiaolin; Ge, Yun; Hu, Yueming; Chen, Wei; Liu, Aili; Liu, Hongxing; Chen, Ying; Ning, Xinbao] Nanjing Univ, Sch Elect Sci & Engn, Nanjing, Jiangsu, Peoples R China; [Li, Bin] Nanjing Univ, Sch Life Sci, Nanjing, Jiangsu, Peoples R China	Nanjing University; Nanjing University	Huang, XL (corresponding author), Nanjing Univ, Sch Elect Sci & Engn, Nanjing, Jiangsu, Peoples R China.	xlhuang@nju.edu.cn			Forward-looking Project on the Integration of Industry, Education and Research of Jiangsu Province [BY2015069-06]; Social Development Program of Primary Research & Development Plan in Jiangsu Province [BE2016733]; Priority Academic Program Development of Jiangsu Higher Education Institutions	Forward-looking Project on the Integration of Industry, Education and Research of Jiangsu Province; Social Development Program of Primary Research & Development Plan in Jiangsu Province; Priority Academic Program Development of Jiangsu Higher Education Institutions	This research was supported by Forward-looking Project on the Integration of Industry, Education and Research of Jiangsu Province (BY2015069-06), the Social Development Program of Primary Research & Development Plan in Jiangsu Province (BE2016733) and the Priority Academic Program Development of Jiangsu Higher Education Institutions.	Uriguen JA, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/3/031001; Antony AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077916; Axmacher N, 2010, P NATL ACAD SCI USA, V107, P3228, DOI 10.1073/pnas.0911531107; Barlow JS, 1997, INT J PSYCHOPHYSIOL, V26, P443, DOI 10.1016/S0167-8760(97)00781-2; Bonita JD, 2014, COGN NEURODYNAMICS, V8, P1, DOI 10.1007/s11571-013-9267-8; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Charlton RA, 2010, CORTEX, V46, P474, DOI 10.1016/j.cortex.2009.07.005; Delorme A, 2007, NEUROIMAGE, V34, P1443, DOI 10.1016/j.neuroimage.2006.11.004; Eriksson J, 2015, NEURON, V88, P33, DOI 10.1016/j.neuron.2015.09.020; Fadlallah B, 2012, IEEE T BIO-MED ENG, V59, P2773, DOI 10.1109/TBME.2012.2210283; Fell J, 2001, NAT NEUROSCI, V4, P1259, DOI 10.1038/nn759; Nicolas-Alonso LF, 2012, SENSORS-BASEL, V12, P1211, DOI 10.3390/s120201211; Gazzaley Adam, 2004, Cognitive Affective & Behavioral Neuroscience, V4, P580, DOI 10.3758/CABN.4.4.580; Gilbert SJ, 2006, J COGNITIVE NEUROSCI, V18, P932, DOI 10.1162/jocn.2006.18.6.932; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Holz EM, 2010, NEUROIMAGE, V52, P326, DOI 10.1016/j.neuroimage.2010.04.003; Kilicarslan A, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/2/026013; Lee TG, 2013, J NEUROSCI, V33, P13233, DOI 10.1523/JNEUROSCI.5652-12.2013; Ma WJ, 2014, NAT NEUROSCI, V17, P347, DOI 10.1038/nn.3655; Palva JM, 2010, P NATL ACAD SCI USA, V107, P7580, DOI 10.1073/pnas.0913113107; Plume A., 2014, SCI ENG ETHICS, V38, P16, DOI DOI 10.1016/J.TICS.2013.10.010; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Salazar RF, 2012, SCIENCE, V338, P1097, DOI 10.1126/science.1224000; Sarnthein J, 1998, P NATL ACAD SCI USA, V95, P7092, DOI 10.1073/pnas.95.12.7092; Schall JD, 2004, VISION RES, V44, P1453, DOI 10.1016/j.visres.2003.10.025; Schubert T, 2014, PSYCHOL RES-PSYCH FO, V78, P749, DOI 10.1007/s00426-014-0619-8; Tesche CD, 2000, P NATL ACAD SCI USA, V97, P919, DOI 10.1073/pnas.97.2.919	27	9	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0165168	10.1371/journal.pone.0165168	http://dx.doi.org/10.1371/journal.pone.0165168			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930672	Green Published, gold, Green Submitted			2022-12-26	WOS:000389580900003
J	Gourmelon, V; Maggia, L; Powell, JR; Gigante, S; Hortal, S; Gueunier, C; Letellier, K; Carriconde, F				Gourmelon, Veronique; Maggia, Laurent; Powell, Jeff R.; Gigante, Sarah; Hortal, Sara; Gueunier, Claire; Letellier, Kelly; Carriconde, Fabian			Environmental and Geographical Factors Structure Soil Microbial Diversity in New Caledonian Ultramafic Substrates: A Metagenomic Approach	PLOS ONE			English	Article							BACTERIAL COMMUNITY STRUCTURE; TROPICAL RAIN-FORESTS; SPECIES RICHNESS; ECTOMYCORRHIZAL FUNGI; PYROSEQUENCING ANALYSES; LITTER DECOMPOSITION; FUNCTIONAL DIVERSITY; MYCORRHIZAL STATUS; PRIMARY SUCCESSION; HOST PREFERENCE	Soil microorganisms play key roles in ecosystem functioning and are known to be influenced by biotic and abiotic factors, such as plant cover or edaphic parameters. New Caledonia, a biodiversity hotspot located in the southwest Pacific, is one-third covered by ultramafic substrates. These types of soils are notably characterised by low nutrient content and high heavy metal concentrations. Ultramafic outcrops harbour diverse vegetation types and remarkable plant diversity. In this study, we aimed to assess soil bacterial and fungal diversity in New Caledonian ultramafic substrates and to determine whether floristic composition, edaphic parameters and geographical factors affect this microbial diversity. Therefore, four plant formation types at two distinct sites were studied. These formations represent different stages in a potential chronosequence. Soil cores, according to a given sampling procedure, were collected to assess microbial diversity using a metagenomic approach, and to characterise the physico-chemical parameters. A botanical inventory was also performed. Our results indicated that microbial richness, composition and abundance were linked to the plant cover type and the dominant plant species. Furthermore, a large proportion of Ascomycota phylum (fungi), mostly in non-rainforest formations, and Planctomycetes phylum (bacteria) in all formations were observed. Interestingly, such patterns could be indicators of past disturbances that occurred on different time scales. Furthermore, the bacteria and fungi were influenced by diverse edaphic parameters as well as by the interplay between these two soil communities. Another striking finding was the existence of a site effect. Differences in microbial communities between geographical locations may be explained by dispersal limitation in the context of the biogeographical island theory. In conclusion, each plant formation at each site possesses is own microbial community resulting from multiple interactions between abiotic and biotic factors.	[Gourmelon, Veronique; Maggia, Laurent; Gigante, Sarah; Letellier, Kelly; Carriconde, Fabian] Inst Agron Neocaledonien IAC, Axe Diversites Biol & Fonct Ecosyst Terrestres 2, Noumea, New Caledonia; [Maggia, Laurent] CIRAD, UMR AGAP, Noumea, New Caledonia; [Powell, Jeff R.; Hortal, Sara] Univ Western Sydney, Hawkesbury Inst Environm, Penrith, NSW, Australia; [Gueunier, Claire] Soc Nickel SLN, Dept Environm, Grp ERAMET, Noumea, New Caledonia	CIRAD; Western Sydney University	Gourmelon, V; Carriconde, F (corresponding author), Inst Agron Neocaledonien IAC, Axe Diversites Biol & Fonct Ecosyst Terrestres 2, Noumea, New Caledonia.	gourmelon@iac.nc; carriconde@iac.nc	Powell, Jeff R/A-5076-2010	Powell, Jeff R/0000-0003-1091-2452	Societe Le Nickel (SLN - Groupe ERAMET) [DE2013-041]	Societe Le Nickel (SLN - Groupe ERAMET)	This project was funded by the Societe Le Nickel (SLN - Groupe ERAMET) through a research collaboration agreement (agreement IAC-SLN no DE2013-041). The SLN provided support in the form of salaries for authors [CG] and contributed to the study design, the project administration, the access to the field and the decision to publish.	Aerts R, 1997, OIKOS, V79, P439, DOI 10.2307/3546886; Alexander I, 2009, NEW PHYTOL, V182, P14, DOI 10.1111/j.1469-8137.2009.02798.x; Amir H, 2007, PLANT SOIL, V293, P23, DOI 10.1007/s11104-007-9238-0; Amir H., 2010, MINES ENV NOUVELLE C, P129; Amir H, 2013, MYCORRHIZA, V23, P585, DOI 10.1007/s00572-013-0499-6; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Aponte C, 2010, SOIL BIOL BIOCHEM, V42, P788, DOI 10.1016/j.soilbio.2010.01.014; Austin AT, 2006, NATURE, V442, P555, DOI 10.1038/nature05038; Bequette F., 1997, UNESCO COURIER, V50, P38; Berg G, 2009, FEMS MICROBIOL ECOL, V68, P1, DOI 10.1111/j.1574-6941.2009.00654.x; Bonito G, 2014, MOL ECOL, V23, P3356, DOI 10.1111/mec.12821; Bordez L, 2016, MOL ECOL, V25, P2258, DOI 10.1111/mec.13621; Branco S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011757; Braun-blanquet J., 1932, PLANT SOCIOLOGY STUD, VFirst; Brodie E, 2002, MICROB ECOL, V44, P260, DOI 10.1007/s00248-002-2012-1; Broeckling CD, 2008, APPL ENVIRON MICROB, V74, P738, DOI 10.1128/AEM.02188-07; Bruce T, 2010, MICROB ECOL, V60, P840, DOI 10.1007/s00248-010-9750-2; Buckley DH, 2003, ENVIRON MICROBIOL, V5, P441, DOI 10.1046/j.1462-2920.2003.00404.x; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Chatain A, 2009, PLANT ECOL, V201, P51, DOI 10.1007/s11258-008-9477-z; Clarke KR, 2015, PRIMER V7 USER MANUA; CONNELL JH, 1989, AM NAT, V134, P88, DOI 10.1086/284967; Corneo PE, 2014, MICROB ECOL, V67, P659, DOI 10.1007/s00248-013-0357-2; DANELL E, 1993, MYCOL RES, V97, P1148, DOI 10.1016/S0953-7562(09)80519-4; de Boer W, 2005, FEMS MICROBIOL REV, V29, P795, DOI 10.1016/j.femsre.2004.11.005; de Castro AP, 2008, ARCH MICROBIOL, V190, P129, DOI 10.1007/s00203-008-0374-6; de Vries FT, 2012, ECOL LETT, V15, P1230, DOI 10.1111/j.1461-0248.2012.01844.x; DeGrood SH, 2005, SOIL BIOL BIOCHEM, V37, P1427, DOI 10.1016/j.soilbio.2004.12.013; Dennis PG, 2010, FEMS MICROBIOL ECOL, V72, P313, DOI 10.1111/j.1574-6941.2010.00860.x; Dickie IA, 2007, NEW PHYTOL, V174, P230, DOI 10.1111/j.1469-8137.2007.02055.x; Duponnois R, 2003, MYCORRHIZA, V13, P85, DOI 10.1007/s00572-002-0204-7; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; ELLIOTT WM, 1993, AM MIDL NAT, V129, P87, DOI 10.2307/2426438; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fierer N, 2007, APPL ENVIRON MICROB, V73, P7059, DOI 10.1128/AEM.00358-07; Fitzsimons MS, 2010, PLANT SOIL, V330, P393, DOI 10.1007/s11104-009-0213-9; Frey P, 1997, APPL ENVIRON MICROB, V63, P1852, DOI 10.1128/AEM.63.5.1852-1860.1997; Frey-Klett P, 2005, NEW PHYTOL, V168, P4, DOI 10.1111/j.1469-8137.2005.01553.x; Gobat J.-M., 2010, SOL VIVANT BASES PED; Gomoryova E, 2009, APPL SOIL ECOL, V43, P191, DOI 10.1016/j.apsoil.2009.07.007; Grayston SJ, 2004, APPL SOIL ECOL, V25, P63, DOI 10.1016/S0929-1393(03)00098-2; Haichar FE, 2008, ISME J, V2, P1221, DOI 10.1038/ismej.2008.80; Hartnett DC, 2002, PLANT SOIL, V244, P319, DOI 10.1023/A:1020287726382; He XH, 2008, FRANKIA NODULATION M, P767; Herrera A, 2007, EUR J SOIL BIOL, V43, P130, DOI 10.1016/j.ejsobi.2006.12.001; Hery M, 2003, ENVIRON MICROBIOL, V5, P3, DOI 10.1046/j.1462-2920.2003.00380.x; Ihrmark K, 2012, FEMS MICROBIOL ECOL, V82, P666, DOI 10.1111/j.1574-6941.2012.01437.x; Ishida TA, 2007, NEW PHYTOL, V174, P430, DOI 10.1111/j.1469-8137.2007.02016.x; Isnard S, 2016, PLANT SOIL, V403, P53, DOI 10.1007/s11104-016-2910-5; Jaffre A T, 2001, IRD DOC SCI TECH, P1; Jaffre T., 2010, MINES ENV NOUVELLE C, P45; Jaffre T, 2009, FLORA, V162, P54; Kier G, 2009, P NATL ACAD SCI USA, V106, P9322, DOI 10.1073/pnas.0810306106; Knelman JE, 2012, SOIL BIOL BIOCHEM, V46, P172, DOI 10.1016/j.soilbio.2011.12.001; Koljalg U, 2005, NEW PHYTOL, V166, P1063, DOI 10.1111/j.1469-8137.2005.01376.x; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Lagrange A, 2011, CAN J MICROBIOL, V57, P21, DOI [10.1139/W10-096, 10.1139/w10-096]; Lejon DPH, 2005, MICROB ECOL, V50, P614, DOI 10.1007/s00248-005-5130-8; Lenczewski M, 2009, AUSTRAL ECOL, V34, P567, DOI 10.1111/j.1442-9993.2009.01962.x; Li JJ, 2013, J SOIL SEDIMENT, V13, P760, DOI 10.1007/s11368-013-0652-z; Lisitskaya TB, 2013, RUSS J GEN CHEM+, V83, P2765, DOI 10.1134/S1070363213130252; lvarez-Lopez V, PLANT SOIL, V480, DOI [10.1111/j.1461-0248.2007.01035.x, DOI 10.1111/J.1461-0248.2007.01035.X]; MACARTHUR RH, 1963, EVOLUTION, V17, P373, DOI 10.2307/2407089; Madsen EL, 2011, CURR OPIN BIOTECH, V22, P456, DOI 10.1016/j.copbio.2011.01.008; Majorel C, 2012, MOL ECOL, V21, P2208, DOI 10.1111/j.1365-294X.2012.05527.x; Mansfeld-Giese K, 2002, FEMS MICROBIOL ECOL, V41, P133, DOI 10.1111/j.1574-6941.2002.tb00974.x; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; Mengoni A, 2010, PLANT SOIL, V331, P5, DOI 10.1007/s11104-009-0242-4; Miyashita NT, 2013, GENES GENET SYST, V88, P93, DOI 10.1266/ggs.88.93; Morat P, 2012, ADANSONIA; Myers Norman, 2000, Nature (London), V403, P853, DOI 10.1038/35002501; Ohtonen R, 1999, OECOLOGIA, V119, P239, DOI 10.1007/s004420050782; Oline DK, 2006, APPL ENVIRON MICROB, V72, P6965, DOI 10.1128/AEM.00690-06; Orgiazzi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034847; Pansu M, 2006, HDB SOIL ANAL, DOI 10.1007/978-3-540-31211-6; Pearson K., PHILIOSOPHICAL MAG, V2, P559; Peay KG, 2007, ECOL LETT, V10, P470, DOI 10.1111/j.1461-0248.2007.01035.x; Peay KG, 2010, ECOLOGY, V91, P3631, DOI 10.1890/09-2237.1; Perrier N, 2006, MYCORRHIZA, V16, P449, DOI 10.1007/s00572-006-0057-6; Pessoa M, 2015, ANTON LEEUW INT J G, V107, P935, DOI 10.1007/s10482-015-0386-6; Pfeiffer B, 2013, APPL SOIL ECOL, V72, P150, DOI 10.1016/j.apsoil.2013.06.008; PIELOU EC, 1966, J THEOR BIOL, V13, P131, DOI 10.1016/0022-5193(66)90013-0; Porter SS, 2013, EVOLUTION, V67, P599, DOI 10.1111/j.1558-5646.2012.01788.x; Puga-Freitas R, ENV EXP BOT; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Read J, 1996, ECOLOGY BIOGEOGRAPHY; Roy M, 2013, NEW PHYTOL, V198, P1228, DOI 10.1111/nph.12212; SCHLEGEL HG, 1991, BOT ACTA, V104, P18, DOI 10.1111/j.1438-8677.1991.tb00189.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; schmidt M., 1982, CR HEBD ACAD SCI, V48, P52; Schulz S, 2013, BIOGEOSCIENCES, V10, P3983, DOI 10.5194/bg-10-3983-2013; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Sourkova M, 2005, GEODERMA, V129, P73, DOI 10.1016/j.geoderma.2004.12.032; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; Sun YJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp285; Tedersoo L, 2008, NEW PHYTOL, V180, P479, DOI 10.1111/j.1469-8137.2008.02561.x; TISDALL JM, 1994, PLANT SOIL, V159, P115, DOI 10.1007/BF00000100; Urbanova M, 2015, SOIL BIOL BIOCHEM, V84, P53, DOI 10.1016/j.soilbio.2015.02.011; White C, 2005, SOIL BIOL BIOCHEM, V37, P1359, DOI 10.1016/j.soilbio.2004.12.007; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Wubet T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047500; Zak DR, 2003, ECOLOGY, V84, P2042, DOI 10.1890/02-0433; ZHANG XP, 1991, INT J SYST BACTERIOL, V41, P104, DOI 10.1099/00207713-41-1-104; 2010, APPL ENVIRON MICROB, V76, P3936, DOI DOI 10.1128/AEM.03085-09	106	36	36	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167405	10.1371/journal.pone.0167405	http://dx.doi.org/10.1371/journal.pone.0167405			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907121	gold, Green Published, Green Submitted			2022-12-26	WOS:000389482700147
J	Kamiza, AB; Hsieh, LL; Tang, R; Chien, HT; Lai, CH; Chiu, LL; Lo, TP; Hung, KY; You, JF; Wang, WC; Hsiung, CA; Yeh, CC				Kamiza, Abram Bunya; Hsieh, Ling-Ling; Tang, Reiping; Chien, Huei-Tzu; Lai, Chih-Hsiung; Chiu, Li-Ling; Lo, Tsai-Ping; Hung, Kuan-Yi; You, Jeng-Fu; Wang, Wen-Chang; Hsiung, Chao A.; Yeh, Chih-Ching			TP53 Polymorphisms and Colorectal Cancer Risk in Patients with Lynch Syndrome in Taiwan: A Retrospective Cohort Study	PLOS ONE			English	Article							CODON 72 POLYMORPHISM; AGE-OF-ONSET; P53 CODON-72; GENETIC POLYMORPHISMS; HAPLOTYPE ANALYSIS; ASSOCIATION; POPULATION; GENOTYPE; ADENOCARCINOMAS; SUSCEPTIBILITY	Background and Aim TP53 encodes p53, which has a crucial role in modulating genes that regulate defense against cancer development. This study investigated whether TP53 polymorphisms are associated with colorectal cancer (CRC) in patients with Lynch syndrome and whether TP53 interacts with lifestyle factors to modify CRC risk. Methods We identified 260 MLH1 and MSH2 germline mutation carriers from the Taiwan Hereditary Nonpolyposis Colorectal Cancer Consortium. A weighted Cox proportional hazard model was used to calculate hazard ratios (HRs) and 95% confidence intervals (Cis) to determine the association of TP53 polymorphisms with CRC development. Results The carriers of the variant C allele of rs1042522 were associated with a decreased CRC risk (GC genotype: HR = 0.35, 95% CI = 0.14-0.86; CC genotype: HR = 0.28, 95% CI = 0.13-0.57). In addition, the dominant model of rs1042522 was associated with a decreased CRC risk (HR = 0.32, 95% CI = 0.15-0.67). The CRC risk was decreased in carriers with the CT and TT genotypes of rs12947788 (HR = 0.20, 95% CI = 0.08-0.46 and HR = 0.25, 95% CI = 0.09-0.65, respectively). Moreover, the dominant model of rs12947788 was significantly associated with a decreased CRC risk (HR = 0.21, 95% CI = 0.09-0.46). A haplotype analysis indicated that compared with the most common GC haplotype, the CT haplotype was associated with a decreased CRC risk (HR = 0.26, 95% CI = 0.11-0.59). However, no significant interaction was observed between TP53 polymorphisms and lifestyle factors. Conclusion The study results revealed that the rs1042522 genotype with the C allele and the rs12947788 genotype with the T allele in TP53 were associated with a decreased CRC risk in patients with Lynch syndrome in Taiwan.	[Kamiza, Abram Bunya; Yeh, Chih-Ching] Taipei Med Univ, Sch Publ Hlth, Coll Publ Hlth & Nutr, Taipei, Taiwan; [Hsieh, Ling-Ling; Chien, Huei-Tzu; Lai, Chih-Hsiung; Chiu, Li-Ling] Chang Gung Univ, Dept Publ Hlth, Coll Med, Taoyuan, Taiwan; [Tang, Reiping; You, Jeng-Fu] Chang Gung Mem Hosp, Colorectal Sect, Dept Surg, Taoyuan, Taiwan; [Tang, Reiping; You, Jeng-Fu] Chang Gung Univ, Sch Med, Taoyuan, Taiwan; [Chiu, Li-Ling] Chang Gung Univ Sci & Technol, Dept Nutr & Hlth Sci, Taoyuan, Taiwan; [Lo, Tsai-Ping; Hung, Kuan-Yi; Hsiung, Chao A.] Natl Hlth Res Inst, Inst Populat Hlth Sci, Miaoli, Taiwan; [Wang, Wen-Chang] Taipei Med Univ, Coll Med Sci & Technol, Ph Program Translat Med, Taipei, Taiwan; [Yeh, Chih-Ching] China Med Univ, Dept Publ Hlth, Taichung, Taiwan	Taipei Medical University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University of Science & Technology; National Health Research Institutes - Taiwan; Taipei Medical University; China Medical University Taiwan	Yeh, CC (corresponding author), Taipei Med Univ, Sch Publ Hlth, Coll Publ Hlth & Nutr, Taipei, Taiwan.; Hsiung, CA (corresponding author), Natl Hlth Res Inst, Inst Populat Hlth Sci, Miaoli, Taiwan.; Yeh, CC (corresponding author), China Med Univ, Dept Publ Hlth, Taichung, Taiwan.	hsiung@nhri.org.tw; ccyeh@tmu.edu.tw		Kamiza, Abram Bunya/0000-0002-3919-7651; Wang, Wen-Chang/0000-0003-3124-2136	National Science Council, Executive Yuan, Taiwan [NSC 101-2314-B-038-057]; Ministry of Science and Technology, Taiwan [MOST 104-2314-B-038-009]	National Science Council, Executive Yuan, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by the National Science Council, Executive Yuan, Taiwan (grant NSC 101-2314-B-038-057) and by the Ministry of Science and Technology, Taiwan (MOST 104-2314-B-038-009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the National Science Council, Executive Yuan, Taiwan (grant NSC 101-2314-B-038-057) and by the Ministry of Science and Technology, Taiwan (MOST 104-2314-B-038-009). We would like to thank all patients and their families who participated in this study. We also thank the staff from Chang Gung University and Chang Gung Memorial Hospital.	Antoniou AC, 2005, GENET EPIDEMIOL, V29, P1, DOI 10.1002/gepi.20074; Bartkowiak K, 2012, CANCER MICROENVIRON, V5, P59, DOI 10.1007/s12307-011-0067-6; Berg AO, 2009, GENET MED, V11, P35, DOI [10.1097/GIM.0b013e318181fa2ff, 10.1097/GIM.0b013e31818fa2ff]; Berggren P, 2001, MUTAGENESIS, V16, P475, DOI 10.1093/mutage/16.6.475; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Chen JY, 2009, CANCER CAUSE CONTROL, V20, P1769, DOI 10.1007/s10552-009-9416-x; Dahabreh IJ, 2010, CANCER EPIDEM BIOMAR, V19, P1840, DOI 10.1158/1055-9965.EPI-10-0156; Dakouras A, 2008, ANTICANCER RES, V28, P1039; De Jong AE, 2004, GASTROENTEROLOGY, V126, P42, DOI 10.1053/j.gastro.2003.10.043; de la Chapelle A, 2004, NAT REV CANCER, V4, P769, DOI 10.1038/nrc1453; Fu L, 2013, CELL ONCOL, V36, P225, DOI 10.1007/s13402-013-0130-z; Gemignani F, 2004, ONCOGENE, V23, P1954, DOI 10.1038/sj.onc.1207305; Ihsan R, 2011, DNA CELL BIOL, V30, P163, DOI 10.1089/dna.2010.1119; Jones JS, 2004, CLIN CANCER RES, V10, P5845, DOI 10.1158/1078-0432.CCR-03-0590; Kamiza AB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130018; Kruger S, 2005, J MED GENET, V42, P769, DOI 10.1136/jmg.2004.028506; Li YL, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-607; Malakar M, 2014, ASIAN PAC J CANCER P, V15, P717, DOI 10.7314/APJCP.2014.15.2.717; Meek DW, 2004, DNA REPAIR, V3, P1049, DOI 10.1016/j.dnarep.2004.03.027; Naccarati A, 2012, MUTAGENESIS, V27, P211, DOI 10.1093/mutage/ger067; Naccarati A, 2010, CARCINOGENESIS, V31, P666, DOI 10.1093/carcin/bgq032; Perez LO, 2006, WORLD J GASTROENTERO, V12, P1426, DOI 10.3748/wjg.v12.i9.1426; Pim D, 2004, INT J CANCER, V108, P196, DOI 10.1002/ijc.11548; Polakova V, 2009, HUM MUTAT, V30, P661, DOI 10.1002/humu.20931; Sayhan N, 2001, RES COMMUN MOL PATH, V109, P25; SJALANDER A, 1995, CARCINOGENESIS, V16, P1461, DOI 10.1093/carcin/16.7.1461; Song HR, 2011, GASTRIC CANCER, V14, P242, DOI 10.1007/s10120-011-0034-4; Sotamaa K, 2005, CLIN CANCER RES, V11, P6840, DOI 10.1158/1078-0432.CCR-05-1139; Sprague BL, 2007, CARCINOGENESIS, V28, P1680, DOI 10.1093/carcin/bgm097; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Sucheston L, 2011, HUM MOL GENET, V20, P1502, DOI 10.1093/hmg/ddr028; Talseth BA, 2006, INT J CANCER, V118, P2479, DOI 10.1002/ijc.21661; Tan XL, 2007, PHARMACOGENET GENOM, V17, P639, DOI 10.1097/FPC.0b013e3280d5121c; Tang NP, 2010, EJSO-EUR J SURG ONC, V36, P431, DOI 10.1016/j.ejso.2010.03.010; Tang R, 2009, CLIN GENET, V75, P334, DOI 10.1111/j.1399-0004.2009.01162.x; Watson P, 2008, INT J CANCER, V123, P444, DOI 10.1002/ijc.23508; Whibley C, 2009, NAT REV CANCER, V9, P95, DOI 10.1038/nrc2584; Williams RL, 2000, BIOMETRICS, V56, P645, DOI 10.1111/j.0006-341X.2000.00645.x; Xu H, 2001, Biotechnol Annu Rev, V7, P131, DOI 10.1016/S1387-2656(01)07035-1; Zahary MN, 2015, ONCOL LETT, V10, P3216, DOI 10.3892/ol.2015.3728; Zhu ZZ, 2007, JPN J CLIN ONCOL, V37, P385, DOI 10.1093/jjco/hym034	41	6	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167354	10.1371/journal.pone.0167354	http://dx.doi.org/10.1371/journal.pone.0167354			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907203	Green Submitted, gold, Green Published			2022-12-26	WOS:000389482700126
J	Reis, ST; Viana, NI; Leite, KRM; Diogenes, E; Antunes, AA; Iscaife, A; Nesrallah, AJ; Passerotti, CC; Srougi, V; Pontes, J; Salles, ME; Nahas, WC; Srougi, M				Reis, Sabrina T.; Viana, Nayara I.; Leite, Katia R. M.; Diogenes, Erico; Antunes, Alberto A.; Iscaife, Alexandre; Nesrallah, Adriano J.; Passerotti, Carlo C.; Srougi, Victor; Pontes-Junior, Jose; Salles, Mary Ellen; Nahas, William C.; Srougi, Miguel			Role of Genetic Polymorphisms in the Development and Prognosis of Sporadic and Familial Prostate Cancer	PLOS ONE			English	Article							GENOME-WIDE; ASSOCIATION; MULTIPLE; LOCI; RISK; VARIANTS	Backgrounds Our aim was to evaluate the role of 20 genetic polymorphisms in the development and prognosis of sporadic and familial PC. A case-control study of 185 patients who underwent radical prostatectomy from 1997 to 2011. These patients were divided into two groups based on their family history. Gleason grade, PSA value and pathological TNM 2002 stage were used as prognostic factors. Blood samples from 70 men without PC were used as controls. The SNPs were genotyped using a TaqMan SNP Genotyping Assay Kit. Results Considering susceptibility, the polymorphic allele in the SNP rs2660753 on chromosome 3 was significantly more prevalent in controls (p = 0.01). For familial clustering, the polymorphic homozygote genotype of the SNP rs7931342 was five times more frequent in patients with familial PC compared to sporadic PC (p = 0.01). Regarding the SNP 1447295, the polymorphic homozygote genotype was more prevalent in patients with organ-confined PC (p = 0.05), and most importantly, the polymorphic allele occurred more frequently in patients without biochemical recurrence (p = 0.01). Kaplan-Meier analysis showed a median biochemical recurrence free survival of 124.2 compared to 85.6 months for patients with the wild-type allele (p = 0.007). Conclusion Our findings provide the evidence for the association of 20 recently highlighted SNPs and their susceptibility, familial clustering, staging, Gleason score and biochemical recurrence of PC. We believe that the association between these SNPs and PC may contribute to the development of alternative tools that can facilitate the early detection and prognosis of this disease.	[Reis, Sabrina T.; Viana, Nayara I.; Leite, Katia R. M.; Diogenes, Erico; Antunes, Alberto A.; Iscaife, Alexandre; Passerotti, Carlo C.; Srougi, Victor; Pontes-Junior, Jose; Salles, Mary Ellen; Srougi, Miguel] Univ Sao Paulo, Sch Med, Dept Urol, Lab Med Invest LIM55, Sao Paulo, Brazil; [Nesrallah, Adriano J.; Pontes-Junior, Jose; Nahas, William C.] Univ Sao Paulo, Sch Med, Dept Urol, Urooncol Grp, Sao Paulo, Brazil; [Nesrallah, Adriano J.; Pontes-Junior, Jose; Nahas, William C.] ICESP, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Reis, ST (corresponding author), Univ Sao Paulo, Sch Med, Dept Urol, Lab Med Invest LIM55, Sao Paulo, Brazil.	sasareis@gmail.com	Pontes Junior, Jose/GOH-2262-2022; Antunes, Alberto Azoubel/AAT-2023-2020; Srougi, Miguel/AAT-8625-2021; Srougi, Miguel Srougi/AEV-2674-2022; Iscaife, Alexandre/I-8536-2012; LEITE, KATIA RM/C-2055-2008; Viana, Nayara I/P-6868-2015	Iscaife, Alexandre/0000-0001-6388-8228; LEITE, KATIA RM/0000-0002-2615-7730; Reis, Sabrina Thalita dos/0000-0002-3564-3597; Viana, Nayara/0000-0003-4505-8508	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [2012/19258-5]	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) under protocol number 2012/19258-5.	Baade PD, 2009, MOL NUTR FOOD RES, V53, P171, DOI 10.1002/mnfr.200700511; CARTER BS, 1993, J UROLOGY, V150, P797, DOI 10.1016/S0022-5347(17)35617-3; Cody NAL, 2009, MOL CARCINOGEN, V48, P1077, DOI 10.1002/mc.20535; Cussenot O, 1996, PATHOL BIOL, V44, P737; Du MJ, 2015, HUM MOL GENET, V24, P154, DOI 10.1093/hmg/ddu426; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Huang SP, 2009, CANCER EPIDEM BIOMAR, V18, P3068, DOI 10.1158/1055-9965.EPI-09-0665; Kote-Jarai Z, 2008, CANCER EPIDEM BIOMAR, V17, P2052, DOI 10.1158/1055-9965.EPI-08-0317; Liu H, 2011, PROSTATE, V71, P209, DOI 10.1002/pros.21235; MEIKLE AW, 1985, PROSTATE, V6, P121; Siegel RL, 2015, CA-CANCER J CLIN, V65, P457, DOI 10.3322/caac.21314; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Simard J, 2002, ENDOCRINOLOGY, V143, P2029, DOI 10.1210/en.143.6.2029; Smith JR, 1996, SCIENCE, V274, P1371, DOI 10.1126/science.274.5291.1371; SPITZ MR, 1991, J UROLOGY, V146, P1305, DOI 10.1016/S0022-5347(17)38074-6; STEINBERG GD, 1990, PROSTATE, V17, P337, DOI 10.1002/pros.2990170409; Teerlink CC, 2014, HUM GENET, V133, P347, DOI 10.1007/s00439-013-1384-2; Waters KM, 2009, CANCER EPIDEM BIOMAR, V18, P1285, DOI 10.1158/1055-9965.EPI-08-1142; Zhang YR, 2012, ASIAN PAC J CANCER P, V13, P6273, DOI 10.7314/APJCP.2012.13.12.6273; Zheng SL, 2008, NEW ENGL J MED, V358, P910, DOI 10.1056/NEJMoa075819; Zhou Lin, 2011, Zhonghua Nan Ke Xue, V17, P682	21	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166380	10.1371/journal.pone.0166380	http://dx.doi.org/10.1371/journal.pone.0166380			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27906997	gold, Green Published, Green Submitted			2022-12-26	WOS:000389482700024
J	Rosso, OA; Ospina, R; Frery, AC				Rosso, Osvaldo A.; Ospina, Raydonal; Frery, Alejandro C.			Classification and Verification of Handwritten Signatures with Time Causal Information Theory Quantifiers	PLOS ONE			English	Article							COMPLEX NETWORK; DIVERGENCE; ENTROPY; SERIES; STATE	We present a new approach for handwritten signature classification and verification based on descriptors stemming from time causal information theory. The proposal uses the Shannon entropy, the statistical complexity, and the Fisher information evaluated over the Bandt and Pompe symbolization of the horizontal and vertical coordinates of signatures. These six features are easy and fast to compute, and they are the input to an One-Class Support Vector Machine classifier. The results are better than state-of-the-art online techniques that employ higher-dimensional feature spaces which often require specialized software and hardware. We assess the consistency of our proposal with respect to the size of the training sample, and we also use it to classify the signatures into meaningful groups.	[Rosso, Osvaldo A.] Univ Fed Alagoas UFAL, Inst Fis, Maceio, AL, Brazil; [Rosso, Osvaldo A.] ITBA, Buenos Aires, DF, Argentina; [Rosso, Osvaldo A.] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina; [Rosso, Osvaldo A.] Univ Los Andes, Fac Ingn & Ciencias Aplicadas, Santiago, Chile; [Ospina, Raydonal] Univ Fed Pernambuco UFPE, Dept Estatist, Ctr Ciencias Exatas & Nat, Recife, PE, Brazil; [Frery, Alejandro C.] Univ Fed Alagoas UFAL, Lab Comp Cient & Anal Numer, Maceio, AL, Brazil	Universidade Federal de Alagoas; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad de los Andes - Chile; Universidade Federal de Pernambuco; Universidade Federal de Alagoas	Rosso, OA (corresponding author), Univ Fed Alagoas UFAL, Inst Fis, Maceio, AL, Brazil.; Rosso, OA (corresponding author), ITBA, Buenos Aires, DF, Argentina.; Rosso, OA (corresponding author), Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina.; Rosso, OA (corresponding author), Univ Los Andes, Fac Ingn & Ciencias Aplicadas, Santiago, Chile.	oarosso@gmail.com	Ospina, Raydonal/I-8878-2012; Frery, Alejandro C./A-8855-2008; Rosso, Osvaldo/O-4929-2019	Ospina, Raydonal/0000-0002-9884-9090; Frery, Alejandro C./0000-0002-8002-5341; Rosso, Osvaldo/0000-0002-1288-2528	CONICET (Argentina); CNPq (Brazil) [447229/2014-1]; FACEPE (Brazil)	CONICET (Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); CNPq (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FACEPE (Brazil)(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE))	The authors are grateful to CONICET (Argentina, OAR), CNPq (447229/2014-1, Brazil, ACF) and FACEPE (Brazil, RO) for partial funding of this research. No individuals employed or contracted by the funders (other than the named authors) played any role in: study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.; The authors are grateful to CONICET (Argentina), CNPq and FACEPE (Brazil) for partial funding of this research. The Biometrics Research Lab (ATVS), Universidad Autonoma de Madrid, provided the MCYT-100 signature corpus employed in this work.	Bandt C, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.174102; BARON R, 1989, IEEE T INSTRUM MEAS, V38, P1132, DOI 10.1109/19.46414; Bohner M., 2009, P 14 INT C DIFF EQ A, P291; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; Bouletreau V, 1998, INT C PATT RECOG, P1758, DOI 10.1109/ICPR.1998.712067; Campbell C., 2011, SYNTH, V5, P1, DOI [10.2200/S00324ED1V01Y201102AIM010, DOI 10.2200/S00324ED1V01Y201102AIM010]; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cherkassky V, 1997, IEEE Trans Neural Netw, V8, P1564, DOI 10.1109/TNN.1997.641482; El-Henawy I., 2013, INT J COMPUT TECHNOL, V4, P664; Fierrez J, 2007, PATTERN RECOGN LETT, V28, P2325, DOI 10.1016/j.patrec.2007.07.012; Fierrez-Aguilar J, 2005, LECT NOTES COMPUT SC, V3546, P523; Gao ZK, 2016, CHEM ENG J, V291, P74, DOI 10.1016/j.cej.2016.01.039; Gao ZK, 2015, EPL-EUROPHYS LETT, V109, DOI 10.1209/0295-5075/109/30005; Gao ZK, 2015, SCI REP-UK, V5, DOI 10.1038/srep08222; Gao ZK, 2015, EXP THERM FLUID SCI, V60, P157, DOI 10.1016/j.expthermflusci.2014.09.008; Gao ZK, 2012, NONLINEAR ANAL-REAL, V13, P947, DOI 10.1016/j.nonrwa.2011.08.029; Garcia-Salicetti S, 2009, GUIDE BIOMETRIC REFE, P125; Ravetti MG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108004; Goncalves BA, 2016, PHYSICA A IN PRESS; Grosse I, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041905; HILTON O, 1992, J FORENSIC SCI, V37, P125; Hlavackova-Schindler K, 2007, PHYS REP, V441, P1, DOI 10.1016/j.physrep.2006.12.004; Houmani N., 2014, SIGNAL IMAGE PROCESS, P255, DOI [10.1007/978-3-642-54080-6_10, DOI 10.1007/978-3-642-54080-6_10]; Impedovo D, 2008, IEEE T SYST MAN CY C, V38, P609, DOI 10.1109/TSMCC.2008.923866; Leclerc F., 1994, International Journal of Pattern Recognition and Artificial Intelligence, V8, P643, DOI 10.1142/S0218001494000346; LIN JH, 1991, IEEE T INFORM THEORY, V37, P145, DOI 10.1109/18.61115; Longstaff MG, 1999, HUM MOVEMENT SCI, V18, P485, DOI 10.1016/S0167-9457(99)00028-7; McCabe A., 1997, REV DYNAMIC HANDWRIT; Nalwa VS, 1997, P IEEE, V85, P215, DOI 10.1109/5.554220; Ortega-Garcia J, 2004, IEEE SIGNAL PROC MAG, V21, P50, DOI 10.1109/MSP.2004.1276113; Ortega-Garcia J, 2003, IEE P-VIS IMAGE SIGN, V150, P395, DOI 10.1049/ip-vis:20031078; Pascual-Gaspar JM, 2009, LECT NOTES COMPUT SC, V5558, P1180, DOI 10.1007/978-3-642-01793-3_119; PLAMONDON R, 1989, PATTERN RECOGN, V22, P107, DOI 10.1016/0031-3203(89)90059-9; Re MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093532; Richards J. A., 2006, REMOTE SENSING DIGIT, P439, DOI DOI 10.1007/3-540-29711-1; Rosso OA, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.154102; Rosso OA, 2015, PAP PHYS-LA PLATA, V7, DOI 10.4279/PIP.070006; Sanchez-Moreno P, 2012, J PHYS A-MATH THEOR, V45, DOI 10.1088/1751-8113/45/12/125305; Schieber TA, 2016, PHYS LETT A, V380, P359, DOI 10.1016/j.physleta.2015.10.055; VANDERGON JJ, 1965, KYBERNETIK, V2, P145; Vincent N, 2000, FRACTALS, V8, P85, DOI 10.1142/S0218348X0000010X; Zhang LP, 2016, IEEE GEOSC REM SEN M, V4, P22, DOI 10.1109/MGRS.2016.2540798; Zunino L, 2015, EPL-EUROPHYS LETT, V109, DOI 10.1209/0295-5075/109/10005	43	21	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166868	10.1371/journal.pone.0166868	http://dx.doi.org/10.1371/journal.pone.0166868			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907014	gold, Green Published, Green Submitted			2022-12-26	WOS:000389482700046
J	Roszko, ML; Karninska, M; Szymczyk, K; Jedrzejczak, R				Roszko, Marek Lukasz; Karninska, Marta; Szymczyk, Krystyna; Jedrzejczak, Renata			Levels of Selected Persistent Organic Pollutants (PCB, PBDE) and Pesticides in Honey Bee Pollen Sampled in Poland	PLOS ONE			English	Article							POLYBROMINATED DIPHENYL ETHERS; NEONICOTINOID INSECTICIDES; APIS-MELLIFERA; POLYCHLORINATED-BIPHENYLS; GAS-CHROMATOGRAPHY; ORGANOCHLORINE PESTICIDES; EXPOSURE; RESIDUES; COLONY; IMPACT	Chemical plant protection is a commonly discussed factor potentially responsible for decline in pollinators and other beneficial insect populations. Various groups of chemicals including persistent organic pollutants could impact a bee colony's welfare and are reported to be present in bee tissue and apiary products. The aim of this work was to evaluate the presence of selected persistent organic pollutant and pesticide residues in bee pollen originating from different geographical regions of Poland. Pesticide residues were identified in 60% of tested bee pollen samples. The compounds identified were mainly active ingredients of fungicide preparations. Insecticide active ingredients were up to 30% of the identified residues. The triazole fungicide tebuconazole and the neonicotinoid insecticide thiacloprid were the most frequently found pesticides in pollen. The highest pesticide concentration was determined for prothioconazole (356 mu g kg(-1)). Mean concentrations of chlorinated biphenyls-EC6 and EC12 were 194 pg g(-1) and 74 pg g(-1), respectively. CB #28 has the greatest share in the EC6 profile (mean 61 pg g(-1), 31% contribution). Relatively high contributions were also observed for CBs # 101 (35 pg g(-1), 18%), # 138 (36 pg g(-1), 19%) and # 153 (33 pg g(-1), 17%). CB # 114 and 118 have the highest share in the dioxin-like biphenyls fraction with mean concentrations of 17.6 and 37.6 pg g(-1) (respectively 23 and 50%). Mean calculated concentrations of 39 polybrominated diphenyl ether congeners (S39 BDE) were 20 +/- 27.7 pg g(-1). High variability was observed between maximal and minimal determined concentration values. Individual BDEs were found at different frequencies and varying concentration levels. BDEs # 47, 75 and 99 dominated the profile with average concentrations of 3 pg g(-1), 3.1 pg g(-1), and 2.9 pg g(-1), respectively.	[Roszko, Marek Lukasz; Karninska, Marta; Szymczyk, Krystyna; Jedrzejczak, Renata] Inst Agr & Food Biotechnol, Dept Food Anal, Warsaw, Poland	Warsaw University of Life Sciences	Roszko, ML (corresponding author), Inst Agr & Food Biotechnol, Dept Food Anal, Warsaw, Poland.	roszko@ibprs.pl	Serrano, Jose/A-2854-2009	Serrano, Jose/0000-0002-1565-5216; Szymczyk, Krystyna/0000-0001-6486-2660; Roszko, Marek/0000-0003-1848-2100				[Anonymous], 2013, SCIENCE, V340, P924, DOI 10.1126/science.340.6135.924-a; [Anonymous], 2013, OFFICIAL J EUROPEAN, V139, P12; [Anonymous], 2005, OFF J EUR UNION L, V70, P1; Balayannis PG, 2001, J APICULT RES, V40, P71, DOI 10.1080/00218839.2001.11101054; Balayiannis G, 2008, ARCH ENVIRON CON TOX, V55, P462, DOI 10.1007/s00244-007-9126-x; Bernal J, 2010, J ECON ENTOMOL, V103, P1964, DOI 10.1603/EC10235; Blacquiere T, 2012, ECOTOXICOLOGY, V21, P973, DOI 10.1007/s10646-012-0863-x; BROMENSHENK JJ, 1986, ENVIRON MONIT ASSESS, V6, P35, DOI 10.1007/BF00394286; Burkle LA, 2013, SCIENCE, V339, P1611, DOI 10.1126/science.1232728; Chauzat MP, 2006, J ECON ENTOMOL, V99, P253, DOI 10.1603/0022-0493-99.2.253; Codling G, 2016, CHEMOSPHERE, V144, P2321, DOI 10.1016/j.chemosphere.2015.10.135; CRAILSHEIM K, 1992, J INSECT PHYSIOL, V38, P409, DOI 10.1016/0022-1910(92)90117-V; Cutler GC, 2007, J ECON ENTOMOL, V100, P765, DOI 10.1603/0022-0493(2007)100[765:ETCSCH]2.0.CO;2; Cutler GC, 2014, PEST MANAG SCI, V70, P779, DOI 10.1002/ps.3613; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; DEVILLERS J, 2002, HONEY BEES ESTIMATIN; Eckert JE, 1942, J ECON ENTOMOL, V35, P309, DOI 10.1093/jee/35.3.309; Elliott JE, 2015, SCI TOTAL ENVIRON, V524, P157, DOI 10.1016/j.scitotenv.2015.04.008; EP European Parliament, 2012, EXISTING SCIENTIFIC; EPA Environmental Protection Agency Health Canada Pest Management Regulatory Agency California Department of Pesticide Regulation, 2014, GUIDANCE FOR ASSESSI; Erdogrul O, 2007, FOOD CONTROL, V18, P866, DOI 10.1016/j.foodcont.2006.05.001; Europe Parlament and Council of European Union, 2009, OFF J EUR UNION, V309, P1; Fairbrother A, 2014, ENVIRON TOXICOL CHEM, V33, P719, DOI 10.1002/etc.2527; Gekeler W, 2014, PORADNIK HODOWCY; Genersch E, 2010, APIDOLOGIE, V41, P332, DOI 10.1051/apido/2010014; Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585; Girolami V, 2012, J APPL ENTOMOL, V136, P17, DOI 10.1111/j.1439-0418.2011.01648.x; Giroud B, 2013, J CHROMATOGR A, V1316, P53, DOI 10.1016/j.chroma.2013.09.088; Goulson D, 2015, PEERJ, V3, DOI 10.7717/peerj.854; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Gregorc A, 2012, J INSECT PHYSIOL, V58, P1042, DOI 10.1016/j.jinsphys.2012.03.015; HC Health Canada, 2014, UPDATE ON NEONICOTIN; Herrera A, 2005, ANAL BIOANAL CHEM, V381, P695, DOI 10.1007/s00216-004-2924-3; Iwasa T, 2004, CROP PROT, V23, P371, DOI 10.1016/j.cropro.2003.08.018; Johnson RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054092; Jones-Otazo HA, 2005, ENVIRON SCI TECHNOL, V39, P5121, DOI 10.1021/es048267b; Kasiotis KM, 2014, SCI TOTAL ENVIRON, V485, P633, DOI 10.1016/j.scitotenv.2014.03.042; Krupke CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029268; Kujawski MW, 2012, EUR FOOD RES TECHNOL, V234, P223, DOI 10.1007/s00217-011-1635-1; Lambert O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067007; Maini S, 2010, B INSECTOL, V63, P153; Medrzycki P, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.4.14; Mohr S, 2014, SCI TOTAL ENVIRON, V472, P741, DOI 10.1016/j.scitotenv.2013.11.035; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Neumann P, 2010, J APICULT RES, V49, P1, DOI 10.3896/IBRA.1.49.1.01; Nguyen BK, 2009, J ECON ENTOMOL, V102, P616, DOI 10.1603/029.102.0220; Nuyttens D, 2013, PEST MANAG SCI, V69, P564, DOI 10.1002/ps.3485; OPERA, 2013, BEE HLTH GROUP BEE H; Perry CJ, 2015, P NATL ACAD SCI USA, V112, P3427, DOI 10.1073/pnas.1422089112; Pettis JS, 2012, NATURWISSENSCHAFTEN, V99, P153, DOI 10.1007/s00114-011-0881-1; Pochi D, 2012, B ENVIRON CONTAM TOX, V89, P354, DOI 10.1007/s00128-012-0664-1; Pohorecka K, 2012, J APIC SCI, V56, P115, DOI 10.2478/v10289-012-0029-3; Porrini C., 2003, APIACTA, V38, P63, DOI DOI 10.1080/10942912.2015.1107578; Raeymaekers B, 2006, ENVIRON MONIT ASSESS, V116, P233, DOI 10.1007/s10661-006-7389-8; Rennich K, 2013, 2011 2012 NATIONAL H; Rondeau G, 2014, SCI REP-UK, V4, DOI 10.1038/srep05566; Roszko M, 2013, FOOD ADDIT CONTAM A, V30, P181, DOI 10.1080/19440049.2012.721012; Roszko M, 2015, ENVIRON SCI POLLUT R, V22, P18381, DOI 10.1007/s11356-015-5065-7; Roszko M, 2015, TALANTA, V144, P171, DOI 10.1016/j.talanta.2015.04.070; Roszko M, 2014, SCI TOTAL ENVIRON, V466, P136, DOI [10.1015/j.scitotenv.2013.07.016, 10.1016/j.scitotenv.2013.07.016]; Roszko M, 2013, ANAL CHIM ACTA, V799, P88, DOI 10.1016/j.aca.2013.08.053; Sanchez-Bayo F, 2016, ENVIRON INT, V89-90, P7, DOI 10.1016/j.envint.2016.01.009; Sanchez-Bayo F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094482; Schmehl DR, 2014, J INSECT PHYSIOL, V71, P177, DOI 10.1016/j.jinsphys.2014.10.002; Schneider CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030023; Scott-Dupree CD, 2009, J ECON ENTOMOL, V102, P177, DOI 10.1603/029.102.0125; Sgolastra F, 2012, B INSECTOL, V65, P273; Simon-Delso N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103073; Stoner KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077550; Tasei JN, 2001, J ECON ENTOMOL, V94, P623, DOI 10.1603/0022-0493-94.3.623; Thompson H, 2013, FOOD AND ENVIRONMENT; Thompson HM, 2014, APIDOLOGIE, V45, P545, DOI 10.1007/s13592-014-0273-6; Tylianakis JM, 2013, SCIENCE, V339, P1532, DOI 10.1126/science.1235464; Wang J, 2010, FOOD RES INT, V43, P2329, DOI 10.1016/j.foodres.2010.08.006; Wang J, 2010, J AGR FOOD CHEM, V58, P3495, DOI 10.1021/jf904490g; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025; WHO World Health Organization, 2009, CHLORPYRIFOS; Williams GR, 2015, SCI REP-UK, V5, DOI 10.1038/srep14621; Williamson SM, 2013, J EXP BIOL, V216, P1799, DOI 10.1242/jeb.083931	79	37	37	3	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167487	10.1371/journal.pone.0167487	http://dx.doi.org/10.1371/journal.pone.0167487			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907097	Green Published, gold, Green Submitted			2022-12-26	WOS:000389482700167
J	Meehan, TD; Gratton, C				Meehan, Timothy D.; Gratton, Claudio			A Landscape View of Agricultural Insecticide Use across the Conterminous US from 1997 through 2012	PLOS ONE			English	Article							GEOGRAPHICALLY WEIGHTED REGRESSION; SPATIAL AUTOCORRELATION; NATURAL ENEMIES; SOYBEAN APHID; CROP PEST; SIMPLIFICATION; MODELS; BIODIVERSITY; MANAGEMENT; DIVERSITY	Simplification of agricultural landscapes is expected to have positive effects on many crop pests and negative effects on their natural enemies, potentially leading to increased pest pressure, decreased crop yield, and increased insecticide use. While many intermediate links in this causal chain have empirical support, there is mixed evidence for ultimate relationships between landscape simplification, crop yield, and insecticide use, especially at large spatial and temporal scales. We explored relationships between landscape simplification (proportion of a county in harvested cropland) and insecticide use (proportion of harvested cropland treated with insecticides), using county-level data from the US Census of Agriculture and a variety of standard and spatiotemporal regression techniques. The best model indicated that insecticide use across the US has increased between 1997 and 2012, was strongly dependent on the crops grown in a county, increased with average farm income and size, and increased with annual growing degree days. After accounting for those variables, and other unidentified spatial and temporal structure in the data, there remained a statistically significant, moderate, positive relationship between insecticide use and landscape simplification. These results lend general support to the causal chain outlined above, and to the notion that a landscape perspective is useful for managing ecosystem services that are provided by mobile organisms and valuable to agriculture.	[Meehan, Timothy D.] Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA; Univ Wisconsin, Great Lakes Bioenergy Res Ctr, Madison, WI USA; [Meehan, Timothy D.] Natl Audubon Soc, Div Sci, Boulder, CO 80302 USA	University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison	Meehan, TD (corresponding author), Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA.; Meehan, TD (corresponding author), Natl Audubon Soc, Div Sci, Boulder, CO 80302 USA.	tmeehan@audubon.org		Gratton, Claudio/0000-0001-6262-9670	US Department of Energy (DOE) Great Lakes Bioenergy Research Center (DOE BER Office of Science) [DE-FC02-07ER64494]; US DOE OBP Office of Energy and Renewable Energy [DE-AC05-76RL01830]	US Department of Energy (DOE) Great Lakes Bioenergy Research Center (DOE BER Office of Science)(United States Department of Energy (DOE)); US DOE OBP Office of Energy and Renewable Energy(United States Department of Energy (DOE))	This work was funded by the US Department of Energy (DOE) Great Lakes Bioenergy Research Center (DOE BER Office of Science DE-FC02-07ER64494) and by the US DOE OBP Office of Energy and Renewable Energy (DE-AC05-76RL01830). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136580; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Allen R. G., 1998, FAO Irrigation and Drainage Paper; Altieri M. A., 1984, REV PLANT SCI, V2, P131, DOI DOI 10.1080/07352688409382193; [Anonymous], 2014, R LANG ENV STAT COMP; Anselin L, 1998, STAT TEXTB MONOG, V155, P237; Anselin L., 1988, PAP REG SCI ASSOC, V65, P34, DOI 10.1111/j.1435-5597.1988.tb01155.x; Bahlai CA, 2010, ENVIRON ENTOMOL, V39, P50, DOI 10.1603/EN09127; Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x; Banerjee S., 2014, HIERARCHICAL MODELIN; Barton BT, 2014, ECOLOGY, V95, P1479, DOI 10.1890/13-1977.1; Beale CM, 2010, ECOL LETT, V13, P246, DOI 10.1111/j.1461-0248.2009.01422.x; Benbrook Charles M., 2012, Environmental Sciences Europe, V24, P24, DOI 10.1186/2190-4715-24-24; BESAG J, 1974, J ROY STAT SOC B MET, V36, P192; Bhar R., 1998, CONSERV ECOL, V2, P3; Bianchi FJJA, 2006, P ROY SOC B-BIOL SCI, V273, P1715, DOI 10.1098/rspb.2006.3530; Bianchi FJJA, 2005, AGR ECOSYST ENVIRON, V107, P145, DOI 10.1016/j.agee.2004.11.007; Blangiardo M, 2013, SPAT SPATIO-TEMPORAL, V7, P39, DOI [10.1016/j.sste.2013.07.003, 10.1016/j.sste.2012.12.001]; Brunsdon C, 1996, GEOGR ANAL, V28, P281, DOI 10.1111/j.1538-4632.1996.tb00936.x; Burnham K. P., 1998, MODEL SELECTION INFE; CAMMELL ME, 1992, ADV ECOL RES, V22, P117, DOI 10.1016/S0065-2504(08)60135-X; Chaplin-Kramer R, 2011, ECOL LETT, V14, P922, DOI 10.1111/j.1461-0248.2011.01642.x; Congdon P., 2014, APPL BAYESIAN MODELL; Dale M.R.T., 2014, SPATIAL ANAL GUIDE E; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Dormann CF, 2007, GLOBAL ECOL BIOGEOGR, V16, P129, DOI 10.1111/j.1466-8238.2006.00279.x; Ehler LE, 2006, PEST MANAG SCI, V62, P787, DOI 10.1002/ps.1247; Fausti SW, 2012, RENEW AGR FOOD SYST, V27, P295, DOI 10.1017/S1742170511000561; FLORAX R, 1992, REG SCI URBAN ECON, V22, P405, DOI 10.1016/0166-0462(92)90037-2; Franzese RJ, 2007, POLIT ANAL, V15, P140, DOI 10.1093/pan/mpm005; Gassmann AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022629; Gilman SE, 2010, TRENDS ECOL EVOL, V25, P325, DOI 10.1016/j.tree.2010.03.002; Gneiting T, 2007, J R STAT SOC B, V69, P243, DOI 10.1111/j.1467-9868.2007.00587.x; Heimpel GE, 2010, BIOL INVASIONS, V12, P2913, DOI 10.1007/s10530-010-9736-5; Jamieson MA, 2012, PLANT PHYSIOL, V160, P1719, DOI 10.1104/pp.112.206524; Kissling WD, 2008, GLOBAL ECOL BIOGEOGR, V17, P59, DOI 10.1111/j.1466-8238.2007.00334.x; Korner-Nievergelt F., 2015, BAYESIAN DATA ANAL E, DOI DOI 10.1007/S13398-014-0173-7.2; Kuminoff NV, 2010, J ENVIRON ECON MANAG, V60, P145, DOI 10.1016/j.jeem.2010.06.001; Landis DA, 2000, ANNU REV ENTOMOL, V45, P175, DOI 10.1146/annurev.ento.45.1.175; Larsen AE, 2015, ECOL APPL, V25, P1976, DOI 10.1890/14-1283.1; Larsen AE, 2013, P NATL ACAD SCI USA, V110, P15330, DOI 10.1073/pnas.1301900110; Leung Y, 2000, ENVIRON PLANN A, V32, P9, DOI 10.1068/a3162; Liere H, 2015, ECOL APPL, V25, P652, DOI 10.1890/14-0570.1; Lu YH, 2010, SCIENCE, V328, P1151, DOI 10.1126/science.1187881; Lunn D., 2012, BUGS BOOK PRACTICAL; Margosian ML, 2009, BIOSCIENCE, V59, P141, DOI 10.1525/bio.2009.59.2.7; Marino PC, 1996, ECOL APPL, V6, P276, DOI 10.2307/2269571; Martins TG, 2013, COMPUT STAT DATA AN, V67, P68, DOI 10.1016/j.csda.2013.04.014; McMaster GS, 1997, AGR FOREST METEOROL, V87, P291, DOI 10.1016/S0168-1923(97)00027-0; Meehan TD, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/11/114001; Meehan TD, 2011, P NATL ACAD SCI USA, V108, P11500, DOI 10.1073/pnas.1100751108; Norris RF, 2000, WEED SCI, V48, P94, DOI 10.1614/0043-1745(2000)048[0094:IBWAPA]2.0.CO;2; PRICE PW, 1994, INTRO INSECT PEST MA, P35; PRISM Climate Group, 2012, US PREC NORM 1981 20; RUE H., 2005, GAUSSIAN MARKOV RAND; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Rusch A, 2016, AGR ECOSYST ENVIRON, V221, P198, DOI 10.1016/j.agee.2016.01.039; Saas Y, 2014, ECOGRAPHY, V37, P476, DOI 10.1111/j.1600-0587.2013.00279.x; Sexton SE, 2007, INT REV ENVIRON RESO, V1, P270, DOI 10.1561/101.00000007; Simpson D, 2011, ARXIV11052982; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Tscharntke T, 2007, BIOL CONTROL, V43, P294, DOI 10.1016/j.biocontrol.2007.08.006; USDA CSREES, 2010, N CENTR REG SOYB APH; USDA-NASS, 2007, CENS AGR; Van Buskirk J, 2004, CONSERV BIOL, V18, P987, DOI 10.1111/j.1523-1739.2004.00359.x; Veres A, 2013, AGR ECOSYST ENVIRON, V166, P110, DOI 10.1016/j.agee.2011.05.027; Waller L.A., 2004, APPL SPATIAL STAT PU; Waller LA, 2007, STOCH ENV RES RISK A, V21, P573, DOI 10.1007/s00477-007-0139-9; Werling BP, 2011, GCB BIOENERGY, V3, P347, DOI 10.1111/j.1757-1707.2011.01092.x; Yang W. R., 2015, Journal of Agricultural Science (Toronto), V7, P1	70	27	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0166724	10.1371/journal.pone.0166724	http://dx.doi.org/10.1371/journal.pone.0166724			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FV	27902726	Green Published, gold, Green Submitted			2022-12-26	WOS:000389474100034
J	Siddiqui, S; Schwarz, F; Springer, S; Khedri, Z; Yu, H; Deng, LQ; Verhagen, A; Naito-Matsui, Y; Jiang, WP; Kim, D; Zhou, J; Ding, BB; Chen, X; Varki, N; Varki, A				Siddiqui, Shoib; Schwarz, Flavio; Springer, Stevan; Khedri, Zahra; Yu, Hai; Deng, Lingquan; Verhagen, Andrea; Naito-Matsui, Yuko; Jiang, Weiping; Kim, Daniel; Zhou, Jie; Ding, Beibei; Chen, Xi; Varki, Nissi; Varki, Ajit			Studies on the Detection, Expression, Glycosylation, Dimerization, and Ligand Binding Properties of Mouse Siglec-E	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MSIGLEC-E; PROTEIN; CELLS; NEUTROPHIL; ROLES; CD22; RECOGNITION; ENGAGEMENT; RECEPTOR; LECTIN	CD33-related Siglecs are a family of proteins widely expressed on innate immune cells. Binding of sialylated glycans or other ligands triggers signals that inhibit or activate inflammation. Immunomodulation by Siglecs has been extensively studied, but relationships between structure and functions are poorly explored. Here we present new data relating to the structure and function of Siglec-E, the major CD33-related Siglec expressed on mouse neutrophils, monocytes, macrophages, and dendritic cells. Wegenerated nine new rat monoclonal antibodies specific to mouse Siglec-E, with no cross-reactivity to Siglec-F. Although all antibodies detected Siglec-E on transfected human HEK293T cells, only two reacted with mouse bone marrow neutrophils by flow cytometry and on spleen sections by immunohistochemistry. Moreover, whereas all antibodies recognized Siglec-E-Fc on immunoblots, binding was dependent on intact disulfide bonds and N-glycans, and only two antibodies recognized native Siglec-E within spleen lysates. Thus, we further investigated the impact of Siglec-E homodimerization. Homology-based structural modeling predicted a cysteine residue (Cys-298) in position to form a disulfide bridge between two Siglec-E polypeptides. Mutagenesis of Cys-298 confirmed its role in dimerization. In keeping with the high level of 9-O-acetylation found in mice, sialoglycan array studies indicate that this modification has complex effects on recognition by Siglec-E, in relationship to the underlying structures. However, we found no differences in phosphorylation or SHP-1 recruitment between dimeric and monomeric Siglec-E expressed on HEK293A cells. Phylogenomic analyses predicted that only some human and mouse Siglecs form disulfide-linked dimers. Notably, Siglec-9,	[Siddiqui, Shoib; Schwarz, Flavio; Springer, Stevan; Khedri, Zahra; Deng, Lingquan; Verhagen, Andrea; Naito-Matsui, Yuko; Varki, Nissi; Varki, Ajit] Univ Calif San Diego, Dept Med, GRTC, La Jolla, CA 92093 USA; [Siddiqui, Shoib; Schwarz, Flavio; Springer, Stevan; Khedri, Zahra; Deng, Lingquan; Verhagen, Andrea; Naito-Matsui, Yuko; Varki, Nissi; Varki, Ajit] Univ Calif San Diego, Dept Cellular & Mol Med, GRTC, La Jolla, CA 92093 USA; [Yu, Hai; Chen, Xi] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; [Jiang, Weiping; Kim, Daniel; Zhou, Jie; Ding, Beibei] BioLegend Inc, San Diego, CA 92121 USA; [Schwarz, Flavio] DE Res & Technol Ctr, 200 Gbc Dr, Newark, DE 19702 USA; [Deng, Lingquan] GlycoMimetics Inc, 9708 Med Ctr Dr, Rockville, MD 20850 USA; [Naito-Matsui, Yuko] Kobe Pharmaceut Univ, Higashinada Ku, 4-19-1 Motoyamakita, Kobe, Hyogo 6588558, Japan	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California Davis; Kobe Pharmaceutical University	Varki, A (corresponding author), Univ Calif San Diego, 9500 Gilman Dr, La Jolla, CA 92093 USA.	a1varki@ucsd.edu	chen, xi/GXH-3653-2022; Chen, Xi/H-1811-2018; Siddiqui, Shoib/M-7713-2017	Chen, Xi/0000-0002-3160-614X; Siddiqui, Shoib/0000-0002-7028-290X	National Institutes of Health [P01HL107150, R01GM32373]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032373] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P01HL107150 and R01GM32373 (to A. V.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ali SR, 2014, J EXP MED, V211, P1231, DOI 10.1084/jem.20131853; Angata T, 2006, FASEB J, V20, P1964, DOI 10.1096/fj.06-5800com; Boyd CR, 2009, J IMMUNOL, V183, P7703, DOI 10.4049/jimmunol.0902780; Carlin AF, 2009, J EXP MED, V206, P1691, DOI 10.1084/jem.20090691; Chang YC, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003846; Chen G., 2014, APPL INFORM, V1, P1, DOI DOI 10.7554/ELIFE.04066; Chen LY, 2003, HUM MOL GENET, V12, P2547, DOI 10.1093/hmg/ddg263; Claude J, 2013, J NEUROSCI, V33, P18270, DOI 10.1523/JNEUROSCI.2211-13.2013; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; Cornish AL, 1998, BLOOD, V92, P2123, DOI 10.1182/blood.V92.6.2123.418k20_2123_2132; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Deng LQ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004540; DULAC C, 1992, NEURON, V8, P323, DOI 10.1016/0896-6273(92)90298-R; Erdmann H, 2009, CELL MICROBIOL, V11, P1600, DOI 10.1111/j.1462-5822.2009.01350.x; Floyd H, 2000, J BIOL CHEM, V275, P861, DOI 10.1074/jbc.275.2.861; Hamerman JA, 2009, IMMUNOL REV, V232, P42, DOI 10.1111/j.1600-065X.2009.00841.x; Han S, 2005, NAT CHEM BIOL, V1, P93, DOI 10.1038/nchembio713; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; KOJIMA N, 1994, J BIOL CHEM, V269, P30451; Laubli H, 2014, P NATL ACAD SCI USA, V111, P14211, DOI 10.1073/pnas.1409580111; Macauley MS, 2014, NAT REV IMMUNOL, V14, P653, DOI 10.1038/nri3737; McMillan SJ, 2013, BLOOD, V121, P2084, DOI 10.1182/blood-2012-08-449983; Nicoll G, 1999, J BIOL CHEM, V274, P34089, DOI 10.1074/jbc.274.48.34089; POWELL LD, 1995, J BIOL CHEM, V270, P7523, DOI 10.1074/jbc.270.13.7523; POWELL LD, 1995, J BIOL CHEM, V270, P14243, DOI 10.1074/jbc.270.24.14243; Razi N, 1999, GLYCOBIOLOGY, V9, P1225, DOI 10.1093/glycob/9.11.1225; Schnaar RL, 2016, J LEUKOCYTE BIOL, V99, P825, DOI 10.1189/jlb.3RI0116-021R; Schwarz F, 2015, ELIFE, V4, DOI 10.7554/eLife.06184; Schwarz F, 2015, ADV EXP MED BIOL, V842, P1, DOI 10.1007/978-3-319-11280-0_1; Spence S, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab3459; Varki A., 2009, ESSENTIALS GLYCOBIOL, P459; Yu ZB, 2001, BIOCHEM J, V353, P483, DOI 10.1042/0264-6021:3530483; Zhang JQQ, 2004, EUR J IMMUNOL, V34, P1175, DOI 10.1002/eji.200324723; Zhang M, 2004, GLYCOBIOLOGY, V14, P939, DOI 10.1093/glycob/cwh126; Zhuravleva MA, 2008, J MOL BIOL, V375, P437, DOI 10.1016/j.jmb.2007.10.009	35	17	18	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2017	292	3					1029	1037		10.1074/jbc.M116.738351	http://dx.doi.org/10.1074/jbc.M116.738351			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2LL	27920204	Green Published, hybrid			2022-12-26	WOS:000392318700022
J	Yagita, Y; Shinohara, K; Abe, Y; Nakagawa, K; Al-Owain, M; Alkuraya, FS; Fujiki, Y				Yagita, Yuichi; Shinohara, Kyoko; Abe, Yuichi; Nakagawa, Keiko; Al-Owain, Mohammed; Alkuraya, Fowzan S.; Fujiki, Yukio			Deficiency of a Retinal Dystrophy Protein, Acyl-CoA Binding Domain-containing 5 (ACBD5), Impairs Peroxisomal beta-Oxidation of Very-long-chain Fatty Acids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-LINKED ADRENOLEUKODYSTROPHY; OVARY CELL MUTANTS; DOCOSAHEXAENOIC ACID; ZELLWEGER-SYNDROME; LIGAND-BINDING; DIPOLYUNSATURATED PHOSPHATIDYLCHOLINES; COMPLEMENTATION GROUP; MACULAR DYSTROPHY; VERTEBRATE RETINA; ABC TRANSPORTERS	Acyl-CoA binding domain-containing 5 (ACBD5) is a peroxisomal protein that carries an acyl-CoA binding domain (ACBD) at its N-terminal region. The recent identification of a mutation in the ACBD5 gene in patients with a syndromic form of retinal dystrophy highlights the physiological importance of ACBD5 in humans. However, the underlying pathogenic mechanisms and the precise function of ACBD5 remain unclear. We herein report that ACBD5 is a peroxisomal tail-anchored membrane protein exposing its ACBD to the cytosol. Using patient-derived fibroblasts and ACBD5 knock-out HeLa cells generated via genome editing, we demonstrate that ACBD5 deficiency causes a moderate but significant defect in peroxisomal beta-oxidation of very-long-chain fatty acids (VLCFAs) and elevates the level of cellular phospholipids containing VLCFAs without affecting peroxisome biogenesis, including the import of membrane and matrix proteins. Both the N-terminal ACBD and peroxisomal localization of ACBD5 are prerequisite for efficient VLCFA beta-oxidation in peroxisomes. Furthermore, ACBD5 preferentially binds very-long-chain fatty acyl-CoAs (VLC-CoAs). Together, these results suggest a direct role of ACBD5 in peroxisomal VLCFA beta-oxidation. Based on our findings, we propose that ACBD5 captures VLC-CoAs on the cytosolic side of the peroxisomal membrane so that the transport of VLC-CoAs into peroxisomes and subsequent beta-oxidation thereof can proceed efficiently. Our study reclassifies ACBD5-related phenotype as a novel peroxisomal disorder.	[Yagita, Yuichi; Shinohara, Kyoko; Nakagawa, Keiko] Kyushu Univ, Dept Biol, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan; [Yagita, Yuichi; Shinohara, Kyoko; Nakagawa, Keiko] Kyushu Univ, Grad Sch Syst Life Sci, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan; [Abe, Yuichi; Fujiki, Yukio] Kyushu Univ, Med Inst Bioregulat, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan; [Al-Owain, Mohammed; Alkuraya, Fowzan S.] King Faisal Specialist Hosp & Res Ctr, MBC 03 POB 3354, Riyadh 11211, Saudi Arabia	Kyushu University; Kyushu University; Kyushu University; King Faisal Specialist Hospital & Research Center	Fujiki, Y (corresponding author), Kyushu Univ, Med Inst Bioregulat, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	yfujiki@kyudai.jp			Kyushu University Interdisciplinary Programs in Education and Projects in Research Development; King Salman Center for Disability Research; Takeda Science Foundation; Naito Foundation; Japan Foundation for Applied Enzymology;  [24247038];  [25112518];  [25116717];  [26116007];  [15K14511];  [15K21743]; Grants-in-Aid for Scientific Research [15K14511] Funding Source: KAKEN	Kyushu University Interdisciplinary Programs in Education and Projects in Research Development; King Salman Center for Disability Research; Takeda Science Foundation(Takeda Science Foundation (TSF)); Naito Foundation(Naito Memorial Foundation); Japan Foundation for Applied Enzymology; ; ; ; ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid for Scientific Research 24247038, 25112518, 25116717, 26116007, 15K14511, and 15K21743 (to Y. F.); Kyushu University Interdisciplinary Programs in Education and Projects in Research Development (to Y. Y.); a grant from the King Salman Center for Disability Research grant (to F. S. A.); and grants from the Takeda Science Foundation, the Naito Foundation, and Japan Foundation for Applied Enzymology (to Y. F.). The authors declare that they have no conflicts of interest with the contents of this article.	Abe Y, 2014, BBA-MOL CELL BIOL L, V1841, P610, DOI 10.1016/j.bbalip.2014.01.001; Abu-Safieh L, 2013, GENOME RES, V23, P236, DOI 10.1101/gr.144105.112; Agbaga MP, 2010, J LIPID RES, V51, P1624, DOI 10.1194/jlr.R005025; Augoff K, 2010, ACTA BIOCHIM POL, V57, P533; AVELDANO MI, 1987, J BIOL CHEM, V262, P1180; AVELDANO MI, 1983, J LIPID RES, V24, P620; AVELDANO MI, 1987, J BIOL CHEM, V262, P1172; Bazan NG, 2007, INVEST OPHTH VIS SCI, V48, P4866, DOI 10.1167/iovs.07-0918; Berger J, 2016, BBA-MOL CELL RES, V1863, P934, DOI 10.1016/j.bbamcr.2015.12.005; Bernstein PS, 2001, INVEST OPHTH VIS SCI, V42, P3331; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Borgese N, 2007, CURR OPIN CELL BIOL, V19, P368, DOI 10.1016/j.ceb.2007.04.019; Braverman NE, 2012, BBA-MOL BASIS DIS, V1822, P1442, DOI 10.1016/j.bbadis.2012.05.008; Burton M, 2005, BIOCHEM J, V392, P299, DOI 10.1042/BJ20050664; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Faergeman NJ, 2007, MOL CELL BIOCHEM, V299, P55, DOI 10.1007/s11010-005-9040-3; Faergeman NJ, 1996, BIOCHEMISTRY-US, V35, P14118, DOI 10.1021/bi960545z; Fan JJ, 2010, PROG LIPID RES, V49, P218, DOI 10.1016/j.plipres.2009.12.003; Ferdinandusse S, 2006, ANN NEUROL, V59, P92, DOI 10.1002/ana.20702; Ferdinandusse S, 2001, J LIPID RES, V42, P1987; Ferdinandusse S, 2007, HUM MUTAT, V28, P904, DOI 10.1002/humu.20535; FLIESLER SJ, 1983, PROG LIPID RES, V22, P79; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Fujiki Y, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00307; Gaigg B, 2001, MOL BIOL CELL, V12, P1147, DOI 10.1091/mbc.12.4.1147; Harkewicz R, 2012, J BIOL CHEM, V287, P11469, DOI 10.1074/jbc.M111.256073; Honsho M, 2008, BBA-MOL CELL RES, V1783, P1857, DOI 10.1016/j.bbamcr.2008.05.018; Itoyama A, 2012, J CELL SCI, V125, P589, DOI 10.1242/jcs.087452; Kemp S, 2001, HUM MUTAT, V18, P499, DOI 10.1002/humu.1227; Kikuchi M, 2004, J BIOL CHEM, V279, P421, DOI 10.1074/jbc.M305623200; Kinoshita N, 1998, J BIOL CHEM, V273, P24122, DOI 10.1074/jbc.273.37.24122; Kutay Ulrike, 1993, Trends in Cell Biology, V3, P72, DOI 10.1016/0962-8924(93)90066-A; MARTINEZ M, 1992, BRAIN RES, V583, P171, DOI 10.1016/S0006-8993(10)80021-6; MARTINEZ M, 1989, LIPIDS, V24, P261, DOI 10.1007/BF02535160; Morita M, 2012, BBA-MOL BASIS DIS, V1822, P1387, DOI 10.1016/j.bbadis.2012.02.009; MOSSER J, 1993, NATURE, V361, P726, DOI 10.1038/361726a0; Mukai S, 2002, J BIOL CHEM, V277, P9548, DOI 10.1074/jbc.M108635200; Mukai S, 2006, J BIOL CHEM, V281, P37311, DOI 10.1074/jbc.M607178200; Nazarko TY, 2014, AUTOPHAGY, V10, P1348, DOI 10.4161/auto.29073; Nazarko TY, 2014, J CELL BIOL, V204, P541, DOI 10.1083/jcb.201307050; Neess D, 2015, PROG LIPID RES, V59, P1, DOI 10.1016/j.plipres.2015.04.001; Netik A, 1999, HUM MOL GENET, V8, P907, DOI 10.1093/hmg/8.5.907; Neuringer M, 2003, J PEDIATR-US, V143, pS87, DOI 10.1067/S0022-3476(03)00406-2; Okumoto K, 1998, HUM MOL GENET, V7, P1399, DOI 10.1093/hmg/7.9.1399; Otera H, 2000, J BIOL CHEM, V275, P21703, DOI 10.1074/jbc.M000720200; Otera H, 1998, MOL CELL BIOL, V18, P388, DOI 10.1128/MCB.18.1.388; POLLTHE BT, 1988, AM J HUM GENET, V42, P422; RASMUSSEN JT, 1990, BIOCHEM J, V265, P849, DOI 10.1042/bj2650849; ROSENDAL J, 1993, BIOCHEM J, V290, P321, DOI 10.1042/bj2900321; SanGiovanni JP, 2005, PROG RETIN EYE RES, V24, P87, DOI 10.1016/j.preteyeres.2004.06.002; Shimizu N, 1999, J BIOL CHEM, V274, P12593, DOI 10.1074/jbc.274.18.12593; SHIMOZAWA N, 1992, J CLIN INVEST, V90, P1864, DOI 10.1172/JCI116063; Shimozawa N, 2011, BRAIN DEV-JPN, V33, P770, DOI 10.1016/j.braindev.2011.03.004; Smith KD, 1999, NEUROCHEM RES, V24, P521, DOI 10.1023/A:1022535930009; Soupene E, 2015, J LIPID RES, V56, P1961, DOI 10.1194/jlr.M061937; Suzuki Y, 1997, AM J HUM GENET, V61, P1153, DOI 10.1086/301599; SUZUKI Y, 1991, BIOCHEM PHARMACOL, V41, P453, DOI 10.1016/0006-2952(91)90544-F; TSUKAMOTO T, 1990, J CELL BIOL, V110, P651, DOI 10.1083/jcb.110.3.651; Wanders RJA, 2004, AM J MED GENET A, V126A, P355, DOI 10.1002/ajmg.a.20661; WANDERS RJA, 1992, J INHERIT METAB DIS, V15, P389, DOI 10.1007/BF02435984; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; Wanders RJA, 2014, BIOCHIMIE, V98, P36, DOI 10.1016/j.biochi.2013.08.022; Waterham HR, 2016, BBA-MOL CELL RES, V1863, P922, DOI 10.1016/j.bbamcr.2015.11.015; Weller S, 2003, ANNU REV GENOM HUM G, V4, P165, DOI 10.1146/annurev.genom.4.070802.110424; Wiese S, 2007, MOL CELL PROTEOMICS, V6, P2045, DOI 10.1074/mcp.M700169-MCP200; Wiesinger C, 2013, J BIOL CHEM, V288, P19269, DOI 10.1074/jbc.M112.445445; Xiao S, 2011, PROG LIPID RES, V50, P141, DOI 10.1016/j.plipres.2010.11.002; Yagita Y, 2013, J CELL BIOL, V200, P651, DOI 10.1083/jcb.201211077; Zhang K, 2001, NAT GENET, V27, P89, DOI 10.1038/83817	69	54	54	3	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2017	292	2					691	705		10.1074/jbc.M116.760090	http://dx.doi.org/10.1074/jbc.M116.760090			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2KN	27899449	Green Published, hybrid			2022-12-26	WOS:000392316100024
J	Chen, H; Zhu, WJ; Lu, J; Fan, JQ; Sun, LN; Feng, XK; Liu, H; Zhang, ZH; Wang, YQ				Chen, Huan; Zhu, Weijian; Lu, Jing; Fan, Jinqing; Sun, Luning; Feng, Xiaoke; Liu, Hao; Zhang, Zhaohui; Wang, Yongqing			The Effects of Auricular Electro-Acupuncture on Ameliorating the Dysfunction of Interstitial Cells of Cajal Networks and nNOSmRNA Expression in Antrum of STZ-Induced Diabetic Rats	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; AUTONOMIC NEUROPATHY; ACUPUNCTURE; MECHANISMS; MOTILITY; MUSCLE; GASTROPARESIS; LOCALIZATION; PATHWAY	Backgroud Interstitial cells of Cajal (ICCs) and nNOS play a crucial role in diabetic gastrointestinal dysmotility(DGD). Our previous study found that electro-acupuncture(EA) on ear point 'stomach' could repair the gastric dysrhythmias in rats induced by rectal distention(RD) after meal. However, little were known about the possible effect of auricular electro-acupuncture (AEA) on diabetic rats. Thus, we designed this study to investigate the effect of AEA on streptozotocin(STZ)-induced diabetic rats. Method Forty male Sprague_Dawley (SD) rats were injected with STZ, at the end of 8th week after injection, animals were randomly divided into four groups and received 2 weeks-treatment (10 times) respectively: control group(CON, n = 10, no stimulation), sham auricular electro-acupuncture group(SEA, n = 10, low frequency EA on earlobes), auricular eletro-acupuncture group(AEA, n = 10, low frequency EA on ear point 'stomach'), and ST-36 group(ST-36, n = 10, low frequency EA on ST-36). Gastrointestinal (GI) motility was measured by GI transit rate. ICCs(c-kit+ expression) in antrum were analyzed by Immunohistochemistry and western blotting. NO level in blood serum were detected by Griess Reagent, and nNOSmRNA expression in antrum were determined by Real-time PCR. Results GI transit rate and ICCs(c-kit+ expression) in antrum of AEA group have the tendency to increase compared with CON group, but had no statistics difference (P>0.05). nNOSmRNA expression in antrum of AEA group was dramatically increased compared with CON group (P = 0.037). Conclusions Low frequency EA on ear 'stomach' point could significantly up-regulate nNOS mRNA expression and ameliorate the ICCs networks partly in gastric antrum of STZ -induced diabetic rats, which may has benefits on regulating the GI motility.	[Chen, Huan; Zhu, Weijian; Lu, Jing; Fan, Jinqing; Zhang, Zhaohui] Nanjing Med Univ, Dept Acupuncture, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Sun, Luning; Wang, Yongqing] Nanjing Med Univ, Dept Pharm, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Feng, Xiaoke; Liu, Hao] Nanjing Med Univ, Dept Tradit Chinese Med, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Zhang, ZH (corresponding author), Nanjing Med Univ, Dept Acupuncture, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China.; Wang, YQ (corresponding author), Nanjing Med Univ, Dept Pharm, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China.	Z1356@126.com; wyqjsph@163.com	zhang, zh/GWV-4677-2022		Project of Jiangsu Province Bureau of Traditional Chinese Medicine [LZ13214 ZZ]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) [JX10231801]; National Natural Sciences Foundation of China [81503160, 8150150393]	Project of Jiangsu Province Bureau of Traditional Chinese Medicine; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	Financial support was received from the the Project of Jiangsu Province Bureau of Traditional Chinese Medicine (LZ13214 ZZ http://www.jstcm.gov.cn/), Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) (JX10231801 http://202.119.175.131/pages/xkmd.aspx?onetype=2), and the National Natural Sciences Foundation of China (81503160 LS & 8150150393 HC http://www.nsfc.gov.cn/).	AIMI Y, 1993, NEUROSCIENCE, V53, P553, DOI 10.1016/0306-4522(93)90220-A; Al-Sajee Dhuha, 2012, Sultan Qaboos Univ Med J, V12, P411; Al-Shboul OA, 2013, SAUDI J GASTROENTERO, V19, P3, DOI 10.4103/1319-3767.105909; Boulton AJM, 2005, DIABETES CARE, V28, P956, DOI 10.2337/diacare.28.4.956; BREDT DS, 1990, NATURE, V347, P768, DOI 10.1038/347768a0; Cellek S, 2003, DIABETES, V52, P2353, DOI 10.2337/diabetes.52.9.2353; Chen Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083904; Chen Y, 2013, AM J CHINESE MED, V41, P1233, DOI 10.1142/S0192415X13500833; Chrasekharan B., 2008, NEUROGASTROENT MOTIL, V19, P951; Deli G, 2013, NEUROENDOCRINOLOGY, V98, P267, DOI 10.1159/000358728; Du F, 2015, AM J PHYSIOL-REG I, V309, pR109, DOI 10.1152/ajpregu.00396.2014; Edwards JL, 2008, PHARMACOL THERAPEUT, V120, P1, DOI 10.1016/j.pharmthera.2008.05.005; Gangula PRR, 2011, DIGEST DIS SCI, V56, P2520, DOI 10.1007/s10620-011-1735-6; Gangula P. R. R., 2010, NEUROGASTROENT MOTIL, V22, P351; Gori L, 2007, EVID-BASED COMPL ALT, V4, P13, DOI 10.1093/ecam/nem106; Han LT, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/517931; He W, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/786839; Henry TR, 2002, NEUROLOGY, V59, pS3, DOI 10.1212/WNL.59.6_suppl_4.S3; Hou PW, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/495684; Joel P., 2007, AJP GASTROINTESTINAL, V292, P718; Kito Yoshihiko, 2011, Journal of Smooth Muscle Research, V47, P47; Kluppel M, 1998, DEV DYNAM, V211, P60; Komuro T, 1999, MICROSC RES TECHNIQ, V47, P267, DOI 10.1002/(SICI)1097-0029(19991115)47:4<267::AID-JEMT5>3.0.CO;2-O; Li G., 2015, ACUPUNCTURE MED J BR, V33; Li H, 2013, ACUPUNCT MED, V31, P57, DOI 10.1136/acupmed-2012-010173; Li H, 2015, WORLD J GASTROENTERO, V21, P8304, DOI 10.3748/wjg.v21.i27.8304; Li MK, 2010, J ALTERN COMPLEM MED, V16, P435, DOI 10.1089/acm.2009.0348; Li YQ, 2007, WORLD J GASTROENTERO, V13, P709, DOI 10.3748/wjg.v13.i5.709; Lu HL, 2014, WORLD J GASTROENTERO, V20, P4626, DOI 10.3748/wjg.v20.i16.4626; Mostafa RM, 2010, WORLD J GASTROENTERO, V16, P3239, DOI 10.3748/wjg.v16.i26.3239; Noguchi E, 2010, AUTON NEUROSCI-BASIC, V156, P15, DOI 10.1016/j.autneu.2010.06.010; O'Grady G, 2015, GASTROENTEROL CLIN N, V44, P169, DOI 10.1016/j.gtc.2014.11.013; Ordog T, 2008, NEUROGASTROENT MOTIL, V20, P8, DOI 10.1111/j.1365-2982.2007.01056.x; Oh JH, 2013, J NEUROGASTROENTEROL, V19, P18, DOI 10.5056/jnm.2013.19.1.18; Ordog T, 2000, DIABETES, V49, P1731, DOI 10.2337/diabetes.49.10.1731; Pop-Busui R, 2010, DIABETES CARE, V33, P434, DOI 10.2337/dc09-1294; Powley TL, 2012, NEUROGASTROENT MOTIL, V24, pe526, DOI 10.1111/nmo.12003; Powley TL, 2011, NEUROSCIENCE, V186, P188, DOI 10.1016/j.neuroscience.2011.04.036; Powley TL, 2016, J COMP NEUROL, V524, P713, DOI 10.1002/cne.23892; SATO A, 1993, NEUROSCI RES, V18, P53, DOI 10.1016/0168-0102(93)90105-Y; SCHMIDT RE, 1983, LAB INVEST, V49, P538; Spallone V, 2011, NUTR METAB CARDIOVAS, V21, P69, DOI 10.1016/j.numecd.2010.07.005; Takahashi T, 2003, J GASTROENTEROL, V38, P421, DOI 10.1007/s00535-003-1094-y; Tan YY, 2014, INT J CLIN EXP MED, V7, P4099; Tesfaye S, 2010, DIABETES CARE, V33, P2285, DOI 10.2337/dc10-1303; Ueshima S, 2014, BIOMED RES-TOKYO, V35, P251, DOI 10.2220/biomedres.35.251; Wang XY, 2009, NEUROGASTROENT MOTIL, V21, DOI 10.1111/j.1365-2982.2009.01336.x; Wang YG, 2007, CHINESE ACUPUNCTURE, V27; Wrzos HF, 1997, DIGEST DIS SCI, V42, P2106, DOI 10.1023/A:1018830820537; Yang ZK, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/276320; Yin JY, 2010, AM J PHYSIOL-GASTR L, V298, pG563, DOI 10.1152/ajpgi.00252.2009; Zhaohui Z., 2015, PLOS ONE, V10	53	2	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0166638	10.1371/journal.pone.0166638	http://dx.doi.org/10.1371/journal.pone.0166638			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930657	Green Published, gold, Green Submitted			2022-12-26	WOS:000389580900013
J	Nagpal, BN; Gupta, SK; Shamim, A; Vikram, K; Srivastava, A; Tuli, NR; Saxena, R; Singh, H; Singh, VP; Bhagat, VN; Yadav, NK; Valecha, N				Nagpal, B. N.; Gupta, Sanjeev Kumar; Shamim, Arshad; Vikram, Kumar; Srivastava, Aruna; Tuli, N. R.; Saxena, Rekha; Singh, Himmat; Singh, V. P.; Bhagat, V. N.; Yadav, N. K.; Valecha, Neena			Control of Aedes aegypti Breeding: A Novel Intervention for Prevention and Control of Dengue in an Endemic Zone of Delhi, India	PLOS ONE			English	Article							SOLID-WASTE MANAGEMENT; HEMORRHAGIC-FEVER; VECTORS; INDEXES; CITIES	Background and objective The study is based on hypothesis that whether continuous entomological surveillance of Ae. aegypti and simultaneous appropriate interventions in key containers during non-transmission (December -May) months would have any impact on breeding of Aedes and dengue cases during the following transmission months (June -November). The impact of the surveillance and intervention measures undertaken during non-transmission months were assessed by entomological indicators namely container index (CI), house index (HI), pupal index (PI) and breteau index (BI). Methods A total of 28 localities of West Zone of Delhi with persistent dengue endemicity were selected for the study. Out of these localities, 20 were included in study group while other 8 localities were in control group. IEC and various Aedes breeding control activities were carried out in study group in both non-transmission and transmission season whereas control group did not have any such interventions during non-transmission months as per guidelines of MCD. These activities were undertaken by a team of investigators from NIMR and SDMC, Delhi. In control group, investigators from NIMR carried out surveillance activity to monitor the breeding of Aedes mosquito in localities. Results Comparison of baseline data revealed that all indices in control and study group of localities were comparable and statistically non-significant (p>0.05). In both study and control groups, indices were calculated after pooling data on seasonal basis, i.e., transmission and non-transmission months for both years. The test of significance conducted on all the four indices, i.e., HI, PI, CI, and BI, revealed a significant difference (p<0.05) between the study group and control group during transmission and non-transmission months except in HI. Due to consistent intervention measures undertaken in non-transmission months in study group, reduction in CI, HI, BI and PI was observed 63%, 62%, 64% and 99% respectively during transmission months as compared to control group where increase of 59%, 102%, 73% and 71% respectively. As a result of reduction in larval indices, no dengue case (except one NS1) was observed in study group, whereas 38 dengue cases were observed in control group. Conclusion Through this pilot study, it is concluded that proper intervention in non-transmission season reduces vector density and subsequently dengue cases in transmission season-	[Nagpal, B. N.; Gupta, Sanjeev Kumar; Shamim, Arshad; Vikram, Kumar; Srivastava, Aruna; Saxena, Rekha; Singh, Himmat; Valecha, Neena] Natl Inst Malaria Res, New Delhi, India; [Tuli, N. R.; Bhagat, V. N.; Yadav, N. K.] Municipal Corp Delhi, Delhi, India; [Singh, V. P.] Minist Hlth & Family Welf, Dept Hlth Res, Delhi, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR)	Nagpal, BN (corresponding author), Natl Inst Malaria Res, New Delhi, India.	b_n_nagpal@hotmail.com	Singh, Himmat/J-3579-2014; Singh, Himmat/GWZ-4925-2022	Singh, Himmat/0000-0001-7682-651X; Gupta, Sanjeev/0000-0002-2014-5333	Indian Council of Medical Research (Vector Science Forum); Indian Council of Medical Research	Indian Council of Medical Research (Vector Science Forum); Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	Indian Council of Medical Research (Vector Science Forum).; Authors are thankful to vector science forum of Indian Council of Medical Research for funding of study. We are also thankful to MCD for assisting in study sites selection and also in conducting control activities. We thank the entire field staff for their constant support in surveillance, control and providing health education to community. Acknowledgment is also due to Mr. Mrityunjay Prasad and Ms Ashoo Sharma for data management. Institute Publication Committee is acknowledged for giving consent for publication of manuscript vide Approval No. 003/2016.	Balakrishnan N, 2006, J Commun Dis, V38, P164; Bhoyar RV., 1996, J IAEM, V23, P53; Centers for Disease Control and Prevention, 2012, DENG AED ALB MOSQ; Chang FS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004043; Chareonviriyaphap Theeraphap, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P529; Dutta P, 1999, J ENVIRON BIOL, V20, P343; Edillo FE, 2012, SE ASIAN J TROP MED, V43, P1365; Erica RW, 2009, PRENSA MED ARGENT, V96, P185; Focks D.A., 2004, REV ENTOMOLOGICAL SA; Hartjes Laurie B, 2011, Nurse Pract, V36, P45, DOI 10.1097/01.NPR.0000397912.05693.20; Kumar VA, 2010, TROP BIOMED, V27, P330; Kumar S, 2009, WASTE MANAGE, V29, P883, DOI 10.1016/j.wasman.2008.04.011; Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005; Maciel-de-Freitas R, 2011, TROP MED INT HEALTH, V16, P965, DOI 10.1111/j.1365-3156.2011.02797.x; Mandagere N, 2003, BUFFER OPERATIONS GI; Mondal R, 2014, MODERN PARASITOLOGY, V28, P255; Montgomery BL, 2002, AM J TROP MED HYG, V67, P244, DOI 10.4269/ajtmh.2002.67.244; Nagpal BN, 2015, DENGUE B IN PRESS, V39; Nandi J., 2014, Dengue Bulletin, V38, P1; PANDYA G, 1982, DEFENCE SCI J, V32, P359; Salamat MSS, 2013, ACTA MED PHILIPP, V47, P63; Sanchez L, 2006, EMERG INFECT DIS, V12, P800; Sarkar P, 2003, P 3 INT C ENV HLTH C, P451; Sharholy M, 2008, WASTE MANAGE, V28, P459, DOI 10.1016/j.wasman.2007.02.008; Sinh Vu N., 2013, BEST PRACTICES DENGU, P51; Sulaiman S, 1996, J AM MOSQUITO CONTR, V12, P494; Thammapalo S, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000263; Vikram Kumar, 2015, International Journal of Mosquito Research, V2, P83; World Health Organization, 2015, DENG PREV CONTR; World Health Organization ROfS-EA, 2011, COMPR GUID PREV CONT	30	12	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2016	11	12							e0166768	10.1371/journal.pone.0166768	http://dx.doi.org/10.1371/journal.pone.0166768			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4MR	27918577	Green Submitted, Green Published, gold			2022-12-26	WOS:000389577100004
J	Li, XY; Deng, YP; Yang, K; Gan, WX; Zeng, RK; Deng, LJ; Song, ZB				Li, Xiaoyan; Deng, Yuanping; Yang, Kun; Gan, Weixiong; Zeng, Rukui; Deng, Longjun; Song, Zhaobin			Genetic Diversity and Structure Analysis of Percocypris pingi (Cypriniformes: Cyprinidae): Implications for Conservation and Hatchery Release in the Yalong River	PLOS ONE			English	Article							MICROSATELLITE DNA ANALYSIS; POPULATION-STRUCTURE; FRESH-WATER; CONTROL REGION; STATISTICAL TESTS; FISH ASSEMBLAGES; YANGTZE-RIVER; MANAGEMENT; SEQUENCE; CHINA	Percocypris pingi is a near threatened cyprinid species, which has suffered a dramatic decline due to anthropogenic factors. As one response to this decline, hatchery release for P. pingi has been conducted in the lower reaches of the Yalong River since 2012. To understand the conservation status of this species and the potential impact of the release of hatchery-reared fish, we studied the genetic diversity and population structure of wild and hatchery populations of P. pingi. Two hatchery populations (Jinping [JPH] and Ya'an [YAH]) and two wild populations (Muli [MLW] and Woluo [WLW]) of P. pingi were analyzed based on microsatellite markers and the mitochondrial DNA control region. The results showed that P. pingi possesses moderate levels of genetic diversity, with observed heterozygosities ranging from 0.657 to 0.770 and nucleotide diversities ranging from 0.00212 to 0.00491. Our results also suggested WLW harbors considerable proportions of genetic diversity in this species and serves as a refuge for P. pingi during anthropogenic disturbance, thus playing an important role for the conservation of P. pingi populations. Microsatellite and mitochondrial markers both indicated close genetic relationships between YAH and MLW, JPH and WLW, respectively. The results to some extent reflected the geographical provenances for original broodstocks of the two hatchery populations, which provide some practical guidance for hatchery release of P. pingi. The existence of remarkable genetic divergence distributed along limited geographical range (approximately 10 kilometers) suggests the two wild populations should be regarded at least as two distinct evolutionary significant units (ESUs) and management units (MUs). Considering reduced intra-population genetic variation in hatchery population for release and significant genetic compositions of the two hatchery populations, some appropriate breeding strategies were proposed to benefit conservation of P. pingi.	[Li, Xiaoyan; Deng, Yuanping; Yang, Kun; Song, Zhaobin] Sichuan Univ, Coll Life Sci, Sichuan Key Lab Conservat Biol Endangered Wildlif, Chengdu, Peoples R China; [Gan, Weixiong; Zeng, Rukui; Deng, Longjun] Yalong River Hydropower Dev Co Ltd, Chengdu, Peoples R China; [Song, Zhaobin] Sichuan Univ, Coll Life Sci, Minist Educ, Key Lab Bioresources & Ecoenvironm, Chengdu, Peoples R China	Sichuan University; Sichuan University	Song, ZB (corresponding author), Sichuan Univ, Coll Life Sci, Sichuan Key Lab Conservat Biol Endangered Wildlif, Chengdu, Peoples R China.; Song, ZB (corresponding author), Sichuan Univ, Coll Life Sci, Minist Educ, Key Lab Bioresources & Ecoenvironm, Chengdu, Peoples R China.	zbsong@scu.edu.cn		Yang, Kun/0000-0003-4409-6836	Yalong River Hydropower Development Company, Ltd. [12H0856]; Program for New Century Excellent Talents in University [NCET-11-0347]	Yalong River Hydropower Development Company, Ltd.; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	Yalong River Hydropower Development Company, Ltd. (No. 12H0856) and Program for New Century Excellent Talents in University (No. NCET-11-0347). Yalong River Hydropower Development Company, Ltd. provided financial support for field studies and relevant expenditure (e.g., field sampling and purchasing artificial propagated samples); Program for New Century Excellent Talents in University provided financial support for laboratory experiments and relevant expenditure (e.g., DNA extraction, genotyping and sequencing). Weixiong Gan, Rukui Zeng and Longjun Deng are employed by Yalong River Hydropower Development Company, Ltd. Yalong River Hydropower Development Company, Ltd. provided support in the form of salaries for authors WG, RZ and LD and played a role in data collection, contributed reagents and analysis tools. The specific roles of these authors are articulated in the 'author contributions' section.	Abdolhay HA, 2011, REV FISH BIOL FISHER, V21, P247, DOI 10.1007/s11160-010-9163-9; ALLENDORF FW, 1980, T AM FISH SOC, V109, P537, DOI 10.1577/1548-8659(1980)109&lt;537:LOGVIA&gt;2.0.CO;2; Araki H, 2007, SCIENCE, V318, P100, DOI 10.1126/science.1145621; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Beaumont M, 2000, README 2MOD; BROWN JR, 1993, MOL BIOL EVOL, V10, P326; Chen XH, 2006, FRESHWATER FISHERIES, V36; Cheng F, 2011, FISHERIES SCI, V77, P765, DOI 10.1007/s12562-011-0383-2; Cornuet JM, 1996, GENETICS, V144, P2001; Dadswell MJ, 1996, REMOVAL EDWARDS DAM, V1-3, P92; Deng YP, 2015, ISOLATION MICROSATEL, P13; Deng YP, 2015, CONSERV GENET RESOUR, V7, P99, DOI 10.1007/s12686-014-0302-9; DeWoody JA, 2000, J FISH BIOL, V56, P461, DOI 10.1111/j.1095-8649.2000.tb00748.x; Ding RH, 1994, FISHES SICHUAN, P219; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; Dong Xinpei, 2014, Journal of Hebei University Natural Science Edition, V34, P201; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edmands S, 2007, MOL ECOL, V16, P463, DOI 10.1111/j.1365-294X.2006.03148.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; Ferreira D, 2015, CONSERV GENET, V16, P151, DOI 10.1007/s10592-014-0648-2; Fu YX, 1997, GENETICS, V147, P915; Gilk SE, 2004, OUTBREEDING DEPRESSI, P287; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Thanh HN, 2015, BIOCHEM SYST ECOL, V59, P144, DOI 10.1016/j.bse.2014.12.023; Hey J, 2010, MOL BIOL EVOL, V27, P905, DOI 10.1093/molbev/msp296; Huang F, 2011, ENVIRON BIOL FISH, V92, P569, DOI 10.1007/s10641-011-9880-5; Hughes JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040546; Jiang Hong, 2007, Acta Hydrobiologica Sinica, V31, P532; Jiang Zhigang, 2016, Biodiversity Science, V24, P500, DOI 10.17520/biods.2016076; Koizumi I, 2006, MOL ECOL, V15, P3175, DOI 10.1111/j.1365-294X.2006.03019.x; Kotus A, 2016, AQUAT LIVING RESOUR, V29, P103; Kubota H, 2003, ICHTHYOL RES, V50, P123, DOI 10.1007/s10228-002-0146-2; Kumar S, 2016, MOL BIOL EVOL, V33, P2628; Laikre L, 2005, AMBIO, V34, P111, DOI 10.1639/0044-7447(2005)034[0111:GPSOFI]2.0.CO;2; LEBER KM, 1995, AM FISH S S, V15, P376; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu HZ, 2002, CAN J ZOOL, V80, P569, DOI 10.1139/Z02-035; Lorenzen K, 2012, BIOL REV, V87, P639, DOI 10.1111/j.1469-185X.2011.00215.x; Loukovitis D, 2015, MEDITERR MAR SCI, V16, P197; McNeely JA, 1990, CONSERVING THE WORLD; [孟玮 Meng Wei], 2012, [水生生物学报, Acta Hydrobiologica Sinica], V36, P851; Paiva SR, 2006, HYDROBIOLOGIA, V560, P393, DOI 10.1007/s10750-005-9415-1; Paz-Vinas I, 2013, MOL ECOL, V22, P3279, DOI 10.1111/mec.12321; Philipp DP, 2002, AM FISH S S, V31, P349; Piorski NM, 2008, BRAZ J BIOL, V68, P1039, DOI 10.1590/S1519-69842008000500011; Pritchard JK, 2000, GENETICS, V155, P945; Rambaut A., 2014, TRACER V1 6; Ramstad KM, 2004, MOL ECOL, V13, P277, DOI 10.1046/j.1365-294X.2003.2062.x; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; RYMAN N, 1991, CONSERV BIOL, V5, P325, DOI 10.1111/j.1523-1739.1991.tb00144.x; Sato T, 2014, FISHERIES SCI, V80, P493, DOI 10.1007/s12562-014-0730-1; Sekino M, 2002, AQUACULTURE, V213, P101, DOI 10.1016/S0044-8486(01)00885-7; Shaw PW, 1999, HEREDITY, V83, P490, DOI 10.1038/sj.hdy.6885860; Song J, 2014, BIOCHEM SYST ECOL, V55, P1, DOI 10.1016/j.bse.2014.02.008; Song Xiao, 2009, Acta Hydrobiologica Sinica, V33, P709, DOI 10.3724/SP.J.1035.2009.40709; Swenson NG, 2005, AM NAT, V166, P581, DOI 10.1086/491688; TAJIMA F, 1989, GENETICS, V123, P585; THOMPSON D, 1985, AQUACULTURE, V46, P341, DOI 10.1016/0044-8486(85)90112-7; Van de Putte AP, 2012, MAR GENOM, V8, P23, DOI 10.1016/j.margen.2012.05.002; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vogiatzi E, 2014, BIOL J LINN SOC, V111, P334, DOI 10.1111/bij.12206; Wang M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061827; Wang YM, 2013, SICHUAN J ZOOLOGY, V32, P012; Wright JM, 1995, MOL GENETICS FISHERI, P230; Wright S., 1978, EVOLUTION GENETICS P; Wu XW, 1977, CYPRINID FISHES CHIN, P266; Yan L, 2008, ENVIRON BIOL FISH, V82, P35, DOI 10.1007/s10641-007-9248-z; [易建华 Yi Jianhua], 2013, [西南师范大学学报. 自然科学版, Journal of Southwest China Normal University. Natural Science Edition], V38, P62; [岳兴建 Yue Xingjian], 2015, [淡水渔业, Freshwater Fisheries], V45, P14; Zhang CG, 2016, SPECIES DIVERSITY DI, P94; Zhang X, 2015, ENVIRON BIOL FISH, V98, P261, DOI 10.1007/s10641-014-0257-4; Zhao H, 2012, IUCN 2012 IUCN RED L	73	10	11	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0166769	10.1371/journal.pone.0166769	http://dx.doi.org/10.1371/journal.pone.0166769			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3TF	27911911	gold, Green Published, Green Submitted			2022-12-26	WOS:000389520600012
J	Bruske, EI; Dimonte, S; Enderes, C; Tschan, S; Flotenmeyer, M; Koch, I; Berger, J; Kremsner, P; Frank, M				Bruske, Ellen Inga; Dimonte, Sandra; Enderes, Corinna; Tschan, Serena; Floetenmeyer, Matthias; Koch, Iris; Berger, Juergen; Kremsner, Peter; Frank, Matthias			In Vitro Variant Surface Antigen Expression in Plasmodium falciparum Parasites from a Semi-Immune Individual Is Not Correlated with Var Gene Transcription	PLOS ONE			English	Article							ERYTHROCYTE-MEMBRANE PROTEIN-1; FREQUENT RECOMBINATION EVENTS; SEVERE CHILDHOOD MALARIA; BRAIN ENDOTHELIAL-CELLS; INFECTED ERYTHROCYTES; ACQUIRED-IMMUNITY; DIFFERENTIAL EXPRESSION; ANTIBODY RECOGNITION; EPIGENETIC MEMORY; VIRULENCE GENES	Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) is considered to be the main variant surface antigen (VSA) of Plasmodium falciparum and is mainly localized on electron-dense knobs in the membrane of the infected erythrocyte. Switches in PfEMP1 expression provide the basis for antigenic variation and are thought to be critical for parasite persistence during chronic infections. Recently, strain transcending anti-PfEMP1 immunity has been shown to develop early in life, challenging the role of PfEMP1 in antigenic variation during chronic infections. In this work we investigate how P. falciparum achieves persistence during a chronic asymptomatic infection. The infected individual (MOA) was parasitemic for 42 days and multilocus vargene genotyping showed persistence of the same parasite population throughout the infection. Parasites from the beginning of the infection were adapted to tissue culture and cloned by limiting dilution. Flow cytometry using convalescent serum detected a variable surface recognition signal on isogenic clonal parasites. Quantitative real-time PCR with a field isolate specific vargene primer set showed that the surface recognition signal was not correlated with transcription of individual vargenes. Strain transcending anti-PfEMP1 immunity of the convalescent serum was demonstrated with CD36 selected and PfEMP1 knock-down NF54 clones. In contrast, knock-down of PfEMP1 did not have an effect on the antibody recognition signal in MOA clones. Trypsinisation of the membrane surface proteins abolished the surface recognition signal and immune electron microscopy revealed that antibodies from the convalescent serum bound to membrane areas without knobs and with knobs. Together the data indicate that PfEMP1 is not the main variable surface antigen during a chronic infection and suggest a role for trypsin sensitive non-PfEMP1 VSAs for parasite persistence in chronic infections.	[Bruske, Ellen Inga; Dimonte, Sandra; Enderes, Corinna; Tschan, Serena; Kremsner, Peter; Frank, Matthias] Univ Tubingen, Inst Trop Med, Tubingen, Germany; [Kremsner, Peter; Frank, Matthias] CERMEL Ctr Rech Med Lambarene, Lambarene, Gabon; [Floetenmeyer, Matthias; Koch, Iris; Berger, Juergen] Max Planck Inst Dev Biol, Tubingen, Germany	Eberhard Karls University of Tubingen; Max Planck Society	Frank, M (corresponding author), Univ Tubingen, Inst Trop Med, Tubingen, Germany.; Frank, M (corresponding author), CERMEL Ctr Rech Med Lambarene, Lambarene, Gabon.	Matthias.Frank@praxis-frank-tuebingen.de	Mordmuller, Benjamin/A-5749-2010	Mordmuller, Benjamin/0000-0001-9101-2768; Floetenmeyer, Matthias/0000-0002-0133-1632; Dimonte, Sandra/0000-0002-4612-4979	BMBF of the German ministry for education and research (BMBF) [01KA110]; GIF of the German Israeli Foundation [997/2008]; BMBF [01KA1101]; Landesgraduiertenforderung Baden-Wurtemberg; GIF [997/2008]	BMBF of the German ministry for education and research (BMBF); GIF of the German Israeli Foundation; BMBF(Federal Ministry of Education & Research (BMBF)); Landesgraduiertenforderung Baden-Wurtemberg; GIF(German-Israeli Foundation for Scientific Research and Development)	his work was funded by BMBF-grant 01KA110 of the German ministry for education and research (BMBF) and GIF-Research Project No. 997/2008 of the German Israeli Foundation to MFrank. SD, EB and MFrank received salary support through the BMBF-grant 01KA1101. CE was the recipient of a PhD scholarship by the Landesgraduiertenforderung Baden-Wurtemberg. CE and SD received additional salary support through GIF-Research Project No. 997/2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Latif MS, 2004, AM J TROP MED HYG, V71, P179, DOI 10.4269/ajtmh.2004.71.2.0700179; Abdel-Latif MS, 2002, INFECT IMMUN, V70, P7013, DOI 10.1128/IAI.70.12.7013-7021.2002; Abdi AI, 2016, SCI REP, P6; Avraham I, 2012, P NATL ACAD SCI USA, V109, pE3678, DOI 10.1073/pnas.1214572109; Avril M, 2012, P NATL ACAD SCI USA, V109, pE1782, DOI 10.1073/pnas.1120534109; Bachmann A, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005538; Barfod L, 2011, P NATL ACAD SCI USA, V108, P12485, DOI 10.1073/pnas.1103708108; Barry AE, 2007, PLOS PATHOG, P3; Barry AE, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.008326; BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; Bopp SER, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003293; Bull PC, 2000, J INFECT DIS, V182, P252, DOI 10.1086/315652; Bull PC, 1999, INFECT IMMUN, V67, P733, DOI 10.1128/IAI.67.2.733-739.1999; Bull PC, 1998, NAT MED, V4, P358, DOI 10.1038/nm0398-358; Bull PC, 2008, MOL MICROBIOL, V68, P1519, DOI 10.1111/j.1365-2958.2008.06248.x; Calderwood MS, 2003, J BIOL CHEM, V278, P34125, DOI 10.1074/jbc.M213065200; Cham GKK, 2009, J IMMUNOL, V183, P3356, DOI 10.4049/jimmunol.0901331; Chan JA, 2016, CELL MOL LIFE SCI, V73, P4141, DOI 10.1007/s00018-016-2267-1; Chan JA, 2012, J CLIN INVEST, V122, P3227, DOI 10.1172/JCI62182; Chen QJ, 1998, NATURE, V394, P392, DOI 10.1038/28660; Cheng Q, 1998, MOL BIOCHEM PARASIT, V97, P161, DOI 10.1016/S0166-6851(98)00144-3; Chookajorn T, 2007, P NATL ACAD SCI USA, V104, P899, DOI 10.1073/pnas.0609084103; Claessens A, 2014, PLOS GENET, P10; Claessens A, 2012, P NATL ACAD SCI USA, V109, pE1772, DOI 10.1073/pnas.1120461109; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Collins WE, 1999, AM J TROP MED HYG, V61, P44, DOI 10.4269/tropmed.1999.61-044; Crabb BS, 1997, CELL, V89, P287, DOI 10.1016/S0092-8674(00)80207-X; Dal-Bianco MP, 2007, AM J TROP MED HYG, V77, P939, DOI 10.4269/ajtmh.2007.77.939; Deitsch KW, 2001, NATURE, V412, P875, DOI 10.1038/35091146; Deitsch KW, 2001, NUCLEIC ACIDS RES, V29, P850, DOI 10.1093/nar/29.3.850; Dimonte S, 2016, J INFECT DIS, V214, P884, DOI 10.1093/infdis/jiw225; Dzikowski R, 2006, PLOS PATHOG, P2; Dzikowski R, 2008, J MOL BIOL, V382, P288, DOI 10.1016/j.jmb.2008.07.015; EDOZIEN JC, 1962, LANCET, V280, P951; Enderes C, 2011, J INFECT DIS, V204, P1620, DOI 10.1093/infdis/jir594; Fernandez V, 1999, J EXP MED, V190, P1393, DOI 10.1084/jem.190.10.1393; Frank M, 2006, J BIOL CHEM, V281, P9942, DOI 10.1074/jbc.M513067200; Frank M, 2008, INT J PARASITOL, V38, P1099, DOI 10.1016/j.ijpara.2008.01.010; Frank M, 2007, MOL MICROBIOL, V64, P1486, DOI 10.1111/j.1365-2958.2007.05736.x; Frank M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-304; Freitas-Junior LH, 2000, NATURE, V407, P1018, DOI 10.1038/35039531; Fried M, 1998, NATURE, V395, P851, DOI 10.1038/27570; Gannoun-Zaki L, 2005, EUKARYOT CELL, V4, P490, DOI 10.1128/EC.4.2.490-492.2005; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Giha HA, 1999, INFECT IMMUN, V67, P4092, DOI 10.1128/IAI.67.8.4092-4098.1999; Goel S, 2015, NAT MED, V21, P314, DOI 10.1038/nm.3812; Horrocks P, 2004, P NATL ACAD SCI USA, V101, P11129, DOI 10.1073/pnas.0402347101; Hviid L, 2010, HUM VACCINES, V6, P84, DOI 10.4161/hv.6.1.9602; Jensen ATR, 2004, J EXP MED, V199, P1179, DOI 10.1084/jem.20040274; Kaestli M, 2006, J INFECT DIS, V193, P1567, DOI 10.1086/503776; Kraemer SM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-45; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; Lau CKY, 2015, CELL HOST MICROBE, V17, P118, DOI 10.1016/j.chom.2014.11.007; Lavstsen T, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-21; Lavstsen T, 2012, P NATL ACAD SCI USA, V109, pE1791, DOI 10.1073/pnas.1120455109; Lopez-Rubio JJ, 2007, MOL MICROBIOL, V66, P1296, DOI 10.1111/j.1365-2958.2007.06009.x; MARSH K, 1986, SCIENCE, V231, P150, DOI 10.1126/science.2417315; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Molineaux L, 2001, PARASITOLOGY, V122, P379, DOI 10.1017/S0031182001007533; Mordmuller B, 2015, MALARIA J, P14; Moussian B, 2005, J MORPHOL, V264, P117, DOI 10.1002/jmor.10324; Niang M, 2009, PLOS PATHOG, P5; Niang M, 2014, CELL HOST MICROBE, V16, P81, DOI 10.1016/j.chom.2014.06.004; Nielsen MA, 2004, INFECT IMMUN, V72, P3531, DOI 10.1128/IAI.72.6.3531-3535.2004; Nielsen MA, 2002, J IMMUNOL, V168, P3444, DOI 10.4049/jimmunol.168.7.3444; Ofori MF, 2002, INFECT IMMUN, V70, P2982, DOI 10.1128/IAI.70.6.2982-2988.2002; Planche T, 2001, AM J TROP MED HYG, V65, P599, DOI 10.4269/ajtmh.2001.65.599; R Development Core Team, 2009, R A LANGUAGE AND ENV; Recker M, 2004, NATURE, V429, P555, DOI 10.1038/nature02486; Recker M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001306; Rottmann M, 2006, INFECT IMMUN, V74, P3904, DOI 10.1128/IAI.02073-05; Rupp I, 2011, CELL RES, V21, P683, DOI 10.1038/cr.2010.176; SABCHAREON A, 1991, AM J TROP MED HYG, V45, P297, DOI 10.4269/ajtmh.1991.45.297; Sam-Yellowe TY, 2004, GENOME RES, V14, P1052, DOI 10.1101/gr.2126104; Scherf A, 1998, EMBO J, V17, P5418, DOI 10.1093/emboj/17.18.5418; Smith JD, 2013, CELL MICROBIOL, P15; Spycher C, 2008, MOL MICROBIOL, V68, P1300, DOI 10.1111/j.1365-2958.2008.06235.x; Staalsoe T, 1999, CYTOMETRY, V35, P329, DOI 10.1002/(SICI)1097-0320(19990401)35:4&lt;329::AID-CYTO5&gt;3.0.CO;2-Y; Stanisic DI, 2016, INFECT IMMUN; Struik SS, 2004, IMMUNOL REV, V201, P268, DOI 10.1111/j.0105-2896.2004.00181.x; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Tan J, 2016, NATURE, V529, P105, DOI 10.1038/nature16450; Taylor HM, 2000, MOL BIOCHEM PARASIT, V105, P13, DOI 10.1016/S0166-6851(99)00159-0; Taylor HM, 2000, MOL BIOCHEM PARASIT, V110, P391, DOI 10.1016/S0166-6851(00)00286-3; Tonkin CJ, 2009, PLOS BIOL, P7; Turner L, 2013, NATURE, V498, P502, DOI 10.1038/nature12216; Ward CP, 1999, MOL BIOCHEM PARASIT, V102, P167, DOI 10.1016/S0166-6851(99)00106-1; Waterkeyn JG, 2000, EMBO J, V19, P2813, DOI 10.1093/emboj/19.12.2813; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Winter G, 2005, J EXP MED, V201, P1853, DOI 10.1084/jem.20041392	90	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166135	10.1371/journal.pone.0166135	http://dx.doi.org/10.1371/journal.pone.0166135			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907004	Green Submitted, Green Published, gold			2022-12-26	WOS:000389482700016
J	De Gasperi, R; Graham, ZA; Harlow, LM; Bauman, WA; Qin, WP; Cardozo, CP				De Gasperi, Rita; Graham, Zachary A.; Harlow, Lauren M.; Bauman, William A.; Qin, Weiping; Cardozo, Christopher P.			The Signature of MicroRNA Dysregulation in Muscle Paralyzed by Spinal Cord Injury Includes Downregulation of MicroRNAs that Target Myostatin Signaling	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; SKELETAL-MUSCLE; GENE-EXPRESSION; ATROPHY; CITED2; MIR-145; PROTEIN; IDENTIFICATION; RECEPTOR; DISUSE	Spinal cord injury (SCI) results in muscle atrophy, reduced force generation and an oxidative-to-glycolytic fiber type shift. The mechanisms responsible for these alterations remain incompletely understood. To gain new insights regarding mechanisms involved in deterioration of muscle after SCI, global expression profiles of miRs in paralyzed gastrocnemius muscle were compared between sham-operated (Sham) and spinal cord-transected (SCI) rats. Ingenuity Pathways Analysis of the altered miRs identified signaling via insulin, IGF-1, integrins and TGF-beta as being significantly enriched for target genes. By qPCR, miRs 23a, 23b, 27b, 145, and 206, were downregulated in skeletal muscle 56 days after SCI. Using FISH, miR-145, a miR not previously implicated in the function of skeletal muscle, was found to be localized to skeletal muscle fibers. One predicted target of miR-145 was Cited2, a transcriptional regulator that modulates signaling through NF-KB, Smad3 and other transcription factors. The 3' UTR of Cited2 mRNA contained a highly conserved miR-145 seed sequence. Luciferase reporter assays confirmed that miR-145 interacts with this seed sequence. However, Cited2 protein levels were similar between Sham and SCI groups, indicating a biochemical interaction that was not involved in the context of adaptations after SCI. Taken together, the findings indicate dysregulation of several highly expressed miRs in skeletal muscle after SCI and suggest that reduced expression of miR-23a, 145 and 206 may have roles in alteration in skeletal muscle mass and insulin responsiveness in muscle paralyzed by upper motor neuron injuries.	[De Gasperi, Rita; Graham, Zachary A.; Harlow, Lauren M.; Bauman, William A.; Qin, Weiping; Cardozo, Christopher P.] James J Peters Med Ctr, VA RR&D Serv Natl Ctr Med Consequences Spinal Cor, Bronx, NY 10468 USA; [De Gasperi, Rita] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [Graham, Zachary A.; Bauman, William A.; Qin, Weiping; Cardozo, Christopher P.] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA; [Bauman, William A.; Cardozo, Christopher P.] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA; [Cardozo, Christopher P.] Icahn Sch Med Mt Sinai, Dept Pharmacol Sci, New York, NY 10029 USA; [De Gasperi, Rita] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Cardozo, CP (corresponding author), James J Peters Med Ctr, VA RR&D Serv Natl Ctr Med Consequences Spinal Cor, Bronx, NY 10468 USA.; Cardozo, CP (corresponding author), Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA.; Cardozo, CP (corresponding author), Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA.; Cardozo, CP (corresponding author), Icahn Sch Med Mt Sinai, Dept Pharmacol Sci, New York, NY 10029 USA.	chris.cardozo@mssm.edu	Cardozo, Christopher/R-6021-2019	Cardozo, Christopher/0000-0003-4013-2537; Graham, Zachary/0000-0002-6506-7025	VA Rehabilitation and Research Development Grant [B9212C]	VA Rehabilitation and Research Development Grant	VA Rehabilitation and Research Development Grant B9212C to WAB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding was provided by Veterans Affairs RR&D Service National Center Grant B9212-C to W.A.B.	Adams CM, 2011, MUSCLE NERVE, V43, P65, DOI 10.1002/mus.21831; Allen DL, 2009, J APPL PHYSIOL, V106, P582, DOI 10.1152/japplphysiol.90780.2008; Biering-Sorensen B, 2009, MUSCLE NERVE, V40, P499, DOI 10.1002/mus.21391; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bodine SC, 2014, AM J PHYSIOL-ENDOC M, V307, pE469, DOI 10.1152/ajpendo.00204.2014; Bodine SC, 2013, INT J BIOCHEM CELL B, V45, P2200, DOI 10.1016/j.biocel.2013.06.011; Cea LA, 2013, P NATL ACAD SCI USA, V110, P16229, DOI 10.1073/pnas.1312331110; Cha MJ, 2013, BIOCHEM BIOPH RES CO, V435, P720, DOI 10.1016/j.bbrc.2013.05.050; Chou YT, 2006, ONCOGENE, V25, P5547, DOI 10.1038/sj.onc.1209552; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Davis-Dusenbery BN, 2011, J BIOL CHEM, V286, P28097, DOI 10.1074/jbc.M111.236950; Dudley-Javoroski S, 2008, J REHABIL RES DEV, V45, P283, DOI 10.1682/JRRD.2007.02.0031; Floro KL, 2011, HUM MOL GENET, V20, P1097, DOI 10.1093/hmg/ddq554; Freedman SJ, 2003, NAT STRUCT BIOL, V10, P504, DOI 10.1038/nsb936; Georgantas RW, 2014, ARTHRITIS RHEUMATOL, V66, P1022, DOI 10.1002/art.38292; Glass DJ, 2010, CURR OPIN CLIN NUTR, V13, P225, DOI 10.1097/MCO.0b013e32833862df; Glass DJ, 2005, INT J BIOCHEM CELL B, V37, P1974, DOI 10.1016/j.biocel.2005.04.018; Graham ZA, 2015, SPINAL CORD; Hitachi K, 2014, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00408; Huang HP, 2015, TUMOR BIOL, V36, P4123, DOI 10.1007/s13277-015-3046-6; Huang QK, 2016, MED SCI MONITOR, V22, P1161, DOI 10.12659/MSM.897909; Jackman RW, 2013, EXP PHYSIOL, V98, P19, DOI 10.1113/expphysiol.2011.063321; Kirby TJ, 2015, FRONT BIOSCI-LANDMRK, V20, P37, DOI 10.2741/4298; Kunkel SD, 2011, CELL METAB, V13, P627, DOI 10.1016/j.cmet.2011.03.020; Lee JY, 2009, BIOCHEM BIOPH RES CO, V387, P641, DOI 10.1016/j.bbrc.2009.07.029; Lee SJ, 2004, ANNU REV CELL DEV BI, V20, P61, DOI 10.1146/annurev.cellbio.20.012103.135836; Leong DJ, 2011, FASEB J, V25, P182, DOI 10.1096/fj.10-164277; Li Q, 2014, J BIOL CHEM, V289, P251, DOI 10.1074/jbc.M113.497594; Li Q, 2012, J BIOL CHEM, V287, P29088, DOI 10.1074/jbc.M112.378034; Li Rong, 2012, J WUHAN U SCI EDIT S, VS2, P145, DOI DOI 10.1371/J0URNAL.P0NE.0044907; Li RT, 2013, FEBS LETT, V587, P1754, DOI 10.1016/j.febslet.2013.04.018; Liu N, 2012, J CLIN INVEST, V122, P2054, DOI 10.1172/JCI62656; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long YC, 2011, J APPL PHYSIOL, V110, P1204, DOI 10.1152/japplphysiol.00686.2010; Lou XW, 2011, J IMMUNOL, V186, P539, DOI 10.4049/jimmunol.1001650; McCarthy JJ, 2009, PHYSIOL GENOMICS, V39, P219, DOI 10.1152/physiolgenomics.00042.2009; McCarthy JJ, 2008, BBA-GENE REGUL MECH, V1779, P682, DOI 10.1016/j.bbagrm.2008.03.001; Megiorni F, 2013, J CYST FIBROS, V12, P797, DOI 10.1016/j.jcf.2013.03.007; Mittal A, 2010, J CELL BIOL, V188, P833, DOI 10.1083/jcb.200909117; Mullokandov G, 2012, NAT METHODS, V9, P840, DOI [10.1038/nmeth.2078, 10.1038/NMETH.2078]; Murphy KT, 2011, J APPL PHYSIOL, V110, P1065, DOI 10.1152/japplphysiol.01183.2010; Qin WP, 2010, ANN NY ACAD SCI, V1211, P66, DOI 10.1111/j.1749-6632.2010.05806.x; Qu X, 2007, EMBO J, V26, P4445, DOI 10.1038/sj.emboj.7601883; Raychaudhuri S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034596; Rezen T, 2014, ACTA PHYSIOL, V210, P655, DOI 10.1111/apha.12228; Ruegg MA, 2011, ANNU REV PHARMACOL, V51, P373, DOI 10.1146/annurev-pharmtox-010510-100537; Sakai M, 2012, NAT MED, V18, P612, DOI 10.1038/nm.2691; Sato S, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00018; Soares RJ, 2014, J BIOL CHEM, V289, P21909, DOI 10.1074/jbc.M114.561845; Tien ES, 2004, J BIOL CHEM, V279, P24053, DOI 10.1074/jbc.M401489200; Tobimatsu K, 2009, BIOCHEM BIOPH RES CO, V378, P399, DOI 10.1016/j.bbrc.2008.11.062; Urso ML, 2007, J PHYSIOL-LONDON, V579, P877, DOI 10.1113/jphysiol.2006.118042; Wada S, 2011, J BIOL CHEM, V286, P38456, DOI 10.1074/jbc.M111.271270; Waddell DS, 2008, AM J PHYSIOL-ENDOC M, V295, pE785, DOI 10.1152/ajpendo.00646.2007; Wiberg R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142699; Williams AH, 2009, SCIENCE, V326, P1549, DOI 10.1126/science.1181046; Wu Y, 2011, SPINAL CORD, V49, P867, DOI 10.1038/sc.2011.28; Wu Y, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-81; Wu Y, 2012, J NEUROTRAUM, V29, P1663, DOI 10.1089/neu.2011.2203; Xu B, 2008, DEV BIOL, V317, P95, DOI 10.1016/j.ydbio.2008.02.019; Yan GJ, 2012, FEBS LETT, V586, P3263, DOI 10.1016/j.febslet.2012.06.048; Yokota H, 2003, J BIOL CHEM, V278, P47275, DOI 10.1074/jbc.M304652200; Zeman RJ, 2009, PFLUG ARCH EUR J PHY, V458, P525, DOI 10.1007/s00424-009-0643-5	63	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166189	10.1371/journal.pone.0166189	http://dx.doi.org/10.1371/journal.pone.0166189			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907012	Green Published, gold, Green Submitted			2022-12-26	WOS:000389482700018
J	Liu, XJ; Qian, WS; Jin, RC; Li, X; Luk, KDK; Wu, EX; Hu, Y				Liu, Xiaojia; Qian, Wenshu; Jin, Richu; Li, Xiang; Luk, Keith D. K.; Wu, Ed. X.; Hu, Yong			Amplitude of Low Frequency Fluctuation (ALFF) in the Cervical Spinal Cord with Stenosis: A Resting State fMRI Study	PLOS ONE			English	Article							INTRINSIC FUNCTIONAL CONNECTIVITY; LINE BRAIN ACTIVITY; SPONDYLOTIC MYELOPATHY; SIGNAL INTENSITY; NEURONAL-ACTIVITY; COMPRESSION; PLASTICITY; PROGNOSIS; DIAGNOSIS; SURGERY	Cervical spondylotic myelopathy (CSM) is a common spinal cord dysfunction disease with complex symptoms in clinical presentation. Resting state fMRI (rsfMRl) has been introduced to study the mechanism of neural development of CSM. However, most of those studies focused on intrinsic functional connectivity rather than intrinsic regional neural activity level which is also frequently analyzed in rsfMRl studies. Thus, this study aims to explore whether the level of neural activity changes on the myelopathic cervical cord and evaluate the possible relationship between this change and clinical symptoms through amplitude of low frequency fluctuation (ALFF). Eighteen CSM patients and twenty five healthy subjects participated in rsfMRl scanning. ALFF was investigated on each patient and subject. The results suggested that ALFF values were higher in the CSM patients at all cervical segments, compared to the healthy controls. The severity of myelopathy was associated with the increase of ALFF. This finding would enrich our understanding on the neural development mechanism of CSM.	[Liu, Xiaojia; Qian, Wenshu; Jin, Richu; Li, Xiang; Luk, Keith D. K.; Hu, Yong] Univ Hong Kong, Li Ka Shing Fac Med, Dept Orthopaed & Traumatol, Pokfulam, Hong Kong, Peoples R China; [Liu, Xiaojia; Wu, Ed. X.] Univ Hong Kong, Fac Engn, Dept Elect & Elect Engn, Pokfulam, Hong Kong, Peoples R China; [Hu, Yong] Guangdong Med Univ, Affiliated Hosp, Dept Orthopaed, Spinal Div, Zhanjiang, Guangdong, Peoples R China	University of Hong Kong; University of Hong Kong; Guangdong Medical University	Hu, Y (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Orthopaed & Traumatol, Pokfulam, Hong Kong, Peoples R China.; Hu, Y (corresponding author), Guangdong Med Univ, Affiliated Hosp, Dept Orthopaed, Spinal Div, Zhanjiang, Guangdong, Peoples R China.	yhud@hku.hk	; Hu, Yong/C-4276-2009; Wu, Ed Xuekui/C-1579-2009	Jin, Richu/0000-0002-7015-5302; Hu, Yong/0000-0003-0305-5616; Wu, Ed Xuekui/0000-0001-5581-1546	Research Grants Council of Hong Kong [HKU 774211M]; National Science Foundation of China [81572193]	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the Research Grants Council of Hong Kong (HKU 774211M) and the National Science Foundation of China (81572193). Both funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avadhani A, 2010, SPINE J, V10, P475, DOI 10.1016/j.spinee.2010.03.024; Barry RL, 2014, ELIFE, V3, DOI 10.7554/eLife.02812; Buckner RL, 2013, NAT NEUROSCI, V16, P832, DOI 10.1038/nn.3423; Chen CJ, 2001, RADIOLOGY, V221, P789, DOI 10.1148/radiol.2213010365; Chen LM, 2015, P NATL ACAD SCI USA, V112, P5991, DOI 10.1073/pnas.1424106112; COOPER PR, 1985, J NEUROSURG, V63, P492, DOI 10.3171/jns.1985.63.4.0492; Dalitz K, 2008, SPINE J; Ding YM, 2005, CURR PHARM DESIGN, V11, P1441, DOI 10.2174/1381612053507855; Dong MH, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00099; Ganzetti M, 2013, NEUROSCIENCE, V240, P297, DOI 10.1016/j.neuroscience.2013.02.032; Giove F, 2004, MAGN RESON IMAGING, V22, P1505, DOI 10.1016/j.mri.2004.10.015; HARSH GR, 1987, J NEUROSURG, V67, P349, DOI 10.3171/jns.1987.67.3.0349; Henson JW, 2010, NEUROLOGY, V74, pE53, DOI 10.1212/WNL.0b013e3181d7b472; HERDMANN J, 1994, ADV NEUROS, V22, P266; Hoptman MJ, 2010, SCHIZOPHR RES, V117, P13, DOI 10.1016/j.schres.2009.09.030; Kato F, 2012, EUR SPINE J, V21, P1499, DOI 10.1007/s00586-012-2176-4; Kim HJ, 2013, SPINE, V38, pS78, DOI 10.1097/BRS.0b013e3182a7eb06; Kong YZ, 2014, P NATL ACAD SCI USA, V111, P18067, DOI 10.1073/pnas.1414293111; LAW MD, 1993, YALE J BIOL MED, V66, P165; Li JF, 2013, ARCH ORTHOP TRAUM SU, V133, P745, DOI 10.1007/s00402-013-1719-4; Li X, 2014, SPINE, V39, pE615, DOI 10.1097/BRS.0000000000000288; Madi S, 2001, AM J NEURORADIOL, V22, P1768; MEHALIC TF, 1990, NEUROSURGERY, V26, P217, DOI 10.1227/00006123-199002000-00006; Meier J, 2016, BRAIN CONNECT, V6, P298, DOI 10.1089/brain.2015.0408; Mitra A, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0546; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Nakashima H, 2015, SPINE PHILA PA 1976, V40, P392; Nateras OSE, 2016, RADIOLOGY, V279, P262, DOI 10.1148/radiol.2015150768; NURICK S, 1972, BRAIN, V95, P87; OGINO H, 1983, SPINE, V8, P1, DOI 10.1097/00007632-198301000-00001; OKADA Y, 1993, SPINE, V18, P2024, DOI 10.1097/00007632-199310001-00016; PANJABI M, 1988, SPINE, V13, P838, DOI 10.1097/00007632-198807000-00024; PROLO DJ, 1986, SPINE, V11, P601, DOI 10.1097/00007632-198607000-00012; Rhee JM, 2013, SPINE, V38, pS55, DOI 10.1097/BRS.0b013e3182a7f41d; Schwab ME, 2002, SCIENCE, V295, P1029, DOI 10.1126/science.1067840; Shin JJ, 2010, ACTA NEUROCHIR, V152, P1687, DOI 10.1007/s00701-010-0692-8; Stracke CP, 2005, NEURORADIOLOGY, V47, P127, DOI 10.1007/s00234-004-1318-8; Stroman PW, 1999, MAGNET RESON MED, V42, P571, DOI 10.1002/(SICI)1522-2594(199909)42:3<571::AID-MRM20>3.0.CO;2-N; Summers PE, 2010, MAGN RESON IMAGING, V28, P1216, DOI 10.1016/j.mri.2010.05.001; TAKAHASHI M, 1989, RADIOLOGY, V173, P219, DOI 10.1148/radiology.173.1.2781011; Tetreault L, 2015, NEUROSURGERY, V77, pS51, DOI 10.1227/NEU.0000000000000951; Tracy JA, 2010, NEUROLOGIST, V16, P176, DOI 10.1097/NRL.0b013e3181da3a29; Turner JA, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00137; Uchida K, 2005, J ORTHOP SCI, V10, P564, DOI 10.1007/s00776-005-0953-1; Wen CY, 2014, RADIOLOGY, V270, P197, DOI 10.1148/radiol.13121885; Xu J, 2014, NEUROSCIENCE, V263, P181, DOI 10.1016/j.neuroscience.2014.01.020; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zhou FQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep09975; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	49	23	24	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167279	10.1371/journal.pone.0167279	http://dx.doi.org/10.1371/journal.pone.0167279			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907060	Green Published, Green Submitted, gold			2022-12-26	WOS:000389482700109
J	Miftahussurur, M; Syam, AF; Nusi, IA; Makmun, D; Waskito, LA; Zein, LH; Akil, F; Uwan, WB; Simanjuntak, D; Wibawa, IDN; Waleleng, JB; Saudale, AMJ; Yusuf, F; Mustika, S; Adi, P; Maimunah, U; Maulahela, H; Rezkitha, YAA; Subsomwong, P; Nasronudin; Rahardjo, D; Suzuki, R; Akada, J; Yamaoka, Y				Miftahussurur, Muhammad; Syam, Ari Fahrial; Nusi, Iswan Abbas; Makmun, Dadang; Waskito, Langgeng Agung; Zein, Lukman Hakim; Akil, Fardah; Uwan, Willy Brodus; Simanjuntak, David; Wibawa, I. Dewa Nyoman; Waleleng, Jimmy Bradley; Saudale, Alexander Michael Joseph; Yusuf, Fauzi; Mustika, Syifa; Adi, Pangestu; Maimunah, Ummi; Maulahela, Hasan; Rezkitha, Yudith Annisa Ayu; Subsomwong, Phawinee; Nasronudin; Rahardjo, Dadik; Suzuki, Rumiko; Akada, Junko; Yamaoka, Yoshio			Surveillance of Helicobacter pylori Antibiotic Susceptibility in Indonesia: Different Resistance Types among Regions and with Novel Genetic Mutations	PLOS ONE			English	Article							GASTRIC-CANCER; ANTIMICROBIAL SUSCEPTIBILITY; CLARITHROMYCIN RESISTANCE; METRONIDAZOLE RESISTANCE; VIRULENCE FACTORS; CONSENSUS REPORT; POINT MUTATIONS; GYRA MUTATIONS; INFECTION; IDENTIFICATION	Information regarding Helicobacter pylori antibiotic resistance in Indonesia was previously inadequate. We assessed antibiotic susceptibility for H. pylori in Indonesia, and determined the association between virulence genes or genetic mutations and antibiotic resistance. We recruited 849 dyspeptic patients who underwent endoscopy in 11 cities in Indonesia. E-test was used to determine the minimum inhibitory concentration of five antibiotics. PCR-based sequencing assessed mutations in 23S rRNA, rdxA, gyrA, gyrB, and virulence genes. Next generation sequencing was used to obtain full-length sequences of 23S rRNA, infB, and rp122. We cultured 77 strains and identified 9.1% with clarithromycin resistance. Low prevalence was also found for amoxicillin and tetracycline resistance (5.2% and 2.6%, respectively). In contrast, high resistance rates to metronidazole (46.7%) and levofloxacin (31.2%) were demonstrated. Strains isolated from Sumatera Island had significantly higher metronidazole resistance than those from other locations. Metronidazole resistant strains had highly distributed rdxA amino acid substitutions and the 23S rRNA A2143G mutation was associated with clarithromycin resistance (42.9%). However, one strain with the highest MIC value had a novel mutation in rp122 without an A2143G mutation. Mutation at Asn-87 and/or Asp 91 of gyrA was associated with levofloxacin-resistance and was related to gyrB mutations. In conclusions, although this is a pilot study for a larger survey, our current data show that Indonesian strains had the high prevalence of metronidazole and levofloxacin resistance with low prevalence of clarithromycin, amoxicillin, and tetracycline resistance. Nevertheless, clarithromycin-or metronidazole-based triple therapy should be administered with caution in some regions of Indonesia.	[Miftahussurur, Muhammad; Waskito, Langgeng Agung; Subsomwong, Phawinee; Suzuki, Rumiko; Akada, Junko; Yamaoka, Yoshio] Oita Univ, Dept Environm & Prevent Med, Fac Med, Yufu, Japan; [Miftahussurur, Muhammad; Yamaoka, Yoshio] Baylor Coll Med, Dept Med, Gastroenterol & Hepatol Sect, Houston, TX 77030 USA; [Miftahussurur, Muhammad; Nusi, Iswan Abbas; Maimunah, Ummi] Univ Airlangga, Fac Med, Dept Internal Med, Div Gastroenterohepatol, Surabaya, Indonesia; [Miftahussurur, Muhammad; Waskito, Langgeng Agung; Adi, Pangestu; Rezkitha, Yudith Annisa Ayu; Nasronudin; Rahardjo, Dadik] Univ Airlangga, Inst Trop Dis, Surabaya, Indonesia; [Syam, Ari Fahrial; Makmun, Dadang; Maulahela, Hasan] Univ Indonesia, Div Gastroenterol, Dept Internal Med, Fac Med, Jakarta, Indonesia; [Zein, Lukman Hakim] Univ Sumatera Utara, Div Gastroenterohepatol, Dept Internal Med, Fac Med, Medan, Indonesia; [Akil, Fardah] Hasanuddin Univ, Dept Internal Med, Ctr Gastroenterohepatol, Fac Med, Makassar, Indonesia; [Uwan, Willy Brodus] Santo Antonius Hosp, Dept Internal Med, Pontianak, Indonesia; [Simanjuntak, David] Yowari Hosp, Dept Internal Med, Jayapura, Indonesia; [Wibawa, I. Dewa Nyoman] Univ Udayana, Fac Med, Dept Internal Med, Div Gastroenterohepatol, Denpasar, Indonesia; [Waleleng, Jimmy Bradley] Univ Sam Ratulangi, Prof Dr RD Kandou Hosp, Fac Med, Div Gastroenterohepatol,Dept Internal Med, Manado, Indonesia; [Saudale, Alexander Michael Joseph] Prof Dr WZ Johannes Gen Hosp, Div Gastroenterohepatol, Kupang, Indonesia; [Yusuf, Fauzi] Dr Zainoel Abidin Gen Hosp, Dept Internal Med, Div Gastroenterohepatol, Banda Aceh, Indonesia; [Mustika, Syifa] Dr Saiful Anwar Gen Hosp, Dept Internal Med, Div Gastroenterohepatol, Malang, Indonesia	Oita University; Baylor College of Medicine; Airlangga University; Airlangga University; University of Indonesia; University of North Sumatra; Universitas Hasanuddin; Universitas Udayana; Universitas Sam Ratulangi	Yamaoka, Y (corresponding author), Oita Univ, Dept Environm & Prevent Med, Fac Med, Yufu, Japan.; Yamaoka, Y (corresponding author), Baylor Coll Med, Dept Med, Gastroenterol & Hepatol Sect, Houston, TX 77030 USA.	yyamaoka@oita-u.ac.jp	Miftahussurur, Muhammad/AAB-6151-2021; Syam, Ari Fahrial/ABI-4994-2020; MAIMUNAH, UMMI/GQH-0117-2022	maulahela, hasan/0000-0002-0396-4433; Mustika, Syifa/0000-0003-4831-2719; Miftahussurur, Muhammad/0000-0003-1415-6033; Syam, Ari Fahrial/0000-0003-0041-3553; Maimunah, Ummi/0000-0002-2496-4336; Rezkitha, Yudith Annisa Ayu/0000-0001-7600-9114; Akil, Fardah/0000-0002-4222-6011; effendi, wiwin is/0000-0003-3716-2452; Subsomwong, Phawinee/0000-0002-9961-9350; Yamaoka, Yoshio/0000-0002-1222-5819; nasronudin, nasronudin/0000-0001-7882-9992; Yusuf, Fauzi/0000-0002-5822-300X	National Institutes of Health [DK62813]; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [24406015, 24659200, 25293104, 26640114, 15H02657, 221S0002]; Japan Society for the Promotion of Science (JSPS) Institutional Program for Young Researcher Overseas Visits; Strategic Funds for the Promotion of Science and Technology from Japan Science and Technology Agency (JST)	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS) Institutional Program for Young Researcher Overseas Visits; Strategic Funds for the Promotion of Science and Technology from Japan Science and Technology Agency (JST)	This study was funded by grants from the National Institutes of Health (DK62813) and the Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan (24406015, 24659200, 25293104, 26640114,15H02657 and 221S0002) (YY). It was also supported by the Japan Society for the Promotion of Science (JSPS) Institutional Program for Young Researcher Overseas Visits (YY) and the Strategic Funds for the Promotion of Science and Technology from Japan Science and Technology Agency (JST) (YY).	Abdullah Arman A, 2012, Acta Med Indones, V44, P298; Ang TL, 2016, CHANGING PROFILE HEL; Asaka M, 2013, INT J CANCER, V132, P1272, DOI 10.1002/ijc.27965; ATHERTON JC, 1995, J BIOL CHEM, V270, P17771, DOI 10.1074/jbc.270.30.17771; Binh TT, 2015, ANTIMICROB AGENTS CH; Cambau E, 2009, J CLIN MICROBIOL, V47, P3600, DOI 10.1128/JCM.00744-09; Cammarota G, 2000, ALIMENT PHARM THER, V14, P1339, DOI 10.1046/j.1365-2036.2000.00846.x; Cuadrado-Lavin A, 2012, J ANTIMICROB CHEMOTH, V67, P170, DOI 10.1093/jac/dkr410; De Francesco V, 2006, ANN INTERN MED, V144, P94, DOI 10.7326/0003-4819-144-2-200601170-00006; De Francesco V, 2010, J GASTROINTEST LIVER, V19, P409; Fock KM, 2009, J GASTROEN HEPATOL, V24, P1587, DOI 10.1111/j.1440-1746.2009.05982.x; Fock KM, 2010, J GASTROEN HEPATOL, V25, P479, DOI 10.1111/j.1440-1746.2009.06188.x; Francesco Vincenzo De, 2011, World J Gastrointest Pathophysiol, V2, P35, DOI 10.4291/wjgp.v2.i3.35; Garcia M, 2012, ANTIMICROB AGENTS CH, V56, P550, DOI 10.1128/AAC.05243-11; Gerrits MM, 2004, J MED MICROBIOL, V53, P1123, DOI 10.1099/jmm.0.45701-0; Glocker E, 2007, ANTIMICROB AGENTS CH, V51, P346, DOI 10.1128/AAC.00614-06; Ho SL, 2010, J DIGEST DIS, V11, P101, DOI 10.1111/j.1751-2980.2010.00423.x; Ierardi E, 2013, WORLD J GASTROENTERO, V19, P8168, DOI 10.3748/wjg.v19.i45.8168; Khan A, 2012, WORLD J GASTROENTERO, V18, P2245, DOI 10.3748/wjg.v18.i18.2245; Kim Sang Gyun, 2013, Korean J Gastroenterol, V62, P3; Kobayashi I, 2007, J CLIN MICROBIOL, V45, P4006, DOI 10.1128/JCM.00740-07; Kumala Widyasari, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P970; Kwon DH, 2000, J ANTIMICROB CHEMOTH, V46, P793, DOI 10.1093/jac/46.5.793; Lee JW, 2013, HELICOBACTER, V18, P206, DOI 10.1111/hel.12031; Li AQ, 2007, WORLD J GASTROENTERO, V13, P1847, DOI 10.3748/wjg.v13.i12.1847; Liu WZ, 2013, J DIGEST DIS, V14, P211, DOI 10.1111/1751-2980.12034; Malfertheiner P, 2007, GUT, V56, P772, DOI 10.1136/gut.2006.101634; Malfertheiner P, 2012, GUT, V61, P646, DOI 10.1136/gutjnl-2012-302084; Matsumoto Y, 2005, DIGEST LIVER DIS, V37, P821, DOI 10.1016/j.dld.2005.06.002; Matsunari O, 2012, J CLIN MICROBIOL, V50, P876, DOI 10.1128/JCM.05562-11; Megraud F, 1998, GASTROENTEROLOGY, V115, P1278, DOI 10.1016/S0016-5085(98)70101-5; Megraud F, 2013, GUT, V62, P34, DOI 10.1136/gutjnl-2012-302254; Megraud F, 2012, THER ADV GASTROENTER, V5, P103, DOI 10.1177/1756283X11432492; Miftahussurur M, 2015, EPIDEMIOL INFECT, V143, P986, DOI 10.1017/S095026881400154X; Miftahussurur M, 2015, GUT PATHOG, V7, DOI 10.1186/s13099-015-0072-2; Miftahussurur M, 2015, MOLECULES, V20, P6068, DOI 10.3390/molecules20046068; Miwa H, 2002, AM J GASTROENTEROL, V97, P1106, DOI 10.1111/j.1572-0241.2002.05663.x; Nishizawa T, 2006, ANTIMICROB AGENTS CH, V50, P1538, DOI 10.1128/AAC.50.4.1538-1540.2006; Nishizawa T, 2009, J CLIN BIOCHEM NUTR, V44, P119, DOI 10.3164/jcbn.08-220R; Oleastro M, 2006, INFECT IMMUN, V74, P4064, DOI 10.1128/IAI.00123-06; Oleastro M, 2003, J CLIN MICROBIOL, V41, P397, DOI 10.1128/JCM.41.1.397-402.2003; Pandya HB, 2014, INDIAN J MED MICROBI, V32, P408, DOI 10.4103/0255-0857.142256; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Rhead JL, 2007, GASTROENTEROLOGY, V133, P926, DOI 10.1053/j.gastro.2007.06.056; Rimbara E, 2012, HELICOBACTER, V17, P36, DOI 10.1111/j.1523-5378.2011.00912.x; Sugano K, 2015, GUT, V64, P1353, DOI 10.1136/gutjnl-2015-309252; Syam AF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140186; Takahashi A, 2012, INTACT LONG TYPE DUP; Teh X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101481; Binh TT, 2014, J ANTIMICROB CHEMOTH, V69, P1796, DOI 10.1093/jac/dku050; Uchida T, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-175; Vilaichone RK, 2013, DIAGN MICR INFEC DIS, V77, P346, DOI 10.1016/j.diagmicrobio.2013.08.010; Wang LH, 2010, WORLD J GASTROENTERO, V16, P2272, DOI 10.3748/wjg.v16.i18.2272; Yamaoka Y, 1999, J CLIN MICROBIOL, V37, P2274, DOI 10.1128/JCM.37.7.2274-2279.1999; Yamaoka Y, 1999, GASTROENTEROLOGY, V117, P342, DOI 10.1053/gast.1999.0029900342; Yamaoka Y, 2002, GASTROENTEROLOGY, V123, P414, DOI 10.1053/gast.2002.34781	56	42	43	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166199	10.1371/journal.pone.0166199	http://dx.doi.org/10.1371/journal.pone.0166199			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27906990	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000389482700020
J	Takahashi, S; Yonekura, Y; Sasaki, R; Yokoyama, Y; Tanno, K; Sakata, K; Ogawa, A; Kobayashi, S; Yamamoto, T				Takahashi, Shuko; Yonekura, Yuki; Sasaki, Ryohei; Yokoyama, Yukari; Tanno, Kozo; Sakata, Kiyomi; Ogawa, Akira; Kobayashi, Seichiro; Yamamoto, Taro			Weight Gain in Survivors Living in Temporary Housing in the Tsunami-Stricken Area during the Recovery Phase following the Great East Japan Earthquake and Tsunami	PLOS ONE			English	Article							BODY-MASS INDEX; ATHENS-INSOMNIA-SCALE; RISK-FACTORS; DIETARY PATTERNS; OBESITY; STRESS; ENVIRONMENT; POPULATION; PREVALENCE; VALIDATION	Introduction Survivors who lost their homes in the Great East Japan Earthquake and Tsunami were forced to live in difficult conditions in temporary housing several months after the disaster. Body weights of survivors living in temporary housing for a long period might increase due to changes in their life style and psychosocial state during the medium-term and long-term recovery phases. The aim of this study was to determine whether there were differences between body weight changes of people living in temporary housing and those not living in temporary housing in a tsunami-stricken area during the medium-term and long-term recovery phases. Materials and methods Health check-ups were performed about 7 months after the disaster (in 2011) and about 18 months after the disaster (in 2012) for people living in a tsunami-stricken area (n = 6,601, mean age = 62.3 y). We compared the changes in body weight in people living in temporary housing (TH group, n = 2,002) and those not living in temporary housing (NTH group, n = 4,599) using a multiple linear regression model. Results While there was no significant difference between body weights in the TH and NTH groups in the 2011 survey, there was a significant difference between the mean changes in body weight in both sexes. We found that the changes in body weight were significantly greater in the TH group than in the NTH group in both sexes. The partial regression coefficients of mean change in body weight were +0.52 kg (P-value < 0.001) in males in the TH group and +0.56 kg (P-value < 0.001) in females in the TH group (reference: NTH group). Conclusion Analysis after adjustment for life style, psychosocial factors and cardiovascular risk factors found that people living in temporary housing in the tsunami-stricken area had a significant increase in body weight.	[Takahashi, Shuko; Yamamoto, Taro] Nagasaki Univ, Grad Sch Biomed Sci, Dept Int Hlth, Nagasaki, Japan; [Yonekura, Yuki; Tanno, Kozo; Sakata, Kiyomi] Iwate Med Univ, Sch Med, Dept Hyg & Prevent Med, Yahaba, Iwate, Japan; [Sasaki, Ryohei] Iwate Tohoku Med Megabank Org, Yahaba, Iwate, Japan; [Yokoyama, Yukari] Nihon Fukushi Univ, Dept Social Welf, Mihama, Aichi, Japan; [Ogawa, Akira] Iwate Med Univ, Morioka, Iwate, Japan; [Kobayashi, Seichiro] Iwate Med Univ, Sch Med, Dept Plast & Reconstruct Surg, Morioka, Iwate, Japan; [Takahashi, Shuko; Yamamoto, Taro] Nagasaki Univ, Inst Trop Med, Dept Int Hlth, Nagasaki, Japan	Nagasaki University; Iwate Medical University; Iwate Medical University; Iwate Medical University; Nagasaki University	Takahashi, S (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Int Hlth, Nagasaki, Japan.; Takahashi, S (corresponding author), Nagasaki Univ, Inst Trop Med, Dept Int Hlth, Nagasaki, Japan.	shutakahashi-iwt@umin.ac.jp	Tanno, Kozo/ABE-5165-2020; Tanno, Kozo/HDM-5952-2022; Yonekura, Yuki/C-5973-2013	Tanno, Kozo/0000-0002-1264-0684; Tanno, Kozo/0000-0002-1264-0684; Yonekura, Yuki/0000-0002-2590-2022	Ministry of Health, Labour, and Welfare of Japan [H23-Tokubetsu-Shitei-002, H24-kenki-sitei-001]; Research Institute for Humanity and Nature, Japan; Environment Research and Technology Development Fund of Ministry of the Environment, Japan [S-11-3]	Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Research Institute for Humanity and Nature, Japan; Environment Research and Technology Development Fund of Ministry of the Environment, Japan	The study was supported by a Health Labour Sciences Research Grant from the Ministry of Health, Labour, and Welfare of Japan (H23-Tokubetsu-Shitei-002; H24-kenki-sitei-001). This work was partly conducted at the Joint Usage / Research Center on Tropical Disease, Institute of Tropical Medicine, Nagasaki University (http://www.mext.go.jp/a_menu/kyoten/). This study is a part of the incubation study "Exploratory Studies on Human Adaptation Mechanism to Modern Plague" funded by the Research Institute for Humanity and Nature, Japan. This research was in part supported by Environment Research and Technology Development Fund (S-11-3) of Ministry of the Environment, Japan.	Arai H, 2012, GUIDELINES PRIMARY P; Aranceta J, 2001, EUR J CLIN NUTR, V55, P430, DOI 10.1038/sj.ejcn.1601189; Aranceta J, 2007, PUBLIC HEALTH NUTR, V10, P1187, DOI 10.1017/S1368980007000699; Arbeeny CM, 2004, OBES RES, V12, P1191, DOI 10.1038/oby.2004.150; Arcaya M, 2014, PREV MED, V65, P40, DOI 10.1016/j.ypmed.2014.04.006; Cabinet Office Government of Japan, 2011, NUMB VICT EV SHELT G; Centers for Disease Control and Prevention, 2015, AD OB CAUS CONS; Centers for Disease Control and Prevention, 2015, OTH FACT WEIGHT GAIN; Chapman IM, 2011, MED CLIN N AM, V95, P579, DOI 10.1016/j.mcna.2011.02.004; Chiriboga DE, 2008, OBESITY, V16, P137, DOI 10.1038/oby.2007.38; Division of Consumer and Environmental Protection Reconstruction bureau Iwate prefecture, 2015, SIT VICT EM TEMP HOU; Drewnowski A, 2014, INT J OBESITY, V38, P306, DOI 10.1038/ijo.2013.97; Economic Research Bureau The Cabinet Office Government of Japan, 2011, AM CAP STOCK DAM EST; Geospatial Information Authority of Japan Ministry of Land Infrastructure Transport and Tourism, 2011, AR IN RANG CAUS TSUN; Goff DC, 2013, CIRCULATION, V2014, P129, DOI DOI 10.1161/01.CIR.0000437741.48606; Harding JL, 2014, OBESITY, V22, P277, DOI 10.1002/oby.20423; Harsha DW, 2008, HYPERTENSION, V51, P1420, DOI 10.1161/HYPERTENSIONAHA.107.094011; Ishii Takeaki, 2015, Prev Med Rep, V2, P916, DOI 10.1016/j.pmedr.2015.10.009; Ishiki A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147025; Japan Science and Technology Agency, 2014, GREAT E JAP EARTHQ I; Jousilahti P, 1996, CIRCULATION, V93, P1372, DOI 10.1161/01.CIR.93.7.1372; Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184; Kivimaki M, 2006, INT J OBESITY, V30, P982, DOI 10.1038/sj.ijo.0803229; KLESGES RC, 1989, PSYCHOL BULL, V106, P204, DOI 10.1037/0033-2909.106.2.204; Koyama S, 2014, TOHOKU J EXP MED, V234, P241, DOI 10.1620/tjem.234.241; Martikainen PT, 1999, AM J CLIN NUTR, V69, P719; Ministry of health labor and welfare Japan, 2015, EX GUID GOOD HLTH 20; Ministry of Internal Affairs and Communications, 2015, 2011 PAC COAST TOH E; Moore CJ, 2012, J ACAD NUTR DIET, V112, P518, DOI 10.1016/j.jand.2011.12.001; Murakami Haruka, 2013, Nihon Koshu Eisei Zasshi, V60, P222; Newby P, 2003, AM J CLIN NUTR, V77, P1417, DOI 10.1093/ajcn/77.6.1417; Newby PK, 2006, J NUTR, V136, P2580, DOI 10.1093/jn/136.10.2580; Nishi N, 2013, J EPIDEMIOL, V23, P376, DOI 10.2188/jea.JE20130025; Office of Disease Prevention and Health Promotion, 2016, DIET PATT BOD WEIGHT; Okajima I, 2013, PSYCHIAT CLIN NEUROS, V67, P420, DOI 10.1111/pcn.12073; Panagiotakos DB, 2004, OBES RES, V12, P1914, DOI 10.1038/oby.2004.239; Papas MA, 2007, EPIDEMIOL REV, V29, P129, DOI 10.1093/epirev/mxm009; Research and Survey Division Department of Policy and Regional Affairs Iwate Prefectural Government, 2011, MONTHL EST IWATE PRE; Sakurai K, 2011, PSYCHIAT CLIN NEUROS, V65, P434, DOI 10.1111/j.1440-1819.2011.02236.x; Seino Y, 2010, J DIABETES INVEST, V1, P1, DOI 10.1111/j.2040-1124.2010.00005.x; Soldatos CR, 2000, J PSYCHOSOM RES, V48, P555, DOI 10.1016/S0022-3999(00)00095-7; Soldatos CR, 2005, SLEEP MED, V6, P5, DOI 10.1016/j.sleep.2004.10.006; Soldatos CR, 2003, J PSYCHOSOM RES, V55, P263, DOI 10.1016/S0022-3999(02)00604-9; Sone T, 2016, SOC SCI MED, V152, P96, DOI 10.1016/j.socscimed.2016.01.037; Takahashi S, 2015, DISASTER MED PUBLIC, V9, P103, DOI 10.1017/dmp.2015.6; The National Police Agency, 2014, DAM SIT POL MEAS 201; TREVISAN M, 1986, ARTERIOSCLEROSIS, V6, P491, DOI 10.1161/01.ATV.6.5.491; Tsubokura M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-267; Tsuboyama-Kasaoka N, 2014, ASIA PAC J CLIN NUTR, V23, P159, DOI 10.6133/apjcn.2014.23.1.17; Ueda S, 2012, TOHOKU J EXP MED, V227, P199, DOI 10.1620/tjem.227.199; Yokoyama Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102497; Yoshimura E., 2014, IWATE KOSHU EISEI ZA, V25, p7.	52	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166817	10.1371/journal.pone.0166817	http://dx.doi.org/10.1371/journal.pone.0166817			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3JC	27907015	gold, Green Published, Green Submitted			2022-12-26	WOS:000389482700043
J	Verburgh, L; Scherder, EJA; Van Lange, PAM; Oosterlaan, J				Verburgh, Lot; Scherder, Erik J. A.; Van Lange, Paul A. M.; Oosterlaan, Jaap			Do Elite and Amateur Soccer Players Outperform Non-Athletes on Neurocognitive Functioning? A Study Among 8-12 Year Old Children	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; SEDENTARY BEHAVIOR; WORKING-MEMORY; INTERVENTION; ASSOCIATIONS; ACHIEVEMENT; EXERCISE; FITNESS; OBESITY	Aim Research suggested a positive association between physical fitness and neurocognitive functioning in children. Aim of the present study is to investigate possible dose-response relationships between diverse daily physical activities and a broad range of neurocognitive functions in preadolescent children. Furthermore, the relationship between several sedentary behaviours, including TV-watching, gaming and computer time, and neurocognitive functioning will be investigated in this group of children. Methods A total of 168 preadolescent boys, aged 8 to 12 years, were recruited from various locations, including primary schools, an amateur soccer club, and a professional soccer club, to increase variability in the amount of participation in sports. All children performed neurocognitive tasks measuring inhibition, short term memory, working memory, attention and information processing speed. Regression analyses examined the predictive power of a broad range of physical activities, including sports, active transport to school, physical education (PE), outdoor play, and sedentary behaviour such as TV-watching and gaming, for neurocognitive functioning. Results Time spent in sports significantly accounted for the variance in inhibition, short term memory, working memory and lapses of attention, where more time spent in sports was associated with better performance. Outdoor play was also positively associated with working memory. In contrast, time spent on the computer was negatively associated with inhibition. Conclusions Results of the current study suggest a positive relationship between participation in sports and several important neurocognitive functions. Interventions are recommended to increase sports participation and to reduce sedentary behaviour in preadolescent children.	[Verburgh, Lot; Scherder, Erik J. A.; Oosterlaan, Jaap] Vrije Univ Amsterdam, Clin Neuropsychol Sect, Amsterdam, Netherlands; [Van Lange, Paul A. M.] Vrije Univ Amsterdam, Dept Expt & Appl Psychol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Oosterlaan, J (corresponding author), Vrije Univ Amsterdam, Clin Neuropsychol Sect, Amsterdam, Netherlands.	j.oosterlaan@vu.nl		Van Lange, Paul/0000-0001-7774-6984				Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Anobile G, 2013, J EXP CHILD PSYCHOL, V116, P380, DOI 10.1016/j.jecp.2013.06.006; Baddeley A, 2012, ANNU REV PSYCHOL, V63, P1, DOI 10.1146/annurev-psych-120710-100422; Ballester R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123898; Biddle SJH, 2004, J R SOC PROMO HEALTH, V124, P29, DOI 10.1177/146642400312400110; Brockman R, 2010, PREV MED, V51, P144, DOI 10.1016/j.ypmed.2010.05.012; Buckley J, 2014, FRONT HUM NEUROSCI, V8, DOI [10.3389/Mhum.2014.00747, 10.3389/fnhum.2014.00747, 10.3389/fnhum.2014.00584]; Bull R, 2008, DEV NEUROPSYCHOL, V33, P205, DOI 10.1080/87565640801982312; Carlson JA, 2013, PREV MED, V57, P591, DOI 10.1016/j.ypmed.2013.08.003; Chen AG, 2014, PSYCHOL SPORT EXERC, V15, P627, DOI 10.1016/j.psychsport.2014.06.004; Chin A, 2015, PREV MED, V70, P1, DOI [10.1016/j.ypmed.2014.10.029, DOI 10.1016/J.YPMED.2014.10.029]; Cohen J.E., 1988, STAT POWER ANAL BEHA; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Dietz WH, 1999, AM J CLIN NUTR, V70, p123S; Dollman J, 2009, J SCI MED SPORT, V12, P518, DOI 10.1016/j.jsams.2008.09.007; Eime RM, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-98; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Field A., 2009, DISCOVERING STAT USI, V3, DOI DOI 10.1080/1057610X.2016.1157408; Friedman SL, 2003, ARCH PEDIAT ADOL MED, V157, P185; Guagliano JM, 2013, MED SCI SPORT EXER, V45, P116, DOI 10.1249/MSS.0b013e31826a0a73; Hamer M, 2014, MED SCI SPORT EXER, V46, P718, DOI 10.1249/MSS.0000000000000156; Kamijo K, 2011, DEVELOPMENTAL SCI, V14, P1046, DOI 10.1111/j.1467-7687.2011.01054.x; Kesse-Guyot E, 2012, PLOS ONE; Kessels R P, 2000, Appl Neuropsychol, V7, P252, DOI 10.1207/S15324826AN0704_8; Kimm SYS, 2002, NEW ENGL J MED, V347, P709, DOI 10.1056/NEJMoa003277; Lacouture Y, 2008, TUTOR QUANT METHODS, V4, P35, DOI 10.20982/tqmp.04.1.p035; LIN H, 2013, MATH PROBL ENG, V2013, P1, DOI DOI 10.1371/J0URNAL.P0NE.0060516; Littel M, 2012, ADDICT BIOL, V17, P934, DOI 10.1111/j.1369-1600.2012.00467.x; Ljach V, 2012, PERCEPT MOTOR SKILL, V114, P485, DOI 10.2466/05.10.25.PMS.114.2.485-506; LOGAN GD, 1984, PSYCHOL REV, V91, P295, DOI 10.1037/0033-295X.91.3.295; Nevo E, 2011, J EXP CHILD PSYCHOL, V109, P73, DOI 10.1016/j.jecp.2010.09.010; Nutley SB, 2010, DEV NEUROPSYCHOL, V35, P81, DOI 10.1080/87565640903325741; Ooijendijk W, 2007, CONSENSUS VRAGENLIJS; Pate RR, 2011, BRIT J SPORT MED, V45, P906, DOI 10.1136/bjsports-2011-090192; Pearson N, 2014, OBES REV, V15, P666, DOI 10.1111/obr.12188; Pulles I, 2014, JEUGDBELEID, V8, P21; Schaeffer DJ, 2014, PSYCHOPHYSIOLOGY, V51, P728, DOI 10.1111/psyp.12227; Silva G, 2013, J SPORT SCI, V31, P1359, DOI 10.1080/02640414.2013.781666; Smith E, 2011, OBES REV, V12, P740, DOI 10.1111/j.1467-789X.2011.00920.x; Soga K., 2016, J PHYS FITNESS SPORT, V5, P57, DOI [10.7600/jpfsm.5.57, DOI 10.7600/JPFSM.5.57]; Strong WB, 2005, J PEDIATR-US, V146, P732, DOI 10.1016/j.jpeds.2005.01.055; Tabachnick BG, 2001, USING MULTIVARIATE S, P62; Tamnes CK, 2012, J NEUROSCI, V32, P972, DOI 10.1523/JNEUROSCI.4779-11.2012; Treuth MS, 2004, MED SCI SPORT EXER, V36, P198, DOI 10.1249/01.MSS.0000113666.98463.B0; van der Niet AG, 2016, PEDIATR EXERC SCI, V28, P64, DOI 10.1123/pes.2015-0084; Verburgh L., 2013, BR J SPORTS MED; Verburgh L, 2016, J SPORTS SCI, P1; Verburgh L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091254; Voss MW, 2014, MENT HEALTH PHYS ACT, V7, P9, DOI 10.1016/j.mhpa.2014.01.001; Wechsler D, 2008, WAIS 3 WECHSLER ADUL, VFourth; Whelan R, 2008, PSYCHOL RECORD, V58; Wickel EE, 2007, MED SCI SPORT EXER, V39, P1493, DOI 10.1249/mss.0b013e318093f56a	53	36	37	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0165741	10.1371/journal.pone.0165741	http://dx.doi.org/10.1371/journal.pone.0165741			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3JC	27906965	gold, Green Published, Green Submitted			2022-12-26	WOS:000389482700010
J	Biswas, T; Islam, MS; Linton, N; Rawal, LB				Biswas, Tuhin; Islam, Md. Saimul; Linton, Natalie; Rawal, Lal B.			Socio-Economic Inequality of Chronic Non Communicable Diseases in Bangladesh	PLOS ONE			English	Article							HEALTH INEQUALITIES; NONCOMMUNICABLE DISEASES	Introduction Chronic non-communicable diseases (NCDs) are a major public health challenge, and undermine social and economic development in much of the developing world, including Bangladesh. Epidemiologic evidence on the socioeconomic status (SES)-related pattern of NCDs remains limited in Bangladesh. This study assessed the relationship between three chronic NCDs and SES among the Bangladeshi population, paying particular attention to the differences between urban and rural areas. Materials and Method Data from the 2011 Bangladesh Demographic and Health Survey were used for this study. Using a concentration index (CI), we measured relative inequality across pre-diabetes, diabetes, pre-hypertension, hypertension, and BMI (underweight, normal weight, and overweight/obese) in urban and rural areas in Bangladesh. A CI and its associated curve can be used to identify whether socioeconomic inequality exists for a given health variable. In addition, we estimated the health achievement index, integrating mean coverage and the distribution of coverage by rural and urban populations. Results Socioeconomic inequalities were observed across diseases and risk factors. Using CI, significant inequalities observed for pre-hypertension (CI = 0.09, p = 0.001), hypertension (CI = 0.10, p = 0.001), pre-diabetes (CI = -0.01, p = 0.005), diabetes (CI = 0.19, p<0.001), and overweight/obesity (CI = 0.45, p<0.001). In contrast to the high prevalence of the chronic health conditions among the urban richest, a significant difference in CI was observed for pre-hypertension (CI = -0.20, p = 0.001), hypertension (CI = -0.20, p = 0.005), pre-diabetes (CI = -0.15, p = 0.005), diabetes (CI = -0.26, p = 0.004) and overweight/obesity (CI = 0.25, p = 0.004) were observed more among the low wealth quintiles of rural population. In the same vein, the poorest rural households had more co-morbidities compared to the richest rural households (p = 0.003), and prevalence of co-morbidities was much higher for the richest urban households compared to the poorest urban households. On the other hand in that no competing interests exist. rural the "disachievement" of health indicators is more noticeable than the urban ones. Conclusion The findings indicate the high burden of selected NCDs among the low wealth quintile populations in rural areas and wealthy populations in urban areas. Particular attentions may be necessary to address the problem of NCDs among these groups.	[Biswas, Tuhin; Islam, Md. Saimul; Rawal, Lal B.] Icddr B, Hlth Syst & Populat Studies Div, Mohakhali, Bangladesh; [Linton, Natalie] Oregon State Univ, Corvallis, OR 97331 USA; [Rawal, Lal B.] BRAC Univ, James P Grant Sch Publ Hlth, Dhaka, Bangladesh	International Centre for Diarrhoeal Disease Research (ICDDR); Oregon State University; Bangladesh Rural Advancement Committee BRAC; BRAC University	Biswas, T (corresponding author), Icddr B, Hlth Syst & Populat Studies Div, Mohakhali, Bangladesh.	tuhin.biswas@icddrb.org	Linton, Natalie/AGY-8116-2022	Linton, Natalie/0000-0002-5464-0076; Rawal, Lal/0000-0003-1106-0108; Biswas, Tuhin/0000-0002-7837-0306				ABUSAYEED M, 1995, DIABETES CARE, V18, P555, DOI 10.2337/diacare.18.4.555; Ahmed S., 2013, J NUTR HLTH, V1, P18, DOI [10.12691/jnh-1-1-3, DOI 10.12691/JNH-1-1-3]; Akter S, 2014, B WORLD HEALTH ORGAN, V92, P204, DOI 10.2471/BLT.13.128371; [Anonymous], 2008, ANAL HLTH EQUITY USI; Avendano M, 2006, HEART, V92, P461, DOI 10.1136/hrt.2005.065532; Baker J, 1993, EQUITY FINANCE DELIV; Baker J. L., 2007, DHAKA IMPROVING LIVI; BBS, 2011, TAT POCK BANGL 2010; Bleich SN, 2011, HEALTH POLICY, V100, P282, DOI 10.1016/j.healthpol.2010.09.004; Chalasani S, 2012, SOC SCI MED, V75, P2160, DOI 10.1016/j.socscimed.2012.08.012; Chowdhury ME, 2009, J HEALTH POPUL NUTR, V27, P108; Commission BP, 2013, MILL DEV GOALS BANGL; D'Orazio P, 2005, CLIN CHEM, V51, P1573, DOI 10.1373/clinchem.2005.051979; Demographic B, 2013, HLTH SURV BDHS 2011; Demographic B, 2012, HLTH SURV 2011; DHS M, 2012, DEM HLTH SURV; Di Cesare M, 2013, LANCET, V381, P585, DOI 10.1016/S0140-6736(12)61851-0; El Arifeen S, 2014, LANCET, V384, P1366, DOI 10.1016/S0140-6736(14)60955-7; Giashuddin M. S., 2005, Indian Journal of Pediatrics, V72, P481, DOI 10.1007/BF02724424; Gupta R, 2003, J Assoc Physicians India, V51, P470; Gupta R, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-8; Gupta R, 2010, PREV MED, V51, P408, DOI 10.1016/j.ypmed.2010.08.014; Gwatkin D. R., 2009, SOCIOECONOMIC DIFFER; Hosseinpoor AR, 2012, BMC PUBLIC HEALTH, V12, DOI [10.1186/1471-2458-12-198, 10.1186/1471-2458-12-912]; Islam A., 2014, AM J HLTH RES, V6, P366, DOI [10.11648/j.ajhr.20140206.18, DOI 10.11648/J.AJHR.20140206.18]; Islam A, HLTH SYSTEM BOTTLENE; Islam A, 2015, EUROPEAN J PREVENTIV, V3, P63; Islam A, HLTH SYSTEM FINANCIN; Kakwani N, 1997, J ECONOMETRICS, V77, P87, DOI 10.1016/S0304-4076(96)01807-6; KAKWANI NC, 1977, ECON J, V87, P71, DOI 10.2307/2231833; Kakwani NC, 1980, INCOME INEQUALITY PO; Le Gales-Camus C, 2005, PREVENTING CHRONIC D; Mackintosh M., 2001, POVERTY INEQUALITY H; Organization WH, 2009, GLOB HLTH RISKS MORT; Organization WH, 2011, NONC DIS RISK FACT S; Rahman MM, 2014, J HYPERTENSION; Reddy KS, 2007, P NATL ACAD SCI USA, V104, P16263, DOI 10.1073/pnas.0700933104; Ruger JP, 2006, J EPIDEMIOL COMMUN H, V60, P928, DOI 10.1136/jech.2005.041954; Siegel KR, 2014, BRIT MED BULL, V111, P31, DOI 10.1093/bmb/ldu018; Sommer I, 2015, BMC PUBLIC HEALTH, V15, P1; Vellakkal S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068219; WAGSTAFF A, 1994, HEALTH ECON, V3, P281, DOI 10.1002/hec.4730030409; Wagstaff A, 2005, HEALTH ECON, V14, P429, DOI 10.1002/hec.953; Wagstaff A, 2002, B WORLD HEALTH ORGAN, V80, P97; Wagstaff A, 2002, J HEALTH ECON, V21, P627, DOI 10.1016/S0167-6296(02)00006-1; Wagstaff A., 2000, RES EQUITY POVERTY H; Wagstaff A., 2002, INEQUALITIES HLTH DE; World Health Organization, 2006, DEF DIAGN DIAB MELL; Zaman MJ, 2012, INT J EPIDEMIOL	50	46	48	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167140	10.1371/journal.pone.0167140	http://dx.doi.org/10.1371/journal.pone.0167140			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FV	27902760	Green Published, gold			2022-12-26	WOS:000389474100056
J	Leung, JM; Malagoli, A; Santoro, A; Besutti, G; Ligabue, G; Scaglioni, R; Dai, D; Hague, C; Leipsic, J; Sin, DD; Man, SFP; Guaraldi, G				Leung, Janice M.; Malagoli, Andrea; Santoro, Antonella; Besutti, Giulia; Ligabue, Guido; Scaglioni, Riccardo; Dai, Darlene; Hague, Cameron; Leipsic, Jonathon; Sin, Don D.; Man, S. F. Paul; Guaraldi, Giovanni			Emphysema Distribution and Diffusion Capacity Predict Emphysema Progression in Human Immunodeficiency Virus Infection	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; ANTIRETROVIRAL THERAPY; HIV; COPD; CT; RISK; INFLAMMATION; SYMPTOMS; SMOKERS; LUNG	Background Chronic obstructive pulmonary disease (COPD) and emphysema are common amongst patients with human immunodeficiency virus (HIV). We sought to determine the clinical factors that are associated with emphysema progression in HIV. Methods 345 HIV-infected patients enrolled in an outpatient HIV metabolic clinic with >= 2 chest computed tomography scans made up the study cohort. Images were qualitatively scored for emphysema based on percentage involvement of the lung. Emphysema progression was defined as any increase in emphysema score over the study period. Univariate analyses of clinical, respiratory, and laboratory data, as well as multivariable logistic regression models, were performed to determine clinical features significantly associated with emphysema progression. Results 17.4% of the cohort were emphysema progressors. Emphysema progression was most strongly associated with having a low baseline diffusion capacity of carbon monoxide (DLCO) and having combination centrilobular and paraseptal emphysema distribution. In adjusted models, the odds ratio (OR) for emphysema progression for every 10% increase in DLCO percent predicted was 0.58 (95% confidence interval [CI] 0.41-0.81). The equivalent OR (95% CI) for centrilobular and paraseptal emphysema distribution was 10.60 (2.93-48.98). Together, these variables had an area under the curve (AUC) statistic of 0.85 for predicting emphysema progression. This was an improvement over the performance of spirometry (forced expiratory volume in 1 second to forced vital capacity ratio), which predicted emphysema progression with an AUC of only 0.65. Conclusion Combined paraseptal and centrilobular emphysema distribution and low DLCO could identify HIV patients who may experience emphysema progression.	[Leung, Janice M.; Sin, Don D.; Man, S. F. Paul] Univ British Columbia, Ctr Heart Lung Innovat, Vancouver, BC, Canada; [Leung, Janice M.; Sin, Don D.; Man, S. F. Paul] St Pauls Hosp, Div Resp Med, Dept Med, Vancouver, BC, Canada; [Malagoli, Andrea; Santoro, Antonella; Besutti, Giulia; Ligabue, Guido; Scaglioni, Riccardo; Guaraldi, Giovanni] Univ Modena & Reggio Emilia, Modena HIV Metab Clin, Modena, Italy; [Dai, Darlene] Univ British Columbia, PROOF Ctr Excellence, Vancouver, BC, Canada; [Hague, Cameron; Leipsic, Jonathon] Univ British Columbia, Dept Radiol, Vancouver, BC, Canada	University of British Columbia; St. Paul's Hospital; University of Saskatchewan; Universita di Modena e Reggio Emilia; University of British Columbia; University of British Columbia	Guaraldi, G (corresponding author), Univ Modena & Reggio Emilia, Modena HIV Metab Clin, Modena, Italy.	Giovanni.guaraldi@unimore.it	Leipsic, Jonathon/ABE-6194-2020; Sin, Don/AAC-2219-2021; Guaraldi, Giovanni/J-9467-2018; Besutti, Giulia/K-5453-2018; Malagoli, Andrea/I-7744-2015	Besutti, Giulia/0000-0001-5319-5495; Malagoli, Andrea/0000-0001-7857-4133; Santoro, Antonella/0000-0002-2345-9135	RICERCA FINALIZZATA, Ministry of Health [GR-2011-0230596]	RICERCA FINALIZZATA, Ministry of Health	This work was supported by RICERCA FINALIZZATA 2011-2012, Ministry of Health (Project code: GR-2011-0230596). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by RICERCA FINALIZZATA 2011-2012, Ministry of Health (Project code: GR-2011-0230596). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron CP, 2015, RESP MED, V109, P255, DOI 10.1016/j.rmed.2014.10.004; Attia EF, 2014, CHEST, V146, P1543, DOI 10.1378/chest.14-0543; Barr RG, 2012, COPD, V9, P151, DOI 10.3109/15412555.2012.654923; Bhavani S, 2015, AM J RESP CRIT CARE, V192, P1171, DOI 10.1164/rccm.201504-0736OC; Castaldi PJ, 2013, AM J RESP CRIT CARE, V188, P1083, DOI 10.1164/rccm.201305-0873OC; Clausen E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112237; Coxson HO, 2013, LANCET RESP MED, V1, P129, DOI 10.1016/S2213-2600(13)70006-7; Crothers K, 2006, CHEST, V130, P1326, DOI 10.1378/chest.130.5.1326; Crothers K, 2011, AM J RESP CRIT CARE, V183, P388, DOI 10.1164/rccm.201006-0836OC; Diaz AA, 2010, CHEST, V138, P880, DOI 10.1378/chest.10-0542; Drummond MB, 2013, AIDS, V27, P1303, DOI 10.1097/QAD.0b013e32835e395d; Edge J, 1966, BR J DIS CHEST, V60, P10; Fitzpatrick ME, 2014, AIDS, V28, P2505, DOI 10.1097/QAD.0000000000000471; George MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006328; Gietema HA, 2013, RESP MED, V107, P1201, DOI 10.1016/j.rmed.2013.04.016; Gingo MR, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-75; Guaraldi G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109027; JONES PW, 1991, RESP MED, V85, P25, DOI 10.1016/S0954-6111(06)80166-6; Kazerooni EA, 1997, AM J ROENTGENOL, V169, P977, DOI 10.2214/ajr.169.4.9308447; Leung JM, 2014, AIDS PATIENT CARE ST, V28, P240, DOI 10.1089/apc.2013.0373; Liu JCY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124426; Miller MR, 2005, EUR RESPIR J, V26, P153, DOI 10.1183/09031936.05.00034505; Norris KA, 2006, IMMUNOL RES, V36, P175, DOI 10.1385/IR:36:1:175; Norris KA, 2011, IMMUNOL RES, V50, P175, DOI 10.1007/s12026-011-8218-x; Samperiz G, 2014, HIV MED, V15, P321, DOI 10.1111/hiv.12117; Schroeder JD, 2013, AM J ROENTGENOL, V201, pW460, DOI 10.2214/AJR.12.10102; Sigel K, 2014, AIDS LONDON ENGLAND; Smith BM, 2014, AM J MED, V127, DOI 10.1016/j.amjmed.2013.09.020; SNIDER GL, 1985, AM REV RESPIR DIS, V132, P182; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP	30	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167247	10.1371/journal.pone.0167247	http://dx.doi.org/10.1371/journal.pone.0167247			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902753	Green Published, Green Submitted, gold			2022-12-26	WOS:000389474100063
J	Malatesta, L; Tardella, FM; Piermarteri, K; Catorci, A				Malatesta, Luca; Tardella, Federico Maria; Piermarteri, Karina; Catorci, Andrea			Evidence of Facilitation Cascade Processes as Drivers of Successional Patterns of Ecosystem Engineers at the Upper Altitudinal Limit of the Dry Puna	PLOS ONE			English	Article							PLANT-PLANT INTERACTIONS; STRESS-GRADIENT HYPOTHESIS; SPECIES RICHNESS; PHYLOGENETIC DIVERSITY; COMMUNITY ORGANIZATION; POSITIVE INTERACTIONS; SPATIAL INTERACTIONS; CUSHION PLANTS; NURSE PLANTS; SOIL	Facilitation processes constitute basic elements of vegetation dynamics in harsh systems. Recent studies in tropical alpine environments demonstrated how pioneer plant species defined as "ecosystem engineers" are capable of enhancing landscape-level richness by adding new species to the community through the modification of microhabitats, and also provided hints about the alternation of different ecosystem engineers over time. Nevertheless, most of the existing works analysed different ecosystem engineers separately, without considering the interaction of different ecosystem engineers. Focusing on the altitudinal limit of Peruvian Dry Puna vegetation, we hypothesized that positive interactions structure plant communities by facilitation cascades involving different ecosystem engineers, determining the evolution of the microhabitat patches in terms of abiotic resources and beneficiary species hosted. To analyze successional mechanisms, we used a "space-for-time" substitution to account for changes over time, and analyzed data on soil texture, composition, and temperature, facilitated species and their interaction with nurse species, and surface area of engineered patches by means of chemical analyses, indicator species analysis, and rarefaction curves. A successional process, resulting from the dynamic interaction of different ecosystem engineers, which determined a progressive amelioration of soil conditions (e.g. nitrogen and organic matter content, and temperature), was the main driver of species assemblage at the community scale, enhancing species richness. Cushion plants act as pioneers, by starting the successional processes that continue with shrubs and tussocks. Tussock grasses have sometimes been found to be capable of creating microhabitat patches independently. The dynamics of species assemblage seem to follow the nested assemblage mechanism, in which the first foundation species to colonize a habitat provides a novel substrate for colonization by other foundation species through a facilitation cascade process.	[Malatesta, Luca; Piermarteri, Karina] Univ Camerino, Sch Adv Studies, Camerino, Macerata, Italy; [Tardella, Federico Maria; Catorci, Andrea] Univ Camerino, Sch Biosci & Vet Med, Camerino, Macerata, Italy	University of Camerino; University of Camerino	Tardella, FM (corresponding author), Univ Camerino, Sch Biosci & Vet Med, Camerino, Macerata, Italy.	dtfederico.tardella@unicam.it		Malatesta, Luca/0000-0003-1887-4163	University Research Funds (FAR); School of Advanced Studies PhD Course in Environmental Sciences and Public Health, University of Camerino (Italy)	University Research Funds (FAR); School of Advanced Studies PhD Course in Environmental Sciences and Public Health, University of Camerino (Italy)	The research was funded by University Research Funds (FAR 2012) assigned by the University of Camerino (Italy) to AC (http://www. unicam.it/) and a grant of the School of Advanced Studies PhD Course in Environmental Sciences and Public Health, University of Camerino (Italy) assigned to LM (http://isas.unicamit/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar MR, 1999, TRENDS ECOL EVOL, V14, P273, DOI 10.1016/S0169-5347(99)01612-2; Angelini C, 2011, BIOSCIENCE, V61, P782, DOI 10.1525/bio.2011.61.10.8; Anthelme F, 2012, PERSPECT PLANT ECOL, V14, P363, DOI 10.1016/j.ppees.2012.05.002; Anthelme F, 2012, J VEG SCI, V23, P62, DOI 10.1111/j.1654-1103.2011.01333.x; Armas C, 2013, NEW PHYTOL, V200, P7, DOI 10.1111/nph.12460; Arredondo-Nunez A, 2009, COMMUNITY ECOL, V10, P1, DOI 10.1556/ComEc.10.2009.1.1; Badano EI, 2002, REV CHIL HIST NAT, V75, P757; Badano EI, 2006, OIKOS, V115, P369, DOI 10.1111/j.2006.0030-1299.15132.x; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Brack Egg A, 2000, ECOLOGIA DEL PERU; Brako L, 1993, MONOGRAPHS SYSTEMATI, P45; Bruno JF, 2001, MARINE COMMUNITY ECOLOGY, P201; Caceres Y, 2015, PLANT ECOL DIVERS, V8, P147, DOI 10.1080/17550874.2014.960173; Callaway R. M., 2007, POSITIVE INTERACTION; Callaway RM, 2002, NATURE, V417, P844, DOI 10.1038/nature00812; Callaway RM, 2005, ECOLOGY, V86, P1856, DOI 10.1890/04-0784; Carteni F, 2012, J THEOR BIOL, V313, P153, DOI 10.1016/j.jtbi.2012.08.008; Catorci A, 2012, COMMUNITY ECOL, V13, P253, DOI 10.1556/ComEc.13.2012.2.16; Catorci A, 2016, J PLANT ECOL, V9, P296, DOI 10.1093/jpe/rtv062; Catorci A, 2014, POL J ECOL, V62, P385, DOI 10.3161/104.062.0201; Catorci A, 2014, PHYTOCOENOLOGIA, V44, P103, DOI 10.1127/0340-269X/2014/0044-0577; Catorci A, 2011, ALPINE BOT, V121, P113, DOI 10.1007/s00035-011-0097-1; Cavieres LA, 2007, ARCT ANTARCT ALP RES, V39, P229, DOI 10.1657/1523-0430(2007)39[229:MMOCPA]2.0.CO;2; Cavieres LA, 2014, ECOL LETT, V17, P193, DOI 10.1111/ele.12217; Dickie IA, 2005, ECOL LETT, V8, P1191, DOI 10.1111/j.1461-0248.2005.00822.x; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; El-Keblawy A, 2016, J ARID ENVIRON, V125, P127, DOI 10.1016/j.jaridenv.2015.10.007; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; HALVORSON JJ, 1995, SOIL SCI SOC AM J, V59, P1476, DOI 10.2136/sssaj1995.03615995005900050038x; He Q, 2013, ECOL LETT, V16, P695, DOI 10.1111/ele.12080; Badano EI, 2010, ACTA OECOL, V36, P46, DOI 10.1016/j.actao.2009.09.008; Jones CG, 1997, ECOLOGY, V78, P1946, DOI 10.1890/0012-9658(1997)078[1946:PANEOO]2.0.CO;2; Kleier C, 2009, PLANT BIOLOGY, V11, P351, DOI 10.1111/j.1438-8677.2008.00115.x; Korner C., 2003, ALPINE PLANT LIFE FU, V2nd ed.; Li XR, 2007, PLANT SOIL, V300, P221, DOI 10.1007/s11104-007-9407-1; Maestre FT, 2009, J ECOL, V97, P199, DOI 10.1111/j.1365-2745.2008.01476.x; McCune B, 2002, ANAL ECOLOGICAL COMM; Michalet R, 2006, ECOL LETT, V9, P767, DOI 10.1111/j.1461-0248.2006.00935.x; Michalet R, 2015, J VEG SCI, V26, P207, DOI 10.1111/jvs.12226; Miriti MN, 2006, J ECOL, V94, P973, DOI 10.1111/j.1365-2745.2006.01138.x; Molina-Montenegro Marco A, 2005, Ecol. austral, V15, P49; Molina-Montenegro Marco A., 2000, Gayana Botanica, V57, P161; Monteiro JAF, 2011, FLORA, V206, P387, DOI 10.1016/j.flora.2011.01.001; Moro MJ, 1997, FUNCT ECOL, V11, P425, DOI 10.1046/j.1365-2435.1997.00106.x; Nunez CI, 1999, J VEG SCI, V10, P357, DOI 10.2307/3237064; Padilla FM, 2006, FRONT ECOL ENVIRON, V4, P196, DOI 10.1890/1540-9295(2006)004[0196:TRONPI]2.0.CO;2; Piston N, 2016, PERSPECT PLANT ECOL, V19, P30, DOI 10.1016/j.ppees.2016.02.002; Ramirez L, 2013, THESIS; Ramirez LA, 2015, PLANT ECOL, V216, P213, DOI 10.1007/s11258-014-0429-5; Schob C, 2013, J ECOL, V101, P753, DOI 10.1111/1365-2745.12062; Schob C, 2012, NEW PHYTOL, V196, P824, DOI 10.1111/j.1469-8137.2012.04306.x; SCOTTWENDT J, 1988, SOIL SCI, V145, P414, DOI 10.1097/00010694-198806000-00002; Sklenar P, 2009, FLORA, V204, P270, DOI 10.1016/j.flora.2008.04.001; Soil Laboratory Staff, 1984, AN METH SERV LAB SOI, P63; Soliveres S, 2014, PERSPECT PLANT ECOL, V16, P154, DOI 10.1016/j.ppees.2014.04.001; Sparling G, 2003, SOIL BIOL BIOCHEM, V35, P1575, DOI 10.1016/j.soilbio.2003.08.002; Spasojevic MJ, 2012, J ECOL, V100, P652, DOI 10.1111/j.1365-2745.2011.01945.x; Sturges HA, 1926, J AM STAT ASSOC, V21, P65, DOI 10.1080/01621459.1926.10502161; Tighe M, 2009, AGR ECOSYST ENVIRON, V132, P212, DOI 10.1016/j.agee.2009.04.001; TILMAN D, 1987, ECOL MONOGR, V57, P189, DOI 10.2307/2937080; Valiente-Banuet A, 2007, ECOL LETT, V10, P1029, DOI 10.1111/j.1461-0248.2007.01100.x; VALIENTEBANUET A, 1991, J VEG SCI, V2, P11, DOI 10.2307/3235892; Van Reeuwijk L.P., 2006, PROCEDURES SOIL ANAL, V7th ed.; Vuille M, 1998, J GEOPHYS RES-ATMOS, V103, P11191, DOI 10.1029/98JD00681; Wilson BR, 2007, AUST J SOIL RES, V45, P199, DOI 10.1071/SR07019; Xiao S, 2009, OIKOS, V118, P1343, DOI 10.1111/j.1600-0706.2009.17588.x; Yakovis EL, 2008, OECOLOGIA, V155, P785, DOI 10.1007/s00442-007-0945-2	67	11	11	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167265	10.1371/journal.pone.0167265	http://dx.doi.org/10.1371/journal.pone.0167265			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902757	Green Published, Green Submitted, gold			2022-12-26	WOS:000389474100066
J	Mayeur, S; Veilleux, A; Pouliot, Y; Lamarche, B; Beaulieu, JF; Hould, FS; Richard, D; Tchernof, A; Levy, E				Mayeur, Sylvain; Veilleux, Alain; Pouliot, Yves; Lamarche, Benoit; Beaulieu, Jean-Francois; Hould, Frederic S.; Richard, Denis; Tchernof, Andre; Levy, Emile			Plasma Lactoferrin Levels Positively Correlate with Insulin Resistance despite an Inverse Association with Total Adiposity in Lean and Severely Obese Patients	PLOS ONE			English	Article							GENE-EXPRESSION; HEART-DISEASE; CACO-2 CELLS; VISCERAL FAT; WEIGHT-LOSS; IN-VIVO; WOMEN; TISSUE; MEN; METABOLISM	Context Lactoferrin (Lf) is an important protein found on mucosal surfaces, within neutrophils and various cells, and in biological fluids. It displays multiple functions, including iron-binding as well as antimicrobial, immunomodulatory and anti-inflammatory activities. Although Lf ingestion has been suggested to cause adiposity reduction in murine models and humans, its relationship with insulin resistance (IR) has not been studied thoroughly. Objective To establish the association between circulating Lf levels, glucose status and blood lipid/lipoprotein profile. Methods Two independent cohorts were examined: lean to moderately obese women admitted for gynecological surgery (n = 53) and severely obese subjects undergoing biliopancreatic diversion (n = 62). Results Although body mass index (BMI) and total body fat mass were negatively associated with Lf, IR (assessed by the HOMA-IR index) was positively and independently associated with plasma Lf concentrations of the first cohort of lean to moderately obese women. These observations were validated in the second cohort in view of the positive correlation between plasma Lf concentrations and the HOMA-IR index, but without a significant association with the body mass index (BMI) of severely obese subjects. In subsamples of severely obese subjects matched for sex, age and BMI, but with either relatively low (1.89 +/- 0.73) or high (13.77 +/- 8.81) IR states (according to HOMA-IR), higher plasma Lf levels were noted in insulin- resistant vs insulin-sensitive subjects (P<0.05). Finally, Lf levels were significantly higher in lean to moderately obese women than in severely obese subjects (P<0.05). Conclusion Our findings revealed that plasma Lf levels are strongly associated with IR independently of total adiposity, which suggests an intriguing Lf regulation mechanism in conditions of obesity and IR.	[Mayeur, Sylvain; Veilleux, Alain; Levy, Emile] Univ Montreal, Res Ctr CHU St Justine, Montreal, PQ, Canada; [Pouliot, Yves; Lamarche, Benoit; Tchernof, Andre; Levy, Emile] Univ Laval, Inst Nutr & Funct Foods INAF, Quebec City, PQ, Canada; [Beaulieu, Jean-Francois] Univ Sherbrooke, Fac Med & Hlth Sci, Dept Anat & Cellular Biol, Sherbrooke, PQ, Canada; [Hould, Frederic S.; Richard, Denis] Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada; [Levy, Emile] Univ Montreal, Dept Nutr, Montreal, PQ, Canada	Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Laval University; University of Sherbrooke; Universite de Montreal	Levy, E (corresponding author), Univ Montreal, Res Ctr CHU St Justine, Montreal, PQ, Canada.; Levy, E (corresponding author), Univ Laval, Inst Nutr & Funct Foods INAF, Quebec City, PQ, Canada.; Levy, E (corresponding author), Univ Montreal, Dept Nutr, Montreal, PQ, Canada.	emile.levy@recherche-ste-justine.qc.ca	Veilleux, Alain/I-5028-2019; Lamarche, Benoit/ABA-4785-2021; Pouliot, Yves/AAD-5836-2020	Veilleux, Alain/0000-0003-4078-1908; Lamarche, Benoit/0000-0002-4443-5378; Tchernof, Andre/0000-0002-2587-1000				Abrink M, 2000, KIDNEY INT, V57, P2004, DOI 10.1046/j.1523-1755.2000.00050.x; Antuna-Puente B, 2011, DIABETES METAB, V37, P179, DOI 10.1016/j.diabet.2011.01.002; Baveye S, 2000, INFECT IMMUN, V68, P6519, DOI 10.1128/IAI.68.12.6519-6525.2000; BEAULIEU JF, 1991, BIOCHEM J, V280, P599, DOI 10.1042/bj2800599; Blanchette S, 2005, J CLIN ENDOCR METAB, V90, P264, DOI 10.1210/jc.2004-0583; Brock JH, 2012, BIOCHEM CELL BIOL, V90, P245, DOI [10.1139/O2012-018, 10.1139/o2012-018]; Denis MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053725; Doursout MF, 2013, INT IMMUNOPHARMACOL, V15, P227, DOI 10.1016/j.intimp.2012.12.009; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Garcia-Rios A, 2013, CURR OPIN CARDIOL, V28, P475, DOI 10.1097/HCO.0b013e32836081a5; Hirotani Y, 2008, YAKUGAKU ZASSHI, V128, P1363, DOI 10.1248/yakushi.128.1363; Hu WP, 2012, BIOCHEM CELL BIOL, V90, P485, DOI [10.1139/o2012-003, 10.1139/O2012-003]; Jenssen H, 2009, BIOCHIMIE, V91, P19, DOI 10.1016/j.biochi.2008.05.015; Kim JY, 2014, PEDIAT OBESITY; Kruzel ML, 2010, INNATE IMMUN-LONDON, V16, P67, DOI 10.1177/1753425909105317; Latorre D, 2012, BIOCHEM CELL BIOL, V90, P269, DOI [10.1139/O11-059, 10.1139/o11-059]; Legrand D, 2012, BIOCHEM CELL BIOL, V90, P252, DOI [10.1139/O11-056, 10.1139/o11-056]; Li YG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111707; Moreno-Navarrete JM, 2008, CLIN CHEM, V54, P301, DOI 10.1373/clinchem.2007.095943; Moreno-Navarrete JM, 2014, J CELL MOL MED, V18, P391, DOI 10.1111/jcmm.12234; Moreno-Navarrete JM, 2013, J NUTR BIOCHEM, V24, P1266, DOI 10.1016/j.jnutbio.2012.10.002; Mastromarino P, 2014, BIOMETALS INT J ROLE; MOORJANI S, 1987, METABOLISM, V36, P244, DOI 10.1016/0026-0495(87)90183-1; Moreno-Navarrete JM, 2009, J CLIN ENDOCR METAB, V94, P4036, DOI 10.1210/jc.2009-0215; Moreno-Navarrete JM, 2009, INT J OBESITY, V33, P991, DOI 10.1038/ijo.2009.143; Morishita S, 2013, J OLEO SCI, V62, P97, DOI 10.5650/jos.62.97; Oda H, 2014, BIOMETALS INT J ROLE; Ono T, 2010, BRIT J NUTR, V104, P1688, DOI 10.1017/S0007114510002734; Pilvi TK, 2009, BRIT J NUTR, V102, P337, DOI 10.1017/S0007114508199445; Poddar K, 2011, NUTR CLIN PRACT, V26, P539, DOI 10.1177/0884533611419859; Suzuki YA, 2001, BIOCHEMISTRY-US, V40, P15771, DOI 10.1021/bi0155899; Takeuchi T, 2004, EXP PHYSIOL, V89, P263, DOI 10.1113/expphysiol.2003.026633; Tchernof A, 2006, DIABETES, V55, P1353, DOI 10.2337/db05-1439; Troost FJ, 2002, J NUTR, V132, P2597, DOI 10.1093/jn/132.9.2597; Troost FJ, 2001, J NUTR, V131, P2101, DOI 10.1093/jn/131.8.2101; Veilleux A, 2014, ARTERIOSCLEROSIS THR; Vengen IT, 2010, ATHEROSCLEROSIS, V212, P614, DOI 10.1016/j.atherosclerosis.2010.06.008; Wang YZ, 2006, ARCH ANIM NUTR, V60, P1, DOI 10.1080/17450390500468255; Ward PP, 2005, CELL MOL LIFE SCI, V62, P2540, DOI 10.1007/s00018-005-5369-8; Yagi Motohiko, 2008, J Oral Sci, V50, P419; Zhong J, 2010, J PROTEOME RES, V9, P5228, DOI 10.1021/pr100521c	41	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0166138	10.1371/journal.pone.0166138	http://dx.doi.org/10.1371/journal.pone.0166138			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902700	Green Published, gold, Green Submitted			2022-12-26	WOS:000389474100014
J	Hayashi, Y; Nemoto-Sasaki, Y; Matsumoto, N; Tanikawa, T; Oka, S; Tanaka, Y; Arai, S; Wada, I; Sugiura, T; Yamashita, A				Hayashi, Yasuhiro; Nemoto-Sasaki, Yoko; Matsumoto, Naoki; Tanikawa, Takashi; Oka, Saori; Tanaka, Yusuke; Arai, Seisuke; Wada, Ikuo; Sugiura, Takayuki; Yamashita, Atsushi			Carboxyl-terminal Tail-mediated Homodimerizations of Sphingomyelin Synthases Are Responsible for Efficient Export from the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIMOLECULAR FLUORESCENCE COMPLEMENTATION; MEMBRANE-PROTEIN; MAMMALIAN-CELLS; LIVING CELLS; RECEPTOR; OLIGOMERIZATION; LOCALIZATION; TOPOLOGY; ER; PHOSPHATIDYLCHOLINE	Sphingomyelin synthase (SMS) is the key enzyme for crosstalk between bioactive sphingolipids and glycerolipids. In mammals, SMS consists of two isoforms: SMS1 is localized in the Golgi apparatus, whereas SMS2 is localized in both the Golgi and plasma membranes. SMS2 seems to exert cellular functions through protein-protein interactions; however, the existence and functions of quaternary structures of SMS1 and SMS2 remain unclear. Here we demonstrate that both SMS1 and SMS2 form homodimers. The SMSs have six membrane-spanning domains, and theNandCtermini of both proteins face the cytosolic side of the Golgi apparatus. Chemical cross-linking and bimolecular fluorescence complementation revealed that the N-and/or C-terminal tails of the SMSs were in close proximity to those of the other SMS in the homodimer. Homodimer formation was significantly decreased by C-terminal truncations, SMS1-Delta C22 and SMS2-C30, indicating that the C-terminal tails of the SMSs are primarily responsible for homodimer formation. Moreover, immunoprecipitation using deletion mutants revealed that the C-terminal tail of SMS2 mainly interacted with the C-terminal tail of its homodimer partner, whereas the C-terminal tail of SMS1 mainly interacted with a site other than the C-terminal tail of its homodimer partner. Interestingly, homodimer formation occurred in the endoplasmic reticulum ( ER) membrane before trafficking to the Golgi apparatus. Reduced homodimerization caused by C-terminal truncations of SMSs significantly reduced ER-to-Golgi transport. Our findings suggest that the C-terminal tails of SMSs are involved in homodimer formation, which is required for efficient transport from the ER.	[Hayashi, Yasuhiro; Nemoto-Sasaki, Yoko; Matsumoto, Naoki; Tanikawa, Takashi; Oka, Saori; Tanaka, Yusuke; Sugiura, Takayuki; Yamashita, Atsushi] Teikyo Univ, Fac Pharma Sci, Itabashi Ku, Kaga 2-11-1, Tokyo 1738605, Japan; [Arai, Seisuke; Wada, Ikuo] Fukushima Med Univ, Sch Med, Dept Cell Sci, Inst Biomed Sci, Hikarigaoka 1, Fukushima, Fukushima 9601295, Japan	Teikyo University; Fukushima Medical University	Yamashita, A (corresponding author), Teikyo Univ, Fac Pharma Sci, Itabashi Ku, Kaga 2-11-1, Tokyo 1738605, Japan.	ayamashi@pharm.teikyo-u.ac.jp		Wada, Ikuo/0000-0001-5668-6994; Yamashita, Atsushi/0000-0002-2544-2134	Japan Society for the Promotion of Science [15K18868, 15K07946]; Supported Program for the Strategic Research Foundation at Private Universities from the Ministry of Education, Culture, Sports, and Technology; Grants-in-Aid for Scientific Research [15K14462] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Supported Program for the Strategic Research Foundation at Private Universities from the Ministry of Education, Culture, Sports, and Technology; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Young Scientists (B) 15K18868 (to Y. H.) and for Scientific Research (C) 15K07946 (to A. Y.) from the Japan Society for the Promotion of Science. This work was also supported in part by the Supported Program for the Strategic Research Foundation at Private Universities from the Ministry of Education, Culture, Sports, and Technology. The authors declare that they have no conflicts of interest with the contents of this article.	Asano S, 2012, MOL CELL BIOL, V32, P3242, DOI 10.1128/MCB.00121-12; BOROCHOV H, 1977, BIOCHIM BIOPHYS ACTA, V470, P382, DOI 10.1016/0005-2736(77)90129-8; Boulaflous A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-144; Cranfill PJ, 2016, NAT METHODS, V13, P557, DOI [10.1038/nmeth.3891, 10.1038/NMETH.3891]; Crichton PG, 2013, J BIOL CHEM, V288, P22163, DOI 10.1074/jbc.M113.484329; Fasana E, 2010, FASEB J, V24, P1419, DOI 10.1096/fj.09-147850; Feramisco JD, 2004, J BIOL CHEM, V279, P8487, DOI 10.1074/jbc.M312623200; Gao XD, 2000, J BIOL CHEM, V275, P17718, DOI 10.1074/jbc.M909946199; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359; Hayashi Y, 2014, J BIOL CHEM, V289, P30842, DOI 10.1074/jbc.M114.574285; Heerklotz H, 2000, BIOPHYS J, V78, P2435, DOI 10.1016/S0006-3495(00)76787-7; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Huitema K, 2004, EMBO J, V23, P33, DOI 10.1038/sj.emboj.7600034; Korkhov VM, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-59; Lenormand C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060813; Li E, 2012, BBA-BIOMEMBRANES, V1818, P183, DOI 10.1016/j.bbamem.2011.08.031; Liu Y, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.266pe23; Lopez-Gimenez JF, 2007, MOL PHARMACOL, V71, P1015, DOI 10.1124/mol.106.033035; Lord C, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013367; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; MARGGRAF WD, 1984, BIOCHIM BIOPHYS ACTA, V793, P346, DOI 10.1016/0005-2760(84)90248-0; Martzoukou O, 2015, J MOL BIOL, V427, P2679, DOI 10.1016/j.jmb.2015.05.021; Mitsutake S, 2011, J BIOL CHEM, V286, P28544, DOI 10.1074/jbc.M111.255646; Nazari M, 2012, BIOPHYS J, V102, P498, DOI 10.1016/j.bpj.2011.12.029; Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556; Overton MC, 2003, J BIOL CHEM, V278, P49369, DOI 10.1074/jbc.M308654200; Ozalp C, 2005, DRUG METAB DISPOS, V33, P1382, DOI 10.1124/dmd.105.005538; Rabouille C, 2005, NAT REV MOL CELL BIO, V6, P812, DOI 10.1038/nrm1735; Romano C, 1996, J BIOL CHEM, V271, P28612, DOI 10.1074/jbc.271.45.28612; Salahpour A, 2004, J BIOL CHEM, V279, P33390, DOI 10.1074/jbc.M403363200; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Separovic D, 2007, BIOCHEM BIOPH RES CO, V358, P196, DOI 10.1016/j.bbrc.2007.04.095; Skube SB, 2010, CYTOSKELETON, V67, P1, DOI 10.1002/cm.20409; Snapp EL, 2003, J CELL BIOL, V163, P257, DOI 10.1083/jcb.200306020; Springer S, 2014, TRAFFIC, V15, P531, DOI 10.1111/tra.12157; Subathra M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023644; Tani M, 2009, BIOCHEM BIOPH RES CO, V381, P328, DOI 10.1016/j.bbrc.2009.02.063; Van Itallie CM, 2011, J BIOL CHEM, V286, P3442, DOI 10.1074/jbc.M110.195578; Volkova EG, 2012, BIOL OPEN, V1, P802, DOI 10.1242/bio.20121537; Walz T, 1997, NATURE, V387, P624, DOI 10.1038/42512; Wurch T, 1998, BIOTECHNOL TECH, V12, P653, DOI 10.1023/A:1008848517221; Yamaoka S, 2004, J BIOL CHEM, V279, P18688, DOI 10.1074/jbc.M401205200; Yamashita A, 2014, PROG LIPID RES, V53, P18, DOI 10.1016/j.plipres.2013.10.001; Yang W, 2008, J BIOL CHEM, V283, P8643, DOI 10.1074/jbc.M709824200; Yasuda S, 2003, J BIOL CHEM, V278, P4176, DOI 10.1074/jbc.M209602200; Yeang C, 2008, BBA-MOL CELL BIOL L, V1781, P610, DOI 10.1016/j.bbalip.2008.07.002; Yeang C, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-89; Zhao Y, 2008, J BIOL CHEM, V283, P8258, DOI 10.1074/jbc.M710422200; Zhu QS, 2007, METHODS, V41, P439, DOI 10.1016/j.ymeth.2006.08.004	50	7	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2017	292	3					1122	1141		10.1074/jbc.M116.746602	http://dx.doi.org/10.1074/jbc.M116.746602			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2LL	27927984	hybrid, Green Published			2022-12-26	WOS:000392318700031
J	Ting, YH; Lu, TJ; Johnson, AW; Shie, JT; Chen, BR; Suresh, SS; Lo, KY				Ting, Ya-Han; Lu, Ting-Jun; Johnson, Arlen W.; Shie, Jing-Ting; Chen, Bo-Ru; Kumar, Suresh S.; Lo, Kai-Yin			Bcp1 Is the Nuclear Chaperone of Rpl23 in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							60S RIBOSOMAL-SUBUNIT; EXPORT RECEPTOR; CRYSTAL-STRUCTURE; PROTEIN COMPLEXES; INITIATION-FACTOR; DIAMOND-SYNDROME; PLASMA-MEMBRANE; CELL-GROWTH; YEAST; BIOGENESIS	Eukaryotic ribosomes are composed of rRNAs and ribosomal proteins. Ribosomal proteins are translated in the cytoplasm and imported into the nucleus for assembly with the rRNAs. It has been shown that chaperones or karyopherins responsible for import can maintain the stability of ribosomal proteins by neutralizing unfavorable positive charges and thus facilitate their transports. Among 79 ribosomal proteins in yeast, only a few are identified with specific chaperones. Besides the classic role in maintaining protein stability, chaperones have additional roles in transport, chaperoning the assembly site, and dissociation of ribosomal proteins from karyopherins. Bcp1 has been shown to be necessary for the export of Mss4, a phosphatidylinositol 4-phosphate 5-kinase, and required for ribosome biogenesis. However, its specific function in ribosome biogenesis has not been described. Here, we show that Bcp1 dissociates Rpl23 from the karyopherins and associates with Rpl23 afterward. Loss of Bcp1 causes instability of Rpl23 and deficiency of 60S subunits. In summary, Bcp1 is a novel 60S biogenesis factor via chaperoning Rpl23 in the nucleus.	[Ting, Ya-Han; Lu, Ting-Jun; Shie, Jing-Ting; Chen, Bo-Ru; Kumar, Suresh S.; Lo, Kai-Yin] Natl Taiwan Univ, Dept Agr Chem, 1 Sec 4,Roosevelt Rd, Taipei 10617, Taiwan; [Johnson, Arlen W.] Univ Texas Austin, Inst Cellular & Mol Biol, Dept Mol Biosci, Austin, TX 78712 USA; [Kumar, Suresh S.] Univ Putra Malaysia, Dept Med Microbiol & Parasitol, Serdang 43400, Malaysia	National Taiwan University; University of Texas System; University of Texas Austin; Universiti Putra Malaysia	Lo, KY (corresponding author), Natl Taiwan Univ, Dept Agr Chem, 1 Sec 4,Roosevelt Rd, Taipei 10617, Taiwan.	kaiyin@ntu.edu.tw		Johnson, Arlen/0000-0002-4742-085X; LO, KAI-YIN/0000-0003-0440-6836	National Science Council of Taiwan [NSC 99-2313-B-002-048-MY2]; National Taiwan University [101R7818]; National Institutes of Health [GM53655]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053655] Funding Source: NIH RePORTER	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University(National Taiwan University); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Science Council of Taiwan under Contract NSC 99-2313-B-002-048-MY2, National Taiwan University Career Development Project Grant 101R7818, and National Institutes of Health Grant GM53655(to A. W. J.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Audhya A, 2003, EMBO J, V22, P4223, DOI 10.1093/emboj/cdg397; Audhya A, 2002, DEV CELL, V2, P593, DOI 10.1016/S1534-5807(02)00168-5; Basu U, 2001, MOL CELL BIOL, V21, P1453, DOI 10.1128/MCB.21.5.1453-1462.2001; BISCHOFF FR, 1994, P NATL ACAD SCI USA, V91, P2587, DOI 10.1073/pnas.91.7.2587; Bradatsch B, 2007, MOL CELL, V27, P767, DOI 10.1016/j.molcel.2007.06.034; Calvino FR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7510; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Defoiche J, 2009, CLIN CHEM, V55, P1824, DOI 10.1373/clinchem.2008.119446; Desrivieres S, 1998, J BIOL CHEM, V273, P15787, DOI 10.1074/jbc.273.25.15787; Eisinger DP, 1997, MOL CELL BIOL, V17, P5146, DOI 10.1128/MCB.17.9.5146; Fan JJ, 2009, CELL CYCLE, V8, P3019; Finch AJ, 2011, GENE DEV, V25, P917, DOI 10.1101/gad.623011; Gadal O, 2001, MOL CELL BIOL, V21, P3405, DOI 10.1128/MCB.21.10.3405-3415.2001; Gartmann M, 2010, J BIOL CHEM, V285, P14848, DOI 10.1074/jbc.C109.096057; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Groft CM, 2000, NAT STRUCT BIOL, V7, P1156; Ho JHN, 2000, J CELL BIOL, V151, P1057, DOI 10.1083/jcb.151.5.1057; Holzer S, 2013, J MOL BIOL, V425, P4154, DOI 10.1016/j.jmb.2013.08.022; Homma K, 1998, J BIOL CHEM, V273, P15779, DOI 10.1074/jbc.273.25.15779; Horigome C, 2009, BIOSCI BIOTECH BIOCH, V73, P443, DOI 10.1271/bbb.80599; Hung NJ, 2008, MOL BIOL CELL, V19, P735, DOI 10.1091/mbc.E07-09-0968; Iouk TL, 2001, MOL CELL BIOL, V21, P1260, DOI 10.1128/MCB.21.4.1260-1271.2001; Jakel S, 2002, EMBO J, V21, P377, DOI 10.1093/emboj/21.3.377; Jenner L, 2012, CURR OPIN STRUC BIOL, V22, P759, DOI 10.1016/j.sbi.2012.07.013; Jesch SA, 2006, J BIOL CHEM, V281, P24070, DOI 10.1074/jbc.M604541200; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Klinge S, 2011, SCIENCE, V334, P941, DOI 10.1126/science.1211204; Koch B, 2012, J BIOL CHEM, V287, P21806, DOI 10.1074/jbc.M112.365791; Kressler D, 2012, SCIENCE, V338, P666, DOI 10.1126/science.1226960; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Krogan NJ, 2004, MOL CELL, V13, P225, DOI 10.1016/S1097-2765(04)00003-6; Li ZH, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000213; Liu JM, 2001, ONCOGENE, V20, P336, DOI 10.1038/sj.onc.1204098; Lo KY, 2010, MOL CELL, V39, P196, DOI 10.1016/j.molcel.2010.06.018; Maurer P, 2001, MOL BIOL CELL, V12, P539, DOI 10.1091/mbc.12.3.539; Meng XB, 2003, GENE, V302, P139, DOI 10.1016/S0378-1119(02)01098-3; Menne TF, 2007, NAT GENET, V39, P486, DOI 10.1038/ng1994; Panse VG, 2010, TRENDS BIOCHEM SCI, V35, P260, DOI 10.1016/j.tibs.2010.01.001; Pausch P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8494; Pillet B, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005565; Rout MP, 1997, CELL, V89, P715, DOI 10.1016/S0092-8674(00)80254-8; Schutz S, 2014, ELIFE, V3, DOI 10.7554/eLife.03473; Si K, 1999, MOL CELL BIOL, V19, P1416; Stelter P, 2015, MOL CELL, V58, P854, DOI 10.1016/j.molcel.2015.03.029; Strahl T, 2007, BBA-MOL CELL BIOL L, V1771, P353, DOI 10.1016/j.bbalip.2007.01.015; Thomas F, 2003, J CELL SCI, V116, P2409, DOI 10.1242/jcs.00464; Tschochner H, 2003, TRENDS CELL BIOL, V13, P255, DOI 10.1016/S0962-8924(03)00054-0; Tsuno A, 2000, MOL CELL BIOL, V20, P2066, DOI 10.1128/MCB.20.6.2066-2074.2000; Venema J, 1999, ANNU REV GENET, V33, P261, DOI 10.1146/annurev.genet.33.1.261; West M, 2005, MOL CELL BIOL, V25, P3802, DOI 10.1128/MCB.25.9.3802-3813.2005; Woolford JL, 2013, GENETICS, V195, P643, DOI 10.1534/genetics.113.153197; Wyler E, 2014, FEBS LETT, V588, P3685, DOI 10.1016/j.febslet.2014.08.013; Yao W, 2007, MOL CELL, V26, P51, DOI 10.1016/j.molcel.2007.02.018; Yao YH, 2010, RNA, V16, P1007, DOI 10.1261/rna.2012310; YOSHIDA S, 1994, MOL GEN GENET, V242, P631, DOI 10.1007/BF00283416; Zhang JY, 2007, GENE DEV, V21, P2580, DOI 10.1101/gad.1569307; Zinzalla V, 2011, CELL, V144, P757, DOI 10.1016/j.cell.2011.02.014	58	25	25	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2017	292	2					585	596		10.1074/jbc.M116.747634	http://dx.doi.org/10.1074/jbc.M116.747634			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2KN	27913624	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000392316100015
J	MacIvor, JS; Packer, L				MacIvor, J. Scott; Packer, Laurence			The Bees among Us: Modelling Occupancy of Solitary Bees	PLOS ONE			English	Article							ESTIMATING SITE OCCUPANCY; LAND-USE; DETECTION PROBABILITY; SPECIES OCCURRENCE; FORAGING RANGES; INTRODUCED BEES; WILD BEES; HYMENOPTERA; POLLINATION; CITY	Occupancy modelling has received increasing attention as a tool for differentiating between true absence and non-detection in biodiversity data. This is thought to be particularly useful when a species of interest is spread out over a large area and sampling is constrained. We used occupancy modelling to estimate the probability of three phylogenetically independent pairs of native-introduced species [Megachile campanulae (Robertson)-Megachile rotundata (Fab.), Megachile pugnata Say-Megachile centuncularis (L.), Osmia pumila Cresson-Osmia caerulescens (L.)] (Apoidea: Megachilidae) being present when repeated sampling did not always find them. Our study occurred along a gradient of urbanization and used nest boxes (bee hotels) set up over three consecutive years. Occupancy modelling discovered different patterns to those obtained by species detection and abundance-based data alone. For example, it predicted that the species that was ranked 4th in terms of detection actually had the greatest occupancy among all six species. The native M. pugnata had decreased occupancy with increasing building footprint and a similar but not significant pattern was found for the native O. pumila. Two introduced bees (M. rotundata and M. centuncularis), and one native (M. campanulae) had modelled occupancy values that increased with increasing urbanization. Occupancy probability differed among urban green space types for three of six bee species, with values for two native species (M. campanulae and O. pumila) being highest in home gardens and that for the exotic O. caerulescens being highest in community gardens. The combination of occupancy modelling with analysis of habitat variables as an augmentation to detection and abundance-based sampling is suggested to be the best way to ensure that urban habitat management results in the desired outcomes.	[MacIvor, J. Scott] Univ Toronto Scarborough, Dept Biol Sci, Toronto, ON, Canada; [MacIvor, J. Scott; Packer, Laurence] York Univ, Dept Biol, Toronto, ON, Canada	University of Toronto; University Toronto Scarborough; York University - Canada	MacIvor, JS (corresponding author), Univ Toronto Scarborough, Dept Biol Sci, Toronto, ON, Canada.; MacIvor, JS (corresponding author), York Univ, Dept Biol, Toronto, ON, Canada.	scott.macivor@utoronto.ca			Canadian National Science and Engineering Council [CGS D 408565]; NSERC discovery grant; Natural Sciences and Engineering Research Council of Canada [CGS D 408565]	Canadian National Science and Engineering Council; NSERC discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	The first author was funded by a scholarship awarded by the Canadian National Science and Engineering Council (CGS D 408565) and an NSERC discovery grant funding awarded to the second author.; We thank the participants of the study that permitted access to their properties to monitor nest boxes and the bees therein. Thanks to Dr. Alana Pindar, three anonymous reviewers and the editor for comments on the manuscript. As well, to Baharak Salehi, Jen Albert, Jennifer Cabral, Veronica Ladico, and Armando Ponte for help organizing, sorting, and rearing nest box contents and to the PCYU team for discussion. The first author was funded by a scholarship awarded by the Natural Sciences and Engineering Research Council of Canada (CGS D 408565) and both were supported by an NSERC discovery grant awarded to the second author.	Ahrne K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005574; Aizen MA, 2008, PLOS BIOL, V6, P396, DOI 10.1371/journal.pbio.0060031; Bailey LL, 2004, ECOL APPL, V14, P692, DOI 10.1890/03-5012; Baldock KCR, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2849; Banaszak-Cibicka W, 2012, J INSECT CONSERV, V16, P331, DOI 10.1007/s10841-011-9419-2; Barthell JF, 1998, ENVIRON ENTOMOL, V27, P240, DOI 10.1093/ee/27.2.240; Bartomeus I, 2013, P NATL ACAD SCI USA, V110, P4656, DOI 10.1073/pnas.1218503110; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Blair RB, 1996, ECOL APPL, V6, P506, DOI 10.2307/2269387; BOHART GE, 1972, ANNU REV ENTOMOL, V17, P287, DOI 10.1146/annurev.en.17.010172.001443; Bradford DF, 2003, ECOLOGY, V84, P1012, DOI 10.1890/0012-9658(2003)084[1012:HPOBTB]2.0.CO;2; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Cane James H., 2003, P113; Cane JH, 2006, ECOL APPL, V16, P632, DOI 10.1890/1051-0761(2006)016[0632:CRWADB]2.0.CO;2; Colding J, 2007, LANDSCAPE URBAN PLAN, V81, P46, DOI 10.1016/j.landurbplan.2006.10.016; Colla SR, 2008, BIODIVERS CONSERV, V17, P1379, DOI 10.1007/s10531-008-9340-5; Davies Richard G., 2008, Urban Ecosystems, V11, P269, DOI 10.1007/s11252-008-0062-y; Dunnett N., 2010, PLANTING GREEN ROOFS; Fetridge ED, 2008, ANN ENTOMOL SOC AM, V101, P1067, DOI 10.1603/0013-8746-101.6.1067; Field SA, 2005, J WILDLIFE MANAGE, V69, P473, DOI 10.2193/0022-541X(2005)069[0473:OAOMEU]2.0.CO;2; Fortel L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104679; Francis RA, 2012, APPL GEOGR, V32, P514, DOI 10.1016/j.apgeog.2011.06.013; Frankie GW, 2009, CALIF AGR, V63, P113, DOI 10.3733/ca.v063n03p113; Frankie GW, 1998, ENVIRON ENTOMOL, V27, P1137, DOI 10.1093/ee/27.5.1137; Garbuzov M, 2014, BIOSCIENCE, V64, P1019, DOI 10.1093/biosci/biu150; Gathmann A, 2002, J ANIM ECOL, V71, P757, DOI 10.1046/j.1365-2656.2002.00641.x; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Gibb H, 2002, BIOL CONSERV, V106, P91, DOI 10.1016/S0006-3207(01)00232-4; Gilbert O.L., 1989, ECOLOGY URBAN HABITA; Giles V, 2006, J HYMENOPT RES, V15, P208; Goddard MA, 2010, TRENDS ECOL EVOL, V25, P90, DOI 10.1016/j.tree.2009.07.016; Gonzalez V. H., 2008, THESIS; Goodell K, 2003, OECOLOGIA, V134, P518, DOI 10.1007/s00442-002-1159-2; Goulson D, 2003, ANNU REV ECOL EVOL S, V34, P1, DOI 10.1146/annurev.ecolsys.34.011802.132355; Greenleaf SS, 2007, OECOLOGIA, V153, P589, DOI 10.1007/s00442-007-0752-9; Grixti JC, 2006, CAN ENTOMOL, V138, P147; Gu WD, 2004, BIOL CONSERV, V116, P195, DOI 10.1016/S0006-3207(03)00190-3; Guillera-Arroita G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099571; Guillera-Arroita G, 2010, METHODS ECOL EVOL, V1, P131, DOI 10.1111/j.2041-210X.2010.00017.x; Hernandez JL, 2009, CITIES ENV, V2, P1, DOI DOI 10.15365/cate.2132009; Hudewenz A, 2013, J INSECT CONSERV, V17, P1275, DOI 10.1007/s10841-013-9609-1; Jimenez-Valverde A, 2011, BIOL INVASIONS, V13, P2785, DOI 10.1007/s10530-011-9963-4; Kawanishi K, 2004, BIOL CONSERV, V120, P329, DOI 10.1016/j.biocon.2004.03.005; Kearns CA, 1998, ANNU REV ECOL SYST, V29, P83, DOI 10.1146/annurev.ecolsys.29.1.83; Kennedy CM, 2013, ECOL LETT, V16, P584, DOI 10.1111/ele.12082; Kerr JT, 2015, SCIENCE, V349, P177, DOI 10.1126/science.aaa7031; Klatt BK, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2440; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Leonhardt SD, 2013, BASIC APPL ECOL, V14, P461, DOI 10.1016/j.baae.2013.06.003; Lizee MH, 2011, ECOL INDIC, V11, P353, DOI 10.1016/j.ecolind.2010.06.003; Lobo JM, 2010, ECOGRAPHY, V33, P103, DOI 10.1111/j.1600-0587.2009.06039.x; Lowenstein DM, 2014, BIODIVERS CONSERV, V23, P2857, DOI 10.1007/s10531-014-0752-0; MacIvor JS, 2017, APIDOLOGIE, V48, P311, DOI 10.1007/s13592-016-0477-z; MacIvor JS, 2015, URBAN ECOSYST, V18, P419, DOI 10.1007/s11252-014-0408-6; MacIvor JS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122126; Macivor JS, 2014, ENVIRON ENTOMOL, V43, P1027, DOI 10.1603/EN13241; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Mackenzie DI, 2009, ECOLOGY, V90, P823, DOI 10.1890/08-0141.1; Mackenzie DI, 2005, J APPL ECOL, V42, P1105, DOI 10.1111/j.1365-2664.2005.01098.x; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Madjidian JA, 2008, OECOLOGIA, V156, P835, DOI 10.1007/s00442-008-1039-5; Mangum WA, 2003, J KANSAS ENTOMOL SOC, V76, P658; Matteson K.C., 2009, CITIES ENV, V2, P1, DOI [10.15365/cate.2152009, DOI 10.15365/CATE.2152009]; Matteson KC, 2008, ANN ENTOMOL SOC AM, V101, P140, DOI 10.1603/0013-8746(2008)101[140:BRAAIN]2.0.CO;2; Matteson Kevin C., 2010, Urban Ecosystems, V13, P333, DOI 10.1007/s11252-010-0122-y; McDonnell Mark J., 1997, Urban Ecosystems, V1, P21, DOI 10.1023/A:1014359024275; McFrederick QS, 2006, BIOL CONSERV, V129, P372, DOI 10.1016/j.biocon.2005.11.004; McIntyre NE, 2001, BASIC APPL ECOL, V2, P209, DOI 10.1078/1439-1791-00051; Morales CL, 2013, FRONT ECOL ENVIRON, V11, P529, DOI 10.1890/120321; Morales Carolina L., 2002, Biological Invasions, V4, P87, DOI 10.1023/A:1020513012689; Oertli S, 2005, EUR J ENTOMOL, V102, P53, DOI 10.14411/eje.2005.008; Olea PP, 2011, DIVERS DISTRIB, V17, P714, DOI 10.1111/j.1472-4642.2011.00777.x; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Osborne JL, 2008, J APPL ECOL, V45, P784, DOI 10.1111/j.1365-2664.2007.01359.x; Pardee GL, 2014, URBAN ECOSYST, V17, P641, DOI 10.1007/s11252-014-0349-0; Pitts-Singer TL, 2011, ANNU REV ENTOMOL, V56, P221, DOI 10.1146/annurev-ento-120709-144836; Plummer M., 2013, RJAGS BAYESIAN GRAPH; Pollock KH, 2002, ENVIRONMETRICS, V13, P105, DOI 10.1002/env.514; Potter A, 2015, URBAN ECOSYST, V18, P885, DOI 10.1007/s11252-015-0435-y; R Core Team, 2021, R LANGUAGE ENV STAT; Roulston T, 2012, J KANSAS ENTOMOL SOC, V85, P387, DOI 10.2317/0022-8567-85.4.387; Salisbury A, 2015, J APPL ECOL, V52, P1156, DOI 10.1111/1365-2664.12499; Sheffield CS, 2013, APIDOLOGIE, V44, P501, DOI 10.1007/s13592-013-0200-2; Stephen WP, 2003, NONNATIVE CROPS WHEN; Stout JC, 2002, BIOL CONSERV, V106, P425, DOI 10.1016/S0006-3207(02)00046-0; Studds CE, 2005, ECOLOGY, V86, P2380, DOI 10.1890/04-1145; Suarez AV, 1998, ECOLOGY, V79, P2041, DOI 10.1890/0012-9658(1998)079[2041:EOFAIO]2.0.CO;2; Tanadini LG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028244; Torrance S, 2013, CITY TORONTO GUIDELI; Tscharntke T, 1998, J APPL ECOL, V35, P708, DOI 10.1046/j.1365-2664.1998.355343.x; Tyre AJ, 2003, ECOL APPL, V13, P1790, DOI 10.1890/02-5078; Welsh AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052015; Westphal C, 2008, ECOL MONOGR, V78, P653, DOI 10.1890/07-1292.1; WHITNEY GG, 1985, URBAN ECOL, V9, P143, DOI 10.1016/0304-4009(85)90003-8; Williams NM, 2010, BIOL CONSERV, V143, P2280, DOI 10.1016/j.biocon.2010.03.024; Williams NM, 2001, CONSERV ECOL, V5; Zurbuchen A, 2010, BIOL CONSERV, V143, P669, DOI 10.1016/j.biocon.2009.12.003	97	8	8	2	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0164764	10.1371/journal.pone.0164764	http://dx.doi.org/10.1371/journal.pone.0164764			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3TF	27911954	gold, Green Published, Green Submitted			2022-12-26	WOS:000389520600001
J	Bai, WK; Zhang, FJ; He, TJ; Su, PW; Ying, XZ; Zhang, LL; Wang, T				Bai, Wen Kai; Zhang, Fei Jing; He, Tian Jin; Su, Peng Wei; Ying, Xiong Zhi; Zhang, Li Li; Wang, Tian			Dietary Probiotic Bacillus subtilis Strain fmbj Increases Antioxidant Capacity and Oxidative Stability of Chicken Breast Meat during Storage	PLOS ONE			English	Article							PROTEIN OXIDATION; GROWTH-PERFORMANCE; FREE-RADICALS; ORGAN WEIGHT; QUALITY; EXTRACTS; FOOD; SUPPLEMENTATION; SUPEROXIDE; PRODUCTS	This study was aimed to measure the dietary effects of probiotic Bacillus subtilis strain fmbj (BS fmbj) on antioxidant capacity and oxidative stability of chicken breast meat during storage. Treatment groups were fed the basal diet with BS fmbj at 0 g/kg (CON), 0.2 g/kg (BS 1), 0.3 g/kg (BS-2), or 0.4 g/kg (BS-3) doses without antibiotics. During 8 days of storage at 4 degrees C, BS-2 group showed a significant improvement (P < 0.05) on meat quality (pH, Drip loss, Cooking loss, Shear force, color L*, a*, b*), free radical scavenging activity (DPPH, ABTS(+), H2O2), tissues antioxidant enzyme capacity (SOD, CAT, GSH-Px, GSH, T-SH), mitochondria antioxidant enzyme capacity (MnSOD, GPx, GSH), mRNA expression of antioxidant genes (Nrf2, HO-1, SOD, CAT, GSH-Px) and mitochondrial function genes (avUCP, NRF1, NRF2, TFAM, PGC-1 alpha), oxidative damage index (MDA, ROS, PC, 8-OHdG), and MMP level in chicken breast meat as compared to the CON group. These results indicate that dietary BS fmbj in broiler diets can protect breast meat against the storage-induced oxidative stress by improving their free radical scavenging capacity and antioxidant activity during 8 days of storage at 4 degrees C.	[Bai, Wen Kai; Zhang, Fei Jing; He, Tian Jin; Su, Peng Wei; Ying, Xiong Zhi; Zhang, Li Li; Wang, Tian] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Wang, T (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China.	tianwangnjau@163.com						Ahmed ST, 2014, BRIT POULTRY SCI, V55, P540, DOI 10.1080/00071668.2014.938021; Alam ZI, 1997, J NEUROCHEM, V69, P1196, DOI 10.1046/j.1471-4159.1997.69031196.x; Ananthi S, 2010, FOOD CHEM TOXICOL, V48, P187, DOI 10.1016/j.fct.2009.09.036; Baboota RK, 2013, J FUNCT FOODS, V5, P997, DOI 10.1016/j.jff.2013.04.014; Bai KW, 2017, POULTRY SCI, V96, P74, DOI 10.3382/ps/pew246; Bottje W, 2002, POULTRY SCI, V81, P546, DOI 10.1093/ps/81.4.546; Butterfield DA, 2002, J NUTR BIOCHEM, V13, P444, DOI 10.1016/S0955-2863(02)00205-X; Capcarova M, 2010, J ANIM PHYSIOL AN N, V94, pe215, DOI 10.1111/j.1439-0396.2010.01010.x; Chamani J, 2011, J PHARMACEUT BIOMED, V55, P114, DOI 10.1016/j.jpba.2010.12.029; CHAN KM, 1994, CRIT REV FOOD SCI, V34, P403, DOI 10.1080/10408399409527669; Dean RT, 1997, BIOCHEM J, V324, P1; Decker E.A., 2000, ANTIOXIDANTMUSCLE; Delles RM, 2014, POULTRY SCI, V93, P1561, DOI 10.3382/ps.2013-03682; Dridi S, 2004, COMP BIOCHEM PHYS A, V139, P273, DOI 10.1016/j.cbpb.2004.09.010; Endo Tsuyoshi, 1999, Animal Science Journal, V70, P207; Fraternale A, 2009, MOL ASPECTS MED, V30, P99, DOI 10.1016/j.mam.2008.09.001; Fuentes V, 2010, MEAT SCI, V85, P506, DOI 10.1016/j.meatsci.2010.02.024; Gray JI, 1996, MEAT SCI, V43, pS111, DOI 10.1016/0309-1740(96)84583-9; HALLIWELL B, 1995, CRIT REV FOOD SCI, V35, P7, DOI 10.1080/10408399509527682; Hosainzadeh A, 2012, J BIOMOL STRUCT DYN, V29, P1013, DOI 10.1080/073911012010525029; Hota KB, 2012, HIPPOCAMPUS, V22, P723, DOI 10.1002/hipo.20934; Housaindokht MR, 2001, B KOR CHEM SOC, V22, P145; Hseu YC, 2008, FOOD CHEM TOXICOL, V46, P105, DOI 10.1016/j.fct.2007.07.003; Kayali R, 2007, BIOGERONTOLOGY, V8, P653, DOI 10.1007/s10522-007-9107-5; Kazemi S, 2011, FOOD BIOPROCESS TECH, V4, P102, DOI 10.1007/s11947-009-0201-3; Kikusato M, 2005, NUCLEIC ACIDS RES, V33, P6953; Kowald A, 2011, P NATL ACAD SCI USA, V108, P10237, DOI 10.1073/pnas.1101604108; Leygonie C, 2011, FOOD CHEM, V127, P1659, DOI 10.1016/j.foodchem.2011.02.033; Li WF, 2012, PAK VET J, V32, P530; Liu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049916; Liu XL, 2012, ASIAN AUSTRAL J ANIM, V25, P682, DOI 10.5713/ajas.2011.11334; Mahajan P, 2000, J FOOD SCI TECH MYS, V37, P67; Mercier Y, 1998, MEAT SCI, V48, P301, DOI 10.1016/S0309-1740(97)00113-7; Moon JK, 2009, J AGR FOOD CHEM, V57, P1655, DOI 10.1021/jf803537k; Moosavi-Movahedi AA, 2003, BIOORGAN MED CHEM, V11, P4303, DOI 10.1016/S0968-0896(03)00524-8; Mozaffarian D, 2012, J NUTR, V142, p614S, DOI 10.3945/jn.111.149633; Park JH, 2015, J ANIM PHYSIOL AN N, V99, P326, DOI 10.1111/jpn.12248; Park JH, 2014, POULTRY SCI, V93, P2054, DOI 10.3382/ps.2013-03818; Pelicano ERL, 2003, Braz. J. Poult. Sci., V5, P207, DOI 10.1590/S1516-635X2003000300009; Perez-Granados AM, 2010, J NUTR BIOCHEM, V21, P948, DOI 10.1016/j.jnutbio.2009.07.010; Piantadosi CA, 2012, FREE RADICAL BIO MED, V53, P2043, DOI 10.1016/j.freeradbiomed.2012.09.014; Pilger A, 2001, FREE RADICAL RES, V35, P273, DOI 10.1080/10715760100300811; Rajput IR, 2013, INT J AGRIC BIOL, V15, P231; RiceEvans CA, 1996, FREE RADICAL BIO MED, V20, P933, DOI 10.1016/0891-5849(95)02227-9; SANDERS ME, 1993, J DAIRY SCI, V76, P1819, DOI 10.3168/jds.S0022-0302(93)77514-1; Seifried HE, 2007, J NUTR BIOCHEM, V18, P567, DOI 10.1016/j.jnutbio.2006.10.007; Siddhuraju P, 2007, FOOD CHEM, V105, P950, DOI 10.1016/j.foodchem.2007.04.040; Sies H, 1999, FREE RADICAL BIO MED, V27, P916, DOI 10.1016/S0891-5849(99)00177-X; Takahashi M, 2004, J GASTROENTEROL, V39, P1210, DOI 10.1007/s00535-004-1474-y; Tang XH, 2006, J NUTR BIOCHEM, V17, P177, DOI 10.1016/j.jnutbio.2005.06.008; Tornberg E, 2005, MEAT SCI, V70, P493, DOI 10.1016/j.meatsci.2004.11.021; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Ventanas S, 2006, MEAT SCI, V72, P647, DOI 10.1016/j.meatsci.2005.09.011; Wei QY, 2006, BBA-GEN SUBJECTS, V1760, P70, DOI 10.1016/j.bbagen.2005.09.008; Wen Jing, 2011, Acta Agriculturae Zhejiangensis, V23, P70; Wettasinghe M, 2000, FOOD CHEM, V70, P17, DOI 10.1016/S0308-8146(99)00269-1; Winterbourn CC, 2003, BIOCHEM BIOPH RES CO, V305, P729, DOI 10.1016/S0006-291X(03)00810-6; Wojdylo A, 2007, FOOD CHEM, V105, P940, DOI 10.1016/j.foodchem.2007.04.038; Wood JD, 2008, MEAT SCI, V78, P343, DOI 10.1016/j.meatsci.2007.07.019; Xiong Y. L., 2000, Antioxidants in muscle foods: nutritional strategies to improve quality, P85; Zhang AW, 2005, POULTRY SCI, V84, P1015, DOI 10.1093/ps/84.7.1015; Zhou X, 2010, POULTRY SCI, V89, P588, DOI 10.3382/ps.2009-00319	62	40	42	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167339	10.1371/journal.pone.0167339	http://dx.doi.org/10.1371/journal.pone.0167339			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907152	Green Submitted, Green Published, gold			2022-12-26	WOS:000389482700123
J	Bossange, AV; Knudson, KM; Shrestha, A; Harben, R; Mitchell, JP				Bossange, Anne V.; Knudson, Kandace M.; Shrestha, Anil; Harben, Ronald; Mitchell, Jeffrey P.			The Potential for Conservation Tillage Adoption in the San Joaquin Valley, California: A Qualitative Study of Farmer Perspectives and Opportunities for Extension	PLOS ONE			English	Article							NO-TILLAGE; AGRICULTURAL INNOVATION; CARBON SEQUESTRATION; UNITED-STATES; SOIL CARBON; SYSTEMS; MANAGEMENT; INFILTRATION; ROTATIONS; EVOLUTION	Conservation tillage (CT) systems have a number of potential benefits including lower crop production costs and the ability to reduce soil erosion that have made them common in several regions of the world. Although CT systems have been researched and successfully implemented on some farms in California's San Joaquin Valley (SJV), overall adoption is low and the reasons for the region's comparatively low rates of adoption are not known. In 2011, we conducted written surveys and interviews with SJV farmers to identify characteristics of farmers who adopt or do not adopt CT, to determine reasons for non-adoption of CT, and to learn how successful CT adoption takes place in the SJV. We found that a universally acceptable definition of CT needs to be developed in order for effective research, outreach and communication on CT. Our research, which examined CT adoption within the expected progression of the diffusion of innovation model, suggested that larger and less diverse farms were more likely to use CT. Most farmers expressed transition to CT as a continuous learning process. Further, we conclude that gaining meaningful experience with CT practices by researchers in the local context is also a large component of successful adoption.	[Bossange, Anne V.] Univ Calif Davis, Dept Land Air & Water Resources Dept, Davis, CA 95616 USA; [Knudson, Kandace M.] Univ Calif Davis, John Muir Inst Environm, Davis, CA 95616 USA; [Shrestha, Anil] Calif State Univ Fresno, Dept Plant Sci, Fresno, CA 93740 USA; [Harben, Ronald] Calif Assoc Resource Conservat Dist, Arroyo Grande, CA USA; [Mitchell, Jeffrey P.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; California State University System; California State University Fresno; University of California System; University of California Davis	Mitchell, JP (corresponding author), Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.	jpmitchell@ucdavis.edu			California Department of Food and Agriculture Specialty Crop Block Grant Program [SCB09011]	California Department of Food and Agriculture Specialty Crop Block Grant Program	This work was supported by the California Department of Food and Agriculture Specialty Crop Block Grant Program under Grant SCB09011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLMARAS RR, 1985, SOIL TILL RES, V5, P197, DOI 10.1016/0167-1987(85)90030-3; [Anonymous], 2000, CONSERVATION TILLAGE; [Anonymous], 1989, JPM VERRS 10; [Anonymous], EXPRESSSCRIBE; Awada L, 2014, INT SOIL WATER CONSE, V2, P47, DOI 10.1016/S2095-6339(15)30013-7; Aziz I, 2013, SOIL TILL RES, V131, P28, DOI 10.1016/j.still.2013.03.002; Baker JM, 2007, AGR ECOSYST ENVIRON, V118, P1, DOI 10.1016/j.agee.2006.05.014; Ball E. V., 2015, APPL ECON PERSPECT P, P30; Bell M.M., 2004, FARMING US ALL PRACT; Bernoux M, 2006, AGRON SUSTAIN DEV, V26, P1, DOI 10.1051/agro:2005055; Bettner T., 2012, EXP CAL OPT M ITS WA; Bitsch V., 2005, Journal of Agribusiness, V23, P75; BULTENA GL, 1983, J SOIL WATER CONSERV, V38, P281; Busscher WJ, 1996, J SOIL WATER CONSERV, V51, P188; California Department of Food and Agriculture, 2015, CAL AGR STAT REV 201; Corbin J, 1998, BASICS QUALITATIVE R; Crabtree B., 2010, SEARCH SUSTAINABILIT; De Vita P, 2007, SOIL TILL RES, V92, P69, DOI 10.1016/j.still.2006.01.012; Derpsch R, 2014, SOIL TILL RES, V137, P16, DOI 10.1016/j.still.2013.10.002; Derpsch Rolf, 2010, International Journal of Agricultural and Biological Engineering, V3, P1, DOI 10.3965/j.issn.1934-6344.2010.01.001-025; Derpsch R., 2009, 4 WORLD C CONS AGR N 4 WORLD C CONS AGR N; Dumanski J., 2009, P MARCH 24 25 C SASK; Eckert E., 2005, J EXTENSION, V43; FEDER G, 1993, TECHNOL FORECAST SOC, V43, P215, DOI 10.1016/0040-1625(93)90053-A; Fleming Aysha., 2009, EXTENSION FARMING SY, V5, P1; Franzluebbers AJ, 2002, SOIL TILL RES, V66, P197, DOI 10.1016/S0167-1987(02)00027-2; Ghadim AKA, 1999, AGR ECON-BLACKWELL, V21, P145, DOI 10.1016/S0169-5150(99)00023-7; Ghadim AKA, 2005, AGR ECON-BLACKWELL, V33, P1, DOI 10.1111/j.1574-0862.2005.00433.x; Junior R.C., 2012, NO TILL AGR SO BRAZI, P1; Kassam A, 2014, INT SOIL WATER CONSE, V2, P5, DOI 10.1016/S2095-6339(15)30009-5; Klerkx L, 2010, AGR SYST, V103, P390, DOI 10.1016/j.agsy.2010.03.012; Knowler D, 2007, FOOD POLICY, V32, P25, DOI 10.1016/j.foodpol.2006.01.003; KORSCHING PF, 1983, J SOIL WATER CONSERV, V38, P428; Lal R, 2007, SOIL TILL RES, V93, P1, DOI 10.1016/j.still.2006.11.004; Licht MA, 2005, SOIL TILL RES, V80, P233, DOI 10.1016/j.still.2004.03.017; Lindwall W, 2009, P LANDSCAPES TRANSFO; Llewellyn RS, 2007, FIELD CROP RES, V104, P148, DOI 10.1016/j.fcr.2007.03.022; Llewellyn RS, 2012, FIELD CROP RES, V132, P204, DOI 10.1016/j.fcr.2012.03.013; Madden NM, 2008, ATMOS ENVIRON, V42, P3795, DOI 10.1016/j.atmosenv.2007.12.058; Medellin-Azuara J, 2015, ARE UPDATE, V18, P6; Mitchell JP, 2007, AUST J EXP AGR, V47, P1383, DOI 10.1071/EA07044; Mitchell JP, 2016, SOIL TILL RES, V157, P52, DOI 10.1016/j.still.2015.10.015; Mitchell J.P., 2009, U CAL DIV AGR NAT RE, P8; Mitchell J. P, 2009, UC ANR COMMUNICATION, V8330; Mitchell JP, 2015, AGRON J, V107, P588, DOI 10.2134/agronj14.0415; Mitchell JP, 2012, HORTTECHNOLOGY, V22, P617, DOI 10.21273/HORTTECH.22.5.617; Mitchell JP, 2012, CALIF AGR, V66, P108, DOI 10.3733/ca.v066n03p108; Mitchell JR, 2008, CALIF AGR, V62, P74, DOI 10.3733/ca.v062n02p74; Morrison J.E., 2000, CHIN INT C DRYL WAT; Muhr Thomas, 2016, ATLAS TI COMPUTER SO; NAPIER TL, 1984, J SOIL WATER CONSERV, V39, P205; NOWAK P, 1992, J SOIL WATER CONSERV, V47, P14; NRCS USDA, 2005, 329 NRCS USDA; Pannell DJ, 2006, AUST J EXP AGR, V46, P1407, DOI 10.1071/EA05037; PIMENTEL D, 1995, SCIENCE, V267, P1117, DOI 10.1126/science.267.5201.1117; Prokopy LS, 2008, J SOIL WATER CONSERV, V63, P300, DOI 10.2489/63.5.300; Reicosky DC, 2015, J SOIL WATER CONSERV, V70, P103, DOI 10.2489/jswc.70.5.103A; Rodriguez JM, 2009, RENEW AGR FOOD SYST, V24, P60, DOI 10.1017/S1742170508002421; Rogers E. M., 1961, RES B, V882, P1; Roling N.G., 2000, FACILITATING SUSTAIN; Rollins T, 1993, J AGR ED, V34, P46, DOI DOI 10.5032/JAE.1993.04046; Siebert R, 2006, SOCIOL RURALIS, V46, P318, DOI 10.1111/j.1467-9523.2006.00420.x; Uri ND, 2000, AGR ECOSYST ENVIRON, V77, P263, DOI 10.1016/S0167-8809(99)00085-7; Vanclay F, 2004, AUST J EXP AGR, V44, P213, DOI 10.1071/EA02139; Vitale JD, 2011, J SOIL WATER CONSERV, V66, P250, DOI 10.2489/jswc.66.4.250	65	14	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167612	10.1371/journal.pone.0167612	http://dx.doi.org/10.1371/journal.pone.0167612			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907196	Green Submitted, gold, Green Published			2022-12-26	WOS:000389482700212
J	Guo, YN; Dreier, JR; Cao, JX; Du, H; Granter, SR; Kwiatkowski, DJ				Guo, Yanan; Dreier, John R.; Cao, Juxiang; Du, Heng; Granter, Scott R.; Kwiatkowski, David J.			Analysis of a Mouse Skin Model of Tuberous Sclerosis Complex	PLOS ONE			English	Article							SPORADIC PULMONARY LYMPHANGIOLEIOMYOMATOSIS; STROMAL FIBROBLASTS; ANGIOMYOLIPOMA; EXPRESSION; MUTATIONS; SURVIVAL; MARKERS; TUMORS; CELLS; TSC2	Tuberous Sclerosis Complex (TSC) is an autosomal dominant tumor suppressor gene syndrome in which patients develop several types of tumors, including facial angiofibroma, subungual fibroma, Shagreen patch, angiomyolipomas, and lymphangioleiomyomatosis. It is due to inactivating mutations in TSC1 or TSC2. We sought to generate a mouse model of one or more of these tumor types by targeting deletion of the Tsc1 gene to fibroblasts using the Fsp-Cre allele. Mutant, Tsc1(cc)Fsp-Cre+ mice survived a median of nearly a year, and developed tumors in multiple sites but did not develop angiomyolipoma or lymphangioleiomyomatosis. They did develop a prominent skin phenotype with marked thickening of the dermis with accumulation of mast cells, that was minimally responsive to systemic rapamycin therapy, and was quite different from the pathology seen in human TSC skin lesions. Recombination and loss of Tsc1 was demonstrated in skin fibroblasts in vivo and in cultured skin fibroblasts. Loss of Tsc1 in fibroblasts in mice does not lead to a model of angiomyolipoma or lymphangioleiomyomatosis.	[Guo, Yanan; Dreier, John R.; Cao, Juxiang; Du, Heng; Granter, Scott R.; Kwiatkowski, David J.] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Kwiatkowski, DJ (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA.	dk@rics.bwh.harvard.edu			NIH NCI [1P01CA120964]	NIH NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grant NIH NCI 1P01CA120964. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badri KR, 2013, AM J RESP CRIT CARE, V187, P663, DOI 10.1164/ajrccm.187.6.663; Bissler JJ, 2013, LANCET, V381, P817, DOI 10.1016/S0140-6736(12)61767-X; Bonetti F, 1996, EUR RESPIR J, V9, P399, DOI 10.1183/09031936.96.09030399; Carbonara C, 1996, GENE CHROMOSOME CANC, V15, P18, DOI 10.1002/(SICI)1098-2264(199601)15:1<18::AID-GCC3>3.0.CO;2-7; Carsillo T, 2000, P NATL ACAD SCI USA, V97, P6085, DOI 10.1073/pnas.97.11.6085; Chilosi M, 2009, MODERN PATHOL, V22, P161, DOI 10.1038/modpathol.2008.189; Darling TN, 2010, TUBEROUS SCLEROSIS C, P285; Giannikou K, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006242; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Henske EP, 1997, AM J PATHOL, V151, P1639; KERR LA, 1993, UROLOGY, V41, P440, DOI 10.1016/0090-4295(93)90504-4; Koenig MK, 2012, DRUGS R&D, V12, P121, DOI 10.2165/11634580-000000000-00000; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Lim SD, 2007, MOL MED, V13, P160, DOI 10.2119/2006-00070.Lim; Matsumoto Y, 1999, AM J RESP CELL MOL, V21, P327, DOI 10.1165/ajrcmb.21.3.3693; McCormack FX, 2011, NEW ENGL J MED, V364, P1595, DOI 10.1056/NEJMoa1100391; Meikle L, 2008, J NEUROSCI, V28, P5422, DOI 10.1523/JNEUROSCI.0955-08.2008; Northrup H, 2013, PEDIATR NEUROL, V49, P243, DOI 10.1016/j.pediatrneurol.2013.08.001; QinWB V, 2011, PLOS ONE IN PRESS; Seyama Kuniaki, 2006, Lymphatic Research and Biology, V4, P143, DOI 10.1089/lrb.2006.4.143; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Trimboli AJ, 2009, NATURE, V461, P1084, DOI 10.1038/nature08486; Tyburczy ME, 2014, HUM MOL GENET, V23, P2023, DOI 10.1093/hmg/ddt597; Urban T, 1999, MEDICINE, V78, P321, DOI 10.1097/00005792-199909000-00004; Yu SQ, 2012, PROSTATE, V72, P437, DOI 10.1002/pros.21445; Zeng LH, 2008, ANN NEUROL, V63, P444, DOI 10.1002/ana.21331; Zhang H, 2003, J CLIN INVEST, V112 54, P728, DOI [10.1165/rcmb.2015-0111OC, DOI 10.1172/JCI17222]; Zhe XN, 2004, J HISTOCHEM CYTOCHEM, V52, P1537, DOI 10.1369/jhc.4A6438.2004; Zhou QY, 2016, AM J RESP CELL MOL, V54, P728, DOI 10.1165/rcmb.2015-0111OC	29	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167384	10.1371/journal.pone.0167384	http://dx.doi.org/10.1371/journal.pone.0167384			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907099	Green Published, gold, Green Submitted			2022-12-26	WOS:000389482700136
J	Jordan, S; Morris, JK; Davies, GI; Tucker, D; Thayer, DS; Luteijn, JM; Morgan, M; Garne, E; Hansen, AV; Klungsoyr, K; Engeland, A; Boyle, B; Dolk, H				Jordan, Sue; Morris, Joan K.; Davies, Gareth I.; Tucker, David; Thayer, Daniel S.; Luteijn, Johannes M.; Morgan, Margery; Garne, Ester; Hansen, Anne V.; Klungsoyr, Kari; Engeland, Anders; Boyle, Breidge; Dolk, Helen			Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants in Pregnancy and Congenital Anomalies: Analysis of Linked Databases in Wales, Norway and Funen, Denmark	PLOS ONE			English	Article							PERSISTENT PULMONARY-HYPERTENSION; BIRTH-DEFECTS; HEART-DEFECTS; MATERNAL DEPRESSION; PRENATAL EXPOSURE; PRETERM BIRTH; CARDIAC-MALFORMATIONS; MEDICATION USE; RISK; WOMEN	Background Hypothesised associations between in utero exposure to selective serotonin reuptake inhibitors (SSRIs) and congenital anomalies, particularly congenital heart defects (CHD), remain controversial. We investigated the putative teratogenicity of SSRI prescription in the 91 days either side of first day of last menstrual period (LMP). Methods and Findings Three population-based EUROCAT congenital anomaly registries- Norway (2004-2010), Wales (2000-2010) and Funen, Denmark (2000-2010)-were linked to the electronic healthcare databases holding prospectively collected prescription information for all pregnancies in the timeframes available. We included 519,117 deliveries, including foetuses terminated for congenital anomalies, with data covering pregnancy and the preceding quarter, including 462,641 with data covering pregnancy and one year either side. For SSRI exposures 91 days either side of LMP, separately and together, odds ratios with 95% confidence intervals (ORs, 95% CI) for all major anomalies were estimated. We also explored: pausing or discontinuing SSRIs preconception, confounding, high dose regimens, and, in Wales, diagnosis of depression. Results were combined in meta-analyses. SSRI prescription 91 days either side of LMP was associated with increased prevalence of severe congenital heart defects (CHD) (as defined by EUROCAT guide 1.3, 2005) (34/12,962 [0.26%] vs. 865/506,155 [0.17%] OR 1.50, 1.06-2.11), and the composite adverse outcome of 'anomaly or stillbirth' (473/12962, 3.65% vs. 15829/ 506,155, 3.13%, OR 1.13, 1.03-1.24). The increased prevalence of all major anomalies combined did not reach statistical significance (3.09% [400/12,962] vs. 2.67% [13,536/506,155] OR 1.09, 0.99-1.21). Adjusting for socioeconomic status left ORs largely unchanged. The prevalence of anomalies and severe CHD was reduced when SSRI prescriptions were stopped or paused preconception, and increased when > 1 prescription was recorded, but differences were not statistically significant. The dose-response relationship between severe CHD and SSRI dose (meta-regression OR 1.49, 1.12-1.97) was consistent with SSRI-exposure related risk. Analyses in Wales suggested no associations between anomalies and diagnosed depression. Conclusion The additional absolute risk of teratogenesis associated with SSRIs, if causal, is small. However, the high prevalence of SSRI use augments its public health importance, justifying modifications to preconception care.	[Jordan, Sue; Davies, Gareth I.; Thayer, Daniel S.] Swansea Univ, Dept Nursing, Coll Human & Hlth Sci, Swansea, W Glam, Wales; [Morris, Joan K.; Luteijn, Johannes M.] Queen Mary Univ London, London, England; [Tucker, David; Morgan, Margery] Publ Hlth Wales, Swansea, W Glam, Wales; [Garne, Ester] Hosp Lillebaelt, Dept Paediat, Kolding, Denmark; [Hansen, Anne V.] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark; [Klungsoyr, Kari; Engeland, Anders] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Klungsoyr, Kari] Norwegian Inst Publ Hlth, Dept Hlth Registries, Bergen, Norway; [Engeland, Anders] Norwegian Inst Publ Hlth Bergen, Dept Pharmacoepidemiol, Bergen, Norway; [Boyle, Breidge; Dolk, Helen] Univ Ulster, Ctr Maternal Fetal & Infant Res, Newtownabbey, Co Antrim, North Ireland	Swansea University; University of London; Queen Mary University London; University of Copenhagen; University of Bergen; Norwegian Institute of Public Health (NIPH); Norwegian Institute of Public Health (NIPH); Ulster University	Jordan, S (corresponding author), Swansea Univ, Dept Nursing, Coll Human & Hlth Sci, Swansea, W Glam, Wales.	S.E.Jordan@swansea.ac.uk	Engeland, Anders/AAG-7437-2021; Klungsøyr, Kari/ABC-6147-2020; Morris, Joan/AAT-9211-2020; jordan, sue/O-1297-2019	Klungsøyr, Kari/0000-0003-2482-1690; Morris, Joan/0000-0002-7164-612X; jordan, sue/0000-0002-5691-2987; Thayer, Dan/0000-0003-1847-4362; Davies, Gareth/0000-0001-9005-1618; Luteijn, Michiel/0000-0002-9526-9015; Hansen, Anne Vinkel/0000-0003-4523-3521	European Union under the 7th Framework Program [HEALTH-F5-2011-260598]	European Union under the 7th Framework Program	Financial support for the EUROmediCAT study was provided by the European Union under the 7th Framework Program (grant agreement HEALTH-F5-2011-260598). Start date: 1 March 2011. Duration: 48 months. Coordinator: Prof. Helen Dolk, University of Ulster, UK, Tel: +44 28 90368540, Email: h.dolk@ulster.ac.uk. Further information can be found at www.euromedicat.eu. The funder played no part in the study or production of the paper and the research report.	Alwan S, 2007, NEW ENGL J MED, V356, P2684, DOI 10.1056/NEJMoa066584; Alwan S, 2015, BIRTH DEFECTS RES A, V103, P721, DOI 10.1002/bdra.23394; Alwan S, 2011, J CLIN PHARMACOL, V51, P264, DOI 10.1177/0091270010373928; American College of Obstetricians and Gynecologists' Committee on Obstetric Practice, 2016, Obstet Gynecol, V127, P418, DOI 10.1097/AOG.0000000000001309; Amick HR, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6019; Angermeyer MC, 2014, SOC SCI MED, V103, P60, DOI 10.1016/j.socscimed.2013.11.014; Ban L, 2014, BJOG-INT J OBSTET GY, V121, P1471, DOI 10.1111/1471-0528.12682; Bar-Oz B, 1999, LANCET, V354, P1700, DOI 10.1016/S0140-6736(99)04411-6; BEARDON PHG, 1993, BRIT MED J, V307, P846, DOI 10.1136/bmj.307.6908.846; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berard A, 2007, BIRTH DEFECTS RES B, V80, P18, DOI 10.1002/bdrb.20099; Berard A, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2015.01.034; BNF, 2013, BRITISH MEDICAL ASSO; BNF, 2016, BRITISH NATIONAL FOR; Bradshaw PJ, CHANGING CHILDHOOD I; Bukowski R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001633; Burdan F, 2006, PHARMACOL RES, V53, P287, DOI 10.1016/j.phrs.2005.12.006; Byatt N, 2013, ACTA PSYCHIAT SCAND, V127, P94, DOI 10.1111/acps.12042; Carmichael SL, 2014, PAEDIATR PERINAT EP, V28, P338, DOI 10.1111/ppe.12123; Casson IF, 1997, BRIT MED J, V315, P275, DOI 10.1136/bmj.315.7103.275; Chambers CD, 2006, NEW ENGL J MED, V354, P579, DOI 10.1056/NEJMoa052744; Chambers CD, 1996, NEW ENGL J MED, V335, P1010, DOI 10.1056/NEJM199610033351402; Charlton RA, 2015, BJOG-INT J OBSTET GY, V122, P1010, DOI 10.1111/1471-0528.13143; Charlton RA, 2014, PHARMACOEPIDEM DR S, V23, P586, DOI 10.1002/pds.3613; Cohen LS, 2006, JAMA-J AM MED ASSOC, V295, P499, DOI 10.1001/jama.295.5.499; Cole JA, 2007, PHARMACOEPIDEM DR S, V16, P1075, DOI 10.1002/pds.1463; Colvin L, 2011, BIRTH DEFECTS RES A, V91, P142, DOI 10.1002/bdra.20773; Coughlin CG, 2015, OBSTET GYNECOL, V125, P1224, DOI 10.1097/AOG.0000000000000759; Coupland C, 2015, BMJ-BRIT MED J, V350, DOI [10.1136/BMJ.h517, 10.1136/bmj.h517]; Davis RL, 2007, PHARMACOEPIDEM DR S, V16, P1086, DOI 10.1002/pds.1462; Daws LC, 2011, PHARMACOL THERAPEUT, V131, P61, DOI 10.1016/j.pharmthera.2011.03.013; Demidenko E, 2007, STAT MED, V26, P3385, DOI 10.1002/sim.2771; Dietz PM, 2011, AM J EPIDEMIOL, V173, P355, DOI 10.1093/aje/kwq381; Einarson A, 2012, J CLIN PSYCHIAT, V73, P1443, DOI 10.4088/JCP.12com08192; Eke AC, 2016, BJOG-INT J OBSTET GY, V123, P1900, DOI 10.1111/1471-0528.14144; EUROCAT, 2013, EUROCAT EUROPEAN SUR; EUROCAT, 2005, EUROCAT EUROPEAN SUR; EUROmediCAT. (EMC), 2015, SELECTIVE SEROTONIN; European Commission, 2008, OBJECTIVE 1 SUPPORTI; Fischer MA, 2010, J GEN INTERN MED, V25, P284, DOI 10.1007/s11606-010-1253-9; Flower A, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-238; Ford DV, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-157; Furu K, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1798; Furu K, 2010, BASIC CLIN PHARMACOL, V106, P86, DOI 10.1111/j.1742-7843.2009.00494.x; Gadkari AS, 2010, CURR MED RES OPIN, V26, P683, DOI 10.1185/03007990903550586; Gardosi J, 2005, BMJ-BRIT MED J, V331, P1113, DOI 10.1136/bmj.38629.587639.7C; Gentile S, 2011, ACTA PSYCHIAT SCAND, V123, P266, DOI 10.1111/j.1600-0447.2011.01673.x; Gentile S, 2010, SCHIZOPHRENIA BULL, V36, P518, DOI 10.1093/schbul/sbn107; Golder S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071813; Golder S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001026; Greenland S, 2016, EUR J EPIDEMIOL, V31, P337, DOI 10.1007/s10654-016-0149-3; Greenlees R, 2011, BIRTH DEFECTS RES A, V91, pS51, DOI 10.1002/bdra.20775; Grigoriadis S, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f6932; Grigoriadis S, 2013, J CLIN PSYCHIAT, V74, pE293, DOI 10.4088/JCP.12r07966; Grigoriadis S, 2013, J CLIN PSYCHIAT, V74, pE321, DOI 10.4088/JCP.12r07968; Grote NK, 2010, ARCH GEN PSYCHIAT, V67, P1012, DOI 10.1001/archgenpsychiatry.2010.111; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.03.017, 10.1016/j.jclinepi.2011.06.004]; HALL JG, 1980, AM J MED, V68, P122, DOI 10.1016/0002-9343(80)90181-3; Hamer DM, 2013, CARDIFF WALES D CHIL; Handal M, 2016, BJOG-INT J OBSTET GY, V123, P1908, DOI 10.1111/1471-0528.13582; Hannerfors AK, 2015, PSYCHONEUROENDOCRINO, V58, P104, DOI 10.1016/j.psyneuen.2015.04.009; Hendrick V, 2003, AM J PSYCHIAT, V160, P993, DOI 10.1176/appi.ajp.160.5.993; Hiemke C, 2000, PHARMACOL THERAPEUT, V85, P11, DOI 10.1016/S0163-7258(99)00048-0; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Hippocrates, 1923, THE HIPPOCRATIC CORP; Huang H, 2014, GEN HOSP PSYCHIAT, V36, P13, DOI 10.1016/j.genhosppsych.2013.08.002; Hutton C, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-71; Huybrechts KF, 2015, JAMA-J AM MED ASSOC, V314, P1294, DOI 10.1001/jama.2015.10048; Huybrechts KF, 2014, NEW ENGL J MED, V370, P2397, DOI 10.1056/NEJMoa1312828; IBM Corp, 2011, IBM SPSS STATISTICS; ICH, 1996, ICH HARMONISED TRIPA; Ionescu-Ittu R, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1673; Jimenez-Solem E, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001148; Jimenez-Solem E, 2013, AM J PSYCHIAT, V170, P299, DOI 10.1176/appi.ajp.2012.11081251; Jordan S, 2015, MARC SOC C ARCH WOM, V18, P269, DOI DOI 10.1007/S00737-014-0488-6.; Jordan S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067912; Kendrick T, 2005, BRIT J GEN PRACT, V55, P280; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; KLEMETTI A, 1967, AM J PUBLIC HEALTH N, V57, P2071, DOI 10.2105/AJPH.57.12.2071; Knudsen TM, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-333; Kornum Jette B, 2010, Clin Epidemiol, V2, P29; Laine K, 2003, ARCH GEN PSYCHIAT, V60, P720, DOI 10.1001/archpsyc.60.7.720; Langhoff-Roos J, 2014, ACTA OBSTET GYN SCAN, V93, P132, DOI 10.1111/aogs.12302; Latendresse Gwen, 2013, Open J Obstet Gynecol, V3, P184; Lattimore Keri A, 2005, J Perinatol, V25, P595; Li YJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0080475, 10.1371/journal.pone.0070390]; Liu SL, 2013, CIRCULATION, V128, P583, DOI 10.1161/CIRCULATIONAHA.112.001054; Louik C, 2007, NEW ENGL J MED, V356, P2675, DOI 10.1056/NEJMoa067407; Lyons RA, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-3; Malm H, 2011, OBSTET GYNECOL, V118, P111, DOI 10.1097/AOG.0b013e318220edcc; Margulis AV, 2013, PHARMACOEPIDEM DR S, V22, P942, DOI 10.1002/pds.3462; Maschi S, 2008, BJOG-INT J OBSTET GY, V115, P283, DOI 10.1111/j.1471-0528.2007.01518.x; McDonagh M, 2014, ANTIDEPRESSANT TREAT; Menchetti M, 2014, BRIT J PSYCHIAT, V204, P144, DOI 10.1192/bjp.bp.112.122663; Morrow J, 2006, J NEUROL NEUROSUR PS, V77, P193, DOI 10.1136/jnnp.2005.074203; Myles N, 2013, AUST NZ J PSYCHIAT, V47, P1002, DOI 10.1177/0004867413492219; NCCMH. (National Collaborating Centre for Mental Health), 2014, ANTENATAL AND POSTNA, P192; NCCMH. (National Collaborating Centre for Mental Health), 2007, ANTENATAL AND POSTNA; Nikfar S, 2012, DARU, V20, DOI 10.1186/2008-2231-20-75; Oberlander TF, 2009, CLIN PHARMACOL THER, V86, P672, DOI 10.1038/clpt.2009.201; Oberlander TF, 2008, BIRTH DEFECTS RES B, V83, P68, DOI 10.1002/bdrb.20144; Oberlander TF, 2010, ARCH PEDIAT ADOL MED, V164, P444, DOI 10.1001/archpediatrics.2010.51; Olivier JDA, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00073; Palmsten K, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4877; Pearlstein T, 2015, BEST PRACT RES CL OB, V29, P754, DOI 10.1016/j.bpobgyn.2015.04.004; Pedersen LH, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3569; Peters P, 2015, DRUGS DURING PREGNANCY AND LACTATION: TREATMENT OPTIONS AND RISK ASSESSMENT, 3RD EDITION, P1, DOI 10.1016/B978-0-12-408078-2.00001-9; Pierpont ME, 2007, CIRCULATION, V115, P3015, DOI 10.1161/CIRCULATIONAHA.106.183056; Pop Anca, 2015, Clujul Med, V88, P381, DOI 10.15386/cjmed-474; Raisanen S, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004883; Ramos E, 2008, BRIT J PSYCHIAT, V192, P344, DOI 10.1192/bjp.bp.107.042523; Ray S, 2014, BEST PRACT RES CL OB, V28, P71, DOI 10.1016/j.bpobgyn.2013.09.005; Reefhuis J, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3190; Reis M, 2010, PSYCHOL MED, V40, P1723, DOI 10.1017/S0033291709992194; Reis M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002166; Ross LE, 2013, JAMA PSYCHIAT, V70, P436, DOI 10.1001/jamapsychiatry.2013.684; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Sadler TW, 2011, REPROD TOXICOL, V32, P484, DOI 10.1016/j.reprotox.2011.09.004; Salisbury AL, 2009, CLIN PERINATOL, V36, P595, DOI 10.1016/j.clp.2009.06.002; Santos-Silva AJ, 2009, REPROD SCI, V16, P1175, DOI 10.1177/1933719109343787; Schaefer C, 2007, DRUGS DURING PREGNANCY AND LACTATION: TREATMENT OPTIONS AND RISK ASSESSMENT, 2ND EDITION, P1; Schroll JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041174; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; Skurtveit S, 2013, J CLIN EPIDEMIOL, V66, P964, DOI 10.1016/j.jclinepi.2013.02.011; Sljivic S, 2006, MED HYPOTHESES, V67, P57, DOI 10.1016/j.mehy.2005.07.037; StataCorp, 2011, STATA STATISTICAL SO; Stats Wales ELMS Welsh Government Cardiff Wales, 2014, Q REPORT; Stein A, 2014, LANCET, V384, P1800, DOI 10.1016/S0140-6736(14)61277-0; Stephansson O, 2013, JAMA-J AM MED ASSOC, V309, P48, DOI 10.1001/jama.2012.153812; Sweeting MJ, 2004, STAT MED, V23, P1351, DOI 10.1002/sim.1761; Talbot J., 2012, STEPHENS DETECTION E, P215; Torfs CP, 1999, EPIDEMIOLOGY, V10, P264, DOI 10.1097/00001648-199905000-00013; Tracy TS, 2005, AM J OBSTET GYNECOL, V192, P633, DOI 10.1016/j.ajog.2004.08.030; United Nations, 2007, THE MILLENNIUM DEVEL; van Geffen ECG, 2009, BRIT J GEN PRACT, V59, P81, DOI 10.3399/bjgp09X395067; VANALLEN MI, 1981, PEDIATR ANN, V10, P219; Velasquez JC, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00047; Wadhwa PD, 2004, AM J OBSTET GYNECOL, V191, P1063, DOI 10.1016/j.ajog.2004.06.070; Wadhwa PD, 2002, REGUL PEPTIDES, V108, P149, DOI 10.1016/S0167-0115(02)00102-7; Wemakor A, 2015, EUR J EPIDEMIOL, V30, P1187, DOI 10.1007/s10654-015-0065-y; WERLER MM, 1992, TERATOLOGY, V45, P361, DOI 10.1002/tera.1420450407; Whitworth M, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007058.pub3; WHO Collaborating Centre for Drug Statistics Methodology, 2016, GUIDELINES FOR ATC C; Wilffert B, 2011, PHARMACOGENOMICS, V12, P547, DOI [10.2217/pgs.10.201, 10.2217/PGS.10.201]; Willner P, 2013, NEUROSCI BIOBEHAV R, V37, P2331, DOI 10.1016/j.neubiorev.2012.12.007; Wisner K, 2015, DRUGS PREGNANCY LACT, P293; Wogelius P, 2005, INT J ANTIMICROB AG, V26, P323, DOI 10.1016/j.ijantimicag.2005.06.017; World Bank Group, 2014, THE WORLD BANK WORKI; Yazdy MM, 2014, EPIDEMIOLOGY, V25, P859, DOI 10.1097/EDE.0000000000000157; Yonkers KA, 2011, EPIDEMIOLOGY, V22, P848, DOI 10.1097/EDE.0b013e3182306847; Yonkers KA, 2009, GEN HOSP PSYCHIAT, V31, P403, DOI [10.1097/AOG.0b013e3181ba0632, 10.1016/j.genhosppsych.2009.04.003]	152	28	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0165122	10.1371/journal.pone.0165122	http://dx.doi.org/10.1371/journal.pone.0165122			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3JC	27906972	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000389482700008
J	Nalley, L; Tsiboe, F; Durand-Morat, A; Shew, A; Thoma, G				Nalley, Lawton; Tsiboe, Francis; Durand-Morat, Alvaro; Shew, Aaron; Thoma, Greg			Economic and Environmental Impact of Rice Blast Pathogen (Magnaporthe oryzae) Alleviation in the United States	PLOS ONE			English	Article							CISGENIC PLANTS; DISEASE; RESISTANCE; VARIETIES	Rice blast (Magnaporthe oryzae) is a key concern in combating global food insecurity given the disease is responsible for approximately 30% of rice production losses globally-the equivalent of feeding 60 million people. These losses increase the global rice price and reduce consumer welfare and food security. Rice is the staple crop for more than half the world's population so any reduction in rice blast would have substantial beneficial effects on consumer livelihoods. In 2012, researchers in the US began analyzing the feasibility of creating blast-resistant rice through cisgenic breeding. Correspondingly, our study evaluates the changes in producer, consumer, and environmental welfare, if all the rice produced in the Mid-South of the US were blast resistant through a process like cisgenics, using both international trade and environmental assessment modeling. Our results show that US rice producers would gain 69.34 million dollars annually and increase the rice supply to feed an additional one million consumers globally by eliminating blast from production in the Mid-South. These results suggest that blast alleviation could be even more significant in increasing global food security given that the US is a small rice producer by global standards and likely experiences lower losses from blast than other rice-producing countries because of its ongoing investment in production technology and management. Furthermore, results from our detailed life cycle assessment (LCA) show that producing blast-resistant rice has lower environmental (fossil fuel depletion, ecotoxicity, carcinogenics, eutrophication, acidification, global warming potential, and ozone depletion) impacts per unit of rice than non-blast resistant rice production. Our findings suggest that any reduction in blast via breeding will have significantly positive impacts on reducing global food insecurity through increased supply, as well as decreased price and environmental impacts in production.	[Nalley, Lawton; Tsiboe, Francis; Durand-Morat, Alvaro; Shew, Aaron] Univ Arkansas, Dept Agr Econ, Fayetteville, AR 72701 USA; [Thoma, Greg] Univ Arkansas, Dept Chem Engn, Fayetteville, AR 72701 USA	University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas System; University of Arkansas Fayetteville	Nalley, L (corresponding author), Univ Arkansas, Dept Agr Econ, Fayetteville, AR 72701 USA.	llnalley@uark.edu	Tsiboe, Francis/A-6485-2018; Thoma, Greg/W-8646-2019; Nalley, Lawton/AAN-7643-2021	Tsiboe, Francis/0000-0001-5984-1072; Thoma, Greg/0000-0001-8757-7635; Shew, Aaron/0000-0003-3788-7891	Agriculture and Food Research Initiative Competitive from the United States Department of Agriculture National Institute of Food and Agriculture [2013-68004-20378]; National Science Foundation Research Fellowship Program [DGE-1450079]	Agriculture and Food Research Initiative Competitive from the United States Department of Agriculture National Institute of Food and Agriculture; National Science Foundation Research Fellowship Program	This study was supported by the Agriculture and Food Research Initiative Competitive Grant no. 2013-68004-20378 from the United States Department of Agriculture National Institute of Food and Agriculture and the National Science Foundation Research Fellowship Program under grant no. (DGE-1450079).	Andersson HC, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2561; Arkansas Agricultural Experiment Station (AAES), 2002, ARK RIC PERF TRIALS; Bare J, 2006, ENVIRON SCI TECHNOL, V40, P5108, DOI 10.1021/es052494b; BASTIAANS L, 1993, NETH J PLANT PATHOL, V99, P205, DOI 10.1007/BF01974665; Blanchard T, 2016, BLAST OUTBREAK RICE; BONMAN JM, 1991, PLANT DIS, V75, P462, DOI 10.1094/PD-75-0462; Brennan JP, 1984, REV MARKETING AGR EC, V52; Briones RM, 2012, CLIMATE CHANGE PRICE; Falconer L, 2015, MISSISSIPPI RICE PLA; Flanders A, 2015, ARKANSAS CROP ENTERP; Ganesh N.R., 2012, J BIOSCI BIOTECHNOL, V1, P18; Grassini P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3918; Groth D, 2014, 105 ANN RES REP RIC; Groth D, 2014, RICE DIS CONTROL STU; High-Level Expert Forum, 2009, FEED WORLD 2050; INTERNATIONAL MONETARY FUND (IMF), 2015, INT FIN STAT IFS; Khush GS, 2009, ADVANCES IN GENETICS, GENOMICS AND CONTROL OF RICE BLAST DISEASE, P1, DOI 10.1007/978-1-4020-9500-9_1; Koutroubas SD, 2008, AUSTRALAS PLANT PATH, V37, P53, DOI 10.1071/AP07078; Koutroubas SD, 2009, TURK J AGRIC FOR, V33, P487, DOI 10.3906/tar-0812-15; Louisiana State University Agricultural Center (LSU AgCenter), 2003, RIC VAR MAN TIPS; Marasas CN, 2003, AGR ECON, V29, P253, DOI 10.1111/j.1574-0862.2003.tb00162.x; Mississippi Agricultural and Forester Experiment Station (MAFES), 2002, MISS RIC VAR TRIALS; Nalley L. L., 2011, Journal of Agricultural and Applied Economics, V43, P131; Norman R, 2002, WELLS ARKANSAS RICE; Peng SB, 2010, FIELD CROP RES, V119, P342, DOI 10.1016/j.fcr.2010.08.003; Peter M, 2013, K STATE TODAY   0619; Qu SH, 2006, GENETICS, V172, P1901, DOI 10.1534/genetics.105.044891; Ray DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066428; Rice Technical Working Group (RTWG), 2001, P RIC TECHN WORK GRO; Salassi M, 2015, PROJECTED COSTS RETU; Schouten HJ, 2006, EMBO REP, V7, P750, DOI 10.1038/sj.embor.7400769; Schouten HJ, 2006, NAT BIOTECHNOL, V24, P753, DOI 10.1038/nbt0706-753; Skamnioti P, 2009, TRENDS BIOTECHNOL, V27, P141, DOI 10.1016/j.tibtech.2008.12.002; University of Arkansas Cooperative Extension Service (UACES), 2015, RIC PROD HDB; University of Arkansas Cooperative Extension Service (UACES), 2016, 2016 CROP ENT BUDG A; USDA, 2015, QUICK STATS WORLD AG; Wailes E., 2010, RICEFLOW MULTIREGION; Wailes EJ, 2015, FRONT ECON GLOBAL, V15, P255, DOI 10.1108/S1574-871520150000015025; Wang G.-L., 2009, ADV GENETICS GENOMIC; Wang XY, 2015, MOL PLANT MICROBE IN, V28, P1383, DOI 10.1094/MPMI-06-15-0131-R; Zeigler R.S., 1994, RICE BLAST DIS; Zhou EX, 2007, FUNGAL GENET BIOL, V44, P1024, DOI 10.1016/j.fgb.2007.02.003	42	89	100	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167295	10.1371/journal.pone.0167295	http://dx.doi.org/10.1371/journal.pone.0167295			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907101	gold, Green Submitted, Green Published			2022-12-26	WOS:000389482700112
J	Partridge, CG; MacManes, MD; Knapp, R; Neff, BD				Partridge, Charlyn G.; MacManes, Matthew D.; Knapp, Rosemary; Neff, Bryan D.			Brain Transcriptional Profiles of Male Alternative Reproductive Tactics and Females in Bluegill Sunfish	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; O-GLCNAC TRANSFERASE; LEPOMIS-MACROCHIRUS; PARENTAL CARE; SUBORDINATE RELATIONSHIPS; AROMATASE-ACTIVITY; SPERM COMPETITION; LIFE-HISTORIES; TELEOST FISH; PLASTICITY	Bluegill sunfish (Lepomis macrochirus) are one of the classic systems for studying male alternative reproductive tactics (ARTs) in teleost fishes. In this species, there are two distinct life histories: parental and cuckolder, encompassing three reproductive tactics, parental, satellite, and sneaker. The parental life history is fixed, whereas individuals who enter the cuckolder life history transition from sneaker to satellite tactic as they grow. For this study, we used RNAseq to characterize the brain transcriptome of the three male tactics and females during spawning to identify gene ontology (GO) categories and potential candidate genes associated with each tactic. We found that sneaker males had higher levels of gene expression differentiation compared to the other two male tactics. Sneaker males also had higher expression in ionotropic glutamate receptor genes, specifically AMPA receptors, compared to other males, which may be important for increased spatial working memory while attempting to cuckold parental males at their nests. Larger differences in gene expression also occurred among male tactics than between males and females. We found significant expression differences in several candidate genes that were previously identified in other species with ARTs and suggest a previously undescribed role for cAMP-responsive element modulator (crem) in influencing parental male behaviors during spawning.	[Partridge, Charlyn G.] Grand Valley State Univ, Annis Water Resources Inst, Muskegon, MI 49442 USA; [Partridge, Charlyn G.; Neff, Bryan D.] Univ Western Ontario, Dept Biol, London, ON, Canada; [MacManes, Matthew D.] Univ New Hampshire, Dept Mol Cellular & Biomed Sci, Durham, NH 03824 USA; [Knapp, Rosemary] Univ Oklahoma, Dept Biol, Norman, OK 73019 USA	Grand Valley State University; Western University (University of Western Ontario); University System Of New Hampshire; University of New Hampshire; University of Oklahoma System; University of Oklahoma - Norman	Partridge, CG (corresponding author), Grand Valley State Univ, Annis Water Resources Inst, Muskegon, MI 49442 USA.; Partridge, CG (corresponding author), Univ Western Ontario, Dept Biol, London, ON, Canada.	partridc@gvsu.edu		Knapp, Rosemary/0000-0001-6923-8410; Neff, Bryan/0000-0001-8499-250X	Natural Sciences and Engineering Research Council of Canada (NSERC) [250071-2012]; University of Oklahoma Department of Biology	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of Oklahoma Department of Biology	Funding for this project was supported through the Natural Sciences and Engineering Research Council of Canada (NSERC) to B.D.N (#250071-2012) and the University of Oklahoma Department of Biology to R.K. The funders had no role in any study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], ALIGNING SEQUENCE RE, DOI DOI 10.48550/ARXIV.1303.3997; Arslan T, 2004, AQUAC RES, V35, P397, DOI 10.1111/j.1365-2109.2004.01029.x; Asahina K, 2014, CELL, V156, P221, DOI 10.1016/j.cell.2013.11.045; Aubin-Horth N, 2005, P ROY SOC B-BIOL SCI, V272, P1655, DOI 10.1098/rspb.2005.3125; Aubin-Horth N, 2009, MOL ECOL, V18, P3763, DOI 10.1111/j.1365-294X.2009.04313.x; AVILA VL, 1976, AM MIDL NAT, V96, P195, DOI 10.2307/2424577; Baumgart M, 2014, AGING CELL, V13, P965, DOI 10.1111/acel.12257; BLOCH GJ, 1993, PHYSIOL BEHAV, V54, P615, DOI 10.1016/0031-9384(93)90068-Q; Bloch GJ, 1996, PHYSIOL BEHAV, V59, P1147, DOI 10.1016/0031-9384(95)02087-X; Bolger AM, 2014, BIOINFORMATICS; Bourgeois CF, 2004, PROG NUCLEIC ACID RE, V78, P37, DOI 10.1016/S0079-6603(04)78002-2; Burmeister SS, 2005, PLOS BIOL, V3, P1996, DOI 10.1371/journal.pbio.0030363; Cardoso SD, 2015, BRIAN BEHAV EVOL, V85, P287; Churcher AM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-799; COLGAN P W, 1979, Environmental Biology of Fishes, V4, P29, DOI 10.1007/BF00005925; Diotel N, 2010, FRONT NEUROENDOCRIN, V31, P172, DOI 10.1016/j.yfrne.2010.01.003; DOMINEY WJ, 1980, NATURE, V284, P546, DOI 10.1038/284546a0; Fergus DJ, 2013, J COMP NEUROL, V521, P2850, DOI 10.1002/cne.23320; Foran CM, 1998, GEN COMP ENDOCR, V111, P271, DOI 10.1006/gcen.1998.7113; Forlano PM, 2005, J NEUROBIOL, V65, P37, DOI 10.1002/neu.20179; FOULKES NS, 1992, CELL, V68, P411, DOI 10.1016/0092-8674(92)90178-F; Foulkes NS, 1997, TRENDS NEUROSCI, V20, P487, DOI 10.1016/S0166-2236(97)01109-0; FOULKES NS, 1992, NATURE, V355, P80, DOI 10.1038/355080a0; Fraser BA, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2310; Frisch Ashley, 2004, Reviews in Fish Biology and Fisheries, V14, P481, DOI 10.1007/s11160-005-3586-8; Gao ZX, 2009, AQUACULTURE, V294, P138, DOI 10.1016/j.aquaculture.2009.05.024; Gomez Y, 2006, NEUROBIOL LEARN MEM, V85, P252, DOI 10.1016/j.nlm.2005.11.006; Goncalves D, 2008, HORM BEHAV, V54, P717, DOI 10.1016/j.yhbeh.2008.07.014; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Greenwood AK, 2008, P ROY SOC B-BIOL SCI, V275, P2393, DOI 10.1098/rspb.2008.0622; Grober MS, 2002, BRAIN RES BULL, V57, P423, DOI 10.1016/S0361-9230(01)00704-3; Gross MR, 1998, J THEOR BIOL, V192, P445, DOI 10.1006/jtbi.1998.0665; GROSS MR, 1980, P NATL ACAD SCI-BIOL, V77, P6937, DOI 10.1073/pnas.77.11.6937; GROSS MR, 1981, BEHAV ECOL SOCIOBIOL, V8, P163, DOI 10.1007/BF00299826; Gross MR, 1996, TRENDS ECOL EVOL, V11, P92, DOI 10.1016/0169-5347(96)81050-0; GROSS MR, 1982, Z TIERPSYCHOL, V60, P1; GROSS MR, 1979, CAN J ZOOL, V57, P1507, DOI 10.1139/z79-197; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Howerton CL, 2013, P NATL ACAD SCI USA, V110, P5169, DOI 10.1073/pnas.1300065110; Jazin E, 2010, NAT REV NEUROSCI, V11, P9, DOI 10.1038/nrn2754; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; KINDLER PM, 1991, HORM BEHAV, V25, P410, DOI 10.1016/0018-506X(91)90011-6; KINDLER PM, 1989, GEN COMP ENDOCR, V75, P446, DOI 10.1016/0016-6480(89)90180-9; Knapp R, 2007, BIOL LETTERS, V3, P628, DOI 10.1098/rsbl.2007.0379; Kupper C, 2016, NAT GENET, V48, P79, DOI 10.1038/ng.3443; Lagerlof O, 2016, SCIENCE, V351, P1293, DOI 10.1126/science.aad5494; Lamichhaney S, 2016, NAT GENET, V48, P84, DOI 10.1038/ng.3430; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; LANK DB, 1995, NATURE, V378, P59, DOI 10.1038/378059a0; Larson ET, 2006, BEHAV BRAIN RES, V167, P94, DOI 10.1016/j.bbr.2005.08.020; Le Page Y, 2010, EUR J NEUROSCI, V32, P2105, DOI 10.1111/j.1460-9568.2010.07519.x; Lepage O, 2005, HORM BEHAV, V48, P233, DOI 10.1016/j.yhbeh.2005.02.012; MacManes MD, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00013; Magee SE, 2006, HORM BEHAV, V49, P598, DOI 10.1016/j.yhbeh.2005.12.003; Marden JH, 2008, HEREDITY, V100, P111, DOI 10.1038/sj.hdy.6800904; MOLINA CA, 1993, CELL, V75, P875, DOI 10.1016/0092-8674(93)90532-U; MOORE MC, 1991, HORM BEHAV, V25, P154, DOI 10.1016/0018-506X(91)90048-M; Mouriec K, 2009, BIOL REPROD, V80, P889, DOI 10.1095/biolreprod.108.073643; MUNRO AD, 1986, J PINEAL RES, V3, P257, DOI 10.1111/j.1600-079X.1986.tb00748.x; Myers SA, 2011, P NATL ACAD SCI USA, V108, P9490, DOI 10.1073/pnas.1019289108; Neff BD, 2004, BEHAV ECOL, V15, P327, DOI 10.1093/beheco/arh016; Neff BD, 2001, J HERED, V92, P111, DOI 10.1093/jhered/92.2.111; Neff BD, 2001, P ROY SOC B-BIOL SCI, V268, P1559, DOI 10.1098/rspb.2001.1678; Neff BD, 2009, CENTRARCHID FISHES D, P96; Neff BD, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0045; Oliveira Rui F., 2006, Fish Physiology, V24, P297; Ota Y, 1999, GEN COMP ENDOCR, V116, P40, DOI [10.1006/gcen.1999.7344, 10.1006/gcen.1999.7343]; Parsch J, 2013, NAT REV GENET, V14, P83, DOI 10.1038/nrg3376; Partridge C, 2015, CAN J ZOOL, V93, P9, DOI 10.1139/cjz-2014-0157; Paula JR, 2015, BEHAV ECOL, V26, P1005, DOI 10.1093/beheco/arv039; Piche A J, 2008, P ROY SOC LOND B BIO, V275, P1571; Reisel D, 2002, NAT NEUROSCI, V5, P868, DOI 10.1038/nn910; Renn SCP, 2008, J EXP BIOL, V211, P3041, DOI 10.1242/jeb.018242; Rexach JE, 2012, NAT CHEM BIOL, V8, P253, DOI [10.1038/NCHEMBIO.770, 10.1038/nchembio.770]; Riedel G, 2003, BEHAV BRAIN RES, V140, P1, DOI 10.1016/S0166-4328(02)00272-3; Roberts A, 2013, NAT METHODS, V10, P71, DOI [10.1038/NMETH.2251, 10.1038/nmeth.2251]; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sassone-Corsi P, 1998, INT J BIOCHEM CELL B, V30, P27, DOI 10.1016/S1357-2725(97)00093-9; Schlinger BA, 1999, P ROY SOC B-BIOL SCI, V266, P131, DOI 10.1098/rspb.1999.0612; Schunter C, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-167; Shuster SM, 1997, NATURE, V388, P373, DOI 10.1038/41089; Sneddon LU, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018181; Stamm S, 2008, J BIOL CHEM, V283, P1223, DOI 10.1074/jbc.R700034200; Stiver KA, 2015, ETHOLOGY, V121, P152, DOI 10.1111/eth.12324; Stoltz JA, 2006, BEHAV ECOL SOCIOBIOL, V59, P811, DOI 10.1007/s00265-005-0127-3; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Taborsky M, 1998, TRENDS ECOL EVOL, V13, P222, DOI 10.1016/S0169-5347(97)01318-9; Taborsky M, 2010, ANIMAL BEHAVIOUR: EVOLUTION AND MECHANISMS, P537, DOI 10.1007/978-3-642-02624-9_18; Taborsky M, 2008, ALTERNATIVE REPRODUCTIVE TACTICS: AN INTEGRATIVE APPROACH, P1, DOI 10.1017/CBO9780511542602.002; Thomson JS, 2011, HORM BEHAV, V59, P67, DOI 10.1016/j.yhbeh.2010.10.010; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wu Z, 2014, NATURE, V509, P325, DOI 10.1038/nature13307; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668	93	19	19	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167509	10.1371/journal.pone.0167509	http://dx.doi.org/10.1371/journal.pone.0167509			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907106	Green Published, gold, Green Submitted			2022-12-26	WOS:000389482700175
J	Roed, KH; Kvie, KS; Hasle, G; Gilbert, L; Leinaas, HP				Roed, Knut H.; Kvie, Kjersti S.; Hasle, Gunnar; Gilbert, Lucy; Leinaas, Hans Petter			Phylogenetic Lineages and Postglacial Dispersal Dynamics Characterize the Genetic Structure of the Tick, Ixodes ricinus, in Northwest Europe	PLOS ONE			English	Article							BORNE ENCEPHALITIS-VIRUS; BORRELIA-BURGDORFERI; POPULATION-GENETICS; STATISTICAL TESTS; PASSERINE BIRDS; LYME-DISEASE; WILD BOAR; COLONIZATION; PREVALENCE; DIVERGENCE	Dispersal and gene flow are important mechanisms affecting the dynamics of vectors and their pathogens. Here, patterns of genetic diversity were analyzed in many North European populations of the tick, Ixodes ricinus. Population sites were selected within and between areas separated by geographical barriers in order to evaluate the importance of tick transportation by birds in producing genetic connectivity across open sea and mountain ranges. The phylogenetic analyses of the mitochondrial control region and the cytochrome b gene revealed two distinct clades with supported sub-clades, with three genetic lineages: GB and WNo associated with Great Britain and western Norway respectively, and Eu with a wider distribution across continental Europe in agreement with much lower efficiency of tick dispersal by birds than by large mammals. The results suggest different ancestry of I. ricinus colonizing Britain and the rest of northern Europe, possibly from different glacial refuges, while ticks from western Norway and continental Europe share a more recent common ancestry. Demographic history modeling suggests a period of strong increase in tick abundance coincident with progression of the European Neolithic culture, long after their post-glacial colonization of NW Europe.	[Roed, Knut H.; Kvie, Kjersti S.] Norwegian Univ Life Sci, Dept Basic Sci & Aquat Med, Oslo, Norway; [Hasle, Gunnar] Oslo Travel Clin, St Olays Plass 3, Oslo, Norway; [Gilbert, Lucy] James Hutton Inst, Macaulay Dr, Aberdeen, Scotland; [Leinaas, Hans Petter] Univ Oslo, Dept Biosci, Oslo, Norway	Norwegian University of Life Sciences; James Hutton Institute; University of Oslo	Leinaas, HP (corresponding author), Univ Oslo, Dept Biosci, Oslo, Norway.	h.p.leinaas@ibv.uio.no	Hasle, Gunnar/AAF-4863-2020		University of Oslo; Norwegian University if Life Sciences; Scottish Government's Rural and Environment Science and Analytical Services Division (RESAS)	University of Oslo; Norwegian University if Life Sciences; Scottish Government's Rural and Environment Science and Analytical Services Division (RESAS)	Support was provided by SAK 6-Fundings for Collaboration in Life Science between University of Oslo and Norwegian University if Life Sciences (to KHR and HPL) and the Scottish Government's Rural and Environment Science and Analytical Services Division (RESAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreassen A, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-177; Araya-Anchetta A, 2015, INFECT GENET EVOL, V29, P164, DOI 10.1016/j.meegid.2014.11.008; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Barrett PN, 2004, VACCINES, P773; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; Casati S, 2008, INFECT GENET EVOL, V8, P152, DOI 10.1016/j.meegid.2007.11.007; Chomel B, 2015, REV SCI TECH OIE, V34, P569, DOI 10.20506/rst.34.2.2380; Criscione CD, 2005, MOL ECOL, V14, P2247, DOI 10.1111/j.1365-294X.2005.02587.x; de Meeus T, 2002, EVOLUTION, V56, P1802, DOI 10.1111/j.0014-3820.2002.tb00194.x; Dietrich M, 2014, MOL ECOL, V23, P3292, DOI 10.1111/mec.12815; Dinnis RE, 2014, TICKS TICK-BORNE DIS, V5, P152, DOI 10.1016/j.ttbdis.2013.10.001; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Emerson BC, 2001, TRENDS ECOL EVOL, V16, P707, DOI 10.1016/S0169-5347(01)02305-9; Estrada-Pena A, 2013, EXP APPL ACAROL, V59, P351, DOI 10.1007/s10493-012-9600-7; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FU YX, 1993, GENETICS, V133, P693; Fu YX, 1997, GENETICS, V147, P915; Gilbert L, 2014, ECOL EVOL, V4, P1186, DOI 10.1002/ece3.1014; Gilbert L, 2010, OECOLOGIA, V162, P217, DOI 10.1007/s00442-009-1430-x; Grard G, 2007, VIROLOGY, V361, P80, DOI 10.1016/j.virol.2006.09.015; Gray J S, 2009, Interdiscip Perspect Infect Dis, V2009, P593232, DOI 10.1155/2009/593232; Handeland K, 2013, VET PARASITOL, V195, P142, DOI 10.1016/j.vetpar.2013.02.012; Hasle G, 2011, TICKS TICK-BORNE DIS, V2, P37, DOI 10.1016/j.ttbdis.2010.10.004; Hasle G, 2010, ACTA VET SCAND, V52, DOI 10.1186/1751-0147-52-55; Hasle G, 2009, J PARASITOL, V95, P1342, DOI 10.1645/GE-2146.1; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hillyard PD, 1996, SYNOPSES OF THE BRIT, V52; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Hogestol M, 2006, ENVIRON ARCHAEOL, V11, P19, DOI 10.1179/174963106x97034; Ishida S, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-52; James MC, 2011, IBIS, V153, P293, DOI 10.1111/j.1474-919X.2011.01111.x; Jongejan F, 2004, PARASITOLOGY, V129, pS3, DOI 10.1017/S0031182004005967; Kempf F, 2010, INFECT GENET EVOL, V10, P989, DOI 10.1016/j.meegid.2010.06.003; Kriz B, 2014, VECTOR-BORNE ZOONOT, V14, P801, DOI 10.1089/vbz.2013.1569; Manel S, 2013, TRENDS ECOL EVOL, V28, P614, DOI 10.1016/j.tree.2013.05.012; McCoy KD, 2003, EVOLUTION, V57, P288, DOI 10.1111/j.0014-3820.2003.tb00263.x; Montgomery WI, 2014, QUATERNARY SCI REV, V98, P144, DOI 10.1016/j.quascirev.2014.05.026; MOREL PC, 1978, ACAROLOGIA, V19, P579; Noureddine R, 2011, INT J PARASITOL, V41, P183, DOI 10.1016/j.ijpara.2010.08.010; Papadopoulou A, 2010, MOL BIOL EVOL, V27, P1659, DOI 10.1093/molbev/msq051; Pesole G, 1999, J MOL EVOL, V48, P427, DOI 10.1007/PL00006487; Pietzsch ME, 2008, VET PARASITOL, V155, P328, DOI 10.1016/j.vetpar.2008.05.006; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A., 2014, TRACER V1 6; Randolph SE, 2002, INT J PARASITOL, V32, P979, DOI 10.1016/S0020-7519(02)00030-9; Rauter C, 2005, APPL ENVIRON MICROB, V71, P7203, DOI 10.1128/AEM.71.11.7203-7216.2005; Rosvold J, 2010, HOLOCENE, V20, P1113, DOI 10.1177/0959683610369505; Rowley-Conwy P, 2004, CURR ANTHROPOL, V45, pS83, DOI 10.1086/422083; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sparagano O, 2015, VET PARASITOL, V213, P61, DOI 10.1016/j.vetpar.2015.08.028; Stuen S, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00031; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; Templeton AR, 1998, MOL ECOL, V7, P381, DOI 10.1046/j.1365-294x.1998.00308.x; Valarcher JF, 2015, REV SCI TECH OIE, V34, P453; Ytrehus B, 2013, VECTOR-BORNE ZOONOT, V13, P762, DOI 10.1089/vbz.2012.1023	57	13	13	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167450	10.1371/journal.pone.0167450	http://dx.doi.org/10.1371/journal.pone.0167450			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907193	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000389482700161
J	Schaefer, B; Wurtinger, P; Finkenstedt, A; Braithwaite, V; Viveiros, A; Effenberger, M; Sulzbacher, I; Moschen, A; Griesmacher, A; Tilg, H; Vogel, W; Zoller, H				Schaefer, Benedikt; Wuertinger, Philipp; Finkenstedt, Armin; Braithwaite, Vickie; Viveiros, Andre; Effenberger, Maria; Sulzbacher, Irene; Moschen, Alexander; Griesmacher, Andrea; Tilg, Herbert; Vogel, Wolfgang; Zoller, Heinz			Choice of High-Dose Intravenous Iron Preparation Determines Hypophosphatemia Risk	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; RANDOMIZED CONTROLLED-TRIAL; GROWTH-FACTOR 23; FERRIC CARBOXYMALTOSE; DEFICIENCY ANEMIA; OSTEOMALACIA; MANAGEMENT; RICKETS	Background Ferric carboxymaltose (FCM) and iron isomaltoside 1000 (IIM) are increasingly used because they allow correction of severe iron deficiency in a single infusion. A transient decrease in serum phosphate concentrations is a frequent side effect of FCM. Aim To characterize this adverse event and search for its predictors in a gastroenterology clinic patient cohort. Methods Electronic medical records of patients attending the University Hospital of Innsbruck were searched for the keywords ferric carboxymaltose or iron isomaltoside. Eighty-one patients with documented administration of FCM or IIM with plasma phosphate concentrations before and after treatment were included. Results The prevalence of hypophosphatemia (<0.8 mmol/L) increased from 11% to 32.1% after treatment with i.v. iron. The hypophosphatemia risk was greater after FCM (45.5%) compared with IIM (4%). Severe hypophosphatemia (<0.6 mmol/L) occurred exclusively after FCM (32.7%). The odds for hypophosphatemia after i.v. iron treatment were independently determined by baseline phosphate and the choice of i.v. iron preparation (FCM vs. IIM-OR = 20.8; 95% CI, 2.6-166; p = 0.004). The median time with hypophosphatemia was 41 days, but prolonged hypophosphatemia of >= 2 months was documented in 13 of 17 patients in whom follow-up was available. A significant increase in the phosphaturic hormone intact FGF-23 in hypophosphatemic patients shows that this adverse event is caused by FCM-induced hormone dysregulation. Conclusion Treatment with FCM is associated with a high risk of developing severe and prolonged hypophosphatemia and should therefore be monitored. Hypophosphatemia risk appears to be substantially lower with IIM.	[Schaefer, Benedikt; Finkenstedt, Armin; Viveiros, Andre; Vogel, Wolfgang; Zoller, Heinz] Med Univ Innsbruck, Dept Med Gastroenterol & Hepatol 2, Anichstr, Innsbruck, Austria; [Wuertinger, Philipp; Griesmacher, Andrea] Univ Innsbruck Hosp, Cent Inst Med & Chem Lab Diag, Anichstr, Innsbruck, Austria; [Braithwaite, Vickie] Elsie Widdowson Labs, Med Res Council MRC Human Nutr Res, Fulbourn Rd, Cambridge, England; [Effenberger, Maria; Moschen, Alexander; Tilg, Herbert] Med Univ Innsbruck, Dept Med Gastroenterol Endocrinol & Metab 1, Anichstr, Innsbruck, Austria; [Sulzbacher, Irene] Med Univ Vienna, Dept Pathol, Vienna, Austria	Medical University of Innsbruck; Medical University of Innsbruck; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; Medical University of Innsbruck; Medical University of Vienna	Zoller, H (corresponding author), Med Univ Innsbruck, Dept Med Gastroenterol & Hepatol 2, Anichstr, Innsbruck, Austria.	heinz.zoller@i-med.ac.at	Zoller, Heinz/AAD-7225-2019; Schaefer, Benedikt/V-6096-2019; Moschen, Alexander/ABF-2267-2021	Moschen, Alexander R/0000-0003-3598-7848	Medical University of Innsbruck; Medical Research Council; Verein zur Foerderung der Wissenschaft in Gastroenterologie Hepatologie	Medical University of Innsbruck; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Verein zur Foerderung der Wissenschaft in Gastroenterologie Hepatologie	The study was funded by the Medical University of Innsbruck and the Medical Research Council. Benedikt Schaefer received a grant from the "Verein zur Foerderung der Wissenschaft in Gastroenterologie & Hepatologie." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Mendoza JAB, 2014, MED CLIN-BARCELONA, V143, P284, DOI 10.1016/j.medcli.2013.11.030; Basha B, 2000, AM J MED, V108, P296, DOI 10.1016/S0002-9343(99)00460-X; Blazevic A, 2014, NETH J MED, V72, P49; David V, 2015, KIDNEY INT; Dignass AU, 2015, J CROHNS COLITIS, V9, P211, DOI 10.1093/ecco-jcc/jju009; Evstatiev R, 2011, GASTROENTEROLOGY, V141, P846, DOI 10.1053/j.gastro.2011.06.005; Farrow EG, 2011, P NATL ACAD SCI USA, V108, pE1146, DOI 10.1073/pnas.1110905108; Fierz YC, 2014, EUR J CLIN NUTR, V68, P531, DOI 10.1038/ejcn.2014.20; FINCH PJ, 1992, Q J MED, V83, P439; Keating GM, 2015, DRUGS, V75, P101, DOI 10.1007/s40265-014-0332-3; Kulnigg S, 2008, AM J GASTROENTEROL, V103, P1182, DOI 10.1111/j.1572-0241.2007.01744.x; Mani LY, 2010, TRANSPLANTATION, V90, P804, DOI 10.1097/TP.0b013e3181f00a18; Moore Kari Lenita Falck, 2013, Tidsskr Nor Laegeforen, V133, P165, DOI 10.4045/tidsskr.12.0494; National Cancer Institute, 2009, NIH PUBLICATION; New Drug Application (NDA), 2008, NEW DRUG APPL NDA 22; Onken JE, 2014, TRANSFUSION, V54, P306, DOI 10.1111/trf.12289; Pavord S, 2012, BRIT J HAEMATOL, V156, P588, DOI 10.1111/j.1365-2141.2011.09012.x; Poursac N., 2015, RHUMATOS, V12, P61; Reinisch W, 2015, SCAND J GASTROENTERO, V50, P1226, DOI 10.3109/00365521.2015.1031168; Sangros Sahun MJ, 2016, REV ESP MED NUCL IMA; Soeren AS, 2016, EUR IR CLUB M 2016 I; Van Wyck DB, 2009, TRANSFUSION, V49, P2719, DOI 10.1111/j.1537-2995.2009.02327.x; Vandemergel X, 2014, CASE REP ENDOCRINOL, V2014, DOI 10.1155/2014/843689; Wolf M, 2014, CURR OPIN NEPHROL HY, V23, P411, DOI 10.1097/01.mnh.0000447020.74593.6f; Wolf M, 2013, J BONE MINER RES, V28, P1793, DOI 10.1002/jbmr.1923	25	53	55	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167146	10.1371/journal.pone.0167146	http://dx.doi.org/10.1371/journal.pone.0167146			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907058	Green Published, Green Submitted, gold			2022-12-26	WOS:000389482700081
J	Sibiya, HP; Mabandla, MV; Musabayane, CT				Sibiya, Happiness P.; Mabandla, Musa V.; Musabayane, Cephas T.			The Effects of Transdermally Delivered Oleanolic Acid on Malaria Parasites and Blood Glucose Homeostasis in P. berghei-Infected Male Sprague-Dawley Rats	PLOS ONE			English	Article							INDUCED DIABETIC-RATS; IN-VITRO; ANTIOXIDANT; ARTEMISININ; CHLOROQUINE; FALCIPARUM; EXTRACT	The present study investigated the effects of transdermally delivered oleanolic acid (OA) monotherapy and in combination with chloroquine (CHQ) on malaria parasites and glucose homeostasis of P. berghei-infected male Sprague-Dawley rats. Oral glucose test (OGT) responses to OA-pectin patch and CHQ-OA combination matrix patch were monitored in non-infected and infected rats. To evaluate the short-term effects of treatment, percentage parasitaemia, blood glucose, glycogen and plasma insulin were monitored in separate groups of animals treated with either OA-patch monotherapy or CHQ-OA combination pectin patch over a 21-days period. Animals treated with drug-free pectin and CHQ acted as untreated and treated positive controls, respectively. Infected control rats exhibited significantly increased parasitaemia which was accompanied by hypoglycaemia. Both OA monotherapy and CHQ-OA combination therapy reduced and cleared the malaria parasites within a period of 4 and 3 days, respectively. Compared to respective controls groups, O-GT responses of animals treated with OA monotherapy or CHQ-OA combination therapy exhibited lower blood glucose levels at all time points. A once-off transdermal application of OApatch or CHQ-OA combination patch significantly improved blood glucose concentrations inducing any changes in insulin concentration. Transdermal OA used as a monotherapy or in combination with CHQ is able to clear and reduce the malaria parasites within a shorter period of time without eliciting any adverse effects on glucose homeostasis of P. berghei-infected rats.	[Sibiya, Happiness P.; Mabandla, Musa V.; Musabayane, Cephas T.] Univ KwaZulu Natal, Sch Lab Med & Med Sci, Durban, South Africa	University of Kwazulu Natal	Sibiya, HP (corresponding author), Univ KwaZulu Natal, Sch Lab Med & Med Sci, Durban, South Africa.	208512883@stu.ukzn.ac.za		Sibiya, Happiness/0000-0001-9985-4759	NRF South Africa; University of KwaZulu-Natal Research Division	NRF South Africa(National Research Foundation - South Africa); University of KwaZulu-Natal Research Division	The authors are grateful to the NRF South Africa and the University of KwaZulu-Natal Research Division for financial support. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaratunga C, 2012, LANCET INFECT DIS, V12, P851, DOI 10.1016/S1473-3099(12)70181-0; [Anonymous], 2001, ANT DRUG COMB THER; [Anonymous], 2013, EXPL PAT PART RED HL; Bai XP, 2007, ASIA PAC J CLIN NUTR, V16, P169; Barsoum RS, 2000, J AM SOC NEPHROL, V11, P2147, DOI 10.1681/ASN.V11112147; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Bero J, 2013, J ETHNOPHARMACOL, V149, P176, DOI 10.1016/j.jep.2013.06.018; Bevan AP, 1997, J BIOL CHEM, V272, P26833, DOI 10.1074/jbc.272.43.26833; Das B. S., 2008, Journal of Vector Borne Diseases, V45, P83; Davis TME, 1997, BRIT J CLIN PHARMACO, V44, P1, DOI 10.1046/j.1365-2125.1997.00597.x; Dekker E, 1997, J CLIN ENDOCR METAB, V82, P2514, DOI 10.1210/jc.82.8.2514; Erhart LM, 2004, AM J TROP MED HYG, V70, P8, DOI 10.4269/ajtmh.2004.70.8; Gao DW, 2009, PHYTOTHER RES, V23, P1257, DOI 10.1002/ptr.2603; Gumede B, 2003, PARASITOL INT, V52, P53, DOI 10.1016/S1383-5769(02)00081-8; Hadebe SI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101461; Horiuchi K, 2007, BIOL PHARM BULL, V30, P1147, DOI 10.1248/bpb.30.1147; Jager S, 2007, PLANTA MED, V73, P157, DOI 10.1055/s-2007-967106; Jarzyna R, 2001, EUR J PHARMACOL, V428, P381, DOI 10.1016/S0014-2999(01)01221-3; Jiang QK, 2016, EUR J PHARM BIOPHARM, V99, P65, DOI 10.1016/j.ejpb.2015.11.013; JONES RG, 1986, J ROY SOC MED, V79, P426, DOI 10.1177/014107688607900714; Khathi A, 2013, J DIABETES, V5, P80, DOI 10.1111/j.1753-0407.2012.00230.x; KNUTSON VP, 1985, J BIOL CHEM, V260, P4180; Krishna S, 1999, LANCET, V353, P546, DOI 10.1016/S0140-6736(98)06316-8; Liu H, 2005, J ETHNOPHARMACOL, V100, P92, DOI 10.1016/j.jep.2005.05.024; Lu YF, 2013, MOLECULES, V18, P3060, DOI 10.3390/molecules18033060; LUFKIN EG, 1992, ANN INTERN MED, V117, P1, DOI 10.7326/0003-4819-117-1-1; Madlala HP, 2012, EFFECTS SYZYGIUM ARO; Mapanga RF, 2009, RENAL FAILURE, V31, P481, DOI 10.1080/08860220902963558; Mkhwanazi BN, 2014, RENAL FAILURE, V36, P419, DOI 10.3109/0886022X.2013.867799; Musabayane CT, 2007, RENAL FAILURE, V29, P389, DOI 10.1080/08860220701260735; Musabayane CT, 2003, RENAL FAILURE, V25, P525, DOI 10.1081/JDI-120022543; Ngubane PS, 2015, RENAL FAILURE, V37, P151, DOI 10.3109/0886022X.2014.970469; Noedl H, 2010, CLIN INFECT DIS, V51, pE82, DOI 10.1086/657120; Prausnitz MR, 2008, NAT BIOTECHNOL, V26, P1261, DOI 10.1038/nbt.1504; Sairafianpour M, 2003, PLANTA MED, V69, P846, DOI 10.1055/s-2003-43212; Steele JCP, 1999, PHYTOTHER RES, V13, P115, DOI 10.1002/(SICI)1099-1573(199903)13:2&lt;115::AID-PTR404&gt;3.0.CO;2-1; Visser BJ, 2014, EXPERT OPIN PHARMACO, V15, P2219, DOI 10.1517/14656566.2014.944499; Wang X, 2013, MOL CELL ENDOCRINOL, V376, P70, DOI 10.1016/j.mce.2013.06.014; White NJ, 2008, SCIENCE, V320, P330, DOI 10.1126/science.1155165; WHITE NJ, 1987, LANCET, V1, P708; World Health Organization, 2015, WORLD MAL REP 2015; Wu J, 2010, P NATL ACAD SCI USA, V107, P11698, DOI 10.1073/pnas.1004714107	42	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167132	10.1371/journal.pone.0167132	http://dx.doi.org/10.1371/journal.pone.0167132			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907019	Green Submitted, gold, Green Published			2022-12-26	WOS:000389482700079
J	Parisi, S; Passaro, F; Russo, L; Musto, A; Navarra, A; Romano, S; Petrosino, G; Russo, T				Parisi, Silvia; Passaro, Fabiana; Russo, Luigi; Musto, Anna; Navarra, Angelica; Romano, Simona; Petrosino, Giuseppe; Russo, Tommaso			Lin28 is induced in primed embryonic stem cells and regulates let-7-independent events	FASEB JOURNAL			English	Article						differentiation; Hmga2; Otx2; pluripotency; RNA-binding proteins	MESSENGER-RNAS; LET-7 MICRORNA; SELF-RENEWAL; PLURIPOTENCY; TRANSITION; PROTEINS; HMGA2; IDENTIFICATION; TRANSFORMATION; SUPPRESSOR	Lin28 RNA-binding proteins play important roles in pluripotent stem cells, but the regulation of their expression and the mechanisms underlying their functions are still not definitively understood. Here we address the above-mentioned issues in the first steps of mouse embryonic stem cell (ESC) differentiation. We observed that the expression of Lin28 genes is transiently induced soon after the exit of ESCs from the naive ground state and that this induction is due to the Hmga2-dependent engagement of Otx2 with enhancers present at both Lin28 gene loci. These mechanisms are crucial for Lin28 regulation, as demonstrated by the abolishment of the Lin28 accumulationin Otx2 or Hmga2-knockout cells compared to the control cells. We have also found that Lin28 controls Hmga2 expression levels during ESC differentiation through a let-7-independent mechanism. Indeed, we found that Lin28 proteins bind a highly conserved element in the 3' UTR of Hmga2 mRNA, and this provokes a down-regulation of its translation. This mechanism prevents the inappropriate accumulation of Hmga2 that would modify the proliferation and physiological apoptosis of differentiating ESCs. In summary, we demonstrated that during ESC differentiation, Lin28 transient induction is dependent on Otx2 and Hmga2 and prevents an inappropriate excessive rise of Hmga2 levels.	[Parisi, Silvia; Passaro, Fabiana; Russo, Luigi; Musto, Anna; Navarra, Angelica; Romano, Simona] Univ Naples Federico II, Dipartimento Med Mol & Biotecnol Med, Via S Pansini 5, I-80131 Naples, Italy; [Petrosino, Giuseppe] BioMed X Innovat Ctr, Heidelberg, Germany	University of Naples Federico II	Parisi, S (corresponding author), Univ Naples Federico II, Dipartimento Med Mol & Biotecnol Med, Via S Pansini 5, I-80131 Naples, Italy.	silvia.parisi@unina.it	Passaro, Fabiana/I-5941-2012; RUSSO, Tommaso/K-1331-2016	Passaro, Fabiana/0000-0003-0150-5302; RUSSO, Tommaso/0000-0003-4426-0106; RUSSO, Luigi/0000-0002-1577-176X; Petrosino, Giuseppe/0000-0002-2835-4308	Italian Ministry of University and Research [RBFR13YZ2Y, CESMA]; Regione Campania (Special Projects Movie); Associazione Italiana per la Ricerca sul Cancro [IG11508]	Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); Regione Campania (Special Projects Movie); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	The authors are grateful to A. Simeone and D. Acampora (National Research Council, Naples, Italy) for Otx2-KO cells, and to M. Caiazzo (University of Utrecht, Utrecht The Netherlands) for Lin28 plasmid. This work was supported by grants from the Italian Ministry of University and Research (RBFR13YZ2Y and CESMA), from Regione Campania (Special Projects Movie), and from the Associazione Italiana per la Ricerca sul Cancro (IG11508).	Acampora D, 2016, CELL REP, V15, P2651, DOI 10.1016/j.celrep.2016.05.041; Acampora D, 2013, DEVELOPMENT, V140, P43, DOI 10.1242/dev.085290; Alam M, 2015, MOL CANCER RES, V13, P449, DOI 10.1158/1541-7786.MCR-14-0363; Balzer E, 2010, DEVELOPMENT, V137, P891, DOI 10.1242/dev.042895; Buecker C, 2014, CELL STEM CELL, V14, P838, DOI 10.1016/j.stem.2014.04.003; Cacchiarelli D, 2015, CELL, V162, P412, DOI 10.1016/j.cell.2015.06.016; Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106; Cho J, 2012, CELL, V151, P765, DOI 10.1016/j.cell.2012.10.019; Copley MR, 2013, NAT CELL BIOL, V15, P916, DOI 10.1038/ncb2783; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; Guo L, 2013, ONCOGENE, V32, P5272, DOI 10.1038/onc.2012.573; Hafner M, 2013, RNA, V19, P613, DOI 10.1261/rna.036491.112; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Keene JD, 2006, NAT PROTOC, V1, P302, DOI 10.1038/nprot.2006.47; Kumar RM, 2014, NATURE, V516, P56, DOI 10.1038/nature13920; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Musto A, 2015, CELL DEATH DIFFER, V22, P1047, DOI 10.1038/cdd.2014.198; Navarra A, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0246-5; Peng SP, 2011, STEM CELLS, V29, P496, DOI 10.1002/stem.591; Piskounova E, 2011, CELL, V147, P1066, DOI 10.1016/j.cell.2011.10.039; Reeves R, 2010, BBA-GENE REGUL MECH, V1799, P3, DOI 10.1016/j.bbagrm.2009.09.001; Tsialikas J, 2015, DEVELOPMENT, V142, P2397, DOI 10.1242/dev.117580; Van Wynsberghe PM, 2011, NAT STRUCT MOL BIOL, V18, P302, DOI 10.1038/nsmb.1986; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Wilbert ML, 2012, MOL CELL, V48, P195, DOI 10.1016/j.molcel.2012.08.004; Xu BS, 2009, RNA, V15, P357, DOI 10.1261/rna.1368009; Yang SH, 2014, CELL REP, V7, P1968, DOI 10.1016/j.celrep.2014.05.037; Zhang J, 2016, CELL STEM CELL, V19, P66, DOI 10.1016/j.stem.2016.05.009; Zhou JB, 2013, INT J BIOCHEM CELL B, V45, P973, DOI 10.1016/j.biocel.2013.02.006	33	22	24	2	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2017	31	3					1046	+		10.1096/fj.201600848R	http://dx.doi.org/10.1096/fj.201600848R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EM9ZX	27920151				2022-12-26	WOS:000395671200019
J	Luhtala, N; Aslanian, A; Yates, JR; Hunter, T				Luhtala, Natalie; Aslanian, Aaron; Yates, John R., III; Hunter, Tony			Secreted Glioblastoma Nanovesicles Contain Intracellular Signaling Proteins and Active Ras Incorporated in a Farnesylation-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXOSOMAL PROTEINS; GROWTH-FACTOR; CANCER EXOSOMES; MESSENGER-RNAS; LEUKEMIA-CELLS; ACTIVATION; MEDIATE; IDENTIFICATION; MICROVESICLES; EXPRESSION	Glioblastomas (GBMs) are malignant brain tumors with a median survival of less than 18 months. Redundancy of signaling pathways represented within GBMs contributes to their therapeutic resistance. Exosomes are extracellular nanovesicles released from cells and present in human biofluids that represent a possible biomarker of tumor signaling state that could aid in personalized treatment. Herein, we demonstrate that mouse GBM cell-derived extracellular nanovesicles resembling exosomes from an H-RasV12 myr-Akt mouse model for GBM are enriched for intracellular signaling cascade proteins (GO: 0007242) and Ras protein signal transduction (GO: 0007265), and contain active Ras. Active Ras isolated from human and mouse GBM extracellular nanovesicles lysates using the Ras-binding domain of Raf also coprecipitates with ESCRT (endosomal sorting complex required for transport)-associated exosome proteins Vps4a and Alix. Although we initially hypothesized a role for active Ras protein signaling in exosome biogenesis, we found that GTP binding of K-Ras was dispensable for its packaging within extracellular nanovesicles and for the release of Alix. By contrast, farnesylation of K-Ras was required for its packaging within extracellular nanovesicles, yet expressing a K-Ras farnesylation mutant did not decrease the number of nanovesicles or the amount of Alix protein released per cell. Overall, these results emphasize the primary importance of membrane association in packaging of extracellular nanovesicle factors and indicate that screening nanovesicles within human fluids could provide insight into tissue origin and the wiring of signaling proteins at membranes to predict onset and behavior of cancer and other diseases linked to deregulated membrane signaling states.	[Luhtala, Natalie; Aslanian, Aaron; Hunter, Tony] Salk Inst Biol Studies, Mol & Cell Biol Lab, Canc Biol, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Aslanian, Aaron; Yates, John R., III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA	Salk Institute; Scripps Research Institute	Hunter, T (corresponding author), 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	hunter@salk.edu			National Institutes of Health NCI [CA194584, CA80100, CA82683]; Cancer Center Support Grant [CA14195]; National Center for Research Resources [5P41RR011823-17]; National Institutes of Health NIGMS [8P41GM103533-17]; George E. Hewitt Foundation for Medical Research Fellowship; American Cancer Society [127795-PF-15-030-01-CSM]; Leona M. and Harry B. Helmsley Charitable Trust; NATIONAL CANCER INSTITUTE [R01CA082683, R01CA194584, P30CA014195, R01CA080100] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103533] Funding Source: NIH RePORTER	National Institutes of Health NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Center Support Grant; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); George E. Hewitt Foundation for Medical Research Fellowship; American Cancer Society(American Cancer Society); Leona M. and Harry B. Helmsley Charitable Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health NCI Grants CA194584, CA80100, and CA82683 (to T. H.), Cancer Center Support Grant CA14195 (Waitt Advanced Biophotonics Core), and National Center for Research Resources Grant 5P41RR011823-17 and National Institutes of Health NIGMS Grant 8P41GM103533-17 (to J. R. Y.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported by the George E. Hewitt Foundation for Medical Research Fellowship and American Cancer Society Fellowship 127795-PF-15-030-01-CSM.r Supported by the Leona M. and Harry B. Helmsley Charitable Trust.	Adjei AA, 2001, CLIN CANCER RES, V7, P1438; Amos S, 2006, CELL DEATH DIFFER, V13, P642, DOI 10.1038/sj.cdd.4401783; Baietti MF, 2012, NAT CELL BIOL, V14, P677, DOI 10.1038/ncb2502; Baumgartel V, 2011, NAT CELL BIOL, V13, P469, DOI 10.1038/ncb2215; Beckler MD, 2013, MOL CELL PROTEOMICS, V12, P343, DOI 10.1074/mcp.M112.022806; Bissig C, 2014, TRENDS CELL BIOL, V24, P19, DOI 10.1016/j.tcb.2013.10.009; Bleck M, 2014, P NATL ACAD SCI USA, V111, P12211, DOI 10.1073/pnas.1321655111; Blum R, 2005, CANCER RES, V65, P999; Bouterfa HL, 2000, ANTICANCER RES, V20, P2761; BRTVA TR, 1995, J BIOL CHEM, V270, P9809, DOI 10.1074/jbc.270.17.9809; Butch ER, 1996, J BIOL CHEM, V271, P4230; Cai ZJ, 2012, J IMMUNOL, V188, P5954, DOI 10.4049/jimmunol.1103466; Clark MJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000832; Costa-Silva B, 2015, NAT CELL BIOL, V17, P816, DOI 10.1038/ncb3169; Courtois-Cox S, 2006, CANCER CELL, V10, P459, DOI 10.1016/j.ccr.2006.10.003; Donello JE, 1998, J VIROL, V72, P5085, DOI 10.1128/JVI.72.6.5085-5092.1998; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fiordalis JJ, 2002, J BIOL CHEM, V277, P10813, DOI 10.1074/jbc.M107684200; Friedmann-Morvinski D, 2012, SCIENCE, V338, P1080, DOI 10.1126/science.1226929; Gelabert-Baldrich M, 2014, FASEB J, V28, P3023, DOI 10.1096/fj.13-241158; Goetzl EJ, 2015, ANN CLIN TRANSL NEUR, V2, P769, DOI 10.1002/acn3.211; Goldberg L, 2006, CANCER RES, V66, P11709, DOI 10.1158/0008-5472.CAN-06-1878; Grange C, 2011, CANCER RES, V71, P5346, DOI 10.1158/0008-5472.CAN-11-0241; Gui YX, 2015, ONCOTARGET, V6, P37043, DOI 10.18632/oncotarget.6158; Holmen SL, 2005, CANCER RES, V65, P8250, DOI 10.1158/0008-5472.CAN-05-1173; Hong BS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-556; Hood JL, 2011, CANCER RES, V71, P3792, DOI 10.1158/0008-5472.CAN-10-4455; Hood JL, 2009, LAB INVEST, V89, P1317, DOI 10.1038/labinvest.2009.94; Hoshino A, 2015, NATURE, V527, P329, DOI 10.1038/nature15756; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hurh S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070486; Jeuken J, 2007, ACTA NEUROPATHOL, V114, P121, DOI 10.1007/s00401-007-0239-0; Kahlert C, 2014, J BIOL CHEM, V289, P3869, DOI 10.1074/jbc.C113.532267; Keerthikumar S, 2016, J MOL BIOL, V428, P688, DOI 10.1016/j.jmb.2015.09.019; Keller S, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-86; Kiel C, 2009, J BIOL CHEM, V284, P31893, DOI 10.1074/jbc.M109.031153; Kucharzewska P, 2013, P NATL ACAD SCI USA, V110, P7312, DOI 10.1073/pnas.1220998110; Li YC, 2014, CELL REP, V9, P1946, DOI 10.1016/j.celrep.2014.10.058; Lobert VH, 2010, DEV CELL, V19, P148, DOI 10.1016/j.devcel.2010.06.010; Luga V, 2013, CANCER RES, V73, P6843, DOI 10.1158/0008-5472.CAN-13-1791; Luga V, 2012, CELL, V151, P1542, DOI 10.1016/j.cell.2012.11.024; Lugli G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139233; Marumoto T, 2009, NAT MED, V15, P110, DOI 10.1038/nm.1863; Mathivanan S, 2012, NUCLEIC ACIDS RES, V40, pD1241, DOI 10.1093/nar/gkr828; Mathivanan S, 2009, PROTEOMICS, V9, P4997, DOI 10.1002/pmic.200900351; McCullough J, 2008, P NATL ACAD SCI USA, V105, P7687, DOI 10.1073/pnas.0801567105; McDonald WH, 2004, RAPID COMMUN MASS SP, V18, P2162, DOI 10.1002/rcm.1603; McGillicuddy LT, 2009, CANCER CELL, V16, P44, DOI 10.1016/j.ccr.2009.05.009; Melo SA, 2015, NATURE, V523, P177, DOI 10.1038/nature14581; Mineo M, 2012, ANGIOGENESIS, V15, P33, DOI 10.1007/s10456-011-9241-1; Mudunuri U, 2009, BIOINFORMATICS, V25, P555, DOI 10.1093/bioinformatics/btn654; Nassar N, 2010, BIOCHEMISTRY-US, V49, P1970, DOI 10.1021/bi9020742; Nazarenko I, 2010, CANCER RES, V70, P1668, DOI 10.1158/0008-5472.CAN-09-2470; Ostrem JM, 2013, NATURE, V503, P548, DOI 10.1038/nature12796; Park JE, 2010, MOL CELL PROTEOMICS, V9, P1085, DOI 10.1074/mcp.M900381-MCP200; Pathan M, 2015, PROTEOMICS, V15, P2597, DOI 10.1002/pmic.201400515; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Prigent SA, 1996, J BIOL CHEM, V271, P25639, DOI 10.1074/jbc.271.41.25639; Reilly KM, 2000, NAT GENET, V26, P109, DOI 10.1038/79075; Robbins PD, 2014, NAT REV IMMUNOL, V14, P195, DOI 10.1038/nri3622; Robert Mc, 2008, Biomed Imaging Interv J, V4, pe3, DOI 10.2349/biij.4.1.e3; Rodriguez M, 2015, ONCOTARGET, V6, P40575, DOI 10.18632/oncotarget.5818; Russell JS, 1999, CANCER RES, V59, P5239; Salomon C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068451; Schiebe M, 2000, J NEURO-ONCOL, V49, P197, DOI 10.1023/A:1006410702284; Schneider A, 2013, CELL TISSUE RES, V352, P33, DOI 10.1007/s00441-012-1428-2; Scott A, 2005, P NATL ACAD SCI USA, V102, P13813, DOI 10.1073/pnas.0502165102; Sharghi-Namini S, 2014, SCI REP-UK, V4, DOI 10.1038/srep04031; Shen BY, 2011, J BIOL CHEM, V286, P14383, DOI 10.1074/jbc.M110.208660; Simpson RJ, 2012, J EXTRACELL VESICLES, V1, DOI 10.3402/jev.v1i0.18374; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Stuffers S, 2009, TRAFFIC, V10, P925, DOI 10.1111/j.1600-0854.2009.00920.x; Subra C, 2010, J LIPID RES, V51, P2105, DOI 10.1194/jlr.M003657; Suetsugu A, 2013, ADV DRUG DELIVER REV, V65, P383, DOI 10.1016/j.addr.2012.08.007; Svensson KJ, 2013, J BIOL CHEM, V288, P17713, DOI 10.1074/jbc.M112.445403; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Tadokoro H, 2013, J BIOL CHEM, V288, P34343, DOI 10.1074/jbc.M113.480822; Tauro BJ, 2013, MOL CELL PROTEOMICS, V12, P2148, DOI 10.1074/mcp.M112.027086; Taverna S, 2012, INT J CANCER, V130, P2033, DOI 10.1002/ijc.26217; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Tomlinson PR, 2015, ANN CLIN TRANSL NEUR, V2, P353, DOI 10.1002/acn3.175; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; WESTERMARK B, 1995, GLIA, V15, P257, DOI 10.1002/glia.440150307; Williams C, 2014, CELL RES, V24, P766, DOI 10.1038/cr.2014.44; Zhang L, 2015, NATURE, V527, P100, DOI 10.1038/nature15376; Zhang L, 2013, MOL MED REP, V8, P272, DOI 10.3892/mmr.2013.1458; Zheng ZY, 2012, ONCOGENE, V31, P4630, DOI 10.1038/onc.2011.607; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n	92	30	31	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2017	292	2					611	628		10.1074/jbc.M116.747618	http://dx.doi.org/10.1074/jbc.M116.747618			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2KN	27909058	hybrid, Green Published			2022-12-26	WOS:000392316100017
J	Roy, S; Lu, K; Nayak, MK; Bhuniya, A; Ghosh, T; Kundu, S; Ghosh, S; Baral, R; Dasgupta, PS; Basu, S				Roy, Soumyabrata; Lu, Kai; Nayak, Mukti Kant; Bhuniya, Avishek; Ghosh, Tithi; Kundu, Suman; Ghosh, Sarbari; Baral, Rathindranath; Dasgupta, Partha Sarathi; Basu, Sujit			Activation of D-2 Dopamine Receptors in CD133+ve Cancer Stem Cells in Non-small Cell Lung Carcinoma Inhibits Proliferation, Clonogenic Ability, and Invasiveness of These Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALDEHYDE DEHYDROGENASE 1A1; TUMOR-INITIATING CELLS; ENDOTHELIAL GROWTH-FACTOR; SELF-RENEWAL; PROGNOSTIC VALUE; DOWN-REGULATION; GASTRIC-CANCER; EXPRESSION; IDENTIFICATION; MARKER	Lung carcinoma is the leading cause of cancer-related death worldwide, and among this cancer, non-small cell lung carcinoma (NSCLC) comprises the majority of cases. Furthermore, recurrence and metastasis of NSCLC correlate well with CD133+ve tumor cells, a small population of tumor cells that have been designated as cancer stem cells (CSC). We have demonstrated for the first time high expression of D-2 dopamine (DA) receptors in CD133+ve adenocarcinoma NSCLC cells. Also, activation of D-2 DA receptors in these cells significantly inhibited their proliferation, clonogenic ability, and invasiveness by suppressing extracellular signal-regulated kinases 1/2 (ERK1/2) and AKT, as well as down-regulation of octamer-binding transcription factor 4 (Oct-4) expression and matrix metalloproteinase-9 (MMP-9) secretion by these cells. These results are of significance as D-2 DA agonists that are already in clinical use for treatment of other diseases may be useful in combination with conventional chemotherapy and radiotherapy for better management of NSCLC patients by targeting both tumor cells and stem cell compartments in the tumor mass.	[Roy, Soumyabrata; Bhuniya, Avishek; Ghosh, Tithi; Ghosh, Sarbari; Baral, Rathindranath; Dasgupta, Partha Sarathi] Chittaranjan Natl Canc Inst, Dept Immunoregulat & Immunodiagnost, Kolkata 700026, W Bengal, India; [Lu, Kai; Basu, Sujit] Ohio State Univ, Dept Pathol, 166 Hamilton Hall,1645 Neil Ave, Columbus, OH 43210 USA; [Nayak, Mukti Kant] Natl Inst Cholera & Enter Dis, Div Virol, Kolkata 700010, India; [Kundu, Suman] Indian Inst Chem Biol, Canc Biol & Inflammatory Disorder Div, Kolkata 700032, India; [Basu, Sujit] Ohio State Univ, Dept Internal Med, Div Med Oncol, 166 Hamilton Hall,1645 Neil Ave, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); University System of Ohio; Ohio State University	Basu, S (corresponding author), Ohio State Univ, Dept Pathol, 166 Hamilton Hall,1645 Neil Ave, Columbus, OH 43210 USA.; Dasgupta, PS (corresponding author), Chittaranjan Natl Canc Inst, Kolkata 700026, W Bengal, India.; Basu, S (corresponding author), Ohio State Univ, Dept Med Oncol, 166 Hamilton Hall,1645 Neil Ave, Columbus, OH 43210 USA.	partha42002@yahoo.com; sujit.basu@osumc.edu	Kundu, Suman/AAL-6066-2021	Kundu, Suman/0000-0002-8591-1166; GHOSH HALDER, TITHI/0000-0002-4292-1153; Bhuniya, Avishek/0000-0001-6253-0400	Council of Scientific and Industrial Research [21(0895)/12/EMR-II]; National Institutes of Health [R01DK098045, R01CA169158, R01HL131405]; NATIONAL CANCER INSTITUTE [R01CA169158] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL131405] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098045] Funding Source: NIH RePORTER	Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by Council of Scientific and Industrial Research Grant 21(0895)/12/EMR-II (to P. S. D.) and National Institutes of Health Grants R01DK098045, R01CA169158, and R01HL131405 (to S. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al-Lamki RS, 2016, ONCOTARGET, V7, P24111, DOI 10.18632/oncotarget.8125; Alamgeer M, 2013, THORAX, V68, P1095, DOI 10.1136/thoraxjnl-2012-203021; Alberg AJ, 2007, CHEST, V132, p29S, DOI 10.1378/chest.07-1347; Alcaro A, 2007, BRAIN RES REV, V56, P283, DOI 10.1016/j.brainresrev.2007.07.014; Barr MP, 2016, J THORAC ONCOL, V11, pS87, DOI 10.1016/S1556-0864(16)30188-5; Basu S, 2001, NAT MED, V7, P569, DOI 10.1038/87895; Beaulieu JM, 2007, J NEUROSCI, V27, P881, DOI 10.1523/JNEUROSCI.5074-06.2007; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Bertolini G, 2009, P NATL ACAD SCI USA, V106, P16281, DOI 10.1073/pnas.0905653106; Bidlingmaier S, 2008, J MOL MED, V86, P1025, DOI 10.1007/s00109-008-0357-8; Bozzi Y, 2006, TRENDS NEUROSCI, V29, P167, DOI 10.1016/j.tins.2006.01.002; Brumbaugh J, 2012, P NATL ACAD SCI USA, V109, P7162, DOI 10.1073/pnas.1203874109; Cao L, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-71; Chakroborty D, 2004, CLIN CANCER RES, V10, P4349, DOI 10.1158/1078-0432.CCR-04-0059; Chakroborty D, 2008, J CLIN INVEST, V118, P1380, DOI 10.1172/JCI33125; Chakroborty D, 2011, P NATL ACAD SCI USA, V108, P20730, DOI 10.1073/pnas.1108696108; Chang HW, 2014, J MOL ENDOCRINOL, V52, P87, DOI 10.1530/JME-13-0044; Charafe-Jauffret E, 2010, CLIN CANCER RES, V16, P45, DOI 10.1158/1078-0432.CCR-09-1630; Chavali PL, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.449; Chen YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002637; Danesi R, 2009, ADV DRUG DELIVER REV, V61, P408, DOI 10.1016/j.addr.2009.03.001; Dawood S, 2014, ONCOLOGY-NY, V28, P1101; Denton MD, 1996, KIDNEY INT, V50, P4, DOI 10.1038/ki.1996.280; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Eramo A, 2010, ONCOGENE, V29, P4625, DOI 10.1038/onc.2010.207; Fargeas CA, 2007, TISSUE ANTIGENS, V69, P602, DOI 10.1111/j.1399-0039.2007.00825.x; Ganguly S, 2010, AM J PATHOL, V177, P2701, DOI 10.2353/ajpath.2010.100617; GOLDBERG LI, 1989, J CARDIOVASC PHARM, V14, pS19, DOI 10.1097/00005344-198906145-00005; Gomez-Casal R, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-94; Han J, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-173; Hoeppner LH, 2015, MOL ONCOL, V9, P270, DOI 10.1016/j.molonc.2014.08.008; Hsu HS, 2011, CANCER-AM CANCER SOC, V117, P2970, DOI 10.1002/cncr.25869; Huang C, 2007, CANCER GENET CYTOGEN, V175, P19, DOI 10.1016/j.cancergencyto.2007.01.003; ISHIBASHI M, 1994, CANCER RES, V54, P3442; Jiang F, 2009, MOL CANCER RES, V7, P330, DOI 10.1158/1541-7786.MCR-08-0393; Le HB, 2013, MOL MED REP, V8, P1511, DOI 10.3892/mmr.2013.1667; Li HW, 2011, J SURG ONCOL, V103, P558, DOI 10.1002/jso.21806; Li T, 2010, LAB INVEST, V90, P234, DOI 10.1038/labinvest.2009.127; Li X, 2012, J THORAC ONCOL, V7, P1235, DOI 10.1097/JTO.0b013e318257cc6d; Li Z, 2013, EXP HEMATOL ONCOL, V2, DOI 10.1186/2162-3619-2-17; Lin YJ, 2012, MOL CELL, V48, P627, DOI 10.1016/j.molcel.2012.08.030; Liu F, 2014, ACTA BIOCH BIOPH SIN, V46, P15, DOI 10.1093/abbs/gmt123; Liu H, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.340; Liu JC, 2002, J BIOL CHEM, V277, P35819, DOI 10.1074/jbc.M202920200; Liu SP, 2013, GASTROENTEROLOGY, V144, P1031, DOI 10.1053/j.gastro.2013.01.046; Lu K., 2012, COMP MATH MATH PHYS, V2012, P7; Lu K, 2015, SCI REP-UK, V5, DOI 10.1038/srep09642; Mak AB, 2011, J BIOL CHEM, V286, P41046, DOI 10.1074/jbc.M111.261545; Masters JR, 2001, P NATL ACAD SCI USA, V98, P8012, DOI 10.1073/pnas.121616198; Nassar D, 2016, ANNU REV PATHOL-MECH, V11, P47, DOI 10.1146/annurev-pathol-012615-044438; Qu HY, 2013, INT J CLIN EXP PATHO, V6, P2644; Rappa F, 2013, BIOCHIMIE, V95, P782, DOI 10.1016/j.biochi.2012.11.007; Roudi R, 2015, CANCER INVEST, V33, P294, DOI 10.3109/07357907.2015.1034869; Sarkar C, 2008, CLIN CANCER RES, V14, P2502, DOI 10.1158/1078-0432.CCR-07-1778; Schiffer D, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/725921; Senogles SE, 2007, ANTI-CANCER DRUG, V18, P801, DOI 10.1097/CAD.0b013e3280b10d36; Sheikhpour M, 2013, INT J IMMUNOPATH PH, V26, P393, DOI 10.1177/039463201302600212; Shome S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031682; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; SOKOLOFF P, 1989, BIOCHEM BIOPH RES CO, V162, P575, DOI 10.1016/0006-291X(89)92349-8; Steinmetz Nicole F, 2011, Cancers (Basel), V3, P2870, DOI 10.3390/cancers3032870; Su Y, 2010, CANCER EPIDEM BIOMAR, V19, P327, DOI 10.1158/1055-9965.EPI-09-0865; Tirino V, 2009, EUR J CARDIO-THORAC, V36, P446, DOI 10.1016/j.ejcts.2009.03.063; Tomita H, 2016, ONCOTARGET, V7, P11018, DOI 10.18632/oncotarget.6920; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Wang WM, 2014, TUMOR BIOL, V35, P9769, DOI 10.1007/s13277-014-2270-9; Wang YK, 2010, CARCINOGENESIS, V31, P1376, DOI 10.1093/carcin/bgq120; Wu H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100168; Xu DM, 2010, CANCER RES, V70, P6988, DOI 10.1158/0008-5472.CAN-10-0242; Yang L, 2014, MODERN PATHOL, V27, P775, DOI 10.1038/modpathol.2013.189; Zhang LH, 2015, SCI REP-UK, V5, DOI 10.1038/srep09447; Zhu YF, 2014, EXP CELL RES, V324, P146, DOI 10.1016/j.yexcr.2014.03.020	74	32	35	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2017	292	2					435	445		10.1074/jbc.M116.748970	http://dx.doi.org/10.1074/jbc.M116.748970			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2KN	27920206	Green Published, hybrid			2022-12-26	WOS:000392316100003
J	Goring, SJ; Mladenoff, DJ; Cogbill, CV; Record, S; Paciorek, CJ; Jackson, ST; Dietze, MC; Dawson, A; Matthes, JH; McLachlan, JS; Williams, JW				Goring, Simon J.; Mladenoff, David J.; Cogbill, Charles V.; Record, Sydne; Paciorek, Christopher J.; Jackson, Stephen T.; Dietze, Michael C.; Dawson, Andria; Matthes, Jaclyn Hatala; McLachlan, Jason S.; Williams, John W.			Novel and Lost Forests in the Upper Midwestern United States, from New Estimates of Settlement-Era Composition, Stem Density, and Biomass	PLOS ONE			English	Article							HISTORICAL LAND-USE; GREAT-LAKES FORESTS; LANDSCAPE-SCALE; ANCIENT FORESTS; CLIMATE-CHANGE; VEGETATION CHANGE; BIG WOODS; PRESETTLEMENT; DISTURBANCE; WISCONSIN	Background EuroAmerican land-use and its legacies have transformed forest structure and composition across the United States (US). More accurate reconstructions of historical states are critical to understanding the processes governing past, current, and future forest dynamics. Here we present new gridded (8x8km) reconstructions of pre-settlement (1800s) forest composition and structure from the upper Midwestern US (Minnesota, Wisconsin, and most of Michigan), using 19th Century Public Land Survey System (PLSS), with estimates of relative composition, above-ground biomass, stem density, and basal area for 28 tree types. This mapping is more robust than past efforts, using spatially varying correction factors to accommodate sampling design, azimuthal censoring, and biases in tree selection. Changes in Forest Structure We compare pre-settlement to modern forests using US Forest Service Forest Inventory and Analysis (FIA) data to show the prevalence of lost forests (pre-settlement forests with no current analog), and novel forests (modern forests with no past analogs). Differences between pre-settlement and modern forests are spatially structured owing to differences in land-use impacts and accompanying ecological responses. Modern forests are more homogeneous, and ecotonal gradients are more diffuse today than in the past. Novel forest assemblages represent 28% of all FIA cells, and 28% of pre-settlement forests no longer exist in a modern context. Lost forests include tamarack forests in northeastern Minnesota, hemlock and cedar dominated forests in north-central Wisconsin and along the Upper Peninsula of Michigan, and elm, oak, basswood and ironwood forests along the forest-prairie boundary in south central Minnesota and eastern Wisconsin. Novel FIA forest assemblages are distributed evenly across the region, but novelty shows a strong relationship to spatial distance from remnant forests in the upper Midwest, with novelty predicted at between 20 to 60km from remnants, depending on historical forest type. The spatial relationships between remnant and novel forests, shifts in ecotone structure and the loss of historic forest types point to significant challenges for land managers if landscape restoration is a priority. The spatial signals of novelty and ecological change also point to potential challenges in using modern spatial distributions of species and communities and their relationship to underlying geophysical and climatic attributes in understanding potential responses to changing climate. The signal of human settlement on modern forests is broad, spatially varying and acts to homogenize modern forests relative to their historic counterparts, with significant implications for future management.	[Goring, Simon J.] Univ Wisconsin, Dept Geog, Madison, WI 53706 USA; [Mladenoff, David J.] Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI USA; [Cogbill, Charles V.; Record, Sydne] Harvard Univ, Harvard Forest, Petersham, MA USA; [Record, Sydne] Bryn Mawr Coll, Dept Biol, Bryn Mawr, PA 19010 USA; [Paciorek, Christopher J.; Dawson, Andria] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Jackson, Stephen T.] US Geol Survey, Dept Interior Southwest Climate Sci Ctr, Tucson, AZ USA; [Jackson, Stephen T.] Univ Arizona, Sch Nat Resources & Environm, Tucson, AZ USA; [Jackson, Stephen T.] Univ Arizona, Dept Geosci, Tucson, AZ USA; [Dietze, Michael C.] Boston Univ, Dept Earth & Environm, Boston, MA 02215 USA; [Matthes, Jaclyn Hatala] Dartmouth Coll, Dept Geog, Hanover, NH 03755 USA; [McLachlan, Jason S.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Williams, John W.] Univ Wisconsin, Dept Geog, Madison, WI 53706 USA; [Williams, John W.] Univ Wisconsin, Ctr Climat Res, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Harvard University; Bryn Mawr College; University of California System; University of California Berkeley; United States Department of the Interior; United States Geological Survey; University of Arizona; University of Arizona; Boston University; Dartmouth College; University of Notre Dame; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Goring, SJ (corresponding author), Univ Wisconsin, Dept Geog, Madison, WI 53706 USA.	goring@wisc.edu	Dietze, Michael/A-5834-2009	Dietze, Michael/0000-0002-2324-2518; Record, Sydne/0000-0001-7293-2155; Goring, Simon/0000-0002-2700-4605; Jackson, Stephen/0000-0002-1487-4652; Matthes, Jaclyn/0000-0001-8999-8062	National Science Foundation PaIEON MacroSystems Biology [DEB-1065702, DEB-1065656, DEB-1065848, DEB-1065732]	National Science Foundation PaIEON MacroSystems Biology	This material is based upon work supported by the National Science Foundation PaIEON MacroSystems Biology under grant nos. DEB-1065702 (JSM, CJP, AD), DEB-1065656 (SJG, JWW), DEB-1065848 (MCD, JHM), DEB-1065732 (STJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMENDINGER J. C., 1996, MINNESOTAS BEARING T; Andersen BJ, 2005, MICH BOT, V44, P127; ANDERSON R C, 1975, Castanea, V40, P345; [Anonymous], 2014, R LANG ENV STAT COMP; Auguie B, 2012, GRIDEXTRA FUNCTIONS; Bellemare J, 2002, J BIOGEOGR, V29, P1401, DOI 10.1046/j.1365-2699.2002.00762.x; Birks HJB., 2010, OPEN ECOL J, V3, P68, DOI [10.2174/1874213001003020068, DOI 10.2174/1874213001003020068, https://doi.org/10.1016/j.quaint.2012.07.228, DOI 10.1016/J.QUAINT.2012.07.228]; Bivand R., 2014, RGEOS INTERFACE GEOM; Bivand R, 2014, RGDAL BINDINGS GEOSP; BIVAND R., 2014, SPDEP SPATIAL DEPEND; Bivand R., 2013, APPL SPATIAL DATA AN, V2nd; Bolliger J, 2004, RESTOR ECOL, V12, P124, DOI 10.1111/j.1526-100X.2004.00285.x; Booth RK, 2012, ECOLOGY, V93, P219, DOI 10.1890/11-1068.1; Bouldin J, 2008, J BIOGEOGR, V35, P2000, DOI 10.1111/j.1365-2699.2008.01940.x; BOURDO EA, 1956, ECOLOGY, V37, P754, DOI 10.2307/1933067; BRUGAM RB, 1978, QUATERNARY RES, V9, P349, DOI 10.1016/0033-5894(78)90038-8; Cogbill CV, 2002, J BIOGEOGR, V29, P1279, DOI 10.1046/j.1365-2699.2002.00757.x; Cogbill CV, ESTIMATION ROBUST CO; COTTAM G, 1956, ECOLOGY, V37, P451, DOI 10.2307/1930167; Cramer VA, 2008, TRENDS ECOL EVOL, V23, P104, DOI 10.1016/j.tree.2007.10.005; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Curtis JT, 1959, VEGETATION WISCONSIN; Dawson A, 2016, QUATERNARY SCI REV, V137, P156, DOI 10.1016/j.quascirev.2016.01.012; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; Deines JM, AM MIDLAND IN PRESS; DUNN CP, 1983, CAN J BOT, V61, P211, DOI 10.1139/b83-023; Dupouey JL, 2002, ECOLOGY, V83, P2978, DOI 10.1890/0012-9658(2002)083[2978:IIOPLU]2.0.CO;2; Duren OC, 2012, NORTHWEST SCI, V86, P310, DOI 10.3955/046.086.0407; Ellis EC, 2008, FRONT ECOL ENVIRON, V6, P439, DOI 10.1890/070062; Etienne D, 2013, HOLOCENE, V23, P678, DOI 10.1177/0959683612470173; Ewing HA, 2002, ECOLOGY, V83, P2766, DOI 10.1890/0012-9658(2002)083[2766:TIOSOV]2.0.CO;2; Fahey RT, 2012, LANDSCAPE ECOL, V27, P999, DOI 10.1007/s10980-012-9754-z; FAITH DP, 1987, VEGETATIO, V69, P57, DOI 10.1007/BF00038687; Foster D, 2003, BIOSCIENCE, V53, P77, DOI 10.1641/0006-3568(2003)053[0077:TIOLUL]2.0.CO;2; Foster DR, 1998, ECOSYSTEMS, V1, P96, DOI 10.1007/s100219900008; Friedman SK, 2005, ECOL APPL, V15, P726, DOI 10.1890/04-0748; Fritschle JA, 2008, ANN ASSOC AM GEOGR, V98, P24, DOI 10.1080/00045600701734018; Fuller TL, 1998, ECOSYSTEMS, V1, P76; Gimmi U, 2013, ENVIRON MANAGE, V52, P481, DOI 10.1007/s00267-013-0102-0; Goring S, 2009, J BIOGEOGR, V36, P626, DOI 10.1111/j.1365-2699.2008.02021.x; Gray AN, 2012, VEG DATABASES 21 CEN, P255; GRIMM EC, 1984, ECOL MONOGR, V54, P291, DOI 10.2307/1942499; Groffman PM, 2012, BIOSCIENCE, V62, P1056, DOI 10.1525/bio.2012.62.12.7; Grossmann EB, 2008, FOREST ECOL MANAG, V256, P827, DOI 10.1016/j.foreco.2008.05.048; Hamburg SP, 1986, B ECOL SOC AM, V67, P169; Hanberry BB, 2014, ECOSYSTEMS, V17, P66, DOI 10.1007/s10021-013-9707-7; Hanberry BB, 2012, LANDSCAPE ECOL, V27, P1495, DOI 10.1007/s10980-012-9805-5; Hanberry BB, 2012, AM MIDL NAT, V167, P285, DOI 10.1674/0003-0031-167.2.285; Hanberry BB, 2011, LANDSCAPE ECOL, V26, P59, DOI 10.1007/s10980-010-9533-7; Hartig F, 2012, J BIOGEOGR, V39, P2240, DOI 10.1111/j.1365-2699.2012.02745.x; He HS, 1999, ECOSYSTEMS, V2, P308, DOI 10.1007/s100219900082; Heffernan JB, 2014, FRONT ECOL ENVIRON, V12, P5, DOI 10.1890/130017; Higgs E., 2012, SUSTAINABILITY SCI, P383, DOI [10.1007/978-1-4614-3188-6_18, DOI 10.1007/978-1-4614-3188-6_18]; Hijmans R.J., 2019, GEOGRAPHIC DATA ANAL; Hobbs RJ, 2014, FRONT ECOL ENVIRON, V12, P557, DOI 10.1890/130300; Hobbs RJ, 2014, TRENDS ECOL EVOL, V29, P645, DOI 10.1016/j.tree.2014.09.006; Hotchkiss SC, 2007, LANDSCAPE ECOL, V22, P25, DOI 10.1007/s10980-007-9133-3; Iverson LR, 2013, LANDSCAPE ECOL, V28, P879, DOI 10.1007/s10980-013-9885-x; Iverson LR, 1998, ECOL MONOGR, V68, P465, DOI 10.1890/0012-9615(1998)068[0465:PAOTSF]2.0.CO;2; Jenkins J.C., 2004, COMPREHENSIVE DATABA; Johnson WC, 1988, LANDSCAPE ECOL, V1, P175, DOI 10.1007/BF00162743; Knoot TG, 2010, ECOL SOC, V15; Kronenfeld BJ, 2007, CAN J FOREST RES, V37, P2365, DOI 10.1139/X07-068; Kronenfeld BJ, 2010, PROF GEOGR, V62, P182, DOI 10.1080/00330120903546759; Kronenfeld BJ, 2014, ECOGRAPHY; Leahy MJ, 2003, AM MIDL NAT, V149, P71, DOI 10.1674/0003-0031(2003)149[0071:ACOPAP]2.0.CO;2; Li D-J, 2014, ECOLOGY; Liu F, 2011, ECOL MONOGR, V81, P259, DOI 10.1890/10-0232.1; Lynch EA, 2014, CAN J FOREST RES, V44, P1331, DOI 10.1139/cjfr-2014-0107; Maechler M, 2014, CLUSTER CLUSTER ANAL; Manies KL, 2000, LANDSCAPE ECOL, V15, P741, DOI 10.1023/A:1008115200471; Manies KL, 2001, CAN J FOREST RES, V31, P1719, DOI 10.1139/cjfr-31-10-1719; Martinuzzi S, 2015, ECOSYSTEMS, V18, P1332, DOI 10.1007/s10021-015-9901-x; Matthes JH, 2016, J GEOPHYS RES-BIOGEO, V121, P523, DOI 10.1002/2015JG003175; McAndrews JH, 1988, VEGETATION HIST, P673; Menz MHM, 2013, SCIENCE, V339, P526, DOI 10.1126/science.1228334; Mladenoff DJ, 2002, ECOSYSTEMS, V5, P539, DOI 10.1007/s10021-002-0167-8; MORISHITA. MASAAKI, 1957, PHYSIOL AND ECOL [JAPAN], V7, P134; Morisita M., 1954, MEMOIRS FACULTY SCI, V1, P187; Munoz SE, 2014, J BIOGEOGR, V41, P2195, DOI 10.1111/jbi.12386; Murcia C, 2014, TRENDS ECOL EVOL, V29, P548, DOI 10.1016/j.tree.2014.07.006; Nyamai PA, 2014, FOREST ECOL MANAG, V322, P37, DOI 10.1016/j.foreco.2014.03.027; Oksanen J., 2014, VEGAN COMMUNITY ECOL; Paciorek CJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150087; Paciorek CJ, 2009, J AM STAT ASSOC, V104, P608, DOI 10.1198/jasa.2009.0026; Pebesma E.I., 2005, CLASSES METHODS SPAT, V5; Pederson N, 2014, ECOL MONOGR, V84, P599, DOI 10.1890/13-1025.1; Persson O, 1971, STAT ECOLOGY SAMPLIN; Radeloff VC, 2000, RESTOR ECOL, V8, P119, DOI 10.1046/j.1526-100x.2000.80018.x; Radeloff VC, 2015, ECOL APPL, V25, P2051, DOI 10.1890/14-1781.1; Ramankutty N, 1999, GLOBAL BIOGEOCHEM CY, V13, P997, DOI 10.1029/1999GB900046; Ratajczak Z, 2012, ECOLOGY, V93, P697, DOI 10.1890/11-1199.1; Rayburn AP, 2009, NAT AREA J, V29, P4, DOI 10.3375/043.029.0102; Record S, 2013, GLOBAL ECOL BIOGEOGR, V22, P760, DOI 10.1111/geb.12017; Rhemtulla JM, 2009, ECOL APPL, V19, P1061, DOI 10.1890/08-1453.1; Rhemtulla JM, 2009, P NATL ACAD SCI USA, V106, P6082, DOI 10.1073/pnas.0810076106; Schulte LA, 2005, ECOLOGY, V86, P431, DOI 10.1890/03-4065; Schulte LA, 2005, ECOSYSTEMS, V8, P73, DOI 10.1007/s10021-004-0052-8; Schulte LA, 2002, CAN J FOREST RES, V32, P1616, DOI 10.1139/X02-082; Schulte LA, 2001, J FOREST, V99, P5; Schulte LA, 2007, LANDSCAPE ECOL, V22, P1089, DOI 10.1007/s10980-007-9095-5; Seddon PJ, 2010, RESTOR ECOL, V18, P796, DOI 10.1111/j.1526-100X.2010.00724.x; Smyth G, 2016, STATMOD STAT MODELIN; St Jacques JM, 2008, J BIOGEOGR, V35, P306, DOI 10.1111/j.1365-2699.2007.01785.x; Staver AC, 2011, SCIENCE, V334, P230, DOI 10.1126/science.1210465; Stewart LO, 1935, PUBLIC LAND SURVEYS, P202; Terrail R, 2014, J VEG SCI, V25, P691, DOI 10.1111/jvs.12142; Thompson JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072540; Umbanhowar CE, 2004, HOLOCENE, V14, P661, DOI 10.1191/0959683604hl745rp; Umbanhowar CE, 2006, QUATERNARY RES, V66, P53, DOI 10.1016/j.yqres.2006.03.005; White CA., 1983, HIST RECTANGULAR SUR, P774; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wickham H, 2011, J STAT SOFTW, V40, P1, DOI 10.18637/jss.v040.i01; Wickham H, 2007, J STAT SOFTW, V21, P1; Williams MA, 2011, ECOL MONOGR, V81, P63, DOI 10.1890/10-0256.1; Wolkovich EM, 2014, ECOL LETT, V17, P1365, DOI 10.1111/ele.12353; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Woudenberg, 2010, FOREST INVENTORY ANA, DOI 10.2737/RMRS-GTR-245	118	34	35	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0151935	10.1371/journal.pone.0151935	http://dx.doi.org/10.1371/journal.pone.0151935			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935944	Green Published, Green Submitted, gold			2022-12-26	WOS:000389587100001
J	Liu, YH; Zhang, B; Lu, GM; Zhang, D				Liu, Yahui; Zhang, Bob; Lu, Guangming; Zhang, David			Online 3D Ear Recognition by Combining Global and Local Features	PLOS ONE			English	Article							FIELD	The three-dimensional shape of the ear has been proven to be a stable candidate for biometric authentication because of its desirable properties such as universality, uniqueness, and permanence. In this paper, a special laser scanner designed for online three- dimensional ear acquisition was described. Based on the dataset collected by our scanner, two novel feature classes were defined from a three-dimensional ear image: the global feature class (empty centers and angles) and local feature class (points, lines, and areas). These features are extracted and combined in an optimal way for three- dimensional ear recognition. Using a large dataset consisting of 2,000 samples, the experimental results illustrate the effectiveness of fusing global and local features, obtaining an equal error rate of 2.2%.	[Liu, Yahui; Lu, Guangming; Zhang, David] Harbin Inst Technol, Shenzhen Grad Sch, Dept Comp Sci & Technol, Shenzhen, Peoples R China; [Zhang, Bob] Univ Macau, Dept Comp & Informat Sci, Macau, Peoples R China	Harbin Institute of Technology; University Town of Shenzhen; University of Macau	Zhang, D (corresponding author), Harbin Inst Technol, Shenzhen Grad Sch, Dept Comp Sci & Technol, Shenzhen, Peoples R China.	cvpro1024@gmail.com	Zhang, Bob/ABD-5926-2021; Zhang, Hao/HHM-1940-2022; Zhang, David D/O-9396-2016; Zhang, Bob/HIR-3656-2022	Zhang, Bob/0000-0003-2497-9519; Zhang, David D/0000-0002-5027-5286; liu, yahui/0000-0002-8764-0769; LIU, Yahui/0000-0002-4632-2369	GRF fund from the HKSAR Government; central fund from Hong Kong Polytechnic University; NSFC fund [61332011, 61272292, 61271344]; Shenzhen Fundamental Research fund [JCYJ20150403161923528]; Key Laboratory of Network Oriented Intelligent Computation, Shenzhen, China	GRF fund from the HKSAR Government; central fund from Hong Kong Polytechnic University; NSFC fund(National Natural Science Foundation of China (NSFC)); Shenzhen Fundamental Research fund; Key Laboratory of Network Oriented Intelligent Computation, Shenzhen, China	The work is partially supported by the GRF fund from the HKSAR Government, the central fund from Hong Kong Polytechnic University, the NSFC fund (61332011, 61272292, 61271344), Shenzhen Fundamental Research fund (JCYJ20150403161923528), and Key Laboratory of Network Oriented Intelligent Computation, Shenzhen, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaza A., 2010, BIOM THEOR APPL SYST, P1; Abaza A, 2013, ACM COMPUT SURV, V45, DOI 10.1145/2431211.2431221; Burge M, 2000, INT C PATT RECOG, P822, DOI 10.1109/ICPR.2000.906202; Chen H, 2009, IEEE T PATTERN ANAL, V31, P172, DOI 10.1109/TPAMI.2008.176; Chen H, 2007, IEEE T PATTERN ANAL, V29, P718, DOI 10.1109/TPAMI.2007.1005; Chen L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129505; Ear M., 2005, ELCVIA ELECT LETT CO, V5, P84; Huang C, 2009, ICCIT: 2009 FOURTH INTERNATIONAL CONFERENCE ON COMPUTER SCIENCES AND CONVERGENCE INFORMATION TECHNOLOGY, VOLS 1 AND 2, P511, DOI 10.1109/ICCIT.2009.56; Hurley DJ, 2005, COMPUT VIS IMAGE UND, V98, P491, DOI 10.1016/j.cviu.2004.11.001; Iannarelli A., 1989, FORENSIC IDENTIFICAT; Islam SMS, 2012, ACM COMPUT SURV, V44, DOI 10.1145/2187671.2187676; Islam SMS, 2011, INT J COMPUT VISION, V95, P52, DOI 10.1007/s11263-011-0436-0; JAIN AK, 1999, BIOMETRICS PERSONAL; Kakadiaris IA, 2007, IEEE T PATTERN ANAL, V29, P640, DOI 10.1109/TPAMI.2007.1017; Li W, 2012, IEEE T SYST MAN CY A, V42, P443, DOI 10.1109/TSMCA.2011.2164066; Liu Y., 2014, PATTERN RECOGN, V53, P9; Liu Y., 2015, J GEOSCI ENV PROT, V3, P10, DOI [10.4236/gep.2015.32002, DOI 10.1371/J0URNAL.P0NE.0129439]; Mian AS, 2008, INT J COMPUT VISION, V79, P1, DOI 10.1007/s11263-007-0085-5; Pang YW, 2011, SIGNAL PROCESS, V91, P773, DOI 10.1016/j.sigpro.2010.08.010; Pang YW, 2010, IEEE T CIRC SYST VID, V20, P172, DOI 10.1109/TCSVT.2009.2020337; Pang YW, 2010, INT J COMPUT MATH, V87, P956, DOI 10.1080/00207160802044118; Purkait R, 2008, FORENSIC SCI INT, V178, P112, DOI 10.1016/j.forsciint.2008.02.009; Yan P, 2007, IEEE T PATTERN ANAL, V29, P1297, DOI 10.1109/TPAMI.2007.1067; Zhang D, 2003, IEEE T PATTERN ANAL, V25, P1041, DOI 10.1109/TPAMI.2003.1227981; Zhang D., 2013, AUTOMATED BIOMETRICS, V7; Zhang D, 2010, PATTERN RECOGN, V43, P358, DOI 10.1016/j.patcog.2009.04.026; Zhang D, 2009, IEEE T SYST MAN CY C, V39, P505, DOI 10.1109/TSMCC.2009.2020790; Zhang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095506; Zhang YB, 2007, LECT NOTES COMPUT SC, V4781, P154; Zhou JD, 2012, IEEE T INF FOREN SEC, V7, P978, DOI 10.1109/TIFS.2012.2189005	31	6	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0166204	10.1371/journal.pone.0166204	http://dx.doi.org/10.1371/journal.pone.0166204			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935955	Green Published, Green Submitted, gold			2022-12-26	WOS:000389587100020
J	Luo, T; Liu, H; Kim, JK				Luo, Tao; Liu, Han; Kim, Jin Kyung			Estrogen Protects the Female Heart from Ischemia/Reperfusion Injury through Manganese Superoxide Dismutase Phosphorylation by Mitochondrial p38 beta at Threonine 79 and Serine 106	PLOS ONE			English	Article							P38 MAP KINASES; PREVENTS CARDIOMYOCYTE APOPTOSIS; ACUTE MYOCARDIAL PROTECTION; CARDIAC MYOCYTES; RECEPTOR-BETA; NULL MICE; ACTIVATION; STRESS; ALPHA; 17-BETA-ESTRADIOL	A collective body of evidence indicates that estrogen protects the heart from myocardial ischemia/reperfusion (I/R) injury, but the underlying mechanism remains incompletely understood. We have previously delineated a novel mechanism of how 17 beta-estradiol (E2) protects cultured neonatal rat cardiomyocytes from hypoxia/reoxygenation (H/R) by identifying a functionally active mitochondrial pool of p38 beta and E2-driven upregulation of manganese superoxide dismutase (MnSOD) activity via p38 beta, leading to the suppression of reactive oxygen species (ROS) and apoptosis. Here we investigate these cytoprotective actions of E2 in vivo. Left coronary artery ligation and reperfusion was used to produce I/R injury in ovariectomized (OVX) female mice and in estrogen receptor (ER) null female mice. E2 treatment in OVX mice reduced the left ventricular infarct size accompanied by increased activity of mitochondrial p38 beta and MnSOD. I/R-induced infarct size in ER alpha knockout (ERKO), ER beta knockout (BERKO) and ER alpha and beta double knockout (DERKO) female mice was larger than that in wild type (WT) mice, with little difference among ERKO, BERKO, and DERKO. Loss of both ER alpha and ER beta led to reduced activity of mitochondrial p38 beta and MnSOD at baseline and after I/R. The physical interaction between mitochondrial p38 beta and MnSOD in the heart was detected by co-immunoprecipitation (co-IP). Threonine 79 (T79) and serine 106 (S106) of MnSOD were identified to be phosphorylated by p38 beta in kinase assays. Overexpression of WT MnSOD in cardiomyocytes reduced ROS generation during H/R, while point mutation of T79 and S106 of MnSOD to alanine abolished its antioxidative function. We conclude that the protective effects of E2 and ER against cardiac I/R injury involve the regulation of MnSOD via posttranslational modification of the dismutase by p38 beta.	[Luo, Tao; Liu, Han; Kim, Jin Kyung] Univ Calif Irvine, Sch Med, Dept Med, Div Cardiol, Irvine, CA 92717 USA	University of California System; University of California Irvine	Kim, JK (corresponding author), Univ Calif Irvine, Sch Med, Dept Med, Div Cardiol, Irvine, CA 92717 USA.	jkim13@uci.edu	LUO, TAO/G-5064-2018	LUO, TAO/0000-0002-4144-4500	National Heart, Lung, and Blood Institute [R01 HL111180]	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by The National Heart, Lung, and Blood Institute; grand number: R01 HL111180; URL: http://www.nhlbi.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias-Loza PA, 2007, HYPERTENSION, V50, P432, DOI 10.1161/HYPERTENSIONAHA.106.084798; Beenstock J, 2016, MOL CELL BIOL, V36, P1540, DOI 10.1128/MCB.01105-15; Beenstock J, 2014, J BIOL CHEM, V289, P23546, DOI 10.1074/jbc.M114.578237; Booth EA, 2003, J PHARMACOL EXP THER, V307, P395, DOI 10.1124/jpet.103.054205; Borras C, 2006, FASEB J, V20, P2136, DOI 10.1096/fj.05-5522fje; Candas D, 2013, J MOL CELL BIOL, V5, P166, DOI 10.1093/jmcb/mjs062; Ceravolo GS, 2013, STEROIDS, V78, P341, DOI 10.1016/j.steroids.2012.11.018; Costa TJ, 2015, AM J PHYSIOL-HEART C, V308, pH723, DOI 10.1152/ajpheart.00681.2014; Couse JF, 1999, ENDOCR REV, V20, P358, DOI 10.1210/er.20.3.358; Cross HR, 2009, ACTA PHYSIOL HUNG, V96, P307, DOI 10.1556/APhysiol.96.2009.3.5; Barrantes IDB, 2011, P NATL ACAD SCI USA, V108, P12764, DOI 10.1073/pnas.1015013108; Gabel Scott A, 2005, J Mol Cell Cardiol, V38, P289, DOI 10.1016/j.yjmcc.2004.11.013; Gottipati S, 2008, MOL VIS, V14, P898; Grohe C, 1997, FEBS LETT, V416, P107, DOI 10.1016/S0014-5793(97)01179-4; Hsia J, 2006, ARCH INTERN MED, V166, P357, DOI 10.1001/archinte.166.3.357; Jazbutyte V, 2009, BIOCHEM BIOPH RES CO, V384, P450, DOI 10.1016/j.bbrc.2009.04.139; Jiang Y, 1996, J BIOL CHEM, V271, P17920, DOI 10.1074/jbc.271.30.17920; Jin CH, 2015, FREE RADICAL BIO MED, V81, P77, DOI 10.1016/j.freeradbiomed.2014.12.026; Jovanovic S, 2000, J AM COLL CARDIOL, V36, P948, DOI 10.1016/S0735-1097(00)00798-1; Kim JK, 2006, J BIOL CHEM, V281, P6760, DOI 10.1074/jbc.M511024200; Kim YD, 1996, CIRCULATION, V94, P2901, DOI 10.1161/01.CIR.94.11.2901; Kurian GA, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/1656450; Lan XL, 2009, NUCL MED BIOL, V36, P207, DOI 10.1016/j.nucmedbio.2008.10.016; Li QX, 2008, J BIOL CHEM, V283, P11014, DOI 10.1074/jbc.M709682200; Liu H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085272; Liu H, 2011, CARDIOVASC RES, V89, P119, DOI 10.1093/cvr/cvq265; Luo T, 2016, CAN J CARDIOL, V32, P1017, DOI 10.1016/j.cjca.2015.10.021; Luo T, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0342-4; Manson JE, 2007, NEW ENGL J MED, V356, P2591, DOI 10.1056/NEJMoa071513; New L, 2003, MOL BIOL CELL, V14, P2603, DOI 10.1091/mbc.E02-08-0538; Nuedling S, 1999, CARDIOVASC RES, V43, P666, DOI 10.1016/S0008-6363(99)00093-0; Rattanasopa C, 2015, J STEROID BIOCHEM, V147, P1, DOI 10.1016/j.jsbmb.2014.11.009; Satoh M, 2007, CIRCULATION, V115, P3197, DOI 10.1161/CIRCULATIONAHA.106.657981; Schierbeck LL, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6409; Strehlow K, 2003, CIRC RES, V93, P170, DOI 10.1161/01.RES.0000082334.17947.11; Sugden PH, 1998, CIRC RES, V83, P345, DOI 10.1161/01.RES.83.4.345; Wang MJ, 2008, SURGERY, V144, P233, DOI 10.1016/j.surg.2008.03.009; Wang MJ, 2006, AM J PHYSIOL-HEART C, V290, pH2204, DOI 10.1152/ajpheart.01219.2005; Wang YB, 1998, J BIOL CHEM, V273, P2161, DOI 10.1074/jbc.273.4.2161; Xin HB, 2002, NATURE, V416, P334, DOI 10.1038/416334a; Yamakura F, 2010, BBA-PROTEINS PROTEOM, V1804, P318, DOI 10.1016/j.bbapap.2009.10.010; Yang SH, 2004, P NATL ACAD SCI USA, V101, P4130, DOI 10.1073/pnas.0306948101; Yokota T, 2016, GENE, V575, P369, DOI 10.1016/j.gene.2015.09.030	43	21	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167761	10.1371/journal.pone.0167761	http://dx.doi.org/10.1371/journal.pone.0167761			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930699	Green Published, gold, Green Submitted			2022-12-26	WOS:000389580900044
J	Murphy, N; Falk, RT; Messinger, DB; Pollak, M; Xue, XN; Lin, J; Sgueglia, R; Strickler, HD; Gaudet, MM; Gunter, MJ				Murphy, Neil; Falk, Roni T.; Messinger, Diana B.; Pollak, Michael; Xue, Xiaonan; Lin, Juan; Sgueglia, Robin; Strickler, Howard D.; Gaudet, Mia M.; Gunter, Marc J.			Influence of Fasting Status and Sample Preparation on Metabolic Biomarker Measurements in Postmenopausal Women	PLOS ONE			English	Article							GROWTH-FACTOR-I; SERUM C-PEPTIDE; COLORECTAL-CANCER; BREAST-CANCER; PLASMA ADIPONECTIN; DIABETES-MELLITUS; HEALTHY-SUBJECTS; BINDING-PROTEIN; RISK; INSULIN	Background Epidemiologic data linking metabolic markers-such as insulin, insulin-like growth factors (IGFs)-and adipose tissue-derived factors with cancer are inconsistent. Between-study differences in blood collection protocols, in particular participant's fasting status, may influence measurements. Methods We investigated the impact of fasting status and blood sample processing time on components of the insulin/IGF axis and in adipokines in a controlled feeding study of 45 healthy postmenopausal-women aged 50-75 years. Fasting blood samples were drawn (T0), after which subjects ate a standardized breakfast; subsequent blood draws were made at 1 hour (T1), 3 hours (T3), and 6 hours (T6) after breakfast. Serum samples were assayed for insulin, C-peptide, total-and free-IGF-I, IGF-binding protein [BP]-1 and -3, total and high molecular weight (HMW)-adiponectin, retinol binding protein-4, plasminogen activator inhibitor (PAI)-1, and resistin. Results Insulin and C-peptide levels followed similar postprandial trajectories; intra-class correlation coefficients [ICC] for insulin = 0.75, (95% CI: 0.64-0.97) and C-peptide (ICC = 0.66, 95% CI: 0.54-0.77) were similarly correlated in fasting (Spearman correlation, r = 0.78, 95% CI: 0.64-0.88) and postprandial states (T1, r = 0.77 (95% CI: 0.62-0.87); T3, r = 0.78 (95% CI: 0.63-0.87); T6, r = 0.77 (95% CI: 0.61-0.87)). Free-IGF-I and IGFBP-1 levels were also affected by fasting status, whereas total-IGF-I and IGFBP-3 levels remained unchanged. Levels of adipokines were largely insensitive to fasting status and blood sample processing delays. Conclusion Several components of the insulin/IGF axis were significantly impacted by fasting state and in particular, C-peptide levels were substantially altered postprandially and in a similar manner to insulin.	[Murphy, Neil] Imperial Coll London, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Murphy, Neil; Gunter, Marc J.] Int Agcy Res Canc, Lyon, France; [Falk, Roni T.] NCI, Div Canc Epidemiol & Genet, Hormonal & Reprod Epidemiol Branch, Bethesda, MD 20892 USA; [Messinger, Diana B.] Rockefeller Univ Hosp, 1230 York Ave, New York, NY 10021 USA; [Pollak, Michael] McGill Univ, Dept Oncol, Montreal, PQ, Canada; [Xue, Xiaonan; Lin, Juan; Sgueglia, Robin; Strickler, Howard D.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Gaudet, Mia M.] Amer Canc Soc, Epidemiol Res Program, Atlanta, GA USA	Imperial College London; World Health Organization; International Agency for Research on Cancer (IARC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Rockefeller University; McGill University; Yeshiva University; Albert Einstein College of Medicine; American Cancer Society	Murphy, N (corresponding author), Imperial Coll London, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England.; Murphy, N (corresponding author), Int Agcy Res Canc, Lyon, France.	murphyn@iarc.fr	Murphy, Neil/E-1189-2017; Gunter, Marc/AAP-8621-2020	Murphy, Neil/0000-0003-3347-8249; Gunter, Marc/0000-0001-5472-6761; Pollak, Michael/0000-0003-3047-0604	National Center for Advancing Translational Sciences (NCATS), National Institutes of Health [UL1RR024143]; National Cancer Institute [R03CA143956-01]; ICTR Einstein-Montefiore CTSA [UL1TR001073]; Diabetes Research Center [DK020541];  [8 UL1 TR000043]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020541] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences (NCATS), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ICTR Einstein-Montefiore CTSA; Diabetes Research Center; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The study population were recruited at the Center for Clinical and Translational Science (CCTS) at the Rockefeller University Hospital (New York, NY) using funds Grant # 8 UL1 TR000043. Supported in part by grant # UL1RR024143 from the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health. The funds for the measurement of adipokines were obtained from the National Cancer Institute (R03CA143956-01). Robin Sgueglia is supported by the ICTR Einstein-Montefiore CTSA (UL1TR001073) and the Diabetes Research Center (DK020541).	Aleksandrova K, 2012, CARCINOGENESIS, V33, P1211, DOI 10.1093/carcin/bgs133; BONSER AM, 1984, CRC CR REV CL LAB SC, V19, P297, DOI 10.3109/10408368409165766; COTTERILL AM, 1993, CLIN ENDOCRINOL, V39, P357, DOI 10.1111/j.1365-2265.1993.tb02377.x; Esposito K, 2003, AM J CLIN NUTR, V78, P1135, DOI 10.1093/ajcn/78.6.1135; Esposito K, 2012, DIABETES CARE, V35, P2402, DOI 10.2337/dc12-0336; Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666; Gunter MJ, 2009, JNCI-J NATL CANCER I, V101, P48, DOI 10.1093/jnci/djn415; Harris TG, 2006, GROWTH HORM IGF RES, V16, P86, DOI 10.1016/j.ghir.2006.01.002; HOLLY JMP, 1988, CLIN ENDOCRINOL, V29, P667, DOI 10.1111/j.1365-2265.1988.tb03715.x; Imbeault P, 2004, CLIN ENDOCRINOL, V60, P429, DOI 10.1111/j.1365-2265.2004.01997.x; Jellema A, 2004, EUR J CLIN INVEST, V34, P766, DOI 10.1111/j.1365-2362.2004.01414.x; Jenab M, 2007, INT J CANCER, V121, P368, DOI 10.1002/ijc.22697; Karlsson FA, 2004, OBES RES, V12, P1031, DOI 10.1038/oby.2004.126; Keinan-Boker L, 2003, INT J CANCER, V106, P90, DOI 10.1002/ijc.11193; Lewandowski KC, 2005, MOL GENET METAB, V85, P61, DOI 10.1016/j.ymgme.2004.12.014; Lukanova A, 2006, CANCER EPIDEM BIOMAR, V15, P401, DOI 10.1158/1055-9965.EPI-05-0836; Ma J, 2004, JNCI-J NATL CANCER I, V96, P546, DOI 10.1093/jnci/djh082; Peake PW, 2003, INT J OBESITY, V27, P657, DOI 10.1038/sj.ijo.0802289; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Sanders TAB, 2001, AM J CLIN NUTR, V73, P715; Shea SA, 2005, J CLIN ENDOCR METAB, V90, P2537, DOI 10.1210/jc.2004-2232; Verheus M, 2006, INT J CANCER, V119, P659, DOI 10.1002/ijc.21861; Wei EK, 2005, JNCI-J NATL CANCER I, V97, P1688, DOI 10.1093/jnci/dji376	23	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167832	10.1371/journal.pone.0167832	http://dx.doi.org/10.1371/journal.pone.0167832			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930694	Green Published, gold, Green Submitted			2022-12-26	WOS:000389580900048
J	Sprenger, JU; Bork, NI; Herting, J; Fischer, TH; Nikolaev, VO				Sprenger, Julia U.; Bork, Nadja I.; Herting, Jonas; Fischer, Thomas H.; Nikolaev, Viacheslav O.			Interactions of Calcium Fluctuations during Cardiomyocyte Contraction with Real-Time cAMP Dynamics Detected by FRET	PLOS ONE			English	Article							CARDIAC MYOCYTES; ADENYLYL-CYCLASE; CYCLIC-AMP; IN-VIVO; PHOSPHODIESTERASE; HEART; COMPARTMENTATION; SIGNALS; KINASE	Calcium (Ca2+) and 3',5'-cyclic adenosine monophosphate (cAMP) play a critical role for cardiac excitation-contraction-coupling. Both second messengers are known to interact with each other, for example via Ca2+-dependent modulation of phosphodiesterase 1 (PDE1) and adenylyl cyclase 5/6 (AC 5/6) activities, which is supposed to occur especially at the local level in distinct subcellular microdomains. Currently, many studies analyze global and local cAMP signaling and its regulation in resting cardiomyocytes devoid of electrical stimulation. For example, Forster resonance energy transfer (FRET) microscopy is a popular approach for visualization of real time cAMP dynamics performed in resting cardiomyocytes to avoid potential contractility-related movement artifacts. However, it is unknown whether such data are comparable with the cell behavior under more physiologically relevant conditions during contraction. Here, we directly compare the cAMP-FRET responses to AC stimulation and PDE inhibition in resting vs. paced adult mouse ventricular cardiomyocytes for both cytosolic and subsarcolemmal microdomains. Interestingly, no significant differences in cAMP dynamics could be detected after beta-adrenergic (isoproterenol) stimulation, suggesting low impact of rapidly changing contractile Ca2+ concentrations on cytosolic cAMP levels associated with AC activation. However, the contribution of the calcium-dependent PDE1, but not of the Ca2+-insensitive PDE4, to the regulation of cAMP levels after forskolin stimulation was significantly increased. This increase could be mimicked by pretreatment of resting cells with Ca2+ elevating agents. Ca2+ imaging demonstrated significantly higher amplitudes of Ca2+ transients in forskolin than in isoproterenol stimulated cells, suggesting that forskolin stimulation might lead to stronger activation of PDE1. In conclusion, changes in intracellular Ca2+ during cardiomyocyte contraction dynamically interact with cAMP levels, especially after strong AC stimulation. The use of resting cells for FRET-based measurements of cAMP can be justified under beta-adrenergic stimulation, while the reliable analysis of PDE1 effects may require electric field stimulation.	[Sprenger, Julia U.; Bork, Nadja I.; Nikolaev, Viacheslav O.] Univ Med Ctr Hamburg Eppendorf, Inst Expt Cardiovasc Res, Hamburg, Germany; [Sprenger, Julia U.; Herting, Jonas; Fischer, Thomas H.] Univ Med Ctr Gottingen, Heart Res Ctr Gottingen, Clin Cardiol & Pulmonol, Gottingen, Germany; [Bork, Nadja I.; Nikolaev, Viacheslav O.] DZHK German Ctr Cardiovasc Res, Partner Site Hamburg Kiel Lubeck, Berlin, Germany; [Herting, Jonas; Fischer, Thomas H.] DZHK German Ctr Cardiovasc Res, Partner Site Gottingen, Berlin, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Gottingen; German Centre for Cardiovascular Research; German Centre for Cardiovascular Research	Nikolaev, VO (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Expt Cardiovasc Res, Hamburg, Germany.; Nikolaev, VO (corresponding author), DZHK German Ctr Cardiovasc Res, Partner Site Hamburg Kiel Lubeck, Berlin, Germany.	v.nikolaev@uke.de	Nikolaev, Vyacheslav/AAT-7746-2020		"Deutsche Forschungsgemeinschaft" (DFG, German Research Council) [NI 1301/1, NI 1301/2, SFB 1002]; Gertraud and Heinz-Rose Stiftung	"Deutsche Forschungsgemeinschaft" (DFG, German Research Council)(German Research Foundation (DFG)); Gertraud and Heinz-Rose Stiftung	Support was provided by the "Deutsche Forschungsgemeinschaft" (DFG, German Research Council) grants NI 1301/1, NI 1301/2, SFB 1002) and the Gertraud and Heinz-Rose Stiftung [www.dfg.de].	Agarwal SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095835; Agarwal SR, 2011, J MOL CELL CARDIOL, V50, P500, DOI 10.1016/j.yjmcc.2010.11.015; Beavo JA, 2002, NAT REV MOL CELL BIO, V3, P710, DOI 10.1038/nrm911; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Borner S, 2011, NAT PROTOC, V6, P427, DOI 10.1038/nprot.2010.198; Brooker G, 1979, Adv Cyclic Nucleotide Res, V10, P1; Calebiro D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000172; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; De Arcangelis V, 2010, MOL PHARMACOL, V78, P340, DOI 10.1124/mol.110.064444; Despa S, 2014, CIRC RES, V115, P339, DOI 10.1161/CIRCRESAHA.115.303582; Fischmeister R, 2006, CIRC RES, V99, P816, DOI 10.1161/01.RES.0000246118.98832.04; KATSUSHIKA S, 1992, P NATL ACAD SCI USA, V89, P8774, DOI 10.1073/pnas.89.18.8774; Leroy J, 2008, CIRC RES, V102, P1091, DOI 10.1161/CIRCRESAHA.107.167817; Lompre AM, 2010, CIRCULATION, V121, P822, DOI 10.1161/CIRCULATIONAHA.109.890954; Miller CL, 2009, CIRC RES, V105, P956, DOI 10.1161/CIRCRESAHA.109.198515; Molina CE, 2012, J AM COLL CARDIOL, V59, P2182, DOI 10.1016/j.jacc.2012.01.060; Nikolaev VO, 2006, CIRC RES, V99, P1084, DOI 10.1161/01.RES.0000250046.69918.d5; Perera RK, 2013, ACTA PHYSIOL, V207, P650, DOI 10.1111/apha.12077; Perera RK, 2015, CIRC RES, V116, P1304, DOI 10.1161/CIRCRESAHA.116.306082; Richter W, 2008, EMBO J, V27, P384, DOI 10.1038/sj.emboj.7601968; Richter W, 2013, EMBO REP, V14, P276, DOI 10.1038/embor.2013.4; Rochais F, 2004, J BIOL CHEM, V279, P52095, DOI 10.1074/jbc.M405697200; Sprenger JU, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7965; Stangherlin A, 2011, CIRC RES, V108, P929, DOI 10.1161/CIRCRESAHA.110.230698; Willoughby D, 2007, PHYSIOL REV, V87, P965, DOI 10.1152/physrev.00049.2006; Zaccolo M, 2009, BRIT J PHARMACOL, V158, P50, DOI 10.1111/j.1476-5381.2009.00185.x	26	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167974	10.1371/journal.pone.0167974	http://dx.doi.org/10.1371/journal.pone.0167974			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930744	Green Published, gold, Green Submitted			2022-12-26	WOS:000389580900066
J	Hubel, TY; Shotton, J; Wilshin, SD; Horgan, J; Klein, R; McKenna, R; Wilson, AM				Hubel, Tatjana Y.; Shotton, Justine; Wilshin, Simon D.; Horgan, Jane; Klein, Rebecca; McKenna, Rick; Wilson, Alan M.			Cheetah Reunion - The Challenge of Finding Your Friends Again	PLOS ONE			English	Article							HABITAT SELECTION; PLAYBACK EXPERIMENTS; ACINONYX-JUBATUS; RANGE USE; PREDATORS; BEHAVIOR; LIONS; MECHANISMS; NAVIGATION; AVOIDANCE	Animals navigate their environment using a variety of senses and strategies. This multiplicity enables them to respond to different navigational requirements resulting from habitat, scale and purpose. One of the challenges social animals face is how to reunite after periods of separation. We explore a variety of possible mechanisms used to reunite the members of a cheetah coalition dispersed within a large area after prolonged separation. Using GPS data from three cheetahs reuniting after weeks of separation, we determined that 1) the likelihood of purely coincidental reunion is miniscule 2) the reunion occurred in an area not normally frequented 3) with very little time spent in the region in advance of the reunion. We therefore propose that timely encounter of scent markings where paths cross is the most likely mechanism used to aid the reunion.	[Hubel, Tatjana Y.; Shotton, Justine; Wilshin, Simon D.; Wilson, Alan M.] Royal Vet Coll, Struct & Motion Lab, Hatfield, Herts, England; [Horgan, Jane; Klein, Rebecca; McKenna, Rick] Cheetah Conservat Botswana, Kgale Siding Pk,Plot 1069 KO, Gaborone, Botswana	University of London; University of London Royal Veterinary College	Hubel, TY (corresponding author), Royal Vet Coll, Struct & Motion Lab, Hatfield, Herts, England.	thubel@rvc.ac.uk		Wilson, Alan/0000-0001-9914-3455; Hubel, Tatjana/0000-0002-6749-6747	Engineering and Physical Sciences Research Council [EP/H013016/1]; Biotechnology and Biological Sciences Research Council [BB/J018007/1]; European Research Council [323041]; BBSRC [BB/J018007/1] Funding Source: UKRI; EPSRC [EP/H013016/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Research Council(European Research Council (ERC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the Engineering and Physical Sciences Research Council (EP/H013016/1), https://www.epsrc.ac.uk/; Biotechnology and Biological Sciences Research Council (BB/J018007/1), http://www.bbsrc.ac.uk/; European Research Council, (323041), https://erc.europa.eu/.	Akesson S, 2005, J NAVIGATION, V58, P365, DOI 10.1017/S0373463305003401; [Anonymous], 2010, WOLVES BEHAV ECOLOGY; [Anonymous], 2014, PHEROMONES ANIMAL BE; Boinski S., 2000, MOVE WHY ANIMALS TRA; Caro T., 1994, CHEETAHS SERENGETI P; Dacke M, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0036; Dittman AH, 1996, J EXP BIOL, V199, P83; Durant SM, 2000, BEHAV ECOL, V11, P624, DOI 10.1093/beheco/11.6.624; Eaton R.L., 1974, CHEETAH BIOL ECOLOGY; EMLEN ST, 1970, SCIENCE, V170, P1198, DOI 10.1126/science.170.3963.1198; ESTES RD, 1991, BEHAV GUIDE AFRICAN; Etienne AS, 1996, J EXP BIOL, V199, P201; Foo P, 2005, J EXP PSYCHOL LEARN, V31, P195, DOI 10.1037/0278-7393.31.2.195; GREGORY RS, 1993, CAN J FISH AQUAT SCI, V50, P241, DOI 10.1139/f93-027; Grinnell J, 1996, BEHAV ECOL, V7, P55, DOI 10.1093/beheco/7.1.55; Grinnell J, 2001, ANIM BEHAV, V62, P93, DOI 10.1006/anbe.2001.1735; Heithaus MR, 2001, OIKOS, V92, P542, DOI 10.1034/j.1600-0706.2001.920315.x; Houser A, 2009, S AFR J WILDL RES, V39, P11, DOI 10.3957/056.039.0102; HUGIE DM, 1994, J FISH BIOL, V45, P151, DOI 10.1111/j.1095-8649.1994.tb01090.x; Hunter L, 2005, CATS OF AFRICA; Justus KA, 2005, J NEUROPHYSIOL, V93, P2233, DOI 10.1152/jn.00888.2004; Lamm N., 2013, WHAT DO CATS SEE; LAURENSON MK, 1993, ZOO BIOL, V12, P31, DOI 10.1002/zoo.1430120106; Lohmann Kenneth J., 2008, Navigation. Journal of the Institute of Navigation, V55, P115; Luschi P, 1998, P ROY SOC B-BIOL SCI, V265, P2279, DOI 10.1098/rspb.1998.0571; Marker LL, 2008, J ZOOL, V274, P226, DOI 10.1111/j.1469-7998.2007.00375.x; Marnewick K, 2006, S AFR J WILDL RES, V36, P147; Mauck B, 2008, ANIM COGN, V11, P715, DOI 10.1007/s10071-008-0156-1; MCCRACKEN GF, 1991, ETHOLOGY, V89, P305; MULLER M, 1988, P NATL ACAD SCI USA, V85, P5287, DOI 10.1073/pnas.85.14.5287; Rosenheim JA, 2004, ISRAEL J ZOOL, V50, P129, DOI 10.1560/K796-DMB2-546Q-Y4AQ; Ruiz-Miranda CR, 1998, ZOO BIOL, V17, P1, DOI 10.1002/(SICI)1098-2361(1998)17:1<1::AID-ZOO1>3.0.CO;2-D; Schaller G. B., 1972, SERENGETI LION STUDY; Schulz S, 2005, CHEM PHEROMONES OTHE, VII; Sih Andrew, 1998, P221; Sunquist ME, 2002, WILD CATS WORLD; Vanak AT, 2013, ECOLOGY, V94, P2619, DOI 10.1890/13-0217.1; von Saint Paul U., 1982, P298; Webster H, 2012, ETHOLOGY, V118, P147, DOI 10.1111/j.1439-0310.2011.01992.x; Webster H, 2010, ETHOLOGY, V116, P233, DOI 10.1111/j.1439-0310.2009.01729.x; Wehner R, 1996, J EXP BIOL, V199, P129; Wilson AM, 2013, NATURE, V498, P185, DOI 10.1038/nature12295; WILTSCHKO W, 1980, TRENDS NEUROSCI, V3, P140, DOI 10.1016/0166-2236(80)90052-1; Wright HWY, 2006, ANIM BEHAV, V71, P503, DOI 10.1016/j.anbehav.2005.03.043	44	3	3	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2016	11	12							e0166864	10.1371/journal.pone.0166864	http://dx.doi.org/10.1371/journal.pone.0166864			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4NG	27926915	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000389578800008
J	Pfankuche, VM; Sayed-Ahmed, M; Contioso, VB; Spitzbarth, I; Rohn, K; Ulrich, R; Deschl, U; Kalkuhl, A; Baumgartner, W; Puff, C				Pfankuche, Vanessa Maria; Sayed-Ahmed, Mohamed; Contioso, Vanessa Bono; Spitzbarth, Ingo; Rohn, Karl; Ulrich, Reiner; Deschl, Ulrich; Kalkuhl, Arno; Baumgaertner, Wolfgang; Puff, Christina			Persistent Morbillivirus Infection Leads to Altered Cortactin Distribution in Histiocytic Sarcoma Cells with Decreased Cellular Migration Capacity	PLOS ONE			English	Article							CANINE-DISTEMPER VIRUS; MATRIX-METALLOPROTEINASE; EPITHELIAL TRANSITION; CONTACT INHIBITION; INVADOPODIA; CANCER; EXPRESSION; MEASLES; INVASION; ROLES	Histiocytic sarcomas represent rare but fatal neoplasms in humans. Based on the absence of a commercially available human histiocytic sarcoma cell line the frequently affected dog displays a suitable translational model. Canine distemper virus, closely related to measles virus, is a highly promising candidate for oncolytic virotherapy. Therapeutic failures in patients are mostly associated with tumour invasion and metastasis often induced by misdirected cytoskeletal protein activities. Thus, the impact of persistent canine distemper virus infection on the cytoskeletal protein cortactin, which is frequently overexpressed in human cancers with poor prognosis, was investigated in vitro in a canine histiocytic sarcoma cell line (DH82). Though phagocytic activity, proliferation and apoptotic rate were unaltered, a significantly reduced migration activity compared to controls (6 hours and 1 day after seeding) accompanied by a decreased number of cortactin mRNA transcripts (1 day) was detected. Furthermore, persistently canine distemper virus infected DH82 cells showed a predominant diffuse intracytoplasmic cortactin distribution at 6 hours and 1 day compared to controls with a prominent membranous expression pattern (p <= 0.05). Summarized, persistent canine distemper virus infection induces reduced tumour cell migration associated with an altered intracellular cortactin distribution, indicating cytoskeletal changes as one of the major pathways of virus-associated inhibition of tumour spread.	[Pfankuche, Vanessa Maria; Sayed-Ahmed, Mohamed; Contioso, Vanessa Bono; Spitzbarth, Ingo; Ulrich, Reiner; Baumgaertner, Wolfgang; Puff, Christina] Univ Vet Med Hannover, Dept Pathol, Hannover, Germany; [Rohn, Karl] Univ Vet Med Hannover, Inst Biometry Epidemiol & Informat Proc, Hannover, Germany; [Deschl, Ulrich; Kalkuhl, Arno] Boehringer Ingelheim Pharma GmbH & Co KG, Dept Nonclin Drug Safety, Biberach, Riss, Germany; [Pfankuche, Vanessa Maria; Spitzbarth, Ingo; Ulrich, Reiner; Baumgaertner, Wolfgang] Univ Vet Med Hannover, Ctr Syst Neurosci, Hannover, Germany	University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation; Boehringer Ingelheim; University of Veterinary Medicine Hannover, Foundation	Baumgartner, W (corresponding author), Univ Vet Med Hannover, Dept Pathol, Hannover, Germany.; Baumgartner, W (corresponding author), Univ Vet Med Hannover, Ctr Syst Neurosci, Hannover, Germany.	wolfgang.baumgaertner@tiho-hannover.de	Sayed-Ahmed, Mohamed Zakaria/ABF-6616-2020	Sayed-Ahmed, Mohamed Zakaria/0000-0003-0777-8256	Akademie fur Tiergesundheit e. V. (Bonn, Germany); Ministry of Higher Education (Cairo, Egypt); German Research Foundation (Researcher's group) [1103, BA815/10-2, UL421/1-2]; Gesellschaft zur Forderung Kynologischer Forschung e.V (GkF, Bonn, Germany)	Akademie fur Tiergesundheit e. V. (Bonn, Germany); Ministry of Higher Education (Cairo, Egypt)(Ministry of Higher Education & Scientific Research (MHESR)); German Research Foundation (Researcher's group); Gesellschaft zur Forderung Kynologischer Forschung e.V (GkF, Bonn, Germany)	VMP was financially supported by the Akademie fur Tiergesundheit e. V. (Bonn, Germany; http://www.aft-onlinemet/home/die-akademie/). MSA received financial support from the Ministry of Higher Education (Cairo, Egypt). WBA and RU: This study was in part supported by the German Research Foundation (Researcher's group 1103; grants BA815/10-2 and UL421/1-2 (http:/www.dfg.de/). WBA: This study was in part supported by the Gesellschaft zur Forderung Kynologischer Forschung e.V (GkF, Bonn, Germany; https://www.gkl-berndeiindex.php/startate.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams VJ, 2010, J SMALL ANIM PRACT, V51, P512, DOI 10.1111/j.1748-5827.2010.00974.x; Artym VV, 2006, CANCER RES, V66, P3034, DOI 10.1158/0008-5472.CAN-05-2177; Banon-Rodriguez I, 2011, EUR J CELL BIOL, V90, P213, DOI 10.1016/j.ejcb.2010.09.001; BARKALOW K, 1995, CURR BIOL, V5, P1000, DOI 10.1016/S0960-9822(95)00200-4; Batson J, 2013, J MICROSC-OXFORD, V251, P232, DOI 10.1111/jmi.12024; BAUMGARTNER W, 1988, AM J VET RES, V49, P477; Beineke A, 2009, VET IMMUNOL IMMUNOP, V127, P1, DOI 10.1016/j.vetimm.2008.09.023; Bergman A, 2014, CELL ADHES MIGR, V8, P273, DOI 10.4161/cam.28349; Bowden ET, 1999, ONCOGENE, V18, P4440, DOI 10.1038/sj.onc.1202827; Bozzuto G, 2010, ANN I SUPER SANITA, V46, P66, DOI 10.4415/ANN_10_01_09; Buday L, 2007, BBA-REV CANCER, V1775, P263, DOI 10.1016/j.bbcan.2006.12.002; Cai JH, 2010, J GASTROINTEST SURG, V14, P1248, DOI 10.1007/s11605-010-1247-2; CARTER RL, 1978, INVEST CELL PATHOL, V1, P275; Clark ES, 2008, EUR J CELL BIOL, V87, P581, DOI 10.1016/j.ejcb.2008.01.008; Clark ES, 2007, CANCER RES, V67, P4227, DOI 10.1158/0008-5472.CAN-06-3928; Cosen-Binker LI, 2006, PHYSIOLOGY, V21, P352, DOI 10.1152/physiol.00012.2006; Eckert MA, 2011, ONCOTARGET, V2, P562; Fidel J, 2006, VET COMP ONCOL, V4, P63, DOI 10.1111/j.1476-5810.2006.00090.x; Gibcus JH, 2008, BRIT J CANCER, V98, P950, DOI 10.1038/sj.bjc.6604246; Grone A, 2002, VIRAL IMMUNOL, V15, P493, DOI 10.1089/088282402760312368; Grote D, 2001, BLOOD, V97, P3746, DOI 10.1182/blood.V97.12.3746; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hedan B, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-201; Hernandez-Sanchez M, 2015, ONCOTARGET, V6, P17479, DOI 10.18632/oncotarget.4127; Hornick JL, 2004, AM J SURG PATHOL, V28, P1133, DOI 10.1097/01.pas.0000131541.95394.23; HOWARD JM, 1983, J GEN VIROL, V64, P2379, DOI 10.1099/0022-1317-64-11-2379; ITO M, 1979, CELL IMMUNOL, V46, P48, DOI 10.1016/0008-8749(79)90244-2; Jeanes A, 2008, ONCOGENE, V27, P6920, DOI 10.1038/onc.2008.343; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Katayama H, 2004, J VET MED SCI, V66, P409, DOI 10.1292/jvms.66.409; Kirkbride KC, 2011, CELL ADHES MIGR, V5, P187, DOI 10.4161/cam.5.2.14773; Klauschies F, 2010, ARCH VIROL, V155, P1503, DOI 10.1007/s00705-010-0737-6; Lapp S, 2014, VIRUSES-BASEL, V6, P2340, DOI 10.3390/v6062340; Linder S, 2009, J CELL SCI, V122, P3009, DOI 10.1242/jcs.032631; Lu P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088918; Mayor R, 2010, TRENDS CELL BIOL, V20, P319, DOI 10.1016/j.tcb.2010.03.005; Msaouel P, 2012, CURR PHARM BIOTECHNO, V13, P1732, DOI 10.2174/138920112800958896; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Palosaari H, 2003, J VIROL, V77, P7635, DOI 10.1128/JVI.77.13.7635-7644.2003; Patil SS, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-3; Pringproa K, 2010, BRAIN RES, V1327, P24, DOI 10.1016/j.brainres.2010.02.068; Puff C, 2009, VET J, V182, P100, DOI 10.1016/j.tvjl.2008.03.026; Qeska V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096121; Raddatz BBR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086643; Revach OY, 2014, CELL ADHES MIGR, V8, P215, DOI 10.4161/cam.27842; Rheinwald JG, 2002, MOL CELL BIOL, V22, P5157, DOI 10.1128/MCB.22.14.5157-5172.2002; Rozen S, 2000, Methods Mol Biol, V132, P365; Saito T, 2006, HUM PATHOL, V37, P689, DOI 10.1016/j.humpath.2006.01.017; Saitoh Y, 2009, INT J ONCOL, V35, P1277, DOI 10.3892/ijo_00000445; Schiffman JD, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0231; Schlick K, 2012, ONKOLOGIE, V35, P447, DOI 10.1159/000340066; Schwens C, 2011, TIERAERZTL PRAX K H, V39, P176; Seehusen F, 2007, ACTA NEUROPATHOL, V114, P597, DOI 10.1007/s00401-007-0307-5; Seeliger FA, 2007, VET PATHOL, V44, P621, DOI 10.1354/vp.44-5-621; Small JV, 1999, MICROSC RES TECHNIQ, V47, P3; Somarelli JA, 2016, MOL CELL BIOL, V36, P2503, DOI 10.1128/MCB.00373-16; Stoletov K, 2015, EXPERT REV ANTICANC, V15, P733, DOI 10.1586/14737140.2015.1058711; Stylli SS, 2008, J CLIN NEUROSCI, V15, P725, DOI 10.1016/j.jocn.2008.03.003; Suter SE, 2005, CLIN CANCER RES, V11, P1579, DOI 10.1158/1078-0432.CCR-04-1944; Takada M, 2014, CANCER RES, V74, DOI 10.1158/1538-7445.AM2014-3931; Tang H, 2016, ONCOTARGET; Techangamsuwan S, 2009, J NEUROSCI METH, V176, P112, DOI 10.1016/j.jneumeth.2008.08.030; Trepat X, 2012, COMPR PHYSIOL, V2, P2369, DOI 10.1002/cphy.c110012; Tsai WC, 2013, APMIS, V121, P171, DOI 10.1111/j.1600-0463.2012.02952.x; Vos JA, 2005, MODERN PATHOL, V18, P693, DOI 10.1038/modpathol.3800346; Walker A, 2014, INT J ONCOL, V45, P1699, DOI 10.3892/ijo.2014.2549; Weaver AM, 2006, CLIN EXP METASTAS, V23, P97, DOI 10.1007/s10585-006-9014-1; WELLMAN ML, 1988, IN VITRO CELL DEV B, V24, P223, DOI 10.1007/BF02623551; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455; Yamaguchi H, 2012, EUR J CELL BIOL, V91, P902, DOI 10.1016/j.ejcb.2012.04.005; Yang JL, 2014, EUR J CANCER, V50, P593, DOI 10.1016/j.ejca.2013.11.006; Yang JL, 2010, MOL CELL PROTEOMICS, V9, P2405, DOI 10.1074/mcp.M110.000240	72	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0167517	10.1371/journal.pone.0167517	http://dx.doi.org/10.1371/journal.pone.0167517			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3TF	27911942	Green Published, Green Submitted, gold			2022-12-26	WOS:000389520600040
J	Ballot, A; Cerasino, L; Hostyeva, V; Cires, S				Ballot, Andreas; Cerasino, Leonardo; Hostyeva, Vladyslava; Cires, Samuel			Variability in the sxt Gene Clusters of PSP Toxin Producing Aphanizomenon gracile Strains from Norway, Spain, Germany and North America	PLOS ONE			English	Article							FRESH-WATER CYANOBACTERIUM; PARALYTIC SHELLFISH POISONS; IN-SILICO PCR; SAXITOXIN PRODUCTION; NOSTOCALES; CYLINDROSPERMOPSIN; PHYLOGENY; RELEASE; ROUTES; LAKES	Paralytic shellfish poisoning (PSP) toxin production has been detected worldwide in the cyanobacterial genera Anabaena, Lyngbya, Scytonema, Cuspidothrix and Aphanizomenon. In Europe Aphanizomenon gracile and Cuspidothrix issatschenkoi are the only known producers of PSP toxins and are found in Southwest and Central European freshwater bodies. In this study the PSP toxin producing Aphanizomenon sp. strain NIVA-CYA 851 was isolated from the Norwegian Lake Hillestadvannet. In a polyphasic approach NIVA-CYA 851 was morphologically and phylogenetically classified, and investigated for toxin production. The strain NIVA-CYA 851 was identified as A. gracile using 16S rRNA gene phylogeny and was confirmed to produce neosaxitoxin, saxitoxin and gonyautoxin 5 by LC-MS. The whole sxt gene clusters (circa 27.3 kb) of four A. gracile strains: NIVA-CYA 851 (Norway); NIVA-CYA 655 & NIVA-CYA 676 (Germany); and UAM 529 (Spain), all from latitudes between 40 degrees and 59 degrees North were sequenced and compared with the sxt gene cluster of reference strain A. gracile NH-5 from the USA. All five sxt gene clusters are highly conserved with similarities exceeding 99.4%, but they differ slightly in the number and presence of single nucleotide polymorphisms (SNPs) and insertions/deletions (In/Dels). Altogether 178 variable sites (44 SNPs and 4 In/Dels, comprising 134 nucleotides) were found in the sxt gene clusters of the Norwegian, German and Spanish strains compared to the reference strain. Thirty-nine SNPs were located in 16 of the 27 coding regions. The sxt gene clusters of NIVA-CYA 851, NIVA-CYA 655, NIVA-CYA 676 and UAM 529, were characterized by 15, 16, 19 and 23 SNPs respectively. Only the Norwegian strain NIVA-CYA 851 possessed an insertion of 126 base pairs (bp) in the noncoding area between the sxtA and sxtE genes and a deletion of 6 nucleotides in the sxtN gene. The sxtI gene showed the highest variability and is recommended as the best genetic marker for further phylogenetic studies of the sxt gene cluster of A. gracile. This study confirms for the first time the role of A. gracile as a PSP toxin producer in Norwegian waters, representing the northernmost occurrence of PSP toxin producing A. gracile in Europe known so far.	[Ballot, Andreas; Hostyeva, Vladyslava] Norwegian Inst Water Res, Oslo, Norway; [Cerasino, Leonardo] Fdn E Mach, IASMA Res & Innovat Ctr, Ist Agr S Michele Adige, San Michele All Adige, Trento, Italy; [Cires, Samuel] Univ Autonoma Madrid, Dept Biol, Madrid, Spain	Norwegian Institute for Water Research (NIVA); Fondazione Edmund Mach; Autonomous University of Madrid	Ballot, A (corresponding author), Norwegian Inst Water Res, Oslo, Norway.	andreas.ballot@niva.no	Ballot, Andreas/G-7752-2019; Cirés, Samuel/B-2508-2017; cerasino, leonardo/G-8466-2011	Ballot, Andreas/0000-0002-4088-0677; Cirés, Samuel/0000-0001-8272-5512; cerasino, leonardo/0000-0002-0839-9832				Al-Tebrineh J, 2010, APPL ENVIRON MICROB, V76, P7836, DOI 10.1128/AEM.00174-10; Ballot A, 2008, MICROB ECOL, V55, P608, DOI 10.1007/s00248-007-9304-4; Ballot A, 2014, MAR FRESHWATER RES, V65, P175, DOI 10.1071/MF13153; Ballot A, 2010, APPL ENVIRON MICROB, V76, P1173, DOI 10.1128/AEM.02285-09; Boopathi T, 2014, TOXINS, V6, P1951, DOI 10.3390/toxins6071951; Borges HLF, 2015, HARMFUL ALGAE, V43, P46, DOI 10.1016/j.hal.2015.01.003; Brumfield RT, 2003, TRENDS ECOL EVOL, V18, P249, DOI 10.1016/S0169-5347(03)00018-1; Carmichael WW, 1997, APPL ENVIRON MICROB, V63, P3104, DOI 10.1128/AEM.63.8.3104-3110.1997; Carneiro RL, 2013, MAR DRUGS, V11, P2949, DOI 10.3390/md11082949; Cires S, 2016, HARMFUL ALGAE, V54, P21, DOI 10.1016/j.hal.2015.09.007; Cires S, 2014, APPL ENVIRON MICROB, V80, P1359, DOI 10.1128/AEM.03002-13; Codd GA, 1999, EUR J PHYCOL, V34, P405, DOI 10.1080/09670269910001736462; Casero MC, 2014, HARMFUL ALGAE, V37, P28, DOI 10.1016/j.hal.2014.05.006; D'Agostino PM, 2014, TOXINS AND BIOLOGICALLY ACTIVE COMPOUNDS FROM MICROALGAE, VOL 1: ORIGIN, CHEMISTRY AND DETECTION, P251; Dell'Aversano C, 2005, J CHROMATOGR A, V1081, P190, DOI 10.1016/j.chroma.2005.05.056; Dittmann E, 2013, FEMS MICROBIOL REV, V37, P23, DOI 10.1111/j.1574-6976.2012.12000.x; EDWARDS U, 1989, NUCLEIC ACIDS RES, V17, P7843, DOI 10.1093/nar/17.19.7843; Gentile JH, 1971, MICROBIAL TOXINS, V7, P27; Gkelis S, 2005, MICROB ECOL, V49, P176, DOI 10.1007/s00248-003-2030-7; Gkelis S, 2014, TOXICON, V78, P1, DOI 10.1016/j.toxicon.2013.11.010; Hepperle D., 2008, ALIGN MANUAL DNA SEQ; Hoffmann C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066019; Jancula D, 2014, ENVIRON SCI POLLUT R, V21, P8006, DOI 10.1007/s11356-014-2699-9; Kaas H, 2000, WATER RES, V34, P2089, DOI 10.1016/S0043-1354(99)00372-3; Kalendar R, 2014, METHODS MOL BIOL, V1116, P271, DOI 10.1007/978-1-62703-764-8_18; Kalendar R, 2011, GENOMICS, V98, P137, DOI 10.1016/j.ygeno.2011.04.009; Kellmann R, 2008, J MOL EVOL, V67, P526, DOI 10.1007/s00239-008-9169-2; Kokocinski M, 2013, ENVIRON SCI POLLUT R, V20, P5243, DOI 10.1007/s11356-012-1426-7; Komarek J., 2013, CYANOPROKARYOTA, V19; Komarek J., 2006, CZECH PHYCOL, V6, P1; Kotai J., 1972, PUBLICATION B; Ledreux A, 2010, HARMFUL ALGAE, V10, P88, DOI 10.1016/j.hal.2010.07.004; Li RH, 2000, HYDROBIOLOGIA, V438, P99, DOI 10.1023/A:1004166029866; Li RH, 2003, J PHYCOL, V39, P814, DOI 10.1046/j.1529-8817.2003.02199.x; Llewellyn LE, 2001, ENVIRON SCI TECHNOL, V35, P1445, DOI 10.1021/es001575z; MAHMOOD NA, 1986, TOXICON, V24, P175, DOI 10.1016/0041-0101(86)90120-0; Mihali TK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014657; Mihali Troco K, 2009, BMC Biochem, V10, P8, DOI 10.1186/1471-2091-10-8; Moustafa A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005758; Murray SA, 2011, MOL BIOL EVOL, V28, P1173, DOI 10.1093/molbev/msq295; Pereira P, 2004, EUR J PHYCOL, V39, P361, DOI 10.1080/09670260410001714723; Rapala J, 2005, ENVIRON TOXICOL, V20, P331, DOI 10.1002/tox.20109; Smith FMJ, 2012, PHYCOLOGIA, V51, P542, DOI 10.2216/11-84.1; Soto-Liebe K, 2012, TOXICON, V60, P1324, DOI 10.1016/j.toxicon.2012.09.001; Soto-Liebe K, 2010, TOXICON, V56, P1350, DOI 10.1016/j.toxicon.2010.07.022; Suikkanen S, 2013, HARMFUL ALGAE, V26, P52, DOI 10.1016/j.hal.2013.04.001; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Wiese M, 2010, MAR DRUGS, V8, P2185, DOI 10.3390/md8072185	48	21	21	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167552	10.1371/journal.pone.0167552	http://dx.doi.org/10.1371/journal.pone.0167552			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907126	Green Published, Green Submitted, gold			2022-12-26	WOS:000389482700191
J	Benton, MA; Kenny, NJ; Conrads, KH; Roth, S; Lynch, JA				Benton, Matthew A.; Kenny, Nathan J.; Conrads, Kai H.; Roth, Siegfried; Lynch, Jeremy A.			Deep, Staged Transcriptomic Resources for the Novel Coleopteran Models Atrachya menetriesi and Callosobruchus maculatus	PLOS ONE			English	Article							DENDROCTONUS-PONDEROSAE HOPKINS; MOUNTAIN PINE-BEETLE; SHORT-GERM; GENOME; ANNOTATION; TRIBOLIUM; PATTERNS; DIVERSIFICATION; SPECIFICATION; COMPONENTS	Despite recent efforts to sample broadly across metazoan and insect diversity, current sequence resources in the Coleoptera do not adequately describe the diversity of the clade. Here we present deep, staged transcriptomic data for two coleopteran species, Atrachya menetriesi (Faldermann 1835) and Callosobruchus maculatus (Fabricius 1775). Our sampling covered key stages in ovary and early embryonic development in each species. We utilized this data to build combined assemblies for each species which were then analysed in detail. The combined A. menetriesi assembly consists of 228,096 contigs with an N50 of 1,598 bp, while the combined C. maculatus assembly consists of 128,837 contigs with an N50 of 2,263 bp. For these assemblies, 34.6% and 32.4% of contigs were identified using Blast2GO, and 97% and 98.3% of the BUSCO set of metazoan orthologs were present, respectively. We also carried out manual annotation of developmental signalling pathways and found that nearly all expected genes were present in each transcriptome. Our analyses show that both transcriptomes are of high quality. Lastly, we performed read mapping utilising our timed, stage specific RNA samples to identify differentially expressed contigs. The resources presented here will provide a firm basis for a variety of experimentation, both in developmental biology and in comparative genomic studies.	[Benton, Matthew A.; Conrads, Kai H.; Roth, Siegfried] Univ Cologne, Inst Dev Biol, Cologne, Germany; [Kenny, Nathan J.] Chinese Univ Hong Kong, Simon FS Li Sch Life Sci, Shatin, Hong Kong, Peoples R China; [Lynch, Jeremy A.] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA; [Kenny, Nathan J.] Nat Hist Museum London, Dept Life Sci, London, England	University of Cologne; Chinese University of Hong Kong; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Natural History Museum London	Roth, S (corresponding author), Univ Cologne, Inst Dev Biol, Cologne, Germany.; Lynch, JA (corresponding author), Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA.	siegfried.roth@uni-koeln.de; jlynch42@uic.edu	Roth, Siegfried/E-8241-2010; Kenny, Nathan/AAD-2391-2020	Roth, Siegfried/0000-0001-5772-3558; Kenny, Nathan/0000-0003-4816-4103; Benton, Matthew A./0000-0001-7953-0765	Alexander von Hum boldt; Deutsche Forschungsgemeinschaft [Collaborative Research Center Grant 680]	Alexander von Hum boldt(Alexander von Humboldt Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	MAB was supported by an Alexander von Hum boldt (https://www.humboldt-foundation.de/ web/home.html) Fellowship for Postdoctoral Researchers. KHC, SR and JAL were supported by the Deutsche Forschungsgemeinschaft (http://www.dfg.de/en/index.jsp) Collaborative Research Center Grant 680. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson D.T., 1972, pUnpaginated; ANDO Y, 1979, APPL ENTOMOL ZOOL, V14, P193, DOI 10.1303/aez.14.193; Ando Y, 1968, B FAC AGR IWATE U, V9, P87; Andrews S., 2010, FASTQC QUALITY CONTR; [Anonymous], 2015, 1KITE 1000 INSECT TR; Blumer LS, 2015, BEAN BEETLES MODEL O; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brocchieri L, 2005, NUCLEIC ACIDS RES, V33, P3390, DOI 10.1093/nar/gki615; Chen HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114238; Chi YH, 2009, INSECT MOL BIOL, V18, P97, DOI 10.1111/j.1365-2583.2008.00854.x; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cunningham CB, 2015, GENOME BIOL EVOL, V7, P3383, DOI 10.1093/gbe/evv194; Davis GK, 2002, ANNU REV ENTOMOL, V47, P669, DOI 10.1146/annurev.ento.47.091201.145251; Evans JD, 2013, J HERED, V104, P595, DOI 10.1093/jhered/est050; Flagel LE, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-195; Gilbert S.F., 2003, DEV BIOL, V7th Edn; Gotz S, 2011, BIOINFORMATICS, V27, P919, DOI 10.1093/bioinformatics/btr059; Gomez-Zurita J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000360; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grimaldi David, 2005, pi; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hansen KD, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq224; Hegner RW, 1908, BIOL BULL-US, V16, P19, DOI 10.2307/1536121; Hegner RW, 1909, J MORPHOL, V20, P231, DOI 10.1002/jmor.1050200204; Hui JHL, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-43; Hunt T, 2007, SCIENCE, V438, P1; Jacobs CGC, 2015, INSECT BIOCHEM MOLEC, V60, P7, DOI 10.1016/j.ibmb.2015.02.014; Jolivet PH, 1994, NOVEL ASPECTS BIOL C; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Keeling CI, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r27; Keeling CI, 2012, INSECT BIOCHEM MOLEC, V42, P525, DOI 10.1016/j.ibmb.2012.03.010; Kenny NJ, 2015, GENOME BIOL EVOL, V7, P1280, DOI 10.1093/gbe/evv070; Kenny NJ, 2014, INT J DEV BIOL, V58, P533, DOI 10.1387/ijdb.140080nk; Kirsch Roy, 2012, BMC Genomics, V13, P587, DOI 10.1186/1471-2164-13-587; Kumar A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086012; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lynch JA, 2006, NATURE, V439, P728, DOI 10.1038/nature04445; MIYA K, 1974, Journal of the Faculty of Agriculture Iwate University, V12, P39; Miya K., 1965, Journal of the Faculty of Agriculture Iwate University, V7, P155; Miya K, 1966, P 26 ANN M ENT SOC J, P9; O'Neil ST, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-310; Oberhofer G, 2014, DEVELOPMENT, V141, P4740, DOI 10.1242/dev.112797; Ozuak O, 2014, DEV GENES EVOL, V224, P223, DOI 10.1007/s00427-014-0481-0; PATEL NH, 1994, NATURE, V367, P429, DOI 10.1038/367429a0; Pauchet Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015635; Pauchet Y, 2009, INSECT BIOCHEM MOLEC, V39, P403, DOI 10.1016/j.ibmb.2009.04.001; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Schmieder R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017288; Schulz C, 1998, DEV GENES EVOL, V208, P283, DOI 10.1007/s004270050183; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Stappert D, DEVELOPMENT IN PRESS; STORK NE, 1988, BIOL J LINN SOC, V35, P321, DOI 10.1111/j.1095-8312.1988.tb00474.x; Strauss AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098637; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tosar JP, 2014, RNA, V20, P754, DOI 10.1261/rna.044263.114; Tran BMD, 1995, BIOL J LINN SOC, V56, P483, DOI 10.1111/j.1095-8312.1995.tb01106.x; Van Der Meer JM, 1977, DROS INF SERV, V52; van der Zee M, 2005, CURR BIOL, V15, P624, DOI 10.1016/j.cub.2005.02.057; Van der Zee M, 2008, DEV GENES EVOL, V218, P203, DOI 10.1007/s00427-007-0179-7; VANDERMEER JM, 1984, ROUX ARCH DEV BIOL, V193, P339, DOI 10.1007/BF00848161; VANDERMEER JM, 1979, J EMBRYOL EXP MORPH, V51, P1; Wilson MJ, 2009, DEV BIOL, V335, P276, DOI 10.1016/j.ydbio.2009.09.002; Yin A, 2015, INSECT SCI, V22, P65, DOI 10.1111/1744-7917.12092; Zhong YF, 2008, EVOL DEV, V10, P516, DOI 10.1111/j.1525-142X.2008.00266.x	66	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167431	10.1371/journal.pone.0167431	http://dx.doi.org/10.1371/journal.pone.0167431			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907180	gold, Green Published, Green Submitted			2022-12-26	WOS:000389482700155
J	Blanco-Reina, E; Garcia-Merino, MR; Ocana-Riola, R; Aguilar-Cano, L; Valdellos, J; Bellido-Estevez, I; Ariza-Zafra, G				Blanco-Reina, Encarnacion; Garcia-Merino, Maria Rosa; Ocana-Riola, Ricardo; Aguilar-Cano, Lorena; Valdellos, Jennifer; Bellido-Estevez, Inmaculada; Ariza-Zafra, Gabriel			Assessing Potentially Inappropriate Prescribing in Community-Dwelling Older Patients Using the Updated Version of STOPP-START Criteria: A Comparison of Profiles and Prevalences with Respect to the Original Version	PLOS ONE			English	Article							STOPP/START CRITERIA; SCREENING TOOL; PRIMARY-CARE; PRESCRIPTIONS/SCREENING TOOL; HOSPITALIZED-PATIENTS; ALERT DOCTORS; COST OUTCOMES; PEOPLE; POPULATION; ADULTS	Emerging and changing evidence made it necessary to update STOPP-START criteria, and version 2 was published recently. In this study the objectives were to determine the prevalence of potentially inappropriate medication prescribing (PIM) in primary care using STOPP versions 1 (v1) and 2 (v2), as well as 2012 AGS Beers criteria, and analyze the factors associated with inappropriate prescribing according to STOPP/START v2. A cross-sectional study was carried out including community-dwelling older adults over the age of 65. Socio-demographic, clinical, functional and comprehensive drug therapy data were collected. The primary endpoint was the percentage of patients receiving at least one PIM. This variable was measured using three tools: STOPP v1, 2012 AGS Beers criteria and STOPP v2. Similarly, the percentage of patients receiving at least one potential prescribing omission (PPO) was calculated using START versions 1 and 2. A total of 1,615 prescriptions were reviewed. The median number of medications per patient was 7.1 drugs (+/- 3.8). The prevalence of elderly people exposed to polypharmacy (>= 5 medications) was 72.9%, whereas 28.4% of the participants took >= 10 drugs regularly. PIM were present in 18.7%, 37.3% and 40.4% of participants, according to the STOPP v1, 2012 Beers criteria and STOPP v2, respectively. According to STOPP v2, the number of medications taken (OR: 1.14, 1.06-1.25), the presence of a psychological disorder (OR: 2.22, 1.13-4.37) and insomnia (OR: 3.35, 1.80-6.32) were risk factors for taking a PIM. The prevalence of PPOs was 34.7% and 21.8% according to version 1 and 2, respectively. In conclusion, STOPP-START criteria have been remarkably modified, which is evidenced by the different prevalence rates detected using version 2, as compared to version 1. In fact, the level of agreement between version 1 and the updated version is only moderate. Special attention should be paid on benzodiazepines, which keep being the most frequent PIM.	[Blanco-Reina, Encarnacion; Bellido-Estevez, Inmaculada] Univ Malaga, Malaga Biomed Inst IBIMA, Sch Med, Dept Pharmacol & Therapeut, Malaga, Spain; [Garcia-Merino, Maria Rosa] Hlth Dist Cordoba Sur, Cordoba, Spain; [Ocana-Riola, Ricardo] Andalusian Sch Publ Hlth, Dept Stat, Granada, Spain; [Aguilar-Cano, Lorena] Hlth Dist Malaga, Malaga, Spain; [Valdellos, Jennifer] Hlth Area Malaga Norte, Malaga, Spain; [Ariza-Zafra, Gabriel] Univ Hosp Albacete, Dept Geriatr, Albacete, Spain	Universidad de Malaga; Escuela Andaluza de Salud Publica	Blanco-Reina, E (corresponding author), Univ Malaga, Malaga Biomed Inst IBIMA, Sch Med, Dept Pharmacol & Therapeut, Malaga, Spain.	eblanco@uma.es	Estevez, Inmaculada Bellido/AAU-9222-2021; Ocaña-Riola, Ricardo/F-1576-2011	Ocaña-Riola, Ricardo/0000-0002-8965-0418; Bellido, Inmaculada/0000-0002-9362-8635; Valdellos Cabello, Jenifer/0000-0002-1034-5649; Blanco Reina, Encarnacion/0000-0001-5892-5450; Ariza-Zafra, Gabriel/0000-0001-9171-5535	Fundacion Publica Andaluza Progreso y Salud, Consejena de Salud, Junta de Andalucia [PI 0234/14]	Fundacion Publica Andaluza Progreso y Salud, Consejena de Salud, Junta de Andalucia	This research has been supported by public grant funding provided by the Fundacion Publica Andaluza Progreso y Salud, Consejena de Salud, Junta de Andalucia (grant number PI 0234/14). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahat G, 2016, GERIATR GERONTOL INT; Blanco-Reina E, 2015, EUR J CLIN PHARMACOL, V71, P199, DOI 10.1007/s00228-014-1780-0; Blanco-Reina E, 2014, J AM GERIATR SOC, V62, P1217, DOI 10.1111/jgs.12891; Bradley MC, 2012, EUR J CLIN PHARMACOL, V68, P1425, DOI 10.1007/s00228-012-1249-y; Cahir C, 2014, BRIT J CLIN PHARMACO, V77, P201, DOI 10.1111/bcp.12161; Cahir C, 2010, BRIT J CLIN PHARMACO, V69, P543, DOI 10.1111/j.1365-2125.2010.03628.x; Di Giorgio C, 2016, INT J CLIN PHARM-NET, V38, P462, DOI 10.1007/s11096-016-0284-7; Fick D, 2012, J AM GERIATR SOC, V60, P616, DOI 10.1111/j.1532-5415.2012.03923.x; Gallagher P, 2008, INT J CLIN PHARM TH, V46, P72; Gallagher P, 2011, EUR J CLIN PHARMACOL, V67, P1175, DOI 10.1007/s00228-011-1061-0; Galvin R, 2014, EUR J CLIN PHARMACOL, V70, P599, DOI 10.1007/s00228-014-1651-8; Hamilton H, 2011, ARCH INTERN MED, V171, P1013, DOI 10.1001/archinternmed.2011.215; Hedna K, 2015, EUR J CLIN PHARMACOL, V71, P1525, DOI 10.1007/s00228-015-1950-8; Hill-Taylor B, 2016, J CLIN PHARM THER, V41, P158, DOI 10.1111/jcpt.12372; Hill-Taylor B, 2013, J CLIN PHARM THER, V38, P360, DOI 10.1111/jcpt.12059; Khong TP, 2012, CALCIFIED TISSUE INT, V91, P24, DOI 10.1007/s00223-012-9603-8; Kovacevic SV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095536; Lozano-Montoya I, 2015, AGE AGEING, V44, P861, DOI 10.1093/ageing/afv079; Martinez-Almazan E, 2013, J AM GERIATR SOC, V61, P1622, DOI 10.1111/jgs.12432; Moriarty F, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008656; Moriarty F, 2015, EUR J CLIN PHARMACOL, V71, P473, DOI 10.1007/s00228-015-1815-1; O'Mahony D, 2015, AGE AGEING, V44, P213, DOI 10.1093/ageing/afu145; O'Sullivan DP, 2013, DRUG AGING, V30, P39, DOI 10.1007/s40266-012-0039-7; Lopez NP, 2014, ATEN PRIM, V46, P290, DOI 10.1016/j.aprim.2013.12.007; Projovic I, 2016, EUR J CLIN PHARMACOL, V72, P93, DOI 10.1007/s00228-015-1957-1; Ryan C, 2013, INT J CLIN PHARM-NET, V35, P230, DOI 10.1007/s11096-012-9733-0; Ryan C, 2009, BRIT J CLIN PHARMACO, V68, P936, DOI 10.1111/j.1365-2125.2009.03531.x; Tommelein E, 2015, EUR J CLIN PHARMACOL, V71, P1415, DOI 10.1007/s00228-015-1954-4; Tosato M, 2014, AGE AGEING, V43, P767, DOI 10.1093/ageing/afu029; Verdoorn S, 2015, EUR J CLIN PHARMACOL, V71, P1255, DOI 10.1007/s00228-015-1908-x	30	28	30	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167586	10.1371/journal.pone.0167586	http://dx.doi.org/10.1371/journal.pone.0167586			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3JC	27907210	gold, Green Submitted, Green Published			2022-12-26	WOS:000389482700204
J	Deuschl, C; Goericke, S; Grueneisen, J; Sawicki, LM; Goebel, J; El Hindy, N; Wrede, K; Binse, I; Poeppel, T; Quick, H; Forsting, M; Hense, J; Umutlu, L; Schlamann, M				Deuschl, Cornelius; Goericke, Sophia; Grueneisen, Johannes; Sawicki, Lino Morris; Goebel, Juliane; El Hindy, Nicolai; Wrede, Karsten; Binse, Ina; Poeppel, Thorsten; Quick, Harald; Forsting, Michael; Hense, Joerg; Umutlu, Lale; Schlamann, Marc			Simultaneous 11C-Methionine Positron Emission Tomography/Magnetic Resonance Imaging of Suspected Primary Brain Tumors	PLOS ONE			English	Article							LOW-GRADE GLIOMAS; C-11-METHIONINE PET; F-18 FLUORODEOXYGLUCOSE; RESPONSE ASSESSMENT; INTEGRATED PET/MRI; VOLUME; TOOL; HISTOPATHOLOGY; NEUROONCOLOGY; EXPERIENCES	Introduction The objective of this study was to assess the diagnostic value of integrated 11C-methionine PET/MRI for suspected primary brain tumors, in comparison to MRI alone. Material and Methods Forty-eight consecutive patients with suspected primary brain tumor were prospectively enrolled for an integrated 11C-methionine PET/MRI. Two neuro-radiologists separately evaluated the MRI alone and the integrated PET/MRI data sets regarding most likely diagnosis and diagnostic confidence on a 5-point scale. Reference standard was histopathology or follow-up imaging. Results Fifty-one suspicious lesions were detected: 16 high-grade glioma and 25 low-grade glioma. Ten non-malignant cerebral lesions were described by the reference standard. MRI alone and integrated PET/MRI each correctly classified 42 of the 51 lesions (82.4%) as neoplastic lesions (WHO grade II, III and IV) or non-malignant lesions (infectious and neoplastic lesions). Diagnostic confidence for all lesions, low-grade astrocytoma and high-grade astrocytoma (3.7 vs. 4.2, 3,1 vs. 3.8, 4.0 vs. 4,7) were significantly (p < 0.05) better with integrated PET/MRI than in MRI alone. Conclusions The present study demonstrates the high potential of integrated 11C-methionine-PET/MRI for the assessment of suspected primary brain tumors. Although integrated methionine PET/MRI does not lead to an improvement of correct diagnoses, diagnostic confidence is significantly improved.	[Deuschl, Cornelius; Goericke, Sophia; Grueneisen, Johannes; Goebel, Juliane; Forsting, Michael; Umutlu, Lale; Schlamann, Marc] Univ Hosp Essen, Inst Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany; [Deuschl, Cornelius; Quick, Harald] Univ Duisburg Essen, Erwin L Hahn Inst Magnet Resonance Imaging, Essen, Germany; [Sawicki, Lino Morris] Univ Hosp Duesseldorf, Inst Diagnost & Intervent Radiol, Dusseldorf, Germany; [El Hindy, Nicolai; Wrede, Karsten] Univ Hosp Essen, Dept Neurosurg, Essen, Germany; [Binse, Ina; Poeppel, Thorsten] Univ Hosp Essen, Dept Nucl Med, Essen, Germany; [Quick, Harald] Univ Hosp Essen, High Field & Hybrid MR Imaging, Essen, Germany; [Hense, Joerg] Univ Hosp Essen, Dept Med Oncol, West German Canc Ctr, Essen, Germany; [Schlamann, Marc] Univ Hosp Giessen, Dept Neuroradiol, Giessen, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; University Hospital of Giessen & Marburg	Deuschl, C (corresponding author), Univ Hosp Essen, Inst Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany.; Deuschl, C (corresponding author), Univ Duisburg Essen, Erwin L Hahn Inst Magnet Resonance Imaging, Essen, Germany.	cornelius.deuschl@uk-essen.de	Wrede, Karsten/AAZ-2154-2020	Wrede, Karsten/0000-0001-7076-3503; Hense, Jorg/0000-0003-4679-2026	University Duisburg-Essen	University Duisburg-Essen	An IFORES grant to CD from the University Duisburg-Essen supported the research [http://www.uni-due.de/med/forschun//forschungsfoerderung/ifores.shtml]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batra A, 2004, Australas Radiol, V48, P324, DOI 10.1111/j.0004-8461.2004.01315.x; Becherer A, 2003, EUR J NUCL MED MOL I, V30, P1561, DOI 10.1007/s00259-003-1259-1; Boss A, 2010, J NUCL MED, V51, P1198, DOI 10.2967/jnumed.110.074773; Ceyssens S, 2006, AM J NEURORADIOL, V27, P1432; Chung JK, 2002, EUR J NUCL MED MOL I, V29, P176, DOI 10.1007/s00259-001-0690-4; Delso G, 2011, J NUCL MED, V52, P1914, DOI 10.2967/jnumed.111.092726; Fan GG, 2006, BRIT J RADIOL, V79, P652, DOI 10.1259/bjr/25349497; Gumprecht HK, 1999, NEUROSURGERY, V44, P97, DOI 10.1097/00006123-199901000-00056; Hatakeyama T, 2008, EUR J NUCL MED MOL I, V35, P2009, DOI 10.1007/s00259-008-0847-5; Herholz K, 1998, NEUROLOGY, V50, P1316, DOI 10.1212/WNL.50.5.1316; Kato T, 2008, AM J NEURORADIOL, V29, P1176, DOI 10.3174/ajnr.A1008; Kobayashi K, 2015, EUR J NUCL MED MOL I, V42, P1071, DOI 10.1007/s00259-015-3046-1; Kubota K, 2001, ANN NUCL MED, V15, P471, DOI 10.1007/BF02988499; LEE YY, 1989, AM J ROENTGENOL, V152, P361, DOI 10.2214/ajr.152.2.361; Liu X, 2011, NEURO-ONCOLOGY, V13, P447, DOI 10.1093/neuonc/noq197; Mabray Marc C, 2015, Brain Tumor Res Treat, V3, P8, DOI 10.14791/btrt.2015.3.1.8; Moulin-Romsee G, 2007, EUR J NUCL MED MOL I, V34, P2082, DOI 10.1007/s00259-007-0557-4; Nariai T, 2005, J NEUROSURG, V103, P498, DOI 10.3171/jns.2005.103.3.0498; Navarria P, 2014, RADIOTHER ONCOL, V112, P425, DOI 10.1016/j.radonc.2014.09.004; Nojiri T, 2009, J NEURO-ONCOL, V93, P233, DOI 10.1007/s11060-008-9767-2; Preuss M, 2014, CHILD NERV SYST, V30, P1399, DOI 10.1007/s00381-014-2412-9; Quick HH, 2014, J MAGN RESON IMAGING, V39, P243, DOI 10.1002/jmri.24523; Sadeghi N, 2007, AM J NEURORADIOL, V28, P455; Sasaki M, 1998, EUR J NUCL MED, V25, P1261, DOI 10.1007/s002590050294; Shinozaki N, 2011, J NEUROSURG, V114, P1640, DOI 10.3171/2010.11.JNS10553; Singhal T, 2012, J NUCL MED, V53, P1709, DOI 10.2967/jnumed.111.102533; Takano K, 2016, AM J NEURORADIOL, V37, P44, DOI 10.3174/ajnr.A4460; van den Bent MJ, 2011, LANCET ONCOL, V12, P583, DOI 10.1016/S1470-2045(11)70057-2; Vogelbaum MA, 2012, NEUROSURGERY, V70, P234, DOI 10.1227/NEU.0b013e318223f5a7; Voges J, 1997, STEREOT FUNCT NEUROS, V69, P129, DOI 10.1159/000099864; Watanabe A, 2016, J NEURO-ONCOL, V126, P577, DOI 10.1007/s11060-015-2004-x; Weckesser M, 2005, EUR J NUCL MED MOL I, V32, P422, DOI 10.1007/s00259-004-1705-8; Yamamoto Y, 2008, MOL IMAGING BIOL, V10, P281, DOI 10.1007/s11307-008-0152-5	33	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167596	10.1371/journal.pone.0167596	http://dx.doi.org/10.1371/journal.pone.0167596			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907162	Green Published, gold, Green Submitted			2022-12-26	WOS:000389482700209
J	Diedhiou, AG; Mbaye, FK; Mbodj, D; Faye, MN; Pignoly, S; Ndoye, I; Djaman, K; Gaye, S; Kane, A; Laplaze, L; Manneh, B; Champion, A				Diedhiou, Abdala Gamby; Mbaye, Fatou Kine; Mbodj, Daouda; Faye, Mathieu Ndigue; Pignoly, Sarah; Ndoye, Ibrahima; Djaman, Koffi; Gaye, Souleymane; Kane, Aboubacry; Laplaze, Laurent; Manneh, Baboucarr; Champion, Antony			Field Trials Reveal Ecotype-Specific Responses to Mycorrhizal Inoculation in Rice	PLOS ONE			English	Article							PLANT-GROWTH; PHOSPHATE SOLUBILIZATION; FUNCTIONAL DIVERSITY; FUNGI; SOIL; ARCHITECTURE; ADAPTATION; ENDOPHYTES; INFECTION; NUTRIENT	The overuse of agricultural chemicals such as fertilizer and pesticides aimed at increasing crop yield results in environmental damage, particularly in the Sahelian zone where soils are fragile. Crop inoculation with beneficial soil microbes appears as a good alternative for reducing agricultural chemical needs, especially for small farmers. This, however, requires selecting optimal combinations of crop varieties and beneficial microbes tested in field conditions. In this study, we investigated the response of rice plants to inoculation with arbuscular mycorrhizal fungi (AMF) and plant growth promoting bacteria (PGPB) under screenhouse and field conditions in two consecutive seasons in Senegal. Evaluation of single and mixed inoculations with AMF and PGPB was conducted on rice (Oryza sativa) variety Sahel 202, on sterile soil under screenhouse conditions. We observed that inoculated plants, especially plants treated with AMF, grew taller, matured earlier and had higher grain yield than the non-inoculated plants. Mixed inoculation trials with two AMF strains were then conducted under irrigated field conditions with four O. sativa varieties, two O. glaberrima varieties and two interspecific NERICA varieties, belonging to 3 ecotypes (upland, irrigated, and rainfed lowland). We observed that the upland varieties had the best responses to inoculation, especially with regards to grain yield, harvest index and spikelet fertility. These results show the potential of using AMF to improve rice production with less chemical fertilizers and present new opportunities for the genetic improvement in rice to transfer the ability of forming beneficial rice-microbe associations into high yielding varieties in order to increase further rice yield potentials.	[Diedhiou, Abdala Gamby; Mbaye, Fatou Kine; Ndoye, Ibrahima; Kane, Aboubacry] Univ Cheikh Anta Diop, Fac Sci & Tech, Dept Biol Vegetale, Dakar, Senegal; [Diedhiou, Abdala Gamby; Mbaye, Fatou Kine; Mbodj, Daouda; Faye, Mathieu Ndigue; Pignoly, Sarah; Ndoye, Ibrahima; Djaman, Koffi; Gaye, Souleymane; Kane, Aboubacry; Laplaze, Laurent; Manneh, Baboucarr; Champion, Antony] Ctr Rech Bel Air, Lab Mixte Int Adaptat Plantes & Microorganismes A, Dakar, Senegal; [Diedhiou, Abdala Gamby; Mbaye, Fatou Kine; Faye, Mathieu Ndigue; Pignoly, Sarah; Ndoye, Ibrahima; Kane, Aboubacry; Laplaze, Laurent; Champion, Antony] Ctr Rech Bel Air, Lab Commun Microbiol, IRD ISRAU CAD, Dakar, Senegal; [Pignoly, Sarah; Laplaze, Laurent; Champion, Antony] IRD, UMR DIADE, Equipe CERES, Montpellier, France; [Mbodj, Daouda; Djaman, Koffi; Gaye, Souleymane; Manneh, Baboucarr] Africa Rice Ctr AfricaRice, St Louis, Senegal	University Cheikh Anta Diop Dakar; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; CGIAR; Africa Rice Center	Diedhiou, AG (corresponding author), Univ Cheikh Anta Diop, Fac Sci & Tech, Dept Biol Vegetale, Dakar, Senegal.; Diedhiou, AG; Laplaze, L (corresponding author), Ctr Rech Bel Air, Lab Mixte Int Adaptat Plantes & Microorganismes A, Dakar, Senegal.; Diedhiou, AG; Laplaze, L (corresponding author), Ctr Rech Bel Air, Lab Commun Microbiol, IRD ISRAU CAD, Dakar, Senegal.; Laplaze, L (corresponding author), IRD, UMR DIADE, Equipe CERES, Montpellier, France.	abdala.diedhiou@ucad.edu.sn; laurent.laplaze@ird.fr	Champion, Antony/E-4148-2015; Laplaze, Laurent/I-5435-2016; DIALLO, Sara/N-4362-2018	Champion, Antony/0000-0002-3731-1510; Laplaze, Laurent/0000-0002-6568-6504; DIALLO, Sara/0000-0003-1891-9982; DIEDHIOU, Abdala Gamby/0000-0002-1790-6883	IRD; Senegalese Ministere de l'Enseignement Superieur et de la Recherche from the Fonds d'Impulsion de la Recherche Scientifique et Technique	IRD; Senegalese Ministere de l'Enseignement Superieur et de la Recherche from the Fonds d'Impulsion de la Recherche Scientifique et Technique	This work was supported by IRD and the Senegalese Ministere de l'Enseignement Superieur et de la Recherche through a grant from the Fonds d'Impulsion de la Recherche Scientifique et Technique (FIRST 2014).	Ahmadi N, 2014, RICE, V7, DOI 10.1186/s12284-014-0029-y; Artursson V, 2006, ENVIRON MICROBIOL, V8, P1, DOI 10.1111/j.1462-2920.2005.00942.x; BARBER DA, 1976, NEW PHYTOL, V76, P69, DOI 10.1111/j.1469-8137.1976.tb01439.x; Bhattacharyya PN, 2012, WORLD J MICROB BIOT, V28, P1327, DOI 10.1007/s11274-011-0979-9; Bonfante P, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1046; BRYLA DR, 1990, OECOLOGIA, V84, P74, DOI 10.1007/BF00665598; Cartieaux F, 2008, MOL PLANT MICROBE IN, V21, P244, DOI 10.1094/MPMI-21-2-0244; Cavagnaro TR, 2005, PLANT CELL ENVIRON, V28, P642, DOI 10.1111/j.1365-3040.2005.01310.x; Chaintreuil C, 2000, APPL ENVIRON MICROB, V66, P5437, DOI 10.1128/AEM.66.12.5437-5447.2000; Davison J, 2015, SCIENCE, V349, P970, DOI 10.1126/science.aab1161; Dobermann A, 2004, SCOPE SER, V65, P261; Dodd IC, 2012, CURR OPIN BIOTECH, V23, P236, DOI 10.1016/j.copbio.2011.09.005; Dupuy N, 1992, INTERACTIONS PLANTES, P371; Food and Agriculture Organization of the United Nations. FAOSTAT, 2013, FAOSTAT PRODUCTION I; Franche C, 2009, PLANT SOIL, V321, P35, DOI 10.1007/s11104-008-9833-8; Gamalero E, 2011, BACTERIA IN AGROBIOLOGY: PLANT NUTRIENT MANAGEMENT, P17, DOI 10.1007/978-3-642-21061-7_2; GERDEMANN J. W., 1963, TRANS BRIT MYCOL SOC, V46, P235; Gutjahr C, 2009, NEW PHYTOL, V182, P829, DOI 10.1111/j.1469-8137.2009.02839.x; Hardoim PR, 2008, TRENDS MICROBIOL, V16, P463, DOI 10.1016/j.tim.2008.07.008; Harper J. L., 1974, Annual Review of Ecology and Systematics, V5, P419, DOI 10.1146/annurev.es.05.110174.002223; HETRICK BAD, 1991, CAN J BOT, V69, P112, DOI 10.1139/b91-016; Hrynkiewicz K, 2012, STRAT SUSTAIN, P35, DOI 10.1007/978-94-007-1591-2_2; Khush G, 2003, NUTR REV, V61, pS114, DOI 10.1301/nr.2003.jun.S114-S116; Koide RT, 2010, ARBUSCULAR MYCORRHIZAS: PHYSIOLOGY AND FUNCTION, P297, DOI 10.1007/978-90-481-9489-6_14; Kruger M, 2012, NEW PHYTOL, V193, P970, DOI 10.1111/j.1469-8137.2011.03962.x; Lafitte HR, 2001, FIELD CROP RES, V71, P57, DOI 10.1016/S0378-4290(01)00150-2; Lioussanne L, 2010, SPAN J AGRIC RES, V8, pS51; LU XH, 1994, NEW PHYTOL, V128, P211, DOI 10.1111/j.1469-8137.1994.tb04004.x; Malakoff D, 1998, SCIENCE, V281, P190, DOI 10.1126/science.281.5374.190; McDowell RW, 2001, NUTR CYCL AGROECOSYS, V59, P269, DOI 10.1023/A:1014419206761; Miller SH, 2010, ENV MICROBIOL REP, V2, P403, DOI 10.1111/j.1758-2229.2009.00105.x; Parniske M, 2008, NAT REV MICROBIOL, V6, P763, DOI 10.1038/nrmicro1987; Perez-Montano F, 2014, MICROBIOL RES, V169, P325, DOI 10.1016/j.micres.2013.09.011; PHILLIPS JM, 1970, T BRIT MYCOL SOC, V55, P158, DOI 10.1016/S0007-1536(70)80110-3; Poulton JL, 2002, NEW PHYTOL, V154, P255, DOI 10.1046/j.1469-8137.2002.00366.x; Poussin JC, 2003, EUR J AGRON, V19, P341, DOI 10.1016/S1161-0301(02)00078-3; Read DJ, 2003, NEW PHYTOL, V157, P475, DOI 10.1046/j.1469-8137.2003.00704.x; Rodriguez H, 2004, NATURWISSENSCHAFTEN, V91, P552, DOI 10.1007/s00114-004-0566-0; Rodriguez R, 2008, J EXP BOT, V59, P1109, DOI 10.1093/jxb/erm342; Rodriguez-Echeverria S, 2016, NEW PHYTOL; Rua MA, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0698-9; Ruiz-Sanchez M, 2011, J PLANT PHYSIOL, V168, P1031, DOI 10.1016/j.jplph.2010.12.019; Santi C, 2013, ANN BOT-LONDON, V111, P743, DOI 10.1093/aob/mct048; Schultz PA, 2001, AM J BOT, V88, P1650, DOI 10.2307/3558410; Selosse MA, 2011, SCIENCE, V333, P828, DOI 10.1126/science.1210722; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Sweeney M, 2007, ANN BOT-LONDON, V100, P951, DOI 10.1093/aob/mcm128; Trebuil G, 2004, LE RIZ ENJEUX ECOLOG; Trouvelot A, 1986, PHYSIOLOGICAL GENETI, P217, DOI DOI 10.1177/004057368303900411; Verbruggen E, 2010, EVOL APPL, V3, P547, DOI 10.1111/j.1752-4571.2010.00145.x; WACEK TJ, 1976, CROP SCI, V16, P519, DOI 10.2135/cropsci1976.0011183X001600040020x; Wang L, 2012, ADV INTEL SOFT COMPU, V134, P935; Wopereis-Pura MM, 2002, EUR J AGRON, V17, P191, DOI 10.1016/S1161-0301(02)00009-6; Yoshida S., 1981, FUNDAMENTALS OF RICE	54	16	16	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167014	10.1371/journal.pone.0167014	http://dx.doi.org/10.1371/journal.pone.0167014			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907023	Green Published, Green Submitted, gold			2022-12-26	WOS:000389482700063
J	Giles, C; Takechi, R; Mellett, NA; Meikle, PJ; Dhaliwal, S; Mamo, JC				Giles, Corey; Takechi, Ryusuke; Mellett, Natalie A.; Meikle, Peter J.; Dhaliwal, Satvinder; Mamo, John C.			The Effects of Long-Term Saturated Fat Enriched Diets on the Brain Lipidome	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; WILD-TYPE MICE; ALZHEIMERS-DISEASE; INSULIN-RESISTANCE; DOCOSAHEXAENOIC ACID; OXIDATIVE STRESS; BARRIER DYSFUNCTION; EPISODIC MEMORY; NERVOUS-SYSTEM; WHITE-MATTER	The brain is highly enriched in lipids, where they influence neurotransmission, synaptic plasticity and inflammation. Non-pathological modulation of the brain lipidome has not been previously reported and few studies have investigated the interplay between plasma lipid homeostasis relative to cerebral lipids. This study explored whether changes in plasma lipids induced by chronic consumption of a well-tolerated diet enriched in saturated fatty acids (SFA) was associated with parallel changes in cerebral lipid homeostasis. Male C57Bl/6 mice were fed regular chow or the SFA diet for six months. Plasma, hippocampus (HPF) and cerebral cortex (CTX) lipids were analysed by LC-ESI-MS/MS. A total of 348 lipid species were determined, comprising 25 lipid classes. The general abundance of HPF and CTX lipids was comparable in SFA fed mice versus controls, despite substantial differences in plasma lipid-class abundance. However, significant differences in 50 specific lipid species were identified as a consequence of SFA treatment, restricted to phosphatidylcholine (PC), phosphatidylethanolamine (PE), alkyl-PC, alkenyl-PC, alkyl-PE, alkenyl-PE, cholesterol ester (CE), diacylglycerol (DG), phosphatidylinositol (PI) and phosphatidylserine (PS) classes. Partial least squares regression of the HPF/CTX lipidome versus plasma lipidome revealed the plasma lipidome could account for a substantial proportion of variation. The findings demonstrate that cerebral abundance of specific lipid species is strongly associated with plasma lipid homeostasis.	[Giles, Corey; Takechi, Ryusuke; Mamo, John C.] Curtin Univ, Curtin Hlth Innovat Res Inst, Perth, WA, Australia; [Giles, Corey; Takechi, Ryusuke; Dhaliwal, Satvinder; Mamo, John C.] Curtin Univ, Fac Hlth Sci, Sch Publ Hlth, Perth, WA, Australia; [Mellett, Natalie A.; Meikle, Peter J.] Baker IDI Heart & Diabet Inst, Metabol Lab, Melbourne, Vic, Australia	Curtin University; Curtin University; Baker Heart and Diabetes Institute	Mamo, JC (corresponding author), Curtin Univ, Curtin Hlth Innovat Res Inst, Perth, WA, Australia.; Mamo, JC (corresponding author), Curtin Univ, Fac Hlth Sci, Sch Publ Hlth, Perth, WA, Australia.	J.Mamo@curtin.edu.au	Giles, Corey/AAM-9003-2020; Takechi, Ryusuke/D-3692-2012; Takechi, Ryu/T-9970-2019	Giles, Corey/0000-0002-6050-1259; Takechi, Ryusuke/0000-0001-6359-3382; Takechi, Ryu/0000-0001-6359-3382; Mamo, John/0000-0002-5741-7849; Meikle, Peter/0000-0002-2593-4665	Australian National Health and Medical Research Council [1064567]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	JM acknowledges the Australian National Health and Medical Research Council (www.nhmrc.gov.au) Project grant 1064567. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal R, 2012, J PHYSIOL-LONDON, V590, P2485, DOI 10.1113/jphysiol.2012.230078; Alles B, 2012, NUTR RES REV, V25, P207, DOI 10.1017/S0954422412000133; Aung HH, 2016, J LIPID RES, V57, P955, DOI 10.1194/jlr.M061853; Bascoul-Colombo C, 2016, BBA-MOL CELL BIOL L, V1861, P524, DOI 10.1016/j.bbalip.2016.03.005; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benoit SC, 2009, J CLIN INVEST, V119, P2577, DOI 10.1172/JCI36714; Borg ML, 2012, J PHYSIOL-LONDON, V590, P4377, DOI 10.1113/jphysiol.2012.233288; Breteler MMB, 2000, NEUROBIOL AGING, V21, P153, DOI 10.1016/S0197-4580(99)00110-4; Brites P, 2004, BBA-MOL CELL BIOL L, V1636, P219, DOI 10.1016/j.bbalip.2003.12.010; Carrie I, 2000, J LIPID RES, V41, P465; Cermenati G, 2015, BBA-MOL CELL BIOL L, V1851, P51, DOI 10.1016/j.bbalip.2014.08.011; Chan RB, 2012, J BIOL CHEM, V287, P2678, DOI 10.1074/jbc.M111.274142; Chen CT, 2008, PROSTAG LEUKOTR ESS, V79, P85, DOI 10.1016/j.plefa.2008.09.003; Cheng ML, 2016, J NUTR BIOCHEM, V31, P38, DOI 10.1016/j.jnutbio.2015.12.001; Chetelat G, 2003, BRAIN, V126, P1955, DOI 10.1093/brain/awg196; Cunnane SC, 2013, PROSTAG LEUKOTR ESS, V88, P61, DOI 10.1016/j.plefa.2012.04.006; Cunnane SC, 2012, J ALZHEIMERS DIS, V29, P691, DOI 10.3233/JAD-2012-110629; Cutler RG, 2004, P NATL ACAD SCI USA, V101, P2070, DOI 10.1073/pnas.0305799101; Dehouck B, 1997, J CELL BIOL, V138, P877, DOI 10.1083/jcb.138.4.877; Edmond J, 2001, J MOL NEUROSCI, V16, P181, DOI 10.1385/JMN:16:2-3:181; Elahy M, 2015, IMMUN AGEING, V12, DOI 10.1186/s12979-015-0029-9; Folch-Fortuny A, 2015, CHEMOMETR INTELL LAB, V146, P77, DOI 10.1016/j.chemolab.2015.05.006; Goodenowe DB, 2007, J LIPID RES, V48, P2485, DOI 10.1194/jlr.P700023-JLR200; Greenwood CE, 2001, NEUROBIOL LEARN MEM, V75, P179, DOI 10.1006/nlme.2000.3964; Guan ZQ, 2009, J CHROMATOGR B, V877, P2814, DOI 10.1016/j.jchromb.2009.03.002; Guan ZZ, 1999, J NEUROPATH EXP NEUR, V58, P740, DOI 10.1097/00005072-199907000-00008; Han XL, 2010, BBA-MOL CELL BIOL L, V1801, P774, DOI 10.1016/j.bbalip.2010.01.010; Herrero A, 2001, MECH AGEING DEV, V122, P427, DOI 10.1016/S0047-6374(01)00214-7; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Holland WL, 2011, J CLIN INVEST, V121, P1858, DOI 10.1172/JCI43378; Horrocks LA, 2004, PROSTAG LEUKOTR ESS, V70, P361, DOI 10.1016/j.plefa.2003.12.011; Hsu TM, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00088; Kaduk M, 2014, J CHROMATOGR B, V966, P93, DOI 10.1016/j.jchromb.2014.04.048; Kalmijn S, 1997, ANN NEUROL, V42, P776, DOI 10.1002/ana.410420514; Kanoski SE, 2011, PHYSIOL BEHAV, V103, P59, DOI 10.1016/j.physbeh.2010.12.003; Kim HW, 2011, PROSTAG LEUKOTR ESS, V85, P361, DOI 10.1016/j.plefa.2011.08.002; Kramer JH, 2005, NEUROPSYCHOLOGY, V19, P799, DOI 10.1037/0894-4105.19.6.799; Lagarde M, 2001, J MOL NEUROSCI, V16, P201, DOI 10.1385/JMN:16:2-3:201; Lam SM, 2014, NEUROBIOL AGING, V35, P2369, DOI 10.1016/j.neurobiolaging.2014.02.025; Le Cao K.-A., 2015, MIXOMICS OMICS DATA; Lepinay AL, 2015, PSYCHONEUROENDOCRINO, V53, P82, DOI 10.1016/j.psyneuen.2014.12.008; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Lyn-Cook LE, 2009, J ALZHEIMERS DIS, V16, P715, DOI 10.3233/JAD-2009-0984; Meikle PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074341; Mielke MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073094; Mielke MM, 2012, NEUROLOGY, V79, P633, DOI 10.1212/WNL.0b013e318264e380; Mielke MM, 2011, J ALZHEIMERS DIS, V27, P259, DOI 10.3233/JAD-2011-110405; Moraes JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005045; Morris MC, 2014, NEUROBIOL AGING, V35, pS59, DOI 10.1016/j.neurobiolaging.2014.03.038; Muller CP, 2015, BBA-MOL CELL BIOL L, V1851, P1052, DOI 10.1016/j.bbalip.2014.12.014; Naudi A, 2015, INT REV NEUROBIOL, V122, P133, DOI 10.1016/bs.irn.2015.05.008; OBRIEN JS, 1965, J LIPID RES, V6, P537; Oh H, 2013, BRAIN RES, V1537, P191, DOI 10.1016/j.brainres.2013.09.025; Pipatpiboon N, 2013, EUR J NEUROSCI, V37, P839, DOI 10.1111/ejn.12088; Posey KA, 2009, AM J PHYSIOL-ENDOC M, V296, pE1003, DOI 10.1152/ajpendo.90377.2008; Quehenberger O, 2010, J LIPID RES, V51, P3299, DOI 10.1194/jlr.M009449; R_Core_Team, 2015, R LANG ENV STAT COMP; Rabiei Z, 2013, CURR NEUROVASC RES, V10, P231, DOI 10.2174/15672026113109990007; Rubingh CM, 2006, METABOLOMICS, V2, P53, DOI 10.1007/s11306-006-0022-6; Schaefer EJ, 2006, ARCH NEUROL-CHICAGO, V63, P1545, DOI 10.1001/archneur.63.11.1545; Sparks DL, 2000, ANN NY ACAD SCI, V903, P335, DOI 10.1111/j.1749-6632.2000.tb06384.x; Sprecher H, 2001, J MOL NEUROSCI, V16, P215; Stenvinkel P, 2004, NEPHROL DIAL TRANSPL, V19, P972, DOI 10.1093/ndt/gfh035; Steyerberg EW, 2003, J CLIN EPIDEMIOL, V56, P441, DOI 10.1016/S0895-4356(03)00047-7; Stranahan AM, 2011, J NEUROCHEM, V118, P611, DOI 10.1111/j.1471-4159.2011.07351.x; Sun GY, 2004, J LIPID RES, V45, P205, DOI 10.1194/jlr.R300016-JLR200; Szymanska E, 2012, METABOLOMICS, V8, pS3, DOI 10.1007/s11306-011-0330-3; Taha AY, 2016, PROSTAG LEUKOTR ESS, V105, P26, DOI 10.1016/j.plefa.2015.12.002; Takechi R, 2013, NEURODEGENER DIS, V12, P125, DOI 10.1159/000343211; Takechi R, 2013, CLIN EXP PHARMACOL P, V40, P45, DOI 10.1111/1440-1681.12032; Tu WC, 2013, PROSTAG LEUKOTR ESS, V88, P53, DOI 10.1016/j.plefa.2012.04.005; van de Haar HJ, 2016, RADIOLOGY, V281, P527, DOI 10.1148/radiol.2016152244; Weir JM, 2013, J LIPID RES, V54, P2898, DOI 10.1194/jlr.P035808; Wood PL, 2015, ACTA NEUROPSYCHIATR, V27, P270, DOI 10.1017/neu.2015.18; Wood PL, 2010, J PSYCHIATR NEUROSCI, V35, P59, DOI 10.1503/jpn.090059; Yu HL, 2010, INT J DEV NEUROSCI, V28, P271, DOI 10.1016/j.ijdevneu.2009.12.001	76	25	25	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166964	10.1371/journal.pone.0166964	http://dx.doi.org/10.1371/journal.pone.0166964			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907021	gold, Green Published			2022-12-26	WOS:000389482700056
J	Prasad, R; Hochmuth, GJ				Prasad, Rishi; Hochmuth, George J.			Environmental Nitrogen Losses from Commercial Crop Production Systems in the Suwannee River Basin of Florida	PLOS ONE			English	Article							NORTH CHINA PLAIN; AMMONIA VOLATILIZATION; SURFACE APPLICATION; GROUNDWATER; GRASSLAND; POTATO; MANAGEMENT; BUDGETS; SLURRY; MANURE	The springs and the Suwannee river of northern Florida in Middle Suwanee River Basin (MSRB) are among several examples in this planet that have shown a temporal trend of increasing nitrate concentration primarily due to the impacts of non-point sources such as agriculture. The rate of nitrate increase in the river as documented by Ham and Hatzell (1996) was 0.02 mg N L-1 y(-1). Best management practices (BMPs) for nutrients were adopted by the commercial farms in the MSRB region to reduce the amounts of pollutants entering the water bodies, however the effectiveness of BMPs remains a topic of interest and discussion among the researchers, environmental administrators and policy makers about the loads of nitrogen entering into groundwater and river systems. Through this study, an initiative was taken to estimate nitrogen losses into the environment from commercial production systems of row and vegetable crops that had adopted BMPs and were under a presumption of compliance with state water quality standards. Nitrogen mass budget was constructed by quantifying the N sources and sinks for three crops (potato (Solanum tuberosum L.), sweet corn (Zea mays L.) and silage corn (Zea mays L.)) over a four year period (2010-2013) on a large representative commercial farm in northern Florida. Fertilizer N was found to be the primary N input and represented 98.0 +/- 1.4, 91.0 +/- 13.9, 78.0 +/- 17.3% of the total N input for potato, sweet corn, and silage corn, respectively. Average crop N uptake represented 55.5%, 60.5%, and 65.2% of the mean total input N whereas average mineral N left in top 0.3 m soil layer at harvest represented 9.1%, 4.5%, and 2.6% of the mean total input N. Mean environmental N losses represented 35.3%, 34.3%, and 32.7% of the mean total input N for potato, sweet corn, and silage corn, respectively. Nitrogen losses showed a linear trend with increase in N inputs. Although, there is no quick fix for controlling N losses from crop production in MSRB, the strategies to reduce N losses must focus on managing the crop residues, using recommended fertilizer rates, and avoiding late-season application of nitrogen.	[Prasad, Rishi; Hochmuth, George J.] Univ Florida, Inst Food & Agr Sci, Soil & Water Sci Dept, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Prasad, R (corresponding author), Univ Florida, Inst Food & Agr Sci, Soil & Water Sci Dept, Gainesville, FL 32611 USA.	rprasad3@ufl.edu			Florida Department of Agriculture and Consumer Services; Florida Department of Environmental Protection; Suwannee River Water Management District;  [015765]	Florida Department of Agriculture and Consumer Services; Florida Department of Environmental Protection; Suwannee River Water Management District; 	Funding was provided by Grant no:015765. Funding agencies: Florida Department of Agriculture and Consumer Services, Florida Department of Environmental Protection, Suwannee River Water Management District. GH received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andraski TW, 1999, AGR ABSTR, P244; [Anonymous], 2000, EOS, DOI [DOI 10.1029/00E000244, DOI 10.1029/00EO00244]; Asci S, 2013, FLORIDA WATERSHED J, P104; Autry LP, 2003, EPA600R04003; BENNETT JM, 1989, FIELD CROP RES, V19, P297, DOI 10.1016/0378-4290(89)90100-7; Bundy LG, 2005, SOIL SCI SOC AM J, V69, P640, DOI 10.2136/sssaj2004.0216; Clean Air Status and Trends Network (CASTNET), 2014, WET DEP; Eichler F, 1998, ENVIRON POLLUT, V102, P609, DOI 10.1016/S0269-7491(98)80089-4; Errebhi M, 1998, AGRON J, V90, P10, DOI 10.2134/agronj1998.00021962009000010003x; Errebhi M, 1998, COMMUN SOIL SCI PLAN, V29, P23, DOI 10.1080/00103629809369926; Fernald E. A., 1998, WATER RESOURCES ATLA; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Ham LK, 1996, 964037 INV US GEOL S; Hellmuth R, 2013, THESIS; Hornsby D, 2007, THESIS; Huijsmans JFM, 2001, NETH J AGR SCI, V49, P323, DOI 10.1016/S1573-5214(01)80021-X; Institute of Food and Agricultural Sciences-University of Florida (IFAS-UF), 2006, CITR BMPS; Ju XT, 2006, ENVIRON POLLUT, V143, P117, DOI 10.1016/j.envpol.2005.11.005; Katz BG, 1999, 994252 US GEO SURV; Katz BG, 2000, 004210  US GEOL SURV; Kraft GJ, 2003, AGR ECOSYST ENVIRON, V100, P63, DOI 10.1016/S0167-8809(03)00172-5; Li YC, 2002, COMMUN SOIL SCI PLAN, V33, P1671, DOI 10.1081/CSS-120004307; Liu GD, 2015, VEGETABLE PRODUCTION, pCV296; Liu XJ, 2003, FIELD CROP RES, V83, P111, DOI 10.1016/S0378-4290(03)00068-6; Mylavarapu RS, 2009, 1248 COOP EXT SERV; Mylavarapu RS, 2015, UF FAS STAND FERT RE; National Atmospheric Deposition Program (NADP), 2011, NADP PROGR OFF ILL S; Obreza Tom, 2006, CHARACTERIZING AGR F; Oenema O, 2003, EUR J AGRON, V20, P3, DOI 10.1016/S1161-0301(03)00067-4; Peters J, 2003, PUBLICATION A U WISC; Pfluke PD, 2011, J ENVIRON QUAL, V40, P374, DOI 10.2134/jeq2010.0102; Pittman JR, 1997, 974152 US GEOL SURV; Prasad R., 2015, UNDERSTANDING NITROG; Prasad R., 2014, THESIS; Prasad R, 2014, CALCULATE PARTIAL NI; Prasad R, 2015, UNDERSTANDING AVAILA; Prasad R, 2015, ANAEROBIC DIGESTERS; Prasad R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117891; SAS Institute Incorporation, 2012, SAS 9 3 MICR WIND OP; Shrestha RK, 2010, AM J POTATO RES, V87, P229, DOI 10.1007/s12230-010-9131-x; Suwannee River Water Management District (SRWMD), 2010, POT SURF MAP; THOMPSON RB, 1990, PLANT SOIL, V125, P119, DOI 10.1007/BF00010751; THOMPSON RB, 1987, J SOIL SCI, V38, P689, DOI 10.1111/j.1365-2389.1987.tb02166.x; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Upchurch SB, 2007, 3017076 SD 2 GLOB CO	45	14	14	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167558	10.1371/journal.pone.0167558	http://dx.doi.org/10.1371/journal.pone.0167558			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907130	Green Published, gold, Green Submitted			2022-12-26	WOS:000389482700194
J	Moyer-Horner, L; Beever, EA; Johnson, DH; Biel, M; Belt, J				Moyer-Horner, Lucas; Beever, Erik A.; Johnson, Douglas H.; Biel, Mark; Belt, Jami			Predictors of Current and Longer-Term Patterns of Abundance of American Pikas (Ochotona princeps) across a Leading- Edge Protected Area	PLOS ONE			English	Article							CLIMATE-CHANGE; BEHAVIORAL THERMOREGULATION; POPULATION-DENSITY; NATIONAL-PARK; RANGE SHIFTS; GREAT-BASIN; GENE FLOW; COMMUNITIES; RESPONSES; TRENDS	American pikas (Ochotona princeps) have been heralded as indicators of montane-mammal response to contemporary climate change. Pikas no longer occupy the driest and lowest-elevation sites in numerous parts of their geographic range. Conversely, pikas have exhibited higher rates of occupancy and persistence in Rocky Mountain and Sierra Nevada montane 'mainlands'. Research and monitoring efforts on pikas across the western USA have collectively shown the nuance and complexity with which climate will often act on species in diverse topographic and climatic contexts. However, to date no studies have investigated habitat, distribution, and abundance of pikas across hundreds of sites within a remote wilderness area. Additionally, relatively little is known about whether climate acts most strongly on pikas through direct or indirect (e.g., vegetation-mediated) mechanisms. During 2007-2009, we collectively hiked > 16,000 km throughout the 410,077-ha Glacier National Park, Montana, USA, in an effort to identify topographic, microrefugial, and vegetative characteristics predictive of pika abundance. We identified 411 apparently pika-suitable habitat patches with binoculars (in situ), and surveyed 314 of them for pika signs. Ranking of alternative logistic-regression models based on AIC(c) scores revealed that short-term pika abundances were positively associated with intermediate elevations, greater cover of mosses, and taller forbs, and decreased each year, for a total decline of 68% during the three-year study; whereas longer-term abundances were associated only with static variables (longitude, elevation, gradient) and were lower on north-facing slopes. Earlier Julian date and time of day of the survey (i.e., midday vs. not) were associated with lower observed pika abundance. We recommend that wildlife monitoring account for this seasonal and diel variation when surveying pikas. Broad-scale information on status and abundance determinants of montane mammals, especially for remote protected areas, is crucial for land and wildlife-resource managers trying to anticipate mammalian responses to climate change.	[Moyer-Horner, Lucas] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Beever, Erik A.] US Geol Survey, Northern Rocky Mt Sci Ctr, Bozeman, MT USA; [Beever, Erik A.] Montana State Univ, Dept Ecol, Bozeman, MT 59717 USA; [Johnson, Douglas H.] US Geol Survey, Northern Prairie Wildlife Res Ctr, St Paul, MN USA; [Johnson, Douglas H.] Univ Minnesota, Fisheries Wildlife & Conservat Biol Dept, St Paul, MN 55108 USA; [Biel, Mark] Natl Pk Serv, Glacier Natl Pk, West Glacier, MT USA; [Belt, Jami] Natl Pk Serv, Klondike Gold Rush Natl Hist Pk, Skagway, AK USA	Utah System of Higher Education; University of Utah; United States Department of the Interior; United States Geological Survey; Montana State University System; Montana State University Bozeman; United States Department of the Interior; United States Geological Survey; University of Minnesota System; University of Minnesota Twin Cities; United States Department of the Interior; United States Department of the Interior	Moyer-Horner, L (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	Lrmhorner@gmail.com	Beever, Erik/Q-3869-2019	Beever, Erik/0000-0002-9369-486X	Glacier National Park Conservancy	Glacier National Park Conservancy	LMH received funding in support of this work from the Glacier National Park Conservancy (https://www.glacierconservaocy.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancillotto L, 2016, SCI NAT-HEIDELBERG, V103, DOI 10.1007/s00114-016-1334-7; [Anonymous], 2008, ESRI ARCGIS GIS SOFT; Barnard P, 2008, BIOL LETTERS, V4, P553, DOI 10.1098/rsbl.2008.0374; Beaugrand G, 2015, PHILOS T ROYAL SOC B, V370; Beever E. A, 2002, PARK SCI, V21, P23; Beever EA, 2003, J MAMMAL, V84, P37, DOI 10.1644/1545-1542(2003)084<0037:POAEAI>2.0.CO;2; Beever EA, J MAMMALOGY IN PRESS; Beever EA, 2008, WEST N AM NATURALIST, V68, P8, DOI 10.3398/1527-0904(2008)68[8:APOPIN]2.0.CO;2; Beever EA, 2013, ECOLOGY, V94, P1563, DOI 10.1890/12-2174.1; Beever EA, 2011, GLOBAL CHANGE BIOL, V17, P2054, DOI 10.1111/j.1365-2486.2010.02389.x; Beever EA, 2010, ECOL APPL, V20, P164, DOI 10.1890/08-1011.1; Beniston M, 2003, CLIMATIC CHANGE, V59, P5, DOI 10.1023/A:1024458411589; BROWN RN, 1989, J MAMMAL, V70, P622, DOI 10.2307/1381435; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cahill AE, 2012, P ROYAL SOC B, V280; Calkins MT, 2012, ECOGRAPHY, V35, P780, DOI 10.1111/j.1600-0587.2011.07227.x; Castillo JA, 2016, ECOL APPL, V26, P1660, DOI 10.1890/15-1452.1; Castillo JA, 2014, MOL ECOL, V23, P843, DOI 10.1111/mec.12650; CONNER DA, 1983, CAN J ZOOL, V61, P411, DOI 10.1139/z83-054; Dearing MD, 1997, J MAMMAL, V78, P1156, DOI 10.2307/1383058; Diaz HF, 2003, CLIMATIC CHANGE, V59, P1, DOI 10.1023/A:1024416227887; Erb LP, 2014, ECOL APPL, V24, P429, DOI 10.1890/13-1072.1; Erb LP, 2011, ECOLOGY, V92, P1730, DOI 10.1890/11-0175.1; Galbreath KE, 2009, EVOLUTION, V63, P2848, DOI 10.1111/j.1558-5646.2009.00803.x; Grayson DK, 2005, J BIOGEOGR, V32, P2103, DOI 10.1111/j.1365-2699.2005.01341.x; Grinnell J, 1917, AM NAT, V51, P115, DOI 10.1086/279591; HAFNER DJ, 1993, QUATERNARY RES, V39, P373, DOI 10.1006/qres.1993.1044; HAFNER DJ, 1994, ARCTIC ALPINE RES, V26, P375, DOI 10.2307/1551799; Hall MHP, 2003, BIOSCIENCE, V53, P131, DOI 10.1641/0006-3568(2003)053[0131:MCIGCI]2.0.CO;2; Hijmans RJ, 2006, GLOBAL CHANGE BIOL, V12, P2272, DOI 10.1111/j.1365-2486.2006.01256.x; HUNTLY NJ, 1987, ECOLOGY, V68, P274, DOI 10.2307/1939258; HUNTLY NJ, 1986, J MAMMAL, V67, P139, DOI 10.2307/1381010; Jackson ST, 2000, PALEOBIOLOGY, V26, P194, DOI 10.1666/0094-8373(2000)26[194:ROPPAC]2.0.CO;2; Jeffress MR, 2013, ECOL APPL, V23, P864, DOI 10.1890/12-0979.1; Kelly AE, 2008, P NATL ACAD SCI USA, V105, P11823, DOI 10.1073/pnas.0802891105; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Krear H.R., 1965, ECOLOGICAL ETHOLOGIC; Kreuzer MP, 2003, OECOLOGIA, V134, P343, DOI 10.1007/s00442-002-1145-8; Lyons SK, 2003, J MAMMAL, V84, P385, DOI 10.1644/1545-1542(2003)084<0385:AQAOTR>2.0.CO;2; MACARTHUR RA, 1974, CAN J ZOOL, V52, P353, DOI 10.1139/z74-042; MACARTHUR RA, 1973, CAN J ZOOL, V51, P11, DOI 10.1139/z73-002; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Manning T, 2011, WEST N AM NATURALIST, V71, P106, DOI 10.3398/064.071.0114; Martinez-Meyer E, 2004, GLOBAL ECOL BIOGEOGR, V13, P305, DOI 10.1111/j.1466-822X.2004.00107.x; Millar CI, 2010, ARCT ANTARCT ALP RES, V42, P76, DOI 10.1657/1938-4246-42.1.76; MILLAR J S, 1973, Canadian Field-Naturalist, V87, P457; MILLAR J S, 1972, Mammalia, V36, P657, DOI 10.1515/mamm.1972.36.4.657; Minder JR, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013493; Mori E, 2013, ITAL J ZOOL, V80, P469, DOI 10.1080/11250003.2013.857729; Moritz C, 2008, SCIENCE, V322, P261, DOI 10.1126/science.1163428; Morrison SF, 2007, J ANIM ECOL, V76, P899, DOI 10.1111/j.1365-2656.2007.01276.x; Mote PW, 2012, ECOLOGICAL CONSEQUEN; Moyer-Horner L, 2015, ECOL EVOL, V5, pS810, DOI 10.1002/ece3.1848; Moyer-Horner L, 2012, J WILDLIFE MANAGE, V76, P1472, DOI 10.1002/jwmg.373; Oyler JW, 2015, GEOPHYS RES LETT, V42, P153, DOI 10.1002/2014GL062803; Peacock MM, 1997, MOL ECOL, V6, P801; Pepin NC, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034026; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; Rapacciuolo G, 2014, GLOBAL CHANGE BIOL, V20, P2841, DOI 10.1111/gcb.12638; Raphael MG, 2001, FOREST ECOL MANAG, V153, P63, DOI 10.1016/S0378-1127(01)00454-6; Ray C., 2007, DISTRIBUTION ABUNDAN; Ray C, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1379; Rodhouse TJ, 2010, J MAMMAL, V91, P1287, DOI 10.1644/09-MAMM-A-334.1; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Rowe KC, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.1857; Schwalm D, 2016, GLOBAL CHANGE BIOL, V22, P1572, DOI 10.1111/gcb.13189; Scott JM, 2001, ECOL APPL, V11, P999, DOI 10.1890/1051-0761(2001)011[0999:NRDTCT]2.0.CO;2; Sekercioglu CH, 2008, CONSERV BIOL, V22, P140, DOI 10.1111/j.1523-1739.2007.00852.x; Simpson WG, 2009, WEST N AM NATURALIST, V69, P243, DOI 10.3398/064.069.0213; SMITH A T, 1990, Mammalian Species, P1, DOI 10.2307/3504319; SMITH AT, 1978, ECOLOGY, V59, P133, DOI 10.2307/1936639; SMITH AT, 1974, ECOLOGY, V55, P1368, DOI 10.2307/1935464; SMITH AT, 1980, ECOLOGY, V61, P8, DOI 10.2307/1937147; Smith JA, 2013, ARCT ANTARCT ALP RES, V45, P396, DOI 10.1657/1938-4246-45.3.396; SOUTHWICK CH, 1986, J MAMMAL, V67, P149, DOI 10.2307/1381011; Stewart JAE, 2015, J BIOGEOGR, V42, P880, DOI 10.1111/jbi.12466; Stewart JAE, 2012, WILDLIFE SOC B, V36, P759, DOI 10.1002/wsb.220; Stocker T. F., 2013, CLIMATE CHANGE 2013; Thomas CD, 2006, TRENDS ECOL EVOL, V21, P415, DOI 10.1016/j.tree.2006.05.012; Trook J, 2009, EFFECTS CLIMATE CHAN; TYSER RW, 1980, AM MIDL NAT, V104, P32, DOI 10.2307/2424955; Varner J, 2016, BEHAV PROCESS, V125, P63, DOI 10.1016/j.beproc.2016.01.009; Varner J, 2015, INT J WILDLAND FIRE, V24, P921, DOI 10.1071/WF15038; Varner J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104648; Walther GR, 2007, SCIENCE, V315, P606, DOI 10.1126/science.1138574; Walther GR, 2005, P ROY SOC B-BIOL SCI, V272, P1427, DOI 10.1098/rspb.2005.3119; Walther GR, 2005, J VEG SCI, V16, P541, DOI 10.1111/j.1654-1103.2005.tb02394.x; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; West EW, 1981, ADAPTIVE PATTERNS BE; Wilkening JL, 2011, QUATERN INT, V235, P77, DOI 10.1016/j.quaint.2010.05.004; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037; Wilson R.J., 2012, ECOLOGICAL CONSEQUEN, P107; Wilson RJ, 2005, ECOL LETT, V8, P1138, DOI 10.1111/j.1461-0248.2005.00824.x; Yandow LH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131082; Yandow LH, 2012, DELINEATING LIMITING	96	5	5	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167051	10.1371/journal.pone.0167051	http://dx.doi.org/10.1371/journal.pone.0167051			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902732	gold, Green Published, Green Submitted			2022-12-26	WOS:000389474100046
J	Shimizu, T; Kitajima, A; Nonaka, K; Yoshioka, T; Ohta, S; Goto, S; Toyoda, A; Fujiyama, A; Mochizuki, T; Nagasaki, H; Kaminuma, E; Nakamura, Y				Shimizu, Tokurou; Kitajima, Akira; Nonaka, Keisuke; Yoshioka, Terutaka; Ohta, Satoshi; Goto, Shingo; Toyoda, Atsushi; Fujiyama, Asao; Mochizuki, Takako; Nagasaki, Hideki; Kaminuma, Eli; Nakamura, Yasukazu			Hybrid Origins of Citrus Varieties Inferred from DNA Marker Analysis of Nuclear and Organelle Genomes	PLOS ONE			English	Article							BAC END SEQUENCES; PHYLOGENETIC-RELATIONSHIPS; GENETIC DIVERSITY; R-PACKAGE; MOLECULAR PHYLOGENY; POPULATION-GENETICS; CHLOROPLAST GENOMES; HARDY-WEINBERG; RFLP ANALYSIS; GENUS CITRUS	Most indigenous citrus varieties are assumed to be natural hybrids, but their parentage has so far been determined in only a few cases because of their wide genetic diversity and the low transferability of DNA markers. Here we infer the parentage of indigenous citrus varieties using simple sequence repeat and indel markers developed from various citrus genome sequence resources. Parentage tests with 122 known hybrids using the selected DNA markers certify their transferability among those hybrids. Identity tests confirm that most variant strains are selected mutants, but we find four types of kunenbo (Citrus nobilis) and three types of tachibana (Citrus tachibana) for which we suggest different origins. Structure analysis with DNA markers that are in Hardy-Weinberg equilibrium deduce three basic taxa coinciding with the current understanding of citrus ancestors. Genotyping analysis of 101 indigenous citrus varieties with 123 selected DNA markers infers the parentages of 22 indigenous citrus varieties including Satsuma, Temple, and iyo, and single parents of 45 indigenous citrus varieties, including kunenbo, C. ichangensis, and Ichang lemon by allele-sharing and parentage tests. Genotyping analysis of chloroplast and mitochondrial genomes using 11 DNA markers classifies their cytoplasmic genotypes into 18 categories and deduces the combination of seed and pollen parents. Likelihood ratio analysis verifies the inferred parentages with significant scores. The reconstructed genealogy identifies 12 types of varieties consisting of Kishu, kunenbo, yuzu, koji, sour orange, dancy, kobeni mikan, sweet orange, tachibana, Cleopatra, willowleaf mandarin, and pummelo, which have played pivotal roles in the occurrence of these indigenous varieties. The inferred parentage of the indigenous varieties confirms their hybrid origins, as found by recent studies.	[Shimizu, Tokurou; Nonaka, Keisuke; Yoshioka, Terutaka; Ohta, Satoshi; Goto, Shingo] NARO, Inst Fruit Tree & Tea Sci, Div Citrus Res, Shimizu, Shizuoka, Japan; [Kitajima, Akira] Kyoto Univ, Grad Sch Agr, Expt Farm, Kyoto, Japan; [Toyoda, Atsushi; Fujiyama, Asao] Natl Inst Genet, Comparat Genom Lab, Mishima, Shizuoka, Japan; [Mochizuki, Takako; Nagasaki, Hideki; Kaminuma, Eli; Nakamura, Yasukazu] Natl Inst Genet, Ctr Informat Biol, Mishima, Shizuoka, Japan; [Nagasaki, Hideki] Kazusa DNA Res Inst, Dept Frontier Res, Kisarazu, Chiba, Japan	National Agriculture & Food Research Organization - Japan; Kyoto University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Kazusa DNA Research Institute	Shimizu, T (corresponding author), NARO, Inst Fruit Tree & Tea Sci, Div Citrus Res, Shimizu, Shizuoka, Japan.	tshimizu@affrc.go.jp	Goto, Shingo/AAU-4777-2021	Goto, Shingo/0000-0002-2298-7016; Nakamura, Yasukazu/0000-0002-6782-5715	Japanese Ministry of Agriculture, Forestry and Fisheries [NGB1006]; KAKEN [24405025]; Grants-in-Aid for Scientific Research [15K18643] Funding Source: KAKEN	Japanese Ministry of Agriculture, Forestry and Fisheries(Ministry of Agriculture Forestry & Fisheries - Japan); KAKEN(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant for Research Project "Genomics for Agricultural Innovation NGB1006" from Japanese Ministry of Agriculture, Forestry and Fisheries for TS. A part of this work was also supported by KAKEN (No. 24405025) for AK.	Abe K, 1904, CITRUS OF JAPAN; Abkenar AA, 2004, SCI HORTIC-AMSTERDAM, V102, P233, DOI 10.1016/j.scienta.2004.01.003; Ayres KL, 1998, HEREDITY, V80, P769, DOI 10.1046/j.1365-2540.1998.00360.x; Barrett H. C., 1976, Systematic Botany, V1, P105, DOI 10.2307/2418763; Bausher MG, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-21; Bayer RJ, 2009, AM J BOT, V96, P668, DOI 10.3732/ajb.0800341; Blouin MS, 2003, TRENDS ECOL EVOL, V18, P503, DOI 10.1016/S0169-5347(03)00225-8; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; BRENNER CH, 1993, TRANSFUSION, V33, P51, DOI 10.1046/j.1537-2995.1993.33193142310.x; Brenner CH, 2003, THEOR POPUL BIOL, V63, P173, DOI 10.1016/S0040-5809(03)00008-X; Brenner CH, 1983, INCLUSION PROBABILIT, P632; Breto MP, 2001, MOL PHYLOGENET EVOL, V21, P285, DOI 10.1006/mpev.2001.1008; Brownstein MJ, 1996, BIOTECHNIQUES, V20, P1004, DOI 10.2144/96206st01; Carbonell-Caballero J, 2015, MOL BIOL EVOL, V32, P2015, DOI 10.1093/molbev/msv082; Chen CX, 2008, TREE GENET GENOMES, V4, P1, DOI 10.1007/s11295-007-0083-3; Chen CX, 2006, THEOR APPL GENET, V112, P1248, DOI 10.1007/s00122-006-0226-1; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Close Timothy J., 2007, V406, P161; Coletta HD, 1998, EUPHYTICA, V102, P133, DOI 10.1023/A:1018300900275; Committee on Identifying the Needs of the Forensic Sciences Community: National Research Council, 2009, STRENGTH FOR SCI US; Corazza-Nunes MJ, 2002, EUPHYTICA, V126, P169, DOI 10.1023/A:1016332030738; Curk F, 2016, ANN BOT-LONDON, V117, P565, DOI 10.1093/aob/mcw005; Curk F, 2014, BMC GENET, V15, DOI 10.1186/s12863-014-0152-1; de Araujo EF, 2003, ORG DIVERS EVOL, V3, P55, DOI 10.1078/1439-6092-00058; Deng Z, 1996, P INT SOC CITRIC, V2, P84; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Elisiario PJ, 1999, SCI HORTIC-AMSTERDAM, V81, P287, DOI 10.1016/S0304-4238(99)00013-8; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Fang DQ, 1997, THEOR APPL GENET, V95, P408, DOI 10.1007/s001220050577; Foreign Agricultural Service/USDA O of GA, 2016, CITR WORLD MARK TRAD; Froelicher Y, 2011, TREE GENET GENOMES, V7, P49, DOI 10.1007/s11295-010-0314-x; Fukuba H, 1882, RECORDS CITRUS KII P; Glaubitz JC, 2004, MOL ECOL NOTES, V4, P309, DOI 10.1111/j.1471-8286.2004.00597.x; Gmitter FG., 2010, ORIGIN EVOLUTION BRE, P345, DOI [10.1002/9780470650059.ch10, DOI 10.1002/9780470650059.CH10]; Gmitter FG, 2012, TREE GENET GENOMES, V8, P611, DOI 10.1007/s11295-012-0499-2; Goodwin W, 2011, J CHEM INFORM MODELI; Goto S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162408; Goudet J, 2005, MOL ECOL NOTES, V5, P184, DOI 10.1111/j.1471-8286.2004.00828.x; Grattapaglia D, 2014, TREE GENET GENOMES, V10, P1631, DOI 10.1007/s11295-014-0784-3; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; HANDA T, 1986, JPN J GENET, V61, P15, DOI 10.1266/jjg.61.15; HIRAI M, 1987, JPN J BREED, V37, P377; HIRAI M, 1990, J JPN SOC HORTIC SCI, V59, P1, DOI 10.2503/jjshs.59.1; Hodgson RW, 1967, CITRUS IND, V1, P431, DOI DOI 10.1016/J.FOODCHEM.2006.02.05910.1039/; Hui W, 2008, J STAT SOFTW, V28, P1; Iwamasa M, 1976, VARIETIES OF CITRUS; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jena SN, 2009, SCI HORTIC-AMSTERDAM, V119, P403, DOI 10.1016/j.scienta.2008.08.030; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jones AG, 2003, MOL ECOL, V12, P2511, DOI 10.1046/j.1365-294X.2003.01928.x; Jung YH, 2005, SCI HORTIC-AMSTERDAM, V104, P179, DOI 10.1016/j.scienta.2004.08.008; Kaibara E., 1709, YAMATO HONZO; Kepiro JL, 2010, TREE GENET GENOMES, V6, P1, DOI 10.1007/s11295-009-0223-z; Khan IA, 2007, CITRUS GENETICS, BREEDING AND BIOTECHNOLOGY, P1, DOI 10.1079/9780851990194.0000; Kolpakov R, 2003, NUCLEIC ACIDS RES, V31, P3672, DOI 10.1093/nar/gkg617; Kotoda N, 2017, HORTICULT J, V86, P183, DOI [10.2503/hortj.OKD-016, 10.2503/hortj.okd-016]; Kotoda N, 2016, HORTICULT J, V85, P128, DOI 10.2503/hortj.MI-085; Lacombe T, 2013, THEOR APPL GENET, V126, P401, DOI 10.1007/s00122-012-1988-2; Ladaniya MS, 2008, CITRUS FRUIT: BIOLOGY, TECHNOLOGY AND EVALUATION, pXIII, DOI 10.1016/B978-012374130-1.50001-2; Lassois L, 2016, PLANT MOL BIOL REP, V34, P827, DOI 10.1007/s11105-015-0966-7; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Luro F., 1994, Fruits (Paris), V49, P404; Luro FL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-287; Ma L, 2015, CURR ZOOL, V61, P886, DOI 10.1093/czoolo/61.5.886; Mabberley D. J., 1997, Telopea, V7, P167; Mabberley DJ, 2004, BLUMEA, V49, P481; Machado M.A. Natividade Targon, 2000, ACTA HORTIC, V535, P51; Machado MA, 1996, EUPHYTICA, V92, P321, DOI 10.1007/BF00037115; Marshall OJ, 2004, BIOINFORMATICS, V20, P2471, DOI 10.1093/bioinformatics/bth254; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Matsumoto R, 1985, B FRUIT TREE RES S D, V10, P1; MEAGHER TR, 1986, AM NAT, V128, P199, DOI 10.1086/284554; Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x; Moore GA, 2001, TRENDS GENET, V17, P536, DOI 10.1016/S0168-9525(01)02442-8; Nakano M, J JAPAN SOC HORT SCI; Nakano M, 2013, TREE GENET GENOMES, V9, P795, DOI 10.1007/s11295-013-0598-8; Nakano M, 2012, PLANT SCI, V183, P131, DOI 10.1016/j.plantsci.2011.08.002; Nakatani M., 1989, STUD CITROL, V15, P75; Nei M., 1987, MOL EVOLUTIONARY GEN, V512; Nei M., 2000, MOL EVOLUTION PHYLOG; Nicolosi E, 2000, THEOR APPL GENET, V100, P1155, DOI 10.1007/s001220051419; Nicolosi E, 2007, CITRUS GENETICS, BREEDING AND BIOTECHNOLOGY, P19, DOI 10.1079/9780851990194.0019; NISHIURA. M, 1967, Japan Agricultural Research Quarterly, V2, P15; Novelli VM, 2000, GENET MOL BIOL, V23, P163, DOI 10.1590/S1415-47572000000100030; Okamura S., 1848, KEIEN KIFFU; Ollitrault F, 2010, AM J BOT, V97, pE124, DOI 10.3732/ajb.1000280; Ollitrault P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-13; Paradis E, 2010, BIOINFORMATICS, V26, P419, DOI 10.1093/bioinformatics/btp696; PEMBERTON JM, 1995, MOL ECOL, V4, P249, DOI 10.1111/j.1365-294X.1995.tb00214.x; Penjor Tshering, 2014, Horticultural Research (Japan), V13, P307, DOI 10.2503/hrj.13.307; Penjor T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062574; Perrier X., 2006, DARWIN SOFTWARE; Perrier X., 2003, GENETIC DIVERSITY CU, P43; POTVIN C, 1983, SYST BOT, V8, P127, DOI 10.2307/2418689; Pritchard JK, 2000, GENETICS, V155, P945; Roose M, 2008, GENOMICS TROPICAL CR, DOI [10.1007/978-0-387-71219-2_8, DOI 10.1007/978-0-387-71219-2_8]; ROUSE RE, 1988, HORTSCIENCE, V23, P680; Rozen S, 2000, Methods Mol Biol, V132, P365; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Saunt J., 2000, CITRUS VARIETIES WOR; SCORA RW, 1975, B TORREY BOT CLUB, V102, P369, DOI 10.2307/2484763; Shaw PD, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-259; Shimizu T, 2016, ACTA HORTIC, V1135, P23, DOI 10.17660/ActaHortic.2016.1135.4; Shimizu Tokurou, 2011, BMC Res Notes, V4, P161, DOI 10.1186/1756-0500-4-161; Siebert T, 2010, CITROGRAPH       MAR, P20; Sieberts SK, 2002, AM J HUM GENET, V70, P170, DOI 10.1086/338444; Staden R, 2000, Methods Mol Biol, V132, P115; Swingle W T, 1967, CITRUS IND, P190; Talon Manuel, 2008, Int J Plant Genomics, V2008, P528361, DOI 10.1155/2008/528361; TANAKA T., 1969, Bulletin of the University of Osaka Prefecture. Series B. Agriculture and Biology, V21, P139; Tanaka T., 1961, CITROLOGIA; Tanaka T., 1932, MEM FS AGR TAIHOKU U, V4, P1; TANAKA T, 1954, REVISIO AURANTIACEAR, V9; Tanaka Y., 1942, KANKITSU, V9, P5; Tanaka Y., 1941, KANKITSU, V8, P308; Terol J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-423; TORRES AM, 1978, AM J BOT, V65, P869, DOI 10.2307/2442183; Tripolitsiotis C, 2013, NOT BOT HORTI AGROBO, V41, P463; Uzun A, 2009, SCI HORTIC-AMSTERDAM, V121, P306, DOI 10.1016/j.scienta.2009.02.018; Uzun A, 2012, GENETIC DIVERSITY IN PLANTS, P213; Webber H.J., 1967, CITRUS IND, V1, P1; Weising K, 1999, GENOME, V42, P9, DOI 10.1139/gen-42-1-9; Winter DJ, 2012, MOL ECOL RESOUR, V12, P1158, DOI 10.1111/j.1755-0998.2012.03174.x; Wu GA, 2014, NAT BIOTECHNOL, V32, P656, DOI 10.1038/nbt.2906; Xu Q, 2013, NAT GENET, V45, P59, DOI 10.1038/ng.2472; YAMAMOTO M, 1993, JPN J BREED, V43, P355; Yamamoto M, 2006, J JPN SOC HORTIC SCI, V75, P372, DOI 10.2503/jjshs.75.372; Yamamoto M, 2013, J JPN SOC HORTIC SCI, V82, P106, DOI 10.2503/jjshs1.82.106; Yang XM, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-015-0955-x	132	49	51	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0166969	10.1371/journal.pone.0166969	http://dx.doi.org/10.1371/journal.pone.0166969			58	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902727	Green Published, gold			2022-12-26	WOS:000389474100042
J	Bode, DC; Baker, MD; Viles, JH				Bode, David C.; Baker, Mark D.; Viles, John H.			Ion Channel Formation by Amyloid-beta(42) Oligomers but Not Amyloid-beta(40) in Cellular Membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID-BETA-PROTEIN; ALZHEIMERS-DISEASE; A-BETA; IN-VIVO; ZN2+-SENSITIVE CHANNEL; CALCIUM-CHANNELS; SINGLE-MOLECULE; LIPID-BILAYERS; PEPTIDE; PORE	A central hallmark of Alzheimer's disease is the presence of extracellular amyloid plaques chiefly consisting of amyloid-beta (A beta) peptides in the brain interstitium. A beta largely exists in two isoforms, 40 and 42 amino acids long, but a large body of evidence points toA beta (1-42) rather than A beta (1-40) as the cytotoxic form. One proposed mechanism by which A beta exerts toxicity is the formation of ion channel pores that disrupt intracellular Ca2+ homeostasis. However, previous studies using membrane mimetics have not identified any notable difference in the channel forming properties between A beta (1-40) and A beta (1-42). Here, we tested whether a more physiological environment, membranes excised from HEK293 cells of neuronal origin, would reveal differences in the relative channel forming ability of monomeric, oligomeric, and fibrillar forms of both A beta (1-40) and A beta (1-42). A beta preparations were characterized with transmission electron microscopy and thioflavin T fluorescence. A beta was then exposed to the extracellular face of excised membranes, and transmembrane currents were monitored using patch clamp. Our data indicated that A beta (1-42) assemblies in oligomeric preparations form voltage-independent, non-selective ion channels. In contrast, A beta (1-40) oligomers, fibers, and monomers did not form channels. Ion channel conductance results suggested that A beta (1-42) oligomers, but not monomers and fibers, formed three distinct pore structures with 1.7-, 2.1-, and 2.4-nm pore diameters. Our findings demonstrate that only A beta (1-42) contains unique structural features that facilitate membrane insertion and channel formation, now aligning ion channel formation with the differential neurotoxic effect of A beta (1-40) and A beta (1-42) in Alzheimer's disease.	[Bode, David C.; Viles, John H.] Queen Mary Univ London, Sch Biol & Chem Sci, Mile End Rd, London E1 4NS, England; [Baker, Mark D.] Queen Mary Univ London, Barts & London Sch Med & Dent, Ctr Neurosci & Trauma, Blizard Inst, 4 Newark St, London E1 2AT, England	University of London; Queen Mary University London; University of London; Queen Mary University London	Viles, JH (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, Mile End Rd, London E1 4NS, England.; Baker, MD (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Ctr Neurosci & Trauma, Blizard Inst, 4 Newark St, London E1 2AT, England.	m.d.baker@qmul.ac.uk; j.viles@qmul.ac.uk			Life Science initiative, Queen Mary, University of London; Biotechnology and Biological Sciences Research Council [BB/M023877/1]; BBSRC [BB/M023877/1] Funding Source: UKRI	Life Science initiative, Queen Mary, University of London; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Life Science initiative, Queen Mary, University of London and Biotechnology and Biological Sciences Research Council Grant BB/M023877/1. The authors declare that they have no conflicts of interest with the contents of this article.	Arispe N, 2004, J MEMBRANE BIOL, V197, P33, DOI 10.1007/s00232-003-0638-7; Arispe N, 2002, FASEB J, V16, P1526, DOI 10.1096/fj.02-0829com; ARISPE N, 1993, P NATL ACAD SCI USA, V90, P567, DOI 10.1073/pnas.90.2.567; Arispe N, 1996, P NATL ACAD SCI USA, V93, P1710, DOI 10.1073/pnas.93.4.1710; Arispe N, 2007, BBA-BIOMEMBRANES, V1768, P1952, DOI 10.1016/j.bbamem.2007.03.014; Ashley RH, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-21; Bahadi R, 2003, AM J PHYSIOL-CELL PH, V285, pC873, DOI 10.1152/ajpcell.00147.2003; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bezprozvanny I, 2008, TRENDS NEUROSCI, V31, P454, DOI 10.1016/j.tins.2008.06.005; Brouillette J, 2012, J NEUROSCI, V32, P7852, DOI 10.1523/JNEUROSCI.5901-11.2012; Capone R, 2012, BIOCHEMISTRY-US, V51, P776, DOI 10.1021/bi2017427; Cruickshank CC, 1997, BIOPHYS J, V73, P1925, DOI 10.1016/S0006-3495(97)78223-7; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Ding H, 2012, BIOPHYS J, V103, P1500, DOI 10.1016/j.bpj.2012.08.051; DURELL SR, 1994, BIOPHYS J, V67, P2137, DOI 10.1016/S0006-3495(94)80717-9; GRAVINA SA, 1995, J BIOL CHEM, V270, P7013, DOI 10.1074/jbc.270.13.7013; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; HILLE B, 1968, J GEN PHYSIOL, V51, P199, DOI 10.1085/jgp.51.2.199; HILLE B, 1978, BIOPHYS J, V22, P283, DOI 10.1016/S0006-3495(78)85489-7; Hirakura Y, 1999, J NEUROSCI RES, V57, P458, DOI 10.1002/(SICI)1097-4547(19990815)57:4<458::AID-JNR5>3.0.CO;2-4; Hong S, 2014, NEURON, V82, P308, DOI 10.1016/j.neuron.2014.02.027; Jang H, 2010, P NATL ACAD SCI USA, V107, P6538, DOI 10.1073/pnas.0914251107; Jang H, 2009, BIOPHYS J, V97, P3029, DOI 10.1016/j.bpj.2009.09.014; Johansson AS, 2006, FEBS J, V273, P2618, DOI 10.1111/j.1742-4658.2006.05263.x; Kawahara M, 1997, BIOPHYS J, V73, P67, DOI 10.1016/S0006-3495(97)78048-2; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Kayed R, 2009, J BIOL CHEM, V284, P4230, DOI 10.1074/jbc.M808591200; Kim HY, 2009, J AM CHEM SOC, V131, P17482, DOI 10.1021/ja9077599; Klein AM, 1999, ANN NY ACAD SCI, V893, P314, DOI 10.1111/j.1749-6632.1999.tb07845.x; Kourie JI, 2002, CELL BIOCHEM BIOPHYS, V36, P191, DOI 10.1385/CBB:36:2-3:191; Kourie JI, 2001, CELL MOL NEUROBIOL, V21, P255, DOI 10.1023/A:1010995121153; Kuperstein I, 2010, EMBO J, V29, P3408, DOI 10.1038/emboj.2010.211; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lasagna-Reeves CA, 2011, J BIOL CHEM, V286, P22122, DOI 10.1074/jbc.M111.236257; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Lin H, 1999, BIOCHEMISTRY-US, V38, P11189, DOI 10.1021/bi982997c; Lin H, 2001, FASEB J, V15, P2433, DOI 10.1096/fj.01-0377com; Mayeux R, 1999, ANN NEUROL, V46, P412, DOI 10.1002/1531-8249(199909)46:3<412::AID-ANA19>3.0.CO;2-A; Meleleo D, 2013, J BIOENERG BIOMEMBR, V45, P369, DOI 10.1007/s10863-013-9513-0; Mobley DL, 2004, BIOPHYS J, V86, P3585, DOI 10.1529/biophysj.103.032342; Narayan P, 2013, J AM CHEM SOC, V135, P1491, DOI 10.1021/ja3103567; Naslund J, 2000, JAMA-J AM MED ASSOC, V283, P1571, DOI 10.1001/jama.283.12.1571; Peters C, 2016, J ALZHEIMERS DIS, V53, P197, DOI 10.3233/JAD-160170; Peters C, 2016, J ALZHEIMERS DIS, V51, P689, DOI 10.3233/JAD-150896; Prangkio P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047261; Prince M, 2015, WORLD ALZHEIMERS REP; Qiu LM, 2011, J PHYS CHEM B, V115, P9795, DOI 10.1021/jp2012842; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Rhee SK, 1998, J BIOL CHEM, V273, P13379, DOI 10.1074/jbc.273.22.13379; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Schlumberger Limited, 2009, LOG INT CHARTS; Serra-Batiste M, 2016, P NATL ACAD SCI USA, V113, P10866, DOI 10.1073/pnas.1605104113; Spangler S G, 1972, Ala J Med Sci, V9, P218; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Tosatto L, 2012, BBA-BIOMEMBRANES, V1818, P2876, DOI 10.1016/j.bbamem.2012.07.007; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Williams TL, 2011, FEBS J, V278, P3905, DOI 10.1111/j.1742-4658.2011.08228.x; Younan ND, 2015, BIOCHEMISTRY-US, V54, P4297, DOI 10.1021/acs.biochem.5b00309	60	112	115	3	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2017	292	4					1404	1413		10.1074/jbc.M116.762526	http://dx.doi.org/10.1074/jbc.M116.762526			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ6OX	27927987	hybrid, Green Published			2022-12-26	WOS:000393339800022
J	Sondergaard, MT; Liu, YJ; Larsen, KT; Nani, A; Tian, XX; Holt, C; Wang, RW; Wimmer, R; Van Petegem, F; Fill, M; Chen, SRW; Overgaard, MT				Sondergaard, Mads Toft; Liu, Yingjie; Larsen, Kamilla Taunsig; Nani, Alma; Tian, Xixi; Holt, Christian; Wang, Ruiwu; Wimmer, Reinhard; Van Petegem, Filip; Fill, Michael; Chen, S. R. Wayne; Overgaard, Michael Toft			The Arrhythmogenic Calmodulin p.Phe142Leu Mutation Impairs C-domain Ca2+ Binding but Not Calmodulin-dependent Inhibition of the Cardiac Ryanodine Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG QT SYNDROME; VENTRICULAR-TACHYCARDIA; CALCIUM-BINDING; RELEASE; ACTIVATION; THRESHOLD; DISSOCIATION; HYPERTROPHY; TERMINATION; MUTANTS	A number of point mutations in the intracellular Ca2+ -sensing protein calmodulin (CaM) are arrhythmogenic, yet their underlying mechanisms are not clear. These mutations generally decrease Ca2+ binding to CaM and impair inhibition of CaM-regulated Ca2+ channels like the cardiac Ca2+ release channel (ryanodine receptor, RyR2), and it appears that attenuated CaM Ca2+ binding correlates with impaired CaM-dependent RyR2 inhibition. Here, we investigated the RyR2 inhibitory action of the CaM p.Phe142Leu mutation (F142L; numbered including the start-Met), which markedly reduces CaM Ca2+ binding. Surprisingly, CaM-F142L had little to no aberrant effect on RyR2-mediated store overload-induced Ca2+ release in HEK293 cells compared with CaM-WT. Furthermore, CaM-F142L enhanced CaM-dependent RyR2 inhibition at the single channel level compared with CaM-WT. This is in stark contrast to the actions of arrhythmogenic CaM mutations N54I, D96V, N98S, and D130G, which all diminish CaM-dependent RyR2 inhibition. Thermodynamic analysis showed that apoCaM-F142L converts an endothermal interaction between CaM and the CaM-binding domain (CaMBD) of RyR2 into an exothermal one. Moreover, NMR spectra revealed that the CaM-F142L-CaMBD interaction is structurally different from that of CaM-WT at low Ca2+. These data indicate a distinct interaction between CaM-F142L and the RyR2 CaMBD, which may explain the stronger CaM-dependent RyR2 inhibition by CaM-F142L, despite its reduced Ca2+ binding. Collectively, these results add to our understanding of CaM-dependent regulation of RyR2 as well as the mechanistic effects of arrhythmogenic CaM mutations. The unique properties of the CaM-F142L mutation may provide novel clues on how to suppress excessive RyR2 Ca2+ release by manipulating the CaM-RyR2 interaction.	[Sondergaard, Mads Toft; Larsen, Kamilla Taunsig; Holt, Christian; Wimmer, Reinhard; Overgaard, Michael Toft] Aalborg Univ, Dept Chem & Biosci, Fredrik Bajers Vej 7H, DK-9220 Aalborg, Denmark; [Sondergaard, Mads Toft; Liu, Yingjie; Tian, Xixi; Wang, Ruiwu; Chen, S. R. Wayne] Univ Calgary, Dept Physiol & Pharmacol, Libin Cardiovasc Inst Alberta, Calgary, AB T2N 1N4, Canada; [Sondergaard, Mads Toft; Liu, Yingjie; Tian, Xixi; Wang, Ruiwu; Chen, S. R. Wayne] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 1N4, Canada; [Van Petegem, Filip] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Nani, Alma; Fill, Michael; Chen, S. R. Wayne] Rush Univ, Med Ctr, Dept Mol Biophys & Physiol, Chicago, IL 60612 USA	Aalborg University; Libin Cardiovascular Institute Of Alberta; University of Calgary; University of Calgary; University of British Columbia; Rush University	Overgaard, MT (corresponding author), Aalborg Univ, Dept Chem & Biosci, Fredrik Bajers Vej 7H, DK-9220 Aalborg, Denmark.	mto@bio.aau.dk	Wimmer, Reinhard/M-2346-2019; Overgaard, Michael Toft/E-1354-2011; Wimmer, Reinhard/A-7901-2012; Van petegem, Filip/M-6061-2016	Overgaard, Michael Toft/0000-0002-1423-2481; Wimmer, Reinhard/0000-0001-6942-5056; Sondergaard, Mads Toft/0000-0001-6779-5109; Van petegem, Filip/0000-0003-2728-8537	Danish Council for Independent Research [DFF-4181-00447, DFF-4093-00242]; Obelske Family Foundation; Novo Nordic Foundation [NNF15OC001776299]; Lundbeck Foundation [2013-14432]; Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada; Canada Foundation for Innovation; Heart and Stroke Foundation/Libin Professorship in Cardiovascular Research; National Institutes of Health [AR054098, HL057832]; Lundbeck Foundation [R151-2013-14432] Funding Source: researchfish; Novo Nordisk Fonden [NNF15OC0017762, NNF16OC0023344] Funding Source: researchfish; Alberta Innovates [201400104] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057832] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111397] Funding Source: NIH RePORTER	Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Obelske Family Foundation; Novo Nordic Foundation(Novo Nordisk Foundation); Lundbeck Foundation(Lundbeckfonden); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Heart and Stroke Foundation/Libin Professorship in Cardiovascular Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation); Alberta Innovates; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by research grants from the Danish Council for Independent Research (DFF-4181-00447), the Obelske Family Foundation, the Novo Nordic Foundation (NNF15OC001776299), and the Lundbeck Foundation (2013-14432) (to M. T. O.) and by a postdoctoral fellowship from the Danish Council for Independent Research (DFF-4093-00242 to M. T. S.). This work was also supported by research grants from the Canadian Institutes of Health Research, the Heart and Stroke Foundation of Canada, the Canada Foundation for Innovation, and the Heart and Stroke Foundation/Libin Professorship in Cardiovascular Research (to S. R. W. C.). Support for this research was also provided by National Institutes of Health Grants AR054098 and HL057832 (to M. F.) and HL057832 (to S. R. W. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adair GS, 1925, J BIOL CHEM, V63, P529; Arnaiz-Cot JJ, 2013, J PHYSIOL-LONDON, V591, P4287, DOI 10.1113/jphysiol.2013.256123; Berridge M. J., 2014, BIOCHEM J, DOI [10.1042/csb0001007, DOI 10.1042/CSB0001007]; Boczek NJ, 2016, CIRC-CARDIOVASC GENE, V9, P136, DOI 10.1161/CIRCGENETICS.115.001323; Breitwieser GE, 2001, AM J PHYSIOL-CELL PH, V280, pC1412, DOI 10.1152/ajpcell.2001.280.6.C1412; CHAMBERLAIN BK, 1984, J BIOL CHEM, V259, P7540; Crotti L, 2013, CIRCULATION, V127, P1009, DOI 10.1161/CIRCULATIONAHA.112.001216; Driessen HE, 2014, NETH HEART J, V22, P198, DOI 10.1007/s12471-014-0549-5; Dweck D, 2005, ANAL BIOCHEM, V347, P303, DOI 10.1016/j.ab.2005.09.025; Fearnley CJ, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004242; Fruen BR, 2003, BIOCHEMISTRY-US, V42, P2740, DOI 10.1021/bi0267689; Holdgate GA, 2001, BIOTECHNIQUES, V31, P164; Hwang HS, 2014, CIRC RES, V114, P1114, DOI 10.1161/CIRCRESAHA.114.303391; Jiang DW, 2004, P NATL ACAD SCI USA, V101, P13062, DOI 10.1073/pnas.0402388101; Jiang DW, 2005, CIRC RES, V97, P1173, DOI 10.1161/01.RES.0000192146.85173.4b; Jiang J, 2010, BIOCHEM J, V432, P89, DOI 10.1042/BJ20100505; Jimenez-Jaimez J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153851; Johny MB, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2727; Jones PP, 2008, BIOCHEM J, V412, P171, DOI 10.1042/BJ20071287; Lau K, 2014, BIOCHEMISTRY-US, V53, P932, DOI 10.1021/bi401502x; Limpitikul WB, 2014, J MOL CELL CARDIOL, V74, P115, DOI 10.1016/j.yjmcc.2014.04.022; LINSE S, 1991, J BIOL CHEM, V266, P8050; Makita N, 2014, CIRC-CARDIOVASC GENE, V7, P466, DOI 10.1161/CIRCGENETICS.113.000459; Marsman RF, 2014, J AM COLL CARDIOL, V63, P259, DOI 10.1016/j.jacc.2013.07.091; Maximciuc AA, 2006, STRUCTURE, V14, P1547, DOI 10.1016/j.str.2006.08.011; Mizusawa Y, 2014, CIRC J, V78, P2827, DOI 10.1253/circj.CJ-14-0905; Nyegaard M, 2012, AM J HUM GENET, V91, P703, DOI 10.1016/j.ajhg.2012.08.015; Oda T, 2015, J MOL CELL CARDIOL, V85, P240, DOI 10.1016/j.yjmcc.2015.06.009; Ono M, 2010, CARDIOVASC RES, V87, P609, DOI 10.1093/cvr/cvq108; Oo YW, 2015, MOL PHARMACOL, V88, P57, DOI 10.1124/mol.115.097691; PEDIGO S, 1995, BIOCHEMISTRY-US, V34, P10676, DOI 10.1021/bi00033a044; Qin J, 2009, BIOPHYS J, V97, P1961, DOI 10.1016/j.bpj.2009.07.030; Saimi Y, 2002, ANNU REV PHYSIOL, V64, P289, DOI 10.1146/annurev.physiol.64.100301.111649; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shea MA, 1996, BIOCHEMISTRY-US, V35, P2943, DOI 10.1021/bi951934g; Sondergaard MT, 2015, J BIOL CHEM, V290, P26151, DOI 10.1074/jbc.M115.676627; Sondergaard MT, 2015, FEBS J, V282, P803, DOI 10.1111/febs.13184; Sorensen AB, 2013, FEBS J, V280, P5511, DOI 10.1111/febs.12337; Tan Z, 2016, BIOCHEM J, V473, P4159, DOI 10.1042/BCJ20160620; Tian XX, 2013, BIOCHEM J, V455, P367, DOI 10.1042/BJ20130805; Uchinoumi H, 2016, BIOPHYS J, V110, p599A, DOI 10.1016/j.bpj.2015.11.3198; Van Petegem F, 2015, J MOL BIOL, V427, P31, DOI 10.1016/j.jmb.2014.08.004; VanScyoc WS, 2002, BIOPHYS J, V83, P2767, DOI 10.1016/S0006-3495(02)75286-7; Vassilakopoulou V, 2015, BBA-GEN SUBJECTS, V1850, P2168, DOI 10.1016/j.bbagen.2015.07.001; Venetucci L, 2012, NAT REV CARDIOL, V9, P561, DOI 10.1038/nrcardio.2012.93; Walweel K, 2017, CLIN EXP PHARMACOL P, V44, P135, DOI 10.1111/1440-1681.12669; Xu L, 2004, BIOPHYS J, V86, P797, DOI 10.1016/S0006-3495(04)74155-7; Yamaguchi N, 2003, J BIOL CHEM, V278, P23480, DOI 10.1074/jbc.M301125200; Yamaguchi N, 2007, J CLIN INVEST, V117, P1344, DOI 10.1172/JCI29515; Yamaguchi N, 2013, AM J PHYSIOL-HEART C, V305, pH86, DOI 10.1152/ajpheart.00144.2013; Yang Y, 2014, CIRC RES, V114, P295, DOI 10.1161/CIRCRESAHA.114.302857; Yin G, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000996; Zhang M, 2012, STRUCTURE, V20, P911, DOI 10.1016/j.str.2012.03.019; Zhou Q, 2011, NAT MED, V17, P1003, DOI 10.1038/nm.2406	54	23	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2017	292	4					1385	1395		10.1074/jbc.M116.766253	http://dx.doi.org/10.1074/jbc.M116.766253			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ6OX	27927985	Green Published, hybrid			2022-12-26	WOS:000393339800020
J	Goldberg, AB; Cho, E; Miller, CJ; Lou, HJ; Turk, BE				Goldberg, Allison B.; Cho, Eunice; Miller, Chad J.; Lou, Hua Jane; Turk, Benjamin E.			Identification of a Substrate-selective Exosite within the Metalloproteinase Anthrax Lethal Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; BACILLUS-ANTHRACIS; CRYSTAL-STRUCTURE; MELANOMA-CELLS; MAPK; INHIBITORS; DOMAIN; SITE; PHOSPHORYLATION; INACTIVATION	The metalloproteinase anthrax lethal factor (LF) is secreted by Bacillus anthracis to promote disease virulence through disruption of host signaling pathways. LF is a highly specific protease, exclusively cleaving mitogen-activated protein kinase kinases (MKKs) and rodent NLRP1B (NACHT leucine-rich repeat and pyrin domain-containing protein 1B). How LF achieves such restricted substrate specificity is not understood. Previous studies have suggested the existence of an exosite interaction between LF and MKKs that promotes cleavage efficiency and specificity. Through a combination of in silico prediction and site-directed mutagenesis, we have mapped an exosite to a non-catalytic region of LF. Mutations within this site selectively impair proteolysis of full-length MKKs yet have no impact on cleavage of short peptide substrates. Although this region appears important for cleaving all LF protein substrates, we found that mutation of specific residues within the exosite differentially affects MKK and NLRP1B cleavage in vitro and in cultured cells. Oneresidue in particular, Trp-271, is essential for cleavage of MKK3, MKK4, and MKK6 but dispensable for targeting of MEK1, MEK2, and NLRP1B. Analysis of chimeric substrates suggests that this residue interacts with the MKK catalytic domain. Wefound that LF-W271A blocked ERK phosphorylation and growth in a melanoma cell line, suggesting that it may provide a highly selective inhibitor of MEK1/2 for use as a cancer therapeutic. These findings provide insight into how a bacterial toxin functions to specifically impair host signaling pathways and suggest a general strategy for mapping protease exosite interactions.	[Goldberg, Allison B.; Cho, Eunice; Miller, Chad J.; Lou, Hua Jane; Turk, Benjamin E.] Yale Univ, Sch Med, Dept Pharmacol, POB 208066,333 Cedar St, New Haven, CT 06520 USA	Yale University	Turk, BE (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, POB 208066,333 Cedar St, New Haven, CT 06520 USA.	ben.turk@yale.edu		Miller, Chad/0000-0002-2087-6566	National Institutes of Health [R01 GM105947, R01 GM104047, T32 GM007324]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105947, R01GM104047, T32GM007324] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 GM105947, R01 GM104047, and T32 GM007324. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abi-Habib RJ, 2005, MOL CANCER THER, V4, P1303, DOI 10.1158/1535-7163.MCT-05-0145; Alouf JE, 2000, METH MOL B, V145, P1; ARORA N, 1993, J BIOL CHEM, V268, P3334; ARORA N, 1992, J BIOL CHEM, V267, P15542; Bannwarth L, 2012, CHEM BIOL, V19, P875, DOI 10.1016/j.chembiol.2012.05.013; BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0; Brossier F, 2004, INFECT IMMUN, V72, P6313, DOI 10.1128/IAI.72.11.6313-6317.2004; Brown GE, 2004, J BIOL CHEM, V279, P27059, DOI 10.1074/jbc.M314258200; Cafardi V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081306; Cara DC, 2001, J IMMUNOL, V167, P6552, DOI 10.4049/jimmunol.167.11.6552; Chavarria-Smith J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003452; Chopra AP, 2003, J BIOL CHEM, V278, P9402, DOI 10.1074/jbc.M211262200; de Vries SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017695; DeLano W.L., 2015, PYMOL MOL GRAPHICS S; Dumas JJ, 2003, SCIENCE, V301, P222, DOI 10.1126/science.1083917; Forino M, 2005, P NATL ACAD SCI USA, V102, P9499, DOI 10.1073/pnas.0502733102; Golden HB, 2013, INT J CARDIOL, V168, P3884, DOI 10.1016/j.ijcard.2013.06.050; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Haling JR, 2014, CANCER CELL, V26, P402, DOI 10.1016/j.ccr.2014.07.007; Hao YH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001375; Hardy JA, 2004, P NATL ACAD SCI USA, V101, P12461, DOI 10.1073/pnas.0404781101; Hellmich KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049741; Hoffmaster AR, 2006, J CLIN MICROBIOL, V44, P3352, DOI 10.1128/JCM.00561-06; Jabaiah AM, 2012, BIOL CHEM, V393, P933, DOI 10.1515/hsz-2012-0162; Kandadi MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013335; Khashan R, 2012, PROTEINS, V80, P2207, DOI 10.1002/prot.24110; Koo HM, 2002, P NATL ACAD SCI USA, V99, P3052, DOI 10.1073/pnas.052707699; Kufareva I, 2007, PROTEINS, V67, P400, DOI 10.1002/prot.21233; Lee CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017165; Levinsohn JL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002638; Liang SD, 2006, NUCLEIC ACIDS RES, V34, P3698, DOI 10.1093/nar/gkl454; Liang XD, 2004, J BIOL CHEM, V279, P52473, DOI 10.1074/jbc.M409105200; Liu SH, 2013, NATURE, V501, P63, DOI 10.1038/nature12510; Maize KM, 2014, ACTA CRYSTALLOGR D, V70, P2813, DOI 10.1107/S1399004714018161; MANSOUR SJ, 1994, J BIOCHEM-TOKYO, V116, P304, DOI 10.1093/oxfordjournals.jbchem.a124524; Ngai S, 2010, FEBS J, V277, P119, DOI 10.1111/j.1742-4658.2009.07458.x; Panchal RG, 2004, NAT STRUCT MOL BIOL, V11, P67, DOI 10.1038/nsmb711; Pannifer AD, 2001, NATURE, V414, P229, DOI 10.1038/n35101998; Park HS, 2011, SCIENCE, V333, P1151, DOI 10.1126/science.1207203; Park JM, 2002, SCIENCE, V297, P2048, DOI 10.1126/science.1073163; Rabideau AE, 2016, ACS CHEM BIOL, V11, P1490, DOI 10.1021/acschembio.6b00169; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Schnell S, 1997, J THEOR BIOL, V187, P207, DOI 10.1006/jtbi.1997.0425; Shoop WL, 2005, P NATL ACAD SCI USA, V102, P7958, DOI 10.1073/pnas.0502159102; Tiedje C, 2014, J INTERF CYTOK RES, V34, P220, DOI 10.1089/jir.2013.0146; Tonello F, 2009, MOL ASPECTS MED, V30, P431, DOI 10.1016/j.mam.2009.07.006; Tsao H, 2012, GENE DEV, V26, P1131, DOI 10.1101/gad.191999.112; Turk BE, 2004, NAT STRUCT MOL BIOL, V11, P60, DOI 10.1038/nsmb708; Turk BE, 2007, BIOCHEM J, V402, P405, DOI 10.1042/BJ20061891; Vin H, 2013, ELIFE, V2, DOI 10.7554/eLife.00969; Vitale G, 1998, BIOCHEM BIOPH RES CO, V248, P706, DOI 10.1006/bbrc.1998.9040; Xu QP, 2012, J BACTERIOL, V194, P2987, DOI 10.1128/JB.00038-12	53	4	4	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2017	292	3					814	825		10.1074/jbc.M116.761734	http://dx.doi.org/10.1074/jbc.M116.761734			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2LL	27909054	hybrid, Green Published			2022-12-26	WOS:000392318700005
J	Tsutsui, H; Yamanishi, Y; Ohtsuka, H; Sato, S; Yoshikawa, S; Karasuyama, H				Tsutsui, Hidemitsu; Yamanishi, Yoshinori; Ohtsuka, Hiromi; Sato, Shingo; Yoshikawa, Soichiro; Karasuyama, Hajime			The Basophil-specific Protease mMCP-8 Provokes an Inflammatory Response in the Skin with Microvascular Hyperpermeability and Leukocyte Infiltration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAST-CELL TRYPTASE; CHRONIC ALLERGIC INFLAMMATION; SERINE PROTEASES; TRICHINELLA-SPIRALIS; MAMMALIAN EVOLUTION; IMMUNE-RESPONSES; CHYMASE LOCUS; HOST-DEFENSE; EXPRESSION; BIOLOGY	Basophils have often been erroneously considered to be minor relatives or blood-circulating precursors of tissue-resident mast cells because of some phenotypic similarity between them, including basophilic secretory granules in the cytoplasm. However, recent studies revealed that the repertoire of serine proteases stored in secretory granules is distinct in them. Particularly, mouse mast cell protease 8 (mMCP-8) is specifically expressed by basophils but not mast cells despite its name. Therefore, mMCP-8 is commonly used as a basophil-specific marker, but its functional property remains uncertain. Here we prepared recombinant mMCP-8 and examined its activity in vitro and in vivo. Purified recombinant mMCP-8 showed heatsensitive proteolytic activity when beta-tubulin was used as a substrate. One intradermal shot of mMCP-8, not heat-inactivated, induced cutaneous swelling with increased microvascular permeability in a cyclooxygenase-dependent manner. Moreover, repeated intradermal injection of mMCP-8 promoted skin infiltration of leukocytes, predominantly neutrophils and, to a lesser extent, monocytes and eosinophils, in conjunction with up-regulation of chemokine expression in the skin lesion. These results suggest that mMCP-8 is an important effector molecule in basophil- elicited inflammation, providing novel insights into how basophils exert a crucial and non-redundant role, distinct from that played by mast cells, in immune responses.	[Tsutsui, Hidemitsu; Yamanishi, Yoshinori; Ohtsuka, Hiromi; Sato, Shingo; Yoshikawa, Soichiro; Karasuyama, Hajime] Tokyo Med & Dent Univ, Dept Immune Regulat, Grad Sch Med & Dent Sci, Tokyo 1138519, Japan	Tokyo Medical & Dental University (TMDU)	Yamanishi, Y (corresponding author), Tokyo Med & Dent Univ, Dept Immune Regulat, Grad Sch Med & Dent Sci, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	yamanishi.mbch@tmd.ac.jp	Karasuyama, Hajime/A-7966-2011	Karasuyama, Hajime/0000-0003-0689-0836	Japan Science and Technology Agency [1A145]; Japan Society for the Promotion of Science [15H05786, 15K20969]; Grants-in-Aid for Scientific Research [15H05786] Funding Source: KAKEN	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Research Grant 1A145 from the Japan Science and Technology Agency (to H. K.) and Japan Society for the Promotion of Science Grants 15H05786 (to H. K.) and 15K20969 (to Y. Y.). The authors declare that they have no conflicts of interest with the contents of this article.	Caughey GH, 2007, IMMUNOL REV, V217, P141, DOI 10.1111/j.1600-065X.2007.00509.x; Egawa M, 2013, IMMUNITY, V38, P570, DOI 10.1016/j.immuni.2012.11.014; Falcone FH, 2000, BLOOD, V96, P4028; Galli SJ, 2000, CURR OPIN HEMATOL, V7, P32, DOI 10.1097/00062752-200001000-00007; Gallwitz M, 2007, IMMUNOGENETICS, V59, P391, DOI 10.1007/s00251-007-0202-1; Gallwitz M, 2006, IMMUNOGENETICS, V58, P655, DOI 10.1007/s00251-006-0126-1; Gallwitz M, 2006, IMMUNOGENETICS, V58, P641, DOI 10.1007/s00251-006-0123-4; Goping IS, 2006, J CELL SCI, V119, P858, DOI 10.1242/jcs.02791; Griffith JW, 2014, ANNU REV IMMUNOL, V32, P659, DOI 10.1146/annurev-immunol-032713-120145; Hallgren J, 2006, FEBS J, V273, P1871, DOI 10.1111/j.1742-4658.2006.05211.x; Hamilton MJ, 2011, P NATL ACAD SCI USA, V108, P290, DOI 10.1073/pnas.1005758108; Huang CF, 1998, J IMMUNOL, V160, P1910; Hunt JE, 1997, J BIOL CHEM, V272, P29158, DOI 10.1074/jbc.272.46.29158; Izawa K, 2007, J BIOL CHEM, V282, P17997, DOI 10.1074/jbc.M701100200; KARASUYAMA H, 1988, EUR J IMMUNOL, V18, P97, DOI 10.1002/eji.1830180115; Karasuyama H, 2011, ANNU REV IMMUNOL, V29, P45, DOI 10.1146/annurev-immunol-031210-101257; Knight PA, 2000, J EXP MED, V192, P1849, DOI 10.1084/jem.192.12.1849; Kuziel WA, 1997, P NATL ACAD SCI USA, V94, P12053, DOI 10.1073/pnas.94.22.12053; Lee PY, 2013, J LEUKOCYTE BIOL, V94, P585, DOI 10.1189/jlb.0113014; Lutzelschwab C, 1997, J EXP MED, V185, P13, DOI 10.1084/jem.185.1.13; Lutzelschwab C, 1998, EUR J IMMUNOL, V28, P1022, DOI 10.1002/(SICI)1521-4141(199803)28:03<1022::AID-IMMU1022>3.0.CO;2-1; McNeil HP, 2008, ARTHRITIS RHEUM-US, V58, P2338, DOI 10.1002/art.23639; McNeil HP, 2007, J BIOL CHEM, V282, P20785, DOI 10.1074/jbc.R700017200; Miller HRP, 2002, IMMUNOLOGY, V105, P375, DOI 10.1046/j.1365-2567.2002.01375.x; Mukai K, 2005, IMMUNITY, V23, P191, DOI 10.1016/j.immuni.2005.06.011; Obata K, 2007, BLOOD, V110, P913, DOI 10.1182/blood-2007-01-068718; Ohnmacht C, 2010, IMMUNITY, V33, P364, DOI 10.1016/j.immuni.2010.08.011; Poorafshar M, 2000, EUR J IMMUNOL, V30, P2660, DOI 10.1002/1521-4141(200009)30:9<2660::AID-IMMU2660>3.0.CO;2-I; Shin K, 2008, J IMMUNOL, V180, P4885, DOI 10.4049/jimmunol.180.7.4885; Shin K, 2009, J IMMUNOL, V182, P647, DOI 10.4049/jimmunol.182.1.647; Siracusa MC, 2011, ANN NY ACAD SCI, V1217, P166, DOI 10.1111/j.1749-6632.2010.05918.x; Sokol CL, 2010, MUCOSAL IMMUNOL, V3, P129, DOI 10.1038/mi.2009.137; Stone KD, 2010, J ALLERGY CLIN IMMUN, V125, pS73, DOI 10.1016/j.jaci.2009.11.017; Sullivan BM, 2011, NAT IMMUNOL, V12, P527, DOI 10.1038/ni.2036; Tani K, 2000, J LEUKOCYTE BIOL, V67, P585, DOI 10.1002/jlb.67.4.585; Terakawa M, 2005, BIOCHEM BIOPH RES CO, V332, P969, DOI 10.1016/j.bbrc.2005.04.172; Thakurdas SM, 2007, J BIOL CHEM, V282, P20809, DOI 10.1074/jbc.M611842200; Ugajin T, 2009, J LEUKOCYTE BIOL, V86, P1417, DOI 10.1189/jlb.0609400; Voehringer D, 2013, NAT REV IMMUNOL, V13, P362, DOI 10.1038/nri3427; Wada T, 2010, J CLIN INVEST, V120, P2867, DOI 10.1172/JCI42680; Wong GW, 2004, J BIOL CHEM, V279, P2438, DOI 10.1074/jbc.M308209200; Yamanishi Y, 2010, J EXP MED, V207, P1501, DOI 10.1084/jem.20090581	42	18	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2017	292	3					1061	1067		10.1074/jbc.M116.754648	http://dx.doi.org/10.1074/jbc.M116.754648			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2LL	27932459	hybrid, Green Published			2022-12-26	WOS:000392318700025
J	Lill, Y; Jordan, LD; Smallwood, CR; Newton, SM; Lill, MA; Klebba, PE; Ritchie, K				Lill, Yoriko; Jordan, Lorne D.; Smallwood, Chuck R.; Newton, Salete M.; Lill, Markus A.; Klebba, Phillip E.; Ritchie, Ken			Confined Mobility of TonB and FepA in Escherichia coli Membranes	PLOS ONE			English	Article							SINGLE-MOLECULE TRACKING; FERRIC ENTEROBACTIN TRANSPORT; BACTERIAL OUTER-MEMBRANE; GRAM-NEGATIVE BACTERIA; CRYSTAL-STRUCTURE; SPATIAL-DISTRIBUTION; ENERGY TRANSDUCTION; INNER MEMBRANE; PROTEIN; EXBD	The important process of nutrient uptake in Escherichia coli, in many cases, involves transit of the nutrient through a class of beta-barrel proteins in the outer membrane known as TonB-dependent transporters (TBDTs) and requires interaction with the inner membrane protein TonB. Here we have imaged the mobility of the ferric enterobactin transporter FepA and TonB by tracking them in the membranes of live E. coli with single-molecule resolution at time-scales ranging from milliseconds to seconds. We employed simple simulations to model/analyze the lateral diffusion in the membranes of E. coli, to take into account both the highly curved geometry of the cell and artifactual effects expected due to finite exposure time imaging. We find that both molecules perform confined lateral diffusion in their respective membranes in the absence of ligand with FepA confined to a region 0.180(-0.007)(+0.006) mu m in radius in the outer membrane and TonB confined to a region 0.266(0.009)(+0.007) mu m in radius in the inner membrane. The diffusion coefficient of these molecules on millisecond time-scales was estimated to be 21(-5)(+9) mu m(2)/s and 5.4(-0.8)(+1.5) mu m(2)/s for FepA and TonB, respectively, implying that each molecule is free to diffuse within its domain. Disruption of the inner membrane potential, deletion of ExbB/D from the inner membrane, presence of ligand or antibody to FepA and disruption of the MreB cytoskeleton was all found to further restrict the mobility of both molecules. Results are analyzed in terms of changes in confinement size and interactions between the two proteins.	[Lill, Yoriko; Ritchie, Ken] Purdue Univ, Dept Phys, W Lafayette, IN 47907 USA; [Jordan, Lorne D.; Newton, Salete M.; Klebba, Phillip E.] Kansas State Univ, Dept Biochem & Mol Biophys, Manhattan, KS 66506 USA; [Smallwood, Chuck R.] Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA; [Lill, Markus A.] Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA; [Smallwood, Chuck R.] Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Kansas State University; University of Oklahoma System; University of Oklahoma - Norman; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of California System; University of California Berkeley	Ritchie, K (corresponding author), Purdue Univ, Dept Phys, W Lafayette, IN 47907 USA.; Klebba, PE (corresponding author), Kansas State Univ, Dept Biochem & Mol Biophys, Manhattan, KS 66506 USA.	peklebba@ksu.edu; kpritchie@purdue.edu	Lill, Markus A/E-5118-2017; Smallwood, Chuck/P-5421-2017	Lill, Markus A/0000-0003-3023-5188; Smallwood, Chuck/0000-0003-2221-5726	National Science Foundation [MCB09522999]; National Institutes of Health [GM53836]	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	These studies were supported by grant MCB09522999 from the National Science Foundation (P.E.K., S.M.N., and K.R.) and GM53836 from the National Institutes of Health (P.E.K. and S.M.N.).	Bakshi S, 2011, BIOPHYS J, V101, P2535, DOI 10.1016/j.bpj.2011.10.013; Bean GJ, 2009, BIOCHEMISTRY-US, V48, P4852, DOI 10.1021/bi900014d; BRADBEER C, 1993, J BACTERIOL, V175, P3146, DOI 10.1128/JB.175.10.3146-3150.1993; Buchanan SK, 1999, NAT STRUCT BIOL, V6, P56; Cao ZH, 2003, J BIOL CHEM, V278, P1022, DOI 10.1074/jbc.M210360200; Chang CS, 2001, J BIOL CHEM, V276, P27535, DOI 10.1074/jbc.M102778200; Deich J, 2004, P NATL ACAD SCI USA, V101, P15921, DOI 10.1073/pnas.0404200101; English BP, 2011, P NATL ACAD SCI USA, V108, pE365, DOI 10.1073/pnas.1102255108; Faraldo-Gomez JD, 2003, NAT REV MOL CELL BIO, V4, P105, DOI 10.1038/nrm1015; GELLES J, 1988, NATURE, V331, P450, DOI 10.1038/331450a0; Gibbs KA, 2004, MOL MICROBIOL, V53, P1771, DOI 10.1111/j.1365-2958.2004.04242.x; Gresock MG, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00206; Haas BL, 2015, MOL MICROBIOL, V96, P4, DOI 10.1111/mmi.12834; HASHIMOTOGOTOH T, 1981, GENE, V16, P227, DOI 10.1016/0378-1119(81)90079-2; Higgs PI, 2002, MOL MICROBIOL, V44, P271, DOI 10.1046/j.1365-2958.2002.02880.x; Jordan LD, 2013, P NATL ACAD SCI USA, V110, P11553, DOI 10.1073/pnas.1304243110; KAMPFENKEL K, 1992, J BACTERIOL, V174, P5485, DOI 10.1128/JB.174.16.5485-5487.1992; Kaserer WA, 2008, J BACTERIOL, V190, P4001, DOI 10.1128/JB.00135-08; KLEBBA PE, 1982, J BACTERIOL, V149, P880, DOI 10.1128/JB.149.3.880-888.1982; Kodding J, 2005, J BIOL CHEM, V280, P3022, DOI 10.1074/jbc.M411155200; Kohler SD, 2010, PROTEIN SCI, V19, P625, DOI 10.1002/pro.345; Kojima S, 2001, BIOCHEMISTRY-US, V40, P13041, DOI 10.1021/bi011263o; KUSUMI A, 1993, BIOPHYS J, V65, P2021, DOI 10.1016/S0006-3495(93)81253-0; Leake MC, 2008, P NATL ACAD SCI USA, V105, P15376, DOI 10.1073/pnas.0806338105; Leake MC, 2006, NATURE, V443, P355, DOI 10.1038/nature05135; Lill Y, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.021907; Ma L, 2007, J BIOL CHEM, V282, P397, DOI 10.1074/jbc.M605333200; MURPHY CK, 1990, J BACTERIOL, V172, P2736, DOI 10.1128/jb.172.5.2736-2746.1990; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Newton SM, 2010, J BIOL CHEM, V285, P17488, DOI 10.1074/jbc.M109.100206; Newton SMC, 1999, MOL MICROBIOL, V32, P1153, DOI 10.1046/j.1365-2958.1999.01424.x; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Noinaj N, 2010, ANNU REV MICROBIOL, V64, P43, DOI 10.1146/annurev.micro.112408.134247; Oddershede L, 2002, BIOPHYS J, V83, P3152, DOI 10.1016/S0006-3495(02)75318-6; Oh D, 2014, BIOPHYS J, V106, P145, DOI 10.1016/j.bpj.2013.09.059; Ollis AA, 2012, J BACTERIOL, V194, P3069, DOI 10.1128/JB.00015-12; Ollis AA, 2009, MOL MICROBIOL, V73, P466, DOI 10.1111/j.1365-2958.2009.06785.x; Pawelek PD, 2006, SCIENCE, V312, P1399, DOI 10.1126/science.1128057; Peacock RS, 2006, BIOMETALS, V19, P127, DOI 10.1007/s10534-005-5420-0; Postle K, 2007, BIOMETALS, V20, P453, DOI 10.1007/s10534-006-9071-6; Rassam P, 2015, NATURE, V523, P333, DOI 10.1038/nature14461; Ritchie K, 2005, BIOPHYS J, V88, P2266, DOI 10.1529/biophysj.104.054106; Schauer K, 2008, TRENDS BIOCHEM SCI, V33, P330, DOI 10.1016/j.tibs.2008.04.012; Scott DC, 2001, J BIOL CHEM, V276, P13025, DOI 10.1074/jbc.M011282200; Shultis DD, 2006, SCIENCE, V312, P1396, DOI 10.1126/science.1127694; Smallwood CR, 2014, J GEN PHYSIOL, V144, P69, DOI 10.1085/jgp.201311159; Smallwood CR, 2009, MOL MICROBIOL, V72, P1171, DOI 10.1111/j.1365-2958.2009.06715.x; Sverzhinsky A, 2014, STRUCTURE, V22, P791, DOI 10.1016/j.str.2014.02.010; WAYNE R, 1976, J BACTERIOL, V126, P7, DOI 10.1128/JB.126.1.7-12.1976; Young KD, 2010, ANNU REV MICROBIOL, V64, P223, DOI 10.1146/annurev.micro.112408.134102	50	4	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0160862	10.1371/journal.pone.0160862	http://dx.doi.org/10.1371/journal.pone.0160862			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935943	Green Published, gold, Green Submitted			2022-12-26	WOS:000389587100003
J	Kilpelainen, M; Theeuwes, J				Kilpelainen, Markku; Theeuwes, Jan			Efficient Avoidance of the Penalty Zone in Human Eye Movements	PLOS ONE			English	Article							SACCADES; REWARD; INTEGRATION; INFORMATION; DISTRACTOR; SELECTION; CAPTURE; TARGET	People use eye movements extremely effectively to find objects of interest in a cluttered visual scene. Distracting, task-irrelevant attention capturing regions in the visual field should be avoided as they jeopardize the efficiency of search. In the current study, we used eye tracking to determine whether people are able to avoid making saccades to a predetermined visual area associated with a financial penalty, while making fast and accurate saccades towards stimuli placed near the penalty area. We found that in comparison to the same task without a penalty area, the introduction of a penalty area immediately affected eye movement behaviour: the proportion of saccades to the penalty area was immediately reduced. Also, saccadic latencies increased, but quite modestly, and mainly for saccades towards stimuli near the penalty area. We conclude that eye movement behaviour is under efficient cognitive control and thus quite flexible: it can immediately be adapted to changing environmental conditions to improve reward outcome.	[Kilpelainen, Markku] Univ Helsinki, Inst Behav Sci, Helsinki, Finland; [Theeuwes, Jan] Vrije Univ Amsterdam, Dept Cognit Psychol, Amsterdam, Netherlands	University of Helsinki; Vrije Universiteit Amsterdam	Kilpelainen, M (corresponding author), Univ Helsinki, Inst Behav Sci, Helsinki, Finland.	markku.kilpelainen@helsinki.fi	Theeuwes, Jan/ABF-3771-2020; Kilpeläinen, Markku/AAF-3420-2021; Kilpeläinen, Markku/C-7613-2011	Kilpeläinen, Markku/0000-0002-4112-7548; Kilpeläinen, Markku/0000-0002-4112-7548; Theeuwes, Jan/0000-0002-5849-7721	Academy of Finland [266007]; ERC [ERC-2012-AdG - 323413]	Academy of Finland(Academy of Finland); ERC(European Research Council (ERC)European Commission)	This work was supported by Academy of Finland grant (266007) to MK and ERC advanced grant (ERC-2012-AdG - 323413) to JT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews TJ, 1999, VISION RES, V39, P2947, DOI 10.1016/S0042-6989(99)00019-X; Aron AR, 2007, J NEUROSCI, V27, P3743, DOI 10.1523/JNEUROSCI.0519-07.2007; Blaukopf CL, 2006, EXP BRAIN RES, V174, P786, DOI 10.1007/s00221-006-0685-2; Bucker B, 2015, VISION RES, V108, P103, DOI 10.1016/j.visres.2015.01.020; Carpenter RHS, 2000, CURR BIOL, V10, pR291, DOI 10.1016/S0960-9822(00)00430-9; Chelazzi L, 2014, J NEUROSCI, V34, P8594, DOI 10.1523/JNEUROSCI.0277-14.2014; Chou IH, 1999, VISION RES, V39, P4200, DOI 10.1016/S0042-6989(99)00133-9; Cornelissen FW, 2002, BEHAV RES METH INS C, V34, P613, DOI 10.3758/BF03195489; DEJONG R, 1995, J EXP PSYCHOL HUMAN, V21, P498, DOI 10.1037/0096-1523.21.3.498; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; Deubel H., 1984, THEORETICAL APPL ASP, P55, DOI DOI 10.1016/S0166-4115(08)61818-X; Godijn R, 2003, J EXP PSYCHOL HUMAN, V29, P882, DOI 10.1037/0096-1523.29.5.882; Godijn R, 2002, J EXP PSYCHOL HUMAN, V28, P1039, DOI 10.1037//0096-1523.28.5.1039; GUITTON D, 1985, EXP BRAIN RES, V58, P455; HALLETT PE, 1978, VISION RES, V18, P1279, DOI 10.1016/0042-6989(78)90218-3; Kilpelainen M, 2013, J VISION, V13, DOI 10.1167/13.6.5; Kleiner M, 2007, PERCEPTION, V36, P14; Ludwig CJH, 2002, J EXP PSYCHOL HUMAN, V28, P902, DOI 10.1037//0096-1523.28.4.902; Munneke J, 2008, ACTA PSYCHOL, V129, P101, DOI 10.1016/j.actpsy.2008.05.004; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; OTTES FP, 1985, VISION RES, V25, P849, DOI 10.1016/0042-6989(85)90193-2; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; Ross M, 2011, NEUROSCIENCE, V196, P168, DOI 10.1016/j.neuroscience.2011.08.006; Ruff CC, 2006, J COGNITIVE NEUROSCI, V18, P522, DOI 10.1162/jocn.2006.18.4.522; Schiller PH, 2001, PROG BRAIN RES, V134, P127; Schutz AC, 2012, P NATL ACAD SCI USA, V109, P7547, DOI 10.1073/pnas.1115638109; Schutz AC, 2011, J VIS, V11; Tatler BW, 2011, J VISION, V11, DOI 10.1167/11.5.5; Theeuwes J, 1998, PSYCHOL SCI, V9, P379, DOI 10.1111/1467-9280.00071; Theeuwes J, 1999, J EXP PSYCHOL HUMAN, V25, P1595, DOI 10.1037/0096-1523.25.6.1595; Van der Stigchel S, 2006, NEUROSCI BIOBEHAV R, V30, P666, DOI 10.1016/j.neubiorev.2005.12.001; Van der Stigchel S, 2011, J EYE MOVEMENT RES, V4; Verbruggen F, 2008, TRENDS COGN SCI, V12, P418, DOI 10.1016/j.tics.2008.07.005	33	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167956	10.1371/journal.pone.0167956	http://dx.doi.org/10.1371/journal.pone.0167956			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4OA	27930724	Green Published, Green Submitted, gold			2022-12-26	WOS:000389580900063
J	Lankarani, KB; Malek-Hosseini, SA; Nikeghbalian, S; Dehghani, M; Pourhashemi, M; Kazemi, K; Janghorban, P; Akbari, M; Ghahramani, S; Eghtesad, B; Moini, M; Jaberi, AR; Shamsaifar, A; Gholami, S; Rahmanian, F; Geramizadeh, B				Lankarani, Kamran B.; Malek-Hosseini, Seyed Ali; Nikeghbalian, Saman; Dehghani, Mohsen; Pourhashemi, Mohammad; Kazemi, Kourosh; Janghorban, Parisa; Akbari, Maryam; Ghahramani, Sulmaz; Eghtesad, Bijan; Moini, Maryam; Jaberi, Abbas Rahmi; Shamsaifar, Alireza; Gholami, Siavosh; Rahmanian, Fatemeh; Geramizadeh, Bita			Fourteen Years of Experience of Liver Transplantation for Wilson's Disease; a Report on 107 Cases from Shiraz, Iran	PLOS ONE			English	Article							OUTCOMES; DIAGNOSIS	Background and Aim Liver transplantation is a potential cure for liver damage from Wilson's disease but the course of neuropsychiatric manifestations after transplantation remains undetermined. Material and methods In this study, data on all patients who'd received a liver transplant for Wilson's disease at the Shiraz Organ Transplantation Center between December 2000 and March 2014 were reviewed and compared to data on a control group who'd received a liver transplant over the same period but due to other causes. Results Out of 2198 patients who'd received a liver transplant in the period; 107 patients were diagnosed with Wilson's disease (21 with fulminant hepatic failure); age of patient ranged from 5 to 59 years; 56.07% of patients in this series had some type of neuropsychiatric manifestation before transplantation, of which 66.67% showed improvement after the procedure. 18 patients had aggravation of neuropsychiatric symptoms after transplantation. These neuropsychiatric symptoms were mostly for anxiety, tremor and depression but there were four cases of new onset dysarthria, rigidity and ataxia in various combinations. Survival rates of 1-month, 1-year, and 5-years for patients with Wilson's disease were 88%, 86%, 82%, respectively, evaluations were not statistically different from that of the control group. Conclusions Liver transplantation showed good long-term results in patients with Wilson's disease, even in those presenting fulminant hepatic failure. Neuropsychiatric manifestations normally show improvement after transplantation but in some cases new onset of manifestations occurred after successful liver transplantation.	[Lankarani, Kamran B.; Pourhashemi, Mohammad; Akbari, Maryam; Ghahramani, Sulmaz] Shiraz Univ Med Sci, Ctr Hlth Policy Res, Shiraz, Iran; [Malek-Hosseini, Seyed Ali; Nikeghbalian, Saman; Kazemi, Kourosh; Janghorban, Parisa; Shamsaifar, Alireza; Gholami, Siavosh; Geramizadeh, Bita] Shiraz Univ Med Sci, Shiraz Transplant Res Ctr, Shiraz, Iran; [Dehghani, Mohsen] Shiraz Univ Med Sci, Pediat Gastroenterol & Hepatol Dept, Shiraz, Iran; [Eghtesad, Bijan] Cleveland Clin, Transplant Ctr, Cleveland, OH 44106 USA; [Moini, Maryam; Rahmanian, Fatemeh] Shiraz Univ Med Sci, Gastroenterohepatol Res Ctr, Shiraz, Iran; [Jaberi, Abbas Rahmi] Shiraz Univ Med Sci, Shiraz Neurol Res Ctr, Shiraz, Iran	Shiraz University of Medical Science; Shiraz University of Medical Science; Shiraz University of Medical Science; Cleveland Clinic Foundation; Shiraz University of Medical Science; Shiraz University of Medical Science	Lankarani, KB (corresponding author), Shiraz Univ Med Sci, Ctr Hlth Policy Res, Shiraz, Iran.	lankaran@sums.ac.ir	Ghahramani, Sulmaz/S-3942-2019; Geramizadeh, Bita/AAA-9497-2021; Shamsaeefar, Alireza/Z-5309-2019; Kazemi, Kourosh/AAW-9184-2020; Malek-Hosseini, Seyed Ali/AAQ-9080-2021; Lankarani, Kamran B/P-5336-2019; Ghahramani, Sulmaz/S-7384-2017; Nikeghbalian, Saman/T-6992-2019; Rahmanian, Fatemeh/L-9036-2016; lankarani, kamran b/D-5901-2012; Moini, Maryam/C-5213-2018; Lankarani, Kamran Bagheri/P-2066-2017; Dehghani, Seyed Mohsen/A-9226-2018	Ghahramani, Sulmaz/0000-0002-4161-5146; Geramizadeh, Bita/0000-0002-4867-5686; Shamsaeefar, Alireza/0000-0003-3798-6064; Kazemi, Kourosh/0000-0003-4477-7121; Malek-Hosseini, Seyed Ali/0000-0002-0853-9938; Lankarani, Kamran B/0000-0002-7524-9017; Ghahramani, Sulmaz/0000-0002-4161-5146; Nikeghbalian, Saman/0000-0003-4530-8829; Rahmanian, Fatemeh/0000-0003-4270-5554; Moini, Maryam/0000-0001-9619-4206; Lankarani, Kamran Bagheri/0000-0002-7524-9017; Dehghani, Seyed Mohsen/0000-0001-5930-0110; Rahimi jaberi, Abbas/0000-0002-3402-6060	Shiraz University of Medical Sciences	Shiraz University of Medical Sciences	This work was funded by Shiraz University of Medical Sciences for access to data and software costs but the authors received no specific funding for this work.	Ala A, 2007, LANCET, V369, P397, DOI 10.1016/S0140-6736(07)60196-2; Annema C, 2015, LIVER TRANSPLANT, V21, P524, DOI 10.1002/lt.24075; BELLARY S, 1995, J HEPATOL, V23, P373, DOI 10.1016/0168-8278(95)80194-4; Borhani-Haghighi A, 2005, TRANSPL P, V37, P3197, DOI 10.1016/j.transproceed.2005.08.025; Catana AM, 2012, WORLD J HEPATOL, V4, P5, DOI 10.4254/wjh.v4.i1.5; Coffey AJ, 2013, BRAIN, V136, P1476, DOI 10.1093/brain/awt035; Dalvi A, 2014, DM-DIS MON, V60, P450, DOI 10.1016/j.disamonth.2014.07.002; Dare AJ, 2014, LIVER TRANSPLANT, V20, P281, DOI 10.1002/lt.23818; DUBOIS RS, 1971, LANCET, V1, P505; Eghtesad B, 1999, LIVER TRANSPLANT SUR, V5, P467, DOI 10.1002/lt.500050614; Emre S, 2001, TRANSPLANTATION, V72, P1232, DOI 10.1097/00007890-200110150-00008; Ferenci P, 2003, LIVER INT, V23, P139, DOI 10.1034/j.1600-0676.2003.00824.x; Geissler I, 2003, TRANSPLANTATION P; Gollan John L., 1998, Journal of Hepatology, V28, P28, DOI 10.1016/S0168-8278(98)80373-5; Guillaud O, 2014, J HEPATOL, V60, P579, DOI 10.1016/j.jhep.2013.10.025; Haseli N, 2013, HEPAT MON, V13, DOI 10.5812/hepatmon.10257; Lankarani KB, 2013, ARCH IRAN MED, V16, P64, DOI 013162/AIM.003; Malek-Hosseini S-A, 2002, ARCH IRAN MED, V5, P213; Martinez-Camacho A, 2009, J HEPATOL, V50, pS23, DOI 10.1016/S0168-8278(09)60055-6; ODER W, 1991, J NEUROL, V238, P281; Peedikayil MC, 2013, WORLD J HEPATOL, V5, P127, DOI 10.4254/wjh.v5.i3.127; Roberts EA, 2003, HEPATOLOGY, V37, P1475, DOI 10.1053/jhep.2003.50252; Saberifiroozi Mehdi, 2006, Indian J Gastroenterol, V25, P11; SCHILSKY ML, 1994, HEPATOLOGY, V19, P583, DOI 10.1002/hep.1840190307; Semis S, 2008, TRANSPL P, V40, P228, DOI 10.1016/j.transproceed.2007.11.007; STARZL TE, 1971, TRANSPLANT P, V3, P308; Taly AB, 2007, MEDICINE, V86, P112, DOI 10.1097/MD.0b013e318045a00e; Wadhwa S, 2013, CANCER LETT, V337, P8, DOI 10.1016/j.canlet.2013.05.027; Weiss KH, 2013, CLIN TRANSPLANT, V27, P914, DOI 10.1111/ctr.12259	29	10	10	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167890	10.1371/journal.pone.0167890	http://dx.doi.org/10.1371/journal.pone.0167890			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930723	gold, Green Published, Green Submitted			2022-12-26	WOS:000389580900056
J	Patel, RC; Odoyo, J; Anand, K; Stanford-Moore, G; Wakhungu, I; Bukusi, EA; Baeten, JM; Brown, JM				Patel, Rena C.; Odoyo, Josephine; Anand, Keerthana; Stanford-Moore, Gaelen; Wakhungu, Imeldah; Bukusi, Elizabeth A.; Baeten, Jared M.; Brown, Joelle M.			Facilitators and Barriers of Antiretroviral Therapy Initiation among HIV Discordant Couples in Kenya: Qualitative Insights from a Pre-Exposure Prophylaxis Implementation Study	PLOS ONE			English	Article							TEST-AND-TREAT; ADHERENCE; CARE; INTERVENTIONS; STRATEGIES; ENGAGEMENT; RETENTION; ATTITUDES; REASONS; ACCESS	Introduction The World Health Organization now recommends antiretroviral therapy (ART) initiation for all HIV-infected individuals regardless of CD4 cell count or disease status. Understanding the facilitators and barriers to initiation of and adherence to ART is essential to successful scale-up of "universal" ART. Methods To investigate facilitators and barriers to ART initiation, we conducted 44 in-depth individual or couple interviews with 63 participants (33 participants with HIV and 30 without HIV) already enrolled in a prospective implementation study of oral antiretroviral-based prevention in Kisumu, Kenya between August and September 2014. A semi-structured interview guided discussions on: 1) perceived advantages and disadvantages of ART; 2) reasons for accepting or declining ART initiation; and 3) influence of prevention of transmission to partner or infant influencing ART use. Transcripts from the interviews were iteratively analyzed using inductive content analysis. Results HIV-infected participants indicated that living a healthier life, preventing HIV transmission to others, and appearing "normal" or "healthy" again facilitated their initiation of ART. While appearing "normal" allowed these individuals to interact with their communities without stigmatization, they also perceived community opposition to their initiating ART, because appearing "normal" again prevented community members from easily identifying infected individuals in their community. Denial of diagnosis, disclosure stigma, perceived side-effects, and challenges in obtaining refills were additional barriers to ART initiation. Conclusions Community perceptions play an important role in both facilitating and inhibiting ART initiation. Perceived stigma, including perceived community opposition to widespread ART use, is an important barrier to ART initiation. Addressing such barriers, while capitalizing on facilitators, to ART initiation should be central to universal ART scale-up efforts.	[Patel, Rena C.] Univ Washington, Dept Med, Div Allergy & Infect Dis, Seattle, WA 98195 USA; [Odoyo, Josephine; Wakhungu, Imeldah; Bukusi, Elizabeth A.] Kenya Govt Med Res Ctr, Ctr Microbiol Res, Kisumu, Kenya; [Anand, Keerthana] Northwestern Univ, Chicago, IL 60611 USA; [Stanford-Moore, Gaelen] Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA; [Bukusi, Elizabeth A.] Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA; [Bukusi, Elizabeth A.; Baeten, Jared M.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Baeten, Jared M.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Baeten, Jared M.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Brown, Joelle M.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Brown, Joelle M.] Univ Calif San Francisco, Dept Obstet, San Francisco, CA 94143 USA; [Brown, Joelle M.] Univ Calif San Francisco, Dept Gynecol, San Francisco, CA 94143 USA; [Brown, Joelle M.] Univ Calif San Francisco, Dept Reprod Sci, San Francisco, CA 94143 USA	University of Washington; University of Washington Seattle; Kenya Medical Research Institute; Northwestern University; University of California System; University of California San Francisco; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Patel, RC (corresponding author), Univ Washington, Dept Med, Div Allergy & Infect Dis, Seattle, WA 98195 USA.	rcpatel@uw.edu			U.S. National Institute of Health (NIH) National Institute of Mental Health [K01MH100994]; Kenya Medical Research Institute (KEMRI); NIH Biology of Infectious Diseases Training Program [T32AI007641]; NIH National Institute of Allergy and Infectious Diseases [K23AI120855]; University of California, San Francisco School of Medicine by the Pathways Explore Summer Fellowship; University of California, San Francisco-Clinical and Translational Science Institute [KL2TR000143]; National Institute of Mental Health of the US National Institutes of Health [R01 MH095507]; Bill & Melinda Gates Foundation [OPP1056051]; US Agency for International Development [AID-OAA-A-12-00023]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI120855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095507, K01MH100994] Funding Source: NIH RePORTER	U.S. National Institute of Health (NIH) National Institute of Mental Health; Kenya Medical Research Institute (KEMRI); NIH Biology of Infectious Diseases Training Program; NIH National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of California, San Francisco School of Medicine by the Pathways Explore Summer Fellowship; University of California, San Francisco-Clinical and Translational Science Institute(University of California System); National Institute of Mental Health of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); US Agency for International Development(United States Agency for International Development (USAID)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was funded by the U.S. National Institute of Health (NIH) National Institute of Mental Health (K01MH100994) and Kenya Medical Research Institute (KEMRI). Dr. Patel was supported by the NIH Biology of Infectious Diseases Training Program (T32AI007641) and NIH National Institute of Allergy and Infectious Diseases (K23AI120855). Ms. Gaelen Stanford-Moore was supported by the University of California, San Francisco School of Medicine by the Pathways Explore Summer Fellowship. Dr. Brown received support from the University of California, San Francisco-Clinical and Translational Science Institute (KL2TR000143). The Partners Demonstration Project was funded by the National Institute of Mental Health of the US National Institutes of Health (R01 MH095507), the Bill & Melinda Gates Foundation (OPP1056051), and through the generous support of the American people through the US Agency for International Development (AID-OAA-A-12-00023). Gilead Sciences donated the PrEP medication but had no role in data collection or analysis. The study results are solely the responsibility of the authors and do not necessarily represent the official views of the funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; [Anonymous], NVIVO QUAL DAT AN SO; [Anonymous], 2011, GUID ANT THER KEN; Baeten JM, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002099; Brubaker SG, 2011, HIV MED, V12, P316, DOI 10.1111/j.1468-1293.2010.00884.x; Cambiano V, 2011, CURR OPIN INFECT DIS, V24, P19, DOI 10.1097/QCO.0b013e3283422c8c; Connell R., 1987, GENDER POWER SOC PER, pxvii; Curran K, 2014, AIDS, V28, P227, DOI 10.1097/QAD.0000000000000025; da Silva M, 2015, AIDS BEHAV, V19, P666, DOI 10.1007/s10461-014-0874-0; El-Khatib Z, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-88; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Govindasamy D, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19032; Guthrie BL, 2011, JAIDS-J ACQ IMM DEF, V58, pE87, DOI 10.1097/QAI.0b013e31822f064e; Hodgson I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111421; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Johnson MO, 2009, J GEN INTERN MED, V24, P247, DOI 10.1007/s11606-008-0854-z; Kahn TR, 2013, AIDS CARE, V25, P265, DOI 10.1080/09540121.2012.712660; Kaiser R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017842; Kurth AE, 2012, JAIDS-J ACQ IMM DEF, V61, pE65, DOI [10.1097/QAI.0b013e31826a184c., 10.1097/QAI.0b013e31826a184c]; Lyimo RA, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-716; Mugavero MJ, 2013, CLIN INFECT DIS, V57, P1164, DOI 10.1093/cid/cit420; Munro S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-104; Nabukeera-Barungi N, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1265-5; NASCOP N., 2014, KEN HIV EST; Organization) WWH, 2015, GUID START ANT THER; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Patel RC, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.21134; Posse M, 2008, TROP MED INT HEALTH, V13, P904, DOI 10.1111/j.1365-3156.2008.02091.x; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Scanlon ML, 2013, HIV AIDS-RES PALLIAT, V5, P1, DOI 10.2147/HIV.S28912; Sutcliffe CG, 2016, PEDIATR INFECT DIS J, V35, pE107, DOI 10.1097/INF.0000000000001021; Tabatabai J, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.24795; Vittinghoff E, 1999, J INFECT DIS, V179, P717, DOI 10.1086/314623; Wouters E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163963; Wouters E, 2012, SOC THEOR HEALTH, V10, P368, DOI 10.1057/sth.2012.12	35	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0168057	10.1371/journal.pone.0168057	http://dx.doi.org/10.1371/journal.pone.0168057			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930740	Green Published, gold, Green Submitted			2022-12-26	WOS:000389580900075
J	Mason, MJ; Cornwall, HL; Smith, ES				Mason, Matthew J.; Cornwall, Hannah L.; Smith, Ewan St J.			Ear Structures of the Naked Mole-Rat, Heterocephalus glaber, and Its Relatives (Rodentia: Bathyergidae)	PLOS ONE			English	Article							MIDDLE-EAR; SPALAX-EHRENBERGI; FUNCTIONAL-MORPHOLOGY; ACOUSTIC COMMUNICATION; CRYPTOMYS-HOTTENTOTUS; CONDUCTING APPARATUS; VOCAL COMMUNICATION; SUBTERRANEAN RODENT; SOUND LOCALIZATION; FREQUENCY HEARING	Although increasingly popular as a laboratory species, very little is known about the peripheral auditory system of the naked mole-rat, Heterocephalus glaber. In this study, middle and inner ears of naked mole-rats of a range of ages were examined using micro-computed tomography and dissection. The ears of five other bathyergid species (Bathyergus suillus, Cryptomys hottentotus, Fukomys micklemi, Georychus capensis and Heliophobius argenteocinereus) were examined for comparative purposes. The middle ears of bathyergids show features commonly found in other members of the Ctenohystrica rodent clade, including a fused malleus and incus, a synovial stapedio-vestibular articulation and the loss of the stapedius muscle. Heterocephalus deviates morphologically from the other bathyergids examined in that it has a more complex mastoid cavity structure, poorly-ossified processes of the malleus and incus, a 'columelliform' stapes and fewer cochlear turns. Bathyergids have semicircular canals with unusually wide diameters relative to their radii of curvature. How the lateral semicircular canal reaches the vestibule differs between species. Heterocephalus has much more limited high-frequency hearing than would be predicted from its small ear structures. The spongy bone forming its ossicular processes, the weak incudo-stapedial articulation, the columelliform stapes and (compared to other bathyergids) reduced cochlear coiling are all potentially degenerate features which might reflect a lack of selective pressure on its peripheral auditory system. Substantial intraspecific differences were found in certain middle and inner ear structures, which might also result from relaxed selective pressures. However, such interpretations must be treated with caution in the absence of experimental evidence.	[Mason, Matthew J.; Cornwall, Hannah L.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Smith, Ewan St J.] Univ Cambridge, Dept Pharmacol, Cambridge, England	University of Cambridge; University of Cambridge	Mason, MJ (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England.	mjm68@hermes.cam.ac.uk	St. John Smith, Ewan/G-1776-2011; Mason, Matthew James/AAX-9783-2021	St. John Smith, Ewan/0000-0002-2699-1979; Mason, Matthew James/0000-0001-7845-0720; Cornwall, Hannah/0000-0001-7647-9503	John Ray Trust Summer Research Grant; Royal Society Research Grant [RG130110]	John Ray Trust Summer Research Grant; Royal Society Research Grant(Royal Society of London)	Support was provided by a John Ray Trust Summer Research Grant (2015) to HLC [http://johnraytrust.com/] and a Royal Society Research Grant (RG130110) to ESS [https://royalsociety.org/grants-schemes-awards/grants/?gclid=CObSzoidrc8CFeQp0wodk4QENg]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The authors would like to record their immense gratitude to Phil Cox for sending us specimens and CT scans, and to Dominique Adriaens, Paul van Daele, Nigel Bennett and Radim umbera for originally providing the specimens concerned. Matt Lowe and Robert Asher at the University Museum of Zoology, Cambridge, kindly allowed access to that collection. We thank Mrs. Anita Shelley for making the histological slides, members of the Smith lab for help with specimen preparation, the Cambridge Biotomography Centre for the use of their scanner and the two reviewers for commenting on this paper. This work was supported by a John Ray Trust Summer Research Grant to H.L.C. and a Royal Society Research Grant (RG130110) to E.S.J.S.	Argyle EC, 2008, J MAMMAL, V89, P1447, DOI 10.1644/07-MAMM-A-401.1; Begall S, 2006, J MORPHOL, V267, P382, DOI 10.1002/jmor.10411; Begall S, 2004, J COMP PHYSIOL A, V190, P963, DOI 10.1007/s00359-004-0552-1; Bruckmann G, 1997, J COMP PHYSIOL A, V181, P83, DOI 10.1007/s003590050095; BRUNS V, 1988, HEARING RES, V33, P1, DOI 10.1016/0378-5955(88)90017-2; Buffenstein R, 2005, J GERONTOL A-BIOL, V60, P1369, DOI 10.1093/gerona/60.11.1369; BURDA H, 1990, Zoologische Jahrbuecher Abteilung fuer Systematik Oekologie und Geographie der Tiere, V117, P369; BURDA H, 1992, J MORPHOL, V214, P49, DOI 10.1002/jmor.1052140104; BURDA H, 1989, HEARING RES, V39, P225, DOI 10.1016/0378-5955(89)90042-7; Burda H, 2006, ANIM BIOL, V56, P475, DOI 10.1163/157075606778967847; COHEN YE, 1992, HEARING RES, V62, P187, DOI 10.1016/0378-5955(92)90185-P; Credner S, 1997, J COMP PHYSIOL A, V180, P245, DOI 10.1007/s003590050045; Crumpton N, 2015, J MORPHOL, V276, P900, DOI 10.1002/jmor.20391; Ekdale EG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066624; Ekdale EG, 2010, ANAT REC, V293, P1896, DOI 10.1002/ar.21234; Fabre PH, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-88; FLEISCHER G, 1973, Saeugetierkundliche Mitteilungen, V21, P131; Fleischer G., 1978, Advances in Anatomy Embryology and Cell Biology, V55, P1; Gessele N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146428; HEFFNER RS, 1993, J COMP NEUROL, V331, P418, DOI 10.1002/cne.903310311; Heffner RS, 2001, HEARING RES, V157, P138, DOI 10.1016/S0378-5955(01)00298-2; HEFFNER RS, 1990, HEARING RES, V46, P239, DOI 10.1016/0378-5955(90)90005-A; HEFFNER RS, 1992, HEARING RES, V62, P206, DOI 10.1016/0378-5955(92)90188-S; HEMILA S, 1995, HEARING RES, V85, P31, DOI 10.1016/0378-5955(95)00031-X; HETH G, 1986, EXPERIENTIA, V42, P1287, DOI 10.1007/BF01946426; Hetling JR, 2005, J COMP PHYSIOL A, V191, P317, DOI 10.1007/s00359-004-0584-6; HOYTE DA, 1961, AM J ANAT, V108, P1, DOI 10.1002/aja.1001080102; Huang GT, 2002, J COMP PHYSIOL A, V188, P663, DOI 10.1007/s00359-002-0332-8; HUANGFU M, 1983, J MORPHOL, V176, P249, DOI 10.1002/jmor.1051760302; Huttenbrink KB, 1996, LARYNGO RHINO OTOL, V75, P123, DOI 10.1055/s-2007-997549; Ingram CM, 2004, MOL PHYLOGENET EVOL, V31, P997, DOI 10.1016/j.ympev.2003.11.004; Jarvis Jennifer U.M., 2002, Mammalian Species, V706, P1, DOI 10.1644/1545-1410(2002)706<0001:HG>2.0.CO;2; Knotkova E, 2009, BIOACOUSTICS, V18, P241, DOI 10.1080/09524622.2009.9753604; Kossl M, 1996, J COMP PHYSIOL A, V178, P427; Kott O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011810; Lange S, 2005, AFRICAN BIODIVERSITY: MOLECULES, ORGANISMS, ECOSYSTEMS, P329, DOI 10.1007/0-387-24320-8_33; Lange S, 2007, NATURWISSENSCHAFTEN, V94, P134, DOI 10.1007/s00114-006-0168-0; Lange S, 2005, BELG J ZOOL, V135, P5; Laube B, 1990, VERH DTSCH ZOOL GES, V83, P415; LAY DOUGLAS, 1972, J MORPHOL, V138, P41, DOI 10.1002/jmor.1051380103; LINDENLAUB T, 1994, ANAT RECORD, V240, P286, DOI 10.1002/ar.1092400217; LINDENLAUB T, 1995, J MORPHOL, V224, P303, DOI 10.1002/jmor.1052240305; LINDENLAUB T, 1993, ANAT EMBRYOL, V188, P159; Manoussaki D, 2008, P NATL ACAD SCI USA, V105, P6162, DOI 10.1073/pnas.0710037105; Mason MJ, 2013, J LARYNGOL OTOL, V127, P2, DOI 10.1017/S0022215112002496; Mason MJ, 2016, J ANAT, V228, P300, DOI 10.1111/joa.12316; Mason MJ, 2016, J ANAT, V228, P284, DOI 10.1111/joa.12313; Mason MJ, 2013, HEARING RES, V301, P4, DOI 10.1016/j.heares.2012.10.004; Mason MJ, 2010, J MORPHOL, V271, P462, DOI 10.1002/jmor.10810; Mason MJ, 2006, J MORPHOL, V267, P678, DOI 10.1002/jmor.10430; Mason MJ, 2004, J MAMMAL, V85, P797, DOI 10.1644/BEL-102; Mason MJ, 2003, J ZOOL, V260, P391, DOI 10.1017/S095283690300387X; Mason MJ, 2001, J ZOOL, V255, P467; Mason MJ, 1999, FUNCTIONAL ANATOMY M; Mason MJ, 2015, CAMBRIDGE STUDIES MO, P373; Mason MJ, 2010, USE VIBRATIONS COMMU, P121; Mennecart B, 2016, J ANAT, V229, P422, DOI 10.1111/joa.12487; MULLER M, 1989, NATURWISSENSCHAFTEN, V76, P134, DOI 10.1007/BF00366611; MULLER M, 1992, J COMP PHYSIOL A, V171, P469; Oaks ECJ., 1967, STRUCTURE FUNCTION I; OMAN CM, 1987, ACTA OTO-LARYNGOL, V103, P1, DOI 10.3109/00016488709134691; Parent J.P., 1980, Memoires et Travaux de l'Institut de Montpellier de l'Ecole Pratique des Hautes Etudes, P1; PARENT JP, 1976, CR ACAD SCI D NAT, V283, P243; PEAKE WT, 1992, HEARING RES, V57, P245, DOI 10.1016/0378-5955(92)90155-G; Pepper J.W., 1991, P243; Potapova E.G., 2001, TRAKYA U J SCI RES, V2, P159; Prochel J, 2014, ACTA ZOOL-STOCKHOLM, V95, P220, DOI 10.1111/azo.12022; PYE A, 1977, J ZOOL, V182, P309; Pye A, 1972, SOUND, V6, P14; RADO R, 1989, HEARING RES, V41, P23, DOI 10.1016/0378-5955(89)90175-5; RAVICZ ME, 1992, J ACOUST SOC AM, V92, P157, DOI 10.1121/1.404280; Rosowski JJ, 2006, J COMP PHYSIOL A, V192, P1287, DOI 10.1007/s00359-006-0159-9; Schleich CE, 2004, J MAMMAL, V85, P290, DOI 10.1644/1545-1542(2004)085<0290:FMOTME>2.0.CO;2; Schumacher L, 2015, OPEN ACCESS ANIM PHY, V7, P137, DOI [DOI 10.2147/OAAP.S50376, 10.2147/OAAP.S50376, 10.2147/oaap.s50376]; SEGALL W, 1973, ACTA ANAT, V86, P96; SILVA M, 1995, CRC HDB MAMMALIAN BO; STEPHENS CB, 1972, ACTA OTO-LARYNGOL, P1; Van Daele PAAG, 2009, PHYSIOL BIOCHEM ZOOL, V82, P40, DOI 10.1086/594379; Vanden Hole C, 2014, BIOACOUSTICS, V23, P143, DOI 10.1080/09524622.2013.841085; VRETTAKOS PA, 1988, AM J OTOLARYNG, V9, P58, DOI 10.1016/S0196-0709(88)80009-7; Walton AH, 2000, MOL PHYLOGENET EVOL, V16, P467, DOI 10.1006/mpev.2000.0808; WEBSTER DB, 1975, J MORPHOL, V146, P343, DOI 10.1002/jmor.1051460304; WEBSTER DB, 1975, J MORPHOL, V146, P377, DOI 10.1002/jmor.1051460305; WEST CD, 1985, J ACOUST SOC AM, V77, P1091, DOI 10.1121/1.392227; ZIMMER WM, 1994, ANAT REC, V239, P475, DOI 10.1002/ar.1092390413; [No title captured]	86	36	36	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2016	11	12							e0167079	10.1371/journal.pone.0167079	http://dx.doi.org/10.1371/journal.pone.0167079			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4NG	27926945	gold, Green Published, Green Submitted			2022-12-26	WOS:000389578800009
J	Cisneros-Montemayor, AM; Pauly, D; Weatherdon, LV; Ota, Y				Cisneros-Montemayor, Andreas M.; Pauly, Daniel; Weatherdon, Lauren V.; Ota, Yoshitaka			A Global Estimate of Seafood Consumption by Coastal Indigenous Peoples	PLOS ONE			English	Article							CLIMATE-CHANGE IMPACTS; FISHERIES; FOOD; METAANALYSIS; RIGHTS; FRAMEWORK; BENEFITS; MERCURY; LOSSES; RISKS	Coastal Indigenous peoples rely on ocean resources and are highly vulnerable to ecosystem and economic change. Their challenges have been observed and recognized at local and regional scales, yet there are no global-scale analyses to inform international policies. We compile available data for over 1,900 coastal Indigenous communities around the world representing 27 million people across 87 countries. Based on available data at local and regional levels, we estimate a total global yearly seafood consumption of 2.1 million (1.5 million -2.8 million) metric tonnes by coastal Indigenous peoples, equal to around 2% of global yearly commercial fisheries catch. Results reflect the crucial role of seafood for these communities; on average, consumption per capita is 15 times higher than non-Indigenous country populations. These findings contribute to an urgently needed sense of scale to coastal Indigenous issues, and will hopefully prompt increased recognition and directed research regarding the marine knowledge and resource needs of Indigenous peoples. Marine resources are crucial to the continued existence of coastal Indigenous peoples, and their needs must be explicitly incorporated into management policies.	[Cisneros-Montemayor, Andreas M.; Ota, Yoshitaka] Univ British Columbia, Inst Oceans & Fisheries, NEREUS Program, Vancouver, BC, Canada; [Pauly, Daniel] Univ British Columbia, Sea Us Project, Inst Oceans & Fisheries, Vancouver, BC, Canada; [Weatherdon, Lauren V.] UNEP World Conservat Monitoring Ctr, Cambridge, England	University of British Columbia; University of British Columbia	Cisneros-Montemayor, AM; Ota, Y (corresponding author), Univ British Columbia, Inst Oceans & Fisheries, NEREUS Program, Vancouver, BC, Canada.	a.cisneros@oceans.ubc.ca; y.ota@oceans.ubc.ca	Pauly, Daniel Marc/AAY-2316-2021	Weatherdon, Lauren V./0000-0002-3989-027X; Cisneros-Montemayor, Andres M./0000-0002-4132-5317; Pauly, Daniel/0000-0003-3756-4793	Nippon Foundation Nereus Program; Sea Around US project; UN World Conservation Monitoring Centre	Nippon Foundation Nereus Program; Sea Around US project; UN World Conservation Monitoring Centre	The authors are supported by The Nippon Foundation Nereus Program (http://www.nereusprogram.org/), the Sea Around US project (http://www.seaaroundus.org/), and the UN World Conservation Monitoring Centre (http://www.unep-wcmc.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acheson JM, 2011, INT J COMMONS, V5, P319; Adger WN, 2009, FRONT ECOL ENVIRON, V7, P150, DOI 10.1890/070148; Alfred GT, 2009, INT J INDIG HEALTH, V5, P42; [Anonymous], [No title captured]; Anticamara JA, 2011, FISH RES, V107, P131, DOI 10.1016/j.fishres.2010.10.016; Australian Bureau of Statistics, 2015, COMMUNITY PROFILES; Bailar JC, 1997, NEW ENGL J MED, V337, P559, DOI 10.1056/NEJM199708213370810; Berkes F, 2000, ECOL APPL, V10, P1251, DOI 10.1890/1051-0761(2000)010[1251:ROTEKA]2.0.CO;2; Berkes F, 2006, ECOL SOC, V11; Brashares JS, 2014, SCIENCE, V345, P376, DOI 10.1126/science.1256734; Cantor-Graae E, 2014, AM J PSYCHIAT; Capistrano RCG, 2012, OCEAN COAST MANAGE, V69, P200, DOI 10.1016/j.ocecoaman.2012.08.011; Castro-Gonzalez MI, 2008, ENVIRON TOXICOL PHAR, V26, P263, DOI 10.1016/j.etap.2008.06.001; Cheung WWL, 2013, NATURE, V497, P365, DOI 10.1038/nature12156; Cheung WWL, 2010, GLOBAL CHANGE BIOL, V16, P24, DOI 10.1111/j.1365-2486.2009.01995.x; Cinner JE, 2012, P NATL ACAD SCI USA, V109, P5219, DOI 10.1073/pnas.1121215109; Cisneros-Montemayor A. M., 2010, J BIOECONOMICS, V12, P245, DOI DOI 10.1007/S10818-010-9092-7; Clark CW, 2005, J ENVIRON ECON MANAG, V50, P47, DOI 10.1016/j.jeem.2004.11.002; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; CROWLEY PH, 1992, ANNU REV ECOL SYST, V23, P405, DOI 10.1146/annurev.es.23.110192.002201; Crystal D., 2000, LANGUAGE DEATH; Cunneen C., 2006, CURRENT ISSUES CRIMI, V17, P329, DOI DOI 10.1080/10345329.2006.12036363; DAA, 2014, ABORIGINAL COMMUNITI; Davis A, 2001, MAR POLICY, V25, P223, DOI 10.1016/S0308-597X(01)00014-8; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; FAO, 2015, FOOD BALANCE SHEET O; FAO, 2014, STATE OF WORLD FISHE; FAO, 2015, CWP HANDBOOK OF FISH; FAO (Food and Agriculture Organization of the United Nations), 2015, VOLUNTARY GUIDELINES; Gillett R., 2009, FISHERIES EC PACIFIC, P521; Government of Canada, 2015, FIRST NATION PROFILE; Gutierrez NL, 2011, NATURE, V470, P386, DOI 10.1038/nature09689; anazaki Natalia, 2007, Ambient. soc., V10, P121, DOI 10.1590/S1414-753X2007000100008; Howard BV, 1999, CIRCULATION, V99, P2389, DOI 10.1161/01.CIR.99.18.2389; Hsiang SM, 2013, SCIENCE, V341, P1212, DOI 10.1126/science.1235367; Human Relations Area Files, 2015, EHRAF WORLD CULTURES; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jentoft S, 2015, MARE PUBL SER, V13, P727, DOI 10.1007/978-3-319-17034-3_37; Johannes RE., 1992, MARINE RESOURCE EC, V7, P249, DOI [10.1086/mre.7.4.42629038, DOI 10.1086/MRE.7.4.42629038]; Kirk JL, 2012, ENVIRON RES, V119, P64, DOI 10.1016/j.envres.2012.08.012; Kleisner K, 2015, REPORT NO 2015 02; Kuhnlein HV, 2007, J NUTR, V137, P1110, DOI 10.1093/jn/137.4.1110; Laird BD, 2013, J NUTR, V143, P923, DOI 10.3945/jn.112.173351; Lam VWY, 2012, AFR J MAR SCI, V34, P103, DOI 10.2989/1814232X.2012.673294; Martinez Cobo JR, 1983, REPORT NO E CN 4 SUB; Masson-Delmotte V., 2018, GLOBAL WARMING 15 C; McGoodwin JR, 1990, CRISIS IN THE WORLD; McNiven IJ, 2003, WORLD ARCHAEOL, V35, P329, DOI 10.1080/0043824042000185757; Meur C., 2001, PEOPLES AFRICA ETHNO; Minority Rights Group International, 2005, WORLD DIRECTORY OF M; Office of the High Commissioner for Human Rights Asia Pacific Forum of National Human Rights Institutions, 2013, THE UNITED NATIONS D; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Pauly D., 2006, MAR STUD MAST, V4, P7, DOI DOI 10.1126/SCIENCE.279.5352.860.PMID:9452385; Pauly D, 1950, GLOBAL FISHERIES CAT; Pauly D, 2014, FISH FISH, V15, P474, DOI 10.1111/faf.12032; Poe MR, 2015, ECOL ECON, V116, P241, DOI 10.1016/j.ecolecon.2015.05.003; Rosenberger RS, 2006, ECOL ECON, V60, P372, DOI 10.1016/j.ecolecon.2006.03.018; Rosenthal R, 2001, ANNU REV PSYCHOL, V52, P59, DOI 10.1146/annurev.psych.52.1.59; Rouja PM, 1998, FISHING FOR CULTURE; Russian Federal State Statistics Service, 2010, LANGUAGES OF INDIGEN, V4; Sanders D.E., 1999, INT J CULT PROP, V8, P4, DOI [DOI 10.1017/S0940739199770591, 10.1017/S0940739199770591]; Sidhu KS, 2003, REGUL TOXICOL PHARM, V38, P336, DOI 10.1016/j.yrtph.2003.07.002; Smith LC, 2013, P NATL ACAD SCI USA, V110, pE1191, DOI 10.1073/pnas.1214212110; Srinivasan UT, 2012, MAR POLICY, V36, P544, DOI 10.1016/j.marpol.2011.10.001; Stuck AE, 1998, BRIT MED J, V316, P469, DOI 10.1136/bmj.316.7129.469; Sumaila UR, 2011, NAT CLIM CHANGE, V1, P449, DOI 10.1038/NCLIMATE1301; Taylor LE, 2014, VACCINE, V32, P3623, DOI 10.1016/j.vaccine.2014.04.085; The Fund for Peace, 2015, FRAGILE STATES INDEX; Thorson JT, 2015, FISH FISH, V16, P342, DOI 10.1111/faf.12061; UN, 2008, UN EXP GROUP M POP D, P1; UN, 2015, WORKING GROUP ON IND; UN, 2015, COMPOSITION OF MACRO; UN-DESA, 2009, STATE OF THE WORLDS; United Nations, 2015, SUSTAINABLE DEV GOAL, DOI DOI 10.1163/157180910X12665776638740; US Census Bureau, 2010, 2010 AMERICAN INDIAN; Weatherdon LV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145285; Witter R, 2014, CONSERV BIOL, V28, P1394, DOI 10.1111/cobi.12283; Wittman H, 2011, ENVIRON SOC, V2, P87, DOI 10.3167/ares.2011.020106; World Bank, 2009, THE SUNKEN BILLIONS, P130; YOUNG TK, 1992, INT J EPIDEMIOL, V21, P730, DOI 10.1093/ije/21.4.730; Zeller D, 2011, POLAR BIOL, V34, P955, DOI 10.1007/s00300-010-0952-3	82	98	99	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2016	11	12							e0166681	10.1371/journal.pone.0166681	http://dx.doi.org/10.1371/journal.pone.0166681			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4MR	27918581	Green Published, gold, Green Submitted			2022-12-26	WOS:000389577100003
J	Andrienko, T; Pasdois, P; Rossbach, A; Halestrap, AP				Andrienko, Tatyana; Pasdois, Philippe; Rossbach, Andreas; Halestrap, Andrew P.			Real-Time Fluorescence Measurements of ROS and [Ca2+] in Ischemic/Reperfused Rat Hearts: Detectable Increases Occur only after Mitochondrial Pore Opening and Are Attenuated by Ischemic Preconditioning	PLOS ONE			English	Article							PERMEABILITY TRANSITION PORE; INTRACELLULAR FREE CALCIUM; IMAGING HYDROGEN-PEROXIDE; OXYGEN SPECIES PRODUCTION; REPERFUSION INJURY; OXIDATIVE STRESS; HYPOXIA-REOXYGENATION; LIVER MITOCHONDRIA; CARDIAC ISCHEMIA; CYCLOSPORINE-A	Mitochondrial permeability transition pore (mPTP) opening is critical for ischemia / reperfusion (I/R) injury and is associated with increased [Ca2+] and reactive oxygen species (ROS). Here we employ surface fluorescence to establish the temporal sequence of these events in beating perfused hearts subject to global I/R. A bespoke fluorimeter was used to synchronously monitor surface fluorescence and reflectance of Langendorff-perfused rat hearts at multiple wavelengths, with simultaneous measurements of hemodynamic function. Potential interference by motion artefacts and internal filtering was assessed and minimised. Re-oxidation of NAD(P)H and flavoproteins on reperfusion (detected using autofluorescence) was rapid (t(0.5) < 15 s) and significantly slower following ischemic preconditioning (IP). This argues against superoxide production from reduced Complex 1 being a critical mediator of initial mPTP opening during early reperfusion. Furthermore, MitoPY1 (a mitochondria-targeted H2O2-sensitive fluorescent probe) and aconitase activity measurements failed to detect matrix ROS increases during early reperfusion. However, two different fluorescent cytosolic ROS probes did detect ROS increases after 2-3 min of reperfusion, which was shown to be after initiation of mPTP opening. Cyclosporin A (CsA) and IP attenuated these responses and reduced infarct size. [Ca2+](i) (monitored with Indo-1) increased progressively during ischemia, but dropped rapidly within 90 s of reperfusion when total mitochondrial [Ca2+] was shown to be increased. These early changes in [Ca2+] were not attenuated by IP, but substantial [Ca2+] increases were observed after 2-3 min reperfusion and these were prevented by both IP and CsA. Our data suggest that the major increases in ROS and [Ca2+] detected later in reperfusion are secondary to mPTP opening. If earlier IP-sensitive changes occur that might trigger initial mPTP opening they are below our limit of detection. Rather, we suggest that IP may inhibit initial mPTP opening by alternative mechanisms such as prevention of hexokinase 2 dissociation from mitochondria during ischemia.	[Andrienko, Tatyana; Pasdois, Philippe; Rossbach, Andreas; Halestrap, Andrew P.] Univ Bristol, Sch Biochem, Biomed Sci Bldg, Bristol, Avon, England; [Andrienko, Tatyana; Pasdois, Philippe; Rossbach, Andreas; Halestrap, Andrew P.] Univ Bristol, Bristol Cardiovasc, Biomed Sci Bldg, Bristol, Avon, England; [Pasdois, Philippe] Univ Bordeaux, INSERM, U1045, Inst Rythmol & Modelisat Cardiaque LIRYC, Bordeaux, France	University of Bristol; University of Bristol; CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Halestrap, AP (corresponding author), Univ Bristol, Sch Biochem, Biomed Sci Bldg, Bristol, Avon, England.; Halestrap, AP (corresponding author), Univ Bristol, Bristol Cardiovasc, Biomed Sci Bldg, Bristol, Avon, England.	a.halestrap@bristol.ac.uk	Pasdois, Philippe/AAH-9365-2020	Pasdois, Philippe/0000-0002-2385-4469; Rossbach, Andreas/0000-0002-6041-7348	Medical Research Council [G0801237]; British Heart Foundation [RG/08/001/24717, PG/12/40/29634]; MRC [G0801237] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council (www.mrc.ac.uk/) grant number G0801237 to APH and PP and the British Heart Foundation (www.bhf.org.uk) grant numbers RG/08/001/24717 (to APH) and PG/12/40/29634 (to APH, PP and TA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlam VJ, 2005, FASEB J, V19, P1088, DOI 10.1096/fj.05-3718com; Arai AE, 1999, AM J PHYSIOL-HEART C, V277, pH683, DOI 10.1152/ajpheart.1999.277.2.H683; Assaly R, 2012, EUR J PHARMACOL, V675, P6, DOI 10.1016/j.ejphar.2011.11.036; Becker LB, 2004, CARDIOVASC RES, V61, P461, DOI 10.1016/j.cardiores.2003.10.025; Calmettes G, 2015, J MOL CELL CARDIOL, V78, P107, DOI 10.1016/j.yjmcc.2014.09.020; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; Clarke SJ, 2008, CIRC RES, V102, P1082, DOI 10.1161/CIRCRESAHA.107.167072; Clarke SJ, 2002, J BIOL CHEM, V277, P34793, DOI 10.1074/jbc.M202191200; Cross HR, 1996, CIRC RES, V78, P482, DOI 10.1161/01.RES.78.3.482; Cung TT, 2015, NEW ENGL J MED, V373, P1021, DOI 10.1056/NEJMoa1505489; Davidson SM, 2012, CARDIOVASC RES, V93, P445, DOI 10.1093/cvr/cvr349; Garcia-Rivas GD, 2006, BRIT J PHARMACOL, V149, P829, DOI 10.1038/sj.bjp.0706932; Dickinson BC, 2008, J AM CHEM SOC, V130, P9638, DOI 10.1021/ja802355u; Dickinson BC, 2010, J AM CHEM SOC, V132, P5906, DOI 10.1021/ja1014103; Dikalov SI, 2014, ANTIOXID REDOX SIGN, V20, P372, DOI 10.1089/ars.2012.4886; Doran E, 2000, BIOCHEM J, V348, P343, DOI 10.1042/0264-6021:3480343; Fancelli D, 2014, J MED CHEM, V57, P5333, DOI 10.1021/jm500547c; GRIFFITHS EJ, 1993, J MOL CELL CARDIOL, V25, P1461, DOI 10.1006/jmcc.1993.1162; GRIFFITHS EJ, 1995, BIOCHEM J, V307, P93, DOI 10.1042/bj3070093; Griffiths EJ, 1997, AM J PHYSIOL-CELL PH, V273, pC37, DOI 10.1152/ajpcell.1997.273.1.C37; Halestrap AP, 2015, BRIT J PHARMACOL, V172, P2085, DOI 10.1111/bph.12899; Halestrap AP, 2015, J MOL CELL CARDIOL, V78, P129, DOI 10.1016/j.yjmcc.2014.08.018; Halestrap AP, 2010, BIOCHEM SOC T, V38, P841, DOI 10.1042/BST0380841; HALESTRAP AP, 1982, BIOCHEM J, V204, P37, DOI 10.1042/bj2040037; Halestrap AP, 1997, MOL CELL BIOCHEM, V174, P167, DOI 10.1023/A:1006879618176; Hansson MJ, 2015, EUR J PHARMACOL, V760, P7, DOI 10.1016/j.ejphar.2015.04.009; Heusch G, 2015, CIRC RES, V116, P674, DOI 10.1161/CIRCRESAHA.116.305348; Javadov SA, 2003, J PHYSIOL-LONDON, V549, P513, DOI 10.1113/jphysiol.2003.034231; Karch J, 2014, P NATL ACAD SCI USA, V111, P10396, DOI 10.1073/pnas.1410104111; Karlsson M, 2010, BIOCHEM J, V428, P183, DOI 10.1042/BJ20100208; Kevin LG, 2003, AM J PHYSIOL-HEART C, V284, pH566, DOI 10.1152/ajpheart.00711.2002; Kim JS, 2006, AM J PHYSIOL-HEART C, V290, pH2024, DOI 10.1152/ajpheart.00683.2005; Kwong JQ, 2015, CELL REP, V12, P15, DOI 10.1016/j.celrep.2015.06.002; LATTANZIO FA, 1991, BIOCHEM BIOPH RES CO, V177, P184, DOI 10.1016/0006-291X(91)91966-G; Lee S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2060; Liimatta E, 2007, J BIOCHEM BIOPH METH, V70, P547, DOI 10.1016/j.jbbm.2007.01.006; Lu LS, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2186321; Luongo TS, 2015, CELL REP, V12, P23, DOI 10.1016/j.celrep.2015.06.017; Murphy E, 2013, CIRC RES, V113, P852, DOI 10.1161/CIRCRESAHA.113.301950; Napankangas JP, 2012, J MOL CELL CARDIOL, V53, P906, DOI 10.1016/j.yjmcc.2012.09.011; Nederlof R, 2014, BRIT J PHARMACOL, V171, P2067, DOI 10.1111/bph.12363; Ong SB, 2015, BRIT J PHARMACOL, V172, P2074, DOI 10.1111/bph.13013; Ong SB, 2015, J MOL CELL CARDIOL, V78, P23, DOI 10.1016/j.yjmcc.2014.11.005; OWEN MR, 1993, BIOCHIM BIOPHYS ACTA, V1142, P11, DOI 10.1016/0005-2728(93)90079-U; Pagliaro P, 2015, BRIT J PHARMACOL, V172, P1974, DOI 10.1111/bph.12975; Pasdois P, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.005645; Pasdois P, 2011, BIOCHEM J, V436, P493, DOI 10.1042/BJ20101957; Pell VR, 2016, CARDIOVASC RES, V111, P134, DOI 10.1093/cvr/cvw100; SILVERMAN HS, 1994, CARDIOVASC RES, V28, P581, DOI 10.1093/cvr/28.5.581; STONE D, 1989, J MOL CELL CARDIOL, V21, P963, DOI 10.1016/0022-2828(89)90795-5; Varadarajan SG, 2001, AM J PHYSIOL-HEART C, V280, pH280, DOI 10.1152/ajpheart.2001.280.1.H280; Varanyuwatana P, 2012, MITOCHONDRION, V12, P120, DOI 10.1016/j.mito.2011.04.006; Vinten-Johansen J, 2005, CIRCULATION, V112, P2085, DOI 10.1161/CIRCULATIONAHA.105.569798; Ylitalo KV, 2000, J MOL CELL CARDIOL, V32, P1223, DOI 10.1006/jmcc.2000.1157; Zhao HT, 2005, P NATL ACAD SCI USA, V102, P5727, DOI 10.1073/pnas.0501719102; Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013	56	40	40	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167300	10.1371/journal.pone.0167300	http://dx.doi.org/10.1371/journal.pone.0167300			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907091	Green Published, Green Submitted, gold			2022-12-26	WOS:000389482700113
J	Haridy, Y; Macdougall, MJ; Scott, D; Reisz, RR				Haridy, Yara; Macdougall, Mark J.; Scott, Diane; Reisz, Robert R.			Ontogenetic Change in the Temporal Region of the Early Permian Parareptile Delorhynchus cifellii and the Implications for Closure of the Temporal Fenestra in Amniotes	PLOS ONE			English	Article							COLOBOMYCTER-PHOLETER; BONE ORNAMENTATION; SP-NOV; GROWTH; DIFFERENTIATION; OSTEOLOGY; OKLAHOMA; ANATOMY; REPTILE; SUTURES	A juvenile specimen of Delorhynchus cifellii, collected from the Early Permian fissure-fill deposits of Richards Spur, Oklahoma, permits the first detailed study of cranial ontogeny in this parareptile. The specimen, consisting of a partially articulated skull and mandible, exhibits several features that identify it as juvenile. The dermal tuberosities that ornament the dorsal side and lateral edges of the largest skull of D. cifellii specimens, are less prominent in the intermediate sized holotype, and are absent in the new specimen. This indicates that the new specimen represents an earlier ontogenetic stage than all previously described members of this species. In addition, the incomplete interdigitation of the sutures, most notably along the fronto-nasal contact, plus the proportionally larger sizes of the orbit and temporal fenestrae further support an early ontogenetic stage for this specimen. Comparisons between this juvenile and previously described specimens reveal that the size and shape of the temporal fenestra in Delorhynchus appear to vary through ontogeny, due to changes in the shape and size of the bordering cranial elements. The jugal of the juvenile specimen is tri-radiate and similar in outline with those found in other amniotes with temporal fenestrae. The available growth series of D. cifellii shows that the jugal gradually becomes a more robust, tetra-radiate element, as the proportionate size of the temporal fenestra is reduced. Ontogenetic changes of other elements that form the border of the fenestra also contribute to its reduction. This growth series provides valuable new information regarding the ontogenetic trajectory of the temporal fenestra in a Palaeozoic reptile, which may be applicable to the evolutionary event of loss of temporal fenestration in other amniotes.	[Haridy, Yara; Macdougall, Mark J.; Scott, Diane; Reisz, Robert R.] Univ Toronto, Dept Biol, Mississauga, ON, Canada	University of Toronto; University Toronto Mississauga	Haridy, Y (corresponding author), Univ Toronto, Dept Biol, Mississauga, ON, Canada.	yara.hardy@mail.utoronta.ca	haridy, yara/AAT-3129-2021	haridy, yara/0000-0002-6908-5749	University of Toronto Mississauga; Natural Science and Engineering council of Canada; NSERC	University of Toronto Mississauga(University of Toronto); Natural Science and Engineering council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	R.R. - support by grants from the University of Toronto Mississauga, and a Discovery grant Natural Science and Engineering council of Canada.; We thank R. Cifelli and W. May of the Sam Noble Museum of Natural History for the loan of specimens. R.R.R is supported by grants from the University of Toronto Mississauga and NSERC Discovery Grant Program.	Bailleul AM, 2016, CR PALEVOL, V15, P49, DOI 10.1016/j.crpv.2014.12.004; Bailleul AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036112; Brochu CA, 1996, J VERTEBR PALEONTOL, V16, P49, DOI 10.1080/02724634.1996.10011283; Cisneros JC, 2004, P ROY SOC B-BIOL SCI, V271, P1541, DOI 10.1098/rspb.2004.2748; Currie PJ, 2016, J VERTEBR PALEONTOL, V36, DOI 10.1080/02724634.2015.1048348; de Buffrenil V, 2015, J MORPHOL, V276, P425, DOI 10.1002/jmor.20351; de Buffrenil V, 2016, J MORPHOL, V277, P634, DOI 10.1002/jmor.20525; Debraga M, 1996, J VERTEBR PALEONTOL, V16, P384, DOI 10.1080/02724634.1996.10011328; FOX RICHARD C., 1962, UNIV KANSAS PUBL MUS NAT HIST, V12, P297; GOW CE, 1972, J ZOOL, V167, P219; LAURIN M, 1995, ZOOL J LINN SOC-LOND, V113, P165, DOI 10.1111/j.1096-3642.1995.tb00932.x; MacDougall MJ, 2014, ZOOL J LINN SOC-LOND, V172, P616, DOI 10.1111/zoj12180; MacDougall MJ, 2016, J VERTEBR PALEONTOL, V36, DOI 10.1080/02724634.2016.1179641; Macdougall MJ, 2012, J VERTEBR PALEONTOL, V32, P1018, DOI 10.1080/02724634.2012.679757; MacDougall MJ, ZOOL J LINN IN PRESS; Modesto SP, 2008, J VERTEBR PALEONTOL, V28, P677, DOI 10.1671/0272-4634(2008)28[677:NMOCPA]2.0.CO;2; Modesto SP, 1999, J VERTEBR PALEONTOL, V19, P466, DOI 10.1080/02724634.1999.10011159; Muller J, 2003, NATURWISSENSCHAFTEN, V90, P473, DOI 10.1007/s00114-003-0461-0; Opperman LA, 2000, DEV DYNAM, V219, P472, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1073>3.0.CO;2-F; Reisz R.R., 1984, Journal of Vertebrate Paleontology, V4, P57; Reisz RR, 2007, ZOOL J LINN SOC-LOND, V151, P191, DOI 10.1111/j.1096-3642.2007.00312.x; Reisz RR, 2002, J VERTEBR PALEONTOL, V22, P244, DOI 10.1671/0272-4634(2002)022[0244:OKSNAS]2.0.CO;2; RIEPPEL O, 1990, BIOL J LINN SOC, V39, P177, DOI 10.1111/j.1095-8312.1990.tb00510.x; Tsuji LA, 2006, J VERTEBR PALEONTOL, V26, P849, DOI 10.1671/0272-4634(2006)26[849:CAAPAO]2.0.CO;2; Tsuji LA, 2013, EARTH ENV SCI T R SO, V104, P81, DOI 10.1017/S1755691013000492; Tsuji LA, 2010, J SYST PALAEONTOL, V8, P245, DOI 10.1080/14772010903461099	26	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166819	10.1371/journal.pone.0166819	http://dx.doi.org/10.1371/journal.pone.0166819			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907071	Green Submitted, Green Published, gold			2022-12-26	WOS:000389482700044
J	Hu, FW; Zhai, N; Gao, W; Wu, P; Luo, YY; Pan, DF; Liu, Y; Li, DY				Hu, Fengwang; Zhai, Nana; Gao, Wen; Wu, Pei; Luo, Yuanyuan; Pan, Defeng; Liu, Yang; Li, Dongye			Outer Balloon Ligation Increases Success Rate of Ischemia-Reperfusion Injury Model in Mice	PLOS ONE			English	Article							CORONARY COLLATERAL GROWTH; MYOCARDIAL-INFARCTION; INFLAMMATORY RESPONSE; ARTERY LIGATION; ANIMAL-MODELS; CLOSED-CHEST; MOUSE	Background Coronary artery disease is a growing public health problem and a major cause of morbidity and mortality. Experimental animal models provide valuable tools for studying myocardial ischemia reperfusion (I/R) injury in vivo. Objective The purpose of this study was to describe a new method (outer balloon ligation) to induce myocardial I/R injury in mice. Methods Ninety-nine male C57BL/6J mice were randomly divided into three groups: sham group, classic method group (I/R-C) and the new method group (I/R-N). The surgical procedure and recovery time were recorded. The levels of TNF-alpha, IL-6, cTnT and LDH were detected by ELISA kits. Hematoxylin-eosin staining was applied to assess neutrophil infiltration. Moreover, surgical survival, myocardial infarction areas, and cardiac function measurements were also recorded. Results The reperfusion operation time in the I/R-N group were markedly less than the I/R-C group (14.73 +/- 2.86 vs. 168.60 +/- 33.01 sec, p<0.0001). Similarly, the recovery time in I/R-N group was shorter than the I/R-C group (45.39 +/- 15.39 vs. 101.70 +/- 19.33 min, p<0.0001). The levels of TNF-a and IL-6 in I/R-N group were also markedly lower than in I/R-C group (136.5 +/- 22.21 vs. 170.5 +/- 24.79 pg/ml, p<0.05 and 100.3 +/- 23.74 vs. 144.40 +/- 22.24 pg/ml, p<0.001). Compared I/R-N group with I/R-C group, the levels of neutrophil infiltration, cTnT and LDH had no significant differences. Surgical survival rate was 96.7% in the I/R-N group, which was significantly improved compared to the rate of 80% in the I/R-C group. However, there were no significant differences in the areas of myocardial infarction and cardiac function between the two groups. Conclusions Compared with the classic method, our new method of inducing myocardial I/R injury has higher efficiency and less tissue damage in mice, but achieves the same modeling effects.	[Hu, Fengwang; Gao, Wen; Wu, Pei; Liu, Yang; Li, Dongye] Xuzhou Med Univ, Inst Cardiovasc Dis, Xuzhou, Jiangsu, Peoples R China; [Zhai, Nana; Luo, Yuanyuan; Pan, Defeng] Xuzhou Med Univ, Affiliated Hosp, Dept Cardiol, Xuzhou, Jiangsu, Peoples R China	Xuzhou Medical University; Xuzhou Medical University	Li, DY (corresponding author), Xuzhou Med Univ, Inst Cardiovasc Dis, Xuzhou, Jiangsu, Peoples R China.	ldy@xzmc.edu.cn	李, 东/GYA-4703-2022; 李, 东野/AAY-6410-2020		National Natural Science Foundation of China [81570326]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study is supported by National Natural Science Foundation of China (81570326). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarbanell AM, 2010, J SURG RES, V162, P239, DOI 10.1016/j.jss.2009.06.021; Ahn D, 2004, AM J PHYSIOL-HEART C, V286, pH1201, DOI 10.1152/ajpheart.00862.2003; Bian C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144877; Borst O, 2011, CELL PHYSIOL BIOCHEM, V28, P1, DOI 10.1159/000331708; Diepenhorst GMP, 2009, ANN SURG, V249, P889, DOI 10.1097/SLA.0b013e3181a38f45; Eckle T, 2006, AM J PHYSIOL-HEART C, V291, pH2533, DOI 10.1152/ajpheart.00472.2006; Eckle T, 2011, JOVE-J VIS EXP, DOI 10.3791/2526; Fontes JA, 2015, CYTOKINE, V74, P62, DOI 10.1016/j.cyto.2014.12.024; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; Gao E, 2010, CIRC RES, V107, P1445, DOI 10.1161/CIRCRESAHA.110.223925; Gehrmann J, 2001, BASIC RES CARDIOL, V96, P237, DOI 10.1007/s003950170054; H-Ici DO, 2016, RADIOLOGY, V278, P742, DOI 10.1148/radiol.2015151332; H-Ici DO, 2015, INT J CARDIOVAS IMAG, V31, P115, DOI 10.1007/s10554-014-0539-0; Hale SL, 1998, CARDIOVASC RES, V40, P502, DOI 10.1016/S0008-6363(98)00191-6; Hashmi S, 2015, INT J CLIN EXP PATHO, V8, P8786; Hattan N, 2007, BASIC RES CARDIOL, V102, P217, DOI 10.1007/s00395-007-0646-3; Jong WMC, 2014, INT J CARDIOL, V177, P41, DOI 10.1016/j.ijcard.2014.09.148; Jong WMC, 2003, COMPARATIVE MED, V53, P522; Kaiser RA, 2005, AM J PHYSIOL-HEART C, V289, pH2747, DOI 10.1152/ajpheart.01280.2004; Krombach GA, 2005, INVEST RADIOL, V40, P14; Kumar D, 2005, CORONARY ARTERY DIS, V16, P41, DOI 10.1097/00019501-200502000-00008; Liao XL, 2013, J CARDIOVASC PHARM, V61, P430, DOI 10.1097/FJC.0b013e318288a68d; Lips DJ, 2004, BASIC RES CARDIOL, V99, P351, DOI 10.1007/s00395-004-0476-5; Lukacs E, 2012, ACTA PHYSIOL HUNG, V99, P365, DOI 10.1556/APhysiol.99.2012.4.1; Lutgens E, 1999, CARDIOVASC RES, V41, P586, DOI 10.1016/S0008-6363(98)00216-8; Michael LH, 1995, AM J PHYSIOL-HEART C, V269, pH2147, DOI 10.1152/ajpheart.1995.269.6.H2147; NEELY JR, 1967, AM J PHYSIOL, V212, P804; Nossuli TO, 2000, AM J PHYSIOL-HEART C, V278, pH1049, DOI 10.1152/ajpheart.2000.278.4.H1049; Patten RD, 1998, AM J PHYSIOL, V274, P1812; Pung YF, 2012, ARTERIOSCL THROM VAS, V32, P325, DOI 10.1161/ATVBAHA.111.241802; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Schultz JE, 2001, PHARMACOL THERAPEUT, V89, P123, DOI 10.1016/S0163-7258(00)00106-6; Toyota E, 2005, CIRCULATION, V112, P2108, DOI 10.1161/CIRCULATIONAHA.104.526954; van Hout GPJ, 2015, J CELL MOL MED, V19, P2655, DOI 10.1111/jcmm.12656; Verdouw PD, 1998, CARDIOVASC RES, V39, P121, DOI 10.1016/S0008-6363(98)00069-8; Virag JAI, 2011, JOVE-J VIS EXP, DOI 10.3791/2581; Xu ZB, 2014, JOVE-J VIS EXP, DOI 10.3791/51329	37	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167631	10.1371/journal.pone.0167631	http://dx.doi.org/10.1371/journal.pone.0167631			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907155	Green Submitted, Green Published, gold			2022-12-26	WOS:000389482700216
J	Janssens, GE; Veenhoff, LM				Janssens, Georges E.; Veenhoff, Liesbeth M.			The Natural Variation in Lifespans of Single Yeast Cells Is Related to Variation in Cell Size, Ribosomal Protein, and Division Time	PLOS ONE			English	Article							TOR; HYPERTROPHY; TRANSLATION; LONGEVITY; EXTENSION; GENETICS; KINASE; AGE	There is a large variability in lifespans of individuals even if they are genetically identical and raised under the same environmental conditions. Our recent system wide study of replicative aging in baker's yeast predicts that protein biogenesis is a driver of aging. Here, we address how the natural variation in replicative lifespan within wild-type populations of yeast cells correlates to three biogenesis-related parameters, namely cell size, ribosomal protein Rpl13A-GFP levels, and division times. Imaging wild type yeast cells in microfluidic devices we observe that in all cells and at all ages, the division times as well as the increase in cell size that single yeast undergo while aging negatively correlate to their lifespan. In the longer-lived cells Rpl13A-GFP levels also negatively correlate to lifespan. Interestingly however, at young ages in the population, ribosome concentration was lowest in the cells that increased the most in size and had shorter lifespans. The correlations between these molecular and cellular properties related to biogenesis and lifespan explain a small portion of the variation in lifespans of individual cells, consistent with the highly individual and multifactorial nature of aging.	[Janssens, Georges E.; Veenhoff, Liesbeth M.] Univ Groningen, Univ Med Ctr Groningen, European Res Inst Biol Ageing, Groningen, Netherlands	University of Groningen	Veenhoff, LM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, European Res Inst Biol Ageing, Groningen, Netherlands.	lm.veenhoff@rug.nl		Veenhoff, Liesbeth/0000-0002-0158-4728; Janssens, Georges/0000-0003-2104-8145	Netherlands Organization for Scientific Research (NWO)	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was financially supported by the Netherlands Organization for Scientific Research (NWO), grant ID: Systems biology, SBC-EMA.	Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; BARTON AA, 1950, J GEN MICROBIOL, V4, P84, DOI 10.1099/00221287-4-1-84; Core Development Team R, 2014, R LANG ENV STAT COMP; Crane MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086660; Delaney JR, 2013, FEMS YEAST RES, V13, P267, DOI 10.1111/1567-1364.12030; Delaney JR, 2011, CELL CYCLE, V10, P156, DOI 10.4161/cc.10.1.14457; EGILMEZ NK, 1990, J GERONTOL, V45, pB9, DOI 10.1093/geronj/45.1.B9; Fehrmann S, 2013, CELL REP, V5, P1589, DOI 10.1016/j.celrep.2013.11.013; Finch CE, 1997, SCIENCE, V278, P407, DOI 10.1126/science.278.5337.407; Ganley ARD, 2012, FEMS YEAST RES, V12, P267, DOI 10.1111/j.1567-1364.2012.00796.x; Haruki H, 2008, MOL CELL, V31, P925, DOI 10.1016/j.molcel.2008.07.020; He C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004860; Hu Z, 2014, GENE DEV, V28, P396, DOI 10.1101/gad.233221.113; Huberts DHEW, 2014, P NATL ACAD SCI USA, V111, P11727, DOI 10.1073/pnas.1410024111; Huberts DHEW, 2013, JOVE-J VIS EXP, DOI 10.3791/50143; Huberts DHEW, 2013, NAT PROTOC, V8, P1019, DOI 10.1038/nprot.2013.060; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Janssens GE, 2015, ELIFE, V4, DOI 10.7554/eLife.08527; Jo MC, 2015, P NATL ACAD SCI USA; Jo MC, 2015, P NATL ACAD SCI; Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861; Jorgensen P, 2004, GENE DEV, V18, P2491, DOI 10.1101/gad.1228804; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kaeberlein M, 2012, FEMS YEAST RES, V12, P269, DOI 10.1111/j.1567-1364.2012.00798.x; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; KENNEDY BK, 1994, J CELL BIOL, V127, P1985, DOI 10.1083/jcb.127.6.1985; Kennedy BK, 2009, AGING CELL, V8, P617, DOI 10.1111/j.1474-9726.2009.00522.x; Lee SS, 2012, P NATL ACAD SCI USA, V109, P4916, DOI 10.1073/pnas.1113505109; Lippuner AD, 2014, FEMS MICROBIOL REV, V38, P300, DOI 10.1111/1574-6976.12060; Maniere X, 2014, EXP GERONTOL, V60, P12, DOI 10.1016/j.exger.2014.09.005; Moretto F, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.60; MORTIMER RK, 1959, NATURE, V183, P1751, DOI 10.1038/1831751a0; Pan KZ, 2007, AGING CELL, V6, P111, DOI 10.1111/j.1474-9726.2006.00266.x; Pincus Z, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002306; Rea SL, 2005, NAT GENET, V37, P894, DOI 10.1038/ng1608; Rudra D, 2004, GENE DEV, V18, P2431, DOI 10.1101/gad.1256704; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221; Skotheim JM, 2008, NATURE, V454, P291, DOI 10.1038/nature07118; Steffen KK, 2008, CELL, V133, P292, DOI 10.1016/j.cell.2008.02.037; Therneau T, 2012, PACKAGE SURVIVAL ANA; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; Warnes GR, 2012, J PHYCOL, DOI [10.1111/j.0022-3646.1997.00569.x, DOI 10.1111/J.0022-3646.1997.00569.X]; Xie ZW, 2015, CELL, V160, P928, DOI 10.1016/j.cell.2015.02.002; Xie ZW, 2012, AGING CELL, V11, P599, DOI 10.1111/j.1474-9726.2012.00821.x; Yang JY, 2011, CELL CYCLE, V10, P144, DOI 10.4161/cc.10.1.14455; Zadrag R, 2006, ACTA BIOCHIM POL, V53, P747, DOI 10.18388/abp.2006_3302; Zadrag-Tecza R, 2012, FEMS YEAST RES, P97; Zhang YC, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0044465, 10.1155/2012/583417]	49	28	29	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167394	10.1371/journal.pone.0167394	http://dx.doi.org/10.1371/journal.pone.0167394			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907085	Green Published, gold, Green Submitted			2022-12-26	WOS:000389482700142
J	Luo, XM; Liang, XJ; Li, JN; Shi, J; Zhang, WL; Chai, W; Wu, JP; Guo, SA; Fang, G; Zhou, XL; Zhang, JH; Xu, KC; Zeng, JY; Niu, LZ				Luo, Xiaomei; Liang, Xianjun; Li, Jiannan; Shi, Jian; Zhang, Wenlong; Chai, Wei; Wu, Jiuping; Guo, Shuai; Fang, Gang; Zhou, Xulong; Zhang, Jianhua; Xu, Kecheng; Zeng, Jianying; Niu, Lizhi			The Effects of Irreversible Electroporation on the Colon in a Porcine Model	PLOS ONE			English	Article							TISSUE ABLATION; CHEMOTHERAPY	Background and Aim Irreversible electroporation (IRE) is a method of targeted cell ablation which has been suggested as a potential cancer therapy as it leaves structures such as blood vessels and the extracellular matrix intact, thereby allowing the rapid recovery of healthy tissue. Here, we investigated the effects of IRE on the colon in vivo in a porcine model. Methods IRE ablation was performed on the colon walls of 12 female Tibet mini-pigs, creating a total of 24 lesions. Lesions were monitored periodically by endoscopy. The pigs were euthanized 7, 14, 21 or 28 days after IRE ablation and the colons harvested for gross and histological analysis. Sections were stained with hematoxylin and eosin (H&E), Masson's trichrome (MT) stain and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay. Results All pigs tolerated the ablation procedure without serious clinical symptoms or complications. There was no evidence of perforation by endoscopy or gross postmortem examination. All lesions were characterized by necrotic cell death with mild inflammation and hyperemia, with a sharp demarcation between ablated and adjacent normal tissue. A fibrous scar was observed in the ablated colon tissue. Histological analysis revealed damage to each layer of the colon. Histopathology findings also showed the preservation of extracellular structures and the recovery of the ablated colon. Conclusions The complete ablation of the target area, its rapid recovery and the lack of posttreatment symptoms suggest that IRE ablation may be a promising therapy for tumors located adjacent to or violating the colon wall.	[Luo, Xiaomei] Jinan Univ, Sch Med, Guangzhou, Guangdong, Peoples R China; [Liang, Xianjun] Taizhou Cent Hosp Zhejiang Prov, Dept Gastrointestinal Surg, Taizhou, Peoples R China; [Li, Jiannan; Shi, Jian] Jilin Univ, Hosp 2, Dept Gen Surg, Changchun, Peoples R China; [Zhang, Wenlong] Jilin Univ, Dept Hematol & Oncol, China Japan Union Hosp, Changchun, Peoples R China; [Chai, Wei] Jilin Univ, Hosp 1, Dept Gynecol & Obstet, Changchun, Peoples R China; [Wu, Jiuping] Jilin Univ, Hosp 2, Orthopaed Hosp, Dept Spinal Surg, Changchun, Peoples R China; [Guo, Shuai] Taizhou Cent Hosp Zhejiang Prov, Dept Endocrinol, Taizhou, Peoples R China; [Fang, Gang; Xu, Kecheng; Niu, Lizhi] Jinan Univ, Sch Med, Dept Surg & Anesthesia, Fuda Canc Hosp,Guangzhou Fuda Canc Hosp, Guangzhou, Guangdong, Peoples R China; [Zhou, Xulong] Jinan Univ, Sch Med, Dept Pathol, Fuda Canc Hosp,Guangzhou Fuda Canc Hosp, Guangzhou, Guangdong, Peoples R China; [Zhang, Jianhua] Jinan Univ, Sch Med, Dept Endoscopy, Fuda Canc Hosp,Guangzhou Fuda Canc Hosp, Guangzhou, Guangdong, Peoples R China; [Zeng, Jianying] Jinan Univ, Sch Med, Guangzhou Fuda Canc Inst, Fuda Canc Hosp,Guangzhou Fuda Canc Hosp, Guangzhou, Guangdong, Peoples R China	Jinan University; Jilin University; Jilin University; Jilin University; Jilin University; Jinan University; Jinan University; Jinan University; Jinan University	Niu, LZ (corresponding author), Jinan Univ, Sch Med, Dept Surg & Anesthesia, Fuda Canc Hosp,Guangzhou Fuda Canc Hosp, Guangzhou, Guangdong, Peoples R China.	lxm-vi-p@163.com	li, jn/ABH-3120-2021	Li, Jiannan/0000-0001-9744-7666	International Scientific Fund of Fuda Cancer Hospital, Guangzhou, China [Y2015-ZD-001]	International Scientific Fund of Fuda Cancer Hospital, Guangzhou, China	This work was supported by a grant from the International Scientific Fund of Fuda Cancer Hospital, Guangzhou (Y2015-ZD-001), China. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choi JW, 2014, CARDIOVASC INTER RAD, V37, P224, DOI 10.1007/s00270-013-0731-y; Davalos RV, 2005, ANN BIOMED ENG, V33, P223, DOI 10.1007/s10439-005-8981-8; DeSantis CE, 2014, CA-CANCER J CLIN, V64, P252, DOI 10.3322/caac.21235; Edd JF, 2006, IEEE T BIO-MED ENG, V53, P1409, DOI 10.1109/TBME.2006.873745; Grothey A, 2013, LANCET, V381, P303, DOI 10.1016/S0140-6736(12)61900-X; Han XD, 2011, BIOMED PHARMACOTHER, V65, P547, DOI 10.1016/j.biopha.2011.03.008; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Keefe DMK, 2000, GUT, V47, P632, DOI 10.1136/gut.47.5.632; Lee EW, 2010, GUT LIVER, V4, pS99, DOI 10.5009/gnl.2010.4.S1.S99; Onik G, 2007, TECHNOL CANCER RES T, V6, P295, DOI 10.1177/153303460700600405; Phillips MA, 2012, BRIT J CANCER, V106, P490, DOI 10.1038/bjc.2011.582; Phillips M, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4001882; Rubinsky B, 2007, TECHNOL CANCER RES T, V6, P255, DOI 10.1177/153303460700600401; Rubinsky B, 2007, TECHNOL CANCER RES T, V6, P37, DOI 10.1177/153303460700600106; Schoellnast H, 2013, CARDIOVASC INTER RAD, V36, P213, DOI 10.1007/s00270-012-0393-1; Srimathveeravalli G, 2013, J VASC INTERV RADIOL, V24, P1249, DOI 10.1016/j.jvir.2013.04.025; Thomson KR, 2011, J VASC INTERV RADIOL, V22, P611, DOI 10.1016/j.jvir.2010.12.014; Van Cutsem E, 2016, CLIN COLORECTAL CANC, V15, P91, DOI 10.1016/j.clcc.2015.09.005	18	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167275	10.1371/journal.pone.0167275	http://dx.doi.org/10.1371/journal.pone.0167275			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907057	Green Published, gold, Green Submitted			2022-12-26	WOS:000389482700107
J	Mutenda, N; Bukowski, A; Nitschke, AM; Nakanyala, T; Hamunime, N; Mekonen, T; Tjituka, F; Mazibuko, G; Mwinga, S; Mabirizi, D; Sagwa, E; Indongo, R; Dean, N; Jordan, MR; Hong, SY				Mutenda, Nicholus; Bukowski, Alexandra; Nitschke, Anne-Marie; Nakanyala, Tuli; Hamunime, Ndapewa; Mekonen, Tadesse; Tjituka, Francina; Mazibuko, Greatjoy; Mwinga, Samson; Mabirizi, David; Sagwa, Evans; Indongo, Rosalia; Dean, Natalie; Jordan, Michael R.; Hong, Steven Y.			Assessment of the World Health Organization's HIV Drug Resistance Early Warning Indicators in Main and Decentralized Outreach Antiretroviral Therapy Sites in Namibia	PLOS ONE			English	Article							VIROLOGICAL OUTCOMES; ADHERENCE; PROTEASE; PREDICTORS; MORTALITY	Background The World Health Organization (WHO) early warning indicators (EWIs) of HIV drug resistance (HIVDR) assess factors at individual ART sites that are known to create situations favourable to the emergence of HIVDR. Methods In 2014, the Namibia HIV care and treatment program abstracted the following adult and pediatric EWIs from all public ART sites (50 main sites and 143 outreach sites): On-time pill pick-up, Retention in care, Pharmacy stock-outs, Dispensing practices, and Viral load suppression. Comparisons were made between main and outreach sites and between 2014 and 2012 using the Wilcoxon signed-rank test in a matched analysis. Results The national estimates were: On-time pill pick-up 81.9% (95% CI 81.1-82.8) for adults and 82.4% (81.3-83.4) for pediatrics, Retention in care 79% retained on ART after 12 months for adults and 82% for pediatrics, Pharmacy stock-outs 94% of months without a stock-out for adults and 88% for pediatrics, and Dispensing practices 0.01% (0.001-0.056) dispensed mono-or dual-therapy for adults and 0.01% (0.001-0.069) for pediatrics. Viral load suppression was significantly affected by low rates of Viral load completion. Main sites had higher On-time pill pick-up than outreach sites for adults (p<0.001) and pediatrics (p<0.001), and no difference between main and outreach sites for Retention in care for adults (p = 0.761) or pediatrics (p = 0.214). From 2012 to 2014 in adult sites, On-time pill pick-up (p = 0.001), Retention in care (p<0.001), and Pharmacy stock-outs (p = 0.002) worsened. In pediatric sites, On-time pill pick-up (p<0.001) and Pharmacy stock-outs (p = 0.012) worsened. Conclusions Results of EWIs monitoring in Namibia provide evidence about ART programmatic functioning and contextualize results from national surveys of HIVDR. These results are worrisome as they show a decline in program performance over time. The national ART program is taking steps to minimize the emergence of HIVDR by strengthening adherence and retention of patients on ART, reducing stock-outs, and strengthening ART data quality.	[Mutenda, Nicholus; Nitschke, Anne-Marie; Nakanyala, Tuli; Hamunime, Ndapewa; Mekonen, Tadesse; Tjituka, Francina] Republ Namibia Minist Hlth & Social Serv, Directorate Special Programmes, Windhoek, Namibia; [Bukowski, Alexandra; Jordan, Michael R.; Hong, Steven Y.] Tufts Univ, Sch Med, Dept Publ Hlth & Community Med, Boston, MA 02111 USA; [Mazibuko, Greatjoy; Mwinga, Samson; Mabirizi, David; Sagwa, Evans] Management Sci Hlth, SIAPS, Windhoek, Namibia; [Indongo, Rosalia] US Agcy Int Dev, Windhoek, Namibia; [Dean, Natalie] Univ Florida, Dept Biostat, Gainesville, FL USA; [Jordan, Michael R.; Hong, Steven Y.] Tufts Med Ctr, Div Geog Med & Infect Dis, Boston, MA 02111 USA	Massachusetts Department of Public Health; Tufts University; United States Agency for International Development (USAID); State University System of Florida; University of Florida; Tufts Medical Center	Hong, SY (corresponding author), Tufts Univ, Sch Med, Dept Publ Hlth & Community Med, Boston, MA 02111 USA.; Hong, SY (corresponding author), Tufts Med Ctr, Div Geog Med & Infect Dis, Boston, MA 02111 USA.	shong@tuftsmedicalcenter.org		Bukowski, Alexandra/0000-0001-7634-7340				[Anonymous], 2013, MINISTRY HLTH CHILD; Bangsberg DR, 2006, AIDS, V20, P223, DOI 10.1097/01.aids.0000199825.34241.49; Bennett DE, 2012, CLIN INFECT DIS, V54, pS280, DOI 10.1093/cid/cis207; Boender TS, 2015, CLIN INFECT DIS, V61, P1453, DOI 10.1093/cid/civ556; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Cambiano V, 2014, AIDS, V28, pS15, DOI 10.1097/QAD.0000000000000082; Central Intelligence Agency, WORLD FACTBOOK; Chan AK, 2010, TROP MED INT HEALTH, V15, P90, DOI 10.1111/j.1365-3156.2010.02503.x; de Olalla PG, 2002, J ACQ IMMUN DEF SYND, V30, P105, DOI 10.1097/00042560-200205010-00014; Fokam J, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0129210, 10.137]; Fokam J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-308; Harrigan PR, 2005, J INFECT DIS, V191, P339, DOI 10.1086/427192; Hong SY, 2015, JAIDS-J ACQ IMM DEF, V68, P463, DOI 10.1097/QAI.0000000000000509; Hong SY, 2010, JAIDS-J ACQ IMM DEF, V55, pE27, DOI 10.1097/QAI.0b013e3181f5376d; Jonas A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100539; Jonas A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065653; Lima VD, 2009, JAIDS-J ACQ IMM DEF, V50, P529, DOI 10.1097/QAI.0b013e31819675e9; Maggiolo F, 2005, CLIN INFECT DIS, V40, P158, DOI 10.1086/426595; Martin M, 2008, AIDS RES HUM RETROV, V24, P1263, DOI 10.1089/aid.2008.0141; Nachega JB, 2007, ANN INTERN MED, V146, P564, DOI 10.7326/0003-4819-146-8-200704170-00007; Nachega JB, 2006, JAIDS-J ACQ IMM DEF, V43, P78, DOI 10.1097/01.qai.0000225015.43266.46; Nichols BE, 2014, AIDS, V28, P73, DOI 10.1097/01.aids.0000433239.01611.52; Oyugi JH, 2007, AIDS, V21, P965, DOI 10.1097/QAD.0b013e32802e6bfa; Parienti JJ, 2004, CLIN INFECT DIS, V38, P1311, DOI 10.1086/383572; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Reidy William J, 2014, J Acquir Immune Defic Syndr, V67, pe34, DOI 10.1097/QAI.0000000000000264; Republic of Namibia Ministry of Health and Social Services Directorate of Special Programmes Surveil-lance Report of the, 2014, REPUBLIC NAMIBIA MIN; Sethi AK, 2003, CLIN INFECT DIS, V37, P1112, DOI 10.1086/378301; Sigaloff KCE, 2012, CLIN INFECT DIS, V54, pS294, DOI 10.1093/cid/cir1015; Tweya H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075761; UNAIDS, 2021, YOUNG PEOPL HIV; UNAIDS, 2014, AMB TREATM TARG WRIT; UNAIDS, FACT SHEET 2016; USAID, 2015, NAM PROGR PROF STREN; WHO, 2015, HIV DRUG RES SURV GU; WHO, 2016, GLOB REP EARL WARN I; World Health Organization, 2013, CONGUID UANT DRU; World Health Organization, 2015, GUID START ANT THER; World Health Organization, 2015, CONS STRAT INF GUID; World Health Organization, 2011, EARL ADV IND PAN M 1	40	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166649	10.1371/journal.pone.0166649	http://dx.doi.org/10.1371/journal.pone.0166649			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27906995	gold, Green Published, Green Submitted			2022-12-26	WOS:000389482700031
J	Starha, P; Vanco, J; Travnicek, Z; Hosek, J; Klusakova, J; Dvorak, Z				Starha, Pavel; Vanco, Jan; Travnicek, Zdenek; Hosek, Jan; Klusakova, Jarmila; Dvorak, Zdenek			Platinum(II) Iodido Complexes of 7-Azaindoles with Significant Antiproliferative Effects: An Old Story Revisited with Unexpected Outcomes	PLOS ONE			English	Article							IN-VITRO; PT(II) COMPLEXES; CISPLATIN; DNA; CIS; CYTOTOXICITY; FLUORESCENCE; DERIVATIVES; BINDING; REACTIVITY	A series of platinum(II) diiodido complexes containing 7-azaindole derivatives, having the general formula cis-[ PtI2(naza)(2)] (1-8), has been prepared and thoroughly characterized, including X-ray structure analysis of cis-[ PtI2(2Me4Claza)(2)].DMF (8.DMF; 2Me4Claza = 2-methyl-4-chloro-7-azaindole). Complexes showed high in vitro cytotoxicity against nine human cancer cell lines (IC50 ranging from 0.4 to 12.8 mu M), including the cisplatin-resistant ovarian cancer cell line (A2780R; IC50 = 1.0-3.5 mu M). The results of in vivo testing, using the L1210 lymphocytic leukaemia model, at the equimolar doses of Pt with cisplatin (2 mg/kg) confirmed the activity of complex 8 comparable to cisplatin. From the mechanistic point of view, evaluated ex vivo by Western blot analyses on the samples of isolated tumour tissues, the treatment of the animals with complex 8, contrary to cisplatin, decreased the levels of tumour suppressor p53 and increased significantly the amount of intracellular anti-apoptotic protein MCL-1(L) (37 kDa). Additionally, the active form of caspase 3 was significantly elevated in the sample of tumour tissues treated with complex 8, indicating that the activation of p53-independent cell-death pathway was initiated. The light and electron microscopy observations of the cancerous tissues revealed necrosis as a dominant mechanism of cell death, followed by scarce signs of apoptosis. The additional results (e.g. in vitro interaction experiments with selected biomolecules, cell cycle perturbations, gel electrophoretic studies on pUC19 plasmid DNA) supported the hypothesis that the complexes might be involved in the mechanism of action quite different from cisplatin.	[Starha, Pavel; Vanco, Jan; Travnicek, Zdenek; Hosek, Jan] Palacky Univ Olomouc, Dept Inorgan Chem, Fac Sci, Olomouc, Czech Republic; [Starha, Pavel; Vanco, Jan; Travnicek, Zdenek; Hosek, Jan] Palacky Univ Olomouc, Reg Ctr Adv Technol & Mat, Fac Sci, Olomouc, Czech Republic; [Klusakova, Jarmila] Univ Vet & Pharmaceut Sci Brno, Fac Pharm, Dept Human Pharmacol & Toxicol, Brno, Czech Republic; [Dvorak, Zdenek] Palacky Univ Olomouc, Fac Sci, Dept Cell Biol & Genet, Olomouc, Czech Republic; [Dvorak, Zdenek] Palacky Univ Olomouc, Fac Sci, Reg Ctr Adv Technol & Mat, Dept Inorgan Chem, Olomouc, Czech Republic	Palacky University Olomouc; Palacky University Olomouc; University of Veterinary Sciences Brno; Palacky University Olomouc; Palacky University Olomouc	Travnicek, Z (corresponding author), Palacky Univ Olomouc, Dept Inorgan Chem, Fac Sci, Olomouc, Czech Republic.; Travnicek, Z (corresponding author), Palacky Univ Olomouc, Reg Ctr Adv Technol & Mat, Fac Sci, Olomouc, Czech Republic.	zdenek.travnicek@upol.cz	Vanco, Jan/H-2705-2013; Hosek, Jan/B-6274-2009; Starha, Pavel/H-3902-2016	Vanco, Jan/0000-0003-3351-1192; Hosek, Jan/0000-0003-0975-1671; Travnicek, Zdenek/0000-0002-5890-7874; Dvorak, Zdenek/0000-0002-3938-3585	Ministry of Education, Youth and Sports (MEYS, MSMT in Czech) [L01305]	Ministry of Education, Youth and Sports (MEYS, MSMT in Czech)	This study was funded by the Ministry of Education, Youth and Sports (MEYS, MSMT in Czech), L01305, http://www.msmt.cz/index.php?lang=2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGGARWAL SK, 1980, CANCER CHEMOTH PHARM, V4, P249; Arandjelovic S, 2002, J EXP CLIN CANC RES, V21, P519; Bartel C, 2012, J BIOL INORG CHEM, V17, P465, DOI 10.1007/s00775-011-0869-5; Berners-Price SJ, 2011, ANGEW CHEM INT EDIT, V50, P804, DOI 10.1002/anie.201004552; Brandenburg K., 2015, DIAMOND VERSION 4 0; BUTOUR JL, 1977, EUR J BIOCHEM, V78, P455, DOI 10.1111/j.1432-1033.1977.tb11758.x; Chardon E, 2012, ORGANOMETALLICS, V31, P7618, DOI 10.1021/om300806g; Chtchigrovsky M, 2013, J MED CHEM, V56, P2074, DOI 10.1021/jm301780s; Cleare, 1973, BIOINORG CHEM, V2, P187, DOI DOI 10.1016/S0006-3061(00)80249-5; de Mier-Vinue J, 2008, J INORG BIOCHEM, V102, P973, DOI 10.1016/j.jinorgbio.2007.12.026; Dhara S. C., 1970, IND J CHEM, P193; Gulyaeva N, 2002, EUR J PHARM SCI, V17, P81, DOI 10.1016/S0928-0987(02)00146-X; Hissler M, 2000, INORG CHEM, V39, P447, DOI 10.1021/ic991250n; Holford J, 1998, BRIT J CANCER, V77, P366, DOI 10.1038/bjc.1998.59; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; MacKeigan JP, 2000, J BIOL CHEM, V275, P38953, DOI 10.1074/jbc.C000684200; Macrae CF, 2008, J APPL CRYSTALLOGR, V41, P466, DOI 10.1107/S0021889807067908; Margiotta N, 2006, J INORG BIOCHEM, V100, P1849, DOI 10.1016/j.jinorgbio.2006.07.010; Margiotta N, 2014, CHEMMEDCHEM, V9, P1161, DOI 10.1002/cmdc.201402028; Marzo T, 2015, DALTON T, V44, P14896, DOI 10.1039/c5dt01196e; Messori L, 2013, INORG CHEM, V52, P13827, DOI 10.1021/ic402611m; Messori L, 2012, INORG CHEM, V51, P1717, DOI 10.1021/ic202036c; Messori L, 2010, ACS MED CHEM LETT, V1, P381, DOI 10.1021/ml100081e; Muchova T, 2013, J BIOL INORG CHEM, V18, P579, DOI 10.1007/s00775-013-1003-7; New EJ, 2009, J INORG BIOCHEM, V103, P1120, DOI 10.1016/j.jinorgbio.2009.05.005; Onoa GB, 1998, NUCLEIC ACIDS RES, V26, P1473, DOI 10.1093/nar/26.6.1473; Ormerod MG, 1996, CANCER CHEMOTH PHARM, V37, P463, DOI 10.1007/s002800050413; Ossipov K, 2014, J INORG BIOCHEM, V137, P40, DOI 10.1016/j.jinorgbio.2014.04.008; Oxford Diffraction, CRYSALIS RED CRYSALI; PASTERNACK RF, 1991, J AM CHEM SOC, V113, P6835, DOI 10.1021/ja00018a019; Ploner C, 2009, ONCOGENE, V27, P84; Pracharova J, 2015, J MED CHEM, V58, P847, DOI 10.1021/jm501420k; Roy S, 2009, DALTON T, P10846, DOI 10.1039/b911542k; Sakai K, 2007, ACTA CRYSTALLOGR E, V63, pM97, DOI 10.1107/S1600536806051610; Savic A, 2014, EUR J MED CHEM, V82, P372, DOI 10.1016/j.ejmech.2014.05.060; Sbovata SM, 2007, J MED CHEM, V50, P4775, DOI 10.1021/jm070426p; Sharp SY, 2002, EUR J CANCER, V38, P2309, DOI 10.1016/S0959-8049(02)00244-7; Sheldrick GM, 2015, ACTA CRYSTALLOGR C, V71, P3, DOI [10.1107/S2053229614024218, 10.1107/S0108767307043930]; Shi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051076; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Skander M, 2010, J MED CHEM, V53, P2146, DOI 10.1021/jm901693m; Starha P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136338; Starha P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123595; Starha P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090341; Starha P, 2012, J INORG BIOCHEM, V115, P57, DOI 10.1016/j.jinorgbio.2012.05.006; Starha P, 2012, POLYHEDRON, V33, P404, DOI 10.1016/j.poly.2011.11.059; Suntharalingam K, 2014, METALLOMICS, V6, P437, DOI 10.1039/c3mt00364g; Tessier C, 1999, INORG CHIM ACTA, V295, P25, DOI 10.1016/S0020-1693(99)00303-5; Tetko IV, 2016, J INORG BIOCHEM, V156, P1, DOI 10.1016/j.jinorgbio.2015.12.006; Vardevanyan PO, 2003, EXP MOL MED, V35, P527, DOI 10.1038/emm.2003.68; Wang K, 2002, SPECTROCHIM ACTA A, V58, P2595, DOI 10.1016/S1386-1425(02)00004-5; Wheate NJ, 2010, DALTON T, V39, P8113, DOI 10.1039/c0dt00292e; Wu SN, 2014, J INORG BIOCHEM, V139, P77, DOI 10.1016/j.jinorgbio.2014.06.006	53	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0165065	10.1371/journal.pone.0165062	http://dx.doi.org/10.1371/journal.pone.0165062			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27906967	Green Published, Green Submitted, gold			2022-12-26	WOS:000389482700007
J	Vergni, D; Santoni, D				Vergni, Davide; Santoni, Daniele			Nullomers and High Order Nullomers in Genomic Sequences	PLOS ONE			English	Article							MINIMAL ABSENT WORDS; DNA	A nullomer is an oligomer that does not occur as a subsequence in a given DNA sequence, i.e. it is an absent word of that sequence. The importance of nullomers in several applications, from drug discovery to forensic practice, is now debated in the literature. Here, we investigated the nature of nullomers, whether their absence in genomes has just a statistical explanation or it is a peculiar feature of genomic sequences. We introduced an extension of the notion of nullomer, namely high order nullomers, which are nullomers whose mutated sequences are still nullomers. We studied different aspects of them: comparison with nullomers of random sequences, CpG distribution and mean helical rise. In agreement with previous results we found that the number of nullomers in the human genome is much larger than expected by chance. Nevertheless antithetical results were found when considering a random DNA sequence preserving dinucleotide frequencies. The analysis of CpG frequencies in nullomers and high order nullomers revealed, as expected, a high CpG content but it also highlighted a strong dependence of CpG frequencies on the dinucleotide position, suggesting that nullomers have their own peculiar structure and are not simply sequences whose CpG frequency is biased. Furthermore, phylogenetic trees were built on eleven species based on both the similarities between the dinucleotide frequencies and the number of nullomers two species share, showing that nullomers are fairly conserved among close species. Finally the study of mean helical rise of nullomers sequences revealed significantly high mean rise values, reinforcing the hypothesis that those sequences have some peculiar structural features. The obtained results show that nullomers are the consequence of the peculiar structure of DNA ( also including biased CpG frequency and CpGs islands), so that the hypermutability model, also taking into account CpG islands, seems to be not sufficient to explain nullomer phenomenon. Finally, high order nullomers could emphasize those features that already make simple nullomers useful in several applications.	[Vergni, Davide] CNR, Ist Applicaz Calcolo Mauro Picone, Via Taurini 19, I-00185 Rome, Italy; [Santoni, Daniele] CNR, Ist Analisi Sistemi Informat Antonio Ruberti, Via Taurini 19, I-00185 Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto per le Applicazioni del Calcolo "Mauro Picone" (IAC-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Analisi dei Sistemi ed Informatica "Antonio Ruberti" (IASI-CNR)	Santoni, D (corresponding author), CNR, Ist Analisi Sistemi Informat Antonio Ruberti, Via Taurini 19, I-00185 Rome, Italy.	daniele.santoni@iasi.cnr.it		SANTONI, DANIELE/0000-0003-1898-5285				Acquisti C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001022; Alileche A, 2012, PEPTIDES, V38, P302, DOI 10.1016/j.peptides.2012.09.015; Chairungsee S, 2012, THEOR COMPUT SCI, V450, P109, DOI 10.1016/j.tcs.2012.04.031; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Garcia SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016065; Goswami J, 2013, J FORENSIC LEG MED, V20, P513, DOI 10.1016/j.jflm.2013.02.003; GUIBAS LJ, 1981, J COMB THEORY A, V30, P183, DOI 10.1016/0097-3165(81)90005-4; Hampikian G, 2007, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2007, P355; Herold J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-167; JOSSE J, 1961, J BIOL CHEM, V236, P864; Karlin S, 1997, P NATL ACAD SCI USA, V94, P10227, DOI 10.1073/pnas.94.19.10227; Karlin S, 1997, J BACTERIOL, V179, P3899, DOI 10.1128/jb.179.12.3899-3913.1997; LIN JH, 1991, IEEE T INFORM THEORY, V37, P145, DOI 10.1109/18.61115; Pedone F, 2012, DNA RES, P043; Pedone F, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-105; Pinho AJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-137; Rahmann S, 2003, COMB PROBAB COMPUT, V12, P73, DOI 10.1017/S0963548302005473; Rahmann S, 2000, LECT NOTES COMPUT SC, V1848, P375; Silva RM, 2015, BIOINFORMATICS, V31, P2421, DOI 10.1093/bioinformatics/btv189; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; SVED J, 1990, P NATL ACAD SCI USA, V87, P4692, DOI 10.1073/pnas.87.12.4692	21	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e164540	10.1371/journal.pone.0164540	http://dx.doi.org/10.1371/journal.pone.0164540			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27906971	Green Submitted, gold, Green Published			2022-12-26	WOS:000389482700004
J	Koprich, JB; Johnston, TH; Reyes, G; Omana, V; Brotchie, JM				Koprich, James B.; Johnston, Tom H.; Reyes, Gabriela; Omana, Vanessa; Brotchie, Jonathan M.			Towards a Non-Human Primate Model of Alpha-Synucleinopathy for Development of Therapeutics for Parkinson's Disease: Optimization of AAV1/2 Delivery Parameters to Drive Sustained Expression of Alpha Synuclein and Dopaminergic Degeneration in Macaque	PLOS ONE			English	Article							PATHOLOGY; OVEREXPRESSION; DYSFUNCTION; PROTEINS; MIDBRAIN; NEURONS; BRAIN	Recent failures in clinical trials for disease modification in Parkinson's disease have highlighted the need for a non-human primate model of the synucleinopathy underpinning dopaminergic neuron degeneration. The present study was defined to begin the development of such a model in cynomolgus macaque. We have validated surgical and vector parameters to define a means to provide a robust over-expression of alpha-synuclein which is associated with Lewy-like pathology and robust degeneration of the nigrostriatal pathway. Thus, an AAV1/2 vector incorporating strong transcription and transduction regulatory elements was used to deliver the gene for the human A53T mutation of alpha-synuclein. When injected into 4 sites within each substantia nigra (7 mu l per site, 1.7 x 10(12) gp/ml), this vector provided expression lasting at least 4 months, and a 50% loss of nigral dopaminergic neurons and a 60% reduction in striatal dopamine. Further studies will be required to develop this methodology into a validated model of value as a drug development platform.	[Koprich, James B.; Johnston, Tom H.; Brotchie, Jonathan M.] Atuka Inc, Toronto, ON, Canada; [Koprich, James B.; Johnston, Tom H.; Reyes, Gabriela; Omana, Vanessa; Brotchie, Jonathan M.] Univ Hlth Network, Krembil Res Inst, Toronto, ON, Canada	Krembil Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Koprich, JB (corresponding author), Atuka Inc, Toronto, ON, Canada.; Koprich, JB (corresponding author), Univ Hlth Network, Krembil Res Inst, Toronto, ON, Canada.	j.koprich@atuka.com	Johnston, Tom H/D-2531-2018	Johnston, Tom H/0000-0002-1537-8175; Brotchie, Jonathan/0000-0003-2337-0816	Atuka Inc.; Krembil Foundation	Atuka Inc.; Krembil Foundation	Funding was provided for by Atuka Inc. and the Krembil Foundation. There was no additional external funding received for this study. The funder (Atuka Inc.) provided support in the form of consultancies for authors [JBK, THJ, JMB], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bellucci A, 2016, NEUROPATH APPL NEURO, V42, P77, DOI 10.1111/nan.12297; Butler B, 2015, J BIOL CHEM; Chu YP, 2012, BRAIN, V135, P2058, DOI 10.1093/brain/aws133; Chung CY, 2009, P NATL ACAD SCI USA, V106, P22474, DOI 10.1073/pnas.0912193106; Chung CY, 2009, J NEUROSCI, V29, P3365, DOI 10.1523/JNEUROSCI.5427-08.2009; Decressac M, 2011, BRAIN, V134, P2302, DOI 10.1093/brain/awr149; Del Tredici K, 2016, NEUROPATH APPL NEURO, V42, P33, DOI 10.1111/nan.12298; Eslamboli A, 2007, BRAIN, V130, P799, DOI 10.1093/brain/awl382; Hauck B, 2003, MOL THER, V7, P419, DOI 10.1016/S1525-0016(03)00012-1; Kirik D, 2003, P NATL ACAD SCI USA, V100, P2884, DOI 10.1073/pnas.0536383100; Koprich JB, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-8; Koprich JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017698; Koprich JB, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-43; Mazzulli JR, 2016, P NATL ACAD SCI USA, V113, P1931, DOI 10.1073/pnas.1520335113; McFarland MA, 2008, MOL CELL PROTEOMICS, V7, P2123, DOI 10.1074/mcp.M800116-MCP200; Ozansoy M, 2013, MOL NEUROBIOL, V47, P460, DOI 10.1007/s12035-012-8369-3; Peelaerts W, 2015, NATURE, V522, P340, DOI 10.1038/nature14547; Roberts RF, 2015, BRAIN, V138, P1642, DOI 10.1093/brain/awv040; Ronzitti G, 2015, CHANNELS, V9, P169, DOI 10.1080/19336950.2015.1063285; Saito Y, 2016, MOVEMENT DISORD, V31, P135, DOI 10.1002/mds.26463; Tagliafierro L, 2016, NEUROGENETICS; Tang FL, 2015, J NEUROSCI, V35, P10613, DOI 10.1523/JNEUROSCI.0042-15.2015; Xu W, 2015, NEUROBIOL AGING, V36, P1505, DOI 10.1016/j.neurobiolaging.2014.10.042; Yang WL, 2015, J NEUROSCI, V35, P8345, DOI 10.1523/JNEUROSCI.0772-15.2015	24	29	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167235	10.1371/journal.pone.0167235	http://dx.doi.org/10.1371/journal.pone.0167235			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902767	Green Published, Green Submitted, gold			2022-12-26	WOS:000389474100061
J	Wajima, T; Anzai, Y; Yamada, T; Ikoshi, H; Noguchi, N				Wajima, Takeaki; Anzai, Yui; Yamada, Tetsuya; Ikoshi, Hideaki; Noguchi, Norihisa			Oldenlandia diffusa Extract Inhibits Biofilm Formation by Haemophilus influenzae Clinical Isolates	PLOS ONE			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; OTITIS-MEDIA; BETA; LUXS; CLARITHROMYCIN; AUTOINDUCER-2; RESISTANCE; CHILDREN; SYNTHASE; SURFACE	Oldenlandia diffusa has been empirically used as a therapeutic adjunct for the treatment of respiratory infections. To establish the basic evidence of its clinical usefulness, antimicrobial and biofilm inhibitory activities of an O. diffusa extract were examined against clinical isolates of Haemophilus influenzae, a major causative pathogen of respiratory and sensory organ infections. No significant growth inhibitory activity was observed during incubation for more than 6 h after the extract addition into a culture of H. influenzae. On the other hand, biofilm formation by H. influenzae, evaluated by a crystal violet method, was significantly and dose-dependently inhibited by the O. diffusa extract. Furthermore, the mRNA level of the biofilm-associated gene luxS of H. influenzae significantly decreased soon after the extract addition, and the suppressive effect continued for at least 2 h. At 2 h after the addition of the O. diffusa extract, the autoinducer in the culture supernatant was also significantly reduced by the O. diffusa extract in a dose-dependent manner. These results revealed that O. diffusa extract shows inhibitory activity against luxS-dependent biofilm formation but has no antimicrobial activity against planktonic cells of H. influenzae. Thus, O. diffusa extract might be useful as an adjunctive therapy for the treatment of respiratory infections caused by H. influenzae.	[Wajima, Takeaki; Anzai, Yui; Noguchi, Norihisa] Tokyo Univ Pharm & Life Sci, Dept Microbiol, Sch Pharm, Tokyo, Japan; [Yamada, Tetsuya; Ikoshi, Hideaki] Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Tradit Chinese Med, Tokyo, Japan	Tokyo University of Pharmacy & Life Sciences; Tokyo University of Pharmacy & Life Sciences	Noguchi, N (corresponding author), Tokyo Univ Pharm & Life Sci, Dept Microbiol, Sch Pharm, Tokyo, Japan.	noguchin@toyaku.ac.jp	Wajma, Takeaki/AAF-4743-2020	Wajma, Takeaki/0000-0001-9506-707X; Noguchi, Norihisa/0000-0003-4710-7297				Armbruster CE, 2009, INFECT IMMUN, V77, P4081, DOI 10.1128/IAI.00320-09; Benninger MS, 2008, OTOLARYNG HEAD NECK, V138, P274, DOI 10.1016/j.otohns.2007.11.011; Chung HS, 2002, BIOL PHARM BULL, V25, P1142, DOI 10.1248/bpb.25.1142; Erwin AL, 2007, TRENDS MICROBIOL, V15, P355, DOI 10.1016/j.tim.2007.06.004; Goossens H, 2009, CLIN MICROBIOL INFEC, V15, P12, DOI 10.1111/j.1469-0691.2009.02725.x; Gupta Salin, 2004, J Herb Pharmacother, V4, P21, DOI 10.1080/J157v04n01_03; Hardie KR, 2008, NAT REV MICROBIOL, V6, P635, DOI 10.1038/nrmicro1916; Iino Y, 2015, ACTA OTO-LARYNGOL, V135, P217, DOI 10.3109/00016489.2014.975893; Kalia M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135495; Morozumi M, 2013, J INFECT CHEMOTHER, V19, P432, DOI 10.1007/s10156-012-0500-x; MURPHY TF, 1987, REV INFECT DIS, V9, P1; Novotny LA, 2015, MOL MICROBIOL, V96, P276, DOI 10.1111/mmi.12934; Puig C, 2014, INFECT IMMUN, V82, P1591, DOI 10.1128/IAI.01445-13; Sakaue Y, 2016, MICROBIOL IMMUNOL, V60, P10, DOI 10.1111/1348-0421.12343; Seyama S, 2016, ANTIMICROB AGENTS CH, V60, P3207, DOI 10.1128/AAC.00163-16; Song YH, 2012, BIOL PHARM BULL, V35, P1022, DOI 10.1248/bpb.b110660; Teng J, 2007, CHINESE MAT MED; Unal CM, 2012, INT J MED MICROBIOL, V302, P261, DOI 10.1016/j.ijmm.2012.07.013; Vilchez R, 2007, ANAL BIOANAL CHEM, V387, P489, DOI 10.1007/s00216-006-0824-4; Wajima T, 2016, J GLOB ANTIMICROB RE, V6, P22, DOI 10.1016/j.jgar.2016.01.014; Wiertsema SP, 2011, VACCINE, V29, P5163, DOI 10.1016/j.vaccine.2011.05.035	21	10	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167335	10.1371/journal.pone.0167335	http://dx.doi.org/10.1371/journal.pone.0167335			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902758	Green Published, Green Submitted, gold			2022-12-26	WOS:000389474100074
J	Riess, M; Fuchs, NV; Idica, A; Hamdorf, M; Flory, E; Pedersen, IM; Konig, R				Riess, Maximilian; Fuchs, Nina V.; Idica, Adam; Hamdorf, Matthias; Flory, Egbert; Pedersen, Irene Munk; Koenig, Renate			Interferons Induce Expression of SAMHD1 in Monocytes through Down-regulation of miR-181a and miR-30a	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AICARDI-GOUTIERES SYNDROME; RESTRICTS HIV-1 INFECTION; COMMUNITY-DRIVEN RESOURCE; ADAPTIVE IMMUNE-RESPONSES; GAMMA-INDUCED PROTEIN; STERILE ALPHA MOTIF; BINDING-SITES; UP-REGULATION; GENE; IDENTIFICATION	SAMHD1 is a phosphohydrolase maintaining cellular dNTP homeostasis but also acts as a critical regulator in innate immune responses due to its antiviral activity and association with autoimmune disease, leading to aberrant activation of interferon. SAMHD1 expression is differentially regulated by interferon in certain primary cells, but the underlying mechanism is not understood. Here, we report a detailed characterization of the promotor region, the 5' - and 3'-untranslated region (UTR) of SAMHD1, and the mechanism responsible for the cell type-dependent up-regulation of SAMHD1 protein by interferon. We demonstrate that induction of SAMHD1 by type I and II interferons depends on 3'-UTR post-transcriptional regulation, whereas the promoter drives basal expression levels. We reveal novel functional target sites for the microRNAs miR-181a, miR30a, and miR-155 in the SAMHD1 3'-UTR. Furthermore, we demonstrate that down-regulation of endogenous miR-181a and miR-30a levels inversely correlates with SAMHD1 protein up-regulation upon type I and II interferon stimulation in primary human monocytes. These miRNAs are not modulated by interferon in macrophages or dendritic cells, and consequently protein levels of SAMHD1 remain unchanged. These results suggest that SAMHD1 is a non-classical interferon-stimulated gene regulated through cell type-dependent down-regulation of miR-181a and miR-30a in innate sentinel cells.	[Riess, Maximilian; Fuchs, Nina V.; Koenig, Renate] Paul Ehrlich Inst, Host Pathogen Interact Grp, D-63225 Langen, Germany; [Flory, Egbert] Paul Ehrlich Inst, Div Med Biotechnol, D-63225 Langen, Germany; [Idica, Adam; Hamdorf, Matthias; Pedersen, Irene Munk] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; [Koenig, Renate] Sanford Burnham Prebys Med Discovery Inst, Immun & Pathogenesis Program, La Jolla, CA 92037 USA; [Koenig, Renate] German Ctr Infect Res DZIF, D-63225 Langen, Germany	Paul Ehrlich Institute; Paul Ehrlich Institute; University of California System; University of California Irvine; Sanford Burnham Prebys Medical Discovery Institute; German Center for Infection Research	Konig, R (corresponding author), Paul Ehrlich Inst, Host Pathogen Interact, D-63225 Langen, Germany.	renate.koenig@pei.de	Riess, Maximilian/AAI-9050-2020; König, Renate/AAB-8918-2019	Riess, Maximilian/0000-0001-5545-4825; König, Renate/0000-0003-4882-9179; Fuchs, Nina/0000-0003-4175-0740	DZIF [TTU 01.802, TTU 04.802]	DZIF	This work was supported by DZIF TTU 01.802 and TTU 04.802 (to R. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Abdel-Mohsen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109220; Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; Ballana E, 2015, TRENDS MICROBIOL, V23, P680, DOI 10.1016/j.tim.2015.08.002; Barriocanal M, 2015, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00655; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Berger A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002425; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bonifati S, 2016, VIROLOGY, V495, P92, DOI 10.1016/j.virol.2016.05.002; Buchanan EL, 2016, SCI REP-UK, V6, DOI 10.1038/srep22629; Cribier A, 2013, CELL REP, V3, P1036, DOI 10.1016/j.celrep.2013.03.017; Crow YJ, 2015, NAT REV IMMUNOL, V15, P429, DOI 10.1038/nri3850; Danino YM, 2015, BBA-GENE REGUL MECH, V1849, P1116, DOI 10.1016/j.bbagrm.2015.04.003; Dreos R, 2013, NUCLEIC ACIDS RES, V41, pD157, DOI 10.1093/nar/gks1233; Enright AJ, 2004, GENOME BIOL, V5; Fang Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018067; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Forster SC, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00334; Franzolin E, 2013, P NATL ACAD SCI USA, V110, P14272, DOI 10.1073/pnas.1312033110; Gelais CS, 2014, J VIROL, V88, P5834, DOI 10.1128/JVI.00155-14; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Gottwein E, 2007, NATURE, V450, P1096, DOI 10.1038/nature05992; Goujon C, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-23; Griffith OL, 2008, NUCLEIC ACIDS RES, V36, pD107, DOI 10.1093/nar/gkm967; Guo ZW, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav102; Hartman ZC, 2007, J VIROL, V81, P1796, DOI 10.1128/JVI.01936-06; Hausser J, 2014, NAT REV GENET, V15, P599, DOI 10.1038/nrg3765; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Jeggari A, 2012, BIOINFORMATICS, V28, P2062, DOI 10.1093/bioinformatics/bts344; Jin CZ, 2016, AIDS, V30, P2053, DOI 10.1097/QAD.0000000000001166; Jin CZ, 2014, BIOCHEM BIOPH RES CO, V452, P760, DOI 10.1016/j.bbrc.2014.08.151; Juven-Gershon T, 2010, DEV BIOL, V339, P225, DOI 10.1016/j.ydbio.2009.08.009; Kambara H, 2015, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00676; Kim B, 2012, J BIOL CHEM, V287, P21570, DOI 10.1074/jbc.C112.374843; Kretschmer S, 2015, ANN RHEUM DIS, V74, DOI 10.1136/annrheumdis-2013-204845; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee TY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S1-S3; Lesurf R, 2016, NUCLEIC ACIDS RES, V44, pD126, DOI 10.1093/nar/gkv1203; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li N, 2000, IMMUNOL LETT, V74, P221, DOI 10.1016/S0165-2478(00)00276-5; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; [李帅 Li Shuai], 2011, [水文, Hydrology], V31, P35; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Liao WP, 2008, PROTEOMICS, V8, P2640, DOI 10.1002/pmic.200700954; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maelfait J, 2016, CELL REP, V16, P1492, DOI 10.1016/j.celrep.2016.07.002; Manel N, 2010, NATURE, V467, P214, DOI 10.1038/nature09337; Martin-Gayo E, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004930; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Montgomery SB, 2006, BIOINFORMATICS, V22, P637, DOI 10.1093/bioinformatics/btk027; Ohler U, 2000, Pac Symp Biocomput, P380; Pauls E, 2013, J IMMUNOL, V190, P4736, DOI 10.4049/jimmunol.1203226; Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205; Pilakka-Kanthikeel S, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0285-9; Powell RD, 2011, J BIOL CHEM, V286, P43596, DOI 10.1074/jbc.C111.317628; Prehaud C, 2005, J VIROL, V79, P12893, DOI 10.1128/JVI.79.20.12893-12904.2005; Proudfoot NJ, 2011, GENE DEV, V25, P1770, DOI 10.1101/gad.17268411; Reese M.G., 1995, 7 INT GEN SEQ AN C H; Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Schmidt S, 2015, J LEUKOCYTE BIOL, V98, P5, DOI 10.1189/jlb.4HI0714-338RR; Schmitt MJ, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-41; Schug J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r33; Sedger LM, 2013, MOL IMMUNOL, V56, P781, DOI 10.1016/j.molimm.2013.07.009; Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682; Solovyev VV, 2010, METHODS MOL BIOL, V674, P57, DOI 10.1007/978-1-60761-854-6_5; Sommer AFR, 2016, SCI REP-UK, V6, DOI 10.1038/srep26616; St Gelais C, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-105; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; Yang S, 2016, SCI REP-UK, V6, DOI 10.1038/srep29665; Zhao DC, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-114	74	38	38	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2017	292	1					264	277		10.1074/jbc.M116.752584	http://dx.doi.org/10.1074/jbc.M116.752584			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2DQ	27909056	hybrid, Green Published			2022-12-26	WOS:000391578000023
J	Baumgartner, T; Saulin, A; Hein, G; Knoch, D				Baumgartner, Thomas; Saulin, Anne; Hein, Grit; Knoch, Daria			Structural Differences in Insular Cortex Reflect Vicarious Injustice Sensitivity	PLOS ONE			English	Article							SURFACE-BASED ANALYSIS; JUSTICE SENSITIVITY; INDIVIDUAL-DIFFERENCES; BRAIN STRUCTURE; SEGMENTATION; THICKNESS; BEHAVIOR; EMPATHY; SHAPES; GAME	Sensitivity to injustice inflicted on others is a strong motivator of human social behavior. There are, however, enormous individual differences in vicarious injustice sensitivity. Some people are strongly affected when witnessing injustice, while others barely notice it, but the factors behind this heterogeneity are poorly understood. Here we examine the neuroanatomical basis of these differences using voxel-based morphometry and Freesurfer image analysis suite. Whole brain corrected analyses show that a person's propensity to be vicariously affected by injustice to others is reflected by the gray matter volume and thickness of the bilateral mid insular cortex. The larger a person's gray matter volume and thickness of the mid insula, the higher that person's sensitivity to injustice experienced by others. These findings show that the individual neuroanatomy of the mid insular cortex captures a person's predisposition to be vicariously affected by injustice, and thus adds a novel aspect to previous functional work that has linked this region to the processing of transient vicarious states.	[Baumgartner, Thomas; Saulin, Anne; Hein, Grit; Knoch, Daria] Univ Bern, Inst Psychol, Dept Social Psychol & Social Neurosci, Bern, Switzerland	University of Bern	Baumgartner, T; Knoch, D (corresponding author), Univ Bern, Inst Psychol, Dept Social Psychol & Social Neurosci, Bern, Switzerland.	thomas.baumgartner@psy.unibe.ch; daria.knoch@psy.unibe.ch	Hein, Grit/AAF-7964-2019	Baumgartner, Thomas/0000-0001-5966-7377	Swiss National Science Foundation [PP00P1_146317]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This project was supported by a grant to D.K. by the Swiss National Science Foundation (PP00P1_146317). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki Y, 2014, SOC COGN AFFECT NEUR, V9, P1223, DOI 10.1093/scan/nst104; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Baumert A., 2016, HDB SOCIAL JUSTICE T, P161, DOI DOI 10.1007/978-1-4939-3216-0_9; Baumgartner T, 2013, NEUROIMAGE, V81, P317, DOI 10.1016/j.neuroimage.2013.05.047; Bickart KC, 2011, NAT NEUROSCI, V14, P163, DOI 10.1038/nn.2724; Corradi-Dell'Acqua C, 2016, NAT COMMUN, V7, P1; Corradi-Dell'Acqua C, 2013, SOC COGN AFFECT NEUR, V8, P424, DOI 10.1093/scan/nss014; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Critchley HD, 2013, NEURON, V77, P624, DOI 10.1016/j.neuron.2013.02.008; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Davidson RJ, 2012, NAT NEUROSCI, V15, P689, DOI 10.1038/nn.3093; Decety Jean, 2015, AJOB Neurosci, V6, P3; DeYoung CG, 2010, PSYCHOL SCI, V21, P820, DOI 10.1177/0956797610370159; Edele A, 2013, LEARN INDIVID DIFFER, V24, P96, DOI 10.1016/j.lindif.2012.12.020; Fetchenhauer D, 2004, PERS INDIV DIFFER, V36, P1015, DOI 10.1016/S0191-8869(03)00197-1; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Frye RE, 2010, CEREB CORTEX, V20, P2625, DOI 10.1093/cercor/bhq010; Gollwitzer M, 2009, J RES PERS, V43, P999, DOI 10.1016/j.jrp.2009.07.003; Han X, 2006, NEUROIMAGE, V32, P180, DOI 10.1016/j.neuroimage.2006.02.051; Hein G, 2016, P NATL ACAD SCI USA, V113, P80, DOI 10.1073/pnas.1514539112; Hoffman Martin L., 2011, EMPATHY PHILOS PSYCH, P230; Im K, 2008, CEREB CORTEX, V18, P2181, DOI 10.1093/cercor/bhm244; Kanai R, 2011, NAT REV NEUROSCI, V12, P231, DOI 10.1038/nrn3000; Klimecki O, 2013, CAMBRIDGE HDB HUMAN, P533; Klimecki OM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151028; Klimecki OM, 2014, SOC COGN AFFECT NEUR, V9, P873, DOI 10.1093/scan/nst060; KRACH S, 2011, PLOS ONE, V6; Lamm C, 2011, NEUROIMAGE, V54, P2492, DOI 10.1016/j.neuroimage.2010.10.014; Lotz S, 2011, NEGOT CONFL MANAG R, V4, P297, DOI 10.1111/j.1750-4716.2011.00084.x/abstract; Lu F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097743; Masten CL, 2010, SOC NEUROSCI-UK, V5, P496, DOI 10.1080/17470919.2010.490673; Morishima Y, 2012, NEURON, V75, P73, DOI 10.1016/j.neuron.2012.05.021; Muller-Pinzler L, 2015, SOC COGN AFFECT NEUR, P1; Nash K, 2015, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00458; Panizzon MS, 2009, CEREB CORTEX, V19, P2728, DOI 10.1093/cercor/bhp026; Reese G, 2014, ANAL SOC ISS PUB POL, V14, P217, DOI 10.1111/asap.12032; Schmid M, 2005, AIP CONF PROC, V786, P202, DOI 10.1063/1.2103852; Schmitt M, 2005, EUR J PSYCHOL ASSESS, V21, P202, DOI 10.1027/1015-5759.21.3.202; Schmitt M, 2010, SOC JUSTICE RES, V23, P211, DOI 10.1007/s11211-010-0115-2; Silk TJ, 2011, J DEV BEHAV PEDIATR, V32, P158, DOI 10.1097/DBP.0b013e318206d58f; Singer T, 2009, TRENDS COGN SCI, V13, P334, DOI 10.1016/j.tics.2009.05.001; Steinbeis N, 2012, NEURON, V73, P1040, DOI 10.1016/j.neuron.2011.12.027; Tanaka S, 2013, PLOS ONE, V8, P4, DOI DOI 10.1371/J0URNAL.P0NE.0066998; Uddin LQ, 2015, NAT REV NEUROSCI, V16, P55, DOI 10.1038/nrn3857; Wesselmann ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00153; Yoder KJ, 2014, J NEUROSCI, V34, P4161, DOI 10.1523/JNEUROSCI.4648-13.2014	50	6	6	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167538	10.1371/journal.pone.0167538	http://dx.doi.org/10.1371/journal.pone.0167538			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4OA	27930678	Green Published, gold, Green Submitted			2022-12-26	WOS:000389580900028
J	Cong, L; Liao, Y; Yang, ST; Yang, RY				Cong, Lin; Liao, Yong; Yang, Suteng; Yang, Rongya			In Vitro Antifungal Activity of Sertraline and Synergistic Effects in Combination with Antifungal Drugs against Planktonic Forms and Biofilms of Clinical Trichosporon asahii Isolates	PLOS ONE			English	Article							AMPHOTERICIN-B; CRYPTOCOCCUS-NEOFORMANS; SUSCEPTIBILITY; CASPOFUNGIN; INFECTIONS; RESISTANCE; FUNGEMIA	Trichosporon asahii (T. asahii) is the major pathogen of invasive trichosporonosis which occurred mostly in immunocompromised patients. The biofilms formation ability of T. asahii may account for resistance to antifungal drugs and results a high mortality rate. Sertraline, a commonly prescribed antidepressant, has been demonstrated to show in vitro and in vivo antifungal activities against many kinds of pathogenic fungi, especially Cryptococcus species. In the present study, the in vitro activities of sertraline alone or combined with fluconazole, voriconazole, itraconazole, caspofungin and amphotericin B against planktonic forms and biofilms of 21 clinical T. asahii isolates were evaluated using broth microdilution checker-board method and XTT reduction assay, respectively. The fractional inhibitory concentration index (FICI) was used to interpret drug interactions. Sertraline alone exhibited antifungal activities against both T. asahii planktonic cells (MICs, 4-8 mu g/ml) and T. asahii biofilms (SMICs, 16-32 mu g/ml). Furthermore, SRT exhibited synergistic effects against T. asahii planktonic cells in combination with amphotericin B, caspofungin or fluconazole (FICI <= 0.5) and exhibited synergistic effects against T. asahii biofilms in combination with amphotericin B (FICI <= 0.5). SRT exhibited mostly indifferent interactions against T. asahii biofilms in combination with three azoles in this study. Sertraline-amphotericin B combination showed the highest percentage of synergistic effects against both T. asahii planktonic cells (90.5%) and T. asahii biofilms (81.0%). No antagonistic interaction was observed. Our study suggests the therapeutic potential of sertraline against invasive T. asahii infection, especially catheter-related T. asahii infection. Further in vivo studies are needed to validate our findings.	[Cong, Lin] Third Mil Med Univ, Grad Sch, Chongqing, Peoples R China; [Cong, Lin; Liao, Yong; Yang, Suteng; Yang, Rongya] PLA Army Gen Hosp, Dept Dermatol, Beijing, Peoples R China	Army Medical University	Yang, RY (corresponding author), PLA Army Gen Hosp, Dept Dermatol, Beijing, Peoples R China.	yangrya_l@sina.com		Yang, Rongya/0000-0002-4490-4007	National Natural Science Foundation of China [81301410]; Beijing Natural Science Foundation [7163225]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by the National Natural Science Foundation of China (No. 81301410) (http://www.nsfc.gov.cn/) and Beijing Natural Science Foundation (NO. 7163225). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antachopoulos C, 2005, J PEDIAT HEMATOL ONC, V27, P283, DOI 10.1097/01.mph.0000164865.70522.d7; Arendrup MC, 2014, CLIN MICROBIOL INFEC, V20, P76, DOI 10.1111/1469-0691.12360; Bassetti M, 2004, J ANTIMICROB CHEMOTH, V54, P575, DOI 10.1093/jac/dkh337; Bayramoglu G, 2008, INFECTION, V36, P68, DOI 10.1007/s15010-007-6278-6; Bujdakova H, 2016, FUTURE MICROBIOL, V11, P235, DOI 10.2217/fmb.15.139; Colombo AL, 2011, CLIN MICROBIOL REV, V24, P682, DOI 10.1128/CMR.00003-11; DeVane CL, 2002, CLIN PHARMACOKINET, V41, P1247, DOI 10.2165/00003088-200241150-00002; Di Bonaventura G, 2006, ANTIMICROB AGENTS CH, V50, P3269, DOI 10.1128/AAC.00556-06; Hawser SP, 1998, J CLIN MICROBIOL, V36, P1450, DOI 10.1128/JCM.36.5.1450-1452.1998; Heller I, 2004, INT J ANTIMICROB AG, V24, P401, DOI 10.1016/j.ijantimicag.2004.03.021; Iturrieta-Gonzalez IA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109553; Lass-Florl C, 2001, J ANTIMICROB CHEMOTH, V48, P775, DOI 10.1093/jac/48.6.775; Lass-Florl C, 2001, CLIN INFECT DIS, V33, P135, DOI 10.1086/324589; Lewis RJ, 2013, J ANAL TOXICOL, V37, P208, DOI 10.1093/jat/bkt014; Li HM, 2010, INT J ANTIMICROB AG, V35, P550, DOI 10.1016/j.ijantimicag.2010.01.013; Liao Y, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv141; Liao Y, 2015, MED MYCOL, V53, P396, DOI 10.1093/mmy/myv006; Liu SY, 2014, INT J ANTIMICROB AG, V43, P395, DOI 10.1016/j.ijantimicag.2013.12.009; Naranjo CA, 1999, INT CLIN PSYCHOPHARM, V14, pS35; Nayak R., 2010, Mycology - An International Journal on Fungal Biology, V1, P99, DOI 10.1080/21501203.2010.487054; Nett JE, 2011, EUKARYOT CELL, V10, P1660, DOI 10.1128/EC.05126-11; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; Oliveira dos Santos C, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1477-3; Pierce CG, 2008, NAT PROTOC, V3, P1494, DOI 10.1038/nprot.2008.141; Rainey MM, 2010, GENETICS, V185, P1221, DOI 10.1534/genetics.110.117846; Rex JH, 2008, REFERENCE METHOD BRO, P1; Rhein J, 2016, LANCET INFECT DIS, V16, P809, DOI 10.1016/S1473-3099(16)00074-8; Rossato L, 2016, FOLIA MICROBIOL, P1; Smith KD, 2015, ANTIMICROB AGENTS CH, V59, P7197, DOI 10.1128/AAC.01299-15; Spitzer M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.31; Sun W, 2012, J MED MICROBIOL, V61, P1750, DOI 10.1099/jmm.0.049817-0; TREMAINE LM, 1989, DRUG METAB DISPOS, V17, P542; Trevino-Rangel RD, 2016, MED MYCOL, V54, P280, DOI 10.1093/mmy/myv109; Walker LA, 2010, FUNGAL GENET BIOL, V47, P117, DOI 10.1016/j.fgb.2009.09.003; Walraven CJ, 2013, ANTIMICROB AGENTS CH, V57, P1, DOI 10.1128/AAC.01351-12; Wolf DG, 2001, J CLIN MICROBIOL, V39, P4420, DOI 10.1128/JCM.39.12.4420-4425.2001; Yang ST, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157047; Zhai B, 2012, ANTIMICROB AGENTS CH, V56, P3758, DOI 10.1128/AAC.00212-12	38	13	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167903	10.1371/journal.pone.0167903	http://dx.doi.org/10.1371/journal.pone.0167903			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930704	Green Submitted, Green Published, gold			2022-12-26	WOS:000389580900057
J	Cottrell, KA; Djuranovic, S				Cottrell, Kyle A.; Djuranovic, Sergej			Urb-RIP - An Adaptable and Efficient Approach for Immunoprecipitation of RNAs and Associated RNAs/Proteins	PLOS ONE			English	Article							AFFINITY PURIFICATION; POLY(A)-BINDING PROTEIN; BINDING PROTEIN; BC200 RNA; IDENTIFICATION; COMPLEXES; MICRORNAS; INTERACT; SEQUENCE; PLATFORM	Post-transcriptional regulation of gene expression is an important process that is mediated by interactions between mRNAs and RNA binding proteins (RBP), non-coding RNAs (ncRNA) or ribonucleoproteins (RNP). Key to the study of post-transcriptional regulation of mRNAs and the function of ncRNAs such as long non-coding RNAs (lncRNAs) is an understanding of what factors are interacting with these transcripts. While several techniques exist for the enrichment of a transcript whether it is an mRNA or an ncRNA, many of these techniques are cumbersome or limited in their application. Here we present a novel method for the immunoprecipitation of mRNAs and ncRNAs, Urb-RNA immunoprecipitation (Urb-RIP). This method employs the RRM1 domain of the "resurrected" snRNA-binding protein Urb to enrich messages containing a stem-loop tag. Unlike techniques which employ the MS2 protein, which require large repeats of the MS2 binding element, Urb-RIP requires only one stem-loop. This method routinely provides over similar to 100-fold enrichment of tagged messages. Using this technique we have shown enrichment of tagged mRNAs and lncRNAs as well as miRNAs and RNA-binding proteins bound to those messages. We have confirmed, using Urb-RIP, interaction between RNA PolIII transcribed lncRNA BC200 and polyA binding protein.	[Cottrell, Kyle A.; Djuranovic, Sergej] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Djuranovic, S (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA.	sergej.djuranovic@wustl.edu		Djuranovic, Sergej/0000-0002-9417-0822; Cottrell, Kyle/0000-0003-1779-4292	NIH [T32 GM007067, RO1 GM112824]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007067, R01GM112824] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by an NIH training grant T32 GM007067 to KAC and NIH Grant RO1 GM112824 to SD.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Braun J, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku127; Chang TH, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S2-S4; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Chu C, 2012, JOVE-J VIS EXP, DOI 10.3791/3912; Chu L, 2012, J CLIN INVEST, V122, P2793, DOI 10.1172/JCI63051; Cook KB, 2011, NUCLEIC ACIDS RES, V39, pD301, DOI 10.1093/nar/gkq1069; Darnell RB, 2010, WIRES RNA, V1, P266, DOI 10.1002/wrna.31; Davis CP, 2015, METHODS MOL BIOL, V1262, P167, DOI 10.1007/978-1-4939-2253-6_10; Delaney KJ, 2014, RNA, V20, P1035, DOI 10.1261/rna.044255.114; Dong YC, 2015, INT J MOL SCI, V16, P22456, DOI 10.3390/ijms160922456; Engreitz J, 2015, METHODS MOL BIOL, V1262, P183, DOI 10.1007/978-1-4939-2253-6_11; Fukaya T, 2012, MOL CELL, V48, P825, DOI 10.1016/j.molcel.2012.09.024; Gautier T, 1997, MOL CELL BIOL, V17, P7088, DOI 10.1128/MCB.17.12.7088; Gong CG, 2015, METHODS MOL BIOL, V1206, P81, DOI 10.1007/978-1-4939-1369-5_7; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hamzeiy H, 2014, METHODS MOL BIOL, V1107, P207, DOI 10.1007/978-1-62703-748-8_12; Hershey JW, 2012, COLD SPRING HARB PER, V4; Hogg JR, 2007, RNA, V13, P868, DOI 10.1261/rna.565207; Iioka H, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1316; Khanam Tasneem, 2006, RNA Biol, V3, P170; Kondrashov AV, 2005, J MOL BIOL, V353, P88, DOI 10.1016/j.jmb.2005.07.049; Law MJ, 2006, RNA, V12, P1168, DOI 10.1261/rna.75206; Lechertier T, 2009, EXP CELL RES, V315, P928, DOI 10.1016/j.yexcr.2009.01.016; LECUYER KA, 1995, BIOCHEMISTRY-US, V34, P10600, DOI 10.1021/bi00033a035; Lee HY, 2013, P NATL ACAD SCI USA, V110, P5416, DOI 10.1073/pnas.1302807110; Leppek K, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt956; Liu S, 2015, APPL BIOCH BIOTECHNO; Marin-Bejar O, 2015, METHODS MOL BIOL, V1206, P87, DOI 10.1007/978-1-4939-1369-5_8; MARTIGNETTI JA, 1993, P NATL ACAD SCI USA, V90, P11563, DOI 10.1073/pnas.90.24.11563; Muddashetty RS, 2002, J MOL BIOL, V321, P433, DOI 10.1016/S0022-2836(02)00655-1; Mullin C, 2004, FEBS LETT, V576, P437, DOI 10.1016/j.febslet.2004.09.054; Muppirala UK, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-489; Olanich ME, 2011, ONCOGENE, V30, P77, DOI 10.1038/onc.2010.404; PICKETT GG, 1993, NUCLEIC ACIDS RES, V21, P4621, DOI 10.1093/nar/21.19.4621; Said N, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp719; Slobodin B, 2010, RNA, V16, P2277, DOI 10.1261/rna.2091710; Suresh V, 2015, NUCLEIC ACIDS RES, V43, P1370, DOI 10.1093/nar/gkv020; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Wang XW, 2009, RNA, V15, P716, DOI 10.1261/rna.1460509; Wei K, 2014, INT J MOL SCI, V15, P14753, DOI 10.3390/ijms150814753; Williams SG, 2013, J MOL BIOL, V425, P3846, DOI 10.1016/j.jmb.2013.05.031; Yoon JH, 2012, METHODS, V58, P81, DOI 10.1016/j.ymeth.2012.07.004; Yue D, 2009, CURR GENOMICS, V10, P478, DOI 10.2174/138920209789208219	46	6	6	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167877	10.1371/journal.pone.0167877	http://dx.doi.org/10.1371/journal.pone.0167877			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930710	Green Published, gold, Green Submitted			2022-12-26	WOS:000389580900055
J	He, S; Zhao, TC; Guo, H; Meng, YZ; Qin, GJ; Goukassian, DA; Han, JH; Gao, XM; Zhu, Y				He, Shuang; Zhao, Tiechan; Guo, Hao; Meng, Yanzhi; Qin, Gangjian; Goukassian, David A.; Han, Jihong; Gao, Xuimei; Zhu, Yan			Coordinated Activation of VEGF/VEGFR-2 and PPARd Pathways by a Multi-Component Chinese Medicine DHI Accelerated Recovery from Peripheral Arterial Disease in Type 2 Diabetic Mice	PLOS ONE			English	Article							ISCHEMIA-INDUCED NEOVASCULARIZATION; DANHONG INJECTION; HYDROXYSAFFLOR YELLOW; SALVIA-MILTIORRHIZA; RECEPTOR-DELTA; RAT MODEL; IN-VIVO; ANGIOGENESIS; DANSHENSU; PROMOTES	Diabetic mellitus (DM) patients are at an increased risk of developing peripheral arterial disease (PAD). Danhong injection (DHI) is a Chinese patent medicine widely used for several cardiovascular indications but the mechanism of action is not well-understood. We investigated the therapeutic potential of DHI on experimental PAD in mice with chemically induced as well as genetic (KKAy) type 2 DM and the overlapping signaling pathways regulating both therapeutic angiogenesis and glucose homeostasis. Compared with normal genetic background wild type (WT) mice, both DM mice showed impaired perfusion recovery in hind-limb ischemia (HLI) model. DHI treatment significantly accelerated perfusion recovery, lowered blood glucose and improved glucose tolerance in both DM models. Bioluminescent imaging demonstrated a continuous ischemia-induced vascular endothelial growth factor receptor 2 (VEGFR-2) gene expressions with a peak time coincident with the maximal DHI stimulation. Flow cytometry analysis showed a DHI-mediated increase in endothelial progenitor cell (EPC) mobilization from bone marrow to circulating peripheral blood. DHI administration upregulated the expression of vascular endothelial growth factor A (VEGF-A) and VEGF receptor-2 (VEGFR-2) in ischemic muscle. A cross talk between ischemia-induced angiogenesis and glucose tolerance pathways was analyzed by Ingenuity Pathway Analysis (IPA) which suggested an interaction of VEGF-A/VEGFR-2 and peroxisome proliferator-activated receptor delta (PPAR delta)/peroxisome proliferator-activated receptor gamma (PPAR gamma) genes. We confirmed that upregulation of VEGF-A/VEGFR-2 by DHI promoted PPAR delta gene expression in both type 2 diabetic mice. Our findings demonstrated that a multi-component Chinese medicine DHI effectively increased blood flow recovery after tissue ischemia in diabetic mice by promoting angiogenesis and improving glucose tolerance through a concomitant activation of VEGF-A/VEGFR-2 and PPAR delta signaling pathways.	[He, Shuang; Zhao, Tiechan; Guo, Hao; Meng, Yanzhi; Qin, Gangjian; Gao, Xuimei; Zhu, Yan] Tianjin Univ Tradit Chinese Med, Tianjin State Key Lab Modern Chinese Med, Tianjin, Peoples R China; [He, Shuang; Zhao, Tiechan; Guo, Hao; Meng, Yanzhi; Zhu, Yan] Tianjin Int Joint Acad Biotechnol & Med, Res & Dev Ctr TCM, Tianjin, Peoples R China; [Zhu, Yan] Tufts Med Ctr, Mol Cardiol Res Inst, Boston, MA USA; [Zhu, Yan] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Qin, Gangjian] Northwestern Univ, Feinberg Sch Med, Dept Med Cardiol, Chicago, IL 60611 USA; [Qin, Gangjian] Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA; [Goukassian, David A.] Tufts Univ, Sch Med, Ctr Biomed Res, Boston, MA 02111 USA; [Han, Jihong] Nankai Univ, State Key Lab Med Chem Biol, Tianjin, Peoples R China; [Han, Jihong] Nankai Univ, Collaborat Innovat Ctr Biotherapy, Tianjin, Peoples R China	Tianjin University of Traditional Chinese Medicine; Tianjin International Joint Academy of Biomedicine; Tufts Medical Center; Tufts University; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Tufts University; Nankai University; Nankai University	Zhu, Y (corresponding author), Tianjin Univ Tradit Chinese Med, Tianjin State Key Lab Modern Chinese Med, Tianjin, Peoples R China.; Zhu, Y (corresponding author), Tianjin Int Joint Acad Biotechnol & Med, Res & Dev Ctr TCM, Tianjin, Peoples R China.; Zhu, Y (corresponding author), Tufts Med Ctr, Mol Cardiol Res Inst, Boston, MA USA.; Zhu, Y (corresponding author), Tufts Univ, Sch Med, Boston, MA 02111 USA.	yanzhu.harvard@iCloud.com	Zhu, Yan/A-1548-2017	Zhu, Yan/0000-0002-3197-7936; Goukassian, David/0000-0001-5270-5270	National Key Basic Research Program of China [2012CB723504]; National Major New Drug Discovery Grant [2013ZX09201020]; National Science Foundation of China [NSFC 81274128]; Program for Tianjin Innovative Research Team in University [TD12-5031]	National Key Basic Research Program of China(National Basic Research Program of China); National Major New Drug Discovery Grant; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Tianjin Innovative Research Team in University	This study was supported by grants from the National Key Basic Research Program of China (2012CB723504), the National Major New Drug Discovery Grant (2013ZX09201020), the National Science Foundation of China (NSFC 81274128); and the Program for Tianjin Innovative Research Team in University (TD12-5031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishop-Bailey D, 2011, BIOCHEM SOC T, V39, P1601, DOI 10.1042/BST20110643; Bojic LA, 2014, J LIPID RES, V55, P1254, DOI 10.1194/jlr.M046037; Boucher JM, 2014, NAT MED, V20, P1383, DOI 10.1038/nm.3767; Chen HX, 2014, SCI REP-UK, V4, DOI 10.1038/srep06222; Clark N, 2003, DIABETES CARE, V26, P3333; Dokun AO, 2014, CARDIOVASC RES, V101, P364, DOI 10.1093/cvr/cvt342; Ehrenborg E, 2013, ATHEROSCLEROSIS, V231, P95, DOI 10.1016/j.atherosclerosis.2013.08.027; Freudenberg U, 2015, J CONTROL RELEASE, V220, P79, DOI 10.1016/j.jconrel.2015.10.028; Guo H, 2014, NEUROCHEM RES, V39, P1817, DOI 10.1007/s11064-014-1384-1; He HB, 2008, J PHARM PHARMACOL, V60, P115, DOI 10.1211/jpp.60.1.0015; He Y, 2012, J ETHNOPHARMACOL, V144, P387, DOI 10.1016/j.jep.2012.09.025; Herkenne S, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa2403; Huang PH, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-99; Huang PH, 2012, ANGIOGENESIS, V15, P377, DOI 10.1007/s10456-012-9267-z; Huang PH, 2010, ATHEROSCLEROSIS, V212, P426, DOI 10.1016/j.atherosclerosis.2010.06.034; Huang PH, 2009, ARTERIOSCL THROM VAS, V29, P1179, DOI 10.1161/ATVBAHA.109.189175; Ishikawa Y, 2012, EXP DIABETES RES, DOI 10.1155/2012/702948; Jiang MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105412; Jiang XQ, 2015, J ETHNOPHARMACOL, V174, P270, DOI 10.1016/j.jep.2015.08.026; Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054; Li YG, 2015, CHEM-BIOL INTERACT, V225, P70, DOI 10.1016/j.cbi.2014.11.003; Li YJ, 2014, J ETHNOPHARMACOL, V151, P218, DOI 10.1016/j.jep.2013.10.019; Liao P, 2015, EVID-BASED COMPL ALT, V2015, DOI [10.1155/2015/646530, DOI 10.1155/2015646530]; Liu HT, 2013, BIOMED CHROMATOGR, V27, P655, DOI 10.1002/bmc.2842; Liu MY, 2015, SCI REP-UK, V5, DOI 10.1038/srep11219; Lu HY, 2014, BIOL PHARM BULL, V37, P961, DOI 10.1248/bpb.b13-00921; Mao HP, 2016, J ETHNOPHARMACOL, V186, P20, DOI 10.1016/j.jep.2016.03.015; Nie PH, 2012, J ETHNOPHARMACOL, V139, P746, DOI 10.1016/j.jep.2011.11.054; Oliver WR, 2001, P NATL ACAD SCI USA, V98, P5306, DOI 10.1073/pnas.091021198; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Petznick Allison M, 2010, Osteopath Med Prim Care, V4, P5, DOI 10.1186/1750-4732-4-5; Qin GJ, 2006, P NATL ACAD SCI USA, V103, P11015, DOI 10.1073/pnas.0509533103; Rao XQ, 2011, CIRCULATION, V123, P2964, DOI 10.1161/CIRCULATIONAHA.110.966408; Selvin E, 2006, DIABETES CARE, V29, P877, DOI 10.2337/diacare.29.04.06.dc05-2018; Sun K, 2014, PAK J PHARM SCI, V27, P1699; Tateishi-Yuyama E, 2002, LANCET, V360, P427, DOI 10.1016/S0140-6736(02)09670-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Vazquez-Carrera M, 2016, TRENDS ENDOCRIN MET, V27, P319, DOI 10.1016/j.tem.2016.02.008; Wang DD, 2013, J CARDIOVASC PHARM, V62, P457, DOI 10.1097/FJC.0b013e3182a29657; Yang MZ, 2016, BRAIN RES, V1642, P516, DOI 10.1016/j.brainres.2016.04.046; Yang RX, 2010, ACTA PHARMACOL SIN, V31, P1395, DOI 10.1038/aps.2010.167; Yoon JW, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0131785, DOI 10.1371/JOURNALPONE0131785]; Youngblood RC, 2014, INT J MED SCI, V11, P545, DOI 10.7150/ijms.6994; Yu JW, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0408-3; Yu JM, 2015, MOL MED REP, V12, P6718, DOI 10.3892/mmr.2015.4307; Zhang Hao, 2011, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V36, P44, DOI 10.3969/j.issn.1672-7347.2011.01.007; Zhang QQ, 2016, CHIN J NAT MEDICINES, V14, P147, DOI 10.1016/S1875-5364(16)60008-0; Zhao BL, 1996, BIOCHEM MOL BIOL INT, V38, P1171; Zhao DL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071472; Zhao GR, 2008, FOOD CHEM TOXICOL, V46, P73, DOI 10.1016/j.fct.2007.06.034; Zhou XL, 2012, PHYTOMEDICINE, V19, P1263, DOI 10.1016/j.phymed.2012.08.011	51	25	27	4	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167305	10.1371/journal.pone.0167305	http://dx.doi.org/10.1371/journal.pone.0167305			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930695	Green Submitted, Green Published, gold			2022-12-26	WOS:000389580900024
J	Marmamula, S; Khanna, RC; Shekhar, K; Rao, GN				Marmamula, Srinivas; Khanna, Rohit C.; Shekhar, Konegari; Rao, Gullapalli N.			Outcomes of Cataract Surgery in Urban and Rural Population in the South Indian State of Andhra Pradesh: Rapid Assessment of Visual Impairment (RAVI) Project	PLOS ONE			English	Article							AVOIDABLE BLINDNESS; EYE SURVEY; SATKHIRA DISTRICT; OLDER ADULTS; PREVALENCE; BANGLADESH; NUMBER; NEPAL	Objective To assess the visual outcomes after cataract surgery among urban and rural population aged >= 40 years in the South India state of Andhra Pradesh. Methods A population based cross-sectional study was conducted in which 7800 subjects were sampled from two rural and one urban location. Visual Acuity was assessed and eye examination were performed by trained personnel. A questionnaire was used to collect personal and demographic information, and history of cataract surgery. Blindness and moderate Visual Impairment (MVI) was defined as presenting VA <6/60 and <6/18 to 6/60 in the better eye respectively. Results In total, 7378 (94.6%) were examined. Of these, 1228 eyes of 870 individuals were operated for cataract. The mean age of operated subjects was 63.7 years (SD: 10.7 years). Overall, 56.3% of those operated were women, 76% were illiterate and 42% of them were using spectacles after cataract surgery. Even after surgery, 12.2% of the operated eyes had MVI and blindness was seen in 14.7% of the eyes. A significantly higher proportion of subjects in urban area had good outcome as compared to those in the rural area (p = 0.01). Uncorrected refractive error (58.7%) was the leading cause of MVI, and posterior segment disease (34.3%) was the leading cause of blindness. On applying multiple logistic regression, risk factors for poor outcomes were age >= 70 years (OR: 1.9, 95% CI: 1.3-2.8), rural residence (OR: 1.3, 95% CI: 1.0-1.8) and presence of aphakia (OR: 8.9, 95% CI: 5.7-13.8). Conclusions Post cataract surgery, refractive errors remain an important correctable cause of MVI, in the south Indian state of Andhra Pradesh. The correction of refractive errors is required to provide good visual recovery and achieve the benefit of cataract surgery.	[Marmamula, Srinivas; Khanna, Rohit C.; Shekhar, Konegari; Rao, Gullapalli N.] LV Prasad Eye Inst, Allen Foster Community Eye Hlth Res Ctr, Gullapalli Pratibha Rao Int Ctr Adv Rural Eye Car, Hyderabad, Andhra Pradesh, India; [Marmamula, Srinivas; Khanna, Rohit C.; Rao, Gullapalli N.] LV Prasad Eye Inst, Brien Holden Inst Optometry & Vis Sci, Hyderabad, Andhra Pradesh, India; [Marmamula, Srinivas] LV Prasad Eye Inst, Wellcome Trust Dept Biotechnol India Alliance, Hyderabad, Andhra Pradesh, India	L. V. Prasad Eye Institute; L. V. Prasad Eye Institute; L. V. Prasad Eye Institute; Wellcome Trust DBT India Alliance	Khanna, RC (corresponding author), LV Prasad Eye Inst, Allen Foster Community Eye Hlth Res Ctr, Gullapalli Pratibha Rao Int Ctr Adv Rural Eye Car, Hyderabad, Andhra Pradesh, India.; Khanna, RC (corresponding author), LV Prasad Eye Inst, Brien Holden Inst Optometry & Vis Sci, Hyderabad, Andhra Pradesh, India.	rohit@lvpei.org			Hyderabad Eye Research Foundation	Hyderabad Eye Research Foundation	This study was funded by the Hyderabad Eye Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dandona L, 2003, CLIN EXP OPHTHALMOL, V31, P23, DOI 10.1046/j.1442-9071.2003.00595.x; Dandona L, 1999, AM J OPHTHALMOL, V127, P650, DOI 10.1016/S0002-9394(99)00044-6; Finger RP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044268; Garms R C, 1998, Community Eye Health, V11, P56; Haider S, 2003, OPHTHALMIC EPIDEMIOL, V10, P249, DOI 10.1076/opep.10.4.249.15907; Huang WY, 2011, INVEST OPHTH VIS SCI, V52, P16, DOI 10.1167/iovs.10-5382; Kalua K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019226; Kandel RP, 2010, OPHTHAL EPIDEMIOL, V17, P276, DOI 10.3109/09286586.2010.508355; Khairallah M, 2015, INVEST OPHTH VIS SCI, V56, P6762, DOI 10.1167/iovs.15-17201; Khanna RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035701; Lamoureux EL, 2011, CURR OPIN OPHTHALMOL, V22, P19, DOI 10.1097/ICU.0b013e3283414284; Lepcha NT, 2013, OPHTHAL EPIDEMIOL, V20, P212, DOI 10.3109/09286586.2013.794902; Limburg H, 1996, BRIT J OPHTHALMOL, V80, P951, DOI 10.1136/bjo.80.11.951; Limburg H, 1999, B WORLD HEALTH ORGAN, V77, P455; Lindfield R, 2008, EYE, V22, P1054, DOI 10.1038/sj.eye.6702836; Marmamula S, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005125; Marmamula S, 2014, CLIN EXP OPHTHALMOL, V42, P227, DOI 10.1111/ceo.12160; Marmamula S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070120; Mathenge W, 2007, PLOS MED, V4, P1187, DOI 10.1371/journal.pmed.0040217; Murthy GVS, 2009, OPHTHAL EPIDEMIOL, V16, P400, DOI 10.3109/09286580903315809; Murthy GVS, 1996, ACTA OPHTHALMOL SCAN, V74, P60; Murthy GVS, 2001, OPHTHALMOLOGY, V108, P686, DOI 10.1016/S0161-6420(00)00578-9; Nirmalan PK, 2002, BRIT J OPHTHALMOL, V86, P505, DOI 10.1136/bjo.86.5.505; Polack S, 2012, OPHTHALMOLOGY, V119, P1033, DOI 10.1016/j.ophtha.2011.11.002; Sapkota YD, 2010, OPHTHAL EPIDEMIOL, V17, P82, DOI 10.3109/09286581003624947; StataCorp, 2011, STAT STAT SOFTW REL, P173; Stevens GA, 2013, OPHTHALMOLOGY, V120, P2377, DOI 10.1016/j.ophtha.2013.05.025; Thulasiraj RD, 2002, OPHTHALMIC EPIDEMIOL, V9, P313, DOI 10.1076/opep.9.5.313.10339; Vijaya L, 2010, INDIAN J OPHTHALMOL, V58, P223, DOI 10.4103/0301-4738.62648; Wadud Z, 2006, BRIT J OPHTHALMOL, V90, P1225, DOI 10.1136/bjo.2006.101287; Wu M, 2008, OPHTHALMOLOGY, V115, P969, DOI 10.1016/j.ophtha.2007.08.002	31	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2016	11	12							e0167708	10.1371/journal.pone.0167708	http://dx.doi.org/10.1371/journal.pone.0167708			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4MR	27918589	Green Submitted, Green Published, gold			2022-12-26	WOS:000389577100016
J	Shu, CC; Yeh, CC; Jhang, WS; Lo, SC				Shu, Che-Chi; Yeh, Chen-Chao; Jhang, Wun-Sin; Lo, Shih-Chiang			Driving Cells to the Desired State in a Bimodal Distribution through Manipulation of Internal Noise with Biologically Practicable Approaches	PLOS ONE			English	Article							GENETIC TOGGLE SWITCH; REGULATORY NETWORKS; LINEAGE-COMMITMENT; POSITIVE FEEDBACK; ESCHERICHIA-COLI; EXPRESSION; PU.1; CONSEQUENCES; BISTABILITY; DYNAMICS	The stochastic nature of gene regulatory networks described by Chemical Master Equation (CME) leads to the distribution of proteins. A deterministic bistability is usually reflected as a bimodal distribution in stochastic simulations. Within a certain range of the parameter space, a bistable system exhibits two stable steady states, one at the low end and the other at the high end. Consequently, it appears to have a bimodal distribution with one sub-population (mode) around the low end and the other around the high end. In most cases, only one mode is favorable, and guiding cells to the desired state is valuable. Traditionally, the population was redistributed simply by adjusting the concentration of the inducer or the stimulator. However, this method has limitations; for example, the addition of stimulator cannot drive cells to the desired state in a common bistable system studied in this work. In fact, it pushes cells only to the undesired state. In addition, it causes a position shift of the modes, and this shift could be as large as the value of the mode itself. Such a side effect might damage coordination, and this problem can be avoided by applying a new method presented in this work. We illustrated how to manipulate the intensity of internal noise by using biologically practicable methods and utilized it to prompt the population to the desired mode. As we kept the deterministic behavior untouched, the aforementioned drawback was overcome. Remarkably, more than 96% of cells has been driven to the desired state. This method is genetically applicable to biological systems exhibiting a bimodal distribution resulting from bistability. Moreover, the reaction network studied in this work can easily be extended and applied to many other systems.	[Shu, Che-Chi; Yeh, Chen-Chao; Jhang, Wun-Sin; Lo, Shih-Chiang] Natl Taipei Univ Technol, Dept Chem Engn & Biotechnol, Taipei, Taiwan	National Taipei University of Technology	Shu, CC (corresponding author), Natl Taipei Univ Technol, Dept Chem Engn & Biotechnol, Taipei, Taiwan.	cshu@ntut.edu.tw		Shu, Che-Chi/0000-0002-6930-1050	Ministry of Science and Technology, R.O.C [MOST 104-2221-E-027-100, MOST 105-2221-E-027-116]	Ministry of Science and Technology, R.O.C	This work was supported by the grant (MOST 104-2221-E-027-100 -) and the grant (MOST 105-2221-E-027-116 -) from the Ministry of Science and Technology, R.O.C to C.-C. Shu (https://www.most.gov.Mte/en/public). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. decision to publish, or preparation of the manuscript.; This work was supported by the grant (MOST 104-2221-E-027-100 -) and the grant (MOST 105-2221-E-027-116 -) from the Ministry of Science and Technology, R.O.C.	Andrecut M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019358; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; Chatterjee A, 2013, P NATL ACAD SCI USA, V110, P7086, DOI 10.1073/pnas.1212256110; Chatterjee A, 2011, P NATL ACAD SCI USA, V108, P9721, DOI 10.1073/pnas.1101569108; Chickarmane V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003478; Dar RD, 2014, SCIENCE, V344, P1392, DOI 10.1126/science.1250220; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Hasty J, 2001, NAT REV GENET, V2, P268, DOI 10.1038/35066056; Hill AD, 2008, BIOINFORMATICS, V24, P2551, DOI 10.1093/bioinformatics/btn468; Huang S, 2007, DEV BIOL, V305, P695, DOI 10.1016/j.ydbio.2007.02.036; Huang S, 2009, BIOESSAYS, V31, P546, DOI 10.1002/bies.200800189; Iwasaki H, 2005, BLOOD, V106, P1590, DOI 10.1182/blood-2005-03-0860; Kepler TB, 2001, BIOPHYS J, V81, P3116, DOI 10.1016/S0006-3495(01)75949-8; Kobayashi H, 2004, P NATL ACAD SCI USA, V101, P8414, DOI 10.1073/pnas.0402940101; Maamar H, 2005, MOL MICROBIOL, V56, P615, DOI 10.1111/j.1365-2958.2005.04592.x; Mehra S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002724; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Paulsson J, 2000, P NATL ACAD SCI USA, V97, P7148, DOI 10.1073/pnas.110057697; Ptashne M, 1992, PHAGE LAMBDA HIGHER; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Reddy VA, 2002, BLOOD, V100, P483, DOI 10.1182/blood.V100.2.483; Shu CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079196; Shu CC, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002140; Singh A, 2009, CURR OPIN MICROBIOL, V12, P460, DOI 10.1016/j.mib.2009.06.016; Song HS, 2013, PROCESSES, V1, P263, DOI 10.3390/pr1030263; Tian TH, 2006, P NATL ACAD SCI USA, V103, P8372, DOI 10.1073/pnas.0507818103; Xu Y, 2014, PHYSICA A, V416, P461, DOI 10.1016/j.physa.2014.08.042; Yildirim N, 2003, BIOPHYS J, V84, P2841, DOI 10.1016/S0006-3495(03)70013-7; Zhang P, 1999, P NATL ACAD SCI USA, V96, P8705, DOI 10.1073/pnas.96.15.8705	32	6	6	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0167563	10.1371/journal.pone.0167563	http://dx.doi.org/10.1371/journal.pone.0167563			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3TF	27911933	gold, Green Published, Green Submitted			2022-12-26	WOS:000389520600043
J	Alsaleh, NB; Persaud, I; Brown, JM				Alsaleh, Nasser B.; Persaud, Indushekhar; Brown, Jared M.			Silver Nanoparticle-Directed Mast Cell Degranulation Is Mediated through Calcium and PI3K Signaling Independent of the High Affinity IgE Receptor	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; B TYPE-I; SCAVENGER RECEPTORS; PHOSPHOINOSITIDE 3-KINASE; SELECTIVE INHIBITORS; HISTAMINE-SECRETION; OXIDE NANOPARTICLES; ACTIVATION; TOXICITY; MECHANISM	Engineered nanomaterial (ENM)-mediated toxicity often involves triggering immune responses. Mast cells can regulate both innate and adaptive immune responses and are key effectors in allergic diseases and inflammation. Silver nanoparticles (AgNPs) are one of the most prevalent nanomaterials used in consumer products due to their antimicrobial properties. We have previously shown that AgNPs induce mast cell degranulation that was dependent on nanoparticle physicochemical properties. Furthermore, we identified a role for scavenger receptor B1 (SR-B1) in AgNP-mediated mast cell degranulation. However, it is completely unknown how SR-B1 mediates mast cell degranulation and the intracellular signaling pathways involved. In the current study, we hypothesized that SR-B1 interaction with AgNPs directs mast cell degranulation through activation of signal transduction pathways that culminate in an increase in intracellular calcium signal leading to mast cell degranulation. For these studies, we utilized bone marrow-derived mast cells (BMMC) isolated from C57BI/6 mice and RBL-2H3 cells (rat basophilic leukemia cell line). Our data support our hypothesis and show that AgNP-directed mast cell degranulation involves activation of PI3K, PLC gamma and an increase in intracellular calcium levels. Moreover, we found that influx of extracellular calcium is required for the cells to degranulate in response to AgNP exposure and is mediated at least partially via the CRAC channels. Taken together, our results provide new insights into AgNP-induced mast cell activation that are key for designing novel ENMs that are devoid of immune system activation.	[Alsaleh, Nasser B.; Persaud, Indushekhar; Brown, Jared M.] Univ Colorado Anschutz Med Campus, Skaggs Sch Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Brown, JM (corresponding author), Univ Colorado Anschutz Med Campus, Skaggs Sch Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Aurora, CO 80045 USA.	jared.brown@ucdenver.edu	ALSALEH, NASSER/AAY-3067-2020	ALSALEH, NASSER/0000-0002-2650-5934	Saudi Arabian Cultural Mission (SACM); King Saud University(KSU); National Institute of Environmental Health Sciences [R01 ES019311]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019311] Funding Source: NIH RePORTER	Saudi Arabian Cultural Mission (SACM); King Saud University(KSU); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	NBA is supported by Studentships from Saudi Arabian Cultural Mission (SACM) and King Saud University(KSU) (no grant number) (http:// ksu.edu.sa/en/). This work was supported by the National Institute of Environmental Health Sciences grant R01 ES019311 (JMB) (http://www.niehs.nih.gov/). The funders had no role in design, analysis, decision to publish or preparation of the manuscript.	Abraham SN, 2010, NAT REV IMMUNOL, V10, P440, DOI 10.1038/nri2782; Aldossari AA, 2015, J NANOPART RES, V17, DOI 10.1007/s11051-015-3116-0; Aldossari AA, 2015, TOXICOL IN VITRO, V29, P195, DOI 10.1016/j.tiv.2014.10.008; Baba Y, 2008, NAT IMMUNOL, V9, P81, DOI 10.1038/ni1546; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bonner JC, 2013, ENVIRON HEALTH PERSP, V121, P676, DOI 10.1289/ehp.1205693; Boudreau RTM, 2002, J BIOL CHEM, V277, P5322, DOI 10.1074/jbc.M108623200; Brown JM, 2008, CLIN EXP ALLERGY, V38, P4, DOI 10.1111/j.1365-2222.2007.02886.x; Canton J, 2013, NAT REV IMMUNOL, V13, P621, DOI 10.1038/nri3515; Carlson C, 2008, J PHYS CHEM B, V112, P13608, DOI 10.1021/jp712087m; Catanese MT, 2007, J VIROL, V81, P8063, DOI 10.1128/JVI.00193-07; Chen EY, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-2; Chen X, 2008, TOXICOL LETT, V176, P1, DOI 10.1016/j.toxlet.2007.10.004; Chopra I, 2007, J ANTIMICROB CHEMOTH, V59, P587, DOI 10.1093/jac/dkm006; Christensen FM, 2010, NANOTOXICOLOGY, V4, P284, DOI 10.3109/17435391003690549; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; DAVIS PD, 1989, FEBS LETT, V259, P61, DOI 10.1016/0014-5793(89)81494-2; Deane JA, 2004, ANNU REV IMMUNOL, V22, P563, DOI 10.1146/annurev.immunol.22.012703.104721; Dobrovolskaia MA, 2016, TOXICOL APPL PHARM, V299, P78, DOI 10.1016/j.taap.2015.12.022; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; Gilfillan AM, 2006, NAT REV IMMUNOL, V6, P218, DOI 10.1038/nri1782; Grewal T, 2003, J BIOL CHEM, V278, P16478, DOI 10.1074/jbc.C300085200; Grundy S, 2014, CLIN SCI, V126, P223, DOI 10.1042/CS20130152; Guo DD, 2013, INT J BIOCHEM CELL B, V45, P1849, DOI 10.1016/j.biocel.2013.06.002; Guo H, 2016, PART FIBRE TOXICOL, V13, DOI 10.1186/s12989-016-0133-9; Hamilton RF, 2014, INT J MOL SCI, V15, P6815, DOI 10.3390/ijms15046815; Hofstra CL, 2003, J PHARMACOL EXP THER, V305, P1212, DOI 10.1124/jpet.102.046581; Inoue T, 2009, J LEUKOCYTE BIOL, V86, P167, DOI [10.1189/JLB.1108691, 10.1189/jlb.1108691]; Jiang JK, 2009, J NANOPART RES, V11, P77, DOI 10.1007/s11051-008-9446-4; Kanno S, 2007, TOXICOL SCI, V97, P398, DOI 10.1093/toxsci/kfm050; Kettiger H, 2013, INT J NANOMED, V8, P3255, DOI 10.2147/IJN.S49770; Kim MS, 2008, TRENDS IMMUNOL, V29, P493, DOI 10.1016/j.it.2008.07.004; Kim S, 2009, TOXICOL IN VITRO, V23, P1076, DOI 10.1016/j.tiv.2009.06.001; Kocher O, 2003, J BIOL CHEM, V278, P52820, DOI 10.1074/jbc.M310482200; Kocher O, 2009, CURR OPIN LIPIDOL, V20, P236, DOI 10.1097/MOL.0b013e32832aee82; Lam V, 2003, BLOOD, V102, P1405, DOI 10.1182/blood-2002-10-3176; Liu Y, 2007, J EXP MED, V204, P93, DOI 10.1084/jem.20061598; MAEYAMA K, 1986, J BIOL CHEM, V261, P2583; Means TK, 2009, J EXP MED, V206, P637, DOI 10.1084/jem.20082109; Mineo C, 2003, J BIOL CHEM, V278, P9142, DOI 10.1074/jbc.M211394200; Navarro E, 2008, ENVIRON SCI TECHNOL, V42, P8959, DOI 10.1021/es801785m; Ng SW, 2008, J BIOL CHEM, V283, P31348, DOI 10.1074/jbc.M804942200; Nishanth RP, 2011, NANOTOXICOLOGY, V5, P502, DOI 10.3109/17435390.2010.541604; Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339; Okayama Y, 2003, EUR J IMMUNOL, V33, P1450, DOI 10.1002/eji.200323563; Olivera A, 2005, J IMMUNOL, V174, P1153, DOI 10.4049/jimmunol.174.3.1153; OZAWA K, 1993, J BIOL CHEM, V268, P2280; Park EJ, 2010, ENVIRON TOXICOL PHAR, V30, P162, DOI 10.1016/j.etap.2010.05.004; Parravicini V, 2002, NAT IMMUNOL, V3, P741, DOI 10.1038/ni817; Patel PC, 2010, BIOCONJUGATE CHEM, V21, P2250, DOI 10.1021/bc1002423; Pernas-Sueiras O, 2006, J CELL BIOCHEM, V99, P1651, DOI 10.1002/jcb.21009; Rauch J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00868; Raynal I, 2004, INVEST RADIOL, V39, P56, DOI 10.1097/01.rli.0000101027.57021.28; Recordati C, 2016, PART FIBRE TOXICOL, V13, DOI 10.1186/s12989-016-0124-x; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Roy R, 2014, TOXICOL LETT, V230, P421, DOI 10.1016/j.toxlet.2014.08.008; Sabuncu AC, 2012, COLLOID SURFACE B, V95, P96, DOI 10.1016/j.colsurfb.2012.02.022; Saddar S, 2010, ARTERIOSCL THROM VAS, V30, P144, DOI 10.1161/ATVBAHA.109.196170; Santoni G, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00034; SCHILLING CG, 1988, AM J HOSP PHARM, V45, P313, DOI 10.1093/ajhp/45.2.313; SCHWARTZ LB, 1994, CURR OPIN IMMUNOL, V6, P91, DOI 10.1016/0952-7915(94)90039-6; SELDIN DC, 1985, P NATL ACAD SCI USA, V82, P3871, DOI 10.1073/pnas.82.11.3871; Shannahan JH, 2015, TOXICOL SCI, V143, P136, DOI 10.1093/toxsci/kfu217; Sung JH, 2008, INHAL TOXICOL, V20, P567, DOI 10.1080/08958370701874671 ; Suresh AK, 2010, ENVIRON SCI TECHNOL, V44, P5210, DOI 10.1021/es903684r; Suzuki Y, 2002, J IMMUNOL, V169, P3954, DOI 10.4049/jimmunol.169.7.3954; Sydlik U, 2006, AM J PHYSIOL-LUNG C, V291, pL725, DOI 10.1152/ajplung.00131.2006; Tang ML, 2008, ENVIRON HEALTH PERSP, V116, P915, DOI 10.1289/ehp.11225; Trigatti B, 1999, P NATL ACAD SCI USA, V96, P9322, DOI 10.1073/pnas.96.16.9322; Tsou TC, 2013, TOXICOL APPL PHARM, V273, P492, DOI 10.1016/j.taap.2013.09.014; Vance ME, 2015, BEILSTEIN J NANOTECH, V6, P1769, DOI 10.3762/bjnano.6.181; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Visnapuu M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/819252; Walczak-Drzewiecka A, 2003, ENVIRON HEALTH PERSP, V111, P708, DOI 10.1289/ehp.5960; Weldon BA, 2016, NANOTOXICOLOGY, V10, P945, DOI 10.3109/17435390.2016.1148793; WILKINSON SE, 1993, BIOCHEM J, V294, P335, DOI 10.1042/bj2940335; Wymann MP, 2003, BIOCHEM SOC T, V31, P275, DOI 10.1042/bst0310275; Yang XY, 2012, ENVIRON SCI TECHNOL, V46, P1119, DOI 10.1021/es202417t; Yin LY, 2011, ENVIRON SCI TECHNOL, V45, P2360, DOI 10.1021/es103995x; Yoshimaru T, 2006, FREE RADICAL BIO MED, V40, P1949, DOI 10.1016/j.freeradbiomed.2006.01.023; Zhang LW, 2009, TOXICOL SCI, V110, P138, DOI 10.1093/toxsci/kfp087; Zhu PM, 2009, J BIOL CHEM, V284, P22878, DOI 10.1074/jbc.M109.018580	83	39	41	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167366	10.1371/journal.pone.0167366	http://dx.doi.org/10.1371/journal.pone.0167366			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907088	gold, Green Published, Green Submitted			2022-12-26	WOS:000389482700131
J	Barnabas, K; Zhang, L; Wang, HY; Kirouac, G; Vrontakis, M				Barnabas, Karen; Zhang, Lin; Wang, Huiying; Kirouac, Gilbert; Vrontakis, Maria			Changes in Galanin Systems in a Rat Model of Post-Traumatic Stress Disorder (PTSD)	PLOS ONE			English	Article							PREPROGALANIN MESSENGER-RNA; CHRONIC RESTRAINT STRESS; LOCUS-COERULEUS; CENTRAL AMYGDALA; ANXIOLYTIC-LIKE; FOOT-SHOCKS; EXPRESSION; ANXIETY; DEPRESSION; RESPONSES	Post-traumatic stress disorder (PTSD) is a chronic syndrome triggered by exposure to trauma and a failure to recover from a normal negative emotional reaction to traumatic stress. The neurobiology of PTSD and the participation of neuropeptides in the neural systems and circuits that control fear and anxiety are not fully understood. The long-term dysregulation of neuropeptide systems contributes to the development of anxiety disorders, including PTSD. The neuropeptide galanin (Gal) and its receptors participate in anxiety-like and depression-related behaviors via the modulation of neuroendocrine and monoaminergic systems. The objective of this research was to investigate how Gal expression changes in the brain of rats 2 weeks after exposure to footshock. Rats exposed to footshocks were subdivided into high responders (HR; immobility>60%) and low responders (LR; immobility<40%) based on immobility elicited by a novel tone one day after exposure. On day 14, rats were anesthetized, and the amygdala, hypothalamus, pituitary and adrenal glands were removed for analysis using real-time polymerase chain reaction (RT-PCR). Gal mRNA levels were increased in the amygdala and hypothalamus of HR compared with the control and LR. In contrast, Gal mRNA levels were decreased in the adrenal and pituitary glands of HR compared with the control and LR. Thus, the differential regulation (dysregulation) of the neuropeptide Gal in these tissues may contribute to anxiety and PTSD development.	[Barnabas, Karen; Zhang, Lin; Vrontakis, Maria] Univ Manitoba, Fac Med, Winnipeg, MB, Canada; [Wang, Huiying; Kirouac, Gilbert] Univ Manitoba, Fac Dent, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba	Vrontakis, M (corresponding author), Univ Manitoba, Fac Med, Winnipeg, MB, Canada.	Maria.Vrontakis@umanitoba.ca		Wang, Huiying/0000-0001-7219-122X; Kirouac, Gilbert/0000-0002-3632-2189	University Res Grant Program (URGP) [UM44541]	University Res Grant Program (URGP)	This work was supported by the University Res Grant Program (URGP), grant UM44541 (https://umanitoba.ca/research/ors/media/Guidelines_URG.pdf). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrera G, 2005, NEUROPEPTIDES, V39, P289, DOI 10.1016/j.npep.2004.12.008; Barrera G, 2006, SYNAPSE, V59, P27, DOI 10.1002/syn.20208; BING O, 1993, NEUROSCI LETT, V164, P17, DOI 10.1016/0304-3940(93)90846-D; Bonne O, 2004, NEUROSCI BIOBEHAV R, V28, P65, DOI 10.1016/j.neubiorev.2003.12.001; Bruijnzeel AW, 2001, PSYCHOPHARMACOLOGY, V158, P132; Bruijnzeel AW, 2001, EUR J PHARMACOL, V426, P77, DOI 10.1016/S0014-2999(01)01210-9; Charney DS, 2004, AM J PSYCHIAT, V161, P195, DOI 10.1176/appi.ajp.161.2.195; Chen XY, 2014, BRAIN STRUCT FUNCT, V219, P2103, DOI 10.1007/s00429-013-0626-3; Chen XY, 2012, BEHAV BRAIN RES, V226, P112, DOI 10.1016/j.bbr.2011.09.004; Davidson JRT, 2004, J NEUROPSYCH CLIN N, V16, P135, DOI 10.1176/appi.neuropsych.16.2.135; Davidson S, 2011, NEUROPSYCHOPHARMACOL, V36, P2211, DOI 10.1038/npp.2011.93; Heim C, 2009, CNS SPECTRUMS, V14, P13; Holmes A, 2003, NEUROPSYCHOPHARMACOL, V28, P1031, DOI 10.1038/sj.npp.1300164; Holmes A, 2002, NEUROPSYCHOPHARMACOL, V27, P914, DOI 10.1016/S0893-133X(02)00374-3; Holmes A, 2013, TRENDS NEUROSCI, V36, P23, DOI 10.1016/j.tins.2012.11.003; HOLMES PV, 1995, PHARMACOL BIOCHEM BE, V50, P655, DOI 10.1016/0091-3057(94)00334-3; Karlsson RM, 2006, AMINO ACIDS, V31, P231, DOI 10.1007/s00726-006-0336-8; Khoshbouei H, 2002, PHARMACOL BIOCHEM BE, V71, P407, DOI 10.1016/S0091-3057(01)00683-9; Khoshbouei H, 2002, NEUROPSYCHOPHARMACOL, V27, P25, DOI 10.1016/S0893-133X(01)00424-9; Kolakowski LF, 1998, J NEUROCHEM, V71, P2239; Kozlovsky N, 2009, BIOL PSYCHIAT, V65, P383, DOI 10.1016/j.biopsych.2008.10.034; Lang R, 2007, PHARMACOL THERAPEUT, V115, P177, DOI 10.1016/j.pharmthera.2007.05.009; Lang R, 2015, PHARMACOL REV, V67, P118, DOI 10.1124/pr.112.006536; Louvart N, 2005, PSYCHONEUROENDOCRINO, V30, P316, DOI 10.1016/j.psyneuen.2004.09.003; Madaan V, 2009, DRUG NEWS PERSPECT, V22, P319, DOI 10.1358/dnp.2009.22.6.1395255; MALENDOWICZ LK, 1994, ENDOCR RES, V20, P307, DOI 10.1080/07435809409035866; Max MB, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-14; Mennicken F, 2002, J CHEM NEUROANAT, V24, P257, DOI 10.1016/S0891-0618(02)00068-6; Mikics E, 2008, PSYCHONEUROENDOCRINO, V33, P1198, DOI 10.1016/j.psyneuen.2008.06.006; Moller C, 1999, NEUROPSYCHOPHARMACOL, V21, P507, DOI 10.1016/S0893-133X(98)00102-X; Murck H, 2004, PSYCHONEUROENDOCRINO, V29, P1205, DOI 10.1016/j.psyneuen.2004.02.006; Narvaez M, 2015, BRAIN STRUCT FUNCT, V220, P2289, DOI 10.1007/s00429-014-0788-7; O'Neal HA, 2001, NEUROSCI LETT, V299, P69, DOI 10.1016/S0304-3940(00)01780-8; Palkovits M, 2000, EUR J PHARMACOL, V405, P161, DOI 10.1016/S0014-2999(00)00549-5; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Sergeyev V, 2005, PSYCHOPHARMACOLOGY, V178, P115, DOI 10.1007/s00213-004-2015-3; Sherin Jonathan E, 2011, Dialogues Clin Neurosci, V13, P263; Stam R, 2007, NEUROSCI BIOBEHAV R, V31, P558, DOI 10.1016/j.neubiorev.2007.01.001; Swanson CJ, 2005, P NATL ACAD SCI USA, V102, P17489, DOI 10.1073/pnas.0508970102; Sweerts BW, 2000, BRAIN RES, V873, P318, DOI 10.1016/S0006-8993(00)02558-0; Sweerts BW, 1999, MOL BRAIN RES, V69, P113, DOI 10.1016/S0169-328X(99)00095-9; Unschuld PG, 2008, J AFFECT DISORDERS, V105, P177, DOI 10.1016/j.jad.2007.05.006; Unschuld PG, 2010, NEUROPSYCHOPHARMACOL, V35, P1583, DOI 10.1038/npp.2010.30; Vermetten E, 2002, DEPRESS ANXIETY, V16, P14, DOI 10.1002/da.10017; Vrontakis ME, 2002, CNS NEUROL DISORD-DR, V1, P533, DOI 10.2174/1568007023338914; Wang YQ, 1999, GEN COMP ENDOCR, V113, P38, DOI 10.1006/gcen.1998.7174; Wray NR, 2012, MOL PSYCHIATR, V17, P36, DOI 10.1038/mp.2010.109; Xu ZQD, 2001, NEUROREPORT, V12, P1779, DOI 10.1097/00001756-200106130-00052; Zhang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033901	49	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167569	10.1371/journal.pone.0167569	http://dx.doi.org/10.1371/journal.pone.0167569			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907151	Green Submitted, Green Published, gold			2022-12-26	WOS:000389482700198
J	Govindarajan, K; MacSharry, J; Casey, PG; Shanahan, F; Joyce, SA; Gahan, CGM				Govindarajan, Kalaimathi; MacSharry, John; Casey, Patrick G.; Shanahan, Fergus; Joyce, Susan A.; Gahan, Cormac G. M.			Unconjugated Bile Acids Influence Expression of Circadian Genes: A Potential Mechanism for Microbe-Host Crosstalk	PLOS ONE			English	Article							DIURNAL-VARIATION; GUT; HOMEOSTASIS; CLOCK; ENTRAINMENT; METABOLISM; REGULATORS; PHYSIOLOGY; RECEPTORS; BACTERIA	Disruptions to circadian rhythm in mice and humans have been associated with an increased risk of obesity and metabolic syndrome. The gut microbiota is known to be essential for the maintenance of circadian rhythm in the host suggesting a role for microbe-host interactions in the regulation of the peripheral circadian clock. Previous work suggested a role for gut bacterial bile salt hydrolase (BSH) activity in the regulation of host circadian gene expression. Here we demonstrate that unconjugated bile acids, known to be generated through the BSH activity of the gut microbiota, are potentially chronobiological regulators of host circadian gene expression. We utilised a synchronised Caco-2 epithelial colorectal cell model and demonstrated that unconjugated bile acids, but not the equivalent tauro-conjugated bile salts, enhance the expression levels of genes involved in circadian rhythm. In addition oral administration of mice with unconjugated bile acids significantly altered expression levels of circadian clock genes in the ileum and colon as well as the liver with significant changes to expression of hepatic regulators of circadian rhythm (including Dbp) and associated genes (Per2, Per3 and Cry2). The data demonstrate a potential mechanism for microbe-host crosstalk that significantly impacts upon host circadian gene expression.	[Govindarajan, Kalaimathi; MacSharry, John; Casey, Patrick G.; Shanahan, Fergus; Joyce, Susan A.; Gahan, Cormac G. M.] Univ Coll Cork, APC Microbiome Inst, Cork, Ireland; [MacSharry, John; Gahan, Cormac G. M.] Univ Coll Cork, Sch Microbiol, Cork, Ireland; [MacSharry, John; Shanahan, Fergus] Univ Coll Cork, Sch Med, Cork, Ireland; [Joyce, Susan A.] Univ Coll Cork, Sch Biochem & Cell Biol, Cork, Ireland; [Gahan, Cormac G. M.] Univ Coll Cork, Sch Pharm, Cork, Ireland	University College Cork; University College Cork; University College Cork; University College Cork; University College Cork	Joyce, SA; Gahan, CGM (corresponding author), Univ Coll Cork, APC Microbiome Inst, Cork, Ireland.; Gahan, CGM (corresponding author), Univ Coll Cork, Sch Microbiol, Cork, Ireland.; Joyce, SA (corresponding author), Univ Coll Cork, Sch Biochem & Cell Biol, Cork, Ireland.; Gahan, CGM (corresponding author), Univ Coll Cork, Sch Pharm, Cork, Ireland.	s.joyce@ucc.ie; c.gahan@ucc.ie	Joyce, Susan/ABE-2616-2020; Gahan, Cormac G/AAE-9346-2019; Sharry, John A Mac/M-7209-2017; Shanahan, Fergus/ABF-2390-2020	Joyce, Susan/0000-0003-4771-3123; Gahan, Cormac G/0000-0003-2385-8192; Sharry, John A Mac/0000-0002-9528-6261; Shanahan, Fergus/0000-0003-0467-0936	Health Research Board Ireland [HRA-POR-2013-296]; Science Foundation Ireland (SFI) [SFI/12/RC/2273]	Health Research Board Ireland; Science Foundation Ireland (SFI)(Science Foundation Ireland)	This work was supported by Health Research Board Ireland (grant number HRA-POR-2013-296): http://www.hrb.ie/home/ and Science Foundation Ireland (SFI) under Grant Number SFI/12/RC/2273, http://www.sfi.ie/.	Ballesta A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002143; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Begley M, 2005, FEMS MICROBIOL REV, V29, P625, DOI 10.1016/j.femsre.2004.09.003; Degirolamo C, 2014, CELL REP, V7, P12, DOI 10.1016/j.celrep.2014.02.032; Dey N, 2015, CELL, V163, P95, DOI 10.1016/j.cell.2015.08.059; Galman C, 2005, GASTROENTEROLOGY, V129, P1445, DOI 10.1053/j.gastro.2005.09.009; Golombek DA, 2010, PHYSIOL REV, V90, P1063, DOI 10.1152/physrev.00009.2009; HIDALGO IJ, 1989, GASTROENTEROLOGY, V96, P736; Hu X, 2014, J INTERN MED, V275, P27, DOI 10.1111/joim.12140; Islam KBMS, 2011, GASTROENTEROLOGY, V141, P1773, DOI 10.1053/j.gastro.2011.07.046; Jones BV, 2008, P NATL ACAD SCI USA, V105, P13580, DOI 10.1073/pnas.0804437105; Joyce SA, 2016, ANNU REV FOOD SCI T, V7, P313, DOI 10.1146/annurev-food-041715-033159; Joyce SA, 2014, GUT MICROBES, V5, P669, DOI 10.4161/19490976.2014.969986; Joyce SA, 2014, P NATL ACAD SCI USA, V111, P7421, DOI 10.1073/pnas.1323599111; Korpela K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10410; Le Martelot G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000181; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Leone V, 2015, CELL HOST MICROBE, V17, P681, DOI 10.1016/j.chom.2015.03.006; Li F, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3384; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006843; Mistlberger RE, 2011, ESSAYS BIOCHEM, V49, P119, DOI [10.1042/BSE0490119, 10.1042/bse0490119]; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Montagner A, 2016, SCI REP-UK, V6, DOI 10.1038/srep20127; Mukherji A, 2013, CELL, V153, P812, DOI 10.1016/j.cell.2013.04.020; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; Rieu I, 2009, PLANT CELL, V21, P1031, DOI 10.1105/tpc.109.066001; Stenman LK, 2013, AM J PHYSIOL-GASTR L, V304, pG227, DOI 10.1152/ajpgi.00267.2012; Stroeve JHM, 2010, LAB INVEST, V90, P1457, DOI 10.1038/labinvest.2010.107; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Thaiss CA, 2014, CELL, V159, P514, DOI 10.1016/j.cell.2014.09.048	31	64	66	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167319	10.1371/journal.pone.0167319	http://dx.doi.org/10.1371/journal.pone.0167319			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907092	Green Published, Green Submitted, gold			2022-12-26	WOS:000389482700119
J	Ma, X; Guo, J; Sun, X				Ma, Xin; Guo, Jing; Sun, Xiao			DNABP: Identification of DNA-Binding Proteins Based on Feature Selection Using a Random Forest and Predicting Binding Residues	PLOS ONE			English	Article							SUPPORT VECTOR MACHINES; SEQUENCE-BASED PREDICTION; AMINO-ACID-COMPOSITION; MRMR FEATURE-SELECTION; RIBOSOMAL-RNA-BINDING; WEB SERVER; INFORMATION; SVM; REDUNDANCY; RELEVANCE	DNA-binding proteins are fundamentally important in cellular processes. Several computational -based methods have been developed to improve the prediction of DNA-binding proteins in previous years. However, insufficient work has been done on the prediction of DNA binding proteins from protein sequence information. In this paper, a novel predictor, DNABP (DNA-binding proteins), was designed to predict DNA-binding proteins using the random forest (RF) classifier with a hybrid feature. The hybrid feature contains two types of novel sequence features, which reflect information about the conservation of physicochemical properties of the amino acids, and the binding propensity of DNA-binding residues and nonbinding propensities of non-binding residues. The comparisons with each feature demonstrated that these two novel features contributed most to the improvement in predictive ability. Furthermore, to improve the prediction performance of the DNABP model, feature selection using the minimum redundancy maximum relevance (mRMR) method combined with incremental feature selection (IFS) was carried out during the model construction. The results showed that the DNABP model could achieve 86.90% accuracy, 83.76% sensitivity, 90.03% specificity and a Matthews correlation coefficient of 0.727. High prediction accuracy and performance comparisons with previous research suggested that DNABP could be a useful approach to identify DNA-binding proteins from sequence information.	[Ma, Xin] Nanjing Audit Univ, Sch Sci, Nanjing, Jiangsu, Peoples R China; [Guo, Jing; Sun, Xiao] Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing, Jiangsu, Peoples R China	Nanjing Audit University; Southeast University - China	Ma, X (corresponding author), Nanjing Audit Univ, Sch Sci, Nanjing, Jiangsu, Peoples R China.	maxin@nau.edu.cn		Ma, Xin/0000-0002-8101-7271	National Natural Science Foundation of China [61305072]; Natural Science Foundation of the Jiangsu Higher Education Institutions of China [14KJB520020]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of the Jiangsu Higher Education Institutions of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 61305072) http://www.nsfc.gov.cn/ and had the data collection and analysis, decision to publish. This work was also supported by the Natural Science Foundation of the Jiangsu Higher Education Institutions of China (No. 14KJB520020) and had study design and also by the Qing Lan Project and had preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-33; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Bonchev D, 2001, J CHEM INF COMP SCI, V41, P582, DOI 10.1021/ci000104t; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2001, MACH LEARN, V45, P5; Cai CZ, 2003, NUCLEIC ACIDS RES, V31, P3692, DOI 10.1093/nar/gkg600; Cai YD, 2003, BBA-PROTEINS PROTEOM, V1648, P127, DOI 10.1016/S1570-9639(03)00112-2; Chen JJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep19062; DUBCHAK I, 1995, P NATL ACAD SCI USA, V92, P8700, DOI 10.1073/pnas.92.19.8700; Fang Y, 2008, AMINO ACIDS, V34, P103, DOI 10.1007/s00726-007-0568-2; Gao YF, 2013, MOL BIOSYST, V9, P61, DOI 10.1039/c2mb25327e; Gui TT, 2015, J COMPUT BIOL, V22, P63, DOI 10.1089/cmb.2014.0122; Han LY, 2004, RNA, V10, P355, DOI 10.1261/rna.5890304; Ho SY, 2007, BIOSYSTEMS, V90, P234, DOI 10.1016/j.biosystems.2006.08.007; Hwang S, 2007, BIOINFORMATICS, V23, P634, DOI 10.1093/bioinformatics/btl672; Imamova LR, 1997, BIOCHEMISTRY-MOSCOW+, V62, P1152; Kawashima Shuichi, 2000, NUCL ACIDS RES, V28, P374; KRAJEWSKA WM, 1992, INT J BIOCHEM, V24, P1885, DOI 10.1016/0020-711X(92)90284-8; Kumar KK, 2009, J BIOMOL STRUCT DYN, V26, P679, DOI 10.1080/07391102.2009.10507281; Kumar M, 2011, J MOL RECOGNIT, V24, P303, DOI 10.1002/jmr.1061; Kumar M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-463; Li BQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045854; Li BQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043927; Li BQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039308; Lin WZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024756; Liu B, 2016, IEEE T NANOBIOSCI, V15, P328, DOI 10.1109/TNB.2016.2555951; Liu B, 2015, BIOINFORMATICS, V31, P3492, DOI 10.1093/bioinformatics/btv413; Liu B, 2015, SCI REP-UK, V5, DOI 10.1038/srep15479; Liu B, 2015, NUCLEIC ACIDS RES, V43, pW65, DOI 10.1093/nar/gkv458; Liu B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121501; Liu B, 2015, MOL INFORM, V34, P8, DOI 10.1002/minf.201400025; Liu B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106691; Lou WC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086703; Luscombe NM, 2000, GENOME BIOL, V1; Ma X, 2014, J THEOR BIOL, V360, P59, DOI 10.1016/j.jtbi.2014.06.037; Ma X, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/524502; Ma X, 2012, IEEE ACM T COMPUT BI, V9, P1766, DOI 10.1109/TCBB.2012.106; Nimrod G, 2009, J MOL BIOL, V387, P1040, DOI 10.1016/j.jmb.2009.02.023; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Song L, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-298; Szaboova A, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-66; Vapnik Vladimir N., 1998, STATISICAL LEARNING; Veljkovic V, 2007, CURR MED CHEM, V14, P441, DOI 10.2174/092986707779941014; WANG J, 2002, BIOCH HIGHER ED; Wang J, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-S5-S9; Wang LJ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S1-S3; Wang LJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S1; Wang R, 2016, SCI REP-UK, V6, DOI 10.1038/srep23934; Wu JS, 2009, BIOINFORMATICS, V25, P30, DOI 10.1093/bioinformatics/btn583; Xu RF, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/294279; Yu XJ, 2006, J THEOR BIOL, V240, P175, DOI 10.1016/j.jtbi.2005.09.018; Zhang N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107464; Zhang YP, 2014, COMPUT BIOL CHEM, V52, P51, DOI 10.1016/j.compbiolchem.2014.09.002; Zhao HY, 2010, BIOINFORMATICS, V26, P1857, DOI 10.1093/bioinformatics/btq295; Zou CX, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-90	56	22	22	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167345	10.1371/journal.pone.0167345	http://dx.doi.org/10.1371/journal.pone.0167345			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907159	Green Submitted, Green Published, gold			2022-12-26	WOS:000389482700124
J	Pagan, I; Rojas, P; Ramos, JT; Holguin, A				Pagan, Israel; Rojas, Patricia; Ramos, Jose Tomas; Holguin, Africa			Clinical Determinants of HIV-1B Between-Host Evolution and their Association with Drug Resistance in Pediatric Patients	PLOS ONE			English	Article							NON-B SUBTYPES; DISEASE PROGRESSION; GENETIC DIVERSITY; PERINATAL TRANSMISSION; WITHIN-HOST; VIRUS; POPULATION; INDIVIDUALS; CHILDREN; RATES	Understanding the factors that modulate the evolution of virus populations is essential to design efficient control strategies. Mathematical models predict that factors affecting viral within-host evolution may also determine that at the between-host level. Although HIV-1 within-host evolution has been associated with clinical factors used to monitor AIDS progression, such as patient age, CD4 cells count, viral load, and antiretroviral experience, little is known about the role of these clinical factors in determining between-host HIV-1 evolution. Moreover, whether the relative importance of such factors in HIV-1 evolution vary in adult and children patients, in which the course of infection is different, has seldom been analysed. To address these questions, HIV-1 subtype B (HIV-1B) pol sequences of 163 infected children and 450 adults of Madrid, Spain, were used to estimate genetic diversity, rates of synonymous and non-synonymous mutations, selection pressures and frequency of drug-resistance mutations (DRMs). The role and relative importance of patient age, % CD4, CD4/mm(3), viral load, and antiretroviral experience in HIV-1B evolution was analysed. In the pediatric HIV-1B population, three clinical factors were primary predictors of virus evolution: Higher HIV-1B genetic diversity was observed with increasing children age, decreasing CD4/mm(3) and upon antiretroviral experience. This was mostly due to higher rates of non-synonymous mutations, which were associated with higher frequency of DRMs. Using this data, we have also constructed a simple multivariate model explaining between 55% and 66% of the variance in HIV-1B evolutionary parameters in pediatric populations. On the other hand, the analysed clinical factors had little effect in adult-infecting HIV-1B evolution. These findings highlight the different evolutionary dynamics of HIV-1B in children and adults, and contribute to understand the factors shaping HIV-1B evolution and the appearance of drug-resistance mutation in pediatric patients.	[Pagan, Israel] Univ Politecn Madrid, Ctr Biotecnol & Genom Plantas UPMI NIA, Madrid, Spain; [Pagan, Israel] Univ Politecn Madrid, ETSI Agronomos, Madrid, Spain; [Rojas, Patricia; Holguin, Africa] Hosp Ramon & Cajal, IRYCIS, HIV Mol Epidemiol Lab 1, Dept Microbiol, Madrid, Spain; [Rojas, Patricia; Holguin, Africa] CIBER ESP, Madrid, Spain; [Ramos, Jose Tomas] Univ Complutense Madrid, Hosp Clin San Carlos, Madrid, Spain; [Ramos, Jose Tomas] Univ Complutense Madrid, Fac Med, Madrid, Spain	Universidad Politecnica de Madrid; Universidad Politecnica de Madrid; Hospital Universitario Ramon y Cajal; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Complutense University of Madrid; Hospital Clinico San Carlos; Complutense University of Madrid	Pagan, I (corresponding author), Univ Politecn Madrid, Ctr Biotecnol & Genom Plantas UPMI NIA, Madrid, Spain.; Pagan, I (corresponding author), Univ Politecn Madrid, ETSI Agronomos, Madrid, Spain.; Holguin, A (corresponding author), Hosp Ramon & Cajal, IRYCIS, HIV Mol Epidemiol Lab 1, Dept Microbiol, Madrid, Spain.; Holguin, A (corresponding author), CIBER ESP, Madrid, Spain.	jesusisrael.pagan@upm.es; africa.holguin@salud.madrid.org	Holguín, Africa/AAF-9001-2021; Pagán, Israel/H-1843-2015	Holguín, Africa/0000-0002-1330-8050; Pagán, Israel/0000-0001-8876-1194; , Patricia/0000-0001-6935-0066	Plan Nacional de I+D+i; Institute de Salud Carlos III [FIS PI12/00240, FIS PI15/01005]; European Development Regional Fund "A way to achieve Europe (ERDF); GIBER [CB06/02/0053]; Ministerio de Economia y Competitividad [RYC-2011-08574]	Plan Nacional de I+D+i; Institute de Salud Carlos III(Instituto de Salud Carlos III); European Development Regional Fund "A way to achieve Europe (ERDF)(European Commission); GIBER; Ministerio de Economia y Competitividad(Spanish Government)	This work was supported in part by Plan Nacional de I+D+i 2008-2011, Institute de Salud Carlos III, FIS PI12/00240 and FIS PI15/01005, and co-financed by the European Development Regional Fund "A way to achieve Europe (ERDF) and GIBER (grant number CB06/02/0053) to AH, and Ramon y Cajal contract from Ministerio de Economia y Competitividad (grant number RYC-2011-08574) to IP. The Madrid cohort of HIV infected pediatric patients is part of CoRlspe, Red Tematica de Investigacion Cooperativa en SIDA (ISCIII-RETIC RD06/006), and Red Tematica de Investigacion Cooperativa Sanitaria ISCIII (RED RIS RD12-0017-0037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis AB, 2009, J VIROL, V83, P12917, DOI 10.1128/JVI.01022-09; Abrams EJ, 1998, J INFECT DIS, V178, P101, DOI 10.1086/515596; Alizon S, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-49; ANDERSON R M, 1991; [Anonymous], 1994, MMWR Recomm Rep, V43, P1; Beauchemin CAA, 2008, J THEOR BIOL, V254, P439, DOI 10.1016/j.jtbi.2008.05.031; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burns DN, 1999, LANCET, V354, pS1, DOI 10.1016/S0140-6736(99)90249-0; Carvajal-Rodriguez A, 2008, INFECT GENET EVOL, V8, P110, DOI 10.1016/j.meegid.2007.10.009; Castro H, 2011, LANCET, V377, P1580, DOI 10.1016/S0140-6736(11)60208-0; Castro-Nallar E, 2012, MOL PHYLOGENET EVOL, V62, P777, DOI 10.1016/j.ympev.2011.11.019; Ceballos A, 2008, J GEN VIROL, V89, P2773, DOI 10.1099/vir.0.83697-0; Chakraborty R, 2005, CURR HIV RES, V3, P31, DOI 10.2174/1570162052773022; Chen Xue-qing, 2011, Virologica Sinica, V26, P147, DOI 10.1007/s12250-011-3180-2; de Mulder M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052155; de Mulder M, 2012, PEDIATR INFECT DIS J, V31, pE213, DOI 10.1097/INF.0b013e3182678c7c; de Mulder M, 2011, J ANTIMICROB CHEMOTH, V66, P2362, DOI 10.1093/jac/dkr305; Dickover RE, 2001, J VIROL, V75, P2194, DOI 10.1128/JVI.75.5.2194-2203.2001; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Einer-jensen K, 2004, J GEN VIROL, V85, P1167, DOI 10.1099/vir.0.79820-0; Gall A, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-8; Gifford RJ, 2009, BIOINFORMATICS, V25, P1197, DOI 10.1093/bioinformatics/btp134; Gijsbers EF, 2014, SCI REP-UK, V4, DOI 10.1038/srep05079; Holguin A, 2008, CURR HIV RES, V6, P327, DOI 10.2174/157016208785132455; de Jose MI, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-2; Kearney MF, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004010; Kosakovsky Pond SL, 2005, BIOINFORMATICS, V21, P2531, DOI DOI 10.1093/BI0INF0RMATICS/BTI320; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lanfear R, 2014, TRENDS ECOL EVOL, V29, P33, DOI 10.1016/j.tree.2013.09.009; Leal E, 2007, INFECT GENET EVOL, V7, P694, DOI 10.1016/j.meegid.2007.07.008; Lemey P, 2007, PLOS COMPUT BIOL, V3, P282, DOI 10.1371/journal.pcbi.0030029; Liu TF, 2006, CLIN INFECT DIS, V42, P1608, DOI 10.1086/503914; Lorenzo E, 2004, VIROLOGY, V330, P116, DOI 10.1016/j.virol.2004.09.015; Maldarelli F, 2013, J VIROL, V87, P10313, DOI 10.1128/JVI.01225-12; Mani I, 2002, J VIROL, V76, P10745, DOI 10.1128/JVI.76.21.10745-10755.2002; Markham RB, 1998, P NATL ACAD SCI USA, V95, P12568, DOI 10.1073/pnas.95.21.12568; Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003; Murray J., 1910, REPORTS SCI EXPEDITI, P17; Pai NP, 2012, JAIDS-J ACQ IMM DEF, V59, P382, DOI 10.1097/QAI.0b013e31824a0628; Palladino C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096307; Pennings PS, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002527; Peres-Neto PR, 2003, ECOLOGY, V84, P2347, DOI 10.1890/00-0634; Prendergast AJ, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001273; Rambaut A., 1996, SEQUENCE ALIGNMENT E; Resino S, 2006, CLIN INFECT DIS, V43, P243, DOI 10.1086/505213; Rojas P, 2015, CLIN MICROBIOL INFEC, V21; Sanchez PR, 2014, J ANTIMICROB CHEMOTH, V69, P2032, DOI 10.1093/jac/dku104; Ryland EG, 2010, J VIROL, V84, P12437, DOI 10.1128/JVI.01617-10; Sainz T, 2013, AIDS, V27, P1513, DOI 10.1097/QAD.0b013e32835faa72; Salemi M, 1999, P NATL ACAD SCI USA, V96, P13253, DOI 10.1073/pnas.96.23.13253; Scholle SO, 2013, AM NAT, V182, P494, DOI 10.1086/672000; Seo TK, 2002, BIOINFORMATICS, V18, P115, DOI 10.1093/bioinformatics/18.1.115; Shriner D, 2006, EVOLUTION, V60, P1165, DOI 10.1554/05-473.1; Sokal RR, 1995, BIOMETRY; Sundaravaradan V, 2006, P NATL ACAD SCI USA, V103, P11701, DOI 10.1073/pnas.0602185103; Tazi L, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-62; UNAIDS, 2016, GLOB AIDS UPD; Volk SM, 2010, J VIROL, V84, P6497, DOI 10.1128/JVI.01603-09; Wensing Annemarie M, 2014, Top Antivir Med, V22, P642; Wertheim JO, 2012, MOL BIOL EVOL, V29, P451, DOI 10.1093/molbev/msr266; Yebra G, 2010, ANTIVIR RES, V85, P409, DOI 10.1016/j.antiviral.2009.11.010; Zhang Hongwei, 2010, Chin Med, V5, P1, DOI 10.1186/1749-8546-5-1	63	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167383	10.1371/journal.pone.0167383	http://dx.doi.org/10.1371/journal.pone.0167383			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907076	Green Accepted, Green Published, gold			2022-12-26	WOS:000389482700135
J	Engel, NW; Neumann, JE; Ahlfeld, J; Wefers, AK; Merk, DJ; Ohli, J; Schuller, U				Engel, Nils W.; Neumann, Julia E.; Ahlfeld, Julia; Wefers, Annika K.; Merk, Daniel J.; Ohli, Jasmin; Schueller, Ulrich			Canonical Wnt Signaling Drives Tumor-Like Lesions from Sox2-Positive Precursors of the Murine Olfactory Epithelium	PLOS ONE			English	Article							BETA-CATENIN GENE; CONSTITUTIVE ACTIVATION; SINONASAL HEMANGIOPERICYTOMA; PROGENITOR CELLS; SMALL-INTESTINE; STEM-CELLS; MUTATIONS; PROLIFERATION; EXPRESSION; CARCINOMA	Canonical Wnt signaling is known to promote proliferation of olfactory stem cells. In order to investigate the effects of a constitutive activation of Wnt signaling in Sox2-positive precursor cells of the olfactory epithelium, we used transgenic mice that allowed an inducible deletion of exon 3 of the Ctnnb1 gene, which is responsible for the phosphorylation and degradation of Ctnnb1 protein. After induction of aberrant Wnt activation by Ctnnb1 deletion at embryonic day 14, such mice developed tumor-like lesions in upper parts of the nasal cavity. We still observed areas of epithelial hyperplasia within the olfactory epithelium following early postnatal Wnt activation, but the olfactory epithelial architecture remained unaffected in most parts when Wnt was activated at postnatal day 21 or later. In summary, our results suggest an age-dependent tumorigenic potential of aberrant Wnt signaling in the olfactory epithelium of mice.	[Engel, Nils W.; Neumann, Julia E.; Ahlfeld, Julia; Wefers, Annika K.; Merk, Daniel J.; Ohli, Jasmin; Schueller, Ulrich] Ludwig Maximilians Univ Munchen, Ctr Neuropathol, Munich, Germany; [Engel, Nils W.] Univ Med Ctr, Dept Internal Med 2, Hamburg, Germany; [Neumann, Julia E.; Schueller, Ulrich] Univ Med Ctr, Inst Neuropathol, Hamburg, Germany; [Schueller, Ulrich] Res Inst Childrens Canc Ctr, Hamburg, Germany; [Schueller, Ulrich] Univ Med Ctr, Dept Pediat Hematol & Oncol, Hamburg, Germany; [Ahlfeld, Julia] Ludwig Maximilians Univ Munchen, Dept Internal Med 4, Div Clin Pharmacol, Munich, Germany; [Wefers, Annika K.] Heidelberg Univ, Inst Pathol, Dept Neuropathol, D-69115 Heidelberg, Germany; [Merk, Daniel J.] Dana Farber Canc Inst, Boston, MA 02115 USA	University of Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich; Ruprecht Karls University Heidelberg; Harvard University; Dana-Farber Cancer Institute	Schuller, U (corresponding author), Ludwig Maximilians Univ Munchen, Ctr Neuropathol, Munich, Germany.; Schuller, U (corresponding author), Univ Med Ctr, Inst Neuropathol, Hamburg, Germany.; Schuller, U (corresponding author), Res Inst Childrens Canc Ctr, Hamburg, Germany.; Schuller, U (corresponding author), Univ Med Ctr, Dept Pediat Hematol & Oncol, Hamburg, Germany.	u.schueller@uke.de	Wefers, Annika K./ABF-3832-2020	Wefers, Annika K./0000-0001-9394-8519; Schuller, Ulrich/0000-0002-8731-1121; Thorn-Seshold, Julia/0000-0002-4879-4159; Engel, Nils/0000-0002-3514-5686	Deutsche Krebshilfe [111630]	Deutsche Krebshilfe(Deutsche Krebshilfe)	This work was supported by Deutsche Krebshilfe, grant number 111630.	Agaimy A, 2014, HISTOPATHOLOGY, V65, P667, DOI 10.1111/his.12452; Arnold K, 2011, CELL STEM CELL, V9, P317, DOI 10.1016/j.stem.2011.09.001; Bak M, 2012, HEMATOL ONCOL CLIN N, V26, P1185, DOI 10.1016/j.hoc.2012.08.005; Beites CL, 2005, EXP CELL RES, V306, P309, DOI 10.1016/j.yexcr.2005.03.027; Bhutta MF, 2011, RHINOLOGY, V49, P185, DOI 10.4193/Rhino09.171; Breuhahn K, 2006, ONCOGENE, V25, P3787, DOI 10.1038/sj.onc.1209556; CARNEY ME, 1995, J NEURO-ONCOL, V26, P35, DOI 10.1007/BF01054767; Cau E, 1997, DEVELOPMENT, V124, P1611; Chen MF, 2014, J NEUROSCI, V34, P8268, DOI 10.1523/JNEUROSCI.0240-14.2014; Chen SQ, 2001, J CELL BIOL, V152, P87, DOI 10.1083/jcb.152.1.87; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Faragalla H, 2009, ADV ANAT PATHOL, V16, P322, DOI 10.1097/PAP.0b013e3181b544cf; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fukuchi T, 1998, CANCER RES, V58, P3526; Gibson P, 2010, NATURE, V468, P1095, DOI 10.1038/nature09587; GRAZIADEI PPC, 1979, J NEUROCYTOL, V8, P1, DOI 10.1007/BF01206454; Guo Z, 2010, J COMP NEUROL, V518, P4395, DOI 10.1002/cne.22463; Haller F, 2015, AM J PATHOL, V185, P563, DOI 10.1016/j.ajpath.2014.10.019; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Huff V, 2011, NAT REV CANCER, V11, P111, DOI 10.1038/nrc3002; Hulse KE, 2015, CLIN EXP ALLERGY, V45, P328, DOI 10.1111/cea.12472; Knor M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141722; Kondo K, 2010, J COMP NEUROL, V518, P1962, DOI 10.1002/cne.22316; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Kuhnert F, 2004, P NATL ACAD SCI USA, V101, P266, DOI 10.1073/pnas.2536800100; Lasota J, 2015, MODERN PATHOL, V28, P715, DOI 10.1038/modpathol.2014.161; Leslie A, 2002, BRIT J SURG, V89, P845, DOI 10.1046/j.1365-2168.2002.02120.x; Longo KA, 2002, J BIOL CHEM, V277, P38239, DOI 10.1074/jbc.M206402200; Lorenz A, 2011, MOL CELL BIOL, V31, P3326, DOI 10.1128/MCB.05718-11; Loseva E, 2009, BRAIN RES REV, V59, P374, DOI 10.1016/j.brainresrev.2008.10.004; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Murdoch B, 2007, J MOL HISTOL, V38, P581, DOI 10.1007/s10735-007-9141-2; Ow TJ, 2013, NEUROSURG CLIN N AM, V24, P51, DOI 10.1016/j.nec.2012.08.005; Palacios J, 1998, CANCER RES, V58, P1344; Park WS, 1999, CANCER RES, V59, P4257; Poschl J, 2013, DEV BIOL, V374, P319, DOI 10.1016/j.ydbio.2012.12.001; Ralston J, 2008, MODERN PATHOL, V21, P1357, DOI 10.1038/modpathol.2008.118; Schuller U, 2008, CANCER CELL, V14, P123, DOI 10.1016/j.ccr.2008.07.005; Schwob James E., 2002, Anatomical Record, V269, P33, DOI 10.1002/ar.10047; Selvadurai HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023012; Sunaga N, 2001, GENE CHROMOSOME CANC, V30, P316, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1097>3.0.CO;2-9; Swartling FJ, 2014, EXP NEUROL, V260, P56, DOI 10.1016/j.expneurol.2013.01.027; Tian P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048997; Walther A, 2009, NAT REV CANCER, V9, P489, DOI 10.1038/nrc2645; Wang YZ, 2011, J CELL SCI, V124, P1553, DOI 10.1242/jcs.080580; Wenig BM, 2005, WHO IARC CLASSIFICAT, V9, P65	48	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0166690	10.1371/journal.pone.0166690	http://dx.doi.org/10.1371/journal.pone.0166690			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902722	gold, Green Submitted, Green Published			2022-12-26	WOS:000389474100033
J	Hinduja, A; Limaye, K; Ravilla, R; Sasapu, A; Papanikolaou, X; Wei, L; Torbey, M; Waheed, S				Hinduja, Archana; Limaye, Kaustubh; Ravilla, Rahul; Sasapu, Appalnaidu; Papanikolaou, Xenofon; Wei, Lai; Torbey, Michel; Waheed, Sarah			Spectrum of Cerebrovascular Disease in Patients with Multiple Myeloma Undergoing Chemotherapy-Results of a Case Control Study	PLOS ONE			English	Article							THALIDOMIDE PLUS DEXAMETHASONE; TRANSIENT ISCHEMIC ATTACK; PROGNOSTIC IMPLICATIONS; RECEIVING THALIDOMIDE; RENAL-FUNCTION; TOTAL THERAPY; YOUNG-ADULTS; STROKE RISK; SURVIVAL; KIDNEY	Objectives Patients with multiple myeloma (MM) are at increased risk of arterial thrombosis. Our aim was to determine the risk factors, mechanisms and outcome of strokes in these patients. Methods We conducted a retrospective matched case-control study from our database of MM patients enrolled in Total Therapy (TT) 2, TT3a and TT3b protocols who developed a vascular event (transient ischemic attack, ischemic stroke, or intracerebral hemorrhage) from October 1998 to January 2014. Cases were matched for age-matched selected controls. Baseline demographics, risk factors, MM characteristics, laboratory values, and mortality of cases were compared to those of controls. Multivariate logistic regression analysis identified risk factors associated with stroke. Ischemic strokes (IS) were classified with modified Trial of Org 10172 in Acute Stroke Treatment (TOAST) criteria. Results Of 1,148 patients, 46 developed a vascular event (ischemic stroke, 33; transient ischemic attack, 11; hypertensive intracerebral hemorrhage, 2). Multivariate logistic regression analysis determined renal insufficiency (odds Ratio, 3.528; 95% CI, 1.36-9.14; P = 0.0094) and MM Stages I and II (odds Ratio, 2.770, 95% CI, 1.31-5.81; p = 0.0073) were independent predictors of stroke. In our study, strokes attributable to hypercoagulability, atrial fibrillation and small-vessel occlusion were common mechanisms. After a stroke, 78% of patients were discharged to home or a rehabilitation facility and 4% to a long-term nursing facility; in-hospital mortality was 15%. Despite suffering a stroke no significant differences in survival were observed. Conclusion In our cohort of multiple myeloma patients, renal failure and MM Stages I and II had increased risk of stroke.	[Hinduja, Archana; Limaye, Kaustubh] Univ Arkansas Med Sci, Dept Neurol, Little Rock, AR 72205 USA; [Ravilla, Rahul; Sasapu, Appalnaidu] Univ Arkansas Med Sci, Dept Hematol & Oncol, Little Rock, AR 72205 USA; [Papanikolaou, Xenofon; Waheed, Sarah] Univ Arkansas Med Sci, Multiple Myeloma Res & Therapy, Little Rock, AR 72205 USA; [Hinduja, Archana; Wei, Lai; Torbey, Michel] Ohio State Univ, Dept Neurol, Wexner Med Ctr, Columbus, OH 43210 USA; [Torbey, Michel] Ohio State Univ, Dept Neurosurg, Wexner Med Ctr, Columbus, OH 43210 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Hinduja, A (corresponding author), Univ Arkansas Med Sci, Dept Neurol, Little Rock, AR 72205 USA.; Hinduja, A (corresponding author), Ohio State Univ, Dept Neurol, Wexner Med Ctr, Columbus, OH 43210 USA.	archanahinduja@yahoo.com	Ravilla, Rahul/AFS-1497-2022	Ravilla, Rahul/0000-0001-8403-0386; Limaye, Kaustubh/0000-0002-7280-7407	 [U10NS080368]		This work was supported by grant U10NS080368.	Aarnio K, 2015, STROKE, V46, P1601, DOI 10.1161/STROKEAHA.115.008694; ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Barlogie B, 2006, NEW ENGL J MED, V354, P1021, DOI 10.1056/NEJMoa053583; Barlogie B, 2014, BLOOD, V124, P3043, DOI 10.1182/blood-2014-07-552059; Bejot Y, 2008, J NEUROL NEUROSUR PS, V79, P1344, DOI 10.1136/jnnp.2008.150318; Bennett CL, 2006, JAMA-J AM MED ASSOC, V296, P2558, DOI 10.1001/jama.296.21.2558-c; CATOVSKY D, 1970, BRIT MED J, V3, P438, DOI 10.1136/bmj.3.5720.438; Cestari DM, 2004, NEUROLOGY, V62, P2025, DOI 10.1212/01.WNL.0000129912.56486.2B; Dimopoulos M, 2007, NEW ENGL J MED, V357, P2123, DOI 10.1056/NEJMoa070594; Easton JD, 2009, STROKE, V40, P2276, DOI 10.1161/STROKEAHA.108.192218; Fernyhough LJ, 2013, INTERN MED J, V43, P130, DOI 10.1111/j.1445-5994.2012.02819.x; Fonarow GC, 2010, CIRC-CARDIOVASC QUAL, V3, P291, DOI 10.1161/CIRCOUTCOMES.109.921858; Gansevoort RT, 2013, LANCET, V382, P339, DOI 10.1016/S0140-6736(13)60595-4; Hajat C, 2011, J NEUROL NEUROSUR PS, V82, P527, DOI 10.1136/jnnp.2010.222919; Holzmann MJ, 2012, ANN MED, V44, P607, DOI 10.3109/07853890.2011.582136; Hong KS, 2011, CIRCULATION, V123, P2111, DOI 10.1161/CIRCULATIONAHA.109.934786; Ikram MA, 2008, STROKE, V39, P55, DOI 10.1161/STROKEAHA.107.493494; Jung SH, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2645-y; Kang DH, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133806; Khan R, 2015, LEUKEMIA, V29, P1195, DOI 10.1038/leu.2015.15; Khatri M, 2014, J STROKE CEREBROVASC, V23, P25, DOI 10.1016/j.jstrokecerebrovasdis.2012.06.005; Knight R, 2006, NEW ENGL J MED, V354, P2079; KNUDSEN LM, 1994, EUR J HAEMATOL, V53, P207; Kristinsson SY, 2012, HAEMATOL-HEMATOL J, V97, P1603, DOI 10.3324/haematol.2012.064444; Kristinsson SY, 2010, BLOOD, V115, P4991, DOI 10.1182/blood-2009-11-252072; Kumai Y, 2012, Neurology, V78, P1909, DOI 10.1212/WNL.0b013e318259e110; Kyle RA, 2003, MAYO CLIN PROC, V78, P21, DOI 10.4065/78.1.21; Lau KK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088283; Lee JT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089386; Libourel EJ, 2010, BLOOD, V116, P22, DOI 10.1182/blood-2009-12-257519; Moe SM, 2012, CIRCULATION, V125, P2181, DOI 10.1161/CIRCULATIONAHA.112.104828; Mogi M, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/306189; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Nair B, 2010, BLOOD, V115, P4168, DOI 10.1182/blood-2009-11-255620; Navi BB, 2014, NEUROLOGY, V83, P26, DOI 10.1212/WNL.0000000000000539; Neben K, 2002, CLIN CANCER RES, V8, P3377; O'Rourke MF, 2005, HYPERTENSION, V46, P200, DOI 10.1161/01.HYP.0000168052.00426.65; Ovbiagele B, 2013, STROKE, V44, P3223, DOI 10.1161/STROKEAHA.113.002463; Putaala J, 2009, STROKE, V40, P2698, DOI 10.1161/STROKEAHA.109.554998; Rajkumar SV, 2006, J CLIN ONCOL, V24, P431, DOI 10.1200/JCO.2005.03.0221; Rajkumar SV, 2002, J CLIN ONCOL, V20, P4319, DOI 10.1200/JCO.2002.02.116; Rios R, 2013, REV CLIN ESP, V213, P330, DOI 10.1016/j.rce.2013.02.014; Schlaich MP, 2011, HYPERTENSION, V57, P683, DOI 10.1161/HYPERTENSIONAHA.110.167189; Schwarzbach CJ, 2012, STROKE, V43, P3029, DOI 10.1161/STROKEAHA.112.658625; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Stefan O, 2009, J NEURO-ONCOL, V94, P221, DOI 10.1007/s11060-009-9818-3; Toyoda K, 2014, LANCET NEUROL, V13, P823, DOI 10.1016/S1474-4422(14)70026-2; Tsukamoto Y, 2012, J STROKE CEREBROVASC, V21, P547, DOI 10.1016/j.jstrokecerebrovasdis.2010.12.005; van Rhee F, 2010, BLOOD, V116, P1220, DOI 10.1182/blood-2010-01-264333; Weber D, 2003, J CLIN ONCOL, V21, P16, DOI 10.1200/JCO.2003.03.139; Zangari M, 2002, BLOOD, V100, P1168, DOI 10.1182/blood-2002-01-0335; Zangari M, 2001, BLOOD, V98, P1614, DOI 10.1182/blood.V98.5.1614; Zhang YY, 2006, ACTA NEUROL SCAND, V114, P378, DOI 10.1111/j.1600-0404.2006.00709.x; Zonder JA, 2006, BLOOD, V108, P403, DOI 10.1182/blood-2006-01-0154	54	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0166627	10.1371/journal.pone.0166627	http://dx.doi.org/10.1371/journal.pone.0166627			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902730	Green Published, gold, Green Submitted			2022-12-26	WOS:000389474100030
J	Chen, XJ; Li, WN; Riley, AM; Soliman, M; Chakraborty, S; Stamatkin, CW; Obukhov, AG				Chen, Xingjuan; Li, Wennan; Riley, Ashley M.; Soliman, Mario; Chakraborty, Saikat; Stamatkin, Christopher W.; Obukhov, Alexander G.			Molecular Determinants of the Sensitivity to G(q/11)-Phospholipase C-dependent Gating, Gd3(+) Potentiation, and Ca2(+) Permeability in the Transient Receptor Potential Canonical Type 5 (TRPC5) Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATION CHANNELS; MOUSE-BRAIN; IDENTIFICATION; MECHANISMS; INJECTION; PROTEINS; RESIDUE; CLONING	Transient receptor potential canonical type 5 (TRPC5) is a Ca2+ -permeable cation channel that is highly expressed in the brain and is implicated in motor coordination, innate fear behavior, and seizure genesis. The channel is activated by a signal downstream of the G-protein-coupled receptor (GPCR)-G(q/ 11) -phospholipase C (PLC) pathway. In this study we aimed to identify the molecular mechanisms involved in regulating TRPC5 activity. Wereport that Arg-593, a residue located in the E4 loop near the TRPC5 extracellular Gd3+ binding site, is critical for conferring the sensitivity to GPCR-G(q/11)-PLC-dependent gating on TRPC5. Indeed, guanosine 5' -O-(thiotriphosphate) and GPCR agonists only weakly activate the TRPC5(R593A) mutant, whereas the addition of Gd3+ rescues the mutant's sensitivity to GPCR-G(q/ 11)-PLC-dependent gating. Computer modeling suggests that Arg-593 may cross-bridge the E3 and E4 loops, forming the " molecular fulcrum." While validating the model using site-directed mutagenesis, we found that the Tyr542 residue is critical for establishing a functional Gd3+ binding site, the Tyr-541 residue participates in fine-tuning Gd3+ -sensitivity, and that the Asn-584 residue determines Ca2+ permeability of the TRPC5 channel. This is the first report providing molecular insights into the molecular mechanisms regulating the sensitivity to GPCR-G(q/ 11)-PLC-dependent gating of a receptor- operated channel.	[Chen, Xingjuan; Li, Wennan; Riley, Ashley M.; Soliman, Mario; Chakraborty, Saikat; Stamatkin, Christopher W.; Obukhov, Alexander G.] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, 635 Barnhill Dr,MS360A, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington	Obukhov, AG (corresponding author), Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, 635 Barnhill Dr,MS360A, Indianapolis, IN 46202 USA.	aobukhov@iu.edu	chen, xingjuan/V-4064-2019; Obukhov, Alexander G./C-7246-2008	chen, xingjuan/0000-0002-7380-8399; Obukhov, Alexander G./0000-0002-3862-6004	National Institutes of Health [R01HL083381, R01HL115140]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083381, R01HL115140] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL083381 and R01HL115140 (NHLBI; to A. G. O.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Beck A, 2013, J BIOL CHEM, V288, P19471, DOI 10.1074/jbc.M113.478305; Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Blair NT, 2009, J GEN PHYSIOL, V133, P525, DOI 10.1085/jgp.200810153; BLANK JL, 1991, J BIOL CHEM, V266, P18206; Blondeau P, 2007, CHEM SOC REV, V36, P198, DOI 10.1039/b603089k; BORDERS CL, 1994, PROTEIN SCI, V3, P541; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Chen XJ, 2014, CELLS-BASEL, V3, P247, DOI 10.3390/cells3020247; Garcia-Martinez C, 2000, J BIOL CHEM, V275, P32552, DOI 10.1074/jbc.M002391200; Greka A, 2003, NAT NEUROSCI, V6, P837, DOI 10.1038/nn1092; Jung S, 2003, J BIOL CHEM, V278, P3562, DOI 10.1074/jbc.M211484200; Kapoor R, 2010, PAIN PHYSICIAN, V13, pE321; Kumar S, 2012, J CELL PHYSIOL, V227, P1408, DOI 10.1002/jcp.22855; Obukhov AG, 2005, J NEUROSCI, V25, P1234, DOI 10.1523/JNEUROSCI.4451-04.2005; Obukhov AG, 2004, J CELL PHYSIOL, V201, P227, DOI 10.1002/jcp.20057; Obukhov AG, 2008, J CELL PHYSIOL, V216, P162, DOI 10.1002/jcp.21388; Okada T, 1998, J BIOL CHEM, V273, P10279, DOI 10.1074/jbc.273.17.10279; Owsianik G, 2006, ANNU REV PHYSIOL, V68, P685, DOI 10.1146/annurev.physiol.68.040204.101406; Park KW, 2010, J KOREAN MED SCI, V25, P505, DOI 10.3346/jkms.2010.25.3.505; Phelan KD, 2014, P NATL ACAD SCI USA, V111, P11533, DOI 10.1073/pnas.1411442111; Plant TD, 2005, N-S ARCH PHARMACOL, V371, P266, DOI 10.1007/s00210-005-1055-5; Puram SV, 2011, GENE DEV, V25, P2659, DOI 10.1101/gad.174060.111; Riccio A, 2009, CELL, V137, P761, DOI 10.1016/j.cell.2009.03.039; Schaefer M, 2000, J BIOL CHEM, V275, P17517, DOI 10.1074/jbc.275.23.17517; Semtner M, 2007, J BIOL CHEM, V282, P33868, DOI 10.1074/jbc.M702577200; Sossey-Alaoui K, 1999, GENOMICS, V60, P330, DOI 10.1006/geno.1999.5924; Sukumar P, 2010, BIOCHEM BIOPH RES CO, V393, P50, DOI 10.1016/j.bbrc.2010.01.074; Tai C, 2011, HIPPOCAMPUS, V21, P958, DOI 10.1002/hipo.20807; Thakur DP, 2016, P NATL ACAD SCI USA, V113, P1092, DOI 10.1073/pnas.1522294113; Trebak M, 2009, PFLUG ARCH EUR J PHY, V457, P757, DOI 10.1007/s00424-008-0550-1; Venkatachalam K, 2003, J BIOL CHEM, V278, P29031, DOI 10.1074/jbc.M302751200; Xu SZ, 2005, NAT BIOTECHNOL, V23, P1289, DOI 10.1038/nbt1148; Zheng F, 2014, CELLS-BASEL, V3, P288, DOI 10.3390/cells3020288	33	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2017	292	3					898	911		10.1074/jbc.M116.755470	http://dx.doi.org/10.1074/jbc.M116.755470			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2LL	27920205	Green Published, hybrid			2022-12-26	WOS:000392318700012
J	Enyindah-Asonye, G; Li, Y; Xin, W; Singer, NG; Gupta, N; Fung, J; Lin, F				Enyindah-Asonye, Gospel; Li, Yan; Xin, Wei; Singer, Nora G.; Gupta, Neetu; Fung, John; Lin, Feng			CD6 Receptor Regulates Intestinal Ischemia/Reperfusion-induced Injury by Modulating Natural IgM-producing B1a Cell Self-renewal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISCHEMIA-REPERFUSION INJURY; CHRONIC PLAQUE PSORIASIS; B-1 CELLS; B-CELLS; ANTIBODY REPERTOIRE; DOUBLE-BLIND; T-CELLS; LYMPHOCYTES; MICE; COMPLEMENT	Intestinal ischemia/reperfusion (I/R) injury is a relatively common pathological condition that can lead to multi-organ failure and mortality. Regulatory mechanism for this disease is poorly understood, although it is established that circulating pathogenic natural IgM, which is primarily produced by B1a cells outside of the peritoneal cavity, are integrally involved. CD6 was originally identified as a marker for T cells and was later found to be present on some subsets of B cells in humans; however, whether CD6 plays any role in intestinal I/R-induced injury and, if so, the underlying mechanisms, remain unknown. Here we report that CD6(-/-) mice were significantly protected from intestinal inflammation and mucosal damage compared with WT mice in a model of intestinal I/R-induced injury. Mechanistically, we found that CD6 was selectively expressed on B1 cells outside of the bone marrow and peritoneal cavity and that pathogenic natural IgM titers were reduced in the CD6(-/-) mice in association with significantly decreased B1a cell population. Our results reveal an unexpected role of CD6 in the pathogenesis of intestinal IR-induced injury by regulating the self-renewal of B1a cells.	[Enyindah-Asonye, Gospel; Li, Yan; Gupta, Neetu; Lin, Feng] Cleveland Clin, Dept Immunol, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Xin, Wei] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Singer, Nora G.] Metrohlth Med Ctr, Div Rheumatol, Cleveland, OH 44106 USA; [Singer, Nora G.] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Fung, John] Cleveland Clin, Inst Digest Dis, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Case Western Reserve University; MetroHealth System; Case Western Reserve University; Cleveland Clinic Foundation	Lin, F (corresponding author), Cleveland Clin, Dept Immunol, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.	linf2@ccf.org	FUNG, John Julian/A-2679-2012	FUNG, John Julian/0000-0002-3038-0441; Enyindah-Asonye, Gospel/0000-0002-4575-9622	National Institutes of Health [NS081443, AR061564]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR061564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS081443] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants NS081443 and AR061564 (to F. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alonso R, 2010, J AUTOIMMUN, V35, P336, DOI 10.1016/j.jaut.2010.07.005; Ansel KM, 2002, IMMUNITY, V16, P67, DOI 10.1016/S1074-7613(01)00257-6; Austen WG, 2003, INT J IMMUNOPATH PH, V16, P1; Ban KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041584; Baumgarth N, 2011, NAT REV IMMUNOL, V11, P34, DOI 10.1038/nri2901; Berland R, 2003, P NATL ACAD SCI USA, V100, P13459, DOI 10.1073/pnas.2233620100; Braun F, 2004, TRANSPL P, V36, P267, DOI 10.1016/j.transproceed.2004.01.082; Choi YS, 2012, EUR J IMMUNOL, V42, P120, DOI 10.1002/eji.201141890; Chopra A, 2016, CLIN RHEUMATOL, V35, P1059, DOI 10.1007/s10067-015-2988-9; Chumley MJ, 2002, J IMMUNOL, V169, P1735, DOI 10.4049/jimmunol.169.4.1735; Cuzzocrea S, 1999, J LEUKOCYTE BIOL, V66, P471, DOI 10.1002/jlb.66.3.471; Dal Porto JM, 2004, IMMUNITY, V21, P443, DOI 10.1016/j.immuni.2004.07.018; Dogra S, 2015, J AM ACAD DERMATOL, V73, P331, DOI 10.1016/j.jaad.2015.03.040; DUNN R, 1979, J MOL BIOL, V128, P277, DOI 10.1016/0022-2836(79)90088-3; Edgerton C, 2009, CLIN IMMUNOL, V130, P313, DOI 10.1016/j.clim.2008.09.019; Ehrenstein MR, 2010, NAT REV IMMUNOL, V10, P778, DOI 10.1038/nri2849; Fleming SD, 2002, J IMMUNOL, V169, P2126, DOI 10.4049/jimmunol.169.4.2126; Gimferrer I, 2004, J IMMUNOL, V173, P2262, DOI 10.4049/jimmunol.173.4.2262; Gimferrer I, 2003, J BIOL CHEM, V278, P8564, DOI 10.1074/jbc.M209591200; Grootjans J, 2010, AM J PATHOL, V176, P2283, DOI 10.2353/ajpath.2010.091069; Haas MS, 2010, CARDIOVASC RES, V87, P618, DOI 10.1093/cvr/cvq141; HAYAKAWA K, 1985, J EXP MED, V161, P1554, DOI 10.1084/jem.161.6.1554; Hoffmann A, 2007, NAT IMMUNOL, V8, P694, DOI 10.1038/ni1480; Holodick NE, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00129; Holodick NE, 2010, EUR J IMMUNOL, V40, P3007, DOI 10.1002/eji.201040545; Jordo ED, 2011, MOL IMMUNOL, V48, P1307, DOI 10.1016/j.molimm.2011.01.010; Kretschmer K, 2003, J IMMUNOL, V171, P1192, DOI 10.4049/jimmunol.171.3.1192; Krop I, 1996, EUR J IMMUNOL, V26, P238, DOI 10.1002/eji.1830260137; Krupashankar DS, 2014, J AM ACAD DERMATOL, V71, P484, DOI 10.1016/j.jaad.2014.01.897; Kulik L, 2009, J IMMUNOL, V182, P5363, DOI 10.4049/jimmunol.0803980; Kyaw T, 2011, CIRC RES, V109, P830, DOI 10.1161/CIRCRESAHA.111.248542; Lenaerts K, 2013, CURR OPIN ORGAN TRAN, V18, P298, DOI 10.1097/MOT.0b013e32835ef1eb; Merino MC, 2006, MEDICINA-BUENOS AIRE, V66, P165; Nair P, 2010, CLIN EXP IMMUNOL, V162, P116, DOI 10.1111/j.1365-2249.2010.04235.x; Nguyen TTT, 2015, J IMMUNOL, V194, P1489, DOI 10.4049/jimmunol.1401880; Oliveira MI, 2012, EUR J IMMUNOL, V42, P195, DOI 10.1002/eji.201040528; Orta-Mascaro M, 2016, J EXP MED, V213, P1387, DOI 10.1084/jem.20151785; Osorio LM, 1997, BLOOD, V89, P2833, DOI 10.1182/blood.V89.8.2833; Padilla ND, 2007, SURGERY, V142, P722, DOI 10.1016/j.surg.2007.05.015; Pierro Agostino, 2004, Semin Pediatr Surg, V13, P11, DOI 10.1053/j.sempedsurg.2003.09.003; Pinto M, 2013, BIODRUGS, V27, P191, DOI 10.1007/s40259-013-0027-4; Reid RR, 2002, J IMMUNOL, V169, P5433, DOI 10.4049/jimmunol.169.10.5433; Rodriguez Pedro C, 2012, Results Immunol, V2, P204, DOI 10.1016/j.rinim.2012.11.001; Roncagalli R, 2014, NAT IMMUNOL, V15, P384, DOI 10.1038/ni.2843; Shigematsu T, 2002, MICROCIRCULATION, V9, P99, DOI 10.1038/sj.mn.7800126; STALL AM, 1992, ANN NY ACAD SCI, V651, P33; Stoermann B, 2007, EUR J IMMUNOL, V37, P1613, DOI 10.1002/eji.200636640; Tuboly E, 2016, MICROBIOL IMMUNOL, V60, P35, DOI 10.1111/1348-0421.12338; Vollmar B, 2011, LANGENBECK ARCH SURG, V396, P13, DOI 10.1007/s00423-010-0727-x; Wardemann H, 2002, J EXP MED, V195, P771, DOI 10.1084/jem.20011140; Watson MJ, 2012, SURGERY, V152, P843, DOI 10.1016/j.surg.2012.03.001; Williams JP, 1999, J APPL PHYSIOL, V86, P938, DOI 10.1152/jappl.1999.86.3.938; Wong SC, 2002, J BIOL CHEM, V277, P30707, DOI 10.1074/jbc.M202460200; WORTIS HH, 1995, P NATL ACAD SCI USA, V92, P3348, DOI 10.1073/pnas.92.8.3348; Xu DZ, 2009, SHOCK, V31, P493, DOI 10.1097/SHK.0b013e318188b3cc; Yang Y, 2007, P NATL ACAD SCI USA, V104, P4542, DOI 10.1073/pnas.0700001104; Zhang M, 2004, P NATL ACAD SCI USA, V101, P3886, DOI 10.1073/pnas.0400347101; Zhang M, 2008, MOL IMMUNOL, V45, P4036, DOI 10.1016/j.molimm.2008.06.013; Zimmerman AW, 2006, BLOOD, V107, P3212, DOI 10.1182/blood-2005-09-3881	59	17	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2017	292	2					661	671		10.1074/jbc.M116.749804	http://dx.doi.org/10.1074/jbc.M116.749804			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2KN	27909060	Green Published, hybrid			2022-12-26	WOS:000392316100021
J	Ferres, MA; Bianchi, DW; Siegel, AE; Bronson, RT; Huggins, GS; Guedj, F				Ferres, Millie A.; Bianchi, Diana W.; Siegel, Ashley E.; Bronson, Roderick T.; Huggins, Gordon S.; Guedj, Faycal			Perinatal Natural History of the Ts1Cje Mouse Model of Down Syndrome: Growth Restriction, Early Mortality, Heart Defects, and Delayed Development	PLOS ONE			English	Article							MIDTRIMESTER AMNIOCENTESIS; BEHAVIORAL ABNORMALITIES; CARDIAC ANOMALIES; SYNDROME FETUSES; SYNDROME MICE; MATERNAL AGE; SURVIVAL; PHENOTYPE; REGIONS; TRENDS	Background The Ts1Cje model of Down syndrome is of particular interest for perinatal studies because affected males are fertile. This permits affected pups to be carried in wild-type females, which is similar to human pregnancies. Here we describe the early natural history and growth profiles of Ts1Cje embryos and neonates and determine if heart defects are present in this strain. Methods Pups were studied either on embryonic (E) day 15.5, or from postnatal (P) day 3 through weaning on P21. PCR amplification targeting the neomycin cassette (present in Ts1Cje) and Sry (present in males) was used to analyze pup genotypes and sex ratios. Body weights and lengths, as well as developmental milestones, were recorded in Ts1Cje mice and compared to their wild-type (WT) littermates. Histological evaluations were performed at E15.5 to investigate the presence or absence of heart defects. Pups were divided into two groups: Ts1Cje-I pups survived past weaning and Ts1Cje-II pups died at some point before P21. Results Ts1Cje mouse embryos showed expected Mendelian ratios (45.8%, n = 66 for Ts1Cje embryos; 54.2%, n = 78 for WT embryos). Histological analysis revealed the presence of ventricular septal defects (VSDs) in 21% of Ts1Cje E15.5 embryos. After weaning, only 28.2% of pups were Ts1Cje (185 Ts1Cje out of 656 total pups generated), with males predominating (male: female ratio of 1.4:1). Among the recovered dead pups (n = 207), Ts1Cje (63.3%, n = 131, p<0.01) genotype was found significantly more often than WT (36.7%, n = 76). Retrospective analysis of Ts1Cje-II (pre-weaning deceased) pups showed that they were growth restricted compared to Ts1Cje-I pups (post-weaning survivors). Growth restriction correlated with statistically significant delays in achieving several neonatal milestones between P3 and P21 compared to Ts1Cje-I (post-weaning survivors) neonates and WT littermates. Conclusions Ts1Cje genotype is not associated with increased early in utero mortality. Cardiac defects, specifically VSDs, are part of the phenotype in this strain. There is increased neonatal mortality in Ts1Cje pups, with sex differences observed. Ts1Cje mice that died in the neonatal period were more likely to be growth restricted and delayed in achieving neonatal developmental milestones.	[Ferres, Millie A.; Bianchi, Diana W.; Siegel, Ashley E.; Guedj, Faycal] Tufts Med Ctr, MIRI, Boston, MA 02111 USA; [Ferres, Millie A.; Bianchi, Diana W.; Siegel, Ashley E.; Guedj, Faycal] Floating Hosp Children, Boston, MA 02116 USA; [Ferres, Millie A.] Beth Israel Deaconess Med Ctr, Div Maternal Fetal Med, Dept Obstet & Gynecol, Boston, MA 02215 USA; [Bronson, Roderick T.] Dana Farber Harvard Canc Ctr, Rodent Histopathol Core, Boston, MA USA; [Huggins, Gordon S.] Tufts Med Ctr, Mol Cardiol Res Inst, Boston, MA USA	Tufts Medical Center; Floating Hospital For Children; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Dana-Farber Cancer Institute; Tufts Medical Center	Ferres, MA; Guedj, F (corresponding author), Tufts Med Ctr, MIRI, Boston, MA 02111 USA.; Ferres, MA; Guedj, F (corresponding author), Floating Hosp Children, Boston, MA 02116 USA.; Ferres, MA (corresponding author), Beth Israel Deaconess Med Ctr, Div Maternal Fetal Med, Dept Obstet & Gynecol, Boston, MA 02215 USA.	mferres@bidmc.harvard.edu; faycal.guedj@tufts.edu			Verinata Health, Inc., an Illumina company [250-10396-12547000001]; Tufts Clinical and Translational Science Institute (CTSI, NIH) [UL1TR001064]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001064] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200399] Funding Source: NIH RePORTER	Verinata Health, Inc., an Illumina company; Tufts Clinical and Translational Science Institute (CTSI, NIH); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was sponsored by a research grant from Verinata Health, Inc., an Illumina company, Grant Number: 250-10396-12547000001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge the Department of Laboratory Animal Medicine (DLAM) for providing helpful advice concerning breeding strategies; Tufts University Histology Core for their help in sectioning and staining the embryo hearts; and Dr. Lauren Richey (DLAM); and Tufts Clinical and Translational Science Institute (CTSI, NIH award UL1TR001064) for assistance with the statistical analysis. After submission of this paper for consideration of publication, another study was published demonstrating the presence of heart defects in the Ts1Cje mouse model of DS (Li et al, 2016, PMID 27029737) [35].	Bray IC, 1998, PRENATAL DIAG, V18, P1045, DOI 10.1002/(SICI)1097-0223(1998100)18:10<1045::AID-PD403>3.3.CO;2-I; Cocchi G, 2010, BIRTH DEFECTS RES A, V88, P474, DOI 10.1002/bdra.20666; DAVISSON MT, 1990, PROG CLIN BIOL RES, V360, P263; Delabar JM, 2006, THESCIENTIFICWORLDJO, V6, P1945, DOI 10.1100/tsw.2006.322; Duchon A, 2011, MAMM GENOME, V22, P674, DOI 10.1007/s00335-011-9356-0; Egan JFX, 2011, PRENATAL DIAG, V31, P389, DOI 10.1002/pd.2702; Glasson EJ, 2002, CLIN GENET, V62, P390, DOI 10.1034/j.1399-0004.2002.620506.x; Goodliffe JW, 2016, J NEUROSCI, V36, P2926, DOI 10.1523/JNEUROSCI.2513-15.2016; Guedj F, 2015, AM J MED GENET A, V167, P1993, DOI 10.1002/ajmg.a.37156; Guedj F, 2015, BRAIN PATHOL, V25, P11, DOI 10.1111/bpa.12151; Guedj F, 2012, NEUROBIOL DIS, V46, P190, DOI 10.1016/j.nbd.2012.01.007; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Hill Joanna M., 2008, V39, P131, DOI 10.1007/978-1-60327-099-1_10; HOOK EB, 1989, AM J HUM GENET, V45, P855; HOOK EB, 1983, AM J HUM GENET, V35, P110; HOOK EB, 1978, NEW ENGL J MED, V299, P1036, DOI 10.1056/NEJM197811092991903; HOOK EB, 1978, LANCET, V1, P1053; Johnson KL, 2010, FERTIL STERIL, V93, P1718, DOI 10.1016/j.fertnstert.2009.08.042; Kucik JE, 2013, PEDIATRICS, V131, pE27, DOI 10.1542/peds.2012-1616; Lana-Elola E, 2016, ELIFE, V5, DOI 10.7554/eLife.11614; Leonard S, 2000, PAEDIATR PERINAT EP, V14, P163; Li HQ, 2016, GENETICS, V203, P763, DOI 10.1534/genetics.116.188045; Li ZY, 2007, HUM MOL GENET, V16, P1359, DOI 10.1093/hmg/ddm086; Liu CH, 2011, HUM GENET, V130, P623, DOI 10.1007/s00439-011-0980-2; Moore CS, 2006, MAMM GENOME, V17, P1005, DOI 10.1007/s00335-006-0032-8; Moore CS, 2010, MAMM GENOME, V21, P543, DOI 10.1007/s00335-010-9300-8; Mutton D, 1996, J MED GENET, V33, P387, DOI 10.1136/jmg.33.5.387; Raveau M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002724; Roper RJ, 2006, GENETICS, V172, P437, DOI 10.1534/genetics.105.050898; Sago H, 2000, PEDIATR RES, V48, P606, DOI 10.1203/00006450-200011000-00009; Sago H, 1998, P NATL ACAD SCI USA, V95, P6256, DOI 10.1073/pnas.95.11.6256; Savolainen SM, 2009, TOXICOL PATHOL, V37, P395, DOI 10.1177/0192623309335060; Wessels MW, 2003, AM J MED GENET A, V116A, P147, DOI 10.1002/ajmg.a.10823; Williams AD, 2008, DEV DYNAM, V237, P426, DOI 10.1002/dvdy.21416; Yu T, 2010, HUM MOL GENET, V19, P2780, DOI 10.1093/hmg/ddq179	35	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0168009	10.1371/journal.pone.0168009	http://dx.doi.org/10.1371/journal.pone.0168009			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930746	Green Published, Green Submitted, gold			2022-12-26	WOS:000389580900070
J	Kashiyama, N; Miyagawa, S; Fukushima, S; Kawamura, T; Kawamura, A; Yoshida, S; Harada, A; Watabe, T; Kanai, Y; Toda, K; Hatazawa, J; Sawa, Y				Kashiyama, Noriyuki; Miyagawa, Shigeru; Fukushima, Satsuki; Kawamura, Takuji; Kawamura, Ai; Yoshida, Shohei; Harada, Akima; Watabe, Tadashi; Kanai, Yasukazu; Toda, Koichi; Hatazawa, Jun; Sawa, Yoshiki			Development of PET Imaging to Visualize Activated Macrophages Accumulated in the Transplanted iPSc-Derived Cardiac Myocytes of Allogeneic Origin for Detecting the Immune Rejection of Allogeneic Cell Transplants in Mice	PLOS ONE			English	Article							ALLOGRAFT-REJECTION; SURVIVAL; LIGAND; SHEETS; BRAIN; HEART; MODEL; TSPO	Allogeneic transplantation (Tx) of induced pluripotent stem cells (iPSCs) is a promising tissue regeneration therapy. However, this inevitably induces macrophage-mediated immune response against the graft, limiting its therapeutic efficacy. Monitoring the magnitude of the immune response using imaging tools would be useful for prolonging graft survival and increasing the therapy longevity. Minimally invasive quantitative detection of activated macrophages by medical imaging technologies such as positron emission tomography (PET) imaging targets translocator protein (TSPO), which is highly expressed on mitochondrial membrane, especially in activated macrophage. N,N-diethyl-2-[4-(2-fluoroethoxy)phenyl]5,7-dimethylpyrazolo[1,5-a]pyrimidine-3-acetamide (DPA-714) is known as a TSPO ligand used in clinical settings. We herein hypothesized that immune rejection of the transplanted iPSC-derived cardiomyocytes (iPSC-CMs) of allogeneic origin may be quantitated using F-18-DPA-714-PET imaging study. iPSC-CM cell-sheets of C57BL/6 mice origin were transplanted on the surface of the left ventricle (LV) of C57BL/6 mice as a syngeneic cell-transplant model (syngeneic Tx group), or Balb/c mice as an allogeneic model (allogeneic Tx group). F-18-DPA-714-PET was used to determine the uptake ratio, calculated as the maximum standardized uptake value in the anterior and septal wall of the LV. The uptake ratio was significantly higher in the allogeneic Tx group than in the syngeneic group or the sham group at days 7 and day 10 after the cell transplantation. In addition, the immunochemistry showed significant presence of CD68 and CD3-positive cells at day 7 and 10 in the transplanted graft of the allogeneic Tx group. The expression of TSPO, CD68, IL-1 beta, and MCP-1 was significantly higher in the allogeneic Tx group than in the syngeneic Tx and the sham groups at day 7. The F-18-DPA-714-PET imaging study enabled quantitative visualization of the macrophages-mediated immune rejection of the allogeneic iPSC-cardiac. This imaging tool may enable the understanding and monitoring host-immune response of the host, allogeneic cell transplantation therapy.	[Kashiyama, Noriyuki; Miyagawa, Shigeru; Fukushima, Satsuki; Kawamura, Takuji; Kawamura, Ai; Yoshida, Shohei; Harada, Akima; Toda, Koichi; Sawa, Yoshiki] Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Osaka, Japan; [Watabe, Tadashi; Hatazawa, Jun] Osaka Univ, Grad Sch Med, Dept Nucl Med & Tracer Kinet, Osaka, Japan; [Watabe, Tadashi; Hatazawa, Jun] Osaka Univ, Grad Sch Med, PET Mol Imaging Ctr, Osaka, Japan; [Kanai, Yasukazu] Osaka Univ, Grad Sch Med, Dept Mol Imaging Med, Osaka, Japan; [Hatazawa, Jun] Osaka Univ, Immunol Frontier Res Ctr, Osaka, Japan	Osaka University; Osaka University; Osaka University; Osaka University; Osaka University	Sawa, Y (corresponding author), Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Osaka, Japan.	sawa-p@surg1.med.osaka-u.ac.jp	Watabe, Tadashi/AHD-6866-2022; Fukushima, Satsuki/ABE-6582-2020	Watabe, Tadashi/0000-0001-8658-2395; Fukushima, Satsuki/0000-0002-9481-8860; Miyagawa, Shigeru/0000-0003-0015-6569				Arlicot N, 2012, NUCL MED BIOL, V39, P570, DOI 10.1016/j.nucmedbio.2011.10.012; Bao Q, 2009, J NUCL MED, V50, P401, DOI 10.2967/jnumed.108.056374; Ching ASC, 2012, INSIGHTS IMAGING, V3, P111, DOI 10.1007/s13244-011-0128-x; Cooper LT, 2007, CIRCULATION, V116, P2216, DOI 10.1161/CIRCULATIONAHA.107.186093; Daly KP, 2015, TRANSPLANTATION, V99, pE132, DOI 10.1097/TP.0000000000000618; Dhingra S, 2015, CELL TRANSPLANT, V24, P1013, DOI 10.3727/096368914X681036; Fairweather D, 2014, J CARDIOVASC TRANSL, V7, P192, DOI 10.1007/s12265-013-9538-0; Gabriel SA, 2013, INFLAMMATORY RESPONS, P203; Galli SJ, 2011, NAT IMMUNOL, V12, P1035, DOI 10.1038/ni.2109; James ML, 2008, J NUCL MED, V49, P814, DOI 10.2967/jnumed.107.046151; Kawamura A, 2016, SCI REP-UK, V6, DOI 10.1038/srep19464; Kawamura M, 2013, CIRCULATION, V128, pS87, DOI 10.1161/CIRCULATIONAHA.112.000366; Kawamura M, 2012, CIRCULATION, V126, pS29, DOI 10.1161/CIRCULATIONAHA.111.084343; Kawamura T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111064; Morizane A, 2013, STEM CELL REP, V1, P283, DOI 10.1016/j.stemcr.2013.08.007; Nahrendorf M, 2008, CIRCULATION, V117, P379, DOI 10.1161/CIRCULATIONAHA.107.741181; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Rupprecht R, 2010, NAT REV DRUG DISCOV, V9, P971, DOI 10.1038/nrd3295; Sasaki H, 2015, TRANSPLANTATION, V99, P2301, DOI 10.1097/TP.0000000000000875; Spahn JH, 2014, CURR OPIN ORGAN TRAN, V19, P14, DOI 10.1097/MOT.0000000000000041; Ueno T, 2013, CIRC-CARDIOVASC IMAG, V6, P568, DOI 10.1161/CIRCIMAGING.113.000481; Vicidomini C, 2015, NUCL MED BIOL, V42, P309, DOI 10.1016/j.nucmedbio.2014.11.009; Wyburn KR, 2005, TRANSPLANTATION, V80, P1641, DOI 10.1097/01.tp.0000173903.26886.20; Ye Q, 2008, CIRCULATION, V118, P149, DOI 10.1161/CIRCULATIONAHA.107.746354; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135	25	16	16	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0165748	10.1371/journal.pone.0165748	http://dx.doi.org/10.1371/journal.pone.0165748			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930666	Green Submitted, Green Published, gold			2022-12-26	WOS:000389580900006
J	Niediek, J; Bostrom, J; Elger, CE; Mormann, F				Niediek, Johannes; Bostroem, Jan; Elger, Christian E.; Mormann, Florian			Reliable Analysis of Single-Unit Recordings from the Human Brain under Noisy Conditions: Tracking Neurons over Hours	PLOS ONE			English	Article							SPIKE; QUALITY; LONG	Recording extracellulary from neurons in the brains of animals in vivo is among the most established experimental techniques in neuroscience, and has recently become feasible in humans. Many interesting scientific questions can be addressed only when extracellular recordings last several hours, and when individual neurons are tracked throughout the entire recording. Such questions regard, for example, neuronal mechanisms of learning and memory consolidation, and the generation of epileptic seizures. Several difficulties have so far limited the use of extracellular multi-hour recordings in neuroscience: Datasets become huge, and data are necessarily noisy in clinical recording environments. No methods for spike sorting of such recordings have been available. Spike sorting refers to the process of identifying the contributions of several neurons to the signal recorded in one electrode. To overcome these difficulties, we developed Combinato: a complete data-analysis framework for spike sorting in noisy recordings lasting twelve hours or more. Our framework includes software for artifact rejection, automatic spike sorting, manual optimization, and efficient visualization of results. Our completely automatic framework excels at two tasks: It outperforms existing methods when tested on simulated and real data, and it enables researchers to analyze multi-hour recordings. We evaluated our methods on both short and multi-hour simulated datasets. To evaluate the performance of our methods in an actual neuroscientific experiment, we used data from from neurosurgical patients, recorded in order to identify visually responsive neurons in the medial temporal lobe. These neurons responded to the semantic content, rather than to visual features, of a given stimulus. To test our methods with multi-hour recordings, we made use of neurons in the human medial temporal lobe that respond selectively to the same stimulus in the evening and next morning.	[Niediek, Johannes; Elger, Christian E.; Mormann, Florian] Univ Bonn, Dept Epileptol, Bonn, Germany; [Bostroem, Jan] Univ Bonn, Dept Neurosurg, Bonn, Germany	University of Bonn; University of Bonn	Niediek, J (corresponding author), Univ Bonn, Dept Epileptol, Bonn, Germany.	jonied@posteo.de	Mormann, Florian/K-1582-2014	Mormann, Florian/0000-0003-1305-8028; Niediek, Johannes/0000-0003-3323-2986	Volkswagen Foundation (Lichtenberg) [86 507]; German Research Council [DFG MO 930/4-1, SFB 1089]; Seventh Framework Program [602102 EPITARGET]	Volkswagen Foundation (Lichtenberg); German Research Council(German Research Foundation (DFG)); Seventh Framework Program(European Commission)	This work was supported by Volkswagen Foundation (Lichtenberg 86 507, https:/www.volkswagenstiftung.de): FM; German Research Council (DFG MO 930/4-1, SFB 1089, http://www.dfg.de): FM, JN; and Seventh Framework Program (602102 EPITARGET, https://ec.europa.eu/research/fp7/index_en.cfm): FM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berenyi A, 2014, J NEUROPHYSIOL, V111, P1132, DOI 10.1152/jn.00785.2013; Blatt M, 1996, PHYS REV LETT, V76, P3251, DOI 10.1103/PhysRevLett.76.3251; Bondar IV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008222; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Einevoll GT, 2012, CURR OPIN NEUROBIOL, V22, P11, DOI 10.1016/j.conb.2011.10.001; Friedman A, 2015, P NATL ACAD SCI USA, V112, P4477, DOI 10.1073/pnas.1503940112; Gast H, 2016, CLIN NEUROPHYSIOL, V127, P3329, DOI 10.1016/j.clinph.2016.08.010; Hagen E, 2015, J NEUROSCI METH, V245, P182, DOI 10.1016/j.jneumeth.2015.01.029; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Hill DN, 2011, J NEUROSCI, V31, P8699, DOI 10.1523/JNEUROSCI.0971-11.2011; Kadir SN, 2014, NEURAL COMPUT, V26, P2379, DOI 10.1162/NECO_a_00661; Knieling S, 2016, INT J NEURAL SYST, V26, DOI 10.1142/S0129065715500422; Martinez J, 2009, J NEUROSCI METH, V184, P285, DOI 10.1016/j.jneumeth.2009.08.017; Misra A, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/2/026013; Mormann F, 2008, J NEUROSCI, V28, P8865, DOI 10.1523/JNEUROSCI.1640-08.2008; Mormann F, 2007, BRAIN, V130, P314, DOI 10.1093/brain/awl241; Mormann F, 2015, NAT NEUROSCI, V18, P1568, DOI 10.1038/nn.4139; Mormann F, 2011, NAT NEUROSCI, V14, P1247, DOI 10.1038/nn.2899; Pedreira C, 2012, J NEUROSCI METH, V211, P58, DOI 10.1016/j.jneumeth.2012.07.010; Quiroga RQ, 2009, CURR BIOL, V19, P1308, DOI 10.1016/j.cub.2009.06.060; Quiroga RQ, 2004, NEURAL COMPUT, V16, P1661, DOI 10.1162/089976604774201631; Quiroga RQ, 2005, NATURE, V435, P1102, DOI 10.1038/nature03687; Rey HG, 2015, BRAIN RES BULL, V119, P106, DOI 10.1016/j.brainresbull.2015.04.007; Rossant C, 2016, NAT NEUROSCI, V19, P634, DOI 10.1038/nn.4268; Rutishauser U, 2006, J NEUROSCI METH, V154, P204, DOI 10.1016/j.jneumeth.2005.12.033; Schmitzer-Torbert N, 2005, NEUROSCIENCE, V131, P1, DOI 10.1016/j.neuroscience.2004.09.066; Tolias AS, 2007, J NEUROPHYSIOL, V98, P3780, DOI 10.1152/jn.00260.2007	30	38	38	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0166598	10.1371/journal.pone.0166598	http://dx.doi.org/10.1371/journal.pone.0166598			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930664	Green Submitted, gold, Green Published			2022-12-26	WOS:000389580900012
J	Sauve, S; Aubin, Y				Sauve, Simon; Aubin, Yves			Dodecylphosphocholine Micelles Induce Amyloid Formation of the PrP(110-136) Peptide via an alpha-Helical Metastable Conformation	PLOS ONE			English	Article							THIOFLAVIN-T-BINDING; PRION PROTEIN; MULTIDIMENSIONAL NMR; SYNUCLEIN; SCRAPIE; VISUALIZATION; RESOLUTION; MECHANISM; FIBRILS; SYSTEM	A peptide encompassing the conserved hydrophobic region and the first beta-strand of the prion protein (PrP(110-136)) shown to interact with the surface of dodecylphosphocholine micelles adopts an alpha-helical conformation that is localized below the head-group layer. This surface-bound peptide has a half-life of one day, and readily initiates the formation of amyloid fibrils. The presence of the latter was confirmed using birefringence microscopy upon Congo red binding and thioflavin T-binding induced fluorescence. The observation of this metastable alpha-helical conformer provides a unique snapshot of the early steps of the interconversion pathway. These findings together with the body of evidence from the prion literature allowed us to propose a mechanism for the conversion of PrPC to amyloid material.	[Sauve, Simon; Aubin, Yves] Hlth Canada, Biol & Genet Therapies Directorate, Ctr Biol Evaluat, Ottawa, ON, Canada; [Aubin, Yves] Carleton Univ, Dept Chem, Ottawa, ON, Canada	Health Canada; Carleton University	Aubin, Y (corresponding author), Hlth Canada, Biol & Genet Therapies Directorate, Ctr Biol Evaluat, Ottawa, ON, Canada.; Aubin, Y (corresponding author), Carleton Univ, Dept Chem, Ottawa, ON, Canada.	yves.aubin@hc-sc.gc.ca		Aubin, Yves/0000-0002-8554-0297	Government of Canada	Government of Canada(CGIAR)	The Government of Canada.	Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001; Chandra S, 2003, J BIOL CHEM, V278, P15313, DOI 10.1074/jbc.M213128200; Coleman BM, 2014, J VIROL, V88, P2690, DOI 10.1128/JVI.02720-13; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Du HN, 2003, BIOCHEMISTRY-US, V42, P8870, DOI 10.1021/bi034028+; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Hawe A, 2008, PHARM RES-DORDR, V25, P1487, DOI 10.1007/s11095-007-9516-9; Hegde RS, 1998, SCIENCE, V279, P827, DOI 10.1126/science.279.5352.827; Holscher C, 1998, J VIROL, V72, P1153; Hornemann S, 2009, J BIOL CHEM, V284, P22713, DOI 10.1074/jbc.M109.000430; Hyberts SG, 2012, TOP CURR CHEM, V316, P125, DOI 10.1007/128_2011_187; Jaravine V, 2006, NAT METHODS, V3, P605, DOI 10.1038/NMETH900; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Khurana R, 2005, J STRUCT BIOL, V151, P229, DOI 10.1016/j.jsb.2005.06.006; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Lawson VA, 2001, J BIOL CHEM, V276, P35265, DOI 10.1074/jbc.M103799200; Luhrs TT, 2006, J MOL BIOL, V357, P833, DOI 10.1016/j.jmb.2006.01.016; Norstrom EM, 2005, J BIOL CHEM, V280, P27236, DOI 10.1074/jbc.M413441200; Orekhov VY, 2003, J BIOMOL NMR, V27, P165, DOI 10.1023/A:1024944720653; Peretz D, 1997, J MOL BIOL, V273, P614, DOI 10.1006/jmbi.1997.1328; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1983, CELL, V35, P349, DOI 10.1016/0092-8674(83)90168-X; Sauve S, 2012, J BIOL CHEM, V287, P1915, DOI 10.1074/jbc.M111.279364; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Supattapone S, 2014, J BIOL CHEM, V289, P19850, DOI 10.1074/jbc.R113.511329; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; VASSAR PS, 1959, ARCH PATHOL, V68, P487; Vilches S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070881	30	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0168021	10.1371/journal.pone.0168021	http://dx.doi.org/10.1371/journal.pone.0168021			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930722	Green Published, gold			2022-12-26	WOS:000389580900071
J	Garcia-Morales, R; Moreno, CE; Badano, EI; Zuria, I; Galindo-Gonzalez, J; Rojas-Martinez, AE; Avila-Gomez, ES				Garcia-Morales, Rodrigo; Moreno, Claudia E.; Badano, Ernesto I.; Zuria, Iriana; Galindo-Gonzalez, Jorge; Rojas-Martinez, Alberto E.; Avila-Gomez, Eva S.			Deforestation Impacts on Bat Functional Diversity in Tropical Landscapes	PLOS ONE			English	Article							SPECIES RICHNESS; COMMUNITY-LEVEL; FOREST; RESPONSES; BIODIVERSITY; ASSEMBLAGES; CONFIGURATION; FRAMEWORK; PATTERNS; FAUNA	Functional diversity is the variability in the functional roles carried out by species within ecosystems. Changes in the environment can affect this component of biodiversity and can, in turn, affect different processes, including some ecosystem services. This study aimed to determine the effect of forest loss on species richness, abundance and functional diversity of Neotropical bats. To this end, we identified six landscapes with increasing loss of forest cover in the Huasteca region of the state of Hidalgo, Mexico. We captured bats in each landscape using mist nets, and calculated functional diversity indices (functional richness and functional evenness) along with species richness and abundance. We analyzed these measures in terms of percent forest cover. We captured 906 bats (Phyllostomidae and Mormoopidae), including 10 genera and 12 species. Species richness, abundance and functional richness per night are positively related with forest cover. Generalized linear models show that species richness, abundance and functional richness per night are significantly related with forest cover, while seasonality had an effect on abundance and functional richness. Neither forest cover nor season had a significant effect on functional evenness. All these findings were consistent across three spatial scales (1, 3 and 5 km radius around sampling sites). The decrease in species, abundance and functional richness of bats with forest loss may have implications for the ecological processes they carry out such as seed dispersal, pollination and insect predation, among others.	[Garcia-Morales, Rodrigo; Moreno, Claudia E.; Zuria, Iriana; Rojas-Martinez, Alberto E.; Avila-Gomez, Eva S.] Univ Autonoma Estado Hidalgo, Inst Ciencias Basicas & Ingn, Ctr Invest Biol, Mineral De La Reforma, Hidalgo, Mexico; [Badano, Ernesto I.] Inst Potosino Invest Cient & Tecnol AC, Div Ciencias Ambientales, San Luis Potosi, San Luis Potosi, Mexico; [Galindo-Gonzalez, Jorge] Univ Veracruzana, Inst Biotecnol & Ecol Aplicada INBIOTECA, Xalapa, Veracruz, Mexico; [Garcia-Morales, Rodrigo] Ctr Cambio Global & Sustentabilidad Sureste AC, Villahermosa, Tabasco, Mexico	Universidad Autonoma del Estado de Hidalgo; Instituto Potosino Investigacion Cientifica y Tecnologica; Universidad Veracruzana	Moreno, CE (corresponding author), Univ Autonoma Estado Hidalgo, Inst Ciencias Basicas & Ingn, Ctr Invest Biol, Mineral De La Reforma, Hidalgo, Mexico.	cmoreno@uaeh.edu.mx	García-Morales, Rodrigo/AAB-3594-2022; Zuria, Iriana/A-8490-2018; Moreno, Claudia/GRJ-1036-2022; Galindo-González, Jorge/M-2585-2014; Badano, Ernesto I./C-3585-2013; Moreno, Claudia E./B-2733-2013	García-Morales, Rodrigo/0000-0001-7417-8192; Zuria, Iriana/0000-0002-0004-3540; Galindo-González, Jorge/0000-0003-2583-2754; Badano, Ernesto I./0000-0002-9591-0984; Moreno, Claudia E./0000-0002-9584-2619	CONACYT [270780]; FOMIX CONACYT [191908]; SEP-CONACYT Basic Science project [222632]	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); FOMIX CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); SEP-CONACYT Basic Science project	RGM is grateful to CONACYT for the doctoral studies scholarship (270780). This study was funded by FOMIX CONACYT, project No. 191908 "Diversidad Biologica del Estado de Hidalgo (tercera etapa)", and SEP-CONACYT Basic Science project No. 222632, "Evaluacion de la diversidad de especies mediante el analisis e integracion de elementos ecologicos, funcionales y evolutivos", awarded to CEM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard F, 2002, SCIENCE, V297, P999, DOI 10.1126/science.1070656; Aguirre LF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158170; AHLEN I, 1983, OIKOS, V41, P352, DOI 10.2307/3544093; Alanis FGJ, 2004, BIODIVERSIDAD SIERRA, P503; Arita HT, 1997, TRENDS ECOL EVOL, V12, P53, DOI 10.1016/S0169-5347(96)10058-6; Arroyo-Rodriguez V, 2016, BIOL CONSERV, V198, P84, DOI 10.1016/j.biocon.2016.03.026; AUGUST PV, 1983, ECOLOGY, V64, P1495, DOI 10.2307/1937504; Avila-Gomez ES, 2015, TROP CONSERV SCI, V8, P646, DOI 10.1177/194008291500800305; Brigham RM, 1997, CAN J ZOOL, V75, P131, DOI 10.1139/z97-017; Cadotte MW, 2011, J APPL ECOL, V48, P1079, DOI 10.1111/j.1365-2664.2011.02048.x; Casanoves F, 2011, METHODS ECOL EVOL, V2, P233, DOI 10.1111/j.2041-210X.2010.00082.x; Castro-Luna AA, 2007, ANIM CONSERV, V10, P219, DOI 10.1111/j.1469-1795.2007.00097.x; Challenger A, 2009, CAPITAL NATURAL MEXI, V2; CHAO A, 1992, J AM STAT ASSOC, V87, P210, DOI 10.2307/2290471; Chillo V, 2012, J ARID ENVIRON, V87, P95, DOI 10.1016/j.jaridenv.2012.06.016; Cisneros LM, 2015, DIVERS DISTRIB, V21, P523, DOI 10.1111/ddi.12277; Colwell RK, 2013, ESTIMATES STAT ESTIM; Comision Nacional de Areas Naturales Protegidas-Deutsche Gesellschaft fur Internationale Zusammenarbeit (CONANP-GIZ), 2013, PROGR AD CAMB CLIM R; Avila-Cabadilla LD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035228; de la Pena-Cuellar E, 2012, BIODIVERS CONSERV, V21, P1381, DOI 10.1007/s10531-012-0249-7; Devictor V, 2010, ECOL LETT, V13, P1030, DOI 10.1111/j.1461-0248.2010.01493.x; Estrada A, 2002, BIOL CONSERV, V103, P237, DOI 10.1016/S0006-3207(01)00135-5; Farias AA, 2009, OIKOS, V118, P591, DOI 10.1111/j.1600-0706.2009.16859.x; Fenton MB, 2001, J TROP ECOL, V17, P511, DOI 10.1017/S0266467401001389; Galindo-González Jorge, 2004, Acta Zool. Mex, V20, P239; Galindo-Gonzalez J, 2009, J TROP ECOL, V25, P205, DOI 10.1017/S0266467409005859; Garcia-Morales R, 2014, COMMUNITY ECOL, V15, P158, DOI [10.1556/COMEC.15.2014.2.4, 10.1556/ComEc.15.2014.2.4]; Garcia-Morales R, 2013, CONSERV BIOL, V27, P1096, DOI 10.1111/cobi.12099; Garcia-Morales R, 2012, ACTA CHIROPTEROL, V14, P357, DOI 10.3161/150811012X661675; Gorresen PM, 2005, ECOL APPL, V15, P2126, DOI 10.1890/04-0532; Gorresen PM, 2004, J MAMMAL, V85, P688, DOI 10.1644/BWG-125; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Jimenez-Ortega A, 2008, REV I U TECNOLOGICA, V27, P100, DOI [10.18636/ribd, DOI 10.18636/RIBD]; Kalko EKV, 2001, PLANT ECOL, V153, P319, DOI 10.1023/A:1017590007861; Klingbeil BT, 2010, OIKOS, V119, P1654, DOI 10.1111/j.1600-0706.2010.18328.x; Klingbeil BT, 2009, J APPL ECOL, V46, P203, DOI 10.1111/j.1365-2664.2008.01594.x; Kunz TH, 2011, ANN NY ACAD SCI, V1223, P1, DOI 10.1111/j.1749-6632.2011.06004.x; Mace GM, 2003, SCIENCE, V300, P1707, DOI 10.1126/science.1085510; Mayfield MM, 2010, GLOBAL ECOL BIOGEOGR, V19, P423, DOI 10.1111/j.1466-8238.2010.00532.x; Medellin R, 2008, IDENTIFICACION MURCI; Moreno CE, 2000, J APPL ECOL, V37, P149, DOI 10.1046/j.1365-2664.2000.00483.x; Moreno CE, 2006, OECOLOGIA, V149, P133, DOI 10.1007/s00442-006-0417-0; Norberg Ulla M., 1994, P205; NORBERG UM, 1987, PHILOS T R SOC B, V316, P337; Patriquin KJ, 2003, J APPL ECOL, V40, P646, DOI 10.1046/j.1365-2664.2003.00831.x; Patterson BD, 2003, BAT ECOLOGY, P536; Pech-Canche JM, 2011, REV MEX BIODIVERS, V82, P896; Petchey OL, 2002, P ROY SOC B-BIOL SCI, V269, P1721, DOI 10.1098/rspb.2002.2073; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; Pineda E, 2005, CONSERV BIOL, V19, P400, DOI 10.1111/j.1523-1739.2005.00531.x; PUIC H., 1991, VEGETACION HUASTECA; Purvis A, 2000, NATURE, V405, P212, DOI 10.1038/35012221; Ramirez-Pulido J., 2014, LIST RECENT LAND MAM; Ricotta C, 2005, BASIC APPL ECOL, V6, P479, DOI 10.1016/j.baae.2005.02.008; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Saldana-Vazquez RA, 2010, BIODIVERS CONSERV, V19, P2111, DOI 10.1007/s10531-010-9829-6; Schleuter D, 2010, ECOL MONOGR, V80, P469, DOI 10.1890/08-2225.1; Simmons N., 2005, MAMMAL SPECIES WORLD, P312, DOI DOI 10.1007/S10914-006-9022-6; Soriano Pascual J., 2006, Ecotropicos, V19, P1; Soriano Pascual J., 2000, Ecotropicos (Caracas), V13, P1; SPP (Secretaria de Programacion y Presupuesto), 1992, SINT GEOGR EST HID; Stevens RD, 2003, ECOL LETT, V6, P1099, DOI 10.1046/j.1461-0248.2003.00541.x; Strauss Axel, 2010, BMC Ecology, V10, P12, DOI 10.1186/1472-6785-10-12; Suding KN, 2008, GLOBAL CHANGE BIOL, V14, P1125, DOI 10.1111/j.1365-2486.2008.01557.x; Vandewalle M, 2010, BIODIVERS CONSERV, V19, P2921, DOI 10.1007/s10531-010-9798-9; Villavicencio Nicto MA, 2010, CIENCIA U, V1, P23; Villeger S, 2008, ECOLOGY, V89, P2290, DOI 10.1890/07-1206.1; Vleut I, 2015, BIOTROPICA, V47, P606, DOI 10.1111/btp.12238; Weiher Evan, 2011, P175; Williams-Guillen K, 2010, BIOTROPICA, V42, P605, DOI 10.1111/j.1744-7429.2010.00626.x	72	34	40	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2016	11	12							e0166765	10.1371/journal.pone.0166765	http://dx.doi.org/10.1371/journal.pone.0166765			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4NG	27926923	gold, Green Published, Green Submitted			2022-12-26	WOS:000389578800005
J	Takagi, A; Beckers, N; Burdet, E				Takagi, Atsushi; Beckers, Niek; Burdet, Etienne			Motion Plan Changes Predictably in Dyadic Reaching	PLOS ONE			English	Article								Parents can effortlessly assist their child to walk, but the mechanism behind such physical coordination is still unknown. Studies have suggested that physical coordination is achieved by interacting humans who update their movement or motion plan in response to the partner's behaviour. Here, we tested rigidly coupled pairs in a joint reaching task to observe such changes in the partners' motion plans. However, the joint reaching movements were surprisingly consistent across different trials. A computational model that we developed demonstrated that the two partners had a distinct motion plan, which did not change with time. These results suggest that rigidly coupled pairs accomplish joint reaching movements by relying on a pre-programmed motion plan that is independent of the partner's behaviour.	[Takagi, Atsushi; Burdet, Etienne] Imperial Coll Sci Technol & Med, Dept Bioengn, London, England; [Beckers, Niek] Univ Twente, Dept Biomech Engn, Enschede, Netherlands	Imperial College London; University of Twente	Burdet, E (corresponding author), Imperial Coll Sci Technol & Med, Dept Bioengn, London, England.	e.burdet@imperial.ac.uk		Takagi, Atsushi/0000-0003-4733-7471; Beckers, Niek/0000-0001-7077-9812; Burdet, Etienne/0000-0002-2123-0185	European Union's Seventh Framework Programme grant CONTEST [ITN-317488]; European Union's Horizon 2020 grant COGI MON [ICT-23-2014]; European Union's Seventh Framework Programme grant BALANCE [ICT-601003]; European Union's Seventh Framework Programme grant SYMBITRON [ICT-661626]; European Union's Seventh Framework Programme grant COST [TD1006]	European Union's Seventh Framework Programme grant CONTEST; European Union's Horizon 2020 grant COGI MON; European Union's Seventh Framework Programme grant BALANCE; European Union's Seventh Framework Programme grant SYMBITRON; European Union's Seventh Framework Programme grant COST	This research was supported by the European Union's Seventh Framework Programme grants CONTEST (ITN-317488, http://cordis.europa.eu/project/rcn/104707_en.html), BALANCE (ICT-601003, http://cordis.europa.eu/project/rcn/106654_en.html), SYMBITRON (ICT-661626, http://cordis.europa.eu/project/rcn/110314_en.html) and COST (TD1006, http://www.cost.eu/COST_Actions/brnbs/TD1006) and the European Union's Horizon 2020 grant COGI MON (ICT-23-2014, http://cordis.europa.eu/project/rcn/194239_en.html), all awarded to EB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Feth D, 2009, WORLD HAPTICS 2009: THIRD JOINT EUROHAPTICS CONFERENCE AND SYMPOSIUM ON HAPTIC INTERFACES FOR VIRTUAL ENVIRONMENT AND TELEOPERATOR SYSTEMS, PROCEEDINGS, P338, DOI 10.1109/WHC.2009.4810854; Franklin DW, 2008, J NEUROSCI, V28, P11165, DOI 10.1523/JNEUROSCI.3099-08.2008; Ganesh G, 2014, SCI REP-UK, V4, DOI 10.1038/srep03824; Gentry S., 2005, 2005 IEEE/RSJ International Conference on Intelligent Robots and Systems, P3402; Groten Raphaela, 2009, RO-MAN 2009 - The 18th IEEE International Symposium on Robot and Human Interactive Communication, P723, DOI 10.1109/ROMAN.2009.5326315; Jarrasse N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049945; McKay JL, 2013, J NEUROPHYSIOL, V109, P591, DOI 10.1152/jn.00447.2012; Melendez-Calderon A, 2015, PHYSIOL BEHAV, V147, P348, DOI 10.1016/j.physbeh.2015.04.046; Melendez-Calderon A., 2011, 2011 IEEE/RSJ International Conference on Intelligent Robots and Systems (IROS 2011), P2578, DOI 10.1109/IROS.2011.6048068; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Reed KB, 2008, IEEE T HAPTICS, V1, P108, DOI [10.1109/TOH.2008.13, 10.1109/ToH.2008.13]; Sawers A, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-142; Sebanz N, 2006, TRENDS COGN SCI, V10, P70, DOI 10.1016/j.tics.2005.12.009; Stefanov N, 2009, WORLD HAPTICS 2009: THIRD JOINT EUROHAPTICS CONFERENCE AND SYMPOSIUM ON HAPTIC INTERFACES FOR VIRTUAL ENVIRONMENT AND TELEOPERATOR SYSTEMS, PROCEEDINGS, P51, DOI 10.1109/WHC.2009.4810846; Stengel RF, 2012, Optimal control and estimation; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; van der Wel RPRD, 2011, J EXP PSYCHOL HUMAN, V37, P1420, DOI 10.1037/a0022337; Winter D., 2009, BIOMECHANICS MOTOR C, V4th	18	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0167314	10.1371/journal.pone.0167314	http://dx.doi.org/10.1371/journal.pone.0167314			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3TF	27911938	Green Published, Green Submitted, gold			2022-12-26	WOS:000389520600028
J	Aurpibul, L; Tangmunkongvorakul, A; Musumari, PM; Srithanaviboonchai, K; Tarnkehard, S				Aurpibul, Linda; Tangmunkongvorakul, Arunrat; Musumari, Patou Masika; Srithanaviboonchai, Kriengkrai; Tarnkehard, Surapee			Patterns of Sexual Behavior in Lowland Thai Youth and Ethnic Minorities Attending High School in Rural Chiang Mai, Thailand	PLOS ONE			English	Article							HEALTH-SERVICES; HIV; ADOLESCENTS; INITIATION; STUDENTS; GENDER	Introduction The rural areas of Northern Thailand are home to a large cultural diversity of ethnic minority groups. Previous studies have shown that young people in rural Thailand have low levels of knowledge on HIV/AIDS and high sexual risks. We compared sexual behaviors between the lowland Thai youth and the youth from ethnic minority groups. Methods and findings This is a cross-sectional quantitative study conducted among high-school Thai and ethnic students in Chiang Mai. From a total 1215 participants, 487 (40.1%) were lowland Thai and 728 (59.9%) were from ethnic minorities. Overall, 17.9% of respondents reported "ever had sex." Lowland Thai adolescents were more likely to have ever had sex compared with ethnic minority adolescents (AOR, 1.61; CI, 1.06-2.45; P<0.01). A higher proportion of lowland Thai respondents reported having >= 2 lifetime sexual partners (51.9% vs. 33.3%, P= 0.003), or currently having a boy/girlfriend (59.9% vs. 45.3%, P< 0.001) compared to ethnic minority adolescents. Consistent condom use was low in both groups (22.6%). The common significant factors associated with "ever had sex" in both groups were "ever drunk alcohol in the past year" and "currently having a boy/girlfriend." Specifically, for lowland Thai youth, being around the age of 17 or 18 years and "ever used methamphetamine in the past year" were associated with increased odds of "ever had sex". For ethnic minority adolescents, being female and belonging to religions other than Buddhism were associated with decreased odds of "ever had sex". Conclusion A substantially higher proportion of lowland Thai engage in risky sexual behaviors when compared to ethnic minorities. However, both groups remained vulnerable to HIV and other sexually transmitted infections. To minimize sexual risks, education program and school-based interventions are warranted to increase awareness of young people about risky behaviors and to promote essential life skills.	[Aurpibul, Linda; Tangmunkongvorakul, Arunrat; Srithanaviboonchai, Kriengkrai; Tarnkehard, Surapee] Chiang Mai Univ, Res Inst Hlth Sci, Chiang Mai, Thailand; [Musumari, Patou Masika] Kyoto Univ, Sch Publ Hlth, Dept Global Hlth & Socioepidemiol, Kyoto, Japan; [Srithanaviboonchai, Kriengkrai] Chiang Mai Univ, Fac Med, Chiang Mai, Thailand	Chiang Mai University; Kyoto University; Chiang Mai University	Tangmunkongvorakul, A (corresponding author), Chiang Mai Univ, Res Inst Hlth Sci, Chiang Mai, Thailand.	arunrat@rihes.org	., ksrithan/AAO-2228-2020	., ksrithan/0000-0002-1683-4259	Chiang Mai University Center of Excellence in HIV/AIDS Research; National Research University Project under Thailand's Office of the Higher Education Commission; Kyoto University "Strategic Young Researcher Overseas Visit Program for Accelerating Brain Circulation Program"	Chiang Mai University Center of Excellence in HIV/AIDS Research; National Research University Project under Thailand's Office of the Higher Education Commission; Kyoto University "Strategic Young Researcher Overseas Visit Program for Accelerating Brain Circulation Program"	The study was supported by the Chiang Mai University Center of Excellence in HIV/AIDS Research and the National Research University Project under Thailand's Office of the Higher Education Commission (Dr. Arunrat Tangmunkongvorakul). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was part of the HIV/AIDS Prevention Program among Ethnic Young People in Chiang Mai. It was supported by the Chiang Mai University Center of Excellence in HIV/AIDS Research. It was also supported by the National Research University Project under Thailand's Office of the Higher Education Commission. We thank the young people in rural Chiang Mai Province who contributed to this research. We also thank the Kyoto University "Strategic Young Researcher Overseas Visit Program for Accelerating Brain Circulation Program" for supporting the collaboration between Kyoto University and the Research Institute for Health Sciences, Chiang Mai University.	Baba S., 2010, INT C FUT IMP COMM I; Bozon M, 1998, SOC AS AIDS, P37; Chai Podhisita PX, 2001, POPULATION SERIES, V108-5; Dahlfred K., LIFE MINISTRY D MCGI; David Ross, 2006, UNAIDS INTERAGENCY T; Fongkaew W, 2007, J ASSOC NURSE AIDS C, V18, P60, DOI 10.1016/j.jana.2007.01.005; FRIEDMAN HL, 1992, J ADOLESCENT HEALTH, V13, P345, DOI 10.1016/1054-139X(92)90026-8; HalpernFelsher BL, 1996, J ADOLESCENT HEALTH, V19, P331, DOI 10.1016/S1054-139X(96)00024-9; Huguet A., 2011, APHICHAT CHAMRATRITH; Idele P, 1999, J ACQ IMMUN DEF SYND, V2014; Kilmarx PH, 2000, AIDS, V14, P2731, DOI 10.1097/00002030-200012010-00013; Kumpirat P., SOCIAL CULTURAL FACT; Liebowitz J., 2002, IMPACT FAITH BASED O; Lindley LL, PUBLIC HLTH REP, V1, P12; Listman JB, 2011, AM J PHYS ANTHROPOL, V144, P300, DOI 10.1002/ajpa.21408; Liu A, 2006, INT FAM PLAN PERSPEC, V32, P126, DOI 10.1363/3212606; Liulan WC, 2006, SE ASIAN STUDIES, V44, P337; Ministry of Social Development and Human Security, 2010, PREGN THAI AD; Mulu W, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-84; Musumari PM, 2016, PLOS ONE, V11; National AIDS Prevention and Alleviation Committee, 2006, UNGASSCOUNTRY PROGR; Ngamprapasom N., 2001, THESIS; Pettifor A, 2013, JAIDS-J ACQ IMM DEF, V63, pS155, DOI 10.1097/QAI.0b013e31829871fb; Rongkavilit Chokechai, 2007, J Adolesc Health, V40, DOI 10.1016/j.jadohealth.2006.11.004; Sirinan Kittisuksathit, 2007, SEXUAL RISK BEHAV HI, P99; Srisuriyawet R, 2006, THESIS; Tangmunkongvorakul A, 2005, CULT HEALTH SEX, V7, P361, DOI 10.1080/13691050500100740; Tangmunkongvorakul A, SE ASIAN J TROPICAL, V45, P1437; Tangmunkongvorakul A, 2012, SE ASIAN J TROP MED, V43, P479; Tangmunkongvorakul A, 2012, ASIAN POPUL STUD, V8, P39, DOI 10.1080/17441730.2012.646837; Tangmunkongvorakul A, 2010, SE ASIAN J TROP MED, V41, P1475; Taywaditep KJ, 2004, CONTINUUM COMPLETE I, P1021; Techasrivichien T, 2014, ARCH SEXUAL BEHAV; UNAIDS, 2012, FACT SHEET; Wingood GM, 2013, AM J PUBLIC HEALTH, V103, P2226, DOI 10.2105/AJPH.2013.301386; World Health Organisation, 2013, TRAD FOR POL DIPL HL; Yongpanichkul S, REV SEXUALITY REPROD	37	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0165866	10.1371/journal.pone.0165866	http://dx.doi.org/10.1371/journal.pone.0165866			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3JC	27906980	Green Published, Green Submitted, gold			2022-12-26	WOS:000389482700012
J	Bachelot, A; Nicolas, C; Gricourt, S; Dulon, J; Leban, M; Golmard, JL; Touraine, P				Bachelot, Anne; Nicolas, Carole; Gricourt, Solenne; Dulon, Jerome; Leban, Monique; Golmard, Jean Louis; Touraine, Philippe			Poor Compliance to Hormone Therapy and Decreased Bone Mineral Density in Women with Premature Ovarian Insufficiency	PLOS ONE			English	Article							EARLY BILATERAL OOPHORECTOMY; YOUNG-WOMEN; TURNER-SYNDROME; EARLY MENOPAUSE; FAILURE; MORTALITY; REPLACEMENT; COHORT	Premature ovarian insufficiency leads to through infertility and estrogen deficiency. Optimal management encompasses estrogen replacement therapy. Long-term outcome of women with POI is not known. We design a study to evaluate the medical care, hormone replacement therapy compliance and bone mineral density (BMD) in POI women with at least a five-year follow-up after the first evaluation. One hundred and sixty-two patients (37.3 +/- 8.0 years) were evaluated (follow-up 7.9 +/- 2.8 years). Sixty-nine patients (42.6%) had stopped their hormone replacement therapy (HRT) for at least one year during the follow up period. BMD determination at initial evaluation and at follow-up visit was completed in 92 patients. At first evaluation, 28 patients (30%) had osteopenia and 7 (8%) had osteoporosis. At follow up, 31 women (34%) had BMD impairment with osteopenia in 61% and osteoporosis in 5%. In univariate analysis and multivariate analysis, there was a significant loss of femoral BMD in women who had stopped their HRT for over a year. In conclusion, this first study concerning long-term follow-up of POI patients shows the poor compliance to their HRT, despite its importance in the prevention of bone demineralization. This study reinforces the need for follow up and specific care for POI women.	[Bachelot, Anne; Nicolas, Carole; Gricourt, Solenne; Dulon, Jerome; Touraine, Philippe] Hop La Pitie Salpetriere, AP HP, IE3M,Dept Endocrinol & Reprod Med,Ctr Reference P, Ctr Reference Malad Endocriniennes Rares Croissan, Paris, France; [Bachelot, Anne; Nicolas, Carole; Golmard, Jean Louis; Touraine, Philippe] Univ Paris, Univ Pierre & Marie Curie, Paris, France; [Leban, Monique] Hop La Pitie Salpetriere, AP HP, Dept Hormonal Biochem, Paris, France; [Golmard, Jean Louis] Hop La Pitie Salpetriere, AP HP, Clin Res Unit, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Touraine, P (corresponding author), Hop La Pitie Salpetriere, AP HP, IE3M,Dept Endocrinol & Reprod Med,Ctr Reference P, Ctr Reference Malad Endocriniennes Rares Croissan, Paris, France.; Touraine, P (corresponding author), Univ Paris, Univ Pierre & Marie Curie, Paris, France.	philippe.touraine@aphp.fr	Bachelot, Anne/GQZ-0551-2022					Amarante F, 2011, BRAZ J MED BIOL RES, V44, P78, DOI 10.1590/S0100-879X2011000100012; Anasti JN, 1998, OBSTET GYNECOL, V91, P12, DOI 10.1016/S0029-7844(97)00583-8; Arlot ME, 1997, J BONE MINER RES, V12, P683, DOI 10.1359/jbmr.1997.12.4.683; Atsma F, 2006, MENOPAUSE, V13, P265, DOI 10.1097/01.gme.0000218683.97338.ea; Bachelot A, 2016, CLIN ENDOCRINOL OXF; Bachelot A, 2009, EUR J ENDOCRINOL, V161, P179, DOI 10.1530/EJE-09-0231; Bakalov VK, 2003, J CLIN ENDOCR METAB, V88, P5717, DOI 10.1210/jc.2003-030913; Bidet M, 2011, J CLIN ENDOCR METAB, V96, P3864, DOI 10.1210/jc.2011-1038; Cummings SR, 2002, JAMA-J AM MED ASSOC, V288, P1889, DOI 10.1001/jama.288.15.1889; DAVIES MC, 1990, BRIT MED J, V301, P790, DOI 10.1136/bmj.301.6755.790; Francucci C M, 2010, J Endocrinol Invest, V33, P39; Gallagher JC, 2007, MENOPAUSE, V14, P567, DOI 10.1097/gme.0b013e31804c793d; Hanton L, 2003, J WOMENS HEALTH, V12, P971, DOI 10.1089/154099903322643893; Jacobsen BK, 2003, AM J EPIDEMIOL, V157, P923, DOI 10.1093/aje/kwg066; Khadr SN, 2010, CLIN ENDOCRINOL, V73, P637, DOI 10.1111/j.1365-2265.2010.03857.x; Langrish JP, 2009, HYPERTENSION, V53, P805, DOI 10.1161/HYPERTENSIONAHA.108.126516; Management of women with premature ovarian insufficiency, MANAGEMENT WOMEN PRE; Nelson LM, 2009, NEW ENGL J MED, V360, P606, DOI 10.1056/NEJMcp0808697; Popat VB, 2014, J CLIN ENDOCR METAB, V99, P3418, DOI 10.1210/jc.2013-4145; Popat VB, 2009, J CLIN ENDOCR METAB, V94, P2277, DOI 10.1210/jc.2008-1878; Rivera CM, 2009, MENOPAUSE, V16, P15, DOI 10.1097/gme.0b013e31818888f7; Rivera CM, 2009, NEUROEPIDEMIOLOGY, V33, P32, DOI 10.1159/000211951; Schoemaker MJ, 2008, J CLIN ENDOCR METAB, V93, P4735, DOI 10.1210/jc.2008-1049; Shuster LT, 2010, MATURITAS, V65, P161, DOI 10.1016/j.maturitas.2009.08.003; Soares PM, 2010, SAO PAULO MED J, V128, P211, DOI 10.1590/S1516-31802010000400007; van Lennep JER, 2016, EUR J PREV CARDIOL, V23, P178, DOI 10.1177/2047487314556004; Vearncombe KJ, 2009, MENOPAUSE, V16, P188, DOI 10.1097/gme.0b013e3181775eb4	27	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0164638	10.1371/journal.pone.0164638	http://dx.doi.org/10.1371/journal.pone.0164638			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27906970	Green Published, gold, Green Submitted			2022-12-26	WOS:000389482700005
J	Fjellman-Wiklundl, A; Nordin, E; Skelton, DA; Lundin-Olsson, L				Fjellman-Wiklundl, Anncristine; Nordin, Ellinor; Skelton, Dawn A.; Lundin-Olsson, Lillemor			Reach the Person behind the Dementia Physical Therapists' Reflections and Strategies when Composing Physical Training	PLOS ONE			English	Article							OLDER-PEOPLE; FOCUS GROUPS; CARE; COMORBIDITY; RESIDENTS; PROGRAM; DISEASE	Dementia is a disease characterized by cognitive impairment and physical decline that worsens over time. Exercise is one lifestyle factor that has been identified as a potential means of reducing or delaying progression of the symptoms of dementia, maximizing function and independence. The purpose of this study was to explore physical therapists' (PTs) experiences and reflections on facilitating high-intensity functional exercise with older people living with dementia, in residential care home settings. The study used a qualitative design based on interviews, individually or in small groups, with seven PTs engaged as leaders in the training of older people with dementia. The interviews were analyzed with a modified Grounded Theory method with focus on constant comparisons. To increase trustworthiness the study used triangulation within investigators and member checking. The core category "Discover and act in the moment-learn over time" reflects how the PTs continuously developed their own learning in an iterative process. They built on previous knowledge to communicate with residents and staff and to tailor the high intensity training in relation to each individual at that time point. The category "Be on your toes" highlights how the PTs searched for sufficient information about each individual, before and during training, by eliciting the person's current status from staff and by interpreting the person's body language. The category "Build a bond with a palette of strategies" describes the importance of confirmation to build up trust and the use of group members and the room to create an interplay between exercise and social interaction. These findings highlight the continuous iterative process of building on existing knowledge, sharing and reflecting, being alert to any alterations needed for individuals that day, communication skills (both with residents and staff) and building a relationship and trust with residents in the effective delivery of high intensity functional exercise to older people living with dementia in care settings.	[Fjellman-Wiklundl, Anncristine; Nordin, Ellinor; Skelton, Dawn A.; Lundin-Olsson, Lillemor] Umea Univ, Physiotherapy, Dept Community Hlth & Rehabil, Umea, Sweden; [Skelton, Dawn A.] Glasgow Caledonian Univ, Inst Appl Hlth Res, Sch Hlth & Life Sci, Glasgow, Lanark, Scotland	Umea University; Glasgow Caledonian University	Fjellman-Wiklundl, A (corresponding author), Umea Univ, Physiotherapy, Dept Community Hlth & Rehabil, Umea, Sweden.	anncristinefielirron-wiklund@umu.se	Skelton, Dawn A/B-7552-2013	Skelton, Dawn A/0000-0001-6223-9840	Dementia Association - The National Association for the Rights of the Demented, in Sweden; Umea University	Dementia Association - The National Association for the Rights of the Demented, in Sweden; Umea University	This work received support from The Dementia Association - The National Association for the Rights of the Demented, in Sweden, http://www.demensforbundet.se/, to LLO and Umea University, http://www.umu.se/, to LLO.	Chartered Society of Physiotherapy United Kingdom, 2011, DEM CAR PHYS DEL PAR; Collin C, 1988, Int Disabil Stud, V10, P61; Dahlgren L, QUALITATIVE METHODOL; Doraiswamy PM, 2002, J GERONTOL A-BIOL, V57, pM173, DOI 10.1093/gerona/57.3.M173; Eggenberger E, 2013, INT PSYCHOGERIATR, V25, P345, DOI 10.1017/S1041610212001664; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Forbes D, 2013, COCHRANE DATABASE SY, V12; Fox C, 2014, AGE AGEING, V43, P741, DOI 10.1093/ageing/afu101; Galik EM, 2009, INT J NURS PRACT, V15, P48, DOI 10.1111/j.1440-172X.2008.01721.x; Guzman-Velez E, 2014, COGN BEHAV NEUROL, V27, P117, DOI 10.1097/WNN.0000000000000020; Johannessen A, 2014, SCAND J CARING SCI, V28, P749, DOI 10.1111/scs.12107; Kitwood T, 1997, AGING MENT HEALTH, V1, P13, DOI 10.1080/13607869757344; KITZINGER J, 1994, SOCIOL HEALTH ILL, V16, P103, DOI 10.1111/1467-9566.ep11347023; KITZINGER J, 1995, BRIT MED J, V311, P299, DOI 10.1136/bmj.311.7000.299; Kovach CR, 2010, AM J ALZHEIMERS DIS, V25, P317, DOI 10.1177/1533317510363471; Laventure B, 2010, J ACTIVE AGING   SEP, P63; Lincoln Y.S., 1985, NATURALISTIC ENQUIRY; Littbrand H, 2006, PHYS THER, V86, P489, DOI 10.1093/ptj/86.4.489; Martin-Garcia S, 2013, INT PSYCHOGERIATR, V25, P1077, DOI 10.1017/S1041610213000458; Morgan D.L., 1998, PLANNING FOCUS GROUP; NICE, 2011, SUPP PEOPL DEM THEIR; Prince M., 2013, WORLD ALZHEIMER REPO; Rockwood K, 2007, ALZHEIMERS DEMENT, V3, pS38, DOI 10.1016/j.jalz.2007.01.003; Schon D. A, 1986, REFLECTIVE PRACTITIO; Schon D. A., 1983, REFLECTIVE PRACTITIO, DOI [10.2307/J.CTVPBNPJG.24, DOI 10.4324/9781315237473]; Scottish Intercollegiate Guideline Network (SIGN), 2006, MAN PAT DEM NAT CLIN; Shumway-Cook A., 2011, MOTOR CONTROL TRANSL, V4th; Strauss A., 1998, BASICS QUALITATIVE R; Teri L, 2015, HDB PSYCHOL AGING; Toots A, 2015, J AM GER SO IN PRESS; Willemse BM, 2015, AGING MENT HEALTH, V19, P444, DOI 10.1080/13607863.2014.944088	31	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166686	10.1371/journal.pone.0166686	http://dx.doi.org/10.1371/journal.pone.0166686			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3JC	27906996	Green Published, gold, Green Submitted			2022-12-26	WOS:000389482700035
J	Camargos, AC; Mendonca, VA; de Andrade, CA; Oliveira, KSC; Tossige-Gomes, R; Rocha-Vieira, E; Neves, CDC; Vieira, EL; Leite, HR; Oliveira, MX; Teixeira, AL; Coimbra, CC; Lacerda, ACR				Resende Camargos, Ana Cristina; Mendonca, Vanessa Amaral; de Andrade, Camila Alves; Caires Oliveira, Katherine Simone; Tossige-Gomes, Rosalina; Rocha-Vieira, Etel; Cunha Neves, Camila Danielle; Marciano Vieira, Erica Leandro; Leite, Hercules Ribeiro; Oliveira, Murilo Xavier; Teixeira Junior, Antonio Lucio; Coimbra, Candido Celso; Lacerda, Ana Cristina Rodrigues			Neuroendocrine Inflammatory Responses in Overweight/Obese Infants	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; ADIPOSE-TISSUE BIOLOGY; HIGH-MOLECULAR-WEIGHT; OBESE CHILDREN; OXIDATIVE STRESS; METABOLIC SYNDROME; NEUROTROPHIC FACTOR; CHILDHOOD OBESITY; BREAST-MILK; ADIPONECTIN	Childhood obesity is related to a cascade of neuroendocrine inflammatory changes. However, there remains a gap in the current literature regarding the possible occurrence of these changes in overweight/obese infants. The objective of this study was to evaluate adipokines, cortisol, brain-derived neurotrophic factor (BDNF) and redox status in overweight/obese infants versus normal-weight peers. A cross-sectional study was conducted with 50 infants (25 in the overweight/obese group and 25 in the normal-weight group) between 6 and 24 months. Plasma levels of leptin, adiponectin, resistin, soluble tumor necrosis factor (TNF) receptors, chemokines, BDNF, serum cortisol and redox status were measured. Unpaired Student's t-test was used to analyze the results and a probability of p<0.05 was acceptable for rejection of the null hypothesis. The Pearson correlation was used to verify the association between the biomarkers analyzed in each group. Plasma levels of leptin (p = 0.0001), adiponectin (p = 0.0007) and BDNF (p = 0.003), and serum cortisol (p = 0.048) were significantly higher in overweight/obese infants than normal-weight infants. In contrast, the concentration of thiobarbituric acid reactive substances (TBARS) (p = 0.004), and catalase (p = 0.045) and superoxide dismutase activity (p = 0.02) were lower in overweight/obese infants than normal-weight peers. All the results together indicate neuroendocrine inflammatory response changes in overweight/obese infants between 6 and 24 months. Although there is already an environment that predisposes for a subsequent pro-inflammatory response, neuroendocrine secretion changes that permit the control of the inflammatory process in this age interval can be observed.	[Resende Camargos, Ana Cristina; Mendonca, Vanessa Amaral; de Andrade, Camila Alves; Caires Oliveira, Katherine Simone; Leite, Hercules Ribeiro; Oliveira, Murilo Xavier; Lacerda, Ana Cristina Rodrigues] Univ Fed Vales Jequitinhonha & Mucuri, Dept Fisioterapia, Diamantina, MG, Brazil; [Resende Camargos, Ana Cristina; Mendonca, Vanessa Amaral; Tossige-Gomes, Rosalina; Rocha-Vieira, Etel; Cunha Neves, Camila Danielle; Leite, Hercules Ribeiro; Lacerda, Ana Cristina Rodrigues] Soc Brasileira Fisiol, Programa Multicentr Posgrad Ciencias Fisiol, Diamantina, Brazil; [Marciano Vieira, Erica Leandro; Teixeira Junior, Antonio Lucio] Univ Fed Minas Gerais, Fac Med, Belo Horizonte, MG, Brazil; [Coimbra, Candido Celso] Univ Fed Minas Gerais, Inst Ciencias Biol, Belo Horizonte, MG, Brazil	Universidade Federal dos Vales do Jequitinhonha e Mucuri (UFVJM); Sociedade Brasileira de Fisiologia; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Camargos, AC (corresponding author), Univ Fed Vales Jequitinhonha & Mucuri, Dept Fisioterapia, Diamantina, MG, Brazil.; Camargos, AC (corresponding author), Soc Brasileira Fisiol, Programa Multicentr Posgrad Ciencias Fisiol, Diamantina, Brazil.	anacristinarcamargos@gmail.com	Teixeira, Antonio L/N-3315-2014; Lacerda, Ana Cristina/J-2181-2012; Mendonça, Vanessa Amaral/T-7958-2019; Oliveira, Murilo/I-7346-2013; Vieira, Erica L M/A-1976-2013; Camargos, Ana Cristina/O-5993-2016; Camargos, Ana Cristina/R-8436-2018; Leite, Hércules Ribeiro/GVT-1268-2022; Leite, Hércules Ribeiro/T-8366-2019; Rocha-Vieira, Etel/A-2524-2017	Teixeira, Antonio L/0000-0002-9621-5422; Lacerda, Ana Cristina/0000-0001-5366-3754; Mendonça, Vanessa Amaral/0000-0002-1696-6091; Oliveira, Murilo/0000-0001-6358-4910; Vieira, Erica L M/0000-0002-4147-5614; Camargos, Ana Cristina/0000-0003-2719-4231; Camargos, Ana Cristina/0000-0003-2719-4231; Leite, Hércules Ribeiro/0000-0001-8977-8131; Leite, Hércules Ribeiro/0000-0001-8977-8131; Rocha-Vieira, Etel/0000-0001-6908-7237	CNPq; FAPEMIG; CAPES	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by the Universidade Federal dos Vales do Jequitinhonha e Mucuri for institutional support, the CNPq, FAPEMIG, and CAPES for financial support and scholarships. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Universidade Federal dos Vales do Jequitinhonha e Mucuri for institutional support, the CNPq, FAPEMIG, and CAPES for financial support and scholarships. The authors are in debt to David Lee Nelson for kindly reading the manuscript.	Adamska A, 2012, ACTA DIABETOL, V49, P17, DOI 10.1007/s00592-010-0252-y; Aprath-Husmann I, 2001, INT J OBESITY, V25, P1465, DOI 10.1038/sj.ijo.0801737; Araki S, 2014, OBES RES CLIN PRACT, V8, pE63, DOI 10.1016/j.orcp.2012.07.003; Arner E, 2010, DIABETES, V59, P105, DOI 10.2337/db09-0942; Associacao Brasileira de Empresas de Pesquisa, 2008, CRIT CLASS EC BRAS; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Bernhard F, 2013, DIABETOLOGIA, V56, P311, DOI 10.1007/s00125-012-2773-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Catli G, 2014, J CLIN RES PEDIATR E, V6, P192, DOI [10.4274/Jcrpe.1531, 10.4274/jcrpe.1531]; Codoner-Franch P, 2014, CLIN BIOCHEM, V47, P44, DOI [10.1016/j.clinbiochem.2013.10.021, DOI 10.1016/J.CLINBIOCHEM.2013.10.021]; Codoner-Franch P, 2014, CLIN BIOCHEM, V47, P44, DOI 10.1016/j.clinbiochem.2013.10.021; Dalmas E, 2011, TRENDS IMMUNOL, V32, P307, DOI 10.1016/j.it.2011.04.008; de Onis M, 2010, INT J PEDIATR OBES, V5, P458, DOI 10.3109/17477161003615583; Economou EV, 2004, J CARDIOVASC PHARM, V44, P310, DOI 10.1097/01.fjc.0000133587.01718.59; Faienza MF, 2012, HORM RES PAEDIAT, V78, P158, DOI 10.1159/000342642; Fantuzzi G, 2005, J ALLERGY CLIN IMMUN, V115, P911, DOI 10.1016/j.jaci.2005.02.023; Fu YC, 2005, J LIPID RES, V46, P1369, DOI 10.1194/jlr.M400373-JLR200; GLASS GA, 1981, BIOCHEM BIOPH RES CO, V103, P1245, DOI 10.1016/0006-291X(81)90256-4; Guzzetti C, 2014, J ENDOCRINOL INVEST, V37, P51, DOI 10.1007/s40618-013-0014-0; Harris RBS, 2014, BBA-MOL BASIS DIS, V1842, P414, DOI 10.1016/j.bbadis.2013.05.009; Jeffery AN, 2008, INT J PEDIATR OBES, V3, P130, DOI 10.1080/17477160801954538; Jin YJ, 2015, NUTR NEUROSCI, V18, P376, DOI 10.1179/1476830515Y.0000000039; KNITTLE JL, 1979, J CLIN INVEST, V63, P239, DOI 10.1172/JCI109295; Korner A, 2005, BIOCHEM BIOPH RES CO, V337, P540, DOI 10.1016/j.bbrc.2005.09.064; Kotani Y, 2004, CLIN ENDOCRINOL, V61, P418, DOI 10.1111/j.1365-2265.2004.02041.x; Lacasa D, 2007, ENDOCRINOLOGY, V148, P868, DOI 10.1210/en.2006-0687; Landgraf K, 2015, DIABETES, V64, P1249, DOI 10.2337/db14-0744; Laudes M, 2011, J MOL ENDOCRINOL, V46, pR65, DOI 10.1530/JME-10-0169; Lee MJ, 2014, BBA-MOL BASIS DIS, V1842, P473, DOI 10.1016/j.bbadis.2013.05.029; Leoni MC, 2010, PEDIATRIC REP, V2, P62, DOI 10.4081/pr.2010.e19; Li SH, 2016, OBESITY, V24, P408, DOI 10.1002/oby.21378; Martos-Moreno GA, 2010, OBESITY, V18, P2288, DOI 10.1038/oby.2010.68; Martos-Moreno GA, 2013, VITAM HORM, V91, P107, DOI 10.1016/B978-0-12-407766-9.00006-7; Molgat ASD, 2012, J ENDOCRINOL, V214, P21, DOI 10.1530/JOE-12-0114; NELSON DP, 1972, ANAL BIOCHEM, V49, P474, DOI 10.1016/0003-2697(72)90451-4; Ohashi K, 2010, J BIOL CHEM, V285, P6153, DOI 10.1074/jbc.M109.088708; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Okamoto Y, 2008, CIRC RES, V102, P218, DOI 10.1161/CIRCRESAHA.107.164988; Oliver SR, 2010, INT J PEDIATR OBES, V5, P436, DOI 10.3109/17477160903545163; Oyama C, 2006, TOHOKU J EXP MED, V209, P257, DOI 10.1620/tjem.209.257; Patsouris D, 2009, J BIOL CHEM, V284, P31223, DOI 10.1074/jbc.M109.041665; Pham-Huy Lien Ai, 2008, Int J Biomed Sci, V4, P89; Prodam F, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-44; Romacho T, 2015, NUTRIENTS, V7, P865, DOI 10.3390/nu7020865; Rosas-Vargas H, 2011, ARCH MED RES, V42, P482, DOI 10.1016/j.arcmed.2011.09.005; Roth CL, 2013, METABOLISM, V62, P226, DOI 10.1016/j.metabol.2012.08.001; Sabin MA, 2015, J PAEDIATR CHILD H, V51, P82, DOI 10.1111/jpc.12819; Skinner AC, 2010, PEDIATRICS, V125, pE801, DOI 10.1542/peds.2009-2182; Sorisky A, 2013, ADV NUTR, V4, P67, DOI 10.3945/an.112.003020; Srivastava S, 2007, CARDIOVASC RES, V74, P445, DOI 10.1016/j.cardiores.2007.02.016; Suganami T, 2005, ARTERIOSCL THROM VAS, V25, P2062, DOI 10.1161/01.ATV.0000183883.72263.13; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Tenenbaum-Gavish K, 2013, FETAL DIAGN THER, V34, P1, DOI 10.1159/000350170; Veldhorst MAB, 2014, J CLIN ENDOCR METAB, V99, P285, DOI 10.1210/jc.2013-2924; WHO, 2011, CHILD GROWTH STANDAR; Wosiski-Kuhn M, 2014, PSYCHONEUROENDOCRINO, V42, P165, DOI 10.1016/j.psyneuen.2014.01.020; Yoshinaga M, 2008, CIRC J, V72, P1874, DOI 10.1253/circj.CJ-08-0180; Zarban A, 2015, BREASTFEED MED, V10, P214, DOI 10.1089/bfm.2014.0143; Zhang MX, 2011, BIOMED ENVIRON SCI, V24, P12, DOI 10.3967/0895-3988.2011.01.002; Zhu YG, 2006, BIOMED ENVIRON SCI, V19, P353	60	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167593	10.1371/journal.pone.0167593	http://dx.doi.org/10.1371/journal.pone.0167593			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907172	Green Published, gold, Green Submitted			2022-12-26	WOS:000389482700208
J	Samsiah, A; Othman, N; Jamshed, S; Hassali, MA				Samsiah, A.; Othman, Noordin; Jamshed, Shazia; Hassali, Mohamed Azmi			Perceptions and Attitudes towards Medication Error Reporting in Primary Care Clinics: A Qualitative Study in Malaysia	PLOS ONE			English	Article							ADMINISTRATION ERRORS; NURSING ERRORS; PATIENT SAFETY; BARRIERS; NURSES; SYSTEM; INFORMATION; MANAGEMENT; PHYSICIANS; INCIDENTS	Objective To explore and understand participants' perceptions and attitudes towards the reporting of medication errors (MEs). Methods A qualitative study using in-depth interviews of 31 healthcare practitioners from nine publicly funded, primary care clinics in three states in peninsular Malaysia was conducted for this study. The participants included family medicine specialists, doctors, pharmacists, pharmacist assistants, nurses and assistant medical officers. The interviews were audiotaped and transcribed verbatim. Analysis of the data was guided by the framework approach. Results Six themes and 28 codes were identified. Despite the availability of a reporting system, most of the participants agreed that MEs were underreported. The nature of the error plays an important role in determining the reporting. The reporting system, organisational factors, provider factors, reporter's burden and benefit of reporting also were identified. Conclusions Healthcare practitioners in primary care clinics understood the importance of reporting MEs to improve patient safety. Their perceptions and attitudes towards reporting of MEs were influenced by many factors which affect the decision-making process of whether or not to report. Although the process is complex, it primarily is determined by the severity of the outcome of the errors. The participants voluntarily report the errors if they are familiar with the reporting system, what error to report, when to report and what form to use.	[Samsiah, A.; Jamshed, Shazia] Int Islamic Univ Malaysia, Kulliyyah Pharm, Kuantan, Pahang, Malaysia; [Samsiah, A.] Minist Hlth, Inst Hlth Syst Res, Shah Alam, Selangor, Malaysia; [Othman, Noordin] Taibah Univ, Coll Pharm, Dept Clin & Hosp Pharm, Almadinah Almunawwarah, Saudi Arabia; [Hassali, Mohamed Azmi] Univ Sains Malaysia, Sch Pharmaceut Sci, George Town, Malaysia	International Islamic University Malaysia; Kementerian Kesihatan Malaysia; Taibah University; Universiti Sains Malaysia	Othman, N (corresponding author), Taibah Univ, Coll Pharm, Dept Clin & Hosp Pharm, Almadinah Almunawwarah, Saudi Arabia.	noordin_uia@yahoo.com	Hassali, Mohamed Azmi/A-6895-2011; Jamshed, Shazia/AAF-6525-2020	Hassali, Mohamed Azmi/0000-0001-9575-403X; Jamshed, Shazia/0000-0003-0773-0463; Othman, Noordin/0000-0001-7672-9226				ABOSHAIQAH AE, 2013, MIDDLE EAST J SCI RE, V17, P130, DOI DOI 10.5829/idosi.mejsr.2013.17.02.76110; Ashcroft DM, 2006, QUAL SAF HEALTH CARE, V15, P48, DOI 10.1136/qshc.2005.014639; Bayazidi Snor, 2012, J Caring Sci, V1, P231, DOI 10.5681/jcs.2012.032; Beasley John W, 2004, WMJ, V103, P56; Benn J, 2009, QUAL SAF HEALTH CARE, V18, P11, DOI 10.1136/qshc.2007.024166; Boyle TA, 2011, RES SOC ADMIN PHARM, V7, P93, DOI 10.1016/j.sapharm.2009.12.001; Cheng Lan, 2011, J Evid Based Med, V4, P32, DOI 10.1111/j.1756-5391.2011.01119.x; Cheung KC, 2011, J AM MED INFORM ASSN, V18, P799, DOI 10.1136/amiajnl-2011-000191; Chiang HY, 2010, NURS OUTLOOK, V58, P17, DOI 10.1016/j.outlook.2009.06.001; Covell CL, 2009, J NURS CARE QUAL, V24, P287, DOI 10.1097/NCQ.0b013e3181a4d506; Elder NC, 2007, J AM BOARD FAM MED, V20, P115, DOI 10.3122/jabfm.2007.02.060081; Evans SM, 2006, QUAL SAF HEALTH CARE, V15, P39, DOI 10.1136/qshc.2004.012559; Furukawa H, 2003, ANN PHARMACOTHER, V37, P1716, DOI 10.1345/aph.1C330; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; GLADSTONE J, 1995, J ADV NURS, V22, P628, DOI 10.1046/j.1365-2648.1995.22040628.x; Handler SM, 2007, J AM MED DIR ASSOC, V8, P568, DOI 10.1016/j.jamda.2007.06.009; Hartnell N, 2012, BMJ QUAL SAF, V21, P361, DOI 10.1136/bmjqs-2011-000299; Hashemi F, 2012, BMC NURS, V11, DOI 10.1186/1472-6955-11-20; Hickner J, 2010, ANN FAM MED, V8, P517, DOI 10.1370/afm.1169; Holmstrom AR, 2012, J PATIENT SAF, V8, P165, DOI 10.1097/PTS.0b013e3182676cf3; Jeffe Donna B, 2004, Jt Comm J Qual Saf, V30, P471; Kaldjian LC, 2008, ARCH INTERN MED, V168, P40, DOI 10.1001/archinternmed.2007.12; Kennedy Amanda G, 2004, J Am Pharm Assoc (2003), V44, P434, DOI 10.1331/1544345041475724; Khoo EM, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-127; Kreckler S, 2009, QUAL SAF HEALTH CARE, V18, P116, DOI 10.1136/qshc.2008.026534; Larizgoitia I, 2013, J PUBLIC HEALTH RES, V2, P168, DOI 10.4081/jphr.2013.e29; Lin YH, 2009, WORLDV EVID-BASED NU, V6, P237, DOI 10.1111/j.1741-6787.2009.00169.x; MOH, 2009, GUID MED ERR REP; Mrayyan Majd T, 2007, J Nurs Manag, V15, P659, DOI 10.1111/j.1365-2834.2007.00724.x; Patel I, 2010, INDIAN J PHARM SCI, V72, P539, DOI 10.4103/0250-474X.78518; Patrician PA, 2009, J NURS CARE QUAL, V24, P277, DOI 10.1097/NCQ.0b013e3181afa4cb; Petrova E, 2010, Nurs Stand, V24, P41; Pham Julius Cuong, 2013, J Public Health Res, V2, pe27, DOI 10.4081/jphr.2013.e27; Phillips MAS, 2002, AM J HEALTH-SYST PH, V59, P2326, DOI 10.1093/ajhp/59.23.2326; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Psuedonym Olgen R., 2008, SAGE ENCY QUALITATIV, P195; Rea D, 2016, HEALTH SOC CARE COMM, V24, P411, DOI 10.1111/hsc.12221; Roughead L., 2013, LIT REV MEDICATION S; Roulston KJ, 2008, SAGE ENCY QUALITATIV, P681; Runciman WB, 2006, QUAL SAF HEALTH CARE, V15, pI82, DOI 10.1136/qshc.2005.017467; Samsiah A, 2016, EUR J CLIN PHARM; Sanghera IS, 2007, ANAESTHESIA, V62, P53, DOI 10.1111/j.1365-2044.2006.04858.x; Sarvadikar A, 2010, EUR J CLIN PHARMACOL, V66, P843, DOI 10.1007/s00228-010-0838-x; Saumure K., 2008, SAGE ENCY QUALITATIV, P195; Schectman JM, 2006, JT COMM J QUAL PATIE, V32, P337, DOI 10.1016/S1553-7250(06)32043-0; Teoh BC, 2015, PHARMACOEPIDEMIOL AD, V4; Throckmorton Terry, 2007, J Perianesth Nurs, V22, P400, DOI 10.1016/j.jopan.2007.09.006; Toruner EK, 2012, AUST J ADV NURS, V29, P28; Ulanimo VM, 2007, J NURS CARE QUAL, V22, P28, DOI 10.1097/00001786-200701000-00007; Uribe CL, 2002, J HEALTHC MANAG, V47, P263, DOI 10.1097/00115514-200207000-00009; Wagner LM, 2013, J PATIENT SAF, V9, P1, DOI 10.1097/PTS.0b013e3182699919; Walker S B, 1998, Int J Nurs Pract, V4, P97, DOI 10.1046/j.1440-172X.1998.00058.x; Williams SD, 2013, RES SOC ADMIN PHARM, V9, P80, DOI 10.1016/j.sapharm.2012.02.002; World Health Organization, 2005, WHO DRAFT GUID ADV E; World Health Organization (WHO), 2014, REP LEARN SYST MED E	55	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166114	10.1371/journal.pone.0166114	http://dx.doi.org/10.1371/journal.pone.0166114			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3JC	27906960	Green Published, Green Submitted, gold			2022-12-26	WOS:000389482700015
J	Serra, MM; Alonso, AC; Peterson, M; Mochizuki, L; Greve, JMD; Garcez-Leme, LE				Serra, Marcos Mauricio; Alonso, Angelica Castilho; Peterson, Mark; Mochizuki, Luis; D'Andrea Greve, Julia Maria; Garcez-Leme, Luiz Eugenio			Balance and Muscle Strength in Elderly Women Who Dance Samba	PLOS ONE			English	Article							PHYSICAL PERFORMANCE; PROGRAM	Considering the growth of the aging population, and the increasing risk for falls and related morbidity, it is vital to seek efficient, comprehensive, and culturally relevant prevention programs for elderly people to reduce risks for falls. The aim of the present study was to evaluate the postural balance and muscle strength among women participating in the "Wing of Baianas" in the carnival parades. One hundred and ten women, with an average age of 67.4 5.9 years, were divided into two groups: Baianas group elderly participants of the carnival parades in the "Wing of Baianas", and a Control group of women who do not dance samba. Assessments included a physical activity questionnaire, isokinetic muscle strength testing for the knee extensors and flexors, and a postural balance assessment completed on a force platform. There were no differences between groups, for postural balance outcomes, during the eyes open condition; however, with eyes closed, there was a significant effect between groups (Baianas vs Control) in all variables. The Baianas group showed less medio-lateral displacement (p < 0.04); and anteroposterior displacement (p < 0.007); larger amplitudes of medio-lateral displacement (p < 0.001); and anteroposterior displacement (p < 0.001); increased mean velocity (p < 0.01); and elliptical area (p < 0.01) There were no differences in the isokinetic peak torque corrected by body weight, total work and flexor/extensor ratio. Participation in the Wing of Baianas is associated with better balance with closed eyes, but there were no differences between dancers and non-dancers for muscle strength.	[Serra, Marcos Mauricio; Alonso, Angelica Castilho; Mochizuki, Luis; D'Andrea Greve, Julia Maria; Garcez-Leme, Luiz Eugenio] Univ Sao Paulo, Sch Med, Inst Orthoped & Traumatol, Lab Study Movement, Sao Paulo, Brazil; [Peterson, Mark] Univ Michigan Hlth Syst, Dept Phys Med & Rehabil, Ann Arbor, MI USA; [Alonso, Angelica Castilho] Sao Judas Tadeu Univ USJT, Dept Pos Grad Program Aging Sci, Sao Paulo, Brazil	Universidade de Sao Paulo; University of Michigan System; University of Michigan; Universidade Sao Judas Tadeu	Alonso, AC (corresponding author), Univ Sao Paulo, Sch Med, Inst Orthoped & Traumatol, Lab Study Movement, Sao Paulo, Brazil.; Alonso, AC (corresponding author), Sao Judas Tadeu Univ USJT, Dept Pos Grad Program Aging Sci, Sao Paulo, Brazil.	angelicacastilho@msn.com	GREVE, JULIA/A-7849-2013; Peterson, Mark/ABD-3853-2020; Mochizuki, Luis/H-3044-2012; /J-7743-2012; Garcez Leme, Luiz/C-6759-2009	GREVE, JULIA/0000-0003-1778-0448; Peterson, Mark/0000-0002-9861-4275; Mochizuki, Luis/0000-0002-7550-2537; /0000-0002-9644-5068; Garcez Leme, Luiz/0000-0002-9738-5466				Alonso Angélica Castilho, 2014, MedicalExpress (São Paulo, online), V1, P298, DOI 10.5935/MedicalExpress.2014.06.03; Alonso AC, 2012, CLINICS, V67, P1433, DOI 10.6061/clinics/2012(12)14; Alpert PT, 2009, J AM ACAD NURSE PRAC, V21, P108, DOI 10.1111/j.1745-7599.2008.00392.x; Brech GC, 2011, MATURITAS, V70, P379, DOI 10.1016/j.maturitas.2011.09.004; Eyigor S, 2009, ARCH GERONTOL GERIAT, V48, P84, DOI 10.1016/j.archger.2007.10.008; Ferrufino L, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00169; Garcez-Leme LE, 2005, J AM GERIATR SOC, V53, P2018, DOI 10.1111/j.1532-5415.2005.53557.x; Garcez-Leme Luiz E., 2014, MedicalExpress (São Paulo, online), V1, P3, DOI 10.5935/MedicalExpress.2014.01.02; Garcia Rosamaria, 2006, Clinics, V61, P539, DOI 10.1590/S1807-59322006000600009; Granacher U, 2012, GERONTOLOGY, V58, P305, DOI 10.1159/000334814; Gschwind YJ, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-105; Hui E, 2009, ARCH GERONTOL GERIAT, V49, pE45, DOI 10.1016/j.archger.2008.08.006; Janyacharoen Taweesak, 2013, Clin Interv Aging, V8, P855, DOI 10.2147/CIA.S41076; Kattenstroth JC, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00031; Kattenstroth JC, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00005; Krampe J, 2013, WESTERN J NURS RES, V35, P39, DOI 10.1177/0193945911423266; MAKI BE, 1994, J GERONTOL, V49, pM72, DOI 10.1093/geronj/49.2.M72; Matsudo SM., 2002, REV BRAS CIENC MOV, V10, P41; Mochizuki L, 2006, J APPL BIOMECH, V22, P51, DOI 10.1123/jab.22.1.51; Muehlbauer T, 2012, GERONTOLOGY, V58, P504, DOI 10.1159/000341614; Pichierri G, 2012, BMC GERIATR, V12, DOI 10.1186/1471-2318-12-74; Sofianidis G, 2009, J AGING PHYS ACTIV, V17, P167, DOI 10.1123/japa.17.2.167; van Wegen EEH, 2002, HUM MOVEMENT SCI, V21, P61, DOI 10.1016/S0167-9457(02)00077-5; Zhang JG, 2008, GAIT POSTURE, V27, P697, DOI 10.1016/j.gaitpost.2007.09.004	24	15	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166105	10.1371/journal.pone.0166105	http://dx.doi.org/10.1371/journal.pone.0166105			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3JC	27906984	Green Published, Green Submitted, gold			2022-12-26	WOS:000389482700014
J	Yang, WC; Zhang, XZ; Wang, N; Tan, J; Fang, XH; Wang, Q; Tao, T; Li, WZ				Yang, Wanchao; Zhang, Xuezhong; Wang, Nan; Tan, Jing; Fang, Xianhai; Wang, Qi; Tao, Tao; Li, Wenzhi			Effects of Acute Systemic Hypoxia and Hypercapnia on Brain Damage in a Rat Model of Hypoxia-Ischemia	PLOS ONE			English	Article							FOCAL CEREBRAL ISCHEMIA/REPERFUSION; BLOOD-FLOW; THERAPEUTIC HYPERCAPNIA; BARRIER PERMEABILITY; PROTEIN EXPRESSION; PERINATAL-PERIOD; HEAD-INJURY; ADULT RATS; EDEMA; REOXYGENATION	Therapeutic hypercapnia has the potential for neuroprotection after global cerebral ischemia. Here we further investigated the effects of different degrees of acute systemic hypoxia in combination with hypercapnia on brain damage in a rat model of hypoxia and ischemia. Adult wistar rats underwent unilateral common carotid artery (CCA) ligation for 60 min followed by ventilation with normoxic or systemic hypoxic gas containing 11%O-2,13%O-2,15% O-2 and 18%O-2 (targeted to PaO2 30-39 mmHg, 40-49 mmHg, 50-59 mmHg, and 60-69 mmHg, respectively) or systemic hypoxic gas containing 8% carbon dioxide (targeted to PaCO2 60-80 mmHg) for 180 min. The mean artery pressure (MAP), blood gas, and cerebral blood flow (CBF) were evaluated. The cortical vascular permeability and brain edema were examined. The ipsilateral cortex damage and the percentage of hippocampal apoptotic neurons were evaluated by Nissl staining and terminal deoxynucleotidyl transferase-mediated 2'-deoxyuridine 5'-triphosphate-biotin nick end labeling (TUNEL) assay as well as flow cytometry, respectively. Immunofluorescence and western blotting were performed to determine aquaporin-4 (AQP4) expression. In rats treated with severe hypoxia (PaO2 < 50 mmHg), hypercapnia augmented the decline of MAP with cortical CBF and damaged blood brain barrier permeability (p < 0.05). In contrast, in rats treated with mild to moderate hypoxia (PaO2 > 50 mmHg), hypercapnia protected against these pathophysiological changes. Moreover, hypercapnia treatment significantly reduced brain damage in the ischemic ipsilateral cortex and decreased the percentage of apoptotic neurons in the hippocampus after the CCA ligated rats were exposed to mild or moderate hypoxemia (PaO2 > 50 mmHg); especially under mild hypoxemia (PaO2 > 60 mmHg), hypercapnia significantly attenuated the expression of AQP4 protein with brain edema (p < 0.05). Hypercapnia exerts beneficial effects under mild to moderate hypoxemia and augments detrimental effects under severe hypoxemia on brain damage in a rat model of hypoxia-ischemia.	[Li, Wenzhi] Harbin Med Univ, Affiliated Hosp 2, Dept Anesthesiol, Harbin, Heilongjiang Sh, Peoples R China; Harbin Med Univ, Dept Educ, Anesthesiol Key Lab, Harbin, Heilongjiang Pr, Peoples R China	Harbin Medical University; Harbin Medical University	Li, WZ (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Dept Anesthesiol, Harbin, Heilongjiang Sh, Peoples R China.	Wenzhili9@126.com			National Natural Science Foundation of China [8140050107]; Educational Commission of Heilong Jiang Province of China [12541387]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Educational Commission of Heilong Jiang Province of China	This study was supported by the National Natural Science Foundation of China (grant no. 8140050107) and Educational Commission of Heilong Jiang Province of China (grant no. 12541387).; This study was supported by the National Natural Science Foundation of China (grant no. 8140050107) and Educational Commission of Heilong Jiang Province of China (grant no. 12541387). We thank Medjaden Bioscience Limited for assisting in the preparation of this manuscript.	ANDINE P, 1991, DEV BRAIN RES, V64, P115, DOI 10.1016/0165-3806(91)90214-4; Bogoslovsky T, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-46; Calvert JW, 2005, NEUROL RES, V27, P246, DOI 10.1179/016164105X25216; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chew LJ, 2006, MENT RETARD DEV D R, V12, P105, DOI 10.1002/mrdd.20102; Chonghaile MN, 2008, ANESTHESIOLOGY, V109, P837, DOI 10.1097/ALN.0b013e3181895fb7; Chonghaile MN, 2008, CRIT CARE MED, V36, P3135, DOI 10.1097/CCM.0b013e31818f0d13; Duong TQ, 2001, MAGN RESON MED, V45, P61, DOI 10.1002/1522-2594(200101)45:1<61::AID-MRM1010>3.0.CO;2-8; Ferriero DM, 2004, NEW ENGL J MED, V351, P1985, DOI 10.1056/NEJMra041996; GOLD R, 1994, LAB INVEST, V71, P219; ISHIGE N, 1987, J CEREBR BLOOD F MET, V7, P759, DOI 10.1038/jcbfm.1987.131; Kempski O, 1999, ACT NEUR S, V73, P41; KOSTIC V, 1991, J NEUROCHEM, V57, P1962, DOI 10.1111/j.1471-4159.1991.tb06410.x; Krizbai IA, 2005, SHOCK, V24, P428, DOI 10.1097/01.shk.0000183389.98519.d3; LEVINE S, 1960, AM J PATHOL, V36, P1; Li Z, 2009, J CEREBR BLOOD F MET, V29, P287, DOI 10.1038/jcbfm.2008.118; Mark KS, 2002, AM J PHYSIOL-HEART C, V282, pH1485, DOI 10.1152/ajpheart.00645.2001; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; Morita Yoko, 1997, Keio Journal of Medicine, V46, P120; Muramatsu K, 1997, STROKE, V28, P2281, DOI 10.1161/01.STR.28.11.2281; Niatsetskaya ZV, 2012, J CEREBR BLOOD F MET, V32, P232, DOI 10.1038/jcbfm.2011.164; NIDA TY, 1995, J NEUROTRAUM, V12, P77, DOI 10.1089/neu.1995.12.77; Papadopoulos MC, 2007, PEDIATR NEPHROL, V22, P778, DOI 10.1007/s00467-006-0411-0; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; Rosenberg GA, 1999, PROG CARDIOVASC DIS, V42, P209, DOI 10.1016/S0033-0620(99)70003-4; SALFORD LG, 1974, ACTA PHYSIOL SCAND, V92, P130, DOI 10.1111/j.1748-1716.1974.tb05729.x; SALFORD LG, 1973, ARCH NEUROL-CHICAGO, V29, P234, DOI 10.1001/archneur.1973.00490280046006; Shian W J, 1994, Zhonghua Yi Xue Za Zhi (Taipei), V53, P154; Singhal AB, 2002, J CEREBR BLOOD F MET, V22, P861, DOI 10.1097/00004647-200207000-00011; Stavale LM, 2013, TOXICON, V66, P37, DOI 10.1016/j.toxicon.2013.01.026; SUTTER R, 1976, STROKE, V7, P500, DOI 10.1161/01.STR.7.5.500; Tao T, 2014, NEUROSCI LETT, V573, P1, DOI 10.1016/j.neulet.2014.04.051; Tao T, 2013, BRAIN RES, V1533, P52, DOI 10.1016/j.brainres.2013.08.014; TOWFIGHI J, 1994, BIOL NEONATE, V65, P108; Uekawa K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163329; Vannucci RC, 1997, PEDIATR RES, V42, P24, DOI 10.1203/00006450-199707000-00005; Vannucci RC, 1997, ANN NY ACAD SCI, V835, P234, DOI 10.1111/j.1749-6632.1997.tb48634.x; Volpe J J, 1981, Major Probl Clin Pediatr, V22, P1; Willis CL, 2010, J CEREBR BLOOD F MET, V30, P1847, DOI 10.1038/jcbfm.2010.119; Witt KA, 2003, AM J PHYSIOL-HEART C, V285, pH2820, DOI 10.1152/ajpheart.00589.2003; Witt KA, 2008, MICROVASC RES, V75, P91, DOI 10.1016/j.mvr.2007.06.004; Wuyam B, 2002, RESP PHYSIOL, V129, P375, DOI 10.1016/S0034-5687(01)00319-X; Yu LS, 2016, EXP THER MED, V11, P709, DOI 10.3892/etm.2016.3022; Zammit C, 2015, CURR PHARM DESIGN, V21, P1418, DOI 10.2174/1381612821666150105122008; Zhang Q, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054250, 10.1371/journal.pone.0059667]; Zhou Q, 2010, ANESTHESIOLOGY, V112, P288, DOI 10.1097/ALN.0b013e3181ca8257	46	22	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167359	10.1371/journal.pone.0167359	http://dx.doi.org/10.1371/journal.pone.0167359			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907083	Green Published, Green Submitted, gold			2022-12-26	WOS:000389482700127
J	Zhang, T; Hu, Q; Shi, LY; Qin, L; Zhang, QY; Mi, MT				Zhang, Ting; Hu, Qin; Shi, Linying; Qin, Li; Zhang, Qianyong; Mi, Mantian			Equol Attenuates Atherosclerosis in Apolipoprotein E-Deficient Mice by Inhibiting Endoplasmic Reticulum Stress via Activation of Nrf2 in Endothelial Cells	PLOS ONE			English	Article							HUMAN HEPATOCELLULAR-CARCINOMA; UNFOLDED PROTEIN RESPONSE; DEPENDENT ACTIVATION; DEATH; APOPTOSIS; PATHWAY; PERK; SOY; INVOLVEMENT; DYSFUNCTION	The development of atherosclerosis is closely related to excessive endoplasmic reticulum stress (ERs). Equol reportedly protects against cardiovascular disease; however, the underlying mechanism for this protection remains unknown. Herein, the mechanisms contributing to the atheroprotective effect of equol were addressed using apolipoprotein E knockout (apoE-/-) mice fed a high-fat diet (HFD) with or without equol. Equol intervention reduced atherosclerotic lesions in the aorta in HFD-fed apoE-/-mice. Plasma lipid analysis showed that equol intervention reduced triglycerides, total cholesterol and LDL-cholesterol and increased HDL-cholesterol. Additionally, equol administration decreased lipid accumulation in the liver. Simultaneously, equol treatment inhibited cell apoptosis induced by t-BHP and thapsigargin in human umbilical vein endothelial cells (HUVECs). Furthermore, equol treatment attenuated palmitate, t-BHP or thapsigargin-induced upregulation of ER stress markers, including p-PERK, p-eIF2 alpha, GRP78, ATF6 and CHOP proteins expression. The same tendency was also observed in aortic lysates in apoE-/-mice fed with equol plus HFD compared with HFD alone. Moreover, equol treatment dose dependently activated the Nrf2 signaling pathway under oxidative stress. Additionally, elevation of Nrf2 induction was found in aortic lysates in apoE-/-mice fed with a HFD diet containing equol compared with a HFD diet without equol. Importantly, Nrf2 siRNA interference induced CHOP and attenuated the effect of equol to inhibit t-BHP mediated CHOP induction, furthermore, abrogated cell apoptosis induced by t-BHP, suggesting a role for Nrf2 in the protective effect of equol in HUVECs. Collectively, these findings implicate that the improvement of atherosclerosis by equol through attenuation of ER stress is mediated, at least in part, by activating the Nrf2 signaling pathway.	[Zhang, Ting; Hu, Qin; Shi, Linying; Qin, Li; Zhang, Qianyong; Mi, Mantian] Third Mil Med Univ, Res Ctr Nutr & Food Safety, Inst Mil Prevent Med, Chongqing Key Lab Nutr & Food Safety, Chongqing, Peoples R China	Army Medical University	Zhang, QY; Mi, MT (corresponding author), Third Mil Med Univ, Res Ctr Nutr & Food Safety, Inst Mil Prevent Med, Chongqing Key Lab Nutr & Food Safety, Chongqing, Peoples R China.	248141998@qq.com; mantianmi@hotmail.com			National Natural Science Foundation of China [81102129, 81072288]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by The National Natural Science Foundation of China (No. 81102129; No. 81072288). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by The National Natural Science Foundation of China (No. 81102129; No. 81072288). The authors thank Xinyu Liang, Huiling Deng, Juan Huang and Changjun Zhao for assistance with experiment work. All authors contributed to the final version. M. T. M. had primary responsibility for final content. The authors state that there are no conflicts of interest.	Chen CY, 2010, CHEM-BIOL INTERACT, V183, P105, DOI 10.1016/j.cbi.2009.09.024; Chin-Dusting JPF, 2001, BRIT J PHARMACOL, V133, P595, DOI 10.1038/sj.bjp.0704088; Cnop M, 2010, DIABETES OBES METAB, V12, P76, DOI 10.1111/j.1463-1326.2010.01279.x; Cominacini L, 2015, FREE RADICAL BIO MED, V88, P233, DOI 10.1016/j.freeradbiomed.2015.05.027; Cominacini L, 2015, CURR MED CHEM, V22, P1565, DOI 10.2174/0929867322666150311150829; Cullinan SB, 2003, MOL CELL BIOL, V23, P7198, DOI 10.1128/MCB.23.20.7198-7209.2003; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; Cullinan SB, 2004, J BIOL CHEM, V279, P20108, DOI 10.1074/jbc.M314219200; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Eyster K, 2014, NUTR METAB CARDIOVAS, V24, P423, DOI 10.1016/j.numecd.2013.09.014; Gao D, 2012, FREE RADICAL BIO MED, V53, P796, DOI 10.1016/j.freeradbiomed.2012.05.026; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Inoguchi T, 2000, DIABETES, V49, P1939, DOI 10.2337/diabetes.49.11.1939; ITOH K, 1995, MOL CELL BIOL, V15, P4184, DOI 10.1128/mcb.15.8.4184; Jackson RL, 2011, NUTR REV, V69, P432, DOI 10.1111/j.1753-4887.2011.00400.x; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; Kim DS, 2010, J PHARM PHARMACOL, V62, P197, DOI [10.1211/jpp.62.02.0007, 10.1211/jpp/62.02.0007]; Krogmann A, 2011, MICROVASC RES, V81, P52, DOI 10.1016/j.mvr.2010.11.008; Lenna S, 2014, IUBMB LIFE, V66, P530, DOI 10.1002/iub.1292; Li X, 2013, ARTERIOSCL THROM VAS, V33, P232, DOI 10.1161/ATVBAHA.112.252239; Liang XL, 2014, ANTI-CANCER DRUG, V25, P633, DOI 10.1097/CAD.0000000000000085; Loutchanwoot P, 2015, LIFE SCI, V128, P1, DOI 10.1016/j.lfs.2015.02.002; Ma Q, 2010, PHARMACOL THERAPEUT, V125, P376, DOI 10.1016/j.pharmthera.2009.11.004; Maier JAM, 2012, CLIN SCI, V122, P397, DOI 10.1042/CS20110506; Muruganandan S, 2006, TOXICOL SCI, V94, P118, DOI 10.1093/toxsci/kfl084; Myers L, 2014, J EPIDEMIOL GLOB HEA, V4, P23, DOI 10.1016/j.jegh.2013.09.007; Myoishi M, 2007, CIRCULATION, V116, P1226, DOI 10.1161/CIRCULATIONAHA.106.682054; Nagarajan S, 2008, J NUTR, V138, P332, DOI 10.1093/jn/138.2.332; Namgaladze D, 2014, DIABETOLOGIA, V57, P1067, DOI 10.1007/s00125-014-3173-4; Niture SK, 2014, FREE RADICAL BIO MED, V66, P36, DOI 10.1016/j.freeradbiomed.2013.02.008; Obiorah IE, 2014, CANCER PREV RES, V7, P939, DOI 10.1158/1940-6207.CAPR-14-0061; Ozcan L, 2012, ANNU REV MED, V63, P317, DOI 10.1146/annurev-med-043010-144749; Palomer X, 2014, CLIN INVEST ARTERIOS, V26, P255, DOI 10.1016/j.arteri.2014.02.003; Park YJ, 2013, NEUROCHEM RES, V38, P1561, DOI 10.1007/s11064-013-1057-5; Park YJ, 2010, AMINO ACIDS, V39, P785, DOI 10.1007/s00726-010-0523-5; Rajendran P, 2013, INT J BIOL SCI, V9, P1057, DOI 10.7150/ijbs.7502; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Setchell KDR, 2002, J NUTR, V132, P3577, DOI 10.1093/jn/132.12.3577; Setchell KDR, 2010, J NUTR, V140, p1355S, DOI 10.3945/jn.109.119776; Shuda M, 2003, J HEPATOL, V38, P605, DOI 10.1016/S0168-8278(03)00029-1; Sykiotis GP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3112re3; Tabas I, 2010, CIRC RES, V107, P839, DOI 10.1161/CIRCRESAHA.110.224766; Trojanowska M, 2010, NAT REV RHEUMATOL, V6, P453, DOI 10.1038/nrrheum.2010.102; Versari D, 2009, DIABETES CARE, V32, pS314, DOI 10.2337/dc09-S330; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang SY, 2012, J CELL BIOL, V197, P857, DOI 10.1083/jcb.201110131; Wang YZ, 2013, J NANOMATER, V2013, DOI 10.1155/2013/169405; Wei YR, 2009, MOL CELL BIOCHEM, V331, P31, DOI 10.1007/s11010-009-0142-1; Yao ST, 2014, J BIOL CHEM, V289, P4032, DOI 10.1074/jbc.M113.524512; Yi N, 2012, ANAT REC, V295, P1462, DOI 10.1002/ar.22539; Yuan JP, 2007, MOL NUTR FOOD RES, V51, P765, DOI 10.1002/mnfr.200600262; Zhang C, 2001, J BIOL CHEM, V276, P35867, DOI 10.1074/jbc.M100747200; Zhang T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079075; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	54	24	29	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167020	10.1371/journal.pone.0167020	http://dx.doi.org/10.1371/journal.pone.0167020			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907038	Green Submitted, Green Published, gold			2022-12-26	WOS:000389482700065
J	Abrieux, A; Mhamdi, A; Rabhi, KK; Egon, J; Debernard, S; Duportets, L; Tricoire-Leignel, H; Anton, S; Gadenne, C				Abrieux, Antoine; Mhamdi, Amel; Rabhi, Kaouther K.; Egon, Julie; Debernard, Stephane; Duportets, Line; Tricoire-Leignel, Helene; Anton, Sylvia; Gadenne, Christophe			An Insecticide Further Enhances Experience-Dependent Increased Behavioural Responses to Sex Pheromone in a Pest Insect	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; BLACK CUTWORM MOTH; APIS-MELLIFERA; PLASTICITY; SUSCEPTIBILITY; SENSITIZATION; LEPIDOPTERA; SENSITIVITY; ATTRACTION; RESISTANCE	Neonicotinoid insecticides are widely used to protect plants against pest insects, and insecticide residues remaining in the environment affect both target and non-target organisms. Whereas low doses of neonicotinoids have been shown to disturb the behaviour of pollinating insects, recent studies have revealed that a low dose of the neonicotinoid clothianidin can improve behavioural and neuronal sex pheromone responses in a pest insect, the male moth Agrotis ipsilon, and thus potentially improve reproduction. As male moth behaviour depends also on its physiological state and previous experience with sensory signals, we wondered if insecticide effects would be dependent on plasticity of olfactory-guided behaviour. We investigated, using wind tunnel experiments, whether a brief pre-exposure to the sex pheromone could enhance the behavioural response to this important signal in the moth A. ipsilon at different ages (sexually immature and mature males) and after different delays (2 h and 24 h), and if the insecticide clothianidin would interfere with age effects or the potential pre-exposure-effects. Brief pre-exposure to the pheromone induced an age-independent significant increase of sex pheromone responses 24 h later, whereas sex pheromone responses did not increase significantly 2 h after exposure. However, response delays were significantly shorter compared to naive males already two hours after exposure. Oral treatment with clothianidin increased sex pheromone responses in sexually mature males, confirming previous results, but did not influence responses in young immature males. Males treated with clothianidin after pre-exposure at day 4 responded significantly more to the sex pheromone at day 5 than males treated with clothianidin only and than males pre-exposed only, revealing an additive effect of experience and the insecticide. Plasticity of sensory systems has thus to be taken into account when investigating the effects of sublethal doses of insecticides on behaviour.	[Abrieux, Antoine; Mhamdi, Amel; Rabhi, Kaouther K.; Egon, Julie; Tricoire-Leignel, Helene; Anton, Sylvia; Gadenne, Christophe] Univ Angers, INRA, Neuroethol RCIM, Beaucouze, France; [Debernard, Stephane; Duportets, Line] IEES, Dept Ecol Sensorielle, Paris, France; [Duportets, Line] Univ Paris Saclay, Univ Paris Sud, Orsay, France; [Abrieux, Antoine] Univ Calif Davis, Dept Entomol & Nematol, Davis, CA 95616 USA	INRAE; Universite d'Angers; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); UDICE-French Research Universities; Universite Paris Saclay; University of California System; University of California Davis	Gadenne, C (corresponding author), Univ Angers, INRA, Neuroethol RCIM, Beaucouze, France.	christophe.gadenne@inra.fr	Tricoire-Leignel, Hélène/ABG-2320-2020	Tricoire-Leignel, Hélène/0000-0002-2881-2962; abrieux, antoine/0000-0002-2977-2034	Region Pays de la Loire; National French Funding Agency ANR [ANR-12-ADAP-0012-01]; Agronomy Institute Chott Meriem, Tunisia	Region Pays de la Loire(Region Pays de la Loire); National French Funding Agency ANR(French National Research Agency (ANR)); Agronomy Institute Chott Meriem, Tunisia	This work was supported by a PhD grant to A. A., and a research grant from Region Pays de la Loire to S. A. and C. G., as well as a grant from the National French Funding Agency ANR (ANR-12-ADAP-0012-01) to S. A., C. G. and H. T. -L. A. M. was supported by a grant from the Agronomy Institute Chott Meriem, Tunisia.; We thank C. Le Corre and L. Gamier for help in insect rearing. This work was supported by a PhD grant to A. A., and research grant from Region Pays de la Loire to S. A. and C. G., as well as a grant from the National French Funding Agency ANR (ANR-12 ADAP-0012-01) to S. A., C. G. and H. T. -L. A. M. was supported by a grant from the Agronomy Institute Chott Meriem, Tunisia.	Abrieux A, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00312; Agrawal AA, 2001, SCIENCE, V294, P321, DOI 10.1126/science.1060701; Anderson P, 2003, CHEM SENSES, V28, P285, DOI 10.1093/chemse/28.4.285; Anderson P, 2007, CHEM SENSES, V32, P483, DOI 10.1093/chemse/bjm017; Anton S, 1999, P NATL ACAD SCI USA, V96, P5764, DOI 10.1073/pnas.96.10.5764; Anton S, 2016, CELL TISSUE RES, V364, P59, DOI 10.1007/s00441-015-2299-0; Auld JR, 2010, P ROY SOC B-BIOL SCI, V277, P503, DOI 10.1098/rspb.2009.1355; BAKER TC, 1989, EXPERIENTIA, V45, P248, DOI 10.1007/BF01951811; Banken JAO, 1997, J ECON ENTOMOL, V90, P1102, DOI 10.1093/jee/90.5.1102; Barrozo RB, 2010, J EXP BIOL, V213, P2933, DOI 10.1242/jeb.043430; Bass C, 2015, PESTIC BIOCHEM PHYS, V121, P78, DOI 10.1016/j.pestbp.2015.04.004; Bouvier JC, 2002, ARCH INSECT BIOCHEM, V51, P55, DOI 10.1002/arch.10052; Bues R., 1974, ANN ZOOL ECOL ANIM, V2, P79; Cutler GC, 2013, DOSE-RESPONSE, V11, P154, DOI 10.2203/dose-response.12-008.Cutler; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Decourtye A, 2003, PEST MANAG SCI, V59, P269, DOI 10.1002/ps.631; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Duportets L, 2013, GEN COMP ENDOCR, V186, P58, DOI 10.1016/j.ygcen.2013.02.024; Dupuis J, 2012, NEUROSCI BIOBEHAV R, V36, P1553, DOI 10.1016/j.neubiorev.2012.04.003; Fan RJ, 1997, J EXP BIOL, V200, P2969; GADENNE C, 1993, EXPERIENTIA, V49, P721, DOI 10.1007/BF01923960; Gadenne C, 2016, ANNU REV ENTOMOL, V61, P317, DOI 10.1146/annurev-ento-010715-023523; Gemeno C, 1998, J CHEM ECOL, V24, P999, DOI 10.1023/A:1022398318465; Goulson D, 2013, J APPL ECOL, V50, P977, DOI 10.1111/1365-2664.12111; Grubb MS, 2004, CURR OPIN NEUROBIOL, V14, P503, DOI 10.1016/j.conb.2004.06.006; Guedes RNC, 2016, ANNU REV ENTOMOL, V61, P43, DOI 10.1146/annurev-ento-010715-023646; Guerrieri F, 2012, J EXP BIOL, V215, P2334, DOI 10.1242/jeb.060988; Hartlieb E, 1999, NATURWISSENSCHAFTEN, V86, P396, DOI 10.1007/s001140050640; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Hudson R, 1999, J COMP PHYSIOL A, V185, P297, DOI 10.1007/s003590050390; Jarriault D, 2009, HORM BEHAV, V56, P185, DOI 10.1016/j.yhbeh.2009.04.005; Jeschke P, 2011, J AGR FOOD CHEM, V59, P2897, DOI 10.1021/jf101303g; Jones CM, 2011, PESTIC BIOCHEM PHYS, V101, P53, DOI 10.1016/j.pestbp.2011.07.004; Leonova IN, 1996, ARCH INSECT BIOCHEM, V32, P157, DOI 10.1002/(SICI)1520-6327(1996)32:2&lt;157::AID-ARCH1&gt;3.0.CO;2-W; de Oliveira IM, 2010, TOXICOL LETT, V192, P294, DOI 10.1016/j.toxlet.2009.11.005; Menzel R, 1996, ANNU REV NEUROSCI, V19, P379, DOI 10.1146/annurev.ne.19.030196.002115; Menzel R, 1996, J PHYSIOL-PARIS, V90, P395, DOI 10.1016/S0928-4257(97)87928-4; Minoli S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034141; Oliveira EE, 2011, INSECT BIOCHEM MOLEC, V41, P872, DOI 10.1016/j.ibmb.2011.08.001; Picimbon JF, 1997, J CHEM ECOL, V23, P211, DOI 10.1023/B:JOEC.0000006355.13207.91; Rabhi KK, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2987; Rabhi KK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114411; RAKITIN A, 1991, PHYSIOL BEHAV, V50, P477, DOI 10.1016/0031-9384(91)90533-T; Salgado VL, 2016, NEUROTOXICOLOGY, V56, P188, DOI 10.1016/j.neuro.2016.08.003; Sokal R.R., 2012, BIOMETRY; Vinson S.B., 1984, P205; Walters ET, 2001, J EXP BIOL, V204, P457; Yang EC, 2008, J ECON ENTOMOL, V101, P1743, DOI 10.1603/0022-0493-101.6.1743	48	6	6	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167469	10.1371/journal.pone.0167469	http://dx.doi.org/10.1371/journal.pone.0167469			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902778	Green Published, Green Submitted, gold			2022-12-26	WOS:000389474100083
J	Mentzel, CMJ; Alkan, F; Keinicke, H; Jacobsen, MJ; Gorodkin, J; Fredholm, M; Cirera, S				Mentzel, Caroline M. Junker; Alkan, Ferhat; Keinicke, Helle; Jacobsen, Mette J.; Gorodkin, Jan; Fredholm, Merete; Cirera, Susanna			Joint Profiling of miRNAs and mRNAs Reveals miRNA Mediated Gene Regulation in the Gottingen Minipig Obesity Model	PLOS ONE			English	Article							HIGH-FAT-DIET; ADIPOSE-TISSUE; METABOLIC SYNDROME; LIPID-METABOLISM; EXPRESSION; LIVER; PROTEIN; MUSCLE; LEPTIN; CXCR4	Obesity and its comorbidities are an increasing challenge for both affected individuals and health care systems, worldwide. In obese individuals, perturbation of expression of both protein-coding genes and microRNAs (miRNA) are seen in obesity-relevant tissues (i.e. adipose tissue, liver and skeletal muscle). miRNAs are small non-coding RNA molecules which have important regulatory roles in a wide range of biological processes, including obesity. Rodents are widely used animal models for human diseases including obesity. However, not all research is applicable for human health or diseases. In contrast, pigs are emerging as an excellent animal model for obesity studies, due to their similarities in their metabolism, their digestive tract and their genetics, when compared to humans. The Gottingen minipig is a small sized easy-to-handle pig breed which has been extensively used for modeling human obesity, due to its capacity to develop severe obesity when fed ad libitum. The aim of this study was to identify differentially expressed of protein-coding genes and miRNAs in a Gottingen minipig obesity model. Liver, skeletal muscle and abdominal adipose tissue were sampled from 7 lean and 7 obese minipigs. Differential gene expression was investigated using high-throughput quantitative real-time PCR (qPCR) on 90 mRNAs and 72 miRNAs. The results revealed de-regulation of several obesity and inflammation-relevant protein-coding genes and miRNAs in all tissues examined. Many genes that are known to be de-regulated in obese humans were confirmed in the obese minipigs and several of these genes have target sites for miRNAs expressed in the opposing direction of the gene, confirming miRNA-mediated regulation in obesity. These results confirm the translational value of the pig for human obesity studies.	[Mentzel, Caroline M. Junker; Keinicke, Helle; Jacobsen, Mette J.; Fredholm, Merete; Cirera, Susanna] Univ Copenhagen, Dept Vet Clin & Anim Sci, Anim Genet, Fac Hlth Sci, Frederiksberg, Denmark; [Mentzel, Caroline M. Junker; Alkan, Ferhat; Gorodkin, Jan; Fredholm, Merete] Univ Copenhagen, Dept Vet Clin & Anim Sci, Ctr Noncoding RNA Technol & Hlth, Computat Biol & Bioinformat,Fac Hlth Sci, Frederiksberg, Denmark	University of Copenhagen; University of Copenhagen	Cirera, S (corresponding author), Univ Copenhagen, Dept Vet Clin & Anim Sci, Anim Genet, Fac Hlth Sci, Frederiksberg, Denmark.	scs@sund.ku.dk	Alkan, Ferhat/U-4058-2019; Mentzel, Caroline/AAX-1577-2021; Cirera, Susanna/K-8540-2017	Alkan, Ferhat/0000-0001-6709-9605; Mentzel, Caroline/0000-0003-4688-7367; Cirera, Susanna/0000-0001-8105-1579; Gorodkin, Jan/0000-0001-5823-4000; Jacobsen, Mette Juul/0000-0001-9264-7554	Danish Independent Research Council [DFF-1335-00127]; Innovation Fund Denmark; Danish Center for Scientific Computing (DCSC, DeIC); SHARE foundation; Danielsen's Foundation	Danish Independent Research Council(Det Frie Forskningsrad (DFF)); Innovation Fund Denmark; Danish Center for Scientific Computing (DCSC, DeIC); SHARE foundation; Danielsen's Foundation	The project was funded by the Danish Independent Research Council (DFF-1335-00127), Innovation Fund Denmark, Danish Center for Scientific Computing (DCSC, DeIC). The lean minipigs were funded by the SHARE foundation and Danielsen's Foundation. The obese minipigs were donated by Novo Nordisk A/S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Anty R, 2006, AM J GASTROENTEROL, V101, P1824, DOI 10.1111/j.1572-0241.2006.00724.x; Auguet T, 2013, EXP CLIN ENDOCR DIAB, V121, P119, DOI 10.1055/s-0032-1331696; Balcells I, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-70; Bezaire V, 2005, FASEB J, V19, P977, DOI 10.1096/fj.04-2765fje; Boonen HCM, 2014, PFLUG ARCH EUR J PHY, V466, P2167, DOI 10.1007/s00424-014-1486-2; Busk PK, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-29; Celikbilek M, 2014, WORLD J HEPATOL, V6, P613, DOI 10.4254/wjh.v6.i8.613; Chartoumpekis DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034872; Chou CH, 2016, NUCLEIC ACIDS RES, V44, pD239, DOI 10.1093/nar/gkv1258; Cirera S, 2014, ANIM GENET, V45, P59, DOI 10.1111/age.12082; Cirera S, 2014, METHODS MOL BIOL, V1182, P73, DOI 10.1007/978-1-4939-1062-5_7; Diawara MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091375; Enright AJ, 2004, GENOME BIOL, V5; Ersen BOC, 2007, COMPARATIVE MED, V57, P493; Feldstein AE, 2003, GASTROENTEROLOGY, V125, P437, DOI 10.1016/S0016-5085(03)00907-7; Felipe F, 2003, INT J OBESITY, V27, P60, DOI 10.1038/sj.ijo.0802188; Fu T, 2012, P NATL ACAD SCI USA, V109, P16137, DOI 10.1073/pnas.1205951109; Goossens GH, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00055; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Guess MG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118229; Heneghan HM, 2011, J CLIN ENDOCR METAB, V96, pE846, DOI 10.1210/jc.2010-2701; Herrera BM, 2010, DIABETOLOGIA, V53, P1099, DOI 10.1007/s00125-010-1667-2; Hong F, 2009, HEPATOLOGY, V49, P2055, DOI 10.1002/hep.22890; Huynh FK, 2013, HEPATOLOGY, V57, P543, DOI 10.1002/hep.26043; Jacobsen MJ, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/8539057; Johansen T, 2001, COMPARATIVE MED, V51, P150; Jones BH, 1996, AM J PHYSIOL-ENDOC M, V271, pE44, DOI 10.1152/ajpendo.1996.271.1.E44; Kawanishi N, 2010, EXERC IMMUNOL REV, V16, P105; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kong L, 2011, ACTA DIABETOL, V48, P61, DOI 10.1007/s00592-010-0226-0; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Lee B, 2014, AM J PHYSIOL-ENDOC M, V306, pE1144, DOI 10.1152/ajpendo.00002.2014; Li JH, 2014, NUCLEIC ACIDS RES, V42, pD92, DOI 10.1093/nar/gkt1248; Li YJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0080475, 10.1371/journal.pone.0070390]; Liu YM, 2004, J CLIN ENDOCR METAB, V89, P2684, DOI 10.1210/jc.2003-031978; Lu J, 2014, CARCINOGENESIS, V35, P554, DOI 10.1093/carcin/bgt354; Madeira MS, 2013, BRIT J NUTR, V110, P216, DOI 10.1017/S0007114512004916; Matsuzaka T, 2007, NAT MED, V13, P1193, DOI 10.1038/nm1662; Matsuzaka T, 2012, HEPATOLOGY, V56, P2199, DOI 10.1002/hep.25932; Mentzel Caroline M J, 2014, Microrna, V3, P174; Mentzel CMJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131650; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Mika A, 2015, EUR J LIPID SCI TECH, V117, P926, DOI 10.1002/ejlt.201400372; Musa CV, 2012, INT J OBESITY, V36, P207, DOI 10.1038/ijo.2011.81; Oliver P, 2012, INT J OBESITY, V36, P225, DOI 10.1038/ijo.2011.92; Padilla J, 2013, PHYSIOL GENOMICS, V45, P434, DOI 10.1152/physiolgenomics.00038.2013; Pant SD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137356; Park HS, 2005, DIABETES RES CLIN PR, V69, P29, DOI 10.1016/j.diabres.2004.11.007; Rennie W, 2014, NUCLEIC ACIDS RES, V42, pW114, DOI 10.1093/nar/gku376; Rodgaard T, 2014, ANIM GENET, V45, P67, DOI 10.1111/age.12090; Sainz N, 2015, METABOLISM, V64, P35, DOI 10.1016/j.metabol.2014.10.015; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Spurlock ME, 2008, J NUTR, V138, P397, DOI 10.1093/jn/138.2.397; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tomita K, 2008, HEPATOLOGY, V48, P458, DOI 10.1002/hep.22365; Traini M, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.612341; Troseid M, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-11; Trujillo ME, 2004, J CLIN ENDOCR METAB, V89, P5577, DOI 10.1210/jc.2004-0603; Vienberg S, 2016, ACTA PHYSL OXF; Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pD153, DOI 10.1093/nar/gku1215; Wenzel A, 2012, BIOINFORMATICS, V28, P2738, DOI 10.1093/bioinformatics/bts519; World Health Organization,, 2015, OB OV; Xie HM, 2009, DIABETES, V58, P1050, DOI 10.2337/db08-1299; Yao LB, 2014, FASEB J, V28, P4534, DOI 10.1096/fj.14-249797; Yates A, 2015, NUCLEIC ACIDS RES; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zhang J, 2012, J BIOL CHEM, V287, P21093, DOI 10.1074/jbc.M111.330381; Zhu HM, 2015, DIABETOLOGIA, V58, P900, DOI 10.1007/s00125-015-3510-2	70	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167285	10.1371/journal.pone.0167285	http://dx.doi.org/10.1371/journal.pone.0167285			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902747	gold, Green Submitted, Green Published			2022-12-26	WOS:000389474100067
J	Rasool, M; Malik, A; Ashraf, MAB; Parveen, G; Iqbal, S; Ali, I; Qazi, MH; Asif, M; Kamran, K; Iqbal, A; Iram, S; Khan, SU; Mustafa, MZ; Zaheer, A; Shaikh, R; Choudhry, H; Jamal, MS				Rasool, Mahmood; Malik, Arif; Ashraf, Muhammad Abdul Basit; Parveen, Gulshan; Iqbal, Shazia; Ali, Irfan; Qazi, Mahmood Husain; Asif, Muhammad; Kamran, Kashif; Iqbal, Asim; Iram, Saima; Khan, Sami Ullah; Mustafa, Mohammad Zahid; Zaheer, Ahmad; Shaikh, Rozeena; Choudhry, Hani; Jamal, Mohammad Sarwar			Evaluation of Matrix Metalloproteinases, Cytokines and Their Potential Role in the Development of Ovarian Cancer	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; LIPID-PEROXIDATION; VITAMIN-E; PROGNOSTIC-SIGNIFICANCE; ANTIOXIDANT STATUS; CAROTENOIDS; PROGRESSION; DISEASE; ADENOCARCINOMA; INTERLEUKIN-1	Background Ovarian cancer is the 5(th) most common cause of deaths in the women among gynecological tumors. There are many growing evidences that stress and other behavioral factors may affect cancer progression and patient survival. The purpose of this study is to determine the key role of matrix metalloproteinases (MMPs), and cytokines in the aggregation and progression of ovarian cancer. Methodology Stress variables (MDA, AGEs, AOPPs, NO), profile of antioxidants (SOD, Catalase, Vitamin E & A, GSH, GRx, GPx) and inflammatory biomarkers (MMP-9, MMP-2, MMP-11, IL-1 alpha and TNF-alpha) were biochemically assessed from venous blood of fifty ovarian cancer patients and twenty healthy control subjects. The results of all parameters were analyzed statistically by independent sample t-test. Results The results of the study demonstrated that the levels of stress variables like MDA (3.38 +/- 1.12nmol/ml), AGEs (2.72 +/- 0.22 ng/ml), AOPPs (128.48 +/- 27.23 ng/ml) and NO (58.71 +/- 8.67 ng/ml) were increased in the patients of ovarian cancer as compared to control individuals whereas the profile of antioxidants like SOD, Catalase, Vitamin E, Vitamin A, GSH andGRx were decreased in ovarian cancer patients (0.11 +/- 0.08 mu mol/mol, 2.41 +/- 1.01 mu mol/mol of protein, 0.22 +/- 0.04 mu g/ml, 45.84 +/- 9.07 mu g/ml, 4.88 +/- 1.18 mu g/ml, 5.33 +/- 1.26 mu mol/ml respectively). But the level of GPx antioxidant was increased in ovarian cancer patients (6.58 +/- 0.21 mu mol/ml). Moreover the levels of MMP-9 (64.87 +/- 5.35 ng/ml), MMP-2 (75.87 +/- 18.82 ng/ml) and MMP-11 (63.58 +/- 8.48 ng/ml) were elevated in the patients. Similarly, the levels of various cytokines TNF-alpha and IL-1 alpha were also increased in the patients of ovarian cancer (32.17 +/- 3.52 pg/mI and 7.04 +/- 0.85 pg/mI respectively). Conclusion MMPs are commonly expressed in ovarian cancer which are potential extrapolative biomarkers and have a major role in metastasis. Due to oxidative stress, different cytokines are released by tumor associated macrophages (TAMS) that result in the cancer progression. Consequently, tissue inhibitors of matrix metalloproteinases (TIMPs) are the valuable therapeutic approaches to complement conservative anticancer strategies.	[Rasool, Mahmood] King Abdulaziz Univ, CEGMR, Jeddah, Saudi Arabia; [Malik, Arif; Ashraf, Muhammad Abdul Basit; Parveen, Gulshan; Iqbal, Shazia] Univ Lahore, Inst Mol Biol & Biotechnol IMBB, Lahore, Pakistan; [Ali, Irfan] Akhuwat Faisalabad Inst Res Sci & Technol, Faisalabad, Pakistan; [Qazi, Mahmood Husain] Univ Lahore, CRIMM, Lahore, Pakistan; [Asif, Muhammad; Shaikh, Rozeena] BUITEMS, Dept Biotechnol, Quetta, Pakistan; [Kamran, Kashif; Iqbal, Asim] Univ Balochistan, Fac Life Sci, Quetta, Pakistan; [Iram, Saima] Bolan Med Hosp, Quetta, Pakistan; [Khan, Sami Ullah] Women Univ Azad Jammu & Kashmir, Dept Bot, Bagh, Pakistan; [Mustafa, Mohammad Zahid] Univ Balochistan, CASVAB, Quetta, Pakistan; [Zaheer, Ahmad] Natl Inst Biotechnol & Genet Engn, Faisalabad, Pakistan; [Choudhry, Hani] King Abdulaziz Univ, Dept Biochem, Ctr Innovat Personalized Med, Fac Sci,King Fahd Ctr Med Res, Jeddah, Saudi Arabia; [Jamal, Mohammad Sarwar] King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah, Saudi Arabia	King Abdulaziz University; University of Lahore; University of Lahore; Balochistan University of Information Technology, Engineering & Management Sciences BUITEMS; University of Balochistan; University of Balochistan; Pakistan Institute of Engineering & Applied Science; King Abdulaziz University; King Abdulaziz University	Jamal, MS (corresponding author), King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah, Saudi Arabia.	sarwar4u@gmail.com	Iqbal, Shazia/AAH-2282-2020; Rasool, Mahmood/H-9475-2012; Asif, Muhammad/AAF-3615-2020; Zaheer, Ahmad/H-4182-2013; Jamal, Mohammad Sarwar/K-3842-2013; Malik, Arif/A-5218-2016; Iqbal, Shazia/AAE-7042-2019	Iqbal, Shazia/0000-0003-4890-5864; Rasool, Mahmood/0000-0003-2997-5891; Asif, Muhammad/0000-0003-4761-837X; Zaheer, Ahmad/0000-0001-5131-3240; Malik, Arif/0000-0002-1894-6772; Choudhry, Hani/0000-0003-0401-6619	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah; DSR	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah; DSR	We are thankful to all participants of this study. This article was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah. The authors, therefore, acknowledge with thanks DSR technical and financial support.	Abdalla M. Y., 2011, Jordan Journal of Biological Sciences (JJBS), V4, P119; Abei H, 1974, METHODS ENZYMATIC AN; Agnani D, 2011, J OVARIAN RES, V4, DOI 10.1186/1757-2215-4-18; Bhurgri Y, 2000, INT J CANCER, V85, P325, DOI 10.1002/(SICI)1097-0215(20000201)85:3&lt;325::AID-IJC5&gt;3.0.CO;2-J; Borish Larry C., 2003, Journal of Allergy and Clinical Immunology, V111, pS460; Cannistra SA, 2004, NEW ENGL J MED, V351, P2519, DOI 10.1056/NEJMra041842; Cathcart J, 2015, GENES DIS, V2, P26, DOI 10.1016/j.gendis.2014.12.002; Colvin EK, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00137; Cramer DW, 2001, INT J CANCER, V94, P128, DOI 10.1002/ijc.1435; DINARELLO CA, 1993, NEW ENGL J MED, V328, P106; Fukumura D, 2006, NAT REV CANCER, V6, P521, DOI 10.1038/nrc1910; Goldberg DM., 1983, METHODS ENZYM ANAL, V3, P258, DOI DOI 10.1016/B978-0-12-091302-2.X5001-4; Heijst J. W., 2005, ANN NY ACAD SCI, V1043, P725; HEINONEN PK, 1987, ARCH GYNECOL OBSTET, V241, P151, DOI 10.1007/BF00931311; Herrera E, 2001, J PHYSIOL BIOCHEM, V57, P43, DOI 10.1007/BF03179812; Holschneider CH, 2000, OVARIAN CANC EPIDEMI; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; KAKKAR P, 1984, INDIAN J BIOCHEM BIO, V21, P130; Kalousova M, 2002, PHYSIOL RES, V51, P597; Kenny HA, 2008, J CLIN INVEST, V118, P1367, DOI 10.1172/JCI33775; Kenny HA, 2007, INT J CANCER, V121, P1463, DOI 10.1002/ijc.22874; KIKUGAWA K, 1984, ARCH BIOCHEM BIOPHYS, V229, P7, DOI 10.1016/0003-9861(84)90124-3; Korde S, 2012, ORAL ONCOL, V48, P475, DOI 10.1016/j.oraloncology.2012.01.003; Kumaraguruparan R, 2002, CLIN BIOCHEM, V35, P275, DOI 10.1016/S0009-9120(02)00310-7; Manju V, 2002, CLIN BIOCHEM, V35, P621, DOI 10.1016/S0009-9120(02)00376-4; MORON MS, 1979, BIOCHIM BIOPHYS ACTA, V582, P67, DOI 10.1016/0304-4165(79)90289-7; MOSHAGE H, 1995, CLIN CHEM, V41, P892; Nayak SB, 2004, INDIAN J PHYSL PHARM, V48; NAYLOR MS, 1993, J CLIN INVEST, V91, P2194, DOI 10.1172/JCI116446; Noel AC, 1996, J CLIN INVEST, V97, P1924, DOI 10.1172/JCI118624; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Parveen S, 1999, SPECIALIST KARACHI, V16, P209; Peng HL, 2013, J BUON, V18, P202; Piwowar A., 2013, POSTEPY HIGIENY MEDY, V68, P179; POLLARD JW, 1991, CURR OPIN IMMUNOL, V3, P772, DOI 10.1016/0952-7915(91)90112-E; Rashid MU, 2006, INT J CANCER, V119, P2832, DOI 10.1002/ijc.22269; ROSENBERG HR, 1959, ARCH BIOCHEM BIOPHYS, V80, P86, DOI 10.1016/0003-9861(59)90345-5; Rutkowski M, 2007, ACTA SCI POLON-TECHN, V6, P17; Schweigert FJ, 2004, ANN NUTR METAB, V48, P241, DOI 10.1159/000080457; Skrzydlewska E, 2001, J TOXICOL ENV HEAL A, V64, P213, DOI 10.1080/15287390152543690; Srinivasan D, 2008, FENNEEMALS FOOD CHEM; Torng PL, 2004, GYNECOL ONCOL, V92, P559, DOI 10.1016/j.ygyno.2003.11.011; TRACEY KJ, 1993, ANNU REV CELL BIOL, V9, P317, DOI 10.1146/annurev.cb.09.110193.001533; Tung KH, 2005, CANCER EPIDEM BIOMAR, V14, P669, DOI 10.1158/1055-9965.EPI-04-0550; Zeisler H, 1998, EUR J CANCER, V34, P931	45	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167149	10.1371/journal.pone.0167149	http://dx.doi.org/10.1371/journal.pone.0167149			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902750	gold, Green Submitted, Green Published			2022-12-26	WOS:000389474100057
J	Soyama, H; Miyamoto, M; Ishibashi, H; Takano, M; Sasa, H; Furuya, K				Soyama, Hiroaki; Miyamoto, Morikazu; Ishibashi, Hiroki; Takano, Masashi; Sasa, Hidenori; Furuya, Kenichi			Relation between Birth Weight and Intraoperative Hemorrhage during Cesarean Section in Pregnancy with Placenta Previa	PLOS ONE			English	Article							FETAL-GROWTH RESTRICTION; TRANSVAGINAL ULTRASONOGRAPHY; MASSIVE HEMORRHAGE; PRETERM DELIVERY; RISK; ACCRETA	Background Placenta previa, one of the most severe obstetric complications, carries an increased risk of intraoperative massive hemorrhage. Several risk factors for intraoperative hemorrhage have been identified to date. However, the correlation between birth weight and intraoperative hemorrhage has not been investigated. Here we estimate the correlation between birth weight and the occurrence of intraoperative massive hemorrhage in placenta previa. Materials and Methods We included all 256 singleton pregnancies delivered via cesarean section at our hospital because of placenta previa between 2003 and 2015. We calculated not only measured birth weights but also standard deviation values according to the Japanese standard growth curve to adjust for differences in gestational age. We assessed the correlation between birth weight and the occurrence of intraoperative massive hemorrhage (>1500 mL blood loss). Receiver operating characteristic curves were constructed to determine the cutoff value of intraoperative massive hemorrhage. Results Of 256 pregnant women with placenta previa, 96 (38%) developed intraoperative massive hemorrhage. Receiver-operating characteristic curves revealed that the area under the curve of the combination variables between the standard deviation of birth weight and intraoperative massive hemorrhage was 0.71. The cutoff value with a sensitivity of 81.3% and specificity of 55.6% was -0.33 standard deviation. The multivariate analysis revealed that a standard deviation of >-0.33 (odds ratio, 5.88; 95% confidence interval, 3.04-12.00), need for hemostatic procedures (odds ratio, 3.31; 95% confidence interval, 1.79-6.25), and placental adhesion (odds ratio, 12.68; 95% confidence interval, 2.85-92.13) were independent risk of intraoperative massive hemorrhage. Conclusion In patients with placenta previa, a birth weight >-0.33 standard deviation was a significant risk indicator of massive hemorrhage during cesarean section. Based on this result, further studies are required to investigate whether fetal weight estimated by ultrasonography can predict hemorrhage during cesarean section in patients with placental previa.	[Soyama, Hiroaki; Miyamoto, Morikazu; Ishibashi, Hiroki; Takano, Masashi; Sasa, Hidenori; Furuya, Kenichi] Natl Def Med Coll, Dept Obstet & Gynecol, Tokorozawa, Saitama, Japan	National Defense Medical College - Japan	Soyama, H (corresponding author), Natl Def Med Coll, Dept Obstet & Gynecol, Tokorozawa, Saitama, Japan.	h.soyama55@gmail.com						Ananth CV, 2003, AM J OBSTET GYNECOL, V188, P1299, DOI 10.1067/mob.2003.76; Ananth CV, 2001, OBSTET GYNECOL, V98, P299, DOI 10.1016/S0029-7844(01)01413-2; Baba Y, 2014, J OBSTET GYNAECOL RE, V40, P1243, DOI 10.1111/jog.12340; Cali G, 2013, ULTRASOUND OBST GYN, V41, P406, DOI 10.1002/uog.12385; Cresswell JA, 2013, TROP MED INT HEALTH, V18, P712, DOI 10.1111/tmi.12100; Ghourab S, 2001, ULTRASOUND OBST GYN, V18, P103, DOI 10.1046/j.1469-0705.2001.00420.x; Gregory KD, 1998, OBSTET GYNECOL, V92, P507, DOI 10.1016/S0029-7844(98)00224-5; Harper LM, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.05.014; Hasegawa J, 2009, ULTRASOUND OBST GYN, V34, P80, DOI 10.1002/uog.6426; Hwu YM, 2005, BJOG-INT J OBSTET GY, V112, P1420, DOI 10.1111/j.1471-0528.2005.00666.x; Jang Dong Gyu, 2011, Int J Med Sci, V8, P439; Minakami H, 2014, J OBSTET GYNAECOL RE, V40, P1469, DOI 10.1111/jog.12419; Oyelese Y, 2006, OBSTET GYNECOL, V107, P927, DOI 10.1097/01.AOG.0000207559.15715.98; Raisanen S, 2014, OBSTET GYNECOL, V124, P285, DOI 10.1097/AOG.0000000000000368; Reynolds LP, 2005, PLACENTA, V26, P689, DOI 10.1016/j.placenta.2004.11.010; Sekiguchi A, 2013, INT J MED SCI, V10, P1683, DOI 10.7150/ijms.6416; Shinozuka N., 2002, ULTRASOUND REV OBSTE, V2, P156, DOI DOI 10.3109/14722240208500478; Smith RS, 1997, ULTRASOUND OBST GYN, V9, P22, DOI 10.1046/j.1469-0705.1997.09010022.x; Stafford IA, 2010, OBSTET GYNECOL, V116, P595, DOI 10.1097/AOG.0b013e3181ea2deb; Tuzovic L, 2006, INT J GYNECOL OBSTET, V93, P110, DOI 10.1016/j.ijgo.2006.02.006; Vergani P, 2007, OBSTET GYNECOL, V109, P410, DOI 10.1097/01.AOG.0000250470.78700.f0; Walfish M, 2009, BR J ANAESTH S1, V103, pi47, DOI [DOI 10.1093/BJA/AEP303, DOI 10.1093/bja/aep303]; Yeniel AO, 2012, ARCH GYNECOL OBSTET, V286, P295, DOI 10.1007/s00404-012-2296-4; Zaitoun MM, 2011, ARCH GYNECOL OBSTET, V284, P867, DOI 10.1007/s00404-010-1737-1; Zhang S, 2015, NUTRIENTS, V7, P360, DOI 10.3390/nu7010360	25	3	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167332	10.1371/journal.pone.0167332	http://dx.doi.org/10.1371/journal.pone.0167332			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902772	Green Published, Green Submitted, gold			2022-12-26	WOS:000389474100073
J	van Kooten, GC; Duan, J; Lynch, R				van Kooten, G. Cornelis; Duan, Jun; Lynch, Rachel			Is There a Future for Nuclear Power? Wind and Emission Reduction Targets in Fossil-Fuel Alberta	PLOS ONE			English	Article								This paper explores the viability of relying on wind power to replace upwards of 60% of electricity generation in Alberta that would be lost if coal-fired generation is phased out. Using hourly wind data from 17 locations across Alberta, we are able to simulate the potential wind power output available to the Alberta grid when modern, 3.5 MW-capacity wind turbines are spread across the province. Using wind regimes for the years 2006 through 2015, we find that available wind power is less than 60% of installed capacity 98% of the time, and below 30% of capacity 74% of the time. There is only a small amount of correlation between wind speeds at different locations, but yet it remains necessary to rely on fossil fuel generation. Then, based on the results from a grid allocation model, we find that CO2 emissions can be reduced by about 30%, but only through a combination of investment in wind energy and reliance on purchases of hydropower from British Columbia. Only if nuclear energy is permitted into the generation mix would Alberta be able to meet its CO2-emissions reduction target in the electricity sector. With nuclear power, emissions can be reduced by upwards of 85%.	[van Kooten, G. Cornelis; Duan, Jun; Lynch, Rachel] Univ Victoria, Dept Econ, Victoria, BC, Canada	University of Victoria	van Kooten, GC (corresponding author), Univ Victoria, Dept Econ, Victoria, BC, Canada.	kooten@uvic.ca	van Kooten, G. Cornelis/AAS-4867-2020		Natural Sciences and Engineering Research Council of Canada [RGPIN-2015-03959]; NSERC (Canada) [RGPIN 2015-03959]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NSERC (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Natural Sciences and Engineering Research Council of Canada. Grant #RGPIN-2015-03959. http://www. nserc-crsng.gc.ca/index_eng.asp to GCvK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Subject to the usual qualifier, the authors would like to thank the Journal reviewers for helpful comments and suggestions. Funding for the research reported here was provided by NSERC (Canada) Discovery Grant RGPIN 2015-03959.	BP, 2021, UPD METH CONV NONF E; Government of Alberta, 2016, SUMM ALB NEW POL RES; Lovering JR, 2016, ENERG POLICY, V91, P371, DOI 10.1016/j.enpol.2016.01.011; Monahan K, 2010, ENV EC, V1, P92; Nordhaus W, 2014, J ASSOC ENVIRON RESO, V1, P273, DOI 10.1086/676035; Taylor G.S., 2015, LEVELIZED COST ELECT; Tol R.S.J., 2014, CLIMATE EC EC ANAL C; U.S. ENERGY INFO. ADMIN, 2021, LEV COSTS NEW GEN RE, P4; van Kooten GC, 2013, AM J AGR ECON, V95, P505, DOI 10.1093/ajae/aas094; van Kooten GC, 2016, ANN REV RESOURCE EC, V8; van Kooten GC, 2016, P CAN SOC MECH ENG I	11	7	7	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0165822	10.1371/journal.pone.0165822	http://dx.doi.org/10.1371/journal.pone.0165822			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902712	Green Published, gold, Green Submitted			2022-12-26	WOS:000389474100008
J	Cirkovic, I; Bozic, DD; Draganic, V; Lozo, J; Beric, T; Kojic, M; Arsic, B; Garalejic, E; Djukic, S; Stankovic, S				Cirkovic, Ivana; Bozic, Dragana D.; Draganic, Veselin; Lozo, Jelena; Beric, Tanja; Kojic, Milan; Arsic, Biljana; Garalejic, Eliana; Djukic, Slobodanka; Stankovic, Slavisa			Licheniocin 50.2 and Bacteriocins from Lactococcus lactis subsp lactis biovar. diacetylactis BGBU1-4 Inhibit Biofilms of Coagulase Negative Staphylococci and Listeria monocytogenes Clinical Isolates	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; MECHANISMS; PEPTIDES; SURVIVAL; IMMUNITY	Background Coagulase negative staphylococci (CoNS) and Listeria monocytogenes have important roles in pathogenesis of various genital tract infections and fatal foetomaternal infections, respectively. The aim of our study was to investigate the inhibitory effects of two novel bacteriocins on biofilms of CoNS and L. monocytogenes genital isolates. Methods The effects of licheniocin 50.2 from Bacillus licheniformis VPS50.2 and crude extract of bacteriocins produced by Lactococcus lactis subsp. lactis biovar. diacetylactis BGBU1-4 (BGBU1-4 crude extract) were evaluated on biofilm formation and formed biofilms of eight CoNS (four S. epidermidis, two S. hominis, one S. lugdunensis and one S. haemolyticus) and 12 L. monocytogenes genital isolates. Results Licheniocin 50.2 and BGBU1-4 crude extract inhibited the growth of both CoNS and L. monocytogenes isolates, with MIC values in the range between 200-400 AU/ml for licheniocin 50.2 and 400-3200 AU/ml for BGBU1-4 crude extract. Subinhibitory concentrations (1/2 x and 1/4 x MIC) of licheniocin 50.2 inhibited biofilm formation by all CoNS isolates (p < 0.05, respectively), while BGBU1-4 crude extract inhibited biofilm formation by all L. monocytogenes isolates (p < 0.01 and p < 0.05, respectively). Both bacteriocins in concentrations of 100 AU/mL and 200 AU/mL reduced the amount of 24 h old CoNS and L. monocytogenes biofilms (p < 0.05, p < 0.01, p < 0.001). Conclusions This study suggests that novel bacteriocins have potential to be used for genital application, to prevent biofilm formation and/or to eradicate formed biofilms, and consequently reduce genital and neonatal infections by CoNS and L. monocytogenes.	[Cirkovic, Ivana; Djukic, Slobodanka] Univ Belgrade, Inst Microbiol & Immunol, Fac Med, Belgrade, Serbia; [Bozic, Dragana D.] Univ Belgrade, Dept Microbiol & Immunol, Fac Pharm, Belgrade, Serbia; [Draganic, Veselin; Arsic, Biljana; Garalejic, Eliana] Univ Belgrade, Fac Med, Clin Gynecol & Obstet Narodni Front, Belgrade, Serbia; [Lozo, Jelena; Beric, Tanja; Stankovic, Slavisa] Univ Belgrade, Fac Biol, Belgrade, Serbia; [Kojic, Milan] Univ Belgrade, Inst Mol Genet & Genet Engn, Belgrade, Serbia	University of Belgrade; University of Belgrade; University of Belgrade; University of Belgrade; University of Belgrade	Cirkovic, I (corresponding author), Univ Belgrade, Inst Microbiol & Immunol, Fac Med, Belgrade, Serbia.	cirkoviciv@yahoo.com	Lozo, Jelena/R-7354-2018; Beric, Tanja/GLR-4901-2022; Stanković, Slaviša/S-6273-2018; Kojic, Milan/I-4528-2019	Lozo, Jelena/0000-0001-9888-5270; Stanković, Slaviša/0000-0003-0527-8741; Kojic, Milan/0000-0001-5645-750X; Bozic, Dragana/0000-0002-5373-5540; Beric, Tanja/0000-0002-4860-2225; Cirkovic, Ivana/0000-0003-1515-1824	Ministry of Education, Science and Technological Development of Serbia [175039, 173026]	Ministry of Education, Science and Technological Development of Serbia(Ministry of Education, Science & Technological Development, Serbia)	This work was supported by the Ministry of Education, Science and Technological Development of Serbia, Grants No. 175039 and 173026, http://www.mpn.gov.rs/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldunate M, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00164; Amer EI, 2014, EXP PARASITOL, V146, P52, DOI 10.1016/j.exppara.2014.09.005; Balaji K, 2013, INDIAN J MED RES, V137, P963; Beric T, 2014, J APPL MICROBIOL, V116, P502, DOI 10.1111/jam.12393; Borges S, 2013, J APPL MICROBIOL, V115, P527, DOI 10.1111/jam.12232; Borges SF, 2011, FEMS IMMUNOL MED MIC, V62, P315, DOI 10.1111/j.1574-695X.2011.00815.x; Bozic DD, 2014, BRAZ J MICROBIOL, V45, P263, DOI 10.1590/S1517-83822014000100038; Clinical and Laboratory Standards Institute (CLSI), 2007, CLSI DOCUMENT M100 S; Cotter PD, 2014, MOL MICROBIOL, V92, P1159, DOI 10.1111/mmi.12645; Cotter PD, 2013, NAT REV MICROBIOL, V11, P95, DOI 10.1038/nrmicro2937; Cotter PD, 2005, NAT REV MICROBIOL, V3, P777, DOI 10.1038/nrmicro1273; Diep DB, 2007, P NATL ACAD SCI USA, V104, P2384, DOI 10.1073/pnas.0608775104; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Fan AP, 2013, ARCH GYNECOL OBSTET, V287, P329, DOI 10.1007/s00404-012-2571-4; Fraczek M, 2012, ANDROLOGIA, V44, P315, DOI 10.1111/j.1439-0272.2012.01283.x; GAJIC O, 1999, ARCH BIOL SCI, V51, P69; Hassan M, 2012, J APPL MICROBIOL, V113, P723, DOI 10.1111/j.1365-2672.2012.05338.x; Ivanov Yuri Boris, 2007, Journal of Microbiology Immunology and Infection, V40, P157; KOJIC M, 1991, APPL ENVIRON MICROB, V57, P1753, DOI 10.1128/AEM.57.6.1753-1757.1991; Lawton EM, 2007, MINI-REV MED CHEM, V7, P1236, DOI 10.2174/138955707782795638; Leong D, 2014, FRONT MICROBIOL, V5, DOI [10.3389/fmicb.2014.00683, 10.3389/fmicb.2014.00436, 10.3389/fmicb.2014.00241]; Nishie M, 2012, BIOCONTROL SCI, V17, P1; Piper Clare, 2009, Curr Drug Discov Technol, V6, P1; Robichon D, 1997, J BACTERIOL, V179, P7591, DOI 10.1128/jb.179.23.7591-7594.1997; Ruiz FO, 2015, PATHOG DIS, V73, DOI 10.1093/femspd/ftv013; Saising J, 2012, ANTIMICROB AGENTS CH, V56, P5804, DOI 10.1128/AAC.01296-12; Stepanovic S., 2007, Acta Microbiologica et Immunologica Hungarica, V54, P195, DOI 10.1556/AMicr.54.2007.2.9; Stepanovic S, 2007, APMIS, V115, P891, DOI 10.1111/j.1600-0463.2007.apm_630.x; Stewart PS, 2002, INT J MED MICROBIOL, V292, P107, DOI 10.1078/1438-4221-00196; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Tansarli GS, 2013, EUR J CLIN MICROBIOL, V32, P977, DOI 10.1007/s10096-013-1846-4; van Reenen CA, 1998, J APPL MICROBIOL, V84, P1131	32	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167995	10.1371/journal.pone.0167995	http://dx.doi.org/10.1371/journal.pone.0167995			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930711	Green Published, Green Submitted, gold			2022-12-26	WOS:000389580900068
J	Chang, TH; Chen, MC; Chang, JP; Huang, HD; Ho, WC; Lin, YS; Pan, KL; Huang, YK; Liu, WH; Wu, CC				Chang, Tzu-Hao; Chen, Mien-Cheng; Chang, Jen-Ping; Huang, Hsien-Da; Ho, Wan-Chun; Lin, Yu-Sheng; Pan, Kuo-Li; Huang, Yao-Kuang; Liu, Wen-Hao; Wu, Chia-Chen			Exploring Regulatory Mechanisms of Atrial Myocyte Hypertrophy of Mitral Regurgitation through Gene Expression Profiling Analysis: Role of NFAT in Cardiac Hypertrophy	PLOS ONE			English	Article							FIBRILLATION	Background Left atrial enlargement in mitral regurgitation (MR) predicts a poor prognosis. The regulatory mechanisms of atrial myocyte hypertrophy of MR patients remain unknown. Methods and Results This study comprised 14 patients with MR, 7 patients with aortic valve disease (AVD), and 6 purchased samples from normal subjects (NC). We used microarrays, enrichment analysis and quantitative RT-PCR to study the gene expression profiles in the left atria. Microarray results showed that 112 genes were differentially up-regulated and 132 genes were differentially down-regulated in the left atria between MR patients and NC. Enrichment analysis of differentially expressed genes demonstrated that "NFAT in cardiac hypertrophy" pathway was not only one of the significant associated canonical pathways, but also the only one predicted with a non-zero score of 1.34 (i.e. activated) through Ingenuity Pathway Analysis molecule activity predictor. Ingenuity Pathway Analysis Global Molecular Network analysis exhibited that the highest score network also showed high association with cardiac related pathways and functions. Therefore, 5 NFAT associated genes (PPP3R1, PPP3CB, CAMK1, MEF2C, PLCE1) were studies for validation. The mRNA expressions of PPP3CB and MEF2C were significantly up-regulated, and CAMK1 and PPP3R1 were significantly down-regulated in MR patients compared to NC. Moreover, MR patients had significantly increased mRNA levels of PPP3CB, MEF2C and PLCE1 compared to AVD patients. The atrial myocyte size of MR patients significantly exceeded that of the AVD patients and NC. Conclusions Differentially expressed genes in the "NFAT in cardiac hypertrophy" pathway may play a critical role in the atrial myocyte hypertrophy of MR patients.	[Chang, Tzu-Hao] Taipei Med Univ, Grad Inst Biomed Informat, Taipei, Taiwan; [Chen, Mien-Cheng; Ho, Wan-Chun; Liu, Wen-Hao] Chang Gung Univ, Coll Med, Div Cardiol, Kaohsiung Chang Gung Mem Hosp, Kaohsiung, Taiwan; [Chen, Mien-Cheng; Ho, Wan-Chun; Liu, Wen-Hao] Chang Gung Univ, Coll Med, Dept Internal Med, Kaohsiung Chang Gung Mem Hosp, Kaohsiung, Taiwan; [Chang, Jen-Ping; Wu, Chia-Chen] Chang Gung Univ, Coll Med, Div Cardiovasc Surg, Kaohsiung Chang Gung Mem Hosp, Kaohsiung, Taiwan; [Huang, Hsien-Da] Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan; [Lin, Yu-Sheng; Pan, Kuo-Li] Chang Gung Mem Hosp, Div Cardiol, Chiayi, Taiwan; [Huang, Yao-Kuang] Chang Gung Mem Hosp, Dept Thorac & Cardiovasc Surg, Chiayi, Taiwan	Taipei Medical University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; National Yang Ming Chiao Tung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Chen, MC (corresponding author), Chang Gung Univ, Coll Med, Div Cardiol, Kaohsiung Chang Gung Mem Hosp, Kaohsiung, Taiwan.; Chen, MC (corresponding author), Chang Gung Univ, Coll Med, Dept Internal Med, Kaohsiung Chang Gung Mem Hosp, Kaohsiung, Taiwan.	chenmien@ms76.hinet.net	Huang, Hsien-Da/AAA-7376-2019; Huang, Yao-Kuang/AAK-5137-2021	Huang, Yao-Kuang/0000-0003-2699-2207	National Science Council; Chang Gung Memorial Hospital, Taiwan [NSC 101-2314-B-182A-096, NSC 102-2314-B-182A-107-MY2, CM RPG8A0571]	National Science Council(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital, Taiwan(Chang Gung Memorial Hospital)	This work was supported by grants from the National Science Council, and the Chang Gung Memorial Hospital, Taiwan (grant number NSC 101-2314-B-182A-096, NSC 102-2314-B-182A-107-MY2, CM RPG8A0571). MCC received all the fundings. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akazawa H, 2003, CIRC RES, V92, P1079, DOI 10.1161/01.RES.0000072977.86706.23; Bueno OF, 2002, P NATL ACAD SCI USA, V99, P4586, DOI 10.1073/pnas.072647999; Chang JP, 2011, INT J CARDIOL, V146, P44, DOI 10.1016/j.ijcard.2009.06.012; Chen HC, 2015, BMC CARDIOVASC DISOR, V15, DOI 10.1186/s12872-015-0038-9; Chen MC, 2015, TRANSL RES, V165, P599, DOI 10.1016/j.trsl.2014.11.005; Corradi D, 2012, J CARDIOVASC ELECTR, V23, P271, DOI 10.1111/j.1540-8167.2011.02187.x; di Gioia CRT, 2000, BIOCHEM BIOPH RES CO, V279, P965, DOI 10.1006/bbrc.2000.4049; Gentleman R, GENEFILTER GENEFILTE; Iung B, 2002, EUR HEART J, V23, P1253, DOI 10.1053/euhj.2002.3320; Kang M, 2007, PHYSIOLOGY, V22, P174, DOI 10.1152/physiol.00051.2006; Kolodziejczyk SM, 1999, CURR BIOL, V9, P1203, DOI 10.1016/S0960-9822(00)80027-5; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Martins PAD, 2012, CARDIOVASC RES, V93, P563, DOI 10.1093/cvr/cvs013; McWhinnie R, 2007, AM J PHYSIOL-LUNG C, V292, pL278, DOI 10.1152/ajplung.00111.2006; Otto CM, 2003, HEART, V89, P100, DOI 10.1136/heart.89.1.100; SANFILIPPO AJ, 1990, CIRCULATION, V82, P792, DOI 10.1161/01.CIR.82.3.792; Sun LL, 2013, MOL CELL BIOCHEM, V377, P151, DOI 10.1007/s11010-013-1581-2; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Rooij E, 2004, CIRC RES, V94, pE18, DOI 10.1161/01.RES.0000118597.54416.00; Wilkins BJ, 2004, CIRC RES, V94, P110, DOI 10.1161/01.RES.0000109415.17511.18; Zhang CL, 2002, MOL CELL BIOL, V22, P7302, DOI 10.1128/MCB.22.20.7302-7312.2002; Zhang LH, 2013, CELL, V153, P216, DOI 10.1016/j.cell.2013.02.047	22	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166791	10.1371/journal.pone.0166791	http://dx.doi.org/10.1371/journal.pone.0166791			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907007	gold, Green Submitted, Green Published			2022-12-26	WOS:000389482700040
J	Hsieh, YP; Chang, CC; Kor, CT; Yang, Y; Wen, YK; Chiu, PF				Hsieh, Yao-Peng; Chang, Chia-Chu; Kor, Chew-Teng; Yang, Yu; Wen, Yao-Ko; Chiu, Ping-Fang			The Predictive Role of Red Cell Distribution Width in Mortality among Chronic Kidney Disease Patients	PLOS ONE			English	Article							HEART-FAILURE; PERITONEAL-DIALYSIS; PROGNOSTIC MARKER; CRITICAL ILLNESS; ASSOCIATION; HEMOGLOBIN; COHORT; RISK; ERYTHROPOIESIS; DYSFUNCTION	Background Recently, accumulating evidence has demonstrated that RDW independently predicts clinically important outcomes in many populations. However, the role of RDW has not been elucidated in chronic kidney disease (CKD) patients. We conducted the present study with the aim to evaluate the predictive value of RDW in CKD patients. Methods A retrospective observational cohort study of 1075 stage 3-5 CKD patients was conducted in a medical center. The patients' baseline information included demographic data, laboratory values, medications, and comorbid conditions. The upper limit of normal RDW value (14.9%) was used to divide the whole population. Multivariate Cox regression analysis was used to determine the independent predictors of mortality. Results Of the 1075 participants, 158 patients (14.7%) died over a mean follow-up of approximately 2.35 years. The crude mortality rate was significantly higher in the high RDW group (high RDW group, 22.4%; low RDW group 11%, p <0.001). From the adjusted model, the high RDW group was correlated with a hazard ratio of 2.19 for overall mortality as compared with the low RDW group (95% CI = 1.53-3.09, p<0.001). In addition, the high RDW group was also associated with an increased risk for cardiovascular disease (HR = 2.28, 95% CI = 1.14-4.25, p = 0.019) and infection (HR = 1.9, 95% CI = 1.15-3.14, p = 0.012)) related mortality in comparison with the low RDW group. Conclusions In stage 3-5 CKD patients, RDW was associated with patient mortality of all-cause, cardiovascular disease and infection. RDW should be considered as a clinical predictor for mortality when providing healthcare to CKD patients.	[Hsieh, Yao-Peng; Chang, Chia-Chu; Kor, Chew-Teng; Yang, Yu; Wen, Yao-Ko; Chiu, Ping-Fang] Changhua Christian Hosp, Div Nephrol, Dept Internal Med, Changhua, Taiwan; [Hsieh, Yao-Peng] Natl Chung Hsing Univ, Coll Life Sci, PhD Program Translat Med, Taichung, Taiwan; [Hsieh, Yao-Peng] Kaohsiung Med Univ, Kaohsiung, Taiwan; [Hsieh, Yao-Peng; Chang, Chia-Chu; Yang, Yu; Chiu, Ping-Fang] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Hsieh, Yao-Peng] Changhua Christian Hosp, Div Nephrol, Internal Med, Changhua, Taiwan	Changhua Christian Hospital; National Chung Hsing University; Kaohsiung Medical University; Chung Shan Medical University; Changhua Christian Hospital	Hsieh, YP (corresponding author), Changhua Christian Hosp, Div Nephrol, Dept Internal Med, Changhua, Taiwan.; Hsieh, YP (corresponding author), Natl Chung Hsing Univ, Coll Life Sci, PhD Program Translat Med, Taichung, Taiwan.; Hsieh, YP (corresponding author), Kaohsiung Med Univ, Kaohsiung, Taiwan.; Hsieh, YP (corresponding author), Chung Shan Med Univ, Sch Med, Taichung, Taiwan.; Hsieh, YP (corresponding author), Changhua Christian Hosp, Div Nephrol, Internal Med, Changhua, Taiwan.	102407@cch.org.tw						Akin F, 2015, CORONARY ARTERY DIS, V26, P289, DOI 10.1097/MCA.0000000000000223; Al-Najjar Y, 2009, EUR J HEART FAIL, V11, P1155, DOI 10.1093/eurjhf/hfp147; Bion JF, 2000, INTENS CARE MED, V26, pS57, DOI 10.1007/s001340051120; Borne Y, 2011, EUR J HEART FAIL, V13, P1355, DOI 10.1093/eurjhf/hfr127; Celik A, 2012, KAOHSIUNG J MED SCI, V28, P165, DOI 10.1016/j.kjms.2011.06.024; Forhecz Z, 2009, AM HEART J, V158, P659, DOI 10.1016/j.ahj.2009.07.024; Gromadzinski L, 2015, CLIN EXP NEPHROL, V19, P616, DOI 10.1007/s10157-014-1033-7; Kalay N, 2011, TURK KARDIYOL DERN A, V39, P463, DOI 10.5543/tkda.2011.01578; Lappe JM, 2011, CLIN CHIM ACTA, V412, P2094, DOI 10.1016/j.cca.2011.07.018; Lee JH, 2013, AM J EMERG MED, V31, P72, DOI 10.1016/j.ajem.2012.06.004; Lee WS, 2010, ARCH PATHOL LAB MED, V134, P505, DOI 10.1043/1543-2165-134.4.505.c; MCCLURE S, 1985, JAMA-J AM MED ASSOC, V253, P1021, DOI 10.1001/jama.253.7.1021; Molnar MZ, 2011, CLIN J AM SOC NEPHRO, V6, P1973, DOI 10.2215/CJN.01050211; Mucsi I, 2014, INT UROL NEPHROL, V46, P641, DOI 10.1007/s11255-013-0530-z; Oh HJ, 2012, NEPHROL DIAL TRANSPL, V27, P589, DOI 10.1093/ndt/gfr307; Pascual-Figal DA, 2012, INT J CARDIOL, V160, P196, DOI 10.1016/j.ijcard.2011.04.018; Patel KV, 2013, ADV EXP MED BIOL, V765, P211, DOI 10.1007/978-1-4614-4989-8_29; Patel KV, 2010, J GERONTOL A-BIOL, V65, P258, DOI 10.1093/gerona/glp163; Peng FF, 2014, INT J CARDIOL, V176, P1379, DOI 10.1016/j.ijcard.2014.08.030; Perlstein TS, 2009, ARCH INTERN MED, V169, P588, DOI 10.1001/archinternmed.2009.55; Pierce CN, 2005, PERFUSION-UK, V20, P83, DOI 10.1191/0267659105pf793oa; Purtle SW, 2014, CRIT CARE MED, V42, P918, DOI 10.1097/CCM.0000000000000118; Sabatine MS, 2005, CIRCULATION, V111, P2042, DOI 10.1161/01.CIR.0000162477.70955.5F; Semba RD, 2010, CLIN NUTR, V29, P600, DOI 10.1016/j.clnu.2010.03.001; Solak Y, 2014, AM J MED SCI, V347, P118, DOI 10.1097/MAJ.0b013e3182996a96; Tekce H, 2014, INT J NEPHROL, V2014, DOI 10.1155/2014/754370; van Kimmenade RRJ, 2010, EUR J HEART FAIL, V12, P129, DOI 10.1093/eurjhf/hfp179; Ye Z, 2011, AM J CARDIOL, V107, P1241, DOI 10.1016/j.amjcard.2010.12.023; Zakai NA, 2005, ARCH INTERN MED, V165, P2214, DOI 10.1001/archinte.165.19.2214; Zalawadiya SK, 2012, AM J CARDIOL, V109, P1664, DOI 10.1016/j.amjcard.2012.01.396; Zalawadiya SK, 2010, AM J CARDIOL, V106, P988, DOI 10.1016/j.amjcard.2010.06.006; Zorlu A, 2012, AM J CARDIOL, V109, P128, DOI 10.1016/j.amjcard.2011.08.015	32	19	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0162025	10.1371/journal.pone.0162025	http://dx.doi.org/10.1371/journal.pone.0162025			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27906969	Green Published, gold, Green Submitted			2022-12-26	WOS:000389482700002
J	Ribeiro, RS; Terry, SA; Sacramento, JP; Silveira, SRE; Bento, CBP; da Silva, EF; Mantovani, HC; da Gama, MAS; Pereira, LGR; Tomich, TR; Mauricio, RM; Chaves, AV				Ribeiro, Rafael Sandin; Terry, Stephanie Amelia; Sacramento, Joao Paulo; Rocha e Silveira, Sylvia; Pereira Bento, Claudia Braga; da Silva, Elsa Fernandes; Mantovani, Hilario Cuquetto; Sundfeld da Gama, Marco Antonio; Ribeiro Pereira, Luiz Gustavo; Tomich, Thierry Ribeiro; Mauricio, Rogerio Martins; Chaves, Alexandre Vieira			Tithonia diversifolia as a Supplementary Feed for Dairy Cows	PLOS ONE			English	Article							CONJUGATED LINOLEIC-ACID; NEUTRAL DETERGENT FIBER; METHANE PRODUCTION; TRACER TECHNIQUE; FATTY-ACIDS; IN-VITRO; MILK-FAT; CORN; DIET; BIOHYDROGENATION	The objective of this study was to examine the effects of Tithonia diversifolia as a supplementary forage on dairy cow performance and methane production. Nine lactating Holstein x Zebu dairy cows (519 +/- 53.3 kg of body weight and 66 +/- 13.3 d in milk) were paired by milk yield (21.3 +/- 2.34 kg/d) and body weight and randomly assigned to three dietary treatments in a Latin square design with 21-d experimental periods (14 d for diet adaptation and 7 d for measurements and sample collection). The dietary treatments included the control diet consisting of fresh sugar cane plus concentrate (44:56, % of diet DM), and two treatment diets containing different levels of fresh T. diversifolia (6.5 and 15.4%, DM basis) which partially replaced both sugarcane and concentrates. Methane production was measured using the sulphur hexafluoride (SF6) technique from d 16 to d 21 of each experimental period. Analysis of the gas samples was performed by gas chromatography. The inclusion of T. diversifolia at 15.4% DM had no effects on DM intake, milk production, nitrogen balance or methane production. There was no effect on the concentrations of total saturated fatty acids (SFA), monounsaturated fatty acids (MUFA), and polyunsaturated fatty acids (PUFA) in milk fat (P >= 0.28), though individual milk fatty acids were affected. Serum concentrations of glucose, urea nitrogen (BUN), triglycerides, P-hydroxybutyrate (BHBA), and cholesterol were unaffected by the dietary treatments (P >= 0.13). There was a time (2 and 6 h post-feeding) and dietary treatment effect (P < 0.01) on the acetate to propionate ratio in the rumen. A denaturing gradient gel electrophoresis analysis of the archaeal community showed distinct clustering of the archaea populations for control and treatment diets. Taken together, our results indicate the potential of T. diversifolia as a supplementary forage for dairy cattle in the tropics.	[Ribeiro, Rafael Sandin; Sacramento, Joao Paulo; Rocha e Silveira, Sylvia; Mauricio, Rogerio Martins] Univ Fed Sao Joao Del Rei, Bioengn Dept, Sao Joao Del Rei, MG, Brazil; [Terry, Stephanie Amelia; Chaves, Alexandre Vieira] Univ Sydney, Sch Life & Environm Sci, Fac Vet Sci, Sydney, NSW, Australia; [Pereira Bento, Claudia Braga; da Silva, Elsa Fernandes; Mantovani, Hilario Cuquetto] Univ Fed Vicosa, Dept Microbiol, Vicosa, MG, Brazil; [Sundfeld da Gama, Marco Antonio; Ribeiro Pereira, Luiz Gustavo; Tomich, Thierry Ribeiro] Embrapa Gado Leite, Juiz De Fora, MG, Brazil	Universidade Federal de Sao Joao del-Rei; University of Sydney; Universidade Federal de Vicosa; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Chaves, AV (corresponding author), Univ Sydney, Sch Life & Environm Sci, Fac Vet Sci, Sydney, NSW, Australia.	alex.chaves@sydney.edu.au	Mantovani, Hilario C/J-5287-2012; Bento, Cláudia Braga Pereira/AAW-4415-2021; Mauricio, Rogerio M/G-3728-2013; Chaves, Alexandre Vieira/B-8843-2012	Mantovani, Hilario C/0000-0002-3481-5318; Chaves, Alexandre Vieira/0000-0001-5065-7367; Terry, Stephanie Amelia/0000-0003-2567-6368	CAPES	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	All the funding of support received during this specific study came from CAPES, http://www.capes.gov.br/, proposal n#129089 (Funding from Feb 2014 to Feb 2016), title: "Adaptacao de bovinos leiteiros as mudancas climaticas e avancos tecnologicos para mensuracao de metano enterico". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Alexandre V. Chaves received R$14,000/month during his stay in Brazil during this proposal. Dr Chaves spent 7 months in total during this 3 year period project (2014-2016) funded by CAPES.	Barros-Rodriguez MA, 2015, TROP ANIM HEALTH PRO, V47, P757, DOI 10.1007/s11250-015-0790-y; Aoac, 1997, OFFICIAL METHODS ANA, DOI DOI 10.1016/0165-9936(90)87098-7; AOAC (Association of Official Analytical Chemists), 1999, OFFICIAL METHODS ANA, V16; Baldin M, 2013, J ANIM SCI, V91, P3305, DOI 10.2527/jas.2012-5766; Berends H, 2014, J THEOR BIOL, V353, P1, DOI 10.1016/j.jtbi.2014.02.040; Berndt A., 2014, GUIDELINES USE SULPH; Broderick GA, 2004, J DAIRY SCI, V87, P2997, DOI 10.3168/jds.S0022-0302(04)73431-1; Broucek J., 2014, Journal of Environmental Protection, V5, P1482, DOI 10.4236/jep.2014.515141; Delgado DC, 2012, TROP ANIM HEALTH PRO, V44, P1097, DOI 10.1007/s11250-011-0045-5; CHANEY AL, 1962, CLIN CHEM, V8, P130; Chilliard Y, 2007, EUR J LIPID SCI TECH, V109, P828, DOI 10.1002/ejlt.200700080; Cruz-Hernandez C, 2007, J DAIRY SCI, V90, P3786, DOI 10.3168/jds.2006-698; Deighton MH, 2014, ANIM FEED SCI TECH, V197, P47, DOI 10.1016/j.anifeedsci.2014.08.003; Henderson G, 2015, SCI REP-UK, V5, DOI 10.1038/srep14567; Holtshausen L, 2009, J DAIRY SCI, V92, P2809, DOI 10.3168/jds.2008-1843; Jayanegara A, 2011, ANIM PROD SCI, V51, P1127, DOI 10.1071/AN11059; JOHNSON KA, 1995, J ANIM SCI, V73, P2483; Kay JK, 2004, J DAIRY SCI, V87, P369, DOI 10.3168/jds.S0022-0302(04)73176-8; Kratz M, 2013, EUR J NUTR, V52, P1, DOI 10.1007/s00394-012-0418-1; Lana RP, 1998, J ANIM SCI, V76, P2190; Lee C, 2013, J DAIRY SCI, V96, P5295, DOI 10.3168/jds.2012-6442; Mahecha L, 2007, LIVEST RES RURAL DEV, P19; Martin C, 2008, J ANIM SCI, V86, P2642, DOI 10.2527/jas.2007-0774; McCann JC, 2014, BIOINFORM BIOL INSIG, V8, P109, DOI 10.4137/BBI.S15389; Moate PJ, 2016, ANIM PROD SCI, V56, P1017, DOI 10.1071/AN15222; Motta EF, 2014, 19 NAT M METH EMBR L; Muhling M, 2008, ISME J, V2, P379, DOI 10.1038/ismej.2007.97; Olabode O. S., 2007, World Journal of Agricultural Sciences, V3, P503; Palmquist DL, 2005, BIOSYNTHESIS CONJUGA, P179; Petri RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083424; Ramirez-Rivera U, 2010, AGROFOREST SYST, V80, P295, DOI 10.1007/s10457-010-9320-0; Ruiz T. E., 2014, Cuban Journal of Agricultural Science, V48, P79; Sao VN, 2010, LIVEST RES RURAL DEV, P22; Shingfield KJ, 2008, ADV EXP MED BIOL, V606, P3, DOI 10.1007/978-0-387-74087-4_1; SIEGFRIED R, 1984, LANDWIRT FORSCH, V37, P298; Stevenson DM, 2007, APPL MICROBIOL BIOT, V75, P165, DOI 10.1007/s00253-006-0802-y; SUKHIJA PS, 1988, J AGR FOOD CHEM, V36, P1202, DOI 10.1021/jf00084a019; Tendonkeng F, 2014, TROP ANIM HEALTH PRO, V46, P981, DOI 10.1007/s11250-014-0597-2; Terry SA, 2016, ANIM PROD SCI, V56, P437, DOI 10.1071/AN15560; Valadares RFD, 1999, J DAIRY SCI, V82, P2686, DOI 10.3168/jds.S0022-0302(99)75525-6; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Waghorn G, 2008, ANIM FEED SCI TECH, V147, P116, DOI 10.1016/j.anifeedsci.2007.09.013; Wambui C. C., 2006, Livestock Research for Rural Development, V18, P64; Ward AT, 2003, J DAIRY SCI, V86, P1742, DOI 10.3168/jds.S0022-0302(03)73760-6; Wolff RL, 1995, J AM OIL CHEM SOC, V72, P1471, DOI 10.1007/BF02577840	45	11	13	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0165751	10.1371/journal.pone.0165751	http://dx.doi.org/10.1371/journal.pone.0165751			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27906983	Green Published, Green Submitted, gold			2022-12-26	WOS:000389482700011
J	Seo, MH; Lee, J; Hong, SW; Rhee, EJ; Park, SE; Park, CY; Oh, KW; Park, SW; Lee, WY				Seo, Mi Hae; Lee, Jinmi; Hong, Seok-Woo; Rhee, Eun-Jung; Park, Se Eun; Park, Cheol Young; Oh, Ki Won; Park, Sung Woo; Lee, Won-Young			Exendin-4 Inhibits Hepatic Lipogenesis by Increasing beta-Catenin Signaling	PLOS ONE			English	Article							FATTY LIVER-DISEASE; PPAR-GAMMA; INSULIN-RESISTANCE; GENETIC-VARIANTS; LIPID-METABOLISM; STEATOSIS; ADIPOGENESIS; ACTIVATION; PATHWAY; TCF7L2	The aim of this study is to investigate whether the beneficial effect of exendin-4 on hepatic steatosis is mediated by beta-catenin signaling. After the HepG2 human hepatoma cells were treated with PA for 24 hours, total triglycerides levels were increased in a dose-dependent manner, and the expression levels of perilipin family members were upregulated in cells treated with 400 mu M PA. For our in vitro model of hepatic steatosis, HepG2 cells were treated with 400 mu M palmitic acid (PA) in the presence or absence of 100 nM exendin-4 for 24 hours. PA increased the expression of lipogenic genes, such as sterol regulatory element- binding protein 1c (SREBP-1c), peroxisome proliferator-activated receptor gamma (PPAR.), stearoyl-CoA desaturase 1 (SCD1), fatty acid synthase (FAS), and acetyl-CoA carboxylase (ACC) and triglyceride synthesis-involved genes, such as diacylglycerol acyltransferase 1 (DGAT1) and diacylglycerol acyltransferase 2 (DGAT2) in HepG2 cells, whereas exendin-4 treatment significantly prevented the upregulation of SREBP-1c, PPAR gamma, SCD1, FAS, ACC, DGAT1 and DGAT2. Moreover, exendin-4 treatment increased the expression of phosphorylated glycogen synthase kinase-3 beta (GSK-3 beta) in the cytosolic fraction and the expression of beta-catenin and transcription factor 4 (TCF4) in the nuclear fraction. In addition, siRNA-mediated inhibition of beta-catenin upregulated the expression of lipogenic transcription factors. The protective effects of exendin-4 on intracellular triglyceride content and total triglyceride levels were not observed in cells treated with the beta-catenin inhibitor IWR-1. These data suggest that exendin-4 treatment improves hepatic steatosis by inhibiting lipogenesis via activation of Wnt/beta-catenin signaling.	[Seo, Mi Hae] Soonchunhyang Univ, Gumi Hosp, Dept Internal Med, Gumi, South Korea; [Lee, Jinmi; Hong, Seok-Woo] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Inst Med Res, Seoul, South Korea; [Rhee, Eun-Jung; Park, Se Eun; Park, Cheol Young; Oh, Ki Won; Park, Sung Woo; Lee, Won-Young] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Internal Med, Seoul, South Korea	Soonchunhyang University; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Lee, WY (corresponding author), Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Internal Med, Seoul, South Korea.	drlwy@hanmail.net	Rhee, Eun-Jung/M-9294-2015; LEE, WON-YOUNG/C-7249-2018	Rhee, Eun-Jung/0000-0002-6108-7758; LEE, WON-YOUNG/0000-0002-1082-7592	National Research Foundation (NRF) - funded by the Korean government [NRF2013R1A1A2063069]; Samsung Biomedical Research Institute (SBRI)	National Research Foundation (NRF) - funded by the Korean government; Samsung Biomedical Research Institute (SBRI)	This study was supported by a grant from the National Research Foundation (NRF), which is funded by the Korean government (NRF2013R1A1A2063069) (http:www.nrf.rekr), and Samsung Biomedical Research Institute (SBRI) (http://www.sbri.or.kr). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiola M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008509; Cauchi S, 2008, CURR DIABETES REP, V8, P149, DOI 10.1007/s11892-008-0026-x; Cho YM, 2013, ENDOCRINOL METAB, V28, P262, DOI 10.3803/EnM.2013.28.4.262; Christodoulides C, 2009, TRENDS ENDOCRIN MET, V20, P16, DOI 10.1016/j.tem.2008.09.002; Ding XK, 2006, HEPATOLOGY, V43, P173, DOI 10.1002/hep.21006; Ferre P, 2010, DIABETES OBES METAB, V12, P83, DOI 10.1111/j.1463-1326.2010.01275.x; Foufelle F, 2002, BIOCHEM J, V366, P377, DOI 10.1042/BJ20020430; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Gupta NA, 2010, HEPATOLOGY, V51, P1584, DOI 10.1002/hep.23569; Gurnell M, 2003, CLIN ENDOCRINOL, V59, P267, DOI 10.1046/j.1365-2265.2003.01767.x; Hong SW, 2012, MOL CELL ENDOCRINOL, V362, P242, DOI 10.1016/j.mce.2012.07.004; Inoue M, 2005, BIOCHEM BIOPH RES CO, V336, P215, DOI 10.1016/j.bbrc.2005.08.070; Kallwitz ER, 2008, WORLD J GASTROENTERO, V14, P22, DOI 10.3748/wjg.14.22; Kanazawa A, 2004, AM J HUM GENET, V75, P832, DOI 10.1086/425340; Kawai M, 2007, BIOCHEM BIOPH RES CO, V363, P276, DOI 10.1016/j.bbrc.2007.08.088; Kim HY, 2014, ENDOCRINOL METAB, V29, P320, DOI 10.3803/EnM.2014.29.3.320; Lee J, 2014, METABOLISM, V63, P1041, DOI 10.1016/j.metabol.2014.04.011; Lee J, 2012, DIABETES METAB J, V36, P262, DOI 10.4093/dmj.2012.36.4.262; Lee J, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-32; Liu PH, 2009, J CLIN ENDOCR METAB, V94, P3575, DOI 10.1210/jc.2009-0609; Liu ZY, 2008, J BIOL CHEM, V283, P8723, DOI 10.1074/jbc.M706105200; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Neuschwander-Tetri BA, 2010, HEPATOLOGY, V52, P774, DOI 10.1002/hep.23719; Postic C, 2008, DIABETES METAB, V34, P643, DOI 10.1016/S1262-3636(08)74599-3; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Prestwich TC, 2007, CURR OPIN CELL BIOL, V19, P612, DOI 10.1016/j.ceb.2007.09.014; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Tessari P, 2009, NUTR METAB CARDIOVAS, V19, P291, DOI 10.1016/j.numecd.2008.12.015; Wang CH, 2006, J FORMOS MED ASSOC, V105, P743, DOI 10.1016/S0929-6646(09)60202-3; Welters HJ, 2008, TRENDS ENDOCRIN MET, V19, P349, DOI 10.1016/j.tem.2008.08.004	31	23	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166913	10.1371/journal.pone.0166913	http://dx.doi.org/10.1371/journal.pone.0166913			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907035	Green Published, gold, Green Submitted			2022-12-26	WOS:000389482700053
J	Soler-Hurtado, MM; Sandoval-Sierra, JV; Machordom, A; Dieguez-Uribeondo, J				Soler-Hurtado, M. Mar; Sandoval-Sierra, Jose Vladimir; Machordom, Annie; Dieguez-Uribeondo, Javier			Aspergillus sydowii and Other Potential Fungal Pathogens in Gorgonian Octocorals of the Ecuadorian Pacific	PLOS ONE			English	Article							POPULATION-STRUCTURE; SEA FANS; VENTALINA; DISTURBANCE; HEALTHY; DISEASE; CORALS; DUST	Emerging fungal diseases are threatening ecosystems and have increased in recent decades. In corals, the prevalence and consequences of these infections have also increased in frequency and severity. Coral reefs are affected by an emerging fungal disease named aspergillosis, caused by Aspergillus sydowii. This disease and its pathogen have been reported along the Caribbean and Pacific coasts of Colombia. Despite this, an important number of coral reefs worldwide have not been investigated for the presence of this pathogen. In this work, we carried out the surveillance of the main coral reef of the Ecuadorian Pacific with a focus on the two most abundant and cosmopolitan species of this ecosystem, Leptogorgia sp. and Leptogorgia obscura. We collected 59 isolates and obtained the corresponding sequences of the Internal Transcribed Spacers (ITS) of the ribosomal DNA. These were phylogenetically analyzed using MrBayes, which indicated the presence of two isolates of the coral reef pathogen A. sydowii, as well as 16 additional species that are potentially pathogenic to corals. Although the analyzed gorgonian specimens appeared healthy, the presence of these pathogens, especially of A. sydowii, alert us to the potential risk to the health and future survival of the Pacific Ecuadorian coral ecosystem under the current scenario of increasing threats and stressors to coral reefs, such as habitat alterations by humans and global climate change.	[Soler-Hurtado, M. Mar; Machordom, Annie] CSIC, MNCN, Dept Biodiversidad & Biol Evolut, Madrid, Spain; [Soler-Hurtado, M. Mar] Univ Seville, Fac Biol, Dept Biodiversidad & Ecol Invertebrados Marinos, Seville, Spain; [Sandoval-Sierra, Jose Vladimir; Dieguez-Uribeondo, Javier] Real Jardin Bot CSIC, Dept Micol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Real Jardin Botanico de Madrid	Dieguez-Uribeondo, J (corresponding author), Real Jardin Bot CSIC, Dept Micol, Madrid, Spain.	dieguez@rjb.csic.es	Diéguez-Uribeondo, Javier/ABF-1130-2021; dieguez-uribeondo, javier/I-2178-2015; Sandoval, Vladimir/GYD-5018-2022; Machordom, Annie/K-1737-2014	Diéguez-Uribeondo, Javier/0000-0002-4488-0658; dieguez-uribeondo, javier/0000-0002-4488-0658; Sandoval, Vladimir/0000-0003-2007-6582; Machordom, Annie/0000-0003-0341-0809	Spanish Ministry of Economy and Competitiveness [CTM2014-57949-R]	Spanish Ministry of Economy and Competitiveness(Spanish Government)	This research was only partially supported by a grant from the Spanish Ministry of Economy and Competitiveness (CTM2014-57949-R). The authors have not had any additional funding and coauthors have supported the sampling and sequencing from other projects. Both author and coauthors have currently not funding to pay publication fees.; We thank the Museo Ecuatoriano de Ciencias Naturales, Machalilla National Park and Ministerio del Ambiente of Ecuador (Manabi) for participation and collection permits (No 016 RM-DPM-MA). Thanks to Michel Guerrero and his team (Exploramar Diving) for his special interest from the early stages of our research. Special thanks to Micaela Peria for unconditional help and support. This research was partially supported by a grant from the Spanish Ministry of Economy and Competitiveness (CTM2014-57949-R).	Alker AP, 2001, HYDROBIOLOGIA, V460, P105, DOI 10.1023/A:1013145524136; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barrero-Canosa J, 2013, CORAL REEFS, V32, P35, DOI 10.1007/s00338-012-0972-2; Bielschowsky E., 1929, Zoologische Jahrbuecher Jena Supplement, V16, P63; Buhl-Mortensen L, 2004, SYMBIOSIS, V37, P33; Contreras AC, 2011, 64 GULF CAR FISH I, P28; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; De Hoog G. S., 2000, ATLAS CLIN FUNGI; Dieguez-Uribeondo J, 2011, PHYTOPATHOLOGY, V101, P1013, DOI 10.1094/PHYTO-07-10-0193; Enochs I, 2008, P 11 INT COR REEF S, V26, P1368; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; GARZONFERREIRA J, 1992, B MAR SCI, V50, P522; Gates RD, 2011, J EXP MAR BIOL ECOL, V408, P94, DOI 10.1016/j.jembe.2011.07.029; Geiser DM, 1998, NATURE, V394, P137, DOI 10.1038/28079; Green EP, 2000, BIOL CONSERV, V96, P347, DOI 10.1016/S0006-3207(00)00073-2; Hallegraeff G, 2014, APPL ENVIRON MICROB, V80, P3315, DOI 10.1128/AEM.04118-13; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kim K, 2004, AM NAT, V164, pS52, DOI 10.1086/424609; Kim Kiho, 2002, P813; Klinch MA, 2002, IDENTIFICATION COMMO; Koh LL, 2000, P 9 INT COR REEF S, V1, P521; Landry E.T., 2006, MYCOLOGIST, V20, P15, DOI [DOI 10.1016/J.MYC0L.2005.11.010, 10.1016/j.mycol.2005.11.010]; Milne-Edwards H, 1857, HIST NATURELLE CORAL; Moree WJ, 2014, ACS CHEM BIOL, V9, P2300, DOI 10.1021/cb500432j; Nagarajan C, 2014, INT J CASE REPORTS I, V5, P13, DOI [10.5348/ijcri-2014-01-430-CS-3, DOI 10.5348/ijcri-2014-01-430-CS-3]; Nagelkerken I, 1997, MAR ECOL PROG SER, V160, P255, DOI 10.3354/meps160255; Nagelkerken I, 1997, P 8 INT COR REEF S S, V1, P679; Nystrom M, 2000, TRENDS ECOL EVOL, V15, P413, DOI 10.1016/S0169-5347(00)01948-0; Petes LE, 2003, MAR ECOL PROG SER, V264, P167, DOI 10.3354/meps264167; Raper KB, 1965, GENUS ASPERGILLUS GE; Rivera KG, 2012, MYCOTAXON, V119, P315, DOI 10.5248/119.315; Rypien K., 2008, THE ORIGINS AND SPRE; Rypien KL, 2008, MAR ECOL PROG SER, V367, P125, DOI 10.3354/meps07600; Rypien KL, 2008, MOL ECOL, V17, P4068, DOI 10.1111/j.1365-294X.2008.03894.x; Sánchez Juan A., 2011, Bol. Invest. Mar. Cost., V40, P139; Sarmiento-Ramirez JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085853; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Smith GW, 1996, NATURE, V383, P487, DOI 10.1038/383487a0; SODERHALL K, 1978, MYCOPATHOLOGIA, V64, P9, DOI 10.1007/BF00443081; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Szmant AM, 2002, ESTUARIES, V25, P743, DOI 10.1007/BF02804903; Thrush SF, 2002, ANNU REV ECOL SYST, V33, P449, DOI 10.1146/annurev.ecolsys.33.010802.150515; Toledo-Hernandez C, 2008, CORAL REEFS, V27, P707, DOI 10.1007/s00338-008-0387-2; Toledo-Hernandez C, 2007, CORAL REEFS, V26, P725, DOI 10.1007/s00338-007-0252-8; Tsounis G, 2006, MAR BIOL, V149, P1059, DOI 10.1007/s00227-006-0302-8; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Wilkinson C., 2008, STATUS CORAL REEFS W, V2008, P5; Yang KL, 2012, J NAT PROD, V75, P935, DOI 10.1021/np300103w; Zhang XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109118; Zhang XY, 2013, CURR MICROBIOL, V67, P525, DOI 10.1007/s00284-013-0394-6; Zuluaga-Montero A, 2010, AQUAT BIOL, V8, P151, DOI 10.3354/ab00218	51	28	33	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0165992	10.1371/journal.pone.0165992	http://dx.doi.org/10.1371/journal.pone.0165992			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902710	gold, Green Published, Green Submitted			2022-12-26	WOS:000389474100009
J	Uytingco, CR; Puche, AC; Munger, SD				Uytingco, Cedric R.; Puche, Adam C.; Munger, Steven D.			Using Intrinsic Flavoprotein and NAD(P)H Imaging to Map Functional Circuitry in the Main Olfactory Bulb	PLOS ONE			English	Article							CORTEX IN-VIVO; EXTERNAL TUFTED CELLS; FLUORESCENCE TRANSIENTS; LASER PHOTOSTIMULATION; MITOCHONDRIAL-FUNCTION; NEURONAL ACTIVATION; SURROUND INHIBITION; LATERAL INHIBITION; SENSORY NEURONS; ENERGY BUDGET	Neurons exhibit strong coupling of electrochemical and metabolic activity. Increases in intrinsic fluorescence from either oxidized flavoproteins or reduced nicotinamide adenine dinucleotide (phosphate) [NAD(P)H] in the mitochondria have been used as an indicator of neuronal activity for the functional mapping of neural circuits. However, this technique has not been used to investigate the flow of olfactory information within the circuitry of the main olfactory bulb (MOB). We found that intrinsic flavoprotein fluorescence signals induced by electrical stimulation of single glomeruli displayed biphasic responses within both the glomerular (GL) and external plexiform layers (EPL) of the MOB. Pharmacological blockers of mitochondrial activity, voltage-gated Na+ channels, or ionotropic glutamate receptors abolished stimulus-dependent flavoprotein responses. Blockade of GABAA receptors enhanced the amplitude and spatiotemporal spread of the flavoprotein signals, indicating an important role for inhibitory neurotransmission in shaping the spread of neural activity in the MOB. Stimulus-dependent spread of fluorescence across the GL and EPL displayed a spatial distribution consistent with that of individual glomerular microcircuits mapped by neuroanatomic tract tracing. These findings demonstrated the feasibility of intrinsic fluorescence imaging in the olfactory systems and provided a new tool to examine the functional circuitry of the MOB.	[Uytingco, Cedric R.; Puche, Adam C.] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Uytingco, Cedric R.; Puche, Adam C.] Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA; [Munger, Steven D.] Univ Florida, Ctr Smell & Taste, Gainesville, FL 32611 USA; [Munger, Steven D.] Univ Florida, Dept Pharmacol & Therapeut, Gainesville, FL 32611 USA; [Munger, Steven D.] Univ Florida, Dept Med, Div Endocrinol Diabet & Metab, Gainesville, FL 32611 USA; [Uytingco, Cedric R.] Univ Florida, Dept Pharmacol & Therapeut, POB 100267, Gainesville, FL 32610 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Munger, SD (corresponding author), Univ Florida, Ctr Smell & Taste, Gainesville, FL 32611 USA.; Munger, SD (corresponding author), Univ Florida, Dept Pharmacol & Therapeut, Gainesville, FL 32611 USA.; Munger, SD (corresponding author), Univ Florida, Dept Med, Div Endocrinol Diabet & Metab, Gainesville, FL 32611 USA.	steven.munger@ufl.edu		Uytingco, Cedric/0000-0003-1625-3988	National Institute of Deafness and Other Communicative Disorders [R01-DC005633]; National Institute of Neurological Disorders and Stroke [T32-NS063391]; National Institute of General Medical Sciences [T32-GM008181, T32-GM55036]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005633] Funding Source: NIH RePORTER	National Institute of Deafness and Other Communicative Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was supported by grant R01-DC005633 (SDM) National Institute of Deafness and Other Communicative Disorders. CRU received training support from T32-NS063391 (National Institute of Neurological Disorders and Stroke), T32-GM008181 (National Institute of General Medical Sciences), and T32-GM55036 (National Institute of General Medical Sciences). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnould S, 1997, BIOCHEMISTRY-US, V36, P10178, DOI 10.1021/bi970549j; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Aungst JL, 2003, NATURE, V426, P623, DOI 10.1038/nature02185; Brennan AM, 2007, J NEUROSCI RES, V85, P3233, DOI 10.1002/jnr.21288; Brennan AM, 2006, J CEREBR BLOOD F MET, V26, P1389, DOI 10.1038/sj.jcbfm.9600292; Chaigneau E, 2003, P NATL ACAD SCI USA, V100, P13081, DOI 10.1073/pnas.2133652100; Chaigneau E, 2007, J NEUROSCI, V27, P6452, DOI 10.1523/JNEUROSCI.3141-06.2007; Charpak S, 2001, P NATL ACAD SCI USA, V98, P1230, DOI 10.1073/pnas.021422798; Chery R, 2011, JOVE-J VIS EXP, DOI 10.3791/3336; Djurisic M, 2008, J NEUROSCI, V28, P4057, DOI 10.1523/JNEUROSCI.5296-07.2008; Feinstein P, 2004, CELL, V117, P817, DOI 10.1016/j.cell.2004.05.011; Gire DH, 2009, J NEUROSCI, V29, P13454, DOI 10.1523/JNEUROSCI.2368-09.2009; GRAZIADEI GAM, 1979, J NEUROCYTOL, V8, P197; Husson TR, 2007, J NEUROSCI, V27, P8665, DOI 10.1523/JNEUROSCI.2156-07.2007; Igarashi KM, 2012, J NEUROSCI, V32, P7970, DOI 10.1523/JNEUROSCI.0154-12.2012; Kann O, 2007, AM J PHYSIOL-CELL PH, V292, pC641, DOI 10.1152/ajpcell.00222.2006; Kasischke KA, 2004, SCIENCE, V305, P99, DOI 10.1126/science.1096485; Kasowski HJ, 1999, J COMP NEUROL, V407, P261, DOI 10.1002/(SICI)1096-9861(19990503)407:2<261::AID-CNE7>3.0.CO;2-G; Ke MT, 2013, NAT NEUROSCI, V16, P1154, DOI 10.1038/nn.3447; Kikuta S, 2013, NEURON, V77, P1122, DOI 10.1016/j.neuron.2013.01.022; Kiyokage E, 2010, J NEUROSCI, V30, P1185, DOI 10.1523/JNEUROSCI.3497-09.2010; Kosaka T, 2005, NEUROSCIENCE, V134, P757, DOI 10.1016/j.neuroscience.2005.04.057; Kosaka T, 2008, NEUROSCI RES, V60, P349, DOI 10.1016/j.neures.2007.11.012; L'Heureux B, 2009, OPT EXPRESS, V17, P9477, DOI 10.1364/OE.17.009477; Liu SL, 2008, J NEUROSCI, V28, P10311, DOI 10.1523/JNEUROSCI.2608-08.2008; Llano DA, 2009, J NEUROPHYSIOL, V101, P3325, DOI 10.1152/jn.91291.2008; Llano DA, 2012, J NEUROSCI, V32, P16141, DOI 10.1523/JNEUROSCI.2499-12.2012; MAJANDER A, 1994, J BIOL CHEM, V269, P21037; Mallik AK, 2008, VISION RES, V48, P1545, DOI 10.1016/j.visres.2008.04.014; Margrie TW, 2001, P NATL ACAD SCI USA, V98, P319, DOI 10.1073/pnas.011523098; Migliore M, 2014, FRONT COMPUT NEUROSC, V8, DOI 10.3389/fncom.2014.00050; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; MORI K, 1983, J COMP NEUROL, V219, P339, DOI 10.1002/cne.902190308; Murakami H, 2004, EUR J NEUROSCI, V19, P1352, DOI 10.1111/j.1460-9568.2004.03237.x; Najac M, 2011, J NEUROSCI, V31, P8722, DOI 10.1523/JNEUROSCI.0527-11.2011; Nawroth JC, 2007, J NEUROSCI, V27, P9790, DOI 10.1523/JNEUROSCI.1415-07.2007; ORONA E, 1984, J COMP NEUROL, V226, P346, DOI 10.1002/cne.902260305; PALAY SANFORD L., 1956, JOUR BIOPHYS AND BIOCHEM CYTOL, V2, P193, DOI 10.1083/jcb.2.4.193; PINCHING AJ, 1971, J CELL SCI, V9, P305; PINCHING AJ, 1971, J CELL SCI, V9, P379; PINCHING AJ, 1971, J CELL SCI, V9, P347; Ratz JD, 2000, J PHARMACOL EXP THER, V293, P569; Reinert KC, 2004, J NEUROPHYSIOL, V92, P199, DOI 10.1152/jn.01275.2003; Reinert KC, 2007, J NEUROSCI RES, V85, P3221, DOI 10.1002/jnr.21348; Reinert KC, 2011, CEREBELLUM, V10, P585, DOI 10.1007/s12311-011-0278-x; Schuchmann S, 2001, BRAIN RES PROTOC, V7, P267, DOI 10.1016/S1385-299X(01)00080-0; Shepherd GM, 2004, PLOS BIOL, V2, P572, DOI 10.1371/journal.pbio.0020146; Shibuki K, 2003, J PHYSIOL-LONDON, V549, P919, DOI 10.1113/jphysiol.2003.040709; Shirley CH, 2010, BRAIN RES BULL, V81, P406, DOI 10.1016/j.brainresbull.2009.10.022; Shuttleworth CW, 2010, NEUROCHEM INT, V56, P379, DOI 10.1016/j.neuint.2009.12.015; Shuttleworth CW, 2003, J NEUROSCI, V23, P3196; Takahashi K, 2006, EUR J NEUROSCI, V23, P1365, DOI 10.1111/j.1460-9568.2006.04662.x; Theyel BB, 2011, NAT PROTOC, V6, P502, DOI 10.1038/nprot.2011.315; Theyel BB, 2010, NEUROREPORT, V21, P861, DOI 10.1097/WNR.0b013e32833d7cec; Uytingco CR, PLOS ONE FORTHCOMING; Wang X, 2009, NEUROSCIENCE, V162, P713, DOI 10.1016/j.neuroscience.2009.01.071; Whitesell JD, 2013, J NEUROSCI, V33, P1552, DOI 10.1523/JNEUROSCI.3410-12.2013; Yaseen MA, 2013, BIOMED OPT EXPRESS, V4, P307, DOI 10.1364/BOE.4.000307; Yuan Q, 2004, LEARN MEMORY, V11, P406, DOI 10.1101/lm.75204; Zhou ZS, 2006, EUR J NEUROSCI, V24, P1623, DOI 10.1111/j.1460-9568.2006.05076.x	62	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0165342	10.1371/journal.pone.0165342	http://dx.doi.org/10.1371/journal.pone.0165342			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902689	Green Published, gold, Green Submitted			2022-12-26	WOS:000389474100001
J	Uytingco, CR; Puche, AC; Munger, SD				Uytingco, Cedric R.; Puche, Adam C.; Munger, Steven D.			Interglomerular Connectivity within the Canonical and GC-D/Necklace Olfactory Subsystems	PLOS ONE			English	Article							COMMISSURAL FIBER SYSTEMS; EXTERNAL TUFTED CELLS; SHORT-AXON CELLS; LATERAL INHIBITION; CHOLINE-ACETYLTRANSFERASE; SURROUND INHIBITION; LOCUS-COERULEUS; BULB CIRCUITS; RAT; ORGANIZATION	The mammalian main olfactory system contains several subsystems that differ not only in the receptors they express and the glomerular targets they innervate within the main olfactory bulb (MOB), but also in the strategies they use to process odor information. The canonical main olfactory system employs a combinatorial coding strategy that represents odorant identity as a pattern of glomerular activity. By contrast, the "GC-D/necklace" olfactory subsystem D formed by olfactory sensory neurons expressing the receptor guanylyl cyclase GC-D and their target necklace glomeruli (NGs) encircling the caudal MOB D is critical for the detection of a small number of semiochemicals that promote the acquisition of food preferences. The formation of these socially-transmitted food preferences requires the animal to integrate information about two types of olfactory stimuli: these specialized social chemosignals and the food odors themselves. However, the neural mechanisms with which the GC-D/necklace subsystem processes this information are unclear. We used stimulus-induced increases in intrinsic fluorescence signals to map functional circuitry associated with NGs and canonical glomeruli (CGs) in the MOB. As expected, CG-associated activity spread laterally through both the glomerular and external plexiform layers associated with activated glomeruli. Activation of CGs or NGs resulted in activity spread between the two types of glomeruli; there was no evidence of preferential connectivity between individual necklace glomeruli. These results support previous anatomical findings that suggest the canonical and GC-D/necklace subsystems are functionally connected and may integrate general odor and semiochemical information in the MOB.	[Uytingco, Cedric R.; Puche, Adam C.] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Uytingco, Cedric R.; Puche, Adam C.] Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA; [Munger, Steven D.] Univ Florida, Ctr Smell & Taste, Gainesville, FL 32611 USA; [Munger, Steven D.] Univ Florida, Dept Pharmacol & Therapeut, Gainesville, FL 32611 USA; [Munger, Steven D.] Univ Florida, Dept Med, Div Endocrinol Diabet & Metab, Gainesville, FL 32611 USA; [Uytingco, Cedric R.] Univ Florida, Dept Pharmacol & Therapeut, Gainesville, FL USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Munger, SD (corresponding author), Univ Florida, Ctr Smell & Taste, Gainesville, FL 32611 USA.; Munger, SD (corresponding author), Univ Florida, Dept Pharmacol & Therapeut, Gainesville, FL 32611 USA.; Munger, SD (corresponding author), Univ Florida, Dept Med, Div Endocrinol Diabet & Metab, Gainesville, FL 32611 USA.	steven.munger@ufl.edu		Uytingco, Cedric/0000-0003-1625-3988	National Institute on Deafness and Other Communication Disorders (NIDCD) [R01 DC005633]; National Institute of General Medical Sciences (NIGMS) [GM008181, GM55036]; National Institute of Neurological Disorders and Stroke (NINDS) [NS063391]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005633] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Institute on Deafness and Other Communication Disorders (NIDCD) grant, R01 DC005633 (SDM). CRU was supported in part by the National Institute of General Medical Sciences (NIGMS) training grants, GM008181 and GM55036, and National Institute of Neurological Disorders and Stroke (NINDS) training grant, NS063391. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa H, 2013, CHEM SENSES, V38, P391, DOI 10.1093/chemse/bjt015; Aungst JL, 2003, NATURE, V426, P623, DOI 10.1038/nature02185; Boyd AM, 2012, NEURON, V76, P1161, DOI 10.1016/j.neuron.2012.10.020; Buonviso N, 1996, J NEUROPHYSIOL, V76, P2393, DOI 10.1152/jn.1996.76.4.2393; Cockerham RE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004657; DEVRIES SH, 1993, CELL, V72, P139, DOI 10.1016/S0092-8674(05)80033-9; Eyre MD, 2008, J NEUROSCI, V28, P8217, DOI 10.1523/JNEUROSCI.2490-08.2008; Eyre MD, 2009, EUR J NEUROSCI, V29, P1397, DOI 10.1111/j.1460-9568.2009.06703.x; Gire DH, 2009, J NEUROSCI, V29, P13454, DOI 10.1523/JNEUROSCI.2368-09.2009; HABERLY LB, 1978, J COMP NEUROL, V178, P711, DOI 10.1002/cne.901780408; HABERLY LB, 1978, J COMP NEUROL, V181, P781, DOI 10.1002/cne.901810407; Hayar A, 2007, J NEUROPHYSIOL, V98, P1052, DOI 10.1152/jn.01214.2006; ICHIKAWA T, 1986, J NEUROSCI, V6, P281; Igarashi KM, 2012, J NEUROSCI, V32, P7970, DOI 10.1523/JNEUROSCI.0154-12.2012; Juilfs DM, 1997, P NATL ACAD SCI USA, V94, P3388, DOI 10.1073/pnas.94.7.3388; Kasowski HJ, 1999, J COMP NEUROL, V407, P261, DOI 10.1002/(SICI)1096-9861(19990503)407:2<261::AID-CNE7>3.0.CO;2-G; Kiyokage E, 2010, J NEUROSCI, V30, P1185, DOI 10.1523/JNEUROSCI.3497-09.2010; Kobayakawa K, 2007, NATURE, V450, P503, DOI 10.1038/nature06281; KUFFLER SW, 1953, J NEUROPHYSIOL, V16, P37, DOI 10.1152/jn.1953.16.1.37; Leinders-Zufall T, 2007, P NATL ACAD SCI USA, V104, P14507, DOI 10.1073/pnas.0704965104; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; Ma XF, 2004, J NEUROPHYSIOL, V92, P3192, DOI 10.1152/jn.00301.2004; MCLEAN JH, 1989, J COMP NEUROL, V285, P339, DOI 10.1002/cne.902850305; MCLEAN JH, 1987, J NEUROSCI, V7, P3029; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mori K, 2006, PHYSIOL REV, V86, P409, DOI 10.1152/physrev.00021.2005; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; Mori K, 2011, ANNU REV NEUROSCI, V34, P467, DOI 10.1146/annurev-neuro-112210-112917; Munger SD, 2010, CURR BIOL, V20, P1438, DOI 10.1016/j.cub.2010.06.021; Munger SD, 2009, ANNU REV PHYSIOL, V71, P115, DOI 10.1146/annurev.physiol.70.113006.100608; Nagayama S, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00098; OJIMA H, 1988, ANAT EMBRYOL, V178, P481, DOI 10.1007/BF00305035; Pacifico R, 2012, CELL REP, V2, P76, DOI 10.1016/j.celrep.2012.06.006; Perez-Gomez A, 2015, CURR BIOL, V25, P1340, DOI 10.1016/j.cub.2015.03.026; PRICE JL, 1970, J ANAT, V107, P215; PRICE JL, 1970, J CELL SCI, V7, P157; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; SCHNEIDER SP, 1978, BRAIN RES BULL, V3, P73, DOI 10.1016/0361-9230(78)90063-1; Schoppa NE, 2003, TRENDS NEUROSCI, V26, P501, DOI 10.1016/S0166-2236(03)00228-5; SHINODA K, 1993, BRAIN RES, V618, P160, DOI 10.1016/0006-8993(93)90440-X; SHIPLEY MT, 1985, BRAIN RES, V329, P294, DOI 10.1016/0006-8993(85)90537-2; Shirley CH, 2010, BRAIN RES BULL, V81, P406, DOI 10.1016/j.brainresbull.2009.10.022; SUR M, 1980, BRAIN RES, V198, P465, DOI 10.1016/0006-8993(80)90762-3; Theyel BB, 2011, NAT PROTOC, V6, P502, DOI 10.1038/nprot.2011.315; Urban NN, 2002, J PHYSIOL-LONDON, V542, P355, DOI 10.1113/jphysiol.2001.013491; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Walz A, 2007, DEVELOPMENT, V134, P4063, DOI 10.1242/dev.008722; Whitesell JD, 2013, J NEUROSCI, V33, P1552, DOI 10.1523/JNEUROSCI.3410-12.2013; Won MH, 1998, NEUROSCI LETT, V243, P53; Zufall F, 2010, MOL CELL BIOCHEM, V334, P191, DOI 10.1007/s11010-009-0325-9	50	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0165343	10.1371/journal.pone.0165343	http://dx.doi.org/10.1371/journal.pone.0165343			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902696	Green Published, gold, Green Submitted			2022-12-26	WOS:000389474100002
J	Hemming, S; Cakouros, D; Codrington, J; Vandyke, K; Arthur, A; Zannettino, A; Gronthos, S				Hemming, Sarah; Cakouros, Dimitrios; Codrington, John; Vandyke, Kate; Arthur, Agneiszka; Zannettino, Andrew; Gronthos, Stan			EZH2 deletion in early mesenchyme compromises postnatal bone micro architecture and structural integrity and accelerates remodeling	FASEB JOURNAL			English	Article						mesenchymal stem cells; skeletal development; differentiation; epigenetics; conditional knockout	GROUP GENE EZH2; STEM-CELLS; OSTEOGENIC DIFFERENTIATION; EPIGENETIC CONTROL; PAGETS-DISEASE; POLYCOMB; METHYLATION; EXPRESSION; GUIDELINES; RESORPTION	In this study, we examined the functional importance of EZH2 during skeletal development and homeo stasis using the conditional deletion of Ezh2 (Ezh2(fl/fl)) in early mesenchyme with the use of a Prrx-1-cre driver mouse (Ezh2(+/+)). Heterozygous (Ezh2(+/-)) newborn and 4-wk-old mice exhibited increased skeletal size, growth plate size, and weight when compared to the wild-type control (Ezh2(+/+)), whereas homozygous deletion of Ezh2 (Ezh2(-7-)) resulted in skeletal deformities and reduced skeletal size, growth plate size, and weight in newborn and 4-wk-old mice. Ezh2(-/-) mice exhibited enhanced trabecular patterning. Osteogenic cortical and trabecular bone formation was enhanced in Ezh2(+/-) and Ezh2(-/-) animals. Ezh2(+/-) and Ezh2(-/-) mice displayed thinner cortical bone and decreased mechanical strength compared to the wild-type control. Differences in cortical bone thickness were attributed to an increased number of osteoclasts, corresponding with elevated levels of the bone turnover markers cross-linked C-telopeptide-1 and tartrate-resistant acid phosphatase, detected within serum. Moreover, Ezh2(+/-) mice displayed increased osteoclastogenic potential coinciding with an up regulation of Rankl and M-csf expression by mesenchymal stem cells (MSCs). MSCs isolated from Ezh2(+/-) mice also exhibited increased trilineage potential compared with wild-type bone marrow stromal/stemcells (BMSCs). Gene expression studies confirmed the upregulation of known Ezh2 target genes in Ezh2(-/-) bone tissue, many of which are involved in Wnt/BMP signaling as promoters of osteogenesis and inhibitors of adipogenesis. In summary, EZH2 appears to be an important orchestrator of skeletal development, postnatal bone remodelling and BMSC fate determination in vitro and in vivo.	[Hemming, Sarah; Cakouros, Dimitrios; Arthur, Agneiszka; Gronthos, Stan] Univ Adelaide, Fac Hlth Sci, Sch Med, Mesenchymal Stem Cell Lab, Adelaide, SA, Australia; [Vandyke, Kate; Zannettino, Andrew] Univ Adelaide, Fac Hlth Sci, Sch Med, Myeloma Res Lab, Adelaide, SA, Australia; [Codrington, John] Univ Adelaide, Sch Mech Engn, Adelaide, SA, Australia; [Hemming, Sarah; Cakouros, Dimitrios; Vandyke, Kate; Arthur, Agneiszka; Zannettino, Andrew; Gronthos, Stan] South Australian Hlth & Med Res Inst, Canc Theme, Adelaide, SA, Australia; [Vandyke, Kate] South Australia Pathol, Adelaide, SA, Australia	University of Adelaide; University of Adelaide; University of Adelaide; South Australian Health & Medical Research Institute (SAHMRI)	Gronthos, S (corresponding author), Univ Adelaide, Fac Hlth Sci, Sch Med, Adelaide, SA 5005, Australia.	stan.gronthos@adelaide.edu.au	Vandyke, Kate/G-6280-2010; Gronthos, Stan/Y-4419-2019	Vandyke, Kate/0000-0002-1033-849X; Gronthos, Stan/0000-0002-6225-3084; Arthur, Agnes/0000-0002-0539-8797; Zannettino, Andrew/0000-0002-6646-6167	National Health and Medical Research Council Project Grant [APP1046053]; Australia Postgraduate Award; Dawes Top-up scholarship;  [APP1042677]	National Health and Medical Research Council Project Grant(National Health and Medical Research Council (NHMRC) of Australia); Australia Postgraduate Award; Dawes Top-up scholarship; 	The authors thank the University of Adelaide's Microscopy Service for their technical support with micro-CT imaging and analysis. The authors also thank David Haynes, Kencana Dharmapatni, and Julia Kuliwaba for the use of their laboratory facilities (Adelaide Medical School, University of Adelaide, Adelaide, SA, Australia). This study was partially supported by National Health and Medical Research Council Project Grant APP1046053 (to S.G.), Fellowship APP1042677 (to S.G.), Australia Postgraduate Award (to S.H.), and Dawes Top-up scholarship (to S.H.). D.C. and S.G. are co-senior authors. The authors declare no conflicts of interest.	Aloia L, 2013, DEVELOPMENT, V140, P2525, DOI 10.1242/dev.091553; Arthur A, 2013, J BONE MINER RES, V28, P926, DOI 10.1002/jbmr.1821; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Bulger M, 1999, GENE DEV, V13, P2465, DOI 10.1101/gad.13.19.2465; Cakouros D, 2015, STEM CELLS DEV, V24, P1297, DOI 10.1089/scd.2014.0471; Cakouros D, 2012, MOL CELL BIOL, V32, P1433, DOI 10.1128/MCB.06315-11; Cantley MD, 2011, J CELL PHYSIOL, V226, P3233, DOI 10.1002/jcp.22684; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; de Haan G, 2007, ANN NY ACAD SCI, V1106, P233, DOI 10.1196/annals.1392.008; DENELL RE, 1978, GENETICS, V90, P277; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Dudakovic A, 2015, J BIOL CHEM, V290, P27604, DOI 10.1074/jbc.M115.672345; Fitter S., 2013, J CLIN ENDOCR METAB, V95, P3763; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Geoffroy V, 2002, MOL CELL BIOL, V22, P6222, DOI 10.1128/MCB.22.17.6222-6233.2002; Gibson WT, 2012, AM J HUM GENET, V90, P110, DOI 10.1016/j.ajhg.2011.11.018; Gronthos S, 2003, J CELL SCI, V116, P1827, DOI 10.1242/jcs.00369; Hemming S, 2016, STEM CELLS DEV, V25, P909, DOI 10.1089/scd.2015.0384; Hemming S, 2014, STEM CELLS, V32, P802, DOI 10.1002/stem.1573; Hirabayashi Y, 2009, NEURON, V63, P600, DOI 10.1016/j.neuron.2009.08.021; HOSKING DJ, 1981, BRIT MED J, V283, P686, DOI 10.1136/bmj.283.6293.686; Huang XJ, 2014, REPROD FERT DEVELOP, V26, P1166, DOI 10.1071/RD13169; Isenmann S, 2009, STEM CELLS, V27, P2457, DOI 10.1002/stem.181; JALAGUIER J, 1983, J GENET HUM, V31, P385; Jepsen KJ, 2015, J BONE MINER RES, V30, P951, DOI 10.1002/jbmr.2539; Jing H, 2016, MOL THER, V24, P217, DOI 10.1038/mt.2015.152; Kamminga LM, 2006, BLOOD, V107, P2170, DOI 10.1182/blood-2005-09-3585; Kouzarides T, 2007, CELL, V131, DOI 10.1016/j.cell.2007.11.005; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; McNeil PJ, 1997, J HISTOTECHNOL, V20, P307; Mikalef P, 2010, HIPPOKRATIA, V14, P212; Nemoto E, 2012, BIOCHEM BIOPH RES CO, V422, P627, DOI 10.1016/j.bbrc.2012.05.039; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Pearson OM, 2004, YEARB PHYS ANTHROPOL, V47, P63, DOI 10.1002/ajpa.20155; Richly H, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.84; Sabharwal Robin, 2014, Niger J Surg, V20, P9, DOI 10.4103/1117-6806.127098; Schriefer JL, 2005, J BIOMECH, V38, P467, DOI 10.1016/j.jbiomech.2004.04.020; Schwarz D, 2014, DEVELOPMENT, V141, P867, DOI 10.1242/dev.094342; Sher F, 2008, STEM CELLS, V26, P2875, DOI 10.1634/stemcells.2008-0121; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; Vandamme J, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002642; Vandyke K, 2009, LEUKEMIA, V23, P2155, DOI 10.1038/leu.2009.150; Vandyke K, 2010, J BONE MINER RES, V25, P1759, DOI 10.1002/jbmr.85; Wang LF, 2010, P NATL ACAD SCI USA, V107, P7317, DOI 10.1073/pnas.1000031107; Wei YK, 2011, NAT CELL BIOL, V13, P87, DOI 10.1038/ncb2139; Wyngaarden LA, 2011, DEVELOPMENT, V138, P3759, DOI 10.1242/dev.063180; YATES AJP, 1988, BAILLIERE CLIN ENDOC, V2, P267, DOI 10.1016/S0950-351X(88)80015-6	51	41	41	1	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2017	31	3					1011	+		10.1096/fj.201600748R	http://dx.doi.org/10.1096/fj.201600748R			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EM9ZX	27934660				2022-12-26	WOS:000395671200017
J	Kareva, I; Abou-Slaybi, A; Dodd, O; Dashevsky, O; Klement, GL				Kareva, Irina; Abou-Slaybi, Abdo; Dodd, Oliver; Dashevsky, Olga; Klement, Giannoula Lakka			Normal Wound Healing and Tumor Angiogenesis as a Game of Competitive Inhibition	PLOS ONE			English	Article							PLATELET HEMOSTATIC FUNCTIONS; ENDOTHELIAL GROWTH-FACTOR; ALPHA-GRANULE PROTEINS; HEPARIN AFFINITY; RELEASE; ENDOSTATIN; CANCER; STROMA; CELLS	Both normal wound healing and tumor angiogenesis are mitigated by the sequential, carefully orchestrated release of growth stimulators and inhibitors. These regulators are released from platelet clots formed at the sites of activated endothelium in a temporally and spatially controlled manner, and the order of their release depends on their affinity to glycosaminoglycans (GAG) such as heparan sulfate (HS) within the extracellular matrix, and platelet open canallicular system. The formation of vessel sprouts, triggered by angiogenesis regulating factors with lowest affinities for heparan sulfate (e.g. VEGF), is followed by vessel-stabilizing PDGF-B or bFGF with medium affinity for HS, and by inhibitors such as PF-4 and TSP-1 with the highest affinities for HS. The invasive wound-like edge of growing tumors has an overabundance of angiogenesis stimulators, and we propose that their abundance out-competes angiogenesis inhibitors, effectively preventing inhibition of angiogenesis and vessel maturation. We evaluate this hypothesis using an experimentally motivated agent-based model, and propose a general theoretical framework for understanding mechanistic similarities and differences between the processes of normal wound healing and pathological angiogenesis from the point of view of competitive inhibition.	[Kareva, Irina; Abou-Slaybi, Abdo; Dodd, Oliver; Dashevsky, Olga; Klement, Giannoula Lakka] Tufts Med Ctr, Floating Hosp Children, Boston, MA 02111 USA; [Kareva, Irina] Arizona State Univ, Math Computat & Modeling Sci Ctr, Tempe, AZ USA; [Dodd, Oliver] MIT, Boston, MA USA; [Dashevsky, Olga] Harvard Med Sch, Dana Farber Canc Inst, Dept Med, Dept Med Oncol, Boston, MA USA; [Klement, Giannoula Lakka] Tufts Med Ctr, Floating Hosp Children, Pediat Hematol Oncol, Boston, MA 02111 USA; [Klement, Giannoula Lakka] Tufts Univ, Sackler Sch Grad Biomed Sci, Boston, MA 02111 USA	Floating Hospital For Children; Tufts Medical Center; Arizona State University; Arizona State University-Tempe; Massachusetts Institute of Technology (MIT); Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Floating Hospital For Children; Tufts Medical Center; Tufts University	Klement, GL (corresponding author), Tufts Med Ctr, Floating Hosp Children, Boston, MA 02111 USA.; Klement, GL (corresponding author), Tufts Med Ctr, Floating Hosp Children, Pediat Hematol Oncol, Boston, MA 02111 USA.; Klement, GL (corresponding author), Tufts Univ, Sackler Sch Grad Biomed Sci, Boston, MA 02111 USA.	Giannoula.Klement@tufts.edu	Klement, Giannoula Lakka/U-3091-2019		NIH [R01GM093050];  [R01GM093050-01A1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093050] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by R01GM093050-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge the editorial help of Allison Jenks in preparation of this manuscript. GLK would like to acknowledge funding from NIH R01GM093050 grant.	Abramovitch R, 1998, FEBS LETT, V425, P441, DOI 10.1016/S0014-5793(98)00283-X; Anderson ARA, 1998, B MATH BIOL, V60, P857, DOI 10.1006/bulm.1998.0042; Blanco R, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a006569; Boas SEM, 2013, MECH CHEM SIGNALING, P161; Carmeliet P, 2011, NAT REV DRUG DISCOV, V10, P417, DOI 10.1038/nrd3455; Cervi D, 2008, BLOOD, V111, P1201, DOI 10.1182/blood-2007-04-084798; Chaplain MAJ, 2006, ANNU REV BIOMED ENG, V8, P233, DOI 10.1146/annurev.bioeng.8.061505.095807; Dejana E, 2009, CELL TISSUE RES, V335, P17, DOI 10.1007/s00441-008-0694-5; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; ELDOR A, 1987, SEMIN THROMB HEMOST, V13, P475, DOI 10.1055/s-2007-1003524; Estrella V, 2013, CANCER RES, V73, P1524, DOI 10.1158/0008-5472.CAN-12-2796; Etulain J, 2011, J THROMB HAEMOST, V9, P1562, DOI 10.1111/j.1538-7836.2011.04394.x; Etulain J, 2012, THROMB HAEMOSTASIS, V107, P99, DOI 10.1160/TH11-06-0443; FOLKMAN J, 1992, ADV EXP MED BIOL, V313, P355; Fukumura D, 2001, CANCER RES, V61, P6020; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gerhardt Holger, 2008, P68, DOI 10.1007/978-0-387-78632-2_6; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Italiano JE, 2009, J THROMB HAEMOST, V7, P173, DOI 10.1111/j.1538-7836.2009.03387.x; Italiano JE, 2003, J THROMB HAEMOST, V1, P1174, DOI 10.1046/j.1538-7836.2003.00290.x; Italiano JE, 2008, BLOOD, V111, P1227, DOI 10.1182/blood-2007-09-113837; Jakobsson L, 2009, BIOCHEM SOC T, V37, P1233, DOI 10.1042/BST0371233; KLAGSBRUN M, 1985, P NATL ACAD SCI USA, V82, P805, DOI 10.1073/pnas.82.3.805; Klement GL, 2011, CURR PROTEOMICS, V8, P169; Klement GL, 2009, BLOOD, V113, P2835, DOI 10.1182/blood-2008-06-159541; Levine HA, 2001, B MATH BIOL, V63, P801, DOI 10.1006/bulm.2001.0240; Ma L, 2005, P NATL ACAD SCI USA, V102, P216, DOI 10.1073/pnas.0406682102; Ma L, 2001, BRIT J PHARMACOL, V134, P701, DOI 10.1038/sj.bjp.0704312; Mehdizadeh H, 2013, BIOMATERIALS, V34, P2875, DOI 10.1016/j.biomaterials.2012.12.047; Mekhail K, 2004, NAT CELL BIOL, V6, P642, DOI 10.1038/ncb1144; Peirce S, 2008, MICROCIRCULATION, V15, P739, DOI 10.1080/10739680802220331; Peterson JE, 2010, AM J HEMATOL, V85, P487, DOI 10.1002/ajh.21732; SHING Y, 1984, SCIENCE, V223, P1296, DOI 10.1126/science.6199844; VLODAVSKY I, 1995, THROMB HAEMOSTASIS, V74, P534; Vlodavsky I, 1988, Adv Exp Med Biol, V233, P201; Vlodavsky I, 2011, RAMBAM MAIMONIDES ME, V2, DOI 10.5041/RMMJ.10019; Xie L, 2011, P NATL ACAD SCI USA, V108, P9939, DOI 10.1073/pnas.1105041108	37	21	21	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0166655	10.1371/journal.pone.0166655	http://dx.doi.org/10.1371/journal.pone.0166655			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935954	Green Published, gold, Green Submitted			2022-12-26	WOS:000389587100039
J	Amiri, M; Khosravi, A; Eghtesadi, AR; Sadeghi, Z; Abedi, G; Ranjbar, M; Mehrabian, F				Amiri, Mohammad; Khosravi, Ahmad; Eghtesadi, Ahmad Reza; Sadeghi, Zakieh; Abedi, Ghasem; Ranjbar, Mansour; Mehrabian, Fardin			Burnout and its Influencing Factors among Primary Health Care Providers in the North East of Iran	PLOS ONE			English	Article							JOB-SATISFACTION; COMPASSION SATISFACTION; NURSES; STRESS; RESOURCES; WORKERS; ENVIRONMENT; PREVALENCE; RESIDENTS; DEMANDS	Introduction Burnout is a popular research topics in service providing jobs, including the health care field. This study aimed at assessing the level of job burnout and to consider the important antecedents which might be related to job burnout among primary health care providers in Iran. Methods The participants in this applied cross-sectional study which was conducted in 2013 were 548 primary health care providers who were randomly selected from among those working in Shahroud, Sabzevar, Neishabour, Bojnord (provinces located in the north east of Iran). Maslach Burnout Inventory (MBI) was administered to the participants and the collected data were analyzed using SPSS through chi-square test and ordinal logistic regression model. Results The burnout mean score among the participants was 54.1 +/- 27.2 and the mean scores of burnout components i. e., emotional exhaustion, depersonalization and personal accomplishment were 15.5 +/- 13.6, 3.7 +/- 5.4 and 35.5 +/- 13.5 respectively. In terms of levels of burnout, 64.2% of the participants showed low levels (n = 352), 18.4% average levels (n = 101) and 17.3% high levels (n = 95). A significant relationship was observed between burnout, job resources and interest in job (p <= 0.05). However, no significant relationship was observed between burnout and the place (university) of working, age, satisfaction with income, experience, gender, level of education, marital status, housing status, having a second job and place of residence (p >= 0.05). Conclusion Lack of personal accomplishment was highly prevalent among the participating primary health care providers. Lack of career advancement and job transfer opportunities may play a role in the burnout of primary health care providers. Therefore, paying attention to this aspect may help to reduce burnout and even increase job engagement.	[Amiri, Mohammad] Shahroud Univ Med Sci, Sch Publ Hlth, Dept Publ Hlth, Shahroud, Iran; [Khosravi, Ahmad] Shahroud Univ Med Sci, Ctr Hlth Related Social & Behav Sci Res, Shahroud, Iran; [Eghtesadi, Ahmad Reza] Farhangian Univ, Dept English Language Teaching, Shahid Beheshti Campus, Mashhad, Iran; [Abedi, Ghasem] Mazandaran Univ Med Sci, Hlth Sci Res Ctr, Sari, Iran; [Ranjbar, Mansour] Mazandaran Univ Med Sci, Dept Publ Hlth, Sari, Iran; [Mehrabian, Fardin] Guilan Univ Med Sci, Sch Hlth, Dept Hlth Educ & Promot, Rasht, Iran	Shahroud University Medical Sciences; Shahroud University Medical Sciences; Mazandaran University Medical Sciences; Mazandaran University Medical Sciences	Mehrabian, F (corresponding author), Guilan Univ Med Sci, Sch Hlth, Dept Hlth Educ & Promot, Rasht, Iran.	mehrabian@gums.ac.ir	Amiri, Mohammd -/P-6088-2018; Mehrabian, Fardin/A-6706-2018	Amiri, Mohammd -/0000-0003-2151-8530; 	Shahroud University of Medical Sciences [9121]	Shahroud University of Medical Sciences	The present work was supported by Shahroud University of Medical Sciences (# 9121).	Adriaenssens J, 2015, INT J NURS STUD, V52, P649, DOI 10.1016/j.ijnurstu.2014.11.004; Adwan JZ, 2014, J PEDIATR NURS, V29, P329, DOI 10.1016/j.pedn.2014.01.011; Allen J, 2002, WESTERN J NURS RES, V24, P905, DOI 10.1177/019394502237701; Anagnostopoulos F, 2012, J CLIN PSYCHOL MED S, V19, P401, DOI 10.1007/s10880-011-9278-8; Arab M, 2012, J SHAHREKORD U MED S, V14, P62; Arefi M, 2010, LEVELS BURN OUT ITS; Ashill NJ, 2011, J BUS RES, V64, P1116, DOI 10.1016/j.jbusres.2010.11.004; Bakker A., 2014, BURNOUT RES, V1, P112, DOI [10.1016/j.burn.2014.04.003, DOI 10.1016/J.BURN.2014.04.003]; Boyas J, 2012, CHILD YOUTH SERV REV, V34, P50, DOI 10.1016/j.childyouth.2011.08.033; Burisch M, 2002, WORK STRESS, V16, P1, DOI 10.1080/02678370110112506; Caliskan A, 2012, PROCD SOC BEHV, V47, P1392, DOI 10.1016/j.sbspro.2012.06.831; Chin WS, 2015, INT J NURS STUD, V52, P297, DOI 10.1016/j.ijnurstu.2014.09.003; Craiovan PM, 2014, PROCD SOC BEHV, V127, P534, DOI 10.1016/j.sbspro.2014.03.304; Demerouti E, 2001, J APPL PSYCHOL, V86, P499, DOI 10.1037//0021-9010.86.3.499; Felton JS, 1998, OCCUP MED-OXFORD, V48, P237, DOI 10.1093/occmed/48.4.237; Fletcher CE, 2001, J NURS ADMIN, V31, P324, DOI 10.1097/00005110-200106000-00011; Garrosa E, 2011, INT J NURS STUD, V48, P479, DOI 10.1016/j.ijnurstu.2010.08.004; Gil-Monte PR, 2002, SALUD PUBLICA MEXICO, V44, P33; Hillhouse JJ, 1997, SOC SCI MED, V45, P1781, DOI 10.1016/S0277-9536(97)00109-3; Kalliath T, 2002, J NURS ADMIN, V32, P648, DOI 10.1097/00005110-200212000-00010; Kendrick P, 2000, AANA J, V68, P115; Ksiazek I, 2011, EUR J ONCOL NURS, V15, P347, DOI 10.1016/j.ejon.2010.09.002; Li A, 2014, J PROF NURS, V30, P89, DOI 10.1016/j.profnurs.2013.04.004; Lizano EL, 2012, CHILD YOUTH SERV REV, V34, P1769, DOI 10.1016/j.childyouth.2012.02.006; Losa Iglesias ME, 2010, INT J NURS STUD, V47, P30, DOI 10.1016/j.ijnurstu.2009.06.014; Martini S, 2006, ACAD PSYCHIATR, V30, P352, DOI 10.1176/appi.ap.30.4.352; Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; Maslach C, 2001, PSYCHOL HEALTH, V16, P607, DOI 10.1080/08870440108405530; Maslach C, 2016, MASLACH BURNOUT INVE; Meyer RML, 2015, J PEDIATR NURS, V30, P174, DOI 10.1016/j.pedn.2013.12.008; Miller, 2011, J RADIOLOGICAL NURSI, V30, P146, DOI DOI 10.1016/J.JRADNU.2011.07.004; Mirabzadeh A, 2007, BURNOUT ITS EFFECTIV; Olley B O, 2003, Afr J Med Med Sci, V32, P297; Organization WHO, 1998, PRIM PREV MENT NEUR, P91; Pardakhtchi M, 2009, QUALITY WORK LIFE BU; Piko BF, 2006, INT J NURS STUD, V43, P311, DOI 10.1016/j.ijnurstu.2005.05.003; Portoghese I, 2014, SAF HEALTH WORK-KR, V5, P152, DOI 10.1016/j.shaw.2014.05.004; Rashedi V, 2012, J KERMANSHAH U MED S, V16, P28; Rudman A, 2011, INT J NURS STUD, V48, P292, DOI 10.1016/j.ijnurstu.2010.07.012; Sahebzadeh M, 2011, JOB BURNOUT NURSING; Scarnera P, 2009, COMMUNITY MENT HLT J, V45, P222, DOI 10.1007/s10597-008-9178-z; Schmitz N, 2000, INT J NURS STUD, V37, P95, DOI 10.1016/S0020-7489(99)00069-3; Sherman DW, 2004, AM J NURS, V104, P48, DOI 10.1097/00000446-200405000-00020; Sotudeh Asl N, 2006, SCI J KURDISTAN U ME, V11, P77; Stechmiller J, 1992, HEART LUNG J CRITICA, V22, P534; Talaei A., 2008, Koomesh, V9, P237; Thomsen S, 1999, PSYCHOTHER PSYCHOSOM, V68, P157, DOI 10.1159/000012325; Van Bogaert P, 2013, INT J NURS STUD, V50, P357, DOI 10.1016/j.ijnurstu.2012.05.006; Williams S, 2013, J MANIP PHYSIOL THER, V36, P376, DOI 10.1016/j.jmpt.2013.05.025; Zalaquett CP, 1998, EVALUATING STRESS; Zhang LF, 2014, NURS OUTLOOK, V62, P128, DOI 10.1016/j.outlook.2013.10.010	51	21	24	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167648	10.1371/journal.pone.0167648	http://dx.doi.org/10.1371/journal.pone.0167648			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4OA	27930726	gold, Green Submitted, Green Published			2022-12-26	WOS:000389580900033
J	Kurobe, M; Kojima, T; Nishimura, K; Kandori, S; Kawahara, T; Yoshino, T; Ueno, S; Iizumi, Y; Mitsuzuka, K; Arai, Y; Tsuruta, H; Habuchi, T; Kobayashi, T; Matsui, Y; Ogawa, O; Sugimoto, M; Kakehi, Y; Nagumo, Y; Tsutsumi, M; Oikawa, T; Kikuchi, K; Nishiyama, H				Kurobe, Masahiro; Kojima, Takahiro; Nishimura, Kouichi; Kandori, Shuya; Kawahara, Takashi; Yoshino, Takayuki; Ueno, Satoshi; Iizumi, Yuichi; Mitsuzuka, Koji; Arai, Yoichi; Tsuruta, Hiroshi; Habuchi, Tomonori; Kobayashi, Takashi; Matsui, Yoshiyuki; Ogawa, Osamu; Sugimoto, Mikio; Kakehi, Yoshiyuki; Nagumo, Yoshiyuki; Tsutsumi, Masakazu; Oikawa, Takehiro; Kikuchi, Koji; Nishiyama, Hiroyuki			Development of RNA-FISH Assay for Detection of Oncogenic FGFR3-TACC3 Fusion Genes in FFPE	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR-3; LETHAL SKELETAL DYSPLASIA; UROTHELIAL CARCINOMA; URINARY-BLADDER; FGFR3 MUTATIONS; LUNG-CANCER; CELL-LINES; LOW-GRADE; ACTIVATION; IDENTIFICATION	Introduction and Objectives Oncogenic FGFR3-TACC3 fusions and FGFR3 mutations are target candidates for small molecule inhibitors in bladder cancer (BC). Because FGFR3 and TACC3 genes are located very closely on chromosome 4p16.3, detection of the fusion by DNA-FISH (fluorescent in situ hybridization) is not a feasible option. In this study, we developed a novel RNA-FISH assay using branched DNA probe to detect FGFR3-TACC3 fusions in formaldehyde-fixed paraffin-embedded (FFPE) human BC samples. Materials and Methods The RNA-FISH assay was developed and validated using a mouse xenograft model with human BC cell lines. Next, we assessed the consistency of the RNA-FISH assay using 104 human BC samples. In this study, primary BC tissues were stored as frozen and FFPE tissues. FGFR3-TACC3 fusions were independently detected in FFPE sections by the RNA-FISH assay and in frozen tissues by RT-PCR. We also analyzed the presence of FGFR3 mutations by targeted sequencing of genomic DNA extracted from deparaffinized FFPE sections. Results FGFR3-TACC3 fusion transcripts were identified by RNA-FISH and RT-PCR in mouse xenograft FFPE tissues using the human BC cell lines RT112 and RT4. These cell lines have been reported to be fusion-positive. Signals for FGFR3-TACC3 fusions by RNA-FISH were positive in 2/60 (3%) of non-muscle-invasive BC (NMIBC) and 2/44 (5%) muscle-invasive BC (MIBC) patients. The results of RT-PCR of all 104 patients were identical to those of RNA-FISH. FGFR3 mutations were detected in 27/60 (45%) NMIBC and 8/44 (18%) MIBC patients. Except for one NMIBC patient, FGFR3 mutation and FGFR3-TACC3 fusion were mutually exclusive. Conclusions We developed an RNA-FISH assay for detection of the FGFR3-TACC3 fusion in FFPE samples of human BC tissues. Screening for not only FGFR3 mutations, but also for FGFR3-TACC3 fusion transcripts has the potential to identify additional patients that can be treated with FGFR inhibitors.	[Kurobe, Masahiro; Kojima, Takahiro; Kandori, Shuya; Kawahara, Takashi; Yoshino, Takayuki; Nishiyama, Hiroyuki] Univ Tsukuba, Dept Urol, Fac Med, Tsukuba, Ibaraki, Japan; [Nishimura, Kouichi] Astellas Pharma Inc, Tsukuba, Ibaraki, Japan; [Ueno, Satoshi; Iizumi, Yuichi] Univ Tsukuba, Fac Med, Tsukuba Clin Res & Dev Org T CReDO, Tsukuba, Ibaraki, Japan; [Mitsuzuka, Koji; Arai, Yoichi] Tohoku Univ, Grad Sch Med, Dept Urol, Sendai, Miyagi, Japan; [Tsuruta, Hiroshi; Habuchi, Tomonori] Akita Univ, Grad Sch Med, Dept Urol, Akita, Japan; [Kobayashi, Takashi; Matsui, Yoshiyuki; Ogawa, Osamu] Kyoto Univ, Grad Sch Med, Dept Urol, Kyoto, Japan; [Sugimoto, Mikio; Kakehi, Yoshiyuki] Kagawa Univ, Dept Urol, Fac Med, Takamatsu, Kagawa, Japan; [Nagumo, Yoshiyuki; Tsutsumi, Masakazu] Hitachi Gen Hosp, Dept Urol, Hitachi, Ibaraki, Japan; [Oikawa, Takehiro; Kikuchi, Koji] Tsukuba Med Ctr Hosp, Dept Urol, Tsukuba, Ibaraki, Japan	University of Tsukuba; Astellas Pharmaceuticals; University of Tsukuba; Tohoku University; Akita University; Kyoto University; Kagawa University	Nishiyama, H (corresponding author), Univ Tsukuba, Dept Urol, Fac Med, Tsukuba, Ibaraki, Japan.	nishiuro@md.tsukuba.ac.jp	Kandori, Shuya/V-4257-2019; KUROBE, MASAHIRO/AAE-7786-2021; MATSUI, Yoshiyuki/I-2323-2019	Kandori, Shuya/0000-0003-4621-8470; UENO, Satoshi/0000-0001-9495-737X	Astellas; Japan Society for the Promotion of Science (JSPS) [26670696, 26293349]	Astellas(Astellas Pharmaceuticals); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The study was funded by Astellas (H.N.), and designed and analyzed by the authors in collaboration with Astellas. Astellas had a role in the design and conduct of the study; management, analysis, and interpretation of the data; and preparation, review, and approval of the manuscript. This work was also supported in part by a Grant-in-Aid for Challenging Exploratory Research (H.N.) (grant number 26670696) and a Grant-in-Aid for Scientific Research B (H.N.) (grant number 26293349) from the Japan Society for the Promotion of Science (JSPS) (https://www.jsps.go.jp/english/). The JSPS had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adar R, 2002, J BONE MINER RES, V17, P860, DOI 10.1359/jbmr.2002.17.5.860; Al-Ahmadie HA, 2011, J PATHOL, V224, P270, DOI 10.1002/path.2892; Bakkar AA, 2003, CANCER RES, V63, P8108; Battich N, 2013, NAT METHODS, V10, P1127, DOI 10.1038/nmeth.2657; Bernard-Pierrot I, 2006, CARCINOGENESIS, V27, P740, DOI 10.1093/carcin/bgi290; Billerey C, 2001, AM J PATHOL, V158, P1955, DOI 10.1016/S0002-9440(10)64665-2; BUBENIK J, 1973, INT J CANCER, V11, P765, DOI 10.1002/ijc.2910110327; Carneiro BA, 2015, GYNECOL ONCOL REP, V13, P53, DOI 10.1016/j.gore.2015.06.005; d'Avis PY, 1998, CELL GROWTH DIFFER, V9, P71; Di Stefano AL, 2015, CLIN CANCER RES, V21, P3307, DOI 10.1158/1078-0432.CCR-14-2199; Elliott K, 2015, J CLIN PATHOL, V68, P766, DOI 10.1136/jclinpath-2015-203178; Femino A, 1998, SCIENCE, V280, P585, DOI 10.1126/science.280.5363.585; Guancial EA, 2014, CANCER MED-US, V3, P835, DOI 10.1002/cam4.262; Guo GW, 2013, NAT GENET, V45, P1459, DOI 10.1038/ng.2798; Hayat M A., 2006, HDB IMMUNOHISTOCHEMI, V1, P8; Kiflemariam S, 2014, J PATHOL, V234, P253, DOI 10.1002/path.4392; Kimura T, 2001, CANCER-AM CANCER SOC, V92, P2555, DOI 10.1002/1097-0142(20011115)92:10<2555::AID-CNCR1607>3.0.CO;2-M; Knowles MA, 2015, NAT REV CANCER, V15, P25, DOI 10.1038/nrc3817; Kwon S, 2013, BMB REP, V46, P65, DOI 10.5483/BMBRep.2013.46.2.016; Lu B, 2009, UROLOGY, V74, P1156, DOI 10.1016/j.urology.2009.01.087; Majewski IJ, 2013, J PATHOL, V230, P270, DOI 10.1002/path.4209; Markey FB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093488; MARSHALL CJ, 1977, J NATL CANCER I, V58, P1743, DOI 10.1093/jnci/58.6.1743; Nakanishi Y, 2015, MOL CANCER THER, V14, P704, DOI 10.1158/1535-7163.MCT-14-0927-T; Parker BC, 2013, J CLIN INVEST, V123, P855, DOI 10.1172/JCI67144; Perner S, 2008, NEOPLASIA, V10, P298, DOI 10.1593/NEO.07878; Poyet C, 2015, ONCOL LETT, V10, P2753, DOI 10.3892/ol.2015.3691; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Rieger-Christ KM, 2003, CANCER-AM CANCER SOC, V98, P737, DOI 10.1002/cncr.11536; RIGBY CC, 1970, BRIT J CANCER, V24, P746, DOI 10.1038/bjc.1970.89; Ross JS, 2014, MODERN PATHOL, V27, P271, DOI 10.1038/modpathol.2013.135; Semrau S, 2014, CELL REP, V6, P18, DOI 10.1016/j.celrep.2013.12.002; Shinmura K, 2014, ONCOL REP, V31, P1219, DOI 10.3892/or.2014.2984; Singh D, 2012, SCIENCE, V337, P1231, DOI 10.1126/science.1220834; Smal M. P., 2014, Experimental Oncology, V36, P246; TKACHUK DC, 1990, SCIENCE, V250, P559, DOI 10.1126/science.2237408; Tomlinson D, 2007, ONCOGENE, V26, P5889, DOI 10.1038/sj.onc.1210399; Tomlinson DC, 2007, J PATHOL, V213, P91, DOI 10.1002/path.2207; Urdinguio RG, 2013, CANCER RES, V73, P395, DOI 10.1158/0008-5472.CAN-12-0806; van Rhijn BSW, 2004, CANCER RES, V64, P1911, DOI 10.1158/0008-5472.CAN-03-2421; van Rhijn BWG, 2002, EUR J HUM GENET, V10, P819, DOI 10.1038/sj.ejhg.5200883; Webster MK, 1996, MOL CELL BIOL, V16, P4081; Weier C, 2013, J PATHOL, V230, P174, DOI 10.1002/path.4186; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Williams SV, 2013, HUM MOL GENET, V22, P795, DOI 10.1093/hmg/dds486; Wu YM, 2013, CANCER DISCOV, V3, P636, DOI 10.1158/2159-8290.CD-13-0050; YANAGIHARA K, 1991, CANCER RES, V51, P381	47	12	12	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0165109	10.1371/journal.pone.0165109	http://dx.doi.org/10.1371/journal.pone.0165109			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930669	Green Published, Green Submitted, gold			2022-12-26	WOS:000389580900002
J	Purcell, SW; Ngaluafe, P; Foale, SJ; Cocks, N; Cullis, BR; Lalavanua, W				Purcell, Steven W.; Ngaluafe, Poasi; Foale, Simon J.; Cocks, Nicole; Cullis, Brian R.; Lalavanua, Watisoni			Multiple Factors Affect Socioeconomics and Wellbeing of Artisanal Sea Cucumber Fishers	PLOS ONE			English	Article							JOB-SATISFACTION; FOOD SECURITY; MANAGEMENT; LIVELIHOODS; GOVERNANCE; TRADE; WOMEN	Small-scale fisheries are important to livelihoods and subsistence seafood consumption of millions of fishers. Sea cucumbers are fished worldwide for export to Asia, yet few studies have assessed factors affecting socioeconomics and wellbeing among fishers. We interviewed 476 men and women sea cucumber fishers at multiple villages within multiple locations in Fiji, Kiribati, Tonga and New Caledonia using structured questionnaires. Low rates of subsistence consumption confirmed a primary role of sea cucumbers in income security. Prices of sea cucumbers sold by fishers varied greatly among countries, depending on the species. Gender variation in landing prices could be due to women catching smaller sea cucumbers or because some traders take advantage of them. Dissatisfaction with fishery income was common (44% of fishers), especially for i-Kiribati fishers, male fishers, and fishers experiencing difficulty selling their catch, but was uncorrelated with sale prices. Income dissatisfaction worsened with age. The number of livelihood activities averaged 2.2-2.5 across countries, and varied significantly among locations. Sea cucumbers were often a primary source of income to fishers, especially in Tonga. Other common livelihood activities were fishing other marine resources, copra production in Kiribati, agriculture in Fiji, and salaried jobs in New Caledonia. Fishing other coastal and coral reef resources was the most common fall-back livelihood option if fishers were forced to exit the fishery. Our data highlight large disparities in subsistence consumption, gender-related price equity, and livelihood diversity among parallel artisanal fisheries. Improvement of supply chains in dispersed small-scale fisheries appears as a critical need for enhancing income and wellbeing of fishers. Strong evidence for co-dependence among small-scale fisheries, through fall-back livelihood preferences of fishers, suggests that resource managers must mitigate concomitant effects on other fisheries when considering fishery closures. That is likely to depend on livelihood diversification programs to take pressure off co-dependent fisheries.	[Purcell, Steven W.] Southern Cross Univ, Natl Marine Sci Ctr, Coffs Harbour, NSW, Australia; [Ngaluafe, Poasi] Minist Agr & Food Forests & Fisheries, Nukualofa, Tonga; [Foale, Simon J.] James Cook Univ, Coll Arts Soc & Educ, Townsville, Qld, Australia; [Cocks, Nicole; Cullis, Brian R.] Univ Wollongong, Fac Engn & Informat Sci, Natl Inst Appl Stat Res Australia, Sch Math & Appl Stat, Wollongong, NSW, Australia; [Lalavanua, Watisoni] Partners Community Dev Fiji, Suva, Fiji; [Lalavanua, Watisoni] Wildlife Conservat Soc, Suva, Fiji	Southern Cross University; James Cook University; University of Wollongong	Purcell, SW (corresponding author), Southern Cross Univ, Natl Marine Sci Ctr, Coffs Harbour, NSW, Australia.	steven.w.purcell@gmail.com	Purcell, Steven/I-2554-2013; Purcell, Steven/AAQ-1326-2021; Foale, Simon/M-5872-2014	Purcell, Steven/0000-0002-6227-6454; Purcell, Steven/0000-0002-6227-6454; Foale, Simon/0000-0003-0809-872X; Cullis, Brian/0000-0001-6319-8155	Australian Centre for International Agricultural Research (ACIAR) [PARDI/2010/004, FIS/2010/096]; Southern Cross University; Kiribati Ministry of Fisheries and Marine Resources Development; Tonga Ministry of Agriculture & Food, Forests and Fisheries, Department of Fisheries Fiji; Partners in Community Development Fiji	Australian Centre for International Agricultural Research (ACIAR)(Australian Ctr Intl Agr Res); Southern Cross University; Kiribati Ministry of Fisheries and Marine Resources Development; Tonga Ministry of Agriculture & Food, Forests and Fisheries, Department of Fisheries Fiji; Partners in Community Development Fiji	This study was funded by The Australian Centre for International Agricultural Research (ACIAR) through projects PARDI/2010/004 and FIS/2010/096. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Chris Barlow for guidance on the research. We are grateful for constructive criticisms and suggestions by the academic editor and two anonymous reviewers, which improved the quality of the manuscript. We acknowledge and thank Karibanang Tamuera-Aram for data collection in Kiribati, Sailasa Tagica for assistance with data collection in Fiji, and Natacha Agudo for data collection in New Caledonia. Support was also provided by Southern Cross University, Kiribati Ministry of Fisheries and Marine Resources Development, Tonga Ministry of Agriculture & Food, Forests and Fisheries, Department of Fisheries Fiji, and Partners in Community Development Fiji.	Allison EH, 2001, MAR POLICY, V25, P377, DOI 10.1016/S0308-597X(01)00023-9; [Anonymous], 2008, SPC BECHE DE MER INF; Bailey R. A., 2008, DESIGN COMP EXPT; Bene C, 2010, DEV POLICY REV, V28, P325, DOI 10.1111/j.1467-7679.2010.00486.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett Judith A., 1987, WEALTH SOLOMONS HIST; Berkes F., 2001, MANAGING SMALL SCALE; Brien CJ, 2009, J AGR BIOL ENVIR ST, V14, P253, DOI 10.1198/jabes.2009.08001; Browne C., 2006, PACIFIC ISLAND EC; Butler D, 2009, ASREML ASREML FITS L; Caldwell J, 2001, POPULATION OCEANIA 2; Campbell JR, 2015, REG ENVIRON CHANGE, V15, P1313, DOI 10.1007/s10113-014-0697-6; Carleton C., 2013, SPC FISHERIES NEWSLE, V140, P24; Catala R.L.A., 1957, ATOLL RES B, V59; Choo PohSze, 2008, FAO Fisheries and Aquaculture Technical Paper, P81; Christensen AE, 2010, MAKING ISLAND LIVING; Christensen AE, 2011, NAT RESOUR FORUM, V35, P9, DOI 10.1111/j.1477-8947.2011.01343.x; Cinner JE, 2009, CONSERV BIOL, V23, P124, DOI 10.1111/j.1523-1739.2008.01041.x; Cinner JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011999; Conand C., 2008, FAO Fisheries and Aquaculture Technical Paper, P143; Conand C, 1990, 2722 FAO; Connell J., 2005, REMITTANCES PACIFIC; Connell J, 2013, ISLANDS AT RISK?: ENVIRONMENTS, ECONOMIES AND CONTEMPORARY CHANGE, P230; Coulthard S, 2015, EXPLORING WELLBEING; Coulthard S, 2012, CURR OPIN ENV SUST, V4, P358, DOI 10.1016/j.cosust.2012.06.001; Coulthard S, 2011, GLOBAL ENVIRON CHANG, V21, P453, DOI 10.1016/j.gloenvcha.2011.01.003; Coulthard S, 2011, MAR POLICY, V35, P405, DOI 10.1016/j.marpol.2010.11.006; Demmke A., 2011, VULNERABILITY TROPIC, P733; Eriksson BH, 2010, AQUAT LIVING RESOUR, V23, P387, DOI 10.1051/alr/2011002; Eriksson H, 2015, MAR POLICY, V56, P16, DOI 10.1016/j.marpol.2015.02.005; Fabinyi M, 2015, FISH FISH, V16, P471, DOI 10.1111/faf.12069; FAO, 2011, STAT WORLD FISH AQ O; Foale S, 1997, FISH RES, V33, P1, DOI 10.1016/S0165-7836(97)00062-3; Foale SJ, 2005, SEA SLUGS SKIRMISHES; Friedman K, 2009, PAPUA NEW GUINEA COU; Friedman K, 2011, FISH FISH, V12, P75, DOI 10.1111/j.1467-2979.2010.00384.x; Frocklin S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091161; Gillett R, 2009, FISHERIES EC PACIFIC; Gillett R, 2011, FISHERIES PACIFIC IS; Gillett R., 2001, CONTRIBUTION FISHERI; Green A., 2006, SOLOMON ISLANDS MARI; Hair C, 2016, REG STUD MAR SCI, V5, P69, DOI 10.1016/j.rsma.2016.02.001; Hamel J. F., 2008, FAO Fisheries and Aquaculture Technical Paper, P257; Harper S, 2013, MAR POLICY, V39, P56, DOI 10.1016/j.marpol.2012.10.018; Jentoft S, 2010, MAR POLICY, V34, P1315, DOI 10.1016/j.marpol.2010.06.004; Kinch J., 2008, FAO Fisheries and Aquaculture Technical Paper, P57; Kinch J., 2008, FAO Fisheries and Aquaculture Technical Paper, P7; KIRCH PV, 2000, ROAD WINDS ARCHAEOLO; Kittinger JN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123856; Kleiber D, 2015, FISH FISH, V16, P547, DOI 10.1111/faf.12075; Koczberski G, 2006, VILLAGE BASED MARINE; Lambeth L., 2014, SPC WOMEN FISH INF B, V25, P21; Lindsay S, 2009, SEA CUCUMBER FISHERI; Militz TA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151624; Muallil RN, 2011, FISH RES, V111, P74, DOI 10.1016/j.fishres.2011.06.013; Namudu MT, 2006, J APPL PHYCOL, V18, P241, DOI 10.1007/s10811-006-9023-0; Ochiewo J, 2010, OCEAN COAST MANAGE, V53, P192, DOI 10.1016/j.ocecoaman.2010.01.010; Otero-Villanueva M., 2007, SPC BECHE DE MER INF, V25, P32; Pakoa K, 2013, STATUS SEA CUCUMBER; Pakoa K, 2013, BECHE INF BULL, V33, P49; Pakoa KM, 2013, STATUS TONGAS SEA CU; Pollnac RB, 2001, OCEAN COAST MANAGE, V44, P531, DOI 10.1016/S0964-5691(01)00064-3; Pollnac RB, 2006, HUM ORGAN, V65, P329, DOI 10.17730/humo.65.3.3j2w39a21tq3j4l1; Purcell S., 2016, BECHE INF BULL, V36, P58; Purcell SW, 2014, MAR POLICY, V45, P240, DOI 10.1016/j.marpol.2013.11.005; Purcell S.W., 2010, FAO FISH AQUAC TECH, V520, P157; Purcell S. W., 2009, WORLDFISH CTR STUDIE; Purcell SW, 2016, FISH RES, V183, P99, DOI 10.1016/j.fishres.2016.05.010; Purcell SW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095075; Purcell SW, 2013, FISH FISH, V14, P34, DOI 10.1111/j.1467-2979.2011.00443.x; Purcell SW, 2009, SPC BECHE DE MER INF, V29, P3; R Core Team, 2021, R LANGUAGE ENV STAT; Ram R., 2008, IMPACTS HARVEST POST; Reddy SMW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096817; Ruiz V, 2012, SOC INDIC RES, V109, P81, DOI 10.1007/s11205-012-0057-1; SHINEBERG D, 1966, J PAC HIST, V1, P129, DOI 10.1080/00223346608572084; Skewes T, 2004, CONVERSION RATIOS CO; Sugiyama S, 2004, USITC PUBL, V2004/25; Teh LSL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065397; Thomas FR, 2002, GEOGR J, V168, P163, DOI 10.1111/1475-4959.00045; Trimble M, 2013, MAR POLICY, V37, P37, DOI 10.1016/j.marpol.2012.04.002; United Nations Development Programme (UNDP), 2015, HUM DEV REP 2015 WOR; Ward Gerard, 1972, MAN PACIFIC ISLANDS, P91; Weeratunge N, 2010, FISH FISH, V11, P405, DOI 10.1111/j.1467-2979.2010.00368.x; Young MAL, 2016, MAR POLICY, V66, P114, DOI 10.1016/j.marpol.2016.01.018; Zhao MH, 2013, MAR POLICY, V37, P69, DOI 10.1016/j.marpol.2012.04.013	86	18	19	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0165633	10.1371/journal.pone.0165633	http://dx.doi.org/10.1371/journal.pone.0165633			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4OA	27930649	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000389580900005
J	Yeh, TC; Huang, TT; Yeh, TS; Chen, YR; Hsu, KW; Yin, PH; Lee, HC; Tseng, LM				Yeh, Ting-Chih; Huang, Tzu-Ting; Yeh, Tien-Shun; Chen, Yu-Ren; Hsu, Kai-Wen; Yin, Pen-Hui; Lee, Hsin-Chen; Tseng, Ling-Ming			miR-151-3p Targets TWIST1 to Repress Migration of Human Breast Cancer Cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; FOCAL-ADHESION KINASE; GASTRIC CARCINOGENESIS; GENE-EXPRESSION; METASTASIS; TUMOR; MICRORNAS; PROGNOSIS; CISPLATIN; SURVIVAL	TWIST1 is a highly conserved basic helix-loop-helix transcription factor that contributes to cancer metastasis by promoting an epithelial-mesenchymal transition and repressing E-cadherin gene expression in breast cancer. In this study, we explored the potential role of miR-151 in TWIST1 expression and cancer properties in human breast cancer cells. We found that the human TWIST1 3'UTR contains a potential binging site for miR-151-3p at the putative target sequence 5'-CAGUCUAG-3'. Using a TWIST1-3'UTR luciferase reporter assay, we demonstrated that the target sequence within the TWIST1 3'UTR is required for miR-151-3p regulation of TWIST1 expression. Moreover, we found that ectopic expression of miR-151-3p by infection with adenoviruses expressing miR-151 significantly decreased TWIST1 expression, migration and invasion, but did not affect cell growth and tumorsphere formation of human breast cancer cells. In addition, overexpression of the protein coding region without the 3'UTR of TWIST1 reversed the repression of cell migration by miR-151-3p. Furthermore, knockdown of miR-151-3p increased TWIST1 expression, reduced E-cadherin expression, and enhanced cell migration. In conclusion, these results suggest that miR-151-3p directly regulates TWIST1 expression by targeting the TWIST1 3'UTR and thus repressing the migration and invasion of human breast cancer cells by enhancing E-cadherin expression. Our findings add to accumulating evidence that microRNAs are involved in breast cancer progression by modulating TWIST1 expression.	[Yeh, Ting-Chih; Huang, Tzu-Ting; Yeh, Tien-Shun; Hsu, Kai-Wen] Natl Yang Ming Univ, Inst Anat & Cell Biol, Sch Med, Taipei, Taiwan; [Yeh, Ting-Chih; Huang, Tzu-Ting; Chen, Yu-Ren; Lee, Hsin-Chen] Natl Yang Ming Univ, Sch Med, Dept & Inst Pharmacol, Taipei, Taiwan; [Yin, Pen-Hui] Taipei Vet Gen Hosp, Dept Med Res, Taipei, Taiwan; [Tseng, Ling-Ming] Taipei Vet Gen Hosp, Dept Surg, Taipei, Taiwan; [Tseng, Ling-Ming] Natl Yang Ming Univ, Taipei, Taiwan; [Tseng, Ling-Ming] Taipei Veterans Gen Hosp, Comprehens Breast Hlth Ctr, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital	Lee, HC (corresponding author), Natl Yang Ming Univ, Sch Med, Dept & Inst Pharmacol, Taipei, Taiwan.; Tseng, LM (corresponding author), Taipei Vet Gen Hosp, Dept Surg, Taipei, Taiwan.; Tseng, LM (corresponding author), Natl Yang Ming Univ, Taipei, Taiwan.; Tseng, LM (corresponding author), Taipei Veterans Gen Hosp, Comprehens Breast Hlth Ctr, Taipei, Taiwan.	hclee2@ym.edu.tw; lmtseng@vghtpe.gov.tw	Lee, Hsin-Chen/H-6767-2019; Huang, Tzu-Ting/S-9455-2019	Huang, Tzu-Ting/0000-0002-3675-2760; Hsu, Kai-Wen/0000-0002-9736-8869; Lee, Hsin-Chen/0000-0001-7455-9593	Center of Excellence for Cancer Research at Taipei Veterans General; Ministry of Health and Welfare [MOHW103-TD-B-111-02, MOHW104-TDU-B-211-124-001, MOHW105-TDU-B-211-134003]; Executive Yuan; Ministry of Education, Aim for the Top University Plan; Ministry of Science and Technology, Taiwan [MOST101-2320-B-010-068-MY3, MOST101-2314-B-075-015-MY3, MOST 104-2320-B-075-006, MOST 104-2320-B-010-031, MOST 105-2320-B-010-034]	Center of Excellence for Cancer Research at Taipei Veterans General; Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan); Executive Yuan; Ministry of Education, Aim for the Top University Plan(Ministry of Education, Taiwan); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work was partly supported by grants from the Center of Excellence for Cancer Research at Taipei Veterans General, the Ministry of Health and Welfare (MOHW103-TD-B-111-02; MOHW104-TDU-B-211-124-001; MOHW105-TDU-B-211-134003), Executive Yuan; the grant from the Ministry of Education, Aim for the Top University Plan; and the grants MOST101-2320-B-010-068-MY3, MOST101-2314-B-075-015-MY3, MOST 104-2320-B-075-006, MOST 104-2320-B-010-031, and MOST 105-2320-B-010-034 from the Ministry of Science and Technology, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abba ML, 2016, J CLIN MED, V5, DOI 10.3390/jcm5010008; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bourgeois P, 1996, MAMM GENOME, V7, P915, DOI 10.1007/s003359900269; Chang YS, 2015, CANCER RES, V75, P3077, DOI 10.1158/0008-5472.CAN-14-3380; Chou YS, 2015, J CHIN MED ASSOC, V78, P438, DOI 10.1016/j.jcma.2015.05.002; Ding J, 2010, NAT CELL BIOL, V12, P390, DOI 10.1038/ncb2039; Edmonds MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101802; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Gu J, 2013, CURR PHARM DESIGN, V19, P1292; Guidi M, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-95; Haga CL, 2012, J BIOL CHEM, V287, P42695, DOI 10.1074/jbc.M112.387761; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hernandez JM, 2013, ANN SURG ONCOL, V20, pS625, DOI 10.1245/s10434-013-3106-3; Hsu KW, 2016, ONCOTARGET, V7, P38036, DOI 10.18632/oncotarget.9342; Hsu KW, 2014, CARCINOGENESIS, V35, P208, DOI 10.1093/carcin/bgt285; Huang TT, 2015, ONCOTARGET, V6, P18012, DOI 10.18632/oncotarget.4000; Hui ABY, 2013, CLIN CANCER RES, V19, P2154, DOI 10.1158/1078-0432.CCR-12-3572; Iorio MV, 2012, CARCINOGENESIS, V33, P1126, DOI 10.1093/carcin/bgs140; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Krell J, 2012, MOL DIAGN THER, V16, P167, DOI 10.2165/11632740-000000000-00000; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Li LZ, 2014, CARCINOGENESIS, V35, P469, DOI 10.1093/carcin/bgt330; Liu S, 2014, TUMOR BIOL, V35, P9131, DOI 10.1007/s13277-014-2177-5; Luedde L, 2010, HEPATOLOGY, V52, P1164, DOI [10.1002/hep.23854, DOI 10.1002/HEP23854]; Martin TA, 2005, ANN SURG ONCOL, V12, P488, DOI 10.1245/ASO.2005.04.010; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; McNally ME, 2013, HPB, V15, P260, DOI 10.1111/j.1477-2574.2012.00523.x; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Nairismagi ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066070; Puisieux A, 2006, BRIT J CANCER, V94, P13, DOI 10.1038/sj.bjc.6602876; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Steeg PS, 2016, NAT REV CANCER, V16, P201, DOI 10.1038/nrc.2016.25; Sun EH, 2014, EUR REV MED PHARMACO, V18, P2783; Tsukerman P, 2014, ONCOTARGET, V5, P12141, DOI 10.18632/oncotarget.2559; Vesuna F, 2008, BIOCHEM BIOPH RES CO, V367, P235, DOI 10.1016/j.bbrc.2007.11.151; Wang AM, 2014, ONCOTARGET, V5, P5002, DOI 10.18632/oncotarget.2073; Wei H, 2015, J CELL PHYSIOL, V230, P1003, DOI 10.1002/jcp.24793; Xu Y, 2014, INT J BIOL SCI, V10, P396, DOI 10.7150/ijbs.8193; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang LH, 2015, SCI REP-UK, V5, DOI 10.1038/srep13677; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Zhou Y, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/1756-9966-33-12; Zhu X, 2016, ONCOGENE, V35, P323, DOI 10.1038/onc.2015.84	43	34	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0168171	10.1371/journal.pone.0168171	http://dx.doi.org/10.1371/journal.pone.0168171			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930738	gold, Green Submitted, Green Published			2022-12-26	WOS:000389580900084
J	Jungmann, PM; Baum, T; Nevitt, MC; Nardo, L; Gersing, AS; Lane, NE; McCulloch, CE; Rummeny, EJ; Link, TM				Jungmann, Pia M.; Baum, Thomas; Nevitt, Michael C.; Nardo, Lorenzo; Gersing, Alexandra S.; Lane, Nancy E.; McCulloch, Charles E.; Rummeny, Ernst J.; Link, Thomas M.			Degeneration in ACL Injured Knees with and without Reconstruction in Relation to Muscle Size and Fat Content-Data from the Osteoarthritis Initiative	PLOS ONE			English	Article							ANTERIOR CRUCIATE LIGAMENT; PATIENT RELEVANT OUTCOMES; PHYSICAL-ACTIVITY; FOLLOW-UP; ARTICULAR-CARTILAGE; IMAGING TECHNIQUES; RANDOMIZED-TRIAL; HIGH PREVALENCE; SOCCER PLAYERS; ROTATOR CUFF	Background Anterior cruciate ligaments (ACL) injuries represent a major risk factor for early osteoarthritis (OA). Purpose To evaluate the prevalence and 4-year progression of knee OA measured with 3T MR-imaging in individuals with ruptured, reconstructed or normal ACL and to assess the impact of thigh muscle characteristics. Methods A total of 54 knees (23/54 male, 31/54 female) were recruited from the Osteoarthritis Initiative (OAI). At baseline, 15/54 subjects had prevalent ACL ruptures and 15/54 subjects had prevalent ACL reconstruction (24/54 normal ACL). Western Ontario and McMasters Universities Arthritis Index (WOMAC) scores, Physical Activity Scores of the Elderly (PASE) and thigh muscle characteristics including strength, fat infiltration (Goutallier score) and thigh muscle cross-sectional area (CSA) MR measurements were obtained at baseline. Wholeorgan MR-imaging Scores (WORMS) were obtained at baseline and at a 4-year follow-up time-point. Multivariate regression models, adjusting for covariates (age, gender, body mass index), were used for statistical analysis. Results At baseline, subjects with prevalent ACL ruptures had worse WORMS total scores (mean +/- SEM, 44.1 +/- 3.5) than subjects with ACL reconstruction (30.8 +/- 4.0; P = 0.015) and worse than subjects with normal ACL (21.3 +/- 3.0; P<0.001). Cartilage scores were worse in both femorotibial compartments in ACL injured knees than in knees with normal ACL (P<0.05). Knees with ACL reconstruction showed an increased degeneration of the medial meniscus (P = 0.036), cartilage degeneration at the medial femoral condyle (P = 0.011). In a multivariate regression model, including both ACL groups and total muscle characteristics as influence parameters, high thigh muscle CSA, high muscle/fat ratio and low Goutallier scores were associated with less degenerative changes at the knee, independent of ACL status. Knees with ACL reconstruction showed an increased progression of cartilage degeneration at the medial tibia compared to the normal ACL group (P = 0.027). Conclusions High thigh muscle CSA is associated with less degenerative changes at the knee, independent of the ACL status and may potentially be advantageous in the prevention of early OA.	[Jungmann, Pia M.; Baum, Thomas; Gersing, Alexandra S.; Rummeny, Ernst J.] Tech Univ Munich, Dept Radiol, Munich, Germany; [Nevitt, Michael C.; McCulloch, Charles E.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Nardo, Lorenzo; Link, Thomas M.] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, Musculoskeletal & Quantitat Imaging Res, San Francisco, CA 94143 USA; [Lane, Nancy E.] UC Davis Med Ctr, Dept Internal Med, Sacramento, CA USA	Technical University of Munich; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Davis	Jungmann, PM (corresponding author), Tech Univ Munich, Dept Radiol, Munich, Germany.	pia.jungmann@tum.de	Link, Thomas M. M/E-7522-2012; Baum, Thomas/M-6522-2014	Baum, Thomas/0000-0002-4574-5212; Jungmann, Pia/0000-0003-2198-3678	German Research Foundation (DFG); Technische Universitat Munchen; Commission for Clinical Research, Technische Universitaet Muenchen (TUM), TUM School of Medicine, Munich, Germany [8762152]; NIH [U01-AR055079, P50-AR060752, K24-AR04884, R01-AR052000]; OAI; National Institutes of Health, a branch of the Department of Health and Human Services [N01-AR-2-2258, N01-AR-2-2259, N01-AR-2-2260, N01-AR-2-2261, N01-AR-2-2262]; Pfizer, Inc.; Novartis Pharmaceuticals Corporation; Merck Research Laboratories; GlaxoSmithKline; NIH (National Institute of Arthritis and Musculoskeletal and Skin Diseases) [P50-AR060752, R01AR064771]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR066262] Funding Source: NIH RePORTER	German Research Foundation (DFG)(German Research Foundation (DFG)); Technische Universitat Munchen; Commission for Clinical Research, Technische Universitaet Muenchen (TUM), TUM School of Medicine, Munich, Germany; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OAI; National Institutes of Health, a branch of the Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer, Inc.(Pfizer); Novartis Pharmaceuticals Corporation(Novartis); Merck Research Laboratories(Merck & Company); GlaxoSmithKline(GlaxoSmithKline); NIH (National Institute of Arthritis and Musculoskeletal and Skin Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the German Research Foundation (DFG) and the Technische Universitat Munchen within the funding programme Open Access Publishing. The study was supported by the Commission for Clinical Research, Technische Universitaet Muenchen (TUM), TUM School of Medicine, Munich, Germany (Project Number 8762152). This study was funded by NIH U01-AR055079 and P50-AR060752, by NIH K24-AR04884 and R01-AR052000 and by the OAI. The OAI is a public private partnership comprised of five contracts (N01-AR-2-2258; N01-AR-2-2259; N01-AR-2-2260; N01-AR-2-2261; N01-AR-2-2262) funded by the National Institutes of Health, a branch of the Department of Health and Human Services, and conducted by the OAI Study Investigators. Private funding partners include Pfizer, Inc.; Novartis Pharmaceuticals Corporation; Merck Research Laboratories; and GlaxoSmithKline. The analyses in this study were funded through the NIH (National Institute of Arthritis and Musculoskeletal and Skin Diseases grants R01AR064771 and P50-AR060752). Private sector funding for the OAI is managed by the Foundation for the National Institutes of Health. This manuscript was prepared using an OAI public use data set and does not necessarily reflect the opinions or views of the OAI investigators, the NIH, or the private funding partners. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizai H, 2012, EUR RADIOL, V22, P1592, DOI 10.1007/s00330-012-2404-7; Alshewaier S, 2016, CLINICAL REHABILITAT; Asano H, 2004, ARTHROSCOPY, V20, P474, DOI 10.1016/j.arthro.2004.03.006; Asik M, 2007, KNEE SURG SPORT TR A, V15, P965, DOI 10.1007/s00167-007-0344-6; Bellabarba C, 1997, Am J Orthop (Belle Mead NJ), V26, P18; Bellamy N, 2005, CLIN EXP RHEUMATOL, V23, pS148; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; BENEKE R, 1991, EUR J APPL PHYSIOL O, V63, P424, DOI 10.1007/BF00868073; Crema MD, 2011, RADIOGRAPHICS, V31, P37, DOI 10.1148/rg.311105084; DANIEL DM, 1994, AM J SPORT MED, V22, P632, DOI 10.1177/036354659402200511; Desai N, 2014, KNEE SURG SPORT TR A, V22, P379, DOI 10.1007/s00167-013-2803-6; FERRETTI A, 1991, INT ORTHOP, V15, P367, DOI 10.1007/BF00186881; Fithian DC, 2005, AM J SPORT MED, V33, P335, DOI 10.1177/0363546504269590; Fleming Braden C, 2005, Curr Opin Orthop, V16, P354, DOI 10.1097/01.bco.0000176423.07865.d2; Frobell RB, 2015, BRIT J SPORT MED, V49, P700, DOI 10.1136/bjsports-2014-f232rep; Fuchs B, 1999, J SHOULDER ELB SURG, V8, P599, DOI 10.1016/S1058-2746(99)90097-6; Gersing AS, 2016, EUR RADIOL; Goldstein MG, 1999, ANN BEHAV MED, V21, P40, DOI 10.1007/BF02895032; Hanypsiak BT, 2008, AM J SPORT MED, V36, P671, DOI 10.1177/0363546508315468; Harris KP, 2015, JOURNAL OF ATHLETIC; Haughom B, 2012, KNEE, V19, P482, DOI 10.1016/j.knee.2011.06.015; Jomha NM, 1999, CLIN ORTHOP RELAT R, P188; Jungmann PM, 2015, OSTEOARTHR CARTILAGE, V23, P1144, DOI 10.1016/j.joca.2015.03.022; Jungmann PM, 2013, J MAGN RESON IMAGING, V38, P1415, DOI 10.1002/jmri.24137; Jungmann PM, 2012, AM J SPORT MED, V40, P2700, DOI 10.1177/0363546512461594; KANNUS P, 1987, J BONE JOINT SURG AM, V69A, P1007, DOI 10.2106/00004623-198769070-00008; Li XJ, 2011, RADIOLOGY, V258, P505, DOI 10.1148/radiol.10101006; Lippe J, 2012, ARTHROSCOPY, V28, P154, DOI 10.1016/j.arthro.2011.07.016; Lohmander LS, 2007, AM J SPORT MED, V35, P1756, DOI 10.1177/0363546507307396; Lohmander LS, 2004, ARTHRITIS RHEUM-US, V50, P3145, DOI 10.1002/art.20589; Louboutin H, 2009, KNEE, V16, P239, DOI 10.1016/j.knee.2008.11.004; Maletius W, 1999, AM J SPORT MED, V27, P711, DOI 10.1177/03635465990270060501; Meunier A, 2007, SCAND J MED SCI SPOR, V17, P230, DOI 10.1111/j.1600-0838.2006.00547.x; Mihelic R, 2011, INT ORTHOP; MOSTELLER RD, 1987, NEW ENGL J MED, V317, P1098, DOI 10.1056/nejm198710223171717; Murray MM, 2009, CLIN SPORT MED, V28, P51, DOI 10.1016/j.csm.2008.08.005; Nardo L, 2014, J MAGN RESON IMAGING, V39, P1178, DOI 10.1002/jmri.24278; Nishimori M, 2008, KNEE SURG SPORT TR A, V16, P270, DOI 10.1007/s00167-007-0458-x; Nordenvall R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104681; Oiestad BE, 2013, KNEE SURG SPORT TR A, V21, P942, DOI 10.1007/s00167-012-2161-9; Pan J, 2011, OSTEOARTHR CARTILAGE, V19, P65, DOI 10.1016/j.joca.2010.10.023; Peterfy CG, 2008, OSTEOARTHR CARTILAGE, V16, P1433, DOI 10.1016/j.joca.2008.06.016; Peterfy CG, 2004, OSTEOARTHR CARTILAGE, V12, P177, DOI 10.1016/j.joca.2003.11.003; Piasecki M, 2016, J PHYSIOL-LONDON, V594, P4525, DOI 10.1113/JP271087; Racine Jennifer, 2014, R I Med J (2013), V97, P25; Rau R, 2003, Z RHEUMATOL, V62, P555, DOI 10.1007/s00393-003-0516-9; Ronga M., 2014, JOINTS, V2, P137; Roos H, 1995, OSTEOARTHR CARTILAGE, V3, P261, DOI 10.1016/S1063-4584(05)80017-2; Safran M R, 1995, Am J Knee Surg, V8, P168; Selmi TAS, 2006, KNEE, V13, P353, DOI 10.1016/j.knee.2006.02.014; Slemenda C, 1998, ARTHRITIS RHEUM, V41, P1951, DOI 10.1002/1529-0131(199811)41:11<1951::AID-ART9>3.0.CO;2-9; Slemenda C, 1997, ANN INTERN MED, V127, P97, DOI 10.7326/0003-4819-127-2-199707150-00001; Stehling C, 2010, OSTEOARTHR CARTILAGE, V18, P776, DOI 10.1016/j.joca.2010.02.008; Stehling C, 2010, RADIOLOGY, V254, P509, DOI 10.1148/radiol.09090596; Tashman S, 2004, AM J SPORT MED, V32, P975, DOI 10.1177/0363546503261709; Theologis AA, 2011, ARTHROSCOPY, V27, P65, DOI 10.1016/j.arthro.2010.06.026; van der Hart Cor P, 2008, J Orthop Surg Res, V3, P24, DOI 10.1186/1749-799X-3-24; von Porat A, 2004, ANN RHEUM DIS, V63, P269, DOI 10.1136/ard.2003.008136; Wakahara T, 2015, CLIN PHYSIOL FUNCT I; WASHBURN RA, 1993, J CLIN EPIDEMIOL, V46, P153, DOI 10.1016/0895-4356(93)90053-4	60	16	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2016	11	12							e0166865	10.1371/journal.pone.0166865	http://dx.doi.org/10.1371/journal.pone.0166865			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4MR	27918596	Green Published, gold			2022-12-26	WOS:000389577100005
J	Perea, S; Vukic, J; Sanda, R; Doadrio, I				Perea, Silvia; Vukic, Jasna; Sanda, Radek; Doadrio, Ignacio			Ancient Mitochondrial Capture as Factor Promoting Mitonuclear Discordance in Freshwater Fishes: A Case Study in the Genus Squalius (Actinopterygii, Cyprinidae) in Greece	PLOS ONE			English	Article							INCIPIENT SPECIATION; INTROGRESSIVE HYBRIDIZATION; HAPLOTYPE RECONSTRUCTION; PHYLOGENETIC NETWORKS; EVOLUTIONARY HISTORY; ALBURNOIDES COMPLEX; POROUS GENOMES; DNA; PELOPONNESE; OSTEICHTHYES	Hybridization and incomplete lineage sorting are common confounding factors in phylogeny and speciation resulting in mitonuclear disparity. Mitochondrial introgression, a particular case of hybridization, may, in extreme cases, lead to replacement of the mitochondrial genome of one species with that of another (mitochondrial capture). We investigated mitochondrial introgression involving two species of the cyprinid genus Squalius in the western Peloponnese region of Greece using molecular and morphological data. We found evidence of complete mitochondrial introgression of Squalius keadicus into two populations recognized as Squalius peloponensis from the Miras and Pamissos River basins and a divergence of mitochondrial genomes of S. keadicus from the Evrotas basin from that of the introgressed populations dating from the Pleistocene. Secondary contact among basins is a possible factor in connection of the species and the introgression event. Morphological analyses support the hypothesis of mitochondrial introgression, as S. keadicus was different from the other three populations recognized as S. peloponensis, although significant differences were found among the four populations. Isolation by geographical barriers arose during Pleistocene in the western Peloponnese were the source of the evolution of the two reciprocally monophyletic subclades found in the S. keadicus mitochondrial Glade, and the morphological differences found among the four populations. Along with the lack of structure in the nuclear genome in the three populations ascribed to S. peloponensis, this suggests an incipient speciation process occurring in these Squalius species in the western Peloponnese.	[Perea, Silvia; Doadrio, Ignacio] Museo Nacl Ciencias Nat CSIC, Biodivers & Evolutionary Grp, C Jose Gutierrez Abascal, Madrid, Spain; [Vukic, Jasna] Charles Univ Prague, Fac Sci, Dept Ecol, Prague, Czech Republic; [Sanda, Radek] Natl Museum, Dept Zool, Prague, Czech Republic	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Charles University Prague; National Museum	Perea, S (corresponding author), Museo Nacl Ciencias Nat CSIC, Biodivers & Evolutionary Grp, C Jose Gutierrez Abascal, Madrid, Spain.	sperea2@gmail.com	Perea, Silvia/A-7620-2018; Doadrio, Ignacio/F-8448-2016; Vukic, Jasna/D-2811-2015	Perea, Silvia/0000-0003-0436-8577; Doadrio, Ignacio/0000-0003-4863-9711; Vukic, Jasna/0000-0003-2243-0303	Spanish Ministry of Economy and Competitiveness [CGL2013-41375-P]; Czech Science Foundation [GM 5-19382S]; SYNTHESYS Programme at the Museo Nacional de Ciencias Naturales (CSIC) - European Community Research Infrastructure Action under the FP7 "Capacities" Programme [ES-TAF-5255]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Czech Science Foundation(Grant Agency of the Czech Republic); SYNTHESYS Programme at the Museo Nacional de Ciencias Naturales (CSIC) - European Community Research Infrastructure Action under the FP7 "Capacities" Programme	This study was financially sponsored by the Spanish Ministry of Economy and Competitiveness (project CGL2013-41375-P) to ID and SP, the Czech Science Foundation (project GM 5-19382S) to JV and RS, and by the SYNTHESYS Programme project ES-TAF-5255 at the Museo Nacional de Ciencias Naturales (CSIC), financed by European Community Research Infrastructure Action under the FP7 "Capacities" Programme to RS.	Aboim MA, 2010, J EVOLUTION BIOL, V23, P817, DOI 10.1111/j.1420-9101.2010.01953.x; Aguilar A, 2009, MOL PHYLOGENET EVOL, V51, P373, DOI 10.1016/j.ympev.2008.11.028; Alexander HJ, 2004, J EVOLUTION BIOL, V17, P1238, DOI 10.1111/j.1420-9101.2004.00788.x; [Anonymous], 2007, TRACER V 1 6; Athanassas C, 2010, THESIS; Athanassas C, 2013, J EARTH SCI-CHINA, V24, P410, DOI 10.1007/s12583-013-0334-1; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Barbanera F, 2009, MOL PHYLOGENET EVOL, V52, P103, DOI 10.1016/j.ympev.2009.02.006; Bohlen J, 2006, MOL PHYLOGENET EVOL, V39, P552, DOI 10.1016/j.ympev.2005.12.007; Bohme M., 2003, FOSFARBASE; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Broughton RE, 2011, GENETICA, V139, P699, DOI 10.1007/s10709-011-9578-9; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Bryson RW, 2014, ZOOL J LINN SOC-LOND, V172, P103, DOI 10.1111/zoj12169; Bryson RW, 2010, EVOLUTION, V64, P2315, DOI 10.1111/j.1558-5646.2010.01014.x; BURNABY TP, 1966, BIOMETRICS, V22, P96, DOI 10.2307/2528217; CABRERA L, 1985, Acta Geologica Hispanica, V20, P219; Chan KMA, 2005, EVOLUTION, V59, P720; Cheviron ZA, 2009, EVOLUTION, V63, P1593, DOI 10.1111/j.1558-5646.2009.00644.x; Costedoat C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000357; Cunha C, 2004, MOL ECOL, V13, P2807, DOI 10.1111/j.1365-294X.2004.02283.x; Cunha C, 2004, J EVOLUTION BIOL, V22, P718; Currat M, 2008, EVOLUTION, V62, P1908, DOI 10.1111/j.1558-5646.2008.00413.x; Cuvier G, 1844, CYPRINOIDES, V17, P487; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; Doadrio I., 2007, Graellsia, V63, P89; Doadrio I, 1998, J FISH BIOL, V53, P591, DOI 10.1111/j.1095-8649.1998.tb01004.x; Durand JD, 2000, P ROY SOC B-BIOL SCI, V267, P1687; Edwards S, 2009, MOL ECOL, V18, P2930, DOI 10.1111/j.1365-294X.2009.04270.x; Fountoulis I, 2014, B GEOFIS TEOR APPL, V55, P303, DOI 10.4430/bgta0074; Fountoulis I, 2008, Z DTSCH GES GEOWISS, V159, P485, DOI 10.1127/1860-1804/2008/0159-0485; Freyhof J, 2005, MOL PHYLOGENET EVOL, V37, P347, DOI 10.1016/j.ympev.2005.07.018; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Gaudant J, 1977, CIENCIAS TERRA, V3, P129; Geiger MF, 2016, J FISH BIOL, V88, P1038, DOI 10.1111/jfb.12871; Good JM, 2008, MOL ECOL, V17, P1313, DOI 10.1111/j.1365-294X.2007.03640.x; Harper DAT, 2001, PALEONTOLOGICAL ELEC, V41; HUDSON RR, 1987, GENETICS, V116, P153; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jan C. C., 2002, Helia, V25, P123, DOI 10.2298/HEL0236123J; Joly S, 2009, AM NAT, V174, pE54, DOI 10.1086/600082; Knudsen R, 2006, P ROY SOC B-BIOL SCI, V273, P2291, DOI 10.1098/rspb.2006.3582; Kokkalas S, 2006, GEOL SOC AM SPEC PAP, V409, P97, DOI 10.1130/2006.2409(06); Kottelat M., 2007, HDB EUROPEAN FRESHWA, P646; Koukouvelas IK, 2010, INT GEOL REV, V52, P249, DOI 10.1080/00206810802674329; Kumar S, 2015, MOL BIOL EVOL UNPUB; Leache AD, 2006, MOL PHYLOGENET EVOL, V39, P628, DOI 10.1016/j.ympev.2005.12.016; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Linnen CR, 2007, EVOLUTION, V61, P1417, DOI 10.1111/j.1558-5646.2007.00114.x; Ludwig A, 2003, MOL ECOL, V12, P3253, DOI 10.1046/j.1365-294X.2003.01999.x; Machordom A, 1990, AQUAT LIVING RESOUR, V3, P295, DOI 10.1051/alr:1990030; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Magalhaes IS, 2009, J EVOLUTION BIOL, V22, P260, DOI 10.1111/j.1420-9101.2008.01637.x; Markova S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069497; Mckay BD, 2010, MOL PHYLOGENET EVOL, V54, P647, DOI 10.1016/j.ympev.2009.08.024; Meng C, 2009, THEOR POPUL BIOL, V75, P35, DOI 10.1016/j.tpb.2008.10.004; Meyer A, 2006, MOL ECOL, V15, P721, DOI 10.1111/j.1365-294X.2006.02810.x; Nevado B, 2009, MOL ECOL, V18, P4240, DOI 10.1111/j.1365-294X.2009.04348.x; Nosil P, 2009, TRENDS ECOL EVOL, V24, P145, DOI 10.1016/j.tree.2008.10.011; Ntageretzis K, 2015, Z GEOMORPHOL, V59, P253, DOI 10.1127/zfg_suppl/2015/S-00207; Papanikolaou D, 2007, QUATERN INT, V171-72, P14, DOI 10.1016/j.quaint.2007.04.005; Perdices A, 2003, MOL PHYLOGENET EVOL, V26, P289, DOI 10.1016/S1055-7903(02)00334-2; Perea S, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-265; Rabosky DL, 2009, MOL PHYLOGENET EVOL, V53, P368, DOI 10.1016/j.ympev.2009.06.020; Rheindt FE, 2011, AUK, V128, P620, DOI 10.1525/auk.2011.128.4.620; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; ROHLF FJ, 1987, SYST ZOOL, V36, P356, DOI 10.2307/2413400; Rosenberg NA, 2013, MOL BIOL EVOL; Sanjur OI, 2003, MOL PHYLOGENET EVOL, V29, P20, DOI 10.1016/S1055-7903(03)00088-5; Sinama M, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-22; Sousa-Santos C, 2006, J FISH BIOL, V68, P292, DOI 10.1111/j.0022-1112.2006.01081.x; Stadler T, 2009, J THEOR BIOL, V261, P58, DOI 10.1016/j.jtbi.2009.07.018; Stamatakis A, 2007, J VLSI SIG PROC SYST, V48, P271, DOI 10.1007/s11265-007-0067-4; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tang QY, 2012, ZOOL SCR, V41, P233, DOI 10.1111/j.1463-6409.2011.00530.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toews DPL, 2012, MOL ECOL, V21, P3907, DOI 10.1111/j.1365-294X.2012.05664.x; Vila M, 2005, MOL PHYLOGENET EVOL, V36, P249, DOI 10.1016/j.ympev.2005.02.019; Weisrock DW, 2005, MOL ECOL, V14, P1457, DOI 10.1111/j.1365-294X.2005.02524.x; Willis SC, 2014, EVOLUTION, V68, P256, DOI 10.1111/evo.12230; Yu Y, 2011, SYST BIOL, V60, P138, DOI 10.1093/sysbio/syq084; Zink RM, 2008, MOL ECOL, V17, P2107, DOI 10.1111/j.1365-294X.2008.03737.x	86	21	21	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166292	10.1371/journal.pone.0166292	http://dx.doi.org/10.1371/journal.pone.0166292			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27906993	gold, Green Published, Green Submitted			2022-12-26	WOS:000389482700022
J	Yang, JY; Yang, X; Li, Y; Xu, J; Zhou, Y; Wang, AX; Gao, X; Xu, L; Wu, SL; Wei, WB; Zhao, XQ; Jonas, JB				Yang, Jing Yan; Yang, Xuan; Li, Yang; Xu, Jie; Zhou, Yong; Wang, An Xin; Gao, Xiang; Xu, Liang; Wu, Shou Ling; Wei, Wen Bin; Zhao, Xing Quan; Jonas, Jost B.			Carotid Atherosclerosis, Cerebrospinal Fluid Pressure, and Retinal Vessel Diameters: The Asymptomatic Polyvascular Abnormalities in Community Study	PLOS ONE			English	Article							FIBER LAYER DEFECTS; MICROVASCULAR ABNORMALITIES; ARTERIAL-HYPERTENSION; BEIJING EYE; VENULAR DIAMETER; RISK; THICKNESS; STROKE	Purpose To assess relationships between carotid artery atherosclerosis and retinal arteriolar and venular diameters. Methods The community-based longitudinal Asymptomatic Polyvascular Abnormalities Community Study (APAC) included a sub-population of the Kailuan study which consisted of 101,510 employees and retirees of a coal mining industry. Based on the Chinese National Census 2010 and excluding individuals with history of cerebrovascular ischemic events, 4004 individuals were included into the APAC. All participants underwent a detailed clinical examination including blood laboratory tests and carotid artery duplex ultrasound examination. The cerebrospinal fluid pressure (CSFP) was estimated using the formula: CSFP[mmHg] = 0.44xBody Mass Index[kg/m(2)]+ 0.16xDiastolic Blood Pressure[mmHg]-0.18 x Age[Years]-1.91. Results In multivariable analysis (goodness of fit r(2) : 0.12), thicker retinal arteries were associated with a thinner common carotid artery intima-media thickness (IMT) (P = 0.002; standardized regression coefficient beta:-0.06; non-standardized regression coefficient B:-6.92; 95% confidence interval (CI):-11.2,-2.61) after adjusting for thicker retinal nerve fiber layer (P< 0.001; beta: 0.18; B: 0.35; 95% CI: 0.28,0.42), lower diastolic blood pressure (P<0.001; beta:-0.16; B:-0.17; 95% CI:-0.21,-0.3), younger age (P<0.001; beta:-0.08; B:-0.16; 95%; CI:-0.25,-0.08), and less abdominal circumference (P = 0.003; beta:-0.06; B:-0.11; 95% CI:-0.18,-0.03). Thicker retinal vein diameter was associated (r = 0.40) with higher estimated CSFP (P<0.001; beta: 0.09; B: 0.78; 95% CI: 0.47,1.08) after adjusting for wider retinal arteries (P<0.001; beta: 0.27; B: 0.36; 95% CI: 0.31,0.41), thicker retinal nerve fiber layer thickness (P = 0.03; beta: 0.22; B: 0.56; 95% CI: 0.46,0.65) and male gender (P<0.001; beta:-0.08; B:-3.98; 95% CI:-5.88,2.09). Conclusions Thinner retinal artery diameter was significantly, however weakly, associated with increased common carotid artery IMT. It suggests that retinal microvascular changes were only week indicators for an atherosclerotic carotid artery pathology. Thicker retinal vein diameter was associated with higher estimated CSFP, confirming associations between higher estimated CSFP and higher incidence of retinal vein occlusion.	[Yang, Jing Yan; Yang, Xuan; Li, Yang; Xu, Jie; Wei, Wen Bin] Capital Med Univ, Beijing Ophthalmol & Visual Sci Key Lab, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing, Peoples R China; [Zhou, Yong; Wang, An Xin; Zhao, Xing Quan] Capital Med Univ, Beijing TianTan Hosp, Dept Neurol, Beijing, Peoples R China; [Gao, Xiang] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Gao, Xiang] Harvard Med Sch, Boston, MA USA; [Gao, Xiang] Penn State Univ, Dept Nutr Sci, University Pk, PA 16802 USA; [Xu, Liang; Jonas, Jost B.] Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing Inst Ophthalmol,Ophthalmol & Visual Sci K, Beijing, Peoples R China; [Wu, Shou Ling] Hebei United Univ, Kailuan Hosp, Dept Cardiol, Tangshan, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Mannheim, Germany	Capital Medical University; Capital Medical University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Capital Medical University; North China University of Science & Technology; Ruprecht Karls University Heidelberg	Wei, WB (corresponding author), Capital Med Univ, Beijing Ophthalmol & Visual Sci Key Lab, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing, Peoples R China.; Zhao, XQ (corresponding author), Capital Med Univ, Beijing TianTan Hosp, Dept Neurol, Beijing, Peoples R China.; Wu, SL (corresponding author), Hebei United Univ, Kailuan Hosp, Dept Cardiol, Tangshan, Peoples R China.	drwusl@163.com; tr_weiwenbin@163.com; zxq@vip.163.com	Xu, Jie/AIE-0524-2022; wei, wei/HHR-8613-2022; xu, jie/GQR-1913-2022	xu, jie/0000-0002-2039-7055; , Xiang/0000-0003-2617-6509	Beijing Municipal Administration of Hospitals' Ascent Plan [DFL20150201]; Science & Technology Project of Beijing Municipal Science & Technology Commission [Z151100001615052]; National Natural Science Foundation of China [81570891, 81272981]; Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support [ZYLX201307]; Beijing Natural Science Foundation [7151003]; Advanced Health Care Professionals Development Project of Beijing Municipal Health Bureau [2014-2-003]	Beijing Municipal Administration of Hospitals' Ascent Plan; Science & Technology Project of Beijing Municipal Science & Technology Commission; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support; Beijing Natural Science Foundation(Beijing Natural Science Foundation); Advanced Health Care Professionals Development Project of Beijing Municipal Health Bureau	This work was supported by the Beijing Municipal Administration of Hospitals' Ascent Plan (code: DFL20150201); Science & Technology Project of Beijing Municipal Science & Technology Commission (code: Z151100001615052); National Natural Science Foundation of China (Nr. 81570891 and Nr. 81272981); Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support (code: ZYLX201307); Beijing Natural Science Foundation (Nr.7151003); Advanced Health Care Professionals Development Project of Beijing Municipal Health Bureau (No. 2014-2-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cuspidi C, 2004, J HYPERTENS, V22, P2095, DOI 10.1097/00004872-200411000-00010; Grant EG, 2003, RADIOLOGY, V229, P340, DOI 10.1148/radiol.2292030516; Hanff TC, 2014, STROKE, V45, P1012, DOI 10.1161/STROKEAHA.113.004166; Hayreh SS, 2005, PROG RETIN EYE RES, V24, P493, DOI 10.1016/j.preteyeres.2004.12.001; HAYREH SS, 1989, OPHTHALMOLOGICA, V198, P178, DOI 10.1159/000309998; Hubbard LD, 1999, OPHTHALMOLOGY, V106, P2269, DOI 10.1016/S0161-6420(99)90525-0; JONAS JB, 1993, INVEST OPHTH VIS SCI, V34, P2260; JONAS JB, 1989, INVEST OPHTH VIS SCI, V30, P1604; Jonas JB, 2003, BRIT J OPHTHALMOL, V87, P361, DOI 10.1136/bjo.87.3.361-a; Jonas JB, 1997, AM J OPHTHALMOL, V124, P488, DOI 10.1016/S0002-9394(14)70864-5; Jonas JB, 2015, ACTA OPHTHALMOL, V93, pE522, DOI 10.1111/aos.12575; Jonas JB, 2014, INVEST OPHTH VIS SCI, V55, P1292, DOI 10.1167/iovs.13-13351; Kawasaki R, 2009, J HYPERTENS, V27, P2386, DOI 10.1097/HJH.0b013e3283310f7e; KLEIN R, 1994, ARCH OPHTHALMOL-CHIC, V112, P92, DOI 10.1001/archopht.1994.01090130102026; Miller RG, 2009, AM J OPHTHALMOL, V147, P653, DOI 10.1016/j.ajo.2008.10.004; Myers CE, 2012, OPHTHALMOLOGY, V119, P2563, DOI 10.1016/j.ophtha.2012.06.038; Torres FS, 2013, ATHEROSCLEROSIS, V229, P134, DOI 10.1016/j.atherosclerosis.2013.04.019; Wang AX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113205; Wang DD, 2014, STROKE, V45, P1651, DOI 10.1161/STROKEAHA.113.004629; Wang S, 2012, OPHTHALMOLOGY, V119, P2592, DOI 10.1016/j.ophtha.2012.06.031; Wong TY, 2001, LANCET, V358, P1134, DOI 10.1016/S0140-6736(01)06253-5; Xu L, 2013, AM J HYPERTENS, V26, P511, DOI 10.1093/ajh/hps081; Zhou Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084685	23	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166993	10.1371/journal.pone.0166993	http://dx.doi.org/10.1371/journal.pone.0166993			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907041	Green Published, gold, Green Submitted			2022-12-26	WOS:000389482700060
J	Zhang, HY; Sun, LL; Wang, K; Wu, D; Trappio, M; Witting, C; Cao, K				Zhang, Haoyue; Sun, Linlin; Wang, Kun; Wu, Di; Trappio, Mason; Witting, Celeste; Cao, Kan			Loss of H3K9me3 Correlates with ATM Activation and Histone H2AX Phosphorylation Deficiencies in Hutchinson-Gilford Progeria Syndrome	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; DNA-DAMAGE RESPONSE; HOMOLOGOUS RECOMBINATION; RADIATION SENSITIVITY; DEFECTIVE MATURATION; GENOMIC INSTABILITY; IONIZING-RADIATION; MOUSE MODEL; PRELAMIN-A; CELL-CYCLE	Compelling evidence suggests that defective DNA damage response (DDR) plays a key role in the premature aging phenotypes in Hutchinson-Gilford progeria syndrome (HGPS). Studies document widespread alterations in histone modifications in HGPS cells, especially, the global loss of histone H3 trimethylated on lysine 9 (H3K9me3). In this study, we explore the potential connection(s) between H3K9me3 loss and the impaired DDR in HGPS. When cells are exposed to a DNA-damaging agent Doxorubicin (Dox), double strand breaks (DSBs) are generated that result in the phosphorylation of histone H2A variant H2AX (gammaH2AX) within an hour. We find that the intensities of gammaH2AX foci appear significantly weaker in the G0/G1 phase HGPS cells compared to control cells. This reduction is associated with a delay in the recruitment of essential DDR factors. We further demonstrate that ataxia-telangiectasia mutated (ATM) is responsible for the amplification of gammaH2AX signals at DSBs during G0/G1 phase, and its activation is inhibited in the HGPS cells that display significant loss of H3K9me3. Moreover, methylene (MB) blue treatment, which is known to save heterochromatin loss in HGPS, restores H3K9me3, stimulates ATM activity, increases gammaH2AX signals and rescues deficient DDR. In summary, this study demonstrates an early DDR defect of attenuated gammaH2AX signals in G0/G1 phase HGPS cells and provides a plausible connection between H3K9me3 loss and DDR deficiency.	[Zhang, Haoyue; Sun, Linlin; Wang, Kun; Wu, Di; Trappio, Mason; Witting, Celeste; Cao, Kan] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [Wang, Kun] Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Cao, K (corresponding author), Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA.	kcao@umd.edu			NIH/NHLBI [R01HL126784]; Maryland Stem Cell Research Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL126784] Funding Source: NIH RePORTER	NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Maryland Stem Cell Research Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH/NHLBI Grant R01HL126784 (KC) and by an exploratory grant from the Maryland Stem Cell Research Fund (KC).	Alabert C, 2012, NAT REV MOL CELL BIO, V13, P153, DOI 10.1038/nrm3288; Ayrapetov MK, 2014, P NATL ACAD SCI USA, V111, P9169, DOI 10.1073/pnas.1403565111; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Banath JP, 2004, CANCER RES, V64, P7144, DOI 10.1158/0008-5472.CAN-04-1433; Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; Bassing CH, 2004, CELL CYCLE, V3, P149; Booth EA, 2015, SOFT MATTER, V11, P6412, DOI 10.1039/c5sm00521c; Bouquet F, 2006, CELL CYCLE, V5, P1116, DOI 10.4161/cc.5.10.2799; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Capell BC, 2006, NAT REV GENET, V7, P940, DOI 10.1038/nrg1906; Chapman JR, 2008, EMBO REP, V9, P795, DOI 10.1038/embor.2008.103; Chapman JR, 2013, MOL CELL, V49, P858, DOI 10.1016/j.molcel.2013.01.002; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; di Fagagna FD, 2008, NAT REV CANCER, V8, P512, DOI 10.1038/nrc2440; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Dion V, 2013, CELL, V152, P1355, DOI 10.1016/j.cell.2013.02.010; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Escribano-Diaz C, 2013, MOL CELL, V49, P872, DOI 10.1016/j.molcel.2013.01.001; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Felgentreff K, 2014, P NATL ACAD SCI USA, V111, P8889, DOI 10.1073/pnas.1323649111; Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101; Gorbunova V, 2007, NUCLEIC ACIDS RES, V35, P7466, DOI 10.1093/nar/gkm756; Gordon LB, 2007, PEDIATRICS, V120, P824, DOI 10.1542/peds.2007-1357; Hartlerode AJ, 2015, NAT STRUCT MOL BIOL, V22, P736, DOI 10.1038/nsmb.3072; Hsiao KY, 2013, J MOL CELL BIOL, V5, P157, DOI 10.1093/jmcb/mjs066; Kelley JB, 2011, MOL CELL BIOL, V31, P3378, DOI 10.1128/MCB.05087-11; Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550; Krishnan V, 2011, P NATL ACAD SCI USA, V108, P12325, DOI 10.1073/pnas.1102789108; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Kurz EU, 2004, J BIOL CHEM, V279, P53272, DOI 10.1074/jbc.M406879200; Lee Jong-Soo, 2007, Cancer Res Treat, V39, P125, DOI 10.4143/crt.2007.39.3.125; Liu BH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2885; Liu BH, 2013, AGING CELL, V12, P316, DOI 10.1111/acel.12035; Liu BH, 2005, NAT MED, V11, P780, DOI 10.1038/nm1266; Liu Y, 2008, FASEB J, V22, P603, DOI 10.1096/fj.07-8598com; Liu YY, 2006, J CELL SCI, V119, P4644, DOI 10.1242/jcs.03263; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Mah LJ, 2010, LEUKEMIA, V24, P679, DOI 10.1038/leu.2010.6; Maison C, 2004, NAT REV MOL CELL BIO, V5, P296, DOI 10.1038/nrm1355; Manju K, 2006, J CELL SCI, V119, P2704, DOI 10.1242/jcs.03009; Mao ZY, 2008, CELL CYCLE, V7, P2902, DOI 10.4161/cc.7.18.6679; Mao ZY, 2012, P NATL ACAD SCI USA, V109, P11800, DOI 10.1073/pnas.1200583109; McClintock D, 2006, P NATL ACAD SCI USA, V103, P2154, DOI 10.1073/pnas.0511133103; McCord RP, 2013, GENOME RES, V23, P260, DOI 10.1101/gr.138032.112; Merideth MA, 2008, NEW ENGL J MED, V358, P592, DOI 10.1056/NEJMoa0706898; Murga M, 2007, J CELL BIOL, V178, P1101, DOI 10.1083/jcb.200704140; Musich PR, 2011, BIOCHEM SOC T, V39, P1764, DOI 10.1042/BST20110687; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Rodriguez S, 2009, EUR J HUM GENET, V17, P928, DOI 10.1038/ejhg.2008.270; Roukos V, 2013, SCIENCE, V341, P660, DOI 10.1126/science.1237150; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Shumaker DK, 2006, P NATL ACAD SCI USA, V103, P8703, DOI 10.1073/pnas.0602569103; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Sun YL, 2009, NAT CELL BIOL, V11, P1376, DOI 10.1038/ncb1982; Tang JB, 2013, NAT STRUCT MOL BIOL, V20, P317, DOI 10.1038/nsmb.2499; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Ward IM, 2003, J BIOL CHEM, V278, P19579, DOI 10.1074/jbc.C300117200; Xie AY, 2004, MOL CELL, V16, P1017, DOI 10.1016/j.molcel.2004.12.007; Xiong ZM, 2015, AGING CELL; You ZS, 2005, MOL CELL BIOL, V25, P5363, DOI 10.1128/MCB.25.13.5363-5379.2005; Zee BM, 2012, MOL CELL BIOL, V32, P2503, DOI 10.1128/MCB.06673-11; Zhang HY, 2014, P NATL ACAD SCI USA, V111, pE2261, DOI 10.1073/pnas.1320843111; Zhang HY, 2013, AGING CELL, V12, P2, DOI 10.1111/acel.12021; Zhang WQ, 2015, SCIENCE, V348, P1160, DOI 10.1126/science.aaa1356; Zimmermann M, 2013, SCIENCE, V339, P700, DOI 10.1126/science.1231573	65	17	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167454	10.1371/journal.pone.0167454	http://dx.doi.org/10.1371/journal.pone.0167454			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907109	Green Submitted, gold, Green Published			2022-12-26	WOS:000389482700162
J	Zhao, XY; Jiang, ZZ; Yang, F; Wang, Y; Gao, XM; Wang, YF; Chai, X; Pan, GX; Zhu, Y				Zhao, Xiaoya; Jiang, Zhenzuo; Yang, Fan; Wang, Yan; Gao, Xiumei; Wang, Yuefei; Chai, Xin; Pan, Guixiang; Zhu, Yan			Sensitive and Simplified Detection of Antibiotic Influence on the Dynamic and Versatile Changes of Fecal Short-Chain Fatty Acids	PLOS ONE			English	Article							HUMAN GUT MICROBIOTA; BUTYRATE; METABOLITES; SPECTRUM; OLIGOSACCHARIDES; IDENTIFICATION; FERMENTATION; AZITHROMYCIN; SPECTROMETRY; PROPIONATE	Short-chain fatty acids (SCFAs), produced by anaerobic fermentation of mainly indigestible dietary carbohydrates by gut microbiota, have a profound influence on intestinal function and host energy metabolism. Antibiotics may seriously disturb the balance of fecal SCFAs. To evaluate the impacts of antibiotics on fecal SCFAs produced by gut microbiota, a simple, reproducible and accurate gas chromatography (GC) method, which can simultaneously analyze seven SCFAs in fecal samples, was developed and validated. The ranges of detection and quantitation of the SCFAs reached 0.0868 similar to 0.393 and 0.261 similar to 1.18 mu g.mL(-1) respectively, in an optimized protocol for SCFAs extraction and analysis that used 10 mL 75% ethanol aqueous solution containing 1% HCl, without ultrasonication. The technique exhibited excellent intra-day (relative standard deviation (RSD) <= 2.54%) and inter-day (RSD <= 4.33%) precisions for all the SCFAs. Later, we administered broad-spectrum antibiotics, cefdinir or azithromycin to rats and analyzed the alterations in fecal SCFAs. The total amount, types and distribution of nearly all fecal SCFAs were significantly altered during the administration and even after withdrawal of the antibiotics in rats. The effects of cefdinir on the SCFAs were more pronounced than those of azithromycin. Our findings suggest SCFAs may serve as sensitive indicators to monitor the influences of antibiotics on SCFAs originated by intestinal bacteria. Our improved SCFAs analysis method is a potential platform for a standard clinical test of the effects of new antibiotics on SCFAs.	[Zhao, Xiaoya; Jiang, Zhenzuo; Yang, Fan; Wang, Yan; Gao, Xiumei; Wang, Yuefei; Chai, Xin; Pan, Guixiang; Zhu, Yan] Tianjin Univ Tradit Chinese Med, Tianjin State Key Lab Modern Chinese Med, Tianjin, Peoples R China; [Zhao, Xiaoya; Jiang, Zhenzuo; Yang, Fan; Wang, Yan; Wang, Yuefei; Chai, Xin; Pan, Guixiang; Zhu, Yan] Tianjin Int Joint Acad Biotechnol & Med, Res & Dev Ctr TCM, Tianjin, Peoples R China	Tianjin University of Traditional Chinese Medicine; Tianjin International Joint Academy of Biomedicine	Wang, YF; Zhu, Y (corresponding author), Tianjin Univ Tradit Chinese Med, Tianjin State Key Lab Modern Chinese Med, Tianjin, Peoples R China.; Wang, YF; Zhu, Y (corresponding author), Tianjin Int Joint Acad Biotechnol & Med, Res & Dev Ctr TCM, Tianjin, Peoples R China.	wangyuefei_2006@hotmail.com; yanzhu.harvard@icloud.com	Zhu, Yan/A-1548-2017	Zhu, Yan/0000-0002-3197-7936	National Science and Technology Major Projects for "Major New Drugs Innovation and Development" [2015ZX09J15102-004-004, 2013ZX09201020]	National Science and Technology Major Projects for "Major New Drugs Innovation and Development"	This work was supported by grants from the National Science and Technology Major Projects for "Major New Drugs Innovation and Development" (No. 2015ZX09J15102-004-004 and 2013ZX09201020).	Antonopoulos DA, 2009, INFECT IMMUN, V77, P2367, DOI 10.1128/IAI.01520-08; Arboleya S, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050649; Arellano M, 2000, J CHROMATOGR B, V741, P89, DOI 10.1016/S0378-4347(00)00066-9; Bird A R, 2000, Curr Issues Intest Microbiol, V1, P25; Bokulich NA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7121; Canani RB, 2011, WORLD J GASTROENTERO, V17, P1519, DOI [10.3748/wjg.v17.i12. 1519, 10.3748/wjg.v17.i12.1519]; Cheng HH, 2000, J NUTR, V130, P1991, DOI 10.1093/jn/130.8.1991; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Destandau E, 2005, J CHROMATOGR A, V1088, P49, DOI 10.1016/j.chroma.2005.01.002; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Perez-Cobas AE, 2013, GUT, V62, P1591, DOI 10.1136/gutjnl-2012-303184; Gao XF, 2009, ANAL BIOCHEM, V393, P163, DOI 10.1016/j.ab.2009.06.036; Guay DRP, 2002, CLIN THER, V24, P473, DOI 10.1016/S0149-2918(02)85125-6; HOVERSTAD T, 1986, SCAND J GASTROENTERO, V21, P621, DOI 10.3109/00365528609003109; Iraporda C, 2015, IMMUNOBIOLOGY, V220, P1161, DOI 10.1016/j.imbio.2015.06.004; Kasubuchi M, 2015, NUTRIENTS, V7, P2839, DOI 10.3390/nu7042839; Ketabi A, 2011, J APPL MICROBIOL, V110, P1297, DOI 10.1111/j.1365-2672.2011.04984.x; Lagier JC, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00136; Lagkouvardos I, 2015, MOL NUTR FOOD RES, V59, P1614, DOI 10.1002/mnfr.201500125; LEVISON ME, 1973, INFECT IMMUN, V8, P30, DOI 10.1128/IAI.8.1.30-35.1973; Louis P, 2014, NAT REV MICROBIOL, V12, P661, DOI 10.1038/nrmicro3344; Louis P, 2010, ENVIRON MICROBIOL, V12, P304, DOI 10.1111/j.1462-2920.2009.02066.x; Macfarlane S, 2003, P NUTR SOC, V62, P67, DOI 10.1079/PNS2002207; Meyer D, 2009, EUR J CLIN NUTR, V63, P1277, DOI 10.1038/ejcn.2009.64; Miller TL, 1996, APPL ENVIRON MICROB, V62, P1589, DOI 10.1128/AEM.62.5.1589-1592.1996; Morrison DJ, 2004, RAPID COMMUN MASS SP, V18, P2593, DOI 10.1002/rcm.1662; MURASE M, 1995, J CHROMATOGR B, V664, P415, DOI 10.1016/0378-4347(94)00491-M; Nilsson NE, 2003, BIOCHEM BIOPH RES CO, V303, P1047, DOI 10.1016/S0006-291X(03)00488-1; Park J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156334; RASMUSSEN HS, 1988, SCAND J GASTROENTERO, V23, P178, DOI 10.3109/00365528809103964; RETSEMA J, 1987, ANTIMICROB AGENTS CH, V31, P1939, DOI 10.1128/AAC.31.12.1939; Romick-Rosendale LE, 2009, MAGN RESON CHEM, V47, pS36, DOI 10.1002/mrc.2511; Ruuskanen O, 2004, PEDIATR INFECT DIS J, V23, pS135, DOI 10.1097/01.inf.0000112528.75956.41; Sako T, 1999, INT DAIRY J, V9, P69, DOI 10.1016/S0958-6946(99)00046-1; Salonen A, 2014, ISME J, V8, P2218, DOI 10.1038/ismej.2014.63; SCHEPPACH W, 1995, EUR J CANCER, V31A, P1077, DOI 10.1016/0959-8049(95)00165-F; Schneider SM, 2005, WORLD J GASTROENTERO, V11, P6165, DOI 10.3748/wjg.v11.i39.6165; Tangerman A, 1996, ANAL BIOCHEM, V236, P1, DOI 10.1006/abio.1996.0123; van den Bogaard AE, 2000, INT J ANTIMICROB AG, V14, P327, DOI 10.1016/S0924-8579(00)00145-X; van Eijk HMH, 2009, J CHROMATOGR B, V877, P719, DOI 10.1016/j.jchromb.2009.01.039; Westerbeek EAM, 2013, EUR J CLIN MICROBIOL, V32, P269, DOI 10.1007/s10096-012-1739-y; Yap IKS, 2008, J PROTEOME RES, V7, P3718, DOI 10.1021/pr700864x; Yassour M, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad0917; Young VB, 2004, J CLIN MICROBIOL, V42, P1203, DOI 10.1128/JCM.42.3.1203-1206.2004; Zambell KL, 2003, J NUTR, V133, P3509, DOI 10.1093/jn/133.11.3509; Zheng XJ, 2013, METABOLOMICS, V9, P818, DOI 10.1007/s11306-013-0500-6; Zoetendal EG, 2008, GUT, V57, P1605, DOI 10.1136/gut.2007.133603	48	33	34	9	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167032	10.1371/journal.pone.0167032	http://dx.doi.org/10.1371/journal.pone.0167032			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907030	gold, Green Published, Green Submitted			2022-12-26	WOS:000389482700067
J	Luo, W; Sandy, J; Trella, K; Gorski, D; Gao, SG; Li, J; Brounts, S; Galante, J; Plaas, A				Luo, Wei; Sandy, John; Trella, Katie; Gorski, Daniel; Gao, Shuguang; Li, Jun; Brounts, Sabrina; Galante, Jorge; Plaas, Anna			Degenerative Suspensory Ligament Desmitis (DSLD) in Peruvian Paso Horses Is Characterized by Altered Expression of TGF beta Signaling Components in Adipose-Derived Stromal Fibroblasts	PLOS ONE			English	Article							TRANSFORMING GROWTH-FACTOR-BETA-1; AGGRECAN ACCUMULATION; TENDINOPATHY; RISK; ADAMTS5; GENES; CELLS; MODEL	Equine degenerative suspensory ligament desmitis (DSLD) in Peruvian Paso horses typically presents at 7-15 years and is characterized by lameness, focal disorganization of collagen fibrils, and chondroid deposition in the body of the ligament. With the aim of developing a test for disease risk (that can be used to screen horses before breeding) we have quantified the expression of 76 TGF beta-signaling target genes in adipose-derived stromal fibroblasts (ADSCs) from six DSLD-affected and five unaffected Paso horses. Remarkably, 35 of the genes showed lower expression (p<0.05) in cells from DSLD-affected animals and this differential was largely eliminated by addition of exogenous TGF beta 1. More-over, TGF beta 1-mediated effects on expression were prevented by the TGF beta R1/2 inhibitor LY2109761, showing that the signaling was via a TGF beta R1/2 complex. The genes affected by the pathology indicate that it is associated with a generalized metabolic disturbance, since some of those most markedly altered in DSLD cells (ATF3, MAPK14, ACVRL1 (ALK1), SMAD6, FOS, CREBBP, NFKBIA, and TGFBR2) represent master-regulators in a wide range of cellular metabolic responses.	[Luo, Wei; Gorski, Daniel; Gao, Shuguang; Li, Jun; Plaas, Anna] Rush Univ, Med Ctr, Dept Internal Med, Chicago, IL 60612 USA; [Sandy, John; Galante, Jorge; Plaas, Anna] Rush Univ, Med Ctr, Dept Orthoped Surg, Chicago, IL 60612 USA; [Trella, Katie] Univ Illinois, Dept Bioengn, Chicago, IL USA; [Sandy, John] Rush Univ, Med Ctr, Dept Biochem, Chicago, IL 60612 USA; [Brounts, Sabrina] Univ Wisconsin, Sch Vet Med, Dept Surg Sci, Madison, WI 53706 USA; [Luo, Wei] Cent S Univ, Dept Orthoped, Xiangya Hosp, Changsha, Hunan, Peoples R China; [Trella, Katie] Colorado State Univ, Dept Clin Sci, Ft Collins, CO 80523 USA; [Gorski, Daniel] Heinrich Heine Univers, Inst Pharmakol & Klin Pharmakol, Dusseldorf, Germany	Rush University; Rush University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Rush University; University of Wisconsin System; University of Wisconsin Madison; Central South University; Colorado State University	Plaas, A (corresponding author), Rush Univ, Med Ctr, Dept Internal Med, Chicago, IL 60612 USA.; Plaas, A (corresponding author), Rush Univ, Med Ctr, Dept Orthoped Surg, Chicago, IL 60612 USA.	aplaas@gmail.com		Gorski, Daniel/0000-0001-9734-7008; Brounts, Sabrina/0000-0001-8748-7912	Rush Arthritis Institute; Katz/Rubschlager Endowed Chair	Rush Arthritis Institute; Katz/Rubschlager Endowed Chair	This study received funding from the Rush Arthritis Institute and the Katz/Rubschlager Endowed Chair. Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbah SA, 2016, SCI REP-UK, V6, DOI 10.1038/srep20922; Ashley SL, 2016, MUCOSAL IMMUNOLOGY; Bell R, 2013, J BIOMECH, V46, P498, DOI 10.1016/j.jbiomech.2012.10.020; BROWN CT, 1995, J CELL BIOCHEM, V59, P57, DOI 10.1002/jcb.240590108; Danielpour D, 1989, GROWTH FACTORS, V2, P61, DOI 10.3109/08977198909069082; Fenwick SA, 2001, J ANAT, V199, P231, DOI 10.1046/j.1469-7580.2001.19930231.x; Gibson KT, 2002, EQUINE VET EDUC, V14, P39, DOI 10.1111/j.2042-3292.2002.tb00137.x; Gorski DJ, 2015, MATRIX BIOL J INT SO; Halper Jaroslava, 2006, BMC Vet Res, V2, P12, DOI 10.1186/1746-6148-2-12; Halper J, 2011, PAK VET J, V31, P1; Khan KM, 1999, SPORTS MED, V27, P393, DOI 10.2165/00007256-199927060-00004; Kim B, 2010, ARCH BIOCHEM BIOPHYS, V501, P221, DOI 10.1016/j.abb.2010.06.017; Li C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157181; Little PJ, 2002, ARTERIOSCL THROM VAS, V22, P55, DOI 10.1161/hq0102.101100; Lombana KG, 2015, FRONT VET SCI, V2, DOI 10.3389/fvets.2015.00067; Melisi D, 2008, MOL CANCER THER, V7, P829, DOI 10.1158/1535-7163.MCT-07-0337; Mero JL, 2005, J EQUINE VET SCI, V25, P224, DOI 10.1016/j.jevs.2005.04.001; Monestier O, 2016, WFIKKN1 WFIKKN2 COMP; Trinh NT, 2016, STEM CELLS DEV, V25, P760, DOI 10.1089/scd.2015.0335; Oida T, 2010, J IMMUNOL METHODS, V362, P195, DOI 10.1016/j.jim.2010.09.008; Plaas A, 2011, J ORTHOP RES, V29, P900, DOI 10.1002/jor.21332; Prantl L, 2016, PLAST RECONSTR SURG, V137, P1181, DOI 10.1097/PRS.0000000000002013; Saunders CJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep19820; Saunders CJ, 2015, J ORTHOP RES, V33, P898, DOI 10.1002/jor.22820; Sayegh ET, 2015, RECENT SCI ADV DEV T, V4, P128, DOI [10.2174/2211542004666150713190231, DOI 10.2174/2211542004666150713190231]; Schenkman D, 2009, J EQUINE VET SCI, V29; Strong DI, 2005, USE WHOLE GENOME SCA; Taga Y, 2016, J BIOL CHEM, V291, P837, DOI 10.1074/jbc.M115.686105; Tiedemann K, 2005, GLYCOBIOLOGY, V15, P1277, DOI 10.1093/glycob/cwj027; Trella KJ, 2016, T ORTHOP RES; Tully LJ, 2014, EQUINE VET J, V46, P289, DOI 10.1111/evj.12134; Vandenberghe A, 2015, FRONT VET SCI, V2, DOI 10.3389/fvets.2015.00049; Velasco J, 2011, J BIOL CHEM, V286, P26016, DOI 10.1074/jbc.M110.208694; Wang VM, 2012, J ORTHOP RES, V30, P620, DOI 10.1002/jor.21558; Wang WB, 2015, CONNECT TISSUE RES, V56, P288, DOI 10.3109/03008207.2015.1023433; Yin JR, 2009, BRAIN RES, V1263, P10, DOI 10.1016/j.brainres.2009.01.042	36	5	5	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167069	10.1371/journal.pone.0167069	http://dx.doi.org/10.1371/journal.pone.0167069			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902739	Green Submitted, gold, Green Published			2022-12-26	WOS:000389474100048
J	Bloch, N; Glasker, S; Sitaram, P; Hofmann, H; Shepard, CN; Schultz, ML; Kim, B; Landau, NR				Bloch, Nicolin; Glasker, Sabine; Sitaram, Poojitha; Hofmann, Henning; Shepard, Caitlin N.; Schultz, Megan L.; Kim, Baek; Landau, Nathaniel R.			A Highly Active Isoform of Lentivirus Restriction Factor SAMHD1 in Mouse	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; AICARDI-GOUTIERES SYNDROME; GMP-AMP SYNTHASE; HIV-1 RESTRICTION; ACCESSORY PROTEIN; ANTIRETROVIRAL ACTIVITY; ALLOSTERIC ACTIVATION; NUCLEASE ACTIVITY; DNTPASE ACTIVITY; STRUCTURAL BASIS	The triphosphohydrolase SAMHD1 ( sterile beta motif and histidine-aspartate domain-containing protein 1) restricts HIV-1 replication in nondividing myeloid cells by depleting the dNTP pool, preventing reverse transcription. SAMHD1 is also reported to have ribonuclease activity that degrades the virus genomic RNA. Human SAMHD1 is regulated by phosphorylation of its carboxyl terminus at Thr-592, which abrogates its antiviral function yet has only a small effect on its phosphohydrolase activity. In the mouse, SAMHD1 is expressed as two isoforms (ISF1 and ISF2) that differ at the carboxyl terminus due to alternative splicing of the last coding exon. In this study we characterized the biochemical and antiviral properties of the two mouse isoforms of SAMHD1. Both are antiviral in nondividing cells. Mass spectrometry analysis showed that SAMHD1 is phosphorylated at several amino acid residues, one of which (Thr-634) is homologous to Thr-592. Phosphomimetic mutation at Thr-634 of ISF1 ablates its antiviral activity yet has little effect on phosphohydrolase activity in vitro. dGTP caused ISF1 to tetramerize, activating its catalytic activity. In contrast, ISF2, which lacks the phosphorylation site, was significantly more active, tetramerized, and was active without added dGTP. Neither isoform nor human SAMHD1 had detectable RNase activity in vitro or affected HIV-1 genomic RNA stability in newly infected cells. These data support a model in which SAMHD1 catalytic activity is regulated through tetramer stabilization by the carboxyl-terminal tail, phosphorylation destabilizing the complexes and inactivating the enzyme. ISF2 may serve to reduce the dNTP pool to very low levels as a means of restricting virus replication.	[Bloch, Nicolin; Glasker, Sabine; Sitaram, Poojitha; Hofmann, Henning; Schultz, Megan L.; Landau, Nathaniel R.] New York Sch Med, Dept Microbiol, New York, NY 10016 USA; [Shepard, Caitlin N.; Kim, Baek] Emory Sch Med, Ctr Drug Discovery, Dept Pediat, Atlanta, GA 30322 USA; [Kim, Baek] Kyung Hee Univ, Sch Pharm, Seoul 02447, South Korea	Emory University; Kyung Hee University	Landau, NR (corresponding author), NYU Langone Med Ctr, Smilow Res Ctr, Dept Microbiol, 1003,550 First Ave, New York, NY 10016 USA.	nathaniel.landau@med.nyu.edu		Sitaram, Poojitha/0000-0003-3285-5057	National Institutes of Health [AI067059, AI058864, AI049781, GM104198]; Vilcek Fellowship Endowment Fund award; amfAR Mathilde Krim Fellowship in Basic Biomedical Research [108982-57-RKGN]; Deutsche Forschungs Gemeinschaft [HO 5262/1-1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI049781, R01AI067059, R01AI049781, R01AI058864] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104198] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vilcek Fellowship Endowment Fund award; amfAR Mathilde Krim Fellowship in Basic Biomedical Research; Deutsche Forschungs Gemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI067059 and AI058864 (to N. R. L.) and AI049781 and GM104198 (to B. K.). This work was also supported by a Vilcek Fellowship Endowment Fund award (to N. B.) and an amfAR Mathilde Krim Fellowship in Basic Biomedical Research (108982-57-RKGN) and a Deutsche Forschungs Gemeinschaft post-doctoral fellowship (HO 5262/1-1; to H. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amie SM, 2013, J BIOL CHEM, V288, P25001, DOI 10.1074/jbc.C113.493619; Arnold LH, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005194; Behrendt R, 2013, CELL REP, V4, P689, DOI 10.1016/j.celrep.2013.07.037; Beloglazova N, 2013, J BIOL CHEM, V288, P8101, DOI 10.1074/jbc.M112.431148; Bobadilla S, 2013, GENE THER, V20, P514, DOI 10.1038/gt.2012.61; Choi J, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0174-4; Cribier A, 2013, CELL REP, V3, P1036, DOI 10.1016/j.celrep.2013.03.017; Diamond TL, 2004, J BIOL CHEM, V279, P51545, DOI 10.1074/jbc.M408573200; Franzolin E, 2013, P NATL ACAD SCI USA, V110, P14272, DOI 10.1073/pnas.1312033110; Gao DX, 2013, SCIENCE, V341, P903, DOI 10.1126/science.1240933; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Goujon C, 2006, GENE THER, V13, P991, DOI 10.1038/sj.gt.3302753; Hofmann H, 2012, J VIROL, V86, P12552, DOI 10.1128/JVI.01657-12; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Ji XY, 2014, P NATL ACAD SCI USA, V111, pE4305, DOI 10.1073/pnas.1412289111; Ji XY, 2013, NAT STRUCT MOL BIOL, V20, P1304, DOI 10.1038/nsmb.2692; Kim B, 2012, J BIOL CHEM, V287, P21570, DOI 10.1074/jbc.C112.374843; Koharudin LMI, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.591958; Laguette N, 2012, CELL HOST MICROBE, V11, P205, DOI 10.1016/j.chom.2012.01.007; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; Lim ES, 2012, CELL HOST MICROBE, V11, P194, DOI 10.1016/j.chom.2012.01.004; Maelfait J, 2016, CELL REP, V16, P1492, DOI 10.1016/j.celrep.2016.07.002; Pauls E, 2014, J IMMUNOL, V193, P1988, DOI 10.4049/jimmunol.1400873; Powell RD, 2011, J BIOL CHEM, V286, P43596, DOI 10.1074/jbc.C111.317628; Rehwinkel J, 2013, EMBO J, V32, P2454, DOI 10.1038/emboj.2013.163; Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373; Ryoo J, 2014, NAT MED, V20, P936, DOI 10.1038/nm.3626; Seamon KJ, 2015, NUCLEIC ACIDS RES, V43, P6486, DOI 10.1093/nar/gkv633; St Gelais C, 2014, J VIROL, V88, P7689, DOI 10.1128/JVI.01089-14; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sunseri N, 2011, J VIROL, V85, P6263, DOI 10.1128/JVI.00346-11; Tang CX, 2015, J BIOL CHEM, V290, P26352, DOI 10.1074/jbc.M115.677435; Wang FF, 2016, VIROLOGY, V487, P273, DOI 10.1016/j.virol.2015.10.024; Welbourn S, 2013, J VIROL, V87, P11516, DOI 10.1128/JVI.01642-13; White TE, 2013, CELL HOST MICROBE, V13, P441, DOI 10.1016/j.chom.2013.03.005; Wittmann S, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0229-6; Xu P, 2003, J BIOL CHEM, V278, P48422, DOI 10.1074/jbc.M307888200; Yan JP, 2015, J BIOL CHEM, V290, P13279, DOI 10.1074/jbc.M115.646588; Yan JP, 2013, J BIOL CHEM, V288, P10406, DOI 10.1074/jbc.M112.443796; Zhang RN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089558; Zhu CF, 2015, ACTA CRYSTALLOGR D, V71, P516, DOI 10.1107/S1399004714027527	42	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2017	292	3					1068	1080		10.1074/jbc.M116.743740	http://dx.doi.org/10.1074/jbc.M116.743740			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2LL	27920203	Green Published, hybrid			2022-12-26	WOS:000392318700026
J	Horayama, M; Shinha, K; Kabayama, K; Fujii, T; Kimura, H				Horayama, Masayuki; Shinha, Kenta; Kabayama, Kazuya; Fujii, Teruo; Kimura, Hiroshi			Spatial Chemical Stimulation Control in Microenvironment by Microfluidic Probe Integrated Device for Cell-Based Assay	PLOS ONE			English	Article							ON-A-CHIP	Cell-cell interactions play an important role in the development and function of multicellular organisms. To investigate these interactions in detail, it is necessary to evaluate the behavior of a cell population when the minimum number of cells in the population is stimulated by some chemical factors. We propose a microfluidic device integrated with microfluidic probe (MFP) functionality; this device is capable of imparting a chemical stimulus to cells within a microenvironment, for cell-based assays. The device contains MFP channels at the walls of the cell culture microchannels, and it can control a localized chemical stimulation area at the scale of a single cell to a few cells using MFP fluid control in a microspace. The results of a finite element method-based simulation indicated that it is possible to control the chemical stimulation area at the scale of a single cell to a few cells by optimizing the MFP channel apex width and the flow ratio. In addition, localized cell staining was demonstrated successfully using a spatial chemical stimulus. We confirmed the device functionality as a novel cell-based assay tool. We succeeded in performing localized cell collection using this method, which suggested that the single cell analysis of a cell monolayer that is subjected to a specific chemical stimulus is possible. The method proposed in this paper can contribute significantly to the fields of cell biology and drug development.	[Horayama, Masayuki; Shinha, Kenta; Kimura, Hiroshi] Tokai Univ, Dept Mech Engn, Hiratsuka, Kanagawa, Japan; [Kabayama, Kazuya] Osaka Univ, Dept Chem, Toyonaka, Osaka, Japan; [Kabayama, Kazuya; Kimura, Hiroshi] Tokai Univ, Micro Nano Technol Ctr, Hiratsuka, Kanagawa, Japan; [Fujii, Teruo] Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo, Japan	Tokai University; Osaka University; Tokai University; University of Tokyo	Kimura, H (corresponding author), Tokai Univ, Dept Mech Engn, Hiratsuka, Kanagawa, Japan.; Kimura, H (corresponding author), Tokai Univ, Micro Nano Technol Ctr, Hiratsuka, Kanagawa, Japan.	hkimura@tokai-u.jp	Kimura, Hiroshi/ABA-5971-2021; Kabayama, Kazuya/ABD-5748-2020	Kimura, Hiroshi/0000-0003-0623-0248; Kabayama, Kazuya/0000-0002-7583-5454	Ministry of Education, Culture, Sports, Science and Technology [25127716]; CREST(Japan Science and Technology Agency); MEXT; Ministry of Education, Culture, Sports, Science and Technology (MEXT); CREST from Japan Science and Technology Agency (JST)	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); CREST(Japan Science and Technology Agency)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); CREST from Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas (the Ministry of Education, Culture, Sports, Science and Technology) Project Number:25127716 to HK; CREST(Japan Science and Technology Agency) to TF HK; MEXT-Supported Program for the Strategic Research Foundation at Private Universities(the Ministry of Education, Culture, Sports, Science and Technology) to HK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Mr. T. Ohkubo and Mr. K. Arai for their technical assistance. This work was supported in part by a Grant-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), and CREST from Japan Science and Technology Agency (JST).	Abhyankar VV, 2006, LAB CHIP, V6, P389, DOI 10.1039/b514133h; Beebe DJ, 2002, ANNU REV BIOMED ENG, V4, P261, DOI 10.1146/annurev.bioeng.4.112601.125916; Cors JF, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4866976; Huh D, 2010, SCIENCE, V328, P1662, DOI 10.1126/science.1188302; Hung PJ, 2005, BIOTECHNOL BIOENG, V89, P1, DOI 10.1002/bit.20289; Irimia D, 2006, ANAL CHEM, V78, P3472, DOI 10.1021/ac0518710; Jang KJ, 2013, INTEGR BIOL-UK, V5, P1119, DOI 10.1039/c3ib40049b; Juncker D, 2005, NAT MATER, V4, P622, DOI 10.1038/nmat1435; Kaigala GV, 2011, LANGMUIR, V27, P5686, DOI 10.1021/la2003639; Kim HJ, 2016, P NATL ACAD SCI USA, V113, pE7, DOI 10.1073/pnas.1522193112; Kim HJ, 2013, INTEGR BIOL-UK, V5, P1130, DOI 10.1039/c3ib40126j; Kraus T, 2006, LAB CHIP, V6, P218, DOI 10.1039/b511768b; McDonald JC, 2002, ACCOUNTS CHEM RES, V35, P491, DOI 10.1021/ar010110q; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Ostromohov N, 2016, LAB CHIP, V16, P3015, DOI 10.1039/c6lc00473c; Queval A, 2010, LAB CHIP, V10, P326, DOI 10.1039/b916669f; Sarkar A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4421; Shao JB, 2009, LAB CHIP, V9, P3118, DOI 10.1039/b909312e; Takagi M, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2779350; Takayama S, 2001, NATURE, V411, P1016, DOI 10.1038/35082637; Walker GM, 2005, LAB CHIP, V5, P611, DOI 10.1039/b417245k; Young EWK, 2010, CHEM SOC REV, V39, P1036, DOI 10.1039/b909900j; Zaari N, 2004, ADV MATER, V16, P2133, DOI 10.1002/adma.200400883	23	6	6	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0168158	10.1371/journal.pone.0168158	http://dx.doi.org/10.1371/journal.pone.0168158			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930750	Green Submitted, Green Published, gold			2022-12-26	WOS:000389580900083
J	Muselimyan, N; Swift, LM; Asfour, H; Chahbazian, T; Mazhari, R; Mercader, MA; Sarvazyan, NA				Muselimyan, Narine; Swift, Luther M.; Asfour, Huda; Chahbazian, Tigran; Mazhari, Ramesh; Mercader, Marco A.; Sarvazyan, Narine A.			Seeing the Invisible: Revealing Atrial Ablation Lesions Using Hyperspectral Imaging Approach	PLOS ONE			English	Article							PULMONARY VEIN ISOLATION; OPTICAL-PROPERTIES; RADIOFREQUENCY ABLATION	Background Currently, there are limited means for high-resolution monitoring of tissue injury during radio-frequency ablation procedures. Objective To develop the next generation of visualization catheters that can reveal irreversible atrial muscle damage caused by ablation and identify viability gaps between the lesions. Methods Radiofrequency lesions were placed on the endocardial surfaces of excised human and bovine atria and left ventricles of blood perfused rat hearts. Tissue was illuminated with 365nm light and a series of images were acquired from individual spectral bands within 420-720nm range. By extracting spectral profiles of individual pixels and spectral unmixing, the relative contribution of ablated and unablated spectra to each pixel was then displayed. Results of spectral unmixing were compared to lesion pathology. Results RF ablation caused significant changes in the tissue autofluorescence profile. The magnitude of these spectral changes in human left atrium was relatively small (<10% of peak fluorescence value), yet highly significant. Spectral unmixing of hyperspectral datasets enabled high spatial resolution, in-situ delineation of radiofrequency lesion boundaries without the need for exogenous markers. Lesion dimensions derived from hyperspectral imaging approach strongly correlated with histological outcomes. Presence of blood within the myocardium decreased the amplitude of the autofluorescence spectra while having minimal effect on their overall shapes. As a result, the ability of hyperspectral imaging to delineate ablation lesions in vivo was not affected. Conclusions Hyperspectral imaging greatly increases the contrast between ablated and unablated tissue enabling visualization of viability gaps at clinically relevant locations. Data supports the possibility for developing percutaneous hyperspectral catheters for high-resolution ablation guidance.	[Muselimyan, Narine; Swift, Luther M.; Asfour, Huda; Sarvazyan, Narine A.] George Washington Univ, Sch Med & Hlth Sci, Dept Physiol & Pharmacol, Washington, DC 20052 USA; [Chahbazian, Tigran] Strasbourg Med Univ, Strasbourg, France; [Mazhari, Ramesh; Mercader, Marco A.] George Washington Univ, Div Cardiol, Med Fac Associates, Washington, DC USA	George Washington University; George Washington University	Sarvazyan, NA (corresponding author), George Washington Univ, Sch Med & Hlth Sci, Dept Physiol & Pharmacol, Washington, DC 20052 USA.	phynas@gwu.edu	Swift, Luther/AGI-6464-2022; Swift, Luther/AGI-6431-2022	Swift, Luther/0000-0002-0050-1329; Swift, Luther/0000-0002-0050-1329; Asfour, Huda/0000-0003-1968-1881; Sarvazyan, Narine/0000-0002-2002-5630	LuxCath-GW Research Agreement, awards from the National Institutes of Health [R41HL120511, R42 HL120511]; intramural George Washington University funds; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R42HL120511] Funding Source: NIH RePORTER	LuxCath-GW Research Agreement, awards from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); intramural George Washington University funds; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by LuxCath-GW Research Agreement, R41HL120511 & R42 HL120511 awards from the National Institutes of Health, and intramural George Washington University funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agah R, 1996, IEEE T BIO-MED ENG, V43, P839, DOI 10.1109/10.508546; Armstrong K, 2015, HEAR RHYTHM, V20, pS117; Baxter WT, 2001, BIOPHYS J, V80, P516, DOI 10.1016/S0006-3495(01)76034-1; Calin MA, 2014, APPL SPECTROSC REV, V49, P435, DOI 10.1080/05704928.2013.838678; Chin MS, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.2.026010; Dana N, 2014, HEART RHYTHM, V11, P150, DOI 10.1016/j.hrthm.2013.09.071; Deshpande Sanjay, 2014, Card Electrophysiol Clin, V6, P1, DOI 10.1016/j.ccep.2013.10.006; Dickfeld T, 2006, J AM COLL CARDIOL, V47, P370, DOI 10.1016/j.jacc.2005.07.070; Dukkipati SR, 2015, J AM COLL CARDIOL, V66, P1350, DOI 10.1016/j.jacc.2015.07.036; Gan Y, 2016, J BIOMED OPT, V21, DOI 10.1117/1.JBO.21.10.101407; Gandjbakhche AH, 1999, AM J PHYSIOL-HEART C, V277, pH698, DOI 10.1152/ajpheart.1999.277.2.H698; Gil D.A., 2016, J BIOPHOTONICS; Kay M, 2008, AM J PHYSIOL-HEART C, V294, pH2400, DOI 10.1152/ajpheart.01158.2007; Koruth J, 2015, HEAR RHYTHM, V20, pS111; Lu GL, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.1.010901; Lu GL, 2014, PROC SPIE, V9034, DOI 10.1117/12.2043796; Mansfield JR, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2032458; Mercader M, 2012, AM J PHYSIOL-HEART C, V302, pH2131, DOI 10.1152/ajpheart.01141.2011; Nakai Kanji, 1999, Frontiers of Medical and Biological Engineering, V9, P241; Oral H, 2002, J AM COLL CARDIOL, V40, P100, DOI 10.1016/S0735-1097(02)01939-3; PICKERING JW, 1993, APPL OPTICS, V32, P367, DOI 10.1364/AO.32.000367; PRIES AR, 1983, AM J PHYSIOL, V245, pH167, DOI 10.1152/ajpheart.1983.245.1.H167; Saito T, 2000, J CARDIOVASC ELECTR, V11, P888, DOI 10.1111/j.1540-8167.2000.tb00068.x; Schade A, 2012, EXPERT REV CARDIOVAS, V10, P995, DOI [10.1586/ERC.12.86, 10.1586/erc.12.86]; Schwartzman D, 2013, EUROPACE, V15, P1557, DOI 10.1093/europace/eut099; Silverman DA, 1996, MICROVASC RES, V52, P143, DOI 10.1006/mvre.1996.0050; Swartling J, 2003, MED BIOL ENG COMPUT, V41, P403, DOI 10.1007/BF02348082; Swift L, 2008, PHYSIOL MEAS, V29, P269, DOI 10.1088/0967-3334/29/2/009; Swift L, 2014, CIRC-ARRHYTHMIA ELEC, V7, P929, DOI 10.1161/CIRCEP.114.001750; THOMSEN S, 1990, P SOC PHOTO-OPT INS, V1202, P2, DOI 10.1117/12.17605	30	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167760	10.1371/journal.pone.0167760	http://dx.doi.org/10.1371/journal.pone.0167760			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930718	gold, Green Submitted, Green Published			2022-12-26	WOS:000389580900043
J	Pegolo, S; Cecchinato, A; Mach, N; Babbucci, M; Pauletto, M; Bargelloni, L; Schiavon, S; Bittante, G				Pegolo, Sara; Cecchinato, Alessio; Mach, Nuria; Babbucci, Massimiliano; Pauletto, Marianna; Bargelloni, Luca; Schiavon, Stefano; Bittante, Giovanni			Transcriptomic Changes in Liver of Young Bulls Caused by Diets Low in Mineral and Protein Contents and Supplemented with n-3 Fatty Acids and Conjugated Linoleic Acid	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; MUSCLED PIEMONTESE BULLS; GENE-EXPRESSION; DAIRY-COWS; MAMMARY-GLAND; CHOLESTEROL HOMEOSTASIS; INFLAMMATORY DISEASES; GLUCOSE-HOMEOSTASIS; LIPOGENIC GENES; BEEF STEERS	The aim of the present study was to identify transcriptional modifications and regulatory networks accounting for physiological and metabolic responses to specific nutrients in the liver of young Belgian Blue x Holstein bulls using RNA-sequencing. A larger trial has been carried out in which animals were fed with different diets: 1] a conventional diet; 2] a low-protein/low-mineral diet (low-impact diet) and 3] a diet enriched in n-3 fatty acids (FAs), conjugated linoleic acid (CLA) and vitamin E (nutraceutical diet). The initial hypothesis was that the administration of low-impact and nutraceutical diets might influence the transcriptional profiles in bovine liver and the resultant nutrient fluxes, which are essential for optimal liver function and nutrient interconversion. Results showed that the nutraceutical diet significantly reduced subcutaneous fat covering in vivo and liver pH. Dietary treatments did not affect overall liver fat content, but significantly modified the liver profile of 33 FA traits (out of the total 89 identified by gas-chromatography). In bulls fed nutraceutical diet, the percentage of n-3 and CLA FAs increased around 2.5-fold compared with the other diets, whereas the ratio of n6/n3 decreased 2.5-fold. Liver transcriptomic analyses revealed a total of 198 differentially expressed genes (DEGs) when comparing low-impact, nutraceutical and conventional diets, with the nutraceutical diet showing the greatest effects on liver transcriptome. Functional analyses using ClueGo and Ingenuity Pathway Analysis evidenced that DEGs in bovine liver were variously involved in energy reserve metabolic process, glutathione metabolism, and carbohydrate and lipid metabolism. Modifications in feeding strategies affected key transcription factors regulating the expression of several genes involved in fatty acid metabolism, e.g. insulin-induced gene 1, insulin receptor substrate 2, and RAR-related orphan receptor C. This study provides noteworthy insights into the molecular changes occurring as a result of nutrient variation in diets (aimed at reducing the environmental impact and improving human health) and broadens our understanding of the relationship between nutrients variation and phenotypic effects.	[Pegolo, Sara; Cecchinato, Alessio; Schiavon, Stefano; Bittante, Giovanni] Univ Padua, Dept Agron Food Nat Resources Anim & Environm DAF, Padua, Italy; [Mach, Nuria] Univ Paris Saclay, AgroParisTech, INRA, Anim Genet & Integrat Biol Unit GABI, Jouy En Josas, France; [Babbucci, Massimiliano; Pauletto, Marianna; Bargelloni, Luca] Univ Padua, Dept Comparat Biomed & Food Sci, Padua, Italy	University of Padua; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Padua	Pegolo, S (corresponding author), Univ Padua, Dept Agron Food Nat Resources Anim & Environm DAF, Padua, Italy.	sara.pegolo@unipd.it	Bittante, Giovanni/M-4521-2019; Mach, Núria/C-5985-2012; Pauletto, Marianna/K-5518-2019; Schiavon, Stefano/C-6253-2011; Bittante, Giovanni/B-2332-2010	Bittante, Giovanni/0000-0001-7137-7049; Mach, Núria/0000-0002-8001-6314; Pauletto, Marianna/0000-0002-2424-7484; Schiavon, Stefano/0000-0002-5539-8947; Bittante, Giovanni/0000-0001-7137-7049; BABBUCCI, MASSIMILIANO/0000-0002-4060-4728; pegolo, sara/0000-0001-6390-9826	University of Padova (Ricerca Scientifica fondi quota) [EX 60% -649 60A08-7943/14]	University of Padova (Ricerca Scientifica fondi quota)	This research was supported by the University of Padova (Ricerca Scientifica fondi quota EX 60% -649 60A08-7943/14).	Ahnadi CE, 2002, J DAIRY RES, V69, P521, DOI 10.1017/S0022029902005769; Alonso ML, 2000, FOOD ADDIT CONTAM A, V17, P447, DOI 10.1080/02652030050034028; Alonso ML, 2004, BIOMETALS, V17, P389, DOI 10.1023/B:BIOM.0000029434.89679.a2; Anders S, 2013, NAT PROTOC, V8, P1765, DOI 10.1038/nprot.2013.099; Andrews S., 2010, FASTQC QUALITY CONTR, DOI DOI 10.1038/NPROT.2013.099; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Azain MJ, 2000, J NUTR, V130, P1548; Bagashev A, 2010, J INTERF CYTOK RES, V30, P843, DOI 10.1089/jir.2010.0017; Baldwin RL, 2012, PHYSIOL GENOMICS, V44, P543, DOI 10.1152/physiolgenomics.00144.2011; Baldwin RL VI, 2012, GENE REGUL SYST BIO, V6, P67, DOI 10.4137/GRSB.S9687; Baumgard LH, 2002, J DAIRY SCI, V85, P2155, DOI 10.3168/jds.S0022-0302(02)74294-X; Berg JM, 2002, BIOCHEMISTRY-US, V5th; Bernard L, 2008, ADV EXP MED BIOL, V606, P67, DOI 10.1007/978-0-387-74087-4_2; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; BOYER JL, 1992, ANNU REV PHYSIOL, V54, P415, DOI 10.1146/annurev.ph.54.030192.002215; Calder PC, 2006, AM J CLIN NUTR, V83, p1505S, DOI 10.1093/ajcn/83.6.1505S; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Cannell IG, 2008, BIOCHEM SOC T, V36, P1224, DOI 10.1042/BST0361224; Cildir G, 2013, TRENDS MOL MED, V19, P487, DOI 10.1016/j.molmed.2013.05.001; Corl BA, 2003, J NUTR, V133, P2893, DOI 10.1093/jn/133.9.2893; Coyne GS, 2008, THERIOGENOLOGY, V70, P772, DOI 10.1016/j.theriogenology.2008.05.048; Dacasto M, 2005, VET RES, V36, P179, DOI 10.1051/vetres:2004066; Davidson AJ, 2004, LIVER INT, V24, P179, DOI 10.1111/j.1478-3231.2004.00917.x; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dong XY, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-173; Dray S, 2003, ECOLOGY, V84, P3078, DOI 10.1890/03-0178; Fernandez ML, 2005, J NUTR, V135, P2075, DOI 10.1093/jn/135.9.2075; Frost RJA, 2011, P NATL ACAD SCI USA, V108, P21075, DOI 10.1073/pnas.1118922109; Gleeson M, 2000, IMMUNOL CELL BIOL, V78, P554, DOI 10.1046/j.1440-1711.2000.00953.x; Gruffat D, 2011, ANIMAL, V5, P1090, DOI 10.1017/S1751731111000073; da Costa ASH, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-65; Hiller B, 2013, LIPIDS, V48, P357, DOI 10.1007/s11745-012-3737-3; Jacobs AAA, 2013, ANIMAL, V7, P1508, DOI 10.1017/S175173111300061X; Jenkins TC, 2010, J DAIRY SCI, V93, P1170, DOI 10.3168/jds.2009-2509; Jeoung NH, 2006, BIOCHEM J, V397, P417, DOI 10.1042/BJ20060125; Jump DB, 2008, CURR OPIN LIPIDOL, V19, P242, DOI 10.1097/MOL.0b013e3282ffaf6a; KOTULA AW, 1982, J ANIM SCI, V54, P544, DOI 10.2527/jas1982.543544x; Kreipe L, 2011, J DAIRY SCI, V94, P5435, DOI 10.3168/jds.2011-4208; Kris-Etherton PM, 2002, CIRCULATION, V106, P2747, DOI 10.1161/01.CIR.0000038493.65177.94; Loewen CJR, 2002, CURR BIOL, V12, pR779, DOI 10.1016/S0960-9822(02)01292-7; Lopez-Alonso Marta, 2012, ISRN Vet Sci, V2012, P704825, DOI 10.5402/2012/704825; Mach N, 2013, J ANIM PHYSIOL AN N, V97, P89, DOI 10.1111/jpn.12042; Mach N, 2011, ANIMAL, V5, P1217, DOI 10.1017/S1751731111000103; Madron MS, 2002, J ANIM SCI, V80, P1135; Markiewski MM, 2007, AM J PATHOL, V171, P715, DOI 10.2353/ajpath.2007.070166; Matsunami T, 2011, METABOLISM, V60, P805, DOI 10.1016/j.metabol.2010.07.032; Matthews JC, 2014, BIOL TRACE ELEM RES, V160, P321, DOI 10.1007/s12011-014-0050-4; Mattos R, 2000, REV REPROD, V5, P38, DOI 10.1530/revreprod/5.1.38; Mir Z, 2000, SMALL RUMINANT RES, V36, P25, DOI 10.1016/S0921-4488(99)00087-5; Nakamura TJ, 2010, STEROIDS, V75, P203, DOI 10.1016/j.steroids.2010.01.007; Nuernberg K, 2005, LIVEST PROD SCI, V94, P137, DOI 10.1016/j.livprodsci.2004.11.036; Ogata H., 1999, NUCLEIC ACIDS RES, V27, P29, DOI DOI 10.1093/nar/27.1.29; Okamura Y, 2001, J BIOL CHEM, V276, P10229, DOI 10.1074/jbc.M100099200; Palmiter RD, 2004, P NATL ACAD SCI USA, V101, P4918, DOI 10.1073/pnas.0401022101; Park Y, 1999, LIPIDS, V34, P235, DOI 10.1007/s11745-999-0358-8; Pellattiero E, 2015, J AGR FOOD CHEM, V63, P963, DOI 10.1021/jf504956x; Ravi S, 2015, J NUTR, V145, P841, DOI 10.3945/jn.114.203216; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roden M, 1996, J CLIN INVEST, V97, P642, DOI 10.1172/JCI118460; Schiavon S, 2013, LIVEST SCI, V157, P462, DOI 10.1016/j.livsci.2013.09.015; Schiavon S, 2012, ANIM FEED SCI TECH, V174, P96, DOI 10.1016/j.anifeedsci.2012.02.011; Schiavon S, 2011, MEAT SCI, V89, P133, DOI 10.1016/j.meatsci.2011.03.025; Schiavon S, 2010, J ANIM SCI, V88, P3372, DOI 10.2527/jas.2009-2558; Schiavon S, 2016, J DAIRY SCI IN PRESS; Schmitz G, 2008, PROG LIPID RES, V47, P147, DOI 10.1016/j.plipres.2007.12.004; Shen SH, 2014, P NATL ACAD SCI USA, V111, pE5593, DOI 10.1073/pnas.1419161111; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sun CZ, 2015, INT J MOL MED, V35, P847, DOI 10.3892/ijmm.2015.2076; White ES, 2011, IUBMB LIFE, V63, P538, DOI 10.1002/iub.493; Yang MH, 2014, J LIPID RES, V55, P226, DOI 10.1194/jlr.M041335; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050	71	8	8	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167747	10.1371/journal.pone.0167747	http://dx.doi.org/10.1371/journal.pone.0167747			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930681	gold, Green Published, Green Submitted			2022-12-26	WOS:000389580900042
J	Sanchez, O; Campuzano, O; Fernandez-Falgueras, A; Sarquella-Brugada, G; Cesar, S; Mademont, I; Mates, J; Perez-Serra, A; Coll, M; Pico, F; Iglesias, A; Tiron, C; Allegue, C; Carro, E; Gallego, MA; Ferrer-Costa, C; Hospital, A; Bardalet, N; Borondo, JC; Vingut, A; Arbelo, E; Brugada, J; Castella, J; Medallo, J; Brugada, R				Sanchez, Olallo; Campuzano, Oscar; Fernandez-Falgueras, Anna; Sarquella-Brugada, Georgia; Cesar, Sergi; Mademont, Irene; Mates, Jesus; Perez-Serra, Alexandra; Coll, Monica; Pico, Ferran; Iglesias, Anna; Tiron, Coloma; Allegue, Catarina; Carro, Esther; Gallego, Maria Angeles; Ferrer-Costa, Carles; Hospital, Anna; Bardalet, Narcis; Borondo, Juan Carlos; Vingut, Albert; Arbelo, Elena; Brugada, Josep; Castella, Josep; Medallo, Jordi; Brugada, Ramon			Natural and Undetermined Sudden Death: Value of Post-Mortem Genetic Investigation	PLOS ONE			English	Article							CHANNEL MOLECULAR AUTOPSY; 2015 ESC GUIDELINES; LONG QT SYNDROME; CARDIAC DEATH; UNEXPLAINED DEATH; VENTRICULAR-ARRHYTHMIAS; YOUNG-ADULTS; CHANNELOPATHIES; MUTATIONS; DISEASE	Background Sudden unexplained death may be the first manifestation of an unknown inherited cardiac disease. Current genetic technologies may enable the unraveling of an etiology and the identification of relatives at risk. The aim of our study was to define the etiology of natural deaths, younger than 50 years of age, and to investigate whether genetic defects associated with cardiac diseases could provide a potential etiology for the unexplained cases. Methods and Findings Our cohort included a total of 789 consecutive cases (77.19% males) <50 years old (average 38.6 +/- 12.2 years old) who died suddenly from non-violent causes. A comprehensive autopsy was performed according to current forensic guidelines. During autopsy a cause of death was identified in most cases (81.1%), mainly due to cardiac alterations (56.87%). In unexplained cases, genetic analysis of the main genes associated with sudden cardiac death was performed using Next Generation Sequencing technology. Genetic analysis was performed in suspected inherited diseases (cardiomyopathy) and in unexplained death, with identification of potentially pathogenic variants in nearly 50% and 40% of samples, respectively. Conclusions Cardiac disease is the most important cause of sudden death, especially after the age of 40. Close to 10% of cases may remain unexplained after a complete autopsy investigation. Molecular autopsy may provide an explanation for a significant part of these unexplained cases. Identification of genetic variations enables genetic counseling and undertaking of preventive measures in relatives at risk.	[Sanchez, Olallo; Campuzano, Oscar; Fernandez-Falgueras, Anna; Mademont, Irene; Mates, Jesus; Perez-Serra, Alexandra; Coll, Monica; Pico, Ferran; Iglesias, Anna; Allegue, Catarina; Brugada, Ramon] Univ Girona, Cardiovasc Genet Ctr, IDIBGI, Girona, Spain; [Campuzano, Oscar; Brugada, Ramon] Univ Girona, Dept Med Sci, Sch Med, Girona, Spain; [Fernandez-Falgueras, Anna; Tiron, Coloma; Brugada, Ramon] Hosp Josep Trueta, Cardiovasc Genet Unit, Girona, Spain; [Sarquella-Brugada, Georgia; Cesar, Sergi; Carro, Esther; Brugada, Josep] Univ Barcelona, Hosp St Joan de Deu, Arrhythmia Unit, Barcelona, Spain; [Gallego, Maria Angeles; Castella, Josep; Medallo, Jordi] Inst Med Legal Ciencies Med Catalunya, Forens Pathol Serv, Barcelona, Spain; [Ferrer-Costa, Carles] Gendiag SL, Barcelona, Spain; [Hospital, Anna; Bardalet, Narcis] Inst Med Legal & Ciencies Forenses Catalunya, Forens Pathol Serv, Girona, Spain; [Borondo, Juan Carlos; Vingut, Albert] Inst Nacl Toxicol & Ciencias Forenses, Histopathol Unit, Barcelona, Spain; [Arbelo, Elena; Brugada, Josep] Univ Barcelona, Hosp Clin Barcelona, Arrhythmia Unit, Barcelona, Spain	Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); Universitat de Girona; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona	Brugada, R (corresponding author), Univ Girona, Cardiovasc Genet Ctr, IDIBGI, Girona, Spain.; Brugada, R (corresponding author), Univ Girona, Dept Med Sci, Sch Med, Girona, Spain.; Brugada, R (corresponding author), Hosp Josep Trueta, Cardiovasc Genet Unit, Girona, Spain.	ramon@brugada.org	Arbelo, Elena/GRS-2793-2022; Arbelo, Elena/GMX-0351-2022; Sarquella-Brugada, Georgia/W-9278-2018; campuzano, oscar/J-1968-2014; Cesar, Sergi/ABH-4429-2020	Sarquella-Brugada, Georgia/0000-0002-6857-8904; campuzano, oscar/0000-0001-5298-5276; CESAR, SERGI/0000-0002-2798-1756; ARBELO, ELENA/0000-0003-0424-6393; Tiron, Coloma/0000-0002-8424-5907; Mademont-Soler, Irene/0000-0002-6501-9250; ALLEGUE TOSCANO, CATARINA/0000-0002-5121-3159	Fondo Investigacion Sanitaria-FIS - from the Institute de Salud Carlos III (ISCIII) [PI14/01773]; Fundacio Academia de Ciencies Mediques i de la Salut de Catalunya i de Balears [ACMCB-2013]; Gendiag S.L	Fondo Investigacion Sanitaria-FIS - from the Institute de Salud Carlos III (ISCIII); Fundacio Academia de Ciencies Mediques i de la Salut de Catalunya i de Balears; Gendiag S.L	This work was supported by Fondo Investigacion Sanitaria-FIS PI14/01773- from the Institute de Salud Carlos III (ISCIII); Fundacio Academia de Ciencies Mediques i de la Salut de Catalunya i de Balears (ACMCB-2013). The commercial funder Gendiag S.L provided support in the form of salaries for authors CF and RB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ackerman MJ, 2011, EUROPACE, V13, P1077, DOI 10.1093/europace/eur245; Ackerman MJ, 2009, PACE, V32, pS86, DOI 10.1111/j.1540-8159.2009.02393.x; Amendola LM, 2016, AM J HUM GENET, V98, P1067, DOI 10.1016/j.ajhg.2016.03.024; Anderson JH, 2016, CIRC CARDIOVASC GENE; Arzamendi D, 2011, AM HEART J, V161, P574, DOI 10.1016/j.ahj.2010.10.040; Bagnall RD, 2016, NEW ENGL J MED, V374, P2441, DOI 10.1056/NEJMoa1510687; Bagnall RD, 2014, HEART RHYTHM, V11, P655, DOI 10.1016/j.hrthm.2014.01.017; Basso C, 2008, VIRCHOWS ARCH, V452, P11, DOI 10.1007/s00428-007-0505-5; Behr E, 2003, LANCET, V362, P1457, DOI 10.1016/S0140-6736(03)14692-2; Brion M, 2010, FORENSIC SCI INT, V203, P15, DOI 10.1016/j.forsciint.2010.07.015; Brion M, 2012, FORENSIC SCI INT, V219, P278, DOI 10.1016/j.forsciint.2012.01.018; Burke AP, 1997, NEW ENGL J MED, V336, P1276, DOI 10.1056/NEJM199705013361802; Campuzano O, 2016, INT J CARDIOL, V214, P404, DOI 10.1016/j.ijcard.2016.03.194; Campuzano O, 2015, J AM COLL CARDIOL, V66, P2913, DOI 10.1016/j.jacc.2015.10.049; Campuzano O, 2014, FORENSIC SCI INT, V245, P30, DOI 10.1016/j.forsciint.2014.10.004; Campuzano O, 2014, INT J LEGAL MED, V128, P599, DOI 10.1007/s00414-014-0966-4; Campuzano O, 2010, GENET MED, V12, P260, DOI 10.1097/GIM.0b013e3181d81636; Cerrone M, 2014, TRENDS CARDIOVAS MED, V24, P184, DOI 10.1016/j.tcm.2014.02.001; Cerrone M, 2014, CIRCULATION, V129, P1092, DOI 10.1161/CIRCULATIONAHA.113.003077; CORRADO D, 1994, CIRCULATION, V90, P2315, DOI 10.1161/01.CIR.90.5.2315; Corrado D, 2001, CARDIOVASC RES, V50, P399, DOI 10.1016/S0008-6363(01)00254-1; Davies MJ, 1999, HISTOPATHOLOGY, V34, P93; Eckart RE, 2011, J AM COLL CARDIOL, V58, P1254, DOI 10.1016/j.jacc.2011.01.049; Faragli A, 2016, J CARDIOVASC ELECTRO; Farrugia A, 2015, FORENSIC SCI INT, V254, P5, DOI 10.1016/j.forsciint.2015.06.023; Giudicessi JR, 2013, TRANSL RES, V161, P1, DOI 10.1016/j.trsl.2012.08.005; Gladding PA, 2010, HEART RHYTHM, V7, P481, DOI 10.1016/j.hrthm.2009.12.023; Hayashi M, 2015, CIRC RES, V116, P1887, DOI 10.1161/CIRCRESAHA.116.304521; Hertz CL, 2016, INT J LEGAL MED, V130, P91, DOI 10.1007/s00414-015-1261-8; Hertz CL, 2016, EUR J HUM GENET, V24, P817, DOI 10.1038/ejhg.2015.198; Ingles J, 2007, INTERN MED J, V37, P32, DOI 10.1111/j.1445-5994.2006.01241.x; Langlois NEI, 2009, FORENSIC SCI MED PAT, V5, P210, DOI 10.1007/s12024-009-9099-3; LAWLER W, 1990, J CLIN PATHOL, V43, P977, DOI 10.1136/jcp.43.12.977; LEACH IH, 1995, EUR HEART J, V16, P1181, DOI 10.1093/oxfordjournals.eurheartj.a061073; Lombardi R, 2013, CURR OPIN CARDIOL, V28, P272, DOI 10.1097/HCO.0b013e32835fb7f3; Loporcaro CG, 2014, ARCH PATHOL LAB MED, V138, P1083, DOI 10.5858/arpa.2013-0479-SA; Maron BJ, 1996, JAMA-J AM MED ASSOC, V276, P199, DOI 10.1001/jama.276.3.199; McNair WP, 2011, J AM COLL CARDIOL, V57, P2160, DOI 10.1016/j.jacc.2010.09.084; Miles CJ, 2016, TRANSL RES, V168, P59, DOI 10.1016/j.trsl.2015.06.007; Narula N, 2015, PEDIATR CARDIOL, V36, P768, DOI 10.1007/s00246-014-1082-4; Neubauer J, 2016, INT J LEGAL MED; Nunn LM, 2016, EUROPACE, V18, P888, DOI 10.1093/europace/euv285; Oliva A, 2011, AM J FOREN MED PATH, V32, P1, DOI 10.1097/PAF.0b013e3181c2dc96; Priori SG, 2015, EUR HEART J, V36, P2793, DOI 10.1093/eurheartj/ehv316; Priori SG, 2015, EUROPACE, V17, P1601, DOI 10.1093/europace/euv319; Puranik R, 2005, HEART RHYTHM, V2, P1277, DOI 10.1016/j.hrthm.2005.09.008; Rodriguez-Calvo MS, 2008, FORENSIC SCI INT, V182, P1, DOI 10.1016/j.forsciint.2008.09.013; Sarquella-Brugada G, 2016, INT J LEGAL MED, V130, P415, DOI 10.1007/s00414-016-1330-7; Semsarian C, 2015, EUR HEART J, V36, P1290, DOI 10.1093/eurheartj/ehv063; SHEN WK, 1995, AM J CARDIOL, V76, P148, DOI 10.1016/S0002-9149(99)80047-2; Sinard JH, 2013, ARCH PATHOL LAB MED, V137, P228, DOI 10.5858/arpa.2012-0012-CP; Skinner JR, 2011, HEART RHYTHM, V8, P412, DOI 10.1016/j.hrthm.2010.11.016; Stattin EL, 2016, INT J LEGAL MED, V130, P59, DOI 10.1007/s00414-015-1237-8; Tester DJ, 2007, J AM COLL CARDIOL, V49, P240, DOI 10.1016/j.jacc.2006.10.010; Tester DJ, 2012, MAYO CLIN PROC, V87, P524, DOI 10.1016/j.mayocp.2012.02.017; Tester DJ, 2012, PEDIATR CARDIOL, V33, P461, DOI 10.1007/s00246-012-0160-8; Tester DJ, 2011, MAYO CLIN PROC, V86, P941, DOI 10.4065/mcp.2011.0373; Tester DJ, 2004, MAYO CLIN PROC, V79, P1380, DOI 10.4065/79.11.1380; Vassalini M, 2016, J CARDIOVASC MED, V17, P446, DOI 10.2459/JCM.0000000000000234; Wang D, 2014, FORENSIC SCI INT, V237, P90, DOI 10.1016/j.forsciint.2014.01.014; Wilhelm M, 2015, SWISS MED WKLY, V145, DOI 10.4414/smw.2015.14129; Yu J, 2014, HERZ, V39, P271, DOI 10.1007/s00059-013-3998-5	62	39	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167358	10.1371/journal.pone.0167358	http://dx.doi.org/10.1371/journal.pone.0167358			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930701	gold, Green Published			2022-12-26	WOS:000389580900026
J	Etiaba, E; Onwujekwe, O; Torpey, K; Uzochukwu, B; Chiegil, R				Etiaba, Enyi; Onwujekwe, Obinna; Torpey, Kwasi; Uzochukwu, Benjamin; Chiegil, Robert			What Is the Economic Burden of Subsidized HIV/AIDS Treatment Services on Patients in Nigeria and Is This Burden Catastrophic to Households?	PLOS ONE			English	Article							INEQUALITIES; COSTS; CARE	Background A gap in knowledge exists regarding the economic burden on households of subsidized anti-retroviral treatment (ART) programs in Nigeria. This is because patients also incur non ART drug costs, which may constrain the delivery and utilisation of subsidized services. Methods An exit survey of adults (18+years) attending health facilities for HIV/AIDS treatment was conducted in three states in Nigeria (Adamawa, Akwa Ibom and Anambra). In the states, ART was fully subsidized but there were different payment modalities for other costs of treatment. Data was collected and analysed for direct and indirect costs of treatment of HIV/AIDS and co-morbidities' during out-and in-patient visits. The levels of catastrophic health expenditure (CHE) were computed and disaggregated by state, socio-economic status (SES) and urban-rural location of the respondents. Catastrophic Health Expenditure (CHE) in this study measures the number of respondents whose monthly ART-related household expenditure (for in-patient and out-patient visits) as a proportion of monthly non-food expenditure was greater than 40% and 10% respectively. Results The average out-patient and in-patient direct costs were $5.49 and $122.10 respectively. Transportation cost was the highest non-medical cost and it was higher than most medical costs. The presence of co-morbidities contributed to household costs. All the costs were catastrophic to households at 10% and 40% thresholds in the three states, to varying degrees. The poorest SES quintile had the highest incidence of CHE for out-patient costs (p<0.0001).Rural dwellers incurred more CHE for all categories of costs compared to urban dwellers, but the costs were statistically significant for only outpatient costs. Conclusion ART subsidization is not enough to eliminate economic burden of treatment on HIV patients. Service decentralization to reduce travel costs, and subsidy on other components of HIV treatment services should be introduced to eliminate the persisting inequitable and high cost burden of ART services. Full inclusion of ART services within the benefit package of the National Health Insurance Scheme should be considered.	[Etiaba, Enyi; Onwujekwe, Obinna; Uzochukwu, Benjamin] Univ Nigeria, Dept Hlth Adm & Management, Coll Med, Enugu Campus, Enugu, Nigeria; [Etiaba, Enyi; Onwujekwe, Obinna; Uzochukwu, Benjamin] Univ Nigeria, Dept Pharmacol & Pharmacotherapeut, Coll Med, Hlth Policy Res Grp, Enugu Campus, Enugu, Nigeria; [Torpey, Kwasi; Chiegil, Robert] Strengthening Integrated Delivery HIV AIDS Serv, FHI 360,Plot 1073 JS Tarka St, Pmb, Abuja, Nigeria; [Uzochukwu, Benjamin] Univ Nigeria, Coll Med, Dept Community Med, Enugu Campus, Enugu, Nigeria	University of Nigeria; University of Nigeria; University of Nigeria	Etiaba, E (corresponding author), Univ Nigeria, Dept Hlth Adm & Management, Coll Med, Enugu Campus, Enugu, Nigeria.; Etiaba, E (corresponding author), Univ Nigeria, Dept Pharmacol & Pharmacotherapeut, Coll Med, Hlth Policy Res Grp, Enugu Campus, Enugu, Nigeria.	enyi.etiaba@unn.edu.ng	Onwujekwe, Obinna/O-6232-2014	Onwujekwe, Obinna/0000-0002-1214-4285; Torpey, Kwasi/0000-0003-1628-2922	U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through U.S. Agency for International Development (USAID) [620-A-11-00002]	U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through U.S. Agency for International Development (USAID)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Support for this paper was provided by FH1360's Strengthening Integrated Delivery of HIV/AID Services with funds from the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through U.S. Agency for International Development (USAID) Cooperative Agreement No. 620-A-11-00002. The views expressed in this publication do not necessarily reflect those of FHI360, nor the United States Government.; Support for this paper was provided by FHI360's Strengthening Integrated Delivery of HIV/AID Services with funds from the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through U.S. Agency for International Development (USAID) Cooperative Agreement No. 620-A-11-00002. The views expressed in this publication do not necessarily reflect those of FHI360, nor the United States Government.	Apanga S, 2012, PAN AFRICAN MED J, V12; Beauliere A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011213; Central Bank of Nigeria (CBN), 2013, CURR EXCH RAT; Centre for Disease Control (CDC), 2014, CHALL HIV PREV FACT; Centre for Disease Control (CDC) Centre for Disease Control (CDC), COST AN; Chuma J, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-413; Dray-Spira R, 2003, AIDS, V17, P283, DOI 10.1097/00002030-200302140-00001; Federal Ministry of Health (FMOH), 2010, NAT HIV SER SER SENT, V2010; Kumarasamy N, 2007, INDIAN J MED RES, V126, P509; Mari-Dell'Olmo M, 2007, J EPIDEMIOL COMMUN H, V61, P232, DOI 10.1136/jech.2006.048017; Moon S, 2008, AIDS CARE, V20, P984, DOI 10.1080/09540120701768446; Onoka C, 2012, WHY ARE STATES NOT A; Onwujekwe O, 2009, HEALTH POLICY, V90, P223, DOI 10.1016/j.healthpol.2008.10.006; Wabiri N, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1037; WHO, 2013, GLOB UPD HIV TREATM	15	14	16	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0167117	10.1371/journal.pone.0167117	http://dx.doi.org/10.1371/journal.pone.0167117			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3TF	27911921	Green Published, Green Submitted, gold			2022-12-26	WOS:000389520600022
J	Xu, X; Dechesne, A; Visser, RGF; Trindade, LM				Xu, Xuan; Dechesne, Annemarie; Visser, Richard G. F.; Trindade, Luisa M.			Expression of an (Engineered) 4,6-alpha-Glucanotransferase in Potato Results in Changes in Starch Characteristics	PLOS ONE			English	Article							BRANCHING ENZYME; BINDING DOMAIN; GRANULE SIZE; AMYLOSE; AMYLOPECTIN; GENE; PLANTS; GELATINIZATION; INHIBITION; REDUCTION	Starch structure strongly influences starch physicochemical properties, determining the end uses of starch in various applications. To produce starches with novel structure and exploit the mechanism of starch granule formation, an (engineered) 4, 6-alpha-glucanotransferase (GTFB) from Lactobacillus reuteri 121 was introduced into two potato genetic backgrounds: amylose-containing line Kardal and amylose-free mutant amf. The resulting starches showed severe changes in granule morphology regardless of genetic backgrounds. Modified starches from amf background exhibited a significant increase in granule size and starch phosphate content relative to the control, while starches from Kardal background displayed a higher digestibility, but did not show changes in granule size and phosphate content. Transcriptome analysis revealed the existence of a mechanism to restore the regular packing of double helices in starch granules, which possibly resulted in the removal of novel glucose chains potentially introduced by the (engineered) GTFB. This amendment mechanics would also explain the difficulties to detect alterations in starch fine structure in the transgenic lines.	[Xu, Xuan; Dechesne, Annemarie; Visser, Richard G. F.; Trindade, Luisa M.] Wageningen Univ & Res, Wageningen UR Plant Breeding, POB 386, NL-6700 AJ Wageningen, Netherlands; [Xu, Xuan] Huazhong Agr Univ, Natl Ctr Vegetable Improvement Cent China, Key Lab Hort Plant Biol, Minist Educ, Wuhan 430070, Peoples R China	Wageningen University & Research; Huazhong Agricultural University	Trindade, LM (corresponding author), Wageningen Univ & Res, Wageningen UR Plant Breeding, POB 386, NL-6700 AJ Wageningen, Netherlands.	luisa.trindade@wur.nl	Visser, Richard GF/B-3423-2012; Xu, Xuan/AAK-5677-2020; Trindade, Luisa M/F-8824-2010	Visser, Richard GF/0000-0002-0213-4016; Xu, Xuan/0000-0003-1410-0873; 				Av?rous L, 2014, STARCH POLYM GENETIC, P79; Bai YX, 2015, APPL ENVIRON MICROB, V81, P7223, DOI 10.1128/AEM.01860-15; Blauth SL, 2002, PLANT MOL BIOL, V48, P287, DOI 10.1023/A:1013335217744; Blennow A, 2002, TRENDS PLANT SCI, V7, P445, DOI 10.1016/S1360-1385(02)02332-4; Capriles VD, 2008, J FOOD SCI, V73, pH160, DOI 10.1111/j.1750-3841.2008.00869.x; Dobruchowska JM, 2012, GLYCOBIOLOGY, V22, P517, DOI 10.1093/glycob/cwr167; Edwards A, 1999, PLANT J, V17, P251, DOI 10.1046/j.1365-313X.1999.00371.x; Firouzabadi FN, 2007, TRANSGENIC RES, V16, P645, DOI 10.1007/s11248-006-9053-z; Fredriksson H, 1998, CARBOHYD POLYM, V35, P119, DOI 10.1016/S0144-8617(97)00247-6; HOVENKAMPHERMELINK JHM, 1988, POTATO RES, V31, P241, DOI 10.1007/BF02365532; Huang XF, 2014, PLANTA, V240, P409, DOI 10.1007/s00425-014-2095-1; Huang XF, 2013, PLANT BIOTECHNOL J, V11, P470, DOI 10.1111/pbi.12033; Jane J, 1999, CEREAL CHEM, V76, P629, DOI 10.1094/CCHEM.1999.76.5.629; JENKINS JPJ, 1993, STARCH-STARKE, V45, P417; Ji Q, 2004, PLANT BIOTECHNOL J, V2, P251, DOI 10.1111/j.1467-7652.2004.00069.x; Jobling SA, 2002, NAT BIOTECHNOL, V20, P295, DOI 10.1038/nbt0302-295; Katayama K, 2002, STARCH-STARKE, V54, P51, DOI 10.1002/1521-379X(200202)54:2&lt;51::AID-STAR51&gt;3.0.CO;2-6; Kaur B, 2012, FOOD HYDROCOLLOID, V26, P398, DOI 10.1016/j.foodhyd.2011.02.016; Kaur L, 2007, J FOOD ENG, V82, P383, DOI 10.1016/j.jfoodeng.2007.02.059; Kim HS, 2008, J CEREAL SCI, V48, P159, DOI 10.1016/j.jcs.2007.09.002; Kok-Jacon GA, 2005, PLANT BIOTECHNOL J, V3, P341, DOI 10.1111/j.1467-7652.2005.00128.x; Kortstee AJ, 1996, PLANT J, V10, P83, DOI 10.1046/j.1365-313X.1996.10010083.x; KUIPERS AGJ, 1994, PLANT CELL, V6, P43, DOI 10.1105/tpc.6.1.43; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leemhuis H, 2014, J AGR FOOD CHEM, V62, P12034, DOI 10.1021/jf503970a; Lindeboom N, 2004, STARCH-STARKE, V56, P89, DOI 10.1002/star.200300218; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorberth R, 1998, NAT BIOTECHNOL, V16, P473, DOI 10.1038/nbt0598-473; Moire L, 2003, J PLANT PHYSIOL, V160, P831, DOI 10.1078/0176-1617-01030; Naguleswaran S, 2011, CEREAL CHEM, V88, P87, DOI 10.1094/CCHEM-04-10-0062; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Safford R, 1998, CARBOHYD POLYM, V35, P155, DOI 10.1016/S0144-8617(97)00249-X; Satoh H, 2003, PLANT PHYSIOL, V133, P1111, DOI 10.1104/pp.103.021527; Snell KD, 2015, CURR OPIN BIOTECH, V32, P68, DOI 10.1016/j.copbio.2014.11.005; Streb S, 2008, PLANT CELL, V20, P3448, DOI 10.1105/tpc.108.063487; Tan I, 2014, STRUCTURE PROPERTY R, V1947; Tester RF, 2006, ANIM FEED SCI TECH, V130, P39, DOI 10.1016/j.anifeedsci.2006.01.016; Umemoto T, 2002, THEOR APPL GENET, V104, P1, DOI 10.1007/s001220200000; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Vincken QJJP, 2003, PLANT MOL BIOL, V51, P789, DOI 10.1023/A:1022528705590; VISSER RGF, 1991, PLANT MOL BIOL, V17, P691, DOI 10.1007/BF00037054; Warren FJ, 2015, CARBOHYD POLYM, V117, P192, DOI 10.1016/j.carbpol.2014.09.043; Wu AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065768	43	1	2	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0166981	10.1371/journal.pone.0166981	http://dx.doi.org/10.1371/journal.pone.0166981			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3TF	27911907	Green Published, Green Submitted, gold			2022-12-26	WOS:000389520600019
J	Bannerman, P; Burns, T; Xu, J; Miers, L; Pleasure, D				Bannerman, Peter; Burns, Travis; Xu, Jie; Miers, Laird; Pleasure, David			Mice Hemizygous for a Pathogenic Mitofusin-2 Allele Exhibit Hind Limb/Foot Gait Deficits and Phenotypic Perturbations in Nerve and Muscle	PLOS ONE			English	Article							MARIE-TOOTH-DISEASE; MITOCHONDRIAL FUSION; SKELETAL-MUSCLE; MOUSE MODEL; MUTATIONS; MFN2; EXPRESSION; TRANSPORT; GENE; 2A	Charcot-Marie-Tooth disease type 2A (CMT2A), the most common axonal form of hereditary sensory motor neuropathy, is caused by mutations of mitofusin-2 (MFN2). Mitofusin-2 is a GTPase required for fusion of mitochondrial outer membranes, repair of damaged mitochondria, efficient mitochondrial energetics, regulation of mitochondrial-endoplasmic reticulum calcium coupling and axonal transport of mitochondria. We knocked T105M MFN2 preceded by a loxP-flanked STOP sequence into the mouse Rosa26 locus to permit cell type-specific expression of this pathogenic allele. Crossing these mice with nestin-Cre transgenic mice elicited T105M MFN2 expression in neuroectoderm, and resulted in diminished numbers of mitochondria in peripheral nerve axons, an alteration in skeletal muscle fiber type distribution, and a gait abnormality.	[Bannerman, Peter; Pleasure, David] Shriners Hosp Children Northern Calif, Inst Pediat Regenerat Med, Sacramento, CA 95817 USA; [Bannerman, Peter] Univ Calif Davis, Dept Cell Biol & Human Anat, Davis, CA 95616 USA; [Burns, Travis; Xu, Jie; Miers, Laird; Pleasure, David] Univ Calif Davis, Dept Neurol, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis	Bannerman, P (corresponding author), Shriners Hosp Children Northern Calif, Inst Pediat Regenerat Med, Sacramento, CA 95817 USA.; Bannerman, P (corresponding author), Univ Calif Davis, Dept Cell Biol & Human Anat, Davis, CA 95616 USA.	pgbannerman@ucdavis.edu			Shriners Hospitals for Children; Hereditary Neuropathy Foundation	Shriners Hospitals for Children; Hereditary Neuropathy Foundation	This work was funded by Shriners Hospitals for Children and by a pilot grant from the Hereditary Neuropathy Foundation.	Ainbinder A, 2015, CELL CALCIUM, V57, P14, DOI 10.1016/j.ceca.2014.11.002; Amiott EA, 2009, MOL BIOL CELL, V20, P5026, DOI 10.1091/mbc.E09-07-0622; Baloh RH, 2007, J NEUROSCI, V27, P422, DOI 10.1523/JNEUROSCI.4798-06.2007; Cartoni R, 2010, BRAIN, V133, P1460, DOI 10.1093/brain/awq082; Chen G., 2015, J NANOMATER, V2015, P1, DOI DOI 10.18632/0NC0TARGET.4376; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen HC, 2005, HUM MOL GENET, V14, pR283, DOI 10.1093/hmg/ddi270; Ciciliot S, 2013, INT J BIOCHEM CELL B, V45, P2191, DOI 10.1016/j.biocel.2013.05.016; Day K, 2007, DEV BIOL, V304, P246, DOI 10.1016/j.ydbio.2006.12.026; de Brito OM, 2009, MITOCHONDRION, V9, P222, DOI 10.1016/j.mito.2009.02.005; Detmer SA, 2008, HUM MOL GENET, V17, P367, DOI 10.1093/hmg/ddm314; Dubowitz V, 2013, EUROGENIC DISORDERS; Eura Y, 2003, J BIOCHEM, V134, P333, DOI 10.1093/jb/mvg150; Feely SME, 2011, NEUROLOGY, V76, P1690, DOI 10.1212/WNL.0b013e31821a441e; Feng HZ, AM J PHYSL CELL PHYS; Guo FZ, 2011, J NEUROSCI, V31, P11914, DOI 10.1523/JNEUROSCI.1759-11.2011; Guo FZ, 2010, J NEUROSCI, V30, P12036, DOI 10.1523/JNEUROSCI.1360-10.2010; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Honda S, 2005, J CELL SCI, V118, P3153, DOI 10.1242/jcs.02449; Klein CJ, 2011, ARCH NEUROL-CHICAGO, V68, P1295, DOI 10.1001/archneurol.2011.225; Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793; Lawson VH, 2005, NEUROLOGY, V65, P197, DOI 10.1212/01.wnl.0000168898.76071.70; Loiseau D, 2007, ANN NEUROL, V61, P315, DOI 10.1002/ana.21086; McCorquodale DS, 2011, J NEUROL, V258, P1234, DOI 10.1007/s00415-011-5910-7; Misko A, 2010, J NEUROSCI, V30, P4232, DOI 10.1523/JNEUROSCI.6248-09.2010; Moldovan M, 2016, EUR J NEUROSCI, V43, P388, DOI 10.1111/ejn.13047; Ngoh GA, 2012, J BIOL CHEM, V287, P20321, DOI 10.1074/jbc.M112.359174; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Pham AH, 2012, GENESIS, V50, P833, DOI 10.1002/dvg.22050; Polke JM, 2011, NEUROLOGY, V77, P168, DOI 10.1212/WNL.0b013e3182242d4d; Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323; Saporta Mario A, 2014, Continuum (Minneap Minn), V20, P1208, DOI 10.1212/01.CON.0000455885.37169.4c; Sebastian D, 2012, P NATL ACAD SCI USA, V109, P5523, DOI 10.1073/pnas.1108220109; Sheng ZH, 2012, NAT REV NEUROSCI, V13, P77, DOI 10.1038/nrn3156; Song ZY, 2009, MOL BIOL CELL, V20, P3525, DOI 10.1091/mbc.E09-03-0252; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Strickland AV, 2014, J PERIPHER NERV SYST, V19, P152, DOI 10.1111/jns5.12066; Stuppia G, 2015, J NEUROL SCI, V356, P7, DOI 10.1016/j.jns.2015.05.033; Verhoeven K, 2006, BRAIN, V129, P2093, DOI 10.1093/brain/awl126; Vielhaber S, 2013, ACTA NEUROPATHOL, V125, P245, DOI 10.1007/s00401-012-1036-y; Vital A, 2012, NEUROMUSCULAR DISORD, V22, P735, DOI 10.1016/j.nmd.2012.04.001; Yu D, 2015, SURG RADIOL ANAT; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	43	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167573	10.1371/journal.pone.0167573	http://dx.doi.org/10.1371/journal.pone.0167573			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907123	Green Submitted, gold, Green Published			2022-12-26	WOS:000389482700199
J	Chochua, S; D'Acremont, V; Hanke, C; Alfa, D; Shak, J; Kilowoko, M; Kyungu, E; Kaiser, L; Genton, B; Klugman, KP; Vidal, JE				Chochua, Sopio; D'Acremont, Valerie; Hanke, Christiane; Alfa, David; Shak, Joshua; Kilowoko, Mary; Kyungu, Esther; Kaiser, Laurent; Genton, Blaise; Klugman, Keith P.; Vidal, Jorge E.			Increased Nasopharyngeal Density and Concurrent Carriage of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis Are Associated with Pneumonia in Febrile Children	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; PNEUMOCOCCAL COLONIZATION; MICROBIAL INTERACTIONS; BACTERIAL INTERACTIONS; RESPIRATORY PATHOGENS; PCR; ACQUISITION; VACCINATION; INFECTIONS	Background We assessed nasopharyngeal (NP) carriage of five pathogens in febrile children with and without acute respiratory infection (ARI) of the upper (URTI) or lower tract, attending health facilities in Tanzania. Methods NP swabs collected from children (N = 960) aged 2 months to 10 years, and with a temperature >= 38 degrees C, were utilized to quantify bacterial density of S. pneumoniae (Sp), H. influenzae (Hi), M. catarrhalis (Mc), S. aureus (Sa), and N. meningitidis (Nm). We determined associations between presence of individual species, densities, or concurrent carriage of all species combination with respiratory diseases including clinical pneumonia, pneumonia with normal chest radiography (CXR) and endpoint pneumonia. Results Individual carriage, and NP density, of Sp, Hi, or Mc, but not Sa, or Nm, was significantly associated with febrile ARI and clinical pneumonia when compared to febrile non-ARI episodes. Density was also significantly increased in severe pneumonia when compared to mild URTI (Sp, p<0.002; Hi p<0.001; Mc, p = 0.014). Accordingly, concurrent carriage of sp(+), H1(+), and mc(+), in the absence of Sa-and Nm, was significantly more prevalent in children with ARI (p = 0.03), or clinical pneumonia (p<0.001) than non-ARI, and in children with clinical pneumonia (p = 0.0007) than URTI. Furthermore, sp(+), HI+, and Mc(+) differentiated children with pneumonia with normal CXR, or endpoint pneumonia, from those with URTI, and non-ARI cases. Conclusions Concurrent NP carriage of Sp, Hi, and Mc was a predictor of clinical pneumonia and identified children with pneumonia with normal CXR and endpoint pneumonia from those with febrile URTI, or non-ARI episodes.	[Chochua, Sopio; Hanke, Christiane; Alfa, David; Shak, Joshua; Klugman, Keith P.; Vidal, Jorge E.] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; [D'Acremont, Valerie; Genton, Blaise] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [D'Acremont, Valerie; Genton, Blaise] Univ Basel, Basel, Switzerland; [D'Acremont, Valerie; Genton, Blaise] Univ Lausanne, Dept Ambulatory Care & Community Med, Lausanne, Switzerland; [Kilowoko, Mary] Amana Hosp, Dar Es Salaam, Tanzania; [Kyungu, Esther] St Francis Hosp, Ifakara, Tanzania; [Kaiser, Laurent] Univ Geneva, Univ Hosp Geneva, Virol Lab, Div Infect Dis, Geneva, Switzerland; [Kaiser, Laurent] Univ Geneva, Univ Hosp Geneva, Div Lab Med, Geneva, Switzerland; [Kaiser, Laurent] Univ Geneva, Fac Med, Geneva, Switzerland; [Genton, Blaise] Univ Lausanne Hosp, Infect Dis Serv, Lausanne, Switzerland	Emory University; Rollins School Public Health; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of Lausanne; University of Geneva; University of Geneva; University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Vidal, JE (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA.	jvidalg@emory.edu	Boillat-Blanco, Noémie/GLT-5579-2022	Kaiser, Laurent/0000-0002-0857-2252	National Institutes of Health NIH [R21AI112768-01A1]; Swiss National Science Foundation [3270B0-109696, IZ70Z0-124023, 32003B_127160]; Commission for International Medicine of the University Hospital of Geneva; Bill and Melinda Gates Foundation; National Institutes of Health (NIH) [R21AI112768-01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI112768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008169] Funding Source: NIH RePORTER	National Institutes of Health NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Commission for International Medicine of the University Hospital of Geneva; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by grants from the National Institutes of Health NIH) R21AI112768-01A1, Swiss National Science Foundation 3270B0-109696, IZ70Z0-124023 and 32003B_127160), the Commission for International Medicine of the University Hospital of Geneva, and the Bill and Melinda Gates Foundation. JEV was in part funded by a grant from the National Institutes of Health (NIH; R21AI112768-01A1). The content is solely the responsibility of the authors and does not necessarily represent the official view of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrich WC, 2012, CLIN INFECT DIS, V54, P601, DOI 10.1093/cid/cir859; Bogaert D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017035; Carvalho MDS, 2007, J CLIN MICROBIOL, V45, P2460, DOI 10.1128/JCM.02498-06; Cherian T, 2005, B WORLD HEALTH ORGAN, V83, P353; Chien YW, 2013, PEDIATR INFECT DIS J, V32, P72, DOI 10.1097/INF.0b013e318270d850; Christensen H, 2010, LANCET INFECT DIS, V10, P853, DOI 10.1016/S1473-3099(10)70251-6; D'Acremont V, 2014, NEW ENGL J MED, V370, P809, DOI 10.1056/NEJMoa1214482; D'haene B, 2010, METHODS, V50, P262, DOI 10.1016/j.ymeth.2009.12.007; Dunne EM, 2013, VACCINE, V31, P2333, DOI 10.1016/j.vaccine.2013.03.024; Dunne EM, 2012, J CLIN MICROBIOL, V50, P1034, DOI 10.1128/JCM.06589-11; Elizaquivel P, 2008, FOOD MICROBIOL, V25, P705, DOI 10.1016/j.fm.2008.03.002; Garcia-Rodriguez JA, 2002, J ANTIMICROB CHEMOTH, V50, P59, DOI 10.1093/jac/dkf506; Grijalva CG, 2014, CLIN INFECT DIS, V58, P1369, DOI 10.1093/cid/ciu148; [Group WHOPVTI Biologicals DoVa], 2001, JCM, V39, P1021; Huong TTV, 2011, PEDIATR INFECT DIS J, V30, P11, DOI 10.1097/INF.0b013e3181f111a2; Kaiser L, 2001, EUR J CLIN MICROBIOL, V20, P445, DOI 10.1007/s10096-001-8150-4; Kwambana BA, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-175; O'Brien KL, 2001, J CLIN MICROBIOL, V39, P1021, DOI 10.1128/JCM.39.3.1021-1024.2001; Pettigrew MM, 2008, EMERG INFECT DIS, V14, P1584, DOI 10.3201/eid1410.080119; Revai K, 2008, CLIN INFECT DIS, V46, pE34, DOI 10.1086/525856; Sakai F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067147; Sakal F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121064; Satzke C, 2013, VACCINE, V32, P165, DOI 10.1016/j.vaccine.2013.08.062; Shakl JR, 2013, TRENDS MICROBIOL, V21, P129, DOI 10.1016/j.tim.2012.11.005; STEPHENS DS, 1991, INFECT IMMUN, V59, P4097, DOI 10.1128/IAI.59.11.4097-4102.1991; Thomas JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019361; van den Bergh MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047711; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; Wang X, 2011, INT J MED MICROBIOL, V301, P303, DOI 10.1016/j.ijmm.2010.11.004; Wolter N, 2014, J INFECT DIS, V210, P1649, DOI 10.1093/infdis/jiu326; Xu QF, 2012, EMERG INFECT DIS, V18, P1738, DOI 10.3201/eid1811.111904	31	30	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167725	10.1371/journal.pone.0167725	http://dx.doi.org/10.1371/journal.pone.0167725			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907156	Green Published, Green Accepted, gold			2022-12-26	WOS:000389482700226
J	Eng, F; Haroth, S; Feussner, K; Meldau, D; Rekhter, D; Ischebeck, T; Brodhun, F; Feussner, I				Eng, Felipe; Haroth, Sven; Feussner, Kirstin; Meldau, Dorothea; Rekhter, Dmitrij; Ischebeck, Till; Brodhun, Florian; Feussner, Ivo			Optimized Jasmonic Acid Production by Lasiodiplodia theobromae Reveals Formation of Valuable Plant Secondary Metabolites	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; ALLENE OXIDE SYNTHASE; BOTRYODIPLODIA-THEOBROMAE; INDOLE-3-CARBOXYLIC ACID; GIBBERELLA-FUJIKUROI; FUSARIUM-OXYSPORUM; SALICYLIC-ACID; L-ISOLEUCINE; FERMENTATION; BIOSYNTHESIS	Jasmonic acid is a plant hormone that can be produced by the fungus Lasiodiplodia theobromae via submerged fermentation. From a biotechnological perspective jasmonic acid is a valuable feedstock as its derivatives serve as important ingredients in different cosmetic products and in the future it may be used for pharmaceutical applications. The objective of this work was to improve the production of jasmonic acid by L. theobromae strain 2334. We observed that jasmonic acid formation is dependent on the culture volume. Moreover, cultures grown in medium containing potassium nitrate as nitrogen source produced higher amounts of jasmonic acid than analogous cultures supplemented with ammonium nitrate. When cultivated under optimal conditions for jasmonic acid production, L. theobromae secreted several secondary metabolites known from plants into the medium. Among those we found 3-oxo-2-(pent-2-enyI)-cyclopentane-1-butanoic acid (OPC-4) and hydroxy-jasmonic acid derivatives, respectively, suggesting that fungal jasmonate metabolism may involve similar reaction steps as that of plants. To characterize fungal growth and jasmonic acid-formation, we established a mathematical model describing both processes. This model may form the basis of industrial upscaling attempts. Importantly, it showed that jasmonic acid-formation is not associated to fungal growth. Therefore, this finding suggests that jasmonic acid, despite its enormous amount being produced upon fungal development, serves merely as secondary metabolite.	[Eng, Felipe] Cuban Res Inst Sugar Cane Byprod, Via Blanca & Carretera Cent 804, Havana, Cuba; [Eng, Felipe; Haroth, Sven; Feussner, Kirstin; Meldau, Dorothea; Rekhter, Dmitrij; Ischebeck, Till; Brodhun, Florian; Feussner, Ivo] Georg August Univ Gottingen, Albrecht von Haller Inst Plant Sci, Dept Plant Biochem, Gottingen, Germany; [Feussner, Ivo] Georg August Univ Gottingen, Gottingen Ctr Mol Biosci GZMB, Dept Plant Biochem, Gottingen, Germany	University of Gottingen; University of Gottingen	Feussner, I (corresponding author), Georg August Univ Gottingen, Albrecht von Haller Inst Plant Sci, Dept Plant Biochem, Gottingen, Germany.; Feussner, I (corresponding author), Georg August Univ Gottingen, Gottingen Ctr Mol Biosci GZMB, Dept Plant Biochem, Gottingen, Germany.	ifeussn@uni-goettingen.de	Eng, Felipe FE/J-6087-2018; Ischebeck, Till/AAM-4327-2020; Feussner, Ivo/H-9320-2013	Eng, Felipe FE/0000-0002-1137-3721; Ischebeck, Till/0000-0003-0737-3822; Feussner, Ivo/0000-0002-9888-7003	Deutscher Akademischer Austauschdienst scholarship (DAAD) [50015559]; Deutsche Forschungsgemeinschaft (ZUK) [45/2010]; IRTG "PRoTECT" of the Gottingen Graduate School of Neuroscience and Molecular Biology (GGNB) [2172]	Deutscher Akademischer Austauschdienst scholarship (DAAD); Deutsche Forschungsgemeinschaft (ZUK); IRTG "PRoTECT" of the Gottingen Graduate School of Neuroscience and Molecular Biology (GGNB)	FE was supported through a Deutscher Akademischer Austauschdienst scholarship (DAAD, 50015559) and IF by the Deutsche Forschungsgemeinschaft (ZUK 45/2010). IF, SH and DR were supported by the IRTG 2172 "PRoTECT" of the Gottingen Graduate School of Neuroscience and Molecular Biology (GGNB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; FE was supported through a Deutscher Akademischer Austauschdienst scholarship (DAAD, 50015559) and IF by the Deutsche Forschungsgemeinschaft (ZUK 45/2010). IF, SH and DR were supported by the IRTG 2172 "PRoTECT" of the Gottingen Graduate School of Neuroscience and Molecular Biology (GGNB). We thank Pia Meyer and Pablo Tarazona for excellent assistance and Dr. Otto Miersch (IPB, Halle/Saale, Germany) for providing jasmonate standards as well as for fruitful discussions.	ALDRIDGE DC, 1971, J CHEM SOC C, P1623, DOI 10.1039/j39710001623; Andolfi A, 2016, CHEM BIODIVERS, V13, P395, DOI 10.1002/cbdv.201500104; Andolfi A, 2014, PHYTOCHEMISTRY, V103, P145, DOI 10.1016/j.phytochem.2014.03.016; Bao JY, 2014, RAPID COMMUN MASS SP, V28, P457, DOI 10.1002/rcm.6803; Biermann U, 2011, ANGEW CHEM INT EDIT, V50, P3854, DOI 10.1002/anie.201002767; Bottcher C, 2014, PLANT PHYSIOL, V165, P841, DOI 10.1104/pp.114.235630; Brodhun F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064919; Brodhun F, 2011, FEBS J, V278, P1047, DOI 10.1111/j.1742-4658.2011.08027.x; Busch Rainer, 2006, Biotechnology Journal, V1, P770, DOI 10.1002/biot.200600057; Castillo G, 2014, WORLD J MICROB BIOT, V30, P1937, DOI 10.1007/s11274-014-1612-5; Christensen SA, 2011, FUNGAL GENET BIOL, V48, P4, DOI 10.1016/j.fgb.2010.05.005; Creelman RA, 1997, ANNU REV PLANT PHYS, V48, P355, DOI 10.1146/annurev.arplant.48.1.355; CROSS BE, 1970, J CHEM SOC C, P1839, DOI 10.1039/j39700001839; DAVIS PJ, 1976, J BACTERIOL, V126, P544, DOI 10.1128/JB.126.1.544-546.1976; DEEG R, 1980, J CLIN CHEM CLIN BIO, V18, P49; DEMOLE E, 1962, HELV CHIM ACTA, V45, P675, DOI 10.1002/hlca.19620450233; Dhandhukia PC, 2008, J APPL MICROBIOL, V105, P636, DOI 10.1111/j.1365-2672.2008.03803.x; Dhandhukia PC, 2007, AFR J BIOTECHNOL, V6, P707; Durgbanshi A, 2005, J AGR FOOD CHEM, V53, P8437, DOI 10.1021/jf050884b; Eng F, 1998, PROCESS BIOCHEM, V33, P715, DOI 10.1016/S0032-9592(98)00035-1; GHASEMI PA, 2014, ARCH PHARM, V347, P229, DOI DOI 10.1002/ARDP.201300287; Heitz T, 2012, J BIOL CHEM, V287, P6296, DOI 10.1074/jbc.M111.316364; Hoffmann I, 2013, J LIPID RES, V54, P3471, DOI 10.1194/jlr.M044347; Iven T, 2012, MOL PLANT, V5, P1389, DOI 10.1093/mp/sss044; Jerneren F, 2012, LIPIDS, V47, P65, DOI 10.1007/s11745-011-3622-5; Kitaoka N, 2014, PHYTOCHEMISTRY, V99, P6, DOI 10.1016/j.phytochem.2013.12.019; Kitaoka N, 2011, PLANT CELL PHYSIOL, V52, P1757, DOI 10.1093/pcp/pcr110; Koo AJK, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00019; Koo AJK, 2011, P NATL ACAD SCI USA, V108, P9298, DOI 10.1073/pnas.1103542108; Lin L, 2011, CHEM REV, V111, P2734, DOI 10.1021/cr100061j; Luedeking R, 2000, BIOTECHNOL BIOENG, V67, P636, DOI 10.1002/(SICI)1097-0290(20000320)67:6<636::AID-BIT3>3.0.CO;2-U; Mano Y, 2012, J EXP BOT, V63, P2853, DOI 10.1093/jxb/ers091; MARQUES AM, 1986, APPL ENVIRON MICROB, V52, P1221; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; MIERSCH O, 1991, PHYTOCHEMISTRY, V30, P4049, DOI 10.1016/0031-9422(91)83464-V; Miersch O, 1999, PHYTOCHEMISTRY, V50, P1147, DOI 10.1016/S0031-9422(98)00698-0; Miersch O, 1999, PHYTOCHEMISTRY, V50, P517, DOI 10.1016/S0031-9422(98)00596-2; MIERSCH O, 1987, PHYTOCHEMISTRY, V26, P1037, DOI 10.1016/S0031-9422(00)82345-6; MIERSCH O, 1992, PHYTOCHEMISTRY, V31, P3835, DOI 10.1016/S0031-9422(00)97537-X; Patkar RN, 2015, NAT CHEM BIOL, V11, P733, DOI [10.1038/nchembio.1885, 10.1038/NCHEMBIO.1885]; Poudel AN, 2016, BIOCH BIOPHYS ACTA; Qian CD, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0297-0; Raviv Z, 2013, CANCER CHEMOTH PHARM, V71, P275, DOI 10.1007/s00280-012-2039-z; Schaller A, 2009, PHYTOCHEMISTRY, V70, P1532, DOI 10.1016/j.phytochem.2009.07.032; Scognamiglio J, 2012, FOOD CHEM TOXICOL, V50, pS572, DOI 10.1016/j.fct.2012.03.035; Segarra G, 2006, PHYTOCHEMISTRY, V67, P395, DOI 10.1016/j.phytochem.2005.11.017; Sembdner G., 1993, NAT PROD LETT, V2, P293, DOI [10.1080/10575639308043825, DOI 10.1080/10575639308043825]; Sirrenberg A, 2007, PHYSIOL PLANTARUM, V131, P581, DOI 10.1111/j.1399-3054.2007.00983.x; Song MC, 2014, NAT PROD REP, V31, P1497, DOI 10.1039/c4np00057a; Tsukada K, 2010, PHYTOCHEMISTRY, V71, P2019, DOI 10.1016/j.phytochem.2010.09.013; UEDA J, 1991, Bulletin of the University of Osaka Prefecture Series B Agriculture and Life Sciences, V43, P103; Wasternack C, 2013, ANN BOT-LONDON, V111, P1021, DOI 10.1093/aob/mct067; WEISS RM, 1980, BIOTECHNOL BIOENG, V22, P859, DOI 10.1002/bit.260220410; Widemann E, 2015, PHYTOCHEMISTRY, V117, P388, DOI 10.1016/j.phytochem.2015.06.027; Widemann E, 2015, METABOLOMICS, V11, P991, DOI 10.1007/s11306-014-0754-7; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108	56	18	18	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167627	10.1371/journal.pone.0167627	http://dx.doi.org/10.1371/journal.pone.0167627			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907207	Green Published, gold, Green Submitted			2022-12-26	WOS:000389482700213
J	Nakajima, E; Shimaji, K; Umegawachi, T; Tomida, S; Yoshida, H; Yoshimoto, N; Izawa, S; Kimura, H; Yamaguchi, M				Nakajima, Ei; Shimaji, Kouhei; Umegawachi, Takanari; Tomida, Saki; Yoshida, Hideki; Yoshimoto, Nana; Izawa, Shingo; Kimura, Hiroshi; Yamaguchi, Masamitsu			The Histone Deacetylase Gene Rpd3 Is Required for Starvation Stress Resistance	PLOS ONE			English	Article							DROSOPHILA FAT-BODY; NUCLEOLAR STRUCTURE; MEDIATED REGULATION; AUTOPHAGY; ACETYLATION; EXPRESSION; TRANSLATION; TRANSCRIPTION; METHYLATION; METABOLISM	Epigenetic regulation in starvation is important but not fully understood yet. Here we identified the Rpd3 gene, a Drosophila homolog of histone deacetylase 1, as a critical epigenetic regulator for acquiring starvation stress resistance. Immunostaining analyses of Drosophila fat body revealed that the subcellular localization and levels of Rpd3 dynamically changed responding to starvation stress. In response to starvation stress, the level of Rpd3 rapidly increased, and it accumulated in the nucleolus in what appeared to be foci. These observations suggest that Rpd3 plays a role in regulation of rRNA synthesis in the nucleolus. The RT-qPCR and ChIP-qPCR analyses clarified that Rpd3 binds to the genomic region containing the rRNA promoters and activates rRNA synthesis in response to starvation stress. Polysome analyses revealed that the amount of polysomes was decreased in Rpd3 knockdown flies under starvation stress compared with the control flies. Since the autophagy-related proteins are known to be starvation stress tolerance proteins, we examined autophagy activity, and it was reduced in Rpd3 knockdown flies. Taken together, we conclude that Rpd3 accumulates in the nucleolus in the early stage of starvation, upregulates rRNA synthesis, maintains the polysome amount for translation, and finally increases stress tolerance proteins, such as autophagy-related proteins, to acquire starvation stress resistance.	[Nakajima, Ei; Shimaji, Kouhei; Umegawachi, Takanari; Tomida, Saki; Yoshida, Hideki; Yoshimoto, Nana; Izawa, Shingo; Yamaguchi, Masamitsu] Kyoto Inst Technol, Dept Appl Biol, Kyoto, Japan; [Nakajima, Ei; Shimaji, Kouhei; Umegawachi, Takanari; Tomida, Saki; Yoshida, Hideki; Yamaguchi, Masamitsu] Kyoto Inst Technol, Insect Biomed Res Ctr, Kyoto, Japan; [Kimura, Hiroshi] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa, Japan	Kyoto Institute of Technology; Kyoto Institute of Technology; Tokyo Institute of Technology	Yamaguchi, M (corresponding author), Kyoto Inst Technol, Dept Appl Biol, Kyoto, Japan.; Yamaguchi, M (corresponding author), Kyoto Inst Technol, Insect Biomed Res Ctr, Kyoto, Japan.	myamaguc@kit.ac.jp	Kimura, Hiroshi/B-9524-2015	Kimura, Hiroshi/0000-0003-0854-083X; Izawa, Shingo/0000-0002-4920-2450; Yamaguchi, Masamitsu/0000-0002-6321-9750	Japan Society for the Promotion of Science (JSPS); Asia-Africa Science Platforms; JSPS KAKENHI Grant [15J0948, 16K07346.]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Asia-Africa Science Platforms; JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Support was provided by the Japan Society for the Promotion of Science (JSPS; https://www.jsps.go.jp/) Core-to-Core Program, Asia-Africa Science Platforms, JSPS KAKENHI Grant Number 15J0948 and 16K07346.	Baker KD, 2007, CELL METAB, V6, P257, DOI 10.1016/j.cmet.2007.09.002; Barrio L, 2014, CELL REP, V8, P527, DOI 10.1016/j.celrep.2014.06.020; Birse RT, 2010, CELL METAB, V12, P533, DOI 10.1016/j.cmet.2010.09.014; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Cesarini E, 2012, MOL BIOL CELL, V23, P2770, DOI 10.1091/mbc.E12-02-0095; Darling N.J., 2014, SCI REP-UK, V1843, P2150, DOI DOI 10.1016/J.BBAMCR.2014.01.009; de Nadal E, 2011, NAT REV GENET, V12, P833, DOI 10.1038/nrg3055; Eng CH, 2011, ONCOGENE, V30, P4687, DOI 10.1038/onc.2011.220; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Gutierrez E, 2007, NATURE, V445, P275, DOI 10.1038/nature05382; Harbison ST, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r36; Hofmann S, 2012, MOL BIOL CELL, V23, P3786, DOI 10.1091/mbc.E12-04-0296; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Inada T, 2005, EMBO J, V24, P1584, DOI 10.1038/sj.emboj.7600636; Jin M, 2014, AUTOPHAGY, V10, P1681, DOI 10.4161/auto.29641; Kato M, 2014, DNA REPAIR, V23, P49, DOI 10.1016/j.dnarep.2014.07.009; Kimura H, 2008, CELL STRUCT FUNCT, V33, P61, DOI 10.1247/csf.07035; Koutsounas I, 2013, WORLD J GASTROENTERO, V19, P813, DOI 10.3748/wjg.v19.i6.813; Kurdistani SK, 2002, NAT GENET, V31, P248, DOI 10.1038/ng907; Li W, 2014, DEVELOPMENT, V141, P3910, DOI 10.1242/dev.109306; Lopez-Maury L, 2008, NAT REV GENET, V9, P583, DOI 10.1038/nrg2398; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; MIAN A, 1990, NUCLEIC ACIDS RES, V18, P3795, DOI 10.1093/nar/18.13.3795; Mikawa T, 2010, GENES CELLS, V15, P229, DOI 10.1111/j.1365-2443.2009.01376.x; Musselman LP, 2013, J BIOL CHEM, V288, P8028, DOI 10.1074/jbc.M112.371047; Naveed Sidra, 2014, Oman Med J, V29, P391, DOI 10.5001/omj.2014.107; Oakes ML, 2006, MOL CELL BIOL, V26, P3889, DOI 10.1128/MCB.26.10.3889-3901.2006; Pritchett TL, 2012, CELL DEATH DIFFER, V19, P1069, DOI 10.1038/cdd.2011.200; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Rodkaer SV, 2014, FEMS YEAST RES, V14, P683, DOI 10.1111/1567-1364.12157; Rundlett SE, 1996, P NATL ACAD SCI USA, V93, P14503, DOI 10.1073/pnas.93.25.14503; Russell RC, 2014, CELL RES, V24, P42, DOI 10.1038/cr.2013.166; Rusten TE, 2004, DEV CELL, V7, P179, DOI 10.1016/j.devcel.2004.07.005; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Spriggs KA, 2010, MOL CELL, V40, P228, DOI 10.1016/j.molcel.2010.09.028; Tie F, 2009, DEVELOPMENT, V136, P3131, DOI 10.1242/dev.037127; Tsang CK, 2003, EMBO J, V22, P6045, DOI 10.1093/emboj/cdg578; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Xie T, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0042001, 10.1371/journal.pone.0047577]; Yan CH, 2006, MOL CELL BIOL, V26, P6357, DOI 10.1128/MCB.00311-06; Zeitlinger J, 2007, GENE DEV, V21, P385, DOI 10.1101/gad.1509607; Zupkovitz G, 2006, MOL CELL BIOL, V26, P7913, DOI 10.1128/MCB.01220-06	45	10	10	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167554	10.1371/journal.pone.0167554	http://dx.doi.org/10.1371/journal.pone.0167554			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907135	Green Submitted, Green Published, gold			2022-12-26	WOS:000389482700192
J	Nguyen, V; Rizzo, J; Sanii, B				Nguyen, Victoria; Rizzo, John; Sanii, Babak			An Assemblable, Multi-Angle Fluorescence and Ellipsometric Microscope	PLOS ONE			English	Article							IMAGING ELLIPSOMETRY; PHOSPHOLIPID-MEMBRANES; VISUALIZATION	We introduce a multi-functional microscope for research laboratories that have significant cost and space limitations. The microscope pivots around the sample, operating in upright, inverted, side-on and oblique geometries. At these geometries it is able to perform brightfield, fluorescence and qualitative ellipsometric imaging. It is the first single instrument in the literature to be able to perform all of these functionalities. The system can be assembled by two undergraduate students from a provided manual in less than a day, from off-the-shelf and 3D printed components, which together cost approximately $ 16k at 2016 market prices. We include a highly specified assembly manual, a summary of design methodologies, and all associated 3D-printing files in hopes that the utility of the design outlives the current component market. This open design approach prepares readers to customize the instrument to specific needs and applications. We also discuss how to select household LEDs as low-cost light sources for fluorescence microscopy. We demonstrate the utility of the microscope in varied geometries and functionalities, with particular emphasis on studying hydrated, solidsupported lipid films and wet biological samples.	[Nguyen, Victoria; Sanii, Babak] Scripps Coll, Keck Sci Dept, Claremont, CA 91711 USA; [Rizzo, John; Sanii, Babak] Claremont Mckenna Coll, Keck Sci Dept, Claremont, CA 91711 USA; [Sanii, Babak] Pitzer Coll, Keck Sci Dept, Claremont, CA 91711 USA	Claremont Colleges; Scripps College; Claremont Colleges; Claremont Graduate School; Claremont McKenna College; Claremont Colleges; Pitzer College	Sanii, B (corresponding author), Scripps Coll, Keck Sci Dept, Claremont, CA 91711 USA.; Sanii, B (corresponding author), Claremont Mckenna Coll, Keck Sci Dept, Claremont, CA 91711 USA.; Sanii, B (corresponding author), Pitzer Coll, Keck Sci Dept, Claremont, CA 91711 USA.	bsanii@kecksci.claremont.edu	Rizzo, J. Ricardo/N-5879-2014	Rizzo, J. Ricardo/0000-0002-8443-6631	Department of Keck Science; S.D. Bechtel, Jr. Foundation [5666]	Department of Keck Science; S.D. Bechtel, Jr. Foundation	This project was primarily funded through startup funds via the Department of Keck Science (https://www.kecksci.claremont.edu). Additionally, one of the co-authors (Victoria Nguyen, VN) was funded for a summer through the S.D. Bechtel, Jr. Foundation (http://sdbjrfoundation.org, Grant ID #5666). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors appreciate advice and assistance from W. Cook and A. Schwartzberg, and spectrophotometer assistance from L. Schmitz. We thank J. Zehner and M. Swift who test-assembled the device from parts and the manual in a day, as well as T. Liu and C. Hu who prepared lipid-spreading samples for ellipsometry. Yeast and brain-tissue samples were generously provided by the laboratories of Z.I. Tang and R. Spence respectively. We gratefully acknowledge summer financial support of V.N. through the S.D. Bechtel Jr. Foundation (Grant ID 5666).	[Anonymous], COMMUNICATION; ASPNES DE, 1975, APPL OPTICS, V14, P220, DOI 10.1364/AO.14.000220; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Azzam R.M., 1987, ELLIPSOMETRY POLARIZ, V3rd, DOI [10.1063/1.2994821, DOI 10.1063/1.2994821]; Baden T, 2015, PLOS COLLECTIONS; Baden T, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002086; Campbell RAA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088977; Carnahan RH, 2005, EUKARYOT CELL, V4, P577, DOI 10.1128/EC.4.3.577-587.2005; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; Cybulski JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098781; Davis JL, 2014, THERM MECH MULT SIM, P1, DOI 10.1109/; Deegan RD, 1997, NATURE, V389, P827, DOI 10.1038/39827; Dougherty Dale, 2012, DISPLAY DESIGN IDEAS, V27, P80, DOI [10.1162/INOV_a_00135, DOI 10.1162/INOV_A_00135]; Edelstein A., 2010, CURR PROTOC MOL BIOL, P20, DOI [DOI 10.1002/0471142727.MB1420S92, 10.1002/0471142727.mb1420s92]; Faiss S, 2007, J PHYS CHEM B, V111, P13979, DOI 10.1021/jp073671t; Ghosh KK, 2011, NAT METHODS, V8, P871, DOI [10.1038/NMETH.1694, 10.1038/nmeth.1694]; Greenbaum A, 2012, LAB CHIP, V12, P1242, DOI 10.1039/c2lc21072j; Hilfiker JN, 2003, J VAC SCI TECHNOL A, V21, P1103, DOI 10.1116/1.1569928; HONIG D, 1991, J PHYS CHEM-US, V95, P4590, DOI 10.1021/j100165a003; Howland MC, 2007, BIOPHYS J, V92, P1306, DOI 10.1529/biophysj.106.097071; Jin G, 1996, REV SCI INSTRUM, V67, P2930, DOI 10.1063/1.1147074; JIN G, 1995, ANAL BIOCHEM, V232, P69, DOI 10.1006/abio.1995.9959; Kintel M., 2011, OPENSCAD PROGRAMMERS; Kohler A., 1894, J R MICROSCOP SOC, V14, P261, DOI DOI 10.1111/J.1365-2818.1894; Kondoh E., SPREADSHEET ELLIPSOM; Leonenko ZV, 2004, BIOPHYS J, V86, P3783, DOI 10.1529/biophysj.103.036681; Liu KN, 2015, SOFT MATTER, V11, P8217, DOI 10.1039/c5sm02013a; LOSCHE M, 1983, BER BUNSEN PHYS CHEM, V87, P848, DOI 10.1002/bbpc.19830871004; Miller AR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011890; Mota C., 2011, PROC 8 ACM C CREATIV, P279, DOI [10.1145/2069618.2069665, DOI 10.1145/2069618.2069665]; MULLER RH, 1969, SURF SCI, V16, P14, DOI 10.1016/0039-6028(69)90003-X; NADKARNI GD, 1992, EUROPHYS LETT, V20, P523, DOI 10.1209/0295-5075/20/6/009; NAKAMURA S, 1991, JPN J APPL PHYS 2, V30, pL1998, DOI 10.1143/JJAP.30.L1998; Nissen J, 1999, EUR PHYS J B, V10, P335, DOI 10.1007/s100510050862; Phillips ZF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124938; Rosenegger DG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110475; Sharkey JP, 2016, REV SCI INSTRUM, V87, DOI 10.1063/1.4941068; Shin D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011218; Smith JL, 1852, AM J SCI ARTS, VXIV; Stewart C, 2016, J CHEM EDUC, V93, P1310, DOI 10.1021/acs.jchemed.5b00984; Sung YL, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.4.047005; Tapley A, 2013, J CLIN MICROBIOL, V51, P1774, DOI 10.1128/JCM.03432-12; Tompkins H, 2005, HDB ELLIPSOMETRY; Tompkins HG, 2012, USERS GUIDE ELLIPSOM; Wilczynski V., 2015, P 2015 ASEE ANN C EX, DOI 10.18260/p.23477; Wirth M, 2014, P EUR C INF SYST ECI; Yang B, 2014, CELL, V158, P945, DOI 10.1016/j.cell.2014.07.017; Young MD, 2015, ADV OPT PHOTONICS, V7, P276, DOI 10.1364/AOP.7.000276; Young T., 1805, PHILOS T R SOC LONDO, V95, P65, DOI [10.1098/rstl.1805.0005, DOI 10.1098/RSTL.1805.0005]	49	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166735	10.1371/journal.pone.0166735	http://dx.doi.org/10.1371/journal.pone.0166735			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907008	Green Published, Green Submitted, gold			2022-12-26	WOS:000389482700037
J	Steegen, K; Carmona, S; Bronze, M; Papathanasopoulos, MA; van Zyl, G; Goedhals, D; MacLeod, W; Sanne, I; Stevens, WS				Steegen, Kim; Carmona, Sergio; Bronze, Michelle; Papathanasopoulos, Maria A.; van Zyl, Gert; Goedhals, Dominique; MacLeod, William; Sanne, Ian; Stevens, Wendy S.			Moderate Levels of Pre-Treatment HIV-1 Antiretroviral Drug Resistance Detected in the First South African National Survey	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; TREATMENT-NAIVE PATIENTS; VIROLOGICAL FAILURE; SUBTYPE-B; MUTATIONS; THERAPY; SURVEILLANCE; TRANSMISSION; PREVALENCE; INDIVIDUALS	Background In order to assess the level of transmitted and/or pre-treatment antiretroviral drug resistance to HIV-1, the World Health Organization (WHO) recommends that regular surveys are conducted. This study's objective was to assess the frequency of HIV-1 antiretroviral drug resistance in patients initiating antiretroviral treatment (ART) in the public sector throughout South Africa. Methods A prospective cross-sectional survey was conducted using probability proportional to size sampling. This method ensured that samples from each province were proportionally collected, based on the number of patients receiving ART in each region. Samples were collected between March 2013 and October 2014. Po/sequences were obtained using RTPCR and Sanger sequencing and submitted to the Stanford Calibrated Population Resistance tool v6.0. Results A total of 277 sequences were available for analysis. Most participants were female (58.8%) and the median age was 34 years (IQR: 29-42). The median baseline CD4-count was 149 cells/mm3 (IQR: 62-249) and, based on self-reporting, participants had been diagnosed as HIV-positive approximately 44 days prior to sample collection (IQR: 23-179). Subtyping revealed that 98.2% were infected with HIV-1 subtype C. Overall, 25 out of 277 patients presented with >= 1 surveillance drug resistance mutation (SDRM, 9.0%, 95% CI: 6.1-13.0%). Non-nucleoside reverse transcriptase inhibitor (NNRTI) mutations were the most numerous mutations detected (n = 23). Only two patients presented with a protease inhibitor (PI) mutation. In four patients >= 4 SDRMs were detected, which might indicate that these patients were not truly ART-naive or were infected with a multi-resistant virus. Conclusions These results show that the level of antiretroviral drug resistance in ART-na ve South Africans has reached moderate levels, as per the WHO classification. Therefore, regular surveys of pre-treatment drug resistance levels in all regions of South Africa is highly recommended to monitor the changing levels of pre-treatment antiretroviral drug resistance.	[Steegen, Kim; Carmona, Sergio; Papathanasopoulos, Maria A.; Stevens, Wendy S.] Univ Witwatersrand, Dept Mol Med & Haematol, Johannesburg, South Africa; [Carmona, Sergio; Bronze, Michelle; van Zyl, Gert; Goedhals, Dominique; Stevens, Wendy S.] Natl Hlth Lab Serv, Johannesburg, South Africa; [van Zyl, Gert] Univ Stellenbosch, Div Med Virol, Stellenbosch, South Africa; [Goedhals, Dominique] Univ Free State, Dept Med Microbiol & Virol, Bloemfontein, South Africa; [MacLeod, William] Boston Univ, Sch Publ Hlth, Ctr Global Hlth & Dev, Boston, MA USA; [MacLeod, William] Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, Hlth Econ & Epidemiol Res Off,Dept Internal Med, Johannesburg, South Africa; [Sanne, Ian] Right Care, Johannesburg, South Africa	University of Witwatersrand; National Health Laboratory Service; Stellenbosch University; University of the Free State; Boston University; University of Witwatersrand	Steegen, K (corresponding author), Univ Witwatersrand, Dept Mol Med & Haematol, Johannesburg, South Africa.	kim.steegen@nhls.ac.za	van Zyl, Gert/I-7357-2019; Steegen, Kim/ABH-4471-2020; Sanne, Ian/ABH-2231-2020; Steegen, K/AAF-6512-2020	van Zyl, Gert/0000-0003-3021-5101; Steegen, Kim/0000-0003-3226-7685; Carmona, Sergio/0000-0002-6792-4748; MacLeod, William/0000-0001-8003-8874	Global Fund to Fight AIDS, Tuberculosis and Malaria (SAF-H-RTC)	Global Fund to Fight AIDS, Tuberculosis and Malaria (SAF-H-RTC)	The survey was funded by The Global Fund to Fight AIDS, Tuberculosis and Malaria (SAF-H-RTC, www.theglobalfund.org). The views described herein are the views of the researchers involved, and do not represent the views or opinions of the Global Fund to Fight AIDS, Tuberculosis & Malaria, nor is there any approval or authorisation of this material, express or implied, by the Global Fund to Fight AIDS, Tuberculosis and Malaria. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bennett DE, 2008, ANTIVIR THER, V13, P25; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Brenner BG, 2011, J INFECT DIS, V204, P1115, DOI 10.1093/infdis/jir468; Bronze M., 1 INT C AFR SOC LAB; Cambiano V, 2013, J INFECT DIS, V207, pS57, DOI 10.1093/infdis/jit111; Chalmet K, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-262; Claassen M, 2008, IMPROVEMENT VALIDATI; Hamers RL, 2012, LANCET INFECT DIS, V12, P307, DOI 10.1016/S1473-3099(11)70255-9; Hamers RL, 2011, LANCET INFECT DIS, V11, P750, DOI 10.1016/S1473-3099(11)70149-9; Huang KHG, 2009, ANTIVIR THER, V14, P975, DOI 10.3851/IMP1416; Hunt GM, 2012, CLIN INFECT DIS, V54, pS334, DOI 10.1093/cid/cir1017; Jacobs GB, 2008, AIDS RES HUM RETROV, V24, P1009, DOI 10.1089/aid.2008.0028; Jacobs GB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090845; Johnston V, 2012, JAIDS-J ACQ IMM DEF, V61, P370, DOI 10.1097/QAI.0b013e318266ee3f; Li JZ, 2012, AIDS, V26, P185, DOI 10.1097/QAD.0b013e32834e9d7d; Lukhwareni A, 2012, PATHP C PATHP C CAP; Manasa J, 2016, AIDS RES HUMAN RETRO; Manasa J, 2012, AIDS RES HUM RETROV, V28, P558, DOI [10.1089/aid.2011.0284, 10.1089/AID.2011.0284]; Nichols BE, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19164; Nwobegahay JM, 2011, J HEALTH POPUL NUTR, V29, P303, DOI 10.3329/jhpn.v29i4.8444; Orrell C, 2009, ANTIVIR THER, V14, P523; Parboosing R, 2011, J MED VIROL, V83, P1508, DOI 10.1002/jmv.22143; Parikh UM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059787; Pillay V, 2008, ANTIVIR THER, V13, P101; Pingen M, 2011, J ANTIMICROB CHEMOTH, V66, P1467, DOI 10.1093/jac/dkr157; Rhee SY, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001810; Richard N, 2004, AIDS RES HUM RETROV, V20, P355, DOI 10.1089/088922204323048104; UNAIDS, 90 90 90 AMB TREATM; UNAIDS, UNAIDS ANN GOAL 15 M; Wainberg Mark A, 2004, Expert Rev Anti Infect Ther, V2, P147, DOI 10.1586/14787210.2.1.147; Weber J, 2005, J CLIN MICROBIOL, V43, P1395, DOI 10.1128/JCM.43.3.1395-1400.2005; White KL, 2002, ANTIMICROB AGENTS CH, V46, P3437, DOI 10.1128/AAC.46.11.3437-3446.2002; World Health Organization, 2012, HIV DRUG RES REP 201	33	32	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166305	10.1371/journal.pone.0166305	http://dx.doi.org/10.1371/journal.pone.0166305			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907009	Green Published, gold			2022-12-26	WOS:000389482700023
J	Tian, X; Patel, K; Ridpath, JR; Chen, YJ; Zhou, YH; Neo, D; Clement, J; Takata, M; Takeda, S; Sale, J; Wright, FA; Swenberg, JA; Nakamura, J				Tian, Xu; Patel, Keyur; Ridpath, John R.; Chen, Youjun; Zhou, Yi-Hui; Neo, Dayna; Clement, Jean; Takata, Minoru; Takeda, Shunichi; Sale, Julian; Wright, Fred A.; Swenberg, James A.; Nakamura, Jun			Homologous Recombination and Translesion DNA Synthesis Play Critical Roles on Tolerating DNA Damage Caused by Trace Levels of Hexavalent Chromium	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; IN-VITRO; SACCHAROMYCES-CEREVISIAE; ACCESSORY SUBUNITS; CANCER-MORTALITY; MAMMALIAN-CELLS; POLYMERASE-ZETA; CR(VI) EXPOSURE; DRINKING-WATER; CROSS-LINKING	Contamination of potentially carcinogenic hexavalent chromium (Cr(VI)) in the drinking water is a major public health concern worldwide. However, little information is available regarding the biological effects of a nanomoler amount of Cr(VI). Here, we investigated the genotoxic effects of Cr(VI) at nanomoler levels and their repair pathways. We found that DNA damage response analyzed based on differential toxicity of isogenic cells deficient in various DNA repair proteins is observed after a three-day incubation with K2CrO4 in REV1-deficient DT40 cells at 19.2 mu g/L or higher as well as in TK6 cells deficient in polymerase delta subunit 3 (POLD3) at 9.8 mu g/L or higher. The genotoxicity of Cr(VI) decreased similar to 3000 times when the incubation time was reduced from three days to ten minutes. TK mutation rate also significantly decreased from 6 day to 1 day exposure to Cr(VI). The DNA damage response analysis suggest that DNA repair pathways, including the homologous recombination and REV1- and POLD3-mediated error-prone translesion synthesis pathways, are critical for the cells to tolerate to DNA damage caused by trace amount of Cr(VI).	[Tian, Xu; Patel, Keyur; Ridpath, John R.; Neo, Dayna; Clement, Jean; Swenberg, James A.; Nakamura, Jun] Univ North Carolina Chapel Hill, Dept Environm Sci & Engn, Chapel Hill, NC 27514 USA; [Chen, Youjun] Univ North Carolina Chapel Hill, Dept Neurol, UNC Neurosci Ctr, Sch Med, Chapel Hill, NC USA; [Zhou, Yi-Hui; Wright, Fred A.] North Carolina State Univ, Bioinformat Res Ctr, Raleigh, NC 27695 USA; [Zhou, Yi-Hui; Wright, Fred A.] North Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA; [Takata, Minoru] Kyoto Univ, Lab DNA Damage Signaling, Dept Late Effects Studies, Ctr Radiat Biol, Kyoto, Japan; [Takeda, Shunichi] Kyoto Univ, Grad Sch Med, Dept Radiat Genet, Kyoto, Japan; [Sale, Julian] MRC, Mol Biol Lab, Cambridge, England; [Wright, Fred A.] North Carolina State Univ, Dept Stat, Raleigh, NC 27695 USA; [Swenberg, James A.] Univ North Carolina Chapel Hill, Curriculum Toxicol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; Kyoto University; Kyoto University; MRC Laboratory Molecular Biology; University of North Carolina; North Carolina State University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Nakamura, J (corresponding author), Univ North Carolina Chapel Hill, Dept Environm Sci & Engn, Chapel Hill, NC 27514 USA.; Wright, FA (corresponding author), North Carolina State Univ, Bioinformat Res Ctr, Raleigh, NC 27695 USA.; Wright, FA (corresponding author), North Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA.; Wright, FA (corresponding author), North Carolina State Univ, Dept Stat, Raleigh, NC 27695 USA.	fred_wright@ncsu.edu; ynakamur@ernail.unc.edu	Takata, Minoru/K-3772-2019	Neo, Dayna/0000-0001-7044-7260; Takata, Minoru/0000-0002-4926-3675; Nakamura, Jun/0000-0002-1756-7199; Takeda, Shunichi/0000-0002-7924-7991; Sale, Julian/0000-0002-5031-3780; Zhou, Yi-Hui/0000-0002-4092-7463	National Institutes of Health [P42 ES005948, P30 ES010126]; Medical Research Council [MC_U105178808] Funding Source: researchfish; MRC [MC_U105178808] Funding Source: UKRI; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES005948, T32ES007126, P30ES010126] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was fully supported by grants from the National Institutes of Health (P42 ES005948, P30 ES010126 to JAS and JN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RA, 1989, SCI TOTAL ENVIRON, V86, P75, DOI 10.1016/0048-9697(89)90196-4; [Anonymous], 2012, U S EPA 100 R 12 001; [Anonymous], 2000, AG TOX SUBST DIS REG; Arakawa H, 2008, CHEM RES TOXICOL, V21, P1284, DOI 10.1021/tx800046y; Beaumont JJ, 2008, EPIDEMIOLOGY, V19, P12, DOI 10.1097/EDE.0b013e31815cea4c; BRIDGEWATER LC, 1994, CARCINOGENESIS, V15, P2421, DOI 10.1093/carcin/15.11.2421; Bryant HE, 2006, MUTAT RES-FUND MOL M, V599, P116, DOI 10.1016/j.mrfmmm.2006.02.001; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Ha LN, 2004, CARCINOGENESIS, V25, P2265, DOI 10.1093/carcin/bgh242; Hu J, 2012, ENVIRON SCI TECHNOL, V46, P4607, DOI 10.1021/es300020e; Ishiai Masamichi, 2012, Methods Mol Biol, V920, P39, DOI 10.1007/978-1-61779-998-3_4; Ji K, 2011, ENVIRON SCI TECHNOL, V45, P7481, DOI 10.1021/es200724x; Johnson AJ, 2016, METALLOMICS, V8, P542, DOI 10.1039/c6mt00039h; Kerger BD, 2009, J TOXICOL ENV HEAL A, V72, P329, DOI 10.1080/15287390802529898; Lee YS, 2014, P NATL ACAD SCI USA, V111, P2954, DOI 10.1073/pnas.1324001111; Liu FJ, 2009, TOXICOL SCI, V110, P307, DOI 10.1093/toxsci/kfp104; Liu KJ, 2001, MOL CELL BIOCHEM, V222, P41, DOI 10.1023/A:1017994720562; Makarova AV, 2012, NUCLEIC ACIDS RES, V40, P11618, DOI 10.1093/nar/gks948; Messer J, 2006, FREE RADICAL BIO MED, V40, P1981, DOI 10.1016/j.freeradbiomed.2006.01.028; Morse JL, 2013, CHEM RES TOXICOL, V26, P1591, DOI 10.1021/tx400293s; National Toxicology P, 2008, NATL TOXICOLOGY PROG, P1; O'Brien TJ, 2005, MOL CELL BIOCHEM, V279, P85, DOI 10.1007/s11010-005-8225-0; O'Brien TJ, 2002, DNA REPAIR, V1, P617, DOI 10.1016/S1568-7864(02)00078-2; O'Brien TJ, 2009, MUTAT RES-FUND MOL M, V663, P77, DOI 10.1016/j.mrfmmm.2009.01.012; Reynolds M, 2004, J BIOL CHEM, V279, P30419, DOI 10.1074/jbc.M402486200; Reynolds M, 2007, NUCLEIC ACIDS RES, V35, P465, DOI 10.1093/nar/gkl1069; Ridpath JR, 2007, CANCER RES, V67, P11117, DOI 10.1158/0008-5472.CAN-07-3028; Ridpath JR, 2011, ENVIRON MOL MUTAGEN, V52, P153, DOI 10.1002/em.20595; Santoyo G, 2008, MICROBIOL RES, V163, P113, DOI 10.1016/j.micres.2007.09.001; Sonoda E, 2001, PHILOS T ROY SOC B, V356, P111, DOI 10.1098/rstb.2000.0755; Sugden KD, 1997, CHEM RES TOXICOL, V10, P1397, DOI 10.1021/tx970135r; Sugden KD, 2001, CHEM RES TOXICOL, V14, P1315, DOI 10.1021/tx010088+; Sutton R., 2010, CHROMIUM 6 US TAP WA, P1; Suzuki Aussie, 2011, Curr Protoc Cell Biol, VChapter 8, DOI 10.1002/0471143030.cb0807s50; USEPA, 2010, EPA635R10004A; Vilcheck SK, 2002, ENVIRON HEALTH PERSP, V110, P773, DOI 10.1289/ehp.02110s5773; Vilcheck SK, 2006, MUTAT RES-GEN TOX EN, V610, P21, DOI 10.1016/j.mrgentox.2006.06.009; VOITKUN V, 1994, ENVIRON HEALTH PERSP, V102, P251, DOI 10.2307/3431796; Walden H, 2014, ANNU REV BIOPHYS, V43, P257, DOI 10.1146/annurev-biophys-051013-022737; Xie H, 2005, MUTAT RES-GEN TOX EN, V586, P160, DOI 10.1016/j.mrgentox.2005.06.002; Zecevic A, 2010, MUTAGENESIS, V25, P381, DOI 10.1093/mutage/geq017; Zhitkovich A, 2005, CHEM RES TOXICOL, V18, P3, DOI 10.1021/tx049774+; Zhitkovich A, 1996, BIOCHEMISTRY-US, V35, P7275, DOI 10.1021/bi960147w; Zhitkovich A, 2011, CHEM RES TOXICOL, V24, P1617, DOI 10.1021/tx200251t	44	3	3	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167503	10.1371/journal.pone.0167503	http://dx.doi.org/10.1371/journal.pone.0167503			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907204	Green Published, gold			2022-12-26	WOS:000389482700172
J	Wang, HS; Zhai, KL; Xue, YC; Yang, J; Yang, Q; Fu, Y; Hu, Y; Liu, F; Wang, WQ; Cui, LX; Chen, H; Zhang, JM; He, W				Wang, Huaishan; Zhai, Kangle; Xue, Yingchao; Yang, Jia; Yang, Qi; Fu, Yi; Hu, Yu; Liu, Fang; Wang, Weiqing; Cui, Lianxian; Chen, Hui; Zhang, Jianmin; He, Wei			Global Deletion of TSPO Does Not Affect the Viability and Gene Expression Profile	PLOS ONE			English	Article							TRANSLOCATOR PROTEIN TSPO; POSITRON-EMISSION-TOMOGRAPHY; CELL-TARGETED DELETION; 18 KDA TSPO; BENZODIAZEPINE-RECEPTOR; MOUSE MODEL; CHOLESTEROL TRANSPORT; CRUCIAL ROLE; IN-VIVO; STEROIDOGENESIS	Translocator Protein (18kDa, TSPO) is a mitochondrial outer membrane transmembrane protein. Its expression is elevated during inflammation and injury. However, the function of TSPO in vivo is still controversial. Here, we constructed a TSPO global knockout (KO) mouse with a Cre-LoxP system that abolished TSPO protein expression in all tissues and showed normal phenotypes in the physiological condition. The birth rates of TSPO heterozygote (Het) x Het or KO x KO breeding were consistent with Mendel's Law, suggesting a normal viability of TSPO KO mice at birth. RNA-seq analysis showed no significant difference in the gene expression profile of lung tissues from TSPO KO mice compared with wild type mice, including the genes associated with bronchial alveoli immune homeostasis. The alveolar macrophage population was not affected by TSPO deletion in the physiological condition. Our findings contradict the results of Papadopoulos, but confirmed Selvaraj's findings. This study confirms TSPO deficiency does not affect viability and bronchial alveolar immune homeostasis.	[Wang, Huaishan; Zhai, Kangle; Xue, Yingchao; Yang, Jia; Yang, Qi; Fu, Yi; Hu, Yu; Cui, Lianxian; Chen, Hui; Zhang, Jianmin; He, Wei] Chinese Acad Med Sci, Inst Basic Med Sci, Res Ctr Pediat Dev & Dis, Dept Immunol, Beijing, Peoples R China; [Wang, Huaishan; Zhai, Kangle; Xue, Yingchao; Yang, Jia; Yang, Qi; Fu, Yi; Hu, Yu; Cui, Lianxian; Chen, Hui; Zhang, Jianmin; He, Wei] Peking Union Med Coll, Sch Basic Med, State Key Lab Med Mol Biol, Beijing, Peoples R China; [Liu, Fang] Beijing Thorgene Med Lab, Yizhuang Biomed Pk, Beijing, Peoples R China; [Wang, Weiqing] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Otolaryngol, Beijing, Peoples R China; [Wang, Weiqing] Peking Union Med Coll, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Zhang, JM; He, W (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Res Ctr Pediat Dev & Dis, Dept Immunol, Beijing, Peoples R China.; Zhang, JM; He, W (corresponding author), Peking Union Med Coll, Sch Basic Med, State Key Lab Med Mol Biol, Beijing, Peoples R China.	jzhang42@163.com; heweingd@126.com	Wang, Huaishan/P-1882-2014; YANG, JIA/AAW-3653-2021	Wang, Huaishan/0000-0002-8686-4357; YANG, JIA/0000-0002-3992-4070; Xue, Yingchao/0000-0002-7830-3146; Wang, Weiqing/0000-0002-9440-1117	National Natural Science Foundation of China [31471016]; CAMS Initiative for Innovative Medicine [2016-I2M-1-008]; PUMC Scholarship [3332015109]; CAMS Central Public Welfare Scientific Research Institute Basal Research Expenses [2016ZX310182-3]; Beijing Thorgene Medical Laboratory	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAMS Initiative for Innovative Medicine; PUMC Scholarship; CAMS Central Public Welfare Scientific Research Institute Basal Research Expenses; Beijing Thorgene Medical Laboratory	This study was supported by grants from National Natural Science Foundation of China to JZ (31471016), CAMS Initiative for Innovative Medicine to JZ (2016-I2M-1-008), PUMC Scholarship for Young Scientists to HW (3332015109) and CAMS Central Public Welfare Scientific Research Institute Basal Research Expenses to HW (2016ZX310182-3). Beijing Thorgene Medical Laboratory provided support in the form of salaries for author FL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'Author Contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by grants from National Natural Science Foundation of China to JZ (31471016), CAMS Initiative for Innovative Medicine to JZ (2016-I2M-1-008), PUMC Scholarship for Young Scientists to HW (3332015109) and CAMS Central Public Welfare Scientific Research Institute Basal Research Expenses to HW (2016ZX310182-3). Beijing Thorgene Medical Laboratory provided support in the form of salary for FL, but did not have any additional roles in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank Dr. Austin Cape at ASJ Editors for careful review and feedback.	Anders S, 2012, DIFFERENTIAL EXPRESS; Anders S., 2010, MOL BIOL+, V43, P1, DOI DOI 10.1186/GB-2010-11-10-R106; ANHOLT RRH, 1986, J BIOL CHEM, V261, P576; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Banati RB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6452; Barron AM, 2013, J NEUROSCI, V33, P8891, DOI 10.1523/JNEUROSCI.1350-13.2013; Daugherty DJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep22556; Daugherty DJ, 2013, EMBO MOL MED, V5, P891, DOI 10.1002/emmm.201202124; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fan JJ, 2015, P NATL ACAD SCI USA, V112, P7261, DOI 10.1073/pnas.1502670112; Gavish M, 1999, PHARMACOL REV, V51, P629; Guilarte TR, 2016, TRENDS PHARMACOL SCI, V37, P334, DOI 10.1016/j.tips.2016.02.008; Guo YZ, 2015, SCIENCE, V347, P551, DOI 10.1126/science.aaa1534; Hatori A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045065; Hatty CR, 2015, PHARMACOL RES, V100, P58, DOI 10.1016/j.phrs.2015.07.029; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hussell T, 2014, NAT REV IMMUNOL, V14, P81, DOI 10.1038/nri3600; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karlstetter M, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-3; Korkhov VM, 2010, STRUCTURE, V18, P677, DOI 10.1016/j.str.2010.03.001; Li F, 2015, SCIENCE, V347, P555, DOI 10.1126/science.1260590; Liu GJ, 2014, BRAIN PATHOL, V24, P631, DOI 10.1111/bpa.12196; Liu J, 2006, J BIOL CHEM, V281, P38879, DOI 10.1074/jbc.M608820200; Middleton RJ, 2015, BIOCHEM SOC T, V43, P553, DOI 10.1042/BST20150039; Mirzaei N, 2016, GLIA, V64, P993, DOI 10.1002/glia.22978; Morohaku K, 2014, ENDOCRINOLOGY, V155, P89, DOI 10.1210/en.2013-1556; O'Gorman S, 1997, P NATL ACAD SCI USA, V94, P14602, DOI 10.1073/pnas.94.26.14602; Papadopoulos V, 1997, STEROIDS, V62, P21, DOI 10.1016/S0039-128X(96)00154-7; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rupprecht R, 2010, NAT REV DRUG DISCOV, V9, P971, DOI 10.1038/nrd3295; Rupprecht R, 2009, SCIENCE, V325, P490, DOI 10.1126/science.1175055; Seidler B, 2008, P NATL ACAD SCI USA, V105, P10137, DOI 10.1073/pnas.0800487105; Selvaraj V, 2016, P NATL ACAD SCI USA, V112, P7261; Selvaraj V, 2016, J ENDOCRINOL, V231, pR1, DOI 10.1530/JOE-16-0241; Selvaraj V, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00091; Selvaraj V, 2015, TRENDS ENDOCRIN MET, V26, P341, DOI 10.1016/j.tem.2015.02.007; Selvaraj V, 2015, MOL ENDOCRINOL, V29, P490, DOI 10.1210/me.2015-1033; Sileikyte J, 2014, J BIOL CHEM, V289, P13769, DOI 10.1074/jbc.M114.549634; Stocco DM, 2014, ENDOCRINOLOGY, V155, P6, DOI 10.1210/en.2013-2041; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tu LN, 2016, ENDOCRINOLOGY, V157, P1110, DOI 10.1210/en.2015-1795; Tu LN, 2015, ENDOCRINOLOGY, V156, P1033, DOI 10.1210/en.2014-1707; Tu LN, 2014, J BIOL CHEM, V289, P27444, DOI 10.1074/jbc.M114.578286; Wang WQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep26604; Yin SS, 2015, SCI REP-UK, V5, DOI 10.1038/srep14432; Yin SS, 2013, J BIOL CHEM, V288, P26448, DOI 10.1074/jbc.M113.484600; Zhao AH, 2016, J BIOL CHEM, V291, P1591, DOI 10.1074/jbc.M115.686360	51	32	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167307	10.1371/journal.pone.0167307	http://dx.doi.org/10.1371/journal.pone.0167307			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907096	Green Published, gold, Green Submitted			2022-12-26	WOS:000389482700115
J	Richard, G; Cox, SL; Picard, B; Vacquie-Garcia, J; Guinet, C				Richard, Gaetan; Cox, Samantha L.; Picard, Baptiste; Vacquie-Garcia, Jade; Guinet, Christophe			Southern Elephant Seals Replenish Their Lipid Reserves at Different Rates According to Foraging Habitat	PLOS ONE			English	Article							ANTARCTIC CIRCUMPOLAR CURRENT; ACCELERATION DATA LOGGERS; MIROUNGA-LEONINA; ENERGY-EXPENDITURE; STROKING PATTERNS; STABLE-ISOTOPES; MARINE PREDATOR; BODY CONDITION; OCEAN; BEHAVIOR	Assessing energy gain and expenditure in free ranging marine predators is difficult. However, such measurements are critical if we are to understand how variation in foraging efficiency, and in turn individual body condition, is impacted by environmentally driven changes in prey abundance and/or accessibility. To investigate the influence of oceanographic habitat type on foraging efficiency, ten post-breeding female southern elephant seals Mirounga leonina (SES) were equipped and tracked with bio-loggers to give continuous information of prey catch attempts, body density and body activity. Variations in these indices of foraging efficiency were then compared between three different oceanographic habitats, delineated by the main frontal structures of the Southern Ocean. Results show that changes in body density are related not only to the number of previous prey catch attempts and to the body activity (at a 6 day lag), but also foraging habitat type. For example, despite a lower daily prey catch attempt rate, SESs foraging north of the sub-Antarctic front improve their body density at a higher rate than individuals foraging south of the sub-Antarctic and polar fronts, suggesting that they may forage on easier to catch and/or more energetically rich prey in this area. Our study highlights a need to understand the influence of habitat type on top predator foraging behaviour and efficiency when attempting a better comprehension of marine ecosystems.	[Richard, Gaetan; Cox, Samantha L.; Picard, Baptiste; Vacquie-Garcia, Jade; Guinet, Christophe] CEBC CNRS, Villiers En Bois, France	Centre National de la Recherche Scientifique (CNRS)	Richard, G; Guinet, C (corresponding author), CEBC CNRS, Villiers En Bois, France.	gaetan-gs.richard@laposte.net; christophe.guinet@cebc.cnrs.fr	Guinet, Christophe/AAR-8457-2020; Cox, S L/ABD-5059-2021; Cox, S L/AEX-9613-2022	Cox, S L/0000-0002-5409-4458; Cox, S L/0000-0002-5409-4458; Baptiste, Picard/0000-0001-9565-9446; VACQUIE GARCIA, Jade/0000-0002-3126-3423; Richard, Gaetan/0000-0003-3709-2909	IPEV program [109]; Total Foundation	IPEV program; Total Foundation(Total SA)	This study is part of Institut Paul Emile Victor; IPEV program no. 109 led by H. Weimerskirch and the national observatory Mammiferes Explorateurs du Milieu Oceanique, MEMO SOERE CTD 02. This work was carried out in the framework of the ANR Blanc MYCTO-3D-MAP and ANR VMC 07: IPSOS-SEAL programs and CNES-TOSCA program (Elephants de mer oceanographes'). The funder, Total Foundation, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank all the Kerguelen fieldworkers involved in data collection. We are also grateful to Dr. Martin Biuw and two anonymous reviewers for their insightful comments. This study is part of the Institut Paul Emile Victor; IPEV program no. 109 led by H. Weimerskirch and the national observatory Mammiferes Explorateurs du Milieu Oceanique, MEMO SOERE CTD 02). This work was carried out in the framework of the ANR Blanc MYCTO-3D-MAP and ANR VMC 07: IPSOS-SEAL programs and CNES-TOSCA program ('Elephants de mer oceanographes'). The authors wish to additionally thank the Total Foundation for financial support.	Adachi T, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.2120; Aoki K, 2011, J EXP BIOL, V214, P2973, DOI 10.1242/jeb.055137; Authier M, 2012, P ROY SOC B-BIOL SCI, V279, P2681, DOI 10.1098/rspb.2012.0199; Bailleul F, 2010, ECOGRAPHY, V33, P709, DOI 10.1111/j.1600-0587.2009.06034.x; Biuw M, 2007, P NATL ACAD SCI USA, V104, P13705, DOI 10.1073/pnas.0701121104; Biuw M, 2003, J EXP BIOL, V206, P3405, DOI 10.1242/jeb.00583; Cherel Y, 2008, MAR ECOL PROG SER, V370, P239, DOI 10.3354/meps07673; Crocker DE, 1997, CAN J ZOOL, V75, P27, DOI 10.1139/z97-004; Daneri GA, 2002, POLAR BIOL, V25, P739, DOI 10.1007/s00300-002-0408-5; Davies NB, 2012, INTRO BEHAV ECOLOGY; Dragon AC, 2012, MAR ECOL PROG SER, V452, P253, DOI 10.3354/meps09618; Dragon AC, 2012, MAR ECOL PROG SER, V447, P243, DOI 10.3354/meps09498; Field IC, 2007, MAR BIOL, V150, P1441, DOI 10.1007/s00227-006-0417-y; Gallon S, 2013, DEEP-SEA RES PT II, V88-89, P14, DOI 10.1016/j.dsr2.2012.09.002; Gleiss AC, 2011, METHODS ECOL EVOL, V2, P23, DOI 10.1111/j.2041-210X.2010.00057.x; Guinet C, 2014, MAR ECOL PROG SER, V499, P285, DOI 10.3354/meps10660; Halsey LG, 2009, PHYSIOL BIOCHEM ZOOL, V82, P396, DOI 10.1086/589815; Halsey LG, 2011, COMP BIOCHEM PHYS A, V158, P305, DOI 10.1016/j.cbpa.2010.09.002; Hindell MA, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1213; Hulley PA., 1981, RESULTS RES CRUISES; KAREIVA P, 1987, AM NAT, V130, P233, DOI 10.1086/284707; Kooyman G. L., 1965, Polar Record, V12, P391; McConnell BJ, 1992, ANTARCT SCI, V4, DOI [10.1017/S0954102092000590, DOI 10.1017/S0954102092000590]; McIntyre T, 2011, MAR ECOL PROG SER, V441, P257, DOI 10.3354/meps09383; Miller PJO, 2012, J EXP BIOL, V215, P3622, DOI 10.1242/jeb.070128; Miller PJO, 2004, J EXP BIOL, V207, P1953, DOI 10.1242/jeb.00993; Mori Y, 1998, J ZOOL, V245, P279, DOI 10.1111/j.1469-7998.1998.tb00102.x; Naito Y, 2013, FUNCT ECOL, V27, P710, DOI 10.1111/1365-2435.12083; Noren DP, 2002, PHYSIOL BIOCHEM ZOOL, V75, P513, DOI 10.1086/342254; ORSI AH, 1995, DEEP-SEA RES PT I, V42, P641, DOI 10.1016/0967-0637(95)00021-W; Park YH, 1998, J MARINE SYST, V17, P5, DOI 10.1016/S0924-7963(98)00026-8; PARK YH, 1991, MAR CHEM, V35, P45, DOI 10.1016/S0304-4203(09)90007-X; Pinheiro J., 2006, MIXED EFFECTS MODELS; Richard G, 2014, J EXP BIOL, V217, P2609, DOI 10.1242/jeb.088542; Robinson PW, 2010, J ANIM ECOL, V79, P1146, DOI 10.1111/j.1365-2656.2010.01735.x; Sato K, 2003, J EXP BIOL, V206, P1461, DOI 10.1242/jeb.00265; Schick RS, 2013, J ANIM ECOL, V82, P1300, DOI 10.1111/1365-2656.12102; SLIP DJ, 1995, CAN J ZOOL, V73, P1519, DOI 10.1139/z95-180; Thums M, 2008, MAR ECOL PROG SER, V370, P249, DOI 10.3354/meps07613; Vacquie-Garcia J, 2015, MAR ECOL PROG SER, V541, P265, DOI 10.3354/meps11511; Viviant M, 2010, POLAR BIOL, V33, P713, DOI 10.1007/s00300-009-0750-y; WHITWORTH T, 1987, J GEOPHYS RES-OCEANS, V92, P6462, DOI 10.1029/JC092iC06p06462; YDENBERG RC, 1994, BEHAV ECOL, V5, P28, DOI 10.1093/beheco/5.1.28; Yoda K, 1999, J EXP BIOL, V202, P3121	44	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0166747	10.1371/journal.pone.0166747	http://dx.doi.org/10.1371/journal.pone.0166747			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902786	Green Published, Green Submitted, gold			2022-12-26	WOS:000389474100037
J	Santo-Domingo, J; Chareyron, I; Dayon, L; Galindo, AN; Cominetti, O; Gimenez, MPG; De Marchi, U; Canto, C; Kussmann, M; Wiederkehr, A				Santo-Domingo, Jaime; Chareyron, Isabelle; Dayon, Loic; Galindo, Antonio Nunez; Cominetti, Ornella; Gimenez, Maria Pilar Giner; De Marchi, Umberto; Canto, Carles; Kussmann, Martin; Wiederkehr, Andreas			Coordinated activation of mitochondrial respiration and exocytosis mediated by PKC signaling in pancreatic beta cells	FASEB JOURNAL			English	Article						human islets; energy metabolism; ERK signaling; phosphoproteome	PROTEIN-KINASE-C; INDUCED INSULIN-SECRETION; NEONATAL CARDIAC MYOCYTES; OXIDASE SUBUNIT-IV; PHORBOL-ESTER; B-CELLS; ELECTRICAL-ACTIVITY; ION CHANNELS; GLUCOSE; ISLETS	Mitochondria play a central role in pancreatic beta-cell nutrient sensing by coupling their metabolism to plasma membrane excitability and insulin granule exocytosis. Whether non-nutrient secretagogues stimulate mitochondria as part of the molecular mechanism to promote insulin secretion is not known. Here, we show that PKC signaling, which is employed by many non-nutrient secretagogues, augments mitochondrial respiration in INS-1E (rat insulinoma cell line clone 1E) and human pancreatic beta cells. The phorbol ester, phorbol 12-myristate 13-acetate, accelerates mitochondrial respiration at both resting and stimulatory glucose concentrations. A range of inhibitors of novel PKC is forms prevent phorbol ester-induced respiration. Respiratory response was blocked by oligomycin that demonstrated PKC-dependent acceleration of mitochondrial ATP synthesis. Enhanced respiration was observed even when glycolysis was bypassed or fatty acid transport was blocked, which suggested that PKC regulates mitochondrial processes rather than upstream catabolic fluxes. A phosphoproteome study of phorbol ester stimulated INS-1E cells maintained under resting (2.5 mM) glucose revealed a large number of phosphorylation sites that were altered during short-termactivation of PKC signaling. The data set was enriched for proteins that are involved in gene expression, cytoskeleton remodeling, secretory vesicle transport, and exocytosis. Inter actome analysis identified PKC, C-Raf, and ERK1/2 as the central phosphointeraction cluster. Prevention of ERK1/2 signaling by using a MEK1 inhibitor caused a marked decreased in phorbol 12-myristate 13-acetate-induced mitochondrial respiration. ERK1/2 signaling module therefore links PKC activation to downstream mitochondrial activation. We conclude that non-nutrient secretagogues act, in part, via PKC and downstream ERK1/2 signaling to stimulate mitochondrial energy production to compensate for energy expenditure that is linked to beta-cell activation.	[Santo-Domingo, Jaime; Chareyron, Isabelle; De Marchi, Umberto; Wiederkehr, Andreas] Nestle Inst Hlth Sci, Mitochondrial Funct, Lausanne, Switzerland; [Dayon, Loic; Galindo, Antonio Nunez; Cominetti, Ornella; Gimenez, Maria Pilar Giner; Kussmann, Martin] Nestle Inst Hlth Sci, Syst Nutr Metabon & Prote, Lausanne, Switzerland; [Canto, Carles] Nestle Inst Hlth Sci, Diabet & Metab Hlth, Lausanne, Switzerland	Nestle SA; Nestle SA; Nestle SA	Wiederkehr, A (corresponding author), Nestle Inst Hlth Sci, Quartier Innovat Batiment G, CH-1015 Lausanne, Switzerland.	andreas.wiederkehr@rd.nestle.com	Domingo, Jaime Santo/AAA-4995-2020; Kussmann, Martin/AAB-7453-2022; Cominetti, Ornella/GQA-4684-2022; Cominetti, Ornella/AFV-1516-2022; Dayon, Loïc/J-2499-2019	Domingo, Jaime Santo/0000-0001-5501-0482; Kussmann, Martin/0000-0002-0966-2313; Cominetti, Ornella/0000-0001-8564-1963; Dayon, Loïc/0000-0002-8499-270X; De Marchi, Umberto/0000-0002-6011-5446; Canto, Carles/0000-0002-5167-7922				Acin-Perez R, 2010, FASEB J, V24, P5033, DOI 10.1096/fj.10-166934; Acin-Perez R, 2010, FASEB J, V24, P627, DOI 10.1096/fj.09-142281; AMMALA C, 1994, P NATL ACAD SCI USA, V91, P4343, DOI 10.1073/pnas.91.10.4343; Baines CP, 2003, CIRC RES, V92, P873, DOI 10.1161/01.RES.0000069215.36389.8D; BOZEM M, 1987, PFLUG ARCH EUR J PHY, V410, P457, DOI 10.1007/BF00586525; BOZEM M, 1987, ENDOCRINOLOGY, V121, P1025, DOI 10.1210/endo-121-3-1025; Braun M, 2008, DIABETES, V57, P1618, DOI 10.2337/db07-0991; Burant CF, 2013, DIABETES CARE, V36, pS175, DOI 10.2337/dcS13-2037; CASTAGNA M, 1982, J BIOL CHEM, V257, P7847; De Marchi U, 2014, J BIOL CHEM, V289, P9182, DOI 10.1074/jbc.M113.513184; Detimary P, 1996, ENDOCRINOLOGY, V137, P4671, DOI 10.1210/en.137.11.4671; Ferdaoussi M, 2012, DIABETOLOGIA, V55, P2682, DOI 10.1007/s00125-012-2650-x; Fransson U, 2006, DIABETOLOGIA, V49, P1578, DOI 10.1007/s00125-006-0263-y; Galindo AN, 2015, ANAL CHEM, V87, P10755, DOI 10.1021/acs.analchem.5b02748; GANESAN S, 1992, J CELL BIOL, V119, P313, DOI 10.1083/jcb.119.2.313; Gautam D, 2006, CELL METAB, V3, P449, DOI 10.1016/j.cmet.2006.04.009; Gilon P, 2001, ENDOCR REV, V22, P565, DOI 10.1210/er.22.5.565; Gonelle-Gispert C, 2002, BIOCHEM J, V368, P223, DOI 10.1042/BJ20020896; Guo DH, 2007, AM J PHYSIOL-HEART C, V293, pH2219, DOI 10.1152/ajpheart.01306.2006; Harris TE, 1996, MOL CELL ENDOCRINOL, V121, P133, DOI 10.1016/0303-7207(96)03858-0; Harris TE, 1996, BIOCHEM BIOPH RES CO, V227, P672, DOI 10.1006/bbrc.1996.1567; HELLMAN B, 1974, P NATL ACAD SCI USA, V71, P3405, DOI 10.1073/pnas.71.9.3405; Henquin JC, 2009, DIABETOLOGIA, V52, P739, DOI 10.1007/s00125-009-1314-y; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Ishihara H, 1999, J CLIN INVEST, V104, P1621, DOI 10.1172/JCI7515; Jing YL, 2011, NUTR METAB CARDIOVAS, V21, P398, DOI 10.1016/j.numecd.2009.11.004; JONES PM, 1991, J MOL ENDOCRINOL, V6, P121, DOI 10.1677/jme.0.0060121; Kalwat MA, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.73; Kawasaki E, 1996, BIOCHEM BIOPH RES CO, V227, P440, DOI 10.1006/bbrc.1996.1526; KOMATSU M, 1995, P NATL ACAD SCI USA, V92, P10728, DOI 10.1073/pnas.92.23.10728; Kristinsson H, 2015, BBA-MOL CELL RES, V1853, P3248, DOI 10.1016/j.bbamcr.2015.09.022; Liang BT, 1997, AM J PHYSIOL-HEART C, V273, pH847, DOI 10.1152/ajpheart.1997.273.2.H847; Ljubicic S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068255; Malhotra A, 2005, MOL CELL BIOCHEM, V268, P169, DOI 10.1007/s11010-005-3858-6; Mangat R, 2006, AM J PHYSIOL-HEART C, V291, pH854, DOI 10.1152/ajpheart.01205.2005; Montero M, 2003, J BIOL CHEM, V278, P49972, DOI 10.1074/jbc.M308378200; Morgan D, 2007, J PHYSIOL-LONDON, V579, P327, DOI 10.1113/jphysiol.2006.124248; Nesher R, 2002, DIABETES, V51, pS68, DOI 10.2337/diabetes.51.2007.S68; Nesher R, 2001, DIABETES, V50, P308, DOI 10.2337/diabetes.50.2.308; Nguyen T, 2008, J BIOL CHEM, V283, P29831, DOI 10.1074/jbc.M801642200; Nowak G, 2015, J BIOL CHEM, V290, P7054, DOI 10.1074/jbc.M114.588244; Ogbi M, 2004, BIOCHEM J, V382, P923, DOI 10.1042/BJ20040468; Pagliarini DJ, 2006, TRENDS BIOCHEM SCI, V31, P26, DOI 10.1016/j.tibs.2005.11.005; Pinton P, 2004, J CELL BIOL, V165, P223, DOI 10.1083/jcb.200311061; Pinton P, 2002, J BIOL CHEM, V277, P37702, DOI 10.1074/jbc.M204478200; RORSMAN P, 1994, DIABETES METAB, V20, P138; Sadoul K, 1997, J BIOL CHEM, V272, P33023, DOI 10.1074/jbc.272.52.33023; Schleifenbaum A, 2004, J AM CHEM SOC, V126, P11786, DOI 10.1021/ja0460155; Schmitz-Peiffer C, 2007, CELL METAB, V6, P320, DOI 10.1016/j.cmet.2007.08.012; Shu YL, 2008, J NEUROSCI, V28, P21, DOI 10.1523/JNEUROSCI.2352-07.2008; Suckalel J, 2010, TRENDS ENDOCRIN MET, V21, P599, DOI 10.1016/j.tem.2010.06.003; THAMS P, 1990, BIOCHEM J, V265, P777, DOI 10.1042/bj2650777; Tomas A, 2006, J CELL SCI, V119, P2156, DOI 10.1242/jcs.02942; Warwar N, 2006, DIABETES, V55, P590, DOI 10.2337/diabetes.55.03.06.db05-0001; Wiederkehr A, 2004, J CELL BIOL, V167, P875, DOI 10.1083/jcb.200408001; Wiederkehr A, 2012, MOL CELL ENDOCRINOL, V353, P128, DOI 10.1016/j.mce.2011.07.016; Wiederkehr A, 2011, CELL METAB, V13, P601, DOI 10.1016/j.cmet.2011.03.015; Wikstrom JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033023; Wu-Zhang AX, 2013, BIOCHEM J, V452, P195, DOI 10.1042/BJ20130220; Wu-Zhang AX, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.412635; Yamazaki H, 2010, J NUTR SCI VITAMINOL, V56, P1, DOI 10.3177/jnsv.56.1; Yu W, 2000, DIABETES, V49, P945, DOI 10.2337/diabetes.49.6.945; Zawalich WS, 2001, MOL CELL ENDOCRINOL, V177, P95, DOI 10.1016/S0303-7207(01)00422-1; Zielonka J, 2014, J BIOL CHEM, V289, P16176, DOI 10.1074/jbc.M114.548693	64	12	14	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2017	31	3					1028	+		10.1096/fj.201600837R	http://dx.doi.org/10.1096/fj.201600837R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EM9ZX	27927723				2022-12-26	WOS:000395671200018
J	Hwang, JS; Kwon, MY; Kim, KH; Lee, Y; Lyoo, IK; Kim, JE; Oh, ES; Han, IO				Hwang, Ji-Sun; Kwon, Mi-Youn; Kim, Kyung-Hong; Lee, Yunkyoung; Lyoo, In Kyoon; Kim, Jieun E.; Oh, Eok-Soo; Han, Inn-Oc			Lipopolysaccharide (LPS)-stimulated iNOS Induction Is Increased by Glucosamine under Normal Glucose Conditions but Is Inhibited by Glucosamine under High Glucose Conditions in Macrophage Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glucose; inflammation; NF-B; O-GlcNAcylation; O-linked N-acetylglucosamine (O-GlcNAc) transferase (OGT)	NITRIC-OXIDE SYNTHASE; NF-KAPPA-B; POSTTRANSCRIPTIONAL REGULATION; O-GLCNACYLATION; HEXOSAMINE BIOSYNTHESIS; INSULIN-RESISTANCE; INTERFERON-GAMMA; GENE-EXPRESSION; BINDING; INFLAMMATION	We investigated the regulatory effect of glucosamine (GlcN) for the production of nitric oxide (NO) and expression of inducible NO synthase (iNOS) under various glucose conditions in macrophage cells. At normal glucose concentrations, GlcN dose dependently increased LPS-stimulated production of NO/iNOS. However, GlcN suppressed NO/iNOS production under high glucose culture conditions. Moreover, GlcN suppressed LPS-induced up-regulation of COX-2, IL-6, and TNF- mRNAs under 25 mm glucose conditions yet did not inhibit up-regulation under 5 mm glucose conditions. Glucose itself dose dependently increased LPS-induced iNOS expression. LPS-induced MAPK and IB- phosphorylation did not significantly differ at normal and high glucose conditions. The activity of LPS-induced nuclear factor-B (NF-B) and DNA binding of c-Rel to the iNOS promoter were inhibited under high glucose conditions in comparison with no significant changes under normal glucose conditions. In addition, we found that the LPS-induced increase in O-GlcNAcylation as well as DNA binding of c-Rel to the iNOS promoter were further increased by GlcN under normal glucose conditions. However, both O-GlcNAcylation and DNA binding of c-Rel decreased under high glucose conditions. The NF-B inhibitor, pyrrolidine dithiocarbamate, inhibited LPS-induced iNOS expression under high glucose conditions but it did not influence iNOS induction under normal glucose conditions. In addition, pyrrolidine dithiocarbamate inhibited NF-B DNA binding and c-Rel O-GlcNAcylation only under high glucose conditions. By blocking transcription with actinomycin D, we found that stability of LPS-induced iNOS mRNA was increased by GlcN under normal glucose conditions. These results suggest that GlcN regulates inflammation by sensing energy states of normal and fuel excess.	[Hwang, Ji-Sun; Kwon, Mi-Youn; Kim, Kyung-Hong; Han, Inn-Oc] Inha Univ, Dept Physiol & Biophys, Coll Med, Incheon 22212, South Korea; [Lee, Yunkyoung; Lyoo, In Kyoon; Kim, Jieun E.] Ewha Womans Univ, Dept Brain & Cognit Sci, Ewha Brain Inst, Coll Pharm, Seoul 03760, South Korea; [Oh, Eok-Soo; Han, Inn-Oc] Ewha Womans Univ, Dept Life Sci, Res Ctr Cellular Homeostasis, Seoul 03760, South Korea	Inha University; Ewha Womans University; Ewha Womans University	Han, IO (corresponding author), 100 Inha Ro, Incheon 22212, South Korea.	iohan@inha.ac.kr			National Research Federation of Korea [NRF-2013R1A1A2058244, NRF-2012R1A5A1048236]; Fire Fighting Safety; 119 Rescue Technology Research and Development Program - Ministry of Public Safety and Security [MPSS-Fire Fighting Safety-2016-86]	National Research Federation of Korea; Fire Fighting Safety; 119 Rescue Technology Research and Development Program - Ministry of Public Safety and Security	This work was supported by National Research Federation of Korea Grants NRF-2013R1A1A2058244 and NRF-2012R1A5A1048236 and The Fire Fighting Safety & 119 Rescue Technology Research and Development Program supported by the Ministry of Public Safety and Security (MPSS-Fire Fighting Safety-2016-86). The authors declare that they have no conflicts of interest with the contents of this article.	Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Anderson JW, 2005, FOOD CHEM TOXICOL, V43, P187, DOI 10.1016/j.fct.2004.11.006; Baudoin L, 2015, FRONT ENDOCRINOL, V5, DOI [10.3389/fendo.2014.00235, 10.3389/fendo.2016.00235]; Chen YJ, 2006, CELL BIOL INT, V30, P817, DOI 10.1016/j.cellbi.2006.06.003; Dasgupta S, 2004, J IMMUNOL, V173, P1344, DOI 10.4049/jimmunol.173.2.1344; Eberhardt W, 1998, J IMMUNOL, V160, P4961; Esposito K, 2002, CIRCULATION, V106, P2067, DOI 10.1161/01.CIR.0000034509.14906.AE; Gao JJ, 1997, J BIOL CHEM, V272, P1226, DOI 10.1074/jbc.272.2.1226; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Gouze JN, 2002, FEBS LETT, V510, P166, DOI 10.1016/S0014-5793(01)03255-0; Han IO, 2002, NEUROSCI LETT, V325, P9, DOI 10.1016/S0304-3940(02)00218-5; Hawkins M, 1997, J CLIN INVEST, V99, P2173, DOI 10.1172/JCI119390; Hoffmann A, 2006, ONCOGENE, V25, P6706, DOI 10.1038/sj.onc.1209933; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; Hua KF, 2012, INFLAMM RES, V61, P1107, DOI 10.1007/s00011-012-0503-1; Hwang JS, 2015, METABOLISM, V64, P368, DOI 10.1016/j.metabol.2014.11.005; Hwang SY, 2013, BRIT J PHARMACOL, V169, P1551, DOI 10.1111/bph.12223; Hwang SY, 2013, NITRIC OXIDE-BIOL CH, V31, P1, DOI 10.1016/j.niox.2013.02.082; Hwang SY, 2010, GLIA, V58, P1881, DOI 10.1002/glia.21058; Issad T, 2010, DIABETES METAB, V36, P423, DOI 10.1016/j.diabet.2010.09.001; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kengatharan M, 1996, BRIT J PHARMACOL, V117, P1163, DOI 10.1111/j.1476-5381.1996.tb16711.x; Khan MI, 2009, ANTIOXID REDOX SIGN, V11, P2289, DOI [10.1089/ars.2009.2569, 10.1089/ARS.2009.2569]; Korhonen R, 2007, MOL PHARMACOL, V71, P1427, DOI 10.1124/mol.106.033449; Largo R, 2003, OSTEOARTHR CARTILAGE, V11, P290, DOI 10.1016/S1063-4584(03)00028-1; Laroia G, 2002, P NATL ACAD SCI USA, V99, P1842, DOI 10.1073/pnas.042575699; Linker K, 2005, NUCLEIC ACIDS RES, V33, P4813, DOI 10.1093/nar/gki797; Love Dona C, 2005, Sci STKE, V2005, pre13, DOI 10.1126/stke.3122005re13; Ma JF, 2013, EXPERT REV PROTEOMIC, V10, P365, DOI 10.1586/14789450.2013.820536; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Marks-Konczalik J, 1998, J BIOL CHEM, V273, P22201, DOI 10.1074/jbc.273.35.22201; MARSHALL S, 1991, J BIOL CHEM, V266, P4706; Meininger CJ, 2000, BIOCHEM BIOPH RES CO, V279, P234, DOI 10.1006/bbrc.2000.3912; Mohanty P, 2000, J CLIN ENDOCR METAB, V85, P2970, DOI 10.1210/jc.85.8.2970; Monauni T, 2000, DIABETES, V49, P926, DOI 10.2337/diabetes.49.6.926; Moore F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031062; Parker GJ, 2003, J BIOL CHEM, V278, P10022, DOI 10.1074/jbc.M207787200; Pautz A, 2006, J BIOL CHEM, V281, P32294, DOI 10.1074/jbc.M603915200; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shikhman AR, 2009, OSTEOARTHR CARTILAGE, V17, P1022, DOI 10.1016/j.joca.2009.03.004; Soesanto YA, 2008, AM J PHYSIOL-ENDOC M, V295, pE974, DOI 10.1152/ajpendo.90366.2008; TRAXINGER RR, 1991, J BIOL CHEM, V266, P10148; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Won JS, 2003, J NEUROSCI, V23, P7470; XIE QW, 1994, J BIOL CHEM, V269, P4705; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Yi HA, 2005, CLIN EXP PHARMACOL P, V32, P1097, DOI 10.1111/j.1440-1681.2005.04305.x; Zhang GX, 2005, J IMMUNOL, V175, P7202, DOI 10.4049/jimmunol.175.11.7202; Zhang HF, 1998, BIOCHEM PHARMACOL, V55, P1873, DOI 10.1016/S0006-2952(98)00078-1	51	39	40	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1724	1736		10.1074/jbc.M116.737940	http://dx.doi.org/10.1074/jbc.M116.737940			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	27927986	Green Published, hybrid			2022-12-26	WOS:000395515600015
J	Su, CC; Lee, KI; Chen, MK; Kuo, CY; Tang, CH; Liu, SH				Su, Chin-Chuan; Lee, Kuan-I; Chen, Mu-Kuan; Kuo, Chun-Ying; Tang, Chih-Hsin; Liu, Shing Hwa			Cantharidin Induced Oral Squamous Cell Carcinoma Cell Apoptosis via the JNK-Regulated Mitochondria and Endoplasmic Reticulum Stress-Related Signaling Pathways	PLOS ONE			English	Article							CANCER CELLS; GROWTH-INHIBITION; NECK-CANCER; TREATING PATIENTS; NEURONAL CELLS; ER STRESS; ACTIVATION; CHEMOTHERAPY; KINASE; DEATH	Oral cancer is a subtype of head and neck cancer which represents 2.65% of all human malignancies. Most of oral cancer is histopathologically diagnosed as oral squamous cell carcinoma (OSCC). OSCC is characterized by a high degree of local invasion and a high rate of metastasis to the cervical lymph nodes. How to prevention and treatment of OSCC is important and imperative. Here, we investigated the therapeutic effect and molecular mechanism of cantharidin, an active compound isolated from blister beetles, on OSCC in vitro. Results showed that cantharidin significantly decreased cell viability in human tongue squamous carcinoma-derived SAS, CAL-27, and SCC-4 cell lines. The further mechanistic studies were carried out in SAS cells. Cantharidin also significantly increased apoptosis-related signals, including caspase-9, caspase-7 and caspase-3 proteins. Besides, cantharidin decreased mitochondrial transmembrane potential (MMP) and induced cytochrome c and apoptosis inducing factor (AIF) release. Cantharidin also increased Bax, Bid, and Bak protein expressions and decreased Bcl-2 protein expression. Cantharidin could also increase the endoplasmic reticulum (ER) stress signals, including the expressions of phosphorylated eIF-2 alpha and CHOP, but not Grp78 and Grp94. Furthermore, cantharidin reduced pro-caspase-12 protein expression. In signals of mitogen-activated protein kinases, cantharidin increased the phosphorylation of JNK, but not ERK and p38. Transfection of shRNA-JNK to OSCC cells effectively reversed the cantharidin-induced cell apoptotic signals, including the mitochondrial and ER stress-related signaling molecules. Taken together, these findings suggest that cantharidin induces apoptosis in OSCC cells via the JNK-regulated mitochondria and ER stress-related signaling pathways.	[Su, Chin-Chuan; Tang, Chih-Hsin] China Med Univ, Grad Inst Basic Med Sci, Coll Med, Taichung, Taiwan; [Su, Chin-Chuan; Chen, Mu-Kuan; Kuo, Chun-Ying] Changhua Christian Hosp, Dept Otorhinolaryngol Head & Neck Surg, Changhua, Taiwan; [Lee, Kuan-I] Taichung Tzu Chi Hosp, Dept Emergency, Buddhist Tzu Chi Med Fdn, Taichung, Taiwan; [Liu, Shing Hwa] Natl Taiwan Univ, Inst Toxicol, Coll Med, Taipei, Taiwan; [Liu, Shing Hwa] China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung, Taiwan	China Medical University Taiwan; Changhua Christian Hospital; Buddhist Tzu Chi General Hospital; Taichung Tzu Chi Hospital; National Taiwan University; China Medical University Taiwan; China Medical University Hospital - Taiwan	Tang, CH (corresponding author), China Med Univ, Grad Inst Basic Med Sci, Coll Med, Taichung, Taiwan.; Liu, SH (corresponding author), Natl Taiwan Univ, Inst Toxicol, Coll Med, Taipei, Taiwan.; Liu, SH (corresponding author), China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung, Taiwan.	chtang@mail.cmu.edu.tw; shinghwaliu@ntu.edu.tw		LIU, SHING-HWA/0000-0002-9976-1197	National Science Council of Taiwan [NSC 102-2314-B-371-007]; Changhua Christian Hospital, Changhua, Taiwan [100-CCH-IRP-53]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Changhua Christian Hospital, Changhua, Taiwan	This work was supported by research grants from the National Science Council of Taiwan (NSC 102-2314-B-371-007), and the Changhua Christian Hospital, Changhua, Taiwan (100-CCH-IRP-53). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bologna MA, 2001, SYST ENTOMOL, V26, P33, DOI 10.1046/j.1365-3113.2001.00132.x; Chen CH, 2013, TOXICOLOGY, V303, P72, DOI 10.1016/j.tox.2012.10.008; Chen YW, 2012, ARCH TOXICOL, V86, P1547, DOI 10.1007/s00204-012-0873-8; Chen YJ, 2008, CANCER SCI, V99, P1507, DOI 10.1111/j.1349-7006.2008.00863.x; De Lima PO, 2014, ANTICANCER RES, V34, P605; Degterev A, 2003, ONCOGENE, V22, P8543, DOI 10.1038/sj.onc.1207107; Eckert AW, 2010, J ORAL PATHOL MED, V39, P313, DOI 10.1111/j.1600-0714.2009.00829.x; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Gopalan A, 2013, CANCER LETT, V329, P9, DOI 10.1016/j.canlet.2012.08.031; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hsia TC, 2015, ENVIRON TOXICOL, V30, P1135, DOI 10.1002/tox.21986; Huan SKH, 2006, TOXICOLOGY, V223, P136, DOI 10.1016/j.tox.2006.03.012; Huang WW, 2011, INT J ONCOL, V38, P1067, DOI 10.3892/ijo.2011.922; HUNDT HKL, 1990, HUM EXP TOXICOL, V9, P35, DOI 10.1177/096032719000900108; Hung CM, 2013, INT J MOL SCI, V14, P17147, DOI 10.3390/ijms140817147; Johnson NW, 2011, PERIODONTOL 2000, V57, P19, DOI 10.1111/j.1600-0757.2011.00401.x; Karras DJ, 1996, AM J EMERG MED, V14, P478, DOI 10.1016/S0735-6757(96)90158-8; Kim DM, 2010, APOPTOSIS, V15, P1540, DOI 10.1007/s10495-010-0531-7; Kim JY, 2013, PHYTOTHER RES, V27, P493, DOI 10.1002/ptr.4746; Kim SY, 2011, ANN SURG ONCOL, V18, P2310, DOI 10.1245/s10434-011-1614-6; Kok SH, 2005, CANCER LETT, V217, P43, DOI 10.1016/j.canlet.2004.07.045; Kuo JH, 2010, INT J ONCOL, V37, P1243, DOI 10.3892/ijo_00000775; Lee JY, 2014, BIOCHEM BIOPH RES CO, V447, P371, DOI 10.1016/j.bbrc.2014.04.035; Li W, 2010, CANCER SCI, V101, P1226, DOI 10.1111/j.1349-7006.2010.01523.x; Liu B, 2012, ASIAN PAC J CANCER P, V13, P3705, DOI 10.7314/APJCP.2012.13.8.3705; Liu SH, 2014, AM J CHINESE MED, V42, P869, DOI 10.1142/S0192415X14500554; Lorenzo PI, 2008, NEOPLASIA, V10, P418, DOI 10.1593/neo.07985; Lu TH, 2015, CHEM-BIOL INTERACT, V225, P1, DOI 10.1016/j.cbi.2014.10.022; Lu TH, 2014, TOXICOL LETT, V224, P130, DOI 10.1016/j.toxlet.2013.10.013; Lu TH, 2011, TOXICOL LETT, V204, P71, DOI 10.1016/j.toxlet.2011.04.013; Massano J, 2006, ORAL SURG ORAL MED O, V102, P67, DOI 10.1016/j.tripleo.2005.07.038; McCluskey A, 2003, BIOORG CHEM, V31, P68, DOI 10.1016/S0045-2068(02)00524-2; Mod D, 2014, J NEPAL HLTH RES COU, V11, P300; Nam W, 2007, HEAD NECK-J SCI SPEC, V29, P335, DOI 10.1002/hed.20524; OAKS WW, 1960, ARCH INTERN MED, V105, P574, DOI 10.1001/archinte.1960.00270160072009; Oliveira LR, 2011, INT J ORAL MAX SURG, V40, P298, DOI 10.1016/j.ijom.2010.12.003; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Patil TT, 2014, J ORAL ONCOL, V2014; PEREZSAYANS GM, 2012, CANC LETT, V323, P11, DOI DOI 10.1016/J.CANLET.2012.03.040; Prasad SB, 2013, MICROSC MICROANAL, V19, P1377, DOI 10.1017/S143192761301324X; Galvis CEP, 2013, CHEM BIOL DRUG DES, V82, P477, DOI 10.1111/cbdd.12180; Rahman MA, 2010, NUTR CANCER, V62, P973, DOI 10.1080/01635581.2010.509538; Ryu MJ, 2015, IN VITRO CELL DEV-AN, V51, P92, DOI 10.1007/s11626-014-9806-6; Sagawa M, 2008, CANCER SCI, V99, P1820, DOI 10.1111/j.1349-7006.2008.00872.x; Sappayatosok K, 2015, HEAD NECK PATHOL, V9, P173, DOI 10.1007/s12105-014-0559-z; Selimovic D, 2011, CARCINOGENESIS, V32, P1268, DOI 10.1093/carcin/bgr112; Simon C, 2008, HNO, V56, P575, DOI 10.1007/s00106-008-1718-x; State Pharmacopoeia Commission, 2010, PHARMACOPOEIA OF PEO; Tan S, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.95; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Wang CC, 2000, TOXICOLOGY, V147, P77, DOI 10.1016/S0300-483X(00)00185-2; WANG GS, 1989, J ETHNOPHARMACOL, V26, P147, DOI 10.1016/0378-8741(89)90062-7; Wang L, 2014, ASIAN PAC J CANCER P, V15, P5597, DOI 10.7314/APJCP.2014.15.14.5597; Wang XZ, 1996, SCIENCE, V272, P1347, DOI 10.1126/science.272.5266.1347; Wei G, 2010, J CELL PHYSIOL, V224, P112, DOI 10.1002/jcp.22099; World Health Organization, 2007, INT CLASS DIS; Wu JY, 2010, ORAL ONCOL, V46, P226, DOI 10.1016/j.oraloncology.2010.01.007; Yang YH, 2005, J ORAL PATHOL MED, V34, P596, DOI 10.1111/j.1600-0714.2005.00266.x; Yu Z J, 1993, Zhongguo Zhong Xi Yi Jie He Za Zhi, V13, P327; Zhan YP, 2012, ASIAN PAC J CANCER P, V13, P4773, DOI 10.7314/APJCP.2012.13.9.4773; Ziegler DS, 2008, CURR OPIN ONCOL, V20, P97, DOI 10.1097/CCO.0b013e3282f310f6; Zong WX, 2003, J CELL BIOL, V162, P59, DOI 10.1083/jcb.200302084	62	35	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0168095	10.1371/journal.pone.0168095	http://dx.doi.org/10.1371/journal.pone.0168095			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930712	Green Submitted, Green Published, gold			2022-12-26	WOS:000389580900081
J	Maass, JC; Gu, RD; Cai, TT; Wan, YW; Cantellano, SC; Asprer, JST; Zhang, HY; Jen, HI; Edlund, RK; Liu, ZD; Groves, AK				Maass, Juan C.; Gu, Rende; Cai, Tiantian; Wan, Ying-Wooi; Cantellano, Silvia C.; Asprer, Joanna S. T.; Zhang, Hongyuan; Jen, Hsin-i; Edlund, Renee K.; Liu, Zhandong; Groves, Andrew K.			Transcriptomic Analysis of Mouse Cochlear Supporting Cell Maturation Reveals Large-Scale Changes in Notch Responsiveness Prior to the Onset of Hearing	PLOS ONE			English	Article							OUTER HAIR-CELLS; EXPRESSION ANALYSIS; SIGNALING PATHWAY; BETA-CATENIN; STEM-CELLS; GENE; REGENERATION; GENERATION; INHIBITION; PILLAR	Neonatal mouse cochlear supporting cells have a limited ability to divide and trans-differentiate into hair cells, but this ability declines rapidly in the two weeks after birth. This decline is concomitant with the morphological and functional maturation of the organ of Corti prior to the onset of hearing. However, despite this association between maturation and loss of regenerative potential, little is known of the molecular changes that underlie these events. To identify these changes, we used RNA-seq to generate transcriptional profiles of purified cochlear supporting cells from 1-and 6-day-old mice. We found many significant changes in gene expression during this period, many of which were related to regulation of proliferation, differentiation of inner ear components and the maturation of the organ of Corti prior to the onset of hearing. One example of a change in regenerative potential of supporting cells is their robust production of hair cells in response to a blockade of the Notch signaling pathway at the time of birth, but a complete lack of response to such blockade just a few days later. By comparing our supporting cell transcriptomes to those of supporting cells cultured in the presence of Notch pathway inhibitors, we show that the transcriptional response to Notch blockade disappears almost completely in the first postnatal week. Our results offer some of the first molecular insights into the failure of hair cell regeneration in the mammalian cochlea.	[Gu, Rende; Cai, Tiantian; Asprer, Joanna S. T.; Zhang, Hongyuan; Edlund, Renee K.; Groves, Andrew K.] Baylor Coll Med, Dept Neurosci, 1 Baylor Plaza, Houston, TX 77030 USA; [Jen, Hsin-i; Groves, Andrew K.] Baylor Coll Med, Program Dev Biol, 1 Baylor Plaza, Houston, TX 77030 USA; [Groves, Andrew K.] Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza, Houston, TX 77030 USA; [Wan, Ying-Wooi; Liu, Zhandong] Baylor Coll Med, Dept Pediat, 1 Baylor Plaza, Houston, TX 77030 USA; [Wan, Ying-Wooi; Liu, Zhandong] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [Maass, Juan C.; Cantellano, Silvia C.] Univ Chile, Dept Otolaryngol, Hosp Clin Univ Chile, Santiago, Chile; [Maass, Juan C.; Cantellano, Silvia C.] Univ Chile, Interdisciplinary Program Physiol & Biophys ICBM, Santiago, Chile; [Maass, Juan C.] Univ Desarrollo, Dept Otolaryngol, Clin Alemana Santiago, Fac Med Clin Alemana, Santiago, Chile; [Gu, Rende] Sound Pharmaceut, Seattle, WA USA; [Asprer, Joanna S. T.] Thermo Fisher Sci, Stem Cell Res Unit, Waltham, MA USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Universidad de Chile; Universidad de Chile; Clinica Alemana; Universidad del Desarrollo; Thermo Fisher Scientific	Groves, AK (corresponding author), Baylor Coll Med, Dept Neurosci, 1 Baylor Plaza, Houston, TX 77030 USA.; Groves, AK (corresponding author), Baylor Coll Med, Program Dev Biol, 1 Baylor Plaza, Houston, TX 77030 USA.; Groves, AK (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza, Houston, TX 77030 USA.	akgroves@bcm.edu		Maass, Juan/0000-0002-1586-4608; Liu, Zhandong/0000-0002-7608-0831; Groves, Andrew/0000-0002-0784-7998	Genomic and RNA Profiling Core; RNA In Situ Core at Baylor College of Medicine; NIH from the Eunice Kennedy Shriver National Institute of Child Health and Human Development [P30HD024064]; Cytometry and Cell Sorting Core at Baylor College of Medicine; NIH [P30 AI036211, P30 CA125123, S10 RR024574, DC006185, DC011657]; Department of Defense [DOD W81XWH-11-2-004]; Hearing Restoration Project consortium grant from the Hearing Health Foundation; CONICYT (Chile) [FONDECYT 11130247]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC011657, R01DC014832, R01DC006185] Funding Source: NIH RePORTER	Genomic and RNA Profiling Core; RNA In Situ Core at Baylor College of Medicine; NIH from the Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Cytometry and Cell Sorting Core at Baylor College of Medicine; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Hearing Restoration Project consortium grant from the Hearing Health Foundation; CONICYT (Chile)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This project was supported in part by (1) The Genomic and RNA Profiling Core and the RNA In Situ Core at Baylor College of Medicine with the expert assistance of Dr. Lisa D. White, Ph.D., Cecilia Ljunberg, Ph.D., and funding from the NIH grant P30HD024064 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development; (2) The Cytometry and Cell Sorting Core at Baylor College of Medicine with the expert assistance of Joel M. Sederstrom and funding from the NIH grants P30 AI036211, P30 CA125123, and S10 RR024574; (3) NIH Grants DC006185 and DC011657 to A.K.G.; (4) Department of Defense Grant DOD W81XWH-11-2-004 to A.K.G.; (5) A Hearing Restoration Project consortium grant from the Hearing Health Foundation to A.K.G.; and (6) An Initiation into Research grant FONDECYT 11130247 from CONICYT (Chile) to J.C.M.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Atkinson PJ, 2015, DEVELOPMENT, V142, P1561, DOI 10.1242/dev.114926; Barkalow K, 1996, J CELL BIOL, V134, P389, DOI 10.1083/jcb.134.2.389; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; Bramhall NF, 2014, STEM CELL REP, V2, P311, DOI 10.1016/j.stemcr.2014.01.008; Burns JC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9557; Cai TT, 2015, J NEUROSCI, V35, P5870, DOI 10.1523/JNEUROSCI.5083-14.2015; Chai RJ, 2012, P NATL ACAD SCI USA, V109, P8167, DOI 10.1073/pnas.1202774109; Cox BC, 2014, DEVELOPMENT, V141, P816, DOI 10.1242/dev.103036; Doetzlhofer A, 2009, DEV CELL, V16, P58, DOI 10.1016/j.devcel.2008.11.008; Engel J, 2006, NEUROSCIENCE, V143, P837, DOI 10.1016/j.neuroscience.2006.08.060; Geschwind D, 2004, LANCET NEUROL, V3, P82, DOI 10.1016/S1474-4422(03)00658-6; Groves AK, 2010, EXP BIOL MED, V235, P434, DOI 10.1258/ebm.2009.009281; Hayashi T, 2008, DEV BIOL, V316, P87, DOI 10.1016/j.ydbio.2008.01.006; Heintz N, 2004, NAT NEUROSCI, V7, P483, DOI 10.1038/nn0504-483; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang W, 2014, J CELL PHYSIOL, V229, P580, DOI 10.1002/jcp.24480; Jacques BE, 2007, DEVELOPMENT, V134, P3021, DOI 10.1242/dev.02874; Jansson L, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00066; Katayama K, 2009, PLOS ONE, V4; Kelly MC, 2012, J NEUROSCI, V32, P6699, DOI 10.1523/JNEUROSCI.5420-11.2012; Khatri SB, 2013, GENE EXPR PATTERNS, V13, P38, DOI 10.1016/j.gep.2012.10.001; Kiernan AE, 2005, DEVELOPMENT, V132, P4353, DOI 10.1242/dev.02002; Kiernan AE, 2013, SEMIN CELL DEV BIOL, V24, P470, DOI 10.1016/j.semcdb.2013.04.002; Kuo BR, 2015, J NEUROSCI, V35, P10786, DOI 10.1523/JNEUROSCI.0967-15.2015; Lanford PJ, 1999, NAT GENET, V21, P289, DOI 10.1038/6804; Lee C, 2007, DEVELOPMENT, V134, P1431, DOI 10.1242/dev.02828; Lelli A, 2009, J NEUROPHYSIOL, V101, P2961, DOI 10.1152/jn.00136.2009; Leonova EV, 1997, HEARING RES, V113, P14, DOI 10.1016/S0378-5955(97)00130-5; Li WY, 2015, P NATL ACAD SCI USA, V112, P166, DOI 10.1073/pnas.1415901112; LIM DJ, 1985, ACTA OTO-LARYNGOL, P1; Lin V, 2011, J NEUROSCI, V31, P15329, DOI 10.1523/JNEUROSCI.2057-11.2011; Liu ZM, 2014, INT J ANTENN PROPAG, V2014, DOI 10.1155/2014/959386; Liu ZY, 2012, J NEUROSCI, V32, P6600, DOI 10.1523/JNEUROSCI.0818-12.2012; Maass JC, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00110; Mann ZF, 2011, HEARING RES, V276, P2, DOI 10.1016/j.heares.2011.01.011; Mansour SL, 2013, GENE DEV, V27, P2320, DOI 10.1101/gad.228957.113; Mizutari K, 2013, NEURON, V77, P58, DOI 10.1016/j.neuron.2012.10.032; Monroe JD, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00131; Mueller KL, 2002, J NEUROSCI, V22, P9368; Orosz F, 2008, FEBS LETT, V582, P3757, DOI 10.1016/j.febslet.2008.10.011; Oshima K, 2007, JARO-J ASSOC RES OTO, V8, P18, DOI 10.1007/s10162-006-0058-3; Puligilla C, 2007, DEV DYNAM, V236, P1905, DOI 10.1002/dvdy.21192; Raphael Y, 2003, BRAIN RES BULL, V60, P397, DOI 10.1016/S0361-9230(03)00047-9; Roccio M, 2015, SCI REP-UK, V5, DOI 10.1038/srep17886; Schmidt EF, 2013, COLD SPRING HARB PRO, V2013, P3; Shi FX, 2013, P NATL ACAD SCI USA, V110, P13851, DOI 10.1073/pnas.1219952110; Shim K, 2005, DEV CELL, V8, P553, DOI 10.1016/j.devcel.2005.02.009; Slepecky N. B., 1996, COCHLEA, V8, P44; Slowik AD, 2013, JARO-J ASSOC RES OTO, V14, P813, DOI 10.1007/s10162-013-0414-z; Son EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040735; Stern CD, 1998, CURR TOP DEV BIOL, V36, P223; Stone JS, 2007, INT J DEV BIOL, V51, P633, DOI 10.1387/ijdb.072408js; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Takebayashi S, 2007, DEV BIOL, V307, P165, DOI 10.1016/j.ydbio.2007.04.035; Tateya T, 2011, DEV BIOL, V352, P329, DOI 10.1016/j.ydbio.2011.01.038; Thomas ED, 2015, WIRES DEV BIOL, V4, P1, DOI 10.1002/wdev.160; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Waldhaus J, 2015, CELL REP, V11, P1385, DOI 10.1016/j.celrep.2015.04.062; Walters BJ, 2014, J NEUROSCI, V34, P15751, DOI 10.1523/JNEUROSCI.3200-14.2014; Walters BJ, 2013, HEARING RES, V297, P68, DOI 10.1016/j.heares.2012.11.009; White PM, 2006, NATURE, V441, P984, DOI 10.1038/nature04849; White PM, 2012, DEV BIOL, V363, P191, DOI 10.1016/j.ydbio.2011.12.035; Wong ACY, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00058; Yang CH, 2015, FRONT CELL NEUROSCI, V9, DOI [10.3389/fncel.2015.0026, 10.3389/fncel.2015.00276]; Zheng JL, 2000, DEVELOPMENT, V127, P4551; Zine A, 2001, J NEUROSCI, V21, P4712, DOI 10.1523/JNEUROSCI.21-13-04712.2001	72	29	31	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2016	11	12							e0167286	10.1371/journal.pone.0167286	http://dx.doi.org/10.1371/journal.pone.0167286			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4MR	27918591	Green Published, gold, Green Submitted			2022-12-26	WOS:000389577100009
J	Oakley, MS; Verma, N; Zheng, H; Anantharaman, V; Takeda, K; Gao, YM; Myers, TG; Pham, PT; Mahajan, B; Kumar, N; Sangweme, D; Tripathi, AK; Mlambo, G; Aravind, L; Kumar, S				Oakley, Miranda S.; Verma, Nitin; Zheng, Hong; Anantharaman, Vivek; Takeda, Kazuyo; Gao, Yamei; Myers, Timothy G.; Phuong Thao Pham; Mahajan, Babita; Kumar, Nirbhay; Sangweme, Davison; Tripathi, Abhai K.; Mlambo, Godfree; Aravind, L.; Kumar, Sanjai			Molecular Markers of Radiation Induced Attenuation in Intrahepatic Plasmodium falciparum Parasites	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; PROTEIN PALMITOYLATION; MALARIA; IDENTIFICATION; IMMUNIZATION; SPOROZOITES; EXPRESSION; PROTECTION; UBIQUITIN; GENE	Experimental immunization with radiation attenuated sporozoites (RAS) and genetically attenuated sporozoites has proved to be a promising approach for malaria vaccine development. However, parasite biomarkers of growth attenuation and enhanced immune protection in response to radiation remain poorly understood. Here, we report on the effect of an attenuating dose of.-irradiation (15 krad) on the Plasmodium falciparum sporozoite (PfSPZ) ultrastructure by electron microscopy, growth rate of liver stage P. falciparum in liver cell cultures, and genome-wide transcriptional profile of liver stage parasites by microarray. We find that.-irradiation treated PfSPZ retained a normal cellular structure except that they were vacuous with a partially disrupted plasma membrane and inner membrane complex. A similar infection rate was observed by.-irradiation-treated and untreated PfSPZ in human HCO-4 liver cells (0.47% versus 0.49%, respectively) on day 3 post-infection. In the microarray studies, cumulatively, 180 liver stage parasite genes were significantly transcriptionally altered on day 3 and/or 6 post-infection. Among the transcriptionally altered biomarkers, we identified a signature of seven candidate parasite genes that associated with functionally diverse pathways that may regulate radiation induced cell cycle arrest of the parasite within the hepatocyte. A repertoire of 14 genes associated with protein translation is transcriptionally overexpressed within the parasite by radiation. Additionally, 37 genes encode proteins expressed on the cell surface or exported into the host cell, 4 encode membrane associated transporters, and 10 encode proteins related to misfolding and stress-related protein processing. These results have significantly increased the repertoire of novel targets for 1) biomarkers of safety to define proper attenuation, 2) generating genetically attenuated parasite vaccine candidates, and 3) subunit candidate vaccines against liver stage malaria.	[Oakley, Miranda S.; Verma, Nitin] US FDA, Div Bacterial Parasit & Allergen Prod, Ctr Biol Evaluat & Res, Silver Spring, MD USA; [Zheng, Hong; Phuong Thao Pham; Mahajan, Babita; Kumar, Sanjai] US FDA, Div Emerging & Transfus Transmitted Dis, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA; [Anantharaman, Vivek; Aravind, L.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bldg 10, Bethesda, MD 20892 USA; [Takeda, Kazuyo; Gao, Yamei] US FDA, Div Viral Prod, Ctr Biol Evaluat & Res, Silver Spring, MD USA; [Myers, Timothy G.] NIAID, Genom Technol Sect, Res Technol Branch, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Kumar, Nirbhay; Sangweme, Davison; Tripathi, Abhai K.; Mlambo, Godfree] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Kumar, S (corresponding author), US FDA, Div Emerging & Transfus Transmitted Dis, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA.	Sanjai.kumar@fda.hhs.gov	Anantharaman, Vivek/ABB-9991-2021	Anantharaman, Vivek/0000-0001-8395-0009; Aravind, L/0000-0003-0771-253X; Tripathi, Abhai/0000-0001-9848-0142; Myers, Timothy Gene/0000-0002-7059-5906	FDA intramural research program; PATH-Malaria Vaccine Initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZICAI001051] Funding Source: NIH RePORTER	FDA intramural research program; PATH-Malaria Vaccine Initiative(United States Agency for International Development (USAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the FDA intramural research program and a research grant from the PATH-Malaria Vaccine Initiative.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aravind L, 2013, BIOL DIRECT, V8, DOI 10.1186/1745-6150-8-20; CLYDE DF, 1973, AM J MED SCI, V266, P169, DOI 10.1097/00000441-197309000-00002; DAVIS JR, 1994, VACCINE, V12, P321, DOI 10.1016/0264-410X(94)90096-5; Dumoulin PC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129623; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Epstein JE, 2011, SCIENCE, V334, P475, DOI 10.1126/science.1211548; Era S, 2012, BIOCHEM BIOPH RES CO, V426, P310, DOI 10.1016/j.bbrc.2012.08.066; Fujii K, 2009, GENE DEV, V23, P963, DOI 10.1101/gad.1775609; Goyal M, 2012, NUCLEIC ACIDS RES, V40, P1174, DOI 10.1093/nar/gkr821; Hoffman BU, 2008, EXP PARASITOL, V118, P247, DOI 10.1016/j.exppara.2007.08.014; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; Issar N, 2008, CELL MICROBIOL, V10, P1999, DOI 10.1111/j.1462-5822.2008.01183.x; Jackson KE, 2011, TRENDS PARASITOL, V27, P467, DOI 10.1016/j.pt.2011.05.005; Jones ML, 2012, TRENDS PARASITOL, V28, P496, DOI 10.1016/j.pt.2012.08.009; Jones ML, 2012, CELL HOST MICROBE, V12, P246, DOI 10.1016/j.chom.2012.06.005; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Khan SM, 2012, CURR OPIN BIOTECH, V23, P908, DOI 10.1016/j.copbio.2012.04.003; KINOSHITA N, 1991, MOL CELL BIOL, V11, P5839, DOI 10.1128/MCB.11.12.5839; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kudryashev M, 2010, CELL MICROBIOL, V12, P362, DOI 10.1111/j.1462-5822.2009.01399.x; Lassmann T, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-298; Lassmann T, 2006, NUCLEIC ACIDS RES, V34, pW596, DOI 10.1093/nar/gkl191; Lee I, 2004, TRENDS BIOCHEM SCI, V29, P567, DOI 10.1016/j.tibs.2004.09.005; Lin JW, 2013, MOL MICROBIOL, V88, P318, DOI 10.1111/mmi.12187; Mair GR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000767; Mani J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022463; March S, 2015, NAT PROTOC, V10, P2027, DOI 10.1038/nprot.2015.128; MELLOUK S, 1990, LANCET, V335, P721, DOI 10.1016/0140-6736(90)90832-P; Michel JJ, 2003, J BIOL CHEM, V278, P22828, DOI 10.1074/jbc.M210358200; Murakami H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000317; Murphy SC, 2013, P NATL ACAD SCI USA, V110, P6055, DOI 10.1073/pnas.1303834110; NUSSENZWEIG RS, 1967, NATURE, V216, P160, DOI 10.1038/216160a0; Oakley MS, 2008, INFECT IMMUN, V76, P4518, DOI 10.1128/IAI.00525-08; Oakley MS, 2013, J INFECT DIS, V207, P164, DOI 10.1093/infdis/jis645; Oakley MS, 2011, INFECT IMMUN, V79, P1244, DOI 10.1128/IAI.00964-10; Oakley MSM, 2007, INFECT IMMUN, V75, P2012, DOI 10.1128/IAI.01236-06; OZAKI LS, 1984, J PARASITOL, V70, P831, DOI 10.2307/3281779; Pei JM, 2003, BIOINFORMATICS, V19, P427, DOI 10.1093/bioinformatics/btg008; Ponder EL, 2011, CHEM BIOL, V18, P711, DOI 10.1016/j.chembiol.2011.04.010; Ponts N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002386; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; RIECKMANN KH, 1990, B WORLD HEALTH ORGAN, V68, P13; Rivier C, 2001, EMBO J, V20, P1765, DOI 10.1093/emboj/20.7.1765; Sattabongkot J, 2006, AM J TROP MED HYG, V74, P708, DOI 10.4269/ajtmh.2006.74.708; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; Schmidt-Christensen A, 2008, CELL MICROBIOL, V10, P1723, DOI 10.1111/j.1462-5822.2008.01162.x; Seder RA, 2013, SCIENCE, V341, P1359, DOI 10.1126/science.1241800; Shi L, 1997, MUTAT RES-DNA REPAIR, V384, P145, DOI 10.1016/S0921-8777(97)00023-2; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Song SS, 2012, CELL RES, V22, P1285, DOI 10.1038/cr.2012.107; Spring M, 2013, VACCINE, V31, P4975, DOI 10.1016/j.vaccine.2013.08.007; Subota I, 2011, MOL BIOL CELL, V22, P4205, DOI 10.1091/mbc.E11-06-0511; Trosch R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023039; van Dooren GG, 2002, J BIOL CHEM, V277, P23612, DOI 10.1074/jbc.M201748200; Yang YH, 2007, NAT CELL BIOL, V9, P1253, DOI 10.1038/ncb1645; Zou XY, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-394	58	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0166814	10.1371/journal.pone.0166814	http://dx.doi.org/10.1371/journal.pone.0166814			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3TF	27911910	Green Published, gold			2022-12-26	WOS:000389520600014
J	Hashimoto, K; Kurosawa, K; Murayama, A; Seo, H; Ohta, K				Hashimoto, Koji; Kurosawa, Kohei; Murayama, Akiho; Seo, Hidetaka; Ohta, Kunihiro			B Cell-Based Seamless Engineering of Antibody Fc Domains	PLOS ONE			English	Article							IMMUNOGLOBULIN GENE CONVERSION; CLASS SWITCH RECOMBINATION; EFFECTOR FUNCTIONS; RAPID GENERATION; HUMAN IGG1; FUSION PROTEINS; GAMMA-RIII; CHICKEN; BINDING; REGION	Engineering of monoclonal antibodies (mAbs) enables us to obtain mAbs with additional functions. In particular, modifications in antibody's Fc (fragment, crystallizable) region can provide multiple benefits such as added toxicity by drug conjugation, higher affinity to Fc receptors on immunocytes, or the addition of functional modules. However, the generation of recombinant antibodies requires multiple laborious bioengineering steps. We previously developed a technology that enables rapid in vitro screening and isolation of specific mAb-expressing cells from the libraries constructed with chicken B-cell line DT40 (referred to as the 'ADLib system'). To upgrade this ADLib system with the ability to generate customized mAbs, we developed a novel and rapid engineering technology that enables seamless exchanges of mAbs' Fc domains after initial selections of mAb-producing clones by the ADLib system, using a gene-replacement unit for recombinase-mediated cassette exchange (RMCE). In this system, Cre-recombinase recognition sites were inserted into the Fc region of the active DT40 IgM allele, allowing the replacement of the Fc domain by the sequences of interest upon co-transfection of a Cre recombinase and a donor DNA, enabling the rapid exchange of Fc regions. Combining this method with the ADLib system, we demonstrate rapid Fc engineering to generate fluorescent antibodies and to enhance affinity to Fc receptors.	[Hashimoto, Koji; Kurosawa, Kohei; Murayama, Akiho; Seo, Hidetaka; Ohta, Kunihiro] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo, Japan; [Kurosawa, Kohei] NYU, Laura & Isaac Perlmutter Canc Ctr, Langone Med Ctr, New York, NY USA	University of Tokyo; New York University; NYU Langone Medical Center	Seo, H (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo, Japan.	hidetakaseo@bio.c.u-tokyo.ac.jp		Hashimoto, Koji/0000-0001-8024-0060	Platform for Dynamic Approaches to Living System from the Ministry of Education, Culture, Sports, Science and Technology, Japan;  [3114003];  [21241046];  [26291018]	Platform for Dynamic Approaches to Living System from the Ministry of Education, Culture, Sports, Science and Technology, Japan; ; ; 	Support was provided by the Japanese Society for the Promotion of Science Fellows (3114003, 21241046, 26291018) [https://www.isps.go.jp/english/] and The Platform for Dynamic Approaches to Living System from the Ministry of Education, Culture, Sports, Science and Technology, Japan [http//www/mext.go.jp/english/].; We thank Dr. Moritoshi Sato for use of cell counter. This work was supported by Japanese Society for the Promotion of Science Fellows [3114003, 21241046, 26291018 to K.O.] and the Platform for Dynamic Approaches to Living System from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Arakawa H, 2004, DEV DYNAM, V229, P458, DOI 10.1002/dvdy.10495; Bouhassira EE, 1997, BLOOD, V90, P3332, DOI 10.1182/blood.V90.9.3332; Bruhns P, 2015, IMMUNOL REV, V268, P25, DOI 10.1111/imr.12350; BUERSTEDDE JM, 1991, CELL, V67, P179, DOI 10.1016/0092-8674(91)90581-I; BUERSTEDDE JM, 1990, EMBO J, V9, P921, DOI 10.1002/j.1460-2075.1990.tb08190.x; Derer Stefanie, 2012, Methods Mol Biol, V907, P519, DOI 10.1007/978-1-61779-974-7_30; DiLillo DJ, 2015, CANCER IMMUNOL RES, V3, P704, DOI 10.1158/2326-6066.CIR-15-0120; Ecker DM, 2015, MABS-AUSTIN, V7, P9, DOI 10.4161/19420862.2015.989042; Goding J., 1986, MONOCLONAL ANTIBODIE, P108; Goodwin EC, 1992, BIOCHEMISTRY-US, P16330; Griep RA, 1999, PROTEIN EXPRES PURIF, V16, P63, DOI 10.1006/prep.1999.1041; Guy AT, 2015, SCIENCE, V349, P974, DOI 10.1126/science.aab3516; Haas AK, 2010, MABS-AUSTIN, V2, P648, DOI 10.4161/mabs.2.6.13179; Jostock T, 2004, J IMMUNOL METHODS, V289, P65, DOI 10.1016/j.jim.2004.03.014; Kitao H, 1996, IMMUNOL LETT, V52, P99, DOI 10.1016/0165-2478(96)02592-8; Kohler G, 1975, NATURE; Kubota T, 2009, CANCER SCI, V100, P1566, DOI 10.1111/j.1349-7006.2009.01222.x; Lazar GA, 2006, P NATL ACAD SCI USA, V103, P4005, DOI 10.1073/pnas.0508123103; Lee G, 1998, GENE, V216, P55, DOI 10.1016/S0378-1119(98)00325-4; Lin W, 2008, GENES CELLS, V13, P255, DOI 10.1111/j.1365-2443.2008.01166.x; Lin W, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1122; Maizels N, 2005, ANNU REV GENET, V39, P23, DOI 10.1146/annurev.genet.39.073003.110544; MCCAFFERTY J, 1990, NATURE, V348, P552, DOI 10.1038/348552a0; Menzel C, 2008, BLOOD, V111, P3830, DOI 10.1182/blood-2007-04-082768; Natsume A, 2008, DRUG DES DEV THER, V3, P7; Nimmerjahn F, 2015, TRENDS IMMUNOL, V36, P325, DOI 10.1016/j.it.2015.04.005; Omi K, 2015, CLIN CHEM, V61, P627, DOI 10.1373/clinchem.2014.232728; REYNAUD CA, 1989, CELL, V59, P171, DOI 10.1016/0092-8674(89)90879-9; REYNAUD CA, 1985, CELL, V40, P283, DOI 10.1016/0092-8674(85)90142-4; REYNAUD CA, 1987, CELL, V48, P379, DOI 10.1016/0092-8674(87)90189-9; Richards JO, 2008, MOL CANCER THER, V7, P2517, DOI 10.1158/1535-7163.MCT-08-0201; Sauer Brian, 1994, Current Opinion in Biotechnology, V5, P521, DOI 10.1016/0958-1669(94)90068-X; Schroeder HW, 2010, J ALLERGY CLIN IMMUN, V125, pS41, DOI 10.1016/j.jaci.2009.09.046; Seo H, 2005, NAT BIOTECHNOL, V23, P731, DOI 10.1038/nbt1092; Seo H, 2006, NAT PROTOC, V1, P1502, DOI 10.1038/nprot.2006.248; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; Shinkawa T, 2003, J BIOL CHEM, V278, P3466, DOI 10.1074/jbc.M210665200; Smith P, 2012, P NATL ACAD SCI USA, V109, P6181, DOI 10.1073/pnas.1203954109; Stavnezer J, 2014, J IMMUNOL, V193, P5370, DOI 10.4049/jimmunol.1401849; Takagaki Y, 1996, CELL, V87, P941, DOI 10.1016/S0092-8674(00)82000-0; Umana P, 1999, NAT BIOTECHNOL, V17, P176, DOI 10.1038/6179; Vincent KJ, 2012, BIOTECHNOL J, P1; Yamashita N, 2015, INT IMMUNOL, V27, P459, DOI 10.1093/intimm/dxv014; Yamazoe M, 2004, DNA REPAIR, V3, P1175, DOI 10.1016/j.dnarep.2004.03.039; Zhao Y, 2000, IMMUNOLOGY, V101, P348, DOI 10.1046/j.1365-2567.2000.00106.x	46	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167232	10.1371/journal.pone.0167232	http://dx.doi.org/10.1371/journal.pone.0167232			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907066	gold, Green Published, Green Submitted			2022-12-26	WOS:000389482700099
J	Hu, HB; Kortner, TM; Gajardo, K; Chikwati, E; Tinsley, J; Krogdahl, A				Hu, Haibin; Kortner, Trond M.; Gajardo, Karina; Chikwati, Elvis; Tinsley, John; Krogdahl, Ashild			Intestinal Fluid Permeability in Atlantic Salmon (Salmo salar L.) Is Affected by Dietary Protein Source	PLOS ONE			English	Article							SOYBEAN-MEAL; RAINBOW-TROUT; SEAWATER ACCLIMATION; FISH-MEAL; EXPRESSION; PLANT; SMOLTIFICATION; SALINITY; SUPPLEMENTATION; ENTEROPATHY	In Atlantic salmon (Salmo salar L.), and also in other fish species, certain plant protein ingredients can increase fecal water content creating a diarrhea-like condition which may impair gut function and reduce fish growth. The present study aimed to strengthen understanding of the underlying mechanisms by observing effects of various alternative plant protein sources when replacing fish meal on expression of genes encoding proteins playing key roles in regulation of water transport across the mucosa of the distal intestine (DI). A 48-day feeding trial was conducted with five diets: A reference diet (FM) in which fish meal (72%) was the only protein source; Diet SBMWG with a mix of soybean meal (30%) and wheat gluten (22%); Diet SPCPM with a mix of soy protein concentrate (30%) and poultry meal (6%); Diet GMWG with guar meal (30%) and wheat gluten (14.5%); Diet PM with 58% poultry meal. Compared to fish fed the FM reference diet, fish fed the soybean meal containing diet (SBMWG) showed signs of enteritis in the DI, increased fecal water content of DI chyme and higher plasma osmolality. Altered DI expression of a battery of genes encoding aquaporins, ion transporters, tight junction and adherens junction proteins suggested reduced transcellular transport of water as well as a tightening of the junction barrier in fish fed the SBMWG diet, which may explain the observed higher fecal water content and plasma osmolality. DI structure was not altered for fish fed the other experimental diets but alterations in target gene expression and fecal water content were observed, indicating that alterations in water transport components may take place without clear effects on intestinal structure.	[Hu, Haibin; Kortner, Trond M.; Gajardo, Karina; Chikwati, Elvis; Krogdahl, Ashild] Norwegian Univ Life Sci, Dept Basic Sci & Aquat Med, Fac Vet Med & Biosci, Oslo, Norway; [Hu, Haibin] Ocean Univ China, Key Lab Aquaculture Nutr & Feed, Minist Agr, Qingdao, Shandong, Peoples R China; [Hu, Haibin] Ocean Univ China, Key Lab Mariculture, Minist Educ, Qingdao, Shandong, Peoples R China; [Tinsley, John] BioMar Ltd, Grangemouth Docks, Grangemouth, Scotland	Norwegian University of Life Sciences; Ministry of Agriculture & Rural Affairs; Ocean University of China; Ocean University of China	Gajardo, K (corresponding author), Norwegian Univ Life Sci, Dept Basic Sci & Aquat Med, Fac Vet Med & Biosci, Oslo, Norway.	karina.gajardo@nmbu.no		Chikwati, Elvis Mashingaidze/0000-0003-2630-0653	BioMar Ltd.; China Scholarship Council (CSC)	BioMar Ltd.; China Scholarship Council (CSC)(China Scholarship Council)	The present paper publishes results of contract research partly funded by BioMar Ltd. The funding body participated in study design, but had no role in data collection, analysis and interpretation, decision to publish or preparation of the manuscript. Other costs related to this study were covered by The NMBU School of Veterinary Medicine and Biosciences. In addition, the China Scholarship Council (CSC) provided financial assistance to H. H. to visit, as a PhD student, the Norwegian University of Life Sciences.; The authors thank BioMar AS for making the investigated samples available for this study. Thanks are also due to technician Ellen K. Hage in the nutrition laboratory at NMBU School of Veterinary Science for excellent technical assistance. The authors thank China Scholarship Council (CSC) for providing financial assistance to H. H. as a visiting PhD student at the Norwegian University of Life Sciences.	Ando M, 2014, AM J PHYSIOL-REG I, V307, pR653, DOI 10.1152/ajpregu.00543.2013; [Anonymous], 2011, AQUACULTURE, V310, P267; [Anonymous], 1994, ACTA AGR SCAND A-AN, V44, P185; Baeverfjord G, 1996, J FISH DIS, V19, P375, DOI 10.1111/j.1365-2761.1996.tb00376.x; Bureau D, 2006, ESSENTIAL RENDERING; Cerda J, 2010, J EXP ZOOL PART A, V313A, P623, DOI 10.1002/jez.634; Chen H, 2013, BRIT J NUTR, V110, P1837, DOI 10.1017/S0007114513001293; Chikwati EM, 2012, BRIT J NUTR, V107, P1570, DOI 10.1017/S0007114511004892; De Santis C, 2015, COMP BIOCHEM PHYS D, V15, P1, DOI 10.1016/j.cbd.2015.04.001; Gatlin DM, 2007, AQUAC RES, V38, P551, DOI 10.1111/j.1365-2109.2007.01704.x; Grammes F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083213; Gu JN, 2013, BRIT J NUTR, V109, P1408, DOI 10.1017/S000711451200325X; Hartviksen M, 2014, FISH PHYSIOL BIOCHEM, V40, P1621, DOI 10.1007/s10695-014-9953-4; Hu HB, 2015, AQUACULTURE, V444, P13, DOI 10.1016/j.aquaculture.2015.03.008; Hussain M, 2012, WORLD POULTRY SCI J, V68, P253, DOI 10.1017/S0043933912000311; Javid SH, 2005, CARCINOGENESIS, V26, P587, DOI 10.1093/carcin/bgh346; Knepper MA, 2015, NEW ENGL J MED, V372, P1349, DOI 10.1056/NEJMra1404726; Kortner TM, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-101; Kortner TM, 2011, AQUACULTURE, V318, P355, DOI 10.1016/j.aquaculture.2011.05.038; Kosinska A, 2013, FOOD RES INT, V54, P951, DOI 10.1016/j.foodres.2012.12.038; Krogdahl A, 2003, AQUACULT NUTR, V9, P361, DOI 10.1046/j.1365-2095.2003.00264.x; Krogdahl A, 2015, J AGR FOOD CHEM, V63, P3887, DOI 10.1021/jf506242t; Lambert J, 2015, FASEB J, V29, P922; Liu N, 2008, J ANIM SCI, V86, P3432, DOI 10.2527/jas.2008-1234; Liu Y, 2013, J ANIM SCI, V91, P5294, DOI 10.2527/jas.2012-6194; Madsen SS, 2009, J EXP BIOL, V212, P78, DOI 10.1242/jeb.024612; MCCORMICK SD, 1993, CAN J FISH AQUAT SCI, V50, P656, DOI 10.1139/f93-075; Muller PY, 2002, BIOTECHNIQUES, V33, P514; Nordrum S, 2000, COMP BIOCHEM PHYS B, V125, P317, DOI 10.1016/S0305-0491(99)00190-X; Refstie S, 1997, AQUACULTURE, V153, P263, DOI 10.1016/S0044-8486(97)00025-2; Refstie Stale, 2001, Aquaculture, V193, P91, DOI 10.1016/S0044-8486(00)00473-7; Ricanek P, 2015, CLIN EXP GASTROENTER, V8, P49, DOI 10.2147/CEG.S70119; Romarheim OH, 2006, AQUACULTURE, V256, P354, DOI 10.1016/j.aquaculture.2006.02.006; Selle PH, 2012, NUTR RES REV, V25, P1, DOI 10.1017/S0954422411000151; Storebakken T, 2000, AQUACULTURE, V184, P115, DOI 10.1016/S0044-8486(99)00316-6; Sundell KS, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00388; Sundh H, 2014, J FISH BIOL, V85, P1227, DOI 10.1111/jfb.12531; Suzuki T, 2011, J NUTR BIOCHEM, V22, P401, DOI 10.1016/j.jnutbio.2010.08.001; Takei Y, 2007, GEN COMP ENDOCR, V152, P339, DOI 10.1016/j.ygcen.2007.05.005; Tipsmark CK, 2012, COMP BIOCHEM PHYS A, V162, P378, DOI 10.1016/j.cbpa.2012.04.020; Tipsmark CK, 2010, J EXP BIOL, V213, P368, DOI 10.1242/jeb.034785; Tipsmark CK, 2010, COMP BIOCHEM PHYS A, V155, P361, DOI 10.1016/j.cbpa.2009.11.025; VANDENINGH TSGAM, 1991, AQUACULTURE, V94, P297, DOI 10.1016/0044-8486(91)90174-6; Venold FF, 2012, AQUACULTURE, V364, P281, DOI 10.1016/j.aquaculture.2012.08.035; Yang BC, 2008, J AGR FOOD CHEM, V56, P7522, DOI 10.1021/jf8012508; Yuge S, 2007, ZOOL SCI, V24, P1222, DOI 10.2108/zsj.24.1222; Zhang JX, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058115, 10.1371/journal.pone.0076378]; Zhou XL, 2014, NUTR RES, V34, P780, DOI 10.1016/j.nutres.2014.08.008	48	39	41	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167515	10.1371/journal.pone.0167515	http://dx.doi.org/10.1371/journal.pone.0167515			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907206	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000389482700178
J	Menon, N; Rogers, CJ; Lukaszewicz, AI; Axtelle, J; Yadav, M; Song, FF; Chakravarti, A; Jacob, NK				Menon, Naresh; Rogers, Claude J.; Lukaszewicz, Agnes I.; Axtelle, James; Yadav, Marshleen; Song, Feifei; Chakravarti, Arnab; Jacob, Naduparambil K.			Detection of Acute Radiation Sickness: A Feasibility Study in Non-Human Primates Circulating miRNAs for Triage in Radiological Events	PLOS ONE			English	Article							BODY IRRADIATION MODEL; IONIZING-RADIATION; IN-VIVO; MICRORNA EXPRESSION; PERIPHERAL-BLOOD; CELLS; INJURY; RNA; MANAGEMENT; EXPOSURE	Development of biomarkers capable of estimating absorbed dose is critical for effective triage of affected individuals after radiological events. Levels of cell-free circulating miRNAs in plasma were compared for dose-response analysis in non-human primates (NHP) exposed to lethal (6.5 Gy) and sub-lethal (1 and 3 Gy) doses over a 7 day period. The doses and test time points were selected to mimic triage needs in the event of a mass casualty radiological event. Changes in miRNA abundance in irradiated animals were compared to a non-irradiated cohort and a cohort experiencing acute inflammation response from exposure to lipopolysaccharide (LPS). An amplification-free, hybridization-based direct digital counting method was used for evaluation of changes in microRNAs in plasma from all animals. Consistent with previous murine studies, circulating levels of miR-150-5p exhibited a dose-and time-dependent decrease in plasma. Furthermore, plasma miR-150-5p levels were found to correlate well with lymphocyte and neutrophil depletion kinetics. Additionally, plasma levels of several other evolutionarily and functionally conserved miRNAs were found altered as a function of dose and time. Interestingly, miR-574-5p exhibited a distinct, dose-dependent increase 24 h post irradiation in NHPs with lethal versus sub-lethal exposure before returning to the baseline level by day 3. This particular miRNA response was not detected in previous murine studies but was observed in animals exposed to LPS, indicating distinct molecular and inflammatory responses. Furthermore, an increase in low-abundant miR-126, miR-144, and miR-21 as well as high-abundant miR-1-3p and miR-206 was observed in irradiated animals on day 3 and/or day 7. The data from this study could be used to develop a multi-marker panel with known tissue-specific origin that could be used for developing rapid assays for dose assessment and evaluation of radiation injury on multiple organs. Furthermore this approach may be utilized to screen for tissue toxicity in patients who receive myeloablative and therapeutic radiation.	[Menon, Naresh; Rogers, Claude J.; Lukaszewicz, Agnes I.; Axtelle, James] ChromoLogic LLC, Monrovia, CA 91016 USA; [Yadav, Marshleen; Song, Feifei; Chakravarti, Arnab; Jacob, Naduparambil K.] Ohio State Univ, Comprehens Canc Ctr Columbus, Dept Radiat Oncol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Menon, N (corresponding author), ChromoLogic LLC, Monrovia, CA 91016 USA.; Jacob, NK (corresponding author), Ohio State Univ, Comprehens Canc Ctr Columbus, Dept Radiat Oncol, Columbus, OH 43210 USA.	nmenon@chromologic.com; naduparambil.jacob@osumc.edu	Yadav, Marshleen/J-8795-2019	Yadav, Marshleen/0000-0002-4778-8347; /0000-0002-4700-8064	Biomedical Advanced Research and Development Agency, Office of the Assistant Secretary for Preparedness and Response, Office of the Secretary, Department of Health and Human Services [HHS0100201000005C]; National Institute of Allergies and Infectious Disease (NIAID) [1R43AI108019-01 A1]; Office of the Assistant Secretary of Defense for Health Affairs through the Peer Reviewed Medical Research Program [W81XWH-15-2-0054]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R43AI108019] Funding Source: NIH RePORTER	Biomedical Advanced Research and Development Agency, Office of the Assistant Secretary for Preparedness and Response, Office of the Secretary, Department of Health and Human Services; National Institute of Allergies and Infectious Disease (NIAID); Office of the Assistant Secretary of Defense for Health Affairs through the Peer Reviewed Medical Research Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	All NHP studies were performed at CiTox Laboratories (Laval, Canada). This project has been funded in whole or in part with Federal funds from the Biomedical Advanced Research and Development Agency, Office of the Assistant Secretary for Preparedness and Response, Office of the Secretary, Department of Health and Human Services (Contract No. HHS0100201000005C); the National Institute of Allergies and Infectious Disease (NIAID; Grant 1R43AI108019-01 A1); the Office of the Assistant Secretary of Defense for Health Affairs through the Peer Reviewed Medical Research Program (Award No. W81XWH-15-2-0054). The Grants 1R43AI108019-01 A1 provided support in the form of salaries for authors [NJ, CR, AL, NM, JA], purchasing reagents and services, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Contract W81XWH-15-2-0054 provided support in the form of salaries for authors [MY, FS, NJ], and purchasing reagents and services, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Contract HHS0100201000005C provided support in the form of salaries for authors [NM, JA], and purchasing reagents and services, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; All NHP studies were performed at CiTox Laboratories (Laval, Canada). This project has been funded in whole or in part with Federal funds from the Biomedical Advanced Research and Development Agency, Office of the Assistant Secretary for Preparedness and Response, Office of the Secretary, Department of Health and Human Services (Contract No. HHS0100201000005C); the National Institute of Allergies and Infectious Disease (NIAID; Grant 1R43AI108019-01 A1); the Office of the Assistant Secretary of Defense for Health Affairs through the Peer Reviewed Medical Research Program (Award No. W81XWH-15-2-0054).; The Grants 1R43AI108019-01 A1 provided support in the form of salaries for authors [NJ, CR, AIL, NM, JA], purchasing reagents and services, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Contract W81XWH-15-2-0054 provided support in the form of salaries for authors [MY, FS, NJ], and purchasing reagents and services, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Contract HHS0100201000005C provided support in the form of salaries for authors [NM, JA], and purchasing reagents and services, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Only authors [CR, AIL, JA, NM] are full time employees of ChromoLogic LLC while authors [NJ, MY, AC] have no financial interest in ChromoLogic LLC. Grant 1R43AI108019-01 A1 and Contract HHS0100201000005C were awarded to ChromoLogic LLC. All ChromoLogic LLC staff adhere strictly to Ethical Scientific Conduct guidelines documented by the company in their Employee Agreement and, independently, those established by the National Institutes of Health. This does not alter our adherence to PLOS ONE policies on sharing data and materials.	Abend M, 2016, RADIAT RES, V185, P109, DOI 10.1667/RR14221.1; ACHARYA SS, 2015, SCI TRANSL MED, V7; Adams BD, 2012, CELL REP, V2, P1048, DOI 10.1016/j.celrep.2012.09.014; Al-Mayah AHJ, 2012, RADIAT RES, V177, P539, DOI 10.1667/RR2868.1; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bhaumik D, 2009, AGING-US, V1, P402, DOI 10.18632/aging.100042; Blakely WF, 2014, RADIAT PROT DOSIM, V159, P46, DOI 10.1093/rpd/ncu127; Bolduc DL, 2014, COMPUT MATH METHOD M, V2014, DOI 10.1155/2014/685286; Buddemeir B. R., 2011, KEY RESPONSE PLANNIN; Carver JR, 2007, J CLIN ONCOL, V25, P3991, DOI 10.1200/JCO.2007.10.9777; Cheng HS, 2013, EMBO MOL MED, V5, P1017, DOI 10.1002/emmm.201202318; Christensen DM, 2014, J AM OSTEOPATH ASSOC, V114, P189, DOI 10.7556/jaoa.2014.037; Dainiak N, 2007, EXP HEMATOL, V35, P17, DOI 10.1016/j.exphem.2007.01.007; Dicarlo AL, 2011, DISASTER MED PUBLIC, P5; Dickey JS, 2011, RADIAT ENVIRON BIOPH, V50, P491, DOI 10.1007/s00411-011-0386-5; Fliedner TM, 2005, BR J RADIOL S27, P1, DOI DOI 10.1259/BJR/77700378; Flynn DF, 2006, SURG CLIN N AM, V86, P601, DOI 10.1016/j.suc.2006.03.005; Forsbach A, 2008, J IMMUNOL, V180, P3729, DOI 10.4049/jimmunol.180.6.3729; Ghosh SP, 2009, INT J RADIAT BIOL, V85, P598, DOI 10.1080/09553000902985128; Girardi C, 2012, PLOS ONE, P7; GOANS RE, 1997, HLTH PHYS, V72; Graessle DH, 2015, HEALTH PHYS, V109, P493, DOI 10.1097/HP.0000000000000355; He Y, 2014, INFLAMMATION, V37, P71, DOI 10.1007/s10753-013-9713-0; Horai R, 2011, J INTERF CYTOK RES, V31, P733, DOI 10.1089/jir.2011.0042; Jacob NK, 2013, PLOS ONE, P8; Jusufovic E, 2012, PLOS ONE, P7; Knebel AR, 2011, DISASTER MED PUBLIC, V5, pS20, DOI 10.1001/dmp.2011.25; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Li Q., 2012, IACR CRYPTOL EPRINT, V2012, P7, DOI DOI 10.1371/J0URNAL.P0NE.0048278; Ludwig N, 2016, NUCLEIC ACIDS RES, P1; Ludwig N., 2016, NUCL ACIDS RES; LUSHBAUGH CC, 1987, BRIT J RADIOL, V60, P1159, DOI 10.1259/0007-1285-60-720-1159; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Ossetrova NI, 2014, RADIAT PROT DOSIM, V159, P61, DOI 10.1093/rpd/ncu165; Ossetrova NI, 2010, HEALTH PHYS, V98, P204, DOI 10.1097/HP.0b013e3181abaabf; Ossetrova NI, 2009, INT J RADIAT BIOL, V85, P837, DOI 10.3109/09553000903154799; Prasanna Pataje G S, 2010, Radiat Res, V173, P245, DOI 10.1667/RR1993.1; Quesenberry PJ, 2014, STEM CELLS DEV, V23, P1429, DOI 10.1089/scd.2013.0594; Ranganathan P, 2015, AM J PHYSIOL-RENAL, V309, pF551, DOI 10.1152/ajprenal.00076.2015; Rothkamm K, 2013, RADIAT RES, V180, P111, DOI 10.1667/RR3231.1; Shin S, 2009, INT J ONCOL, V35, P81, DOI 10.3892/ijo_00000315; Simone N.L., 2009, PLOS ONE, P4; Sine R C, 2001, Mil Med, V166, P85; Stone HB, 2003, LANCET ONCOL, V4, P529, DOI 10.1016/S1470-2045(03)01191-4; Tano N, 2011, PLOS ONE, P6; TAYLOR AMR, 1975, NATURE, V258, P427, DOI 10.1038/258427a0; Templin T, 2011, INT J RADIAT ONCOL, V80, P549, DOI 10.1016/j.ijrobp.2010.12.061; Templin T, 2011, INT J RADIAT BIOL, V87, P653, DOI 10.3109/09553002.2010.549537; Van der Meeren A, 2005, RADIAT RES, V163, P144, DOI 10.1667/RR3293; Vincenti S, 2011, RADIAT RES, V175, P535, DOI 10.1667/RR2200.1; Wagner-Ecker M, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-25; Weber JM, 2010, BONE, P281; Williams JP, 2010, RADIAT RES, V173, P557, DOI 10.1667/RR1880.1; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Yu ZY, 2013, MOL MED REP, V8, P287, DOI 10.3892/mmr.2013.1493; Zhou BY, 2007, P NATL ACAD SCI USA, V104, P7080, DOI 10.1073/pnas.0702409104	57	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167333	10.1371/journal.pone.0167333	http://dx.doi.org/10.1371/journal.pone.0167333			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907140	gold, Green Published, Green Submitted			2022-12-26	WOS:000389482700121
J	Santos, UP; Campos, JF; Torquato, HFV; Paredes-Gamero, EJ; Carollo, CA; Estevinho, LM; Souza, KD; dos Santos, EL				Santos, Uilson P.; Campos, Jaqueline F.; Torquato, Heron Fernandes V.; Paredes-Gamero, Edgar Julian; Carollo, Carlos Alexandre; Estevinho, Leticia M.; Souza, Kely de Picoli; dos Santos, Edson Lucas			Antioxidant, Antimicrobial and Cytotoxic Properties as Well as the Phenolic Content of the Extract from Hancornia speciosa Gomes	PLOS ONE			English	Article							MEDICINAL-PLANTS; CELL-DEATH; OXIDATIVE DAMAGE; NATURAL-PRODUCTS; BLOOD-CELLS; APOPTOSIS; INHIBITION; RUTIN; ANTIBACTERIAL; PROPOLIS	Hancornia speciosa Gomes (Apocynaceae) is a fruit tree, popularly known as mangabeira, and it is widely distributed throughout Brazil. Several parts of the plant are used in folk medicine, and the leaf and bark extracts have anti-inflammatory, antihypertensive, antidiabetic, and antimicrobial properties. In this study, we investigated the chemical composition of the ethanolic extract of Hancornia speciosa leaves (EEHS) and its antioxidant, antimicrobial, and cytotoxic activities as well as the mechanisms involved in cell death. The chemical compounds were identified by liquid chromatography coupled to mass spectrometry (LC-MS/MS). The antioxidant activity of the EEHS was investigated using the method that involves the scavenging of 2,2-dipheny1-1-picrylhydrazyl free radicals as well as the inhibition of oxidative hemolysis and lipid peroxidation induced by 2,2'-azobis (2-amidinopropane) in human erythrocytes. The antimicrobial activity was determined by calculating the minimum inhibitory concentration, minimum bactericidal concentration, minimum fungicidal concentration, and zone of inhibition. Kasumi-1 leukemic cells were used to assess the cytotoxic activity and mechanisms involved in cell death promoted by the EEHS. The chemical compounds identified were quinic acid, chlorogenic acid, catechin, rutin, isoquercitrin, kaempferol-rutinoside, and catechin-pentoside. The EEHS demonstrated antioxidant activity via the sequestration of free radicals, inhibition of hemolysis, and inhibition of lipid peroxidation in human erythrocytes incubated with an oxidizing agent. The antimicrobial activity was observed against American Type Culture Collection (ATCC) and hospital strains of bacteria and fungi, filamentous fungi and dermatophytes. The cytotoxic activity of the EEHS was induced by apoptosis, reduction of the mitochondrial membrane potential, and activation of cathepsins. Together, these results indicate the presence of phenolic compounds and flavonoids in the EEHS and that their antioxidant, antimicrobial, and cytotoxic activities in acute myeloid leukemia cells are mediated by apoptosis.	[Santos, Uilson P.; Campos, Jaqueline F.; Souza, Kely de Picoli; dos Santos, Edson Lucas] Fed Univ Grande Dourados, Sch Environm & Biol Sci, Rodovia Dourados Ithaum, Dourados, MS, Brazil; [Torquato, Heron Fernandes V.; Paredes-Gamero, Edgar Julian] Univ Fed Sao Paulo, Dept Biochem, Sao Paulo, SP, Brazil; [Paredes-Gamero, Edgar Julian] Univ Mogi Das Cruzes, Ctr Interdisciplinary Res Biochem, Av Dr Candido Xavier de Almeida Souza, Mogi Das Cruzes, SP, Brazil; [Carollo, Carlos Alexandre] Univ Fed Mato Grosso do Sul, Ctr Biol & Hlth Sci, Lab Nat Prod & Mass Spectrometry, Campo Grande, MS, Brazil; [Estevinho, Leticia M.] Polytech Inst Braganca, Agr Coll Braganca, Campus Santa Apolonia, Braganca, Portugal; [Estevinho, Leticia M.] Univ Minho, Ctr Mol & Environm Biol, Campus Gualtar, Braga, Portugal	Universidade Federal da Grande Dourados; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Mogi das Cruzes; Universidade Federal de Mato Grosso do Sul; Instituto Politecnico de Braganca; Universidade do Minho	dos Santos, EL (corresponding author), Fed Univ Grande Dourados, Sch Environm & Biol Sci, Rodovia Dourados Ithaum, Dourados, MS, Brazil.	edson.lucas@pq.cnpq.br	de Picoli Souza, Kely/AAU-5978-2020; dos Santos, Edson Lucas/AAU-5857-2020; de Picoli Souza, Kely/I-1248-2015; Santos, Edson/C-6820-2014; Estevinho, Leticia M./L-2656-2017; Torquato, Heron/AAQ-2462-2020; Paredes-Gamero, Edgar J/C-4791-2012	de Picoli Souza, Kely/0000-0001-5764-2125; dos Santos, Edson Lucas/0000-0002-6557-7914; de Picoli Souza, Kely/0000-0001-5764-2125; Santos, Edson/0000-0002-6557-7914; Estevinho, Leticia M./0000-0002-9249-1948; Paredes-Gamero, Edgar J/0000-0003-3686-8402	Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT, Brazil); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil); PRODER [24.073]; CNPq, Brazil	Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT, Brazil)(Fundacao de Apoio ao Desenvolvimento do Ensino Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT MS)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PRODER; CNPq, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT, Brazil), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil) and PRODER, (24.073 - A, Portugal). E.L.S.; E.J.P.G e C.A.L.C., were recipient of felowship from CNPq, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT, Brazil), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil) and PRODER, (24.073 - A Portugal). E.L.S.; E.J.P.G e C.A.L.C., were recipient of felowship from CNPq, Brazil.	Akintobi OA, 2013, REPORT OPINION, V5, P41; Al-Fatimi M, 2007, J ETHNOPHARMACOL, V111, P657, DOI 10.1016/j.jep.2007.01.018; Amin MU, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0580-0; Bardaweel SK, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/790838; Joray MB, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/912484; Almeida MMB, 2011, FOOD RES INT, V44, P2155, DOI 10.1016/j.foodres.2011.03.051; Brown DG, 2014, BIOORG MED CHEM LETT, V24, P413, DOI 10.1016/j.bmcl.2013.12.059; Campos JF, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/296186; Campos JF, 2014, FOOD CHEM TOXICOL, V65, P374, DOI 10.1016/j.fct.2014.01.008; Casagrande JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112748; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Cowan MM, 1999, CLIN MICROBIOL REV, V12, P564, DOI 10.1128/CMR.12.4.564; da Silva AO, 2014, J ETHNOPHARMACOL, V154, P319, DOI 10.1016/j.jep.2014.03.017; Marcondes DBD, 2014, J ETHNOPHARMACOL, V157, P243, DOI 10.1016/j.jep.2014.09.018; Pereira ABD, 2012, J CHROMATOGR B, V887, P133, DOI 10.1016/j.jchromb.2012.01.009; Djeridane A, 2006, FOOD CHEM, V97, P654, DOI 10.1016/j.foodchem.2005.04.028; Endringer DC, 2007, ACTA CRYSTALLOGR E, V63, pO1067, DOI 10.1107/S1600536806037019; Endringer DC, 2010, PHYTOTHER RES, V24, P928, DOI 10.1002/ptr.3050; Endringer DC, 2009, PHYTOMEDICINE, V16, P1064, DOI 10.1016/j.phymed.2009.03.022; Erdal H, 2005, P NATL ACAD SCI USA, V102, P192, DOI 10.1073/pnas.0408592102; Favela-Hernandez JMJ, 2015, MOLECULES, V20, P12450, DOI 10.3390/molecules200712450; Feas X, 2013, MOLECULES, V18, P4573, DOI 10.3390/molecules18044573; Ferreira HC, 2007, PHYTOMEDICINE, V14, P473, DOI 10.1016/j.phymed.2006.11.008; Ferreira HC, 2007, J ETHNOPHARMACOL, V109, P161, DOI 10.1016/j.jep.2006.06.009; Foghsgaard L, 2002, J BIOL CHEM, V277, P39499, DOI 10.1074/jbc.M206669200; Franci G, 2015, MOLECULES, V20, P8856, DOI 10.3390/molecules20058856; Galluzzi L, 2007, CELL DEATH DIFFER, V14, P1237, DOI 10.1038/sj.cdd.4402148; Geller FC, 2015, PHYTOTHER RES, V29, P1887, DOI 10.1002/ptr.5438; Gobeil S, 2001, CELL DEATH DIFFER, V8, P588, DOI 10.1038/sj.cdd.4400851; Grandi TSM, 1989, ACTA BOT BRAS, V3, P185, DOI [10.1590/S0102-33061989000300018, DOI 10.1590/S0102-33061989000300018]; Groth-Pedersen L, 2007, CANCER RES, V67, P2217, DOI 10.1158/0008-5472.CAN-06-3520; Gudlaugsson O, 2003, CLIN INFECT DIS, V37, P1172, DOI 10.1086/378745; Gupta D, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-13; Haider L, 2011, BRAIN, V134, P1914, DOI 10.1093/brain/awr128; Havlickova B, 2008, MYCOSES, V51, P2, DOI 10.1111/j.1439-0507.2008.01606.x; Henneberg Railson, 2013, Rev. Bras. Hematol. Hemoter., V35, P52, DOI 10.5581/1516-8484.20130015; HIRSCHMANN GS, 1990, J ETHNOPHARMACOL, V29, P159, DOI 10.1016/0378-8741(90)90052-U; Kaznelson DW, 2004, VIROLOGY, V320, P301, DOI 10.1016/j.virol.2003.12.018; Kesharwani Rajesh Kumar, 2012, Org Med Chem Lett, V2, P12, DOI 10.1186/2191-2858-2-12; Khan R, 2009, MOLECULES, V14, P586, DOI 10.3390/molecules14020586; Kroemer G, 2005, NAT MED, V11, P725, DOI 10.1038/nm1263; Li TY, 2016, FOOD FUNCT, V7, P1147, DOI 10.1039/c5fo01036e; Liberio SA, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-108; Marinho DG, 2011, J ETHNOPHARMACOL, V135, P530, DOI 10.1016/j.jep.2011.03.059; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; Meda A, 2005, FOOD CHEM, V91, P571, DOI 10.1016/j.foodchem.2004.10.006; Moraes TDM, 2008, J ETHNOPHARMACOL, V120, P161, DOI 10.1016/j.jep.2008.08.001; Moraes VWR, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.190; Morais M, 2011, FOOD CHEM TOXICOL, V49, P1096, DOI 10.1016/j.fct.2011.01.020; Moreira L, 2008, FOOD CHEM TOXICOL, V46, P3482, DOI 10.1016/j.fct.2008.08.025; Newman DJ, 2016, J NAT PROD, V79, P629, DOI 10.1021/acs.jnatprod.5b01055; Oliveira P. S., 2002, THE CERRADOS OF BRAZ; Owen S.O., 2006, HANDBOOK OF PHARMACE; Paredes-Gamero EJ, 2012, BBA-GEN SUBJECTS, V1820, P1062, DOI 10.1016/j.bbagen.2012.02.015; Pereira AC, 2015, J ETHNOPHARMACOL, V161, P30, DOI 10.1016/j.jep.2014.11.050; Pietkiewicz S, 2015, J IMMUNOL METHODS, V423, P99, DOI 10.1016/j.jim.2015.04.025; Plaper A, 2003, BIOCHEM BIOPH RES CO, V306, P530, DOI 10.1016/S0006-291X(03)01006-4; Ribeiro AB, 2015, PHARM BIOL, V53, P1691, DOI 10.3109/13880209.2014.1001407; Rizzo JA, 1990, C NAC BOT AN, V2, P691; Rodrigues V. E. G., 2001, Ciencia e Agrotecnologia, V25, P102; Roy S, 2014, ENVIRON TOXICOL PHAR, V37, P234, DOI 10.1016/j.etap.2013.11.008; Sahreen S, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-372; Sharma S, 2013, EXPERT OPIN INV DRUG, V22, P1063, DOI 10.1517/13543784.2013.805744; Shi YG, 2001, NAT STRUCT BIOL, V8, P394, DOI 10.1038/87548; Silva GC, 2011, J ETHNOPHARMACOL, V137, P709, DOI 10.1016/j.jep.2011.06.031; Sofi FR, 2016, J FOOD SCI TECH MYS, V53, P104, DOI 10.1007/s13197-015-1983-0; Stoka V, 2001, J BIOL CHEM, V276, P3149, DOI 10.1074/jbc.M008944200; The Japanese Mycology Study Group, 2007, GUIDELINES FOR MANAG; Umarani V, 2015, TOXICOL MECH METHOD, V25, P143, DOI 10.3109/15376516.2014.1003359; Valente MJ, 2011, FOOD CHEM TOXICOL, V49, P86, DOI 10.1016/j.fct.2010.10.001; Wannes WA, 2010, FOOD CHEM TOXICOL, V48, P1362, DOI 10.1016/j.fct.2010.03.002; Williams GM, 1999, FOOD CHEM TOXICOL, V37, P1027, DOI 10.1016/S0278-6915(99)00085-X; Wintola OA, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0835-9; Yu XL, 2015, FOOD FUNCT, V6, P3296, DOI 10.1039/c5fo00500k; Zhao M, 2001, FEBS LETT, V509, P399, DOI 10.1016/S0014-5793(01)03184-2; Zhao M, 2003, EUR J BIOCHEM, V270, P3778, DOI 10.1046/j.1432-1033.2003.03765.x; Zou CG, 2001, LIFE SCI, V69, P75, DOI 10.1016/S0024-3205(01)01112-2	77	28	28	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167531	10.1371/journal.pone.0167531	http://dx.doi.org/10.1371/journal.pone.0167531			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907185	Green Published, Green Submitted, gold			2022-12-26	WOS:000389482700185
J	Sundberg, M; Strage, EM; Bergquist, J; Holst, BS; Ramstrom, M				Sundberg, Marten; Strage, Emma M.; Bergquist, Jonas; Holst, Bodil S.; Ramstrom, Margareta			Quantitative and Selective Analysis of Feline Growth Related Proteins Using Parallel Reaction Monitoring High Resolution Mass Spectrometry	PLOS ONE			English	Article							MULTIPLEXED ABSOLUTE QUANTIFICATION; CONCATENATED SIGNATURE PEPTIDES; FACTOR-I; LIQUID-CHROMATOGRAPHY; TARGETED PROTEOMICS; DIABETES-MELLITUS; PERFORMANCE; PLASMA; IDENTIFICATION; BIOMARKERS	Today immunoassays are widely used in veterinary medicine, but lack of species specific assays often necessitates the use of assays developed for human applications. Mass spectrometry (MS) is an attractive alternative due to high specificity and versatility, allowing for species-independent analysis. Targeted MS-based quantification methods are valuable complements to large scale shotgun analysis. A method referred to as parallel reaction monitoring (PRM), implemented on Orbitrap MS, has lately been presented as an excellent alternative to more traditional selected reaction monitoring/multiple reaction monitoring (SRM/MRM) methods. The insulin-like growth factor (IGF)-system is not well described in the cat but there are indications of important differences between cats and humans. In feline medicine IGF-I is mainly analyzed for diagnosis of growth hormone disorders but also for research, while the other proteins in the IGF-system are not routinely analyzed within clinical practice. Here, a PRM method for quantification of IGF-I, IGF-II, IGF binding protein (BP)-3 and IGFBP-5 in feline serum is presented. Selective quantification was supported by the use of a newly launched internal standard named QPrEST (TM). Homology searches demonstrated the possibility to use this standard of human origin for quantification of the targeted feline proteins. Excellent quantitative sensitivity at the attomol/mu L (pM) level and selectivity were obtained. As the presented approach is very generic we show that high resolution mass spectrometry in combination with PRM and nQPrEST (TM) internal standards is a versatile tool for protein quantitation across multispecies.	[Sundberg, Marten; Bergquist, Jonas; Ramstrom, Margareta] Uppsala Univ, Dept Chem BMC, Analyt Chem, Uppsala, Sweden; [Sundberg, Marten; Bergquist, Jonas; Ramstrom, Margareta] Uppsala Univ, Sci Life Lab, Uppsala, Sweden; [Strage, Emma M.; Holst, Bodil S.] Swedish Univ Agr Sci, Dept Clin Sci, Uppsala, Sweden; [Strage, Emma M.] Swedish Univ Agr Sci, Univ Anim Hosp, Clin Pathol Lab, Uppsala, Sweden	Uppsala University; Uppsala University; Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences	Ramstrom, M (corresponding author), Uppsala Univ, Dept Chem BMC, Analyt Chem, Uppsala, Sweden.; Ramstrom, M (corresponding author), Uppsala Univ, Sci Life Lab, Uppsala, Sweden.	margareta.ramstrom@kemi.uu.se	Holst, Bodil Strom/D-4487-2014	Holst, Bodil Strom/0000-0001-7623-7141; Strage, Emma/0000-0003-4731-2960; Ramstrom, Margareta/0000-0003-1471-7291; Bergquist, Jonas/0000-0002-4597-041X	Swedish research council [621-2011-4423, 2015-4870]; Agria; Swedish Kennel Club Research Foundation; Michael Forsgren Foundation	Swedish research council(Swedish Research CouncilEuropean Commission); Agria; Swedish Kennel Club Research Foundation; Michael Forsgren Foundation	This work was supported by the Swedish research council (621-2011-4423), http://www.vr.se/; the Agria and Swedish Kennel Club Research Foundation, http://www.skk.se/sv/Agria-SKK-Forskningsfond/; and the Michael Forsgren Foundation, http://stiftelsemedel.se/michael-forsgrens-stiftelse/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Swedish research council (621-2011-4423, 2015-4870), the Agria and Swedish Kennel Club Research Foundation and the Michael Forsgren Foundation are acknowledged for financial support. We thank Anne Konzer and Katarina Hornaeus for valuable discussions and support. The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE [41] partner repository with the data set identifier PXD005337 and PXD005340.	Beynon RJ, 2005, NAT METHODS, V2, P587, DOI 10.1038/NMETH774; Boisclair YR, 2001, J ENDOCRINOL, V170, P63, DOI 10.1677/joe.0.1700063; Bredehoft M, 2008, RAPID COMMUN MASS SP, V22, P477, DOI 10.1002/rcm.3388; Bystrom C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043457; Bystrom CE, 2011, ANAL CHEM, V83, P9005, DOI 10.1021/ac201800g; CLEMMONS DR, 1991, J CLIN ENDOCR METAB, V73, P727, DOI 10.1210/jcem-73-4-727; Cox HD, 2014, CLIN CHEM, V60, P541, DOI 10.1373/clinchem.2013.208538; de Kock SS, 2001, RAPID COMMUN MASS SP, V15, P1191, DOI 10.1002/rcm.363; Duriez E, 2015, J PROTEOME RES, V14, P728, DOI 10.1021/pr500764e; Edfors F, 2014, MOL CELL PROTEOMICS, V13, P1611, DOI 10.1074/mcp.M113.034140; Frystyk J, 2010, GROWTH HORM IGF RES, V20, P8, DOI 10.1016/j.ghir.2009.09.004; Gallien S, 2015, MOL CELL PROTEOMICS; Gallien S, 2015, METHODS; Gallien S, 2014, J PROTEOMICS, V100, P147, DOI 10.1016/j.jprot.2013.10.029; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Kay RG, 2009, RAPID COMMUN MASS SP, V23, P3173, DOI 10.1002/rcm.4237; Kay R, 2013, CLIN ENDOCRINOL, V78, P424, DOI 10.1111/cen.12085; Kelley KM, 1996, INT J BIOCHEM CELL B, V28, P619, DOI 10.1016/1357-2725(96)00005-2; Kirsch S, 2007, J CHROMATOGR A, V1153, P300, DOI 10.1016/j.chroma.2007.03.058; Krebs A, 2008, CLIN CHEM LAB MED, V46, P1776, DOI 10.1515/CCLM.2008.349; Lange V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.61; Lewitt MS, 2000, J ENDOCRINOL, V166, P21, DOI 10.1677/joe.0.1660021; Livingstone C, 2014, CLIN ENDOCRINOL, V80, P773, DOI 10.1111/cen.12446; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; MOHAN S, 1995, J CLIN ENDOCR METAB, V80, P637, DOI 10.1210/jc.80.2.637; Niederkofler EE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081125; Peterson AC, 2012, MOL CELL PROTEOMICS, V11, P1475, DOI 10.1074/mcp.O112.020131; Picotti P, 2012, NAT METHODS, V9, P555, DOI [10.1038/NMETH.2015, 10.1038/nmeth.2015]; Popot MA, 2001, CHROMATOGRAPHIA, V54, P737, DOI 10.1007/BF02492492; Pratt JM, 2006, NAT PROTOC, V1, P1029, DOI 10.1038/nprot.2006.129; Rezeli M, 2013, J PROTEOMICS, V87, P16, DOI 10.1016/j.jprot.2013.05.016; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rijnberk A., 2010, TIER RZTLICHE PRAXIS, V38, P105; Scott KB, 2015, ANAL CHEM, V87, P4429, DOI 10.1021/acs.analchem.5b00331; Shrivastava A., 2011, CHRONICLES YOUNG SCI, V2, P21, DOI [DOI 10.4103/2229-5186.79345, 10.4103/2229-5186.79345]; Thomas A, 2011, ANALYST, V136, P1003, DOI 10.1039/c0an00632g; Tschuor F, 2012, AM J VET RES, V73, P1925, DOI 10.2460/ajvr.73.12.1925; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; ZAPF J, 1981, J CLIN INVEST, V68, P1321, DOI 10.1172/JCI110379; Zeiler M, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.O111.009613	41	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167138	10.1371/journal.pone.0167138	http://dx.doi.org/10.1371/journal.pone.0167138			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907059	Green Published, gold, Green Submitted			2022-12-26	WOS:000389482700080
J	Tseng, CH				Tseng, Chin-Hsiao			Factors Associated with Cancer- and Non-Cancer-Related Deaths among Taiwanese Patients with Diabetes after 17 Years of Follow-Up	PLOS ONE			English	Article							OBESITY PARADOX; BLADDER-CANCER; MORTALITY; POPULATION; HYPERTENSION; PREVALENCE; INSULIN; DISEASE; IMPACT	Objective A previous 12-year follow-up of a large diabetes cohort in Taiwan suggested a survival advantage in the patients with obesity. The present study further investigated additional determinants for cancer and non-cancer death in the cohort after a follow-up of 17 years. Methods A cohort of 92546 diabetes patients recruited since 1995 was followed for vital status by matching the National Death Certificate Database until 2011. Cox regression estimated the hazard ratios for the following variables: age at baseline, sex, diabetes type, screen-detected diabetes (diabetes diagnosed accidentally through epidemiological screening programs or during visits to medical settings without a history of diabetes), diabetes duration, body mass index, insulin use, hypertension, smoking, and living region. Fasting glucose and history of dyslipidemia were available for additional adjustment in a subcohort of the patients (n = 14559). Results A total of 40229 diabetes patients (43.5% of the cohort) died during follow-up and 10.9% died under the age of 60. Insulin use and smoking significantly predicted cancer and non-cancer death. The adjusted hazard ratio (95% confidence interval) associated with insulin use was 1.161 (1.052-1.281) for cancer death and 1.469 (1.413-1.526) for non-cancer death. Screen-detected diabetes and body mass index were consistently associated with a lower risk, but diabetes duration a higher risk, for non-cancer death, with adjusted hazard ratio of 0.683 (0.666-0.702), 0.955 (0.951-0.958) and 1.018 (1.017-1.020), respectively. Diabetes type had a null association disregarding the causes of death and living in rural areas was significantly associated with a higher mortality from non-cancer death. Hypertension, fasting glucose and dyslipidemia showed differential impacts on cancer and non-cancer death, and were significantly predictive for non-cancer death. Conclusions Screen-detected diabetes and a higher body mass index provide a survival advantage, especially for non-cancer death. However, insulin use is associated with a significantly higher risk of either cancer or non-cancer death.	[Tseng, Chin-Hsiao] Natl Taiwan Univ, Dept Internal Med, Coll Med, Taipei, Taiwan; [Tseng, Chin-Hsiao] Natl Taiwan Univ Hosp, Dept Internal Med, Div Endocrinol & Metab, Taipei, Taiwan; [Tseng, Chin-Hsiao] Natl Hlth Res Inst, Div Environm Hlth & Occupat Med, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Health Research Institutes - Taiwan	Tseng, CH (corresponding author), Natl Taiwan Univ, Dept Internal Med, Coll Med, Taipei, Taiwan.; Tseng, CH (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Div Endocrinol & Metab, Taipei, Taiwan.; Tseng, CH (corresponding author), Natl Hlth Res Inst, Div Environm Hlth & Occupat Med, Taipei, Taiwan.	ccktsh@ms6.hinet.net			Department of Health [DOH89-TD-1035]; Ministry of Science and Technology of Taiwan [MOST 103-2314-B-002-187-MY3]	Department of Health; Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	The study was supported by the Department of Health (DOH89-TD-1035) and the Ministry of Science and Technology (MOST 103-2314-B-002-187-MY3) of Taiwan.	[Anonymous], 2015, IDF DIABETES ATLAS; Brun E, 2000, DIABETES CARE, V23, P1119, DOI 10.2337/diacare.23.8.1119; Calori G, 2011, DIABETES CARE, V34, P210, DOI 10.2337/dc10-0665; Canchola AJ, COX REGRESSION USING; Carpenter CL, 2013, J OBES, V2013, DOI 10.1155/2013/790654; Chang HY, 2010, DIABETES RES CLIN PR, V90, P358, DOI 10.1016/j.diabres.2010.09.032; Eborall HC, 2007, BMJ-BRIT MED J, V335, P486, DOI 10.1136/bmj.39303.723449.55; Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666; Gu K, 1998, DIABETES CARE, V21, P1138, DOI 10.2337/diacare.21.7.1138; Hainer V, 2013, DIABETES CARE, V36, pS276, DOI 10.2337/dcS13-2023; Hsieh MC, 2012, EXP DIABETES RES, DOI 10.1155/2012/413782; Jones MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077941; Lavie CJ, 2011, CLIN PHARMACOL THER, V90, P23, DOI 10.1038/clpt.2011.87; Lavie CJ, 2009, J AM COLL CARDIOL, V53, P1925, DOI 10.1016/j.jacc.2008.12.068; Rahman M, 2012, DIABETIC MED, V29, P886, DOI 10.1111/j.1464-5491.2012.03570.x; Rahman M, 2012, DIABETOLOGIA, V55, P1651, DOI 10.1007/s00125-011-2441-9; Rotella CM, 2013, INT J ENDOCRINOL MET, V11, P137, DOI 10.5812/ijem.7551; Simmons RK, 2011, DIABETOLOGIA, V54, P312, DOI 10.1007/s00125-010-1949-8; Tseng CH, 2006, DIABETOLOGIA, V49, P1755, DOI 10.1007/s00125-006-0314-4; Tseng CH, 2012, ANN ONCOL, V23, P153, DOI 10.1093/annonc/mdr334; Tseng CH, 2009, DIABETOLOGIA, V52, P240, DOI 10.1007/s00125-008-1204-8; Tseng CH, 2004, DIABETES CARE, V27, P1605, DOI 10.2337/diacare.27.7.1605; Tseng CH, 2009, OPEN DIABETES J, V2, P18; Tseng CH, 2008, CIRC J, V72, P1419, DOI 10.1253/circj.CJ-08-0009; Tseng CH, 2007, CIRC J, V71, P1749, DOI 10.1253/circj.71.1749; Tseng Chin-Hsiao, 2006, CMAJ, V174, P319, DOI 10.1503/cmaj.050680; Tseng CH, 2006, ARCH INTERN MED, V166, P1184, DOI 10.1001/archinte.166.11.1184; Tseng CH, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1876-7; Tseng CH, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/678756; Tseng CH, 2015, J ENVIRON SCI HEAL C, V33, P67, DOI 10.1080/10590501.2015.1003496; Tseng CH, 2014, J ENVIRON SCI HEAL C, V32, P1, DOI 10.1080/10590501.2014.877645; Tseng CH, 2013, ATHEROSCLEROSIS, V226, P186, DOI 10.1016/j.atherosclerosis.2012.09.004; Tseng CH, 2012, DIABETES CARE, V35, P278, DOI 10.2337/dc11-1449; Tseng CH, 2011, DIABETES CARE, V34, P616, DOI 10.2337/dc10-1640; Tseng CH, 2010, ATHEROSCLEROSIS, V210, P585, DOI 10.1016/j.atherosclerosis.2009.12.015; W.H. Organization, 1999, DEFINITION DIAGNOSIS; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; World Health Organization, 1985, TECHNICAL REPORT SER, V727; XU Y, 2010, JAMA-J AM MED ASSOC, V310, P948, DOI DOI 10.1001/JAMA.2013.168118	39	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0147916	10.1371/journal.pone.0147916	http://dx.doi.org/10.1371/journal.pone.0147916			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27906989	Green Published, Green Submitted, gold			2022-12-26	WOS:000389482700001
J	Zhang, DP; Lu, HY; Zhuang, MH; Wu, GH; Yan, HJ; Xu, J; Wei, XL; Li, CM; Meng, SN; Fu, XJ; Qi, JL; Wang, P; Luo, M; Dai, M; Yip, R; Sun, JP; Wu, ZY				Zhang, Dapeng; Lu, Hongyan; Zhuang, Minghua; Wu, Guohui; Yan, Hongjing; Xu, Jun; Wei, Xiaoli; Li, Chengmei; Meng, Sining; Fu, Xiaojing; Qi, Jinlei; Wang, Peng; Luo, Mei; Dai, Min; Yip, Ray; Sun, Jiangping; Wu, Zunyou			Enhancing HIV Testing and Treatment among Men Who Have Sex with Men in China: A Pilot Model with Two-Rapid Tests, Single Blood Draw Session, and Intensified Case Management in Six Cities in 2013	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; CARE; LINKAGE; TRANSMISSION; PREVENTION; INFECTION; IMPACT; POLICY; NO	Objectives To explore models to improve HIV testing, linkage to care and treatment among men who have sex with men (MSM) in cooperation with community-based organizations (CBOs) in China. Methods We introduced a new model for HIV testing services targeting MSM in six cities in 2013. These models introduced provision of rapid HIV testing by CBO staff and streamlined processes for HIV screening, confirmation of initial reactive screening results, and linkage to care among diagnosed people. We monitored attrition along each step of the continuum of care from screening to treatment and compared program performance between 2012 and 2013. According to the providers of two rapid tests (HIV screening), four different services delivery models were examined in 2013: Model A = first screen at CDC, second at CDC (Model A = CDC+CDC), Model B = first and second screens at CBOs (Model B = CBO + CBO), Model C = first screen at CBO, second at Hospital (Model C = CBO+Hosp), and Model D = first screen at CBO, second at CDC (Model D = CBO+CDC). Logistic regressions were performed to assess advantages of different screening models of case finding and case management. Results Compared to 2012, the number of HIV screening tests performed for MSM increased 35.8% in 2013 (72,577 in 2013 vs. 53,455 in 2012). We observed a 5.6% increase in proportion of cases screened reactive receiving HIV confirmatory tests (93.9% in 2013 vs. 89.2% in 2012, chi(2) = 48.52, p<0.001) and 65% reduction in loss to CD4 cell count tests (15% in 2013 vs. 43% in 2012, chi(2) = 628.85, p<0.001). Regarding linkage to care and treatment, the 2013 pilot showed that the Model D had the highest rate of loss between screening reactive and confirmatory test among the four models, with 18.1% fewer receiving a second screening test and a further 5.9% loss among those receiving HIV confirmatory tests. The Model B and the Model C showed lower losses (0.8% and 1.3%) for newly diagnosed HIV positives receiving CD4 cell count tests, and higher rates of HIV positives referred to designated ART hospitals (88.0% and 93.3%) than the Model A and Model D (4.6% and 5.7% for CD4 cell count test, and 68.9% and 64.4% for referring to designated ART hospitals). The proportion of cases where the screening test was reactive that were commenced on ART was highest in Model C; 52.8% of cases commenced on ART compared to 38.9%, 34.2% and 21.1% in Models A, B and D respectively. Using Model A as a reference group, the multivariate logistic regression results also showed the advantages of Models B, C and D, which increased CD4 cell count test, referral to designated ART hospitals and initiation of ART, when controlling for program city and other factors. Conclusions This study has demonstrated that involvement of CBOs in HIV rapid testing provision, streamlining testing and care procedures and early hospital case management can improve testing, linkage to, and retention in care and treatment among MSM in China.	[Zhang, Dapeng; Li, Chengmei; Meng, Sining; Fu, Xiaojing; Qi, Jinlei; Sun, Jiangping; Wu, Zunyou] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China; [Lu, Hongyan] Beijing Ctr Dis Control & Prevent, Beijing, Peoples R China; [Zhuang, Minghua] Shanghai Municipal Ctr Dis Control & Prevent, Shanghai, Peoples R China; [Wu, Guohui] Chongqing Ctr Dis Control & Prevent, Chongqing, Peoples R China; [Yan, Hongjing] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Xu, Jun] Wuhan Ctr Dis Prevent & Control, Wuhan, Peoples R China; [Wei, Xiaoli] Xian Ctr Dis Control & Prevent, Xian, Peoples R China; [Wang, Peng] Chinese Prevent Med Assoc, Beijing, Peoples R China; [Luo, Mei] Chinese Assoc STD & AIDS Prevent & Control, Beijing, Peoples R China; [Dai, Min; Yip, Ray] Bill & Melinda Gates Fdn China Off, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Shanghai Center for Disease Control & Prevention; Jiangsu Provincial Center for Disease Control & Prevention	Wu, ZY (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China.	wuzy@263.net	DAI, M/GPS-8291-2022		China-Gates Foundation HIV Cooperation Program [Opp 49277]	China-Gates Foundation HIV Cooperation Program	This program was funded by the China-Gates Foundation HIV Cooperation Program (Opp 49277).	Andrews JR, 2012, J INFECT DIS, V206, P543, DOI 10.1093/infdis/jis401; [Anonymous], 2012, CHIN J BOOD TRANSFUS, P702; Bao Z, 2012, CHINA STD AIDS, P371; China Ministry of Health UNAIDS WHO, 2012, CHIN J AIDS STD, V18, P1; Chinese Center for Diseae Control and Prevention, 2009, NAT GUILD DET HIV AI; Clark HA, 2008, PUBLIC HEALTH REP, V123, P86, DOI 10.1177/00333549081230S311; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Fang CT, 2004, J INFECT DIS, V190, P879, DOI 10.1086/422601; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Han J, 2009, CHIN J AIDS STD, V3, P311; Han M., 2011, INT J LAB MED, V32, P1185; Kilmarx PH, 2013, CURR OPIN HIV AIDS, V8, P59, DOI 10.1097/COH.0b013e32835b806e; Li J, 2011, ZHEJING PREVENT MED, V23, P6; Liu Y, 2012, J APPL MATH, DOI 10.1155/2012/391372; Luo ST, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126893; McNairy ML, 2012, AIDS, V26, P1735, DOI 10.1097/QAD.0b013e328355d67b; Millar R, 2016, J HEALTH ORGAN MANAG, V30, P324, DOI 10.1108/JHOM-12-2014-0200; Plate DK, 2007, AIDS RES HUM RETROV, V23, P1491, DOI 10.1089/aid.2007.0020; Qvist T, 2014, SEX TRANSM DIS, V41, P209, DOI 10.1097/OLQ.0000000000000096; Rodger AJ, 2016, JAMA-J AM MED ASSOC, V316, P171, DOI 10.1001/jama.2016.5148; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Rothman RE, 2012, ACAD EMERG MED, V19, P497, DOI 10.1111/j.1553-2712.2012.01351.x; Shrestha RK, 2011, AIDS EDUC PREV, V23, P49, DOI 10.1521/aeap.2011.23.3_supp.49; Sorensen SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029098; Tucker JD, 2012, SEX TRANSM DIS, V39, P182, DOI 10.1097/OLQ.0b013e318237b3b4; Wei CY, 2011, SEX TRANSM INFECT, V87, P225, DOI 10.1136/sti.2010.047407; Wilcox Ronald D, 2012, HIV Clin, V24, P1; World Health Organization, 2015, GUID START ANT THER; World Health Organization, 2015, CONS GUID US ANT DRU; Wu ZY, 2006, SCIENCE, V312, P1475, DOI 10.1126/science.1120682; Wu ZY, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001874; Wynberg E, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18809; Yan HJ, 2014, SEX TRANSM INFECT, V90, P388, DOI 10.1136/sextrans-2013-051397; Zhang D, 2014, AIDS CARE, V31, P31; Zhang D, 2014, INT J STD AIDS, V15; Zhang Da-peng, 2013, Zhonghua Yu Fang Yi Xue Za Zhi, V47, P431; Zhang L, 2012, SEX HEALTH, V9, P261, DOI 10.1071/SH11104; Zou J, 2010, LAB MED CLIC, V7, P93	39	7	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166812	10.1371/journal.pone.0166812	http://dx.doi.org/10.1371/journal.pone.0166812			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27906994	Green Published, gold, Green Submitted			2022-12-26	WOS:000389482700042
J	Agus, DB; Gaudette, E; Goldman, DP; Messali, A				Agus, David B.; Gaudette, Etienne; Goldman, Dana P.; Messali, Andrew			The Long-Term Benefits of Increased Aspirin Use by At-Risk Americans Aged 50 and Older	PLOS ONE			English	Article							ATHEROSCLEROTIC VASCULAR-DISEASE; LOW-DOSE ASPIRIN; CARDIOVASCULAR-DISEASE; SECONDARY PREVENTION; AHA/ACC GUIDELINES; HEART-ASSOCIATION; HEALTH; UPDATE; METAANALYSIS; CORONARY	Background The usefulness of aspirin to defend against cardiovascular disease in both primary and secondary settings is well recognized by the medical profession. Multiple studies also have found that daily aspirin significantly reduces cancer incidence and mortality. Despite these proven health benefits, aspirin use remains low among populations targeted by cardiovascular prevention guidelines. This article seeks to determine the long-term economic and population-health impact of broader use of aspirin by older Americans at higher risk for cardiovascular disease. Methods and Findings We employ the Future Elderly Model, a dynamic microsimulation that follows Americans aged 50 and older, to project their lifetime health and spending under the status quo and in various scenarios of expanded aspirin use. The model is based primarily on data from the Health and Retirement Study, a large, representative, national survey that has been ongoing for more than two decades. Outcomes are chosen to provide a broad perspective of the individual and societal impacts of the interventions and include: heart disease, stroke, cancer, life expectancy, quality-adjusted life expectancy, disability-free life expectancy, and medical costs. Eligibility for increased aspirin use in simulations is based on the 2011-2012 questionnaire on preventive aspirin use of the National Health and Nutrition Examination Survey. These data reveal a large unmet need for daily aspirin, with over 40% of men and 10% of women aged 50 to 79 presenting high cardiovascular risk but not taking aspirin. We estimate that increased use by high-risk older Americans would improve national life expectancy at age 50 by 0.28 years (95% CI 0.08-0.50) and would add 900,000 people (95% CI 300,000- 1,400,000) to the American population by 2036. After valuing the quality-adjusted life-years appropriately, Americans could expect $692 billion (95% CI 345-975) in net health benefits over that period. Conclusions Expanded use of aspirin by older Americans with elevated risk of cardiovascular disease could generate substantial population health benefits over the next twenty years and do so very cost-effectively.	[Agus, David B.] Univ Southern Calif, Keck Sch Med, Lawrence J Ellison Inst Transformat Med, Beverly Hills, CA 90211 USA; [Agus, David B.] Viterbi Sch Engn, Beverly Hills, CA 90089 USA; [Gaudette, Etienne; Goldman, Dana P.] Univ Southern Calif, Price Sch, Schaeffer Ctr Hlth Policy & Econ, Los Angeles, CA USA; [Gaudette, Etienne; Goldman, Dana P.] Sch Pharm, Los Angeles, CA USA; [Messali, Andrew] Anal Grp Inc, Boston, MA USA	University of Southern California; University of Southern California; Analysis Group Inc.	Agus, DB (corresponding author), Univ Southern Calif, Keck Sch Med, Lawrence J Ellison Inst Transformat Med, Beverly Hills, CA 90211 USA.; Agus, DB (corresponding author), Viterbi Sch Engn, Beverly Hills, CA 90089 USA.	agus@usc.edu	Goldman, Dana P/E-7667-2013	Goldman, Dana P/0000-0001-8498-6396; Agus, David B./0000-0002-7499-7822; Gaudette, Etienne/0000-0003-0359-2083	National Institute on Aging [P30AG024968]; Lawrence J. Ellison Institute for Transformative Medicine; Stephenson Family Personalized Medicine Center	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Lawrence J. Ellison Institute for Transformative Medicine; Stephenson Family Personalized Medicine Center	The authors did not receive financial support for conducting this study. The authors are grateful to the National Institute on Aging for its support through the Robal Center for Health Policy Simulation (grant no. P30AG024968) and to the Lawrence J. Ellison Institute for Transformative Medicine and Stephenson Family Personalized Medicine Center. The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health, the Lawrence J. Ellison Institute for Transformative Medicine or the Stephenson Family Personalized Medicine Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg AO, 2002, ANN INTERN MED, V136, P157, DOI 10.7326/0003-4819-136-2-200201150-00015; Berger JS, 2008, AM J MED, V121, P43, DOI 10.1016/j.amjmed.2007.10.002; Berger JS, 2006, JAMA-J AM MED ASSOC, V295, P306, DOI 10.1001/jama.295.3.306; Bibbins-Domingo K, 2016, ANN INTERNAL MED; Calonge N, 2009, ANN INTERN MED, V150, P396; Cuzick J, 2014, ANN ONCOLOGY; Dube C, 2007, ANN INTERN MED, V146, P365, DOI 10.7326/0003-4819-146-5-200703060-00009; Frakt A, 2015, THE UPSHOT; Gaudette Etienne, 2015, Forum Health Econ Policy, V18, P75; Gaudette E, 2015, PHARMACOECONOMICS, V33, P723, DOI 10.1007/s40273-014-0234-y; Goldman DP, 2016, AM J PREV MED, V50, pS45, DOI 10.1016/j.amepre.2015.12.005; Goldman DP, 2013, HEALTH AFFAIR, V32, P1698, DOI 10.1377/hlthaff.2013.0052; Goldman DP, 2004, DTIC DOCUMENT; Health WBCoMa, 2001, MACR HLTH INV HLTH E; Jemal A, 2005, JAMA-J AM MED ASSOC, V294, P1255, DOI 10.1001/jama.294.10.1255; Kaestner R, 2014, J HEALTH ECON, V36, P151, DOI 10.1016/j.jhealeco.2014.04.006; McQuaid KR, 2006, AM J MED, V119, P624, DOI 10.1016/j.amjmed.2005.10.039; Michaud PC, 2012, J HEALTH ECON, V31, P630, DOI 10.1016/j.jhealeco.2012.04.006; Prevention CfDCa, 2015, CHRON DIS PREV HLTH; Seshasai SRK, 2012, ARCH INTERN MED, V172, P209, DOI 10.1001/archinternmed.2011.628; Smith SC, 2001, J AM COLL CARDIOL, V38, P1581, DOI 10.1016/S0735-1097(01)01682-5; Smith SC, 2006, CIRCULATION, V113, P2363, DOI 10.1161/CIRCULATIONAHA.106.174516; Smith SC, 2011, J AM COLL CARDIOL, V58, P2432, DOI 10.1016/j.jacc.2011.10.824; Survey NHaNE, 2013, 2011 2012 DAT DOC CO; Zissimopoulos Julie, 2014, Forum Health Econ Policy, V18, P25	25	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0166103	10.1371/journal.pone.0166103	http://dx.doi.org/10.1371/journal.pone.0166103			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902693	Green Submitted, Green Published, gold			2022-12-26	WOS:000389474100013
J	Dugo, M; Cotroneo, CE; Lavoie-Charland, E; Incarbone, M; Santambrogio, L; Rosso, L; van den Berge, M; Nickle, D; Pare, PD; Bosse, Y; Dragani, TA; Colombo, F				Dugo, Matteo; Cotroneo, Chiara E.; Lavoie-Charland, Emilie; Incarbone, Matteo; Santambrogio, Luigi; Rosso, Lorenzo; van den Berge, Maarten; Nickle, David; Pare, Peter D.; Bosse, Yohan; Dragani, Tommaso A.; Colombo, Francesca			Human Lung Tissue Transcriptome: Influence of Sex and Age	PLOS ONE			English	Article							GENE-EXPRESSION; BLOOD; METAANALYSIS; SIGNATURE; EVOLUTION; PIPELINE; SURVIVAL; REVEALS; PROFILE; COPD	Background Sex and age strongly influence the pathophysiology of human lungs, but scarce information is available about their effects on pulmonary gene expression. Methods We followed a discovery-validation strategy to identify sex-and age-related transcriptional differences in lung. Results We identified transcriptional profiles significantly associated with sex (215 genes; FDR < 0.05) and age at surgery (217 genes) in non-involved lung tissue resected from 284 lung adenocarcinoma patients. When these profiles were tested in three independent series of non-tumor lung tissue from an additional 1,111 patients, we validated the association with sex and age for 25 and 22 genes, respectively. Among the 17 sex-biased genes mapping on chromosome X, 16 have been reported to escape X-chromosome inactivation in other tissues or cells, suggesting that this mechanism influences lung transcription too. Our 22 age-related genes partially overlap with genes modulated by age in other tissues, suggesting that the aging process has similar consequences on gene expression in different organs. Finally, seven genes whose expression was modulated by sex in non-tumor lung tissue, but no age-related gene, were also validated using publicly available data from 990 lung adenocarcinoma samples, suggesting that the physiological regulatory mechanisms are only partially active in neoplastic tissue. Conclusions Gene expression in non-tumor lung tissue is modulated by both sex and age. These findings represent a validated starting point for research on the molecular mechanisms underlying the observed differences in the course of lung diseases among men and women of different ages.	[Dugo, Matteo] Fdn IRCCS Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Milan, Italy; [Cotroneo, Chiara E.; Dragani, Tommaso A.; Colombo, Francesca] Fdn IRCCS Ist Nazl Tumori, Dept Predict & Prevent Med, Milan, Italy; [Lavoie-Charland, Emilie; Bosse, Yohan] Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada; [Incarbone, Matteo] San Giuseppe Hosp MultiMed, Dept Surg, Milan, Italy; [Santambrogio, Luigi; Rosso, Lorenzo] Univ Milan, Fdn IRCCS Osped Maggiore Policlin, Milan, Italy; [van den Berge, Maarten] Univ Groningen, Univ Med Ctr Groningen, Dept Pulmonol, GRIAC, Groningen, Netherlands; [Nickle, David] Merck & Co Inc, Rahway, NJ 07065 USA; [Pare, Peter D.] Univ British Columbia, Ctr Heart Lung Innovat, Vancouver, BC, Canada; [Pare, Peter D.] St Pauls Hosp, Inst Heart & Lung Hlth, Vancouver, BC, Canada; [Pare, Peter D.] Univ British Columbia, Dept Med, Div Resp, Vancouver, BC, Canada; [Bosse, Yohan] Univ Laval, Dept Mol Med, Quebec City, PQ, Canada; [Cotroneo, Chiara E.] Univ Coll Dublin, UCD Sch Biomol & Biomed Sci, Dublin, Ireland	Fondazione IRCCS Istituto Nazionale Tumori Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Groningen; Merck & Company; University of British Columbia; St. Paul's Hospital; University of Saskatchewan; University of British Columbia; Laval University; University College Dublin	Dragani, TA (corresponding author), Fdn IRCCS Ist Nazl Tumori, Dept Predict & Prevent Med, Milan, Italy.	tommaso.dragani@istitutotumori.mi.it	Pare, Peter D/C-7425-2011; Rosso, Lorenzo Paolo/J-6815-2015; Rosso, Lorenzo/O-6063-2017; Santambrogio, Luigi/O-7335-2017; Nickle, David/ABF-2727-2020; Dugo, Matteo/H-6860-2014; Colombo, Francesca/B-4617-2013; Colombo, Francesca/Q-5292-2019	Rosso, Lorenzo Paolo/0000-0002-9809-7140; Rosso, Lorenzo/0000-0002-9809-7140; Santambrogio, Luigi/0000-0002-6192-8190; Dugo, Matteo/0000-0001-9786-2763; Colombo, Francesca/0000-0003-2015-4317; Colombo, Francesca/0000-0003-2015-4317; Cotroneo, Chiara Elisabetta/0000-0001-6648-2987; van den Berge, Maarten/0000-0002-9336-7340	Italian Association for Cancer Research (AIRC) [14714]; Chaire de pneumologie de la Fondation JD Begin de l'Universite Laval; Fondation de l'Institut universitaire de cardiologie et de pneumologie de Quebec; Respiratory Health Network of the FRQS; Canadian Institutes of Health Research [MOP 123369]; Cancer Research Society and Read for the Cure; Fonds de recherche Quebec Sante (FRQS)	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Chaire de pneumologie de la Fondation JD Begin de l'Universite Laval; Fondation de l'Institut universitaire de cardiologie et de pneumologie de Quebec; Respiratory Health Network of the FRQS; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Cancer Research Society and Read for the Cure; Fonds de recherche Quebec Sante (FRQS)	This work was supported by grants from the Italian Association for Cancer Research (AIRC, grant no. 14714). One of the authors (D.N.) has an affiliation to a commercial funder of this research (Merck & Co. Inc.); the funder provided support in the form of salary for the author (D.N.), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section. The funders had no role in the design or conduction of the study, in the collection, analysis or interpretation of the data, or in the preparation, review and approval of the manuscript. The collection of lung samples from Laval University was supported by the Chaire de pneumologie de la Fondation JD Begin de l'Universite Laval, the Fondation de l'Institut universitaire de cardiologie et de pneumologie de Quebec, the Respiratory Health Network of the FRQS, the Canadian Institutes of Health Research (MOP 123369), and the Cancer Research Society and Read for the Cure. Y. Bosse is the recipient of a Junior 2 Research Scholar award from the Fonds de recherche Quebec Sante (FRQS). The authors would like to thank the staff at the Respiratory Health Network Tissue Bank of the FRQS for their valuable assistance.	Assis R, 2012, GENOME BIOL EVOL, V4, P1189, DOI 10.1093/gbe/evs093; Bacalini MG, 2015, AGING-US, V7, P97, DOI 10.18632/aging.100718; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berletch JB, 2011, HUM GENET, V130, P237, DOI 10.1007/s00439-011-1011-z; Bosse Y, 2012, CANCER RES, V72, P3753, DOI 10.1158/0008-5472.CAN-12-1160; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; de Magalhaes JP, 2009, BIOINFORMATICS, V25, P875, DOI 10.1093/bioinformatics/btp073; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Ellegren H, 2007, NAT REV GENET, V8, P689, DOI 10.1038/nrg2167; Galvan A, 2013, CARCINOGENESIS, V34, P2767, DOI 10.1093/carcin/bgt294; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Glass D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r75; Gruber MP, 2006, AM J RESP CELL MOL, V35, P65, DOI 10.1165/rcmb.2004-0261OC; Hao K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003029; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ito K, 2012, INT J CHRONIC OBSTR, V7, P641, DOI 10.2147/COPD.S28250; Jansen R, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-33; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kapetanaki MG, 2013, J PATHOL, V229, P310, DOI 10.1002/path.4122; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Lowery EM, 2013, CLIN INTERV AGING, V8, P1489, DOI 10.2147/CIA.S51152; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Palma DA, 2010, J THORAC ONCOL, V5, P818, DOI 10.1097/JTO.0b013e3181d6e052; Papaioannou AI, 2013, CURR DRUG TARGETS, V14, P149; Renzoni Elisabetta, 2014, F1000Prime Rep, V6, P69, DOI 10.12703/P6-69; Rodwell GEJ, 2004, PLOS BIOL, V2, P2191, DOI 10.1371/journal.pbio.0020427; Sagerup CMT, 2011, THORAX, V66, P301, DOI 10.1136/thx.2010.151621; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Singmann P, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0035-3; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Talebizadeh Z, 2006, GENOMICS, V88, P675, DOI 10.1016/j.ygeno.2006.07.016; Tong BC, 2014, J THORAC CARDIOV SUR, V148, P13, DOI 10.1016/j.jtcvs.2014.03.012; Townsend EA, 2012, ENDOCR REV, V33, P1, DOI 10.1210/er.2010-0031; Xu HQ, 2014, HUM MOL GENET, V23, P1260, DOI 10.1093/hmg/ddt516; Zahn JM, 2006, PLOS GENET, V2, P1058, DOI 10.1371/journal.pgen.0020115	35	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167460	10.1371/journal.pone.0167460	http://dx.doi.org/10.1371/journal.pone.0167460			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902768	Green Published, gold, Green Submitted			2022-12-26	WOS:000389474100082
J	Chenge, JT; Duyet, LV; Swami, S; McLean, KJ; Kavanagh, ME; Coyne, AG; Rigby, SEJ; Cheesman, MR; Girvan, HM; Levy, CW; Rupp, B; von Kries, JP; Abell, C; Leys, D; Munro, AW				Chenge, Jude T.; Le Van Duyet; Swami, Shalini; McLean, Kirsty J.; Kavanagh, Madeline E.; Coyne, Anthony G.; Rigby, Stephen E. J.; Cheesman, Myles R.; Girvan, Hazel M.; Levy, Colin W.; Rupp, Bernd; von Kries, Jens P.; Abell, Chris; Leys, David; Munro, Andrew W.			Structural Characterization and Ligand/Inhibitor Identification Provide Functional Insights into the Mycobacterium tuberculosis Cytochrome P450 CYP126A1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAGNETIC CIRCULAR-DICHROISM; BIOPHYSICAL CHARACTERIZATION; CRYSTAL-STRUCTURE; AZOLE ANTIFUNGALS; PROTEIN COMPLEXES; P450; EXPRESSION; PURIFICATION; AGENTS; INHIBITORS	The Mycobacterium tuberculosis H37Rv genome encodes 20 cytochromes P450, including P450s crucial to infection and bacterial viability. Many M. tuberculosis P450s remain uncharacterized, suggesting that their further analysis may provide new insights into M. tuberculosis metabolic processes and new targets for drug discovery. CYP126A1 is representative of a P450 family widely distributed in mycobacteria and other bacteria. Here we explore the biochemical and structural properties of CYP126A1, including its interactions with new chemical ligands. A survey of azole antifungal drugs showed that CYP126A1 is inhibited strongly by azoles containing an imidazole ring but not by those tested containing a triazole ring. To further explore the molecular preferences of CYP126A1 and search for probes of enzyme function, we conducted a high throughput screen. Compounds containing three or more ring structures dominated the screening hits, including nitroaromatic compounds that induce substrate-like shifts in the heme spectrum of CYP126A1. Spectroelectrochemical measurements revealed a 155-mV increase in heme iron potential when bound to one of the newly identified nitroaromatic drugs. CYP126A1 dimers were observed in crystal structures of ligand-free CYP126A1 and for CYP126A1 bound to compounds discovered in the screen. However, ketoconazole binds in an orientation that disrupts the BC-loop regions at the P450 dimer interface and results in a CYP126A1 monomeric crystal form. Structural data also reveal that nitroaromatic ligands "moonlight" as substrates by displacing the CYP126A1 distal water but inhibit enzyme activity. The relatively polar active site of CYP126A1 distinguishes it from its most closely related sterol-binding P450s in M. tuberculosis, suggesting that further investigations will reveal its diverse substrate selectivity.	[Chenge, Jude T.; Le Van Duyet; Swami, Shalini; McLean, Kirsty J.; Rigby, Stephen E. J.; Girvan, Hazel M.; Levy, Colin W.; Leys, David; Munro, Andrew W.] Univ Manchester, Sch Chem, Manchester Inst Biotechnol, 131 Princess St, Manchester M1 7DN, Lancs, England; [Kavanagh, Madeline E.; Coyne, Anthony G.; Abell, Chris] Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England; [Cheesman, Myles R.] Univ East Anglia, Sch Chem, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England; [Rupp, Bernd; von Kries, Jens P.] Leibniz Inst Mol Pharmacol, Robert Rossle Str 10, D-13125 Berlin, Germany	University of Manchester; University of Cambridge; University of East Anglia; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP)	Munro, AW (corresponding author), Univ Manchester, Sch Chem, Manchester Inst Biotechnol, 131 Princess St, Manchester M1 7DN, Lancs, England.	Andrew.Munro@Manchester.ac.uk	Coyne, Anthony/O-2938-2019; Munro, Andrew/G-5639-2019; McLean, Kirsty J/GXI-2853-2022	Coyne, Anthony/0000-0003-0205-5630; Munro, Andrew/0000-0002-4642-180X; McLean, Kirsty/0000-0002-7193-5044; Rupp, Bernd/0000-0001-9447-9638; Kavanagh, Madeline E./0000-0002-4735-1559; Girvan, Hazel/0000-0003-2299-8644	Biotechnology and Biological Research Council (BBSRC) [BB/I019227/1, BB/I019669/1]; United States Department of Education William D. Ford Program; Vietnamese Government Ph.D. scholarship; National Overseas Ph.D. scholarship from the Ministry of Social Justice and Empowerment, Government of India (New Delhi); Commonwealth (University of Cambridge) Scholarship; Commonwealth Scholarship Commission in the United Kingdom; Cambridge Trusts; Royal Society Wolfson Merit Award; BBSRC [BB/I019669/1, BB/E013007/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E013007/1, BB/I019669/1] Funding Source: researchfish	Biotechnology and Biological Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); United States Department of Education William D. Ford Program; Vietnamese Government Ph.D. scholarship; National Overseas Ph.D. scholarship from the Ministry of Social Justice and Empowerment, Government of India (New Delhi); Commonwealth (University of Cambridge) Scholarship; Commonwealth Scholarship Commission in the United Kingdom; Cambridge Trusts; Royal Society Wolfson Merit Award(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Research Council (BBSRC) Grants BB/I019227/1 (to A. W. M.) and BB/I019669/1 (to C. A.) underpinning this research program and supporting the research of A. J. C. and K. J. M. The authors declare that they have no conflicts of interest with the contents of this article.r Recipient of a Ph.D. studentship supported by funding from the United States Department of Education William D. Ford Program.r Recipient of a Vietnamese Government Ph.D. scholarship.r Recipient of a National Overseas Ph.D. scholarship from the Ministry of Social Justice and Empowerment, Government of India (New Delhi).r Supported by a Commonwealth (University of Cambridge) Scholarship, awarded jointly by the Commonwealth Scholarship Commission in the United Kingdom and the Cambridge Trusts.r Holder of a Royal Society Wolfson Merit Award.	Aguero F, 2008, NAT REV DRUG DISCOV, V7, P900, DOI 10.1038/nrd2684; Ahmad Z, 2006, INT J ANTIMICROB AG, V28, P543, DOI 10.1016/j.ijantimicag.2006.07.028; Ahmad Z, 2006, FEMS MICROBIOL LETT, V261, P181, DOI 10.1111/j.1574-6968.2006.00350.x; Aoyama Y, 1998, J BIOCHEM-TOKYO, V124, P694; Banerjee S, 2012, INT J ANAL CHEM, V2012, DOI 10.1155/2012/282574; Belcher J, 2014, J BIOL CHEM, V289, P6535, DOI 10.1074/jbc.M113.527325; Belin P, 2009, P NATL ACAD SCI USA, V106, P7426, DOI 10.1073/pnas.0812191106; Bellamine A, 1999, P NATL ACAD SCI USA, V96, P8937, DOI 10.1073/pnas.96.16.8937; Bui SH, 2012, J BIOL CHEM, V287, P19699, DOI 10.1074/jbc.M111.319202; Byrne ST, 2007, J MED MICROBIOL, V56, P1047, DOI 10.1099/jmm.0.47058-0; Capyk JK, 2009, J BIOL CHEM, V284, P35534, DOI 10.1074/jbc.M109.072132; Chenge J, 2016, SCI REP-UK, V6, DOI 10.1038/srep26628; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cubrilovic D, 2013, ANAL CHEM, V85, P2724, DOI 10.1021/ac303197p; CUPPVICKERY JR, 1995, NAT STRUCT BIOL, V2, P144, DOI 10.1038/nsb0295-144; Daff SN, 1997, BIOCHEMISTRY-US, V36, P13816, DOI 10.1021/bi971085s; de Souza GA, 2011, J PROTEOMICS, V75, P502, DOI 10.1016/j.jprot.2011.08.016; Driscoll MD, 2010, J BIOL CHEM, V285, P38270, DOI 10.1074/jbc.M110.164293; Driscoll MD, 2011, BBA-PROTEINS PROTEOM, V1814, P76, DOI 10.1016/j.bbapap.2010.05.015; Duffell KM, 2013, ANAL CHEM, V85, P5707, DOI 10.1021/ac400236z; Dutton P L, 1978, Methods Enzymol, V54, P411; Esposito S, 2015, EXPERT OPIN PHARMACO, V16, P2319, DOI 10.1517/14656566.2015.1080240; Etienne G, 2005, MICROBIOL-SGM, V151, P2075, DOI 10.1099/mic.0.27869-0; Fernandez C., 2011, THESIS U NACL MAYOR; Green AJ, 2001, J BIOL INORG CHEM, V6, P523, DOI 10.1007/s007750100229; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; Gustafsson MCU, 2004, BIOCHEMISTRY-US, V43, P5474, DOI 10.1021/bi035904m; Hotsclaw CM, 2008, ACS CHEM BIOL, V3, P619, DOI 10.1021/cb800145r; Hudson SA, 2014, CHEMBIOCHEM, V15, P549, DOI 10.1002/cbic.201300697; Hudson SA, 2013, CHEMMEDCHEM, V8, P1451, DOI 10.1002/cmdc.201300219; Hudson SA, 2012, ANGEW CHEM INT EDIT, V51, P9311, DOI 10.1002/anie.201202544; Johnston JB, 2009, P NATL ACAD SCI USA, V106, P20687, DOI 10.1073/pnas.0907398106; Kavanagh ME, 2016, J MED CHEM, V59, P3272, DOI 10.1021/acs.jmedchem.6b00007; Khatri Y, 2011, FEBS LETT, V585, P1506, DOI 10.1016/j.febslet.2011.04.035; Lawson RJ, 2004, BIOCHEMISTRY-US, V43, P12410, DOI 10.1021/bi049132l; Leys D, 2003, J BIOL CHEM, V278, P5141, DOI 10.1074/jbc.M209928200; LIM HK, 1995, J MASS SPECTROM, V30, P708, DOI 10.1002/jms.1190300509; Lisurek M, 2010, MOL DIVERS, V14, P401, DOI 10.1007/s11030-009-9187-z; Loo JA, 1997, J AM SOC MASS SPECTR, V8, P234, DOI 10.1016/S1044-0305(96)00238-3; Loo JA, 1997, MASS SPECTROM REV, V16, P1; Lorenzen Kristina, 2010, Curr Protoc Protein Sci, VChapter 17, DOI 10.1002/0471140864.ps1712s62; Maple HJ, 2012, J MED CHEM, V55, P837, DOI 10.1021/jm201347k; Matsumoto M, 2007, CURR TOP MED CHEM, V7, P499, DOI 10.2174/156802607780059727; Mawuenyega KG, 2005, MOL BIOL CELL, V16, P396, DOI 10.1091/mbc.e04-04-0329; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; MCKNIGHT J, 1993, EUR J BIOCHEM, V213, P683, DOI 10.1111/j.1432-1033.1993.tb17808.x; McLean KJ, 2008, DRUG METAB REV, V40, P427, DOI 10.1080/03602530802186389 ; McLean KJ, 2006, BIOCHEMISTRY-US, V45, P8427, DOI 10.1021/bi0601609; McLean KJ, 2009, J BIOL CHEM, V284, P35524, DOI 10.1074/jbc.M109.032706; McLean KJ, 2008, J BIOL CHEM, V283, P33406, DOI 10.1074/jbc.M802115200; McLean KJ, 2002, MICROBIOL-SGM, V148, P2937, DOI 10.1099/00221287-148-10-2937; McLean KJ, 2002, J INORG BIOCHEM, V91, P527, DOI 10.1016/S0162-0134(02)00479-8; Milano A, 2009, TUBERCULOSIS, V89, P84, DOI 10.1016/j.tube.2008.08.003; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; Mukherjee P, 2014, CHEM SOC REV, V43, P6814, DOI 10.1039/c3cs60467e; Munro AW, 2002, TRENDS BIOCHEM SCI, V27, P250, DOI 10.1016/S0968-0004(02)02086-8; Munro AW, 2001, BIOCHEMISTRY-US, V40, P1956, DOI 10.1021/bi001718u; Nelson David R., 2009, Human Genomics, V4, P59; Ogura H, 2004, BIOCHEMISTRY-US, V43, P14712, DOI 10.1021/bi048980d; Ouellet H, 2008, J BIOL CHEM, V283, P5069, DOI 10.1074/jbc.M708734200; Ouellet H, 2010, ARCH BIOCHEM BIOPHYS, V493, P82, DOI 10.1016/j.abb.2009.07.011; Podust LM, 2001, P NATL ACAD SCI USA, V98, P3068, DOI 10.1073/pnas.061562898; Seward HE, 2006, J BIOL CHEM, V281, P39437, DOI 10.1074/jbc.M607665200; Shenoi S, 2009, ANNU REV MED, V60, P307, DOI 10.1146/annurev.med.60.053107.103955; SIMPKIN D, 1989, BIOCHEMISTRY-US, V28, P8033, DOI 10.1021/bi00446a010; SLIGAR SG, 1976, BIOCHEMISTRY-US, V15, P5399, DOI 10.1021/bi00669a029; Sterling HJ, 2011, J AM SOC MASS SPECTR, V22, P1178, DOI 10.1007/s13361-011-0116-x; Tjernberg A, 2006, J BIOMOL SCREEN, V11, P131, DOI 10.1177/1087057105284218; Van der Geize R, 2007, P NATL ACAD SCI USA, V104, P1947, DOI 10.1073/pnas.0605728104; Warman AJ, 2012, FEBS J, V279, P1675, DOI 10.1111/j.1742-4658.2012.08543.x; WEBER C, 1987, P NATL ACAD SCI USA, V84, P6687, DOI 10.1073/pnas.84.19.6687; World Health Organization, 2015, GLOB TUB REP 2015; Zhu J, 2010, J MOL BIOL, V397, P835, DOI 10.1016/j.jmb.2010.01.041	73	11	11	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2017	292	4					1310	1329		10.1074/jbc.M116.748822	http://dx.doi.org/10.1074/jbc.M116.748822			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ6OX	27932461	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000393339800014
J	Gottier, P; Gonzalez-Salgado, A; Menon, AK; Liu, YC; Acosta-Serrano, A; Butikofer, P				Gottier, Petra; Gonzalez-Salgado, Amaia; Menon, Anant K.; Liu, Yuk-Chien; Acosta-Serrano, Alvaro; Butikofer, Peter			RFT1 Protein Affects Glycosylphosphatidylinositol (GPI) Anchor Glycosylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VARIANT SURFACE GLYCOPROTEIN; TRYPANOSOMA-BRUCEI OLIGOSACCHARYLTRANSFERASES; ACIDIC REPETITIVE PROTEIN; MEMBRANE; BIOSYNTHESIS; EXPRESSION; PROCYCLIN; IDENTIFICATION; PATHWAY; GLYCAN	The membrane protein RFT1 is essential for normal protein N- glycosylation, but its precise function is not known. RFT1 was originally proposed to translocate the glycolipid Man(5)GlcNAc(2)-PP-dolichol (needed to synthesize N-glycan precursors) across the endoplasmic reticulum membrane, but subsequent studies showed that it does not play a direct role in transport. In contrast to the situation in yeast, RFT1 is not essential for growth of the parasitic protozoan Trypanosoma brucei, enabling the study of its function in a null background. We now report that lack of T. brucei RFT1 (TbRFT1) not only affects protein N-glycosylation but also glycosylphosphatidylinositol (GPI) anchor side-chain modification. Analysis by immunoblotting, metabolic labeling, and mass spectrometry demonstrated that the major GPI-anchored proteins of T. brucei procyclic forms have truncated GPI anchor side chains in TbRFT1 null parasites when compared with wild-type cells, a defect that is corrected by expressing a tagged copy of TbRFT1 in the null background. In vivo and in vitro labeling experiments using radiolabeled GPI precursors showed that GPI underglycosylation was not the result of decreased formation of the GPI precursor lipid or defective galactosylation of GPI intermediates in the endoplasmic reticulum, but rather due to modifications that are expected to occur in the Golgi apparatus. Unexpectedly, immunofluorescence microscopy localized TbRFT1 to both the endoplasmic reticulum and the Golgi, consistent with the proposal that TbRFT1 plays a direct or indirect role in GPI anchor glycosylation in the Golgi apparatus. Our results implicate RFT1 in a wider range of glycosylation processes than previously appreciated.	[Gottier, Petra; Gonzalez-Salgado, Amaia; Butikofer, Peter] Univ Bern, Inst Biochem & Mol Med, CH-3012 Bern, Switzerland; [Gottier, Petra] Univ Bern, Grad Sch Cellular & Biochem Sci, CH-3012 Bern, Switzerland; [Menon, Anant K.] Weill Cornell Med Coll, Dept Biochem, New York, NY 10065 USA; [Liu, Yuk-Chien; Acosta-Serrano, Alvaro] Univ Liverpool Liverpool Sch Trop Med, Dept Parasitol, Liverpool L3 5QA, Merseyside, England; [Acosta-Serrano, Alvaro] Univ Liverpool Liverpool Sch Trop Med, Dept Vector Biol, Liverpool L3 5QA, Merseyside, England	University of Bern; University of Bern; Cornell University; Liverpool School of Tropical Medicine; Liverpool School of Tropical Medicine	Butikofer, P (corresponding author), Inst Biochem & Mol Med, Buhlstr 28, CH-3012 Bern, Switzerland.	peter.buetikofer@ibmm.unibe.ch	Acosta-Serrano, Alvaro/L-5503-2015; Menon, Anant/AAN-8663-2021	Acosta-Serrano, Alvaro/0000-0002-2576-7959; Menon, Anant/0000-0001-6924-2698	Swiss National Science Foundation [CRSII3_141913, 149353]; National Institutes of Health [R21NS093457]; GlycoPar-EU FP7 Marie Curie Initial Training Network Grant [GA. 608295]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS093457] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GlycoPar-EU FP7 Marie Curie Initial Training Network Grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by Swiss National Science Foundation Grants Sinergia CRSII3_141913 and 149353 (to P. B.), National Institutes of Health Grant R21NS093457 (to A. K. M.), and GlycoPar-EU FP7 Marie Curie Initial Training Network Grant GA. 608295 (to A. A. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acosta-Serrano A, 2004, EUKARYOT CELL, V3, P255, DOI 10.1128/EC.3.2.255-263.2004; Acosta-Serrano A, 1999, J BIOL CHEM, V274, P29763, DOI 10.1074/jbc.274.42.29763; Acosta-Serrano A, 2001, P NATL ACAD SCI USA, V98, P1513, DOI 10.1073/pnas.041611698; ALLEN G, 1982, J MOL BIOL, V157, P527, DOI 10.1016/0022-2836(82)90474-0; BLUM B, 1990, CELL, V60, P189, DOI 10.1016/0092-8674(90)90735-W; Butikofer P, 1997, BIOCHEM J, V326, P415; Butikofer P, 1999, J CELL SCI, V112, P1785; CLAYTON CE, 1989, J BIOL CHEM, V264, P15088; CROSS GAM, 1977, AM J TROP MED HYG, V26, P240, DOI 10.4269/ajtmh.1977.26.240; Farine L, 2015, SCI REP-UK, V5, DOI 10.1038/srep16787; Ferguson M. A. J., 1993, GLYCOBIOLOGY, P349; FERGUSON MAJ, 1985, J BIOL CHEM, V260, P4547; Ferguson MAJ, 1999, J CELL SCI, V112, P2799; FERGUSON MAJ, 1993, BIOCHEM J, V291, P51, DOI 10.1042/bj2910051; FERGUSON MAJ, 1988, SCIENCE, V239, P753, DOI 10.1126/science.3340856; FIELD MC, 1991, EMBO J, V10, P2731, DOI 10.1002/j.1460-2075.1991.tb07821.x; FIELD MC, 1991, J BIOL CHEM, V266, P8392; Frank CG, 2008, NATURE, V454, pE3, DOI 10.1038/nature07165; Furger A, 1997, MOL CELL BIOL, V17, P4372, DOI 10.1128/MCB.17.8.4372; Haeuptle MA, 2008, AM J HUM GENET, V82, P600, DOI 10.1016/j.ajhg.2007.12.021; Hall BS, 2005, EXP PARASITOL, V111, P160, DOI 10.1016/j.exppara.2005.07.005; He CY, 2004, J CELL BIOL, V165, P313, DOI 10.1083/jcb.200311076; Helenius J, 2002, NATURE, V415, P447, DOI 10.1038/415447a; Hong Y, 2009, KOREAN J PARASITOL, V47, P197, DOI 10.3347/kjp.2009.47.3.197; Hwa KY, 1999, GLYCOBIOLOGY, V9, P181, DOI 10.1093/glycob/9.2.181; Izquierdo L, 2009, MOL MICROBIOL, V71, P478, DOI 10.1111/j.1365-2958.2008.06542.x; Izquierdo L, 2015, GLYCOBIOLOGY, V25, P438, DOI 10.1093/glycob/cwu131; Izquierdo L, 2012, GLYCOBIOLOGY, V22, P696, DOI 10.1093/glycob/cws003; Izquierdo L, 2009, EMBO J, V28, P2650, DOI 10.1038/emboj.2009.203; Jelk J, 2013, J BIOL CHEM, V288, P20616, DOI 10.1074/jbc.M113.479642; KOERTE A, 1995, J BIOL CHEM, V270, P22556, DOI 10.1074/jbc.270.38.22556; Lahiri S, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001969; Leal S, 2004, J BIOL CHEM, V279, P28979, DOI 10.1074/jbc.M403479200; Liu L, 2013, J BIOL CHEM, V288, P10599, DOI 10.1074/jbc.M113.453597; Manthri S, 2008, GLYCOBIOLOGY, V18, P367, DOI 10.1093/glycob/cwn014; Martin KL, 2006, BIOCHEM J, V396, P287, DOI 10.1042/BJ20051825; MASTERSON WJ, 1989, CELL, V56, P793, DOI 10.1016/0092-8674(89)90684-3; MAYOR S, 1992, J BIOL CHEM, V267, P754; MBAWA ZR, 1992, EUR J BIOCHEM, V204, P371, DOI 10.1111/j.1432-1033.1992.tb16646.x; MOWATT MR, 1988, MOL CELL BIOL, V8, P4055, DOI 10.1128/MCB.8.10.4055; Nakanishi M, 2014, PARASITOL INT, V63, P513, DOI 10.1016/j.parint.2014.01.007; Orlean P, 2007, J LIPID RES, V48, P993, DOI 10.1194/jlr.R700002-JLR200; RODITI I, 1987, NATURE, V325, P272, DOI 10.1038/325272a0; RODITI I, 1989, J CELL BIOL, V108, P737, DOI 10.1083/jcb.108.2.737; Rush JS, 2009, J BIOL CHEM, V284, P19835, DOI 10.1074/jbc.M109.000893; Sanyal S, 2008, BIOCHEMISTRY-US, V47, P7937, DOI 10.1021/bi800723n; Sanyat S, 2009, ACS CHEM BIOL, V4, P895, DOI 10.1021/cb900163d; SUTTON RE, 1986, CELL, V47, P527, DOI 10.1016/0092-8674(86)90617-3; Vassella E, 2000, GENE DEV, V14, P615	49	7	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2017	292	3					1103	1111		10.1074/jbc.M116.758367	http://dx.doi.org/10.1074/jbc.M116.758367			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2LL	27927990	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000392318700029
J	Najjar, K; Erazo-Oliveras, A; Brock, DJ; Wang, TY; Pellois, JP				Najjar, Kristina; Erazo-Oliveras, Alfredo; Brock, Dakota J.; Wang, Ting-Yi; Pellois, Jean-Philippe			An L- to D-Amino Acid Conversion in an Endosomolytic Analog of the Cell- penetrating Peptide TAT Influences Proteolytic Stability, Endocytic Uptake, and Endosomal Escape	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO; INTRACELLULAR DELIVERY; LIVE CELLS; PROTEINS; MEMBRANE; RICH; MACROPINOCYTOSIS; INTERNALIZATION; PROTEOGLYCANS; BIOGENESIS	Cell-penetrating peptides (CPPs) are well established as delivery agents for otherwise cell-impermeable cargos. CPPs can also theoretically be used to modulate intracellular processes. However, their susceptibility to proteolytic degradation often limits their utility in these applications. Previous studies have explored the consequences for cellular uptake of converting the residues in CPPs from L-to D-stereochemistry, but conflicting results have been reported and specific steps en route to intracellular activity have not been explored. Here we use dimeric fluorescenceTATas a model CPP to explore the broader consequences of L-to D-stereochemical conversion. We show that inversion of chirality provides protease resistance without altering the overall mode of cellular entry, a process involving endocytic uptake followed by endosomal escape and cytosolic access. However, whereas inversion of chirality reduces endocytic uptake, the D-peptide, once in the endosome, is significantly more prone to escape than its L-counterpart. Moreover, the D-peptide is retained in the cytosol of cells for several days, whereas the L-peptide is degraded within hours. Notably, while the L-peptide is relatively innocuous to cells, the D-peptide exerts a prolonged antiproliferative activity. Together, our results establish connections between chirality, protease resistance, cellular penetration, and intracellular activity that may be useful for the development of future delivery agents with improved properties.	[Najjar, Kristina; Erazo-Oliveras, Alfredo; Brock, Dakota J.; Wang, Ting-Yi; Pellois, Jean-Philippe] Texas A&M Univ, Dept Biochem & Biophys, Biochem & Biophys Bldg,Rm 430,300 Olsen Blvd, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Pellois, JP (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, Biochem & Biophys Bldg,Rm 430,300 Olsen Blvd, College Stn, TX 77843 USA.; Pellois, JP (corresponding author), Texas A&M Univ, Dept Chem, Biochem & Biophys Bldg,Rm 430,300 Olsen Blvd, College Stn, TX 77843 USA.	pellois@tamu.edu		Pellois, Jean-Philippe/0000-0001-8528-4652; Brock, Dakota/0000-0002-7115-6876; Wang, Ting-Yi/0000-0001-5536-925X	National Institutes of Health [R01GM110137]; Cancer Prevention and Research Institute of Texas [RP100819]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110137] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This article was supported by National Institutes of Health Grant R01GM110137 and Cancer Prevention and Research Institute of Texas Grant RP100819. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bechara C, 2013, FEBS LETT, V587, P1693, DOI 10.1016/j.febslet.2013.04.031; BRUGIDOU J, 1995, BIOCHEM BIOPH RES CO, V214, P685, DOI 10.1006/bbrc.1995.2340; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Colpitts TM, 2007, VIROLOGY, V369, P78, DOI 10.1016/j.virol.2007.07.012; Derossi D, 1996, J BIOL CHEM, V271, P18188, DOI 10.1074/jbc.271.30.18188; Duchardt F, 2007, TRAFFIC, V8, P848, DOI 10.1111/j.1600-0854.2007.00572.x; Elmquist A, 2003, BIOL CHEM, V384, P387, DOI 10.1515/BC.2003.044; Erazo-Oliveras A, 2016, CELL CHEM BIOL, V23, P598, DOI 10.1016/j.chembiol.2016.03.016; Erazo-Oliveras A, 2014, NAT METHODS, V11, P861, DOI [10.1038/NMETH.2998, 10.1038/nmeth.2998]; Erazo-Oliveras A, 2012, PHARMACEUTICALS-BASE, V5, P1177, DOI 10.3390/ph5111177; Fretz MM, 2007, BIOCHEM J, V403, P335, DOI 10.1042/BJ20061808; Gupta B, 2005, ADV DRUG DELIVER REV, V57, P637, DOI 10.1016/j.addr.2004.10.007; Jiang T, 2004, P NATL ACAD SCI USA, V101, P17867, DOI 10.1073/pnas.0408191101; Kobayashi T, 1999, NAT CELL BIOL, V1, P113, DOI 10.1038/10084; Kobayashi T, 1998, NATURE, V392, P193, DOI 10.1038/32440; Kobayashi T, 2001, BIOL CHEM, V382, P483, DOI 10.1515/BC.2001.059; Krosl J, 2003, NAT MED, V9, P1428, DOI 10.1038/nm951; Lee YJ, 2008, J AM CHEM SOC, V130, P2398, DOI 10.1021/ja7102026; Lindgren ME, 2004, BIOCHEM J, V377, P69, DOI 10.1042/BJ20030760; Madani Fatemeh, 2011, J Biophys, V2011, P414729, DOI 10.1155/2011/414729; Mitchell DJ, 2000, J PEPT RES, V56, P318, DOI 10.1034/j.1399-3011.2000.00723.x; Morris MC, 2001, NAT BIOTECHNOL, V19, P1173, DOI 10.1038/nbt1201-1173; Mueller J, 2008, BIOCONJUGATE CHEM, V19, P2363, DOI 10.1021/bc800194e; Munyendo WL, 2012, BIOMOLECULES, V2, P187, DOI 10.3390/biom2020187; Nakase I, 2007, BIOCHEMISTRY-US, V46, P492, DOI 10.1021/bi0612824; Olson ES, 2009, INTEGR BIOL-UK, V1, P382, DOI 10.1039/b904890a; Palm C, 2007, BBA-BIOMEMBRANES, V1768, P1769, DOI 10.1016/j.bbamem.2007.03.029; Pan CY, 2010, MOL BIOL REP, V37, P2117, DOI 10.1007/s11033-009-9680-6; Peitz M, 2002, P NATL ACAD SCI USA, V99, P4489, DOI 10.1073/pnas.032068699; Piper RC, 2007, ANNU REV CELL DEV BI, V23, P519, DOI 10.1146/annurev.cellbio.23.090506.123319; Poon GMK, 2007, BIOCHEM SOC T, V35, P788, DOI 10.1042/BST0350788; Pujals S, 2007, BIOCHEM SOC T, V35, P794, DOI 10.1042/BST0350794; Pujals S, 2008, CHEMMEDCHEM, V3, P296, DOI 10.1002/cmdc.200700267; Rizzuti M, 2015, DRUG DISCOV TODAY, V20, P76, DOI 10.1016/j.drudis.2014.09.017; Stewart MP, 2016, NATURE, V538, P183, DOI 10.1038/nature19764; TAMAI M, 1986, J PHARMACOBIO-DYNAM, V9, P672, DOI 10.1248/bpb1978.9.672; Tuunnemann G, 2008, J PEPT SCI, V14, P469, DOI 10.1002/psc.968; Verdurmen WPR, 2011, CHEM BIOL, V18, P1000, DOI 10.1016/j.chembiol.2011.06.006; VIDARD L, 1991, J IMMUNOL, V147, P1786; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; Wender PA, 2000, P NATL ACAD SCI USA, V97, P13003, DOI 10.1073/pnas.97.24.13003; Youngblood DS, 2007, BIOCONJUGATE CHEM, V18, P50, DOI 10.1021/bc060138s; Zorko M, 2005, ADV DRUG DELIVER REV, V57, P529, DOI 10.1016/j.addr.2004.10.010	44	48	48	2	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2017	292	3					847	861		10.1074/jbc.M116.759837	http://dx.doi.org/10.1074/jbc.M116.759837			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2LL	27923812	Green Published, hybrid			2022-12-26	WOS:000392318700008
J	Harun-Or-Rashid, M; Konjusha, D; Galindo-Romero, C; Hallbook, F				Harun-Or-Rashid, Mohammad; Konjusha, Dardan; Galindo-Romero, Caridad; Hallbook, Finn			Endothelin B Receptors on Primary Chicken Muller Cells and the Human MIO-M1 Muller Cell Line Activate ERK Signaling via Transactivation of Epidermal Growth Factor Receptors	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; SMOOTH-MUSCLE-CELLS; PRIMARY OPEN-ANGLE; EGF RECEPTOR; KINASE ACTIVATION; RETINAL NEURONS; RAS ACTIVATION; AQUEOUS-HUMOR; ETB-RECEPTOR; NITRIC-OXIDE	Injury to the eye or retina triggers Muller cells, the major glia cell of the retina, to dedifferentiate and proliferate. In some species they attain retinal progenitor properties and have the capacity to generate new neurons. The epidermal growth factor receptor (EGFR) system and extracellular signal-regulated kinase (ERK) signaling are key regulators of these processes in Muller cells. The extracellular signals that modulate and control these processes are not fully understood. In this work we studied whether endothelin receptor signaling can activate EGFR and ERK signaling in Muller cells. Endothelin expression is robustly upregulated at retinal injury and endothelin receptors have been shown to transactivate EGFRs in other cell types. We analyzed the endothelin signaling system in chicken retina and cultured primary chicken Muller cells as well as the human Muller cell line MIO-M1. The Muller cells were stimulated with receptor agonists and treated with specific blockers to key enzymes in the signaling pathway or with siRNAs. We focused on endothelin receptor mediated transactivation of EGFRs by using western blot analysis, quantitative reverse transcriptase PCR and immunocytochemistry. The results showed that chicken Muller cells and the human Muller cell line MIO-M1 express endothelin receptor B. Stimulation by the endothelin receptor B agonist IRL1620 triggered phosphorylation of ERK1/2 and autophosphorylation of (Y1173) EGFR. The effects could be blocked by Src-kinase inhibitors (PP1, PP2), EGFR-inhibitor (AG1478), EGFR-siRNA and by inhibitors to extracellular matrix metalloproteinases (GM6001), consistent with a Src-kinase mediated endothelin receptor response that engage ligand-dependent and ligand-independent EGFR activation. Our data suggest a mechanism for how injury-induced endothelins, produced in the retina, may modulate the Muller cell responses by Src-mediated transactivation of EGFRs. The data give support to a view in which endothelins among several other functions, serve as an injury-signal that regulate the gliotic response of Muller cells.	[Harun-Or-Rashid, Mohammad; Konjusha, Dardan; Galindo-Romero, Caridad; Hallbook, Finn] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Galindo-Romero, Caridad] Univ Murcia, Fac Med, Dept Oftalmol, Murcia, Spain; [Galindo-Romero, Caridad] Inst Murciano Invest Biosanitaria Virgen Arrixaca, Murcia, Spain	Uppsala University; University of Murcia; Hospital Clinico Universitario Virgen de la Arrixaca	Hallbook, F (corresponding author), Uppsala Univ, Dept Neurosci, Uppsala, Sweden.	Finn.Hallbook@neuro.uu.se	GALINDO-ROMERO, CARIDAD/AAF-8324-2021	GALINDO-ROMERO, CARIDAD/0000-0001-9469-9868; Hallbook, Finn/0000-0001-7552-187X	Swedish Research Council [M 12187]; Ogonfonden, FH; Stiftelsen Kronprinsessan Margaretas Arbetsnamnd for synskadade [34:2015]; FPU-UM Universidad de Murcia Spain [R-480/2014]; Red Tem'atica de Investigaci'on Cooperativa en Salud (RETICS) [RD12/0034/0014]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Ogonfonden, FH; Stiftelsen Kronprinsessan Margaretas Arbetsnamnd for synskadade; FPU-UM Universidad de Murcia Spain; Red Tem'atica de Investigaci'on Cooperativa en Salud (RETICS)(European Commission)	This work was supported by the Swedish Research Council M 12187, FH; Ogonfonden, FH; Stiftelsen Kronprinsessan Margaretas Arbetsnamnd for synskadade 34:2015, FH; FPU-UM Universidad de Murcia Spain R-480/2014, CGR; Red Tem'atica de Investigaci'on Cooperativa en Salud (RETICS) RD12/0034/0014, CGR.	BAYNASH AG, 1994, CELL, V79, P1277, DOI 10.1016/0092-8674(94)90018-3; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; Boije H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050890; BOULTON TG, 1991, CELL REGUL, V2, P357, DOI 10.1091/mbc.2.5.357; Bramall AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058023; Braunger BM, 2013, NEUROBIOL DIS, V50, P1, DOI 10.1016/j.nbd.2012.09.008; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Chen HY, 2013, J GLAUCOMA, V22, P117, DOI 10.1097/IJG.0b013e31822e8c65; Choritz L, 2012, INVEST OPHTH VIS SCI, V53, P7336, DOI 10.1167/iovs.12-10216; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; Du T, 2009, NEUROCHEM INT, V55, P593, DOI 10.1016/j.neuint.2009.05.016; Fischer AJ, 2009, GLIA, V57, P1538, DOI 10.1002/glia.20868; Fischer AJ, 2009, GLIA, V57, P166, DOI 10.1002/glia.20743; Gadea A, 2008, J NEUROSCI, V28, P2394, DOI 10.1523/JNEUROSCI.5652-07.2008; Grantcharova E, 2006, ARTERIOSCL THROM VAS, V26, P1288, DOI 10.1161/01.ATV.0000220377.51354.30; Gutwein P, 2000, J BIOL CHEM, V275, P15490, DOI 10.1074/jbc.275.20.15490; HAEFLIGER IO, 1992, INVEST OPHTH VIS SCI, V33, P2340; Han YC, 1996, CANCER RES, V56, P3859; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Harun-Or-Rashid M, 2015, INVEST OPHTH VIS SCI, V56, P5933, DOI 10.1167/iovs.15-16816; Harun-Or-Rashid M, 2014, INVEST OPHTH VIS SCI, V55, P3385, DOI 10.1167/iovs.13-13823; HAWES BE, 1995, J BIOL CHEM, V270, P17148, DOI 10.1074/jbc.270.29.17148; He SQ, 2015, INVEST OPHTH VIS SCI, V56, P6144, DOI 10.1167/iovs.15-16569; INOUE A, 1989, P NATL ACAD SCI USA, V86, P2863, DOI 10.1073/pnas.86.8.2863; ISHIKAWA K, 1994, P NATL ACAD SCI USA, V91, P4892, DOI 10.1073/pnas.91.11.4892; Joly S, 2008, J NEUROSCI, V28, P13765, DOI 10.1523/JNEUROSCI.5114-08.2008; Ka S, 2013, PHYSIOL GENOMICS, V45, P367, DOI 10.1152/physiolgenomics.00078.2012; Karkoulias G, 2006, CELL SIGNAL, V18, P729, DOI 10.1016/j.cellsig.2005.06.014; Kim H, 2005, ONCOGENE, V24, P7599, DOI 10.1038/sj.onc.1208898; Krishnamoorthy RR, 2008, CAN J PHYSIOL PHARM, V86, P380, DOI 10.1139/Y08-040; Lahav R, 1996, P NATL ACAD SCI USA, V93, P3892, DOI 10.1073/pnas.93.9.3892; Lawrence JM, 2007, STEM CELLS, V25, P2033, DOI 10.1634/stemcells.2006-0724; Lecoin L, 1998, P NATL ACAD SCI USA, V95, P3024, DOI 10.1073/pnas.95.6.3024; Li YA, 2010, AM J PHYSIOL-HEART C, V299, pH1959, DOI 10.1152/ajpheart.00526.2010; Limb GA, 2002, INVEST OPHTH VIS SCI, V43, P864; Ling L, 2013, BRIT J PHARMACOL, V168, P283, DOI 10.1111/j.1476-5381.2011.01786.x; Linser PJ, 1997, DEV GENET, V20, P186; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luttrell LM, 1997, J BIOL CHEM, V272, P4637, DOI 10.1074/jbc.272.7.4637; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Mi XS, 2012, INVEST OPHTH VIS SCI, V53, P4842, DOI 10.1167/iovs.12-9999; Nakazawa T, 2008, J NEUROSCI RES, V86, P136, DOI 10.1002/jnr.21472; Ochrietor JD, 2010, MOL VIS, V16, P961; Oku H, 2008, EXP EYE RES, V86, P118, DOI 10.1016/j.exer.2007.10.001; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Rattner A, 2005, J NEUROSCI, V25, P4540, DOI 10.1523/JNEUROSCI.0492-05.2005; Rogers SD, 1997, EXP NEUROL, V145, P180, DOI 10.1006/exnr.1997.6468; Rojas M, 1996, J BIOL CHEM, V271, P27456, DOI 10.1074/jbc.271.44.27456; SAKURAI T, 1990, NATURE, V348, P732, DOI 10.1038/348732a0; Santiskulvong C, 2003, EXP CELL RES, V290, P437, DOI 10.1016/S0014-4827(03)00355-0; Sarthy VP, 2015, CURR EYE RES, P1; Schinelli S, 2001, J NEUROSCI, V21, P8842, DOI 10.1523/JNEUROSCI.21-22-08842.2001; TAKAI M, 1992, BIOCHEM BIOPH RES CO, V184, P953, DOI 10.1016/0006-291X(92)90683-C; TAKIGAWA M, 1995, EUR J BIOCHEM, V228, P102, DOI 10.1111/j.1432-1033.1995.0102o.x; Tezel G, 1997, J GLAUCOMA, V6, P83; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wan J, 2012, DEV CELL, V22, P334, DOI 10.1016/j.devcel.2011.11.020; Zhang YZ, 2000, J NEUROSCI, V20, P5671, DOI 10.1523/JNEUROSCI.20-15-05671.2000	58	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167778	10.1371/journal.pone.0167778	http://dx.doi.org/10.1371/journal.pone.0167778			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930693	Green Published, gold			2022-12-26	WOS:000389580900045
J	Wren, JLK; Kobayashi, DR; Jia, Y; Toonen, RJ				Wren, Johanna L. K.; Kobayashi, Donald R.; Jia, Yanli; Toonen, Robert J.			Modeled Population Connectivity across the Hawaiian Archipelago	PLOS ONE			English	Article							CORAL-REEF FISH; CALIFORNIA CURRENT SYSTEM; MARINE POPULATIONS; LARVAL DISPERSAL; GENETIC-STRUCTURE; BUILDING CORAL; JOHNSTON ATOLL; OCEAN CURRENTS; F-STATISTICS; IN-SITU	We present the first comprehensive estimate of connectivity of passive pelagic particles released from coral reef habitat throughout the Hawaiian Archipelago. Potential connectivity is calculated using a Lagrangian particle transport model coupled offline with currents generated by an oceanographic circulation model, MITgcm. The connectivity matrices show a surprising degree of self-recruitment and directional dispersal towards the northwest, from the Main Hawaiian Islands (MHI) to the northwestern Hawaiian Islands (NWHI). We identify three predicted connectivity breaks in the archipelago, that is, areas in the mid and northern part of the archipelago that have limited connections with surrounding islands and reefs. Predicted regions of limited connectivity generally match observed patterns of genetic structure reported for coral reef species in the uninhabited NWHI, but multiple genetic breaks observed in the inhabited MHI are not explained by passive dispersal. The better congruence in our modeling results based on physical transport of passive particles in the low-lying atolls of the uninhabited NWHI, but not in the anthropogenically impacted high islands of the MHI begs the question: what ultimately controls connectivity in this system?	[Wren, Johanna L. K.] Univ Hawaii Manoa, Joint Inst Marine & Atmospher Res, Honolulu, HI 96822 USA; [Wren, Johanna L. K.; Toonen, Robert J.] Univ Hawaii Manoa, Sch Ocean & Earth Sci & Technol, Hawaii Inst Marine Biol, Honolulu, HI 96822 USA; [Kobayashi, Donald R.] NOAA, Ecosyst & Oceanog Program, Pacific Isl Fisheries Sci Ctr, Honolulu, HI USA; [Jia, Yanli] Univ Hawaii Manoa, Int Pacific Res Ctr, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; National Oceanic Atmospheric Admin (NOAA) - USA; University of Hawaii System; University of Hawaii Manoa	Wren, JLK (corresponding author), Univ Hawaii Manoa, Joint Inst Marine & Atmospher Res, Honolulu, HI 96822 USA.; Wren, JLK (corresponding author), Univ Hawaii Manoa, Sch Ocean & Earth Sci & Technol, Hawaii Inst Marine Biol, Honolulu, HI 96822 USA.	jwren@hawaii.edu	Toonen, Rob/V-6230-2019	Toonen, Rob/0000-0001-6339-4340; Kobayashi, Donald/0000-0002-1582-1544; Wren, Johanna/0000-0002-5014-8105	NSF [OCE12-60169]; National Oceanic and Atmospheric Administration [R/SS-13]; University of Hawaii Sea Grant College Program, SOEST, under NOAA Office of Sea Grant, Department of Commerce [NA14OAR4170071];  [NIHI-SEAGRANT-JC-13-16]; Division Of Ocean Sciences [1260169] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); University of Hawaii Sea Grant College Program, SOEST, under NOAA Office of Sea Grant, Department of Commerce; ; Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This paper was funded by NSF (OCE12-60169), and in part by a grant/cooperative agreement from the National Oceanic and Atmospheric Administration, Project R/SS-13, which is sponsored by the University of Hawaii Sea Grant College Program, SOEST, under Institutional Grant No. NA14OAR4170071 from NOAA Office of Sea Grant, Department of Commerce (for RJT and JLKW). The views expressed herein are those of the authors and do not necessarily reflect the views of NOM or any of its subagencies This is Sea Grant contribution UNIHI-SEAGRANT-JC-13-16, SOEST contribution number 9638 and contribution number 1661 from the Hawaii Institute of Marine Biology.	Andrews KR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091665; Baird AH, 2009, ANNU REV ECOL EVOL S, V40, P551, DOI 10.1146/annurev.ecolsys.110308.120220; Battista T. A., 2007, 61 NOAA NOS NCCOS BI; Baums IB, 2006, LIMNOL OCEANOGR, V51, P1969, DOI 10.4319/lo.2006.51.5.1969; Bird CE, 2007, MOL ECOL, V16, P3173, DOI 10.1111/j.1365-294X.2007.03385.x; Botsford LW, 2009, REV FISH BIOL FISHER, V19, P69, DOI 10.1007/s11160-008-9092-z; Bradbury IR, 2008, P ROY SOC B-BIOL SCI, V275, P1803, DOI 10.1098/rspb.2008.0216; Bradbury IR, 2007, MAR ECOL PROG SER, V340, P245, DOI 10.3354/meps340245; Burgess SC, 2014, ECOL APPL, V24, P257, DOI 10.1890/13-0710.1; Burgess SC, 2012, ECOLOGY, V93, P1378; Bushnell ME, 2010, J FISH BIOL, V76, P1343, DOI 10.1111/j.1095-8649.2010.02569.x; Calabrese JM, 2004, FRONT ECOL ENVIRON, V2, P529, DOI 10.1890/1540-9295(2004)002[0529:ACGTCM]2.0.CO;2; Carson HS, 2010, CURR BIOL, V20, P1926, DOI 10.1016/j.cub.2010.09.057; Chassignet EP, 2009, OCEANOGRAPHY, V22, P64, DOI 10.5670/oceanog.2009.39; Christie MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015715; Concepcion G.T., 2016, Galaxea - Tokyo, V18, P9; Concepcion GT, 2014, B MAR SCI, V90, P257, DOI 10.5343/bms.2012.1109; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; Cowen RK, 2015, GULF CARIBB RES, V14, P129; Crandall ED, 2012, MOL ECOL, V21, P5579, DOI 10.1111/mec.12031; DeMartini EE, 2013, MAR ECOL PROG SER, V485, P165, DOI 10.3354/meps10306; Donahue MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130694; Drake PT, 2013, J MAR RES, V71, P317, DOI 10.1357/002224013808877099; Eble JA, 2011, MAR ECOL PROG SER, V428, P245, DOI 10.3354/meps09083; Fox HE, 2012, MAR ECOL PROG SER, V463, P259, DOI 10.3354/meps09838; Franklin EC, 2013, MAR ECOL PROG SER, V481, P121, DOI 10.3354/meps10252; Friedlander A, 2009, MARINE BIOGEOGRAPHIC, P291; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; GRIGG RW, 1981, PAC SCI, V35, P15; Hastings A, 2006, P NATL ACAD SCI USA, V103, P6067, DOI 10.1073/pnas.0506651103; Hijmans RJ., 2015, GEOSPHERE SPHERICAL; Holstein DM, 2014, MAR ECOL PROG SER, V499, P1, DOI 10.3354/meps10647; HOURIGAN TF, 1987, TRENDS ECOL EVOL, V2, P187, DOI 10.1016/0169-5347(87)90018-8; HUGHES TP, 1990, ECOLOGY, V71, P12, DOI 10.2307/1940242; Jia Y, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2011JC007305; Jones GP, 2009, CORAL REEFS, V28, P307, DOI 10.1007/s00338-009-0469-9; Jones GP, 2005, CURR BIOL, V15, P1314, DOI 10.1016/j.cub.2005.06.061; KAY EA, 1987, TRENDS ECOL EVOL, V2, P183, DOI 10.1016/0169-5347(87)90017-6; Kittinger J. N., 2011, J MAR BIOL, V2011; Kobayashi Donald R., 2006, Atoll Research Bulletin, P365; Kobayashi DR, 2006, CORAL REEFS, V25, P407, DOI 10.1007/s00338-006-0118-5; Kolinski Steven P., 2003, Pacific Science, V57, P17, DOI 10.1353/psc.2003.0005; Kool JT, 2015, MAR ECOL PROG SER, V539, P77, DOI 10.3354/meps11477; KOSAKI R K, 1991, Pacific Science, V45, P186; Kough AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064970; Kritzer JP, 2004, FISH FISH, V5, P131, DOI 10.1111/j.1467-2979.2004.00131.x; Leis JM, 2007, MAR ECOL PROG SER, V347, P185, DOI 10.3354/meps06977; Leis JM, 2014, MAR ECOL PROG SER, V505, P193, DOI 10.3354/meps10792; Lester SE, 2007, ECOL LETT, V10, P745, DOI 10.1111/j.1461-0248.2007.01070.x; Liggins L, 2016, J BIOGEOGR, V43, P256, DOI 10.1111/jbi.12647; Lipcius RN, 2008, REV FISH SCI, V16, P101, DOI 10.1080/10641260701812574; Lobel PS, 2011, DYNAM ATMOS OCEANS, V52, P119, DOI 10.1016/j.dynatmoce.2011.01.001; LOBEL PS, 1989, ENVIRON BIOL FISH, V24, P161, DOI 10.1007/BF00001221; Lobel PS, 1983, REEF FISHES SEA OCEA, P29; MARAGOS JE, 1986, CORAL REEFS, V4, P141, DOI 10.1007/BF00427935; Marshall J, 1997, J GEOPHYS RES-OCEANS, V102, P5753, DOI 10.1029/96JC02775; Maximenko NA, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022728; Mitarai S, 2008, J MARINE SYST, V69, P295, DOI 10.1016/j.jmarsys.2006.02.017; Mitarai S, 2016, P NATL ACAD SCI; Mora C, 2002, TRENDS ECOL EVOL, V17, P422, DOI 10.1016/S0169-5347(02)02584-3; Morgan S., 2014, ADV OCEANOGRAPHY; Neuheimer AB, 2007, CAN J FISH AQUAT SCI, V64, P375, DOI 10.1139/F07-003; Oksanen J., 2019, VEGAN COMMUNITY ECOL; Padilla-Gamino JL, 2012, MAR ECOL PROG SER, V449, P145, DOI 10.3354/meps09530; Paris CB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072808; Pogson GH, 2001, EVOLUTION, V55, P131, DOI 10.1111/j.0014-3820.2001.tb01279.x; Polato NR, 2010, MOL ECOL, V19, P4661, DOI 10.1111/j.1365-294X.2010.04836.x; Polovina JJ, 1999, FISH B-NOAA, V97, P132; Puritz JB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1238; Putman NF, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0979; Qiu B, 1997, J PHYS OCEANOGR, V27, P431, DOI 10.1175/1520-0485(1997)027<0431:EAFMOT>2.0.CO;2; Rasmuson LK, 2014, MAR ECOL PROG SER, V511, P143, DOI 10.3354/meps10926; RICHMOND RH, 1990, MAR ECOL PROG SER, V60, P185, DOI 10.3354/meps060185; Riginos C, 2013, GEOGR COMPASS, V7, P197, DOI 10.1111/gec3.12032; Riginos C, 2011, ECOGRAPHY, V34, P566, DOI 10.1111/j.1600-0587.2010.06511.x; Rivera Malia Ana J., 2011, Journal of Marine Biology, V2011, P1, DOI 10.1155/2011/765353; Robins PE, 2013, LIMNOL OCEANOGR, V58, P505, DOI 10.4319/lo.2013.58.2.0505; ROUGHGARDEN J, 1985, ECOLOGY, V66, P54, DOI 10.2307/1941306; ROUGHGARDEN J, 1988, SCIENCE, V241, P1460, DOI 10.1126/science.11538249; Rousset F, 1997, GENETICS, V145, P1219; Ruttenberg BI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021062; Seki MP, 2002, J OCEANOGR, V58, P739, DOI 10.1023/A:1022854609312; Selkoe KA, 2009, CORAL REEFS, V28, P635, DOI 10.1007/s00338-009-0490-z; Selkoe KA, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0354; Selkoe KA, 2014, MOL ECOL, V23, P3064, DOI 10.1111/mec.12804; Selkoe KA, 2010, MOL ECOL, V19, P3708, DOI 10.1111/j.1365-294X.2010.04658.x; Shanks AL, 2009, BIOL BULL-US, V216, P373; Siegel DA, 2008, P NATL ACAD SCI USA, V105, P8974, DOI 10.1073/pnas.0802544105; Siegel DA, 2003, MAR ECOL PROG SER, V260, P83, DOI 10.3354/meps260083; Skillings DJ, 2011, J MAR BIOL; Staaterman E, 2014, ICES J MAR SCI, V71, P918, DOI 10.1093/icesjms/fst103; Staaterman E, 2012, J THEOR BIOL, V304, P188, DOI 10.1016/j.jtbi.2012.03.016; STIMSON JS, 1978, MAR BIOL, V48, P173, DOI 10.1007/BF00395017; Swearer SE, 2002, B MAR SCI, V70, P251; Swearer SE, 1999, NATURE, V402, P799, DOI 10.1038/45533; Szabo Z, 2014, B MAR SCI, V90, P493, DOI 10.5343/bms.2013.1032; THORSON G, 1950, BIOL REV, V25, P1, DOI 10.1111/j.1469-185X.1950.tb00585.x; Timmers MA, 2011, J MAR BIOL; Toonen RJ, 2007, MAR ECOL PROG SER, V349, P43, DOI 10.3354/meps06963; Toonen RJ, 2013, MAR POLLUT BULL, V77, P7, DOI 10.1016/j.marpolbul.2013.10.039; Toonen Robert J, 2011, J Mar Biol, V2011, DOI 10.1155/2011/460173; Treml EA, 2008, LANDSCAPE ECOL, V23, P19, DOI 10.1007/s10980-007-9138-y; Treml EA, 2015, MOV ECOL, V3, DOI 10.1186/s40462-015-0045-6; Vaz AC, 2013, GEOPHYS RES LETT, V40, P332, DOI 10.1029/2012GL054519; Weiss J, 2009, 84 NOAA NOS NCCOS, P65; Wessel P., 1991, EOS T AM GEOPHYS UN, V72, P445, DOI [10.1029/90EO00319, DOI 10.1029/90EO00319, DOI 10.1029/90E000319]; White C, 2010, P ROY SOC B-BIOL SCI, V277, P1685, DOI 10.1098/rspb.2009.2214; Wolanski E, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0209; Wood S, 2014, GLOBAL ECOL BIOGEOGR, V23, P1, DOI 10.1111/geb.12101; Wren JLK, 2016, PEERJ, V4, DOI 10.7717/peerj.1636; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450; Wright S, 1943, GENETICS, V28, P114	112	21	22	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167626	10.1371/journal.pone.0167626	http://dx.doi.org/10.1371/journal.pone.0167626			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930680	gold, Green Submitted, Green Published			2022-12-26	WOS:000389580900032
J	Enzenhofer, E; Parzefall, T; Haymerle, G; Schneider, S; Kadletz, L; Heiduschka, G; Pammer, J; Oberndorfer, F; Wrba, F; Loader, B; Grasl, MC; Perisanidis, C; Erovic, BM				Enzenhofer, Elisabeth; Parzefall, Thomas; Haymerle, Georg; Schneider, Sven; Kadletz, Lorenz; Heiduschka, Gregor; Pammer, Johannes; Oberndorfer, Felicitas; Wrba, Fritz; Loader, Benjamin; Grasl, Matthaeus Christoph; Perisanidis, Christos; Erovic, Boban M.			Impact of Sonic Hedgehog Pathway Expression on Outcome in HPV Negative Head and Neck Carcinoma Patients after Surgery and Adjuvant Radiotherapy	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; HUMAN-PAPILLOMAVIRUS; OROPHARYNGEAL CANCER; IMPROVED SURVIVAL; ACTIVATION; GROWTH; PROFILES; GENOMICS; MARKERS; PROTEIN	Introduction HPV positive patients suffering from head and neck cancer benefit from intensified radiotherapy when applied as a primary as well as an adjuvant treatment strategy. However, HPV negative patients treated with surgery and adjuvant radiotherapy lack validated prognostic biomarkers. It is therefore important to define prognostic biomarkers in this particular patient population. Especially, A high-risk groups A need to be defined in order to adapt treatment protocols. Since dysregulation of the sonic hedgehog pathway plays an important role in carcinogenesis, we aimed to assess whether members of the sonic hedgehog-signaling pathway may act as prognostic factors in patients with HPV negative head and neck squamous cell carcinoma. Materials and Methods In this prospective study, pretreatment tumor biopsies of patients with head and neck squamous cell carcinoma were taken during panendoscopy (2005 to 2008). All patients were treated with surgery and postoperative radiotherapy. After assessment of HPV and p16 status, protein expression profiles of the Sonic hedgehog-signaling pathway were determined by immunohistochemistry and tissue microarray analyses in 36 HPV negative tumor biopsies. Expression profiles of Sonic hedgehog, Indian hedgehog, Patched, Smoothened, Gli1, Gli-2 and Gli-3 were correlated with patients A clinical data, local-control rate, disease-free as well as overall survival. Data from The Cancer Genome Atlas databank were used for external validation of our results. Results Gli-1 (p = 0.04) and Gli-2 (p = 0.02) overexpression was significantly linked to improved overall survival of HPV negative patients. Gli-2 (p = 0.04) overexpression correlated significantly with prolonged disease-free survival. Cox-multivariate analysis showed that overexpression of Gli-2 correlated independently (HR 0.40, 95% CI 0.16-0.95, p = 0.03) with increased overall survival. Discussion Gli-1 and Gli-2 overexpression represents a substantial prognostic factor for overall and disease-free survival in patients with locally advanced HPV negative head and neck cancer undergoing surgery and postoperative radiotherapy.	[Enzenhofer, Elisabeth; Parzefall, Thomas; Haymerle, Georg; Schneider, Sven; Kadletz, Lorenz; Heiduschka, Gregor; Grasl, Matthaeus Christoph; Erovic, Boban M.] Med Univ Vienna, Dept Otorhinolaryngol Head & Neck Surg, Vienna, Austria; [Pammer, Johannes; Oberndorfer, Felicitas; Wrba, Fritz] Med Univ Vienna, Dept Clin Pathol, Vienna, Austria; [Loader, Benjamin] Rudolfstiftung, Dept Otorhinolaryngol Head & Neck Surg, Vienna, Austria; [Perisanidis, Christos] Med Univ Vienna, Dept Oral & Maxillofacial Surg, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Rudolfstiftung Hospital; Medical University of Vienna	Erovic, BM (corresponding author), Med Univ Vienna, Dept Otorhinolaryngol Head & Neck Surg, Vienna, Austria.	boban.erovic@meduniwien.ac.at	Erovic, Boban/S-7824-2018	Erovic, Boban/0000-0002-7404-2583; Schneider, Sven/0000-0002-7631-3746; Parzefall, Thomas/0000-0002-7817-5789				Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; Argiris A, 2008, LANCET, V371, P1695, DOI 10.1016/S0140-6736(08)60728-X; Brunner M, 2012, EUR ARCH OTO-RHINO-L, V269, P2265, DOI 10.1007/s00405-011-1894-2; Caro I, 2010, CLIN CANCER RES, V16, P3335, DOI 10.1158/1078-0432.CCR-09-2570; Carpenter RL, 2012, DISCOV MED, V13, P105; Buim MEC, 2011, HUM PATHOL, V42, P1484, DOI 10.1016/j.humpath.2010.12.015; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chaudary N, 2012, CANCER-AM CANCER SOC, V118, P3105, DOI 10.1002/cncr.26635; Dayyani F, 2010, HEAD NECK ONCOL, V2, DOI 10.1186/1758-3284-2-15; Dennler S, 2007, CANCER RES, V67, P6981, DOI 10.1158/0008-5472.CAN-07-0491; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; Fakhry C, 2008, JNCI-J NATL CANCER I, V100, P261, DOI 10.1093/jnci/djn011; Farnebo L, 2013, INT J CANCER, V133, P1994, DOI 10.1002/ijc.28200; Farnebo L, 2011, J ORAL PATHOL MED, V40, P739, DOI 10.1111/j.1600-0714.2011.01036.x; Fertig EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078127; Fotopoulos G, 2015, EUR J CLIN INVEST, V45, P1145, DOI 10.1111/eci.12518; Gan GN, 2014, CANCER RES, V74, P7024, DOI 10.1158/0008-5472.CAN-14-1346; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gillison ML, 2008, JNCI-J NATL CANCER I, V100, P407, DOI 10.1093/jnci/djn025; Gupta S, 2009, INT J CANCER, V125, P2159, DOI 10.1002/ijc.24533; Heiduschka G, 2015, STRAHLENTHER ONKOL, V191, P209, DOI 10.1007/s00066-014-0753-7; Heiduschka G, 2014, STRAHLENTHER ONKOL, V190, P832, DOI 10.1007/s00066-014-0652-y; Inman GJ, 2011, CURR OPIN GENET DEV, V21, P93, DOI 10.1016/j.gde.2010.12.004; Jordan RC, 2012, AM J SURG PATHOL, V36, P945, DOI 10.1097/PAS.0b013e318253a2d1; Kasper M, 2006, MOL CELL BIOL, V26, P6283, DOI 10.1128/MCB.02317-05; Kim JE, 2013, ANN SURG ONCOL, V20, pS570, DOI 10.1245/s10434-013-3022-6; Lill C, 2011, WIEN KLIN WOCHENSCHR, V123, P215, DOI 10.1007/s00508-011-1553-z; Polanska H, 2016, TUMOR BIOL, V37, P7193, DOI 10.1007/s13277-015-4569-6; Rades D, 2016, ANTICANCER RES, V36, P2989; Rusthoven KE, 2008, INT J RADIAT ONCOL, V72, P343, DOI 10.1016/j.ijrobp.2007.12.046; Seto M, 2009, MOL CARCINOGEN, V48, P703, DOI 10.1002/mc.20516; SHAH JP, 1995, CA-CANCER J CLIN, V45, P352, DOI 10.3322/canjclin.45.6.352; Sharma N, 2015, ONCOTARGET, V6, P32039, DOI 10.18632/oncotarget.5055; Sims-Mourtada J, 2006, CLIN CANCER RES, V12, P6565, DOI 10.1158/1078-0432.CCR-06-0176; Vickova K, 2016, CELL DEATH DIS, V14, pe2048, DOI 10.1038/cddis.2015.389; Wang S, 2013, RADIAT RES, V179, P69, DOI 10.1667/RR3091.1; Yan M, 2011, ORAL ONCOL, V47, P504, DOI 10.1016/j.oraloncology.2011.03.027; Zhu H, 2010, CURR GENOMICS, V11, P238, DOI 10.2174/138920210791233108	38	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2016	11	12							e0167665	10.1371/journal.pone.0167665	http://dx.doi.org/10.1371/journal.pone.0167665			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4MR	27918595	Green Published, gold, Green Submitted			2022-12-26	WOS:000389577100015
J	Zhang, Y; Chen, SG; Wei, CY; Gong, H; Li, LQ; Ye, XQ				Zhang, Yu; Chen, Shiguo; Wei, Chaoyang; Gong, Hui; Li, Lanqi; Ye, Xingqian			Chemical and Cellular Assays Combined with In Vitro Digestion to Determine the Antioxidant Activity of Flavonoids from Chinese Bayberry (Myrica rubra Sieb. et Zucc.) Leaves	PLOS ONE			English	Article							MYRICITRIN; CYTOTOXICITY; EXTRACTS; DISEASE; HEALTH; FRUITS; CELLS	Oxidative stress is highly associated with the development of cardiovascular diseases and cancer and has drawn great attention. Natural products suggest a potential role in prevention of these disorders. The aim of this study was to investigate the antioxidant and anti-cancer properties of Chinese bayberry leaves (Myrica rubra Sieb. et Zucc.) flavonoids (BLF) comprehensively through the combination of in vitro digestion, chemical and cellular antioxidant assays. Based on the LC/MS data, the major flavonoids of BLF were myricitrin and quercetin 3-rhamnoside. BLF owned strong chemical and cellular antioxidant activity (CAA) with its CAA value at 4253.884 +/- 435.366 mu mol of QE/100 g DW. After the in vitro digestion, the total flavonoids content, myricitrin and quercetin 3-rhamnoside decreased significantly (P < 0.05). Lower levels of the total flavonoid content and cellular uptake of myricitrin and quercetin 3-rhamnoside might contribute to the lower CAA value of digested BLF (DBLF). However, DBLF still owns considerable chemical antioxidant activities and CAA compared with many plants. Furthermore, both BLF and DBLF exhibited dose-dependent relationship against HepG2 proliferation. Taken together, BLF has a great potential to be developed as a natural antioxidant for promoting public health.	[Zhang, Yu; Chen, Shiguo; Wei, Chaoyang; Gong, Hui; Li, Lanqi; Ye, Xingqian] Zhejiang Univ, Zhejiang Key Lab Agrofood Proc, Dept Food Sci & Nutr, Fuli Inst Food Sci,Zhejiang R&D Ctr Food Technol, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Ye, XQ (corresponding author), Zhejiang Univ, Zhejiang Key Lab Agrofood Proc, Dept Food Sci & Nutr, Fuli Inst Food Sci,Zhejiang R&D Ctr Food Technol, Hangzhou, Zhejiang, Peoples R China.	psu@zju.edu.cn	CHEN, SHIGUO/AGP-0850-2022	Li, Lanqi/0000-0002-1518-6480; CHEN, SHIGUO/0000-0001-8470-7983; Zhang, Yu/0000-0002-6488-0591	National Natural Science Foundation of China [C200501]; National Key Research and Development Program [2016YFD0400805]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program	This research project was supported by the National Natural Science Foundation of China (C200501) and the National Key Research and Development Program (2016YFD0400805). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akazawa-Ogawa Y, 2015, FREE RADICAL BIO MED, V79, P164, DOI 10.1016/j.freeradbiomed.2014.12.004; Bao JS, 2005, J AGR FOOD CHEM, V53, P2327, DOI 10.1021/jf048312z; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Boyer J, 2005, NUTR J, V4, DOI 10.1186/1475-2891-4-1; Boaventura BCB, 2015, FOOD RES INT, V77, P257, DOI 10.1016/j.foodres.2015.05.004; Chamani J, 2011, J PHARMACEUT BIOMED, V55, P114, DOI 10.1016/j.jpba.2010.12.029; Chen R. R., 1999, J GUIZHOU NORMAL U N, V17, P30; Chen W, 2013, FOOD CHEM, V141, P927, DOI 10.1016/j.foodchem.2013.04.033; De Martino L, 2012, INT J MOL SCI, V13, P5406, DOI 10.3390/ijms13055406; Dong M, 2007, J AGR FOOD CHEM, V55, P6044, DOI 10.1021/jf070706d; Edenharder R, 2003, MUTAT RES-GEN TOX EN, V540, P1, DOI 10.1016/S1383-5718(03)00114-1; Felice DL, 2009, J FUNCT FOODS, V1, P109, DOI 10.1016/j.jff.2008.09.014; Giampieri F, 2016, FOOD CHEM TOXICOL, V94, P128, DOI 10.1016/j.fct.2016.06.003; Gumienna M, 2011, INT J FOOD SCI NUTR, V62, P226, DOI 10.3109/09637486.2010.532115; Huang DJ, 2002, J AGR FOOD CHEM, V50, P4437, DOI 10.1021/jf0201529; Huang HZ, 2014, FOOD CHEM, V146, P363, DOI 10.1016/j.foodchem.2013.09.071; Rodriguez-Roque MJ, 2013, J AGR FOOD CHEM, V61, P1859, DOI 10.1021/jf3044204; Kim HH, 2013, ARCH PHARM RES, V36, P1533, DOI 10.1007/s12272-013-0147-x; Faller ALK, 2012, J AGR FOOD CHEM, V60, P4826, DOI 10.1021/jf300602w; Meotti FC, 2008, FREE RADICAL BIO MED, V44, P109, DOI 10.1016/j.freeradbiomed.2007.09.017; Moosavi-Movahedi AA, 2003, BIOORGAN MED CHEM, V11, P4303, DOI 10.1016/S0968-0896(03)00524-8; Odegaard AO, 2011, CIRCULATION, V124, P2847, DOI 10.1161/CIRCULATIONAHA.111.048843; RiceEvans CA, 1996, FREE RADICAL BIO MED, V20, P933, DOI 10.1016/0891-5849(95)02227-9; Rufian-Henares JA, 2009, FOOD RES INT, V42, P394, DOI 10.1016/j.foodres.2009.01.011; Shen JianGuo, 2004, Journal of Fujian Agriculture and Forestry University (Natural Science Edition), V33, P441; Shiomi K, 2013, FOOD CHEM, V139, P910, DOI 10.1016/j.foodchem.2013.01.009; Vauzour D, 2010, NUTRIENTS, V2, P1106, DOI 10.3390/nu2111106; Wen LR, 2015, FOOD CHEM, V186, P54, DOI 10.1016/j.foodchem.2015.03.017; Wolfe KL, 2008, J AGR FOOD CHEM, V56, P8418, DOI 10.1021/jf801381y; Wolfe KL, 2007, J AGR FOOD CHEM, V55, P8896, DOI 10.1021/jf0715166; [夏其乐 Xia Qile], 2004, [食品科学, Food Science], V25, P80; Xu RR, 2013, FOOD CHEM, V138, P48, DOI 10.1016/j.foodchem.2012.09.102; Yang HH, 2011, FOOD CHEM, V128, P1128, DOI 10.1016/j.foodchem.2011.03.118; Yokomizo A, 2005, BIOSCI BIOTECH BIOCH, V69, P693, DOI 10.1271/bbb.69.693; Yokomizo A, 2014, BIOSCIENCE BIOTECHNO, V69, P693; Zhang Y, 2016, J FUNCT FOODS, V27, P645, DOI 10.1016/j.jff.2016.10.004; Zhao P, 2015, FOOD CHEM, V173, P54, DOI 10.1016/j.foodchem.2014.10.010; Zheng H, 2011, J AGR FOOD CHEM, V59, P592, DOI 10.1021/jf1032476; Zinov'eva VN, 2011, BIOCHEM MOSC-SUPPL S, V5, P113, DOI 10.1134/S1990750811020181	39	26	28	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0167484	10.1371/journal.pone.0167484	http://dx.doi.org/10.1371/journal.pone.0167484			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3TF	27911932	Green Published, gold, Green Submitted			2022-12-26	WOS:000389520600038
J	Afrooz, ARMN; Boehm, AB				Afrooz, A. R. M. Nabiul; Boehm, Alexandria B.			Escherichia coli Removal in Biochar-Modified Biofilters: Effects of Biofilm	PLOS ONE			English	Article							HETEROGENEOUS POROUS-MEDIA; FECAL INDICATOR BACTERIA; SECONDARY ENERGY MINIMUM; ATOMIC-FORCE MICROSCOPY; AERUGINOSA PAO1 BIOFILM; NATURAL ORGANIC-MATTER; PSEUDOMONAS-AERUGINOSA; STORMWATER BIOFILTERS; INTERMITTENT FLOW; COLLOID TRANSPORT	The presence of microbial contaminants in urban stormwater is a significant concern for public health; however, their removal by traditional stormwater biofilters has been reported as inconsistent and inadequate. Recent work has explored the use of biochar to improve performance of stormwater biofilters under simplified conditions that do not consider potential effects of biofilm development on filter media. The present study investigates the role of biofilm on microbial contaminant removal performance of stormwater biofilters. Pseudomonas aeruginosa biofilms were formed in laboratory-scale sand and biochar-modified sand packed columns, which were then challenged with Escherichia coli laden synthetic stormwater containing natural organic matter. Results suggests that the presence of biofilm influences the removal of E. coli. However, the nature of the influence depends on the specific surface area and the relative hydrophobicity of filter media. The distribution of attached bacteria within the columns indicates that removal by filter media varies along the length of the column: the inlet was the primary removal zone regardless of experimental conditions. Findings from this research inform the design of field-scale biofilters for better and consistent performance in removing microbial contaminants from urban stormwater.	[Afrooz, A. R. M. Nabiul; Boehm, Alexandria B.] Stanford Univ, Dept Civil & Environm Engn, Stanford, CA 94305 USA; [Afrooz, A. R. M. Nabiul; Boehm, Alexandria B.] Engn Res Ctr ERC Reinventing Nations Urban Water, Stanford, CA USA	Stanford University	Boehm, AB (corresponding author), Stanford Univ, Dept Civil & Environm Engn, Stanford, CA 94305 USA.; Boehm, AB (corresponding author), Engn Res Ctr ERC Reinventing Nations Urban Water, Stanford, CA USA.	aboehm@stanford.edu	Afrooz, ARM/B-1701-2014	Afrooz, ARM/0000-0002-9141-9426; Boehm, Alexandria/0000-0002-8162-5090; Afrooz, Nabiul/0000-0002-0588-6942	United States National Science Foundation [EEC-1028968]; U.S. National Science Foundation [EEC-1028968]	United States National Science Foundation(National Science Foundation (NSF)); U.S. National Science Foundation(National Science Foundation (NSF))	This work was supported by the United States National Science Foundation through EEC-1028968. (https://www.nsf.gov/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is supported by Re-inventing Nations Urban Water Infrastructure (ReNUWIt), an Engineering Research Center (ERC) funded by the U.S. National Science Foundation (Grant#EEC-1028968). We thank Andrew Torkelson (University of California, Berkeley) for sharing the biofilm characterization protocol.	Abit SM, 2012, ENVIRON SCI TECHNOL, V46, P8097, DOI 10.1021/es300797z; Abu-Lail LI, 2007, ENVIRON SCI TECHNOL, V41, P8031, DOI 10.1021/es071047o; Abu-Lail NI, 2003, ENVIRON SCI TECHNOL, V37, P2173, DOI 10.1021/es026159o; Ahmad M, 2014, CHEMOSPHERE, V99, P19, DOI 10.1016/j.chemosphere.2013.10.071; Arnold JW, 2000, POULTRY SCI, V79, P1839, DOI 10.1093/ps/79.12.1839; Atabek A, 2007, J BACTERIOL, V189, P8503, DOI 10.1128/JB.00769-07; Bauman WJ, 2009, BIOFOULING, V25, P229, DOI 10.1080/08927010802688566; BENNETT JM, 1981, APPL OPTICS, V20, P1785, DOI 10.1364/AO.20.001785; Bozorg A, 2015, J CONTAM HYDROL, V183, P109, DOI 10.1016/j.jconhyd.2015.10.008; Bratieres K, 2008, WATER RES, V42, P3930, DOI 10.1016/j.watres.2008.06.009; Burks GA, 2003, LANGMUIR, V19, P2366, DOI 10.1021/la026375a; Chandrasena GI, 2014, J HYDROL, V519, P814, DOI 10.1016/j.jhydrol.2014.08.015; Chen GX, 2012, ENVIRON SCI TECHNOL, V46, P8782, DOI 10.1021/es301378q; Clement TP, 1996, GROUND WATER, V34, P934, DOI 10.1111/j.1745-6584.1996.tb02088.x; Cunningham A, 1997, BIOFILM PROCESSES PO, P325; CUNNINGHAM AB, 1991, ENVIRON SCI TECHNOL, V25, P1305, DOI 10.1021/es00019a013; Dai XJ, 2002, WATER RES, V36, P3523, DOI 10.1016/S0043-1354(02)00045-3; de Kerchove AJ, 2005, LANGMUIR, V21, P6462, DOI 10.1021/la047049t; Díaz Carolina, 2007, Mat. Res., V10, P11, DOI 10.1590/S1516-14392007000100004; Dietz ME, 2007, WATER AIR SOIL POLL, V186, P351, DOI 10.1007/s11270-007-9484-z; Elimelech M, 2000, ENVIRON SCI TECHNOL, V34, P2143, DOI 10.1021/es9910309; Fang QL, 2014, ENVIRON SCI TECHNOL, V48, P279, DOI 10.1021/es403711y; FONTES DE, 1991, APPL ENVIRON MICROB, V57, P2473, DOI 10.1128/AEM.57.9.2473-2481.1991; Garrett TR, 2008, PROG NAT SCI-MATER, V18, P1049, DOI 10.1016/j.pnsc.2008.04.001; Ghezzehei TA, 2014, SOLID EARTH, V5, P953, DOI 10.5194/se-5-953-2014; Janjaroen D, 2013, WATER RES, V47, P2531, DOI 10.1016/j.watres.2013.02.032; Johnson PR, 1996, ENVIRON SCI TECHNOL, V30, P3284, DOI 10.1021/es960053+; Johnson WP, 2007, ENVIRON SCI TECHNOL, V41, P1279, DOI 10.1021/es061301x; Johnson WP, 1996, WATER RES, V30, P923, DOI 10.1016/0043-1354(95)00225-1; Kobayashi H, 2009, CLIN ORTHOP RELAT R, V467, P1360, DOI 10.1007/s11999-008-0609-5; LECHEVALLIER MW, 1992, J AM WATER WORKS ASS, V84, P136; Liu Y, 2008, ENVIRON SCI TECHNOL, V42, P443, DOI 10.1021/es071861b; Lorite GS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075247; Mitzel MR, 2014, ENVIRON SCI TECHNOL, V48, P2715, DOI 10.1021/es404598v; Moges ME, 2015, MANAGEMENT ENV QUALI, V26; Mohanty SK, 2014, ENVIRON SCI TECHNOL, V48, P11535, DOI 10.1021/es5033162; Mohanty SK, 2014, WATER RES, V61, P288, DOI 10.1016/j.watres.2014.05.026; Mohanty SK, 2013, ENVIRON SCI TECHNOL, V47, P10791, DOI 10.1021/es305136b; National Academies of Sciences E Medicine, 2016, US GRAYW STORMW ENH; Papineau I, 2013, J ENVIRON ENG, V139, P603, DOI 10.1061/(ASCE)EE.1943-7870.0000672; Pieper AP, 1997, ENVIRON SCI TECHNOL, V31, P1163, DOI 10.1021/es960670y; Reddy KR, 2014, J ENVIRON ENG, V140, DOI 10.1061/(ASCE)EE.1943-7870.0000872; Redman JA, 2004, ENVIRON SCI TECHNOL, V38, P1777, DOI 10.1021/es034887l; Rippy MA, 2015, WIRES WATER, V2, P577, DOI 10.1002/wat2.1096; Sauer K, 2004, J BACTERIOL, V186, P7312, DOI 10.1128/JB.186.21.7312-7326.2004; Smith DP, 2008, J IRRIG DRAIN ENG, V134, P624, DOI 10.1061/(ASCE)0733-9437(2008)134:5(624); STOODLEY P, 1994, APPL ENVIRON MICROB, V60, P2711, DOI 10.1128/AEM.60.8.2711-2716.1994; TAYLOR SW, 1990, WATER RESOUR RES, V26, P2153; Tian J, 2014, WORLD ENV WAT RES C, p197 ; Torkzaban S, 2007, LANGMUIR, V23, P9652, DOI 10.1021/la700995e; Tripathi S, 2012, ENVIRON SCI TECHNOL, V46, P6942, DOI 10.1021/es202833k; Truesdail SE, 1998, J COLLOID INTERF SCI, V203, P369, DOI 10.1006/jcis.1998.5541; Tufenkji N, 2005, LANGMUIR, V21, P841, DOI 10.1021/la048102g; Velten S, 2007, WATER RES, V41, P1973, DOI 10.1016/j.watres.2007.01.021; Wang AM, 2011, GROUND WATER, V49, P20, DOI 10.1111/j.1745-6584.2010.00690.x; Wang YG, 2010, J ENVIRON QUAL, V39, P1925, DOI 10.2134/jeq2009.0411; Waterboard, ATTACHMENT H BIORETE; YEH TCJ, 1995, ENVIRON HEALTH PERSP, V103, P41, DOI 10.2307/3432011	58	25	26	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167489	10.1371/journal.pone.0167489	http://dx.doi.org/10.1371/journal.pone.0167489			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907127	Green Submitted, Green Published, gold			2022-12-26	WOS:000389482700168
J	Chevallier, C; Tonge, N; Safra, L; Kahn, D; Kohls, G; Miller, J; Schultz, RT				Chevallier, Coralie; Tonge, Natasha; Safra, Lou; Kahn, David; Kohls, Gregor; Miller, Judith; Schultz, Robert T.			Measuring Social Motivation Using Signal Detection and Reward Responsiveness	PLOS ONE			English	Article							ATTENTION; SCALES	Background Recent trends in psychiatry have emphasized the need for a shift from categorical to dimensional approaches. Of critical importance to this transformation is the availability of tools to objectively quantify behaviors dimensionally. The present study focuses on social motivation, a dimension of behavior that is central to a range of psychiatric conditions but for which a particularly small number of assays currently exist. Methods In Study 1 (N = 48), healthy adults completed a monetary reward task and a social reward task, followed by completion of the Chapman Physical and Social Anhedonia Scales. In Study 2 (N = 26), an independent sample was recruited to assess the robustness of Study 1's findings. Results The reward tasks were analyzed using signal detection theory to quantify how much reward cues bias participants' responses. In both Study 1 and Study 2, social anhedonia scores were negatively correlated with change in response bias in the social reward task but not in the monetary reward task. A median split on social anhedonia scores confirmed that participants with high social anhedonia showed less change in response bias in the social reward task compared to participants with low social anhedonia. Conclusions This study confirms that social anhedonia selectively affects how much an individual changes their behavior based on the presence of socially rewarding cues and establishes a tool to quantify social reward responsiveness dimensionally.	[Chevallier, Coralie; Tonge, Natasha; Kahn, David; Miller, Judith; Schultz, Robert T.] Childrens Hosp Philadelphia, Ctr Autism Res, Philadelphia, PA 19104 USA; [Chevallier, Coralie; Safra, Lou] ENS PSL, INSERM U960, LNC, Paris, France; [Kahn, David; Miller, Judith; Schultz, Robert T.] Univ Penn, Ctr Cognit Neurosci, Philadelphia, PA 19104 USA; [Kohls, Gregor] Rhein Westfal TH Aachen, Dept Child & Adolescent Psychiat Psychosomat & Ps, Child Neuropsychol Sect, Aachen, Germany; [Schultz, Robert T.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Schultz, Robert T.] Univ Penn, Dept Psychiat, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); University of Pennsylvania; Pennsylvania Medicine; RWTH Aachen University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Chevallier, C (corresponding author), Childrens Hosp Philadelphia, Ctr Autism Res, Philadelphia, PA 19104 USA.; Chevallier, C (corresponding author), ENS PSL, INSERM U960, LNC, Paris, France.	coralie.chevallier@ens.fr	Tonge, Natasha April/ABI-1770-2020; Chevallier, Coralie/AAR-4748-2020; Kohls, Gregor/AAH-6429-2020; Chevallier, Coralie/L-3120-2017	Tonge, Natasha April/0000-0001-7670-7991; Chevallier, Coralie/0000-0002-7358-4962; 	Pennsylvania Department of Health [4100047863]; Fondation Roger de Spoelberch [ANR-11-0001-02 PSL*, ANR-10-LABX-0087]; NATIONAL INSTITUTE OF MENTAL HEALTH [RC1MH088791] Funding Source: NIH RePORTER	Pennsylvania Department of Health; Fondation Roger de Spoelberch; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was funded by a grant from the Pennsylvania Department of Health (SAP # 4100047863) awarded to RTS. CC and LS were also supported by Fondation Roger de Spoelberch, ANR-11-0001-02 PSL*, ANR-10-LABX-0087. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam D, 2013, NATURE, V496, P416, DOI 10.1038/496416a; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Behrmann M, 2006, TRENDS COGN SCI, V10, P258, DOI 10.1016/j.tics.2006.05.001; CHAPMAN LJ, 1976, J ABNORM PSYCHOL, V85, P374, DOI 10.1037/0021-843X.85.4.374; Chevallier C, 2012, TRENDS COGN SCI; Chevallier C, 2015, AUTISM RES, V8, P620, DOI 10.1002/aur.1479; Collet L, 1986, LENCEPHALE, V10, P77; CRONBACH LJ, 1955, PSYCHOL BULL, V52, P281, DOI 10.1037/h0040957; Dubey I, 2015, MOL AUTISM, V6, DOI 10.1186/s13229-015-0031-2; Green DM, 1966, SIGNAL DETECTION THE; Happe F, 2003, ANN NY ACAD SCI, V1001, P134, DOI 10.1196/annals.1279.008; Hasler G, 2004, NEUROPSYCHOPHARMACOL, V29, P1765, DOI 10.1038/sj.npp.1300506; HAUTUS MJ, 1995, BEHAV RES METH INS C, V27, P46, DOI 10.3758/BF03203619; Insel T, 2010, AM J PSYCHIAT, V167, P748, DOI 10.1176/appi.ajp.2010.09091379; Johnstone V, 2000, J EXP ANAL BEHAV, V73, P275, DOI 10.1901/jeab.2000.73-275; Kohls G, 2013, NEUROPSYCHOLOGIA, V51, P2062, DOI 10.1016/j.neuropsychologia.2013.07.020; Kosmadakis CS, 1995, ENCEPHALE, V21, P437; Macmillan N. A., 2004, DETECTION THEORY USE; McCarthy D. C., 1991, SIGNAL DETECTION MEC, P239; Mehrabian A, 1970, ED PSYCHOL MEAS; NIMH, SOC PROC WORKSH P; Pizzagalli DA, 2005, BIOL PSYCHIAT, V57, P319, DOI 10.1016/j.biopsych.2004.11.026; Rilling JK, 2007, BIOL PSYCHIAT, V61, P1260, DOI 10.1016/j.biopsych.2006.07.021; Rutter M, 2011, J CHILD PSYCHOL PSYC, V52, P647, DOI 10.1111/j.1469-7610.2011.02367.x; Silvia PJ, 2011, J PERS, V79, P1013, DOI 10.1111/j.1467-6494.2010.00702.x; Tripp G, 1999, J CLIN CHILD PSYCHOL, V28, P366, DOI 10.1207/S15374424jccp280309; Uziel L, 2010, PERSPECT PSYCHOL SCI, V5, P243, DOI 10.1177/1745691610369465; Watson KK, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00036	28	17	17	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167024	10.1371/journal.pone.0167024	http://dx.doi.org/10.1371/journal.pone.0167024			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3JC	27907025	gold, Green Published, Green Submitted			2022-12-26	WOS:000389482700066
J	Duan, YP; Feng, MS; Zhong, XY; Shang, RS; Huang, LH				Duan, Yiping; Feng, Mingshi; Zhong, Xinyan; Shang, Ruishu; Huang, Lihong			Thermodynamic Simulation of Carbonate Cements-Water-Carbon Dioxide Equilibrium in Sandstone for Prediction of Precipitation/Dissolution of Carbonate Cements	PLOS ONE			English	Article							EQUATION-OF-STATE; TAHE OIL-FIELD; CALCITE DISSOLUTION; TARIM BASIN; CO2; RESERVOIR; SEQUESTRATION; DIAGENESIS; PRESSURES; KINETICS	Carbonate cements, such as calcite, dolomite, ferrocalcite and ankerite, play important roles in the formation of pores in sandstones: precipitation of carbonate cements modifies pores and inhibits compaction, while dissolution creates secondary pores. This work proposed a precipitation- dissolution model for carbonate cements-CO2-H2O system by means of ion equilibrium concentration ([M2+], M = Ca, Mg, Fe or Mn) with different factors, such as temperature, depth, pH, P-CO2, variable rock composition and overpressure. Precipitation-dissolution reaction routes were also analyzed by minimization of the total Gibbs free energy (Delta G).Delta[M2+], the variation of [Ca2+], [Fe2+], [Mg2+] or [Mn2+] for every 100 m of burial depths, is used to predict precipitation or dissolution. The calculation results indicate that the increasing temperature results in decrease of equilibrium constant of reactions, while the increasing pressure results in a relatively smaller increase of equilibrium constant; As a result, with increasing burial depth, which brings about increase of both temperature and pressure, carbonate cements dissolve firstly and produces the maximal dissolved amounts, and then precipitation happens with further increasing depth; For example, calcite is dissolving from 0.0 km to 3.0 km with a maximal value of [Ca2+] at depth of 0.8 km, and then precipitates with depth deeper than 3.0 km. Meanwhile, with an increasing CO2 mole fraction in the gaseous phase from 0.1% to 10.0% in carbonate systems, the aqueous concentration of metal ions increases, e.g., dissolved amount of CaFe0.7Mg0.3(CO3)(2) increases and reaches maximum of 1.78 mmol.L-1 and 8.26 mmol.L-1 at burial depth of 0.7 km with CO2 mole fraction of 0.1% and 10.0%, respectively. For the influence of overpressure in the calcite system, with overpressure ranging from 36 MPa to 83 MPa, pH reaches a minimum of 6.8 at overpressure of 51 MPa; meanwhile, Delta[Ca2+] increases slightly from -2.24 mmol.L-1 to -2.17 mmol.L-1 and remains negative, indicating it is also a precipitation process at burial depth of 3.9 km where overpressure generated. The method used in this study can be applied in assessing burial precipitation-dissolution processes and predicting possible pores in reservoirs with carbonate cement-water-carbon dioxide.	[Duan, Yiping; Zhong, Xinyan; Shang, Ruishu; Huang, Lihong] Chengdu Univ Technol, Dept Chem & Pharmaceut Engn, Chengdu, Peoples R China; [Duan, Yiping; Feng, Mingshi] Chengdu Univ Technol, State Key Lab Oil & Gas Reservoir Geol & Exploita, Chengdu, Peoples R China; [Huang, Lihong] Indiana Univ Purdue Univ, Richard G Lugar Ctr Renewable Energy, Indianapolis, IN 46202 USA	Chengdu University of Technology; Chengdu University of Technology; Indiana University System; Indiana University-Purdue University Indianapolis	Huang, LH (corresponding author), Chengdu Univ Technol, Dept Chem & Pharmaceut Engn, Chengdu, Peoples R China.; Feng, MS (corresponding author), Chengdu Univ Technol, State Key Lab Oil & Gas Reservoir Geol & Exploita, Chengdu, Peoples R China.; Huang, LH (corresponding author), Indiana Univ Purdue Univ, Richard G Lugar Ctr Renewable Energy, Indianapolis, IN 46202 USA.	fengmingshi09@cdut.cn; huanglihong06@cdut.cn			Open Fund of State Key Laboratory of Oil and Gas Reservoir Geology and Exploitation (Chengdu University of Technology) [PLC201205]; National Natural Science Foundation of China [21276031]; Department of Science and Technology of Sichuan Province [2015HH0013]	Open Fund of State Key Laboratory of Oil and Gas Reservoir Geology and Exploitation (Chengdu University of Technology); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Science and Technology of Sichuan Province	This work was financially supported by the Open Fund (PLC201205) of State Key Laboratory of Oil and Gas Reservoir Geology and Exploitation (Chengdu University of Technology), the National Natural Science Foundation of China (21276031), and by the Department of Science and Technology of Sichuan Province (2015HH0013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achal V, 2015, EARTH-SCI REV, V148, P1, DOI 10.1016/j.earscirev.2015.05.008; Achal V, 2011, CURR MICROBIOL, V62, P894, DOI 10.1007/s00284-010-9801-4; Al-Najrani F., 2010, THESIS; Bateman K, 2005, OIL GAS SCI TECHNOL, V60, P161, DOI 10.2516/ogst:2005010; BELONOSHKO A, 1991, GEOCHIM COSMOCHIM AC, V55, P381, DOI 10.1016/0016-7037(91)90425-5; BHIRUD VL, 1978, AICHE J, V24, P880, DOI 10.1002/aic.690240514; Bloch S, 2002, AAPG BULL, V86, P301; BOLES JR, 1978, CONTRIB MINERAL PETR, V68, P13, DOI 10.1007/BF00375443; Camy S, 2003, J SUPERCRIT FLUID, V25, P19, DOI 10.1016/S0896-8446(02)00087-6; Chai L, 1996, AM MINERAL, V81, P1141; Delavar H, 2014, FLUID PHASE EQUILIBR, V369, P1, DOI 10.1016/j.fluid.2014.02.009; Fischer S, 2010, CHEM ERDE-GEOCHEM, V70, P155, DOI 10.1016/j.chemer.2010.06.001; Guimara L, 2007, CHEM PHYS, V333, P10; Guo XW, 2011, ORG GEOCHEM, V42, P1343, DOI 10.1016/j.orggeochem.2011.08.017; Haase C, 2013, APPL GEOCHEM, V33, P306, DOI 10.1016/j.apgeochem.2013.03.001; Hammes F, 2003, APPL MICROBIOL BIOT, V62, P191, DOI 10.1007/s00253-003-1287-6; HELGESON HC, 1978, AM J SCI, V278, P1; Holland TJB, 2011, J METAMORPH GEOL, V29, P333, DOI 10.1111/j.1525-1314.2010.00923.x; Holland TJB, 1998, J METAMORPH GEOL, V16, P309, DOI 10.1111/j.1525-1314.1998.00140.x; Huang S J, 2010, CARBONATE DIAGENSIS, P73; Huang SJ, 2000, CHIN J GEOCHEM, V19, P58; Jin ZJ, 2009, MAR PETROL GEOL, V26, P753, DOI 10.1016/j.marpetgeo.2008.08.005; Kaufmann G, 2007, GEOCHIM COSMOCHIM AC, V71, P1398, DOI 10.1016/j.gca.2006.10.024; Ketzer JM, 2009, APPL GEOCHEM, V24, P760, DOI 10.1016/j.apgeochem.2009.01.001; Li H, 2009, APPL ENERG, V86, P2760, DOI 10.1016/j.apenergy.2009.04.013; Lin CY, 2013, APPL GEOCHEM, V29, P13, DOI 10.1016/j.apgeochem.2012.10.029; LUNDEGARD PD, 1989, CHEM GEOL, V74, P277, DOI 10.1016/0009-2541(89)90038-7; Mandalaparty P., 2012, THESIS; Rossi C, 2001, J SEDIMENT RES, V71, P459, DOI 10.1306/2DC40955-0E47-11D7-8643000102C1865D; Ruan Z, 2013, CHEM ERDE-GEOCHEM, V73, P469, DOI 10.1016/j.chemer.2013.03.004; SHOCK EL, 1988, GEOCHIM COSMOCHIM AC, V52, P2009, DOI 10.1016/0016-7037(88)90181-0; Soli AL, 2002, MAR CHEM, V78, P65, DOI 10.1016/S0304-4203(02)00010-5; Sung RT, 2014, INT J GREENH GAS CON, V20, P168, DOI 10.1016/j.ijggc.2013.11.003; SVERJENSKY DA, 1984, GEOCHIM COSMOCHIM AC, V48, P1127, DOI 10.1016/0016-7037(84)90203-5; Sverjensky DA, 1997, GEOCHIM COSMOCHIM AC, V61, P1359, DOI 10.1016/S0016-7037(97)00009-4; Tempel RN, 2000, APPL GEOCHEM, V15, P1071, DOI 10.1016/S0883-2927(99)00108-0; Wang TY, 2013, MAR POLLUT BULL, V76, P307, DOI 10.1016/j.marpolbul.2013.08.014; Wunsch A, 2013, APPL GEOCHEM, V38, P33, DOI 10.1016/j.apgeochem.2013.08.005; Xu J, 2012, CHEM GEOL, V322, P11, DOI 10.1016/j.chemgeo.2012.04.019; Yao LL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139117; Yu BS, 2008, SCI CHINA SER D, V51, P567, DOI 10.1007/s11430-008-0027-2; Zenger D.H., 1980, SEPM SPECIAL PUBLICA, V28, P320, DOI [10.2110/pec.80.28, DOI 10.2110/PEC.80.28]; Zhang Z J., 2007, J YANGLING VOCATIONA, V6, P9; Zhao L, 2014, MAR POLLUT BULL, V85, P78, DOI 10.1016/j.marpolbul.2014.06.019	44	3	4	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167035	10.1371/journal.pone.0167035	http://dx.doi.org/10.1371/journal.pone.0167035			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907043	Green Published, gold, Green Submitted			2022-12-26	WOS:000389482700068
J	Gulzari, UA; Sajid, M; Anjum, S; Agha, S; Torres, FS				Gulzari, Usman Ali; Sajid, Muhammad; Anjum, Sheraz; Agha, Shahrukh; Torres, Frank Sill			A New Cross-By-Pass-Torus Architecture Based on CBP-Mesh and Torus Interconnection for On-Chip Communication	PLOS ONE			English	Article								A Mesh topology is one of the most promising architecture due to its regular and simple structure for on-chip communication. Performance of mesh topology degraded greatly by increasing the network size due to small bisection width and large network diameter. In order to overcome this limitation, many researchers presented modified Mesh design by adding some extra links to improve its performance in terms of network latency and power consumption. The Cross-By-Pass-Mesh was presented by us as an improved version of Mesh topology by intelligent addition of extra links. This paper presents an efficient topology named Cross-By-Pass-Torus for further increase in the performance of the Cross-By-Pass-Mesh topology. The proposed design merges the best features of the Cross-By-Pass-Mesh and Torus, to reduce the network diameter, minimize the average number of hops between nodes, increase the bisection width and to enhance the overall performance of the network. In this paper, the architectural design of the topology is presented and analyzed against similar kind of 2D topologies in terms of average latency, throughput and power consumption. In order to certify the actual behavior of proposed topology, the synthetic traffic trace and five different real embedded application workloads are applied to the proposed as well as other competitor network topologies. The simulation results indicate that Cross-By-Pass-Torus is an efficient candidate among its predecessor's and competitor topologies due to its less average latency and increased throughput at a slight cost in network power and energy for on-chip communication.	[Gulzari, Usman Ali; Sajid, Muhammad; Agha, Shahrukh] COMSATS Inst Informat Technol, Dept Elect Engn, Islamabad, Pakistan; [Anjum, Sheraz] COMSATS Inst Informat Technol, Dept Comp Sci, Wah Cantt, Pakistan; [Torres, Frank Sill] Univ Minas Gerais, Dept Elect Engn, Belo Horizonte, MG, Brazil	COMSATS University Islamabad (CUI); COMSATS University Islamabad (CUI); Universidade Federal de Minas Gerais	Gulzari, UA (corresponding author), COMSATS Inst Informat Technol, Dept Elect Engn, Islamabad, Pakistan.	usmangulzari2000@yahoo.com	Torres, Frank Sill/A-1634-2013; gulzari, usman/L-4289-2018	Sill Torres, Frank/0000-0002-4028-455X; gulzari, usman/0000-0002-9726-9254				Ahmadi A, 2014, EFFICIENT ROUTING AL; Arora LK, 2013, 2013 IEEE INT C; Bhardwaj M, 2015, AM J NETWORKS COMMUN; Bhat S., 2005, ENERGY MODELS NETWOR; Butun I, 2016, IEEE COMMUN; Dally W. J., 2004, PRINCIPLES PRACTICES; Du Q, 2015, PERS UBIQUITOUS COMP; Elmiligi H, 2009, MICROPROCESS; Goossens K, 2005, IEEE DES TEST COMPUT; Grecu C, 2007, NETWORKS CHIP; Gulzari U, 2015, 9 INT S; Hansson A, 2011, DES AUTOM EMBED SYST, V15, P159, DOI 10.1007/s10617-011-9073-7; Houbing Song CB., 2016, CYBER PHYS SYSTEMS F; Jerger NE, 2009, SYNTH LECT COMPUT AR; Ju X, 2012, MICROPROCESS MICROSY; Ju XG, 2012, MICROPROCESS MICROSY, V36, P505, DOI 10.1016/j.micpro.2012.04.006; Kahng A, 2015, IEEE EMBED SYST LETT; Khawaja SG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125230; Li W, 2016, FUTUR GENER; Lo'ai A, 2016, HEAL APPL SYST; Naranjo P, 2016, P PSE; Ogras U, 2005, P 3 IEEE ACM IFIP; Ouyang Y, 2009, COMPUT ENG; Rezaei A, 2016, 2016 24 EUROMICRO; Sehgal V, 2010, J SUPERCOMPUT; Song Houbing, 2003, COMPUTER COMMUNICATI, V4; Tang K, 1994, IEEE T COMPUT; Tran A. T., 2012, NOCTWEAK HIGHLY PARA; Wang Y, 2011, J CHINA U POSTS; Wei W, 2018, IEEE T SERV COMPUT, V11, P78, DOI 10.1109/TSC.2016.2528246; Zhang Y, 2015, A NEW MULTI SERVICE	31	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167590	10.1371/journal.pone.0167590	http://dx.doi.org/10.1371/journal.pone.0167590			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907147	Green Published, Green Submitted, gold			2022-12-26	WOS:000389482700206
J	Jacobs, M; Cooper, SA; McGowan, R; Nelson, SM; Pell, JP				Jacobs, Myrthe; Cooper, Sally-Ann; McGowan, Ruth; Nelson, Scott M.; Pell, Jill P.			Pregnancy Outcome following Prenatal Diagnosis of Chromosomal Anomaly: A Record Linkage Study of 26,261 Pregnancies	PLOS ONE			English	Article							DOWN-SYNDROME; PARENTAL DECISIONS; ABNORMALITIES; TERMINATION; ABORT; DETERMINANTS; PREVALENCE; ANEUPLOIDY; TRENDS; IMPACT	Previous studies have demonstrated the influence of changes in the age at which women give birth, and of developments in prenatal screening and diagnosis on the number of pregnancies diagnosed and terminated with chromosomal anomalies. However, we are unaware of any population studies examining pregnancy terminations after diagnosis of chromosomal anomalies that has included all aneuploidies and the influence of maternal factors. The aims of this study were to examine the association between results of prenatal tests and pregnancy termination, and the proportion of foetuses with and without chromosomal anomalies referred for invasive diagnostic tests over time. Diagnostic information of 26,261 prenatal invasive tests from all genetic service laboratories in Scotland from 2000 to 2011 was linked to Scottish Morbidity Records to obtain details on pregnancy outcome. Binary logistic regression was carried out to test the associations of year and type of diagnosis with pregnancy termination, while controlling for maternal age, neighbourhood deprivation and parity. There were 24,155 (92.0%) with no chromosomal anomalies, 1,483 (5.6%) aneuploidy diagnoses, and 623 (2.4%) diagnoses of anomaly that was not aneuploidy (including translocations and single chromosome deletions). In comparison with negative test results, pregnancies diagnosed with trisomy were most likely to be terminated (adjusted OR 437.40, 95% CI 348.19-549.46) followed by other aneuploid anomalies (adjusted OR 95.94, 95% CI 69.21-133.01). During the study period, fewer pregnancies that were diagnosed with aneuploidy were terminated, including trisomy diagnoses (adjusted OR 0.44, 95% CI 0.26-0.73). Older women were less likely to terminate (OR 0.35, 95% CI 0.28, 0.42), and parity was also an independent predictor of termination. In keeping with previous findings, while the number of invasive diagnostic tests declined, the proportion of abnormal results increased from 6.09% to 10.88%. Systematic advances in prenatal screening have improved detection rates for aneuploidy. This has been accompanied by a reduction in the rate of termination for aneuploidy. This may reflect societal changes with acceptance of greater diversity, but this is speculation, and further research would be needed to test this.	[Jacobs, Myrthe; Cooper, Sally-Ann; Pell, Jill P.] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland; [McGowan, Ruth] West Scotland Reg Genet Serv, Glasgow, Lanark, Scotland; [Nelson, Scott M.] Univ Glasgow, Sch Med, Glasgow, Lanark, Scotland	University of Glasgow; University of Glasgow	Cooper, SA (corresponding author), Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland.	Sally-Ann.Cooper@glasgow.ac.uk		Nelson, Scott/0000-0002-9099-3047; Pell, Jill/0000-0002-8898-7035; Jacobs, Myrthe/0000-0001-8301-2020	Scottish Government [60559]; Medical Research Council [MR/K007017/1, MC_PC_13040] Funding Source: researchfish; MRC [MR/K007017/1] Funding Source: UKRI	Scottish Government; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was funded by a grant from the Scottish Government (http://www.gov.scot/) awarded to SAC; Grant number: 60559 (Scottish Learning Disabilities Observatory). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balkan M, 2010, J GENET COUNS, V19, P241, DOI 10.1007/s10897-009-9275-3; Burns H, 2011, CMO 2011 06 CHANGES; Carothers AD, 1999, GENET EPIDEMIOL, V16, P179, DOI 10.1002/(SICI)1098-2272(1999)16:2<179::AID-GEPI5>3.0.CO;2-7; Choi H, 2012, J MIDWIFERY WOM HEAL, V57, P156, DOI 10.1111/j.1542-2011.2011.00109.x; Collins VR, 2008, J PEDIATR-US, V152, P20, DOI 10.1016/j.jpeds.2007.07.045; DRUGAN A, 1990, PRENATAL DIAG, V10, P483, DOI 10.1002/pd.1970100802; Ekelund CK, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2547; Hawkins A, 2013, J GENET COUNS, V22, P238, DOI 10.1007/s10897-012-9539-1; Hecht CA, 1996, AM J MED GENET, V62, P376, DOI 10.1002/(SICI)1096-8628(19960424)62:4<376::AID-AJMG10>3.0.CO;2-L; Information Services Division, 2014, BIRTHS SCOTT HOSP NA; Irving C, 2008, EUR J HUM GENET, V16, P1336, DOI 10.1038/ejhg.2008.122; Jeon KC, 2012, GENET MED, V14, P27, DOI 10.1038/gim.0b013e31822e57a7; Khoshnood B, 2004, BJOG-INT J OBSTET GY, V111, P485, DOI 10.1111/j.1471-0528.2004.00117.x; Kramer RL, 1998, AM J MED GENET, V79, P172, DOI 10.1002/(SICI)1096-8628(19980923)79:3<172::AID-AJMG4>3.0.CO;2-P; Mezei G, 2004, OBSTET GYNECOL, V104, P94, DOI 10.1097/01.AOG.0000128171.14081.eb; Morris JK, 2014, NATL SYNDROME CYTOGE; Morris JK, 2009, BMJ-BRIT MED J, V339, pb3794, DOI DOI 10.1136/BMJ.B3794; Morris S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093559; National Records of Scotland, 2001, CENS AGGR DAT SCOTL; National Records of Scotland, 2011, CENS AGGR DAT SCOTL; National Statistics, 2012, SCOTT IND MULT DEPR; Natoli JL, 2012, PRENATAL DIAG, V32, P142, DOI 10.1002/pd.2910; Olsen CL, 2003, HUM BIOL, V75, P503, DOI 10.1353/hub.2003.0059; Robson G, 2001, HDL 2001 34 ANTENATA, P34; Shaffer BL, 2006, PRENATAL DIAG, V26, P667, DOI 10.1002/pd.1462; VINCENT VA, 1991, SOUTHERN MED J, V84, P1210, DOI 10.1097/00007611-199110000-00012; Whittle P., 2008, CEL31 2008 CHANGES P; Zlotogora J, 2002, PRENATAL DIAG, V22, P1102, DOI 10.1002/pd.472	28	10	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166909	10.1371/journal.pone.0166909	http://dx.doi.org/10.1371/journal.pone.0166909			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907018	Green Submitted, gold, Green Accepted, Green Published			2022-12-26	WOS:000389482700052
J	Lardy, S; Fortin, D; Pays, O				Lardy, Sophie; Fortin, Daniel; Pays, Olivier			Increased Exploration Capacity Promotes Group Fission in Gregarious Foraging Herbivores	PLOS ONE			English	Article							FUSION DYNAMICS; GROUP-SIZE; SEARCHING BEHAVIOR; DECISION-MAKING; MAMMALIAN HERBIVORES; ORGANIZATION; SEGREGATION; POPULATION; STRATEGIES; LEADERSHIP	Many gregarious species display rapid fission-fusion dynamics with individuals frequently leaving their groups to reunite or to form new ones soon after. The adaptive value of such ephemeral associations might reflect a frequent tilt in the balance between the costs and benefits of maintaining group cohesion. The lack of information on the short-term advantages of group fission, however, hampers our understanding of group dynamics. We investigated the effect of group fission on area-restricted search, a search tactic that is commonly used when food distribution is spatially autocorrelated. Specifically, we determine if roe deer (Capreolus capreolus) improve key aspects of their extensive search mode immediately after fission. We found that groups indeed moved faster and farther over time immediately after than before fission. This gain was highest for the smallest group that resulted from fission, which was more likely to include the fission's initiator. Sex of group members further mediated the immediate gain in search capacity, as post-fission groups moved away at farthest rate when they were only comprised of males. Our study suggests that social conflicts during the extensive search mode can promote group fission and, as such, can be a key determinant of group fission-fusion dynamics that are commonly observed in gregarious herbivores.	[Lardy, Sophie] Univ Angers, Grp Ecol & Conservat Vertebras, Angers, France; [Fortin, Daniel] Univ Laval, CEF, Quebec City, PQ, Canada; [Fortin, Daniel] Univ Laval, Dept Biol, Quebec City, PQ, Canada; [Pays, Olivier] Univ Angers, CNRS, UMR 6554, LETG Angers, Angers, France	Universite d'Angers; Laval University; Laval University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite d'Angers	Pays, O (corresponding author), Univ Angers, CNRS, UMR 6554, LETG Angers, Angers, France.	olivier.pays@univ-angers.fr	Fortin, Daniel/ABG-3554-2020		Communaute de Communes de l'Argonne Ardennaise'; Conseil Regional de Champagne Ardenne; Universite d'Angers	Communaute de Communes de l'Argonne Ardennaise'(Region Grand-Est); Conseil Regional de Champagne Ardenne(Region Grand-Est); Universite d'Angers	The 'Communaute de Communes de l'Argonne Ardennaise', the 'Conseil Regional de Champagne Ardenne' and the 'Universite d'Angers' provided financial support to conduct the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alados C.L., 1985, P134; Aplin LM, 2012, P ROY SOC B-BIOL SCI, V279, P4199, DOI 10.1098/rspb.2012.1591; Aureli F, 2008, CURR ANTHROPOL, V49, P627, DOI 10.1086/586708; Aureli F, 2012, BEHAV ECOL, V23, P1308, DOI 10.1093/beheco/ars122; BENHAMOU S, 1992, J THEOR BIOL, V159, P67, DOI 10.1016/S0022-5193(05)80768-4; Body G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095618; CALDER WA, 1983, ANNU REV ECOL SYST, V14, P213, DOI 10.1146/annurev.es.14.110183.001241; Cezilly F, 1996, REV ECOL-TERRE VIE, V51, P43; Clutton-Brock TH., 1982, RED DEER BEHAV ECOLO; Couzin ID, 2011, SCIENCE, V334, P1578, DOI 10.1126/science.1210280; Couzin ID, 2009, CURR BIOL, V19, pR633, DOI 10.1016/j.cub.2009.05.034; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Farine DR, 2014, ANIM BEHAV, V89, P141, DOI 10.1016/j.anbehav.2014.01.001; Fortin D, 2004, OIKOS, V107, P172, DOI 10.1111/j.0030-1299.2004.12976.x; Fortin D, 2005, OECOLOGIA, V145, P335, DOI 10.1007/s00442-005-0122-4; Fortin D, 2003, BEHAV ECOL SOCIOBIOL, V54, P194, DOI 10.1007/s00265-003-0599-y; Fortin D, 2004, ECOLOGY, V85, P2312, DOI 10.1890/03-0485; Fortin D, 2009, ANIM BEHAV, V78, P887, DOI 10.1016/j.anbehav.2009.06.026; Fortin D, 2009, ECOLOGY, V90, P2480, DOI 10.1890/08-0345.1; FRID A, 1994, BIOL CONSERV, V67, P13, DOI 10.1016/0006-3207(94)90003-5; Fryxell JM, 2004, ECOLOGY, V85, P2429, DOI 10.1890/04-0147; Fryxell JM, 2008, P NATL ACAD SCI USA, V105, P19114, DOI 10.1073/pnas.0801737105; GERARD JF, 1995, J THEOR BIOL, V176, P511, DOI 10.1006/jtbi.1995.0217; GETTY T, 1991, AM NAT, V138, P1459, DOI 10.1086/285296; Haskell DG, 1997, BEHAV ECOL, V8, P448, DOI 10.1093/beheco/8.4.448; HIGASHI M, 1993, AM NAT, V142, P553, DOI 10.1086/285555; Illius AW, 2002, OIKOS, V98, P558, DOI 10.1034/j.1600-0706.2002.980323.x; Krause J, 2002, LIVING GROUPS; Leca JB, 2003, ANIM BEHAV, V66, P1045, DOI 10.1006/anbe.2003.2276; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Marchal C, 1998, REV ECOL-TERRE VIE, V53, P59; Morand-Ferron J, 2011, P NATL ACAD SCI USA, V108, P15898, DOI 10.1073/pnas.1111560108; Mueller T, 2008, J APPL ECOL, V45, P649, DOI 10.1111/j.1365-2664.2007.01371.x; Mysterud A, 2000, OECOLOGIA, V124, P40, DOI 10.1007/s004420050023; Parrish JK, 1999, SCIENCE, V284, P99, DOI 10.1126/science.284.5411.99; Pays O, 2007, ANIM BEHAV, V74, P1429, DOI 10.1016/j.anbehav.2007.02.012; Pays O, 2013, BEHAV ECOL, V24, P1229, DOI 10.1093/beheco/art057; Pays O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034678; Pearson HC, 2009, BEHAV ECOL SOCIOBIOL, V63, P1437, DOI 10.1007/s00265-009-0821-7; PULLIAM HR, 1973, J THEOR BIOL, V38, P419, DOI 10.1016/0022-5193(73)90184-7; R Development Core Team, 2014, R LANG ENV STAT COMP; Ramseyer A, 2009, BEHAVIOUR, V146, P351, DOI 10.1163/156853909X410955; RANNALA BH, 1994, TRENDS ECOL EVOL, V9, P117, DOI 10.1016/0169-5347(94)90172-4; Rubenstein DI, 2004, SEXUAL SELECTION PRI; Ruckstuhl K.E., 2005, SEXUAL SEGREGATION V; Ruckstuhl KE, 2002, BIOL REV, V77, P77, DOI 10.1017/S1464793101005814; Shipley LA, 1996, FUNCT ECOL, V10, P234, DOI 10.2307/2389848; SIBLY RM, 1983, ANIM BEHAV, V31, P947, DOI 10.1016/S0003-3472(83)80250-4; Silk MJ, 2014, IBIS, V156, P701, DOI 10.1111/ibi.12191; Smith JE, 2008, ANIM BEHAV, V76, P619, DOI 10.1016/j.anbehav.2008.05.001; SMITH JNM, 1974, BEHAVIOUR, V49, P1, DOI 10.1163/156853974X00390; Sueur C, 2010, J EXP BIOL, V213, P1338, DOI 10.1242/jeb.039016; Sueur C, 2008, INT J PRIMATOL, V29, P1085, DOI 10.1007/s10764-008-9262-9; Sueur C, 2011, OIKOS, V120, P1608, DOI 10.1111/j.1600-0706.2011.19685.x; Uccheddu S, 2015, OECOLOGIA, V179, P711, DOI 10.1007/s00442-015-3392-5; VICKERY WL, 1991, AM NAT, V137, P847, DOI 10.1086/285197; Villerette N, 2006, CAN J ZOOL, V84, P787, DOI 10.1139/Z06-052; Viswanathan GM, 1999, NATURE, V401, P911, DOI 10.1038/44831; Zollner PA, 1999, ECOLOGY, V80, P1019, DOI 10.2307/177035; [No title captured]; [No title captured]	61	1	1	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167516	10.1371/journal.pone.0167516	http://dx.doi.org/10.1371/journal.pone.0167516			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907143	Green Published, gold, Green Submitted			2022-12-26	WOS:000389482700179
J	Okonechnikov, K; Imai-Matsushima, A; Paul, L; Seitz, A; Meyer, TF; Garcia-Alcalde, F				Okonechnikov, Konstantin; Imai-Matsushima, Aki; Paul, Lukas; Seitz, Alexander; Meyer, Thomas F.; Garcia-Alcalde, Fernando			InFusion: Advancing Discovery of Fusion Genes and Chimeric Transcripts from Deep RNA-Sequencing Data	PLOS ONE			English	Article							SEQ DATA; CANCER; IDENTIFICATION; EXPRESSION; QUANTIFICATION; COMPLEXITY; ALGORITHM; ALIGNMENT; TUMOR	Analysis of fusion transcripts has become increasingly important due to their link with cancer development. Since high-throughput sequencing approaches survey fusion events exhaustively, several computational methods for the detection of gene fusions from RNA-seq data have been developed. This kind of analysis, however, is complicated by native trans-splicing events, the splicing-induced complexity of the transcriptome and biases and artefacts introduced in experiments and data analysis. There are a number of tools available for the detection of fusions from RNA-seq data; however, certain differences in specificity and sensitivity between commonly used approaches have been found. The ability to detect gene fusions of different types, including isoform fusions and fusions involving non-coding regions, has not been thoroughly studied yet. Here, we propose a novel computational toolkit called InFusion for fusion gene detection from RNA-seq data. InFusion introduces several unique features, such as discovery of fusions involving intergenic regions, and detection of anti-sense transcription in chimeric RNAs based on strand-specificity. Our approach demonstrates superior detection accuracy on simulated data and several public RNA-seq datasets. This improved performance was also evident when evaluating data from RNA deep-sequencing of two well-established prostate cancer cell lines. InFusion identified 26 novel fusion events that were validated in vitro, including alternatively spliced gene fusion isoforms and chimeric transcripts that include intergenic regions. The toolkit is freely available to download from httplbabucketorg/kokonechhnfusion.	[Okonechnikov, Konstantin; Imai-Matsushima, Aki; Meyer, Thomas F.; Garcia-Alcalde, Fernando] Max Planck Inst Infect Biol, Dept Mol Biol, Berlin, Germany; [Paul, Lukas; Seitz, Alexander] Lexogen GmbH, Bioctr 5, Campus Vienna, Vienna, Austria; [Okonechnikov, Konstantin] German Canc Res Ctr, Div Pediat Neurooncol, Heidelberg, Germany; [Garcia-Alcalde, Fernando] Roche Innovat Ctr Basel, Roche Pharma Res & Early Dev, Inflammat & Infect Dis, Immunol, Basel, Switzerland	Max Planck Society; Helmholtz Association; German Cancer Research Center (DKFZ); Roche Holding	Meyer, TF; Garcia-Alcalde, F (corresponding author), Max Planck Inst Infect Biol, Dept Mol Biol, Berlin, Germany.; Garcia-Alcalde, F (corresponding author), Roche Innovat Ctr Basel, Roche Pharma Res & Early Dev, Inflammat & Infect Dis, Immunol, Basel, Switzerland.	meyer@mpiib-berlin.mpg.de; fernando.garcia-alcalde@roche.com	Okonechnikov, Konstantin/AAD-4239-2019; Paul, Lukas/L-9231-2015; Meyer, Thomas F./J-2485-2013	Paul, Lukas/0000-0001-9410-4078; Meyer, Thomas F./0000-0002-6120-8679				Akiva P, 2006, GENOME RES, V16, P30, DOI 10.1101/gr.4137606; Berger MF, 2010, GENOME RES, V20, P413, DOI 10.1101/gr.103697.109; Carrara M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/340620; Chen K, 2012, BIOINFORMATICS, V28, P1923, DOI 10.1093/bioinformatics/bts272; Cocquet J, 2006, GENOMICS, V88, P127, DOI 10.1016/j.ygeno.2005.12.013; DeLuca DS, 2012, BIOINFORMATICS, V28, P1530, DOI 10.1093/bioinformatics/bts196; Di Segni G, 2008, P NATL ACAD SCI USA, V105, P6864, DOI 10.1073/pnas.0800420105; Doring A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-11; Edgren H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r6; Fernandez-Cuesta L, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0558-0; Frenkel-Morgenstern M, 2015, NUCLEIC ACIDS RES, V43, pD68, DOI 10.1093/nar/gku1199; Frenkel-Morgenstern M, 2012, GENOME RES, V22, P1231, DOI 10.1101/gr.130062.111; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/nmeth.1613, 10.1038/NMETH.1613]; Garcia-Alcalde F, 2012, BIOINFORMATICS, V28, P2678, DOI 10.1093/bioinformatics/bts503; Gonzalez-Porta M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r70; Holtgrewe M., 2010, TECH REP TB B 10 06; Iyer MK, 2011, BIOINFORMATICS, V27, P2903, DOI 10.1093/bioinformatics/btr467; Jia WL, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-2-r12; Jividen K, 2014, GENE CHROMOSOME CANC, V53, P963, DOI 10.1002/gcc.22207; Kangaspeska S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048745; Kim D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r72; Kim HP, 2014, ONCOGENE, V33, P5434, DOI 10.1038/onc.2013.490; Kleinman CL, 2014, NAT GENET, V46, P39, DOI 10.1038/ng.2849; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li X, 2009, J MOL EVOL, V68, P56, DOI 10.1007/s00239-008-9187-0; Li Y, 2011, BIOINFORMATICS, V27, P1708, DOI 10.1093/bioinformatics/btr265; Liu SQ, 2015, MOL CELL TOXICOL, V11, P11, DOI 10.1007/s13273-015-0002-x; LUGO TG, 1990, SCIENCE, V247, P1079, DOI 10.1126/science.2408149; Maher CA, 2009, P NATL ACAD SCI USA, V106, P12353, DOI 10.1073/pnas.0904720106; McPherson A, 2012, GENOME RES, V22, P2250, DOI 10.1101/gr.136572.111; McPherson A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001138; Mertens F, 2015, NAT REV CANCER, V15, P371, DOI 10.1038/nrc3947; Mills JD, 2013, CURR GENOMICS, V14, P173, DOI 10.2174/1389202911314030003; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nicorici, 2014, BIORXIV, DOI [10.1101/011650, DOI 10.1101/011650V1]; Panagopoulos I, 2013, GENE CHROMOSOME CANC, V52, P610, DOI 10.1002/gcc.22057; Parra G, 2006, GENOME RES, V16, P37, DOI 10.1101/gr.4145906; Robinson DR, 2013, NAT GENET, V45, P180, DOI 10.1038/ng.2509; Ross MG, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r51; Rubin BP, 1998, AM J PATHOL, V153, P1451, DOI 10.1016/S0002-9440(10)65732-X; Sboner A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r104; Shah N, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-818; Sheng WQ, 2001, AM J CLIN PATHOL, V115, P348; Sims D, 2014, NAT REV GENET, V15, P121, DOI 10.1038/nrg3642; Steidl C, 2011, NATURE, V471, P377, DOI 10.1038/nature09754; Tarazona S, 2011, GENOME RES, V21, P2213, DOI 10.1101/gr.124321.111; Tognon C, 2002, CANCER CELL, V2, P367, DOI 10.1016/S1535-6108(02)00180-0; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Weirather JL, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv562; Wu CX, 2012, GENE CHROMOSOME CANC, V51, P1144, DOI 10.1002/gcc.21999	52	27	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167417	10.1371/journal.pone.0167417	http://dx.doi.org/10.1371/journal.pone.0167417			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907167	Green Submitted, gold, Green Published			2022-12-26	WOS:000389482700148
J	Dalem, A; Demeester, S; Balti, EV; Keymeulen, B; Gillard, P; Lapauw, B; De Blocks, C; Abrams, P; Weber, E; Vermeulen, I; De Pauw, P; Pipeleers, D; Weets, I; Gorus, FK				Van Dalem, Annelien; Demeester, Simke; Balti, Eric V.; Keymeulen, Bart; Gillard, Pieter; Lapauw, Bruno; De Blocks, Christophe; Abrams, Pascale; Weber, Eric; Vermeulen, Ilse; De Pauw, Pieter; Pipeleers, Daniel; Weets, Ilse; Gorus, Frans K.		Belgian Diabetes Registry	Prediction of Impending Type 1 Diabetes through Automated Dual-Label Measurement of Proinsulin: C-Peptide Ratio	PLOS ONE			English	Article							ACUTE INSULIN-RESPONSE; HYPERGLYCEMIC CLAMP; CLINICAL ONSET; ISLET AUTOANTIBODIES; PROGRESSION; SENSITIVITY; PREVENTION; RESISTANCE; APPEARANCE; ANTIBODIES	Background The hyperglycemic clamp test, the gold standard of beta cell function, predicts impending type 1 diabetes in islet autoantibody-positive individuals, but the latter may benefit from less invasive function tests such as the proinsulin: C-peptide ratio (PI:C). The present study aims to optimize precision of PI:C measurements by automating a dual-label trefoil-type time-resolved fluorescence immunoassay (TT-TRFIA), and to compare its diagnostic performance for predicting type 1 diabetes with that of clamp-derived C-peptide release. Methods Between-day imprecision (n = 20) and split-sample analysis (n = 95) were used to compare TT-TRFIA (Auto Delfia, Perkin-Elmer) with separate methods for proinsulin (in-house TRFIA) and C-peptide (Elecsys, Roche). High-risk multiple autoantibody-positive firstdegree relatives (n = 49; age 5-39) were tested for fasting PI:C, HOMA2-IR and hyperglycemic clamp and followed for 20-57 months (interquartile range). Results TT-TRFIA values for proinsulin, C-peptide and PI:C correlated significantly (r(2) = 0.96-0.99; P<0.001) with results obtained with separate methods. TT-TRFIA achieved better between-day % CV for PI:C at three different levels (4.5-7.1 vs 6.7-9.5 for separate methods). In high-risk relatives fasting PI:C was significantly and inversely correlated ( r(s) = -0.596; P<0.001) with first-phase C-peptide release during clamp ( also with second phase release, only available for age 12-39 years; n = 31), but only after normalization for HOMA2-IR. In ROC- and Cox regression analysis, HOMA2-IR-corrected PI:C predicted 2-year progression to diabetes equally well as clamp-derived C-peptide release. Conclusions The reproducibility of PI:C benefits from the automated simultaneous determination of both hormones. HOMA2-IR-corrected PI:C may serve as a minimally invasive alternative to the more tedious hyperglycemic clamp test.	[Van Dalem, Annelien; Demeester, Simke; Balti, Eric V.; Keymeulen, Bart; Gillard, Pieter; Vermeulen, Ilse; De Pauw, Pieter; Pipeleers, Daniel; Weets, Ilse; Gorus, Frans K.] Brussels Free Univ VUB, Diabet Res Ctr, Brussels, Belgium; [Van Dalem, Annelien; Demeester, Simke; Weets, Ilse; Gorus, Frans K.] Univ Ziekenhuis Brussel, Dept Clin Chem & Radioimmunol, Brussels, Belgium; [Keymeulen, Bart] Univ Ziekenhuis Brussel, Dept Diabetol, Brussels, Belgium; [Gillard, Pieter] Univ Ziekenhuis Leuven, Dept Endocrinol, Leuven, Belgium; [Lapauw, Bruno] Univ Ziekenhuis Gent, Dept Endocrinol, Ghent, Belgium; [De Blocks, Christophe] Univ Ziekenhuis Antwerpen, Dept Endocrinol Diabetol & Metab, Edegem, Belgium; [Abrams, Pascale] GZA Campus Sint Augustinus Sint Vincentius, Dept Endocrinol & Diabetol, Antwerp, Belgium; [Weber, Eric] Clin Sud Luxembourg, Dept Endocrinol & Diabetol, Arlon, Belgium; [Weber, Eric] Clin St Joseph, Arlon, Belgium	Vrije Universiteit Brussel; University Hospital Brussels; Vrije Universiteit Brussel; University Hospital Brussels; Vrije Universiteit Brussel; KU Leuven; University Hospital Leuven; Ghent University; Ghent University Hospital; University of Antwerp	Weets, I (corresponding author), Brussels Free Univ VUB, Diabet Res Ctr, Brussels, Belgium.; Weets, I (corresponding author), Univ Ziekenhuis Brussel, Dept Clin Chem & Radioimmunol, Brussels, Belgium.	ilsa.weets@uzbrussel.be	Gillard, Pieter/AAY-1483-2020; Gillard, Pieter/AAA-9820-2020; Gillard, Pieter/GPX-1490-2022; Lapauw, Bruno/AAB-4463-2021	Gillard, Pieter/0000-0001-9111-4561; Gillard, Pieter/0000-0001-9111-4561; De Pauw, Pieter/0000-0002-6463-4585; Gorus, Frans/0000-0002-9007-6177; Van Dalem, Annelien/0000-0003-2304-5298; Keymeulen, Bart/0000-0002-8671-4527; Pipeleers, Daniel/0000-0002-6440-2485; Demeester, Simke/0000-0001-7179-1717; Weets, Ilse/0000-0002-9007-5203	Juvenile Diabetes Research Foundation (JDRF) [4-2005-1327, 17-2012-615]; European Union (FP-7) [241883]; Research Foundation Flanders (FWO Vlaanderen) [G.0868.11, 1880115N, G080009N, 11D1214N]; Flemish government [IWT 130138]; Research Council of the Brussels Free University-VUB [OZR 1615]	Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); European Union (FP-7)(European Commission); Research Foundation Flanders (FWO Vlaanderen)(FWO); Flemish government(European Commission); Research Council of the Brussels Free University-VUB	This work was supported by Juvenile Diabetes Research Foundation (JDRF Center Grant No. 4-2005-1327 to DGP and Project No. 17-2012-615 to FKG), the European Union (FP-7 Project No. 241883), the Research Foundation Flanders (FWO Vlaanderen Projects No. G.0868.11; senior clinical research fellowship for IW (1880115N) and BK (G080009N); junior research fellowship for AVD (11D1214N)), the Flemish government (Grant No. IWT 130138), and the Research Council of the Brussels Free University-VUB (Projects No. OZR 1615).	[Anonymous], 2015, DIABETES CARE, V38, pS8, DOI 10.2337/dc15-S005; Bach JF, 2011, SEMIN IMMUNOL, V23, P174, DOI 10.1016/j.smim.2011.07.009; Balti EV, 2015, J CLIN ENDOCR METAB, V100, P551, DOI 10.1210/jc.2014-2035; BINGLEY PJ, 1993, DIABETES, V42, P213, DOI 10.2337/diabetes.42.2.213; Bingley PJ, 2008, DIABETES CARE, V31, P146, DOI 10.2337/dc07-0103; Carlsson A, 2010, ENDOCRINOLOGY, V151, P5048, DOI 10.1210/en.2010-0433; De Grijse J, 2010, DIABETOLOGIA, V53, P517, DOI 10.1007/s00125-009-1618-y; De Pauw PE, 2009, J CHROMATOGR B, V877, P2403, DOI 10.1016/j.jchromb.2008.11.024; De Pauw PEM, 2008, CLIN CHEM, V54, P1990, DOI 10.1373/clinchem.2008.109710; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dons RF, 2009, ENDOCRINE METABOLIC, pXXV; Elahl D, 1996, DIABETES CARE, V19, P278, DOI 10.2337/diacare.19.3.278; GARCIAWEBB P, 1983, CLIN CHIM ACTA, V129, P103, DOI 10.1016/0009-8981(83)90157-2; Gorus FK, 2013, CLIN EXP IMMUNOL, V171, P82, DOI 10.1111/j.1365-2249.2012.04675.x; Gorus FK, 2013, EXPERT REV CLIN IMMU, V9, P1173, DOI 10.1586/1744666X.2013.856757; Helminen O, 2015, DIABETES, V64, P1719, DOI 10.2337/db14-0497; Insel RA, 2015, DIABETES CARE, V38, P1964, DOI 10.2337/dc15-1419; KJEMS LL, 1993, CLIN CHEM, V39, P2146; Levene H., 1960, CONTRIBUTIONS PROBAB, P278; Mahon JL, 1997, DIABETES CARE, V20, P1027, DOI 10.2337/diacare.20.6.1027; Meah FA, 2016, DIABETOLOGIA, V59, P1186, DOI 10.1007/s00125-016-3924-5; Mykkanen L, 1997, DIABETES, V46, P1990, DOI 10.2337/diabetes.46.12.1990; Mykkanen L, 1999, DIABETOLOGIA, V42, P1060, DOI 10.1007/s001250051271; Petrie JR, 1996, CLIN SCI, V91, P65, DOI 10.1042/cs0910065; RODER ME, 1994, J CLIN ENDOCR METAB, V79, P1570, DOI 10.1210/jc.79.6.1570; Roder ME, 1998, J CLIN ENDOCR METAB, V83, P604, DOI 10.1210/jc.83.2.604; Rodriguez-Cabaleiro D, 2006, CLIN CHEM, V52, P1193, DOI 10.1373/clinchem.2005.062505; Saisho Y, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050744; Selo I, 1996, J IMMUNOL METHODS, V199, P127, DOI 10.1016/S0022-1759(96)00173-1; Siljander HT, 2013, EUR J ENDOCRINOL, V169, P479, DOI 10.1530/EJE-13-0206; Sims EK, 2016, DIABETES CARE, V39, P1519, DOI 10.2337/dc15-2849; Skyler JS, 2013, DIABETIC MED, V30, P161, DOI 10.1111/dme.12100; Steck AK, 2015, DIABETES CARE, V38, P808, DOI 10.2337/dc14-2426; Steck AK, 2011, DIABETES CARE, V34, P1397, DOI 10.2337/dc10-2088; Truyen I, 2005, DIABETOLOGIA, V48, P2322, DOI 10.1007/s00125-005-1959-0; Van Dalem A, 2015, DIABETOLOGIA, V58, P2753, DOI 10.1007/s00125-015-3761-y; Vandemeulebroucke E, 2010, DIABETOLOGIA, V53, P36, DOI 10.1007/s00125-009-1569-3; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Wareham NJ, 1999, DIABETES CARE, V22, P262, DOI 10.2337/diacare.22.2.262; Watkins RA, 2016, TRANSL RES, V168, P96, DOI 10.1016/j.trsl.2015.08.010; Zethelius B, 2004, DIABETES CARE, V27, P1433, DOI 10.2337/diacare.27.6.1433; Ziegler AG, 2013, JAMA-J AM MED ASSOC, V309, P2473, DOI 10.1001/jama.2013.6285	43	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166702	10.1371/journal.pone.0166702	http://dx.doi.org/10.1371/journal.pone.0166702			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907006	gold, Green Published, Green Submitted			2022-12-26	WOS:000389482700036
J	Kanemoto, K; Fukuta, K; Kawai, N; Tozawa, K; Ochiai, M; Okamoto, K; Ohnami, S; Sakamoto, H; Yoshida, T; Kanai, Y; Katoh, M; Yasui, T; Kohri, K; Kakizoe, T; Nakagama, H				Kanemoto, Kazuhiro; Fukuta, Katsuhiro; Kawai, Noriyasu; Tozawa, Keiichi; Ochiai, Masako; Okamoto, Koji; Ohnami, Sumiko; Sakamoto, Hiromi; Yoshida, Teruhiko; Kanai, Yae; Katoh, Masaru; Yasui, Takahiro; Kohri, Kenjiro; Kakizoe, Tadao; Nakagama, Hitoshi			Genomic Landscape of Experimental Bladder Cancer in Rodents and Its Application to Human Bladder Cancer: Gene Amplification and Potential Overexpression of Cyp2a5/CYP2A6 Are Associated with the Invasive Phenotype	PLOS ONE			English	Article							CONFERS SUSCEPTIBILITY; SYNERGISTIC CYTOTOXICITY; URINARY METABOLITE; SEQUENCE VARIANT; WIDE ASSOCIATION; TUMOR INVASION; C-OXIDATION; COPY NUMBER; CYP2A6; INDUCTION	Non-muscle invasive (superficial) bladder cancer is a low-grade malignancy with good prognosis, while muscle invasive (invasive) bladder cancer is a high-grade malignancy with poor prognosis. N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN) induces superficial bladder cancers with papillary morphology in rats and invasive bladder cancers with infiltrating phenotype in mice. In this study, we analyzed genomic landscapes of rodent BBN-induced bladder cancers using array-based comparative genomic hybridization (array CGH). While no significant copy number alterations were detected in superficial bladder tumors in rats, copy number gains in chromosomal regions 2D-E1, 7qA3, 9F2, and 11C-D were detected in invasive bladder tumors in mice. Amplification of representative genes located on 2D-E1 and 7qA3 chromosomal regions was confirmed by quantitative PCR. Cyp2a22 and Cyp2a5 genes but not Cyp2g1, Cyp2a12, and Rab4b genes on mouse chromosome 7qA3 were amplified in invasive bladder cancers. Although the human ortholog gene of Cyp2a22 has not been confirmed, the mouse Cyp2a5 gene is the ortholog of the human CYP2A6 gene located in chromosomal region 19q13.2, and CYP2A6 was identified by database search as one of the closest human homolog to mouse Cyp2a22. Considering a possibility that this region may be related to mouse 7qA3, we analyzed CYP2A6 copy number and expression in human bladder cancer using cell lines and resected tumor specimens. Although only one of eight cell lines showed more than one copy increase of the CYP2A6 gene, CYP2A6 amplification was detected in six out of 18 primary bladder tumors where it was associated with the invasive phenotype. Immunohistochemical analyses of 118 primary bladder tumors revealed that CYP2A6 protein expression was also higher in invasive tumors, especially in those of the scattered type. Together, these findings indicate that the amplification and overexpression of the CYP2A6 gene are characteristic of human bladder cancers with increased malignancy and that CYP2A6 can be a candidate prognostic biomarker in this type of cancer.	[Kanemoto, Kazuhiro; Ochiai, Masako; Nakagama, Hitoshi] Natl Canc Ctr, Div Canc Dev Syst, Res Inst, Tokyo, Japan; [Kanemoto, Kazuhiro; Fukuta, Katsuhiro; Kawai, Noriyasu; Tozawa, Keiichi; Yasui, Takahiro; Kohri, Kenjiro] Nagoya City Univ, Grad Sch Med Sci, Dept Nephrourol, Nagoya, Aichi, Japan; [Okamoto, Koji] Natl Canc Ctr, Div Canc Differentiat, Res Inst, Tokyo, Japan; [Ohnami, Sumiko; Sakamoto, Hiromi; Yoshida, Teruhiko] Natl Canc Ctr, Div Genet, Res Inst, Tokyo, Japan; [Kanai, Yae] Natl Canc Ctr, Div Mol Pathol, Res Inst, Tokyo, Japan; [Katoh, Masaru] Natl Canc Ctr, Dept Omics Network, Res Inst, Tokyo, Japan; [Kakizoe, Tadao] Natl Canc Ctr, Res Inst, Tokyo, Japan	National Cancer Center - Japan; Nagoya City University; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan	Kanemoto, K; Nakagama, H (corresponding author), Natl Canc Ctr, Div Canc Dev Syst, Res Inst, Tokyo, Japan.; Kanemoto, K (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Nephrourol, Nagoya, Aichi, Japan.	k.kanemoto7@gmail.com; hnakagam@ncc.go.jp	Kanai, Yae/AAE-6987-2019; YASUI, Takahiro/E-6401-2018	YASUI, Takahiro/0000-0003-2197-2477; Katoh, Masaru/0000-0003-3274-4066				Agundez JAG, 2004, CURR DRUG METAB, V5, P211, DOI 10.2174/1389200043335621; Babjuk M, 2013, EUR UROL, V64, P639, DOI 10.1016/j.eururo.2013.06.003; BELL DA, 1993, J NATL CANCER I, V85, P1159, DOI 10.1093/jnci/85.14.1159; Blaveri E, 2005, CLIN CANCER RES, V11, P7012, DOI 10.1158/1078-0432.CCR-05-0177; Blaveri E, 2005, CLIN CANCER RES, V11, P4044, DOI 10.1158/1078-0432.CCR-04-2409; Chu HY, 2013, J BIOMED RES, V27, P170, DOI 10.7555/JBR.27.20130026; Edwards RJ, 2003, DRUG METAB DISPOS, V31, P1476, DOI 10.1124/dmd.31.12.1476; FERNANDEZSALGUERO P, 1995, AM J HUM GENET, V57, P651; Figueroa JD, 2014, HUM MOL GENET, V23, P1387, DOI 10.1093/hmg/ddt519; Fujiwara K, 2004, CARCINOGENESIS, V25, P1495, DOI 10.1093/carcin/bgh155; HASHIMOTO Y, 1972, GANN, V63, P637; HASHIMOTO Y, 1974, GANN, V65, P69; Iyer G, 2013, J CLIN ONCOL, V31, P3133, DOI 10.1200/JCO.2012.46.5740; Katoh M, 2011, CURR PHARM BIOTECHNO, V12, P160, DOI 10.2174/138920111794295710; Kawanishi H, 2008, CLIN CANCER RES, V14, P2579, DOI 10.1158/1078-0432.CCR-07-1922; Kiemeney LA, 2008, NAT GENET, V40, P1307, DOI 10.1038/ng.229; Kiemeney LA, 2010, NAT GENET, V42, P415, DOI 10.1038/ng.558; Knowles MA, 2006, CARCINOGENESIS, V27, P361, DOI 10.1093/carcin/bgi310; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lindgren D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038863; London SJ, 1999, LANCET, V353, P898, DOI 10.1016/S0140-6736(98)04984-8; Matsuda K, 2015, HUM MOL GENET, V24, P1177, DOI 10.1093/hmg/ddu512; Matsuda Y, 2007, CANCER SCI, V98, P1582, DOI 10.1111/j.1349-7006.2007.00572.x; Matsuda Y, 2007, ONCOL REP, V18, P53; Matsui Y, 2007, CANCER RES, V67, P1212, DOI 10.1158/0008-5472.CAN-06-3283; Messina ES, 1997, J PHARMACOL EXP THER, V282, P1608; Miyazaki M, 2005, CARCINOGENESIS, V26, P1947, DOI 10.1093/carcin/bgi156; Mizutani Y, 1999, CLIN CANCER RES, V5, P2605; Mizutani Y, 2002, J UROLOGY, V168, P2650, DOI 10.1016/S0022-5347(05)64237-1; Nakada T, 2012, J TOXICOL SCI, V37, P555; Nakagama H, 1997, P NATL ACAD SCI USA, V94, P10813, DOI 10.1073/pnas.94.20.10813; Nakajima M, 1996, DRUG METAB DISPOS, V24, P1212; Nishiyama N, 2011, CARCINOGENESIS, V32, P462, DOI 10.1093/carcin/bgq274; Ochiai M, 2003, AM J PATHOL, V163, P1607, DOI 10.1016/S0002-9440(10)63517-1; OKADA M, 1977, XENOBIOTICA, V7, P11, DOI 10.3109/00498257709036241; Rothman N, 2010, NAT GENET, V42, P978, DOI 10.1038/ng.687; Saito R, 2013, ONCOGENE, V32, P894, DOI 10.1038/onc.2012.101; Sampson JN, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv279; Song DK, 2009, CANCER DETECT PREV, V32, P416, DOI 10.1016/j.cdp.2009.02.003; Sugano K, 2006, NAT CLIN PRACT UROL, V3, P642, DOI 10.1038/ncpuro0649; SUGIMURA T, 1992, SCIENCE, V258, P603, DOI 10.1126/science.1411570; Vedder MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096849; Veltman JA, 2003, CANCER RES, V63, P2872; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Witjes JA, 2014, EUR UROL, V65, P778, DOI 10.1016/j.eururo.2013.11.046; Wu XF, 2009, NAT GENET, V41, P991, DOI 10.1038/ng.421; Zeegers MPA, 2000, CANCER-AM CANCER SOC, V89, P630, DOI 10.1002/1097-0142(20000801)89:3<630::AID-CNCR19>3.0.CO;2-Q; Zeegers MPA, 2001, OCCUP ENVIRON MED, V58, P590, DOI 10.1136/oem.58.9.590; Zhang B, 2014, NATURE, V513, P382, DOI 10.1038/nature13438	49	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167374	10.1371/journal.pone.0167374	http://dx.doi.org/10.1371/journal.pone.0167374			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902773	Green Published, gold, Green Submitted			2022-12-26	WOS:000389474100079
J	Morici, P; Fais, R; Rizzato, C; Tavanti, A; Lupetti, A				Morici, Paola; Fais, Roberta; Rizzato, Cosmeri; Tavanti, Arianna; Lupetti, Antonella			Inhibition of Candida albicans Biofilm Formation by the Synthetic Lactoferricin Derived Peptide hLF1-11	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDES; GENE-EXPRESSION; GROWTH; INFECTIONS; MECHANISMS; VIRULENCE; PATHWAYS; CELLS	The aim of this study was to evaluate the in vitro activity of the synthetic peptide hLF1-11 against biofilm produced by clinical isolates of Candida albicans with different fluconazole susceptibility. The antibiofilm activity of the peptide hLF1-11 was assessed in terms of reduction of biofilm cellular density, metabolic activity and sessile cell viability. The extent of morphogenesis in hLF1-11 treated and untreated biofilms was also investigated microscopically. Transcription levels of genes related to cell adhesion, hyphal development and extracellular matrix production were analysed by qRT-PCR in hLF1-11 treated and untreated biofilms. Exogenous dibutyryl-cAMP (db-cAMP) was used to rescue morphogenesis in cells exposed to the peptide. The results revealed that hLF1-11 exhibited an inhibitory effect on biofilm formation by all C. albicans isolates tested in a dose-dependent manner, regardless of their fluconazole susceptibility. Visual inspection of treated or untreated biofilm cells with an inverted microscope revealed a significant reduction in hyphal formation by hLF1-11 treated cells, as early as 3 hours of incubation. Moreover, hLF1-11 showed a reduced activity on preadherent cells. hLF1-11 induced the down-regulation of biofilm and hyphal-associated genes, which were predominantly regulated via the Ras1-cAMP-Efg1 pathway. Indeed, exogenous db-cAMP restored morphogenesis in hLF1-11 treated cells. The hLF1-11 peptide significantly inhibited biofilm formation by C. albicans mainly at early stages, interfering with biofilm cellular density and metabolic activity, and affected morphogenesis through the Ras1-cAMP-Efg1 pathway. Our findings provide the first evidence that hLF1-11 could represent a potential candidate for the prevention of biofilm formation by C. albicans.	[Morici, Paola; Fais, Roberta; Rizzato, Cosmeri; Lupetti, Antonella] Univ Pisa, Dept Translat Res & New Technol Med & Surg, Pisa, Italy; [Tavanti, Arianna] Univ Pisa, Dept Biol, Pisa, Italy; [Morici, Paola] CNR, Inst Nanosci, NEST, Pisa, Italy; [Morici, Paola] Scuola Normale Super Pisa, Pisa, Italy	University of Pisa; University of Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto Nanoscienze (NANO-CNR); Scuola Normale Superiore di Pisa	Lupetti, A (corresponding author), Univ Pisa, Dept Translat Res & New Technol Med & Surg, Pisa, Italy.	antonella.lupetti@med.unipi.it	Rizzato, Cosmeri/AAI-1261-2020	Tavanti, Arianna/0000-0001-5791-686X	Italian Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) [2012WJSX8K_005]	Italian Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work was supported by the Italian Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR), research grant number 2012WJSX8K_005.	Al-Fattani MA, 2006, J MED MICROBIOL, V55, P999, DOI 10.1099/jmm.0.46569-0; Alves D, 2014, BIOFOULING, V30, P483, DOI 10.1080/08927014.2014.889120; BELLAMY W, 1992, BIOCHIM BIOPHYS ACTA, V1121, P130, DOI 10.1016/0167-4838(92)90346-F; Biswas S, 2007, MICROBIOL MOL BIOL R, V71, P348, DOI 10.1128/MMBR.00009-06; Bonhomme J, 2013, CURR OPIN MICROBIOL, V16, P398, DOI 10.1016/j.mib.2013.03.007; Chandra J, 2001, J BACTERIOL, V183, P5385, DOI 10.1128/JB.183.18.5385-5394.2001; Clinical LSI, 2008, M27A3 CLIN LSI; Dongari-Bagtzoglou A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007967; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Douglas LJ, 2003, TRENDS MICROBIOL, V11, P30, DOI 10.1016/S0966-842X(02)00002-1; Fox JL, 2013, NAT BIOTECHNOL, V31, P379, DOI 10.1038/nbt.2572; Godoy-Gallardo M, 2014, ACTA BIOMATER, V10, P3522, DOI 10.1016/j.actbio.2014.03.026; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Hasan F, 2009, MICROBES INFECT, V11, P753, DOI 10.1016/j.micinf.2009.04.018; Hogan DA, 2009, FUTURE MICROBIOL, V4, P1263, DOI 10.2217/FMB.09.106; Kim MJ, 2008, J MICROBIOL BIOTECHN, V18, P242; Lane S, 2001, MOL CELL BIOL, V21, P6418, DOI 10.1128/MCB.21.19.6418-6428.2001; Leberer E, 2001, MOL MICROBIOL, V42, P673, DOI 10.1046/j.1365-2958.2001.02672.x; Li Y, 2009, BIOCHIMIE, V91, P58, DOI 10.1016/j.biochi.2008.04.014; Lupetti A, 2002, ANTIMICROB AGENTS CH, V46, P1634, DOI 10.1128/AAC.46.6.1634-1639.2002; Lupetti A, 2007, J INFECT DIS, V196, P1416, DOI 10.1086/522427; Nibbering PH, 2001, INFECT IMMUN, V69, P1469, DOI 10.1128/IAI.69.3.1469-1476.2001; Nobile CJ, 2006, EUKARYOT CELL, V5, P1604, DOI 10.1128/EC.00194-06; Nobile CJ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000133; Nuijens JH, 1996, J MAMMARY GLAND BIOL, V1, P285, DOI 10.1007/BF02018081; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Ramage G, 2005, EUKARYOT CELL, V4, P633, DOI 10.1128/EC.4.4.633-638.2005; Ramage G, 2002, FEMS MICROBIOL LETT, V214, P95, DOI 10.1111/j.1574-6968.2002.tb11330.x; Raman N, 2015, PHARMACEUTICALS, V8, P483, DOI 10.3390/ph8030483; Staab JF, 1999, SCIENCE, V283, P1535, DOI 10.1126/science.283.5407.1535; Sudbery PE, 2011, NAT REV MICROBIOL, V9, P737, DOI 10.1038/nrmicro2636; Sun LM, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0117695, 10.1371/journal.pone.0143820]; Taff HT, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002848; Tati S, 2014, ANTIMICROB AGENTS CH, V58, P756, DOI 10.1128/AAC.01851-13; Theberge S, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-246; Tronchin G, 2008, MED MYCOL, V46, P749, DOI 10.1080/13693780802206435; Tsai PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017755; van der Does AM, 2012, J INNATE IMMUN, V4, P284, DOI 10.1159/000332941; van der Does AM, 2010, BIOMETALS, V23, P493, DOI 10.1007/s10534-010-9322-4; van der Velden WJFM, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-44; Viudes A, 2002, EUR J CLIN MICROBIOL, V21, P767, DOI 10.1007/s10096-002-0822-1; Vriens K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132701; Wenzel RP, 2005, CLIN INFECT DIS, V41, pS389, DOI 10.1086/430923; Zhao LX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079671	44	41	43	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167470	10.1371/journal.pone.0167470	http://dx.doi.org/10.1371/journal.pone.0167470			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902776	Green Published, Green Submitted, gold			2022-12-26	WOS:000389474100084
J	Nelson, GD; Rae, A				Nelson, Garrett Dash; Rae, Alasdair			An Economic Geography of the United States: From Commutes to Megaregions	PLOS ONE			English	Article								The emergence in the United States of large-scale "megaregions" centered on major metropolitan areas is a phenomenon often taken for granted in both scholarly studies and popular accounts of contemporary economic geography. This paper uses a data set of more than 4,000,000 commuter flows as the basis for an empirical approach to the identification of such megaregions. We compare a method which uses a visual heuristic for understanding areal aggregation to a method which uses a computational partitioning algorithm, and we reflect upon the strengths and limitations of both. We discuss how choices about input parameters and scale of analysis can lead to different results, and stress the importance of comparing computational results with "common sense" interpretations of geographic coherence. The results provide a new perspective on the functional economic geography of the United States from a megaregion perspective, and shed light on the old geographic problem of the division of space into areal units.	[Nelson, Garrett Dash] Dartmouth Coll, Dept Geog, Hanover, NH 03755 USA; [Nelson, Garrett Dash] Dartmouth Coll, Soc Fellows, Hanover, NH 03755 USA; [Rae, Alasdair] Univ Sheffield, Dept Urban Studies & Planning, Sheffield, S Yorkshire, England	Dartmouth College; Dartmouth College; University of Sheffield	Rae, A (corresponding author), Univ Sheffield, Dept Urban Studies & Planning, Sheffield, S Yorkshire, England.	a.j.rae@sheffield.ac.uk		Rae, Alasdair/0000-0003-0136-7659	University of Sheffield	University of Sheffield	The publication fee for this article was provided by the University of Sheffield.	Agnew J, 1994, REV INT POLIT ECON, V1, P53, DOI 10.1080/09692299408434268; Amin Ash, 2004, GEOGR ANN B, V86, P33, DOI [10.1111/j.0435-3684.2004.00152.x, DOI 10.1111/j.0435-3684.2004.00152.x]; [Anonymous], 1954, BALKANIZATION LABOR; [Anonymous], [No title captured]; [Anonymous], 1974, PROG PLANN; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], 1970, EC SCI; [Anonymous], [No title captured]; Bogart WT, 1999, URBAN STUD, V36, P2099, DOI 10.1080/0042098992566; Cervero R, 1998, URBAN STUD, V35, P1059, DOI 10.1080/0042098984484; Cervero R, 1997, ENVIRON PLANN A, V29, P865, DOI 10.1068/a290865; Christaller W., 1933, CENTRAL PLACES SO GE; Clark WAV, 2003, REG SCI URBAN ECON, V33, P199, DOI 10.1016/S0166-0462(02)00012-1; Cronon William., 1991, NATURES METROPOLIS C; Dewar M, 2007, J PLAN LIT, V22, P108, DOI 10.1177/0885412207306615; Dickinson RE, 1947, CITY REGION REGIONAL; Gaudart J, 2015, J STAT SOFTW, V63, P1; Gottmann J., 1961, MEGALOPOLIS URBANIZE; Hanson S, 2004, GEOGRAPHY URBAN TRAN, Vthird; Hartshorne R, 1939, ANN ASSOC AM GEOGR, V29, P173, DOI 10.2307/2561063; Innes JE, 2011, J AM PLANN ASSOC, V77, P55, DOI 10.1080/01944363.2011.533640; Jones Clarence F., 1954, AM GEOGRAPHY INVENTO, P19; Jones M, 2009, PROG HUM GEOG, V33, P487, DOI 10.1177/0309132508101599; Kallus Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126713; Khanna Parag., 2016, SEXUALNESS; MacEachren A.M., 1995, MAPS WORK REPRESENTA; McKenzie B., 2014, DESIGN COMP LODES AC, P14; McLafferty S, 1996, PROF GEOGR, V48, P420, DOI 10.1111/j.0033-0124.1996.00420.x; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; PAASI A, 1991, ENVIRON PLANN A, V23, P239, DOI 10.1068/a230239; Papps K., 2002, 443 IZA; Peterson M., 1987, CARTOGR J, V24, P35; Polya G., 1945, AM MATH MON, DOI DOI 10.2307/2306109; Rae A, 2009, COMPUT ENVIRON URBAN, V33, P161, DOI 10.1016/j.compenvurbsys.2009.01.007; Ratti C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014248; RICHARDSON HW, 1988, ANN REGIONAL SCI, V22, P1, DOI 10.1007/BF01287319; Royuela V, 2009, URBAN STUD, V46, P2381, DOI 10.1177/0042098009342600; Sauer CO, 1918, AM POLIT SCI REV, V12, P403, DOI 10.2307/1946093; SIMON HA, 1990, ANNU REV PSYCHOL, V41, P1, DOI 10.1146/annurev.ps.41.020190.000245; Smelcer JB, 1997, DECISION SCI, V28, P391, DOI 10.1111/j.1540-5915.1997.tb01316.x; Sobolevsky S, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.012811; Sobolevsky S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081707; TOBLER WR, 1970, ECON GEOGR, V46, P234, DOI 10.2307/143141; Tolbert C., 1987, LABOR MARKET AREAS U; Tolbert C. M., 1996, 9614 ERS	50	80	81	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0166083	10.1371/journal.pone.0166083	http://dx.doi.org/10.1371/journal.pone.0166083			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FV	27902707	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000389474100011
J	Saini, V; Zhao, HG; Petit, ET; Gori, F; Demay, MB				Saini, Vaibhav; Zhao, Hengguang; Petit, Elizabeth T.; Gori, Francesca; Demay, Marie B.			Absence of vitamin D receptor (VDR)-mediated PPAR gamma suppression causes alopecia in VDR-null mice	FASEB JOURNAL			English	Article						hair cycle; vitamin D-resistant rickets; keratinocyte stem cell; mouse model	HAIR FOLLICLE MORPHOGENESIS; KNOCKOUT MICE; STEM-CELLS; TARGETED ABLATION; SIGNALING PATHWAY; ANIMAL-MODEL; EXPRESSION; DIFFERENTIATION; RICKETS; SKIN	Vitamin D receptor (VDR) mutations in humans and mice cause alopecia. VDR-null (VDR-/-) mice exhibit lack of postmorphogenic hair cycles as a result of impaired keratinocyte stem cell (KSC) function. To identify the molecular basis for abnormal KSC function, RNA sequencing of wild-type(WT) and VDR-/- KSCs was performed. These studies demonstrated that >80% of differentially expressed genes are up-regulated in VDR-/- KSCs; thus, the VDR is a transcriptional suppressor in WT KSCs. Peroxisome proliferator-activated receptor gamma (PPAR gamma), PPAR gamma coactivator 1 beta (PGC1 beta), and lipoprotein lipase (LPL) were among the up-regulated genes identified. Chromatin immunoprecipitation analyses demonstrated that these genes are direct VDR targets in WT keratinocytes. Notably, VDR occupancy of the PPAR gamma regulatory region precludes PPAR gamma occupancy of this site, based on the observation that PPAR gamma interacts with these sequences in VDR-/- but not WT keratinocytes. This contrasts with the VDR and PPAR gamma co-occupancy observed on PGC1 beta and LPL gene regulatory regions identified. Studies in mice with keratinocyte-specific PPAR gamma haploinsufficiency were performed to identify the functional consequences of enhanced PPAR gamma expression. PPAR gamma haploinsufficiency normalized PPAR gamma mRNA levels in VDR-/- keratinocytes and restored anagen responsiveness in vivo in VDR-/- mice, resulting in hair regrowth. Thus, absence of VDR-mediated PPAR gamma suppression underlies alopecia in VDR-/- mice.	[Saini, Vaibhav; Zhao, Hengguang; Petit, Elizabeth T.; Gori, Francesca; Demay, Marie B.] Harvard Med Sch, Massachusetts Gen Hosp, Endocrine Unit, Boston, MA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Demay, MB (corresponding author), Massachusetts Gen Hosp, 50 Blossom St,Thier 11, Boston, MA 02114 USA.	demay@helix.mgh.harvard.edu	Gori, Francesca/S-9422-2019		U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [DK46974]; Center for Skeletal Research Core (NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases) [P30 AR066261]; Endocrine Unit at Massachusetts General Hospital; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR066261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046974] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Center for Skeletal Research Core (NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases); Endocrine Unit at Massachusetts General Hospital; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in part, by U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases Grant DK46974 (to M.B.D). The authors thank the Center for Skeletal Research Core (NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases; P30 AR066261), and the Endocrine Unit at Massachusetts General Hospital, for supporting histological analyses.	Alimirah F, 2012, EXP CELL RES, V318, P2490, DOI 10.1016/j.yexcr.2012.07.020; Alonso L, 2006, J CELL SCI, V119, P391, DOI 10.1242/jcs02793; Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; Chen CH, 2001, ENDOCRINOLOGY, V142, P5386, DOI 10.1210/en.142.12.5386; Cianferotti L, 2007, P NATL ACAD SCI USA, V104, P9428, DOI 10.1073/pnas.0702884104; Dardenne O, 2001, ENDOCRINOLOGY, V142, P3135, DOI 10.1210/en.142.7.3135; Ding N, 2013, CELL, V153, P601, DOI 10.1016/j.cell.2013.03.028; Feldman David, 2014, Bonekey Rep, V3, P510, DOI 10.1038/bonekey.2014.5; Festa E, 2011, CELL, V146, P761, DOI 10.1016/j.cell.2011.07.019; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Hsu YC, 2014, NAT MED, V20, P847, DOI 10.1038/nm.3643; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; HUGHES MR, 1988, SCIENCE, V242, P1702, DOI 10.1126/science.2849209; Karnik P, 2009, J INVEST DERMATOL, V129, P1243, DOI 10.1038/jid.2008.369; Kishimoto J, 2000, GENE DEV, V14, P1181; Lee SM, 2014, ENDOCRINOLOGY, V155, P4137, DOI 10.1210/en.2014-1417; Li YC, 1997, P NATL ACAD SCI USA, V94, P9831, DOI 10.1073/pnas.94.18.9831; Li YC, 1998, ENDOCRINOLOGY, V139, P4391, DOI 10.1210/en.139.10.4391; Lim XH, 2013, SCIENCE, V342, P1226, DOI 10.1126/science.1239730; Lim XH, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008029; Lim YY, 2014, CLIN EXP DERMATOL, V39, P368, DOI 10.1111/ced.12241; Lisse TS, 2014, MOL ENDOCRINOL, V28, P1698, DOI 10.1210/me.2014-1043; Luderer HF, 2011, J BIOL CHEM, V286, P18444, DOI 10.1074/jbc.M110.188219; Niemann C, 2002, DEVELOPMENT, V129, P95; Palmer HG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001483; Panda DK, 2001, P NATL ACAD SCI USA, V98, P7498, DOI 10.1073/pnas.131029498; Reddy S, 2001, MECH DEVELOP, V107, P69, DOI 10.1016/S0925-4773(01)00452-X; REICHRATH J, 1994, BRIT J DERMATOL, V131, P477; Rieusset J, 2004, MOL ENDOCRINOL, V18, P2363, DOI 10.1210/me.2003-0325; Rivier M, 1998, J INVEST DERMATOL, V111, P1116, DOI 10.1046/j.1523-1747.1998.00439.x; Sakai Y, 2001, J CLIN INVEST, V107, P961, DOI 10.1172/JCI11676; Sakai Y, 2000, ENDOCRINOLOGY, V141, P2043, DOI 10.1210/en.141.6.2043; Sherman MH, 2014, CELL, V159, P80, DOI 10.1016/j.cell.2014.08.007; Skorija K, 2005, MOL ENDOCRINOL, V19, P855, DOI 10.1210/me.2004-0415; Teichert A, 2010, J CELL PHYSIOL, V225, P482, DOI 10.1002/jcp.22227; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; Wakabayashi K, 2009, MOL CELL BIOL, V29, P3544, DOI 10.1128/MCB.01856-08; Wang FF, 2013, P NATL ACAD SCI USA, V110, P18656, DOI 10.1073/pnas.1314863110; Wang L, 2016, SCIENCE, V351, P613, DOI 10.1126/science.aad5440; Yoshizawa T, 1997, NAT GENET, V16, P391, DOI 10.1038/ng0897-391	40	6	6	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2017	31	3					1059	+		10.1096/fj.201600863R	http://dx.doi.org/10.1096/fj.201600863R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EM9ZX	27932380	Green Published			2022-12-26	WOS:000395671200020
J	Cole, DK; van den Berg, HA; Lloyd, A; Crowther, MD; Beck, K; Ekeruche-Makinde, J; Miles, JJ; Bulek, AM; Dolton, G; Schauenburg, AJ; Wall, A; Fuller, A; Clement, M; Laugel, B; Rizkallah, PJ; Wooldridge, L; Sewell, AK				Cole, David K.; van den Berg, Hugo A.; Lloyd, Angharad; Crowther, Michael D.; Beck, Konrad; Ekeruche-Makinde, Julia; Miles, John J.; Bulek, Anna M.; Dolton, Garry; Schauenburg, Andrea J.; Wall, Aaron; Fuller, Anna; Clement, Mathew; Laugel, Bruno; Rizkallah, Pierre J.; Wooldridge, Linda; Sewell, Andrew K.			Structural Mechanism Underpinning Cross-reactivity of a CD8(+) T-cell Clone That Recognizes a Peptide Derived from Human Telomerase Reverse Transcriptase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS-I; CARDIOVASCULAR TOXICITY; RECEPTOR RECOGNITION; ANTIGEN RECOGNITION; BETA-CELLS; AFFINITY; BINDING; TCR; SPECIFICITY	T-cell cross-reactivity is essential for effective immune surveillance but has also been implicated as a pathway to autoimmunity. Previous studies have demonstrated that T-cell receptors (TCRs) that focus on a minimal motif within the peptide are able to facilitate a high level of T-cell cross-reactivity. However, the structural database shows that most TCRs exhibit less focused antigen binding involving contact with more peptide residues. To further explore the structural features that allow the clonally expressed TCR to functionally engage with multiple peptide-major histocompatibility complexes (pMHCs), we examined the ILA1 CD8(+) T-cell clone that responds to a peptide sequence derived from human telomerase reverse transcriptase. The ILA1 TCR contacted its pMHC with a broad peptide binding footprint encompassing spatially distant peptide residues. Despite the lack of focused TCR-peptide binding, the ILA1 T-cell clone was still cross-reactive. Overall, the TCR-peptide contacts apparent in the structure correlated well with the level of degeneracy at different peptide positions. Thus, the ILA1 TCR was less tolerant of changes at peptide residues that were at, or adjacent to, key contact sites. This study provides new insights into the molecular mechanisms that control T-cell cross-reactivity with important implications for pathogen surveillance, autoimmunity, and transplant rejection.	[Cole, David K.; Lloyd, Angharad; Crowther, Michael D.; Ekeruche-Makinde, Julia; Miles, John J.; Bulek, Anna M.; Dolton, Garry; Schauenburg, Andrea J.; Wall, Aaron; Fuller, Anna; Clement, Mathew; Laugel, Bruno; Rizkallah, Pierre J.; Sewell, Andrew K.] Cardiff Univ, Sch Med, Div Infect & Immun, Heath Pk, Cardiff CF14 4XN, S Glam, Wales; [Cole, David K.; Lloyd, Angharad; Crowther, Michael D.; Ekeruche-Makinde, Julia; Miles, John J.; Bulek, Anna M.; Dolton, Garry; Schauenburg, Andrea J.; Wall, Aaron; Fuller, Anna; Clement, Mathew; Laugel, Bruno; Rizkallah, Pierre J.; Sewell, Andrew K.] Cardiff Univ, Sch Med, Syst Immun Res Inst, Heath Pk, Cardiff CF14 4XN, S Glam, Wales; [van den Berg, Hugo A.] Univ Warwick, Math Inst, Coventry CV4 7AL, W Midlands, England; [Beck, Konrad] Cardiff Univ, Sch Dent, Heath Pk, Cardiff CF14 4XY, S Glam, Wales; [Miles, John J.] Queensland Inst Med Res, Berghofer Med Res Inst, Brisbane, Qld 4029, Australia; [Miles, John J.] James Cook Univ, Cairns, Qld 4870, Australia; [Wooldridge, Linda] Univ Bristol, Fac Hlth Sci, Bristol BS8 1TD, Avon, England	Cardiff University; Cardiff University; University of Warwick; Cardiff University; QIMR Berghofer Medical Research Institute; James Cook University; University of Bristol	Cole, DK; Sewell, AK (corresponding author), Cardiff Univ, Sch Med, Div Infect & Immun, Heath Pk, Cardiff CF14 4XN, S Glam, Wales.; Cole, DK; Sewell, AK (corresponding author), Cardiff Univ, Sch Med, Syst Immun Res Inst, Heath Pk, Cardiff CF14 4XN, S Glam, Wales.	coledk@cf.ac.uk; sewellak@cf.ac.uk	Sewell, Andrew/GPT-4220-2022; Rizkallah, Pierre J/A-5367-2012; Miles, John J/ABC-1105-2020; Beck, Konrad/AAX-1351-2020	Sewell, Andrew/0000-0003-3194-3135; Rizkallah, Pierre J/0000-0002-9290-0369; Miles, John J/0000-0001-5506-6304; Beck, Konrad/0000-0001-5098-9484; Cole, David/0000-0003-0028-9396; Wooldridge, Linda/0000-0002-6213-347X; Makinde, Julia/0000-0002-9906-7437; Fuller, Anna/0000-0002-8655-6741; van den Berg, Hugo/0000-0002-8230-6227; Crowther, Michael Douglas/0000-0003-4765-2818	United Kingdom Biotechnology and Biological Sciences Research Council [BB/H001085/1]; Wellcome Trust [WT079848MA, WT095767]; Research Councils UK fellowship; BBSRC [BB/H001085/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H001085/1] Funding Source: researchfish; Wellcome Trust [100327/Z/12/Z] Funding Source: researchfish; Health and Care Research Wales [HS-14-23] Funding Source: researchfish	United Kingdom Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Research Councils UK fellowship(UK Research & Innovation (UKRI)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Health and Care Research Wales	This work was supported in part by United Kingdom Biotechnology and Biological Sciences Research Council Grant BB/H001085/1 and Wellcome Trust Intermediate Clinical Fellowship WT079848MA (to L.W.). The authors declare that they have no conflicts of interest with the contents of this article.; A Wellcome Trust Research Career Development Fellow (Grant WT095767). To whom correspondence may be addressed. E-mail:coledk@cf.ac.uk.; Supported by a Research Councils UK fellowship.	Adams JJ, 2016, NAT IMMUNOL, V17, P87, DOI 10.1038/ni.3310; Adams JJ, 2011, IMMUNITY, V35, P681, DOI 10.1016/j.immuni.2011.09.013; Aleksic M, 2012, EUR J IMMUNOL, V42, P3174, DOI 10.1002/eji.201242606; Arstila TP, 1999, SCIENCE, V286, P958, DOI 10.1126/science.286.5441.958; Birnbaum ME, 2014, CELL, V157, P1073, DOI 10.1016/j.cell.2014.03.047; Borg NA, 2005, NAT IMMUNOL, V6, P171, DOI 10.1038/ni1155; Bridgeman JS, 2012, IMMUNOLOGY, V135, P9, DOI 10.1111/j.1365-2567.2011.03515.x; Bulek AM, 2012, J IMMUNOL METHODS, V382, P203, DOI 10.1016/j.jim.2012.06.007; Bulek AM, 2012, NAT IMMUNOL, V13, P283, DOI 10.1038/ni.2206; Burrows SR, 2010, P NATL ACAD SCI USA, V107, P10608, DOI 10.1073/pnas.1004926107; Cameron BJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006034; Cole DK, 2008, MOL IMMUNOL, V45, P2700, DOI 10.1016/j.molimm.2007.12.009; Cole DK, 2007, J IMMUNOL, V178, P5727, DOI 10.4049/jimmunol.178.9.5727; Cole DK, 2007, PROTEINS, V67, P65, DOI 10.1002/prot.21176; Cole DK, 2016, J CLIN INVEST, V126, P2191, DOI 10.1172/JCI85679; Cole DK, 2014, J BIOL CHEM, V289, P628, DOI 10.1074/jbc.M113.522110; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Degano M, 2000, IMMUNITY, V12, P251, DOI 10.1016/S1074-7613(00)80178-8; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Ekeruche-Makinde J, 2013, BLOOD, V121, P1112, DOI 10.1182/blood-2012-06-437202; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gras S, 2010, J EXP MED, V207, P1555, DOI 10.1084/jem.20100603; Greenfield NJ, 2004, METHOD ENZYMOL, V383, P282; Kloverpris HN, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0149-5; Laugel B, 2007, J BIOL CHEM, V282, P23799, DOI 10.1074/jbc.M700976200; Laugel B, 2007, EUR J IMMUNOL, V37, P905, DOI 10.1002/eji.200636718; Linette GP, 2013, BLOOD, V122, P863, DOI 10.1182/blood-2013-03-490565; Madura F, 2015, EUR J IMMUNOL, V45, P584, DOI 10.1002/eji.201445114; Madura F, 2013, J BIOL CHEM, V288, P18766, DOI 10.1074/jbc.M113.464560; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Melenhorst JJ, 2008, J IMMUNOL METHODS, V338, P31, DOI 10.1016/j.jim.2008.07.008; Miles JJ, 2005, J IMMUNOL, V175, P3826, DOI 10.4049/jimmunol.175.6.3826; Miles KM, 2011, MOL IMMUNOL, V48, P728, DOI 10.1016/j.molimm.2010.11.004; Motozono C, 2015, J BIOL CHEM, V290, P18924, DOI 10.1074/jbc.M114.622522; Purbhoo MA, 2001, J BIOL CHEM, V276, P32786, DOI 10.1074/jbc.M102498200; Raman MCC, 2016, SCI REP-UK, V6, DOI 10.1038/srep18851; Rossjohn J, 2015, ANNU REV IMMUNOL, V33, P169, DOI 10.1146/annurev-immunol-032414-112334; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Sethi DK, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3623; Sewell AK, 2012, NAT REV IMMUNOL, V12, P668, DOI 10.1038/nri3279; Skowera A, 2008, J CLIN INVEST, V118, P3390, DOI 10.1172/JCI35449; Tickle IJ, 2000, ACTA CRYSTALLOGR D, V56, P442, DOI 10.1107/S0907444999016868; Tynan FE, 2005, NAT IMMUNOL, V6, P1114, DOI 10.1038/ni1257; van den Berg HA, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00250; VENYAMINOV SY, 1993, ANAL BIOCHEM, V214, P17, DOI 10.1006/abio.1993.1450; Wilson DB, 2004, MOL IMMUNOL, V40, P1047, DOI 10.1016/j.molimm.2003.11.022; Winter G, 2013, ACTA CRYSTALLOGR D, V69, P1260, DOI 10.1107/S0907444913015308; Wooldridge L, 2012, J BIOL CHEM, V287, P1168, DOI 10.1074/jbc.M111.289488; Wooldridge L, 2010, J IMMUNOL, V185, P4625, DOI 10.4049/jimmunol.1001480	50	17	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2017	292	3					802	813		10.1074/jbc.M116.741603	http://dx.doi.org/10.1074/jbc.M116.741603			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2LL	27903649	Green Published, Green Accepted, hybrid, Green Submitted			2022-12-26	WOS:000392318700004
J	Kang, YJ; Kang, MY				Kang, Young Joong; Kang, Mo-Yeol			Chronic Diseases, Health Behaviors, and Demographic Characteristics as Predictors of Ill Health Retirement: Findings from the Korea Health Panel Survey (2008-2012)	PLOS ONE			English	Article							LABOR-FORCE PARTICIPATION; POPULATION; EMPLOYMENT; HEPATITIS; RISK	Purpose The research aim was to identify demographic characteristics, chronic diseases, and unhealthy behaviors predicting ill health retirement in South Korea. Methods Data were collected from 15,407 individuals enrolled in the first through the fifth phases of the Korea Health Panel Survey (2008-2012) using structured questionnaires examining retirement, morbidities, and health-related behaviors. The Cox proportional hazard model was used to examine demographic and clinical characteristics' effects on ill health retirement. Lost years of working life expectancy were calculated for demographic and clinical characteristics. Results Older, female, and manual workers were more likely to experience ill health retirement, as were respondents reporting poor health-related habits (e.g., heavy drinking, irregular meals, less sleep hours, obesity, and no regular exercise). The chronic diseases most closely associated with ill health retirement were, in order, psychiatric disease, ophthalmologic disease, neurologic disease, infectious disease, and musculoskeletal diseases. The average reduction in working life expectancy was 9.73 years. Conclusions Our study results can help contribute to the development of strategies for reducing the risk of ill health retirement and promoting sustainable labor force participation in an aging society.	[Kang, Young Joong] Korea Occupat Safety & Hlth Agcy, Occupat Safety & Hlth Res Inst, Ulsan, South Korea; [Kang, Mo-Yeol] Seoul Natl Univ, Dept Prevent Med, Coll Med, Seoul, South Korea	Seoul National University (SNU)	Kang, MY (corresponding author), Seoul Natl Univ, Dept Prevent Med, Coll Med, Seoul, South Korea.	snaptoon@snu.ac.kr		Kang, Young Joong/0000-0002-2043-985X				Alavinia SM, 2008, INT ARCH OCC ENV HEA, V82, P39, DOI 10.1007/s00420-008-0304-6; [Anonymous], 2012, POPULATION IOMCOTL R; Bloom DE, 2010, OXFORD REV ECON POL, V26, P583, DOI 10.1093/oxrep/grq038; Brinton MC, 2001, WOMENS WORKING LIVES, P1; Chung Woo-Jin, 2006, J Prev Med Public Health, V39, P21; Ciulla TA, 2003, DIABETES CARE, V26, P2653, DOI 10.2337/diacare.26.9.2653; Clemens Tom, 2009, Health Stat Q, P7; Daley M, 2009, SLEEP MED, V10, P427, DOI 10.1016/j.sleep.2008.04.005; Eckert KA, 2015, OPHTHAL EPIDEMIOL, V22, P349, DOI 10.3109/09286586.2015.1066394; Flippen C, 2000, J GERONTOL B-PSYCHOL, V55, pS14; Hassan MM, 2002, HEPATOLOGY, V36, P1206, DOI 10.1053/jhep.2002.36780; Ilmarinen JE, 2001, OCCUP ENVIRON MED, V58, P546, DOI 10.1136/oem.58.8.546; Kang MY, 2015, J OCCUP HEALTH, V57, P28, DOI 10.1539/joh.14-0117-OA; Kang MY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113495; Karpansalo M, 2002, J OCCUP ENVIRON MED, V44, P930, DOI 10.1097/00043764-200210000-00012; Ko C-F, 2010, CRISIS WELFARE E ASI, P43; Krueger PM, 2009, AM J EPIDEMIOL, V169, P1052, DOI 10.1093/aje/kwp023; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; MacDonald Z, 2004, HEALTH ECON, V13, P139, DOI 10.1002/hec.816; OECD, 2013, STATEXTRACTS LAB FOR; OECD, 2012, OECD EC SURV KOR 201; Palmer KT., 2007, FITNESS WORK MED ASP; Schofield DJ, 2008, MED J AUSTRALIA, V189, P447, DOI 10.5694/j.1326-5377.2008.tb02119.x; Schofield DJ, 2013, BMJ OPEN, V3; Stattin M, 2005, OCCUP ENVIRON MED, V62, P135, DOI 10.1136/oem.2004.015669; Tuomi K, 1997, SCAND J WORK ENV HEA, V23, P58; WHO/IASO/IOTF, 2000, ASIA PACIFIC PERSPEC; Yu WH, 2005, DEMOGRAPHY, V42, P693, DOI 10.1353/dem.2005.0039	28	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0166921	10.1371/journal.pone.0166921	http://dx.doi.org/10.1371/journal.pone.0166921			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4OA	27930661	gold, Green Published, Green Submitted			2022-12-26	WOS:000389580900017
J	Sousa, JD; Temudo, MP; Hewlett, BS; Camacho, RJ; Muller, V; Vandamme, AM				Sousa, Joao Dinis; Temudo, Marina Padrao; Hewlett, Barry Stephen; Camacho, Ricardo Jorge; Mueller, Viktor; Vandamme, Anne-Mieke			Male Circumcision and the Epidemic Emergence of HIV-2 in West Africa	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; GENITAL ULCER DISEASES; SUB-SAHARAN AFRICA; GUINEA-BISSAU; COTE-DIVOIRE; MOLECULAR EPIDEMIOLOGY; DEVELOPING-COUNTRIES; GENETIC DIVERSITY; SOOTY MANGABEYS; RISK-FACTORS	Background Epidemic HIV-2 (groups A and B) emerged in humans circa 1930-40. Its closest ancestors are SIVsmm infecting sooty mangabeys from southwestern Cote d'Ivoire. The earliest large-scale serological surveys of HIV-2 in West Africa (1985-91) show a patchy spread. Cote d'Ivoire and Guinea-Bissau had the highest prevalence rates by then, and phylogeographical analysis suggests they were the earliest epicenters. Wars and parenteral transmission have been hypothesized to have promoted HIV-2 spread. Male circumcision (MC) is known to correlate negatively with HIV-1 prevalence in Africa, but studies examining this issue for HIV-2 are lacking. Methods We reviewed published HIV-2 serosurveys for 30 cities of all West African countries and obtained credible estimates of real prevalence through Bayesian estimation. We estimated past MC rates of 218 West African ethnic groups, based on ethnographic literature and fieldwork. We collected demographic tables specifying the ethnic partition in cities. Uncertainty was incorporated by defining plausible ranges of parameters (e.g. timing of introduction, proportion circumcised). We generated 1,000 sets of past MC rates per city using Latin Hypercube Sampling with different parameter combinations, and explored the correlation between HIV-2 prevalence and estimated MC rate (both logit-transformed) in the 1,000 replicates. Results and Conclusions Our survey reveals that, in the early 20th century, MC was far less common and geographically more variable than nowadays. HIV-2 prevalence in 1985-91 and MC rates in 1950 were negatively correlated (Spearman rho = -0.546, IQR: -0.553--0.546, p <= 0.0021). Guinea-Bissau and Cote d'Ivoire cities had markedly lower MC rates. In addition, MC was uncommon in rural southwestern Cote d'Ivoire in 1930. The differential HIV-2 spread in West Africa correlates with different historical MC rates. We suggest HIV-2 only formed early substantial foci in cities with substantial uncircumcised populations. Lack of MC in rural areas exposed to bushmeat may have had a role in successful HIV-2 emergence.	[Sousa, Joao Dinis; Camacho, Ricardo Jorge; Vandamme, Anne-Mieke] KU Leuven Univ Leuven, Dept Microbiol & Immunol, Rega Inst Med Res Clin & Epidemiol Virol, B-3000 Leuven, Belgium; [Sousa, Joao Dinis; Vandamme, Anne-Mieke] Univ Nova Lisboa, Inst Higiene & Med Trop, Unidade Microbiol Med, Ctr Global Hlth & Trop Med, Lisbon, Portugal; [Temudo, Marina Padrao] Univ Lisbon, CEF, Sch Agr, Dept Nat Resources Environm & Land, Lisbon, Portugal; [Hewlett, Barry Stephen] Washington State Univ, Dept Anthropol, Vancouver, WA USA; [Mueller, Viktor] Eotvos Lorand Univ, Inst Biol, Budapest, Hungary; [Mueller, Viktor] Parmenides Ctr Conceptual Fdn Sci, Pullach Munich, Germany	KU Leuven; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Universidade de Lisboa; Washington State University; Eotvos Lorand University	Sousa, JD; Vandamme, AM (corresponding author), KU Leuven Univ Leuven, Dept Microbiol & Immunol, Rega Inst Med Res Clin & Epidemiol Virol, B-3000 Leuven, Belgium.; Sousa, JD; Vandamme, AM (corresponding author), Univ Nova Lisboa, Inst Higiene & Med Trop, Unidade Microbiol Med, Ctr Global Hlth & Trop Med, Lisbon, Portugal.	joao.sousa@kuleuven.be; annemie.vandamme@uzleuven.be	Vandamme, Anne-Mieke/I-4127-2012; Müller, Viktor/B-3493-2009	Vandamme, Anne-Mieke/0000-0002-6594-2766; Müller, Viktor/0000-0001-8212-4880; Temudo, Marina/0000-0002-8254-4233; Sousa, Joao/0000-0002-7604-3109	Fonds voor Wetenschappelijk Onderzoek Flanders (FWO), Belgium [G.0611.09N]; Fundacao para a Ciencia e Tecnologia, (FCT), Portugal [PTDC/AFR/111546/2009]	Fonds voor Wetenschappelijk Onderzoek Flanders (FWO), Belgium(FWO); Fundacao para a Ciencia e Tecnologia, (FCT), Portugal(Portuguese Foundation for Science and Technology)	The research done by JDS and AMV in this study has been supported in part by grant G.0611.09N, funded by the Fonds voor Wetenschappelijk Onderzoek Flanders (FWO, http://www.fwo.be/en/), Belgium. MPTs fieldwork in Guinea-Bissau was conducted within the framework of the project The prophetess and the rice farmer: innovations in religion, agriculture and gender in Guinea-Bissau, PTDC/AFR/111546/2009, funded by Fundacao para a Ciencia e Tecnologia, (FCT, http://www.fct.pt/), Portugal. VM is a Fellow of the Parmenides Center for the Conceptual Foundations of Science, part of Parmenides Foundation (https://www.parmenides-foundation.org/home/), Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	agencia Geral das Colonias, 1929, B GER COL, V44; Andreasson PA, 1989, 5 INT C AIDS JUN 4 9, V5, P1000; Auguie B, 2017, GRIDEXTRA MISCELLANE; Auvert B, 2001, AIDS, V15, pS31, DOI 10.1097/00002030-200108004-00004; Auvert B, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001509; Ayouba A, 2013, AIDS, V27, P2488, DOI 10.1097/01.aids.0000432443.22684.50; Banton M, 1957, W AFRICAN CITY STUDY; Baumann H, 1962, PEUPLES CIVILIZATION; Biyi E, 1929, TRIBES LIBERIAN HINT, V29, P181; Biyi E, 1929, W AFRICA J ROY AFR S, V29, P71; BONGAARTS J, 1989, AIDS, V3, P373, DOI 10.1097/00002030-198906000-00006; Booth A. H., 1958, Bull Inst franY Afr N, V20A, P587; Botas J, 1989, 5 INT C AIDS JUN 4 9, V5, P90; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; Brun-Vezinet F, 1988, MED MALADIES INFECT, V18, P698; Carvalho Viegas LA, 1936, HIST GUINE PORTUGUES, VIII; Carvalho Viegas LA, 1936, HIST GUINE PORTUGUES, VII; Chen ZW, 1997, J VIROL, V71, P3953, DOI 10.1128/JVI.71.5.3953-3960.1997; Chevannes B., 2001, ENCY AFRICAN AFRICAN, P282; Chitnis A, 2000, AIDS RES HUM RETROV, V16, P5, DOI 10.1089/088922200309548; Clozel FJ, 1902, COUTUMES COTE LVOIRE; Coquery-Vidrovitch Catherine, 1994, AFRICAINES HIST FEMM; Cunha L, 2007, J MED VIROL, V79, P1832, DOI 10.1002/jmv.21010; D'arc M, 2015, P NATL ACAD SCI USA, V112, pE1343, DOI 10.1073/pnas.1502022112; DAZEVEDO WL, 1962, ANN NY ACAD SCI, V96, P512, DOI 10.1111/j.1749-6632.1962.tb50146.x; de Sousa JD, 2012, VIRUSES-BASEL, V4, P1950, DOI 10.3390/v4101950; DECOCK KM, 1991, AIDS, V5, pS21; DECOCK KM, 1989, AIDS, V3, pS89, DOI 10.1097/00002030-198901001-00013; Delafosse M., 1912, HAUT SENEGAL NIGER P; Delval R., 1980, MUSULMANS TOGO; DIALLO MO, 1992, AIDS, V6, P581, DOI 10.1097/00002030-199206000-00010; Dorai-Raj S., 2014, BINOMIAL CONFIDENCE; Drain PK, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-172; Drain PK, 2004, JAIDS-J ACQ IMM DEF, V35, P407, DOI 10.1097/00126334-200404010-00011; Faria NR, 2014, SCIENCE, V346, P56, DOI 10.1126/science.1256739; Faria NR, 2012, J GEN VIROL, V93, P889, DOI 10.1099/vir.0.038638-0; Fischetti L, 2004, J MED VIROL, V73, P158, DOI 10.1002/jmv.20070; FROBENIUS L, 1929, ATLAS AFRICANUS BELE; Froelich JC, 1955, CARTE POPULATIONS AF; GAO F, 1994, J VIROL, V68, P7433, DOI 10.1128/JVI.68.11.7433-7447.1994; GAO F, 1992, NATURE, V358, P495, DOI 10.1038/358495a0; Gebremedhin S, 2011, SAHARA J-J SOC ASP H, V8, P13, DOI 10.1080/17290376.2011.9724979; Gisselquist D, 2003, AIDS RES HUM RETROV, V19, P1071, DOI 10.1089/088922203771881158; GOERG O, 1990, CAH ETUD AFR, V30, P73, DOI 10.3406/cea.1990.2127; Gomes P, 2003, LANCET INFECT DIS, V3, P683, DOI 10.1016/S1473-3099(03)00797-7; Gottlieb GS, 2008, AIDS, V22, P2069, DOI 10.1097/QAD.0b013e32830edd44; Gottlieb GS, 2003, AIDS RES HUM RETROV, V19, P575, DOI 10.1089/088922203322230941; Gray J.P., 1999, ETHNOGRAPHIC ATLAS R; Gray R, 2012, AIDS, V26, P609, DOI 10.1097/QAD.0b013e3283504a3f; GRIMES BF, 1996, ETHNOLOGUE; GROVES C P, 1978, Primates, V19, P1, DOI 10.1007/BF02373224; HOLAS B, 1957, AFRICA, V27, P241, DOI 10.2307/1156631; Jensen Adolf E., 1933, BESCHNEIDUNG REIFEZE; Kanki PJ, 1994, REPROD BIOL, V8, pS85; Kannangai R, 2000, CLIN DIAGN LAB IMMUN, V7, P987, DOI 10.1128/CDLI.7.6.987-989.2000; Keele BF, 2006, SCIENCE, V313, P523, DOI 10.1126/science.1126531; Korber B, 2000, SCIENCE, V288, P1789, DOI 10.1126/science.288.5472.1789; Kurtz RJ, 1969, ETHNOGRAPHIC SURVEY; Lauret P, GUERRA COLONIAL 1961; Lee S., 2012, CERCOCEBUS ATYS; Lemey P, 2004, GENETICS, V167, P1059, DOI 10.1534/genetics.104.026666; Lemey P, 2003, P NATL ACAD SCI USA, V100, P6588, DOI 10.1073/pnas.0936469100; Lewis M. P., 2015, ETHNOLOGUE LANGUAGES, V18th; Marx PA, 2001, PHILOS T R SOC B, V356, P911, DOI 10.1098/rstb.2001.0867; Ministerio dos Negocios Estrangeiros, 1978, 9 REC GER POP LISB; MOSES S, 1990, INT J EPIDEMIOL, V19, P693, DOI 10.1093/ije/19.3.693; Mota-Miranda A, 2004, LANCET INFECT DIS, V4, P265, DOI 10.1016/S1473-3099(04)01001-1; Mota-Miranda A, 1993, 9 INT C AIDS JUN 6 1, V9, P683; Murdock G.P., 1967, ETHNOGRAPHIC ATLAS; Niang CI, 2007, REPROD HEALTH MATTER, V15, P22, DOI 10.1016/S0968-8080(07)29312-7; PELISSIER R., 1989, HIST GUINE PORTUGUES; PEPIN J, 1992, AIDS, V6, P489, DOI 10.1097/00002030-199205000-00008; PEPIN J, 1991, AIDS, V5, P69, DOI 10.1097/00002030-199101000-00010; PEPIN J, 2008, TROP MED INT HEALTH, V13, P1; Pepin J, 2006, AIDS, V20, P1303, DOI 10.1097/01.aids.0000232239.05545.33; Peterson Dale, 2003, EATING APES; Pieniazek D, 1999, AIDS RES HUM RETROV, V15, P603, DOI 10.1089/088922299311132; Poulsen AG, 2000, SCAND J INFECT DIS, V32, P169, DOI 10.1080/003655400750045286; POULSEN AG, 1989, LANCET, V333, P827; Remy G., 1993, Medecine d'Afrique Noire, V40, P15; Remy G., 1993, Medecine d'Afrique Noire, V40, P9; ROUCH J, 1957, ETUDES EBURNEENNES, V6, P231; Salemi M, 2001, FASEB J, V15, P276, DOI 10.1096/fj.00-0449fje; Santiago ML, 2005, J VIROL, V79, P12515, DOI 10.1128/JVI.79.19.12515-12527.2005; SARPONG PK, 1967, ANTHROPOS, V62, P1; Schwab C., 1947, TRIBES LIBERIAN HINT; Smith SM, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-103; SOUSA JDD, 2010, PLOS ONE, V0005; Temudo M, 2015, DEV CHANGE, V46, P464, DOI 10.1111/dech.12166; The DHS Program, 2015, DEM HLTH SURV; Valadas E, 2009, CLIN INFECT DIS, V48, P1166, DOI 10.1086/597504; van der Loeff MFS, 1999, AIDS, V13, pS69; Vidal N, 2000, J VIROL, V74, P10498, DOI 10.1128/JVI.74.22.10498-10507.2000; Viegas L. A. C, 1936, GUINE PORTUGUESA, V1-3; VILLAMUR R., 1903, NOTRE COLONIE COTE I; Weiss HA, 2000, AIDS, V14, P2361, DOI 10.1097/00002030-200010200-00018; Weiss HA, 2006, SEX TRANSM INFECT, V82, P101, DOI 10.1136/sti.2005.017442; Weiss HA, 2008, AIDS, V22, P567, DOI 10.1097/QAD.0b013e3282f3f406; White Luise, 1990, COMFORTS HOME PROSTI; WILKINS A, 1991, AIDS, V5, P1127, DOI 10.1097/00002030-199109000-00012; Worobey M, 2008, NATURE, V455, P661, DOI 10.1038/nature07390; Zaborowski M, 1896, ANTHROPOLOGIE, V7, P653; Zetterstrom K, 1969, ETHNOGRAPHIC SURVEY	103	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2016	11	12							e0166805	10.1371/journal.pone.0166805	http://dx.doi.org/10.1371/journal.pone.0166805			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4NG	27926927	Green Submitted, Green Published, gold			2022-12-26	WOS:000389578800006
J	Fu, F; Zhang, T				Fu, Fang; Zhang, Tao			A New Model for Solving Time-Cost-Quality Trade-Off Problems in Construction	PLOS ONE			English	Article							FROG-LEAPING ALGORITHM; PROJECT SCHEDULING PROBLEMS; DECISION-MAKING; OPTIMIZATION; MANAGEMENT	A poor quality affects project makespan and its total costs negatively, but it can be recovered by repair works during construction. We construct a new non-linear programming model based on the classic multi-mode resource constrained project scheduling problem considering repair works. In order to obtain satisfactory quality without a high increase of project cost, the objective is to minimize total quality cost which consists of the prevention cost and failure cost according to Quality-Cost Analysis. A binary dependent normal distribution function is adopted to describe the activity quality; Cumulative quality is defined to determine whether to initiate repair works, according to the different relationships among activity qualities, namely, the coordinative and precedence relationship. Furthermore, a shuffled frog-leaping algorithm is developed to solve this discrete trade-off problem based on an adaptive serial schedule generation scheme and adjusted activity list. In the program of the algorithm, the frog-leaping progress combines the crossover operator of genetic algorithm and a permutation-based local search. Finally, an example of a construction project for a framed railway overpass is provided to examine the algorithm performance, and it assist in decision making to search for the appropriate makespan and quality threshold with minimal cost.	[Fu, Fang; Zhang, Tao] China Univ Petr East China, Sch Econ & Management, Qingdao, Shandong, Peoples R China	China University of Petroleum	Zhang, T (corresponding author), China Univ Petr East China, Sch Econ & Management, Qingdao, Shandong, Peoples R China.	zhangtao@upc.edu.cn			Shandong provincial Natural Science Foundation of China [BS2015SF010]	Shandong provincial Natural Science Foundation of China(Natural Science Foundation of Shandong Province)	The authors received the support from Shandong provincial Natural Science Foundation of China (Grant NO. BS2015SF010).	Azadeh A, 2015, RELIAB ENG SYST SAFE, V136, P62, DOI 10.1016/j.ress.2014.11.009; Babu AJG, 1996, EUR J OPER RES, V88, P320, DOI 10.1016/0377-2217(94)00202-9; Cheng JZL, 2015, COMPUT OPER RES, V53, P275, DOI 10.1016/j.cor.2014.04.018; Dou H, 2016, PERS UBIQUIT COMPUT, V20, P681, DOI 10.1007/s00779-016-0941-9; Eusuff M, 2006, ENG OPTIMIZ, V38, P129, DOI 10.1080/03052150500384759; Fang C, 2012, COMPUT OPER RES, V39, P890, DOI 10.1016/j.cor.2011.07.010; Jiang D, 2016, IEEE INTERN IN PRESS; Khang D. B., 1999, INT J PROJ MANAG, V17, P249, DOI [DOI 10.1016/S0263-7863(98)00043-X, 10.1016/S0263-7863(98)00043-X]; Kim J, 2012, INT J PROJ MANAG, V30, P264, DOI 10.1016/j.ijproman.2011.05.004; Li JQ, 2012, APPL MATH COMPUT, V218, P9353, DOI 10.1016/j.amc.2012.03.018; Liberatore MJ, 2013, IEEE T ENG MANAGE, V60, P518, DOI 10.1109/TEM.2012.2219586; Monghasemi S, 2015, EXPERT SYST APPL, V42, P3089, DOI 10.1016/j.eswa.2014.11.032; Omachonu V. K., 2004, International Journal of Quality Reliability Management, V21, P277, DOI 10.1108/02656710410522720; Paquin JP, 2000, IEEE T ENG MANAGE, V47, P88, DOI 10.1109/17.820728; Pollack-Johnson B, 2006, IEEE T ENG MANAGE, V53, P534, DOI 10.1109/TEM.2006.883705; Salmasnia A, 2012, INT J ADV MANUF TECH, V60, P631, DOI 10.1007/s00170-011-3627-5; Tareghian HR, 2007, APPL MATH COMPUT, V190, P1136, DOI 10.1016/j.amc.2007.01.100; Tavana M, 2014, EXPERT SYST APPL, V41, P1830, DOI 10.1016/j.eswa.2013.08.081; Tiwari V, 2009, EUR J OPER RES, V193, P780, DOI 10.1016/j.ejor.2007.11.005; Wei W, 2018, IEEE T SERV COMPUT, V11, P78, DOI 10.1109/TSC.2016.2528246; Zhang H, 2010, AUTOMAT CONSTR, V19, P1067, DOI 10.1016/j.autcon.2010.07.014	22	9	9	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0167142	10.1371/journal.pone.0167142	http://dx.doi.org/10.1371/journal.pone.0167142			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3TF	27911939	Green Submitted, Green Published, gold			2022-12-26	WOS:000389520600023
J	Pan, F; Den, J; Zhang, CF; Wang, H; Cheng, J; Wu, WZ; Hong, N; Wang, Y				Pan, Feng; Den, Jie; Zhang, Chunfang; Wang, He; Cheng, Jin; Wu, Weizhen; Hong, Nan; Wang, Yi			The Therapeutic Response of Gastrointestinal Stromal Tumors to Imatinib Treatment Assessed by Intravoxel Incoherent Motion Diffusion-Weighted Magnetic Resonance Imaging with Histopathological Correlation	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; TYROSINE KINASE; MESYLATE; PERFUSION; PET; GIST; DIFFERENTIATION; EXPRESSION; PARAMETERS; CRITERIA	Purpose To exploit the intravoxel incoherent motion (IVIM) diffusion-weighted (DW) MRI when evaluating the therapeutic response of gastrointestinal stromal tumors (GIST) to Imatinib in a mouse model. Materials and Methods Mice with xenografts bearing cells from the GIST-T1 cell line were randomly divided into a treated group receiving Imatinib and a control group. DWMRI scans with 14 b-values (0- 1500 s/mm(2)) were performed before and after treatment (days 1, 3 and 7). IVIM related parameters perfusion fractions (fp) and perfusion-related diffusion coefficients (D*) and the conventional apparent diffusion coefficients (ADC) were calculated by fitting the DWMRI signal decay. The mean changes from baseline to each post-treatment time point for each measurement (Delta ADC,Delta fp and Delta D*) were calculated. The differences of mean changes between the two groups were tested for statistical significance. Histopathological analyses including Ki-67, CD31, TUNEL and H&E were conducted in conjunction with the MRI scans. Results Increases in ADC of the treated group were higher than those of the control group after treatment, whereas statistical significances were not observed. Compared to the control group, D* in the treated group decreased significantly (Delta D*(treated) = -41%, -49%, and -49% with P = 0.0001, 0.0001 and 0.0001), and fp increased significantly (Delta fp(treated) = 79%, 82% and 110%, with P = 0.001, 0.0001 and P = 0.0007) on days 1, 3 and 7 after treatment. Histopathological analyses demonstrated different tumor tissue characteristics between the treated and control groups. Conclusion IVIM measurements may serve as more sensitive imaging biomarkers than ADC when assessing GIST response to Imatinib as early as one day after treatment.	[Pan, Feng; Cheng, Jin; Wu, Weizhen; Hong, Nan; Wang, Yi] Peking Univ, Peoples Hosp, Dept Radiol, Beijing, Peoples R China; [Den, Jie] Northwestern Univ, Ann & Robert H Lurie Childrens Hosp Chicago, Feinberg Sch Med, Dept Med Imaging,Dept Radiol, Chicago, IL 60611 USA; [Zhang, Chunfang] Peking Univ, Clin Epidemiol & Med Stat, Peoples Hosp, Beijing, Peoples R China; [Wang, He] GE Healthcare, Shanghai, Peoples R China	Peking University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Peking University; General Electric	Wang, Y (corresponding author), Peking Univ, Peoples Hosp, Dept Radiol, Beijing, Peoples R China.	wangyi@pkuph.edu.cn			National Nature Science Foundation of China	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	Our study was supported by the National Nature Science Foundation of China, which provided support in the implementation of the experiments and preparation of the manuscript. No salary support was given to any author.	Abdulkader I, 2005, HISTOPATHOLOGY, V46, P470, DOI 10.1111/j.1365-2559.2005.02014.x; [Anonymous], 2009, NEOPLASIA, V11, P102, DOI 10.1593/neo.81328; Blanke CD, 2008, J CLIN ONCOL, V26, P626, DOI 10.1200/JCO.2007.13.4452; Choi H, 2004, AM J ROENTGENOL, V183, P1619, DOI 10.2214/ajr.183.6.01831619; Choi H, 2008, ONCOLOGIST, V13, P4, DOI 10.1634/theoncologist.13-S2-4; Choi H, 2007, J CLIN ONCOL, V25, P1753, DOI 10.1200/JCO.2006.07.3049; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Doblas S, 2013, INVEST RADIOL, V48, P722, DOI 10.1097/RLI.0b013e3182915912; Dzik-Jurasz A, 2002, LANCET, V360, P307, DOI 10.1016/S0140-6736(02)09520-X; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Ganten MK, 2013, CANCER IMAGING, V13, P548, DOI 10.1102/1470-7330.2013.0045; Gong NJ, 2013, NMR BIOMED, V26, P185, DOI 10.1002/nbm.2834; Hauser T, 2013, NEURORADIOLOGY, V55, P527, DOI 10.1007/s00234-013-1154-9; Holdsworth CH, 2007, AM J ROENTGENOL, V189, pW324, DOI 10.2214/AJR.07.2496; Jin TF, 2006, WORLD J GASTROENTERO, V12, P703, DOI 10.3748/wjg.v12.i5.703; Joensuu H, 2001, NEW ENGL J MED, V344, P1052, DOI 10.1056/NEJM200104053441404; Joensuu H, 2013, LANCET, V382, P973, DOI 10.1016/S0140-6736(13)60106-3; Joo I, 2014, RADIOLOGY; Kang KM, 2014, RADIOLOGY, V270, P444, DOI 10.1148/radiol.13122712; Le Bihan D, 2008, RADIOLOGY, V249, P748, DOI 10.1148/radiol.2493081301; Le Bihan DJ, 1998, RADIOLOGY, V207, P305, DOI 10.1148/radiology.207.2.9577472; LEBIHAN D, 1988, RADIOLOGY, V168, P497, DOI 10.1148/radiology.168.2.3393671; Lewin M, 2011, EUR RADIOL, V21, P281, DOI 10.1007/s00330-010-1914-4; Liu CL, 2013, EUR J RADIOL, V82, pE782, DOI 10.1016/j.ejrad.2013.08.006; Lopes LF, 2010, J CELL MOL MED, V14, P42, DOI 10.1111/j.1582-4934.2009.00983.x; Patterson DM, 2008, NAT CLIN PRACT ONCOL, V5, P220, DOI 10.1038/ncponc1073; Revheim ME, 2014, ACTA ONCOL, V53, P143, DOI 10.3109/0284186X.2013.798428; Schmidt S, 2013, ACTA RADIOL, V54, P837, DOI 10.1177/0284185113485732; Shinto A, 2008, CLIN NUCL MED, V33, P486, DOI 10.1097/RLU.0b013e31817792a3; Sumi M, 2013, AM J NEURORADIOL, V34, P410, DOI 10.3174/ajnr.A3227; Sumi M, 2012, RADIOLOGY, V263, P770, DOI 10.1148/radiol.12111248; Tang L, 2011, RADIOLOGY, V258, P729, DOI 10.1148/radiol.10100402; Treglia G, 2012, CLIN IMAG, V36, P167, DOI 10.1016/j.clinimag.2011.08.012; Van den Abbeele AID, 2012, J NUCL MED, V53, P567, DOI 10.2967/jnumed.111.094425; Woo S, 2014, RADIOLOGY, V270, P758, DOI 10.1148/radiol.13130444	35	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0167720	10.1371/journal.pone.0167720	http://dx.doi.org/10.1371/journal.pone.0167720			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3TF	27911930	gold, Green Published, Green Submitted			2022-12-26	WOS:000389520600050
J	Zhao, XK; Che, PL; Cheng, ML; Zhang, Q; Mu, M; Li, H; Luo, Y; Liang, YD; Luo, XH; Gao, CQ; Jackson, PL; Wells, JM; Zhou, Y; Hu, M; Cai, GQ; Thannickal, VJ; Steele, C; Blalock, JE; Han, XS; Chen, CY; Ding, Q				Zhao, Xue-Ke; Che, Pulin; Cheng, Ming-Liang; Zhang, Quan; Mu, Mao; Li, Hong; Luo, Yuan; Liang, Yue-Dong; Luo, Xin-Hua; Gao, Chang-Qing; Jackson, Patricia L.; Wells, J. Michael; Zhou, Yong; Hu, Meng; Cai, Guoqiang; Thannickal, Victor J.; Steele, Chad; Blalock, J. Edwin; Han, Xiaosi; Chen, Ching-Yi; Ding, Qiang			Tristetraprolin Down-Regulation Contributes to Persistent TNF-Alpha Expression Induced by Cigarette Smoke Extract through a Post-Transcriptional Mechanism	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; AU-RICH ELEMENTS; MESSENGER-RNA TURNOVER; ZINC-FINGER PROTEINS; AIRWAY INFLAMMATION; ACTIN-FILAMENTS; N-WASP; LUNG; CANCER; DESTABILIZATION	Rationale Tumor necrosis factor-alpha (TNF-alpha) is a potent pro-inflammatory mediator and its expression is up-regulated in chronic obstructive pulmonary disease (COPD). Tristetraprolin (TTP) is implicated in regulation of TNF-alpha expression; however, whether TTP is involved in cigarette smoke-induced TNF-alpha expression has not been determined. Methods TTP expression was examined by western blot analysis in murine alveolar macrophages and alveolar epithelial cells challenged without or with cigarette smoke extract (CSE). TNF-alpha mRNA stability, and the decay of TNF-alpha mRNA, were determined by real-time quantitative RT-PCR. TNF-alpha protein levels were examined at the same time in these cells. To identify the molecular mechanism involved, a construct expressing the human beta-globin reporter mRNA containing the TNF-alpha 3'-untranslated region was generated to characterize the TTP targeted site within TNF-alpha mRNA. Results CSE induced TTP down-regulation in alveolar macrophages and alveolar epithelial cells. Reduced TTP expression resulted in significantly increased TNF-alpha mRNA stability. Importantly, increased TNF-alpha mRNA stability due to impaired TTP function resulted in significantly increased TNF-alpha levels in these cells. Forced TTP expression abrogated the increased TNF-alpha mRNA stability and expression induced by CSE. By using the globin reporter construct containing TNF-alpha mRNA 3'-untranslated region, the data indicate that TTP directly targets the adenine-and uridine-rich region (ARE) of TNF-alpha mRNA and negatively regulates TNF-alpha expression at the post-transcriptional level. Conclusion The data demonstrate that cigarette smoke exposure reduces TTP expression and impairs TTP function, resulting in significantly increased TNF-alpha mRNA stability and excessive TNF-alpha expression in alveolar macrophages and epithelial cells. The data suggest that TTP is a novel post-transcriptional regulator and limits excessive TNF-alpha expression and inflammatory response induced by cigarette smoke.	[Zhao, Xue-Ke; Cheng, Ming-Liang; Zhang, Quan; Mu, Mao; Li, Hong] Guizhou Med Univ, Hosp Affiliated, Dept Infect Dis, Guiyang, Guizhou, Peoples R China; [Zhao, Xue-Ke; Che, Pulin; Gao, Chang-Qing; Jackson, Patricia L.; Wells, J. Michael; Zhou, Yong; Hu, Meng; Cai, Guoqiang; Thannickal, Victor J.; Steele, Chad; Blalock, J. Edwin; Ding, Qiang] Univ Alabama Birmingham, Dept Med, Div Pulm Allergy & Crit Care Med, Birmingham, AL 35294 USA; [Luo, Yuan] Fudan Univ, Shanghai Stomatol Hosp, Dept Oral Surg, Shanghai, Peoples R China; [Liang, Yue-Dong] Publ Hlth Ctr Guiyang, Dept Infect Dis, Guiyang, Guizhou, Peoples R China; [Luo, Xin-Hua] Peoples Hosp Guizhou Prov, Dept Infect Dis, Guiyang, Guizhou, Peoples R China; [Han, Xiaosi] Univ Alabama Birmingham, Neurol, Birmingham, AL USA; [Chen, Ching-Yi] Univ Alabama Birmingham, Dept Biochem, Birmingham, AL USA	Guizhou Medical University; University of Alabama System; University of Alabama Birmingham; Fudan University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Cheng, ML (corresponding author), Guizhou Med Univ, Hosp Affiliated, Dept Infect Dis, Guiyang, Guizhou, Peoples R China.; Ding, Q (corresponding author), Univ Alabama Birmingham, Dept Med, Div Pulm Allergy & Crit Care Med, Birmingham, AL 35294 USA.	mlcheng@yeah.net; qding@uab.edu			Flight Attendant Medical Research Institute (FAMRI) [HL085324, HL127338]; National Natural Science Foundation of China [81560104]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL127338, K08HL123940, R01HL077783, R01HL085324, R01HL124076] Funding Source: NIH RePORTER	Flight Attendant Medical Research Institute (FAMRI); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Flight Attendant Medical Research Institute (FAMRI), HL085324 and HL127338 (to QD) and National Natural Science Foundation of China (#81560104) (to XKZ).; This work was supported by Flight Attendant Medical Research Institute (FAMRI), HL085324, HL127338 (to Q.D.) and National Natural Science Foundation of China (#81560104) (to XKZ). We thank Anni Zheng for her technical assistance for this study. The authors declare no conflict of interest.	Adcock IM, 2011, RESPIRATION, V81, P265, DOI 10.1159/000324601; BAKER RR, 1990, ENVIRON INT, V16, P231, DOI 10.1016/0160-4120(90)90117-O; BEUTLER B, 1989, ANNU REV IMMUNOL, V7, P625, DOI 10.1146/annurev.immunol.7.1.625; Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; Boutaud O, 2003, ADV EXP MED BIOL, V525, P157; Brooks SA, 2004, J IMMUNOL, V172, P7263, DOI 10.4049/jimmunol.172.12.7263; Cai GQ, 2012, AM J PHYSIOL-LUNG C, V303, pL692, DOI 10.1152/ajplung.00390.2011; Cai GQ, 2010, EXP CELL RES, V316, P1600, DOI 10.1016/j.yexcr.2010.01.021; Canonica GW, 2006, CHEST, V130, p21S, DOI 10.1378/chest.130.1_suppl.21S; Cao HP, 2008, OBESITY, V16, P1208, DOI 10.1038/oby.2008.65; Cao H, 2007, EXPERT REV PROTEOMIC, V4, P711, DOI 10.1586/14789450.4.6.711; Cao HP, 2006, BIOCHEM J, V394, P285, DOI 10.1042/BJ20051316; Carballo E, 2000, BLOOD, V95, P1891, DOI 10.1182/blood.V95.6.1891; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Carrick DM, 2004, ARTHRITIS RES THER, V6, P248, DOI 10.1186/ar1441; Che PL, 2015, SCI REP-UK, V5, DOI 10.1038/srep08453; Chou CF, 2006, MOL CELL BIOL, V26, P3695, DOI 10.1128/MCB.26.10.3695-3706.2006; Churg A, 2007, AM J RESP CELL MOL, V37, P144, DOI 10.1165/rcmb.2006-0345OC; Corti M, 1996, AM J RESP CELL MOL, V14, P309, DOI 10.1165/ajrcmb.14.4.8600933; Cosio MG, 2009, NEW ENGL J MED, V360, P2445, DOI 10.1056/NEJMra0804752; Croft M, 2009, NAT REV IMMUNOL, V9, P271, DOI 10.1038/nri2526; Croxton TL, 2003, AM J RESP CRIT CARE, V167, P1142, DOI 10.1164/rccm.200207-756WS; Datta S, 2008, J IMMUNOL, V180, P2545, DOI 10.4049/jimmunol.180.4.2545; Deleault KM, 2008, MOL IMMUNOL, V45, P13, DOI 10.1016/j.molimm.2007.05.017; Di YP, 2012, J BIOL CHEM, V287, P27948, DOI 10.1074/jbc.M111.334375; DIFRANCIA M, 1994, AM J RESP CRIT CARE, V150, P1453, DOI 10.1164/ajrccm.150.5.7952575; Ding Q, 2008, J BIOL CHEM, V283, P26839, DOI 10.1074/jbc.M803645200; Dominguez R, 2009, CRIT REV BIOCHEM MOL, V44, P351, DOI 10.3109/10409230903277340; Eid AA, 2001, AM J RESP CRIT CARE, V164, P1414, DOI 10.1164/ajrccm.164.8.2008109; Fine-Schi S, 2008, AM J RESP CELL MOL, V39, P458, DOI 10.1165/rcmb.2007-0320OC; Keatings VM, 2000, CHEST, V118, P971, DOI 10.1378/chest.118.4.971; Kim Victor, 2008, Proc Am Thorac Soc, V5, P478, DOI 10.1513/pats.200802-014ET; Kolsum Umme, 2009, Int J Chron Obstruct Pulmon Dis, V4, P149; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; Lai WS, 2000, J BIOL CHEM, V275, P17827, DOI 10.1074/jbc.M001696200; LAI WS, 1990, J BIOL CHEM, V265, P16556; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Li HX, 2006, J BIOL CHEM, V281, P13636, DOI 10.1074/jbc.M600620200; Matera MG, 2010, PULM PHARMACOL THER, V23, P121, DOI 10.1016/j.pupt.2009.10.007; MUSSALORAUHAMAA H, 1986, ARCH ENVIRON HEALTH, V41, P49, DOI 10.1080/00039896.1986.9935765; Oudijk EJD, 2003, EUR RESPIR J, V22, p5S, DOI 10.1183/09031936.03.00004603a; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Rennard Stephen I, 2006, Proc Am Thorac Soc, V3, P703, DOI 10.1513/pats.200605-121SF; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Rutgers SR, 2000, CHEST, V117, p262S, DOI 10.1378/chest.117.5_suppl_1.262S; Schaub MC, 2008, BIOCHEM BIOPH RES CO, V369, P247, DOI 10.1016/j.bbrc.2007.10.082; Shapiro SD, 2005, AM J RESP CELL MOL, V32, P367, DOI 10.1165/rcmb.F296; Su YC, 1998, AM J RESP CELL MOL, V19, P819, DOI 10.1165/ajrcmb.19.5.3091; Suzuki K, 2003, J EXP MED, V198, P1717, DOI 10.1084/jem.20031701; Takenawa T, 2001, J CELL SCI, V114, P1801; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Togo S, 2008, AM J RESP CRIT CARE, V178, P248, DOI 10.1164/rccm.200706-929OC; TURATO G, 1995, AM J RESP CRIT CARE, V152, P1262, DOI 10.1164/ajrccm.152.4.7551380; Wagener BM, 2016, FASEB J, V30, P2557, DOI 10.1096/fj.201600102R; Wells JM, 2014, AM J RESP CRIT CARE, V190, P51, DOI 10.1164/rccm.201401-0145OC; Willemse BWM, 2005, EUR RESPIR J, V26, P835, DOI 10.1183/09031936.05.00108904; Yao HW, 2009, CURR OPIN PHARMACOL, V9, P375, DOI 10.1016/j.coph.2009.06.009; Young LE, 2009, GASTROENTEROLOGY, V136, P1669, DOI 10.1053/j.gastro.2009.01.010; Zhan SQ, 2011, BBA-MOL BASIS DIS, V1812, P565, DOI 10.1016/j.bbadis.2010.11.003; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	60	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0167451	10.1371/journal.pone.0167451	http://dx.doi.org/10.1371/journal.pone.0167451			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3TF	27911957	gold, Green Published, Green Submitted			2022-12-26	WOS:000389520600035
J	Li, SJ; Cao, WJ; Sun, XH				Li, Shengjie; Cao, Wenjun; Sun, Xinghuai			Role of Platelet Parameters on Neovascular Glaucoma: A Retrospective Case-Control Study in China	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; RETINAL VEIN OCCLUSION; ENDOTHELIAL GROWTH-FACTOR; DISTRIBUTION WIDTH; VOLUME; COUNT; ACTIVATION; INDEXES; ASSOCIATION; DETERMINANTS	Purpose Retinal vein occlusion (RVO) and diabetic retinopathy (DR) are two major sight-threatening diseases which may lead to neovascular glaucoma (NVG). The aim of this study was to explore the association between platelet parameters and NVG. Methods A total of 185 subjects were enrolled for the study from January, 2012 to December, 2015 at the Eye-ENT Hospital of Fudan University. Patients include those with NVG secondary to RVO (RVO group, n = 38), patients with NVG secondary to DR (DR group, n = 47), diabetics mellitus without retinopathy (DM group, n = 52), and healthy individuals (control group, n = 48). A complete ophthalmological examination including visual field examination, A-scan ultrasound, Fundus photography, and measurement of platelet parameters were performed for NVG subjects. Results There was no statistical difference in the mean age and gender among the RVO, DR, and control groups (p>0.05). The mean level of platelet distribution width (PDW) was higher (p<0.001) in the RVO group (15.16 +/- 2.13fl) and DR group (16.17 +/- 1.66fl) when compared with the control group (13.77 +/- 2.99fl). The mean plateletcrit (PCT) value of the RVO group (0.229 +/- 0.063%) was also higher (p = 0.049) than the control group (0.199 +/- 0.045). In the DR group, mean platelet volume (MPV) value (10.72 +/- 1.57fl) was significantly higher (p = 0.002) than the control group (9.75 +/- 0.89fl). A similar trend was observed when platelet parameters were compared among the 3 groups with respect to age. The mean level of PDW was significantly higher (p<0.001) in the DR group (16.17 +/- 1.66fl) compared with the DM group (13.80 +/- 3.32fl). Stepwise multiple logistic regression analysis revealed that PDW (OR = 1.44, 95% CI = 1.149-1.805, p = 0.002) and MPV (OR = 1.503, 95% CI = 1.031-2.192, p = 0.034) were associated with the DR group, PDW (OR = 1.207, 95% CI = 1.010-1.443, p = 0.039) and PCT (OR = 1.663, 95% CI = 1.870-2.654, p = 0.036) were associated with the RVO group. Conclusion Our results suggest that increased PDW and MPV are associated with the NVG secondary to DR group, elevated PDW and PCT are associated with the RVO group. It indicates that platelets might be an important factor in the onset and/or development of NVG.	[Li, Shengjie; Cao, Wenjun] Fudan Univ, Shanghai Med Coll, Eye & ENT Hosp, Dept Clin Lab, Shanghai, Peoples R China; [Cao, Wenjun; Sun, Xinghuai] Fudan Univ, Shanghai Med Coll, Eye & ENT Hosp, Dept Ophthalmol & Visual Sci, Shanghai, Peoples R China; [Sun, Xinghuai] Fudan Univ, Inst Brain Sci, State Key Lab Med Neurobiol, Shanghai, Peoples R China; [Sun, Xinghuai] Fudan Univ, Minist Hlth, Key Lab Myopia, Shanghai, Peoples R China; [Sun, Xinghuai] Fudan Univ, Shanghai Key Lab Visual Impairment & Restorat, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University; Fudan University	Cao, WJ (corresponding author), Fudan Univ, Shanghai Med Coll, Eye & ENT Hosp, Dept Clin Lab, Shanghai, Peoples R China.; Cao, WJ; Sun, XH (corresponding author), Fudan Univ, Shanghai Med Coll, Eye & ENT Hosp, Dept Ophthalmol & Visual Sci, Shanghai, Peoples R China.; Sun, XH (corresponding author), Fudan Univ, Inst Brain Sci, State Key Lab Med Neurobiol, Shanghai, Peoples R China.; Sun, XH (corresponding author), Fudan Univ, Minist Hlth, Key Lab Myopia, Shanghai, Peoples R China.; Sun, XH (corresponding author), Fudan Univ, Shanghai Key Lab Visual Impairment & Restorat, Shanghai, Peoples R China.	wgkiyk@aliyun.com; xhsun@shmu.edu.cn	Li, Shengjie/AAU-7902-2021	Cao, Wenjun/0000-0001-6383-9012	Funds for International Cooperation and Exchange of the National Natural Science Foundation of China [81020108017]; National Health and Family Planning Commission, China [201302015]; National Major Scientific Equipment program; Ministry of Science and Technology, China [2012YQ12008003]; State Key Program of National Natural Science Foundation of China [81430007]; New Technology Research Project, Shanghai Municipal Commission of Health and Family Planning [2013SY058]	Funds for International Cooperation and Exchange of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Health and Family Planning Commission, China; National Major Scientific Equipment program; Ministry of Science and Technology, China(Ministry of Science and Technology, China); State Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Technology Research Project, Shanghai Municipal Commission of Health and Family Planning	This research project was supported by the Funds for International Cooperation and Exchange of the National Natural Science Foundation of China (81020108017), the National Health and Family Planning Commission, China (201302015), the National Major Scientific Equipment program, the Ministry of Science and Technology, China (2012YQ12008003), the State Key Program of National Natural Science Foundation of China (81430007), and the New Technology Research Project, Shanghai Municipal Commission of Health and Family Planning (2013SY058).; This research project was supported by the Funds for International Cooperation and Exchange of the National Natural Science Foundation of China (81020108017), the National Health and Family Planning Commission, China(201302015), the National Major Scientific Equipment program, the Ministry of Science and Technology, China (2012YQ12008003), the State Key Program of National Natural Science Foundation of China (81430007), and the New Technology Research Project, Shanghai Municipal Commission of Health and Family Planning (2013SY058). The sponsor or funding organization had no role in the design or conduct of this research.	AABERG TM, 1981, OPHTHALMOLOGY, V88, P639; Akpinar I, 2014, J CARDIOL, V63, P112, DOI 10.1016/j.jjcc.2013.07.010; Aksoy Y, 2013, INDIAN J OPHTHALMOL, V61, P686, DOI 10.4103/0301-4738.119414; Ates O., 2009, EUR J MED, V6, P99, DOI DOI 10.29333/EIGM/82648; Beer PM, 2006, RETINA-J RET VIT DIS, V26, P871, DOI 10.1097/01.iae.0000233327.68433.02; Chen SD, 2015, ACTA OPHTHALMOL, V93, pE556, DOI 10.1111/aos.12624; Citirik M, 2015, EYE, V29, P376, DOI 10.1038/eye.2014.298; CLARKSON JG, 1993, ARCH OPHTHALMOL-CHIC, V111, P1087; Daly ME, 2011, HAEMATOL-HEMATOL J, V96, P10, DOI 10.3324/haematol.2010.035287; De Luca G, 2010, PLATELETS, V21, P508, DOI 10.3109/09537104.2010.494743; Du J, 2016, INT J LAB HEMATOL, V38, P233, DOI 10.1111/ijlh.12474; ERNE P, 1988, THROMB HAEMOSTASIS, V59, P259; Han JS, 2013, PLATELETS, V24, P590, DOI 10.3109/09537104.2012.748187; HAVER VM, 1981, J LAB CLIN MED, V97, P187; Higashide T, 2015, PLOS ONE, V10; Jindal S, 2011, HEMATOLOGY, V16, P86, DOI 10.1179/102453311X12902908412110; Kamisli O, 2013, CLIN APPL THROMB-HEM, V19, P29, DOI 10.1177/1076029612453196; Khandekar MM, 2006, J CLIN PATHOL, V59, P146, DOI 10.1136/jcp.2004.025387; Kodiatte Thomas Alex, 2012, J Lab Physicians, V4, P5, DOI 10.4103/0974-2727.98662; Latorre R, 2016, LIVER INT, V36, P232, DOI 10.1111/liv.12908; Leoncini G, 2007, THROMB HAEMOSTASIS, V97, P218, DOI 10.1160/TH06-05-0257; Nakano S, 2016, J OPHTHALMOL, V2016, DOI 10.1155/2016/1205895; OMALLEY T, 1995, STROKE, V26, P995, DOI 10.1161/01.STR.26.6.995; Onder HI, 2013, INDIAN J OPHTHALMOL, V61, P160, DOI 10.4103/0301-4738.111063; Ornek N, 2014, EUR REV MED PHARMACO, V18, P2778; Osselaer JC, 1997, CLIN CHEM, V43, P1072; Papanas N, 2004, PLATELETS, V15, P475, DOI 10.1080/0953710042000267707; Park Y, 2002, PLATELETS, V13, P301, DOI 10.1080/095371002220148332; Sahin A, 2013, J OPHTHALMOL, V2013, DOI 10.1155/2013/236371; Sahin M, 2016, J OPHTHALMOL, V2016, DOI 10.1155/2016/1051572; Sahin M, 2016, ARQ BRAS OFTALMOL, V79, P12, DOI 10.5935/0004-2749.20160005; Sansanayudh N, 2016, EUR J INTERN MED, V30, P37, DOI 10.1016/j.ejim.2015.11.028; Tuzcu EA, 2014, GRAEF ARCH CLIN EXP, V252, P237, DOI 10.1007/s00417-013-2444-y; Tvedten H, 2008, VET CLIN PATH, V37, P266, DOI 10.1111/j.1939-165X.2008.00054.x; Ugur M, 2014, J CRIT CARE, V29, P978, DOI 10.1016/j.jcrc.2014.07.001; Ulu S, 2013, EUR ARCH OTO-RHINO-L, V270, P2875, DOI 10.1007/s00405-013-2348-9; Vagdatli E, 2010, HIPPOKRATIA, V14, P28; Varol E, 2011, SCAND J CLIN LAB INV, V71, P163, DOI 10.3109/00365513.2010.547596; Wakabayashi T, 2008, OPHTHALMOLOGY, V115, P1571, DOI 10.1016/j.ophtha.2008.02.026; Yazgan S, 2016, EYE CONTACT LENS, V42, P328, DOI 10.1097/ICL.0000000000000197; Yoshizumi MO, 1996, AM J OPHTHALMOL, V121, P728, DOI 10.1016/S0002-9394(14)70649-X; Zhong ZL, 2011, INT J OPHTHALMOL-CHI, V4, P182, DOI 10.3980/j.issn.2222-3959.2011.02.15	42	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166893	10.1371/journal.pone.0166893	http://dx.doi.org/10.1371/journal.pone.0166893			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907042	gold, Green Published, Green Submitted			2022-12-26	WOS:000389482700050
J	Muanda, M; Ndongo, PG; Taub, LD; Bertrand, JT				Muanda, Mbadu; Ndongo, Parfait Gahungu; Taub, Leah D.; Bertrand, Jane T.			Barriers to Modern Contraceptive Use in Kinshasa, DRC	PLOS ONE			English	Article								Recent research from Kinshasa, DRC, has shown that only one in five married women uses modern contraception; over one quarter have an unmet need for family planning; and almost 400 health facilities across Kinshasa report that they provide modern contraception. This study addresses the question: with reasonable physical access and relatively high unmet need, why is modern contraceptive prevalence so low? To this end, the research team conducted 6 focus groups of women (non-users of any method, users of traditional methods, and users of modern methods) and 4 of husbands (of users of traditional methods and in non-user unions) in health zones with relatively strong physical access to FP services. Five key barriers emerged from the focus group discussions: fear of side effects (especially sterility), costs of the method, sociocultural norms (especially the dominant position of the male in family decision-making), pressure from family members to avoid modern contraception, and lack of information/misinformation. These findings are very similar to those from 12 other studies of sociocultural barriers to family planning in sub-Saharan Africa. Moreover, they have strong programmatic implications for the training of FP workers to counsel future clients and for the content of behavior change communication interventions.	[Muanda, Mbadu] Minist Hlth, Programme Natl Sante Adolescent, Natl Program Adolescent Hlth, Kinshasa, DEM REP CONGO; [Ndongo, Parfait Gahungu] Inst Super Dev Rural, Matadi, Kongo Cent, DEM REP CONGO; [Taub, Leah D.] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Global Community Hlth & Behav Sci, New Orleans, LA USA; [Bertrand, Jane T.] Tulane Univ, Dept Global Hlth Management & Policy, Sch Publ Hlth & Trop Med, New Orleans, LA 70118 USA	Tulane University; Tulane University	Bertrand, JT (corresponding author), Tulane Univ, Dept Global Hlth Management & Policy, Sch Publ Hlth & Trop Med, New Orleans, LA 70118 USA.	bertrand@tulanae.edu			Bill and Melinda Gates Foundation [OPP1117997]; Bill & Melinda Gates Foundation	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The study was funded by the Bill and Melinda Gates Foundation (grant #OPP1117997; URL: http://www.gatesfoundation.org/). JTB and MM received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This article was developed under grant #OPP1117997 awarded to the Tulane University School of Public Health and Tropical Medicine by the Bill & Melinda Gates Foundation. The findings and conclusions contained within are those of the authors and do not necessarily reflect positions or policies of the Bill & Melinda Gates Foundation. The authors wish to thank Ms. Perri Sutton for her diligent oversight of the work under this grant.	Adongo PB, 2014, FRONT PUBLIC HEALTH, V2, P1; Adongo PB, 2014, BMC INT HEALTH HUM R, V14, DOI 10.1186/1472-698X-14-16; [Anonymous], 2014, ENQ DEM SANT REP DEM; Aransiola JO, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-869; Barnes J., 2012, TOTAL MARKET INITIAT; Becker G., 1960, EC ANAL FERTILITY DE, P209; Bertrand J. T., 2016, ANAL SUPPLY DEMAND F; Chapman S, 2012, SEX HEALTH, V9, P44, DOI 10.1071/SH10165; Diamond-Smith N, 2012, CULT HEALTH SEX, V14, P421, DOI 10.1080/13691058.2012.664659; Farmer DB, 2015, GLOB HEALTH, V3, P242, DOI 10.9745/GHSP-D-14-00198; Gebremariam Alem, 2014, Int J Family Med, V2014, P878639, DOI 10.1155/2014/878639; Hennink M, 2005, AFRICAN POPULATION S, V20, P101; John NA, 2015, INT PERSPECT SEX R H, V41, P99, DOI 10.1363/4109915; Kabagenyi A, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-21; Kayembe P, 2015, GLOB HEALTH-SCI PRAC, V3, P630, DOI 10.9745/GHSP-D-15-00298; Kenya National Bureau of Statistics (KNBS) and ICF Macro, 2015, KENY DEM HLTH SURV K; Morgan D.L, 1996, FOCUS GROUPS QUALITA; Namey E, 2005, QUALITATIVE RES METH; Okwor EU, 2010, INT Q COMMUNITY HEAL, V30, P223, DOI 10.2190/IQ.30.3.d; Patton M, 2015, UTILIZATION FOCUSED, VFourth; Pitorak H, 2014, HEALTH CARE WOMEN IN, V35, P234, DOI 10.1080/07399332.2012.736575; PMA, 2015, PMA2015 KINSH ROUND; Rossier C, 2014, POP ASS AM ANN M BOS; Uganda Bureau of Statistics, 2012, UG DEM HLTH SURV 201; United Nations Department of Economic and Social Affairs Population Division, 2016, WORLD POP PROSP 2015; Zambia Statistics Agency Ministry of Health Zambia ICF., 2019, ZAMB DEM HLTH SURV 2; Zimbabwe National Statistics Agency (ZIMSTAT) and ICF International, 2012, ZIMB DEM HLTH SURV 2	27	29	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167560	10.1371/journal.pone.0167560	http://dx.doi.org/10.1371/journal.pone.0167560			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907138	Green Submitted, Green Published, gold			2022-12-26	WOS:000389482700195
J	Sohn, YS; Lee, SG; Lee, KH; Ku, B; Shine, HC; Cha, SS; Kim, YG; Lee, HS; Kang, SG; Oh, BH				Sohn, Young-Sik; Lee, Seong-Gyu; Lee, Kwang-Hoon; Ku, Bonsu; Shine, Ho-Chul; Cha, Sun-Shin; Kim, Yeon-Gil; Lee, Hyun Sook; Kang, Sung-Gyun; Oh, Byung-Ha			Identification of a Highly Conserved Hypothetical Protein TON_0340 as a Probable Manganese-Dependent Phosphatase	PLOS ONE			English	Article							IB RIBONUCLEOTIDE REDUCTASE; N-OXYGENASE AURF; CRYSTAL-STRUCTURE; SEQUENCE; DNA	A hypothetical protein TON_0340 of a Thermococcus species is a protein conserved in a variety of organisms including human. Herein, we present four different crystal structures of TON_0340, leading to the identification of an active-site cavity harboring a metal-binding site composed of six invariant aspartate and glutamate residues that coordinate one to three metal ions. Biochemical and mutational analyses involving many phosphorous compounds show that TON_0340 is a Mn2+-dependent phosphatase. Mg2+ binds to TON_0340 less tightly and activates the phosphatase activity less efficiently than Mn2+. Whereas Ca2+ and Zn2+ are able to bind to the protein, they are unable to activate its enzymatic activity. Since the active-site cavity is small and largely composed of nearly invariant stretches of 11 or 13 amino acids, the physiological substrates of TON_0340 and its homologues are likely to be a small and the same molecule. The Mn2+-bound TON_0340 structure provides a canonical model for the ubiquitously present TON_0340 homologues and lays a strong foundation for the elucidation of their substrate and biological function.	[Sohn, Young-Sik; Lee, Seong-Gyu; Lee, Kwang-Hoon; Oh, Byung-Ha] Korea Adv Inst Sci & Technol, KAIST Inst Biocentury, Dept Biol Sci, Daejeon, South Korea; [Ku, Bonsu; Shine, Ho-Chul] Korea Res Inst Biosci & Biotechnol, Dis Target Struct Res Ctr, Daejeon, South Korea; [Cha, Sun-Shin] Ewha Womans Univ, Dept Chem & Nano Sci, Seoul, South Korea; [Kim, Yeon-Gil] Pohang Univ Sci & Technol, Pohang Accelerator Lab, Pohang, Kyungbuk, South Korea; [Lee, Hyun Sook; Kang, Sung-Gyun] Korea Inst Ocean Sci & Technol, Marine Biotechnol Res Ctr, Ansan, South Korea; [Lee, Kwang-Hoon] Yuhan R&D Inst, Global Res Ctr, Yongin, Gyeonggi Do, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Ewha Womans University; Pohang University of Science & Technology (POSTECH); Korea Institute of Ocean Science & Technology (KIOST)	Oh, BH (corresponding author), Korea Adv Inst Sci & Technol, KAIST Inst Biocentury, Dept Biol Sci, Daejeon, South Korea.	bhoh@kaist.ac.kr	Oh, Byung-Ha/C-2061-2011	Ku, Bonsu/0000-0003-1784-8975; Cha, Sun-Shin/0000-0002-0913-8706	Ministry of Oceans and Fisheries; Ministry of Oceans and Fisheries, Korea	Ministry of Oceans and Fisheries; Ministry of Oceans and Fisheries, Korea	This work was funded by Ministry of Oceans and Fisheries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study made use of the Beamline 5C at the Pohang Accelerator Laboratory, Korea and the Beamline NW12A at Photon Factory, Japan. This research was a part of the project titled "Marine and Extreme Genome Research Center Program" funded by Ministry of Oceans and Fisheries, Korea.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bae SS, 2006, J MICROBIOL BIOTECHN, V16, P1826; Bae SS, 2012, BIOTECHNOL LETT, V34, P75, DOI 10.1007/s10529-011-0732-3; Barynin VV, 2001, STRUCTURE, V9, P725, DOI 10.1016/S0969-2126(01)00628-1; Boal AK, 2012, BIOCHEMISTRY-US, V51, P3861, DOI 10.1021/bi201925t; Boal AK, 2010, SCIENCE, V329, P1526, DOI 10.1126/science.1190187; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cha SS, 2012, ACTA CRYSTALLOGR D, V68, P1253, DOI 10.1107/S0907444912024420; Cheng KY, 2016, ELIFE, V5, DOI 10.7554/eLife.14294; Choi YS, 2008, P NATL ACAD SCI USA, V105, P6858, DOI 10.1073/pnas.0712073105; Creekmore AL, 2007, MOL CELL ENDOCRINOL, V267, P106, DOI 10.1016/j.mce.2007.01.001; Dokmanic I, 2008, ACTA CRYSTALLOGR D, V64, P257, DOI 10.1107/S090744490706595X; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kim YJ, 2010, NATURE, V467, P352, DOI 10.1038/nature09375; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leavitt S, 2001, CURR OPIN STRUC BIOL, V11, P560, DOI 10.1016/S0959-440X(00)00248-7; Lee HS, 2008, J BACTERIOL, V190, P7491, DOI 10.1128/JB.00746-08; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pereira SFF, 2011, MICROBIOL MOL BIOL R, V75, P192, DOI 10.1128/MMBR.00042-10; Shen A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008119; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wakamatsu T, 2010, J BIOL CHEM, V285, P9762, DOI 10.1074/jbc.M109.096487; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; Yamagata A, 2002, P NATL ACAD SCI USA, V99, P5908, DOI 10.1073/pnas.092547099; Zheng H, 2008, J INORG BIOCHEM, V102, P1765, DOI 10.1016/j.jinorgbio.2008.05.006; Zocher G, 2007, J MOL BIOL, V373, P65, DOI 10.1016/j.jmb.2007.06.014	28	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167549	10.1371/journal.pone.0167549	http://dx.doi.org/10.1371/journal.pone.0167549			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907125	Green Published, gold, Green Submitted			2022-12-26	WOS:000389482700189
J	Terry-Lorenzo, RT; Torres, VI; Wagh, D; Galaz, J; Swanson, SK; Florens, L; Washburn, MP; Waites, CL; Gundelfinger, ED; Reimer, RJ; Garner, CC				Terry-Lorenzo, Ryan T.; Torres, Viviana I.; Wagh, Dhananjay; Galaz, Jose; Swanson, Selene K.; Florens, Laurence; Washburn, Michael P.; Waites, Clarissa L.; Gundelfinger, Eckart D.; Reimer, Richard J.; Garner, Craig C.			Trio, a Rho Family GEF, Interacts with the Presynaptic Active Zone Proteins Piccolo and Bassoon	PLOS ONE			English	Article							SYNAPTIC VESICLE EXOCYTOSIS; NUCLEOTIDE-EXCHANGE FACTORS; DEVELOPING RAT-BRAIN; IDENTIFICATION TECHNOLOGY; NEUROTRANSMITTER RELEASE; EXCITATORY SYNAPSES; HIPPOCAMPAL-NEURONS; SHOTGUN PROTEOMICS; PRECURSOR VESICLES; NEURITE OUTGROWTH	Synaptic vesicles (SVs) fuse with the plasma membrane at a precise location called the pre synaptic active zone (AZ). This fusion is coordinated by proteins embedded within a cytoskeletal matrix assembled at the AZ (CAZ). In the present study, we have identified a novel binding partner for the CAZ proteins Piccolo and Bassoon. This interacting protein, Trio, is a member of the Dbl family of guanine nucleotide exchange factors (GEFs) known to regulate the dynamic assembly of actin and growth factor dependent axon guidance and synaptic growth. Trio was found to interact with the C-terminal PBH 9/10 domains of Piccolo and Bassoon via its own N-terminal Spectrin repeats, a domain that is also critical for its localization to the CAZ. Moreover, our data suggest that regions within the C-terminus of Trio negatively regulate its interactions with Piccolo/Bassoon. These findings provide a mechanism for the presynaptic targeting of Trio and support a model in which Piccolo and Bassoon play a role in regulating neurotransmission through interactions with proteins, including Trio, that modulate the dynamic assembly of F-actin during cycles of synaptic vesicle exo- and endocytosis.	[Terry-Lorenzo, Ryan T.; Torres, Viviana I.; Wagh, Dhananjay; Galaz, Jose; Waites, Clarissa L.; Garner, Craig C.] Stanford Univ, Nancy Pritzker Lab, Dept Psychiat & Behav Sci, Palo Alto, CA 94304 USA; [Torres, Viviana I.] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Biol Celular & Mol, Ctr Envejecimiento & Regenerac, Santiago, Chile; [Swanson, Selene K.; Florens, Laurence; Washburn, Michael P.] Stowers Inst Med Res, Kansas City, MO USA; [Gundelfinger, Eckart D.] Leibniz Inst Neurobiol, Dept Neurochem & Mol Biol, Magdeburg, Germany; [Reimer, Richard J.] Stanford Univ, Dept Neurol & Neurol Sci, Palo Alto, CA 94304 USA; [Reimer, Richard J.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Garner, Craig C.] Charite, German Ctr Neurodegenerat Dis, Berlin, Germany; [Terry-Lorenzo, Ryan T.] Sunov Pharmaceut, Discovery & Preclin Res Dept, Marlborough, MA USA; [Galaz, Jose] Univ Bernardo O Higgins, Lab Bionanotecnol, Santiago, Chile; [Washburn, Michael P.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA; [Waites, Clarissa L.] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY USA	Stanford University; Pontificia Universidad Catolica de Chile; Stowers Institute for Medical Research; Leibniz Institut fur Neurobiologie (LIN); Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Dainippon Sumitomo Pharmaceutical Company; Sunovion Pharmaceuticals Inc.; Universidad  Bernardo O'Higgins; University of Kansas; University of Kansas Medical Center; Columbia University	Garner, CC (corresponding author), Stanford Univ, Nancy Pritzker Lab, Dept Psychiat & Behav Sci, Palo Alto, CA 94304 USA.	Craig-Curtis.Garner@dzne.de	Torres, Viviana/AAC-3329-2019	Torres, Viviana/0000-0002-1220-7709; Florens, Laurence/0000-0002-9310-6650; Garner, Craig/0000-0003-1970-5417	NIH [NS39471, NS353862]; Deutsches Zentrum fur Neurodegenerative Erkrankung (DZNE); Deutsche Forschungsgemeinschaft [SFB-958, SFB779]; Max Planck Award of the Alexander von Humboldt Foundation/Max Planck Society; Stowers Institute for Medical Research	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsches Zentrum fur Neurodegenerative Erkrankung (DZNE); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Award of the Alexander von Humboldt Foundation/Max Planck Society; Stowers Institute for Medical Research	This work was supported by grants from the NIH (NS39471 and NS353862), Deutsches Zentrum fur Neurodegenerative Erkrankung (DZNE) and Deutsche Forschungsgemeinschaft (SFB-958) to CCG, NRSAs to CLW and RTTL, and a Max Planck Award of the Alexander von Humboldt Foundation/Max Planck Society and the Deutsche Forschungsgemeinschaft (SFB779) to EDG. SKS, LF and MPW are supported by the Stowers Institute for Medical Research.	Ackermann F, 2015, EMBO REP, V16, P923, DOI 10.15252/embr.201540434; Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Altrock WD, 2003, NEURON, V37, P787, DOI 10.1016/S0896-6273(03)00088-6; Awasaki T, 2000, NEURON, V26, P119, DOI 10.1016/S0896-6273(00)81143-5; Bader MF, 2004, BBA-MOL CELL RES, V1742, P37, DOI 10.1016/j.bbamcr.2004.09.028; Ball RW, 2010, NEURON, V66, P536, DOI 10.1016/j.neuron.2010.04.011; BANKER G, 1998, CULTURING NERVE CELL; Bateman J, 2000, NEURON, V26, P93, DOI 10.1016/S0896-6273(00)81141-1; Bateman J, 2001, J CELL SCI, V114, P1973; Boyl PP, 2007, EMBO J, V26, P2991, DOI 10.1038/sj.emboj.7601737; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; CasesLanghoff C, 1996, EUR J CELL BIOL, V69, P214; Castillo PE, 2002, NATURE, V415, P327, DOI 10.1038/415327a; Cerpa W, 2008, J BIOL CHEM, V283, P5918, DOI 10.1074/jbc.M705943200; Charrasse S, 2007, MOL BIOL CELL, V18, P1734, DOI 10.1091/mbc.E06-08-0766; Ciani L, 2005, NAT REV NEUROSCI, V6, P351, DOI 10.1038/nrn1665; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; Dai Y, 2006, NAT NEUROSCI, V9, P1479, DOI 10.1038/nn1808; Davydova D, 2014, NEURON, V82, P181, DOI 10.1016/j.neuron.2014.02.012; Debant A, 1996, P NATL ACAD SCI USA, V93, P5466, DOI 10.1073/pnas.93.11.5466; Dick O, 2003, NEURON, V37, P775, DOI 10.1016/S0896-6273(03)00086-2; Dieck ST, 2005, J CELL BIOL, V168, P825, DOI 10.1083/jcb.200408157; Dieck ST, 1998, J CELL BIOL, V142, P499, DOI 10.1083/jcb.142.2.499; Dillon C, 2005, ANNU REV NEUROSCI, V28, P25, DOI 10.1146/annurev.neuro.28.061604.135757; Dresbach T, 2006, J BIOL CHEM, V281, P6038, DOI 10.1074/jbc.M508784200; Dresbach T, 2003, MOL CELL NEUROSCI, V23, P279, DOI 10.1016/S1044-7431(03)00015-0; Engqvist-Goldstein AEY, 2003, ANNU REV CELL DEV BI, V19, P287, DOI 10.1146/annurev.cellbio.19.111401.093127; Estrach S, 2002, CURR BIOL, V12, P307, DOI 10.1016/S0960-9822(02)00658-9; Evergren E, 2007, J NEUROSCI RES, V85, P2648, DOI 10.1002/jnr.21176; Fenster SD, 2000, NEURON, V25, P203, DOI 10.1016/S0896-6273(00)80883-1; Florens Laurence, 2006, V328, P159; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; GRAY EG, 1963, J ANAT, V97, P101; Gundelfinger Eckart D, 2015, Front Synaptic Neurosci, V7, P19, DOI 10.3389/fnsyn.2015.00019; Hakeda-Suzuki S, 2002, NATURE, V416, P438, DOI 10.1038/416438a; Herring BE, 2016, P NATL ACAD SCI USA, V113, P2264, DOI 10.1073/pnas.1600179113; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jose M, 2008, BIOPHYS J, V94, P1483, DOI 10.1529/biophysj.107.111674; Katoh H, 2000, MOL CELL BIOL, V20, P7378, DOI 10.1128/MCB.20.19.7378-7387.2000; Khimich D, 2005, NATURE, V434, P889, DOI 10.1038/nature03418; Kim S, 2003, J BIOL CHEM, V278, P6291, DOI 10.1074/jbc.M212287200; KINDLER S, 1990, J BIOL CHEM, V265, P19679; Ko J, 2003, J BIOL CHEM, V278, P42377, DOI 10.1074/jbc.M307561200; Langnaese K, 1996, MOL BRAIN RES, V42, P118, DOI 10.1016/S0169-328X(96)00147-7; Leal-Ortiz S, 2008, J CELL BIOL, V181, P831, DOI 10.1083/jcb.200711167; Liebl EC, 2000, NEURON, V26, P107, DOI 10.1016/S0896-6273(00)81142-3; Lin MZ, 2000, CELL, V101, P239, DOI 10.1016/S0092-8674(00)80833-8; Lucas FR, 1997, DEV BIOL, V192, P31, DOI 10.1006/dbio.1997.8734; Ma XM, 2005, J COMP NEUROL, V482, P333, DOI 10.1002/cne.20404; Maas C, 2012, J NEUROSCI, V32, P11095, DOI 10.1523/JNEUROSCI.0195-12.2012; McPherson CE, 2005, GENE, V347, P125, DOI 10.1016/j.gene.2004.12.028; Mukherjee K, 2010, P NATL ACAD SCI USA, V107, P6504, DOI 10.1073/pnas.1002307107; Newsome TP, 2000, CELL, V101, P283, DOI 10.1016/S0092-8674(00)80838-7; Ohtsuka T, 2002, J CELL BIOL, V158, P577, DOI 10.1083/jcb.200202083; Patel MR, 2006, NAT NEUROSCI, V9, P1488, DOI 10.1038/nn1806; Pawson C, 2008, J NEUROSCI, V28, P11111, DOI 10.1523/JNEUROSCI.0833-08.2008; Phillips GR, 2001, NEURON, V32, P63, DOI 10.1016/S0896-6273(01)00450-0; Portales-Casamar E, 2006, BIOL CELL, V98, P183, DOI 10.1042/BC20050009; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Rosso SB, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00103; Schneggenburger R, 2015, NAT NEUROSCI, V18, P935, DOI 10.1038/nn.4044; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; Schoch S, 2006, CELL TISSUE RES, V326, P379, DOI 10.1007/s00441-006-0244-y; Schroder MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058814; Shapira M, 2003, NEURON, V38, P237, DOI 10.1016/S0896-6273(03)00207-1; Shen WH, 2006, NEURON, V50, P401, DOI 10.1016/j.neuron.2006.03.017; Shibasaki T, 2004, J BIOL CHEM, V279, P7956, DOI 10.1074/jbc.M309068200; Steven R, 2005, GENE DEV, V19, P2016, DOI 10.1101/gad.1319905; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sun YJ, 2006, MOL CELL BIOL, V26, P6923, DOI 10.1128/MCB.02474-05; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Takao-Rikitsu E, 2004, J CELL BIOL, V164, P301, DOI 10.1083/jcb.200307101; van Haren J, 2014, CURR BIOL, V24, P1778, DOI 10.1016/j.cub.2014.06.037; Varela-Nallar L, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-41; Wagh D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120093; Waites CL, 2013, EMBO J, V32, P954, DOI 10.1038/emboj.2013.27; Waites CL, 2011, J NEUROSCI, V31, P14250, DOI 10.1523/JNEUROSCI.1835-11.2011; Wang XL, 1999, J CELL BIOL, V147, P151, DOI 10.1083/jcb.147.1.151; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Williams SL, 2007, GENE DEV, V21, P2731, DOI 10.1101/gad.1592007; Witke W, 1998, EMBO J, V17, P967, DOI 10.1093/emboj/17.4.967; Wolters DA, 2001, ANAL CHEM, V73, P5683, DOI 10.1021/ac010617e; Xin XN, 2004, J CELL SCI, V117, P4739, DOI 10.1242/jcs.01333; Yao J, 2006, J NEUROSCI, V26, P8137, DOI 10.1523/JNEUROSCI.1183-06.2006; Zhai R, 2000, MOL CELL NEUROSCI, V15, P417, DOI 10.1006/mcne.2000.0839; Zhai RG, 2001, NEURON, V29, P131, DOI 10.1016/S0896-6273(01)00185-4; Zhang WD, 2001, J NEUROSCI, V21, P5169, DOI 10.1523/JNEUROSCI.21-14-05169.2001; Zhang Y, 2010, ANAL CHEM, V82, P2272, DOI 10.1021/ac9023999	89	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167535	10.1371/journal.pone.0167535	http://dx.doi.org/10.1371/journal.pone.0167535			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907191	Green Submitted, Green Published, gold			2022-12-26	WOS:000389482700187
J	Mymrikov, EV; Daake, M; Richter, B; Haslbeck, M; Buchner, J				Mymrikov, Evgeny V.; Daake, Marina; Richter, Bettina; Haslbeck, Martin; Buchner, Johannes			The Chaperone Activity and Substrate Spectrum of Human Small Heat Shock Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-B-CRYSTALLIN; MOLECULAR CHAPERONES; SKELETAL-MUSCLE; AGGREGATION; HSPB8; EXPRESSION; HSP20; TRANSITIONS; ASSEMBLIES; STRESS	Small heat shock proteins (sHsps) are a ubiquitous family of molecular chaperones that suppress the unspecific aggregation of miscellaneous proteins. Multicellular organisms contain a large number of different sHsps, raising questions as to whether they function redundantly or are specialized in terms of substrates and mechanism. To gain insight into this issue, we undertook a comparative analysis of the eight major human sHsps on the aggregation of both model proteins and cytosolic lysates under standardized conditions. We discovered that sHsps, which form large oligomers (HspB1/Hsp27, HspB3, HspB4/alpha A-crystallin, and HspB5/alpha B-crystallin) are promiscuous chaperones, whereas the chaperone activity of the other sHsps is more substrate-dependent. However, all human sHsps analyzed except HspB7 suppressed the aggregation of cytosolic proteins of HEK293 cells. We identified similar to 1100 heat-sensitive HEK293 proteins, 12% of which could be isolated in complexes with sHsps. Analysis of their biochemical properties revealed that most of the sHsp substrates have a molecular mass from 50 to 100 kDa and a slightly acidic pI (5.4-6.8). The potency of the sHsps to suppress aggregation of model substrates is correlated with their ability to form stable substrate complexes; especially HspB1 and HspB5, but also B3, bind tightly to a variety of proteins, whereas fewer substrates were detected in complex with the other sHsps, although these were also efficient in preventing the aggregation of cytosolic proteins.	[Mymrikov, Evgeny V.; Daake, Marina; Richter, Bettina; Haslbeck, Martin; Buchner, Johannes] Tech Univ Munich, Dept Chem, Ctr Integrated Prot Sci, Lichtenbergstr 4, D-85748 Garching, Germany; [Mymrikov, Evgeny V.] Univ Freiburg, Inst Biochem & Mol Biol, Stefan Meier Str 17, D-79104 Freiburg, Germany	Technical University of Munich; University of Freiburg	Buchner, J (corresponding author), Tech Univ Munich, Dept Chem, Ctr Integrated Prot Sci, Lichtenbergstr 4, D-85748 Garching, Germany.	johannes.buchner@tum.de	Haslbeck, Martin/A-4413-2013; Buchner, Johannes/A-2651-2010	Mymrikov, Evgeny/0000-0003-4817-6278; Buchner, Johannes/0000-0003-1282-7737	Deutsche Forschungsgemeinschaft [SFB 1035]; CIPSM; Peter und Traudl Engelhorn Stiftung post-doctoral fellowship	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); CIPSM; Peter und Traudl Engelhorn Stiftung post-doctoral fellowship	The work was supported by the Deutsche Forschungsgemeinschaft (SFB 1035) and CIPSM. The authors declare that they have no conflicts of interest with the contents of this article.r Recipient of a Peter und Traudl Engelhorn Stiftung post-doctoral fellowship. Present address: Institute for Biochemistry and Molecular Biology, University of Freiburg, Stefan- Meier-Strasse 17, 79104 Freiburg, Germany.	Asthana A, 2012, CELL BIOCHEM BIOPHYS, V64, P61, DOI 10.1007/s12013-012-9366-x; Bakthisaran R, 2015, BBA-PROTEINS PROTEOM, V1854, P291, DOI 10.1016/j.bbapap.2014.12.019; Basha E, 2012, TRENDS BIOCHEM SCI, V37, P106, DOI 10.1016/j.tibs.2011.11.005; Bepperling A, 2012, P NATL ACAD SCI USA, V109, P20407, DOI 10.1073/pnas.1209565109; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braun N, 2011, P NATL ACAD SCI USA, V108, P20491, DOI 10.1073/pnas.1111014108; Bukach OV, 2004, EUR J BIOCHEM, V271, P291, DOI 10.1046/j.1432-1033.2003.03928.x; Carra S, 2005, HUM MOL GENET, V14, P1659, DOI 10.1093/hmg/ddi174; Carra S, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0409; Chalova AS, 2014, CELL STRESS CHAPERON, V19, P963, DOI 10.1007/s12192-014-0520-9; Chowdary TK, 2004, BIOCHEM J, V381, P379, DOI 10.1042/BJ20031958; Cox D, 2016, J BIOL CHEM, V291, P22618, DOI 10.1074/jbc.M116.739250; Dashivets T, 2009, CHEMBIOCHEM, V10, P869, DOI 10.1002/cbic.200800697; DULBECCO R, 1954, J EXP MED, V99, P167, DOI 10.1084/jem.99.2.167; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Ehrnsperger M, 2000, METH MOL B, V99, P421; FARAHBAKHSH ZT, 1995, BIOCHEMISTRY-US, V34, P509, DOI 10.1021/bi00002a015; Fleckenstein T, 2015, MOL CELL, V58, P1067, DOI 10.1016/j.molcel.2015.04.019; Fu XM, 2014, PROTEIN SCI, V23, P229, DOI 10.1002/pro.2404; GASTMANN O, 1993, MOL REPROD DEV, V36, P407, DOI 10.1002/mrd.1080360402; Geiger T, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014050; Golenhofen N, 2004, HISTOCHEM CELL BIOL, V122, P415, DOI 10.1007/s00418-004-0711-z; Haley DA, 1998, J MOL BIOL, V277, P27, DOI 10.1006/jmbi.1997.1611; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Haslbeck M, 2015, METHODS MOL BIOL, V1292, P39, DOI 10.1007/978-1-4939-2522-3_3; Haslbeck M, 2015, J MOL BIOL, V427, P1537, DOI 10.1016/j.jmb.2015.02.002; Hayes D, 2009, J BIOL CHEM, V284, P18801, DOI 10.1074/jbc.M109.011353; Horwitz J, 2003, EXP EYE RES, V76, P145, DOI 10.1016/S0014-4835(02)00278-6; Horwitz J, 1998, METHOD ENZYMOL, V290, P365, DOI 10.1016/S0076-6879(98)90032-5; Hristozova N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161970; Huntley MA, 2006, MOL BIOL EVOL, V23, P2017, DOI 10.1093/molbev/msl073; JAKOB U, 1993, J BIOL CHEM, V268, P1517; Jovcevski B, 2015, CHEM BIOL, V22, P186, DOI 10.1016/j.chembiol.2015.01.001; Kampinga HH, 2009, CELL STRESS CHAPERON, V14, P105, DOI 10.1007/s12192-008-0068-7; Kappe G, 2003, CELL STRESS CHAPERON, V8, P53, DOI 10.1379/1466-1268(2003)8<53:THGECS>2.0.CO;2; Kappe G, 2001, BBA-GENE STRUCT EXPR, V1520, P1, DOI 10.1016/S0167-4781(01)00237-8; KATO K, 1994, J BIOL CHEM, V269, P15302; KATO K, 1992, J BIOL CHEM, V267, P7718; Khanova HA, 2007, BIOPHYS CHEM, V125, P521, DOI 10.1016/j.bpc.2006.11.002; Kim MV, 2004, BIOCHEM BIOPH RES CO, V315, P796, DOI 10.1016/j.bbrc.2004.01.130; Kriehuber T, 2010, FASEB J, V24, P3633, DOI 10.1096/fj.10-156992; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lee GJ, 1997, EMBO J, V16, P659, DOI 10.1093/emboj/16.3.659; Mi HY, 2016, NUCLEIC ACIDS RES, V44, pD336, DOI 10.1093/nar/gkv1194; Morrow G, 2012, INT J BIOCHEM CELL B, V44, P1613, DOI 10.1016/j.biocel.2012.03.009; Mymrikov EV, 2015, EXPERT REV PROTEOMIC, V12, P295, DOI 10.1586/14789450.2015.1039993; Mymrikov EV, 2011, PHYSIOL REV, V91, P1123, DOI 10.1152/physrev.00023.2010; Mymrikov EV, 2010, CELL STRESS CHAPERON, V15, P365, DOI 10.1007/s12192-009-0151-8; Narberhaus F, 2002, MICROBIOL MOL BIOL R, V66, P64, DOI 10.1128/MMBR.66.1.64-93.2002; Numoto N, 2012, BIOCHEM BIOPH RES CO, V425, P601, DOI 10.1016/j.bbrc.2012.07.138; Panasenko OO, 2002, BBA-PROTEINS PROTEOM, V1601, P64, DOI 10.1016/S1570-9639(02)00430-2; Patel S, 2014, BIOPHYS J, V106, P2644, DOI 10.1016/j.bpj.2014.04.048; Peschek J, 2013, P NATL ACAD SCI USA, V110, pE3780, DOI 10.1073/pnas.1308898110; Peschek J, 2009, P NATL ACAD SCI USA, V106, P13272, DOI 10.1073/pnas.0902651106; Prabhu S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029810; Quinlan RA, 2015, SCIENCE, V350, P636, DOI 10.1126/science.aad6303; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Sharma KK, 2000, J BIOL CHEM, V275, P3767, DOI 10.1074/jbc.275.6.3767; Stromer T, 2003, J BIOL CHEM, V278, P18015, DOI 10.1074/jbc.M301640200; Sugiyama Y, 2000, J BIOL CHEM, V275, P1095, DOI 10.1074/jbc.275.2.1095; SWAMY MS, 1991, CURR EYE RES, V10, P213, DOI 10.3109/02713689109003443; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Verschuure P, 2003, EUR J CELL BIOL, V82, P523, DOI 10.1078/0171-9335-00337; Vos MJ, 2011, AUTOPHAGY, V7, P101, DOI 10.4161/auto.7.1.13935; Vos MJ, 2010, HUM MOL GENET, V19, P4677, DOI 10.1093/hmg/ddq398; Wallace EWJ, 2015, CELL, V162, P1286, DOI 10.1016/j.cell.2015.08.041; Walther DM, 2015, CELL, V161, P919, DOI 10.1016/j.cell.2015.03.032; Wang M, 2012, MOL CELL PROTEOMICS, V11, P492, DOI 10.1074/mcp.O111.014704	68	84	85	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2017	292	2					672	684		10.1074/jbc.M116.760413	http://dx.doi.org/10.1074/jbc.M116.760413			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2KN	27909051	Green Published, hybrid			2022-12-26	WOS:000392316100022
J	Huang, XL; Knoble, JL; Zeng, M; Aguila, FN; Patel, T; Chambers, LW; Hu, HL; Liu, H				Huang, Xiaolun; Knoble, Jeanna L.; Zeng, Ming; Aguila, Fernando N.; Patel, Tara; Chambers, Lowell W.; Hu, Honglin; Liu, Hao			Neoadjuvant Gemcitabine Chemotherapy followed by Concurrent IMRT Simultaneous Boost Achieves High R0 Resection in Borderline Resectable Pancreatic Cancer Patients	PLOS ONE			English	Article							RADIATION-THERAPY; INDUCTION CHEMOTHERAPY; CHEMORADIATION; RADIOTHERAPY; LUNG; OXALIPLATIN; CARCINOMA; OUTCOMES; PHASE-2; TRIAL	Background To study the feasibility of down stage the borderline resectable pancreatic cancer (BRPC) to resectable disease, we reported our institutional results using an intensity-modulated radiation therapy (IMRT) simultaneous integrated boost (SIB) dose escalation approach to improve R0 resectability. Methods We reviewed our past 7 years of experience of using neoadjuvant induction chemotherapy with Gemcitabine followed by concurrent chemoradiaiton for BRPC. During the concurrent, chemo was 5-FU and radiation were IMRT with SIB technique to target the key areas with dose escalation to 5600 in 28 fractions. The key areas were defined by PET positive area. This was followed by restaging imaging to rule out distant metastases before resection. Results 25 finished dose escalation protocol. 2 of the 25 cases developed distant metastases, 23 (92%) patients without distant metastases underwent pancreatectomy. Among the those received pancreatectomy, 22 (95%) achieved negative margin (R0). The gastrointestinal toxicity > grade 2 was 8% and there was no grade 4 toxicity. Conclusion Neoadjuvant Gemcitabine-based induction chemotherapy followed by 5-FU-based IMRT-SIB is a feasible option in improving the likelihood of R0 resection rate in BRPC without compromising the organs at risk for toxicity.	[Huang, Xiaolun] Univ Elect Sci & Technol, Dept Hepatobiliary Pancreat Surg, Chengdu, Sichuan, Peoples R China; [Huang, Xiaolun] Univ Elect Sci & Technol, Affiliated Hosp, Cell Transplant Ctr, Chengdu, Sichuan, Peoples R China; [Knoble, Jeanna L.; Patel, Tara] Mt Carmel Hlth Syst, Dept Hematol & Oncol, Zangmeister Canc Ctr, Columbus, OH USA; [Zeng, Ming] Mt Carmel Hlth Syst, Dept Radiat Oncol, Columbus, OH 43215 USA; [Aguila, Fernando N.; Chambers, Lowell W.] Cent Ohio Surg Associates Inc, Columbus, OH USA; [Hu, Honglin; Liu, Hao] Univ Elect Sci & Technol, Ctr Canc, Affiliated Hosp, Chengdu, Sichuan, Peoples R China	University of Electronic Science & Technology of China; University of Electronic Science & Technology of China; University of Electronic Science & Technology of China	Zeng, M (corresponding author), Mt Carmel Hlth Syst, Dept Radiat Oncol, Columbus, OH 43215 USA.	miller2002@yahoo.com		zeng, ming/0000-0002-4294-2077				Assifi MM, 2011, SURGERY, V150, P466, DOI 10.1016/j.surg.2011.07.006; Ben-Josef E, 2012, INT J RADIAT ONCOL, V84, P1166, DOI 10.1016/j.ijrobp.2012.02.051; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Compton CC, 2012, AJCC CANC STAGING MA, DOI [DOI 10.1007/978-1-4614-2080-4, 10.1007/978-1-4614-2080-4]; COX JD, 1993, INT J RADIAT ONCOL, V27, P493, DOI 10.1016/0360-3016(93)90371-2; Dirkx MLP, 2004, LUNG CANCER-J IASLC, V45, P57, DOI 10.1016/j.lungcan.2004.01.003; Esnaola NF, 2014, INT J RADIAT ONCOL, V88, P837, DOI 10.1016/j.ijrobp.2013.12.030; Gillen S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000267; Jabbour SK, 2014, PRACT RADIAT ONCOL, V4, P82, DOI 10.1016/j.prro.2013.06.004; Katz MHG, 2012, CANCER-AM CANCER SOC, V118, P5749, DOI 10.1002/cncr.27636; Katz MHG, 2011, ANN SURG ONCOL, V18, P608, DOI 10.1245/s10434-010-1460-y; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kim EJ, 2013, CANCER-AM CANCER SOC, V119, P2692, DOI 10.1002/cncr.28117; Krishnan S, 2007, CANCER-AM CANCER SOC, V110, P47, DOI 10.1002/cncr.22735; Machtay M, 2005, INT J RADIAT ONCOL, V63, P667, DOI 10.1016/j.ijrobp.2005.03.037; Mellon EA, 2015, ACTA ONCOL, V54, P979, DOI 10.3109/0284186X.2015.1004367; Murphy JD, 2007, INT J RADIAT ONCOL, V68, P801, DOI 10.1016/j.ijrobp.2006.12.053; Patel M, 2011, J SURG ONCOL, V104, P155, DOI 10.1002/jso.21954; Takahashi H, 2013, ANN SURG, V258, P1040, DOI 10.1097/SLA.0b013e31829b3ce4; Yates F., 1934, JR STATIST SOC     S, V1, P217, DOI DOI 10.2307/2983604	20	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0166606	10.1371/journal.pone.0166606	http://dx.doi.org/10.1371/journal.pone.0166606			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935952	Green Published, gold, Green Submitted			2022-12-26	WOS:000389587100036
J	ten Berge, JC; van Rosmalen, J; Vermeer, J; Hellstrom, C; Lindskog, C; Nilsson, P; Qundos, U; Rothova, A; Schreurs, MWJ				ten Berge, Josianne C.; van Rosmalen, Joost; Vermeer, Jacolien; Hellstrom, Cecilia; Lindskog, Cecilia; Nilsson, Peter; Qundos, Ulrika; Rothova, Aniki; Schreurs, Marco W. J.			Serum Autoantibody Profiling of Patients with Paraneoplastic and Non-Paraneoplastic Autoimmune Retinopathy	PLOS ONE			English	Article							MELANOMA-ASSOCIATED RETINOPATHY; CANCER-ASSOCIATED RETINOPATHY; ANTI-RETINAL ANTIBODIES; ANTIRETINAL ANTIBODIES; MULTIPLE-SCLEROSIS; CATION CHANNELS; BINDING PROTEIN; BIPOLAR CELLS; RECOVERIN; RECEPTOR	Purpose Although multiple serum antiretinal autoantibodies (ARAs) have been reported in patients with paraneoplastic and non-paraneoplastic autoimmune retinopathy ((n)pAIR), not all retinal antigens involved in (n)pAIR are specified. This study aims to serologically identify patients with presumed (n)pAIR through determination of both known and unknown ARAs by autoantibody profiling. Methods An antigen suspension bead array using 188 different antigens representing 97 ocular proteins was performed to detect ARAs in serum samples of patients with presumed (n)pAIR (n = 24), uveitis (n = 151) and cataract (n = 21). Logistic regressions were used to estimate the associations between ocular antigens and diagnosis. Validation of interphotoreceptor matrix proteoglycan 2 (IMPG2) and recoverin antigens was performed by immunohistochemistry and immunoblot, respectively. Results Samples of patients with presumed (n)pAIR exhibited a broad spectrum of ARAs. We identified retinal antigens that have already been described previously (e.g. recoverin), but also identified novel ARA targets. Most ARAs were not specific for (n)pAIR since their presence was also observed in patients with cataract or uveitis. High titers of autoantibodies directed against photoreceptor-specific nuclear receptor and retinol-binding protein 3 were more common in patients with presumed (n)pAIR compared to uveitis (p = 0.015 and p = 0.018, respectively). The presence of all other ARAs did not significantly differ between groups. In patients with presumed (n)pAIR, anti-recoverin autoantibodies were the most prevalent ARAs. Validation of bead array results by immunohistochemistry (anti-IMPG2) and immunoblot (anti-recoverin) showed concordant results in (n)pAIR patients. Conclusions Patients with (n)pAIR are characterized by the presence of a broad spectrum of ARAs. The diagnosis of (n)pAIR cannot be based on the mere presence of serum ARAs, as these are also commonly present in uveitis as well as in age-related cataract patients.	[ten Berge, Josianne C.; Rothova, Aniki] Erasmus Univ, Med Ctr, Dept Ophthalmol, Rotterdam, Netherlands; [van Rosmalen, Joost] Erasmus Univ, Med Ctr, Dept Biostat, Rotterdam, Netherlands; [Vermeer, Jacolien; Schreurs, Marco W. J.] Erasmus Univ, Med Ctr, Dept Immunol, Rotterdam, Netherlands; [Hellstrom, Cecilia; Nilsson, Peter; Qundos, Ulrika] KTH Royal Inst Technol, Sch Biotechnol, SciLifeLab, Affin Prote, Stockholm, Sweden; [Lindskog, Cecilia] Uppsala Univ, SciLifeLab, Dept Immunol Genet & Pathol, Uppsala, Sweden	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Royal Institute of Technology; SciLifeLab; SciLifeLab; Uppsala University	ten Berge, JC (corresponding author), Erasmus Univ, Med Ctr, Dept Ophthalmol, Rotterdam, Netherlands.	j.tenberge@erasmusmc.nl	Lindskog, Cecilia/AAE-5462-2019; Nilsson, Peter/E-4547-2010; Lindskog, Cecilia/AAO-2441-2021	Nilsson, Peter/0000-0002-4657-8532; Lindskog, Cecilia/0000-0001-5611-1015	Stichting Lijf en Leven	Stichting Lijf en Leven	This research was supported by Stichting Lijf en Leven. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamus G, 1996, CLIN IMMUNOL IMMUNOP, V78, P120, DOI 10.1006/clin.1996.0021; Adamus Grazyna, 2004, BMC Ophthalmol, V4, P5, DOI 10.1186/1471-2415-4-5; Adamus G, 2011, J OPHTHALMIC INFLAMM, V1, P111, DOI 10.1007/s12348-011-0028-8; Adamus Grazyna, 2002, Int Rev Immunol, V21, P209, DOI 10.1080/08830180212068; Adamus G, 2009, EXP MOL PATHOL, V87, P195, DOI 10.1016/j.yexmp.2009.08.003; Adamus G, 2009, J AUTOIMMUN, V32, P133, DOI 10.1016/j.jaut.2009.02.001; Adamus G, 2009, AUTOIMMUN REV, V8, P410, DOI 10.1016/j.autrev.2009.01.002; Ayoglu B, 2016, BIOANALYSIS, V8, P1105, DOI 10.4155/bio.16.31; Ayoglu B, 2016, P NATL ACAD SCI USA, V113, P2188, DOI 10.1073/pnas.1518553113; Ayoglu B, 2013, MOL CELL PROTEOMICS, V12, P2657, DOI 10.1074/mcp.M112.026757; Bazhin AV, 2009, INT J CANCER, V124, P140, DOI 10.1002/ijc.23909; Bazhin AV, 2004, LUNG CANCER, V44, P193, DOI 10.1016/j.lungcan.2003.10.006; Bianciotto C, 2010, BRIT J OPHTHALMOL, V94, P1684, DOI 10.1136/bjo.2008.151480; Braithwaite T, 2014, AUTOIMMUN REV, V13, P534, DOI 10.1016/j.autrev.2014.01.039; Cai Y, 2014, OCUL IMMUNOL INFLAMM, V22, P330, DOI 10.3109/09273948.2013.836543; Comlekoglu DU, 2013, CURR OPIN OPHTHALMOL, V24, P598, DOI 10.1097/ICU.0b013e3283654e1e; Coon SL, 1996, GENOMICS, V34, P76, DOI 10.1006/geno.1996.0243; Dhingra A, 2011, J NEUROSCI, V31, P3962, DOI 10.1523/JNEUROSCI.6007-10.2011; Eksandh L, 2008, ARCH OPHTHALMOL-CHIC, V126, P432, DOI 10.1001/archopht.126.3.432; Faez S, 2013, JAMA OPHTHALMOL, V131, P113, DOI 10.1001/jamaophthalmol.2013.574; Ferreyra HA, 2009, ARCH OPHTHALMOL-CHIC, V127, P390, DOI 10.1001/archophthalmol.2009.24; Flynn MF FG, 2000, ARVO; Forooghian F, 2008, AM J OPHTHALMOL, V146, P489, DOI 10.1016/j.ajo.2008.05.046; Forooghian F, 2015, JAMA OPHTHALMOL, V133, P744, DOI 10.1001/jamaophthalmol.2015.0812; Fox AR, 2016, AM J OPHTHALMOL; Grange L, 2014, AM J OPHTHALMOL, V157, P266, DOI 10.1016/j.ajo.2013.09.019; Grewal DS, 2014, RETINA-J RET VIT DIS, V34, P827, DOI 10.1097/IAE.0000000000000119; Gurevich EV, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-236; Haggmark A, 2015, AM J RESP CRIT CARE, V191, P574, DOI 10.1164/rccm.201407-1341OC; Hartmann TB, 2005, INT J CANCER, V114, P88, DOI 10.1002/ijc.20762; Heckenlively JR, 2008, SEMIN IMMUNOPATHOL, V30, P127, DOI 10.1007/s00281-008-0114-7; Heckenlively JR, 1999, AM J OPHTHALMOL, V127, P565, DOI 10.1016/S0002-9394(98)00446-2; Kampf C, 2012, JOVE-J VIS EXP, DOI 10.3791/3620; Kikuchi T, 2000, J NEUROIMMUNOL, V103, P26, DOI 10.1016/S0165-5728(99)00163-0; Kobayashi M, 1999, P NATL ACAD SCI USA, V96, P4814, DOI 10.1073/pnas.96.9.4814; Kondo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019911; KORF HW, 1992, ACTA NEUROPATHOL, V83, P482, DOI 10.1007/BF00310024; Lu Y, 2009, ARCH OPHTHALMOL-CHIC, V127, P1572, DOI 10.1001/archophthalmol.2009.311; Miyagawa Y, 2003, BIOCHEM BIOPH RES CO, V300, P669, DOI 10.1016/S0006-291X(02)02888-7; Nakamura M, 2010, MOL VIS, V16, P425; Ohguro HN, 1999, INVEST OPHTH VIS SCI, V40, P82; Omasits U, 2014, BIOINFORMATICS, V30, P884, DOI 10.1093/bioinformatics/btt607; Persson A, 2006, CURR OPIN MOL THER, V8, P185; POLANS AS, 1995, P NATL ACAD SCI USA, V92, P9176, DOI 10.1073/pnas.92.20.9176; Potter MJ, 2002, AM J OPHTHALMOL, V134, P128, DOI 10.1016/S0002-9394(02)01431-9; Shimazaki K, 2008, J NEURO-OPHTHALMOL, V28, P5, DOI 10.1097/WNO.0b013e318167549f; Team RC, 2013, LANG ENV STAT COMP 2; Ten Berge JC, 2016, ACTA OPHTHALMOL; THIRKILL CE, 1992, INVEST OPHTH VIS SCI, V33, P2768; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P1920, DOI 10.1074/mcp.M500279-MCP200; Wang YJ, 2012, BMC OPHTHALMOL, V12, DOI 10.1186/1471-2415-12-56	51	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167909	10.1371/journal.pone.0167909	http://dx.doi.org/10.1371/journal.pone.0167909			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930731	gold, Green Published, Green Submitted			2022-12-26	WOS:000389580900058
J	Fernandez-Gallardo, M; Gonzalez-Ramirez, R; Sandoval, A; Felix, R; Monjaraz, E				Fernandez-Gallardo, Miriam; Gonzalez-Ramirez, Ricardo; Sandoval, Alejandro; Felix, Ricardo; Monjaraz, Eduardo			Adenosine Stimulate Proliferation and Migration in Triple Negative Breast Cancer Cells	PLOS ONE			English	Article							GATED SODIUM-CHANNEL; RECEPTOR EXPRESSION; GROWTH; A(2B); MICROENVIRONMENT; PHARMACOLOGY; ACTIVATION; NAV1.5; LINES	Emerging evidence suggests that the adenosine (Ado) receptors may play crucial roles in tumor progression. Here, we show that Ado increases proliferation and migration in a triple negative breast cancer model, the MDA-MB 231 cell line. The use of specific agonists and antagonists evidenced that these effects depend on the activation of the A(2B) receptor, which then triggers an intracellular response mediated by the adenylate cyclase/PKA/cAMP signaling pathway. Ado also increases the expression of Na(V)1.5 channels, a potential bio-marker in breast cancer. Together, these data suggest important roles of the A(2B) receptors and Na(V)1.5 channels in the Ado-induced increase in proliferation and migration of the MDA-MB 231 cells.	[Fernandez-Gallardo, Miriam; Monjaraz, Eduardo] Benemerita Univ Autonoma Puebla BUAP, Lab Neuroendocrinol Mol, Puebla, Mexico; [Gonzalez-Ramirez, Ricardo] Hosp Gen Dr Manuel Gea Gonzalez, Dept Biol Mol & Histocompatibilidad, Secretaria Salud, Ciudad De Mexico, Mexico; [Sandoval, Alejandro] Univ Nacl Autonoma Mexico, Fac Estudios Super Iztacala, Tlalnepantla, Mexico; [Felix, Ricardo] Inst Politecn Nacl Cinvestav IPN, Ctr Invest & Estudios Avanzados, Dept Biol Celular, Ciudad De Mexico, Mexico	Benemerita Universidad Autonoma de Puebla; Universidad Nacional Autonoma de Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Monjaraz, E (corresponding author), Benemerita Univ Autonoma Puebla BUAP, Lab Neuroendocrinol Mol, Puebla, Mexico.	emguzman360@hotmail.com	Felix, Ricardo/A-6989-2008; González-Ramírez, Ricardo/O-1792-2014	Felix, Ricardo/0000-0002-5383-7176; González-Ramírez, Ricardo/0000-0003-1399-8036; Sandoval, Alejandro/0000-0002-8558-6033	National Council for Science and Technology (Conacyt, Mexico) [221660]	National Council for Science and Technology (Conacyt, Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was partially supported by funds from The National Council for Science and Technology (Conacyt, Mexico; Grant 221660) to RF.	Aherne CM, 2011, BBA-BIOMEMBRANES, V1808, P1329, DOI 10.1016/j.bbamem.2010.05.016; Bieber D., 2008, NAUNYN SCHMIEDEBERGS, V377, P1; Blay J, 1997, CANCER RES, V57, P2602; Brackenbury WJ, 2007, BREAST CANCER RES TR, V101, P149, DOI 10.1007/s10549-006-9281-1; Burnstock G, 2002, ARTERIOSCL THROM VAS, V22, P364, DOI 10.1161/hq0302.105360; Decking UKM, 1997, CIRC RES, V81, P154, DOI 10.1161/01.RES.81.2.154; Dominguez B, 2009, AM J PHYSIOL-ENDOC M, V296, pE1148, DOI 10.1152/ajpendo.90954.2008; Dubey RK, 2002, HYPERTENSION, V39, P530, DOI 10.1161/hy0202.103075; Feoktistov I, 2003, CIRC RES, V92, P485, DOI 10.1161/01.RES.0000061572.10929.2D; Feoktistov I, 2002, CIRC RES, V90, P531, DOI 10.1161/01.RES.0000012203.21416.14; Fraser SP, 2005, CLIN CANCER RES, V11, P5381, DOI 10.1158/1078-0432.CCR-05-0327; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Fredholm BB, 2010, EXP CELL RES, V316, P1284, DOI 10.1016/j.yexcr.2010.02.004; Gao R, 2010, ONCOL REP, V23, P1293, DOI 10.3892/or_00000763; Gessi S, 2007, J CELL PHYSIOL, V211, P826, DOI 10.1002/jcp.20994; Gessi S, 2011, BBA-BIOMEMBRANES, V1808, P1400, DOI 10.1016/j.bbamem.2010.09.020; Ghiringhelli F, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/473712; Gorlach A, 2009, CURR PHARM DESIGN, V15, P3844, DOI 10.2174/138161209789649420; Headrick JP, 2013, PHARMACOL THERAPEUT, V140, P92, DOI 10.1016/j.pharmthera.2013.06.002; HOSKIN DW, 1994, INT J CANCER, V59, P854, DOI 10.1002/ijc.2910590625; Linden J, 2001, ANNU REV PHARMACOL, V41, P775, DOI 10.1146/annurev.pharmtox.41.1.775; Merighi S, 2003, PHARMACOL THERAPEUT, V100, P31, DOI 10.1016/S0163-7258(03)00084-6; Mittal D, 2016, CANCER RES, V76, P4372, DOI 10.1158/0008-5472.CAN-16-0544; Mujoomdar M, 2004, J CELL PHYSIOL, V201, P429, DOI 10.1002/jcp.20089; Onkal R, 2009, EUR J PHARMACOL, V625, P206, DOI 10.1016/j.ejphar.2009.08.040; Panjehpour M, 2005, BRIT J PHARMACOL, V145, P211, DOI 10.1038/sj.bjp.0706180; Poth JM, 2013, J MOL MED, V91, P183, DOI 10.1007/s00109-012-0988-7; Quezada C, 2013, J CELL PHYSIOL, V228, P602, DOI 10.1002/jcp.24168; ROY ML, 1992, J NEUROSCI, V12, P2104; Schneider BP, 2008, CLIN CANCER RES, V14, P8010, DOI 10.1158/1078-0432.CCR-08-1208; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Spychala J, 2000, PHARMACOL THERAPEUT, V87, P161, DOI 10.1016/S0163-7258(00)00053-X; Stagg J, 2010, P NATL ACAD SCI USA, V107, P1547, DOI 10.1073/pnas.0908801107; Zhi XL, 2012, IUBMB LIFE, V64, P911, DOI 10.1002/iub.1086	34	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0167445	10.1371/journal.pone.0167445	http://dx.doi.org/10.1371/journal.pone.0167445			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3TF	27911956	Green Published, gold, Green Submitted			2022-12-26	WOS:000389520600034
J	Gouda, HN; Hodge, A; Bermejo, R; Zeck, W; Jimenez-Soto, E				Gouda, Hebe N.; Hodge, Andrew; Bermejo, Raoul, III; Zeck, Willibald; Jimenez-Soto, Eliana			The Impact of Healthcare Insurance on the Utilisation of Facility-Based Delivery for Childbirth in the Philippines	PLOS ONE			English	Article							PROPENSITY SCORE; INSTITUTIONAL DELIVERY; MATCHING ESTIMATORS; POOR; SCHEMES; HOMEOWNERSHIP; SERVICES; PROGRAM; EQUITY; BIAS	Objectives In recent years, the government of the Philippines embarked upon an ambitious Universal Health Care program, underpinned by the rapid scale-up of subsidized insurance coverage for poor and vulnerable populations. With a view of reducing the stubbornly high maternal mortality rates in the country, the program has a strong focus on maternal health services and is supported by a national policy of universal facility-based delivery (FBD). In this study, we examine the impact that recent reforms expanding health insurance coverage have had on FBD. Results Data from the most recent Philippines 2013 Demographic Health Survey was employed. This study applies quasi-experimental methods using propensity scores along with alternative matching techniques and weighted regression to control for self-selection and investigate the impact of health insurance on the utilization of FBD. Findings Our findings reveal that the likelihood of FBD for women who are insured is between 5 to 10 percent higher than for those without insurance. The impact of health insurance is more pronounced amongst rural and poor women for whom insurance leads to a 9 to 11 per cent higher likelihood of FBD. Conclusions We conclude that increasing health insurance coverage is likely to be an effective approach to increase women's access to FBD. Our findings suggest that when such coverage is subsidized, as it is the case in the Philippines, women from poor and rural populations are likely to benefit the most.	[Gouda, Hebe N.; Hodge, Andrew] Univ Queensland, Sch Publ Hlth, Publ Hlth Bldg, Brisbane, Qld, Australia; [Gouda, Hebe N.] Queensland Ctr Mental Hlth Res, Pk Ctr Mental Hlth, Wacol, Qld, Australia; [Bermejo, Raoul, III; Zeck, Willibald] UNICEF Philippines Country Off, Manila, Philippines; [Bermejo, Raoul, III] Inst Trop Med, Antwerp, Belgium; [Zeck, Willibald] Med Univ Graz, Dept Obstet & Gynaecol, Graz, Austria; [Jimenez-Soto, Eliana] Abt Associates Inc, Brisbane, Qld, Australia	University of Queensland; Queensland Centre for Mental Health Research; Institute of Tropical Medicine (ITM); Medical University of Graz; ABT Associates	Gouda, HN (corresponding author), Univ Queensland, Sch Publ Hlth, Publ Hlth Bldg, Brisbane, Qld, Australia.; Gouda, HN (corresponding author), Queensland Ctr Mental Hlth Res, Pk Ctr Mental Hlth, Wacol, Qld, Australia.	h.gouda@uq.edu.au		Gouda, Hebe/0000-0002-5709-4509				Aali B. S., 2005, Eastern Mediterranean Health Journal, V11, P663; Abadie A, MATCHING ESTIMATED P; Abadie A, 2011, J BUS ECON STAT, V29, P1, DOI 10.1198/jbes.2009.07333; Agha S, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-31; Aldaba B, 2011, PHILIPPINES SCALE RE; [Anonymous], 2014, REP OP WORK GROUP GE; [Anonymous], 2014, NAT DEM HLTH SURV 20; [Anonymous], 2015, JOINT LEARNING NETWO; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Blundell R., 2000, FISC STUD, V21, P427, DOI [DOI 10.1111/J.1475-5890.2000.TB00031.X, 10.1111/j.1475-5890.2000.tb00031.x]; Bohren MA, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-71; Bredenkamp C, 2015, 7258 POL RES; Brookhart MA, 2006, AM J EPIDEMIOL, V163, P1149, DOI 10.1093/aje/kwj149; Caliendo M, 2008, J ECON SURV, V22, P31, DOI 10.1111/j.1467-6419.2007.00527.x; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Comfort AB, 2013, J HEALTH POPUL NUTR, V31, P81; Do M, 2015, MATERN CHILD HLTH J, V19, P755, DOI 10.1007/s10995-014-1561-5; Dzakpasu S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049430; Filipski MJ, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0871-7; Freedman DA, 2008, EVALUATION REV, V32, P392, DOI 10.1177/0193841X08317586; Gabrysch S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-34; Giedion U, 2010, IMPACT OF HEALTH INSURANCE IN LOW- AND MIDDLE-INCOME COUNTRIES, P155; Grinstein-Weiss M, 2013, SOC WORK RES, V37, P37, DOI 10.1093/swr/svs035; Grinstein-Weiss M, 2012, URBAN STUD, V49, P3545, DOI 10.1177/0042098012443861; Heckman JJ, 1997, REV ECON STUD, V64, P605, DOI 10.2307/2971733; Hindle D, 2001, Aust Health Rev, V24, P96; Hirano K., 2001, HLTH SERVICES OUTCOM, V2, P259, DOI [10.1023/A:1020371312283, DOI 10.1023/A:1020371312283]; Jones Andrew., 2007, APPL ECONOMETRICS HL; Jutting JP, 2004, WORLD DEV, V32, P273, DOI 10.1016/j.worlddev.2003.10.001; Kesterton AJ, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-30; Kozhimannil KB, 2009, HEALTH POLICY, V92, P55, DOI 10.1016/j.healthpol.2009.02.009; Kruk ME, 2015, TROP MED INT HEALTH, V20, P1057, DOI 10.1111/tmi.12518; Liao Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152091; Lu CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039282; Mayne SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144962; Mensah J, 2010, HEALTH ECON, V19, P95, DOI 10.1002/hec.1633; Murray CJ, 2014, LANCET; Ndao-Brumblay SK, 2012, HLTH POLICY PLANNING; Obermann K, 2006, SOC SCI MED, V62, P3177, DOI 10.1016/j.socscimed.2005.11.047; Parmar D, 2014, HEALTH POLICY PLANN, V29, P76, DOI 10.1093/heapol/czs136; Patrick AR, 2011, PHARMACOEPIDEM DR S, V20, P551, DOI 10.1002/pds.2098; Quick Jonathan, 2014, PLoS Med, V11, pe1001580, DOI 10.1371/journal.pmed.1001580; Quimbo S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003379; Ravallion M, 2008, HBK ECON, V9, P3787, DOI 10.1016/S1573-4471(07)04059-4; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; Rutstein SO, 2004, DHS WEALTH INDEX DHS, V6; Sachs JD, 2012, LANCET, V380, P944, DOI 10.1016/S0140-6736(12)61149-0; Sedgwick P, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1286; Singh K, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0762-y; Smith JA, 2005, J ECONOMETRICS, V125, P305, DOI 10.1016/j.jeconom.2004.04.011; Sparrow R, 2013, SOC SCI MED, V96, P264, DOI 10.1016/j.socscimed.2012.09.043; Tobe M, 2013, HEALTH POLICY PLANN, V28, P536, DOI 10.1093/heapol/czs092; Vogel JP, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0047-2; Wang W., 2014, HLTH INSURANCE COVER; WHO UNICEF UNFPA Bank W & UNDP, 2014, TRENDS MAT MORT 1990; World Bank, 2011, TRANSF PHIL HLTH SEC; Zhou ZX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112918; Zhou ZL, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/1475-9276-13-23	61	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0167268	10.1371/journal.pone.0167268	http://dx.doi.org/10.1371/journal.pone.0167268			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3TF	27911935	Green Submitted, Green Published, gold			2022-12-26	WOS:000389520600027
J	Lazarus, L; Patel, S; Shaw, A; Leblanc, S; Lalonde, C; Hladio, M; Mandryk, K; Horvath, C; Petrcich, W; Kendall, C; Tyndall, MW				Lazarus, Lisa; Patel, Sheetal; Shaw, Ashley; Leblanc, Sean; Lalonde, Christine; Hladio, Manisha; Mandryk, Kira; Horvath, Cynthia; Petrcich, William; Kendall, Claire; Tyndall, Mark W.		Proud Community Advisory Comm	Uptake of Community-Based Peer Administered HIV Point-of-Care Testing: Findings from the PROUD Study	PLOS ONE			English	Article							INJECTION-DRUG USERS; PREVENTION INTERVENTION; EXPANDING ACCESS; HEALTH-CARE; SEX WORKERS; CANADA; SETTINGS	Objectives HIV prevalence among people who inject drugs (PWID) in Ottawa is estimated at about 10%. The successful integration of peers into outreach efforts and wider access to HIV point-of-care testing (POCT) create opportunities to explore the role of peers in providing HIV testing. The PROUD study, in partnership with Ottawa Public Health (OPH), sought to develop a model for community-based peer-administered HIV POCT. Methods PROUD draws on community-based participatory research methods to better understand the HIV risk environment of people who use drugs in Ottawa. From March-October 2013, 593 people who reported injecting drugs or smoking crack cocaine were enrolled through street-based recruitment. Trained peer or medical student researchers administered a quantitative survey and offered an HIV POCT (bioLytical INSTI test) to participants who did not self-report as HIV positive. Results 550 (92.7%) of the 593 participants were offered a POCT, of which 458 (83.3%) consented to testing. Of those participants, 74 (16.2%) had never been tested for HIV. There was no difference in uptake between testing offered by a peer versus a non-peer interviewer (OR = 1.05; 95% CI = 0.67-1.66). Despite testing those at high risk for HIV, only one new reactive test was identified. Conclusion The findings from PROUD demonstrate high uptake of community-based HIV POCT. Peers were able to successfully provide HIV POCT and reach participants who had not previously been tested for HIV. Community-based and peer testing models provide important insights on ways to scale-up HIV prevention and testing among people who use drugs.	[Lazarus, Lisa; Patel, Sheetal; Shaw, Ashley; Petrcich, William; Kendall, Claire; Tyndall, Mark W.] Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Leblanc, Sean; Lalonde, Christine] PROUD Community Advisory Comm, Ottawa, ON, Canada; [Leblanc, Sean] Drug Users Advocacy League, Ottawa, ON, Canada; [Hladio, Manisha] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Mandryk, Kira; Horvath, Cynthia] Ottawa Publ Hlth, Ottawa, ON, Canada; [Kendall, Claire] Univ Ottawa, Bruyere Res Inst, Dept Family Med, CT Lamont Primary Hlth Care Res Ctr, Ottawa, ON, Canada; [Tyndall, Mark W.] Univ Ottawa, Ottawa Hosp, Div Infect Dis, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute	Lazarus, L (corresponding author), Ottawa Hosp Res Inst, Ottawa, ON, Canada.	lis_laz@yahoo.com		Tyndall, Mark/0000-0003-4450-5679; Kendall, Claire/0000-0003-2686-1135	Canadian Institutes of Health Research [FRN 134048]; Ontario HIV Treatment Network; Ottawa Hospital, Department of Medicine and Division of Infectious Diseases	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario HIV Treatment Network; Ottawa Hospital, Department of Medicine and Division of Infectious Diseases	Funding has been received for this work from the Canadian Institutes of Health Research (FRN 134048; http.//www.cihr-irsc.gc.ca/e/193.html), the Ontario HIV Treatment Network (http.//www.ohtn.on.ca), and The Ottawa Hospital, Department of Medicine and Division of Infectious Diseases (https://www.ottawahospital.on.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam Barry D, 2011, J Int AIDS Soc, V14 Suppl 2, pS2, DOI 10.1186/1758-2652-14-S2-S2; Bowles KE, 2008, PUBLIC HEALTH REP, V123, P78, DOI 10.1177/00333549081230S310; Champenois K, 2012, BMJ OPEN, V2, DOI [10.1136/bmjopen-2011-000693, DOI 10.1136/bmjopen-2011-000693]; Coupland H, 2005, INT J DRUG POLICY, V16, P191, DOI 10.1016/j.drugpo.2004.12.002; Davidson P, 2012, AM J PUBLIC HEALTH, V102, P1254, DOI 10.2105/AJPH.2011.300418; Dickson-Gomez J, 2006, SUBST USE MISUSE, V41, P669, DOI 10.1080/10826080500411403; Girardi E, 2007, JAIDS-J ACQ IMM DEF, V46, pS3, DOI 10.1097/01.qai.0000286597.57066.2b; Gordon MS, 2013, AIDS BEHAV, V17, P2022, DOI 10.1007/s10461-013-0456-6; Grigoryan A, 2009, PLOS ONE, V4, pe4445, DOI DOI 10.1371/JOURNAL.PONE.0004445; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Johnston KM, 2010, AIDS, V24, P1929, DOI 10.1097/QAD.0b013e32833af85d; Kim SR, 2015, INT J GYNECOL OBSTET, V128, P201, DOI 10.1016/j.ijgo.2014.09.026; Kouyoumdjian F, 2016, CAN FAM PHYSICIAN, V62, P215; Latkin C A, 1998, Public Health Rep, V113 Suppl 1, P151; Laupland KB, 2012, CAN J INFECT DIS MED, V23, P106, DOI 10.1155/2012/297530; Lazarus L, 2014, HARM REDUCT J, V11, DOI 10.1186/1477-7517-11-26; Lazarus L, 2012, CULT HEALTH SEX, V14, P139, DOI 10.1080/13691058.2011.628411; Marwick N, 2014, J EPIDEMIOL COMMUNIT, V68, P675, DOI [10.1136/jech-2013-203707, DOI 10.1136/JECH-2013-203707]; Montaner JSG, 2006, LANCET, V368, P531, DOI 10.1016/S0140-6736(06)69162-9; Ottawa Public Health, 2014, OV HIV HEP C INF PEO; Ottawa Public Health, 2013, SUBST MIS OTT; Pujol F, 2010, INT AIDS C VIENN AUS, P18; Remis RS, 2012, REPORT HIV AIDS ONTA; Rhodes T., 2002, INT J DRUG POLICY, V13, P85, DOI [10.1016/S0955-3959(02)00007-5, DOI 10.1016/S0955-3959(02)00007-5]; Ruutel K, 2012, SCAND J PUBLIC HEALT, V40, P629, DOI 10.1177/1403494812458987; Tobin KE, 2011, ADDICTION, V106, P366, DOI 10.1111/j.1360-0443.2010.03146.x; Tolson M., 2011, SEEK TREAT OPTIMALLY; Walter SD, 2000, J CLIN EPIDEMIOL, V53, P931, DOI 10.1016/S0895-4356(00)00210-9; Wood E, 2008, AIDS, V22, P1247, DOI 10.1097/QAD.0b013e3282fbd1ed; Yan HJ, 2014, SEX TRANSM INFECT, V90, P388, DOI 10.1136/sextrans-2013-051397	30	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0166942	10.1371/journal.pone.0166942	http://dx.doi.org/10.1371/journal.pone.0166942			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3TF	27911908	Green Published, Green Submitted, gold			2022-12-26	WOS:000389520600017
J	Orfano, AS; Duarte, APM; Molina-Cruz, A; Pimenta, PF; Barillas-Mury, C				Orfano, Alessandra S.; Duarte, Ana Paula M.; Molina-Cruz, Alvaro; Pimenta, Paulo F.; Barillas-Mury, Carolina			Plasmodium yoelii nigeriensis (N67) Is a Robust Animal Model to Study Malaria Transmission by South American Anopheline Mosquitoes	PLOS ONE			English	Article							COMPLEMENT; SUSCEPTIBILITY; DETERMINANT; AQUASALIS; DARLINGI; IMMUNITY; EVASION; VECTOR	Malaria is endemic in the American continent and the Amazonian rainforest is the region with the highest risk of transmission. However, the lack of suitable experimental models to infect malaria vectors from the Americas has limited the progress to understand the biology of transmission in this region. Anopheles aquasalis, a major vector in coastal areas of South America, was found to be highly refractory to infection with two strains of Plasmodium falciparum (NF54 and 7G8) and with Plasmodium berghei (mouse malaria), even when the micro biota was eliminated with antibiotics and oxidative stress was reduced with uric acid. In contrast, An. aquasalis females treated with antibiotics and uric acid are susceptible to infection with a second murine parasite, Plasmodium yoelii nigeriensis N67 (PyN67). Anopheles albimanus, one of the main malaria vectors in Central America, Southern Mexico and the Caribbean, was more susceptible to infection with PyN67 than An. aquasalis, even in the absence of any pre-treatment, but was still less susceptible than Anopheles stephensi. Disruption of the complement-like system in An. albimanus significantly enhanced PyN67 infection, indicating that the mosquito immune system is mounting effective antiplasmodial responses. PyN67 has the ability to infect a broad range of anophelines and is an excellent model to study malaria transmission by South American vectors.	[Orfano, Alessandra S.; Duarte, Ana Paula M.; Molina-Cruz, Alvaro; Barillas-Mury, Carolina] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA; [Orfano, Alessandra S.; Duarte, Ana Paula M.; Pimenta, Paulo F.] Fundacao Oswaldo Cruz FIOCRUZ, Ctr Pesquisas Rene Rachou, Lab Med Entomol, Belo Horizonte, MG, Brazil; [Duarte, Ana Paula M.; Pimenta, Paulo F.] Fundacao Med Trop Dr Heitor Vieira Dourado, Manaus, Amazonas, Brazil	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Fundacao Oswaldo Cruz	Molina-Cruz, A; Barillas-Mury, C (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA.; Pimenta, PF (corresponding author), Fundacao Oswaldo Cruz FIOCRUZ, Ctr Pesquisas Rene Rachou, Lab Med Entomol, Belo Horizonte, MG, Brazil.; Pimenta, PF (corresponding author), Fundacao Med Trop Dr Heitor Vieira Dourado, Manaus, Amazonas, Brazil.	amolina-cruz@niaid.nih.gov; pimenta@cpqrr.fiocruz.br; cbarillas@niaid.nih.gov	Pimenta, Paulo/AAH-1502-2020		Intramural Research Program of the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; Conselho Nacional de Desenvolvimento Tecnologico (CNPq-PAPES); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacoes de Amparo a Pesquisas do Amazonas e de Minas Gerais (FAPEAM e FAPEMIG); FIOCRUZ; CNPq; CAPES post-doctoral fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000947] Funding Source: NIH RePORTER	Intramural Research Program of the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; Conselho Nacional de Desenvolvimento Tecnologico (CNPq-PAPES); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacoes de Amparo a Pesquisas do Amazonas e de Minas Gerais (FAPEAM e FAPEMIG); FIOCRUZ; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES post-doctoral fellowship(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program of the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health and the following Brazilian agencies: Conselho Nacional de Desenvolvimento Tecnologico (CNPq-PAPES), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and the Fundacoes de Amparo a Pesquisas do Amazonas e de Minas Gerais (FAPEAM e FAPEMIG). ASO was supported by PhD fellowships from FIOCRUZ and CNPq; and APMD by a CAPES post-doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahia AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057014; Bahia AC, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001317; Billker O, 1997, PARASITOLOGY, V115, P1, DOI 10.1017/S0031182097008895; Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4; Contreras-Garduno J, 2015, DEV COMP IMMUNOL, V52, P172, DOI 10.1016/j.dci.2015.05.004; da Silva ANM, 2006, MEM I OSWALDO CRUZ, V101, P547, DOI 10.1590/S0074-02762006000500011; DeJong RJ, 2007, P NATL ACAD SCI USA, V104, P2121, DOI 10.1073/pnas.0608407104; FELDMANN AM, 1989, MED VET ENTOMOL, V3, P41, DOI 10.1111/j.1365-2915.1989.tb00473.x; Fraiture M, 2009, CELL HOST MICROBE, V5, P273, DOI 10.1016/j.chom.2009.01.005; Garver LS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002737; Gendrin M, 2015, NATURE COMMUNICATION, V6, DOI [10.1073/pnas.0608407104, DOI 10.1073/PNAS.0608407104]; Harbach RE, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P3, DOI 10.5772/54695; Horosko S, 1997, J AM MOSQUITO CONTR, V13, P95; Jaramillo-Gutierrez G, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-154; Laubach HE, 2001, W INDIAN MED J, V50, P319; Molina-Cruz A, 2012, P NATL ACAD SCI US; Molina-Cruz A, 2008, J BIOL CHEM, V283, P3217, DOI 10.1074/jbc.M705873200; Molina-Cruz A, 2015, P NATL ACAD SCI USA, V112, P15178, DOI 10.1073/pnas.1520426112; Molina-Cruz A, 2013, SCIENCE, V340, P984, DOI 10.1126/science.1235264; Moreno M, 2014, AM J TROP MED HYG, V90, P612, DOI 10.4269/ajtmh.13-0708; Osta MA, 2004, SCIENCE, V303, P2030, DOI 10.1126/science.1091789; Pimenta PFP, 2015, MEM I OSWALDO CRUZ, V110, P23, DOI 10.1590/0074-02760140266; Povelones M, 2009, SCIENCE, V324, P258, DOI 10.1126/science.1171400; Reidenbach KR, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-298; VALENCIO DA, 1969, NATURE, V223, P1353, DOI 10.1038/2231353a0; WHO, 2013, WORLD MALARIA REPORT 2013, P1; World Health Organization, 2015, WORLD MAL REP 2015; Zerpa Noraida, 1998, Revista do Instituto de Medicina Tropical de Sao Paulo, V40, P173, DOI 10.1590/S0036-46651998000300007	28	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0167178	10.1371/journal.pone.0167178	http://dx.doi.org/10.1371/journal.pone.0167178			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3TF	27911924	gold, Green Published, Green Submitted			2022-12-26	WOS:000389520600025
J	Song, DG; Pan, KW; Tariq, A; Azizullah, A; Sun, F; Li, ZL; Xiong, QL				Song, Dagang; Pan, Kaiwen; Tariq, Akash; Azizullah, Azizullah; Sun, Feng; Li, Zilong; Xiong, Qinli			Adsorptive Removal of Toxic Chromium from Waste-Water Using Wheat Straw and Eupatorium adenophorum	PLOS ONE			English	Article							AQUEOUS-SOLUTIONS; AGRICULTURAL WASTE; ACTIVATED CARBON; HEXAVALENT CHROMIUM; CR(VI); BIOSORPTION; CU(II); THERMODYNAMICS; REDUCTION; KINETICS	Environmental pollution with heavy metals is a serious issue worldwide posing threats to humans, animals and plants and to the stability of overall ecosystem. Chromium (Cr) is one of most hazardous heavy metals with a high carcinogenic and recalcitrant nature. Aim of the present study was to select low-cost biosorbent using wheat straw and Eupatorium adenophorum through simple carbonization process, capable of removing Cr (VI) efficiently from wastewater. From studied plants a low cost adsorbent was prepared for removing Cr (VI) from aqueous solution following very simple carbonization method excluding activation process. Several factors such as pH, contact time, sorbent dosage and temperature were investigated for attaining ideal condition. For analysis of adsorption equilibrium isotherm data, Langmuir, Freundlich and Temkin models were used while pseudo-first-order, pseudo-second-order, external diffusion and intra-particle diffusion models were used for the analysis of kinetic data. The obtained results revealed that 99.9% of Cr (VI) removal was observed in the solution with a pH of 1.0. Among all the tested models Langmuir model fitted more closely according to the data obtained. Increase in adsorption capacity was observed with increasing temperature revealing endothermic nature of Cr (VI). The maximum Cr (VI) adsorption potential of E. adenophorum and wheat straw was 89.22 mg per 1 gram adsorbent at 308K. Kinetic data of absorption precisely followed pseudo-second-order model. Present study revealed highest potential of E. adenophorum and wheat straw for producing low cost adsorbent and to remove Cr (VI) from contaminated water.	[Song, Dagang; Pan, Kaiwen; Tariq, Akash; Sun, Feng; Li, Zilong; Xiong, Qinli] Chinese Acad Sci, Chengdu Inst Biol, Key Lab Mt Ecol Restorat & Bioresource Utilizat, Chengdu, Peoples R China; [Song, Dagang; Pan, Kaiwen; Tariq, Akash; Sun, Feng; Li, Zilong; Xiong, Qinli] Chinese Acad Sci, Chengdu Inst Biol, Ecol Restorat Biodivers Conservat Key Lab Sichuan, Chengdu, Peoples R China; [Song, Dagang; Tariq, Akash; Sun, Feng; Li, Zilong; Xiong, Qinli] Univ Chinese Acad Sci, Beijing, Peoples R China; [Azizullah, Azizullah] Kohat Univ Sci & Technol, Dept Bot, Kohat, Pakistan	Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Kohat University of Science & Technology	Pan, KW; Tariq, A (corresponding author), Chinese Acad Sci, Chengdu Inst Biol, Key Lab Mt Ecol Restorat & Bioresource Utilizat, Chengdu, Peoples R China.; Pan, KW; Tariq, A (corresponding author), Chinese Acad Sci, Chengdu Inst Biol, Ecol Restorat Biodivers Conservat Key Lab Sichuan, Chengdu, Peoples R China.; Tariq, A (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.	pankw@cib.ac.cn; atm_bot@hotmail.com	Tariq, Akash/AAI-9880-2020; Xiong, Qinli/Y-7212-2018	Xiong, Qinli/0000-0003-3827-3437; Pan, Kaiwen/0000-0003-1770-8219; Song, Dagang/0000-0002-0362-3591; Tariq, Akash/0000-0002-5382-9336	National Natural Science Foundation of China [31370632]; Ministry of Sciences and Technology of China [2011BAC09B04-01-03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Sciences and Technology of China(Ministry of Science and Technology, China)	Present study was financially supported by National Natural Science Foundation of China (Grant No. 31370632) and by the Ministry of Sciences and Technology of China (Grant No. 2011BAC09B04-01-03).	Acar FN, 2004, BIORESOURCE TECHNOL, V94, P13, DOI 10.1016/j.biortech.2003.10.032; ALAERTS GJ, 1989, WATER SCI TECHNOL, V21, P1701, DOI 10.2166/wst.1989.0148; Bansal M, 2009, J HAZARD MATER, V162, P312, DOI 10.1016/j.jhazmat.2008.05.037; Bayrak Y, 2013, J DISPER SCI TECHNOL, V34, P1248, DOI 10.1080/01932691.2012.743347; Bhattacharya AK, 2008, CHEM ENG J, V137, P529, DOI 10.1016/j.cej.2007.05.021; Bhattacharyya KG, 2007, J COLLOID INTERF SCI, V310, P411, DOI 10.1016/j.jcis.2007.01.080; Brito F, 1997, POLYHEDRON, V16, P3835, DOI 10.1016/S0277-5387(97)00128-9; Chen JF, 2014, FRONT ENV SCI ENG, V8, P960, DOI 10.1007/s11783-013-0612-2; [陈金发 Chen Jinfa], 2013, [环境工程学报, Chinese Journal of Environmental Engineering], V7, P2197; Chen SH, 2011, CHEM ENG J, V168, P909, DOI 10.1016/j.cej.2011.01.063; COTTON FA, 1972, ADV INORGANIC CHEM C; Dakiky M, 2002, ADV ENVIRON RES, V6, P533, DOI 10.1016/S1093-0191(01)00079-X; De Lasa H, 2010, INT J CHEM REACT ENG, V8, P47; Deng LP, 2009, MINER ENG, V22, P372, DOI 10.1016/j.mineng.2008.10.006; Deveci H, 2013, J IND ENG CHEM, V19, P190, DOI 10.1016/j.jiec.2012.08.001; El Nemr A, 2009, J HAZARD MATER, V161, P132, DOI 10.1016/j.jhazmat.2008.03.093; Fu FL, 2011, J ENVIRON MANAGE, V92, P407, DOI 10.1016/j.jenvman.2010.11.011; Gao RY, 2007, J HAZARD MATER, V145, P398, DOI 10.1016/j.jhazmat.2006.11.036; Garbisu C, 1998, BIODEGRADATION, V9, P133, DOI 10.1023/A:1008358816529; Garg UK, 2007, J HAZARD MATER, V140, P60, DOI 10.1016/j.jhazmat.2006.06.056; Goyal N, 2003, ADV ENVIRON RES, V7, P311, DOI 10.1016/S1093-0191(02)00004-7; Gupta S, 2009, CHEM ENG J, V150, P352, DOI 10.1016/j.cej.2009.01.013; Gupta VK, 2009, J COLLOID INTERF SCI, V335, P24, DOI 10.1016/j.jcis.2009.03.056; Jain AK, 2004, ENVIRON SCI TECHNOL, V38, P1195, DOI 10.1021/es034412u; Khamis M, 2009, J HAZARD MATER, V169, P948, DOI 10.1016/j.jhazmat.2009.04.053; Kiran B, 2008, BIOCHEM ENG J, V38, P47, DOI 10.1016/j.bej.2007.06.007; Kobya M, 2004, BIORESOURCE TECHNOL, V91, P317, DOI 10.1016/j.biortech.2003.07.001; Li KB, 2014, CLEAN-SOIL AIR WATER, V42, P1549, DOI 10.1002/clen.201300399; Lin QY, 2013, SEP SCI TECHNOL, V48, P2843, DOI 10.1080/01496395.2013.808216; Louhab K, 2006, EUROPEAN J SCI RES; Memon JR, 2009, COLLOID SURFACE B, V70, P232, DOI 10.1016/j.colsurfb.2008.12.032; Mittal A, 2010, J COLLOID INTERF SCI, V343, P463, DOI 10.1016/j.jcis.2009.11.060; Namasivayam C, 1998, BIORESOURCE TECHNOL, V64, P77, DOI 10.1016/S0960-8524(97)86722-3; Park D, 2008, BIORESOURCE TECHNOL, V99, P8810, DOI 10.1016/j.biortech.2008.04.042; Park D, 2008, CHEM ENG J, V136, P173, DOI 10.1016/j.cej.2007.03.039; Ponou J, 2011, CHEM ENG J, V172, P906, DOI 10.1016/j.cej.2011.06.081; Praveen P, 2016, J HAZARD MATER, V314, P204, DOI 10.1016/j.jhazmat.2016.04.054; Qiu JY, 2009, J HAZARD MATER, V166, P270, DOI 10.1016/j.jhazmat.2008.11.053; Ramon GZ, 2013, CHEM ENG J, V218, P173, DOI 10.1016/j.cej.2012.12.006; Ronghua LI, 2009, ACTA SCI CIRCUMSTANT; Shanthi T, 2013, J CHEM-NY, V2013, DOI 10.1155/2013/304970; Singh KK, 2009, CHEM ENG J, V151, P113, DOI 10.1016/j.cej.2009.02.003; Stout MD, 2009, ENVIRON HEALTH PERSP, V117, P716, DOI 10.1289/ehp.0800208; Sun Kang, 2010, Scientia Silvae Sinicae, V46, P178; Tarley CRT, 2004, CHEMOSPHERE, V54, P987, DOI 10.1016/j.chemosphere.2003.09.001; Tian YH, 2007, TROP GRASSLANDS, V41, P285; Uluozlu OD, 2009, J HAZARD MATER, V172, P395, DOI 10.1016/j.jhazmat.2009.07.021; Venugopal V, 2011, CHEM ENG J, V174, P151, DOI 10.1016/j.cej.2011.08.068; Wang XS, 2008, J HAZARD MATER, V153, P1176, DOI 10.1016/j.jhazmat.2007.09.079; Wang XS, 2009, CHEM ENG J, V148, P217, DOI 10.1016/j.cej.2008.08.020; Weber WJ, 2015, J SANITARY ENG DIVIS, V89, P53	51	24	24	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0167037	10.1371/journal.pone.0167037	http://dx.doi.org/10.1371/journal.pone.0167037			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3TF	27911906	gold, Green Published			2022-12-26	WOS:000389520600020
J	Costa, CP; Elias-Neto, M; Falcon, T; Dallacqua, RP; Martins, JR; Bitondi, MMG				Costa, Claudineia Pereira; Elias-Neto, Moyses; Falcon, Tiago; Dallacqua, Rodrigo Pires; Martins, Juliana Ramos; Gentile Bitondi, Marcia Maria			RNAi-Mediated Functional Analysis of Bursicon Genes Related to Adult Cuticle Formation and Tanning in the Honeybee, Apis mellifera	PLOS ONE			English	Article							ECDYSIS BEHAVIOR; WING EXPANSION; MANDUCA-SEXTA; CELL-DEATH; PROTEIN; HORMONE; RECEPTOR; EXPRESSION; SCLEROTIZATION; IDENTIFICATION	Bursicon is a heterodimeric neurohormone that acts through a G protein-coupled receptor named rickets (rk), thus inducing an increase in cAMP and the activation of tyrosine hydroxylase, the rate-limiting enzyme in the cuticular tanning pathway. In insects, the role of bursicon in the post-ecdysial tanning of the adult cuticle and wing expansion is well characterized. Here we investigated the roles of the genes encoding the bursicon subunits during the adult cuticle development in the honeybee, Apis mellifera. RNAi-mediated knockdown of AmBurs a and AmBurs beta bursicon genes prevented the complete formation and tanning (melanization/sclerotization) of the adult cuticle. A thinner, much less tanned cuticle was produced, and ecdysis toward adult stage was impaired. Consistent with these results, the knockdown of bursicon transcripts also interfered in the expression of genes encoding its receptor, AmRk, structural cuticular proteins, and enzymes in the melanization/sclerotization pathway, thus evidencing roles for bursicon in adult cuticle formation and tanning. Moreover, the expression of AmBurs a, AmBurs beta and AmRk is contingent on the declining ecdysteroid titer that triggers the onset of adult cuticle synthesis and deposition. The search for transcripts of AmBurs a, AmBurs beta and candidate targets in RNA-seq libraries prepared with brains and integuments strengthened our data on transcript quantification through RT-qPCR. Together, our results support our premise that bursicon has roles in adult cuticle formation and tanning, and are in agreement with other recent studies pointing for roles during the pharate-adult stage, in addition to the classical post-ecdysial ones.	[Costa, Claudineia Pereira; Falcon, Tiago; Martins, Juliana Ramos] Univ Sao Paulo, Dept Genet, Fac Med Ribeirao Preto, Ribeirao Preto, SP, Brazil; [Costa, Claudineia Pereira; Elias-Neto, Moyses; Gentile Bitondi, Marcia Maria] Univ Sao Paulo, Dept Biol, Fac Filosofia Ciencias & Letras Ribeirao Preto, Ribeirao Preto, SP, Brazil; [Dallacqua, Rodrigo Pires] Univ Fed Mato Grosso do Sul, Ctr Ciencias Biol & Saude, Campo Grande, MS, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Mato Grosso do Sul	Bitondi, MMG (corresponding author), Univ Sao Paulo, Dept Biol, Fac Filosofia Ciencias & Letras Ribeirao Preto, Ribeirao Preto, SP, Brazil.	mmgbit@usp.br	Lopes, Tiago F/G-3409-2016; Lopes, Tiago Falcon/U-5883-2019; Costa, Claudineia/G-7267-2017; Martins, Juliana Ramos/AAD-4694-2021; Bitondi, Marcia MG/E-8014-2012; Elias-Neto, Moysés/B-6437-2012; Dallacqua, Rodrigo P/I-6592-2012; Martins, Juliana Ramos/F-6726-2012	Lopes, Tiago F/0000-0002-8936-0381; Costa, Claudineia/0000-0002-5458-4502; Martins, Juliana Ramos/0000-0002-7185-6477; Bitondi, Marcia MG/0000-0002-5619-6378; 	FAPESP (Sao Paulo Research Foundation, Brazil) [2010/16380-9, 2014/13136-0]; CNPq (National Counsel of Technological and Scientific Development Process) [134995/2010-4]; FAPESP [2009/15635-6]	FAPESP (Sao Paulo Research Foundation, Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (National Counsel of Technological and Scientific Development Process); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Financial support was provided to MMGB (Processes 2010/16380-9; 2014/13136-0) by FAPESP (Sao Paulo Research Foundation, Brazil). FAPESP (Process 2009/15635-6) and CNPq (National Counsel of Technological and Scientific Development Process 134995/2010-4) provided fellowships to CPC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034510; An SH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-424; Andersen SO, 2010, INSECT BIOCHEM MOLEC, V40, P166, DOI 10.1016/j.ibmb.2009.10.007; Andrews S., 2010, FASTQC QUALITY CONTR; Arakane Y, 2008, MECH DEVELOP, V125, P984, DOI 10.1016/j.mod.2008.09.002; Bai H, 2010, DEV BIOL, V344, P248, DOI 10.1016/j.ydbio.2010.05.003; Baker JD, 2002, J EXP BIOL, V205, P2555; Chung JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046299; COTTRELL CB, 1962, J EXP BIOL, V39, P395; Cunha AD, 2015, J INSECT PHYSL, V51, P1135; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Davis MM, 2007, DEVELOPMENT, V134, P4395, DOI 10.1242/dev.009902; Dewey EM, 2004, CURR BIOL, V14, P1208, DOI 10.1016/j.cub.2004.06.051; Dong SZ, 2015, ARCH INSECT BIOCHEM, V89, P87, DOI 10.1002/arch.21227; Elias-Neto M, 2009, APIDOLOGIE, V40, P29, DOI 10.1051/apido:2008064; Eriksen KK, 2000, GENOME RES, V10, P924, DOI 10.1101/gr.10.7.924; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FRAENKEL G, 1962, SCIENCE, V138, P27, DOI 10.1126/science.138.3536.27; FRAENKEL G., 1965, J INSECT PHYSIOL, V11, P513, DOI 10.1016/0022-1910(65)90137-X; FRAENKEL G, 1966, SCIENCE, V151, P91, DOI 10.1126/science.151.3706.91; Garcia-Hughes G, 2015, MECH DEVELOP, V138, P349, DOI 10.1016/j.mod.2015.07.008; Guan X, 2006, P NATL ACAD SCI USA, V103, P16794, DOI 10.1073/pnas.0607616103; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HASSON C, 1987, ARCH INSECT BIOCHEM, V5, P13, DOI 10.1002/arch.940050103; Hauser F, 2006, PROG NEUROBIOL, V80, P1, DOI 10.1016/j.pneurobio.2006.07.005; Henrich VC, 2012, INSECT ENDOCRINOLOGY, P177; Hepburn H.R., 1985, P1; Honegger HW, 2008, J COMP PHYSIOL A, V194, P989, DOI 10.1007/s00359-008-0386-3; Huang JH, 2007, FEBS LETT, V581, P697, DOI 10.1016/j.febslet.2007.01.034; Jarosch A, 2011, J INSECT PHYSIOL, V57, P851, DOI 10.1016/j.jinsphys.2011.03.013; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kimura KI, 2004, DEVELOPMENT, V131, P1597, DOI 10.1242/dev.01049; Kucharski R, 2007, INSECT BIOCHEM MOLEC, V37, P128, DOI 10.1016/j.ibmb.2006.10.009; Lahr EC, 2012, J NEUROSCI, V32, P6819, DOI 10.1523/JNEUROSCI.5301-11.2012; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOCKE M, 1969, Tissue and Cell, V1, P555, DOI 10.1016/S0040-8166(69)80021-2; Lourenco AP, 2008, APIDOLOGIE, V39, P372, DOI 10.1051/apido:2008015; Loveall BJ, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-92; Luo CW, 2005, P NATL ACAD SCI USA, V102, P2820, DOI 10.1073/pnas.0409916102; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mendive FM, 2005, FEBS LETT, V579, P2171, DOI 10.1016/j.febslet.2005.03.006; MESSNER B, 1991, ZOOL JAHRB ALLG ZOOL, V95, P31; MICHELETTE ERD, 1993, APIDOLOGIE, V24, P431, DOI 10.1051/apido:19930410; Soares MPM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-576; Peabody NC, 2008, J NEUROSCI, V28, P14379, DOI 10.1523/JNEUROSCI.2842-08.2008; REBERS JE, 1988, J MOL BIOL, V203, P411, DOI 10.1016/0022-2836(88)90009-5; Rebers JE, 2001, INSECT BIOCHEM MOLEC, V31, P1083, DOI 10.1016/S0965-1748(01)00056-X; Riddiford LM, 2003, INSECT BIOCHEM MOLEC, V33, P1327, DOI 10.1016/j.ibmb.2003.06.001; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sadd BM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0623-3; SELIGMAN M, 1969, J INSECT PHYSIOL, V15, P553, DOI 10.1016/0022-1910(69)90254-6; Soares MPM, 2007, INSECT BIOCHEM MOLEC, V37, P1272, DOI 10.1016/j.ibmb.2007.07.014; Soares MPM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020513; Song Q., 2012, INSECT ENDOCRINOLOGY, P93; Tang L, 2010, INSECT BIOCHEM MOLEC, V40, P228, DOI 10.1016/j.ibmb.2010.01.010; THOMPSON PR, 1978, J APICULT RES, V17, P32, DOI 10.1080/00218839.1978.11099896; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Van Loy T, 2007, GEN COMP ENDOCR, V153, P59, DOI 10.1016/j.ygcen.2006.12.004; Veverytsa L, 2011, DEVELOPMENT, V138, P3147, DOI 10.1242/dev.064105; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Werren JH, 2010, SCIENCE, V327, P343, DOI 10.1126/science.1178028; Willis JH, 2010, INSECT BIOCHEM MOLEC, V40, P189, DOI 10.1016/j.ibmb.2010.02.001; Yao QO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014058; Zitnan D., 2012, INSECT ENDOCNNOLOGY, P253, DOI DOI 10.1016/B978-0-12-384749-2.10007-X	68	13	16	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167421	10.1371/journal.pone.0167421	http://dx.doi.org/10.1371/journal.pone.0167421			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907116	Green Published, Green Submitted, gold			2022-12-26	WOS:000389482700150
J	Lee, YS; Song, JS; Hwang, M; Lim, B; Joung, B; Pak, HN				Lee, Young-Seon; Song, Jun-Seop; Hwang, Minki; Lim, Byounghyun; Joung, Boyoung; Pak, Hui-Nam			A New Efficient Method for Detecting Phase Singularity in Cardiac Fibrillation	PLOS ONE			English	Article							ATRIAL-FIBRILLATION; VENTRICULAR-FIBRILLATION; FOCAL IMPULSE; MECHANISMS; ROTORS; LOCALIZATION; ARRHYTHMIA; DYNAMICS; ABLATION; BREAKUP	Background The point of phase singularity (PS) is considered to represent a spiral wave core or a rotor in cardiac fibrillation. Computational efficiency is important for detection of PS in clinical electrophysiology. We developed a novel algorithm for highly efficient and robust detection of PS. Methods In contrast to the conventional method, which calculates PS based on the line integral of the phase around a PS point equal to +/- 2 pi (the Iyer-Gray method), the proposed algorithm (the location-centric method) looks for the phase discontinuity point at which PS actually occurs. We tested the efficiency and robustness of these two methods in a two-dimensional mathematical model of atrial fibrillation (AF), with and without remodeling of ionic currents. Results 1. There was a significant association, in terms of the Hausdorff distance (3.30 +/- 0.0 mm), between the PS points measured using the Iyer-Gray and location-centric methods, with almost identical PS trajectories generated by the two methods. 2. For the condition of electrical remodeling of AF (0.3 x I-CaL), the PS points calculated by the two methods were satisfactorily co-localized (with the Hausdorff distance of 1.64 +/- 0.09 mm). 3. The proposed location-centric method was substantially more efficient than the Iyer-Gray method, with a 28.6-fold and 28.2-fold shorter run times for the control and remodeling scenarios, respectively. Conclusion We propose a new location-centric method for calculating PS, which is robust and more efficient compared with the conventionally used method.	[Lee, Young-Seon; Song, Jun-Seop; Hwang, Minki; Lim, Byounghyun; Joung, Boyoung; Pak, Hui-Nam] Yonsei Univ Hlth Syst, Seoul, South Korea	Yonsei University; Yonsei University Health System	Pak, HN (corresponding author), Yonsei Univ Hlth Syst, Seoul, South Korea.	hnpak@yuhs.ac	Lee, Young-Seon/L-3636-2013; Pak, Hui-Nam/C-4266-2015	Lee, Young-Seon/0000-0003-1396-2172; Song, Jun-Seop/0000-0002-5886-4210; Pak, Hui-Nam/0000-0002-3256-3620; Joung, Boyoung/0000-0001-9036-7225	Korea Health 21 R&D Project, Ministry of Health and Welfare [A085136]; National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning (MSIP) [NRF-2013R1A2A2A01014634]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2014R1A1A2059391]; Korea Health 21 RD Project [A085136]; Ministry of Education [2014R1A1A2059391]	Korea Health 21 R&D Project, Ministry of Health and Welfare; National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning (MSIP); Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; Korea Health 21 RD Project; Ministry of Education	This work was supported by the Korea Health 21 R&D Project, Ministry of Health and Welfare (https://www.htdream.kr/) [A085136 to HNP], the Basic Science Research Program run by the National Research Foundation of Korea (NRF) (http://www.nrf.re krinteng_cms/) which is funded by the Ministry of Science, ICT & Future Planning (MSIP) [NRF-2013R1A2A2A01014634 to HNP], and Basic Science Research Program through the National Research Foundation of Korea (NRF) (http://www.nrf.kr/nrf.eng_cms/) funded by the Ministry of Education [2014R1A1A2059391 to MH]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by grants (A085136) from the Korea Health 21 R&D Project and the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (MSIP) (NRF-2013R1A2A2A01014634) and the Ministry of Education (2014R1A1A2059391).	Arevalo HJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11437; Bayer JD, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00108; Berenfeld O, 2014, CARDIOL CLIN, V32, P495, DOI 10.1016/j.ccl.2014.07.001; Bray MA, 2001, J CARDIOVASC ELECTR, V12, P716, DOI 10.1046/j.1540-8167.2001.00716.x; Clayton RH, 2008, PROG BIOPHYS MOL BIO, V96, P19, DOI 10.1016/j.pbiomolbio.2007.07.004; Courtemanche M, 1998, AM J PHYSIOL-HEART C, V275, pH301, DOI 10.1152/ajpheart.1998.275.1.H301; Fenton FH, 2002, CHAOS, V12, P852, DOI 10.1063/1.1504242; Gray RA, 1998, NATURE, V392, P75, DOI 10.1038/32164; GRAY RA, 1995, SCIENCE, V270, P1222, DOI 10.1126/science.270.5239.1222; Gray RA, 2009, CHAOS, V19, DOI 10.1063/1.3204256; Haissaguerre M, 2006, CIRCULATION, V113, P616, DOI 10.1161/CIRCULATIONAHA.105.546648; HUTTENLOCHER DP, 1993, IEEE T PATTERN ANAL, V15, P850, DOI 10.1109/34.232073; Hwang M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149695; Iyer AN, 2001, ANN BIOMED ENG, V29, P47, DOI 10.1114/1.1335538; Jalife J, 2000, ANNU REV PHYSIOL, V62, P25, DOI 10.1146/annurev.physiol.62.1.25; Jalife J, 2002, CARDIOVASC RES, V54, P204, DOI 10.1016/S0008-6363(02)00223-7; Keener JP, 2009, MATH PHYSL; Krummen DE, 2015, J THORAC DIS, V7, P142, DOI 10.3978/j.issn.2072-1439.2014.11.15; Kuklik P, 2015, IEEE T BIO-MED ENG, V62, P296, DOI 10.1109/TBME.2014.2350029; Lee YS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150779; Liu YB, 2003, J CARDIOVASC ELECTR, V14, P1103, DOI 10.1046/j.1540-8167.2003.03218.x; McDowell KS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117110; McDowell KS, 2013, BIOPHYS J, V104, P2764, DOI 10.1016/j.bpj.2013.05.025; MOE GK, 1964, AM HEART J, V67, P200, DOI 10.1016/0002-8703(64)90371-0; Moreno J, 2004, REV ESP CARDIOL, V57, P69; Nakagawa H, 1998, CIRCULATION, V98, P458, DOI 10.1161/01.CIR.98.5.458; Narayan SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046034; Narayan SM, 2012, J AM COLL CARDIOL, V60, P628, DOI 10.1016/j.jacc.2012.05.022; Narayan SM, 2012, J CARDIOVASC ELECTR, V23, P447, DOI 10.1111/j.1540-8167.2012.02332.x; Nattel S, 2014, J AM COLL CARDIOL, V63, P2335, DOI 10.1016/j.jacc.2014.02.555; Pak HN, 2003, AM J PHYSIOL-HEART C, V285, pH2704, DOI 10.1152/ajpheart.00366.2003; Pandit SV, 2013, CIRC RES, V112, P849, DOI 10.1161/CIRCRESAHA.111.300158; Qu ZL, 2000, ANN BIOMED ENG, V28, P755, DOI 10.1114/1.1289474; Quintanilla JG, 2016, CIRC-ARRHYTHMIA ELEC, V9, DOI 10.1161/CIRCEP.115.002481; Roes SD, 2009, CIRC-CARDIOVASC IMAG, V2, P183, DOI 10.1161/CIRCIMAGING.108.826529; Umapathy K, 2010, CIRC-ARRHYTHMIA ELEC, V3, P105, DOI 10.1161/CIRCEP.110.853804; Ustrell X, 2010, CURR CARDIOL REV, V6, P175, DOI 10.2174/157340310791658721; Valderrabano M, 2003, CIRCULATION, V108, P354, DOI 10.1161/01.CIR.0000080322.67408.B4; Winfree A.T., 1987, TIME BREAKS 3 DIMENS, V14; Zahid S, 2016, CARDIOVASC RES, V110, P443, DOI 10.1093/cvr/cvw073; Zipes DP, 2014, CARDIAC ELECTROPHYSI, Vxxvi; Zou RQ, 2002, CHAOS, V12, P764, DOI 10.1063/1.1497505	42	8	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167567	10.1371/journal.pone.0167567	http://dx.doi.org/10.1371/journal.pone.0167567			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907144	Green Published, Green Submitted, gold			2022-12-26	WOS:000389482700197
J	Montana, G; Lampiasi, N				Montana, Giovanna; Lampiasi, Nadia			Substance P Induces HO-1 Expression in RAW 264.7 Cells Promoting Switch towards M2-Like Macrophages	PLOS ONE			English	Article							NF-KAPPA-B; PROLIFERATOR-ACTIVATED RECEPTORS; HEME OXYGENASE-1 EXPRESSION; HUMAN MONOCYTES; CYTOKINE PRODUCTION; GENE-EXPRESSION; CARBON-MONOXIDE; UP-REGULATION; TNF-ALPHA; INHIBITION	Substance P (SP) is a neuropeptide that mediates many physiological as well as inflammatory responses. Recently, SP has been implicated in the resolution of inflammation through induction of M2 macrophages phenotype. The shift between M1-like and M2-like, allowing the resolution of inflammatory processes, also takes place by means of hemeoxygenase-1 (HO-1). HO-1 is induced in response to oxidative stress and inflammatory stimuli and modulates the immune response through macrophages polarisation. SP induces HO-1 expression in human periodontal ligament (PDL), the latter potentially plays a role in cytoprotection. We demonstrated that SP promotes M2-like phenotype from resting as well as from M1 macrophages. Indeed, SP triggers the production of interleukine-10 (IL-10), interleukine-4 (IL-4) and arginase-1 (Arg1) without nitric oxide (NO) generation. In addition, SP increases HO-1 expression in a dose- and time-dependent manner. Here we report that SP, without affecting cell viability, significantly reduces the production of pro-inflammatory cytokines and enzymes, such as tumor necrosis factor-alpha (TNF-alpha), interleukine-6 (IL-6), inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2), and ameliorates migration and phagocytic properties in LPS-stimulated RAW 264.7 cells. M2-like conversion required retention of NF-kappa B p65 into the cytoplasm and HO-1 induced expression. Silencing of the HO-1 mRNA expression reversed the induction of pro-inflammatory cytokines in RAW 264.7 stimulated by LPS and down-regulated anti-inflammatory hallmarks of M2 phenotype. In conclusion, our data show that SP treatment might be associated with anti-inflammatory effects in LPS-stimulated RAW 264.7 cells by suppressing NF-kappa B activation and inducing HO-1 expression.	[Montana, Giovanna; Lampiasi, Nadia] CNR, Ist Biomed & Immunol Mol Alberto Monroy, Via Ugo La Malfa, Palermo, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biomedicina e di Immunologia Molecolare "Alberto Monroy" (IBIM-CNR)	Lampiasi, N (corresponding author), CNR, Ist Biomed & Immunol Mol Alberto Monroy, Via Ugo La Malfa, Palermo, Italy.	lampiasi@ibim.cnr.it	Lampiasi, Nadia/AAR-8451-2020; Lampiasi, Nadia/AAC-8751-2019	Lampiasi, Nadia/0000-0002-6831-4781; Lampiasi, Nadia/0000-0002-6831-4781; Montana, Giovanna/0000-0003-3368-4114				Abraham NG, 2008, PHARMACOL REV, V60, P79, DOI 10.1124/pr.107.07104; Alam J, 2003, CURR PHARM DESIGN, V9, P2499, DOI 10.2174/1381612033453730; Amoruso A, 2008, BRIT J PHARMACOL, V154, P144, DOI 10.1038/bjp.2008.50; Azzolina A, 2003, BBA-MOL CELL RES, V1643, P75, DOI 10.1016/j.bbamcr.2003.09.003; Camara NOS, 2005, FREE RADICAL BIO MED, V38, P426, DOI 10.1016/j.freeradbiomed.2004.11.019; Canton J, 2014, J LEUKOCYTE BIOL, V96, P729, DOI 10.1189/jlb.1MR0114-021R; Castagliuolo I, 2002, BRIT J PHARMACOL, V136, P271, DOI 10.1038/sj.bjp.0704697; Chinetti G, 2003, CURR OPIN LIPIDOL, V14, P459, DOI 10.1097/00041433-200310000-00006; Chinetti G, 1998, J BIOL CHEM, V273, P25573, DOI 10.1074/jbc.273.40.25573; Chora AA, 2007, J CLIN INVEST, V117, P438, DOI 10.1172/JCI28844; FAN TPD, 1993, BRIT J PHARMACOL, V110, P43, DOI 10.1111/j.1476-5381.1993.tb13769.x; Galvan-Pena S, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00420; Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600; Ho WZ, 1997, J IMMUNOL, V159, P5654; Hong HS, 2014, BIOCHEM BIOPH RES CO, V453, P179, DOI 10.1016/j.bbrc.2014.09.090; Hong HS, 2009, NAT MED, V15, P425, DOI 10.1038/nm.1909; Janelsins BM, 2009, BLOOD, V113, P3017, DOI 10.1182/blood-2008-06-163121; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Jiang MH, 2012, NEUROREPORT, V23, P786, DOI 10.1097/WNR.0b013e3283572206; Kobayashi A, 2004, METHOD ENZYMOL, V378, P273; Koon HW, 2007, P NATL ACAD SCI USA, V104, P2013, DOI 10.1073/pnas.0610664104; Lampiasi N, 2014, BBA-MOL CELL RES, V1843, P2662, DOI 10.1016/j.bbamcr.2014.07.010; Lee TS, 2003, J BIOL CHEM, V278, P19325, DOI 10.1074/jbc.M300498200; Lee TS, 2002, NAT MED, V8, P240, DOI 10.1038/nm0302-240; Lin PH, 2008, BBA-MOL CELL RES, V1783, P1826, DOI 10.1016/j.bbamcr.2008.05.008; Liu W, 2001, J CELL BIOCHEM, V83, P271, DOI 10.1002/jcb.1234; LOTZ M, 1987, SCIENCE, V235, P893, DOI 10.1126/science.2433770; Lucrezi JD, 2014, INT IMMUNOPHARMACOL, V21, P44, DOI 10.1016/j.intimp.2014.04.007; Morse D, 2003, J BIOL CHEM, V278, P36993, DOI 10.1074/jbc.M302942200; Motterlini R, 2010, NAT REV DRUG DISCOV, V9, P728, DOI 10.1038/nrd3228; Naito Y, 2014, ARCH BIOCHEM BIOPHYS, V564, P83, DOI 10.1016/j.abb.2014.09.005; Ndisang JF, 2010, AM J PHYSIOL-REG I, V298, pR211, DOI 10.1152/ajpregu.91000.2008; NILSSON J, 1985, NATURE, V315, P61, DOI 10.1038/315061a0; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Otterbein LE, 2003, TRENDS IMMUNOL, V24, P449, DOI 10.1016/S1471-4906(03)00181-9; Paine A, 2010, BIOCHEM PHARMACOL, V80, P1895, DOI 10.1016/j.bcp.2010.07.014; Rameshwar P, 1997, CLIN IMMUNOL IMMUNOP, V85, P129, DOI 10.1006/clin.1997.4446; Reddy SA, 2015, INT IMMUNOPHARMACOL, V24, P440, DOI 10.1016/j.intimp.2014.12.037; Rhee JW, 2007, J BIOCHEM MOL BIOL, V40, P88; Seldon MP, 2007, J IMMUNOL, V179, P7840, DOI 10.4049/jimmunol.179.11.7840; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Steinhoff MS, 2014, PHYSIOL REV, V94, P265, DOI 10.1152/physrev.00031.2013; Sun J, 2008, AM J PHYSIOL-CELL PH, V295, pC679, DOI 10.1152/ajpcell.00042.2008; Sun J, 2009, FASEB J, V23, P997, DOI 10.1096/fj.08-121756; Sung J, 2014, NUTR RES PRACT, V8, P352, DOI 10.4162/nrp.2014.8.4.352; Tajima T, 2008, J PHARMACOL EXP THER, V326, P493, DOI 10.1124/jpet.108.137992; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Tu TH, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/290708; ZICHE M, 1990, BRIT J PHARMACOL, V100, P11, DOI 10.1111/j.1476-5381.1990.tb12043.x	49	26	28	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167420	10.1371/journal.pone.0167420	http://dx.doi.org/10.1371/journal.pone.0167420			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907187	Green Submitted, gold, Green Published			2022-12-26	WOS:000389482700149
J	Zhang, B; Xia, Y; Wen, XH; Wang, XH; Yang, YF; Zhou, JZ; Zhang, Y				Zhang, Bing; Xia, Yu; Wen, Xianghua; Wang, Xiaohui; Yang, Yunfeng; Zhou, Jizhong; Zhang, Yu			The Composition and Spatial Patterns of Bacterial Virulence Factors and Antibiotic Resistance Genes in 19 Wastewater Treatment Plants	PLOS ONE			English	Article							ACTIVATED-SLUDGE; DIVERSITY; PATHOGENS; DISSEMINATION; GEOCHIP; COMMUNITIES; TEMPERATURE; MECHANISMS; MICROARRAY; REMOVAL	Bacterial pathogenicity and antibiotic resistance are of concern for environmental safety and public health. Accumulating evidence suggests that wastewater treatment plants (WWTPs) are as an important sink and source of pathogens and antibiotic resistance genes (ARGs). Virulence genes (encoding virulence factors) are good indicators for bacterial pathogenic potentials. To achieve a comprehensive understanding of bacterial pathogenic potentials and antibiotic resistance in WWTPs, bacterial virulence genes and ARGs in 19 WWTPs covering a majority of latitudinal zones of China were surveyed by using GeoChip 4.2. A total of 1610 genes covering 13 virulence factors and 1903 genes belonging to 11 ARG families were detected respectively. The bacterial virulence genes exhibited significant spatial distribution patterns of a latitudinal biodiversity gradient and a distance-decay relationship across China. Moreover, virulence genes tended to coexist with ARGs as shown by their strongly positive associations. In addition, key environmental factors shaping the overall virulence gene structure were identified. This study profiles the occurrence, composition and distribution of virulence genes and ARGs in current WWTPs in China, and uncovers spatial patterns and important environmental variables shaping their structure, which may provide the basis for further studies of bacterial virulence factors and antibiotic resistance in WWTPs.	[Zhang, Bing; Xia, Yu; Wen, Xianghua; Wang, Xiaohui; Yang, Yunfeng; Zhou, Jizhong] Tsinghua Univ, Environm Simulat & Pollut Control State Key Joint, Sch Environm, Beijing, Peoples R China; [Zhou, Jizhong] Univ Oklahoma, Inst Environm Genom, Dept Microbiol & Plant Biol, Norman, OK 73019 USA; [Zhou, Jizhong] Univ Oklahoma, Sch Civil Engn & Environm Sci, Norman, OK 73019 USA; [Zhou, Jizhong] Lawrence Berkeley Natl Lab, Div Earth Sci, Berkeley, CA USA; [Zhang, Yu] Chinese Acad Sci, State Key Lab Environm Aquat Chem, Res Ctr Ecoenvironm Sci, Beijing, Peoples R China	Tsinghua University; University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES)	Wen, XH (corresponding author), Tsinghua Univ, Environm Simulat & Pollut Control State Key Joint, Sch Environm, Beijing, Peoples R China.	xhwen@tsinghua.edu.cn	wen, xianghua/A-7551-2015; Zhang, Bing/AAH-8513-2021; 吴, 昊/AAB-1620-2020	Zhang, Bing/0000-0002-1213-5151; 	NSFC [51678335]; State Key Joint Laboratory of Environment Simulation and Pollution Control [15L03ESPC]; Tsinghua University Initiative Scientific Research Program [20161080112]	NSFC(National Natural Science Foundation of China (NSFC)); State Key Joint Laboratory of Environment Simulation and Pollution Control; Tsinghua University Initiative Scientific Research Program	This study was supported by the NSFC (51678335), State Key Joint Laboratory of Environment Simulation and Pollution Control (15L03ESPC) and Tsinghua University Initiative Scientific Research Program (No.20161080112).	Berglund Bjorn, 2015, Infection Ecology & Epidemiology, V5, P28564, DOI 10.3402/iee.v5.28564; Blair JMA, 2015, NAT REV MICROBIOL, V13, P42, DOI 10.1038/nrmicro3380; Chan YK, 2013, P NATL ACAD SCI USA, V110, P8990, DOI 10.1073/pnas.1300643110; Chen LH, 2005, NUCLEIC ACIDS RES, V33, pD325, DOI 10.1093/nar/gki008; Czekalski N, 2014, ISME J, V8, P1381, DOI 10.1038/ismej.2014.8; DAVIES J, 1994, SCIENCE, V264, P375, DOI 10.1126/science.8153624; Davies JE, 1997, CIBA F SYMP, V207, P15; Dowle EJ, 2013, HEREDITY, V110, P501, DOI 10.1038/hdy.2013.4; Finlay BB, 1997, MICROBIOL MOL BIOL R, V61, P136, DOI 10.1128/.61.2.136-169.1997; Friman VP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017651; Handzlik J, 2013, ANTIBIOTICS-BASEL, V2, P28, DOI 10.3390/antibiotics2010028; He ZL, 2007, ISME J, V1, P67, DOI 10.1038/ismej.2007.2; He ZL, 2012, CURR OPIN BIOTECH, V23, P49, DOI 10.1016/j.copbio.2011.11.001; He ZL, 2010, ISME J, V4, P1167, DOI 10.1038/ismej.2010.46; Ju F, 2016, WATER RES, V91, P1, DOI 10.1016/j.watres.2015.11.071; Koczura R, 2012, SCI TOTAL ENVIRON, V414, P680, DOI 10.1016/j.scitotenv.2011.10.036; Koleff P, 2001, ECOGRAPHY, V24, P341, DOI 10.1034/j.1600-0587.2001.240312.x; Konkel ME, 2000, MICROBES INFECT, V2, P157, DOI 10.1016/S1286-4579(00)00272-0; Lee DY, 2006, J MICROBIOL METH, V65, P453, DOI 10.1016/j.mimet.2005.09.008; Lee YJ, 2013, ISME J, V7, P1974, DOI 10.1038/ismej.2013.88; Liang YT, 2011, ISME J, V5, P403, DOI 10.1038/ismej.2010.142; Lindberg R, 2004, CHEMOSPHERE, V57, P1479, DOI 10.1016/j.chemosphere.2004.09.015; Martinez JL, 2008, SCIENCE, V321, P365, DOI 10.1126/science.1159483; Miller SM, 2008, APPL ENVIRON MICROB, V74, P2200, DOI 10.1128/AEM.01962-07; NEILANDS JB, 1995, J BIOL CHEM, V270, P26723, DOI 10.1074/jbc.270.45.26723; Russell AD, 2003, LANCET INFECT DIS, V3, P794, DOI 10.1016/S1473-3099(03)00833-8; Shade A, 2013, ISME J, V7, P1493, DOI 10.1038/ismej.2013.54; Shanks OC, 2013, APPL ENVIRON MICROB, V79, P2906, DOI 10.1128/AEM.03448-12; Sun JJ, 2014, BIOCHEM BIOPH RES CO, V453, P254, DOI 10.1016/j.bbrc.2014.05.090; Szczepanowski R, 2008, J BIOTECHNOL, V136, P54, DOI 10.1016/j.jbiotec.2008.03.020; Toze S, 1997, MICROBIAL PATHOGENS; Tu Qichao, 2014, Mol Ecol Resour, V14, P914, DOI 10.1111/1755-0998.12239; Wang X, 2016, APPL ENVIRON MICROB; Wang XH, 2010, J ENVIRON SCI-CHINA, V22, P627, DOI 10.1016/S1001-0742(09)60155-8; Wright GD, 2010, CURR OPIN MICROBIOL, V13, P589, DOI 10.1016/j.mib.2010.08.005; Wu HJ, 2008, CURR OPIN CHEM BIOL, V12, P93, DOI 10.1016/j.cbpa.2008.01.023; Yang Y, 2013, ENVIRON SCI TECHNOL, V47, P10197, DOI 10.1021/es4017365; Yang YF, 2014, ISME J, V8, P430, DOI 10.1038/ismej.2013.146; Yildiz FH, 2007, RES MICROBIOL, V158, P195, DOI 10.1016/j.resmic.2006.12.005; Zhang T, 2015, APPL MICROBIOL BIOT, V99, P5033, DOI 10.1007/s00253-015-6556-7; Zhang XX, 2011, ENVIRON SCI TECHNOL, V45, P2598, DOI 10.1021/es103672x; Zhang XX, 2009, APPL MICROBIOL BIOT, V82, P1169, DOI 10.1007/s00253-009-1886-y; Zhang Y, 2013, WATER RES, V47, P6298, DOI 10.1016/j.watres.2013.08.003; Zhao MX, 2014, ISME J, V8, P2045, DOI 10.1038/ismej.2014.46; Zhou JZ, 2008, P NATL ACAD SCI USA, V105, P7768, DOI 10.1073/pnas.0709016105; Zhou JZ, 2015, MBIO, V6, DOI 10.1128/mBio.02288-14; Zhou JZ, 1996, APPL ENVIRON MICROB, V62, P316, DOI 10.1128/AEM.62.2.316-322.1996	47	18	18	2	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167422	10.1371/journal.pone.0167422	http://dx.doi.org/10.1371/journal.pone.0167422			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907117	Green Published, gold, Green Submitted			2022-12-26	WOS:000389482700151
J	Zhu, D; Wang, Y; Yang, XR; Yang, DY; Guo, K; Guo, YY; Jing, XX; Pan, CW				Zhu, Dan; Wang, Yan; Yang, Xianrong; Yang, Dayong; Guo, Kai; Guo, Yuanyuan; Jing, Xinxia; Pan, Chen-Wei			Pre- and Postcycloplegic Refractions in Children and Adolescents	PLOS ONE			English	Article							AGE-RELATED CATARACT; AXIAL LENGTH; ERRORS; MYOPIA; AUTOREFRACTION; REPEATABILITY; CYCLOPLEGIA; PREVALENCE; SINGAPORE	Purpose To determine the difference between cycloplegic and non-cycloplegic refractive error and its associated factors in Chinese children and adolescents with a high prevalence of myopia. Methods A school-based study including 1565 students aged 6 to 21 years was conducted in 2013 in Ejina, Inner Mongolia, China. Comprehensive eye examinations were performed. Pre-and postcycloplegic refractive error were measured using an auto-refractor. For cycloplegic refraction, one drop of topical 1.0% cyclopentolate was administered to each eye twice with a 5-minute interval and a third drop was administered 15 minutes after the second drop if the pupil size was less than 6 mm or if the pupillary light reflex was still present. Results Two drops of cyclopentolate were found to be sufficient in 59% of the study participants while the other 41% need an additional drop. The prevalence of myopia was 89.5% in participants aged over 12 years and 68.6% in those aged 12 years or younger (P<0.001). When myopia was defined as spherical equivalent (SE) of less than -0.5 diopter (D), the prevalence estimates were 76.7% (95% confidence interval [CI] 74.6-78.8) and 54.1% (95%Cl 51.6-56.6) before and after cycloplegic refraction, respectively. When hyperopia was defined as SE of more than 0.5D, the prevalence was only 2.8% (95%CI 1.9-3.6) before cycloplegic refraction while it was 15.5% (95%Cl 13.7-17.3) after cycloplegic refraction. Increased difference between cycloplegic and non-cycloplegic refractive error was associated with decreased intraocular pressures (P = 0.01). Conclusions Lack of cycloplegia in refractive error measurement was associated with significant misclassifications in both myopia and hyperopia among Chinese children and adolescents. Decreased intraocular pressure was related to a greater difference between cycloplegic and non-cycloplegic refractive error.	[Zhu, Dan; Wang, Yan; Yang, Xianrong; Yang, Dayong; Guo, Kai; Guo, Yuanyuan; Jing, Xinxia] Inner Mongolia Med Univ, Affiliated Hosp, Dept Ophthalmol, Hohhot, Inner Mongolia, Peoples R China; [Pan, Chen-Wei] Soochow Univ, Coll Med, Jiangsu Key Lab Prevent & Translat Med Geriatr Di, Sch Publ Hlth, Suzhou, Peoples R China	Inner Mongolia Medical University; Soochow University - China	Pan, CW (corresponding author), Soochow Univ, Coll Med, Jiangsu Key Lab Prevent & Translat Med Geriatr Di, Sch Publ Hlth, Suzhou, Peoples R China.	pcwonly@gmail.com	Pan, Chen-Wei/L-7174-2019	Pan, Chen-Wei/0000-0003-3362-4613; Zhu, Dan/0000-0002-8402-8929	National Natural Science Foundation of China [81560165]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the National Natural Science Foundation of China (grant no. 81560165). The sponsor or funding organization had no role in the design or conduct of this research.; This study was funded by the National Natural Science Foundation of China (Grant No. 81560165). The sponsor or funding organization had no role in the design or conduct of this research.	Bailey MD, 2005, J CATARACT REFR SURG, V31, P1025, DOI 10.1016/j.jcrs.2004.12.040; Bullimore MA, 1998, OPTOMETRY VISION SCI, V75, P617, DOI 10.1097/00006324-199808000-00028; Chen J, 2011, INVEST OPHTH VIS SCI, V52, P2456, DOI 10.1167/iovs.10-5441; Fotedar R, 2007, AM J OPHTHALMOL, V144, P307, DOI 10.1016/j.ajo.2007.03.041; Fotouhi A, 2012, ACTA OPHTHALMOL, V90, P380, DOI 10.1111/j.1755-3768.2010.01983.x; Guo K, 2015, INVEST OPHTH VIS SCI, V56, P1769, DOI 10.1167/iovs.14-15737; Holden B.A., 2016, OPHTHALMOLOGY; Hu YY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117482; Jenssen F, 2012, J GLAUCOMA, V21, P45, DOI 10.1097/IJG.0b013e31820277a9; MAUGER RR, 1984, AM J OPTOM PHYS OPT, V61, P28; Morgan IG, 2012, LANCET, V379, P1739, DOI 10.1016/S0140-6736(12)60272-4; Morgan IG, 2015, ACTA OPHTHALMOL; Pan C-W, 2015, OPTOM VIS SCI; Pan CW, 2013, AM J OPHTHALMOL, V156, P1021, DOI 10.1016/j.ajo.2013.06.005; Pan CW, 2013, OPHTHALMOLOGY, V120, P2058, DOI 10.1016/j.ophtha.2013.03.028; Pan CW, 2013, INVEST OPHTH VIS SCI, V54, P4498, DOI 10.1167/iovs.13-12271; Pan CW, 2012, OPHTHAL PHYSL OPT, V32, P3, DOI 10.1111/j.1475-1313.2011.00884.x; Pokharel GP, 2000, AM J OPHTHALMOL, V129, P436, DOI 10.1016/S0002-9394(99)00453-5; Read SA, 2010, BRIT J OPHTHALMOL, V94, P332, DOI 10.1136/bjo.2009.166355; Rudnicka AR, 2016, BR J OPHTHALMOL; Sanfilippo PG, 2014, ACTA OPHTHALMOL, V92, pE458, DOI 10.1111/aos.12388; Yang DY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109355; Zhang MZ, 2000, OPTOMETRY VISION SCI, V77, P302, DOI 10.1097/00006324-200006000-00010; Zhao JL, 2004, OPTOMETRY VISION SCI, V81, P49, DOI 10.1097/00006324-200401000-00010	24	26	30	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167628	10.1371/journal.pone.0167628	http://dx.doi.org/10.1371/journal.pone.0167628			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907165	gold, Green Published, Green Submitted			2022-12-26	WOS:000389482700214
J	Choi, SY; Piao, ZH; Jin, L; Kim, JH; Kim, GR; Ryu, Y; Lin, MQ; Kim, HS; Kee, HJ; Jeong, MH				Choi, Sin Young; Piao, Zhe Hao; Jin, Li; Kim, Jung Ha; Kim, Gwi Ran; Ryu, Yuhee; Lin, Ming Quan; Kim, Hyung-Seok; Kee, Hae Jin; Jeong, Myung Ho			Piceatannol Attenuates Renal Fibrosis Induced by Unilateral Ureteral Obstruction via Downregulation of Histone Deacetylase 4/5 or p38-MAPK Signaling	PLOS ONE			English	Article							INTERSTITIAL FIBROSIS; CARDIAC-HYPERTROPHY; NEPHROPATHY; INHIBITION; INJURY; RATS	Piceatannol, a resveratrol metabolite, is a phenolic compound found in red wine and grapes. We investigated the effect of piceatannol on renal fibrosis and histone deacetylase (HDAC) expression in a mouse model of unilateral ureteral obstruction (UUO). Fibrosis was established by UUO and piceatannol was intraperitoneally injected for 2 weeks. Piceatannol suppressed extracellular matrix (ECM) protein deposition including collagen type I and fibronectin as well as connective tissue growth factor (CTGF) and a-smooth muscle actin (a-SMA) in UUO kidneys. However, the expressions of epithelial-mesenchymal transition (EMT) marker genes, such as N-cadherin and E-cadherin, were not changed in the kidneys after UUO. Masson's trichrome staining and fluorescence immunostaining showed that piceatannol administration attenuated collagen deposition in UUO kidneys. HDAC1, HDAC4, HDAC5, HDAC6, and HDAC10 protein expression was upregulated in UUO kidneys, whereas that of HDAC8 was downregulated. Piceatannol treatment significantly reduced HDAC4 and HDAC5 protein expression. Further, piceatannol attenuated phosphorylation of p38 mitogen-activated protein kinase (p38-MAPK) in UUO kidneys, but not that of transforming growth factor beta1-Smad2/3. These results suggest that class I HDACs and class IIa/b HDACs are involved in renal fibrosis development. Piceatannol may be a beneficial therapeutic agent for treating renal fibrosis via reduction of HDAC4 and HDAC5 protein expression or suppression of the p38-MAPK signaling pathway.	[Choi, Sin Young; Jin, Li; Kim, Jung Ha; Kim, Gwi Ran; Ryu, Yuhee; Lin, Ming Quan; Kim, Hyung-Seok; Kee, Hae Jin; Jeong, Myung Ho] Chonnam Natl Univ Hosp, Heart Res Ctr, Gwangju, South Korea; [Piao, Zhe Hao] Jilin Univ, Hosp 2, Changchun, Peoples R China; [Jin, Li] Jilin Univ, Jilin Hosp, Changchun, Jilin, Peoples R China; [Lin, Ming Quan] Yanbian Univ Hosp, Jilin Yanbian, Peoples R China; [Kim, Hyung-Seok] Chonnam Natl Univ, Sch Med, Dept Forens Med, Gwangju, South Korea	Chonnam National University; Chonnam National University Hospital; Jilin University; Jilin University; Yanbian University; Chonnam National University	Kee, HJ; Jeong, MH (corresponding author), Chonnam Natl Univ Hosp, Heart Res Ctr, Gwangju, South Korea.	sshjkee@empas.com; myungho@chollian.net	Kee, Hae Jin/ABC-9979-2021	Kee, Hae Jin/0000-0002-9774-4828	Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI13C1527]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2015R1D1A1A01056798]	Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This study was supported by a grant of the Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI13C1527). This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2015R1D1A1A01056798). The funders had no role in study design, data collection and analysis,	Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; Choi S. Y., 2016, J CELL MOL MED; Choi SY, 2015, VASC PHARMACOL, V72, P130, DOI 10.1016/j.vph.2015.04.006; Kanasaki Keizo, 2013, Front Endocrinol (Lausanne), V4, P7, DOI 10.3389/fendo.2013.00007; Kee HJ, 2013, KIDNEY BLOOD PRESS R, V37, P229, DOI 10.1159/000350148; Kee HJ, 2006, CIRCULATION, V113, P51, DOI 10.1161/CIRCULATIONAHA.105.559724; Khan S, 2015, EXP MOL PATHOL, V98, P230, DOI 10.1016/j.yexmp.2015.01.003; Leoni F, 2005, MOL MED, V11, P1, DOI 10.2119/2006-00005.Dinarello; Liu N, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00121; Ma N, 2016, CURR TOP MED CHEM, V16, P415, DOI 10.2174/1568026615666150813145629; Marumo T, 2010, AM J PHYSIOL-RENAL, V298, pF133, DOI 10.1152/ajprenal.00400.2009; Moon JA, 2006, KIDNEY INT, V70, P1234, DOI 10.1038/sj.ki.5001775; Nakatsuji S, 1998, VET PATHOL, V35, P352, DOI 10.1177/030098589803500504; Noh H, 2009, AM J PHYSIOL-RENAL, V297, pF729, DOI 10.1152/ajprenal.00086.2009; Qi WE, 2006, INT J BIOCHEM CELL B, V38, P1, DOI 10.1016/j.biocel.2005.09.005; Takenaka M, 2009, PROSTAG LEUKOTR ESS, V80, P263, DOI 10.1016/j.plefa.2009.03.002; Zeisberg M, 2013, AM J PHYSIOL-CELL PH, V304, pC216, DOI 10.1152/ajpcell.00328.2012	17	30	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167340	10.1371/journal.pone.0167340	http://dx.doi.org/10.1371/journal.pone.0167340			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902771	Green Submitted, Green Published, gold			2022-12-26	WOS:000389474100075
J	Johnston, O; Johnston, F; Todd, J; Williamson, G				Johnston, Olivia; Johnston, Fay; Todd, John; Williamson, Grant			Community-Wide Distribution of a Catalytic Device to Reduce Winter Ambient Fine Particulate Matter from Residential Wood Combustion: A Field Study	PLOS ONE			English	Article							AIR-POLLUTION; EMISSIONS; SMOKE	Residential wood combustion is the main source of elevated concentrations of fine particulate matter (PM2.5) during winter in many towns of Tasmania, Australia. A commercially available firebox catalyst in Australia has previously been shown to reduce visible smoke emissions and the manufacturer reports reductions in particle emissions generated from individual wood heaters in laboratory settings. This study aimed to evaluate the potential for community-wide distribution of the catalyst to improve the ambient winter air quality in the field. The study was set in four rural towns in northern Tasmania with similar topography, population size, and proportion of houses using wood heaters for space heating. Hourly PM2.5 concentrations and meteorological conditions were monitored in all locations by fixed stations from May-September, 2013 and 2014. In June 2014, residents of one town, Perth, were offered a free catalyst for placement in their fireboxes. A general linear model evaluated the impact of the intervention using an indicator variable adjusted for hourly conditions of weather. Almost 80% of wood heater owners in Perth accepted a catalytic device. However, no significant changes in ambient PM2.5 concentrations were associated with the catalyst trial. Future community-level research should address maintenance of the catalyst in the firebox, and the adequacy of conditions that facilitate catalysed combustion in individual heaters.	[Johnston, Olivia] Univ Tasmania, Sch Hlth Sci, Launceston, Tas 7250, Australia; [Johnston, Fay; Williamson, Grant] Univ Tasmania, Menzies Inst Med Res, Private Bag 23, Hobart, Tas 7000, Australia; [Todd, John] Edith Cowan Univ, Sch Nat Sci, Joondalup, WA 6027, Australia; [Williamson, Grant] Univ Tasmania, Sch Biol Sci, Private Bag 55, Hobart, Tas 7001, Australia	University of Tasmania; University of Tasmania; Menzies Institute for Medical Research; Edith Cowan University; University of Tasmania	Johnston, O (corresponding author), Univ Tasmania, Sch Hlth Sci, Launceston, Tas 7250, Australia.	Olivia.Johnston@utas.edu.au	Williamson, Grant/J-7514-2014	Williamson, Grant/0000-0002-3469-7550; Johnston, Fay Helena/0000-0002-5150-8678	National Health and Medical Research Council (NHMRC) via the Centre for Air Quality Research and Evaluation; Fay Johnston	National Health and Medical Research Council (NHMRC) via the Centre for Air Quality Research and Evaluation(National Health and Medical Research Council (NHMRC) of Australia); Fay Johnston	This research was supported by the National Health and Medical Research Council (NHMRC) via the Centre for Air Quality Research and Evaluation. Funding was received by Fay Johnston. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, COMMUNITY INTERVENTI; Bergauff M, 2008, INT J ENVIRON AN CH, V88, P473, DOI 10.1080/03067310701809110; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Carno J, 1996, FUEL, V75, P959, DOI 10.1016/0016-2361(96)00047-6; Department of Environment and Heritage, 2004, NAT WOODH AUD PROGR; EPA Tasmania, 2016, BURN BRIGHT WINT; Government of Tasmania, 2007, ENV MAN POLL CONTR D; Hine DW, 2011, J ENVIRON PSYCHOL, V31, P282, DOI 10.1016/j.jenvp.2011.05.003; Hukkanen A, 2012, ATMOS ENVIRON, V50, P16, DOI 10.1016/j.atmosenv.2012.01.016; John I, 2012, 22 ENV PROT AUTH; John I, 2015, 31 ENV PROT AUTH; Johnston FH, 2013, BMJ-BRIT MED J, V346, P11; Kaivosoja T, 2012, CHEMOSPHERE, V88, P278, DOI 10.1016/j.chemosphere.2012.02.027; McGowan JA, 2002, AUST NZ J PUBL HEAL, V26, P23, DOI 10.1111/j.1467-842X.2002.tb00266.x; Noonan CW, 2012, OCCUP ENVIRON MED, V69, P354, DOI 10.1136/oemed-2011-100394; Sanhueza PA, 2009, J AIR WASTE MANAGE, V59, P1481, DOI 10.3155/1047-3289.59.12.1481; Smartburn Australia, 2016, DOES SMARTB WORK; Smith E. P., 2013, ENCY ENV, V1, P141, DOI DOI 10.1002/9780470057339.VAB001.PUB2; Todd J, 2013, P CASANZ C SYDN CLEA	19	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0166677	10.1371/journal.pone.0166677	http://dx.doi.org/10.1371/journal.pone.0166677			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902719	gold, Green Published			2022-12-26	WOS:000389474100031
J	Liu, J; Ando, H				Liu, Juan; Ando, Hiroshi			Metal Sounds Stiffer than Drums for Ears, but Not Always for Hands: Low-Level Auditory Features Affect Multisensory Stiffness Perception More than High-Level Categorical Information	PLOS ONE			English	Article							INTEGRATION; OBJECT; PSYCHOMECHANICS; CORTEX; SIZE	Most real-world events stimulate multiple sensory modalities simultaneously. Usually, the stiffness of an object is perceived haptically. However, auditory signals also contain stiff-ness-related information, and people can form impressions of stiffness from the different impact sounds of metal, wood, or glass. To understand whether there is any interaction between auditory and haptic stiffness perception, and if so, whether the inferred material category is the most relevant auditory information, we conducted experiments using a force-feedback device and the modal synthesis method to present haptic stimuli and impact sound in accordance with participants' actions, and to modulate low-level acoustic parameters, i.e., frequency and damping, without changing the inferred material categories of sound sources. We found that metal sounds consistently induced an impression of stiffer surfaces than did drum sounds in the audio-only condition, but participants haptically perceived surfaces with modulated metal sounds as significantly softer than the same surfaces with modulated drum sounds, which directly opposes the impression induced by these sounds alone. This result indicates that, although the inferred material category is strongly associated with audio-only stiffness perception, low-level acoustic parameters, especially damping, are more tightly integrated with haptic signals than the material category is. Frequency played an important role in both audio-only and audio-haptic conditions. Our study provides evidence that auditory information influences stiffness perception differently in unisensory and multisensory tasks. Furthermore, the data demonstrated that sounds with higher frequency and/or shorter decay time tended to be judged as stiffer, and contact sounds of stiff objects had no effect on the haptic perception of soft surfaces. We argue that the intrinsic physical relationship between object stiffness and acoustic parameters may be applied as prior knowledge to achieve robust estimation of stiffness in multisensory perception.	[Liu, Juan] Natl Inst Informat & Communicat Technol, Ctr Informat & Neural Networks CiNet, Osaka, Japan; Osaka Univ, Osaka, Japan	National Institute of Information & Communications Technology (NICT) - Japan; Osaka University	Liu, J (corresponding author), Natl Inst Informat & Communicat Technol, Ctr Informat & Neural Networks CiNet, Osaka, Japan.	juanliu@nict.go.jp						Adelstein BD, 2003, 5 INT C MULT INT; Avanzini F, 2006, COMPUT ANIMAT VIRT W, V17, P411, DOI 10.1002/cav.144; Bizley JK, 2013, NAT REV NEUROSCI, V14, P693, DOI 10.1038/nrn3565; Carello C, 1998, PSYCHOL SCI, V9, P211, DOI 10.1111/1467-9280.00040; Chaigne A, 1997, J ACOUST SOC AM, V101, P539, DOI 10.1121/1.418117; De Gelder B, 2003, TRENDS COGN SCI, V7, P460, DOI 10.1016/j.tics.2003.08.014; DiFranco D. E., 1997, Proceedings of the ASME Dynamic Systems and Control Division, P17; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Foxe JJ, 2002, J NEUROPHYSIOL, V88, P540, DOI 10.1152/jn.2002.88.1.540; FREED DJ, 1990, J ACOUST SOC AM, V87, P311, DOI 10.1121/1.399298; Giordano BL, 2006, J ACOUST SOC AM, V119, P1171, DOI 10.1121/1.2149839; Giordano BL, 2014, SPRINGER SERIES TOUC, P49; Giordano BL, 2010, J EXP PSYCHOL HUMAN, V36, P462, DOI 10.1037/a0018388; Grassi M, 2013, ACTA PSYCHOL, V143, P96, DOI 10.1016/j.actpsy.2013.02.005; Griffiths TD, 2004, NAT REV NEUROSCI, V5, P887, DOI 10.1038/nrn1538; Guest S, 2002, EXP BRAIN RES, V146, P161, DOI 10.1007/s00221-002-1164-z; James T. W., 2012, NEURAL BASEMULTISE; Kayser C, 2005, NEURON, V48, P373, DOI 10.1016/j.neuron.2005.09.018; Klatzky RL, 2000, PRESENCE-TELEOP VIRT, V9, P399, DOI 10.1162/105474600566907; Kunkler-Peck AJ, 2000, J EXP PSYCHOL HUMAN, V26, P279, DOI 10.1037/0096-1523.26.1.279; Kurihara Y, 2013, ACM SIGGRAPH AS 2013; Lakatos S, 1997, PERCEPT PSYCHOPHYS, V59, P1180, DOI 10.3758/BF03214206; LANDY MS, 1995, VISION RES, V35, P389, DOI 10.1016/0042-6989(94)00176-M; Lederman SJ, 2003, 11 S HAPT INT VIRT E; Lederman SJ, 2002, 10 S HAPT INT VIRT E; Liu J, 2008, IEEE C HUM SYST INT; Lutfi RA, 1997, J ACOUST SOC AM, V102, P3647, DOI 10.1121/1.420151; Lutfi RA, 2001, J ACOUST SOC AM, V110, P1010, DOI 10.1121/1.1385903; McAdams S, 2004, J ACOUST SOC AM, V115, P1306, DOI 10.1121/1.1645855; McAdams S, 2010, J ACOUST SOC AM, V128, P1401, DOI 10.1121/1.3466867; Menon S, 2014, 36 ANN C IEEE ENG ME; Morse PM, 1948, VIBRATION SOUND, P172; Parise CV, 2012, CURR BIOL, V22, P46, DOI 10.1016/j.cub.2011.11.039; Quesada FJ, 2006, IEEE MELECON 2006 MA; Rocchesso D, 2001, 2001 INT C AUD DISPL; Rodgers KM, 2008, CEREB CORTEX, V18, P2941, DOI 10.1093/cercor/bhn054; Sato S, 1985, TOUKEITEKI KANNOU KE, P263; SCHEFFE H, 1952, J AM STAT ASSOC, V47, P381, DOI 10.2307/2281310; Senna I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091688; Servos P, 2001, COGNITIVE BRAIN RES, V12, P307, DOI 10.1016/S0926-6410(01)00041-6; Stein BE, 2014, NAT REV NEUROSCI, V15, P520, DOI 10.1038/nrn3742; Tajadura-Jimenez A, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00689; Tajadura-Jimenez A, 2015, IEEE MULTIMEDIA, V22, P48, DOI 10.1109/MMUL.2015.14; van den Doel K, 1998, PRESENCE-TELEOP VIRT, V7, P382, DOI 10.1162/105474698565794; van den Doel K., 1998, THESIS; Weisenberger JM, 2004, 12 INT S HAPT INT VI; Wildes R.P., 1988, NATURAL COMPUTATION, P356	47	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167023	10.1371/journal.pone.0167023	http://dx.doi.org/10.1371/journal.pone.0167023			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FV	27902718	gold, Green Published, Green Submitted			2022-12-26	WOS:000389474100044
J	Liu, YC; Gau, JP; Lin, PY; Liu, CJL; Liu, CJ; Liu, JH; Fan, NW				Liu, Yao-Chung; Gau, Jyh-Pyng; Lin, Pei-Yu; Liu, Catherine Jui-Ling; Liu, Chia-Jen; Liu, Jin-Hwang; Fan, Nai-Wen			Conjunctival Acute Graft-versus-Host Disease in Adult Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation: A Cohort Study	PLOS ONE			English	Article							BONE-MARROW-TRANSPLANTATION; RISK-FACTORS; OCULAR FINDINGS; GVHD; EYE; CRITERIA; BLOOD; SCORE	Background To investigate the incidence, risk factors and survival of conjunctival acute graft-versus-host disease (aGVHD) in adult patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT) Methods This retrospective study included a total of 139 patients undergoing allogeneic HSCT between January 2012 and December 2014 at a tertiary referral hospital. Patients with ocular complaints after allogeneic HSCT or first donor lymphocyte infusion were evaluated by ophthalmologists. The risk factors for conjunctival aGVHD were analyzed using the Cox proportional hazards model. The overall survival was evaluated using Kaplan-Meier estimates. Results Thirteen (9.4%) patients developed conjunctival aGVHD, including eight patients with pseudomembranous conjunctivitis. The cumulative incidence of conjunctival aGVHD was 2.1 cases per 10,000 person-day. The median age at HSCT was 47 years (range, 18 to 66) in all patients and 42 years (range, 24 to 58) in the 13 patients with conjunctival aGVHD. Median time of follow-up after allogeneic HSCT was 353 days (range, 11 to 1184). In univariate analysis, grades II-IV skin aGVHD (P = 0.002) and advanced systemic aGVHD except skin aGVHD (overall grades III-IV) (P = 0.001) were significant predictors for conjunctival aGVHD. In multivariate analysis, grades II-IV skin aGVHD was a significant risk factor (P=0.04). The severity of conjunctival aGVHD was generally correlated with the systemic aGVHD (P=0.001). Overall survival was significantly shorter in patients with grades II-IV aGVHD compared to those with grade 0-I (P=0.01). Survival in patients with conjunctival aGVHD did not differ significantly from those without this complication (P = 0.94). In the subgroup analysis of patients with grades III-IV aGVHD, survival was significantly longer in patients with conjunctival involvement than those without (P=0.03). Conclusions The severity of conjunctival aGVHD is correlated with systemic aGVHD, but not with inferior overall survival.	[Liu, Yao-Chung; Gau, Jyh-Pyng; Liu, Chia-Jen; Liu, Jin-Hwang] Taipei Vet Gen Hosp, Div Hematol, Dept Med, Taipei, Taiwan; [Liu, Yao-Chung; Gau, Jyh-Pyng; Lin, Pei-Yu; Liu, Catherine Jui-Ling; Liu, Chia-Jen; Liu, Jin-Hwang; Fan, Nai-Wen] Natl Yang Ming Univ, Fac Med, Taipei, Taiwan; [Lin, Pei-Yu; Liu, Catherine Jui-Ling; Fan, Nai-Wen] Taipei Vet Gen Hosp, Dept Ophthalmol, Taipei, Taiwan; [Fan, Nai-Wen] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Fan, NW (corresponding author), Natl Yang Ming Univ, Fac Med, Taipei, Taiwan.; Fan, NW (corresponding author), Taipei Vet Gen Hosp, Dept Ophthalmol, Taipei, Taiwan.; Fan, NW (corresponding author), Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan.	nwfan@vghtpe.gov.tw	Fan, Nai-Wen/ACB-0737-2022		Taipei Veterans General Hospital [V105B-009]	Taipei Veterans General Hospital(Taipei Veterans General Hospital)	This work was supported in part by grants from Taipei Veterans General Hospital (V105B-009).	Arora M, 2011, BLOOD, V117, P6714, DOI 10.1182/blood-2010-12-323824; Bacigalupo A, 2007, BRIT J HAEMATOL, V137, P87, DOI 10.1111/j.1365-2141.2007.06533.x; BRAY LC, 1991, BRIT J OPHTHALMOL, V75, P611, DOI 10.1136/bjo.75.10.611; Buttgereit F, 1998, ARTHRITIS RHEUM, V41, P761, DOI 10.1002/1529-0131(199805)41:5<761::AID-ART2>3.0.CO;2-M; Chiang CC, 2007, CORNEA, V26, P861, DOI 10.1097/ICO.0b013e3180645cd7; Copelan EA, 2006, NEW ENGL J MED, V354, P1813, DOI 10.1056/NEJMra052638; Dai E, 2007, CORNEA, V26, P756, DOI 10.1097/ICO.0b013e318059b55f; Elborai Y, 2012, IMMUNOTHERAPY-UK, V4, P947, DOI [10.2217/IMT.12.95, 10.2217/imt.12.95]; Ferrara JLM, 2009, LANCET, V373, P1550, DOI 10.1016/S0140-6736(09)60237-3; Filipovich AH, 2005, BIOL BLOOD MARROW TR, V11, P945, DOI 10.1016/j.bbmt.2005.09.004; FRANKLIN RM, 1983, OPHTHALMOLOGY, V90, P4; Gratwohl A, 2012, BONE MARROW TRANSPL, V47, P749, DOI 10.1038/bmt.2011.110; Hessen M, 2012, CURR OPIN ALLERGY CL, V12, P540, DOI 10.1097/ACI.0b013e328357b4b9; HIRST LW, 1983, ARCH OPHTHALMOL-CHIC, V101, P580, DOI 10.1001/archopht.1983.01040010580010; JABS DA, 1989, ARCH OPHTHALMOL-CHIC, V107, P1343, DOI 10.1001/archopht.1989.01070020413046; Jacobs R, 2012, BONE MARROW TRANSPL, V47, P1470, DOI 10.1038/bmt.2012.56; Janin A, 1996, HUM PATHOL, V27, P307, DOI 10.1016/S0046-8177(96)90074-X; Kerty E, 1999, OPHTHALMOLOGY, V106, P1334, DOI 10.1016/S0161-6420(99)00720-4; Kim SK, 2006, CURR OPIN OPHTHALMOL, V17, P344, DOI 10.1097/01.icu.0000233952.09595.d8; Lee SJ, 2002, BLOOD, V100, P406, DOI 10.1182/blood.V100.2.406; Liu YC, 2015, BRIT J HAEMATOL, V169, P737, DOI 10.1111/bjh.13357; Migita K, 1997, TRANSPLANTATION, V63, P583, DOI 10.1097/00007890-199702270-00017; Na KS, 2015, BONE MARROW TRANSPL, V50, P1459, DOI 10.1038/bmt.2015.187; Nassiri Nariman, 2013, J Ophthalmic Vis Res, V8, P351; Saboo US, 2015, OPHTHALMOLOGY, V122, P1669, DOI 10.1016/j.ophtha.2015.04.011; Shikari H, 2013, SURV OPHTHALMOL, V58, P233, DOI 10.1016/j.survophthal.2012.08.004; Tabbara KF, 2009, OPHTHALMOLOGY, V116, P1624, DOI 10.1016/j.ophtha.2009.04.054; THOMAS ED, 1975, NEW ENGL J MED, V292, P895, DOI 10.1056/NEJM197504242921706; Westeneng AC, 2010, CORNEA, V29, P758, DOI 10.1097/ICO.0b013e3181ca321c	29	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167129	10.1371/journal.pone.0167129	http://dx.doi.org/10.1371/journal.pone.0167129			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902756	gold, Green Submitted, Green Published			2022-12-26	WOS:000389474100054
J	Zhu, DQ; Wang, SS; Lawless, J; He, JC; Zheng, ZG				Zhu, Dongqing; Wang, Shanshan; Lawless, John; He, Jianchen; Zheng, Zhengui			Dose Dependent Dual Effect of Baicalin and Herb Huang Qin Extract on Angiogenesis	PLOS ONE			English	Article							SCUTELLARIA-BAICALENSIS; TUMOR ANGIOGENESIS; IN-VITRO; THERAPEUTIC ANGIOGENESIS; ANTICANCER ACTIVITY; RADIX-SCUTELLARIAE; OVARIAN-CANCER; GROWTH; EXPRESSION; WOGONIN	Huang Qin (root of Scutellaria baicalensis) is a widely used herb in different countries for adjuvant therapy of inflammation, diabetes, hypertension, different kinds of cancer and virus related diseases. Baicalin is the main flavonoid in this herb and has been extensively studied for 30 years. The angiogenic effect of herb Huang Qin extract and baicalin was found 13 years ago, however, the results were controversial with pro-angiogenic effect in some studies and anti-angiogenic effect in others. In this paper, the angiogenic effect of baicalin, its aglycone form baicalein and aqueous extract of Huang Qin was studied in chick embryo chorioallantoic membrane (CAM) model. Dose dependent dual effect was found in both aqueous extract and baicalin, but not in baicalein, in which only inhibitory effect was observed. In order to reveal the cellular and molecular mechanism of how baicalin and baicalein affect angiogenesis, cell proliferation and programmed cell death assays were performed in treated CAM. In addition, quantitative PCR array including 84 angiogenesis related genes was used to detect high and low dosage of baicalin and baicalein responsive genes. Low dose baicalin increased cell proliferation in developing blood vessels through upregulation of multiple angiogenic genes expression, but high dose baicalin induced cell death, performing inhibitory effect on angiogenesis. Both high and low dose of baicalein down regulated the expression of multiple angiogenic genes, decreased cell proliferation, and leads to inhibitory effects on angiogenesis.	[Zhu, Dongqing; Wang, Shanshan; Lawless, John; Zheng, Zhengui] Southern Illinois Univ Carbondale, Sch Med, Dept Physiol, Carbondale, IL 62901 USA; [Zhu, Dongqing] Jiangsu Food & Pharmaceut Sci Coll, Dept Pharm, Huaian, Jiangsu, Peoples R China; [He, Jianchen] Shanghai Univ Tradit Chinese Med, Sch Basic Med Sci, Shanghai, Peoples R China	Southern Illinois University System; Southern Illinois University; Jiangsu Food & Pharmaceutical Science College; Shanghai University of Traditional Chinese Medicine	Zheng, ZG (corresponding author), Southern Illinois Univ Carbondale, Sch Med, Dept Physiol, Carbondale, IL 62901 USA.; He, JC (corresponding author), Shanghai Univ Tradit Chinese Med, Sch Basic Med Sci, Shanghai, Peoples R China.	hejc@shutcm.edu.cn; zzheng@siu.edu		Zheng, Zhengui/0000-0003-0997-2976	School of Medicine at Southern Illinois University	School of Medicine at Southern Illinois University	ZZ was supported by the School of Medicine at Southern Illinois University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahnfelt-Ronne J, 2007, J HISTOCHEM CYTOCHEM, V55, P925, DOI 10.1369/jhc.7A7226.2007; Alanentalo T, 2007, NAT METHODS, V4, P31, DOI 10.1038/NMETH985; Auerbach R, 2003, CLIN CHEM, V49, P32, DOI 10.1373/49.1.32; Bai Y, 2014, CELL TISSUE RES, V356, P109, DOI 10.1007/s00441-013-1781-9; Bassino E, 2016, NAT PROD RES, V2, P1; Bisht M, 2010, INDIAN J PHARMACOL, V42, P2, DOI 10.4103/0253-7613.62395; Bochorakova H, 2003, PHYTOTHER RES, V17, P640, DOI 10.1002/ptr.1216; Bokhari AA, 2015, J CELL BIOCHEM, V116, P1797, DOI 10.1002/jcb.25138; Bonham M, 2005, CLIN CANCER RES, V11, P3905, DOI 10.1158/1078-0432.CCR-04-1974; Cao YH, 1998, P NATL ACAD SCI USA, V95, P14389, DOI 10.1073/pnas.95.24.14389; Chan FL, 2000, CANCER LETT, V160, P219, DOI 10.1016/S0304-3835(00)00591-7; Chen JC, 2013, INT J MOL SCI, V14, P6012, DOI 10.3390/ijms14036012; Chen SS, 2012, DISCOV MED, V13, P7; CHOMCZYNSKI P, 1995, BIOTECHNIQUES, V19, P942; Chong HC, 2014, MOL THER, V22, P1593, DOI 10.1038/mt.2014.102; Chung H, 2015, BIOCHEM BIOPH RES CO, V458, P707, DOI 10.1016/j.bbrc.2015.02.032; Cohen MH, 2007, ONCOLOGIST, V12, P356, DOI 10.1634/theoncologist.12-3-356; Cook KM, 2010, CA-CANCER J CLIN, V60, P222, DOI 10.3322/caac.20075; Deveza L, 2012, THERANOSTICS, V2, P801, DOI 10.7150/thno.4419; El Sayed KA, 2005, MINI-REV MED CHEM, V5, P971, DOI 10.2174/138955705774575291; El-Kenawi AE, 2013, BRIT J PHARMACOL, V170, P712, DOI 10.1111/bph.12344; Fantin A, 2014, DEVELOPMENT, V141, P556, DOI 10.1242/dev.103028; Fogel JL, 2012, JOVE-J VIS EXP, DOI 10.3791/4254; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Gao J, 2008, J PHARM PHARM SCI, V11, P77; Griffioen AW, 2000, PHARMACOL REV, V52, P237; Gu YX, 2016, INSTRUM SCI TECHNOL, V44, P593, DOI 10.1080/10739149.2016.1177541; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hehlgans T, 2002, CANCER RES, V62, P4034; Huang WH, 2006, BIOSCI BIOTECH BIOCH, V70, P2371, DOI 10.1271/bbb.50698; Huang Y, 2015, MOL CARCINOG; ISHIMARU K, 1995, PHYTOCHEMISTRY, V40, P279, DOI 10.1016/0031-9422(95)00200-Q; Jo H, 2015, BMB REP, V48, P271, DOI 10.5483/BMBRep.2015.48.5.131; Kee HJ, 2004, FEBS LETT, V569, P307, DOI 10.1016/j.febslet.2004.06.011; Kim EH, 2009, J ETHNOPHARMACOL, V126, P320, DOI 10.1016/j.jep.2009.08.027; Kren V, 2001, CURR MED CHEM, V8, P1303, DOI 10.2174/0929867013372193; Li GH, 2016, NEURAL REGEN RES, V11, P1015, DOI 10.4103/1673-5374.184506; Li-Weber M, 2009, CANCER TREAT REV, V35, P57, DOI 10.1016/j.ctrv.2008.09.005; Liu JJ, 2003, INT J CANCER, V106, P559, DOI 10.1002/ijc.11267; Liu W, 2015, BIOMED RES-INDIA, V26, P13; Logsdon EA, 2014, J CELL MOL MED, V18, P1491, DOI 10.1111/jcmm.12164; Losordo DW, 1998, CIRCULATION, V98, P2800, DOI 10.1161/01.CIR.98.25.2800; Lu N, 2008, LIFE SCI, V82, P956, DOI 10.1016/j.lfs.2008.02.013; Miocinovic R, 2005, INT J ONCOL, V26, P241; Padwal M., 2016, NEPHROL DIAL TRANSPL; Reizis A, 2005, J EXP BIOL, V208, P2483, DOI 10.1242/jeb.01662; Ribatti D, 2008, ONCOL REP, V19, P1109; Rosing H, 2000, J LIQ CHROMATOGR R T, V23, P329, DOI 10.1081/JLC-100101455; Sagar S M, 2006, Curr Oncol, V13, P99; Sagar S M, 2006, Curr Oncol, V13, P14; Sato D, 2013, MOL CLIN ONCOL, V1, P105, DOI 10.3892/mco.2012.14; Scheck Adrienne C, 2006, BMC Complement Altern Med, V6, P27, DOI 10.1186/1472-6882-6-27; Seifert AW, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1020; Shang DD, 2015, ONCOL REP, V33, P2077, DOI 10.3892/or.2015.3786; Shang XF, 2010, J ETHNOPHARMACOL, V128, P279, DOI 10.1016/j.jep.2010.01.006; Shao ZH, 1999, J MOL CELL CARDIOL, V31, P1885, DOI 10.1006/jmcc.1999.1021; Silvestre JS, 2002, ARCH MAL COEUR VAISS, V95, P189; Soikkeli J, 2010, AM J PATHOL, V177, P387, DOI 10.2353/ajpath.2010.090748; Song XM, 2013, TOXICOL APPL PHARM, V271, P144, DOI 10.1016/j.taap.2013.04.031; Tang W, 2004, PHYTOMEDICINE, V11, P277, DOI 10.1078/0944711041495173; TPCoPR C, 2005, PHARMACOPOEIA PEOPLE; Tufan AC, 2005, CURR CANCER DRUG TAR, V5, P249, DOI 10.2174/1568009054064624; Vale PR, 2001, REV ESP CARDIOL, V54, P1210, DOI 10.1016/S0300-8932(01)76480-9; Waisundara VY, 2008, AM J CHINESE MED, V36, P517, DOI 10.1142/S0192415X08005953; Wang B, 2006, J BIOL CHEM, V281, P6020, DOI 10.1074/jbc.M509134200; Wang SS, 2004, LIFE SCI, V74, P2467, DOI 10.1016/j.lfs.2003.03.005; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; Yance DR, 2006, INTEGR CANCER THER, V5, P9, DOI 10.1177/1534735405285562; Yang Li-xin, 2002, Zhongguo Zhongyao Zazhi, V27, P166; Ye F, 2002, J ALTERN COMPLEM MED, V8, P567, DOI 10.1089/107555302320825075; Yin Hui-Fu, 2014, Zhongguo Zhong Yao Za Zhi, V39, P3757; Zhang KQ, 2011, CARDIOVASC RES, V89, P426, DOI 10.1093/cvr/cvq296; Zhang X, 2016, J ETHNOPHARMACOL, V186, P91, DOI 10.1016/j.jep.2016.03.057; Zheng ZG, 2015, P NATL ACAD SCI USA, V112, pE7194, DOI 10.1073/pnas.1515981112; Zhou M, 2014, VASC PHARMACOL, V60, P110, DOI 10.1016/j.vph.2014.01.010	76	23	27	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167125	10.1371/journal.pone.0167125	http://dx.doi.org/10.1371/journal.pone.0167125			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902752	Green Submitted, Green Published, gold			2022-12-26	WOS:000389474100053
J	Balaji, S; Wang, X; King, A; Le, LD; Bhattacharya, SS; Moles, CM; Butte, MJ; Perez, VAD; Liechty, KW; Wight, TN; Crombleholme, TM; Bollyky, PL; Keswani, SG				Balaji, Swathi; Wang, Xinyi; King, Alice; Le, Louis D.; Bhattacharya, Sukanta S.; Moles, Chad M.; Butte, Manish J.; Perez, Vinicio A. de Jesus; Liechty, Kenneth W.; Wight, Thomas N.; Crombleholme, Timothy M.; Bollyky, Paul L.; Keswani, Sundeep G.			Interleukin-10-mediated regenerative postnatal tissue repair is dependent on regulation of hyaluronan metabolism via fibroblast-specific STAT3 signaling	FASEB JOURNAL			English	Article						fibrosis; scarless; wound healing; extracellular matrix; inflammatory cytokines	EXTRACELLULAR-MATRIX; COLLAGEN DEPOSITION; CULTURED FETAL; SCAR FORMATION; T-CELLS; ACID; INFLAMMATION; FIBROSIS; WOUNDS; SKIN	The cytokine IL-10 has potent antifibrotic effects in models of adult fibrosis, but the mechanisms of action are unclear. Here, we report a novel finding that IL-10 triggers a signal transducer and activator of transcription 3 (STAT3)-dependent signaling pathway that regulates hyaluronan (HA) metabolism and drives adult fibroblasts to synthesize an HA-rich pericellular matrix, which mimics the fetal regenerative wound healing phenotype with reduced fibrosis. By using cre-lox-mediated novel, inducible, fibroblast-,keratinocyte-, and wound-specific STAT3knockdown postnatal mice-plus syngeneic fibroblast cell-transplant models-we demonstrate that the regenerative effects of IL-10 in postnatal wounds are dependent on HA synthesis and fibroblast- specific STAT3-dependent signaling. The importance of IL-10-induced HA synthesis for regenerative wound healing is demonstrated by inhibition of HA synthesis in a murine wound model by administering 4-methylumbelliferone. Although IL-10 and STAT3 signaling were intact, the antifibrotic repair phenotype that is induced by IL-10 overexpression was abrogated in this model. Our data show a novel role for IL-10 beyond its accepted immune-regulatory mechanism. The opportunity for IL-10 to regulate a fibroblast- specific formation of a regenerative, HA-rich wound extracellular matrixmay lead to the development of innovative therapies to attenuate postnatal fibrosis in organ systems or diseases in which dysregulated inflammation and HA intersect.-Balaji, S., Wang, X., King, A., Le, L. D., Bhattacharya, S. S., Moles, C. M., Butte, M. J., de Jesus Perez, V. A., Liechty, K. W., Wight, T. N., Crombleholme, T. M., Bollyky, P. L., Keswani, S. G. Interleukin10- mediated regenerative postnatal tissue repair is dependent on regulation of hyaluronan metabolism via fibroblastspecific STAT3 signaling.	[Balaji, Swathi; Wang, Xinyi; King, Alice; Le, Louis D.; Bhattacharya, Sukanta S.; Moles, Chad M.; Keswani, Sundeep G.] Texas Childrens Hosp, Baylor Coll Med, Div Pediat Surg, Lab Regenerat Tissue Repair, Houston, TX 77030 USA; [Perez, Vinicio A. de Jesus] Stanford Univ, Div Pulm & Crit Care Med, Stanford, CA 94305 USA; [Perez, Vinicio A. de Jesus; Bollyky, Paul L.] Stanford Univ, Dept Med, Div Infect Dis, Stanford, CA 94305 USA; [Butte, Manish J.] Stanford Univ, Dept Pediat, Div Immunol, Stanford, CA 94305 USA; [Liechty, Kenneth W.; Crombleholme, Timothy M.] Univ Colorado, Sch Med, Childrens Hosp Colorado, Ctr Childrens Surg, Aurora, CO USA; [Wight, Thomas N.] Benaroya Res Inst, Matrix Biol Program, Seattle, WA USA	Baylor College of Medicine; Stanford University; Stanford University; Stanford University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Benaroya Research Institute	Keswani, SG (corresponding author), Texas Childrens Hosp, Baylor Coll Med, Feigin Ctr, C450-06,1102 Bates Ave, Houston, TX 77030 USA.	keswani@bcm.edu	Butte, Manish/AAM-8604-2020; Crombleholme, Timothy/Y-1477-2019; Wang, Xinyi/AAN-4271-2020; Butte, Manish/T-8860-2019	Butte, Manish/0000-0002-4490-5595; Wang, Xinyi/0000-0003-1780-7719; Butte, Manish/0000-0002-4490-5595	U.S. National Institutes of Health (NIH), National Institute of General Medical Sciences Grants [K08-GM098831-04, 1R01-GM111808-01]; Wound Healing Society Foundation 3M Award; NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant [1R01-DK096087]; NIH National Heart, Lung, and Blood Institute [1R01-HL113294-01A1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL105884, R01HL139664, R01HL113294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK096087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K08GM098831, R01GM111808] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH), National Institute of General Medical Sciences Grants; Wound Healing Society Foundation 3M Award; NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant; NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Dr. Ana Maria Rodriguez and Chi-Han Lu for editorial help, and Dr. Rita Serda (all from Baylor College of Medicine) for help with the scanning electron microscopy. The authors also thank Elizabeth Sumner (Texas Children's Hospital Multimedia Team) for help with the schematic illustration of the mechanism; Dr. Jeffrey A. Whitsett, Dr. Christopher L. Karp, Dr. Michael A. Helmrath, and all the faculty members in the Center for Fetal Cellular and Molecular Therapy at the Cincinnati Children's Hospital Medical Center for scientific discussions. The authors also thank Charles Klanke, Stephanie A. Lang, and Nathaniel Han, (Cincinnati Children's Hospital Medical Center), and Dr. Hui Li and Dr. Pu Duann (Baylor College of Medicine) for technical help with immunohistochemistry and molecular biology work. This work was supported by the U.S. National Institutes of Health (NIH), National Institute of General Medical Sciences Grants K08-GM098831-04 and 1R01-GM111808-01 (to S.G.K.), the Wound Healing Society Foundation 3M Award (to S.G.K.), NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant 1R01-DK096087 (to P.L.B.), and NIH National Heart, Lung, and Blood Institute 1R01-HL113294-01A1 (to P.L.B.). The authors declare no conflicts of interest.	ADZICK NS, 1985, J PEDIATR SURG, V20, P315; Balaji S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124302; Barnes L, 2013, J INVEST DERMATOL, V133, P1017, DOI 10.1038/jid.2012.439; Bayat A, 2003, BRIT MED J, V326, P88, DOI 10.1136/bmj.326.7380.88; Cao YP, 2003, TRANSPLANTATION, V75, P1390, DOI 10.1097/01.TP.0000061599.24682.EC; Caskey RC, 2013, CELL TISSUE RES, V351, P117, DOI 10.1007/s00441-012-1504-7; CHEN WYJ, 1989, J CELL SCI, V94, P577; Csoka AB, 2001, MATRIX BIOL, V20, P499, DOI 10.1016/S0945-053X(01)00172-X; Cyktor JC, 2013, J IMMUNOL, V190, P2778, DOI 10.4049/jimmunol.1202722; Darby IA, 2007, INT REV CYTOL, V257, P143, DOI 10.1016/S0074-7696(07)57004-X; de la Motte C, 2009, AM J PATHOL, V174, P2254, DOI 10.2353/ajpath.2009.080831; DEPALMA RL, 1989, MATRIX, V9, P224; Gittes C, 2000, J PEDIATR SURG, V35, P872; Glowacka E, 2010, ADV MED SCI-POLAND, V55, P254, DOI 10.2478/v10039-010-0037-0; Gordon A, 2008, WOUND REPAIR REGEN, V16, P70, DOI 10.1111/j.1524-475X.2007.00326.x; Hadley HS, 2013, VET SURG, V42, P161, DOI 10.1111/j.1532-950X.2012.01048.x; Hiramatsu K, 2011, J CLIN INVEST, V121, P640, DOI 10.1172/JCI44605; Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085; Jin YM, 2013, LAB INVEST, V93, P801, DOI 10.1038/labinvest.2013.64; Juhlin L, 1997, J INTERN MED, V242, P61, DOI 10.1046/j.1365-2796.1997.00175.x; Kieran I, 2013, WOUND REPAIR REGEN, V21, P428, DOI 10.1111/wrr.12043; King A, 2013, J SURG RES, V184, P671, DOI 10.1016/j.jss.2013.04.009; King A, 2013, J PEDIATR SURG, V48, P1211, DOI 10.1016/j.jpedsurg.2013.03.014; Krishnamurthy P, 2009, CIRC RES, V104, pE9, DOI 10.1161/CIRCRESAHA.108.188243; KRUMMEL TM, 1987, J PEDIATR SURG, V22, P640, DOI 10.1016/S0022-3468(87)80117-3; Kultti A, 2009, EXP CELL RES, V315, P1914, DOI 10.1016/j.yexcr.2009.03.002; Kwan P, 2009, HAND CLIN, V25, P511, DOI 10.1016/j.hcl.2009.06.007; Lepperdinger G, 1998, J BIOL CHEM, V273, P22466, DOI 10.1074/jbc.273.35.22466; Liechty KW, 2000, J PEDIATR SURG, V35, P866, DOI 10.1053/jpsu.2000.6868; Liechty KW, 2000, CYTOKINE, V12, P671, DOI 10.1006/cyto.1999.0598; LONGAKER MT, 1990, J PEDIATR SURG, V25, P63, DOI 10.1016/S0022-3468(05)80165-4; Mack JA, 2012, J INVEST DERMATOL, V132, P198, DOI 10.1038/jid.2011.248; MAST BA, 1993, MATRIX, V13, P441, DOI 10.1016/S0934-8832(11)80110-1; MAST BA, 1992, PLAST RECONSTR SURG, V89, P503, DOI 10.1097/00006534-199203000-00019; McInnes IB, 2001, J IMMUNOL, V167, P4075, DOI 10.4049/jimmunol.167.7.4075; MEYER K, 1952, T NEW YORK ACAD SCI, V14, P164, DOI 10.1111/j.2164-0947.1952.tb01088.x; MEYER LJM, 1994, J INVEST DERMATOL, V102, P385, DOI 10.1111/1523-1747.ep12371800; Mir SA, 2012, J BIOL CHEM, V287, P2666, DOI 10.1074/jbc.M111.246173; Miyoshi K, 2011, J INVEST DERMATOL, V131, P108, DOI 10.1038/jid.2010.255; Moles C. M., 2015, SCARLESS SURG ARE WE; Moriarty Kevin P., 1996, Wound Repair and Regeneration, V4, P346, DOI 10.1046/j.1524-475X.1996.40311.x; Namazi MR, 2011, INT J DERMATOL, V50, P85, DOI 10.1111/j.1365-4632.2010.04678.x; O'Reilly S, 2014, J BIOL CHEM, V289, P9952, DOI 10.1074/jbc.M113.545822; Oba T, 2012, J AM COLL CARDIOL, V59, P838, DOI 10.1016/j.jacc.2011.10.887; Olutoye OO, 1996, J PEDIATR SURG, V31, P91, DOI 10.1016/S0022-3468(96)90326-7; Olutoye OO, 1997, J PEDIATR SURG, V32, P1037, DOI 10.1016/S0022-3468(97)90394-8; Park JC, 2001, YONSEI MED J, V42, P587, DOI 10.3349/ymj.2001.42.6.587; Peranteau WH, 2008, J INVEST DERMATOL, V128, P1852, DOI 10.1038/sj.jid.5701232; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rockey DC, 2015, NEW ENGL J MED, V372, P1138, DOI 10.1056/NEJMra1300575; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Shi JH, 2013, ARCH DERMATOL RES, V305, P341, DOI 10.1007/s00403-013-1314-0; Shi JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098228; Stern R, 2007, J INVEST DERMATOL, V127, P512, DOI 10.1038/sj.jid.5700605; Sziksz E, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/764641; Takiishi T, 2012, J LEUKOCYTE BIOL, V92, P259, DOI 10.1189/jlb.1111569; Wulff BC, 2013, WOUND REPAIR REGEN, V21, P103, DOI 10.1111/j.1524-475X.2012.00860.x; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Yoshida H, 2013, P NATL ACAD SCI USA, V110, P5612, DOI 10.1073/pnas.1215432110	59	38	41	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2017	31	3					868	881		10.1096/fj.201600856R	http://dx.doi.org/10.1096/fj.201600856R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EM9ZX	27903619	Green Published, hybrid			2022-12-26	WOS:000395671200004
J	Halmo, SM; Singh, D; Patel, S; Wang, S; Edlin, M; Boons, GJ; Moremen, KW; Live, D; Wells, L				Halmo, Stephanie M.; Singh, Danish; Patel, Sneha; Wang, Shuo; Edlin, Melanie; Boons, Geert-Jan; Moremen, Kelley W.; Live, David; Wells, Lance			Protein O-Linked Mannose beta-1,4-N-Acetylglucosaminyl-transferase 2 (POMGNT2) Is a Gatekeeper Enzyme for Functional Glycosylation of alpha-Dystroglycan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANNOSYLATION PATHWAY; MUSCULAR-DYSTROPHY; GLYCAN STRUCTURES; LAMININ-BINDING; SKELETAL-MUSCLE; EXPRESSION; SEQUENCE; IDENTIFICATION; SUBSTRATE	Disruption of theO-mannosylation pathway involved in functional glycosylation of alpha-dystroglycan gives rise to congenital muscular dystrophies. Protein O-linked mannose beta-1,4-Nacetylglucosaminyltransferase 2 (POMGNT2) catalyzes the first step toward the functional matriglycan structure on alpha-dystroglycan that is responsible for binding extracellular matrix proteins and certain arenaviruses. Alternatively, protein O-linked mannose beta-1,2-N-acetylglucosaminyltransferase 1 (POMGNT1) catalyzes the first step toward other various glycan structures present on alpha-dystroglycan of unknown function. Here, we demonstrate that POMGNT1 is promiscuous for O-mannosylated peptides, whereas POMGNT2 displays significant primary amino acid selectivity near the site of O-mannosylation. We define a POMGNT2 acceptor motif, conserved among 59 vertebrate species, in alpha-dystroglycan that when engineered into a POMGNT1-only site is sufficient to convert the O-mannosylated peptide to a substrate for POMGNT2. Additionally, an acceptor glycopeptide is a less efficient substrate forPOMGNT2 when two of the conserved amino acids are replaced. These findings begin to define the selectivity of POMGNT2 and suggest that this enzyme functions as a gatekeeper enzyme to prevent the vast majority of O-mannosylated sites on proteins from becoming modified with glycan structures functional for binding laminin globular domain-containing proteins.	[Halmo, Stephanie M.; Singh, Danish; Patel, Sneha; Wang, Shuo; Edlin, Melanie; Boons, Geert-Jan; Moremen, Kelley W.; Live, David; Wells, Lance] Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA; [Halmo, Stephanie M.; Singh, Danish; Moremen, Kelley W.; Wells, Lance] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Edlin, Melanie; Boons, Geert-Jan] Univ Georgia, Dept Chem, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Wells, L (corresponding author), Univ Georgia, Dept Biochem, Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA.	lwells@ccrc.uga.edu	Boons, Geert-Jan P H/J-3211-2016; Moremen, Kelley/AAD-4661-2019	Boons, Geert-Jan P H/0000-0003-3111-5954; Halmo, Stephanie/0000-0001-8369-3620; Wells, Lance/0000-0003-4956-5363	National Institutes of Health [R01GM111939, P01GM107012, P41GM103490, P41GM103390, S10RR027155]; National Institutes of Health Training Grant [T32GM107004]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103390, P41GM103490, R01GM111939, P01GM107012] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants R01GM111939 (to D. L. and L. W.), P01GM107012 (to G.-J. B., K. W. M., and L. W.), P41GM103490 (to K. W. M. and L. W.), P41GM103390 (to K. W. M. and D. L.), and S10RR027155 for purchase of the peptide synthesizer (to D. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported in part by National Institutes of Health Training Grant T32GM107004.	Barb AW, 2012, BIOCHEMISTRY-US, V51, P4618, DOI 10.1021/bi300319q; Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; Gerhard DS, 2004, GENOME RES, V14, P2121, DOI 10.1101/gr.2596504; Godfrey C, 2011, CURR OPIN GENET DEV, V21, P278, DOI 10.1016/j.gde.2011.02.001; Hara Y, 2011, P NATL ACAD SCI USA, V108, P17426, DOI 10.1073/pnas.1114836108; Harrison R, 2012, GLYCOBIOLOGY, V22, P662, DOI 10.1093/glycob/cws002; Jae LT, 2013, SCIENCE, V340, P479, DOI 10.1126/science.1233675; Kanagawa M, 2004, CELL, V117, P953, DOI 10.1016/j.cell.2004.06.003; Kanagawa M, 2016, CELL REP, V14, P2209, DOI 10.1016/j.celrep.2016.02.017; Lee JK, 2012, J BIOL CHEM, V287, P28526, DOI 10.1074/jbc.M112.367565; Liu MA, 2008, BIOPOLYMERS, V90, P358, DOI 10.1002/bip.20847; Live D, 2013, CHEMBIOCHEM, V14, P2392, DOI 10.1002/cbic.201300417; Manya H, 2004, P NATL ACAD SCI USA, V101, P500, DOI 10.1073/pnas.0307228101; Manya H, 2007, J BIOL CHEM, V282, P20200, DOI 10.1074/jbc.M702369200; Meng L, 2013, J BIOL CHEM, V288, P34680, DOI 10.1074/jbc.M113.519041; Mo KF, 2011, J AM CHEM SOC, V133, P14418, DOI 10.1021/ja205473q; Nilsson J, 2010, GLYCOBIOLOGY, V20, P1160, DOI 10.1093/glycob/cwq082; Ogawa M, 2013, BIOCHEM BIOPH RES CO, V440, P88, DOI 10.1016/j.bbrc.2013.09.022; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Phan J, 2002, J BIOL CHEM, V277, P50564, DOI 10.1074/jbc.M207224200; Praissman JL, 2016, ELIFE, V5, DOI 10.7554/eLife.14473; Praissman JL, 2014, ELIFE, V3, DOI 10.7554/eLife.03943; Praissman JL, 2014, BIOCHEMISTRY-US, V53, P3066, DOI 10.1021/bi500153y; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Stalnaker SH, 2010, J BIOL CHEM, V285, P24882, DOI 10.1074/jbc.M110.126474; Takahashi S, 2001, GLYCOBIOLOGY, V11, P37, DOI 10.1093/glycob/11.1.37; Vandersall-Nairn AS, 1998, GLYCOBIOLOGY, V8, P1183, DOI 10.1093/glycob/8.12.1183; Varki A, 2015, GLYCOBIOLOGY, V25, P1323, DOI 10.1093/glycob/cwv091; Vester-Christensen MB, 2013, P NATL ACAD SCI USA, V110, P21018, DOI 10.1073/pnas.1313446110; Voglmeir J, 2011, BIOCHEM J, V436, P447, DOI 10.1042/BJ20101059; Wells L, 2013, J BIOL CHEM, V288, P6930, DOI 10.1074/jbc.R112.438978; Yagi H, 2013, SCI REP-UK, V3, DOI 10.1038/srep03288; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157; Yoshida-Moriguchi T, 2015, GLYCOBIOLOGY, V25, P702, DOI 10.1093/glycob/cwv021; Yoshida-Moriguchi T, 2013, SCIENCE, V341, P896, DOI 10.1126/science.1239951; Yoshida-Moriguchi T, 2010, SCIENCE, V327, P88, DOI 10.1126/science.1180512	38	20	20	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2101	2109		10.1074/jbc.M116.764712	http://dx.doi.org/10.1074/jbc.M116.764712			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	27932460	Green Published, hybrid			2022-12-26	WOS:000395530300005
J	Battram, AM; Durrant, TN; Agbani, EO; Heesom, KJ; Paul, DS; Piatt, R; Poole, AW; Cullen, PJ; Bergmeier, W; Moore, SF; Hers, I				Battram, Anthony M.; Durrant, Tom N.; Agbani, Ejaife O.; Heesom, Kate J.; Paul, David S.; Piatt, Raymond; Poole, Alastair W.; Cullen, Peter J.; Bergmeier, Wolfgang; Moore, Samantha F.; Hers, Ingeborg			The Phosphatidylinositol 3,4,5-trisphosphate (PI(3,4,5)P-3) Binder Rasa3 Regulates Phosphoinositide 3-kinase (PI3K)-dependent Integrin alpha(II)b beta(3) Outside-in Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; integrin; phosphatidylinositide 3-kinase (PI3K); platelet; Ras-related protein 1 (Rap1); GAP1IP4BP; Rasa3	VON-WILLEBRAND-FACTOR; PROTEIN-KINASE-C; HUMAN PLATELETS; THROMBUS FORMATION; GAP1 FAMILY; ACTIVATION; PHOSPHORYLATION; RAP1B; GAP1(IP4BP); FIBRINOGEN	The class I PI3K family of lipid kinases plays an important role in integrin (IIb3) function, thereby supporting thrombus growth and consolidation. Here, we identify Ras/Rap1GAP Rasa3 (GAP1(IP4BP)) as a major phosphatidylinositol 3,4,5-trisphosphate-binding protein in human platelets and a key regulator of integrin (IIb3) outside-in signaling. We demonstrate that cytosolic Rasa3 translocates to the plasma membrane in a PI3K-dependent manner upon activation of human platelets. Expression of wild-type Rasa3 in integrin (IIb3)-expressing CHO cells blocked Rap1 activity and integrin (IIb3)-mediated spreading on fibrinogen. In contrast, Rap1GAP-deficient (P489V) and Ras/Rap1GAP-deficient (R371Q) Rasa3 had no effect. We furthermore show that two Rasa3 mutants (H794L and G125V), which are expressed in different mouse models of thrombocytopenia, lack both Ras and Rap1GAP activity and do not affect integrin (IIb3)-mediated spreading of CHO cells on fibrinogen. Platelets from thrombocytopenic mice expressing GAP-deficient Rasa3 (H794L) show increased spreading on fibrinogen, which in contrast to wild-type platelets is insensitive to PI3K inhibitors. Together, these results support an important role for Rasa3 in PI3K-dependent integrin (IIb3)-mediated outside-in signaling and cell spreading.	[Battram, Anthony M.; Durrant, Tom N.; Agbani, Ejaife O.; Poole, Alastair W.; Moore, Samantha F.; Hers, Ingeborg] Univ Bristol, Sch Physiol Pharmacol & Neurosci, Biomed Sci Bldg, Bristol BS8 1TD, Avon, England; [Heesom, Kate J.; Cullen, Peter J.] Univ Bristol, Sch Biochem, Bristol BS8 1TD, Avon, England; [Paul, David S.; Piatt, Raymond; Bergmeier, Wolfgang] Univ North Carolina Chapel Hill, McAllister Heart Inst, Chapel Hill, NC 27514 USA; [Bergmeier, Wolfgang] Univ North Carolina Chapel Hill, Dept Biochem & Biophys, Chapel Hill, NC 27514 USA	University of Bristol; University of Bristol; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Hers, I (corresponding author), Univ Bristol, Sch Physiol Pharmacol & Neurosci, Biomed Sci Bldg, Bristol BS8 1TD, Avon, England.	i.hers@bristol.ac.uk	Hers, Ingeborg/ABG-3357-2020; Battram, Anthony/AAC-8243-2020; Agbani, Ejaife O./AAC-9418-2020	Battram, Anthony/0000-0002-9179-0639; Moore, Samantha/0000-0003-0944-7055; Cullen, Peter/0000-0002-9070-8349; Durrant, Tom N/0000-0002-0503-9364; Hers, Ingeborg/0000-0002-6467-5715; Poole, Alastair/0000-0002-0868-297X	British Heart Foundation [FS/12/22/29510, PG/12/79/29884, PG/13/11/30016, PG/14/3/30565]; National Institutes of Health [R01 HL121650]; British Heart Foundation [PG/16/3/31833, PG/16/21/32083] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL121650] Funding Source: NIH RePORTER	British Heart Foundation(British Heart Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); British Heart Foundation(British Heart Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by British Heart Foundation Grants FS/12/22/29510, PG/12/79/29884, PG/13/11/30016, and PG/14/3/30565 and National Institutes of Health Grant R01 HL121650. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bertoni A, 2002, J BIOL CHEM, V277, P25715, DOI 10.1074/jbc.M202791200; Blair TA, 2014, ARTERIOSCL THROM VAS, V34, P1681, DOI 10.1161/ATVBAHA.114.303954; Blanc L, 2012, P NATL ACAD SCI USA, V109, P12099, DOI 10.1073/pnas.1204948109; Burkhart JM, 2012, BLOOD, V120, pE73, DOI 10.1182/blood-2012-04-416594; Canault M, 2014, J EXP MED, V211, P1346, DOI 10.1084/jem.20130477; Canobbio I, 2009, BLOOD, V114, P2193, DOI 10.1182/blood-2009-03-208074; Chrzanowska-Wodnicka M, 2005, J CLIN INVEST, V115, P680, DOI 10.1172/JCI200522973; Consonni A, 2012, BLOOD, V119, P847, DOI 10.1182/blood-2011-07-364992; Cozier GE, 2000, J BIOL CHEM, V275, P28261; Crittenden JR, 2004, NAT MED, V10, P982, DOI 10.1038/nm1098; CULLEN PJ, 1995, BIOCHEM J, V305, P139, DOI 10.1042/bj3050139; CULLEN PJ, 1995, NATURE, V376, P527, DOI 10.1038/376527a0; Gilio K, 2009, J BIOL CHEM, V284, P33750, DOI 10.1074/jbc.M109.048439; Goggs R, 2013, J BIOL CHEM, V288, P34217, DOI 10.1074/jbc.M113.504100; Goncalves I, 2003, J BIOL CHEM, V278, P34812, DOI 10.1074/jbc.M306504200; Guidetti Gianni Francesco, 2012, J Signal Transduct, V2012, P412089, DOI 10.1155/2012/412089; HAIMOVICH B, 1993, J BIOL CHEM, V268, P15868; Hammond GRV, 2009, J CELL BIOL, V184, P297, DOI 10.1083/jcb.200809073; Heraud JM, 1998, J BIOL CHEM, V273, P17817, DOI 10.1074/jbc.273.28.17817; Hughes PE, 1997, CELL, V88, P521, DOI 10.1016/S0092-8674(00)81892-9; Hunter RW, 2009, J BIOL CHEM, V284, P12339, DOI 10.1074/jbc.M807536200; Iwashita S, 2007, J BIOL CHEM, V282, P3413, DOI 10.1074/jbc.C600293200; Jackson SP, 2005, NAT MED, V11, P507, DOI 10.1038/nm1232; JACKSON SP, 1994, J BIOL CHEM, V269, P27093; Ji P, 1999, BBA-MOL CELL RES, V1448, P543, DOI 10.1016/S0167-4889(98)00160-8; Jirouskova M, 2007, BLOOD, V109, P5260, DOI 10.1182/blood-2006-10-054015; KUCERA GL, 1990, J BIOL CHEM, V265, P5345; Kupzig S, 2006, J BIOL CHEM, V281, P9891, DOI 10.1074/jbc.M512802200; Kupzig S, 2009, MOL CELL BIOL, V29, P3929, DOI 10.1128/MCB.00427-09; Laurent Pierre-Alexandre, 2014, Advances in Biological Regulation, V54, P162, DOI 10.1016/j.jbior.2013.09.006; Lockyer PJ, 1997, CURR BIOL, V7, P1007, DOI 10.1016/S0960-9822(06)00423-4; Lova P, 2002, J BIOL CHEM, V277, P12009, DOI 10.1074/jbc.M111803200; Martin V, 2010, BLOOD, V115, P2008, DOI 10.1182/blood-2009-04-217224; Molina-Ortiz P, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004420; Moore SF, 2013, BLOOD, V121, P1209, DOI 10.1182/blood-2012-05-431288; Rowley JW, 2011, BLOOD, V118, pE101, DOI 10.1182/blood-2011-03-339705; SAVAGE B, 1992, J BIOL CHEM, V267, P11300; Shock DD, 1997, BIOCHEM J, V321, P525, DOI 10.1042/bj3210525; Stefanini L, 2015, J CLIN INVEST, V125, P1419, DOI 10.1172/JCI77993; Stefanini L, 2012, ARTERIOSCL THROM VAS, V32, P434, DOI 10.1161/ATVBAHA.111.239194; Tulasne D, 2002, EUR J BIOCHEM, V269, P1511, DOI 10.1046/j.1432-1033.2002.02798.x; Watanabe N, 2008, J CELL BIOL, V181, P1211, DOI 10.1083/jcb.200803094; Williams CM, 2014, PLATELETS, V25, P62, DOI 10.3109/09537104.2012.761686; Wolthuis RMF, 1998, MOL CELL BIOL, V18, P2486, DOI 10.1128/MCB.18.5.2486; Yi WX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102394; Zhang GY, 2011, J BIOL CHEM, V286, P39466, DOI 10.1074/jbc.M111.239608	46	29	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1691	1704		10.1074/jbc.M116.746867	http://dx.doi.org/10.1074/jbc.M116.746867			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	27903653	Green Published, hybrid			2022-12-26	WOS:000395515600013
J	Talens-Perales, D; Gorska, A; Huson, DH; Polaina, J; Marin-Navarro, J				Talens-Perales, David; Gorska, Anna; Huson, Daniel H.; Polaina, Julio; Marin-Navarro, Julia			Analysis of Domain Architecture and Phylogenetics of Family 2 Glycoside Hydrolases (GH2)	PLOS ONE			English	Article							GALACTOSIDASE ESCHERICHIA-COLI; BETA-GALACTOSIDASE; ACTIVE-SITE; CRYSTAL-STRUCTURE; OLIGOSACCHARIDES; LACTOSE; BINDING; SPECIFICITY; GENERATION; EFFICIENCY	In this work we report a detailed analysis of the topology and phylogenetics of family 2 glycoside hydrolases (GH2). We distinguish five topologies or domain architectures based on the presence and distribution of protein domains defined in Pfam and Interpro databases. All of them share a central TIM barrel (catalytic module) with two beta-sandwich domains (non-catalytic) at the N-terminal end, but differ in the occurrence and nature of additional non-catalytic modules at the C-terminal region. Phylogenetic analysis was based on the sequence of the Pfam Glyco_hydro_2_C catalytic module present in most GH2 proteins. Our results led us to propose a model in which evolutionary diversity of GH2 enzymes is driven by the addition of different non-catalytic domains at the C-terminal region. This model accounts for the divergence of beta-galactosidases from beta-glucuronidases, the diversification of beta-galactosidases with different transglycosylation specificities, and the emergence of bicistronic beta-galactosidases. This study also allows the identification of groups of functionally uncharacterized protein sequences with potential biotechnological interest.	[Talens-Perales, David; Polaina, Julio; Marin-Navarro, Julia] CSIC, Inst Agroquim & Tecnol Alimentos, Valencia, Spain; [Gorska, Anna; Huson, Daniel H.] Univ Tubingen, Ctr Bioinformat, Tubingen, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA); Eberhard Karls University of Tubingen	Marin-Navarro, J (corresponding author), CSIC, Inst Agroquim & Tecnol Alimentos, Valencia, Spain.	jumana@iata.csic.es	Polaina, Julio/H-4498-2012; Talens-Perales, David/E-8558-2017; Talens-Perales, David/AAE-9116-2020; Huson, Daniel H./AAC-5494-2019; Marin-Navarro, Julia/F-7630-2016	Talens-Perales, David/0000-0002-8693-4239; Marin-Navarro, Julia/0000-0001-7893-3423; Polaina, Julio/0000-0001-9912-0640	European Union [H2020 - 634486 - INMARE]; Spain 'Secretaria de Estado de Investigacion, Desarrollo e Innovacion' [BIO2013-48779-C4-3-R]; Ministerio de Economia y Competitividad	European Union(European Commission); Spain 'Secretaria de Estado de Investigacion, Desarrollo e Innovacion'; Ministerio de Economia y Competitividad(Spanish Government)	This work was supported by a grant from the European Union, H2020 - 634486 - INMARE (JP) (https://ec.europa.eu/programmes/horizon2020/); and a grant from Spain 'Secretaria de Estado de Investigacion, Desarrollo e Innovacion' BIO2013-48779-C4-3-R (JP) (http://www.mineco.gob.es/portal/site/mineco/idi). DT-P was supported by a FPU predoctoral fellowship from 'Ministerio de Economia y Competitividad'.	Adam AC, 2004, CRIT REV FOOD SCI, V44, P553, DOI 10.1080/10408690490931411; Bae T, 2003, J BACTERIOL, V185, P2910, DOI 10.1128/JB.185.9.2910-2919.2003; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Baumgartner S, 1998, PROTEIN SCI, V7, P1626, DOI 10.1002/pro.5560070717; Cheng W, 2012, J BIOL CHEM, V287, P22910, DOI 10.1074/jbc.M112.367128; Crittenden RG, 1996, TRENDS FOOD SCI TECH, V7, P353, DOI 10.1016/S0924-2244(96)10038-8; DeDent A, 2008, EMBO J, V27, P2656, DOI 10.1038/emboj.2008.185; GEBLER JC, 1992, J BIOL CHEM, V267, P11126; Huber RE, 2003, BIOCHEMISTRY-US, V42, P1796, DOI 10.1021/bi0270642; Huber RE, 2001, BIOCHEM CELL BIOL, V79, P183, DOI 10.1139/o00-101; Hung MN, 2001, APPL ENVIRON MICROB, V67, P4256, DOI 10.1128/AEM.67.9.4256-4263.2001; Husain Q, 2010, CRIT REV BIOTECHNOL, V30, P41, DOI 10.3109/07388550903330497; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Ishikawa K, 2015, FEBS J, V282, P2540, DOI 10.1111/febs.13298; JACOBSON RH, 1994, NATURE, V369, P761, DOI 10.1038/369761a0; Jain S, 1996, NAT STRUCT BIOL, V3, P375, DOI 10.1038/nsb0496-375; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jorgensen F, 2001, APPL MICROBIOL BIOT, V57, P647, DOI 10.1007/s00253-001-0845-z; Juers DH, 2001, BIOCHEMISTRY-US, V40, P14781, DOI 10.1021/bi011727i; Juers DH, 1999, PROTEIN SCI, V8, P122; Juers DH, 2012, PROTEIN SCI, V21, P1792, DOI 10.1002/pro.2165; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Marin-Navarro J, 2014, WORLD J MICROB BIOT, V30, P989, DOI 10.1007/s11274-013-1517-8; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; Pereira-Rodriguez A, 2012, J STRUCT BIOL, V177, P392, DOI 10.1016/j.jsb.2011.11.031; Petzelbauer I, 2000, EUR J BIOCHEM, V267, P5055, DOI 10.1046/j.1432-1327.2000.01562.x; Rigden DJ, 2005, FEBS LETT, V579, P5466, DOI 10.1016/j.febslet.2005.09.011; Rodriguez-Colinas B, 2011, J AGR FOOD CHEM, V59, P10477, DOI 10.1021/jf2022012; Roth NJ, 1996, J BIOL CHEM, V271, P14296, DOI 10.1074/jbc.271.24.14296; RUTENBER E, 1987, NATURE, V326, P624, DOI 10.1038/326624a0; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Singh AK, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004364; Skalova T, 2005, J MOL BIOL, V353, P282, DOI 10.1016/j.jmb.2005.08.028; Song JY, 2011, BIOSCI BIOTECH BIOCH, V75, P1194, DOI 10.1271/bbb.110014; Splechtna B, 2006, J AGR FOOD CHEM, V54, P4999, DOI 10.1021/jf053127m; Talens-Perales D, 2016, J AGR FOOD CHEM, V64, P2917, DOI 10.1021/acs.jafc.6b00222; Tamura K., 2013, MOL BIOL EVOL, P197; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Torres DPM, 2010, COMPR REV FOOD SCI F, V9, P438, DOI 10.1111/j.1541-4337.2010.00119.x; Wallace BD, 2015, CHEM BIOL, V22, P1238, DOI 10.1016/j.chembiol.2015.08.005; Wallace BD, 2010, SCIENCE, V330, P831, DOI 10.1126/science.1191175; Warmerdam A, 2013, APPL BIOCHEM BIOTECH, V170, P340, DOI 10.1007/s12010-013-0181-7; Wheatley RW, 2012, ARCH BIOCHEM BIOPHYS, V521, P51, DOI 10.1016/j.abb.2012.03.014; Xu J, 2004, BIOCHEM CELL BIOL, V82, P275, DOI 10.1139/o04-004; YANAHIRA S, 1995, BIOSCI BIOTECH BIOCH, V59, P1021, DOI 10.1271/bbb.59.1021	47	19	19	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0168035	10.1371/journal.pone.0168035	http://dx.doi.org/10.1371/journal.pone.0168035			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930742	Green Submitted, Green Published, gold			2022-12-26	WOS:000389580900073
J	Zhang, CM; Liu, JJ; Jin, N; Zhang, GM; Xi, YH; Liu, HL				Zhang, Chunmei; Liu, Jingjing; Jin, Na; Zhang, Guiming; Xi, Yahui; Liu, Hongling			SiRNA Targeting mTOR Effectively Prevents the Proliferation and Migration of Human Lens Epithelial Cells	PLOS ONE			English	Article							PHOSPHOINOSITIDE 3-KINASE; MESENCHYMAL TRANSITION; CANCER; GROWTH; SURVIVAL; PATHWAY; AKT; RAPAMYCIN; BETA; PHOSPHORYLATION	Posterior capsule opacification (PCO) is the most common complication that causes visual decrease after extracapsular cataract surgery. The primary cause of PCO formation is the proliferation of the residual lens epithelial cells (LECs). The mammalian target of rapamycin (mTOR) plays an important role in the growth and migration of LECs. In the current study, we used small interfering RNA (siRNA) to specifically attenuate mTOR in human lens epithelial B3 cells (HLE B3). We aimed to examine the effect of mTOR-siRNA on the proliferation, migration and epithelial-to-mesenchymal transition (EMT) of HLE B3 cells and explore the underlying mechanisms. The mTOR-siRNA was transfected into HLE B3 cells using lipofectamine 2000. The mRNA and protein levels of mTOR were examined to confirm the efficiency of mTOR-siRNA. The levels of mRNA and protein as well as the activity of mTOR down-stream effectors p70 ribosomal protein S6 kinase (p70S6K) and protein kinase B (PKB, AKT) were examined using real-time PCR or Western blot, respectively. The cell proliferation was determined using cell counting kit (CCK) 8 and cell growth curve assay. The cell migration was examined using Transwell system and Scratch assay. MTOR-siRNA effectively eliminated mTOR mRNA and protein. The proliferation and migration were significantly suppressed by mTOR-siRNA transfection. mTOR-siRNA reduced the mRNA of p70S6K and AKT in a time-dependent manner. Furthermore, the phosphorylation of p70S6K and AKT was decreased by mTOR-siRNA. MTOR-siRNA also eliminated the formation of mTORC1 and mTORC2 protein complex and blocked the transforming growth factor (TGF)-beta-induced EMT. Our results suggested that mTOR-siRNA could effectively inhibit the proliferation, migration and EMT of HLE B3 cells through the inhibition of p70S6K and AKT. These results indicated that mTOR-siRNA might be an effective agent inhibiting HLE cells growth and EMT following cataract surgery and provide an alternative therapy for preventing PCO.	[Zhang, Chunmei; Liu, Jingjing; Jin, Na; Xi, Yahui; Liu, Hongling] Harbin Med Univ, Dept Ophthalmol, Affiliated Hosp 1, Harbin, Peoples R China; [Zhang, Guiming] 2 Hosp Xiamen, Dept Ophthalmol, Xiamen, Fujian, Peoples R China	Harbin Medical University	Liu, HL (corresponding author), Harbin Med Univ, Dept Ophthalmol, Affiliated Hosp 1, Harbin, Peoples R China.	hydliuhl@163.com			National Natural Science Foundation (NSFC) [81301325]	National Natural Science Foundation (NSFC)(National Natural Science Foundation of China (NSFC))	This study was supported by a grant from the National Natural Science Foundation (NSFC: 81301325) to HL.	Bjornsti MA, 2004, NAT REV CANCER, V4, P335, DOI 10.1038/nrc1362; Boonanuntanasarn S, 2004, PIGM CELL RES, V17, P413, DOI 10.1111/j.1600-0749.2004.00166.x; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Carayol N, 2010, P NATL ACAD SCI USA, V107, P12469, DOI 10.1073/pnas.1005114107; Cho HJ, 2007, BIOCHEM BIOPH RES CO, V353, P337, DOI 10.1016/j.bbrc.2006.12.035; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Easton JB, 2006, ONCOGENE, V25, P6436, DOI 10.1038/sj.onc.1209886; Gotoh N, 2007, INVEST OPTHAMOL VIS, V48, P4079; Grewe M, 1999, CANCER RES, V59, P3581; Higashi Y, 2000, J NEUROCHEM, V75, P1771, DOI 10.1046/j.1471-4159.2000.0751771.x; Hou GQ, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/845763; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Jacinto E, 2003, NAT REV MOL CELL BIO, V4, P117, DOI 10.1038/nrm1018; Kim AH, 2001, MOL CELL BIOL, V21, P893, DOI 10.1128/MCB.21.3.893-901.2001; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Lamouille S, 2012, J CELL SCI, V125, P1259, DOI 10.1242/jcs.095299; Lawrence Jr JC, 2003, SCI STKE, V212, P1; Liu HL, 2010, MOL VIS, V16, P1646; Marques M, 2009, P NATL ACAD SCI USA, V106, P7525, DOI 10.1073/pnas.0812000106; Matsubara H, 2012, INT J CLIN EXP PATHO, V5, P119; Meng QL, 2013, GRAEF ARCH CLIN EXP, V251, P2363, DOI 10.1007/s00417-013-2435-z; Moore SM, 1998, CANCER RES, V58, P5239; Noh WC, 2011, BREAST CANC RES TREA, V110, P477; Plasterk RHA, 2002, SCIENCE, V296, P1263, DOI 10.1126/science.1072148; Saika S, 2002, BRIT J OPHTHALMOL, V86, P1428, DOI 10.1136/bjo.86.12.1428; Saika S, 2001, EXP EYE RES, V72, P679, DOI 10.1006/exer.2001.1002; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Tato I, 2011, J BIOL CHEM, V286, P6128, DOI 10.1074/jbc.M110.166991; Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369; Zhang YJ, 2009, ANN SURG ONCOL, V16, P2617, DOI 10.1245/s10434-009-0555-9; Zhang Zhi-yong, 2011, Zhonghua Yi Xue Za Zhi, V91, P2899; Zhou Y, 2007, BRIT J CANCER, V97, P218, DOI 10.1038/sj.bjc.6603838	32	10	11	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0167349	10.1371/journal.pone.0167349	http://dx.doi.org/10.1371/journal.pone.0167349			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3TF	27911920	Green Published, Green Submitted, gold			2022-12-26	WOS:000389520600031
J	Brazdova, M; Tichy, V; Helma, R; Bazantova, P; Polaskova, A; Krejci, A; Petr, M; Navratilova, L; Ticha, O; Nejedly, K; Bennink, ML; Subramaniam, V; Babkova, Z; Martinek, T; Lexa, M; Adamik, M				Brazdova, Marie; Tichy, Vlastimil; Helma, Robert; Bazantova, Pavla; Polaskova, Alena; Krejci, Aneta; Petr, Marek; Navratilova, Lucie; Ticha, Olga; Nejedly, Karel; Bennink, Martin L.; Subramaniam, Vinod; Babkova, Zuzana; Martinek, Tomas; Lexa, Matej; Adamik, Matej			p53 Specifically Binds Triplex DNA In Vitro and in Cells	PLOS ONE			English	Article							C-TERMINAL DOMAIN; SUPPRESSOR PROTEIN P53; HIGH-AFFINITY; GENE-EXPRESSION; MUTANT P53; H-DNA; SEQUENCE; IDENTIFICATION; MODULATION; REQUIRES	Triplex DNA is implicated in a wide range of biological activities, including regulation of gene expression and genomic instability leading to cancer. The tumor suppressor p53 is a central regulator of cell fate in response to different type of insults. Sequence and structure specific modes of DNA recognition are core attributes of the p53 protein. The focus of this work is the structure-specific binding of p53 to DNA containing triplex-forming sequences in vitro and in cells and the effect on p53-driven transcription. This is the first DNA binding study of full-length p53 and its deletion variants to both intermolecular and intramolecular T.A.T triplexes. We demonstrate that the interaction of p53 with intermolecular T.A.T triplex is comparable to the recognition of CTG-hairpin non-B DNA structure. Using deletion mutants we determined the C-terminal DNA binding domain of p53 to be crucial for triplex recognition. Furthermore, strong p53 recognition of intramolecular T.A.T triplexes (H-DNA), stabilized by negative superhelicity in plasmid DNA, was detected by competition and immunoprecipitation experiments, and visualized by AFM. Moreover, chromatin immunoprecipitation revealed p53 binding T.A.T forming sequence in vivo. Enhanced reporter transactivation by p53 on insertion of triplex forming sequence into plasmid with p53 consensus sequence was observed by luciferase reporter assays. In-silico scan of human regulatory regions for the simultaneous presence of both consensus sequence and T.A.T motifs identified a set of candidate p53 target genes and p53-dependent activation of several of them (ABCG5, ENOX1, INSR, MCC, NFAT5) was confirmed by RT-qPCR. Our results show that T.A.T triplex comprises a new class of p53 binding sites targeted by p53 in a DNA structure-dependent mode in vitro and in cells. The contribution of p53 DNA structure-dependent binding to the regulation of transcription is discussed.	[Brazdova, Marie; Tichy, Vlastimil; Helma, Robert; Bazantova, Pavla; Polaskova, Alena; Petr, Marek; Navratilova, Lucie; Ticha, Olga; Nejedly, Karel; Adamik, Matej] Acad Sci Czech Republ, Inst Biophys, Dept Biophys Chem & Mol Oncol, Vvi, Brno, Czech Republic; [Krejci, Aneta; Babkova, Zuzana] Univ Vet & Pharmaceut Sci Brno, Dept Mol Biol & Pharmaceut Biotechnol, Fac Pharm, Brno, Czech Republic; [Bennink, Martin L.; Subramaniam, Vinod] Univ Twente, Fac Sci & Technol, Biophys Engn Grp, Enschede, Netherlands; [Martinek, Tomas] Brno Univ Technol, Fac Informat Technol, Dept Comp Syst, Brno, Czech Republic; [Lexa, Matej] Masaryk Univ, Fac Informat, Dept Informat Technol, Brno, Czech Republic	Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; University of Veterinary Sciences Brno; University of Twente; Brno University of Technology; Masaryk University Brno	Brazdova, M (corresponding author), Acad Sci Czech Republ, Inst Biophys, Dept Biophys Chem & Mol Oncol, Vvi, Brno, Czech Republic.	maruska@ibp.cz	Subramaniam, Vinod/B-4197-2010; Lexa, Matej/S-7256-2019; Brazdova, Marie/H-1924-2014; Lexa, Matej/A-1772-2011; Tichy, Vlastimil/H-1913-2014; Bazantova, Pavla/J-2102-2017	Subramaniam, Vinod/0000-0001-6712-7266; Lexa, Matej/0000-0002-4213-5259; Adamik, Matej/0000-0003-0683-5853; Bazantova, Pavla/0000-0002-4221-1370; Soldanova, Zuzana/0000-0002-7757-776X	Czech Science Foundation [13-36108S, 204/06/P369, 15-02891S]; University of Veterinary and Pharmaceutical Sciences Brno [IGAVFU Brno 316/2016/FaF]; IT4Innovations excellence in science project [IT41 XS - LQ1602]; Czech Academy of Sciences [RV068081707]	Czech Science Foundation(Grant Agency of the Czech Republic); University of Veterinary and Pharmaceutical Sciences Brno; IT4Innovations excellence in science project; Czech Academy of Sciences(Czech Academy of Sciences)	This work was supported by the Czech Science Foundation (13-36108S and 204/06/P369 to MB, 15-02891S to ML), University of Veterinary and Pharmaceutical Sciences Brno (IGAVFU Brno 316/2016/FaF to AK), IT4Innovations excellence in science project (IT41 XS - LQ1602 to TM) and by the Czech Academy of Sciences (RV068081707 to VT, MB, RH, PB, AP, MP, LN, MA).	Adamik M, 2016, BIOCHIMIE; Allen MA, 2014, ELIFE, V3, DOI 10.7554/eLife.02200; Bacolla A, 2006, NUCLEIC ACIDS RES, V34, P2663, DOI 10.1093/nar/gkl354; Bacolla A, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005696; BAKALKIN G, 1995, NUCLEIC ACIDS RES, V23, P362, DOI 10.1093/nar/23.3.362; Bisio A, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-552; Brazdova M, 2002, NUCLEIC ACIDS RES, V30, P4966, DOI 10.1093/nar/gkf616; Brazdova M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059567; Brazdova M, 2009, NUCLEIC ACIDS RES, V37, P1486, DOI 10.1093/nar/gkn1085; Broz DK, 2013, GENE DEV, V27, P1016, DOI 10.1101/gad.212282.112; Buske FA, 2013, BIOINFORMATICS, V29, P1895, DOI 10.1093/bioinformatics/btt315; Buske FA, 2011, RNA BIOL, V8, P427, DOI 10.4161/rna.8.3.14999; Buzek J, 1999, J BIOMOL STRUCT DYN, V17, P41; Castel AL, 2010, NAT REV MOL CELL BIO, V11, P165, DOI 10.1038/nrm2854; Cer RZ, 2011, NUCLEIC ACIDS RES, V39, pD383, DOI 10.1093/nar/gkq1170; Cherny DI, 2005, BIOPHYS CHEM, V114, P261, DOI 10.1016/j.bpc.2004.12.042; Cobb AM, 2013, ANAL BIOCHEM, V442, P51, DOI 10.1016/j.ab.2013.07.033; Collavin L, 2010, CELL DEATH DIFFER, V17, P901, DOI 10.1038/cdd.2010.35; Dudenhoffer C, 1999, ONCOGENE, V18, P5773, DOI 10.1038/sj.onc.1202964; Dudenhoffer C, 1998, MOL CELL BIOL, V18, P5332, DOI 10.1128/MCB.18.9.5332; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; FELSENFELD G, 1957, BIOCHIM BIOPHYS ACTA, V26, P457, DOI 10.1016/0006-3002(57)90091-4; Fojta M, 2003, BIOCHEM PHARMACOL, V65, P1305, DOI 10.1016/S0006-2952(03)00078-9; Fonseca NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107026; FOX KR, 1990, NUCLEIC ACIDS RES, V18, P5387, DOI 10.1093/nar/18.18.5387; FRANKKAMENETSKII MD, 1995, ANNU REV BIOCHEM, V64, P65, DOI 10.1146/annurev.bi.64.070195.000433; Friedler A, 2005, STRUCTURE, V13, P629, DOI 10.1016/j.str.2005.01.020; Gohler T, 2002, J BIOL CHEM, V277, P41192, DOI 10.1074/jbc.M202344200; Goni JR, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-63; Guieysse AL, 1997, J MOL BIOL, V267, P289, DOI 10.1006/jmbi.1997.0884; Hamppa S, 2016, P NATL ACAD SCI USA, V113, pE4311, DOI 10.1073/pnas.1605828113; Janky R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003731; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kauffmann A, 2009, BIOINFORMATICS, V25, P2092, DOI 10.1093/bioinformatics/btp354; Kim E, 2003, BIOCHEM CELL BIOL, V81, P141, DOI 10.1139/o03-046; Kim H, 2012, J MOL BIOL, V415, P843, DOI 10.1016/j.jmb.2011.12.001; KIYAMA R, 1991, P NATL ACAD SCI USA, V88, P10450, DOI 10.1073/pnas.88.23.10450; Kolesnikov N, 2015, NUCLEIC ACIDS RES, V43, pD1113, DOI 10.1093/nar/gku1057; Kracikova M, 2013, CELL DEATH DIFFER, V20, P576, DOI 10.1038/cdd.2012.155; Kudoh T, 2010, EXP CELL RES, V316, P2849, DOI 10.1016/j.yexcr.2010.06.025; Kusic J, 2010, MOL BIOL REP, V37, P2317, DOI 10.1007/s11033-009-9735-8; Lacroix L, 1999, BIOCHEMISTRY-US, V38, P1893, DOI 10.1021/bi982290q; Laptenko O, 2016, TRENDS BIOCHEM SCI, P6808, DOI [10.1128/MCB.22.19.6797-6808.2002, DOI 10.1128/MCB.22.19.6797-6808.2002]; Laptenko O, 2015, MOL CELL, V57, P1034, DOI 10.1016/j.molcel.2015.02.015; LEE S, 1995, CELL, V81, P1013, DOI 10.1016/S0092-8674(05)80006-6; Lexa M, 2014, BIOINFORMATICS 2014: PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON BIOINFORMATICS MODELS, METHODS AND ALGORITHMS, P80; Lexa M, 2011, BIOINFORMATICS, V27, P2510, DOI 10.1093/bioinformatics/btr439; Liu XF, 2016, EMBO REP, V17, P349, DOI 10.15252/embr.201540505; McKinney K, 2004, MOL CELL, V16, P413, DOI 10.1016/j.molcel.2004.09.032; McKinney K, 2002, MOL CELL BIOL, V22, P6797, DOI 10.1128/MCB.22.19.6797-6808.2002; Melo CA, 2013, MOL CELL, V49, P524, DOI 10.1016/j.molcel.2012.11.021; Menendez D, 2013, NUCLEIC ACIDS RES, V41, P7286, DOI 10.1093/nar/gkt504; MIRKIN SM, 1994, ANNU REV BIOPH BIOM, V23, P541, DOI 10.1146/annurev.bb.23.060194.002545; Nejedly K, 2007, BIOPHYS CHEM, V125, P237, DOI 10.1016/j.bpc.2006.08.007; Nikulenkov F, 2012, CELL DEATH DIFFER, V19, P1992, DOI 10.1038/cdd.2012.89; Palecek E, 2004, ONCOGENE, V23, P2119, DOI 10.1038/sj.onc.1207324; PALECEK E, 1991, CRIT REV BIOCHEM MOL, V26, P151, DOI 10.3109/10409239109081126; Palecek E, 1997, ONCOGENE, V15, P2201, DOI 10.1038/sj.onc.1201398; Palecek E, 1999, ONCOGENE, V18, P3617, DOI 10.1038/sj.onc.1202710; PECINKA P, 1995, J BIOMOL STRUCT DYN, V13, P29; Petr M, 2016, BIOSCIENCE REP, V36, DOI 10.1042/BSR20160232; Quante T, 2012, CELL CYCLE, V11, P3290, DOI 10.4161/cc.21646; REED M, 1995, P NATL ACAD SCI USA, V92, P9455, DOI 10.1073/pnas.92.21.9455; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Rohaly G, 2005, CELL, V122, P21, DOI 10.1016/j.cell.2005.04.032; Sanchez Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6812; Sauer M, 2008, NUCLEIC ACIDS RES, V36, P1900, DOI 10.1093/nar/gkn044; SCHROTH GP, 1995, NUCLEIC ACIDS RES, V23, P1977, DOI 10.1093/nar/23.11.1977; Sebest P, 2015, INT J MOL SCI, V16, P3163, DOI 10.3390/ijms16023163; Stros M, 2004, BIOCHEMISTRY-US, V43, P7215, DOI 10.1021/bi049928k; Subramanian D, 2005, BIOCHEMISTRY-US, V44, P2536, DOI 10.1021/bi048700u; Szak ST, 1999, J BIOL CHEM, V274, P3904, DOI 10.1074/jbc.274.6.3904; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tebaldi T, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1643-9; Tiwari MK, 2016, NUCLEIC ACIDS RES, V44, P7742, DOI 10.1093/nar/gkw515; Tutton S, 2016, EMBO J, V35, P193, DOI 10.15252/embj.201490880; van Noort SJT, 1998, BIOPHYS J, V74, P2840, DOI 10.1016/S0006-3495(98)77991-3; Vasquez KM, 2002, Q REV BIOPHYS, V35, P89, DOI 10.1017/S0033583502003773; VOGELSTEIN B, 1992, CELL, V70, P523, DOI 10.1016/0092-8674(92)90421-8; Walter K, 2005, J BIOL CHEM, V280, P42497, DOI 10.1074/jbc.M507038200; Wang B, 2014, CELL DEATH DIFFER, V21, P521, DOI 10.1038/cdd.2013.132; Wang GL, 2009, MOL CARCINOGEN, V48, P286, DOI 10.1002/mc.20508; Wang GL, 2008, JNCI-J NATL CANCER I, V100, P1815, DOI 10.1093/jnci/djn385; Younger ST, 2015, NUCLEIC ACIDS RES, V43, P4447, DOI 10.1093/nar/gkv284; Zhao JH, 2010, CELL MOL LIFE SCI, V67, P43, DOI 10.1007/s00018-009-0131-2; Zotchev SB, 2000, NUCLEIC ACIDS RES, V28, P4005, DOI 10.1093/nar/28.20.4005	86	13	13	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167439	10.1371/journal.pone.0167439	http://dx.doi.org/10.1371/journal.pone.0167439			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907175	gold, Green Published, Green Submitted			2022-12-26	WOS:000389482700156
J	Konagaya, Y; Miyakawa, R; Sato, M; Matsugami, A; Watanabe, S; Hayashi, F; Kigawa, T; Nishimura, C				Konagaya, Yuta; Miyakawa, Rina; Sato, Masumi; Matsugami, Akimasa; Watanabe, Satoru; Hayashi, Fumiaki; Kigawa, Takanori; Nishimura, Chiaki			Effect of Glu12-His89 Interaction on Dynamic Structures in HIV-1 p17 Matrix Protein Elucidated by NMR	PLOS ONE			English	Article							AMIDE PROTON-EXCHANGE; TRIPLE-RESONANCE NMR; ROTATIONAL DIFFUSION; PLASMA-MEMBRANE; SALT BRIDGES; BACKBONE DYNAMICS; GAG POLYPROTEIN; BINDING DOMAIN; TYPE-1; RELAXATION	To test the existence of the salt bridge and stability of the HIV-1 p17 matrix protein, an E12A (mutated at helix 1) was established to abolish possible electrostatic interactions. The chemical shift perturbation from the comparison between wild type and E12A suggested the existence of an electrostatic interaction in wild type between El 2 and H89 (located in helix 4). Unexpectedly, the studies using urea denaturation indicated that the E12A substitution slightly stabilized the protein. The dynamic structure of E12A was examined under physiological conditions by both amide proton exchange and relaxation studies. The quick exchange method of amide protons revealed that the residues with faster exchange were located at the mutated region, around A12, compared to those of the wild-type protein. In addition, some residues at the region of helix 4, including H89, exhibited faster exchange in the mutant. In contrast, the average values of the kinetic rate constants for amide proton exchange for residues located in all loop regions were slightly lower in E12A than in wild type. Furthermore, the analyses of the order parameter revealed that less flexible structures existed at each loop region in E12A. Interestingly, the structures of the regions including the alphal-2 loop and helix 5 of E12A exhibited more significant conformational exchanges with the NMR time-scale than those of wild type. Under lower pH conditions, for further destabilization, the helix 1 and alpha2-3 loop in E12A became more fluctuating than at physiological pH. Because the El 2A mutant lacks the activities for trimer formation on the basis of the analytical ultra-centrifuge studies on the sedimentation distribution of p17 (Fledderman et al. Biochemistry 49, 9551-9562, 2010), it is possible that the changes in the dynamic structures induced by the absence of the E12-H89 interaction in the p17 matrix protein contributes to a loss of virus assembly.	[Konagaya, Yuta; Miyakawa, Rina; Sato, Masumi; Nishimura, Chiaki] Teikyo Heisei Univ, Fac Pharmaceut Sci, Nakano Ku, Tokyo, Japan; [Matsugami, Akimasa; Hayashi, Fumiaki] RIKEN Ctr Life Sci Technol, Div Struct & Synthet Biol, Yokohama, Kanagawa, Japan; [Watanabe, Satoru; Kigawa, Takanori] RIKEN Quantitat Biol Ctr, Lab Biomol Struct & Dynam, Yokohama, Kanagawa, Japan	RIKEN; RIKEN	Nishimura, C (corresponding author), Teikyo Heisei Univ, Fac Pharmaceut Sci, Nakano Ku, Tokyo, Japan.	cnishimura@thu.ac.jp	Kigawa, Takanori/A-7679-2010; watanabe, satoru s/E-9501-2012	Kigawa, Takanori/0000-0003-0146-9719; watanabe, satoru s/0000-0001-5329-9278	 [23107726];  [16K08204]; Grants-in-Aid for Scientific Research [16K08204] Funding Source: KAKEN	; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid for Scientific Research (23107726) on Innovative Areas (Molecular Science of Fluctuations toward Biological Functions) and for Scientific Research C (16K08204) in Japan.	Alfadhi A, 2009, VIROLOGY, V387, P466, DOI 10.1016/j.virol.2009.02.048; Alfadhli A, 2013, J BIOL CHEM, V288, P666, DOI 10.1074/jbc.M112.399865; Alfadhli A, 2011, J MOL BIOL, V410, P653, DOI 10.1016/j.jmb.2011.04.063; Aoki M, 2009, PROTEIN EXPRES PURIF, V68, P128, DOI 10.1016/j.pep.2009.07.017; Aurora R, 1998, PROTEIN SCI, V7, P21, DOI 10.1002/pro.5560070103; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Bosshard HR, 2004, J MOL RECOGNIT, V17, P1, DOI 10.1002/jmr.657; Cannon PM, 1997, J VIROL, V71, P3474, DOI 10.1128/JVI.71.5.3474-3483.1997; Chukkapalli V, 2011, J MOL BIOL, V410, P512, DOI 10.1016/j.jmb.2011.04.015; De Francesco MA, 2002, P NATL ACAD SCI USA, V99, P9972, DOI 10.1073/pnas.142274699; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dogan J, 2013, SCI REP-UK, V3, DOI 10.1038/srep02076; Dolcetti R, 2015, P NATL ACAD SCI USA, V112, P14331, DOI 10.1073/pnas.1514748112; Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620; Ellenrieder AD, 2004, BIOL CHEM, V385, P303, DOI 10.1515/BC.2004.026; ERICKSONVIITANEN S, 1989, AIDS RES HUM RETROV, V5, P577, DOI 10.1089/aid.1989.5.577; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Fiorentini S, 2006, NEW MICROBIOL, V29, P1; Fiorentini S, 2010, PHARMACOL THERAPEUT, V128, P433, DOI 10.1016/j.pharmthera.2010.08.005; Fledderman EL, 2010, BIOCHEMISTRY-US, V49, P9551, DOI 10.1021/bi101245j; Ghanam RH, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00055; GHEYSEN D, 1989, CELL, V59, P103, DOI 10.1016/0092-8674(89)90873-8; Goh GKM, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-126; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; GRZESIEK S, 1992, J MAGN RESON, V96, P432, DOI 10.1016/0022-2364(92)90099-S; HENDSCH ZS, 1994, PROTEIN SCI, V3, P211; Hill CP, 1996, P NATL ACAD SCI USA, V93, P3099, DOI 10.1073/pnas.93.7.3099; Hwang TL, 1998, J BIOMOL NMR, V11, P221, DOI 10.1023/A:1008276004875; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kay Lewis E, 2011, J Magn Reson, V213, P423, DOI 10.1016/j.jmr.2011.09.004; Kigawa Takanori, 2004, Journal of Structural and Functional Genomics, V5, P63, DOI 10.1023/B:JSFG.0000029204.57846.7d; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Mandel AM, 1996, BIOCHEMISTRY-US, V35, P16009, DOI 10.1021/bi962089k; MASSIAH MA, 1994, J MOL BIOL, V244, P198, DOI 10.1006/jmbi.1994.1719; MATTHEWS S, 1994, NATURE, V370, P666, DOI 10.1038/370666a0; Morikawa Y, 1998, J VIROL, V72, P7659, DOI 10.1128/JVI.72.9.7659-7663.1998; Nayek A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093862; Nishimura C, 2005, P NATL ACAD SCI USA, V102, P4765, DOI 10.1073/pnas.0409538102; Nishimura C, 2003, J MOL BIOL, V334, P293, DOI 10.1016/j.jmb.2003.09.042; Nishimura C, 2010, J MOL BIOL, V396, P1319, DOI 10.1016/j.jmb.2009.12.040; Ohori Y, 2014, BBA-PROTEINS PROTEOM, V1844, P520, DOI 10.1016/j.bbapap.2013.12.010; Ono A, 2000, J VIROL, V74, P2855, DOI 10.1128/JVI.74.6.2855-2866.2000; Osborne MJ, 2001, J BIOMOL NMR, V19, P209, DOI 10.1023/A:1011283809984; Pornillos O, 2011, NATURE, V469, P424, DOI 10.1038/nature09640; Pornillos O, 2009, CELL, V137, P1282, DOI 10.1016/j.cell.2009.04.063; Radding W, 2000, AIDS RES HUM RETROV, V16, P1519, DOI 10.1089/088922200750006047; Saad JS, 2008, J MOL BIOL, V382, P434, DOI 10.1016/j.jmb.2008.07.027; Saad JS, 2007, J MOL BIOL, V366, P574, DOI 10.1016/j.jmb.2006.11.068; Saad JS, 2006, P NATL ACAD SCI USA, V103, P11364, DOI 10.1073/pnas.0602818103; Samal AB, 2011, J BIOL CHEM, V286, P33533, DOI 10.1074/jbc.M111.273623; Schwarzinger S, 2001, J AM CHEM SOC, V123, P2970, DOI 10.1021/ja003760i; STONE MJ, 1993, BIOCHEMISTRY-US, V32, P426, DOI 10.1021/bi00053a007; Tang C, 2002, NAT STRUCT BIOL, V9, P537, DOI 10.1038/nsb806; Taylor JE, 2012, BIOPHYS J, V103, P541, DOI 10.1016/j.bpj.2012.06.042; Tsan P, 2000, J AM CHEM SOC, V122, P5603, DOI 10.1021/ja993654k; Verli H, 2007, J MOL GRAPH MODEL, V26, P62, DOI 10.1016/j.jmgm.2006.09.009; Vlach J, 2014, J BIOL CHEM, V289, P8697, DOI 10.1074/jbc.M113.543694; WALDBURGER CD, 1995, NAT STRUCT BIOL, V2, P122, DOI 10.1038/nsb0295-122; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; Wu ZB, 2004, P NATL ACAD SCI USA, V101, P11587, DOI 10.1073/pnas.0404649101; Yabuki Takashi, 2007, Journal of Structural and Functional Genomics, V8, P173, DOI 10.1007/s10969-007-9038-z	62	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167176	10.1371/journal.pone.0167176	http://dx.doi.org/10.1371/journal.pone.0167176			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907055	Green Submitted, gold, Green Published			2022-12-26	WOS:000389482700087
J	Lee, J; Baek, SH; Ahn, SY; Chin, HJ; Na, KY; Chae, DW; Kim, S				Lee, Jeonghwan; Baek, Seon Ha; Ahn, Shin Young; Chin, Ho Jun; Na, Ki Young; Chae, Dong-Wan; Kim, Sejoong			Pre-Stage Acute Kidney Injury Can Predict Mortality and Medical Costs in Hospitalized Patients	PLOS ONE			English	Article							WORSENING RENAL-FUNCTION; LENGTH-OF-STAY; SERUM CREATININE; MINIMAL CHANGES; DIALYSIS; INCREASES; FAILURE; DISEASE; DEFINITIONS; THERAPY	The significance of minimal increases in serum creatinine below the levels indicative of the acute kidney injury (AKI) stage is not well established. We aimed to investigate the influence of pre-stage AKI (pre-AKI) on clinical outcomes. We enrolled a total of 21,261 patients who were admitted to the Seoul National University Bundang Hospital from January 1, 2013 to December 31, 2013. Pre-AKI was defined as a 25-50% increase in peak serum creatinine levels from baseline levels during the hospital stay. In total, 5.4% of the patients had pre-AKI during admission. The patients with pre-AKI were predominantly female (55.0%) and had a lower body weight and lower baseline levels of serum creatinine (0.63 +/- 0.18 mg/dl) than the patients with AKI and the patients without AKI (P < 0.001). The patients with pre-AKI had a higher prevalence of diabetes mellitus (25.1%) and malignancy (32.6%). The adjusted hazard ratio of in-hospital mortality for pre-AKI was 2.112 [95% confidence interval (CI), 1.143 to 3.903]. In addition, patients with pre-AKI had an increased length of stay (7.7 +/- 9.7 days in patients without AKI, 11.4 +/- 11.4 days in patients with pre-AKI, P < 0.001) and increased medical costs (4,061 +/- 4,318 USD in patients without AKI, 4,966 +/- 5,099 USD in patients with pre-AKI, P < 0.001) during admission. The adjusted hazard ratio of all-cause mortality for pre-AKI during the follow-up period of 2.0 +/- 0.6 years was 1.473 (95% CI, 1.228 to 1.684). Although the adjusted hazard ratio of pre-AKI for overall mortality was not significant among the patients admitted to the surgery department or who underwent surgery, pre-AKI was significantly associated with mortality among the non-surgical patients (adjusted HR 1.542 [95% CI, 1.330 to 1.787]) and the patients admitted to the medical department (adjusted HR 1.384 [95% CI, 1.153 to 1.662]). Pre-AKI is associated with increased mortality, longer hospital stay, and increased medical costs during admission. More attention should be paid to the clinical significance of pre-AKI.	[Lee, Jeonghwan] Hallym Univ, Hangang Sacred Heart Hosp, Dept Internal Med, Seoul, South Korea; [Baek, Seon Ha; Chin, Ho Jun; Na, Ki Young; Chae, Dong-Wan; Kim, Sejoong] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seongnam, South Korea; [Ahn, Shin Young] Korea Univ, Guro Hosp, Med Ctr, Dept Internal Med, Seoul, South Korea	Hallym University; Seoul National University (SNU); Korea University; Korea University Medicine (KU Medicine)	Kim, S (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seongnam, South Korea.	sejoong2@snu.ac.kr	Lee, Jeonghwan/C-5214-2011; Kim, Sejoong/J-5356-2015	Lee, Jeonghwan/0000-0003-3199-635X; Kim, Sejoong/0000-0002-7238-9962	Young Investigator Research Grant from the Korean Society of Nephrology (Kyowa Hakko Kirin) [06-2014-151]; SNUBH Research Fund [02-2014-058]	Young Investigator Research Grant from the Korean Society of Nephrology (Kyowa Hakko Kirin); SNUBH Research Fund	This study was supported by the Young Investigator Research Grant (no 06-2014-151) from the Korean Society of Nephrology (Kyowa Hakko Kirin 2014) and was Supported by grant no 02-2014-058 from the SNUBH Research Fund. The sponsors of this study played no role in its design, or in the collection, analysis, or interpretation of data, or the writing of the report.	Baek SH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156444; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Garner AE, 2012, ANN CLIN BIOCHEM, V49, P59, DOI 10.1258/acb.2011.011125; Gottlieb SS, 2002, J CARD FAIL, V8, P136, DOI 10.1054/jcaf.2002.125289; Jin DC, 2015, KIDNEY RES CLIN PRAC, V34, P132, DOI 10.1016/j.krcp.2015.08.004; Jin DC, 2015, KIDNEY INT SUPPL, V5, P8, DOI 10.1038/kisup.2015.3; Jin DC, 2015, KOREAN J INTERN MED, V30, P17, DOI 10.3904/kjim.2015.30.1.17; Kerr M, 2014, NEPHROL DIAL TRANSPL, V29, P1362, DOI 10.1093/ndt/gfu016; Kork F, 2015, ANESTHESIOLOGY, V123, P1301, DOI 10.1097/ALN.0000000000000891; Lafrance JP, 2010, AM J KIDNEY DIS, V56, P651, DOI 10.1053/j.ajkd.2010.05.011; Lafrance JP, 2010, J AM SOC NEPHROL, V21, P345, DOI 10.1681/ASN.2009060636; Lassnigg A, 2004, J AM SOC NEPHROL, V15, P1597, DOI 10.1097/01.ASN.0000130340.93930.DD; Lee CS, 2010, J KOREAN MED SCI, V25, P1616, DOI 10.3346/jkms.2010.25.11.1616; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Liotta M, 2014, AM J CARDIOL, V113, P70, DOI 10.1016/j.amjcard.2013.09.012; Metra M, 2008, EUR J HEART FAIL, V10, P188, DOI 10.1016/j.ejheart.2008.01.011; Newsome BB, 2008, ARCH INTERN MED, V168, P609, DOI 10.1001/archinte.168.6.609; Siew ED, 2013, CLIN J AM SOC NEPHRO, V8, P10, DOI 10.2215/CJN.00200112; Smith GL, 2003, J CARD FAIL, V9, P13, DOI 10.1054/jcaf.2003.3; Susantitaphong P, 2013, CLIN J AM SOC NEPHRO, V8, P1482, DOI 10.2215/CJN.00710113; Wald R, 2009, JAMA-J AM MED ASSOC, V302, P1179, DOI 10.1001/jama.2009.1322; Weisbord SD, 2006, J AM SOC NEPHROL, V17, P2871, DOI 10.1681/ASN.2006030301; Wu VC, 2011, KIDNEY INT, V80, P1222, DOI 10.1038/ki.2011.259; Xue JL, 2006, J AM SOC NEPHROL, V17, P1135, DOI 10.1681/ASN.2005060668; Zavada J, 2010, NEPHROL DIAL TRANSPL, V25, P3911, DOI 10.1093/ndt/gfp766	27	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167038	10.1371/journal.pone.0167038	http://dx.doi.org/10.1371/journal.pone.0167038			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907046	Green Submitted, Green Published, gold			2022-12-26	WOS:000389482700069
J	Gonzalez, RP; Comba, PC; Esteban, MR; Sanchez, JJA; Afonso, JH; Perez, MDR; Rodriguez, IM; Diaz, BB; Elosua, R; de Leon, AC				Pimienta Gonzalez, Raquel; Couto Comba, Patricia; Rodriguez Esteban, Marcos; Aleman Sanchez, Jose Juan; Hernandez Afonso, Julio; Rodriguez Perez, Maria del Cristo; Marcelino Rodriguez, Itahisa; Brito Diaz, Buenaventura; Elosua, Roberto; Cabrera de Leon, Antonio			Incidence, Mortality and Positive Predictive Value of Type 1 Cardiorenal Syndrome in Acute Coronary Syndrome	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; 11TH CONSENSUS CONFERENCE; MYOCARDIAL-INFARCTION; HEART-FAILURE; RENAL-FUNCTION; OUTCOMES; GUIDELINES; PATHOPHYSIOLOGY; DETERIORATION; PATHOGENESIS	Objectives To determine whether the risk of cardiovascular mortality associated with cardiorenal syndrome subtype 1 (CRS1) in patients who were hospitalized for acute coronary syndrome (ACS) was greater than the expected risk based on the sum of its components, to estimate the predictive value of CRS1, and to determine whether the severity of CRS1 worsens the prognosis. Methods Follow-up study of 1912 incident cases of ACS for 1 year after discharge. Cox regression models were estimated with time to event (in-hospital death, and readmission or death during the first year after discharge) as the dependent variable. Results The incidence of CRS1 was 9.2/1000 person-days of hospitalization (95% CI = 8.1-10.5), but these patients accounted for 56.6% (95% CI = 47.4-65.) of all mortality. The positive predictive value of CRS1 was 29.6% (95% CI = 23.9-36.0) for in-hospital death, and 51.4% (95% CI = 44.8-58.0) for readmission or death after discharge. The risk of in-hospital death from CRS1 (RR = 18.3; 95% CI = 6.3-53.2) was greater than the sum of risks associated with either acute heart failure (RR = 7.6; 95% CI = 1.8-31.8) or acute kidney injury (RR = 2.8; 95% CI = 0.9-8.8). The risk of events associated with CRS1 also increased with syndrome severity, reaching a RR of 10.6 (95% CI = 6.2-18.1) for in-hospital death at the highest severity level. Conclusions The effect of CRS1 on in-hospital mortality is greater than the sum of the effects associated with each of its components, and it increases with the severity of the syndrome. CRS1 accounted for more than half of all mortality, and its positive predictive value approached 30% in-hospital and 50% after discharge.	[Pimienta Gonzalez, Raquel; Couto Comba, Patricia; Rodriguez Esteban, Marcos; Hernandez Afonso, Julio] Hosp Univ Nuestra Senora de la Candelaria, Serv Cardiol, Santa Cruz De Tenerife, Spain; [Aleman Sanchez, Jose Juan; Rodriguez Perez, Maria del Cristo; Marcelino Rodriguez, Itahisa; Brito Diaz, Buenaventura; Cabrera de Leon, Antonio] Unidad Invest Atenc Primaria, Santa Cruz De Tenerife, Spain; [Aleman Sanchez, Jose Juan; Rodriguez Perez, Maria del Cristo; Marcelino Rodriguez, Itahisa; Brito Diaz, Buenaventura; Cabrera de Leon, Antonio] Hosp Univ Nuestra Senora de la Candelaria, Santa Cruz De Tenerife, Spain; [Aleman Sanchez, Jose Juan; Rodriguez Perez, Maria del Cristo; Marcelino Rodriguez, Itahisa; Brito Diaz, Buenaventura; Elosua, Roberto; Cabrera de Leon, Antonio] Inst Salud Carlos III, Red Invest Cardiovasc, Madrid, Spain; [Elosua, Roberto] IMIM, Epidemiol Cardiovasc & Genet, Barcelona, Spain; [Cabrera de Leon, Antonio] Univ La Laguna, Area Med Prevent & Salud Publ, San Cristobal la Laguna, Spain	Instituto de Salud Carlos III; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Universidad de la Laguna	de Leon, AC (corresponding author), Unidad Invest Atenc Primaria, Santa Cruz De Tenerife, Spain.; de Leon, AC (corresponding author), Hosp Univ Nuestra Senora de la Candelaria, Santa Cruz De Tenerife, Spain.; de Leon, AC (corresponding author), Inst Salud Carlos III, Red Invest Cardiovasc, Madrid, Spain.; de Leon, AC (corresponding author), Univ La Laguna, Area Med Prevent & Salud Publ, San Cristobal la Laguna, Spain.	acableo@gobiernodecanarias.org	Marcelino-Rodríguez, Itahisa/AAH-1469-2021; Marcelino-RodrÃguez, Itahisa/AGE-3176-2022; Hernandez Afonso, Julio/I-2223-2017	Marcelino-Rodríguez, Itahisa/0000-0003-3645-3207; ELOSUA, ROBERTO/0000-0001-8235-0095; Hernandez Afonso, Julio/0000-0002-0982-1759	Canary Islands Health Service; Spanish Government (Institute de Salud Carlos III FEDER) [RD12/0042/0031, 0013]	Canary Islands Health Service; Spanish Government (Institute de Salud Carlos III FEDER)	This study was supported by the Canary Islands Health Service and the Spanish Government (Institute de Salud Carlos III, RD12/0042/0031 and 0013. FEDER).	Ali SF, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000171; Cho E, 2013, NEPHROL DIAL TRANSPL, V28, P2766, DOI 10.1093/ndt/gft376; Eren Z, 2012, CARDIORENAL MED, V2, P168, DOI 10.1159/000337714; Fliser D, 2012, NEPHROL DIAL TRANSPL, V27, P4263, DOI 10.1093/ndt/gfs375; Gillespie CD, 2009, MMWR SURVEILL SUMM S, V62; Gruberg L, 2000, J AM COLL CARDIOL, V36, P1542, DOI 10.1016/S0735-1097(00)00917-7; Haase M, 2013, CONTRIB NEPHROL, V182, P99, DOI 10.1159/000349969; Ismail Y, 2012, SEMIN NEPHROL, V32, P18, DOI 10.1016/j.semnephrol.2011.11.003; Kahn R, 2005, DIABETES CARE, V28, P2289, DOI 10.2337/diacare.28.9.2289; Kellum JA, 2002, KIDNEY INT, V62, P1855, DOI 10.1046/j.1523-1755.2002.00613.x; Lekawanvijit S, 2012, AM J PHYSIOL-HEART C, V302, pH1884, DOI 10.1152/ajpheart.00967.2011; Marana I, 2014, NEPHROL THER, V10, P203, DOI 10.1016/j.nephro.2014.02.006; Marui A, 2015, AM J CARDIOL, V115, P1063, DOI 10.1016/j.amjcard.2015.01.544; McCullough PA, 2013, CONTRIB NEPHROL, V182, P82, DOI [10.1159/000349966, 10.1159/000361059]; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Newsome BB, 2008, ARCH INTERN MED, V168, P609, DOI 10.1001/archinte.168.6.609; Niedziela J, 2014, EUR J EPIDEMIOL, V29, P801, DOI 10.1007/s10654-014-9961-9; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Ricci Z, 2011, NAT REV NEPHROL, V7, P201, DOI 10.1038/nrneph.2011.14; Rihal CS, 2002, CIRCULATION, V105, P2259, DOI 10.1161/01.CIR.0000016043.87291.33; Ronco C, 2008, J AM COLL CARDIOL, V52, P1527, DOI 10.1016/j.jacc.2008.07.051; Ronco C, 2010, CONTRIB NEPHROL, V164, P33, DOI 10.1159/000313718; Roubille F, 2014, BLOOD PURIFICAT, V37, P20, DOI 10.1159/000361061; Roy AK, 2013, CARDIORENAL MED, V3, P26, DOI 10.1159/000347037; Shacham Y, 2015, CAN J CARDIOL, V31, P1240, DOI 10.1016/j.cjca.2015.03.031; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Virzi GM, 2014, CARDIORENAL MED, V4, P103, DOI 10.1159/000362650	27	10	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167166	10.1371/journal.pone.0167166	http://dx.doi.org/10.1371/journal.pone.0167166			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907067	gold, Green Published, Green Submitted			2022-12-26	WOS:000389482700085
J	Yang, X; Zeng, ZX; Wang, RD; Sun, XS				Yang, Xin; Zeng, Zhenxiang; Wang, Ruidong; Sun, Xueshan			Bi-Objective Flexible Job-Shop Scheduling Problem Considering Energy Consumption under Stochastic Processing Times	PLOS ONE			English	Article							MATHEMATICAL-MODELS; UNCERTAINTY	This paper presents a novel method on the optimization of bi-objective Flexible Job-shop Scheduling Problem (FJSP) under stochastic processing times. The robust counterpart model and the Non-dominated Sorting Genetic Algorithm II (NSGA-II) are used to solve the bi-objective FJSP with consideration of the completion time and the total energy consumption under stochastic processing times. The case study on GM Corporation verifies that the NSGA-II used in this paper is effective and has advantages to solve the proposed model comparing with HPSO and PSO+SA. The idea and method of the paper can be generalized widely in the manufacturing industry, because it can reduce the energy consumption of the energy-intensive manufacturing enterprise with less investment when the new approach is applied in existing systems.	[Yang, Xin; Zeng, Zhenxiang] Hebei Univ Technol, Sch Econ & Management, Tianjin, Peoples R China; [Yang, Xin; Sun, Xueshan] Tianjin Univ Technol, ZhongHuan Informat Coll, Tianjin, Peoples R China; [Wang, Ruidong] Tianjin Univ Technol, Dept Math, Tianjin, Peoples R China	Hebei University of Technology; Tianjin University of Technology; Tianjin University of Technology	Yang, X; Zeng, ZX (corresponding author), Hebei Univ Technol, Sch Econ & Management, Tianjin, Peoples R China.	wing.lps@163.com; xzeng@hebut.edu.cn			Science technology Support Plan of Hebei Province [14210102D]	Science technology Support Plan of Hebei Province	This research was funded by a Science technology Support Plan of Hebei Province (Grant Number: 14210102D) http://www.hensf.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arabani AB, 2011, APPL SOFT COMPUT, V11, P4954, DOI 10.1016/j.asoc.2011.06.004; Bonfill A, 2008, COMPUT CHEM ENG, V32, P1689, DOI 10.1016/j.compchemeng.2007.08.014; Ciro GC, 2016, IFAC PAPERSONLINE, V49, P1272, DOI 10.1016/j.ifacol.2016.07.690; Demir Y, 2013, APPL MATH MODEL, V37, P977, DOI 10.1016/j.apm.2012.03.020; Dou H, 2016, PERS UBIQUIT COMPUT, V20, P681, DOI 10.1007/s00779-016-0941-9; Dou H, 2015, 2015 INTERNATIONAL CONFERENCE ON IDENTIFICATION, INFORMATION, AND KNOWLEDGE IN THE INTERNET OF THINGS (IIKI), P210, DOI 10.1109/IIKI.2015.52; Fang K., 2011, GLOCALIZED SOLUTIONS, P305, DOI DOI 10.1007/978-3-642-19692-8_53; Fattahi P, 2007, J INTELL MANUF, V18, P331, DOI 10.1007/s10845-007-0026-8; Gutowski T, 2005, J CLEAN PROD, V13, P1, DOI 10.1016/j.jclepro.2003.10.004; He C., 2013, LECT NOTES ELECT ENG, V211, P393, DOI [10.1007/978-3-642-34522-7_42, DOI 10.1007/978-3-642-34522-7_42]; Honkomp SJ, 1997, COMPUT CHEM ENG, V21, pS1055; Hosseinabadi AAR, 2015, ANN OPER RES, V229, P451, DOI 10.1007/s10479-014-1770-8; Janak SL, 2007, COMPUT CHEM ENG, V31, P171, DOI 10.1016/j.compchemeng.2006.05.035; Jiang D, 2016, IEEE INTERNET THINGS; Lei D, 2012, INT J ADV MANUF TECH, V60, P291, DOI 10.1007/s00170-011-3600-3; Lei DM, 2011, COMPUT IND ENG, V61, P1200, DOI 10.1016/j.cie.2011.07.010; Li L., 2011, THESIS; Li WJ, 2016, IEEE T INTELL TRANSP, V17, P960, DOI 10.1109/TITS.2015.2494017; Mehmood A, 2014, NETWORK PROTOCOLS AL, V6; Mouzon G, 2007, INT J PROD RES, V45, P4247, DOI 10.1080/00207540701450013; Navaz S, 2012, INT J SCI RES PUBLIC, V2, P1; Ozguven C, 2010, APPL MATH MODEL, V34, P1539, DOI 10.1016/j.apm.2009.09.002; Peng Y, 2016, INT J GRID DISTRIB, V9, P161, DOI 10.14257/ijgdc.2016.9.4.15; Pooranian Z, 2015, J COMB OPTIM, V30, P413, DOI 10.1007/s10878-013-9644-6; Pooranian Z, 2013, INFORM-J COMPUT INFO, V37, P157; Shamshirband S, 2015, ANN OPER RES, V229, P743, DOI 10.1007/s10479-015-1855-z; Sun YC, 2017, J NETW COMPUT APPL, V83, P204, DOI 10.1016/j.jnca.2015.10.018; Sun ZY, 2017, WIREL NETW, V23, P1201, DOI 10.1007/s11276-016-1213-3; Tang Qiu-hua, 2015, Computer Integrated Manufacturing Systems, V21, P1002, DOI 10.13196/j.cims.2015.04.015; Wei W, 2018, IEEE T SERV COMPUT, V11, P78, DOI 10.1109/TSC.2016.2528246; XIONG Rui, 1998, J TSINGHUA U SCI TEC, V38, P55; Xu Zhen-hao, 2004, Computer Integrated Manufacturing Systems, V10, P1247; Yu Xiaoyi, 2008, China Mechanical Engineering, V19, P2319; Zheng J., 2007, MULTI OBJECTIVE EVOL, P2	34	10	11	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167427	10.1371/journal.pone.0167427	http://dx.doi.org/10.1371/journal.pone.0167427			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907163	gold, Green Published, Green Submitted			2022-12-26	WOS:000389482700153
J	Zakataeva, NP; Romanenkov, DV; Yusupova, YR; Skripnikova, VS; Asahara, T; Gronskiy, SV				Zakataeva, Natalia P.; Romanenkov, Dmitriy V.; Yusupova, Yuliya R.; Skripnikova, Victoria S.; Asahara, Takayuki; Gronskiy, Sergey V.			Identification, Heterologous Expression, and Functional Characterization of Bacillus subtilis YutF, a HAD Superfamily 5'-Nucleotidase with Broad Substrate Specificity	PLOS ONE			English	Article							GENERAL ENZYMATIC SCREENS; ESCHERICHIA-COLI; DEHALOGENASE SUPERFAMILY; CYTOPLASMIC 5'-NUCLEOTIDASES; PHOSPHATASE; REGULATOR; SEQUENCE; NUCLEOTIDE; PROTEINS; USHA	5'-nucleotidases (EC 3.1.3.5) catalyze the hydrolytic dephosphorylation of 5'-ribonucleotides and 5'-deoxyribonucleotides as well as complex nucleotides, such as uridine 5'-diphosphoglucose (UDP-glucose), nicotinamide adenine dinucleotide and flavin adenine dinucleotide, to their corresponding nucleosides plus phosphate. These enzymes have been found in diverse species in intracellular and membrane-bound, surface-localized forms. Soluble forms of 5'-nucleotidases belong to the ubiquitous haloacid dehalogenase superfamily (HADSF) and have been shown to be involved in the regulation of nucleotide, nucleoside and nicotinamide adenine dinucleotide (NAD(+)) pools. Despite the important role of 5'-nucleotidases in cellular metabolism, only a few of these enzymes have been characterized in the Gram-positive bacterium Bacillus subtilis, the workhorse industrial microorganism included in the Food and Drug Administration's GRAS (generally regarded as safe) list. In the present study, we report the identification of a novel 5'-nucleotidase gene from B. subtilis, yutF, which comprises 771 bp encoding a 256-amino-acid protein belonging to the IIA subfamily of the HADSF. The gene product is responsible for the major p-nitrophenyl phosphatase activity in B. subtilis. The yutF gene was overexpressed in Escherichia coli, and its product fused to a polyhistidine tag was purified and biochemically characterized as a soluble 5'-nucleotidase with broad substrate specificity. The recombinant YutF protein was found to hydrolyze various purine and pyrimidine 5'-nucleotides, showing preference for 5'nucleoside monophosphates and, specifically, 5'-XMP. Recombinant YutF also exhibited phosphohydrolase activity toward nucleotide precursors, ribose-5-phosphate and 5-phosphoribosyl- 1-pyrophosphate. Determination of the kinetic parameters of the enzyme revealed a low substrate specificity (Km values in the mM concentration range) and modest catalytic efficiencies with respect to substrates. An initial study of the regulation of yutF expression showed that the yutF gene is a component of the yutDEF transcription unit and that YutF overproduction positively influences yutDEF expression.	[Zakataeva, Natalia P.; Romanenkov, Dmitriy V.; Yusupova, Yuliya R.; Skripnikova, Victoria S.; Gronskiy, Sergey V.] Ajinomoto Genet Res Inst, Moscow, Russia; [Asahara, Takayuki] Ajinomoto Co Inc, Res Inst Biosci Prod & Fine Chem, Kawasaki, Kanagawa, Japan	Ajinomoto Co Inc; Ajinomoto Co Inc	Zakataeva, NP (corresponding author), Ajinomoto Genet Res Inst, Moscow, Russia.	natalia_zakataeva@agri.ru		Zakataeva, Natalia/0000-0002-0976-9874	Ajinomoto-Genetika Research Institute, Moscow, Russia; Research Institute for Bioscience Products & Fine Chemicals Ajinomoto Co., Inc, Kawasaki, Kanagawa, Japan; Ajinomoto Co., Inc	Ajinomoto-Genetika Research Institute, Moscow, Russia; Research Institute for Bioscience Products & Fine Chemicals Ajinomoto Co., Inc, Kawasaki, Kanagawa, Japan; Ajinomoto Co., Inc	Ajinomoto-Genetika Research Institute, Moscow, Russia and Research Institute for Bioscience Products & Fine Chemicals Ajinomoto Co., Inc, Kawasaki, Kanagawa, Japan are research centers of Ajinomoto Co., Inc. Ajinomoto Co., Inc provided support in the form of salaries for authors NPZ DVR YRY VSS TA SVG, and did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleshin VV, 1999, FEMS MICROBIOL LETT, V178, P47, DOI 10.1016/S0378-1097(99)00343-2; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANTONIEWSKI C, 1990, J BACTERIOL, V172, P86, DOI 10.1128/JB.172.1.86-93.1990; Bianchi V, 2003, J BIOL CHEM, V278, P46195, DOI 10.1074/jbc.R300032200; Biswas T, 2009, J BIOL CHEM, V284, P30594, DOI 10.1074/jbc.M109.012278; Bogan KL, 2010, NEW J CHEM, V34, P845, DOI 10.1039/b9nj00758j; Borowiec A, 2006, ACTA BIOCHIM POL, V53, P269; BURNS DM, 1986, NUCLEIC ACIDS RES, V14, P4325, DOI 10.1093/nar/14.10.4325; Burroughs AM, 2006, J MOL BIOL, V361, P1003, DOI 10.1016/j.jmb.2006.06.049; Cariani L, 2004, ANAL BIOCHEM, V324, P79, DOI 10.1016/j.ab.2003.09.008; Chambert R, 2003, J BIOCHEM, V134, P655, DOI 10.1093/jb/mvg189; DEMAIN AL, 1967, J BACTERIOL, V94, P66, DOI 10.1128/JB.94.1.66-74.1967; Gao R, 2007, TRENDS BIOCHEM SCI, V32, P225, DOI 10.1016/j.tibs.2007.03.002; Gautheret D, 2001, J MOL BIOL, V313, P1003, DOI 10.1006/jmbi.2001.5102; Godinho LM, 2011, FEBS J, V278, P2511, DOI 10.1111/j.1742-4658.2011.08177.x; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Hunsucker SA, 2005, PHARMACOL THERAPEUT, V107, P1, DOI 10.1016/j.pharmthera.2005.01.003; Immormino RM, 2015, BIOCHEMISTRY-US, V54, P3514, DOI 10.1021/acs.biochem.5b00286; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Kuznetsova E, 2005, FEMS MICROBIOL REV, V29, P263, DOI 10.1016/j.femsre.2004.12.006; Kuznetsova E, 2006, J BIOL CHEM, V281, P36149, DOI 10.1074/jbc.M605449200; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LUKAT GS, 1992, P NATL ACAD SCI USA, V89, P718, DOI 10.1073/pnas.89.2.718; Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848; OZAKI H, 1979, J BIOCHEM-TOKYO, V85, P1083, DOI 10.1093/oxfordjournals.jbchem.a132416; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; PLUMBRIDGE J, 1993, MOL MICROBIOL, V10, P973, DOI 10.1111/j.1365-2958.1993.tb00969.x; Proudfoot M, 2004, J BIOL CHEM, V279, P54687, DOI 10.1074/jbc.M411023200; Reaves ML, 2013, NATURE, V500, P237, DOI 10.1038/nature12445; Ridder IS, 1999, BIOCHEM J, V339, P223, DOI 10.1042/0264-6021:3390223; Rittmann D, 2005, APPL ENVIRON MICROB, V71, P4339, DOI 10.1128/AEM.71.8.4339-4344.2005; Sambrook J., 2001, MOL CLONING LAB MANU; Sarge S, 2015, CHEMBIOCHEM, V16, P2466, DOI 10.1002/cbic.201500352; Smirnov SV, 2015, Patent WO, pA1, Patent No. 2015056813; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Srinivasan B, 2014, FEBS J, V281, P1613, DOI 10.1111/febs.12727; Srinivasan Bharath, 2007, In Silico Biology, V7, P187; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tremblay LW, 2006, BIOCHEMISTRY-US, V45, P1183, DOI 10.1021/bi051842j; Vagner V, 1998, MICROBIOL-SGM, V144, P3097, DOI 10.1099/00221287-144-11-3097; Wang L, 2014, ENZYME MICROB TECH, V58-59, P75, DOI 10.1016/j.enzmictec.2014.03.003; Wolfe AJ, 2010, CURR OPIN MICROBIOL, V13, P204, DOI 10.1016/j.mib.2010.01.002; Yang KC, 2004, P NATL ACAD SCI USA, V101, P7919, DOI 10.1073/pnas.0400664101; Zakataeva NP, 2012, APPL MICROBIOL BIOT, V93, P2023, DOI 10.1007/s00253-011-3687-3; Zakataeva NP, 2010, APPL MICROBIOL BIOT, V85, P1201, DOI 10.1007/s00253-009-2276-1; ZALKIN H, 1996, ESCHERICHIA COLI SAL, P561; ZIMMERMANN H, 1992, BIOCHEM J, V285, P345, DOI 10.1042/bj2850345	49	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167580	10.1371/journal.pone.0167580	http://dx.doi.org/10.1371/journal.pone.0167580			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907199	gold, Green Published, Green Submitted			2022-12-26	WOS:000389482700203
J	Lheure, C; Grange, PA; Ollagnier, G; Morand, P; Desire, N; Sayon, S; Corvec, S; Raingeaud, J; Marcelin, AG; Calvez, V; Khammari, A; Batteux, F; Dreno, B; Dupin, N				Lheure, Coralie; Grange, Philippe Alain; Ollagnier, Guillaume; Morand, Philippe; Desire, Nathalie; Sayon, Sophie; Corvec, Stephane; Raingeaud, Joel; Marcelin, Anne-Genevieve; Calvez, Vincent; Khammari, Amir; Batteux, Frederic; Dreno, Brigitte; Dupin, Nicolas			TLR-2 Recognizes Propionibacterium acnes CAMP Factor 1 from Highly Inflammatory Strains	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-2; HUMAN KERATINOCYTES; SEQUENCE ALIGNMENT; EXPRESSION; PROTEINS; PATHOGEN; IDENTIFICATION; PERFORMANCE; INFECTIONS; INDUCTION	Background Propionibacterium acnes (P. acnes) is an anaerobic, Gram-positive bacteria encountered in inflammatory acne lesions, particularly in the pilosebaceous follicle. P. acnes triggers a strong immune response involving keratinocytes, sebocytes and monocytes, the target cells during acne development. Lipoteicoic acid and peptidoglycan induce the inflammatory reaction, but no P. acnes surface protein interacting with Toll-like receptors has been identified. P. acnes surface proteins have been extracted by lithium stripping and shown to induce CXCL8 production by keratinocytes. Methodology and principal findings Far-western blotting identified two surface proteins, of 24.5- and 27.5-kDa in size, specifically recognized by TLR2. These proteins were characterized, by LC-MS/MS, as CAMP factor 1 devoid of its signal peptide sequence, as shown by N-terminal sequencing. Purified CAMP factor 1 induces CXCL8 production by activating the CXCL8 gene promoter, triggering the synthesis of CXCL8 mRNA. Antibodies against TLR2 significantly decreased the CXCL8 response. For the 27 P. acnes strains used in this study, CAMP1-TLR2 binding intensity was modulated and appeared to be strong in type IB and II strains, which produced large amounts of CXCL8, whereas most of the type IA(1) and IA(2) strains presented little or no CAMP1-TLR2 binding and low levels of CXCL8 production. The nucleotide sequence of CAMP factor displays a major polymorphism, defining two distinct genetic groups corresponding to CAMP factor 1 with 14 amino-acid changes from strains phylotyped II with moderate and high levels of CAMP1-TLR2 binding activity, and CAMP factor 1 containing 0, 1 or 2 amino-acid changes from strains phylotyped IA(1), IA(2), or IB presenting no, weak or moderate CAMP1-TLR2 binding. Conclusions Our findings indicate that CAMP factor 1 may contribute to P. acnes virulence, by amplifying the inflammation reaction through direct interaction with TLR2.	[Lheure, Coralie; Grange, Philippe Alain; Ollagnier, Guillaume; Batteux, Frederic; Dupin, Nicolas] Univ Sorbonne Paris Descartes, INSERM, Inst Cochin, Fac Med,Lab Dermatol,CNR Syphilis, Paris, France; [Morand, Philippe] Grp Hosp Paris, AP HP, CNR Streptocoques, Ctr Cochin,Hotel Dieu Broca,Serv Bacteriol, Paris, France; [Desire, Nathalie; Sayon, Sophie; Marcelin, Anne-Genevieve; Calvez, Vincent] UPMC Univ Paris 06, Sorbonne Univ, INSERM, Inst Pierre Louis Epidemiol & Sante Publ, Paris, France; [Desire, Nathalie; Sayon, Sophie; Marcelin, Anne-Genevieve; Calvez, Vincent] Grp Hosp Pitie Salpetriere, AP HP, Lab Virol, Paris, France; [Corvec, Stephane] CHU Nantes, Hyg Hosp, Serv Bacteriol, Nantes, France; [Raingeaud, Joel] Inst Gustave Roussy, UMR8126, Villejuif, France; [Khammari, Amir; Dreno, Brigitte] CHU, Serv Dermatol, CIC, Hotel Dieu, Nantes, France; [Batteux, Frederic] Grp Hosp Paris, AP HP, Ctr Cochin, Hotel Dieu Broca,Serv Immunol Biol, Paris, France; [Dupin, Nicolas] Grp Hosp Paris, AP HP, Ctr Cochin, Hotel Dieu Broca,Serv Dermatol Venereol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Nantes Universite; CHU de Nantes; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite	Dupin, N (corresponding author), Univ Sorbonne Paris Descartes, INSERM, Inst Cochin, Fac Med,Lab Dermatol,CNR Syphilis, Paris, France.; Dupin, N (corresponding author), Grp Hosp Paris, AP HP, Ctr Cochin, Hotel Dieu Broca,Serv Dermatol Venereol, Paris, France.	nicolas.dupin@aphp.fr	Morand, Philippe/C-1213-2016; Batteux, Frederic/O-7889-2017; Marcelin, Anne-Genevieve/D-8272-2014; CORVEC, Stephane/K-7655-2015; Grange, Philippe/W-3442-2017	Morand, Philippe/0000-0003-0306-8759; Batteux, Frederic/0000-0002-1265-7996; Marcelin, Anne-Genevieve/0000-0003-4808-8999; Lheure, Coralie/0000-0002-9694-8386; Dupin, Nicolas/0000-0002-6237-4951; CORVEC, Stephane/0000-0003-3176-8111; Grange, Philippe/0000-0001-8151-748X	Societe Frangaise de Dermatologie et de Pathologie Sexuellement Transmissible	Societe Frangaise de Dermatologie et de Pathologie Sexuellement Transmissible	This work was supported by the Societe Frangaise de Dermatologie et de Pathologie Sexuellement Transmissible.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Aubin GG, 2014, MED MALADIES INFECT, V44, P241, DOI 10.1016/j.medmal.2014.02.004; Barnard E, 2015, J CLIN MICROBIOL, V53, P1149, DOI 10.1128/JCM.02460-14; Beylot C, 2014, J EUR ACAD DERMATOL, V28, P271, DOI 10.1111/jdv.12224; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Bruggemann H, 2005, SEMIN CUTAN MED SURG, V24, P67, DOI 10.1016/j.sder.2005.03.001; Bruggemann H, 2004, SCIENCE, V305, P671, DOI 10.1126/science.1100330; Brzuszkiewicz E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021581; Christie R. N. E. Atkins, 1944, AUSTRALIAN JOUR EXP BIOL AND MED SCI, V22, P197; Cohen RJ, 2005, J UROLOGY, V173, P1969, DOI 10.1097/01.ju.0000158161.15277.78; Collier CN, 2008, J AM ACAD DERMATOL, V58, P56, DOI 10.1016/j.jaad.2007.06.045; Dreno B, 2015, J EUR ACAD DERMATOL, V29, P3, DOI 10.1111/jdv.13190; Portillo ME, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/804391; Fluegge K, 2004, EUR J CLIN MICROBIOL, V23, P818, DOI 10.1007/s10096-004-1229-y; FRASER G., 1962, RES VET SCI, V3, P104; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Graham GM, 2004, BRIT J DERMATOL, V150, P421, DOI 10.1046/j.1365-2133.2004.05762.x; Grange PA, 2009, J DERMATOL SCI, V56, P106, DOI 10.1016/j.jdermsci.2009.08.001; Grange PA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000527; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hauck Y, 2015, INFECT GENET EVOL, V33, P233, DOI 10.1016/j.meegid.2015.05.009; Holland C, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-230; Horneff JG, 2014, ORTHOP CLIN N AM, V45, P515, DOI 10.1016/j.ocl.2014.06.004; Jahns AC, 2012, BRIT J DERMATOL, V167, P50, DOI 10.1111/j.1365-2133.2012.10897.x; Jasson F, 2013, EXP DERMATOL, V22, P587, DOI 10.1111/exd.12206; Jugeau S, 2005, BRIT J DERMATOL, V153, P1105, DOI 10.1111/j.1365-2133.2005.06933.x; JURGENS D, 1987, J EXP MED, V165, P720, DOI 10.1084/jem.165.3.720; Kang S, 2005, AM J PATHOL, V166, P1691, DOI 10.1016/S0002-9440(10)62479-0; KARCHOUDHURY TK, 1978, J CLIN MICROBIOL, V8, P238; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kietzman CC, 2010, INFECT IMMUN, V78, P241, DOI 10.1128/IAI.00746-09; Kim J, 2002, J IMMUNOL, V169, P1535, DOI 10.4049/jimmunol.169.3.1535; Kollisch G, 2005, IMMUNOLOGY, V114, P531, DOI 10.1111/j.1365-2567.2005.02122.x; Lalani T, 2007, SCAND J INFECT DIS, V39, P840, DOI 10.1080/00365540701367793; Lang SH, 2007, MED MICROBIOL IMMUN, V196, P1, DOI 10.1007/s00430-006-0021-2; Lee CW, 2015, BIOMOL THER, V23, P564, DOI 10.4062/biomolther.2015.053; Liu PF, 2011, VACCINE, V29, P3230, DOI 10.1016/j.vaccine.2011.02.036; Lo CW, 2011, J INVEST DERMATOL, V131, P401, DOI 10.1038/jid.2010.319; Lodes MJ, 2006, MICROBIOL-SGM, V152, P3667, DOI 10.1099/mic.0.29219-0; Lomholt HB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012277; Mak TN, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-640; McDowell A, 2005, J CLIN MICROBIOL, V43, P326, DOI 10.1128/JCM.43.1.326-334.2005; McDowell A, 2008, J MED MICROBIOL, V57, P218, DOI 10.1099/jmm.0.47489-0; McDowell A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070897; McDowell A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041480; McDowell A, 2011, MICROBIOL-SGM, V157, P1990, DOI 10.1099/mic.0.049676-0; Morath S, 2002, J EXP MED, V195, P1635, DOI 10.1084/jem.20020322; Nagy I, 2005, J INVEST DERMATOL, V124, P931, DOI 10.1111/j.0022-202X.2005.23705.x; Nakatsuji T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014797; PETERSON GL, 1983, METHOD ENZYMOL, V91, P95; Pivarcsi A, 2003, INT IMMUNOL, V15, P721, DOI 10.1093/intimm/dxg068; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Raingeaud J, 2005, FEBS LETT, V579, P3953, DOI 10.1016/j.febslet.2005.06.019; RUHLMANN J, 1988, FEBS LETT, V235, P262, DOI 10.1016/0014-5793(88)81275-4; Scholz CFP, 2016, SCI REP-UK, V6, DOI 10.1038/srep20662; Sorensen M, 2010, J MICROBIOL METH, V83, P211, DOI 10.1016/j.mimet.2010.09.008; Srivastava A, 2005, INFECT IMMUN, V73, P6479, DOI 10.1128/IAI.73.10.6479-6487.2005; Suh DH, 2015, BRIT J DERMATOL, V172, P13, DOI 10.1111/bjd.13634; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Trivedi NR, 2006, J INVEST DERMATOL, V126, P1071, DOI 10.1038/sj.jid.5700213; Valanne S, 2005, MICROBIOL-SGM, V151, P1369, DOI 10.1099/mic.0.27788-0; VOWELS BR, 1995, INFECT IMMUN, V63, P3158, DOI 10.1128/IAI.63.8.3158-3165.1995; Walti LN, 2013, J INFECTION, V66, P424, DOI 10.1016/j.jinf.2012.12.010; Williams HC, 2012, LANCET, V379, P361, DOI 10.1016/S0140-6736(11)60321-8	65	37	39	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167237	10.1371/journal.pone.0167237	http://dx.doi.org/10.1371/journal.pone.0167237			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902761	Green Published, Green Submitted, gold			2022-12-26	WOS:000389474100062
J	McLean, M; Cuetos-Bueno, J; Nedlic, O; Luckymiss, M; Houk, P				McLean, Matthew; Cuetos-Bueno, Javier; Nedlic, Osamu; Luckymiss, Marston; Houk, Peter			Local Stressors, Resilience, and Shifting Baselines on Coral Reefs	PLOS ONE			English	Article							GREAT-BARRIER-REEF; CLIMATE-CHANGE; PHASE-SHIFTS; FISH; FUTURE; DEGRADATION; CONSERVATION; ASSEMBLAGES; CASCADES; IMPACTS	Understanding how and why coral reefs have changed over the last twenty to thirty years is crucial for sustaining coral-reef resilience. We used a historical baseline from Kosrae, a typical small island in Micronesia, to examine changes in fish and coral assemblages since 1986. We found that natural gradients in the spatial distribution of fish and coral assemblages have become amplified, as island geography is now a stronger determinant of species abundance patterns, and habitat forming Acropora corals and large-bodied fishes that were once common on the leeward side of the island have become scarce. A proxy for fishing access best predicted the relative change in fish assemblage condition over time, and in turn, declining fish condition was the only factor correlated with declining coral condition, suggesting overfishing may have reduced ecosystem resilience. Additionally, a proxy for watershed pollution predicted modern coral assemblage condition, suggesting pollution is also reducing resilience in densely populated areas. Altogether, it appears that unsustainable fishing reduced ecosystem resilience, as fish composition has shifted to smaller species in lower trophic levels, driven by losses of large predators and herbivores. While prior literature and anecdotal reports indicate that major disturbance events have been rare in Kosrae, small localized disturbances coupled with reduced resilience may have slowly degraded reef condition through time. Improving coral-reef resilience in the face of climate change will therefore require improved understanding and management of growing artisanal fishing pressure and watershed pollution.	[McLean, Matthew; Cuetos-Bueno, Javier; Houk, Peter] Univ Guam, Marine Lab, Mangilao, GU 96923 USA; [Nedlic, Osamu; Luckymiss, Marston] Kosrae Conservat & Safety Off, Tofol, Kosrae State, Micronesia	University of Guam	McLean, M (corresponding author), Univ Guam, Marine Lab, Mangilao, GU 96923 USA.	mcleamj@gmail.com		McLean, Matthew/0000-0001-6518-6043	Micronesia Conservation Trust; National Fish and Wildlife Foundation's Coral Reef Conservation Fund [0302.14.043741]; Kosrae Village Ecolodge; Pacific Treelodge	Micronesia Conservation Trust; National Fish and Wildlife Foundation's Coral Reef Conservation Fund; Kosrae Village Ecolodge; Pacific Treelodge	This work was funded by Micronesia Conservation Trust (http://ourmicronesia.org/; grant number: N/A), awarded to PH; and National Fish and Wildlife Foundation's Coral Reef Conservation Fund (http://www.nfwf.org/Pages/default.aspx; grant number: 0302.14.043741), awarded to PH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Kosrae Safety and Conservation Organization, Kosrae Department of Resources and Economic Affairs Division of Marine Resources, and Kosrae Island Resource Management Authority provided invaluable support in planning, logistics, and data collection. Unparalleled hospitality and support were provided by the Kosrae Village Ecolodge and the Pacific Treelodge. We are also grateful to Dr. Alexander Kerr who assisted with statistical procedures. Lastly we thank two anonymous reviewers whose comments greatly improved the quality of this paper.	Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anthony KRN, 2000, CORAL REEFS, V19, P59, DOI 10.1007/s003380050227; Armsworth PR, 2002, ECOLOGY, V83, P1092, DOI 10.1890/0012-9658(2002)083[1092:RLPRAL]2.0.CO;2; Aronson RB, 2006, CORAL REEFS, V25, P441, DOI 10.1007/s00338-006-0122-9; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Birkeland C, 2005, TRENDS ECOL EVOL, V20, P356, DOI 10.1016/j.tree.2005.03.015; Bohnsack J.A., 1986, NOAA Technical Report NMFS, V41, P1; Brown CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065765; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Carilli JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006324; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Darling ES, 2010, CONSERV LETT, V3, P122, DOI 10.1111/j.1755-263X.2009.00089.x; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; DeVantier LM, 2006, CORAL REEFS, V25, P329, DOI 10.1007/s00338-006-0115-8; DONE TJ, 1992, CONT SHELF RES, V12, P859, DOI 10.1016/0278-4343(92)90048-O; DOWNING JA, 1990, CAN J FISH AQUAT SCI, V47, P1929, DOI 10.1139/f90-217; Dulvy NK, 2004, ECOL LETT, V7, P410, DOI 10.1111/j.1461-0248.2004.00593.x; Edinger EN, 1998, MAR POLLUT BULL, V36, P617, DOI 10.1016/S0025-326X(98)00047-2; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Friedlander AM, 2003, CORAL REEFS, V22, P291, DOI 10.1007/s00338-003-0317-2; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; George A, 2008, STATE CORAL REEF ECO; Graham NAJ, 2011, CORAL REEFS, V30, P283, DOI 10.1007/s00338-010-0717-z; Graham NAJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003039; Graham NAJ, 2013, FRONT ECOL ENVIRON, V11, P541, DOI 10.1890/120305; Gurney GG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080137; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; HARESTAD AS, 1979, ECOLOGY, V60, P389, DOI 10.2307/1937667; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Houk P, 2014, CORAL REEF DISTURBAN; Houk P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130823; Houk P, 2013, MAR ECOL PROG SER, V488, P23, DOI 10.3354/meps10410; Houk P, 2013, BIOSCIENCE, V63, P297, DOI 10.1525/bio.2013.63.4.10; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Hughes TP, 1999, LIMNOL OCEANOGR, V44, P932, DOI 10.4319/lo.1999.44.3_part_2.0932; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Johannes R.E., 1975, Elsevier oceanogr Ser, V12, P13; Knowlton N, 2001, P NATL ACAD SCI USA, V98, P5419, DOI 10.1073/pnas.091092998; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; Knutson TR, 2010, NAT GEOSCI, V3, P157, DOI 10.1038/NGEO779; Lokrantz J, 2008, CORAL REEFS, V27, P967, DOI 10.1007/s00338-008-0394-3; Maina J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023064; MCCLANAHAN TR, 1994, CORAL REEFS, V13, P231, DOI 10.1007/BF00303637; McClanahan TR, 2002, ENVIRON CONSERV, V29, P460, DOI 10.1017/S0376892902000334; McClenachan L, 2012, CONSERV LETT, V5, P349, DOI 10.1111/j.1755-263X.2012.00253.x; McClenachan L, 2009, CONSERV BIOL, V23, P636, DOI 10.1111/j.1523-1739.2008.01152.x; Mumby PJ, 2006, SCIENCE, V311, P98, DOI 10.1126/science.1121129; Ninio R, 2000, MAR ECOL PROG SER, V194, P65, DOI 10.3354/meps194065; NIXON S W, 1986, Journal of the Limnological Society of Southern Africa, V12, P43; Nystrom M, 2008, CORAL REEFS, V27, P795, DOI 10.1007/s00338-008-0426-z; Nystrom M, 2000, TRENDS ECOL EVOL, V15, P413, DOI 10.1016/S0169-5347(00)01948-0; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; Pinnegar JK, 2008, REV FISH BIOL FISHER, V18, P1, DOI 10.1007/s11160-007-9058-6; Rooney N, 2006, NATURE, V442, P265, DOI 10.1038/nature04887; Saenz-Agudelo P, 2011, P ROYAL SOC B; Szmant AM, 2002, ESTUARIES, V25, P743, DOI 10.1007/BF02804903; USACE, 1989, KOSR COAST RES INV; van Nes EH, 2004, AM NAT, V164, P255, DOI 10.1086/422204; van Woesik R, 2012, ECOL EVOL, V2, P2474, DOI 10.1002/ece3.363; Wilkinson CR, 1999, MAR FRESHWATER RES, V50, P867, DOI 10.1071/MF99121; Wilson SK, 2006, GLOBAL CHANGE BIOL, V12, P2220, DOI 10.1111/j.1365-2486.2006.01252.x; Worm B, 2002, NATURE, V417, P848, DOI 10.1038/nature00830	67	18	18	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0166319	10.1371/journal.pone.0166319	http://dx.doi.org/10.1371/journal.pone.0166319			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902715	Green Published, Green Submitted, gold			2022-12-26	WOS:000389474100020
J	Del Piccolo, N; Sarabipour, S; Hristova, K				Del Piccolo, Nuala; Sarabipour, Sarvenaz; Hristova, Kalina			A New Method to Study Heterodimerization of Membrane Proteins and Its Application to Fibroblast Growth Factor Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; TRANSMEMBRANE HELIX DIMERIZATION; PLASMA-MEMBRANE; TYROSINE KINASES; EGF RECEPTOR; THANATOPHORIC DYSPLASIA; JUXTAMEMBRANE REGION; FLUORESCENT PROTEINS; EXTRACELLULAR DOMAIN; SKELETAL DYSPLASIAS	The activity of receptor tyrosine kinases (RTKs) is controlled through their lateral association in the plasma membrane. RTKs are believed to form both homodimers and heterodimers, and the different dimers are believed to play unique roles in cell signaling. However, RTK heterodimers remain poorly characterized, as compared with homodimers, because of limitations in current experimental methods. Here, we develop a FRET-based methodology to assess the thermodynamics of hetero-interactions in the plasma membrane. To demonstrate the utility of the methodology, we use it to study the hetero-interactions between three fibroblast growth factor receptors-FGFR1, FGFR2, and FGFR3-in the absence of ligand. Our results show that all possible FGFR heterodimers form, suggesting that the biological roles of FGFR heterodimers may be as significant as the homodimer roles. We further investigate the effect of two pathogenic point mutations in FGFR3 (A391E and G380R) on heterodimerization. We show that each of these mutations stabilize most of the heterodimers, with the largest effects observed for FGFR3 wild-type/mutant heterodimers. We thus demonstrate that the methodology presented here can yield new knowledge about RTK interactions and can further our understanding of signal transduction across the plasma membrane.	[Del Piccolo, Nuala; Sarabipour, Sarvenaz; Hristova, Kalina] Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA	Johns Hopkins University	Hristova, K (corresponding author), Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA.	kh@jhu.edu	Sarabipour, Sarvenaz/H-2992-2015	Sarabipour, Sarvenaz/0000-0001-5097-5509; Del Piccolo, Nuala/0000-0002-5104-7322	National Institutes of Health [GM095930, GM068619]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068619, R01GM095930] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM095930 and GM068619. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmad I, 2012, BBA-MOL CELL RES, V1823, P850, DOI 10.1016/j.bbamcr.2012.01.004; Bell CA, 2000, MOL BIOL CELL, V11, P3589, DOI 10.1091/mbc.11.10.3589; BELLOT F, 1991, EMBO J, V10, P2849, DOI 10.1002/j.1460-2075.1991.tb07834.x; Chen FH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056521; Chen LR, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001195; Chen LR, 2010, J AM CHEM SOC, V132, P3628, DOI 10.1021/ja910692u; Chen Y, 2000, ONCOGENE, V19, P3750, DOI 10.1038/sj.onc.1203726; Chung I, 2010, NATURE, V464, P783, DOI 10.1038/nature08827; Cunningham ML, 2007, ORTHOD CRANIOFAC RES, V10, P67, DOI 10.1111/j.1601-6343.2007.00389.x; Cymer F, 2012, BBA-BIOMEMBRANES, V1818, P963, DOI 10.1016/j.bbamem.2011.07.035; Del Piccolo N, 2015, BIOPHYS J, V108, P272, DOI 10.1016/j.bpj.2014.11.3460; Del Piccolo N, 2012, ANAL CHEM, V84, P8650, DOI [10.1021/ac301776j, 10.1021/ac301776J]; Delezoide AL, 1998, MECH DEVELOP, V77, P19, DOI 10.1016/S0925-4773(98)00133-6; Dietz MS, 2013, BMC BIOPHYS, V6, DOI 10.1186/2046-1682-6-6; Drevs J, 2003, CURR DRUG TARGETS, V4, P113, DOI 10.2174/1389450033346885; Duneau JP, 2007, BIOCHEMISTRY-US, V46, P2010, DOI 10.1021/bi061436f; Endres NF, 2013, CELL, V152, P543, DOI 10.1016/j.cell.2012.12.032; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Evers TH, 2006, BIOCHEMISTRY-US, V45, P13183, DOI 10.1021/bi061288t; Fink A, 2012, BBA-BIOMEMBRANES, V1818, P974, DOI 10.1016/j.bbamem.2011.11.029; Foldynova-Trantirkova S, 2012, HUM MUTAT, V33, P29, DOI 10.1002/humu.21636; Gerber D, 2004, J BIOL CHEM, V279, P21177, DOI 10.1074/jbc.M400847200; Harada D, 2009, J BONE MINER METAB, V27, P9, DOI 10.1007/s00774-008-0009-7; He LJ, 2012, BBA-BIOMEMBRANES, V1818, P995, DOI 10.1016/j.bbamem.2011.07.044; He LJ, 2011, J BIOL CHEM, V286, P13272, DOI 10.1074/jbc.M110.205583; He LJ, 2008, J MOL BIOL, V384, P1130, DOI 10.1016/j.jmb.2008.10.036; Hong H, 2009, METHOD ENZYMOL, V455, P213, DOI 10.1016/S0076-6879(08)04208-0; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; JOHNSON ML, 1992, METHOD ENZYMOL, V210, P1; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Kenworthy AK, 2000, MOL BIOL CELL, V11, P1645, DOI 10.1091/mbc.11.5.1645; Khadria AS, 2013, BIOCHEMISTRY-US, V52, P7542, DOI 10.1021/bi4009837; King C, 2016, INTEGR BIOL-UK, V8, P216, DOI 10.1039/c5ib00202h; King C, 2014, BIOPHYS J, V106, P1309, DOI 10.1016/j.bpj.2014.01.039; Krejci P, 2014, MUTAT RES-REV MUTAT, V759, P40, DOI 10.1016/j.mrrev.2013.11.001; Lazar J, 2011, NAT METHODS, V8, P684, DOI [10.1038/NMETH.1643, 10.1038/nmeth.1643]; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Li E, 2005, BIOCHEMISTRY-US, V44, P352, DOI 10.1021/bi048480k; Li E, 2008, ANAL CHEM, V80, P5976, DOI 10.1021/ac800616u; Li E, 2012, BBA-BIOMEMBRANES, V1818, P183, DOI 10.1016/j.bbamem.2011.08.031; Lin CC, 2012, CELL, V149, P1514, DOI 10.1016/j.cell.2012.04.033; Low-Nam ST, 2011, NAT STRUCT MOL BIOL, V18, P1244, DOI 10.1038/nsmb.2135; Merzlyakov M, 2006, J MOL BIOL, V358, P1, DOI 10.1016/j.jmb.2006.01.086; Naski MC, 1996, NAT GENET, V13, P233, DOI 10.1038/ng0696-233; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Ornitz DM, 2015, WIRES DEV BIOL, V4, P215, DOI 10.1002/wdev.176; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Pantaleo MA, 2008, INT J ONCOL, V33, P443, DOI 10.3892/ijo_00000026; Placone J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046678; Red Brewer M, 2009, MOL CELL, V34, P641, DOI 10.1016/j.molcel.2009.04.034; Sarabipour S, 2016, BBA-BIOMEMBRANES, V1858, P1436, DOI 10.1016/j.bbamem.2016.03.027; Sarabipour S, 2016, ELIFE, V5, DOI 10.7554/eLife.13876; Sarabipour S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10262; Sarabipour S, 2015, ACCOUNTS CHEM RES, V48, P2262, DOI 10.1021/acs.accounts.5b00238; Sarabipour S, 2015, BBA-BIOMEMBRANES, V1848, P1591, DOI 10.1016/j.bbamem.2015.04.002; Sarabipour S, 2015, J MOL BIOL, V427, P1705, DOI 10.1016/j.jmb.2015.02.013; Sarabipour S, 2014, ANAL BIOCHEM, V449, P155, DOI 10.1016/j.ab.2013.12.027; Sarabipour S, 2013, BIOPHYS J, V105, P165, DOI 10.1016/j.bpj.2013.05.053; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Shankaran H, 2006, BIOPHYS J, V90, P3993, DOI 10.1529/biophysj.105.080580; Sorkin A, 2000, CURR BIOL, V10, P1395, DOI 10.1016/S0960-9822(00)00785-5; Soumana OS, 2008, EUR BIOPHYS J BIOPHY, V37, P851, DOI 10.1007/s00249-008-0293-0; Su N, 2014, BONE RES, V2, DOI 10.1038/boneres.2014.3; Tamagaki H, 2014, BIOCHEMISTRY-US, V53, P5000, DOI 10.1021/bi500327q; Thiel KW, 2007, P NATL ACAD SCI USA, V104, P19238, DOI 10.1073/pnas.0703854104; Tzahar E, 1996, MOL CELL BIOL, V16, P5276; UENO H, 1992, J BIOL CHEM, V267, P1470; Vajo Z, 2000, ENDOCR REV, V21, P23, DOI 10.1210/er.21.1.23; von Heijne G, 1999, J MOL BIOL, V293, P367, DOI 10.1006/jmbi.1999.2998; Webster MK, 1997, TRENDS GENET, V13, P178, DOI 10.1016/S0168-9525(97)01131-1; WOLBER PK, 1979, BIOPHYS J, V28, P197, DOI 10.1016/S0006-3495(79)85171-1; You M, 2005, ANAL BIOCHEM, V340, P154, DOI 10.1016/j.ab.2005.01.035	73	24	24	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2017	292	4					1288	1301		10.1074/jbc.M116.755777	http://dx.doi.org/10.1074/jbc.M116.755777			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ6OX	27927983	hybrid, Green Published			2022-12-26	WOS:000393339800012
J	Beg, I; Minton, AP; Islam, A; Hassan, MI; Ahmad, F				Beg, Ilyas; Minton, Allen P.; Islam, Asimul; Hassan, Md. Imtaiyaz; Ahmad, Faizan			The pH Dependence of Saccharides' Influence on Thermal Denaturation of Two Model Proteins Supports an Excluded Volume Model for Stabilization Generalized to Allow for Intramolecular Electrostatic Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANIDINE-HYDROCHLORIDE; TREHALOSE SYNTHESIS; ORGANIC OSMOLYTES; CHARGE-DENSITY; IN-VITRO; STABILITY; THERMOTOLERANCE; POLYELECTROLYTE; ACQUISITION; EQUILIBRIA	The reversible thermal denaturation of apo alpha-lactalbumin (alpha-LA) and lysozyme was measured in the absence and presence of multiple concentrations of each of seven saccharides (glucose, galactose, fructose, sucrose, trehalose, raffinose, and stachyose) at multiple pH values. It was observed that with increasing pH, the absolute stability of alpha-LA decreased, whereas the stabilizing effect per mole of all saccharides increased, and that the absolute stability of lysozyme increased, whereas the stabilizing effect per mole of all saccharides decreased. All of the data may be accounted for quantitatively by straightforward electrostatic generalization of a previously introduced coarse-grained model for stabilization of proteins by sugars.	[Beg, Ilyas; Islam, Asimul; Hassan, Md. Imtaiyaz; Ahmad, Faizan] Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi 110025, India; [Minton, Allen P.] NIDDK, Lab Biochem & Genet, NIH, Bethesda, MD 20892 USA	Jamia Millia Islamia; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Ahmad, F (corresponding author), Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi 110025, India.; Minton, AP (corresponding author), NIDDK, Lab Biochem & Genet, NIH, Bethesda, MD 20892 USA.	minton@helix.nih.gov; fahmad@jmi.ac.in	Hassan, Imtaiyaz/ABF-6485-2020; BEG, ILYAS/AAS-2307-2020; Islam, Asimul/V-4526-2019; Hassan, Md Imtaiyaz/G-7072-2017; Hassan, Mohammad/GZA-7507-2022; Ahmad, Faizan/AGH-4493-2022	Hassan, Imtaiyaz/0000-0002-3663-4940; BEG, ILYAS/0000-0002-2008-2619; Islam, Asimul/0000-0001-9060-7970; Hassan, Md Imtaiyaz/0000-0002-3663-4940; Hassan, Mohammad/0000-0002-1712-0004; Ahmad, Faizan/0000-0001-7021-7502; Minton, Allen/0000-0001-8459-1247	Council of Scientific and Industrial Research, India [37(1603)/13/EMRII, 37(1604)/13/EMRII)]; National Institutes of Health Intramural Research Program of the NIDDK	Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); National Institutes of Health Intramural Research Program of the NIDDK	This work was supported by Council of Scientific and Industrial Research, India, Research Grants 37(1603)/13/EMRII and 37(1604)/13/EMRII) (to F. A. and A. I.) and the National Institutes of Health Intramural Research Program of the NIDDK (to A. P. M). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ATTFIELD PV, 1987, FEBS LETT, V225, P259, DOI 10.1016/0014-5793(87)81170-5; Auton M, 2011, BIOPHYS CHEM, V159, P90, DOI 10.1016/j.bpc.2011.05.012; BECKTEL WJ, 1987, BIOPOLYMERS, V26, P1859, DOI 10.1002/bip.360261104; Beg I, 2015, BIOCHEMISTRY-US, V54, P3594, DOI 10.1021/acs.biochem.5b00415; Bolen D W, 2001, Methods Mol Biol, V168, P17; Bolen DW, 2001, J MOL BIOL, V310, P955, DOI 10.1006/jmbi.2001.4819; Burg MB, 2008, J BIOL CHEM, V283, P7309, DOI 10.1074/jbc.R700042200; Davis-Searles PR, 2001, ANNU REV BIOPH BIOM, V30, P271, DOI 10.1146/annurev.biophys.30.1.271; DEVIRGILIO C, 1994, EUR J BIOCHEM, V219, P179; Dou SC, 2006, J POLYM SCI POL PHYS, V44, P2001, DOI 10.1002/polb.20853; HAMAGUCHI K, 1963, J BIOCHEM-TOKYO, V54, P111; HOTTIGER T, 1994, EUR J BIOCHEM, V219, P187, DOI 10.1111/j.1432-1033.1994.tb19929.x; JAENICKE R, 1991, EUR J BIOCHEM, V202, P715, DOI 10.1111/j.1432-1033.1991.tb16426.x; Kaushik JK, 2003, J BIOL CHEM, V278, P26458, DOI 10.1074/jbc.M300815200; Kim WK, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.051926; Kirwan LJ, 2004, NANO LETT, V4, P149, DOI 10.1021/nl034912l; Krasensky J, 2012, J EXP BOT, V63, P1593, DOI 10.1093/jxb/err460; Minton AP, 1998, METHOD ENZYMOL, V295, P127; Minton AP, 2000, BIOPHYS J, V78, P101, DOI 10.1016/S0006-3495(00)76576-3; Pace C N, 1986, Methods Enzymol, V131, P266; Pace CN, 2000, PROTEIN SCI, V9, P1395; Poddar NK, 2008, BIOPHYS CHEM, V138, P120, DOI 10.1016/j.bpc.2008.09.013; Senske M, 2014, J AM CHEM SOC, V136, P9036, DOI 10.1021/ja503205y; Singer MA, 1998, MOL CELL, V1, P639, DOI 10.1016/S1097-2765(00)80064-7; Singh LR, 2011, J IRAN CHEM SOC, V8, P1; SUGAI S, 1973, BIOCHIM BIOPHYS ACTA, V328, P35, DOI 10.1016/0005-2795(73)90327-9; Tanford C., 1961, PHYS CHEM MACROMOLEC; Timasheff SN, 2002, P NATL ACAD SCI USA, V99, P9721, DOI 10.1073/pnas.122225399; Timasheff SN, 2002, BIOCHEMISTRY-US, V41, P13473, DOI 10.1021/bi020316e; TIMASHEFF SN, 1993, ANNU REV BIOPH BIOM, V22, P67, DOI 10.1146/annurev.bb.22.060193.000435; Weast R.C., 1972, HDB CHEM PHYS, V53rd ed.; Welsh DT, 2000, FEMS MICROBIOL REV, V24, P263, DOI 10.1111/j.1574-6976.2000.tb00542.x; Xie GF, 1997, BIOPHYS CHEM, V64, P25, DOI 10.1016/S0301-4622(96)02222-3; Yancey PH, 2005, J EXP BIOL, V208, P2819, DOI 10.1242/jeb.01730; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124	35	23	23	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2017	292	2					505	511		10.1074/jbc.M116.757302	http://dx.doi.org/10.1074/jbc.M116.757302			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2KN	27909048	Green Published, hybrid			2022-12-26	WOS:000392316100008
J	Allen, JW; DiRusso, CC; Black, PN				Allen, James W.; DiRusso, Concetta C.; Black, Paul N.			Carbon and Acyl Chain Flux during Stress-induced Triglyceride Accumulation by Stable Isotopic Labeling of the Polar Microalga Coccomyxa subellipsoidea C169	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIATOM PHAEODACTYLUM-TRICORNUTUM; FATTY-ACID DESATURATION; CHLAMYDOMONAS-REINHARDTII; NITROGEN DEPRIVATION; LIPID-ACCUMULATION; TRIACYLGLYCEROL SYNTHESIS; PHOTOSYNTHETIC APPARATUS; ARABIDOPSIS-THALIANA; MEMBRANE-LIPIDS; ALGAL BIOFUELS	Deriving biofuels and other lipoid products from algae is a promising future technology directly addressing global issues of atmospheric CO2 balance. To better understand the metabolism of triglyceride synthesis in algae, we examined their metabolic origins in the model species, Coccomyxa subellipsoidea C169, using stable isotopic labeling. Labeling patterns arising from [U-C-13]glucose, (CO2)-C-13, or D2O supplementation were analyzed by GC-MS and/or LC-MSover time courses during nitrogen starvation to address the roles of catabolic carbon recycling, acylchain redistribution, and de novo fatty acid(FA) synthesis during the expansion of the lipid bodies. The metabolic origin of stress-induced triglyceride was found to be a continuous 8: 2 ratio between de novo synthesized FA and acyl chain transfer from pre-stressed membrane lipids with little input from lipid remodeling. Membrane lipids were continually synthesized with associated acyl chain editing during nitrogen stress, in contrast to an overall decrease in total membrane lipid. The incorporation rates of de novo synthesized FA into lipid classes were measured over a time course of nitrogen starvation. The synthesis of triglycerides, phospholipids, and galactolipids followed a two-stage pattern where nitrogen starvation resulted in a 2.5-fold increase followed by a gradual decline. Acyl chain flux into membrane lipids was dominant in the first stage followed by triglycerides. These data indicate that the level of metabolic control that determines acyl chain flux between membrane lipids and triglycerides during nitrogen stress relies primarily on the Kennedy pathway and de novo FA synthesis with limited, defined input from acyl editing reactions.	[Allen, James W.; DiRusso, Concetta C.; Black, Paul N.] Univ Nebraska, Dept Biochem, N200 George W Beadle Ctr,1901 Vine St, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln	Black, PN (corresponding author), Univ Nebraska, Dept Biochem, N200 George W Beadle Ctr,1901 Vine St, Lincoln, NE 68588 USA.	pblack2@unl.edu	Allen, James/AAG-6465-2019	DiRusso, Concetta/0000-0001-7388-9152; Black, Paul/0000-0002-6272-6881	National Science Foundation [EPS-1004094, 1264409]; Nebraska Center for Energy Sciences Research	National Science Foundation(National Science Foundation (NSF)); Nebraska Center for Energy Sciences Research	This work was supported by Grants EPS-1004094 (to P. N. B. and C. C. D.) and 1264409 (to C. C. D.) from the National Science Foundation and by a grant from the Nebraska Center for Energy Sciences Research (to P. N. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Alipanah L, 2015, J EXP BOT, V66, P6281, DOI 10.1093/jxb/erv340; Allen JW, 2015, ALGAL RES, V10, P110, DOI 10.1016/j.algal.2015.04.019; Allen JW, 2014, ALGAL RES, V5, P23, DOI 10.1016/j.algal.2014.04.003; Bates PD, 2012, PLANT PHYSIOL, V160, P1530, DOI 10.1104/pp.112.204438; Bates PD, 2009, PLANT PHYSIOL, V150, P55, DOI 10.1104/pp.109.137737; Beisson F, 2003, PLANT PHYSIOL, V132, P681, DOI 10.1104/pp.103.022988; Blanc G, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-5-r39; Blanc G, 2010, PLANT CELL, V22, P2943, DOI 10.1105/tpc.110.076406; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boyle NR, 2012, J BIOL CHEM, V287, P15811, DOI 10.1074/jbc.M111.334052; Burrows EH, 2012, BIOENERG RES, V5, P876, DOI 10.1007/s12155-012-9201-7; Chader S, 2009, INT J HYDROGEN ENERG, V34, P4941, DOI 10.1016/j.ijhydene.2008.10.058; Chisti Y, 2013, J BIOTECHNOL, V167, P201, DOI 10.1016/j.jbiotec.2013.07.020; Chisti Y, 2011, APPL ENERG, V88, P3277, DOI 10.1016/j.apenergy.2011.04.038; CHORNEY W, 1960, BIOCHIM BIOPHYS ACTA, V37, P280, DOI 10.1016/0006-3002(60)90235-3; Cruz-Ramirez A, 2006, P NATL ACAD SCI USA, V103, P6765, DOI 10.1073/pnas.0600863103; Deme B, 2014, FASEB J, V28, P3373, DOI 10.1096/fj.13-247395; Essigmann B, 1998, P NATL ACAD SCI USA, V95, P1950, DOI 10.1073/pnas.95.4.1950; Georgianna DR, 2012, NATURE, V488, P329, DOI 10.1038/nature11479; Guarnieri MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025851; Guerzoni ME, 1997, CAN J MICROBIOL, V43, P569, DOI 10.1139/m97-080; Guschina IA, 2006, PROG LIPID RES, V45, P160, DOI 10.1016/j.plipres.2006.01.001; HARWOOD J, 1989, CRIT REV PLANT SCI, V8, P1, DOI 10.1080/07352680490273310; Hu ZH, 2012, PLANT PHYSIOL, V158, P1944, DOI 10.1104/pp.111.192153; Huard K, 2015, J MED CHEM, V58, P7164, DOI 10.1021/acs.jmedchem.5b01008; HUPPE HC, 1994, PLANT PHYSIOL, V105, P1043, DOI 10.1104/pp.105.4.1043; Ikaran Z, 2015, ALGAL RES, V10, P134, DOI 10.1016/j.algal.2015.04.023; Juergens MT, 2015, PLANT PHYSIOL, V167, P558, DOI 10.1104/pp.114.250530; LANDS WEM, 1958, J BIOL CHEM, V231, P883; Lee SJ, 2011, BIOTECHNOL BIOPROC E, V16, P561, DOI 10.1007/s12257-010-0360-0; Li J, 2014, PLANT CELL, V26, P1645, DOI 10.1105/tpc.113.121418; Li-Beisson Y, 2015, PLANT J, V82, P504, DOI 10.1111/tpj.12787; Lu YD, 2009, EXTREMOPHILES, V13, P875, DOI 10.1007/s00792-009-0275-x; Lv HX, 2013, GENOMICS, V101, P229, DOI 10.1016/j.ygeno.2013.01.004; Miller R, 2010, PLANT PHYSIOL, V154, P1737, DOI 10.1104/pp.110.165159; Nakamura Y, 2005, J BIOL CHEM, V280, P7469, DOI 10.1074/jbc.M408799200; Nicolo MS, 2010, J BIOTECHNOL, V150, pS163, DOI 10.1016/j.jbiotec.2010.08.423; OHLROGGE J, 1995, PLANT CELL, V7, P957, DOI 10.1105/tpc.7.7.957; Pancha I, 2014, BIORESOURCE TECHNOL, V156, P146, DOI 10.1016/j.biortech.2014.01.025; PATTON GM, 1979, BIOCHEMISTRY-US, V18, P3186, DOI 10.1021/bi00581a042; Pollard M, 2015, PHYTOCHEMISTRY, V118, P192, DOI 10.1016/j.phytochem.2015.07.021; Preininger E, 2015, PHOTOSYNTHETICA, V53, P369, DOI 10.1007/s11099-015-0129-y; Ras M, 2013, REV ENVIRON SCI BIO, V12, P153, DOI 10.1007/s11157-013-9310-6; Roston RL, 2014, J BIOL CHEM, V289, P26089, DOI 10.1074/jbc.M114.576694; Schmollinger S, 2014, PLANT CELL, V26, P1410, DOI 10.1105/tpc.113.122523; Shen YX, 2013, J CHROMATOGR B, V930, P36, DOI 10.1016/j.jchromb.2013.04.034; Simionato D, 2013, EUKARYOT CELL, V12, P665, DOI 10.1128/EC.00363-12; Solovchenko AE, 2013, RUSS J PLANT PHYSL+, V60, P1, DOI 10.1134/S1021443713010081; Solovchenko AE, 2012, RUSS J PLANT PHYSL+, V59, P167, DOI 10.1134/S1021443712020161; STYMNE S, 1984, BIOCHEM J, V223, P305, DOI 10.1042/bj2230305; Tang HY, 2011, BIOTECHNOL BIOENG, V108, P2280, DOI 10.1002/bit.23160; Tevatia R, 2014, BIORESOURCE TECHNOL, V170, P152, DOI 10.1016/j.biortech.2014.07.043; Thorlby G, 2004, PLANT CELL, V16, P2192, DOI 10.1105/tpc.104.024018; Tjellstroem H, 2012, PLANT PHYSIOL, V158, P601, DOI 10.1104/pp.111.186122; Upchurch RG, 2008, BIOTECHNOL LETT, V30, P967, DOI 10.1007/s10529-008-9639-z; Urzica EI, 2013, J BIOL CHEM, V288, P30246, DOI 10.1074/jbc.M113.490425; Wallis JG, 2002, PROG LIPID RES, V41, P254, DOI 10.1016/S0163-7827(01)00027-3; Wang LP, 2012, PLANT CELL, V24, P4652, DOI 10.1105/tpc.112.104604; Wang ZT, 2009, EUKARYOT CELL, V8, P1856, DOI 10.1128/EC.00272-09; Wase N, 2014, J PROTEOME RES, V13, P1373, DOI 10.1021/pr400952z; Wen QX, 2013, BIOENERG RES, V6, P877, DOI 10.1007/s12155-013-9308-5; Wickramarathna AD, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0156-6; Yoon K, 2012, PLANT CELL, V24, P3708, DOI 10.1105/tpc.112.100701; Yurchenko OP, 2009, PLANT BIOTECHNOL J, V7, P602, DOI 10.1111/j.1467-7652.2009.00427.x; Zhang M, 2005, PLANT J, V44, P361, DOI 10.1111/j.1365-313X.2005.02536.x	65	20	21	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2017	292	1					361	374		10.1074/jbc.M116.760843	http://dx.doi.org/10.1074/jbc.M116.760843			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2DQ	27903654	Green Published, hybrid			2022-12-26	WOS:000391578000031
J	Janssen, RJ; Jylanki, P; van Gerven, MAJ				Janssen, Ronald J.; Jylanki, Pasi; van Gerven, Marcel A. J.			Let's Not Waste Time: Using Temporal Information in Clustered Activity Estimation with Spatial Adjacency Restrictions (CAESAR) for Parcellating FMRI Data	PLOS ONE			English	Article							RESTING-STATE FMRI; FUNCTIONAL PARCELLATION; BRAIN; CONNECTIVITY	We have proposed a Bayesian approach for functional parcellation of whole-brain FMRI measurements which we call Clustered Activity Estimation with Spatial Adjacency Restrictions (CAESAR). We use distance-dependent Chinese restaurant processes (dd-CRPs) to define a flexible prior which partitions the voxel measurements into clusters whose number and shapes are unknown a priori. With dd-CRPs we can conveniently implement spatial constraints to ensure that our parcellations remain spatially contiguous and thereby physiologically meaningful. In the present work, we extend CAESAR by using Gaussian process (GP) priors to model the temporally smooth haemodynamic signals that give rise to the measured FMRI data. A challenge for GP inference in our setting is the cubic scaling with respect to the number of time points, which can become computationally prohibitive with FMRI measurements, potentially consisting of long time series. As a solution we describe an efficient implementation that is practically as fast as the corresponding time-independent non-GP model with typically-sized FMRI data sets. We also employ a population Monte-Carlo algorithm that can significantly speed up convergence compared to traditional single-chain methods. First we illustrate the benefits of CAESAR and the GP priors with simulated experiments. Next, we demonstrate our approach by parcellating resting state FMRI data measured from twenty participants as taken from the Human Connectome Project data repository. Results show that CAESAR affords highly robust and scalable whole-brain clustering of FMRI timecourses.	[Janssen, Ronald J.; Jylanki, Pasi; van Gerven, Marcel A. J.] Radboud Univ Nijmegen, Donders Ctr Brain Cognit & Behav, Nijmegen, Netherlands	Radboud University Nijmegen	Janssen, RJ (corresponding author), Radboud Univ Nijmegen, Donders Ctr Brain Cognit & Behav, Nijmegen, Netherlands.	janssen.rj@gmail.com	van Gerven, Marcel A. J./D-7800-2012	van Gerven, Marcel A. J./0000-0002-2206-9098; Janssen, Ronald/0000-0001-9622-5420	The Netherlands Organization for Scientific Research (NWO) [612.001.211, 639.072.513]; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH091657] Funding Source: NIH RePORTER	The Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by grant numbers 612.001.211 and 639.072.513 of The Netherlands Organization for Scientific Research (NWO; http://www.nwo.nl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by grant numbers 612.001.211 and 639.072.513 of The Netherlands Organization for Scientific Research (NWO). Data were provided by the Human Connectome Project, WU-Minn Consortium (Principal Investigators: David Van Essen and Kamil Ugurbil; 1U54MH091657).	Andersen Kasper Winther, 2012, Machine Learning and Interpretation in Neuroimaging. International Workshop (MLINI 2011). Held at NIPS 2011. Revised and Selected and Invited Contributions, P226, DOI 10.1007/978-3-642-34713-9_29; Baldassano C, 2015, PEERJ, V3, DOI 10.7717/peerj.784; Bartunov S, 2014, PR MACH LEARN RES, V32, P1404; Bedard C, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.118102; Blei DM, 2006, BAYESIAN ANAL, V1, P121, DOI 10.1214/06-BA104; Blei DM, 2011, J MACH LEARN RES, V12, P2461; Blumensath T, 2013, NEUROIMAGE, V76, P313, DOI 10.1016/j.neuroimage.2013.03.024; Cappe O, 2004, J COMPUT GRAPH STAT, V13, P907, DOI 10.1198/106186004X12803; Cohen AL, 2008, NEUROIMAGE, V41, P45, DOI 10.1016/j.neuroimage.2008.01.066; Craddock RC, 2012, HUM BRAIN MAPP, V33, P1914, DOI 10.1002/hbm.21333; Glasser MF, 2013, NEUROIMAGE, V80, P105, DOI 10.1016/j.neuroimage.2013.04.127; Harrison SJ, 2015, NEUROIMAGE, V109, P217, DOI 10.1016/j.neuroimage.2015.01.013; Hartikainen Jouni, 2010, Proceedings of the 2010 IEEE International Workshop on Machine Learning for Signal Processing (MLSP), P379, DOI 10.1109/MLSP.2010.5589113; Hinne M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117179; Honnorat N, 2015, NEUROIMAGE, V106, P207, DOI 10.1016/j.neuroimage.2014.11.008; Janssen RJ, 2015, NEUROIMAGE, V119, P398, DOI 10.1016/j.neuroimage.2015.06.084; Janssen RJ, 2014, FRONT COMPUT NEUROSC, V8, DOI 10.3389/fncom.2014.00126; Logothetis NK, 2003, J NEUROSCI, V23, P3963; Neal RM, 2000, J COMPUT GRAPH STAT, V9, P249, DOI 10.2307/1390653; Pitman J, 2006, COMBINATORIAL STOCHA; Poldrack RA, 2011, HDB FUNCTIONAL MRI D; Rasmussen CE, 2005, ADAPT COMPUT MACH LE, P1; Shah A, 2014, JMLR WORKSH CONF PRO, V33, P877; Shen X, 2013, NEUROIMAGE, V82, P403, DOI 10.1016/j.neuroimage.2013.05.081; Smith SM, 2013, NEUROIMAGE, V80, P144, DOI 10.1016/j.neuroimage.2013.05.039; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Thirion B, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00167; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van Essen DC, 2013, NEUROIMAGE, V80, P62, DOI 10.1016/j.neuroimage.2013.05.041; Van Essen DC, 2012, CEREB CORTEX, V22, P2241, DOI 10.1093/cercor/bhr291; Vinh NX, 2010, J MACH LEARN RES, V11, P2837; Wig GS, 2014, CEREB CORTEX, V24, P2036, DOI 10.1093/cercor/bht056; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027	34	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0164703	10.1371/journal.pone.0164703	http://dx.doi.org/10.1371/journal.pone.0164703			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935937	Green Published, Green Submitted, gold			2022-12-26	WOS:000389587100007
J	van Rein, N; Lijfering, WM; Bos, MHA; Herruer, MH; Vermaas, HW; van der Meer, FJM; Reitsma, PH				van Rein, Nienke; Lijfering, Willem M.; Bos, Mettine H. A.; Herruer, Martien H.; Vermaas, Helga W.; van der Meer, Felix J. M.; Reitsma, Pieter H.			Objectives and Design of BLEEDS: A Cohort Study to Identify New Risk Factors and Predictors for Major Bleeding during Treatment with Vitamin K Antagonists	PLOS ONE			English	Article							ORAL ANTICOAGULANT-THERAPY; ATRIAL-FIBRILLATION PATIENTS; WARFARIN; COMPLICATIONS; HEMORRHAGE; THROMBOEMBOLISM; THROMBOMODULIN; INTENSITY; EVENTS; STROKE	Background Risk scores for patients who are at high risk for major bleeding complications during treatment with vitamin K antagonists (VKAs) do not perform that well. BLEEDS was initiated to search for new biomarkers that predict bleeding in these patients. Objectives To describe the outline and objectives of BLEEDS and to examine whether the study population is generalizable to other VKA treated populations. Methods A cohort was created consisting of all patients starting VKA treatment at three Dutch anticoagulation clinics between January-2012 and July-2014. We stored leftover plasma and DNA following analysis of the INR. Results Of 16,706 eligible patients, 16,570 (99%) were included in BLEEDS and plasma was stored from 13,779 patients (83%). Patients had a mean age of 70 years (SD 14), 8713 were male (53%). The most common VKA indications were atrial fibrillation (10,876 patients, 66%) and venous thrombosis (3920 patients, 24%). 326 Major bleeds occurred during 17,613 years of follow-up (incidence rate 1.85/100 person years, 95% CI 1.66-2.06). The risk for major bleeding was highest in the initial three months of VKA treatment and increased when the international normalized ratio increased. These results and characteristics are in concordance with results from other VKA treated populations. Conclusion BLEEDS is generalizable to other VKA treated populations and will permit innovative and unbiased research of biomarkers that may predict major bleeding during VKA treatment.	[van Rein, Nienke; Lijfering, Willem M.; Bos, Mettine H. A.; van der Meer, Felix J. M.; Reitsma, Pieter H.] Leiden Univ, Med Ctr, Dept Thrombosis & Hemostasis, Leiden, Netherlands; [van Rein, Nienke; Lijfering, Willem M.; Bos, Mettine H. A.; Reitsma, Pieter H.] Leiden Univ, Med Ctr, Einthoven Lab Expt Vasc Med, Leiden, Netherlands; [Lijfering, Willem M.] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands; [Herruer, Martien H.] Atalmedial Med Diagnost Ctr, Hoofddorp, Netherlands; [Vermaas, Helga W.] Anticoagulat Clin Hague, The Hague, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van Rein, N (corresponding author), Leiden Univ, Med Ctr, Dept Thrombosis & Hemostasis, Leiden, Netherlands.; van Rein, N (corresponding author), Leiden Univ, Med Ctr, Einthoven Lab Expt Vasc Med, Leiden, Netherlands.	n.van_rein@lumc.nl	Lijfering, Willem/J-7442-2019; Bos, Mettine/S-5317-2016	Lijfering, Willem/0000-0002-4638-4623; Bos, Mettine/0000-0002-8164-817X	Hartstichting [2011 T12, 99.165]; Center for Translational Molecular Medicine [01 C-201]	Hartstichting; Center for Translational Molecular Medicine	Hartstichting (2011 T12) https://www.hartstichting.nl/, Center for Translational Molecular Medicine (01 C-201) http://www.ctmm.nl/nl, and Hartstichting (99.165) https://www.hartstichting.nl/.	Ansell J, 2008, CHEST, V133, p160S, DOI 10.1378/chest.08-0670; Beyth RJ, 1998, AM J MED, V105, P91, DOI 10.1016/S0002-9343(98)00198-3; CANNEGIETER SC, 1995, NEW ENGL J MED, V333, P11, DOI 10.1056/NEJM199507063330103; Connolly SJ, 2008, CIRCULATION, V118, P2029, DOI 10.1161/CIRCULATIONAHA.107.750000; Fang MC, 2011, J AM COLL CARDIOL, V58, P395, DOI 10.1016/j.jacc.2011.03.031; Fang MC, 2004, ANN INTERN MED, V141, P745, DOI 10.7326/0003-4819-141-10-200411160-00005; FIHN SD, 1993, ANN INTERN MED, V118, P511, DOI 10.7326/0003-4819-118-7-199304010-00005; Gage BF, 2006, AM HEART J, V151, P713, DOI 10.1016/j.ahj.2005.04.017; Go AS, 2003, JAMA-J AM MED ASSOC, V290, P2685, DOI 10.1001/jama.290.20.2685; Kuijer PMM, 1999, ARCH INTERN MED, V159, P457, DOI 10.1001/archinte.159.5.457; LANDEFELD CS, 1989, AM J MED, V87, P144; Lind M, 2009, ARCH INTERN MED, V169, P1210, DOI 10.1001/archinternmed.2009.170; Linkins LA, 2013, BLOOD REV, V27, P111, DOI 10.1016/j.blre.2013.02.004; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Palareti G, 1996, LANCET, V348, P423, DOI 10.1016/S0140-6736(96)01109-9; PETITTI DB, 1986, AM J MED, V81, P255, DOI 10.1016/0002-9343(86)90260-3; Roldan V, 2011, J AM COLL CARDIOL, V57, P2496, DOI 10.1016/j.jacc.2010.12.033; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236; Schulman S, 2008, CHEST, V133, p257S, DOI 10.1378/chest.08-0674; Shireman TI, 2004, STROKE, V35, P2362, DOI 10.1161/01.STR.0000141933.75462.c2; Singer DE, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.000067; Van Der Heijden JF, 2004, J THROMB HAEMOST, V2, P1104, DOI 10.1111/j.1538-7836.2004.00768.x; van Rein N, 2014, J CLIN EPIDEMIOL, V67, P232, DOI 10.1016/j.jclinepi.2013.05.011; VANDERMEER FJM, 1993, ARCH INTERN MED, V153, P1557, DOI 10.1001/archinte.153.13.1557; White HD, 2007, ARCH INTERN MED, V167, P239, DOI 10.1001/archinte.167.3.239; Zhu WG, 2015, CLIN CARDIOL, V38, P555, DOI 10.1002/clc.22435	27	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0164485	10.1371/journal.pone.0164485	http://dx.doi.org/10.1371/journal.pone.0164485			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935941	Green Submitted, Green Published, gold			2022-12-26	WOS:000389587100005
J	Das, JK; Das, P; Ray, KK; Choudhury, PP; Jana, SS				Das, Jayanta Kumar; Das, Provas; Ray, Korak Kumar; Choudhury, Pabitra Pal; Jana, Siddhartha Sankar			Mathematical Characterization of Protein Sequences Using Patterns as Chemical Group Combinations of Amino Acids	PLOS ONE			English	Article							MYOSIN MOTOR DOMAIN; LIGHT-CHAIN KINASE; GRAPHICAL REPRESENTATION; PHYLOGENETIC ANALYSIS; MOLECULAR EVOLUTION; KINESIN; ALIGNMENT; SIMILARITY/DISSIMILARITY; IDENTIFICATION; SENSITIVITY	Comparison of amino acid sequence similarity is the fundamental concept behind the protein phylogenetic tree formation. By virtue of this method, we can explain the evolutionary relationships, but further explanations are not possible unless sequences are studied through the chemical nature of individual amino acids. Here we develop a new methodology to characterize the protein sequences on the basis of the chemical nature of the amino acids. We design various algorithms for studying the variation of chemical group transitions and various chemical group combinations as patterns in the protein sequences. The amino acid sequence of conventional myosin II head domain of 14 family members are taken to illustrate this new approach. We find two blocks of maximum length 6 aa as 'FPKATD' and 'Y/FTNEKL' without repeating the same chemical nature and one block of maximum length 20 aa with the repetition of chemical nature which are common among all 14 members. We also check commonality with another motor protein sub-family kinesin, KIF1A. Based on our analysis we find a common block of length 8 aa both in myosin II and KIF1A. This motif is located in the neck linker region which could be responsible for the generation of mechanical force, enabling us to find the unique blocks which remain chemically conserved across the family. We also validate our methodology with different protein families such as MYOI, Myosin light chain kinase (MLCK) and Rho-associated protein kinase (ROCK), Na+/K+-ATPase and Ca2+-ATPase. Altogether, our studies provide a new methodology for investigating the conserved amino acids' pattern in different proteins.	[Das, Jayanta Kumar; Choudhury, Pabitra Pal] Indian Stat Inst, Appl Stat Unit, 203 BT Rd, Kolkata 700108, W Bengal, India; [Das, Provas; Jana, Siddhartha Sankar] Indian Assoc Cultivat Sci, Dept Biol Chem, 2A & 2B Raja SC Mullick Rd, Kolkata 700032, W Bengal, India; [Ray, Korak Kumar] Indian Inst Technol, Dept Chem, Bombay 400076, Maharashtra, India	Indian Statistical Institute; Indian Statistical Institute Kolkata; Department of Science & Technology (India); Indian Association for the Cultivation of Science (IACS) - Jadavpur; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Das, JK (corresponding author), Indian Stat Inst, Appl Stat Unit, 203 BT Rd, Kolkata 700108, W Bengal, India.; Das, P (corresponding author), Indian Assoc Cultivat Sci, Dept Biol Chem, 2A & 2B Raja SC Mullick Rd, Kolkata 700032, W Bengal, India.	dasjayantakumar89@gmail.com; bcpd@iacs.res.in	Das, Provas/AAW-5814-2020	Das, Jayanta Kumar/0000-0002-7630-7194; Das, Provas/0000-0002-4339-7445; Ray, Korak Kumar/0000-0001-5390-698X	ISI; IACS	ISI; IACS(Department of Science & Technology (India)Indian Association for the Cultivation of Science (IACS) - Jadavpur)	We thank to group members of Dr. S S Jana and Prof. P Pal Choudhury for their helpful discussion. J. K. D and P. D thank ISI and IACS respectively for supporting their fellowships.	Al-Bassam J, 2003, J CELL BIOL, V163, P743, DOI 10.1083/jcb.200308020; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bresnick AR, 1999, CURR OPIN CELL BIOL, V11, P26, DOI 10.1016/S0955-0674(99)80004-0; Brini M, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004168; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; CHENEY RE, 1993, CELL MOTIL CYTOSKEL, V24, P215, DOI 10.1002/cm.970240402; Coluccio LM, 1997, AM J PHYSIOL-CELL PH, V273, pC347, DOI 10.1152/ajpcell.1997.273.2.C347; Connell LE, 2006, J CELL SCI, V119, P2269, DOI 10.1242/jcs.02926; Cope MJTV, 1996, STRUCTURE, V4, P969, DOI 10.1016/S0969-2126(96)00103-7; Dode L, 2001, J BIOL CHEM, V276, P3911, DOI 10.1074/jbc.M007719200; Dominguez R, 1998, CELL, V94, P559, DOI 10.1016/S0092-8674(00)81598-6; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; FENG DF, 1987, J MOL EVOL, V25, P351, DOI 10.1007/BF02603120; Forrest MD, FRONT PHYSIOL, V5, DOI [10.3389/fphys.2014.00472, DOI 10.3389/FPHYS2014.00472]; Forrest MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051169; Gao Y, 2001, IUBMB LIFE, V51, P337; Gillespie PG, 2001, J CELL BIOL, V155, P703, DOI 10.1083/jcb.200110032; Golomb E, 2004, J BIOL CHEM, V279, P2800, DOI 10.1074/jbc.M309981200; Gromiha MM, 2002, FEBS LETT, V526, P129, DOI 10.1016/S0014-5793(02)03122-8; Hahmann C, 2010, CELL MOL LIFE SCI, V67, P171, DOI 10.1007/s00018-009-0189-x; Hariharan V, 2009, CELL MOL BIOENG, V2, P177, DOI 10.1007/s12195-009-0059-5; Heintzelman MB, 1997, J MOL BIOL, V271, P139, DOI 10.1006/jmbi.1997.1167; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Houdusse A, 1999, CELL, V97, P459, DOI 10.1016/S0092-8674(00)80756-4; Jensen TP, 2007, J PHYSIOL-LONDON, V579, P85, DOI 10.1113/jphysiol.2006.123901; Johnson LS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-431; Kull FJ, 1998, J MUSCLE RES CELL M, V19, P877, DOI 10.1023/A:1005489907021; Lewis JH, 2006, BIOCHEMISTRY-US, V45, P11589, DOI 10.1021/bi0611917; Li C, 2008, BMB REP, V41, P217, DOI 10.5483/BMBRep.2008.41.3.217; Li J, 2006, PROG BIOCHEM BIOPHYS, V33, P1215; Li TP, 2003, PROTEIN ENG, V16, P323, DOI 10.1093/protein/gzg044; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Munteanu CR, 2008, J THEOR BIOL, V254, P476, DOI 10.1016/j.jtbi.2008.06.003; PEARSON WR, 1991, GENOMICS, V11, P635, DOI 10.1016/0888-7543(91)90071-L; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Pearson WR, 2013, CURR PROTOC BIOINFOR, V42, DOI 10.1002/0471250953.bi0301s42; PENNY D, 1992, J CLASSIF, V9, P169, DOI 10.1007/BF02618482; Pereira TV, 2006, P NATL ACAD SCI USA, V103, P5676, DOI 10.1073/pnas.0509562103; Perry GH, 2005, MOL BIOL EVOL, V22, P379, DOI 10.1093/molbev/msi004; Peterson EL, 2009, BIOINFORMATICS, V25, P1356, DOI 10.1093/bioinformatics/btp164; Pham TD, 2004, BIOINFORMATICS, V20, P3455, DOI 10.1093/bioinformatics/bth426; Randic M, 1997, CHEM PHYS LETT, V272, P115, DOI 10.1016/S0009-2614(97)00447-8; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Rokas A., 2011, CURR PROTOC MOL BIOL, V96, P19; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; Smith CA, 1996, BIOPHYS J, V70, P1590, DOI 10.1016/S0006-3495(96)79745-X; Smith SA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003223; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Stedman HH, 2004, NATURE, V428, P415, DOI 10.1038/nature02358; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; Vale RD, 1997, ANNU REV CELL DEV BI, V13, P745, DOI 10.1146/annurev.cellbio.13.1.745; Wen J, 2009, CHEM PHYS LETT, V476, P281, DOI 10.1016/j.cplett.2009.06.017; Xie XL, 2012, J ZHEJIANG UNIV-SC B, V13, P152, DOI 10.1631/jzus.B1100052; Yao YH, 2010, J COMPUT CHEM, V31, P1045, DOI 10.1002/jcc.21391; Yao YH, 2008, PROTEINS, V73, P864, DOI 10.1002/prot.22110; Yau SST, 2008, DNA CELL BIOL, V27, P241, DOI 10.1089/dna.2007.0676; Zhang SL, 2010, MATCH-COMMUN MATH CO, V63, P701; Zhang S, 2009, J MOL STRUC-THEOCHEM, V909, P102, DOI 10.1016/j.theochem.2009.05.031	60	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167651	10.1371/journal.pone.0167651	http://dx.doi.org/10.1371/journal.pone.0167651			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930687	gold, Green Published, Green Submitted			2022-12-26	WOS:000389580900035
J	Salles, JI; Duarte, MEL; Guimaraes, JM; Lopes, LR; Cardoso, JV; Aguiar, DP; Neto, JOM; Machado, DE; Perini, JA				Salles, Jose Inacio; Leite Duarte, Maria Eugenia; Guimaraes, Joao Matheus; Lopes, Lucas Rafael; Cardoso, Jessica Vilarinho; Aguiar, Diego Pinheiro; Machado Neto, Joao Olyntho; Machado, Daniel Escorsim; Perini, Jamila Alessandra			Vascular Endothelial Growth Factor Receptor-2 Polymorphisms Have Protective Effect against the Development of Tendinopathy in Volleyball Athletes	PLOS ONE			English	Article							TORN ROTATOR CUFF; ACHILLES-TENDON; COL5A1 GENE; FACTOR VEGF; EXPRESSION; ULTRASONOGRAPHY; ANGIOGENESIS; ASSOCIATION; PATHOLOGY; DOPPLER	The aim of the study was to investigate whether genetic variants in VEGF and KDR genes can be correlated with susceptibility of tendinopathy in volleyball athletes. This study was conducted at the Brazilian Volleyball Federation, and comprised 179 volleyball athletes: 88 had a confirmed diagnosis of tendinopathy (cases), whereas 91 had no evidence of the disease (controls). The VEGF (-2578C>A, -460T>C and +936C>T) and KDR (-604C>T, 1192G>A and 1719T>A) polymorphisms were determined by TaqMan real-time polymerase chain reaction. The odds ratio (OR) with their 95% confidence intervals (CI) were calculated using an unconditional logistic regression model. The evaluation of demographic and clinical characteristics revealed the athlete age (P < 0.001), years of practice in volleyball (P < 0.001) and presence of pain (P = 0.001) were risk factors for tendinopathy. KDR 1192 GA and GA + AA genotypes were associated with lower risk of tendinopathy (OR: 0.41, 95% CI: 0.19-0.88 and OR: 0.47, 95% CI: 0.23-0.98, respectively). The KDR (-604C>T, 1192G>A and 1719T>A) haplotypes CGA and CAT were associated with decreased tendinopathy risk (OR: 0.46, 95% CI: 0.21-0.99 and OR: 0.23, 95% CI: 0.07-0.76, respectively). With regards to pain, traumatic lesion and away from training due to injury, VEGF and KDR polymorphisms were not associated with clinical symptoms complaints. The present results provide evidence that the KDR polymorphisms were associated with development of tendinopathy, and can contribute to identify new therapeutic targets or personalized training programs to avoid tendinopathy development in athletes.	[Salles, Jose Inacio; Leite Duarte, Maria Eugenia; Guimaraes, Joao Matheus; Lopes, Lucas Rafael; Aguiar, Diego Pinheiro; Perini, Jamila Alessandra] Inst Nacl Traumatol & Ortopedia, Div Pesquisa, Rio De Janeiro, Brazil; [Salles, Jose Inacio] Federat Int Volleyball FIVB Coach Commiss, Rio De Janeiro, Brazil; [Lopes, Lucas Rafael; Cardoso, Jessica Vilarinho; Machado, Daniel Escorsim; Perini, Jamila Alessandra] Ctr Univ Estadual Zona Oeste, Unidade Farm, Lab Pesquisa Ciencias Farmaceut, Rio De Janeiro, Brazil; [Cardoso, Jessica Vilarinho; Perini, Jamila Alessandra] Fundacao Osvaldo Cruz, Escola Nacl Saude Publ, Programa Posgrad Saude Publ & Meio Ambiente, Rio De Janeiro, Brazil; [Machado Neto, Joao Olyntho] Brazilian Volleyball Federat, Rio De Janeiro, Brazil	Centro Universitario Estadual da Zona Oeste; Fundacao Oswaldo Cruz	Perini, JA (corresponding author), Inst Nacl Traumatol & Ortopedia, Div Pesquisa, Rio De Janeiro, Brazil.; Perini, JA (corresponding author), Ctr Univ Estadual Zona Oeste, Unidade Farm, Lab Pesquisa Ciencias Farmaceut, Rio De Janeiro, Brazil.; Perini, JA (corresponding author), Fundacao Osvaldo Cruz, Escola Nacl Saude Publ, Programa Posgrad Saude Publ & Meio Ambiente, Rio De Janeiro, Brazil.	jamilaperini@yahoo.com.br		Lopes, Lucas Rafael/0000-0003-0488-0730	Brazilian agency Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ, Brazil; Brazilian Volleyball Federation	Brazilian agency Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ, Brazil; Brazilian Volleyball Federation	This study was supported by the Brazilian agency Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the support of Brazilian Volleyball Federation and Mayara Calixto da Silva from State University of West Zone (UEZO), Brazil, for her technical assistance.	Alfredson H, 2003, KNEE SURG SPORT TR A, V11, P334, DOI 10.1007/s00167-003-0391-6; Baroneza JE, 2014, GENE, V547, P334, DOI 10.1016/j.gene.2014.07.001; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; de Vos RJ, 2007, AM J SPORT MED, V35, P1696, DOI 10.1177/0363546507303116; El Khoury L, 2013, J SCI MED SPORT, V16, P493, DOI 10.1016/j.jsams.2013.02.006; Eriksen HA, 2002, J ORTHOPAED RES, V20, P1352, DOI 10.1016/S0736-0266(02)00064-5; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Kaux JF, 2011, J SPORT SCI MED, V10, P238; Kulig K, 2015, INT J SPORTS MED, V36, P400, DOI 10.1055/s-0034-1395586; Laguette MJ, 2011, MATRIX BIOL, V30, P338, DOI 10.1016/j.matbio.2011.05.001; Lakemeier S, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-230; Maffulli N, 2003, CLIN SPORT MED, V22, P675, DOI 10.1016/S0278-5919(03)00004-8; Maffulli N, 2004, MED SCI SPORT EXER, V36, P1470, DOI 10.1249/01.MSS.0000139895.94846.8D; Maffulli Nicola, 2013, Muscles Ligaments Tendons J, V3, P173; Matthews TJW, 2006, J BONE JOINT SURG BR, V88B, P489, DOI 10.1302/0301-620X.88B4.16845; Mokone GG, 2006, SCAND J MED SCI SPOR, V16, P19, DOI 10.1111/j.1600-0838.2005.00439.x; Ohberg L, 2001, KNEE SURG SPORT TR A, V9, P233, DOI 10.1007/s001670000189; Pena SDJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017063; Perini JA, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-117; Petersen W, 2004, CLIN ORTHOP RELAT R, P286, DOI 10.1097/01.blo.0000126228.78639.76; Petersen W, 2003, ARCH ORTHOP TRAUM SU, V123, P168, DOI 10.1007/s00402-002-0462-z; Pingel J, 2013, AM J SPORT MED, V41, P2400, DOI 10.1177/0363546513498988; Pufe T, 2005, ANN ANAT, V187, P461, DOI 10.1016/j.aanat.2005.06.008; Pufe T, 2001, VIRCHOWS ARCH, V439, P579, DOI 10.1007/s004280100422; Puthucheary Z, 2011, SPORTS MED, V41, P845, DOI 10.2165/11593200-000000000-00000; Rahim M, 2016, OMICS, V20, P520, DOI 10.1089/omi.2016.0116; Rees JD, 2006, RHEUMATOLOGY, V45, P508, DOI 10.1093/rheumatology/kel046; Seminati E, 2015, SPORT BIOMECH, V14, P216, DOI 10.1080/14763141.2015.1052747; September A V, 2012, Recent Pat DNA Gene Seq, V6, P216; Walsh DA, 2001, ARTHRITIS RES, V3, P147, DOI 10.1186/ar292; Wang JHC, 2006, J BIOMECH, V39, P1563, DOI 10.1016/j.jbiomech.2005.05.011; Wang Y, 2007, J AM COLL CARDIOL, V50, P760, DOI 10.1016/j.jacc.2007.04.074; Watson CJ, 2000, CYTOKINE, V12, P1232, DOI 10.1006/cyto.2000.0692	34	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167717	10.1371/journal.pone.0167717	http://dx.doi.org/10.1371/journal.pone.0167717			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930691	Green Published, Green Submitted, gold			2022-12-26	WOS:000389580900039
J	Wellard, R; Lightbody, K; Fouda, L; Blewitt, M; Riggs, D; Erbe, C				Wellard, Rebecca; Lightbody, Keith; Fouda, Leila; Blewitt, Michelle; Riggs, David; Erbe, Christine			Killer Whale (Orcinus orca) Predation on Beaked Whales (Mesoplodon spp.) in the Bremer Sub-Basin, Western Australia	PLOS ONE			English	Article							NORTH-ATLANTIC; MEDITERRANEAN SEA; HUMPBACK WHALES; MARINE MAMMALS; 1ST RECORD; WATERS; POPULATIONS; ZIPHIIDAE; STRANDINGS; MOVEMENT	Observations of killer whales (Orcinus orca) feeding on the remains of beaked whales have been previously documented; however, to date, there has been no published account of killer whales actively preying upon beaked whales. This article describes the first field observations of killer whales interacting with, hunting and preying upon beaked whales (Mesoplodon spp.) on four separate occasions during 2014, 2015 and 2016 in the Bremer Sub-Basin, off the south coast of Western Australia.	[Wellard, Rebecca; Fouda, Leila; Erbe, Christine] Curtin Univ, Ctr Marine Sci & Technol, GPO Box U1987, Perth, WA 6845, Australia; [Blewitt, Michelle] Univ Sydney, Marine Studies Inst, Sydney, NSW 2006, Australia; [Riggs, David] Riggs Australia Pty Ltd, POB 2076, Esperance, WA 6450, Australia	Curtin University; University of Sydney	Wellard, R (corresponding author), Curtin Univ, Ctr Marine Sci & Technol, GPO Box U1987, Perth, WA 6845, Australia.	becwellard@gmail.com	Erbe, Christine/AAA-3801-2021; Wellard, Rebecca/AAW-7310-2020	Erbe, Christine/0000-0002-7884-9907; Wellard, Rebecca/0000-0001-8427-564X; Fouda, Leila/0000-0002-0723-3697	Holsworth Wildlife Research Endowment; Australian Geographic Society	Holsworth Wildlife Research Endowment; Australian Geographic Society	This research was supported by the Holsworth Wildlife Research Endowment and The Australian Geographic Society. The author who received the funding was RW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. DR was employed by Riggs Australia Pty Ltd. which provided support in the form of salary for co-author DR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AN, 2014, MAR MAMMAL SCI, V30, P154, DOI 10.1111/mms.12028; Amico AD, 2003, IEEE J OCEANIC ENG, V28, P29; ARNBOM T, 1987, J MAMMAL, V68, P450, DOI 10.2307/1381497; Baird RW, 2006, PAC SCI, V60, P523, DOI 10.1353/psc.2006.0024; Baird RW, 1996, BEHAV ECOL, V7, P408, DOI 10.1093/beheco/7.4.408; Baird RW, 1994, FORAGING BEHAV ECOLO; Barrett-Lennard LG, 2011, MAR ECOL PROG SER, V421, P229, DOI 10.3354/meps08906; Barrett-Lennard LG, 2001, POPULATION STRUCTURE; BarrettLennard LG, 1996, ANIM BEHAV, V51, P553, DOI 10.1006/anbe.1996.0059; Beck S, 2012, BEHAV ECOL, V23, P246, DOI 10.1093/beheco/arr151; Bigg M, 1982, ASSESSMENT KILLER WH, P655; Bigg M.A., 1987, KILLER WHALES STUDY; Bisther A, 2001, 14 BIENN C BIOL MAR; Cato DH, 2009, HABITAT MODELING BEA; Cosentino A. Mel, 2015, Marine Biodiversity Records, V8, pe108, DOI 10.1017/S1755267215000895; Dahlheim ME, 2008, MAR MAMMAL SCI, V24, P719, DOI 10.1111/j.1748-7692.2008.00206.x; de Bruyn PJN, 2013, BIOL REV, V88, P62, DOI 10.1111/j.1469-185X.2012.00239.x; Durban J. W., 2016, POLAR BIOL, V40, P1; Exon NF, 2005, AUST J EARTH SCI, V52, P101, DOI 10.1080/08120090500100036; Fearnbach Holly, 2011, Endangered Species Research, V13, P173, DOI 10.3354/esr00330; Ferguson Megan C., 2005, Journal of Cetacean Research and Management, V7, P287; Foote AD, 2011, MOL ECOL, V20, P629, DOI 10.1111/j.1365-294X.2010.04957.x; Foote AD, 2010, EVOL ECOL, V24, P803, DOI 10.1007/s10682-009-9337-x; Foote AD, 2009, MOL ECOL, V18, P5207, DOI 10.1111/j.1365-294X.2009.04407.x; Ford J. K. B., 2000, KILLER WHALES NATURA; Ford JKB, 1998, CAN J ZOOL, V76, P1456, DOI 10.1139/cjz-76-8-1456; FORD JKB, 1989, CAN J ZOOL, V67, P727, DOI 10.1139/z89-105; Ford JKB, 2010, BIOL LETTERS, V6, P139, DOI 10.1098/rsbl.2009.0468; Forney KA, 2006, WHALES WHALING ECOSY, P25; Gannier A, 2008, J MAR BIOL ASSOC UK, V88, P1245, DOI 10.1017/S0025315408000428; Gemmell GL, 2015, AQUAT MAMM, V41, P265, DOI 10.1578/AM.41.3.2015.265; GLADSTONE W, 1988, J MAMMAL, V69, P629, DOI 10.2307/1381360; Groom Christine J., 2014, Marine Biodiversity Records, V7, pe50, DOI 10.1017/S1755267214000475; Hamilton L. J., 2014, Journal of Cetacean Research and Management, V14, P171; Hamilton L. J., 2014, Journal of Cetacean Research and Management, V14, P1; Hancock D., 1965, Journal of Mammalogy, V46, P341, DOI 10.2307/1377867; Hanson MB, 2014, AQUAT MAMM, V40, P274, DOI 10.1578/AM.40.3.2014.274; HOELZEL AR, 1991, BEHAV ECOL SOCIOBIOL, V29, P197, DOI 10.1007/BF00166401; JEFFERSON TA, 1991, MAMMAL REV, V21, P151, DOI 10.1111/j.1365-2907.1991.tb00291.x; Jongard A, 1968, NORSK HVALFANGST TID, V57, P84; MacLeod CD, 2005, MAR BIOL, V147, P1, DOI 10.1007/s00227-004-1546-9; MacLeod Colin D., 2005, Journal of Cetacean Research and Management, V7, P271; McCordic JA, 2014, J MAR BIOL ASSOC UK, V94, P1311, DOI 10.1017/S0025315413001008; Morrice M.G., 2004, KILLER WHALES ORCINU; Moulins A, 2007, J MAR BIOL ASSOC UK, V87, P177, DOI 10.1017/S0025315407055002; Mustoe S, 2008, VICTORIAN NAT, V125, P76, DOI DOI 10.1371/J0URNAL.P0NE.0136535; Nishiwaki M., 1958, Scientific Reports of the Whales Research Institute Tokyo, VNo. 13, P85; Notarbartolo di Sciara G., 1987, MARINE MAMMAL SCI, V3, P356; Olesiuk P.F., 1990, Reports of the International Whaling Commission Special Issue, P209; Pitman RL, 2001, MAR MAMMAL SCI, V17, P494, DOI 10.1111/j.1748-7692.2001.tb01000.x; Pitman Robert L., 2003, Journal of Cetacean Research and Management, V5, P131; Pitman RL, 2015, MAR MAMMAL SCI, V31, P629, DOI 10.1111/mms.12182; Pitman RL, 2012, MAR MAMMAL SCI, V28, P16, DOI 10.1111/j.1748-7692.2010.00453.x; Pitman RL, 2010, POLAR BIOL, V33, P1589, DOI 10.1007/s00300-010-0853-5; Pitman RL, 2011, POLAR BIOL, V34, P303, DOI 10.1007/s00300-010-0871-3; Ryan Conor, 2012, Marine Biodiversity Records, V5, pe10, DOI 10.1017/S1755267211001187; Tyack PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017009; Visser IN, 2010, AQUAT MAMM, V36, P195, DOI 10.1578/AM.36.2.2010.195; Vongraven D, 2014, J MAR BIOL ASSOC UK, V94, P1357, DOI 10.1017/S0025315413001707; Waring GT, 2001, MAR MAMMAL SCI, V17, P703, DOI 10.1111/j.1748-7692.2001.tb01294.x; Weir CR, 2010, J MAR BIOL ASSOC UK, V90, P1601, DOI 10.1017/S002531541000072X; WHITEHEAD H, 1985, J MAMMAL, V66, P183, DOI 10.2307/1380982; Yamada T, 2007, BIOL INDICES OBTAINE, P15	63	17	19	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2016	11	12							e0166670	10.1371/journal.pone.0166670	http://dx.doi.org/10.1371/journal.pone.0166670			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4MY	27923044	gold, Green Published, Green Submitted			2022-12-26	WOS:000389577900002
J	Hornstein, BD; Roman, D; Arevalo-Soliz, LM; Engevik, MA; Zechiedrich, L				Hornstein, Benjamin D.; Roman, Dany; Arevalo-Soliz, Lirio M.; Engevik, Melinda A.; Zechiedrich, Lynn			Effects of Circular DNA Length on Transfection Efficiency by Electroporation into HeLa Cells	PLOS ONE			English	Article							GENE-THERAPY; MINIVECTOR DNA; NUCLEIC-ACID; EXPRESSION; DELIVERY; VECTORS; PROTEIN; DESIGN; LEVEL; SIZE	The ability to produce extremely small and circular supercoiled vectors has opened new territory for improving non-viral gene therapy vectors. In this work, we compared transfection of supercoiled DNA vectors ranging from 383 to 4,548 bp, each encoding shRNA against GFP under control of the H1 promoter. We assessed knockdown of GFP by electroporation into HeLa cells. All of our vectors entered cells in comparable numbers when electroporated with equal moles of DNA. Despite similar cell entry, we found length-dependent differences in how efficiently the vectors knocked down GFP. As vector length increased up to 1,869 bp, GFP knockdown efficiency per mole of transfected DNA increased. From 1,869 to 4,257 bp, GFP knockdown efficiency per mole was steady, then decreased with increasing vector length. In comparing GFP knockdown with equal masses of vectors, we found that the shorter vectors transfect more efficiently per nanogram of DNA transfected. Our results rule out cell entry and DNA mass as determining factors for gene knockdown efficiency via electroporation. The length-dependent effects we have uncovered are likely explained by differences in nuclear translocation or transcription. These data add an important step towards clinical applications of non-viral vector delivery.	[Hornstein, Benjamin D.; Arevalo-Soliz, Lirio M.; Zechiedrich, Lynn] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Roman, Dany] Baylor Coll Med, Postbaccaleureate Res Educ Program, Houston, TX 77030 USA; [Arevalo-Soliz, Lirio M.; Zechiedrich, Lynn] Baylor Coll Med, Verna & Marrs Mclean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Arevalo-Soliz, Lirio M.; Zechiedrich, Lynn] Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA; [Engevik, Melinda A.] Texas Childrens Hosp, Dept Pathol, Houston, TX 77030 USA; [Roman, Dany] Baylor Coll Med, Integrat Mol & Biomed Sci Grad Program, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Zechiedrich, L (corresponding author), Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA.; Zechiedrich, L (corresponding author), Baylor Coll Med, Verna & Marrs Mclean Dept Biochem & Mol Biol, Houston, TX 77030 USA.; Zechiedrich, L (corresponding author), Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA.	elz@bcm.edu	Zechiedrich, Elizabeth Lynn/S-4720-2019; Engevik, Mindy/P-9725-2018	Engevik, Mindy/0000-0002-9742-9932; Zechiedrich, Lynn/0000-0003-0533-1637	Baylor College of Medicine PREP program NIH [R25 GM069234]; Baylor UT Houston Center for AIDS Research Core Support Grant [P30 A1036211]; NIH [R56 A1054830, R01 GM115501]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115501] Funding Source: NIH RePORTER	Baylor College of Medicine PREP program NIH; Baylor UT Houston Center for AIDS Research Core Support Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	D.R. was supported by the Baylor College of Medicine PREP program NIH R25 GM069234 (Slaughter, PI). This project was supported in part by the Baylor UT Houston Center for AIDS Research Core Support Grant number P30 A1036211 (Butel, PI), and in part by NIH grants R56 A1054830 and R01 GM115501 to L.Z.	Akita H, 2015, PHARMACEUTICS, V7, P64, DOI 10.3390/pharmaceutics7020064; Carnes AE, 2010, J GENE MED, V12, P818, DOI 10.1002/jgm.1499; Catanese DJ, 2012, GENE THER, V19, P94, DOI 10.1038/gt.2011.77; Chen ZY, 2003, MOL THER, V8, P495, DOI 10.1016/S1525-0016(03)00168-0; Corish P, 1999, PROTEIN ENG, V12, P1035, DOI 10.1093/protein/12.12.1035; Dean DA, 2005, GENE THER, V12, P881, DOI 10.1038/sj.gt.3302534; Gowers DM, 2005, P NATL ACAD SCI USA, V102, P15883, DOI 10.1073/pnas.0505378102; Halford SE, 2004, NUCLEIC ACIDS RES, V32, P3040, DOI 10.1093/nar/gkh624; Kim JA, 2008, BIOSENS BIOELECTRON, V23, P1353, DOI 10.1016/j.bios.2007.12.009; Kobelt D, 2013, MOL BIOTECHNOL, V53, P80, DOI 10.1007/s12033-012-9535-6; Kohn DB, 2003, NAT REV CANCER, V3, P477, DOI 10.1038/nrc1122; Kreiss P, 1999, NUCLEIC ACIDS RES, V27, P3792, DOI 10.1093/nar/27.19.3792; Layek B, 2015, INT J MOL SCI, V16, P28912, DOI 10.3390/ijms161226142; Ludtke JJ, 1999, J CELL SCI, V112, P2033; Maniar LEG, 2013, MOL THER, V21, P131, DOI 10.1038/mt.2012.244; Martin T., 2015, IEEE T NANOBIOSCIENC; Myer VE, 1998, J BIOL CHEM, V273, P27757, DOI 10.1074/jbc.273.43.27757; Rao RC, 2014, DEV OPHTHALMOL, V53, P167, DOI 10.1159/000357376; Rosazza C, 2016, MOL THER-NUCL ACIDS, V5, P1, DOI 10.1038/mtna.2015.59; Rosazza C, 2013, MOL THER, V21, P2217, DOI 10.1038/mt.2013.182; Safinya CR, 2014, NEW J CHEM, V38, P5164, DOI 10.1039/c4nj01314j; Stenler S, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2013.67; Szafran AT, 2014, ASSAY DRUG DEV TECHN, V12, P87, DOI 10.1089/adt.2013.532; Wen Q, 2015, BMC SYST BIOL, V9, DOI 10.1186/1752-0509-9-S5-S4; Williams JA, 2014, CURR GENE THER, V14, P170, DOI 10.2174/156652321403140819122538; Wirth T, 2013, GENE, V525, P162, DOI 10.1016/j.gene.2013.03.137; Zhao N, 2011, GENE THER, V18, P220, DOI 10.1038/gt.2010.123	27	41	42	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2016	11	12							e0167537	10.1371/journal.pone.0167537	http://dx.doi.org/10.1371/journal.pone.0167537			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4MR	27918590	Green Published, gold, Green Submitted			2022-12-26	WOS:000389577100014
J	Mashock, MJ; Zanon, T; Kappell, AD; Petrella, LN; Andersen, EC; Hristova, KR				Mashock, Michael J.; Zanon, Tyler; Kappell, Anthony D.; Petrella, Lisa N.; Andersen, Erik C.; Hristova, Krassimira R.			Copper Oxide Nanoparticles Impact Several Toxicological Endpoints and Cause Neurodegeneration in Caenorhabditis elegans	PLOS ONE			English	Article							NATURAL VARIATION; DAPHNIA-MAGNA; TOXICITY; SILVER; SENSITIVITY; ALZHEIMERS; RESISTANCE; DISORDERS; MECHANISM; GENETICS	Engineered nanoparticles are becoming increasingly incorporated into technology and consumer products. In 2014, over 300 tons of copper oxide nanoparticles were manufactured in the United States. The increased production of nanoparticles raises concerns regarding the potential introduction into the environment or human exposure. Copper oxide nanoparticles commonly release copper ions into solutions, which contribute to their toxicity. We quantified the inhibitory effects of both copper oxide nanoparticles and copper sulfate on C. elegans toxicological endpoints to elucidate their biological effects. Several toxicological endpoints were analyzed in C. elegans, including nematode reproduction, feeding behavior, and average body length. We examined three wild C. elegans isolates together with the Bristol N2 laboratory strain to explore the influence of different genotypic backgrounds on the physiological response to copper challenge. All strains exhibited greater sensitivity to copper oxide nanoparticles compared to copper sulfate, as indicated by reduction of average body length and feeding behavior. Reproduction was significantly reduced only at the highest copper dose, though still more pronounced with copper oxide nanoparticles compared to copper sulfate treatment. Furthermore, we investigated the effects of copper oxide nanoparticles and copper sulfate on neurons, cells with known vulnerability to heavy metal toxicity. Degeneration of dopaminergic neurons was observed in up to 10% of the population after copper oxide nanoparticle exposure. Additionally, mutants in the divalent-metal transporters, smf-1 or smf-2, showed increased tolerance to copper exposure, implicating both transporters in copper-induced neurodegeneration. These results highlight the complex nature of CuO nanoparticle toxicity, in which a nanoparticle-specific effect was observed in some traits (average body length, feeding behavior) and a copper ion specific effect was observed for other traits (neurodegeneration, response to stress).	[Mashock, Michael J.; Zanon, Tyler; Kappell, Anthony D.; Petrella, Lisa N.; Hristova, Krassimira R.] Marquette Univ, Dept Biol Sci, Milwaukee, WI 53233 USA; [Andersen, Erik C.] Northwestern Univ, Dept Mol Biosci, Evanston, IL USA	Marquette University; Northwestern University	Hristova, KR (corresponding author), Marquette Univ, Dept Biol Sci, Milwaukee, WI 53233 USA.	krassimira.hristova@marquette.edu			National Institute of Environmental Health Sciences; Children's Environmental Health Sciences Core Center grant [P30ES004184-24, ES-04184]; National Institute of Health R01 [GM107227]; Marquette University	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Children's Environmental Health Sciences Core Center grant; National Institute of Health R01(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marquette University	This work was supported by a National Institute of Environmental Health Sciences, Children's Environmental Health Sciences Core Center grant number P30ES004184-24, subcontract ES-04184 to K.R.H. and a National Institute of Health R01 subcontract GM107227 to ECA. Additional funding was provided by Marquette University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen EC, 2015, G3 GENES GENOMES GEN; Andersen EC, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004156; Andersen EC, 2012, NAT GENET, V44, P285, DOI 10.1038/ng.1050; Au C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007792; Baek YW, 2011, SCI TOTAL ENVIRON, V409, P1603, DOI 10.1016/j.scitotenv.2011.01.014; Bergin Ingrid L, 2013, Int J Biomed Nanosci Nanotechnol, V3, DOI 10.1504/IJBNN.2013.054515; Bondarenko O, 2013, ARCH TOXICOL, V87, P1181, DOI 10.1007/s00204-013-1079-4; Boyd WA, 2003, ENVIRON TOXICOL CHEM, V22, P2768, DOI 10.1897/02-573; Boyd WA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001259; Boyd WA, 2010, NEUROTOXICOL TERATOL, V32, P68, DOI 10.1016/j.ntt.2008.12.004; BRENNER S, 1974, GENETICS, V77, P71; Browne RA, 2002, J EXP MAR BIOL ECOL, V267, P107, DOI 10.1016/S0022-0981(01)00363-X; Bush AI, 2003, TRENDS NEUROSCI, V26, P207, DOI 10.1016/S0166-2236(03)00067-5; Calafato S, 2008, TOXICOL SCI, V106, P384, DOI 10.1093/toxsci/kfn180; Cerpa Waldo, 2005, Molecular Aspects of Medicine, V26, P405, DOI 10.1016/j.mam.2005.07.011; Cha YJ, 2012, CHEMOSPHERE, V87, P49, DOI 10.1016/j.chemosphere.2011.11.054; Chen P, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00018; Chu KW, 2005, AQUAT TOXICOL, V74, P320, DOI 10.1016/j.aquatox.2005.06.006; Connor EE, 2005, SMALL, V1, P325, DOI 10.1002/smll.200400093; Cook DE, 2016, GENETICS; Deng SB, 2005, WATER RES, V39, P2167, DOI 10.1016/j.watres.2005.03.033; Dengg Marlene, 2004, Journal of Pharmacological and Toxicological Methods, V50, P209, DOI 10.1016/j.vascn.2004.04.002; Du M, 2009, ENVIRON TOXICOL PHAR, V27, P314, DOI 10.1016/j.etap.2008.11.011; Ellegaard-Jensen L, 2012, ECOTOX ENVIRON SAFE, V80, P216, DOI 10.1016/j.ecoenv.2012.03.003; Farhadifar R, 2015, CURR BIOL, V25, P732, DOI 10.1016/j.cub.2014.12.060; Frezal L, 2015, ELIFE, V4, DOI 10.7554/eLife.05849; Gaertner BE, 2010, GENET RES, V92, P331, DOI 10.1017/S0016672310000601; Gaggelli E, 2006, CHEM REV, V106, P1995, DOI 10.1021/cr040410w; Ghosh R, 2012, SCIENCE, V335, P574, DOI 10.1126/science.1214318; Gomes SIL, 2012, COMP BIOCHEM PHYS C, V155, P219, DOI 10.1016/j.cbpc.2011.08.008; Harada H, 2007, ECOTOX ENVIRON SAFE, V66, P378, DOI 10.1016/j.ecoenv.2006.02.017; Heinlaan M, 2011, WATER RES, V45, P179, DOI 10.1016/j.watres.2010.08.026; Hodgkin J, 1997, GENETICS, V146, P149; Kasemets K, 2013, CHEM RES TOXICOL, V26, P356, DOI 10.1021/tx300467d; Keller AA, 2014, ENVIRON SCI TECH LET, V1, P65, DOI 10.1021/ez400106t; Keller AA, 2013, J NANOPART RES, V15, DOI 10.1007/s11051-013-1692-4; Koch R, 2000, GENOME RES, V10, P1690, DOI 10.1101/gr.GR-1471R; Lim D, 2012, ENVIRON TOXICOL CHEM, V31, P585, DOI 10.1002/etc.1706; Ma HB, 2009, ENVIRON TOXICOL CHEM, V28, P1324, DOI 10.1897/08-262.1; Madsen E, 2007, ANNU REV NEUROSCI, V30, P317, DOI 10.1146/annurev.neuro.30.051606.094232; Martinez-Finley EJ, 2011, METALLOMICS, V3, P271, DOI 10.1039/c0mt00064g; Mashock MJ, 2015, ENV TOXICOLOGY CHEM; Maydan JS, 2007, GENOME RES, V17, P337, DOI 10.1101/gr.5690307; Mudunkotuwa IA, 2012, ENVIRON SCI TECHNOL, V46, P7001, DOI 10.1021/es203851d; Peterson RT, 2008, NEUROTOXICOLOGY, V29, P546, DOI 10.1016/j.neuro.2008.04.006; Petrella LN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112377; R Core Team, 2012, R LANG ENV STAT COMP; Raizen David, 2012, WormBook, P1, DOI 10.1895/wormbook.1.154.1; Rui-xia PJ-hL, SURFACE REACTION BAC; Schrand AM, 2010, WIRES NANOMED NANOBI, V2, P544, DOI 10.1002/wnan.103; Semisch A, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/1743-8977-11-10; Settivari R, 2009, J BIOL CHEM, V284, P35758, DOI 10.1074/jbc.M109.051409; Shi JY, 2011, ENVIRON POLLUT, V159, P1277, DOI 10.1016/j.envpol.2011.01.028; Shimko TC, COPASUTILS R PACKAGE; So SH, 2011, GENES CELLS, V16, P639, DOI 10.1111/j.1365-2443.2011.01514.x; Song SJ, 2014, ARCH ENVIRON CON TOX, V66, P390, DOI 10.1007/s00244-013-9991-4; Sterken MG, TRENDS GENETICS, V31, P224; Stiernagle Theresa, 2006, WormBook, P1; Thompson OA, 2015, GENETICS, V200, P975, DOI 10.1534/genetics.115.175950; Unrine JM, 2010, J ENVIRON QUAL, V39, P1942, DOI 10.2134/jeq2009.0387; Warming TP, 2009, ENVIRON TOXICOL CHEM, V28, P374, DOI 10.1897/08-279.1; Weston DP, 2013, P NATL ACAD SCI USA, V110, P16532, DOI 10.1073/pnas.1302023110; Wu QL, 2013, CHEMOSPHERE, V90, P1123, DOI 10.1016/j.chemosphere.2012.09.019; Yang XY, 2012, ENVIRON SCI TECHNOL, V46, P1119, DOI 10.1021/es202417t; Yu ZY, 2012, CHEMOSPHERE, V87, P1361, DOI 10.1016/j.chemosphere.2012.02.029; Zhang YC, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0044465, 10.1155/2012/583417]	66	33	34	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0167613	10.1371/journal.pone.0167613	http://dx.doi.org/10.1371/journal.pone.0167613			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3TF	27911941	gold, Green Published, Green Submitted			2022-12-26	WOS:000389520600047
J	Balansky, R; La Maestra, S; Micale, RT; Iltcheva, M; Kirov, K; De Flora, S				Balansky, Roumen; La Maestra, Sebastiano; Micale, Rosanna T.; Iltcheva, Marietta; Kirov, Krassimir; De Flora, Silvio			Modulation by Ethanol of Cigarette Smoke Clastogenicity in Cells of Adult Mice and of Transplacentally Exposed Fetuses	PLOS ONE			English	Article							TOBACCO-SMOKE; MICRONUCLEUS TEST; DNA-ADDUCTS; RAT-LIVER; ALCOHOL; CARCINOGENESIS; LUNG; ACETALDEHYDE; CONSUMPTION; PROTECTION	Cigarette smoke (CS) and ethanol (EtOH) are known to synergize in the causation of cancers of the upper aerodigestive tract and of the liver. Little is known about possible interactions between these agents in other organs. These premises prompted us to evaluate the clastogenic effects resulting from the inhalation for 3 weeks of mainstream CS and oral administration of EtOH, which were tested either individually or in combination in cells of adult BDF1 mice and their fetuses. CS exerted clastogenic effects in haematopoietic cells of adult male mice by increasing the frequency of micronucleated erythroid cells both in bone marrow and in peripheral blood as well as the frequency of micronucleated and polynucleated pulmonary alveolar macrophages. Likewise, exposure to CS of pregnant mice resulted in a clastogenic damage in maternal bone marrow cells and in the liver and peripheral blood of their fetuses. Under all experimental conditions, EtOH was consistently devoid of clastogenic effects when given alone. In adult mice, EtOH exhibited a mild stimulating effect on the clastogenicity of CS in haematopoietic cells, while an opposite effect was observed in the respiratory tract, where EtOH attenuated the cytogenetic alterations induced by CS in pulmonary alveolar macrophages. At variance with the mild synergism observed in haematopoietic cells of adult mice, EtOH inhibited the clastogenicity of CS in the liver and peripheral blood cells of transplacentally exposed fetuses. Therefore, the effects of EtOH in CS-exposed mice show different trends depending both on the life stage and on the cells analyzed.	[Balansky, Roumen; Iltcheva, Marietta; Kirov, Krassimir] Natl Oncol Ctr, Sofia, Bulgaria; [La Maestra, Sebastiano; Micale, Rosanna T.; De Flora, Silvio] Univ Genoa, Dept Hlth Sci, Genoa, Italy	National Oncology Center - Bulgaria; University of Genoa	De Flora, S (corresponding author), Univ Genoa, Dept Hlth Sci, Genoa, Italy.	sdf@unige.it	Micale, Rosanna Tindara/AAH-5665-2019	Micale, Rosanna Tindara/0000-0003-4361-2624; LA MAESTRA, SEBASTIANO/0000-0003-4939-2124	Bulgarian Ministry of Education and Science (National Research Fund); Hasumi International Research Foundation - Bulgaria	Bulgarian Ministry of Education and Science (National Research Fund); Hasumi International Research Foundation - Bulgaria	This work was supported by the Bulgarian Ministry of Education and Science (National Research Fund) and by the Hasumi International Research Foundation - Bulgaria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balansky R, 2016, TOXICOLOGY; BALANSKY RB, 1992, CANCER LETT, V64, P123, DOI 10.1016/0304-3835(92)90072-4; BALANSKY RM, 1989, MUTAT RES, V223, P1, DOI 10.1016/0165-1218(89)90056-6; BALANSKY RM, 1993, CANCER LETT, V72, P183, DOI 10.1016/0304-3835(93)90127-U; BALANSKY RM, 1988, MUTAT RES, V208, P237, DOI 10.1016/0165-7992(88)90067-X; BALANSKY RM, 1987, MUTAT RES, V188, P13, DOI 10.1016/0165-1218(87)90109-1; Balansky RM, 1999, CARCINOGENESIS, V20, P1491, DOI 10.1093/carcin/20.8.1491; BALANSKY RM, 1995, CANCER LETT, V94, P91, DOI 10.1016/0304-3835(95)03829-L; Balansky R, 2007, CARCINOGENESIS, V28, P2236, DOI 10.1093/carcin/bgm122; Balansky R, 2012, INT J CANCER, V130, P1001, DOI 10.1002/ijc.26103; Balbo S, 2015, ADV EXP MED BIOL, V815, P71, DOI 10.1007/978-3-319-09614-8_5; Carpenter SP, 1997, J PHARMACOL EXP THER, V282, P1028; De Flora S, 2016, TRENDS PHARMACOL SCI, V37, P120, DOI 10.1016/j.tips.2015.11.003; De Flora S, 2012, INT J CANCER, V131, P2763, DOI 10.1002/ijc.27814; DEFLORA S, 1995, MUTAGENESIS, V10, P47; DeMarini DM, 2004, MUTAT RES-REV MUTAT, V567, P447, DOI 10.1016/j.mrrev.2004.02.001; Dhouib H, 2015, PATHOL BIOL, V63, P258, DOI 10.1016/j.patbio.2015.10.001; Florek E, 2008, PHARMACOL REP, V60, P985; GARRO AJ, 1991, ALCOHOL CLIN EXP RES, V15, P395, DOI 10.1111/j.1530-0277.1991.tb00536.x; GREEN GM, 1977, AM REV RESPIR DIS, V115, P479; Hecht SS, 2012, INT J CANCER, V131, P2724, DOI 10.1002/ijc.27816; Howard LA, 2001, J PHARMACOL EXP THER, V299, P542; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Biological agents, 2012, IARC MON EV CARC RIS, V100; International Agency for Research on Cancer, 2004, IARC MON EV CARC RIS, V83; International Agency for Research on Cancer World Health Organization, 2010, IARC MON EV CARC RIS, V96; Izzotti A, 1998, FASEB J, V12, P753, DOI 10.1096/fasebj.12.9.753; KORTE A, 1981, TOXICOLOGY, V20, P237, DOI 10.1016/0300-483X(81)90054-8; KRISTIANSEN E, 1990, FOOD CHEM TOXICOL, V28, P35, DOI 10.1016/0278-6915(90)90133-8; Linhart K, 2014, REDOX BIOL, V3, P56, DOI 10.1016/j.redox.2014.08.009; MAVOURNIN KH, 1990, MUTAT RES, V239, P29, DOI 10.1016/0165-1110(90)90030-F; Navasumrit P, 2001, MUTAT RES-FUND MOL M, V479, P81, DOI 10.1016/S0027-5107(01)00156-7; Przyblowska M, 2013, PHARM REP, V65, P906; Riedel F, 2003, BEST PRACT RES CL GA, V17, P543, DOI 10.1016/S1521-6918(03)00019-2; SCHMID W, 1975, MUTAT RES, V31, P9, DOI 10.1016/0165-1161(75)90058-8; Schoedel KA, 2003, BIOCHIM BIOPHYS ACTA, V17, P283; Seitz HK, 2015, ADV EXP MED BIOL, V815, P59, DOI 10.1007/978-3-319-09614-8_4; STICH HF, 1983, INT J CANCER, V31, P305, DOI 10.1002/ijc.2910310309; Trosko JE, 2006, CONTRIB MICROBIOL, V13, P45, DOI 10.1159/000092965	38	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167239	10.1371/journal.pone.0167239	http://dx.doi.org/10.1371/journal.pone.0167239			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907070	Green Published, Green Submitted, gold			2022-12-26	WOS:000389482700101
J	Hsu, YC; Chang, CW; Lee, HL; Chuang, CC; Chiu, HC; Li, WY; Horng, JT; Fu, E				Hsu, Yung-Chuang; Chang, Cheng-Wei; Lee, Hsin-Lin; Chuang, Chuan-Chung; Chiu, Hsien-Chung; Li, Wan-Yun; Horng, Jorng-Tzong; Fu, Earl			Association between History of Dental Amalgam Fillings and Risk of Parkinson's Disease: A Population-Based Retrospective Cohort Study in Taiwan	PLOS ONE			English	Article							CLINICAL COMORBIDITY INDEX; ALZHEIMERS-DISEASE; METABOLIC SYNDROME; NATIONWIDE COHORT; OXIDATIVE STRESS; ROOT-CARIES; MERCURY; HEALTH; PREVALENCE; NEURODEGENERATION	The impact of dental amalgam on the development of Parkinson's disease (PD) is still uncertain, although a positive association between dental amalgam and PD has been found in a few case-control studies. The patients with amalgam fillings restored between 2000 and 2008 were identified by using the National Health Insurance Research Database (NHIRD) in Taiwan. The same number of patients who had no new amalgam filling restored was matched by sex, age, and treatment date. Both cohorts were followed up from the treatment date until the date of diagnosis of PD, death, or the end of the year 2008. The individuals who received amalgam fillings had a significantly higher risk of PD afterward (adjusted hazard ratio [HR]=1.583, 95% confidence interval [CI]=1.122-2.234, p=0.0089) than those who did not. In the individuals who received amalgam fillings, being diagnosed with diabetes or hyperlipidemia demonstrated a significantly lower HR of PD occurrence than in the patients without diabetes or hyperlipidemia (HR=0.449, 95% CI=0.254-0.794, p=0.0059; HR=0.445, 95% CI=0.260-0.763, p=0.0032) after adjusting for comorbidities and Charlson-Deyo Comorbidity Index (CCI) scores. Meanwhile, hypertension increased the hazard risk of PD (HR=1.645, 95% CI=1.098-2.464, p=0.0159). The patients exposed to dental amalgam fillings were 1.583 times more likely to have PD afterward compared to their non-exposed counterparts after adjusting for comorbidities and CCI scores.	[Hsu, Yung-Chuang; Lee, Hsin-Lin; Chuang, Chuan-Chung; Chiu, Hsien-Chung; Fu, Earl] Tri Serv Gen Hosp, Dept Dent, Taipei, Taiwan; [Hsu, Yung-Chuang; Lee, Hsin-Lin; Chuang, Chuan-Chung; Chiu, Hsien-Chung; Fu, Earl] Natl Def Med Ctr, Taipei, Taiwan; [Chang, Cheng-Wei] Hsing Wu Univ, Dept Informat Management, New Taipei, Taiwan; [Li, Wan-Yun; Horng, Jorng-Tzong] Natl Cent Univ, Dept Comp Sci & Informat Engn, Chungli, Taiwan; [Horng, Jorng-Tzong] Asia Univ Taiwan, Dept Biomed Informat, Populat Hlth & Clin Informat Res Grp, Taichung, Taiwan	Tri-Service General Hospital; National Defense Medical Center; National Central University; Asia University Taiwan	Fu, E (corresponding author), Tri Serv Gen Hosp, Dept Dent, Taipei, Taiwan.; Fu, E (corresponding author), Natl Def Med Ctr, Taipei, Taiwan.	dentalab@tpts5.seed.net.tw		Fu, Earl/0000-0003-0637-0208				Allam MF, 2005, NEUROL RES, V27, P206, DOI 10.1179/016164105X22057; Aschner M, 2007, BRAZ J MED BIOL RES, V40, P285, DOI 10.1590/S0100-879X2007000300001; Bates MN, 2004, INT J EPIDEMIOL, V33, P894, DOI 10.1093/ije/dyh164; Brailsford SR, 2001, J DENT RES, V80, P1828, DOI 10.1177/00220345010800091101; Bratel J, 1997, EUR J ORAL SCI, V105, P234, DOI 10.1111/j.1600-0722.1997.tb00206.x; Burt B A, 1992, Clin Geriatr Med, V8, P447; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Clarkson TW, 2006, CRIT REV TOXICOL, V36, P609, DOI 10.1080/10408440600845619; Clarkson TW, 2002, ENVIRON HEALTH PERSP, V110, P11, DOI 10.1289/ehp.02110s111; Correa MB, 2012, J DENT, V40, P703, DOI 10.1016/j.jdent.2012.04.020; Cullinan MP, 2009, AUST DENT J, V54, pS62, DOI 10.1111/j.1834-7819.2009.01144.x; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Farina M, 2013, NEUROCHEM INT, V62, P575, DOI 10.1016/j.neuint.2012.12.006; FERRACANE J L, 1992, General Dentistry, V40, P223; Garton BJ, 2012, AUST DENT J, V57, P114, DOI 10.1111/j.1834-7819.2012.01690.x; Glaser V, 2010, NEUROTOXICOLOGY, V31, P454, DOI 10.1016/j.neuro.2010.05.012; Hindle JV, 2010, AGE AGEING, V39, P156, DOI 10.1093/ageing/afp223; Hsu CC, 2011, J ALZHEIMERS DIS, V24, P485, DOI 10.3233/JAD-2011-101524; Hsu YT, 2015, AM J GERIAT PSYCHIAT, V23, P934, DOI 10.1016/j.jagp.2014.10.011; Hu SW, 2002, BRIT DENT J, V193, P411, DOI 10.1038/sj.bdj.4801577; Huang XM, 2004, NEUROLOGY, V62, P2198, DOI 10.1212/01.WNL.0000130159.28215.6A; Hwang LC, 2006, J FORMOS MED ASSOC, V105, P626, DOI 10.1016/S0929-6646(09)60161-3; Jawed M, 2011, J DIABETES COMPLICAT, V25, P183, DOI 10.1016/j.jdiacomp.2010.07.001; Langworth S, 1997, J DENT RES, V76, P1397, DOI 10.1177/00220345970760071001; Leistevuo J, 2001, CARIES RES, V35, P163, DOI 10.1159/000047450; Liu WM, 2016, J FORMOS MED ASSOC, V115, P531, DOI 10.1016/j.jfma.2015.05.014; Lopez-Real A, 2005, J NEUROSCI RES, V81, P865, DOI 10.1002/jnr.20598; Lu L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085781; Mattson MP, 2009, EXP GERONTOL, V44, P625, DOI 10.1016/j.exger.2009.07.003; Nabi S, 2014, TOXIC EFFECT MERCURY, P308, DOI [10.1016/j.cden.2004.10.004, DOI 10.1016/J.CDEN.2004.10.004]; NGIM CH, 1989, NEUROEPIDEMIOLOGY, V8, P128, DOI 10.1159/000110175; Papapetropoulos S, 2004, EUR J NEUROL, V11, P231, DOI 10.1046/j.1468-1331.2003.00748.x; Qiu CX, 2010, J ALZHEIMERS DIS, V20, P689, DOI 10.3233/JAD-2010-091663; Rodriguez-Farre E, 2016, REGUL TOXICOL PHARM; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1075, DOI 10.1016/0895-4356(93)90103-8; Santiago JA, 2013, TRENDS MOL MED, V19, P176, DOI 10.1016/j.molmed.2013.01.002; Satoh H, 2000, IND HEALTH, V38, P153, DOI 10.2486/indhealth.38.153; Saunders Ralph H Jr, 2005, Dent Clin North Am, V49, P293; Seidler A, 1996, NEUROLOGY, V46, P1275, DOI 10.1212/WNL.46.5.1275; Tang CF, 2016, ACTA NEUROL SCAND, V134, P148, DOI 10.1111/ane.12524; Teunissen CE, 2003, NEUROBIOL AGING, V24, P893, DOI 10.1016/S0197-4580(03)00005-8; Timonen P, 2010, J DENT RES, V89, P1068, DOI 10.1177/0022034510376542; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Wahlqvist ML, 2012, PARKINSONISM RELAT D, V18, P753, DOI 10.1016/j.parkreldis.2012.03.010; Zorzon M, 2002, ACTA NEUROL SCAND, V105, P77, DOI 10.1034/j.1600-0404.2002.1o040.x	45	20	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166552	10.1371/journal.pone.0166552	http://dx.doi.org/10.1371/journal.pone.0166552			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27906991	Green Published, Green Submitted, gold			2022-12-26	WOS:000389482700029
J	Jobarteh, K; Shiraishi, RW; Malimane, I; Gudo, PS; Decroo, T; Auld, AF; Macome, V; Couto, A				Jobarteh, Kebba; Shiraishi, Ray W.; Malimane, Inacio; Gudo, Paula Samo; Decroo, Tom; Auld, Andrew F.; Macome, Vania; Couto, Aleny			Community ART Support Groups in Mozambique: The Potential of Patients as Partners in Care	PLOS ONE			English	Article							ANTIRETROVIRAL TREATMENT; MORTALITY; ADHERENCE; THERAPY	Background High rates of attrition are stymying Mozambique's national HIV Program's efforts to achieve 80% treatment coverage. In response, Mozambique implemented a national pilot of Community Adherence and Support Groups (CASG). CASG is a model in which antiretroviral therapy (ART) patients form groups of up to six patients. On a rotating basis one CASG group member collects ART medications at the health facility for all group members, and distributes those medications to the other members in the community. Patients also visit their health facility bi-annually to receive clinical services. Methods A matched retrospective cohort study was implemented using routinely collected patient level data in 68 health facilities with electronic data systems and CASG programs. A total of 129,938 adult ART patients were registered in those facilities. Of the 129,938 patients on ART, 6,760 were CASG members. A propensity score matched analysis was performed to assess differences in mortality and loss to follow-up (LTFU) between matched CASG and non-CASG members. Propensity scores were estimated using a random-effects logistic regression model. The following covariates where included in the model: sex, educational status, WHO stage, year of ART initiation, age, CASG eligibility, CD4 cell count category, weight, and employment status. Results Non-CASG participants had higher LTFU rates (HR 2.356; p = 0.04) than matched CASG participants; however, there were no significant mortality differences between CASG and non-CASG participants. Compared with the full cohort of non-CASG members, CASG members were more likely to be female (74% vs. 68%), tended to have a lower median CD4 counts at ART initiation (183 cells/m3 vs. 200cells/m3) and be less likely to have a second ary school education (15% vs. 23%). Conclusion ART patients enrolled in CASG were significantly less likely to be LTFU compared to matched patients who did not join CASG. CASG appears to be an effective strategy to decrease LTFU in Mozambique's national ART program.	[Jobarteh, Kebba; Malimane, Inacio; Gudo, Paula Samo] Ctr Dis Control & Prevent, Ctr Global Hlth, Div Global HIV AIDS, Maputo, Mozambique; [Shiraishi, Ray W.; Auld, Andrew F.] Ctr Dis Control & Prevent, Div Global HIV AIDS, Ctr Global Hlth, Atlanta, GA USA; [Decroo, Tom] Operat Ctr Brussels, Med Sans Frontieres, Dept Med, Brussels, Belgium; [Macome, Vania; Couto, Aleny] Mozamb Minist Hlth, Maputo, Mozambique	Centers for Disease Control & Prevention - USA; Doctors Without Borders	Jobarteh, K (corresponding author), Ctr Dis Control & Prevent, Ctr Global Hlth, Div Global HIV AIDS, Maputo, Mozambique.	kebba@mac.com	Decroo, Tom/AAV-7208-2020	Decroo, Tom/0000-0002-1205-1484; Shiraishi, Ray/0000-0001-7640-0666; Auld, Andrew/0000-0001-5089-9163				Austin PC, 2008, STAT MED, V27, P2037, DOI 10.1002/sim.3150; Austin PC, 2007, STAT MED, V26, P734, DOI 10.1002/sim.2580; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Decroo T, 2013, INT STD RES REV, V12, P49; Decroo T, 2011, JAIDS-J ACQ IMM DEF, V56, pE39, DOI 10.1097/QAI.0b013e3182055138; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Gifford AL, 2002, JAIDS-J ACQ IMM DEF, V31, pS163, DOI 10.1097/00126334-200212153-00016; Joint United Nations Program on HIV/AIDS, 2014, JOINT UN PROGR HIV A, P14; Lawn SD, 2009, AIDS, V23, P335, DOI 10.1097/QAD.0b013e328321823f; Leuven E, 2014, PSMATCH2 STATA MODUL; Lunt M., 2012, MPBALCHK STATA MODUL; Lunt M., 2012, PBALCHK STATA MODULE; Mermin J, 2008, LANCET, V371, P752, DOI 10.1016/S0140-6736(08)60345-1; MISAU, 2010, INQ NAC PREV RISC CO; Mitra R, 2016, STAT METHODS MED RES, V25, P188, DOI 10.1177/0962280212445945; National Program on HIV AIDS STIs, 2015, NAT PROGR HIV AIDS S; National Program on HIV AIDS STIs, 2011, NAT PROGR HIV AIDS S; Rasschaert F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091544; Rubin DB, 2004, MULTIPLE IMPUTATION; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; The United National Development Program. Human Development Index Trends, 1980, HUM DEV IND TRENDS 1; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; Weidle PJ, 2006, LANCET, V368, P1587, DOI 10.1016/S0140-6736(06)69118-6; Wools-Kaloustian KK, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-22; World Health Organization, 2009, WHOHTMNTDWHOPES20094	25	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166444	10.1371/journal.pone.0166444	http://dx.doi.org/10.1371/journal.pone.0166444			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907084	Green Published, gold			2022-12-26	WOS:000389482700027
J	Kappas, I; Vittas, S; Pantzartzi, CN; Drosopoulou, E; Scouras, ZG				Kappas, Ilias; Vittas, Spiros; Pantzartzi, Chrysoula N.; Drosopoulou, Elena; Scouras, Zacharias G.			A Time-Calibrated Mitogenome Phylogeny of Catfish (Teleostei: Siluriformes)	PLOS ONE			English	Article							COMPLETE MITOCHONDRIAL GENOME; OTOPHYSAN FISHES OSTARIOPHYSI; DNA GENOME; MOLECULAR PHYLOGENETICS; EVOLUTIONARY HISTORY; COMPLETE SEQUENCE; ORIGIN; BIOGEOGRAPHY; NUCLEAR; INTERRELATIONSHIPS	A very significant part of the world's freshwater ichthyofauna is represented by ancient, exceptionally diverse and cosmopolitan ray-finned teleosts of the order Siluriformes. Over the years, catfish have been established as an exemplary model for probing historical biogeography at various scales. Yet, several tantalizing gaps still exist in their phylogenetic history, timeline and mode of diversification. Here, we re-examine the phylogeny of catfish by assembling and analyzing almost all publicly available mitogenome data. We constructed an ingroup matrix of 62 full-length mitogenome sequences from 20 catfish families together with four cypriniform outgroups, spanning 15,557 positions in total. Partitioned maximum likelihood analyses and Bayesian relaxed clock dating using fossil age constraints provide some useful and novel insights into the evolutionary history of this group. Loricarioidei are recovered as the first siluriform group to diversify, rendering Neotropics the cradle of the order. The next deepest clade is the South American Diplomystoidei placed as a sister group to all the remaining Siluroidei. The two multifamilial clades of "Big Asia" and "Big Africa" are also recovered, albeit nodal support for the latter is poor. Within "Big Asia", Bagridae are clearly polyphyletic. Other interfamilial relationships, including Clariidae + Heteropneustidae, Doradidae + Auchenipteridae and Ictaluridae + Cranoglanididae are robustly resolved. Our chronogram shows that siluriforms have a Pangaean origin, at least as far back as the Early Cretaceous. The inferred timeline of the basal splits corroborates the "Out-of-South America" hypothesis and accords well with the fossil record. The divergence of Siluroidei most likely postdated the final separation of Africa and South America. An appealing case of phylogenetic affinity elaborated by biogeographic dispersal is exemplified by the Early Paleogene split between the Southeast Asian Cranoglanididae and Ictaluridae, with the latter radiating into North America's freshwater realm by Eocene. The end of Cretaceous probably concludes the major bout of diversification at the family level while with the dawn of the Cenozoic a prolific radiation is evident at the generic level.	[Kappas, Ilias; Vittas, Spiros; Pantzartzi, Chrysoula N.; Drosopoulou, Elena; Scouras, Zacharias G.] Aristotle Univ Thessaloniki, Sch Biol, Dept Genet Dev & Mol Biol, Thessaloniki, Greece; [Vittas, Spiros] Eurogenet MSA, Thessaloniki, Greece; [Pantzartzi, Chrysoula N.] Inst Mol Genet, Dept Transcript Regulat, Prague, Czech Republic	Aristotle University of Thessaloniki; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences	Scouras, ZG (corresponding author), Aristotle Univ Thessaloniki, Sch Biol, Dept Genet Dev & Mol Biol, Thessaloniki, Greece.	scouras@bio.auth.gr	Kappas, Ilias/AAB-5286-2021; DROSOPOULOU, ELENA/N-2176-2015; Drosopoulou, Elena/AAX-6493-2020; Pantzartzi, Chrysoula/C-2683-2017	Kappas, Ilias/0000-0002-8564-7035; Drosopoulou, Elena/0000-0001-9805-0572; Vittas, Spiros/0000-0003-2879-6074				Alfaro ME, 2009, P NATL ACAD SCI USA, V106, P13410, DOI 10.1073/pnas.0811087106; [Anonymous], 1981, ECLOGAE GEOL HELV; Benton MJ, 2015, PALAEONTOL ELECTRON, V18; Betancur-R R., 2013, PLOS CURR; Betancur-R R, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-175; Briggs JC, 2005, J BIOGEOGR, V32, P287, DOI 10.1111/j.1365-2699.2004.01170.x; Broughton RE, 2001, GENOME RES, V11, P1958, DOI 10.1101/gr.156801; Bruton MN, 1996, AQUAT LIVING RESOUR, V9, P35, DOI 10.1051/alr:1996040; Calcagnotto D, 2005, MOL PHYLOGENET EVOL, V36, P135, DOI 10.1016/j.ympev.2005.01.004; Cavender T.M., 1991, Fish and Fisheries Series, P34; CHANG YS, 1994, J MOL EVOL, V38, P138, DOI 10.1007/BF00166161; Chen WJ, 2013, EVOLUTION, V67, P2218, DOI 10.1111/evo.12104; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Diogo R, 2004, ANIM BIOL, V54, P331, DOI 10.1163/1570756042729546; Diogo R, 2009, GONORYNCHIFORMES OST, P407; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Eschmeyer WN, CATALOG FISHES GENER; FAO, 2012, FISH STAT 2012; Fara E, 2010, SER TELEOST FISH BIO, P173, DOI 10.1201/b10194-7; Ferraris Jr CJ, 2007, ZOOTAXA 0308, V1418, P628, DOI DOI 10.11646/ZOOTAXA.1418.1.1; Fink Sara V., 1996, P209, DOI 10.1016/B978-012670950-6/50012-6; FINK SV, 1981, ZOOL J LINN SOC-LOND, V72, P297, DOI 10.1111/j.1096-3642.1981.tb01575.x; Gayet M, 2003, CATFISHES, VOLS 1-2, P491; Gayet M, 1999, GEOBIOS-LYON, V32, P235, DOI 10.1016/S0016-6995(99)80037-0; GRANDE L, 1986, PALAEONTOLOGY, V29, P113; Grande L., 1991, J VERTEBRATE PA S001, V1, P1, DOI DOI 10.1080/02724634.1991.10011424; Hardman M, 2005, MOL PHYLOGENET EVOL, V37, P700, DOI 10.1016/j.ympev.2005.04.029; Inoue JG, 2010, MOL BIOL EVOL, V27, P2576, DOI 10.1093/molbev/msq147; Iwasaki W, 2013, MOL BIOL EVOL, V30, P2531, DOI 10.1093/molbev/mst141; Jia XY, 2013, MITOCHONDR DNA, V24, P645, DOI 10.3109/19401736.2013.772164; Jia XY, 2013, MITOCHONDR DNA, V24, P373, DOI 10.3109/19401736.2013.763234; Jia XY, 2013, MITOCHONDR DNA, V24, P323, DOI 10.3109/19401736.2012.760075; Jondeung A, 2007, GENE, V387, P49, DOI 10.1016/j.gene.2006.08.001; Kartavtsev YP, 2007, GENE, V396, P13, DOI 10.1016/j.gene.2007.01.027; Kim SK, 2011, MITOCHONDR DNA, V22, P44, DOI 10.3109/19401736.2011.597388; Li CH, 2008, SYST BIOL, V57, P519, DOI 10.1080/10635150802206883; Li Q, 2014, MITOCHONDR DNA, V25, P120, DOI 10.3109/19401736.2013.792057; Liang HW, 2014, MITOCHONDR DNA, V25, P179, DOI 10.3109/19401736.2013.792065; Liang HW, 2014, MITOCHONDR DNA, V25, P169, DOI 10.3109/19401736.2013.792060; Liang HW, 2013, MITOCHONDR DNA, V24, P222, DOI 10.3109/19401736.2012.752471; Liang HW, 2012, MITOCHONDR DNA, V23, P280, DOI 10.3109/19401736.2012.683185; Liang HW, 2012, MITOCHONDR DNA, V23, P170, DOI 10.3109/19401736.2012.668899; Liu J, 2009, SCI CHINA SER D, V52, P189, DOI 10.1007/s11430-009-0022-2; Lukoschek V, 2012, SYST BIOL, V61, P22, DOI 10.1093/sysbio/syr075; Lundberg J.G., 1975, U MICHIGAN MUSEUM PA, V11, P1; Lundberg JG, 2007, P ACAD NAT SCI PHILA, V156, P39, DOI 10.1635/0097-3157(2007)156[39:DOARFT]2.0.CO;2; Miya M, 2000, MOL PHYLOGENET EVOL, V17, P437, DOI 10.1006/mpev.2000.0839; Mo T., 1991, Theses Zoologicae, V17, P1; Nakatani M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-177; Near TJ, 2012, P NATL ACAD SCI USA, V109, P13698, DOI 10.1073/pnas.1206625109; Patterson C., 1993, P621; Peng ZG, 2006, GENE, V370, P113, DOI 10.1016/j.gene.2005.11.024; Peng ZG, 2006, GENE, V376, P290, DOI 10.1016/j.gene.2006.04.014; Saitoh K, 2006, J MOL EVOL, V63, P826, DOI 10.1007/s00239-005-0293-y; Saitoh K, 2003, J MOL EVOL, V56, P464, DOI 10.1007/s00239-002-2417-y; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Smith G.R., 1993, P778; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sullivan JP, 2006, MOL PHYLOGENET EVOL, V41, P636, DOI 10.1016/j.ympev.2006.05.044; Sytchevskaya E.K., 1986, T SOVMESTNAYA SOVETS, V29, P1; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vittas S, 2011, J BIOL RES-THESSALON, V15, P25; Waldbieser GC, 2003, DNA SEQUENCE, V14, P265, DOI 10.1080/1042517031000149057; Wan Q, 2013, MITOCHONDR DNA, V24, P333, DOI 10.3109/19401736.2012.760079; Wang H, 2015, MITOCHONDR DNA, V26, P631, DOI 10.3109/19401736.2013.834437; Wang JL, 2011, MOL BIOL REP, V38, P2507, DOI 10.1007/s11033-010-0388-4; Wang XY, 2013, MITOCHONDR DNA, V24, P1, DOI 10.3109/19401736.2012.710222; Wei M, 2015, MITOCHONDR DNA, V26, P633, DOI 10.3109/19401736.2013.836511; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Zeng Q, 2012, MITOCHONDR DNA, V23, P355, DOI 10.3109/19401736.2012.690755; Zhao HP, 2014, MITOCHONDR DNA, V25, P342, DOI 10.3109/19401736.2013.800492; Zhou CJ, 2012, MITOCHONDR DNA, V23, P414, DOI 10.3109/19401736.2012.710211	73	27	29	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166988	10.1371/journal.pone.0166988	http://dx.doi.org/10.1371/journal.pone.0166988			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907107	Green Published, Green Submitted, gold			2022-12-26	WOS:000389482700059
J	Kasahara, K; Kinoshita, K				Kasahara, Kota; Kinoshita, Kengo			IBiSA_Tools: A Computational Toolkit for Ion-Binding State Analysis in Molecular Dynamics Trajectories of Ion Channels	PLOS ONE			English	Article							POTASSIUM CHANNEL; CONDUCTION; ENERGETICS	Ion conduction mechanisms of ion channels are a long-standing conundrum. Although the molecular dynamics (MD) method has been extensively used to simulate ion conduction dynamics at the atomic level, analysis and interpretation of MD results are not straightforward due to complexity of the dynamics. In our previous reports, we proposed an analytical method called ion-binding state analysis to scrutinize and summarize ion conduction mechanisms by taking advantage of a variety of analytical protocols, e.g., the complex network analysis, sequence alignment, and hierarchical clustering. This approach effectively revealed the ion conduction mechanisms and their dependence on the conditions, i.e., ion concentration and membrane voltage. Here, we present an easy-to-use computational toolkit for ion-binding state analysis, called IBISA_tools. This toolkit consists of a C++ program and a series of Python and R scripts. From the trajectory file of MD simulations and a structure file, users can generate several images and statistics of ion conduction processes. A complex network named ion-binding state graph is generated in a standard graph format (graph modeling language; GML), which can be visualized by standard network analyzers such as Cytoscape. As a tutorial, a trajectory of a 50 ns MD simulation of the Kv1.2 channel is also distributed with the toolkit. Users can trace the entire process of ion-binding state analysis step by step. The novel method for analysis of ion conduction mechanisms of ion channels can be easily used by means of IBISA_tools. This software is distributed under an open source license at the following URL: http://wwwsitsumei.acjp/ktkshr/ibisatools/	[Kasahara, Kota] Ritsumeikan Univ, Coll Life Sci, Shiga, Japan; [Kinoshita, Kengo] Tohoku Univ, Grad Sch Informat Sci, Sendai, Miyagi, Japan; [Kinoshita, Kengo] Tohoku Univ, Tohoku Med Megabank Org, Sendai, Miyagi, Japan; [Kinoshita, Kengo] Tohoku Univ, Inst Dev Aging & Canc, Sendai, Miyagi, Japan	Ritsumeikan University; Tohoku University; Tohoku University; Tohoku University	Kasahara, K (corresponding author), Ritsumeikan Univ, Coll Life Sci, Shiga, Japan.	ktkshr@fc.ritsumei.ac.jp	Kinoshita, Kengo/E-9688-2011	Kinoshita, Kengo/0000-0003-3453-2171; Kasahara, Kota/0000-0003-0207-6271	Japan Society for Promotion of Science [22136005, 15H02773, 16K18526]; Japan Agency for Medical Research and Development; HPCI System Research Projects [hp130061, hp140032, hp150015]; Grants-in-Aid for Scientific Research [16K18526] Funding Source: KAKEN	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); HPCI System Research Projects; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was funded by Japan Society for Promotion of Science, [http://www.jsps.go.jp/english/index.html (grant numbers: 22136005, 15H02773, and 16K18526), and Japan Agency for Medical Research and Development (the project name is "the Platform Project for Supporting in Drug Discovery and Life Science Research"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The supercomputing resources were provided by the Human Genome Center (the University of Tokyo) and the HPCI System Research Projects (project IDs: hp130061, hp140032, and hp150015).	Berneche S, 2001, NATURE, V414, P73, DOI 10.1038/35102067; Chen XR, 2010, P NATL ACAD SCI USA, V107, P11352, DOI 10.1073/pnas.1000142107; Diaz-Franulic I, 2015, J GEN PHYSIOL, V146, P133, DOI 10.1085/jgp.201411353; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Gumbart J, 2012, BIOPHYS J, V102, P795, DOI 10.1016/j.bpj.2012.01.021; HODGKIN AL, 1955, J PHYSIOL-LONDON, V128, P61, DOI 10.1113/jphysiol.1955.sp005291; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Iwamoto M, 2011, J NEUROSCI, V31, P12180, DOI 10.1523/JNEUROSCI.1377-11.2011; Jegla TJ, 2009, COMB CHEM HIGH T SCR, V12, P2, DOI 10.2174/138620709787047957; Jensen MO, 2013, J GEN PHYSIOL, V141, P619, DOI 10.1085/jgp.201210820; Jensen MO, 2010, P NATL ACAD SCI USA, V107, P5833, DOI 10.1073/pnas.0911691107; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kasahara K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150716; Kasahara K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056342; Khalili-Araghi F, 2006, BIOPHYS J, V91, pL2, DOI 10.1529/biophysj.106.091926; Kopfer DA, 2014, SCIENCE, V346, P352, DOI 10.1126/science.1254840; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Michaud-Agrawal N, 2011, J COMPUT CHEM, V32, P2319, DOI 10.1002/jcc.21787; Nelson PH, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3580562; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Sack JT, 2015, J GEN PHYSIOL, V146, P123, DOI 10.1085/jgp.201511469; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Uysal S, 2009, P NATL ACAD SCI USA, V106, P6644, DOI 10.1073/pnas.0810663106; Vandenberg JI, 2012, PHYSIOL REV, V92, P1393, DOI 10.1152/physrev.00036.2011; Ye S, 2010, NAT STRUCT MOL BIOL, V17, P1019, DOI 10.1038/nsmb.1865	27	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167524	10.1371/journal.pone.0167524	http://dx.doi.org/10.1371/journal.pone.0167524			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907142	Green Published, gold, Green Submitted			2022-12-26	WOS:000389482700182
J	Meng, QJ; Ren, MM; Li, YG; Song, X				Meng, Qingjun; Ren, Mingming; Li, Yanguang; Song, Xiang			LncRNA-RMRP Acts as an Oncogene in Lung Cancer	PLOS ONE			English	Article							NONCODING RNA ANRIL; EPITHELIAL-MESENCHYMAL TRANSITION; CELL-PROLIFERATION; POOR-PROGNOSIS; MICRORNA-206 FUNCTIONS; ADENOCARCINOMA CELLS; COLORECTAL-CANCER; TUMOR-SUPPRESSOR; A549 CELLS; EXPRESSION	Accumulating studies have demonstrated that long noncoding RNAs (lncRNAs) act a crucial role in the development of tumors. However, the role of lncRNAs in lung cancer remains largely unknown. In this study, we demonstrated that theexpression of RMRP was upregulated in lung adenocarcinoma tissues compared to the matched adjacent normal tissues. Moreover, of 35 lung adenocarcinoma samples, RMRP expression was upregulated in 25 cases (25/35; 71.4%) compared to the adjacent normal tissues. We also showed that RMRP expression was upregulated in lung adenocarcinoma cell lines (A549, SPC-A1, H1299 and H23) compared to the bronchial epithelial cell line (16HBE). Ectopic expression of RMRP promoted lung adenocarcinoma cell proliferation, colony formation and invasion. In addition, overexpression of RMRP inhibited the miR-206 expression in the H1299 cell and increased the KRAS, FMNL2 and SOX9 expression, which were the target genes of miR-206. Re-expression of miR-206 reversed the RMRP-induced the H1299 cell proliferation and migration. Our data proved that RMRP acted as an oncogene LncRNA to promote the expression of KRAS, FMNL2 and SOX9 by inhibiting miR-206 expression in lung cancer. These data suggested that RMRP might serve as a therapeutic target in lung adenocarcinoma.	[Meng, Qingjun; Ren, Mingming; Li, Yanguang; Song, Xiang] CangZhou Cent Hosp, Dept Thorac Surg, Cangzhou, Hebei, Peoples R China		Song, X (corresponding author), CangZhou Cent Hosp, Dept Thorac Surg, Cangzhou, Hebei, Peoples R China.	xiaoxil1@163.com						Cai X, 2015, J ORTHOPAEDIC RES OF; Chen Q., 2016, ONCOTARGET; Chen QY, 2015, MOL BIOSYST, V11, P2290, DOI 10.1039/c4mb00734d; Cui YZ, 2013, BIOSCI TRENDS, V7, P259, DOI 10.5582/bst.2013.v7.6.259; Endo H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077070; Falcone D, 2013, CELL PROLIFERAT, V46, P172, DOI 10.1111/cpr.12018; Hu X, 2015, TUMOUR BIOL J INT SO; Hua L, 2015, INT J CLIN EXP PATHO, V8, P3076; Keklikoglou I, 2015, ONCOGENE, V34, P4867, DOI 10.1038/onc.2014.408; Li CY, 2013, CELL PROLIFERAT, V46, P272, DOI 10.1111/cpr.12034; Lin L, 2015, DIAGN PATHOL, V10, DOI 10.1186/s13000-015-0247-7; Liu Q, 2013, NUCLEIC ACIDS RES, V41, P4976, DOI 10.1093/nar/gkt182; Lu L, 2015, TOXICOL APPL PHARM, V289, P276, DOI 10.1016/j.taap.2015.09.016; Ma J., 2015, BIOMED RES INT, V2015, P1, DOI DOI 10.1007/S11064-015-1803-Y; Ma YX, 2015, MOL MED REP, V11, P625, DOI 10.3892/mmr.2014.2688; Naemura M, 2015, ANTICANCER RES, V35, P5377; Nakagawa T, 2013, BIOCHEM BIOPH RES CO, V436, P319, DOI 10.1016/j.bbrc.2013.05.101; Nakayama I, 2013, INT J ONCOL, V43, P63, DOI 10.3892/ijo.2013.1935; Nie FQ, 2015, MOL CANCER THER, V14, P268, DOI 10.1158/1535-7163.MCT-14-0492; Plaimee P, 2014, CELL PROLIFERAT, V47, P564, DOI 10.1111/cpr.12140; Postiglione I, 2013, CELL PROLIFERAT, V46, P382, DOI 10.1111/cpr.12040; Qi P, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-122; Ren XL, 2016, J CANCER RES CLIN, V142, P581, DOI 10.1007/s00432-015-2053-8; Rosenbluh J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026270; Sabarinathan R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082699; Saito M, 2014, CLIN CANCER RES, V20, P4784, DOI 10.1158/1078-0432.CCR-14-1096; Shao Y, 2016, ONCOTARGET, DOI 10.18632/oncotarget.9336; Song HJ, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-225; Tang Y, 2015, FEBS LETT, V589, P3189, DOI 10.1016/j.febslet.2015.08.046; Tejero R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101899; Tsay JCJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118132; Wang D, 2015, ONCOTARGET; Wei JL, 2015, MOL MED REP, V11, P571, DOI 10.3892/mmr.2014.2675; Xiao HB, 2015, ONCOTARGET, V6, P38005, DOI 10.18632/oncotarget.5357; Xie X, 2015, TUMOUR BIOL J INT SO; Yu X, 2015, ONCOL LETT, V10, P1953, DOI 10.3892/ol.2015.3553; Zhang C, 2012, ADV ENG FORUM, V2-3, P7, DOI 10.4028/www.scientific.net/AEF.2-3.7; Zhang HH, 2014, ONCOL REP, V31, P1473, DOI 10.3892/or.2014.2973; Zhang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081408; Zhang J, 2015, CLIN TRANSL ONCOL, V17, P209, DOI 10.1007/s12094-014-1213-7; Zhang JS, 2014, ACTA BIOCH BIOPH SIN, V46, P1, DOI 10.1093/abbs/gmt117; Zhang YJ, 2015, INT J CLIN EXP MED, V8, P9107; Zhang ZY, 2015, ONCOTARGET, V6, P1462, DOI 10.18632/oncotarget.2808; Zhou X, 2015, SCI REP-UK, V5, DOI 10.1038/srep15972	44	56	57	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0164845	10.1371/journal.pone.0164845	http://dx.doi.org/10.1371/journal.pone.0164845			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27906963	Green Published, gold, Green Submitted			2022-12-26	WOS:000389482700006
J	Spring, O; Zipper, R				Spring, Otmar; Zipper, Reinhard			Asexual Recombinants of Plasmopara halstedii Pathotypes from Dual Infection of Sunflower	PLOS ONE			English	Article							DOWNY MILDEW; PHYTOPHTHORA; HYBRIDIZATION; INOCULATION; HYBRIDS	Genetically homogenous strains of Plasmopara halstedii differing in host specificity and fungicide tolerance were used to test the hypothesis that asexual genetic recombination occurs and may account for the high genotype diversity of this homothallic reproducing oomycete, which causes downy mildew in sunflower. Dual inoculation of sunflower seedlings with single zoospore strains of complementary infection characteristics caused sporulation under conditions where inoculation with each strain alone failed to infect. PCR-based investigation with strain-specific primers proved the presence of genetic traits from both progenitors in single sporangia collected from sporangiophores of such infections. Sister zoospores released from these sporangia revealed the genotype of the one or the other parental strain thus indicating heterokaryology of sporangia. Moreover, some zoospores showed amplification products of both parents, which suggests that the generally mononucleic spores derived from genetic recombination. The possibility of parasexual genetic exchange in the host-independent stage of infection and the evolutionary consequences are discussed.	[Spring, Otmar; Zipper, Reinhard] Univ Hohenheim, Inst Bot, Stuttgart, Germany	University Hohenheim	Spring, O (corresponding author), Univ Hohenheim, Inst Bot, Stuttgart, Germany.	spring@uni-hohenheim.de						[Anonymous], STRUCTURE DYNAMICF; Bertier L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085385; Choi YJ, 2015, PLOS ONE, V7; DICK MW, 1995, CAN J BOT, V73, pS712, DOI 10.1139/b95-314; ERSEK T, 1995, PHYTOPATHOLOGY, V85, P1343, DOI 10.1094/Phyto-85-1343; Gascuel Q, 2015, MOL PLANT PATHOL, V16, P109, DOI 10.1111/mpp.12164; Goodwin SB, 1997, PHYTOPATHOLOGY, V87, P462, DOI 10.1094/PHYTO.1997.87.4.462; Gu YH, 1998, CURR GENET, V34, P120, DOI 10.1007/s002940050375; Gulya T.J., 2007, ADV DOWNY MILDEW RES, V3, P121; Hammer T, 2006, MITT BIOL BUNDESANST, V400, P206; 't Veld WAMI, 2007, EUR J PLANT PATHOL, V117, P25, DOI 10.1007/s10658-006-9065-9; Judelson HS, 1998, MYCOL RES, V102, P1245, DOI 10.1017/S0953756298006388; May KJ, 2003, AUSTRALAS PLANT PATH, V32, P353, DOI 10.1071/AP03037; Michelmore R, 2008, EUR J PLANT PATHOL, V122, P19, DOI 10.1007/s10658-008-9305-2; Nechwatal J, 2009, PLANT PATHOL, V58, P261, DOI 10.1111/j.1365-3059.2008.01955.x; Roca MG, 2005, EUKARYOT CELL, V4, P911, DOI 10.1128/EC.4.5.911-919.2005; Roca MG, 2004, MYCOL RES, V108, P1320, DOI 10.1017/S0953756204000838; Rozynek B., 2000, Helia, V23, P27; Rozynek B, 2001, J PHYTOPATHOL, V149, P309, DOI 10.1046/j.1439-0434.2001.00618.x; Schardl CL, 2003, MOL ECOL, V12, P2861, DOI 10.1046/j.1365-294X.2003.01965.x; Spring O., 2000, Helia, V23, P19; Spring O, 1997, J PHYTOPATHOL, V145, P189, DOI 10.1111/j.1439-0434.1997.tb00384.x; Spring O, 1998, J PHYTOPATHOL, V146, P577, DOI 10.1111/j.1439-0434.1998.tb04757.x; Spring O, 2006, MYCOL RES, V110, P657, DOI 10.1016/j.mycres.2006.03.009; Spring O, 2011, EUR J PLANT PATHOL, V131, P519, DOI 10.1007/s10658-011-9827-x; Tourvieille LD, P 15 INT SUNFL C 200, V2, P61; Truck T, 2010, J PLANT DIS PROTECT, V3, P143; VIRANYI F, 1991, MYCOL RES, V95, P199, DOI 10.1016/S0953-7562(09)81012-5; Viranyi F, 2011, EUR J PLANT PATHOL, V129, P207, DOI 10.1007/s10658-010-9683-0	29	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167015	10.1371/journal.pone.0167015	http://dx.doi.org/10.1371/journal.pone.0167015			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907026	Green Submitted, Green Published, gold			2022-12-26	WOS:000389482700064
J	Pease, BS; Nielsen, CK; Holzmueller, EJ				Pease, Brent S.; Nielsen, Clayton K.; Holzmueller, Eric J.			Single-Camera Trap Survey Designs Miss Detections: Impacts on Estimates of Occupancy and Community Metrics	PLOS ONE			English	Article							ESTIMATING SITE OCCUPANCY; ILLINOIS OZARK HILLS; SAMPLING DESIGN; IMPERFECT DETECTION; NORTH-AMERICA; FOREST; MODELS; RATES; LOCATION; TRAILS	The use of camera traps as a tool for studying wildlife populations is commonplace. However, few have considered how the number of detections of wildlife differ depending upon the number of camera traps placed at cameras-sites, and how this impacts estimates of occupancy and community composition. During December 2015-February 2016, we deployed four camera traps per camera-site, separated into treatment groups of one, two, and four camera traps, in southern Illinois to compare whether estimates of wildlife community metrics and occupancy probabilities differed among survey methods. The overall number of species detected per camera-site was greatest with the four-camera survey method (P<0.0184). The four-camera survey method detected 1.25 additional species per camerasite than the one-camera survey method, and was the only survey method to completely detect the ground-dwelling silvicolous community. The four-camera survey method recorded individual species at 3.57 additional camera-sites (P = 0.003) and nearly doubled the number of camera-sites where white-tailed deer (Odocoileus virginianus) were detected compared to one-and two-camera survey methods. We also compared occupancy rates estimated by survey methods; as the number of cameras deployed per camera-site increased, occupancy estimates were closer to naive estimates, detection probabilities increased, and standard errors of detection probabilities decreased. Additionally, each survey method resulted in differing top-ranked, species-specific occupancy models when habitat covariates were included. Underestimates of occurrence and misrepresented community metrics can have significant impacts on species of conservation concern, particularly in areas where habitat manipulation is likely. Having multiple camera traps per site revealed significant shortcomings with the common one-camera trap survey method. While we realize survey design is often constrained logistically, we suggest increasing effort to at least two camera traps facing opposite directions per camera-site in habitat association studies, and to utilize camera-trap arrays when restricted by equipment availability.	[Pease, Brent S.; Nielsen, Clayton K.; Holzmueller, Eric J.] Southern Illinois Univ, Dept Forestry, Carbondale, IL 62901 USA; [Nielsen, Clayton K.] Southern Illinois Univ, Cooperat Wildlife Res Lab, Carbondale, IL USA	Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University	Pease, BS (corresponding author), Southern Illinois Univ, Dept Forestry, Carbondale, IL 62901 USA.	bpease1@siu.edu			McIntire Stennis Formula Grant through the National Institute of Food and Agriculture	McIntire Stennis Formula Grant through the National Institute of Food and Agriculture	This work was funded by the McIntire Stennis Formula Grant through the National Institute of Food and Agriculture (httn://nfa.usda.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, ARCGIS E REL 10; Bailey LL, 2004, ECOL APPL, V14, P692, DOI 10.1890/03-5012; Blake John G, 2014, Mastozool. neotrop., V21, P17; Braczkowski AR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151033; BURNHAM KP, 2002, MODEL SELECTION MULT, pR26; Claridge AW, 2014, CAMERA TRAPPING: WILDLIFE MANAGEMENT AND RESEARCH, P205; Cusack JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126373; Di Bitetti Mario S, 2014, Mastozool. neotrop., V21, P37; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Fiske IJ, 2011, J STAT SOFTW, V43, P1; Fralish JS, 1997, CONSERVATION HIGHLY, pxvi; Gerber BD, 2012, POPUL ECOL, V54, P43, DOI 10.1007/s10144-011-0276-3; Gompper ME, 2006, WILDLIFE SOC B, V34, P1142, DOI 10.2193/0091-7648(2006)34[1142:ACONTT]2.0.CO;2; Gu WD, 2004, BIOL CONSERV, V116, P195, DOI 10.1016/S0006-3207(03)00190-3; Guillera-Arroita G, 2012, METHODS ECOL EVOL, V3, P860, DOI 10.1111/j.2041-210X.2012.00225.x; Guillera-Arroita G, 2010, METHODS ECOL EVOL, V1, P131, DOI 10.1111/j.2041-210X.2010.00017.x; Hamel S, 2013, METHODS ECOL EVOL, V4, P105, DOI 10.1111/j.2041-210x.2012.00262.x; Harmsen BJ, 2010, BIOTROPICA, V42, P126, DOI 10.1111/j.1744-7429.2009.00544.x; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Karanth KU, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P97, DOI 10.1007/978-4-431-99495-4_7; Kery M, 2016, APPL HIERARCHICAL MO, V1; Kery M., 2016, APPL HIERARCHICAL MO, V1; Krishnappa YS, 2014, ECOL INFORM, V24, P11, DOI 10.1016/j.ecoinf.2014.06.004; Lesmeister DB, 2015, WILDLIFE MONOGR, V191, P1, DOI 10.1002/wmon.1015; Mackenzie DI, 2005, J APPL ECOL, V42, P1105, DOI 10.1111/j.1365-2664.2005.01098.x; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Meek PD, 2014, BIODIVERS CONSERV, V23, P2321, DOI 10.1007/s10531-014-0712-8; Moilanen A, 2002, OIKOS, V96, P516, DOI 10.1034/j.1600-0706.2002.960313.x; Network T., 2008, TERRESTRIAL VERTEBRA; Nielsen CK, 2001, AM MIDL NAT, V146, P43, DOI 10.1674/0003-0031(2001)146[0043:SOOBLR]2.0.CO;2; Nielsen CK, 2009, NORTHEAST NAT, V16, P153, DOI 10.1656/045.016.0114; [NOAA] NOaAA, 2010, NAT CLIM DAT CTR WOR; O'Brien TG, 2003, ANIM CONSERV, V6, P131, DOI 10.1017/S1367943003003172; OConnell AF, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P1, DOI 10.1007/978-4-431-99495-4; Ozier TB, 2006, AM MIDL NAT, V155, P253, DOI 10.1674/0003-0031(2006)155[253:CCASCI]2.0.CO;2; Ramsey David S.L., 2015, Journal of Wildlife Management, V79, P491; RCore Team, 2020, R LANG ENV STAT COMP; Rovero F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103300; Rovero F, 2013, HYSTRIX, V24, P148, DOI 10.4404/hystrix-24.2-6316; Srbek-Araujo AC, 2013, BIOTA NEOTROP, V13, P51, DOI 10.1590/S1676-06032013000200005; Stokeld D, 2015, WILDLIFE RES, V42, P642, DOI 10.1071/WR15083; Trolliet F, 2014, BIOTECHNOL AGRON SOC, V18, P446; van de Gevel S, 2003, US FOR SERV T R NC, V234, P246; Wearn OR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077598; Welbourne DJ, 2016, REMOTE SENS ECOL CON, V2, P77, DOI 10.1002/rse2.20	45	29	31	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0166689	10.1371/journal.pone.0166689	http://dx.doi.org/10.1371/journal.pone.0166689			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902733	Green Published, Green Submitted, gold			2022-12-26	WOS:000389474100032
J	Bhagat, TD; Zou, YY; Huang, SZ; Park, J; Palmer, MB; Hu, C; Li, WJ; Shenoy, N; Giricz, O; Choudhary, G; Yu, YT; Ko, YA; Izquierdo, MC; Park, ASD; Vallumsetla, N; Laurence, R; Lopez, R; Suzuki, M; Pullman, J; Kaner, J; Gartrell, B; Hakimi, AA; Greally, JM; Patel, B; Benhadji, K; Pradhan, K; Verma, A; Susztak, K				Bhagat, Tushar D.; Zou, Yiyu; Huang, Shizheng; Park, Jihwan; Palmer, Matthew B.; Hu, Caroline; Li, Weijuan; Shenoy, Niraj; Giricz, Orsolya; Choudhary, Gaurav; Yu, Yiting; Ko, Yi-An; Izquierdo, Maria C.; Park, Ae Seo Deok; Vallumsetla, Nishanth; Laurence, Remi; Lopez, Robert; Suzuki, Masako; Pullman, James; Kaner, Justin; Gartrell, Benjamin; Hakimi, A. Ari; Greally, John M.; Patel, Bharvin; Benhadji, Karim; Pradhan, Kith; Verma, Amit; Susztak, Katalin			Notch Pathway Is Activated via Genetic and Epigenetic Alterations and Is a Therapeutic Target in Clear Cell Renal Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KIDNEY; METHYLATION	Clear cell renal cell carcinoma (CCRCC) is an incurable malignancy in advanced stages and needs newer therapeutic targets. Transcriptomic analysis of CCRCCs and matched microdissected renal tubular controls revealed overexpression of NOTCH ligands and receptors in tumor tissues. Examination of theTCGARNA- seq data set also revealed widespread activation of NOTCH pathway in a large cohort of CCRCC samples. Samples with NOTCH pathway activation were also clinically distinct and were associated with better overall survival. Parallel DNA methylation and copy number analysis demonstrated that both genetic and epigenetic alterations led to NOTCH pathway activation in CCRCC. NOTCH ligand JAGGED1 was overexpressed and associated with loss of CpG methylation of H3K4me1- associated enhancer regions. JAGGED2 was also overexpressed and associated with gene amplification in distinct CCRCC samples. Transgenic expression of intracellular NOTCH1 in mice with tubule- specific deletion of VHL led to dysplastic hyperproliferation of tubular epithelial cells, confirming the procarcinogenic role of NOTCH in vivo. Alteration of cell cycle pathways was seen in murine renal tubular cells with NOTCH overexpression, and molecular similarity to human tumors was observed, demonstrating that human CCRCC recapitulates features and gene expression changes observed in mice with transgenic overexpression of the Notch intracellular domain. Treatment with the gamma-secretase inhibitor LY3039478 led to inhibition of CCRCC cells in vitro and in vivo. In sum- mary, these data reveal the mechanistic basis of NOTCH pathway activation in CCRCC and demonstrate this pathway to a potential therapeutic target.	[Bhagat, Tushar D.; Zou, Yiyu; Hu, Caroline; Li, Weijuan; Shenoy, Niraj; Giricz, Orsolya; Choudhary, Gaurav; Yu, Yiting; Vallumsetla, Nishanth; Laurence, Remi; Lopez, Robert; Suzuki, Masako; Kaner, Justin; Gartrell, Benjamin; Greally, John M.; Pradhan, Kith; Verma, Amit] Albert Einstein Coll Med, 1300 Morris Pk Ave,Chanin 302B, Bronx, NY 10461 USA; [Huang, Shizheng; Park, Jihwan; Palmer, Matthew B.; Ko, Yi-An; Izquierdo, Maria C.; Park, Ae Seo Deok; Susztak, Katalin] Univ Penn, Perelman Sch Med, Dept Med & Genet, Renal Electrolyte & Hypertens Div, Philadelphia, PA 19104 USA; [Pullman, James] Montefiore Med Ctr, Dept Pathol, Bronx, NY 10467 USA; [Hakimi, A. Ari] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA; [Patel, Bharvin; Benhadji, Karim] Eli Lilly, Indianapolis, IN 46221 USA	Yeshiva University; Albert Einstein College of Medicine; University of Pennsylvania; Pennsylvania Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Memorial Sloan Kettering Cancer Center; Eli Lilly	Verma, A (corresponding author), Albert Einstein Coll Med, 1300 Morris Pk Ave,Chanin 302B, Bronx, NY 10461 USA.; Susztak, K (corresponding author), Univ Penn, Perelman Sch Med, 415 CRB,415 Curie Blvd, Philadelphia, PA 19104 USA.	amit.verma@einstein.yu.edu; ksusztak@mail.med.upenn.edu	Susztak, Katalin/ABE-7474-2021; Greally, John/AAF-9540-2019; Suzuki, Masako/ABF-6497-2020; Choudhary, Gaurav S./C-3673-2019	Susztak, Katalin/0000-0002-1005-3726; Greally, John/0000-0001-6069-7960; Suzuki, Masako/0000-0003-0605-9225; Choudhary, Gaurav S./0000-0001-5365-6706; Benhadji, Karim/0000-0001-9883-6970; Shenoy, Niraj/0000-0003-2074-1108; Huang, Shizheng/0000-0002-9240-1578; IZQUIERDO, MARIA CONCEPCION/0000-0002-8690-0151	National Institutes of Health [R01DK087635, R01076077, DP3 DK108220]; NYSTEM; Albert Einstein Stem Cell Institute grant; NATIONAL CANCER INSTITUTE [P30CA008748, P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020541, DP3DK108220, R01DK087635, R01DK076077] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NYSTEM; Albert Einstein Stem Cell Institute grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01DK087635, R01076077, and DP3 DK108220 (to K. S.) and a NYSTEM grant and an Albert Einstein Stem Cell Institute grant (to T. D. B.). B. P. and K. B. are employees of Eli Lilly. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alvarez H, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001356; Baldewijns MML, 2008, BBA-REV CANCER, V1785, P133, DOI 10.1016/j.bbcan.2007.12.002; Bielesz B, 2010, J CLIN INVEST, V120, P4040, DOI 10.1172/JCI43025; Choi K, 2009, J BIOL CHEM, V284, P17766, DOI 10.1074/jbc.M109.003111; Cohen HT, 2005, NEW ENGL J MED, V353, P2477, DOI 10.1056/NEJMra043172; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Figueroa ME, 2009, BLOOD, V113, P2795, DOI 10.1182/blood-2008-08-172387; Figueroa ME, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001882; Hakimi AA, 2013, NAT GENET, V45, P849, DOI 10.1038/ng.2708; Herranz D, 2014, NAT MED, V20, P1130, DOI 10.1038/nm.3665; Hu CY, 2014, CLIN CANCER RES, V20, P4349, DOI 10.1158/1078-0432.CCR-14-0494; Huang QB, 2014, ONCOTARGET, V5, P3066, DOI 10.18632/oncotarget.1827; Kinney SRM, 2013, ADV EXP MED BIOL, V754, P57, DOI 10.1007/978-1-4419-9967-2_3; Lamprecht B, 2010, CELL CYCLE, V9, P4276, DOI 10.4161/cc.9.21.13682; Massard C., 2015, J CLIN ONCOL, V33; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; Niranjan T, 2008, NAT MED, V14, P290, DOI 10.1038/nm1731; Oda M, 2009, NUCLEIC ACIDS RES, V37, P3829, DOI 10.1093/nar/gkp260; Pietras A, 2011, MOL CANCER RES, V9, P626, DOI 10.1158/1541-7786.MCR-10-0508; Powles T, 2011, BRIT J CANCER, V104, P741, DOI 10.1038/sj.bjc.6606061; Shao XL, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000016444.90348.50; Sjolund J, 2005, EUR J CANCER, V41, P2620, DOI 10.1016/j.ejca.2005.06.025; Sjolund J, 2008, J CLIN INVEST, V118, P217, DOI 10.1172/JCI32086; Sjolund J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023057; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Woroniecka KI, 2011, DIABETES, V60, P2354, DOI 10.2337/db10-1181; Wu KR, 2011, JPN J CLIN ONCOL, V41, P411, DOI 10.1093/jjco/hyq205	30	33	35	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2017	292	3					837	846		10.1074/jbc.M116.745208	http://dx.doi.org/10.1074/jbc.M116.745208			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2LL	27909050	hybrid, Green Published			2022-12-26	WOS:000392318700007
J	Davis, MJ; Janke, R; Taxon, TN				Davis, Michael J.; Janke, Robert; Taxon, Thomas N.			Assessing Inhalation Exposures Associated with Contamination Events in Water Distribution Systems	PLOS ONE			English	Article							VOLATILE ORGANIC-COMPOUNDS; TAP WATER; CHLOROFORM EXPOSURE; SIZE DISTRIBUTION; ESCHERICHIA-COLI; SENSOR PLACEMENT; SHOWER WATER; INDOOR AIR; VOLATILIZATION; CHEMICALS	When a water distribution system (WDS) is contaminated, short-term inhalation exposures to airborne contaminants could occur as the result of domestic water use. The most important domestic sources of such exposures are likely to be showering and the use of aerosol-producing humidifiers, i.e., ultrasonic and impeller (cool-mist) units. A framework is presented for assessing the potential effects of short-term, system-wide inhalation exposures that could result from such activities during a contamination event. This framework utilizes available statistical models for showering frequency and duration, available exposure models for showering and humidifier use, and experimental results on both aerosol generation and the volatilization of chemicals during showering. New models for the times when showering occurs are developed using time-use data for the United States. Given a lack of similar models for how humidifiers are used, or the information needed to develop them, an analysis of the sensitivity of results to assumptions concerning humidifier use is presented. The framework is applied using network models for three actual WDSs. Simple models are developed for estimating upper bounds on the potential effects of system-wide inhalation exposures associated with showering and humidifier use. From a system-wide, population perspective, showering could result in significant inhalation doses of volatile chemical contaminants, and humidifier use could result in significant inhalation doses of microbial contaminants during a contamination event. From a system-wide perspective, showering is unlikely to be associated with significant doses of microbial contaminants. Given the potential importance of humidifiers as a source of airborne contaminants during a contamination event, an improved understanding of the nature of humidifier use is warranted.	[Davis, Michael J.] Argonne Natl Lab, Div Environm Sci, Argonne Associate Seville, 9700 S Cass Ave, Argonne, IL 60439 USA; [Janke, Robert] US EPA, Natl Homeland Secur Res Ctr, Cincinnati, OH 45268 USA; [Taxon, Thomas N.] Argonne Natl Lab, Global Secur Sci Div, 9700 S Cass Ave, Argonne, IL 60439 USA	United States Department of Energy (DOE); Argonne National Laboratory; United States Environmental Protection Agency; United States Department of Energy (DOE); Argonne National Laboratory	Davis, MJ (corresponding author), Argonne Natl Lab, Div Environm Sci, Argonne Associate Seville, 9700 S Cass Ave, Argonne, IL 60439 USA.; Janke, R (corresponding author), US EPA, Natl Homeland Secur Res Ctr, Cincinnati, OH 45268 USA.	mike_davis@anl.gov; janke.robert@epa.gov			U.S. Environmental Protection Agency through U.S. Department of Energy [DE-AC02-06CH11357]	U.S. Environmental Protection Agency through U.S. Department of Energy	Work at Argonne National Laboratory was sponsored by the U.S. Environmental Protection Agency under interagency agreement through U.S. Department of Energy Contract DE-AC02-06CH11357. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JH, 2016, CURR OPIN BIOTECH, V42, P54, DOI 10.1016/j.copbio.2016.02.034; Allmann TP., 2003, THESIS; Allmann TP, 2005, J AMERICAN WATER WOR, V97; ANDELMAN JB, 1985, SCI TOTAL ENVIRON, V47, P443, DOI 10.1016/0048-9697(85)90349-3; ANDELMAN JB, 1985, ENVIRON HEALTH PERSP, V62, P313, DOI 10.2307/3430131; Anderson WB, 2007, J WATER HEALTH, V5, P553, DOI 10.2166/wh.2007.043; Bureau of Labor Statistics, 2013, AMERICAN TIME USE SU; Burgard A, 2016, CURR OPIN BIOTECH, V42, P118, DOI 10.1016/j.copbio.2016.04.016; Carrera M, 2007, J APPL MICROBIOL, V102, P303, DOI 10.1111/j.1365-2672.2006.03111.x; Chen GQ, 2010, MICROBIOL MONOGR, V14, P121, DOI 10.1007/978-3-642-03287_5_6; Chen GQ, 2009, CHEM SOC REV, V38, P2434, DOI 10.1039/b812677c; Chen MJ, 2003, ATMOS ENVIRON, V37, P4325, DOI 10.1016/S1352-2310(03)00578-8; Chen XZ, 2013, BIOTECHNOL ADV, V31, P1200, DOI 10.1016/j.biotechadv.2013.02.009; Cheng YS, 2003, AEROSOL SCI TECH, V37, P659, DOI 10.1080/02786820300906; Choi S, 2015, METAB ENG, V28, P223, DOI 10.1016/j.ymben.2014.12.007; Cowen KA, 2006, J AIR WASTE MANAGE, V56, P1662, DOI 10.1080/10473289.2006.10464571; Davis MJ, 2008, J WATER RES PL-ASCE, V134, P449, DOI 10.1061/(ASCE)0733-9496(2008)134:5(449); Davis MJ, 2015, J WATER RES PLAN MAN, V141, DOI 10.1061/(ASCE)WR.1943-5452.0000436; Davis MJ, 2014, RISK ANAL, V34, P498, DOI 10.1111/risa.12107; Davis MJ, 2011, J WATER RES PL-ASCE, V137, P1, DOI 10.1061/(ASCE)WR.1943-5452.0000084; Du LL, 2012, INT J ENV RES PUB HE, V9, P4639, DOI 10.3390/ijerph9124639; Falkinham JO, 2015, ENVIRON HEALTH PERSP, V123, P749, DOI 10.1289/ehp.1408692; GIARDINO NJ, 1992, ENVIRON SCI TECHNOL, V26, P1602, DOI 10.1021/es00032a017; Giardino NJ, 1996, ENVIRON SCI TECHNOL, V30, P1242, DOI 10.1021/es950448d; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Gutting BW, 2015, RISK ANAL, V35, P811, DOI 10.1111/risa.12326; HIGHSMITH VR, 1988, ENVIRON SCI TECHNOL, V22, P1109, DOI 10.1021/es00174a019; HIGHSMITH VR, 1992, ENVIRON SCI TECHNOL, V26, P673, DOI 10.1021/es00028a003; Hines SA, 2014, WATER RES, V56, P203, DOI 10.1016/j.watres.2014.02.013; Hung DV, 2010, BIOSYST ENG, V107, P54, DOI 10.1016/j.biosystemseng.2010.07.001; Janke R, 2014, PROT CRIT INFRASTRUC, V2, P29, DOI 10.1007/978-3-319-01092-2_2; JO WK, 1990, RISK ANAL, V10, P581, DOI 10.1111/j.1539-6924.1990.tb00542.x; JO WK, 1990, RISK ANAL, V10, P575, DOI 10.1111/j.1539-6924.1990.tb00541.x; JOHNSTON FL, 1994, HEALTH PHYS, V67, P276, DOI 10.1097/00004032-199409000-00009; Keating GA, 1997, ATMOS ENVIRON, V31, P123, DOI 10.1016/1352-2310(96)00227-0; KEATING GA, 1993, AM SOC TEST MATER, V1205, P14, DOI 10.1520/STP13097S; Kerger BD, 2000, RISK ANAL, V20, P637, DOI 10.1111/0272-4332.205058; Khanal N, 2006, J WATER RES PLAN MAN, V132, P283, DOI 10.1061/(ASCE)0733-9496(2006)132:4(283); Kim E, 2001, J ENVIRON SCI HEAL C, V19, P387, DOI 10.1081/GNC-100107581; Kim EY, 2004, ENVIRON SCI TECHNOL, V38, P1799, DOI 10.1021/es026300t; Klise KA, 2013, J INFRASTRUCT SYST, V19, P465, DOI 10.1061/(ASCE)IS.1943-555X.0000156; LITTLE JC, 1992, ENVIRON SCI TECHNOL, V26, P1341, DOI 10.1021/es00031a010; Little JC, 1999, EXPOSURE TO CONTAMIN, P89; Markham KA, 2015, ANNU REV CHEM BIOMOL, V6, P35, DOI 10.1146/annurev-chembioeng-061114-123303; MCKONE TE, 1987, ENVIRON SCI TECHNOL, V21, P1194, DOI 10.1021/es00165a006; MCKONE TE, 1991, J AIR WASTE MANAGE, V41, P832, DOI 10.1080/10473289.1991.10466881; Moya J, 1999, ENVIRON SCI TECHNOL, V33, P2321, DOI 10.1021/es980876u; Murray R, 2006, J WATER RES PLAN MAN, V132, P293, DOI 10.1061/(ASCE)0733-9496(2006)132:4(293); Nilsson KA, 2005, J WATER RES PLAN MAN, V131, P228, DOI 10.1061/(ASCE)0733-9496(2005)131:3(228); Olin SS, 1999, EXPOSURE TO CONTAMIN; Ostfeld A, 2008, J WATER RES PLAN MAN, V134, P556, DOI 10.1061/(ASCE)0733-9496(2008)134:6(556); R Core Team (n.d.), R A LANGUAGE AND ENV; RODES C, 1990, AEROSOL SCI TECH, V13, P220, DOI 10.1080/02786829008959440; Rossman LA, 2000, REPORT NO EPA 600 R; Sain AE, 2015, ENVIRON ENG SCI, V32, P1027, DOI 10.1089/ees.2015.0238; Schijven J, 2016, WATER RES, V96, P148, DOI 10.1016/j.watres.2016.03.057; Sun J, 2015, J IND MICROBIOL BIOT, V42, P423, DOI 10.1007/s10295-014-1539-8; TANCREDE M, 1992, ATMOS ENVIRON A-GEN, V26, P1103, DOI 10.1016/0960-1686(92)90042-J; TYNDALL RL, 1995, INDOOR AIR, V5, P171, DOI 10.1111/j.1600-0668.1995.t01-1-00003.x; U.S. Environmental Protection Agency, 2012, ENERGY STAR MARKET I; U.S. EPA, 2011, REPORT NO EPA 600 R; U.S. EPA, 2016, REPORT NO EPA 600 R; U.S. EPA, 1992, REPORT NO EPA 600 Z, P18; Umezawa M, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-64; Watson JP, 2009, J INFRASTRUCT SYST, V15, P330, DOI 10.1061/(ASCE)1076-0342(2009)15:4(330); Weir MH, 2011, ENVIRON SCI TECHNOL, V45, P5828, DOI 10.1021/es200901e; WILKES CR, 1992, ATMOS ENVIRON A-GEN, V26, P2227, DOI 10.1016/0960-1686(92)90412-E; Wilkes CR, 2005, RISK ANAL, V25, P317, DOI 10.1111/j.1539-6924.2005.00592.x; Xu X, 2003, ENVIRON SCI TECHNOL, V37, P569, DOI 10.1021/es025747; Xu X, 2005, J EXPO ANAL ENV EPID, V15, P6, DOI 10.1038/sj.jea.7500374; Zhen HJ, 2014, J AEROSOL SCI, V70, P67, DOI 10.1016/j.jaerosci.2014.01.002; Zhou Y, 2007, INHAL TOXICOL, V19, P333, DOI 10.1080/08958370601144241	72	11	11	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0168051	10.1371/journal.pone.0168051	http://dx.doi.org/10.1371/journal.pone.0168051			41	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4OA	27930709	Green Submitted, gold, Green Published			2022-12-26	WOS:000389580900074
J	Farah, D; Nunes, J; Sartori, M; Dias, DD; Sirvente, R; Silva, MB; Fiorino, P; Morris, M; Llesuy, S; Farah, V; Irigoyen, MC; De Angelis, KT				Farah, Daniela; Nunes, Jonas; Sartori, Michelle; Dias, Danielle da Silva; Sirvente, Raquel; Silva, Maikon B.; Fiorino, Patricia; Morris, Mariana; Llesuy, Susana; Farah, Vera; Irigoyen, Maria-Claudia; De Angelis, Katia			Exercise Training Prevents Cardiovascular Derangements Induced by Fructose Overload in Developing Rats	PLOS ONE			English	Article							RENIN-ANGIOTENSIN SYSTEM; OXIDATIVE STRESS; METABOLIC SYNDROME; BLOOD-PRESSURE; LIPID-PEROXIDATION; INSULIN-RESISTANCE; EXPERIMENTAL-MODEL; PHYSICAL-ACTIVITY; AUTONOMIC CONTROL; DYSFUNCTION	The risks of chronic diseases associated with the increasing consumption of fructose-laden foods are amplified by the lack of regular physical activity and have become a serious public health issue worldwide. Moreover, childhood eating habits are strongly related to metabolic syndrome in adults. Thus, we aimed to investigate the preventive role of exercise training undertaken concurrently with a high fructose diet on cardiac function, hemodynamics, cardiovascular autonomic modulation and oxidative stress in male rats after weaning. Male Wistar rats were divided into 4 groups (n = 8/group):Sedentary control (SC), Trained control (TC), Sedentary Fructose (SF) and Trained Fructose (TF). Training was performed on a treadmill (8 weeks, 40-60% of maximum exercise test). Evaluations of cardiac function, hemodynamics, cardiovascular autonomic modulation and oxidative stress in plasma and in left ventricle (LV) were performed. Chronic fructose overload induced glucose intolerance and an increase in white adipose tissue (WAT) weight, in myocardial performance index (MPI) (SF:0.42 +/- 0.04 vs. SC:0.24 +/- 0.05) and in arterial pressure (SF:122 +/- 3 vs. SC:113 +/- 1 mmHg) associated with increased cardiac and vascular sympathetic modulation. Fructose also induced unfavorable changes in oxidative stress profile (plasmatic protein oxidationSF: 3.30 +/- 0.09 vs. SC:1.45 +/- 0.08 nmol/mg prot; and LV total antioxidant capacity (TRAP)SF: 2.5 +/- 0.5 vs. SC:12.7 +/- 1.7 uM trolox). The TF group showed reduced WAT, glucose intolerance, MPI (0.35 +/- 0.04), arterial pressure (118 +/- 2mmHg), sympathetic modulation, plasmatic protein oxidation and increased TRAP when compared to SF group. Therefore, our findings indicate that cardiometabolic dysfunctions induced by fructose overload early in life may be prevented by moderate aerobic exercise training.	[Farah, Daniela; Nunes, Jonas; Fiorino, Patricia; Farah, Vera] Univ Presbiteriana Mackenzie, Lab Metab Cardiovasc & Renal Physiopharmacol, Sao Paulo, Brazil; [Farah, Daniela; Sartori, Michelle; Sirvente, Raquel; Silva, Maikon B.; Irigoyen, Maria-Claudia] Sao Paulo Univ FMUSP, Sch Med, Lab Expt Hypertens,Heart Inst INCOR, Sao Paulo, Brazil; [Sartori, Michelle; Dias, Danielle da Silva; De Angelis, Katia] Univ Nove de Julho, Lab Translat Physiol, Sao Paulo, Brazil; [Morris, Mariana] Nova Southeastern Univ, Inst Neuro Immune Med, Ft Lauderdale, FL USA; [Llesuy, Susana] Univ Buenos Aires, Dept Gen & Inorgan Chem, Buenos Aires, DF, Argentina	Universidade Presbiteriana Mackenzie; Universidade de Sao Paulo; Universidade Nove de Julho; Nova Southeastern University; University of Buenos Aires	De Angelis, KT (corresponding author), Univ Nove de Julho, Lab Translat Physiol, Sao Paulo, Brazil.	kangelis@uni9.pro.br	Farah, Vera/ABA-1171-2021; IRIGOYEN, MARIA CLAUDIA C/N-6880-2014; DE ANGELIS, KATIA/I-6098-2016; da Silva Dias, Danielle/AAN-7618-2020	Farah, Vera/0000-0002-5439-3079; IRIGOYEN, MARIA CLAUDIA C/0000-0003-2097-3662; DE ANGELIS, KATIA/0000-0002-3640-9049; da Silva Dias, Danielle/0000-0003-4152-0849; Farah, Daniela/0000-0002-9727-9460; Francisca Llesuy, Susana/0000-0001-6818-051X	CNPq [457200/2014-6, 309292/2014-0]; FAPESP [2015/11223-6, 2012/01873-5]; CAPES [88881.062178/2014-01]; CNPq Fellowship (CNPq-BPQ)	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq Fellowship (CNPq-BPQ)	This study was supported by CNPq (457200/2014-6; 309292/2014-0) and FAPESP (2015/11223-6; 2012/01873-5); CAPES (88881.062178/2014-01). Katia De Angelis and Maria-Claudia Irigoyen are recipients of CNPq Fellowship (CNPq-BPQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H, 1984, Methods Enzymol, V105, P121; ALESSIO HM, 1988, J APPL PHYSIOL, V64, P1333, DOI 10.1152/jappl.1988.64.4.1333; Amaral SL, 2000, J HYPERTENS, V18, P1563, DOI 10.1097/00004872-200018110-00006; Araujo IC, 2016, EUR J NUTR, V55, P83, DOI 10.1007/s00394-014-0826-5; Bassuk SS, 2005, J APPL PHYSIOL, V99, P1193, DOI 10.1152/japplphysiol.00160.2005; Bertagnolli M, 2006, J HYPERTENS, V24, P2437, DOI 10.1097/01.hjh.0000251905.08547.17; Bidwell AJ, 2014, MED SCI SPORT EXER, V46, P2091, DOI 10.1249/MSS.0000000000000343; BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395; Boa BCS, 2014, MICROVASC RES, V93, P34, DOI 10.1016/j.mvr.2014.02.012; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Bray GA, 2004, AM J CLIN NUTR, V79, P537; Brito JO, 2008, BRAZ J MED BIOL RES, V41, P804, DOI 10.1590/S0100-879X2008005000030; Buege J A, 1978, Methods Enzymol, V52, P302; Camm AJ, 1996, CIRCULATION, V93, P1043; Conti FF, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-185; De Angelis K, 2012, AM J PHYSIOL-REG I, V302, pR950, DOI 10.1152/ajpregu.00450.2011; De Angelis KLD, 2000, BRAZ J MED BIOL RES, V33, P635, DOI 10.1590/S0100-879X2000000600004; DeAngelis KLD, 1997, HYPERTENSION, V30, P767, DOI 10.1161/01.HYP.30.3.767; Del Maestro R., 1985, CRC HDB METHODS OXYG, V1, P294; Duffey KJ, 2010, AM J CLIN NUTR, V92, P954, DOI 10.3945/ajcn.2010.29478; Evelson P, 2001, ARCH BIOCHEM BIOPHYS, V388, P261, DOI 10.1006/abbi.2001.2292; Farah V, 2006, AUTON NEUROSCI-BASIC, V130, P41, DOI 10.1016/j.autneu.2006.05.006; Farah VMA, 2004, PHYSIOL BEHAV, V83, P135, DOI 10.1016/j.physbeh.2004.08.004; Giacchetti G, 2000, J HYPERTENS, V18, P695, DOI 10.1097/00004872-200018060-00006; Girard A, 2006, NUTRITION, V22, P758, DOI 10.1016/j.nut.2006.05.006; Huston JM, 2006, J EXP MED, V203, P1623, DOI 10.1084/jem.20052362; Janssen BJA, 2000, AM J PHYSIOL-REG I, V278, pR215, DOI 10.1152/ajpregu.2000.278.1.R215; Kamide K, 2002, AM J HYPERTENS, V15, P66, DOI 10.1016/S0895-7061(01)02232-4; KOKKINOS PF, 1995, NEW ENGL J MED, V333, P1462, DOI 10.1056/NEJM199511303332204; La Rovere MT, 2002, CIRCULATION, V106, P945, DOI 10.1161/01.CIR.0000027565.12764.E1; Lalande S, 2013, APPL PHYSIOL NUTR ME, V38, P545, DOI 10.1139/apnm-2012-0383; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Machi JF, 2013, EUR J APPL PHYSIOL, V113, P41, DOI 10.1007/s00421-012-2411-z; MALLIANI A, 1991, CIRCULATION, V84, P482, DOI 10.1161/01.CIR.84.2.482; Marriott BP, 2009, J NUTR, V139, pS1228, DOI 10.3945/jn.108.098277; MISRA HP, 1972, J BIOL CHEM, V247, P3170; Mizuno T, 2004, INT J CARDIOL, V97, P455, DOI 10.1016/j.ijcard.2003.10.035; Moraes-Silva IC, 2013, J APPL PHYSIOL, V114, P786, DOI 10.1152/japplphysiol.00586.2012; Morris M, 2012, CLIN EXP PHARMACOL P, V39, P57, DOI 10.1111/j.1440-1681.2011.05636.x; Mostarda C, 2012, CLINICS, V67, P815, DOI 10.6061/clinics/2012(07)18; Mostarda CT, 2014, J DIABETES COMPLICAT, V28, P273, DOI 10.1016/j.jdiacomp.2013.12.005; NEGRAO CE, 1992, J APPL PHYSIOL, V72, P1749, DOI 10.1152/jappl.1992.72.5.1749; Nestorov J, 2014, NUTR RES, V34, P646, DOI 10.1016/j.nutres.2014.06.006; Quinteiro H, 2015, MENOPAUSE, V22, P534, DOI [10.1097/GME.0000000000000344, 10.1097/gme.0000000000000344]; REZNICK AZ, 1994, METHOD ENZYMOL, V233, P357; Rodrigues B, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-38; Sanches IC, 2009, BRAZ J MED BIOL RES, V42, P942, DOI 10.1590/S0100-879X2009001000011; Sanches IC, 2012, MENOPAUSE, V19, P562, DOI 10.1097/gme.0b013e3182358c9c; Shinozaki K, 2004, HYPERTENSION, V43, P255, DOI 10.1161/01.HYP.0000111136.86976.26; SMITH ML, 1989, MED SCI SPORT EXER, V21, P40, DOI 10.1249/00005768-198902000-00008; Thirunavukkarasu V, 2004, DIABETES OBES METAB, V6, P200, DOI 10.1111/j.1462-8902.2004.00332.x; Verma S, 1997, AM J HYPERTENS, V10, P1010, DOI 10.1016/S0895-7061(97)00107-6; Wichi R, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-14; Xu L, 1999, HORM METAB RES, V31, P278, DOI 10.1055/s-2007-978733	54	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167291	10.1371/journal.pone.0167291	http://dx.doi.org/10.1371/journal.pone.0167291			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930685	Green Submitted, Green Published, gold			2022-12-26	WOS:000389580900023
J	Jaffer, S; Valasek, P; Luke, G; Batarfi, M; Whalley, BJ; Patel, K				Jaffer, Sajjida; Valasek, Petr; Luke, Graham; Batarfi, Munirah; Whalley, Benjamin Jason; Patel, Ketan			Characterisation of Development and Electrophysiological Mechanisms Underlying Rhythmicity of the Avian Lymph Heart	PLOS ONE			English	Article							ACTIVATED INWARD CURRENT; MUSCLE; DIFFERENTIATION; MUSCULATURE; EXPRESSION; CHANNELS; BLOCKER; CELLS; CHICK; SLOW	Despite significant advances in tissue engineering such as the use of scaffolds, bioreactors and pluripotent stem cells, effective cardiac tissue engineering for therapeutic purposes has remained a largely intractable challenge. For this area to capitalise on such advances, a novel approach may be to unravel the physiological mechanisms underlying the development of tissues that exhibit rhythmic contraction yet do not originate from the cardiac lineage. Considerable attention has been focused on the physiology of the avian lymph heart, a discrete organ with skeletal muscle origins yet which displays pacemaker properties normally only found in the heart. A functional lymph heart is essential for avian survival and growth in ovo. The histological nature of the lymph heart is similar to skeletal muscle although molecular and bioelectrical characterisation during development to assess mechanisms that contribute towards lymph heart contractile rhythmicity have not been undertaken. A better understanding of these processes may provide exploitable insights for therapeutic rhythmically contractile tissue engineering approaches in this area of significant unmet clinical need. Here, using molecular and electrophysiological approaches, we describe the molecular development of the lymph heart to understand how this skeletal muscle becomes fully functional during discrete in ovo stages of development. Our results show that the lymph heart does not follow the normal transitional programme of myogenesis as documented in most skeletal muscle, but instead develops through a concurrent programme of precursor expansion, commitment to myogenesis and functional differentiation which offers a mechanistic explanation for its rapid development. Extracellular electrophysiological field potential recordings revealed that the peak-to-peak amplitude of electrically evoked local field potentials elicited from isolated lymph heart were significantly reduced by treatment with carbachol; an effect that could be fully reversed by atropine. Moreover, nifedipine and cyclopiazonic acid both significantly reduced peak-to-peak local field potential amplitude. Optical recordings of lymph heart showed that the organ's rhythmicity can be blocked by the HCN channel blocker, ZD7288; an effect also associated with a significant reduction in peak-to-peak local field potential amplitude. Additionally, we also show that isoforms of HCN channels are expressed in avian lymph heart. These results demonstrate that cholinergic signalling and L-type Ca2+ channels are important in excitation and contraction coupling, while HCN channels contribute to maintenance of lymph heart rhythmicity.	[Jaffer, Sajjida; Valasek, Petr; Luke, Graham; Batarfi, Munirah; Patel, Ketan] Univ Reading, Sch Biol Sci, Reading, Berks, England; [Whalley, Benjamin Jason] Univ Reading, Sch Chem Food & Nutr Sci & Pharm, Reading, Berks, England; [Jaffer, Sajjida] UCL, UCL Canc Inst, London, England	University of Reading; University of Reading; University of London; University College London	Patel, K (corresponding author), Univ Reading, Sch Biol Sci, Reading, Berks, England.	ketan.patel@reading.ac.uk	Valasek, Petr/R-4567-2016	Valasek, Petr/0000-0001-9224-4560	UK Biotechnology and Biological Sciences Research Council; BBSRC [BB/J016454/1, BB/H01022X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H01022X/1, BB/J016454/1] Funding Source: researchfish	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	All funding was provided by the UK Biotechnology and Biological Sciences Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AL R, 1960, THE AVIAN EMBRYO; Amthor H, 1998, CURR BIOL, V8, P642, DOI 10.1016/S0960-9822(98)70251-9; BISCHOF B, 1993, LYMPHOLOGY, V26, P177; Blagden CS, 1997, GENE DEV, V11, P2163, DOI 10.1101/gad.11.17.2163; BOSMITH RE, 1993, BRIT J PHARMACOL, V110, P343, DOI 10.1111/j.1476-5381.1993.tb13815.x; Brodde OE, 1999, PHARMACOL REV, V51, P651; Brucke ET UK, 1930, PFLIIG ARCH, V224, P631; BUDRAS KD, 1987, J MORPHOL, V191, P77, DOI 10.1002/jmor.1051910108; Burdick JA, 2009, TISSUE ENG PT A, V15, P205, DOI 10.1089/ten.tea.2008.0131; Cheng L, 2004, DEV BIOL, V274, P348, DOI 10.1016/j.ydbio.2004.07.020; DAY JB, 1963, J CELL COMPAR PHYSL, V62, P33, DOI 10.1002/jcp.1030620106; DELCASTILLO J, 1961, J CELL COMPAR PHYSL, V57, P29, DOI 10.1002/jcp.1030570106; Devoto SH, 1996, DEVELOPMENT, V122, P3371; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117; McCloskey KD, 1999, J PHYSIOL-LONDON, V521, P201, DOI 10.1111/j.1469-7793.1999.00201.x; MEHRKE G, 1994, J PHARMACOL EXP THER, V271, P1483; Meissner G, 1995, BIOSCIENCE REP, V15, P399, DOI 10.1007/BF01788371; Moosmang S, 2001, EUR J BIOCHEM, V268, P1646, DOI 10.1046/j.1432-1327.2001.02036.x; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Nieto MA, 1996, METHOD CELL BIOL, V51, P219, DOI 10.1016/S0091-679X(08)60630-5; Ny A, 2005, NAT MED, V11, P998, DOI 10.1038/nm1285; OF K., 1969, EVOLUTION COMP MORPH; OLSON EN, 1992, DEV BIOL, V154, P261, DOI 10.1016/0012-1606(92)90066-P; Peyrot SM, 2010, DEV BIOL, V339, P429, DOI 10.1016/j.ydbio.2010.01.002; SATOH Y, 1983, ARCH HISTOL JAPON, V46, P115, DOI 10.1679/aohc.46.115; Tang W, 2002, FRONT BIOSCI, V7, pD1583, DOI 10.2741/tang; Terrovitis JV, 2010, CIRC RES, V106, P479, DOI 10.1161/CIRCRESAHA.109.208991; Valasek P, 2007, DEVELOPMENT, V134, P4427, DOI 10.1242/dev.004697; VONRAUTENFELD DB, 1981, LYMPHOLOGY, V14, P186; Vunjak-Noyakovic G, 2011, ANNU REV BIOMED ENG, V13, P245, DOI 10.1146/annurev-bioeng-071910-124701; WILLIAMS BA, 1994, DEVELOPMENT, V120, P785; Wilting J, 2002, FASEB J, V16, P1271, DOI 10.1096/fj.01-1010fje; Wu X, 2012, CHANNELS, V6, P438, DOI 10.4161/chan.22209; Yu X, 2007, AM J PHYSIOL-CELL PH, V292, pC1147, DOI 10.1152/ajpcell.00598.2005	35	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0166428	10.1371/journal.pone.0166428	http://dx.doi.org/10.1371/journal.pone.0166428			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930653	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000389580900010
J	Wilfart, A; Espagnol, S; Dauguet, S; Tailleur, A; Gac, A; Garcia-Launay, F				Wilfart, Aurelie; Espagnol, Sandrine; Dauguet, Sylvie; Tailleur, Aurelie; Gac, Armelle; Garcia-Launay, Florence			ECOALIM: A Dataset of Environmental Impacts of Feed Ingredients Used in French Animal Production	PLOS ONE			English	Article							LIFE-CYCLE ASSESSMENT; PRODUCTION SYSTEMS; DISTILLERS GRAINS; FARMING SYSTEMS; CHICKEN SYSTEMS; UNITED-KINGDOM; ENERGY VALUE; SCENARIOS; SOLUBLES; DIETS	Feeds contribute highly to environmental impacts of livestock products. Therefore, formulating low-impact feeds requires data on environmental impacts of feed ingredients with consistent perimeters and methodology for life cycle assessment (LCA). We created the ECOALIM dataset of life cycle inventories (LCIs) and associated impacts of feed ingredients used in animal production in France. It provides several perimeters for LCIs (field gate, storage agency gate, plant gate and harbour gate) with homogeneously collected data from French R&D institutes covering the 2005-2012 period. The dataset of environmental impacts is available as a Microsoft (R) Excel spreadsheet on the ECOALIM website and provides climate change, acidification, eutrophication, non-renewable and total cumulative energy demand, phosphorus demand, and land occupation. LCIs in the ECOALIM dataset are available in the AGRIBALYSE (R) database in SimaPro (R) software. The typology performed on the dataset classified the 149 average feed ingredients into categories of low impact (co-products of plant origin and minerals), high impact (feed-use amino acids, fats and vitamins) and intermediate impact (cereals, oilseeds, oil meals and protein crops). Therefore, the ECOALIM dataset can be used by feed manufacturers and LCA practitioners to investigate formulation of low-impact feeds. It also provides data for environmental evaluation of feeds and animal production systems. Included in AGRIBALYSE (R) database and SimaPro (R), the ECOALIM dataset will benefit from their procedures for maintenance and regular updating. Future use can also include environmental labelling of commercial products from livestock production.	[Wilfart, Aurelie] INRA, UMR SAS, Agrocampus Ouest, Rennes, France; [Espagnol, Sandrine] Inst Porc, IFIP, Le Rheu, France; [Dauguet, Sylvie] Terres Inovia, Pessac, France; [Tailleur, Aurelie] ARVALIS Inst Vegetal, La Chapelle St Sauveur, France; [Gac, Armelle] Inst Elevage, Monvoisin, Le Rheu, France; [Garcia-Launay, Florence] INRA, UMR PEGASE, Agrocampus Ouest, St Gilles, France	INRAE; Institut Agro; Agrocampus Ouest; INRAE; Institut Agro; Agrocampus Ouest	Wilfart, A (corresponding author), INRA, UMR SAS, Agrocampus Ouest, Rennes, France.	aurelie.wilfart@inra.fr	wilfart, Aurelie/A-7502-2009; SAS, ASAE UMR/M-4978-2013; Garcia-Launay, Florence/G-7197-2012	wilfart, Aurelie/0000-0002-3593-0334; SAS, ASAE UMR/0000-0001-6346-7845; Garcia-Launay, Florence/0000-0001-7015-4433	French Ministry of Agriculture (CASDAR partenariat et innovation); French Environment & Energy Management Agency (ADEME REACCTIF) [1260C0061]	French Ministry of Agriculture (CASDAR partenariat et innovation); French Environment & Energy Management Agency (ADEME REACCTIF)	The dataset described in this article was developed in the ECOALIM project, funded by the French Ministry of Agriculture (CASDAR partenariat et innovation-2012) and the French Environment & Energy Management Agency (ADEME REACCTIF-2012, 1260C0061).	Agreste, 2006, ENQ PRAT CULT; [Anonymous], 2014, FEED GRAINS YB TABL; [Anonymous], 2013, GREENHOUSE GAS EMISS; [Anonymous], 2010, QUICK STATS; [Anonymous], 2014, FARM FIN CROP PROD P; [Anonymous], 2015, SIMAPRO DATABASE MAN; [Anonymous], 2007, THESIS; [Anonymous], 2013, FAOSTAT PROD STAT; Auguie B, 2017, GRIDEXTRA MISCELLANE; Basset-Mens C, 2005, AGR ECOSYST ENVIRON, V105, P127, DOI 10.1016/j.agee.2004.05.007; Bertoluci G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150617; BILLEN G, 2015, ENV RES LETT, V10; Boggia A, 2010, WORLD POULTRY SCI J, V66, P95, DOI 10.1017/S0043933910000103; Boissy J, 2011, AQUACULTURE, V321, P61, DOI 10.1016/j.aquaculture.2011.08.033; Colomb V, 2016, 10 INT C LIF CYCL AS; COMIFER, 2001, DIAGN RISG PROP GEST; Cozannet P, 2010, POULTRY SCI, V89, P2230, DOI 10.3382/ps.2010-00833; Cozannet P, 2010, J ANIM SCI, V88, P2382, DOI 10.2527/jas.2009-2510; da Silva VP, 2014, J ENVIRON MANAGE, V133, P222, DOI 10.1016/j.jenvman.2013.12.011; da Silva VP, 2010, J ENVIRON MANAGE, V91, P1831, DOI 10.1016/j.jenvman.2010.04.001; Dalgaard R, 2008, INT J LIFE CYCLE ASS, V13, P240, DOI 10.1065/lca2007.06.342; de Vries M, 2010, LIVEST SCI, V128, P1, DOI 10.1016/j.livsci.2009.11.007; Dourmad JY, 2014, ANIMAL, V8, P2027, DOI 10.1017/S1751731114002134; Durlinger B., 2014, Proceedings of the 9th International Conference on Life Cycle Assessment in the Agri-Food Sector (LCA Food 2014), San Francisco, California, USA, 8-10 October, 2014, P310; EMEP/EEA, 2013, 12 EMEPEEA; EN ISO 14040, 2006, 14040 EN ISO; FAO, 2010, GREENHOUSE GAS EMISS; Food and Agriculture Organization (FAO), 2011, WORLD LIV 2011 LIV F, DOI DOI 10.1080/; FOSTER GR, 2005, REVISED UNIVERSAL SO; Freiermuth R., 2006, MODELL BERECHNUNG SC; Garcia-Launay F, 2014, LIVEST SCI, V161, P158, DOI 10.1016/j.livsci.2013.11.027; Garcia-Launay F, 2016, 10 INT C LIF CYCL AS; Gerber P.J., 2013, TACKLING CLIMATE CHA, P139; IPCC, 2006, IPCC GUID NAT GREENH, V4, P87; JRC, 2012, CHAR FACT ILCD REC L; Koch P, 2015, AGRIBALYSE R METHODO; Leinonen I, 2012, POULTRY SCI, V91, P26, DOI 10.3382/ps.2011-01635; Leinonen I, 2012, POULTRY SCI, V91, P8, DOI 10.3382/ps.2011-01634; Marinussen M, 2010, BLONK MILIEU ADVIES; Meul M, 2012, LIVEST SCI, V149, P215, DOI 10.1016/j.livsci.2012.07.012; Monteiro ANTR, 2016, J ANIMAL SC IN PRESS; Nemecek T, 2007, V20 SWISS CTR LIF CY; Nguyen TTH, 2012, J CLEAN PROD, V28, P215, DOI 10.1016/j.jclepro.2011.06.029; Nguyen TLT, 2010, J CLEAN PROD, V18, P756, DOI 10.1016/j.jclepro.2009.12.023; Roder M, 2014, ENVIRON SCI POLICY, V39, P13, DOI 10.1016/j.envsci.2014.02.002; SOGREAH, 2007, BIL FLUX CONT ENTR S; State Statistics Service of Ukraine, 2012, AGR UKR STAT YB; Steinfeld H., 2006, LIVESTOCKS LONG SHAD, DOI [10.1890/1540-9295(2007)5[4:D]2.0.CO;2, DOI 10.1890/1540-9295(2007)5[4:D]2.0.CO;2]; Tailleur A, 2012, P 8 INT C LIF CYCL A, P903; van der Werf HMG, 2002, AGR ECOSYST ENVIRON, V93, P131, DOI 10.1016/S0167-8809(01)00354-1; Weidema B, 2013, ECOINVENT DATABASE O; Zanten HHE, 2013, INT J LIFE CYCLE ASS, V19, P79	52	46	48	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167343	10.1371/journal.pone.0167343	http://dx.doi.org/10.1371/journal.pone.0167343			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930682	Green Published, Green Submitted, gold			2022-12-26	WOS:000389580900025
J	Yang, J; Saggiomo, V; Velders, AH; Stuart, MAC; Kamperman, M				Yang, Juan; Saggiomo, Vittorio; Velders, Aldrik H.; Stuart, Martien A. Cohen; Kamperman, Marleen			Reaction Pathways in Catechol/Primary Amine Mixtures: A Window on Crosslinking Chemistry	PLOS ONE			English	Article							COFACTOR; PROTEINS	Catechol chemistry is used as a crosslinking tool abundantly in both natural organisms (e.g. mussels, sandcastle worms) and synthetic systems to achieve the desired mechanical properties. Despite this abundance and success, the crosslinking chemistry is still poorly understood. In this study, to simplify the system, yet to capture the essential chemistry, model compounds 4-methyl catechol and propylamine are used. The reaction of 4-methyl catechol (2 mM) with propylamine (6 mM) is carried out in the presence of NaIO4 (2 mM) in 10 mM Na2CO3 aqueous solution. A variety of spectroscopic/spectrometric and chromatographic methods such as H-1 NMR, LC-MS, and UV-VIS are used to track the reaction and identify the products/intermediates. It is found that the crosslinking chemistry of a catechol and an amine is both fast and complicated. Within five minutes, more than 60 products are formed. These products encompass 19 different masses ranging from molecular weight of 179 to 704. By combining time-dependent data, it is inferred that the dominant reaction pathways: the majority is formed via aryloxyl-phenol coupling and Michael-type addition, whereas a small fraction of products is formed via Schiff base reactions.	[Yang, Juan; Stuart, Martien A. Cohen; Kamperman, Marleen] Wageningen Univ, Lab Phys Chem & Soft Matter, Wageningen, Netherlands; [Saggiomo, Vittorio; Velders, Aldrik H.] Wageningen Univ, Lab BioNanoTechnol, Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research	Kamperman, M (corresponding author), Wageningen Univ, Lab Phys Chem & Soft Matter, Wageningen, Netherlands.	marleen.kamperman@wur.nl	v, a/ABA-6163-2021; Kamperman, Marleen/O-1810-2016; Saggiomo, Vittorio/AAE-5715-2019	Kamperman, Marleen/0000-0002-0520-4534; saggiomo, vittorio/0000-0001-7196-602X; Velders, Aldrik/0000-0002-6925-854X	AkzoNobel Global; AkzoNobel	AkzoNobel Global; AkzoNobel	The study was funded by AkzoNobel Global (http://www.akzonobel.com/our_key_market/our_business_areas/decorative_paints/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge the funding support from AkzoNobel. J. Yang would like to dedicate this work to her newborn baby, Yiran Ni, and wish him all the best in his forthcoming life!	Akagawa M, 2001, BIOCHEM BIOPH RES CO, V281, P193, DOI 10.1006/bbrc.2001.4315; Bittner S, 2006, AMINO ACIDS, V30, P205, DOI 10.1007/s00726-005-0298-2; Burzio LA, 2000, BIOCHEMISTRY-US, V39, P11147, DOI 10.1021/bi0002434; Faure E, 2012, ADV FUNCT MATER, V22, P5271, DOI 10.1002/adfm.201201106; Floriolli RY, 2000, MAR BIOTECHNOL, V2, P352; Haemers S, 2003, BIOMACROMOLECULES, V4, P632, DOI 10.1021/bm025707n; HOLL SM, 1993, ARCH BIOCHEM BIOPHYS, V302, P255, DOI 10.1006/abbi.1993.1207; Kramer KJ, 2001, TETRAHEDRON, V57, P385, DOI 10.1016/S0040-4020(00)00949-2; Land EJ, 2003, ACCOUNTS CHEM RES, V36, P300, DOI 10.1021/ar020062p; Lee BP, 2002, BIOMACROMOLECULES, V3, P1038, DOI 10.1021/bm025546n; Liu B, 2006, J AM CHEM SOC, V128, P15228, DOI 10.1021/ja065794h; Miserez A, 2008, SCIENCE, V319, P1816, DOI 10.1126/science.1154117; Miserez A, 2010, J BIOL CHEM, V285, P38115, DOI 10.1074/jbc.M110.161174; Mure M, 2003, J AM CHEM SOC, V125, P6113, DOI 10.1021/ja0214274; Smith A. M, 2006, BIOL ADHESIVES; Sorrell T. N., 2005, ORGANIC CHEM; Wang SX, 1996, SCIENCE, V273, P1078, DOI 10.1126/science.273.5278.1078; Wu JJ, 2011, LANGMUIR, V27, P13684, DOI 10.1021/la2027237; Yang JJ, 2016, J CHEM-NY, V2016, DOI 10.1155/2016/9761706; Yang J, 2014, CHEM SOC REV, V43, P8271, DOI 10.1039/c4cs00185k; Yu J, 2011, NAT CHEM BIOL, V7, P588, DOI [10.1038/NCHEMBIO.630, 10.1038/nchembio.630]; Yu ME, 1998, MACROMOLECULES, V31, P4739, DOI 10.1021/ma980268z; Zhao H, 2005, BIOCHEMISTRY-US, V44, P15915, DOI 10.1021/bi051530g	23	54	54	4	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0166490	10.1371/journal.pone.0166490	http://dx.doi.org/10.1371/journal.pone.0166490			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930671	Green Published, Green Submitted, gold			2022-12-26	WOS:000389580900011
J	Choi, DJ; Yoon, CH; Lee, H; Ahn, SY; Oh, KJ; Park, HY; Lee, HY; Cho, MC; Chung, IM; Shin, MS; Park, SJ; Shim, CY; Han, SW; Chae, IH				Choi, Dong-Ju; Yoon, Chang-Hwan; Lee, Heesun; Ahn, So-Yeon; Oh, Kyung Joon; Park, Hyun-Young; Lee, Hea Young; Cho, Myeong Chan; Chung, Ick-Mo; Shin, Mi-Seung; Park, Sung-Ji; Shim, Chi Young; Han, Seong Woo; Chae, In-Ho			The Association of Family History of Premature Cardiovascular Disease or Diabetes Mellitus on the Occurrence of Gestational Hypertensive Disease and Diabetes	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; PREGNANCY COMPLICATIONS; NURSES HEALTH; RISK-FACTORS; WOMEN; PREECLAMPSIA; COHORT; PREVENTION; PREVALENCE; CHILDREN	Background Gestational hypertensive diseases (GHD) and gestational diabetes mellitus (GDM) increase the risk of cardiovascular disease (CVD) later in life. However, the association between gestational medical diseases and familial history of CVD has not been investigated to date. In the present study, we examined the association between familial history of CVD and GHD or GDM via reliable questionnaires in a large cohort of registered nurses. Methods The Korean Nurses' Survey was conducted through a web-based computer-assisted self-interview, which was developed through consultation with cardiologists, gynecologists, and statisticians. We enrolled a total of 9,989 female registered nurses who reliably answered the questionnaires including family history of premature CVD (FHpCVD), hypertension (FHH), and diabetes mellitus (FHDM) based on their medical knowledge. Either multi-variable logistic regression analysis or generalized estimation equation was used to clarify the effect of positive family histories on GHD and GDM in subjects or at each repeated pregnancy in an individual. Results In this survey, 3,695 subjects had at least 1 pregnancy and 8,783 cumulative pregnancies. Among them, 247 interviewees (6.3%) experienced GHD and 120 (3.1%) experienced GDM. In a multivariable analysis adjusted for age, obstetric, and gynecologic variables, age at the first pregnancy over 35 years (adjusted OR 1.61, 95% CI 1.02-2.43) and FHpCVD (adjusted OR 1.60, 95% CI 1.16-2.22) were risk factors for GHD in individuals, whereas FHH was not. FHDM and history of infertility therapy were risk factors for GDM in individuals (adjusted OR 2.68, 95% CI 1.86-3.86; 1.84, 95% CI 1.05-3.23, respectively). In any repeated pregnancies in an individual, age at the current pregnancy and at the first pregnancy, and FHpCVD were risk factors for GHD, while age at the current pregnancy, history of infertility therapy, and FHDM were risk factors for GDM. Conclusions The FHpCVD and FHDM are significantly associated with GHD and GDM, respectively. Meticulous family histories should be obtained, and women with family histories of these conditions should be carefully monitored during pregnancy.	[Choi, Dong-Ju; Yoon, Chang-Hwan; Lee, Heesun; Chae, In-Ho] Seoul Natl Univ, Cardiovasc Ctr, Bundang Hosp, Seongnam, South Korea; [Ahn, So-Yeon] Seoul Natl Univ, MRCC, Bundang Hosp, Seongnam, South Korea; [Oh, Kyung Joon] Seoul Natl Univ, Dept Obstet & Gynecol, Bundang Hosp, Seongnam, South Korea; [Park, Hyun-Young] Natl Inst Hlth, Ctr Biomed Sci, Div Cardiovasc & Rare Dis, Chungbuk, South Korea; [Lee, Hea Young] Korean Nurses Assoc, Seoul, South Korea; [Cho, Myeong Chan] Chungbuk Natl Univ, Dept Internal Med, Chungbuk, South Korea; [Chung, Ick-Mo] Ewha Womans Univ, Sch Med, Div Cardiol, Seoul, South Korea; [Shin, Mi-Seung] Gachon Univ, Gil Med Ctr, Dept Internal Med, Div Cardiol, Inchon, South Korea; [Park, Sung-Ji] Sungkyunkwan Univ, Sch Med, Div Cardiol, Cardiovasc Imaging Ctr,Heart Vasc Stroke Inst,Sam, Seoul, South Korea; [Shim, Chi Young] Yonsei Univ, Severance Cardiovasc Hosp, Div Cardiol, Seoul, South Korea; [Han, Seong Woo] Dongtan Sacred Heart Hosp, Dept Cardiovasc Med, Hwaseong, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Biomedical Science; Chungbuk National University; Ewha Womans University; Gachon University; Sungkyunkwan University (SKKU); Yonsei University	Yoon, CH (corresponding author), Seoul Natl Univ, Cardiovasc Ctr, Bundang Hosp, Seongnam, South Korea.	kunson2@snu.ac.kr	Shim, Chi Young/AAK-1057-2021	Shim, Chi Young/0000-0002-6136-0136; Oh, Kyung Joon/0000-0002-4558-7947	Research of Korea Centers for Disease Control and Prevention [2011-E63009-00]; Industrial Strategic Technology Development Program [10052980]; Ministry of Trade, Industry & Energy of Korea	Research of Korea Centers for Disease Control and Prevention; Industrial Strategic Technology Development Program; Ministry of Trade, Industry & Energy of Korea	This research was supported by a grant (2011-E63009-00) by the Research of Korea Centers for Disease Control and Prevention. Chang-Hwan Yoon is supported by the Industrial Strategic Technology Development Program, 10052980, Development of microbiorobotic systems for surgical treatment of chronic total occlusion, funded by the Ministry of Trade, Industry & Energy of Korea.	Anand SS, 2008, EUR HEART J, V29, P932, DOI 10.1093/eurheartj/ehn018; Ananth CV, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6564; Anna V, 2008, DIABETES CARE, V31, P2288, DOI 10.2337/dc08-1038; Bellamy L, 2007, BMJ-BRIT MED J, V335, P974, DOI 10.1136/bmj.39335.385301.BE; Ben-Haroush A, 2004, DIABETIC MED, V21, P103, DOI 10.1046/j.1464-5491.2003.00985.x; Carr DB, 2006, DIABETES CARE, V29, P2078, DOI 10.2337/dc05-2482; Chambers JC, 2001, JAMA-J AM MED ASSOC, V285, P1607, DOI 10.1001/jama.285.12.1607; COLDITZ GA, 1986, AM J EPIDEMIOL, V123, P894, DOI 10.1093/oxfordjournals.aje.a114319; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; De Sutter J, 2003, EUR HEART J, V24, P249, DOI 10.1016/S0195-668X(02)00386-X; Fraser A, 2012, CIRCULATION, V125, P1367, DOI 10.1161/CIRCULATIONAHA.111.044784; Geelhoed JJM, 2010, CIRCULATION, V122, P1192, DOI 10.1161/CIRCULATIONAHA.110.936674; Gunderson EP, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000490; Hunt KJ, 2007, OBSTET GYN CLIN N AM, V34, P173, DOI 10.1016/j.ogc.2007.03.002; LIPNICK RJ, 1986, JAMA-J AM MED ASSOC, V255, P58, DOI 10.1001/jama.255.1.58; McDonald SD, 2008, AM HEART J, V156, P918, DOI 10.1016/j.ahj.2008.06.042; Michels KB, 1998, CIRCULATION, V97, P1540, DOI 10.1161/01.CIR.97.16.1540; Mosca Lori, 2004, J Am Coll Cardiol, V43, P900, DOI 10.1016/j.jacc.2004.02.001; Qiu CF, 2003, HYPERTENSION, V41, P408, DOI 10.1161/01.HYP.0000056996.25503.F5; Rodie VA, 2004, ATHEROSCLEROSIS, V175, P189, DOI 10.1016/j.atherosclerosis.2004.01.038; Romundstad PR, 2010, CIRCULATION, V122, P579, DOI 10.1161/CIRCULATIONAHA.110.943407; Shah BR, 2008, DIABETES CARE, V31, P1668, DOI 10.2337/dc08-0706; Smith GCS, 2001, LANCET, V357, P2002, DOI 10.1016/S0140-6736(00)05112-6; STAMPFER MJ, 1991, NEW ENGL J MED, V325, P756, DOI 10.1056/NEJM199109123251102; Stampfer MJ, 2000, NEW ENGL J MED, V343, P16, DOI 10.1056/NEJM200007063430103; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Ye C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100180	27	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2016	11	12							e0167528	10.1371/journal.pone.0167528	http://dx.doi.org/10.1371/journal.pone.0167528			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4MR	27918585	Green Submitted, Green Published, gold			2022-12-26	WOS:000389577100013
J	Arnold, WD; Duque, S; Iyer, CC; Zaworski, P; McGovern, VL; Taylor, SJ; von Herrmann, KM; Kobayashi, DT; Chen, KS; Kolb, SJ; Paushkin, SV; Burghes, AHM				Arnold, W. David; Duque, Sandra; Iyer, Chitra C.; Zaworski, Phillip; McGovern, Vicki L.; Taylor, Shannon J.; von Herrmann, Katharine M.; Kobayashi, Dione T.; Chen, Karen S.; Kolb, Stephen J.; Paushkin, Sergey V.; Burghes, Arthur H. M.			Normalization of Patient-Identified Plasma Biomarkers in SMN Delta 7 Mice following Postnatal SMN Restoration	PLOS ONE			English	Article							SPINAL MUSCULAR-ATROPHY; MOTOR-NEURON PROTEIN; MOUSE MODEL; COPY NUMBER; SINGLE NUCLEOTIDE; DETERMINING GENE; NATURAL-HISTORY; SURVIVAL; PHENOTYPE; SEVERITY	Introduction and Objective Spinal muscular atrophy (SMA) is an autosomal recessive motor neuron disorder. SMA is caused by homozygous loss of the SMN1 gene and retention of the SMN2 gene resulting in reduced levels of full length SMN protein that are insufficient for motor neuron function. Various treatments that restore levels of SMN are currently in clinical trials and biomarkers are needed to determine the response to treatment. Here, we sought to investigate in SMA mice a set of plasma analytes, previously identified in patients with SMA to correlate with motor function. The goal was to determine whether levels of plasma markers were altered in the SMN Delta 7 mouse model of SMA and whether postnatal SMN restoration resulted in normalization of the biomarkers. Methods SMN Delta 7 and control mice were treated with antisense oligonucleotides (ASO) targeting ISS-N1 to increase SMN protein from SMN2 or scramble ASO (sham treatment) via intracerebroventricular injection on postnatal day 1 (P1). Brain, spinal cord, quadriceps muscle, and liver were analyzed for SMN protein levels at P12 and P90. Ten plasma biomarkers (a subset of biomarkers in the SMA-MAP panel available for analysis in mice) were analyzed in plasma obtained at P12, P30, and P90. Results Of the eight plasma biomarkers assessed, 5 were significantly changed in sham treated SMN Delta 7 mice compared to control mice and were normalized in SMN Delta 7 mice treated with ASO. Conclusion This study defines a subset of the SMA-MAP plasma biomarker panel that is abnormal in the most commonly used mouse model of SMA. Furthermore, some of these markers are responsive to postnatal SMN restoration. These findings support continued clinical development of these potential prognostic and pharmacodynamic biomarkers.	[Arnold, W. David; Kolb, Stephen J.; Burghes, Arthur H. M.] Ohio State Univ, Dept Neurol, Wexner Med Ctr, Columbus, OH 43210 USA; [Arnold, W. David] Ohio State Univ, Dept Phys Med & Rehabil, Wexner Med Ctr, Columbus, OH 43210 USA; [Duque, Sandra] Katholieke Univ Leuven, VIB Ctr Biol Dis, Dept Human Genet, Leuven, Belgium; [Iyer, Chitra C.; McGovern, Vicki L.; Kolb, Stephen J.; Burghes, Arthur H. M.] Ohio State Univ, Wexner Med Ctr, Dept Biol Chem & Pharmacol, Columbus, OH 43210 USA; [Zaworski, Phillip; Taylor, Shannon J.] PharmOptima, Portage, MI USA; [von Herrmann, Katharine M.; Kobayashi, Dione T.; Chen, Karen S.; Paushkin, Sergey V.] SMA Fdn, New York, NY USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Flanders Institute for Biotechnology (VIB); KU Leuven; University System of Ohio; Ohio State University	Burghes, AHM (corresponding author), Ohio State Univ, Dept Neurol, Wexner Med Ctr, Columbus, OH 43210 USA.; Burghes, AHM (corresponding author), Ohio State Univ, Wexner Med Ctr, Dept Biol Chem & Pharmacol, Columbus, OH 43210 USA.	burghes.1@osu.edu	Iyer, Chitra/K-5482-2019; Arnold, W. David/AAM-5649-2020	McGovern, Vicki/0000-0003-3979-9596; Burghes, Arthur/0000-0001-9031-1555; Arnold, W. David/0000-0001-9889-7036; kobayashi, dione/0000-0002-5541-7175	NIH-NICHD [HD060586, 5K12HD001097-17, U01NS079163]; Marshal Heritage Foundation; SMA Foundation; PharmOptima; Spinal Muscular Atrophy Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD060586, K12HD001097] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS079163] Funding Source: NIH RePORTER	NIH-NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Marshal Heritage Foundation; SMA Foundation; PharmOptima; Spinal Muscular Atrophy Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The studies described here were supported by NIH-NICHD grant HD060586, the Marshal Heritage Foundation, and the SMA Foundation. WDA was supported by a NIH-NICHD (5K12HD001097-17). SJK was supported by NIH-NINDS (U01NS079163). PharmOptima provided support in the form of salaries for PZ and ST. The Spinal Muscular Atrophy Foundation provided support in the form of salaries for KVH, DK, KC and SP and supported the cost of the biomarker and SMN levels performed at PharmOptima. PharmOptima had no additional roles in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are specified in the author contributions section. Competing interests: PZ and ST are employees of PharmOptima, Inc. KC and SP are employees of the Spinal Muscular Atrophy Foundation. KVH and DK were employees of the Spinal Muscular Atrophy Foundation at the time of this research. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Arnold W, 2016, NEUROBIOL DIS, V87, P116, DOI 10.1016/j.nbd.2015.12.014; Arnold W.D., 2013, ANN NEUROL; Arnold WD, 2015, JOVE-J VIS EXP, DOI 10.3791/52899; Arnold WD, 2015, MUSCLE NERVE, V51, P157, DOI 10.1002/mus.24497; Arnold WD, 2014, ANN CLIN TRANSL NEUR, V1, P34, DOI 10.1002/acn3.23; Bernal S, 2010, J MED GENET, V47, P640, DOI 10.1136/jmg.2010.079004; Bogdanik LP, 2015, P NATL ACAD SCI USA, V112, pE5863, DOI 10.1073/pnas.1509758112; Bowerman M, 2012, ANN NEUROL, V72, P256, DOI 10.1002/ana.23582; Bromberg MB, 2002, MUSCLE NERVE, V25, P445, DOI 10.1002/mus.10050; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; Burnett BG, 2009, MOL CELL BIOL, V29, P1107, DOI 10.1128/MCB.01262-08; Campbell L, 1997, AM J HUM GENET, V61, P40, DOI 10.1086/513886; Cartegni L, 2002, NAT GENET, V30, P377, DOI 10.1038/ng854; Chen YJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep17632; Chiriboga CA, 2016, NEUROLOGY, V86, P890, DOI 10.1212/WNL.0000000000002445; Choi ST, 2008, RHEUMATOLOGY, V47, P1775, DOI 10.1093/rheumatology/ken385; Coovert DD, 1997, HUM MOL GENET, V6, P1205, DOI 10.1093/hmg/6.8.1205; Crawford TO, 1996, NEUROBIOL DIS, V3, P97, DOI 10.1006/nbdi.1996.0010; Dominguez E, 2011, HUM MOL GENET, V20, P681, DOI 10.1093/hmg/ddq514; Duque SI, 2015, ANN NEUROL, V77, P399, DOI 10.1002/ana.24332; Elsheikh B, 2009, MUSCLE NERVE, V40, P652, DOI 10.1002/mus.21350; Feldkotter M, 2002, AM J HUM GENET, V70, P358, DOI 10.1086/338627; Finkel RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035462; Foust KD, 2010, NAT BIOTECHNOL, V28, P271, DOI 10.1038/nbt.1610; GENNARELLI M, 1995, BIOCHEM BIOPH RES CO, V213, P342, DOI 10.1006/bbrc.1995.2135; Harris VK, 2013, MULT SCLER J, V19, P1462, DOI 10.1177/1352458513477923; Hsieh-Li HM, 2000, NAT GENET, V24, P66, DOI 10.1038/71709; Hua YM, 2011, NATURE, V478, P123, DOI 10.1038/nature10485; Kashima T, 2003, NAT GENET, V34, P460, DOI 10.1038/ng1207; Kaufmann P, 2012, NEUROLOGY, V79, P1889, DOI 10.1212/WNL.0b013e318271f7e4; Kaufmann P, 2011, ARCH NEUROL-CHICAGO, V68, P779, DOI 10.1001/archneurol.2010.373; Kobayashi DT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060113; Kolb SJ, 2016, ANN CLIN TRANSL NEUR, V3, P132, DOI 10.1002/acn3.283; Le TT, 2005, HUM MOL GENET, V14, P845, DOI 10.1093/hmg/ddi078; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Lewelt A, 2010, MUSCLE NERVE, V42, P703, DOI 10.1002/mus.21838; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Lorson CL, 1998, NAT GENET, V19, P63, DOI 10.1038/ng0598-63; Lorson CL, 2000, HUM MOL GENET, V9, P259, DOI 10.1093/hmg/9.2.259; Mailman MD, 2002, GENET MED, V4, P20, DOI 10.1097/00125817-200201000-00004; McAndrew PE, 1997, AM J HUM GENET, V60, P1411, DOI 10.1086/515465; McGovern VL, 2015, HUM MOL GENET; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; Monani UR, 2000, HUM MOL GENET, V9, P333, DOI 10.1093/hmg/9.3.333; MUNSAT TL, 1992, NEUROMUSCULAR DISORD, V2, P423, DOI 10.1016/S0960-8966(06)80015-5; Naryshkin NA, 2014, SCIENCE, V345, P688, DOI 10.1126/science.1250127; Ng KW, 2015, J NEUROL SCI, V358, P178, DOI 10.1016/j.jns.2015.08.1532; Palacino J, 2015, NAT CHEM BIOL, V11, P511, DOI [10.1038/NCHEMBIO.1837, 10.1038/nchembio.1837]; Passini MA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001777; Passini MA, 2010, J CLIN INVEST, V120, P1253, DOI 10.1172/JCI41615; Porensky PN, 2012, HUM MOL GENET, V21, P1625, DOI 10.1093/hmg/ddr600; Prior TW, 2009, AM J HUM GENET, V85, P408, DOI 10.1016/j.ajhg.2009.08.002; ROBERTS DF, 1970, ARCH DIS CHILD, V45, P33, DOI 10.1136/adc.45.239.33; Rohrborn D, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00386; Rutkove SB, 2014, PEDIATR NEUROL, V51, P88, DOI 10.1016/j.pediatrneurol.2014.02.015; Swoboda KJ, 2005, ANN NEUROL, V57, P704, DOI 10.1002/ana.20473; Tiziano FD, 2011, INT J MOL SCI, V12, P24, DOI 10.3390/ijms12010024; Valori CF, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000830; Vezain M, 2010, HUM MUTAT, V31, pE1110, DOI 10.1002/humu.21173; Wirth B, 1999, AM J HUM GENET, V64, P1340, DOI 10.1086/302369; Zaworski P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150640; ZERRES K, 1995, ARCH NEUROL-CHICAGO, V52, P518, DOI 10.1001/archneur.1995.00540290108025	63	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167077	10.1371/journal.pone.0167077	http://dx.doi.org/10.1371/journal.pone.0167077			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907033	Green Published, Green Submitted, gold			2022-12-26	WOS:000389482700072
J	Gilbert, JA; Shenoi, SV; Moll, AP; Friedland, GH; Paltiel, AD; Galvani, AP				Gilbert, Jennifer A.; Shenoi, Sheela V.; Moll, Anthony P.; Friedland, Gerald H.; Paltiel, A. David; Galvani, Alison P.			Cost-Effectiveness of Community-Based TB/HIV Screening and Linkage to Care in Rural South Africa	PLOS ONE			English	Article							ISONIAZID PREVENTIVE THERAPY; DRUG-RESISTANT TUBERCULOSIS; HIV-ASSOCIATED TUBERCULOSIS; ANTIRETROVIRAL THERAPY; TREATMENT OUTCOMES; MYCOBACTERIUM-TUBERCULOSIS; EPIDEMICS; MODEL; TB; TRANSMISSION	South Africa has one of the highest burdens of TB worldwide, driven by the country's widespread prevalence of HIV, and further complicated by drug resistance. Active case finding within the community, particularly in rural areas where healthcare access is limited, can significantly improve diagnosis and treatment coverage in high-incidence settings. We evaluated the potential health and economic consequences of implementing community-based TB/HIV screening and linkage to care. Using a dynamic model of TB and HIV transmission over a time horizon of 10 years, we compared status quo TB/HIV control to community-based TB/HIV screening at frequencies of once every two years, one year, and six months. We also considered the impact of extending IPT from 36 months for TST positive and 12 months for TST negative or unknown patients (36/12) to lifetime use for all HIV-infected patients. We conducted a probabilistic sensitivity analysis to assess the effect of parameter uncertainty on the cost-effectiveness results. We identified four strategies that saved the most life years for a given outlay: status quo TB/HIV control with 36/12 months of IPT and TB/HIV screening strategies at frequencies of once every two years, one year, and six months with lifetime IPT. All of these strategies were very cost-effective at a threshold of $6,618 per life year saved (the per capita GDP of South Africa). Community-based TB/HIV screening with linkage to care is therefore very cost-effective in rural South Africa.	[Gilbert, Jennifer A.; Friedland, Gerald H.; Galvani, Alison P.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA; [Gilbert, Jennifer A.; Galvani, Alison P.] Yale Sch Publ Hlth, Ctr Infect Dis Modeling & Anal, New Haven, CT USA; [Shenoi, Sheela V.; Moll, Anthony P.; Friedland, Gerald H.] Yale Univ Sch Med, Infect Dis Sect, Dept Med, AIDS Program, New Haven, CT USA; [Moll, Anthony P.] Church Scotland Hosp, Tugela Ferry, Kwazulu Natal, South Africa; [Paltiel, A. David] Yale Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT USA	Yale University; Yale University; Yale University; Yale University	Gilbert, JA (corresponding author), Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA.	jennifer.gilbert@aya.yale.edu	Shenoi, Sheela/Z-2641-2019; Shenoi, Sheela/GRY-6103-2022	Shenoi, Sheela/0000-0001-7654-4344; Paltiel, A. David/0000-0002-4861-3290	National Institute on Drug Abuse [R01DA015612, R01DA025932]; Gilead Foundation [157201]; President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control (CDC) and Prevention [1U01GH000524-01]; National Institute of Mental Health [R01MH105203]; National Institutes of Health [2U01GM087719, 5U01GM105627]; National Institute of Allergy and Infectious Diseases [1K23AI089260]; National Institutes of Health's Fogarty International Clinical Research Program [R24TW007988]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI089260] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015612, R37DA015612] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Gilead Foundation(Gilead Sciences); President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control (CDC) and Prevention; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health's Fogarty International Clinical Research Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	JAG and ADP were supported by the National Institute on Drug Abuse (R01DA015612, http://www.drugabuse.gov). GHF was supported by the National Institute on Drug Abuse (R01DA025932, http://www.drugabuse.gov). GHF and SVS were supported by the Gilead Foundation (157201, http://www.gilead.com). GHF, APM, APG, and SVS were supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control (CDC) and Prevention (1U01GH000524-01, http://www.cdc.gov). ADP was supported by the National Institute of Mental Health (R01MH105203, http://www.nimh.nih.gov). APG was supported by the National Institutes of Health (2U01GM087719 and 5U01GM105627, http://nih.gov). SVS was supported by the National Institute of Allergy and Infectious Diseases (1K23AI089260, http://www.niaid.nih.gov) and the National Institutes of Health's Fogarty International Clinical Research Program (R24TW007988, http://nih.gov).	Actuarial Society of South Africa, 2011, ASSA2008 MOD; Akolo C, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000171.pub3; [Anonymous], 2014, NAT TUB MAN GUID; [Anonymous], 2013, S AFR ANT TREATM GUI; [Anonymous], 2011, MULT RES TUB POL FRA; [Anonymous], 2003, LAB MED, DOI DOI 10.1046/J.1439-0477.2003.03049.X; [Anonymous], 2011, GUID INT TUB CAS FIN; Ayles H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005602; Badri M, 2002, LANCET, V359, P2059, DOI 10.1016/S0140-6736(02)08904-3; Bassett IV, 2007, JAIDS-J ACQ IMM DEF, V46, P181, DOI 10.1097/QAI.0b013e31814277c8; Bassett IV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085197; Bassett IV, 2010, AIDS, V24, pS37, DOI 10.1097/01.aids.0000366081.91192.1c; Basu S, 2009, INT J TUBERC LUNG D, V13, P652; Basu S, 2007, LANCET, V370, P1500, DOI 10.1016/S0140-6736(07)61636-5; Basu S, 2009, P NATL ACAD SCI USA, V106, P7672, DOI 10.1073/pnas.0812472106; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Briggs AH, 2012, MED DECIS MAKING, V32, P722, DOI 10.1177/0272989X12458348; Chehab JC, 2012, INT J TUBERC LUNG D, V16, P903, DOI 10.5588/ijtld.11.0722; Churchyard GJ, 2014, SAMJ S AFR MED J, V104, P244, DOI [10.7196/samj.7689, 10.7196/SAMJ.7689]; Cleary S, 2005, S AFRICAN HLTH REV 2; CLEARY S, 2004, COST EFFECTIVENESS A; Cohen T, 2006, P NATL ACAD SCI USA, V103, P7042, DOI 10.1073/pnas.0600349103; Cohen T, 2004, NAT MED, V10, P1117, DOI 10.1038/nm1110; Cohen T, 2007, J R SOC INTERFACE, V4, P523, DOI 10.1098/rsif.2006.0193; Currie CSM, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-130; Dowdy DW, 2008, P NATL ACAD SCI USA, V105, P11293, DOI 10.1073/pnas.0800965105; Dye C, 2000, P NATL ACAD SCI USA, V97, P8180, DOI 10.1073/pnas.140102797; Dye C, 1998, LANCET, V352, P1886, DOI 10.1016/S0140-6736(98)03199-7; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Getahun H, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000391; Gilbert JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126267; Golub JE, 2007, AIDS, V21, P1441, DOI 10.1097/QAD.0b013e328216f441; Govindasamy D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080017; Granich R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030216; Group ISS, 2015, N ENGL J MED; Group TAS, 2015, N ENGL J MED; Gupta S, 2014, INT J TUBERC LUNG D, V18, P1159, DOI 10.5588/ijtld.13.0571; Health Systems Trust, 2015, BACT COV RAT; Health Systems Trust, 2011, DET INT RAT NEW SM C; Hernandez-Garduno E, 2004, THORAX, V59, P286, DOI 10.1136/thx.2003.011759; Houben RMGJ, 2014, P NATL ACAD SCI USA, V111, P5325, DOI 10.1073/pnas.1317660111; Jacobson KR, 2011, CLIN INFECT DIS, V53, P369, DOI 10.1093/cid/cir406; Jacobson KR, 2010, CLIN INFECT DIS, V51, P6, DOI 10.1086/653115; Johnson L., 2011, S AFR J HIV MED, V13, P22; Kompala T, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1627-8; Lawn SD, 2010, LANCET INFECT DIS, V10, P489, DOI 10.1016/S1473-3099(10)70078-5; Lawn SD, 2009, CLIN CHEST MED, V30, P685, DOI 10.1016/j.ccm.2009.08.010; Loveday M, 2012, INT J TUBERC LUNG D, V16, P209, DOI 10.5588/ijtld.11.0401; MARTIN DJ, 1995, J ACQ IMMUN DEF SYND, V8, P386; Menzies NA, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001347; Mills HL, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005260; Mlambo CK, 2008, INT J TUBERC LUNG D, V12, P99; Modjarrad K, 2010, LANCET INFECT DIS, V10, P455, DOI 10.1016/S1473-3099(10)70093-1; Mukherjee JS, 2004, LANCET, V363, P474, DOI 10.1016/S0140-6736(04)15496-2; Murray CJL, 1998, INT J TUBERC LUNG D, V2, pS9; Naik R, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19843; Orenstein EW, 2009, LANCET INFECT DIS, V9, P153, DOI 10.1016/S1473-3099(09)70041-6; Osoti AO, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1053-2; Pooran A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054587; Republic of South Africa Department of Health, 2014, NAT CONS GUID PREV M; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Smith JA, 2015, LANCET HIV, V2, pE159, DOI 10.1016/S2352-3018(15)00016-8; South Africa Department of Health, 2006, THE KZN OUTBR; Statistics South Africa, 2014, MID POP EST 2014; Stinnett AA, 1998, MED DECIS MAKING, V18, pS68, DOI 10.1177/0272989X98018002S09; Tabana H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135048; Upadhya D, 2016, INT J STD AIDS, V27, P662, DOI 10.1177/0956462415592789; van Rooyen H, 2013, JAIDS-J ACQ IMM DEF, V64, pE1, DOI 10.1097/QAI.0b013e31829b567d; Wallengren K, 2011, EMERG INFECT DIS, V17, P1913, DOI 10.3201/eid1710.100952; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2010, ANT THER HIV INF AD; WHO, 2014, GLOB TUB REP 2014; WHO, 2014, WHO TB BURD EST; WHO, 2008, EPI SEM 2008; World Bank, 2013, GDP PER CAP CURR; World Health Organization, 1998, LAB SERV TUB CONTR 3; World Health Organization, 2012, WHO POL COLL TB HIV; World Health Organization, 2015, REC 36 MONTHS IS PRE; World Health Organization, 2001, MACR HLTH INV HLTH E; Yaesoubi R, 2013, P NATL ACAD SCI US	81	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0165614	10.1371/journal.pone.0165614	http://dx.doi.org/10.1371/journal.pone.0165614			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27906986	Green Submitted, Green Published, gold			2022-12-26	WOS:000389482700009
J	Hossain, MI; Haque, R; Mondal, D; Mahfuz, M; Ahmed, AMS; Islam, MM; Guerrant, RL; Petri, WA; Ahmed, T				Hossain, Md. Iqbal; Haque, Rashidul; Mondal, Dinesh; Mahfuz, Mustafa; Ahmed, A. M. Shamsir; Islam, M. Munirul; Guerrant, Richard L.; Petri, William A., Jr.; Ahmed, Tahmeed			Undernutrition, Vitamin A and Iron Deficiency Are Associated with Impaired Intestinal Mucosal Permeability in Young Bangladeshi Children Assessed by Lactulose/Mannitol Test	PLOS ONE			English	Article							AMPEROMETRIC DETECTION; MALNOURISHED CHILDREN; PERSISTENT DIARRHEA; BARRIER FUNCTION; MANNITOL; IMPACT; GROWTH; MALNUTRITION; SUPPLEMENTATION; GASTROENTERITIS	Background Lactulose/mannitol (L:M) test has been used as a non-invasive marker of intestinal mucosal -integrity and -permeability (enteropathy). We investigated the association of enteropathy with anthropometrics, micronutrient-status, and morbidity in children. Methods The urine and blood samples were collected from 925 children aged 6-24 months residing in Mirpur slum of Dhaka, Bangladesh during November 2009 to April 2013. L:M test and micronutrient status were assessed in the laboratory of International Centre for Diarrhoeal Diseases Research, Bangladesh (icddr,b) following standard procedure. Results Mean +/- SD age of the children was 13.2 +/- 5.2 months and 47.8% were female. Urinary-lactulose recovery was 0.264 +/- 0.236, mannitol recovery was 3.423 +/- 3.952, and L:M was 0.109 +/- 0.158. An overall negative correlation (Spearman's-rho) of L:M was found with age (r(s) = -0.087; p = 0.004), weight-for-age (r(s) = -0.077; p = 0.010), weight-for-length (r(s) = -0.060; p = 0.034), mid-upper-arm-circumference (r(s) = -0.098; p = 0.001) and plasma-retinol (r(s) = -0.105; p = 0.002); and a positive correlation with plasma alpha-1-acid glycoprotein (r(s) = 0.066; p = 0.027). However, most of the correlations were not very strong. Approximately 44% of children had enteropathy as reflected by L:M of >= 0.09. Logistic regression analysis revealed that younger age (infancy) (adjusted odds ratio (AOR) = 1.35; p = 0.027), diarrhea (AOR = 4.00; p = 0.039) or fever (AOR = 2.18; p = 0.003) within previous three days of L:M test were the risk factors of enteropathy (L:M of >= 0.09). Conclusions Enteropathy (high L:M) is associated with younger age, undernutrition, low vitamin A and iron status, and infection particularly diarrhea and fever.	[Hossain, Md. Iqbal; Haque, Rashidul; Mondal, Dinesh; Mahfuz, Mustafa; Ahmed, A. M. Shamsir; Islam, M. Munirul; Ahmed, Tahmeed] Int Ctr Diarrhoeal Dis Res, Nutr & Clin Serv Div, Dhaka, Bangladesh; [Hossain, Md. Iqbal; Ahmed, Tahmeed] Brac Univ, James P Grant Sch Publ Hlth, Dhaka, Bangladesh; [Guerrant, Richard L.; Petri, William A., Jr.] Univ Virginia, Div Infect Dis & Int Hlth, Charlottesville, VA USA	International Centre for Diarrhoeal Disease Research (ICDDR); Bangladesh Rural Advancement Committee BRAC; BRAC University; University of Virginia	Hossain, MI (corresponding author), Int Ctr Diarrhoeal Dis Res, Nutr & Clin Serv Div, Dhaka, Bangladesh.; Hossain, MI (corresponding author), Brac Univ, James P Grant Sch Publ Hlth, Dhaka, Bangladesh.	ihossain@icddrb.org	Petri, William A./D-3639-2019; Mahfuz, Mustafa/H-5923-2017; Petri, William/AAL-3642-2020	Mahfuz, Mustafa/0000-0002-4090-785X; Petri, William/0000-0002-7268-1218	University of Virginia (UVA); MAL-ED Network Investigators in the Foundation of National Institute of Health (FNIH), Fogarty International Centre (FIC); Bill & Melinda Gates Foundation; Government of the People's Republic of Bangladesh; Global Affairs Canada (GAC); Swedish International Development Cooperation Agency (Sida); Department for International Development, (UKAid)	University of Virginia (UVA); MAL-ED Network Investigators in the Foundation of National Institute of Health (FNIH), Fogarty International Centre (FIC); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Government of the People's Republic of Bangladesh; Global Affairs Canada (GAC); Swedish International Development Cooperation Agency (Sida); Department for International Development, (UKAid)	This research protocol was funded by University of Virginia (UVA) with support from MAL-ED Network Investigators in the Foundation of National Institute of Health (FNIH), Fogarty International Centre (FIC) with overall support from the Bill & Melinda Gates Foundation. icddr,b acknowledges with gratitude the commitment of UVA, FNIH, FIC and BMGF to its research efforts. icddr,b also gratefully acknowledges the following donors who provide unrestricted support: Government of the People's Republic of Bangladesh; Global Affairs Canada (GAC); Swedish International Development Cooperation Agency (Sida) and the Department for International Development, (UKAid).; This research protocol was funded by University of Virginia (UVA) with support from MAL-ED Network Investigators in the Foundation of National Institute of Health (FNIH), Fogarty International Centre (FIC) with overall support from the Bill & Melinda Gates Foundation. icddr,b acknowledges with gratitude the commitment of UVA, FNIH, FIC and BMGF to its research efforts. icddr,b also gratefully acknowledges the following donors who provided unrestricted support: Government of the People's Republic of Bangladesh; Global Affairs Canada (GAC); Swedish International Development Cooperation Agency (Sida) and the Department for International Development, (UKAid).	Acosta AM, 2014, CLIN INFECT DIS, V59, pS193, DOI 10.1093/cid/ciu653; AGGETT PJ, 1990, NESTLE NUTR WORKS SE, V19, P155; Bao YD, 1996, J CHROMATOGR B, V685, P105, DOI 10.1016/0378-4347(96)00159-4; Barboza MS, 1999, BRAZ J MED BIOL RES, V32, P1499, DOI 10.1590/S0100-879X1999001200008; BEHRENS RH, 1987, AM J CLIN NUTR, V45, P1433, DOI 10.1093/ajcn/45.6.1433; BERANT M, 1992, J PEDIATR GASTR NUTR, V14, P17, DOI 10.1097/00005176-199201000-00004; Boaz RT, 2013, INDIAN PEDIATR, V50, P152, DOI 10.1007/s13312-013-0030-3; Brewster DR, 1997, ARCH DIS CHILD, V76, P236, DOI 10.1136/adc.76.3.236; Brown K H, 1991, Infect Dis Clin North Am, V5, P297; BROWN KH, 1979, AM J CLIN NUTR, V32, P1962, DOI 10.1093/ajcn/32.9.1962; BUTZNER JD, 1985, PEDIATR RES, V19, P476, DOI 10.1203/00006450-198505000-00014; Campbell DI, 2003, J NUTR, V133, P1332; FLEMING SC, 1990, CLIN CHEM, V36, P797; Ford RP, 1985, J PEDIAT GASTROENTER, V4, P474; Goto K, 1999, J PEDIATR GASTR NUTR, V28, P282, DOI 10.1097/00005176-199903000-00013; Goto R, 2009, T ROY SOC TROP MED H, V103, P520, DOI 10.1016/j.trstmh.2008.07.020; ISOLAURI E, 1989, J PEDIATR GASTR NUTR, V8, P466, DOI 10.1097/00005176-198905000-00008; JUBY LD, 1989, GASTROENTEROLOGY, V96, P79, DOI 10.1016/0016-5085(89)90767-1; Lima AAM, 2005, J PEDIATR GASTR NUTR, V40, P28, DOI 10.1097/00005176-200501000-00006; Louis-Auguste J, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-15; Lunn PG, 2000, P NUTR SOC, V59, P147, DOI 10.1017/S0029665100000173; LUNN PG, 1991, LANCET, V338, P907, DOI 10.1016/0140-6736(91)91772-M; MENZIES IS, 1979, LANCET, V2, P1107; MENZIES IS, 1984, FALK S, V36, P527; NOONE C, 1986, EUR J CLIN INVEST, V16, P217, DOI 10.1111/j.1365-2362.1986.tb01332.x; Ramakrishna BS, 2006, POSTGRAD MED J, V82, P779, DOI 10.1136/pgmj.2006.048579; ROY SK, 1992, J PEDIATR GASTR NUTR, V15, P289, DOI 10.1097/00005176-199210000-00010; SULLIVAN PB, 1991, J PEDIATR GASTR NUTR, V12, P195, DOI 10.1097/00005176-199102000-00010; SULLIVAN PB, 1992, J PEDIATR GASTR NUTR, V14, P208, DOI 10.1097/00005176-199202000-00016; UKABAM SO, 1986, T ROY SOC TROP MED H, V80, P204, DOI 10.1016/0035-9203(86)90010-6; VANELBURG RM, 1995, J PEDIATR GASTR NUTR, V20, P184, DOI 10.1097/00005176-199502000-00008; Willumsen JF, 1997, J PEDIATR GASTR NUTR, V24, P235, DOI 10.1097/00005176-199703000-00001	32	20	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0164447	10.1371/journal.pone.0164447	http://dx.doi.org/10.1371/journal.pone.0164447			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27906964	Green Submitted, Green Published, gold			2022-12-26	WOS:000389482700003
J	Kim, WT; Shin, S; Hwang, HJ; Kim, MK; Jung, HS; Park, H; Ryu, CJ				Kim, Won-Tae; Shin, Saemina; Hwang, Hyo Jeong; Kim, Min Kyu; Jung, Han-Sung; Park, Hwangseo; Ryu, Chun Jeih			Molecular Characterization of Two Monoclonal Antibodies against the Same Epitope on B-Cell Receptor Associated Protein 31	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; CLASS-I MOLECULES; ENDOPLASMIC-RETICULUM; BAP31; RECOGNITION; SEQUENCE; DATABASE; COMPLEX; EXPORT; IGD	Previously, we showed that B-cell receptor associated protein 31 (BAP31), an endoplasmic reticulum (ER) membrane chaperone, is also expressed on the cell surface by two monoclonal antibodies (MAbs) 297-D4 and 144-A8. Both MAbs recognize the same linear epitope on the C-terminal domain of BAP31, although they were independently established. Here, flow cytometric analysis showed that 144-A8 had additional binding properties to some cells, as compared to 297-D4. Quantitative antigen binding assays also showed that 144-A8 had higher antigen binding capacity than 297-D4. Affinity measurement revealed that 144A8 had 1.54-fold higher binding affinity than 297-D4. Analysis of the heavy- and light-chain variable region sequences of two MAbs revealed that both MAbs belonged to the same heavy chain (Igh-V3660 VH3) and light chain subgroup (IGKV21) with just two amino acid differences in each framework region, indicating that both MAbs arise from the same germ line origin. Seven amino acid differences were found between the complementarity determining regions (CDRs) of the two MAbs. Molecular modeling of the epitope-paratope complexes revealed that the epitope appeared to reside in closer proximity to the CDRs of 144-A8 than to those of 297-D4 with the stronger hydrogen bond interactions with the former than the latter. More interestingly, an additional hydrophobic interaction appeared to be established between the leucine residue of epitope and the paratope of 144-A8, due to the substitution of H-Tyr101 for H-Phe101 in 144-A8. Thus, the different binding specificity and affinity of 144-A8 appeared to be due to the different hydrogen bonds and hydrophobic interaction induced by the alterations of amino acids in CDRs of 144-A8. The results provide molecular insights into how the binding specificities and affinities of antibodies evolve with the same epitope in different microenvironments.	[Kim, Won-Tae; Shin, Saemina; Hwang, Hyo Jeong; Kim, Min Kyu; Park, Hwangseo; Ryu, Chun Jeih] Sejong Univ, Dept Integrat Biosci & Biotechnol, Inst Anticanc Med Dev, Seoul, South Korea; [Jung, Han-Sung] Yonsei Univ, Dept Oral Biol, Div Anat & Dev Biol, Oral Sci Res Ctr,PLUS Project BK21,Coll Dent, Seoul, South Korea; [Jung, Han-Sung] Univ Hong Kong, Fac Dent, Oral Biosci, Hong Kong, Hong Kong, Peoples R China	Sejong University; Yonsei University; Yonsei University Health System; University of Hong Kong	Park, H; Ryu, CJ (corresponding author), Sejong Univ, Dept Integrat Biosci & Biotechnol, Inst Anticanc Med Dev, Seoul, South Korea.	hspark@sejong.ac.kr; cjryu@sejong.ac.kr	Jung, Han-Sung/I-3848-2012	Jung, Han-Sung/0000-0003-2795-531X	National Research Foundation of Korea [2016918220, 2016008610, 2016903249]; Biomedical Technology Development Project - Ministry of Science, ICT & Future Planning (MSIP) of Korea [NRF-2015M3A9B5030322]; grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI14C3266]	National Research Foundation of Korea(National Research Foundation of Korea); Biomedical Technology Development Project - Ministry of Science, ICT & Future Planning (MSIP) of Korea; grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This study was supported in part by the National Research Foundation of Korea (2016918220, 2016008610, and 2016903249 to CJR). This research was also supported in part by Biomedical Technology Development Project funded by Ministry of Science, ICT & Future Planning (MSIP) of Korea (NRF-2015M3A9B5030322 to HP). This research was also supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (HI14C3266 to HSJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 1996, EMBO J, V15, P1534, DOI 10.1002/j.1460-2075.1996.tb00497.x; Annaert WG, 1997, J CELL BIOL, V139, P1397, DOI 10.1083/jcb.139.6.1397; Breckenridge DG, 2002, P NATL ACAD SCI USA, V99, P4331, DOI 10.1073/pnas.072088099; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Choi HS, 2008, CELL TISSUE RES, V333, P197, DOI 10.1007/s00441-008-0632-6; FRIGUET B, 1985, J IMMUNOL METHODS, V77, P305, DOI 10.1016/0022-1759(85)90044-4; GASTEIGER J, 1980, TETRAHEDRON, V36, P3219, DOI 10.1016/0040-4020(80)80168-2; Iwasawa R, 2011, EMBO J, V30, P556, DOI 10.1038/emboj.2010.346; Kim Jum-Ji, 2013, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, V32, P136, DOI 10.1089/mab.2012.0092; KIM KM, 1994, EMBO J, V13, P3793, DOI 10.1002/j.1460-2075.1994.tb06690.x; Kim WT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130670; Kim WT, 2014, STEM CELLS, V32, P2626, DOI 10.1002/stem.1765; Kim WT, 2014, STEM CELLS, DOI [10.1038/emboj.2010.346, DOI 10.1038/EMBOJ.2010.346PMID]; Martin ACR, 1996, PROTEINS, V25, P130, DOI 10.1002/(SICI)1097-0134(199605)25:1<130::AID-PROT11>3.3.CO;2-Y; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Ng FWH, 1997, J CELL BIOL, V139, P327, DOI 10.1083/jcb.139.2.327; Paquet ME, 2004, J IMMUNOL, V172, P7548, DOI 10.4049/jimmunol.172.12.7548; Quistgaard EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071111; Retter I, 2005, NUCLEIC ACIDS RES, V33, pD671, DOI 10.1093/nar/gki088; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sawicki MW, 1999, MOL IMMUNOL, V36, P423, DOI 10.1016/S0161-5890(99)00062-0; Schamel WWA, 2003, P NATL ACAD SCI USA, V100, P9861, DOI 10.1073/pnas.1633363100; Sela-Culang I, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00302; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Spiliotis ET, 2000, IMMUNITY, V13, P841, DOI 10.1016/S1074-7613(00)00081-9; Wang B, 2011, EMBO J, V30, P451, DOI 10.1038/emboj.2010.352; Zen K, 2004, J BIOL CHEM, V279, P44924, DOI 10.1074/jbc.M402115200	27	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167527	10.1371/journal.pone.0167527	http://dx.doi.org/10.1371/journal.pone.0167527			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907150	Green Published, gold, Green Submitted			2022-12-26	WOS:000389482700183
J	Lan, XQ; Lederman, R; Eng, JM; Shoshtari, SSM; Saleem, MA; Malhotra, A; Singhal, PC				Lan, Xiqian; Lederman, Rivka; Eng, Judith M.; Shoshtari, Seyedeh Shadafarin Marashi; Saleem, Moin A.; Malhotra, Ashwani; Singhal, Pravin C.			Nicotine Induces Podocyte Apoptosis through Increasing Oxidative Stress	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; ACETYLCHOLINE-RECEPTORS; CIGARETTE-SMOKING; RENAL-FUNCTION; CARDIOVASCULAR MORBIDITY; DIABETIC-NEPHROPATHY; NMDA RECEPTORS; ROS PRODUCTION; RISK-FACTOR; INJURY	Background Cigarette smoking plays an important role in the progression of chronic kidney disease (CKD). Nicotine, one of the major components of cigarette smoking, has been demonstrated to increase proliferation of renal mesangial cells. In this study, we examined the effect of nicotine on podocyte injury. Methods To determine the expression of nicotinic acetylcholine receptors (nAChR subunits) in podocytes, cDNAs and cell lysate of cultured human podocytes were used for the expression of nAChR mRNAs and proteins, respectively; and mouse renal cortical sections were subjected to immunofluorescant staining. We also studied the effect of nicotine on podocyte nephrin expression, reactive oxygen species (ROS) generation (via DCFDA loading followed by fluorometric analysis), proliferation, and apoptosis (morphologic assays). We evaluated the effect of nicotine on podocyte downstream signaling including phosphorylation of ERK1/2, JNK, and p38 and established causal relationships by using respective inhibitors. We used nAChR antagonists to confirm the role of nicotine on podocyte injury. Results Human podocytes displayed robust mRNA and protein expression of nAChR in vitro studies. In vivo studies, mice renal cortical sections revealed co-localization of nAChRs along with synaptopodin. In vitro studies, nephrin expression in podocyte was decreased by nicotine. Nicotine stimulated podocyte ROS generation; nonetheless, antioxidants such as N-acetyl cysteine (NAC) and TEMPOL (superoxide dismutase mimetic agent) inhibited this effect of nicotine. Nicotine did not modulate proliferation but promoted apoptosis in podocytes. Nicotine enhanced podocyte phosphorylation of ERK1/2, JNK, and p38, and their specific inhibitors attenuated nicotine-induced apoptosis. nAChR antagonists significantly suppressed the effects of nicotine on podocyte. Conclusions Nicotine induces podocyte apoptosis through ROS generation and associated downstream MAPKs signaling. The present study provides insight into molecular mechanisms involved in smoking associated progression of chronic kidney disease.	[Lan, Xiqian; Lederman, Rivka; Eng, Judith M.; Shoshtari, Seyedeh Shadafarin Marashi; Malhotra, Ashwani; Singhal, Pravin C.] Hofstra North Shore LIJ Med Sch, Feinstein Inst Med Res, Renal Mol Res Lab, New York, NY 11549 USA; [Saleem, Moin A.] Southmead Hosp, Acad Renal Unit, Bristol, Avon, England	Hofstra University; Northwell Health; Southmead Hospital	Lan, XQ; Singhal, PC (corresponding author), Hofstra North Shore LIJ Med Sch, Feinstein Inst Med Res, Renal Mol Res Lab, New York, NY 11549 USA.	xlan@northwell.edu; psinghal@northwell.edu		Saleem, Moin/0000-0002-9808-4518; Singhal, Pravin/0000-0002-6898-358X	NIH [RO1DK 098074, RO1DK084910, RO1DK083931]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grants RO1DK 098074, RO1DK084910, and RO1DK083931 (PCS).	Agrawal S, 2014, KIDNEY INT, V86, P1150, DOI 10.1038/ki.2014.196; Al-Wadei MH, 2016, EUR J CANCER, V52, P188, DOI 10.1016/j.ejca.2015.10.003; Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Anderson M, 2011, AM J PHYSIOL-CELL PH, V300, pC22, DOI 10.1152/ajpcell.00268.2010; Arany I, 2012, AM J PHYSIOL-RENAL, V302, pF722, DOI 10.1152/ajprenal.00338.2011; Arany I, 2011, AM J PHYSIOL-RENAL, V301, pF125, DOI 10.1152/ajprenal.00041.2011; Asanuma Katsuhiko, 2015, Nihon Rinsho Meneki Gakkai Kaishi, V38, P26, DOI 10.2177/jsci.38.26; Benzing T, 2004, J AM SOC NEPHROL, V15, P1382, DOI 10.1097/01.ASN.0000130167.30769.55; Calderon LE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143277; Charpantier E, 2005, J NEUROSCI, V25, P9836, DOI 10.1523/JNEUROSCI.3497-05.2005; Corradi J, 2016, MOL PHARMACOL, V90, P288, DOI 10.1124/mol.116.104240; Dryer SE, 2015, NEPHROL DIAL TRANSPL, V30, P1630, DOI 10.1093/ndt/gfv028; Dyck RF, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-57; Fagerstrom K, 2002, DRUGS, V62, P1, DOI 10.2165/00003495-200262002-00001; Fucile S, 2004, CELL CALCIUM, V35, P1, DOI 10.1016/j.ceca.2003.08.006; Gergalova G, 2014, INT J BIOCHEM CELL B, V49, P26, DOI 10.1016/j.biocel.2014.01.001; Gu YQ, 2016, BIOCHEM BIOPH RES CO, V472, P573, DOI 10.1016/j.bbrc.2016.03.044; Halimi JM, 2000, KIDNEY INT, V58, P1285, DOI 10.1046/j.1523-1755.2000.00284.x; He JCJ, 2004, J CLIN INVEST, V114, P643, DOI 10.1172/JCI200421004; Hillege HL, 2001, J INTERN MED, V249, P519, DOI 10.1046/j.1365-2796.2001.00833.x; Hong Tao, 2015, Sichuan Da Xue Xue Bao Yi Xue Ban, V46, P173; Hua P, 2010, AM J PHYSIOL-RENAL, V299, pF732, DOI 10.1152/ajprenal.00293.2010; Hua W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127507; Ishizaka N, 2008, HYPERTENS RES, V31, P485, DOI 10.1291/hypres.31.485; Jaimes EA, 2009, AM J NEPHROL, V29, P319, DOI 10.1159/000163593; Jaimes EA, 2007, AM J PHYSIOL-HEART C, V292, pH76, DOI 10.1152/ajpheart.00693.2006; Jain G, 2013, BIOCHEM PHARMACOL, V86, P1215, DOI 10.1016/j.bcp.2013.07.014; Kim CS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152591; Kim EY, 2012, MOL PHARMACOL, V82, P728, DOI 10.1124/mol.112.079376; Koshikawa M, 2005, J AM SOC NEPHROL, V16, P2690, DOI 10.1681/ASN.2004121084; Lan XQ, 2014, AM J PHYSIOL-RENAL, V307, pF326, DOI 10.1152/ajprenal.00647.2013; Lan XQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055748; Lan XQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050783; Leeuwis JW, 2010, ADV DRUG DELIVER REV, V62, P1325, DOI 10.1016/j.addr.2010.08.012; Li XZ, 2015, SCI CHINA LIFE SCI, V58, P649, DOI 10.1007/s11427-015-4844-1; Lim AKH, 2009, DIABETOLOGIA, V52, P347, DOI 10.1007/s00125-008-1215-5; Lipovsek M, 2014, MOL BIOL EVOL, V31, P3250, DOI 10.1093/molbev/msu258; Liu YP, 2013, AM J NEPHROL, V38, P430, DOI 10.1159/000355970; Medapalli RK, 2011, CURR OPIN NEPHROL HY, V20, P306, DOI 10.1097/MNH.0b013e328345359a; Menzel S, 2011, PEDIATR NEPHROL, V26, P1775, DOI 10.1007/s00467-010-1725-5; Mercado C, 2007, CURR HYPERTENS REP, V9, P66, DOI 10.1007/s11906-007-0012-8; Miyamoto Y, 2011, NITRIC OXIDE-BIOL CH, V25, P344, DOI 10.1016/j.niox.2011.06.006; Mundel P, 2002, J AM SOC NEPHROL, V13, P3005, DOI 10.1097/01.ASN.0000039661.06947.FD; Nistala R, 2008, ANTIOXID REDOX SIGN, V10, P2047, DOI 10.1089/ars.2008.2034; Nordman JC, 2014, MOL PHARMACOL, V85, P50, DOI 10.1124/mol.113.088484; Orth SR, 2008, CLIN J AM SOC NEPHRO, V3, P226, DOI 10.2215/CJN.03740907; Patel J, 2003, AM J PHYSIOL-RENAL, V285, pF861, DOI 10.1152/ajprenal.00134.2003; Pinto-Sietsma SJ, 2000, ANN INTERN MED, V133, P585, DOI 10.7326/0003-4819-133-8-200010170-00008; Pontieri FE, 1996, NATURE, V382, P255, DOI 10.1038/382255a0; Qiao D, 2005, TOXICOL APPL PHARM, V206, P17, DOI 10.1016/j.taap.2004.11.003; Razani-Boroujerdi S, 2007, J IMMUNOL, V179, P2889, DOI 10.4049/jimmunol.179.5.2889; Roshanravan H, 2016, DIABETES, V65, P3139, DOI 10.2337/db16-0209; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Saurus P, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.125; Schaal C, 2014, MOL CANCER RES, V12, P14, DOI 10.1158/1541-7786.MCR-13-0541; Schneider NG, 2001, CLIN PHARMACOKINET, V40, P661, DOI 10.2165/00003088-200140090-00003; Sciaccaluga M, 2015, FASEB J, V29, P3389, DOI 10.1096/fj.14-268102; Shen JX, 2009, ACTA PHARMACOL SIN, V30, P673, DOI 10.1038/aps.2009.64; Shi DB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043898; Shi JX, 2016, MOL BIOSYST, V12, P1445, DOI 10.1039/c5mb00722d; Susztak K, 2006, DIABETES, V55, P225, DOI 10.2337/diabetes.55.01.06.db05-0894; Tammimaki A, 2012, NEUROPHARMACOLOGY, V63, P1002, DOI 10.1016/j.neuropharm.2012.07.022; Toyonaga J, 2011, NEPHROL DIAL TRANSPL, V26, P2475, DOI 10.1093/ndt/gfq750; Tozawa M, 2002, KIDNEY INT, V62, P956, DOI 10.1046/j.1523-1755.2002.00506.x; Vashistha H, 2009, RENAL FAILURE, V31, P303, DOI 10.1080/08860220902780101; Weber ML, 2008, AM J PHYSIOL-RENAL, V294, pF1388, DOI 10.1152/ajprenal.00389.2007; Xiang T, 2016, ONCOL REP, V35, P205, DOI 10.3892/or.2015.4363; Zanetti F, 2014, FREE RADICAL BIO MED, V76, P173, DOI 10.1016/j.freeradbiomed.2014.08.002; Zhang YJ, 2013, CELL SIGNAL, V25, P2769, DOI 10.1016/j.cellsig.2013.08.044; Zheng R, 2012, PHYTOTHER RES, V26, P892, DOI 10.1002/ptr.3656; Zhou X, 2010, CARDIOLOGY, V115, P243, DOI 10.1159/000301278	71	33	34	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167071	10.1371/journal.pone.0167071	http://dx.doi.org/10.1371/journal.pone.0167071			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907022	gold, Green Submitted, Green Published			2022-12-26	WOS:000389482700071
J	Mohammad, M; Na, M; Welin, A; Svensson, MND; Ali, A; Jin, T; Pullerits, R				Mohammad, Majd; Na, Manli; Welin, Amanda; Svensson, Mattias N. D.; Ali, Abukar; Jin, Tao; Pullerits, Rille			RAGE Deficiency Impairs Bacterial Clearance in Murine Staphylococcal Sepsis, but Has No Significant Impact on Staphylococcal Septic Arthritis	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; RHEUMATOID-ARTHRITIS; EXPERIMENTAL-MODELS; RECEPTOR; EXPRESSION; DISEASE; ENDPRODUCTS; CONTRIBUTE; PROMOTES; RISK	Background Septic arthritis is a serious joint disease often caused by Staphylococcus aureus (S. aureus). Receptor for Advanced Glycation End products (RAGE) has an important role in several infections. We sought to investigate the role of RAGE in staphylococcal septic arthritis and sepsis in mice. Methods Wild-type (WT) and RAGE deficient (RAGE(-/-)) mice were intra-articularly or intravenously inoculated with an arthritic or septic dose of S. aureus LS-1 strain. Clinical arthritis, weight development and mortality were monitored for 14 days. Serum levels of cytokines, kidney bacterial loads as well as micro-CT and histopathology of the joints were assessed. Results RAGE(-/-) mice with septic arthritis had significantly lower IL-17A and higher bone mineral density (BMD) compared to the control group. However, no significant differences between the groups were observed regarding the weight loss, the severity and frequency of arthritis, and bacterial loads in the kidneys. In mice with sepsis, the overall mortality rate was similar in RAGE(-/-) (39%) and in WT mice (45%). However, RAGE(-/-) mice with sepsis had significantly higher bacterial load in their kidneys compared to the WT controls. In line with data from hematogenous S. aureus arthritis, RAGE deficiency had no impact on arthritis severity in local joint infection. Conclusions Our results indicate that lack of RAGE has no significant impact on septic arthritis. However, RAGE(-/-) mice had significantly higher BMD compared to WT mice, which coincided with lower IL-17A in RAGE(-/-) mice. In sepsis, RAGE deficiency impairs bacterial kidney clearance.	[Mohammad, Majd; Na, Manli; Welin, Amanda; Svensson, Mattias N. D.; Ali, Abukar; Jin, Tao; Pullerits, Rille] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden; [Svensson, Mattias N. D.] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA USA	University of Gothenburg; University of California System; University of California San Diego	Mohammad, M (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden.	majd.mohammad@rheuma.gu.se	Pullerits, Rille/AAD-2050-2019; Jin, Tao/K-3323-2015; Svensson, Mattias N.D./A-9827-2012; Na, Manli/AAM-9864-2020; Pullerits, Rille/ABC-0141-2022	Pullerits, Rille/0000-0002-5383-9817; Jin, Tao/0000-0001-9039-0628; Svensson, Mattias N.D./0000-0001-8077-9824; Ali, Abukar/0000-0002-1963-3356; Na, Manli/0000-0002-7306-8941; Mohammad, Majd/0000-0002-3672-2991	Swedish Medical Research Council; Goteborg Medical Society; Swedish Medical Society; Rune and Ulla Amlovs Foundation; Tore Nilsons Foundation; Goteborg Association against Rheumatism; Swedish Association against Rheumatism; Nanna Svartz Foundation; Stiftelsen Clas Groschinskys Minnesfond; Lundberg Foundation; University of Gothenburg	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Goteborg Medical Society; Swedish Medical Society; Rune and Ulla Amlovs Foundation; Tore Nilsons Foundation; Goteborg Association against Rheumatism; Swedish Association against Rheumatism; Nanna Svartz Foundation; Stiftelsen Clas Groschinskys Minnesfond; Lundberg Foundation(European Commission); University of Gothenburg	This work was supported by the Swedish Medical Research Council, the Goteborg Medical Society, the Swedish Medical Society, the Rune and Ulla Amlovs Foundation, the Tore Nilsons Foundation, the Goteborg Association against Rheumatism, the Swedish Association against Rheumatism, the Nanna Svartz Foundation, the Stiftelsen Clas Groschinskys Minnesfond, the Lundberg Foundation, and the University of Gothenburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achouiti A, 2013, CRIT CARE, V17, DOI 10.1186/cc13162; Achouiti A, 2013, J INNATE IMMUN, V5, P603, DOI 10.1159/000348739; Ali A, 2015, J INFECT DIS, V212, P1308, DOI 10.1093/infdis/jiv212; Ali A, 2015, ARTHRITIS RHEUMATOL, V67, P107, DOI 10.1002/art.38902; Bierhaus A, 2005, J MOL MED, V83, P876, DOI 10.1007/s00109-005-0688-7; BREMELL T, 1991, INFECT IMMUN, V59, P2615, DOI 10.1128/IAI.59.8.2615-2623.1991; BRETT J, 1993, AM J PATHOL, V143, P1699; Christaki E, 2011, SHOCK, V35, P492, DOI 10.1097/SHK.0b013e31820b2e1c; Constien R, 2001, GENESIS, V30, P36, DOI 10.1002/gene.1030; Deutschman CS, 2014, IMMUNITY, V40, P464, DOI 10.1016/j.immuni.2014.04.001; Fei Y, 2011, J INFECT DIS, V204, P348, DOI 10.1093/infdis/jir266; Galloway JB, 2011, ANN RHEUM DIS, V70, P1810, DOI 10.1136/ard.2011.152769; Hein GE, 2006, CLIN CHIM ACTA, V371, P32, DOI 10.1016/j.cca.2006.03.017; Henningsson L, 2010, INFECT IMMUN, V78, P3783, DOI 10.1128/IAI.00385-10; Hou FF, 2004, J AM SOC NEPHROL, V15, P1889, DOI 10.1097/01.asn.0000131526.99506.f7; Kaandorp CJE, 1995, ARTHRITIS RHEUM, V38, P1819, DOI 10.1002/art.1780381215; Kaukonen KM, 2014, JAMA-J AM MED ASSOC, V311, P1308, DOI 10.1001/jama.2014.2637; Krishnamurthy A, 2016, ANN RHEUM DIS, V75, P721, DOI 10.1136/annrheumdis-2015-208093; Kwiecinski J, 2013, J INFECT DIS, V208, P990, DOI 10.1093/infdis/jit288; Lee Eun Ji, 2013, Genomics & Informatics, V11, P224, DOI 10.5808/GI.2013.11.4.224; Liliensiek B, 2004, J CLIN INVEST, V113, P1641, DOI 10.1172/JCI200418704; Lutterloh EC, 2007, CRIT CARE, V11, DOI 10.1186/cc6184; Mruthinti S, 2004, NEUROBIOL AGING, V25, P1023, DOI 10.1016/j.neurobiolaging.2003.11.001; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Odetti P, 2005, ANN NY ACAD SCI, V1043, P710, DOI 10.1196/annals.1333.082; SCHMIDT AM, 1992, J BIOL CHEM, V267, P14987; Semba RD, 2010, J GERONTOL A-BIOL, V65, P963, DOI 10.1093/gerona/glq074; Shirtliff ME, 2002, CLIN MICROBIOL REV, V15, P527, DOI 10.1128/CMR.15.4.527-544.2002; Soria LM, 2009, REUMATOL CLIN, V5, P18, DOI 10.1016/S1699-258X(09)70199-8; Stern D, 2002, ADV DRUG DELIVER REV, V54, P1615, DOI 10.1016/S0169-409X(02)00160-6; Tanji N, 2000, J AM SOC NEPHROL, V11, P1656, DOI 10.1681/ASN.V1191656; Tarkowski A, 2006, BEST PRACT RES CL RH, V20, P1029, DOI 10.1016/j.berh.2006.08.001; Toscano MG, 2011, JOVE-J VIS EXP, DOI 10.3791/2860; van Zoelen MAD, 2009, J IMMUNOL, V182, P4349, DOI 10.4049/jimmunol.0801199; Verdrengh M, 2006, J INFECT DIS, V194, P1597, DOI 10.1086/508751; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Yamamoto Y, 2011, J IMMUNOL, V186, P3248, DOI 10.4049/jimmunol.1002253; Zhou Z, 2006, J EXP MED, V203, P1067, DOI 10.1084/jem.20051947; Zhou Z, 2008, J BONE MINER RES, V23, P1084, DOI 10.1359/JBMR.080234	39	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167287	10.1371/journal.pone.0167287	http://dx.doi.org/10.1371/journal.pone.0167287			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907047	Green Published, gold, Green Submitted			2022-12-26	WOS:000389482700111
J	Ogier, JC; Duvic, B; Lanois, A; Givaudan, A; Gaudriault, S				Ogier, Jean-Claude; Duvic, Bernard; Lanois, Anne; Givaudan, Alain; Gaudriault, Sophie			A New Member of the Growing Family of Contact-Dependent Growth Inhibition Systems in Xenorhabdus doucetiae	PLOS ONE			English	Article							TOXIN DELIVERY-SYSTEMS; VI SECRETION SYSTEM; CDI; PHOTORHABDUS; BACTERIOCIN; GENE; PATHOGENICITY; BIOSYNTHESIS; PATHOGENESIS; ACTIVATION	Xenorhabdus is a bacterial symbiont of entomopathogenic Steinernema nematodes and is pathogenic for insects. Its life cycle involves a stage inside the insect cadaver, in which it competes for environmental resources with microorganisms from soil and the insect gut. Xenorhabdus is, thus, a useful model for identifying new interbacterial competition systems. For the first time, in an entomopathogenic bacterium, Xenorhabdus doucetiae strain FRM16, we identified a cdi-like locus. The cdi loci encode contact-dependent inhibition (CDI) systems composed of proteins from the two-partner secretion (TPS) family. CdiB is the outer membrane protein and CdiA is the toxic exoprotein. An immunity protein, CdiI, protects bacteria against inhibition. We describe here the growth inhibition effect of the toxic C-terminus of CdiA from X. doucetiae FRM16, CdiA-CTFRM16, following its production in closely and distantly related enterobacterial species. CdiA-CTFRM16 displayed Mg2+-dependent DNase activity, in vitro. CdiA-CT (FRM16)-mediated growth inhibition was specifically neutralized by CdiI(FRM16). Moreover, the cdi(FRM16) locus encodes an ortholog of toxin-activating proteins C that we named CdiC(FRM16). In addition to E. coli, the cdiBCAI-type locus was found to be widespread in environmental bacteria interacting with insects, plants, rhizospheres and soils. Phylogenetic tree comparisons for CdiB, CdiA and CdiC suggested that the genes encoding these proteins had co-evolved. By contrast, the considerable variability of CdiI protein sequences suggests that the cdiI gene is an independent evolutionary unit. These findings further characterize the sparsely described cdiBCAI-type locus.	[Ogier, Jean-Claude; Duvic, Bernard; Lanois, Anne; Givaudan, Alain; Gaudriault, Sophie] Univ Montpellier, DGIMI, INRA, Montpellier, France	INRAE; Universite de Montpellier	Ogier, JC; Gaudriault, S (corresponding author), Univ Montpellier, DGIMI, INRA, Montpellier, France.	Jean-Claude.Ogier@umontpellier.fr; sophie.gaudriault@umontpellier.fr	Duvic, Bernard/ABG-5094-2020; , Gaudriault/AAK-9152-2021	, Gaudriault/0000-0003-2789-4959; Duvic, Bernard/0000-0002-7618-7719	Institut National de la Recherche Agronomique from the department "Sante des Plantes et Environnement" [010-1133-01]; Universite Montpellier [2011]	Institut National de la Recherche Agronomique from the department "Sante des Plantes et Environnement"; Universite Montpellier	This work was supported by 1) Institut National de la Recherche Agronomique: grant no 010-1133-01 from the department "Sante des Plantes et Environnement"; 2) Universite Montpellier: grant no 2011.	Anderson MS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002877; Aoki SK, 2005, SCIENCE, V309, P1245, DOI 10.1126/science.1115109; Aoki SK, 2011, VIRULENCE, V2, P356, DOI 10.4161/viru.2.4.16463; Aoki SK, 2010, NATURE, V468, P439, DOI 10.1038/nature09490; Bisch G, 2015, J INVERTEBR PATHOL, V124, P15, DOI 10.1016/j.jip.2014.10.002; Bode HB, 2009, CURR OPIN CHEM BIOL, V13, P224, DOI 10.1016/j.cbpa.2009.02.037; Burrus V, 2004, RES MICROBIOL, V155, P376, DOI 10.1016/j.resmic.2004.01.012; Chapelle M, 2009, MOL IMMUNOL, V47, P261, DOI 10.1016/j.molimm.2009.09.028; Chaston JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027909; Crawford JM, 2011, ORG LETT, V13, P5144, DOI 10.1021/ol2020237; Daborn PJ, 2002, P NATL ACAD SCI USA, V99, P10742, DOI 10.1073/pnas.102068099; Forst S, 1997, ANNU REV MICROBIOL, V51, P47, DOI 10.1146/annurev.micro.51.1.47; Fuchs SW, 2011, ORG BIOMOL CHEM, V9, P3130, DOI 10.1039/c1ob05097d; Givaudan A, 2000, J BACTERIOL, V182, P107, DOI 10.1128/JB.182.1.107-115.2000; Goodrich-Blair H, 2007, MOL MICROBIOL, V64, P260, DOI 10.1111/j.1365-2958.2007.05671.x; Gualtieri M, 2009, J ANTIBIOT, V62, P295, DOI 10.1038/ja.2009.31; Guglielmini J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002222; Hayes C. S., 2014, COLD SPRING HARB PER, V4; Hood RD, 2010, CELL HOST MICROBE, V7, P25, DOI 10.1016/j.chom.2009.12.007; Jubelin G, 2011, ENVIRON MICROBIOL, V13, P1271, DOI 10.1111/j.1462-2920.2011.02427.x; Lacey LA, 2015, J INVERTEBR PATHOL, V132, P1, DOI 10.1016/j.jip.2015.07.009; Law RJ, 2008, J BACTERIOL, V190, P7209, DOI 10.1128/JB.00481-08; Luberto C, 2001, GENE DEV, V15, P201, DOI 10.1101/gad.856001; MacIntyre DL, 2010, P NATL ACAD SCI USA, V107, P19520, DOI 10.1073/pnas.1012931107; Mercy C, 2016, PLOS ONE, V11; Morales-Soto N, 2011, J BACTERIOL, V193, P3624, DOI 10.1128/JB.00092-11; Morse RP, 2012, P NATL ACAD SCI USA, V109, P21480, DOI 10.1073/pnas.1216238110; Nielsen-LeRoux C, 2012, CURR OPIN MICROBIOL, V15, P220, DOI 10.1016/j.mib.2012.04.006; Nikolakakis K, 2012, MOL MICROBIOL, V84, P516, DOI 10.1111/j.1365-2958.2012.08039.x; Ogier JC, 2014, GENOME BIOL EVOL, V6, P1495, DOI 10.1093/gbe/evu119; Park D, 2009, MOL MICROBIOL, V73, P938, DOI 10.1111/j.1365-2958.2009.06817.x; Poole SJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002217; Reimer D, 2014, J NAT PROD, V77, P1976, DOI 10.1021/np500390b; Reimer D, 2011, NAT CHEM BIOL, V7, P888, DOI [10.1038/NCHEMBIO.688, 10.1038/nchembio.688]; Reimer D, 2009, CHEMBIOCHEM, V10, P1997, DOI 10.1002/cbic.200900187; Riley MA, 1998, ANNU REV GENET, V32, P255, DOI 10.1146/annurev.genet.32.1.255; Riley MA, 2002, BIOCHIMIE, V84, P357, DOI 10.1016/S0300-9084(02)01421-9; Ruhe ZC, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006145; Ruhe ZC, 2013, MBIO, V4, DOI 10.1128/mBio.00480-13; Ruhe ZC, 2013, TRENDS MICROBIOL, V21, P230, DOI 10.1016/j.tim.2013.02.003; Schwarz S, 2010, TRENDS MICROBIOL, V18, P531, DOI 10.1016/j.tim.2010.09.001; Seth-Smith HMB, 2012, J BACTERIOL, V194, P1494, DOI 10.1128/JB.06403-11; Singh J, 2008, J BACTERIOL, V190, P3877, DOI 10.1128/JB.00209-08; THALER JO, 1995, APPL ENVIRON MICROB, V61, P2049, DOI 10.1128/AEM.61.5.2049-2052.1995; Trent MS, 1998, BIOCHEMISTRY-US, V37, P4644, DOI 10.1021/bi971588y; Webb JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057609; Willett JLE, 2015, J MOL BIOL, V427, P3754, DOI 10.1016/j.jmb.2015.09.010; Willett JLE, 2015, P NATL ACAD SCI USA, V112, P11341, DOI 10.1073/pnas.1512124112; Zheng J, 2011, PLOS ONE, V6	49	14	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167443	10.1371/journal.pone.0167443	http://dx.doi.org/10.1371/journal.pone.0167443			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907104	Green Submitted, Green Published, gold			2022-12-26	WOS:000389482700159
J	Quentmeier, H; Drexler, HG; Hauer, V; MacLeod, RAF; Pommerenke, C; Uphoff, CC; Zaborski, M; Berglund, M; Enblad, G; Amini, RM				Quentmeier, Hilmar; Drexler, Hans G.; Hauer, Vivien; MacLeod, Roderick A. F.; Pommerenke, Claudia; Uphoff, Cord C.; Zaborski, Margarete; Berglund, Mattias; Enblad, Gunilla; Amini, Rose-Marie			Diffuse Large B Cell Lymphoma Cell Line U2946: Model for MCL1 Inhibitor Testing	PLOS ONE			English	Article							GENECHIP DATA; EXPRESSION; SUBGROUPS; ABT-199; CLASSIFICATION; TRANSLOCATIONS; IMMUNOGLOBULIN	Diffuse large B cell lymphoma (DLBCL) is the most common form of non-Hodgkin lymphoma worldwide. We describe the establishment and molecular characteristics of the DLBCL cell line U-2946. This cell line was derived from a 52-year-old male with DLBCL. U-2946 cells carried the chromosomal translocation t(8; 14) and strongly expressed MYC, but not the mature B-cell lymphoma associated oncogenes BCL2 and BCL6. Instead, U-2946 cells expressed the antiapoptotic BCL2 family member MCL1 which was highly amplified genomically (14n). MCL1 amplification is recurrent in DLBCL, especially in the activated B cell (ABC) variant. Results of microarray expression cluster analysis placed U-2946 together with ABC-, but apart from germinal center (GC)-type DLBCL cell lines. The 1q21.3 region including MCL1 was focally coamplified with a short region of 17p11.2 (also present at 14n). The MCL1 inhibitor A-1210477 triggered apoptosis in U-2946 (MCL1(pos)/BCL2(neg)) cells. In contrast to BCL2(pos) DLBCL cell lines, U-2946 did not respond to the BCL2 inhibitor ABT-263. In conclusion, the novel characteristics of cell line U-2946 renders it a unique model system to test the function of small molecule inhibitors, especially when constructing a panel of DLBCL cell lines expressing broad combinations of antiapoptotic BCL2-family members.	[Quentmeier, Hilmar; Drexler, Hans G.; Hauer, Vivien; MacLeod, Roderick A. F.; Pommerenke, Claudia; Uphoff, Cord C.; Zaborski, Margarete] Leibniz Inst DSMZ German Collect Microorganisms &, Dept Human & Anim Cell Lines, Braunschweig, Germany; [Berglund, Mattias; Enblad, Gunilla; Amini, Rose-Marie] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Berglund, Mattias; Enblad, Gunilla; Amini, Rose-Marie] Univ Uppsala Hosp, Uppsala, Sweden	Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); Uppsala University; Uppsala University; Uppsala University Hospital	Quentmeier, H (corresponding author), Leibniz Inst DSMZ German Collect Microorganisms &, Dept Human & Anim Cell Lines, Braunschweig, Germany.	hqu@dsmz.de						Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; CABANILLAS F, 1987, J CLIN ONCOL, V5, P407, DOI 10.1200/JCO.1987.5.3.407; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Davis RE, 2010, NATURE, V463, P88, DOI 10.1038/nature08638; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; Ding J, 2015, HAEMATOLOGICA, V100, P801, DOI 10.3324/haematol.2014.120048; Drexler HG, 2016, LEUKEMIA LYMPHOMA, V57, P1015, DOI 10.3109/10428194.2015.1108414; Drexler HG, 2011, METHODS MOL BIOL, V731, P181, DOI 10.1007/978-1-61779-080-5_16; Drexler HG, 2005, DRUG DISCOV TODAY DI, V2, P51; Drexler HG, 2010, GUIDE LEUKEMIA LYMPH; FARRUGIA MM, 1994, BLOOD, V83, P191; Fridberg M, 2007, LEUKEMIA LYMPHOMA, V48, P2221, DOI 10.1080/10428190701636443; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; Herlaar E, 1999, MOL MED TODAY, V5, P439, DOI 10.1016/S1357-4310(99)01544-0; Klanova M, 2016, CLIN CANCER RES, V22, P1138, DOI 10.1158/1078-0432.CCR-15-1191; Laursen MB, 2014, EXP HEMATOL, V42, P927, DOI 10.1016/j.exphem.2014.07.263; Lenz G, 2007, J EXP MED, V204, P633, DOI 10.1084/jem.20062041; Leverson JD, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.561; Li L, 2015, LEUKEMIA, V29, P1702, DOI 10.1038/leu.2015.99; MacLeod RAF, 2007, NAT PROTOC, V2, P372, DOI 10.1038/nprot.2007.29; MacLeod RAF, 2011, METHODS MOL BIOL, V731, P57, DOI 10.1007/978-1-61779-080-5_6; Monni O, 1997, BLOOD, V90, P1168, DOI 10.1182/blood.V90.3.1168.1168_1168_1174; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; Palanisamy N, 2002, GENE CHROMOSOME CANC, V33, P114, DOI 10.1002/gcc.10016; Pasqualucci L, 2014, CANCER CELL, V25, P132, DOI 10.1016/j.ccr.2013.12.012; Phillips DC, 2015, BLOOD CANCER J, V5, DOI 10.1038/bcj.2015.88; PICHERT G, 1992, ANN ONCOL, V3, P645, DOI 10.1093/oxfordjournals.annonc.a058295; Quentmeier H, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-3; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Ruminy P, 2013, BLOOD, V122, DOI 10.1182/blood.V122.21.84.84; Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048; Swerdlow SH, 2008, WHO CLASSIFICATION T; Swerdlow SH, 2016, BLOOD, V127, P2375, DOI 10.1182/blood-2016-01-643569; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; Visco C, 2012, LEUKEMIA, V26, P2103, DOI 10.1038/leu.2012.83; Wenzel SS, 2013, LEUKEMIA, V27, P1381, DOI 10.1038/leu.2012.367	38	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167599	10.1371/journal.pone.0167599	http://dx.doi.org/10.1371/journal.pone.0167599			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907212	gold, Green Submitted, Green Published			2022-12-26	WOS:000389482700210
J	Rosell-Negre, P; Bustamante, JC; Fuentes-Claramonte, P; Costumero, V; Llopis-Llacer, JJ; Barros-Loscertales, A				Rosell-Negre, Patricia; Bustamante, Juan-Carlos; Fuentes-Claramonte, Paola; Costumero, Victor; Llopis-Llacer, Juan-Jose; Barros-Loscertales, Alfonso			Reward Contingencies Improve Goal-Directed Behavior by Enhancing Posterior Brain Attentional Regions and Increasing Corticostriatal Connectivity in Cocaine Addicts	PLOS ONE			English	Article							IMPAIRED INHIBITORY CONTROL; STROOP-LIKE TASK; COGNITIVE CONTROL; PREFRONTAL CORTEX; DECISION-MAKING; DORSAL STRIATUM; PSYCHOPHYSIOLOGICAL INTERACTIONS; DEFICIT/HYPERACTIVITY DISORDER; FUNCTIONAL CONNECTIVITY; RESPONSE-INHIBITION	The dopaminergic system provides the basis for the interaction between motivation and cognition. It is triggered by the possibility of obtaining rewards to initiate the neurobehavioral adaptations necessary to achieve them by directing the information from motivational circuits to cognitive and action circuits. In drug addiction, the altered dopamine (DA) modulation of the meso-cortico-limbic reward circuitry, such as the prefrontal cortex (PFC), underlies the disproportionate motivational value of drug use at the expense of other non drug reinforcers and the user's loss of control over his/her drug intake. We examine how the magnitude of the reward affects goal-directed processes in healthy control (HC) subjects and abstinent cocaine dependent (ACD) patients by using functional magnetic resonance imaging (fMRI) during a counting Stroop task with blocked levels of monetary incentives of different magnitudes ((sic)0, (sic)0.01, (sic)0.5, (sic)1 or (sic)1.5). Our results showed that increasing reward magnitude enhances (1) performance facilitation in both groups; (2) left dorsolateral prefrontal cortex (DLPFC) activity in HC and left superior occipital cortex activity in ACD; and (3) left DLPFC and left putamen connectivity in ACD compared to HC. Moreover, we observed that (4) dorsal striatal and pallidum activity was associated with craving and addiction severity during the parametric increases in the monetary reward. In conclusion, the brain response to gradients in monetary value was different in HC and ACD, but both groups showed improved task performance due to the possibility of obtaining greater monetary rewards.	[Rosell-Negre, Patricia; Fuentes-Claramonte, Paola; Costumero, Victor; Barros-Loscertales, Alfonso] Univ Jaume 1, Dept Psicol Basica Clin & Psicobiol, Castellon de La Plana, Castello De La, Spain; [Bustamante, Juan-Carlos] Univ Zaragoza, Dept Psicol & Sociol, Zaragoza, Zaragoza, Spain; [Fuentes-Claramonte, Paola] FIDMAG Germanes Hosp Res Fdn Barcelona, Cataluna, Spain; [Llopis-Llacer, Juan-Jose] Conselleria Sanitat, Hosp Gen Univ, Unidad Conductas Adict, Castellon De La Plana, Spain	Universitat Jaume I; University of Zaragoza	Barros-Loscertales, A (corresponding author), Univ Jaume 1, Dept Psicol Basica Clin & Psicobiol, Castellon de La Plana, Castello De La, Spain.	barros@uji.es	Fuentes-Claramonte, Paola/AAC-1196-2021; Costumero, Víctor/A-5784-2019; Barrós-Loscertales, Alfonso/AAA-5611-2019; Barros-Loscertales, Alfonso/D-7069-2013	Fuentes-Claramonte, Paola/0000-0002-1428-7976; Costumero, Víctor/0000-0002-8743-5239; Barrós-Loscertales, Alfonso/0000-0002-2456-6653; Rosell Negre, Patricia/0000-0002-2440-8495	Spanish Ministry of Economy and Competitiveness [PSI2012-33054]; Spanish National Drug Strategy [20111040]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Spanish National Drug Strategy	This research has been supported by Grants PSI2012-33054 from the Spanish Ministry of Economy and Competitiveness (http://www.mineco.gob.es/), and by 20111040 from the Spanish National Drug Strategy (http://www.pnsd.msssi.gob.es/) to ABL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts E, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00163; Aarts E, 2010, NEUROPSYCHOPHARMACOL, V35, P1943, DOI 10.1038/npp.2010.68; Adams ZW, 2011, PSYCHOL ASSESSMENT, V23, P427, DOI 10.1037/a0022112; Ahmed SH, 2002, NAT NEUROSCI, V5, P625, DOI 10.1038/nn872; Arias-Carrion Oscar, 2010, Int Arch Med, V3, P24, DOI 10.1186/1755-7682-3-24; Aron AR, 2011, BIOL PSYCHIAT, V69, pE55, DOI 10.1016/j.biopsych.2010.07.024; Asensio S, 2010, ADDICT BIOL, V15, P504, DOI 10.1111/j.1369-1600.2010.00230.x; Ashburner J, SPM8 MANUAL FIL METH; Balleine BW, 2007, J NEUROSCI, V27, P8161, DOI 10.1523/JNEUROSCI.1554-07.2007; Barros-Loscertales A, 2011, PSYCHIAT RES-NEUROIM, V194, P111, DOI 10.1016/j.pscychresns.2011.05.001; Berridge KC, 2008, PSYCHOPHARMACOLOGY, V199, P457, DOI 10.1007/s00213-008-1099-6; Bolla K, 2004, J NEUROPSYCH CLIN N, V16, P456, DOI 10.1176/appi.neuropsych.16.4.456; Braver TS, 2014, COGN AFFECT BEHAV NE, V14, P443, DOI 10.3758/s13415-014-0300-0; Brewer JA, 2008, BIOL PSYCHIAT, V64, P998, DOI 10.1016/j.biopsych.2008.05.024; Bustamante J. C, 2012, SUBSTANCE ABUSE ASSE; Bustamante JC, 2014, ADDICT BIOL, V19, P885, DOI 10.1111/adb.12041; Carmona S, 2012, HUM BRAIN MAPP, V33, P2350, DOI 10.1002/hbm.21368; Colzato LS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001143; Cools R, 2007, J NEUROSCI, V27, P5506, DOI 10.1523/JNEUROSCI.0601-07.2007; Cools R, 2015, CURR OPIN BEHAV SCI, V4, P152, DOI 10.1016/j.cobeha.2015.05.007; Crunelle CL, 2012, BRAIN BEHAV, V2, P499, DOI 10.1002/brb3.65; Engelmann JB, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.004.2009; Everitt BJ, 2013, NEUROSCI BIOBEHAV R, V37, P1946, DOI 10.1016/j.neubiorev.2013.02.010; Fillmore MT, 2002, DRUG ALCOHOL DEPEN, V66, P265, DOI 10.1016/S0376-8716(01)00206-X; Fleming SM, 2012, J NEUROSCI, V32, P6117, DOI 10.1523/JNEUROSCI.6489-11.2012; Fowler Joanna S, 2007, Sci Pract Perspect, V3, P4; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Garavan H, 2000, AM J PSYCHIAT, V157, P1789, DOI 10.1176/appi.ajp.157.11.1789; Garavan H, 2007, NEUROPSYCHOL REV, V17, P337, DOI 10.1007/s11065-007-9034-x; Garavan H, 2012, PREV MED, V55, pS17, DOI 10.1016/j.ypmed.2012.05.018; Gilbert Alison M., 2004, Cognitive Affective & Behavioral Neuroscience, V4, P540, DOI 10.3758/CABN.4.4.540; Gitelman DR, 2003, NEUROIMAGE, V19, P200, DOI 10.1016/S1053-8119(03)00058-2; Goldstein RZ, 2008, PSYCHOPHYSIOLOGY, V45, P705, DOI 10.1111/j.1469-8986.2008.00670.x; Goldstein RZ, 2007, DRUG ALCOHOL DEPEN, V87, P233, DOI 10.1016/j.drugalcdep.2006.08.022; Goldstein RZ, 2011, NAT REV NEUROSCI, V12, P652, DOI 10.1038/nrn3119; Goldstein RZ, 2009, TRENDS COGN SCI, V13, P372, DOI 10.1016/j.tics.2009.06.004; Goldstein RZ, 2001, NEUROREPORT, V12, P2595, DOI 10.1097/00001756-200108080-00060; Goldstein RZ, 2007, PSYCHIAT INTERPE JAN, P43; Gonzalez-Saiz F, 2009, EUR ADDICT RES, V15, P87, DOI 10.1159/000189787; Grahn JA, 2008, PROG NEUROBIOL, V86, P141, DOI 10.1016/j.pneurobio.2008.09.004; Guitart-Masip M, 2012, NEUROIMAGE, V62, P154, DOI 10.1016/j.neuroimage.2012.04.024; Hester R, 2004, J NEUROSCI, V24, P11017, DOI 10.1523/JNEUROSCI.3321-04.2004; Hester R, 2013, DRUG ALCOHOL DEPEN, V133, P86, DOI 10.1016/j.drugalcdep.2013.05.027; Hester R, 2009, NEUROPSYCHOPHARMACOL, V34, P2450, DOI 10.1038/npp.2009.67; Hyatt CJ, 2012, REWARD RELATED DORSA, V7, P1; Ichihara-Takeda S, 2008, J COGNITIVE NEUROSCI, V20, P563, DOI 10.1162/jocn.2008.20047; Ikemoto S, 2014, NEUROPHARMACOLOGY, V76, P329, DOI 10.1016/j.neuropharm.2013.04.031; Ivanov I, 2012, BRAIN BEHAV, V2, P741, DOI 10.1002/brb3.80; Jasinska AJ, 2014, NEUROSCI BIOBEHAV R, V38, P1, DOI 10.1016/j.neubiorev.2013.10.013; Jia Z, 2012, INITIAL STUDY NEURAL, V70, P553; Jimura K, 2010, P NATL ACAD SCI USA, V107, P8871, DOI 10.1073/pnas.1002007107; Kalivas PW, 2005, AM J PSYCHIAT, V162, P1403, DOI 10.1176/appi.ajp.162.8.1403; Kampman KM, 1998, ADDICT BEHAV, V23, P449, DOI 10.1016/S0306-4603(98)00011-2; Konova AB, 2012, EUR J NEUROSCI, V36, P2979, DOI 10.1111/j.1460-9568.2012.08211.x; Krebs RM, 2011, J NEUROSCI, V31, P9752, DOI 10.1523/JNEUROSCI.0732-11.2011; Kriegeskorte N, 2009, CIRCULAR ANAL SYSTEM, P1; Leung HC, 2000, CEREB CORTEX, V10, P552, DOI 10.1093/cercor/10.6.552; Li CSR, 2008, NEUROPSYCHOPHARMACOL, V33, P1798, DOI 10.1038/sj.npp.1301568; Liu X, 2004, NEUROIMAGE, V22, P1097, DOI 10.1016/j.neuroimage.2004.02.033; LOGAN GD, 1979, MEM COGNITION, V7, P166, DOI 10.3758/BF03197535; LOGAN GD, 1984, PSYCHOL REV, V91, P295, DOI 10.1037/0033-295X.91.3.295; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; McFarland K, 2001, J NEUROSCI, V21, P8655; McLaren DG, 2012, NEUROIMAGE, V61, P1277, DOI 10.1016/j.neuroimage.2012.03.068; Mitchell Marci R., 2013, PRELIMINARY INVESTIG, V39, P1; Modesto-Lowe V, 1997, DRUG ALCOHOL DEPEN, V49, P9, DOI 10.1016/S0376-8716(97)00134-8; Moeller SJ, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.110; Moeller SJ, 2014, J PSYCHIATR RES, V58, P55, DOI 10.1016/j.jpsychires.2014.07.016; Moeller SJ, 2014, CEREB CORTEX, V24, P643, DOI 10.1093/cercor/bhs345; Moeller SJ, 2010, BRAIN, V133, P1484, DOI 10.1093/brain/awq066; Garcia MAM, 2008, PSICOTHEMA, V20, P545; Noel X, 2013, CURR OPIN NEUROBIOL, V23, P632, DOI 10.1016/j.conb.2013.01.018; Noudoost B, 2011, NATURE, V474, P372, DOI 10.1038/nature09995; Nutt DJ, 2015, NAT REV NEUROSCI, V16, P305, DOI 10.1038/nrn3939; Panadero A, 2015, CONSCIOUS COGN, V31, P35, DOI 10.1016/j.concog.2014.09.016; Petty NM, 2002, J CONSULT CLIN PSYCH, V70, P398, DOI 10.1037//0022-006X.70.2.398; Pochon JB, 2002, P NATL ACAD SCI USA, V99, P5669, DOI 10.1073/pnas.082111099; Poldrack RA, 2007, SOC COGN AFFECT NEUR, V2, P67, DOI 10.1093/scan/nsm006; Preacher K. J., 2002, CALCULATION TEST DIF; Robinson TE, 2003, ANNU REV PSYCHOL, V54, P25, DOI 10.1146/annurev.psych.54.101601.145237; Robinson TE, 2008, PHILOS T R SOC B, V363, P3137, DOI 10.1098/rstb.2008.0093; Rogers RE, 2010, DRUG RELATED ACTIVIT, V22, P544; Root DH, 2010, SYNAPSE, V64, P704, DOI 10.1002/syn.20792; Ruiz MJ, 2015, PSYCHOPHARMACOLOGY, V232, P1717, DOI 10.1007/s00213-014-3806-9; Sinha R, 2005, PSYCHOPHARMACOLOGY, V183, P171, DOI 10.1007/s00213-005-0147-8; Small DM, 2005, CEREB CORTEX, V15, P1855, DOI 10.1093/cercor/bhi063; Squire RF, 2013, ANNU REV NEUROSCI, V36, P451, DOI 10.1146/annurev-neuro-062111-150439; Staudinger MR, 2011, CEREB CORTEX, V21, P2578, DOI 10.1093/cercor/bhr041; Stefanik MT, 2013, J NEUROSCI, V33, P13654, DOI 10.1523/JNEUROSCI.1570-13.2013; Stitzer ML, 2010, DRUG ALCOHOL DEPEN, V107, P76, DOI 10.1016/j.drugalcdep.2009.09.006; Stoppel CM, 2011, BRAIN RES, V1383, P218, DOI 10.1016/j.brainres.2011.01.095; Tang DW, 2012, PHYSIOL BEHAV, V106, P317, DOI 10.1016/j.physbeh.2012.03.009; Tau GZ, 2014, NEUROPSYCHOPHARMACOL, V39, P545, DOI 10.1038/npp.2013.189; Tomasi D, 2007, BRAIN RES, V1171, P83, DOI 10.1016/j.brainres.2007.06.102; Tomasi D, 2007, PSYCHIAT RES-NEUROIM, V155, P189, DOI 10.1016/j.pscychresns.2007.03.002; Tricomi E, 2009, EUR J NEUROSCI, V29, P2225, DOI 10.1111/j.1460-9568.2009.06796.x; Vadhan NP, 2009, DRUG ALCOHOL DEPEN, V102, P95, DOI 10.1016/j.drugalcdep.2009.02.003; Volkow ND, 2004, NEUROPHARMACOLOGY, V47, P3, DOI 10.1016/j.neuropharm.2004.07.019; Volkow ND, 2006, J NEUROSCI, V26, P6583, DOI 10.1523/JNEUROSCI.1544-06.2006; Volkow ND, 2012, ANNU REV PHARMACOL, V52, P321, DOI 10.1146/annurev-pharmtox-010611-134625; Watanabe M, 2007, CEREB CORTEX, V17, pI101, DOI 10.1093/cercor/bhm067; Weiland BJ, 2013, DRUG ALCOHOL DEPEN, V128, P130, DOI 10.1016/j.drugalcdep.2012.08.019; Wilcox CE, 2011, DRUG ALCOHOL DEPEN, V115, P137, DOI 10.1016/j.drugalcdep.2011.01.009; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Worhunsky PD, 2013, PSYCHOL ADDICT BEHAV, V27, P477, DOI 10.1037/a0029092; Yager LM, 2015, NEUROSCIENCE, V301, P529, DOI 10.1016/j.neuroscience.2015.06.033	107	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167400	10.1371/journal.pone.0167400	http://dx.doi.org/10.1371/journal.pone.0167400			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3JC	27907134	Green Submitted, Green Published, gold			2022-12-26	WOS:000389482700144
J	Vazquez, N; Chacon, M; Rodriguez-Barrientos, CA; Merayo-Lloves, J; Naveiras, M; Baamonde, B; Alfonso, JF; Zambrano-Andazol, I; Riestra, AC; Meana, A				Vazquez, Natalia; Chacon, Manuel; Rodriguez-Barrientos, Carlos A.; Merayo-Lloves, Jesus; Naveiras, Miguel; Baamonde, Begona; Alfonso, Jose F.; Zambrano-Andazol, Iriana; Riestra, Ana C.; Meana, Alvaro			Human Bone Derived Collagen for the Development of an Artificial Corneal Endothelial Graft. In Vivo Results in a Rabbit Model	PLOS ONE			English	Article							CELL SHEET TRANSPLANTATION; TISSUE; MEMBRANE; PROTEIN; EXPRESSION; HYDROGELS; PRIMATE; SURGERY; CULTURE; CARRIER	Corneal keratoplasty (penetrating or lamellar) using cadaveric human tissue, is nowadays the main treatment for corneal endotelial dysfunctions. However, there is a worldwide shortage of donor corneas available for transplantation and about 53% of the world's population have no access to corneal transplantation. Generating a complete cornea by tissue engineering is still a tough goal, but an endothelial lamellar graft might be an easier task. In this study, we developed a tissue engineered corneal endothelium by culturing human corneal endothelial cells on a human purified type I collagen membrane. Human corneal endothelial cells were cultured from corneal rims after corneal penetrating keratoplasty and type I collagen was isolated from remnant cancellous bone chips. Isolated type I collagen was analyzed by western blot, liquid chromatography -mass spectrometry and quantified using the exponentially modified protein abundance index. Later on, collagen solution was casted at room temperature obtaining an optically transparent and mechanically manageable membrane that supports the growth of human and rabbit corneal endothelial cells which expressed characteristic markers of corneal endothelium: zonula ocluddens-1 and Na+/ K+ ATPase. To evaluate the therapeutic efficiency of our artificial endothelial grafts, human purified type I collagen membranes cultured with rabbit corneal endothelial cells were transplanted in New Zealand white rabbits that were kept under a minimal immunosuppression regimen. Transplanted corneas maintained transparency for as long as 6 weeks without obvious edema or immune rejection and maintaining the same endothelial markers that in a healthy cornea. In conclusion, it is possible to develop an artificial human corneal endothelial graft using remnant tissues that are not employed in transplant procedures. This artificial endothelial graft can restore the integrality of corneal endothelium in an experimental model of endothelial dysfunction. This strategy could supply extra endothelial tissue and compensate the deficit of cadaveric grafts for corneal endothelial transplantation.	[Vazquez, Natalia; Chacon, Manuel; Rodriguez-Barrientos, Carlos A.; Merayo-Lloves, Jesus; Naveiras, Miguel; Baamonde, Begona; Alfonso, Jose F.; Zambrano-Andazol, Iriana; Riestra, Ana C.; Meana, Alvaro] Univ Oviedo, Inst Univ Fernandez Vega, Oviedo, Spain; [Baamonde, Begona] Hosp Univ Cent Asturias, Oviedo, Spain; [Meana, Alvaro] FJD, IIS, CIBER Rare Dis CIBERer, Madrid, Spain	University of Oviedo; Central University Hospital Asturias; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Fundacion Jimenez Diaz	Vazquez, N (corresponding author), Univ Oviedo, Inst Univ Fernandez Vega, Oviedo, Spain.	natalia.vazquez@fio.as	Meana, Alvaro/D-9710-2019; Chacon, Manuel/D-8923-2019; Naveiras, Miguel/AAJ-3867-2021; Vázquez, Natalia/D-9744-2019; Arbaiza, Begoña Baamonde/ABG-8969-2020	Meana, Alvaro/0000-0001-9434-6042; Chacon, Manuel/0000-0003-3391-299X; Vázquez, Natalia/0000-0002-3410-2190; Naveiras, Miguel/0000-0003-1812-7029	Fundacion Mutua Madrilena, Government of Asturias (FEDER-EU) [FC-15-GRUPIN 14-141]; Telefonica	Fundacion Mutua Madrilena, Government of Asturias (FEDER-EU); Telefonica	This work was supported by Fundacion Mutua Madrilena, Government of Asturias (FEDER-EU - FC-15-GRUPIN 14-141) and Telefonica. The funders had no role in the study design, data collection analysis, decision to publish or preparation of the manuscript.	Bae I, 2008, FOOD CHEM, V108, P49, DOI 10.1016/j.foodchem.2007.10.039; Bahar I, 2008, OPHTHALMOLOGY, V115, P1525, DOI 10.1016/j.ophtha.2008.02.010; Bednarz J, 1998, IN VITRO CELL DEV-AN, V34, P149; BIGAR F, 1992, CURR OPIN OPHTHALMOL, V3, P473, DOI 10.1097/00001433-199208000-00007; BIGAR F, 1982, OPHTHALMOLOGY, V89, P596; Campana V, 2014, J MATER SCI-MATER M, V25, P2445, DOI 10.1007/s10856-014-5240-2; Chen KH, 2001, CORNEA, V20, P731, DOI 10.1097/00003226-200110000-00012; Gain P, 2016, JAMA OPHTHALMOL, V134, P167, DOI 10.1001/jamaophthalmol.2015.4776; Gorovoy MS, 2006, CORNEA, V25, P886, DOI 10.1097/01.ico.0000214224.90743.01; Gruskin E, 2012, ADV DRUG DELIVER REV, V64, P1063, DOI 10.1016/j.addr.2012.06.008; Hong Y, 2011, BIOMATERIALS, V32, P3387, DOI 10.1016/j.biomaterials.2011.01.025; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Ishino Y, 2004, INVEST OPHTH VIS SCI, V45, P800, DOI 10.1167/iovs.03-0016; Islam MM, 2015, ACTA BIOMATER, V12, P70, DOI 10.1016/j.actbio.2014.10.035; Joyce NC, 2012, EXP EYE RES, V95, P16, DOI 10.1016/j.exer.2011.08.014; Joyce NC, 1996, INVEST OPHTH VIS SCI, V37, P645; Joyce NC, 1996, INVEST OPHTH VIS SCI, V37, P1566; JUMBLATT MM, 1980, TRANSPLANTATION, V29, P499, DOI 10.1097/00007890-198006000-00013; Koizumi N, 2008, CORNEA, V27, pS48, DOI 10.1097/ICO.0b013e31817f2298; Koizumi N, 2007, INVEST OPHTH VIS SCI, V48, P4519, DOI 10.1167/iovs.07-0567; Laemmli UK, 1970, GROUP, V227, P680, DOI DOI 10.1038/227680A0; Lai JY, 2007, TRANSPLANTATION, V84, P1222, DOI 10.1097/01.tp.0000287336.09848.39; LANGE TM, 1993, J CATARACT REFR SURG, V19, P232, DOI 10.1016/S0886-3350(13)80947-9; Lee JE, 2001, YONSEI MED J, V42, P172, DOI 10.3349/ymj.2001.42.2.172; Madden PW, 2011, BIOMATERIALS, V32, P4076, DOI 10.1016/j.biomaterials.2010.12.034; MCCULLEY JP, 1980, OPHTHALMOLOGY, V87, P194; Melles GRJ, 1998, CORNEA, V17, P618, DOI 10.1097/00003226-199811000-00010; Melles GRJ, 2004, CORNEA, V23, P286, DOI 10.1097/00003226-200404000-00011; Mimura T, 2004, INVEST OPHTH VIS SCI, V45, P2992, DOI 10.1167/iovs.03-1174; Mimura T, 2003, EXP EYE RES, V76, P745, DOI 10.1016/S0014-4835(03)00057-5; Morikubo S, 2004, ARCH OPHTHALMOL-CHIC, V122, P966, DOI 10.1001/archopht.122.7.966; MURPHY C, 1984, INVEST OPHTH VIS SCI, V25, P312; Okumura N, 2016, NAT PUBL GR; Okumura N, 2012, AM J PATHOL, V181, P268, DOI 10.1016/j.ajpath.2012.03.033; Okumura N, 2011, BRIT J OPHTHALMOL, V95, P1006, DOI 10.1136/bjo.2010.194571; Orwin EJ, 2000, TISSUE ENG, V6, P307, DOI 10.1089/107632700418038; Ozcelik B, 2013, ACTA BIOMATER, V9, P6594, DOI 10.1016/j.actbio.2013.01.020; Pietrzak WS, 2011, CELL TISSUE BANK, V12, P81, DOI 10.1007/s10561-009-9168-6; Potaros T., 2009, Kasetsart Journal, Natural Sciences, V43, P584; Satue M, 2015, Arch Soc Esp Oftalmol, V90, P356, DOI 10.1016/j.oftal.2015.01.004; Sawkins MJ, 2013, ACTA BIOMATER, V9, P7865, DOI 10.1016/j.actbio.2013.04.029; SCHWARTZ BD, 1981, INVEST OPHTH VIS SCI, V20, P467; Senoo T, 2000, INVEST OPHTH VIS SCI, V41, P660; Vazquez N, 2015, HISTOL HISTOPATHOL, V30, P813, DOI 10.14670HH-11-585; WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0; Yoeruek E, 2009, CORNEA, V28, P416, DOI 10.1097/ICO.0b013e31818c2c36; Yokoo S, 2005, INVEST OPHTH VIS SCI, V46, P1626, DOI 10.1167/iovs.04-1263; Yoshida J, 2014, INVEST OPHTH VIS SCI, V55, P4975, DOI 10.1167/iovs.14-14211; Zhang J., 2015, ADV MAT SCI ENG, V1, P1; Zhu C, 2004, INVEST OPHTH VIS SCI, V45, P1743, DOI 10.1167/iovs.03-0814	50	17	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167578	10.1371/journal.pone.0167578	http://dx.doi.org/10.1371/journal.pone.0167578			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907157	Green Published, Green Submitted, gold			2022-12-26	WOS:000389482700201
J	Wu, N; Yu, YD; Li, T; Ji, XJ; Jiang, L; Zong, JJ; Huang, H				Wu, Na; Yu, Yadong; Li, Tao; Ji, Xiaojun; Jiang, Ling; Zong, Jiajun; Huang, He			Investigating the Influence of MoS2 Nanosheets on E-coli from Metabolomics Level	PLOS ONE			English	Article							ANTIBACTERIAL ACTIVITY; GRAPHENE; TOXICITY; NANOPARTICLES; CYTOTOXICITY; EXFOLIATION; REVEAL; WS2	Molybdenum disulfide, a type of two-dimensional layered material with unique properties, has been widely used in many fields. However, an exact understanding of its toxicity remains elusive, let alone its effects on the environmental microbial community. In this study, we utilized metabolomics technology to explore the effects of different concentrations of molybdenum disulfide nanosheets on Escherichia coli for the first time. The results showed that with increasing concentration of molybdenum disulfide nanosheets, the survival rate of Escherichia coli was decreased and the release of lactic dehydrogenase was increased. At the same time, intracellular concentrations of reactive oxygen species were dramatically increased. In addition, metabolomics analysis showed that high concentrations of molybdenum disulfide nanosheets (100, 1000 mu g/mL) could significantly affect the metabolic profile of Escherichia coli, including glycine, serine and threonine metabolism, protein biosynthesis, urea cycle and pyruvate metabolism. These results will be beneficial for molybdenum disulfide toxicity assessment and further applications.	[Wu, Na; Li, Tao; Ji, Xiaojun; Zong, Jiajun] Nanjing Tech Univ, Coll Biotechnol & Pharmaceut Engn, Nanjing, Jiangsu, Peoples R China; [Yu, Yadong] Jiangsu Natl Synerget Innovat Ctr Adv Mat SICAM, Nanjing, Peoples R China; [Jiang, Ling] Nanjing Tech Univ, Coll Food Sci & Light Ind, Nanjing, Jiangsu, Peoples R China; [Huang, He] Nanjing Tech Univ, Sch Pharmaceut Sci, Nanjing, Jiangsu, Peoples R China	Nanjing Tech University; Nanjing Tech University; Nanjing Tech University	Yu, YD (corresponding author), Jiangsu Natl Synerget Innovat Ctr Adv Mat SICAM, Nanjing, Peoples R China.; Huang, H (corresponding author), Nanjing Tech Univ, Sch Pharmaceut Sci, Nanjing, Jiangsu, Peoples R China.	yadongyu@njtech.edu.cn; biotech@njtech.edu.cn	Ji, Xiao-Jun/E-6447-2012	Ji, Xiao-Jun/0000-0002-6450-0229	National Natural Science Foundation of China [21506096]; National High Technology Research and Development Program of China [2013AA020302]; Key Laboratory of Agro-Products Processing, Ministry of Agriculture [2015011]; State Key Laboratory of Bio-organic and Natural Products Chemistry, CAS [SKLBNPC15429]; Six Talent Peaks Project in Jiangsu Province [2015-JY-009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Key Laboratory of Agro-Products Processing, Ministry of Agriculture; State Key Laboratory of Bio-organic and Natural Products Chemistry, CAS(Chinese Academy of Sciences); Six Talent Peaks Project in Jiangsu Province	This work was financially supported by the National Natural Science Foundation of China (No. 21506096) and National High Technology Research and Development Program of China (2013AA020302), Key Laboratory of Agro-Products Processing, Ministry of Agriculture (2015011), the State Key Laboratory of Bio-organic and Natural Products Chemistry, CAS (SKLBNPC15429), and the Six Talent Peaks Project in Jiangsu Province (2015-JY-009). This funding was mainly used in the study design, date analysis, and decision to publish.; This work was financially supported by the National Natural Science Foundation of China (No. 21506096) and National High Technology Research and Development Program of China (2013AA020302), Key Laboratory of Agro-Products Processing, Ministry of Agriculture (2015011), the State Key Laboratory of Bio-organic and Natural Products Chemistry, CAS (SKLBNPC15429), and the Six Talent Peaks Project in Jiangsu Province (2015-JY-009).	Akhavan O, 2010, ACS NANO, V4, P5731, DOI 10.1021/nn101390x; Bertolazzi S, 2011, ACS NANO, V5, P9703, DOI 10.1021/nn203879f; Chng ELK, 2014, NANOSCALE, V6, P14412, DOI 10.1039/c4nr04907a; Coleman JN, 2011, SCIENCE, V331, P568, DOI 10.1126/science.1194975; Dutta T, 2015, RSC ADV, V5, P80192, DOI 10.1039/c5ra14061g; Huang KJ, 2013, ELECTROCHIM ACTA, V109, P587, DOI 10.1016/j.electacta.2013.07.168; Jozefczuk S, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.18; Kalantar-zadeh K, 2016, ACS SENSORS, V1, P5, DOI 10.1021/acssensors.5b00142; Karpeta-Kaczmarek J, 2016, ARTHROPOD STRUCT DEV, V45, P253, DOI 10.1016/j.asd.2016.02.002; Karwowska E, 2015, INT J APPL CERAM TEC, V12, P885, DOI 10.1111/ijac.12297; King LA, 2013, J MATER CHEM A, V1, P8935, DOI 10.1039/c3ta11633f; Late DJ, 2013, ACS NANO, V7, P4879, DOI 10.1021/nn400026u; Lee C, 2010, ACS NANO, V4, P2695, DOI 10.1021/nn1003937; Lee C, 2010, SCIENCE, V328, P76, DOI 10.1126/science.1184167; Lee GH, 2013, ACS NANO, V7, P7931, DOI 10.1021/nn402954e; Li H, 2012, ADV FUNCT MATER, V22, P1385, DOI 10.1002/adfm.201102111; Li J, 2013, OMICS, V17, P269, DOI 10.1089/omi.2012.0088; Li QL, 2008, WATER RES, V42, P4591, DOI 10.1016/j.watres.2008.08.015; Liu SB, 2011, ACS NANO, V5, P6971, DOI 10.1021/nn202451x; Lv MY, 2015, BIOANALYSIS, V7, P1527, DOI 10.4155/bio.15.83; Lyon DY, 2006, ENVIRON SCI TECHNOL, V40, P4360, DOI 10.1021/es0603655; Molina Sanchez A, 2011, PHYS REV B, VB 84; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Nel A, 2013, ACCOUNTS CHEM RES, V46, P607, DOI 10.1021/ar300022h; Qureshi N, 2015, APPL NANOSCI, V5, P331, DOI 10.1007/s13204-014-0322-5; Rapoport L, 2005, J MATER CHEM, V15, P1782, DOI 10.1039/b417488g; Ratnasekhar C, 2015, NANOTOXICOLOGY, V9, P994, DOI 10.3109/17435390.2014.993345; REED LJ, 1990, J BIOL CHEM, V265, P8971; Ristic BZ, 2014, BIOMATERIALS, V35, P4428, DOI 10.1016/j.biomaterials.2014.02.014; Sayes CM, 2005, BIOMATERIALS, V26, P7587, DOI 10.1016/j.biomaterials.2005.05.027; Shah P, 2015, NANOTECHNOLOGY, V26, DOI 10.1088/0957-4484/26/31/315102; Sharma VK, 2015, CHEM SOC REV, V44, P8410, DOI 10.1039/c5cs00236b; Siegel G, 2015, APL MATER, V3, DOI DOI 10.1021/NN203879F; Siniossoglou S, 2013, BBA-MOL CELL BIOL L, V1831, P575, DOI 10.1016/j.bbalip.2012.09.014; Smith RJ, 2011, ADV MATER, V23, P3944, DOI 10.1002/adma.201102584; Spohn P, 2009, ENVIRON POLLUT, V157, P1134, DOI 10.1016/j.envpol.2008.08.013; Subbaiah YPV, 2016, ADV FUNCT MATER, V26, P2046, DOI 10.1002/adfm.201504202; Teo WZ, 2014, CHEM-EUR J, V20, P9627, DOI 10.1002/chem.201402680; Thurston TR, 1999, J PHYS CHEM B, V103, P11, DOI 10.1021/jp982337h; Tu YS, 2013, NAT NANOTECHNOL, V8, P594, DOI [10.1038/nnano.2013.125, 10.1038/NNANO.2013.125]; Wang C, 2014, APPL MICROBIOL BIOT, V98, P9735, DOI 10.1007/s00253-014-6143-3; Wang QH, 2012, NAT NANOTECHNOL, V7, P699, DOI [10.1038/NNANO.2012.193, 10.1038/nnano.2012.193]; Wang XS, 2013, J AM CHEM SOC, V135, P5304, DOI 10.1021/ja4013485; Winchester A, 2014, ACS APPL MATER INTER, V6, P2125, DOI 10.1021/am4051316; Winnik FM, 2013, ACCOUNTS CHEM RES, V46, P672, DOI 10.1021/ar3000585; Wu HH, 2011, ACS NANO, V5, P1276, DOI 10.1021/nn102941b; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Yan DH, 2011, LANGMUIR, V27, P13206, DOI 10.1021/la2008107; Yang X, 2014, NANOSCALE, V6, P10126, DOI 10.1039/c4nr01965b; Zhao LJ, 2016, ENVIRON SCI TECHNOL, V50, P2000, DOI 10.1021/acs.est.5b05011; Zhu CF, 2013, J AM CHEM SOC, V135, P5998, DOI 10.1021/ja4019572	51	34	34	2	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167245	10.1371/journal.pone.0167245	http://dx.doi.org/10.1371/journal.pone.0167245			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907068	Green Published, gold, Green Submitted			2022-12-26	WOS:000389482700102
J	Yoshizawa, H; Senda, D; Natori, Y; Tanaka, R; Mizuno, H; Hayashi, A				Yoshizawa, Hidekazu; Senda, Daiki; Natori, Yuhei; Tanaka, Rica; Mizuno, Hiroshi; Hayashi, Ayato			End-to-Side Neurorrhaphy as Schwann Cells Provider to Acellular Nerve Allograft and Its Suitable Application	PLOS ONE			English	Article							P16(INK4A) EXPRESSION; NEUROTROPHIC FACTORS; EPINEURIAL WINDOW; TRANSGENIC MICE; DONOR NERVE; STEM-CELLS; REGENERATION; RECONSTRUCTION; SYSTEM; REPAIR	Axonal regeneration relies on support from proliferating host Schwann cells (SCs), and previous studies on acellular nerve allografts (ANGs) suggest that axons can regenerate into ANGs within a limited distance. Numerous studies have demonstrated that the supplementation of ANGs with exogenous factors, such as cultured SCs, stem cells, and growth factors, promote nerve regeneration in ANGs. However, there are several problems associated with their utilization. In this study, we investigated whether end-to-side (ETS) neurorrhaphy, which is an axonal provider, could be useful as an SC provider to support axonal elongation in ANGs. We found that ETS neurorrhaphy effectively promoted SC migration into ANGs when an epineurium window combined with partial neurectomy was performed, and the effectiveness increased when it was applied bilaterally. When we transplanted ANGs containing migrated SCs via ETS neurorrhaphy (hybrid ANGs) to the nerve gap, hybrid ANGs increased the number of regenerated axons and facilitated rapid axonal elongation, particularly when ETS neurorrhaphy was applied to both edges of the graft. This approach may represent a novel application of ETS neurorrhaphy and lead to the development of hybrid ANGs, making ANGs more practical in a clinical setting.	[Yoshizawa, Hidekazu; Senda, Daiki; Natori, Yuhei; Tanaka, Rica; Mizuno, Hiroshi; Hayashi, Ayato] Juntendo Univ, Sch Med, Dept Plast & Reconstruct Surg, Tokyo, Japan	Juntendo University	Hayashi, A (corresponding author), Juntendo Univ, Sch Med, Dept Plast & Reconstruct Surg, Tokyo, Japan.	ayhayasi@juntendo.ac.jp			JSPS KAKENHI [24592720]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant [Grant-in-Aid for Scientific Research (C)] Number 24592720 (https://kaken.nii.ac.jp/ja/grant/KAKENHI-PROJECT-245927201) awarded to Dr. Ayato Hayashi.	Bangaru MLY, 2012, J MOL NEUROSCI, V46, P497, DOI 10.1007/s12031-011-9628-x; Beris AE, 2009, INT REV NEUROBIOL, V87, P269, DOI 10.1016/S0074-7742(09)87013-X; Brenner MJ, 2007, PLAST RECONSTR SURG, V120, P215, DOI 10.1097/01.prs.0000264094.06272.67; Brooks DN, 2012, MICROSURG, V32, P1, DOI 10.1002/micr.20975; Chan JR, 2001, P NATL ACAD SCI USA, V98, P14661, DOI 10.1073/pnas.251543398; Chen YY, 2005, J NEUROPATH EXP NEUR, V64, P613, DOI 10.1097/01.jnen.0000171650.94341.46; Chomiak T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007754; DEMEDINACELI L, 1995, J NEUROSCI METH, V58, P29, DOI 10.1016/0165-0270(94)00156-B; Fong CY, 2010, J CELL BIOCHEM, V111, P769, DOI 10.1002/jcb.22775; Fox IK, 2005, MICROSURG, V25, P502, DOI 10.1002/micr.20152; Fox IK, 2005, MUSCLE NERVE, V31, P59, DOI 10.1002/mus.20231; Frostick SP, 1998, MICROSURG, V18, P397, DOI 10.1002/(SICI)1098-2752(1998)18:7<397::AID-MICR2>3.0.CO;2-F; Guest JD, 1997, EXP NEUROL, V148, P502, DOI 10.1006/exnr.1997.6693; HALL SM, 1986, NEUROPATH APPL NEURO, V12, P27, DOI 10.1111/j.1365-2990.1986.tb00679.x; HALL SM, 1986, NEUROPATH APPL NEURO, V12, P401, DOI 10.1111/j.1365-2990.1986.tb00151.x; Hayashi A, 2004, PLAST RECONSTR SURG, V114, P129, DOI 10.1097/01.PRS.0000129075.96217.92; Hayashi A, 2008, EXP NEUROL, V211, P539, DOI 10.1016/j.expneurol.2008.02.031; Hayashi A, 2007, EXP NEUROL, V207, P128, DOI 10.1016/j.expneurol.2007.06.004; Ilha J, 2008, NEUROREHAB NEURAL RE, V22, P355, DOI 10.1177/1545968307313502; Iwase T, 2005, J NEUROCHEM, V94, P1488, DOI 10.1111/j.1471-4159.2005.03290.x; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Jessen KR, 1999, TRENDS NEUROSCI, V22, P402, DOI 10.1016/S0166-2236(98)01391-5; Kalantarian B, 1998, J RECONSTR MICROSURG, V14, P459, DOI 10.1055/s-2007-1000208; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; Liu HF, 2014, MICROSURG, V34, P136, DOI 10.1002/micr.22167; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUNDBORG G, 1982, EXP NEUROL, V76, P361, DOI 10.1016/0014-4886(82)90215-1; Lyons DA, 2005, CURR BIOL, V15, P513, DOI 10.1016/j.cub.2005.02.030; Magill CK, 2007, EXP NEUROL, V207, P64, DOI 10.1016/j.expneurol.2007.05.028; Matsuda K, 2005, J RECONSTR MICROSURG, V21, P581, DOI 10.1055/s-2005-922439; Matsuda K, 2008, J PLAST RECONSTR AES, V61, P1357, DOI 10.1016/j.bjps.2008.04.013; Matsuda K, 2015, J PLAST RECONSTR AES, V68, P1054, DOI 10.1016/j.bjps.2015.04.005; Matsumoto M, 1999, J RECONSTR MICROSURG, V15, P281, DOI 10.1055/s-2007-1000102; Meek MF, 2008, ANN PLAS SURG, V60, P110, DOI 10.1097/SAP.0b013e31804d441c; Meek MF, 2002, J RECONSTR MICROSURG, V18, P97, DOI 10.1055/s-2002-19889; Moore AM, 2011, MUSCLE NERVE, V44, P221, DOI 10.1002/mus.22033; Moore Amy M, 2009, Hand (N Y), V4, P180, DOI 10.1007/s11552-008-9158-3; NADIM W, 1990, NEUROPATH APPL NEURO, V16, P411, DOI 10.1111/j.1365-2990.1990.tb01277.x; Ohtani N, 2001, NATURE, V409, P1067, DOI 10.1038/35059131; Passegue E, 2000, EMBO J, V19, P2969, DOI 10.1093/emboj/19.12.2969; Poduslo JF, 1996, MOL BRAIN RES, V36, P280, DOI 10.1016/0169-328X(95)00250-V; Poppler LH, 2016, TISSUE ENG PT A, V22, P949, DOI [10.1089/ten.tea.2016.0003, 10.1089/ten.TEA.2016.0003]; Saheb-Al-Zamani M, 2013, EXP NEUROL, V247, P165, DOI 10.1016/j.expneurol.2013.04.011; Swijnenburg RJ, 2008, STEM CELLS DEV, V17, P1023, DOI 10.1089/scd.2008.0091; Szynkaruk M, 2013, TISSUE ENG PART B-RE, V19, P83, DOI [10.1089/ten.TEB.2012.0275, 10.1089/ten.teb.2012.0275]; Ueda K, 2007, J RECONSTR MICROSURG, V23, P181, DOI 10.1055/s-2007-974654; Viterbo F, 1992, Rev Paul Med, V110, P267; Walker JC, 2004, J NEUROTRAUM, V21, P217, DOI 10.1089/089771504322778677; Walsh S, 2009, NEUROSCIENCE, V164, P1097, DOI 10.1016/j.neuroscience.2009.08.072; Webber C, 2010, EXP NEUROL, V223, P51, DOI 10.1016/j.expneurol.2009.05.037; Whitlock EL, 2009, MUSCLE NERVE, V39, P787, DOI 10.1002/mus.21220; Yamaguchi M, 2000, NEUROREPORT, V11, P1991, DOI 10.1097/00001756-200006260-00037; Yan JG, 2002, J HAND SURG-AM, V27A, P484, DOI 10.1053/jhsu.2002.32953	53	1	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167507	10.1371/journal.pone.0167507	http://dx.doi.org/10.1371/journal.pone.0167507			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907118	Green Published, Green Submitted, gold			2022-12-26	WOS:000389482700174
J	Kulkarni, A; Khan, Y; Ray, K				Kulkarni, Anuttama; Khan, Yasmin; Ray, Krishanu			Heterotrimeric kinesin-2, together with kinesin-1, steers vesicular acetylcholinesterase movements toward the synapse	FASEB JOURNAL			English	Article						intracellular transport; lateral-chordotonal-neuron; Drosophila; mouse brain	DROSOPHILA-MELANOGASTER ACETYLCHOLINESTERASE; AXONAL-TRANSPORT; MOLECULAR-FORMS; CHOLINE-ACETYLTRANSFERASE; CYTOPLASMIC DYNEIN; PROTEIN; MOTORS; EXPRESSION; MUTANTS; SUBUNIT	Acetylcholinesterase (AChE), which is implicated in the pathophysiology of neurological disorders, is distributed along the axon and enriched at the presynaptic basal lamina. It hydrolyses the neurotransmitter acetylcholine, which inhibits synaptic transmission. Aberrant AChE activity and ectopic axonal accumulation of the enzyme are associated with neurodegenerative disorders, such as Alzheimer's disease. The molecular mechanism that underlies AChE transport is still unclear. Here, we show that expression of Drosophila AChE tagged with photoactivatable green fluorescent protein and m-Cherry (GPAC) in cholinergic neurons compensates for the RNA interference-mediated knockdown of endogenous AChE activity. GPAC-AChE, which is enriched in the neuropil region of the brain, moves in the apparently vesicular formin axons with an anterograde bias in Drosophila larvae. Two anterograde motors, kinesin-1 and -2, propel distinct aspects of GPAC-AChE movements. Total loss of kinesin-2 reduces the density of anterograde traffic and increases bidirectional movements of GPAC-AChE vesicles without altering their speed. A partial loss of kinesin-1 reduces both the density and speed of anterograde GPAC-AChE traffic and enhances the pool of stationary vesicles. Together, these results suggest that combining activity of a relatively weak kinesin-2 with that of a stronger kinesin-1 motor could steer AChE-containing vesicles toward synapse, and provides a molecular basis for the observed subcellular distribution of the enzyme.	[Kulkarni, Anuttama; Khan, Yasmin] Sophia Coll, Bombay, Maharashtra, India; [Kulkarni, Anuttama; Ray, Krishanu] Tata Inst Fundamental Res, Homi Bhabba Rd, Bombay 400005, Maharashtra, India	Tata Institute of Fundamental Research (TIFR)	Ray, K (corresponding author), Tata Inst Fundamental Res, Homi Bhabba Rd, Bombay 400005, Maharashtra, India.	krishanu@tifr.res.in	Kulkarni, Anuttama/GXZ-4979-2022	Kulkarni, Anuttama/0000-0002-2265-5820; Ray, Krishanu/0000-0001-6406-3199	University Grants Commission Fellowship (New Delhi, India); Department of Atomic Energy (Government of India Atomic Energy Commission)	University Grants Commission Fellowship (New Delhi, India); Department of Atomic Energy (Government of India Atomic Energy Commission)	The authors thank Akanksha Jain for the Klp68D<SUP>Bex2</SUP> stock; Arkadiuz Welman for the GPAC clone; Shital Suryavanshi, Megha Maheshwari, and Vidita Vaidya for providing mice brain sections and assistance with the immunohistochemistry; and Roop Mallik for useful suggestions on the manuscript (all from the Tata Institute for Fundamental Research). This study was supported by a University Grants Commission Fellowship (New Delhi, India) (to A.K.) and an intramural grant from the Department of Atomic Energy (Government of India Atomic Energy Commission) (to K.R.).	Alvarez A, 1995, NEUROSCI LETT, V201, P49, DOI 10.1016/0304-3940(94)12127-C; Andreasson JOL, 2015, CURR BIOL, V25, P1166, DOI 10.1016/j.cub.2015.03.013; Baqri R, 2006, J NEUROBIOL, V66, P378, DOI 10.1002/neu.20230; Bendayan M, 2001, J HISTOCHEM CYTOCHEM, V49, P29, DOI 10.1177/002215540104900104; BRIMIJOIN S, 1978, J PHYSIOL-LONDON, V285, P129, DOI 10.1113/jphysiol.1978.sp012562; COURAUD JY, 1980, J NEUROCHEM, V35, P1053, DOI 10.1111/j.1471-4159.1980.tb07859.x; COURAUD JY, 1983, EXP NEUROL, V80, P94, DOI 10.1016/0014-4886(83)90009-2; De Ferrari GV, 2001, BIOCHEMISTRY-US, V40, P10447, DOI 10.1021/bi0101392; De Vos KJ, 2008, ANNU REV NEUROSCI, V31, P151, DOI 10.1146/annurev.neuro.31.061307.090711; De Vos KJ, 2007, METHOD CELL BIOL, V80, P627, DOI 10.1016/S0091-679X(06)80030-0; Deacon SW, 2003, J CELL BIOL, V160, P297, DOI 10.1083/jcb.200210066; Doodhi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045981; Encalada SE, 2011, CELL, V144, P551, DOI 10.1016/j.cell.2011.01.021; FOURNIER D, 1989, J MOL BIOL, V210, P15, DOI 10.1016/0022-2836(89)90287-8; Fu MM, 2013, J CELL BIOL, V202, P495, DOI 10.1083/jcb.201302078; Granger E, 2014, SEMIN CELL DEV BIOL, V31, P20, DOI 10.1016/j.semcdb.2014.04.011; Greenfield SA, 2008, FEBS J, V275, P604, DOI 10.1111/j.1742-4658.2007.06235.x; GREENSPAN RJ, 1980, J COMP NEUROL, V189, P741, DOI 10.1002/cne.901890409; Grifman M, 1998, P NATL ACAD SCI USA, V95, P13935, DOI 10.1073/pnas.95.23.13935; HALL JC, 1976, GENETICS, V83, P517; Harel M, 2000, PROTEIN SCI, V9, P1063, DOI 10.1110/ps.9.6.1063; HASSIG R, 1991, J NEUROCHEM, V57, P1913, DOI 10.1111/j.1471-4159.1991.tb06403.x; Hirokawa N, 2008, PHYSIOL REV, V88, P1089, DOI 10.1152/physrev.00023.2007; Hoeprich GJ, 2014, BIOPHYS J, V106, P1691, DOI 10.1016/j.bpj.2014.02.034; Incardona JP, 1996, MOL BIOL CELL, V7, P595, DOI 10.1091/mbc.7.4.595; Kamal A, 2000, NEURON, V28, P449, DOI 10.1016/S0896-6273(00)00124-0; Kanai Y, 2000, J NEUROSCI, V20, P6374, DOI 10.1523/JNEUROSCI.20-17-06374.2000; KASA P, 1973, J NEUROCHEM, V21, P431; KASA P, 1968, NATURE, V218, P1265, DOI 10.1038/2181265a0; Ligon LA, 2004, J BIOL CHEM, V279, P19201, DOI 10.1074/jbc.M313472200; MACPHEEQUIGLEY K, 1985, J BIOL CHEM, V260, P2185; Maday S, 2012, J CELL BIOL, V196, P407, DOI 10.1083/jcb.201106120; MASSOULIE J, 1982, ANNU REV NEUROSCI, V5, P57, DOI 10.1146/annurev.ne.05.030182.000421; Massoulie J, 1998, J PHYSIOLOGY-PARIS, V92, P183, DOI 10.1016/S0928-4257(98)80007-7; Messitt TJ, 2008, DEV CELL, V15, P426, DOI 10.1016/j.devcel.2008.06.014; Murray JW, 2002, ANAL BIOCHEM, V305, P55, DOI 10.1006/abio.2002.5655; Pantelidou M, 2007, NEUROBIOL DIS, V26, P577, DOI 10.1016/j.nbd.2007.02.005; Paraoanu LE, 2008, FEBS J, V275, P618, DOI 10.1111/j.1742-4658.2007.06237.x; Perez-Aguilar B, 2015, BBA-MOL BASIS DIS, V1852, P1380, DOI 10.1016/j.bbadis.2015.04.003; Perrier AL, 2002, NEURON, V33, P275, DOI 10.1016/S0896-6273(01)00584-0; PESAVENTO PA, 1994, J CELL BIOL, V127, P1041, DOI 10.1083/jcb.127.4.1041; Rai A, 2016, CELL, V164, P722, DOI 10.1016/j.cell.2015.12.054; Ray K, 1999, J CELL BIOL, V147, P507, DOI 10.1083/jcb.147.3.507; Reis GF, 2012, MOL BIOL CELL, V23, P1700, DOI 10.1091/mbc.E11-11-0938; Rocha N, 2009, J CELL BIOL, V185, P1209, DOI 10.1083/jcb.200811005; Sadananda A, 2012, TRAFFIC, V13, P979, DOI 10.1111/j.1600-0854.2012.01361.x; Sarpal R, 2003, CURR BIOL, V13, P1687, DOI 10.1016/j.cub.2003.09.025; SAXTON WM, 1991, CELL, V64, P1093, DOI 10.1016/0092-8674(91)90264-Y; Schroeder HW, 2012, BIOPHYS J, V103, P48, DOI 10.1016/j.bpj.2012.05.037; Sharma KV, 2001, J NEUROSCI RES, V63, P165, DOI 10.1002/1097-4547(20010115)63:2<165::AID-JNR1008>3.0.CO;2-O; Silman I, 2005, CURR OPIN PHARMACOL, V5, P293, DOI 10.1016/j.coph.2005.01.014; Soppina V, 2009, P NATL ACAD SCI USA, V106, P19381, DOI 10.1073/pnas.0906524106; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; Twelvetrees AE, 2016, NEURON, V90, P1000, DOI 10.1016/j.neuron.2016.04.046; ZADOR E, 1995, BIOCHEM GENET, V33, P41, DOI 10.1007/BF00554557; Zaganas I, 2013, TOXICOLOGY, V307, P3, DOI 10.1016/j.tox.2013.02.002	56	7	7	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2017	31	3					965	974		10.1096/fj.201600759RRR	http://dx.doi.org/10.1096/fj.201600759RRR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EM9ZX	27920150				2022-12-26	WOS:000395671200013
J	Mallette, E; Kimber, MS				Mallette, Evan; Kimber, Matthew S.			A Complete Structural Inventory of the Mycobacterial Microcompartment Shell Proteins Constrains Models of Global Architecture and Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL MICROCOMPARTMENT; CARBOXYSOME SHELL; PDU MICROCOMPARTMENT; BETA-CARBOXYSOME; ORGANELLES; ENZYME; SOFTWARE	Bacterial microcompartments are bacterial analogs of eukaryotic organelles in that they spatially segregate aspects of cellular metabolism, but they do so by building not a lipid membrane but a thin polyhedral protein shell. Although multiple shell protein structures are known for several microcompartment types, additional uncharacterized components complicate systematic investigations of shell architecture. We report here the structures of all four proteins proposed to form the shell of an uncharacterized microcompartment designated the Rhodococcus and Mycobacterium microcompartment (RMM), which, along with crystal interactions and docking studies, suggests possible models for the particle's vertex and edge organization. MSM0272 is a typical hexameric beta-sandwich shell protein thought to form the bulk of the facet. MSM0273 is a pentameric beta-barrel shell protein that likely plugs the vertex of the particle. MSM0271is an unusual double-ringed bacterial microcompartment shell protein whose rings are organized in an offset position relative to all known related proteins. MSM0275 is related to MSM0271 but self-organizes as linear strips that may line the facet edge; here, the presence of a novel extendable loop may help ameliorate poor packing geometry of the rigid main particle at the angled edges. In contrast to previously characterized homologs, both of these proteins show closed pores at both ends. This suggests a model where key interactions at the vertex and edges are mediated at the inner layer of the shell by MSM0271 (encircling MSM0273) and MSM0275, and the facet is built from MSM0272 hexamers tiling in the outer layer of the shell.	[Mallette, Evan; Kimber, Matthew S.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Kimber, MS (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	mkimber@uoguelph.ca	Kimber, Matthew/Q-8144-2019	Kimber, Matthew/0000-0001-9454-5586	Natural Sciences and Engineering Research Council of Canada [04045-2015]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by Natural Sciences and Engineering Research Council of Canada Grant 04045-2015 (to M. S. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Axen SD, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003898; Cai F, 2013, J BIOL CHEM, V288, P16055, DOI 10.1074/jbc.M113.456897; Chowdhury C, 2015, P NATL ACAD SCI USA, V112, P2990, DOI 10.1073/pnas.1423672112; Chowdhury C, 2014, MICROBIOL MOL BIOL R, V78, P438, DOI 10.1128/MMBR.00009-14; Craciun S, 2012, P NATL ACAD SCI USA, V109, P21307, DOI 10.1073/pnas.1215689109; Crowley CS, 2008, STRUCTURE, V16, P1324, DOI 10.1016/j.str.2008.05.013; Crowley CS, 2010, J BIOL CHEM, V285, P37838, DOI 10.1074/jbc.M110.160580; Dryden KA, 2009, PROTEIN SCI, V18, P2629, DOI 10.1002/pro.272; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Espie GS, 2011, PHOTOSYNTH RES, V109, P7, DOI 10.1007/s11120-011-9656-y; Fan CG, 2012, P NATL ACAD SCI USA, V109, P14995, DOI 10.1073/pnas.1207516109; Fan CG, 2010, P NATL ACAD SCI USA, V107, P7509, DOI 10.1073/pnas.0913199107; Heinhorst S., 2014, NANOMICROBIOLOGY, DOI [10.1007/978-1-4939-1667-2_4, DOI 10.1007/978-1-4939-1667-2_4]; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huseby DL, 2013, J BACTERIOL, V195, P2864, DOI 10.1128/JB.02179-12; Jorda J, 2013, PROTEIN SCI, V22, P179, DOI 10.1002/pro.2196; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kataoka M, 2006, LETT APPL MICROBIOL, V43, P430, DOI 10.1111/j.1472-765X.2006.01970.x; Keeling TJ, 2014, PHOTOSYNTH RES, V121, P125, DOI 10.1007/s11120-014-9973-z; Kerfeld CA, 2005, SCIENCE, V309, P936, DOI 10.1126/science.1113397; Kerfeld CA, 2015, TRENDS MICROBIOL, V23, P22, DOI 10.1016/j.tim.2014.10.003; Klein MG, 2009, J MOL BIOL, V392, P319, DOI 10.1016/j.jmb.2009.03.056; Linster CL, 2013, NAT CHEM BIOL, V9, P72, DOI [10.1038/NCHEMBIO.1141, 10.1038/nchembio.1141]; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Pang A, 2012, ACTA CRYSTALLOGR D, V68, P1642, DOI 10.1107/S0907444912039315; Pitts AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048360; Rae BD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043871; Samborska B, 2012, STRUCTURE, V20, P1353, DOI 10.1016/j.str.2012.05.013; Seedorf H, 2008, P NATL ACAD SCI USA, V105, P2128, DOI 10.1073/pnas.0711093105; Sinha S, 2014, J MOL BIOL, V426, P2328, DOI 10.1016/j.jmb.2014.04.012; Tanaka S, 2008, SCIENCE, V319, P1083, DOI 10.1126/science.1151458; Tanaka S, 2010, SCIENCE, V327, P81, DOI 10.1126/science.1179513; Tanaka S, 2009, PROTEIN SCI, V18, P108, DOI 10.1002/pro.14; Tsai YS, 2009, ACTA CRYSTALLOGR D, V65, P980, DOI 10.1107/S0907444909025153; Urano N, 2011, APPL MICROBIOL BIOT, V89, P739, DOI 10.1007/s00253-010-2924-5; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050; Wheatley NM, 2013, PROTEIN SCI, V22, P660, DOI 10.1002/pro.2246; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yeates TO, 2013, J MOL MICROB BIOTECH, V23, P290, DOI 10.1159/000351347; Zarzycki J, 2013, J EXP BOT, V64, P787, DOI 10.1093/jxb/ers294	41	20	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2017	292	4					1197	1210		10.1074/jbc.M116.754093	http://dx.doi.org/10.1074/jbc.M116.754093			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ6OX	27927988	Green Published, hybrid			2022-12-26	WOS:000393339800005
J	Shah, R; Ohashi, T; Erickson, HP; Oas, TG				Shah, Riddhi; Ohashi, Tomoo; Erickson, Harold P.; Oas, Terrence G.			Spontaneous Unfolding-Refolding of Fibronectin Type III Domains Assayed by Thiol Exchange THERMODYNAMIC STABILITY CORRELATES WITH RATES OF UNFOLDING RATHER THAN FOLDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOGLYCERATE KINASE; DISULFIDE EXCHANGE; CRYSTAL-STRUCTURE; PROTEINS; ELASTICITY; KINETICS; MATRIX; TENASCIN; STATE; ACCESSIBILITY	Globular proteins are not permanently folded but spontaneously unfold and refold on time scales that can span orders of magnitude for different proteins. A longstanding debate in the protein- folding field is whether unfolding rates or folding rates correlate to the stability of a protein. In the present study, we have determined the unfolding and folding kinetics of 10 FNIII domains. FNIII domains are one of the most common protein folds and are present in 2% of animal proteins. FNIII domains are ideal for this study because they have an identical sevenstrand beta-sandwich structure, but they vary widely in sequence and thermodynamic stability. We assayed thermodynamic stability of each domain by equilibrium denaturation in urea. We then assayed the kinetics of domain opening and closing by a technique known as thiol exchange. For this we introduced a buried Cys at the identical location in each FNIII domain and measured the kinetics of labeling with DTNB over a range of urea concentrations. A global fit of the kinetics data gave the kinetics of spontaneous unfolding and refolding in zero urea. We found that the folding rates were relatively similar, similar to 0.1-1 s(- 1), for the different domains. The unfolding rates varied widely and correlated with thermodynamic stability. Our study is the first to address this question using a set of domains that are structurally homologous but evolved with widely varying sequence identity and thermodynamic stability. These data add new evidence that thermodynamic stability correlates primarily with unfolding rate rather than folding rate. The study also has implications for the question of whether opening of FNIII domains contributes to the stretching of fibronectin matrix fibrils.	[Shah, Riddhi; Erickson, Harold P.; Oas, Terrence G.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Ohashi, Tomoo; Erickson, Harold P.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	Duke University; Duke University	Erickson, HP (corresponding author), Duke Univ, Dept Cell Biol, 412 Nanaline Duke Bldg, Durham, NC 27710 USA.; Erickson, HP; Oas, TG (corresponding author), Duke Univ, Dept Biochem, 412 Nanaline Duke Bldg, Durham, NC 27710 USA.	h.erickson@cellbio.duke.edu; oas@duke.edu			National Institutes of Health [CA 47056]; NATIONAL CANCER INSTITUTE [R01CA047056, R37CA047056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM118809] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant CA 47056 (to H. P. E.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AUKHIL I, 1993, J BIOL CHEM, V268, P2542; BALLERY N, 1993, BIOCHEMISTRY-US, V32, P708, DOI 10.1021/bi00053a040; BALLERY N, 1990, PROTEIN ENG, V3, P199, DOI 10.1093/protein/3.3.199; Broom A, 2015, PROTEIN SCI, V24, P580, DOI 10.1002/pro.2606; Clarke J, 1999, STRUCT FOLD DES, V7, P1145, DOI 10.1016/S0969-2126(99)80181-6; Clarke J, 1997, J MOL BIOL, V270, P771, DOI 10.1006/jmbi.1997.1147; Cota E, 2000, J MOL BIOL, V302, P713, DOI 10.1006/jmbi.2000.4053; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; ENGLANDER SW, 1983, Q REV BIOPHYS, V16, P521, DOI 10.1017/S0033583500005217; Erickson HP, 2013, ADIPOCYTE, V2, P289, DOI 10.4161/adip.26082; ERICKSON HP, 1994, P NATL ACAD SCI USA, V91, P10114, DOI 10.1073/pnas.91.21.10114; ERICKSON HP, 1983, J BIOL CHEM, V258, P4539; Erickson HP, 2002, J MUSCLE RES CELL M, V23, P575, DOI 10.1023/A:1023427026818; Feng ZY, 2001, J MOL BIOL, V314, P153, DOI 10.1006/jmbi.2001.5117; Gualfetti PJ, 1999, PROTEIN SCI, V8, P1623, DOI 10.1110/ps.8.8.1623; Jackson SE, 1998, FOLD DES, V3, pR81, DOI 10.1016/S1359-0278(98)00033-9; Jensen KS, 2014, BIOCHEMISTRY-US, V53, P2533, DOI 10.1021/bi4016633; Johnson CP, 2007, SCIENCE, V317, P663, DOI 10.1126/science.1139857; Johnson KJ, 1999, J BIOL CHEM, V274, P15473, DOI 10.1074/jbc.274.22.15473; Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8; Lemmon CA, 2011, J BIOL CHEM, V286, P26375, DOI 10.1074/jbc.M111.240028; Malhotra P, 2014, BIOCHEMISTRY-US, V53, P3608, DOI 10.1021/bi401493t; Maurer LM, 2016, CRIT REV BIOCHEM MOL, V51, P213, DOI 10.1080/10409238.2016.1184224; Oberhauser AF, 2002, J MOL BIOL, V319, P433, DOI 10.1016/S0022-2836(02)00306-6; Oberhauser AF, 1998, NATURE, V393, P181, DOI 10.1038/30270; Ohashi T, 1999, P NATL ACAD SCI USA, V96, P2153, DOI 10.1073/pnas.96.5.2153; Plaxco KW, 1997, J MOL BIOL, V270, P763, DOI 10.1006/jmbi.1997.1148; Plaxco KW, 1998, J MOL BIOL, V277, P985, DOI 10.1006/jmbi.1998.1645; Pogliani L, 1996, J MATH CHEM, V20, P193, DOI 10.1007/BF01165164; Schumacher MA, 2013, J BIOL CHEM, V288, P33738, DOI 10.1074/jbc.M113.516641; Sharma A, 1999, EMBO J, V18, P1468, DOI 10.1093/emboj/18.6.1468; Sivakumar P, 2006, J CELL SCI, V119, P1350, DOI 10.1242/jcs.02830; SKORSTENGAARD K, 1986, EUR J BIOCHEM, V161, P441, DOI 10.1111/j.1432-1033.1986.tb10464.x; Smith ML, 2007, PLOS BIOL, V5, P2243, DOI 10.1371/journal.pbio.0050268; SNYDER GH, 1981, BIOCHEMISTRY-US, V20, P6509, DOI 10.1021/bi00526a001; SOTERIOU A, 1993, P ROY SOC B-BIOL SCI, V254, P83, DOI 10.1098/rspb.1993.0130; Sridevi K, 2002, BIOCHEMISTRY-US, V41, P1568, DOI 10.1021/bi011494v; Stine JM, 2015, BIOCHEMISTRY-US, V54, P6724, DOI 10.1021/acs.biochem.5b00818; Vakonakis I, 2007, EMBO J, V26, P2575, DOI 10.1038/sj.emboj.7601694; Walters J, 2009, METHOD ENZYMOL, V455, P1, DOI 10.1016/S0076-6879(08)04201-8	40	8	8	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2017	292	3					955	966		10.1074/jbc.M116.760371	http://dx.doi.org/10.1074/jbc.M116.760371			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2LL	27909052	Green Published, hybrid			2022-12-26	WOS:000392318700017
J	Yan, ZC; Fang, Q; Liu, Y; Xiao, S; Yang, L; Wang, F; An, CJ; Werren, JH; Ye, GY				Yan, Zhichao; Fang, Qi; Liu, Yang; Xiao, Shan; Yang, Lei; Wang, Fei; An, Chunju; Werren, John H.; Ye, Gongyin			A Venom Serpin Splicing Isoform of the Endoparasitoid Wasp Pteromalus puparum Suppresses Host Prophenoloxidase Cascade by Forming Complexes with Host Hemolymph Proteinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANDUCA-SEXTA HEMOLYMPH; CELLULAR IMMUNE-RESPONSES; PIERIS-RAPAE LEPIDOPTERA; PARASITOID-WASP; ACTIVATING PROTEINASE; OSTRINIA-FURNACALIS; SERINE PROTEASES; INSECT IMMUNITY; INNATE IMMUNITY; DROSOPHILA	To ensure successful parasitism, parasitoid wasps inject venom along with their eggs into their hosts. The venom serves to suppress host immune responses, including melanization. Venom from Pteromalus puparum, a pupal endoparasitoid, inhibits melanization of host hemolymph in vitro in a dose- dependent manner. Using assay- guided fractionation, a serpin splicing isoform with phenoloxidase inhibitory activity was identified as P. puparum serpin- 1, venom isoform (PpS1V). This serpin gene has 16 predicted splicing isoforms that differ only in the C- terminal region. RT- PCR results show that the specific serpin isoform is differentially expressed in the venom gland. Recombinant PpS1V (rPpS1V) suppresses host prophenoloxidase (PPO) activation rather than inhibiting the phenoloxidase directly. Pulldown assays show that PpS1V forms complexes with two host hemolymph proteins, here named Pieris rapae hemolymph proteinase 8 (PrHP8) and P. rapae prophenoloxidase- activating proteinase 1 (PrPAP1), based on gene sequence blasting and phylogenetic analysis. The role of rPrPAP1 in the PPO activation cascade and its interaction with rPpS1V were confirmed. The stoichiometry of inhibition of PrPAP1 by PpS1V is 2.3. PpS1V also inhibits PPO activation in a non- natural host, Ostrinia furnacalis, through forming a complex with O. furnacalis serine protease 13 (OfSP13), an ortholog to PrPAP1. Our results identify a venom- enriched serpin isoform in P. puparum that inhibits host PPO activation, probably by forming a complex with host hemolymph proteinase PrPAP1.	[Yan, Zhichao; Fang, Qi; Liu, Yang; Xiao, Shan; Yang, Lei; Wang, Fei; Ye, Gongyin] Zhejiang Univ, State Key Lab Rice Biol, Hangzhou 310058, Zhejiang, Peoples R China; [Yan, Zhichao; Fang, Qi; Liu, Yang; Xiao, Shan; Yang, Lei; Wang, Fei; Ye, Gongyin] Zhejiang Univ, Minist Agr, Key Lab Agr Entomol, Inst Insect Sci, Hangzhou 310058, Zhejiang, Peoples R China; [An, Chunju] China Agr Univ, Coll Agr & Biotechnol, Dept Entomol, Beijing 100193, Peoples R China; [Werren, John H.] Univ Rochester, Dept Biol, Rochester, NY 14627 USA	Zhejiang University; Ministry of Agriculture & Rural Affairs; Zhejiang University; China Agricultural University; University of Rochester	Ye, GY (corresponding author), Zhejiang Univ, Inst Insect Sci, C1152 Agrobio Complex, Hangzhou 310058, Zhejiang, Peoples R China.	chu@zju.edu.cn	yang, liu/GVU-8760-2022; wei, jiang/GRX-7907-2022	Yan, Zhichao/0000-0001-9140-2926	National Natural Science Foundation of China [31272098, 31472038]; Major International (Regional) Joint Research Project of National Natural Science Foundation [31620103915]; China National Science Fund for Distinguished Young Scholars [31025021]; National Institutes of Health [RO1GM098667]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098667] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major International (Regional) Joint Research Project of National Natural Science Foundation; China National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Natural Science Foundation of China Grants 31272098 and 31472038, Major International (Regional) Joint Research Project of National Natural Science Foundation Grant 31620103915, and China National Science Fund for Distinguished Young Scholars Grant 31025021 and by National Institutes of Health Grant RO1GM098667(to J. H. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	An CJ, 2011, DEV COMP IMMUNOL, V35, P135, DOI 10.1016/j.dci.2010.09.004; An CJ, 2009, J BIOL CHEM, V284, P19716, DOI 10.1074/jbc.M109.007112; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Asgari S, 2006, ARCH INSECT BIOCHEM, V61, P146, DOI 10.1002/arch.20109; Asgari S, 2003, INSECT BIOCHEM MOLEC, V33, P1017, DOI 10.1016/S0965-1748(03)00116-4; Asgari S, 2003, ARCH INSECT BIOCHEM, V53, P92, DOI 10.1002/arch.10088; Asgari S, 2011, ANNU REV ENTOMOL, V56, P313, DOI 10.1146/annurev-ento-120709-144849; Bangham J, 2006, IMMUNITY, V25, P1, DOI 10.1016/j.immuni.2006.07.002; Beck MH, 2007, P NATL ACAD SCI USA, V104, P19267, DOI 10.1073/pnas.0708056104; Benarafa C, 2005, P NATL ACAD SCI USA, V102, P11367, DOI 10.1073/pnas.0502934102; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burke GR, 2014, MOL ECOL, V23, P890, DOI 10.1111/mec.12648; Cai J, 2004, J INSECT PHYSIOL, V50, P315, DOI 10.1016/j.jinsphys.2004.01.007; Carton Y, 2008, INSECT SCI, V15, P67, DOI 10.1111/j.1744-7917.2008.00188.x; Celli J, 2002, TRENDS MICROBIOL, V10, P232, DOI 10.1016/S0966-842X(02)02343-0; Chu Y, 2015, J INVERTEBR PATHOL, V128, P64, DOI 10.1016/j.jip.2015.02.010; Chu Y, 2015, INSECT BIOCHEM MOLEC, V61, P53, DOI 10.1016/j.ibmb.2015.03.007; Colinet D, 2009, DEV COMP IMMUNOL, V33, P681, DOI 10.1016/j.dci.2008.11.013; Colinet D, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-342; Colinet D, 2011, J BIOL CHEM, V286, P40110, DOI 10.1074/jbc.M111.288845; Dillman AR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002527; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Fang Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026888; Fang Q, 2011, INSECT BIOCHEM MOLEC, V41, P852, DOI 10.1016/j.ibmb.2011.07.001; Fang Q, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-484; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Gillespie JP, 1997, ANNU REV ENTOMOL, V42, P611, DOI 10.1146/annurev.ento.42.1.611; Goecks J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064125; Gubb D, 2010, BIOCHIMIE, V92, P1749, DOI 10.1016/j.biochi.2010.09.004; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gulley MM, 2013, J INSECT PHYSIOL, V59, P138, DOI 10.1016/j.jinsphys.2012.08.015; Heraty John, 2009, P445, DOI 10.1002/9781444308211.ch19; Jang IH, 2006, DEV CELL, V10, P45, DOI 10.1016/j.devcel.2005.11.013; Jiang HB, 2003, INSECT BIOCHEM MOLEC, V33, P1049, DOI 10.1016/S0965-1748(03)00123-1; Jiang HB, 2003, J BIOL CHEM, V278, P3552, DOI 10.1074/jbc.M205743200; Jiang HB, 1996, J BIOL CHEM, V271, P28017, DOI 10.1074/jbc.271.45.28017; Jiang HB, 1997, J BIOL CHEM, V272, P1082, DOI 10.1074/jbc.272.2.1082; Jiang HB, 1998, P NATL ACAD SCI USA, V95, P12220, DOI 10.1073/pnas.95.21.12220; Kanost MR, 2015, CURR OPIN INSECT SCI, V11, P47, DOI 10.1016/j.cois.2015.09.003; Kanost MR, 1997, ADV EXP MED BIOL, V425, P155; Kanost MR, 1999, DEV COMP IMMUNOL, V23, P291, DOI 10.1016/S0145-305X(99)00012-9; Kapustin Y, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-20; Law RHP, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-216; Lee SY, 1998, EUR J BIOCHEM, V257, P615, DOI 10.1046/j.1432-1327.1998.2570615.x; Liu Yu-Qiang, 2014, J Anal Methods Chem, V2014, P617367, DOI 10.1155/2014/617367; Lu Z, 2008, J BIOL CHEM, V283, P21325, DOI 10.1074/jbc.M801593200; Lu ZQ, 2010, INSECT BIOCHEM MOLEC, V40, P497, DOI 10.1016/j.ibmb.2010.04.009; Marshall OJ, 2004, BIOINFORMATICS, V20, P2471, DOI 10.1093/bioinformatics/bth254; Martinson EO, 2016, MOL BIOL EVOL, V33, P1042, DOI 10.1093/molbev/msv348; Mortimer NT, 2013, P NATL ACAD SCI USA, V110, P9427, DOI 10.1073/pnas.1222351110; Mrinalini A., 2016, EVOLUTION VENOMOUS A, P1, DOI [DOI 10.1007/978-94-007-6727-0_2-2, 10.1007/978-94-007-6727-0_2-2]; Nappi A, 2009, ADV PARASIT, V70, P99, DOI 10.1016/S0065-308X(09)70004-1; Nappi AJ, 2005, J INSECT PHYSIOL, V51, P197, DOI 10.1016/j.jinsphys.2004.10.013; Nielsen-LeRoux C, 2012, CURR OPIN MICROBIOL, V15, P220, DOI 10.1016/j.mib.2012.04.006; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Poirie M, 2009, CR BIOL, V332, P311, DOI 10.1016/j.crvi.2008.09.004; Ragan EJ, 2010, J BIOL CHEM, V285, P29642, DOI 10.1074/jbc.M110.125419; Satoh D, 1999, J BIOL CHEM, V274, P7441, DOI 10.1074/jbc.274.11.7441; Schmidt O, 2001, BIOESSAYS, V23, P344, DOI 10.1002/bies.1049; Siigur E, 2001, GENE, V263, P199, DOI 10.1016/S0378-1119(00)00571-0; Soderhall I, 2009, J BIOL CHEM, V284, P6301, DOI 10.1074/jbc.M806764200; Suwanchaichinda C, 2009, GENE, V442, P47, DOI 10.1016/j.gene.2009.04.013; Takahashi D, 2015, P NATL ACAD SCI USA, V112, P13856, DOI 10.1073/pnas.1517236112; Tang QY, 2013, INSECT SCI, V20, P254, DOI 10.1111/j.1744-7917.2012.01519.x; Vaiyapuri S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021532; Vavricka CJ, 2010, PROTEIN CELL, V1, P830, DOI 10.1007/s13238-010-0109-8; Whisstock JC, 2006, CURR OPIN STRUC BIOL, V16, P761, DOI 10.1016/j.sbi.2006.10.005; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Wong ESW, 2012, GENE, V496, P1, DOI 10.1016/j.gene.2012.01.009; Yan ZC, 2016, SCI REP-UK, V6, DOI 10.1038/srep19604; Zhang GM, 2004, INSECT BIOCHEM MOLEC, V34, P477, DOI 10.1016/j.ibmb.2004.02.009; Zhang Z, 2005, TOXICON, V46, P337, DOI 10.1016/j.toxicon.2005.05.005; Zheng YP, 2009, COMP BIOCHEM PHYS B, V154, P165, DOI 10.1016/j.cbpb.2009.05.016; Zhu JY, 2008, MICRON, V39, P926, DOI 10.1016/j.micron.2007.11.005; Zhu JY, 2009, ARCH INSECT BIOCHEM, V71, P45, DOI 10.1002/arch.20304; Zhu Y, 2015, ARCH INSECT BIOCHEM, V90, P140, DOI 10.1002/arch.21250; Zou Z, 2009, GENOMICS, V93, P367, DOI 10.1016/j.ygeno.2008.12.010	79	29	36	5	57	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2017	292	3					1038	1051		10.1074/jbc.M116.739565	http://dx.doi.org/10.1074/jbc.M116.739565			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2LL	27913622	Green Published, hybrid			2022-12-26	WOS:000392318700023
J	Chen, YM; Fang, YT; Lai, CH; Rau, KM; Huang, CH; Chang, HC; Chao, TY; Tseng, CC; Fang, WF; Wang, CC; Chen, YC; Chung, YH; Wang, YH; Su, MC; Liu, SF; Huang, KT; Chen, HC; Chang, YC; Chang, YP; Lin, MC				Chen, Yu-Mu; Fang, Ying-Tang; Lai, Chien-Hao; Rau, Kun-Ming; Huang, Cheng-Hua; Chang, Huang-Chih; Chao, Tung-Ying; Tseng, Chia-Cheng; Fang, Wen-Feng; Wang, Chin-Chou; Chen, Yung-Che; Chung, Yu-Hsiu; Wang, Yi-Hsi; Su, Mao-Chang; Liu, Shih-Feng; Huang, Kuo-Tung; Chen, Hung-Chen; Chang, Ya-Chun; Chang, Yu-Ping; Lin, Meng-Chih			A Survival Scoring System for Non-Small Cell Lung Cancer Patients with De Novo Bone Metastases	PLOS ONE			English	Article							FACTOR RECEPTOR MUTATIONS; PHASE-III; TUMOR BURDEN; GEFITINIB; 1ST-LINE; ADENOCARCINOMA; CHEMOTHERAPY; PATHOPHYSIOLOGY; EPIDEMIOLOGY; HISTOLOGY	In the pre-tyrosine kinase inhibitors (TKIs) era, non-small cell lung cancer (NSCLC) patients with de novo bone metastases had a worse prognosis than those without. However, whether epidermal growth factor receptor (EGFR)-TKIs affect the outcomes of EGFR mutant NSCLC patients with de novo bone metastases has not been well studied thus far. We retrospectively studied the effect of EGFR mutation status and first-line EGFR-TKIs on patient outcomes and created a survival scoring system for NSCLC patients with de novo bone metastases. This retrospective study evaluated 1510 NSCLC patients diagnosed between November 2010 and March 2014. Among these patients, 234 patients had de novo bone metastases. We found that 121 of these 234 patients (51.7%) had positive EGFR mutation tests, and a positive EGFR mutation test significantly affected overall survival (OS) (EGFR mutant: 15.2 months, EGFR wild type: 6.5 months; p < 0.001). Other prognostic factors significant in the multivariable analysis for NSCLC with de novo bone metastases included Eastern Cooperative Oncology Group performance status (PS) (OS; PS 0-2: 11.2 months, PS 3-4: 4.9 months; p = 0.002), presence of extraosseous metastases (OS; with extraosseous metastases: 8.8 months, without extraosseous metastases: 14.0 months; p = 0.008), blood lymphocyte-to-monocyte ratio (LMR) (OS; LMR > 3.1: 17.1months, LMR <= 3.1: 6.9months; p < 0.001). A positive EGFR mutation status reversed the poor outcomes of NSCLC patients with de novo bone metastases. A simple and useful survival scoring system including the above clinical parameters was thus created for NSCLC patients with de novo bone metastases.	[Chen, Yu-Mu; Fang, Ying-Tang; Lai, Chien-Hao; Chang, Huang-Chih; Chao, Tung-Ying; Tseng, Chia-Cheng; Fang, Wen-Feng; Wang, Chin-Chou; Chen, Yung-Che; Chung, Yu-Hsiu; Wang, Yi-Hsi; Su, Mao-Chang; Liu, Shih-Feng; Huang, Kuo-Tung; Chen, Hung-Chen; Chang, Ya-Chun; Chang, Yu-Ping; Lin, Meng-Chih] Chang Gung Univ, Coll Med, Div Pulm & Crit Care Med, Dept Internal Med,Chang Gung Mem Hosp,Kaohsiung M, Kaohsiung, Taiwan; [Rau, Kun-Ming; Huang, Cheng-Hua] Kaohsiung Chang Gung Mem Hosp, Div Hematol Oncol, Dept Internal Med, Kaohsiung, Taiwan; [Rau, Kun-Ming; Huang, Cheng-Hua] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Fang, Wen-Feng; Wang, Chin-Chou] Chang Gung Univ Sci & Technol, Dept Resp Care, Chiayi Campus, Chiayi, Taiwan; [Chen, Yung-Che] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University of Science & Technology; Chang Gung University	Lin, MC (corresponding author), Chang Gung Univ, Coll Med, Div Pulm & Crit Care Med, Dept Internal Med,Chang Gung Mem Hosp,Kaohsiung M, Kaohsiung, Taiwan.	linmengchih@hotmail.com	Fang, Wen-Feng/AAT-6296-2021; Chen, Yung-Che/AAL-5167-2020	Fang, Wen-Feng/0000-0003-0350-9059; Chen, Yung-Che/0000-0001-8695-5227; Liu, Shih-Feng/0000-0003-1394-5401; chen, hong cheng/0000-0001-9713-3835				Cha YK, 2015, CLIN LUNG CANCER, V16, P228, DOI 10.1016/j.cllc.2014.11.002; Charloux A, 1997, INT J EPIDEMIOL, V26, P14, DOI 10.1093/ije/26.1.14; Chen G, 2013, ANN ONCOL, V24, P1615, DOI 10.1093/annonc/mdt012; Chen YM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149722; Chen YM, 2016, LUNG CANCER, V93, P47, DOI 10.1016/j.lungcan.2016.01.001; Chen YM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136252; Coleman RE, 2001, CANCER TREAT REV, V27, P165, DOI 10.1053/ctrv.2000.0210; Coleman RE, 1997, CANCER, V80, P1588, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1588::AID-CNCR9>3.0.CO;2-G; Dahlberg SE, 2013, J THORAC ONCOL, V8, P1121, DOI 10.1097/JTO.0b013e31829cf942; Decroisette C, 2011, J THORAC ONCOL, V6, P576, DOI 10.1097/JTO.0b013e318206a1e3; Oliveira MBD, 2016, LUNG CANCER, V96, P19, DOI 10.1016/j.lungcan.2016.03.014; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Hansen BH, 2004, ACTA ORTHOP SCAND, V75, P11, DOI 10.1080/00016470410001708270; Henley SJ, 2014, MMWR-MORBID MORTAL W, V63, P1; Horiike A, 2007, CHEST, V131, P1628, DOI 10.1378/chest.06-1673; Hu PP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108062; Inoue A, 2009, J CLIN ONCOL, V27, P1394, DOI 10.1200/JCO.2008.18.7658; Janssen-Heijnen MLG, 2003, LUNG CANCER-J IASLC, V41, P245, DOI 10.1016/S0169-5002(03)00230-7; Kakhki VRD, 2013, NUCL MED REV, V16, P66, DOI 10.5603/NMR.2013.0037; Kosaka T, 2004, CANCER RES, V64, P8919, DOI 10.1158/0008-5472.CAN-04-2818; Kosteva J, 2008, CURR OPIN ONCOL, V20, P155, DOI 10.1097/CCO.0b013e3282f54cf2; Kuo CW, 2000, CHEST, V117, P354, DOI 10.1378/chest.117.2.354; Langer C, 2004, SEMIN ONCOL, V31, P8, DOI 10.1053/j.seminoncol.2004.10.002; Li JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054839; Lie CH, 2011, CLIN LUNG CANCER, V12, P116, DOI 10.1016/j.cllc.2011.03.006; LIN B, 2015, LEUKEMIA LYMPHOMA, V3, P1, DOI DOI 10.3389/FBI0E.2015.00039; Lin GN, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0070-0; Mercadante S, 1997, PAIN, V69, P1, DOI 10.1016/S0304-3959(96)03267-8; Ni XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111886; NOTTEBAERT M, 1989, INT ORTHOP, V13, P119, DOI 10.1007/BF00266372; Oshita F, 1991, Nihon Kyobu Shikkan Gakkai Zasshi, V29, P231; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Park JH, 2013, CLIN LUNG CANCER, V14, P383, DOI 10.1016/j.cllc.2012.10.007; Porrata LF, 2012, LEUKEMIA LYMPHOMA, V53, P2159, DOI 10.3109/10428194.2012.690605; Quraishi NA, 2013, EUR SPINE J, V22, pS27, DOI 10.1007/s00586-012-2648-6; Rades D, 2014, CLIN NEUROL NEUROSUR, V118, P12, DOI 10.1016/j.clineuro.2013.12.007; Sugiura H, 2008, CLIN ORTHOP RELAT R, V466, P729, DOI 10.1007/s11999-007-0051-0; Tabouret E, 2015, SPINE J, V15, P944, DOI 10.1016/j.spinee.2013.06.036; Thongprasert S, 2011, J THORAC ONCOL, V6, P1872, DOI 10.1097/JTO.0b013e31822adaf7; Tokumo M, 2005, CLIN CANCER RES, V11, P1167; Wang BY, 2013, J THORAC ONCOL, V8, P1128, DOI 10.1097/JTO.0b013e31829ceba4; Yang JCH, 2015, LANCET ONCOL, V16, P141, DOI 10.1016/S1470-2045(14)71173-8; Yang JCH, 2014, LUNG CANCER, V83, P174, DOI 10.1016/j.lungcan.2013.11.021	43	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167923	10.1371/journal.pone.0167923	http://dx.doi.org/10.1371/journal.pone.0167923			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930702	Green Published, Green Submitted, gold			2022-12-26	WOS:000389580900060
J	Chung, HJ; Lee, J; Shin, JS; Kim, MR; Koh, W; Kim, MJ; Lee, JW; Kim, EJ; Lee, IH; Kim, WK; Lee, YJ; Lee, SK; Ha, IH				Chung, Hwa-Jin; Lee, Jinho; Shin, Joon-Shik; Kim, Me-Riong; Koh, Wonil; Kim, Min-Jeong; Lee, Jae-Woong; Kim, Eun Jee; Lee, In-Hee; Kim, Won Kyung; Lee, Yoon Jae; Lee, Sang Kook; Ha, In-Hyuk			In Vitro and In Vivo Anti-Allergic and Anti-Inflammatory Effects of eBV, a Newly Developed Derivative of Bee Venom, through Modulation of IRF3 Signaling Pathway in a Carrageenan-Induced Edema Model	PLOS ONE			English	Article							KAPPA-B-ALPHA; MAST-CELLS; INDUCED INFLAMMATION; DISC HERNIATION; HONEYBEE VENOM; RBL-2H3 CELLS; RATS; LIPOPOLYSACCHARIDE; ACUPUNCTURE; RECEPTOR	Background Bee venom (BV), a type of toxin extracted from honeybees (Apis mellifera), has been empirically and widely used to treat inflammatory diseases throughout Asia. Essential BV (eBV) was developed by removing phospholipase A2 (PLA2) and histamine to lower occurrence of allergic reaction. This study investigated the anti-allergic and anti-inflammatory activities of eBV in vitro and in vivo and its underlying mechanism of action. Methods The anti-inflammatory potential of eBV was assessed in vivo using a carrageenan-induced paw edema model. To further investigate the mechanism by which eBV exerts anti-allergic and anti-inflammatory effects, compound 48/80-stimulated RBL-2H3 cells and lipopolysaccharide (LPS)-stimulated RAW 264.7 murine macrophage cells were studied in vitro. Results Release of beta-hexosaminidase and histamine was increased by eBV in a dose-dependent manner, but these levels were lower in eBV compared to original BV at the same concentration. In addition, eBV suppressed compound 48/80-induced expression of tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 beta (IL-1 beta) in RBL-2H3 cells. eBV was also shown to suppress nitric oxide (NO) production by down-regulating mRNA expression and subsequent protein expression of inflammatory mediators in LPS-induced RAW 264.7 cells. Phosphorylation of activators and signal transducers of transcription 1/interferon regulatory factor 3 (STAT1/IRF3) was attenuated by eBV treatment. eBV significantly inhibited carrageenan-induced acute edema in vivo. Serum levels of prostaglandin E2 (PGE2), TNF-alpha, and IL-1 beta were also down-regulated by eBV. Conclusions These results demonstrate that eBV inhibits allergic and inflammatory response by reducing inflammatory mediator production via regulation of the STAT1/IRF3 signaling pathway, suggesting that eBV is a feasible candidate for regulation of allergic-inflammatory response in complementary and alternative medicine.	[Chung, Hwa-Jin; Lee, Jinho; Shin, Joon-Shik; Kim, Me-Riong; Koh, Wonil; Kim, Min-Jeong; Lee, Jae-Woong; Kim, Eun Jee; Lee, In-Hee; Lee, Yoon Jae; Ha, In-Hyuk] Jaseng Med Fdn, Jaseng Spine & Joint Res Inst, Seoul, South Korea; [Kim, Won Kyung; Lee, Sang Kook] Seoul Natl Univ, Inst Nat Prod Res, Coll Pharm, Seoul, South Korea	Seoul National University (SNU)	Ha, IH (corresponding author), Jaseng Med Fdn, Jaseng Spine & Joint Res Inst, Seoul, South Korea.	hanihata@gmail.com	Lee, Yoon Jae/ABA-8808-2020	Lee, Yoon Jae/0000-0002-1532-0942; Shin, Joon-Shik/0000-0001-5488-3273; Lee, Sang Kook/0000-0002-4306-7024; HA, IN-HYUK/0000-0002-5020-6723; Lee, Jinho/0000-0003-0672-6892	Traditional Korean Medicine R&D Program - Ministry of Health & Welfare through the Korea Health Industry Development Institute (KHIDI) [HB16C0035]	Traditional Korean Medicine R&D Program - Ministry of Health & Welfare through the Korea Health Industry Development Institute (KHIDI)	Drs. In-Hyuk Ha and Yoon Jae Lee were supported by the Traditional Korean Medicine R&D Program funded by the Ministry of Health & Welfare (http://www.mohw.go.kr/eng/index.jsp) through the Korea Health Industry Development Institute (KHIDI) (HB16C0035). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Amin MA, 2014, ARCH PHARM RES, V37, P1016, DOI 10.1007/s12272-013-0308-y; BEG AA, 1993, MOL CELL BIOL, V13, P3301, DOI 10.1128/MCB.13.6.3301; Bellanti JA, 1998, ALLERGY ASTHMA P; Blank S, 2011, PROTEIN PEPTIDE LETT, V18, P415, DOI 10.2174/092986611794653923; Careau E, 2002, AM J RESP CELL MOL, V26, P579, DOI 10.1165/ajrcmb.26.5.4737; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Curcio-Vonlanthen V, 1997, J PEPT SCI, V3, P267; DAINAKA J, 1986, BIOCHEM PHARMACOL, V35, P3739, DOI 10.1016/0006-2952(86)90659-3; Ferrero-Miliani L, 2007, CLIN EXP IMMUNOL, V147, P227, DOI 10.1111/j.1365-2249.2006.03261.x; Rached ICFS, 2010, J ETHNOPHARMACOL, V130, P175, DOI 10.1016/j.jep.2010.04.015; Fujihara M, 2003, PHARMACOL THERAPEUT, V100, P171, DOI 10.1016/j.pharmthera.2003.08.003; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; Gilchrist M, 2002, J LEUKOCYTE BIOL, V71, P618; GOLDEN DBK, 1989, JAMA-J AM MED ASSOC, V262, P240, DOI 10.1001/jama.262.2.240; Gu SM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0344-2; HABERMAN.E, 1972, SCIENCE, V177, P314, DOI 10.1126/science.177.4046.314; Han SM, 2015, CLIN INTERV AGING, V10, DOI 10.2147/CIA.S84940; HARTMAN DA, 1991, AGENTS ACTIONS, V34, P84, DOI 10.1007/BF01993245; Helbling A, 2004, CLIN EXP ALLERGY, V34, P285, DOI 10.1111/j.1365-2222.2004.01882.x; Heo Y, 2015, EVIDENCE BASED COMPL, V2015; HIDER RC, 1988, ENDEAVOUR, V12, P60, DOI 10.1016/0160-9327(88)90082-8; Kim HW, 2003, J VET MED SCI, V65, P349, DOI 10.1292/jvms.65.349; Kim JY, 2015, INT J MOL MED, V35, P1651, DOI 10.3892/ijmm.2015.2180; Kim MR, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003635; Kwon YB, 2001, AM J CHINESE MED, V29, P187, DOI 10.1142/S0192415X01000228; Lee H, 2015, TOX RESEARCH, V31, P33, DOI 10.5487/TR.2015.31.1.033; Lee JH, 2001, J VET MED SCI, V63, P251, DOI 10.1292/jvms.63.251; Lee JA, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006140; Lee MJ, 2016, MOL NEUROBIOL, V53, P1977, DOI 10.1007/s12035-015-9131-4; Lee SH, 2012, J PHARMACOPUNCT, V15, P7, DOI 10.3831/KPI.2012.15.011; Lee SH, 2015, TOXINS, V7, P2835, DOI 10.3390/toxins7082835; Lee WR, 2015, TOXINS, V7, P4758, DOI 10.3390/toxins7114758; Lee WR, 2014, EUR J PHARMACOL, V740, P218, DOI 10.1016/j.ejphar.2014.06.058; Lee WR, 2010, AM J CHINESE MED, V38, P1077, DOI 10.1142/S0192415X10008482; LEME JG, 1973, BRIT J PHARMACOL, V48, P88, DOI 10.1111/j.1476-5381.1973.tb08225.x; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; MARQUARDT DL, 1983, J IMMUNOL, V131, P934; Mastuda H, 2002, BIOORGAN MED CHEM, V10, P3123, DOI 10.1016/S0968-0896(02)00227-4; Moon KY, 2001, ANAL BIOCHEM, V292, P17, DOI 10.1006/abio.2001.5059; Morris Christopher J, 2003, Methods Mol Biol, V225, P115; Nambu Aya, 2010, Allergology International, V59, P125, DOI 10.2332/allergolint.10-RAI-0190; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; Patel RP, 1999, BBA-BIOENERGETICS, V1411, P385, DOI 10.1016/S0005-2728(99)00028-6; Ryu JS, 2014, ARCH PHARM RES, V37, P239, DOI 10.1007/s12272-013-0208-1; Samy RP, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-100; Seo BK, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-132; Seo BK, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-16; Shacter E, 2002, ONCOLOGY-NY, V16, P217; Shakoory B, 2004, J INTERF CYTOK RES, V24, P271, DOI 10.1089/107999004323065057; Shin JS, 2016, SPINE, V41, pE955, DOI 10.1097/BRS.0000000000001494; Shin JS, 2016, J ALTERN COMPLEM MED, V22, P533, DOI 10.1089/acm.2014.0368; Stankiewicz W, 2002, MEDIAT INFLAMM, V11, P307, DOI 10.1080/09629350210000015719; Strayhorn WD, 2002, ARCH BIOCHEM BIOPHYS, V400, P76, DOI 10.1006/abbi.2002.2760; Tuppo EE, 2005, INT J BIOCHEM CELL B, V37, P289, DOI 10.1016/j.biocel.2004.07.009	56	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0168120	10.1371/journal.pone.0168120	http://dx.doi.org/10.1371/journal.pone.0168120			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930719	gold, Green Submitted, Green Published			2022-12-26	WOS:000389580900082
J	He, KY; Zhao, YQ; McPherson, EW; Li, Q; Xia, F; Weng, CH; Wang, K; He, MM				He, Karen Y.; Zhao, Yiqing; McPherson, Elizabeth W.; Li, Quan; Xia, Fan; Weng, Chunhua; Wang, Kai; He, Max M.			Pathogenic Mutations in Cancer-Predisposing Genes: A Survey of 300 Patients with Whole-Genome Sequencing and Lifetime Electronic Health Records	PLOS ONE			English	Article							P53 GENE; NF1 GENE; GERMLINE MUTATIONS; ADENOMATOUS POLYPOSIS; INCIDENTAL FINDINGS; MEDICAL GENETICS; AMERICAN-COLLEGE; PROSTATE-CANCER; BREAST; BRCA1	Background It is unclear whether and how whole-genome sequencing (WGS) data can be used to implement genomic medicine. Our objective is to retrospectively evaluate whether WGS can facilitate improving prevention and care for patients with susceptibility to cancer syndromes. Methods and Findings We analyzed genetic mutations in 60 autosomal dominant cancer-predisposition genes in 300 deceased patients with WGS data and nearly complete long-term (over 30 years) medical records. To infer biological insights from massive amounts of WGS data and comprehensive clinical data in a short period of time, we developed an in-house analysis pipeline within the SeqHBase software framework to quickly identify pathogenic or likely pathogenic variants. The clinical data of the patients who carried pathogenic and/or likely pathogenic variants were further reviewed to assess their clinical conditions using their lifetime EHRs. Among the 300 participants, 5 (1.7%) carried pathogenic or likely pathogenic variants in 5 cancer-predisposing genes: one in APC, BRCA1, BRCA2, NF1, and TP53 each. When assessing the clinical data, each of the 5 patients had one or more different types of cancers, fully consistent with their genetic profiles. Among these 5 patients, 2 died due to cancer while the others had multiple disorders later in their lifetimes; however, they may have benefited from early diagnosis and treatment for healthier lives, had the patients had genetic testing in their earlier lifetimes. Conclusions We demonstrated a case study where the discovery of pathogenic or likely pathogenic germline mutations from population-wide WGS correlates with clinical outcome. The use of WGS may have clinical impacts to improve healthcare delivery.	[He, Karen Y.] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Zhao, Yiqing; McPherson, Elizabeth W.; He, Max M.] Marshfield Clin Res Fdn, Ctr Human Genet, Marshfield, WI 54449 USA; [Li, Quan; Wang, Kai] Univ Southern Calif, Zilkha Neurogenet Inst, Los Angeles, CA 90007 USA; [Xia, Fan] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Weng, Chunhua; Wang, Kai] Columbia Univ, Dept Biomed Informat, Med Ctr, New York, NY 10027 USA; [Wang, Kai] Columbia Univ, Inst Genom Med, Med Ctr, New York, NY 10027 USA; [He, Max M.] Marshfield Clin Res Fdn, Biomed Informat Res Ctr, Marshfield, WI 54449 USA; [He, Max M.] Univ Wisconsin Madison, Computat & Informat Biol & Med, Madison, WI 53706 USA	Case Western Reserve University; University of Southern California; Baylor College of Medicine; Columbia University; Columbia University; University of Wisconsin System; University of Wisconsin Madison	He, MM (corresponding author), Marshfield Clin Res Fdn, Ctr Human Genet, Marshfield, WI 54449 USA.; Wang, K (corresponding author), Univ Southern Calif, Zilkha Neurogenet Inst, Los Angeles, CA 90007 USA.; Wang, K (corresponding author), Columbia Univ, Dept Biomed Informat, Med Ctr, New York, NY 10027 USA.; Wang, K (corresponding author), Columbia Univ, Inst Genom Med, Med Ctr, New York, NY 10027 USA.; He, MM (corresponding author), Marshfield Clin Res Fdn, Biomed Informat Res Ctr, Marshfield, WI 54449 USA.; He, MM (corresponding author), Univ Wisconsin Madison, Computat & Informat Biol & Med, Madison, WI 53706 USA.	kw2701@cumc.columbia.edu; he.max@mcrf.mfldclin.edu	Li, Quan/B-3605-2009; Zhao, Yiqing/AEL-5533-2022	Zhao, Yiqing/0000-0003-2874-8136	National Institutes of Health [HL007567, HG006465, UL1TR000427]; Marshfield Clinic Research Foundation (MCRF); Summer Student Research Internship Program (SSRIP) at MCRF; Summer Student Research Internship Program (SSRIP) at Marshfield Clinic Research Foundation (MCRF); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007567] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG008680] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marshfield Clinic Research Foundation (MCRF); Summer Student Research Internship Program (SSRIP) at MCRF; Summer Student Research Internship Program (SSRIP) at Marshfield Clinic Research Foundation (MCRF); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by the National Institutes of Health [HL007567 to K.Y.H., HG006465 to K.W., UL1TR000427 to M.M.H.]; the Marshfield Clinic Research Foundation (MCRF) to M.M.H.; and the Summer Student Research Internship Program (SSRIP) at MCRF to Y.Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Y.Z. would like to thank the Summer Student Research Internship Program (SSRIP) at Marshfield Clinic Research Foundation (MCRF) for financial support. The authors would like to thank the staff in the Biomedical Informatics Research Center at MCRF for collecting genomic and clinical data, and providing computing infrastructure support as well.	Al-Sukhni W, 2008, HUM GENET, V124, P271, DOI 10.1007/s00439-008-0554-0; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Amendola LM, 2015, GENOME RES, V25, P305, DOI 10.1101/gr.183483.114; Anderson TI, 1996, AM J HUM GENET, V59, P486; Aoki K, 2007, J CELL SCI, V120, P3327, DOI 10.1242/jcs.03485; BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; Baralle D, 2003, AM J MED GENET A, V119A, P1, DOI 10.1002/ajmg.a.20023; Belkadi A, 2015, P NATL ACAD SCI USA, V112, P5473, DOI 10.1073/pnas.1418631112; Biesecker LG, 2016, JAMA-J AM MED ASSOC, V315, P2467, DOI 10.1001/jama.2016.2918; Brunham LR, 2013, HUM GENET, V132, P603, DOI 10.1007/s00439-013-1286-3; Carter TC, 2016, J HEALTHC ENG, V2016, DOI 10.1155/2016/3617572; CHEN PL, 1990, SCIENCE, V250, P1576, DOI 10.1126/science.2274789; Chen Y, 2013, EUR J HUM GENET, V21, P929, DOI 10.1038/ejhg.2012.281; Colaluca IN, 2008, NATURE, V451, P76, DOI 10.1038/nature06412; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Edwards SM, 2003, AM J HUM GENET, V72, P1, DOI 10.1086/345310; Friedenson B, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-152; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Gayther SA, 1997, NAT GENET, V15, P103, DOI 10.1038/ng0197-103; Giardiello FM, 2002, NEW ENGL J MED, V346, P1054, DOI 10.1056/NEJMoa012015; Gottesman O, 2013, GENET MED, V15, P761, DOI 10.1038/gim.2013.72; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Gullapalli RR, 2012, CLIN LAB MED, V32, P585, DOI 10.1016/j.cll.2012.07.005; Hampel H, 2015, GENET MED, V17, P70, DOI 10.1038/gim.2014.147; He M, 2015, J MED GENET, V52, P282, DOI 10.1136/jmedgenet-2014-102907; HSU IC, 1991, NATURE, V350, P427, DOI 10.1038/350427a0; Hu CL, 2016, CANCER EPIDEM BIOMAR, V25, P207, DOI 10.1158/1055-9965.EPI-15-0455; James CR, 2007, ONCOLOGIST, V12, P142, DOI 10.1634/theoncologist.12-2-142; Jensen RB, 2010, NATURE, V467, P678, DOI 10.1038/nature09399; JOHNSON MR, 1993, P NATL ACAD SCI USA, V90, P5539, DOI 10.1073/pnas.90.12.5539; Komiya Yuko, 2008, Organogenesis, V4, P68; Krauthammer M, 2015, NAT GENET, V47, P996, DOI 10.1038/ng.3361; KYRITSIS AP, 1994, JNCI-J NATL CANCER I, V86, P344, DOI 10.1093/jnci/86.5.344; Landrum MJ, 2016, NUCLEIC ACIDS RES, V44, pD862, DOI 10.1093/nar/gkv1222; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; McCarty CA, 2008, J GLAUCOMA, V17, P372, DOI 10.1097/IJG.0b013e31815c5f3f; McCarty CA, 2007, COMMUNITY GENET, V10, P2, DOI 10.1159/000096274; McCarty Catherine A, 2005, Per Med, V2, P49, DOI 10.1517/17410541.2.1.49; McCarty CA, 2008, AM J MED GENET A, V146A, P3026, DOI 10.1002/ajmg.a.32559; Ozcelik H, 1997, NAT GENET, V16, P17, DOI 10.1038/ng0597-17; Rehm HL, 2015, NEW ENGL J MED, V372, P2235, DOI 10.1056/NEJMsr1406261; Ribeiro RC, 2001, P NATL ACAD SCI USA, V98, P9330, DOI 10.1073/pnas.161479898; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Roche Myra I, 2015, Curr Genet Med Rep, V3, P166; Rutherford J, 2002, BRIT J CANCER, V86, P1592, DOI 10.1038/sj.bjc.6600269; Side L, 1997, NEW ENGL J MED, V336, P1713, DOI 10.1056/NEJM199706123362404; Song W, 2015, GENETICS MED OFFICIA; Sonoyama T, 2011, MOL MED REP, V4, P489, DOI 10.3892/mmr.2011.449; Stacey SN, 2011, NAT GENET, V43, P1098, DOI 10.1038/ng.926; Stein T, 2002, ONCOGENE, V21, P2961, DOI 10.1038/sj.onc.1205372; SUN Y, 1992, P NATL ACAD SCI USA, V89, P6516, DOI 10.1073/pnas.89.14.6516; Surget S, 2014, ONCOTARGETS THER, V7, P57, DOI 10.2147/OTT.S53876; TASSABEHJI M, 1993, AM J HUM GENET, V53, P90; Van Driest SL, 2016, JAMA-J AM MED ASSOC, V315, P47, DOI 10.1001/jama.2015.17701; Vassy JL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa2401; Wang B, 2009, GENE DEV, V23, P729, DOI 10.1101/gad.1770309; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Yang YP, 2014, JAMA-J AM MED ASSOC, V312, P1870, DOI 10.1001/jama.2014.14601; Zhang JH, 2015, NEW ENGL J MED, V373, P2336, DOI 10.1056/NEJMoa1508054	61	3	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167847	10.1371/journal.pone.0167847	http://dx.doi.org/10.1371/journal.pone.0167847			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930734	Green Published, gold, Green Submitted			2022-12-26	WOS:000389580900051
J	Hellwig, B; Madjar, K; Edlund, K; Marchan, R; Cadenas, C; Heimes, AS; Almstedt, K; Lebrecht, A; Sicking, I; Battista, MJ; Micke, P; Schmidt, M; Hengstler, JG; Rahnenfuhrer, J				Hellwig, Birte; Madjar, Katrin; Edlund, Karolina; Marchan, Rosemarie; Cadenas, Cristina; Heimes, Anne-Sophie; Almstedt, Katrin; Lebrecht, Antje; Sicking, Isabel; Battista, Marco J.; Micke, Patrick; Schmidt, Marcus; Hengstler, Jan G.; Rahnenfuehrer, Joerg			Epsin Family Member 3 and Ribosome-Related Genes Are Associated with Late Metastasis in Estrogen Receptor-Positive Breast Cancer and Long-Term Survival in Non-Small Cell Lung Cancer Using a Genome-Wide Identification and Validation Strategy	PLOS ONE			English	Article							LATE-DISTANT RECURRENCE; ENDOCRINE THERAPY; RISK; SIGNATURE; TAMOXIFEN; GROWTH; SCORE; INDEX; POPULATION; MASTECTOMY	Background In breast cancer, gene signatures that predict the risk of metastasis after surgical tumor resection are mainly indicative of early events. The purpose of this study was to identify genes linked to metastatic recurrence more than three years after surgery. Methods Affymetrix HG U133A and Plus 2.0 array datasets with information on metastasis-free, disease-free or overall survival were accessed via public repositories. Time restricted Cox regression models were used to identify genes associated with metastasis during or after the first three years post-surgery (early-and late-type genes). A sequential validation study design, with two non-adjuvantly treated discovery cohorts (n = 409) and one validation cohort (n = 169) was applied and identified genes were further evaluated in tamoxifen-treated breast cancer patients (n = 923), as well as in patients with non-small cell lung (n = 1779), colon (n = 893) and ovarian (n = 922) cancer. Results Ten late-and 243 early-type genes were identified in adjuvantly untreated breast cancer. Adjustment to clinicopathological factors and an established proliferation-related signature markedly reduced the number of early-type genes to 16, whereas nine late-type genes still remained significant. These nine genes were associated with metastasis-free survival (MFS) also in a non-time restricted model, but not in the early period alone, stressing that their prognostic impact was primarily based on MFS more than three years after surgery. Four of the ten late-type genes, the ribosome-related factors EIF4B, RPL5, RPL3, and the tumor angiogenesis modifier EPN3 were significantly associated with MFS in the late period also in a meta-analysis of tamoxifen-treated breast cancer cohorts. In contrast, only one late-type gene (EPN3) showed consistent survival associations in more than one cohort in the other cancer types, being associated with worse outcome in two non-small cell lung cancer cohorts. No late-type gene was validated in ovarian and colon cancer. Conclusions Ribosome-related genes were associated with decreased risk of late metastasis in both adjuvantly untreated and tamoxifen-treated breast cancer patients. In contrast, high expression of epsin (EPN3) was associated with increased risk of late metastasis. This is of clinical relevance considering the well-understood role of epsins in tumor angiogenesis and the ongoing development of epsin antagonizing therapies.	[Hellwig, Birte; Madjar, Katrin; Rahnenfuehrer, Joerg] TU Dortmund Univ, Dept Stat, Dortmund, Germany; [Heimes, Anne-Sophie; Almstedt, Katrin; Lebrecht, Antje; Sicking, Isabel; Battista, Marco J.; Schmidt, Marcus] Univ Hosp, Dept Obstet & Gynaecol, Mainz, Germany; [Edlund, Karolina; Marchan, Rosemarie; Cadenas, Cristina; Hengstler, Jan G.] TU Dortmund Univ, Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany; [Micke, Patrick] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden	Dortmund University of Technology; University Hospital Mainz; Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO); Uppsala University	Rahnenfuhrer, J (corresponding author), TU Dortmund Univ, Dept Stat, Dortmund, Germany.	rahnenfuehrer@statistik.tu-dortmund.de	Schmidt, Marcus/H-3383-2013	Schmidt, Marcus/0000-0003-1365-2414; Cadenas, Cristina/0000-0003-3374-6418; Rahnenfuhrer, Jorg/0000-0002-8947-440X; Marchan, Rosemarie/0000-0003-4414-1633; Hengstler, Jan/0000-0002-1427-5246; Madjar, Katrin/0000-0001-6169-8105	German Research Foundation (DFG) [RA 870/5-1]; Federal Ministry of Education and Research of Germany (BMBF, NGFN project Oncoprofile) [01GR0816]	German Research Foundation (DFG)(German Research Foundation (DFG)); Federal Ministry of Education and Research of Germany (BMBF, NGFN project Oncoprofile)	This work was supported by the German Research Foundation (DFG, contract number RA 870/5-1) and the Federal Ministry of Education and Research of Germany (BMBF, NGFN project Oncoprofile, no. 01GR0816). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brewster AM, 2008, JNCI-J NATL CANCER I, V100, P1179, DOI 10.1093/jnci/djn233; Calvisi DF, 2011, GASTROENTEROLOGY, V140, P1071, DOI 10.1053/j.gastro.2010.12.006; Cheng Q, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0407-9; Chia SK, 2004, J CLIN ONCOL, V22, P1630, DOI 10.1200/JCO.2004.09.070; Chiocchetti A, 2007, EXP GERONTOL, V42, P275, DOI 10.1016/j.exger.2006.11.002; Cianfrocca M, 2008, CLIN BREAST CANCER, V8, P493, DOI 10.3816/CBC.2008.n.059; Coon Brian G, 2011, Commun Integr Biol, V4, P95, DOI 10.4161/cib.4.1.14129; Coon BG, 2010, J BIOL CHEM, V285, P33073, DOI 10.1074/jbc.M110.124123; Cuzick J, 2011, J CLIN ONCOL, V29, P4273, DOI 10.1200/JCO.2010.31.2835; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; De Keersmaecker K, 2013, NAT GENET, V45, P186, DOI 10.1038/ng.2508; Demicheli R, 1996, BREAST CANCER RES TR, V41, P177, DOI 10.1007/BF01807163; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Dong YZ, 2015, J CLIN INVEST, V125, P4349, DOI 10.1172/JCI80349; Dowsett M, 2013, J CLIN ONCOL, V31, P2783, DOI 10.1200/JCO.2012.46.1558; Esposito D, 2014, ONCOTARGET, V5, P11737, DOI 10.18632/oncotarget.2591; Goudarzi KM, 2016, INT J ONCOL, V48, P1313, DOI 10.3892/ijo.2016.3387; Hao YQ, 2011, BIOCHEM BIOPH RES CO, V407, P169, DOI 10.1016/j.bbrc.2011.02.132; Karrison TG, 1999, JNCI-J NATL CANCER I, V91, P80, DOI 10.1093/jnci/91.1.80; Kennecke HF, 2007, ANN ONCOL, V18, P45, DOI 10.1093/annonc/mdl334; Kim RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035569; Knoll M, 2016, ONCOTARGET, V7, P418, DOI 10.18632/oncotarget.6225; Konstantinopoulos PA, 2010, J CLIN ONCOL, V28, P3555, DOI 10.1200/JCO.2009.27.5719; Lindstrom MS, 2010, PLOS ONE, V5, pA116, DOI 10.1371/journal.pone.0009578; Liu LP, 2006, MOL CELL, V21, P521, DOI 10.1016/j.molcel.2006.01.010; Lohr M, 2012, J TOXICOL ENV HEAL A, V75, P447, DOI 10.1080/15287394.2012.674912; Loi S, 2007, J CLIN ONCOL, V25, P1239, DOI 10.1200/JCO.2006.07.1522; Ma XJ, 2008, CLIN CANCER RES, V14, P2601, DOI 10.1158/1078-0432.CCR-07-5026; Ma XJ, 2004, CANCER CELL, V5, P607, DOI 10.1016/j.ccr.2004.05.015; Macias E, 2010, CANCER CELL, V18, P231, DOI 10.1016/j.ccr.2010.08.007; Maia CJB, 2008, ENDOCRINE, V34, P108, DOI 10.1007/s12020-008-9113-7; Mazumder B, 2003, CELL, V115, P187, DOI 10.1016/S0092-8674(03)00773-6; McCall MN, 2010, BIOSTATISTICS, V11, P242, DOI 10.1093/biostatistics/kxp059; Mittempergher L, 2013, MOL ONCOL, V7, P987, DOI 10.1016/j.molonc.2013.07.006; Moreaux J, 2012, BIOCHEM BIOPH RES CO, V429, P148, DOI 10.1016/j.bbrc.2012.10.123; Mukhopadhyay R, 2009, TRENDS BIOCHEM SCI, V34, P324, DOI 10.1016/j.tibs.2009.03.004; Nishimura R, 2013, ONCOLOGY-BASEL, V85, P100, DOI 10.1159/000353099; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; R Core Team, 2013, R LANG ENV STAT COMP; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Russo A, 2013, CELL CYCLE, V12, P76, DOI 10.4161/cc.22963; Saphner T, 1996, J CLIN ONCOL, V14, P2738, DOI 10.1200/JCO.1996.14.10.2738; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; Schmidt M, 2012, CLIN CANCER RES, V18, P2695, DOI 10.1158/1078-0432.CCR-11-2210; Schwarzer G., 2015, META GEN PACKAGE MET; Sestak I, 2013, JNCI-J NATL CANCER I, V105, P1504, DOI 10.1093/jnci/djt244; Sgroi DC, 2013, LANCET ONCOL, V14, P1067, DOI 10.1016/S1470-2045(13)70387-5; Shahbazian D, 2010, CELL CYCLE, V9, P4106, DOI 10.4161/cc.9.20.13630; Takeuchi Hideya, 2005, Breast Cancer, V12, P161, DOI 10.2325/jbcs.12.161; Tessneer Kandice L, 2013, J Can Res Updates, V2, P144; Therneau T. M., 2015, A PACKAGE FOR SURVIV; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017; Zhang Y, 2013, CLIN CANCER RES, V19, P4196, DOI 10.1158/1078-0432.CCR-13-0804	54	25	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2016	11	12							e0167585	10.1371/journal.pone.0167585	http://dx.doi.org/10.1371/journal.pone.0167585			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4NG	27926932	Green Published, Green Submitted, gold			2022-12-26	WOS:000389578800011
J	Yeung, HH; Denison, S; Johnson, SP				Yeung, H. Henny; Denison, Stephanie; Johnson, Scott P.			Infants' Looking to Surprising Events: When Eye-Tracking Reveals More than Looking Time	PLOS ONE			English	Article							SELECTIVE ATTENTION; FALSE BELIEF; PROBABILITIES; IMPLICIT; EXPECTATIONS; INTUITIONS; INFERENCE; MOVEMENTS; MOUTH	Research on infants' reasoning abilities often rely on looking times, which are longer to surprising and unexpected visual scenes compared to unsurprising and expected ones. Few researchers have examined more precise visual scanning patterns in these scenes, and so, here, we recorded 8- to 11-month-olds' gaze with an eye tracker as we presented a sampling event whose outcome was either surprising, neutral, or unsurprising: A red (or yellow) ball was drawn from one of three visible containers populated 0%, 50%, or 100% with identically colored balls. When measuring looking time to the whole scene, infants were insensitive to the likelihood of the sampling event, replicating failures in similar paradigms. Nevertheless, a new analysis of visual scanning showed that infants did spend more time fixating specific areas-of-interest as a function of the event likelihood. The drawn ball and its associated container attracted more looking than the other containers in the 0% condition, but this pattern was weaker in the 50% condition, and even less strong in the 100% condition. Results suggest that measuring where infants look may be more sensitive than simply how much looking there is to the whole scene. The advantages of eye tracking measures over traditional looking measures are discussed.	[Yeung, H. Henny] Simon Fraser Univ, Dept Linguist, Burnaby, BC, Canada; [Denison, Stephanie] Univ Waterloo, Dept Psychol, Waterloo, ON, Canada; [Johnson, Scott P.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA USA	Simon Fraser University; University of Waterloo; University of California System; University of California Los Angeles	Yeung, HH (corresponding author), Simon Fraser Univ, Dept Linguist, Burnaby, BC, Canada.	henny_yeung@sfu.ca			National Institutes of Health grant [R01-HD73535]; NIH [R01-HD73535]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD073535] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by a National Institutes of Health grant (R01-HD73535) to SPJ. Please note that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Bryan Nguyen for an immense amount of technical support, and assistance with data collection. This research was supported by a NIH grant (R01-HD73535) to S. P. Johnson.	Albareda-Castellot B, 2011, DEVELOPMENTAL SCI, V14, P395, DOI 10.1111/j.1467-7687.2010.00989.x; Aslin RN, 2007, DEVELOPMENTAL SCI, V10, P48, DOI 10.1111/j.1467-7687.2007.00563.x; BAILLARGEON R, 1985, COGNITION, V20, P191, DOI 10.1016/0010-0277(85)90008-3; CLEMENTS WA, 1994, COGNITIVE DEV, V9, P377, DOI 10.1016/0885-2014(94)90012-4; Daum MM, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00370; Denison S, 2014, DEV PSYCHOL, V50, P2009, DOI 10.1037/a0037158; Denison S, 2014, COGNITION, V130, P335, DOI 10.1016/j.cognition.2013.12.001; Denison S, 2013, DEV PSYCHOL, V49, P243, DOI 10.1037/a0028278; Denison S, 2010, DEVELOPMENTAL SCI, V13, P798, DOI 10.1111/j.1467-7687.2009.00943.x; Denison S, 2010, COGNITIVE SCI, V34, P885, DOI 10.1111/j.1551-6709.2010.01111.x; FANTZ RL, 1964, SCIENCE, V146, P668, DOI 10.1126/science.146.3644.668; Gredeback G, 2010, DEV NEUROPSYCHOL, V35, P1, DOI 10.1080/87565640903325758; Gweon H, 2010, P NATL ACAD SCI USA, V107, P9066, DOI 10.1073/pnas.1003095107; Johnson SP, 2004, PSYCHOL SCI, V15, P769, DOI 10.1111/j.0956-7976.2004.00754.x; Kovacs AM, 2009, P NATL ACAD SCI USA, V106, P6556, DOI 10.1073/pnas.0811323106; Kovacs AM, 2009, SCIENCE, V325, P611, DOI 10.1126/science.1173947; Kulke L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142505; Laeng B, 2012, PERSPECT PSYCHOL SCI, V7, P18, DOI 10.1177/1745691611427305; Lawson CA, 2013, INFANCY, V18, P961, DOI 10.1111/infa.12014; Lewkowicz DJ, 2012, P NATL ACAD SCI USA, V109, P1431, DOI 10.1073/pnas.1114783109; McMurray B, 2005, COGNITION, V95, pB15, DOI 10.1016/j.cognition.2004.07.005; McMurray B, 2004, INFANCY, V6, P203, DOI 10.1207/s15327078in0602_4; Pons F, 2015, PSYCHOL SCI, V26, P490, DOI 10.1177/0956797614568320; Schneider D, 2013, COGNITION, V129, P410, DOI 10.1016/j.cognition.2013.08.004; Southgate V, 2007, PSYCHOL SCI, V18, P587, DOI 10.1111/j.1467-9280.2007.01944.x; Teglas E, 2007, P NATL ACAD SCI USA, V104, P19156, DOI 10.1073/pnas.0700271104; Teglas E, 2015, DEVELOPMENTAL SCI, V18, P183, DOI 10.1111/desc.12196; Teglas E, 2011, SCIENCE, V332, P1054, DOI 10.1126/science.1196404; Thoermer C, 2012, BRIT J DEV PSYCHOL, V30, P172, DOI 10.1111/j.2044-835X.2011.02067.x; Tummeltshammer KS, 2014, CHILD DEV, V85, P1981, DOI 10.1111/cdev.12239; Tummeltshammer KS, 2013, DEVELOPMENTAL SCI, V16, P760, DOI 10.1111/desc.12064; Wang Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030884; Xu F, 2008, P NATL ACAD SCI USA, V105, P5012, DOI 10.1073/pnas.0704450105; Xu F, 2009, COGNITION, V112, P97, DOI 10.1016/j.cognition.2009.04.006; Yu C, 2011, DEVELOPMENTAL SCI, V14, P165, DOI 10.1111/j.1467-7687.2010.00958.x	35	6	6	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2016	11	12							e0164277	10.1371/journal.pone.0164277	http://dx.doi.org/10.1371/journal.pone.0164277			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4NG	27926920	Green Published, Green Submitted, gold			2022-12-26	WOS:000389578800001
J	Li, YS; Song, T; Yang, JS; Zhang, Y; Yang, JL				Li, Yushuang; Song, Tian; Yang, Jiasheng; Zhang, Yi; Yang, Jialiang			An Alignment-Free Algorithm in Comparing the Similarity of Protein Sequences Based on Pseudo-Markov Transition Probabilities among Amino Acids	PLOS ONE			English	Article							PRINCIPAL COMPONENT ANALYSIS; STRUCTURAL CLASSES; GRAPHICAL REPRESENTATION; GENERAL-FORM; PREDICTION; 2D; SIMILARITY/DISSIMILARITY; RECONSTRUCTION; IDENTIFICATION; INFORMATION	In this paper, we have proposed a novel alignment-free method for comparing the similarity of protein sequences. We first encode a protein sequence into a 440 dimensional feature vector consisting of a 400 dimensional Pseudo-Markov transition probability vector among the 20 amino acids, a 20 dimensional content ratio vector, and a 20 dimensional position ratio vector of the amino acids in the sequence. By evaluating the Euclidean distances among the representing vectors, we compare the similarity of protein sequences. We then apply this method into the ND5 dataset consisting of the ND5 protein sequences of 9 species, and the F10 and G11 datasets representing two of the xylanases containing glycoside hydrolase families, i.e., families 10 and 11. As a result, our method achieves a correlation coefficient of 0.962 with the canonical protein sequence aligner ClustalW in the ND5 dataset, much higher than those of other 5 popular alignment-free methods. In addition, we successfully separate the xylanases sequences in the F10 family and the G11 family and illustrate that the F10 family is more heat stable than the G11 family, consistent with a few previous studies. Moreover, we prove mathematically an identity equation involving the Pseudo-Markov transition probability vector and the amino acids content ratio vector.	[Li, Yushuang; Song, Tian] Yanshan Univ, Sch Sci, Qinhuangdao, Peoples R China; [Yang, Jiasheng] Natl Univ Singapore, Dept Civil & Environm Engn, Singapore, Singapore; [Zhang, Yi] Hebei Univ Sci & Technol, Dept Math, Shijiazhuang, Hebei, Peoples R China; [Yang, Jialiang] Henan Polytech Univ, Sch Math & Informat Sci, Jiaozuo, Henan, Peoples R China	Yanshan University; National University of Singapore; Hebei University of Science & Technology; Henan Polytechnic University	Song, T (corresponding author), Yanshan Univ, Sch Sci, Qinhuangdao, Peoples R China.; Yang, JL (corresponding author), Henan Polytech Univ, Sch Math & Informat Sci, Jiaozuo, Henan, Peoples R China.	songtian2012@126.com; jialiang.yang@mssm.edu		Yang, Jialiang/0000-0003-4689-8672	National Natural Science Foundation of China [11201409]; Young Talents Plan of Higher School in Hebei Province [BJ2014060]; National Science Foundation of China [11171088]; Science and technology project of Hebei Province [A2015208108, 1520341]; Science Fund of the Hebei University of Science and Technology Foundation [2014PT67]; Hebei Province Foundation for Advanced Talents [A201400121]; Educational Commission of Hebei Province on of Humanities and Social Sciences [SZ16180]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Young Talents Plan of Higher School in Hebei Province; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and technology project of Hebei Province; Science Fund of the Hebei University of Science and Technology Foundation; Hebei Province Foundation for Advanced Talents; Educational Commission of Hebei Province on of Humanities and Social Sciences	This work was partially supported by the National Natural Science Foundation of China (No. 11201409 to YL), the Young Talents Plan of Higher School in Hebei Province (No. BJ2014060 to YL) and the National Science Foundation of China (No 11171088 to YZ), the Science and technology project of Hebei Province (No A2015208108 and No 1520341 to YZ), the Science Fund of the Hebei University of Science and Technology Foundation (No 2014PT67 to YZ), the Hebei Province Foundation for Advanced Talents (No A201400121 to YZ), the Educational Commission of Hebei Province on of Humanities and Social Sciences (No SZ16180 to YZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bora VB, 2016, J DIGIT IMAGING, V29, P115, DOI 10.1007/s10278-015-9813-5; Collins T, 2005, FEMS MICROBIOL REV, V29, P3, DOI 10.1016/j.femsre.2004.06.005; Ding CHQ, 2001, BIOINFORMATICS, V17, P349, DOI 10.1093/bioinformatics/17.4.349; Dubey AK, 2016, INT J COMPUT ASS RAD, V11, P2033, DOI 10.1007/s11548-016-1437-9; el Maaty MIA, 2010, PHYSICA A, V389, P4668, DOI 10.1016/j.physa.2010.06.031; El-Lakkani A, 2013, CHEM PHYS LETT, V590, P192, DOI 10.1016/j.cplett.2013.10.032; Gao QB, 2012, BIOCHEM BIOPH RES CO, V417, P73, DOI 10.1016/j.bbrc.2011.11.057; Ghosh A, 2016, GENE, V583, P112, DOI 10.1016/j.gene.2016.02.015; Graphical D., 2011, J MATH CHEM, V49, P2345; Gu Q, 2010, PROTEIN PEPTIDE LETT, V17, P559, DOI 10.2174/092986610791112693; Hua HL, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/7639397; Kong L, 2014, J THEOR BIOL, V344, P12, DOI 10.1016/j.jtbi.2013.11.021; Lee SH, 2014, COMPUT METH PROG BIO, V116, P10, DOI 10.1016/j.cmpb.2014.04.012; Liao B, 2006, CHEM PHYS LETT, V422, P282, DOI 10.1016/j.cplett.2006.02.081; Liao B, 2010, BIOINFORMATICS, V26, P2678, DOI 10.1093/bioinformatics/btq521; Liao ZJ, 2016, SCIENTIFICA, V2016, DOI 10.1155/2016/8309253; Ma TT, 2014, PHYSICA A, V403, P21, DOI 10.1016/j.physa.2014.01.067; Mu ZC, 2013, PHYSICA A, V392, P6361, DOI 10.1016/j.physa.2013.08.008; Nandy A, 2006, ARKIVOC, P211, DOI 10.3998/ark.5550190.0007.907; Otu HH, 2003, BIOINFORMATICS, V19, P2122, DOI 10.1093/bioinformatics/btg295; Pietal MJ, 2015, BIOINFORMATICS, V31, P3499, DOI 10.1093/bioinformatics/btv390; Randic M, 2009, J MOL GRAPH MODEL, V27, P637, DOI 10.1016/j.jmgm.2008.10.004; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Wang JR, 2014, BIOCHIMIE, V101, P104, DOI 10.1016/j.biochi.2013.12.021; Wei L, 2014, NANOBIOSCIENCE IEEE, V34, P545; Wei LY, 2015, IEEE T NANOBIOSCI, V14, P649, DOI 10.1109/TNB.2015.2450233; Wei LY, 2014, IEEE ACM T COMPUT BI, V11, P192, DOI 10.1109/TCBB.2013.146; Wen J, 2009, CHEM PHYS LETT, V476, P281, DOI 10.1016/j.cplett.2009.06.017; Xiao X, 2006, J COMPUT CHEM, V27, P478, DOI 10.1002/jcc.20354; Xu CR, 2016, J THEOR BIOL, V406, P105, DOI 10.1016/j.jtbi.2016.06.034; Yang JL, 2008, J COMPUT BIOL, V15, P1295, DOI 10.1089/cmb.2007.0209; Yao YH, 2008, PROTEINS, V73, P864, DOI 10.1002/prot.22110; Yao YH, 2014, J THEOR BIOL, V347, P109, DOI 10.1016/j.jtbi.2014.01.001; Yu CL, 2013, GENE, V529, P250, DOI 10.1016/j.gene.2013.07.092; Yu HJ, 2012, CHEM PHYS LETT, V531, P261, DOI 10.1016/j.cplett.2012.02.030; Zhang L, 2014, J THEOR BIOL, P355; Zhang LC, 2014, J THEOR BIOL, V355, P105, DOI 10.1016/j.jtbi.2014.04.008; Zhang SL, 2014, J THEOR BIOL, V341, P71, DOI 10.1016/j.jtbi.2013.10.002; Zhang SL, 2012, J BIOMOL STRUCT DYN, V29, P634, DOI 10.1080/07391102.2011.672627; Zhang Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152238	41	3	3	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2016	11	12							e0167430	10.1371/journal.pone.0167430	http://dx.doi.org/10.1371/journal.pone.0167430			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4MR	27918587	Green Submitted, Green Published, gold			2022-12-26	WOS:000389577100011
J	Costa, FV; Mello, MAR; Bronstein, JL; Guerra, TJ; Muylaert, RL; Leite, AC; Neves, FS				Costa, Fernanda V.; Mello, Marco A. R.; Bronstein, Judith L.; Guerra, Tadeu J.; Muylaert, Renata L.; Leite, Alice C.; Neves, Frederico S.			Few Ant Species Play a Central Role Linking Different Plant Resources in a Network in Rupestrian Grasslands	PLOS ONE			English	Article							HYMENOPTERA-FORMICIDAE; COMPLEX COMMUNITIES; NEOTROPICAL SAVANNA; HONEYDEW; SPECIALIZATION; NECTAR; MODULARITY; DIVERSITY; SYSTEMS; FAUNA	Ant-plant associations are an outstanding model to study the entangled ecological interactions that structure communities. However, most studies of plant-animal networks focus on only one type of resource that mediates these interactions (e.g, nectar or fruits), leading to a biased understanding of community structure. New approaches, however, have made possible to study several interaction types simultaneously through multilayer networks models. Here, we use this approach to ask whether the structural patterns described to date for ant plant networks hold when multiple interactions with plant-derived food rewards are considered. We tested whether networks characterized by different resource types differ in specialization and resource partitioning among ants, and whether the identity of the core ant species is similar among resource types. We monitored ant interactions with extrafloral nectaries, flowers, and fruits, as well as trophobiont hemipterans feeding on plants, for one year, in seven rupestrian grassland (campo rupestre) sites in southeastern Brazil. We found a highly tangled ant-plant network in which plants offering different resource types are connected by a few central ant species. The multilayer network had low modularity and specialization, but ant specialization and niche overlap differed according to the type of resource used. Beyond detecting structural differences across networks, our study demonstrates empirically that the core of most central ant species is similar across them. We suggest that foraging strategies of ant species, such as massive recruitment, may determine specialization and resource partitioning in ant-plant interactions. As this core of ant species is involved in multiple ecosystem functions, it may drive the diversity and evolution of the entire campo rupestre community.	[Costa, Fernanda V.; Mello, Marco A. R.; Leite, Alice C.; Neves, Frederico S.] Univ Fed Minas Gerais, Grad Sch Ecol Conservat & Wildlife Management, Belo Horizonte, MG, Brazil; [Bronstein, Judith L.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA; [Guerra, Tadeu J.] Univ Fed Minas Gerais, Dept Bot, Belo Horizonte, MG, Brazil; [Muylaert, Renata L.] Sao Paulo State Univ UNESP, Dept Ecol, Sao Paulo, Brazil	Universidade Federal de Minas Gerais; University of Arizona; Universidade Federal de Minas Gerais; Universidade Estadual Paulista	Costa, FV (corresponding author), Univ Fed Minas Gerais, Grad Sch Ecol Conservat & Wildlife Management, Belo Horizonte, MG, Brazil.	fecostabio@gmail.com	Guerra, Tadeu J./O-2320-2013; Muylaert, Renata L./AAD-7248-2020; Neves, Frederico/E-5777-2013; Mello, Marco A. R./B-1095-2008	Guerra, Tadeu J./0000-0003-1247-365X; Muylaert, Renata L./0000-0002-6466-6210; Neves, Frederico/0000-0002-2691-3743; Mello, Marco A. R./0000-0002-9098-9427	Brazilian Council for Scientific and Technological Development (CNPq) [478565/2012-7]; Brazilian Coordination for the Improvement of Higher Education Personnel; Minas Gerais Research Foundation (FAPEMIG); Research Dean of Federal University of Minas Gerais (PRPq-UFMG); Alexander von Humboldt Foundation (AvH); Research Program on the Biodiversity of the Atlantic Forest (PPBio-MA); Sao Paulo Research Foundation [Fapesp 2015/17739-4]; Brazilian Council for Scientific and Technological Development (CNPq); Brazilian Coordination for the Improvement of Higher Education Personnel (CAPES)	Brazilian Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Coordination for the Improvement of Higher Education Personnel; Minas Gerais Research Foundation (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Research Dean of Federal University of Minas Gerais (PRPq-UFMG); Alexander von Humboldt Foundation (AvH)(Alexander von Humboldt Foundation); Research Program on the Biodiversity of the Atlantic Forest (PPBio-MA); Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Our study was funded by the Brazilian Council for Scientific and Technological Development (CNPq 478565/2012-7 to FSN), Brazilian Coordination for the Improvement of Higher Education Personnel, Minas Gerais Research Foundation (FAPEMIG), Research Dean of Federal University of Minas Gerais (PRPq-UFMG), Alexander von Humboldt Foundation (AvH), and the Research Program on the Biodiversity of the Atlantic Forest (PPBio-MA). RLM was funded by Sao Paulo Research Foundation (Fapesp 2015/17739-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to several colleagues, who helped us in many ways. Nico Bluthgen and two anonymous reviewers helped us to improve the clarity of an earlier version of this manuscript. Affonso H. N. Souza and our colleagues from Insect Ecology Lab, especially Laura D. Braga and Fabio T. Pacelhe, assisted in the field and lab work. We thank Rodrigo Feitosa for ant species identification, Fernando A. O. Silveira and Joao R. Stehmann for plant species identification, Takumasa Kondo for scale insect identification, Sonia M. N. Lazzari for aphid identification, and John Ribeiro and Pavel Dodonov for their help with analyses. We also are grateful to the Chico Mendes Institute for Biodiversity (ICMBio), Serra do Cipo National Park, and Vellozia Reserve for their logistical support. Our study was funded by the Brazilian Council for Scientific and Technological Development (CNPq), Brazilian Coordination for the Improvement of Higher Education Personnel (CAPES), Minas Gerais Research Foundation (FAPEMIG), Research Dean of Federal University of Minas Gerais (PRPq-UFMG), Alexander von Humboldt Foundation (AvH), and the Research Program on the Biodiversity of the Atlantic Forest (PPBio-MA). RLM was funded by Sao Paulo Research Foundation (Fapesp 2015/17739-4).	Adams ES, 2016, MYRMECOL NEWS, V23, P101; Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Almeida-Neto M, 2011, ENVIRON MODELL SOFTW, V26, P173, DOI 10.1016/j.envsoft.2010.08.003; Alvares CA, 2013, METEOROL Z, V22, P711, DOI 10.1127/0941-2948/2013/0507; Alves RJV, 2014, BRAZ J BIOL, V74, P355, DOI 10.1590/1519-6984.23212; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], 2016, ECOLOGY CONSERVATION; Baccaro FB, 2015, GUIA FORMIGAS BRASIL; Ballantyne G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043869; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bascompte J., 2014, MUTUALISTIC NETWORKS; Batagelj V., 1998, CONNECTIONS, V21, P47, DOI DOI 10.1017/CB09780511996368; Belchior C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158283; Bluthgen N, 2006, INSECT SOC, V53, P194, DOI 10.1007/s00040-005-0858-1; Bluthgen N, 2007, CURR BIOL, V17, P341, DOI 10.1016/j.cub.2006.12.039; Bluethgen Nico, 2006, BMC Ecology, V6, P9, DOI 10.1186/1472-6785-6-9; Bluthgen N, 2008, ECOLOGY, V89, P3387, DOI 10.1890/07-2121.1; Bluthgen N, 2004, OIKOS, V106, P344, DOI 10.1111/j.0030-1299.2004.12687.x; Bluthgen N, 2004, AUSTRAL ECOL, V29, P418, DOI 10.1111/j.1442-9993.2004.01380.x; Bluthgen N, 2003, OECOLOGIA, V137, P426, DOI 10.1007/s00442-003-1347-8; Boccaletti S, 2014, PHYS REP, V544, P1, DOI 10.1016/j.physrep.2014.07.001; Bronstein JL, 2015, MUTUALISM, P1, DOI 10.1093/acprof:oso/9780199675654.001.0001; Byk J, 2011, POPUL ECOL, V53, P327, DOI 10.1007/s10144-010-0240-7; Cagnolo L, 2015, ECOL ENTOMOL, V40, P553, DOI 10.1111/een.12229; Chamberlain SA, 2014, ECOL LETT, V17, P881, DOI 10.1111/ele.12279; Christianini AV, 2009, OECOLOGIA, V160, P735, DOI 10.1007/s00442-009-1349-2; Costa FV, 2015, SOCIOBIOLOGY, V62, P228; Costa LD, 2006, J STAT PHYS, V125, P845, DOI 10.1007/s10955-006-9130-y; CUSHMAN JH, 1994, ECOLOGY, V75, P1031, DOI 10.2307/1939427; Czechowski W, 2011, ANN ZOOL, V61, P519, DOI 10.3161/000345411X603364; Dattilo W., 2013, OIKOS IN PRESS; Dattilo W, 2014, BIOL J LINN SOC, V113, P405, DOI 10.1111/bij.12350; Davidson DW, 2004, OECOLOGIA, V139, P255, DOI 10.1007/s00442-004-1508-4; Del-Claro K, 1999, BIOTROPICA, V31, P135, DOI 10.2307/2663967; Del-Claro K, 2016, INSECT SOC, V63, P207, DOI 10.1007/s00040-016-0466-2; Diaz-Castelazo C, 2010, ECOLOGY, V91, P793, DOI 10.1890/08-1883.1; Dormann CF, 2014, METHODS ECOL EVOL, V5, P90, DOI 10.1111/2041-210X.12139; Fagundes R, 2016, ARTHROPOD-PLANT INTE, V10, P207, DOI 10.1007/s11829-016-9428-x; Fagundes Roberth, 2011, Psyche (Cambridge), V2012, P1, DOI 10.1155/2012/783945; Fernandes G.W., 2016, ECOLOGY CONSERVATION, P3, DOI [10.1007/978-3-319-29808-5_1, DOI 10.1007/978-3-319-29808-5_1, DOI 10.1007/978-3-319-29808-5]; Fokuhl G, 2007, ECOL RES, V22, P845, DOI 10.1007/s11284-006-0331-2; Fontaine C, 2011, ECOL LETT, V14, P1170, DOI 10.1111/j.1461-0248.2011.01688.x; Frund J, 2016, OIKOS, V125, P502, DOI 10.1111/oik.02256; Genini J, 2010, BIOL LETTERS, V6, P494, DOI 10.1098/rsbl.2009.1021; Genrich CM, 2017, OIKOS, V126, P361, DOI 10.1111/oik.03825; Heil M, 2003, ANNU REV ECOL EVOL S, V34, P425, DOI 10.1146/annurev.ecolsys.34.011802.132410; HORN HS, 1966, AM NAT, V100, P419, DOI 10.1086/282436; Ibarra-Isassi J, 2016, ARTHROPOD-PLANT INTE, V10, P221, DOI 10.1007/s11829-016-9429-9; Ings TC, 2009, J ANIM ECOL, V78, P253, DOI 10.1111/j.1365-2656.2008.01460.x; Ivens ABF, 2016, ANNU REV ENTOMOL, V61, P353, DOI 10.1146/annurev-ento-010715-023719; Kefi S, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002527; Lewinsohn TM, 2012, SCIENCE, V335, P1449, DOI 10.1126/science.1220138; Manly B.F.J., 2006, RANDOMIZATION BOOTST, V3rd, DOI DOI 10.1201/9781315273075; Gonzalez AMM, 2010, ECOL COMPLEX, V7, P36, DOI 10.1016/j.ecocom.2009.03.008; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104; Powell S, 2008, FUNCT ECOL, V22, P902, DOI 10.1111/j.1365-2435.2008.01436.x; R Dev. Team, 2015, R LANG ENV STAT COMP; Rafael JA., 2012, INSETOS BRASIL DIVER; Mello MAR, 2015, OIKOS, V124, P1031, DOI 10.1111/oik.01613; Rico-Gray V, 1998, AM MIDL NAT, V140, P21, DOI 10.1674/0003-0031(1998)140[0021:RASVOA]2.0.CO;2; Rico-Gray V., 2007, ECOLOGY EVOLUTION AN; Rico-Gray V, 2012, ARTHROPOD-PLANT INTE, V6, P289, DOI 10.1007/s11829-011-9170-3; RICOGRAY V, 1993, BIOTROPICA, V25, P301, DOI 10.2307/2388788; Sauve A.M., 2014, OIKOS, V123, P378, DOI DOI 10.1111/J.1600-0706.2013.00743.X; Sendoya SF, 2016, ARTHROPOD-PLANT INTE, V10, P183, DOI 10.1007/s11829-016-9423-2; Silveira FAO, 2016, PLANT SOIL, V403, P129, DOI 10.1007/s11104-015-2637-8; Styrsky JD, 2007, P ROY SOC B-BIOL SCI, V274, P151, DOI 10.1098/rspb.2006.3701; Trager MD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014308	71	29	30	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0167161	10.1371/journal.pone.0167161	http://dx.doi.org/10.1371/journal.pone.0167161			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3TF	27911919	Green Published, Green Submitted, gold			2022-12-26	WOS:000389520600024
J	Chao, CM; Chen, CC; Huang, HL; Chuang, YC; Lai, CC; Tang, HJ				Chao, Chien-Ming; Chen, Chi-Chung; Huang, Hui-Ling; Chuang, Yin-Ching; Lai, Chih-Cheng; Tang, Hung-Jen			Clinical Experience of Patients Receiving Doripenem-Containing Regimens for the Treatment of Healthcare-Associated Infections	PLOS ONE			English	Article							VENTILATOR-ASSOCIATED PNEUMONIA; PSEUDOMONAS-AERUGINOSA; ANTIMICROBIAL ACTIVITY; BACTERIAL-INFECTIONS; IMIPENEM-CILASTATIN; IN-VITRO; EFFICACY; SAFETY; MULTICENTER; SURVEILLANCE	In this study, we retrospectively reviewed the clinical experience of patients receiving doripenem-containing regimens for the treatment of healthcare-associated infections (HCAIs) in a tertiary care center and assessed the clinical usefulness of doripenem therapy in this clinical setting. In this retrospective study, the medical records of all adult patients who had ever received doripenem-containing therapy for the treatment of HCAIs were reviewed between September 1, 2012 and August 31, 2014, and the following data were extracted: age, gender, type of infection, disease severity, underlying comorbidities or conditions, and laboratory results. Additionally, we also extracted data regarding the rates of mortality and clinical and microbiological response. A total of 184 adult patients with HCAIs who had received doripenem-containing therapy were included in this study. Respiratory tract infections (n = 91, 49.5%) were the most common type of infection, followed by urinary tract infections, intra-abdominal infections and skin and soft tissue infections. The mean APACHE II score was 14.5. The rate of clinical success was 78.2%, and the overall in-hospital mortality rate was only 13.0%. Among patients, in-hospital mortality was independently and significantly associated with APACHE II score (odds ratio (OR), 1.2825; 95% CI, 1.1123-1.4788) and achieving clinical success (OR, 0.003; 95% CI, 0.0003-0.409). In conclusion, the overall in hospital mortality rate was low and the clinical success rate was high among HCAI patients receiving doripenem treatment. These results suggest that doripenem may be judiciously used for the treatment of patients with HCAIs.	[Chao, Chien-Ming; Lai, Chih-Cheng] Chi Mei Med Ctr, Dept Intens Care Med, Tainan, Taiwan; [Chen, Chi-Chung; Chuang, Yin-Ching] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Huang, Hui-Ling; Tang, Hung-Jen] Chia Nan Univ Pharm & Sci, Dept Hlth & Nutr, Tainan, Taiwan; [Chuang, Yin-Ching] Chi Mei Med Ctr, Dept Internal Med, Tainan, Taiwan; [Tang, Hung-Jen] Chi Mei Med Ctr, Dept Med, Tainan, Taiwan	Chi Mei Hospital; Chi Mei Hospital; Chia Nan University of Pharmacy & Science; Chi Mei Hospital; Chi Mei Hospital	Tang, HJ (corresponding author), Chia Nan Univ Pharm & Sci, Dept Hlth & Nutr, Tainan, Taiwan.; Tang, HJ (corresponding author), Chi Mei Med Ctr, Dept Med, Tainan, Taiwan.	8409d1@gmail.com	chen, chen/GRY-7085-2022; CHEN, CHEN/HDM-6657-2022					Baldwin CM, 2008, DRUGS, V68, P803, DOI 10.2165/00003495-200868060-00006; Boncagni F, 2015, MINERVA ANESTESIOL, V81, P765; Castanheira M, 2009, DIAGN MICR INFEC DIS, V63, P426, DOI 10.1016/j.diagmicrobio.2009.01.026; Chastre J, 2008, CRIT CARE MED, V36, P1089, DOI 10.1097/CCM.0b013e3181691b99; Chen ZJ, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-217; Dabar G, 2015, INT J INFECT DIS, V37, P80, DOI 10.1016/j.ijid.2015.05.024; Dong SX, 2012, J MICROBIOL IMMUNOL, V45, P459, DOI 10.1016/j.jmii.2012.08.022; Fritsche TR, 2005, CLIN MICROBIOL INFEC, V11, P974, DOI 10.1111/j.1469-0691.2005.01271.x; Hagihara M, 2012, DIAGN MICR INFEC DIS, V72, P258, DOI 10.1016/j.diagmicrobio.2011.11.011; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Jones RN, 2004, J ANTIMICROB CHEMOTH, V54, P144, DOI 10.1093/jac/dkh298; Kamidono S A S, 2005, JPN J CHEMOTHER S1, V53, P244; Kanj SS, 2011, MAYO CLIN PROC, V86, P250, DOI 10.4065/mcp.2010.0674; Kollef MH, 2012, CRIT CARE, V16, DOI [10.1186/cc11862, 10.1186/cc11853]; Kuo SC, 2011, J MICROBIOL IMMUNOL, V44, P45, DOI 10.1016/j.jmii.2011.01.009; Lee H, 2011, MICROB DRUG RESIST, V17, P37, DOI 10.1089/mdr.2010.0034; Livermore DM, 2009, DIAGN MICR INFEC DIS, V63, P455, DOI 10.1016/j.diagmicrobio.2009.02.012; Lo Tze Shien, 2009, Infect Drug Resist, V2, P41; Lucasti C, 2008, CLIN THER, V30, P868, DOI 10.1016/j.clinthera.2008.04.019; Mushtaq S, 2004, ANTIMICROB AGENTS CH, V48, P3086, DOI 10.1128/AAC.48.8.3086-3092.2004; Pogue JM, 2013, EXPERT REV ANTI-INFE, V11, P383, DOI [10.1586/ERI.13.14, 10.1586/eri.13.14]; Qu XY, 2015, BRAZ J INFECT DIS, V19, P156, DOI 10.1016/j.bjid.2014.10.010; Rea-Neto A, 2008, CURR MED RES OPIN, V24, P2113, DOI 10.1185/03007990802179255 ; Rodloff AC, 2006, J ANTIMICROB CHEMOTH, V58, P916, DOI 10.1093/jac/dkl354; Saito A., 2005, J CHEMOTHERAPY, V53, P185, DOI [10.11250/chemotherapy1995.53.supplement1_185, DOI 10.11250/CHEMOTHERAPY1995.53.SUPPLEMENT1_185]; Tan CK, 2010, J INFECTION, V61, P34, DOI 10.1016/j.jinf.2010.04.007; van Vught LA, 2016, JAMA-J AM MED ASSOC, V315, P1469, DOI 10.1001/jama.2016.2691; Vazquez JA, 2012, CURR MED RES OPIN, V28, P1921, DOI 10.1185/03007995.2012.748653	28	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167522	10.1371/journal.pone.0167522	http://dx.doi.org/10.1371/journal.pone.0167522			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907197	Green Published, gold, Green Submitted			2022-12-26	WOS:000389482700181
J	Glaser, DE; Turner, WS; Madfis, N; Wong, L; Zamora, J; White, N; Reyes, S; Burns, AB; Gopinathan, A; McCloskey, KE				Glaser, Drew E.; Turner, William S.; Madfis, Nicole; Wong, Lian; Zamora, Jose; White, Nicholas; Reyes, Samuel; Burns, Andrew B.; Gopinathan, Ajay; McCloskey, Kara E.			Multifactorial Optimizations for Directing Endothelial Fate from Stem Cells	PLOS ONE			English	Article							INDUCED PLURIPOTENT STEM; IN-VITRO; VASCULAR PROGENITORS; SIGNALING PATHWAYS; CD34(+) CELLS; DIFFERENTIATION; VEGF; ANGIOGENESIS; MOUSE; PROLIFERATION	Embryonic stem cells (ESC) and induced pluripotent stem (iPS) cells are attractive in vitro models of vascular development, therapeutic angiogenesis, and tissue engineering. However, distinct ESC and iPS cell lines respond differentially to the same microenvironmental factors. Developing improved/optimized differentiation methodologies tailored/applicable in a number of distinct iPS and ESC lines remains a challenge in the field. Currently published methods for deriving endothelial cells (EC) robustly generate high numbers of endothlelial progenitor cells (EPC) within a week, but their maturation to definitive EC is much more difficult, taking up to 2 months and requiring additional purification. Therefore, we set out to examine combinations/levels of putative EC induction factors-utilizing our stage-specific chemically-defined derivation methodology in 4 ESC lines including: kinetics, cell seeding density, matrix signaling, as well as medium treatment with vascular endothelial growth factor (VEGF), and basic fibroblast growth factor (bFGF). The results indicate that temporal development in both early and late stages is the most significant factor generating the desired cells. The generation of early Flk-1(+)/KDR+ vascular progenitor cells (VPC) from pluripotent ESC is directed predominantly by high cell seeding density and matrix signaling from fibronectin, while VEGF supplementation was NOT statistically significant in more than one cell line, especially with fibronectin matrix which sequesters autocrine VEGF production by the differentiating stem cells. Although some groups have shown that the GSK3-kinase inhibitor (CHIR) can facilitate EPC fate, it hindered the generation of KDR+ cells in our preoptimized medium formulations. The methods summarized here significantly increased the production of mature vascular endothelial (VE)-cadherin+ EC, with up to 93% and 57% purity from mouse and human ESC, respectively, before VE-cadherin+ EC purification.	[Glaser, Drew E.; Turner, William S.; Wong, Lian; White, Nicholas; Reyes, Samuel; McCloskey, Kara E.] Univ Calif Merced, Sch Engn, Merced, CA 95340 USA; [Glaser, Drew E.; Wong, Lian; McCloskey, Kara E.] Univ Calif Merced, Grad Program Biol Engn & Small Scale Technol, Merced, CA 95340 USA; [Madfis, Nicole] Univ Calif Merced, Grad Program Quantitat & Syst Biol, Merced, CA USA; [Zamora, Jose; Gopinathan, Ajay] Univ Calif Merced, Dept Phys, Merced, CA USA; [Zamora, Jose; Burns, Andrew B.] Univ Calif Merced, Dept Mol & Cellular Biol, Merced, CA USA	University of California System; University of California Merced; University of California System; University of California Merced; University of California System; University of California Merced; University of California System; University of California Merced; University of California System; University of California Merced	McCloskey, KE (corresponding author), Univ Calif Merced, Sch Engn, Merced, CA 95340 USA.; McCloskey, KE (corresponding author), Univ Calif Merced, Grad Program Biol Engn & Small Scale Technol, Merced, CA 95340 USA.	kmccloskey@ucmerced.edu		Gopinathan, Ajay/0000-0002-9369-8780	California Institute for Regenerative Medicine (CIRM) New Faculty Award [RN2-00921-1]; Basic Biology Award [RB5-07414]; NSF Integrative Graduate Education and Research Traineeship (IGERT) Award [0965918]; NSF Science and Technology Center (STC) for the Emergent Behavior of Integrated Biological Systems (EBICS) Award [0939511]; James S. McDonnell Foundation Award; NSF [DMS-1616926, EF-1038697]; NSF-CREST: Center for Cellular and Bio-molecular Machines at UC Merced [NSF-HRD-1547848]; Division Of Mathematical Sciences [1616926] Funding Source: National Science Foundation	California Institute for Regenerative Medicine (CIRM) New Faculty Award; Basic Biology Award; NSF Integrative Graduate Education and Research Traineeship (IGERT) Award; NSF Science and Technology Center (STC) for the Emergent Behavior of Integrated Biological Systems (EBICS) Award; James S. McDonnell Foundation Award; NSF(National Science Foundation (NSF)); NSF-CREST: Center for Cellular and Bio-molecular Machines at UC Merced; Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was funded through a California Institute for Regenerative Medicine (CIRM) New Faculty Award (# RN2-00921-1) and Basic Biology Award (#RB5-07414), as well as, NSF Integrative Graduate Education and Research Traineeship (IGERT) Award # 0965918, and NSF Science and Technology Center (STC) for the Emergent Behavior of Integrated Biological Systems (EBICS) Award # 0939511. Statistics and computational modeling work by Ajay Gopinathan was supported by a James S. McDonnell Foundation Award, NSF grant DMS-1616926 and NSF grant EF-1038697. AG also acknowledges support from the NSF-CREST: Center for Cellular and Bio-molecular Machines at UC Merced (NSF-HRD-1547848). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded through a California Institute for Regenerative Medicine (CIRM) New Faculty Award (# RN2-00921-1) and Basic Biology Award (#RB5-07414), as well as, NSF Integrative Graduate Education and Research Traineeship (IGERT) Award # 0965918, and NSF Science and Technology Center (STC) for the Emergent Behavior of Integrated Biological Systems (EBICS) Award # 0939511. Statistics and computational modeling work by Ajay Gopinathan was supported by a James S. McDonnell Foundation Award, NSF grant DMS-1616926 and NSF grant EF-1038697. AG also acknowledges support from the NSF-CREST: Center for Cellular and Bio-molecular Machines at UC Merced (NSF-HRD-1547848).	[Anonymous], [No title captured]; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Blancas A, 2011, STEM CELLS DEV; Blancas AA, 2013, STEM CELLS DEV, V22, P1398, DOI 10.1089/scd.2012.0376; Blancas AA, 2011, STEM CELLS DEV, V20, P2153, DOI 10.1089/scd.2010.0432; Cross MJ, 2001, TRENDS PHARMACOL SCI, V22, P201, DOI 10.1016/S0165-6147(00)01676-X; Cross MJ, 2003, TRENDS BIOCHEM SCI, V28, P488, DOI 10.1016/S0968-0004(03)00193-2; Era T, 2008, STEM CELLS, V26, P401, DOI 10.1634/stemcells.2006-0809; Glaser DE, 2014, STEM CELLS CLONING, V7, P79, DOI 10.2147/SCCAA.S69554; Glaser DE, 2011, J VASC RES, V48, P415, DOI 10.1159/000324752; Godin I, 2002, NAT REV IMMUNOL, V2, P593, DOI 10.1038/nri857; Guo SF, 2010, CELL PHYSIOL BIOCHEM, V26, P679, DOI 10.1159/000322335; Hirashima M, 2003, BLOOD, V101, P2261, DOI 10.1182/blood-2002-01-0003; Hirashima M, 1999, BLOOD, V93, P1253, DOI 10.1182/blood.V93.4.1253.404k31_1253_1263; Huang PP, 2007, THROMB HAEMOSTASIS, V98, P1335, DOI 10.1160/TH07-02-0137; Hwang YS, 2009, BIOMATERIALS, V30, P499, DOI 10.1016/j.biomaterials.2008.07.028; James D, 2010, NAT BIOTECHNOL, V28, P161, DOI 10.1038/nbt.1605; JOHANSSON BM, 1995, MOL CELL BIOL, V15, P141, DOI 10.1128/MCB.15.1.141; Joo HJ, 2011, BLOOD, V118, P2094, DOI 10.1182/blood-2010-12-323907; Kane NM, 2010, ARTERIOSCL THROM VAS, V30, P1389, DOI 10.1161/ATVBAHA.110.204800; Karlsson G, 2007, J EXP MED, V204, P467, DOI 10.1084/jem.20060465; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Kohler EE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085549; Lee SW, 2012, EMBO MOL MED, V4, P924, DOI 10.1002/emmm.201101107; Lee SH, 2013, MOL NUTR FOOD RES, V57, P225, DOI 10.1002/mnfr.201200489; Levenberg S, 2002, P NATL ACAD SCI USA, V99, P4391, DOI 10.1073/pnas.032074999; Levenberg S, 2010, NAT PROTOC, V5, P1115, DOI 10.1038/nprot.2010.31; Lian XJ, 2014, STEM CELL REP, V3, P804, DOI 10.1016/j.stemcr.2014.09.005; Lian XJ, 2013, NAT PROTOC, V8, P162, DOI 10.1038/nprot.2012.150; Lian XJ, 2012, P NATL ACAD SCI USA, V109, pE1848, DOI 10.1073/pnas.1200250109; Marcelo KL, 2013, CIRC RES, V112, P1272, DOI 10.1161/CIRCRESAHA.113.300506; Marelli-Berg FM, 2000, J IMMUNOL METHODS, V244, P205, DOI 10.1016/S0022-1759(00)00258-1; McCloskey Kara E., 2006, V330, P287; McCloskey KE, 2006, J VASC RES, V43, P411, DOI 10.1159/000094791; McCloskey KE, 2003, ENDOTHELIUM-J ENDOTH, V10, P329, DOI 10.1080/10623320390272325; McCloskey KE, 2005, TISSUE ENG, V11, P497, DOI 10.1089/ten.2005.11.497; Nishikawa S, 1998, DEVELOPMENT, V125, P1747; Orlova VV, 2014, NAT PROTOC, V9, P1514, DOI 10.1038/nprot.2014.102; Orlova VV, 2014, ARTERIOSCL THROM VAS, V34, P177, DOI 10.1161/ATVBAHA.113.302598; Pandian RP, 2003, ARCH BIOCHEM BIOPHYS, V420, P169, DOI 10.1016/j.abb.2003.09.008; Pimton P, 2011, CELL ADHES MIGR, V5, P73, DOI 10.4161/cam.5.1.13704; Powers DE, 2008, BIOTECHNOL BIOENG, V101, P241, DOI 10.1002/bit.21986; Purpura KA, 2008, STEM CELLS, V26, P2832, DOI 10.1634/stemcells.2008-0237; Ramirez-Bergeron DL, 2004, DEVELOPMENT, V131, P4623, DOI 10.1242/dev.01310; Sahara M, 2014, CELL RES, V24, P820, DOI 10.1038/cr.2014.59; Sone M, 2007, ARTERIOSCL THROM VAS, V27, P2127, DOI 10.1161/ATVBAHA.107.143149; Stavridis MP, 2003, BIOCHEM SOC T, V31, P45, DOI 10.1042/bst0310045; Suzuki Y, 2008, J BIOCHEM, V143, P199, DOI 10.1093/jb/mvm215; Tepper OM, 2002, CIRCULATION, V106, P2781, DOI 10.1161/01.CIR.0000039526.42991.93; Vodyanik MA, 2005, BLOOD, V105, P617, DOI 10.1182/blood-2004-04-1649; Wang ZZ, 2007, NAT BIOTECHNOL, V25, P317, DOI 10.1038/nbt1287; Wijelath ES, 2004, J VASC SURG, V39, P655, DOI 10.1016/j.jvs.2003.10.042; Wijelath ES, 2002, CIRC RES, V91, P25, DOI 10.1161/01.RES.0000026420.22406.79; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568; Yamashita JK, 2007, TRENDS CARDIOVAS MED, V17, P59, DOI 10.1016/j.tcm.2007.01.001; Yang C, 2004, THROMB HAEMOSTASIS, V91, P1202, DOI 10.1160/TH03-06-0378; Yu J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007040; Yurugi-Kobayashi T, 2006, ARTERIOSCL THROM VAS, V26, P1977, DOI 10.1161/01.ATV.0000234978.10658.41; Zhang S, 2014, BIOMATERIALS, V35, P3786, DOI 10.1016/j.biomaterials.2014.01.037	59	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166663	10.1371/journal.pone.0166663	http://dx.doi.org/10.1371/journal.pone.0166663			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907001	Green Submitted, Green Published, gold			2022-12-26	WOS:000389482700032
J	Martins, RL; Simoes, RC; Rabelo, ED; Farias, ALF; Rodrigues, ABL; Ramos, RD; Fernandes, JB; Santos, LD; de Almeida, SSMD				Martins, Rosany Lopes; Simoes, Ranggel Carvalho; Rabelo, Erica de Menezes; Ferreira Farias, Ana Luzia; Lobato Rodrigues, Alex Bruno; Ramos, Ryan da Silva; Fernandes, Joao Batista; Santos, Lourivaldo da Silva; da Silva de Almeida, Sheylla Susan Moreira			Chemical Composition, an Antioxidant, Cytotoxic and Microbiological Activity of the Essential Oil from the Leaves of Aeollanthus suaveolens Mart. ex Spreng	PLOS ONE			English	Article							ANTIBACTERIAL ACTIVITY; MEDICINAL-PLANTS; BRINE SHRIMP; BIOASSAY	Aeollanthus suaveolens species popularly known as catinga de mulata belongs to the Lamiaceae family. In the Amazon region, it is used in folk medicine for the treatment of gastritis, convulsions of epileptic origin, stomach pain and diarrhea in the form of tea and juice. Essential oils have analgesic, anti-inflammatory, and antimicrobial activity. This study evaluated the chemical composition of the A. suaveolens essential oil, and its cytotoxic, antimicrobial and antioxidant activity on Artemia salina Leach. The plant species was collected in Fazendinha district in the city of Macapa-AP. The essential oil obtained from the process was performed by hydrodistillation and identification of components by gas chromatography coupled with mass spectrometer. The antioxidant activity was evaluated by the kidnapping method of 2,2-diphenyl -1-picrilhidrazil radical, while the cytotoxic activity was assessed using saline A. and the microbiological activity was carried out by microdilution method with Escherichia coli, Salmonella sp. and Staphylococcus aureus bacteria. In a chromatographic analysis, the major constituents found in the essential oil of A. suaveolens were (E) -beta-farnesene (37.615%), Linalool (33.375%), alpha-Santalene (3.255%) and linalyl acetate (3.222%). The results showed that the Escherichia coli and Salmonella sp. bacteria were more susceptible to MIC 50 mg.mL(-1) when compared with the Staphylococcus aureus bacterium MIC 100 mg.mL(-1). With respect to MBC concentration of 100 mg.mL(-1) it was sufficient to inhibit the growth of E. coli. The essential oil did not show antioxidant activity, however, has a high cytotoxic activity against the A. salina, LC50 8.90 mu g.mL(-1).	[Martins, Rosany Lopes; Simoes, Ranggel Carvalho; Rabelo, Erica de Menezes; Ferreira Farias, Ana Luzia; Lobato Rodrigues, Alex Bruno; Ramos, Ryan da Silva; da Silva de Almeida, Sheylla Susan Moreira] Univ Fed Amapa, Lab Pharmacognosy & Phytochem, Macapa, Amapa, Brazil; [Fernandes, Joao Batista] Univ Fed Sao Carlos, Dept Chem, Sao Carlos, SP, Brazil; [Santos, Lourivaldo da Silva] Fed Univ Para, Chem Lab, Belem, Para, Brazil	Fundacao Universidade Federal do Amapa; Universidade Federal de Sao Carlos; Universidade Federal do Para	de Almeida, SSMD (corresponding author), Univ Fed Amapa, Lab Pharmacognosy & Phytochem, Macapa, Amapa, Brazil.	sheyllasusan@yahoo.com.br	Santos, Lourivaldo S/A-2934-2013; Rodrigues, Alex/AAM-3606-2020; MARTINS, ROSANY L/W-7477-2018; Santos, Lourivaldo S/B-5555-2014; Almeida, Sheylla Susan Moreira da Silva de/AAX-9891-2021; Ramos, Ryan/X-5824-2019	Rodrigues, Alex/0000-0003-2170-1773; MARTINS, ROSANY L/0000-0001-7708-6576; Santos, Lourivaldo S/0000-0001-6698-1743; Almeida, Sheylla Susan Moreira da Silva de/0000-0002-7687-8288; Ramos, Ryan/0000-0003-1802-1320; Simoes, Ranggel/0000-0003-4119-2953	CAPES	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by the CAPES for granting master's scholarship and the Postgraduate Diploma in Pharmaceutical Sciences program and the Research Program SUS (PPSUS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RP, 2012, IDENTIFICATION ESSEN, P469; Almeida NR, 2011, MOLECULES, V16, P2726, DOI 10.3390/molecules16032726; Alves TMD, 2000, MEM I OSWALDO CRUZ, V95, P367, DOI 10.1590/S0074-02762000000300012; Andrade MA, 2012, REV CIENC AGRON, V43, P399, DOI 10.1590/S1806-66902012000200025; ANVISA Farmacopeia Brasileira, 2010, FARMACOPEIA BRASILEI, V2, P1; Araujo M. G. F., 2010, Revista de Ciencias Farmaceuticas Basica e Aplicada, V31, P205; Ayres M, 2008, BIOESTAT 2008 5 0 AP; Azevedo MV, 2007, ACTA BOT BRAS, V21, P263; Barreiro EJ, 2007, FARMACOGNOSIA PLANTA, P147; Boscardin DMP, 2012, EVID-BASED COMPL ALT, V2012, P342; Burt S, 2004, INT J FOOD MICROBIOL, V94, P223, DOI 10.1016/j.ijfoodmicro.2004.03.022; Cristani M, 2007, J AGR FOOD CHEM, V55, P6300, DOI 10.1021/jf070094x; do Amarante Cristine Bastos, 2011, Acta Amazonica, V41, P431, DOI 10.1590/S0044-59672011000300015; Donsi F, 2016, J BIOTECHNOL, V233, P106, DOI 10.1016/j.jbiotec.2016.07.005; Franz CM, 2010, FLAVOUR FRAG J, V25, P112, DOI 10.1002/ffj.1983; Freitas Rosangela Correia, 2014, Revista de Ciencias Farmaceuticas Basica e Aplicada, V35, P113; Godoi AA, 2011, REV BRAS FARM, V92, P198; Harley RM, 2012, PHYTOTAXA, V58, P1; Harley RM, 2004, FA GE VAS P, V7, P167; Lôbo K.M.S, 2010, Rev. bras. plantas med., V12, P227, DOI 10.1590/S1516-05722010000200016; Lopes-Lutz D, 2008, PHYTOCHEMISTRY, V69, P1732, DOI 10.1016/j.phytochem.2008.02.014; Lu YR, 2001, FOOD CHEM, V75, P197, DOI 10.1016/S0308-8146(01)00198-4; Mc laughlin JL., 1985, REV SOC VENEZ QUIM, V18, P13; MEYER BN, 1982, PLANTA MED, V45, P31, DOI 10.1055/s-2007-971236; Nascimento CJ, 2011, REV BRAS FARM, V92, P327; Oliveira ASC, 2003, ESTUDO MORFOLOGICO C; Ootani AM, 2013, J BIOTEC BIODIVERS, V4, P162; Performance Standards for Antimicrobial Susceptibility Testing, 2007, M100S17 CLSI; Rashed NK, 2013, AERIAL PARTS BIOMED, V2013, P2; Silveira MS, 2014, FOOD SCI TECHNOL, V59, P86; Simionatto E, 2007, QUIM NOVA, V30, P1923, DOI 10.1590/S0100-40422007000800024; Sousa CMDM, 2007, QUIM NOVA, V30, P351, DOI 10.1590/S0100-40422007000200021; Tepe B, 2005, FOOD CHEM, V90, P685, DOI 10.1016/j.foodchem.2004.04.030; Trevisan MTS, 2006, J AGR FOOD CHEM, V54, P4378, DOI 10.1021/jf060181+; Tucker AO, 2001, J ESSENT OIL RES, V13, P198, DOI 10.1080/10412905.2001.9699662; Yunes RA, 2007, QUIMICA PRODUTOS NAT, P209	36	7	7	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166684	10.1371/journal.pone.0166684	http://dx.doi.org/10.1371/journal.pone.0166684			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907002	Green Submitted, Green Published, gold			2022-12-26	WOS:000389482700034
J	Mercado, E				Mercado, Eduardo, III			Acoustic Signaling by Singing Humpback Whales (Megaptera novaeangliae): What Role Does Reverberation Play?	PLOS ONE			English	Article							SOUND-TRANSMISSION; SONG; COMMUNICATION; DISTANCE; CLASSIFICATION; VOCALIZATION; CONSTRAINTS; ADAPTATIONS; BIRDSONG; HABITAT	When humpback whales (Megaptera novaeangliae) sing in coastal waters, the units they produce can generate reverberation. Traditionally, such reverberant acoustic energy has been viewed as an incidental side-effect of high-amplitude, long-distance, sound transmission in the ocean. An alternative possibility, however, is that reverberation actually contributes to the structure and function of songs. In the current study, this possibility was assessed by analyzing reverberation generated by humpback whale song units, as well as the spectral structure of unit sequences, produced by singers from different regions. Acoustical analyses revealed that: (1) a subset of units within songs generated narrowband reverberant energy that in some cases persisted for periods longer than the interval between units; (2) these highly reverberant units were regularly repeated throughout the production of songs; and (3) units occurring before and after these units often contained spectral energy peaks at non-overlapping, adjacent frequencies that were systematically related to the bands of reverberant energy generated by the units. These findings strongly suggest that some singing humpback whales not only produce sounds conducive to long-duration reverberation, but also may sequentially structure songs to avoid spectral overlap between units and ongoing reverberation. Singer-generated reverberant energy that is received simultaneously with directly transmitted song units can potentially provide listening whales with spatial cues that may enable them to more accurately determine a singer's position.	[Mercado, Eduardo, III] SUNY Buffalo, Dept Psychol, Buffalo, NY 14260 USA; [Mercado, Eduardo, III] SUNY Buffalo, Evolut Ecol & Behav Program, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Mercado, E (corresponding author), SUNY Buffalo, Dept Psychol, Buffalo, NY 14260 USA.; Mercado, E (corresponding author), SUNY Buffalo, Evolut Ecol & Behav Program, Buffalo, NY 14260 USA.	emiii@buffalo.edu			National Science Foundation [0718004]; Cetamada of Madagascar; NSF [0718004]	National Science Foundation(National Science Foundation (NSF)); Cetamada of Madagascar; NSF(National Science Foundation (NSF))	This work was supported by the National Science Foundation Grant No, 0718004, nsf.gov, EM; Cetamada of Madagascar, Travel Grant, cetamada.org, EM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by NSF Grant No, 0718004 and a travel fellowship from Cetamada of Madagascar. I thank Jennifer Schneider and Patchouly Banks for their help in collecting song recordings off the coast of Rincon, as well as Herve Glotin, Marc Lammers, Christina Perazio, David Rothenberg, and Olivier Adam, for providing recordings of humpback whale songs collected in earlier studies, and for permission to include those recordings in the current analyses.	Au WWL, 2006, J ACOUST SOC AM, V120, P1103, DOI 10.1121/1.2211547; Au WWL, 2001, HEARING WHALES DOLPH; Barker NKS, 2009, ETHOLOGY, V115, P897, DOI 10.1111/j.1439-0310.2009.01674.x; Barth M, 2015, ROUTL STUD SUSTAIN, P1; Bass AH, 2003, SPR HDB AUD, V16, P15; Branstetter B., 2006, INT J COMP PSYCHOL, V19, P26; CATO D H, 1991, Memoirs of the Queensland Museum, V30, P277; Cholewiak DM, 2013, MAR MAMMAL SCI, V29, pE312, DOI 10.1111/mms.12005; Clapham PJ, 2000, CETACEAN SOCIETIES, P173; Desharnais F, 1997, IEEE J OCEANIC ENG, V22, P309, DOI 10.1109/48.585950; Edds-Walton Peggy L., 1997, Bioacoustics, V8, P47; ELLIS DD, 1993, IEEE J OCEANIC ENG, V18, P474, DOI 10.1109/48.262297; ELLIS DD, 1995, J ACOUST SOC AM, V97, P2804, DOI 10.1121/1.411910; Ellison WT., 1987, REP INT WHALING COMM, V37, P329; Eriksen N, 2005, BEHAVIOUR, V142, P305, DOI 10.1163/1568539053778283; FRANKEL AS, 1995, CAN J ZOOL, V73, P1134, DOI 10.1139/z95-135; Garland EC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079422; Garland EC, 2013, J ACOUST SOC AM, V133, P560, DOI 10.1121/1.4770232; Garland EC, 2011, CURR BIOL, V21, P687, DOI 10.1016/j.cub.2011.03.019; Green S., 1979, SOCIAL BEHAV COMMUNI, P73, DOI DOI 10.1007/978-1-4615-9116-0_3; Green SR, 2011, BEHAV PROCESS, V86, P284, DOI 10.1016/j.beproc.2010.12.014; GUINEE LN, 1988, ETHOLOGY, V79, P295; Guinee LN., 1983, COMMUNICATION BEHAV; HELWEG DA, 1992, MARINE MAMMAL SENSORY SYSTEMS, P459; Holland J, 1998, J ACOUST SOC AM, V103, P2154, DOI 10.1121/1.421361; Kirschel ANG, 2009, BEHAV ECOL, V20, P1089, DOI 10.1093/beheco/arp101; Lardner B, 2002, NATURE, V420, P475, DOI 10.1038/420475a; LePage KD, 1998, SR301 SACLANT UND RE; MacKay MM, 2016, CAN J ZOOL, V94, P517, DOI 10.1139/cjz-2015-0198; MARTEN K, 1977, BEHAV ECOL SOCIOBIOL, V2, P271, DOI 10.1007/BF00299740; McComb K, 2003, ANIM BEHAV, V65, P317, DOI 10.1006/anbe.2003.2047; Mercado E, 2000, OCEANS 2000 MTS/IEEE - WHERE MARINE SCIENCE AND TECHNOLOGY MEET, VOLS 1-3, CONFERENCE PROCEEDINGS, P1743, DOI 10.1109/OCEANS.2000.882192; Mercado E, 1999, J ACOUST SOC AM, V106, P3004, DOI 10.1121/1.428120; Mercado E, 2013, P M AC, V19, P1; Mercado E, 2007, J ACOUST SOC AM, V121, P2499, DOI 10.1121/1.2717495; Mercado E, 2010, J ACOUST SOC AM, V127, P2678, DOI 10.1121/1.3309453; Mobley J, 2001, ABUNDANCE HUMPBACK W; MORTON ES, 1975, AM NAT, V109, P17, DOI 10.1086/282971; Naguib M, 2003, J ACOUST SOC AM, V113, P1749, DOI 10.1121/1.1539050; Naguib M, 2001, ANIM BEHAV, V62, P825, DOI 10.1006/anbe.2001.1860; Nemeth E, 2006, J ACOUST SOC AM, V119, P620, DOI 10.1121/1.2139072; OBRIST MK, 1995, BEHAV ECOL SOCIOBIOL, V36, P207, DOI 10.1007/s002650050142; Ou H, 2013, J ACOUST SOC AM, V133, P301, DOI 10.1121/1.4770251; Pace F, 2010, APPL ACOUST, V71, P1107, DOI 10.1016/j.apacoust.2010.05.016; PAYNE K, 1985, Z TIERPSYCHOL, V68, P89; Payne K., 1983, COMMUNICATION BEHAV, P9; PAYNE R, 1971, ANN NY ACAD SCI, V188, P110, DOI 10.1111/j.1749-6632.1971.tb13093.x; Payne R., 1983, COMMUNICATION BEHAV, P333; PAYNE RS, 1971, SCIENCE, V173, P585, DOI 10.1126/science.173.3997.585; Perazio CE, MADAGASCAR IN PRESS; RICHARDS DG, 1980, AM NAT, V115, P381, DOI 10.1086/283568; Rothenberg D., 2015, MAUI ONE MADAGASCAR; Rothenberg D, 2008, LEONARDO MUSIC J, V18, P47, DOI 10.1162/lmj.2008.18.47; Slabbekoorn H, 2002, CONDOR, V104, P564, DOI 10.1650/0010-5422(2002)104[0564:BASTTB]2.0.CO;2; Suzuki R, 2006, J ACOUST SOC AM, V119, P1849, DOI 10.1121/1.2161827; Tyack PL, 2000, SPR HDB AUD, V12, P156; Tyack PL, 1997, PERSP ETHOL, V12, P251; Tyack PL, 2000, CETACEAN SOCIETIES, P270; URICK RJ, 1970, J ACOUST SOC AM, V48, P392, DOI 10.1121/1.1912140; WASER PM, 1977, Z TIERPSYCHOL, V43, P239; WILEY RH, 1978, BEHAV ECOL SOCIOBIOL, V3, P69, DOI 10.1007/BF00300047; WINN HE, 1981, BEHAV ECOL SOCIOBIOL, V8, P41, DOI 10.1007/BF00302842; WINN HE, 1978, MAR BIOL, V47, P97, DOI 10.1007/BF00395631	63	11	12	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167277	10.1371/journal.pone.0167277	http://dx.doi.org/10.1371/journal.pone.0167277			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907182	Green Published, gold, Green Submitted			2022-12-26	WOS:000389482700108
J	Rouger, C; Pagie, S; Derbre, S; Le Ray, AM; Richomme, P; Charreau, B				Rouger, Caroline; Pagie, Sylvain; Derbre, Severine; Le Ray, Anne-Marie; Richomme, Pascal; Charreau, Beatrice			Prenylated Polyphenols from Clusiaceae and Calophyllaceae with Immunomodulatory Activity on Endothelial Cells	PLOS ONE			English	Article							MHC CLASS-I; IMMUNE-RESPONSE; CYCLOSPORINE-A; HLA-E; MICA; INHIBITION; EXPRESSION; COUMARINS; STATINS; CALCINEURIN	Endothelial cells (ECs) are key players in inflammation and immune responses involved in numerous pathologies. Although attempts were experimentally undertaken to prevent and control EC activation, drug leads and probes still remain necessary. Natural products (NPs) from Clusiaceous and Calophyllaceous plants were previously reported as potential candidates to prevent endothelial dysfunction. The present study aimed to identify more precisely the molecular scaffolds that could limit EC activation. Here, 13 polyphenols belonging to 5 different chemical types of secondary metabolites (i.e., mammea coumarins, a biflavonoid, a pyranochromanone acid, a polyprenylated polycyclic acylphloroglucinol (PPAP) and two xanthones) were tested on resting and cytokine-activated EC cultures. Quantitative and qualitative changes in the expression of both adhesion molecules (VCAM-1, ICAM-1, E-selectin) and major histocompatibility complex (MHC) molecules have been used to measure their pharmaceutical potential. As a result, we identified 3 mammea coumarins that efficiently reduce (up to >90% at 10 mu M) both basal and cytokine-regulated levels of MHC class I, class II, MICA and HLA-E on EC surface. They also prevented VCAM-1 induction upon inflammation. From a structural point of view, our results associate the loss of the free prenyl group substituting mammea coumarins with a reduced cellular cytotoxicity but also an abrogation of their anti-inflammatory potential and a reduction of their immunosuppressive effects. A PPAP, guttiferone J, also triggers a strong immunomodulation but restricted to HLA-E and MHC class II molecules. In conclusion, mammea coumarins with a free prenyl group and the PPAP guttiferone J emerge as NPs able to drastically decrease both VCAM-1 and a set of MHC molecules and to potentially reduce the immunogenicity of the endothelium.	[Rouger, Caroline; Derbre, Severine; Le Ray, Anne-Marie; Richomme, Pascal] Univ Angers, QUASAV SFR4207, SONAS EA921, Campus Vegetal, Beaucouze, France; [Pagie, Sylvain; Charreau, Beatrice] INSERM UMR1064, Ctr Rech Transplantat & Immunol, IHU CESTI, LabEx IGO, Nantes, France; [Pagie, Sylvain; Charreau, Beatrice] LabEx Transplantex, Nantes, France; [Pagie, Sylvain; Charreau, Beatrice] CHU Nantes, ITUN, Nantes, France; [Pagie, Sylvain; Charreau, Beatrice] Univ Nantes, LUNAM, Fac Med, Nantes, France	Universite d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Nantes Universite	Derbre, S (corresponding author), Univ Angers, QUASAV SFR4207, SONAS EA921, Campus Vegetal, Beaucouze, France.; Charreau, B (corresponding author), INSERM UMR1064, Ctr Rech Transplantat & Immunol, IHU CESTI, LabEx IGO, Nantes, France.; Charreau, B (corresponding author), LabEx Transplantex, Nantes, France.; Charreau, B (corresponding author), CHU Nantes, ITUN, Nantes, France.; Charreau, B (corresponding author), Univ Nantes, LUNAM, Fac Med, Nantes, France.	sevenne.derbre@univ-angers.fr; beatrice.Charreau@univ-nantes.fr	CHARREAU, Beatrice/AAK-8186-2020; DERBRE, Séverine/AAJ-4904-2021	CHARREAU, Beatrice/0000-0001-5870-4615; DERBRE, Séverine/0000-0002-3953-5745; Rouger, Caroline/0000-0002-6442-6567; LE RAY, ANNE-MARIE/0000-0003-0542-6169	Ministere de l'Enseignement Superieur et de la Recherche; Pays de la Loire Region; French government [ANR-10-IBHU-005, ANR-11-LABX-0016-01, ANR-11-LABX-0070]; Nantes Metropole; "Fondation Centaure" (RTRS)	Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research Council); Pays de la Loire Region(Region Pays de la Loire); French government; Nantes Metropole(Region Pays de la Loire); "Fondation Centaure" (RTRS)	This work was supported by a grant from the Ministere de l'Enseignement Superieur et de la Recherche (C.R.), by "PROVASC" and "HYPROTEC", grants from the Pays de la Loire Region (S.P.). It was realized in the context of the IHU-Cesti, LabEx IGO and LabEx Transplantex projects which received French government financial support managed by the National Research Agency (ANR) via the "Investment Into The Future" programs ANR-10-IBHU-005, ANR-11-LABX-0016-01 and ANR-11-LABX-0070. The IHU-Cesti project is also supported by Nantes Metropole and the Pays de la Loire Region. This study was also supported by the "Fondation Centaure" (RTRS) which supports a French transplantation research network.	Aird WC, 2008, PHARMACOL REP, V60, P139; Dang BT, 2014, FITOTERAPIA, V96, P65, DOI 10.1016/j.fitote.2014.04.005; Bedi O, 2016, N-S ARCH PHARMACOL, V389, P695, DOI 10.1007/s00210-016-1252-4; Belliard Guillaume, 2005, Nephrol Ther, V1, P221, DOI 10.1016/j.nephro.2005.06.008; Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869; Cechinel V, 2009, CHEM BIODIVERS, V6, P313, DOI 10.1002/cbdv.200800082; Cen JR, 2015, BIOCHIMIE, V111, P119, DOI 10.1016/j.biochi.2015.02.004; Cen JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066503; Chauveau A, 2014, J INNATE IMMUN, V6, P89, DOI 10.1159/000351605; Choi J, 2004, ANNU REV IMMUNOL, V22, P683, DOI 10.1146/annurev.immunol.22.012703.104639; Cook-Mills JM, 2011, ANTIOXID REDOX SIGN, V15, P1607, DOI 10.1089/ars.2010.3522; Coupel S, 2007, BLOOD, V109, P2806, DOI 10.1182/blood-2006-06-030213; Dang BT, 2015, MOLECULES, V20, P17735, DOI 10.3390/molecules201017735; Dang BT, 2015, PHYTOCHEM LETT, V11, P61, DOI 10.1016/j.phytol.2014.11.011; de Melo MS, 2014, EVID-BASED COMPL ALT, V2014, DOI [10.1155/2014/960258, DOI 10.1155/2014/960258]; Dobson CM, 2004, NATURE, V432, P824, DOI 10.1038/nature03192; Dzoyem JP, 2015, PHYTOCHEM LETT, V14, P153, DOI 10.1016/j.phytol.2015.10.003; Ferchichi L, 2012, PHYTOCHEMISTRY, V78, P98, DOI 10.1016/j.phytochem.2012.02.006; Gavlovsky PJ, 2016, HUM IMMUNOL; Gomez-Verjan J, 2015, SCIENTOMETRICS, V105, P1019, DOI 10.1007/s11192-015-1715-2; Greenwood J, 2006, NAT REV IMMUNOL, V6, P358, DOI 10.1038/nri1839; Guilet D, 2001, J NAT PROD, V64, P563, DOI 10.1021/np000517o; Hay AE, 2004, LIFE SCI, V75, P3077, DOI 10.1016/j.lfs.2004.07.009; Khachigian LM, 1997, AM J PATHOL, V151, P1225; Kwak B, 2000, NAT MED, V6, P1399, DOI 10.1038/82219; Li JY, 2010, PHARM BIOL, V48, P1177, DOI 10.3109/13880200903573169; Magadula J. J., 2012, Journal of Pharmaceutical and Scientific Innovation (JPSI), V1, P31; Merza J, 2006, PLANTA MED, V72, P87, DOI 10.1055/s-2005-873185; Morel C, 1999, HETEROCYCLES, V51, P2183; Muraro M, 2007, CELL IMMUNOL, V249, P63, DOI 10.1016/j.cellimm.2007.11.005; Newman DJ, 2016, J NAT PROD, V79, P629, DOI 10.1021/acs.jnatprod.5b01055; Peng LQ, 2011, IUBMB LIFE, V63, P14, DOI 10.1002/iub.408; Pich C, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00062; Pober JS, 2012, TRENDS IMMUNOL, V33, P49, DOI 10.1016/j.it.2011.09.006; Raad I, 2006, BIOORGAN MED CHEM, V14, P6979, DOI 10.1016/j.bmc.2006.06.026; Reyes-Chilpa R, 2004, LIFE SCI, V75, P1635, DOI 10.1016/j.lfs.2004.03.017; Rouger C, 2015, J NAT PROD, V78, P2187, DOI 10.1021/acs.jnatprod.5b00222; Russell RGG, 2008, OSTEOPOROSIS INT, V19, P733, DOI 10.1007/s00198-007-0540-8; Schmitt EK, 2016, J IND MICROBIOL BIOT, V43, P249, DOI 10.1007/s10295-015-1691-9; Schrambach S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000518; Singh P, 2009, ANN NY ACAD SCI, V1173, P746, DOI 10.1111/j.1749-6632.2009.04646.x; Survase SA, 2011, BIOTECHNOL ADV, V29, P418, DOI 10.1016/j.biotechadv.2011.03.004; Tilkin-Mariame AF, 2005, FASEB J, V19, P1513, DOI 10.1096/fj.04-3482fje; Yazaki K, 2009, PHYTOCHEMISTRY, V70, P1739, DOI 10.1016/j.phytochem.2009.08.023; Zhang YM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146944; Zou Y, 2010, TISSUE ANTIGENS, V76, P171, DOI 10.1111/j.1399-0039.2010.01527.x; Zwirner NW, 1998, IMMUNOGENETICS, V47, P139	47	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167361	10.1371/journal.pone.0167361	http://dx.doi.org/10.1371/journal.pone.0167361			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907087	Green Submitted, Green Published, gold			2022-12-26	WOS:000389482700128
J	Sahyoun, R; Guidetti, P; Di Franco, A; Planes, S				Sahyoun, Rita; Guidetti, Paolo; Di Franco, Antonio; Planes, Serge			Patterns of Fish Connectivity between a Marine Protected Area and Surrounding Fished Areas	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; BREAM DIPLODUS-VULGARIS; POPULATION-STRUCTURE; LARVAL CONNECTIVITY; GENETIC PATCHINESS; MEDITERRANEAN SEA; MICROSATELLITE MARKERS; RESERVE NETWORKS; SELF-RECRUITMENT; WHITE SEA	Patterns of connectivity and self-recruitment are recognized as key factors shaping the dynamics of marine populations. Connectivity is also essential for maintaining and restoring natural ecological processes with genetic diversity contributing to the adaptation and persistence of any species in the face of global disturbances. Estimates of connectivity are crucial to inform the design of both marine protected areas (MPAs) and MPA networks. Among several approaches, genetic structure is frequently used as a proxy for patterns of connectivity. Using 8 microsatellite loci, we investigated genetic structure of the two-banded sea bream Diplodus vulgaris, a coastal fish that is both commercially and ecologically important. Adults were sampled in 7 locations (stretches of coastline approximately 8 km long) and juveniles in 14 sites (similar to 100 to 200 m of coastline) along 200 km of the Apulian Adriatic coast (SW Adriatic Sea), within and outside an MPA (Torre Guaceto MPA, Italy). Our study found similar genetic diversity indices for both the MPA and the surrounding fished areas. An overall lack of genetic structure among samples suggests high gene flow (i.e. connectivity) across a scale of at least 200 km. However, some local genetic divergences found in two locations demonstrate some heterogeneity in processes renewing the population along the Apulian Adriatic coast. Furthermore, two sites appeared genetically divergent, reinforcing our observations within the genetic makeup of adults and confirming heterogeneity in early stage genetics that can come from either different supply populations or from chaotic genetic patchiness occurring under temporal variation in recruitment and in the reproductive success. While the specific role of the MPA is not entirely known in this case, these results confirm the presence of regional processes and the key role of connectivity in maintaining the local population supply.	[Sahyoun, Rita; Di Franco, Antonio; Planes, Serge] PSL Res Univ, EPHE, UPVD, CNRS,USR 3278,CRIOBE, Perpignan, France; [Guidetti, Paolo; Di Franco, Antonio] Univ Cote dAzur, CNRS, ECOMERS, Parc Valrose,Ave Valrose, Nice, France; [Guidetti, Paolo; Di Franco, Antonio] CoNISMa Consorzio Nazl Interuniv Sci Mare, Piazzale Flaminio, Rome, Italy	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; CoNISMa	Sahyoun, R (corresponding author), PSL Res Univ, EPHE, UPVD, CNRS,USR 3278,CRIOBE, Perpignan, France.	rita.sahyoun@gmail.com	PLANES, Serge/ABF-1360-2021; Di Franco, Antonio/A-8796-2010	Di Franco, Antonio/0000-0003-3411-7015	Total Foundation	Total Foundation(Total SA)	This study has been done in the framework of the project entitled 'Designing networks of marine protected areas in the Mediterranean context', funded by Total Foundation (http://fondation.total.com/fr). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis D, 2009, ESTUAR COAST SHELF S, V85, P525, DOI 10.1016/j.ecss.2009.09.001; Almany GR, 2009, CORAL REEFS, V28, P339, DOI 10.1007/s00338-009-0484-x; Almany GR, 2013, CURR BIOL, V23, P626, DOI 10.1016/j.cub.2013.03.006; Alos J, 2012, FISH RES, V115, P82, DOI 10.1016/j.fishres.2011.11.025; Arculeo M, 2003, FISH RES, V63, P339, DOI 10.1016/S0165-7836(03)00102-4; Arnaud-Haond S, 2008, MAR BIOL, V155, P147, DOI 10.1007/s00227-008-1013-0; Artegiani A, 1997, J PHYS OCEANOGR, V27; Aspillaga E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159813; Bell JJ, 2008, BIOL CONSERV, V141, P2807, DOI 10.1016/j.biocon.2008.08.017; Benzie JAH, 2006, MAR ECOL PROG SER, V314, P197, DOI 10.3354/meps314197; Bernal-Ramirez JH, 2003, MAR BIOL, V142, P567, DOI 10.1007/s00227-002-0972-9; Berumen ML, 2012, ECOL EVOL, V2, P444, DOI 10.1002/ece3.208; Botsford LW, 2009, REV FISH BIOL FISHER, V19, P69, DOI 10.1007/s11160-008-9092-z; Buston PM, 2012, P ROY SOC B-BIOL SCI, V279, P1883, DOI 10.1098/rspb.2011.2041; Carreras-Carbonell J, 2007, MAR BIOL, V151, P719, DOI 10.1007/s00227-006-0513-z; Christie MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015715; Claudet J, 2008, ECOL LETT, V11, P481, DOI 10.1111/j.1461-0248.2008.01166.x; Conover DO, 2006, J FISH BIOL, V69, P21, DOI 10.1111/j.1095-8649.2006.01274.x; Cornuet JM, 1999, GENETICS, V153, P1989; Di Franco A, 2015, BIOL CONSERV, V192, P361, DOI 10.1016/j.biocon.2015.10.015; Di Franco A, 2013, MAR ECOL PROG SER, V476, P227, DOI 10.3354/meps10117; Di Franco A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052108; Di Franco A, 2009, MAR ECOL PROG SER, V387, P275, DOI 10.3354/meps08051; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Fenberg PB, 2012, MAR POLICY, V36, P1012, DOI 10.1016/j.marpol.2012.02.021; Gaines SD, 2010, P NATL ACAD SCI USA, V107, P18286, DOI 10.1073/pnas.0906473107; Galarza JA, 2009, P NATL ACAD SCI USA, V106, P1473, DOI 10.1073/pnas.0806804106; Garcia-Charton JA, 2008, J NAT CONSERV, V16, P193, DOI 10.1016/j.jnc.2008.09.007; Gonzalez-Wanguemert M, 2012, J SEA RES, V68, P41, DOI 10.1016/j.seares.2011.12.005; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Gruss A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019960; Guidetti P, 2007, MAR ECOL PROG SER, V335, P43, DOI 10.3354/meps335043; Guidetti P, 2006, ECOL APPL, V16, P963, DOI 10.1890/1051-0761(2006)016[0963:MRRLPI]2.0.CO;2; Harrison HB, 2012, CURR BIOL, V22, P1023, DOI 10.1016/j.cub.2012.04.008; Hartland DL, 1989, PRINCIPLES POPULATIO; Hastings A, 2006, P NATL ACAD SCI USA, V103, P6067, DOI 10.1073/pnas.0506651103; Hellberg ME, 2009, ANNU REV ECOL EVOL S, V40, P291, DOI 10.1146/annurev.ecolsys.110308.120223; Hilborn R, 2004, OCEAN COAST MANAGE, V47, P197, DOI 10.1016/j.ocecoaman.2004.04.001; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; JOHNSON MS, 1984, EVOLUTION, V38, P1371, DOI 10.1111/j.1558-5646.1984.tb05658.x; Johnson MS, 1982, MAR BIOL; Jones GP, 2009, CORAL REEFS, V28, P307, DOI 10.1007/s00338-009-0469-9; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; KRUSKAL W, 1978, SCIENCE, V199, P1026, DOI 10.1126/science.199.4333.1026; La Mesa G, 2011, FISH RES, V111, P24, DOI 10.1016/j.fishres.2011.06.008; Larson RJ, 1999, CAL COOP OCEAN FISH, V40, P94; Lenfant P, 1996, J FISH BIOL, V49, P613, DOI 10.1111/j.1095-8649.1996.tb00058.x; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; Lloret J, 2008, FISH RES, V91, P252, DOI 10.1016/j.fishres.2007.12.002; McCook LJ, 2010, P NATL ACAD SCI USA, V107, P18278, DOI 10.1073/pnas.0909335107; Mitarai S, 2008, J MARINE SYST, V69, P295, DOI 10.1016/j.jmarsys.2006.02.017; Nielsen EE, 2009, MOL ECOL, V18, P3128, DOI 10.1111/j.1365-294X.2009.04272.x; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Palumbi SR, 2001, MARINE COMMUNITY ECOLOGY, P509; Palumbi SR, 2003, ECOL APPL, V13, pS146; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Planes Serge, 2002, P201, DOI 10.1016/B978-012615185-5/50012-8; Pritchard JK, 2000, GENETICS, V155, P945; Pujolar JM, 2013, DIVERS DISTRIB, V19, P1531, DOI 10.1111/ddi.12114; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Roques S, 2007, CONSERV GENET, V8, P1255, DOI 10.1007/s10592-006-9254-2; Roques S, 2007, MOL ECOL NOTES, V7, P661, DOI 10.1111/j.1471-8286.2006.01667.x; Sala E, 1998, OIKOS, V82, P425, DOI 10.2307/3546364; Sala E, 2012, PLOS ONE, V7; Sala-Bozano M, 2009, MOL ECOL, V18, P4811, DOI 10.1111/j.1365-294X.2009.04404.x; Sanford E, 2011, ANNU REV MAR SCI, V3, P509, DOI 10.1146/annurev-marine-120709-142756; Siegel DA, 2008, P NATL ACAD SCI USA, V105, P8974, DOI 10.1073/pnas.0802544105; TAUTZ D, 1989, NUCLEIC ACIDS RES, V17, P6463, DOI 10.1093/nar/17.16.6463; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Watson JR, 2010, MAR ECOL PROG SER, V401, P31, DOI 10.3354/meps08376; White C, 2008, ECOL LETT, V11, P370, DOI 10.1111/j.1461-0248.2007.01151.x	77	10	11	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167441	10.1371/journal.pone.0167441	http://dx.doi.org/10.1371/journal.pone.0167441			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907100	Green Published, Green Submitted, gold			2022-12-26	WOS:000389482700157
J	Winther, M; Holdfeldt, A; Gabl, M; Wang, JM; Forsman, H; Dahlgren, C				Winther, Malene; Holdfeldt, Andre; Gabl, Michael; Wang, Ji Ming; Forsman, Huamei; Dahlgren, Claes			Formylated MHC Class lb Binding Peptides Activate Both Human and Mouse Neutrophils Primarily through Formyl Peptide Receptor 1	PLOS ONE			English	Article							CLASS-IB MOLECULE; STAPHYLOCOCCUS-AUREUS; RESPIRATORY BURST; LIGAND; RESPONSES; H2-M3; FPR; TUBERCULOSIS; INFLAMMATION; RECOGNITION	Two different immune recognition systems have evolved in parallel to recognize peptides starting with an N-formylated methionine, and recognition similarities/differences between these two systems have been investigated. A number of peptides earlier characterized in relation to the H2-M3 complex that presents N-formylated peptides to cytotoxic T cells, have been characterized in relation to the formyl peptide receptors expressed by phagocytic neutrophils in both men (FPRs) and mice (Fprs). FPR1/Fpr1 was identified as the preferred receptor for all fMet-containing peptides examined, but there was no direct correlation between H2-M3 binding and the neutrophil activation potencies. Similarly, there was no direct correlation between the activities induced by the different peptides in human and mouse neutrophils, respectively. The formyl group was important in both H2-M3 binding and FPR activation, but FPR2 was the preferred receptor for the non-formylated peptide. The structural requirements differed between the H2-M3 and FPR/Fpr recognition systems and these data suggest that the two recognition systems have different evolutionary traits.	[Winther, Malene; Holdfeldt, Andre; Gabl, Michael; Forsman, Huamei; Dahlgren, Claes] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden; [Wang, Ji Ming] Frederick Natl Lab Canc Res, Ctr Canc Res, Frederick, MD USA	University of Gothenburg; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Dahlgren, C (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden.	Claes.Dahlgren@microbio.gu.se		de Winther, Menno/0000-0002-4038-6636	Swedish research council; King Gustaf the Vth 80-year foundation; Clas Groschinsky foundation; Ake Wiberg foundation; IngaBritt and Arne Lundbergs foundation; Sahlgrenska university hospital	Swedish research council(Swedish Research CouncilEuropean Commission); King Gustaf the Vth 80-year foundation; Clas Groschinsky foundation; Ake Wiberg foundation; IngaBritt and Arne Lundbergs foundation; Sahlgrenska university hospital	The research was supported by grants from the Swedish research council, The King Gustaf the Vth 80-year foundation, the Clas Groschinsky foundation, the Ake Wiberg foundation, from IngaBritt and Arne Lundbergs foundation, and the Sahlgrenska university hospital through the national ALF-agreement. The funding agencies had no influence on the study design, data collection and analysis, or writing and submission of the report.; We thank the members of the Phagocyte Research Group at the Sahlgrenska Academy for critically discussing the results and the manuscript. The research was supported by grants from the Swedish research council, The King Gustaf the Vth 80-year foundation, the Clas Groschinsky foundation, the Ake Wiberg foundation, from IngaBritt and Arne Lundbergs foundation and, the Sahlgrenska university hospital through the national ALF-agreement. The funding agencies had no influence on the study design, data collection and analysis, or writing and submission of the report.	Arnoult D, 2011, EMBO REP, V12, P901, DOI 10.1038/embor.2011.157; Arterburn JB, 2009, CURR TOP MED CHEM, V9, P1227, DOI 10.2174/156802609789753608; BOYUM A, 1991, SCAND J IMMUNOL, V34, P697, DOI 10.1111/j.1365-3083.1991.tb01594.x; Bylund J., 2014, INFLAMM CELL SIGNAL, V1, P1; Bylund J, 2014, METHODS MOL BIOL, V1124, P321, DOI 10.1007/978-1-62703-845-4_21; Chen KQ, 2010, J IMMUNOL, V184, P3331, DOI 10.4049/jimmunol.0903022; Chiang N, 2000, J EXP MED, V191, P1197, DOI 10.1084/jem.191.7.1197; Chun T, 2001, J EXP MED, V193, P1213, DOI 10.1084/jem.193.10.1213; Colmone A, 2006, MICROBES INFECT, V8, P2277, DOI 10.1016/j.micinf.2006.03.020; Dahlgren C, 1999, J IMMUNOL METHODS, V232, P3, DOI 10.1016/S0022-1759(99)00146-5; Dahlgren C, 2016, BIOCH PHARM; Forsman H, 2015, BBA-MOL CELL RES, V1853, P192, DOI 10.1016/j.bbamcr.2014.10.021; Forsman H, 2012, J IMMUNOL, V189, P629, DOI 10.4049/jimmunol.1101616; Forsman H, 2012, INFECT IMMUN, V80, P1987, DOI 10.1128/IAI.05906-11; Fu HM, 2008, J IMMUNOL METHODS, V331, P50, DOI 10.1016/j.jim.2007.11.005; Fu HM, 2006, J LEUKOCYTE BIOL, V79, P247, DOI 10.1189/jlb.0905498; Gulden PH, 1996, IMMUNITY, V5, P73, DOI 10.1016/S1074-7613(00)80311-8; Hazeldine J, 2015, INJURY, V46, P975, DOI 10.1016/j.injury.2015.03.028; He HQ, 2014, J BIOL CHEM, V289, P2295, DOI 10.1074/jbc.M113.509216; He HQ, 2013, MOL PHARMACOL, V83, P389, DOI 10.1124/mol.112.081315; Holdfeldt A, 2016, J BIOL CHEM; Itou T, 2006, CLIN VACCINE IMMUNOL, V13, P575, DOI 10.1128/CVI.13.5.575-583.2006; Jones RM, 2012, CURR MED CHEM, V19, P1519; Karlsson J, 2009, CELL CALCIUM, V45, P431, DOI 10.1016/j.ceca.2009.02.002; Kerksiek KM, 1999, J EXP MED, V190, P195, DOI 10.1084/jem.190.2.195; Kretschmer D, 2010, CELL HOST MICROBE, V7, P463, DOI 10.1016/j.chom.2010.05.012; Mir SA, 2013, VACCINE, V31, P3818, DOI 10.1016/j.vaccine.2013.04.005; Movitz C, 2010, J BIOL CHEM, V285, P14338, DOI 10.1074/jbc.M109.080465; Schepetkin IA, 2014, CURR MED CHEM, V21, P1478, DOI 10.2174/0929867321666131218095521; Skovbakke SL, 2016, BIOCHEM PHARMACOL, V119, P56, DOI 10.1016/j.bcp.2016.09.004; Stenfeldt AL, 2007, INFLAMMATION, V30, P224, DOI 10.1007/s10753-007-9040-4; VYAS JM, 1992, J IMMUNOL, V149, P3605; WANG CR, 1995, CELL, V82, P655, DOI 10.1016/0092-8674(95)90037-3; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578	34	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167529	10.1371/journal.pone.0167529	http://dx.doi.org/10.1371/journal.pone.0167529			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907124	Green Published, Green Submitted, gold			2022-12-26	WOS:000389482700184
J	Berressem, D; Koch, K; Franke, N; Klein, J; Eckert, GP				Berressem, Dirk; Koch, Konrad; Franke, Nicole; Klein, Jochen; Eckert, Gunter P.			Intravenous Treatment with a Long-Chain Omega-3 Lipid Emulsion Provides Neuroprotection in a Murine Model of Ischemic Stroke - A Pilot Study	PLOS ONE			English	Article							FATTY-ACIDS; CEREBRAL-ISCHEMIA; MITOCHONDRIAL DYSFUNCTION; EICOSAPENTAENOIC ACID; INFLAMMATORY RESPONSE; MOLECULAR-MECHANISMS; BRAIN ISCHEMIA; CELL-DEATH; TRANSIENT; INJURY	Single long-chain omega-3 fatty acids (e.g. docosahexaenoic acid (DHA) or eicosapentaenoic acid (EPA)) are known for their neuroprotective properties associated with ischemic stroke. This pilot study aimed to test the effectiveness of an acute treatment with a long-chain omega-3 lipid emulsion (Omegaven 10%(R), OGV) that contains fish oil (DHA 18 mg/ml; EPA 21 mg/ml) and a-tocopherol (0.2 mg/ml) in a transient middle cerebral artery occlusion (MCAO) model of ischemic stroke in mice. For this purpose, female CD-1 mice were anesthetized and subjected to 90 minutes of MCAO. To reflect a clinically relevant situation for an acute treatment, either after induction of stroke or after reperfusion, a single dose of OGV was injected intravenously into the tail vein (5 ml/kg b.w.). A neurological severity score was used to assess motor function and neurological outcome. Stroke-related parameters were determined 24 hours after MCAO. Microdialysis was used to collect samples from extracellular space of the striatum. Mitochondrial function was determined in isolated mitochondria or dissociated brain cells. Inflammation markers were measured in brain homogenate. According to control experiments, neuroprotective effects could be attributed to the long-chain omega-3 content of the emulsion. Intravenous injection of OGV reduced size and severity of stroke, restored mitochondrial function, and prevented excitotoxic glutamate release. Increases of pro-inflammatory markers (COX-2 and IL-6) were attenuated. Neurological severity scoring and neurochemical data demonstrated that acute OGV treatment shortly after induction of stroke was most efficient and able to improve short-term neurological outcome, reflecting the importance of an acute treatment to improve the outcome. Summarising, acute treatment of stroke with a single intravenous dose of OGV provided strong neuroprotective effects and was most effective when given immediately after onset of ischemia. As OGV is an approved fishoil emulsion for parenteral nutrition in humans, our results may provide first translational data for a possible early management of ischemic stroke with administration of OGV to prevent further brain damage.	[Berressem, Dirk; Koch, Konrad; Franke, Nicole; Klein, Jochen; Eckert, Gunter P.] Goethe Univ Frankfurt, Dept Pharmacol, Frankfurt, Germany; [Eckert, Gunter P.] Justus Liebig Univ Giessen, Inst Nutr Sci, Giessen, Germany	Goethe University Frankfurt; Justus Liebig University Giessen	Berressem, D (corresponding author), Goethe Univ Frankfurt, Dept Pharmacol, Frankfurt, Germany.	dberressem@gmx.net	Klein, Jochen/B-9730-2008	Klein, Jochen/0000-0001-6971-3381	Fresenius Kabi Deutschland GmbH, Bad Homburg, Deutschland	Fresenius Kabi Deutschland GmbH, Bad Homburg, Deutschland	This study was partly supported by Fresenius Kabi Deutschland GmbH, Bad Homburg, Deutschland. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amusquivar E, 2008, LIPIDS, V43, P713, DOI 10.1007/s11745-008-3180-7; Bannenberg G, 2010, BBA-MOL CELL BIOL L, V1801, P1260, DOI 10.1016/j.bbalip.2010.08.002; Bazan NG, 2009, J LIPID RES, V50, pS400, DOI 10.1194/jlr.R800068-JLR200; Belayev L, 2011, TRANSL STROKE RES, V2, P33, DOI 10.1007/s12975-010-0046-0; Belayev L, 2009, STROKE, V40, P3121, DOI 10.1161/STROKEAHA.109.555979; Blondeau N, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/519830; Borow KM, 2015, ATHEROSCLEROSIS, V242, P357, DOI 10.1016/j.atherosclerosis.2015.07.035; Bourourou M, 2016, NEUROPHARMACOLOGY, V108, P60, DOI 10.1016/j.neuropharm.2016.04.040; Byrne J, 2011, J THORAC CARDIOV SUR, V141, P803, DOI 10.1016/j.jtcvs.2010.04.030; Calder PC, 2009, POSTGRAD MED, V121, P148, DOI 10.3810/pgm.2009.11.2083; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Eady TN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077237; Eady Tiffany N, 2012, Exp Transl Stroke Med, V4, P19, DOI 10.1186/2040-7378-4-19; Eckert GP, 2013, NEUROCHEM INT, V62, P595, DOI 10.1016/j.neuint.2013.02.014; Eckert GP, 2013, PROSTAG LEUKOTR ESS, V88, P105, DOI 10.1016/j.plefa.2012.05.006; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Emon ST, 2011, TURK NEUROSURG, V21, P197, DOI 10.5137/1019-5149.JTN.3523-10.2; Franke C, 2007, NEUROBIOL DIS, V25, P438, DOI 10.1016/j.nbd.2006.10.004; Gercek A, JPEN J PARENTER ENTE, V31, P161; Gesellschaft fur Versuchstierkunde (GV-SOLAS), 2010, TIER VER TIERSCH EMP, P4; Hagl S, 2013, PHARMACOL RES, V76, P17, DOI 10.1016/j.phrs.2013.06.008; Harvey KA, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0005-6; Hong SH, 2014, J NEUROL SCI, V338, P135, DOI 10.1016/j.jns.2013.12.033; Horn T, 2013, NEUROCHEM INT, V62, P251, DOI 10.1016/j.neuint.2012.12.017; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Kiewert C, 2010, BRAIN RES, V1312, P101, DOI 10.1016/j.brainres.2009.11.068; Kilian M, 2009, PANCREAS, V38, P436, DOI 10.1097/MPA.0b013e318198283b; Kleinschnitz C, 2013, BLOOD, V121, P679, DOI 10.1182/blood-2012-04-426734; Lang D, 2011, BRAIN RES, V1425, P155, DOI 10.1016/j.brainres.2011.10.005; Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185; Larsson SC, 2012, EUR J EPIDEMIOL, V27, P895, DOI 10.1007/s10654-012-9748-9; Lin Y, 2015, NEUROSCIENCE, V301, P471, DOI 10.1016/j.neuroscience.2015.06.024; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Lopez-Armada MJ, 2013, MITOCHONDRION, V13, P106, DOI 10.1016/j.mito.2013.01.003; Lukiw WJ, 2005, J CLIN INVEST, V115, P2774, DOI 10.1172/JCI25420; Maldonado NJ, 2014, CRIT CARE CLIN, V30, P673, DOI 10.1016/j.ccc.2014.06.002; Molina CA, 2011, STROKE, V42, pS16, DOI 10.1161/STROKEAHA.110.598763; Mozaffarian D, 2011, J AM COLL CARDIOL, V58, P2047, DOI 10.1016/j.jacc.2011.06.063; Mukherjee PK, 2004, P NATL ACAD SCI USA, V101, P8491, DOI 10.1073/pnas.0402531101; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; NAKAHARA I, 1991, J NEUROCHEM, V57, P839, DOI 10.1111/j.1471-4159.1991.tb08227.x; Niizuma K, 2009, J NEUROCHEM, V109, P133, DOI 10.1111/j.1471-4159.2009.05897.x; Orr SK, 2013, PROSTAG LEUKOTR ESS, V88, P97, DOI 10.1016/j.plefa.2012.05.008; Pan HC, 2009, J NUTR BIOCHEM, V20, P715, DOI 10.1016/j.jnutbio.2008.06.014; Pascoe MC, 2015, NEUROPSYCH DIS TREAT, V11, P153, DOI 10.2147/NDT.S72925; Pastor-Clerigues A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115404; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Sanderson TH, 2013, MOL NEUROBIOL, V47, P9, DOI 10.1007/s12035-012-8344-z; Schwarzkopf TM, 2015, NEUROSCIENCE, V300, P201, DOI 10.1016/j.neuroscience.2015.05.014; Schwarzkopf TM, 2013, PHARMAZIE, V68, P584, DOI 10.1691/ph.2013.6513; Schwarzkopf TM, 2013, BRAIN RES, V1529, P178, DOI 10.1016/j.brainres.2013.07.003; Serhan CN., 2008, RESOLVINS PROTECTINS, P1; Spera PA, 1998, NEUROSCI LETT, V251, P189, DOI 10.1016/S0304-3940(98)00537-0; Spite M, 2014, CELL METAB, V19, P21, DOI 10.1016/j.cmet.2013.10.006; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; SUN DD, 1994, J NEUROCHEM, V62, P1921; Szydlowska K, 2010, CELL CALCIUM, V47, P122, DOI 10.1016/j.ceca.2010.01.003; Tanaka K, 2008, STROKE, V39, P2052, DOI 10.1161/STROKEAHA.107.509455; U.S. Department of Health and Human Services Food and Drug Administration, GUID IND EST MAX SAF; Vosler PS, 2009, STROKE, V40, P3149, DOI 10.1161/STROKEAHA.108.543769; Wachira JK, 2014, BRIT J NUTR, V111, P1652, DOI 10.1017/S000711451300425X; Waje-Andreassen U, 2005, ACTA NEUROL SCAND, V111, P360, DOI 10.1111/j.1600-0404.2005.00416.x; Wang Q, 2007, J NEUROIMMUNOL, V184, P53, DOI 10.1016/j.jneuroim.2006.11.014; Williams JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056233; Woodruff TM, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-11	65	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167329	10.1371/journal.pone.0167329	http://dx.doi.org/10.1371/journal.pone.0167329			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902774	gold, Green Published, Green Submitted			2022-12-26	WOS:000389474100072
J	Gamma, A; Schleifer, R; Weinmann, W; Buadze, A; Liebrenz, M				Gamma, Alex; Schleifer, Roman; Weinmann, Wolfgang; Buadze, Anna; Liebrenz, Michael			Could Google Trends Be Used to Predict Methamphetamine-Related Crime? An Analysis of Search Volume Data in Switzerland, Germany, and Austria	PLOS ONE			English	Article							RISE; HEALTH	Objective To compare the time trends of Google search interest in methamphetamine and criminal offences related to this drug. Methods Google Trends data for the search term "meth" was compared to methamphetamine-related crime statistics (incl. use, possession, and dealing) in Switzerland, Germany, and Austria for the years 2004-2016. Google data was availably monthly. Crime data was available yearly, and monthly values were imputed. Results On the country level, internet search trends for "meth" roughly paralleled relevant criminal activity. State-level data, which was available for Austria, showed more heterogeneity. Cross-correlations for yearly data almost always peaked at a lag time of 0 and coefficients were mostly between 0.7 and 1.0 on the country level, and between 0.5 to 1.0 on the state level. Monthly cross-correlations based on imputed values were substantially lower, ranging from 0 to 0.6. Conclusions These results encourage the further evaluation by law enforcement authorities of Google search activity as a possible predictor of methamphetamine-related crime. However, several limitations, in particular the crude temporal resolution of available crime data, precluded a detailed assessment of the relationship between internet search trends and the development of methamphetamine-related crime in central Europe.	[Gamma, Alex; Schleifer, Roman; Liebrenz, Michael] Univ Bern, Inst Forens Med, Dept Forens Psychiat, Bern, Switzerland; [Weinmann, Wolfgang] Univ Bern, Inst Forens Med, Dept Forens Toxicol & Chem, Bern, Switzerland; [Buadze, Anna] Univ Zurich, Hosp Psychiat, Dept Psychiat Psychotherapy & Psychosomat, Zurich, Switzerland	University of Bern; University of Bern; University of Zurich	Gamma, A (corresponding author), Univ Bern, Inst Forens Med, Dept Forens Psychiat, Bern, Switzerland.	Alexander.Gamma@fpd.unibe.ch		Buadze, Ana/0000-0002-8683-6807; Liebrenz, Michael/0000-0001-8040-2744				Ayers JW, 2016, AM J PREV MED, V50, pE173, DOI 10.1016/j.amepre.2015.12.008; Ayers JW, 2014, JAMA-J AM MED ASSOC, V311, P1399, DOI 10.1001/jama.2014.1505; Ayers JW, 2011, AM J PREV MED, V40, P448, DOI 10.1016/j.amepre.2010.12.007; BKA, 2013, BUND DEUTSCHL; Bramness JG, 2015, FORENSIC SCI INT, V246, P92, DOI 10.1016/j.forsciint.2014.11.010; Bruggisser M, 2010, SWISS MED WKLY, V140, DOI 10.4414/smw.2010.13115; Bundesamt fur Sport BASPO, 2014, SPORT SCHWEIZ 2014 O, P60; Cartier J, 2006, J INTERPERS VIOLENCE, V21, P435, DOI 10.1177/0886260505285724; Chomchai C, 2015, CURR OPIN PSYCHIATR, V28, P269, DOI 10.1097/YCO.0000000000000168; Cruickshank CC, 2009, ADDICTION, V104, P1085, DOI 10.1111/j.1360-0443.2009.02564.x; Csemy L, 2002, EUR ADDICT RES, V8, P159, DOI 10.1159/000066134; Dobkin C, 2009, AM ECON REV, V99, P324, DOI 10.1257/aer.99.1.324; European Monitoring Centre for Drugs and Drug Addiction, 2014, EXPL METH TRENDS EUR; Eysenbach G, 2011, AM J PREV MED, V40, pS154, DOI 10.1016/j.amepre.2011.02.006; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Gizzi MC, 2010, INT J OFFENDER THER, V54, P915, DOI 10.1177/0306624X09351825; Griffiths P, 2008, DRUG ALCOHOL REV, V27, P236, DOI 10.1080/09595230801932588; Lazer D, 2014, SCIENCE, V343, P1203, DOI 10.1126/science.1248506; Logan B K, 2002, Forensic Sci Rev, V14, P133; Marshall BDL, 2010, ADDICTION, V105, P991, DOI 10.1111/j.1360-0443.2010.02932.x; Martin I, 2009, EUR ADDICT RES, V15, P32, DOI 10.1159/000173007; Maxwell JC, 2008, DRUG ALCOHOL REV, V27, P229, DOI 10.1080/09595230801919460; Mcketin R, 2008, DRUG ALCOHOL REV, V27, P220, DOI 10.1080/09595230801923710; Milin S, 2015, 18 ANN C EUR ASS SUB; Nuti SV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109583; Panenka WJ, 2013, DRUG ALCOHOL DEPEN, V129, P167, DOI 10.1016/j.drugalcdep.2012.11.016; Pietsch J, 2013, FORENSIC SCI INT, V233, P51, DOI 10.1016/j.forsciint.2013.08.023; R Core Team, 2013, R LANG ENV STAT COMP; Santillana M, 2014, AM J PREV MED, V47, P341, DOI 10.1016/j.amepre.2014.05.020; Senna MC, 2010, FORENSIC SCI INT, V198, P11, DOI 10.1016/j.forsciint.2010.02.014; Stata Statistical Software, STAT STAT SOFTW REL; Sulzer D, 2005, PROG NEUROBIOL, V75, P406, DOI 10.1016/j.pneurobio.2005.04.003; Thanos PK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155457; UN Office on Drugs and Crime, 2016, WORLD DRUG REP	34	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0166566	10.1371/journal.pone.0166566	http://dx.doi.org/10.1371/journal.pone.0166566			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FV	27902717	Green Published, Green Submitted, gold			2022-12-26	WOS:000389474100027
J	Huang, YC; Cheng, WY; Luo, SD; Luo, Y; Ma, CC; He, TL				Huang, Yuecheng; Cheng, Wuyi; Luo, Sida; Luo, Yun; Ma, Chengchen; He, Tailin			Features of the Asynchronous Correlation between the China Coal Price Index and Coal Mining Accidental Deaths	PLOS ONE			English	Article							COMPLEX NETWORK ANALYSIS; VISIBILITY GRAPH; TIME-SERIES; DYNAMICS	The features of the asynchronous correlation between accident indices and the factors that influence accidents can provide an effective reference for warnings of coal mining accidents. However, what are the features of this correlation? To answer this question, data from the China coal price index and the number of deaths from coal mining accidents were selected as the sample data. The fluctuation modes of the asynchronous correlation between the two data sets were defined according to the asynchronous correlation coefficients, symbolization, and sliding windows. We then built several directed and weighted network models, within which the fluctuation modes and the transformations between modes were represented by nodes and edges. Then, the features of the asynchronous correlation between these two variables could be studied from a perspective of network topology. We found that the correlation between the price index and the accidental deaths was asynchronous and fluctuating. Certain aspects, such as the key fluctuation modes, the subgroups characteristics, the transmission medium, the periodicity and transmission path length in the network, were analyzed by using complex network theory, analytical methods and spectral analysis method. These results provide a scientific reference for generating warnings for coal mining accidents based on economic indices.	[Huang, Yuecheng; Cheng, Wuyi; Luo, Yun; He, Tailin] China Univ Geosci, Ctr Safety Res, Beijing, Peoples R China; [Huang, Yuecheng; Cheng, Wuyi; Luo, Yun; Ma, Chengchen; He, Tailin] China Univ Geosci, Sch Engn & Technol, Beijing, Peoples R China; [Ma, Chengchen] Univ Manchester, Sch Environm Educ & Dev, Manchester, Lancs, England; [Luo, Sida] Beihang Univ, Sch Mech Engn & Automat, Beijing, Peoples R China	China University of Geosciences; China University of Geosciences; University of Manchester; Beihang University	Huang, YC (corresponding author), China Univ Geosci, Ctr Safety Res, Beijing, Peoples R China.; Huang, YC (corresponding author), China Univ Geosci, Sch Engn & Technol, Beijing, Peoples R China.	huangyc@cugb.edu.cn		Luo, Sida/0000-0002-5673-6100	National Key Technology RAMP;D Program of China [2015BAK16603]	National Key Technology RAMP;D Program of China	The paper is supported by the National Key Technology R&D Program of China (Grant No. 2015BAK16603). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; An HZ, 2014, PHYSICA A, V393, P382, DOI 10.1016/j.physa.2013.08.055; Bae J, 2014, PHYSICA A, V395, P549, DOI 10.1016/j.physa.2013.10.047; Burt Ronald S, 1992, STRUCTURAL HOLES SOC; Chen WD, 2010, ACTA PHYS SIN-CH ED, V59, P4514, DOI 10.7498/aps.59.4514; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Cui XJ, 2006, J SAFETY SCI TECHNOL, V1, P50; Donner RV, 2012, ACTA GEOPHYS, V60, P589, DOI 10.2478/s11600-012-0032-x; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Gao CJ, 2006, CROSS CULTURAL COMMU, V1, P23; Gao XY, 2014, ENERGY, V73, P380, DOI 10.1016/j.energy.2014.06.028; Gao XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061091; Gao XY, 2012, ACTA PHYS SINICA, V61, P1321; Gao ZK, 2016, SCI REP-UK, V6, DOI 10.1038/srep28151; Gao ZK, 2016, CHEM ENG J, V291, P74, DOI 10.1016/j.cej.2016.01.039; Gao ZK, 2015, EPL-EUROPHYS LETT, V109, DOI 10.1209/0295-5075/109/30005; Gao ZK, 2015, SCI REP-UK, V5, DOI 10.1038/srep08222; Gao ZK, 2015, EXP THERM FLUID SCI, V60, P157, DOI 10.1016/j.expthermflusci.2014.09.008; Gao ZK, 2013, EPL-EUROPHYS LETT, V103, DOI 10.1209/0295-5075/103/50004; Gao ZK, 2012, NONLINEAR ANAL-REAL, V13, P947, DOI 10.1016/j.nonrwa.2011.08.029; Gao ZK, 2016, IEEE T INSTRUM MEAS, V65, P1690, DOI 10.1109/TIM.2016.2540862; Lacasa L, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/30001; Lacasa L, 2008, P NATL ACAD SCI USA, V105, P4972, DOI 10.1073/pnas.0709247105; Li HL, 2014, EXPERT SYST APPL, V41, P2842, DOI 10.1016/j.eswa.2013.10.019; Munnix MC, 2010, PHYSICA A, V389, P767, DOI 10.1016/j.physa.2009.10.033; Opsahl T, 2009, SOC NETWORKS, V31, P155, DOI 10.1016/j.socnet.2009.02.002; Palla G, 2007, NATURE, V446, P664, DOI 10.1038/nature05670; Qi AB, 2011, FUTURE DEV, V2, P29; SEIDMAN SB, 1978, J MATH SOCIOL, V6, P139, DOI 10.1080/0022250X.1978.9989883; SEIDMAN SB, 1978, SOC NETWORKS, V1, P65, DOI 10.1016/0378-8733(78)90013-8; Sun XR, 2014, CHAOS, V24, DOI 10.1063/1.4868261; [汤凌霄 TANG Lingxiao], 2006, [中国工业经济, China Industrial Economy], P53; van Beeck EF, 2000, INT J EPIDEMIOL, V29, P503, DOI 10.1093/ije/29.3.503; WACKERBAUER R, 1994, CHAOS SOLITON FRACT, V4, P133, DOI 10.1016/0960-0779(94)90023-X; Wang N, 2012, PHYSICA A, V391, P6543, DOI 10.1016/j.physa.2012.07.054; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Xiang RX, 2012, CHAOS, V22, DOI 10.1063/1.3673789; Xu XK, 2008, P NATL ACAD SCI USA, V105, P19601, DOI 10.1073/pnas.0806082105; Yang LF, 2015, J XUZHOU I TECHNOLOG, V5, P63; Yang Y, 2009, PHYSICA A, V388, P4431, DOI 10.1016/j.physa.2009.07.016; Yook SH, 2001, PHYS REV LETT, V86, P5835, DOI 10.1103/PhysRevLett.86.5835; Zhang J, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.238701; Zhou YW, 2014, PHYSICA A, V416, P21, DOI 10.1016/j.physa.2014.08.047	43	2	2	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167198	10.1371/journal.pone.0167198	http://dx.doi.org/10.1371/journal.pone.0167198			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FV	27902748	gold, Green Published, Green Submitted			2022-12-26	WOS:000389474100059
J	Lega, T; Weiher, P; Obuchowski, M; Nidzworski, D				Lega, Tomasz; Weiher, Paulina; Obuchowski, Michal; Nidzworski, Dawid			Presenting Influenza A M2e Antigen on Recombinant Spores of Bacillus subtilis	PLOS ONE			English	Article							SURFACE DISPLAY; PROTEIN	Effective vaccination against influenza virus infection is a serious problem mainly due to antigenic variability of the virus. Among many of investigated antigens, the extracellular domain of the M2 protein (M2e) features high homology in all strains of influenza A viruses and antibodies against M2e and is protective in animal models; this makes it a potential candidate for generation of a universal influenza vaccine. However, due to the low immunogenicity of the M2e, formulation of a vaccine based on this antigen requires some modification to induce effective immune responses. In this work we evaluated the possible use of Bacillus subtilis spores as a carrier of the Influenza A M2e antigen in mucosal vaccination. A tandem repeat of 4 consensus sequences coding for human-avian-swine-human M2e (M2eH-A-S-H) peptide was fused to spore coat proteins and stably exposed on the spore surface, as demonstrated by the immunostaining of intact, recombinant spores. Oral immunization of mice with recombinant endospores carrying M2eH-A-S-H elicited specific antibody production without the addition of adjuvants. Bacillus subtilis endospores can serve as influenza antigen carriers. Recombinant spores constructed in this work showed low immunogenicity although were able to induce antibody production. The System of influenza antigen administration presented in this work is attractive mainly due to the omitting time-consuming and cost-intensive immunogen production and purification. Therefore modification should be made to increase the immunogenicity of the presented system.	[Lega, Tomasz] Univ Gdansk, Intercollegiate Fac Biotechnol, Dept Med Biotechnol, Gdansk, Poland; [Lega, Tomasz; Weiher, Paulina; Nidzworski, Dawid] Med Univ Gdansk, Gdansk, Poland; [Weiher, Paulina; Nidzworski, Dawid] Univ Gdansk, Intercollegiate Fac Biotechnol, Dept Recombinant Vaccine, Gdansk, Poland; [Obuchowski, Michal] Med Univ Gdansk, Intercollegiate Fac Biotechnol UG GUMed, Dept Med Biotechnol, Gdansk, Poland	Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; Medical University Gdansk	Lega, T (corresponding author), Univ Gdansk, Intercollegiate Fac Biotechnol, Dept Med Biotechnol, Gdansk, Poland.; Lega, T (corresponding author), Med Univ Gdansk, Gdansk, Poland.	tomasz.lega@biotech.ug.edu.pl	Obuchowski, Michał/N-1118-2019; Obuchowski, Michał/F-5836-2011	Obuchowski, Michał/0000-0001-5410-2350; Obuchowski, Michał/0000-0001-5410-2350; Nidzworski, Dawid/0000-0003-0533-0837	Polish National Center for Research and Development [LIDER/016/489/L-4/12/NCBR/2013]; Foundation for Polish Science grant [START 74.2015]; Foundation for Polish Science (FNP)	Polish National Center for Research and Development; Foundation for Polish Science grant; Foundation for Polish Science (FNP)(Foundation for Polish Science)	The research was supported by the Polish National Center for Research and Development grant no LIDER/016/489/L-4/12/NCBR/2013 and Foundation for Polish Science grant no START 74.2015.; The research was supported by the Polish National Center for Research and Development grant no LIDER/016/489/L-4/12/NCBR/2013; Supported by the Foundation for Polish Science (FNP)	Alvarez P, 2013, VACCINE, V21, P31; Amuguni H, 2012, HUM VACC IMMUNOTHER, V8, P7; ANAGNOSTOPOULOS C, 1961, P NATL ACAD SCI USA, V47, P378, DOI 10.1073/pnas.47.3.378; Bommakanti G, 2010, P NATL ACAD SCI USA, V107, P13701, DOI 10.1073/pnas.1007465107; Deng L, 2015, VACCINES-BASEL, V3, P105, DOI 10.3390/vaccines3010105; Duc H, 2007, VACCINE, V25, P2; Graeme E. Price, 2014, J VIROL, V88, P11; Green MR, 2012, MOL CLONING LAB MANU, V1; Han T, 2011, ANN NY ACAD SCI, V1217, P13; HARRY EJ, 1995, J BACTERIOL, V177, P3386, DOI 10.1128/jb.177.12.3386-3393.1995; Hinc K, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-22; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Huleatt JW, 2008, VACCINE, V26, P201, DOI 10.1016/j.vaccine.2007.10.062; Imamura D, 2011, J BACTERIOL, V193, P4075, DOI 10.1128/JB.05310-11; Imamura D, 2010, J BACTERIOL, V192, P518, DOI 10.1128/JB.01103-09; Isticato R, 2001, J BACTERIOL, V183, P6294, DOI 10.1128/JB.183.21.6294-6301.2001; Iwanicki A, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-30; Julkowska D, 2005, J BACTERIOL, V187, P65, DOI 10.1128/JB.187.1.65-76.2005; Kammoun H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059198; Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254; Liu WL, 2004, VACCINE, V23, P366, DOI 10.1016/j.vaccine.2004.05.028; Liu XB, 2012, J ENERG MATER, V30, P30, DOI 10.1080/07370652.2010.538946; McKenney PT, 2013, NAT REV MICROBIOL, V11, P33, DOI 10.1038/nrmicro2921; Monroe A, 2006, J BACTERIOL, V188, P7609, DOI 10.1128/JB.01116-06; Mozdzanowska K, 2003, VACCINE, V21, P2616, DOI 10.1016/S0264-410X(03)00040-9; Negri A, 2013, J MED MICROBIOL, V62, P1379, DOI 10.1099/jmm.0.057372-0; Neirynck S, 1999, NAT MED, V5, P1157, DOI 10.1038/13484; NICHOLSON WL, 1990, J BACTERIOL, V172, P7, DOI 10.1128/JB.172.1.7-14.1990; Nicholson WL., 1990, MOL BIOL METHODS BAC, P391, DOI DOI 10.1111/J.1751-1097.1991.TB02087.X; Permpoonpattana P, 2011, INFECT IMMUN, V79, P2295, DOI 10.1128/IAI.00130-11; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Setlow P., 2006, J APPL MICROBIOL, V101, P3; Stanekova Z, 2011, ACTA VIROL, V55, P61, DOI 10.4149/av_2011_01_61; Tompkins SM, 2007, EMERG INFECT DIS, V13, P426, DOI 10.3201/eid1303.061125; Woodcock DM, 1989, NUCLEIC ACIDS RES, V17, P9, DOI DOI 10.1093/NAR/17.9.3469; Young-Tae L, 2014, CLIN EXP VACCINE RES, V3, P1; Yuan G, 1995, J BACTERIOL, V177, P19; Zhang ZH, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-89; Zheng M, 2015, HUM VACC IMMUNOTHER, V11, P2	39	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167225	10.1371/journal.pone.0167225	http://dx.doi.org/10.1371/journal.pone.0167225			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902762	Green Published, gold, Green Submitted			2022-12-26	WOS:000389474100060
J	Mizutani, Y; Niizuma, Y; Yoda, K				Mizutani, Yuichi; Niizuma, Yasuaki; Yoda, Ken			How Do Growth and Sibling Competition Affect Telomere Dynamics in the First Month of Life of Long-Lived Seabird?	PLOS ONE			English	Article							OXIDATIVE STRESS; PREDICTS FITNESS; BROOD SIZE; TRADE-OFF; LENGTH; ANTIOXIDANTS; AGE; BIRD; WILD; TESTOSTERONE	Telomeres are nucleotide sequences located at the ends of chromosomes that promote genome stability. Changes in telomere length (dynamics) are related to fitness or life expectancy, and telomere dynamics during the development phase are likely to be affected by growth and stress factors. Here, we examined telomere dynamics of black-tailed gull chicks (Larus crassirostris) in nests with and without siblings. We found that the initial telomere lengths of singletons at hatching were longer than those of siblings, indicating that singletons are higher-quality chicks than siblings in terms of telomere length. Other factors likely affecting individual quality (i.e., sex, laying date, laying order of eggs, and clutch size) were not related to telomere lengths. Within broods, initial telomere lengths were longer in older chicks than in younger chicks, suggesting that maternal effects, which vary with laying sequence, influence the initial lengths. Additionally, telomeres of chicks with a sibling showed more attrition between hatching and fledging than those of singleton chicks, suggesting that being raised with siblings can cause a sustained competitive environment that leads to telomere loss. High growth rates were associated with a low degree of telomere shortening observed in older siblings, perhaps because slower growth reflects higher food stress and/or higher aerobic metabolism from increased begging effort. Our results show that developmental telomere attrition was an inevitable consequence in two-chick nests in the pre- and post-hatching microenvironments due to the combination of social stress within the nest and maternal effects. The results of our study shed light on telomere dynamics in early life, which may represent an important physiological undercurrent of life-history traits.	[Mizutani, Yuichi; Yoda, Ken] Nagoya Univ, Grad Sch Environm Studies, Chikusa Ku, Nagoya, Aichi, Japan; [Niizuma, Yasuaki] Meijo Univ, Fac Agr, Tempaku Ku, Nagoya, Aichi, Japan	Nagoya University; Meijo University	Mizutani, Y (corresponding author), Nagoya Univ, Grad Sch Environm Studies, Chikusa Ku, Nagoya, Aichi, Japan.	yuichi-san@nagoya-u.jp			Japan Society for the Promotion of Science [24681006]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was financially supported by the Japan Society for the Promotion of Science (24681006) [https://www.jsps.go.jp/english/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelier F, 2013, FUNCT ECOL, V27, P342, DOI 10.1111/1365-2435.12041; Asghar M, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2263; Barrett ELB, 2013, MOL ECOL, V22, P249, DOI 10.1111/mec.12110; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beaulieu M, 2009, BEHAV ECOL, V20, P878, DOI 10.1093/beheco/arp076; Bize P, 2009, P R SOC B, V276, P1679, DOI 10.1098/rspb.2008.1817; Blackburn EH, 2015, SCIENCE, V350, P1193, DOI 10.1126/science.aab3389; Boonekamp JJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3287; Braasch A, 2014, GEN COMP ENDOCR, V204, P95, DOI 10.1016/j.ygcen.2014.05.007; Costantini D., 2014, OXIDATIVE STRESS HOR; Cotton PA, 1999, AM NAT, V153, P412, DOI 10.1086/303178; Dantzer B, 2015, EXP GERONTOL, V71, P38, DOI 10.1016/j.exger.2015.08.012; DeKogel CH, 1997, J ANIM ECOL, V66, P167; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Foote CG, 2011, J ZOOL, V283, P203, DOI 10.1111/j.1469-7998.2010.00774.x; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Geiger S, 2012, MOL ECOL, V21, P1500, DOI 10.1111/j.1365-294X.2011.05331.x; Grant JD, 2001, BIOTECHNIQUES, V31, P1314, DOI 10.2144/01316bc02; Groothuis TGG, 2006, J EVOLUTION BIOL, V19, P1304, DOI 10.1111/j.1420-9101.2005.01072.x; GUSTAFSSON L, 1988, NATURE, V335, P813, DOI 10.1038/335813a0; Hall ME, 2004, P ROY SOC B-BIOL SCI, V271, P1571, DOI 10.1098/rspb.2004.2768; Hatakeyama H, 2008, MECH AGEING DEV, V129, P550, DOI 10.1016/j.mad.2008.05.006; Haussmann MF, 2007, EXP GERONTOL, V42, P610, DOI 10.1016/j.exger.2007.03.004; Haussmann MF, 2012, P ROY SOC B-BIOL SCI, V279, P1447, DOI 10.1098/rspb.2011.1913; Haussmann MF, 2003, EXP GERONTOL, V38, P787, DOI 10.1016/S0531-5565(03)00109-8; Heidinger BJ, 2016, FUNCT ECOL; Heidinger BJ, 2012, P NATL ACAD SCI USA, V109, P1743, DOI 10.1073/pnas.1113306109; Herborn KA, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3151; Horn T, 2010, HEREDITY, V105, P497, DOI 10.1038/hdy.2010.113; Horn T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017199; Hudson R, 2008, BEHAV ECOL SOCIOBIOL, V62, P299, DOI 10.1007/s00265-007-0417-z; Iseki Kenichi, 2002, Japanese Journal of Ornithology, V51, P108, DOI 10.3838/jjo.51.108; Johnstone RA, 2003, BEHAV ECOL, V14, P780, DOI 10.1093/beheco/arg024; Kawanishi S, 2004, ANN NY ACAD SCI, V1019, P278, DOI 10.1196/annals.1297.047; Kazama K, 2007, P INT S OR EV NAT DI, P215; Kazama K, 2012, J ETHOL, V30, P279, DOI 10.1007/s10164-011-0324-7; Kim SY, 2013, J EVOLUTION BIOL, V26, P1341, DOI 10.1111/jeb.12136; Kim SY, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0211; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; Lloyd JD, 2003, P ROY SOC B-BIOL SCI, V270, P735, DOI 10.1098/rspb.2002.2289; Mathevon N, 2004, P ROY SOC B-BIOL SCI, V271, pS145, DOI 10.1098/rsbl.2003.0117; Metcalfe NB, 2010, FUNCT ECOL, V24, P984, DOI 10.1111/j.1365-2435.2010.01750.x; Mizutani Y, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0511; Mizutani Yuichi, 2009, Japanese Journal of Ornithology, V58, P192; Monaghan P, 2006, TRENDS ECOL EVOL, V21, P47, DOI 10.1016/j.tree.2005.11.007; Monaghan P, 2009, ECOL LETT, V12, P75, DOI 10.1111/j.1461-0248.2008.01258.x; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Nanda I, 2002, CHROMOSOMA, V111, P215, DOI 10.1007/s00412-002-0206-4; Nettle D, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.1610; Nettle D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083617; Noguera JC, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2014.0938; Noguera JC, 2010, BEHAV ECOL, V21, P479, DOI 10.1093/beheco/arq005; Pariser EC, 2012, BEHAV ECOL SOCIOBIOL, V66, P519, DOI 10.1007/s00265-011-1300-5; Parolini M, 2015, FUNCT ECOL, V29, P1070, DOI 10.1111/1365-2435.12412; Pauliny A, 2006, MOL ECOL, V15, P1681, DOI 10.1111/j.1365-294X.2006.02862.x; Pauliny A, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-257; R Core Team, 2021, R LANGUAGE ENV STAT; Reed WL, 2011, INTEGR COMP BIOL, V51, P73, DOI 10.1093/icb/icr032; Reichert S, 2015, HEREDITY, V114, P10, DOI 10.1038/hdy.2014.60; Reichert S, 2015, J EXP BIOL, V218, P491, DOI 10.1242/jeb.109942; Rodriguez-Girones MA, 2001, ANIM BEHAV, V61, P733, DOI 10.1006/anbe.2000.1660; Royle NJ, 2012, P ROY SOC B-BIOL SCI, V279, P4914, DOI 10.1098/rspb.2012.1701; Royle NJ, 2002, TRENDS ECOL EVOL, V17, P434, DOI 10.1016/S0169-5347(02)02565-X; Royle NJ, 2001, BEHAV ECOL, V12, P381, DOI 10.1093/beheco/12.4.381; Rubolini D, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-24; Salomons HM, 2009, P ROY SOC B-BIOL SCI, V276, P3157, DOI 10.1098/rspb.2009.0517; SCHWABL H, 1993, P NATL ACAD SCI USA, V90, P11446, DOI 10.1073/pnas.90.24.11446; Smiseth PT, 2002, ANIM BEHAV, V63, P577, DOI 10.1006/anbe.2001.1944; Speakman JR, 2014, BIOESSAYS, V36, P93, DOI 10.1002/bies.201300108; Tomita N, 2011, ORNITHOL SCI, V10, P21, DOI 10.2326/osj.10.21; Torok J, 2007, BEHAV ECOL SOCIOBIOL, V61, P541, DOI 10.1007/s00265-006-0282-1; Verhulst S, 2006, BIOL LETTERS, V2, P478, DOI 10.1098/rsbl.2006.0496; von Schantz T, 1999, P ROY SOC B-BIOL SCI, V266, P1, DOI 10.1098/rspb.1999.0597; Von Zglinicki T, 2000, FREE RADICAL BIO MED, V28, P64, DOI 10.1016/S0891-5849(99)00207-5; Watson H, 2015, J EXP BIOL, V218, P668, DOI 10.1242/jeb.104265; WERSCHKUL DF, 1979, IBIS, V121, P97, DOI 10.1111/j.1474-919X.1979.tb05022.x; Williams TD, 2005, BIOSCIENCE, V55, P39, DOI 10.1641/0006-3568(2005)055[0039:MUTCOE]2.0.CO;2; Zeichner SL, 1999, BLOOD, V93, P2824	78	15	15	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167261	10.1371/journal.pone.0167261	http://dx.doi.org/10.1371/journal.pone.0167261			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902754	Green Published, gold, Green Submitted			2022-12-26	WOS:000389474100065
J	Noh, JW; Kwon, YD; Park, J; Oh, IH; Kim, J				Noh, Jin-Won; Kwon, Young Dae; Park, Jumin; Oh, In-Hwan; Kim, Jinseok			Relationship between Physical Disability and Depression by Gender: A Panel Regression Model	PLOS ONE			English	Article							LATE-LIFE; FUNCTIONAL DISABILITY; RISK-FACTORS; PREVALENCE; SYMPTOMS; ANXIETY	Background Depression in persons with physical disabilities may be more common than in the general population. The purpose of this study was to examine the relationship between physical disability and depression by gender among adults, using a large, nationally representative sample. Methods This study used data from the Korean Longitudinal Study of Aging, Wave one through four, and ran a series of random effect panel regression models to test the relationship between physical disability status and depression by gender. We tested the moderating effect of gender on the relationship between disability status and depression level by examining the significance of the cross-product term between disability status and gender. Results After controlling for self-rated health, marital status, employment status, education, and age, subjects who were female or diagnosed as having any disability presented higher levels of depression scores. Further, the difference in terms of their depression level measured by Center for Epidemiologic Studies Short Depression Scale (CES-D 10) scores between those who were diagnosed as having any disability and those who were not was greater for females than for their male counterparts. Conclusion This study reaffirmed that disability is the risk factor of depression, using longitudinal data. In addition, female gender is the effect modifier rather than the risk factor. The effect of gender in the non-disability group, mostly composed of older persons, is limited. On the contrary, the female disability group showed more depressive symptoms than the male disability group. The gender difference in the disability group and the role of culture on these differences need further research.	[Noh, Jin-Won] Eulji Univ, Dept Healthcare Management, Seongnam, South Korea; [Noh, Jin-Won] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci, Global Hlth Unit, Groningen, Netherlands; [Kwon, Young Dae] Catholic Univ Korea, Coll Med, Dept Humanities & Social Med, Seoul, South Korea; [Kwon, Young Dae] Catholic Univ Korea, Catholic Inst Healthcare Management, Seoul, South Korea; [Park, Jumin] NIH, Ctr Clin, Bethesda, MD 20892 USA; [Oh, In-Hwan] Kyung Hee Univ, Sch Med, Dept Prevent Med, Seoul, South Korea; [Kim, Jinseok] Seoul Womens Univ, Dept Social Welf, Seoul, South Korea	Eulji University; University of Groningen; Catholic University of Korea; Catholic University of Korea; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Kyung Hee University; Seoul Women's University	Kim, J (corresponding author), Seoul Womens Univ, Dept Social Welf, Seoul, South Korea.	jskim@swu.ac.kr	Oh, In Hwan/AAI-9070-2020; Kwon, Young Dae/T-1591-2017	Oh, In Hwan/0000-0002-5450-9887; Kwon, Young Dae/0000-0002-8781-6832; Noh, Jin-Won/0000-0001-5172-4023	Seoul Women's University	Seoul Women's University	This work was supported by a research grant from Seoul Women's University (2016).; This work was supported by a research grant from Seoul Women's University (2016).	Bruce ML, 2001, AM J GERIAT PSYCHIAT, V9, P102, DOI 10.1176/appi.ajgp.9.2.102; Chevarley FM, 2006, WOMEN HEALTH ISS, V16, P297, DOI 10.1016/j.whi.2006.10.002; Cole MG, 2003, AM J PSYCHIAT, V160, P1147, DOI 10.1176/appi.ajp.160.6.1147; Franklin DJ, 2000, DEPRESSION INFORM TR; Girgus JS, 2015, CURR OPIN PSYCHOL, V4, P53, DOI 10.1016/j.copsyc.2015.01.019; Hermans H, 2013, J AFFECT DISORDERS, V144, P94, DOI 10.1016/j.jad.2012.06.011; Hsiao C, 2007, TEST-SPAIN, V16, P1, DOI 10.1007/s11749-007-0046-x; Hughes R, 2001, TOPICS SPINAL CORD I, V7, P16, DOI DOI 10.1310/HPKX-D0PV-MNFV-N349; Lepine Jean-Pierre, 2011, Neuropsychiatr Dis Treat, V7, P3, DOI 10.2147/NDT.S19617; Luppa M, 2012, J AFFECT DISORDERS, V136, P212, DOI 10.1016/j.jad.2010.11.033; Marcus M, 2012, WHO DEP MENTAL HLTH; Matheson FI, 2006, SOC SCI MED, V63, P2604, DOI 10.1016/j.socscimed.2006.07.001; McGrath E., 1990, WOMEN DEPRESSION RIS; Nolen-Hoeksema S, 2001, CURR DIR PSYCHOL SCI, V10, P173, DOI 10.1111/1467-8721.00142; Nosek MA, 2003, REHABIL COUNS BULL, V46, P224, DOI 10.1177/003435520304600403; Pachana NA, 2012, INT PSYCHOGERIATR, V24, P145, DOI 10.1017/S1041610211001372; Papadopoulos FC, 2005, INT J GERIATR PSYCH, V20, P350, DOI 10.1002/gps.1288; Park JH, 2012, J AFFECT DISORDERS, V138, P34, DOI 10.1016/j.jad.2011.12.038; Penninx BWJH, 1999, AM J PUBLIC HEALTH, V89, P1346, DOI 10.2105/AJPH.89.9.1346; Pirkis J, 2009, J AFFECT DISORDERS, V115, P54, DOI 10.1016/j.jad.2008.08.014; Regan CO, 2013, INT J GERIATR PSYCH, V28, P1280, DOI 10.1002/gps.3955; Segal DL, 2008, BEHAV MODIF, V32, P3, DOI 10.1177/0145445507303833; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; Takkinen S, 2004, AGING MENT HEALTH, V8, P187, DOI 10.1080/13607860410001669714; TURNER RJ, 1990, J NERV MENT DIS, V178, P343, DOI 10.1097/00005053-199006000-00001; U.S. Department of Health and Human Services, 2000, HLTH PEOPL 2010; Wild B, 2012, INT J GERIATR PSYCH, V27, P375, DOI 10.1002/gps.2728; World Health Organization, DEPR FACT SHEET; Yang Y, 2005, J AGING HEALTH, V17, P263, DOI 10.1177/0898264305276295; Yang Y, 2006, J HEALTH SOC BEHAV, V47, P355, DOI 10.1177/002214650604700404; Zeiss AM, 1996, PSYCHOL AGING, V11, P572, DOI 10.1037/0882-7974.11.4.572	31	51	53	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0166238	10.1371/journal.pone.0166238	http://dx.doi.org/10.1371/journal.pone.0166238			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FV	27902709	gold, Green Published, Green Submitted			2022-12-26	WOS:000389474100015
J	Rastegar-Pouyani, S; Khazaei, N; Wee, P; Mohammadnia, A; Yaqubi, M				Rastegar-Pouyani, Shima; Khazaei, Niusha; Wee, Ping; Mohammadnia, Abdulshakour; Yaqubi, Moein			Role of Hepatic-Specific Transcription Factors and Polycomb Repressive Complex 2 during Induction of Fibroblasts to Hepatic Fate	PLOS ONE			English	Article							NEURAL STEM-CELLS; HEPATOCYTE-LIKE CELLS; MOUSE FIBROBLASTS; DIRECT CONVERSION; DEFINED FACTORS; DOPAMINERGIC-NEURONS; LIVER DEVELOPMENT; SINGLE FACTOR; EZH2; CARDIOMYOCYTES	Direct reprogramming using defined sets of transcription factors (TFs) is a recent strategy for generating induced hepatocytes (iHeps) from fibroblasts for use in regenerative medicine and drug development. Comprehensive studies detailing the regulatory role of TFs during this reprogramming process could help increase its efficiency. This study aimed to find the TFs with the greatest influences on the generation of iHeps from fibroblasts, and to further understand their roles in the regulation of the gene expression program. Here, we used systems biology approaches to analyze high quality expression data sets in combination with TF-binding sites data and protein-protein interactions data during the direct reprogramming of fibroblasts to iHeps. Our results revealed two main patterns for differentially expressed genes (DEGs): up-regulated genes were categorized as hepatic-specific pattern, and down-regulated genes were categorized as mesoderm-and fibroblast-specific pattern. Interestingly, hepatic-specific genes co-expressed and were regulated by hepatic-specific TFs, specifically Hnf4a and Foxa2. Conversely, the mesoderm-and fibroblast-specific pattern was mainly silenced by polycomb repressive complex 2 (PRC2) members, including Suz12, Mtf2, Ezh2, and Jarid2. Independent analysis of both the gene and core regulatory network of DE-TFs showed significant roles for Hnf4a, Foxa2, and PRC2 members in the regulation of the gene expression program and in biological processes during the direct conversion process. Altogether, using systems biology approaches, we clarified the role of Hnf4a and Foxa2 as hepatic-specific TFs, and for the first time, introduced the PRC2 complex as the main regulator that favors the direct reprogramming process in cooperation with hepatic-specific factors.	[Rastegar-Pouyani, Shima; Khazaei, Niusha] NIGEB, Inst Med Biotechnol, Tehran, Iran; [Wee, Ping] Univ Alberta, Dept Med Genet, Edmonton, AB, Canada; [Wee, Ping] Univ Alberta, Signal Transduct Res Grp, Fac Med & Dent, Edmonton, AB, Canada; [Mohammadnia, Abdulshakour] McGill Univ, Dept Human Genet, Div Hematol & Oncol, Fac Med, Montreal, PQ, Canada; [Yaqubi, Moein] McGill Univ, Ludmer Ctr Neuroinformat & Mental Hlth, Montreal, PQ, Canada; [Yaqubi, Moein] McGill Univ, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada	University of Alberta; University of Alberta; McGill University; McGill University; McGill University	Mohammadnia, A (corresponding author), McGill Univ, Dept Human Genet, Div Hematol & Oncol, Fac Med, Montreal, PQ, Canada.; Yaqubi, M (corresponding author), McGill Univ, Ludmer Ctr Neuroinformat & Mental Hlth, Montreal, PQ, Canada.; Yaqubi, M (corresponding author), McGill Univ, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada.	Abdulshakour.mohammadnia@mail.mcgill.com; Moein.yaqubi@mail.mcgill.ca		Mohammadnia, Abdulshakour/0000-0003-1982-3958; Khazaei, Niusha/0000-0002-2756-3386				Ambasudhan R, 2011, CELL STEM CELL, V9, P113, DOI 10.1016/j.stem.2011.07.002; ANG SL, 1993, DEVELOPMENT, V119, P1301; ANG SL, 1994, CELL, V78, P561, DOI 10.1016/0092-8674(94)90522-3; Aoki R, 2010, J HEPATOL, V52, P854, DOI 10.1016/j.jhep.2010.01.027; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Bae WK, 2015, FASEB J, V29, P1653, DOI 10.1096/fj.14-261537; Battle MA, 2006, P NATL ACAD SCI USA, V103, P8419, DOI 10.1073/pnas.0600246103; Bernard D, 2010, AGING-US, V2, P317, DOI 10.18632/aging.100153; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bhatia SN, 1999, FASEB J, V13, P1883, DOI 10.1096/fasebj.13.14.1883; Bindea G, 2013, BIOINFORMATICS, V29, P661, DOI 10.1093/bioinformatics/btt019; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Blazejczyk M, 2007, A STATISTICAL DATA A; Bolotin E, 2010, HEPATOLOGY, V51, P642, DOI 10.1002/hep.23357; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Burri L, 2010, PPAR RES, V2010, DOI 10.1155/2010/542359; Burtscher I, 2009, DEVELOPMENT, V136, P1029, DOI 10.1242/dev.028415; Cahan P, 2014, CELL, V158, P903, DOI 10.1016/j.cell.2014.07.020; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Chistiakov DA, 2012, CELLS TISSUES ORGANS, V196, P291, DOI 10.1159/000335697; Crespo I, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-140; Crespo I, 2013, STEM CELLS, V31, P2127, DOI 10.1002/stem.1473; D'Alessio AC, 2015, STEM CELL REP, V5, P1; DeLaForest A, 2011, DEVELOPMENT, V138, P4143, DOI 10.1242/dev.062547; Ding X, 2014, STEM CELLS DEV, P19; Du YY, 2014, CELL STEM CELL, V14, P394, DOI 10.1016/j.stem.2014.01.008; Efe JA, 2011, NAT CELL BIOL, V13, P215, DOI 10.1038/ncb2164; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fragola G, 2013, PLOS GENET, P9; Gordillo M, 2015, DEVELOPMENT, V142, P2094, DOI 10.1242/dev.114215; Han DW, 2012, CELL STEM CELL, V10, P465, DOI 10.1016/j.stem.2012.02.021; Hannenhalli S, 2009, NAT REV GENET, V10, P233, DOI 10.1038/nrg2523; Huang PY, 2011, NATURE, V475, P386, DOI 10.1038/nature10116; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Inagawa K, 2012, CIRC RES, V111, P1147, DOI 10.1161/CIRCRESAHA.112.271148; Khazaie N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150518; Kim J, 2011, P NATL ACAD SCI USA, V108, P7838, DOI 10.1073/pnas.1103113108; Kim J, 2015, SCI REP-UK, V5, DOI 10.1038/srep15706; Kim J, 2011, CELL STEM CELL, V9, P413, DOI 10.1016/j.stem.2011.09.011; Kim SM, 2014, NAT PROTOC, V9, P871, DOI 10.1038/nprot.2014.056; Koike H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104776; Kyrmizi I, 2006, GENE DEV, V20, P2293, DOI 10.1101/gad.390906; Lachmann A, 2010, BIOINFORMATICS, V26, P2438, DOI 10.1093/bioinformatics/btq466; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lemaigre FP, 2009, GASTROENTEROLOGY, V137, P62, DOI 10.1053/j.gastro.2009.03.035; Lim KT, 2016, CELL REP, V15, P814, DOI 10.1016/j.celrep.2016.03.071; Lujan E, 2012, P NATL ACAD SCI USA, V109, P2527, DOI 10.1073/pnas.1121003109; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Matsui T, 2012, STEM CELLS, V30, P1109, DOI 10.1002/stem.1091; Mohammadnia A, 2016, J CELL PHYSIOL, V231, P1994, DOI 10.1002/jcp.25308; Montgomery ND, 2005, CURR BIOL, V15, P942, DOI 10.1016/j.cub.2005.04.051; Nicolas C, 2016, BIOMEDICINES, V4, DOI 10.3390/biomedicines4010002; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pera MF, 2011, NATURE, V471, P46, DOI 10.1038/471046a; Pfisterer U, 2011, P NATL ACAD SCI USA, V108, P10343, DOI 10.1073/pnas.1105135108; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; Rackham OJL, 2016, NAT GENET, V48, P331, DOI 10.1038/ng.3487; Ring KL, 2012, CELL STEM CELL, V11, P100, DOI 10.1016/j.stem.2012.05.018; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/nmeth.2212, 10.1038/NMETH.2212]; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Scardoni G, 2009, BIOINFORMATICS, V25, P2857, DOI 10.1093/bioinformatics/btp517; Schmidt R, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-10-251; Sekiya S, 2011, NATURE, V475, P390, DOI 10.1038/nature10263; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Son EY, 2011, CELL STEM CELL, V9, P205, DOI 10.1016/j.stem.2011.07.014; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tang C, 2011, NAT BIOTECHNOL, V29, P829, DOI 10.1038/nbt.1947; Taube JH, 2010, J BIOL CHEM, V285, P16135, DOI 10.1074/jbc.M109.088096; Thier M, 2012, CELL STEM CELL, V10, P473, DOI 10.1016/j.stem.2012.03.003; Vuong LM, 2015, MOL CELL BIOL, V35, P3471, DOI 10.1128/MCB.00030-15; WEINSTEIN DC, 1994, CELL, V78, P575, DOI 10.1016/0092-8674(94)90523-1; Xu CR, 2011, SCIENCE, V332, P963, DOI 10.1126/science.1202845; Yaqubi M, 2015, PREDICTING INVOLVEME, P1, DOI [10.1186/s13287-015-0045-x, DOI 10.1186/S13287-015-0045-X]; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Yu B, 2013, CELL STEM CELL, V13, P328, DOI 10.1016/j.stem.2013.06.017; Zaret KS, 2008, NAT REV GENET, V9, P329, DOI 10.1038/nrg2318; Zhang Z, 2011, STEM CELLS, V29, P229, DOI 10.1002/stem.578; Zhou Q, 2012, CELL STEM CELL, V10, P347, DOI 10.1016/j.stem.2012.03.005; Zhu S, 2014, CELL RES, V24, P126, DOI 10.1038/cr.2013.156	83	3	3	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167081	10.1371/journal.pone.0167081	http://dx.doi.org/10.1371/journal.pone.0167081			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902735	gold, Green Published, Green Submitted			2022-12-26	WOS:000389474100049
J	Singh, V; Finke-Isami, J; Hopper-Chidlaw, AC; Schwerk, P; Thompson, A; Tedin, K				Singh, Vikash; Finke-Isami, Johannes; Hopper-Chidlaw, Amanda C.; Schwerk, Peter; Thompson, Arthur; Tedin, Karsten			Salmonella Co-opts Host Cell Chaperone-mediated Autophagy for Intracellular Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autophagy; bacterial metabolism; bacterial pathogenesis; intracellular trafficking; Salmonella enterica	ENTERICA SEROVAR TYPHIMURIUM; ESCHERICHIA-COLI; CONTAINING VACUOLES; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; ANTIMICROBIAL RESISTANCE; BACTERIAL PATHOGENS; SELECTIVE UPTAKE; TYPHOID-FEVER; TRANSPORT; LIVER	Salmonella enterica are invasive intracellular pathogens that replicate within a membrane-bound compartment inside infected host cells known as the Salmonella-containing vacuole. How Salmonella obtains nutrients for growth within this intracellular niche despite the apparent isolation is currently not known. Recent studies have indicated the importance of glucose and related carbon sources for tissue colonization and intracellular proliferation within host cells during Salmonella infections, although none have been found to be essential. We found that wild-type Salmonella are capable of replicating within infected host cells in the absence of both exogenous sugars and/or amino acids. Furthermore, mutants defective in glucose uptake or dependent upon peptides for growth also showed no significant loss in intracellular replication, suggesting host-derived peptides can supply both carbon units and amino acids. Here, we show that intracellular Salmonella recruit the host proteins LAMP-2A and Hsc73, key components of the host protein turnover pathway known as chaperone-mediated autophagy involved in transport of cytosolic proteins to the lysosome for degradation. Host-derived peptides are shown to provide a significant contribution toward the intracellular growth of Salmonella. The results reveal a means whereby intracellular Salmonella gain access to the host cell cytosol from within its membrane-bound compartment to acquire nutrients. Furthermore, this study provides an explanation as to how Salmonella evades activation of autophagy mechanisms as part of the innate immune response.	[Singh, Vikash; Finke-Isami, Johannes; Schwerk, Peter; Tedin, Karsten] Free Univ Berlin, Inst Microbiol & Epizoot, Ctr Infect Med, Robert von Ostertag Str 7-13, D-14163 Berlin, Germany; [Hopper-Chidlaw, Amanda C.; Thompson, Arthur] Inst Food Res, Norwich Res Pk, Norwich NR4 7UA, Norfolk, England; [Singh, Vikash] Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England; [Finke-Isami, Johannes] Cargill Deutschland GmbH & Co KG, D-20539 Hamburg, Germany	Free University of Berlin; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; University of Cambridge	Tedin, K (corresponding author), Free Univ Berlin, Inst Microbiol & Epizoot, Ctr Infect Med, Robert von Ostertag Str 7-13, D-14163 Berlin, Germany.	karsten.tedin@fu-berlin.de		SINGH, VIKASH/0000-0002-6904-1199	Deutsche Forschungsgemeinschaft (DFG) through Priority Program [TE416/1-1]; Graduate Research Training [GRK1121]; Biotechnology and Biological Sciences Research Council [BB/D004810/1]; BBSRC [BB/D004810/1] Funding Source: UKRI	Deutsche Forschungsgemeinschaft (DFG) through Priority Program(German Research Foundation (DFG)); Graduate Research Training; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Deutsche Forschungsgemeinschaft (DFG) through Priority Program SPP1136 Grant TE416/1-1, Graduate Research Training Grant GRK1121 ( to K.T. and V.S.), and Biotechnology and Biological Sciences Research Council Grant BB/D004810/1 ( to A.T.). The authors declare that they have no conflicts of interest with the contents of this article.	Abu Kwaik Y, 2013, CELL MICROBIOL, V15, P882, DOI 10.1111/cmi.12138; Agarraberes FA, 1997, J CELL BIOL, V137, P825, DOI 10.1083/jcb.137.4.825; Alcaine SD, 2007, J FOOD PROTECT, V70, P780, DOI 10.4315/0362-028X-70.3.780; ANIENTO F, 1993, J BIOL CHEM, V268, P10463; Bakowski MA, 2008, TRAFFIC, V9, P2022, DOI 10.1111/j.1600-0854.2008.00827.x; Beuzon CR, 2002, MICROBIOL-SGM, V148, P2705, DOI 10.1099/00221287-148-9-2705; Birmingham CL, 2006, AUTOPHAGY, V2, P156, DOI 10.4161/auto.2825; Birmingham CL, 2006, J BIOL CHEM, V281, P11374, DOI 10.1074/jbc.M509157200; Bowden SD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096266; Bowden SD, 2009, INFECT IMMUN, V77, P3117, DOI 10.1128/IAI.00093-09; Brumell JH, 2002, INFECT IMMUN, V70, P3264, DOI 10.1128/IAI.70.6.3264-3270.2002; Brumell JH, 2004, CURR OPIN MICROBIOL, V7, P78, DOI 10.1016/j.mib.2003.12.005; Chai LC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036201; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Clemente L, 2015, RES MICROBIOL, V166, P574, DOI 10.1016/j.resmic.2015.05.007; CUERVO AM, 1994, J BIOL CHEM, V269, P26374; Cuervo AM, 1997, J BIOL CHEM, V272, P5606, DOI 10.1074/jbc.272.9.5606; Cuervo AM, 1996, SCIENCE, V273, P501, DOI 10.1126/science.273.5274.501; Daniel H, 2015, EXP PHYSIOL, V100, P1441, DOI 10.1113/EP085029; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dice JF, 2007, AUTOPHAGY, V3, P295, DOI 10.4161/auto.4144; Drecktrah D, 2007, TRAFFIC, V8, P212, DOI 10.1111/j.1600-0854.2006.00529.x; Eisenreich W, 2010, NAT REV MICROBIOL, V8, P401, DOI 10.1038/nrmicro2351; Finn PE, 2005, AUTOPHAGY, V1, P141, DOI 10.4161/auto.1.3.2000; Garcia-Del Portillo F, 2000, INFECT IMMUN, V68, P2985, DOI 10.1128/IAI.68.5.2985-2991.2000; Garcia-Gutierrez E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150687; GARCIADELPORTILLO F, 1995, J CELL BIOL, V129, P81, DOI 10.1083/jcb.129.1.81; Gopinath S, 2012, TRENDS MICROBIOL, V20, P320, DOI 10.1016/j.tim.2012.04.004; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; HOLMES R, 1989, GUT, V30, P1667, DOI 10.1136/gut.30.12.1667; Huang J, 2014, NAT REV MICROBIOL, V12, P101, DOI 10.1038/nrmicro3160; Kariuki S, 2015, VACCINE, V33, pS21, DOI 10.1016/j.vaccine.2015.03.102; Kaushik S, 2006, EMBO J, V25, P3921, DOI 10.1038/sj.emboj.7601283; Kaushik S, 2009, METHOD ENZYMOL, V452, P297, DOI 10.1016/S0076-6879(08)03619-7; Keeney KM, 2011, CURR OPIN MICROBIOL, V14, P92, DOI 10.1016/j.mib.2010.12.012; Kingsley RA, 2009, GENOME RES, V19, P2279, DOI 10.1101/gr.091017.109; Kleeb AC, 2007, P NATL ACAD SCI USA, V104, P13907, DOI 10.1073/pnas.0705379104; Klose KE, 1997, INFECT IMMUN, V65, P587, DOI 10.1128/IAI.65.2.587-596.1997; Knodler LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084681; Krieger V, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004374; Kuhle V, 2006, TRAFFIC, V7, P716, DOI 10.1111/j.1600-0854.2006.00422.x; Malik-Kale P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038732; McGourty K, 2012, SCIENCE, V338, P963, DOI 10.1126/science.1227037; Miner-Williams WM, 2014, NUTR RES REV, V27, P308, DOI 10.1017/S0954422414000225; Mostowy S, 2012, TRENDS CELL BIOL, V22, P283, DOI 10.1016/j.tcb.2012.03.006; Mota LJ, 2009, CELL MICROBIOL, V11, P1236, DOI 10.1111/j.1462-5822.2009.01329.x; Orenstein SJ, 2010, SEMIN CELL DEV BIOL, V21, P719, DOI 10.1016/j.semcdb.2010.02.005; PANG T, 1995, TRENDS MICROBIOL, V3, P253, DOI 10.1016/S0966-842X(00)88937-4; Pang T, 1998, TRENDS MICROBIOL, V6, P131, DOI 10.1016/S0966-842X(98)01236-0; PAYNE JW, 1994, ADV MICROB PHYSIOL, V36, P1, DOI 10.1016/S0065-2911(08)60176-9; Pols MS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2360; Portillo FGD, 2001, MICROBES INFECT, V3, P1305, DOI 10.1016/S1286-4579(01)01491-5; Rathman M, 1996, INFECT IMMUN, V64, P2765, DOI 10.1128/IAI.64.7.2765-2773.1996; Roark EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003538; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; SCHMIEGER H, 1972, MOL GEN GENET, V119, P75, DOI 10.1007/BF00270447; Schroeder N, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001002; Scott CC, 2002, J BIOL CHEM, V277, P12770, DOI 10.1074/jbc.M110399200; Seki T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031232; Sezonov G, 2007, J BACTERIOL, V189, P8746, DOI 10.1128/JB.01368-07; Staib L, 2014, MICROBIOL-SGM, V160, P1020, DOI 10.1099/mic.0.078105-0; Steeb B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003301; Steele-Mortimer O, 2002, CELL MICROBIOL, V4, P43, DOI 10.1046/j.1462-5822.2002.00170.x; Steele-Mortimer O, 1999, CELL MICROBIOL, V1, P33, DOI 10.1046/j.1462-5822.1999.00003.x; Strugnell RA, 2014, CURR OPIN MICROBIOL, V17, P99, DOI 10.1016/j.mib.2013.12.004; Tattoli I, 2012, CELL HOST MICROBE, V11, P563, DOI 10.1016/j.chom.2012.04.012; Tennant SM, 2015, VACCINE, V33, pC36, DOI 10.1016/j.vaccine.2015.04.029; Thurston TLM, 2012, NATURE, V482, P414, DOI 10.1038/nature10744; Thurston TLM, 2009, NAT IMMUNOL, V10, P1215, DOI 10.1038/ni.1800; Vazquez-Torres A, 1999, NATURE, V401, P804, DOI 10.1038/44593; Verbrugghe E, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-118; VIRGILIO R, 1981, CAN J MICROBIOL, V27, P1272, DOI 10.1139/m81-195; Vorwerk S, 2015, MOL CELL PROTEOMICS, V14, P81, DOI 10.1074/mcp.M114.041145; WING SS, 1991, BIOCHEM J, V275, P165, DOI 10.1042/bj2750165; Yimga MT, 2006, INFECT IMMUN, V74, P1130, DOI 10.1128/IAI.74.2.1130-1140.2006; Yu HB, 2014, MBIO, V5, DOI 10.1128/mBio.00865-14; Yu XJ, 2010, SCIENCE, V328, P1040, DOI 10.1126/science.1189000	77	23	23	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1847	1864		10.1074/jbc.M116.759456	http://dx.doi.org/10.1074/jbc.M116.759456			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	27932462	hybrid, Green Published			2022-12-26	WOS:000395515600025
J	Alexander, PB; Chen, R; Gong, C; Yuan, LF; Jasper, JS; Ding, Y; Markowitz, GJ; Yang, PY; Xu, X; McDonnell, DP; Song, EW; Wang, XF				Alexander, Peter B.; Chen, Rui; Gong, Chang; Yuan, Lifeng; Jasper, Jeff S.; Ding, Yi; Markowitz, Geoffrey J.; Yang, Pengyuan; Xu, Xin; McDonnell, Donald P.; Song, Erwei; Wang, Xiao-Fan			Distinct Receptor Tyrosine Kinase Subsets Mediate Anti-HER2 Drug Resistance in Breast Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; PHASE-II TRIAL; IMATINIB MESYLATE; PROMOTER METHYLATION; MOLECULAR-MECHANISMS; GROWTH; TRASTUZUMAB; SENESCENCE; INHIBITOR; THERAPY	Targeted inhibitors of the human epidermal growth factor receptor 2 (HER2), such as trastuzumab and lapatinib, are among the first examples of molecularly targeted cancer therapy and have proven largely effective for the treatment of HER2-positive breast cancers. However, approximately half of those patients either do not respond to these therapies or develop secondary resistance. Although a few signaling pathways have been implicated, a comprehensive understanding of mechanisms underlying HER2 inhibitor drug resistance is still lacking. To address this critical question, we undertook a concerted approach using patient expression data sets, HER2-positive cell lines, and tumor samples biopsied both before and after trastuzumab treatment. Together, these methods revealed that high expression and activation of a specific subset of receptor tyrosine kinases (RTKs) was strongly associated with poor clinical prognosis and the development of resistance. Mechanistically, these RTKs are capable of maintaining downstream signal transduction to promote tumor growth via the suppression of cellular senescence. Consequently, these findings provide the rationale for the design of therapeutic strategies for overcoming drug resistance in breast cancer via combinational inhibition of the limited number of targets from this specific subset of RTKs.	[Alexander, Peter B.; Chen, Rui; Yuan, Lifeng; Jasper, Jeff S.; Ding, Yi; Markowitz, Geoffrey J.; Yang, Pengyuan; Xu, Xin; McDonnell, Donald P.; Wang, Xiao-Fan] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, C218 LSRC Bldg,308 Res Dr, Durham, NC 27710 USA; [Gong, Chang; Song, Erwei] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Breast Tumor Ctr, Guangzhou, Guangdong, Peoples R China	Duke University; Sun Yat Sen University	Wang, XF (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, C218 LSRC Bldg,308 Res Dr, Durham, NC 27710 USA.	xiao.fan.wang@duke.edu	Yuan, Lifeng/AAG-4363-2021	Yuan, Lifeng/0000-0002-5367-7512; Markowitz, Geoffrey/0000-0003-3915-8078; Jasper, Jeff/0000-0003-3941-0018	National Institutes of Health [CA154586, CA186800, CA174643, CA059365]; Department of Defense [BC151189]; 973 Projects from the Ministry of Science and Technology of China [2010CB912800, 2011CB504203]; Natural Science Foundation of China [81672594, 81230060, 81261140373, 81272893, 81472466]; National SAMP;T Major Special Project on New Drug Innovation of China [2011ZX09102-010-02]; Guangdong Province [2014A03036003, S2012030006287, 2014A030310378, 2016A050502018]; NATIONAL CANCER INSTITUTE [R21CA186800, R01CA154586, T32CA059365, R01CA174643] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); 973 Projects from the Ministry of Science and Technology of China; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National SAMP;T Major Special Project on New Drug Innovation of China; Guangdong Province; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grants CA154586 and CA186800 (to X.-F. W.), CA174643 (to D. P. M.), and CA059365 (to P. B. A.) and Department of Defense Grant BC151189 (to X.-F. W.). This work was also supported by 973 Projects 2010CB912800 and 2011CB504203 from the Ministry of Science and Technology of China; Natural Science Foundation of China Grants 81672594, 81230060, 81261140373, 81272893, and 81472466; National S&T Major Special Project on New Drug Innovation of China Grant 2011ZX09102-010-02); and Guangdong Province Grants 2014A03036003, S2012030006287, 2014A030310378, and 2016A050502018 (to E. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alexander PB, 2015, FRONT MED-PRC, V9, P134, DOI 10.1007/s11684-015-0396-9; Alexander PB, 2015, CELL RES, V25, P135, DOI 10.1038/cr.2014.141; Bardelli A, 2013, CANCER DISCOV, V3, P658, DOI 10.1158/2159-8290.CD-12-0558; Byers LA, 2013, CLIN CANCER RES, V19, P279, DOI 10.1158/1078-0432.CCR-12-1558; Chakrabarty A, 2012, P NATL ACAD SCI USA, V109, P2718, DOI 10.1073/pnas.1018001108; Chandarlapaty S, 2011, CANCER CELL, V19, P58, DOI 10.1016/j.ccr.2010.10.031; Chang YS, 2002, CLIN CANCER RES, V8, P3669; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Clemmons David R., 1997, Cytokine and Growth Factor Reviews, V8, P45, DOI 10.1016/S1359-6101(96)00053-6; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Elzi DJ, 2012, P NATL ACAD SCI USA, V109, P12052, DOI 10.1073/pnas.1120437109; Garcia-Echeverria C, 2004, CANCER CELL, V5, P231, DOI 10.1016/S1535-6108(04)00051-0; Groenendijk FH, 2014, MOL ONCOL, V8, P1067, DOI 10.1016/j.molonc.2014.05.004; Harris LN, 2007, CLIN CANCER RES, V13, P1198, DOI 10.1158/1078-0432.CCR-06-1304; Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Kastner K, 2014, CHEM-EUR J, V20, P12269, DOI 10.1002/chem.201403592; Kawasaki T, 2007, NEOPLASIA, V9, P1091, DOI 10.1593/neo.07760; Kim KS, 2007, MOL BIOL CELL, V18, P4543, DOI 10.1091/mbc.E07-03-0280; Kojima H, 2012, CELL CYCLE, V11, P730, DOI 10.4161/cc.11.4.19172; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Lu YH, 2004, INT J CANCER, V108, P334, DOI 10.1002/ijc.11445; Lu YH, 2001, JNCI-J NATL CANCER I, V93, P1852, DOI 10.1093/jnci/93.24.1852; Moasser MM, 2007, ONCOGENE, V26, P6469, DOI 10.1038/sj.onc.1210477; Modi S, 2005, BREAST CANCER RES TR, V90, P157, DOI 10.1007/s10549-004-3974-0; Nahta R, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1612; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Niederst MJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004652; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Rivenbark AG, 2006, EPIGENETICS-US, V1, P32, DOI 10.4161/epi.1.1.2358; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Roskoski R, 2007, BIOCHEM BIOPH RES CO, V356, P323, DOI 10.1016/j.bbrc.2007.02.156; Salt MB, 2014, CANCER DISCOV, V4, P186, DOI 10.1158/2159-8290.CD-13-0520; Schilder RJ, 2008, J CLIN ONCOL, V26, P3418, DOI 10.1200/JCO.2007.14.3420; Schroder MS, 2011, BIOINFORMATICS, V27, P3206, DOI 10.1093/bioinformatics/btr511; Sharma P, 2015, CELL, V161, P205, DOI 10.1016/j.cell.2015.03.030; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Spector NL, 2009, J CLIN ONCOL, V27, P5838, DOI 10.1200/JCO.2009.22.1507; Thompson CA, 2015, AM J HEALTH-SYST PH, V72, P592, DOI 10.2146/news150028; Vu T, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00062; Wang QR, 2013, CANCER LETT, V340, P43, DOI 10.1016/j.canlet.2013.06.022; Wiley A, 2006, INT J GYNECOL CANCER, V16, P210, DOI 10.1111/j.1525-1438.2006.00299.x; Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249; Xia W, 2006, P NATL ACAD SCI USA, V103, P7795, DOI 10.1073/pnas.0602468103; Yardley DA, 2009, CLIN BREAST CANCER, V9, P237, DOI 10.3816/CBC.2009.n.040; Zhou J, 2015, ONCOTARGET, V6, P44332, DOI 10.18632/oncotarget.6293	53	22	23	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2017	292	2					748	759		10.1074/jbc.M116.754960	http://dx.doi.org/10.1074/jbc.M116.754960			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2KN	27903634	Green Published, hybrid			2022-12-26	WOS:000392316100028
J	Xu, LF; Zhang, ZY; Xie, TH; Zhang, XY; Dai, T				Xu, Lifang; Zhang, Ziyin; Xie, Tianhua; Zhang, Xiaoyang; Dai, Tu			Inhibition of BDNF-AS Provides Neuroprotection for Retinal Ganglion Cells against Ischemic Injury	PLOS ONE			English	Article							LONG NONCODING RNAS; NEUROTROPHIC FACTOR; GROWTH-FACTOR; RAT RETINA; EXPRESSION; APOPTOSIS	Background: Brain-derived neurotrophic factor (BDNF) protects retinal ganglion cells against ischemia in ocular degenerative diseases. We aimed to determine the effect of BDNF-AS on the ischemic injury of retinal ganglion cells. Methods: The levels of BDNF and BDNF-AS were measured in retinal ganglion cells subjected to oxygen and glucose deprivation. The lentiviral vectors were constructed to either overexpress or knock out BDNF-AS. The luciferase reporter gene assay was used to determine whether BDNF-AS could target its seed sequence on BDNF mRNA. The methyl thiazolyl tetrazolium assay was used to determine cell viability, and TUNEL staining was used for cell apoptosis. Results: The levels of BDNF-AS were negatively correlated with BDNF in ischemic retinal ganglion cells. BDNFAS directly targeted its complementary sequences on BDNF mRNA. BDNF-AS regulated the expression of BDNF and its related genes in retinal ganglion cells. Down-regulation of BDNF-AS increased cell viability and decreased the number of TUNEL-positive retinal ganglion cells under oxygen and glucose deprivation conditions. Conclusion: Inhibition of BDNF-AS protected retinal ganglion cells against ischemia by increasing the levels of BDNF.	[Xu, Lifang; Zhang, Ziyin; Xie, Tianhua; Zhang, Xiaoyang] Wuxi Peoples Hosp, Dept Ophthalmol, Wuxi, Jiangsu, Peoples R China; [Dai, Tu] Wuxi 2 Peoples Hosp, Dept Hepatobiliary, Wuxi, Jiangsu, Peoples R China	Jiangnan University	Dai, T (corresponding author), Wuxi 2 Peoples Hosp, Dept Hepatobiliary, Wuxi, Jiangsu, Peoples R China.	wxdaitut@163.com						Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Dharap A, 2012, STROKE, V43, P2800, DOI 10.1161/STROKEAHA.112.669465; Feng Y, 2012, EXP CLIN ENDOCR DIAB, V120, P199, DOI 10.1055/s-0032-1304571; Guo XJ, 2014, EXP EYE RES, V125, P156, DOI 10.1016/j.exer.2014.06.003; Jiang Y, 2011, NEUROSCIENCE, V172, P398, DOI 10.1016/j.neuroscience.2010.10.054; Khalin I, 2015, INT J NANOMED, V10, P3245, DOI 10.2147/IJN.S77480; Kurokawa T, 1999, INVEST OPHTH VIS SCI, V40, P3006; Lambert WS, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-51; Li JY, 2015, J CRANIOFAC SURG, V26, P548, DOI 10.1097/SCS.0000000000001348; Liu YB, 2015, CELL PHYSIOL BIOCHEM, V35, P1986, DOI 10.1159/000374006; Marler KJ, 2014, J NEUROSCI, V34, P969, DOI 10.1523/JNEUROSCI.1910-13.2014; Mehta SL, 2015, J NEUROSCI, V35, P16443, DOI 10.1523/JNEUROSCI.2943-15.2015; Modarresi F, 2012, NAT BIOTECHNOL, V30, P453, DOI 10.1038/nbt.2158; Qian WF, 2011, BRAZ J MED BIOL RES, V44, P1222, DOI [10.1590/S0100-879X2011007500143, 10.1590/S0100-879X2011001200005]; Roberti G, 2014, J CELL PHYSIOL, V229, P1130, DOI 10.1002/jcp.24573; Steuer H, 2005, INVEST OPHTH VIS SCI, V46, P1047, DOI 10.1167/iovs.04-0925; Strettoi E, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00494; UNOKI K, 1994, INVEST OPHTH VIS SCI, V35, P907; Wang RB, 2016, BRAIN RES, V1632, P82, DOI 10.1016/j.brainres.2015.12.015; Weber AJ, 2013, INVEST OPHTH VIS SCI, V54, P6594, DOI 10.1167/iovs.13-12683; Xie B, 2011, J NEUROSCI, V31, P5032, DOI 10.1523/JNEUROSCI.5504-10.2011; Zhang XM, 2010, MOL VIS, V16, P2867	22	25	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0164941	10.1371/journal.pone.0164941	http://dx.doi.org/10.1371/journal.pone.0164941			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935942	gold, Green Submitted, Green Published			2022-12-26	WOS:000389587100008
J	Fujio, N; Masuoka, S; Shikano, K; Kusunoki, N; Nanki, T; Kawai, S				Fujio, Natsuki; Masuoka, Shotaro; Shikano, Kotaro; Kusunoki, Natsuko; Nanki, Toshihiro; Kawai, Shinichi			Apparent Hypothalamic-Pituitary-Adrenal Axis Suppression via Reduction of Interleukin-6 by Glucocorticoid Therapy in Systemic Autoimmune Diseases	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; POLYMYALGIA-RHEUMATICA; LUPUS-ERYTHEMATOSUS; SERUM-LEVELS; STEROIDOGENESIS; EXPRESSION; CYTOKINES; NCI-H295R; HORMONES; PROTEIN	Context Suppression of the hypothalamic-pituitary-adrenal (HPA) axis is a serious complication of systemic glucocorticoid therapy. Objective To clarify the influence of proinflammatory cytokines on the HPA axis after onset of glucocorticoid therapy in patients with systemic autoimmune diseases. Patients and Methods Forty-eight glucocorticoid-naive patients with systemic autoimmune diseases (28 women) who were starting prednisolone therapy according to our standard regimens were prospectively observed. Patients were classified into high-dose and low-dose groups depending on the dose of prednisolone administered as indicated for their diseases. Plasma adrenocorticotropic hormone (ACTH) and serum cortisol levels were measured by electrochemiluminescence immunoassay. The corticotropin-releasing hormone (CRH) test was performed at baseline and second and forth weeks after starting glucocorticoid therapy. The increased levels of ACTH (Delta ACTH) and cortisol (Delta cortisol) were investigated. Serum levels of 10 proinflammatory cytokines were measured simultaneously by a multi-spot assay system. Results In the high-dose group, both basal and stimulated levels of ACTH and cortisol were significantly decreased by glucocorticoid therapy. In the low-dose group, basal ACTH and cortisol levels were also significantly decreased by glucocorticoid therapy, but Delta ACTH and Delta cortisol were unchanged. Among 10 cytokines, only interleukin (IL)-6 was significantly decreased by glucocorticoid therapy in both groups and was more closely correlated with cortisol than ACTH. Basal cortisol level was positively correlated with serum IL-6 level in all patients before glucocorticoid therapy. Conclusion In patients with systemic autoimmune diseases, apparent suppression of cortisol during glucocorticoid therapy may be partly mediated by reduced production of IL-6.	[Fujio, Natsuki; Masuoka, Shotaro; Shikano, Kotaro; Kusunoki, Natsuko; Nanki, Toshihiro; Kawai, Shinichi] Toho Univ, Sch Med, Fac Med, Dept Internal Med,Div Rheumatol,Ota Ku, Tokyo, Japan		Kawai, S (corresponding author), Toho Univ, Sch Med, Fac Med, Dept Internal Med,Div Rheumatol,Ota Ku, Tokyo, Japan.	skawai@med.toho-u.ac.jp			Heisei 26 Strategic Research Foundation Project for Private Schools from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Agency for Medical Research and Development on Regulatory Science of Pharmaceuticals and Medical Devices	Heisei 26 Strategic Research Foundation Project for Private Schools from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Agency for Medical Research and Development on Regulatory Science of Pharmaceuticals and Medical Devices(Japan Agency for Medical Research and Development (AMED))	This study was partly supported by a grant from the Heisei 26 Strategic Research Foundation Project for Private Schools from the Ministry of Education, Culture, Sports, Science and Technology of Japan to Toho University (2014-2016) and a grant from the Japan Agency for Medical Research and Development on Regulatory Science of Pharmaceuticals and Medical Devices (2015-2016) to SK.	BERTOUCH JV, 1983, ANN RHEUM DIS, V42, P655, DOI 10.1136/ard.42.6.655; Bornstein SR, 1999, J CLIN ENDOCR METAB, V84, P1729; Crofford LJ, 1997, J CLIN ENDOCR METAB, V82, P1279, DOI 10.1210/jc.82.4.1279; Cutolo M, 2002, J RHEUMATOL, V29, P748; Demir H, 2006, SCAND J RHEUMATOL, V35, P217, DOI 10.1080/03009740500474586; Franchimont D, 2000, GASTROENTEROLOGY, V119, P1560, DOI 10.1053/gast.2000.20235; GABAY C, 1994, ARTHRITIS RHEUM, V37, P1744, DOI 10.1002/art.1780371206; Grondal G, 2000, CLIN EXP RHEUMATOL, V18, P565; Hahn BH., 2015, HARRISONS PRINCIPLES, P2124; Hassan AB, 2006, J AUTOIMMUN, V27, P62, DOI 10.1016/j.jaut.2006.06.003; Jenks BG, 2009, ANN NY ACAD SCI, V1163, P17, DOI 10.1111/j.1749-6632.2008.03620.x; MASTORAKOS G, 1993, J CLIN ENDOCR METAB, V77, P1690, DOI 10.1210/jc.77.6.1690; Mikhaylova IV, 2007, ENDOCRINOLOGY, V148, P386, DOI 10.1210/en.2006-0726; PERLSTEIN RS, 1993, ENDOCRINOLOGY, V132, P946, DOI 10.1210/en.132.3.946; Qiu F, 2013, LUPUS, V22, P1011, DOI 10.1177/0961203313498799; Salvarani C, 1997, LANCET, V350, P43, DOI 10.1016/S0140-6736(97)05001-0; Schuetz Philipp, 2008, BMC Pulm Med, V8, P1, DOI 10.1186/1471-2466-8-1; Stewart PM, 2016, WILLIAMS TXB ENDOCRI, V13, P490; Straub RH, 2000, RHEUMATOLOGY, V39, P624, DOI 10.1093/rheumatology/39.6.624; Tkachenko IV, 2011, STEROIDS, V76, P1103, DOI 10.1016/j.steroids.2011.04.018; Wolff C, 2015, ANN RHEUM DIS, V74, P1890, DOI 10.1136/annrheumdis-2013-203885	21	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167854	10.1371/journal.pone.0167854	http://dx.doi.org/10.1371/journal.pone.0167854			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930715	gold, Green Published, Green Submitted			2022-12-26	WOS:000389580900052
J	Han, BC; Wei, W; Mi, XC; Ma, KP				Han, Bao-cai; Wei, Wei; Mi, Xiang-cheng; Ma, Ke-ping			De Novo Sequencing and Comparative Analysis of Schima superba Seedlings to Explore the Response to Drought Stress	PLOS ONE			English	Article							RNA-SEQ; GENE ONTOLOGY; EXPRESSION; BIOSYNTHESIS; MECHANISMS; TOLERANCE; FOREST; KEGG; TOOL	Schima superba is an important dominant species in subtropical evergreen broadleaved forests of China, and plays a vital role in community structure and dynamics. However, the survival rate of its seedlings in the field is low, and water shortage could be a factor that limits its regeneration. In order to better understand the response of its seedlings to drought stress on a functional genomics scale, RNA-seq technology was utilized in this study to perform a large-scale transcriptome sequencing of the S. superba seedlings under drought stress. More than 320 million clean reads were generated and 72218 unique transcripts were obtained through de novo assembly. These unigenes were further annotated by blasting with different public databases and a total of 53300 unique transcripts were annotated. A total of 31586 simple sequence repeat (SSR) loci were presented. Through gene expression profiling analysis between drought treatment and control, 11038 genes were found to be significantly enriched in drought-stressed seedlings. Based on these differentially expressed genes (DEGs), Gene Ontology (GO) terms enrichment and Kyoto Encyclopedia of Genes and Genomes pathway (KEGG) enrichment analysis indicated that drought stress caused a number of changes in the types of sugars, enzymes, secondary mechanisms, and light responses, and induced some potential physical protection mechanisms. In addition, the expression patterns of 18 transcripts induced by drought, as determined by quantitative real-time PCR, were consistent with their transcript abundance changes, as identified by RNA-seq. This transcriptome study provides a rapid method for understanding the response of S. superba seedlings to drought stress and provides a number of gene sequences available for further functional genomics studies.	[Han, Bao-cai; Wei, Wei; Mi, Xiang-cheng; Ma, Ke-ping] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Han, Bao-cai; Ma, Ke-ping] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Ma, KP (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China.; Ma, KP (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.	kpma@ibcas.ac.cn	, Weiwei/B-2681-2008	, Weiwei/0000-0002-1815-9314	National Natural Science Foundation of China [31261120579]; Direct For Biological Sciences [1643052] Funding Source: National Science Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	KPM was supported by the National Natural Science Foundation of China (No. 31261120579), http://www.nsfc.gov/cn.publish/portal1/.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Aranda I., 2012, PLANT RESPONSES DROU, P293, DOI DOI 10.1007/978-3-642-32653-0_12; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ashrafi H, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-571; Audran C, 1998, PLANT PHYSIOL, V118, P1021, DOI 10.1104/pp.118.3.1021; Bassi R, 1997, PHYSIOL PLANTARUM, V100, P769, DOI 10.1034/j.1399-3054.1997.1000404.x; Burbidge A, 1999, PLANT J, V17, P427, DOI 10.1046/j.1365-313X.1999.00386.x; Cornic G, 2000, TRENDS PLANT SCI, V5, P187, DOI 10.1016/S1360-1385(00)01625-3; Ellegren H, 2008, NATURE, V452, P169, DOI 10.1038/nature06737; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hoekstra FA, 2001, TRENDS PLANT SCI, V6, P431, DOI 10.1016/S1360-1385(01)02052-0; Hu XiSheng, 2007, Guangxi Zhiwu / Guihaia, V27, P469; Huang ZhiWei, 2008, Scientia Silvae Sinicae, V44, P101; Kerstiens G, 1996, J EXP BOT, V47, P1813, DOI 10.1093/jxb/47.12.1813; Kissoudis C, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00207; Lai JS, 2013, OIKOS, V122, P1636, DOI 10.1111/j.1600-0706.2013.00436.x; Lee KH, 2000, J ENVIRON QUAL, V29, P1200, DOI 10.2134/jeq2000.2941200x; Li DJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-192; Li HE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0111054; Li Li, 2010, Chinese Journal of Plant Ecology, V34, P241, DOI 10.3773/j.issn.1005-264x.2010.03.001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Marenduzzo D, 2006, J CELL BIOL, V175, P681, DOI 10.1083/jcb.200609066; McDowell NG, 2011, PLANT PHYSIOL, V155, P1051, DOI 10.1104/pp.110.170704; Ming T.L., 2007, FLORA CHINA, V12, P366; Murakami R, 2005, FEBS J, V272, P2165, DOI 10.1111/j.1742-4658.2005.04636.x; Mustroph A, 2010, PLANT PHYSIOL, V152, P1484, DOI 10.1104/pp.109.151845; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Ort DR, 2002, CURR OPIN PLANT BIOL, V5, P193, DOI 10.1016/S1369-5266(02)00259-5; Palatnik JF, 1997, PLANT PHYSIOL, V115, P1721, DOI 10.1104/pp.115.4.1721; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Raj S, 2011, P NATL ACAD SCI USA, V108, P12521, DOI 10.1073/pnas.1103341108; Seki M, 2007, CURR OPIN PLANT BIOL, V10, P296, DOI 10.1016/j.pbi.2007.04.014; Selkoe KA, 2006, ECOL LETT, V9, P615, DOI 10.1111/j.1461-0248.2006.00889.x; Seo PJ, 2011, PLANT CELL, V23, P1138, DOI 10.1105/tpc.111.083485; STAFFORD RE, 1989, BIOCHEMISTRY-US, V28, P5113, DOI 10.1021/bi00438a031; Steinitz O, 2011, MOL ECOL, V20, P4152, DOI 10.1111/j.1365-294X.2011.05203.x; Taji T, 2002, PLANT J, V29, P417, DOI 10.1046/j.0960-7412.2001.01227.x; Thompson AJ, 2000, PLANT J, V23, P363, DOI 10.1046/j.1365-313x.2000.00789.x; Treutter D, 2006, ENVIRON CHEM LETT, V4, P147, DOI 10.1007/s10311-006-0068-8; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wei WL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-451; Wingler A, 2002, PHYTOCHEMISTRY, V60, P437, DOI 10.1016/S0031-9422(02)00137-1; Xie DY, 2003, SCIENCE, V299, P396, DOI 10.1126/science.1078540; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang JY, 2005, PLANT J, V42, P689, DOI 10.1111/j.1365-313X.2005.02405.x; Zhang Shou-Ren, 2007, Zhiwu Shengtai Xuebao, V31, P982	48	3	3	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0166975	10.1371/journal.pone.0166975	http://dx.doi.org/10.1371/journal.pone.0166975			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930677	Green Submitted, Green Published, gold			2022-12-26	WOS:000389580900018
J	Hornok, S; Szoke, K; Kovats, D; Estok, P; Gorfol, T; Boldogh, SA; Takacs, N; Kontschan, J; Foldvari, G; Barti, L; Corduneanu, A; Sandor, AD				Hornok, Sandor; Szoke, Krisztina; Kovats, David; Estok, Peter; Gorfol, Tamas; Boldogh, Sandor A.; Takacs, Nora; Kontschan, Jeno; Foldvari, Gabor; Barti, Levente; Corduneanu, Alexandra; Sandor, Attila D.			DNA of Piroplasms of Ruminants and Dogs in Ixodid Bat Ticks	PLOS ONE			English	Article							PARASITIZING BATS; IXODOIDEA; ARIADNAE; ACARI; VESPERTILIONIS; CHIROPTERA; PHYLOGENY; DIVERSITY; SOUTHERN; WESTERN	In this study 308 ticks (Ixodes ariadnae: 26 larvae, 14 nymphs, five females; I. vespertilionis: 89 larvae, 27 nymphs, eight females; I. simplex: 80 larvae, 50 nymphs, nine females) have been collected from 200 individuals of 17 bat species in two countries, Hungary and Romania. After DNA extraction these ticks were molecularly analysed for the presence of piroplasm DNA. In Hungary I. ariadnae was most frequently identified from bat species in the family Vespertilionidae, whereas I. vespertilionis was associated with Rhinolophidae. Ixodes ariadnae was not found in Romania. Four, four and one new bat host species of I. ariadnae, I. vespertilionis and I. simplex were identified, respectively. DNA sequences of piroplasms were detected in 20 bat ticks (15 larvae, four nymphs and one female). I. simplex carried piroplasm DNA sequences significantly more frequently than I. vespertilionis. In I. ariadnae only Babesia vesperuginis DNA was detected, whereas in I. vespertilionis sequences of both B. vesperuginis and B. crassa. From I. simplex the DNA of B. canis, Theileria capreoli, T. orientalis and Theileria sp. OT3 were amplified, as well as a shorter sequence of the zoonotic B. venatorum. Bat ticks are not known to infest dogs or ruminants, i.e. typical hosts and reservoirs of piroplasms molecularly identified in I. vespertilionis and I. simplex. Therefore, DNA sequences of piroplasms detected in these bat ticks most likely originated from the blood of their respective bat hosts. This may indicate either that bats are susceptible to a broader range of piroplasms than previously thought, or at least the DNA of piroplasms may pass through the gut barrier of bats during digestion of relevant arthropod vectors. In light of these findings, the role of bats in the epidemiology of piroplasmoses deserves further investigation.	[Hornok, Sandor; Szoke, Krisztina; Takacs, Nora; Foldvari, Gabor] Univ Vet Med, Dept Parasitol & Zool, Budapest, Hungary; [Kovats, David] Debrecen Univ, Dept Evolutionary Zool & Human Biol, Debrecen, Hungary; [Estok, Peter] Eszterhazy Karoly Univ, Dept Zool, Eger, Hungary; [Gorfol, Tamas] Hungarian Nat Hist Museum, Dept Zool, Budapest, Hungary; [Boldogh, Sandor A.] Aggtelek Natl Pk Directorate, Nat Conservat Dept, Josvafo, Hungary; [Kontschan, Jeno] Hungarian Acad Sci, Agr Res Ctr, Inst Plant Protect, Budapest, Hungary; [Barti, Levente] Romanian Bat Protect Assoc, Satu Mare, Romania; [Corduneanu, Alexandra; Sandor, Attila D.] Univ Agr Sci & Vet Med, Dept Parasitol & Parasit Dis, Cluj Napoca, Romania	University of Veterinary Medicine Budapest; University of Debrecen; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; University of Agricultural Sciences & Veterinary Medicine Cluj Napoca	Hornok, S (corresponding author), Univ Vet Med, Dept Parasitol & Zool, Budapest, Hungary.	Hornok.Sandor@univet.hu	Földvári, Gábor/A-2612-2011; Sándor, Attila D./A-4782-2009; Kontschan, Jeno/G-6807-2012; Görföl, Tamás/F-7688-2010	Földvári, Gábor/0000-0001-5297-9036; Sándor, Attila D./0000-0001-8852-8341; Görföl, Tamás/0000-0002-1910-4024; Kontschan, Jeno/0000-0001-8274-4238	OTKA [115854, 11475-4/2016/FEKUT, PCE 236/2011]	OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This study was supported by OTKA 115854 (http://www.otka.hu/en), 11475-4/2016/FEKUT (http://2010-2014.kormany.hu/en/ministry-of-human-resources), and PCE 236/2011 (http://www.osztondijak.ro/scholarship/Palyazati-felhivas- magyarorszagi-osztondijak-elnyeresere-MTA-Domus-Hungarica). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktas M, 2014, VET PARASITOL, V200, P276, DOI 10.1016/j.vetpar.2013.12.008; ARTHUR DR, 1956, J PARASITOL, V42, P180, DOI 10.2307/3274734; Burazerovic J, 2015, EXP APPL ACAROL, V66, P281, DOI 10.1007/s10493-015-9891-6; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Casati S, 2006, ANN AGR ENV MED, V13, P65; Corduneanu A, 2016, P 17 INT BAT RES C 2, P50; Dekker Jasja J. A., 2013, Lutra, V56, P111; Dietz C, 2009, BATS BRITAIN EUROPE; Estrada-Pena A, 1999, EXP APPL ACAROL, V23, P685, DOI 10.1023/A:1006241108739; ESTRADA-PENA A, 1989, Revista Iberica de Parasitologia, V49, P165; Feider Z., 1965, FAUNA POPULAR REPUBL, V5/2; FILIPPOVA N A, 1976, Entomologicheskoe Obozrenie, V55, P467; Frank R, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0707-7; Friedhoff KT, 1988, BABESIOSIS DOMESTIC, P45; FUJISAKI K, 1994, PARASITOL TODAY, V10, P31, DOI 10.1016/0169-4758(94)90355-7; GARDNER RA, 1987, PARASITOLOGY, V95, P461, DOI 10.1017/S0031182000057887; Giangaspero A, 2015, TICKS TICK-BORNE DIS, V6, P75, DOI 10.1016/j.ttbdis.2014.09.007; Hammer JF, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1323-x; HASHEMIFESHARKI R, 1981, VET QUART, V3, P1; HOCK RJ, 1951, BIOL BULL-US, V101, P289, DOI 10.2307/1538547; HOOGSTRAAL H, 1964, J PARASITOL, V50, P765, DOI 10.2307/3276200; Hornok S, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1365-0; Hornok S, 2012, VET MICROBIOL, V159, P541, DOI 10.1016/j.vetmic.2012.04.003; Hornok S, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-202; Hornok S, 2016, ACTA VET HUNG, V64, P467, DOI 10.1556/004.2016.043; Hornok S, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1236-0; Hornok S, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1056-2; Hornok S, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1052-6; Hornok S, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0665-0; Hutson AM, 2008, IUCN RED LIST THREAT, V2008, DOI [10.2305/IUCN.UK.2008.RLTS.T13561A4160556.en, DOI 10.2305/IUCN.UK.2008.RLTS.T13561A4160556.EN]; Hutterer R, 2005, NATURSCHUTZ BIOL VIE, V28; Izzo MM, 2010, AUST VET J, V88, P45, DOI 10.1111/j.1751-0813.2009.00540.x; Kamau J, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-22; Korotkov Yu. S., 2004, Parazitologiya (St. Petersburg), V38, P492; Kristofik Jan, 2012, Vespertilio, V16, P167; Kunz TH, 2003, BAT ECOLOGY, P3; Kuttler KL, 1988, BABESIOSIS DOMESTIC, P12; Lack JB, 2012, INT J PARASITOL, V42, P353, DOI 10.1016/j.ijpara.2012.02.005; LEBEDEVA NN, 1981, FOLIA PARASIT, V28, P249; Mihalca AD, 2012, EXP APPL ACAROL, V58, P183, DOI 10.1007/s10493-012-9566-5; Neumann LG, 1911, TIERREICH, V26, P98; Piksa K, 2016, PARASITOL RES, V115, P1727, DOI 10.1007/s00436-016-4936-2; Piksa K, 2013, INT J ACAROL, V39, P1, DOI 10.1080/01647954.2012.737831; Presetnik P, 2013, MAMMALIA, V77, P297, DOI 10.1515/mammalia-2012-0033; Rupp Doris, 2004, Spixiana, V27, P185; Sebek Z., 1975, Mitteilungen der Abteilung fur Zoologie am Landesmuseum Joanneum, V4, P67; Sevcik Martin, 2010, Vespertilio, V13-14, P139; Siuda Krzysztof, 2009, Wiad Parazytol, V55, P39; Spisak S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069805; Szoke K, 2016, MAGY ALLATORVOSOK, V138, P15; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vincent S, 2011, HYSTRIX, V22, P57, DOI 10.4404/Hystrix-22.1-4524	53	34	35	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167735	10.1371/journal.pone.0167735	http://dx.doi.org/10.1371/journal.pone.0167735			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930692	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000389580900041
J	Ritson-Williams, R; Ross, C; Paul, VJ				Ritson-Williams, Raphael; Ross, Cliff; Paul, Valerie J.			Elevated Temperature and Allelopathy Impact Coral Recruitment	PLOS ONE			English	Article							LIFE-HISTORY STAGES; SCLERACTINIAN CORAL; OXIDATIVE STRESS; CLIMATE-CHANGE; POCILLOPORA-DAMICORNIS; MONTASTRAEA-ANNULARIS; OCEAN ACIDIFICATION; PORITES-ASTREOIDES; CHEMICAL DEFENSES; CARIBBEAN CORALS	As climate change continues to alter seawater temperature and chemistry on a global scale, coral reefs show multiple signs of degradation. One natural process that could facilitate the recovery of reef ecosystems is coral recruitment, which can be influenced by the benthic organisms in a local habitat. We experimentally tested both a global stressor (increased seawater temperature) and a local stressor (exposure to microcolin A, a natural product from a common marine benthic cyanobacterium) to determine how these stressors impacted coral larval sublethal stress, survival and settlement. Larvae of Porites astreoides had the same survival and settlement as the controls after exposure to increased temperature alone, but elevated temperature did cause oxidative stress. When exposed to natural concentrations of microcolin A, larval survival and settlement were significantly reduced. When larvae were exposed to these two stressors sequentially there was no interactive effect; but when exposed to both stressors simultaneously, there was a synergistic reduction in larval survival and an increase in oxidative stress more than in either stressor treatment alone. Increased seawater temperatures made larvae more susceptible to a concurrent local stressor disrupting a key process of coral reef recovery and resilience. These results highlight the importance of understanding how interactive stressors of varying spatial scales can impact coral demographics.	[Ritson-Williams, Raphael; Paul, Valerie J.] Smithsonian Marine Stn Ft Pierce, Ft Pierce, FL 34949 USA; [Ritson-Williams, Raphael] Univ Hawaii Manoa, Dept Biol, Honolulu, HI 96822 USA; [Ross, Cliff] Univ North Florida, Dept Biol, 1 UNF Dr, Jacksonville, FL USA	Smithsonian Institution; Smithsonian National Museum of Natural History; University of Hawaii System; University of Hawaii Manoa; State University System of Florida; University of North Florida	Ritson-Williams, R (corresponding author), Smithsonian Marine Stn Ft Pierce, Ft Pierce, FL 34949 USA.; Ritson-Williams, R (corresponding author), Univ Hawaii Manoa, Dept Biol, Honolulu, HI 96822 USA.	rrw33@hawaii.edu			Mote Protect our Reefs Grants [2006-18, 2007-30]; Hunterdon Oceanographic endowment at the Smithsonian Institution; STAR Fellowship Assistance Agreement - U.S. Environmental Protection Agency (EPA) [FP917660]	Mote Protect our Reefs Grants; Hunterdon Oceanographic endowment at the Smithsonian Institution; STAR Fellowship Assistance Agreement - U.S. Environmental Protection Agency (EPA)	This research was funded by Mote Protect our Reefs Grants 2006-18 and 2007-30 and by the Hunterdon Oceanographic endowment at the Smithsonian Institution (RRW CR VJP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The analysis and writing of this research was funded by a STAR Fellowship Assistance Agreement # FP917660 awarded by the U.S. Environmental Protection Agency (EPA) (RRW). It has not been formally reviewed by EPA. The views expressed in this manuscript are solely those of the authors, and EPA does not endorse any products or commercial services mentioned in this publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird A.H., 2006, P 10 INT COR REEF S, P38; Baird AH, 2009, TRENDS ECOL EVOL, V24, P16, DOI 10.1016/j.tree.2008.09.005; Ban SS, 2014, GLOBAL CHANGE BIOL, V20, P681, DOI 10.1111/gcb.12453; Barott KL, 2012, P ROY SOC B-BIOL SCI, V279, P1655, DOI 10.1098/rspb.2011.2155; Bassim KM, 2003, MAR BIOL, V142, P241, DOI 10.1007/S00227-002-0953-z; Bender D, 2014, MAR ECOL PROG SER, V517, P271, DOI 10.3354/meps11037; Birrell CL, 2008, MAR ECOL PROG SER, V362, P129, DOI 10.3354/meps07524; Box SJ, 2007, MAR ECOL PROG SER, V342, P139, DOI 10.3354/meps342139; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Capper A, 2016, J EXP MAR BIOL ECOL, V474, P100, DOI 10.1016/j.jembe.2015.09.008; Chua CM, 2013, MAR ECOL PROG SER, V475, P85, DOI 10.3354/meps10077; Cumbo VR, 2013, J EXP MAR BIOL ECOL, V439, P100, DOI 10.1016/j.jembe.2012.10.019; Cumbo VR, 2013, MAR BIOL, V160, P2903, DOI 10.1007/s00227-013-2280-y; Darling ES, 2008, ECOL LETT, V11, P1278, DOI 10.1111/j.1461-0248.2008.01243.x; Diaz-Pulido G, 2010, CORAL REEFS, V29, P203, DOI 10.1007/s00338-009-0573-x; DONE TJ, 1992, HYDROBIOLOGIA, V247, P121, DOI 10.1007/BF00008211; Downs CA, 2005, MAR POLLUT BULL, V51, P486, DOI 10.1016/j.marpolbul.2005.06.028; Downs CA, 2000, MAR BIOTECHNOL, V2, P533, DOI 10.1007/s101260000038; Dunne RP, 2010, CORAL REEFS, V29, P145, DOI 10.1007/s00338-009-0569-6; Edmunds PJ, 2001, MAR BIOL, V139, P981; Engene N, 2013, J PHYCOL, V49, P1095, DOI 10.1111/jpy.12115; Foster NL, 2008, MAR ECOL PROG SER, V367, P143, DOI 10.3354/meps07594; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Hadfield MG, 2011, ANNU REV MAR SCI, V3, P453, DOI 10.1146/annurev-marine-120709-142753; Hajare SN, 2013, BIOCHIMIE, V95, P1722, DOI 10.1016/j.biochi.2013.05.015; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Humanes A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161616; JACKSON JBC, 1975, P NATL ACAD SCI USA, V72, P5160, DOI 10.1073/pnas.72.12.5160; Krueger T, 2015, COMP BIOCHEM PHYS A, V190, P15, DOI 10.1016/j.cbpa.2015.08.012; Kuffner IB, 2004, CORAL REEFS, V23, P455, DOI 10.1007/s00338-004-0416-8; Kuffner IB, 2006, MAR ECOL PROG SER, V323, P107, DOI 10.3354/meps323107; Lesser MP, 2006, ANNU REV PHYSIOL, V68, P253, DOI 10.1146/annurev.physiol.68.040104.110001; McCook LJ, 2001, CORAL REEFS, V19, P400, DOI 10.1007/s003380000129; Meickle T, 2009, PLANTA MED, V75, P1427, DOI 10.1055/s-0029-1185675; Monaghan P, 2009, ECOL LETT, V12, P75, DOI 10.1111/j.1461-0248.2008.01258.x; Morgan MB, 2001, ENVIRON TOXICOL CHEM, V20, P537, DOI 10.1002/etc.5620200312; Morrow KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044859; Negri AP, 2001, MAR ECOL PROG SER, V223, P121, DOI 10.3354/meps223121; Nelson CE, 2013, ISME J, V7, P962, DOI 10.1038/ismej.2012.161; Olsen K, 2014, MAR ECOL PROG SER, V509, P181, DOI 10.3354/meps10880; Paerl HW, 2012, WATER RES, V46, P1349, DOI 10.1016/j.watres.2011.08.002; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Paul VJ, 2008, ADV EXP MED BIOL, V619, P239, DOI 10.1007/978-0-387-75865-7_11; Paul VJ, 2007, BIOL BULL-US, V213, P226, DOI 10.2307/25066642; Paul VJ, 2011, MAR ECOL PROG SER, V426, P161, DOI 10.3354/meps09032; Paul VJ, 2005, CORAL REEFS, V24, P693, DOI 10.1007/s00338-005-0061-x; Paul VJ, 2001, CRC MAR SCI, P227; Pawlik JR, 2007, LIMNOL OCEANOGR, V52, P907, DOI 10.4319/lo.2007.52.2.0907; Radecker N, 2015, TRENDS MICROBIOL, V23, P490, DOI 10.1016/j.tim.2015.03.008; Rasher DB, 2011, P NATL ACAD SCI USA, V108, P17726, DOI 10.1073/pnas.1108628108; Ritson-Williams Raphael, 2009, Smithsonian Contributions to the Marine Sciences, P437; Ross C, 2013, CORAL REEFS, V32, P71, DOI 10.1007/s00338-012-0956-2; Ross C, 2007, J PHYCOL, V43, P466, DOI 10.1111/j.1529-8817.2007.00346.x; Ross C, 2010, HARMFUL ALGAE, V9, P173, DOI 10.1016/j.hal.2009.09.001; Sharp K, 2009, APPL ENVIRON MICROB, V75, P2879, DOI 10.1128/AEM.02656-08; Smith JE, 2006, ECOL LETT, V9, P835, DOI 10.1111/j.1461-0248.2006.00937.x; Tchernov D, 2004, P NATL ACAD SCI USA, V101, P13531, DOI 10.1073/pnas.0402907101; Thacker RW, 1998, ECOLOGY, V79, P1740; Thurber RV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044246; Titlyanov EA, 2007, J EXP MAR BIOL ECOL, V342, P282, DOI 10.1016/j.jembe.2006.11.007; Underwood AJ, 1997, EXPT ECOLOGY; Veron JEN, 2009, MAR POLLUT BULL, V58, P1428, DOI 10.1016/j.marpolbul.2009.09.009; Webster NS, 2004, APPL ENVIRON MICROB, V70, P1213, DOI 10.1128/AEM.70.2.1213-1221.2004; WIEDENMANN J, 2012, NATURE CLIMATE CHANG, V3, P160, DOI DOI 10.1038/NCLIMATE1661; Yakovleva IM, 2009, MAR ECOL PROG SER, V378, P105, DOI 10.3354/meps07857; Yin HP, 2013, ANTI-CANCER DRUG, V24, P587, DOI 10.1097/CAD.0b013e3283611395	69	21	22	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2016	11	12							e0166581	10.1371/journal.pone.0166581	http://dx.doi.org/10.1371/journal.pone.0166581			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4NG	27926916	gold, Green Published, Green Submitted			2022-12-26	WOS:000389578800003
J	Jangid, K; Kao, MH; Lahamge, A; Williams, MA; Rathbun, SL; Whitman, WB				Jangid, Kamlesh; Kao, Ming-Hung; Lahamge, Aishwarya; Williams, Mark A.; Rathbun, Stephen L.; Whitman, William B.			K-shuff: A Novel Algorithm for Characterizing Structural and Compositional Diversity in Gene Libraries	PLOS ONE			English	Article							MICROBIAL COMMUNITIES; 2ND-ORDER ANALYSIS	K-shuff is a new algorithm for comparing the similarity of gene sequence libraries, providing measures of the structural and compositional diversity as well as the significance of the differences between these measures. Inspired by Ripley's K-function for spatial point pattern analysis, the Intra K-function or IKF measures the structural diversity, including both the richness and overall similarity of the sequences, within a library. The Cross K-function or CKF measures the compositional diversity between gene libraries, reflecting both the number of OTUs shared as well as the overall similarity in OTUs. A Monte Carlo testing procedure then enables statistical evaluation of both the structural and compositional diversity between gene libraries. For 16S rRNA gene libraries from complex bacterial communities such as those found in seawater, salt marsh sediments, and soils, K-shuff yields reproducible estimates of structural and compositional diversity with libraries greater than 50 sequences. Similarly, for pyrosequencing libraries generated from a glacial retreat chrono-sequence and Illumina (R) libraries generated from US homes, K-shuff required >300 and 100 sequences per sample, respectively. Power analyses demonstrated that K-shuff is sensitive to small differences in Sanger or Illumina (R) libraries. This extra sensitivity of K-shuff enabled examination of compositional differences at much deeper taxonomic levels, such as within abundant OTUs. This is especially useful when comparing communities that are compositionally very similar but functionally different. K-shuff will therefore prove beneficial for conventional microbiome analysis as well as specific hypothesis testing.	[Jangid, Kamlesh; Whitman, William B.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; [Jangid, Kamlesh] Savitribai Phule Pune Univ, Natl Ctr Cell Sci, Microbial Culture Collect, Pune, Maharashtra, India; [Kao, Ming-Hung] Arizona State Univ, Sch Math & Stat Sci, Tempe, AZ USA; [Lahamge, Aishwarya] Savitribai Phule Pune Univ, Inst Biotechnol & Bioinformat, Pune, Maharashtra, India; [Williams, Mark A.] Virginia Polytech & State Univ, Coll Agr & Life Sci, Blacksburg, VA USA; [Rathbun, Stephen L.] Univ Georgia, Dept Epidemiol & Biostat, Athens, GA 30602 USA	University System of Georgia; University of Georgia; Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS); Savitribai Phule Pune University; Arizona State University; Arizona State University-Tempe; Savitribai Phule Pune University; Virginia Polytechnic Institute & State University; University System of Georgia; University of Georgia	Jangid, K (corresponding author), Univ Georgia, Dept Microbiol, Athens, GA 30602 USA.; Jangid, K (corresponding author), Savitribai Phule Pune Univ, Natl Ctr Cell Sci, Microbial Culture Collect, Pune, Maharashtra, India.	jangidk@nccs.res.in	Jangid, Kamlesh/AAE-4071-2021; Whitman, William/AAC-5896-2020	Jangid, Kamlesh/0000-0002-9764-8684; Whitman, William/0000-0003-1229-0423; Williams, Mark A./0000-0002-4766-9399	Franklin College of the University of Georgia; USDA; NSF; Department of Biotechnology, Government of India, under the project entitled "Establishment of Microbial Culture Collection" [BT/PR/0054/NDB/52/94/2007]	Franklin College of the University of Georgia; USDA(United States Department of Agriculture (USDA)); NSF(National Science Foundation (NSF)); Department of Biotechnology, Government of India, under the project entitled "Establishment of Microbial Culture Collection"	This work was supported by the Franklin College of the University of Georgia and grants from the USDA and NSF. We thank Mohit Navandar and Rajesh Jangid for helping with the Perl script. KJ acknowledges the funding support of the Department of Biotechnology, Government of India, under the project entitled "Establishment of Microbial Culture Collection" (Grant no. BT/PR/0054/NDB/52/94/2007).	Bunge J., J AM STAT ASSOC, V88, P364, DOI 10.2307/2290733; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; Cuevas A, 2004, COMPUT STAT DATA AN, V47, P111, DOI 10.1016/j.csda.2003.10.021; Diggle P., 2003, STAT ANAL SPATIAL PO; Diggle PJ, 2007, BIOMETRICS, V63, P550, DOI 10.1111/j.1541-0420.2006.00683.x; DIGGLE PJ, 1991, BIOMETRICS, V47, P1155, DOI 10.2307/2532668; Diggle PJ, 2000, ADV APPL PROBAB, V32, P331, DOI 10.1017/S0001867800009952; Dunn RR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064133; Faircloth BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042543; Halwachs B, 2012, COMPUTATIONAL MED, P37; Jangid K, 2008, SOIL BIOL BIOCHEM, V40, P2843, DOI 10.1016/j.soilbio.2008.07.030; Jangid K, 2013, MOL ECOL, V22, P3415, DOI 10.1111/mec.12325; Jangid K, 2011, SOIL BIOL BIOCHEM, V43, P2184, DOI 10.1016/j.soilbio.2011.06.022; Jangid K, 2010, SOIL BIOL BIOCHEM, V42, P302, DOI 10.1016/j.soilbio.2009.11.008; Lasher C, 2009, MICROB ECOL, V58, P244, DOI 10.1007/s00248-008-9481-9; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Martin AP, 2002, APPL ENVIRON MICROB, V68, P3673, DOI 10.1128/AEM.68.8.3673-3682.2002; Matsen FA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056859; McCune B., 2011, MULTIVARIATE ANAL EC; Quail MA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-110; Schloss PD, 2008, ISME J, V2, P265, DOI 10.1038/ismej.2008.5; Schloss PD, 2006, APPL ENVIRON MICROB, V72, P6773, DOI 10.1128/AEM.00474-06; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schloss PD, 2006, APPL ENVIRON MICROB, V72, P2379, DOI 10.1128/AEM.72.4.2379-2384.2006; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Schloss PD, 2004, APPL ENVIRON MICROB, V70, P5485, DOI 10.1128/AEM.70.9.5485-5492.2004; Shokralla S, 2015, SCI REP-UK, V5, DOI 10.1038/srep09687; Singleton DR, 2001, APPL ENVIRON MICROB, V67, P4374, DOI 10.1128/AEM.67.9.4374-4376.2001; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Yarza P, 2014, NATURE REV MICROBIOL, V12, P635	32	6	6	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0167634	10.1371/journal.pone.0167634	http://dx.doi.org/10.1371/journal.pone.0167634			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3TF	27911946	Green Published, gold, Green Submitted			2022-12-26	WOS:000389520600049
J	Chen, M; Lu, XG; Liao, B; Li, ZJ; Cai, LJ; Gu, CL				Chen, Min; Lu, Xingguo; Liao, Bo; Li, Zejun; Cai, Lijun; Gu, Changlong			Uncover miRNA-Disease Association by Exploiting Global Network Similarity	PLOS ONE			English	Article							HUMAN MICRORNA; INTERACTOME; PRIORITIZATION; GENES; WALKING; CANCER	Identification of miRNA-disease association is a fundamental challenge in human health clinic. However, the known miRNA-disease associations are rare and experimental verification methods are expensive and time-consuming. Therefore, there is a strong incentive to develop computational methods. In this paper, we calculate the similarity score for each miRNAs pair by integrating miRNA functional similarity and miRNA family information. We use the disease phenotype similarity data to construct the disease similarity network. Then we introduce a new miRNA-disease association prediction method (NETwork Group Similarity, NetGS) to explore the global network similarity, capturing the relationship between the disease and other diseases, the similarity between the potential disease-related miRNA and other miRNAs. Finally based on the consistency of diffusion profiles we get the miRNAdisease association scores. NetGS is tested by the leave-one-out cross validation and achieves an AUC value of 0.8450, which improves the prediction accuracy. NetGS can also be applied to solve the new miRNA-disease association and obtain reliable accuracy. Moreover, we use NetGS to predict new causing miRNAs of three cancers including breast cancer, lung cancer and Hepatocellular cancer. And the top predictions have been confirmed in the online databases. The encouraging results indicate that NetGS might play an essential role for future scientific research.	[Chen, Min; Lu, Xingguo; Liao, Bo; Li, Zejun; Cai, Lijun; Gu, Changlong] Hunan Univ, Sch Informat Sci & Engn, Changsha, Hunan, Peoples R China; [Chen, Min; Li, Zejun] Hunan Inst Technol, Sch Comp & Informat Sci, Hengyang, Peoples R China	Hunan University; Hunan Institute of Technology	Liao, B (corresponding author), Hunan Univ, Sch Informat Sci & Engn, Changsha, Hunan, Peoples R China.	dragonbw@163.com			Program for National Nature Science Foundation of China [61672214, 61300128, 61472127]	Program for National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the Program for National Nature Science Foundation of China (61672214, 61300128 and 61472127), The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work is supported by the Program for National Nature Science Foundation of China (61672214, 61300128 and 61472127), The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandyopadhyay Sanghamitra, 2010, Silence, V1, P6, DOI 10.1186/1758-907X-1-6; Barad O, 2004, GENOME RES, V14, P2486, DOI 10.1101/gr.2845604; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chen HL, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-12; Chen X, 2014, SCI REP-UK, V4, DOI 10.1038/srep05501; Chen X, 2013, BIOINFORMATICS, V29, P2617, DOI 10.1093/bioinformatics/btt426; Chen X, 2012, MOL BIOSYST, V8, P2792, DOI 10.1039/c2mb25180a; Chen Y, 2011, BIOINFORMATICS, V27, pI167, DOI 10.1093/bioinformatics/btr213; Cheung TH, 2012, CELL CYCLE, V11, P2876, DOI 10.4161/cc.21278; Cui QH, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100089; Esquela-Kerscher A, 2008, CELL CYCLE, V7, P759, DOI 10.4161/cc.7.6.5834; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hwang TH, 2011, BIOINFORMATICS, V27, P2692, DOI 10.1093/bioinformatics/btr463; Jiang QH, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S1-S2; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Li Y, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku182; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Lynam-Lennon N, 2009, BIOL REV, V84, P55, DOI 10.1111/j.1469-185X.2008.00061.x; Mookherjee S., 2009, ARXIV09014211; Shi HB, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-101; van Driel MA, 2006, EUR J HUM GENET, V14, P535, DOI 10.1038/sj.ejhg.5201585; Wang D, 2010, BIOINFORMATICS, V26, P1644, DOI 10.1093/bioinformatics/btq241; Weidhaas J, 2010, LANCET ONCOL, V11, P106, DOI 10.1016/S1470-2045(09)70386-9; Xu J, 2011, MOL CANCER THER, V10, P1857, DOI 10.1158/1535-7163.MCT-11-0055; Xuan P, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0070204, 10.1371/annotation/a076115e-dd8c-4da7-989d-c1174a8cd31e]; Yakhini Z, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-120; Zhou DY, 2004, ADV NEUR IN, V16, P321; Zhu J, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S5-S5	29	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166509	10.1371/journal.pone.0166509	http://dx.doi.org/10.1371/journal.pone.0166509			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907011	Green Submitted, gold, Green Published			2022-12-26	WOS:000389482700028
J	Erel, R; Yermiyahu, U; Yasuor, H; Chamus, DC; Schwartz, A; Ben-Gal, A; Dag, A				Erel, Ran; Yermiyahu, Uri; Yasuor, Hagai; Chamus, Dan Cohen; Schwartz, Amnon; Ben-Gal, Alon; Dag, Arnon			Phosphorous Nutritional Level, Carbohydrate Reserves and Flower Quality in Olives	PLOS ONE			English	Article							OLEA-EUROPAEA L.; OVARY STARCH RESERVES; FRUIT-SET; WATER DEFICITS; FLORAL QUALITY; POLLEN; INFLORESCENCE; CULTIVARS; POLLINATION; BIOLOGY	The olive tree is generally characterized by relatively low final fruit set consequential to a significant rate of undeveloped pistils, pistil abortion, and flower and fruitlet abscission. These processes are acknowledged to be governed by competition for resources between the developing vegetative and reproductive organs. To study the role of phosphorus (P) nutritional level on reproductive development, trees were grown under four levels of P for three years in large containers. Phosphorus nutritional level was positively related to rate of reproductive bud break, inflorescence weight, rate of hermaphrodite flowers, pistil weight, fruitlet persistence, fruit set and the consequential total number of fruits. The positive impact of P nutrition on the productivity parameters was not related to carbohydrate reserves or to carbohydrate transport to the developing inflorescence. Phosphorous deficient trees showed significant impairment of assimilation rate, and yet, carbohydrates were accumulated in inflorescences at levels comparable to or higher than trees receiving high P. In contrast to female reproductive organs, pollen viability was consistently higher in P deficient trees, possibly due to the enhanced carbohydrate availability. Overall, the positive effect of P on female reproductive development was found to be independent of the total carbohydrate availability. Hence, P is speculated to have a direct influence on reproductive processes.	[Erel, Ran; Yermiyahu, Uri; Yasuor, Hagai; Chamus, Dan Cohen; Ben-Gal, Alon; Dag, Arnon] Agr Res Org Israel, Gilat Res Ctr, Bet Dagan, Israel; [Schwartz, Amnon] Hebrew Univ Jerusalem, Inst Plant Sci & Genet Agr, Robert H Smith Fac Agr Food & Environm, Rehovot, Israel	Hebrew University of Jerusalem	Erel, R (corresponding author), Agr Res Org Israel, Gilat Res Ctr, Bet Dagan, Israel.	ranerel@volcani.agri.gov.il	Ben-Gal, Alon/F-5190-2013	Ben-Gal, Alon/0000-0003-4105-7807; Erel, Ran/0000-0003-1780-3291				Alcaraz ML, 2010, PHYSIOL PLANTARUM, V140, P395, DOI 10.1111/j.1399-3054.2010.01410.x; ALEXANDER MP, 1969, STAIN TECHNOL, V44, P117, DOI 10.3109/10520296909063335; Ben-Gal A, 2011, IRRIGATION SCI, V29, P253, DOI 10.1007/s00271-010-0237-1; BERTIN R I, 1982, Evolutionary Theory, V6, P25; Beutel J., 1983, BULLETIN, V1879, P15; Bustan A, 2011, TREE PHYSL; CLEMENT C, 1994, SEX PLANT REPROD, V7, P347, DOI 10.1007/BF00230513; Cuevas J, 2004, ANN BOT-LONDON, V93, P547, DOI 10.1093/aob/mch079; Cuevas J., 1995, Advances in Horticultural Science, V9, P92; CUEVAS J, 1994, SCI HORTIC-AMSTERDAM, V59, P123, DOI 10.1016/0304-4238(94)90079-5; Dag A, 2009, CROP PASTURE SCI, V60, P427, DOI 10.1071/CP08143; De la Rosa R, 2000, HORTSCIENCE, V35, P1223, DOI 10.21273/HORTSCI.35.7.1223; DROSSOPOULOS JB, 1988, ANN BOT-LONDON, V62, P321, DOI 10.1093/oxfordjournals.aob.a087664; Erel R, 2008, J AM SOC HORTIC SCI, V133, P639, DOI 10.21273/JASHS.133.5.639; Erel R, 2014, TREE PHYSIOL, V34, P1102, DOI 10.1093/treephys/tpu081; Erel R, 2013, SCI HORTIC-AMSTERDAM, V159, P8, DOI 10.1016/j.scienta.2013.04.036; Fernandez-Escobar R, 2008, ENVIRON EXP BOT, V64, P113, DOI 10.1016/j.envexpbot.2008.04.007; Fernandez-Escobar R., 2010, OLIVE GROWING, P267; Ferrara G, 2012, 6 INT S OL GROW 2012; Granot D, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00044; Grattan SR, 2006, AGR WATER MANAGE, V85, P133, DOI 10.1016/j.agwat.2006.04.001; Hartmann H, 1950, P AM SOC HORT SCI; Hermans C, 2006, TRENDS PLANT SCI, V11, P610, DOI 10.1016/j.tplants.2006.10.007; Jean D, 2001, PHYSIOL PLANTARUM, V112, P379, DOI 10.1034/j.1399-3054.2001.1120311.x; Kelly G, 2013, PLANT J, V75, P977, DOI 10.1111/tpj.12258; Kitsaki CK, 1999, J PLANT GROWTH REGUL, V18, P1, DOI 10.1007/PL00007040; Lavee S., 2002, Oliva, P25; Lavee S., 1990, Advances in Horticultural Science, V4, P135; Lavee S, 1996, SCI HORTIC-AMSTERDAM, V66, P149, DOI 10.1016/S0304-4238(96)00941-7; Lavee S, 1999, SCI HORTIC-AMSTERDAM, V82, P181, DOI 10.1016/S0304-4238(99)00057-6; Lavee S., 1996, WORLD OLIVE ENCY, P59; Lawson T, 2014, NEW PHYTOL, V203, P1064, DOI 10.1111/nph.12945; Levin AG, 2005, AUST J AGR RES, V56, P827, DOI 10.1071/AR04094; Alcaraz ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078467; Lynch Jonathan P., 2008, V7, P83; Marschner P, 2012, MARSCHNER'S MINERAL NUTRITION OF HIGHER PLANTS, 3RD EDITION, P1; Martins P. C., 2006, Advances in Horticultural Science, V20, P262; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Moreno-Alias I, 2013, SCI HORTIC-AMSTERDAM, V154, P17, DOI 10.1016/j.scienta.2013.02.014; Moriana A, 2003, J AM SOC HORTIC SCI, V128, P425, DOI 10.21273/JASHS.128.3.0425; Olive Lavee S., 1986, CRC HDB FRUIT SET DE, P261; Perica S, 2012, FLOWER STERILITY GER, V87, P237; Pinillos V, 2009, HORTSCIENCE, V44, P499, DOI 10.21273/HORTSCI.44.2.499; Pinney K, 1989, INT S OL GROW, V286; RALLO L, 1985, J AM SOC HORTIC SCI, V110, P303; Rapoport HF, 2012, ENVIRON EXP BOT, V77, P227, DOI 10.1016/j.envexpbot.2011.11.021; RAPOPORT HF, 1991, J AM SOC HORTIC SCI, V116, P720, DOI 10.21273/JASHS.116.4.720; Rapoport HF, 2006, P 2 INT SEM REC ADV; Reale L, 2006, SEX PLANT REPROD, V19, P151, DOI 10.1007/s00497-006-0032-6; Reale L, 2009, SEX PLANT REPROD, V22, P109, DOI 10.1007/s00497-009-0096-1; Rodrigo J, 2000, PHYSIOL PLANTARUM, V108, P35, DOI 10.1034/j.1399-3054.2000.108001035.x; Rodriguez D, 1998, PLANT SOIL, V200, P227, DOI 10.1023/A:1004310217694; Rojo J, 2015, TREES-STRUCT FUNCT, P1; Rosati A, 2010, SCI HORTIC-AMSTERDAM, V126, P200, DOI 10.1016/j.scienta.2010.07.010; Ruiz R, 2001, ANN BOT-LONDON, V87, P805, DOI 10.1006/anbo.2001.1415; Selak GV, 2012, J HORTIC SCI BIOTECH, V87, P237; Selak GV, 2014, TREES-STRUCT FUNCT, V28, P1497, DOI 10.1007/s00468-014-1053-7; Selak GV, 2014, SCI HORTIC-AMSTERDAM, V165, P36, DOI 10.1016/j.scienta.2013.10.041; Selak GV, 2011, HORTSCIENCE, V46, P186, DOI 10.21273/HORTSCI.46.2.186; STITT M, 1989, PHYSIOL PLANTARUM, V77, P633, DOI 10.1111/j.1399-3054.1989.tb05402.x; STONE JL, 1995, AM J BOT, V82, P1186, DOI 10.2307/2446073; STUTTE GW, 1986, J AM SOC HORTIC SCI, V111, P27; Ulger S, 2004, PLANT GROWTH REGUL, V42, P89, DOI 10.1023/B:GROW.0000014897.22172.7d; Uriu K, 1959, P AM SOC HORT SCI; Vance CP, 2003, NEW PHYTOL, V157, P423, DOI 10.1046/j.1469-8137.2003.00695.x; Vishnevetsky J, 2000, PHYSIOL PLANTARUM, V108, P361, DOI 10.1034/j.1399-3054.2000.108004361.x; Wissuwa M, 2005, J EXP BOT, V56, P1943, DOI 10.1093/jxb/eri189; Zamski E., 1996, PHOTOASSIMILATE DIST; Zipori I, 2015, IRRIGATION SCI, P1	70	26	27	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167591	10.1371/journal.pone.0167591	http://dx.doi.org/10.1371/journal.pone.0167591			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907133	gold, Green Published, Green Submitted			2022-12-26	WOS:000389482700207
J	Johnson, TW; Wu, Y; Nathoo, N; Rogers, JA; Yong, VW; Dunn, JF				Johnson, Thomas W.; Wu, Ying; Nathoo, Nabeela; Rogers, James A.; Yong, V. Wee; Dunn, Jeff F.			Gray Matter Hypoxia in the Brain of the Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis	PLOS ONE			English	Article							NF-KAPPA-B; CLINICALLY ISOLATED SYNDROMES; INDUCIBLE-FACTOR; PROLYL HYDROXYLATION; INCREASED EXPRESSION; CORTICAL ATROPHY; IRON DEPOSITION; WHITE-MATTER; LESION LOAD; MS PATIENTS	Background Multiple sclerosis (MS) has a significant inflammatory component and may have significant gray matter (GM) pathophysiology. Brain oxygenation is a sensitive measurement of the balance between metabolic need and oxygen delivery. There is evidence that inflammation and hypoxia are interdependent. In this paper, we applied novel, implanted PO2 sensors to measure hypoxia in cortical and cerebellar GM, in an inflammation-induced mouse model of MS. Objective Quantify oxygenation in cortical and cerebellar GM in the awake, unrestrained experimental autoimmune encephalomyelitis (EAE) mouse model and to relate the results to symptom level and disease time-course. Methods C57BL/6 mice were implanted with a fiber-optic sensor in the cerebellum (n = 13) and cortex (n = 24). Animals were induced with stimulation of the immune response and sensitization to myelin oligodendrocyte glycoprotein (MOG). Controls did not have MOG. We measured PO2 in awake, unrestrained animals from pre-induction (baseline) up to 36 days post-induction for EAE and controls. Results There were more days with hypoxia than hyperoxia (cerebellum: 34/67 vs. 18/67 days; cortex: 85/112 vs. 22/112) compared to time-matched controls. The average decline in PO2 on days that were significantly lower than time-matched controls was -8.8 +/- 6.0 mmHg (mean +/- SD) for the cerebellum and -8.0 4.6 for the cortex. Conversely, the average increase in PO2 on days that were significantly hyperoxic was +3.2 +/- 2.8 mmHg (mean +/- SD) for the cerebellum and +0.8 +/- 2.1 for the cortex. Cortical hypoxia related to increased behavioral deficits. Evidence for hypoxia occurred before measurable behavioral deficits. Conclusions A highly inflammatory condition primed to a white matter (WM) autoimmune response correlates with significant hypoxia and increased variation in oxygenation in GM of both cerebellum and cortex in the mouse EAE model of MS.	[Johnson, Thomas W.; Wu, Ying; Nathoo, Nabeela; Dunn, Jeff F.] Univ Calgary, Cumming Sch Med, Dept Radiol, Calgary, AB, Canada; [Rogers, James A.; Yong, V. Wee] Univ Calgary, Cumming Sch Med, Dept Clin Neurosci, Calgary, AB, Canada	University of Calgary; University of Calgary	Dunn, JF (corresponding author), Univ Calgary, Cumming Sch Med, Dept Radiol, Calgary, AB, Canada.	dunnj@ucalgary.ca	Nathoo, Nabeela/AAC-6098-2022	Nathoo, Nabeela/0000-0001-6446-1146; Yong, V. Wee/0000-0002-2600-3563	Canada Foundation for Innovation [PP780226]; MS Society of Canada [RT757368]; Canadian Institutes of Health Research [CRH-120244]; Alberta Innovates: Health Solutions CRIO Team Grant [20140144]; National Institute of Biomedical Imaging and Bioengineering [R21 EB021397]; Alberta Innovates [201300669] Funding Source: researchfish; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB021397] Funding Source: NIH RePORTER	Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); MS Society of Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates: Health Solutions CRIO Team Grant; National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Alberta Innovates; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	Funding for this research was provided by the Natural Science and Engineering Research Council of Canada (RGPIN/386056-2010; www.nserc-crsng.gc.ca), Canada Foundation for Innovation (PP780226; www.innovation.ca), MS Society of Canada (RT757368; www.endmsnetwork.ca), Canadian Institutes of Health Research (CRH-120244; www.cihr.ca), Alberta Innovates: Health Solutions CRIO Team Grant (20140144; www.aihealthsolutions.ca), and the National Institute of Biomedical Imaging and Bioengineering (R21 EB021397; www.nibib.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboul-Enein F, 2005, ACTA NEUROPATHOL, V109, P49, DOI 10.1007/s00401-004-0954-8; Aboul-Enein F, 2003, J NEUROPATH EXP NEUR, V62, P25, DOI 10.1093/jnen/62.1.25; ADAMS CWM, 1988, J NEUROL NEUROSUR PS, V51, P260, DOI 10.1136/jnnp.51.2.260; Agrawal SM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-64; Aktan F, 2004, LIFE SCI, V75, P639, DOI 10.1016/j.lfs.2003.10.042; Amato MP, 2007, ARCH NEUROL-CHICAGO, V64, P1157, DOI 10.1001/archneur.64.8.1157; Amato MP, 2004, NEUROLOGY, V63, P89, DOI 10.1212/01.WNL.0000129544.79539.D5; Blinkenberg M, 2000, NEUROLOGY, V54, P558, DOI 10.1212/WNL.54.3.558; BROOKS DJ, 1984, J NEUROL NEUROSUR PS, V47, P1182, DOI 10.1136/jnnp.47.11.1182; Buxton RB, 2004, NEUROIMAGE, V23, pS220, DOI 10.1016/j.neuroimage.2004.07.013; Calabrese M, 2011, NEUROLOGY, V77, P257, DOI 10.1212/WNL.0b013e318220abd4; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Cummins EP, 2006, P NATL ACAD SCI USA, V103, P18154, DOI 10.1073/pnas.0602235103; Dalton CM, 2004, BRAIN, V127, P1101, DOI 10.1093/brain/awh126; Davies AL, 2013, ANN NEUROL, V74, P815, DOI 10.1002/ana.24006; Derache N, 2006, J NEUROL SCI, V245, P103, DOI 10.1016/j.jns.2005.09.017; Desai RA, 2016, ANN NEUROL, V79, P591, DOI 10.1002/ana.24607; Dunn JF, 1985, METABOLIC ADJUSTMENT; Ehrismann D, 2007, BIOCHEM J, V401, P227, DOI 10.1042/BJ20061151; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Fisher E, 2008, ANN NEUROL, V64, P255, DOI 10.1002/ana.21436; Fisniku LK, 2008, ANN NEUROL, V64, P247, DOI 10.1002/ana.21423; Ge YL, 2012, J CEREBR BLOOD F MET, V32, P403, DOI 10.1038/jcbfm.2011.191; Graumann U, 2003, BRAIN PATHOL, V13, P554, DOI 10.1111/j.1750-3639.2003.tb00485.x; Griffiths JR, 1999, BRIT J RADIOL, V72, P627, DOI 10.1259/bjr.72.859.10624317; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Horakova D, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-10; Houtchens MK, 2007, NEUROLOGY, V69, P1213, DOI 10.1212/01.wnl.0000276992.17011.b5; Inglese M, 2008, J CEREBR BLOOD F MET, V28, P164, DOI 10.1038/sj.jcbfm.9600504; Inglese M, 2007, ARCH NEUROL-CHICAGO, V64, P196, DOI 10.1001/archneur.64.2.196; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; LENIGERFOLLERT E, 1976, PFLUG ARCH EUR J PHY, V366, P39, DOI 10.1007/BF02486558; Lindsey J. William, 2005, P1; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; MacKenzie-Graham A, 2006, NEUROIMAGE, V32, P1016, DOI 10.1016/j.neuroimage.2006.05.006; MacKenzie-Graham A, 2012, NEUROIMAGE, V60, P95, DOI 10.1016/j.neuroimage.2011.11.099; MacKenzie-Graham A, 2009, NEUROIMAGE, V48, P637, DOI 10.1016/j.neuroimage.2009.06.073; Mahad DH, 2015, LANCET NEUROL, V14, P183, DOI 10.1016/S1474-4422(14)70256-X; McMahon JM, 2012, MULT SCLER J, V18, P1437, DOI 10.1177/1352458512438455; Mhaille AN, 2008, J NEUROPATH EXP NEUR, V67, P200, DOI 10.1097/NEN.0b013e318165b239; Michaelis L, 1913, BIOCHEM Z, V49, P333; Nathoo N, 2013, MULT SCLER J, V19, P721, DOI 10.1177/1352458512460602; Ortiz-Prado E, 2010, J NEUROSCI METH, V193, P217, DOI 10.1016/j.jneumeth.2010.08.019; Papadopoulos D, 2006, EXP NEUROL, V197, P373, DOI 10.1016/j.expneurol.2005.10.033; Paulesu E, 1996, NEUROIMAGE, V4, P87, DOI 10.1006/nimg.1996.0032; Rashid W, 2004, J NEUROL NEUROSUR PS, V75, P1288, DOI 10.1136/jnnp.2003.026021; Roosendaal SD, 2011, MULT SCLER J, V17, P1098, DOI 10.1177/1352458511404916; Semenza GL, 2001, CURR OPIN CELL BIOL, V13, P167, DOI 10.1016/S0955-0674(00)00194-0; SEMENZA GL, 2006, NOVART FDN SYMP, V272, P8, DOI DOI 10.1002/9780470035009.CH2; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Sun X, 1998, Ann Nucl Med, V12, P89; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; van Uden P, 2008, BIOCHEM J, V412, P477, DOI 10.1042/BJ20080476; WANG GL, 1993, P NATL ACAD SCI USA, V90, P4304, DOI 10.1073/pnas.90.9.4304; Weaver A, 2005, FASEB J, V19, P1668, DOI 10.1096/fj.04-2030fje; Xia YF, 2001, BIOCHEM BIOPH RES CO, V289, P851, DOI 10.1006/bbrc.2001.6067; Yang R, 2015, SCI REPORTS; Zhou J, 2003, AM J PHYSIOL-CELL PH, V284, pC439, DOI 10.1152/ajpcell.00294.2002	61	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167196	10.1371/journal.pone.0167196	http://dx.doi.org/10.1371/journal.pone.0167196			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907119	Green Published, Green Submitted, gold			2022-12-26	WOS:000389482700089
J	Kiontke, A; Oliveira-Birkmeier, A; Opitz, A; Birkemeyer, C				Kiontke, Andreas; Oliveira-Birkmeier, Ariana; Opitz, Andreas; Birkemeyer, Claudia			Electrospray Ionization Efficiency Is Dependent on Different Molecular Descriptors with Respect to Solvent pH and Instrumental Configuration	PLOS ONE			English	Article							PRESSURE CHEMICAL-IONIZATION; MASS-SPECTROMETRY; AROMATIC-AMINES; GAS-PHASE; DROPLETS; MODEL; ELUENT; MATRIX; SCALE; IONS	Over the past decades, electrospray ionization for mass spectrometry (ESI-MS) has become one of the most commonly employed techniques in analytical chemistry, mainly due to its broad applicability to polar and semipolar compounds and the superior selectivity which is achieved in combination with high resolution separation techniques. However, responsiveness of an analytical method also determines its suitability for the quantitation of chemical compounds; and in electrospray ionization for mass spectrometry, it can vary significantly among different analytes with identical solution concentrations. Therefore, we investigated the ESI-response behavior of 56 nitrogen-containing compounds including aromatic amines and pyridines, two compound classes of high importance to both, synthetic organic chemistry as well as to pharmaceutical sciences. These compounds are increasingly analyzed employing ESI mass spectrometry detection due to their polar, basic character. Signal intensities of the peaks from the protonated molecular ion (MH+) were acquired under different conditions and related to compound properties such as basicity, polarity, volatility and molecular size exploring their quantitative impact on ionization efficiency. As a result, we found that though solution basicity of a compound is the main factor initially determining the ESI response of the protonated molecular ion, other factors such as polarity and vaporability become more important under acidic solvent conditions and may nearly outweigh the importance of basicity under these conditions. Moreover, we show that different molecular descriptors may become important when using different types of instruments for such investigations, a fact not detailed so far in the available literature.	[Kiontke, Andreas; Oliveira-Birkmeier, Ariana; Birkemeyer, Claudia] Univ Leipzig, Inst Analyt Chem, Linnestr, Leipzig, Germany; [Opitz, Andreas] Univ Leipzig, Inst Linguist, Beethovenstr, Leipzig, Germany; [Oliveira-Birkmeier, Ariana] Astellas Pharma GmbH, Munich, Germany	Leipzig University; Leipzig University; Astellas Pharmaceuticals	Birkemeyer, C (corresponding author), Univ Leipzig, Inst Analyt Chem, Linnestr, Leipzig, Germany.	birkemeyer@chemie.uni.leipzig.de	Opitz, Andreas/AAJ-6731-2021; Birkemeyer, Claudia/L-8687-2015	Opitz, Andreas/0000-0002-1494-7591; Birkemeyer, Claudia/0000-0002-8538-8838; Kiontke, Andreas/0000-0002-0297-797X	German Research Foundation (DFG); Universitat Leipzig; Deutsche Bundesstiftung Umwelt (DBU) [20015/375]; European Fund for Structural Development EFRE ("Europe funds Saxony") [2592-2014]; German Academic Exchange Service (DAAD "Rise" program)	German Research Foundation (DFG)(German Research Foundation (DFG)); Universitat Leipzig; Deutsche Bundesstiftung Umwelt (DBU); European Fund for Structural Development EFRE ("Europe funds Saxony"); German Academic Exchange Service (DAAD "Rise" program)(Deutscher Akademischer Austausch Dienst (DAAD))	The author(s) acknowledge support from the German Research Foundation (DFG) and Universitat Leipzig within the program of Open Access Publishing. This work was financed by the Deutsche Bundesstiftung Umwelt (DBU grant No. 20015/375), the European Fund for Structural Development EFRE ("Europe funds Saxony", grant No. 2592-2014), the German Academic Exchange Service (DAAD "Rise" program 2016) and the University of Leipzig." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Dr. ing. Susan Billig, Ramona Oehme, Elisabeth Klinge, and Carolin Oswald (all University of Leipzig, Germany) and Aigerim Galyamova (Penn State University, USA) for technical assistance. In addition, we thank Prof. em. Berger, Prof. Belder and Prof. Reemtsma (University of Leipzig, Germany) for kind and constant support. The author(s) acknowledge support from the German Research Foundation (DFG) and Universitat Leipzig within the program of Open Access Publishing. This work was financed by the Deutsche Bundesstiftung Umwelt (DBU grant No. 20015/375), the European Fund for Structural Development EFRE ("Europe funds Saxony", grant No. 2592-2014), the German Academic Exchange Service (DAAD "Rise" program 2016) and the University of Leipzig.	Abburi R, 2012, EUR J MASS SPECTROM, V18, P301, DOI 10.1255/ejms.1187; ASHTON DS, 1993, ORG MASS SPECTROM, V28, P721, DOI 10.1002/oms.1210280612; Caetano S, 2005, ANAL CHIM ACTA, V550, P92, DOI 10.1016/j.aca.2005.06.069; Cech NB, 2000, ANAL CHEM, V72, P2717, DOI 10.1021/ac9914869; Cech NB, 2001, ANAL CHEM, V73, P208, DOI 10.1021/ac0006019; Chalcraft KR, 2009, ANAL CHEM, V81, P2506, DOI 10.1021/ac802272u; CHENG ZL, 1992, J AM SOC MASS SPECTR, V3, P281, DOI 10.1016/1044-0305(92)87055-4; Cole RB, 2000, J MASS SPECTROM, V35, P763, DOI 10.1002/1096-9888(200007)35:7<763::AID-JMS16>3.0.CO;2-#; Constantopoulos TL, 1999, J AM SOC MASS SPECTR, V10, P625, DOI 10.1016/S1044-0305(99)00031-8; DELAMORA JF, 1994, J FLUID MECH, V260, P155, DOI 10.1017/S0022112094003472; DOLE M, 1968, J CHEM PHYS, V49, P2240, DOI 10.1063/1.1670391; Ehrmann BM, 2008, J AM SOC MASS SPECTR, V19, P719, DOI 10.1016/j.jasms.2008.01.003; Enke CG, 1997, ANAL CHEM, V69, P4885, DOI 10.1021/ac970095w; Gabelica V, 2004, INT J MASS SPECTROM, V231, P189, DOI 10.1016/j.ijms.2003.10.010; Girod M, 2012, PHYS CHEM CHEM PHYS, V14, P9389, DOI [10.1039/c2cp23341j, 10.1039/c2cp23341]; Golubovic J, 2016, J CHROMATOGR A, V1438, P123, DOI 10.1016/j.chroma.2016.02.021; Henriksen T, 2005, J AM SOC MASS SPECTR, V16, P446, DOI 10.1016/j.jasms.2004.11.021; Hiraoka K., 1995, J MASS SPECTROM SOC, V43, P127; IKONOMOU MG, 1990, ANAL CHEM, V62, P957, DOI 10.1021/ac00208a012; IRIBARNE JV, 1976, J CHEM PHYS, V64, P2287, DOI 10.1063/1.432536; Kebarle P, 2000, ANAL CHIM ACTA, V406, P11, DOI 10.1016/S0003-2670(99)00598-X; KEBARLE P, 1993, ANAL CHEM, V65, pA972, DOI 10.1021/ac00070a001; Kostiainen R, 2009, J CHROMATOGR A, V1216, P685, DOI 10.1016/j.chroma.2008.08.095; Leito I, 2008, RAPID COMMUN MASS SP, V22, P379, DOI 10.1002/rcm.3371; Liigand J, 2014, J AM SOC MASS SPECTR, V25, P1853, DOI 10.1007/s13361-014-0969-x; Mandra VJ, 2015, RAPID COMMUN MASS SP, V29, P1661, DOI 10.1002/rcm.7263; Mansoori BA, 1997, RAPID COMMUN MASS SP, V11, P1120, DOI 10.1002/(SICI)1097-0231(19970630)11:10<1120::AID-RCM976>3.3.CO;2-H; NAKAGAKI R, 1993, J PHYS ORG CHEM, V6, P261, DOI 10.1002/poc.610060503; Olumee Z, 1998, J PHYS CHEM A, V102, P9154, DOI 10.1021/jp982027z; Oss M, 2010, ANAL CHEM, V82, P2865, DOI 10.1021/ac902856t; Peng L, 2008, J CHROMATOGR A, V1179, P131, DOI 10.1016/j.chroma.2007.11.048; RADOMSKI JL, 1979, ANNU REV PHARMACOL, V19, P129, DOI 10.1146/annurev.pa.19.040179.001021; Raji MA, 2009, INT J MASS SPECTROM, V279, P100, DOI 10.1016/j.ijms.2008.10.013; Raji MA, 2009, RAPID COMMUN MASS SP, V23, P2221, DOI 10.1002/rcm.4141; Rauha JP, 2001, J MASS SPECTROM, V36, P1269, DOI 10.1002/jms.231; Richter G, 2008, ANAL BIOCHEM, V376, P157, DOI 10.1016/j.ab.2008.01.029; Schmidt A, 2001, ANAL CHEM, V73, P6040, DOI 10.1021/ac010451h; Stewart R., 1985, PROTON APPL ORGANIC; TANG L, 1993, ANAL CHEM, V65, P3654, DOI 10.1021/ac00072a020; Van Berkel GJ, 1998, J ANAL ATOM SPECTROM, V13, P603, DOI 10.1039/a800373d; Vaschetto ME, 1999, J MOL STRUC-THEOCHEM, V468, P209, DOI 10.1016/S0166-1280(98)00624-1; Voyksner RD, 1999, ANAL CHEM, V71, P1441, DOI 10.1021/ac980995s; Weisburger JH, 2002, MUTAT RES-FUND MOL M, V506, P9, DOI 10.1016/S0027-5107(02)00147-1; YAMASHITA M, 1984, J PHYS CHEM-US, V88, P4451, DOI 10.1021/j150664a002; Yang XJ, 2013, ANALYST, V138, P659, DOI 10.1039/c2an36022e; Yen TY, 1996, J AM SOC MASS SPECTR, V7, P1106, DOI 10.1016/S1044-0305(96)00073-6; Yidong Li, 2010, Proceedings 2010 10th IEEE International Conference on Data Mining Workshops (ICDMW 2010), P491, DOI 10.1109/ICDMW.2010.112; Zhou SL, 2000, J AM SOC MASS SPECTR, V11, P961, DOI 10.1016/S1044-0305(00)00174-4; Zhou SL, 2001, J AM SOC MASS SPECTR, V12, P206, DOI 10.1016/S1044-0305(00)00213-0	49	50	51	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167502	10.1371/journal.pone.0167502	http://dx.doi.org/10.1371/journal.pone.0167502			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907110	Green Published, Green Submitted, gold			2022-12-26	WOS:000389482700171
J	Laranjeira, FO; da Silva, EN; Pereira, MG				Laranjeira, Fernanda O.; da Silva, Everton Nunes; Pereira, Mauricio G.			Budget Impact of Long-Acting Insulin Analogues: The Case in Brazil	PLOS ONE			English	Article							NATIONWIDE MULTICENTER; NPH INSULIN; TASK-FORCE; TYPE-1; CARE; REIMBURSEMENT; METAANALYSIS; ADOLESCENTS; PRINCIPLES; GLARGINE	Background Long-acting insulin analogues for type 1 diabetes (T1D) treatment have been available on the Brazilian market since 2002. However, the population cannot access the analogues through the public health system. Objective To estimate the incremental budget impact of long-acting insulin analogues coverage for T1D patients in the Brazilian public health system compared to NPH insulin. Methods We performed a budget impact analysis of a five-year period. The eligible population was projected using epidemiological data from the International Diabetes Federation estimates for patients between 0-14 and 20-79 years old. The prevalence of T1D was estimated in children, and the same proportion was applied to the 15-19-year-old group due to a gap in epidemiological information. We considered 4,944 new cases per year and a 34.61/100,000 inhabitants mortality rate. Market share for long-acting insulin analogues was assumed as 20% in the first year, reaching 40% in the fifth year. The mean daily dose was taken from clinical trials. We calculated the bargaining power of the Ministry of Health by dividing the price paid for human insulin in the last purchase by the average regulated price. We performed univariate and multivariate sensitivity analyses. Results The incremental budget impact of long-acting insulin analogues was US$ 28.6 million in the first year, and reached US$ 58.7 million in the fifth year. The total incremental budget impact was US$ 217.9 million over the five-year period. The sensitivity analysis showed that the percentage of T1D among diabetic adults and the insulin analogue price were the main factors that affected the budget impact. Conclusions The cost of the first year of long-acting insulin analogue coverage would correspond to 0.03% of total public health expenditure. The main advantage of this study is that it identifies potential bargaining power because it features more realistic profiles of resource usage, once centralized purchasing is established as an economically sustainable strategy. Clinical guidelines restricting the use of insulin analogues would make the decision towards insulin analogue coverage more affordable.	[Laranjeira, Fernanda O.; da Silva, Everton Nunes; Pereira, Mauricio G.] Univ Brasilia, Brasilia, DF, Brazil	Universidade de Brasilia	Laranjeira, FO (corresponding author), Univ Brasilia, Brasilia, DF, Brazil.	flaranjeira.oliveira@gmail.com		Silva, Everton/0000-0001-8747-4185	Coordination for the Improvement of Higher Education Personnel, Brazilian Ministry of Education	Coordination for the Improvement of Higher Education Personnel, Brazilian Ministry of Education	FOL received a PhD scholarship by Coordination for the Improvement of Higher Education Personnel, Brazilian Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The other authors received no specific funding for this work.	[Anonymous], 2015, INS AN DIAB MELL TIP; Araujo S, 2014, DIRETRIZES SOC BRASI; Bachle C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070567; Banerjee S, 2007, SHORT ACTING INSULIN; BETZ JL, 1995, DIABETES EDUCATOR, V21, P195, DOI 10.1177/014572179502100306; Brazilian society of diabetes, CLIN GUID US INS AN; de Souza ALC, 2014, APPL HEALTH ECON HEA, V12, P19, DOI 10.1007/s40258-013-0073-6; Cammarota S, 2014, NUTR METAB CARDIOVAS, V24, P10, DOI 10.1016/j.numecd.2013.04.002; Chalkidou K, 2010, HLTH EC POLICY LAW C, V4, P1; Chiang JL, 2014, DIABETES CARE, V37, P2034, DOI 10.2337/dc14-1140; Cobas RA, 2013, B WORLD HEALTH ORGAN, V91, P434, DOI 10.2471/BLT.12.110387; Drummond M, 2011, EUR J HEALTH ECON, V12, P263, DOI 10.1007/s10198-010-0274-y; Ferraes Alide Marina Biehl, 2007, Rev. Adm. Pública, V41, P475; Ferreira-Da-Silva AL, 2012, CAD SAUDE PUBLICA, V28, P1223, DOI 10.1590/S0102-311X2012000700002; Frier BM, 2013, DIABETES OBES METAB, V15, P978, DOI 10.1111/dom.12106; Gomes MB, 2012, DIABETES RES CLIN PR, V97, P63, DOI 10.1016/j.diabres.2012.02.008; Gomes MB, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-67; Grunberger G, 2014, DIABETES CARE, V37, P1767, DOI 10.2337/dc14-0031; Hartman I, 2008, CLIN MED RES, V6, P54, DOI 10.3121/cmr.2008.793; Haukka J, 2013, PHARMACOEPIDEM DR S, V22, P1326, DOI 10.1002/pds.3534; Holcombe JH, 2002, CLIN THER, V24, P629, DOI 10.1016/S0149-2918(02)85138-4; Holden SE, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000258; Holden SE, 2012, DIABETES MANAGE, V2, P173; Home PD, 2005, DIABETES-METAB RES, V21, P545, DOI 10.1002/dmrr.572; Instituto Brasileiro de Geografia e Estatistica, 2015, HOUS BUDG SURV 2008; International Diabetes Federation, 2015, IDF DIABETES ATLAS; Kostev Karel, 2013, J Diabetes Sci Technol, V7, P736; Leite EB, 2015, DIABETOL METAB SYNDR, V7, DOI 10.1186/s13098-015-0061-0; Mattos PE, 2012, ARQ BRAS ENDOCRINOL, V56, P39, DOI 10.1590/S0004-27302012000100007; Mauskopf JA, 2007, VALUE HEALTH, V10, P336, DOI 10.1111/j.1524-4733.2007.00187.x; Ministerio da Saude. Secretaria de Tecnologia e Insumos Estrategicos. Departamento de e Insumos Estrategicos, 2014, SPEC COMP PHARM CAR; Monami M, 2009, DIABETES OBES METAB, V11, P372, DOI 10.1111/j.1463-1326.2008.00976.x; National Health Surveillance Agency, 2015, CAM REG MERC MED LIS; National Institute for Clinical Excellence, 2002, GUID US LONG ACT INS, P53; National Institute of Health and Care Excellence, 2015, TYP 1 DIAB DIAGN MAN; Negrato CA, 2010, J ENDOCRINOL INVEST, V33, P373, DOI [10.3275/6439, 10.1007/BF03346606]; Orlewska E, 2011, VALUE HEALTH, V14, pA475, DOI 10.1016/j.jval.2011.08.1326; Orlewska E, 2009, VALUE HEALTH, V12, pA414, DOI 10.1016/S1098-3015(10)75044-0; Palmer AJ, 2007, CURR MED RES OPIN, V23, P895, DOI 10.1185/030079907X182194; Patterson C, 2014, DIABETES RES CLIN PR, V103, P161, DOI 10.1016/j.diabres.2013.11.005; Schober E, 2001, DIABETES CARE, V24, P2005, DOI 10.2337/diacare.24.11.2005; do Amaral SMS, 2011, REV SAUDE PUBL, V45, P799, DOI 10.1590/S0034-89102011005000016; Shah A, 2012, VALUE HEALTH, V15, pA190, DOI 10.1016/j.jval.2012.03.1027; Sullivan SD, 2014, VALUE HEALTH, V17, P5, DOI 10.1016/j.jval.2013.08.2291; Tao B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011501; Tran K, 2007, LONG ACTING INSULIN; Tricco AC, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5459; Vieira FS, 2013, SAUDE SOC-SAO PAULO, V22, P73, DOI 10.1590/S0104-12902013000100008; World Health Organization, 2014, WHO GLOB HLTH EXP AT; Zangheline F, 2014, REV ELETRON FARM, VXI, P15	50	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167039	10.1371/journal.pone.0167039	http://dx.doi.org/10.1371/journal.pone.0167039			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907034	Green Submitted, gold, Green Published			2022-12-26	WOS:000389482700070
J	Mylenko, M; Boland, S; Penkov, S; Sampaio, JL; Lombardot, B; Vorkel, D; Verbavatz, JM; Kurzchalia, TV				Mylenko, Mykola; Boland, Sebastian; Penkov, Sider; Sampaio, Julio L.; Lombardot, Benoit; Vorkel, Daniela; Verbavatz, Jean-Marc; Kurzchalia, Teymuras V.			NAD(+) Is a Food Component That Promotes Exit from Dauer Diapause in Caenorhabditis elegans	PLOS ONE			English	Article							IMAGE-ANALYSIS; C. ELEGANS; PHEROMONE; METABOLISM; SEROTONIN; BACTERIA; BEHAVIOR; RENALASE; MUTANTS; LARVA	The free-living soil nematode Caenorhabditis elegans adapts its development to the availability of food. When food is scarce and population density is high, worms enter a developmentally arrested non-feeding diapause stage specialized for long-term survival called the dauer larva. When food becomes available, they exit from the dauer stage, resume growth and reproduction. It has been postulated that compound(s) present in food, referred to as the "food signal", promote exit from the dauer stage. In this study, we have identified NAD(+) as a component of bacterial extract that promotes dauer exit. NAD(+), when dissolved in alkaline medium, causes opening of the mouth and ingestion of food. We also show that to initiate exit from the dauer stage in response to NAD(+) worms require production of serotonin. Thus, C. elegans can use redox cofactors produced by dietary organisms to sense food.	[Mylenko, Mykola; Boland, Sebastian; Penkov, Sider; Sampaio, Julio L.; Lombardot, Benoit; Vorkel, Daniela; Verbavatz, Jean-Marc; Kurzchalia, Teymuras V.] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany	Max Planck Society	Kurzchalia, TV (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany.	kurzchalia@mpi-cbg.de	Sampaio, Julio/S-3810-2019; Mylenko, Mykola/T-8790-2018; Boland, Sebastian/AAL-4065-2020; Boland, Sebastian/AAJ-3560-2020	Boland, Sebastian/0000-0002-6694-2039; Verbavatz, Jean-Marc/0000-0002-4654-1174; Sampaio, Julio/0000-0002-2881-7827; Mylenko, Mykola/0000-0002-2662-2137	MPI-CBG internal grants	MPI-CBG internal grants	This study was funded by MPI-CBG internal grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abada EAE, 2009, MOL CELLS, V28, P209, DOI 10.1007/s10059-009-0124-x; ALBE KR, 1990, J THEOR BIOL, V143, P163, DOI 10.1016/S0022-5193(05)80266-8; ALBERT PS, 1988, DEV BIOL, V126, P270, DOI 10.1016/0012-1606(88)90138-8; ALBERT PS, 1983, J COMP NEUROL, V219, P461, DOI 10.1002/cne.902190407; [Anonymous], 2015, ACD CHEMSKETCH FREEW; AVERY L, 1990, J EXP ZOOL, V253, P263, DOI 10.1002/jez.1402530305; Beaupre BA, 2015, BIOCHEMISTRY-US, V54, P795, DOI 10.1021/bi5013436; Beaupre BA, 2013, J AM CHEM SOC, V135, P13980, DOI 10.1021/ja407384h; BRENNER S, 1974, GENETICS, V77, P71; Butcher RA, 2007, NAT CHEM BIOL, V3, P420, DOI 10.1038/nchembio.2007.3; Canto C, 2011, COLD SH Q B, V76, P291, DOI 10.1101/sqb.2012.76.010439; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; Chase Daniel L, 2007, WormBook, P1; Entchev EV, 2015, ELIFE, V4, DOI 10.7554/eLife.06259; Erkut C, 2011, CURR BIOL, V21, P1331, DOI 10.1016/j.cub.2011.06.064; Frezal L, 2015, ELIFE, V4, DOI 10.7554/eLife.05849; GBEWONYO K, 1994, BIO-TECHNOL, V12, P51, DOI 10.1038/nbt0194-51; GOLDEN JW, 1984, P NATL ACAD SCI-BIOL, V81, P819, DOI 10.1073/pnas.81.3.819; GOLDEN JW, 1984, J CHEM ECOL, V10, P1265, DOI 10.1007/BF00988553; GOLDEN JW, 1982, SCIENCE, V218, P578, DOI 10.1126/science.6896933; HOLM S, 1979, SCAND J STAT, V6, P65; HORVITZ HR, 1982, SCIENCE, V216, P1012, DOI 10.1126/science.6805073; Jeong PY, 2005, NATURE, V433, P541, DOI 10.1038/nature03201; JOHNSON RW, 1988, J AM CHEM SOC, V110, P2257, DOI 10.1021/ja00215a041; JOHNSON SL, 1970, J BIOL CHEM, V245, P4519; Kiyama Y, 2012, J EXP BIOL, V215, P1178, DOI 10.1242/jeb.067199; Ludewig Andreas H, 2013, WormBook, P1, DOI 10.1895/wormbook.1.155.1; Mann H.B., 1947, TEST WHETHER ONE 2 R, P50; Milo R, 2010, NUCLEIC ACIDS RES, V38, pD750, DOI 10.1093/nar/gkp889; Murayama T, 2013, CURR BIOL, V23, P1007, DOI 10.1016/j.cub.2013.04.052; Penkov S, 2014, NAT CHEM BIOL, V10, P281, DOI [10.1038/NCHEMBIO.1460, 10.1038/nchembio.1460]; Pungaliya C, 2009, P NATL ACAD SCI USA, V106, P7708, DOI 10.1073/pnas.0811918106; R Core Team, 2013, R LANG ENV STAT COMP; Riddle DL, 1997, LIFE HIST EVOLUTION; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shivers RP, 2009, CELL HOST MICROBE, V6, P321, DOI 10.1016/j.chom.2009.09.001; Shtonda BB, 2006, J EXP BIOL, V209, P89, DOI 10.1242/jeb.01955; Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39; Sobol RW, 2014, DNA REPAIR, V23, P1, DOI 10.1016/j.dnarep.2014.10.007; SULSTON JE, 1974, GENETICS, V77, P95; Sze JY, 2000, NATURE, V403, P560, DOI 10.1038/35000609; Verdin E, 2015, SCIENCE, V350, P1208, DOI 10.1126/science.aac4854; Voet D., 2010, BIOCHEMISTRY	45	11	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167208	10.1371/journal.pone.0167208	http://dx.doi.org/10.1371/journal.pone.0167208			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907064	Green Submitted, Green Published, gold			2022-12-26	WOS:000389482700092
J	Yap, R; Wilkins, S; Staples, M; Oliva, K; McMurrick, PJ				Yap, Raymond; Wilkins, Simon; Staples, Margaret; Oliva, Karen; McMurrick, Paul J.			The Effect of Diabetes on the Perioperative Outcomes of Colorectal Cancer Surgery Patients	PLOS ONE			English	Article							SURGICAL SITE INFECTIONS; ADVERSE OUTCOMES; CHRONIC WOUNDS; MELLITUS; HYPERGLYCEMIA; MANAGEMENT; RISK	There are approximately 1.3 million patients in Australia with diabetes. Conflicting reports exist in the literature as to the effect of diabetes on the outcomes of colorectal cancer patients. We hypothesized that patients with diabetes would have poorer perioperative outcomes, and that diabetes was an independent risk factor for both 30-day mortality and perioperative morbidity. The aim of this study was to assess the impact of diabetes on perioperative colorectal cancer surgery outcomes, as compared to a diabetes-free reference population, and to examine factors affecting perioperative risk. We conducted an analysis of a prospectively collected, clinician-led colorectal cancer database of patients from 2010-2015. Patients with diabetes were compared to patients without diabetes on a range of perioperative outcomes. Pearson chi-squared tests, Wilcoxon rank sum tests and t-tests were employed for univariate analyses. Confounding factors were controlled for by separate logistic and linear regression analyses. The Huber-White Sandwich Estimator was used to calculate robust standard errors. A total of 1725 patients were analysed over 1745 treatment episodes in the study period with 267 patients (268 episodes) with diabetes studied. Diabetes contributed to medical, surgical complications, and increased length of inpatient stay in univariate analyses. Multivariable analysis adjusted for variables independently associated with each outcome revealed that diabetes was an independent contributor to an increased risk of surgical complications, with no significant effect on medical complications, return to the operating room, 30-day mortality, or readmission within 30 days. In this study, where overall baseline morbidity and mortality levels are low, the effect of diabetes alone on perioperative surgical outcomes appears to be overstated with control of associated perioperative risk factors such as cardiac, renal and respiratory factors being more important.	[Yap, Raymond; Wilkins, Simon; Oliva, Karen; McMurrick, Paul J.] Cabrini Monash Univ, Dept Surg, Cabrini Hosp, Malvern, Vic, Australia; [Wilkins, Simon] Monash Univ, Sch Publ Hlth & Prevent Med, Dept Epidemiol & Prevent Med, Clayton, Vic, Australia; [Staples, Margaret] Cabrini Hosp, Monash Dept Clin Epidemiol, Malvern, Vic, Australia	Cabrini Health; Monash University; Monash University; Cabrini Health; Monash University	Yap, R (corresponding author), Cabrini Monash Univ, Dept Surg, Cabrini Hosp, Malvern, Vic, Australia.	ryap@cabrini.com.au	Wilkins, Simon/D-1174-2009	Wilkins, Simon/0000-0001-7712-4114				Anand N, 2010, J GEN INTERN MED, V25, P809, DOI 10.1007/s11606-010-1336-7; Ata A, 2010, AM SURGEON, V76, P697; BAGDADE JD, 1978, DIABETES, V27, P677, DOI 10.2337/diabetes.27.6.677; Brem H, 2007, MOL MED, V13, P30, DOI 10.2119/2006-00054.Brem; Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169; Chang CC, 2012, EPILEPSIA, V53, P987, DOI 10.1111/j.1528-1167.2012.03448.x; Clement S, 2004, DIABETES CARE, V27, P553, DOI 10.2337/diacare.27.2.553; Coursin DB, 2004, CRIT CARE MED, V32, pS116, DOI 10.1097/01.CCM.0000115623.52021.C0; Fransgaard T, 2016, COLORECTAL DIS, V18, pO22, DOI 10.1111/codi.13158; Frisch A, 2010, DIABETES CARE, V33, P1783, DOI 10.2337/dc10-0304; Heriot A., 2015, AUSTR COLORECTAL SUR; International Diabetes Federation, 2013, IDF DIABETES ATLAS; Liao CC, 2012, J NEUROL NEUROSUR PS, V83, P1186, DOI 10.1136/jnnp-2012-302337; McConnell YJ, 2009, J GASTROINTEST SURG, V13, P508, DOI 10.1007/s11605-008-0734-1; McMurrick PJ, 2014, DIS COLON RECTUM, V57, P167, DOI 10.1097/DCR.0000000000000041; Mejia J, 2014, EUR J ANAESTH, V31, P205, DOI 10.1097/00003643-201406001-00588; Mills KT, 2013, DIS COLON RECTUM, V56, P1304, DOI 10.1097/DCR.0b013e3182a479f9; MOWAT AG, 1971, NEW ENGL J MED, V284, P621, DOI 10.1056/NEJM197103252841201; Rogers W., 1994, STATA TECHNICAL B, V3, P1, DOI DOI 10.1016/J.SCITOTENV.2014.04.059; Stojadinovic O, 2005, AM J PATHOL, V167, P59, DOI 10.1016/S0002-9440(10)62953-7; Yeh CC, 2013, DIABETES CARE, V36, P3216, DOI 10.2337/dc13-0770	21	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167271	10.1371/journal.pone.0167271	http://dx.doi.org/10.1371/journal.pone.0167271			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907053	Green Published, Green Submitted, gold			2022-12-26	WOS:000389482700106
J	Zhang, H; Zhu, NX; Huang, K; Cai, BZ; Zeng, Y; Xu, YM; Liu, Y; Yuan, YP; Lin, CM				Zhang, Huan; Zhu, Ning-Xia; Huang, Keng; Cai, Bo-Zhi; Zeng, Yang; Xu, Yan-Ming; Liu, Yang; Yuan, Yan-Ping; Lin, Chang-Min			iTRAQ-Based Quantitative Proteomic Comparison of Early- and Late-Passage Human Dermal Papilla Cell Secretome in Relation to Inducing Hair Follicle Regeneration	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; WNT SIGNALING PATHWAY; TGF-BETA ACTIVITY; MATRIX METALLOPROTEINASES; CANCER; PROGENITORS; PROGRESSION; MODULATION; PREDICTION; BIGLYCAN	Alopecia is an exceedingly prevalent problem that lacks effective therapy. Recently, research has focused on early-passage dermal papilla cells (DPCs), which have hair inducing activity both in vivo and in vitro. Our previous study indicated that factors secreted from early-passage DPCs contribute to hair follicle (HF) regeneration. To identify which factors are responsible for HF regeneration and why late-passage DPCs lose this potential, we collected 48-h-culture medium (CM) from both of passage 3 and 9 DPCs, and subcutaneously injected the DPC-CM into NU/NU mice. Passage 3 DPC-CM induced HF regeneration, based on the emergence of a white hair coat, but passage 9 DPC-CM did not. In order to identify the key factors responsible for hair induction, CM from passage 3 and 9 DPCs was analyzed by iTRAQ-based quantitative proteomic technology. We identified 1360 proteins, of which 213 proteins were differentially expressed between CM from early-passage vs. late-passage DPCs, including SDF1, MMP3, biglycan and LTBP1. Further analysis indicated that the differentially-expressed proteins regulated the Wnt, TGF-beta and BMP signaling pathways, which directly and indirectly participate in HF morphogenesis and regeneration. Subsequently, we selected 19 proteins for further verification by multiple reaction monitoring (MRM) between the two types of CM. These results indicate DPC-secreted proteins play important roles in HF regeneration, with SDF1, MMP3, biglycan, and LTBP1 being potential key inductive factors secreted by dermal papilla cells in the regeneration of hair follicles.	[Zhang, Huan; Zeng, Yang; Liu, Yang; Yuan, Yan-Ping; Lin, Chang-Min] Shantou Univ, Dept Histol & Embryol, Coll Med, Shantou, Guangdong, Peoples R China; [Zhu, Ning-Xia] Shantou Univ, Affiliated Hosp 1, Dept Cardiol, Coll Med, Shantou, Guangdong, Peoples R China; [Huang, Keng] Shantou Univ, Affiliated Hosp 2, Emergency Dept, Coll Med, Shantou, Guangdong, Peoples R China; [Cai, Bo-Zhi] Shantou Univ, Affiliated Hosp 1, Tissue Engn Lab, Coll Med, Shantou, Guangdong, Peoples R China; [Xu, Yan-Ming] Shantou Univ, Coll Med, Lab Canc Biol & Epigenet, Dept Cell Biol & Genet, Shantou, Guangdong, Peoples R China	Shantou University; Shantou University; Shantou University; Shantou University; Shantou University	Lin, CM (corresponding author), Shantou Univ, Dept Histol & Embryol, Coll Med, Shantou, Guangdong, Peoples R China.	cocolin@126.com	Xu, yanming/Q-4931-2019		National Science Foundation of China [81372084, 81171832, 81501685]; Guangdong Province Outstanding Young Teacher Training Program [Yq2013078]; Guangdong Scientific Research Funding Program [2014A020211024]; National Science Foundation of Guangdong Province [2016A030310078]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Outstanding Young Teacher Training Program; Guangdong Scientific Research Funding Program; National Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This work was supported by grants from the National Science Foundation of China (http://www.nsfc.gov.cn) (Nos. 81372084 to KH, 81171832 to CML and 81501685 to NXZ), the Guangdong Province Outstanding Young Teacher Training Program (http://www.gdhed.edu.cn) (No. Yq2013078 to CML), the Guangdong Scientific Research Funding Program (http://www.gdstc.gov.cn) (No. 2014A020211024 to CML), and by the National Science Foundation of Guangdong Province (http://pro.gdstc.gov.cn/) (No.2016A030310078 to NXZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belmadani A, 2009, DIFFERENTIATION, V77, P395, DOI 10.1016/j.diff.2008.10.015; Bendtsen JD, 2004, PROTEIN ENG DES SEL, V17, P349, DOI 10.1093/protein/gzh037; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Berendsen AD, 2011, P NATL ACAD SCI USA, V108, P17022, DOI 10.1073/pnas.1110629108; Blavier L, 2010, CANCER BIOL THER, V10, P198, DOI 10.4161/cbt.10.2.12193; Chen DM, 2015, CANCER CELL INT, V15, DOI 10.1186/s12935-015-0198-9; Balana ME, 2015, WORLD J STEM CELLS, V7, P711, DOI 10.4252/wjsc.v7.i4.711; Fujie T, 2001, J DERMATOL SCI, V25, P206, DOI 10.1016/S0923-1811(00)00130-4; Gomez-Duran A, 2006, J CELL BIOCHEM, V97, P380, DOI 10.1002/jcb.20637; Guo R, 2015, IN VITRO CELL DEV-AN, V51, P578, DOI 10.1007/s11626-014-9862-y; Hamada K, 2006, BRIT J DERMATOL, V154, P609, DOI 10.1111/j.1365-2133.2006.07144.x; Hu TH, 2014, CANCER LETT, V354, P417, DOI 10.1016/j.canlet.2014.08.012; Inamatsu M, 1998, J INVEST DERMATOL, V111, P767, DOI 10.1046/j.1523-1747.1998.00382.x; Karagiannis GS, 2010, MOL ONCOL, V4, P496, DOI 10.1016/j.molonc.2010.09.001; Kessenbrock K, 2015, MATRIX BIOL, V44-46, P184, DOI 10.1016/j.matbio.2015.01.022; Kessenbrock K, 2013, CELL STEM CELL, V13, P300, DOI 10.1016/j.stem.2013.06.005; Li X, 2014, J PROTEOMICS, V98, P138, DOI 10.1016/j.jprot.2013.12.025; Lin CM, 2008, ARCH DERMATOL RES, V300, P531, DOI 10.1007/s00403-008-0852-3; Lin CM, 2009, CHIN J TRAUMATOL, V12, P49, DOI 10.3760/cma.j.issn.1008-1275.2009.01.010; Luo YQ, 2006, NEUROSCI LETT, V398, P291, DOI 10.1016/j.neulet.2006.01.024; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Malgouries S, 2008, BRIT J DERMATOL, V158, P234, DOI 10.1111/j.1365-2133.2007.08339.x; Mathivanan S, 2009, PROTEOMICS, V9, P4997, DOI 10.1002/pmic.200900351; Narumi R, 2012, J PROTEOME RES, V11, P5311, DOI 10.1021/pr3005474; Plikus MV, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a015198; Rishikaysh P, 2014, INT J MOL SCI, V15, P1647, DOI 10.3390/ijms15011647; Todorovic V, 2007, DEVELOPMENT, V134, P3723, DOI 10.1242/dev.008599; Tritschler I, 2009, INT J CANCER, V125, P530, DOI 10.1002/ijc.24443; Upton PD, 2013, AM J RESP CELL MOL, V49, P1135, DOI 10.1165/rcmb.2012-0470OC; Wang H, 2015, J BIOMECH, V48, P432, DOI 10.1016/j.jbiomech.2014.12.032; Wang Z, 2008, BRIT J CANCER, V99, P1695, DOI 10.1038/sj.bjc.6604745; Won CH, 2012, BMB REP, V45, P253, DOI 10.5483/BMBRep.2012.45.4.253; Yan H, 2010, BIOCHEM BIOPH RES CO, V391, P1187, DOI 10.1016/j.bbrc.2009.12.015; Yang CC, 2010, J DERMATOL SCI, V57, P2, DOI 10.1016/j.jdermsci.2009.11.005; Yu L, 2005, J DERMATOL SCI, V37, P58, DOI 10.1016/j.jdermsci.2004.10.001; Zhang FL, 2014, J PROTEOMICS, V102, P125, DOI 10.1016/j.jprot.2014.03.007; Zhang PP, 2014, J TISSUE ENG, V5, DOI 10.1177/2041731414556850	37	11	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167474	10.1371/journal.pone.0167474	http://dx.doi.org/10.1371/journal.pone.0167474			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907131	gold, Green Published, Green Submitted			2022-12-26	WOS:000389482700164
J	Makowska, A; Eble, M; Prescher, K; Hoss, M; Kontny, U				Makowska, Anna; Eble, Michael; Prescher, Kirsten; Hoss, Mareike; Kontny, Udo			Chloroquine Sensitizes Nasopharyngeal Carcinoma Cells but Not Nasoepithelial Cells to Irradiation by Blocking Autophagy	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; IN-VITRO; INHIBITION; APOPTOSIS; HYDROXYCHLOROQUINE; TEMOZOLOMIDE; 5-FLUOROURACIL; CHEMOTHERAPY; CONTRIBUTES; INDUCTION	Background Treatment of nasopharyngeal carcinoma requires the application of high dosages of radiation, leading to severe long-term complications in the majority of patients. Sensitizing tumor cells to radiation could be a means to increase the therapeutic window of radiation. Nasopharyngeal carcinoma cells display alterations in autophagy and blockade of autophagy has been shown to sensitize them against chemotherapy. Methods We investigated the effect of chloroquine, a known inhibitor of autophagy, on sensitization against radiation-induced apoptosis in a panel of five nasopharyngeal carcinoma cell lines and a SV40-transformed nasoepithelial cell line. Autophagy was measured by immunoblot of autophagy-related proteins, immunofluorescence of autophagosomic microvesicles and electron microscopy. Autophagy was blocked by siRNA against autophagy-related proteins 3, 5, 6 and 7 (ATG3, ATG5, ATG6 and ATG7). Results C hloroquine sensitized four out of five nasopharyngeal cancer cell lines towards radiation-induced apoptosis. The sensitizing effect was based on the blockade of autophagy as inhibition of ATG3, ATG5, ATG6 and ATG7 by specific siRNA could substitute for the effect of chloroquine. No sensitization was seen in nasoepithelial cells. Conclusion Chloroquine sensitizes nasopharyngeal carcinoma cells but not nasoepithelial cells towards radiation-induced apoptosis by blocking autophagy. Further studies in a mouse-xenograft model are warranted to substantiate this effect in vivo.	[Makowska, Anna; Kontny, Udo] Rhein Westfal TH Aachen, Fac Med, Div Pediat Hematol Oncol & Stem Cell Transplantat, Aachen, Germany; [Eble, Michael; Prescher, Kirsten] Rhein Westfal TH Aachen, Fac Med, Dept Radiat Oncol, Aachen, Germany; [Hoss, Mareike] Rhein Westfal TH Aachen, Fac Med, Inst Pathol, Electron Microscop Facil, Aachen, Germany	RWTH Aachen University; RWTH Aachen University; RWTH Aachen University	Kontny, U (corresponding author), Rhein Westfal TH Aachen, Fac Med, Div Pediat Hematol Oncol & Stem Cell Transplantat, Aachen, Germany.	ukontny@ukaachen.de						Al Dhaheri Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109630; Alam MM, 2016, APOPTOSIS, V21, P1191, DOI 10.1007/s10495-016-1277-7; [Anonymous], 1978, Sci Sin, V21, P127; Apel A, 2008, CANCER RES, V68, P1485, DOI 10.1158/0008-5472.CAN-07-0562; Buehrlen M, 2012, CANCER-AM CANCER SOC, V118, P4892, DOI 10.1002/cncr.27395; Casanova M, 2012, CANCER-AM CANCER SOC, V118, P2718, DOI 10.1002/cncr.26528; Cheuk DKL, 2011, CANCER-AM CANCER SOC, V117, P197, DOI 10.1002/cncr.25376; Cheung ST, 1999, INT J CANCER, V83, P121, DOI 10.1002/(SICI)1097-0215(19990924)83:1<121::AID-IJC21>3.0.CO;2-F; Chua MLK, 2016, LANCET, V387, P1012, DOI 10.1016/S0140-6736(15)00055-0; Cook KL, 2014, CLIN CANCER RES, V20, P3222, DOI 10.1158/1078-0432.CCR-13-3227; Cullen SP, 2009, CELL DEATH DIFFER, V16, P935, DOI 10.1038/cdd.2009.59; Dong Y, 2010, J CARDIOVASC PHARM T, V15, P220, DOI 10.1177/1074248410370327; Du HL, 2012, ONCOL REP, V27, P143, DOI 10.3892/or.2011.1464; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fernandez AF, 2015, J CLIN INVEST, V125, P33, DOI 10.1172/JCI73940; Gewirtz DA, 2009, RADIOTHER ONCOL, V92, P323, DOI 10.1016/j.radonc.2009.05.022; GLASER R, 1989, P NATL ACAD SCI USA, V86, P9524, DOI 10.1073/pnas.86.23.9524; Gump JM, 2011, TRENDS CELL BIOL, V21, P387, DOI 10.1016/j.tcb.2011.03.007; Hori YS, 2015, J NEURO-ONCOL, V122, P11, DOI 10.1007/s11060-014-1686-9; Inoue S, 2009, CELL DEATH DIFFER, V16, P1053, DOI 10.1038/cdd.2009.29; Lakhter AJ, 2013, J INVEST DERMATOL, V133, P2247, DOI 10.1038/jid.2013.56; Lee AWM, 2015, J CLIN ONCOL, V33, P3356, DOI 10.1200/JCO.2015.60.9347; Li J, 2010, EUR J CANCER, V46, P1900, DOI 10.1016/j.ejca.2010.02.021; LI Jing-gang, 2009, J NATURAL RESOURCE, V5, DOI DOI 10.2514/1.52476.31; Lin DC, 2014, NAT GENET, V46, P866, DOI 10.1038/ng.3006; Lomonaco SL, 2009, INT J CANCER, V125, P717, DOI 10.1002/ijc.24402; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Mo N, 2014, ONCOL REP, V32, P1905, DOI 10.3892/or.2014.3427; Raab-Traub N, 2002, SEMIN CANCER BIOL, V12, P431, DOI 10.1016/S1044579X0200086X; Rangwala R, 2014, AUTOPHAGY, V10, P1369, DOI 10.4161/auto.29118; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Rodemann H, 2011, RADIOTHER ONCOL, V99, P287, DOI [10.1016/j.radonc.2011.06.002, DOI 10.1016/J.RADONC.2011.06.002]; Rodriguez-Galindo C, 2005, CANCER-AM CANCER SOC, V103, P850, DOI 10.1002/cncr.20823; Rojas-Puentes LL, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-209; Rosenfeld MR, 2014, AUTOPHAGY, V10, P1359, DOI 10.4161/auto.28984; Selvakumaran M, 2013, CLIN CANCER RES, V19, P2995, DOI 10.1158/1078-0432.CCR-12-1542; Sloman S. A., 2014, MEM COGNITION, V1, P1, DOI DOI 10.1371/J0URNAL.P0NE.0100819; Solomon VR, 2009, EUR J PHARMACOL, V625, P220, DOI 10.1016/j.ejphar.2009.06.063; Song LL, 2013, ONCOL LETT, V6, P1031, DOI 10.3892/ol.2013.1498; Thome R, 2013, IMMUNOL LETT, V153, P50, DOI 10.1016/j.imlet.2013.07.004; Tsai WL, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-856; Tsao SW, 2002, BBA-MOL CELL RES, V1590, P150, DOI 10.1016/S0167-4889(02)00208-2; Wei WI, 2005, LANCET, V365, P2041, DOI 10.1016/S0140-6736(05)66698-6; Yeh SA, 2005, INT J RADIAT ONCOL, V62, P672, DOI 10.1016/j.ijrobp.2004.11.002; ZHANG SH, 1983, INT J CANCER, V31, P587, DOI 10.1002/ijc.2910310509; Zhang Y, 2015, CURR MED RES OPIN, V31, P1009, DOI 10.1185/03007995.2015.1025731; Zhao XG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126147; Zhou ZR, 2013, ONCOL REP, V29, P2498, DOI 10.3892/or.2013.2382; Zois CE, 2009, AUTOPHAGY, V5, P442, DOI 10.4161/auto.5.4.7667	50	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0166766	10.1371/journal.pone.0166766	http://dx.doi.org/10.1371/journal.pone.0166766			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902742	Green Published, Green Submitted, gold			2022-12-26	WOS:000389474100039
J	Prause, N; Siegle, GJ; Deblieck, C; Wu, A; Iacoboni, M				Prause, Nicole; Siegle, Greg J.; Deblieck, Choi; Wu, Allan; Iacoboni, Marco			EEG to Primary Rewards: Predictive Utility and Malleability by Brain Stimulation	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; THETA-BURST-STIMULATION; STRIATAL DOPAMINE RELEASE; RISKY SEXUAL-BEHAVIOR; INDIVIDUAL-DIFFERENCES; NEURAL ACTIVITY; TIME-COURSE; BLOOD-FLOW; AROUSAL; MOTOR	Theta burst stimulation (TBS) is thought to affect reward processing mechanisms, which may increase and decrease reward sensitivity. To test the ability of TBS to modulate response to strong primary rewards, participants hypersensitive to primary rewards were recruited. Twenty men and women with at least two opposite-sex, sexual partners in the last year received two forms of TBS. Stimulations were randomized to avoid order effects and separated by 2 hours to reduce carryover. The two TBS forms have been demonstrated to inhibit (continuous) or excite (intermittent) the left dorsolateral prefrontal cortex using different pulse patterns, which links to brain areas associated with reward conditioning. After each TBS, participants completed tasks assessing their reward responsiveness to monetary and sexual rewards. Electroencephalography (EEG) was recorded. They also reported their number of orgasms in the weekend following stimulation. This signal was malleable by TBS, where excitatory TBS resulted in lower EEG alpha relative to inhibitory TBS to primary rewards. EEG responses to sexual rewards in the lab (following both forms of TBS) predicted the number of orgasms experienced over the forthcoming weekend. TBS may be useful in modifying hypersensitivity or hyposensitivity to primary rewards that predict sexual behaviors. Since TBS altered the anticipation of a sexual reward, TBS may offer a novel treatment for sexual desire problems.	[Prause, Nicole] Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA 90095 USA; [Siegle, Greg J.] Univ Pittsburgh, Western Psychiat Inst & Clin, 3811 Ohara St, Pittsburgh, PA 15213 USA; [Deblieck, Choi; Wu, Allan; Iacoboni, Marco] Univ Calif Los Angeles, Ahmanson Lovelace Brain Mapping Ctr, Los Angeles, CA USA	University of California System; University of California Los Angeles; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Western Psychiatric Institute & Clinic of UPMC; University of California System; University of California Los Angeles	Prause, N (corresponding author), Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA 90095 USA.	nicole.prause@gmail.com						Ahn HM, 2013, BRAIN STIMUL, V6, P310, DOI 10.1016/j.brs.2012.05.013; Arnow BA, 2002, BRAIN, V125, P1014, DOI 10.1093/brain/awf108; Badcock NA, 2013, PEERJ, V1, DOI 10.7717/peerj.38; Beam W, 2009, BRAIN STIMUL, V2, P50, DOI 10.1016/j.brs.2008.09.006; Beck A, 2009, BIOL PSYCHIAT, V66, P734, DOI 10.1016/j.biopsych.2009.04.035; Beck SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009251; Benning S, 2001, PSYCHOPHYSIOLOGY, V38, pS24; Bilek E, 2013, J NEUROSCI, V33, P7050, DOI 10.1523/JNEUROSCI.3081-12.2013; Binson D, 1998, PUBLIC OPIN QUART, V62, P190, DOI 10.1086/297840; Bobrov P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020674; Both S, 2008, J SEX MED, V5, P1386, DOI 10.1111/j.1743-6109.2008.00815.x; Both S, 2008, J SEX MED, V5, P100, DOI 10.1111/j.1743-6109.2007.00643.x; BOWERS MB, 1971, AM J PSYCHIAT, V127, P1691, DOI 10.1176/ajp.127.12.1691; Bowman CH, 2003, BRAIN COGNITION, V53, P207, DOI 10.1016/S0278-2626(03)00111-8; Bradley MM, 2001, EMOTION, V1, P276, DOI 10.1037//1528-3542.1.3.276; BRASILNETO JP, 1992, J CLIN NEUROPHYSIOL, V9, P132, DOI 10.1097/00004691-199201000-00014; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; Catania JA, 2005, ANN BEHAV MED, V29, P86, DOI 10.1207/s15324796abm2902_2; Chistyakov AV, 2010, INT J NEUROPSYCHOPH, V13, P387, DOI 10.1017/S1461145710000027; Cho SS, 2010, BRAIN STIMUL, V3, P170, DOI 10.1016/j.brs.2009.10.002; Crosby R, 2008, INT J STD AIDS, V19, P590, DOI 10.1258/ijsa.2008.008120; Deblieck C, 2008, HUM BRAIN MAPP, V29, P662, DOI 10.1002/hbm.20427; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Demos KE, 2012, J NEUROSCI, V32, P5549, DOI 10.1523/JNEUROSCI.5958-11.2012; Derefinko KJ, 2014, ARCH SEX BEHAV, V43, P1149, DOI 10.1007/s10508-014-0327-x; Di Lazzaro V, 2005, J PHYSIOL-LONDON, V565, P945, DOI 10.1113/jphysiol.2005.087288; Diekhof EK, 2008, BRAIN RES REV, V59, P164, DOI 10.1016/j.brainresrev.2008.07.004; Donamayor N, 2012, NEUROIMAGE, V62, P17, DOI 10.1016/j.neuroimage.2012.04.038; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Fortenberry JD, 2005, HEALTH PSYCHOL, V24, P252, DOI 10.1037/0278-6133.24.3.252; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Georgiadis JR, 2012, PROG NEUROBIOL, V98, P49, DOI 10.1016/j.pneurobio.2012.05.004; Georgiadis JR, 2006, EUR J NEUROSCI, V24, P3305, DOI 10.1111/j.1460-9568.2006.05206.x; Georgiadis JR, 2010, NEUROIMAGE, V50, P208, DOI 10.1016/j.neuroimage.2009.12.034; GILLAN P, 1979, PSYCHOPHYSIOLOGY, V16, P471, DOI 10.1111/j.1469-8986.1979.tb01507.x; Goldin PR, 2008, BIOL PSYCHIAT, V63, P577, DOI 10.1016/j.biopsych.2007.05.031; Gratton C, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00124; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Grov C, 2013, AIDS BEHAV, V17, P773, DOI 10.1007/s10461-012-0345-4; GUTHRIE D, 1991, PSYCHOPHYSIOLOGY, V28, P240, DOI 10.1111/j.1469-8986.1991.tb00417.x; Hallschmid M, 2002, CLIN NEUROPHYSIOL, V113, P1059, DOI 10.1016/S1388-2457(02)00142-6; Herbenick D, 2009, J SEX MED, V6, P1857, DOI 10.1111/j.1743-6109.2009.01318.x; Herwig U, 2003, BRAIN TOPOGR, V16, P95, DOI 10.1023/B:BRAT.0000006333.93597.9d; Hindriks R, 2013, NEUROIMAGE, V70, P150, DOI 10.1016/j.neuroimage.2012.12.018; Huang YZ, 2007, CLIN NEUROPHYSIOL, V118, P1028, DOI 10.1016/j.clinph.2007.01.021; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Hubl D, 2008, NEUROSCIENCE, V151, P921, DOI 10.1016/j.neuroscience.2007.10.049; Iacono WG, 2006, PSYCHOPHYSIOLOGY, V43, P465, DOI 10.1111/j.1469-8986.2006.00422.x; JANSSEN E, 1994, J CONSULT CLIN PSYCH, V62, P1222, DOI 10.1037/0022-006X.62.6.1222; Johnson AM, 2012, SEX TRANSM INFECT, V88, P212, DOI 10.1136/sextrans-2011-050306; Juckel G, 2006, NEUROIMAGE, V29, P409, DOI 10.1016/j.neuroimage.2005.07.051; KAFKA MP, 1991, J CLIN PSYCHIAT, V52, P60; Kahkonen S, 2004, CLIN NEUROPHYSIOL, V115, P583, DOI 10.1016/j.clinph.2003.10.032; Keck ME, 2000, EUR J NEUROSCI, V12, P3713, DOI 10.1046/j.1460-9568.2000.00243.x; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Knutson B, 2004, NEURON, V43, P261, DOI 10.1016/j.neuron.2004.06.030; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; Knutson B, 2000, NEUROIMAGE, V12, P20, DOI 10.1006/nimg.2000.0593; Knutson B, 2008, BIOL PSYCHIAT, V63, P686, DOI 10.1016/j.biopsych.2007.07.023; Ko JH, 2008, EUR J NEUROSCI, V28, P2147, DOI 10.1111/j.1460-9568.2008.06501.x; Ko JH, 2013, HUM BRAIN MAPP, V34, P1591, DOI 10.1002/hbm.22006; KOLIN EA, 1964, J CONSULT PSYCHOL, V28, P477; Kruger THC, 2005, WORLD J UROL, V23, P130, DOI 10.1007/s00345-004-0496-7; Laan E, 2002, ANUNAL MEETING OF TH; Lega BC, 2011, NEUROREPORT, V22, P795, DOI 10.1097/WNR.0b013e32834b2975; Leicht G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083414; LEVIN RJ, 1985, ARCH SEX BEHAV, V14, P439, DOI 10.1007/BF01542004; Louwerse M, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00385; Luber B, 2014, NEUROIMAGE, V85, P961, DOI 10.1016/j.neuroimage.2013.06.007; Marcus BS, 2011, J SEX MED, V8, P3398, DOI 10.1111/j.1743-6109.2010.02132.x; Mastropasqua C, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00097; Mishra BR, 2010, ADDICTION, V105, P49, DOI 10.1111/j.1360-0443.2009.02777.x; Moll JL, 2011, J SEX MED, V8, P956, DOI 10.1111/j.1743-6109.2010.02190.x; Mori N, 2007, J ENG MECH, V133, P122, DOI 10.1061/(ASCE)0733-9399(2007)133:1(122); Nauczyciel C, 2011, PSYCHIAT RES, V186, P232, DOI 10.1016/j.psychres.2010.06.012; Norris CJ, 2010, BIOL PSYCHOL, V84, P422, DOI 10.1016/j.biopsycho.2010.03.011; O'Reardon JP, 2007, BIOL PSYCHIAT, V62, P1208, DOI 10.1016/j.biopsych.2007.01.018; Oei NYL, 2012, NEUROPSYCHOPHARMACOL, V37, P1729, DOI 10.1038/npp.2012.19; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Ott DVM, 2011, NEUROIMAGE, V57, P617, DOI 10.1016/j.neuroimage.2011.04.038; Paterson LQP, 2013, THE JOURNAL OF SEXUA; Pogarell O, 2006, J PSYCHIATR RES, V40, P307, DOI 10.1016/j.jpsychires.2005.09.001; Politi E, 2008, AM J ADDICTION, V17, P345, DOI 10.1080/10550490802139283; Prause N, 2014, SOCIAL COGNITIVE AND; Prause N, 2014, PSYCHOPHYSIOLOGY, V51, P226, DOI 10.1111/psyp.12173; Prause N, 2012, SEX RELATSH THER, V27, P17, DOI 10.1080/14681994.2012.660141; Pripfl J, 2014, BRAIN STIMUL, V7, P226, DOI 10.1016/j.brs.2013.11.003; Rizk S, 2013, EUR J NEUROSCI, V38, P3230, DOI 10.1111/ejn.12334; Rosenbaum MS, 2013, J HOMOSEXUAL, V60, P505, DOI 10.1080/00918369.2013.760305; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Rowland D L, 1994, Int J Impot Res, V6, P153; Rowland DL, 2004, INT J IMPOT RES, V16, P270, DOI 10.1038/sj.ijir.3901156; Rowland DL, 1996, J ABNORM PSYCHOL, V105, P194, DOI 10.1037/0021-843X.105.2.194; ROWLAND DL, 1992, ARCH SEX BEHAV, V21, P387, DOI 10.1007/BF01542027; Ruohonen J, 2010, NEUROPHYSIOL CLIN, V40, P7, DOI 10.1016/j.neucli.2010.01.006; Sadaghiani S, 2015, CEREB CORTEX, V25, P2763, DOI 10.1093/cercor/bhu072; Sadato N, 1998, NEUROREPORT, V9, P893, DOI 10.1097/00001756-199803300-00024; Santesso DL, 2008, NEUROIMAGE, V42, P807, DOI 10.1016/j.neuroimage.2008.05.032; Schaefer HS, 2006, BIOL PSYCHIAT, V60, P974, DOI 10.1016/j.biopsych.2006.03.024; Schober JM, 2004, BJU INT, V94, P589, DOI 10.1111/j.1464-410X.2004.05006.x; Schober JM, 2009, BJU INT, V103, P1096, DOI 10.1111/j.1464-410X.2008.08166.x; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Schultz W, 2016, DOPAMINE REWARD PRED; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Semple SJ, 2006, J ADDICT DIS, V25, P105, DOI 10.1300/J069v25n04_10; Sescousse G, 2013, BRAIN, V136, P2527, DOI 10.1093/brain/awt126; Shankman SA, 2011, INT J PSYCHOPHYSIOL, V79, P287, DOI 10.1016/j.ijpsycho.2010.11.004; Simons RF, 2003, MEDIA PSYCHOL, V5, P283, DOI 10.1207/S1532785XMEP0503_03; SOBOTKA SS, 1992, ELECTROEN CLIN NEURO, V83, P236, DOI 10.1016/0013-4694(92)90117-Z; Sparing R, 2008, HUM BRAIN MAPP, V29, P82, DOI 10.1002/hbm.20360; Sporns O, 2014, NAT NEUROSCI, V17, P652, DOI 10.1038/nn.3690; STEINMETZ H, 1990, AM J NEURORADIOL, V11, P1123; Stoleru S, 1999, ARCH SEX BEHAV, V28, P1, DOI 10.1023/A:1018733420467; Storholm ED, 2011, ARCH SEX BEHAV, V40, P1301, DOI 10.1007/s10508-010-9712-2; Stoy M, 2012, J PSYCHOPHARMACOL, V26, P677, DOI 10.1177/0269881111416686; Strafella AP, 2003, BRAIN, V126, P2609, DOI 10.1093/brain/awg268; Stuart B, 2010, J BIOSOC SCI, V42, P27, DOI 10.1017/S0021932009990289; Torrubia R, 2001, PERS INDIV DIFFER, V31, P837, DOI 10.1016/S0191-8869(00)00183-5; Urban NBL, 2012, PSYCHOPHARMACOLOGY, V221, P67, DOI 10.1007/s00213-011-2543-6; Van den Eynde F, 2010, BIOL PSYCHIAT, V67, P793, DOI 10.1016/j.biopsych.2009.11.023; van Lankveld JJDM, 2008, BIOL PSYCHOL, V79, P200, DOI 10.1016/j.biopsycho.2008.04.016; Walter M, 2008, NEUROIMAGE, V40, P1482, DOI 10.1016/j.neuroimage.2008.01.040; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8; Weinberg A, 2011, PSYCHOPHYSIOLOGY, V48, P842, DOI 10.1111/j.1469-8986.2010.01149.x; Wing VC, 2013, BRAIN STIMUL, V6, P221, DOI 10.1016/j.brs.2012.06.008; Wischnewski M, 2015, BRAIN STIMUL, V8, P685, DOI 10.1016/j.brs.2015.03.004; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Wu CC, 2014, NEUROIMAGE, V84, P279, DOI [10.1016/J.neuroimage.2013.08.055, 10.1016/j.neuroimage.2013.08.055]; Zangen A, 2002, NEUROREPORT, V13, P2401, DOI 10.1097/00001756-200212200-00005	131	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0165646	10.1371/journal.pone.0165646	http://dx.doi.org/10.1371/journal.pone.0165646			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902711	gold, Green Published, Green Submitted			2022-12-26	WOS:000389474100007
J	Rechetelo, J; Grice, A; Reside, AE; Hardesty, BD; Moloney, J				Rechetelo, Juliana; Grice, Anthony; Reside, April Elizabeth; Hardesty, Britta Denise; Moloney, James			Movement Patterns, Home Range Size and Habitat Selection of an Endangered Resource Tracking Species, the Black-Throated Finch (Poephila cincta cincta)	PLOS ONE			English	Article							GRANIVOROUS BIRDS; RADIO-TRANSMITTERS; NORTHERN AUSTRALIA; BREEDING BIOLOGY; SPARROWS; BEHAVIOR; PASSERINES; RETENTION; MAMMALS; RATES	Understanding movement patterns and home range of species is paramount in ecology; it is particularly important for threatened taxa as it can provide valuable information for conservation management. To address this knowledge gap for a range-restricted endangered bird, we estimated home range size, daily movement patterns and habitat use of a granivorous subspecies in northeast Australia, the black-throated finch (Poephila cincta cincta; BTF) using radio-tracking and re-sighting of colour banded birds. Little is known about basic aspects of its ecology including movement patterns and home range sizes. From 2011 - 2014 we colour-banded 102 BTF and radio-tracked 15 birds. We generated home ranges (calculated using kernel and Minimum Convex Polygons techniques of the 15 tracked BTF). More than 50% of the re-sightings occurred within 200 m of the banding site (n = 51 out of 93 events) and within 100 days of capture. Mean home-range estimates with kernel (50%, 95% probability) and Minimum Convex Polygons were 10.59 ha, 50.79 ha and 46.27 ha, respectively. Home range size differed between two capture sites but no seasonal differences were observed. BTF home ranges overlapped four habitat types among eight available. Habitat selection was different from random at Site 1 (chi(2) = 373.41, df = 42, p<0.001) and Site 2 (chi(2) = 1896.1, df = 45, p<0.001); however, the preferred habitats differed between the two sites. BTF moved further than expected on the basis of current knowledge, with three individuals being resighted over 15 km from the banding location. However, BTF maintain small home ranges over short time-frames. Occasional long-distance movements may be related to resource bottleneck periods. Daily movement patterns differed between sites, which is likely linked to the fact that the sites differ in the spatial distribution of resources. The work provides information about home range sizes and local movement of BTF that will be valuable for targeting effective management and conservation strategies for this endangered granivore.	[Rechetelo, Juliana; Reside, April Elizabeth; Moloney, James] James Cook Univ, Coll Marine & Environm Sci, Townsville, Qld, Australia; [Rechetelo, Juliana; Hardesty, Britta Denise] CSIRO, Oceans & Atmosphere Flagship, Hobart, Tas, Australia; [Grice, Anthony] CSIRO, Land & Water Flagship, Townsville, Qld, Australia; [Rechetelo, Juliana] Univ Parana, Ornithol Lab, Matinhos, Parana, Brazil; [Grice, Anthony] James Cook Univ, Townsville, Qld, Australia	James Cook University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); James Cook University	Rechetelo, J (corresponding author), James Cook Univ, Coll Marine & Environm Sci, Townsville, Qld, Australia.; Rechetelo, J (corresponding author), CSIRO, Oceans & Atmosphere Flagship, Hobart, Tas, Australia.; Rechetelo, J (corresponding author), Univ Parana, Ornithol Lab, Matinhos, Parana, Brazil.	jurechetelo@gmail.com	Hardesty, Britta Denise/A-3189-2011; Rechetelo, Juliana/AAE-3692-2022; Reside, April/H-4940-2011	Hardesty, Britta Denise/0000-0003-1948-5098; Rechetelo, Juliana/0000-0002-3191-5268; Reside, April/0000-0002-0760-9527	Black-throated finch Trust; James Moloney and Anthony Grice; Bird Life Australia; Juliana Rechetelo WildLife Queensland; Juliana Rechetelo College of Marine & Environmental Sciences; James Cook University -Juliana Rechetelo Tropical Landscapes Joint Venture (JCU and SCIRO)	Black-throated finch Trust; James Moloney and Anthony Grice; Bird Life Australia; Juliana Rechetelo WildLife Queensland; Juliana Rechetelo College of Marine & Environmental Sciences; James Cook University -Juliana Rechetelo Tropical Landscapes Joint Venture (JCU and SCIRO)	Funded by Black-throated finch Trust- no grant number- James Moloney and Anthony Grice; Bird Life Australia -no grant number- Juliana Rechetelo WildLife Queensland no grant number Juliana Rechetelo College of Marine & Environmental Sciences, James Cook University -Juliana Rechetelo Tropical Landscapes Joint Venture (JCU and SCIRO)-scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBISCHER NJ, 1993, ECOLOGY, V74, P1313, DOI 10.2307/1940062; Anich NM, 2009, J FIELD ORNITHOL, V80, P206, DOI 10.1111/j.1557-9263.2009.00210.x; [Anonymous], 2001, RADIO TRACKING ANIMA; [Anonymous], 2014, R LANG ENV STAT COMP; Baldwin HQ, 2010, WILSON J ORNITHOL, V122, P139, DOI 10.1676/08-160.1; Barg JJ, 2005, J ANIM ECOL, V74, P139, DOI 10.1111/j.1365-2656.2004.00906.x; Beyer H. L, 2012, GEOSPATIAL MODELLING; Beyer HL, 2010, PHILOS T R SOC B, V365, P2245, DOI 10.1098/rstb.2010.0083; BirdLife International, 2015, IUCN RED LIST BIRDS; Brandt MJ, 2008, IBIS, V150, P495, DOI 10.1111/j.1474-919X.2008.00811.x; Brandt MJ, 2007, TRADE OFFS RISKS PRE; BTFRT, 2007, NAT REC PLAN BLACK T; Bureau of Meteorology, 2015, CLIM STAT AUSTR LOC; Calenge C, 2006, ECOLOGY, V87, P2349, DOI 10.1890/0012-9658(2006)87[2349:EOSRFA]2.0.CO;2; Calladine J, 327 BTO; Clarke MF, 1997, EMU, V97, P283, DOI 10.1071/MU97041; Crowley G, 1999, AUST J ECOL, V24, P208, DOI 10.1046/j.1442-9993.1999.00964.x; Crowley G.M., 2003, MANAGEMENT GUIDELINE; DAVIES SJJF, 1984, J ARID ENVIRON, V7, P183; Dean WRJ, 1997, J BIOGEOGR, V24, P769, DOI 10.1046/j.1365-2699.1997.00163.x; Department of the Environment, 2015, PEOPH CINCT CINCT SP; Diemer KM, 2014, WILSON J ORNITHOL, V126, P39, DOI 10.1676/13-098.1; EVANS SM, 1985, IBIS, V127, P348, DOI 10.1111/j.1474-919X.1985.tb05076.x; EVANS SM, 1987, EMU, V87, P124, DOI 10.1071/MU9870124; Franklin DC, 2005, WILDLIFE RES, V32, P399, DOI 10.1071/WR05052; Franklin DC, 2000, J BIOGEOGR, V27, P829, DOI 10.1046/j.1365-2699.2000.00446.x; Garnett S. T., 2011, ACTION PLAN AUSTR BI; Garnett ST, 2000, ACTION PLAN AUSTR BI; Garnett ST, 2009, BIODIVERS CONSERV, P189; Ginter DL, 2005, WILSON BULL, V117, P63, DOI 10.1676/04-017; Gitzen RA, 2003, WILDLIFE SOC B, V31, P823; Gitzen RA, 2006, J WILDLIFE MANAGE, V70, P1334, DOI 10.2193/0022-541X(2006)70[1334:BSFFAO]2.0.CO;2; Gordon CE, 2000, AUK, V117, P748, DOI 10.1642/0004-8038(2000)117[0748:MPOWGS]2.0.CO;2; Grice AC, 2013, WILDLIFE SOC B, V37, P478, DOI 10.1002/wsb.314; HARRIS S, 1990, MAMMAL REV, V20, P97, DOI 10.1111/j.1365-2907.1990.tb00106.x; Higgins P.J., 2006, VOLUME 7 BOATBILL ST; Isles NL, 2007, PATTERNS FORAGING BE; JENKINS SH, 1981, AM NAT, V118, P126, DOI 10.1086/283807; JOHNSON GD, 1991, J FIELD ORNITHOL, V62, P486; KEAST ALLEN, 1958, EMU, V58, P219; Lewis M., 2007, TEMPORAL DIMENSIONS, P218, DOI [10.1007/978-0-387-45447-4_13, DOI 10.1007/978-0-387-45447-4_13]; Manly B. F. J., 2002, RESOURCE SELECTION A, V2; Maute K. L., 2011, THESIS; Milenkaya O, 2011, EMU, V111, P312, DOI 10.1071/MU10088; Millspaugh Joshua J., 2001, P383, DOI 10.1016/B978-012497781-5/50016-5; Mitchell DF, 1996, FORAGING ECOLOGY BLA; Morrison M.L., 1998, WILDLIFE HABITAT REL; MORTON SR, 1983, AUST J ECOL, V8, P235; O'Malley C., 2006, NATL RECOVERY PLAN G; Protection DoEaH, 2014, ENV MAPS DAT ONL; Queensland Government, 2014, MAT SERV MOD; Remnant Vegetation in Queensland, 2013, REMN VEG QUEENSL AN; Rivera JHV, 2003, J FIELD ORNITHOL, V74, P141, DOI 10.1648/0273-8570-74.2.141; Sattler P., 1999, CONSERVATION STATUS; Smith N.M.., 2002, WEEDS WETDRY TROPICS; Smolinsky JA, 2013, BEHAV ECOL SOCIOBIOL, V67, P2041, DOI 10.1007/s00265-013-1614-6; Tidemann Sonia C., 1993, Victorian Naturalist (South Yarra), V110, P238; Willems EP, 2009, ECOLOGY, V90, P546, DOI 10.1890/08-0765.1; Withey John C., 2001, P43, DOI 10.1016/B978-012497781-5/50004-9; WOINARSKI JCZ, 1992, EMU, V92, P33, DOI 10.1071/MU9920033; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; ZANN RA, 1995, EMU, V95, P208, DOI 10.1071/MU9950208; Zann RA., 1996, ZEBRA FINCH SYNTHESI	63	18	20	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167254	10.1371/journal.pone.0167254	http://dx.doi.org/10.1371/journal.pone.0167254			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902764	Green Published, Green Accepted, gold			2022-12-26	WOS:000389474100064
J	Hanske, J; Schulze, J; Aretz, J; McBride, R; Loll, B; Schmidt, H; Knirel, Y; Rabsch, W; Wahl, MC; Paulson, JC; Rademacher, C				Hanske, Jonas; Schulze, Jessica; Aretz, Jonas; McBride, Ryan; Loll, Bernhard; Schmidt, Henrik; Knirel, Yuriy; Rabsch, Wolfgang; Wahl, Markus C.; Paulson, James C.; Rademacher, Christoph			Bacterial Polysaccharide Specificity of the Pattern Recognition Receptor Langerin Is Highly Species- dependent	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TYPE LECTIN; CARBOHYDRATE-RECOGNITION; STRUCTURAL BASIS; DC-SIGN; BINDING; PROTEIN; CELLS; DIVERSITY; PATHOGEN; ANTIGENS	The recognition of pathogen surface polysaccharides by glycan- binding proteins is a cornerstone of innate host defense. Many members of the C-type lectin receptor family serve as pattern recognition receptors facilitating pathogen uptake, antigen processing, and immunomodulation. Despite the high evolutionary pressure in host-pathogen interactions, it is still widely assumed that genetic homology conveys similar specificities. Here, we investigate the ligand specificities of the human and murine forms of the myeloid C-type lectin receptor langerin for simple and complex ligands augmented by structural insight into murine langerin. Although the two homologs share the same three-dimensional structure and recognize simple ligands identically, a screening of more than 300 bacterial polysaccharides revealed highly diverging avidity and selectivity for larger and more complex glycans. Structural and evolutionary conservation analysis identified a highly variable surface adjacent to the canonic binding site, potentially forming a secondary site of interaction for large glycans.	[Hanske, Jonas; Schulze, Jessica; Aretz, Jonas; Schmidt, Henrik; Rademacher, Christoph] Max Planck Inst Colloids & Interfaces, Dept Biomol Syst, Wissensch Pk Golm,Muhlenberg 1, D-14424 Potsdam, Germany; [Hanske, Jonas; Schulze, Jessica; Aretz, Jonas; Loll, Bernhard; Schmidt, Henrik; Wahl, Markus C.; Rademacher, Christoph] Free Univ Berlin, Dept Biol Chem & Pharm, D-14195 Berlin, Germany; [McBride, Ryan; Paulson, James C.] Scripps Res Inst, Dept Immunol & Microbial Sci, Dept Cell & Mol Biol, La Jolla, CA 92037 USA; [McBride, Ryan; Paulson, James C.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Knirel, Yuriy] Russian Acad Sci, ND Zelinsky Inst Organ Chem, Moscow 119991, Russia; [Rabsch, Wolfgang] Robert Koch Inst, Wernigerode Branch, Natl Reference Ctr Salmonellae & Other Bacterial, D-38855 Wernigerode, Germany	Max Planck Society; Free University of Berlin; Scripps Research Institute; Scripps Research Institute; Russian Academy of Sciences; Zelinsky Institute of Organic Chemistry; Robert Koch Institute	Rademacher, C (corresponding author), Max Planck Inst Colloids & Interfaces, Dept Biomol Syst, Wissensch Pk Golm,Muhlenberg 1, D-14424 Potsdam, Germany.	Christoph.Rademacher@mpikg.mpg.de	Rademacher, Christoph/H-3101-2012; Knirel, Yuriy A/E-2058-2014; Loll, Bernhard/J-4815-2019; McBride, Ryan/E-6812-2011; Wahl, Markus C./D-6365-2017; Aretz, Jonas/AAL-4829-2020; Paulson, James/AAG-3565-2019	Rademacher, Christoph/0000-0001-7082-7239; Loll, Bernhard/0000-0001-7928-4488; Wahl, Markus C./0000-0002-2811-5307; Aretz, Jonas/0000-0002-4623-5820; Hanske, Jonas/0000-0002-8854-3012	Helmholtz Zentrum Berlin fur Materialien und Energie; Freie Universitat Berlin; Humboldt-Universitat zu Berlin; Max-Delbruck Centrum; Leibniz-Institut fur Molekulare Pharmakologie; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	Helmholtz Zentrum Berlin fur Materialien und Energie; Freie Universitat Berlin; Humboldt-Universitat zu Berlin; Max-Delbruck Centrum; Leibniz-Institut fur Molekulare Pharmakologie; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Daniel Varon Silva for generously providing alpha-methyl-(alpha-1,2)-mannobiose and Willie Vann for granting access to polysialic acid structures. J. H. thanks Daniel Tesolin for help with optimizing protein expression and labeling. We acknowledge Claudia Alings for excellent technical support. C. R. and J. H. thank Peter Seeberger for providing the research environment and fruitful discussions. We accessed beamlines of the BESSY II (Berliner Elektronenspeicherring-Gesellschaft fur Synchrotronstrahlung II) storage ring (Berlin, Germany) via the Joint Berlin MX-Laboratory sponsored by the Helmholtz Zentrum Berlin fur Materialien und Energie, the Freie Universitat Berlin, the Humboldt-Universitat zu Berlin, the Max-Delbruck Centrum, and the Leibniz-Institut fur Molekulare Pharmakologie. We acknowledge beamtime and support at the EMBL beamline P14 of PETRA III (Deutsches Elektronen Synchrotron, Hamburg, Germany).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Aretz J, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00323; Chabrol E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050722; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Collins BE, 2004, CURR OPIN CHEM BIOL, V8, P617, DOI 10.1016/j.cbpa.2004.10.004; de Jong MAWP, 2010, MOL IMMUNOL, V47, P1216, DOI 10.1016/j.molimm.2009.12.016; de Witte L, 2007, NAT MED, V13, P367, DOI 10.1038/nm1541; DRICKAMER K, 1995, CURR OPIN STRUC BIOL, V5, P612, DOI 10.1016/0959-440X(95)80052-2; DRICKAMER K, 1992, NATURE, V360, P183, DOI 10.1038/360183a0; Drickamer K, 2015, CURR OPIN STRUC BIOL, V34, P26, DOI 10.1016/j.sbi.2015.06.003; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Feinberg H, 2013, J BIOL CHEM, V288, P36762, DOI 10.1074/jbc.M113.528000; Feinberg H, 2011, J MOL BIOL, V405, P1027, DOI 10.1016/j.jmb.2010.11.039; Feinberg H, 2010, J BIOL CHEM, V285, P13285, DOI 10.1074/jbc.M109.086058; Forni D, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004189; Gagneux P, 1999, GLYCOBIOLOGY, V9, P747, DOI 10.1093/glycob/9.8.747; Galustian C, 2004, INT IMMUNOL, V16, P853, DOI 10.1093/intimm/dxh089; Garcia-Vallejo JJ, 2013, TRENDS IMMUNOL, V34, P482, DOI 10.1016/j.it.2013.03.001; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Guo Y, 2004, NAT STRUCT MOL BIOL, V11, P591, DOI 10.1038/nsmb784; Horan N, 1999, P NATL ACAD SCI USA, V96, P11782, DOI 10.1073/pnas.96.21.11782; Hsu TL, 2009, J BIOL CHEM, V284, P34479, DOI 10.1074/jbc.M109.065961; Hunger RE, 2004, J CLIN INVEST, V113, P701, DOI 10.1172/JCI200419655; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Lebeer S, 2010, NAT REV MICROBIOL, V8, P171, DOI 10.1038/nrmicro2297; Mayer M, 2004, J AM CHEM SOC, V126, P4453, DOI 10.1021/ja0398870; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meier M, 2000, J MOL BIOL, V300, P857, DOI 10.1006/jmbi.2000.3853; Munoz-Garcia JC, 2015, J AM CHEM SOC, V137, P4100, DOI 10.1021/ja511529x; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Stambach NS, 2003, GLYCOBIOLOGY, V13, P401, DOI 10.1093/glycob/cwg045; Stowell SR, 2014, NAT CHEM BIOL, V10, P470, DOI [10.1038/nchembio.1525, 10.1038/NCHEMBIO.1525]; Tateno H, 2010, J BIOL CHEM, V285, P6390, DOI 10.1074/jbc.M109.041863; Thepaut M, 2009, BIOCHEMISTRY-US, V48, P2684, DOI 10.1021/bi802151w; Valdar WSJ, 2002, PROTEINS, V48, P227, DOI 10.1002/prot.10146; Valladeau J, 2002, J IMMUNOL, V168, P782, DOI 10.4049/jimmunol.168.2.782; van den Berg LM, 2015, J IMMUNOL, V195, P1763, DOI 10.4049/jimmunol.1402356; van der Vlist M, 2011, EUR J IMMUNOL, V41, P2619, DOI 10.1002/eji.201041305; van Kooyk Y, 2008, NAT IMMUNOL, V9, P593, DOI 10.1038/ni.f.203; Varki A, 2006, CELL, V126, P841, DOI 10.1016/j.cell.2006.08.022; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x	44	25	24	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2017	292	3					862	871		10.1074/jbc.M116.751750	http://dx.doi.org/10.1074/jbc.M116.751750			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2LL	27903635	hybrid, Green Published			2022-12-26	WOS:000392318700009
J	Van de Velde, LA; Subramanian, C; Smith, AM; Barron, L; Qualls, JE; Neale, G; Alfonso-Pecchio, A; Jackowski, S; Rock, CO; Wynn, TA; Murray, PJ				Van de Velde, Lee-Ann; Subramanian, Chitra; Smith, Amber M.; Barron, Luke; Qualls, Joseph E.; Neale, Geoffrey; Alfonso-Pecchio, Adolfo; Jackowski, Suzanne; Rock, Charles O.; Wynn, Thomas A.; Murray, Peter J.			T Cells Encountering Myeloid Cells Programmed for Amino Acid-dependent Immunosuppression Use Rictor/mTORC2 Protein for Proliferative Checkpoint Decisions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE-SYNTHASE; L-ARGININE METABOLISM; DENDRITIC CELLS; ACTIVATION; MTOR; MACROPHAGES; INTERLEUKIN-2; SCHISTOSOMIASIS; DIFFERENTIATION; AVAILABILITY	Modulation of T cell proliferation and function by immunoregulatory myeloid cells are an essential means of preventing self-reactivity and restoring tissue homeostasis. Consumption of amino acids such as arginine and tryptophan by immunoregulatory macrophages is one pathway that suppresses local T cell proliferation. Using a reduced complexity in vitro macrophage-T cell co-culture system, we show that macrophage arginase-1 is the only factor required by M2 macrophages to block T cells in G1, and this effect is mediated by L-arginine elimination rather than metabolite generation. Tracking how T cells adjust their metabolism when deprived of arginine revealed the significance of macrophage-mediated arginine deprivation to T cells. We found mTORC1 activity was unaffected in the initial G1 block. After 2 days of arginine deprivation, mTORC1 activity declined paralleling a selective down-regulation of SREBP target gene expression, whereas mRNAs involved in glycolysis, gluconeogenesis, and T cell activation were unaffected. Cell cycle arrest was reversible at any point by exogenous arginine, suggesting starved T cells remain poised awaiting nutrients. Arginine deprivation-induced cell cycle arrest was mediated in part by Rictor/mTORC2, providing evidence that this nutrient recognition pathway is a central component of how T cells measure environmental arginine.	[Van de Velde, Lee-Ann; Subramanian, Chitra; Smith, Amber M.; Qualls, Joseph E.; Alfonso-Pecchio, Adolfo; Jackowski, Suzanne; Rock, Charles O.; Murray, Peter J.] St Jude Childrens Res Hosp, Dept Infect Dis, Mail Stop 320,262 Danny Thomas Pl, Memphis, TN 38105 USA; [Van de Velde, Lee-Ann; Smith, Amber M.; Qualls, Joseph E.; Murray, Peter J.] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Neale, Geoffrey] St Jude Childrens Res Hosp, Dept Computat Biol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Barron, Luke; Wynn, Thomas A.] NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Qualls, Joseph E.] Cincinnati Childrens Hosp Med Ctr, Div Infect Dis, Cincinnati, OH 45229 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Murray, PJ (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, Mail Stop 320,262 Danny Thomas Pl, Memphis, TN 38105 USA.	peter.murray@stjude.org	Chitra, S/GPX-8113-2022; Subramanian, Chitra/N-9210-2018; Jackowski, Suzanne/N-8168-2018; Murray, Peter J/K-4725-2018; Wynn, Thomas A/AAO-3523-2021	Subramanian, Chitra/0000-0003-1101-5307; Jackowski, Suzanne/0000-0002-6855-1429; Murray, Peter J/0000-0001-6329-9802; Wynn, Thomas A/0000-0002-7244-8731; Qualls, Joseph/0000-0002-0113-2166	National Institutes of Health [AI062921, CA138064]; Cancer Center Core Grant [P30 CA21765]; American Lebanese Syrian Associated Charities; National Institutes of Health Intramural Program; NATIONAL CANCER INSTITUTE [F32CA138064, P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000829, R01AI062921] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034496] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Core Grant; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); National Institutes of Health Intramural Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants AI062921 (to P. J. M.) and CA138064 (to J. E. Q.), Cancer Center Core Grant P30 CA21765, the American Lebanese Syrian Associated Charities, and the National Institutes of Health Intramural Program. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barron L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061961; Barron L, 2011, EUR J IMMUNOL, V41, P2509, DOI 10.1002/eji.201141869; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bensinger SJ, 2008, CELL, V134, P97, DOI 10.1016/j.cell.2008.04.052; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Bronte V, 2003, J IMMUNOL, V170, P270, DOI 10.4049/jimmunol.170.1.270; Carroll B, 2016, ELIFE, V5, DOI 10.7554/eLife.11058; Chantranupong L, 2016, CELL, V165, P153, DOI 10.1016/j.cell.2016.02.035; CHUANG JC, 1990, CLIN EXP IMMUNOL, V81, P173; Cobbold SP, 2009, P NATL ACAD SCI USA, V106, P12055, DOI 10.1073/pnas.0903919106; CURRIE GA, 1979, BRIT J CANCER, V39, P613, DOI 10.1038/bjc.1979.112; Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Demetriades C, 2014, CELL, V156, P786, DOI 10.1016/j.cell.2014.01.024; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; El Kasmi KC, 2008, NAT IMMUNOL, V9, P1399, DOI 10.1038/ni.1671; El-Gayar S, 2003, J IMMUNOL, V171, P4561, DOI 10.4049/jimmunol.171.9.4561; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Geiger R, 2016, CELL, V167, P829, DOI 10.1016/j.cell.2016.09.031; Gundra UM, 2014, BLOOD, V123, pE110, DOI 10.1182/blood-2013-08-520619; Herbert DR, 2010, J IMMUNOL, V184, P6438, DOI 10.4049/jimmunol.0902009; Hogan LH, 2002, J IMMUNOL, V169, P6386, DOI 10.4049/jimmunol.169.11.6386; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang SR, 2012, J LIPID RES, V53, P2002, DOI 10.1194/jlr.D029546; Huber S, 2010, BLOOD, V116, P3311, DOI 10.1182/blood-2010-02-271981; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jewell JL, 2013, NAT REV MOL CELL BIO, V14, P133, DOI 10.1038/nrm3522; Keller TL, 2012, NAT CHEM BIOL, V8, P311, DOI [10.1038/NCHEMBIO.790, 10.1038/nchembio.790]; Levin AM, 2012, NATURE, V484, P529, DOI 10.1038/nature10975; Manner CK, 2003, J NEUROCHEM, V85, P476, DOI 10.1046/j.1471-4159.2003.01695.x; Marigo I, 2016, CANCER CELL, V30, P377, DOI 10.1016/j.ccell.2016.08.004; Munn DH, 2013, TRENDS IMMUNOL, V34, P137, DOI 10.1016/j.it.2012.10.001; Murray PJ, 2016, NAT IMMUNOL, V17, P132, DOI 10.1038/ni.3323; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nascimento M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004282; Njau F, 2009, MICROBES INFECT, V11, P1002, DOI 10.1016/j.micinf.2009.07.006; Nohturfft A, 2009, ANNU REV CELL DEV BI, V25, P539, DOI 10.1146/annurev.cellbio.24.110707.175344; Norian LA, 2009, CANCER RES, V69, P3086, DOI 10.1158/0008-5472.CAN-08-2826; Offman MN, 2011, BLOOD, V117, P1614, DOI 10.1182/blood-2010-07-298422; Panda K, 2002, J BIOL CHEM, V277, P31020, DOI 10.1074/jbc.M203749200; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000371; Pollizzi KN, 2015, TRENDS IMMUNOL, V36, P13, DOI 10.1016/j.it.2014.11.005; Qualls JE, 2012, CELL HOST MICROBE, V12, P313, DOI 10.1016/j.chom.2012.07.012; Rebsamen M, 2015, NATURE, V519, P477, DOI 10.1038/nature14107; Rodriguez PC, 2007, BLOOD, V109, P1568, DOI 10.1182/blood-2006-06-031856; Rodriguez PC, 2003, J IMMUNOL, V171, P1232, DOI 10.4049/jimmunol.171.3.1232; Ross SH, 2016, IMMUNITY, V45, P685, DOI 10.1016/j.immuni.2016.07.022; Rutschman R, 2001, J IMMUNOL, V166, P2173, DOI 10.4049/jimmunol.166.4.2173; Saxton RA, 2016, NATURE, V536, P229, DOI 10.1038/nature19079; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; TURNER JM, 1993, INT IMMUNOL, V5, P1199, DOI 10.1093/intimm/5.10.1199; Van De Velde LA, 2016, CELL REP, V17, P2247, DOI 10.1016/j.celrep.2016.10.079; Van de Velde LA, 2016, J BIOL CHEM, V291, P25815, DOI 10.1074/jbc.C116.763623; Vannella KM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004372; Wang SY, 2015, SCIENCE, V347, P188, DOI 10.1126/science.1257132; Waysbort N, 2013, J IMMUNOL, V191, P5822, DOI 10.4049/jimmunol.1301575; Werner A, 2016, EUR J IMMUNOL, V46, P92, DOI 10.1002/eji.201546047; Yang K, 2013, IMMUNITY, V39, P1043, DOI 10.1016/j.immuni.2013.09.015; Yang K, 2011, NAT IMMUNOL, V12, P888, DOI 10.1038/ni.2068	60	39	39	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2017	292	1					15	30		10.1074/jbc.M116.766238	http://dx.doi.org/10.1074/jbc.M116.766238			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2DQ	27903651	hybrid, Green Published			2022-12-26	WOS:000391578000002
J	Ho, V; Chung, LP; Revoltar, M; Lim, SH; Tut, TG; Abubakar, A; Henderson, CJ; Chua, W; Ng, W; Lee, M; De Souza, P; Morgan, M; Lee, CS; Shin, JS				Ho, Vincent; Chung, Liping; Revoltar, Maxine; Lim, Stephanie H.; Tut, Thein-Ga; Abubakar, Askar; Henderson, Chris J.; Chua, Wei; Ng, Weng; Lee, Mark; De Souza, Paul; Morgan, Matthew; Lee, C. Soon; Shin, Joo-Shik			MRE11 and ATM Expression Levels Predict Rectal Cancer Survival and Their Association with Radiotherapy Response	PLOS ONE			English	Article							PREOPERATIVE CHEMORADIATION; LOCAL RECURRENCE; COMPLEX; REPAIR	Background Aberrant expression of DNA repair proteins is associated with poor survival in cancer patients. We investigated the combined expression of MRE11 and ATM as a predictive marker of response to radiotherapy in rectal cancer. Methods MRE11 and ATM expression were examined in tumor samples from 262 rectal cancer patients who underwent surgery for rectal cancer, including a sub-cohort of 54 patients who were treated with neoadjuvant radiotherapy. The relationship between expression of the two-protein panel and tumor regression grade (TRG) was assessed by Mann-Whitney U test and receiver operating characteristics area under curve (ROC-AUC) analysis. The association between expression of the two-protein panel and clinicopathologic variables and survival was examined by Kaplan-Meier methods and Cox regression analysis. Results A high score for two-protein combined expression in the tumor center (TC) was significantly associated with worse disease-free survival (DFS) (P = 0.035) and overall survival (OS) (P = 0.003) in the whole cohort, and with DFS (P = 0.028) and OS (P = 0.024) in the neoadjuvant subgroup (n = 54). In multivariate analysis, the two-protein combination panel (HR = 2.178, 95% CI 1.115-4.256, P = 0.023) and perineural invasion (HR = 2.183, 95% CI 1.222-3.899, P = 0.008) were significantly associated with DFS. Using ROC-AUC analysis of good versus poor histological tumor response among patients treated preoperatively with radiotherapy, the average ROC-AUC was 0.745 for the combined panel, 0.618 for ATM alone, and 0.711 for MRE11 alone. Conclusions The MRE11/ATM two-protein panel developed in this study may have clinical value as a predictive marker of tumor response to neoadjuvant radiotherapy, and a prognostic marker for disease-free and overall survival.	[Ho, Vincent; Chung, Liping; Revoltar, Maxine; Abubakar, Askar; Henderson, Chris J.; De Souza, Paul; Lee, C. Soon; Shin, Joo-Shik] Univ Western Sydney, Sch Med, Penrith, NSW, Australia; [Chung, Liping; Tut, Thein-Ga; Abubakar, Askar; Lee, C. Soon; Shin, Joo-Shik] Ingham Inst Appl Med Res, Liverpool, NSW, Australia; [Lim, Stephanie H.; Chua, Wei; Ng, Weng; De Souza, Paul] Liverpool Hosp, Dept Med Oncol, Liverpool, NSW, Australia; [Lim, Stephanie H.] Univ New South Wales, South Western Sydney Clin Sch, Liverpool, NSW, Australia; [Tut, Thein-Ga; Henderson, Chris J.; Lee, C. Soon; Shin, Joo-Shik] Liverpool Hosp, Dept Anat Pathol, Liverpool, NSW, Australia; [Lee, Mark] Liverpool Hosp, Dept Radiat Oncol, Liverpool, NSW, Australia; [De Souza, Paul] Univ Western Sydney, Sch Med, Discipline Med Oncol, Liverpool, NSW, Australia; [Morgan, Matthew] Bankstown Hosp, Dept Surg, Bankstown, NSW, Australia; [Lee, C. Soon; Shin, Joo-Shik] Univ Western Sydney, Sch Med, Discipline Pathol, Campbelltown, NSW, Australia	Western Sydney University; Ingham Institute for Applied Medical Research; Liverpool Hospital; University of New South Wales Sydney; Liverpool Hospital; Liverpool Hospital; Western Sydney University; Western Sydney University	Ho, V (corresponding author), Univ Western Sydney, Sch Med, Penrith, NSW, Australia.	v.ho@westernsydney.edu.au	de Souza, Paul/P-5069-2019	Tut, Thein Ga/0000-0002-1608-9092; Ng, Weng/0000-0003-2354-1857; Lim, Stephanie Hui-Su/0000-0001-5940-7137; Ho, Vincent/0000-0003-3127-2933	Cancer Institute of NSW [13/TRC/1-01]	Cancer Institute of NSW	We would like to declare that funding support for this research was in part contributed through the Cancer Institute of NSW grant awarded to Professor Paul DeSouza and Professor C Soon Lee (Center for Oncology Education and Research Translation) Award number: 13/TRC/1-01.	Ahmed KA, 2015, ONCOTARGET, V6, P34414, DOI 10.18632/oncotarget.5437; Angele S, 2004, AM J CLIN PATHOL, V121, P231, DOI 10.1309/JTKGGGKURFX3XMGT; Birgisson H, 2005, J CLIN ONCOL, V23, P8697, DOI 10.1200/JCO.2005.02.9017; Camma C, 2000, JAMA-J AM MED ASSOC, V284, P1008, DOI 10.1001/jama.284.8.1008; Chung LP, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3676; D'Amours D, 2002, NAT REV MOL CELL BIO, V3, P317, DOI 10.1038/nrm805; Das P, 2007, CANCER-AM CANCER SOC, V109, P1750, DOI 10.1002/cncr.22625; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Folkesson J, 2005, J CLIN ONCOL, V23, P5644, DOI 10.1200/JCO.2005.08.144; Forker LJ, 2015, CLIN ONCOL R COLL RA; Garcia-Aguilar J, 2003, DIS COLON RECTUM, V46, P298, DOI 10.1007/s10350-004-6545-x; Gray R, 2001, LANCET, V358, P1291; Harfe BD, 2000, ANNU REV GENET, V34, P359, DOI 10.1146/annurev.genet.34.1.359; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kapiteijn E, 2001, NEW ENGL J MED, V345, P638, DOI 10.1056/NEJMoa010580; Kuroda S, 2012, ACTA MED OKAYAMA, V66, P83; Lee YC, 2013, DIS COLON RECTUM, V56, P1093, DOI 10.1097/DCR.0b013e318298e36b; Lee YA, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0063255, 10.1371/journal.pone.0054889]; Pavelitz T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108483; Permuth-Wey J, 2009, CANCER EPIDEM BIOMAR, V18, P28, DOI 10.1158/1055-9965.EPI-08-0713; Rahbari NN, 2013, ANN SURG ONCOL, V20, P4169, DOI 10.1245/s10434-013-3198-9; Sheridan Juliette, 2013, J Gastrointest Cancer, V44, P41, DOI 10.1007/s12029-012-9442-x; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Trakarnsanga A, 2012, WORLD J GASTROENTERO, V18, P5521, DOI 10.3748/wjg.v18.i39.5521; Tut TG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129313	25	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167675	10.1371/journal.pone.0167675	http://dx.doi.org/10.1371/journal.pone.0167675			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930716	Green Published, gold, Green Submitted			2022-12-26	WOS:000389580900037
J	Laguna, TA; Wagner, BD; Williams, CB; Stevens, MJ; Robertson, CE; Welchlin, CW; Moen, CE; Zemanick, ET; Harris, JK				Laguna, Theresa A.; Wagner, Brandie D.; Williams, Cynthia B.; Stevens, Mark J.; Robertson, Charles E.; Welchlin, Cole W.; Moen, Catherine E.; Zemanick, Edith T.; Harris, Jonathan K.			Airway Microbiota in Bronchoalveolar Lavage Fluid from Clinically Well Infants with Cystic Fibrosis	PLOS ONE			English	Article							YOUNG-CHILDREN; PSEUDOMONAS-AERUGINOSA; BACTERIAL COMMUNITIES; PULMONARY-FUNCTION; DIRECTED THERAPY; LUNG-DISEASE; INFLAMMATION; INFECTION; LIFE; DIVERSITY	Background Upper airway cultures guide the identification and treatment of lung pathogens in infants with cystic fibrosis (CF); however, this may not fully reflect the spectrum of bacteria present in the lower airway. Our objectives were to characterize the airway microbiota using bronch-oalveolar lavage fluid (BALF) from asymptomatic CF infants during the first year of life and to investigate the relationship between BALF microbiota, standard culture and clinical characteristics. Methods BALF, nasopharyngeal (NP) culture and infant pulmonary function testing data were collected at 6 months and one year of age during periods of clinical stability from infants diagnosed with CF by newborn screening. BALF was analyzed for total bacterial load by qPCR and for bacterial community composition by 16S ribosomal RNA sequencing. Clinical characteristics and standard BALF and NP culture results were recorded over five years of longitudinal follow-up. Results 12 BALF samples were collected from 8 infants with CF. Streptococcus, Burkholderia, Prevotella, Haemophilus, Porphyromonas, and Veillonella had the highest median relative abundance in infant CF BALF. Two of the 3 infants with repeat BALF had changes in their microbial communities over six months (Morisita-Horn diversity index 0.36, 0.38). Although there was excellent percent agreement between standard NP and BALF cultures, these techniques did not routinely detect all bacteria identified by sequencing. Conclusions BALF in asymptomatic CF infants contains complex microbiota, often missed by traditional culture of airway secretions. Anaerobic bacteria are commonly found in the lower airways of CF infants.	[Laguna, Theresa A.; Williams, Cynthia B.; Welchlin, Cole W.; Moen, Catherine E.] Univ Minnesota, Sch Med, Dept Pediat, Minneapolis, MN 55455 USA; [Laguna, Theresa A.; Williams, Cynthia B.; Welchlin, Cole W.; Moen, Catherine E.] Mason Childrens Hosp, Minneapolis, MN 55455 USA; [Wagner, Brandie D.] Univ Colorado Denver, Colorado Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO USA; [Stevens, Mark J.; Zemanick, Edith T.; Harris, Jonathan K.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA; [Robertson, Charles E.] Univ Colorado, Sch Med, Dept Med, Aurora, CO USA	University of Minnesota System; University of Minnesota Twin Cities; Children's Hospital Colorado; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Laguna, TA (corresponding author), Univ Minnesota, Sch Med, Dept Pediat, Minneapolis, MN 55455 USA.; Laguna, TA (corresponding author), Mason Childrens Hosp, Minneapolis, MN 55455 USA.	lagun005@umn.edu	Zemanick, Edith/D-5260-2017; Zemanick, Edith T/ABF-9455-2020	Zemanick, Edith/0000-0002-7507-9337; Zemanick, Edith T/0000-0002-7507-9337; Wagner, brandie/0000-0002-2745-0103; ROBERTSON, CHARLES/0000-0002-4136-4121; Harris, Jonathan/0000-0002-2378-4202; Laguna, Theresa/0000-0003-4255-0310	American Thoracic Society/Cystic Fibrosis Foundation [ATS/CFF CF-08-001]; National Institutes of Health [K12HD068322]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000114] Funding Source: NIH RePORTER	American Thoracic Society/Cystic Fibrosis Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by: 1. American Thoracic Society/Cystic Fibrosis Foundation [ATS/CFF CF-08-001]- T.A.L.; 2. National Institutes of Health [K12HD068322] - T.A.L.	American Thoracic Society, 2005, Am J Respir Crit Care Med, V172, P1463; Armstrong DS, 2005, PEDIATR PULM, V40, P500, DOI 10.1002/ppul.20294; Brennan S, 2005, THORAX, V60, P159, DOI 10.1136/thx.2004.026419; Burns JL, 2014, J CYST FIBROS, V13, P1, DOI 10.1016/j.jcf.2013.09.004; Castile R, 2000, PEDIATR PULM, V30, P215, DOI 10.1002/1099-0496(200009)30:3<215::AID-PPUL6>3.0.CO;2-V; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Coburn B, 2015, SCI REP-UK, V5, DOI 10.1038/srep10241; Dakin CJ, 2002, AM J RESP CRIT CARE, V165, P904, DOI 10.1164/ajrccm.165.7.2010139; Davis SD, 2007, AM J RESP CRIT CARE, V175, P943, DOI 10.1164/rccm.200603-343OC; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Farrell PM, 2003, PEDIATR PULM, V36, P230, DOI 10.1002/ppul.10336; Gilchrist FJ, 2011, ARCH DIS CHILD, V96, P215, DOI 10.1136/adc.2009.177618; Guss AM, 2011, ISME J, V5, P20, DOI 10.1038/ismej.2010.88; Gutierrez JP, 2001, EUR RESPIR J, V17, P281, DOI 10.1183/09031936.01.17202810; Hara N, 2012, J IMMUNOL, V189, P3805, DOI 10.4049/jimmunol.1201257; Hilliard TN, 2007, ARCH DIS CHILD, V92, P898, DOI 10.1136/adc.2006.105825; Hoen AG, 2015, J PEDIATR-US, V167, P138, DOI 10.1016/j.jpeds.2015.02.049; Kahn SE, 2008, DIABETES OBES METAB, V10, P63, DOI 10.1111/j.1463-1326.2008.00945.x; Keiser NW, 2015, AM J RESP CELL MOL, V52, P683, DOI 10.1165/rcmb.2014-0250OC; Klepac-Ceraj V, 2010, ENVIRON MICROBIOL, V12, P1293, DOI 10.1111/j.1462-2920.2010.02173.x; Laguna TA, 2015, AM J RESP CRIT CARE, V191; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; LiPuma JJ, 2015, J CLIN MICROBIOL, V53, P2006, DOI 10.1128/JCM.01218-15; Long FR, 2004, J PEDIATR-US, V144, P154, DOI 10.1016/j.jpeds.2003.09.026; Madan JC, 2012, MBIO, V3, DOI 10.1128/mBio.00251-12; Magurran A.E., 2004, MEASURING BIOL DIVER; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Mirkovic B, 2015, AM J RESP CRIT CARE, V192, P1314, DOI 10.1164/rccm.201505-0943OC; Moodie M, 2014, J PEDIATR-US, V165, P564, DOI 10.1016/j.jpeds.2014.05.031; Mott LS, 2012, THORAX, V67, P509, DOI 10.1136/thoraxjnl-2011-200912; Mott LS, 2013, J PEDIAT, P516, DOI [10.1136/thoraxjnl-2011-200912, DOI 10.1136/THORAXJNL2011200912]; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Paganin P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124348; Pezzulo AA, 2012, NATURE, V487, P109, DOI 10.1038/nature11130; Pillarisetti N, 2011, AM J RESP CRIT CARE, V184, P75, DOI 10.1164/rccm.201011-1892OC; Prevaes SMPJ, 2016, AM J RESP CRIT CARE, V193, P504, DOI 10.1164/rccm.201509-1759OC; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Ranganathan SC, 2002, AM J RESP CRIT CARE, V166, P1350, DOI 10.1164/rccm.2202041; Ranganathan SC, 2001, LANCET, V358, P1964, DOI 10.1016/S0140-6736(01)06970-7; Renwick J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109798; Robertson CE, 2013, BIOINFORMATICS, V29, P3100, DOI 10.1093/bioinformatics/btt526; Saiman L, 2003, INFECT CONT HOSP EP, V24, pS6, DOI 10.1086/503485; Saiman L, 2014, INFECT CONT HOSP EP, V35, pS1, DOI 10.1086/676882; Schloss PD, 2011, APPL ENVIRON MICROB, V77, P3219, DOI 10.1128/AEM.02810-10; Sly PD, 2009, AM J RESP CRIT CARE, V180, P146, DOI 10.1164/rccm.200901-0069OC; Stafler P, 2011, PEDIATR PULM, V46, P696, DOI 10.1002/ppul.21434; Stick SM, 2009, J PEDIATR-US, V155, P623, DOI 10.1016/j.jpeds.2009.05.005; Stocks J, 2001, EUR RESPIR J, V17, P302, DOI 10.1183/09031936.01.17203020; Stressmann FA, 2012, THORAX, V67, P867, DOI 10.1136/thoraxjnl-2011-200932; Wainwright CE, 2011, JAMA-J AM MED ASSOC, V306, P163, DOI 10.1001/jama.2011.954; Zemanick ET, 2015, ANN AM THORAC SOC, V12, P221, DOI 10.1513/AnnalsATS.201407-310OC; Zemanick ET, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062917; Zemanick ET, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015101; Zemanick ET, 2010, PEDIATR PULM, V45, P569, DOI 10.1002/ppul.21221; Zhao JC, 2012, P NATL ACAD SCI USA, V109, P5809, DOI 10.1073/pnas.1120577109	58	40	41	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167649	10.1371/journal.pone.0167649	http://dx.doi.org/10.1371/journal.pone.0167649			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930727	Green Published, gold, Green Submitted			2022-12-26	WOS:000389580900034
J	Park, SY; Choi, CH; Park, JM; Chun, M; Han, JH; Kim, JI				Park, So-Yeon; Choi, Chang Heon; Park, Jong Min; Chun, MinSoo; Han, Ji Hye; Kim, Jung-in			A Patient-Specific Polylactic Acid Bolus Made by a 3D Printer for Breast Cancer Radiation Therapy	PLOS ONE			English	Article							ELECTRON BOLUS; RADIOTHERAPY; PHOTON; BEAMS; CT	Purpose The aim of this study was to assess the feasibility and advantages of a patient-specific breast bolus made using a 3D printer technique. Methods We used the anthropomorphic female phantom with breast attachments, which volumes are 200, 300, 400, 500 and 650 cc. We simulated the treatment for a right breast patient using parallel opposed tangential fields. Treatment plans were used to investigate the effect of unwanted air gaps under bolus on the dose distribution of the whole breast. The commercial Super-Flex bolus and 3D-printed polylactic acid (PLA) bolus were applied to investigate the skin dose of the breast with the MOSFET measurement. Two boluses of 3 and 5 mm thicknesses were selected. Results There was a good agreement between the dose distribution for a virtual bolus generated by the TPS and PLA bolus. The difference in dose distribution between the virtual bolus and Super-Flex bolus was significant within the bolus and breast due to unwanted air gaps. The average differences between calculated and measured doses in a 200 and 300 cc with PLA bolus were not significant, which were -0.7% and -0.6% for 3mm, and -1.1% and -1.1% for 5 mm, respectively. With the Super-Flex bolus, however, significant dose differences were observed (-5.1% and -3.2% for 3mm, and -6.3% and -4.2% for 5 mm). Conclusion The 3D-printed solid bolus can reduce the uncertainty of the daily setup and help to overcome the dose discrepancy by unwanted air gaps in the breast cancer radiation therapy.	[Park, So-Yeon; Choi, Chang Heon; Park, Jong Min; Chun, MinSoo; Han, Ji Hye; Kim, Jung-in] Seoul Natl Univ Hosp, Dept Radiat Oncol, Seoul, South Korea; [Park, So-Yeon; Choi, Chang Heon; Park, Jong Min; Chun, MinSoo; Kim, Jung-in] Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Seoul, South Korea; [Park, So-Yeon; Choi, Chang Heon; Park, Jong Min; Chun, MinSoo; Han, Ji Hye; Kim, Jung-in] Seoul Natl Univ, Coll Med, Biomed Res Inst, Seoul, South Korea; [Park, Jong Min] Adv Inst Convergence Technol, Ctr Convergence Res Robot, Suwon, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU)	Kim, JI (corresponding author), Seoul Natl Univ Hosp, Dept Radiat Oncol, Seoul, South Korea.; Kim, JI (corresponding author), Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Seoul, South Korea.; Kim, JI (corresponding author), Seoul Natl Univ, Coll Med, Biomed Res Inst, Seoul, South Korea.	madangin@gmail.com	Chun, Minsoo/C-4493-2014	Chun, Minsoo/0000-0001-8578-9976	SNUH Research Fund [04-2015-0890]; Seoul National University Hospital Research Fund [04-2015-0890]	SNUH Research Fund; Seoul National University Hospital Research Fund	This research was supported by a grant of the SNUH Research Fund (grant number: 04-2015-0890). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by grant no. 04-2015-0890 from the Seoul National University Hospital Research Fund.	Andic F, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-41; Arac M, 2003, RADIOLOGY, V229, P195, DOI 10.1148/radiol.2291020642; Blitzblau RC, 2013, PRACT RADIAT ONCOL, V3, P241, DOI 10.1016/j.prro.2012.09.004; Burleson S, 2015, J APPL CLIN MED PHYS, V16, P166, DOI 10.1120/jacmp.v16i3.5247; Butson MJ, 2000, RADIAT MEAS, V32, P201, DOI 10.1016/S1350-4487(99)00276-0; Cho JH, 2003, J KOREAN SOC THER RA, V21, P82; Gupta T, 2011, CLIN ONCOL-UK, V23, P86, DOI 10.1016/j.clon.2010.08.029; Hsu SH, 2008, PHYS MED BIOL, V53, P2593, DOI 10.1088/0031-9155/53/10/010; Khan Y., 2013, J CANC THER, V04, P1251, DOI [10.4236/jct.2013.47147, DOI 10.4236/JCT.2013.47147]; Klein Eric E, 2003, J Appl Clin Med Phys, V4, P1, DOI 10.1120/1.1520113; Kudchadker R, 2002, MED PHYS, V29, P1337; Kudchadker R J, 2003, J Appl Clin Med Phys, V4, P321, DOI 10.1120/1.1621494; Lamb A, 1998, PHYS MED BIOL, V43, P1133, DOI 10.1088/0031-9155/43/5/006; LOEVINGER R, 1981, MED PHYS, V8, P1, DOI 10.1118/1.594901; Low DA, 1995, INT J RADIAT ONCOL, V33, P1127, DOI 10.1016/0360-3016(95)00257-X; Mihaylov IB, 2009, RADIOTHER ONCOL, V93, P147, DOI 10.1016/j.radonc.2009.05.008; Park JM, 2014, BR J RADIOL, V87; Park K, 2016, ONCOTARGET, P1; Perkins GH, 2001, INT J RADIAT ONCOL, V51, P1142, DOI 10.1016/S0360-3016(01)01744-8; Su S., 2014, J APPL CLIN MED PHYS, V15, P4831, DOI [DOI 10.1120/JACMP.V15I4.4831, 10.1120/jacmp.v15i4.4831]; Sung W, 2012, RADIAT ONCOL J, V30, P27, DOI 10.3857/roj.2012.30.1.27; TARVER RD, 1988, AM J ROENTGENOL, V151, P1117, DOI 10.2214/ajr.151.6.1117; Turner JY, 2016, BRIT J RADIOL, V89, DOI 10.1259/bjr.20160060; Vyas V, 2013, MED DOSIM, V38, P268, DOI 10.1016/j.meddos.2013.02.007; Yoon Mee Sun, 2012, [PROGRESS in MEDICAL PHYSICS, 의학물리], V23, P219; Zou W, 2015, J APPL CLIN MED PHYS, V16, P90, DOI 10.1120/jacmp.v16i1.5090	26	34	37	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0168063	10.1371/journal.pone.0168063	http://dx.doi.org/10.1371/journal.pone.0168063			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930717	Green Published, Green Submitted, gold			2022-12-26	WOS:000389580900077
J	Wang, L; Wu, ZW; Li, Y; Dong, JG; Zhang, LY; Liang, PS; Liu, YL; Zhao, YH; Song, CX				Wang, Lei; Wu, Zhi-wei; Li, Yan; Dong, Jian-guo; Zhang, Le-yi; Liang, Peng-shuai; Liu, Yan-ling; Zhao, Ya-hua; Song, Chang-xu			Profiling and Identification of Novel Immunogenic Proteins of Staphylococcus hyicus ZC-4 by Immunoproteomic Assay	PLOS ONE			English	Article							SUBCELLULAR-LOCALIZATION; EXUDATIVE EPIDERMITIS; VIRULENCE GENES; CELL-DEATH; AUREUS; PATHOGENESIS; PURIFICATION; RESISTANCE; EXPRESSION; PREDICTION	Staphylococcus hyicus has caused great losses in the swine industry by inducing piglet exudative epidermitis (EE), sow mastitis, metritis, and other diseases and is a threat to human health. The pathogenesis of EE, sow mastitis, and metritis involves the interaction between the host and virulent protein factors of S. hyicus, however, the proteins that interact with the host, especially the host immune system, are unclear. In the present study, immunoproteomics was used to screen the immunogenic proteins of S. hyicus strain ZC-4. The cellular and secreted proteins of S. hyicus strain ZC-4 were obtained, separated by 2D gel electrophoresis, and further analyzed by western blot with S. hyicus strain ZC-4-infected swine serum. Finally, 28 specific immunogenic proteins including 15 cellular proteins and 13 secreted proteins, 26 of which were novel immunogenic proteins from S. hyicus, were identified by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. To further verify their immunogenicity, two representative proteins (acetate kinase [cellular] and enolase [secreted]) were chosen for expression, and the resultant recombinant proteins could react with S. hyicus ZC-4-infected swine serum. In mice, both acetate kinase and enolase activated the immune response by increasing G-CSF and MCP-5 expression, and acetate kinase further activated the immune response by increasing IL-12 expression. Enolase can confer better protection against S. hycius than acetate kinase in mice. For the first time to our knowledge, our results provide detailed descriptions of the cellular and secreted proteins of S. hyicus strain ZC-4. These immunogenic proteins may contribute to investigation and elucidation of the pathogenesis of S. hyicus and provide new candidates for subunit vaccines in the future.	[Wang, Lei; Wu, Zhi-wei; Dong, Jian-guo; Zhang, Le-yi; Liang, Peng-shuai; Liu, Yan-ling; Zhao, Ya-hua; Song, Chang-xu] South China Agr Univ, Coll Anim Sci, Guangzhou, Guangdong, Peoples R China; [Wang, Lei; Wu, Zhi-wei; Dong, Jian-guo; Zhang, Le-yi; Liang, Peng-shuai; Liu, Yan-ling; Zhao, Ya-hua; Song, Chang-xu] South China Agr Univ, Natl Engn Ctr Swine Breeding Ind, Guangzhou, Guangdong, Peoples R China; [Li, Yan; Song, Chang-xu] Guangdong Acad Agr Sci, Inst Anim Hlth, Guangzhou, Guangdong, Peoples R China; [Dong, Jian-guo] Xinyang Coll Agr & Forestry, Xinyang Anim Dis Prevent & Control Engn Res Ctr, Xinyang, Peoples R China	South China Agricultural University; South China Agricultural University; Guangdong Academy of Agricultural Sciences	Zhao, YH; Song, CX (corresponding author), South China Agr Univ, Coll Anim Sci, Guangzhou, Guangdong, Peoples R China.; Zhao, YH; Song, CX (corresponding author), South China Agr Univ, Natl Engn Ctr Swine Breeding Ind, Guangzhou, Guangdong, Peoples R China.	Yahuazhao@yeah.net; cxsong2004@163.com	liu, yan/HCI-5542-2022; liu, yan/HGV-1365-2022	Song, Chang-xu/0000-0001-5311-0439	Guangdong Provincial Projects [2012A020200014, 2013B020202002]; Guangzou City Project [201508020062]	Guangdong Provincial Projects; Guangzou City Project	This work was supported by the Guangdong Provincial Projects (2012A020200014, and 2013B020202002) and Guangzou City Project (201508020062). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alverdy J, 2000, ANN SURG, V232, P480, DOI 10.1097/00000658-200010000-00003; Andresen LO, 1997, MICROB PATHOGENESIS, V22, P113, DOI 10.1006/mpat.1996.0097; Avilan L., 2011, ENZYME RES, V2011, DOI DOI 10.4061/2011/932549; Basavanna S, 2009, INFECT IMMUN, V77, P3412, DOI 10.1128/IAI.01543-08; Cadieux B, 2014, J BACTERIOL, V196, P4044, DOI 10.1128/JB.02044-14; Casas-Godoy L, 2012, METHODS MOL BIOL, V861, P3, DOI 10.1007/978-1-61779-600-5_1; Claro T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018748; De Leon G, 2008, CANCER BIOL THER, V7, P833, DOI 10.4161/cbt.7.6.5839; DEMLEITNER G, 1994, FEMS MICROBIOL LETT, V121, P189, DOI 10.1016/0378-1097(94)90126-0; DEVRIESE LA, 1978, INT J SYST BACTERIOL, V28, P482, DOI 10.1099/00207713-28-4-482; Dutta S, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0914-x; FARRIAUX JP, 1974, Z KINDERHEILKD, V118, P231, DOI 10.1007/BF00464614; Foster TJ, 2014, NAT REV MICROBIOL, V12, P49, DOI 10.1038/nrmicro3161; Fudaba Y, 2005, MICROB PATHOGENESIS, V39, P171, DOI 10.1016/j.micpath.2005.08.003; Gorg A, 2004, PROTEOMICS, V4, P3665, DOI 10.1002/pmic.200401031; Gupta MK, 2009, J PROTEOME RES, V8, P2319, DOI 10.1021/pr8009462; Hu CY, 2012, BIOCHEM BIOPH RES CO, V419, P617, DOI 10.1016/j.bbrc.2012.02.057; Hughes MJG, 2002, INFECT IMMUN, V70, P1254, DOI 10.1128/IAI.70.3.1254-1259.2002; JONES LD, 1961, VET MED, V14, P1028; KOBAYASHI M, 1989, J EXP MED, V170, P827, DOI 10.1084/jem.170.3.827; Kofoed CB, 2002, ANTIMICROB AGENTS CH, V46, P3339, DOI 10.1128/AAC.46.11.3339-3342.2002; Krucher NA, 2006, EXP CELL RES, V312, P2757, DOI 10.1016/j.yexcr.2006.05.002; Kurien BT, 2011, METHODS MOL BIOL, V717, P55, DOI 10.1007/978-1-61779-024-9_3; Langan KJ, 1997, PROTOPLASMA, V196, P87, DOI 10.1007/BF01281062; Lee VT, 2001, GENE DEV, V15, P1725, DOI 10.1101/gad.896801; LINDMARK R, 1983, J IMMUNOL METHODS, V62, P1, DOI 10.1016/0022-1759(83)90104-7; Liu KY, 2006, MOL CELL BIOCHEM, V288, P65, DOI 10.1007/s11010-006-9119-5; Liu XK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057959; Mei JM, 1997, MOL MICROBIOL, V26, P399, DOI 10.1046/j.1365-2958.1997.5911966.x; Mitchell RA, 2002, P NATL ACAD SCI USA, V99, P345, DOI 10.1073/pnas.012511599; Rosander A, 2011, VET MICROBIOL, V149, P273, DOI 10.1016/j.vetmic.2010.10.011; Sadykov MR, 2013, J BACTERIOL, V195, P3035, DOI 10.1128/JB.00042-13; Saha S, 2006, PROTEINS, V65, P40, DOI 10.1002/prot.21078; Sato H, 1990, Kitasato Arch Exp Med, V63, P119; Schneider A, 2005, J CLIN INVEST, V115, P2083, DOI 10.1172/JCI23559; SCHULZ W, 1969, Archiv fuer Experimentelle Veterinaermedizin, V23, P415; Shao Changli, 2012, Am J Biomed Sci, V4, P85; Shen HB, 2009, PROTEIN PEPTIDE LETT, V16, P1478, DOI 10.2174/092986609789839322; Takeuchi S, 2000, VET MICROBIOL, V71, P169, DOI 10.1016/S0378-1135(99)00158-3; Trinchieri Giorgio, 1992, Progress in Growth Factor Research, V4, P355, DOI 10.1016/0955-2235(92)90016-B; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Veiga-Malta I, 2004, CELL MICROBIOL, V6, P79, DOI 10.1046/j.1462-5822.2003.00344.x; Wang J, 2015, INT J MOL SCI, V16, P14490, DOI 10.3390/ijms160714490; WEGENER HC, 1993, CAN J VET RES, V57, P119; WEGENER HC, 1993, VET MICROBIOL, V34, P363, DOI 10.1016/0378-1135(93)90061-B; Winterhoff N, 2002, J BACTERIOL, V184, P6768, DOI 10.1128/JB.184.24.6768-6776.2002; Yang L, 2003, BIOPHYS J, V84, P509, DOI 10.1016/S0006-3495(03)74870-X; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249	48	2	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167686	10.1371/journal.pone.0167686	http://dx.doi.org/10.1371/journal.pone.0167686			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930728	Green Published, Green Submitted, gold			2022-12-26	WOS:000389580900038
J	Santostasi, NL; Bonizzoni, S; Bearzi, G; Eddy, L; Gimenez, O				Santostasi, Nina Luisa; Bonizzoni, Silvia; Bearzi, Giovanni; Eddy, Lavinia; Gimenez, Olivier			A Robust Design Capture-Recapture Analysis of Abundance, Survival and Temporary Emigration of Three Odontocete Species in the Gulf of Corinth, Greece	PLOS ONE			English	Article							BOTTLE-NOSED DOLPHINS; BEAKED COMMON DOLPHINS; TURSIOPS-TRUNCATUS; DELPHINUS-DELPHIS; CONSERVATION; PATTERNS; CALIFORNIA; VAQUITA; WHALES; MODELS	While the Mediterranean Sea has been designated as a Global Biodiversity Hotspot, assessments of cetacean population abundance are lacking for large portions of the region, particularly in the southern and eastern basins. The challenges and costs of obtaining the necessary data often result in absent or poor abundance information. We applied capturere-capture models to estimate abundance, survival and temporary emigration of odontocete populations within a 2,400 km(2) semi-enclosed Mediterranean bay, the Gulf of Corinth. Boat surveys were conducted in 2011-2015 to collect photo-identification data on striped dolphins Stenella coeruleoalba, short-beaked common dolphins Delphinus delphis (always found together with striped dolphins in mixed groups) and common bottlenose dolphins Tursiops truncatus, totaling 1,873 h of tracking. After grading images for quality and marking distinctiveness, 23,995 high-quality photos were included in a striped and common dolphin catalog, and 2,472 in a bottlenose dolphin catalog. The proportions of striped and common dolphins were calculated from the photographic sample and used to scale capture-recapture estimates. Best-fitting robust design capture-recapture models denoted no temporary emigration between years for striped and common dolphins, and random temporary emigration for bottlenose dolphins, suggesting different residency patterns in agreement with previous studies. Average estimated abundance over the five years was 1,331 (95% CI 1,122-1,578) striped dolphins, 22 (16-32) common dolphins, 55 (36-84) "intermediate" animals (potential striped x common dolphin hybrids) and 38 (32-46) bottlenose dolphins. Apparent survival was constant for striped, common and intermediate dolphins (0.94, 95% CI 0.92-0.96) and year-dependent for bottlenose dolphins (an average of 0.85, 95% CI 0.76-0.95). Our work underlines the importance of long-term monitoring to contribute reliable baseline information that can help assess the conservation status of wildlife populations.	[Santostasi, Nina Luisa; Bonizzoni, Silvia; Bearzi, Giovanni; Eddy, Lavinia] Dolphin Biol & Conservat, Oria, Italy; [Santostasi, Nina Luisa; Gimenez, Olivier] Ctr Ecol Fonct & Evolut, Montpellier, France; [Santostasi, Nina Luisa; Bonizzoni, Silvia; Bearzi, Giovanni; Eddy, Lavinia] OceanCare, Wadenswil, Switzerland; [Santostasi, Nina Luisa] Sapienza Univ Roma, Rome, Italy	UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Sapienza University Rome	Santostasi, NL (corresponding author), Dolphin Biol & Conservat, Oria, Italy.; Santostasi, NL (corresponding author), Ctr Ecol Fonct & Evolut, Montpellier, France.; Santostasi, NL (corresponding author), OceanCare, Wadenswil, Switzerland.; Santostasi, NL (corresponding author), Sapienza Univ Roma, Rome, Italy.	n.santostasi@gmail.com	Gimenez, Olivier/G-4281-2010; Bonizzoni, Silvia/AAC-4612-2021; Bearzi, Giovanni/L-6115-2016	Bonizzoni, Silvia/0000-0001-7331-4439; Bearzi, Giovanni/0000-0001-6633-3324; Eddy, Lavinia/0000-0002-2934-7441; Gimenez, Olivier/0000-0001-7001-5142	OceanCare; Sapienza University of Rome	OceanCare; Sapienza University of Rome	The collection of field data was largely funded by OceanCare, a non-profit non-governmental organization committed to ocean conservation (https://www.oceancare org/en/). No grant number is available. OceanCare provided support in the form of salaries for co-authors GB and SB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Nina Luisa Santostasi was supported by a research grant by Sapienza University of Rome (http://www.uniroma1.it/didattica/borse-di-studio/borse-di-perfezionamento-allestero). No grant number is available	Aguilar A., 2012, IUCN RED LIST THREAT, V2012, DOI [10.2305/IUCN.UK.2012-1.RLTS.T16674437A16674052.en, DOI 10.2305/IUCN.UK.2012-1.RLTS.T16674437A16674052.EN]; Allendorf FW, 2001, TRENDS ECOL EVOL, V16, P613, DOI 10.1016/S0169-5347(01)02290-X; Amstrup S, 2005, HANDBOOK OF CAPTURE-RECAPTURE ANALYSIS, P36; [Anonymous], 1982, ESTIMATION ANIMAL AB; [Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], 2007, 3 M CONTR PART ACCOB; [Anonymous], 1951, U CALIFORNIA PUBLICA; BALLANCE LT, 1992, MAR MAMMAL SCI, V8, P262, DOI 10.1111/j.1748-7692.1992.tb00408.x; Bearzi G, 2003, MAMMAL REV, V33, P224, DOI 10.1046/j.1365-2907.2003.00032.x; Bearzi G., 2003, IUCN RED LIST THREAT; Bearzi G, 2012, IUCN RED LIST THREAT, V2012; Bearzi Giovanni, 2008, Endangered Species Research, V5, P1, DOI 10.3354/esr00103; Bearzi G, 2008, AQUAT CONSERV, V18, P130, DOI 10.1002/aqc.843; Bearzi G, 2011, MAR MAMMAL SCI, V27, pE165, DOI 10.1111/j.1748-7692.2010.00448.x; Bearzi G, 2011, J ETHOL, V29, P369, DOI 10.1007/s10164-010-0245-x; Bejder Lars, 2012, Pacific Conservation Biology, V18, P22; Bejder L, 2006, CONSERV BIOL, V20, P1791, DOI 10.1111/j.1523-1739.2006.00540.x; Berrow S, 2012, AQUAT MAMM, V38, P136, DOI 10.1578/AM.38.2.2012.136; Birkun  Jr A, 2010, CONSERVING WHALES DO; Brown AM, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00004; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burnham KP, 1987, AM FISHERIES SOC MON; Calambokidis J, 2004, MAR MAMMAL SCI, V20, P63, DOI 10.1111/j.1748-7692.2004.tb01141.x; Cantor M, 2012, MAR MAMMAL SCI, V28, P63, DOI 10.1111/j.1748-7692.2010.00456.x; Choquet R, 2009, ECOGRAPHY, V32, P1071, DOI 10.1111/j.1600-0587.2009.05968.x; Crossman CA, 2016, ECOL EVOL, V6, P1293, DOI 10.1002/ece3.1913; Currey RJC, 2009, BIOL CONSERV, V142, P1570, DOI 10.1016/j.biocon.2009.02.036; Currey RJC, 2009, AQUAT CONSERV, V19, P658, DOI 10.1002/aqc.1015; de Silva S, 2011, BIOL CONSERV, V144, P1742, DOI 10.1016/j.biocon.2011.03.011; Defran RH, 1999, MAR MAMMAL SCI, V15, P381, DOI 10.1111/j.1748-7692.1999.tb00808.x; Fortuna CM., 2006, THESIS; Frantzis A., 2003, Journal of Cetacean Research and Management, V5, P219; Frantzis Alexandros, 2002, Aquatic Mammals, V28, P188; Gary AN., 2015, FISHMETHODS FISHERY; Gaspari S, 2015, AQUAT CONSERV, V25, P212, DOI 10.1002/aqc.2415; GERRODETTE T, 1993, WILDLIFE SOC B, V21, P515; GERRODETTE T, 1987, ECOLOGY, V68, P1364, DOI 10.2307/1939220; Gkafas A, 2007, P 10 INT C ENV SCI T; Gkafas GA, 2011, THESIS; Gormley AM, 2005, MAR MAMMAL SCI, V21, P204, DOI 10.1111/j.1748-7692.2005.tb01224.x; Hammond P.S., 1990, Reports of the International Whaling Commission Special Issue, P135; Hammond P. S., 2008, IUCN RED LIST THREAT; Hammond PS, 2012, IUCN RED LIST THREAT, DOI 10. 2305/IUCN. UK. 2012. RLTS. T41714A17600466. en; Hammond PS, 1990, IWC, V12; Hansen L.J., 1990, Reports of the International Whaling Commission Special Issue, P101; Iatrou M, 2010, RAPP COMM INT MER ME, V39, P260; Iatrou M., 2010, B GEOLOGICAL SOC GRE, P1018; Iatrou M, 2013, THESIS; IUCN, 2012, IUCN RED LIST CATEGO, V2nd ed., P32; IUCN, 2012, MAR MAMM SEA TURTL M; IUCN, 2003, GUID APPL IUCN RED L; Karanth KU, 2006, ECOLOGY, V87, P2925, DOI 10.1890/0012-9658(2006)87[2925:ATPDUP]2.0.CO;2; Kendall W. L., 2004, Animal Biodiversity and Conservation, V27, P97; Kendall WL, 1997, ECOLOGY, V78, P563; KENDALL WL, 1995, BIOMETRICS, V51, P293, DOI 10.2307/2533335; Laake JL., 2013, RMARK R INTERFACE AN; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Lukoschek V, 2008, WILDLIFE RES, V35, P593, DOI 10.1071/WR07021; Manlik O, 2016, ECOL EVOL, V6, P3496, DOI 10.1002/ece3.2130; Mansur RM, 2012, MAR MAMMAL SCI, V28, P561, DOI 10.1111/j.1748-7692.2011.00520.x; Micheli F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079889; MOURA A, 2010, THESIS; Moura AE, 2013, J EVOLUTION BIOL, V26, P63, DOI 10.1111/jeb.12032; Nicholson K, 2012, MAR FRESHWATER RES, V63, P1059, DOI 10.1071/MF12210; OTIS DL, 1978, WILDLIFE MONOGR, P1; Parra GJ, 2006, BIOL CONSERV, V129, P167, DOI 10.1016/j.biocon.2005.10.031; Phillips N. M, 2014, NMFSSEFSC665 NOAA; Pledger S, 2003, BIOMETRICS, V59, P786, DOI 10.1111/j.0006-341X.2003.00092.x; Pleslic G, 2015, AQUAT CONSERV, V25, P125, DOI 10.1002/aqc.2416; POLLOCK KH, 1990, WILDLIFE MONOGR, P1; POLLOCK KH, 1982, J WILDLIFE MANAGE, V46, P752, DOI 10.2307/3808568; Pradel R., 2005, Animal Biodiversity and Conservation, V28, P189; Pradel R, 1997, BIOMETRICS, V53, P60, DOI 10.2307/2533097; Read AJ, 2003, MAR MAMMAL SCI, V19, P59, DOI 10.1111/j.1748-7692.2003.tb01092.x; Santostasi N. L., 2016, P 30 ANN C EUR CET S; Schaub M, 2004, ECOLOGY, V85, P2107, DOI 10.1890/03-3110; Schwarz CJ, 1996, BIOMETRICS, V52, P860, DOI 10.2307/2533048; Schwarz CJ, 1999, STAT SCI, V14, P427; Silva MA, 2009, MAR ECOL PROG SER, V392, P263, DOI 10.3354/meps08233; Silva MA, 2008, MAR BIOL, V156, P179, DOI 10.1007/s00227-008-1075-z; Slooten Elisabeth, 2007, Endangered Species Research, V3, P169, DOI 10.3354/esr003169; Smith HC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076574; Stolen MK, 2003, MAR MAMMAL SCI, V19, P630, DOI 10.1111/j.1748-7692.2003.tb01121.x; Taylor BL, 2007, MAR MAMMAL SCI, V23, P157, DOI 10.1111/j.1748-7692.2006.00092.x; Taylor BL, 1999, MAR MAMMAL SCI, V15, P1004, DOI 10.1111/j.1748-7692.1999.tb00875.x; TAYLOR BL, 1993, CONSERV BIOL, V7, P489, DOI 10.1046/j.1523-1739.1993.07030489.x; Tezanos-Pinto G, 2013, MAR MAMMAL SCI, V29, pE390, DOI 10.1111/mms.12008; Thompson PM, 2000, CONSERV BIOL, V14, P1253, DOI 10.1046/j.1523-1739.2000.00099-410.x; Tyne JA, 2016, BIOL CONSERV, V201, P252, DOI 10.1016/j.biocon.2016.07.024; Tyne JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086132; Urian K, 2015, MAR MAMMAL SCI, V31, P298, DOI 10.1111/mms.12141; Urian KW., 1999, NMFSSEFSC425 NOAA; Vermeulen E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119182; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; WILLIAMS JA, 1993, CAN J ZOOL, V71, P2080, DOI 10.1139/z93-293; Wilson B, 1999, ECOL APPL, V9, P288, DOI 10.1890/1051-0761(1999)009[0288:ESAATI]2.0.CO;2; Wolf DE, 2001, CONSERV BIOL, V15, P1039, DOI 10.1046/j.1523-1739.2001.0150041039.x; WURSIG B, 1977, SCIENCE, V198, P755, DOI 10.1126/science.198.4318.755; Wursig B., 1990, Reports of the International Whaling Commission Special Issue, P43; Zeh J, 2002, BIOMETRICS, V58, P832, DOI 10.1111/j.0006-341X.2002.00832.x	100	25	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2016	11	12							e0166650	10.1371/journal.pone.0166650	http://dx.doi.org/10.1371/journal.pone.0166650			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4NG	27926926	Green Published, gold, Green Submitted			2022-12-26	WOS:000389578800004
J	Xu, CS; Kozlov, G; Wong, K; Gehring, K; Cygler, M				Xu, Caishuang; Kozlov, Guennadi; Wong, Kathy; Gehring, Kalle; Cygler, Miroslaw			Crystal Structure of the Salmonella Typhimurium Effector GtgE	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; CONTAINING VACUOLE; HOST-CELLS; COMPARTMENTS; INHIBITION; MATURATION; VIRULENCE; DELIVERY; NETWORK; PATHWAY	Salmonella Typhimurium GtgE is an effector protein contributing to the virulence of this pathogen. It was shown to possess highly selective proteolytic activity against a subset of Rab proteins that helps in evasion of Salmonella-containing vacuole (SCV) fusion with lysosomes. Cys45, His151 and Asp169 are essential for proteolytic activity. The structure of a C-terminal fragment GtgE(79-214) indicated the presence of a papain-like fold. Here, we present the structure of GtgE(17-214) containing the fully assembled active site. The design of a proteolytically active and crystallizable GtgE construct was aided by NMR spectroscopy. The protein indeed displays papain-like fold with an assembled Cys-His-Asp catalytic triad. Like the full-length GtgE, the crystallizable construct showed low activity in vitro for its known substrates, Rab32 and Rab29. NMR titration experiments showed at most very weak binding of GtgE to the peptide encompassing the Rab29 cleavage site. In view of the low in vitro activity and poor substrate binding, we postulate that the function of GtgE in vivo as a proteolytic enzyme is dependent on other factor(s), such as a protein partner or interactions with the SCV membrane, which stimulate(s) GtgE activity in vivo.	[Xu, Caishuang; Cygler, Miroslaw] Univ Saskatchewan, Dept Biochem, Saskatoon, SK, Canada; [Kozlov, Guennadi; Wong, Kathy; Gehring, Kalle; Cygler, Miroslaw] McGill Univ, Dept Biochem, Grp Rech Axe Struct Prot, Montreal, PQ, Canada	University of Saskatchewan; McGill University	Cygler, M (corresponding author), Univ Saskatchewan, Dept Biochem, Saskatoon, SK, Canada.; Cygler, M (corresponding author), McGill Univ, Dept Biochem, Grp Rech Axe Struct Prot, Montreal, PQ, Canada.	miroslaw.cygler@usask.ca	Gehring, Kalle/N-2945-2019; Gehring, Kalle/I-4403-2013	Gehring, Kalle/0000-0001-6500-1184; Gehring, Kalle/0000-0001-6500-1184	CIHR [GSP-48370]; CIHR Genomics grant [GSP-48370]; NSF & NIH/NIGMS via NSF award [DMR-0225180]; NIH/NCRR [RR-01646]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER	CIHR(Canadian Institutes of Health Research (CIHR)); CIHR Genomics grant; NSF & NIH/NIGMS via NSF award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)National Science Foundation (NSF)); NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Support was provided by CIHR, GSP-48370 [http://www.cihr-irsc.gc.ca/e/]; The authors declare no conflict of interests. We would like to thank Dr. Tara Sprules at the Quebec/Eastern Canada High Field NMR Facility for assistance with NMR data collection and analysis. This work was funded by a CIHR Genomics grant GSP-48370 to MC and KG. Data were acquired at the Macromolecular Diffraction (MacCHESS) facility at the Cornell High Energy Synchrotron Source (CHESS). CHESS is supported by the NSF & NIH/NIGMS via NSF award DMR-0225180, and the MacCHESS resource is supported by NIH/NCRR award RR-01646.	Bakowski MA, 2008, TRAFFIC, V9, P2022, DOI 10.1111/j.1600-0854.2008.00827.x; Brumell JH, 2003, TRAFFIC, V4, P36, DOI 10.1034/j.1600-0854.2003.40106.x; Brumell JH, 2004, CURR OPIN MICROBIOL, V7, P78, DOI 10.1016/j.mib.2003.12.005; Bujny MV, 2008, J CELL SCI, V121, P2027, DOI 10.1242/jcs.018432; Cantalupo G, 2001, EMBO J, V20, P683, DOI 10.1093/emboj/20.4.683; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eschenfeldt William H., 2009, V498, P105, DOI 10.1007/978-1-59745-196-3_7; Figueroa-Bossi N, 1999, MOL MICROBIOL, V33, P167, DOI 10.1046/j.1365-2958.1999.01461.x; Grishin AM, 2014, STRUCTURE, V22, P878, DOI 10.1016/j.str.2014.04.010; Haghjoo E, 2004, P NATL ACAD SCI USA, V101, P4614, DOI 10.1073/pnas.0400932101; Ho TD, 2002, J BACTERIOL, V184, P5234, DOI 10.1128/JB.184.19.5234-5239.2002; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kim DW, 2005, P NATL ACAD SCI USA, V102, P14046, DOI 10.1073/pnas.0504466102; Knodler LA, 2003, TRAFFIC, V4, P587, DOI 10.1034/j.1600-0854.2003.00118.x; Kohler AC, 2014, ACTA CRYSTALLOGR D, V70, P384, DOI 10.1107/S1399004713028393; Kuijl C, 2007, NATURE, V450, P725, DOI 10.1038/nature06345; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Mallo GV, 2008, J CELL BIOL, V182, P741, DOI 10.1083/jcb.200804131; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGhie EJ, 2009, CURR OPIN MICROBIOL, V12, P117, DOI 10.1016/j.mib.2008.12.001; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pfeffer SR, 2013, CURR OPIN CELL BIOL, V25, P414, DOI 10.1016/j.ceb.2013.04.002; Ramsden AE, 2007, TRENDS MICROBIOL, V15, P516, DOI 10.1016/j.tim.2007.10.002; Smith AC, 2007, J CELL BIOL, V176, P263, DOI 10.1083/jcb.200611056; Spano S, 2008, CELL HOST MICROBE, V3, P30, DOI 10.1016/j.chom.2007.11.001; Spano S, 2012, SCIENCE, V338, P960, DOI 10.1126/science.1229224; Spano S, 2011, P NATL ACAD SCI USA, V108, P18418, DOI 10.1073/pnas.1111959108; Steele-Mortimer O, 2008, CURR OPIN MICROBIOL, V11, P38, DOI 10.1016/j.mib.2008.01.002; Stenmark H, 2001, GENOME BIOL, V2; TOUCHOT N, 1987, P NATL ACAD SCI USA, V84, P8210, DOI 10.1073/pnas.84.23.8210; Tsuge H, 1999, BIOCHEM BIOPH RES CO, V266, P411, DOI 10.1006/bbrc.1999.1830; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	35	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2016	11	12							e0166643	10.1371/journal.pone.0166643	http://dx.doi.org/10.1371/journal.pone.0166643			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4MY	27923041	Green Published, Green Submitted, gold			2022-12-26	WOS:000389577900001
J	Varthaman, A; Moreau, HD; Maurin, M; Benaroch, P				Varthaman, Aditi; Moreau, Helene D.; Maurin, Mathieu; Benaroch, Philippe			TLR3-Induced Maturation of Murine Dendritic Cells Regulates CTL Responses by Modulating PD-L1 Trafficking	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-3; ENDOGENOUS IFN-BETA; DOUBLE-STRANDED-RNA; EFFECTOR DIFFERENTIATION; ANTITUMOR IMMUNITY; LIGAND; TLR3; ANTIGEN; ACTIVATION; CANCER	Targeting TLR3 through formulations of polyl:C is widely studied as an adjuvant in cancer immunotherapy. The efficacy of such targeting has been shown to increase in combination with anti-PD-L1 treatment. Nevertheless, the mechanistic details of the effect of polyl:C on DC maturation and the impact on T-DC interactions upon PD-L1 blockade is largely unknown. Here we found that although DC treatment with polyl:C induced a potent inflammatory response including the production of type I interferon, polyl:C treatment of DCs impaired activation of peptide specific CD8(+) T cells mainly due to PD-L1. Interestingly, we found that PD-L1 trafficking to the cell surface is regulated in two waves in polyl:C-treated DCs. One induced upon overnight treatment and a second more rapid one, specific to polyl: C treatment, was induced upon CD40 signaling leading to a further increase in surface PD-L1 in DCs. The polyl:C-induced cell surface PD-L1 reduced the times of contact between DCs and T cells, potentially accounting for limited T cell activation. Our results reveal a novel CD40-dependent regulation of PD-L1 trafficking induced upon TLR3 signaling that dictates its inhibitory activity. These results provide a mechanistic framework to understand the efficacy of anti-PD-L1 cancer immunotherapy combined with TLR agonists.	[Varthaman, Aditi; Moreau, Helene D.; Maurin, Mathieu; Benaroch, Philippe] PSL Res Univ, Inst Curie, INSERM, U 932, Paris, France; [Varthaman, Aditi] Univ Oxford, Weatherall Inst Mol Med, Radcliffe Dept Med, MRC Human Immunol Unit, Oxford, England	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Cite; University of Oxford	Benaroch, P (corresponding author), PSL Res Univ, Inst Curie, INSERM, U 932, Paris, France.	benaroch@curie.fr		Varthaman, Aditi/0000-0002-8703-5534; Moreau, Helene/0000-0001-5715-6864; Benaroch, Philippe/0000-0002-2655-0129	Fondation ARC pour la recherche sur le Cancer; program "Investissements d'Avenir" [ANR-10-IDEX-0001-02 PSL*, ANR-11-LABX-0043, ANR-09-MIEN-021-01, ANR 15 CE13 0009 01]; Insitut National du Cancer [INCA_9301]	Fondation ARC pour la recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer); program "Investissements d'Avenir"(French National Research Agency (ANR)); Insitut National du Cancer	HDM was supported by a fellowship from the Fondation ARC pour la recherche sur le Cancer. This work has received support under the program "Investissements d'Avenir" launched by the French Government and implemented by the Agence Nationale de la Recherche with the reference (ANR-10-IDEX-0001-02 PSL* and ANR-11-LABX-0043), ANR-09-MIEN-021-01, ANR 15 CE13 0009 01. The work was also supported by Insitut National du Cancer (INCA_9301). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Aumeunier A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011484; BANCHEREAU J, 1994, ANNU REV IMMUNOL, V12, P881, DOI 10.1146/annurev.iy.12.040194.004313; Bergtold A, 2005, IMMUNITY, V23, P503, DOI 10.1016/j.immuni.2005.09.013; Boes M, 2015, CANCER LETT, V361, P49, DOI 10.1016/j.canlet.2015.02.027; Caskey M, 2011, J EXP MED, V208, P2357, DOI 10.1084/jem.20111171; Cavassani KA, 2008, J EXP MED, V205, P2609, DOI 10.1084/jem.20081370; Daffis S, 2008, J VIROL, V82, P10349, DOI 10.1128/JVI.00935-08; Deng LF, 2014, J CLIN INVEST, V124, P687, DOI 10.1172/JCI67313; Estornes Y, 2012, CELL DEATH DIFFER, V19, P1482, DOI 10.1038/cdd.2012.22; Fife BT, 2009, NAT IMMUNOL, V10, P1185, DOI 10.1038/ni.1790; Gatti G, 2013, EUR J IMMUNOL, V43, P1849, DOI 10.1002/eji.201242902; Gibbons RM, 2014, CANCER IMMUNOL IMMUN, V63, P859, DOI 10.1007/s00262-014-1563-6; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Honda T, 2014, IMMUNITY, V40, P235, DOI 10.1016/j.immuni.2013.11.017; Kariko K, 2004, J BIOL CHEM, V279, P12542, DOI 10.1074/jbc.M310175200; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Lafaille FG, 2012, NATURE, V491, P769, DOI 10.1038/nature11583; Nagato T, 2014, CLIN CANCER RES, V20, P1223, DOI 10.1158/1078-0432.CCR-13-2781; Ngoi SM, 2012, P NATL ACAD SCI USA, V109, P10486, DOI 10.1073/pnas.1202607109; Nocera DA, 2016, J IMMUNOL, DOI [10.1084/jem.20081370, 10.1172/JCI67313, DOI 10.1084/JEM.20081370]; Pentcheva-Hoang T, 2007, P NATL ACAD SCI USA, V104, P17765, DOI 10.1073/pnas.0708767104; Pradere JP, 2014, ONCOGENE, V33, P3485, DOI 10.1038/onc.2013.302; Pulko V, 2009, J IMMUNOL, V183, P3634, DOI 10.4049/jimmunol.0900974; Salem ML, 2005, J IMMUNOTHER, V28, P220, DOI 10.1097/01.cji.0000156828.75196.0d; Salmon H, 2016, IMMUNITY, V44, P924, DOI 10.1016/j.immuni.2016.03.012; Sato Y, 2009, CANCER MICROENVIRON, V2, pS205, DOI 10.1007/s12307-009-0022-y; Savina A, 2010, METHODS MOL BIOL, V595, P383, DOI 10.1007/978-1-60761-421-0_25; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; SERREZE DV, 1989, J AUTOIMMUN, V2, P759, DOI 10.1016/0896-8411(89)90003-6; Sistigu A, 2014, NAT MED, V20, P1301, DOI 10.1038/nm.3708; Touil T, 2006, J IMMUNOL, V177, P7505, DOI 10.4049/jimmunol.177.11.7505; Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140; Wilson NS, 2006, NAT IMMUNOL, V7, P165, DOI 10.1038/ni1300; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522	35	14	15	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0167057	10.1371/journal.pone.0167057	http://dx.doi.org/10.1371/journal.pone.0167057			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3TF	27911948	Green Published, gold, Green Submitted			2022-12-26	WOS:000389520600021
J	Bin, LH; Deng, LH; Yang, HW; Zhu, LQ; Wang, X; Edwards, MG; Richers, B; Leung, DYM				Bin, Lianghua; Deng, Liehua; Yang, Hengwen; Zhu, Leqing; Wang, Xiao; Edwards, Michael G.; Richers, Brittany; Leung, Donald Y. M.			Forkhead Box C1 Regulates Human Primary Keratinocyte Terminal Differentiation	PLOS ONE			English	Article							SKIN BARRIER; CORNIFIED ENVELOPE; FOXC1; GENE; ABCA12; PATHOGENESIS; EXPRESSION; MUTATIONS; PROTEINS	The epidermis serves as a critical protective barrier between the internal and external environment of the human body. Its remarkable barrier function is established through the keratinocyte (KC) terminal differentiation program. The transcription factors specifically regulating terminal differentiation remain largely unknown. Using a RNA-sequencing (RNA-seq) profiling approach, we found that forkhead box c1 (FOXC1) was significantly up-regulated in human normal primary KC during the course of differentiation. This observation was validated in human normal primary KC from several different donors and human skin biopsies. Silencing FOXC1 in human normal primary KC undergoing differentiation led to significant down-regulation of late terminal differentiation genes markers including epidermal differentiation complex genes, keratinization genes, sphingolipid/ceramide metabolic process genes and epidermal specific cell-cell adhesion genes. We further demonstrated that FOXC1 works down-stream of ZNF750 and KLF4, and upstream of GRHL3. Thus, this study defines FOXC1 as a regulator specific for KC terminal differentiation and establishes its potential position in the genetic regulatory network.	[Bin, Lianghua; Deng, Liehua; Yang, Hengwen; Zhu, Leqing; Wang, Xiao] Jinan Univ, Affiliated Hosp 1, Biomed Translat Res Inst, Int Immunol Ctr, Guangzhou, Guangdong, Peoples R China; [Bin, Lianghua; Deng, Liehua; Yang, Hengwen; Zhu, Leqing; Wang, Xiao] Jinan Univ, Key Lab Antibody Engn Guangdong Prov, Guangzhou, Guangdong, Peoples R China; [Bin, Lianghua; Richers, Brittany; Leung, Donald Y. M.] Natl Jewish Hlth, Dept Pediat, Denver, CO 80206 USA; [Edwards, Michael G.] Univ Colorado Denver, Div Pulm Sci & Crit Care Med, Dept Med, Aurora, CO USA; [Leung, Donald Y. M.] Guangzhou Med Univ, Guangdong Prov Key Lab Allergy & Clin Immunol, State Key Clin Specialty Allergy, Affiliated Hosp 2, Guangzhou, Guangdong, Peoples R China	Jinan University; Jinan University; National Jewish Health; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Guangzhou Medical University	Bin, LH (corresponding author), Jinan Univ, Affiliated Hosp 1, Biomed Translat Res Inst, Int Immunol Ctr, Guangzhou, Guangdong, Peoples R China.; Bin, LH (corresponding author), Jinan Univ, Key Lab Antibody Engn Guangdong Prov, Guangzhou, Guangdong, Peoples R China.; Bin, LH (corresponding author), Natl Jewish Hlth, Dept Pediat, Denver, CO 80206 USA.	Binl@njhealth.org	yang, hengwen/GQH-7922-2022	yang, hengwen/0000-0002-6418-1985; Bin, Lianghua/0000-0002-3786-0106	National Natural Science Foundation of China [81371718]; NIH [R01 AR41256]; Overall Atopic Dermatitis Research Network (NIH/NIAID) [1U19 AI 117673-01]; Edelstein Family Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI117673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041256] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Overall Atopic Dermatitis Research Network (NIH/NIAID); Edelstein Family Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Natural Science Foundation of China (No. 81371718)(LB); NIH grants R01 AR41256 (DL); Overall Atopic Dermatitis Research Network (NIH/NIAID 1U19 AI 117673-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript; Lianghua Bin is the advisory board member of Astellas Pharma Inc. The authors wish to thank the Edelstein Family Foundation for their generous support of this work.	Akiyama M, 2005, J CLIN INVEST, V115, P1777, DOI 10.1172/JCI24834; Akiyama M, 2014, BBA-MOL CELL BIOL L, V1841, P435, DOI 10.1016/j.bbalip.2013.08.009; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Caubet C, 2004, J INVEST DERMATOL, V122, P1235, DOI 10.1111/j.0022-202X.2004.22512.x; Cui CY, 2016, J INVEST DERMATOL; Czarnowicki T, 2014, J ALLER CL IMM-PRACT, V2, P371, DOI 10.1016/j.jaip.2014.03.006; Furio L, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005389; Jung M, 2014, J DERMATOL SCI, V76, P231, DOI 10.1016/j.jdermsci.2014.09.004; Kalinin AE, 2004, J BIOL CHEM, V279, P22773, DOI 10.1074/jbc.M313660200; Kaufmann E, 1996, MECH DEVELOP, V57, P3, DOI 10.1016/0925-4773(96)00539-4; Kelsell DP, 2005, AM J HUM GENET, V76, P794; Kostera MI, 2004, J DERMATOL SCI, V34, P3, DOI 10.1016/j.jdermsci.2003.10.003; Kume T, 1998, CELL, V93, P985, DOI 10.1016/S0092-8674(00)81204-0; Kypriotou M, 2012, EXP DERMATOL, V21, P643, DOI 10.1111/j.1600-0625.2012.01472.x; Lay K, 2016, P NATL ACAD SCI USA, V113, pE1506, DOI 10.1073/pnas.1601569113; Lee WH, 2005, J INVEST DERMATOL, V125, P995, DOI 10.1111/j.0022-202X.2005.23887.x; Lopez-Pajares V, 2015, DEV CELL, V32, P693, DOI 10.1016/j.devcel.2015.01.028; Magnusdottir E, 2007, P NATL ACAD SCI USA, V104, P14988, DOI 10.1073/pnas.0707323104; Marchesini N, 2003, J BIOL CHEM, V278, P13775, DOI 10.1074/jbc.M212262200; Mattiuzzo NR, 2011, EXP DERMATOL, V20, P113, DOI 10.1111/j.1600-0625.2010.01188.x; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Sen GL, 2012, DEV CELL, V22, P669, DOI 10.1016/j.devcel.2011.12.001; Somerville TDD, 2015, CANCER CELL, V28, P329, DOI 10.1016/j.ccell.2015.07.017; Spradling KD, 2001, J BIOL CHEM, V276, P29257, DOI 10.1074/jbc.M101663200; Stawczyk-Macieja M, 2015, POSTEP DERM ALERGOL, V32, P123, DOI 10.5114/pdia.2014.44003; Strong CD, 2006, J CELL BIOL, V175, P661, DOI 10.1083/jcb.200605057; Tkocz D, 2012, ONCOGENE, V31, P3667, DOI 10.1038/onc.2011.531; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Xia LM, 2013, HEPATOLOGY, V57, P610, DOI 10.1002/hep.26029; Xing Y, 2006, NUCLEIC ACIDS RES, V34, P3150, DOI 10.1093/nar/gkl396; Yu ZQ, 2006, DEV BIOL, V299, P122, DOI 10.1016/j.ydbio.2006.07.015; Zhao LH, 2015, P NATL ACAD SCI USA, V112, P12962, DOI 10.1073/pnas.1516733112; Zhou Y, 2002, GENOMICS, V80, P465, DOI 10.1006/geno.2002.6860	33	14	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167392	10.1371/journal.pone.0167392	http://dx.doi.org/10.1371/journal.pone.0167392			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907090	Green Submitted, Green Published, gold			2022-12-26	WOS:000389482700141
J	Ding, Y; Vrionis, HA; Schneider, J; Berezuk, A; Khursigara, CM; Jarrell, KF				Ding, Yan; Vrionis, Helen A.; Schneider, James; Berezuk, Alison; Khursigara, Cezar M.; Jarrell, Ken F.			Complementation of an aglB Mutant of Methanococcus maripaludis with Heterologous Oligosaccharyltransferases	PLOS ONE			English	Article							S-LAYER GLYCOPROTEIN; ARCHAEON SULFOLOBUS-ACIDOCALDARIUS; ASPARAGINE-LINKED OLIGOSACCHARIDE; TERMINAL GLOBULAR DOMAIN; N-GLYCOSYLATION; HALOFERAX-VOLCANII; PROTEIN GLYCOSYLATION; HYPERTHERMOPHILIC ARCHAEON; STRUCTURAL ELUCIDATION; CRYSTAL-STRUCTURE	The oligosaccharyltransferase is the signature enzyme for N-linked glycosylation in all domains of life. In Archaea, this enzyme termed AglB, is responsible for transferring lipid carrier-linked glycans to select asparagine residues in a variety of target proteins including archaellins, S-layer proteins and pilins. This study investigated the ability of a variety of AglBs to compensate for the oligosaccharyltransferase activity in Methanococcus maripaludis deleted for aglB, using archaellin FIaB2 as the reporter protein since all archaellins in Mc. maripaludis are modified at multiple sites by an N-linked tetrasaccharide and this modification is required for archaellation. In the Mc. maripaludis Delta aglB strain FIaB2 runs as at a smaller apparent molecular weight in western blots and is nonarchaellated. We demonstrate that AglBs from Methanococcus voltae and Methanothermococcus the rmolithotrophicus functionally replaced the oligosaccharyltransferase activity missing in the Mc. maripaludis Delta aglB strain, both returning the apparent molecular weight of FIaB2 to wildtype size and restoring archaellation. This demonstrates that AglB from Mc. voltae has a relaxed specificity for the linking sugar of the transferred glycan since while the N-linked glycan present in Mc. voltae is similar to that of Mc. maripaludis, the Mc. voltae glycan uses N-acetylglucosamine as the linking sugar. In Mc. maripaludis that role is held by N-acetylgalactosamine. This study also identifies aglB from Mtc. thermolithotrophicus for the first time by its activity. Attempts to use AglB from Methanocaldococcus jannaschii, Haloferax volcanii or Sulfolobus acidocaldarius to functionally replace the oligosaccharyltransferase activity missing in the Mc. maripaludis Delta aglB strain were unsuccessful.	[Ding, Yan; Vrionis, Helen A.; Schneider, James; Jarrell, Ken F.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Berezuk, Alison; Khursigara, Cezar M.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON, Canada	Queens University - Canada; University of Guelph	Jarrell, KF (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada.	jarrellk@queensu.ca			Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding for the project was supplied by two separate grants from Natural Sciences and Engineering Research Council of Canada (NSERC), one to KFJ and the other to CMK. NSERC website http://www.nserc-crsng.gc.ca/index_eng.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Qarn M, 2006, MOL MICROBIOL, V61, P511, DOI 10.1111/j.1365-2958.2006.05252.x; Albers SV, 2015, MICROBE, V10, P283, DOI DOI 10.1128/MICR0BE.10.283.1; BALCH WE, 1979, MICROBIOL REV, V43, P260, DOI 10.1128/MMBR.43.2.260-296.1979; Calo D, 2011, MICROB BIOTECHNOL, V4, P461, DOI 10.1111/j.1751-7915.2011.00250.x; Calo D, 2010, APPL ENVIRON MICROB, V76, P5684, DOI 10.1128/AEM.00681-10; Chaban B, 2007, MOL MICROBIOL, V66, P596, DOI 10.1111/j.1365-2958.2007.05913.x; Chaban B, 2006, MOL MICROBIOL, V61, P259, DOI 10.1111/j.1365-2958.2006.05226.x; Chang MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130482; Chong PLG, 2012, ARCHAEA, V2012, DOI 10.1155/2012/138439; Cohen-Rosenzweig C, 2014, APPL ENVIRON MICROB, V80, P486, DOI 10.1128/AEM.03191-13; Cohen-Rosenzweig C, 2012, J BACTERIOL, V194, P6909, DOI 10.1128/JB.01716-12; Ding Y, 2016, MOL MICROBIOL, V102, P54, DOI 10.1111/mmi.13444; Ding Y, 2016, MICROBIOL-SGM, V162, P339, DOI 10.1099/mic.0.000221; Ding Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116402; Ding Y, 2013, J BACTERIOL, V195, P4094, DOI 10.1128/JB.00668-13; Eichler J, 2013, NAT REV MICROBIOL, V11, P151, DOI 10.1038/nrmicro2957; Esquivel RN, 2016, J BIOL CHEM, V291, P10602, DOI 10.1074/jbc.M115.693556; FERRANTE G, 1990, BIOCHEM CELL BIOL, V68, P274, DOI 10.1139/o90-038; Fujinami D, 2015, CARBOHYD RES, V413, P55, DOI 10.1016/j.carres.2015.05.010; Fujinami D, 2014, CARBOHYD RES, V387, P30, DOI 10.1016/j.carres.2014.01.021; GRANT WD, 1985, J GEN MICROBIOL, V131, P3277; Guan ZQ, 2016, FEBS LETT, V590, P3168, DOI 10.1002/1873-3468.12341; Guan ZQ, 2011, BBA-MOL CELL BIOL L, V1811, P607, DOI 10.1016/j.bbalip.2011.06.022; Guan ZQ, 2012, ENVIRON MICROBIOL, V14, P743, DOI 10.1111/j.1462-2920.2011.02625.x; Guan ZQ, 2011, BBA-MOL CELL BIOL L, V1811, P800, DOI 10.1016/j.bbalip.2011.04.009; HEDRICK DB, 1991, J LIPID RES, V32, P659; Igura M, 2008, EMBO J, V27, P234, DOI 10.1038/sj.emboj.7601940; Igura M, 2011, J BIOL CHEM, V286, P13255, DOI 10.1074/jbc.M110.213900; Ihssen J, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-67; Izquierdo L, 2009, EMBO J, V28, P2650, DOI 10.1038/emboj.2009.203; Jain S, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00641; Jarrell KF, 2014, MICROBIOL MOL BIOL R, V78, P304, DOI 10.1128/MMBR.00052-13; Jarrell KF, 2012, TRENDS MICROBIOL, V20, P307, DOI 10.1016/j.tim.2012.04.007; Jarrell Ken F, 2010, Int J Microbiol, V2010, P470138, DOI 10.1155/2010/470138; Kaminski L, 2013, MBIO, V4, DOI 10.1128/mBio.00716-13; Kaminski L, 2013, MOL PHYLOGENET EVOL, V68, P327, DOI 10.1016/j.ympev.2013.03.024; Kaminski L, 2013, BIOCHEM SOC T, V41, P432, DOI 10.1042/BST20120142; Kandiba L, 2016, GLYCOBIOLOGY, V26, P745, DOI 10.1093/glycob/cww014; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; Kelly J, 2009, CARBOHYD RES, V344, P648, DOI 10.1016/j.carres.2009.01.006; KOSTYUKOVA AS, 1992, CAN J MICROBIOL, V38, P1162, DOI 10.1139/m92-190; Langworthy TA, 1985, ARCHAEBACTERIA, V8, P459; Larkin A, 2013, NAT CHEM BIOL, V9, P367, DOI 10.1038/nchembio.1249; LECHNER J, 1989, ANNU REV BIOCHEM, V58, P173, DOI 10.1146/annurev.bi.58.070189.001133; Lie TJ, 2005, J BIOL CHEM, V280, P5236, DOI 10.1074/jbc.M411778200; Lie TJ, 2003, MOL MICROBIOL, V47, P235, DOI 10.1046/j.1365-2958.2003.03293.x; Maita N, 2010, J BIOL CHEM, V285, P4941, DOI 10.1074/jbc.M109.081752; Matsumoto S, 2013, P NATL ACAD SCI USA, V110, P17868, DOI 10.1073/pnas.1309777110; Matsumoto S, 2013, BMC STRUCT BIOL, V13, DOI 10.1186/1472-6807-13-11; Matsumoto S, 2012, BIOCHEMISTRY-US, V51, P4157, DOI 10.1021/bi300076u; Meyer BH, 2015, BIOCHIMIE, V118, P294, DOI 10.1016/j.biochi.2014.10.018; Meyer BH, 2014, MICROBIOLOGYOPEN, V3, P531, DOI 10.1002/mbo3.185; Meyer BH, 2013, BIOCHEM SOC T, V41, P384, DOI 10.1042/BST20120296; Moore BC, 2005, J BACTERIOL, V187, P972, DOI 10.1128/JB.187.3.972-979.2005; Nair Divya B., 2015, Life-Basel, V5, P85, DOI 10.3390/life5010085; Ng SYM, 2006, J MOL MICROB BIOTECH, V11, P167, DOI 10.1159/000094053; Ng SYM, 2011, J BACTERIOL, V193, P804, DOI 10.1128/JB.00822-10; Peyfoon E, 2010, ARCHAEA, V2010, DOI 10.1155/2010/754101; Schwarz F, 2011, CURR OPIN STRUC BIOL, V21, P576, DOI 10.1016/j.sbi.2011.08.005; Siu S, 2015, J BACTERIOL, V197, P1668, DOI 10.1128/JB.00040-15; SPROTT GD, 1991, J BACTERIOL, V173, P3907, DOI 10.1128/JB.173.12.3907-3910.1991; Szymanski CM, 2003, TRENDS MICROBIOL, V11, P233, DOI 10.1016/S0966-842X(03)00079-9; Taguchi Y, 2016, J BIOL CHEM, V291, P11042, DOI 10.1074/jbc.M115.713156; Tripepi M, 2012, J BACTERIOL, V194, P4876, DOI 10.1128/JB.00731-12; TUMBULA DL, 1994, FEMS MICROBIOL LETT, V121, P309, DOI 10.1016/0378-1097(94)90309-3; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; van de Vossenberg JLCM, 1998, EXTREMOPHILES, V2, P163, DOI 10.1007/s007920050056; VanDyke DJ, 2009, MOL MICROBIOL, V72, P633, DOI 10.1111/j.1365-2958.2009.06671.x; Voisin S, 2005, J BIOL CHEM, V280, P16586, DOI 10.1074/jbc.M500329200; WIELAND F, 1985, J BIOL CHEM, V260, P5180	70	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167611	10.1371/journal.pone.0167611	http://dx.doi.org/10.1371/journal.pone.0167611			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907170	Green Published, gold, Green Submitted			2022-12-26	WOS:000389482700211
J	Grandellis, C; Fantino, E; Garcia, MNM; Bialer, MG; Santin, F; Capiati, DA; Ulloa, RM				Grandellis, Carolina; Fantino, Elisa; Garcia, Maria Noelia Muniz; Bialer, Magali Graciela; Santin, Franco; Capiati, Daniela Andrea; Ulloa, Rita Maria			StCDPK3 Phosphorylates In Vitro Two Transcription Factors Involved in GA and ABA Signaling in Potato: StRSG1 and StABF1	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; REPRESSION OFSHOOT GROWTH; DROUGHT STRESS TOLERANCE; ABSCISIC-ACID; SUBSTRATE-SPECIFICITY; SEED-GERMINATION; GENE; EXPRESSION; TUBERIZATION; ACTIVATOR	Calcium-dependent protein kinases, CDPKs, decode calcium (Ca2+) transients and initiate downstream responses in plants. In order to understand how CDPKs affect plant physiology, their specific target proteins must be identified. In tobacco, the bZIP transcription factor (R) under bar epression of (S) under bar hoot (G) under bar rowth (NtRSG) that modulates gibberellin (GA) content is a specific target of NtCDPK1. StCDPK3 from potato is homologous (88% identical) to NtCDPK1 even in its N-terminal variable domain. In this work, we observe that NtRSG is also phosphorylated by StCDPK3. The potato RSG family of transcription factors is composed of three members that share similar features. The closest homologue to NtRSG, which was named StRSG1, was amplified and sequenced. qRT-PCR data indicate that StRSG1 is mainly expressed in petioles, stems, lateral buds, and roots. In addition, GA treatment affected StRSG1 expression. StCDPK3 transcripts were detected in leaves, petioles, stolons, roots, and dormant tubers, and transcript levels were modified in response to GA. The recombinant StRSG1-GST protein was produced and tested as a substrate for StCDPK3 and StCDPK1. 6xHisStCDPK3 was able to phosphorylate the potato StRSG1 in a Ca2+-dependent way, while 6xHisStCDPK1 could not. StCDPK3 also interacts and phosphorylates the transcription factor StABF1 (ABRE binding factor 1) involved in ABA signaling, as shown by EMSA and phosphorylation assays. StABF1 transcripts were mainly detected in roots, stems, and stolons. Our data suggest that StCDPK3 could be involved in the cross-talk between ABA and GA signaling at the onset of tuber development.	[Grandellis, Carolina; Fantino, Elisa; Garcia, Maria Noelia Muniz; Bialer, Magali Graciela; Santin, Franco; Capiati, Daniela Andrea; Ulloa, Rita Maria] Natl Res Council CONICET, Inst Genet Engn & Mol Biol INGEBI, 2do Piso, Buenos Aires, DF, Argentina; [Capiati, Daniela Andrea; Ulloa, Rita Maria] Univ Buenos Aires, Sch Exact & Nat Sci, Dept Biochem, Buenos Aires, DF, Argentina; [Grandellis, Carolina] Rosario IBR Ocampo 210 Bis CONICET, Inst Mol & Cellular Biol, Rosario, Santa Fe, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Ulloa, RM (corresponding author), Natl Res Council CONICET, Inst Genet Engn & Mol Biol INGEBI, 2do Piso, Buenos Aires, DF, Argentina.; Ulloa, RM (corresponding author), Univ Buenos Aires, Sch Exact & Nat Sci, Dept Biochem, Buenos Aires, DF, Argentina.	rulloa@dna.uba.ar		Capiati, Daniela/0000-0002-7169-2003; Grandellis, Carolina/0000-0002-1092-5045; Muniz Garcia, Maria Noelia/0000-0003-3794-5617	Consejo Nacional de Investigaciones Cientificas y Tecnicas, CONICET (PIP-CONICET) [00037]; Universidad de Buenos Aires, UBA (UBACYT) [20020120100115]	Consejo Nacional de Investigaciones Cientificas y Tecnicas, CONICET (PIP-CONICET); Universidad de Buenos Aires, UBA (UBACYT)	This work was funded by Consejo Nacional de Investigaciones Cientificas y Tecnicas, CONICET (PIP-CONICET 00037) and Universidad de Buenos Aires, UBA (UBACYT 20020120100115). RU and DC received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beenstock J, 2016, TRENDS BIOCH SCI; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Boudsocq M, 2013, TRENDS PLANT SCI, V18, P30, DOI 10.1016/j.tplants.2012.08.008; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cheng SH, 2002, PLANT PHYSIOL, V129, P469, DOI 10.1104/pp.005645; Choi HI, 2005, PLANT PHYSIOL, V139, P1750, DOI 10.1104/pp.105.069757; Curran A, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00036; Dubrovina AS, 2013, J PLANT PHYSIOL, V170, P1491, DOI 10.1016/j.jplph.2013.06.014; Fujita Y, 2013, PHYSIOL PLANTARUM, V147, P15, DOI 10.1111/j.1399-3054.2012.01635.x; Fujita Y, 2011, J PLANT RES, V124, P509, DOI 10.1007/s10265-011-0412-3; Fukazawa J, 2000, PLANT CELL, V12, P901, DOI 10.1105/tpc.12.6.901; Fukazawa J, 2010, PLANT J, V62, P1035, DOI 10.1111/j.1365-313X.2010.04215.x; Giammaria V, 2011, PLANTA, V233, P593, DOI 10.1007/s00425-010-1319-2; Grandellis C, 2016, FUNCT INTEGR GENOMIC; Grandellis C, 2012, PLANTA, V236, P1831, DOI 10.1007/s00425-012-1732-9; Gravino M, 2015, PLANT J, V84, P1073, DOI 10.1111/tpj.13057; Correa LGG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002944; Hartmann A, 2011, PLANT PHYSIOL, V155, P776, DOI 10.1104/pp.110.168252; Hegeman AD, 2006, PROTEOMICS, V6, P3649, DOI 10.1002/pmic.200500926; Huang HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075850; Igarashi D, 2001, PLANT CELL, V13, P2483, DOI 10.1105/tpc.13.11.2483; Ishida S, 2004, PLANT CELL, V16, P2641, DOI 10.1105/tpc.104.024604; Ishida S, 2008, PLANT CELL, V20, P3273, DOI 10.1105/tpc.107.057489; Ito T, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/15592324.2014.977721; Ito T, 2011, PLANT SIGNAL BEHAV, V6, P924, DOI 10.4161/psb.6.7.15604; Ito T, 2010, PLANT CELL, V22, P1592, DOI 10.1105/tpc.109.073577; Jackson SD, 1999, PLANT PHYSIOL, V119, P1, DOI 10.1104/pp.119.1.1; Jakoby M, 2002, TRENDS PLANT SCI, V7, P106, DOI 10.1016/S1360-1385(01)02223-3; Jiang SS, 2013, PLANT PHYSIOL BIOCH, V71, P112, DOI 10.1016/j.plaphy.2013.07.004; Kagaya Y, 2002, PLANT CELL, V14, P3177, DOI 10.1105/tpc.005272; Kanchiswamy CN, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-97; Kawamoto N, 2015, SCI REP-UK, V5, DOI 10.1038/srep08341; Kirchler T, 2010, EUR J CELL BIOL, V89, P175, DOI 10.1016/j.ejcb.2009.11.023; Kloosterman B, 2007, PLANT J, V52, P362, DOI 10.1111/j.1365-313X.2007.03245.x; Kobayashi M, 2007, PLANT CELL, V19, P1065, DOI 10.1105/tpc.106.048884; KUMAR D, 1972, NEW PHYTOL, V71, P639, DOI 10.1111/j.1469-8137.1972.tb01274.x; Li A, 2014, PLANT SIGNAL BEHAV, V3, P654; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma SY, 2007, PLANT MOL BIOL, V65, P511, DOI 10.1007/s11103-007-9187-2; Machackova I, 1998, PHYSIOL PLANTARUM, V102, P272, DOI 10.1034/j.1399-3054.1998.1020215.x; Mair A, 2015, ELIFE, V4, DOI 10.7554/eLife.05828; Mayfield JD, 2007, PLANT PHYSIOL, V145, P1692, DOI 10.1104/pp.107.108654; MENZEL CM, 1983, ANN BOT-LONDON, V52, P697, DOI 10.1093/oxfordjournals.aob.a086627; Garcia MNM, 2014, PLANTA, V239, P615, DOI 10.1007/s00425-013-2001-2; Garcia MNM, 2012, PLANTA, V235, P761, DOI 10.1007/s00425-011-1540-7; Myers C, 2009, PLANT J, V59, P528, DOI 10.1111/j.1365-313X.2009.03894.x; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Olszewski N, 2002, PLANT CELL, V14, pS61, DOI 10.1105/tpc.010476; Raices M, 2003, CELL MOL BIOL, V49, P959; Raices M, 2003, J EXP BOT, V54, P2589, DOI 10.1093/jxb/erg282; Raices M, 2003, PLANT MOL BIOL, V52, P1011, DOI 10.1023/A:1025478315648; Rodriguez-Falcon M, 2006, ANNU REV PLANT BIOL, V57, P151, DOI 10.1146/annurev.arplant.57.032905.105224; Roumeliotis E, 2013, J PLANT PHYSIOL, V170, P1228, DOI 10.1016/j.jplph.2013.04.003; Gargantini P, 2009, PLANT MOL BIOL, V70, P153, DOI 10.1007/s11103-009-9462-5; Ryu H, 2007, PLANT CELL, V19, P2749, DOI 10.1105/tpc.107.053728; Santin F, 2016, PHYSL PLANT; Schoonheim PJ, 2009, PLANT CELL ENVIRON, V32, P439, DOI 10.1111/j.1365-3040.2009.01932.x; Schulz P, 2013, PLANT PHYSIOL, V163, P523, DOI 10.1104/pp.113.222539; Sheen J, 1996, SCIENCE, V274, P1900, DOI 10.1126/science.274.5294.1900; Shu K, 2016, J EXP BOT, V67, P195, DOI 10.1093/jxb/erv459; Shu K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003577; Simeunovic A, 2016, J EXP BOT, V67, P3855, DOI 10.1093/jxb/erw157; SMITH OE, 1969, AM POTATO J, V46, P185, DOI 10.1007/BF02863046; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Vreugdenhil D, 2004, AM J POTATO RES, V81, P275, DOI 10.1007/BF02871769; Wei SY, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-133; Xu X, 1998, J EXP BOT, V49, P573, DOI 10.1093/jexbot/49.320.573; Ye NH, 2012, J EXP BOT, V63, P1809, DOI 10.1093/jxb/err336; Zhang HF, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-211; Zhao R, 2011, NEW PHYTOL, V192, P61, DOI 10.1111/j.1469-8137.2011.03793.x; Zhu SY, 2007, PLANT CELL, V19, P3019, DOI 10.1105/tpc.107.050666; Zou JJ, 2010, PLANT PHYSIOL, V154, P1232, DOI 10.1104/pp.110.157545	73	14	15	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167389	10.1371/journal.pone.0167389	http://dx.doi.org/10.1371/journal.pone.0167389			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907086	gold, Green Submitted, Green Published			2022-12-26	WOS:000389482700139
J	Gupta, R; Reneaux, M; Karmeshu				Gupta, Rahul; Reneaux, Melissa; Karmeshu			Role of Heterogeneous Macromolecular Crowding and Geometrical Irregularity at Central Excitatory Synapses in Shaping Synaptic Transmission	PLOS ONE			English	Article							CENTRAL GLUTAMATERGIC SYNAPSES; EXTRACELLULAR-MATRIX; DIFFUSION-COEFFICIENTS; QUANTAL TRANSMISSION; DENDRITIC SPINES; RAT HIPPOCAMPUS; AMPA RECEPTORS; CA1 SYNAPSES; CLEFT; TRANSMITTER	Besides the geometrical tortousity due to the extrasynaptic structures, macromolecular crowding and geometrical irregularities constituting the cleft composition at central excitatory synapses has a major and direct role in retarding the glutamate diffusion within the cleft space. However, the cleft composition may not only coarsely reduce the overall diffusivity of the glutamate but may also lead to substantial spatial variation in the diffusivity across the cleft space. Decrease in the overall diffusivity of the glutamate may have straightforward consequences to the glutamate transients in the cleft. However, how spatial variation in the diffusivity may further affect glutamate transients is an intriguing aspect. Therefore, to understand the role of cleft heterogeneity, the present study adopts a novel approach of glutamate diffusion which considers a gamma statistical distribution of the diffusion coefficient of glutamate (Dglut) across the cleft space, such that its moments discernibly capture the dual impacts of the cleft composition, and further applies the framework of superstatistics. The findings reveal a power law behavior in the glutamate transients, akin to the long-range anomalous subdiffusion, which leads to slower decay profile of cleft glutamate at higher intensity of cleft heterogeneity. Moreover, increase in the cleft heterogeneity is seen to eventually cause slower-rising excitatory postsynaptic currents with higher amplitudes, lesser noise, and prolonged duration of charge transfer across the postsynaptic membrane. Further, with regard to the conventional standard diffusion approach, the study suggests that the effective Dglut essentially derives from the median of the Dglut distribution and does not necessarily need to be the mean Dglut. Together, the findings indicate a strong implication of cleft heterogeneity to the metabolically cost-effective tuning of synaptic response during the phenomenon of plasticity at individual synapses and also provide an additional factor of variability in transmission across identical synapses.	[Gupta, Rahul; Reneaux, Melissa; Karmeshu] Jawaharlal Nehru Univ, Sch Computat & Integrat Sci, New Delhi 110067, India; [Karmeshu] Jawaharlal Nehru Univ, Sch Comp & Syst Sci, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi; Jawaharlal Nehru University, New Delhi	Karmeshu (corresponding author), Jawaharlal Nehru Univ, Sch Computat & Integrat Sci, New Delhi 110067, India.; Karmeshu (corresponding author), Jawaharlal Nehru Univ, Sch Comp & Syst Sci, New Delhi 110067, India.	karmeshu@mail.jnu.ac.in			Council of Scientific and Industrial Research (CSIR), India [09/ 263(1057)/2015-EMR-I]; CSIR, India [09/263(0991)/2013-EMR-I]	Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); CSIR, India(Council of Scientific & Industrial Research (CSIR) - India)	RG received funding from Council of Scientific and Industrial Research (CSIR), India (grant no. 09/ 263(1057)/2015-EMR-I and URL: www.csirhrdg.res.in) for this research. MR also acknowledges the Senior Research Fellowship (SRF) provided by CSIR, India under the Grant No. 09/263(0991)/2013-EMR-I. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; BARBOUR B, 1994, NEURON, V12, P1331, DOI 10.1016/0896-6273(94)90448-0; Beck C, 2003, PHYSICA A, V322, P267, DOI 10.1016/S0378-4371(03)00019-0; Boucher J, 2010, BRAIN STRUCT FUNCT, V215, P49, DOI 10.1007/s00429-010-0273-x; Budisantoso T, 2013, J PHYSIOL-LONDON, V591, P219, DOI 10.1113/jphysiol.2012.241398; BURGER PM, 1989, NEURON, V3, P715, DOI 10.1016/0896-6273(89)90240-7; Clements JD, 1996, TRENDS NEUROSCI, V19, P163, DOI 10.1016/S0166-2236(96)10024-2; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; Cohen EGD, 2004, PHYSICA D, V193, P35, DOI 10.1016/j.physd.2004.01.007; Cory Sean M., 2006, Critical Reviews in Neurobiology, V18, P61; Diamond JS, 1997, J NEUROSCI, V17, P4672; DiGregorio DA, 2002, NEURON, V35, P521, DOI 10.1016/S0896-6273(02)00787-0; Dityatev A, 2003, NAT REV NEUROSCI, V4, P456, DOI 10.1038/nrn1115; Dityatev A, 2010, NAT REV NEUROSCI, V11, P735, DOI 10.1038/nrn2898; Franks KM, 2003, J NEUROSCI, V23, P3186; Franks KM, 2002, BIOPHYS J, V83, P2333, DOI 10.1016/S0006-3495(02)75248-X; Freche D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025122; HARRIS KM, 1989, J NEUROSCI, V9, P2982; HARRIS KM, 1995, NEUROPHARMACOLOGY, V34, P1387, DOI 10.1016/0028-3908(95)00142-S; HARRIS KM, 1992, J NEUROSCI, V12, P2685; ICHIMURA T, 1988, J NEUROCYTOL, V17, P3, DOI 10.1007/BF01735373; Kessler JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070791; Kleinle J, 1996, BIOPHYS J, V71, P2413, DOI 10.1016/S0006-3495(96)79435-3; Lachamp P, 2002, J NEUROBIOL, V52, P336, DOI 10.1002/neu.10091; Lacks DJ, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.041912; LAND BR, 1984, P NATL ACAD SCI-BIOL, V81, P1594, DOI 10.1073/pnas.81.5.1594; LERNER IV, 1993, NUCL PHYS A, V560, P274, DOI 10.1016/0375-9474(93)90096-G; Lisman JE, 2007, NAT REV NEUROSCI, V8, P597, DOI 10.1038/nrn2191; LONGSWORTH LG, 1953, J AM CHEM SOC, V75, P5705, DOI 10.1021/ja01118a065; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; Milstein AD, 2007, NEURON, V55, P905, DOI 10.1016/j.neuron.2007.08.022; Namiki S, 2007, EUR J NEUROSCI, V25, P2249, DOI 10.1111/j.1460-9568.2007.05511.x; Nielsen TA, 2004, NEURON, V42, P757, DOI 10.1016/j.neuron.2004.04.003; Niven JE, 2008, J EXP BIOL, V211, P1792, DOI 10.1242/jeb.017574; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; Okubo Y, 2011, J PHYSIOL-LONDON, V589, P481, DOI 10.1113/jphysiol.2010.199539; Postlethwaite M, 2007, J PHYSIOL-LONDON, V579, P69, DOI 10.1113/jphysiol.2006.123612; Raghavachari S, 2004, J NEUROPHYSIOL, V92, P2456, DOI 10.1152/jn.00258.2004; RAMBOURG A, 1967, J CELL BIOL, V32, P27, DOI 10.1083/jcb.32.1.27; Ronen I, 2006, MAGN RESON IMAGING, V24, P61, DOI 10.1016/j.mri.2005.10.023; Rostaing P, 2006, EUR J NEUROSCI, V24, P3463, DOI 10.1111/j.1460-9568.2006.05234.x; Rusakov DA, 1998, J NEUROSCI, V18, P3158; Rusakov DA, 2011, TRENDS NEUROSCI, V34, P359, DOI 10.1016/j.tins.2011.03.002; Saxton MJ, 1997, BIOPHYS J, V72, P1744, DOI 10.1016/S0006-3495(97)78820-9; Schikorski T, 1997, J NEUROSCI, V17, P5858; Scimemi A, 2009, MOL NEUROBIOL, V40, P289, DOI 10.1007/s12035-009-8087-7; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Siksou L, 2007, J NEUROSCI, V27, P6868, DOI 10.1523/JNEUROSCI.1773-07.2007; SKAUGEN E, 1979, ACTA PHYSIOL SCAND, V107, P343, DOI 10.1111/j.1748-1716.1979.tb06486.x; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; Stylianopoulos T, 2010, BIOPHYS J, V99, P1342, DOI 10.1016/j.bpj.2010.06.016; Trommershauser J, 1999, J THEOR BIOL, V198, P101, DOI 10.1006/jtbi.1999.0905; Tzingounis AV, 2007, NAT REV NEUROSCI, V8, P935, DOI 10.1038/nrn2274; Ventriglia F, 2011, BIOSYSTEMS, V104, P14, DOI 10.1016/j.biosystems.2010.12.008; WADE WF, 1989, J CELL BIOL, V109, P3325, DOI 10.1083/jcb.109.6.3325; Wang RB, 2007, COGN NEURODYNAMICS, V1, P203, DOI 10.1007/s11571-007-9015-z; Yamashita T, 2003, J NEUROSCI, V23, P3633; Zuber B, 2005, P NATL ACAD SCI USA, V102, P19192, DOI 10.1073/pnas.0509527102	58	2	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167505	10.1371/journal.pone.0167505	http://dx.doi.org/10.1371/journal.pone.0167505			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907112	Green Published, gold, Green Submitted			2022-12-26	WOS:000389482700173
J	Itoh, T; Hibi, T; Suzuki, F; Sugimoto, I; Fujiwara, A; Inaka, K; Tanaka, H; Ohta, K; Fujii, Y; Taketo, A; Kimoto, H				Itoh, Takafumi; Hibi, Takao; Suzuki, Fumiko; Sugimoto, Ikumi; Fujiwara, Akihiro; Inaka, Koji; Tanaka, Hiroaki; Ohta, Kazunori; Fujii, Yutaka; Taketo, Akira; Kimoto, Hisashi			Crystal Structure of Chitinase ChiW from Paenibacillus sp str. FPU-7 Reveals a Novel Type of Bacterial Cell-Surface-Expressed Multi-Modular Enzyme Machinery	PLOS ONE			English	Article							CARBOHYDRATE-BINDING MODULES; X-RAY-DIFFRACTION; SP STRAIN FPU-7; BETA-1,3-GLUCANASE LIC16A; CLOSTRIDIUM-THERMOCELLUM; CATALYTIC DOMAINS; VIRULENCE FACTOR; HIGH-RESOLUTION; PROTEIN; CRYSTALLIZATION	The Gram-positive bacterium Paenibacillus sp. str. FPU-7 effectively hydrolyzes chitin by using a number of chitinases. A unique chitinase with two catalytic domains, ChiW, is expressed on the cell surface of this bacterium and has high activity towards various chitins, even crystalline chitin. Here, the crystal structure of ChiW at 2.1 angstrom resolution is presented and describes how the enzyme degrades chitin on the bacterial cell surface. The crystal structure revealed a unique multi-modular architecture composed of six domains to function efficiently on the cell surface: a right-handed beta-helix domain (carbohydrate-binding module family 54, CBM-54), a Gly-Ser-rich loop, 1st immunoglobulin-like (Ig-like) fold domain, 1st beta/alpha-barrel catalytic domain (glycoside hydrolase family 18, GH-18), 2nd Ig-like fold domain and 2nd beta/alpha-barrel catalytic domain (GH-18). The structure of the CBM-54, flexibly linked to the catalytic region of ChiW, is described here for the first time. It is similar to those of carbohydrate lyases but displayed no detectable carbohydrate degradation activities. The CBM-54 of ChiW bound to cell wall polysaccharides, such as chin, chitosan, beta-1,3-glucan, xylan and cellulose. The structural and biochemical data obtained here also indicated that the enzyme has deep and short active site clefts with endo-acting character. The affinity of CBM-54 towards cell wall polysaccharides and the degradation pattern of the catalytic domains may help to efficiently decompose the cell wall chitin through the contact surface. Furthermore, we clarify that other Gram-positive bacteria possess similar cell-surface-expressed multi-modular enzymes for cell wall polysaccharide degradation.	[Itoh, Takafumi; Hibi, Takao; Suzuki, Fumiko; Sugimoto, Ikumi; Fujiwara, Akihiro; Kimoto, Hisashi] Fukui Prefectural Univ, Dept Biosci, Eiheiji, Fukui, Japan; [Inaka, Koji] Maruwa Foods & Biosci Inc, Yamato Koriyama, Nara, Japan; [Tanaka, Hiroaki] Confocal Sci Inc, Chiyoda Ku, Tokyo, Japan; [Ohta, Kazunori] Japan Aerosp Explorat Agcy, Tsukuba, Ibaraki, Japan; [Fujii, Yutaka] Univ Fukui, Fac Med, Dept Mol Biol & Chem, Fukui, Fukui, Japan; [Taketo, Akira] Fukui Univ Technol, Dept Environm & Biotechnol Frontier Engn, Fukui, Fukui, Japan	Fukui Prefectural University; Japan Aerospace Exploration Agency (JAXA); University of Fukui	Itoh, T; Kimoto, H (corresponding author), Fukui Prefectural Univ, Dept Biosci, Eiheiji, Fukui, Japan.	ito-t@fpu.ac.jp; kimoto@fpu.ac.jp		Tanaka, Hiroaki/0000-0001-8814-740X; Fujii, Yutaka/0000-0001-6357-3795; Hibi, Takao/0000-0003-4394-4426	High-Quality Protein Crystal Growth Experiment on JEM; FPU Promotion of Community Fund; Special Coordination Funds for Promoting Science and Technology of the Ministry of Education, Culture, Sports, Science and Technology, Japan; Japan Society for the Promotion of Science [25850234, 26450099, 16K08114]	High-Quality Protein Crystal Growth Experiment on JEM; FPU Promotion of Community Fund; Special Coordination Funds for Promoting Science and Technology of the Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was partially supported by the "High-Quality Protein Crystal Growth Experiment on JEM" promoted by JAXA (Japan Aerospace Exploration Agency). This work was also supported by a grant from the FPU Promotion of Community Fund, by the Special Coordination Funds for Promoting Science and Technology of the Ministry of Education, Culture, Sports, Science and Technology, Japan and by a Grant-in-Aid for Young Scientists (B) (TI, Grant Number 25850234) and Scientific Research (C) (HK, Grand Number 26450099; TI, Grant Number 16K08114) from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aam BB, 2010, MAR DRUGS, V8, P1482, DOI 10.3390/md8051482; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Berisio R, PROTEIN PEPT LETT, V19, P1045; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carvalho AL, 2003, P NATL ACAD SCI USA, V100, P13809, DOI 10.1073/pnas.1936124100; Cheng YM, 2009, APPL MICROBIOL BIOT, V81, P1051, DOI 10.1007/s00253-008-1617-9; CLARKE ND, 1994, P NATL ACAD SCI USA, V91, P11084, DOI 10.1073/pnas.91.23.11084; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; CREMER D, 1975, J AM CHEM SOC, V97, P1354, DOI 10.1021/ja00839a011; Davies GJ, 2012, ACCOUNTS CHEM RES, V45, P308, DOI 10.1021/ar2001765; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Dembek M, 2012, J BIOL CHEM, V287, P1538, DOI 10.1074/jbc.M111.302463; Dietmann S, 2001, NUCLEIC ACIDS RES, V29, P55, DOI 10.1093/nar/29.1.55; Doi RH, 2004, NAT REV MICROBIOL, V2, P541, DOI 10.1038/nrmicro925; Dvortsov IA, 2009, MICROBIOL-SGM, V155, P2442, DOI 10.1099/mic.0.026930-0; Emsley P, 1996, NATURE, V381, P90, DOI 10.1038/381090a0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GARCIARUIZ JM, 1994, ACTA CRYSTALLOGR D, V50, P484, DOI 10.1107/S0907444993014350; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Halaby DM, 1999, PROTEIN ENG, V12, P563, DOI 10.1093/protein/12.7.563; Hall TMT, 1997, CELL, V91, P85, DOI 10.1016/S0092-8674(01)80011-8; HARPAZ Y, 1994, J MOL BIOL, V238, P528, DOI 10.1006/jmbi.1994.1312; Hemsworth GR, 2014, NAT CHEM BIOL, V10, P122, DOI 10.1038/nchembio.1417; Herve C, 2010, P NATL ACAD SCI USA, V107, P15293, DOI 10.1073/pnas.1005732107; Itoh T, 2014, BIOSCI BIOTECH BIOCH, V78, P624, DOI 10.1080/09168451.2014.891935; Itoh T, 2014, ACTA CRYSTALLOGR F, V70, P350, DOI 10.1107/S2053230X14002325; Itoh T, 2013, APPL ENVIRON MICROB, V79, P7482, DOI 10.1128/AEM.02483-13; Kielak AM, 2013, APPL ENVIRON MICROB, V79, P263, DOI 10.1128/AEM.02546-12; Kislitsyn YA, 2015, ACTA CRYSTALLOGR F, V71, P217, DOI 10.1107/S2053230X15000539; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008654; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lynd LR, 2005, CURR OPIN BIOTECH, V16, P577, DOI 10.1016/j.copbio.2005.08.009; Manjeet K, 2013, MICROBIOL RES, V168, P461, DOI 10.1016/j.micres.2013.01.006; Marshall KC, 1990, ADV MICROB ECOL, P387, DOI DOI 10.1007/978-1-4684-7612-5_10; Matsumoto T, 1999, P JPN ACAD B-PHYS, V75, P269, DOI 10.2183/pjab.75.269; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Newstead SL, 2005, ACTA CRYSTALLOGR D, V61, P1483, DOI 10.1107/S0907444905026132; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Papanikolau Y, 2001, BIOCHEMISTRY-US, V40, P11338, DOI 10.1021/bi010505h; Park BK, 2010, INT J MOL SCI, V11, P5153, DOI 10.3390/ijms11125152; Perriere G, 1996, BIOCHIMIE, V78, P364, DOI 10.1016/0300-9084(96)84768-7; ROBYT JF, 1972, ANAL BIOCHEM, V45, P510, DOI 10.1016/0003-2697(72)90213-8; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schneewind O, 2012, PHILOS T R SOC B, V367, P1123, DOI 10.1098/rstb.2011.0210; Shoseyov O, 2006, MICROBIOL MOL BIOL R, V70, P283, DOI 10.1128/MMBR.00028-05; STEINBACHER S, 1994, SCIENCE, V265, P383, DOI 10.1126/science.8023158; Takahashi S, 2013, J SYNCHROTRON RADIAT, V20, P968, DOI 10.1107/S0909049513021596; Tanaka H, 2004, J SYNCHROTRON RADIAT, V11, P45, DOI 10.1107/S0909049503023446; Tews I, 1997, J AM CHEM SOC, V119, P7954, DOI 10.1021/ja970674i; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsuji H, 2010, FEBS J, V277, P2683, DOI [10.1111/j.1742-464X.2010.07685.x, 10.1111/j.1742-4658.2010.07685.x]; Vaaje-Kolstad G, 2013, FEBS J, V280, P3028, DOI 10.1111/febs.12181; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; YODER MD, 1993, SCIENCE, V260, P1503, DOI 10.1126/science.8502994	58	19	20	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167310	10.1371/journal.pone.0167310	http://dx.doi.org/10.1371/journal.pone.0167310			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907169	Green Published, Green Submitted, gold			2022-12-26	WOS:000389482700117
J	Li, TS; Xu, YF; Liu, LZ; Huang, ML; Wang, Z; Tong, ZX; Zhang, H; Guo, F; Chen, CF				Li, Tiansen; Xu, Yafang; Liu, Laizhen; Huang, Meiling; Wang, Zhen; Tong, Zhixia; Zhang, Hui; Guo, Fei; Chen, Chuangfu			Brucella Melitensis 16M Regulates the Effect of AIR Domain on Inflammatory Factors, Autophagy, and Apoptosis in Mouse Macrophage through the ROS Signaling Pathway	PLOS ONE			English	Article							SELECTIVE AUTOPHAGY; IN-VITRO; MATURATION; SECRETION; ACTIVATION; EXPRESSION; IL-1-BETA; INFECTION; PARTNERS; RECEPTOR	Brucellosis is a highly contagious zoonosis caused by Brucella. Brucella can invade and persist inside host cells, which results in chronic infection. We constructed AIR interference and overexpression lentiviruses to acquire AIR interference, overexpression, and rescue stable expression cell lines. We also established a Brucella melitensis 16M-infected macrophage model, which was treated with either the vehicle control or NAC (ROS scavenger N-acetylcysteine (NAC) for 0, 3, 6, 12, and 24 h. Confocal laser microscopy, transmission electron microscopy, fluorescence quantitative PCR, flow cytometry, ELISA, and Western blot were used to detect inflammation, cell autophagy and apoptosis-related protein expression levels, ROS levels, and the distribution of mitochondria. It was found that after interference and overexpression of AIR, ROS release was significantly changed, and mitochondria became abnormally aggregated. B. melitensis 16M activated the NLRP3/AIM2 inflammatory complex, and induced RAW264.7 cells to secrete IL-1 beta and IL-18 through the ROS pathway. B. melitensis 16M also altered autophagy-related gene expression, increased autophagy activity, and induced cell apoptosis through the ROS pathway. The results showed that after B. melitensis 16M infection, ROS induced apoptosis, inflammation, and autophagy while AIR inhibited autophagosome maturation and autophagy initiation. Autophagy negatively regulated the activation of inflammasomes and prevented inflammation from occurring. In addition, mitophagy could promote cell apoptosis.	[Li, Tiansen; Xu, Yafang; Liu, Laizhen; Wang, Zhen; Tong, Zhixia; Zhang, Hui; Chen, Chuangfu] Shihezi Univ, Coll Anim Sci & Technol, Shihezi, Xinjiang, Peoples R China; [Huang, Meiling] Shihezi Univ, Coll Life Sci, Shihezi, Xinjiang, Peoples R China; [Guo, Fei] Shihezi Univ, Coll Med, Shihezi, Xinjiang, Peoples R China	Shihezi University; Shihezi University; Shihezi University	Chen, CF (corresponding author), Shihezi Univ, Coll Anim Sci & Technol, Shihezi, Xinjiang, Peoples R China.; Guo, F (corresponding author), Shihezi Univ, Coll Med, Shihezi, Xinjiang, Peoples R China.	119783783@qq.com; chen_chuangfu@163.com			National Natural Science Foundation of China [31460650, 31572491, 31360610, 31201863, 81360239]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (31460650,31572491,31360610,31201863, 81360239). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed W, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00030; BENNETT BL, 1947, J BACTERIOL, V54, P93; Brezden A., 2016, J AM CHEM SOC; Carrasco E, 2016, METHODS; Carrasco-Pozo C, 2016, REDOX BIOL, V9, P229, DOI 10.1016/j.redox.2016.08.007; Castaneda-Ramirez A, 2012, VIRULENCE, V3, P434, DOI 10.4161/viru.21251; Celli J, 2015, CELL MICROBIOL, V17, P951, DOI 10.1111/cmi.12452; Chen DD, 2012, AUTOPHAGY, V8, P985, DOI 10.4161/auto.20255; Chen DD, 2012, MOL CELL, V45, P629, DOI 10.1016/j.molcel.2011.12.036; Miraglia MC, 2016, J IMMUNOL, V196, P3794, DOI 10.4049/jimmunol.1500908; de Figueiredo P, 2015, AM J PATHOL, V185, P1505, DOI 10.1016/j.ajpath.2015.03.003; Espinoza MB, 2016, J CELL BIOCH; Del Giudice MG, 2016, J BIOL CHEM, V291, P12383, DOI 10.1074/jbc.M116.730994; Hale AN, 2013, AUTOPHAGY, V9, P951, DOI 10.4161/auto.24273; Han J, 2016, J CELL BIOCH; Im YB, 2016, VET RES, V47, DOI 10.1186/s13567-016-0311-7; Ke YH, 2015, FRONT CELL INFECT MI, V5, DOI [10.3389/fcimb.2015.00072, 10.3389/famb.2015.00072]; Kerrinnes T, 2015, ANTIMICROB AGENTS CH, V59, P6717, DOI 10.1128/AAC.00792-15; Kim JH, 2015, BMB REP, V48, P129, DOI 10.5483/BMBRep.2015.48.3.048; Kim JH, 2015, AUTOPHAGY, V11, P75, DOI 10.4161/15548627.2014.984276; Lee WS, 2016, INT IMMUNOPHARMACOL, V40, P146, DOI 10.1016/j.intimp.2016.08.021; Ma QL, 2015, INT J CLIN EXP MED, V8, P17530; Marquardt N, 2016, J IMMUNOL; Martinvalet D, 2015, MOL CELL ONCOL, V2, DOI 10.4161/23723556.2014.992639; Miller C, 2016, J MOL BIOL; Nuber S, 2016, P NATL ACAD SCI US; Ogawa M, 2011, AUTOPHAGY, V7, P1389, DOI 10.4161/auto.7.11.17151; Ogawa M, 2011, CELL HOST MICROBE, V9, P376, DOI 10.1016/j.chom.2011.04.010; Osman AY, 2016, MICROB PATHOG; Otani K, 2016, SCI REP-UK, V6, DOI 10.1038/srep32587; Viglietti AIP, 2016, INFECT IMMUN, V84, P11, DOI 10.1128/IAI.01049-15; Reddy SS, 2016, TOXICOL APPL PHARM; Sun XL, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0643-2; Yu QQ, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006175; Zhang YQ, 2016, INT J MOL MED; Zhang Y, 2016, WORLD J MICROB BIOT, V32, DOI 10.1007/s11274-016-2015-6	36	10	13	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167486	10.1371/journal.pone.0167486	http://dx.doi.org/10.1371/journal.pone.0167486			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907115	Green Published, gold, Green Submitted			2022-12-26	WOS:000389482700166
J	Richter, FR; Yeung, N				Richter, Franziska R.; Yeung, Nick			ERP Correlates of Encoding Success and Encoding Selectivity in Attention Switching	PLOS ONE			English	Article							PREFRONTAL CORTEX; BRAIN ACTIVITY; PROCESSING RESOURCES; COGNITIVE CONTROL; EPISODIC MEMORY; TASK; EVENT; PARADIGM; RECOLLECTION; PERFORMANCE	Long-term memory encoding depends critically on effective processing of incoming information. The degree to which participants engage in effective encoding can be indexed in electroencephalographic (EEG) data by studying event-related potential (ERP) subsequent memory effects. The current study investigated ERP correlates of memory success operationalised with two different measures-memory selectivity and global memory-to assess whether previously observed ERP subsequent memory effects reflect focused encoding of task-relevant information (memory selectivity), general encoding success (global memory), or both. Building on previous work, the present study combined an attention switching paradigm-in which participants were presented with compound object-word stimuli and switched between attending to the object or the word across trials with a later recognition memory test for those stimuli, while recording their EEG. Our results provided clear evidence that subsequent memory effects resulted from selective attentional focusing and effective top-down control (memory selectivity) in contrast to more general encoding success effects (global memory). Further analyses addressed the question of whether successful encoding depended on similar control mechanisms to those involved in attention switching. Interestingly, differences in the ERP correlates of attention switching and successful encoding, particularly during the poststimulus period, indicated that variability in encoding success occurred independently of prestimulus demands for top-down cognitive control. These results suggest that while effects of selective attention and selective encoding co-occur behaviourally their ERP correlates are at least partly dissociable.	[Richter, Franziska R.; Yeung, Nick] Univ Oxford, Dept Expt Psychol, Oxford, England; [Richter, Franziska R.] Univ Cambridge, Dept Psychol, Cambridge, England	University of Oxford; University of Cambridge	Richter, FR (corresponding author), Univ Oxford, Dept Expt Psychol, Oxford, England.; Richter, FR (corresponding author), Univ Cambridge, Dept Psychol, Cambridge, England.	frr28@cam.ac.uk		Richter, Franziska Rebekka/0000-0002-1917-0435; Yeung, Nick/0000-0003-1905-2129	German Academic Exchange Service (Deutscher Akademischer Austauschdienst, or DAAD)	German Academic Exchange Service (Deutscher Akademischer Austauschdienst, or DAAD)	FRR was supported by a doctoral scholarship from the German Academic Exchange Service (Deutscher Akademischer Austauschdienst, or DAAD). Other than this scholarship, the authors received no specific funding for this work.; F. R. R. was supported by a Doctoral Scholarship from the German Academic Exchange Service (Deutscher Akademischer Austauschdienst, or DAAD).	BOWER GH, 1969, J VERB LEARN VERB BE, V8, P323, DOI 10.1016/S0022-5371(69)80124-6; Chiu YC, 2016, J EXP PSYCHOL HUMAN, V42, P1, DOI 10.1037/xhp0000181; Chiu YC, 2015, J NEUROSCI, V35, P11936, DOI 10.1523/JNEUROSCI.0519-15.2015; Chun MM, 2007, CURR OPIN NEUROBIOL, V17, P177, DOI 10.1016/j.conb.2007.03.005; CRAIK FIM, 1975, J EXP PSYCHOL GEN, V104, P268, DOI 10.1037/0096-3445.104.3.268; Craik FIM, 1996, J EXP PSYCHOL GEN, V125, P159, DOI 10.1037/0096-3445.125.2.159; Dunlosky J., 2008, METACOGNITION; Elchlepp H, 2012, HUM BRAIN MAPP, V33, P1137, DOI 10.1002/hbm.21277; Evans LH, 2015, NEUROIMAGE; Evans LH, 2015, PSYCHOL SCI; FABIANI M, 1995, J EXP PSYCHOL LEARN, V21, P224, DOI 10.1037/0278-7393.21.1.224; FABIANI M, 1990, ELECTROEN CLIN NEURO, V75, P22, DOI 10.1016/0013-4694(90)90149-E; Falkenstein M, 2003, PSYCHOPHYSIOLOGY, V40, P914, DOI 10.1111/1469-8986.00109; Fernandez G, 1998, PSYCHOPHYSIOLOGY, V35, P709, DOI 10.1017/S0048577298970500; Galli G, 2013, CORTEX, V49, P2239, DOI 10.1016/j.cortex.2012.10.011; Galli G, 2012, COGN NEUROSCI-UK, V3, P160, DOI 10.1080/17588928.2012.670105; Guo CY, 2004, NEUROSCI LETT, V356, P79, DOI 10.1016/j.neulet.2003.09.049; Karayanidis F, 2003, PSYCHOPHYSIOLOGY, V40, P329, DOI 10.1111/1469-8986.00037; Karayanidis F., 2014, TASK SWITCHING COGNI, P200, DOI DOI 10.1093/ACPROF:OSOBL/9780199921959.003.0009; Karayanidis F, 2011, PSYCHOPHYSIOLOGY, V48, P559, DOI 10.1111/j.1469-8986.2010.01115.x; KARIS D, 1984, COGNITIVE PSYCHOL, V16, P177, DOI 10.1016/0010-0285(84)90007-0; Kieffaber PD, 2005, PSYCHOPHYSIOLOGY, V42, P56, DOI 10.1111/j.1469-8986.2005.00262.x; Kim C, 2011, J NEUROSCI, V31, P4771, DOI 10.1523/JNEUROSCI.5923-10.2011; Koriat A, 1996, PSYCHOL REV, V103, P490, DOI 10.1037/0033-295X.103.3.490; Krebs RM, 2015, CEREB CORTEX, V25, P833, DOI 10.1093/cercor/bht283; Longman CS, 2014, J EXP PSYCHOL HUMAN, V40, P1580, DOI 10.1037/a0036552; Mayr U, 2000, J EXP PSYCHOL GEN, V129, P4, DOI 10.1037/0096-3445.129.1.4; Monsell S., 1996, UNSOLVED MYSTERIES M, P93; MORRIS CD, 1977, J VERB LEARN VERB BE, V16, P519, DOI 10.1016/S0022-5371(77)80016-9; Otten LJ, 2010, J COGNITIVE NEUROSCI, V22, P1212, DOI 10.1162/jocn.2009.21298; Otten LJ, 2006, NAT NEUROSCI, V9, P489, DOI 10.1038/nn1663; Otten LJ, 2001, CURR BIOL, V11, P1528, DOI 10.1016/S0960-9822(01)00454-7; Padovani T, 2013, BRAIN BEHAV, V3, P464, DOI 10.1002/brb3.150; Padovani T, 2011, J COGNITIVE NEUROSCI, V23, P4008, DOI 10.1162/jocn_a_00096; PALLER KA, 1988, BIOL PSYCHOL, V26, P269, DOI 10.1016/0301-0511(88)90023-3; PALLER KA, 1987, ELECTROEN CLIN NEURO, V67, P360, DOI 10.1016/0013-4694(87)90124-6; Paller KA, 2002, TRENDS COGN SCI, V6, P93, DOI 10.1016/S1364-6613(00)01845-3; Poldrack RA, 1999, NEUROIMAGE, V10, P15, DOI 10.1006/nimg.1999.0441; Poljac E, 2012, JOURNAL OF AUTISM AN; Poljac E, 2014, CEREBRAL CORTEX; Richter F.R., 2014, TASK SWITCHING COGNI, P237, DOI DOI 10.1093/ACPROF:OSOBL/9780199921959.003.0010; Richter F. R., 2013, THESIS; Richter FR, 2015, Q J EXP PSYCHOL, V68, P1124, DOI 10.1080/17470218.2014.976579; Richter FR, 2012, PSYCHOL SCI, V23, P1256, DOI 10.1177/0956797612444613; Roediger HL, 2014, MEMORY, V22, P76, DOI 10.1080/09658211.2013.795974; Rugg M.D., 1995, OX PSYCH S, P133; Sakai K, 2008, ANNU REV NEUROSCI, V31, P219, DOI 10.1146/annurev.neuro.31.060407.125642; SANQUIST TF, 1980, PSYCHOPHYSIOLOGY, V17, P568, DOI 10.1111/j.1469-8986.1980.tb02299.x; Schacter DL, 1998, ANNU REV PSYCHOL, V49, P289, DOI 10.1146/annurev.psych.49.1.289; Schott B, 2002, J COGNITIVE NEUROSCI, V14, P578, DOI 10.1162/08989290260045828; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; SOMMER W, 1991, ELECTROEN CLIN NEURO, V79, P457, DOI 10.1016/0013-4694(91)90165-Z; Uncapher MR, 2009, J NEUROSCI, V29, P8270, DOI 10.1523/JNEUROSCI.1043-09.2009; Yeung N, 2006, J NEUROSCI, V26, P1429, DOI 10.1523/JNEUROSCI.3109-05.2006; Yonelinas AP, 2010, HIPPOCAMPUS, V20, P1178, DOI 10.1002/hipo.20864	55	6	6	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167396	10.1371/journal.pone.0167396	http://dx.doi.org/10.1371/journal.pone.0167396			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3JC	27907075	Green Published, gold, Green Submitted			2022-12-26	WOS:000389482700143
J	Tollefsrud, MM; Myking, T; Sonstebo, JH; Lygis, V; Hietala, AM; Heuertz, M				Tollefsrud, Mari Mette; Myking, Tor; Sonstebo, Jorn Henrik; Lygis, Vaidotas; Hietala, Ari Mikko; Heuertz, Myriam			Genetic Structure in the Northern Range Margins of Common Ash, Fraxinus excelsior L.	PLOS ONE			English	Article							CHLOROPLAST DNA VARIATION; LONG-DISTANCE DISPERSAL; POPULATION-STRUCTURE; POSTGLACIAL RECOLONIZATION; COMPUTER-PROGRAM; SEED DISPERSAL; HYMENOSCYPHUS-PSEUDOALBIDUS; CONTRASTING PATTERNS; FRAGMENTED LANDSCAPE; MICROSATELLITE LOCI	During post glacial colonization, loss of genetic diversity due to leading edge effects may be attenuated in forest trees because of their prolonged juvenile phase, allowing many migrants to reach the colonizing front before populations become reproductive. The northern range margins of temperate tree taxa in Europe are particularly suitable to study the genetic processes that follow colonization because they have been little affected by northern refugia. Here we examined how post glacial range dynamics have shaped the genetic structure of common ash (Fraxinus excelsior L.) in its northern range compared to its central range in Europe. We used four chloroplast and six nuclear microsatellites to screen 42 populations (1099 trees), half of which corresponded to newly sampled populations in the northern range and half of which represented reference populations from the central range obtained from previously studies. We found that northern range populations of common ash have the same chloroplast haplotypes as south-eastern European populations, suggesting that colonization of the northern range took place along a single migration route, a result confirmed by the structure at the nuclear microsatellites. Along this route, diversity strongly decreased only in the northern range, concomitantly with increasing population differentiation and complex population substructures, a pattern consistent with a leading edge colonization model. Our study highlights that while diversity is maintained in the central range of common ash due to broad colonizing fronts and high levels of gene flow, it profoundly decreases in the northern range, where colonization was unidirectional and probably involved repeated founder events and population fluctuations. Currently, common ash is threatened by ash dieback, and our results on northern populations will be valuable for developing gene conservation strategies.	[Tollefsrud, Mari Mette; Myking, Tor; Sonstebo, Jorn Henrik; Hietala, Ari Mikko] Norwegian Inst Bioecon Res, As, Norway; [Lygis, Vaidotas] Nat Res Ctr, Inst Bot, Vilnius, Lithuania; [Heuertz, Myriam] INIA Forest Res Ctr, Dept Forest Ecol & Genet, Madrid, Spain; [Heuertz, Myriam] Univ Bordeaux, BIOGECO, INRA, Cestas, France	Norwegian Institute of Bioeconomy Research; Nature Research Center - Lithuania; Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); INRAE; UDICE-French Research Universities; Universite de Bordeaux	Tollefsrud, MM (corresponding author), Norwegian Inst Bioecon Res, As, Norway.	mari.mette.tollefsrud@nibio.no	Lygis, Vaidotas/I-6242-2019; Sønstebø, Jørn Henrik/Q-1144-2019; Heuertz, Myriam/A-7831-2011	Lygis, Vaidotas/0000-0001-5121-2052; Hietala, Ari Mikko/0000-0002-3195-6318; Heuertz, Myriam/0000-0002-6322-3645; Sonstebo, Jorn Henrik/0000-0002-3204-1283	Research Council of Norway [Ash die back in Norway causes, impact and control] [203822/E40]; Spanish Ministry of Science and Innovation, Ramon y Cajal program [RYC2009-04537]; Norges Forskningsrad [203822/E40]	Research Council of Norway [Ash die back in Norway causes, impact and control]; Spanish Ministry of Science and Innovation, Ramon y Cajal program; Norges Forskningsrad	This study was supported by the Research Council of Norway [Ash die back in Norway causes, impact and control, 203822/E40 to MMT, TM, JHS, AMH and MH] and the Spanish Ministry of Science and Innovation, Ramon y Cajal program [RYC2009-04537 to MH]. Norges Forskningsrad 203822/E40 to MMT, TM, JHS, AMH and MH. Spanish Ministry of Science and Innovation, Ramon y Cajal program RYC2009-04537 to MH.	Austerlitz F, 2000, GENETICS, V154, P1309; Bacles CFE, 2008, HEREDITY, V101, P368, DOI 10.1038/hdy.2008.66; Bacles CFE, 2006, SCIENCE, V311, P628, DOI 10.1126/science.1121543; Bacles CFE, 2005, EVOLUTION, V59, P979, DOI 10.1111/j.0014-3820.2005.tb01037.x; Baral HO, 2014, IMA FUNGUS, V5, P79, DOI 10.5598/imafungus.2014.05.01.09; Beatty GE, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-015-0879-5; Bialozyt R, 2006, J EVOLUTION BIOL, V19, P12, DOI 10.1111/j.1420-9101.2005.00995.x; BJORCK S, 1995, QUATERN INT, V27, P19, DOI 10.1016/1040-6182(94)00057-C; Brachet S, 1999, MOL ECOL, V8, P160; Brewer S, 2016, J MAPS; BREWER S, 2002, RECOLONISATION POSTG; Caballero A, 2013, GENETICS, V195, P1373, DOI 10.1534/genetics.113.158410; Campagne P, 2012, MOL ECOL RESOUR, V12, P975, DOI 10.1111/1755-0998.12015; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Chen C, 2007, MOL ECOL NOTES, V7, P747, DOI 10.1111/j.1471-8286.2007.01769.x; Chhatre VE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097291; Chybicki IJ, 2009, J HERED, V100, P106, DOI 10.1093/jhered/esn088; Comps B, 2001, GENETICS, V157, P389; Cornille A, 2013, MOL ECOL, V22, P2249, DOI 10.1111/mec.12231; Crawford NG, 2010, MOL ECOL RESOUR, V10, P556, DOI 10.1111/j.1755-0998.2009.02801.x; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Dobrowolska D, 2011, FORESTRY, V84, P133, DOI 10.1093/forestry/cpr001; Durand E, 2009, MOL BIOL EVOL, V26, P1963, DOI 10.1093/molbev/msp106; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Ferrazzini D, 2007, ANN FOREST SCI, V64, P159, DOI 10.1051/forest:2006100; Gerard PR, 2013, J BIOGEOGR, V40, P835, DOI 10.1111/jbi.12021; Giesecke T, 2005, VEG HIST ARCHAEOBOT, V14, P133, DOI 10.1007/s00334-005-0070-2; Gonzalez-Martinez SC, 2010, MOL PHYLOGENET EVOL, V55, P805, DOI 10.1016/j.ympev.2010.03.001; GOUDET J., 2001, FSTAT VERSION 2 9 3; Gross A, 2014, MOL ECOL, V23, P2943, DOI 10.1111/mec.12792; Gross A, 2014, MOL PLANT PATHOL, V15, P5, DOI 10.1111/mpp.12073; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; Hampe A, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1070; Hamrick JL, 1996, PHILOS T ROY SOC B, V351, P1291, DOI 10.1098/rstb.1996.0112; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Havrdova A, 2015, MOL ECOL, V24, P4759, DOI 10.1111/mec.13348; Henriksen S, 2015, NORGE ARTSDATABANKEN; Heuertz M, 2004, MOL ECOL, V13, P3437, DOI 10.1111/j.1365-294X.2004.02333.x; Heuertz M, 2004, EVOLUTION, V58, P976; Heuertz M, 2003, MOL ECOL, V12, P2483, DOI 10.1046/j.1365-294X.2003.01923.x; Heuertz M, 2001, MOL ECOL, V10, P1615, DOI 10.1046/j.1365-294X.2001.01300.x; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hoban SM, 2010, MOL ECOL, V19, P4876, DOI 10.1111/j.1365-294X.2010.04834.x; Holliday JA, 2012, P ROY SOC B-BIOL SCI, V279, P1675, DOI 10.1098/rspb.2011.1805; Holtken AM, 2003, SILVAE GENET, V52, P206; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jensen JS, 2002, FOREST ECOL MANAG, V156, P167, DOI 10.1016/S0378-1127(01)00641-7; Kalinowski ST, 2004, CONSERV GENET, V5, P539, DOI 10.1023/B:COGE.0000041021.91777.1a; Kowalski T, 2006, FOREST PATHOL, V36, P264, DOI 10.1111/j.1439-0329.2006.00453.x; Kowalski T, 2009, FOREST PATHOL, V39, P304, DOI 10.1111/j.1439-0329.2008.00589.x; Kramer AT, 2008, CONSERV BIOL, V22, P878, DOI 10.1111/j.1523-1739.2008.00944.x; LeCorre V, 1997, GENET RES, V69, P117, DOI 10.1017/S0016672397002668; Lefort F, 1999, MOL ECOL, V8, P1088, DOI 10.1046/j.1365-294X.1999.00655_8.x; LESICA P, 1995, CONSERV BIOL, V9, P753, DOI 10.1046/j.1523-1739.1995.09040753.x; Lesser MR, 2013, ECOL LETT, V16, P380, DOI 10.1111/ele.12053; Liepelt S, 2009, REV PALAEOBOT PALYNO, V153, P139, DOI 10.1016/j.revpalbo.2008.07.007; Lygis V, 2014, EUR J FOREST RES, V133, P501, DOI 10.1007/s10342-014-0780-z; Magri D, 2006, NEW PHYTOL, V171, P199, DOI 10.1111/j.1469-8137.2006.01740.x; McKinney LV, 2014, PLANT PATHOL, V63, P485, DOI 10.1111/ppa.12196; Mimura M, 2007, AM J BOT, V94, P991, DOI 10.3732/ajb.94.6.991; Morand ME, 2002, MOL ECOL, V11, P377, DOI 10.1046/j.1365-294X.2002.01461.x; Morand-Prieur ME, 2002, MOL ECOL, V11, P613, DOI 10.1046/j.1365-294X.2002.01453.x; Myking T, 2009, FORESTRY, V82, P529, DOI 10.1093/forestry/cpp022; Nadeau S, 2015, AM J BOT, V102, P1342, DOI 10.3732/ajb.1500160; Naess R., 1999, TRE NATURENS VAKREST; Naydenov K, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-233; Nei M., 1987, MOL EVOLUTIONARY GEN; Palme AE, 2003, MOL ECOL, V12, P201, DOI 10.1046/j.1365-294X.2003.01724.x; Pautasso M, 2013, BIOL CONSERV, V158, P37, DOI 10.1016/j.biocon.2012.08.026; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Persson H, 2004, PLANT SYST EVOL, V244, P157, DOI 10.1007/s00606-003-0073-3; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Petit RJ, 2002, FOREST ECOL MANAG, V156, P5, DOI 10.1016/S0378-1127(01)00645-4; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; PLIURA A, 2003, TECHNICAL GUIDELINES; Pritchard JK, 2000, GENETICS, V155, P945; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 1997, GENETICS, V145, P1219; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Solbraa K, 1996, VEIEN BOEREKRAFTIG S; Spielman D, 2004, P NATL ACAD SCI USA, V101, P15261, DOI 10.1073/pnas.0403809101; Sumegi P, 2013, QUATERN INT, V293, P34, DOI 10.1016/j.quaint.2012.07.032; Sutherland BG, 2010, MOL ECOL, V19, P2196, DOI 10.1111/j.1365-294X.2009.04376.x; Svenning JC, 2008, J ECOL, V96, P1117, DOI 10.1111/j.1365-2745.2008.01422.x; Svenning JC, 2007, GLOBAL ECOL BIOGEOGR, V16, P234, DOI 10.1111/j.1466-8238.2006.00280.x; Thomas PA, 2016, J ECOL, V104, P1158, DOI 10.1111/1365-2745.12566; Tollefsrud MM, 2009, HEREDITY, V102, P549, DOI 10.1038/hdy.2009.16; Tollefsrud MM, 2008, MOL ECOL, V17, P4134, DOI 10.1111/j.1365-294X.2008.03893.x; Tollefsrud MM, 2015, J BIOGEOGR, V42, P1431, DOI 10.1111/jbi.12484; Tzedakis PC, 2013, TRENDS ECOL EVOL, V28, P696, DOI 10.1016/j.tree.2013.09.001; Vilas A, 2015, MOL ECOL, V24, P4419, DOI 10.1111/mec.13334; WALLANDER E, 2001, EVOLUTION WIND POLLI; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Weising K, 1999, GENOME, V42, P9, DOI 10.1139/gen-42-1-9; Willi Y, 2006, ANNU REV ECOL EVOL S, V37, P433, DOI 10.1146/annurev.ecolsys.37.091305.110145; Willis KJ, 2004, QUATERNARY SCI REV, V23, P2369, DOI 10.1016/j.quascirev.2004.06.002	103	10	11	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167104	10.1371/journal.pone.0167104	http://dx.doi.org/10.1371/journal.pone.0167104			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907032	Green Published, Green Submitted, gold			2022-12-26	WOS:000389482700077
J	Tryfinopoulou, K; Kesanopoulos, K; Xirogianni, A; Marmaras, N; Papandreou, A; Papaevangelou, V; Tsolia, M; Jasir, A; Tzanakaki, G				Tryfinopoulou, Kyriaki; Kesanopoulos, Konstantinos; Xirogianni, Athanasia; Marmaras, Nektarios; Papandreou, Anastasia; Papaevangelou, Vassiliki; Tsolia, Maria; Jasir, Aftab; Tzanakaki, Georgina			Meningococcal Carriage in Military Recruits and University Students during the Pre MenB Vaccination Era in Greece (2014-2015)	PLOS ONE			English	Article							NEISSERIA-MENINGITIDIS; CONJUGATE VACCINES; HERD-IMMUNITY; RISK-FACTORS; DISEASE; ADOLESCENTS; POPULATION; EUROPE; EPIDEMIOLOGY; PREVALENCE	Purpose The aim of the study was to estimate the meningococcal carriage rate and to identify the genotypic characteristics of the strains isolated from healthy military recruits and university students in order to provide data that might increase our understanding on the epidemiology of meningococcus and obtain information which helps to evaluate the potential effects on control programs such as vaccination., Methods A total of 1420 oropharyngeal single swab samples were collected from military recruits and university students on voluntary basis, aged 18-26 years. New York City Medium was used for culture and the suspected N. meningitidis colonies were identified by Gram stain, oxidase and rapid carbohydrate utilization tests. Further characterisation was carried out by molecular methods (multiplex PCR, MLST, WGS). Results The overall carriage rate was of 12.7%; 15% and 10.4% for recruits and university students respectively. MenB (39.4%) was the most prevalent followed by MenY (12.8%) and MenW (4.4%). Among the initial 76 Non Groupable (NG) isolates, Whole Genome Sequence Analysis (WGS) revealed that 8.3% belonged to MenE, 3.3% to MenX and 1.1% to MenZ, while, 53 strains (29.4%) were finally identified as capsule null. Genetic diversity was found among the MenB isolates, with 41/44 cc and 35 cc predominating. Conclusion Meningococcal carriage rate in both groups was lower compared to our previous studies (25% and 18% respectively) with predominance of MenB isolates. These findings, help to further our understanding on the epidemiology of meningococcal disease in Greece. Although the prevalence of carriage seems to have declined compared to our earlier studies, the predominant MenB clonal complexes (including 41/44cc and 35cc) are associated with invasive meningococcal disease.	[Tryfinopoulou, Kyriaki; Kesanopoulos, Konstantinos; Xirogianni, Athanasia; Marmaras, Nektarios; Papandreou, Anastasia; Tzanakaki, Georgina] Natl Sch Publ Hlth, NMRL, Dept Publ Hlth, Athens, Greece; [Tryfinopoulou, Kyriaki; Jasir, Aftab] European Ctr Dis Prevent & Control, European Publ Hlth Microbiol Training Programme E, Stockholm, Sweden; [Papaevangelou, Vassiliki] ATTIKON Natl Kapodistrian Univ Athens, Univ Gen Hosp, Dept Paediat 3, Athens, Greece; [Tsolia, Maria] Univ Athens, Sch Med, Dept Paediat 2, Aglaia Kyriakou Childrens Hosp, Athens, Greece	National & Kapodistrian University of Athens; European Centre for Disease Prevention & Control; Athens Medical School; National & Kapodistrian University of Athens	Tzanakaki, G (corresponding author), Natl Sch Publ Hlth, NMRL, Dept Publ Hlth, Athens, Greece.	gtzanakaki@esdy.edu.gr	Xirogianni, Athanasia/ABG-6686-2022; Tryfinopoulou, Kyriaki/W-8519-2019; Tzanakaki, Georgina/AAZ-6598-2021	Xirogianni, Athanasia/0000-0002-2959-8216; 	GSK; Ministries of Defence and Education	GSK(GlaxoSmithKline); Ministries of Defence and Education	The principal investigator of this study (GT) has received funding from GSK while, the rest of the authors received no funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The MLST data were obtained from the WGS data carried out at University of Oxford (Dept. of Zoology). The authors would like to thank Prof Martin Maiden and Dr Holly Bracher for their great help on assembling, annotation and curation of the data and Dr Arnold Bosman and Prof Michael Catchpole (ECDC) for critical reviewing of the manuscript. The authors also would like to thank the Ministries of Defence and Education for their permission and support.	Ala'Aldeen DAA, 2011, EMERG INFECT DIS, V17, P1761, DOI 10.3201/eid1709.101762; BLACKWELL CC, 1992, EPIDEMIOL INFECT, V108, P441, DOI 10.1017/S0950268800049943; Bratcher HB, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1138; Broker M, 2015, HUM VACC IMMUNOTHER, V11, P2281, DOI 10.1080/21645515.2015.1051276; Campbell H, 2009, VACCINE, V27, pB20, DOI 10.1016/j.vaccine.2009.04.067; CAUGANT DA, 1992, EPIDEMIOL INFECT, V109, P241, DOI 10.1017/S0950268800050196; CAUGANT DA, 1994, J CLIN MICROBIOL, V32, P323, DOI 10.1128/JCM.32.2.323-330.1994; Caugant DA, 1998, APMIS, V106, P505, DOI 10.1111/j.1699-0463.1998.tb01379.x; Christensen H, 2010, LANCET INFECT DIS, V10, P853, DOI 10.1016/S1473-3099(10)70251-6; Claus H, 2002, MICROBIOL-SGM, V148, P1813, DOI 10.1099/00221287-148-6-1813; de Moraes JC, 2015, PEDIATR INFECT DIS J, V34, P1197, DOI 10.1097/INF.0000000000000853; Drakopoulou Z, 2008, FEMS IMMUNOL MED MIC, V53, P178, DOI 10.1111/j.1574-695X.2008.00406.x; Dyet KH, 2006, EPIDEMIOL INFECT, V134, P377, DOI 10.1017/S0950268805004954; Gasparini R, 2014, J CLIN MICROBIOL, V52, P1901, DOI 10.1128/JCM.03584-13; Harrison OB, 2013, EMERG INFECT DIS, V19, P566, DOI 10.3201/eid1904.111799; Jeppesen CA, 2015, J INFECTION, V71, P43, DOI 10.1016/j.jinf.2015.02.006; Kafetzis DA, 2007, CLIN MICROBIOL INFEC, V13, P550, DOI 10.1111/j.1469-0691.2007.01704.x; Kremastinou J, 1999, FEMS IMMUNOL MED MIC, V23, P13, DOI 10.1111/j.1574-695X.1999.tb01716.x; MacLennan J, 2006, EMERG INFECT DIS, V12, P950; Maiden MCJ, 2008, J INFECT DIS, V197, P737, DOI 10.1086/527401; Moreno J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135497; OLCEN P, 1981, SCAND J INFECT DIS, V13, P105, DOI 10.3109/inf.1981.13.issue-2.05; Read RC, 2014, LANCET, V384, P2123, DOI 10.1016/S0140-6736(14)60842-4; Sakou II, 2011, EUR J PEDIATR, V170, P1419, DOI 10.1007/s00431-011-1456-z; Sakou II, 2009, VACCINE, V27, P4408, DOI 10.1016/j.vaccine.2009.05.047; Soriano-Gabarro M, 2011, EXPERT REV ANTI-INFE, V9, P761, DOI [10.1586/ERI.11.89, 10.1586/eri.11.89]; Stuart J, 1989, LANSET, V334, P723; Taha MK, 2014, LANCET, V384, P2088, DOI 10.1016/S0140-6736(14)60935-1; Trotter CL, 2007, FEMS MICROBIOL REV, V31, P101, DOI 10.1111/j.1574-6976.2006.00053.x; Trotter CL, 2009, EXPERT REV VACCINES, V8, P851, DOI [10.1586/erv.09.48, 10.1586/ERV.09.48]; Tsolia M, 2015, MENINGOCOCCAL DIS GR; Tsolia MN, 2006, EUR J CLIN MICROBIOL, V25, P449, DOI 10.1007/s10096-006-0155-6; Tzanakaki G, NATL MENINGITIS REFE; Tzanakaki G, 2007, INT J ANTIMICROB AG, V29, P621, DOI 10.1016/j.ijantimicag.2006.11.031; Tzanakaki G, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-111	35	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167404	10.1371/journal.pone.0167404	http://dx.doi.org/10.1371/journal.pone.0167404			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907129	Green Submitted, Green Published, gold			2022-12-26	WOS:000389482700146
J	Wang, HT; Huang, C; Zhao, WX; Dai, BS; Shen, C; Zhang, BB; Li, DG; Lin, ZX				Wang, Hantao; Huang, Cong; Zhao, Wenxia; Dai, Baosheng; Shen, Chao; Zhang, Beibei; Li, Dingguo; Lin, Zhongxu			Identification of QTL for Fiber Quality and Yield Traits Using Two Immortalized Backcross Populations in Upland Cotton	PLOS ONE			English	Article							ENVIRONMENT INTERACTIONS CONTRIBUTE; GOSSYPIUM-HIRSUTUM; PARTIAL DOMINANCE; GENE-EXPRESSION; CELL ELONGATION; EPISTASIS; HETEROSIS; LOCI; MAP; CONSTRUCTION	Two immortalized backcross populations (DHBCF(1)s and JMBCF(1)s) were developed using a recombinant inbred line (RIL) population crossed with the two parents DH962 and Jimian5 (as the males), respectively. The fiber quality and yield component traits of the two backcross populations were phenotyped at four environments (two locations, two years). One hundred seventy-eight quantitative trait loci (QTL) were detected including 76 for fiber qualities and 102 for yield components, explaining 4.08-17.79% of the phenotypic variation (PV). Among the 178 QTL, 22 stable QTL were detected in more than one environment or population. A stable QTL, qFL-c10-1, was detected in the previous F-2 population, a RIL population in 3 environments and the current two BCF1 populations in this study, explaining 5.79-37.09% of the PV. Additionally, 117 and 110 main-effect QTL (M-QTL) and 47 and 191 digenic epistatic QTL (E-QTL) were detected in the DHBCF(1)s and JMBCF(1)s populations, respectively. The effect of digenic epistasis played a more important role on lint percentage, fiber length and fiber strength. These results obtained in the present study provided more resources to obtain stable QTL, confirming the authenticity and reliability of the QTL for molecular marker-assisted selection breeding and QTL cloning.	[Wang, Hantao; Huang, Cong; Zhao, Wenxia; Dai, Baosheng; Shen, Chao; Zhang, Beibei; Lin, Zhongxu] Huazhong Agr Univ, Coll Plant Sci & Technol, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China; [Wang, Hantao] CAAS, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Henan, Peoples R China; [Li, Dingguo] Yangtze Univ, Coll Agr, Inst Crop Genet & Breeding, Jingzhou, Hubei, Peoples R China	Huazhong Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Yangtze University	Lin, ZX (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China.; Li, DG (corresponding author), Yangtze Univ, Coll Agr, Inst Crop Genet & Breeding, Jingzhou, Hubei, Peoples R China.	lidingguo654456@126.com; linzhongxu@mail.hzau.edu.cn	shen, chao/GZL-3987-2022; Wang, Han/GPW-9809-2022	Shen, Chao/0000-0001-5483-3348	Fundamental Research Funds for the Central Universities [2014PY015]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was financially supported by the Fundamental Research Funds for the Central Universities (Grant No. 2014PY015).	Al-Ghazi Y, 2009, PLANT CELL PHYSIOL, V50, P1364, DOI 10.1093/pcp/pcp084; Arpat AB, 2004, PLANT MOL BIOL, V54, P911, DOI 10.1007/s11103-004-0392-y; BASRA AS, 1984, INT REV CYTOL, V89, P65, DOI 10.1016/S0074-7696(08)61300-5; Chen ZJ, 2007, PLANT PHYSIOL, V145, P1303, DOI 10.1104/pp.107.107672; CHURCHILL GA, 1994, GENETICS, V138, P963; Deng FL, 2012, PLANT PHYSIOL, V158, P890, DOI 10.1104/pp.111.186742; Fang DD, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-397; Gou JY, 2007, CELL RES, V17, P422, DOI 10.1038/sj.cr.7310150; Hao J, 2012, J EXP BOT, V63, P6267, DOI 10.1093/jxb/ers278; He DH, 2005, EUPHYTICA, V144, P141, DOI 10.1007/s10681-005-5297-6; Hovav R, 2008, PLANTA, V227, P319, DOI 10.1007/s00425-007-0619-7; Islam MS, 2014, MOL BREEDING, V34, P373, DOI 10.1007/s11032-014-0040-4; Jia YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095882; Li Y, 2016, PLANT BIOTECHNOL J, V14, P951, DOI 10.1111/pbi.12450; Li YJ, 2010, PLANT CELL REP, V29, P193, DOI 10.1007/s00299-009-0812-1; Li ZK, 2001, GENETICS, V158, P1737; Liang QZ, 2014, J GENET, V93, P63, DOI 10.1007/s12041-014-0341-8; Lin Z, 2005, PLANT BREEDING, V124, P180, DOI 10.1111/j.1439-0523.2004.01039.x; Liu NA, 2014, PLANT J, V80, P331, DOI 10.1111/tpj.12636; McCouch SR, 1997, RICE GENET NEWSLETT, V14, P11, DOI [DOI 10.1007/S10142-013-0328-1, DOI 10.1007/S10681-005-0449-2]; Meredith WR, 2005, CROP SCI, V45, P807, DOI 10.2135/cropsci2005.0807; Nie XH, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2662-x; Ning ZY, 2014, EUPHYTICA, V195, P143, DOI 10.1007/s10681-013-0990-3; Qin HD, 2008, THEOR APPL GENET, V117, P883, DOI 10.1007/s00122-008-0828-x; Qin HD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118073; Said JI, 2015, MOL GENET GENOMICS, V290, P1003, DOI [10.1007/s00438-015-1021-y, 10.1007/s00438-014-0963-9]; Said JI, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-776; Shang LG, 2016, THEOR APPL GENET, V129, P1429, DOI 10.1007/s00122-016-2714-2; Shang LG, 2016, PLANT BREEDING, V135, P224, DOI 10.1111/pbr.12352; Shang LG, 2016, G3-GENES GENOM GENET, V6, P499, DOI 10.1534/g3.115.025809; Shao QS, 2014, EUPHYTICA, V198, P43, DOI 10.1007/s10681-014-1082-8; Shen XL, 2006, CROP SCI, V20; Shi YH, 2006, PLANT CELL, V18, P651, DOI 10.1105/tpc.105.040303; Sun FD, 2012, MOL BREEDING, V30, P569, DOI 10.1007/s11032-011-9645-z; Tan ZY, 2015, EUPHYTICA, V203, P615, DOI 10.1007/s10681-014-1288-9; Tang SY, 2015, EUPHYTICA, V201, P195, DOI [10.1007/s10681-014-1189-y, 10.1007/s10681-]; Tang WX, 2014, PLANT MOL BIOL, V85, P613, DOI 10.1007/s11103-014-0208-7; Tang WX, 2014, NEW PHYTOL, V202, P509, DOI 10.1111/nph.12676; Tu LL, 2007, PLANT CELL REP, V26, P1309, DOI 10.1007/s00299-007-0337-4; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang HT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130742; Wang HT, 2015, DNA RES, V22, P147, DOI 10.1093/dnares/dsu047; Wendel JF, 2003, ADV AGRON, V78, P139, DOI 10.1016/S0065-2113(02)78004-8; Xia Z, 2014, J INTEGR AGR, V13, P299, DOI 10.1016/S2095-3119(13)60508-0; Yang SS, 2006, PLANT J, V47, P761, DOI 10.1111/j.1365-313X.2006.02829.x; Zhang M, 2011, NAT BIOTECHNOL, V29, P453, DOI 10.1038/nbt.1843; Zhang TZ, 2015, NAT BIOTECHNOL, V33, P531, DOI 10.1038/nbt.3207; Zhang Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135430	48	23	25	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166970	10.1371/journal.pone.0166970	http://dx.doi.org/10.1371/journal.pone.0166970			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907098	gold, Green Submitted, Green Published			2022-12-26	WOS:000389482700057
J	Yeom, SJ; Lee, DH; Kim, YJ; Lee, J; Kwon, KK; Han, GH; Kim, H; Kim, HS; Lee, SG				Yeom, Soo-Jin; Lee, Dae-Hee; Kim, Yu Jung; Lee, Jeongmin; Kwon, Kil Koang; Han, Gui Hwan; Kim, Haseong; Kim, Hak-Sung; Lee, Seung-Goo			Long-Term Stable and Tightly Controlled Expression of Recombinant Proteins in Antibiotics-Free Conditions	PLOS ONE			English	Article							ESCHERICHIA-COLI; CHROMOSOMAL INTEGRATION; PLASMID SELECTION; GENE-EXPRESSION; EFFICIENT; DNA; REPLICATION; SYSTEMS	Plasmid-based gene expression is a fundamental tool in the field of biotechnology. However, overexpression of genes of interest with multi-copy plasmids often causes detrimental effects on host cells. To overcome this problem, chromosomal integration of target genes has been used for decades; however, insufficient protein expression occurred with this method. In this study, we developed a novel cloning and expression system named the chromosomal vector (ChroV) system, that has features of stable and high expression of target genes on the F' plasmid in the Escherichia coli JM109(DE3) strain. We used an RMT cluster (KCTC 11994BP) containing a silent cat gene from a previous study to clone a gene into the F' plasmid. The ChroV system was applied to clone two model targets, GFPuv and carotenoids gene clusters (4 kb), and successfully used to prove the inducible tightly regulated protein expression in the F' plasmid. In addition, we verified that the expression of heterologous genes in ChroV system maintained stably in the absence of antibiotics for 1 week, indicating ChroV system is applicable to antibiotics-free production of valuable proteins. This protocol can be widely applied to recombinant protein expression for antibiotics-free, stable, and genome-based expression, providing a new platform for recombinant protein synthesis in E. coli. Overall, our approach can be widely used for the economical and industrial production of proteins in E. coli.	[Yeom, Soo-Jin; Lee, Dae-Hee; Kim, Yu Jung; Lee, Jeongmin; Kwon, Kil Koang; Han, Gui Hwan; Kim, Haseong; Lee, Seung-Goo] KRIBB, Synthet Biol & Bioengn Res Ctr, Daejeon, South Korea; [Lee, Dae-Hee; Lee, Seung-Goo] UST, Biosyst & Bioengn, Daejeon, South Korea; [Kim, Yu Jung; Kim, Hak-Sung] Korea Adv Inst Sci & Technol, Dept Biol Sci, Daejeon, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of Science & Technology (UST); Korea Advanced Institute of Science & Technology (KAIST)	Lee, SG (corresponding author), KRIBB, Synthet Biol & Bioengn Res Ctr, Daejeon, South Korea.; Lee, SG (corresponding author), UST, Biosyst & Bioengn, Daejeon, South Korea.	sglee@kribb.re.kr	Lee, Seung-Goo/AAR-9823-2021; LEE, DAE-HEE/O-5243-2018; Lee, Seung-Goo/AAS-1613-2021; Yeom, Soojin/AAE-3558-2022; Kim, Hak-Sung/C-1929-2011	Lee, Seung-Goo/0000-0003-4539-9812; LEE, DAE-HEE/0000-0002-0423-9057; Yeom, Soo-Jin/0000-0001-7307-237X	Intelligent Synthetic Biology Center of the Global Frontier Project [2011-0031944]; New & Renewable Energy Core Technology Program of the Korea Institute of Energy Technology Evaluation and Planning [20133030000300]; C1 Gas Refinery Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2015M3D3A1A01064875]; Korea Research Institute of Bioscience and Biotechnology Research Initiative Program	Intelligent Synthetic Biology Center of the Global Frontier Project; New & Renewable Energy Core Technology Program of the Korea Institute of Energy Technology Evaluation and Planning; C1 Gas Refinery Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning; Korea Research Institute of Bioscience and Biotechnology Research Initiative Program	This research was supported by grants from the Intelligent Synthetic Biology Center of the Global Frontier Project (2011-0031944), the New & Renewable Energy Core Technology Program of the Korea Institute of Energy Technology Evaluation and Planning (20133030000300), C1 Gas Refinery Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2015M3D3A1A01064875), and the Korea Research Institute of Bioscience and Biotechnology Research Initiative Program.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Balbas P, 2001, MOL BIOTECHNOL, V19, P1, DOI 10.1385/MB:19:1:001; Balbas P, 2001, MOL BIOTECHNOL, V19, P251, DOI 10.1385/MB:19:3:251; Bryant JA, 2014, NUCLEIC ACIDS RES, V42, P11383, DOI 10.1093/nar/gku828; Cho SH, 2005, J BIOTECHNOL, V119, P197, DOI 10.1016/j.jbiotec.2005.03.008; Dong WR, 2010, APPL ENVIRON MICROB, V76, P2295, DOI 10.1128/AEM.02462-09; Faridani OR, 2006, NUCLEIC ACIDS RES, V34, P5915, DOI 10.1093/nar/gkl750; Gerdes K, 2000, J BACTERIOL, V182, P561, DOI 10.1128/JB.182.3.561-572.2000; Goh S, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-61; Gu PF, 2015, SCI REP-UK, V5, DOI 10.1038/srep09684; Haldimann A, 2001, J BACTERIOL, V183, P6384, DOI 10.1128/JB.183.21.6384-6393.2001; Hiraga S, 1985, Basic Life Sci, V30, P469; Jana S, 2005, APPL MICROBIOL BIOT, V67, P289, DOI 10.1007/s00253-004-1814-0; Jones KL, 1998, BIOTECHNOL BIOENG, V59, P659, DOI 10.1002/(SICI)1097-0290(19980920)59:6<659::AID-BIT1>3.3.CO;2-1; Kato Y, 2015, PEERJ, V3, DOI 10.7717/peerj.1247; Keasling JD, 2012, METAB ENG, V14, P189, DOI 10.1016/j.ymben.2012.01.004; KEASLING JD, 1991, J BACTERIOL, V173, P2673, DOI 10.1128/jb.173.8.2673-2680.1991; Khlebnikov A, 2002, BIOTECHNOL PROGR, V18, P672, DOI 10.1021/bp010141k; Kofoid E, 2003, J BACTERIOL, V185, P660, DOI 10.1128/JB.185.2.660-663.2003; Kroll J, 2010, MICROB BIOTECHNOL, V3, P634, DOI 10.1111/j.1751-7915.2010.00170.x; Kuhlman TE, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1193; LEE JJ, 2013, PLOS COMPUT BIOL, V9, DOI DOI 10.1371/JOURNAL.PONE.0079979; McKenzie GJ, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-39; Palomares LA, 2004, RECOMBINANT GENE EXP; Preston Andrew, 2003, Methods Mol Biol, V235, P19; Rao XC, 2004, PROTEIN EXPRES PURIF, V36, P11, DOI 10.1016/j.pep.2004.01.020; Sharan SK, 2009, NAT PROTOC, V4, P206, DOI 10.1038/nprot.2008.227; SHIZUYA H, 1992, P NATL ACAD SCI USA, V89, P8794, DOI 10.1073/pnas.89.18.8794; Sibley MH, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1085; Tyo KE, 2007, TRENDS BIOTECHNOL, V25, P132, DOI 10.1016/j.tibtech.2007.01.003; Willenbrock H, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-252; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417; Zucca S, 2013, J BIOL ENG, V7, DOI 10.1186/1754-1611-7-12	34	5	5	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166890	10.1371/journal.pone.0166890	http://dx.doi.org/10.1371/journal.pone.0166890			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907029	gold, Green Published			2022-12-26	WOS:000389482700048
J	Cermak, S; Kosicek, M; Mladenovic-Djordjevic, A; Smiljanic, K; Kanazir, S; Hecimovic, S				Cermak, Stjepko; Kosicek, Marko; Mladenovic-Djordjevic, Aleksandra; Smiljanic, Kosara; Kanazir, Selma; Hecimovic, Silva			Loss of Cathepsin B and L Leads to Lysosomal Dysfunction, NPC-Like Cholesterol Sequestration and Accumulation of the Key Alzheimer's Proteins	PLOS ONE			English	Article							C-DISEASE; BRAIN; BETA; MOUSE; NEURODEGENERATION; EXPRESSION; CELLS; APP	Proper function of lysosomes is particularly important in neurons, as they cannot dilute accumulated toxic molecules and aggregates by cell division. Thus, impairment of lysosomal function plays an important role in neuronal degeneration and in the pathogenesis of numerous neurodegenerative diseases. In this work we analyzed how inhibition and/or loss of the major lysosomal proteases, the cysteine cathepsins B and L (CtsB/L), affects lysosomal function, cholesterol metabolism and degradation of the key Alzheimer's disease (AD) proteins. Here, we show that cysteine CtsB/L, and not the aspartyl cathepsin D (CtsD), represent a major lysosomal protease(s) that control lysosomal function, intracellular cholesterol trafficking and AD-like amyloidogenic features. Intriguingly, accumulation of free cholesterol in late endosomes/lysosomes upon CtsB/L inhibition resembled a phenotype characteristic for the rare neurodegenerative disorder Niemann-Pick type C (NPC). CtsB/L inhibition and not the inhibition of CtsD led to lysosomal impairment assessed by decreased degradation of EGF receptor, enhanced LysoTracker staining and accumulation of several lysosomal proteins LC3II, NPC1 and NPC2. By measuring the levels of NPC1 and ABCA1, the two major cholesterol efflux proteins, we showed that CtsB/L inhibition or genetic depletion caused accumulation of the NPC1 in lysosomes and downregulation of ABCA1 protein levels and its expression. Furthermore, we revealed that CtsB/L are involved in degradation of the key Alzheimer's proteins: amyloid-beta peptides (A beta) and C-terminal fragments of the amyloid precursor protein (APP) and in degradation of beta-secretase (BACE1). Our results imply CtsB/L as major regulators of lysosomal function and demonstrate that CtsB/L may play an important role in intracellular cholesterol trafficking and in degradation of the key AD proteins. Our findings implicate that enhancing the activity or levels of CtsB/L could provide a promising and a common strategy for maintaining lysosomal function and for preventing and/or treating neurodegenerative diseases.	[Cermak, Stjepko; Kosicek, Marko; Hecimovic, Silva] Rudjer Boskovic Inst, Div Mol Med, Zagreb, Croatia; [Mladenovic-Djordjevic, Aleksandra; Smiljanic, Kosara; Kanazir, Selma] Sinisa Stankovic Univ Belgrade, Inst Biol Res, Dept Neurobiol, Mol Neurobiol Lab, Belgrade, Serbia	Rudjer Boskovic Institute; University of Belgrade	Hecimovic, S (corresponding author), Rudjer Boskovic Inst, Div Mol Med, Zagreb, Croatia.	silva.hecimovic@irb.hr	Kanazir, Selma/E-5495-2015; Hecimovic, Silva/T-8091-2017	Kanazir, Selma/0000-0002-7229-5296; Smiljanic, Kosara/0000-0002-6790-5491; Hecimovic, Silva/0000-0001-6077-433X; Mladenovic, Aleksandra/0000-0001-9011-5634	Swiss National Science Foundation grant SCOPES [IZ73Z0_152496]; Ministry of Education, Science and Technological Development of the Republic of Serbia [ON173056]	Swiss National Science Foundation grant SCOPES; Ministry of Education, Science and Technological Development of the Republic of Serbia	This work was funded by the Unity Through Knowledge grant (to S.H.), by the Swiss National Science Foundation grant SCOPES (IZ73Z0_152496, to A.M.-D. and S.H.) and by the Ministry of Education, Science and Technological Development of the Republic of Serbia (Grant No ON173056 to SK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amritraj A, 2009, AM J PATHOL, V175, P2540, DOI 10.2353/ajpath.2009.081096; Berger-Sweeney J, 1999, MOL BRAIN RES, V66, P150, DOI 10.1016/S0169-328X(99)00014-5; BIEDLER JL, 1978, CANCER RES, V38, P3751; Butler D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020501; CATALDO AM, 1990, P NATL ACAD SCI USA, V87, P3861, DOI 10.1073/pnas.87.10.3861; CATALDO AM, 1995, NEURON, V14, P671, DOI 10.1016/0896-6273(95)90324-0; Felbor U, 2002, P NATL ACAD SCI USA, V99, P7883, DOI 10.1073/pnas.112632299; Fukumoto H, 2004, AM J PATHOL, V164, P719, DOI 10.1016/S0002-9440(10)63159-8; German DC, 2001, J COMP NEUROL, V433, P415, DOI 10.1002/cne.1149; Hannaford J, 2013, OBESITY, V21, P1586, DOI 10.1002/oby.20136; HIGASHI Y, 1993, ACTA NEUROPATHOL, V85, P175; Hook G, 2007, BIOL CHEM, V388, P979, DOI 10.1515/BC.2007.117; Hook G, 2014, J ALZHEIMERS DIS, V41, P129, DOI 10.3233/JAD-131370; Hook VYH, 2006, CELL MOL NEUROBIOL, V26, P449, DOI 10.1007/s10571-006-9047-7; Jung M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116972; Kandalepas PC, 2013, ACTA NEUROPATHOL, V126, P329, DOI 10.1007/s00401-013-1152-3; Koike M, 2000, J NEUROSCI, V20; Macias-Vidal J, 2016, PROTEOMICS, V16, P150, DOI 10.1002/pmic.201500110; Malnar M, 2014, NEUROBIOL DIS, V72, P37, DOI 10.1016/j.nbd.2014.05.033; Malnar M, 2012, BBA-MOL BASIS DIS, V1822, P1270, DOI 10.1016/j.bbadis.2012.04.002; Malnar M, 2010, BBA-MOL BASIS DIS, V1802, P682, DOI 10.1016/j.bbadis.2010.05.006; McGlinchey RP, 2015, P NATL ACAD SCI USA, V112, P9322, DOI 10.1073/pnas.1500937112; Millard EE, 2000, J BIOL CHEM, V275, P38445, DOI 10.1074/jbc.M003180200; Mueller-Steiner S, 2006, NEURON, V51, P703, DOI 10.1016/j.neuron.2006.07.027; Nakanishi H, 2003, AGEING RES REV, V2, P367, DOI 10.1016/S1568-1637(03)00027-8; Riemenschneider M, 2006, HUM MUTAT, V27, P532, DOI 10.1002/humu.20326; Schechter I, 2011, BIOL CHEM, V392, P555, DOI 10.1515/BC.2011.054; Settembre C, 2013, NAT REV MOL CELL BIO, V14, P283, DOI 10.1038/nrm3565; Tholen S, 2014, CELL MOL LIFE SCI, V71, P899, DOI 10.1007/s00018-013-1406-1; Xu HX, 2015, ANNU REV PHYSIOL, V77, P57, DOI 10.1146/annurev-physiol-021014-071649; Zheng XY, 2012, J BIOL CHEM, V287, P6084, DOI 10.1074/jbc.C111.328575	31	60	62	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167428	10.1371/journal.pone.0167428	http://dx.doi.org/10.1371/journal.pone.0167428			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902765	Green Published, gold			2022-12-26	WOS:000389474100081
J	Gurariy, G; Killebrew, KW; Berryhill, ME; Caplovitz, GP				Gurariy, Gennadiy; Killebrew, Kyle W.; Berryhill, Marian E.; Caplovitz, Gideon P.			Induced and Evoked Human Electrophysiological Correlates of Visual Working Memory Set-Size Effects at Encoding	PLOS ONE			English	Article							SHORT-TERM-MEMORY; PREDICTS INDIVIDUAL-DIFFERENCES; DELTA OSCILLATIONS; NEURAL MEASURES; PARIETAL LOBE; CAPACITY; ATTENTION; PSYCHOPHYSICS; INFORMATION; PHASE	The ability to encode, store, and retrieve visually presented objects is referred to as visual working memory (VWM). Although crucial for many cognitive processes, previous research reveals that VWM strictly capacity limited. This capacity limitation is behaviorally observable in the set size effect: the ability to successfully report items in VWM asymptotes at a small number of items. Research into the neural correlates of set size effects and VWM capacity limits in general largely focus on the maintenance period of VWM. However, we previously reported that neural resources allocated to individual items during VWM encoding correspond to successful VWM performance. Here we expand on those findings by investigating neural correlates of set size during VWM encoding. We hypothesized that neural signatures of encoding-related VWM capacity limitations should be differentiable as a function of set size. We tested our hypothesis using High Density Electroencephalography (HD-EEG) to analyze frequency components evoked by flickering target items in VWM displays of set size 2 or 4. We found that set size modulated the amplitude of the 1st and 2nd harmonic frequencies evoked during successful VWM encoding across frontal and occipital-parietal electrodes. Frontal sites exhibited the most robust effects for the 2nd harmonic (set size 2 > set size 4). Additionally, we found a set-size effect on the induced power of delta-band (1-4 Hz) activity (set size 2 > set size 4). These results are consistent with a capacity limited VWM resource at encoding that is distributed across to-be-remembered items in a VWM display. This resource may work in conjunction with a task-specific selection process that determines which items are to be encoded and which are to be ignored. These neural set size effects support the view that VWM capacity limitations begin with encoding related processes.	[Gurariy, Gennadiy; Killebrew, Kyle W.; Berryhill, Marian E.; Caplovitz, Gideon P.] Univ Nevada, Reno Dept Psychol, Reno, NV 89557 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno	Gurariy, G (corresponding author), Univ Nevada, Reno Dept Psychol, Reno, NV 89557 USA.	ggurariy@unr.edu		Berryhill, Marian/0000-0002-8218-6587	National Science Foundation [NSF 1632848, NSF 1632849]; National Institutes of Health [1P20GM103650, R15EY022775]; NATIONAL EYE INSTITUTE [R15EY022775] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103650] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This material is based upon work supported by the National Science Foundation under grants: NSF 1632848 and NSF 1632849 and the National Institutes of Health under grants: 1P20GM103650 and R15EY022775. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Averbach E, 1961, INFORMATION THEORY, P196; Basar E, 2001, INT J PSYCHOPHYSIOL, V39, P241, DOI 10.1016/S0167-8760(00)00145-8; Bastiaansen M, 2003, CORTEX, V39, P967, DOI 10.1016/S0010-9452(08)70873-6; Bays PM, 2009, J VISION, V9, DOI 10.1167/9.10.7; Berryhill ME, 2008, NEUROPSYCHOLOGIA, V46, P1775, DOI 10.1016/j.neuropsychologia.2008.03.005; Brady TF, 2013, PSYCHOL REV, V120, P85, DOI 10.1037/a0030779; Brady TF, 2009, J EXP PSYCHOL GEN, V138, P487, DOI 10.1037/a0016797; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BROWN J, 1958, Q J EXP PSYCHOL, V10, P12, DOI 10.1080/17470215808416249; Buschman TJ, 2011, P NATL ACAD SCI USA, V108, P11252, DOI 10.1073/pnas.1104666108; Canolty RT, 2010, TRENDS COGN SCI, V14, P506, DOI 10.1016/j.tics.2010.09.001; Caplovitz GP, 2008, CONSCIOUS COGN, V17, P877, DOI 10.1016/j.concog.2007.08.006; Cohen JR, 2014, CEREB CORTEX, V24, P593, DOI 10.1093/cercor/bhs339; Cooper PS, 2015, NEUROIMAGE, V108, P354, DOI 10.1016/j.neuroimage.2014.12.028; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Culham JC, 2001, NEURON, V32, P737, DOI 10.1016/S0896-6273(01)00499-8; Cusack R, 2009, PSYCHON B REV, V16, P641, DOI 10.3758/PBR.16.4.641; Drew T, 2008, J NEUROSCI, V28, P4183, DOI 10.1523/JNEUROSCI.0556-08.2008; Engle RW, 1999, J EXP PSYCHOL GEN, V128, P309, DOI 10.1037/0096-3445.128.3.309; Eroglu C., 1992, EVOKED POTENTIALS EN; Fell J, 2011, NAT REV NEUROSCI, V12, P105, DOI 10.1038/nrn2979; Fernandez T, 2002, ADV CLIN NEUROPHYSIO; Gazzaley A, 2012, TRENDS COGN SCI, V16, P129, DOI 10.1016/j.tics.2011.11.014; Gazzaley A, 2011, NEUROPSYCHOLOGIA, V49, P1410, DOI 10.1016/j.neuropsychologia.2010.12.022; Gevins A, 1997, CEREB CORTEX, V7, P374, DOI 10.1093/cercor/7.4.374; Habeck C, 2005, COGNITIVE BRAIN RES, V23, P207, DOI 10.1016/j.cogbrainres.2004.10.010; Harmony T, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00083; Harrison SA, 2009, NATURE, V458, P632, DOI 10.1038/nature07832; IRWIN DE, 1991, COGNITIVE PSYCHOL, V23, P420, DOI 10.1016/0010-0285(91)90015-G; IRWIN DE, 1992, J EXP PSYCHOL LEARN, V18, P307, DOI 10.1037/0278-7393.18.2.307; Jiang YH, 2000, J EXP PSYCHOL LEARN, V26, P683, DOI 10.1037/0278-7393.26.3.683; Jovicich J, 2001, J COGNITIVE NEUROSCI, V13, P1048, DOI 10.1162/089892901753294347; Kane MJ, 2007, PSYCHOL SCI, V18, P614, DOI 10.1111/j.1467-9280.2007.01948.x; Killebrew K, 2015, NEUROPSYCHOLOGIA, V73, P12, DOI 10.1016/j.neuropsychologia.2015.04.032; Kim YJ, 2011, J COGNITIVE NEUROSCI, V23, P1875, DOI 10.1162/jocn.2010.21536; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; LaRocque JJ, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00005; Linden DEJ, 2007, NEUROSCIENTIST, V13, P257, DOI 10.1177/1073858406298480; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; Luck SJ, 2013, TRENDS COGN SCI, V17, P391, DOI 10.1016/j.tics.2013.06.006; Ma LS, 2012, HUM BRAIN MAPP, V33, P1850, DOI 10.1002/hbm.21329; Majerus S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069278; McCollough AW, 2007, CORTEX, V43, P77, DOI 10.1016/S0010-9452(08)70447-7; Michel CM, 2004, CLIN NEUROPHYSIOL, V115, P2195, DOI 10.1016/j.clinph.2004.06.001; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/h0043158; Miller R., 1991, CORTICO HIPPOCAMPAL; Missonnier P, 2006, J NEURAL TRANSM, V113, P1477, DOI 10.1007/s00702-005-0443-9; Motes MA, 2010, NEUROIMAGE, V49, P1933, DOI 10.1016/j.neuroimage.2009.08.054; Norcia AM, 2015, J VISION, V15, DOI 10.1167/15.6.4; Oksama L, 2004, VIS COGN, V11, P631, DOI 10.1080/13506280344000473; Olson IR, 2009, NEUROBIOL LEARN MEM, V91, P155, DOI 10.1016/j.nlm.2008.09.006; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Peterson DJ, 2014, NEUROPSYCHOLOGIA, V63, P145, DOI 10.1016/j.neuropsychologia.2014.08.020; PETERSON LR, 1959, J EXP PSYCHOL, V58, P193, DOI 10.1037/h0049234; Phillips W., 1974, PERCEPT PSYCHOPHYS, V16, P193; Prada L, 2014, PSYCHOPHYSIOLOGY, V51, P658, DOI 10.1111/psyp.12210; PYLYSHYN Z, 1987, B PSYCHONOMIC SOC, V25, P332; Rensink RA, 1997, PSYCHOL SCI, V8, P368, DOI 10.1111/j.1467-9280.1997.tb00427.x; Schon K, 2016, CEREB CORTEX, V26, P1965, DOI 10.1093/cercor/bhv013; Schon K, 2009, CEREB CORTEX, V19, P2561, DOI 10.1093/cercor/bhp006; Serences JT, 2009, PSYCHOL SCI, V20, P207, DOI 10.1111/j.1467-9280.2009.02276.x; Sligte IG, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00175; SPERLING G, 1960, PSYCHOL MONOGR, V74, P1, DOI 10.1037/h0093759; Stefanics G, 2010, J NEUROSCI, V30, P13578, DOI 10.1523/JNEUROSCI.0703-10.2010; STERNBERG S, 1969, AM SCI, V57, P421; STERNBERG S, 1966, SCIENCE, V153, P652, DOI 10.1126/science.153.3736.652; Tadel F, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/879716; Todd JJ, 2005, COGN AFFECT BEHAV NE, V5, P144, DOI 10.3758/CABN.5.2.144; Todd JJ, 2004, NATURE, V428, P751, DOI 10.1038/nature02466; Townsend JT, 2004, PERCEPT PSYCHOPHYS, V66, P953, DOI 10.3758/BF03194987; Tsubomi H, 2013, J NEUROSCI, V33, P8257, DOI 10.1523/JNEUROSCI.5348-12.2013; Vogel EK, 2005, NATURE, V438, P500, DOI 10.1038/nature04171; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; Vogel EK, 2001, J EXP PSYCHOL HUMAN, V27, P92, DOI 10.1037/0096-1523.27.1.92; Ward LM, 2003, TRENDS COGN SCI, V7, P553, DOI 10.1016/j.tics.2003.10.012; Wendelken C, 2008, NEUROPSYCHOLOGIA, V46, P665, DOI 10.1016/j.neuropsychologia.2007.09.015; Xu YD, 2006, NATURE, V440, P91, DOI 10.1038/nature04262	77	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167022	10.1371/journal.pone.0167022	http://dx.doi.org/10.1371/journal.pone.0167022			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FV	27902738	Green Published, gold			2022-12-26	WOS:000389474100043
J	Rahman, S; Campbell, CMP; Rollison, DE; Wang, W; Waterboer, T; Michel, A; Pawlita, M; Villa, LL; Ponce, EL; Borenstein, AR; Giuliano, AR				Rahman, Shams; Campbell, Christine M. Pierce; Rollison, Dana E.; Wang, Wei; Waterboer, Tim; Michel, Angelika; Pawlita, Michael; Villa, Luisa L.; Lazcano Ponce, Eduardo; Borenstein, Amy R.; Giuliano, Anna R.			Seroprevalence and Associated Factors of 9-Valent Human Papillomavirus (HPV) Types among Men in the Multinational HIM Study	PLOS ONE			English	Article							ANAL HUMAN-PAPILLOMAVIRUS; HIGH-RISK HPV; VACCINATION RECOMMENDATIONS; ADVISORY-COMMITTEE; NATURAL-HISTORY; UNITED-STATES; INFECTION; POPULATION; PREVALENCE; SEROPOSITIVITY	Background Human papillomavirus (HPV) is one of the most common sexually transmitted infections worldwide. Recently a 9-valent HPV (9vHPV) prophylactic vaccine was licensed. Seroprevalence prior to vaccine dissemination is needed for monitoring vaccine effectiveness over time. Few studies have assessed the seroprevalence of 9vHPV types in men. Objectives To investigate the seroprevalence of 9vHPV vaccine types and associated risk factors among men residing in Brazil, Mexico, and the United States. Methods Six hundred men were randomly selected from the HPV Infection in Men (HIM) Study. Archived serum specimens collected at enrollment were tested for antibodies against nine HPV types (6, 11, 16, 18, 31, 33, 45, 52 and 58) using a glutathione S-transferase (GST) L1-based multiplex serologic assay. Socio-demographic, lifestyle and sexual behavior data at enrollment were collected through a questionnaire. Binomial proportions were used to estimate seroprevalence and logistic regression was used to examine factors associated with seropositivity of type-specific and grouped (i.e. 9vHPV, high-risk 9vHPV, low risk 9vHPV, and five-additional) HPV types. Results Overall, 28.3% of men were seropositive for at least one of the 9vHPV vaccine types, 14.0% for at least one of the seven high-risk types (16, 18, 31, 33, 45, 52 and 58) and 11.2% for at least one of the five high-risk types (31, 33, 45, 52 and 58) not included in the quadrivalent HPV vaccine, and 17.4% for at least one of the low-risk types (6/11). In multivariate analyses, odds ratios adjusted (AOR) for country of residence, age, marital status, smoking, number of anal sex lifetime partners, compared to men with no anal sex lifetime partners, men with >= 2 partners were more likely to be seropositive for grouped HPV [(9vHPV: AOR 2.52; 95% confidence interval (CI) 1.40-4.54), (high-risk 9vHPV: AOR 2.18; 95%Cl: 1.05-4.50) and (low-risk 9vHPV: AOR 2.12; 95%Cl: 1.12-4.03)], and individual HPV types 6, 16, 33 and 58 with AORs ranging from 2.19 to 7.36. Compared to men aged 18-30 years, men older than 30 years were significantly more likely to be seropositive for any high-risk 9vHPV, in addition to individual types 18 and 45; and compared to never smokers, current smokers were more likely to be seropositive to 9vHPV, low-risk 9vHPV and HPV 6. In contrast, married men were less likely to be seropositive to any high-risk 9vHPV and individual HPV types 18 and 31 when compared to single men. Conclusions These data indicate that exposure to the nine HPV types included in the 9vHPV vaccine is common in men and that seropositivity to 9vHPV vaccine types is associated with older age and the lifetime number of anal sex partners. Nine valent HPV vaccination of males and females has the potential to prevent HPV related diseases and transmission in both sexes.	[Rahman, Shams; Campbell, Christine M. Pierce; Rollison, Dana E.; Giuliano, Anna R.] H Lee Moffitt Canc Ctr & Res Inst, Ctr Infect Res Canc, Tampa, FL 33682 USA; [Rahman, Shams; Wang, Wei; Borenstein, Amy R.] Univ S Florida, Coll Publ Hlth, Dept Epidemiol & Biostat, Tampa, FL USA; [Waterboer, Tim; Michel, Angelika; Pawlita, Michael] German Canc Res Ctr, Mol Diagnost Oncogen Infect Div, Heidelberg, Germany; [Waterboer, Tim; Michel, Angelika; Pawlita, Michael] German Canc Res Ctr, Infect Inflammat & Canc Res Program, Heidelberg, Germany; [Villa, Luisa L.] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil; [Lazcano Ponce, Eduardo] Inst Nacl Salud Publ, Ctr Invest Salud Poblac, Cuernavaca, Morelos, Mexico	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Universidade de Sao Paulo; Instituto Nacional de Salud Publica	Giuliano, AR (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Ctr Infect Res Canc, Tampa, FL 33682 USA.	anna.giuliano@moffitt.org	VILLA, LUISA/AAH-4761-2019; Borenstein, Amy/AAN-8884-2021	VILLA, LUISA/0000-0003-4074-2335; Rahman, Shams/0000-0001-5856-7753; Pawlita, Michael/0000-0002-4720-8306	National Cancer Institute, National Institutes of Health (R03) [CA176743]; National Cancer Institute, National Institutes of Health (R01) [CA098803]	National Cancer Institute, National Institutes of Health (R03); National Cancer Institute, National Institutes of Health (R01)	This work was funded by a grant from the National Cancer Institute, National Institutes of Health (R03: CA176743, PI: Anna R. Giuliano), and the HIM Study cohort infrastructure was supported through a grant from the National Cancer Institute, National Institutes of Health (R01: CA098803, PI: Anna R. Giuliano). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, Wkly Epidemiol Rec, V89, P465; [Anonymous], 2007, IARC MON EV CARC RIS; Ault Kevin A, 2006, Infect Dis Obstet Gynecol, V2006 Suppl, P40470; Bruni L., HUMAN PAPILLOMAVIRUS; Clifford GM, 2007, CANCER EPIDEM BIOMAR, V16, P1874, DOI 10.1158/1055-9965.EPI-07-0349; Daling JR, 2004, CANCER-AM CANCER SOC, V101, P270, DOI 10.1002/cncr.20365; Dunne EF, 2009, SEX TRANSM DIS, V36, P671, DOI 10.1097/OLQ.0b013e3181bc094b; Giuliano AR, 2008, CANCER EPIDEM BIOMAR, V17, P2036, DOI 10.1158/1055-9965.EPI-08-0151; Giuliano AR, 2015, INT J CANCER, V136, P2752, DOI 10.1002/ijc.29082; Giuliano AR, 2011, LANCET, V377, P932, DOI 10.1016/S0140-6736(10)62342-2; Goldstone S, 2011, J INFECT DIS, V203, P66, DOI 10.1093/infdis/jiq016; Heiligenberg M, 2013, J INFECT DIS, V208, P1081, DOI 10.1093/infdis/jit295; Heiligenberg M, 2010, SEX TRANSM DIS, V37, P672, DOI 10.1097/OLQ.0b013e3181e71069; Hernandez BY, 2008, CANCER-AM CANCER SOC, V113, P2883, DOI 10.1002/cncr.23743; Introcaso CE, 2014, SEX TRANSM INFECT, V90, P505, DOI 10.1136/sextrans-2013-051490; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; Liu G, 2016, J INFECT DIS, V213, P191, DOI 10.1093/infdis/jiv403; Lu B, 2010, EPIDEMIOLOGIC FACTOR; Lu BB, 2012, CANCER EPIDEM BIOMAR, V21, P1542, DOI 10.1158/1055-9965.EPI-12-0483; Lu BB, 2011, CANCER EPIDEM BIOMAR, V20, P990, DOI 10.1158/1055-9965.EPI-10-1160; Machalek DA, 2012, LANCET ONCOL, V13, P487, DOI 10.1016/S1470-2045(12)70080-3; Markowitz LE, 2014, MMWR RECOMM REP, V63, P1; Masel J, 2015, SEX TRANSM DIS, V42, P253, DOI 10.1097/OLQ.0000000000000277; Mooij SH, 2013, CANCER EPIDEM BIOMAR, V22, P1698, DOI 10.1158/1055-9965.EPI-13-0460; Moscicki AB, 2012, VACCINE, V30, pF24, DOI 10.1016/j.vaccine.2012.05.089; Newall AT, 2008, CLIN INFECT DIS, V46, P1647, DOI 10.1086/587895; Nyitray AG, 2011, J INFECT DIS, V204, P1711, DOI 10.1093/infdis/jir637; Petrosky E, 2015, MMWR-MORBID MORTAL W, V64, P300; Scherpenisse M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048807; Scherpenisse M, 2012, VACCINE, V30, P6686, DOI 10.1016/j.vaccine.2012.08.068; Schiffman Mark, 2009, Infect Agent Cancer, V4, P8, DOI 10.1186/1750-9378-4-8; Sehr P, 2002, J VIROL METHODS, V106, P61, DOI 10.1016/S0166-0934(02)00134-9; Strickler HD, 1999, INT J CANCER, V80, P339, DOI 10.1002/(SICI)1097-0215(19990129)80:3&lt;339::AID-IJC1&gt;3.0.CO;2-F; Syrjanen S, 2015, EUR J CLIN MICROBIOL, V34, P237, DOI 10.1007/s10096-014-2223-7; Thompson DL, 2004, J INFECT DIS, V190, P1563, DOI 10.1086/423817; Trottier H, 2006, VACCINE, V24, P4, DOI 10.1016/j.vaccine.2005.09.054; Villa L, 2014, BMC P S4, V8, pO7; Vriend HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060696; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Waterboer T, 2005, CLIN CHEM, V51, P1845, DOI 10.1373/clinchem.2005.052381; Weaver BA, 2006, J AM OSTEOPATH ASSOC, V106, pS2; WHO, 2009, WEEKL EP REC HUM PAP, P118; Zandberg DP, 2013, CA-CANCER J CLIN, V63, P57, DOI 10.3322/caac.21167; Zhang CY, 2015, SEX TRANSM INFECT, V91, P506, DOI 10.1136/sextrans-2014-051936	44	13	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167173	10.1371/journal.pone.0167173	http://dx.doi.org/10.1371/journal.pone.0167173			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902759	Green Published, gold, Green Submitted			2022-12-26	WOS:000389474100058
J	Singh, C; Glaab, E; Linster, CL				Singh, Charandeep; Glaab, Enrico; Linster, Carole L.			Molecular Identification of D-Ribulokinase in Budding Yeast and Mammals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-XYLULOSE; ESCHERICHIA-COLI; RIBITOL-PHOSPHATE; INBORN ERROR; D-ARABINITOL; D-RIBULOSE; METABOLOMICS; PURIFICATION; DEFICIENCY; GENES	Proteomes of even well characterized organisms still contain a high percentage of proteins with unknown or uncertain molecular and/ or biological function. A significant fraction of those proteins is predicted to have catalytic properties. Here we aimed at identifying the function of the Saccharomyces cerevisiae Ydr109c protein and its human homolog FGGY, both of which belong to the broadly conserved FGGY family of carbohydrate kinases. Functionally identified members of this family phosphorylate 3- to 7-carbon sugars or sugar derivatives, but the endogenous substrate of S. cerevisiae Ydr109c and human FGGY has remained unknown. Untargeted metabolomics analysis of an S. cerevisiae deletion mutant of YDR109C revealed ribulose as one of the metabolites with the most significantly changed intracellular concentration as compared with a wildtype strain. In human HEK293 cells, ribulose could only be detected when ribitol was added to the cultivation medium, and under this condition, FGGY silencing led to ribulose accumulation. Biochemical characterization of the recombinant purified Ydr109c and FGGY proteins showed a clear substrate preference of both kinases for D-ribulose over a range of other sugars and sugar derivatives tested, including L-ribulose. Detailed sequence and structural analyses of Ydr109c and FGGY as well as homologs thereof furthermore allowed the definition of a 5-residue D-ribulokinase signature motif (TCSLV). The physiological role of the herein identified eukaryotic D-ribulokinase remains unclear, but we speculate that S. cerevisiae Ydr109c and human FGGY could act as metabolite repair enzymes, serving to re-phosphorylate free D-ribulose generated by promiscuous phosphatases from D-ribulose 5-phosphate. In human cells, FGGY can additionally participate in ribitol metabolism.	[Singh, Charandeep; Glaab, Enrico; Linster, Carole L.] Univ Luxembourg, Luxembourg Ctr Syst Biomed, Campus Belval,7 Ave Hauts Fourneaux, L-4362 Esch Sur Alzette, Luxembourg	University of Luxembourg	Linster, CL (corresponding author), Univ Luxembourg, Luxembourg Ctr Syst Biomed, Campus Belval,7 Ave Hauts Fourneaux, L-4362 Esch Sur Alzette, Luxembourg.	carole.linster@uni.lu	Glaab, Enrico/A-9136-2012	Glaab, Enrico/0000-0003-3977-7469; Linster, Carole/0000-0001-7143-0719; Singh, Charandeep/0000-0003-4015-0591	Fonds National de la Recherche Luxembourg AFR Ph.D. Grant [6885527]; Fondation du Pelican de Mie et Pierre Hippert-Faber Scholarship	Fonds National de la Recherche Luxembourg AFR Ph.D. Grant(Luxembourg National Research Fund); Fondation du Pelican de Mie et Pierre Hippert-Faber Scholarship	This work was supported by the Fonds National de la Recherche Luxembourg AFR Ph.D. Grant 6885527 and a Fondation du Pelican de Mie et Pierre Hippert-Faber Scholarship (to C. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Berg J. M., 2007, BIOCHEMISTRY-US, P467; BERNARD EM, 1981, J CLIN MICROBIOL, V14, P189, DOI 10.1128/JCM.14.2.189-194.1981; Brockington M, 2001, AM J HUM GENET, V69, P1198, DOI 10.1086/324412; BROWN AD, 1974, J BACTERIOL, V118, P769, DOI 10.1128/JB.118.3.769-777.1974; Bueschl C, 2014, METABOLOMICS, V10, P754, DOI 10.1007/s11306-013-0611-0; Bueschl C, 2012, BIOINFORMATICS, V28, P736, DOI 10.1093/bioinformatics/bts012; Cai B, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2013.12.018; CANH DS, 1975, FOLIA MICROBIOL, V20, P320, DOI 10.1007/BF02878113; Capra JA, 2008, BIOINFORMATICS, V24, P1473, DOI 10.1093/bioinformatics/btn214; Chen YP, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2012.06.004; Chio A, 2009, HUM MOL GENET, V18, P1524, DOI 10.1093/hmg/ddp059; Clasquin MF, 2011, CELL, V145, P969, DOI 10.1016/j.cell.2011.05.022; Creek DJ, 2011, ANAL CHEM, V83, P8703, DOI 10.1021/ac2021823; Daoud H, 2010, AMYOTROPH LATERAL SC, V11, P389, DOI 10.3109/17482960903358857; DEKONING W, 1992, ANAL BIOCHEM, V204, P118, DOI 10.1016/0003-2697(92)90149-2; Dunckley T, 2007, NEW ENGL J MED, V357, P775, DOI 10.1056/NEJMoa070174; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; ELSINGHORST EA, 1988, J BACTERIOL, V170, P5423, DOI 10.1128/jb.170.12.5423-5432.1988; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Ewald JC, 2013, MOL BIOSYST, V9, P440, DOI 10.1039/c2mb25423a; Fernandez-Santiago R, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2009.04.018; Follens A, 1999, J BACTERIOL, V181, P2001, DOI 10.1128/JB.181.7.2001-2007.1999; FUTTERMAN S, 1955, J BIOL CHEM, V215, P257; Gerin I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11534; Gibney PA, 2013, P NATL ACAD SCI USA, V110, pE4393, DOI 10.1073/pnas.1318100110; Glaab E, 2016, BRIEF BIOINFORM, V17, P352, DOI 10.1093/bib/bbv037; Hanson AD, 2010, BIOCHEM J, V425, P1, DOI 10.1042/BJ20091328; Heuel H, 1998, MICROBIOL-SGM, V144, P1631, DOI 10.1099/00221287-144-6-1631; Hewitt JE, 2009, BBA-MOL BASIS DIS, V1792, P853, DOI 10.1016/j.bbadis.2009.06.003; HOLLMANN S, 1957, J BIOL CHEM, V225, P87; Huck JHJ, 2004, AM J HUM GENET, V74, P745, DOI 10.1086/383204; Huck JHJ, 2004, MOL GENET METAB, V82, P231, DOI 10.1016/j.ymgme.2004.05.003; INGRAM JM, 1965, J BACTERIOL, V89, P1186, DOI 10.1128/JB.89.5.1186-1194.1965; Ishikura S, 2005, J BIOCHEM, V137, P303, DOI 10.1093/jb/mvi033; Jewison T, 2012, NUCLEIC ACIDS RES, V40, pD815, DOI 10.1093/nar/gkr916; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; KAGAWA Y, 1960, BIOCHIM BIOPHYS ACTA, V44, P205, DOI 10.1016/0006-3002(60)91553-5; KAMEYAMA T, 1965, J BIOCHEM-TOKYO, V57, P339, DOI 10.1093/oxfordjournals.jbchem.a128087; KAMEYAMA T, 1962, BIOCHIM BIOPHYS ACTA, V64, P180, DOI 10.1016/0006-3002(62)90773-4; Kanagawa M, 2016, CELL REP, V14, P2209, DOI 10.1016/j.celrep.2016.02.017; Kerner Berit, 2013, Front Psychiatry, V4, P154, DOI 10.3389/fpsyt.2013.00154; Kramer B, 1999, PROTEINS, V37, P228, DOI 10.1002/(SICI)1097-0134(19991101)37:2<228::AID-PROT8>3.0.CO;2-8; Kulak NA, 2014, NAT METHODS, V11, P319, DOI [10.1038/NMETH.2834, 10.1038/nmeth.2834]; Kuznetsova E, 2015, J BIOL CHEM, V290, P18678, DOI 10.1074/jbc.M115.657916; Lee LV, 2001, ARCH BIOCHEM BIOPHYS, V396, P219, DOI 10.1006/abbi.2001.2613; Linster CL, 2013, NAT CHEM BIOL, V9, P72, DOI [10.1038/NCHEMBIO.1141, 10.1038/nchembio.1141]; MCCORKINDALE J, 1954, BIOCHEM J, V57, P518, DOI 10.1042/bj0570518; NEUBERGER MS, 1981, BIOCHEM J, V193, P513, DOI 10.1042/bj1930513; Niehaus TD, 2015, PLANT PHYSIOL, V169, P1436, DOI 10.1104/pp.15.00959; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Patti GJ, 2012, NAT REV MOL CELL BIO, V13, P263, DOI 10.1038/nrm3314; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pieper U, 2006, NUCLEIC ACIDS RES, V34, pD291, DOI 10.1093/nar/gkj059; Pluskal T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-395; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; QUONG MW, 1993, BIOCHEM BIOPH RES CO, V196, P1323, DOI 10.1006/bbrc.1993.2397; Reinders J, 2006, J PROTEOME RES, V5, P1543, DOI 10.1021/pr050477f; REINER AM, 1975, J BACTERIOL, V123, P530, DOI 10.1128/JB.123.2.530-536.1975; Riemersma M, 2015, CHEM BIOL, V22, P1643, DOI 10.1016/j.chembiol.2015.10.014; Saghatelian A, 2004, BIOCHEMISTRY-US, V43, P14332, DOI 10.1021/bi0480335; Schneider N, 2012, J COMPUT AID MOL DES, V26, P701, DOI 10.1007/s10822-011-9531-0; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SMILEY JD, 1961, J BIOL CHEM, V236, P357; STAYTON MM, 1979, J BIOL CHEM, V254, P3765; Teste MA, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-99; Treusch S, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004913; Van Es MA, 2009, AMYOTROPH LATERAL SC, V10, P441, DOI 10.3109/17482960802673042; Van Schaftingen E, 2013, J INHERIT METAB DIS, V36, P427, DOI 10.1007/s10545-012-9571-1; Verhoeven NM, 2001, AM J HUM GENET, V68, P1086, DOI 10.1086/320108; Wamelink MMC, 2008, HUM MUTAT, V29, P532, DOI 10.1002/humu.20685; WINKELMAN J, 1961, BIOCHIM BIOPHYS ACTA, V52, P170, DOI 10.1016/0006-3002(61)90914-3; WONG B, 1993, J BACTERIOL, V175, P6314, DOI 10.1128/JB.175.19.6314-6320.1993; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Yeh JI, 2004, BIOCHEMISTRY-US, V43, P362, DOI 10.1021/bi034258o; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang Y, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002318	80	11	11	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2017	292	3					1005	1028		10.1074/jbc.M116.760744	http://dx.doi.org/10.1074/jbc.M116.760744			24	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2LL	27909055	hybrid, Green Published			2022-12-26	WOS:000392318700021
J	Minsky, N; Roeder, RG				Minsky, Neri; Roeder, Robert G.			Control of Secreted Protein Gene Expression and the Mammalian Secretome by the Metabolic Regulator PGC-1 alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PGC-1 COACTIVATORS; ENERGY-METABOLISM; THERMOGENESIS; EXERCISE; MICE	Secreted proteins serve pivotal roles in the development of multicellular organisms, acting as structural matrix, extracellular enzymes, and signal molecules. However, how the secretome is regulated remains incompletely understood. Here we demonstrate, unexpectedly, that peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1 alpha), a critical transcriptional co-activator of metabolic gene expression, functions to down-regulate the expression of diverse genes encoding secreted molecules and extracellular matrix components to modulate the secretome. Using cell lines, primary cells, and mice, we show that both endogenous and exogenous PGC-1 alpha down-regulate the expression of numerous genes encoding secreted molecules. Mechanistically, results obtained using mRNA stability measurements as well as intronic RNA expression analysis are consistent with a transcriptional effect of PGC-1 alpha on the expression of genes encoding secreted proteins. Interestingly, PGC-1 alpha requires the central heat shock response regulator heat shock factor protein 1 (HSF1) to affect some of its targets, and both factors co-reside on several target genes encoding secreted molecules in cells. Finally, using a mass spectrometric analysis of secreted proteins, we demonstrate that PGC-1 alpha modulates the secretome of mouse embryonic fibroblasts. Our results define a link between a key pathway controlling metabolic regulation and the regulation of the mammalian secretome.	[Minsky, Neri; Roeder, Robert G.] Rockefeller Univ, Lab Biochem & Mol Biol, New York, NY 10065 USA	Rockefeller University	Minsky, N; Roeder, RG (corresponding author), Rockefeller Univ, Lab Biochem & Mol Biol, New York, NY 10065 USA.	nminsky@rockefeller.edu; roeder@rockefeller.edu			Sohn Conferences Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071900] Funding Source: NIH RePORTER	Sohn Conferences Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to Bruce Spiegelman for the PGC-1 alpha KO and WT immortalized brown preadipocytes, Daniel Kelly for the PGC-1 alpha KO and WT primary MEFs, Ivor J. Benjamin for the HSF1 knock-out MEFs, and Scott Friedman for the LX2 cells. The Proteomics Resource Center at The Rockefeller University acknowledges funding for mass spectrometer instrumentations from the Sohn Conferences Foundation.	Eisele PS, 2013, J BIOL CHEM, V288, P2246, DOI 10.1074/jbc.M112.375253; Elferink CJ, 1996, BIOTECHNIQUES, V20, P470; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Liu C, 2011, ACTA BIOCH BIOPH SIN, V43, P248, DOI 10.1093/abbs/gmr007; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Minsky N, 2015, P NATL ACAD SCI USA, V112, pE5669, DOI 10.1073/pnas.1516219112; Olesen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032222; Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Scherz-Shouval R, 2014, CELL, V158, P564, DOI 10.1016/j.cell.2014.05.045; Shema E, 2011, MOL CELL, V42, P477, DOI 10.1016/j.molcel.2011.03.011; Wang GX, 2015, TRENDS ENDOCRIN MET, V26, P231, DOI 10.1016/j.tem.2015.03.002; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050	19	1	1	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2017	292	1					43	50		10.1074/jbc.C116.761049	http://dx.doi.org/10.1074/jbc.C116.761049			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2DQ	27909049	hybrid, Green Published			2022-12-26	WOS:000391578000004
J	Li, XC; Cui, JL; Maharjan, S; Lu, LJ; Gong, X				Li, Xiucun; Cui, Jianli; Maharjan, Suraj; Lu, Laijin; Gong, Xu			Reconstruction of the Foot and Ankle Using Pedicled or Free Flaps: Perioperative Flap Survival Analysis	PLOS ONE			English	Article							ARTERY PERFORATOR FLAP; LOWER-EXTREMITY RECONSTRUCTION; ANTEROLATERAL THIGH FLAP; MEDIAL PLANTAR FLAP; RISK-FACTORS; CLINICAL-APPLICATION; PROPELLER FLAPS; LOWER LEG; DEFECTS; EXPERIENCE	Objective The purpose of this study is to determine the correlation between non-technical risk factors and the perioperative flap survival rate and to evaluate the choice of skin flap for the reconstruction of foot and ankle. Methods This was a clinical retrospective study. Nine variables were identified. The Kaplan-Meier method coupled with a log-rank test and a Cox regression model was used to predict the risk factors that influence the perioperative flap survival rate. The relationship between postoperative wound infection and risk factors was also analyzed using a logistic regression model. Results The overall flap survival rate was 85.42%. The necrosis rates of free flaps and pedicled flaps were 5.26% and 20.69%, respectively. According to the Cox regression model, flap type (hazard ratio [HR] = 2.592; 95% confidence interval [CI] (1.606, 4.184); P < 0.001) and postoperative wound infection (HR = 0.266; 95% CI (0.134, 0.529); P < 0.001) were found to be statistically significant risk factors associated with flap necrosis. Based on the logistic regression model, preoperative wound bed inflammation (odds ratio [OR] = 11.371,95% CI (3.117, 41.478), P < 0.001) was a statistically significant risk factor for postoperative wound infection. Conclusion Flap type and postoperative wound infection were both independent risk factors influencing the flap survival rate in the foot and ankle. However, postoperative wound infection was a risk factor for the pedicled flap but not for the free flap. Microvascular anastomosis is a major cause of free flap necrosis. To reconstruct complex or wide soft tissue defects of the foot or ankle, free flaps are safer and more reliable than pedicled flaps and should thus be the primary choice.	[Li, Xiucun; Cui, Jianli; Maharjan, Suraj; Lu, Laijin; Gong, Xu] Jilin Univ, Hosp 1, Dept Hand & Foot Surg, Changchun, Jilin Province, Peoples R China	Jilin University	Gong, X (corresponding author), Jilin Univ, Hosp 1, Dept Hand & Foot Surg, Changchun, Jilin Province, Peoples R China.	triumphlixc@163.com	Li, Xiucun/AAI-9002-2020	Li, Xiucun/0000-0002-3260-6299				Acar MA, 2015, J RECONSTR MICROSURG, V31, P225, DOI 10.1055/s-0034-1395888; Acikel C, 2003, ANN PLAS SURG, V50, P498, DOI 10.1097/01.SAP.0000044141.35292.A7; Balakrishnan Chenicheri, 2009, Can J Plast Surg, V17, pe11; Battiston B, 2011, MICROSURG, V31, P212, DOI 10.1002/micr.20863; Bekara F, 2016, MICROSURG; Bekara F, 2016, PLAST RECONSTR SURG, V137, P314, DOI 10.1097/PRS.0000000000001891; Chai YM, 2007, ANN PLAS SURG, V59, P526, DOI 10.1097/01.sap.0000258969.13723.68; Gir P, 2012, J RECONSTR MICROSURG, V28, P595, DOI 10.1055/s-0032-1315786; GODINA M, 1986, PLAST RECONSTR SURG, V78, P285, DOI 10.1097/00006534-198609000-00001; Gupta A, 2015, J PLAST RECONSTR AES, V68, P1184, DOI 10.1016/j.bjps.2015.05.009; Hollenbeck ST, 2010, PLAST RECONSTR SURG, V125, P924, DOI 10.1097/PRS.0b013e3181cc9630; Hong JP, 2013, ANN PLAS SURG, V71, P380, DOI 10.1097/SAP.0b013e3182503ac5; Hsu WM, 2007, PLAST RECONSTR SURG, V119, P1491, DOI 10.1097/01.prs.0000256057.42415.73; Inui T, 2015, SEMIN VASC SURG, V28, P201, DOI 10.1053/j.semvascsurg.2016.02.002; Kang MJ, 2013, ARCH PLAST SURG-APS, V40, P575, DOI 10.5999/aps.2013.40.5.575; Li Y, 2013, BURNS, V39, P808, DOI 10.1016/j.burns.2012.08.014; Lin YT, 2015, PLAST RECONSTR SURG, V135, P501, DOI 10.1097/PRS.0000000000000884; Liu LF, 2014, ANN PLAS SURG, V72, P689, DOI 10.1097/SAP.0b013e31826c4284; Liu LF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083696; Lu TC, 2011, J PLAST RECONSTR AES, V64, P386, DOI 10.1016/j.bjps.2010.05.004; Pinsolle V, 2006, J PLAST RECONSTR AES, V59, P912, DOI 10.1016/j.bjps.2005.11.037; Ruan HJ, 2010, ANN PLAS SURG, V64, P451, DOI 10.1097/SAP.0b013e3181b0c4f6; Schaverien MV, 2010, PLAST RECONSTR SURG, V125, P1735, DOI 10.1097/PRS.0b013e3181ccdc08; Schoeller T, 2004, MICROSURG, V24, P43, DOI 10.1002/micr.10194; Sekido M, 2004, MICROSURG, V24, P289, DOI 10.1002/micr.20022; Voche P, 2005, ANN PLAS SURG, V54, P49, DOI 10.1097/01.sap.0000139565.36738.b3; Wei JW, 2016, PLAST RECONSTR SURG; Wong AK, 2015, MICROSURG, V35, P6, DOI 10.1002/micr.22223; Xiong L, 2016, MICROSURGERY; Yoon ES, 2007, ANN PLAS SURG, V58, P517, DOI 10.1097/01.sap.0000244929.93375.34; Zelken JA, 2016, ANN PLAS SURG, V76, P221, DOI 10.1097/SAP.0000000000000564; Zhao P, 2015, INT J CLIN EXP MED, V8, P9519; Zhu YL, 2013, MICROSURG, V33, P600, DOI 10.1002/micr.22177	33	17	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167827	10.1371/journal.pone.0167827	http://dx.doi.org/10.1371/journal.pone.0167827			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930679	gold, Green Submitted, Green Published			2022-12-26	WOS:000389580900047
J	Ching, B; Woo, JM; Hiong, KC; Boo, MV; Wong, WP; Chew, SF; Ip, YK				Ching, Biyun; Woo, Jia M.; Hiong, Kum C.; Boo, Mel V.; Wong, Wai P.; Chew, Shit F.; Ip, Yuen K.			Voltage-Gated Na+ Channel Isoforms and Their mRNA Expression Levels and Protein Abundance in Three Electric Organs and the Skeletal Muscle of the Electric Eel Electrophorus electricus	PLOS ONE			English	Article							SENSITIVE SODIUM-CHANNEL; CYTOCHEMICAL-LOCALIZATION; CHARGE MOVEMENT; BETA-1 SUBUNITS; EVOLUTION; INACTIVATION; GENE; ACETYLCHOLINESTERASE; PHOSPHORYLATION; PURIFICATION	This study aimed to obtain the coding cDNA sequences of voltage-gated Na+ channel (scn) alpha-subunit (scna) and beta-subunit (scnb) isoforms from, and to quantify their transcript levels in, the main electric organ (EO), Hunter's EO, Sach's EO and the skeletal muscle (SM) of the electric eel, Electrophorus electricus, which can generate both high and low voltage electric organ discharges (EODs). The full coding sequences of two scna (scn4aa and scn4ab) and three scnb (scn1b, scn2b and scn4b) were identified for the first time (except scn4aa) in E. electricus. In adult fish, the scn4aa transcript level was the highest in the main EO and the lowest in the Sach's EO, indicating that it might play an important role in generating high voltage EODs. For scn4ab/Scn4ab, the transcript and protein levels were unexpectedly high in the EOs, with expression levels in the main EO and the Hunter's EO comparable to those of scn4aa. As the key domains affecting the properties of the channel were mostly conserved between Scn4aa and Scn4ab, Scn4ab might play a role in electrogenesis. Concerning scnb, the transcript level of scn4b was much higher than those of scn1b and scn2b in the EOs and the SM. While the transcript level of scn4b was the highest in the main EO, protein abundance of Scn4b was the highest in the SM. Taken together, it is unlikely that Scna could function independently to generate EODs in the EOs as previously suggested. It is probable that different combinations of Scn4aa/Scn4ab and various Scnb isoforms in the three EOs account for the differences in EODs produced in E. electricus. In general, the transcript levels of various scn isoforms in the EOs and the SM were much higher in adult than in juvenile, and the three EOs of the juvenile fish could be functionally indistinct.	[Ching, Biyun; Woo, Jia M.; Hiong, Kum C.; Boo, Mel V.; Wong, Wai P.; Ip, Yuen K.] Natl Univ Singapore, Dept Biol Sci, Kent Ridge, Singapore; [Ip, Yuen K.] Natl Univ Singapore, Trop Marine Sci Inst, Kent Ridge, Singapore; [Chew, Shit F.] Nanyang Technol Univ, Natl Inst Educ, Nat Sci & Sci Educ, Singapore, Singapore	National University of Singapore; National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National Institute of Education (NIE) Singapore	Ip, YK (corresponding author), Natl Univ Singapore, Dept Biol Sci, Kent Ridge, Singapore.; Ip, YK (corresponding author), Natl Univ Singapore, Trop Marine Sci Inst, Kent Ridge, Singapore.	dbsipyk@nus.edu.sg	Chew, Shit Fun/I-2248-2012; Ip, Yuen Kwong/H-8041-2012	Chew, Shit Fun/0000-0003-4599-5817; Ip, Yuen Kwong/0000-0001-9124-7911	tobacco company	tobacco company	The funders prefer to remain annonymous. None of the research costs or authors' salaries were funded, in whole or in part, by a tobacco company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The identity of the donor is not relevant to editors or reviewers' assessment of the validity of the work. The donor has no competing interests in relation to this work.	AGNEW WS, 1978, P NATL ACAD SCI USA, V75, P2606, DOI 10.1073/pnas.75.6.2606; Ahern CA, 2016, J GEN PHYSIOL, V147, P1, DOI 10.1085/jgp.201511492; Albert J. S., 2005, PHYSL FISHES, P431; ARIYASU RG, 1987, J NEUROCYTOL, V16, P511, DOI 10.1007/BF01668505; Arnegard ME, 2010, P NATL ACAD SCI USA, V107, P22172, DOI 10.1073/pnas.1011803107; BARCHI RL, 1988, ANNU REV NEUROSCI, V11, P455, DOI 10.1146/annurev.ne.11.030188.002323; BARCHI RL, 1983, J NEUROCHEM, V40, P1377, DOI 10.1111/j.1471-4159.1983.tb13580.x; BENDA P, 1970, NATURE, V225, P1149, DOI 10.1038/2251149a0; BENESKI DA, 1980, P NATL ACAD SCI-BIOL, V77, P639, DOI 10.1073/pnas.77.1.639; Bennett MVL, 1971, FISH PHYSIOL, P346; Berra TM., 2001, FRESHWATER FISH DIST; Betts M.J., 2007, BIOINFORMATICS GENET, DOI [10.1002/9780470059180.ch13, DOI 10.1002/0470867302.CH14]; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; BLOOM FE, 1966, J CELL BIOL, V29, P475, DOI 10.1083/jcb.29.3.475; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Catania K, 2014, SCIENCE, V346, P1231, DOI 10.1126/science.1260807; Catterall WA, 2012, J PHYSIOL-LONDON, V590, P2577, DOI 10.1113/jphysiol.2011.224204; Chen CL, 2012, J BIOL CHEM, V287, P39061, DOI 10.1074/jbc.M112.397646; Chen CL, 2004, J NEUROSCI, V24, P4030, DOI 10.1523/JNEUROSCI.4139-03.2004; Chopra SS, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-113; Davis TH, 2004, J BIOL CHEM, V279, P51424, DOI 10.1074/jbc.M410830200; ELLISMAN MH, 1982, P NATL ACAD SCI-BIOL, V79, P6707, DOI 10.1073/pnas.79.21.6707; FRITZ LC, 1983, J NEUROSCI, V3, P2300; Gallant JR, 2014, SCIENCE, V344, P1522, DOI 10.1126/science.1254432; Gerwick L, 2007, FISH SHELLFISH IMMUN, V22, P157, DOI 10.1016/j.fsi.2006.04.003; Gilchrist J, 2013, P NATL ACAD SCI USA, V110, pE5016, DOI 10.1073/pnas.1314557110; Goldin AL, 2001, ANNU REV PHYSIOL, V63, P871, DOI 10.1146/annurev.physiol.63.1.871; GORDON RD, 1988, J NEUROSCI, V8, P3742; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; GRUNDFEST H, 1960, BIOL BULL, V119, P284; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hunter J., 1775, JOHN HUNTER FRS PHIL, V65, P395; ISOM LL, 1992, SCIENCE, V256, P839, DOI 10.1126/science.1375395; Isom LL, CELL; JAMES WM, 1989, BIOCHEMISTRY-US, V28, P6001, DOI 10.1021/bi00440a042; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Keynes KD, 1961, BIOELECTROGENESIS, P14; KEYNES RD, 1953, J PHYSIOL-LONDON, V119, P315, DOI 10.1113/jphysiol.1953.sp004849; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu H, 2007, DEV NEUROBIOL, V67, P1289, DOI 10.1002/dneu.20404; MACHADO RD, 1980, CELL TISSUE RES, V213, P69, DOI 10.1007/BF00236921; Malhotra JD, 2000, J BIOL CHEM, V275, P11383, DOI 10.1074/jbc.275.15.11383; Malhotra JD, 2002, J BIOL CHEM, V277, P26681, DOI 10.1074/jbc.M202354200; Marban E, 1998, J PHYSIOL-LONDON, V508, P647, DOI 10.1111/j.1469-7793.1998.647bp.x; McCormick KA, 1998, J BIOL CHEM, V273, P3954, DOI 10.1074/jbc.273.7.3954; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; MILLER JA, 1983, BIOCHEMISTRY-US, V22, P462, DOI 10.1021/bi00271a032; Miyazaki H, 2007, BIOCHEM BIOPH RES CO, V361, P43, DOI 10.1016/j.bbrc.2007.06.170; NAKAMURA Y, 1965, J GEN PHYSIOL, V49, P321, DOI 10.1085/jgp.49.2.321; Namadurai S, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.140192; Nelson ME, 2011, CURR BIOL, V21, pR528, DOI 10.1016/j.cub.2011.03.045; NODA M, 1984, NATURE, V312, P121, DOI 10.1038/312121a0; Novak AE, 2006, DEV DYNAM, V235, P1962, DOI 10.1002/dvdy.20811; Ortega H., 1986, SMITHS CONTR ZOOL, V437, P1, DOI DOI 10.5479/SI.00810282.437; Patino GA, 2009, J NEUROSCI, V29, P10764, DOI 10.1523/JNEUROSCI.2475-09.2009; Paul C, 2016, J MOL EVOL, V83, P61, DOI 10.1007/s00239-016-9754-8; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Peters Colin H, 2014, Handb Exp Pharmacol, V221, P1, DOI 10.1007/978-3-642-41588-3_1; RECIOPINTO E, 1987, J GEN PHYSIOL, V90, P375, DOI 10.1085/jgp.90.3.375; Rohl CA, 1999, BIOCHEMISTRY-US, V38, P855, DOI 10.1021/bi9823380; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; ROSENBERG RL, 1984, P NATL ACAD SCI-BIOL, V81, P5594, DOI 10.1073/pnas.81.17.5594; Ruben PC, 2014, HDB EXP PHARM, V221; SHENKEL S, 1991, J GEN PHYSIOL, V97, P1013, DOI 10.1085/jgp.97.5.1013; Smith RD, 1997, J NEUROSCI, V17, P6086; Stamatakis A, 2014, BIOINFORMATICS; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; SZABO T, 1966, ANAT REC, V155, P103, DOI 10.1002/ar.1091550112; Thompson A, 2014, MOL BIOL EVOL, V31, P1941, DOI 10.1093/molbev/msu145; WAECHTER CJ, 1983, J BIOL CHEM, V258, P5117; WEST JW, 1992, P NATL ACAD SCI USA, V89, P10910, DOI 10.1073/pnas.89.22.10910; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8; Yarov-Yarovoy V, 2006, P NATL ACAD SCI USA, V103, P7292, DOI 10.1073/pnas.0602350103; Yarov-Yarovoy V, 2012, P NATL ACAD SCI USA, V109, pE93, DOI 10.1073/pnas.1118434109; Yu FH, 2003, J NEUROSCI, V23, P7577; Zakon HH, 2006, P NATL ACAD SCI USA, V103, P3675, DOI 10.1073/pnas.0600160103; Zhao Y, 2004, NEURON, V41, P859, DOI 10.1016/S0896-6273(04)00116-3	78	6	6	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167589	10.1371/journal.pone.0167589	http://dx.doi.org/10.1371/journal.pone.0167589			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907137	Green Published, gold, Green Submitted			2022-12-26	WOS:000389482700205
J	Chung, WY; Chiang, PS; Luo, ST; Lin, TY; Tsao, KC; Lee, MS				Chung, Wan-Yu; Chiang, Pai-Shan; Luo, Shu-Ting; Lin, Tzou-Yien; Tsao, Kuo-Chien; Lee, Min-Shi			A Molecular Approach Applied to Enteroviruses Surveillance in Northern Taiwan, 2008-2012	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; EMERGENCE; RESPONSES; CHILDREN	Traditional methods for detection and serotyping of enterovirus infections are virus isolation and immunofluorescence assay (VI-IFA), which are labor-intensive and time-consuming. Recently, VP1 gene has been targeted to develop a CODEHOP-based RT-PCR (VP1CODEHOP) for the same purpose. In this study, we conducted a 5-year enterovirus surveillance comparing the VI-IFA and VP1-CODEHOP tests. Throat swabs were collected from 431 pediatric patients and 208(48%) and 250(58%) were tested positive by the VI-IFA and VP1-CODEHOP tests, respectively. Among the 47 cases who had inconsistent results between the VI-IFA and VP1-CODEHOP tests and provided paired sera for serological verifications, correct diagnosis for the VI-IFA and VP1-CODEHOP were 5(11%) and 40(85%) cases, respectively. Therefore, the VP1-CODEHOP is more reliable for detection of human enteroviruses than the VI-IFA. Based on serological verifications for the eight cases who had inconsistent serotypes between the two tests and provided paired sera, five and two showed consistent serotypes with the VP1-CODEHOP and VI-IFA tests, respectively. CVA16, CVA6 and EV71 were the most prevalent serotypes in northern Taiwan, 2008 similar to 2012. Moreover, variant CVA2, CVA6 and EV71 viruses were further identified based on phylogenetic analysis of partial VP1 sequences. In conclusion, the VP1-CODEHOP test could be used as the primary method for enterovirus surveillance to support decision-making for outbreak control.	[Chung, Wan-Yu; Chiang, Pai-Shan; Luo, Shu-Ting; Lee, Min-Shi] NHRI, Natl Inst Infect Dis & Vaccinol, Zhunan Town, Miaoli County, Taiwan; [Lin, Tzou-Yien] Chang Gung Mem Hosp, Dept Pediat, Taoyuan, Taiwan; [Lin, Tzou-Yien] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Taoyuan, Taiwan; [Tsao, Kuo-Chien] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Taoyuan, Taiwan; [Tsao, Kuo-Chien] Chang Gung Mem Hosp, Dept Clin Pathol, Taoyuan, Taiwan	National Health Research Institutes - Taiwan; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital	Lee, MS (corresponding author), NHRI, Natl Inst Infect Dis & Vaccinol, Zhunan Town, Miaoli County, Taiwan.	minshi.lee@hotmail.com			National Health Research Institutes	National Health Research Institutes(National Health Research Institutes, JapanNational Health Research Institutes - Taiwan)	This work was supported by the National Health Research Institutes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chia MY, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003044; Chia MY, 2014, PEDIATR NEONATOL, V55, P243, DOI 10.1016/j.pedneo.2013.07.007; Chiang PS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048269; Chuang JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036120; Chung WH, 2013, J INFECT DIS, V208, P1968, DOI 10.1093/infdis/jit383; Huang ML, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002067; Huang ML, 2010, J VIROL METHODS, V165, P42, DOI 10.1016/j.jviromet.2009.12.015; Huang YP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080942; Lee MS, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001737; Lee MS, 2010, PEDIATR INFECT DIS J, V29, P1030, DOI 10.1097/INF.0b013e3181e52945; Luo ST, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116322; Luo ST, 2009, EMERG INFECT DIS, V15, P581, DOI 10.3201/eid1504.081550; Nix WA, 2006, J CLIN MICROBIOL, V44, P2698, DOI 10.1128/JCM.00542-06; Ortner B, 2009, J MED VIROL, V81, P317, DOI 10.1002/jmv.21374; Osterback R, 2009, EMERG INFECT DIS, V15, P1485, DOI 10.3201/eid1509.090438; Pallansch M., 2007, FIELDS VIROL, P839; Rose TM, 2003, NUCLEIC ACIDS RES, V31, P3763, DOI 10.1093/nar/gkg524; Tsao KC, 2010, J VIROL METHODS, V165, P330, DOI 10.1016/j.jviromet.2010.03.001; Tsao LY, 2006, PEDIATR INT, V48, P5, DOI 10.1111/j.1442-200X.2006.02157.x; Vuorinen T, 2003, CLIN INFECT DIS, V37, P452, DOI 10.1086/376635; Wei SH, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-346; World Health Organization, 2015, GUID ENT SURV SUPP P, P40; World Health Organization (WHO): Western Pacific Region, 2011, GUID CLIN MAN PUBL H; Wu TSJ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-18; Wu Y, 2010, INT J INFECT DIS, V14, pE1076, DOI 10.1016/j.ijid.2010.07.006; Yip CCY, 2013, EMERG INFECT DIS, V19, P1285, DOI 10.3201/eid1908.121498; Yoke-Fun C, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-74; Yu HY, 2010, VIRUS GENES, V41, P1, DOI 10.1007/s11262-010-0472-9; Zhu JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056318	29	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167532	10.1371/journal.pone.0167532	http://dx.doi.org/10.1371/journal.pone.0167532			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907198	Green Published, gold, Green Submitted			2022-12-26	WOS:000389482700186
J	DeVries, A; Talley, P; Sweet, K; Kline, S; Stinchfield, P; Tosh, P; Danila, R				DeVries, Aaron; Talley, Pamela; Sweet, Kristin; Kline, Susan; Stinchfield, Patricia; Tosh, Pritish; Danila, Richard			Development and Implementation of the Ebola Traveler Monitoring Program and Clinical Outcomes of Monitored Travelers during October - May 2015, Minnesota	PLOS ONE			English	Article							UNITED-STATES; VIRUS DISEASE; SIERRA-LEONE; DIAGNOSIS	Background In October 2014, the United States began actively monitoring all persons who had traveled from Guinea, Liberia, and Sierra Leone in the previous 21 days. State public health departments were responsible for monitoring all travelers; Minnesota has the largest Liberian population in the United States. The MDH Ebola Clinical Team (ECT) was established to assess travelers with symptoms of concern for Ebola virus disease (EVD), coordinate access to healthcare at appropriate facilities including Ebola Assessment and Treatment Units (EATU), and provide guidance to clinicians. Methods Minnesota Department of Health (MDH) began receiving traveler information collected by U. S. Customs and Border Control and Centers for Disease Control and Prevention staff on October 21, 2014 via encrypted electronic communication. All travelers returning from Liberia, Sierra Leone, and Guinea during 10/21/14-5/15/15 were monitored by MDH staff in the manner recommended by CDC based on the traveler's risk categorization as "low (but not zero)", "some" and "high" risk. When a traveler reported symptoms or a temperature >= 100.4 degrees F at any time during their 21-day monitoring period, an ECT member would speak to the traveler and perform a clinical assessment by telephone or via video-chat. Based on the assessment the ECT member would recommend 1) continued clinical monitoring while at home with frequent telephone follow-up by the ECT member, 2) outpatient clinical evaluation at an outpatient site agreed upon by all parties, or 3) inpatient clinical evaluation at one of four Minnesota EATUs. ECT members assessed and approved testing for Ebola virus infection at MDH. Traveler data, calls to the ECT and clinical outcomes were logged on a secure server at MDH. Results During 10/21/14-5/15/15, a total of 783 travelers were monitored; 729 (93%) traveled from Liberia, 30 (4%) Sierra Leone, and 24 (3%) Guinea. The median number monitored per week was 59 (range 45-143). The median age was 35 years; 136 (17%) were aged <18 years. Thirteen of 256 women of reproductive age (5%) were pregnant. The country of passport issuance was known for 720 of the travelers. The majority of monitored travelers (478 [66%]) used a non-U.S. passport including 442 (61%) Liberian nationals. A total of 772 (99%) travelers were "low (but not zero)" risk; 11 (1%) were "some" risk. Among monitored travelers, 43 (5%) experienced illness symptoms; 29 (67%) had a symptom consistent with EVD. Two were tested for Ebola virus disease and had negative results. Most frequently reported symptoms were fever (20/43, 47%) and abdominal pain (12/43, 28%). During evaluation, 16 (37%) of 43 travelers reported their symptoms began prior to travel; chronic health conditions in 24 travelers including tumors/cancer, pregnancy, and orthopedic conditions were most common. Infectious causes in 19 travelers included upper respiratory infection, malaria, and gastrointestinal infections. Discussion Prior to 2014, no similar active monitoring program for travelers had been performed in Minnesota; assessment and management of symptomatic travelers was a new activity for MDH. Ensuring safe entrance into healthcare was particularly challenging for children, and pregnant women, as well as those without an established connection to healthcare. Unnecessary inpatient evaluations were successfully avoided by close clinical follow-up by phone. Before similar monitoring programs are considered in the future, careful thought must be given to necessary resources and the impact on affected populations, public health, and the healthcare system.	[DeVries, Aaron] Minneapolis VA Med Ctr, Infect Dis Sect, Minneapolis, MN USA; [DeVries, Aaron] Univ Minnesota, Sch Med & Publ Hlth, Minneapolis, MN USA; [Talley, Pamela] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Div Sci Educ & Profess Dev, Atlanta, GA USA; [Talley, Pamela; Sweet, Kristin; Danila, Richard] Minnesota Dept Hlth, Infect Dis Epidemiol Prevent & Control Div, St Paul, MN 55164 USA; [Kline, Susan] Univ Minnesota, Sch Med, Div Infect Dis, Minneapolis, MN 55455 USA; [Stinchfield, Patricia] Childrens Hosp & Clin Minnesota, St Paul, MN USA; [Tosh, Pritish] Mayo Clin, Div Infect Dis, Rochester, MN USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities; Centers for Disease Control & Prevention - USA; Minnesota Department of Health (MHD); University of Minnesota System; University of Minnesota Twin Cities; Children's Hospitals & Clinics of Minnesota; Mayo Clinic	Danila, R (corresponding author), Minnesota Dept Hlth, Infect Dis Epidemiol Prevent & Control Div, St Paul, MN 55164 USA.	richard.danila@state.mn.us	amsalu, ribka/G-8780-2019	DeVries, Aaron/0000-0001-9211-0722	Hospital Preparedness Program (HPP); Public Health Emergency Preparedness (PHEP) [CDC-RFA-TP12-12010302SUPP15, CDC-RFA-TP12-120102CONT14]; Domestic Ebola Supplement to Epidemiology and Laboratory Capacity for Infectious Diseases (ELC)-Building and Strengthening Epidemiology, Laboratory and Health Information Systems Capacity in State and Local Health Departments [CK14-1401PPHFSUPP15]	Hospital Preparedness Program (HPP); Public Health Emergency Preparedness (PHEP); Domestic Ebola Supplement to Epidemiology and Laboratory Capacity for Infectious Diseases (ELC)-Building and Strengthening Epidemiology, Laboratory and Health Information Systems Capacity in State and Local Health Departments	Funded in part by the Hospital Preparedness Program (HPP) and Public Health Emergency Preparedness (PHEP) Cooperative Agreements / PHEP Supplemental for Ebola Preparedness and Response Activities CDC-RFA-TP12-12010302SUPP15 and CDC-RFA-TP12-120102CONT14; and the Domestic Ebola Supplement to Epidemiology and Laboratory Capacity for Infectious Diseases (ELC)-Building and Strengthening Epidemiology, Laboratory and Health Information Systems Capacity in State and Local Health Departments CK14-1401PPHFSUPP15. Funds did not go to individuals but went to the Minnesota Department of Health as an agency, which employed ASD, KS, and RND at the time. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, MMWR-MORBID MORTAL W, V64, P121; Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Bah EI, 2015, NEW ENGL J MED, V372, P40, DOI 10.1056/NEJMoa1411249; Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Boggild AK, 2015, ANN INTERN MED, V162, P757, DOI 10.7326/M15-0074; Cardile AP, 2015, MMWR-MORBID MORTAL W, V64, P690; Centers for Disease Control and Prevention, FACT SHEET SCREEN MO; Centers for Disease Control and Prevention, EB CARE KIT; Centers for Disease Control and Prevention, INT US GUID MON MOV; Chung WM, 2015, ANN INTERN MED, V163, P164, DOI 10.7326/M15-0968; Department of Homeland Security, DHSS COORD RESP EB; Kraemer JD, 2015, HEALTH SECUR, V13, P295, DOI 10.1089/hs.2015.0016; O'Shea MK, 2015, CLIN INFECT DIS, V61, P795, DOI 10.1093/cid/civ399; Stehling-Ariza T, 2015, MMWR-MORBID MORTAL W, V64, P685; U. S. Department of Homeland Security, DHSS COORD RESP EB; WHO, 2015, EB SIT REP	16	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166797	10.1371/journal.pone.0166797	http://dx.doi.org/10.1371/journal.pone.0166797			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907013	Green Submitted, Green Published, gold			2022-12-26	WOS:000389482700041
J	Feng, GL; Wu, YP				Feng, Guo-Lin; Wu, Yong-Ping			Signal of Acceleration and Physical Mechanism of Water Cycle in Xinjiang, China	PLOS ONE			English	Article							VAPOR TRANSPORT; CLIMATE-CHANGE; PATTERNS; FLOODS	Global warming accelerates water cycle with features of regional difference. However, little is known about the physical mechanism behind the phenomenon. To reveal the links between water cycle and climatic environment, we analyzed the changes of water cycle elements and their relationships with climatic and environmental factors. We found that when global warming was significant during the period of 1986-2003, the precipitation in Tarim mountains as well as Xinjiang increased rapidly except for Tarim plains, which indicated that there existed a signal of acceleration for water cycle in Xinjiang. The speed of water cycle is mainly affected by altitude, latitude, longitude, slope direction, and the most fundamental element is temperature. Moreover, according to Clausius-Kela Bai Lung relation, we found that the climate change induced the increase of temperature and accelerated the local water cycle only for the wet places. Our results provide a possible physical mechanisms of water cycle and thus well link the climate change to water circulation.	[Feng, Guo-Lin; Wu, Yong-Ping] Yangzhou Univ, Coll Phys Sci & Technol, Yangzhou 225002, Jiangsu, Peoples R China; [Feng, Guo-Lin] China Meteorol Adm, Natl Climate Ctr, Beijing 100081, Peoples R China; [Wu, Yong-Ping] Univ Calif Riverside, Ecol Complex & Modeling Lab, Riverside, CA 92521 USA	Yangzhou University; China Meteorological Administration; University of California System; University of California Riverside	Wu, YP (corresponding author), Yangzhou Univ, Coll Phys Sci & Technol, Yangzhou 225002, Jiangsu, Peoples R China.; Wu, YP (corresponding author), Univ Calif Riverside, Ecol Complex & Modeling Lab, Riverside, CA 92521 USA.	wuypyz@126.com			National Natural Science Foundation of China [41530531, 41375078, 41375079, 41201062, 41271083]; Major National Scientific Research Programs of China [2013CB430204]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major National Scientific Research Programs of China	The research is funded by the National Natural Science Foundation of China (under grants 41530531, 41375078, 41375079, 41201062, 41271083), and Major National Scientific Research Programs of China (grant nos: 2013CB430204).	Apurv T, 2015, J HYDROL, V527, P281, DOI 10.1016/j.jhydrol.2015.04.056; Boos WR, 2012, J CLIMATE, V25, P992, DOI 10.1175/JCLI-D-11-00010.1; Skansi MD, 2013, GLOBAL PLANET CHANGE, V100, P295, DOI 10.1016/j.gloplacha.2012.11.004; Falconer K., 2004, FRACTAL GEOMETRY MAT; Held IM, 2006, J CLIMATE, V19, P5686, DOI 10.1175/JCLI3990.1; Huang J, 2012, ATMOS CHEM PHYS, V12, P5391, DOI 10.5194/acp-12-5391-2012; Huang JP, 2016, NAT CLIM CHANGE, V6, P166, DOI [10.1038/nclimate2837, 10.1038/NCLIMATE2837]; Karl TR, 2003, SCIENCE, V302, P1719, DOI 10.1126/science.1090228; Kendall M. G., 1975, RANK CORRELATION MET; Kerr RA, 2012, SCIENCE, V336, P405, DOI 10.1126/science.336.6080.405; Mann HB, 1945, ECONOMETRICA, V13, P245, DOI 10.2307/1907187; Piao SL, 2010, NATURE, V467, P43, DOI 10.1038/nature09364; Schmitz JT, 1996, J CLIMATE, V9, P1621, DOI 10.1175/1520-0442(1996)009<1621:WVTAWT>2.0.CO;2; Sherwood S, 2014, SCIENCE, V343, P737, DOI 10.1126/science.1247620; Smith TM, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023402; Sun GQ, 2016, NONLINEAR DYNAM, V85, P1, DOI 10.1007/s11071-016-2671-y; Sun GQ, 2016, NONLINEAR DYNAM, V83, P811, DOI 10.1007/s11071-015-2369-6; Sun GQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11246; Sun GQ, 2012, APPL MATH COMPUT, V218, P11151, DOI 10.1016/j.amc.2012.04.071; Trenberth KE, 1999, J CLIMATE, V12, P1368, DOI 10.1175/1520-0442(1999)012<1368:AMRROA>2.0.CO;2; Trenberth KE, 2011, CLIM RES, V47, P123, DOI 10.3354/cr00953; Vormoor K, 2016, J HYDROL, V538, P33, DOI 10.1016/j.jhydrol.2016.03.066; Wang B.Q., 1995, ACTA SEISMOLOGICA SI, V8, P653; Wu YP, 2016, SCI REP-UK, V6, DOI 10.1038/srep26470; Wu YP, 2015, APPL MATH COMPUT, V268, P478, DOI 10.1016/j.amc.2015.06.059; Wu YP, 2012, ECOL COMPLEX, V9, P63, DOI 10.1016/j.ecocom.2011.12.002; Zhang Q, 2016, GLOBAL PLANET CHANGE, V139, P44, DOI 10.1016/j.gloplacha.2015.10.005; Zhou TJ, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005413	28	10	10	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167387	10.1371/journal.pone.0167387	http://dx.doi.org/10.1371/journal.pone.0167387			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907078	Green Submitted, Green Published, gold			2022-12-26	WOS:000389482700138
J	Feng, K; Hu, WZ; Jiang, AL; Sarengaowa; Xu, YP; Zou, Y; Yang, L; Wang, X				Feng, Ke; Hu, Wenzhong; Jiang, Aili; Sarengaowa; Xu, Yongping; Zou, Yu; Yang, Liu; Wang, Xin			A Dual Filtration-Based Multiplex PCR Method for Simultaneous Detection of Viable Escherichia coli O157:H7, Listeria monocytogenes, and Staphylococcus aureus on Fresh-Cut Cantaloupe	PLOS ONE			English	Article							PROPIDIUM MONOAZIDE TREATMENT; POLYMERASE-CHAIN-REACTION; SALMONELLA SPP.; RAPID DETECTION; IMMUNOMAGNETIC SEPARATION; VIBRIO-PARAHAEMOLYTICUS; MICROBIAL QUALITY; DEAD CELLS; FOOD; O157-H7	Fresh-cut cantaloupe is particularly susceptible to contamination with pathogenic bacteria, such as Escherichia coli O157: H7, Listeria monocytogenes, and Staphylococcus aureus. Therefore, development of rapid, yet accurate detection techniques is necessary to ensure food safety. In this study, a multiplex PCR system and propidium monoazide (PMA) concentration were optimized to detect all viable pathogens in a single tube. A dual filtration system utilized a filtration membrane with different pore sizes to enrich pathogens found on fresh-cut cantaloupe. The results revealed that an optimized multiplex PCR system has the ability to effectively detect three pathogens in the same tube. The viable pathogens were simultaneously detected for PMA concentrations above 10 mu g/ml. The combination of a nylon membrane (15 mu m) and a micro pore filtration membrane (0.22 mu m) formed the dual filtration system used to enrich pathogens. The achieved sensitivity of PMA-mPCR based on this dual filtration system was 2.6 x 10(3) cfu/g for L. monocytogenes, 4.3 x 10 cfu/g for E. coli O157:H7, and 3.1 x 10(2) cfu/g for S. aureus. Fresh-cut cantaloupe was inoculated with the three target pathogens using concentrations of 10(3), 10(2), 10, and 1 cfu/g. After 6-h of enrichment culture, assay sensitivity increased to 1 cfu/g for each of these pathogens. Thus, this technique represents an efficient and rapid detection tool for implementation on fresh-cut cantaloupe.	[Feng, Ke; Sarengaowa; Xu, Yongping] Dalian Univ Technol, Sch Life Sci & Biotechnol, Dalian, Peoples R China; [Feng, Ke; Hu, Wenzhong; Jiang, Aili; Sarengaowa; Zou, Yu; Yang, Liu; Wang, Xin] Dalian Nationalities Univ, Coll Life Sci, Dalian, Peoples R China; [Jiang, Aili] Dalian Nationalities Univ, Coll Life Sci, Engn Ctr quick Detect Foodborne Pathogen Microorg, Dalian, Peoples R China	Dalian University of Technology; Dalian Minzu University; Dalian Minzu University	Hu, WZ (corresponding author), Dalian Nationalities Univ, Coll Life Sci, Dalian, Peoples R China.	wenzhongh@sina.com	Xu, Yongping/AAH-3987-2020	Xu, Yongping/0000-0002-3946-9223	Ministry of Science and Technology of the People's Republic of China [2016YFD0400903]; National Natural Science Foundation of China [31471923]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was financially supported by Ministry of Science and Technology of the People's Republic of China - 2016YFD0400903, and by the National Natural Science Foundation of China - 31471923.	Yanez MA, 2011, J MICROBIOL METH, V85, P124, DOI 10.1016/j.mimet.2011.02.004; Alvarado-Casillas S, 2007, J FOOD PROTECT, V70, P655, DOI 10.4315/0362-028X-70.3.655; Alvarez G, 2013, AMB EXPRESS, V3, DOI 10.1186/2191-0855-3-1; Alves J, 2016, LWT-FOOD SCI TECHNOL, V72, P175, DOI 10.1016/j.lwt.2016.04.051; Bae S, 2009, WATER RES, V43, P4850, DOI 10.1016/j.watres.2009.06.053; Beaulieu JC, 2007, J AM SOC HORTIC SCI, V132, P720, DOI 10.21273/JASHS.132.5.720; Beuchat LR, 2002, MICROBES INFECT, V4, P413, DOI 10.1016/S1286-4579(02)01555-1; Bhaduri S, 2001, MOL CELL PROBE, V15, P267, DOI 10.1006/mcpr.2001.0370; BOBBITT JA, 1992, J MICROBIOL METH, V16, P215, DOI 10.1016/0167-7012(92)90006-P; Bonetta S, 2011, ENVIRON MONIT ASSESS, V177, P493, DOI 10.1007/s10661-010-1650-x; Bowen A, 2006, EPIDEMIOL INFECT, V134, P675, DOI 10.1017/S0950268805005480; Cadirci O, 2010, MEAT SCI, V84, P553, DOI 10.1016/j.meatsci.2009.10.011; Chen SY, 2011, APPL ENVIRON MICROB, V77, P4008, DOI 10.1128/AEM.00354-11; Chiang YC, 2012, J MICROBIOL METH, V88, P110, DOI 10.1016/j.mimet.2011.10.021; Danyluk MD, 2014, FOOD MICROBIOL, V38, P52, DOI 10.1016/j.fm.2013.08.001; DELROSARIO BA, 1995, J FOOD PROTECT, V58, P105, DOI 10.4315/0362-028X-58.1.105; Donhauser SC, 2011, ANAL CHEM, V83, P3153, DOI 10.1021/ac2002214; Elizaquivel P, 2008, FOOD MICROBIOL, V25, P705, DOI 10.1016/j.fm.2008.03.002; D'Urso OF, 2009, FOOD MICROBIOL, V26, P311, DOI 10.1016/j.fm.2008.12.006; Ferretti R, 2001, APPL ENVIRON MICROB, V67, P977, DOI 10.1128/AEM.67.2.977-978.2001; Germini A, 2009, FOOD CONTROL, V20, P733, DOI 10.1016/j.foodcont.2008.09.010; Gil MI, 2006, J AGR FOOD CHEM, V54, P4284, DOI 10.1021/jf060303y; Gilbert C, 2003, MOL CELL PROBE, P17; Hagren V, 2008, INT J FOOD MICROBIOL, V125, P158, DOI 10.1016/j.ijfoodmicro.2008.03.037; Hahm BK, 2015, J MICROBIOL METH, V117, P64, DOI 10.1016/j.mimet.2015.07.016; Heaton JC, 2008, J APPL MICROBIOL, V104, P613, DOI 10.1111/j.1365-2672.2007.03587.x; John EG, 2015, FOOD CONTROL, V19, P1; Kawasaki S, 2005, J FOOD PROTECT, V68, P551, DOI 10.4315/0362-028X-68.3.551; Klerks MM, 2004, J MICROBIOL METH, V59, P337, DOI 10.1016/j.mimet.2004.07.011; Lee HJ, 2009, BIOSENS BIOELECTRON, V24, P3550, DOI 10.1016/j.bios.2009.05.010; Luo JF, 2010, APPL MICROBIOL BIOT, V86, P377, DOI 10.1007/s00253-009-2373-1; Martin B, 2004, LETT APPL MICROBIOL, V39, P290, DOI 10.1111/j.1472-765X.2004.01580.x; Millan-Sango D, 2015, FOOD RES INT, V67, P145, DOI 10.1016/j.foodres.2014.11.001; Morin NJ, 2004, CLIN CHEM, V50, P2037, DOI 10.1373/clinchem.2004.036814; Muhterem-Uyar M, 2015, FOOD CONTROL, V51, P94, DOI 10.1016/j.foodcont.2014.10.042; Mukhopadhyay A, 2007, J MICROBIOL METH, V68, P193, DOI 10.1016/j.mimet.2006.07.009; Nocker A, 2006, APPL ENVIRON MICROB, V72, P1997, DOI 10.1128/AEM.72.3.1997-2004.2006; Nocker A, 2007, J MICROBIOL METH, V70, P252, DOI 10.1016/j.mimet.2007.04.014; Nocker A, 2007, APPL ENVIRON MICROB, V73, P5111, DOI 10.1128/AEM.02987-06; Nocker A, 2006, J MICROBIOL METH, V67, P310, DOI 10.1016/j.mimet.2006.04.015; Park YS, 2006, J MICROBIOL, V44, P92; Richards GM, 2005, INT J FOOD MICROBIOL, V103, P1, DOI 10.1016/j.ijfoodmicro.2004.05.023; Richards GM, 2005, INT J FOOD MICROBIOL, V97, P327, DOI 10.1016/j.ijfoodmicro.2004.05.002; Rodgers SL, 2004, J FOOD PROTECT, V67, P721, DOI 10.4315/0362-028X-67.4.721; Rueckert A, 2005, J APPL MICROBIOL, V99, P1246, DOI 10.1111/j.1365-2672.2005.02728.x; Saroj SD, 2008, MOL CELL PROBE, V22, P201, DOI 10.1016/j.mcp.2008.02.002; Seinige D, 2014, APPL ENVIRON MICROB, V80, P2186, DOI 10.1128/AEM.03962-13; Toh PS, 2000, FOOD CONTROL, V11, P447, DOI 10.1016/S0956-7135(00)00008-6; Ukuku DO, 2006, J FOOD PROTECT, V69, P1835, DOI 10.4315/0362-028X-69.8.1835; Ukuku DO, 2006, J FOOD PROTECT, V69, P1623, DOI 10.4315/0362-028X-69.7.1623; Ukuku DO, 2004, J FOOD PROTECT, V67, P432, DOI 10.4315/0362-028X-67.3.432; Ukuku DO, 2002, J FOOD PROTECT, V65, P924, DOI 10.4315/0362-028X-65.6.924; Valimaa AL, 2015, FOOD CONTROL, V55, P103, DOI 10.1016/j.foodcont.2015.02.037; Vasanth D, 2011, J MEMBRANE SCI, V379, P154, DOI 10.1016/j.memsci.2011.05.050; Wan CX, 2012, INT J FOOD SCI TECH, V47, P2460, DOI 10.1111/j.1365-2621.2012.03123.x; Wang SS, 2006, J MICROBIOL METH, V64, P1, DOI 10.1016/j.mimet.2005.04.023; Yang YJ, 2013, FOOD MICROBIOL, V34, P418, DOI 10.1016/j.fm.2013.01.004; Zhang ZH, 2014, FOOD CONTROL, V35, P401, DOI 10.1016/j.foodcont.2013.07.035; Zhu RG, 2012, J MICROBIOL METH, V90, P262, DOI 10.1016/j.mimet.2012.05.019	59	19	20	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166874	10.1371/journal.pone.0166874	http://dx.doi.org/10.1371/journal.pone.0166874			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27906992	Green Published, gold, Green Submitted			2022-12-26	WOS:000389482700047
J	Kawoos, U; Gu, M; Lankasky, J; McCarron, RM; Chavko, M				Kawoos, Usmah; Gu, Ming; Lankasky, Jason; McCarron, Richard M.; Chavko, Mikulas			Effects of Exposure to Blast Overpressure on Intracranial Pressure and Blood-Brain Barrier Permeability in a Rat Model	PLOS ONE			English	Article							CLOSED-HEAD INJURY; SHOCK-WAVES; MOUSE MODEL; TIME-COURSE; IN-VITRO; INFLAMMATION; DYSFUNCTION; DISRUPTION; MILD; PATHOPHYSIOLOGY	Exposure to blast overpressure (BOP) activates a cascade of pathological processes including changes in intracranial pressure (ICP) and blood-brain barrier (BBB) permeability resulting in traumatic brain injury (TBI). In this study the effect of single and multiple exposures at two intensities of BOP on changes in ICP and BBB permeability in Sprague-Dawley rats was evaluated. Animals were exposed to a single or three repetitive (separated by 0.5 h) BOPs at 72 kPa or 110 kPa. ICP was monitored continuously via telemetry for 6 days after exposure to BOP. The alteration in the permeability of BBB was determined by extravasation of Evans Blue (EB) into brain parenchyma. A significant increase in ICP was observed in all groups except the single 72 kPa BOP group. At the same time a marked increase in BBB permeability was also seen in various parts of the brain. The extent of ICP increase as well as BBB permeability change was dependent on intensity and frequency of blast.	[Kawoos, Usmah; Gu, Ming; Lankasky, Jason; McCarron, Richard M.; Chavko, Mikulas] Naval Med Res Ctr, Dept Neurotrauma, Silver Spring, MD 20910 USA; [McCarron, Richard M.] Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA; [McCarron, Richard M.] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA	Naval Medical Research Center (NMRC); Uniformed Services University of the Health Sciences - USA; Walter Reed National Military Medical Center	Kawoos, U (corresponding author), Naval Med Res Ctr, Dept Neurotrauma, Silver Spring, MD 20910 USA.	Usmah.kawoos.ctr@mail.mil			Office of Naval Research (ONR) [601152N.0000.000.A1308]	Office of Naval Research (ONR)(Office of Naval Research)	This work was supported by Office of Naval Research (ONR) Work Unit 601152N.0000.000.A1308. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Beaumont A, 2000, ACTA NEUROCHIR SUPPL, V76, P125; Cernak Ibolja, 2010, Front Neurol, V1, P151, DOI 10.3389/fneur.2010.00151; Chavko M, 2011, J NEUROSCI METH, V195, P61, DOI 10.1016/j.jneumeth.2010.11.019; Cho HJ, 2013, NEUROSCIENCE, V253, P9, DOI 10.1016/j.neuroscience.2013.08.037; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Elder GA, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00048; Engelborghs K, 1998, J NEUROSURG, V89, P796, DOI 10.3171/jns.1998.89.5.0796; Fritz HG, 2005, J NEUROTRAUM, V22, P807, DOI 10.1089/neu.2005.22.807; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Guild SJ, 2015, J APPL PHYSIOL, V119, P576, DOI 10.1152/japplphysiol.00165.2015; Hall ED, 2004, J NEUROTRAUM, V21, P9, DOI 10.1089/089771504772695904; Huber BR, 2016, NEUROSCIENCE, V319, P206, DOI 10.1016/j.neuroscience.2016.01.022; Hue CD, 2016, J NEUROTRAUM, V33, P1202, DOI 10.1089/neu.2015.4067; Hue CD, 2014, J NEUROTRAUM, V31, P951, DOI 10.1089/neu.2013.3149; Hue CD, 2013, J NEUROTRAUM, V30, P1652, DOI 10.1089/neu.2012.2773; Jamali S, 1998, BRAIN INJURY, V12, P525, DOI 10.1080/026990598122485; Kabu S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127971; Kawoos U, 2014, IEEE T BIO-MED ENG, V61, P841, DOI 10.1109/TBME.2013.2291239; Leonardi AD, 2013, ANN BIOMED ENG, V41, P2488, DOI 10.1007/s10439-013-0850-2; Leonardi AD, 2011, J NEUROTRAUM, V28, P85, DOI 10.1089/neu.2010.1324; Logsdon AF, 2015, COMPR PHYSIOL, V5, P1147, DOI 10.1002/cphy.c140057; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Lucke-Wold BP, 2015, MOL NEUROBIOL, V52, P1119, DOI 10.1007/s12035-014-8902-7; Magnuson J, 2012, CURR NEUROL NEUROSCI, V12, P570, DOI 10.1007/s11910-012-0303-6; Meaney DF, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026364; Mishra V, 2016, SCI REP-UK, V6, DOI 10.1038/srep26992; Needham CE, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00072; Paxinos G, 1998, ACTA NEUROBIOLOGIAE; Rafaels KA, 2012, J TRAUMA ACUTE CARE, V73, P895, DOI 10.1097/TA.0b013e31825a760e; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; Rooker S, 2003, J NEUROSCI METH, V131, P75, DOI 10.1016/S0165-0270(03)00233-4; Saljo A, 2011, NEUROIMAGE, V54, pS83, DOI 10.1016/j.neuroimage.2010.05.050; Saljo A, 2009, J NEUROTRAUM, V26, P1345, DOI [10.1089/neu.2008.0856, 10.1089/neu.2008-0856]; Saunders NR, 2015, FRONT NEUROSCI-SWITZ, V9, DOI [10.3339/fnins.2015.00385, 10.3389/fnins.2015.00385]; Shetty AK, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00232; Skotak M, 2013, J NEUROTRAUM, V30, P1147, DOI 10.1089/neu.2012.2652; Sosa MAG, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-67; Sosa MAG, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-51; Stocchetti N, 2007, J NEUROTRAUM, V24, P1339, DOI 10.1089/neu.2007.0300; Sundaramurthy A, 2012, J NEUROTRAUM, V29, P2352, DOI 10.1089/neu.2012.2413; Tompkins P, 2013, J NEUROTRAUM, V30, P1888, DOI 10.1089/neu.2012.2674; Treggiari MM, 2007, NEUROCRIT CARE, V6, P104, DOI 10.1007/s12028-007-0012-1; Wang Y, 2011, J NEUROTRAUM, V28, P2171, DOI 10.1089/neu.2011.1990; Wojcik BE, 2010, AM J PREV MED, V38, pS108, DOI 10.1016/j.amepre.2009.10.006; Yeoh S, 2013, ANN BIOMED ENG, V41, P2206, DOI 10.1007/s10439-013-0805-7	46	40	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167510	10.1371/journal.pone.0167510	http://dx.doi.org/10.1371/journal.pone.0167510			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907158	gold, Green Submitted, Green Published			2022-12-26	WOS:000389482700176
J	La, T; Phillips, ND; Hampson, DJ				La, Tom; Phillips, Nyree D.; Hampson, David J.			An Investigation into the Etiological Agents of Swine Dysentery in Australian Pig Herds	PLOS ONE			English	Article							FRAGMENT-LENGTH-POLYMORPHISM; MALLARDS ANAS-PLATYRHYNCHOS; DUPLEX PCR ASSAY; BRACHYSPIRA-HYODYSENTERIAE; SERPULINA-HYODYSENTERIAE; ANTIMICROBIAL SUSCEPTIBILITY; HAMPSONII; SEQUENCE; PILOSICOLI; STRAIN	Swine dysentery (SD) is a mucohemorrhagic colitis, classically seen in grower/finisher pigs and caused by infection with the anaerobic intestinal spirochete Brachyspira hyodysenteriae. More recently, however, the newly described species Brachyspira hampsonii and Brachyspira suanatina have been identified as causing SD in North America and/or Europe. Furthermore, there have been occasions where strains of B. hyodysenteriae have been recovered from healthy pigs, including in multiplier herds with high health status. This study investigated whether cases of SD in Australia may be caused by the newly described species; how isolates of B. hyodysenteriae recovered from healthy herds compared to isolates from herds with disease; and how contemporary isolates compare to those recovered in previous decades, including in their plasmid gene content and antimicrobial resistance profiles. In total 1103 fecal and colon samples from pigs in 97 Australian herds were collected and tested. Of the agents of SD only B. hyodysenteriae was found, being present in 34 (35.1%) of the herds, including in 14 of 24 (58%) herds that had been considered to be free of SD. Multilocus sequence typing applied to 96 isolates from 30 herds and to 53 Australian isolates dating from the 1980s through the early 2000s showed that they were diverse, distinct from those reported in other countries, and that the 2014/16 isolates generally were different from those from earlier decades. These findings provided evidence for ongoing evolution of B. hyodysenteriae strains in Australia. In seven of the 20 herds where multiple isolates were available, two to four different sequence types (STs) were identified. Isolates with the same STs also were found in some herds with epidemiological links. Analysis of a block of six plasmid virulence-associated genes showed a lack of consistency between their presence or absence and their origin from herds currently with or without disease; however, significantly fewer isolates from the 2000s and from 2014/16 had this block of genes compared to isolates from the 1980s and 1990s. It is speculated that loss of these genes may have been responsible for the occurrence of milder disease occurring in recent years. In addition, fewer isolates from 2014/16 were susceptible to the antimicrobials lincomycin, and to a lesser extent tiamulin, than those from earlier Australian studies. Four distinct multi-drug resistant strains were identified in five herds, posing a threat to disease control.	[La, Tom; Phillips, Nyree D.; Hampson, David J.] Murdoch Univ, Sch Vet & Life Sci, Murdoch, WA, Australia	Murdoch University	Hampson, DJ (corresponding author), Murdoch Univ, Sch Vet & Life Sci, Murdoch, WA, Australia.	d.hampson@murdoch.edu.au	Hampson, David/AAE-3666-2019; Hampson, David J/A-9464-2008	Hampson, David J/0000-0002-7729-0427	CRC for High Integrity Australian Pork ("The Pork CRC") [2A-111]	CRC for High Integrity Australian Pork ("The Pork CRC")	This work was funded by CRC for High Integrity Australian Pork ("The Pork CRC"), project number 2A-111 to DJ H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achacha M, 1996, CAN J VET RES, V60, P45; Atyeo RF, 1999, EPIDEMIOL INFECT, V123, P133, DOI 10.1017/S0950268899002691; Bellgard MI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004641; Chander Y, 2012, J VET DIAGN INVEST, V24, P903, DOI 10.1177/1040638712456975; Costa MO, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-129; Durmic Z, 1998, J APPL MICROBIOL, V85, P574, DOI 10.1046/j.1365-2672.1998.853539.x; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Francisco AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-87; Hampson DJ, 2016, VET MICROBIOL, V191, P15, DOI 10.1016/j.vetmic.2016.05.016; Hampson DJ, 2015, PORCINE HEALTH MANAG, V1, DOI 10.1186/s40813-015-0002-1; HAMPSON DJ, 1992, VET REC, V131, P318, DOI 10.1136/vr.131.14.318; Hampson DJ, 2012, DIS SWINE, P680; Hampson DJ, 2008, REPORT PREPARED CO O, P1; Hansen CF, 2010, J ANIM SCI, V88, P3327, DOI 10.2527/jas.2009-2719; Hansen CF, 2011, BRIT J NUTR, V106, P1506, DOI 10.1017/S000711451100208X; Jacobson M, 2004, J MED MICROBIOL, V53, P273, DOI 10.1099/jmm.0.05323-0; Jansson DS, 2011, SYST APPL MICROBIOL, V34, P566, DOI 10.1016/j.syapm.2011.10.001; Jansson DS, 2004, J MED MICROBIOL, V53, P293, DOI 10.1099/jmm.0.05488-0; Martinez-Lobo FJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082626; JENSEN NS, 1993, VET MICROBIOL, V36, P221, DOI 10.1016/0378-1135(93)90090-T; Jolley KA, 2001, BIOINFORMATICS, V17, P1230, DOI 10.1093/bioinformatics/17.12.1230; Karlsson M, 1999, FEMS MICROBIOL LETT, V172, P255, DOI 10.1111/j.1574-6968.1999.tb13476.x; Karlsson M, 2002, VET MICROBIOL, V84, P123, DOI 10.1016/S0378-1135(01)00444-8; La T, 2003, J CLIN MICROBIOL, V41, P3372, DOI 10.1128/JCM.41.7.3372-3375.2003; La T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160362; La T, 2014, VET RES, V45, DOI 10.1186/s13567-014-0131-6; La T, 2011, VET MICROBIOL, V153, P150, DOI 10.1016/j.vetmic.2011.02.053; La T, 2009, VET MICROBIOL, V138, P330, DOI 10.1016/j.vetmic.2009.03.025; Lobert S, 2016, TIERAERZTL PRAX G N, V44, P13, DOI 10.15653/TPG-150674; Lysons RJ, 1982, P 7 INT PIG VET SOC, P40; Mahu M, 2014, VET REC, V174, DOI 10.1136/vr.101868; Mahu M, 2016, VET RES, V47, DOI 10.1186/s13567-016-0353-x; Mirajkar NS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107176; Mirajkar NS, 2016, J CLIN MICROBIOL; Mushtaq M, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0537-y; Osorio J, 2013, RES VET SCI, V95, P861, DOI 10.1016/j.rvsc.2013.07.014; Osorio J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039082; Phillips ND, 2007, P 4 INT C COL SPIR I, P19; Phillips ND, 2006, VET MICROBIOL, V116, P239, DOI 10.1016/j.vetmic.2006.03.020; Phillips ND, 2009, VET MICROBIOL, V134, P294, DOI 10.1016/j.vetmic.2008.08.006; Pluske JR, 1996, J NUTR, V126, P2920; Pringle M, 2012, ACTA VET SCAND, V54, DOI 10.1186/1751-0147-54-54; Rasback T, 2007, ENVIRON MICROBIOL, V9, P983, DOI 10.1111/j.1462-2920.2006.01220.x; Rohde J, 2014, VET MICROBIOL, V168, P432, DOI 10.1016/j.vetmic.2013.11.016; Rohde J, 2012, VET MICROBIOL, V158, P211, DOI 10.1016/j.vetmic.2012.02.008; Ronne H, 1990, P INT PIG VET SOC C, P126; Rubin JE, 2013, MICROB ECOL, V66, P813, DOI 10.1007/s00248-013-0273-5; Rubin JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057146; Rugna G, 2015, VET J, V203, P115, DOI 10.1016/j.tvjl.2014.10.033; Siba PM, 1996, EPIDEMIOL INFECT, V116, P207, DOI 10.1017/S0950268800052456; Stege H, 2000, PREV VET MED, V46, P279, DOI 10.1016/S0167-5877(00)00148-3; Thomsen LE, 2007, VET MICROBIOL, V119, P152, DOI 10.1016/j.vetmic.2006.09.004; Thomson JR, 2003, P 2 INT C COL SPIR I; van Duijkeren E, 2014, J ANTIMICROB CHEMOTH, V69, P2022, DOI 10.1093/jac/dku123; Wilberts BL, 2014, VET PATHOL, V51, P1096, DOI 10.1177/0300985813516646; Wilberts BL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114741	56	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167424	10.1371/journal.pone.0167424	http://dx.doi.org/10.1371/journal.pone.0167424			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907102	Green Published, gold, Green Submitted			2022-12-26	WOS:000389482700152
J	Mukui, IN; Ng'ang'a, L; Williamson, J; Wamicwe, JN; Vakil, S; Katana, A; Kim, AA				Mukui, Irene N.; Ng'ang'a, Lucy; Williamson, John; Wamicwe, Joyce N.; Vakil, Shobha; Katana, Abraham; Kim, Andrea A.			Rates and Predictors of Non-Adherence to Antiretroviral Therapy among HIV-Positive Individuals in Kenya: Results from the Second Kenya AIDS Indicator Survey, 2012	PLOS ONE			English	Article							DRUG-USERS; ADHERENCE; ART; SUPPRESSION; INFECTION; OUTCOMES; RISK	Introduction Understanding the levels and associated factors of non-adherence to antiretroviral therapy (ART) is crucial in designing interventions to improve adherence and health outcomes of ART. We assessed non-adherence to ART among HIV-infected persons reporting ART use in a nationally representative survey in Kenya. Methods The Kenya AIDS Indicator Survey 2012 was a population-based, household survey of persons aged 18 months-64 years conducted in 2012-2013. Self-reported information was collected on demographics, sexual behaviour, HIV status, and ART use. Blood was collected for HIV testing, and if HIV infected, CD4 and viral load testing. HIV-positive specimens were tested for the presence of antiretroviral (ARV) drugs using a qualitative ARV assay using liquid chromatography-tandem mass spectrometry. HIV-positive persons who reported receiving ART but did not have the ARV biomarker present were defined as being non-adherent to their ARV medication. We restricted our analysis to HIV-infected persons aged 15-64 years who reported receiving ART and had laboratory-confirmed results from ARV testing. Multivariate logistic regression was used to identify variables associated with non-adherence. Results A total of 648 (5.6%; CI 4.9-6.3) tested HIV-positive of whom 559 (86.3%) had sufficient volume of blood to be tested for ARV drugs. Of those, 271 (47.7%; CI 41.8-53.6) self-reported HIV-positive status during the interview and 186 (69.1%; CI 62.2-76.0) of those reported taking ART. The ARV biomarker was absent in 18 of 186 individuals (9.4%; CI 4.9-13.8) who thus were defined as being non-adherent to ART. Non-adherence was associated with being aged 15-29 years (AOR 8.39; CI 2.26-31.22, p = 0.002) compared to aged 30-64 years, rural residence (AOR 5.87; CI 1.39-25.61, p = 0.016) compared with urban residence and taking recreational drugs in the past 30 days (AOR 5.89; CI 1.30-26.70, p = 0.022). Conclusion Overall, less than 10% of Kenyans aged 15-64 years on ART were not adhering to their HIV medication, highlighting the success of the Kenyan national ART program. Our findings, however, point to the need for targeted interventions particularly for young persons, those in rural areas to improve adherence outcomes, as well as delivery of treatment programs that include psychosocial support as a preventative measure to minimize substance abuse and the risk of treatment failure.	[Mukui, Irene N.; Wamicwe, Joyce N.; Vakil, Shobha] Minist Hlth, Natl AIDS & STI Control Programme, Dept Prevent & Promot Hlth Serv, Nairobi, Kenya; [Ng'ang'a, Lucy; Williamson, John; Katana, Abraham; Kim, Andrea A.] US Ctr Dis Control & Prevent, Div Global HIV AIDS, Nairobi, Kenya		Mukui, IN (corresponding author), Minist Hlth, Natl AIDS & STI Control Programme, Dept Prevent & Promot Hlth Serv, Nairobi, Kenya.	njahira2004@yahoo.com	Mukui, Irene/GYE-0151-2022	Mukui, Irene/0000-0002-3699-1841	National AIDS and STI Control Programme (NASCOP); Kenya National Bureau of Statistics, (KNBS); National Public Health Laboratory Services (NPHLS); National AIDS Control Council (NACC); National Council for Population and Development (NCPD); Kenya Medical Research Institute (KEMRI); U.S. Centers for Disease Control and Prevention (CDC/Kenya, CDC/Atlanta); United States Agency for International Development (USAID/Kenya); University of California, San Francisco (UCSF); Joint United Nations Team on HIV/AIDS; Japan International Cooperation Agency (JICA); Elizabeth Glaser Paediatric AIDS Foundation (EGPAF); Liverpool Voluntary Counselling and Testing (LVCT); African Medical and Research Foundation (AMREF); World Bank; Global Fund; U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention (CDC), Division of Global HIV/AIDS (DGHA) [PS001805, GH000069, PS001814]; Joint United Nations Team for HIV/AIDS	National AIDS and STI Control Programme (NASCOP); Kenya National Bureau of Statistics, (KNBS); National Public Health Laboratory Services (NPHLS); National AIDS Control Council (NACC); National Council for Population and Development (NCPD); Kenya Medical Research Institute (KEMRI); U.S. Centers for Disease Control and Prevention (CDC/Kenya, CDC/Atlanta)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); United States Agency for International Development (USAID/Kenya)(United States Agency for International Development (USAID)); University of California, San Francisco (UCSF)(University of California System); Joint United Nations Team on HIV/AIDS; Japan International Cooperation Agency (JICA); Elizabeth Glaser Paediatric AIDS Foundation (EGPAF); Liverpool Voluntary Counselling and Testing (LVCT); African Medical and Research Foundation (AMREF); World Bank(The World Bank India); Global Fund; U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention (CDC), Division of Global HIV/AIDS (DGHA)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Joint United Nations Team for HIV/AIDS	The second Kenya AIDS Indicator Survey (KAIS 2012) was supported by National AIDS and STI Control Programme (NASCOP), Kenya National Bureau of Statistics, (KNBS), National Public Health Laboratory Services (NPHLS), National AIDS Control Council (NACC), National Council for Population and Development (NCPD), Kenya Medical Research Institute (KEMRI), U.S. Centers for Disease Control and Prevention (CDC/Kenya, CDC/Atlanta), United States Agency for International Development (USAID/Kenya), University of California, San Francisco (UCSF), the United States Agency for International Development (USAID/Kenya), Joint United Nations Team on HIV/AIDS, Japan International Cooperation Agency (JICA), the Elizabeth Glaser Paediatric AIDS Foundation (EGPAF), Liverpool Voluntary Counselling and Testing (LVCT), the African Medical and Research Foundation (AMREF), the World Bank, and the Global Fund. This publication was made possible by support from the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through cooperative agreements [#PS001805, GH000069, and PS001814] through the U.S. Centers for Disease Control and Prevention (CDC), Division of Global HIV/AIDS (DGHA). This work was also funded in part by support from the Global Fund, World Bank, and the Joint United Nations Team for HIV/AIDS.	Amberbir A, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-265; Ammassari A, 2002, JAIDS, V31, pS123, DOI 10.1097/00126334-200212153-00007; [Anonymous], 2011, GUID ANT THER KEN; Arnsten JH, 2001, CLIN INFECT DIS, V33, P1417, DOI 10.1086/323201; Azar P, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0913-0; Beckerleg Susan, 2005, Harm Reduct J, V2, P12, DOI 10.1186/1477-7517-2-12; Bonolo PD, 2013, CLINICS, V68, P612, DOI 10.6061/clinics/2013(05)06; Boruett P, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-242; Chander G, 2006, JAIDS-J ACQ IMM DEF, V43, P411, DOI 10.1097/01.qai.0000243121.44659.a4; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Elul B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053586; Gordillo V, 1999, AIDS, V13, P1763, DOI 10.1097/00002030-199909100-00021; Hansana V, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-617; Hickey MD, 2014, JAIDS-J ACQ IMM DEF, V66, P311, DOI 10.1097/QAI.0000000000000154; Kim AA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155498; Kim SH, 2014, AIDS, V28, P1945, DOI 10.1097/QAD.0000000000000316; KNBS, 2010, 2009 KEN POP HOUS CE; Lester RT, 2010, LANCET, V376, P1838, DOI 10.1016/S0140-6736(10)61997-6; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Ministry of Health (MOH), 2014, KEN HIV EST REP 2014; Murri R, 2000, J ACQ IMMUN DEF SYND, V24, P123; Nabukeera-Barungi N, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1265-5; Nachega JB, 2009, JAIDS-J ACQ IMM DEF, V51, P65, DOI 10.1097/QAI.0b013e318199072e; National AIDS and STI Control Programme (NASCOP), 2012, NAT ARV STOCK STAT R; Nieuwkerk PT, 2001, ARCH INTERN MED, V161, P1962, DOI 10.1001/archinte.161.16.1962; Nozaki I, 2011, AIDS CARE, V23, P831, DOI 10.1080/09540121.2010.542121; Obirikorang Christian, 2013, ISRN AIDS, V2013, P873939, DOI 10.1155/2013/873939; Olds PK, 2015, AIDS CARE, V27, P327, DOI 10.1080/09540121.2014.983452; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Rehle T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133255; Rudy BJ, 2010, AIDS PATIENT CARE ST, V24, P97, DOI 10.1089/apc.2009.0198; Sasaki Y, 2012, ANN CLIN MICROB ANTI, V11, DOI 10.1186/1476-0711-11-34; Sidle J, 2007, 4 INT AIDS SOC C HIV; Sodergard B, 2006, J CLIN PHARM THER, V31, P605, DOI 10.1111/j.1365-2710.2006.00782.x; Spire B, 2008, ANTIVIR THER, V13, P697; Tiyou A, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-39; UNAIDS, 2015, UND FAST TRACK; Wagner G, 2004, JAIDS-J ACQ IMM DEF, V35, P203, DOI 10.1097/00126334-200402010-00016; Wakibi SN, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-43; Waruiru W, 2014, JAIDS-J ACQ IMM DEF, V66, pS3, DOI 10.1097/QAI.0000000000000114; Wood E, 2004, JAIDS-J ACQ IMM DEF, V35, P261, DOI 10.1097/00126334-200403010-00006; World Health Organization, 2016, CONS GUID US ANT DRU	42	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167465	10.1371/journal.pone.0167465	http://dx.doi.org/10.1371/journal.pone.0167465			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907114	Green Submitted, Green Published, gold			2022-12-26	WOS:000389482700163
J	Polez, S; Origi, D; Zahariev, S; Guarnaccia, C; Tisminetzky, SG; Skoko, N; Baralle, M				Polez, Sulena; Origi, Domenico; Zahariev, Sotir; Guarnaccia, Corrado; Tisminetzky, Sergio G.; Skoko, Natasa; Baralle, Marco			A Simplified and Efficient Process for Insulin Production in Pichia pastoris	PLOS ONE			English	Article							RECOMBINANT HUMAN INSULIN; SECRETORY EXPRESSION; ORGANIC-SOLVENTS; MINI-PROINSULIN; PRECURSOR; YEAST; PURIFICATION; TECHNOLOGY; SEMISYNTHESIS; ENZYMES	A significant barrier to insulin is affordability. In this manuscript we describe improvements to key steps in the insulin production process in Pichia pastoris that reduce cost and time. The strategy for recovery and processing of human insulin precursor has been streamlined to two steps from bioreactor to the transpeptidation reaction. In the first step the insulin precursor secreted during the methanol induction phase is recovered directly from the culture broth using Tangential Flow Filtration with a Prostak (TM) module eliminating the laborious and time-consuming multi-step clarification, including centrifugation. In the second step the protein is applied at very high loadings on a cation exchange resin and eluted in a mixture of water and ethanol to obtain a concentrated insulin precursor, suitable for use directly in the transpeptidation reaction. Overall the yield from insulin precursor to human insulin was 51% and consisted of three purification chromatography steps. In addition we describe a method for recovery of the excess of H-Thr(tBu)-OtBu from the transpeptidation reaction mixture, one of the more costly reagents in the process, along with its successful reuse.	[Polez, Sulena; Zahariev, Sotir; Guarnaccia, Corrado; Tisminetzky, Sergio G.; Skoko, Natasa; Baralle, Marco] ICGEB, Trieste, Italy; [Origi, Domenico] Merck SpA, Proc Solut, Biomfg Sci Network, Milan, Italy	International Center for Genetic Engineering & Biotechnology (ICGEB)	Skoko, N; Baralle, M (corresponding author), ICGEB, Trieste, Italy.	skoko@icgeb.org; barallem@icgeb.org		Baralle, Marco/0000-0002-0417-1013				Ahmad M, 2014, APPL MICROBIOL BIOT, V98, P5301, DOI 10.1007/s00253-014-5732-5; Babu PVC, 2008, J CHROMATOGR B, V861, P218, DOI 10.1016/j.jchromb.2007.10.008; Besnard L, 2016, BIOTECHNOL ADV, V34, P1, DOI 10.1016/j.biotechadv.2015.11.005; Castro GR, 1999, ENZYME MICROB TECH, V25, P689, DOI 10.1016/S0141-0229(99)00099-X; FIELD RW, 1995, J MEMBRANE SCI, V100, P259, DOI 10.1016/0376-7388(94)00265-Z; Gurramkonda C, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-31; KEMPKEN R, 1995, BIOTECHNOL BIOENG, V46, P132, DOI 10.1002/bit.260460206; Kjeldsen T, 1996, REMOVABLE SPACER PEP; Klibanov AM, 2001, NATURE, V409, P241, DOI 10.1038/35051719; Kohlbau H-J., 2003, HOUBEN WEYL METHODS; Liu HF, 2013, PROCESS BIOCHEM, V48, P965, DOI 10.1016/j.procbio.2013.04.004; Mansur M, 2005, BIOTECHNOL LETT, V27, P339, DOI 10.1007/s10529-005-1007-7; MARKUSSEN J, 1987, PEPTIDES 1986, P189, DOI DOI 10.1002/BIT.260460206; Meehl MA, 2014, CURR OPIN BIOTECH, V30, P120, DOI 10.1016/j.copbio.2014.06.007; Mollerup I., 2002, INSULIN PURIFICATION; MORIHARA K, 1986, BIOCHEM J, V240, P803, DOI 10.1042/bj2400803; Muniandi K.M., 2013, INT J BIOTECH MOL BI, V4, P28; Pais JM, 2003, BIOTECHNOL LETT, V25, P251, DOI 10.1023/A:1022398917213; Pais-Chanfrau JA, 2004, BIOTECHNOL LETT, V26, P1269, DOI 10.1023/B:BILE.0000044871.80632.f9; Rich J. O., 2001, METH BIOTEC, V15; ROSE K, 1983, BIOCHEM J, V211, P671, DOI 10.1042/bj2110671; Routledge SJ, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-17; Simon LM, 2001, BIOCHEM BIOPH RES CO, V280, P1367, DOI 10.1006/bbrc.2001.4282; Sundaran B, 2002, J BIOSCI BIOENG, V94, P93, DOI 10.1263/jbb.94.93; Urmann M, 2010, MABS-AUSTIN, V2, P395, DOI 10.4161/mabs.12303; van Reis R, 2007, J MEMBRANE SCI, V297, P16, DOI 10.1016/j.memsci.2007.02.045; Walsh G, 2005, APPL MICROBIOL BIOT, V67, P151, DOI 10.1007/s00253-004-1809-x; Wang Y, 2001, BIOTECHNOL BIOENG, V73, P74, DOI 10.1002/1097-0290(20010405)73:1<74::AID-BIT1038>3.0.CO;2-V; Xie T, 2008, PREP BIOCHEM BIOTECH, V38, P308, DOI 10.1080/10826060802165147; Yavorsky D, 2003, PHARMACEUTICAL TECHN; Zhu T, 2009, J APPL MICROBIOL, V107, P954, DOI 10.1111/j.1365-2672.2009.04279.x	31	13	14	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167207	10.1371/journal.pone.0167207	http://dx.doi.org/10.1371/journal.pone.0167207			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907132	Green Submitted, gold, Green Published			2022-12-26	WOS:000389482700091
J	Sobas, EM; Reinoso, R; Cuadrado-Asensio, R; Fernandez, I; Maldonado, MJ; Pastor, JAC				Sobas, Eva M.; Reinoso, Roberto; Cuadrado-Asensio, Ruben; Fernandez, Itziar; Maldonado, Miguel J.; Pastor, Jose A. C.			Reliability of Potential Pain Biomarkers in the Saliva of Healthy Subjects: Inter-Individual Differences and Intersession Variability	PLOS ONE			English	Article							ALPHA-AMYLASE; CORTISOL CONCENTRATIONS; RATING-SCALES; SURGERY; STRESS; VARIABLES; RESPONSES; SYSTEM	Aim Salivary cortisol, alpha-amylase (sAA), secretory IgA (sIgA), testosterone, and soluble fraction of receptor II of TNF alpha (sTNF alpha RII) could serve as objective pain measures, but the normal variability of these potential biomarkers is unknown. Patients & Methods Saliva was collected with the passive secretion method from 34, pain-free subjects in two single samples at least 24 hours apart. Biomarker variation and intersession reliability were assessed with the intraclass correlation coefficient (ICC). Also, we calculated the within-subject standard deviation (S-w) and the reproducibility (2.77 x S-w) of intersession measures. Results Salivary cortisol, sAA, sIgA, testosterone, and sTNF alpha RII yielded the following ICCs: 0.53, 0.003, 0.88, 0.42 and 0.83, respectively. We found no statistically significant systematic differences between sessions in any biomarker except for testosterone, which showed a decrease on the second day (p<0.001). The reproducibility for salivary cortisol, sAA, sIgA, testosterone, and sTNF alpha RII were 0.46 ng/ml, 12.88 U/ml, 11.7 mu g/ml, 14.54 pg/ml and 18.29 pg/ml, respectively. Cortisol, testosterone and TNF alpha RII measurement variability showed a positive correlation with the magnitude (p<0.002), but no relationship was found for sAA and sIgA. Conclusions Salivary sIgA and sTNF alpha RII show a remarkable good reproducibility and, therefore, could be useful as pain biomarkers. When using the passive secretion method, intersession variations in salivary sIgA of more than 11.7 mu g/ml may reflect true biomarker change. In the case of sTNF alpha RII this will depend of the magnitude. The estimates herein provided should help investigators and clinicians differentiate actual biomarker modification from measurement variability.	[Sobas, Eva M.; Reinoso, Roberto; Cuadrado-Asensio, Ruben; Fernandez, Itziar; Maldonado, Miguel J.; Pastor, Jose A. C.] Univ Valladolid, Inst Univ Oftalmobiol Aplicada IOBA, Valladolid, Spain; [Sobas, Eva M.] Univ Valladolid, Escuela Enfermeria, Valladolid, Spain; [Reinoso, Roberto] Vis I D, Valladolid, Spain; [Cuadrado-Asensio, Ruben; Maldonado, Miguel J.; Pastor, Jose A. C.] Univ Valladolid, Fac Med, Dept Cirugia Oftalmol Otorrinolaringol & Fisioter, Valladolid, Spain; [Reinoso, Roberto; Fernandez, Itziar] Networking Res Ctr Bioengn Biomat & Nanomed CIBER, Valladolid, Spain; [Pastor, Jose A. C.] Hosp Clin Univ, Dept Ophthalmol, Valladolid, Spain	Universidad de Valladolid; Universidad de Valladolid; Universidad de Valladolid; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Universidad de la Laguna	Sobas, EM (corresponding author), Univ Valladolid, Inst Univ Oftalmobiol Aplicada IOBA, Valladolid, Spain.; Sobas, EM (corresponding author), Univ Valladolid, Escuela Enfermeria, Valladolid, Spain.	eva@ioba.med.uva.es	Jimeno, J Carlos Pastor/AAP-1156-2020; Tapia, Roberto Reinoso/AAI-3259-2021; Fernández, Itziar/AAF-9590-2020; Cuadrado-Asensio, Rubén/G-8374-2017	Jimeno, J Carlos Pastor/0000-0001-5934-7306; Fernández, Itziar/0000-0002-5077-4448; Cuadrado-Asensio, Rubén/0000-0002-8507-306X; Maldonado, Miguel J./0000-0002-1021-3275; Reinoso, Roberto/0000-0003-0476-4975				[Anonymous], 2014, R LANG ENV STAT COMP; Bell RF, 2001, ACTA ANAESTH SCAND, V45, P576, DOI 10.1034/j.1399-6576.2001.045005576.x; Beltzer EK, 2010, PHYSIOL BEHAV, V101, P289, DOI 10.1016/j.physbeh.2010.05.016; Bland JM, 1996, BRIT MED J, V313, P744; Bland JM, 1996, BRIT MED J, V313, P106, DOI 10.1136/bmj.313.7049.106; Bland M., 2000, INTRO MED STAT, P269; Bosch JA, 2011, PSYCHONEUROENDOCRINO, V36, P449, DOI 10.1016/j.psyneuen.2010.12.019; Choi JC, 2012, ANAESTHESIA, V67, P1146, DOI 10.1111/j.1365-2044.2012.07267.x; Clark P, 2003, J RHEUMATOL, V30, P1584; Campos MJD, 2010, MED SCI MONITOR, V16, pCR405; de Vet HCW, 2006, J CLIN EPIDEMIOL, V59, P1033, DOI 10.1016/j.jclinepi.2005.10.015; DOMZAL T, 1983, PAIN, V17, P67, DOI 10.1016/0304-3959(83)90128-8; Englbrecht M, 2012, J RHEUMATOL, V39, P3, DOI 10.3899/jrheum.120335; Euser AM, 2008, J CLIN EPIDEMIOL, V61, P978, DOI 10.1016/j.jclinepi.2007.11.003; Golatowski C, 2013, CLIN CHIM ACTA, V419, P42, DOI 10.1016/j.cca.2013.01.013; Goodin BR, 2012, PSYCHOPHYSIOLOGY, V49, P118, DOI 10.1111/j.1469-8986.2011.01280.x; Goodin BR, 2012, PAIN MED, V13, P29, DOI 10.1111/j.1526-4637.2011.01293.x; Hanson D, 2010, INFANT BEHAV DEV, V33, P289, DOI 10.1016/j.infbeh.2010.03.003; Harmon AG, 2008, HORM BEHAV, V54, P592, DOI 10.1016/j.yhbeh.2008.05.019; Hirose Noriya, 2009, Masui, V58, P1360; Hirshoren N, 2002, J CLIN ENDOCR METAB, V87, P1569, DOI 10.1210/jc.87.4.1569; Hjermstad MJ, 2011, J PAIN SYMPTOM MANAG, V41, P1073, DOI 10.1016/j.jpainsymman.2010.08.016; Hsieh Shu-Feng, 2016, J Tradit Complement Med, V6, P269, DOI 10.1016/j.jtcme.2015.07.004; Izawa S, 2009, WILD ENVIRON MED, V20, P239, DOI 10.1580/07-WEME-OR-123R2.1; Kanegane Kazue, 2009, J Oral Sci, V51, P515; Lund Irene, 2005, BMC Med Res Methodol, V5, P31, DOI 10.1186/1471-2288-5-31; Malamud Daniel, 2011, Dent Clin North Am, V55, P159, DOI 10.1016/j.cden.2010.08.004; Marchi A, 2009, CLIN DRUG INVEST, V29, P41, DOI 10.2165/0044011-200929001-00006; Maruyama Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039375; McLean SA, 2005, ARTHRITIS RHEUM-US, V52, P3660, DOI 10.1002/art.21372; Muller MJ, 2011, BIOPSYCHOSOC MED, V5, DOI 10.1186/1751-0759-5-8; Nater UM, 2009, PSYCHONEUROENDOCRINO, V34, P486, DOI 10.1016/j.psyneuen.2009.01.014; Nater UM, 2007, PSYCHONEUROENDOCRINO, V32, P392, DOI 10.1016/j.psyneuen.2007.02.007; Paris JJ, 2010, HORM BEHAV, V57, P35, DOI 10.1016/j.yhbeh.2009.06.003; Perroni F, 2009, ERGONOMICS, V52, P484, DOI 10.1080/00140130802707873; Petrelluzzi KFS, 2008, STRESS, V11, P390, DOI 10.1080/10253890701840610; Portney LG, 2000, FDN CLIN RES APPL PR, V2; Robles TF, 2012, J ORAL MAXIL SURG, V70, P2256, DOI 10.1016/j.joms.2012.03.005; Schielzeth H, 2011, RPTR REPEATABILITY G; Shibata M, 2013, EARLY HUM DEV, V89, P503, DOI 10.1016/j.earlhumdev.2013.03.006; Singla NK, 2014, PAIN, V155, P441, DOI 10.1016/j.pain.2013.09.002; Strimbu K, 2010, CURR OPIN HIV AIDS, V5, P463, DOI 10.1097/COH.0b013e32833ed177; Teson M, 2013, INVEST OPHTH VIS SCI, V54, P2093, DOI 10.1167/iovs.12-11361; Tornhage CJ, 2006, J PEDIATR ENDOCR MET, V19, P843; Tornhage CJ, 2009, NEUROIMMUNOMODULAT, V16, P284, DOI 10.1159/000216186; Torres-Harding S, 2008, J APPL BIOBEHAV RES, V13, P157, DOI 10.1111/j.1751-9861.2008.00033.x; VINING RF, 1987, J STEROID BIOCHEM, V27, P81, DOI 10.1016/0022-4731(87)90297-4; Williamson A, 2005, J CLIN NURS, V14, P798, DOI 10.1111/j.1365-2702.2005.01121.x	48	15	15	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166976	10.1371/journal.pone.0166976	http://dx.doi.org/10.1371/journal.pone.0166976			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3JC	27907037	gold, Green Published, Green Submitted			2022-12-26	WOS:000389482700058
J	Takamatsu, S; Yamamoto, K; Maeda, Y; Kawamura, M; Shibata, S; Sato, Y; Terashima, K; Shimizu, Y; Tameshige, Y; Sasaki, M; Asahi, S; Kondou, T; Kobayashi, S; Matsui, O; Gabata, T				Takamatsu, Shigeyuki; Yamamoto, Kazutaka; Maeda, Yoshikazu; Kawamura, Mariko; Shibata, Satoshi; Sato, Yoshitaka; Terashima, Kazuki; Shimizu, Yasuhiro; Tameshige, Yuji; Sasaki, Makoto; Asahi, Satoko; Kondou, Tamaki; Kobayashi, Satoshi; Matsui, Osamu; Gabata, Toshifumi			Evaluation of Focal Liver Reaction after Proton Beam Therapy for Hepatocellular Carcinoma Examined Using Gd-EOB-DTPA Enhanced Hepatic Magnetic Resonance Imaging	PLOS ONE			English	Article							RADIOTHERAPY; TOLERANCE; IRRADIATION; AGREEMENT; VOLUMES; INJURY	Background Proton beam therapy (PBT) achieves good local control for hepatocellular carcinoma (HCC), and toxicity tends to be lower than for photon radiotherapy. Focal liver parenchymal damage in radiotherapy is described as the focal liver reaction (FLR); the threshold doses (TDs) for FLR in the background liver have been analyzed in stereotactic ablative body radiotherapy and brachytherapy. To develop a safer approach for PBT, both TD and liver volume changes are considered clinically important in predicting the extent of damage before treatment, and subsequently in reducing background liver damage. We investigated appearance time, TDs and volume changes regarding FLR after PBT for HCC. Material and Methods Patients who were treated using PBT and were followed up using gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging (Gd-EOB-DTPA MRI) after PBT were enrolled. Sixty-eight lesions in 58 patients were eligible for analysis. MRI was acquired at the end of treatment, and at 1, 2, 3 and 6 months after PBT. We defined the FLR as a clearly depicted hypointense area on the hepatobiliary phase of Gd-EOB-DTPA MRI, and we monitored TDs and volume changes in the FLR area and the residual liver outside of the FLR area. Results FLR was depicted in all lesions at 3 months after PBT. In FLR expressed as the 2-Gy equivalent dose (alpha/beta = 3 Gy), TDs did not differ significantly (27.0 +/- 6.4 CGE [10 fractions [Fr] vs. 30.5 +/- 7.3 CGE [20 Fr]). There were also no correlations between the TDs and clinical factors, and no significant differences between Child-Pugh A and B scores. The volume of the FLR area decreased and the residual liver volume increased, particularly during the initial 3 months. Conclusion This study established the FLR dose for liver with HCC, which might be useful in the prediction of remnant liver volume for PBT	[Takamatsu, Shigeyuki] Kanazawa Univ Hosp, Dept Radiotherapy, Kanazawa, Ishikawa, Japan; [Takamatsu, Shigeyuki; Yamamoto, Kazutaka; Maeda, Yoshikazu; Shibata, Satoshi; Sato, Yoshitaka; Shimizu, Yasuhiro; Tameshige, Yuji; Sasaki, Makoto] Fukui Prefectural Hosp, Proton Therapy Ctr, Fukui, Fukui, Japan; [Kawamura, Mariko] Nagoya Univ, Grad Sch Med, Dept Radiol, Nagoya, Aichi 4648601, Japan; [Terashima, Kazuki] Hyogo Ion Beam Med Ctr, Dept Radiol, Tatsuno, Hyogo, Japan; [Asahi, Satoko] Univ Fukui, Dept Radiol, Fukui, Fukui, Japan; [Kondou, Tamaki] Kanazawa Med Univ, Dept Diagnost & Therapeut Radiol, Kanazawa, Ishikawa, Japan; [Kobayashi, Satoshi; Matsui, Osamu; Gabata, Toshifumi] Kanazawa Univ, Dept Radiol, Kanazawa, Ishikawa 9201192, Japan	Kanazawa University; Nagoya University; University of Fukui; Kanazawa Medical University; Kanazawa University	Takamatsu, S (corresponding author), Kanazawa Univ Hosp, Dept Radiotherapy, Kanazawa, Ishikawa, Japan.; Takamatsu, S (corresponding author), Fukui Prefectural Hosp, Proton Therapy Ctr, Fukui, Fukui, Japan.	shigerad@staff.kanazawa-u.ac.jp	Kobayashi, Satoshi/C-4645-2015; Kawamura, Mariko/Q-5517-2019	Kobayashi, Satoshi/0000-0001-7759-399X; Kawamura, Mariko/0000-0001-9211-4934; Maeda, Yoshikazu/0000-0002-3040-5549; Shimizu, Yasuhiro/0000-0002-3979-953X; Takamatsu, Shigeyuki/0000-0002-0743-4413	JSPSKAKENHI [16K10273]	JSPSKAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPSKAKENHI Grant Number 16K10273.	[Anonymous], 2007, 78 ICRU, V2, P1; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; DeLeve LD, 2002, SEMIN LIVER DIS, V22, P27, DOI 10.1055/s-2002-23204; Dionisi F, 2014, RADIOTHER ONCOL, V111, P1, DOI 10.1016/j.radonc.2014.02.001; EMAMI B, 1991, INT J RADIAT ONCOL, V21, P109, DOI 10.1016/0360-3016(91)90171-Y; Fowler JF, 2009, INT J RADIAT ONCOL, V73, P1532, DOI 10.1016/j.ijrobp.2008.11.039; Haga J, 2008, LIVER TRANSPLANT, V14, P1718, DOI 10.1002/lt.21622; Helmy A, 2006, ALIMENT PHARM THER, V23, P11, DOI 10.1111/j.1365-2036.2006.02742.x; Herfarth KK, 2003, INT J RADIAT ONCOL, V57, P444, DOI 10.1016/S0360-3016(03)00586-8; Imada H, 2010, RADIOTHER ONCOL, V96, P236, DOI 10.1016/j.radonc.2010.03.025; Kitao A, 2010, RADIOLOGY, V256, P817, DOI 10.1148/radiol.10092214; Kundel HL, 2003, RADIOLOGY, V228, P303, DOI 10.1148/radiol.2282011860; Lee NK, 2009, RADIOGRAPHICS, V29, P1707, DOI 10.1148/rg.296095501; Nassif A, 2012, RADIOLOGY, V264, P741, DOI 10.1148/radiol.12112061; Olsen CC, 2009, INT J RADIAT ONCOL, V73, P1414, DOI 10.1016/j.ijrobp.2008.07.032; Qi WX, 2015, RADIOTHER ONCOL, V114, P289, DOI 10.1016/j.radonc.2014.11.033; Richter C, 2014, MED HYPOTHESES, V83, P477, DOI 10.1016/j.mehy.2014.08.004; Ruhl R, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-44; Sanuki N, 2014, INT J RADIAT ONCOL, V88, P306, DOI 10.1016/j.ijrobp.2013.10.045; Seidensticker M, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-40; Son SH, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-61; Takeda A, 2014, J GASTROEN HEPATOL, V29, P372, DOI 10.1111/jgh.12350; Vander Borght S, 2005, J PATHOL, V207, P471, DOI 10.1002/path.1852; Yuan YD, 2013, RADIOTHER ONCOL, V106, P378, DOI 10.1016/j.radonc.2013.01.016; Zhu R, 2014, GASTROENT RES PRACT, V2014, DOI 10.1155/2014/529314	25	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167155	10.1371/journal.pone.0167155	http://dx.doi.org/10.1371/journal.pone.0167155			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907063	Green Published, Green Submitted, gold			2022-12-26	WOS:000389482700082
J	Xu, MC; Zhang, F; Wang, AX; Wang, C; Cao, Y; Zhang, M; Zhang, MM; Su, M; Zou, XP; Xu, GF; Zhuge, YZ				Xu, Mingcui; Zhang, Feng; Wang, Aixiu; Wang, Chen; Cao, Yu; Zhang, Ming; Zhang, Mingming; Su, Min; Zou, Xiaoping; Xu, Guifang; Zhuge, Yuzheng			Tumor Necrosis Factor-Like Weak Inducer of Apoptosis Promotes Hepatic Stellate Cells Migration via Canonical NF-kappa B/MMP9 Pathway	PLOS ONE			English	Article							NF-KAPPA-B; LIVER FIBROSIS; MATRIX METALLOPROTEINASES; TWEAK; INJURY; AXIS; ANGIOGENESIS; PROGRESSION; ACTIVATION; EXPRESSION	In the liver, the signal and function of tumor necrosis factor-like weak inducer of apoptosis (TWEAK) have mainly been assessed in association with liver regeneration. However, the effects of TWEAK on liver fibrosis have not been fully elucidated. To investigate the effects of TWEAK on human hepatic stellate cells (HSCs) and to explore the relevant potential mechanisms, human HSCs line-LX-2 were cultured with TWEAK. Cell migration was detected by transwell assay; cell viability was evaluated by Cell Counting Kit-8; the expression of MMP1, MMP2, MMP3, MMP7, MMP8, MMP9, MMP10, MMP11, MMP12, MMP13 gene was identified by quantitative real-time polymerase chain reaction and western blotting; the activity of matrix metalloproteinases (MMPs) was tested by enzyme-linked immuno sorbent assay; small interfering RNA transfection was applied for depletion of MMP9 and p65. The result of transwell assay revealed that TWEAK promoted LX-2 migration. Subsequently, our data testified that the expression and activity of MMP9 was induced by TWEAK in LX-2 cells, which enhanced the migration. Furthermore, our findings showed that TWEAK upregulated the phosphorylation of I kappa B alpha and p65 protein to increase MMP9 expression in LX-2 cells. Meanwhile, the alpha-smooth muscle actin, vimentin and desmin expression were upregulated following TWEAK treatment. The results in the present study revealed that TWEAK promotes HSCs migration via canonical NF-kappa B/MMP9 pathway, which possibly provides a molecular basis targeting TWEAK for the therapy of liver fibrosis.	[Xu, Mingcui; Zhang, Feng; Zhuge, Yuzheng] Nanjing Med Univ, Affiliated Drum Tower Clin Med Sch, Dept Gastroenterol, Nanjing, Jiangsu, Peoples R China; [Wang, Aixiu; Wang, Chen; Cao, Yu; Zhang, Ming; Zhang, Mingming; Su, Min; Zou, Xiaoping; Xu, Guifang] Nanjing Univ, Sch Med, Drum Tower Hosp, Dept Gastroenterol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing University	Zhuge, YZ (corresponding author), Nanjing Med Univ, Affiliated Drum Tower Clin Med Sch, Dept Gastroenterol, Nanjing, Jiangsu, Peoples R China.	yuzheng9111963@aliyun.com	wang, chen/GWM-9481-2022		National Natural Science Foundation of China [81570550]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (grant number 81570550 http://www.nsfc.gov.cn/) to YZZG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berzal S, 2015, J CELL PHYSIOL, V230, P1580, DOI 10.1002/jcp.24905; Bird TG, 2013, P NATL ACAD SCI USA, V110, P6542, DOI 10.1073/pnas.1302168110; Burkly LC, 2014, SEMIN IMMUNOL, V26, P229, DOI 10.1016/j.smim.2014.02.006; Burkly LC, 2011, IMMUNOL REV, V244, P99, DOI 10.1111/j.1600-065X.2011.01054.x; Cao S, 2010, J CLIN INVEST, V120, P2379, DOI 10.1172/JCI41203; Cao Y, 2010, J BIOL CHEM, V285, P31840, DOI 10.1074/jbc.M110.151696; Castilho-Fernandes A, 2011, EXP MOL PATHOL, V91, P664, DOI 10.1016/j.yexmp.2011.09.002; Coito AJ, 2011, CURR OPIN ORGAN TRAN, V16, P34, DOI 10.1097/MOT.0b013e328342542e; Coulouarn C, 2012, CANCER RES, V72, P2533, DOI 10.1158/0008-5472.CAN-11-3317; Duarte S, 2015, MATRIX BIOL, V44-46, P147, DOI 10.1016/j.matbio.2015.01.004; Ehling J, 2014, GUT, V63, P1960, DOI 10.1136/gutjnl-2013-306294; Garcia-Irigoyen O, 2015, HEPATOLOGY, V62, P166, DOI 10.1002/hep.27798; Henaut L, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.220; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Huang YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136453; Huebert RC, 2010, LAB INVEST, V90, P1770, DOI 10.1038/labinvest.2010.132; Kang NL, 2011, HEPATOLOGY, V54, P707, DOI 10.1002/hep.24384; Kato H, 2014, J HEPATOL, V60, P1032, DOI 10.1016/j.jhep.2013.12.022; Li XiaoXia, 2016, Journal of South China Agricultural University, V37, P1; Lopez-Dupla M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144789; Mannaerts I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084071; Mederacke I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3823; Munch J, 2016, J CARD FAIL; Nakamura K, 2012, J HEPATOL, V57, P1037, DOI 10.1016/j.jhep.2012.07.004; Padrao AI, 2015, ARCH BIOCHEM BIOPHYS, V567, P13, DOI 10.1016/j.abb.2014.12.026; Pettersen I, 2013, INT J ONCOL, V42, P1239, DOI 10.3892/ijo.2013.1800; Puche JE, 2013, COMPR PHYSIOL, V3, P1473, DOI 10.1002/cphy.c120035; Tirnitz-Parker JEE, 2010, HEPATOLOGY, V52, P291, DOI 10.1002/hep.23663; Wang RS, 2015, J BIOL CHEM, V290, P30684, DOI 10.1074/jbc.M115.671735; Wilhelm A, 2016, J PATHOL, V239, P109, DOI 10.1002/path.4707; Winkles JA, 2008, NAT REV DRUG DISCOV, V7, P411, DOI 10.1038/nrd2488; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; Yu GY, 2014, AM J RESP CRIT CARE, V190, P780, DOI 10.1164/rccm.201310-1903OC; Zhang F, 2014, INT IMMUNOPHARMACOL, V19, P193, DOI 10.1016/j.intimp.2014.01.021	34	9	9	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167658	10.1371/journal.pone.0167658	http://dx.doi.org/10.1371/journal.pone.0167658			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907201	Green Submitted, Green Published, gold			2022-12-26	WOS:000389482700219
J	Donald, W; Pasay, C; Guintran, JO; Iata, H; Anderson, K; Nausien, J; Gresty, KJ; Waters, NC; Vestergaard, LS; Taleo, G; Cheng, Q				Donald, Wesley; Pasay, Cielo; Guintran, Jean-Olivier; Iata, Harry; Anderson, Karen; Nausien, Johnny; Gresty, Karryn J.; Waters, Norman C.; Vestergaard, Lasse S.; Taleo, George; Cheng, Qin			The Utility of Malaria Rapid Diagnostic Tests as a Tool in Enhanced Surveillance for Malaria Elimination in Vanuatu	PLOS ONE			English	Article							REACTIVE CASE DETECTION; SYMPTOMATIC MALARIA; AMPLIFICATION KIT; PLASMODIUM-VIVAX; INFECTIONS; PREVALENCE; PARASITE; ISLANDS; ZAMBIA; AREAS	Background As part of efforts to eliminate malaria, Vanuatu has piloted the implementation of enhanced malaria surveillance and response strategies since 2011. This involves passive case detection (PCD) in health facilities, proactive case detection (Pro-ACD) and reactive case detection (Re-ACD) in communities using malaria rapid diagnostic tests (RDTs). While RDTs improve case management, their utility for detection of malaria infections in ACDs in this setting is unclear. Methods The utility of malaria RDTs as diagnostic tools was evaluated in PCD, in five rounds of Pro-ACDs and five rounds of Re-ACDs conducted in Tafea and Torba Provinces between 2011 and 2014. The number of malaria infections detected by RDTs was compared to that detected by PCR from collected used-RDTs. Results PCD in Tafea Province (2013) showed a RDT-positive rate of 0.21% (2/939) and a PCR-positive rate of 0.44% (2/453), indicating less than 1% of suspected malaria cases in Tafea Province were due to malaria. In Pro-ACDs conducted in Tafea and Torba Provinces, RDT-positive rates in 2013 and 2014 were 0.14% (3/2145) and 0% (0/2823), respectively, while the corresponding PCR-positive rates were 0.72% (9/1242) and 0.79% (9/1141). PCR identified villages in both provinces appearing to be transmission foci with a small number of low-density infections, mainly P. falciparum infections. In five rounds of Re-ACD, RDTs did not identify any additional infections while PCR detected only one among 173 subjects screened. Conclusions PCD and Pro-ACDs demonstrate that both Tafea and Torba Provinces in Vanuatu has achieved very low malaria prevalence. In these low-transmission areas, conducting Pro-ACD and Re-ACDs using RDTs appears not cost-effective and may have limited impact on interrupting malaria transmission due to the small number of infections identified by RDTs and considerable operational resources invested. More sensitive, field deployable and affordable diagnostic tools will improve malaria surveillance in malaria elimination settings.	[Donald, Wesley; Iata, Harry; Nausien, Johnny; Taleo, George] Minist Hlth, Malaria & Vector Borne Dis Control, Port Vila, Vanuatu; [Pasay, Cielo; Anderson, Karen; Gresty, Karryn J.; Cheng, Qin] Australian Army Malaria Inst, Drug Resistance & Diagnost, Brisbane, Qld, Australia; [Pasay, Cielo; Anderson, Karen; Gresty, Karryn J.; Cheng, Qin] QIMR Berghofer Med Res Inst, Clin Trop Med, Brisbane, Qld, Australia; [Guintran, Jean-Olivier] WHO, Vanuatu Country Off, Port Vila, Vanuatu; [Waters, Norman C.] Walter Reed Army Inst Res, Malaria Vaccine Branch, Mil Malaria Res Program, Silver Spring, MD USA; [Vestergaard, Lasse S.] WHO, Western Pacific Reginal Off, Manila, Philippines	QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute; World Health Organization; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); WHO Western Pacific Regional Office; World Health Organization	Taleo, G (corresponding author), Minist Hlth, Malaria & Vector Borne Dis Control, Port Vila, Vanuatu.; Cheng, Q (corresponding author), Australian Army Malaria Inst, Drug Resistance & Diagnost, Brisbane, Qld, Australia.; Cheng, Q (corresponding author), QIMR Berghofer Med Res Inst, Clin Trop Med, Brisbane, Qld, Australia.	gtaleo@vanuatu.gov.au; qin.cheng@defence.gov.au	Cheng, Qin/AAO-2198-2020	Cheng, Qin/0000-0001-7776-4437	AusAID through the Pacific Malaria Initiative Supporting Centre, University of Queensland; Department of Defense, Global Emerging Infections Surveillance Program (DoD-GETS), United States	AusAID through the Pacific Malaria Initiative Supporting Centre, University of Queensland; Department of Defense, Global Emerging Infections Surveillance Program (DoD-GETS), United States	The work was partially funded by: AusAID through the Pacific Malaria Initiative Supporting Centre, University of Queensland and the Department of Defense, Global Emerging Infections Surveillance Program (DoD-GETS), United States.	Abeyasinghe RR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043162; Alves FP, 2002, AM J TROP MED HYG, V66, P641, DOI 10.4269/ajtmh.2002.66.641; [Anonymous], 2012, MAL RAP DIAGN TEST P; Bousema JT, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-18; Cheng Q, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003413; Cook J, 2015, J INFECT DIS, V211, P1476, DOI 10.1093/infdis/jiu655; Cordray MS, 2012, AM J TROP MED HYG, V87, P223, DOI 10.4269/ajtmh.2012.11-0685; da Silva-Nunes M, 2007, MEM I OSWALDO CRUZ, V102, P341, DOI 10.1590/S0074-02762007005000051; Gueye CS, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-358; Hamainza B, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-128; Harris I, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-254; Hopkins H, 2013, J INFECT DIS, V208, P645, DOI 10.1093/infdis/jit184; Imwong M, 2015, J INFECT DIS; Ishengoma DS, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-6; Kaneko A, 2000, LANCET, V356, P1560, DOI 10.1016/S0140-6736(00)03127-5; Larsen DA, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0895-9; McMorrow ML, 2011, CLIN MICROBIOL INFEC, V17, P1624, DOI 10.1111/j.1469-0691.2011.03639.x; Moonen B, 2010, LANCET, V376, P1592, DOI 10.1016/S0140-6736(10)61269-X; Morris U, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-106; National Malaria and Vector Borne Diseases Control Programme, 2010, MAL EL GUID; Okell LC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2241; Okell LC, 2009, J INFECT DIS, V200, P1509, DOI 10.1086/644781; Owusu-Agyei S, 2002, TROP MED INT HEALTH, V7, P599, DOI 10.1046/j.1365-3156.2002.00902.x; Polley SD, 2013, J INFECT DIS, V208, P637, DOI 10.1093/infdis/jit183; Program WGM, 2015, ROL MASS DRUG ADM MA; Sturrock HJW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001467; Sutcliffe CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031396; The Global Health Group and the Malaria Atlas Project, 2011, ATL MAL EL COUNTR 20; The Pacific Malaria Initiative Survey Group, 2010, MALARIA J, V9, P218, DOI 10.1186/1475-2875-9-218; Vallejo AF, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1104-1; van Eijk AM, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1120-1; WHO, 2010, GUID TREATM MAL, V2nd; WHO, 2012, DIS SURV MAL EL OP M; WHO-WPRO, 2012, PROGR MAL CONTR MOV; Williams GS, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-168; World Health Organization, 2015, WORLD MAL REP 2015 W	36	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167136	10.1371/journal.pone.0167136	http://dx.doi.org/10.1371/journal.pone.0167136			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902755	Green Published, gold, Green Submitted			2022-12-26	WOS:000389474100055
J	Matsumoto, Y; Hannigan, B; Crews, D				Matsumoto, Yuiko; Hannigan, Brette; Crews, David			Temperature Shift Alters DNA Methylation and Histone Modification Patterns in Gonadal Aromatase (cyp19a1) Gene in Species with Temperature-Dependent Sex Determination	PLOS ONE			English	Article							EARED SLIDER TURTLE; RNA-POLYMERASE-II; TRACHEMYS-SCRIPTA; INCUBATION-TEMPERATURE; HUMAN GENOME; EXPRESSION; EMBRYOS; MARKS; DIFFERENTIATION; PROFILES	The environment surrounding the embryos has a profound impact on the developmental process and phenotypic outcomes of the organism. In species with temperature-dependent sex determination, gonadal sex is determined by the incubation temperature of the eggs. A mechanistic link between temperature and transcriptional regulation of developmental genes, however, remains elusive. In this study, we examine the changes in DNA methylation and histone modification patterns of the aromatase (cyp19a1) gene in embryonic gonads of red-eared slider turtles (Trachemys scripta) subjected to a temperature shift during development. Shifting embryos from a male-producing temperature (MPT) to a female-producing temperature (FPT) at the beginning of the temperature-sensitive period (TSP) resulted in an increase in aromatase mRNA expression while a shift from FPT to MPT resulted in decreased expression. DNA methylation levels at CpG sites in the promoter of the aromatase gene were high (70-90%) at the beginning of TSP, but decreased in embryos that were incubated at constant FPT and those shifted from MPT to the FPT. This decrease in methylation in the promoter inversely correlated with the expected increase in aromatase expression at the FPT. The active demethylation under the FPT was especially prominent at the CpG site upstream of the gonad-specific TATA box at the beginning of TSP and spread downstream of the gene including exon1 as the gonad development progressed. In embryos incubated at FPT, the promoter region was also labeled by canonical transcriptional activation markers, H3K4me3 and RNA polymerase II. A transcriptional repression marker, H3K27me3, was observed in temperature-shifted gonads of both temperature groups, but was not maintained throughout the development in either group. Our findings suggest that DNA hypomethylation and H3K4me3 modification at the aromatase promoter may be a primary mechanism that releases a transcriptional block of aromatase to initiate a cascade of ovarian differentiation.	[Matsumoto, Yuiko; Crews, David] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA; [Hannigan, Brette] Univ Texas Austin, Dept Pharm, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Matsumoto, Y (corresponding author), Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA.	y_matsumoto@utexas.edu			National Science Foundation [201002064-005]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation (grant 201002064-005) to D.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adli M, 2010, NAT METHODS, V7, P615, DOI [10.1038/NMETH.1478, 10.1038/nmeth.1478]; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Brunner AL, 2009, GENOME RES, V19, P1044, DOI 10.1101/gr.088773.108; BULL JJ, 1981, J EXP ZOOL, V218, P435, DOI 10.1002/jez.1402180315; BULL JJ, 1981, HEREDITY, V47, P173, DOI 10.1038/hdy.1981.74; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Couse JF, 1999, SCIENCE, V286, P2328, DOI 10.1126/science.286.5448.2328; DESVAGES G, 1992, J STEROID BIOCHEM, V41, P851, DOI 10.1016/0960-0760(92)90437-N; Devlin RH, 2002, AQUACULTURE, V208, P191, DOI 10.1016/S0044-8486(02)00057-1; Ellis HL, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.099747; FERGUSON MWJ, 1982, NATURE, V296, P850, DOI 10.1038/296850a0; Fisher CR, 1998, P NATL ACAD SCI USA, V95, P6965, DOI 10.1073/pnas.95.12.6965; Gabriel WN, 2001, J EXP ZOOL, V290, P439, DOI 10.1002/jez.1087; Gilbert SF, 2001, DEV BIOL, V233, P1, DOI 10.1006/dbio.2001.0210; GRECO TL, 1994, ENDOCRINOLOGY, V135, P262, DOI 10.1210/en.135.1.262; Greenbaum E, 2011, STANDARDIZED SERIES, V80, P1350; Holleley CE, 2015, NATURE, V523, P79, DOI 10.1038/nature14574; Kim TS, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r75; Lambeth LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068362; Le Martelot G, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001442; Lu FL, 2011, NAT GENET, V43, P715, DOI 10.1038/ng.854; Matsumoto Y, 2014, ENDOCRINOLOGY, V155, P4168, DOI 10.1210/en.2014-1404; Matsumoto Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063599; Matsumoto Y, 2013, J MOL ENDOCRINOL, V50, P389, DOI 10.1530/JME-12-0260; Milnes MR, 2002, ENVIRON HEALTH PERSP, V110, P393, DOI 10.1289/ehp.02110s3393; Moczek AP, 2015, FRONT ECOL EVOL, V3, P553; Morris DP, 2005, J BIOL CHEM, V280, P31368, DOI 10.1074/jbc.M501546200; Mukaka MM, 2012, MALAWI MED J, V24, P69; Navarro-Martin L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002447; Okitsu CY, 2007, MOL CELL BIOL, V27, P2746, DOI 10.1128/MCB.02291-06; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Parrott BB, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.111468; Piferrer F, 2005, FISH PHYSIOL BIOCHEM, V31, P215, DOI 10.1007/s10695-006-0027-0; Ramsey M, 2007, DIFFERENTIATION, V75, P978, DOI 10.1111/j.1432-0436.2007.00182.x; Rhen T, 2007, SEX DEV, V1, P255, DOI 10.1159/000104775; Sachs M, 2013, CELL REP, V3, P1777, DOI 10.1016/j.celrep.2013.04.032; Shoemaker-Daly CM, 2010, DEV DYNAM, V239, P1061, DOI 10.1002/dvdy.22266; Smith CA, 1997, J STEROID BIOCHEM, V60, P295, DOI 10.1016/S0960-0760(96)00196-3; Teves SS, 2011, GENE DEV, V25, P2387, DOI [10.1101/gad.177675.111, 10.1101/gad.178079.111]; Vastenhouw NL, 2012, CURR OPIN CELL BIOL, V24, P374, DOI 10.1016/j.ceb.2012.03.009; Warner DA, 2013, SCI REPORTS, V3; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; WIBBELS T, 1991, J EXP ZOOL, V260, P371, DOI 10.1002/jez.1402600311; Yao HHC, 2004, MECH DEVELOP, V121, P1393, DOI 10.1016/j.mod.2004.06.001; Young MD, 2011, NUCLEIC ACIDS RES, V39, P7415, DOI 10.1093/nar/gkr416; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	47	28	32	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167362	10.1371/journal.pone.0167362	http://dx.doi.org/10.1371/journal.pone.0167362			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902763	Green Published, gold			2022-12-26	WOS:000389474100078
J	MC Langemeijer, S; Mariani, N; Knops, R; Gilissen, C; Woestenenk, R; de Witte, T; Huls, G; van der Reijden, BA; Jansen, JH				MC Langemeijer, Saskia; Mariani, Niccolo; Knops, Ruth; Gilissen, Christian; Woestenenk, Rob; de Witte, Theo; Huls, Gerwin; van der Reijden, Bert A.; Jansen, Joop H.			Apoptosis-Related Gene Expression Profiling in Hematopoietic Cell Fractions of MDS Patients	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; RISK MYELODYSPLASTIC SYNDROMES; BCL-2 FAMILY PROTEINS; BONE-MARROW BIOPSIES; BREAST-CANCER CELLS; EXCESSIVE APOPTOSIS; BIK GENE; BCL-2-RELATED PROTEINS; SURVIVIN EXPRESSION; PROGENITOR CELLS	Although the vast majority of patients with a myelodysplastic syndrome (MDS) suffer from cytopenias, the bone marrow is usually normocellular or hypercellular. Apoptosis of hematopoietic cells in the bone marrow has been implicated in this phenomenon. However, in MDS it remains only partially elucidated which genes are involved in this process and which hematopoietic cells are mainly affected. We employed sensitive real-time PCR technology to study 93 apoptosis-related genes and gene families in sorted immature CD34+ and the differentiating erythroid (CD71+) and monomyeloid (CD13/33+) bone marrow cells. Unsupervised cluster analysis of the expression signature readily distinguished the different cellular bone marrow fractions (CD34+, CD71+ and CD13/33+) from each other, but did not discriminate patients from healthy controls. When individual genes were regarded, several were found to be differentially expressed between patients and controls. Particularly, strong over-expression of BIK (BCL2-interacting killer) was observed in erythroid progenitor cells of low- and high-risk MDS patients (both p = 0.001) and TNFRSF4 (tumor necrosis factor receptor superfamily 4) was down-regulated in immature hematopoietic cells (p = 0.0023) of low- risk MDS patients compared to healthy bone marrow.	[MC Langemeijer, Saskia; Mariani, Niccolo; Knops, Ruth; Woestenenk, Rob; van der Reijden, Bert A.; Jansen, Joop H.] Radboud Univ Nijmegen, Med Ctr Radboudumc, Hematol Lab, Dept Lab Med, Nijmegen, Netherlands; [MC Langemeijer, Saskia; Huls, Gerwin] Radboud Univ Nijmegen, Med Ctr, Dept Hematol, Nijmegen, Netherlands; [Gilissen, Christian] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Nijmegen, Netherlands; [de Witte, Theo] Radboud Univ Nijmegen, Med Ctr, Dept Tumor Immunol, Nijmegen, Netherlands; [Huls, Gerwin] Univ Groningen, Univ Med Ctr Groningen, Dept Hematol, Groningen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; University of Groningen	Jansen, JH (corresponding author), Radboud Univ Nijmegen, Med Ctr Radboudumc, Hematol Lab, Dept Lab Med, Nijmegen, Netherlands.	joop.jansen@radboudumc.nl	Jansen, J.H./H-8054-2014; Woestenenk, Rob/C-6119-2016; de Witte, T.J.M./L-4762-2015; Knops, Ruth G.H.J.N./F-5280-2016; van der Reijden, Bert A/A-3543-2014; Gilissen, Christian/E-5246-2012	Jansen, J.H./0000-0001-9459-568X; Gilissen, Christian/0000-0003-1693-9699	"Dutch Organization for Scientific Research" (NWO) [92003420]; Dutch Cancer Society	"Dutch Organization for Scientific Research" (NWO)(Netherlands Organization for Scientific Research (NWO)); Dutch Cancer Society(KWF Kankerbestrijding)	This work was supported by grants from the "Dutch Organization for Scientific Research" (NWO, 92003420) to SMCL and the "Dutch Cancer Society" (KWF) to NM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arena V, 2003, GENE CHROMOSOME CANC, V38, P91, DOI 10.1002/gcc.10245; Bogdanovic AD, 1997, LEUKEMIA, V11, P656, DOI 10.1038/sj.leu.2400640; Bogenberger JM, 2014, LEUKEMIA, V28, P1657, DOI 10.1038/leu.2014.44; Boudard D, 2000, LEUKEMIA, V14, P2045, DOI 10.1038/sj.leu.2401959; Bouscary D, 1997, LEUKEMIA, V11, P839, DOI 10.1038/sj.leu.2400654; Bouscary D, 2000, EXP HEMATOL, V28, P784, DOI 10.1016/S0301-472X(00)00179-X; BOYD JM, 1995, ONCOGENE, V11, P1921; Bullinger L, 2004, NEW ENGL J MED, V350, P1605, DOI 10.1056/NEJMoa031046; Choi YC, 2015, EXP CELL RES, V339, P320, DOI 10.1016/j.yexcr.2015.10.012; Claessens YE, 2005, BLOOD, V105, P4035, DOI 10.1182/blood-2004-08-3166; Ebert BL, 2008, PLOS MED, V5, P312, DOI 10.1371/journal.pmed.0050035; Economopoulou C, 2008, LEUKEMIA RES, V32, P61, DOI 10.1016/j.leukres.2007.04.012; Elangovan B, 1997, J BIOL CHEM, V272, P24494, DOI 10.1074/jbc.272.39.24494; Evangelisti C, 2015, BBA-MOL CELL RES, V1853, P14, DOI 10.1016/j.bbamcr.2014.09.023; Ferreira AF, 2015, ACTA HAEMATOL-BASEL, V133, P354, DOI 10.1159/000369446; Garcia N, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-93; Germing U, 2013, DTSCH ARZTEBL INT, V110, P783, DOI 10.3238/arztebl.2013.0783; Gianelli U, 2007, ANN HEMATOL, V86, P185, DOI 10.1007/s00277-006-0215-0; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Gramaglia I, 1998, J IMMUNOL, V161, P6510; Greenberg P, 1997, BLOOD, V89, P2079, DOI 10.1182/blood.V89.6.2079; Greenberg PL, 2012, BLOOD, V120, P2454, DOI 10.1182/blood-2012-03-420489; Guerenne L, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0235-8; Huh YO, 2002, LEUKEMIA, V16, P2249, DOI 10.1038/sj.leu.2402704; Hur J, 2006, CANCER RES, V66, P10153, DOI 10.1158/0008-5472.CAN-05-3696; Invernizzi R, 2004, LEUKEMIA LYMPHOMA, V45, P2229, DOI 10.1080/10428190412331283251; Jensen SM, 2010, SEMIN ONCOL, V37, P524, DOI 10.1053/j.seminoncol.2010.09.013; Jilg S, 2016, LEUKEMIA, V30, P112, DOI 10.1038/leu.2015.179; Kitagawa M, 1997, LEUKEMIA, V11, P2049, DOI 10.1038/sj.leu.2400844; Kohlmann A, 2010, LEUKEMIA, V24, P1216, DOI 10.1038/leu.2010.73; Lan KL, 2007, CLIN EXP METASTAS, V24, P461, DOI 10.1007/s10585-007-9083-9; Lane PJL, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00154; Lin CW, 2002, LEUKEMIA RES, V26, P551, DOI 10.1016/S0145-2126(01)00170-9; Lindberg EH, 2001, BRIT J HAEMATOL, V112, P714, DOI 10.1046/j.1365-2141.2001.02581.x; Lu Y, 2006, PLOS MED, V3, P2229, DOI 10.1371/journal.pmed.0030467; Moran AE, 2013, CURR OPIN IMMUNOL, V25, P230, DOI 10.1016/j.coi.2013.01.004; Pang WW, 2013, P NATL ACAD SCI USA, V110, P3011, DOI 10.1073/pnas.1222861110; Parker JE, 2000, BLOOD, V96, P3932, DOI 10.1182/blood.V96.12.3932.h8003932_3932_3938; Parker JE, 1998, BRIT J HAEMATOL, V103, P1075; Pecci A, 2003, ACTA HAEMATOL-BASEL, V109, P29, DOI 10.1159/000067275; Poklepovic A, 2014, AUTOPHAGY, V10, P1478, DOI 10.4161/auto.29428; Rajapaksa R, 1996, BLOOD, V88, P4275; Raponi M, 2008, BLOOD, V111, P2589, DOI 10.1182/blood-2007-09-112730; Rashmi R, 2008, ONCOGENE, V27, P1366, DOI 10.1038/sj.onc.1210783; RAZA A, 1995, AM J HEMATOL, V48, P143, DOI 10.1002/ajh.2830480302; Real PJ, 2006, FEBS LETT, V580, P5905, DOI 10.1016/j.febslet.2006.08.088; Esparza-Garrido RR, 2016, TUMOR BIOL, V37, P6749, DOI 10.1007/s13277-015-4494-8; Sawanobori M, 2003, LEUKEMIA RES, V27, P583, DOI 10.1016/S0145-2126(02)00095-4; Shetty V, 2002, BRIT J HAEMATOL, V116, P817, DOI 10.1046/j.0007-1048.2002.03366.x; Song JX, 2008, J IMMUNOL, V180, P7240, DOI 10.4049/jimmunol.180.11.7240; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Spender LC, 2009, CELL DEATH DIFFER, V16, P593, DOI 10.1038/cdd.2008.183; Stirewalt DL, 2008, GENE CHROMOSOME CANC, V47, P8, DOI 10.1002/gcc.20500; Suarez L, 2004, LEUKEMIA, V18, P1311, DOI 10.1038/sj.leu.2403386; Tefferi A, 2009, NAT REV CLIN ONCOL, V6, P627, DOI 10.1038/nrclinonc.2009.149; Theilgaard-Monch K, 2011, LEUKEMIA, V25, P909, DOI 10.1038/leu.2011.48; Tsimberidou AM, 2008, CANCER-AM CANCER SOC, V113, P1605, DOI 10.1002/cncr.23785; Tsoplou P, 1999, LEUKEMIA, V13, P1554, DOI 10.1038/sj.leu.2401538; Valdez BC, 2008, LEUKEMIA RES, V32, P1684, DOI 10.1016/j.leukres.2008.01.016; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; Viedma-Rodriguez R, 2015, TUMOR BIOL, V36, P6991, DOI 10.1007/s13277-015-3374-6; Viedma-Rodriguez R, 2013, INT J ONCOL, V43, P1777, DOI 10.3892/ijo.2013.2127; Vogl DT, 2014, AUTOPHAGY, V10, P1380, DOI 10.4161/auto.29264; Webb GJ, 2016, CLIN REV ALLERG IMMU, V50, P312, DOI 10.1007/s12016-015-8498-3; Will B, 2012, BLOOD, V120, P2076, DOI 10.1182/blood-2011-12-399683; Xi Y, 2015, J CANCER, V6, P327, DOI 10.7150/jca.11185; Yamamoto K, 2004, LEUKEMIA RES, V28, P1203, DOI 10.1016/j.leukres.2004.03.020; Yoshida A, 2012, HAEMATOL-HEMATOL J, V97, P1372, DOI 10.3324/haematol.2011.055681; Zang DY, 2001, BLOOD, V98, P3058, DOI 10.1182/blood.V98.10.3058; Zou YY, 2002, CANCER RES, V62, P8	70	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0165582	10.1371/journal.pone.0165582	http://dx.doi.org/10.1371/journal.pone.0165582			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902785	Green Published, gold, Green Submitted			2022-12-26	WOS:000389474100005
J	Palmer, MV; Thacker, TC; Waters, WR				Palmer, Mitchell V.; Thacker, Tyler C.; Waters, W. Ray			Differential Cytokine Gene Expression in Granulomas from Lungs and Lymph Nodes of Cattle Experimentally Infected with Aerosolized Mycobacterium bovis	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; NECROSIS-FACTOR-ALPHA; CALMETTE-GUERIN; MESSENGER-RNA; TUBERCULOSIS; MICE; PROGRESSION; DELTA-RD1; RELEVANCE; PATHOLOGY	The hallmark lesion of tuberculosis in humans and animals is the granuloma. The granuloma represents a distinct host cellular immune response composed of epithelioid macrophages, lymphocytes, and multinucleated giant cells, often surrounding a caseous necrotic core. Within the granuloma, host-pathogen interactions determine disease outcome. Factors within the granulomas such as cytokines and chemokines drive cell recruitment, activity, function and ultimately the success or failure of the host's ability to control infection. Hence, an understanding of the granuloma-level cytokine response is necessary to understand tuberculosis pathogenesis. In-situ cytokine expression patterns were measured using a novel in situ hybridization assay, known as RNAScope (R) in granulomas of the lungs, tracheobronchial lymph nodes and caudal mediastinal lymph nodes of cattle experimentally infected with Mycobacterium bovis via aerosol exposure. In spite of microscopic morphological similarities, significant differences were seen between late stage granulomas of the lung compared to those of the tracheobronchial lymph nodes for IL-17A, IFN-gamma, TGF-beta, IL10 and IL22 but not for TNF-alpha. Additionally, significant differences were noted between granulomas from two different thoracic lymph nodes that both receive afferent lymphatics from the lungs (i.e., tracheobronchial and caudal mediastinal lymph nodes) for TNF-alpha, IL-17A, IFN-gamma, TGF-beta and IL-10 but not for IL-22. These findings show that granuloma morphology alone is not a reliable indicator of granuloma function as granulomas of similar morphologies can have disparate cytokine expression patterns. Moreover, anatomically distinct lymph nodes (tracheobronchial vs caudal mediastinal) differ in cytokine expression patterns even when both receive afferent lymphatics from a lung containing tuberculoid granulomas. These findings show that selection of tissue and anatomic location are critical factors in assessing host immune response to M. bovis and should be considered carefully.	[Palmer, Mitchell V.; Thacker, Tyler C.; Waters, W. Ray] ARS, Infect Bacterial Dis Livestock Unit, Natl Anim Dis Ctr, USDA, Ames, IA 50011 USA	United States Department of Agriculture (USDA)	Palmer, MV (corresponding author), ARS, Infect Bacterial Dis Livestock Unit, Natl Anim Dis Ctr, USDA, Ames, IA 50011 USA.	mitchell.palmer@ars.usda.gov	Palmer, Mitchell/R-7091-2018	Palmer, Mitchell/0000-0002-5902-3333	US Department of Agriculture, Agricultural Research Service Project (CRIS) [3625-32000-104]	US Department of Agriculture, Agricultural Research Service Project (CRIS)	Research funds were provided by the US Department of Agriculture, Agricultural Research Service Project (CRIS# 3625-32000-104).	Aranday-Cortes E, 2013, TRANSBOUND EMERG DIS, V60, P525, DOI 10.1111/j.1865-1682.2012.01370.x; Beamer GL, 2008, J IMMUNOL, V181, P5545, DOI 10.4049/jimmunol.181.8.5545; Bhuju S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003077; Boddu-Jasmine HC, 2008, TUBERCULOSIS, V88, P610, DOI 10.1016/j.tube.2008.06.003; Cotran R.S., 1994, ROBBINS PATHOLOGIC B, V5th ed., P700; Cotran RS, 1994, ROBBINS PATHOLOGIC B, P51; DiFazio RM, 2016, FIBROGENESIS TISSUE, V9, DOI 10.1186/s13069-016-0043-3; Dorhoi A, 2014, SEMIN IMMUNOL, V26, P203, DOI 10.1016/j.smim.2014.04.003; Etna MP, 2014, SEMIN IMMUNOL, V26, P543, DOI 10.1016/j.smim.2014.09.011; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Gideon HP, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004603; Johnson L, 2007, TUBERCULOSIS, V87, P71, DOI 10.1016/j.tube.2006.04.002; Johnson L, 2006, VET IMMUNOL IMMUNOP, V111, P219, DOI 10.1016/j.vetimm.2006.01.016; Langer AJ, 2014, ZOONOTIC TUBERCULOSIS: MYCOBACTERIUM BOVIS AND OTHER PATHOGENIC MYCOBACTERIA, 3RD EDITION, P21; Lin PL, 2014, NAT MED, V20, P75, DOI 10.1038/nm.3412; Lin PL, 2013, ANTIMICROB AGENTS CH, V57, P4237, DOI 10.1128/AAC.00277-13; Mustafa T, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-535; Myers R.K., 2012, PATHOLOGIC BASIS VET, V5th ed., P122; Palmer MV, 2007, VET PATHOL, V44, P863, DOI 10.1354/vp.44-6-863; Palmer MV, 2015, J COMP PATHOL, V153, P150, DOI 10.1016/j.jcpa.2015.06.004; Palmer MV, 2002, TUBERCULOSIS, V82, P275, DOI 10.1054/tube.2002.0341; Palmer MV, 1999, AM J VET RES, V60, P310; Rhoades ER, 1997, TUBERCLE LUNG DIS, V78, P57, DOI 10.1016/S0962-8479(97)90016-2; Rodriguez-Campos S, 2014, RES VET SCI, V97, pS5, DOI 10.1016/j.rvsc.2014.02.009; Saar LI, 1975, ANATOMY DOMESTIC ANI, P1024; Salguero FJ, 2016, TRANSBOUND EMERG DIS; Shu D, 2014, VET IMMUNOL IMMUNOP, V160, P81, DOI 10.1016/j.vetimm.2014.03.017; Sizemore C, 2015, TUBERCULOSIS, LEPROSY AND MYCOBACTERIAL DISEASES OF MAN AND ANIMALS: THE MANY HOSTS OF MYCOBACTERIA, pXV; Thacker TC, 2007, VET IMMUNOL IMMUNOP, V119, P204, DOI 10.1016/j.vetimm.2007.05.009; Tubbs RR, 2013, AM J CLIN PATHOL, V140, P736, DOI 10.1309/AJCPJTWK07FSABRJ; USDA APHIS, 2007, BOV TUB ER UN METH R, P1; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002; Wangoo A, 2005, J COMP PATHOL, V133, P223, DOI 10.1016/j.jcpa.2005.05.001; Waters WR, 2014, J COMP PATHOL, V151, P410, DOI 10.1016/j.jcpa.2014.08.007; Waters WR, 2007, VACCINE, V25, P7832, DOI 10.1016/j.vaccine.2007.08.029; Waters WR, 2015, ILAR J, V56, P26, DOI 10.1093/ilar/ilv001; Waters WR, 2014, VET IMMUNOL IMMUNOP, V159, P113, DOI 10.1016/j.vetimm.2014.02.009; Waters WR, 2009, VACCINE, V27, P1201, DOI 10.1016/j.vaccine.2008.12.018; Witchell J, 2010, VET IMMUNOL IMMUNOP, V138, P79, DOI 10.1016/j.vetimm.2010.07.004	39	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167471	10.1371/journal.pone.0167471	http://dx.doi.org/10.1371/journal.pone.0167471			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902779	Green Submitted, gold, Green Published			2022-12-26	WOS:000389474100085
J	Scott, CM; Joo, JE; O'Callaghan, N; Buchanan, DD; Clendenning, M; Giles, GG; Hopper, JL; Wong, EM; Southey, MC				Scott, Cameron M.; Joo, JiHoon Eric; O'Callaghan, Neil; Buchanan, Daniel D.; Clendenning, Mark; Giles, Graham G.; Hopper, John L.; Wong, Ee Ming; Southey, Melissa C.			Methylation of Breast Cancer Predisposition Genes in Early-Onset Breast Cancer: Australian Breast Cancer Family Registry	PLOS ONE			English	Article							POPULATION-BASED ESTIMATE; PERIPHERAL-BLOOD DNA; SPORADIC BREAST; PROMOTER HYPERMETHYLATION; BRCA1 PROMOTER; REPAIR GENES; P53 GENES; MUTATIONS; ATM; VARIANTS	DNA methylation can mimic the effects of both germline and somatic mutations for cancer predisposition genes such as BRCA1 and p16(INK4a). Constitutional DNA methylation of the BRCA1 promoter has been well described and is associated with an increased risk of early-onset breast cancers that have BRCA1-mutation associated histological features. The role of methylation in the context of other breast cancer predisposition genes has been less well studied and often with conflicting or ambiguous outcomes. We examined the role of methylation in known breast cancer susceptibility genes in breast cancer predisposition and tumor development. We applied the Infinium HumanMethylation450 Beadchip (HM450K) array to blood and tumor-derived DNA from 43 women diagnosed with breast cancer before the age of 40 years and measured the methylation profiles across promoter regions of BRCA1, BRCA2, ATM, PALB2, CDH1, TP53, FANCM, CHEK2, MLH1, MSH2, MSH6 and PMS2. Prior genetic testing had demonstrated that these women did not carry a germline mutation in BRCA1, ATM, CHEK2, PALB2, TP53, BRCA2, CDH1 or FANCM. In addition to the BRCA1 promoter region, this work identified regions with variable methylation at multiple breast cancer susceptibility genes including PALB2 and MLH1. Methylation at the region of MLH1 in these breast cancers was not associated with microsatellite instability. This work informs future studies of the role of methylation in breast cancer susceptibility gene silencing.	[Scott, Cameron M.; Joo, JiHoon Eric; O'Callaghan, Neil; Wong, Ee Ming; Southey, Melissa C.] Univ Melbourne, Dept Pathol, Genet Epidemiol Lab, Parkville, Vic 3010, Australia; [Buchanan, Daniel D.; Clendenning, Mark] Univ Melbourne, Dept Pathol, Colorectal Oncogen Grp, Genet Epidemiol Lab, Parkville, Vic, Australia; [Buchanan, Daniel D.; Giles, Graham G.; Hopper, John L.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Epidemiol & Biostat, Parkville, Vic, Australia; [Giles, Graham G.] Canc Council Victoria, Canc Epidemiol Ctr, Melbourne, Vic, Australia	University of Melbourne; University of Melbourne; University of Melbourne; Cancer Council Victoria	Southey, MC (corresponding author), Univ Melbourne, Dept Pathol, Genet Epidemiol Lab, Parkville, Vic 3010, Australia.	msouthey@unimelb.edu.au		Southey, Melissa/0000-0002-6313-9005; Buchanan, Daniel/0000-0003-2225-6675; Wong, Ee Ming/0000-0002-7288-7865	National Health and Medical Research Council of Australia; New South Wales Cancer Council; Victorian Health Promotion Foundation (Australia); USA National Cancer Institute [UM1 CA164920]; Genetic Epidemiology Laboratory Honors Scholarship, Department of Pathology, The University of Melbourne	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); New South Wales Cancer Council(Cancer Council New South Wales); Victorian Health Promotion Foundation (Australia); USA National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Genetic Epidemiology Laboratory Honors Scholarship, Department of Pathology, The University of Melbourne	The Australia site of Breast Cancer Family Registry was supported by the National Health and Medical Research Council of Australia, the New South Wales Cancer Council, the Victorian Health Promotion Foundation (Australia) and grant UM1 CA164920 from the USA National Cancer Institute. The content of this manuscript does not necessarily reflect the views or policies of the National Cancer Institute or any of the collaborating centers in the Breast Cancer Family Registry (BCFR), nor does mention of trade names, commercial products, or organizations imply endorsement by the USA Government or the BCFR. JLH is a Senior Principle Research Fellow and MCS is a Senior Research Fellow of the NHMRC. CMS is a recipient of a Genetic Epidemiology Laboratory Honors Scholarship, Department of Pathology, The University of Melbourne.	Andrulis IL, 2002, HUM MUTAT, V20, P65, DOI 10.1002/humu.10097; Apicella C, 2007, CLIN GENET, V72, P87, DOI 10.1111/j.1399-0004.2007.00841.x; Aryee MJ, 2014, BIOINFORMATICS, V30, P1363, DOI 10.1093/bioinformatics/btu049; Bonadona V, 2011, JAMA-J AM MED ASSOC, V305, P2304, DOI 10.1001/jama.2011.743; Brennan K, 2012, CANCER RES, V72, P2304, DOI 10.1158/0008-5472.CAN-11-3157; Chmelarova M, 2013, CLIN TRANSL ONCOL, V15, P160, DOI 10.1007/s12094-012-0894-z; Deng GR, 1999, CANCER RES, V59, P2029; Dite GS, 2003, J NATL CANCER I, V95, P448, DOI 10.1093/jnci/95.6.448; Easton DF, 2015, NEW ENGL J MED, V372, P2243, DOI 10.1056/NEJMsr1501341; Esteller M, 2000, JNCI-J NATL CANCER I, V92, P564, DOI 10.1093/jnci/92.7.564; Esteller M, 2001, HUM MOL GENET, V10, P3001, DOI 10.1093/hmg/10.26.3001; Flanagan JM, 2009, HUM MOL GENET, V18, P1332, DOI 10.1093/hmg/ddp033; Goldgar DE, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2919; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Hopper JL, 1999, CANCER EPIDEM BIOMAR, V8, P741; Jha AK, 2012, MOL BIOL REP, V39, P9145, DOI 10.1007/s11033-012-1787-5; John EM, 2004, BREAST CANCER RES, V6, pR375, DOI 10.1186/bcr801; Joo JE, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-23; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Le Calvez-Kelm F, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2810; Leong T, 2000, INT J RADIAT ONCOL, V48, P959, DOI 10.1016/S0360-3016(00)00728-8; Maksimovic J, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv526; Mikeska T, 2013, J OVARIAN RES, V6, DOI 10.1186/1757-2215-6-26; Mouchawar J, 2010, CANCER RES, V70, P4795, DOI 10.1158/0008-5472.CAN-09-0851; Murata H, 2002, ONCOGENE, V21, P5696, DOI 10.1038/sj.onc.1205683; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Neuhausen SL, 2009, BREAST CANCER RES TR, V116, P379, DOI 10.1007/s10549-008-0153-8; Parsons MT, 2012, J MED GENET, V49, P151, DOI 10.1136/jmedgenet-2011-100714; Potapova A, 2008, CANCER RES, V68, P998, DOI 10.1158/0008-5472.CAN-07-2418; Poumpouridou N, 2016, CLIN BIOCHEM, V49, P253, DOI 10.1016/j.clinbiochem.2015.10.009; Ramalho EAVF, 2014, BIOL RES, V47, DOI 10.1186/0717-6287-47-3; Smith LD, 2007, EUR J CANCER, V43, P823, DOI 10.1016/j.ejca.2007.01.011; Southey MC, 1999, BRIT J CANCER, V79, P34, DOI 10.1038/sj.bjc.6690008; Southey MC, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2796; ten Broeke SW, 2015, J CLIN ONCOL, V33, P319, DOI 10.1200/JCO.2014.57.8088; Watanabe Y, 2013, GENES CELLS, V18, P1120, DOI 10.1111/gtc.12100; Williams LH, 2006, CLIN CANCER RES, V12, P6967, DOI 10.1158/1078-0432.CCR-06-1770; Wong Ee Ming, 2015, BMC Res Notes, V8, P543, DOI 10.1186/s13104-015-1487-z; Wong EM, 2011, CANCER PREV RES, V4, P23, DOI 10.1158/1940-6207.CAPR-10-0212; Wong EM, 2016, BREAST CANC RES TREA	40	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0165436	10.1371/journal.pone.0165436	http://dx.doi.org/10.1371/journal.pone.0165436			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902704	Green Published, gold			2022-12-26	WOS:000389474100004
J	Lebeau, P; Al-Hashimi, A; Sood, S; Lhotak, S; Yu, P; Gyulay, G; Pare, G; Chen, SRW; Trigatti, B; Prat, A; Seidah, NG; Austin, RC				Lebeau, Paul; Al-Hashimi, Ali; Sood, Sudesh; Lhotak, Sarka; Yu, Pei; Gyulay, Gabriel; Pare, Guillaume; Chen, S. R. Wayne; Trigatti, Bernardo; Prat, Annik; Seidah, Nabil G.; Austin, Richard C.			Endoplasmic Reticulum Stress and Ca2+ Depletion Differentially Modulate the Sterol Regulatory Protein PCSK9 to Control Lipid Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY-LIPOPROTEIN-RECEPTOR; CLEAVAGE-ACTIVATING PROTEIN; ELEMENT-BINDING PROTEINS; CONVERTASE SUBTILISIN/KEXIN TYPE-9; CARDIAC RYANODINE RECEPTOR; MICE LACKING PCSK9; LDL RECEPTOR; VENTRICULAR-TACHYCARDIA; LIVER-REGENERATION; CHOLESTEROL EFFLUX	Accumulating evidence implicates endoplasmic reticulum (ER) stress as a mediator of impaired lipid metabolism, thereby contributing to fatty liver disease and atherosclerosis. Previous studies demonstrated that ER stress can activate the sterol regulatory element-binding protein-2 (SREBP2), an ER-localized transcription factor that directly up-regulates sterol regulatory genes, including PCSK9. Given that PCSK9 contributes to atherosclerosis by targeting low density lipoprotein (LDL) receptor (LDLR) degradation, this study investigates a novel mechanism by which ER stress plays a role in lipid metabolism by examining its ability to modulate PCSK9 expression. Herein, we demonstrate the existence of two independent effects of ER stress on PCSK9 expression and secretion. In cultured HuH7 and HepG2 cells, agents or conditions that cause ER Ca2+ depletion, including thapsigargin, induced SREBP2-dependent up-regulation of PCSK9 expression. In contrast, a significant reduction in the secreted form of PCSK9 protein was observed in the media from both thapsigargin-and tunicamycin (TM)-treated HuH7 cells, mouse primary hepatocytes, and in the plasma of TM-treated C57BL/6 mice. Furthermore, TM significantly increased hepatic LDLR expression and reduced plasma LDL concentrations in mice. Based on these findings, we propose a model in which ER Ca2+ depletion promotes the activation of SREBP2 and subsequent transcription of PCSK9. However, conditions that cause ER stress regardless of their ability to dysregulate ER Ca2+ inhibit PCSK9 secretion, thereby reducing PCSK9-mediated LDLR degradation and promoting LDLR-dependent hepatic cholesterol uptake. Taken together, our studies provide evidence that the retention of PCSK9 in the ER may serve as a potential strategy for lowering LDL cholesterol levels.	[Lebeau, Paul; Al-Hashimi, Ali; Sood, Sudesh; Lhotak, Sarka; Gyulay, Gabriel; Austin, Richard C.] McMaster Univ, Dept Med, Div Nephrol, Hamilton, ON L8N 4A6, Canada; [Lebeau, Paul; Al-Hashimi, Ali; Sood, Sudesh; Lhotak, Sarka; Gyulay, Gabriel; Austin, Richard C.] St Josephs Hamilton Healthcare & Hamilton Ctr Kid, Hamilton, ON L8N 4A6, Canada; [Yu, Pei; Trigatti, Bernardo; Austin, Richard C.] Hamilton Hlth Sci, Thrombosis & Atherosclerosis Res Inst, Hamilton, ON L8L 2X2, Canada; [Yu, Pei; Trigatti, Bernardo; Austin, Richard C.] McMaster Univ, Hamilton, ON L8L 2X2, Canada; [Yu, Pei; Trigatti, Bernardo] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4L8, Canada; [Pare, Guillaume] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, Canada; [Pare, Guillaume] McMaster Univ, Dept Med, Hamilton, ON L8L 2X2, Canada; [Pare, Guillaume] McMaster Univ, Dept Epidemiol, Hamilton, ON L8L 2X2, Canada; [Pare, Guillaume] McMaster Univ, Dept Pathol, Hamilton, ON L8L 2X2, Canada; [Chen, S. R. Wayne] Univ Calgary, Dept Physiol & Pharmacol, Libin Cardiovasc Inst Alberta, Calgary, AB T2N 2T9, Canada; [Prat, Annik; Seidah, Nabil G.] Univ Montreal, Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, Montreal, PQ H2W 1R7, Canada	McMaster University; McMaster University; McMaster University; McMaster University; McMaster University; Population Health Research Institute; McMaster University; McMaster University; McMaster University; Libin Cardiovascular Institute Of Alberta; University of Calgary; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Austin, RC (corresponding author), 50 Charlton Ave East,Rm T-3313, Hamilton, ON L8N 4A6, Canada.	austinr@taari.ca	Prat, Annik/S-6757-2018; Pare, Guillaume/T-9631-2018; Seidah, Nabil/I-3596-2013	Prat, Annik/0000-0002-8007-5277; Pare, Guillaume/0000-0002-6795-4760; Trigatti, Bernardo (Dino) L./0000-0002-4556-119X; Seidah, Nabil/0000-0001-6503-9342	Heart and Stroke Foundation of Ontario Research Grant [T-6146]; Canadian Institutes of Health Research Grant [MOP-74477]; Ontario Research and Development Challenge Fund; Canadian Institute of Health Research; Leducq Foundation [13 CVD 03]; Canada Research Chair [216684]; St. Joseph's Healthcare Hamilton; Canadian Institutes of Health Research Team Grant in Thromboembolism [FRN-79846]	Heart and Stroke Foundation of Ontario Research Grant; Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR)); Ontario Research and Development Challenge Fund(General Electric); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Leducq Foundation(Leducq Foundation); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); St. Joseph's Healthcare Hamilton; Canadian Institutes of Health Research Team Grant in Thromboembolism(Canadian Institutes of Health Research (CIHR))	This work was supported in part by Heart and Stroke Foundation of Ontario Research Grant T-6146 (to R. C. A.), Canadian Institutes of Health Research Grant MOP-74477, the Ontario Research and Development Challenge Fund, the Canadian Institute of Health Research (to S. R. W. C.), Leducq Foundation Grant 13 CVD 03 (to N. G. S. and A. P.), Canada Research Chair 216684 (to N. G. S.), St. Joseph's Healthcare Hamilton and the Canadian Institutes of Health Research Team Grant in Thromboembolism FRN-79846. The authors declare that they have no conflicts of interest with the contents of this article.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Al-Hashimi AA, 2010, J BIOL CHEM, V285, P28912, DOI 10.1074/jbc.M110.119107; Amodio G, 2013, FEBS LETT, V587, P3261, DOI 10.1016/j.febslet.2013.08.021; Austin RC, 2009, ANTIOXID REDOX SIGN, V11, P2279, DOI [10.1089/ars.2009.2686, 10.1089/ARS.2009.2686]; Basseri S, 2009, J LIPID RES, V50, P2486, DOI 10.1194/jlr.M900216-JLR200; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Benjannet S, 2012, J BIOL CHEM, V287, P33745, DOI 10.1074/jbc.M112.399725; Biswas C, 2007, BIOCHEM J, V405, P233, DOI 10.1042/BJ20061867; Butkinaree C, 2015, J BIOL CHEM, V290, P18609, DOI 10.1074/jbc.M115.647180; Canuel M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064145; Cenedella RJ, 2009, LIPIDS, V44, P477, DOI 10.1007/s11745-009-3305-7; Chen Chang-fu, 2015, China Journal of Highway and Transport, V28, P1; Chen WQ, 2014, NAT MED, V20, P184, DOI 10.1038/nm.3440; Chen XW, 2013, ELIFE, V2, DOI 10.7554/eLife.00444; Chen YF, 2011, P NATL ACAD SCI USA, V108, P15225, DOI 10.1073/pnas.1103315108; Choi SB, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-112; Chorba JS, 2014, J BIOL CHEM, V289, P29030, DOI 10.1074/jbc.M114.594861; Coe H, 2009, GEN PHYSIOL BIOPHYS, V28, pF96; Colgan SM, 2007, INT J BIOCHEM CELL B, V39, P1843, DOI 10.1016/j.biocel.2007.05.002; Colgan SM, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399410001742; Corbett EF, 1999, J BIOL CHEM, V274, P6203, DOI 10.1074/jbc.274.10.6203; Corbett EF, 2000, TRENDS BIOCHEM SCI, V25, P307, DOI 10.1016/S0968-0004(00)01588-7; Dara L, 2011, HEPATOLOGY, V53, P1752, DOI 10.1002/hep.24279; Fuller M, 2014, ARTERIOSCL THROM VAS, V34, P2394, DOI 10.1161/ATVBAHA.114.304200; Fullerton MD, 2013, NAT MED, V19, P1649, DOI 10.1038/nm.3372; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; GONZALEZGRONOW M, 1993, J BIOL CHEM, V268, P20791; GREEVE J, 1993, J LIPID RES, V34, P1367; Grefhorst A, 2008, J LIPID RES, V49, P1303, DOI 10.1194/jlr.M800027-JLR200; Gustafsen C, 2014, CELL METAB, V19, P310, DOI 10.1016/j.cmet.2013.12.006; Hawkins JL, 2008, J PHARMACOL EXP THER, V326, P801, DOI 10.1124/jpet.108.139626; Higgins ME, 2001, J LIPID RES, V42, P1939; Holtzman DM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006312; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Hua XX, 1996, CELL, V87, P415, DOI 10.1016/S0092-8674(00)81362-8; INUI M, 1988, METHOD ENZYMOL, V157, P490; INUI M, 1987, J BIOL CHEM, V262, P1740; Iwawaki T, 2004, NAT MED, V10, P98, DOI 10.1038/nm970; Jiang DW, 2010, CHANNELS, V4, P302, DOI 10.4161/chan.4.4.12666; Jiang DW, 2005, CIRC RES, V97, P1173, DOI 10.1161/01.RES.0000192146.85173.4b; Jin WJ, 2007, CELL METAB, V6, P129, DOI 10.1016/j.cmet.2007.07.009; Jo H, 2013, HEPATOLOGY, V57, P1366, DOI 10.1002/hep.26126; Jones PP, 2008, BIOCHEM J, V412, P171, DOI 10.1042/BJ20071287; Kamisuki S, 2009, CHEM BIOL, V16, P882, DOI 10.1016/j.chembiol.2009.07.007; Kaplowitz N, 2007, SEMIN LIVER DIS, V27, P367, DOI 10.1055/s-2007-991513; Kosenko T, 2013, J BIOL CHEM, V288, P8279, DOI 10.1074/jbc.M112.421370; Lagace TA, 2006, J CLIN INVEST, V116, P2995, DOI 10.1172/JCI29383; LAI FA, 1988, NATURE, V331, P315, DOI 10.1038/331315a0; Lamb HK, 2006, J BIOL CHEM, V281, P8796, DOI 10.1074/jbc.M503964200; Lauressergues E, 2012, NEUROPHARMACOLOGY, V62, P784, DOI 10.1016/j.neuropharm.2011.08.048; Lee JN, 2004, J BIOL CHEM, V279, P45257, DOI 10.1074/jbc.M408235200; Lhotak S, 2012, AM J PHYSIOL-RENAL, V303, pF266, DOI 10.1152/ajprenal.00482.2011; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; Mayne J, 2011, CLIN CHEM, V57, P1415, DOI 10.1373/clinchem.2011.165191; McNutt MC, 2009, J BIOL CHEM, V284, P10561, DOI 10.1074/jbc.M808802200; MERLIE JP, 1982, J BIOL CHEM, V257, P2694; Nohturfft A, 1998, P NATL ACAD SCI USA, V95, P12848, DOI 10.1073/pnas.95.22.12848; Nohturfft A, 1999, P NATL ACAD SCI USA, V96, P11235, DOI 10.1073/pnas.96.20.11235; Pai JT, 1996, P NATL ACAD SCI USA, V93, P5437, DOI 10.1073/pnas.93.11.5437; Park SW, 2004, J BIOL CHEM, V279, P50630, DOI 10.1074/jbc.M410077200; Poirier S, 2008, J BIOL CHEM, V283, P2363, DOI 10.1074/jbc.M708098200; Poirier S, 2015, CELL REP, V13, P2064, DOI 10.1016/j.celrep.2015.11.006; Rashid S, 2005, P NATL ACAD SCI USA, V102, P5374, DOI 10.1073/pnas.0501652102; Rohrl C, 2014, J LIPID RES, V55, P94, DOI 10.1194/jlr.M043299; Roubtsova A, 2015, J LIPID RES, V56, P2133, DOI 10.1194/jlr.M061952; Roubtsova A, 2011, ARTERIOSCL THROM VAS, V31, P785, DOI 10.1161/ATVBAHA.110.220988; Sakai J, 1996, CELL, V85, P1037, DOI 10.1016/S0092-8674(00)81304-5; Schuck S, 2009, J CELL BIOL, V187, P525, DOI 10.1083/jcb.200907074; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Seidah NG, 2015, J GLOBAL CARDIOLOGY, V59, P1; Song YF, 2016, CHEMOSPHERE, V144, P2443, DOI 10.1016/j.chemosphere.2015.11.031; Strom TB, 2014, BIOCHEM J, V457, P99, DOI 10.1042/BJ20130930; Sun LP, 2005, J BIOL CHEM, V280, P26483, DOI 10.1074/jbc.M504041200; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; Tong JF, 1999, J BIOL CHEM, V274, P693, DOI 10.1074/jbc.274.2.693; Tran H, 2003, J LIPID RES, V44, P1859, DOI 10.1194/jlr.M200487-JLR200; Vig S, 2015, CELL CYCLE, V14, P2274, DOI 10.1080/15384101.2015.1046654; VOLPE JJ, 1983, J BIOL CHEM, V258, P9220; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Werstuck GH, 2001, J CLIN INVEST, V107, P1263, DOI 10.1172/JCI11596; Yabe D, 2002, P NATL ACAD SCI USA, V99, P12753, DOI 10.1073/pnas.162488899; Zaid A, 2008, HEPATOLOGY, V48, P646, DOI 10.1002/hep.22354; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200	85	27	27	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2017	292	4					1510	1523		10.1074/jbc.M116.744235	http://dx.doi.org/10.1074/jbc.M116.744235			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ6OX	27909053	Green Published, hybrid			2022-12-26	WOS:000393339800030
J	Nair, HAS; Periasamy, S; Yang, L; Kjelleberg, S; Rice, SA				Nair, Harikrishnan A. S.; Periasamy, Saravanan; Yang, Liang; Kjelleberg, Staffan; Rice, Scott A.			Real Time, Spatial, and Temporal Mapping of the Distribution of c-di-GMP during Biofilm Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAPHYLOCOCCUS-EPIDERMIDIS BIOFILMS; GREEN FLUORESCENT PROTEIN; PSEUDOMONAS-AERUGINOSA; BACTERIAL BIOFILM; OXYGEN; CELLS; DIFFERENTIATION; 2ND-MESSENGER; MICROSCOPY; STARVATION	Bis-(3'-5')-cyclic dimeric guanosine monophosphate (c-diGMP) is a dynamic intracellular signaling molecule that plays a central role in the biofilm life cycle. Current methodologies for the quantification of c-di-GMP are typically based on chemical extraction, representing end point measurements. Chemical methodologies also fail to take into consideration the physiological heterogeneity of the biofilm and thus represent an average c-di-GMP concentration across the entire biofilm. To address these problems, a ratiometric, image-based quantification method has been developed based on expression of the green fluorescence protein (GFP) under the control of the c-di-GMP-responsive cdrA promoter (Rybtke, M. T., Borlee, B. R., Murakami, K., Irie, Y., Hentzer, M., Nielsen, T. E., Givskov, M., Parsek, M. R., and Tolker-Nielsen, T. (2012) Appl. Environ. Microbiol. 78, 5060-5069). The methodology uses the cyan fluorescent protein (CFP) as a biomass indicator and the GFP as a c-di-GMP reporter. Thus, the CFP/GFP ratio gives the effective c-di-GMP per biomass. A binary mask was applied to alleviate background fluorescence, and fluorescence was calibrated against known c-di-GMP concentrations. Using flow cells for biofilm formation, c-di-GMP showed a non-uniform distribution across the biofilm, with concentrated hot spots of c-diGMP. Additionally, c-di-GMP was found to be localized at the outer boundary of mature colonies in contrast to a uniform distribution in early stage, small colonies. These data demonstrate the application of a method for the in situ, real time quantification of c-di-GMP and show that the amount of this biofilm-regulating second messenger was dynamic with time and colony size, reflecting the extent of biofilm heterogeneity in real time.	[Nair, Harikrishnan A. S.; Periasamy, Saravanan; Yang, Liang; Kjelleberg, Staffan; Rice, Scott A.] Nanyang Technol Univ, Singapore Ctr Environm Life Sci Engn, Singapore 637551, Singapore; [Nair, Harikrishnan A. S.] Nanyang Technol Univ, Interdisciplinary Grad Sch, Singapore 637551, Singapore; [Yang, Liang; Kjelleberg, Staffan; Rice, Scott A.] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore; [Periasamy, Saravanan] Rajalakshmi Engn Coll, Madras 602105, Tamil Nadu, India	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Rajalakshmi Engineering College	Rice, SA (corresponding author), Nanyang Technol Univ, Singapore Ctr Environm Life Sci Engn, Singapore 637551, Singapore.; Rice, SA (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore.	rscott@ntu.edu.sg	Rice, Scott/A-6084-2019; periasamy, saravanan/AAF-2860-2020; Kjelleberg, Staffan/C-9229-2015; Kjelleberg, Staffan/AAB-4641-2020; Yang, Liang/C-8487-2011	Rice, Scott/0000-0002-9486-2343; Kjelleberg, Staffan/0000-0003-4271-6413; Kjelleberg, Staffan/0000-0003-4271-6413; Yang, Liang/0000-0002-2362-0128	National Research Foundation; Ministry of Education Singapore under its Research Centre of Excellence Program; Nanyang Technological University; Australian Research Council [DP140102192]	National Research Foundation; Ministry of Education Singapore under its Research Centre of Excellence Program(Ministry of Education, Singapore); Nanyang Technological University(Nanyang Technological University); Australian Research Council(Australian Research Council)	This work was supported by the National Research Foundation and Ministry of Education Singapore under its Research Centre of Excellence Program and a Nanyang Technological University research scholarship for the years 2012-2016. This work was also supported by Australian Research Council Grant DP140102192. The authors declare that they have no conflicts of interest with the contents of this article.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Almblad H, 2015, J BACTERIOL, V197, P2190, DOI 10.1128/JB.00193-15; Andersen JB, 1998, APPL ENVIRON MICROB, V64, P2240; Baraquet C, 2013, P NATL ACAD SCI USA, V110, P18478, DOI 10.1073/pnas.1318972110; Barraud N, 2009, J BACTERIOL, V191, P7333, DOI 10.1128/JB.00975-09; Borlee BR, 2010, MOL MICROBIOL, V75, P827, DOI 10.1111/j.1365-2958.2009.06991.x; Choi KH, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-30; Chou SH, 2016, J BACTERIOL, V198, P32, DOI 10.1128/JB.00333-15; Christen M, 2010, SCIENCE, V328, P1295, DOI 10.1126/science.1188658; Chua SL, 2015, SCI REP-UK, V5, DOI 10.1038/srep10052; Chua SL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5462; Conibear TCR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006289; Corish P, 1999, PROTEIN ENG, V12, P1035, DOI 10.1093/protein/12.12.1035; DEBEER D, 1994, BIOTECHNOL BIOENG, V43, P1131, DOI 10.1002/bit.260431118; Drepper T, 2007, NAT BIOTECHNOL, V25, P443, DOI 10.1038/nbt1293; Franklin MJ, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00167; Gjermansen M, 2005, ENVIRON MICROBIOL, V7, P894, DOI 10.1111/j.1462-2920.2005.00775.x; Hansen MC, 2001, MICROBIOL-SGM, V147, P1383, DOI 10.1099/00221287-147-5-1383; Hickman JW, 2005, P NATL ACAD SCI USA, V102, P14422, DOI 10.1073/pnas.0507170102; Hoffman LR, 2005, NATURE, V436, P1171, DOI 10.1038/nature03912; Hunt SM, 2004, APPL ENVIRON MICROB, V70, P7418, DOI 10.1128/AEM.70.12.7418-7425.2004; Hwang G, 2016, SCI REP-UK, V6, DOI 10.1038/srep32841; Irie Y, 2012, P NATL ACAD SCI USA, V109, P20632, DOI 10.1073/pnas.1217993109; Jacobson AR, 2007, ENVIRON SCI TECHNOL, V41, P6343, DOI 10.1021/es070707m; Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423; Kikuchi K, 2004, CURR OPIN CHEM BIOL, V8, P182, DOI 10.1016/j.cbpa.2004.02.007; Kirov SM, 2007, MICROBIOL-SGM, V153, P3264, DOI 10.1099/mic.0.2007/009092-0; Koh KS, 2007, J BACTERIOL, V189, P119, DOI 10.1128/JB.00930-06; Lee KWK, 2016, ISME J, V10, P846, DOI 10.1038/ismej.2015.159; North AJ, 2006, J CELL BIOL, V172, P9, DOI 10.1083/jcb.200507103; Purevdorj-Gage B, 2005, MICROBIOL-SGM, V151, P1569, DOI 10.1099/mic.0.27536-0; Rani SA, 2005, ANTIMICROB AGENTS CH, V49, P728, DOI 10.1128/AAC.49.2.728-732.2005; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; Rybtke MT, 2012, APPL ENVIRON MICROB, V78, P5060, DOI 10.1128/AEM.00414-12; SILVER RA, 1990, NATURE, V343, P751, DOI 10.1038/343751a0; Stewart PS, 2007, LETT APPL MICROBIOL, V44, P454, DOI 10.1111/j.1472-765X.2007.02112.x; Stewart PS, 2008, NAT REV MICROBIOL, V6, P199, DOI 10.1038/nrmicro1838; Taki M, 2004, J AM CHEM SOC, V126, P712, DOI 10.1021/ja039073j; Tolker-Nielsen T., 2011, CURR PROTOC MICROBIO, DOI [10.1002/9780471729259, DOI 10.1002/9780471729259]; Wang DL, 2005, SPEECH SEPARATION BY HUMANS AND MACHINES, P181, DOI 10.1007/0-387-22794-6_12	40	19	22	2	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2017	292	2					477	487		10.1074/jbc.M116.746743	http://dx.doi.org/10.1074/jbc.M116.746743			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2KN	27899451	hybrid, Green Published			2022-12-26	WOS:000392316100006
J	Grimes, L; Doyle, A; Miller, AL; Pyles, RB; Olah, G; Szabo, C; Hoskins, S; Eaves-Pyles, T				Grimes, Logan; Doyle, Allie; Miller, Aaron L.; Pyles, Richard B.; Olah, Gabor; Szabo, Csaba; Hoskins, Sarah; Eaves-Pyles, Tonyia			Intraluminal Flagellin Differentially Contributes to Gut Dysbiosis and Systemic Inflammation following Burn Injury	PLOS ONE			English	Article							INTESTINAL EPITHELIAL-CELLS; NF-KAPPA-B; TOLL-LIKE RECEPTORS; CROHNS-DISEASE; BOWEL-DISEASE; ANKYLOSING-SPONDYLITIS; BACTERIAL FLAGELLIN; BARRIER FUNCTION; IMMUNE-RESPONSE; THERMAL-INJURY	Burn injury is associated with a loss of gut barrier function, resulting in systemic dissemination of gut-derived bacteria and their products. The bacterial protein and TLR5 agonist, flagellin, induces non-specific innate immune responses. Because we detected flagellin in the serum of burn patients, we investigated whether gut-derived flagellin was a primary or secondary contributor to intestinal dysfunction and systemic inflammation following burn injury. The apical surface of polarized human intestinal epithelial cells (IECs), Caco-2BBe, were exposed to 50 or 500 ng of purified flagellin and 1 x 10(5) of an intestinal E. coli (EC) isolate as follows: 1) flagellin added 30 min prior to EC, 2) flagellin and EC added simultaneously, or 3) EC added 30 min prior to flagellin. Our results showed that luminal flagellin and EC modulated each other's biological actions, which influenced their ability to induce basolateral secretion of inflammatory cytokines and subsequent translocation of bacteria and their products. A low dose of flagellin accompanied by an enteric EC in the lumen, tempered inflammation in a dose-and time-dependent manner. However, higher doses of flagellin acted synergistically with EC to induce both intestinal and systemic inflammation that compromised barrier integrity, increasing systemic inflammation following burn injury, a process we have termed flagellemia. In a murine model of burn injury we found that oral gavage of flagellin (1 mu g/mouse) significantly affected the gut microbiome after burn injury. In these mice, flagellin disseminated out of the intestine into the serum and to distal organs (mesenteric lymph nodes and lungs) where it induced secretion of monocyte chemoattractant protein (MCP-1) and CXCL1/KC (mouse equivalent of human IL-8) at 24 and 48h post-burn. Our results illustrated that gut-derived flagellin alone or accompanied by a non-pathogenic enteric EC strain can function as an initiator of luminal and systemic inflammation following burn injury.	[Grimes, Logan; Doyle, Allie; Hoskins, Sarah; Eaves-Pyles, Tonyia] Univ Texas Med Branch, Dept Microbiol, Galveston, TX 77555 USA; [Grimes, Logan; Doyle, Allie; Hoskins, Sarah; Eaves-Pyles, Tonyia] Univ Texas Med Branch, Dept Immunol, Galveston, TX 77555 USA; [Miller, Aaron L.; Pyles, Richard B.] Univ Texas Med Branch, Pediat, Galveston, TX 77555 USA; [Olah, Gabor; Szabo, Csaba] Univ Texas Med Branch, Anesthesiol, Galveston, TX 77555 USA; [Szabo, Csaba; Eaves-Pyles, Tonyia] Shriners Hosp Children, Galveston, TX 77550 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Eaves-Pyles, T (corresponding author), Univ Texas Med Branch, Dept Microbiol, Galveston, TX 77555 USA.; Eaves-Pyles, T (corresponding author), Univ Texas Med Branch, Dept Immunol, Galveston, TX 77555 USA.; Eaves-Pyles, T (corresponding author), Shriners Hosp Children, Galveston, TX 77550 USA.	tdeavesp@utmb.edu	Szabo, Csaba/ABG-2644-2021		Shriners Hospital for Children [85210]; NIAID T35 training grant [AI078878]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T35AI078878] Funding Source: NIH RePORTER	Shriners Hospital for Children; NIAID T35 training grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Shriners Hospital for Children 85210 to Dr. Tonyia Eaves-Pyles. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Shriners Hospitals for Children grant funding (85210). We would also like to thank NIAID T35 training grant (AI078878; PI L. Soong) for supporting Mr. Grimes during this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank Dr. David Herndon for his input and expertise. Additionally, we are grateful to Ms. Mardelle Susman for her thorough review of this manuscript.	ALEXANDER JW, 1991, ANN SURG, V213, P558, DOI 10.1097/00000658-199106000-00005; ALEXANDER JW, 1990, ANN SURG, V212, P496, DOI 10.1097/00000658-199010000-00012; BARON P, 1994, J SURG RES, V57, P197, DOI 10.1006/jsre.1994.1131; Bernstein CN, 2011, CAN J GASTROENTEROL, V25, P269, DOI 10.1155/2011/712350; Cario E, 2002, AM J PATHOL, V160, P165, DOI 10.1016/S0002-9440(10)64360-X; Costantini TW, 2009, J TRAUMA, V67, P1162, DOI 10.1097/TA.0b013e3181ba3577; Costello ME, 2015, ARTHRITIS RHEUMATOL, V67, P686, DOI 10.1002/art.38967; Costello ME, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4228; Deitch E A, 2001, Curr Opin Crit Care, V7, P92, DOI 10.1097/00075198-200104000-00007; Deitch EA, 2006, FRONT BIOSCI-LANDMRK, V11, P520, DOI 10.2741/1816; Dotan I, 2010, DIGEST DIS, V28, P418, DOI 10.1159/000320396; Duerkop BA, 2013, NAT IMMUNOL, V14, P654, DOI 10.1038/ni.2614; Earley ZM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129996; Eaves-Pyles T, 2001, J IMMUNOL, V166, P1248, DOI 10.4049/jimmunol.166.2.1248; Eaves-Pyles T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024869; Eaves-Pyles T, 2008, INT J MED MICROBIOL, V298, P397, DOI 10.1016/j.ijmm.2007.05.011; EavesPyles T, 1996, J TRAUMA, V41, P1013, DOI 10.1097/00005373-199612000-00012; Finnerty CC, 2008, MOL MED, V14, P553, DOI 10.2119/2007-00132.Finnerty; Foca A, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/326032; Gentry M, 2007, INFECT IMMUN, P101128; Gewirtz AT, 2006, AM J PHYSIOL-GASTR L, V290, pG1157, DOI 10.1152/ajpgi.00544.2005; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Hawrelak Jason A, 2004, Altern Med Rev, V9, P180; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Jeschke MG, 2008, ANN SURG, V248, P387, DOI 10.1097/SLA.0b013e3181856241; Kim JG, 2004, INFECT IMMUN, V72, P1487, DOI 10.1128/IAI.72.3.1487-1495.2004; Liaudet L, 2003, SHOCK, V19, P131, DOI 10.1097/00024382-200302000-00008; Liaudet L, 2002, INFECT IMMUN, V70, P192, DOI 10.1128/IAI.70.1.192-198.2002; Liu G, 2009, NANOSCI TECH, V6, P6, DOI DOI 10.1371/J0URNAL.P0NE.0020928; Maass DL, 2002, SHOCK, V17, P293, DOI 10.1097/00024382-200204000-00009; Magnotti LJ, 2005, J BURN CARE REHABIL, V26, P383, DOI 10.1097/01.bcr.0000176878.79267.e8; Magnotti LJ, 1999, ARCH SURG-CHICAGO, V134, P1333, DOI 10.1001/archsurg.134.12.1333; Martin Rumbo, 2006, FEBS LETT; Matsuoka K, 2015, SEMIN IMMUNOPATHOL, V37, P47, DOI 10.1007/s00281-014-0454-4; Neely CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085623; Neville LF, 2005, INT J MOL MED, V16, P165; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Reeves AE, 2012, INFECT IMMUN, V80, P3786, DOI 10.1128/IAI.00647-12; Rolli J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012687; Rolli J, 2010, CRIT CARE, V14, DOI 10.1186/cc9235; ROUMEN RMH, 1993, ARCH SURG-CHICAGO, V128, P453; Schoepfer AM, 2008, NEUROGASTROENT MOTIL, V20, P1110, DOI 10.1111/j.1365-2982.2008.01166.x; Sigman M, 2013, J BURN CARE RES, V34, P633, DOI 10.1097/BCR.0b013e318280e2f8; Swidsinski A, 2008, INFLAMM BOWEL DIS, V14, P147, DOI 10.1002/ibd.20330; Szabo C, 2003, CRIT CARE MED, V31, pS39, DOI 10.1097/00003246-200301001-00006; Takedatsu H, 2009, GUT, V58, P60, DOI 10.1136/gut.2008.156422; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tallant T, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-33; Varedi M, 1999, AM J PHYSIOL-GASTR L, V277, pG175, DOI 10.1152/ajpgi.1999.277.1.G175; Vijay-Kumar M, 2008, J IMMUNOL, V180, P8280, DOI 10.4049/jimmunol.180.12.8280; Xiao Y, 2014, CELLULAR MOL IMMUNOL, V12, P730; Zagar A, 2015, MBIO, V6, P1; Zhang HS, 2014, APPL ENVIRON MICROB, V80, P7551, DOI 10.1128/AEM.02676-14	53	12	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166770	10.1371/journal.pone.0166770	http://dx.doi.org/10.1371/journal.pone.0166770			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907005	Green Published, gold, Green Submitted			2022-12-26	WOS:000389482700038
J	Hellweger, FL; van Sebille, E; Calfee, BC; Chandler, JW; Zinser, ER; Swan, BK; Fredrick, ND				Hellweger, Ferdi L.; van Sebille, Erik; Calfee, Benjamin C.; Chandler, Jeremy W.; Zinser, Erik R.; Swan, Brandon K.; Fredrick, Neil D.			The Role of Ocean Currents in the Temperature Selection of Plankton: Insights from an Individual-Based Model	PLOS ONE			English	Article							MARINE CYANOBACTERIA PROCHLOROCOCCUS; BIOGEOGRAPHIC PATTERNS; RESOURCE-ALLOCATION; GROWTH; DISTRIBUTIONS; COMMUNITIES; ENVIRONMENT; ADAPTATION; MICROBES; ECOTYPES	Biogeography studies that correlate the observed distribution of organisms to environmental variables are typically based on local conditions. However, in cases with substantial translocation, like planktonic organisms carried by ocean currents, selection may happen upstream and local environmental factors may not be representative of those that shaped the local population. Here we use an individual-based model of microbes in the global surface ocean to explore this effect for temperature. We simulate up to 25 million individual cells belonging to up to 50 species with different temperature optima. Microbes are moved around the globe based on a hydrodynamic model, and grow and die based on local temperature. We quantify the role of currents using the "advective temperature differential" metric, which is the optimum temperature of the most abundant species from the model with advection minus that from the model without advection. This differential depends on the location and can be up to 4 degrees C. Poleward-flowing currents, like the Gulf Stream, generally experience cooling and the differential is positive. We apply our results to three global datasets. For observations of optimum growth temperature of phytoplankton, accounting for the effect of currents leads to a slightly better agreement with observations, but there is large variability and the improvement is not statistically significant. For observed Prochlorococcus ecotype ratios and metagenome nucleotide divergence, accounting for advection improves the correlation significantly, especially in areas with relatively strong poleward or equatorward currents.	[Hellweger, Ferdi L.; Fredrick, Neil D.] Northeastern Univ, Dept Civil & Environm Engn, Boston, MA 02115 USA; [van Sebille, Erik] Imperial Coll London, Grantham Inst, London, England; [van Sebille, Erik] Imperial Coll London, Dept Phys, London, England; [van Sebille, Erik] Univ New South Wales, Climate Change Res Ctr, ARC Ctr Excellence Climate Syst Sci, Sydney, NSW, Australia; [Calfee, Benjamin C.; Chandler, Jeremy W.; Zinser, Erik R.] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA; [Swan, Brandon K.] Bigelow Lab Ocean Sci, East Boothbay, ME USA; [Swan, Brandon K.] Natl Biodef Anal & Countermeasures Ctr, Frederick, MD USA	Northeastern University; Imperial College London; Imperial College London; ARC Centre of Excellence for Climate System Science; University of New South Wales Sydney; University of Tennessee System; University of Tennessee Knoxville; Bigelow Laboratory for Ocean Sciences	Hellweger, FL (corresponding author), Northeastern Univ, Dept Civil & Environm Engn, Boston, MA 02115 USA.	ferdi@coe.neu.edu	Swan, Brandon K/O-9824-2018; van Sebille, Erik/F-6781-2010	Swan, Brandon K/0000-0003-0465-1444; van Sebille, Erik/0000-0003-2041-0704	National Science Foundation (NSF) [DEB-1240894, OCE-1030518, OCE-1232982]; National Oceanic and Atmospheric Administration (NOAA) Massachusetts Institute of Technology SeaGrant; Australian Research Council [DE130101336]	National Science Foundation (NSF)(National Science Foundation (NSF)); National Oceanic and Atmospheric Administration (NOAA) Massachusetts Institute of Technology SeaGrant; Australian Research Council(Australian Research Council)	F.L.H. and N.D.F. were supported by grants from the National Science Foundation (NSF) (DEB-1240894) and National Oceanic and Atmospheric Administration (NOAA) Massachusetts Institute of Technology SeaGrant. E.v.S. was supported by the Australian Research Council (DE130101336). E.R.Z. was supported by the NSF (OCE-1030518). B.K.S. was supported by the NSF (OCE-1232982).; Two anonymous reviewers provided constructive criticism. F.L.H. and N.D.F. were supported by grants from the National Science Foundation (NSF) (DEB- 1240894) and National Oceanic and Atmospheric Administration (NOAA) Massachusetts Institute of Technology SeaGrant. E.v.S. was supported by the Australian Research Council (DE130101336). E.R.Z. was supported by the NSF (OCE-1030518). B.K.S. was supported by the NSF (OCE-1232982).	Agogue H, 2011, MOL ECOL, V20, P258, DOI 10.1111/j.1365-294X.2010.04932.x; Berube PM, 2015, ISME J, V9, P1195, DOI 10.1038/ismej.2014.211; Boyd PW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063091; Brown MV, 2014, MAR GENOM, V15, P17, DOI 10.1016/j.margen.2014.03.002; Brown MV, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.28; Bucci V, 2012, AQUAT ECOL, V46, P101, DOI 10.1007/s10452-011-9384-6; Chandler JW, 2016, ENV MICROBIOLOGY REP; Chen BZ, 2014, MAR ECOL PROG SER, V505, P37, DOI 10.3354/meps10773; Clark JR, 2013, LIMNOL OCEANOGR, V58, P1008, DOI 10.4319/lo.2013.58.3.1008; del Giorgio PA, 2008, PHYSL STRUCTURE SING, P243; Doblin MA, 2016, P NATL ACAD SCI USA, V113, P5700, DOI 10.1073/pnas.1521093113; Ducklow H., 2000, MICROBIAL ECOLOGY OC, P85, DOI DOI 10.1002/9780470281840; Dupont CL, 2012, ISME J, V6, P1186, DOI 10.1038/ismej.2011.189; EPPLEY RW, 1972, FISH B-NOAA, V70, P1063; FALKOWSKI PG, 1981, MAR BIOL, V65, P69, DOI 10.1007/BF00397069; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Flombaum P, 2013, P NATL ACAD SCI USA, V110, P9824, DOI 10.1073/pnas.1307701110; Follows MJ, 2007, SCIENCE, V315, P1843, DOI 10.1126/science.1138544; Fuhrman JA, 2008, AQUAT MICROB ECOL, V53, P69, DOI 10.3354/ame01222; Galand PE, 2010, ISME J, V4, P564, DOI 10.1038/ismej.2009.134; Gianoulis TA, 2009, P NATL ACAD SCI USA, V106, P1374, DOI 10.1073/pnas.0808022106; Hamdan LJ, 2013, ISME J, V7, P685, DOI 10.1038/ismej.2012.143; Hanson CA, 2012, NAT REV MICROBIOL, V10, P497, DOI 10.1038/nrmicro2795; Hellweger FL, 2008, COMPUT GEOSCI-UK, V34, P144, DOI 10.1016/j.cageo.2006.12.006; Hellweger FL, 2014, SCIENCE, V345, P1346, DOI 10.1126/science.1254421; Hellweger FL, 2010, ECOL MODEL, V221, P1620, DOI 10.1016/j.ecolmodel.2010.03.015; Hellweger FL, 2009, ENVIRON MICROBIOL, V11, P1386, DOI 10.1111/j.1462-2920.2009.01866.x; Johnson ZI, 2006, SCIENCE, V311, P1737, DOI 10.1126/science.1118052; Kamennaya NA, 2011, APPL ENVIRON MICROB, V77, P291, DOI 10.1128/AEM.01272-10; Kingsolver JG, 2009, AM NAT, V174, P755, DOI 10.1086/648310; Kirchman DL, 2016, ANNU REV MAR SCI, V8, P285, DOI 10.1146/annurev-marine-122414-033938; Lee Z., 2007, GEOPHYS RES, V112, pC3, DOI DOI 10.1029/2006JC003802; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Levy M., 2014, LIMNOL OCEANOGR, V4, P67, DOI [DOI 10.1146/annurev-marine-120710-100912, 10.1215/21573689-2768549, DOI 10.1215/21573689-2768549]; Martiny AC, 2009, ENVIRON MICROBIOL, V11, P823, DOI 10.1111/j.1462-2920.2008.01803.x; Masumoto Y., 2004, J EARTH SIMULATOR, V1, P35; Moore L, 2005, AQUATIC MICROBIAL EC; Moore LR, 2002, LIMNOL OCEANOGR, V47, P989, DOI 10.4319/lo.2002.47.4.0989; Moore LR, 1999, LIMNOL OCEANOGR, V44, P628, DOI 10.4319/lo.1999.44.3.0628; Nagai T, 2003, MAR ECOL PROG SER, V265, P17, DOI 10.3354/meps265017; Norberg J, 2004, LIMNOL OCEANOGR, V49, P1269, DOI 10.4319/lo.2004.49.4_part_2.1269; Ondov BD, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0997-x; Ottesen EA, 2013, P NATL ACAD SCI USA, V110, pE488, DOI 10.1073/pnas.1222099110; Pommier T, 2012, BIOL LETTERS, V8, P562, DOI 10.1098/rsbl.2011.0990; Ramette A, 2007, MICROB ECOL, V53, P197, DOI 10.1007/s00248-005-5010-2; Rusch DB, 2010, P NATL ACAD SCI USA, V107, P16184, DOI 10.1073/pnas.1009513107; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; SMAYDA THEODORE J., 1958, OIKOS, V9, P158, DOI 10.2307/3564763; Sul WJ, 2013, P NATL ACAD SCI USA, V110, P2342, DOI 10.1073/pnas.1212424110; Swan BK, 2013, P NATL ACAD SCI; Thomas MK, 2016, GLOBAL ECOL BIOGEOGR, V25, P75, DOI 10.1111/geb.12387; Thomas MK, 2012, SCIENCE, V338, P1085, DOI 10.1126/science.1224836; Toseland A, 2013, NAT CLIM CHANGE, V3, P979, DOI 10.1038/NCLIMATE1989; van Sebille E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7521; West NJ, 1999, APPL ENVIRON MICROB, V65, P2585; WEYL PK, 1978, SCIENCE, V202, P475, DOI 10.1126/science.202.4367.475; Woods JD, 2005, PROG OCEANOGR, V67, P84, DOI 10.1016/j.pocean.2005.04.003; Zinser ER, 2007, LIMNOL OCEANOGR, V52, P2205, DOI 10.4319/lo.2007.52.5.2205	58	9	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167010	10.1371/journal.pone.0167010	http://dx.doi.org/10.1371/journal.pone.0167010			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907181	Green Published, Green Submitted, gold			2022-12-26	WOS:000389482700062
J	Irwin, C; van Reenen, M; Mason, S; Mienie, LJ; Westerhuis, JA; Reinecke, CJ				Irwin, Cindy; van Reenen, Mari; Mason, Shayne; Mienie, Lodewyk J.; Westerhuis, Johan A.; Reinecke, Carolus J.			Contribution towards a Metabolite Profile of the Detoxification of Benzoic Acid through Glycine Conjugation: An Intervention Study	PLOS ONE			English	Article							LIVER-MITOCHONDRIA; N-ACYLTRANSFERASE; COA LIGASES; METABOLOMICS; NUTRITION	Benzoic acid is widely used as a preservative in food products and is detoxified in humans through glycine conjugation. Different viewpoints prevail on the physiological significance of the glycine conjugation reaction and concerns have been raised on potential public health consequences following uncontrolled benzoic acid ingestion. We performed a metabolomics study which used commercial benzoic acid containing flavored water as vehicle for designed interventions, and report here on the controlled consumption of the benzoic acid by 21 cases across 6 time points for a total of 126 time points. Metabolomics data from urinary samples analyzed by nuclear magnetic resonance spectroscopy were generated in a time-dependent cross-over study. We used ANOVA-simultaneous component analysis (ASCA), repeated measures analysis of variance (RM-ANOVA) and unfolded principal component analysis (unfolded PCA) to supplement conventional statistical methods to uncover fully the metabolic perturbations due to the xenobiotic intervention, encapsulated in the metabolomics tensor (three-dimensional matrices having cases, spectral areas and time as axes). Identification of the biologically important metabolites by the novel combination of statistical methods proved the power of this approach for metabolomics studies having complex data structures in general. The study disclosed a high degree of inter-individual variation in detoxification of the xenobiotic and revealed metabolic information, indicating that detoxification of benzoic acid through glycine conjugation to hippuric acid does not indicate glycine depletion, but is supplemented by ample glycine regeneration. The observations lend support to the view of maintenance of glycine homeostasis during detoxification. The study indicates also that time-dependent metabolomics investigations, using designed interventions, provide a way of interpreting the variation induced by the different factors of a designed experiment-an approach with potential to advance significantly our understanding of normal and pathophysiological perturbations of endogenous or exogenous origin.	[Irwin, Cindy; van Reenen, Mari; Mason, Shayne; Mienie, Lodewyk J.; Reinecke, Carolus J.] North West Univ, Fac Nat Sci, Ctr Human Metabol, Potchefstroom Campus, Potchefstroom, South Africa; [van Reenen, Mari; Westerhuis, Johan A.] North West Univ, Dept Stat, Fac Nat Sci, Potchefstroom Campus, Potchefstroom, South Africa; [Westerhuis, Johan A.] Univ Amsterdam, Swammerdam Inst Life Sci, Biosyst Data Anal, Amsterdam, Netherlands	North West University - South Africa; North West University - South Africa; University of Amsterdam	Reinecke, CJ (corresponding author), North West Univ, Fac Nat Sci, Ctr Human Metabol, Potchefstroom Campus, Potchefstroom, South Africa.	carools.reinecke@nwu.ac.za		Mienie, Japie/0000-0003-0860-5285; van Wyk, Mari/0000-0002-5856-3258; Mason, Shayne/0000-0002-2945-5768	Technological Innovation Agency (TIA) of the Department of Science and Technology of South Africa; National Research Foundation (NRF) of South Africa	Technological Innovation Agency (TIA) of the Department of Science and Technology of South Africa; National Research Foundation (NRF) of South Africa(National Research Foundation - South Africa)	Research funding for the analytical and computational aspects of the project was provided by the Technological Innovation Agency (TIA) of the Department of Science and Technology of South Africa. CI received a post-graduate bursary from the National Research Foundation (NRF) of South Africa. The views and findings of this investigation are those of the authors and do not reflect or represent any policies of the NRF or TIA funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Research funding for the analytical and computational aspects of the project was provided by the Technological Innovation Agency (TIA) of the Department of Science and Technology of South Africa. CI received a post-graduate bursary from the National Research Foundation (NRF) of South Africa. The views and findings of this investigation are those of the authors and do not reflect or represent any policies of the NRF or TIA funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antti H, 2002, J CHEMOMETR, V16, P461, DOI 10.1002/cem.733; APRISON M. H., 1965, LIFE SCI, V4, P2075, DOI 10.1016/0024-3205(65)90325-5; Badenhorst CPS, 2013, EXPERT OPIN DRUG MET, V9, P1139, DOI 10.1517/17425255.2013.796929; Beyoglu D, 2012, PHARMACOL THERAPEUT, V135, P151, DOI 10.1016/j.pharmthera.2012.05.003; Bouatra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073076; CONTI A, 1977, DRUG METAB REV, V6, P1, DOI 10.3109/03602537708993764; Dona AC, 2014, ANAL CHEM, V86, P9887, DOI 10.1021/ac5025039; Ellinger JJ, 2013, CURR METABOL, V1, P28, DOI 10.2174/2213235X11301010028; Fave G, 2011, METABOLOMICS, V7, P469, DOI 10.1007/s11306-011-0289-0; Fingerhut R, 2003, RAPID COMMUN MASS SP, V17, P717, DOI 10.1002/RCM.966; GATLEY SJ, 1977, BIOCHEM J, V166, P39, DOI 10.1042/bj1660039; Gibney MJ, 2005, AM J CLIN NUTR, V82, P497, DOI 10.1093/ajcn/82.3.497; Hisanaga Y, 2004, J BIOL CHEM, V279, P31717, DOI 10.1074/jbc.M400100200; Holtzclaw WD, 2004, ADV ENZYME REGUL, V44, P335, DOI 10.1016/j.advenzreg.2003.11.013; Jana S, 2009, CURR DRUG METAB, V10, P595, DOI 10.2174/138920009789375379; Knights KM, 2000, CURR DRUG METAB, V1, P49, DOI 10.2174/1389200003339261; Kochan G, 2009, J MOL BIOL, V388, P997, DOI 10.1016/j.jmb.2009.03.064; Lindon JC, 2001, PROG NUCL MAG RES SP, V39, P1, DOI 10.1016/S0079-6565(00)00036-4; Mason S. P., 2010, THESIS; MCGUIRE DM, 1984, J BIOL CHEM, V259, P2034; NANDI DL, 1979, J BIOL CHEM, V254, P7230; Nicholson JK, 2005, NAT REV MICROBIOL, V3, P431, DOI 10.1038/nrmicro1152; Park HW, 2011, J FOOD BIOCHEM, V35, P1034, DOI 10.1111/j.1745-4514.2010.00432.x; Powers R, 2009, MAGN RESON CHEM, V47, pS2, DOI 10.1002/mrc.2461; SCHACHTER D, 1953, J BIOL CHEM, V203, P925; SCHACHTER D, 1954, J BIOL CHEM, V208, P263; Smilde AK, 2005, BIOINFORMATICS, V21, P3043, DOI 10.1093/bioinformatics/bti476; Smith RL, BIOCHEM PHARMACOL, DOI DOI 10.1016/J.BCP.2011.12.031; Tanaka I, 2004, NEUROSCI RES, V49, P165, DOI 10.1016/j.neures.2004.02.007; Vessey DA, 1999, BBA-GEN SUBJECTS, V1428, P455, DOI 10.1016/S0304-4165(99)00088-4; Viant MR, 2009, ENVIRON SCI TECHNOL, V43, P219, DOI 10.1021/es802198z; Villez K, 2009, BIOSYST ENG, V103, P23, DOI 10.1016/j.biosystemseng.2009.01.014; Wen H, 2013, MOL CELL PROTEOMICS, V12, P575, DOI 10.1074/mcp.M112.021352; Wishart DS, 2008, TRENDS FOOD SCI TECH, V19, P482, DOI 10.1016/j.tifs.2008.03.003; Zimniak P, 2008, AGEING RES REV, V7, P281, DOI 10.1016/j.arr.2008.04.001; Zwanenburg G, 2011, J CHEMOMETR, V25, P561, DOI 10.1002/cem.1400	36	13	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167309	10.1371/journal.pone.0167309	http://dx.doi.org/10.1371/journal.pone.0167309			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907139	Green Published, Green Submitted, gold			2022-12-26	WOS:000389482700116
J	Just, S; Raphel, L; Berger, IM; Buhler, A; Kessler, M; Rottbauer, W				Just, Steffen; Raphel, Linda; Berger, Ina M.; Buehler, Anja; Kessler, Mirjam; Rottbauer, Wolfgang			Tbx20 Is an Essential Regulator of Embryonic Heart Growth in Zebrafish	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; MESSENGER-RNA; TBX20-RELATED GENES; PROLIFERATION; CELLS; DIFFERENTIATION; TRANSLATION; TERMINATION; EXPRESSION; DROSOPHILA	The molecular mechanisms that regulate cardiomyocyte proliferation during embryonic heart growth are not completely deciphered yet. In a forward genetic N-ethyl-N-nitrosourea (ENU) mutagenesis screen, we identified the recessive embryonic-lethal zebrafish mutant line weiches herz (whz). Homozygous mutant whz embryos display impaired heart growth due to diminished embryonic cardiomyocyte proliferation resulting in cardiac hypoplasia and weak cardiac contraction. By positional cloning, we found in whz mutant zebrafish a missense mutation within the T-box 20 (Tbx20) transcription factor gene leading to destabilization of Tbx20 protein. Morpholino-mediated knock-down of Tbx20 in wild-type zebrafish embryos phenocopies whz, indicating that the whz phenotype is due to loss of Tbx20 function, thereby leading to significantly reduced cardiomyocyte numbers by impaired proliferation of heart muscle cells. Ectopic overexpression of wild-type Tbx20 in whz mutant embryos restored cardiomyocyte proliferation and heart growth. Interestingly, ectopic overexpression of Tbx20 in wild-type zebrafish embryos resulted, similar to the situation in the embryonic mouse heart, in significantly reduced proliferation rates of ventricular cardiomyocytes, suggesting that Tbx20 activity needs to be tightly fine-tuned to guarantee regular cardiomyocyte proliferation and embryonic heart growth in vivo.	[Just, Steffen; Berger, Ina M.; Buehler, Anja; Rottbauer, Wolfgang] Univ Ulm, Mol Cardiol, Dept Med 2, Ulm, Germany; [Raphel, Linda; Kessler, Mirjam; Rottbauer, Wolfgang] Univ Ulm, Dept Med 2, Ulm, Germany	Ulm University; Ulm University	Just, S; Rottbauer, W (corresponding author), Univ Ulm, Mol Cardiol, Dept Med 2, Ulm, Germany.; Rottbauer, W (corresponding author), Univ Ulm, Dept Med 2, Ulm, Germany.	steffen.just@uniklinik-ulm.de; wolfgang.rottbauer@uniklinik-ulm.de		Buhler, Anja/0000-0003-2927-2379	Deutsche Forschungsgemeinschaft (DFG) [RO2173/3-1, RO2173/3-2, JU2859/2-1]; German Federal Ministry of Education and Research (BMBF) [01ZX1407A]; Insight-DCM [01GS0108, 01GS0420, 01GS0836, 01GS1104, 01KU0901C]; European Union (EU-Inheritance); Ministerium fur Wissenschaft, Forschung and Kunst Baden-Wurttemberg (MWK) Juniorprofessurenprogramm; Boehringer Ingelheim Ulm University BioCenter (BIU)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Insight-DCM; European Union (EU-Inheritance)(European Commission); Ministerium fur Wissenschaft, Forschung and Kunst Baden-Wurttemberg (MWK) Juniorprofessurenprogramm; Boehringer Ingelheim Ulm University BioCenter (BIU)	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) RO2173/3-1 (WR), RO2173/3-2 (WR), JU2859/2-1 (SJ) and the German Federal Ministry of Education and Research (BMBF) (e:Med-SYMBOL-HF grant #01ZX1407A) (SJ) as well as 01GS0108 (WR), 01GS0420 (WR), 01GS0836 (WR) and 01GS1104 (WR) (NGFNplus), and 01KU0901C (WR) Insight-DCM; the European Union (EU-Inheritance) (WR); the Ministerium fur Wissenschaft, Forschung and Kunst Baden-Wurttemberg (MWK) Juniorprofessurenprogramm (SJ) and the Boehringer Ingelheim Ulm University BioCenter (BIU) (WR/SJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Deutsche Forschungsgemeinschaft (DFG) RO2173/3-1 (WR), RO2173/3-2 (WR), JU2859/2-1 (SJ) and the German Federal Ministry of Education and Research (BMBF) (e:Med-SYMBOL-HF grant #01ZX1407A) (SJ) as well as 01GS0108 (WR), 01GS0420 (WR), 01GS0836 (WR) and 01GS1104 (WR) (NGFNplus), and 01KU0901C (WR) Insight-DCM; the European Union (EU-Inheritance) (WR); the Ministerium fur Wissenschaft, Forschung and Kunst Baden-Wurttemberg (MWK) Juniorprofessurenprogramm (SJ) and the Boehringer Ingelheim Ulm University BioCenter (BIU) (WR/SJ).	Akimitsu N, 2008, J BIOCHEM, V143, P1, DOI 10.1093/jb/mvm204; Akimitsu N, 2007, EMBO J, V26, P2327, DOI 10.1038/sj.emboj.7601679; Buhler A, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020187; Chakraborty S, 2012, DEV BIOL, V363, P234, DOI 10.1016/j.ydbio.2011.12.034; Foglia MJ, 2016, DEVELOPMENT, V143, P729, DOI 10.1242/dev.132910; Griffin TJ, 1998, ANAL BIOCHEM, V260, P56, DOI 10.1006/abio.1998.2686; Hamby Stephen E., 2011, Human Genomics, V5, P241; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Hirth S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150323; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; Just S, 2016, BIOCHEM BIOPH RES CO, V477, P581, DOI 10.1016/j.bbrc.2016.06.088; Kikuchi K, 2012, ANNU REV CELL DEV BI, V28, P719, DOI 10.1146/annurev-cellbio-101011-155739; Langenbacher AD, 2011, DEV BIOL, V353, P19, DOI 10.1016/j.ydbio.2011.02.011; Pang SY, 2002, J CLIN ENDOCR METAB, V87, P2556, DOI 10.1210/jc.87.6.2556; Papaioannou VE, 2014, DEVELOPMENT, V141, P3819, DOI 10.1242/dev.104471; Plageman TF, 2005, DEV DYNAM, V232, P11, DOI 10.1002/dvdy.20201; Qian L, 2005, DEV BIOL, V279, P509, DOI 10.1016/j.ydbio.2005.01.013; Reim I, 2005, MECH DEVELOP, V122, P1056, DOI 10.1016/j.mod.2005.04.006; Rottbauer W, 2002, CELL, V111, P661, DOI 10.1016/S0092-8674(02)01112-1; Rottbauer W, 2001, DEV CELL, V1, P265, DOI 10.1016/S1534-5807(01)00023-5; Sahara M, 2015, EMBO J, V34, P710, DOI 10.15252/embj.201490563; Shen T, 2011, J CLIN INVEST, V121, P4640, DOI 10.1172/JCI59472; Singh MK, 2005, DEVELOPMENT, V132, P2697, DOI 10.1242/dev.01854; Soonpaa MH, 2013, BBA-MOL CELL RES, V1833, P799, DOI 10.1016/j.bbamcr.2012.10.029; Stainier DYR, 1996, DEVELOPMENT, V123, P285; Stennard FA, 2005, DEVELOPMENT, V132, P2451, DOI 10.1242/dev.01799; Stennard FA, 2005, DEVELOPMENT, V132, P4897, DOI 10.1242/dev.02099; Szeto DP, 2002, DEVELOPMENT, V129, P5093; Takeuchi JK, 2005, DEVELOPMENT, V132, P2463, DOI 10.1242/dev.01827; Takeuchi JK, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1187; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Torres-Torronteras J, 2011, HUM MUTAT, V32, pE2061, DOI 10.1002/humu.21447; Xiang FL, 2016, CIRCULATION, V133, P1081, DOI 10.1161/CIRCULATIONAHA.115.019357; Xin M, 2013, NAT REV MOL CELL BIO, V14, P529, DOI 10.1038/nrm3619; Zebrowski DC, 2015, ELIFE, V4, DOI 10.7554/eLife.05563; Zhong TP, 2000, SCIENCE, V287, P1820, DOI 10.1126/science.287.5459.1820	36	10	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167306	10.1371/journal.pone.0167306	http://dx.doi.org/10.1371/journal.pone.0167306			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907103	Green Published, Green Submitted, gold			2022-12-26	WOS:000389482700114
J	Kogelman, LJA; Fu, JY; Franke, L; Greve, JW; Hofker, M; Rensen, SS; Kadarmideen, HN				Kogelman, Lisette J. A.; Fu, Jingyuan; Franke, Lude; Greve, Jan Willem; Hofker, Marten; Rensen, Sander S.; Kadarmideen, Haja N.			Inter-Tissue Gene Co-Expression Networks between Metabolically Healthy and Unhealthy Obese Individuals	PLOS ONE			English	Article							TYROSINE-PHOSPHATASE-EPSILON; PROTEIN-KINASE-C; ADIPOSE-TISSUE; SKELETAL-MUSCLE; INSULIN SENSITIVITY; DISEASE; EXPRESSION; LIVER; IL-6; IDENTIFICATION	Background Obesity is associated with severe co-morbidities such as type 2 diabetes and nonalcoholic steatohepatitis. However, studies have shown that 10-25 percent of the severely obese individuals are metabolically healthy. To date, the identification of genetic factors underlying the metabolically healthy obese (MHO) state is limited. Systems genetics approaches have led to the identification of genes and pathways in complex diseases. Here, we have used such approaches across tissues to detect genes and pathways involved in obesity-induced disease development. Methods Expression data of 60 severely obese individuals was accessible, of which 28 individuals were MHO and 32 were metabolically unhealthy obese (MUO). A whole genome expression profile of four tissues was available: liver, muscle, subcutaneous adipose tissue and visceral adipose tissue. Using insulin-related genes, we used the weighted gene co-expression network analysis (WGCNA) method to build within- and inter-tissue gene networks. We identified genes that were differentially connected between MHO and MUO individuals, which were further investigated by homing in on the modules they were active in. To identify potentially causal genes, we integrated genomic and transcriptomic data using an eQTL mapping approach. Results Both IL-6 and IL1B were identified as highly differentially co-expressed genes across tissues between MHO and MUO individuals, showing their potential role in obesity-induced disease development. WGCNA showed that those genes were clustering together within tissues, and further analysis showed different co-expression patterns between MHO and MUO subnetworks. A potential causal role for metabolic differences under similar obesity state was detected for PTPRE, IL-6R and SLC6A5. Conclusions We used a novel integrative approach by integration of co-expression networks across tissues to elucidate genetic factors related to obesity-induced metabolic disease development. The identified genes and their interactions give more insight into the genetic architecture of obesity and the association with co-morbidities.	[Kogelman, Lisette J. A.; Kadarmideen, Haja N.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Large Anim Sci, Frederiksberg, Denmark; [Fu, Jingyuan; Franke, Lude] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Fu, Jingyuan] Univ Groningen, Univ Med Ctr Groningen, Dept Paediat, Groningen, Netherlands; [Greve, Jan Willem] Atrium Med Ctr Parkstad, Dept Gen Surg, Heerlen, Netherlands; [Hofker, Marten] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Pediat Mol Genet, Groningen, Netherlands; [Rensen, Sander S.] Maastricht Univ, Dept Surg, NUTRIM Sch Nutr & Translat Res Metab, Maastricht, Netherlands	University of Copenhagen; University of Groningen; University of Groningen; Atrium Medical Center; University of Groningen; Maastricht University; Maastricht University Medical Centre (MUMC)	Kadarmideen, HN (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Large Anim Sci, Frederiksberg, Denmark.	hajak@sund.ku.dk	Fu, Jingyuan/ABE-6868-2020; Rensen, Sander/J-3224-2019; Fu, Jingyuan/E-8980-2012; Fu, JY/GRR-6179-2022; Kogelman, Lisette/Y-5883-2019; Franke, Lude/P-7036-2016	Fu, Jingyuan/0000-0001-5578-1236; Rensen, Sander/0000-0001-5054-8400; Kogelman, Lisette/0000-0001-9782-7810; Franke, Lude/0000-0002-5159-8802; Kadarmideen, Haja/0000-0001-6294-382X	Biochild project; Programme Commission on Individuals, Disease and Society under the Danish Council for Strategic Research (Innovationsfonden) [0603-00457B]; EU [CIG-293511]	Biochild project; Programme Commission on Individuals, Disease and Society under the Danish Council for Strategic Research (Innovationsfonden); EU(European Commission)	Lisette J. A. Kogelman is funded by a post-doctoral fellowship within Biochild project (http://biochild.ku.dk/) with grant (0603-00457B) from the Programme Commission on Individuals, Disease and Society under the Danish Council for Strategic Research (Innovationsfonden). Haja N. Kadarmideen thanks EU-FP7 Marie Curie Actions - Career Integration Grant (CIG-293511) for partially funding his time spent on this research.; Lisette J.A. Kogelman was funded by a post-doctoral fellowship within Biochild project (http://biochild.ku.dk/) with grant (0603-00457B) from the Programme Commission on Individuals, Disease and Society under the Danish Council for Strategic Research (Innovationsfonden). Haja N. Kadarmideen thanks EU-FP7 Marie Curie Actions-Career Integration Grant (CIG-293511) for partially funding his time spent on this research. The authors thank Dr. Tom Michoel for fruitful discussions and input about the methodology regarding across-tissue network construction. Prof. Wim Buurman is thanked for his role in setting up the cohort of severely obese subjects.	Aga-Mizrachi S, 2008, ENDOCRINOLOGY, V149, P605, DOI 10.1210/en.2007-0908; Ahl S, 2015, J CLIN ENDOCR METAB, V100, P4172, DOI 10.1210/jc.2015-2765; Ahrens M, 2013, CELL METAB, V18, P296, DOI 10.1016/j.cmet.2013.07.004; Argiles JM, 2005, MED RES REV, V25, P49, DOI 10.1002/med.20010; Beretta Martina, 2015, Advances in Biological Regulation, V58, P1, DOI 10.1016/j.jbior.2014.11.004; Bing C, 2015, ADIPOCYTE, V4, P149, DOI 10.4161/21623945.2014.979661; Bluher M, 2010, CURR OPIN LIPIDOL, V21, P38, DOI 10.1097/MOL.0b013e3283346ccc; Bogdanik LP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030217; Bonder MJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-860; de Jong S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039498; Dewey FE, 2011, CIRC-CARDIOVASC GENE, V4, P26, DOI 10.1161/CIRCGENETICS.110.941757; Dobrin R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r55; Eldor R, 2006, DIABETES RES CLIN PR, V74, pS3, DOI 10.1016/j.diabres.2006.06.004; Fehrmann RSN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002197; Fornes A, 2008, BIOCHEM J, V412, P495, DOI 10.1042/BJ20071018; Fu JY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002431; Greenawalt DM, 2011, GENOME RES, V21, P1008, DOI 10.1101/gr.112821.110; Haider S, 2009, NUCLEIC ACIDS RES, V37, pW23, DOI 10.1093/nar/gkp265; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hunter CA, 2015, NAT IMMUNOL, V16, P448, DOI 10.1038/ni.3153; Jager J, 2007, ENDOCRINOLOGY, V148, P241, DOI 10.1210/en.2006-0692; John C, 2002, ENDOCRINOLOGY, V143, P3060, DOI 10.1210/en.143.8.3060; Keller P, 2003, BIOCHEM BIOPH RES CO, V310, P550, DOI 10.1016/j.bbrc.2003.09.048; Kogelman LJA, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-57; Kosicka A, 2013, FASEB J, V27, P368, DOI 10.1096/fj.12-213728; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lavie CJ, 2015, NAT REV ENDOCRINOL, V11, P55, DOI 10.1038/nrendo.2014.165; Marques-Vidal P, 2012, EUR J CLIN NUTR, V66, P426, DOI 10.1038/ejcn.2011.170; Medina-Gomez G, 2005, DIABETES, V54, P1706, DOI 10.2337/diabetes.54.6.1706; Min JL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002505; Mojtaba E, 2011, INT J BIOSCI, V1, P93; Nov O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053626; Olson AL, 2013, HORM MOL BIOL CLIN I, V15, P115, DOI 10.1515/hmbci-2013-0019; Rousso-Noori L, 2011, CELL METAB, V13, P562, DOI 10.1016/j.cmet.2011.02.017; SALANS LB, 1968, J CLIN INVEST, V47, P153, DOI 10.1172/JCI105705; Samdani P, 2015, SCI REP-UK, V5, DOI 10.1038/srep12340; SCHOBITZ B, 1995, FASEB J, V9, P659, DOI 10.1096/fasebj.9.8.7768358; Schultze SM, 2012, EXPERT REV MOL MED, V14, DOI 10.1017/S1462399411002109; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Slawik M, 2007, GENES NUTR, V2, P41, DOI 10.1007/s12263-007-0014-9; Spranger J, 2003, DIABETES, V52, P812, DOI 10.2337/diabetes.52.3.812; Talukdar HA, 2016, CELL SYST, V2, P196, DOI 10.1016/j.cels.2016.02.002; van Vliet-Ostaptchouk JV, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-9; Wallerstedt E, 2010, DIABETOLOGIA, V53, P946, DOI 10.1007/s00125-010-1668-1; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Wolfs MGM, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-34; Wunderlich Claudia M, 2013, JAKSTAT, V2, pe23878, DOI 10.4161/jkst.23878; Wunderlich FT, 2010, CELL METAB, V12, P237, DOI 10.1016/j.cmet.2010.06.011	50	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167519	10.1371/journal.pone.0167519	http://dx.doi.org/10.1371/journal.pone.0167519			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907186	Green Published, gold, Green Submitted			2022-12-26	WOS:000389482700180
J	McDonald, KK; Cooper, S; Danielzak, L; Leask, RL				McDonald, Karli K.; Cooper, Scott; Danielzak, Lisa; Leask, Richard L.			Glycocalyx Degradation Induces a Proinflammatory Phenotype and Increased Leukocyte Adhesion in Cultured Endothelial Cells under Flow	PLOS ONE			English	Article							FLUID SHEAR-STRESS; NITRIC-OXIDE SYNTHASE; IN-VITRO; HEPARAN-SULFATE; VASCULAR ENDOTHELIUM; P-SELECTIN; EXPRESSION; ICAM-1; ATHEROSCLEROSIS; SURFACE	Leukocyte adhesion to the endothelium is an early step in the pathogenesis of atherosclerosis. Effective adhesion requires the binding of leukocytes to their cognate receptors on the surface of endothelial cells. The glycocalyx covers the surface of endothelial cells and is important in the mechanotransduction of shear stress. This study aimed to identify the molecular mechanisms underlying the role of the glycocalyx in leukocyte adhesion under flow. We performed experiments using 3-D cell culture models, exposing human abdominal aortic endothelial cells to steady laminar shear stress (10 dynes/cm(2) for 24 hours). We found that with the enzymatic degradation of the glycocalyx, endothelial cells developed a proinflammatory phenotype when exposed to uniform steady shear stress leading to an increase in leukocyte adhesion. Our results show an up-regulation of ICAM-1 with degradation compared to non-degraded controls (3-fold increase, p<0.05) and we attribute this effect to a de-regulation in NF-kappa B activity in response to flow. These results suggest that the glycocalyx is not solely a physical barrier to adhesion but rather plays an important role in governing the phenotype of endothelial cells, a key determinant in leukocyte adhesion. We provide evidence for how the destabilization of this structure may be an early and defining feature in the initiation of atherosclerosis.	[McDonald, Karli K.; Leask, Richard L.] McGill Univ, Dept Biomed Engn, Montreal, PQ, Canada; [Cooper, Scott; Danielzak, Lisa; Leask, Richard L.] McGill Univ, Dept Chem Engn, Montreal, PQ, Canada	McGill University; McGill University	Leask, RL (corresponding author), McGill Univ, Dept Biomed Engn, Montreal, PQ, Canada.; Leask, RL (corresponding author), McGill Univ, Dept Chem Engn, Montreal, PQ, Canada.	richard.leask@mcgill.ca		Leask, Richard/0000-0002-3649-5127	Canadian Institute of Health Research-Individual Grant [MOP-119292]; Natural Science and Engineering Research Council of Canada-Discovery Grant [RGPIN-261938-13]	Canadian Institute of Health Research-Individual Grant; Natural Science and Engineering Research Council of Canada-Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	Support was provided by Canadian Institute of Health Research-Individual Grant MOP-119292 (to RLL) and the Natural Science and Engineering Research Council of Canada-Discovery Grant RGPIN-261938-13 (to RLL).	ARISAKA T, 1995, ANN NY ACAD SCI, V748, P543; Arnaout MA, 2002, CURR OPIN CELL BIOL, V14, P641, DOI 10.1016/S0955-0674(02)00371-X; ASAKURA T, 1990, CIRC RES, V66, P1045, DOI 10.1161/01.RES.66.4.1045; Chen SQ, 1999, J CELL BIOL, V144, P185, DOI 10.1083/jcb.144.1.185; Chiu JJ, 2004, ARTERIOSCL THROM VAS, V24, P73, DOI 10.1161/01.ATV.0000106321.63667.24; Constantinescu AA, 2003, ARTERIOSCL THROM VAS, V23, P1541, DOI 10.1161/01.ATV.0000085630.24353.3D; Davis ME, 2004, J BIOL CHEM, V279, P163, DOI 10.1074/jbc.M307528200; DECATERINA R, 1995, J CLIN INVEST, V96, P60, DOI 10.1172/JCI118074; Ebong EE, 2011, ARTERIOSCL THROM VAS, V31, P1908, DOI 10.1161/ATVBAHA.111.225268; Falanga A, 1996, BLOOD, V87, P613, DOI 10.1182/blood.V87.2.613.bloodjournal872613; Farcas MA, 2009, BIOMED ENG ONLINE, V8, DOI 10.1186/1475-925X-8-30; Florian JA, 2003, CIRC RES, V93, pE136, DOI 10.1161/01.RES.0000101744.47866.D5; Giantsos-Adams KM, 2013, CELL MOL BIOENG, V6, P160, DOI 10.1007/s12195-013-0273-z; Gimbrone MA, 1999, THROMB HAEMOSTASIS, V82, P722; Grumbach IM, 2005, J MOL CELL CARDIOL, V39, P595, DOI 10.1016/j.yjmcc.2005.06.012; Hay DC, 2003, BBA-MOL CELL RES, V1642, P33, DOI 10.1016/S0167-4889(03)00084-3; Herter J, 2013, J IMMUNOL, V190, P4451, DOI 10.4049/jimmunol.1203179; Imberti B, 2000, MICROVASC RES, V60, P182, DOI 10.1006/mvre.2000.2260; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; KOLLER A, 1993, CIRC RES, V72, P1276, DOI 10.1161/01.RES.72.6.1276; Koo A, 2013, AM J PHYSIOL-CELL PH, V304, pC137, DOI 10.1152/ajpcell.00187.2012; KU DN, 1985, ARTERIOSCLEROSIS, V5, P293, DOI 10.1161/01.ATV.5.3.293; Kunkel EJ, 1998, J IMMUNOL, V161, P2449; Kuwano Y, 2010, BLOOD, V116, P617, DOI 10.1182/blood-2010-01-266122; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Matthews JR, 1996, NUCLEIC ACIDS RES, V24, P2236, DOI 10.1093/nar/24.12.2236; Molteni R, 2009, BLOOD, V114, P1073, DOI 10.1182/blood-2008-10-183699; Moon JJ, 2005, J CELL PHYSIOL, V203, P166, DOI 10.1002/jcp.20220; MORIGI M, 1995, BLOOD, V85, P1696, DOI 10.1182/blood.V85.7.1696.bloodjournal8571696; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Mulivor AW, 2002, AM J PHYSIOL-HEART C, V283, pH1282, DOI 10.1152/ajpheart.00117.2002; NAGEL T, 1994, J CLIN INVEST, V94, P885, DOI 10.1172/JCI117410; OBRIEN KD, 1993, J CLIN INVEST, V92, P945, DOI 10.1172/JCI116670; Pahakis MY, 2007, BIOCHEM BIOPH RES CO, V355, P228, DOI 10.1016/j.bbrc.2007.01.137; Potter DR, 2009, CIRC RES, V104, P1318, DOI 10.1161/CIRCRESAHA.108.191585; Rizzo V, 1998, J BIOL CHEM, V273, P26323, DOI 10.1074/jbc.273.41.26323; Rossi J, 2011, ANN BIOMED ENG, V39, P402, DOI 10.1007/s10439-010-0145-9; Rossi J, 2010, EUR J PHARMACOL, V649, P268, DOI 10.1016/j.ejphar.2010.09.016; Rossi J, 2010, LIFE SCI, V87, P92, DOI 10.1016/j.lfs.2010.05.008; Rouleau L, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4001891; Rouleau L, 2010, ANN BIOMED ENG, V38, P2791, DOI 10.1007/s10439-010-0032-4; Rouleau L, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4001217; Rouleau L, 2010, ANN BIOMED ENG, V38, P1451, DOI 10.1007/s10439-010-9934-4; Shaw SK, 2004, J EXP MED, V200, P1571, DOI 10.1084/jem.20040965; Thi MM, 2004, P NATL ACAD SCI USA, V101, P16483, DOI 10.1073/pnas.0407474101; Traub O, 1998, ARTERIOSCL THROM VAS, V18, P677, DOI 10.1161/01.ATV.18.5.677; TSUBOI H, 1995, BIOCHEM BIOPH RES CO, V206, P988, DOI 10.1006/bbrc.1995.1140; van den Berg BM, 2006, AM J PHYSIOL-HEART C, V290, pH915, DOI 10.1152/ajpheart.00051.2005; WALPOLA PL, 1995, ARTERIOSCL THROM VAS, V15, P2, DOI 10.1161/01.ATV.15.1.2; Yao Y, 2007, AM J PHYSIOL-HEART C, V293, pH1023, DOI 10.1152/ajpheart.00162.2007; Yen WY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117133; Zarbock A, 2011, BLOOD, V118, P6743, DOI 10.1182/blood-2011-07-343566; Zeng Y, 2014, AM J PHYSIOL-HEART C, V306, pH363, DOI 10.1152/ajpheart.00687.2013; Zeng Y, 2013, AM J PHYSIOL-HEART C, V305, pH811, DOI 10.1152/ajpheart.00764.2012; Zeng Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043168	56	55	57	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167576	10.1371/journal.pone.0167576	http://dx.doi.org/10.1371/journal.pone.0167576			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907146	Green Submitted, Green Published, gold			2022-12-26	WOS:000389482700200
J	Minagawa, K; Jamil, MO; Al-Obaidi, M; Pereboeva, L; Salzman, D; Erba, HP; Lamb, LS; Bhatia, R; Mineishi, S; Di Stasi, A				Minagawa, Kentaro; Jamil, Muhammad O.; Al-Obaidi, Mustafa; Pereboeva, Larisa; Salzman, Donna; Erba, Harry P.; Lamb, Lawrence S.; Bhatia, Ravi; Mineishi, Shin; Di Stasi, Antonio			In Vitro Pre-Clinical Validation of Suicide Gene Modified Anti-CD33 Redirected Chimeric Antigen Receptor T-Cells for Acute Myeloid Leukemia	PLOS ONE			English	Article							INDUCED KILLER-CELLS; SAFETY SWITCH; GEMTUZUMAB OZOGAMICIN; ON-TARGET; CASPASE-9; LYMPHOCYTES; DEATH; PHARMACOKINETICS; IMMUNOGLOBULIN; IMMUNOTHERAPY	Background Approximately fifty percent of patients with acute myeloid leukemia can be cured with current therapeutic strategies which include, standard dose chemotherapy for patients at standard risk of relapse as assessed by cytogenetic and molecular analysis, or high-dose chemotherapy with allogeneic hematopoietic stem cell transplant for high-risk patients. Despite allogeneic hematopoietic stem cell transplant about 25% of patients still succumb to disease relapse, therefore, novel strategies are needed to improve the outcome of patients with acute myeloid leukemia. Methods and findings We developed an immunotherapeutic strategy targeting the CD33 myeloid antigen, expressed in similar to 85-90% of patients with acute myeloid leukemia, using chimeric antigen receptor redirected T-cells. Considering that administration of CAR T-cells has been associated with cytokine release syndrome and other potential off-tumor effects in patients, safety measures were here investigated and reported. We genetically modified human activated T-cells from healthy donors or patients with acute myeloid leukemia with retroviral supernatant encoding the inducible Caspase9 suicide gene, a Delta CD19 selectable marker, and a humanized third generation chimeric antigen receptor recognizing human CD33. Delta CD19 selected inducible Caspase9-CAR.CD33 T-cells had a 75 +/- 3.8% (average +/- standard error of the mean) chimeric antigen receptor expression, were able to specifically lyse CD33(+) targets in vitro, including freshly isolated leukemic blasts from patients, produce significant amount of tumor-necrosis-factor-alpha and interferon-gamma, express the CD107a degranulation marker, and proliferate upon antigen specific stimulation. Challenging Delta CD19 selected inducible Caspase9-CAR.CD33 T-cells with programmed-death-ligand-1 enriched leukemia blasts resulted in significant killing like observed for the programmed-death-ligand-1 negative leukemic blasts fraction. Since the administration of 10 nanomolar of a non-therapeutic dimerizer to activate the suicide gene resulted in the elimination of only 76.4 +/- 2.0% gene modified cells in vitro, we found that co-administration of the dimerizer with either the BCL-2 inhibitor ABT-199, the pan-BCL inhibitor ABT-737, or mafosfamide, resulted in an additive effect up to complete cell elimination. Conclusions This strategy could be investigated for the safety of CAR T-cell applications, and targeting CD33 could be used as a "bridge" therapy for patients coming to allogeneic hematopoietic stem cell transplant, as anti-leukemia activity from infusing CAR. CD33 T-cells has been demonstrated in an ongoing clinical trial. Albeit never performed in the clinical setting, our future plan is to investigate the utility of iC9-CAR. CD33 T-cells as part of the conditioning therapy for an allogeneic hematopoietic stem cell transplant for acute myeloid leukemia, together with other myelosuppressive agents, whilst the activation of the inducible Caspase9 suicide gene would grant elimination of the infused gene modified T-cells prior to stem cell infusion to reduce the risk of engraftment failure as the CD33 is also expressed on a proportion of the donor stem cell graft.	[Minagawa, Kentaro; Jamil, Muhammad O.; Al-Obaidi, Mustafa; Pereboeva, Larisa; Salzman, Donna; Erba, Harry P.; Lamb, Lawrence S.; Bhatia, Ravi; Mineishi, Shin; Di Stasi, Antonio] Univ Alabama Birmingham, Hematol Oncol, Birmingham, AL 35294 USA; [Mineishi, Shin] Penn State Hershey Med Ctr, Hematol Oncol, Hershey, PA USA	University of Alabama System; University of Alabama Birmingham; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Di Stasi, A (corresponding author), Univ Alabama Birmingham, Hematol Oncol, Birmingham, AL 35294 USA.	adistasi@uabmc.edu		Minagawa, Kentaro/0000-0003-1740-7109; Lamb, Lawrence/0000-0001-7180-0994				Baev Denis V, 2014, Leuk Res Rep, V3, P79, DOI 10.1016/j.lrr.2014.06.001; Barese CN, 2015, STEM CELLS, V33, P91, DOI 10.1002/stem.1869; Bhatia S, 2014, HEMATOL-AM SOC HEMAT, P495, DOI 10.1182/asheducation-2014.1.495; Buckley SA, 2015, CURR HEMATOL MALIG R, V10, P65, DOI 10.1007/s11899-015-0250-9; Casucci M, 2013, BLOOD, V122, P3461, DOI 10.1182/blood-2013-04-493361; Chang EC, 2016, MOL THER, V24, P736, DOI 10.1038/mt.2015.217; Cheng SS, 2015, INT J BIOL MARKER, V30, pE364, DOI 10.5301/jbm.5000170; de Jonge ME, 2005, CLIN PHARMACOKINET, V44, P1135, DOI 10.2165/00003088-200544110-00003; Di Stasi A, 2011, NEW ENGL J MED, V365, P1673, DOI 10.1056/NEJMoa1106152; Di Stasi A, 2009, BLOOD, V113, P6392, DOI 10.1182/blood-2009-03-209650; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Dutour A, 2012, Adv Hematol, V2012, P683065, DOI 10.1155/2012/683065; ESHHAR Z, 1993, P NATL ACAD SCI USA, V90, P720, DOI 10.1073/pnas.90.2.720; Finkelmeier F, 2016, EUR J CANCER, V59, P152, DOI 10.1016/j.ejca.2016.03.002; Gargett T, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00235; Garrido F, 1997, IMMUNOL TODAY, V18, P89, DOI 10.1016/S0167-5699(96)10075-X; Gill S, 2014, BLOOD, V123, P2343, DOI 10.1182/blood-2013-09-529537; Hu YM, 1998, P NATL ACAD SCI USA, V95, P4386, DOI 10.1073/pnas.95.8.4386; Iuliucci JD, 2001, J CLIN PHARMACOL, V41, P870, DOI 10.1177/00912700122010771; Jan M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004315; Karlsson SCH, 2013, CANCER GENE THER, V20, P386, DOI 10.1038/cgt.2013.35; Kenderian SS, 2015, LEUKEMIA, V29, P1637, DOI 10.1038/leu.2015.52; Krupka C, 2016, LEUKEMIA, V30, P484, DOI 10.1038/leu.2015.214; Mardiros A, 2013, BLOOD, V122, P3138, DOI 10.1182/blood-2012-12-474056; Marin V, 2010, HAEMATOL-HEMATOL J, V95, P2144, DOI 10.3324/haematol.2010.026310; Maus MV, 2013, CANCER IMMUNOL RES, V1, P26, DOI 10.1158/2326-6066.CIR-13-0006; McMillan SJ, 2008, CARBOHYD RES, V343, P2050, DOI 10.1016/j.carres.2008.01.009; Minagawa K, 2015, PHARMACEUTICALS, V8, P230, DOI 10.3390/ph8020230; NAKAHATA T, 1994, LEUKEMIA LYMPHOMA, V13, P401, DOI 10.3109/10428199409049629; Pagano L, 2007, ONCOGENE, V26, P3679, DOI 10.1038/sj.onc.1210364; Pan RQ, 2014, CANCER DISCOV, V4, P362, DOI 10.1158/2159-8290.CD-13-0609; Pearce DJ, 2006, BLOOD, V107, P1166, DOI 10.1182/blood-2005-06-2325; Pizzitola I, 2014, LEUKEMIA, V28, P1596, DOI 10.1038/leu.2014.62; Ritchie DS, 2013, MOL THER, V21, P2122, DOI 10.1038/mt.2013.154; Roberts AW, 2016, NEW ENGL J MED, V374, P311, DOI 10.1056/NEJMoa1513257; Savoldo B, 2007, BLOOD, V110, P2620, DOI 10.1182/blood-2006-11-059139; Srinivasula SM, 2001, NATURE, V410, P112, DOI 10.1038/35065125; Stasi R, 2008, EXPERT OPIN BIOL TH, V8, P527, DOI [10.1517/14712598.8.4.527, 10.1517/14712598.8.4.527 ]; Straathof KC, 2005, BLOOD, V105, P4247, DOI 10.1182/blood-2004-11-4564; Tettamanti S, 2013, BRIT J HAEMATOL, V161, P389, DOI 10.1111/bjh.12282; Thomas S, 2010, IMMUNOLOGY, V129, P170, DOI 10.1111/j.1365-2567.2009.03227.x; Wang L, 2015, ONCOTARGET, V6, P41228, DOI 10.18632/oncotarget.5682; Wang QS, 2015, MOL THER, V23, P184, DOI 10.1038/mt.2014.164; Wilkie S, 2008, J IMMUNOL, V180, P4901, DOI 10.4049/jimmunol.180.7.4901; Zhou Q, 2011, BLOOD, V117, P4501, DOI 10.1182/blood-2010-10-310425; Zhou XO, 2016, MOL THER, V24, P823, DOI 10.1038/mt.2015.234; Zhou XO, 2015, BLOOD, V125, P4103, DOI 10.1182/blood-2015-02-628354; Zhou XO, 2014, BLOOD, V123, P3895, DOI 10.1182/blood-2014-01-551671	48	60	65	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166891	10.1371/journal.pone.0166891	http://dx.doi.org/10.1371/journal.pone.0166891			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907031	Green Submitted, Green Published, gold			2022-12-26	WOS:000389482700049
J	Silva-Freitas, ML; Cota, GF; Machado-De-Assis, TS; Giacoia-Gripp, C; Rabello, A; Da-Cruz, AM; Santos-Oliveira, JR				Silva-Freitas, Maria Luciana; Cota, Glaucia Fernandes; Machado-de-Assis, Talia S.; Giacoia-Gripp, Carmem; Rabello, Ana; Da-Cruz, Alda M.; Santos-Oliveira, Joanna R.			Immune Activation and Bacterial Translocation: A Link between Impaired Immune Recovery and Frequent Visceral Leishmaniasis Relapses in HIV-Infected Patients	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; MICROBIAL TRANSLOCATION; TIME; COINFECTION; DEPLETION; LESIONS; AIDS	The maintenance of chronic immune activation due to leishmaniasis or even due to microbial translocation is associated with immunosenescence and may contribute to frequent relapses. Our aim was to investigate whether patients with HIV-associated visceral leishmaniasis (VL/HIV) who experience a single episode of VL have different immunological behaviors in comparison to those who experience frequent relapses. VL/HIV patients were allocated to non-relapsing (NR, n = 6) and relapsing (R, n = 11) groups and were followed from the active phase of VL up to 12 months post-treatment (mpt). The patients were receiving highly active antiretroviral therapy (HAART) and secondary prophylaxis after VL therapy. During active VL, the two groups were similar in all immunological parameters, including the parasite load. At 6 and 12 mpt, the NR group showed a significant gain of CD4(+) T cells, a reduction of lymphocyte activation, and lower soluble CD14 and anti-Leishmania IgG3 levels compared to the R group. The viral load remained low, without correlation with the activation. The two groups showed elevated but similar percentages of senescent T cells. These findings suggest a decreased ability of the R group to downmodulate immune activation compared to the NR group. Such functional impairment of the effector response may be a useful indicator for predicting clinical prognosis and recommending starting or stopping secondary prophylaxis.	[Silva-Freitas, Maria Luciana; Da-Cruz, Alda M.; Santos-Oliveira, Joanna R.] Fiocruz MS, Inst Oswaldo Cruz, Lab Interdisciplinar Pesquisas Med, Rio De Janeiro, Rio De Janeiro, Brazil; [Cota, Glaucia Fernandes; Machado-de-Assis, Talia S.; Rabello, Ana] Fiocruz MS, Lab Pesquisas Clin & Polit Publ Doencas Infeccios, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil; [Cota, Glaucia Fernandes; Machado-de-Assis, Talia S.] Hosp Eduardo de Menezes, Fundacao Hosp Estado Minas Gerais, FHEMIG, Belo Horizonte, MG, Brazil; [Giacoia-Gripp, Carmem] Fiocruz MS, Inst Oswaldo Cruz, Lab AIDS & Imunol, Rio De Janeiro, Rio De Janeiro, Brazil; [Santos-Oliveira, Joanna R.] IFRJ, Inst Fed Educ Ciencia & Tecnol, Nucleo Ciencias Biomed Aplicadas, Rio De Janeiro, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Instituto Federal do Rio de Janeiro (IFRJ); Instituto Federal do Sertao Pernambucano	Santos-Oliveira, JR (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Interdisciplinar Pesquisas Med, Rio De Janeiro, Rio De Janeiro, Brazil.; Santos-Oliveira, JR (corresponding author), IFRJ, Inst Fed Educ Ciencia & Tecnol, Nucleo Ciencias Biomed Aplicadas, Rio De Janeiro, Rio De Janeiro, Brazil.	joannareisoliveira@gmail.com	Cota, Glaucia/ABC-5378-2020; Da-Cruz, Alda Maria/J-2152-2012	Cota, Glaucia/0000-0003-0538-7403; 	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ [E-26/111.443/2013]; Instituto Oswaldo Cruze FIOCRUZ; Conselho Nacional de Desenvolvimento Cientifico e tecnologico - CNPq	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Instituto Oswaldo Cruze FIOCRUZ; Conselho Nacional de Desenvolvimento Cientifico e tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Support was provided by: 1- Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ, http://www.faperj.br/ (E-26/111.443/2013) - JRSO; 2- Instituto Oswaldo Cruze FIOCRUZ - http://www.fiocruz.br/ioc/cgi/cgilua.exe/sys/start.htm?tpl=home (Fellowship - MLSF); 3- Conselho Nacional de Desenvolvimento Cientifico e tecnologico - CNPq, http://cnpq.br/ (Fellowship - AMD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemayehu M, 2016, HIV AIDS-RES PALLIAT, V8, P75, DOI 10.2147/HIV.S96883; Alexandrino-de-Oliveira P, 2010, MEM I OSWALDO CRUZ, V105, P692, DOI 10.1590/S0074-02762010000500016; Alvar J, 2008, CLIN MICROBIOL REV, V21, P334, DOI 10.1128/CMR.00061-07; Appay V, 2008, J PATHOL, V214, P231, DOI 10.1002/path.2276; Baba Chalamalasetty Sreenivasa, 2006, Indian J Gastroenterol, V25, P309; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Casado JL, 2015, HIV MED, V16, P240, DOI 10.1111/hiv.12206; Casado JL, 2001, EUR J CLIN MICROBIOL, V20, P202, DOI 10.1007/s100960100457; Chou J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054676; Cota GF, 2011, PLOS NEGLECT TROP D, V5, P1; Cota GF, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002816; Cota GF, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002195; Cota GF, 2013, AM J TROP MED HYG, V89, P570, DOI 10.4269/ajtmh.13-0239; Cruz I, 2006, INDIAN J MED RES, V123, P357; Da-Cruz AM, 2000, T ROY SOC TROP MED H, V94, P569, DOI 10.1016/S0035-9203(00)90090-7; de la Rosa R, 2001, CLIN INFECT DIS, V32, P633, DOI 10.1086/318708; Deeks SG, 2012, CURR OPIN IMMUNOL, V24, P501, DOI 10.1016/j.coi.2012.05.004; del Giudice P, 2002, J INFECT DIS, V186, P1366, DOI 10.1086/344325; Demarchi IG, 2012, PARASITOL INT, V61, P538, DOI 10.1016/j.parint.2012.04.006; Fagundes-Silva GA, 2012, PARASITE IMMUNOL, V34, P486, DOI 10.1111/j.1365-3024.2012.01379.x; Gomes LI, 2012, EXP PARASITOL, V131, P175, DOI 10.1016/j.exppara.2012.03.021; Senent SG, 2009, GASTROENTEROL HEPATO, V32, P176, DOI 10.1016/j.gastrohep.2008.09.021; Hicks L, 2009, EUR J GASTROEN HEPAT, V21, P117, DOI 10.1097/MEG.0b013e32830e6fdb; Kaushal H, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0653-6; Klatt NR, 2013, TRENDS MICROBIOL, V21, P6, DOI 10.1016/j.tim.2012.09.001; Lindoso JA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003136; Luz KG, 2010, REV SOC BRAS MED TRO, V43, P393, DOI 10.1590/S0037-86822010000400011; Marchetti G, 2013, CLIN MICROBIOL REV, V26, P2, DOI 10.1128/CMR.00050-12; Medrano FJ, 1998, CLIN EXP IMMUNOL, V114, P403; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; Monge-Maillo B, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003021; Okwor I, 2013, IMMUNOL RES, V56, P163, DOI 10.1007/s12026-013-8389-8; Overbergh L, 1999, CYTOKINE, V11, P305, DOI 10.1006/cyto.1998.0426; Peruhype-Magalhaes V, 2006, CLIN EXP IMMUNOL, V146, P124, DOI 10.1111/j.1365-2249.2006.03171.x; Santos LO, 2013, J ANTIMICROB CHEMOTH, V68, P348, DOI 10.1093/jac/dks410; Santos-Oliveira JR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001198; Santos-Oliveira JR, 2013, J INFECT DIS, V208, P57, DOI 10.1093/infdis/jit135; Santos-Oliveira JR, 2011, AM J TROP MED HYG, V85, P55, DOI 10.4269/ajtmh.2011.10-0398; Santos-Oliveira JR, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-358; Serrano-Villar S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085798; Villanueva JL, 2000, EUR J CLIN MICROBIOL, V19, P798, DOI 10.1007/s100960000364; Wortmann G, 2001, AM J TROP MED HYG, V65, P583, DOI 10.4269/ajtmh.2001.65.583; Zijlstra EE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003258	44	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167512	10.1371/journal.pone.0167512	http://dx.doi.org/10.1371/journal.pone.0167512			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907136	Green Submitted, Green Published, gold			2022-12-26	WOS:000389482700177
J	Lallawmsanga; Passari, AK; Mishra, VK; Leo, VV; Singh, BP; Meyyappan, GV; Gupta, VK; Uthandi, S; Upadhyay, RC				Lallawmsanga; Passari, Ajit Kumar; Mishra, Vineet Kumar; Leo, Vincent Vineeth; Singh, Bhim Pratap; Meyyappan, Geetha Valliammai; Gupta, Vijai Kumar; Uthandi, Sivakumar; Upadhyay, Ramesh Chandra			Antimicrobial Potential, Identification and Phylogenetic Affiliation of Wild Mushrooms from Two Sub-Tropical Semi-Evergreen Indian Forest Ecosystems	PLOS ONE			English	Article							SIMPLE SEQUENCE REPEAT; EDIBLE MUSHROOMS; AURICULARIA-AURICULA; GENETIC DIVERSITY; LENTINULA-EDODES; BIOACTIVE COMPOUNDS; CULTIVATED STRAINS; ANTIOXIDANT; CHINA; RAPD	The diversity of wild mushrooms was investigated from two protected forest areas in India and 231 mushroom specimens were morphologically identified. Among them, 76 isolates were screened for their antimicrobial potential against seven bacterial and fungal pathogens. Out of 76 isolates, 45 isolates which displayed significant antimicrobial activities were identified using ITS rRNA gene amplification and subsequently phylogenetically characterized using random amplified polymorphic DNA (RAPD) and inter-simple sequence repeat (ISSR) markers. Sequencing of the ITS rRNA region classified the isolates into 16 genera belonging to 11 families. In total, 11 RAPD and 10 ISSR primers were selected to evaluate genetic diversity based on their banding profile produced. In total 337 RAPD and 312 ISSR bands were detected, among which percentage of polymorphism ranges from 34.2% to 78.8% and 38.6% to 92.4% by using RAPD and ISSR primers respectively. Unweighted Pair-Group Method with Arithmetic Mean (UPGMA) trees of selected two methods were structured similarly, grouping the 46 isolates into two clusters which clearly showed a significant genetic distance among the different strains of wild mushroom, with an similarity coefficient ranges from 0.58 to 1.00 and 0.59 to 1.00 with RAPD and ISSR analysis respectively. This reporthas highlighted both DTR and MNP forests provide a habitat for diverse macrofungal species, therefore having the potential to be used for the discovery of antimicrobials. The report has also demonstrated that both RAPD and ISSR could efficiently differentiate wild mushrooms and could thus be considered as efficient markers for surveying genetic diversity. Additionally, selected six wild edible mushroom strains (Schizophyllum commune BPSM01, Panusgiganteus BPSM27, Pleurotussp. BPSM34, Lentinussp. BPSM37, Pleurotusdjamor BPSM41 and Lentinula sp. BPSM45) were analysed for their nutritional (proteins, carbohydrates, fat and ash content), antioxidant potential. The present findings also suggested that the wild edible mushroom strains do not have only nutritional values but also can be used as an accessible source of natural antioxidants.	[Lallawmsanga; Passari, Ajit Kumar; Mishra, Vineet Kumar; Leo, Vincent Vineeth; Singh, Bhim Pratap] Mizoram Univ, Dept Biotechnol, Mol Microbiol & Systemat Lab, Mizoram, India; [Gupta, Vijai Kumar] Natl Univ Ireland Galway, Dept Biochem, Mol Glycobiotechnol Grp, Galway, Ireland; [Meyyappan, Geetha Valliammai; Uthandi, Sivakumar] Tamil Nadu Agr Univ, Dept Agr Microbiol, Coimbatore, Tamil Nadu, India; [Upadhyay, Ramesh Chandra] ICAR Res Complex, Directorate Mushroom Res, Solan, Himachal Prades, India	Mizoram University; Ollscoil na Gaillimhe-University of Galway; Tamil Nadu Agricultural University; Indian Council of Agricultural Research (ICAR); ICAR - Directorate of Mushroom Research	Singh, BP (corresponding author), Mizoram Univ, Dept Biotechnol, Mol Microbiol & Systemat Lab, Mizoram, India.	bhimpratap@gmail.com	Uthandi, Sivakumar/C-3277-2018; Gupta, Vijai Kumar/O-2445-2014; Singh, Bhim Pratap/G-7268-2016; Passari, Ajit Kumar/X-9807-2019	Uthandi, Sivakumar/0000-0002-7116-1317; Gupta, Vijai Kumar/0000-0003-1565-5918; Singh, Bhim Pratap/0000-0002-9911-4125; Passari, Ajit Kumar/0000-0002-1150-8075; Leo, Vincent Vineeth/0000-0003-1700-2259; LALLAWMSANGA, LALLAWMSANGA/0000-0002-7179-7892	DBT sponsored NER-Twinning project, the Government of India, New Delhi [BT/320/NE/TBP/2012]	DBT sponsored NER-Twinning project, the Government of India, New Delhi	This work was supported by grants sanctioned to BPS from the DBT sponsored NER-Twinning project (No. BT/320/NE/TBP/2012), the Government of India, New Delhi. Authors are thankful to the Department of Biotechnology, for establishment of DBT-BIF centre and DBT-State Biotech Hub in the Department, which has beenused for the present study.	Acharya Krishnendu, 2004, Indian Journal of Experimental Biology, V42, P538; Agrahar-Murugkar D, 2005, FOOD CHEM, V89, P599, DOI 10.1016/j.foodchem.2004.03.042; Andrew E. E., 2013, Journal of Ecology and the Natural Environment, V5, P318; Angelini P, 2016, PLANT BIOSYST, V150, P540, DOI 10.1080/11263504.2014.987844; [Anonymous], 1994, NREL CAT TASK LAB AN; Barros L, 2007, EUR FOOD RES TECHNOL, V225, P151, DOI 10.1007/s00217-006-0394-x; Barua P, 1998, Anc Sci Life, V17, P190; Begerow D, 2010, APPL MICROBIOL BIOT, V87, P99, DOI 10.1007/s00253-010-2585-4; Bhunia SK, 2010, CARBOHYD RES, V345, P2542, DOI 10.1016/j.carres.2010.09.015; Bisht NS, 2011, WOOD DECAYING FUNGI; Bolla K., 2011, International Journal of Agricultural Technology, V7, P957; Borchers AT, 2008, EXP BIOL MED, V233, P259, DOI 10.3181/0708-MR-227; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cai M, 2015, INT J MED MUSHROOMS, V17, P591, DOI 10.1615/IntJMedMushrooms.v17.i6.90; Calvo-Bado L, 2000, APPL ENVIRON MICROB, V66, P728, DOI 10.1128/AEM.66.2.728-734.2000; CENIS JL, 1992, NUCLEIC ACIDS RES, V20, P2380, DOI 10.1093/nar/20.9.2380; Chang CC, 2002, J FOOD DRUG ANAL, V10, P178; Chang S. T., 2003, Current Topics in Nutraceutical Research, V1, P257; Chang ST, 2004, MUSHROOMS CULTIVATIO, P189; Chiu SW, 1996, MYCOL RES, V100, P1393, DOI 10.1016/S0953-7562(96)80069-4; Chowdhury MMH, 2015, ANN CLIN MICROB ANTI, V14, DOI 10.1186/s12941-015-0067-3; Das Sudip Kumar, 2015, Proceedings of the Indian National Science Academy Part B Biological Sciences, V85, P219, DOI 10.1007/s40011-014-0330-y; Dentinger BTM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025081; Du P, 2013, BIOCHEM SYST ECOL, V48, P199, DOI 10.1016/j.bse.2012.11.011; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Dursun N, 2006, J SCI FOOD AGR, V86, P1087, DOI 10.1002/jsfa.2462; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fernandes A, 2016, LWT-FOOD SCI TECHNOL, V69, P91, DOI 10.1016/j.lwt.2016.01.037; Ferreira ICFR, 2009, CURR MED CHEM, V16, P1543, DOI 10.2174/092986709787909587; FOLCH J, 1957, J BIOL CHEM, V226, P497; Guan XJ, 2008, WORLD J MICROB BIOT, V24, P1617, DOI 10.1007/s11274-007-9647-5; Hrudayanath Thatoi, 2014, African Journal of Biotechnology, V13, P523; Hseu RS, 1996, APPL ENVIRON MICROB, V62, P1354, DOI 10.1128/AEM.62.4.1354-1363.1996; Ishikawa NK, 2001, BRAZ J MICROBIOL, V32, P206, DOI 10.1590/S1517-83822001000300008; Islam T, 2016, LWT-FOOD SCI TECHNOL, V72, P423, DOI 10.1016/j.lwt.2016.05.005; Jagadeesh R, 2010, INT J MICROBIOL RES, V1, P110; Jagadish LK, 2009, AFR J BIOTECHNOL, V8, P654; Jose Nayana, 2002, International Journal of Medicinal Mushrooms, V4, P329; Kanaya N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026654; Khaund P, 2014, J KOREAN SOC APPL BI, V57, P263, DOI 10.1007/s13765-013-4225-z; Kosanic M, 2016, J FOOD DRUG ANAL, V24, P477, DOI 10.1016/j.jfda.2016.01.008; Krishna G, 2015, J MYCOL, DOI [10.1155/2015/382476, DOI 10.1155/2015/382476]; Kristensen HL, 2012, FOOD NUTR RES, V56, DOI 10.3402/fnr.v56i0.7114; Kusari P, 2013, FUNGAL DIVERS, V60, P137, DOI 10.1007/s13225-012-0216-3; Largent DL, 1986, IDENTIFY MUSHROOMS G, P1; Lee JS, 2006, J MICROBIOL, V44, P29; Liang HH, 2008, J MICROBIOL, V46, P549, DOI 10.1007/s12275-008-0107-1; Mahendra Rai, 2005, Natural Product Radiance, V4, P246; Manjunathan J., 2010, International Journal of PharmTech Research, V2, P1910; Mattila P, 2000, NUTRITION, V16, P694, DOI 10.1016/S0899-9007(00)00341-5; Metuku RP, 2014, 3 BIOTECH, V4, P227, DOI 10.1007/s13205-013-0138-0; Miles LA, 2012, BIOCONTROL, V57, P697, DOI 10.1007/s10526-012-9442-6; Moon JK, 2009, J AGR FOOD CHEM, V57, P1655, DOI 10.1021/jf803537k; Moore AJ, 2001, APPL MICROBIOL BIOT, V55, P742, DOI 10.1007/s002530000588; Munkhgerell L., 2013, MONGOLIAN J CHEM, V14, P41, DOI DOI 10.5564/MJC.V14I0.197; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nilsson RH, 2008, EVOL BIOINFORM, V4, P193; Nowacka N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140355; Olukanni OD, 2006, AFR J BIOTECHNOL, V5, P1980; Osman M, 2014, J CHEM BIOPHYSCI B, V5, P545; Oyetayo VO, 2009, TROP J PHARM RES, V6, P809; Park HG, 2004, J MICROBIOL BIOTECHN, V14, P816; PATERSON AH, 1991, ADV AGRON, V46, P39; Rajaratnam S, 2012, EUROPEAN J EXPT BIOL, V2, P369; Ramberg JE, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-54; Ramesh C, 2010, PHARMACOGN RES, V2, P107, DOI 10.4103/0974-8490.62953; Ramirez Lucia, 2000, International Microbiology, V3, P147; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Reis FS, 2011, J FOOD SCI, V76, pC824, DOI 10.1111/j.1750-3841.2011.02251.x; Ro HS, 2007, MYCOL RES, V111, P710, DOI 10.1016/j.mycres.2007.03.016; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Seifert KA, 2009, MOL ECOL RESOUR, V9, P83, DOI 10.1111/j.1755-0998.2009.02635.x; Singleton VL, 1999, METHOD ENZYMOL, V299, P152; Sliva D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047873; Smolskaite L, 2015, LWT-FOOD SCI TECHNOL, V60, P462, DOI 10.1016/j.lwt.2014.08.007; Sneath Peter H.A, 1973, NUMERICAL TAXONOMY; Tambekar D. H., 2006, IJP - International Journal of Pharmacology, V2, P582; Tamrakar S, 2016, J NAT MED-TOKYO, V70, P769, DOI 10.1007/s11418-016-1013-1; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang LH, 2010, CURR MICROBIOL, V61, P132, DOI 10.1007/s00284-010-9587-4; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tibuhwa DD, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-49; Udu-Ibiam OE, 2014, INT J SCI TECH RES, V3; Vialle A, 2009, MOL ECOL RESOUR, V9, P99, DOI 10.1111/j.1755-0998.2009.02637.x; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wong JY, 2009, J FOOD COMPOS ANAL, V22, P269, DOI 10.1016/j.jfca.2008.11.021; Yan PS, 2004, WORLD J MICROB BIOT, V20, P795, DOI 10.1007/s11274-004-5840-y; Yin YG, 2014, CURR MICROBIOL, V68, P397, DOI 10.1007/s00284-013-0489-0; Yu MY, 2008, CURR MICROBIOL, V56, P240, DOI 10.1007/s00284-007-9067-7; Yuan ZM, 1998, J NUTR SCI VITAMINOL, V44, P829, DOI 10.3177/jnsv.44.829; Zhang RY, 2007, APPL MICROBIOL BIOT, V74, P140, DOI 10.1007/s00253-006-0628-7; ZIETKIEWICZ E, 1994, GENOMICS, V20, P176, DOI 10.1006/geno.1994.1151	92	12	12	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0166368	10.1371/journal.pone.0166368	http://dx.doi.org/10.1371/journal.pone.0166368			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902725	Green Published, Green Submitted, gold			2022-12-26	WOS:000389474100022
J	Chen, SY; Wen, XA; Zhang, WX; Wang, C; Liu, J; Liu, C				Chen, Siyu; Wen, Xiaoan; Zhang, Wenxiang; Wang, Chen; Liu, Jun; Liu, Chang			Hypolipidemic effect of oleanolic acid is mediated by the miR-98-5p/PGC-1 beta axis in high-fat diet-induced hyperlipidemic mice	FASEB JOURNAL			English	Article						triterpenoid compound; lipid-lowering function; liver; molecular target; miRNA	INDUCED DIABETIC-RATS; INSULIN-RESISTANCE; URSOLIC ACID; SERUM-LIPIDS; PGC-1-BETA; LIPOPROTEINS; ANTIOXIDANT; METABOLISM; SECRETION; CELLS	Oleanolic acid (OA) is an active component of the traditional Chinese herb Olea europaea L. and has been found to exhibit a significant lipid-lowering effect; however, its direct molecular target is still unknown, which limits its clinical application and the possible structure modification to improve its beneficial functions. In this regard, we carried out the present study to identify potential hepatic targets of OA to mediate its lipid-lowering effect. We found that both acute and chronic OA treatments reduced serum levels of triglycerides, total cholesterol, and LDL cholesterol, and decreased hepatic expression levels of peroxisome proliferator-activated receptor- gamma coactivator-1 beta (PGC-1 beta), which is an important regulator in maintaining hepatic lipid homeostasis, and its down stream target genes. Of note, liver-specific knockdown of PGC-1 beta recapitulated the hypolipidemic effects of OA. At the molecular level, OA accelerated mRNA degradation of PGC-1 beta. Microarray analysis revealed a host of microRNAs that potentially mediate OA-induced PGC-1 beta mRNA degradation, among which, miR-98-5p significantly inhibited activity of Pgc-1 beta 3 ' UTR as well as PGC-1 beta expression and promoted its mRNA degradation. Conversely, miR-98-5p inhibitors blunted the inhibitory effects of OA on PGC-1 beta expression. Collectively, our data demonstrated that OA ameliorated hyperlipidemia, likely via regulation of the miR-98-5p/ PGC-1 beta axis.	[Chen, Siyu; Wen, Xiaoan; Liu, Jun; Liu, Chang] China Pharmaceut Univ, State Key Lab Nat Med, Jiangsu Key Lab Drug Discovery Metab Dis, Nanjing, Peoples R China; [Zhang, Wenxiang; Liu, Chang] China Pharmaceut Univ, Sch Life Sci, Nanjing, Peoples R China; [Chen, Siyu] Nanjing Med Univ, Jiangsu Key Lab Human Funct Gen, Nanjing, Jiangsu, Peoples R China; [Liu, Chang] Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Mol & Med Biotechnol, Nanjing, Peoples R China	China Pharmaceutical University; China Pharmaceutical University; Nanjing Medical University; Nanjing Normal University	Liu, C (corresponding author), China Pharmaceut Univ, 24 Tongjiaxiang St, Nanjing 210009, Jiangsu, Peoples R China.; Liu, C (corresponding author), China Pharmaceut Univ, 639 Longmian Ave, Nanjing 211198, Jiangsu, Peoples R China.	changliu@njnu.edu.cn		Zhang, Wenxiang/0000-0002-1077-8014; Chen, Siyu/0000-0002-3809-1062	National Basic Research Program of China (973 Program) [2013CB911600]; National Natural Science Foundation of China [31422028, 31271261, 31401009, 81373303, 81473080, 81573299]; Ten Thousand Talents Program; Natural Science Foundation of Jiangsu Province of China [BK20140041]; Six Talents Summit Project; 333 Talents Project [BRA2015323]; Jiangsu Postdoctoral Research Funding Plan [1601020A]; Collaborative Innovation Center for Cardiovascular Disease Translational Medicine (Nanjing Medical University); Priority Academic Program Development of Jiangsu Higher Education Institutions	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ten Thousand Talents Program; Natural Science Foundation of Jiangsu Province of China(Natural Science Foundation of Jiangsu Province); Six Talents Summit Project; 333 Talents Project; Jiangsu Postdoctoral Research Funding Plan; Collaborative Innovation Center for Cardiovascular Disease Translational Medicine (Nanjing Medical University); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work is supported by grants from the National Basic Research Program of China (973 Program; 2013CB911600), the National Natural Science Foundation of China (31422028, 31271261, 31401009, 81373303, 81473080, and 81573299), Ten Thousand Talents Program, Natural Science Foundation of Jiangsu Province of China (BK20140041), Six Talents Summit Project, 333 Talents Project (BRA2015323), Jiangsu Postdoctoral Research Funding Plan (1601020A), the Collaborative Innovation Center for Cardiovascular Disease Translational Medicine (Nanjing Medical University), and the Priority Academic Program Development of Jiangsu Higher Education Institutions. The authors declare no conflicts of interest.	Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; BISGAIER CL, 1983, ANNU REV PHYSIOL, V45, P625, DOI 10.1146/annurev.ph.45.030183.003205; Bogdanova Katerina, 2007, Biomedical Papers (Olomouc), V151, P237; Carrer M, 2012, P NATL ACAD SCI USA, V109, P15330, DOI 10.1073/pnas.1207605109; de Melo CL, 2010, CHEM-BIOL INTERACT, V185, P59, DOI 10.1016/j.cbi.2010.02.028; DUNN FL, 1990, DIABETES METAB REV, V6, P47, DOI 10.1002/dmr.5610060103; Farnier M, 1998, AM J CARDIOL, V82, p3J, DOI 10.1016/S0002-9149(98)00423-8; Farnier M, 2007, AM HEART J, V153, DOI 10.1016/j.ahj.2006.10.031; Fazio Sergio, 2004, Curr Atheroscler Rep, V6, P148, DOI 10.1007/s11883-004-0104-8; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fujita H, 2015, EMBO J, V34, P1042, DOI 10.15252/embj.201489897; Gao DW, 2009, PHYTOTHER RES, V23, P1257, DOI 10.1002/ptr.2603; Ge X, 2015, INT J MOL SCI, V16, P28180, DOI 10.3390/ijms161226093; Goldberg A, 2000, AM J CARDIOL, V85, P1100, DOI 10.1016/S0002-9149(00)00703-7; Golomb BA, 2008, AM J CARDIOVASC DRUG, V8, P373, DOI 10.2165/0129784-200808060-00004; Haffner SM, 1999, AM J CARDIOL, V83, p17F; Hemandez C, 2010, CELL METAB, V12, P411, DOI 10.1016/j.cmet.2010.09.001; Jeong HG, 1999, TOXICOL LETT, V105, P215, DOI 10.1016/S0378-4274(99)00004-1; Kang JS, 2014, BIOORG MED CHEM LETT, V24, P4763, DOI 10.1016/j.bmcl.2014.07.005; Kawano Y, 2013, J GASTROENTEROL, V48, P434, DOI 10.1007/s00535-013-0758-5; Kelly TJ, 2009, J BIOL CHEM, V284, P19945, DOI 10.1074/jbc.M109.015164; Kim DH, 2005, ARCH PHARM RES, V28, P550, DOI 10.1007/BF02977757; Kim HS, 2014, EXP BIOL MED, V239, P284, DOI 10.1177/1535370213514511; Kim YD, 2008, DIABETES, V57, P306, DOI 10.2337/db07-0381; Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043; Liu C, 2011, ACTA BIOCH BIOPH SIN, V43, P248, DOI 10.1093/abbs/gmr007; LIU J, 1993, J PHARMACOL EXP THER, V266, P1607; Liu J, 1995, J ETHNOPHARMACOL, V49, P57, DOI 10.1016/0378-8741(95)90032-2; LIU J, 1995, ACTA PHARM SINIC, V16, P97; Liu J, 2007, DRUG DEVELOP RES, V68, P261, DOI 10.1002/ddr.20187; Liu W, 2015, WIRES RNA, V6, P581, DOI 10.1002/wrna.1295; Liu YT, 2009, J PHARM SCI-US, V98, P4391, DOI 10.1002/jps.21721; LIU YP, 1993, J PHARMACOL EXP THER, V266, P400; McKenney J, 2005, CURR MED RES OPIN, V21, P1403, DOI 10.1185/030079905X59157; MENDELSON JH, 1973, SCIENCE, V180, P1372, DOI 10.1126/science.180.4093.1372; Musabayane CT, 2010, RENAL FAILURE, V32, P832, DOI 10.3109/0886022X.2010.494802; Nagai Y, 2009, CELL METAB, V9, P252, DOI 10.1016/j.cmet.2009.01.011; NESTEL PJ, 1962, J CLIN INVEST, V41, P1915, DOI 10.1172/JCI104648; Ngubane PS, 2011, RENAL FAILURE, V33, P434, DOI 10.3109/0886022X.2011.568147; Ni WQ, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0073-7; Panda H, 2012, J CLIN ENDOCR METAB, V97, pE1316, DOI 10.1210/jc.2012-1018; Plutzky J, 2000, CURR OPIN CARDIOL, V15, P416, DOI 10.1097/00001573-200011000-00008; SACHS BA, 1974, P SOC EXP BIOL MED, V147, P694; SINGH GB, 1992, J PHARM PHARMACOL, V44, P456, DOI 10.1111/j.2042-7158.1992.tb03646.x; Siragam V, 2012, ONCOTARGET, V3, P1370, DOI 10.18632/oncotarget.717; Somova LO, 2003, PHYTOMEDICINE, V10, P115, DOI 10.1078/094471103321659807; SPRECHER DL, 1994, ANN INTERN MED, V120, P537, DOI 10.7326/0003-4819-120-7-199404010-00002; STONE NJ, 1994, MED CLIN N AM, V78, P117, DOI 10.1016/S0025-7125(16)30179-1; Teodoro T, 2008, FEBS LETT, V582, P1375, DOI 10.1016/j.febslet.2008.03.026; Tsai SJ, 2012, EUR J PHARMACOL, V689, P81, DOI 10.1016/j.ejphar.2012.05.018; Wang HN, 2016, ADV MATER SCI ENG, V2016, DOI 10.1155/2016/6264317; Wang X.J., 2010, GANSU AGR SCI TECHNO, V2, P2; Wang X, 2013, MOL CELL ENDOCRINOL, V376, P70, DOI 10.1016/j.mce.2013.06.014; Wang ZH, 2010, EUR J PHARMACOL, V628, P255, DOI 10.1016/j.ejphar.2009.11.019; Wen XY, 2012, J ETHNOPHARMACOL, V142, P144, DOI 10.1016/j.jep.2012.04.028; Wolfrum C, 2006, CELL METAB, V3, P99, DOI 10.1016/j.cmet.2006.01.001; Yang H. X., 2013, CHIN J ARTERIOSCLER, V6; Yang WY, 2012, CIRCULATION, V125, P2212, DOI 10.1161/CIRCULATIONAHA.111.065904; Yunoki K, 2008, J AGR FOOD CHEM, V56, P12052, DOI 10.1021/jf8026217; Zeng XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042115	60	33	37	2	42	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2017	31	3					1085	1096		10.1096/fj.201601022R	http://dx.doi.org/10.1096/fj.201601022R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EM9ZX	27903618				2022-12-26	WOS:000395671200022
J	Turell, L; Vitturi, DA; Coitino, EL; Lebrato, L; Moller, MN; Sagasti, C; Salvatore, SR; Woodcock, SR; Alvarez, B; Schopfer, FJ				Turell, Lucia; Vitturi, Dario A.; Laura Coitino, E.; Lebrato, Lourdes; Moller, Matias N.; Sagasti, Camila; Salvatore, Sonia R.; Woodcock, Steven R.; Alvarez, Beatriz; Schopfer, Francisco J.			The Chemical Basis of Thiol Addition to Nitro-conjugated Linoleic Acid, a Protective Cell-signaling Lipid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLACEBO-CONTROLLED PHASE-3; PROTON-TRANSFER REACTIONS; HUMAN SERUM-ALBUMIN; FATTY-ACIDS; NUCLEOPHILIC ADDITIONS; MULTIPLE-SCLEROSIS; MICHAEL ADDITION; ORBITAL METHODS; SULFENIC ACID; ORAL BG-12	Nitroalkene fatty acids are formed in vivo and exert protective and anti-inflammatory effects via reversible Michael addition to thiol-containing proteins in key signaling pathways. Nitro-conjugated linoleic acid (NO2-CLA) is preferentially formed, constitutes the most abundant nitrated fatty acid in humans, and contains two carbons that could potentially react with thiols, modulating signaling actions and levels. In this work, we examined the reactions of NO2-CLA with low molecular weight thiols (glutathione, cysteine, homocysteine, cysteinylglycine, and beta-mercaptoethanol) and human serum albumin. Reactions followed reversible biphasic kinetics, consistent with the presence of two electrophilic centers in NO2-CLA located on the beta- and delta-carbons with respect to the nitro group. The differential reactivity was confirmed by computational modeling of the electronic structure. The rates (k(on) and k(off)) and equilibrium constants for both reactions were determined for different thiols. LC-UV-Visible and LC-MS analyses showed that the fast reaction corresponds to beta-adduct formation (the kinetic product), while the slow reaction corresponds to the formation of the beta-adduct (the thermodynamic product). The pH dependence of the rate constants, the correlation between intrinsic reactivity and thiol pK(a), and the absence of deuterium solvent kinetic isotope effects suggested stepwise mechanisms with thiolate attack on NO2-CLA as rate-controlling step. Computational modeling supported the mechanism and revealed additional features of the transition states, anionic intermediates, and final neutral products. Importantly, the detection of cysteine-delta-adducts in human urine provided evidence for the biological relevance of this reaction. Finally, human serum albumin was found to bind NO2-CLA both non-covalently and to form covalent adducts at Cys-34, suggesting potential modes for systemic distribution. These results provide new insights into the chemical basis of NO2-CLA signaling actions.	[Turell, Lucia; Lebrato, Lourdes; Alvarez, Beatriz] Univ Republica, Lab Enzimol, Inst Quim Biol, Fac Ciencias, Montevideo 11400, Uruguay; [Laura Coitino, E.; Sagasti, Camila] Univ Republica, Lab Quim Teor & Computac, Inst Quim Biol, Fac Ciencias, Montevideo 11400, Uruguay; [Moller, Matias N.] Univ Republica, Lab Fisicoquim Biol, Fac Ciencias, Inst Quim Biol, Montevideo 11400, Uruguay; [Turell, Lucia; Lebrato, Lourdes; Moller, Matias N.; Alvarez, Beatriz] Univ Republica, Ctr Free Rad & Biomed Res, Montevideo 11400, Uruguay; [Vitturi, Dario A.; Salvatore, Sonia R.; Woodcock, Steven R.; Schopfer, Francisco J.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA	Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Alvarez, B (corresponding author), Fac Ciencias, Lab Enzimol, Igua 4225, Montevideo 11400, Uruguay.; Schopfer, FJ (corresponding author), Univ Pittsburgh, Dept Pharmacol & Chem Biol, Thomas E Starzl Biomed Sci Tower E1340, Pittsburgh, PA 15213 USA.	beatriz.alvarez@fcien.edu.uy; fjs2@pitt.edu	Schopfer, Francisco/AAW-6505-2021; Woodcock, Steven/AAE-9199-2020; Schopfer, Francisco Jose/AAE-8125-2020; Vitturi, Dario/Z-3469-2019; Coitino, E. Laura/A-8101-2016	Schopfer, Francisco Jose/0000-0001-9526-695X; Turell, Lucia/0000-0002-6660-0784; Salvatore, Sonia/0000-0002-9942-3905; Vitturi, Dario/0000-0003-0354-4567; Coitino, E. Laura/0000-0002-6214-2413; Moller, Matias N./0000-0002-3486-8217; Alvarez, Beatriz/0000-0001-6911-3132	Comision Sectorial de Investigacion Cientifica (Universidad de la Republica, Uruguay); Agencia Nacional de Investigacion e Innovacion (ANII, Uruguay); National Institutes of Health [K01-HL133331, R01-AT006822]; American Heart Association [14GRNT20170024]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL133331] Funding Source: NIH RePORTER	Comision Sectorial de Investigacion Cientifica (Universidad de la Republica, Uruguay); Agencia Nacional de Investigacion e Innovacion (ANII, Uruguay); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants and fellowships from Comision Sectorial de Investigacion Cientifica (Universidad de la Republica, Uruguay) (to L. T., M. N. M., and B. A.), Agencia Nacional de Investigacion e Innovacion (ANII, Uruguay) (to L. L.), National Institutes of Health Grants K01-HL133331 (to D. A. V.) and R01-AT006822 (to F. J. S.), and American Heart Association Grant in Aid 14GRNT20170024 (to F. J. S.). D. A. V., S. R. W., and F. J. S. acknowledge financial interest in Complexa Inc. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alexander RL, 2006, BIOCHEMISTRY-US, V45, P7889, DOI 10.1021/bi0605639; Alvarez B, 2010, METHOD ENZYMOL, V473, P117, DOI 10.1016/S0076-6879(10)73005-6; Ando K, 2011, J ORG CHEM, V76, P3937, DOI 10.1021/jo200383f; Baker LMS, 2007, J BIOL CHEM, V282, P31085, DOI 10.1074/jbc.M704085200; Baker PRS, 2005, J BIOL CHEM, V280, P42464, DOI 10.1074/jbc.M504212200; BEDNAR RA, 1990, BIOCHEMISTRY-US, V29, P3684, DOI 10.1021/bi00467a014; BELL RP, 1966, PROC R SOC LON SER-A, V294, P273, DOI 10.1098/rspa.1966.0207; Bernasconi C. F., 1991, ADV PHYS ORGANIC CHE, P119; BERNASCONI CF, 1988, J AM CHEM SOC, V110, P7506, DOI 10.1021/ja00230a038; BERNASCONI CF, 1988, J ORG CHEM, V53, P3342, DOI 10.1021/jo00249a040; Bonacci G, 2012, J BIOL CHEM, V287, P44071, DOI 10.1074/jbc.M112.401356; BONDI A, 1964, J PHYS CHEM-US, V68, P441, DOI 10.1021/j100785a001; CANN PF, 1974, J CHEM SOC PERK T 2, P820, DOI 10.1039/p29740000820; Chai JD, 2008, PHYS CHEM CHEM PHYS, V10, P6615, DOI 10.1039/b810189b; Charles RL, 2014, P NATL ACAD SCI USA, V111, P8167, DOI 10.1073/pnas.1402965111; CHEN RF, 1967, J BIOL CHEM, V242, P173; Delmastro-Greenwood M, 2015, FREE RADICAL BIO MED, V89, P333, DOI 10.1016/j.freeradbiomed.2015.07.149; Delmastro-Greenwood M, 2014, ANNU REV PHYSIOL, V76, P79, DOI 10.1146/annurev-physiol-021113-170341; Dennington R., 2016, GAUSSVIEW VERSION 6; DITCHFIELD R, 1971, J CHEM PHYS, V54, P724, DOI 10.1063/1.1674902; ELLIS KJ, 1982, METHOD ENZYMOL, V87, P405; Espenson J. H., 1995, CHEM KINETICS REACTI, P142; Fazzari M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084884; Fersht A., 1999, STRUCTURE MECH PROTE, P150; FIERKE CA, 1995, METHOD ENZYMOL, V249, P3; FISHBEIN JC, 1988, J AM CHEM SOC, V110, P5075, DOI 10.1021/ja00223a028; Fox RJ, 2012, NEW ENGL J MED, V367, P1087, DOI 10.1056/NEJMoa1206328; FRIEDMAN M, 1965, J AM CHEM SOC, V87, P3672, DOI 10.1021/ja01094a025; Frisch M.J., 2016, GAUSSIAN 16 REV C 01; FUKUI K, 1981, ACCOUNTS CHEM RES, V14, P363, DOI 10.1021/ar00072a001; Geerlings P, 2003, CHEM REV, V103, P1793, DOI 10.1021/cr990029p; Glendening ED, 2012, WIRES COMPUT MOL SCI, V2, P1, DOI 10.1002/wcms.51; Gold R, 2012, NEW ENGL J MED, V367, P1098, DOI 10.1056/NEJMoa1114287; Gutscher M, 2008, NAT METHODS, V5, P553, DOI 10.1038/NMETH.1212; Hansen RE, 2009, P NATL ACAD SCI USA, V106, P422, DOI 10.1073/pnas.0812149106; Hratchian HP, 2005, J CHEM THEORY COMPUT, V1, P61, DOI 10.1021/ct0499783; JENCKS WP, 1971, J AM CHEM SOC, V93, P4433, DOI 10.1021/ja00747a016; Kelley EE, 2014, CARDIOVASC RES, V101, P352, DOI 10.1093/cvr/cvt341; Krenske EH, 2011, J ORG CHEM, V76, P5074, DOI 10.1021/jo200761w; Krishnan S, 2014, J AM CHEM SOC, V136, P12624, DOI 10.1021/ja505194w; Liu HY, 2008, AM J PHYSIOL-RENAL, V295, pF942, DOI 10.1152/ajprenal.90236.2008; Moutiers G, 1997, J CHEM SOC PERK T 2, P1479, DOI 10.1039/a700737j; Mulliner D, 2011, ORG BIOMOL CHEM, V9, P8400, DOI 10.1039/c1ob06065a; Ostergaard H, 2004, J CELL BIOL, V166, P337, DOI 10.1083/jcb.200402120; Peters Jr T., 1996, ALL ALBUMIN BIOCH GE, p[79, 228, 251, 260, 283, 305]; Portillo-Ledesma S, 2014, BIOCHEMISTRY-US, V53, P6113, DOI 10.1021/bi500389m; Ramsay EE, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00181; Requejo R, 2010, FEBS J, V277, P1465, DOI 10.1111/j.1742-4658.2010.07576.x; Riener CK, 2002, ANAL BIOANAL CHEM, V373, P266, DOI 10.1007/s00216-002-1347-2; Rudolph TK, 2010, ARTERIOSCL THROM VAS, V30, P938, DOI 10.1161/ATVBAHA.109.201582; Rudolph V, 2010, CARDIOVASC RES, V85, P155, DOI 10.1093/cvr/cvp275; Rudolph V, 2009, J BIOL CHEM, V284, P1461, DOI 10.1074/jbc.M802298200; Salvatore SR, 2013, J LIPID RES, V54, P1998, DOI 10.1194/jlr.M037804; Sato M, 2009, J ORG CHEM, V74, P1268, DOI 10.1021/jo8023939; Schopfer FJ, 2009, FREE RADICAL BIO MED, V46, P1250, DOI 10.1016/j.freeradbiomed.2008.12.025; Schopfer FJ, 2011, CHEM REV, V111, P5997, DOI 10.1021/cr200131e; Schopfer FJ, 2010, J BIOL CHEM, V285, P12321, DOI 10.1074/jbc.M109.091512; Smith JM, 2013, J CHEM THEORY COMPUT, V9, P4860, DOI 10.1021/ct400773k; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Thomas BE, 1995, J ORG CHEM, V60, P8375, DOI 10.1021/jo00131a012; Tomasi J, 2011, WIRES COMPUT MOL SCI, V1, P855, DOI 10.1002/wcms.54; Turell L, 2008, BIOCHEMISTRY-US, V47, P358, DOI 10.1021/bi701520y; Turell L, 2013, FREE RADICAL BIO MED, V65, P244, DOI 10.1016/j.freeradbiomed.2013.05.050; Villacorta L, 2013, CARDIOVASC RES, V98, P116, DOI 10.1093/cvr/cvt002; Vitturi DA, 2015, NAT CHEM BIOL, V11, P504, DOI [10.1038/NCHEMBIO.1814, 10.1038/nchembio.1814]; Vitturi DA, 2013, J BIOL CHEM, V288, P25626, DOI 10.1074/jbc.M113.486282; Wang HP, 2010, AM J PHYSIOL-RENAL, V298, pF754, DOI 10.1152/ajprenal.00439.2009; WIBERG KB, 1968, TETRAHEDRON, V24, P1083, DOI 10.1016/0040-4020(68)88057-3; Woodcock SR, 2014, J ORG CHEM, V79, P25, DOI 10.1021/jo4021562; Woodcock SR, 2013, FREE RADICAL BIO MED, V59, P14, DOI 10.1016/j.freeradbiomed.2012.11.015; YANG W, 1986, J AM CHEM SOC, V108, P5708, DOI 10.1021/ja00279a008	71	36	36	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2017	292	4					1145	1159		10.1074/jbc.M116.756288	http://dx.doi.org/10.1074/jbc.M116.756288			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ6OX	27923813	Green Published, hybrid			2022-12-26	WOS:000393339800001
J	Lee, HW; Khan, SQ; Khaliqdina, S; Altintas, MM; Grahammer, F; Zhao, JL; Koh, KH; Tardi, NJ; Faridi, MH; Geraghty, T; Cimbaluk, DJ; Susztak, K; Moita, LF; Baltimore, D; Tharaux, PL; Huber, TB; Kretzler, M; Bitzer, M; Reiser, J; Gupta, V				Lee, Ha Won; Khan, Samia Q.; Khaliqdina, Shehryar; Altintas, Mehmet M.; Grahammer, Florian; Zhao, Jimmy L.; Koh, Kwi Hye; Tardi, Nicholas J.; Faridi, Mohd. Hafeez; Geraghty, Terese; Cimbaluk, David J.; Susztak, Katalin; Moita, Luis F.; Baltimore, David; Tharaux, Pierre-Louis; Huber, Tobias B.; Kretzler, Matthias; Bitzer, Markus; Reiser, Jochen; Gupta, Vineet			Absence of miR-146a in Podocytes Increases Risk of Diabetic Glomerulopathy via Up-regulation of ErbB4 and Notch-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR; TGF-BETA; KIDNEY DEVELOPMENT; MICRORNA-146A; NEPHROPATHY; PROGRESSION; INHIBITION; DISEASE; INJURY; ACTIVATION	Podocyte injury is an early event in diabetic kidney disease and is a hallmark of glomerulopathy. MicroRNA-146a (miR-146a) is highly expressed in many cell types under homeostatic conditions, and plays an important anti-inflammatory role in myeloid cells. However, its role in podocytes is unclear. Here, we show that miR-146a expression levels decrease in the glomeruli of patients with type 2 diabetes (T2D), which correlates with increased albuminuria and glomerular damage. miR-146a levels are also significantly reduced in the glomeruli of albuminuric BTBR ob/ob mice, indicating its significant role in maintaining podocyte health. miR-146a-deficient mice (miR-146a(-/-)) showed accelerated development of glomerulopathy and albuminuria upon streptozotocin (STZ)-induced hyperglycemia. The miR-146a targets, Notch-1 and ErbB4, were also significantly up-regulated in the glomeruli of diabetic patients and mice, suggesting induction of the downstream TGF beta signaling. Treatment with a pan-ErbB kinase inhibitor erlotinib with nanomolar activity against ErbB4 significantly suppressed diabetic glomerular injury and albuminuria in both WT and miR146a(-/-) animals. Treatment of podocytes in vitro with TGF-beta 1 resulted in increased expression of Notch-1, ErbB4, pErbB4, and pEGFR, the heterodimerization partner of ErbB4, suggesting increased ErbB4/EGFR signaling. TGF-beta 1 also increased levels of inflammatory cytokine monocyte chemoattractant protein-1 (MCP-1) and MCP-1 induced protein-1 (MCPIP1), a suppressor of miR-146a, suggesting an autocrine loop. Inhibition of ErbB4/EGFR with erlotinib co-treatment of podocytes suppressed this signaling. Our findings suggest a novel role for miR-146a in protecting against diabetic glomerulopathy and podocyte injury. They also point to ErbB4/EGFR as a novel, druggable target for therapeutic intervention, especially because several pan-ErbB inhibitors are clinically available.	[Lee, Ha Won; Khan, Samia Q.; Khaliqdina, Shehryar; Altintas, Mehmet M.; Koh, Kwi Hye; Tardi, Nicholas J.; Faridi, Mohd. Hafeez; Geraghty, Terese; Reiser, Jochen; Gupta, Vineet] Rush Univ, Med Ctr, Dept Internal Med, Cohn 222, Chicago, IL 60026 USA; [Cimbaluk, David J.] Rush Univ, Med Ctr, Dept Pathol, Chicago, IL 60612 USA; [Grahammer, Florian; Huber, Tobias B.] Univ Freiburg, Fac Med, Med Ctr, Dept Med 4, D-79106 Freiburg, Germany; [Zhao, Jimmy L.] New York Presbyterian Weill Cornell Med Ctr, Dept Med, New York, NY 10065 USA; [Zhao, Jimmy L.; Baltimore, David] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Susztak, Katalin] Univ Penn, Dept Med, Renal Electrolyte & Hypertens Div, Perelman Sch Med, Philadelphia, PA 19104 USA; [Moita, Luis F.] Inst Gulbenkian Ciencias, Rua Quinta Grande 6, P-2780156 Oeiras, Portugal; [Tharaux, Pierre-Louis] INSERM, Paris Cardiovasc Ctr PARCC, F-75015 Paris, France; [Tharaux, Pierre-Louis] Univ Paris 05, Sorbonne Paris Cite, F-75270 Paris, France; [Huber, Tobias B.] Albert Ludwigs Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany; [Huber, Tobias B.] Albert Ludwigs Univ, FRIAS, Freiburg Inst Adv Studies, D-79104 Freiburg, Germany; [Huber, Tobias B.] Albert Ludwigs Univ, ZBSA Ctr Syst Biol, D-79104 Freiburg, Germany; [Kretzler, Matthias; Bitzer, Markus] Univ Michigan, Div Nephrol, Ann Arbor, MI 48109 USA	Rush University; Rush University; University of Freiburg; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; California Institute of Technology; University of Pennsylvania; Pennsylvania Medicine; Instituto Gulbenkian de Ciencia; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Freiburg; University of Freiburg; University of Freiburg; University of Michigan System; University of Michigan	Gupta, V (corresponding author), Rush Univ, Med Ctr, Dept Internal Med, Cohn 222, Chicago, IL 60026 USA.	vineet_gupta@rush.edu	Lee, Hawon/ABQ-4063-2022; Altintas, Mehmet Mete/ABI-5904-2020; Moita, Luis F./L-1296-2013; Altintas, Mehmet Mete/T-5333-2018; Tharaux, Pierre-Louis/A-9155-2009; Grahammer, Florian/ABB-7775-2021; Moita, Luis/HCI-2793-2022; Susztak, Katalin/ABE-7474-2021	Lee, Hawon/0000-0001-5382-9646; Moita, Luis F./0000-0003-0707-315X; Altintas, Mehmet Mete/0000-0002-1871-6985; Tharaux, Pierre-Louis/0000-0002-6062-5905; Moita, Luis/0000-0003-0707-315X; Susztak, Katalin/0000-0002-1005-3726; Huber, Tobias B./0000-0001-7175-5062; Bitzer, Markus/0000-0002-3711-2984	National Institutes of Health [R01DK084195, R01HL109582, R01DK106512, R01DK107984]; Nephcure Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK081943, R01DK107984, R01DK106512, R01DK076077, R01DK084195, R01DK100449] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nephcure Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK084195 and R01HL109582 (to V. G.) and R01DK106512 and R01DK107984 (to V. G. and J. R.), the Nephcure Foundation and resources from the Rush University Medical Center. V. G. and J. R. are inventors on pending patent applications related to this study. These authors and the Rush University Medical Center have the potential for financial benefit from their future commercialization. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Advani A, 2011, NEPHROLOGY, V16, P573, DOI 10.1111/j.1440-1797.2011.01451.x; Alpers CE, 2011, CURR OPIN NEPHROL HY, V20, P278, DOI 10.1097/MNH.0b013e3283451901; [Anonymous], 2003, Am J Kidney Dis, V42, P1; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bai Y, 2012, J IMMUNOL, V188, P5293, DOI 10.4049/jimmunol.1102371; Barak H, 2012, ADV EXP MED BIOL, V727, P99, DOI 10.1007/978-1-4614-0899-4_8; Ben-Dov IZ, 2012, TRANSPLANTATION, V94, P1086, DOI 10.1097/TP.0b013e3182751efd; Bhatt K, 2016, J AM SOC NEPHROL, V27, P2277, DOI 10.1681/ASN.2015010111; Boerries M, 2013, KIDNEY INT, V83, P1052, DOI 10.1038/ki.2012.487; Boldin MP, 2011, J EXP MED, V208, P1189, DOI 10.1084/jem.20101823; Bollee G, 2011, NAT MED, V17, P1242, DOI 10.1038/nm.2491; Bottinger EP, 2002, J AM SOC NEPHROL, V13, P2600, DOI 10.1097/01.ASN.0000033611.79556.AE; BREYER MD, 1990, AM J PHYSIOL, V259, pF553, DOI 10.1152/ajprenal.1990.259.4.F553; Brosius FC, 2009, J AM SOC NEPHROL, V20, P2503, DOI 10.1681/ASN.2009070721; Carpenter G, 2003, EXP CELL RES, V284, P66, DOI 10.1016/S0014-4827(02)00100-3; Chandrasekaran K, 2012, KIDNEY INT, V81, P617, DOI 10.1038/ki.2011.448; Chau BN, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003205; Chen HQ, 2009, DRUG METAB DISPOS, V37, P1841, DOI 10.1124/dmd.109.026609; Chen JC, 2015, J AM SOC NEPHROL, V26, P1115, DOI 10.1681/ASN.2014020192; Chen JC, 2012, J AM SOC NEPHROL, V23, P215, DOI 10.1681/ASN.2011070645; Cheng HS, 2013, EMBO MOL MED, V5, P1017, DOI 10.1002/emmm.201202318; Cheng HT, 2007, DEVELOPMENT, V134, P801, DOI 10.1242/dev.02773; Coaxum SD, 2009, BBA-MOL CELL RES, V1793, P1174, DOI 10.1016/j.bbamcr.2009.03.006; Coward RJM, 2005, DIABETES, V54, P3095, DOI 10.2337/diabetes.54.11.3095; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; Farazi TA, 2012, METHODS, V58, P171, DOI 10.1016/j.ymeth.2012.07.020; Farazi TA, 2011, CANCER RES, V71, P4443, DOI 10.1158/0008-5472.CAN-11-0608; Feng BA, 2011, DIABETES, V60, P2975, DOI 10.2337/db11-0478; Gebeshuber CA, 2013, NAT MED, V19, P481, DOI 10.1038/nm.3142; Godel M, 2011, J CLIN INVEST, V121, P2197, DOI 10.1172/JCI44774; Halkein J, 2013, J CLIN INVEST, V123, P2143, DOI 10.1172/JCI64365; Hartleben B, 2010, J CLIN INVEST, V120, P1084, DOI 10.1172/JCI39492; Ho J, 2012, J AM SOC NEPHROL, V23, P400, DOI 10.1681/ASN.2011080797; Horie T, 2010, CARDIOVASC RES, V87, P656, DOI 10.1093/cvr/cvq148; Hudkins KL, 2010, J AM SOC NEPHROL, V21, P1533, DOI 10.1681/ASN.2009121290; Ichii O, 2012, KIDNEY INT, V81, P280, DOI 10.1038/ki.2011.345; Kato M, 2012, EXP CELL RES, V318, P993, DOI 10.1016/j.yexcr.2012.02.034; Lai JY, 2015, J AM SOC NEPHROL, V26, P805, DOI 10.1681/ASN.2013121274; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee EY, 2009, AM J PHYSIOL-RENAL, V297, pF85, DOI 10.1152/ajprenal.90642.2008; Lee HW, 2015, J AM SOC NEPHROL, V26, P2741, DOI 10.1681/ASN.2014090859; Li JYZ, 2010, NEPHROLOGY, V15, P599, DOI 10.1111/j.1440-1797.2010.01363.x; Liu N, 2012, J AM SOC NEPHROL, V23, P854, DOI 10.1681/ASN.2011050493; Long JY, 2011, J BIOL CHEM, V286, P11837, DOI 10.1074/jbc.M110.194969; Long JY, 2010, J BIOL CHEM, V285, P23455, DOI 10.1074/jbc.M110.136168; Lu LF, 2010, CELL, V142, P914, DOI 10.1016/j.cell.2010.08.012; Mei J, 2011, MOL CELL BIOL, V31, P3584, DOI 10.1128/MCB.05821-11; Meyer TW, 1999, DIABETOLOGIA, V42, P1341, DOI 10.1007/s001250051447; MOGENSEN CE, 1985, UREMIA INVEST, V9, P85, DOI 10.3109/08860228509088195; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Niranjan T, 2008, NAT MED, V14, P290, DOI 10.1038/nm1731; Pagtalunan ME, 1997, J CLIN INVEST, V99, P342, DOI 10.1172/JCI119163; Qu B, 2015, ARTHRITIS RHEUMATOL, V67, P3209, DOI 10.1002/art.39398; Remuzzi G, 2006, J CLIN INVEST, V116, P288, DOI 10.1172/JCI27699; Remuzzi G, 2006, J AM SOC NEPHROL, V17, pS90, DOI 10.1681/ASN.2005121324; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Sandholm N, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002921; Schiffer M, 2001, J CLIN INVEST, V108, P807, DOI 10.1172/JCI12367; Schmid H, 2006, DIABETES, V55, P2993, DOI 10.2337/db06-0477; Shankland SJ, 2007, KIDNEY INT, V72, P26, DOI 10.1038/sj.ki.5002291; Shankland SJ, 2006, KIDNEY INT, V69, P2131, DOI 10.1038/sj.ki.5000410; Sirin Y, 2012, J PATHOL, V226, P394, DOI 10.1002/path.2967; Spurney RF, 2008, J AM SOC NEPHROL, V19, P2035, DOI 10.1681/ASN.2008090955; Susztak K, 2006, DIABETES, V55, P225, DOI 10.2337/diabetes.55.01.06.db05-0894; Suzuki HI, 2011, MOL CELL, V44, P424, DOI 10.1016/j.molcel.2011.09.012; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tao RH, 2008, J CELL SCI, V121, P3207, DOI 10.1242/jcs.033399; Veikkolainen V, 2012, J AM SOC NEPHROL, V23, P112, DOI 10.1681/ASN.2011020160; Waters AM, 2008, J AM SOC NEPHROL, V19, P1139, DOI 10.1681/ASN.2007050596; Wei C, 2008, NAT MED, V14, P55, DOI 10.1038/nm1696; Weil EJ, 2013, DIABETES, V62, P3224, DOI 10.2337/db12-1512; Weil EJ, 2012, KIDNEY INT, V82, P1010, DOI 10.1038/ki.2012.234; Wharram BL, 2005, J AM SOC NEPHROL, V16, P2941, DOI 10.1681/ASN.2005010055; Wiggins RC, 2007, KIDNEY INT, V71, P1205, DOI 10.1038/sj.ki.5002222; Wolf G, 2005, DIABETES, V54, P1626, DOI 10.2337/diabetes.54.6.1626; Wu DT, 2005, J AM SOC NEPHROL, V16, P3211, DOI 10.1681/ASN.2004121055; Xavier S, 2009, J AM SOC NEPHROL, V20, P2127, DOI 10.1681/ASN.2008070806; Zeng F, 2007, MOL BIOL CELL, V18, P4446, DOI 10.1091/mbc.E07-03-0223; Zeng FH, 2014, KIDNEY INT, V86, P538, DOI 10.1038/ki.2014.84; Zhang MZ, 2014, DIABETES, V63, P2063, DOI 10.2337/db13-1279; Zhang Z, 2009, FEBS LETT, V583, P2009, DOI 10.1016/j.febslet.2009.05.021; Zhao JL, 2011, P NATL ACAD SCI USA, V108, P9184, DOI 10.1073/pnas.1105398108	82	60	64	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2017	292	2					732	747		10.1074/jbc.M116.753822	http://dx.doi.org/10.1074/jbc.M116.753822			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2KN	27913625	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000392316100027
J	Murtaza, G; Mermer, P; Pfeil, U; Kummer, W				Murtaza, Ghulam; Mermer, Petra; Pfeil, Uwe; Kummer, Wolfgang			Avertin (R), but Not Volatile Anesthetics Addressing the Two-Pore Domain K plus Channel, TASK-1, Slows Down Cilia-Driven Particle Transport in the Mouse Trachea	PLOS ONE			English	Article							AIRWAY EPITHELIAL-CELLS; IN-VIVO; MUCOCILIARY CLEARANCE; ISOFLURANE; NEURONS; NASAL; MICE; RAT; EXPRESSION; CONTRIBUTE	Rationale Volatile anesthetics inhibit mucociliary clearance in the airways. The two-pore domain K+ channel, TASK-1, represents one of their molecular targets in that they increase its open probability. Here, we determine whether particle transport speed (PTS) at the mucosal surface of the mouse trachea, an important factor of the cilia-driven mechanism in mucociliary clearance, is regulated by TASK-1. Methodology/Results RT-PCR analysis revealed expression of TASK-1 mRNA in the manually dissected and laser-assisted microdissected tracheal epithelium of the mouse. Effects of anesthetics (isoflurane and Avertin (R)) and TASK-1 inhibitors (anandamide and A293) on ciliary activity were investigated by assessment of PTS at the mucosal surface of the explanted and opened murine trachea. Neither TASK-1 inhibitors nor isoflurane had any impact on basal and ATP-stimulated PTS. Avertin (R) reduced basal PTS, and ATP-stimulated PTS decreased in its presence in wild-type (WT) mice. Avertin (R)-induced decrease in basal PTS persisted in WT mice in the presence of TASK-1 inhibitors, and in two different strains of TASK-1 knockout mice. Conclusions/Significance Our findings indicate that TASK-1 is expressed by the tracheal epithelium but is not critically involved in the regulation of tracheal PTS in mice. Avertin (R) reduces PTS independent of TASK-1.	[Murtaza, Ghulam] Justus Liebig Univ, Inst Anat & Cell Biol, Giessen, Germany; German Ctr Lung Res DZL, ECCPS, Giessen, Germany; [Murtaza, Ghulam] King Saud Univ, Dept Neurol, Riyadh, Saudi Arabia	Justus Liebig University Giessen; King Saud University	Murtaza, G (corresponding author), Justus Liebig Univ, Inst Anat & Cell Biol, Giessen, Germany.; Murtaza, G (corresponding author), King Saud Univ, Dept Neurol, Riyadh, Saudi Arabia.	gmurtazay@yahoo.com	Murtaza, Ghulam/AAK-6538-2020	Kummer, Wolfgang/0000-0002-3946-0683				Aller MI, 2005, J NEUROSCI, V25, P11455, DOI 10.1523/JNEUROSCI.3153-05.2005; Berg AP, 2004, J NEUROSCI, V24, P6693, DOI 10.1523/JNEUROSCI.1408-04.2004; Bournival V, 2011, EXP LUNG RES, V37, P205, DOI 10.3109/01902148.2010.536610; Brennan SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080294; Cervin A, 1998, BRIT J ANAESTH, V80, P475, DOI 10.1093/bja/80.4.475; Christopher AB, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00111; De Proost I, 2007, HISTOCHEM CELL BIOL, V128, P301, DOI 10.1007/s00418-007-0318-2; Duprat F, 1997, EMBO J, V16, P5464, DOI 10.1093/emboj/16.17.5464; Gurney AM, 2003, CIRC RES, V93, P957, DOI 10.1161/01.RES.0000099883.68414.61; Hua XY, 2010, J APPL PHYSIOL, V108, P189, DOI 10.1152/japplphysiol.00669.2009; Hussong J, 2013, J BIOMECH, V46, P593, DOI 10.1016/j.jbiomech.2012.08.020; Jiao J, 2012, ORL J OTO-RHINO-LARY, V74, P280, DOI 10.1159/000343800; Keller C, 1998, ANESTH ANALG, V86, P1280, DOI 10.1097/00000539-199806000-00028; Kim D, 1998, CIRC RES, V82, P513, DOI 10.1161/01.RES.82.4.513; Klein MK, 2009, EUR RESPIR J, V33, P1113, DOI 10.1183/09031936.00015108; KORNGREEN A, 1994, BIOPHYS J, V67, P377, DOI 10.1016/S0006-3495(94)80492-8; Krasteva G, 2007, INT J BIOCHEM CELL B, V39, P615, DOI 10.1016/j.biocel.2006.10.019; Lazarenko RM, 2010, J NEUROSCI, V30, P7691, DOI 10.1523/JNEUROSCI.1655-10.2010; Leithner K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157453; Linden AM, 2006, J PHARMACOL EXP THER, V317, P615, DOI 10.1124/jpet.105.098525; Ma WY, 2002, J GEN PHYSIOL, V120, P875, DOI 10.1085/jgp.20028695; Maingret F, 2001, EMBO J, V20, P47, DOI 10.1093/emboj/20.1.47; Matsuura S, 2006, ANESTH ANALG, V102, P1703, DOI 10.1213/01.ane.0000216001.36932.a3; Meuth SG, 2006, MOL PHARMACOL, V69, P1468, DOI 10.1124/mol.105.020594; Mulkey DK, 2007, J NEUROSCI, V27, P14049, DOI 10.1523/JNEUROSCI.4254-07.2007; Ohba T, 2013, J PHARMACOL EXP THER, V347, P145, DOI 10.1124/jpet.113.205138; Patel AJ, 1999, NAT NEUROSCI, V2, P422, DOI 10.1038/8084; Petric S, 2012, CELL PHYSIOL BIOCHEM, V30, P523, DOI 10.1159/000341435; Pfeil U, 2006, BIOCHEM BIOPH RES CO, V343, P885, DOI 10.1016/j.bbrc.2006.03.042; Putzke C, 2007, AM J PHYSIOL-CELL PH, V293, pC1319, DOI 10.1152/ajpcell.00100.2007; Raphael JH, 1996, BRIT J ANAESTH, V76, P854, DOI 10.1093/bja/76.6.854; Raphael JH, 1997, BRIT J ANAESTH, V79, P473, DOI 10.1093/bja/79.4.473; Robertson A, 2004, CLIN OTOLARYNGOL, V29, P157, DOI 10.1111/j.0307-7772.2004.00768.x; RUTLAND J, 1982, AM REV RESPIR DIS, V125, P100; Smuszkiewicz P, 2006, PHARMACOL REP, V58, P736; Turner PJ, 2013, J PHYSIOL-LONDON, V591, P5977, DOI 10.1113/jphysiol.2013.262022; VILLALON M, 1989, BIOPHYS J, V56, P1255, DOI 10.1016/S0006-3495(89)82772-9; Wanner A, 1996, AM J RESP CRIT CARE, V154, P1868, DOI 10.1164/ajrccm.154.6.8970383; Zhao KQ, 2012, AM J PHYSIOL-LUNG C, V302, pL4, DOI 10.1152/ajplung.00102.2011	40	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167919	10.1371/journal.pone.0167919	http://dx.doi.org/10.1371/journal.pone.0167919			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930725	Green Published, gold, Green Submitted			2022-12-26	WOS:000389580900059
J	VandeVoort, CA; Gerona, RR; vom Saal, FS; Tarantal, AF; Hunt, PA; Hillenweck, A; Zalko, D				VandeVoort, Catherine A.; Gerona, Roy R.; vom Saal, Frederick S.; Tarantal, Alice F.; Hunt, Patricia A.; Hillenweck, Anne; Zalko, Daniel			Maternal and Fetal Pharmacokinetics of Oral Radiolabeled and Authentic Bisphenol A in the Rhesus Monkey	PLOS ONE			English	Article							HUMAN HEALTH; EXPOSURE; SERUM; BPA; DISPOSITION; MECHANISMS; ALTERS; DECONJUGATION; PROGESTERONE; GLUCURONIDE	The present study was conducted in pregnant rhesus monkeys to determine the rapidity and extent to which BPA reaches the fetal compartment following oral ingestion, and the 24-hr fate of BPA. To assess metabolism changes during the course of pregnancy, we compared BPA biotransformation during the second and third trimesters in the same animals, measuring the levels of sulfated, gluronidated, and free BPA in maternal serum, amniotic fluid, and fetal serum. All animals showed measurable unconjugated and conjugated BPA in the fetal compartment and slow clearance compared to maternal serum. There were higher levels of BPA-G in amniotic fluid at 150 days gestation compared to 100 days gestation, as well as higher levels of BPA-G than BPA-S. We also monitored H-3-BPA (and metabolites) in key tissues and excreta from a mother and fetus and from a non-pregnant female. The elimination of radioactivity was rapid, but residues were still detectable 24 hr after dosing in all tissues analyzed. These data suggest that, in primates, rapid maternal processing of BPA does not alleviate the risk of exposure to the developing fetus. This study elevates concerns about levels of current BPA human exposure from potentially a large number of unknown sources and the risks posed to developing fetuses.	[VandeVoort, Catherine A.] Univ Calif Davis, Dept Obstet & Gynecol, Davis, CA 95616 USA; [VandeVoort, Catherine A.; Tarantal, Alice F.] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA; [Gerona, Roy R.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Program Reprod Hlth & Environm, San Francisco, CA USA; [vom Saal, Frederick S.] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA; [Tarantal, Alice F.] Univ Calif Davis, Sch Med, Dept Pediat, Davis, CA 95616 USA; [Tarantal, Alice F.] Univ Calif Davis, Sch Med, Dept Cell Biol & Human Anat, Davis, CA 95616 USA; [Hunt, Patricia A.] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA; [Hillenweck, Anne; Zalko, Daniel] Univ Toulouse, INRA, Toxalim, Toulouse, France	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California San Francisco; University of Missouri System; University of Missouri Columbia; University of California System; University of California Davis; University of California System; University of California Davis; Washington State University; INRAE; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	VandeVoort, CA (corresponding author), Univ Calif Davis, Dept Obstet & Gynecol, Davis, CA 95616 USA.; VandeVoort, CA (corresponding author), Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA.	cavandevoort@ucdavis.edu			National Institute of Environmental Health Sciences (NIEHS) [ES016770]; CNPRC Base Grant (National Institutes of Health) [OD011107 (RR00169)]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016770] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011107] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); CNPRC Base Grant (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institute of Environmental Health Sciences (NIEHS) Grants ES016770 and the CNPRC Base Grant (National Institutes of Health) OD011107 (RR00169). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANSES, 2013, ASS HLTH RISKS BISPH; BARKLEY MS, 1979, BIOL REPROD, V20, P733, DOI 10.1095/biolreprod20.4.733; Calhoun KC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085894; Chapalamadugu KC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089096; Corbel T, 2015, DRUG METAB DISPOS, V43, P467, DOI 10.1124/dmd.114.061291; Corbel T, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.112.106369; Doerge DR, 2010, TOXICOL APPL PHARM, V247, P158, DOI 10.1016/j.taap.2010.06.008; Elsworth JD, 2013, NEUROTOXICOLOGY, V35, P113, DOI 10.1016/j.neuro.2013.01.001; Gayrard V, 2013, ENVIRON HEALTH PERSP, V121, P951, DOI 10.1289/ehp.1206339; Gerona RR, 2013, ENVIRON SCI TECHNOL, V47, P12477, DOI 10.1021/es402764d; HODGEN GD, 1972, ENDOCRINOLOGY, V91, P896, DOI 10.1210/endo-91-4-896; Hormann AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110509; Hunt PA, 2012, P NATL ACAD SCI USA, V109, P17525, DOI 10.1073/pnas.1207854109; Jaeg JP, 2004, J AGR FOOD CHEM, V52, P4935, DOI 10.1021/jf049762u; Kopen GC, 1999, J HISTOCHEM CYTOCHEM, V47, P965, DOI 10.1177/002215549904700714; Kurebayashi H, 2005, ARCH TOXICOL, V79, P243, DOI 10.1007/s00204-004-0628-2; Miller V., 2003, PRINCIPLES SEX BASED, P15; MONTANO MM, 1995, BIOL REPROD, V53, P1198, DOI 10.1095/biolreprod53.5.1198; MOTSON RW, 1981, GASTROENTEROLOGY, V80, P655; Pasqualini JR, 2005, J STEROID BIOCHEM, V97, P401, DOI 10.1016/j.jsbmb.2005.08.004; Patterson TA, 2013, TOXICOL APPL PHARM, V267, P41, DOI 10.1016/j.taap.2012.12.006; Peretz J, 2014, ENVIRON HEALTH PERSP, V122, P775, DOI 10.1289/ehp.1307728; POMERANTZ SM, 1985, ENDOCRINOLOGY, V116, P83, DOI 10.1210/endo-116-1-83; RESKO JA, 1975, ENDOCRINOLOGY, V97, P425, DOI 10.1210/endo-97-2-425; REUNING RH, 1989, DRUG METAB DISPOS, V17, P583; Rochester JR, 2013, REPROD TOXICOL, V42, P132, DOI 10.1016/j.reprotox.2013.08.008; Sakamoto H, 2002, BBA-GEN SUBJECTS, V1573, P171, DOI 10.1016/S0304-4165(02)00418-X; SCHELINE RR, 1973, PHARMACOL REV, V25, P451; Seachrist DD, 2016, REPROD TOXICOL, V59, P167, DOI 10.1016/j.reprotox.2015.09.006; Stahlhut RW, 2009, ENVIRON HEALTH PERSP, V117, P784, DOI 10.1289/ehp.0800376; Takeyama J, 2001, J CLIN ENDOCR METAB, V86, P2258, DOI 10.1210/jc.86.5.2258; Tarantal Alice F., 2005, P317, DOI 10.1016/B978-012080261-6/50020-9; Taylor JA, 2011, ENVIRON HEALTH PERSP, V119, P422, DOI 10.1289/ehp.1002514; Teeguarden JG, 2015, TOXICOL APPL PHARM, V288, P131, DOI 10.1016/j.taap.2015.01.009; Tharp AP, 2012, P NATL ACAD SCI USA, V109, P8190, DOI 10.1073/pnas.1120488109; Thayer KA, 2015, ENVIRON INT, V83, P107, DOI 10.1016/j.envint.2015.06.008; Van Winkle LS, 2013, ENVIRON HEALTH PERSP, V121, P912, DOI 10.1289/ehp.1206064; Vandenberg LN, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-25; Vandenberg Laura N., 2013, Reviews on Environmental Health, V28, P37, DOI 10.1515/reveh-2012-0034; Vandenberg LN, 2010, ENVIRON HEALTH PERSP, V118, P1055, DOI 10.1289/ehp.0901716; Vandenberg LN, 2013, ENDOCRINE DISRUPTION, V1, pE1; Vokel W, 2002, CHEM RES TOXICOL, V15, P1281, DOI 10.1021/tx025548t; vom Saal FS, 2007, REPROD TOXICOL, V24, P131, DOI 10.1016/j.reprotox.2007.07.005; vom Saal FS, 2014, MOL CELL ENDOCRINOL, V398, P101, DOI 10.1016/j.mce.2014.09.028; vom Saal FS, 2014, REPROD TOXICOL, V45, P105, DOI 10.1016/j.reprotox.2014.01.007; Welshons WV, 2006, ENDOCRINOLOGY, V147, pS56, DOI 10.1210/en.2005-1159; Zalko D, 2003, ENVIRON HEALTH PERSP, V111, P309, DOI 10.1289/ehp.5603	47	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0165410	10.1371/journal.pone.0165410	http://dx.doi.org/10.1371/journal.pone.0165410			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930651	Green Published, gold, Green Submitted			2022-12-26	WOS:000389580900004
J	Abugalieva, S; Didorenko, S; Anuarbek, S; Volkova, L; Gerasimova, Y; Sidorik, I; Turuspekov, Y				Abugalieva, Saule; Didorenko, Svetlana; Anuarbek, Shynar; Volkova, Lubov; Gerasimova, Yelena; Sidorik, Ivan; Turuspekov, Yerlan			Assessment of Soybean Flowering and Seed Maturation Time in Different Latitude Regions of Kazakhstan	PLOS ONE			English	Article							MAP-BASED CLONING; MATURITY; GENE; RESPONSES; E3; E2; E1	Soybean is still a minor crop in Kazakhstan despite an increase in planting area from 4,500 to 11,400 km(2) between 2006 and 2014. However, the Government's recently accepted crop diversification policy projects the expansion of soybean cultivation area to more than 40,000 km(2) by 2020. The policy is targeting significant expansion of soybean production in Southeastern, Eastern, and Northern regions of Kazakhstan. Successful realization of this policy requires a comprehensive characterization of plant growth parameters to identify optimal genotypes with appropriate adaptive phenotypic traits. In this study 120 soybean accessions from different parts of the World, including 18 accessions from Kazakhstan, were field tested in South-eastern, Eastern, and Northern regions of the country. These studies revealed positive correlation of yield with flowering time in Northern Kazakhstan, with seed maturity time in Eastern Kazakhstan, and with both these growth stages in South-eastern Kazakhstan. It was determined that in South-eastern, Eastern and Northern regions of Kazakhstan the majority of productive genotypes were in maturity groups MGI, MG0, and MG00, respectively. The accessions were genotyped for four major maturity genes (E1, E2, E3, and E4) in order to assess the relationship between E loci and agronomic traits. The allele composition of the majority of accessions was e1-as/e2/E3/E4 (specific frequencies 57.5%, 91.6%, 65.0%, and 63.3%, respectively). Accessions with dominant alleles in either E3 or E4 genes showed higher yield in all three regions, although the specific genotype associated with greatest productivity was different for each site. Genotype-environment interaction studies based on yield performances suggest that South-east and East regions formed one mega-environment, which was well separated from North Kazakhstan where significantly earlier time to maturation is required. The results provide important insights into the relationship between genetic and phenotypic patterns in new soybean growing territories in Kazakhstan.	[Abugalieva, Saule; Anuarbek, Shynar; Volkova, Lubov; Turuspekov, Yerlan] Inst Plant Biol & Biotechnol, Alma Ata, Kazakhstan; [Didorenko, Svetlana] Kazakh Res Inst Agr, Almalybak Vil, Almaty Region, Kazakhstan; [Gerasimova, Yelena] East Kazakhstan Res Inst Agr, Solnechnyi Vil, Ust Kamenogorsk, Kazakhstan; [Sidorik, Ivan] Kostanaiskyi Res Inst Agr, Zarechnoe Vil, Kostanai Region, Kazakhstan	Institute of Plant Biology & Biotechnology in Kazakhstan; Kazakh Scientific Research Institute of Plant Protection & Quarantine of Zh.Zhienbaev	Turuspekov, Y (corresponding author), Inst Plant Biol & Biotechnol, Alma Ata, Kazakhstan.	yerlant@yahoo.com	Abugalieva, Saule/M-6690-2015; Turuspekov, Yerlan/C-3458-2011; Anuarbek, Shynar/AAO-1161-2020; Didorenko, Svetlana/AAO-9646-2020	Abugalieva, Saule/0000-0002-9748-507X; Turuspekov, Yerlan/0000-0001-8590-1745; Didorenko, Svetlana/0000-0002-2223-0718; Anuarbek, Shynar/0000-0002-8673-9820; Gerasimova, Elena/0000-0003-4069-3457	Ministry of Education and science of the Republic of Kazakhstan [1108/GF4]	Ministry of Education and science of the Republic of Kazakhstan(Government of the Republic of KazakhstanMinistry of Education and Science of the Republic of Kazakhstan)	The study funded by grant number 1108/GF4 given by the Ministry of Education and science of the Republic of Kazakhstan. Website of the Ministry: http://edu.gov.kz/en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abugalieva S, 2013, BIOTECHNOLOGY THEORY, V3, P26; Abugalieva S., 2013, BIOTECHNOLOGY THEORY, V4, P13; Anuarbek S, 2015, KAZNU B BIOL SERIES, V3, P110; Buzzell R. I., 1980, SOYBEAN GENETICS NEW, V7, P26, DOI DOI 10.1093/JHERED/ESP113; Duranti M, 2006, FITOTERAPIA, V77, P67, DOI 10.1016/j.fitote.2005.11.008; FEHR WR, 1971, CROP SCI, V11, P929, DOI 10.2135/cropsci1971.0011183X001100060051x; Jia HC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094139; Jiang BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106042; Liu B, 2008, GENETICS, V180, P995, DOI 10.1534/genetics.108.092742; Liu BH, 2010, PLANT PHYSIOL, V153, P198, DOI 10.1104/pp.109.150607; SAINDON G, 1989, CROP SCI, V29, P1436, DOI 10.2135/cropsci1989.0011183X002900060021x; Shin JH, 2012, MOL BREEDING, V30, P1793, DOI 10.1007/s11032-012-9743-6; Tsubokura Y, 2014, ANN BOT-LONDON, V113, P429, DOI 10.1093/aob/mct269; Watanabe S, 2011, BREEDING SCI, V61, P531, DOI 10.1270/jsbbs.61.531; Watanabe S, 2011, GENETICS, V188, P395, DOI 10.1534/genetics.110.125062; Watanabe S, 2009, GENETICS, V182, P1251, DOI 10.1534/genetics.108.098772; Xia ZJ, 2012, PLANT SYST EVOL, V298, P1217, DOI 10.1007/s00606-012-0628-2; Xu ML, 2015, PLANT PHYSIOL, V168, P1735, DOI 10.1104/pp.15.00763; Xu ML, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-91; Zhai H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097636; Zhang, 2007, CROP MANAGE, V6, DOI [10.1094/cm-2007-0927-01-rs, DOI 10.1094/CM-2007-0927-01-RS, 10.1094/CM-2007-0927-01-RS]	21	7	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166894	10.1371/journal.pone.0166894	http://dx.doi.org/10.1371/journal.pone.0166894			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907027	Green Submitted, Green Published, gold			2022-12-26	WOS:000389482700051
J	Kirkeby, C; Graesboll, K; Nielsen, SS; Christiansen, LE; Toft, N; Halasa, T				Kirkeby, Carsten; Graesboll, Kaare; Nielsen, Soren Saxmose; Christiansen, Lasse Engbo; Toft, Nils; Halasa, Tariq			Adaptive Test Schemes for Control of Paratuberculosis in Dairy Cows	PLOS ONE			English	Article							AVIUM SUBSP PARATUBERCULOSIS; JOHNES-DISEASE CONTROL; CONTROL PROGRAM; HERDS; PREVALENCE; PROBABILITY; INFECTION	Paratuberculosis is a chronic infection that in dairy cattle causes reduced milk yield, weight loss, and ultimately fatal diarrhea. Subclinical animals can excrete bacteria (Mycobacterium avium ssp. paratuberculosis, MAP) in feces and infect other animals. Farmers identify the infectious animals through a variety of test-strategies, but are challenged by the lack of perfect tests. Frequent testing increases the sensitivity but the costs of testing are a cause of concern for farmers. Here, we used a herd simulation model using milk ELISA tests to evaluate the epidemiological and economic consequences of continuously adapting the sampling interval in response to the estimated true prevalence in the herd. The key results were that the true prevalence was greatly affected by the hygiene level and to some extent by the test-frequency. Furthermore, the choice of prevalence that will be tolerated in a control scenario had a major impact on the true prevalence in the normal hygiene setting, but less so when the hygiene was poor. The net revenue is not greatly affected by the test-strategy, because of the general variation in net revenues between farms. An exception to this is the low hygiene herd, where frequent testing results in lower revenue. When we look at the probability of eradication, then it is correlated with the testing frequency and the target prevalence during the control phase. The probability of eradication is low in the low hygiene herd, and a test-and-cull strategy should probably not be the primary strategy in this herd. Based on this study we suggest that, in order to control MAP, the standard Danish dairy farm should use an adaptive strategy where a short sampling interval of three months is used when the estimated true prevalence is above 1%, and otherwise use a long sampling interval of one year.	[Kirkeby, Carsten; Graesboll, Kaare; Toft, Nils; Halasa, Tariq] Tech Univ Denmark, Epidemiol Sect, DTU VET, Richard Petersens Plads, Denmark; [Nielsen, Soren Saxmose] Univ Copenhagen, Dept Large Anim Sci, Sect Anim Welf & Dis Control, Copenhagen, Denmark; Tech Univ Denmark, DTU Compute, Sect Dynam Syst, Dept Appl Math & Comp Sci, Richard Petersens Plads, Denmark	Technical University of Denmark; University of Copenhagen; Technical University of Denmark	Kirkeby, C (corresponding author), Tech Univ Denmark, Epidemiol Sect, DTU VET, Richard Petersens Plads, Denmark.	ckir@vet.dtu.dk	Kirkeby, Carsten/GVS-8137-2022	Graesboll, Kaare/0000-0002-6258-8212; Halasa, Tariq/0000-0003-1112-0254; Christiansen, Lasse Engbo/0000-0001-5019-1931; Nielsen, Soren/0000-0003-2417-0787; Kirkeby, Carsten/0000-0001-9292-5526	Green Development and Demonstration Program (GUDP) under the Danish Directorate for Food, Fisheries and Agriculture [34009-13-0596]	Green Development and Demonstration Program (GUDP) under the Danish Directorate for Food, Fisheries and Agriculture	This project was funded by the Green Development and Demonstration Program (GUDP) under the Danish Directorate for Food, Fisheries and Agriculture, grant no. 34009-13-0596.	Al-Mamun MA, 2016, J THEOR BIOL, V408, P105, DOI 10.1016/j.jtbi.2016.08.014; Collins MT, 2010, J DAIRY SCI, V93, P1638, DOI 10.3168/jds.2009-2664; COLLINS MT, 1994, J AM VET MED ASSOC, V204, P208; Dorshorst NC, 2006, PREV VET MED, V75, P92, DOI 10.1016/j.prevetmed.2006.02.002; Frossling J, 2013, PREV VET MED, V108, P47, DOI 10.1016/j.prevetmed.2012.07.010; Graesboll K, 2015, P 12 INT C PAR PARM, P139; Groenendaal H, 2003, J AM VET MED ASSOC, V223, P1757, DOI 10.2460/javma.2003.223.1757; Kennedy DJ, 2000, VET MICROBIOL, V77, P443, DOI 10.1016/S0378-1135(00)00329-1; Kirkeby C, FRONTIERS VET SCI, V3, P90, DOI [10.3389/fvets.2016.00090, DOI 10.3389/FVETS.2016.00090]; Kudahl AB, 2009, J DAIRY SCI, V92, P4340, DOI 10.3168/jds.2009-2039; Lu Z, 2008, J THEOR BIOL, V254, P135, DOI 10.1016/j.jtbi.2008.05.008; McAloon CG, 2016, J DAIRY SCI, V99, P1449, DOI 10.3168/jds.2015-10156; Nielsen SS, 2006, J DAIRY SCI, V89, P4557, DOI 10.3168/jds.S0022-0302(06)72505-X; Nielsen S. S., 2014, CAB Reviews, V9, P1, DOI 10.1079/PAVSNNR20149012; Nielsen S.S., 2007, B INT DAIRY FED, V410, P23; Nielsen SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063009; Ott SL, 1999, PREV VET MED, V40, P179, DOI 10.1016/S0167-5877(99)00037-9; Robins J, 2015, VET RES, V46, DOI 10.1186/s13567-015-0195-y; ROGAN WJ, 1978, AM J EPIDEMIOL, V107, P71, DOI 10.1093/oxfordjournals.aje.a112510; S. Economy, 2008, J DAIRY SCI, V91, P4599, DOI [10.3168/jds.2008-1257, DOI 10.3168/JDS.2008-1257]; Sergeant ESG, 2008, PREV VET MED, V85, P92, DOI 10.1016/j.prevetmed.2008.01.005; Sorge U, 2010, J DAIRY SCI, V93, P1491, DOI 10.3168/jds.2009-2447; Sweeney RW, 2011, VET CLIN N AM-FOOD A, V27, P537, DOI 10.1016/j.cvfa.2011.07.001; Verdugo C, 2015, PREV VET MED, V121, P282, DOI 10.1016/j.prevetmed.2015.07.012; Whitlock RH, 2000, VET MICROBIOL, V77, P387, DOI 10.1016/S0378-1135(00)00324-2; Whittington RJ, 2001, AUST VET J, V79, P267, DOI 10.1111/j.1751-0813.2001.tb11980.x	26	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167219	10.1371/journal.pone.0167219	http://dx.doi.org/10.1371/journal.pone.0167219			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907192	Green Published, Green Submitted, gold			2022-12-26	WOS:000389482700094
J	Schuster, C; Hardiman, O; Bede, P				Schuster, Christina; Hardiman, Orla; Bede, Peter			Development of an Automated MRI-Based Diagnostic Protocol for Amyotrophic Lateral Sclerosis Using Disease-Specific Pathognomonic Features: A Quantitative Disease-State Classification Study	PLOS ONE			English	Article							WHITE-MATTER DEGENERATION; ALS	Background Despite significant advances in quantitative neuroimaging, the diagnosis of ALS remains clinical and MRI-based biomarkers are not currently used to aid the diagnosis. The objective of this study is to develop a robust, disease-specific, multimodal classification protocol and validate its diagnostic accuracy in independent, early-stage and follow-up data sets. Methods 147 participants (81 ALS patients and 66 healthy controls) were divided into a training sample and a validation sample. Patients in the validation sample underwent follow-up imaging longitudinally. After removing age-related variability, indices of grey and white matter integrity in ALS-specific pathognomonic brain regions were included in a cross-validated binary logistic regression model to determine the probability of individual scans indicating ALS. The following anatomical regions were assessed for diagnostic classification: average grey matter density of the left and right precentral gyrus, the average fractional anisotropy and radial diffusivity of the left and right superior corona radiata, inferior corona radiata, internal capsule, mesencephalic crus of the cerebral peduncles, pontine segment of the corticospinal tract, and the average diffusivity values of the genu, corpus and splenium of the corpus callosum. Results Using a 50% probability cut-off value of suffering from ALS, the model was able to discriminate ALS patients and HC with good sensitivity (80.0%) and moderate accuracy (70.0%) in the training sample and superior sensitivity (85.7%) and accuracy (78.4%) in the independent validation sample. Conclusions This diagnostic classification study endeavours to advance ALS biomarker research towards pragmatic clinical applications by providing an approach of automated individual-data interpretation based on group-level observations.	[Schuster, Christina; Hardiman, Orla; Bede, Peter] Trinity Coll Dublin, Inst Biomed Sci, Acad Unit Neurol, Quantitat Neuroimaging Grp, Dublin, Ireland	Trinity College Dublin	Bede, P (corresponding author), Trinity Coll Dublin, Inst Biomed Sci, Acad Unit Neurol, Quantitat Neuroimaging Grp, Dublin, Ireland.	bedepeter@hotmail.com	Hardiman, Orla/Y-3441-2019	Hardiman, Orla/0000-0003-2610-1291; Bede, Peter/0000-0003-0492-4772	Irish Institute of Clinical Neuroscience (IICN)-Novartis Ireland Research Grant; Iris O'Brien Foundation; Perrigo Clinician-Scientist Research Fellowship; Health Research Board; Research Motor Neuron (RMN-Ireland) foundation; European Community's Seventh Framework Programme (FP7) [259867]; EU-Joint Programme for Neurodegeneration (JPND) SOPHIA project	Irish Institute of Clinical Neuroscience (IICN)-Novartis Ireland Research Grant; Iris O'Brien Foundation; Perrigo Clinician-Scientist Research Fellowship; Health Research Board; Research Motor Neuron (RMN-Ireland) foundation; European Community's Seventh Framework Programme (FP7); EU-Joint Programme for Neurodegeneration (JPND) SOPHIA project	This work was supported by the Irish Institute of Clinical Neuroscience (IICN)-Novartis Ireland Research Grant, The Iris O'Brien Foundation, The Perrigo Clinician-Scientist Research Fellowship, the Health Research Board and the Research Motor Neuron (RMN-Ireland) foundation. Professor Hardiman's research group has also received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no [259867] (EUROMOTOR), the EU-Joint Programme for Neurodegeneration (JPND) SOPHIA project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Irish Institute of Clinical Neuroscience (IICN)-Novartis Ireland Research Grant, The Iris O'Brien Foundation, The Perrigo Clinician-Scientist Research Fellowship, the Health Research Board and the Research Motor Neuron (RMN-Ireland) foundation. Professor Hardiman's research group has also received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no [259867] (EUROMOTOR), the EU-Joint Programme for Neurodegeneration (JPND) SOPHIA project. The sponsors of the study had no role in study design, writing of the report, or decision to submit this work for publication.	Agosta F, 2010, EUR J NEUROSCI, V32, P1490, DOI 10.1111/j.1460-9568.2010.07445.x; Arbabshirani M.R., 2016, NEUROIMAGE; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Bede P, 2015, J NEUROL NEUROSUR PS, V86, P468, DOI 10.1136/jnnp-2014-308172; Bede P., 2016, AMYOTROPHIC LATERAL, P1; Bede P, 2013, AMYOTROPHIC LATERAL; Bede P, 2014, NEUROIMAGE-CLIN, V4, P436, DOI 10.1016/j.nicl.2014.02.011; Bede P, 2013, NEUROLOGY, V81, P2107, DOI 10.1212/01.wnl.0000437313.80913.2c; Bede P, 2013, NEUROLOGY, V81, P361, DOI 10.1212/WNL.0b013e31829c5eee; Bede P, 2013, J NEUROL NEUROSUR PS, V84, P766, DOI 10.1136/jnnp-2012-302674; Bede P, 2012, AMYOTROPH LATERAL SC, V13, P407, DOI 10.3109/17482968.2011.649760; Ben Bashat D, 2011, AMYOTROPH LATERAL SC, V12, P398, DOI 10.3109/17482968.2011.582646; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Cellura E, 2012, CLIN NEUROL NEUROSUR, V114, P550, DOI 10.1016/j.clineuro.2011.11.026; Chen SH, 2008, GENET EPIDEMIOL, V32, P152, DOI 10.1002/gepi.20272; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; El Mendili MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095516; Elamin M, 2013, NEUROLOGY, V80, P1590, DOI 10.1212/WNL.0b013e31828f18ac; Filippini N, 2010, NEUROLOGY, V75, P1645, DOI 10.1212/WNL.0b013e3181fb84d1; Foerster BR, 2013, ACAD RADIOL, V20, P1099, DOI 10.1016/j.acra.2013.03.017; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gupta PK, 2012, J NEUROL SCI, V312, P68, DOI 10.1016/j.jns.2011.08.021; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; Koikkalainen J, 2016, NEUROIMAGE CLIN; Koikkalainen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031112; Lillo P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043993; Machts J, 2015, NEUROLOGY, V85, P1301, DOI 10.1212/WNL.0000000000002017; McLaughlin RL, 2015, NEUROBIOL AGING, V36; Mueller Susanne G, 2005, Alzheimers Dement, V1, P55, DOI 10.1016/j.jalz.2005.06.003; Muller H-P, 2016, J NEUROLOGY NEUROSUR; Oishi K, 2008, NEUROIMAGE, V43, P447, DOI 10.1016/j.neuroimage.2008.07.009; Orru G, 2012, NEUROSCI BIOBEHAV R, V36, P1140, DOI 10.1016/j.neubiorev.2012.01.004; Pagani M, 2014, NEUROLOGY, V83, P1067, DOI 10.1212/WNL.0000000000000792; Schuster C, 2016, EUR J NEUROL, V23, P1361, DOI 10.1111/ene.13038; Schuster C, 2015, J NEUROL NEUROSUR PS, V86, P1089, DOI 10.1136/jnnp-2014-309888; Schuster C, 2014, NEUROBIOL AGING, V35, P240, DOI 10.1016/j.neurobiolaging.2013.07.020; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Stonnington CM, 2008, NEUROIMAGE, V39, P1180, DOI 10.1016/j.neuroimage.2007.09.066; Teipel SJ, 2011, PSYCHIAT RES-NEUROIM, V194, P363, DOI [10.1016/j.pscychresns2011.05.012, 10.1016/j.pscychresns.2011.05.012]; Turner MR, 2011, LANCET; Van Laere K, 2014, JAMA NEUROL, V71, P553, DOI 10.1001/jamaneurol.2014.62; Wang SJ, 2012, MED IMAGE ANAL, V16, P933, DOI 10.1016/j.media.2012.02.005; Welsh Robert C, 2013, Front Hum Neurosci, V7, P251, DOI 10.3389/fnhum.2013.00251; Wokke JH, 2000, AMYOTROPH LATERAL SC, V1, pS61, DOI 10.1080/14660820050515773	45	56	54	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167331	10.1371/journal.pone.0167331	http://dx.doi.org/10.1371/journal.pone.0167331			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907080	Green Published, gold, Green Submitted			2022-12-26	WOS:000389482700120
J	Shevtsova, E; Shevtsov, A; Mukanov, K; Filipenko, M; Kamalova, D; Sytnik, I; Syzdykov, M; Kuznetsov, A; Akhmetova, A; Zharova, M; Karibaev, T; Tarlykov, P; Ramanculov, E				Shevtsova, Elena; Shevtsov, Alexandr; Mukanov, Kasim; Filipenko, Maxim; Kamalova, Dinara; Sytnik, Igor; Syzdykov, Marat; Kuznetsov, Andrey; Akhmetova, Assel; Zharova, Mira; Karibaev, Talgat; Tarlykov, Pavel; Ramanculov, Erlan			Epidemiology of Brucellosis and Genetic Diversity of Brucella abortus in Kazakhstan	PLOS ONE			English	Article							MELITENSIS; STRAIN; MLVA; REEMERGENCE; COUNTRIES; VACCINE; CATTLE; LOCI	Brucellosis is a major zoonotic infection in Kazakhstan. However, there is limited data on its incidence in humans and animals, and the genetic diversity of prevalent strains is virtually unstudied. Additionally, there is no detailed overview of Kazakhstan brucellosis control and eradication programs. Here, we analyzed brucellosis epidemiological data, and assessed the effectiveness of eradication strategies employed over the past 70 years to counteract this infection. We also conducted multiple loci variable-number tandem repeat analysis (MLVA) of Brucella abortus strains found in Kazakhstan. We analyzed official data on the incidence of animal brucellosis in Kazakhstan. The records span more than 70 years of anti-brucellosis campaigns, and contain a brief description of the applied control strategies, their effectiveness, and their impact on the incidence in humans. The MLVA-16 method was used to type 94 strains of B. abortus and serial passages of B. abortus 82, a strain used in vaccines. MLVA-8 and MLVA-11 analyses clustered strains into a total of four and seven genotypes, respectively; it is the first time that four of these genotypes have been described. MLVA-16 analysis divided strains into 28 distinct genotypes having genetic similarity coefficient that varies from 60 to100% and a Hunter & Gaston diversity index of 0.871. MST analysis reconstruction revealed clustering into "Kazakhstani-Chinese (Central Asian)", "European" and "American" lines. Detection of multiple genotypes in a single outbreak confirms that poorly controlled trade of livestock plays a crucial role in the spread of infection. Notably, the MLVA-16 profile of the B. abortus 82 strain was unique and did not change during 33 serial passages. MLVA genotyping may thus be useful for epidemiological monitoring of brucellosis, and for tracking the source(s) of infection. We suggest that countrywide application of MLVA genotyping would improve the control of brucellosis in Kazakhstan.	[Shevtsova, Elena; Shevtsov, Alexandr; Mukanov, Kasim; Filipenko, Maxim; Kamalova, Dinara; Tarlykov, Pavel] Natl Biotechnol Ctr, Astana, Kazakhstan; [Filipenko, Maxim] Inst Chem Biol & Fundamental Med, Novosibirsk, Russia; [Filipenko, Maxim] Novosibirsk State Univ, Novosibirsk, Russia; [Sytnik, Igor; Akhmetova, Assel; Zharova, Mira; Karibaev, Talgat] Natl Reference Ctr Vet, Astana, Kazakhstan; [Syzdykov, Marat; Kuznetsov, Andrey] Kazakh Sci Ctr Quarantine & Zoonot Dis, Alma Ata, Kazakhstan; [Ramanculov, Erlan] Nazarbayev Univ, Sch Sci & Technol, Astana, Kazakhstan	National Center for Biotechnology (NCB); Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Novosibirsk State University; Aikimbayev's Kazakh Scientific Centre for Quarantine & Zoonotic Diseases; Kazakh Scientific Research Institute of Plant Protection & Quarantine of Zh.Zhienbaev; Nazarbayev University	Shevtsov, A (corresponding author), Natl Biotechnol Ctr, Astana, Kazakhstan.	ncbshevtsov@gmail.com	Filipenko, Maksim/AAU-9552-2020; Alexandr, Shevtsov/P-2717-2017; Kuznetsov, Andrey/K-8824-2014; Ramankulov, Yerlan/AAG-7450-2019; Tarlykov, Pavel/C-2587-2012; Shevtsova, Elena/G-6288-2017; Kamalova, Dinara/ABB-6600-2020; Mukanov, Kasim/N-4118-2017	Filipenko, Maksim/0000-0002-8950-5368; Alexandr, Shevtsov/0000-0002-0307-1053; Kuznetsov, Andrey/0000-0003-2354-533X; Ramankulov, Yerlan/0000-0001-6786-3028; Tarlykov, Pavel/0000-0003-2075-307X; Shevtsova, Elena/0000-0002-7221-5866; Sytnik, Igor'/0000-0002-3439-7021; Kamalova, Dinara/0000-0002-8444-3305; Kamalova, Dinara/0000-0002-4570-8761; Ramanculov, Erlan/0000-0001-6791-4497	Ministry of Education and Science of the Republic of Kazakhstan [N0115RK01870]	Ministry of Education and Science of the Republic of Kazakhstan(Government of the Republic of KazakhstanMinistry of Education and Science of the Republic of Kazakhstan)	This work was supported by funding received from the Ministry of Education and Science of the Republic of Kazakhstan, grant no. N0115RK01870. AS received the funding. (http://sc.edu.gov.kz/main/?L=2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Dahouk S, 2007, J MICROBIOL METH, V69, P137, DOI 10.1016/j.mimet.2006.12.015; Amato GAJ, 1995, MALTESE MED J, V7, P7; Amireyev SA, 1986, EPIDEMIOLOGIYA EPIZO; Beauvais W, 2015, ECOHEALTH, V30, P30; Bricker BJ, 2003, BMC MICROBIOL, V3, DOI 10.1186/1471-2180-3-15; De Massis F, 2015, TRANSBOUND EMERG DIS, V62, P463, DOI 10.1111/tbed.12397; De Santis R, 2011, BMC MICROBIOL, V11, P1471; de Vegas EZS, 2006, INFECT CONT HOSP EP, V27, P397, DOI 10.1086/503177; Di Giannatale E., 2006, VET ITAL, V44, P383; Doganay Gizem D, 2013, Recent Pat Antiinfect Drug Discov, V8, P27; Dorneles EMS, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-186; Durusoy R, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-71; Ferreira AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042514; Garcia-Yoldi D, 2007, VACCINE, V25, P2858, DOI 10.1016/j.vaccine.2006.09.063; Garofolo G, 2013, INFECT GENET EVOL, V19, P59, DOI 10.1016/j.meegid.2013.06.021; Garofolo G, 2013, J MICROBIOL METH, V92, P103, DOI 10.1016/j.mimet.2012.11.007; Godfroid J, 2002, REV SCI TECH OIE, V21, P277, DOI 10.20506/rst.21.2.1333; Godfroid J, 2002, VET MICROBIOL, V90, P135, DOI 10.1016/S0378-1135(02)00217-1; Godfroid J, 2013, COMP IMMUNOL MICROB, V36, P241, DOI 10.1016/j.cimid.2012.09.001; Grissa I, 2008, BIOCHIMIE, V90, P660, DOI 10.1016/j.biochi.2007.07.014; Grushina T, 2003, BRUC 2003 INT RES C; Guigon G., 2008, Eurosurveillance, V13, P18863; Gwida M, 2012, COMP IMMUNOL MICROB, V35, P181, DOI 10.1016/j.cimid.2011.12.012; Gwida M, 2010, CROAT MED J, V51, P289, DOI 10.3325/cmj.2010.51.289; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Ivanov Arkady V., 2011, Animal Health Research Reviews, V12, P113, DOI 10.1017/S1466252311000028; Jiang HN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067637; Kattar MM, 2008, J CLIN MICROBIOL, V46, P3935, DOI 10.1128/JCM.00464-08; Kineyev MA, 2005, PORODY KRUPNOGO ROGA; Kulakov YK, 2010, VACCINE, V1, P31; Kuznetsov VS, 1962, KAZAKHSKO KITAYSKIYE; Le Fleche P, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-9; Lundervold M, 2004, ACTA VET SCAND, V45, P211, DOI 10.1186/1751-0147-45-211; Mailles A, 2012, EUROSURVEILLANCE, V17, P2; Mantur B G, 2007, Indian J Med Microbiol, V25, P188; Mezenchuk EA, 1941, IZVESTIYA KAZAKHSTAN, V1, P140; Mick V, 2014, PLOS ONE, V9; Millward James, 2021, EURASIAN CROSSROADS, V2nd; Minharro S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081152; Mizanbayeva S, 2009, DIAGN MICR INFEC DIS, V65, P14, DOI 10.1016/j.diagmicrobio.2009.05.002; Neubauer H, 2010, Prilozi, V31, P209; Nicoletti P, 1980, Adv Vet Sci Comp Med, V24, P69; Nicoletti P, 2010, Prilozi, V31, P21; Norman FF, 2016, TRAVEL MED INFECT DI, V14, P182, DOI 10.1016/j.tmaid.2016.05.005; OIE, 2012, MANUAL DIAGNOSTIC TE; Pappas G, 2006, LANCET INFECT DIS, V6, P91, DOI 10.1016/S1473-3099(06)70382-6; Pridorogin MI, 1914, KRUPNYY ROGATYY SKOT; Rementsova MM, 1962, BRUTSELLOZ DIKIKH ZH; Robinson S, 2003, HUM ECOL, V31, P87, DOI 10.1023/A:1022834224257; Shevtsov A, 2013, GENOME ANNOUNC, V1; Shevtsov A, 2015, INFECT GENET EVOL, V34, P173, DOI 10.1016/j.meegid.2015.07.008; Studentsov KP, 1975, BRUTSELLEZ ZHIVOTNYK; Sun YH, 2005, CURR PROTOC MICROBIO; Syzdykov M.S., 2014, GIGIYENA EPIDEMIOLOG, V72, P24; Tappe D, 2012, J MED MICROBIOL, V61, P1335, DOI 10.1099/jmm.0.038612-0; Tukana A, 2015, PREV VET MED, V122, P14, DOI 10.1016/j.prevetmed.2015.10.005; Whatmore AM, 2006, J CLIN MICROBIOL, V44, P1982, DOI 10.1128/JCM.02039-05	57	20	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167496	10.1371/journal.pone.0167496	http://dx.doi.org/10.1371/journal.pone.0167496			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907105	Green Published, gold, Green Submitted			2022-12-26	WOS:000389482700170
J	Tyndall, JDA; Sabherwal, M; Sagatova, AA; Keniya, MV; Negroni, J; Wilson, RK; Woods, MA; Tietjen, K; Monk, BC				Tyndall, Joel D. A.; Sabherwal, Manya; Sagatova, Alia A.; Keniya, Mikhail V.; Negroni, Jacopo; Wilson, Rajni K.; Woods, Matthew A.; Tietjen, Klaus; Monk, Brian C.			Structural and Functional Elucidation of Yeast Lanosterol 14 alpha-Demethylase in Complex with Agrochemical Antifungals	PLOS ONE			English	Article							ASPERGILLUS-FUMIGATUS; AZOLE RESISTANCE; MYCOSPHAERELLA-GRAMINICOLA; TRIAZOLE RESISTANCE; CYP51; CYTOCHROME-P450; FUNGICIDES; SENSITIVITY; MECHANISMS; MUTATIONS	Azole antifungals, known as demethylase inhibitors (DMIs), target sterol 14 alpha-demethylase (CYP51) in the ergosterol biosynthetic pathway of fungal pathogens of both plants and humans. DMIs remain the treatment of choice in crop protection against a wide range of fungal phytopathogens that have the potential to reduce crop yields and threaten food security. We used a yeast membrane protein expression system to overexpress recombinant hexahistidine-tagged S. cerevisiae lanosterol 14 alpha-demethylase and the Y140F or Y140H mutants of this enzyme as surrogates in order characterize interactions with DMIs. The whole-cell antifungal activity (MIC50 values) of both the R-and S-enantiomers of tebuconazole, prothioconazole (PTZ), prothioconazole-desthio, and oxo-prothioconazole (oxo-PTZ) as well as for fluquinconazole, prochloraz and a racemic mixture of difenoconazole were determined. In vitro binding studies with the affinity purified enzyme were used to show tight type II binding to the yeast enzyme for all compounds tested except PTZ and oxo-PTZ. High resolution X-ray crystal structures of ScErg11p6xHis in complex with seven DMIs, including four enantiomers, reveal triazole-mediated coordination of all compounds and the specific orientation of compounds within the relatively hydrophobic binding site. Comparison with CYP51 structures from fungal pathogens including Candida albicans, Candida glabrata and Aspergillus fumigatus provides strong evidence for a highly conserved CYP51 structure including the drug binding site. The structures obtained using S. cerevisiae lanosterol 14 alpha-demethylase in complex with these agrochemicals provide the basis for understanding the impact of mutations on azole susceptibility and a platform for the structure-directed design of the next-generation of DMIs.	[Tyndall, Joel D. A.] Univ Otago, New Zealands Natl Sch Pharm, Dunedin, New Zealand; [Sabherwal, Manya; Sagatova, Alia A.; Keniya, Mikhail V.; Wilson, Rajni K.; Woods, Matthew A.; Monk, Brian C.] Univ Otago, New Zealands Natl Ctr Dent, Sir John Walsh Res Inst, Dunedin, New Zealand; [Keniya, Mikhail V.; Monk, Brian C.] Univ Otago, New Zealands Natl Ctr Dent, Dept Oral Sci, Dunedin, New Zealand; [Negroni, Jacopo] Bayer SAS, Div Crop Sci, Dis Control Res, Lyon, France; [Tietjen, Klaus] Bayer AG, Div Crop Sci, Dis Control Res, Monheim, Germany	University of Otago; University of Otago; University of Otago; Bayer AG; Bayer AG	Tyndall, JDA (corresponding author), Univ Otago, New Zealands Natl Sch Pharm, Dunedin, New Zealand.; Monk, BC (corresponding author), Univ Otago, New Zealands Natl Ctr Dent, Sir John Walsh Res Inst, Dunedin, New Zealand.; Monk, BC (corresponding author), Univ Otago, New Zealands Natl Ctr Dent, Dept Oral Sci, Dunedin, New Zealand.	joel.tyndall@otago.ac.nz; brian.monk@otago.ac.nz	Sagatova, Alia/AAH-7119-2019; tyndall, joel/C-2803-2008	tyndall, joel/0000-0003-0783-1635; Keniya, Mikhail/0000-0001-5193-6982; Monk, Brian/0000-0003-2264-3480	Health Research Council; Bayer Crop Science	Health Research Council; Bayer Crop Science(Bayer AG)	This programme was funded by the Health Research Council and Bayer Crop Science, https://www.cropscince.bayer.com. The funding was provided to BM and used for this study. The commercial funders provided financial support in the form of authors' salaries and/or research materials. JN and KT had a minor role in data analysis, and preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Becher R, 2012, APPL MICROBIOL BIOT, V95, P825, DOI 10.1007/s00253-012-4195-9; Bowyer P, 2014, PEST MANAG SCI, V70, P173, DOI 10.1002/ps.3567; Camps SMT, 2012, J CLIN MICROBIOL, V50, P2674, DOI 10.1128/JCM.00335-12; Chen ZF, 2015, ENVIRON INT, V84, P142, DOI 10.1016/j.envint.2015.07.022; Chowdhary A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003633; Cools HJ, 2013, PEST MANAG SCI, V69, P150, DOI 10.1002/ps.3348; Dong FS, 2013, ENVIRON SCI TECHNOL, V47, P3386, DOI 10.1021/es304982m; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Faria-Ramos I, 2014, FEMS YEAST RES, V14, P1119, DOI 10.1111/1567-1364.12193; Fraaije BA, 2007, MOL PLANT PATHOL, V8, P245, DOI [10.1111/j.1364-3703.2007.00388.x, 10.1111/j.1364-3703.2007.00388.X]; Franceschini S, 2016, COMPOST SCI UTIL, V24, P20, DOI 10.1080/1065657X.2015.1046612; Guengerich FP, 2009, NAT PROTOC, V4, P1245, DOI 10.1038/nprot.2009.121; Haas M., 2004, Pflanzenschutz-Nachrichten Bayer, V57, P207; Hargrove TY, 2015, J BIOL CHEM, V290, P23916, DOI 10.1074/jbc.M115.677310; Kakeya H, 2000, ANTIMICROB AGENTS CH, V44, P2985, DOI 10.1128/AAC.44.11.2985-2990.2000; Kjaerstad MB, 2010, REPROD TOXICOL, V30, P573, DOI 10.1016/j.reprotox.2010.07.009; Kuck K-H, 2012, MODERN CROP PRO TECT, P1; Lamping E, 2007, EUKARYOT CELL, V6, P1150, DOI 10.1128/EC.00091-07; Leroux P, 2007, PEST MANAG SCI, V63, P688, DOI 10.1002/ps.1390; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mo CQ, 2005, BBA-MOL CELL BIOL L, V1737, P152, DOI 10.1016/j.bbalip.2005.11.002; Monk BC, 2014, P NATL ACAD SCI USA, V111, P3865, DOI 10.1073/pnas.1324245111; Mullins JGL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020973; Parker Josie E., 2014, Journal of Chemical Biology, V7, P143, DOI 10.1007/s12154-014-0121-1; Parker JE, 2013, APPL ENVIRON MICROB, V79, P1639, DOI 10.1128/AEM.03246-12; Parker JE, 2011, APPL ENVIRON MICROB, V77, P1460, DOI 10.1128/AEM.01332-10; Price CL, 2015, PEST MANAG SCI, V71, P1054, DOI 10.1002/ps.4029; Price CL, 2015, APPL ENVIRON MICROB, V81, P3379, DOI 10.1128/AEM.03965-14; Reif DM, 2010, ENVIRON HEALTH PERSP, V118, P1714, DOI 10.1289/ehp.1002180; Russell PE, J AGR SCI, V143, P11; Sagatova AA, 2016, SCI REP-UK, V6, DOI 10.1038/srep26213; Sagatova AA, 2015, ANTIMICROB AGENTS CH, V59, P4982, DOI 10.1128/AAC.00925-15; Sanglard D, 1998, ANTIMICROB AGENTS CH, V42, P241, DOI 10.1093/jac/42.2.241; Snelders E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031801; Snelders E, 2011, FUNGAL GENET BIOL, V48, P1062, DOI 10.1016/j.fgb.2011.08.002; Stammler G, 2008, CROP PROT, V27, P1448, DOI 10.1016/j.cropro.2008.07.007; Tietjen K, 2016, MODERN FUNGICIDES AN, VVIII; Trosken E.-R, 2005, TOXICOLOGICAL EVALUA; van der Linden JWM, 2013, CLIN INFECT DIS, V57, P513, DOI 10.1093/cid/cit320; Verweij PE, 2016, CLIN INFECT DIS, V62, P362, DOI 10.1093/cid/civ885; Warrilow AGS, 2010, ANTIMICROB AGENTS CH, V54, P4225, DOI 10.1128/AAC.00316-10	44	37	38	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167485	10.1371/journal.pone.0167485	http://dx.doi.org/10.1371/journal.pone.0167485			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907120	Green Published, Green Submitted, gold			2022-12-26	WOS:000389482700165
J	Stelmokas, J; Gabel, N; Flaherty, JM; Rayson, K; Tran, K; Anderson, JR; Bieliauskas, LA				Stelmokas, Julija; Gabel, Nicolette; Flaherty, Jennifer M.; Rayson, Katherine; Tran, Kathileen; Anderson, Jason R.; Bieliauskas, Linas A.			Delirium Detection and Impact of Comorbid Health Conditions in a Post-Acute Rehabilitation Hospital Setting	PLOS ONE			English	Article							COGNITIVE TEST BATTERY; VALIDATION; UTILITY; CARE	Misdiagnosis and under-detection of delirium may occur in many medical settings. This is important to address as delirium clearly increases risk of morbidity and mortality in such settings. This study assessed whether Veterans who screened positive on a delirium severity measure (Memorial Delirium Assessment Scale; MDAS) differed from those with and without corresponding medical documentation of delirium in terms of cognitive functioning, psychiatric/ medical history, and medication use. A medical record review of 266 inpatients at a VA post-acute rehabilitation unit found that 10.9% were identified as delirious according to the MDAS and/or medical records. Of the Veterans who screened positive on the MDAS (N = 19), 68.4% went undetected by medical screening. Undetected cases had a higher number of comorbid medical conditions as measured by the Age-Adjusted Charlson Index (AACI) scores (median = 9, SD = 3.15; U = 5.5, p = .003) than medically documented cases. For Veterans with a score of 7 or greater on the AACI, the general relative risk for delirium was 4.46. Delirium is frequently under-detected in a post-acute rehabilitation unit, particularly for Veterans with high comorbid illness. The relative risk of delirium is up to 4.46 for those with high medical burden, suggesting the need for more comprehensive delirium screening in these patients.	[Stelmokas, Julija; Rayson, Katherine; Bieliauskas, Linas A.] Vet Affairs Ann Arbor Healthcare Syst, Ann Arbor, MI 48105 USA; [Gabel, Nicolette] Univ Michigan, Sch Med, Ann Arbor, MI USA; [Flaherty, Jennifer M.] Eastern Virginia Med Sch, Dept Psychiat & Behav Sci, Norfolk, VA 23501 USA; [Tran, Kathileen; Bieliauskas, Linas A.] Univ Michigan, Ann Arbor, MI 48109 USA; [Anderson, Jason R.] Kent State Univ, Kent, OH 44242 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan; Eastern Virginia Medical School; University of Michigan System; University of Michigan; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem	Stelmokas, J (corresponding author), Vet Affairs Ann Arbor Healthcare Syst, Ann Arbor, MI 48105 USA.	jstelmok@med.umich.edu						American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Boustani M., 2008, AGING HLTH, V4, P311, DOI [10.2217/1745509x.4.3.311, DOI 10.2217/1745509X.4.3.311, 10.2217/1745509XA3.311, 10.2217/1745509X.4.3.311]; Breitbart W, 1997, J PAIN SYMPTOM MANAG, V13, P128, DOI 10.1016/S0885-3924(96)00316-8; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Collins N, 2010, AGE AGEING, V39, P131, DOI 10.1093/ageing/afp201; Detweiler MB, 2014, PSYCHIAT QUART, V85, P211, DOI 10.1007/s11126-013-9284-0; Eden BM, 1996, HEART LUNG, V25, P388, DOI 10.1016/S0147-9563(96)80082-3; Elie M, 2000, CAN MED ASSOC J, V163, P977; Hope Carol, 2014, BMC Res Notes, V7, P208, DOI 10.1186/1756-0500-7-208; INOUYE SK, 1990, ANN INTERN MED, V113, P941, DOI 10.7326/0003-4819-113-12-941; Kakuma R, 2003, J AM GERIATR SOC, V51, P443, DOI 10.1046/j.1532-5415.2003.51151.x; Kishi Y, 2007, GEN HOSP PSYCHIAT, V29, P442, DOI 10.1016/j.genhosppsych.2007.05.006; Lawlor PG, 2000, CANCER, V88, P2859, DOI 10.1002/1097-0142(20000615)88:12<2859::AID-CNCR29>3.3.CO;2-K; Mason SJ, 2002, Q J ROY METEOR SOC, V128, P2145, DOI 10.1256/003590002320603584; Mathuranath PS, 2000, NEUROLOGY, V55, P1613, DOI 10.1212/01.wnl.0000434309.85312.19; Mioshi E, 2006, INT J GERIATR PSYCH, V21, P1078, DOI 10.1002/gps.1610; Powers JS, 2013, GERONTOLOGIST, V53, P1051, DOI 10.1093/geront/gns161; Ryan DJ, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001772; Swigart SE, 2008, PSYCHOSOMATICS, V49, P104, DOI 10.1176/appi.psy.49.2.104; Tabet N, 2005, AGE AGEING, V34, P152, DOI 10.1093/ageing/afi031; Wechsler D., 1997, WECHSLER ADULT INTEL	21	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0166754	10.1371/journal.pone.0166754	http://dx.doi.org/10.1371/journal.pone.0166754			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FV	27902744	Green Published, Green Submitted, gold			2022-12-26	WOS:000389474100038
J	Guo, YY; An, LW; Ng, HM; Sy, SMH; Huen, MSY				Guo, Yingying; An, Liwei; Ng, Hoi-Man; Sy, Shirley M. H.; Huen, Michael S. Y.			An E2-guided E3 Screen Identifies the RNF17-UBE2U Pair as Regulator of the Radiosensitivity, Immunodeficiency, Dysmorphic Features, and Learning Difficulties (RIDDLE) Syndrome Protein RNF168	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; DNA-DAMAGE RESPONSE; RING-FINGER PROTEIN; UBIQUITIN STRUCTURES; STRUCTURAL BASIS; PIWI PROTEINS; HISTONE H2AX; UBIQUITYLATION; REPAIR; DOMAIN	Protein ubiquitination has emerged as a pivotal regulatory reaction that promotes cellular responses toDNAdamage. With a goal to delineate theDNAdamage signal transduction cascade, we systematically analyzed the human E2 ubiquitin-and ubiquitin-like-conjugating enzymes for their ability to mobilize the DNA damage marker 53BP1 onto ionizing radiation-induced DNA double strand breaks. An RNAi-based screen identified UBE2U as a candidate regulator of chromatin responses at double strand breaks. Further mining of the UBE2U interactome uncovered its cognate E3 RNF17 as a novel factor that, via the radiosensitivity, immunodeficiency, dysmorphic features, and learning difficulties (RIDDLE) syndrome protein RNF168, enforces DNA damage responses. Our screen allowed us to uncover new players in the mammalian DNA damage response and highlights the instrumental roles of ubiquitin machineries in promoting cell responses to genotoxic stress.	[Guo, Yingying; An, Liwei; Ng, Hoi-Man; Sy, Shirley M. H.; Huen, Michael S. Y.] Univ Hong Kong, Sch Biomed Sci, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China; [Huen, Michael S. Y.] Univ Hong Kong, State Key Lab Brain & Cognit Sci, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Sy, SMH; Huen, MSY (corresponding author), Univ Hong Kong, Sch Biomed Sci, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China.; Huen, MSY (corresponding author), Univ Hong Kong, State Key Lab Brain & Cognit Sci, Hong Kong, Hong Kong, Peoples R China.	mhsy@hku.hk; huen.michael@hku.hk		An, Liwei/0000-0003-4514-5476; guo, yingying/0000-0002-7829-6935; Huen, Michael Shing-Yan/0000-0003-1774-2425; Sy, Ming Hui/0000-0002-2731-6692	Research Grants Council Hong Kong [17104215]; The University of Hong Kong	Research Grants Council Hong Kong(Hong Kong Research Grants Council); The University of Hong Kong(University of Hong Kong)	This work was supported by Research Grants Council Hong Kong Project 17104215 and by the Outstanding Young Researcher Award (The University of Hong Kong) (to M. S. Y. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Bohgaki M, 2013, P NATL ACAD SCI USA, V110, P20982, DOI 10.1073/pnas.1320302111; Bohgaki T, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001381; Campbell SJ, 2012, J BIOL CHEM, V287, P23900, DOI 10.1074/jbc.M112.359653; Chen C, 2009, P NATL ACAD SCI USA, V106, P20336, DOI 10.1073/pnas.0911640106; Dantuma NP, 2016, EMBO J, V35, P6, DOI 10.15252/embj.201592595; Devgan SS, 2011, CELL DEATH DIFFER, V18, P1500, DOI 10.1038/cdd.2011.18; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Fradet-Turcotte A, 2013, NATURE, V499, P50, DOI 10.1038/nature12318; Galanty Y, 2009, NATURE, V462, P935, DOI 10.1038/nature08657; Gatti M, 2015, CELL REP, V10, P226, DOI 10.1016/j.celrep.2014.12.021; Gudjonsson T, 2012, CELL, V150, P697, DOI 10.1016/j.cell.2012.06.039; Guzzo CM, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003485; Hodge C. D., 2016, ONCOTARGET, DOI 10.18632/oncotarget.10948; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Huen MSY, 2010, MOL CELL, V37, P854, DOI 10.1016/j.molcel.2009.12.040; Iwasaki YW, 2015, ANNU REV BIOCHEM, V84, P405, DOI 10.1146/annurev-biochem-060614-034258; Jackson SP, 2013, MOL CELL, V49, P795, DOI 10.1016/j.molcel.2013.01.017; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Leung JW, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004178; Li TT, 2014, J CELL SCI, V127, P2238, DOI 10.1242/jcs.138891; Liu C, 2013, J CELL SCI, V126, P2042, DOI 10.1242/jcs.122945; Lou ZK, 2003, NATURE, V421, P957, DOI 10.1038/nature01447; Markson G, 2009, GENOME RES, V19, P1905, DOI 10.1101/gr.093963.109; Mattiroli F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4291; Mattiroli F, 2012, CELL, V150, P1182, DOI 10.1016/j.cell.2012.08.005; Messick TE, 2009, J CELL BIOL, V187, P319, DOI 10.1083/jcb.200908074; Morris JR, 2009, NATURE, V462, P886, DOI 10.1038/nature08593; Morris JR, 2004, HUM MOL GENET, V13, P807, DOI 10.1093/hmg/ddh095; Mosbech A, 2013, J BIOL CHEM, V288, P16579, DOI 10.1074/jbc.M113.459917; Pan JY, 2005, DEVELOPMENT, V132, P4029, DOI 10.1242/dev.02003; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Pinato S, 2011, MOL CELL BIOL, V31, P118, DOI 10.1128/MCB.00818-10; Pinato S, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-55; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Ross RJ, 2014, NATURE, V505, P353, DOI 10.1038/nature12987; Schmidt CK, 2015, NAT CELL BIOL, V17, P1458, DOI 10.1038/ncb3260; Sharma N, 2014, CELL CYCLE, V13, P106, DOI 10.4161/cc.26814; Sheng Y, 2012, MOL CELL PROTEOMICS, V11, P329, DOI 10.1074/mcp.O111.013706; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Stewart GS, 2007, P NATL ACAD SCI USA, V104, P16910, DOI 10.1073/pnas.0708408104; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Sy SMH, 2013, NUCLEIC ACIDS RES, V41, P8572, DOI 10.1093/nar/gkt622; Sy SMH, 2011, J BIOL CHEM, V286, P22355, DOI 10.1074/jbc.M111.232041; Thorslund T, 2015, NATURE, V527, P389, DOI 10.1038/nature15401; van Wijk SJL, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.55; Wasik KA, 2015, GENE DEV, V29, P1403, DOI 10.1101/gad.265215.115; Wilson MD, 2016, NATURE, V536, P100, DOI 10.1038/nature18951; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Yin XY, 1999, ONCOGENE, V18, P6621, DOI 10.1038/sj.onc.1203097; Yin XY, 2001, ONCOGENE, V20, P2908, DOI 10.1038/sj.onc.1204417; Yu HY, 2011, NAT METHODS, V8, P478, DOI [10.1038/NMETH.1597, 10.1038/nmeth.1597]; Yu M, 2016, J BIOL CHEM, V291, P959, DOI 10.1074/jbc.M114.624478; Zhang XQ, 2013, CELL CYCLE, V12, P312, DOI 10.4161/cc.23104; Zhao GY, 2007, MOL CELL, V25, P663, DOI 10.1016/j.molcel.2007.01.029; Zhu QZ, 2015, CELL CYCLE, V14, P1413, DOI 10.1080/15384101.2015.1007785	57	6	6	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2017	292	3					967	978		10.1074/jbc.M116.758854	http://dx.doi.org/10.1074/jbc.M116.758854			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2LL	27903633	hybrid, Green Published			2022-12-26	WOS:000392318700018
J	Vuong, TD; Walker, DR; Nguyen, BT; Nguyen, TT; Dinh, HX; Hyten, DL; Cregan, PB; Sleper, DA; Lee, JD; Shannon, JG; Nguyen, HT				Vuong, Tri D.; Walker, David R.; Nguyen, Binh T.; Nguyen, Tuyet T.; Dinh, Hoan X.; Hyten, David L.; Cregan, Perry B.; Sleper, David A.; Lee, Jeong D.; Shannon, James G.; Nguyen, Henry T.			Molecular Characterization of Resistance to Soybean Rust (Phakopsora pachyrhizi Syd. & Syd.) in Soybean Cultivar DT 2000 (PI 635999)	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; HETERODERA-GLYCINES ICHINOHE; BULKED SEGREGANT ANALYSIS; UNITED-STATES; 1ST REPORT; GENES; IDENTIFICATION; GERMPLASM; CONFIRMATION; POPULATIONS	Resistance to soybean rust (SBR), caused by Phakopsora pachyrhizi Syd. & Syd., has been identified in many soybean germplasm accessions and is conferred by either dominant or recessive genes that have been mapped to six independent loci (Rpp1 -Rpp6), but No U. S. cultivars are resistant to SBR. The cultivar DT 2000 (PI 635999) has resistance to P. pachyrhizi isolates and field populations from the United States as well as Vietnam. A F-6:7 recombinant inbred line (RIL) population derived from Williams 82 x DT 2000 was used to identify genomic regions associated with resistance to SBR in the field in Ha Noi, Vietnam, and in Quincy, Florida, in 2008. Bulked segregant analysis (BSA) was conducted using the soybean single nucleotide polymorphism (SNP) USLP 1.0 panel along with simple sequence repeat (SSR) markers to detect regions of the genome associated with resistance. BSA identified four BARC_SNP markers near the Rpp3 locus on chromosome (Chr.) 6. Genetic analysis identified an additional genomic region around the Rpp4 locus on Chr. 18 that was significantly associated with variation in the area under disease progress curve (AUDPC) values and sporulation in Vietnam. Molecular markers tightly linked to the DT 2000 resistance alleles on Chrs. 6 and 18 will be useful for marker-assisted selection and backcrossing in order to pyramid these genes with other available SBR resistance genes to develop new varieties with enhanced and durable resistance to SBR.	[Vuong, Tri D.; Sleper, David A.; Shannon, James G.; Nguyen, Henry T.] Univ Missouri, Div Plant Sci, Columbia, MO 65211 USA; [Walker, David R.] Univ Illinois, USDA ARS, Soybean Maize Germplasm Pathol & Genet Res Unit, Urbana, IL USA; [Walker, David R.] Univ Illinois, Dept Crop Sci, Urbana, IL USA; [Nguyen, Binh T.; Nguyen, Tuyet T.; Dinh, Hoan X.] PPRI, Hanoi, Vietnam; [Hyten, David L.; Cregan, Perry B.] USDA ARS, Soybean Genom & Improvement Lab, Beltsville, MD USA; [Lee, Jeong D.] Univ Missouri, Div Plant Sci, Portageville, MO USA; [Hyten, David L.] Univ Nebraska, Dept Agron & Hort, Lincoln, NE USA; [Lee, Jeong D.] Kyungpook Natl Univ, Sch Appl Biosci, Daegu, South Korea	University of Missouri System; University of Missouri Columbia; United States Department of Agriculture (USDA); University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; United States Department of Agriculture (USDA); University of Missouri System; University of Missouri Columbia; University of Nebraska System; University of Nebraska Lincoln; Kyungpook National University	Vuong, TD; Nguyen, HT (corresponding author), Univ Missouri, Div Plant Sci, Columbia, MO 65211 USA.	vuongt@missouri.edu; nguyenhenry@missouri.edu	Dinh, Hoan/AGX-7514-2022	Dinh, Hoan/0000-0001-6442-0416	United Soybean Board as a part of the project "Identification and utilization of resistance to soybean rust" (USB) [1235]; National Center for Soybean Biotechnology (USDA-CSREES Award) [2008-34555-19305]; ARS [ARS-0422909] Funding Source: Federal RePORTER	United Soybean Board as a part of the project "Identification and utilization of resistance to soybean rust" (USB); National Center for Soybean Biotechnology (USDA-CSREES Award); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This study was partially funded by the United Soybean Board [http://unitedsoybean.org/] as a part of the project "Identification and utilization of resistance to soybean rust" (USB # 1235) and by the National Center for Soybean Biotechnology (USDA-CSREES Award No. 2008-34555-19305). The United Soybean Board had read the manuscript and has indicted their approval of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamatsu H, 2013, J GEN PLANT PATHOL, V79, P28, DOI 10.1007/s10327-012-0421-7; BERNARD RL, 1988, CROP SCI, V28, P1027; Bonde MR, 2006, PLANT DIS, V90, P708, DOI 10.1094/PD-90-0708; BROMFIELD KR, 1980, CROP SCI, V20, P254, DOI 10.2135/cropsci1980.0011183X002000020026x; Calvo ES, 2008, CROP SCI, V48, P1350, DOI 10.2135/cropsci2007.10.0589; Chakraborty N, 2009, CROP SCI, V49, P783, DOI 10.2135/cropsci2008.06.0335; Elliott RJ, 1999, LEARNING SAS COMPUTE, P39; Fan JB, 2006, METHOD ENZYMOL, V410, P57, DOI 10.1016/S0076-6879(06)10003-8; FEHR WR, 1971, CROP SCI, V11, P929, DOI 10.2135/cropsci1971.0011183X001100060051x; Frederick R. D., 2006, PLANT HLTH PROGR, DOI 10.1094.PHP-2006=0104-01-RS; Garcia A, 2008, THEOR APPL GENET, V117, P545, DOI 10.1007/s00122-008-0798-z; Garcia A, 2011, CROP SCI, V51, P32, DOI 10.2135/cropsci2010.01.0037; Harris DK, 2015, CROP SCI, V55, P2161, DOI 10.2135/cropsci2014.09.0671; Hartman G. L., 2011, CAB Reviews: Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources, V6, P1, DOI 10.1079/PAVSNNR20116025; HARTMAN GL, 1992, PLANT DIS, V76, P396, DOI 10.1094/PD-76-0396; Hartman GL, 2005, PLANT DIS, V89, P664, DOI 10.1094/PD-89-0664; HARTMAN GL, 1991, PLANT DIS, V75, P596, DOI 10.1094/PD-75-0596; HARTWIG EE, 1986, CROP SCI, V26, P1135, DOI 10.2135/cropsci1986.0011183X002600010072x; HARTWIG EE, 1983, CROP SCI, V23, P237, DOI 10.2135/cropsci1983.0011183X002300020012x; Hossain MM, 2015, PLANT PATHOL, V64, P147, DOI 10.1111/ppa.12226; Hyten DL, 2010, CROP SCI, V50, P960, DOI 10.2135/cropsci2009.06.0360; Hyten DL, 2009, CROP SCI, V49, P265, DOI 10.2135/cropsci2008.08.0511; Kendrick MD, 2011, PHYTOPATHOLOGY, V101, P535, DOI 10.1094/PHYTO-09-10-0257; KILLGORE E, 1994, PLANT DIS, V78, P1216, DOI 10.1094/PD-78-1216B; Li SX, 2012, THEOR APPL GENET, V125, P133, DOI 10.1007/s00122-012-1821-y; MCLEAN RJ, 1980, AUST J AGR RES, V31, P951, DOI 10.1071/AR9800951; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; Miles MR, 2008, PLANT DIS, V92, P96, DOI 10.1094/PDIS-92-1-0096; MILES MR, 2003, SOYBEAN RUST IS US C; Monteros MJ, 2007, CROP SCI, V47, P829, DOI 10.2135/cropsci06.07.0462; Paul C, 2013, PLANT DIS, V97, P1379, DOI 10.1094/PDIS-02-13-0182-PDN; Paul C, 2009, CROP SCI, V49, P1781, DOI 10.2135/cropsci2008.12.0710; Pham TA, 2010, FIELD CROP RES, V117, P131, DOI 10.1016/j.fcr.2010.02.011; Pham TA, 2009, PLANT DIS, V93, P224, DOI 10.1094/PDIS-93-3-0224; Ray JD, 2009, THEOR APPL GENET, V119, P271, DOI 10.1007/s00122-009-1036-z; Ronin YI, 1998, THEOR APPL GENET, V97, P1169, DOI 10.1007/s001220051006; Schneider RW, 2005, PLANT DIS, V89, P774, DOI 10.1094/PD-89-0774A; SHANER G, 1977, PHYTOPATHOLOGY, V67, P1051, DOI 10.1094/Phyto-67-1051; Shanmugasundaram S, 2004, P 7 WORLD SOYB RES C, P456; Silva DCG, 2008, THEOR APPL GENET, V117, P57, DOI 10.1007/s00122-008-0752-0; Sinclair J.B., 1999, COMPENDIUM SOYBEAN D, Vfourth, P25; Singh RJ, 2015, THEOR APPL GENET; Twizeyimana M, 2008, PLANT DIS, V92, P947, DOI 10.1094/PDIS-92-6-0947; Twizeyimana M, 2011, PLANT DIS, V95, P43, DOI 10.1094/PDIS-06-10-0436; Twizeyimana M, 2012, PLANT DIS, V96, P75; van Ooijen J.W., 2001, JOINMAP 3 0 SOFTWARE; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Vuong TD, 2011, EUPHYTICA, V181, P101, DOI 10.1007/s10681-011-0430-1; Vuong TD, 2010, THEOR APPL GENET, V121, P1253, DOI 10.1007/s00122-010-1385-7; Walker DR, 2011, CROP SCI, V51, P678, DOI 10.2135/cropsci2010.06.0340; Walker DR, 2014, CROP SCI, V54, P1433, DOI 10.2135/cropsci2013.09.0654; Yang J, 2007, BIOINFORMATICS, V23, P1527, DOI 10.1093/bioinformatics/btm143; Yorinori JT, 2005, PLANT DIS, V89, P675, DOI 10.1094/PD-89-0675	53	16	17	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0164493	10.1371/journal.pone.0164493	http://dx.doi.org/10.1371/journal.pone.0164493			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935940	Green Published, gold			2022-12-26	WOS:000389587100006
J	Akhter, S; Anwar, I; Akter, R; Kumkum, FA; Nisha, MK; Ashraf, F; Islam, F; Begum, N; Chowdhury, ME; Austin, A; Islam, SS; Rahman, A				Akhter, Sadika; Anwar, Iqbal; Akter, Rashida; Kumkum, Feroza Akhter; Nisha, Monjura Khatun; Ashraf, Fatema; Islam, Ferdousi; Begum, Nazneen; Chowdhury, Mahbub Elahi; Austin, Anne; Islam, Syed Shariful; Rahman, Aminur			Barriers to Timely and Safe Blood Transfusion for PPH Patients: Evidence from a Qualitative Study in Dhaka, Bangladesh	PLOS ONE			English	Article								Background and Objectives In Bangladesh, postpartum hemorrhage (PPH) is the leading cause of maternal mortality accounting for 31% of all blood transfusions in the country. Although safe blood transfusion is one of the 8 signal functions of Comprehensive Emergency Obstetric Care (CEmOC) strategy, most of the designated public sector CEmOC facilities do not have on-site blood storage system. Emergent blood is mainly available from external blood banks. As a result, emergent patients are to rely on an unregulated network of brokers for blood which may raise question about blood safety. This study explored lived experiences of patients' attendants, managers, providers, and blood brokers before and after the implementation of an on-line Blood Information and Management Application (BIMA) in regards to barriers and facilitators of blood transfusion for emergent patients. Methods Data were collected at Dhaka Medical College Hospital (DMCH), a tertiary-level teaching hospital before (January 2014) and after (March 2015) the introduction of an online BIMA system. Data collection methods included 24 key informant interviews (KIIs) and 40 in-depth interviews (IDIs). KIIs were conducted with formal health service providers, health managers and unlicensed blood brokers. IDIs were conducted with the relatives and husbands of women who suffered PPH, and needed emergency blood. Results Patients' attendants were unaware of patients' blood type and availability of blood in emergency situation. Newly introduced online BIMA system could facilitate blood transfusion process for poor patients at lower cost and during any time of day and night. However, service providers and service recipients were heavily dependent on a network of unlicensed blood brokers for required blood for emergent PPH patients. Blood collected through unlicensed blood brokers is un-screened, unregulated and probably unsafe. Blood brokers feel that they are providing a needed service, acknowledged a financial incentive and unaware about safety of blood that they supply. Conclusions Ensuring safe and timely blood transfusion is necessary to end preventable maternal mortality. In a context where facilities have no on-site blood, and both providers and patient attendants are heavily dependent on an unregulated cadre of unlicensed blood brokers, access to timely safe blood transfusion is seriously threatened. BIMA is a promising intervention to reduce inefficiencies in obtaining blood, but steps must be taken to ensure buy-in from current purveyors of blood, and to increase the acceptance of the intervention.	[Akhter, Sadika; Anwar, Iqbal; Akter, Rashida; Kumkum, Feroza Akhter; Chowdhury, Mahbub Elahi; Rahman, Aminur] Int Ctr Diarrhoeal & Dis Res Bangladesh Icddr B, Dhaka, Bangladesh; [Akhter, Sadika] Griffith Univ, Ctr Environm & Populat Hlth, Griffith, NSW, Australia; [Nisha, Monjura Khatun] Sydney Med Sch, Sch Publ Hlth, Sydney, NSW, Australia; [Ashraf, Fatema] Shaheed Suhrawardi Med Coll & Hosp, Dhaka, Bangladesh; [Islam, Ferdousi; Begum, Nazneen] Dhaka Med Coll & Hosp, Dhaka, Bangladesh; [Austin, Anne] JSI Res & Training Inst Inc, Boston, MA USA; [Islam, Syed Shariful] Bangabandhu Sheikh Mujib Med Univ, Dept Publ Hlth & Informat, Dhaka, Bangladesh; [Rahman, Aminur] Chulalongkorn Univ, Coll Publ Hlth Sci, Bangkok, Thailand	International Centre for Diarrhoeal Disease Research (ICDDR); Griffith University; University of Sydney; Dhaka Medical College; Bangabandhu Sheikh Mujib Medical University (BSMMU); Chulalongkorn University	Akhter, S (corresponding author), Int Ctr Diarrhoeal & Dis Res Bangladesh Icddr B, Dhaka, Bangladesh.; Akhter, S (corresponding author), Griffith Univ, Ctr Environm & Populat Hlth, Griffith, NSW, Australia.	sadika@icddrb.org	Rahman, Aminur/AAG-5391-2020	Rahman, Aminur/0000-0003-1434-3883	Maternal Health Task Force at the Harvard T. H. Chan School of Public Health from the Bill & Melinda Gates Foundation [01065000621]	Maternal Health Task Force at the Harvard T. H. Chan School of Public Health from the Bill & Melinda Gates Foundation	This project was made possible with support from the Maternal Health Task Force at the Harvard T. H. Chan School of Public Health through Grant# 01065000621 from the Bill & Melinda Gates Foundation.	Alam B, 2015, INT J GYNECOL OBSTET, V131, P63, DOI 10.1016/j.ijgo.2015.04.041; Alkema L, 2015, LANCET; Balki M, 2008, J OBSTET GYNAECOL CA, V30, P1002, DOI 10.1016/S1701-2163(16)32994-2; Bangladesh. Bangladesh Planning Commission. General Economics Division, 2014, MILL DEV GOALS PROGR; Bhuiya I, 1995, SITUATION BLOOD TEST; Boyatzis R. E., 1998, TRANSFORMING QUALITA, DOI 10.1191/1478088706qp063oa; Hossain M, 1994, SOUV 13 SANDH CENTR; Miles M.B., 1994, ANAL DONNEES QUALITA, V2nd; National Institute of Population Research and Training, 2012, BANGL MAT MORT HLTH; Rahman A, 2016, DIGITAL BLOOD MANAGE; Ryan G.W., 2003, FIELD METHOD, V15, P85, DOI DOI 10.1177/1525822X02239569; United Nations, 2016, 17 GOALS TRANSF WORL; WHO (World Health Organization), 2015, TRENDS MATERNAL MORT	13	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0167399	10.1371/journal.pone.0167399	http://dx.doi.org/10.1371/journal.pone.0167399			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3TF	27911959	Green Submitted, gold, Green Published			2022-12-26	WOS:000389520600033
J	Gradnigo, JS; Majumdar, A; Norgren, RB; Moriyama, EN				Gradnigo, Julien S.; Majumdar, Abhishek; Norgren, Robert B., Jr.; Moriyama, Etsuko N.			Advantages of an Improved Rhesus Macaque Genome for Evolutionary Analyses	PLOS ONE			English	Article							TRANSCRIPTOME; ALIGNMENT	The rhesus macaque (Macaca mulatta) is widely used in molecular evolutionary analyses, particularly to identify genes under adaptive or unique evolution in the human lineage. For such studies, it is necessary to align nucleotide sequences of homologous protein-coding genes among multiple species. The validity of these analyses is dependent on high quality genomic data. However, for most mammalian species (other than humans and mice), only draft genomes are available. There has been concern that some results obtained from evolutionary analyses using draft genomes may not be correct. The rhesus macaque provides a unique opportunity to determine whether an improved genome (MacaM) yields better results than a draft genome (rheMac2) for evolutionary studies. We compared protein-coding genes annotated in the rheMac2 and MacaM genomes with their human orthologs. We found many genes annotated in rheMac2 had apparently spurious sequences not present in genes derived from MacaM. The rheMac2 annotations also appeared to inflate a frequently used evolutionary index,. (the ratio of nonsynonymous to synonymous substitution rates). Genes with these spurious sequences must be filtered out from evolutionary analyses to obtain correct results. With the MacaM genome, improved sequence information means many more genes can be examined for indications of selection. These results indicate how upgrading genomes from draft status to a higher level of quality can improve interpretation of evolutionary patterns.	[Gradnigo, Julien S.; Moriyama, Etsuko N.] Univ Nebraska Lincoln, Sch Biol Sci, Lincoln, NE 68588 USA; [Majumdar, Abhishek; Norgren, Robert B., Jr.] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE USA; [Moriyama, Etsuko N.] Univ Nebraska Lincoln, Ctr Plant Sci Innovat, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Lincoln	Moriyama, EN (corresponding author), Univ Nebraska Lincoln, Sch Biol Sci, Lincoln, NE 68588 USA.; Moriyama, EN (corresponding author), Univ Nebraska Lincoln, Ctr Plant Sci Innovat, Lincoln, NE 68588 USA.	emoriyama2@unl.edu		Norgren, Robert/0000-0002-0021-5875	National Institute of Health grant [R24RR017444]; Nebraska Research Initiative	National Institute of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nebraska Research Initiative	This work was supported by National Institute of Health grant R24RR017444 (RBN), and also in part by funds from the Nebraska Research Initiative (RBN and ENM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Karere GM, 2008, GENOMICS, V92, P210, DOI 10.1016/j.ygeno.2008.05.013; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Mallick S, 2009, GENOME RES, V19, P922, DOI 10.1101/gr.086512.108; Maudhoo MD, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0061-x; Maudhoo MD, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-14; Nagy A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-353; National Center for Biotechnology Information, ANN RHEMAC2 GFF FORM; New Rhesus Genome (MacaM), FAST CHROM GTF ANN F, DOI [10.1093/molbev/msm088, DOI 10.1093/MOLBEV/MSM088]; Norgren RB, 2013, ILAR J, V54, P144, DOI 10.1093/ilar/ilt037; Prosdocimi F, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-5; Roberto R, 2008, CHROMOSOME RES, V16, P977, DOI 10.1007/s10577-008-1255-1; Schneider A, 2009, GENOME BIOL EVOL, V1, P114, DOI 10.1093/gbe/evp012; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Thibaud-Nissen F., 2013, NCBI HDB; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vallender EJ, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r87; Yan GM, 2011, NAT BIOTECHNOL, V29, P1019, DOI 10.1038/nbt.1992; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang XF, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-206; Zimin AV, 2014, BIOL DIRECT, V9, DOI 10.1186/1745-6150-9-20	23	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0167376	10.1371/journal.pone.0167376	http://dx.doi.org/10.1371/journal.pone.0167376			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3TF	27911958	Green Submitted, Green Published, gold			2022-12-26	WOS:000389520600032
J	Augustyniak, M; Plachetka-Bozek, A; Kafel, A; Babczynska, A; Tarnawska, M; Janiak, A; Loba, A; Dziewiecka, M; Karpeta-Kaczmarek, J; Zawisza-Raszka, A				Augustyniak, Maria; Plachetka-Bozek, Anna; Kafel, Alina; Babczynska, Agnieszka; Tarnawska, Monika; Janiak, Agnieszka; Loba, Anna; Dziewiecka, Marta; Karpeta-Kaczmarek, Julia; Zawisza-Raszka, Agnieszka			Phenotypic Plasticity, Epigenetic or Genetic Modifications in Relation to the Duration of Cd-Exposure within a Microevolution Time Range in the Beet Armyworm	PLOS ONE			English	Article							SPODOPTERA-EXIGUA LARVAE; COMET ASSAY; DNA-DAMAGE; DROSOPHILA-MELANOGASTER; SOMATIC-CELLS; LEPIDOPTERA-NOCTUIDAE; CADMIUM; ZINC; POPULATION; REPAIR	In the case of the pests inhabiting metal polluted or fields where the use of pesticides is common, a natural selection of resistant individuals can occur. This may pose serious problems for humans, agriculture, as well as the economies of many countries. In this study, the hypothesis that multigenerational (120 generations) exposure to cadmium of a beet army worm population could be a selecting factor toward a more efficient DNA protection was verified. The hemocytes of individuals from two culture strains (control and Cd-exposed) were treated with H2O2 (a DNA-damaging agent) or PBS (reference). The level of DNA damage was assessed using the Comet assay immediately and 5, 15 and 30 min. after the treatment. The immediate result of the contact with H2O2 was that the level of DNA damage in the hemocytes of the insects from both strains increased significantly. However, in the cells of the Cd-exposed individuals, the level of DNA damage decreased over time, while in the cells from the control insects it remained at the same level with no evidence of repair. These results suggest that efficient defense mechanisms may exist in the cells of insects that have prolonged contact with cadmium. Some evolutionary and trade-off aspects of the phenomenon are discussed. In a wider context, comparing the results obtained in the laboratory with field studies may be beneficial for understanding basic mechanisms of the resistance of an organism. To summarize, the high potential for the repair of DNA damage that was observed in the insects from the cadmium strain may confirm the hypothesis that multigenerational exposure to that metal may possibly contribute to the selection of insects that have a wider tolerance to oxidative stress. However, our investigations of polymorphism using AFLP did not reveal differences between the two main insect strains.	[Augustyniak, Maria; Plachetka-Bozek, Anna; Kafel, Alina; Babczynska, Agnieszka; Tarnawska, Monika; Loba, Anna; Dziewiecka, Marta; Karpeta-Kaczmarek, Julia; Zawisza-Raszka, Agnieszka] Univ Silesia, Dept Anim Physiol & Ecotoxicol, Katowice, Poland; [Janiak, Agnieszka] Univ Silesia, Dept Genet, Katowice, Poland	University of Silesia in Katowice; University of Silesia in Katowice	Augustyniak, M (corresponding author), Univ Silesia, Dept Anim Physiol & Ecotoxicol, Katowice, Poland.	maria.augustyniak@us.edu.pl	Augustyniak, Maria/T-7320-2019; Babczyńska, Agnieszka/ABC-9525-2020; Kafel, Alina/AAH-1163-2019; Dziewięcka, Marta/AAN-8973-2020; Tarnawska, Monika/L-6718-2019	Augustyniak, Maria/0000-0003-1960-1669; Kafel, Alina/0000-0001-5111-3791; Dziewiecka, Marta/0000-0001-9321-2579; Babczynska, Agnieszka/0000-0002-0000-789X; Tarnawska, Monika/0000-0002-0286-1379; Janiak, Agnieszka/0000-0003-0225-7216	National Science Centre, Poland [DEC-2013/09/B/NZ9/01754]	National Science Centre, Poland(National Science Centre, Poland)	This project was supported by National Science Centre, Poland (decision DEC-2013/09/B/NZ9/01754).	Augustyniak M, 2016, REV MUTAT RES, V767, P67; Augustyniak M, 2008, J INSECT PHYSIOL, V54, P41, DOI 10.1016/j.jinsphys.2007.08.002; Augustyniak M, 2006, COMP BIOCHEM PHYS C, V144, P242, DOI 10.1016/j.cbpc.2006.09.003; Augustyniak M, 2014, CHEMOSPHERE, V96, P180, DOI 10.1016/j.chemosphere.2013.10.033; Avan H, J INSECT PHYSL, V130, P148; Bilbao C, 2002, MUTAT RES-FUND MOL M, V503, P11, DOI 10.1016/S0027-5107(02)00070-2; Bonduriansky R, 2012, EVOL APPL, V5, P192, DOI 10.1111/j.1752-4571.2011.00213.x; CALOW P, 1990, FUNCT ECOL, V4, P283, DOI 10.2307/2389587; Carmona ER, 2011, MUTAT RES-GEN TOX EN, V724, P35, DOI 10.1016/j.mrgentox.2011.05.008; Carmona ER, 2011, ENVIRON MOL MUTAGEN, V52, P165, DOI 10.1002/em.20604; Carmona ER, 2011, MUTAT RES-GEN TOX EN, V718, P33, DOI 10.1016/j.mrgentox.2010.10.008; Chandler LD, 1996, SOUTHWEST ENTOMOL, V21, P189; Collins AR, 2009, MUTAT RES-REV MUTAT, V681, P24, DOI 10.1016/j.mrrev.2007.10.002; Collins AR, 2004, MOL BIOTECHNOL, V26, P249, DOI 10.1385/MB:26:3:249; Decordier I, 2010, MUTAT RES-REV MUTAT, V705, P107, DOI 10.1016/j.mrrev.2010.05.002; Dhawan A, 2009, CELL BIOL TOXICOL, V25, P5, DOI 10.1007/s10565-008-9072-z; Feil R, 2012, NAT REV GENET, V13, P97, DOI 10.1038/nrg3142; Hendry AP, 2011, EVOL APPL, V4, P159, DOI 10.1111/j.1752-4571.2010.00165.x; Ho DH, 2010, J EXP BIOL, V213, P3, DOI 10.1242/jeb.019752; Imamura T, 2004, J STORED PROD RES, V40, P169, DOI 10.1016/S0022-474X(02)00095-4; Jha AN, 2008, MUTAGENESIS, V23, P207, DOI 10.1093/mutage/gen014; Jongsma MA, 1996, INSECT BIOCHEM MOLEC, V26, P185, DOI 10.1016/0965-1748(95)00082-8; Kafel A, 2003, ENVIRON INT, V28, P683, DOI 10.1016/S0160-4120(02)00111-3; Kafel A, 2012, ECOTOX ENVIRON SAFE, V78, P22, DOI 10.1016/j.ecoenv.2011.10.024; Kojic D, 2009, EUR J ENTOMOL, V106, P451, DOI 10.14411/eje.2009.056; Koo HN, 2011, J ASIA-PAC ENTOMOL, V14, P243, DOI 10.1016/j.aspen.2011.03.001; Kramarz P, 2003, ENVIRON POLLUT, V126, P1, DOI 10.1016/S0269-7491(03)00183-0; Lara P, 2000, TRANSGENIC RES, V9, P169, DOI 10.1023/A:1008905631440; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; McAuslane HJ, 2000, ENTOMOL EXP APPL, V97, P283, DOI 10.1023/A:1004051527347; Mitchelmore CL, 1998, MUTAT RES-FUND MOL M, V399, P135, DOI 10.1016/S0027-5107(97)00252-2; Mladenov E, 2011, MUTAT RES-FUND MOL M, V711, P61, DOI 10.1016/j.mrfmmm.2011.02.005; Mouron SA, 2001, MUTAT RES-GEN TOX EN, V498, P47, DOI 10.1016/S1383-5718(01)00266-2; Nicotra AB, 2015, ECOL EVOL, V5, P634, DOI 10.1002/ece3.1329; Peck LS, 2011, MAR GENOM, V4, P237, DOI 10.1016/j.margen.2011.07.001; Polyakov A, 2004, P ROY SOC B-BIOL SCI, V271, pS156, DOI 10.1098/rsbl.2003.0112; Quintela M, 2014, PLOS ONE, V9, P1; Rojas E, 1999, J CHROMATOGR B, V722, P225, DOI 10.1016/S0378-4347(98)00313-2; Schulze E., 2005, PLANT ECOL, P5; Sestili P, 2005, DNA REPAIR, V4, P271, DOI 10.1016/j.dnarep.2004.09.007; Sharma K, 2016, BBA-GEN SUBJECTS, V1860, P1237, DOI 10.1016/j.bbagen.2016.03.004; Showler AT, 2001, J CHEM ECOL, V27, P2013, DOI 10.1023/A:1012238803311; Sliwinski T, 2007, MUTAT RES-GEN TOX EN, V634, P220, DOI 10.1016/j.mrgentox.2007.07.013; Steinberg CE, 2012, EXPERT OPIN ENV BIOL, DOI [10.4172/2325-9655.1000e104, DOI 10.4172/2325-9655.1000E104]; Wozniak K, 2002, MUTAT RES-GEN TOX EN, V514, P233, DOI 10.1016/S1383-5718(01)00344-8; Yun SH, 2014, RADIAT PHYS CHEM, V96, P44, DOI 10.1016/j.radphyschem.2013.08.008; Zheng SJ, 2000, EUPHYTICA, V114, P77, DOI 10.1023/A:1004089424419; Zieritz A, 2010, EVOL ECOL, V24, P923, DOI 10.1007/s10682-009-9350-0	48	19	21	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167371	10.1371/journal.pone.0167371	http://dx.doi.org/10.1371/journal.pone.0167371			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907095	gold, Green Submitted, Green Published			2022-12-26	WOS:000389482700133
J	Blomstrom, AL; Fossum, C; Wallgren, P; Berg, M				Blomstrom, Anne-Lie; Fossum, Caroline; Wallgren, Per; Berg, Mikael			Viral Metagenomic Analysis Displays the Co-Infection Situation in Healthy and PMWS Affected Pigs	PLOS ONE			English	Article							MULTISYSTEMIC WASTING SYNDROME; PORCINE CIRCOVIRUS TYPE-2; BOCA-LIKE VIRUS; INFECTIONS; MULTIPLE; TISSUE; PCV2; IDENTIFICATION; REPRODUCTION; DISCOVERY	The development of high-throughput sequencing technologies have allowed the possibility to investigate and characterise the entire microbiome of individuals, providing better insight to the complex interaction between different microorganisms. This will help to understand how the microbiome influence the susceptibility of secondary agents and development of disease. We have applied viral metagenomics to investigate the virome of lymph nodes from Swedish pigs suffering from the multifactorial disease postweaning multisystemic wasting syndrome (PMWS) as well as from healthy pigs. The aim is to increase knowledge of potential viruses, apart from porcine circovirus type 2 (PCV2), involved in PMWS development as well as to increase knowledge on the virome of healthy individuals. In healthy individuals, a diverse viral flora was seen with several different viruses present simultaneously. The majority of the identified viruses were small linear and circular DNA viruses, such as different circoviruses, anelloviruses and bocaviruses. In the pigs suffering from PMWS, PCV2 sequences were, as expected, detected to a high extent but other viruses were also identified in the background of PCV2. Apart from DNA viruses also RNA viruses were identified, among them were a porcine pestivirus showing high similarity to a recently (in 2015) discovered atypical porcine pestivirus in the US. Majority of the viruses identified in the background of PCV2 in PMWS pigs could also be identified in the healthy pigs. PCV2 sequences were also identified in the healthy pigs but to a much lower extent than in PMWS affected pigs. Although the method used here is not quantitative the very clear difference in amount of PCV2 sequences in PMWS affected pigs and healthy pigs most likely reflect the very strong replication of PCV2 known to be a hallmark of PMWS. Taken together, these findings illustrate that pigs appear to have a considerable viral flora consisting to a large extent of small single-stranded and circular DNA viruses. Future research on these types of viruses will help to better understand the role that these ubiquitous viruses may have on health and disease of pigs. We also demonstrate for the first time, in Europe, the presence of a novel porcine pestivirus.	[Blomstrom, Anne-Lie; Berg, Mikael] Swedish Univ Agr Sci, Virol Sect, Dept Biomed Sci & Vet Publ Hlth, Uppsala, Sweden; [Fossum, Caroline] Swedish Univ Agr Sci, Immunol Sect, Dept Biomed Sci & Vet Publ Hlth, Uppsala, Sweden; [Wallgren, Per] Natl Vet Inst SVA, Uppsala, Sweden	Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; National Veterinary Institute SVA	Blomstrom, AL (corresponding author), Swedish Univ Agr Sci, Virol Sect, Dept Biomed Sci & Vet Publ Hlth, Uppsala, Sweden.	Anne-Lie.Blomstrom@slu.se		Fossum, Caroline/0000-0003-4639-1652; Berg, Mikael/0000-0001-5779-3345; Blomstrom, Anne-Lie/0000-0003-4455-311X	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning [Formas-2014-862, Formas-2012-586]; SNP&SEQ Technology Platform in Uppsala - Uppsala University; Uppsala University Hospital; Science for Life Laboratory Uppsala; Swedish Research Council [80576801, 70374401]	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas); SNP&SEQ Technology Platform in Uppsala - Uppsala University; Uppsala University Hospital; Science for Life Laboratory Uppsala; Swedish Research Council(Swedish Research CouncilEuropean Commission)	The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning is greatly acknowledged for financial support (Formas-2014-862, Formas-2012-586). Also, the Swedish Farmers' Foundation for Agricultural Research is acknowledged. The authors would like to acknowledge support of the SNP&SEQ Technology Platform in Uppsala, which is supported by Uppsala University, Uppsala University Hospital, Science for Life Laboratory Uppsala and the Swedish Research Council (contracts 80576801 and 70374401).	Alexandersen S, 2010, DIS SWINE, P610; ARTURSSON K, 1995, SCAND J IMMUNOL, V41, P121, DOI 10.1111/j.1365-3083.1995.tb03543.x; Balasch M, 1999, J COMP PATHOL, V121, P139, DOI 10.1053/jcpa.1999.0310; Blomstrom AL, 2009, VIRUS RES, V146, P125, DOI 10.1016/j.virusres.2009.09.006; Blomstrom AL, 2011, VET QUART, V31, P107, DOI 10.1080/01652176.2011.604971; Blomstrom AL, 2010, J CLIN MICROBIOL, V48, P4392, DOI 10.1128/JCM.01040-10; Blomstrom AL, 2010, VIRUS RES, V152, P59, DOI 10.1016/j.virusres.2010.06.004; Brunborg IM, 2010, ACTA VET SCAND, V52, DOI 10.1186/1751-0147-52-22; Cann AJ, 2005, VIRUS GENES, V30, P151, DOI 10.1007/s11262-004-5624-3; Chae C, 2004, VET J, V168, P41, DOI 10.1016/j.tvjl.2003.09.018; Cheng WX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013583; Day JM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-313; Delwart E, 2012, CURR OPIN VIROL, V2, P344, DOI 10.1016/j.coviro.2012.02.012; Ha Y, 2008, VET PATHOL, V45, P842, DOI 10.1354/vp.45-6-842; Hasslung F, 2005, VET MICROBIOL, V106, P49, DOI 10.1016/j.vetmic.2004.12.011; Hause BM, 2015, J GEN VIROL, V96, P2994, DOI 10.1099/jgv.0.000251; Jiang YH, 2014, J GEN VIROL, V95, P453, DOI 10.1099/vir.0.057042-0; Li LL, 2011, J GEN VIROL, V92, P768, DOI 10.1099/vir.0.028704-0; Li LL, 2010, J VIROL, V84, P1674, DOI 10.1128/JVI.02109-09; McMenamy MJ, 2013, VET MICROBIOL, V164, P293, DOI 10.1016/j.vetmic.2013.03.009; Meng XJ, 2012, TRANSBOUNDARY EMERGI; Sachsenroder J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034631; Segales J, 2012, VIRUS RES, V164, P10, DOI 10.1016/j.virusres.2011.10.007; Shan TL, 2011, J VIROL, V85, P11697, DOI 10.1128/JVI.05217-11; Sun SL, 2011, NUCLEIC ACIDS RES, V39, pD546, DOI 10.1093/nar/gkq1102; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Timmusk S, 2008, VIRUS GENES, V36, P509, DOI 10.1007/s11262-008-0217-1; Wallgren P, 1999, J VET MED B, V46, P249; Wattrang E, 2002, VET MICROBIOL, V86, P281, DOI 10.1016/S0378-1135(02)00024-X; Wu ZQ, 2012, J VIROL, V86, P10999, DOI 10.1128/JVI.01394-12; Zeng SL, 2011, J GEN VIROL, V92, P784, DOI 10.1099/vir.0.028340-0	31	32	33	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166863	10.1371/journal.pone.0166863	http://dx.doi.org/10.1371/journal.pone.0166863			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907010	gold, Green Published, Green Submitted			2022-12-26	WOS:000389482700045
J	Kawaguchi, T; Cho, D; Hayashi, M; Tsukiyama, T; Kimura, K; Matsuyama, S; Minami, N; Yamada, M; Imai, H				Kawaguchi, Takamasa; Cho, Dooseon; Hayashi, Masafumi; Tsukiyama, Tomoyuki; Kimura, Koji; Matsuyama, Shuichi; Minami, Naojiro; Yamada, Masayasu; Imai, Hiroshi			Derivation of Induced Trophoblast Cell Lines in Cattle by Doxycycline-Inducible piggyBac Vectors	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; BOVINE CONCEPTUS DEVELOPMENT; INTERFERON-TAU; TRANSCRIPTION FACTOR; PLACENTAL-LACTOGEN; GROWTH-FACTORS; MESSENGER-RNA; IN-VITRO; TROPHECTODERM; EXPRESSION	Trophectoderm lineage specification is one of the earliest differentiation events in mammalian development. The trophoblast lineage, which is derived from the trophectoderm, mediates implantation and placental formation. However, the processes involved in trophoblastic differentiation and placental formation in cattle remain unclear due to interspecies differences when compared with other model systems and the small repertoire of available trophoblast cell lines. Here, we describe the generation of trophoblast cell lines (biTBCs) from bovine amnion-derived cells (bADCs) using an induced pluripotent stem cell technique. bADCs were introduced with piggyBac vectors containing doxycycline (Dox)-inducible transcription factors (Oct3/4(POU5F1), Sox2, Klf4, and c-Myc). Colonies that appeared showed a flattened epithelial-like morphology similar to cobblestones, had a more definite cell boundary between cells, and frequently formed balloon-like spheroids similar to trophoblastic vesicles (TVs). biTBCs were propagated for over 60 passages and expressed trophoblast-related (CDX2, ELF5, ERR/3, and /IFN-tau) and pluripotency-related genes (endogenous OCT3/4, SOX2, KLF4, and c-MYC). Furthermore, when biTBCs were induced to differentiate by removing Dox from culture, they formed binucleate cells and began to express pregnancy -related genes (PL, PRP1, and PAG1). This is the first report demonstrating that the induction of pluripotency in bovine amniotic cells allows the generation of trophoblastic cell lines that possess trophoblast stem cell-like characteristics and have the potential to differentiate into the extra-embryonic cell lineage. These cell lines can be a new cell source as a model for studying trophoblast cell lineages and implantation processes in cattle.	[Kawaguchi, Takamasa; Cho, Dooseon; Hayashi, Masafumi; Minami, Naojiro; Yamada, Masayasu; Imai, Hiroshi] Kyoto Univ, Grad Sch Agr, Reprod Biol Lab, Kyoto, Japan; [Tsukiyama, Tomoyuki] Shiga Univ Med Sci, Res Ctr Anim Life Sci, Shiga, Japan; [Kimura, Koji; Matsuyama, Shuichi] NARO Inst Livestock & Grassland Sci, Anim Feeding & Management Res Div, Nasushiobara, Tochigi, Japan; [Kawaguchi, Takamasa] Ono Pharmaceut Co Ltd, Fukui Res Inst, Fukui, Japan; [Kimura, Koji] Okayama Univ, Grad Sch Environm & Life Sci, Reprod Physiol Lab, Okayama, Japan	Kyoto University; Shiga University of Medical Science; Ono Pharmaceutical Co Ltd; Okayama University	Imai, H (corresponding author), Kyoto Univ, Grad Sch Agr, Reprod Biol Lab, Kyoto, Japan.	imai@kais.kyoto-u.ac.jp	TSUKIYAMA, Tomoyuki/AAI-3082-2020	TSUKIYAMA, Tomoyuki/0000-0002-2657-7719	Ministry of Education, Science and Culture [26292168]	Ministry of Education, Science and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant from the Ministry of Education, Science and Culture to KK and HI (grant 26292168). No additional external funding was received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amita M, 2013, P NATL ACAD SCI USA, V110, pE1212, DOI 10.1073/pnas.1303094110; Bai H, 2011, J REPROD DEVELOP, V57, P518, DOI 10.1262/jrd.10-186K; Bai H, 2009, MOL REPROD DEV, V76, P1143, DOI 10.1002/mrd.21082; Berg DK, 2011, DEV CELL, V20, P244, DOI 10.1016/j.devcel.2011.01.003; Cauffman G, 2005, MOL HUM REPROD, V11, P173, DOI 10.1093/molehr/gah155; Chen LY, 2009, CELL RES, V19, P1052, DOI 10.1038/cr.2009.79; Chen Y, 2013, BIOCHEM BIOPH RES CO, V431, P197, DOI 10.1016/j.bbrc.2012.12.135; Cooke FNT, 2009, REPRODUCTION, V137, P259, DOI 10.1530/REP-08-0396; Degrelle SA, 2005, DEV BIOL, V288, P448, DOI 10.1016/j.ydbio.2005.09.043; Dunne LD, 2000, ANIM REPROD SCI, V58, P39, DOI 10.1016/S0378-4320(99)00088-3; Ezashi T, 2005, P NATL ACAD SCI USA, V102, P4783, DOI 10.1073/pnas.0501283102; Ezashi T, 2011, BIOL REPROD, V85, P779, DOI 10.1095/biolreprod.111.092809; Ezashi T, 2009, P NATL ACAD SCI USA, V106, P10993, DOI 10.1073/pnas.0905284106; Fields SD, 2011, THERIOGENOLOGY, V75, P1466, DOI 10.1016/j.theriogenology.2010.12.007; FLECHON JE, 1995, PLACENTA, V16, P643, DOI 10.1016/0143-4004(95)90033-0; Fujishiro S, 2013, STEM CELLS DEV, V22, P473, DOI 10.1089/scd.2012.0173; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; GUILLOMOT M, 1990, BIOL CELL, V68, P205, DOI 10.1016/0248-4900(90)90309-Q; Hashizume K, 2006, METH MOLEC MED, V121, P179; HOFFMAN LH, 1993, J EXP ZOOL, V266, P559, DOI 10.1002/jez.1402660607; Honda A, 2010, J BIOL CHEM, V285, P31362, DOI 10.1074/jbc.M110.150540; Imakawa K, 2006, MOL REPROD DEV, V73, P559, DOI 10.1002/mrd.20457; IMAKAWA K, 1987, NATURE, V330, P377, DOI 10.1038/330377a0; Ka H, 2001, ENDOCRINOLOGY, V142, P2303, DOI 10.1210/en.142.6.2303; Kawaguchi T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135403; Kimura K, 2004, MOL REPROD DEV, V67, P193, DOI 10.1002/mrd.10389; Kinoshita M, 2014, REPROD MED BIOL; Kobolak J, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-88; Kubaczka C, 2014, STEM CELL REP, V2, P232, DOI 10.1016/j.stemcr.2013.12.013; Kuijk EW, 2008, DEV DYNAM, V237, P918, DOI 10.1002/dvdy.21480; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Miyazaki H, 2002, PLACENTA, V23, P613, DOI 10.1053/plac.2002.0846; Nakano H, 2002, CELL TISSUE RES, V307, P225, DOI 10.1007/s00441-001-0491-x; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ohinata Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107308; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Ozawa M, 2013, REPRODUCTION, V145, P191, DOI 10.1530/REP-12-0220; Pfeffer PL, 2012, REPRODUCTION, V143, P231, DOI 10.1530/REP-11-0374; RAMSOONDAR J, 1993, BIOL REPROD, V49, P681, DOI 10.1095/biolreprod49.4.681; Roberts RM, 2011, BIOL REPROD, V84, P412, DOI 10.1095/biolreprod.110.088724; ROBERTS RM, 1992, ENDOCR REV, V13, P432, DOI 10.1210/er.13.3.432; Sahgal N, 2006, METH MOLEC MED, V121, P159; Sakurai T, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.100180; Shimada A, 2001, PLACENTA, V22, P652, DOI 10.1053/plac.2001.0702; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Sumer H, 2011, J ANIM SCI, V89, P2708, DOI 10.2527/jas.2010-3666; Suzuki Y, 2011, REPRODUCTION, V142, P733, DOI 10.1530/REP-11-0275; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Talbot NC, 2000, BIOL REPROD, V62, P235, DOI 10.1095/biolreprod62.2.235; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Tsukiyama T, 2011, GENES CELLS, V16, P815, DOI 10.1111/j.1365-2443.2011.01528.x; Ushizawa K, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-17; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Yusa K, 2011, P NATL ACAD SCI USA, V108, P1531, DOI 10.1073/pnas.1008322108	56	7	7	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167550	10.1371/journal.pone.0167550	http://dx.doi.org/10.1371/journal.pone.0167550			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907214	gold, Green Published, Green Submitted			2022-12-26	WOS:000389482700190
J	Lamos, C; Mihaljevic, C; Aulmann, S; Bruckner, T; Domschke, C; Wallwiener, M; Paringer, C; Fluhr, H; Schott, S; Dinkic, C; Brucker, J; Golatta, M; Gensthaler, L; Eichbaum, M; Sohn, C; Rom, J				Lamos, Cristina; Mihaljevic, Charlotte; Aulmann, Sebastian; Bruckner, Thomas; Domschke, Christoph; Wallwiener, Markus; Paringer, Carmen; Fluhr, Herbert; Schott, Sarah; Dinkic, Christine; Brucker, Janina; Golatta, Michael; Gensthaler, Lisa; Eichbaum, Michael; Sohn, Christof; Rom, Joachim			Detection of Human Papillomavirus Infection in Patients with Vaginal Intraepithelial Neoplasia	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SQUAMOUS-CELL CARCINOMA; HPV; RISK; WOMEN; CANCER; VULVA; HYSTERECTOMY; PREVALENCE; PREDICTION	Introduction Vaginal intraepithelial neoplasia (VAIN) is a pre-malignant lesion, potentially leading to vaginal cancer. It is a rare disease, representing less than 1% of all intraepithelial neoplasia of the female genital tract. Similar to cervical intraepithelial neoplasia (CIN), there are three different grades of VAIN. VAIN 1 is also known as a low-grade squamous intraepithelial lesion (LSIL), whereas VAIN 2 and VAIN 3 both represent high-grade squamous intraepithelial lesions (HSIL). Risk factors for the development of VAIN are similar to those for cervical neoplasia, i.e. promiscuity, starting sexual activity at an early age, tobacco consumption and infection with human papillomavirus (HPV). However, compared to other intraepithelial neoplasia such as CIN or VIN (vulvar intraepithelial neoplasia), there still is little understanding about the natural course of VAIN and its capacity for pro-or regression. Furthermore, there is controversial data about the HPV detection rate in VAIN lesions. Patients and Methods 67 patients with histologically confirmed VAIN, who were diagnosed between 2003 and 2011 at the University Women's Hospital of Heidelberg Germany, were included in this study. The biopsies of all participating patients were subjected to HPV genotyping. GP-E6/E7 Nested Multiplex PCR (NMPCR) was used to identify and genotype HPV. Eighteen pairs of type-specific nested PCR primers were assessed to detect the following "high-risk" HPV genotypes: 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66 and 68, as well as the "low-risk" genotypes 6/11, 42, 43 and 44. The data was analyzed with the software SAS (Statistical Analysis System). Results All 67 cases were eligible for DNA analysis. The median age was 53 years. The largest group with 53% (n = 36) was formed by women, who were first diagnosed with VAIN between the age of 41 to 60 years. 50% (n = 37) of the patients presented a VAIN in the upper 1/3 of the vagina. 58 (87%) were diagnosed with HSIL (VAIN). The median age in patients with LSIL (VAIN) was 53 years and in patients with HSIL (VAIN) 53.5 years. 12 women (18%) had an immunosuppression. HPV positivity was confirmed in 37 patients (55%). Except for a single patient, who had a triple infection with HPV types 6/11, 16 and 68, only infections with one single HPV genotype were detected. An infection with the HPV genotypes 31, 39, 45, 51, 58, 59, 66, 42, 43 and 44 couldn't be found in any of the patients. In 28 patients with diagnosed VAIN, an infection with HPV 16 could be shown, 24 (86%) of them were diagnosed with a HSIL (VAIN). 16 (24%) women presented condylomata and 13 of them (81%) had a positive HPV status. However, only 47% of the women without condylomata presented a positive HPV status, resulting in a significant correlation (p = 0.0164) between condylomata and HPV infection. In 28 of all 67 patients (42%), recurrence of the neoplasia occurred. Conclusion HPV 16 is the main virus-type to be associated with the development of a VAIN. Also, HPV 16 infection, VIN or condylomata acuminata in the past medical history seemed to be significant factors for early relapse.	[Lamos, Cristina] Ludwigshafen Hosp, Dept Dermatol, Ludwigshafen, Germany; [Mihaljevic, Charlotte; Domschke, Christoph; Wallwiener, Markus; Paringer, Carmen; Fluhr, Herbert; Schott, Sarah; Dinkic, Christine; Brucker, Janina; Golatta, Michael; Sohn, Christof; Rom, Joachim] Heidelberg Univ, Dept Gynecol & Obstet, Heidelberg, Germany; [Bruckner, Thomas] Heidelberg Univ, Inst Med Biometry & Informat, Heidelberg, Germany; [Gensthaler, Lisa] Univ Vienna, Vienna, Austria; [Eichbaum, Michael] Helios Dr Horst Schmidt Kliniken, Dept Gynecol & Obstet, Wiesbaden, Germany	Ludwigshafen Hospital; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Vienna	Rom, J (corresponding author), Heidelberg Univ, Dept Gynecol & Obstet, Heidelberg, Germany.	joachim.rom@med.uni-heidelberg.de	Schott, Sarah/D-5242-2018; Golatta, Michael/AAH-8735-2021; Wallwiener, Markus/AAH-9038-2021; Fluhr, Herbert/AAS-6177-2020	Schott, Sarah/0000-0002-1714-1147; Golatta, Michael/0000-0002-2605-0060; Wallwiener, Markus/0000-0002-4139-9340	Deutsche Forschungsgemeinschaft; Ruprecht-Karls-Universitat Heidelberg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ruprecht-Karls-Universitat Heidelberg	This work was supported by Deutsche Forschungsgemeinschaft and Ruprecht-Karls-Universitat Heidelberg within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHO M, 1991, CANCER, V68, P195, DOI 10.1002/1097-0142(19910701)68:1<195::AID-CNCR2820680135>3.0.CO;2-L; AUDETLAPOINTE P, 1990, GYNECOL ONCOL, V36, P232, DOI 10.1016/0090-8258(90)90180-S; Aulmann S, 2008, J CLIN PATHOL, V61, P1034, DOI 10.1136/jcp.2008.056275; BELL J, 1984, OBSTET GYNECOL, V64, P699; Bosquet EG, 2008, EUR J GYNAECOL ONCOL, V29, P43; Chao A, 2011, INT J CANC; Chao A, 2011, INT J CANCER, V128, P653, DOI 10.1002/ijc.25384; Chiasson MA, 1997, OBSTET GYNECOL, V89, P690, DOI 10.1016/S0029-7844(97)00069-0; Daling JR, 2002, GYNECOL ONCOL, V84, P263, DOI 10.1006/gyno.2001.6502; De Vuyst H, 2009, INT J CANCER, V124, P1626, DOI 10.1002/ijc.24116; Diakomanolis E, 2002, EUR J GYNAECOL ONCOL, V23, P457; Dittmer C, 2011, ARCH GYNECOL OBSTET, V284, P169, DOI 10.1007/s00404-011-1850-9; Dodge JA, 2001, GYNECOL ONCOL, V83, P363, DOI 10.1006/gyno.2001.6401; Ferenzcy AS, 2014, WHO CLASSIFICATION T, P210; Frega A, 2007, CANCER LETT, V249, P235, DOI 10.1016/j.canlet.2006.09.003; Gross G, 1997, CLIN DERMATOL, V15, P457, DOI 10.1016/S0738-081X(96)00152-6; Hampl M, 2007, J CANCER RES CLIN, V133, P235, DOI 10.1007/s00432-006-0162-0; Kalogirou D, 1997, EUR J GYNAECOL ONCOL, V18, P188; Klaes R, 2001, INT J CANCER, V92, P276, DOI 10.1002/ijc.1174; LENEHAN PM, 1986, OBSTET GYNECOL, V68, P333, DOI 10.1097/00006250-198609000-00008; Madsen BS, 2008, INT J CANCER, V122, P2827, DOI 10.1002/ijc.23446; Murta Eddie F. C., 2005, Archives of Gynecology and Obstetrics, V272, P261, DOI 10.1007/s00404-005-0022-1; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Petersen I, 2007, VIRCHOWS ARCH, V451, P701, DOI 10.1007/s00428-007-0437-0; Sankaranarayanan R, 2006, BEST PRACT RES CL OB, V20, P207, DOI 10.1016/j.bpobgyn.2005.10.007; Schockaert S, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.02.026; Smith JS, 2009, OBSTET GYNECOL, V113, P917, DOI 10.1097/AOG.0b013e31819bd6e0; So KA, 2009, J GYNECOL ONCOL, V20, P232, DOI 10.3802/jgo.2009.20.4.232; Sotlar K, 2004, J MED VIROL, V74, P107, DOI 10.1002/jmv.20153; Sotlar K, 2004, J CLIN MICROBIOL, V42, P3176, DOI 10.1128/JCM.42.7.3176-3184.2004; Spitzer M, 1999, Obstet Gynecol Surv, V54, P131, DOI 10.1097/00006254-199902000-00023; WILLIAMS AB, 1994, OBSTET GYNECOL, V83, P205	32	29	33	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167386	10.1371/journal.pone.0167386	http://dx.doi.org/10.1371/journal.pone.0167386			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907089	Green Submitted, gold, Green Published			2022-12-26	WOS:000389482700137
J	Ruff, CB; Burgess, ML; Ketcham, RA; Kappelman, J				Ruff, Christopher B.; Burgess, M. Loring; Ketcham, Richard A.; Kappelman, John			Limb Bone Structural Proportions and Locomotor Behavior in AL288-1 ("Lucy")	PLOS ONE			English	Article							JOINT SURFACE-AREAS; AUSTRALOPITHECUS-AFARENSIS; LONG-BONE; POSTCRANIAL ROBUSTICITY; SKELETAL ALLOMETRY; BODY PROPORTIONS; EARLY HOMINID; SITE SIERRA; LOS HUESOS; HOMO	While there is broad agreement that early hominins practiced some form of terrestrial bipe-dality, there is also evidence that arboreal behavior remained a part of the locomotor repertoire in some taxa, and that bipedal locomotion may not have been identical to that of modern humans. It has been difficult to evaluate such evidence, however, because of the possibility that early hominins retained primitive traits (such as relatively long upper limbs) of little contemporaneous adaptive significance. Here we examine bone structural properties of the femur and humerus in the Australopithecus afarensis A.L. 288-1 ("Lucy", 3.2 Myr) that are known to be developmentally plastic, and compare them with other early hominins, modern humans, and modern chimpanzees. Cross-sectional images were obtained from micro-CT scans of the original specimens and used to derive section properties of the diaphyses, as well as superior and inferior cortical thicknesses of the femoral neck. A.L. 288-1 shows femoral/humeral diaphyseal strength proportions that are intermediate between those of modern humans and chimpanzees, indicating more mechanical loading of the forelimb than in modern humans, and by implication, a significant arboreal locomotor component. Several features of the proximal femur in A.L. 288-1 and other australopiths, including relative femoral head size, distribution of cortical bone in the femoral neck, and cross-sectional shape of the proximal shaft, support the inference of a bipedal gait pattern that differed slightly from that of modern humans, involving more lateral deviation of the body center of mass over the support limb, which would have entailed increased cost of terrestrial locomotion. There is also evidence consistent with increased muscular strength among australopiths in both the forelimb and hind limb, possibly reflecting metabolic trade-offs between muscle and brain development during hominin evolution. Together these findings imply significant differences in both locomotor behavior and ecology between australopiths and later Homo.	[Ruff, Christopher B.; Burgess, M. Loring] Johns Hopkins Univ, Sch Med, Ctr Funct Anat & Evolut, Baltimore, MD 21218 USA; [Ketcham, Richard A.; Kappelman, John] Univ Texas Austin, Dept Geol Sci, Austin, TX USA; [Kappelman, John] Univ Texas Austin, Dept Anthropol, Austin, TX 78712 USA	Johns Hopkins University; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Ruff, CB (corresponding author), Johns Hopkins Univ, Sch Med, Ctr Funct Anat & Evolut, Baltimore, MD 21218 USA.	cbruff@jhmi.edu	Ketcham, Richard/B-5431-2011	Ketcham, Richard/0000-0002-2748-0409	National Science Foundation [BCS-0642297, BCS-1316104, EAR 0646848, EAR-0948842, EAR-1258878]; Paleoanthropology Lab Fund; College of Liberal Arts UT Austin; Houston Museum of Natural Science; Geology Foundation of UT Austin; U.S. National Science Foundation [EAR-0948842, EAR-1258878, EAR-0646848]; NSF [BCS-0642297, BCS-1316104]; Direct For Social, Behav & Economic Scie [1316104] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Paleoanthropology Lab Fund; College of Liberal Arts UT Austin; Houston Museum of Natural Science; Geology Foundation of UT Austin; U.S. National Science Foundation(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This research was supported by the National Science Foundation (www.nsf.gov) BCS-0642297 and BCS-1316104 to C.B. Ruff, and EAR 0646848, EAR-0948842, and EAR-1258878 to R.A. Ketcham. Institutional support was provided by the University of Oulu and the University of Texas at Austin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Authority for Research and Conservation of Cultural Heritage and the National Museum of Ethiopia of the Ministry of Tourism and Culture for permission to scan, study, and photograph Lucy; A. Admassu, K. Ayele, J. A. Bartsch, Y. Beyene, Y. Desta, R. Diehl, R. Flores, R. Harvey, G. Kebede, R. Lariviere, J. H. Mariam, S. M. Miller, L. Rebori, B. Roberts, J. Ten Barge, J. M. Sanchez, D. Slesnick, D. Van Tuerenhout, S. Wilson, M. Woldehan, and M. Yilma for facilitating and assisting with the scanning; T. Getachew and M. Endalamaw for assisting with the photography, and S. Mattox for the photograph in Extended Data Fig 3; A. Witzel for assistance with 3D printing; and Paleoanthropology Lab Fund, College of Liberal Arts UT Austin, and Houston Museum of Natural Science for financial and logistical support, and Owen-Coates Fund of the Geology Foundation of UT Austin for publication costs. The University of Texas High-Resolution X-ray CT Facility was supported by U.S. National Science Foundation grants EAR-0646848, EAR-0948842, and EAR-1258878 (www.nsf.gov). We would also like to thank L. Rodriguez and J. M. Carretero for making available unpublished data on several Atapuerca specimens and Gombore MK3; B. Holt, M. Niskanen, V. Sladek, and M. Berner for collaboration in obtaining the modern European comparative data set, which was supported by NSF (www.nsf.gov) grant BCS-0642297; J-A. Junno for collaboration on obtaining the chimpanzee comparative data set, which was supported by NSF grant (www.nsf.gov) BCS-1316104, with institutional support from the University of Oulu; and J-J. Hublin and C. Boesch for access to chimpanzee specimens in their care. The paper benefited from the comments of three anonymous reviewers.	Aiello L, 1990, INTRO HUMAN EVOLUTIO; AIELLO LC, 1995, CURR ANTHROPOL, V36, P199, DOI 10.1086/204350; Asfaw B, 1999, SCIENCE, V284, P629, DOI 10.1126/science.284.5414.629; Barak MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077687; Berger LR, 2010, SCIENCE, V328, P195, DOI 10.1126/science.1184944; de Castro JMB, 2012, AM J PHYS ANTHROPOL, V147, P604, DOI 10.1002/ajpa.22020; Bozek K, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001871; Carretero JM, 1997, J HUM EVOL, V33, P357, DOI 10.1006/jhev.1997.0128; Carretero JM, 2012, J HUM EVOL, V62, P242, DOI 10.1016/j.jhevol.2011.11.004; Carrier D, 2004, FROM BIPED TO STRIDER, P135; Churchill SE, 2013, SCIENCE, V340, DOI 10.1126/science.1233477; CLARK WE, 1964, FOSSIL EVIDENCE HUMA; Cowgill LW, 2010, AM J PHYS ANTHROPOL, V143, P52, DOI 10.1002/ajpa.21289; de Sousa A, 2012, PROG BRAIN RES, V195, P293, DOI 10.1016/B978-0-444-53860-4.00014-3; DEMES B, 1994, J HUM EVOL, V26, P353, DOI 10.1006/jhev.1994.1023; Demissie S, 2007, BONE, V40, P743, DOI 10.1016/j.bone.2006.09.020; DeSilva JM, 2013, SCIENCE, V340, DOI 10.1126/science.1232999; DeSilva JM, 2012, J HUM EVOL, V63, P487, DOI 10.1016/j.jhevol.2012.05.010; Di Vincenzo F, 2015, QUATERNARY SCI REV, V122, P207, DOI 10.1016/j.quascirev.2015.05.014; Dominguez-Rodrigo M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080347; Doran Diane M., 1996, P213, DOI 10.1017/CBO9780511752414.018; Dowthwaite JN, 2009, J MUSCULOSKEL NEURON, V9, P198; Eser P, 2009, J BONE MINER RES, V24, P1981, DOI [10.1359/JBMR.090521, 10.1359/jbmr.090521]; Fleagle JG, 2013, PRIMATE ADAPTATION AND EVOLUTION, 3RD EDITION, P1; Franciscus RG, 1992, B MEM SOC ANTHRO PAR, V4, P5, DOI [10.3406/bmsap.1992.2300, DOI 10.3406/BMSAP.1992.2300]; GODFREY L, 1991, J ZOOL, V223, P603, DOI 10.1111/j.1469-7998.1991.tb04391.x; GODFREY LR, 1995, AM J PHYS ANTHROPOL, V97, P11, DOI 10.1002/ajpa.1330970103; Green DJ, 2007, J HUM EVOL, V52, P187, DOI 10.1016/j.jhevol.2006.09.001; Green DJ, 2012, SCIENCE, V338, P514, DOI 10.1126/science.1227123; Haile-Selassie Y, 2012, NATURE, V483, P565, DOI 10.1038/nature10922; Haile-Selassie Y, 2010, P NATL ACAD SCI USA, V107, P12121, DOI 10.1073/pnas.1004527107; Harmon EH, 2009, AM J PHYS ANTHROPOL, V139, P154, DOI 10.1002/ajpa.20966; HARTWIGSCHERER S, 1991, J HUM EVOL, V21, P439, DOI 10.1016/0047-2484(91)90094-C; HERMAN GT, 1979, PHYS MED BIOL, V24, P81, DOI 10.1088/0031-9155/24/1/008; Isler K, 2006, J HUM EVOL, V51, P228, DOI 10.1016/j.jhevol.2006.03.006; Isler K, 2009, J HUM EVOL, V57, P392, DOI 10.1016/j.jhevol.2009.04.009; JOHANSON DC, 1982, AM J PHYS ANTHROPOL, V57, P403, DOI 10.1002/ajpa.1330570403; JOHANSON DC, 1987, NATURE, V327, P205, DOI 10.1038/327205a0; Jungers W.L., 1991, P215; JUNGERS WL, 1983, J HUM EVOL, V12, P673, DOI 10.1016/S0047-2484(83)80007-4; JUNGERS WL, 1982, NATURE, V297, P676, DOI 10.1038/297676a0; JUNGERS WL, 1988, J HUM EVOL, V17, P247, DOI 10.1016/0047-2484(88)90056-5; Jungers WL, 2001, ADV PRIMATO, P371; Ketcham RA, 2001, COMPUT GEOSCI-UK, V27, P381, DOI 10.1016/S0098-3004(00)00116-3; Ketcham RA, 2006, P SOC PHOTO-OPT INS, V6318, pO3180, DOI 10.1117/12.680939; KIMBEL WH, 1994, NATURE, V368, P449, DOI 10.1038/368449a0; Kivell TL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9431; LANYON LE, 1980, J ZOOL, V192, P457; LATIMER B, 1987, AM J PHYS ANTHROPOL, V74, P155, DOI 10.1002/ajpa.1330740204; LATIMER B, 1989, AM J PHYS ANTHROPOL, V78, P369, DOI 10.1002/ajpa.1330780306; Latimer B., 1991, P169; Legendre P., 2014, LMODEL2 MODEL 2 REGR; Lieberman DE, 2001, AM J PHYS ANTHROPOL, V116, P266, DOI 10.1002/ajpa.1123; Lovejoy CO, 2009, SCIENCE, V326, DOI 10.1126/science.1175832; LOVEJOY CO, 1988, SCI AM, V259, P118, DOI 10.1038/scientificamerican1188-118; LOVEJOY CO, 1973, AM J PHYS ANTHROPOL, V38, P757, DOI 10.1002/ajpa.1330380315; MacLatchy LM, 1996, J HUM EVOL, V31, P455, DOI 10.1006/jhev.1996.0071; McHenry H.M., 1991, P133; McHenry HM, 1998, J HUM EVOL, V35, P1, DOI 10.1006/jhev.1997.0197; MCHENRY HM, 1978, AM J PHYS ANTHROPOL, V49, P473, DOI 10.1002/ajpa.1330490407; Napier J. R., 1964, Archo Biol Liege (Suppl), V75, P673; Navarrete A, 2011, NATURE, V480, P91, DOI 10.1038/nature10629; O'Neill MC, 2008, J HUM EVOL, V54, P309, DOI 10.1016/j.jhevol.2007.08.008; Ohman JC., 1993, THESIS; Organ JM, 2006, J HUM EVOL, V51, P113, DOI 10.1016/j.jhevol.2006.01.007; Paciulli L. M., 1995, American Journal of Physical Anthropology, V0, P165; Pontzer H, 2016, NATURE, V533, P390, DOI 10.1038/nature17654; Puymerail L, 2012, J HUM EVOL, V63, P741, DOI 10.1016/j.jhevol.2012.08.003; Raichlen DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009769; Richmond B. G., 1998, THESIS; Richmond BG, 2002, J HUM EVOL, V43, P529, DOI 10.1006/jhev.2002.0594; Richmond BG, 2007, J HUM EVOL, V53, P678, DOI 10.1016/j.jhevol.2007.05.011; Richmond BG, 2008, SCIENCE, V319, P1662, DOI 10.1126/science.1154197; Robling AG, 2002, FASEB J, V16, P324, DOI 10.1096/fj.02-0393fje; RUBIN CT, 1982, J EXP BIOL, V101, P187; Ruff C, 2006, AM J PHYS ANTHROPOL, V129, P484, DOI 10.1002/ajpa.20371; Ruff C, 2003, BONE, V33, P317, DOI 10.1016/S8756-3282(03)00161-3; Ruff C, 1998, PRIMATE LOCOMOTION, P449; Ruff C, 2003, J HUM EVOL, V45, P317, DOI 10.1016/j.jhevol.2003.08.006; Ruff CB, 1999, AM J PHYS ANTHROPOL, V109, P509, DOI 10.1002/(SICI)1096-8644(199908)109:4<509::AID-AJPA7>3.0.CO;2-X; Ruff CB, 2000, J HUM EVOL, V38, P269, DOI 10.1006/jhev.1999.0322; RUFF CB, 1995, AM J PHYS ANTHROPOL, V98, P527, DOI 10.1002/ajpa.1330980412; Ruff CB, 2002, AM J PHYS ANTHROPOL, V119, P305, DOI 10.1002/ajpa.10117; RUFF CB, 1994, AM J PHYS ANTHROPOL, V93, P35, DOI 10.1002/ajpa.1330930103; RUFF CB, 1983, AM J PHYS ANTHROPOL, V60, P359, DOI 10.1002/ajpa.1330600308; Ruff CB, STERKFONTEIN HOMININ; RUFF CB, 2008, BIOL ANTHR HUMAN SKE, P183, DOI DOI 10.1002/9780470245842.CH6; Ruff CB, 2016, AM ASS PHYS ANTHR; Ruff C, 2008, J HUM EVOL, V54, P383, DOI 10.1016/j.jhevol.2007.09.001; Ruff C, 2009, AM J PHYS ANTHROPOL, V138, P90, DOI 10.1002/ajpa.20907; Ruff CB, 2015, P NATL ACAD SCI USA, V112, P7147, DOI 10.1073/pnas.1502932112; Ruff CB, 2015, J HUM EVOL, V80, P147, DOI 10.1016/j.jhevol.2014.12.004; Ruff CB, 2015, J HUM EVOL, V80, P74, DOI 10.1016/j.jhevol.2014.09.005; Ruff CB, 2013, J HUM EVOL, V65, P693, DOI 10.1016/j.jhevol.2013.06.008; Ruff CB, 2013, AM J PHYS ANTHROPOL, V150, P512, DOI 10.1002/ajpa.22214; Ruff CB, 2012, AM J PHYS ANTHROPOL, V148, P601, DOI 10.1002/ajpa.22087; Sarringhaus LA, 2016, AM J PHYS ANTHROPOL, V160, P16, DOI 10.1002/ajpa.22930; Scholz MN, 2006, P R SOC B, V273, P2177, DOI 10.1098/rspb.2006.3568; Senut B., 1985, P193; Skinner MM, 2015, SCIENCE, V347, P395, DOI 10.1126/science.1261735; Squyres N, 2015, AM J PHYS ANTHROPOL, V158, P198, DOI 10.1002/ajpa.22789; Stern JT, 2000, EVOL ANTHROPOL, V9, P113, DOI 10.1002/1520-6505(2000)9:3<113::AID-EVAN2>3.0.CO;2-W; STERN JT, 1983, AM J PHYS ANTHROPOL, V60, P279, DOI 10.1002/ajpa.1330600302; SUSMAN RL, 1984, FOLIA PRIMATOL, V43, P113, DOI 10.1159/000156176; Sylvester AD, 2010, AM J PHYS ANTHROPOL, V142, P665, DOI 10.1002/ajpa.21299; Thorpe SKS, 1999, AM J PHYS ANTHROPOL, V110, P179, DOI 10.1002/(SICI)1096-8644(199910)110:2<179::AID-AJPA5>3.0.CO;2-Z; TRINKAUS E, 1994, AM J PHYS ANTHROPOL, V93, P1, DOI 10.1002/ajpa.1330930102; Tsegai ZJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078781; TSUTAKAWA RK, 1977, BIOMETRICS, V33, P215; Walker A., 1993, NARIOKOTOME HOMO ERE; Ward Carol V., 2013, P235; Ward CV, 2012, J HUM EVOL, V63, P1, DOI 10.1016/j.jhevol.2011.11.012; Ward CV, 2001, J HUM EVOL, V41, P255, DOI 10.1006/jhev.2001.0507; Warden SJ, 2014, P NATL ACAD SCI USA, V111, P5337, DOI 10.1073/pnas.1321605111; Warton DI, 2012, METHODS ECOL EVOL, V3, P257, DOI 10.1111/j.2041-210X.2011.00153.x; WHITE TD, 1993, NATURE, V366, P261, DOI 10.1038/366261a0; WOLPOFF MH, 1983, NATURE, V304, P59, DOI 10.1038/304059a0; WOLPOFF MH, 1983, J HUM EVOL, V12, P443, DOI 10.1016/S0047-2484(83)80140-7; WOO SLY, 1981, J BONE JOINT SURG AM, V63, P780, DOI 10.2106/00004623-198163050-00013; Wood B., 1976, EARLIEST MAN ENV LAK, P490; Zipfel B, 2011, SCIENCE, V333, P1417, DOI 10.1126/science.1202703; Zollikofer CPE, 2005, NATURE, V434, P755, DOI 10.1038/nature03397	122	49	49	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0166095	10.1371/journal.pone.0166095	http://dx.doi.org/10.1371/journal.pone.0166095			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FV	27902687	gold, Green Submitted, Green Published			2022-12-26	WOS:000389474100012
J	Back, CR; Sztukowska, MN; Till, M; Lamont, RJ; Jenkinson, HF; Nobbs, AH; Race, PR				Back, Catherine R.; Sztukowska, Maryta N.; Till, Marisa; Lamont, Richard J.; Jenkinson, Howard F.; Nobbs, Angela H.; Race, Paul R.			The Streptococcus gordonii Adhesin CshA Protein Binds Host Fibronectin via a Catch-Clamp Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adhesin; bacterial pathogenesis; intrinsically disordered protein; microbiology; small-angle X-ray scattering (SAXS); X-ray crystallography	CELL-SURFACE; SECONDARY STRUCTURE; ANTIGEN-I/II; SWISS-MODEL; CRYSTAL-STRUCTURE; V-REGION; PREDICTION; HYDROPHOBICITY; DETERMINANTS; POLYPEPTIDES	Adherence of bacteria to biotic or abiotic surfaces is a prerequisite for host colonization and represents an important step in microbial pathogenicity. This attachment is facilitated by bacterial adhesins at the cell surface. Because of their size and often elaborate multidomain architectures, these polypeptides represent challenging targets for detailed structural and functional characterization. The multifunctional fibrillar adhesin CshA, which mediates binding to both host molecules and other microorganisms, is an important determinant of colonization by Streptococcus gordonii, an oral commensal and opportunistic pathogen of animals and humans. CshA binds the high-molecular-weight glycoprotein fibronectin (Fn) via an N-terminal non-repetitive region, and this protein-protein interaction has been proposed to promote S. gordonii colonization at multiple sites within the host. However, the molecular details of how these two proteins interact have yet to be established. Here we present a structural description of the Fn binding N-terminal region of CshA, derived from a combination of X-ray crystallography, small angle X-ray scattering, and complementary biophysical methods. In vitro binding studies support a previously unreported two-state catch-clamp mechanism of Fn binding by CshA, in which the disordered N-terminal domain of CshA acts to catch Fn, via formation of a rapidly assembled but also readily dissociable pre-complex, enabling its neighboring ligand binding domain to tightly clamp the two polypeptides together. This study presents a new paradigm for target binding by a bacterial adhesin, the identification of which will inform future efforts toward the development of anti-adhesive agents that target S. gordonii and related streptococci.	[Back, Catherine R.; Jenkinson, Howard F.; Nobbs, Angela H.] Univ Bristol, Sch Oral & Dent Sci, Lower Maudlin St, Bristol BS1 2LY, Avon, England; [Sztukowska, Maryta N.; Lamont, Richard J.] Univ Louisville, Dept Oral Immunol & Infect Dis, Louisville, KY 40202 USA; [Sztukowska, Maryta N.] Univ Informat Technol & Management, Dept Dent, PL-35225 Rzeszow, Poland; [Till, Marisa; Race, Paul R.] Univ Bristol, Sch Biochem, Biomed Sci Bldg, Bristol BS8 1TD, Avon, England; [Till, Marisa; Race, Paul R.] Univ Bristol, BrisSynBio Synthet Biol Res Ctr, Life Sci Bldg,Tyndall Ave, Bristol BS8 1TQ, Avon, England	University of Bristol; University of Louisville; University of Information Technology & Management Rzeszow; University of Bristol; University of Bristol	Nobbs, AH (corresponding author), Univ Bristol, Sch Oral & Dent Sci, Lower Maudlin St, Bristol BS1 2LY, Avon, England.; Race, PR (corresponding author), Univ Bristol, Sch Biochem, Biomed Sci Bldg, Bristol BS8 1TD, Avon, England.	Angela.Nobbs@bristol.ac.uk; paul.race@bristol.ac.uk	Nobbs, Angela/AAS-3926-2020; Jenkinson, Howard/AAD-9282-2022; Jenkinson, Howard/ABI-1842-2020	Nobbs, Angela/0000-0003-3813-4410; Sztukowska, Maryta/0000-0002-5774-5092	National Institutes of Health Grants [DE016690, DE012505]; Biotechnology and Biological Sciences Research Council Grant [BB/I006478/1]; Royal Society University Research Fellowship Award [UF080534]; BBSRC [BB/I006478/1, BB/L01386X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L01386X/1, BB/I006478/1] Funding Source: researchfish; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE012505, R01DE016690] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society University Research Fellowship Award; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported in part by National Institutes of Health Grants DE016690 (to H. F. J. and R. J. L.) and DE012505 (to R. J. L.), Biotechnology and Biological Sciences Research Council Grant BB/I006478/1 (to P. R. R.), and Royal Society University Research Fellowship Award UF080534 (to P. R. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Attwood TK, 2012, DATABASE-OXFORD, DOI 10.1093/database/bas019; Back CR, 2015, MOL ORAL MICROBIOL, V30, P411, DOI 10.1111/omi.12106; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Biasini Marco, 2014, Nucleic Acids Res, V42, pW252, DOI 10.1093/nar/gku340; Brittan JL, 2015, MICROBES INFECT, V17, P360, DOI 10.1016/j.micinf.2014.12.013; Bryson K, 2007, CURR PROTEIN PEPT SC, V8, P181, DOI 10.2174/138920307780363415; Cid M, 2010, J BIOL CHEM, V285, P35999, DOI 10.1074/jbc.M110.166330; COMPTON LA, 1986, ANAL BIOCHEM, V155, P155, DOI 10.1016/0003-2697(86)90241-1; Corrigan RM, 2007, MICROBIOL-SGM, V153, P2435, DOI 10.1099/mic.0.2007/006676-0; Demuyser L, 2014, PATHOG DIS, V70, P219, DOI 10.1111/2049-632X.12123; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; DOUGLAS CWI, 1993, J MED MICROBIOL, V39, P179, DOI 10.1099/00222615-39-3-179; Edwards AM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000964; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; FISCHETTI VA, 1989, CLIN MICROBIOL REV, V2, P285, DOI 10.1128/CMR.2.3.285-314.1989; Forsgren N, 2009, PROTEIN SCI, V18, P1896, DOI 10.1002/pro.200; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Giomarelli B, 2006, FEMS MICROBIOL LETT, V265, P172, DOI 10.1111/j.1574-6968.2006.00479.x; Gronenborn AM, 2009, CURR OPIN STRUC BIOL, V19, P39, DOI 10.1016/j.sbi.2008.12.002; Gruszka DT, 2012, P NATL ACAD SCI USA, V109, pE1011, DOI 10.1073/pnas.1119456109; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Habchi J, 2014, CHEM REV, V114, P6561, DOI 10.1021/cr400514h; Hirt H, 2000, J BACTERIOL, V182, P2299, DOI 10.1128/JB.182.8.2299-2306.2000; Holmes AR, 1996, INFECT IMMUN, V64, P4680, DOI 10.1128/IAI.64.11.4680-4685.1996; Huang YQ, 2009, J MOL BIOL, V393, P1143, DOI 10.1016/j.jmb.2009.09.010; Jakubovics NS, 2009, MICROBIOL-SGM, V155, P3572, DOI 10.1099/mic.0.032078-0; Jakubovics NS, 2005, INFECT IMMUN, V73, P6629, DOI 10.1128/IAI.73.10.6629-6638.2005; JENKINSON HF, 1987, J GEN MICROBIOL, V133, P1909; Jenkinson HF, 1997, MOL MICROBIOL, V23, P183, DOI 10.1046/j.1365-2958.1997.2021577.x; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kiefer F, 2009, NUCLEIC ACIDS RES, V37, pD387, DOI 10.1093/nar/gkn750; Kiefhaber T, 2012, CURR OPIN STRUC BIOL, V22, P21, DOI 10.1016/j.sbi.2011.09.010; Kline KA, 2009, CELL HOST MICROBE, V5, P580, DOI 10.1016/j.chom.2009.05.011; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Larson MR, 2010, P NATL ACAD SCI USA, V107, P5983, DOI 10.1073/pnas.0912293107; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Lofling J, 2011, CELL MICROBIOL, V13, P186, DOI 10.1111/j.1462-5822.2010.01560.x; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; MANAVALAN P, 1987, ANAL BIOCHEM, V167, P76, DOI 10.1016/0003-2697(87)90135-7; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCNAB R, 1994, MOL MICROBIOL, V14, P743, DOI 10.1111/j.1365-2958.1994.tb01311.x; McNab R, 1996, INFECT IMMUN, V64, P4204, DOI 10.1128/IAI.64.10.4204-4210.1996; McNab R, 1999, J BACTERIOL, V181, P3087, DOI 10.1128/JB.181.10.3087-3095.1999; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; Moschioni M, 2010, MICROB BIOTECHNOL, V3, P370, DOI 10.1111/j.1751-7915.2009.00138.x; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nylander A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063768; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; PAKULA R, 1963, J GEN MICROBIOL, V31, P125, DOI 10.1099/00221287-31-1-125; Plewczynski D, 2007, POLYMER, V48, P5493, DOI 10.1016/j.polymer.2007.07.039; Rego S, 2016, J BIOL CHEM, V291, P15985, DOI 10.1074/jbc.M116.726562; Schwarz-Linek U, 2003, NATURE, V423, P177, DOI 10.1038/nature01589; Servant Florence, 2002, Brief Bioinform, V3, P246, DOI 10.1093/bib/3.3.246; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; Sigrist CJA, 2013, NUCLEIC ACIDS RES, V41, pE344, DOI 10.1093/nar/gks1067; Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Troffer-Charlier N, 2002, J MOL BIOL, V318, P179, DOI 10.1016/S0022-2836(02)00025-6; Uversky VN, 2015, FEBS J, V282, P1182, DOI 10.1111/febs.13202; Uversky VN, 2013, PROTEIN SCI, V22, P693, DOI 10.1002/pro.2261; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011	73	17	17	0	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1538	1549		10.1074/jbc.M116.760975	http://dx.doi.org/10.1074/jbc.M116.760975			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	27920201	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000395515600001
J	Inaba, S; Numoto, N; Ogawa, S; Morii, H; Ikura, T; Abe, R; Ito, N; Oda, M				Inaba, Satomi; Numoto, Nobutaka; Ogawa, Shuhei; Morii, Hisayuki; Ikura, Teikichi; Abe, Ryo; Ito, Nobutoshi; Oda, Masayuki			Crystal Structures and Thermodynamic Analysis Reveal Distinct Mechanisms of CD28 Phosphopeptide Binding to the Src Homology 2 (SH2) Domains of Three Adaptor Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRB2; GADS; CORECEPTOR; ACTIVATION; 3-KINASE; SURFACE; SLP-76; ICOS	Full activation of T cells and differentiation into effector T cells are essential for many immune responses and require costimulatory signaling via the CD28 receptor. Extracellular ligand binding to CD28 recruits protein-tyrosine kinases to its cytoplasmictail, whichcontainsaYMNMmotif. Followingphosphorylation of the tyrosine, the proteins growth factor receptorbound protein 2 (Grb2), Grb2-related adaptor downstream of Shc (Gads), and p85 subunit of phosphoinositide 3-kinase may bind to pYMNM (where pY is phosphotyrosine) via their Src homology 2 (SH2) domains, leading to downstream signaling to distinct immune pathways. These three adaptor proteins bind to the same site on CD28 with variable affinity, and all are important for CD28-mediated co-stimulatory function. However, the mechanism of how these proteins recognize and compete for CD28 is unclear. To visualize their interactions with CD28, we have determined the crystal structures of Gads SH2 and two p85 SH2 domains in complex with a CD28-derived phosphopeptide. The high resolution structures obtained revealed that, whereas the CD28 phosphopeptide bound to Gads SH2 is in a bent conformation similar to that when bound to Grb2 SH2, it adopts a more extended conformation when bound to the N- and C-terminal SH2 domains of p85. These differences observed in the peptide-protein interactions correlated well with the affinity and other thermodynamic parameters for each interaction determined by isothermal titration calorimetry. The detailed insight into these interactions reported here may inform the development of compounds that specifically inhibit the association of CD28 with these adaptor proteins to suppress excessive T cell responses, such as in allergies and autoimmune diseases.	[Inaba, Satomi; Oda, Masayuki] Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Kyoto 6068522, Japan; [Numoto, Nobutaka; Ikura, Teikichi; Ito, Nobutoshi] Tokyo Med & Dent Univ, Med Res Inst, Tokyo 1138510, Japan; [Ogawa, Shuhei; Abe, Ryo] Tokyo Univ Sci, Res Inst Biomed Sci, Chiba 2780022, Japan; [Morii, Hisayuki] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Ibaraki 3050074, Japan	Kyoto Prefectural University; Tokyo Medical & Dental University (TMDU); Tokyo University of Science; National Institute of Advanced Industrial Science & Technology (AIST)	Ito, N (corresponding author), Tokyo Med & Dent Univ, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.; Oda, M (corresponding author), Kyoto Prefectural Univ, Sakyo Ku, 1-5 Hangi Cho, Kyoto, Kyoto 6068522, Japan.	ito.str@tmd.ac.jp; oda@kpu.ac.jp	Ikura, Teikichi/T-5912-2019	Inoue, Satomi/0000-0002-6939-1324; Oda, Masayuki/0000-0002-8568-4223	Medical Research Institute, Tokyo Medical and Dental University	Medical Research Institute, Tokyo Medical and Dental University	This work was supported by the Joint Usage/Research Program of Medical Research Institute, Tokyo Medical and Dental University. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Asada H, 1999, J EXP MED, V189, P1383, DOI 10.1084/jem.189.9.1383; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Esensten JH, 2016, IMMUNITY, V44, P973, DOI 10.1016/j.immuni.2016.04.020; Harada Y, 2003, J EXP MED, V197, P257, DOI 10.1084/jem.20021305; Harada Y, 2001, J BIOL CHEM, V276, P9003, DOI 10.1074/jbc.M005051200; Higo K, 2014, IMMUNOL INVEST, V43, P278, DOI 10.3109/08820139.2013.875039; Higo K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074482; JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kraskouskaya D, 2013, CHEM SOC REV, V42, P3337, DOI 10.1039/c3cs35449k; LADBURY JE, 1995, P NATL ACAD SCI USA, V92, P3199, DOI 10.1073/pnas.92.8.3199; Law CL, 1999, J EXP MED, V189, P1243, DOI 10.1084/jem.189.8.1243; Linsley PS, 2009, IMMUNOL REV, V229, P307, DOI 10.1111/j.1600-065X.2009.00780.x; Liu BA, 2012, FEBS LETT, V586, P2597, DOI 10.1016/j.febslet.2012.04.054; Liu SK, 1998, ONCOGENE, V17, P3073, DOI 10.1038/sj.onc.1202337; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNemar C, 1997, BIOCHEMISTRY-US, V36, P10006, DOI 10.1021/bi9704360; MURPHY KP, 1992, ADV PROTEIN CHEM, V43, P313, DOI 10.1016/S0065-3233(08)60556-2; Nolte RT, 1996, NAT STRUCT BIOL, V3, P364, DOI 10.1038/nsb0496-364; O'Brien R, 2000, PROTEIN SCI, V9, P570; Oda M, 1998, J MOL BIOL, V276, P571, DOI 10.1006/jmbi.1997.1564; Oda M, 2000, MOL IMMUNOL, V37, P1111, DOI 10.1016/S0161-5890(01)00028-1; Ogawa S, 2013, INT IMMUNOL, V25, P671, DOI 10.1093/intimm/dxt028; Ogura K, 1997, J BIOMOL NMR, V10, P273, DOI 10.1023/A:1018340506337; Papaioannou D, 2016, PROTEIN SCI, V25, P627, DOI 10.1002/pro.2856; Pauptit RA, 2001, ACTA CRYSTALLOGR D, V57, P1397, DOI 10.1107/S0907444901012434; Rudd CE, 2003, NAT REV IMMUNOL, V3, P544, DOI 10.1038/nri1131; Rudd CE, 2009, IMMUNOL REV, V229, P12, DOI 10.1111/j.1600-065X.2009.00770.x; Schildberg FA, 2016, IMMUNITY, V44, P955, DOI 10.1016/j.immuni.2016.05.002; SCHNEIDER H, 1995, EUR J IMMUNOL, V25, P1044, DOI 10.1002/eji.1830250428; Schneider H, 2008, BIOCHEM BIOPH RES CO, V369, P616, DOI 10.1016/j.bbrc.2008.02.068; SPOLAR RS, 1992, BIOCHEMISTRY-US, V31, P3947, DOI 10.1021/bi00131a009; Takeda K, 2008, INT IMMUNOL, V20, P1507, DOI 10.1093/intimm/dxn108; Teichmann LL, 2015, IMMUNITY, V42, P552, DOI 10.1016/j.immuni.2015.02.015; Watanabe R, 2006, J IMMUNOL, V177, P1085, DOI 10.4049/jimmunol.177.2.1085; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	39	15	15	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2017	292	3					1052	1060		10.1074/jbc.M116.755173	http://dx.doi.org/10.1074/jbc.M116.755173			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2LL	27927989	hybrid, Green Published			2022-12-26	WOS:000392318700024
J	Pfaff, DH; Fleming, T; Nawroth, P; Teleman, AA				Pfaff, Daniel H.; Fleming, Thomas; Nawroth, Peter; Teleman, Aurelio A.			Evidence Against a Role for the Parkinsonism-associated Protein DJ-1 in Methylglyoxal Detoxification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DROSOPHILA DJ-1; OXIDATIVE STRESS; GLYOXAL; MUTANTS; GLYCATION; DISEASE	Methylglyoxal (MG) is a reactive metabolite that forms adducts on cysteine, lysine and arginine residues of proteins, thereby affecting their function. Methylglyoxal is detoxified by the Glyoxalase system, consisting of two enzymes, Glo1 and Glo2, that act sequentially to convert MG into D-lactate. Recently, the Parkinsonism-associated protein DJ-1 was described in vitro to have glyoxalase activity, thereby detoxifying the MG metabolite, or deglycase activity, thereby removing the adduct formed by MG on proteins. Since Drosophila is an established model system to study signaling, neurodegeneration, and metabolic regulation in vivo, we asked whether DJ-1 contributes to MG detoxification in vivo. Using both DJ-1 knockdown in Drosophila cells in culture, and DJ-1 beta knock-out flies, we could detect no contribution of DJ-1 to survival to MG challenge or to accumulation of MG protein adducts. Furthermore, we provide data suggesting that the previously reported deglycation activity of DJ-1 can be ascribed to a TRIS buffer artifact.	[Pfaff, Daniel H.; Teleman, Aurelio A.] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Pfaff, Daniel H.; Fleming, Thomas; Nawroth, Peter] Univ Heidelberg Hosp, Dept Internal Med & Clin Chem 1, D-69120 Heidelberg, Germany; [Nawroth, Peter] German Ctr Diabet Res DZD, D-85764 Munich, Germany; [Nawroth, Peter] Helmholtz Zentrum, Joint Heidelberg IDC Translat Diabet Program, D-85764 Munich, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association	Teleman, AA (corresponding author), German Canc Res Ctr, D-69120 Heidelberg, Germany.; Nawroth, P (corresponding author), Univ Heidelberg Hosp, Dept Internal Med & Clin Chem 1, D-69120 Heidelberg, Germany.; Nawroth, P (corresponding author), German Ctr Diabet Res DZD, D-85764 Munich, Germany.; Nawroth, P (corresponding author), Helmholtz Zentrum, Joint Heidelberg IDC Translat Diabet Program, D-85764 Munich, Germany.	Peter.Nawroth@med.uni-heidelberg.de; a.teleman@dkfz.de	Teleman, Aurelio A/E-6864-2013; Teleman, Aurelio/V-8470-2019	Teleman, Aurelio A/0000-0002-4237-9368; Teleman, Aurelio/0000-0002-4237-9368	DFG [SFB1118]; Helmholtz Portfolio Topic "Metabolic Dysfunction"; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537] Funding Source: NIH RePORTER	DFG(German Research Foundation (DFG)); Helmholtz Portfolio Topic "Metabolic Dysfunction"; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the DFG SFB1118 and by the Helmholtz Portfolio Topic "Metabolic Dysfunction." The authors declare that they have no conflicts of interest with the contents of this article.	[Anonymous], 2012, INT SCHOLARLY RES NO; Berlanga J, 2005, CLIN SCI, V109, P83, DOI 10.1042/CS20050026; Bierhaus A, 2012, NAT MED, V18, P926, DOI 10.1038/nm.2750; Golej J, 1998, LIFE SCI, V63, P801, DOI 10.1016/S0024-3205(98)00336-1; Kim GH, 2015, EXP NEUROBIOL, V24, P325, DOI 10.5607/en.2015.24.4.325; Lavara-Culebras E, 2007, GENE, V400, P158, DOI 10.1016/j.gene.2007.06.013; Lee JY, 2012, HUM MOL GENET, V21, P3215, DOI 10.1093/hmg/dds155; Menzies FM, 2005, CURR BIOL, V15, P1578, DOI 10.1016/j.cub.2005.07.036; Meulener M, 2005, CURR BIOL, V15, P1572, DOI 10.1016/j.cub.2005.07.064; Mihoub M, 2015, BIOCHEM BIOPH RES CO, V463, P1305, DOI 10.1016/j.bbrc.2015.06.111; Park J, 2005, GENE, V361, P133, DOI 10.1016/j.gene.2005.06.040; Ramasamy R, 2006, CELL, V124, P258, DOI 10.1016/j.cell.2006.01.002; Raninga Prahlad V, 2014, Oncoscience, V1, P95; Riboulet-Chavey A, 2006, DIABETES, V55, P1289, DOI 10.2337/db05-0857; Richarme G, 2015, J BIOL CHEM, V290, P1885, DOI 10.1074/jbc.M114.597815; Thornalley Paul J., 2008, Drug Metabolism and Drug Interactions, V23, P125; Thornalley PJ, 2003, BIOCHEM SOC T, V31, P1343; Thornalley PJ, 1996, GEN PHARMACOL-VASC S, V27, P565, DOI 10.1016/0306-3623(95)02054-3	18	35	36	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2017	292	2					685	690		10.1074/jbc.M116.743823	http://dx.doi.org/10.1074/jbc.M116.743823			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2KN	27903648	hybrid, Green Published			2022-12-26	WOS:000392316100023
J	Viktorova, J; Jandova, Z; Madlenakova, M; Prouzova, P; Bartunek, V; Vrchotova, B; Lovecka, P; Musilova, L; Macek, T				Viktorova, Jitka; Jandova, Zuzana; Madlenakova, Michaela; Prouzova, Petra; Bartunek, Vilem; Vrchotova, Blanka; Lovecka, Petra; Musilova, Lucie; Macek, Tomas			Native Phytoremediation Potential of Urtica dioica for Removal of PCBs and Heavy Metals Can Be Improved by Genetic Manipulations Using Constitutive CaMV 35S Promoter	PLOS ONE			English	Article							BACTERIAL BPHC GENE; ENDOPHYTIC BACTERIA; TRANSGENIC TOBACCO; CONTAMINATED SOIL; PLANT-GROWTH; ACCUMULATION; CADMIUM; METABOLISM; EXPRESSION; TOLERANCE	Although stinging nettle (Urtica dioica) has been shown to reduce HM (heavy metal) content in soil, its wider phytoremediation potential has been neglected. Urtica dioica was cultivated in soils contaminated with HMs or polychlorinated biphenyls (PCBs). After four months, up to 33% of the less chlorinated biphenyls and 8% of HMs (Zn, Pb, Cd) had been removed. Bacteria were isolated from the plant tissue, with the endophytic bacteria Bacillus shackletonii and Streptomyces badius shown to have the most significant effect. These bacteria demonstrated not only benefits for plant growth, but also extreme tolerance to As, Zn and Pb. Despite these results, the native phytoremediation potential of nettles could be improved by biotechnologies. Transient expression was used to investigate the functionality of the most common constitutive promoter, CaMV 35S in Urtica dioica. This showed the expression of the CUP and bphC transgenes. Collectively, our findings suggest that remediation by stinging nettle could have a much wider range of applications than previously thought.	[Viktorova, Jitka; Jandova, Zuzana; Madlenakova, Michaela; Prouzova, Petra; Vrchotova, Blanka; Lovecka, Petra; Musilova, Lucie; Macek, Tomas] UCT Prague, Fac Food & Biochem Technol, Dept Biochem & Microbiol, Tech 3, Prague, Czech Republic; [Bartunek, Vilem] UCT Prague, Fac Chem Technol, Dept Inorgan Chem, Tech 3, Prague, Czech Republic	University of Chemistry & Technology, Prague; University of Chemistry & Technology, Prague	Macek, T (corresponding author), UCT Prague, Fac Food & Biochem Technol, Dept Biochem & Microbiol, Tech 3, Prague, Czech Republic.	tomas.macek@vscht.cz	Musilová, Lucie/AAL-6331-2020; Viktorova, Jitka/B-5707-2014; Macek, Tomas/K-1843-2012; Madlenakova, Michaela/H-9346-2017	Musilová, Lucie/0000-0002-8244-8006; Viktorova, Jitka/0000-0003-0857-153X; Macek, Tomas/0000-0002-7281-9512; Madlenakova, Michaela/0000-0001-9805-0505	Technology Agency of the Czech Republic [TA03011184]; Grant Agency of the Czech Republic [15-22276S]	Technology Agency of the Czech Republic; Grant Agency of the Czech Republic(Grant Agency of the Czech Republic)	This work was supported by Technology Agency of the Czech Republic of project No. TA03011184 and by Grant Agency of the Czech Republic of project No. 15-22276S.	Amaresan N, 2012, ANN MICROBIOL, V62, P805, DOI 10.1007/s13213-011-0321-7; Barzanti R, 2007, MICROB ECOL, V53, P306, DOI 10.1007/s00248-006-9164-3; Boshoff M, 2014, SCI TOTAL ENVIRON, V493, P862, DOI 10.1016/j.scitotenv.2014.06.076; Chaney RL, 1997, CURR OPIN BIOTECH, V8, P279, DOI 10.1016/S0958-1669(97)80004-3; Chebotar VK, 2015, APPL BIOCHEM MICRO+, V51, P271, DOI 10.1134/S0003683815030059; Cumming G, 2007, J CELL BIOL, V177, P7, DOI 10.1083/jcb.200611141; DADARWAL KR, 1981, J BIOSCIENCE, V3, P117, DOI 10.1007/BF02702653; DWORKIN M, 1958, J BACTERIOL, V75, P592, DOI 10.1128/JB.75.5.592-603.1958; Edwards HGM, 1998, SPECTROCHIM ACTA A, V54, P745, DOI 10.1016/S1386-1425(98)00013-4; ERNST WHO, 1987, CHEMOSPHERE, V16, P233, DOI 10.1016/0045-6535(87)90127-5; Fiser J, 2012, 5TH INTERNATIONAL SYMPOSIUM ON BIOSORPTION AND BIOREMEDIATION, P14; Gounden D, 2016, J ENVIRON SCI HEAL B, V51, P1, DOI 10.1080/03601234.2015.1080477; Grubor M, 2008, ARCH BIOL SCI, V60, P239, DOI 10.2298/ABS0802239G; Gulcin I, 2005, J ENZYM INHIB MED CH, V20, P297, DOI 10.1080/1475636032000141890; Hartley L., 2004, CHARACTERIZATION HEA; Hlozkova K, 2013, RES MICROBIOL, V164, P1009, DOI 10.1016/j.resmic.2013.10.002; Ho M-W, 2011, MICROBIAL ECOLOGY IN, V11; Holm FW, 2012, EFFLUENTS ALTERNATIV; Hussain S, 2009, CRIT REV ENV SCI TEC, V39, P843, DOI 10.1080/10643380801910090; Ibanez S, 2016, NEW BIOTECHNOL, V33, P625, DOI 10.1016/j.nbt.2015.11.008; Jasim B, 2013, PLANT GROWTH REGUL, V71, P1, DOI 10.1007/s10725-013-9802-y; Kapila J, 1997, PLANT SCI, V122, P101, DOI 10.1016/S0168-9452(96)04541-4; Khan AL, 2014, J MICROBIOL, V52, P689, DOI 10.1007/s12275-014-4002-7; Koblar A, 2015, J FLUORINE CHEM, V172, P7, DOI 10.1016/j.jfluchem.2015.01.006; Logan NA, 2004, INT J SYST EVOL MICR, V54, P373, DOI 10.1099/ijs.0.02661-0; Macek T, 2002, ACTA BIOTECHNOL, V22, P101, DOI 10.1002/1521-3846(200205)22:1/2&lt;101::AID-ABIO101&gt;3.0.CO;2-N; Macek T, 2008, TRENDS BIOTECHNOL, V26, P146, DOI 10.1016/j.tibtech.2007.11.009; MCINROY JA, 1995, PLANT SOIL, V173, P337, DOI 10.1007/BF00011472; Miliute I., 2011, Biologija, V57, P98; Musilova L, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081205; Novakova M, 2009, BIOTECHNOL BIOENG, V102, P29, DOI 10.1002/bit.22038; Obasi N.A., 2013, INT J CURRENT BIOCH, V1, P16; Ohkama N, 1999, SOIL SCI PLANT NUTR, V45, P767, DOI 10.1080/00380768.1999.10415842; Pachura P, 2016, DESALIN WATER TREAT, V57, P1469, DOI 10.1080/19443994.2015.1017330; Panz K, 2012, J ENVIRON MANAGE, V113, P85, DOI 10.1016/j.jenvman.2012.08.016; Pavlikova D, 2004, PLANT SOIL ENVIRON, V50, P513, DOI 10.17221/4067-PSE; Pavlikova D, 2007, INT J PHYTOREMEDIAT, V9, P71, DOI 10.1080/15226510601139433; Radulescu C, 2013, ROM J PHYS, V58, P1337; Rajkumar M, 2009, CHEMOSPHERE, V77, P153, DOI 10.1016/j.chemosphere.2009.06.047; Robinson T, 2001, BIORESOURCE TECHNOL, V77, P247, DOI 10.1016/S0960-8524(00)00080-8; SAFE S, 1993, ENVIRON HEALTH PERSP, V100, P259, DOI 10.2307/3431532; Scherer J, 2009, MOL MICROBIOL, V73, P601, DOI 10.1111/j.1365-2958.2009.06792.x; Shams KM, 2010, PLANT SOIL, V328, P175, DOI 10.1007/s11104-009-0095-x; Sheoran V, 2009, MINER ENG, V22, P1007, DOI 10.1016/j.mineng.2009.04.001; Shin SH, 2001, J MICROBIOL METH, V44, P89, DOI 10.1016/S0167-7012(00)00229-3; Silver S, 2005, J IND MICROBIOL BIOT, V32, P587, DOI 10.1007/s10295-005-0019-6; Silver S, 2005, APPL ENVIRON MICROB, V71, P599, DOI 10.1128/AEM.71.2.599-608.2005; Sinclair SA, 2012, BBA-MOL CELL RES, V1823, P1553, DOI 10.1016/j.bbamcr.2012.05.016; Tanvir R, 2014, NAT PROD RES, V28, P2048, DOI 10.1080/14786419.2014.919579; Tarhan L, 2016, BIOL PLANTARUM, V60, P163, DOI 10.1007/s10535-015-0570-6; Uhlik O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040653; Uhlik O, 2009, APPL ENVIRON MICROB, V75, P6471, DOI 10.1128/AEM.00466-09; Van Aken B, 2010, ENVIRON SCI TECHNOL, V44, P2767, DOI 10.1021/es902514d; Verbruggen N, 2009, NEW PHYTOL, V181, P759, DOI 10.1111/j.1469-8137.2008.02748.x; Viktorova J, 2014, INT J PHYTOREMEDIAT, V16, P937, DOI 10.1080/15226514.2013.810575; WILKEN A, 1995, ENVIRON TOXICOL CHEM, V14, P2017, DOI [10.1897/1552-8618(1995)14[2017:MODPCI]2.0.CO;2, 10.1002/etc.5620141203]	56	13	15	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167927	10.1371/journal.pone.0167927	http://dx.doi.org/10.1371/journal.pone.0167927			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930707	Green Published, gold			2022-12-26	WOS:000389580900061
J	Gonzalez, CV; Jofre, MF; Vila, HF; Stoffel, M; Bottini, R; Giordano, CV				Veronica Gonzalez, Carina; Florencia Jofre, Maria; Vila, Hernan F.; Stoffel, Markus; Bottini, Ruben; Valeria Giordano, Carla			Morphology and Hydraulic Architecture of Vitis vinifera L. cv. Syrah and Torrontes Riojano Plants Are Unaffected by Variations in Red to Far-Red Ratio	PLOS ONE			English	Article							LEAF-AREA DENSITY; GRAPEVINE CANOPIES; LIGHT ENVIRONMENT; SHADE TOLERANCE; PHYTOCHROME; RESPONSES; MICROCLIMATE; PRESSURE; QUALITY; YIELD	Plants have evolved an array of specific photoreceptors to acclimate to the light environment. By sensing light signals, photoreceptors modulate plant morphology, carbon-and water-physiology, crop yield and quality of harvestable organs, among other responses. Many cultural practices and crop management decisions alter light quantity and quality perceived by plants cultivated in the field. Under full sunlight, phytochromes perceive high red to far red ratios (R:FR; 1.1), whereas overhead or lateral low R:FR (below 1.1) are sensed in the presence of plant shade or neighboring plants, respectively. Grapevine is one of the most important fruit crops in the world. To date, studies on grapevine response to light focused on different Photosynthetic Active Radiation (PAR) levels; however, limited data exist about its response to light quality. In this study we aimed to investigate morphological, biochemical, and hydraulic responses of Vitis vinifera to variations in R:FR. Therefore, we irradiated Syrah and Torronte's Riojano plants, grown in a glasshouse, with lateral FR light (low lateral R:FR treatment), while others, that were kept as controls, were not irradiated (ambient lateral R:FR treatment). In response to the low lateral R:FR treatment, grapevine plants did not display any of the SAS morphological markers (i.e. stem length, petiole length and angle, number of lateral shoots) in any of the cultivars assessed, despite an increase in gibberelins and auxin concentrations in leaf tissues. Low lateral R:FR did not affect dry matter partitioning, water-related traits (stomata density and index, wood anatomy), or water-related physiology (plant conductance, transpiration rate, stem hydraulic conductivity, stomatal conductance). None of the Vitis vinifera varieties assessed displayed the classical morphological and hydraulic responses associated to SAS induced by phytochromes. We discuss these results in the context of natural grapevine environment and agronomical relevance.	[Veronica Gonzalez, Carina; Florencia Jofre, Maria; Bottini, Ruben] UNCuyo, CONICET, IBAM, Fac Ciencias Agr, Almirante Brown 500 Chacras Coria, Mendoza, Argentina; [Veronica Gonzalez, Carina; Florencia Jofre, Maria] Univ Nacl Cuyo, Fac Ciencias Exactas & Nat, Mendoza, Argentina; [Vila, Hernan F.] Inst Nacl Tecnol Agr, Lab Viticulture, Estn Expt Agr Mendoza, San Martin 3853, Mendoza, Argentina; [Stoffel, Markus] Univ Bern, Dendrolab Ch, Baltzerstr 1 3, Bern, Switzerland; [Stoffel, Markus] Univ Geneva, Inst Environm Sci, Climat Change & Climate Impacts, Blvd Carl Vogt 66, Geneva, Switzerland; [Valeria Giordano, Carla] Consejo Nacl Invest Cient & Tecn, IADIZA, Av Ruiz Leal S-N,Parque Gen San Martin, Mendoza, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University Nacional Cuyo Mendoza; Instituto Nacional de Tecnologia Agropecuaria (INTA); University of Bern; University of Geneva; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Giordano, CV (corresponding author), Consejo Nacl Invest Cient & Tecn, IADIZA, Av Ruiz Leal S-N,Parque Gen San Martin, Mendoza, Argentina.	cgiordano@mendoza-conicet.gob.ar	Bottini, Rubén/AAS-9320-2021; Stoffel, Markus/A-1793-2017	Stoffel, Markus/0000-0003-0816-1303; Gonzalez, Carina/0000-0003-3014-7129	Fondo para la Investigacion Cientifica y Tecnologica [PICT 2010-1755]; Secretaria de Ciencia, Tecnica y Posgrado, Universidad Nacional de Cuyo [M008]	Fondo para la Investigacion Cientifica y Tecnologica; Secretaria de Ciencia, Tecnica y Posgrado, Universidad Nacional de Cuyo	This work was funded by PICT 2010-1755 - Fondo para la Investigacion Cientifica y Tecnologica (http://www.agencia.mincyt.gob.ar/) to CVGiordano, and M008 - Secretaria de Ciencia, Tecnica y Posgrado, Universidad Nacional de Cuyo (http://www.uncuyo.edu.ar/ciencia_tecnica_y_posgrado/proyectos-de-investigacion) to CVGonzalez.	Arbellay E, 2012, J EXP BOT, V63, P3271, DOI 10.1093/jxb/ers050; Ballare CL, 2014, ANNU REV PLANT BIOL, V65, P335, DOI 10.1146/annurev-arplant-050213-040145; BALLARE CL, 1987, PLANT CELL ENVIRON, V10, P551, DOI 10.1111/1365-3040.ep11604091; Boccalandro HE, 2003, PLANT PHYSIOL, V133, P1539, DOI 10.1104/pp.103.029579; BUTTROSE M. S., 1969, Vitis, V8, P280; BUTTROSE MS, 1968, ANN BOT-LONDON, V32, P753, DOI 10.1093/oxfordjournals.aob.a084247; CARTECHINI A, 1995, AM J ENOL VITICULT, V46, P227; Casal JJ, 2013, ISRN AGRONOMY, V2013, P16; Casal JJ, 2013, ANNU REV PLANT BIOL, V64, P403, DOI 10.1146/annurev-arplant-050312-120221; Casal Jorge J, 2012, Arabidopsis Book, V10, pe0157, DOI 10.1199/tab.0157; Castellarin SD, 2007, PLANT CELL ENVIRON, V30, P1381, DOI 10.1111/j.1365-3040.2007.01716.x; CHAPPELLE EW, 1992, REMOTE SENS ENVIRON, V39, P239, DOI 10.1016/0034-4257(92)90089-3; Deluc LG, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-212; Demotes-Mainard S, 2016, ENVIRON EXP BOT, V121, P4, DOI 10.1016/j.envexpbot.2015.05.010; Di Rienzo JA, 2002, J AGRIC BIOL ENVIR S, V7, P129, DOI 10.1198/10857110260141193; DOKOOZLIAN NK, 1995, AM J ENOL VITICULT, V46, P209; DOKOOZLIAN NK, 1995, AM J ENOL VITICULT, V46, P219; Downey MO, 2006, AM J ENOL VITICULT, V57, P257; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Franklin KA, 2005, ANN BOT-LONDON, V96, P169, DOI 10.1093/aob/mci165; Franklin KA, 2008, NEW PHYTOL, V179, P930, DOI 10.1111/j.1469-8137.2008.02507.x; Franklin KA, 2010, J EXP BOT, V61, P11, DOI 10.1093/jxb/erp304; Galvao VC, 2015, CURR OPIN NEUROBIOL, V34, P46, DOI 10.1016/j.conb.2015.01.013; Gilbert IR, 2001, NATURE, V411, P792, DOI 10.1038/35081062; Gladstone EA, 2003, VITIS, V42, P123; Gommers CMM, 2013, TRENDS PLANT SCI, V18, P65, DOI 10.1016/j.tplants.2012.09.008; Heindl JC, 1983, PLANT PHYSL, V73; Keller M, 2010, SCIENCE OF GRAPEVINES: ANATOMY AND PHYSIOLOGY, P1; Kuhn N, 2013, J EXPT BOT; Kurepin LV, 2014, PLANT SCI, V229, P280, DOI 10.1016/j.plantsci.2014.10.006; Leicht SA, 2006, AM J BOT, V93, P972, DOI 10.3732/ajb.93.7.972; Libenson S, 2002, CROP SCI, V42, P1180, DOI 10.2135/cropsci2002.1180; Masciarelli O, 2014, MICROBIOL RES, V169, P609, DOI 10.1016/j.micres.2013.10.001; MORGAN DC, 1979, PLANTA, V145, P253, DOI 10.1007/BF00454449; OIV, 2011, VIN WIN OUTL; Palliotti A, 2000, AM J ENOL VITICULT, V51, P122; Pierik R, 2013, J EXPT BOT; Putz F, 2012, ECOLOGY INFO, V24; Robson PRH, 1996, NAT BIOTECHNOL, V14, P995, DOI 10.1038/nbt0896-995; Sanchez LA, 2005, AM J ENOL VITICULT, V56, P319; Schnitzer SA, 2002, TRENDS ECOL EVOL, V17, P223, DOI 10.1016/S0169-5347(02)02491-6; SCHOLANDER PF, 1965, SCIENCE, V148, P339, DOI 10.1126/science.148.3668.339; SCHULTE PJ, 1985, J EXP BOT, V36, P1590, DOI 10.1093/jxb/36.10.1590; SCHULTZ HR, 1993, PLANTA, V190, P393, DOI 10.1007/BF00196969; SMART RE, 1988, AM J ENOL VITICULT, V39, P250; Tambussi E., 2010, TECNICAS MEDICION EC, P129; Terral JF, 2010, ANN BOT-LONDON, V105, P443, DOI 10.1093/aob/mcp298; TYREE MT, 1982, CAN J BOT, V60, P911, DOI 10.1139/b82-117; Ugarte CC, 2010, J EXP BOT; Valladares F, 2008, ANNU REV ECOL EVOL S, V39, P237, DOI 10.1146/annurev.ecolsys.39.110707.173506; Valladares F, 2011, ANN BOT-LONDON, V108, P231, DOI 10.1093/aob/mcr132; Gonzalez CV, 2015, PHYTOCHEMISTRY, V110, P46, DOI 10.1016/j.phytochem.2014.11.018; Gonzalez CV, 2012, PLANT CELL ENVIRON, V35, P1958, DOI 10.1111/j.1365-3040.2012.02529.x; WELLBURN AR, 1994, J PLANT PHYSIOL, V144, P307, DOI 10.1016/S0176-1617(11)81192-2	54	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2016	11	12							e0167767	10.1371/journal.pone.0167767	http://dx.doi.org/10.1371/journal.pone.0167767			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3TF	27911923	Green Published, gold			2022-12-26	WOS:000389520600051
J	Hanieh, H; Mohafez, O; Hairul-Islam, VI; Alzahrani, A; Ismail, MB; Thirugnanasambantham, K				Hanieh, Hamza; Mohafez, Omar; Hairul-Islam, Villianur Ibrahim; Alzahrani, Abdullah; Ismail, Mohammad Bani; Thirugnanasambantham, Krishnaraj			Novel Aryl Hydrocarbon Receptor Agonist Suppresses Migration and Invasion of Breast Cancer Cells	PLOS ONE			English	Article							IN-VITRO; METASTASIS; POLYPHENOLS; ACTIVATION; EXPRESSION; ANTITUMOR; AXIS; AHR; INFLAMMATION; MECHANISMS	Background Despite the remarkable progress to fight against breast cancer, metastasis remains the dominant cause of treatment failure and recurrence. Therefore, control of invasiveness potential of breast cancer cells is crucial. Accumulating evidences suggest Aryl hydrocarbon receptor (Ahr), a helix-loop-helix transcription factor, as a promising target to control migration and invasion in breast cancer cells. Thus, an Ahr-based exploration was performed to identify a new Ahr agonist with inhibitory potentials on cancer cell motility. Methods For prediction of potential interactions between Ahr and candidate molecules, bioinformatics analysis was carried out. The interaction of the selected ligand with Ahr and its effects on migration and invasion were examined in vitro using the MDA-MB-231 and T47D cell lines. The silencing RNAs were transfected into cells by electroporation. Expressions of microRNAs (miRNAs) and coding genes were quantified by real-time PCR, and the protein levels were detected by western blot. Results The in silico and in vitro results identified Flavipin as a novel Ahr agonist. It induces formation of Ahr/Ahr nuclear translocator (Arnt) heterodimer to promote the expression of cytochrome P450 family 1 subfamily A member 1 (Cyp1a1). Migration and invasion of MDA-MB-231 and T47D cells were inhibited with Flavipin treatment in an Ahr-dependent fashion. Interestingly, Flavipin suppressed the pro-metastatic factor SRY-related HMG-box4 (Sox4) by inducing miR-212/132 cluster. Moreover, Flavipin inhibited growth and adhesion of both cell lines by suppressing gene expressions of B-cell lymphoma 2 (BcI2) and integrina4 (ITGA4). Conclusion Taken together, the results introduce Flavipin as a novel Ahr agonist, and provide first evidences on its inhibitory effects on cancer cell motility, suggesting Flavipin as a candidate to control cell invasiveness in breast cancer patients.	[Hanieh, Hamza; Hairul-Islam, Villianur Ibrahim; Alzahrani, Abdullah; Ismail, Mohammad Bani] King Faisal Univ, Coll Sci, Dept Biol Sci, Hofuf Ahsaa, Saudi Arabia; [Mohafez, Omar] Coll Clin Pharm, Biomed Dept, Hofuf Ahsaa, Saudi Arabia; [Mohafez, Omar] Al Azhar Univ Assiut, Coll Pharm, Dept Biochem, Assiut, Egypt; [Hairul-Islam, Villianur Ibrahim; Thirugnanasambantham, Krishnaraj] Pondicherry Ctr Biol Sci, Pondicherry, India	King Faisal University; Egyptian Knowledge Bank (EKB); Al Azhar University; Assiut University	Hanieh, H (corresponding author), King Faisal Univ, Coll Sci, Dept Biol Sci, Hofuf Ahsaa, Saudi Arabia.	hhanieh@kfu.edu.sa	Thirugnanasambantham, Krishnaraj/N-7545-2017; Mohafez, Omar/AAA-4883-2022; Hanieh, Hamza/AAA-7867-2021; Alzahrani, Abdullah M/H-8384-2016; Villianur Ibrahim, Hairul-Islam/I-4689-2016	Thirugnanasambantham, Krishnaraj/0000-0002-5340-8806; Mohafez, Omar/0000-0001-5352-8210; Hanieh, Hamza/0000-0001-9230-3858; Alzahrani, Abdullah M/0000-0003-4372-4968; Villianur Ibrahim, Hairul-Islam/0000-0002-2444-5552; Bani Ismail, Mohammad/0000-0001-9278-7258	Deanship of Scientific Research, King Faisal University, Hofuf, Saudi Arabia [160030, 160036]	Deanship of Scientific Research, King Faisal University, Hofuf, Saudi Arabia	This work was funded by the Deanship of Scientific Research, King Faisal University, Hofuf, Saudi Arabia (Grants 160030 to HH and 160036 to AA).r This work was funded by the Deanship of Scientific Research, King Faisal University, Hofuf, Saudi Arabia (Grants 160030 to HH and 160036 to AA).	Belguise K, 2007, CANCER RES, V67, P11742, DOI 10.1158/0008-5472.CAN-07-2730; Chang CL, 2014, INT SYMP INTEGR CIRC, P1, DOI 10.1109/ISICIR.2014.7029491; Chen LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040202; Chinen I, 2015, INT IMMUNOL, V27, P405, DOI 10.1093/intimm/dxv015; D'Amato NC, 2015, CANCER RES, V75, P4651, DOI 10.1158/0008-5472.CAN-15-2011; Denison MS, 2011, TOXICOL SCI, V124, P1, DOI 10.1093/toxsci/kfr218; Evans DGR, 2009, J MED GENET, V46, P811, DOI 10.1136/jmg.2009.067850; Fukasawa K, 2015, MOL CANCER THER, V14, P343, DOI 10.1158/1535-7163.MCT-14-0158; Gao X, 2016, BIOCH PHARM; Hall JM, 2010, MOL ENDOCRINOL, V24, P359, DOI 10.1210/me.2009-0346; Hamidullah, 2015, BIOCHIMIE, V119, P68, DOI 10.1016/j.biochi.2015.10.012; Hanieh H, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0443-9; Hanieh H, 2013, EUR J IMMUNOL, V43, P2771, DOI 10.1002/eji.201343486; Harquail J, 2012, CANCER BIOMARK, V11, P269, DOI 10.3233/CBM-120291; Hiyoshi H, 2014, SCI REP-UK, V4, DOI 10.1038/srep07095; Hockings JK, 2006, CANCER RES, V66, P2224, DOI 10.1158/0008-5472.CAN-05-1619; Hoye Anette M., 2012, Advances in Biological Regulation, V52, P326, DOI 10.1016/j.jbior.2012.03.004; Jin ZX, 2014, CELL METAB, V20, P483, DOI 10.1016/j.cmet.2014.07.011; Kattimani Vivekanand S, 2013, J Contemp Dent Pract, V14, P227; Kim EJ, 2009, J NUTR, V139, P2373, DOI 10.3945/jn.109.111864; Ko YS, 2016, PHYTOTHER RES, V30, P1180, DOI 10.1002/ptr.5626; Luo KW, 2014, PHYTOMEDICINE, V21, P1078, DOI 10.1016/j.phymed.2014.04.020; MADRIGAL C, 1995, CAN J BOT, V73, P425, DOI 10.1139/b95-043; Martinez V, 2008, BREAST CANCER RES TR, V110, P521, DOI 10.1007/s10549-007-9739-9; Nakahama T, 2013, P NATL ACAD SCI USA, V110, P11964, DOI 10.1073/pnas.1311087110; Nasr T, 2014, EUR J MED CHEM, V76, P539, DOI 10.1016/j.ejmech.2014.02.026; Nguyen CH, 2016, HUM MOL GENET; Novikov O, 2016, MOL PHARM; Parks AJ, 2014, MOL PHARMACOL, V86, P593, DOI 10.1124/mol.114.093369; Potapovich AI, 2011, TOXICOL APPL PHARM, V255, P138, DOI 10.1016/j.taap.2011.06.007; Qu XL, 2014, EUR REV MED PHARMACO, V18, P1269; Rahimi M, 2010, CANCER LETT, V295, P59, DOI 10.1016/j.canlet.2010.02.014; Ronnekleiv-Kelly SM, 2016, CANCER LETT, V370, P91, DOI 10.1016/j.canlet.2015.10.014; Sak Katrin, 2014, Pharmacogn Rev, V8, P122, DOI 10.4103/0973-7847.134247; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scully OJ, 2012, CANCER GENOM PROTEOM, V9, P311; Shi ML, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0332-2; Sun F, 2015, CARCINOGENESIS, V36, P757, DOI 10.1093/carcin/bgv040; Thirugnanasambantham K, 2014, APPL BIOCHEM BIOTECH, V174, P130, DOI 10.1007/s12010-014-1038-4; Tiong CT, 2012, CARCINOGENESIS, V33, P1089, DOI 10.1093/carcin/bgs110; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; van der Flier A, 2001, CELL TISSUE RES, V305, P285, DOI 10.1007/s004410100417; Videira M, 2012, NANOMED-NANOTECHNOL, V8, P1208, DOI 10.1016/j.nano.2011.12.007; Wang YB, 2010, PHYTOMEDICINE, V17, P363, DOI 10.1016/j.phymed.2009.07.019; Wu DL, 2013, MOL CELL BIOL, V33, P4346, DOI 10.1128/MCB.00698-13; Xiao Y, 2013, FEMS MICROBIOL LETT, V339, P130, DOI 10.1111/1574-6968.12065; Young SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120815; Zhang S, 2012, MOL CANCER THER, V11, P108, DOI 10.1158/1535-7163.MCT-11-0548; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhou Y, 2016, NUTRIENTS, V8, DOI 10.3390/nu8080515	50	30	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167650	10.1371/journal.pone.0167650	http://dx.doi.org/10.1371/journal.pone.0167650			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907195	Green Published, gold, Green Submitted			2022-12-26	WOS:000389482700217
J	Neves, LM; Teixeira-Neves, TP; Pereira-Filho, GH; Araujo, FG				Neves, Leonardo M.; Teixeira-Neves, Tatiana P.; Pereira-Filho, Guilherme H.; Araujo, Francisco G.			The Farther the Better: Effects of Multiple Environmental Variables on Reef Fish Assemblages along a Distance Gradient from River Influences	PLOS ONE			English	Article							RIO-DE-JANEIRO; COMMUNITY STRUCTURE; WAVE EXPOSURE; ROCKY REEF; CORAL-REEFS; SWIMMING PERFORMANCE; SOUTHEASTERN BRAZIL; TERRESTRIAL RUNOFF; STRUCTURE PATTERNS; TROPHIC STRUCTURE	The conservation and management of site-attached assemblages of coastal reefs are particularly challenging because of the tremendous environmental variation that exists at small spatial scales. In this sense, understanding the primary sources of variation in spatial patterns of the biota is fundamental for designing effective conservation policies. We investigated spatial variation in fish assemblages around the windward and leeward sides of coastal islands situated across a gradient of riverine influence (13 km in length). Specifically, relationships between rocky reef fish assemblages and benthic, topographic and physical predictors were assessed. We hypothesized that river induced disturbances may overcome local habitat features in modeling spatial patterns of fish distribution. Fish assemblages varied primarily due to the strong directional gradient of riverine influence (22.6% of the estimated components of variation), followed by topographic complexity (15%), wave exposure (9.9%), and benthic cover (8%). The trophic structure of fish assemblages changed from having a high abundance of invertebrate feeders in macroalgae-dominated reefs close to river mouths to a high proportion of herbivores, planktivores and invertebrate feeder species in reefs with large boulders covered by epilithic algal matrices, as the distance from rivers increased. This gradient led to an increase of 4.5-fold in fish richness and fish trophic group diversity, 11-fold in fish biomass and 10-fold in fish abundance. Our results have implications for the conservation and monitoring of assemblages patchily distributed at small spatial scales. The major role of distance from river influences on fish assemblages rather than benthic cover and topographic complexity suggest that managing land-based activities should be a conservation priority toward reef restoration.	[Neves, Leonardo M.; Teixeira-Neves, Tatiana P.; Araujo, Francisco G.] Univ Fed Rural Rio de Janeiro, Dept Biol Anim, Lab Ecol Peixes, Campus Seropedica, Seropedica, RJ, Brazil; [Neves, Leonardo M.] Univ Fed Rural Rio de Janeiro, Dept Ciencias Meio Ambiente, Campus Tres Rios, Seropedica, RJ, Brazil; [Pereira-Filho, Guilherme H.] Univ Fed Sao Paulo, Inst Mar, Lab Ecol & Conservacao Marinha, Campus Baixada Santista, Santos, SP, Brazil	Universidade Federal Rural do Rio de Janeiro (UFRRJ); Universidade Federal Rural do Rio de Janeiro (UFRRJ); Universidade Federal de Sao Paulo (UNIFESP)	Araujo, FG (corresponding author), Univ Fed Rural Rio de Janeiro, Dept Biol Anim, Lab Ecol Peixes, Campus Seropedica, Seropedica, RJ, Brazil.	gersonufrrj@gmail.com	Neves, Leonardo/AAN-1167-2020; Neves, Leonardo M/C-7799-2013; Pereira-Filho, Guilherme-Henrique/I-2946-2013	Neves, Leonardo/0000-0002-0269-6588; Neves, Leonardo M/0000-0002-0269-6588; Pereira-Filho, Guilherme-Henrique/0000-0001-6078-2241	FAPERJ Foundation; CNPq - Brazilian council	FAPERJ Foundation(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq - Brazilian council	This work was supported by FAPERJ Foundation for the research of the Rio de Janeiro State, Brazil; and CNPq - Brazilian council for developing research.	Aburto-Oropeza O, 2001, MAR ECOL-P S Z N I, V22, P283, DOI 10.1046/j.1439-0485.2001.t01-1-01747.x; Airoldi L, 2003, OCEANOGR MAR BIOL, V41, P161; Airoldi L, 2008, J EXP MAR BIOL ECOL, V366, P8, DOI 10.1016/j.jembe.2008.07.034; Almany GR, 2006, CORAL REEFS, V25, P19, DOI 10.1007/s00338-005-0044-y; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], 2004, REV GEOCIENCIAS, V3, P53; [Anonymous], 1988, NMFSSEFC215 NOAA; Balata D, 2011, MAR BIOL, V158, P2459, DOI 10.1007/s00227-011-1747-y; Beger M, 2008, MAR ECOL PROG SER, V361, P1, DOI 10.3354/meps07481; Bejarano S, 2011, MAR BIOL, V158, P489, DOI 10.1007/s00227-010-1575-5; Bellwood DR, 2008, LIMNOL OCEANOGR, V53, P2695, DOI 10.4319/lo.2008.53.6.2695; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bellwood DR, 2001, CORAL REEFS, V20, P139, DOI 10.1007/s003380100156; Bonaldo RM, 2011, CORAL REEFS, V30, P381, DOI 10.1007/s00338-010-0704-4; BOUCHONNAVARO Y, 1989, ENVIRON BIOL FISH, V25, P47, DOI 10.1007/BF00002200; Camilato V, 2010, J APPL ICHTHYOL, V26, P463, DOI 10.1111/j.1439-0426.2009.01343.x; Coni EOC, 2013, ENVIRON BIOL FISH, V96, P45, DOI 10.1007/s10641-012-0021-6; Chemello R, 2002, MAR BIOL, V140, P981, DOI 10.1007/s00227-002-0777-x; Chong-Seng KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042167; CLARKE RD, 1992, CORAL REEFS, V11, P199, DOI 10.1007/BF00301994; Claudet J, 2006, BIOL CONSERV, V130, P349, DOI 10.1016/j.biocon.2005.12.030; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Cooney R., 2004, PRECAUTIONARY PRINCI; DENNY M, 1995, ECOL MONOGR, V65, P371, DOI 10.2307/2963496; Devictor V, 2008, OIKOS, V117, P507, DOI 10.1111/j.2008.0030-1299.16215.x; Dias CD, 2008, HYDROBIOLOGIA, V614, P65, DOI 10.1007/s10750-008-9537-3; EKLOV P, 1994, OECOLOGIA, V98, P344, DOI 10.1007/BF00324223; Engqvist L, 2005, ANIM BEHAV, V70, P967, DOI 10.1016/j.anbehav.2005.01.016; Fabricius K, 2005, MAR POLLUT BULL, V51, P384, DOI 10.1016/j.marpolbul.2004.10.041; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Ferreira CEL, 2004, J BIOGEOGR, V31, P1093, DOI 10.1111/j.1365-2699.2004.01044.x; Ferreira CEL, 2001, ENVIRON BIOL FISH, V61, P353, DOI 10.1023/A:1011609617330; Field CD, 1998, MAR POLLUT BULL, V37, P383; Floeter SR, 2007, ENVIRON BIOL FISH, V78, P147, DOI 10.1007/s10641-006-9084-6; Floeter SR, 2001, GLOBAL ECOL BIOGEOGR, V10, P423, DOI 10.1046/j.1466-822X.2001.00245.x; Francini RB, 2010, J MAR BIOL ASSOC UK, V90, P481, DOI 10.1017/S0025315409991147; Francisco CN, 2004, GEOCIENCIAS, V3, P53; Francisco-Ramos V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078761; Fraschetti S, 2012, MAR ECOL PROG SER, V466, P21, DOI 10.3354/meps09937; Freret-Meurer NV, 2010, MAR POLLUT BULL, V60, P627, DOI 10.1016/j.marpolbul.2010.01.023; Friedlander AM, 1998, J EXP MAR BIOL ECOL, V224, P1, DOI 10.1016/S0022-0981(97)00164-0; Froese R., 2014, FISHBASE; Fulton CJ, 2005, P ROY SOC B-BIOL SCI, V272, P827, DOI 10.1098/rspb.2004.3029; Fulton CJ, 2004, MAR BIOL, V144, P429, DOI 10.1007/s00227-003-1216-3; Garcia-Charton JA, 2004, MAR BIOL, V144, P161, DOI 10.1007/s00227-003-1170-0; GEE JM, 1994, MAR ECOL PROG SER, V103, P141, DOI 10.3354/meps103141; Gibran FZ, 2012, NEOTROP ICHTHYOL, V10, P369, DOI 10.1590/S1679-62252012005000013; Goatley CHR, 2012, BIOL LETTERS, V8, P1016, DOI 10.1098/rsbl.2012.0770; GOLBUU Y, 2011, J MAR BIOL, V2011, DOI DOI 10.1155/2011/981273; Golbuu Y, 2011, MAR POLLUT BULL, V62, P824, DOI 10.1016/j.marpolbul.2010.12.015; Graham NAJ, 2011, CORAL REEFS, V30, P283, DOI 10.1007/s00338-010-0717-z; Guarnieri G, 2012, MAR BIOL, V159, P1155, DOI 10.1007/s00227-012-1895-8; Guerra JV, 2009, J COASTAL RES, P1350; Gusso-Choueri PK, 2015, ENVIRON SCI POLLUT R, V22, P18047, DOI 10.1007/s11356-015-4911-y; Hammond W, 2004, MAR BIOL, V144, P547, DOI 10.1007/s00227-003-1210-9; Harborne AR, 2012, ENVIRON BIOL FISH, V94, P431, DOI 10.1007/s10641-011-9956-2; Hauzy C, 2010, OECOLOGIA, V163, P625, DOI 10.1007/s00442-010-1585-5; Haywick DW, 1997, CORAL REEFS, V16, P39, DOI 10.1007/s003380050057; Hewitt AH, 2006, ENVIRON TOXICOL CHEM, V25, P2288, DOI 10.1897/05-569R.1; Ignacio BL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013065; JACCARD J, 1990, MULTIVAR BEHAV RES, V25, P467, DOI 10.1207/s15327906mbr2504_4; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Karnauskas M, 2012, LIMNOL OCEANOGR, V57, P1403, DOI 10.4319/lo.2012.57.5.1403; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Krajewski JP, 2011, ENVIRON BIOL FISH, V92, P25, DOI 10.1007/s10641-011-9813-3; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; Lehmann A, 2002, BIODIVERS CONSERV, V11, P2085, DOI 10.1023/A:1021354914494; Letourneur Y, 1998, ENVIRON BIOL FISH, V51, P141, DOI 10.1023/A:1007489502060; Lomolino MV, 2000, J BIOGEOGR, V27, P17, DOI 10.1046/j.1365-2699.2000.00377.x; LUCKHURST BE, 1978, MAR BIOL, V49, P317, DOI 10.1007/BF00455026; Luiz OJ, 2008, ZOOTAXA, P1; Macieira RM, 2009, J APPL ICHTHYOL, V25, P358, DOI 10.1111/j.1439-0426.2008.01118.x; Malcolm HA, 2011, AQUAT CONSERV, V21, P173, DOI 10.1002/aqc.1165; Mallela J, 2007, J FISH BIOL, V70, P523, DOI 10.1111/j.1095-8649.2007.01323.x; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; MCGEHEE MA, 1994, MAR ECOL PROG SER, V105, P243, DOI 10.3354/meps105243; McQuaid CD, 2000, MAR ECOL PROG SER, V206, P147, DOI 10.3354/meps206147; Medeiros PR, 2010, ENVIRON BIOL FISH, V87, P237, DOI 10.1007/s10641-010-9593-1; Mueller Erich, 1995, Bulletin de l'Institut Oceanographique Numero Special (Monaco), V14, P89; Mumby PJ, 2008, TRENDS ECOL EVOL, V23, P555, DOI 10.1016/j.tree.2008.06.011; Munday PL, 2002, CORAL REEFS, V21, P105, DOI 10.1007/s00338-001-0200-y; Nemeth RS, 1998, ENVIRON BIOL FISH, V53, P129, DOI 10.1023/A:1007402104047; Newton K, 2007, CURR BIOL, V17, P655, DOI 10.1016/j.cub.2007.02.054; Nogueira CR, 1991, COASTAL ZONE 91 BEAC, V4, P3221; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Peterson AT, 2000, BIOL CONSERV, V93, P85, DOI 10.1016/S0006-3207(99)00074-9; Pinheiro HT, 2013, J MAR BIOL ASSOC UK, V93, P1175, DOI 10.1017/S0025315412001749; Pullin AS, 2004, BIOL CONSERV, V119, P245, DOI 10.1016/j.biocon.2003.11.007; Roberts DE, 2006, MAR ECOL PROG SER, V321, P19, DOI 10.3354/meps321019; Rodriguez-Zaragoza FA, 2008, CARIBB J SCI, V44, P90; Sala E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032742; Santin S, 2007, MAR BIOL, V151, P1683, DOI 10.1007/s00227-006-0586-8; Santos CSG, 2016, NAT CONSERV IN PRESS; Schiel DR, 2006, J EXP MAR BIOL ECOL, V331, P158, DOI 10.1016/j.jembe.2005.10.015; Semmens BX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008895; Sogard SM, 1997, B MAR SCI, V60, P1129; STENECK RS, 1994, OIKOS, V69, P476, DOI 10.2307/3545860; Storlazzi CD, 2011, CORAL REEFS, V30, P23, DOI 10.1007/s00338-010-0705-3; Teixeira TP, 2012, HYDROBIOLOGIA, V684, P161, DOI 10.1007/s10750-011-0980-1; Teixeira-Neves TP, 2016, MAR POLLUT BULL, V109, P290, DOI 10.1016/j.marpolbul.2016.05.067; Teixeira-Neves TP, 2015, ENVIRON BIOL FISH, V98, P1645, DOI 10.1007/s10641-015-0390-8; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Toohey BD, 2007, OIKOS, V116, P1618, DOI 10.1111/j.2007.0030-1299.15689.x; Tuya F, 2006, MAR ECOL PROG SER, V311, P15, DOI 10.3354/meps311015; Vinagre C, 2011, J SEA RES, V65, P362, DOI 10.1016/j.seares.2011.02.003; Wenger AS, 2012, J EXP MAR BIOL ECOL, V428, P43, DOI 10.1016/j.jembe.2012.06.004; Wenger AS, 2011, CORAL REEFS, V30, P879, DOI 10.1007/s00338-011-0773-z; Wootton JT, 1998, AM NAT, V152, P803, DOI 10.1086/286210; Yeager LA, 2011, OECOLOGIA, V167, P157, DOI 10.1007/s00442-011-1959-3; Zuur A.F., 2007, ANAL ECOLOGICAL DATA	111	15	15	4	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166679	10.1371/journal.pone.0166679	http://dx.doi.org/10.1371/journal.pone.0166679			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907017	Green Published, Green Submitted, gold			2022-12-26	WOS:000389482700033
J	Noman, N; Inniss, M; Iba, H; Way, JC				Noman, Nasimul; Inniss, Mara; Iba, Hitoshi; Way, Jeffrey C.			Pulse Detecting Genetic Circuit - A New Design Approach	PLOS ONE			English	Article							BACTERIOPHAGE-LAMBDA; SWITCH; DNA; MECHANISM; REPRESSOR; NETWORKS; YEAST	A robust cellular counter could enable synthetic biologists to design complex circuits with diverse behaviors. The existing synthetic-biological counters, responsive to the beginning of the pulse, are sensitive to the pulse duration. Here we present a pulse detecting circuit that responds only at the falling edge of a pulse analogous to negative edge triggered electric circuits. As biological events do not follow precise timing, use of such a pulse detector would enable the design of robust asynchronous counters which can count the completion of events. This transcription-based pulse detecting circuit depends on the interaction of two co-expressed lambdoid phage-derived proteins: the first is unstable and inhibits the regulatory activity of the second, stable protein. At the end of the pulse the unstable inhibitor protein disappears from the cell and the second protein triggers the recording of the event completion. Using stochastic simulation we showed that the proposed design can detect the completion of the pulse irrespective to the pulse duration. In our simulation we also showed that fusing the pulse detector with a phage lambda memory element we can construct a counter which can be extended to count larger numbers. The proposed design principle is a new control mechanism for synthetic biology which can be integrated in different circuits for identifying the completion of an event.	[Noman, Nasimul] Univ Newcastle, Sch Elect Engn & Comp Sci, Callaghan, NSW, Australia; [Inniss, Mara] Harvard Med Sch, Dept Syst Biol, Boston, MA USA; [Iba, Hitoshi] Univ Tokyo, Grad Sch Informat Sci & Technol, Dept Informat & Commun Engn, Bunkyo Ku, Tokyo, Japan; [Way, Jeffrey C.] Wyss Inst Biol Inspired Engn, Boston, MA USA	University of Newcastle; Harvard University; Harvard Medical School; University of Tokyo	Noman, N (corresponding author), Univ Newcastle, Sch Elect Engn & Comp Sci, Callaghan, NSW, Australia.	nasimul.noman@newcastle.edu.au		Noman, Nasimul/0000-0002-8566-0870	Defense Advanced Research Projects Agency Grant [N66001-11-C-4203]; University of Tokyo	Defense Advanced Research Projects Agency Grant; University of Tokyo	This work was supported by Defense Advanced Research Projects Agency Grant N66001-11-C-4203 and funds from the University of Tokyo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajo-Franklin CM, 2007, GENE DEV, V21, P2271, DOI 10.1101/gad.1586107; BERTRAND KP, 1983, GENE, V23, P149, DOI 10.1016/0378-1119(83)90046-X; Biliouris K, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-9; Buchler NE, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.30; Dodd IB, 2004, GENE DEV, V18, P344, DOI 10.1101/gad.1167904; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Ewen C. D., 2014, NATURE REV MICROBIOL, V12, P381, DOI [10.1038/nrmicro3239, DOI 10.1038/NRMICRO3239]; Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Inniss M. C., 2014, THESIS; ISACKSON PJ, 1985, P NATL ACAD SCI USA, V82, P6226, DOI 10.1073/pnas.82.18.6226; Kotula JW, 2014, P NATL ACAD SCI USA, V111, P4838, DOI 10.1073/pnas.1321321111; Marcand S, 1997, SCIENCE, V275, P986, DOI 10.1126/science.275.5302.986; MCADAMS HH, 1995, SCIENCE, V269, P650, DOI 10.1126/science.7624793; Morelli MJ, 2009, P NATL ACAD SCI USA, V106, P8101, DOI 10.1073/pnas.0810399106; NELSON HCM, 1986, J MOL BIOL, V192, P27, DOI 10.1016/0022-2836(86)90461-4; Ptashne M, 2004, GENETIC SWITCH PHAGE; Ray A, 1999, MOL CELL BIOL, V19, P31; Schubert RA, 2007, GENE DEV, V21, P2461, DOI 10.1101/gad.1584907; SHEA MA, 1985, J MOL BIOL, V181, P211, DOI 10.1016/0022-2836(85)90086-5; Subsoontorn P, 2012, PROCEDIA COMPUT SCI, V11, P43, DOI 10.1016/j.procs.2012.09.006; SUSSKIND MM, 1975, J MOL BIOL, V98, P413, DOI 10.1016/S0022-2836(75)80127-6; Tamsir A, 2011, NATURE, V469, P212, DOI 10.1038/nature09565; Tocci R. J., 2000, DIGITAL SYSTEMS PRIN; Way JC, 2014, CELL, V157, P151, DOI 10.1016/j.cell.2014.02.039	26	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167162	10.1371/journal.pone.0167162	http://dx.doi.org/10.1371/journal.pone.0167162			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907045	gold, Green Published, Green Submitted			2022-12-26	WOS:000389482700084
J	Garbarino, S; Durando, P; Guglielmi, O; Dini, G; Bersi, F; Fornarino, S; Toletone, A; Chiorri, C; Magnavita, N				Garbarino, Sergio; Durando, Paolo; Guglielmi, Ottavia; Dini, Guglielmo; Bersi, Francesca; Fornarino, Stefania; Toletone, Alessandra; Chiorri, Carlo; Magnavita, Nicola			Sleep Apnea, Sleep Debt and Daytime Sleepiness Are Independently Associated with Road Accidents. A Cross-Sectional Study on Truck Drivers	PLOS ONE			English	Article							VEHICLE ACCIDENTS; PROFESSIONAL DRIVERS; COMMERCIAL DRIVERS; UNITED-STATES; SHIFT-WORK; RISK; PERFORMANCE; DEPRIVATION; POPULATION; CRASHES	Background Recent research has found evidence of an association between motor vehicle accidents (MVAs) or near miss accidents (NMAs), and excessive daytime sleepiness (EDS) or its main medical cause, Obstructive Sleep Apnea (OSA). However, EDS can also be due to non-medical factors, such as sleep debt (SD), which is common among professional truck drivers. On the opposite side, rest breaks and naps are known to protect against accidents. Study Objectives To investigate the association of OSA, SD, EDS, rest breaks and naps, with the occurrence of MVAs and NMAs in a large sample of truck drivers. Methods 949 male truck drivers took part in a cross-sectional medical examination and were asked to complete a questionnaire about sleep and waking habits, risk factors for OSA and EDS. Results MVAs and NMAs were reported by 34.8% and 9.2% of participants, respectively. MVAs were significantly predicted by OSA (OR = 2.32 CI95% = 1.68-3.20), SD (OR = 1.45 CI95% = 1.29-1.63), EDS (OR = 1.73 CI95% = 1.15-2.61) and prevented by naps (OR = 0.59 CI95% = 0.44-0.79) or rest breaks (OR = 0.63 CI95% = 0.45-0.89). NMAs were significantly predicted by OSA (OR = 2.39 CI95% = 1.47-3.87) and SD (OR = 1.49 CI95% = 1.27-1.76) and prevented by naps (OR = 0.52 CI95% = 0.32-0.85) or rest breaks (OR = 0.49 CI95% = 0.29-0.82). Conclusions When OSA, SD or EDS are present, the risk of MVAs or NMAs in truck drivers is severely increased. Taking a rest break or a nap appear to be protective against accidents.	[Garbarino, Sergio; Guglielmi, Ottavia; Fornarino, Stefania] Univ Genoa, Dept Neurosci Rehabil Ophthalmol Genet & Maternal, Genoa, Italy; [Garbarino, Sergio; Durando, Paolo; Dini, Guglielmo; Bersi, Francesca; Toletone, Alessandra] Univ Genoa, Postgrad Sch Occupat Med, Dept Hlth Sci, Genoa, Italy; [Garbarino, Sergio; Durando, Paolo; Dini, Guglielmo; Bersi, Francesca; Toletone, Alessandra] IRCCS AOU San Martino 1ST, Occupat Med Unit, Genoa, Italy; [Chiorri, Carlo] Univ Genoa, Dept Educ Sci, Genoa, Italy; [Magnavita, Nicola] Univ Cattolica Sacro Cuore, Inst Publ Hlth, Rome, Italy	University of Genoa; University of Genoa; University of Genoa; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Magnavita, N (corresponding author), Univ Cattolica Sacro Cuore, Inst Publ Hlth, Rome, Italy.	nicolamagnavita@gmail.com	Garbarino, Sergio/X-5368-2018; Magnavita, Nicola/J-6074-2014; Garbarino, Sergio/AAV-4629-2021	Garbarino, Sergio/0000-0002-8508-552X; Magnavita, Nicola/0000-0002-0988-7344; Garbarino, Sergio/0000-0002-8508-552X	CNH-Iveco Industrial Corporation - European Union Road Safety Action [25171877]; Italian Ministry of Transport	CNH-Iveco Industrial Corporation - European Union Road Safety Action; Italian Ministry of Transport	Medical examinations were funded by the CNH-Iveco Industrial Corporation (Grant number 25171877) within the "CNH Iveco Industrial Check Stop Project", an international project for road safety, supported by the European Union Road Safety Action and the Italian Ministry of Transport. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Print expenses will be covered with University funds from NM.; The study was funded by the CNH Iveco Industrial Corporation. Grant number 25171877. We thank Mrs. E. A. Wright who revised the English language of the manuscript.	Braeckman L, 2011, CHRONOBIOL INT, V28, P126, DOI 10.3109/07420528.2010.540363; Carter N, 2003, ACCIDENT ANAL PREV, V35, P613, DOI 10.1016/S0001-4575(02)00033-7; Catarino R, 2014, SLEEP BREATH, V18, P59, DOI 10.1007/s11325-013-0848-x; Chu HC, 2014, ACCIDENT ANAL PREV, V62, P130, DOI 10.1016/j.aap.2013.09.016; Connor J, 2002, BRIT MED J, V324, P1125, DOI 10.1136/bmj.324.7346.1125; DAVIES RJO, 1992, THORAX, V47, P101, DOI 10.1136/thx.47.2.101; de Cordova PB, 2016, WORK, V53, P825, DOI 10.3233/WOR-162250; de Pinho RSN, 2006, CHRONOBIOL INT, V23, P963, DOI 10.1080/07420520600920759; Dewan NA, 2015, CHEST, V147, P266, DOI 10.1378/chest.14-0500; Drummond SPA, 2001, NEUROPSYCHOPHARMACOL, V25, pS68, DOI 10.1016/S0893-133X(01)00325-6; Garbarino S, 2008, G Ital Med Lav Ergon, V30, P291; Garbarino S, 2004, SLEEP, V27, P1295, DOI 10.1093/sleep/27.7.1295; Garbarino S, 2001, SLEEP, V24, P203; Goncalves M, 2015, J SLEEP RES, V24, P242, DOI 10.1111/jsr.12267; Haavisto ML, 2010, J SLEEP RES, V19, P444, DOI 10.1111/j.1365-2869.2010.00823.x; HORNE JA, 1995, BRIT MED J, V310, P565, DOI 10.1136/bmj.310.6979.565; Howard ME, 2014, ACCIDENT ANAL PREV, V62, P1, DOI 10.1016/j.aap.2013.09.003; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Johnson KD, 2014, J OCCUP ENVIRON MED, V56, P510, DOI 10.1097/JOM.0000000000000132; Kales SN, 2014, IND HEALTH, V52, P13, DOI 10.2486/indhealth.2013-0206; Karimi M, 2015, SLEEP, V38, P341, DOI 10.5665/sleep.4486; Liistro G, 2003, EUR RESPIR J, V21, P248, DOI 10.1183/09031936.03.00292403; Lim J, 2007, SLEEP, V30, P61, DOI 10.1093/sleep/30.1.61; MALLAMPATI SR, 1985, CAN ANAESTH SOC J, V32, P429, DOI 10.1007/BF03011357; Mohebbi I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031790; Perttula P, 2011, PSYCHOL REP, V108, P507, DOI 10.2466/06.13.22.PR0.108.2.507-514; Philip P, 2005, IND HEALTH, V43, P30, DOI 10.2486/indhealth.43.30; Pylkkonen M, 2015, ACCIDENT ANAL PREV, V80, P201, DOI 10.1016/j.aap.2015.03.031; Sagaspe P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003493; Smolensky MH, 2011, ACCIDENT ANAL PREV, V43, P533, DOI 10.1016/j.aap.2009.12.004; Talmage JB, 2008, J OCCUP ENVIRON MED, V50, P324, DOI 10.1097/JOM.0b013e3181617ab8; Tefft BC, 2012, ACCIDENT ANAL PREV, V45, P180, DOI 10.1016/j.aap.2011.05.028; Transport T., 2006, SLEEP MED REV, V10, P347, DOI [10.1016/j.smrv.2006.04.002, DOI 10.1016/J.SMRV.2006.04.002]; Vignatelli L, 2003, NEUROL SCI, V23, P295, DOI 10.1007/s100720300004; Wong CKH, 2012, J OCCUP ENVIRON MED, V54, P989, DOI 10.1097/JOM.0b013e3182535d7d; Xie W, 2011, J OCCUP ENVIRON MED, V53, P169, DOI 10.1097/JOM.0b013e3182068ceb	36	82	84	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0166262	10.1371/journal.pone.0166262	http://dx.doi.org/10.1371/journal.pone.0166262			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FV	27902703	Green Published, gold			2022-12-26	WOS:000389474100017
J	Simmonds, MJ; Milne, N; Ong, K; Brotherton, E; McNamee, AP; Horobin, J; Sabapathy, S				Simmonds, Michael J.; Milne, Nikki; Ong, Kee; Brotherton, Emily; McNamee, Antony P.; Horobin, Jarod; Sabapathy, Surendran			Physical Properties of Blood Are Altered in Young and Lean Women with Polycystic Ovary Syndrome	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; PLASMA VISCOSITY; INSULIN-RESISTANCE; DIABETES-MELLITUS; CELL AGGREGATION; ASSOCIATION; PROGRESSION; PREVALENCE; RHEOLOGY	Classic features of polycystic ovary syndrome (PCOS) include derangement of metabolic and cardiovascular health, and vascular dysfunction is commonly reported. These comorbidities indicate impaired blood flow; however, other than limited reports of increased plasma viscosity, surprisingly little is known regarding the physical properties of blood in PCOS. We aimed to investigate whether haemorheology was impaired in women with PCOS. We thus measured a comprehensive haemorheological profile, in a case-control design, of lean women with PCOS and age-matched healthy controls. A clinical examination determined similar cardiovascular risk for the two groups. Whole blood and plasma viscosity was measured using a cone-plate viscometer. The magnitude and rate of red blood cell (RBC) aggregation was determined using a light-transmission aggregometer, and the degree of RBC deformability was measured via laser-diffraction ektacytometry. Plasma viscosity was significantly increased in women with PCOS. Blood viscosity was also increased for PCOS at lower-to-moderate shear rates in both native and standardised haematocrit samples. The magnitude of RBC aggregation-a primary determinant of low-shear blood viscosity-was significantly increased in PCOS at native and 0.4 L . L-1 haematocrit. No difference was detected between PCOS and CON groups for RBC deformability measurements. A novel measure indicating the effectiveness of oxygen transport by RBC (i.e., the haematocrit-to-viscosity ratio; HVR) was decreased at all shear rates in women with PCOS. In a group of young and lean women with PCOS with an unremarkable cardiovascular risk profile based on clinical data, significant haemorheological impairment was observed. The degree of haemorheological derangement observed in the present study reflects that of overt chronic disease, and provides an avenue for future therapeutic intervention in PCOS.	[Simmonds, Michael J.; Brotherton, Emily; McNamee, Antony P.; Horobin, Jarod; Sabapathy, Surendran] Griffith Univ, Menzies Hlth Inst Queensland, Gold Coast, Qld, Australia; [Milne, Nikki] Bond Univ, Bond Inst Hlth & Sport, Fac Hlth Sci & Med, Gold Coast, Qld, Australia; [Ong, Kee] Monash IVF, Southport, Qld, Australia	Griffith University; Menzies Health Institute Queensland; Bond University	Simmonds, MJ (corresponding author), Griffith Univ, Menzies Hlth Inst Queensland, Gold Coast, Qld, Australia.	mike@thesimmonds.id.au	; Simmonds, Michael/U-9339-2017	Milne, Nikki/0000-0002-5121-9825; Simmonds, Michael/0000-0001-8145-6787; Sabapathy, Surendran/0000-0003-1267-6035; Horobin, Jarod/0000-0002-9684-1562				Alexy T, 2006, TRANSFUSION, V46, P912, DOI 10.1111/j.1537-2995.2006.00823.x; Baskurt OK, 2003, SEMIN THROMB HEMOST, V29, P435; Brown CD, 2005, KIDNEY INT, V67, P295, DOI 10.1111/j.1523-1755.2005.00082.x; Brun JF, 2004, CLIN HEMORHEOL MICRO, V30, P365; Burchall GF, 2015, SEMINARS THROMBOSIS; Caglar GS, 2011, FERTIL STERIL, V95, P310, DOI 10.1016/j.fertnstert.2010.06.092; Celik C, 2014, FERTIL STERIL, V101, P1123, DOI 10.1016/j.fertnstert.2013.12.050; Chang AY, 2015, CLIN ENDOCRINOLOGY; Cho YI, 2014, CURR ATHEROSCLER REP, V16, DOI 10.1007/s11883-014-0404-6; Christian RC, 2003, J CLIN ENDOCR METAB, V88, P2562, DOI 10.1210/jc.2003-030334; CROWELL JW, 1967, J APPL PHYSIOL, V22, P501, DOI 10.1152/jappl.1967.22.3.501; Desai V, 2014, J CLIN DIAGN RES, V8, pCC1, DOI 10.7860/JCDR/2014/8125.4530; El Bouhmadi A, 2000, CLIN HEMORHEOL MICRO, V22, P99; Fauser BCJM, 2004, HUM REPROD, V19, P41, DOI 10.1093/humrep/deh098; Gonzalez F, 2012, STEROIDS, V77, P300, DOI 10.1016/j.steroids.2011.12.003; Husstedt IW, 1997, EUR NEUROL, V37, P90, DOI 10.1159/000117416; Kwaan HC, 1999, SEMIN THROMB HEMOST, V25, P199, DOI 10.1055/s-2007-994921; Luque-Ramirez M, 2007, HUM REPROD, V22, P3197, DOI 10.1093/humrep/dem324; Luque-Ramirez M, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0500-6; Manneras-Holm L, 2011, J CLIN ENDOCR METAB, V96, P1068, DOI 10.1210/jc.2010-2279; March WA, 2010, HUM REPROD, V25, P544, DOI 10.1093/humrep/dep399; Markantes G, 2011, GYNECOL ENDOCRINOL, V27, P971, DOI 10.3109/09513590.2011.569783; Moran LJ, 2010, HUM REPROD UPDATE, V16, P347, DOI 10.1093/humupd/dmq001; Neu B, 2002, BIOPHYS J, V83, P2482, DOI 10.1016/S0006-3495(02)75259-4; Okoroh EM, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.08.007; Simmonds MJ, 2013, J GERIATR CARDIOL, V10, P291, DOI 10.3969/j.issn.1671-5411.2013.03.010; Simmonds MJ, 2011, CLIN HEMORHEOL MICRO, V49, P231, DOI 10.3233/CH-2011-1473; Simmonds MJ, 2011, AUST J ZOOL, V59, P26, DOI 10.1071/ZO10083; Sloop Gregory, 2015, Ther Adv Cardiovasc Dis, V9, P19, DOI 10.1177/1753944714553226; Sprung VS, 2013, CLIN ENDOCRINOL, V78, P438, DOI 10.1111/j.1365-2265.2012.04490.x; Teede H, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-41; Vaya A, 2011, CLIN HEMORHEOL MICRO, V49, P493, DOI 10.3233/CH-2011-1499; Vervita V, 2009, GYNECOL ENDOCRINOL, V25, P640, DOI 10.1080/09513590903015486; Young MJ, 1996, CLIN SCI, V90, P183, DOI 10.1042/cs0900183	34	6	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167290	10.1371/journal.pone.0167290	http://dx.doi.org/10.1371/journal.pone.0167290			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902766	Green Published, Green Submitted, gold			2022-12-26	WOS:000389474100068
J	Urfer, M; Elzi, L; Dell-Kuster, S; Bassetti, S				Urfer, Milena; Elzi, Luigia; Dell-Kuster, Salome; Bassetti, Stefano			Intervention to Improve Appropriate Prescribing and Reduce Polypharmacy in Elderly Patients Admitted to an Internal Medicine Unit	PLOS ONE			English	Article							POTENTIALLY INAPPROPRIATE MEDICATION; STOPP SCREENING TOOL; BEERS CRITERIA; OLDER PERSONS; COMMON OUTCOMES; RISK; PRESCRIPTIONS; PEOPLE; ADULTS; HOSPITALIZATION	Background Polypharmacy and inappropriate medication prescriptions are associated with increased morbidity and mortality. Most interventions proposed to improve appropriate prescribing are time and resource intensive and therefore hardly applicable in daily clinical practice. Objective To test the efficacy of an easy-to-use checklist aimed at supporting the therapeutic reasoning of physicians in order to reduce inappropriate prescribing and polypharmacy. Methods We assessed the efficacy and safety of a 5-point checklist to be used by all physicians on the internal medicine wards of a Swiss hospital by comparing outcomes in 450 consecutive patients aged >= 65 years hospitalized after the introduction of the checklist, and in 450 consecutive patients >= 65 years hospitalized before the introduction of the checklist. The main measures were the proportion of patients with prescription of potentially inappropriate medications (PIMs) at discharge, according to STOPP criteria, and the number of prescribed medications at discharge, before and after the introduction of the checklist. Secondary outcomes were the prevalence of polypharmacy (>= 5 drugs) and hyperpolypharmacy (>= 10 drugs), and the prevalence of potentially inappropriate prescribing omissions (PPOs) according to START criteria. Results At admission 59% of the 900 patients were taking >5 drugs, 13% >= 10 drugs, 37% had >= 1 PIM and 25% >= 1 PPO. The introduction of the checklist was associated with a significant reduction by 22% of the risk of being prescribed >= 1 PIM at discharge (adjusted risk ratios [RR] 0.78; 95% CI: 0.68-0.94), but not with a reduction of at least 20% of the number of drugs prescribed at discharge, nor with a reduction of the risk of PPOs at discharge. Conclusions The introduction of an easy-to-use 5-point checklist aimed at supporting therapeutic reasoning of physicians on internal medicine wards significantly reduced the risk of prescriptions of inappropriate medications at discharge.	[Urfer, Milena] Kantonsspital Olten, Div Internal Med, Olten, Switzerland; [Elzi, Luigia] Reg Hosp San Giovanni, Div Infect Dis, Bellinzona, Switzerland; [Dell-Kuster, Salome] Univ Basel Hosp, Basel Inst Clin Epidemiol & Biostat, Basel, Switzerland; [Bassetti, Stefano] Univ Basel Hosp, Div Internal Med, Basel, Switzerland; [Bassetti, Stefano] Univ Basel Hosp, Dept Clin Res, Basel, Switzerland	Kantonsspital Olten; Regional Hospital of Bellinzona & Valleys, San Giovanni; University of Basel; University of Basel; University of Basel	Bassetti, S (corresponding author), Univ Basel Hosp, Div Internal Med, Basel, Switzerland.; Bassetti, S (corresponding author), Univ Basel Hosp, Dept Clin Res, Basel, Switzerland.	stefano.bassetti@usb.ch	Dell-Kuster, Salome/H-4259-2017; Dell-Kuster, Salome/P-2653-2019	Dell-Kuster, Salome/0000-0001-7219-7138; Dell-Kuster, Salome/0000-0001-7219-7138				Bayoumi I, 2009, ANN PHARMACOTHER, V43, P1667, DOI 10.1345/aph.1M059; Blozik E, 2013, DRUG AGING, V30, P561, DOI 10.1007/s40266-013-0073-0; Carey EC, 2008, J AM GERIATR SOC, V56, P68, DOI 10.1111/j.1532-5415.2007.01496.x; Charlesworth CJ, 2015, J GERONTOL A-BIOL, V70, P989, DOI 10.1093/gerona/glv013; Cook TD, 2002, ACAD EMERG MED, V9, P1430; Dalleur O, 2014, DRUG AGING, V31, P291, DOI 10.1007/s40266-014-0157-5; Dalleur O, 2012, DRUG AGING, V29, P829, DOI 10.1007/s40266-012-0016-1; Dovjak P, 2012, Z GERONTOL GERIATR, V45, P468, DOI 10.1007/s00391-012-0362-y; Egger SS, 2006, DRUG AGING, V23, P823, DOI 10.2165/00002512-200623100-00005; Fialova D, 2005, JAMA-J AM MED ASSOC, V293, P1348, DOI 10.1001/jama.293.11.1348; Fick DM, 2003, ARCH INTERN MED, V163, P2716, DOI 10.1001/archinte.163.22.2716; Fried TR, 2014, J AM GERIATR SOC, V62, P2261, DOI 10.1111/jgs.13153; Gallagher P, 2008, INT J CLIN PHARM TH, V46, P72; Gallagher P, 2008, AGE AGEING, V37, P673, DOI 10.1093/ageing/afn197; Gallagher P, 2011, EUR J CLIN PHARMACOL, V67, P1175, DOI 10.1007/s00228-011-1061-0; Greenland S, 2004, AM J EPIDEMIOL, V160, P301, DOI 10.1093/aje/kwh221; Guthrie B, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0322-7; Hamilton H, 2011, ARCH INTERN MED, V171, P1013, DOI 10.1001/archinternmed.2011.215; HANLON JT, 1992, J CLIN EPIDEMIOL, V45, P1045, DOI 10.1016/0895-4356(92)90144-C; Health FOoP, 2015, EV KVG REV BER SPIT, V13; Hubbard RE, 2015, MED J AUSTRALIA, V202, P373, DOI 10.5694/mja13.00172; Lau DT, 2005, ARCH INTERN MED, V165, P68, DOI 10.1001/archinte.165.1.68; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; Onder G, 2010, ARCH INTERN MED, V170, P1142, DOI 10.1001/archinternmed.2010.153; Patterson SM, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008165.pub3, 10.1002/14651858.CD008165.pub4]; Price SD, 2014, ANN PHARMACOTHER, V48, P6, DOI 10.1177/1060028013504904; Scott IA, 2015, JAMA INTERN MED, V175, P827, DOI 10.1001/jamainternmed.2015.0324; Scott IA, 2012, AM J MED, V125, P529, DOI 10.1016/j.amjmed.2011.09.021; Sganga F, 2015, GERIATR GERONTOL INT; Spinewine A, 2007, LANCET, V370, P173, DOI 10.1016/S0140-6736(07)61091-5; Steinman MA, 2014, J GEN INTERN MED, V29, P1379, DOI 10.1007/s11606-014-2924-8; Topinkova E, 2012, DRUG AGING, V29, P477, DOI 10.2165/11632400-000000000-00000; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	33	35	35	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0166359	10.1371/journal.pone.0166359	http://dx.doi.org/10.1371/journal.pone.0166359			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FV	27902720	Green Submitted, Green Published, gold			2022-12-26	WOS:000389474100021
J	King, DT; Wasney, GA; Nosella, M; Fong, A; Strynadka, NCJ				King, Dustin T.; Wasney, Gregory A.; Nosella, Michael; Fong, Anita; Strynadka, Natalie C. J.			Structural Insights into Inhibition of Escherichia coli Penicillin-binding Protein 1B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDOGLYCAN GLYCOSYLTRANSFERASE; STAPHYLOCOCCUS-AUREUS; CRYSTAL-STRUCTURE; BETA-LACTAMASE; BACTERIAL PEPTIDOGLYCAN; CATALYZED-HYDROLYSIS; PBP1B; CEPHALOSPORINS; MOENOMYCIN; TRANSGLYCOSYLASE	In Escherichia coli, the peptidoglycan cell wall is synthesized by bifunctional penicillin-binding proteins such as PBP1b that have both transpeptidase and transglycosylase activities. The PBP1b transpeptidase domain is a major target of beta-lactams, and therefore it is important to attain a detailed understanding of its inhibition. The peptidoglycan glycosyltransferase domain of PBP1b is also considered an excellent antibiotic target yet is not exploited by any clinically approved antibacterials. Herein, we adapt a pyrophosphate sensor assay to monitor PBP1b-catalyzed glycosyltransfer and present an improved crystallographic model for inhibition of the PBP1b glycosyltransferase domain by the potent substrate analog moenomycin. We elucidate the structure of a previously disordered region in the glycosyltransferase active site and discuss its implications with regards to peptidoglycan polymerization. Furthermore, we solve the crystal structures of E. coli PBP1b bound to multiple different beta-lactams in the transpeptidase active site and complement these data with gel-based competition assays to provide a detailed structural understanding of its inhibition. Taken together, these biochemical and structural data allow us to propose new insights into inhibition of both enzymatic domains in PBP1b.	Univ British Columbia, Dept Biochem & Mol, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Ctr Blood Res, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia	Strynadka, NCJ (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Life Sci Ctr, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	ncjs@mail.ubc.ca		King, Dustin/0000-0003-1775-2885	Canadian Institutes of Health Research; Howard Hughes Medical Institute	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by the Canadian Institutes of Health Research and Howard Hughes Medical Institute International Scholar Program and infrastructure support from the Canadian Foundation for Innovation, British Columbia Knowledge Development Fund, and the Canada Research Chair Programs to (N. C. J. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Afonine PV, 2015, ACTA CRYSTALLOGR D, V71, P646, DOI 10.1107/S1399004714028132; Bebrone C, 2001, ANTIMICROB AGENTS CH, V45, P1868, DOI 10.1128/AAC.45.6.1868-1871.2001; BOYD DB, 1985, J ORG CHEM, V50, P886, DOI 10.1021/jo00206a034; Bury D, 2015, BIOCHEM PHARMACOL, V93, P141, DOI 10.1016/j.bcp.2014.11.003; DeLano W. L., 2012, PYMOL MOL GRAPH SYST; Denome SA, 1999, J BACTERIOL, V181, P3981, DOI 10.1128/JB.181.13.3981-3993.1999; Egan AJF, 2014, P NATL ACAD SCI USA, V111, P8197, DOI 10.1073/pnas.1400376111; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feng H, 2014, J AM CHEM SOC, V136, P14694, DOI 10.1021/ja508388e; Gale RT, 2014, CHEM SCI, V5, P3823, DOI 10.1039/c4sc00802b; Goldman RC, 2000, CURR MED CHEM, V7, P801; Han S, 2010, P NATL ACAD SCI USA, V107, P22002, DOI 10.1073/pnas.1013092107; Heaslet H, 2009, J STRUCT BIOL, V167, P129, DOI 10.1016/j.jsb.2009.04.010; Huang CY, 2012, P NATL ACAD SCI USA, V109, P6496, DOI 10.1073/pnas.1203900109; Hutzler JM, 2002, DRUG METAB DISPOS, V30, P355, DOI 10.1124/dmd.30.4.355; Jha RK, 2006, J BIOMOL SCREEN, V11, P1005, DOI 10.1177/1087057106294364; JOHNSON DH, 1995, MED CLIN N AM, V79, P733, DOI 10.1016/S0025-7125(16)30036-0; King DT, 2014, J BIOL CHEM, V289, P19245, DOI 10.1074/jbc.M114.565879; King DT, 2012, J AM CHEM SOC, V134, P11362, DOI 10.1021/ja303579d; KOHLRAUSCH U, 1991, FEMS MICROBIOL LETT, V78, P253; Kurz M, 1998, EUR J BIOCHEM, V252, P500, DOI 10.1046/j.1432-1327.1998.2520500.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lim D, 2002, NAT STRUCT BIOL, V9, P870, DOI 10.1038/nsb858; Lovering AL, 2008, J MOL BIOL, V383, P167, DOI 10.1016/j.jmb.2008.08.020; Lovering AL, 2007, SCIENCE, V315, P1402, DOI 10.1126/science.1136611; Macheboeuf P, 2011, BIOCHEM BIOPH RES CO, V405, P107, DOI 10.1016/j.bbrc.2011.01.003; Martin SF, 2013, ANNU REV BIOCHEM, V82, P267, DOI 10.1146/annurev-biochem-060410-105819; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller C, 2004, SCIENCE, V305, P1629, DOI 10.1126/science.1101630; MOBASHERY S, 1986, J BIOL CHEM, V261, P7879; Offant J, 2010, FEBS J, V277, P4290, DOI 10.1111/j.1742-4658.2010.07817.x; Ostash B, 2010, NAT PROD REP, V27, P1594, DOI 10.1039/c001461n; PAGE MI, 1984, J AM CHEM SOC, V106, P3820, DOI 10.1021/ja00325a019; Paradis-Bleau C, 2010, CELL, V143, P1110, DOI 10.1016/j.cell.2010.11.037; Pepper ED, 2006, FEMS MICROBIOL LETT, V263, P61, DOI 10.1111/j.1574-6968.2006.00418.x; Perlstein DL, 2010, J AM CHEM SOC, V132, P48, DOI 10.1021/ja909325m; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PRATT RF, 1986, J AM CHEM SOC, V108, P5328, DOI 10.1021/ja00277a044; Rafailidis PI, 2007, DRUGS, V67, P1829, DOI 10.2165/00003495-200767130-00003; Sarkar SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048598; Sauvage E, 2008, FEMS MICROBIOL REV, V32, P234, DOI 10.1111/j.1574-6976.2008.00105.x; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwartz B, 2002, BIOCHEMISTRY-US, V41, P12552, DOI 10.1021/bi026205x; Sobhanifar S, 2013, CURR OPIN STRUC BIOL, V23, P695, DOI 10.1016/j.sbi.2013.07.008; Sung MT, 2009, P NATL ACAD SCI USA, V106, P8824, DOI 10.1073/pnas.0904030106; SYKES RB, 1985, REV INFECT DIS, V7, pS579; Terrak M, 2008, J BIOL CHEM, V283, P28464, DOI 10.1074/jbc.M803223200; Typas A, 2012, NAT REV MICROBIOL, V10, P123, DOI 10.1038/nrmicro2677; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103; Vilanova B., 1997, J CHEM SOC PERK T, V2, P2439; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter G, 2013, ACTA CRYSTALLOGR D, V69, P1260, DOI 10.1107/S0907444913015308; WRIGHT DB, 1986, DRUG INTEL CLIN PHAR, V20, P845, DOI 10.1177/106002808602001104; Yuan YQ, 2008, ACS CHEM BIOL, V3, P429, DOI 10.1021/cb800078a; Yuan YQ, 2007, P NATL ACAD SCI USA, V104, P5348, DOI 10.1073/pnas.0701160104; Zhao GS, 1999, ANTIMICROB AGENTS CH, V43, P1124, DOI 10.1128/AAC.43.5.1124	57	31	32	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2017	292	3					979	993		10.1074/jbc.M116.718403	http://dx.doi.org/10.1074/jbc.M116.718403			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2LL	27899450	Green Published, hybrid			2022-12-26	WOS:000392318700019
J	Halabi, S; Sekine, E; Verstak, B; Gay, NJ; Moncrieffe, MC				Halabi, Samer; Sekine, Eiki; Verstak, Brett; Gay, Nicholas J.; Moncrieffe, Martin C.			Structure of the Toll/Interleukin-1 Receptor (TIR) Domain of the B-cell Adaptor That Links Phosphoinositide Metabolism with the Negative Regulation of the Toll-like Receptor (TLR) Signalosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; TYROSINE PHOSPHORYLATION; 3-KINASE; BCAP; ACTIVATION; TRANSDUCTION; MACROPHAGES; REVEALS; CALCIUM; PI3K	Ligand binding to Toll-like receptors (TLRs) results in dimerization of their cytosolic Toll/interleukin-1 receptor (TIR) domains and recruitment of post-receptor signal transducers into a complex signalosome. TLR activation leads to the production of transcription factors and pro-inflammatory molecules and the activation of phosphoinositide 3-kinases (PI3K) in a process that requires the multimodular B-cell adaptor for phosphoinositide 3-kinase (BCAP). BCAP has a sequence previously proposed as a "cryptic" TIR domain. Here, we present the structure of the N-terminal region of human BCAP and show that it possesses a canonical TIR fold. Dimeric BCAP associates with the TIR domains of TLR2/4 and MAL/TIRAP, suggesting that it is recruited to the TLR signalosome by multitypic TIR-TIR interactions. BCAP also interacts with the p85 subunit of PI3K and phospholipase C gamma, enzymes that deplete plasma-membrane phosphatidylinositol 4,5-bisphosphate (PIP2), and these interactions provide a molecular explanation for BCAP-mediated down-regulation of inflammatory signaling.	[Halabi, Samer; Sekine, Eiki; Verstak, Brett; Gay, Nicholas J.; Moncrieffe, Martin C.] Univ Cambridge, Dept Biochem, Sanger Bldg,80 Tennis Court Rd, Cambridge CB2 1GA, England	University of Cambridge	Gay, NJ; Moncrieffe, MC (corresponding author), Univ Cambridge, Dept Biochem, Sanger Bldg,80 Tennis Court Rd, Cambridge CB2 1GA, England.	njg11@cam.ac.uk; mcm35@cam.ac.uk		Sekine, Eiki/0000-0001-6555-7879	UK Medical Research Council [G1000133]; Wellcome Investigator award [WT100321/z/12/Z]; Islamic Development Bank (Jeddah, Kingdom of Saudi Arabia); Cambridge Trust (Cambridge, UK)	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Investigator award; Islamic Development Bank (Jeddah, Kingdom of Saudi Arabia); Cambridge Trust (Cambridge, UK)	This work was supported by a program grant from the UK Medical Research Council (G1000133) and a Wellcome Investigator award (WT100321/z/12/Z to N. J. G.). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by the Islamic Development Bank (Jeddah, Kingdom of Saudi Arabia) and the Cambridge Trust (Cambridge, UK).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aki D, 2008, GENES CELLS, V13, P199, DOI 10.1111/j.1365-2443.2007.01159.x; Arsenault RJ, 2013, CELL SIGNAL, V25, P2246, DOI 10.1016/j.cellsig.2013.07.014; Battersby A, 2003, J MOL BIOL, V329, P479, DOI 10.1016/S0022-2836(03)00489-3; Beck T, 2008, ACTA CRYSTALLOGR D, V64, P1179, DOI 10.1107/S0907444908030266; Bernal-Quiros M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059842; Bernoux M, 2011, CELL HOST MICROBE, V9, P200, DOI 10.1016/j.chom.2011.02.009; Bonham KS, 2014, CELL, V156, P705, DOI 10.1016/j.cell.2014.01.019; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chiang CY, 2012, J BIOL CHEM, V287, P3704, DOI 10.1074/jbc.C111.328559; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Dal Porto JM, 2004, MOL IMMUNOL, V41, P599, DOI 10.1016/j.molimm.2004.04.008; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fan QW, 2011, CURR TOP MICROBIOL, V347, P279, DOI 10.1007/82_2010_67; Gay NJ, 2014, NAT REV IMMUNOL, V14, P546, DOI 10.1038/nri3713; Gibrat JF, 1996, CURR OPIN STRUC BIOL, V6, P377, DOI 10.1016/S0959-440X(96)80058-3; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Inabe K, 2002, BLOOD, V99, P584, DOI 10.1182/blood.V99.2.584; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Khan JA, 2004, J BIOL CHEM, V279, P31664, DOI 10.1074/jbc.M403434200; Khor CC, 2007, NAT GENET, V39, P523, DOI 10.1038/ng1976; Kim YJ, 2004, MOL CELL BIOL, V24, P9986, DOI 10.1128/MCB.24.22.9986-9999.2004; Kohl A, 2003, P NATL ACAD SCI USA, V100, P1700, DOI 10.1073/pnas.0337680100; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kurosaki T, 2000, IMMUNITY, V12, P1, DOI 10.1016/S1074-7613(00)80153-3; Leevers SJ, 1999, CURR OPIN CELL BIOL, V11, P219, DOI 10.1016/S0955-0674(99)80029-5; MacFarlane AW, 2008, BLOOD, V112, P131, DOI 10.1182/blood-2007-08-107847; Matsumura T, 2010, BIOCHEM BIOPH RES CO, V400, P265, DOI 10.1016/j.bbrc.2010.08.055; Musacchio A, 1996, P NATL ACAD SCI USA, V93, P14373, DOI 10.1073/pnas.93.25.14373; Ni MJ, 2012, P NATL ACAD SCI USA, V109, P267, DOI 10.1073/pnas.1111957108; Nyman T, 2008, J BIOL CHEM, V283, P11861, DOI 10.1074/jbc.C800001200; Okada T, 2000, IMMUNITY, V13, P817, DOI 10.1016/S1074-7613(00)00079-0; Okkenhaug K, 2013, ANNU REV IMMUNOL, V31, P675, DOI 10.1146/annurev-immunol-032712-095946; Rameh LE, 1999, J BIOL CHEM, V274, P8347, DOI 10.1074/jbc.274.13.8347; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Snyder GA, 2014, J BIOL CHEM, V289, P669, DOI 10.1074/jbc.M113.523407; Song S, 2011, J IMMUNOL, V187, P619, DOI 10.4049/jimmunol.0903425; Tao X, 2002, BIOCHEM BIOPH RES CO, V299, P216, DOI 10.1016/S0006-291X(02)02581-0; Troutman TD, 2012, P NATL ACAD SCI USA, V109, P273, DOI 10.1073/pnas.1118579109; Valkov E, 2011, P NATL ACAD SCI USA, V108, P14879, DOI 10.1073/pnas.1104780108; Verstak B, 2013, J IMMUNOL, V191, P6101, DOI 10.4049/jimmunol.1300849; Vincent S, 1998, MOL CELL, V2, P515, DOI 10.1016/S1097-2765(00)80151-3; Walter TS, 2006, STRUCTURE, V14, P1617, DOI 10.1016/j.str.2006.09.005; Wu YY, 2013, J IMMUNOL, V191, P6110, DOI 10.4049/jimmunol.1301203; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; Yamazaki T, 2002, J EXP MED, V195, P535, DOI 10.1084/jem.20011751; Yokoyama K, 2002, EMBO J, V21, P83, DOI 10.1093/emboj/21.1.83; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051; Zhang YX, 2011, GENET MOL RES, V10, P7, DOI 10.4238/vol10-1gmr980; Zhou XY, 2006, J BIOL CHEM, V281, P31337, DOI 10.1074/jbc.M602739200	54	18	19	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2017	292	2					652	660		10.1074/jbc.M116.761528	http://dx.doi.org/10.1074/jbc.M116.761528			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2KN	27909057	Green Published, hybrid			2022-12-26	WOS:000392316100020
J	Sarmento, OF; Svingen, PA; Xiong, YN; Sun, ZF; Bamidele, AO; Mathison, AJ; Smyrk, TC; Nair, AA; Gonzalez, MM; Sagstetter, MR; Baheti, S; McGovern, DPB; Friton, JJ; Papadakis, KA; Gautam, G; Xavier, RJ; Urrutia, RA; Faubion, WA				Sarmento, Olga F.; Svingen, Phyllis A.; Xiong, Yuning; Sun, Zhifu; Bamidele, Adebowale O.; Mathison, Angela J.; Smyrk, Thomas C.; Nair, Asha A.; Gonzalez, Michelle M.; Sagstetter, Mary R.; Baheti, Saurabh; McGovern, Dermot P. B.; Friton, Jessica J.; Papadakis, Konstantinos A.; Gautam, Goel; Xavier, Ramnik J.; Urrutia, Raul A.; Faubion, William A.			The Role of the Histone Methyltransferase Enhancer of Zeste Homolog 2 (EZH2) in the Pathobiological Mechanisms Underlying Inflammatory Bowel Disease (IBD)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY T-CELLS; GENE-EXPRESSION; FOXP3; DIFFERENTIATION; PHOSPHORYLATION; TRANSCRIPTION; METHYLATION; REPRESSION; PLASTICITY; STABILITY	Regulatory T (Treg) cells expressing the transcription factor FOXP3 play a pivotal role in maintaining immunologic self-tolerance. We and others have shown previously that EZH2 is recruited to the FOXP3 promoter and its targets in Treg cells. To further address the role for EZH2 in Treg cellular function, we have now generated mice that lack EZH2 specifically in Treg cells (EZH2(Delta/Delta) FOXP3(+)). We find that EZH2 deficiency in FOXP3(+) T cells results in lethal multiorgan autoimmunity. We further demonstrate that EZH2(Delta/Delta)FOXP3(+) T cells lack a regulatory phenotype in vitro and secrete proinflammatory cytokines. Of special interest, EZH2(Delta/Delta)FOXP3(+) mice develop spontaneous inflammatory bowel disease. Guided by these results, we assessed the FOXP3 and EZH2 gene networks by RNA sequencing in isolated intestinal CD4(+) T cells from patients with Crohn's disease. Gene network analysis demonstrates that these CD4(+) T cells display a Th1/Th17-like phenotype with an enrichment of gene targets shared by FOXP3 and EZH2. Combined, these results suggest that the inflammatory milieu found in Crohn's disease could lead to or result from deregulation of FOXP3/EZH2-enforced T cell gene networks contributing to the underlying intestinal inflammation.	[Sarmento, Olga F.; Svingen, Phyllis A.; Xiong, Yuning; Bamidele, Adebowale O.; Mathison, Angela J.; Gonzalez, Michelle M.; Sagstetter, Mary R.; Friton, Jessica J.; Papadakis, Konstantinos A.; Urrutia, Raul A.; Faubion, William A.] Mayo Clin, Div Gastroenterol & Hepatol, Epigenet & Chromatin Dynam Lab, Rochester, MN 55905 USA; [Sarmento, Olga F.; Svingen, Phyllis A.; Xiong, Yuning; Bamidele, Adebowale O.; Mathison, Angela J.; Gonzalez, Michelle M.; Sagstetter, Mary R.; Friton, Jessica J.; Papadakis, Konstantinos A.; Urrutia, Raul A.; Faubion, William A.] Mayo Clin, Translat Epigen Program, Ctr Individualized Med, Rochester, MN 55905 USA; [Sun, Zhifu; Nair, Asha A.; Baheti, Saurabh] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN 55905 USA; [Smyrk, Thomas C.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA; [McGovern, Dermot P. B.] Cedars Sinai Med Ctr, F Widjaja Fdn, Inflammatory Bowel & Immunobiol Res Inst, Los Angeles, CA 90048 USA; [Gautam, Goel; Xavier, Ramnik J.] Harvard Med Sch, Gastrointestinal Unit, Boston, MA 02114 USA; [Gautam, Goel; Xavier, Ramnik J.] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Study Inflammatory Bowel Dis, Boston, MA 02114 USA; [Gautam, Goel; Xavier, Ramnik J.] Broad Inst MIT & Harvard, Ctr Computat & Integrat Biol, Cambridge, MA 02142 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Cedars Sinai Medical Center; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Faubion, WA (corresponding author), 200 First St SW, Rochester, MN 55905 USA.	Faubion.william@mayo.edu	Bamidele, Adebowale O./AAZ-2453-2020	Bamidele, Adebowale O./0000-0002-9547-2195; Sun, Zhifu/0000-0001-8461-7523; Mathison, Angela/0000-0002-6763-2710	Crohn's and Colitis Foundation of America [271332, 401661]; Mayo Clinic Foundation; National Institutes of Health [RO1DK52913]; Career Developmental Award Mayo Clinic SPORE in Pancreatic Cancer; Career Developmental Award Mayo Clinic Center for Cell Signaling in Gastroenterology; NIAID, National Institutes of Health [RO1 AI089714]; Leona Helmsley Charitable Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089714] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052913, P30DK084567, P30DK043351] Funding Source: NIH RePORTER	Crohn's and Colitis Foundation of America; Mayo Clinic Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Career Developmental Award Mayo Clinic SPORE in Pancreatic Cancer; Career Developmental Award Mayo Clinic Center for Cell Signaling in Gastroenterology; NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Leona Helmsley Charitable Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Crohn's and Colitis Foundation of America Fellowship award 271332 and Career Development Award 401661 (to O. F. S.); the Mayo Clinic Foundation (to K. A. P.); National Institutes of Health Grant RO1DK52913 (to R. A. U.); Career Developmental Award Mayo Clinic SPORE in Pancreatic Cancer and Career Developmental Award Mayo Clinic Center for Cell Signaling in Gastroenterology (to G. A. L.); and NIAID, National Institutes of Health Grant RO1 AI089714 and the Leona Helmsley Charitable Trust (to W. A. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Arvey A, 2014, NAT IMMUNOL, V15, P580, DOI 10.1038/ni.2868; Bantug GR, 2016, NAT IMMUNOL, V17, P41, DOI 10.1038/ni.3346; Barzaghi F, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00211; Blatner NR, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004566; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Chen BL, 2013, CELL CYCLE, V12, P112, DOI 10.4161/cc.23030; Chu CS, 2014, P NATL ACAD SCI USA, V111, P1355, DOI 10.1073/pnas.1323226111; Duijvestein M, 2011, STEM CELLS, V29, P1549, DOI 10.1002/stem.698; DuPage M, 2015, IMMUNITY, V42, P227, DOI 10.1016/j.immuni.2015.01.007; Faubion WA, 2004, GASTROENTEROLOGY, V126, P1759, DOI 10.1053/j.gastro.2004.03.015; Feinberg AP, 2016, NAT REV GENET, V17, P284, DOI 10.1038/nrg.2016.13; Fletcher MNC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3464; Fulton DL, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r29; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; GODFREY VL, 1991, AM J PATHOL, V138, P1379; Harms PW., 2014, HUM PATHOL, V1, P21, DOI DOI 10.1016/J.EHPC.2014.07.002; Hovhannisyan Z, 2011, GASTROENTEROLOGY, V140, P957, DOI 10.1053/j.gastro.2010.12.002; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jacob E, 2008, J BIOL CHEM, V283, P13471, DOI 10.1074/jbc.M709886200; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kim E, 2013, CANCER CELL, V23, P839, DOI 10.1016/j.ccr.2013.04.008; Kornete M, 2012, J IMMUNOL, V188, P1064, DOI 10.4049/jimmunol.1101303; Lal G, 2009, BLOOD, V114, P3727, DOI 10.1182/blood-2009-05-219584; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Luo CT, 2016, NATURE, V529, P532, DOI 10.1038/nature16486; Mandal M, 2011, NAT IMMUNOL, V12, P1212, DOI 10.1038/ni.2136; Martinez GJ, 2009, J BIOL CHEM, V284, P35283, DOI 10.1074/jbc.C109.078238; Michels AW, 2010, NAT REV ENDOCRINOL, V6, P270, DOI 10.1038/nrendo.2010.40; Miranda TB, 2009, MOL CANCER THER, V8, P1579, DOI 10.1158/1535-7163.MCT-09-0013; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; O'Meara MM, 2012, CHROMOSOMA, V121, P221, DOI 10.1007/s00412-012-0361-1; Perse M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/718617; Rahman MK, 2010, J IMMUNOL, V184, P7247, DOI 10.4049/jimmunol.0901479; Ramsdell F, 2014, NAT REV IMMUNOL, V14, P343, DOI 10.1038/nri3650; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saeidi K, 2016, CRIT REV ONCOL HEMAT, V98, P375, DOI 10.1016/j.critrevonc.2015.11.004; Sahasrabuddhe AA, 2015, ONCOGENE, V34, P445, DOI 10.1038/onc.2013.571; Schubert LA, 2001, J BIOL CHEM, V276, P37672, DOI 10.1074/jbc.M104521200; Shi LH, 2014, J IMMUNOL, V192, P3057, DOI 10.4049/jimmunol.1302063; Su I, 2005, CELL, V121, P425, DOI 10.1016/j.cell.2005.02.029; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Tartar DM, 2010, J IMMUNOL, V184, P3377, DOI 10.4049/jimmunol.0903324; Tone Y, 2014, J IMMUNOL, V192, P3915, DOI 10.4049/jimmunol.1302174; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tumes DJ, 2013, IMMUNITY, V39, P819, DOI 10.1016/j.immuni.2013.09.012; Ueno A, 2013, INFLAMM BOWEL DIS, V19, P2522, DOI 10.1097/MIB.0b013e3182a85709; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Voo KS, 2009, P NATL ACAD SCI USA, V106, P4793, DOI 10.1073/pnas.0900408106; Wan JH, 2015, NUCLEIC ACIDS RES, V43, P3591, DOI 10.1093/nar/gkv238; Wigle TJ, 2011, FEBS LETT, V585, P3011, DOI 10.1016/j.febslet.2011.08.018; Wu SC, 2011, J BIOL CHEM, V286, P28511, DOI 10.1074/jbc.M111.240515; Xiong YN, 2012, J BIOL CHEM, V287, P34372, DOI 10.1074/jbc.M111.325332; Xu BW, 2015, EXP HEMATOL, V43, P698, DOI 10.1016/j.exphem.2015.05.001; Yang XP, 2015, SCI REP-UK, V5, DOI 10.1038/srep10643; Yap DB, 2011, BLOOD, V117, P2451, DOI 10.1182/blood-2010-11-321208; Zhang H, 2013, J ALLERGY CLIN IMMUN, V132, P1005, DOI 10.1016/j.jaci.2013.05.033; Zhang YX, 2014, BLOOD, V124, P737, DOI 10.1182/blood-2013-12-544106; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	60	42	42	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2017	292	2					706	722		10.1074/jbc.M116.749663	http://dx.doi.org/10.1074/jbc.M116.749663			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2KN	27909059	Green Published, hybrid			2022-12-26	WOS:000392316100025
J	Richter, SH; Kastner, N; Loddenkemper, DH; Kaiser, S; Sachser, N				Richter, S. Helene; Kaestner, Niklas; Loddenkemper, Dirk-Heinz; Kaiser, Sylvia; Sachser, Norbert			A Time to Wean? Impact of Weaning Age on Anxiety-Like Behaviour and Stability of Behavioural Traits in Full Adulthood	PLOS ONE			English	Article							MATERNAL-CARE; HOUSE MICE; ANIMAL PERSONALITY; MUS-MUSCULUS; STRESS; DECREASES; MOUSE; RATS; MECHANISMS; EXPRESSION	In mammals, weaning constitutes an important phase in the progression to adulthood. It comprises the termination of suckling and is characterized by several changes in the behaviour of both mother and offspring. Furthermore, numerous studies in rodents have shown that the time point of weaning shapes the behavioural profile of the young. Most of these studies, however, have focused on 'early weaning', while relatively little work has been done to study 'late weaning' effects. The aim of the present study was therefore to explore behavioural effects of 'late weaning', and furthermore to gain insights into modulating effects of weaning age on the consistency of behavioural expressions over time. In total, 25 male and 20 female C57BL/6J mice, weaned after three (W3) or four (W4) weeks of age, were subjected to a series of behavioural paradigms widely used to assess anxiety-like behaviour, exploratory locomotion, and nest building performance. Behavioural testing took place with the mice reaching an age of 20 weeks and was repeated eight weeks later to investigate the stability of behavioural expressions over time. At the group level, W4 mice behaved less anxious and more explorative than W3 animals in the Open Field and Novel Cage, while anxiety-like behaviour on the Elevated Plus Maze was modulated by a weaning-age-by-sex interaction. Furthermore, weaning age shaped the degree of behavioural stability over time in a sex-specific way. While W3 females and W4 males displayed a remarkable degree of behavioural stability over time, no such patterns were observed in W3 males and W4 females. Adding to the existing literature, we could thus confirm that effects of weaning age do indeed exist when prolonging this phase, and were furthermore able to provide first evidence for the impact of weaning age and sex on the consistency of behavioural expressions over time.	[Richter, S. Helene; Kaestner, Niklas; Loddenkemper, Dirk-Heinz; Kaiser, Sylvia; Sachser, Norbert] Univ Munster, Dept Behav Biol, Munster, Germany	University of Munster	Richter, SH (corresponding author), Univ Munster, Dept Behav Biol, Munster, Germany.	richterh@uni-muenster.de		Kaiser, Sylvia/0000-0003-2770-7367	German Research Foundation [SFB/TRR58]	German Research Foundation(German Research Foundation (DFG))	This study was supplied by a grant from the German Research Foundation to NS (SFB/TRR58, Project A01, http://sfbtrr58.uni-muenster.de/a01.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartolomucci A, 2004, PSYCHONEUROENDOCRINO, V29, P899, DOI 10.1016/j.psyneuen.2003.08.003; Bodden C, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00047; Caldji C, 1998, P NATL ACAD SCI USA, V95, P5335, DOI 10.1073/pnas.95.9.5335; Champagne FA, 2003, PHYSIOL BEHAV, V79, P359, DOI 10.1016/S0031-9384(03)00149-5; Champagne FA, 2007, PHYSIOL BEHAV, V91, P325, DOI 10.1016/j.physbeh.2007.03.014; COUNSILMAN JJ, 1985, ANIM BEHAV, V33, P1023, DOI 10.1016/S0003-3472(85)80037-3; Curley JP, 2009, DEV NEUROSCI-BASEL, V31, P318, DOI 10.1159/000216543; Deacon RMJ, 2006, NAT PROTOC, V1, P1117, DOI 10.1038/nprot.2006.170; Dingemanse NJ, 2002, ANIM BEHAV, V64, P929, DOI 10.1006/anbe.2002.2006; Farshim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep21958; Ferdman N, 2007, BEHAV BRAIN RES, V180, P174, DOI 10.1016/j.bbr.2007.03.011; Freund J, 2013, SCIENCE, V340, P756, DOI 10.1126/science.1235294; Fuss J, 2013, BEHAV BRAIN RES, V243, P191, DOI 10.1016/j.bbr.2013.01.015; GERLACH G, 1990, BIOL J LINN SOC, V41, P271, DOI 10.1111/j.1095-8312.1990.tb00835.x; Gerlach G, 1996, BEHAV ECOL SOCIOBIOL, V39, P159, DOI 10.1007/s002650050277; Groothuis TGG, 2011, DEV PSYCHOBIOL, V53, P641, DOI 10.1002/dev.20574; Heiming RS, 2011, HORM BEHAV, V60, P397, DOI 10.1016/j.yhbeh.2011.07.006; HOLDER JL, 1991, ETHOLOGY, V88, P297; HOLSON RR, 1992, NEUROTOXICOL TERATOL, V14, P221, DOI 10.1016/0892-0362(92)90020-B; Hoyer C, 2012, REPROD TOXICOL, V34, P86, DOI 10.1016/j.reprotox.2012.03.006; Iwata E, 2007, PHYSIOL BEHAV, V91, P318, DOI 10.1016/j.physbeh.2007.03.013; JOHNSTON AL, 1991, PHYSIOL BEHAV, V49, P245, DOI 10.1016/0031-9384(91)90039-Q; Kanari K, 2005, BEHAV BRAIN RES, V156, P45, DOI 10.1016/j.bbr.2004.05.008; Kikusui T, 2005, BEHAV BRAIN RES, V162, P200, DOI 10.1016/j.bbr.2005.03.013; Kikusui T, 2004, PHYSIOL BEHAV, V81, P37, DOI 10.1016/j.physbeh.2003.12.016; Kikusui T, 2007, BRAIN RES, V1133, P115, DOI 10.1016/j.brainres.2006.11.031; Kikusui T, 2006, BEHAV BRAIN RES, V175, P96, DOI 10.1016/j.bbr.2006.08.007; Kikusui T, 2009, PSYCHONEUROENDOCRINO, V34, P762, DOI 10.1016/j.psyneuen.2008.12.009; KONIG B, 1987, BEHAV ECOL SOCIOBIOL, V20, P1, DOI 10.1007/BF00292161; KONIG B, 1994, BEHAV ECOL SOCIOBIOL, V34, P275, DOI 10.1007/s002650050043; KRACKOW S, 1989, ANIM BEHAV, V37, P177, DOI 10.1016/0003-3472(89)90108-5; Latham N, 2004, APPL ANIM BEHAV SCI, V86, P261, DOI 10.1016/j.applanim.2004.02.006; Laviola G, 1997, PSYCHOBIOLOGY, V25, P163; Lazic SE, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-37; Lee P. C., 1996, Evolutionary Anthropology, V5, P87, DOI 10.1002/(SICI)1520-6505(1996)5:3<87::AID-EVAN4>3.0.CO;2-T; LEE PC, 1991, J ZOOL, V225, P99, DOI 10.1111/j.1469-7998.1991.tb03804.x; Lehmann J, 2000, REV NEUROSCIENCE, V11, P383; Lerch S, 2015, BEHAV BRAIN RES, V279, P155, DOI 10.1016/j.bbr.2014.11.007; Lewejohann L, 2011, DEV PSYCHOBIOL, V53, P624, DOI 10.1002/dev.20553; Liu D, 1997, SCIENCE, V277, P1659, DOI 10.1126/science.277.5332.1659; Maestripieri D., 2013, ANIMAL PERSONALITIES, P279; MARTIN P, 1985, ANIM BEHAV, V33, P1024, DOI 10.1016/S0003-3472(85)80038-5; Martin P., 2007, MEASURING BEHAV INTR, DOI 10.1017/CBO9780511810893; Meaney MJ, 2001, ANNU REV NEUROSCI, V24, P1161, DOI 10.1146/annurev.neuro.24.1.1161; MENDL M, 1991, BEHAVIOUR, V116, P11, DOI 10.1163/156853990X00347; Pocock MJO, 2005, BIOL J LINN SOC, V84, P565, DOI 10.1111/j.1095-8312.2005.00455.x; Pryce CR, 2003, NEUROSCI BIOBEHAV R, V27, P57, DOI 10.1016/S0149-7634(03)00009-5; Reale D, 2010, PHILOS T R SOC B, V365, P3937, DOI 10.1098/rstb.2010.0222; Remmes J, FRONT BEHAV IN PRESS; Richter SH, 2016, ANIM BEHAV, V114, P261, DOI 10.1016/j.anbehav.2016.02.003; Richter SH, 2014, BEHAV BRAIN RES, V270, P300, DOI 10.1016/j.bbr.2014.05.002; Ridder S, 2005, J NEUROSCI, V25, P6243, DOI 10.1523/JNEUROSCI.0736-05.2005; Sachser N, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0344; Sachser N, 2011, NEUROSCI BIOBEHAV R, V35, P1518, DOI 10.1016/j.neubiorev.2010.09.002; Schuett W, 2010, BIOL REV, V85, P217, DOI 10.1111/j.1469-185X.2009.00101.x; Shimozuru M, 2007, DEV PSYCHOBIOL, V49, P343, DOI 10.1002/dev.20202; Solomon NG, 2003, J MAMMAL, V84, P1182, DOI 10.1644/BLe-013; Stamps J, 2010, BIOL REV, V85, P301, DOI 10.1111/j.1469-185X.2009.00103.x; Tarantino LM, 2000, MAMM GENOME, V11, P555, DOI 10.1007/s003350010107; TRIVERS RL, 1974, AM ZOOL, V14, P249; Voikar V, 2001, PHYSIOL BEHAV, V72, P271, DOI 10.1016/S0031-9384(00)00405-4; Weber EM, 2008, APPL ANIM BEHAV SCI, V114, P1, DOI 10.1016/j.applanim.2008.06.006; WILLIAMS E, 1953, BEHAVIOUR, V6, P35, DOI 10.1163/156853954X00031; Wolf M, 2012, TRENDS ECOL EVOL, V27, P452, DOI 10.1016/j.tree.2012.05.001; Zorrilla EP, 1997, DEV PSYCHOBIOL, V30, P141, DOI 10.1002/(SICI)1098-2302(199703)30:2<141::AID-DEV5>3.0.CO;2-Q	65	15	15	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2016	11	12							e0167652	10.1371/journal.pone.0167652	http://dx.doi.org/10.1371/journal.pone.0167652			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4OA	27930688	Green Published, gold, Green Submitted			2022-12-26	WOS:000389580900036
J	Pulmanns, N; Mehlig, U; Nordhaus, I; Saint-Paul, U; Diele, K				Pulmanns, Nathalie; Mehlig, Ulf; Nordhaus, Inga; Saint-Paul, Ulrich; Diele, Karen			Mangrove Crab Ucides cordatus Removal Does Not Affect Sediment Parameters and Stipule Production in a One Year Experiment in Northern Brazil	PLOS ONE			English	Article							FIDDLER-CRABS; CAETE ESTUARY; CHASMAGNATHUS-GRANULATA; SULFUR BIOGEOCHEMISTRY; NUTRIENT STATUS; RIVER ESTUARY; SALT; FORESTS; BURROWS; CARBON	Mangrove crabs influence ecosystem processes through bioturbation and/or litter feeding. In Brazilian mangroves, the abundant and commercially important crab Ucides cordatus is the main faunal modifier of microtopography establishing up to 2 m deep burrows. They process more than 70% of the leaf litter and propagule production, thus promoting microbial degradation of detritus and benefiting microbe-feeding fiddler crabs. The accelerated nutrient turn-over and increased sediment oxygenation mediated by U. cordatus may enhance mangrove tree growth. Such positive feed-back loop was tested in North Brazil through a one year crab removal experiment simulating increased harvesting rates in a mature Rhizophora mangle forest. Investigated response parameters were sediment salinity, organic matter content, CO2 efflux rates of the surface sediment, and reduction potential. We also determined stipule fall of the mangrove tree R. mangle as a proxy for tree growth. Three treatments were applied to twelve experimental plots (13 m x 13 m each): crab removal, disturbance control and control. Within one year, the number of U. cordatus burrows inside the four removal plots decreased on average to 52% of the initial number. Despite this distinct reduction in burrow density of this large bioturbator, none of the measured parameters differed between treatments. Instead, most parameters were clearly influenced by seasonal changes in precipitation. Hence, in the studied R. mangle forest, abiotic factors seem to be more important drivers of ecosystem processes than factors mediated by U. cordatus, at least within the studied timespan of one year.	[Pulmanns, Nathalie; Nordhaus, Inga; Saint-Paul, Ulrich] Leibniz Ctr Trop Marine Ecol, Mangrove Ecol Grp, Dept Ecol, Bremen, Germany; [Mehlig, Ulf] Fed Univ Para, Lab Bot, Braganca Paulista, SP, Brazil; [Diele, Karen] Edinburgh Napier Univ, Sch Appl Sci, Edinburgh, Midlothian, Scotland; [Diele, Karen] St Abbs Marine Stn, St Abbs, Berwick, Scotland	Leibniz Zentrum fur Marine Tropenforschung (ZMT); Universidade Federal do Para; Edinburgh Napier University	Pulmanns, N (corresponding author), Leibniz Ctr Trop Marine Ecol, Mangrove Ecol Grp, Dept Ecol, Bremen, Germany.	nathalie.puelmanns@gmail.com	Mehlig, Ulf/A-2280-2013	Mehlig, Ulf/0000-0002-0142-4505	Leibniz Center for Tropical Marine Ecology [6201]; MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland); Scottish Funding Council [HR09011]; Institute do Estudos Costeiros (IECOS) of the Federal University of Para (UFPa)	Leibniz Center for Tropical Marine Ecology; MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland); Scottish Funding Council; Institute do Estudos Costeiros (IECOS) of the Federal University of Para (UFPa)	NP and IN were funded by the Leibniz Center for Tropical Marine Ecology (project 6201, http://zmt-bremen.de). KD received funding from the MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland, http:// www.masts.ac.uk) and its support is gratefully acknowledged. MASTS is funded by the Scottish Funding Council (grant reference HR09011) and contributing institutions. UM was funded by the Institute do Estudos Costeiros (IECOS) of the Federal University of Para (UFPa). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alongi DM, 2001, MAR GEOL, V179, P85, DOI 10.1016/S0025-3227(01)00195-5; Andreetta A, 2014, J SEA RES, V85, P524, DOI 10.1016/j.seares.2013.08.010; Araujo JMC, 2012, GEO-MAR LETT, V32, P289, DOI 10.1007/s00367-011-0268-5; Boeger WA, 2005, MEM I OSWALDO CRUZ, V100, P161, DOI 10.1590/S0074-02762005000200009; Bortolus A, 1999, MAR ECOL PROG SER, V178, P79, DOI 10.3354/meps178079; BOTO KG, 1983, MAR ECOL PROG SER, V11, P63, DOI 10.3354/meps011063; BOTO KG, 1984, ESTUARIES, V7, P61, DOI 10.2307/1351957; Botto F, 1999, J EXP MAR BIOL ECOL, V241, P263, DOI 10.1016/S0022-0981(99)00089-1; de Araujo MSLC, 2011, TROP OCEANOGR, V39, P155; de Magalhaes HF, 2011, BIOTA NEOTROP, V11, P45, DOI 10.1590/S1676-06032011000200005; Diele K, 2005, AQUAT LIVING RESOUR, V18, P169, DOI 10.1051/alr:2005018; Diele K, 2010, ECOL STUD-ANAL SYNTH, V211, P275, DOI 10.1007/978-3-642-13457-9_18; Diele K, 2010, ECOL STUD-ANAL SYNTH, V211, P287, DOI 10.1007/978-3-642-13457-9_19; Dittmann S, 1996, MAR ECOL PROG SER, V134, P119, DOI 10.3354/meps134119; DUKE NC, 1984, AUST J BOT, V32, P87, DOI 10.1071/BT9840087; DYE AH, 1986, MAR ECOL PROG SER, V32, P259, DOI 10.3354/meps032259; Ellison AM, 2008, J SEA RES, V59, P2, DOI 10.1016/j.seares.2007.05.003; EMMERSON WD, 1992, J EXP MAR BIOL ECOL, V157, P41, DOI 10.1016/0022-0981(92)90073-J; Fanjul E, 2007, MAR ECOL PROG SER, V341, P177, DOI 10.3354/meps341177; Ferreira TO, 2007, GEODERMA, V142, P36, DOI 10.1016/j.geoderma.2007.07.010; Gomes de Santa Fe UMG, 2013, ACTAPESCA ACTA FISH, V1, P29; Guerra RS, 2013, MYCOPATHOLOGIA, V175, P421, DOI 10.1007/s11046-013-9636-1; Heron SF, 2008, ESTUAR COAST SHELF S, V78, P135, DOI 10.1016/j.ecss.2007.11.018; Heron SF, 2003, ESTUAR COAST SHELF S, V58, P137, DOI 10.1016/S0272-7714(03)00068-4; Heron SF, 2001, ESTUAR COAST SHELF S, V52, P411, DOI 10.1006/ecss.2000.0761; HOFFMAN JA, 1984, J EXP MAR BIOL ECOL, V82, P161, DOI 10.1016/0022-0981(84)90101-1; Koch V, 2002, MAR ECOL PROG SER, V228, P119, DOI 10.3354/meps228119; Kostka JE, 2002, LIMNOL OCEANOGR, V47, P230, DOI 10.4319/lo.2002.47.1.0230; Krause G, 2010, ECOL STUD-ANAL SYNTH, V211, P19, DOI 10.1007/978-3-642-13457-9_3; Krause G, 2001, ECOTROPICA, V7, P93; Kristensen E, 2008, J SEA RES, V59, P30, DOI 10.1016/j.seares.2007.05.004; Kristensen E, 2006, LIMNOL OCEANOGR, V51, P1557, DOI 10.4319/lo.2006.51.4.1557; Lara Ruben J., 2006, Wetlands Ecology and Management, V14, P349, DOI 10.1007/s11273-005-4991-4; Leopold A, 2015, SCI TOTAL ENVIRON, V502, P617, DOI 10.1016/j.scitotenv.2014.09.066; Marchand C, 2004, MAR GEOL, V208, P361, DOI 10.1016/j.margeo.2004.04.015; Mehlig U, 2006, AQUAT BOT, V84, P158, DOI 10.1016/j.aquabot.2005.09.007; Mehlig U, 2010, ECOL STUD-ANAL SYNTH, V211, P71, DOI 10.1007/978-3-642-13457-9_6; Morrisey DJ, 1999, MAR ECOL PROG SER, V182, P231, DOI 10.3354/meps182231; Nascimento DM, 2016, OCEAN COAST MANAGE, V130, P50, DOI 10.1016/j.ocecoaman.2016.05.010; Nielsen OI, 2003, J EXP MAR BIOL ECOL, V289, P59, DOI 10.1016/S0022-0981(03)00041-8; Nordhaus I, 2006, ESTUAR COAST SHELF S, V67, P239, DOI 10.1016/j.ecss.2005.11.022; Nordhaus I, 2007, MAR BIOL, V151, P1665, DOI 10.1007/s00227-006-0597-5; Nordhaus I, 2009, J EXP MAR BIOL ECOL, V374, P104, DOI 10.1016/j.jembe.2009.04.002; PASSIOURA JB, 1992, FUNCT ECOL, V6, P476, DOI 10.2307/2389286; Penha-Lopes G, 2009, MAR POLLUT BULL, V58, P1694, DOI 10.1016/j.marpolbul.2009.06.015; Pinheiro J, 2001, MIXED EFFECTS MODELS; Pinheiro JC, 2012, NLME LINEAR NONLINEA, P1; Pinheiro MAA, 2006, BRAZILIAN ARCH BIOL; Popel F, 2000, MULLER J VLG CF; Pulmanns N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109532; R Core Team, 2012, R LANG ENV STAT COMP; Reise A, 2003, ESTIMATES BIOMASS PR; Ridd PV, 1996, ESTUAR COAST SHELF S, V43, P617, DOI 10.1006/ecss.1996.0091; ROBERTSON AI, 1986, J EXP MAR BIOL ECOL, V102, P237, DOI 10.1016/0022-0981(86)90179-6; Sarkar D, 2008, USE R, P1; Schmidt AJ, 2012, ANIM BEHAV, V84, P333, DOI 10.1016/j.anbehav.2012.04.023; Schories D, 2003, WETL ECOL MANAG, V11, P243, DOI 10.1023/A:1025011431984; Smith NF, 2009, MAR BIOL, V156, P2255, DOI 10.1007/s00227-009-1253-7; SMITH TJ, 1991, ESTUAR COAST SHELF S, V33, P419, DOI 10.1016/0272-7714(91)90081-L; SMITH TJ, 1987, ECOLOGY, V68, P266; Steubing L, 1992, PFLANZENOKOLOGISCHES; Stieglitz T, 2000, HYDROBIOLOGIA, V421, P69, DOI 10.1023/A:1003925502665; Tavares M, 2003, FAO SPECIES IDENTIFI, P327; Thomas CR, 2010, MAR ECOL PROG SER, V414, P167, DOI 10.3354/meps08708; Twilley RR, 1997, OECOLOGIA, V111, P109, DOI 10.1007/s004420050214; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; WOLANSKI E, 1981, AUST J MAR FRESH RES, V32, P681; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Xin P, 2009, ADV WATER RESOUR, V32, P439, DOI 10.1016/j.advwatres.2008.12.008; Zuur A.F., 2007, ANAL ECOLOGICAL DATA; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x; Zuur Alain F., 2009, P1	73	10	10	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167375	10.1371/journal.pone.0167375	http://dx.doi.org/10.1371/journal.pone.0167375			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907093	Green Published, Green Submitted, gold			2022-12-26	WOS:000389482700134
J	Russell, KA; Chow, NHC; Dukoff, D; Gibson, TWG; LaMarre, J; Bette, DH; Koch, TG				Russell, Keith A.; Chow, Natalie H. C.; Dukoff, David; Gibson, Thomas W. G.; LaMarre, Jonathan; Bette, Dean H.; Koch, Thomas G.			Characterization and Immunomodulatory Effects of Canine Adipose Tissue- and Bone Marrow-Derived Mesenchymal Stromal Cells	PLOS ONE			English	Article							PROLIFERATION IN-VITRO; STEM-CELLS; CORD BLOOD; CHONDROGENIC DIFFERENTIATION; INTERFERON-GAMMA; MECHANISMS; EXPRESSION; CULTURE; BMP2	Background Mesenchymal stromal cells (MSC) hold promise for both cell replacement and immune modulation strategies owing to their progenitor and non-progenitor functions, respectively. Characterization of MSC from different sources is an important and necessary step before clinical use of these cells is widely adopted. Little is known about the biology and function of canine MSC compared to their mouse or human counterparts. This knowledge-gap impedes development of canine evidence-based MSC technologies. Hypothesis and Objectives We hypothesized that canine adipose tissue (AT) and bone marrow (BM) MSC (derived from the same dogs) will have similar differentiation and immune modulatory profiles. Our objectives were to evaluate progenitor and non-progenitor functions as well as other characteristics of AT-and BM-MSC including 1) proliferation rate, 2) cell surface marker expression, 3) DNA methylation levels, 4) potential for trilineage differentiation towards osteogenic, adipogenic, and chondrogenic cell fates, and 5) immunomodulatory potency in vitro. Results 1) AT-MSC proliferated at more than double the rate of BM-MSC (population doubling times in days) for passage (P) 2, AT: 1.69, BM: 3.81; P3, AT: 1.80, BM: 4.06; P4, AT: 2.37, BM: 5.34; P5, AT: 3.20, BM: 7.21). 2) Canine MSC, regardless of source, strongly expressed cell surface markers MHC I, CD29, CD44, and CD90, and were negative for MHC II and CD45. They also showed moderate expression of CD8 and CD73 and mild expression of CD14. Minor differences were found in expression of CD4 and CD34. 3) Global DNA methylation levels were significantly lower in BM-MSC compared to AT-MSC. 4) Little difference was found between AT-and BM-MSC in their potential for adipogenesis and osteogenesis. Chondrogenesis was poor to absent for both sources in spite of adding varying levels of bone-morphogenic protein to our standard transforming growth factor (TGF-beta 3)-based induction medium. 5) Immunomodulatory capacity was equal regardless of cell source when tested in mitogen-stimulated lymphocyte reactions. Priming of MSC with pro-inflammatory factors interferon-gamma and/or tumour necrosis factor did not increase the lymphocyte suppressive properties of the MSC compared to untreated MSC. Conclusions/Significance No significant differences were found between AT-and BM-MSC with regard to their immunophenotype, progenitor, and non-progenitor functions. Both MSC populations showed strong adipogenic and osteogenic potential and poor chondrogenic potential. Both significantly suppressed stimulated peripheral blood mononuclear cells. The most significant differences found were the higher isolation success and proliferation rate of AT-MSC, which could be realized as notable benefits of their use over BM-MSC.	[Russell, Keith A.; Chow, Natalie H. C.; Dukoff, David; LaMarre, Jonathan; Koch, Thomas G.] Univ Guelph, Dept Biomed Sci, Ontario Vet Coll, Guelph, ON, Canada; [Gibson, Thomas W. G.] Univ Guelph, Ontario Vet Coll, Clin Studies, Guelph, ON, Canada; [Bette, Dean H.] Univ Western Ontario, Physiol & Pharmacol, London, ON, Canada; [Koch, Thomas G.] Aarhus Univ, Orthopaed Res Lab, Aarhus, Denmark	University of Guelph; University of Guelph; Western University (University of Western Ontario); Aarhus University	Russell, KA (corresponding author), Univ Guelph, Dept Biomed Sci, Ontario Vet Coll, Guelph, ON, Canada.	karussell.edu@gmail.com	Russell, Keith/HHS-2364-2022	Russell, Keith/0000-0002-1704-2966	Morris Animal Foundation [D12CA-313]; Pet Trust Research Foundation, Ontario Veterinary College; Dean's Office, Ontario Veterinary College; Department of Biomedical Sciences at the University of Guelph	Morris Animal Foundation; Pet Trust Research Foundation, Ontario Veterinary College; Dean's Office, Ontario Veterinary College; Department of Biomedical Sciences at the University of Guelph	This project was supported by the Morris Animal Foundation, grant ID# D12CA-313; Pet Trust Research Foundation, Ontario Veterinary College; The Dean's Office, Ontario Veterinary College and the Department of Biomedical Sciences at the University of Guelph. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An CH, 2010, ANN BIOMED ENG, V38, P1647, DOI 10.1007/s10439-009-9892-x; Bartholomew A, 2002, EXP HEMATOL, V30, P42, DOI 10.1016/S0301-472X(01)00769-X; Berdasco M, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt83; Berg LC, 2009, VET COMP ORTHOPAED, V22, P363, DOI 10.3415/VCOT-08-10-0107; Bertolo A, 2015, CELL TRANSPLANT, V24, P1969, DOI 10.3727/096368914X685294; Brinkhof B, 2006, ANAL BIOCHEM, V356, P36, DOI 10.1016/j.ab.2006.06.001; Choi SA, 2013, IN VITRO CELL DEV-AN, V49, P42, DOI 10.1007/s11626-012-9569-x; Co C, 2014, OSTEOARTHR CARTILAGE, V22, P472, DOI 10.1016/j.joca.2013.12.021; Collas P, 2008, TRANSFUS MED HEMOTH, V35, P205, DOI 10.1159/000127449; Csaki C, 2007, HISTOCHEM CELL BIOL, V128, P507, DOI 10.1007/s00418-007-0337-z; de Bakker E, 2014, VET Q, V2176, P1; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; English K, 2007, IMMUNOL LETT, V110, P91, DOI 10.1016/j.imlet.2007.04.001; Eslaminejad MB, 2010, ANAT HISTOL EMBRYOL, V39, P446, DOI 10.1111/j.1439-0264.2010.01013.x; Figueroa RJ, 2011, VET COMP ORTHOPAED, V24, P354, DOI 10.3415/VCOT-10-10-0142; Griffin MD, 2010, HUM GENE THER, V21, P1641, DOI 10.1089/hum.2010.156; Guercio A, 2013, CELL BIOL INT, V37, P789, DOI 10.1002/cbin.10090; Guilak F, 2004, BIORHEOLOGY, V41, P389; Hodgkiss-Geere HM, 2012, VET J, V194, P361, DOI 10.1016/j.tvjl.2012.05.011; Kamishina H, 2006, AM J VET RES, V67, P1921, DOI 10.2460/ajvr.67.11.1921; Kang BJ, 2012, J VET SCI, V13, P299, DOI 10.4142/jvs.2012.13.3.299; Kang JW, 2008, STEM CELLS DEV, V17, P681, DOI 10.1089/scd.2007.0153; Kisiel AH, 2012, AM J VET RES, V73, P1305, DOI 10.2460/ajvr.73.8.1305; Kol A, 2014, STEM CELLS DEV, V23, P1831, DOI 10.1089/scd.2014.0128; Krampera M, 2006, STEM CELLS, V24, P386, DOI 10.1634/stemcells.2005-0008; Le Blanc K, 2012, NAT REV IMMUNOL, V12, P383, DOI 10.1038/nri3209; Lee J, 2015, EURASIP J WIREL COMM, P1, DOI 10.1186/s13638-015-0359-5; Lee WS, 2011, BIOL BLOOD MARROW TR, V17, P465, DOI 10.1016/j.bbmt.2010.04.016; Martinello T, 2011, RES VET SCI, V91, P18, DOI 10.1016/j.rvsc.2010.07.024; Meirelles LD, 2009, CYTOKINE GROWTH F R, V20, P419, DOI 10.1016/j.cytogfr.2009.10.002; Meisel R, 2004, BLOOD, V103, P4619, DOI 10.1182/blood-2003-11-3909; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; NEUPANE M, 2008, TISSUE ENG PART A, V14, P1007, DOI DOI 10.1089/TEA.2007.0207; Park SA, 2013, CYTOTHERAPY, V15, P1498, DOI 10.1016/j.jcyt.2013.06.009; Puissant N, 2005, BRIT J HAEMATOL, V129, P118, DOI 10.1111/j.1365-2141.2005.05409.x; Reich CM, 2012, VET RES COMMUN, V36, P139, DOI 10.1007/s11259-012-9523-0; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Russell KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136621; Ryan JM, 2007, CLIN EXP IMMUNOL, V149, P353, DOI 10.1111/j.1365-2249.2007.03422.x; Schmitt B, 2003, DIFFERENTIATION, V71, P567, DOI 10.1111/j.1432-0436.2003.07109003.x; Screven R, 2014, VET IMMUNOL IMMUNOP, V161, P21, DOI 10.1016/j.vetimm.2014.06.002; Shirasawa S, 2006, J CELL BIOCHEM, V97, P84, DOI 10.1002/jcb.20546; Sullivan MO, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2015.00082; Takemitsu H, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-150; Toh WS, 2005, GROWTH FACTORS, V23, P313, DOI 10.1080/08977190500252763; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Vieira NM, 2010, CELL TRANSPLANT, V19, P279, DOI 10.3727/096368909X481764; Volk SW, 2012, CELL TRANSPLANT, V21, P2189, DOI 10.3727/096368912X636821; Yagi H, 2010, CELL TRANSPLANT, V19, P667, DOI 10.3727/096368910X508762; Zucconi E, 2010, STEM CELLS DEV, V19, P395, DOI 10.1089/scd.2008.0314	51	74	76	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167442	10.1371/journal.pone.0167442	http://dx.doi.org/10.1371/journal.pone.0167442			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907211	Green Published, gold, Green Submitted			2022-12-26	WOS:000389482700158
J	Zhan, QS; Ye, Z; Clarke, R; Rosenwaks, Z; Zaninovic, N				Zhan, Qiansheng; Ye, Zhen; Clarke, Robert; Rosenwaks, Zev; Zaninovic, Nikica			Direct Unequal Cleavages: Embryo Developmental Competence, Genetic Constitution and Clinical Outcome	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; HUMAN OOCYTES; MULTINUCLEATED BLASTOMERES; MORPHOKINETIC PARAMETERS; STAGE EMBRYOS; CENTROSOMES; ABNORMALITIES; IMPLANTATION; INHERITANCE; INSTABILITY	Objective To investigate the prevalence, developmental potential, chromosomal constitution and clinical outcome of embryos with direct unequal cleavages (DUC). Design A retrospective observational study. Setting Academic Institution. Participant 21,261 embryos from 3,155 cycles cultured in EmbryoScope. Results The total incidence of DUCs per embryo occupying the first three cleavages were 26.1%. Depending of the cell stage, DUC rate was 9.8% at first cleavage (DUC-1), 9.1% at second cleavage (DUC-2), and 3.7% at third cleavage (DUC-3) with 3.6% of embryos exhibiting multiple DUCs (DUC-Plus). The occurrence of DUCs was not correlated with female gamete age or source. The incidence of DUC-1 was significantly higher in embryos fertilized by epididymal and testicular sperm (13.6% and 11.4%, respectively) compared to ejaculated sperm (9.1%, all p<0.05). The total incidences of DUCs were strongly correlated with the onset of blastomere multinucleation (MNB) during the first three divisions. In MNB embryos, DUCs incidence are two to three times more likely to develop when compared to non-MNB embryos (OR = 3.11, 95% CI [2.64, 3.67] at 1 -cell stage, OR = 2.64, 95% CI [2.39, 2.91] at 2 -cell stage and OR = 2.51, 95% CI [1.84, 3.43] at 4 -cell stage). The blastocyst formation rates gradually decreased from 61.0% in non-DUC to 40.2% in DUC-3, 18.8% in DUC-2, 8.2% in DUC-1 and 5.6% in multiple DUC embryos (DUC-Plus). The known implantation rates (FH) for day 3 (D3) transfers were 12.42% (n = 3172) in Non-DUC embryos, 6.3% (n = 127) in DUC-3, and 2.7% (n = 260) in DUC-2 embryos. No live births resulted from either DUC-1 (n = 225) or DUC-Plus (n = 100) embryo transfers. For blastocyst transfers, lower implantation rates (33.3%) but similar live birth (LB) rates (40%) were observed if DUC blastocysts were transferred. Comparatively rates in Non-DUC blastocyst were 45.2% and 34.8%, respectively. The euploid rate gradually increased from DUC-1,-2,-3 to NonDUC (13.3%, 19.5%, 33.3%, 45.6%, p<0.001) for D3 biopsied embryos. Interestingly, the trend of decreased euploidy disappeared in DUC D5/6 biopsied embryos and similar rates were exemplified in DUC (D5 56.3%, D6 35.6%) vs. non-DUC (D5 51.4%, D6 33.8%) embryos. Conclusion Blastocyst formation, implantation potential and euploid rate were significantly reduced in DUC embryos. DUC embryos should be deselected for D3 transfers, but should be culture to blastocyst stage for possible ET.	[Zhan, Qiansheng; Ye, Zhen; Clarke, Robert; Rosenwaks, Zev; Zaninovic, Nikica] Weill Cornell Med, Ronald O Perelman & Claudia Cohen Ctr Reprod Med, New York, NY USA	Cornell University	Zaninovic, N (corresponding author), Weill Cornell Med, Ronald O Perelman & Claudia Cohen Ctr Reprod Med, New York, NY USA.	nizanin@med.cornell.edu						Aguilar J, 2016, FERTIL STERIL, V106, P291, DOI 10.1016/j.fertnstert.2016.03.036; Alikani M, 2005, HUM REPROD, V20, P3369, DOI 10.1093/humrep/dei242; Alikani M, 2000, HUM REPROD, V15, P2634, DOI 10.1093/humrep/15.12.2634; Amer Soc Reprod Med, 2013, FERTIL STERIL, V99, P44, DOI 10.1016/j.fertnstert.2012.09.038; Chamayou S, 2013, J ASSIST REPROD GEN, V30, P703, DOI 10.1007/s10815-013-9992-2; Chatzimeletiou K, 2007, ZYGOTE, V15, P81, DOI 10.1017/S0967199406004059; Chatzimeletiou K, 2005, HUM REPROD, V20, P672, DOI 10.1093/humrep/deh652; Colls P, 2007, FERTIL STERIL, V88, P53, DOI 10.1016/j.fertnstert.2006.11.099; Desai N, 2014, REPROD BIOL ENDOCRIN, V12, DOI 10.1186/1477-7827-12-54; Destouni A, 2016, GENOME RES, V26, P567, DOI 10.1101/gr.200527.115; Duensing S, 2001, BBA-REV CANCER, V1471, pM81, DOI 10.1016/S0304-419X(00)00025-1; Funahashi H, 2003, REPROD FERT DEVELOP, V15, P167, DOI 10.1071/RD02076; Gisselsson D, 2010, P NATL ACAD SCI USA, V107, P20489, DOI 10.1073/pnas.1006829107; Han YM, 1999, BIOL REPROD, V61, P1340, DOI 10.1095/biolreprod61.5.1340; Hlinka D, 2012, PHYSIOL RES, V61, P513, DOI 10.33549/physiolres.932287; Jackson KV, 1998, FERTIL STERIL, V70, P60, DOI 10.1016/S0015-0282(98)00100-9; Johnson GE, 2008, MUTAT RES-GEN TOX EN, V651, P56, DOI 10.1016/j.mrgentox.2007.10.019; Kalatova B, 2014, ACTA HISTOCHEMICA; Kligman I, 1996, HUM REPROD, V11, P1492; Klisch K, 1999, ANAT EMBRYOL, V200, P229, DOI 10.1007/s004290050275; KOLA I, 1987, BIOL REPROD, V37, P395, DOI 10.1095/biolreprod37.2.395; Kroener LL, 2015, FERTIL STERIL, V103, P694, DOI 10.1016/j.fertnstert.2014.12.090; Lagalla C, 2015, HUM REPROD, V30, P3; Lammers J, 2014, REPROD BIOMED ONLINE, V28, P658, DOI 10.1016/j.rbmo.2014.01.009; Lemmen JG, 2008, REPROD BIOMED ONLINE, V17, P385, DOI 10.1016/S1472-6483(10)60222-2; Lingle WL, 2002, P NATL ACAD SCI USA, V99, P1978, DOI 10.1073/pnas.032479999; Manandhar G, 2005, BIOL REPROD, V72, P2, DOI 10.1095/biolreprod.104.031245; Manandhar G, 2000, HUM REPROD, V15, P256, DOI 10.1093/humrep/15.2.256; Meseguer M, 2011, HUM REPROD, V26, P2658, DOI 10.1093/humrep/der256; Moomjy M, 1999, MOL HUM REPROD, V5, P836, DOI 10.1093/molehr/5.9.836; MRAK RE, 1995, NEW ENGL J MED, V332, P718, DOI 10.1056/NEJM199503163321105; Munne S, 1998, HUM REPROD UPDATE, V4, P842, DOI 10.1093/humupd/4.6.842; MUNNE S, 1993, HUM REPROD, V8, P1120, DOI 10.1093/oxfordjournals.humrep.a138204; Munne Santiago, 2002, Reprod Biomed Online, V4, P223; PICKERING SJ, 1995, HUM REPROD, V10, P1912, DOI 10.1093/oxfordjournals.humrep.a136206; Rubio I, 2012, FERTIL STERIL, V98, P1458, DOI 10.1016/j.fertnstert.2012.07.1135; Sathananthan AH, 1999, HUM REPROD UPDATE, V5, P553, DOI 10.1093/humupd/5.5.553; SATHANANTHAN AH, 1991, P NATL ACAD SCI USA, V88, P4806, DOI 10.1073/pnas.88.11.4806; Sathananthan AH, 1998, J ASSIST REPROD GEN, V15, P129, DOI 10.1023/A:1023056804548; SCHATTEN G, 1991, P NATL ACAD SCI USA, V88, P6785, DOI 10.1073/pnas.88.15.6785; Schatten H, 2009, ENVIRON MOL MUTAGEN, V50, P620, DOI 10.1002/em.20493; Schatten H, 2009, MOL HUM REPROD, V15, P531, DOI 10.1093/molehr/gap049; Scott L, 2003, HUM REPROD UPDATE, V9, P237, DOI 10.1093/humupd/dmg023; Simerly C, 1999, MOL BIOL CELL, V10, P2955, DOI 10.1091/mbc.10.9.2955; Somfai T, 2010, J REPROD DEVELOP, V56, P200, DOI 10.1262/jrd.09-097A; Staessen C, 1997, HUM REPROD, V12, P321, DOI 10.1093/humrep/12.2.321; TESARIK J, 1987, HUM REPROD, V2, P127, DOI 10.1093/oxfordjournals.humrep.a136496; Van Royen E, 2003, HUM REPROD, V18, P1062, DOI 10.1093/humrep/deg201; Veeck L.L., 2003, ATLAS HUMAN BLASTOCY, V1st, DOI 10.3109/9780203008935; Wirka KA, 2014, FERTIL STERIL, V101, P1637, DOI 10.1016/j.fertnstert.2014.02.050; Zaninovic N, 2016, FERTIL STERIL, pP; Zaninovic N. RB, 2006, CYCLE LIFE GAMETES S; Zhang MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119285	53	55	59	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0166398	10.1371/journal.pone.0166398	http://dx.doi.org/10.1371/journal.pone.0166398			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	27907016	gold, Green Published, Green Submitted			2022-12-26	WOS:000389482700026
J	Kret, ME; Tomonaga, M				Kret, Mariska E.; Tomonaga, Masaki			Getting to the Bottom of Face Processing. Species-Specific Inversion Effects for Faces and Behinds in Humans and Chimpanzees (Pan Troglodytes)	PLOS ONE			English	Article							CONFIGURAL INFORMATION; SELECTIVE REGIONS; FACIAL COLOR; BODY; SKIN; ATTRACTIVENESS; PERCEPTION; SEARCH; BODIES; ERP	For social species such as primates, the recognition of conspecifics is crucial for their survival. As demonstrated by the 'face inversion effect', humans are experts in recognizing faces and unlike objects, recognize their identity by processing it configurally. The human face, with its distinct features such as eye-whites, eyebrows, red lips and cheeks signals emotions, intentions, health and sexual attraction and, as we will show here, shares important features with the primate behind. Chimpanzee females show a swelling and reddening of the anogenital region around the time of ovulation. This provides an important socio-sexual signal for group members, who can identify individuals by their behinds. We hypothesized that chimpanzees process behinds configurally in a way humans process faces. In four different delayed matching-to-sample tasks with upright and inverted body parts, we show that humans demonstrate a face, but not a behind inversion effect and that chimpanzees show a behind, but no clear face inversion effect. The findings suggest an evolutionary shift in socio-sexual signalling function from behinds to faces, two hairless, symmetrical and attractive body parts, which might have attuned the human brain to process faces, and the human face to become more behind-like.	[Kret, Mariska E.] Leiden Univ, Inst Psychol, Cognit Psychol Unit, Leiden, Netherlands; [Kret, Mariska E.] LIBC, Leiden, Netherlands; [Tomonaga, Masaki] Kyoto Univ, Primate Res Inst, Inuyama, Aichi, Japan	Leiden University; Leiden University - Excl LUMC; Kyoto University	Kret, ME (corresponding author), Leiden Univ, Inst Psychol, Cognit Psychol Unit, Leiden, Netherlands.; Kret, ME (corresponding author), LIBC, Leiden, Netherlands.	m.e.kret@fsw.leidenuniv.nl	Kret, Mariska/B-4798-2010	Kret, Mariska/0000-0002-3197-5084	Japan Society for the Promotion of Science [pE10084, BR120105]; Nederlandse Organisatie voor Wetenschappelijk Onderzoek [016-155-082]; Dobberke Foundation for Comparative Psychology Koningklijke Nederlandse Akademie van Wetenschappen [UPS/BP/5215]; JSPS-KAKENHI [20002001, 23220006, 24000001, 15H05709]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Nederlandse Organisatie voor Wetenschappelijk Onderzoek(Netherlands Organization for Scientific Research (NWO)European Commission); Dobberke Foundation for Comparative Psychology Koningklijke Nederlandse Akademie van Wetenschappen; JSPS-KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science (pE10084 and BR120105), the Nederlandse Organisatie voor Wetenschappelijk Onderzoek (#016-155-082) and the Dobberke Foundation for Comparative Psychology Koningklijke Nederlandse Akademie van Wetenschappen (UPS/BP/5215) awarded to MEK, and JSPS-KAKENHI (20002001, 23220006, 24000001 and 15H05709) to MT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON P, 1983, CURR ANTHROPOL, V24, P25, DOI 10.1086/202933; Changizi MA, 2006, BIOL LETT-UK, V2, P217, DOI 10.1098/rsbl.2006.0440; Dahl CD, 2013, SCI REP-UK, V3, DOI 10.1038/srep01044; de Gelder B, 2010, NEUROSCI BIOBEHAV R, V34, P513, DOI 10.1016/j.neubiorev.2009.10.008; de Valk JM, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01240; de Waal FB., 1990, SOCIOSEXUAL BEHAV US, P378; de Waal FBM, 2008, ADV SCI LETT, V1, P99, DOI 10.1166/asl.2008.006; Deschner T, 2003, ANIM BEHAV, V66, P551, DOI 10.1006/anbe.2003.2210; DIAMOND R, 1986, J EXP PSYCHOL GEN, V115, P107, DOI 10.1037/0096-3445.115.2.107; FARAH MJ, 1995, J EXP PSYCHOL HUMAN, V21, P628, DOI 10.1037/0096-1523.21.3.628; Farroni T, 2002, P NATL ACAD SCI USA, V99, P9602, DOI 10.1073/pnas.152159999; Freire A, 2000, PERCEPTION, V29, P159, DOI 10.1068/p3012; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Jones BC, 2015, PSYCHONEUROENDOCRINO, V56, P29, DOI 10.1016/j.psyneuen.2015.02.021; Kret ME, 2013, EXP BRAIN RES, V228, P399, DOI 10.1007/s00221-013-3557-6; Kret ME, 2011, NEUROIMAGE, V54, P1755, DOI 10.1016/j.neuroimage.2010.08.012; Kret M.E., 2015, FRONT PSYCHOL, V6; Kret ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104886; Kret ME, 2010, EXP BRAIN RES, V203, P169, DOI 10.1007/s00221-010-2220-8; Kret ME, 2016, P NATL ACAD SCI US; Lafer-Sousa R, 2016, J NEUROSCI, V36, P1682, DOI 10.1523/JNEUROSCI.3164-15.2016; Leder H, 2000, Q J EXP PSYCHOL-A, V53, P513, DOI 10.1080/027249800390583; Matsuzawa T, 2006, COGNITIVE DEVELOPMENT IN CHIMPANZEES, P127, DOI 10.1007/4-431-30248-4_8; Minami T, 2015, NEUROSCIENCE, V311, P341, DOI 10.1016/j.neuroscience.2015.10.019; Mori Y, 2007, PRIMATES, V48, P97, DOI 10.1007/s10329-006-0030-1; Morris D., 1967, NAKED APE ZOOLOGISTS; Nakajima K, 2014, HUM BRAIN MAPP, V35, P4958, DOI 10.1002/hbm.22535; Parr LA, 1998, J COGNITIVE NEUROSCI, V10, P615, DOI 10.1162/089892998563013; Peelen MV, 2005, J NEUROPHYSIOL, V93, P603, DOI 10.1152/jn.00513.2004; Perrett DI, 1998, NATURE, V394, P884, DOI 10.1038/29772; RATCLIFF R, 1979, PSYCHOL BULL, V86, P446, DOI 10.1037/0033-2909.86.3.446; Reed CL, 2006, J EXP PSYCHOL HUMAN, V32, P73, DOI 10.1037/0096-1523.32.1.73; Reed CL, 2003, PSYCHOL SCI, V14, P302, DOI 10.1111/1467-9280.14431; RHODES G, 1993, COGNITION, V47, P25, DOI 10.1016/0010-0277(93)90061-Y; Rhodes G, 2005, P ROY SOC B-BIOL SCI, V272, P1379, DOI 10.1098/rspb.2005.3093; Scheib JE, 1999, P ROY SOC B-BIOL SCI, V266, P1913, DOI 10.1098/rspb.1999.0866; Searcy JH, 1996, J EXP PSYCHOL HUMAN, V22, P904, DOI 10.1037/0096-1523.22.4.904; Stekelenburg JJ, 2004, NEUROREPORT, V15, P777, DOI 10.1097/00001756-200404090-00007; Stephen ID, 2010, PERCEPTION, V39, P1104, DOI 10.1068/p6730; Thornhill R., 2008, EVOLUTIONARY BIOL HU; Tomonaga M, 2007, PRIMATES, V48, P1, DOI 10.1007/s10329-006-0011-4; Tomonaga M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11437; Turati C, 2004, INFANCY, V6, P275, DOI 10.1207/s15327078in0602_8; Weston EM, 2004, P ROY SOC B-BIOL SCI, V271, pS416, DOI 10.1098/rsbl.2004.0203; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474	45	9	10	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0165357	10.1371/journal.pone.0165357	http://dx.doi.org/10.1371/journal.pone.0165357			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FV	27902685	gold, Green Published, Green Submitted			2022-12-26	WOS:000389474100003
J	Novais, SMA; Nunes, CA; Santos, NB; D'Amico, AR; Fernandes, GW; Quesada, M; Braga, RF; Neves, ACO				Novais, Samuel M. A.; Nunes, Cassio A.; Santos, Natalia B.; D'Amico, Ana R.; Fernandes, G. Wilson; Quesada, Mauricio; Braga, Rodrigo F.; Neves, Ana Carolina O.			Effects of a Possible Pollinator Crisis on Food Crop Production in Brazil	PLOS ONE			English	Article							HONEY-BEES; SERVICES; LANDSCAPE; ECOSYSTEM; DIVERSITY; RESPONSES; DECLINES; THREATS	Animal pollinators contribute to human food production and security thereby ensuring an important component of human well-being. The recent decline of these agents in Europe and North America has aroused the concern of a potential global pollinator crisis. In order to prioritize efforts for pollinator conservation, we evaluated the extent to which food production depends on animal pollinators in Brazil-one of the world's agriculture leaders-by comparing cultivated area, produced volume and yield value of major food crops that are pollinator dependent with those that are pollinator non-dependent. In addition, we valued the ecosystem service of pollination based on the degree of pollinator dependence of each crop and the consequence of a decline in food production to the Brazilian Gross Domestic Product and Brazilian food security. A total of 68% of the 53 major food crops in Brazil depend to some degree on animals for pollination. Pollinator non-dependent crops produce a greater volume of food, mainly because of the high production of sugarcane, but the cultivated area and monetary value of pollinator dependent crops are higher (59% of total cultivated area and 68% of monetary value). The loss of pollination services for 29 of the major food crops would reduce production by 16.55-51 million tons, which would amount to 4.86-14.56 billion dollars/year, and reduce the agricultural contribution to the Brazilian GDP by 6.46%-19.36%. These impacts would be largely absorbed by family farmers, which represent 74.4% of the agricultural labor force in Brazil. The main effects of a pollinator crisis in Brazil would be felt by the poorer and more rural classes due to their lower income and direct or exclusive dependence on this ecosystem service.	[Novais, Samuel M. A.; Santos, Natalia B.; D'Amico, Ana R.; Fernandes, G. Wilson; Neves, Ana Carolina O.] Univ Fed Minas Gerais, Dept Biol Geral, Belo Horizonte, MG, Brazil; [Novais, Samuel M. A.; Quesada, Mauricio] Univ Nacl Autonoma Mexico, Lab Nacl Anal & Sintesis Ecol, Escuela Nacl Estudios Super, Morelia, Michoacan, Mexico; [Novais, Samuel M. A.; Quesada, Mauricio] Univ Nacl Autonoma Mexico, Inst Invest Ecosistemas & Sustentabilidad, Morelia, Michoacan, Mexico; [Nunes, Cassio A.; Braga, Rodrigo F.] Univ Fed Lavras, Dept Biol, Lavras, MG, Brazil; [D'Amico, Ana R.] Inst Chico Mendes Conservacao Biodiversidade ICMB, Rondonia, Brazil; [Fernandes, G. Wilson] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Universidade Federal de Minas Gerais; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidade Federal de Lavras; Stanford University	Novais, SMA (corresponding author), Univ Fed Minas Gerais, Dept Biol Geral, Belo Horizonte, MG, Brazil.; Novais, SMA (corresponding author), Univ Nacl Autonoma Mexico, Lab Nacl Anal & Sintesis Ecol, Escuela Nacl Estudios Super, Morelia, Michoacan, Mexico.; Novais, SMA (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Ecosistemas & Sustentabilidad, Morelia, Michoacan, Mexico.	snovaisbio@gmail.com	Nunes, Cássio Alencar/I-5528-2019; Fernandes, Geraldo/AAN-5602-2021	Nunes, Cássio Alencar/0000-0002-2783-0210; Fernandes, Geraldo/0000-0003-1559-6049; Novais, Samuel/0000-0003-3863-0860; Britto dos Santos, Natalia/0000-0002-3075-7085; Quesada, Mauricio/0000-0002-7776-9286	Universidad Nacional Autonoma de Mexico (PAPIIT) [1N212714-3]; CONACyT [2009-131008]; CONACyT-UNAM-UAGro-Laboratorio Nacional de Analisis y Sintesis Ecologica [2015-250996, 2016-271449]; Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior (CAPES); Fundagao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); CNPq	Universidad Nacional Autonoma de Mexico (PAPIIT)(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACyT-UNAM-UAGro-Laboratorio Nacional de Analisis y Sintesis Ecologica; Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior (CAPES); Fundagao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by grants from Universidad Nacional Autonoma de Mexico (PAPIIT #1N212714-3) and CONACyT (2009-131008) and CONACyT-UNAM-UAGro-Laboratorio Nacional de Analisis y Sintesis Ecologica (2015-250996 and 2016-271449 MQ). SMA Novais, CA Nunes, RF Braga, GW Fernandes and ACO Neves thank the Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior (CAPES), Fundagao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) and CNPq for scholarships.	Aizen MA, 2008, CURR BIOL, V18, P1572, DOI 10.1016/j.cub.2008.08.066; Aizen MA, 2009, CURR BIOL, V19, P915, DOI 10.1016/j.cub.2009.03.071; Allen-Wardell G, 1998, CONSERV BIOL, V12, P8; Ashworth L, 2009, BIOL CONSERV, V142, P1050, DOI 10.1016/j.biocon.2009.01.016; Assuncao J, 2013, DOES CREDIT AFFECT D; Barona E, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/2/024002; Bernard E, 2014, CONSERV BIOL, V28, P939, DOI 10.1111/cobi.12298; Blaauw BR, 2014, J APPL ECOL, V51, P890, DOI 10.1111/1365-2664.12257; Brosi BJ, 2008, J APPL ECOL, V45, P773, DOI 10.1111/j.1365-2664.2007.01412.x; Calderone NW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037235; CONAB, 2013, AC SAFR CAN DE AC SA; Connelly H, 2015, AGR ECOSYST ENVIRON, V211, P51, DOI 10.1016/j.agee.2015.05.004; De Aguiar WM, 2015, ENV ENTOMOL; De Marco P, 2004, BIODIVERS CONSERV, V13, P1245, DOI 10.1023/B:BIOC.0000019402.51193.e8; Dutch Soy Coalition, 2008, SOY BIG BUS BIG RESP; Ferreira J, 2014, SCIENCE, V346, P706, DOI 10.1126/science.1260194; Ferreira P. A., 2015, LANDSCAPE ECOL, V30, P1; Ferreira PA, 2013, ECOL INDIC, V31, P35, DOI 10.1016/j.ecolind.2012.07.025; Freitas BM, 2009, APIDOLOGIE, V40, P332, DOI 10.1051/apido/2009012; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Garibaldi LA, 2011, ECOL LETT, V14, P1062, DOI 10.1111/j.1461-0248.2011.01669.x; Garibaldi LA, 2011, P NATL ACAD SCI USA, V108, P5909, DOI 10.1073/pnas.1012431108; Ghazoul J, 2005, TRENDS ECOL EVOL, V20, P367, DOI 10.1016/j.tree.2005.04.026; Giannini TC, 2015, APIDOLOGIE, V46, P209, DOI 10.1007/s13592-014-0316-z; Giannini T.C., 2015, J ECON ENTOMOL; Gibbs HK, 2015, SCIENCE, V347, P377, DOI 10.1126/science.aaa0181; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Graesser J, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/3/034017; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Herbert LT, 2014, J EXP BIOL, V217, P3457, DOI 10.1242/jeb.109520; IBGE, 2014, CONT NAC TRIM IND VO; IBGE, 2009, CENSOAGROPECUARIO 20; IBGE Banco de Dados Agregados, 2015, SIST IBGE REC AUTOMA; Instituto Brasileiro de Geografia e Estatistica (IBGE), 2011, PESQ ORC FAM 2008 20; Kennedy CM, 2013, ECOL LETT, V16, P584, DOI 10.1111/ele.12082; Kleijn D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8414; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Krupke CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029268; Lautenbach S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035954; Levy S, 2011, NATURE, V479, P164, DOI 10.1038/479164a; Liow LH, 2001, J APPL ECOL, V38, P180, DOI 10.1046/j.1365-2664.2001.00582.x; MAPA, 2014, INT COM AGR PRINC ME; MAPA, 2016, SIST AGR FIT; Melathopoulos AP, 2015, ECOL ECON, V109, P59, DOI 10.1016/j.ecolecon.2014.11.007; Munyuli M. B. Theodore, 2012, International Journal of Biodiversity Science Ecosystem Services & Management, V8, P190, DOI 10.1080/21513732.2012.682361; *NAT RES COUNC, 2006, STAT POLL N AM; Nepstad D, 2014, SCIENCE, V344, P1118, DOI 10.1126/science.1248525; Nepstad DC, 2006, CONSERV BIOL, V20, P1595, DOI 10.1111/j.1523-1739.2006.00510.x; Pettis JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070182; Pinheiro Jose Nunes, 2010, Oecologia Australis, V14, P266; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Potts SG, 2010, J APICULT RES, V49, P15, DOI 10.3896/IBRA.1.49.1.02; R Core Team, 2021, R LANGUAGE ENV STAT; Scheper J, 2013, ECOL LETT, V16, P912, DOI 10.1111/ele.12128; Soares B, 2014, SCIENCE, V344, P363, DOI 10.1126/science.1246663; Vanbergen AJ, 2013, FRONT ECOL ENVIRON, V11, P251, DOI 10.1890/120126; Williams I. H., 1994, Agricultural Zoology Reviews, VNo.6, P229; Williams NM, 2010, BIOL CONSERV, V143, P2280, DOI 10.1016/j.biocon.2010.03.024; Winfree R, 2011, ANNU REV ECOL EVOL S, V42, P1, DOI 10.1146/annurev-ecolsys-102710-145042; Winfree R, 2011, ECOL ECON, V71, P80, DOI 10.1016/j.ecolecon.2011.08.001; Winfree R, 2009, ECOLOGY, V90, P2068, DOI 10.1890/08-1245.1; World Health Organization, 1990, WHO TECHN REP SER, V797, P98	62	30	30	4	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167292	10.1371/journal.pone.0167292	http://dx.doi.org/10.1371/journal.pone.0167292			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3FV	27902787	Green Published, gold, Green Submitted			2022-12-26	WOS:000389474100069
J	Taylor, M; Simpkin, AJ; Haycock, PC; Dudbridge, F; Zuccolo, L				Taylor, Michelle; Simpkin, Andrew J.; Haycock, Philip C.; Dudbridge, Frank; Zuccolo, Luisa			Exploration of a Polygenic Risk Score for Alcohol Consumption: A Longitudinal Analysis from the ALSPAC Cohort	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MENDELIAN RANDOMIZATION ANALYSIS; DEPENDENCE; GENES; ADOLESCENCE; DEHYDROGENASE; HERITABILITY; METAANALYSIS; METABOLISM; BIOMARKERS	Background Uncertainty remains about the true extent by which alcohol consumption causes a number of health outcomes. Genetic variants, or combinations of variants built into a polygenic risk score (PGRS), can be used in an instrumental variable framework to assess causality between a phenotype and disease outcome of interest, a method known as Mendelian randomisation (MR). We aimed to identify genetic variants involved in the aetiology of alcohol consumption, and develop a PGRS for alcohol. Methods Repeated measures of alcohol consumption from mothers and their offspring were collected as part of the Avon Longitudinal Study of Parents and Children. We tested the association between 89 SNPs (identified from either published GWAS data or from functional literature) and repeated measures of alcohol consumption, separately in mothers (from ages 28-48) and offspring (from ages 15-21) who had ever reported drinking. We modelled log units of alcohol using a linear mixed model and calculated beta coefficients for each SNP separately. Cross-validation was used to determine an allelic score for alcohol consumption, and the AVENGEME algorithm employed to estimate variance of the trait explained. Results Following correction for multiple testing, one SNP (rs1229984) showed evidence for association with alcohol consumption (beta = -0.177, SE = 0.042, p = < 0.0001) in the mothers. No SNPs showed evidence for association in the offspring after correcting for multiple testing. The optimal allelic score was generated using p-value cut offs of 0.5 and 0.05 for the mothers and offspring respectively. These scores explained 0.3% and 0.7% of the variance. Conclusion Our PGRS explains a modest amount of the variance in alcohol consumption and larger sample sizes would be required to use our PGRS in an MR framework.	[Taylor, Michelle; Simpkin, Andrew J.; Haycock, Philip C.; Zuccolo, Luisa] Univ Bristol, Univ Bristol IEU, MRC Integrat Epidemiol Unit, Bristol, Avon, England; [Taylor, Michelle; Simpkin, Andrew J.; Haycock, Philip C.; Zuccolo, Luisa] Univ Bristol, Fac Med & Dent, Sch Social & Community Med, Bristol, Avon, England; [Taylor, Michelle] Univ Bristol, Sch Expt Psychol, UK Ctr Tobacco & Alcohol, Bristol, Avon, England; [Dudbridge, Frank] London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London, England	University of Bristol; University of Bristol; University of Bristol; University of London; London School of Hygiene & Tropical Medicine	Taylor, M (corresponding author), Univ Bristol, Univ Bristol IEU, MRC Integrat Epidemiol Unit, Bristol, Avon, England.; Taylor, M (corresponding author), Univ Bristol, Fac Med & Dent, Sch Social & Community Med, Bristol, Avon, England.; Taylor, M (corresponding author), Univ Bristol, Sch Expt Psychol, UK Ctr Tobacco & Alcohol, Bristol, Avon, England.	michelle.taylor@bristol.ac.uk	Haycock, Philip/I-6188-2019	Haycock, Philip/0000-0001-5001-3350; Simpkin, Andrew/0000-0002-4975-444X; Zuccolo, Luisa/0000-0002-7049-3037	Wellcome Trust [102215/2/13/2]; Wellcome Trust PhD Studentship [097088/Z/11/Z]; UK MRC Population Health Scientist fellowship [G0902144]; UK Medical Research Council grant [MR/L011824/1]; CRUK Population Research Postdoctoral Fellowship [C52724/A20138]; UK Medical Research Council Integrative Epidemiology Unit at the University of Bristol [MC_UU_12013/1]; UK MRC [K006215]; 23andMe; Medical Research Council [MC_UU_12013/1, MC_PC_15018, G9815508, MC_UU_12013/3, G0902144, MC_UU_12013/5, MR/K006215/1, MR/L011824/1] Funding Source: researchfish; MRC [MC_UU_12013/1, MR/K006215/1, MC_UU_12013/5, MC_UU_12013/3, MR/L011824/1, G0902144] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust PhD Studentship(Wellcome Trust); UK MRC Population Health Scientist fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Medical Research Council grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CRUK Population Research Postdoctoral Fellowship; UK Medical Research Council Integrative Epidemiology Unit at the University of Bristol(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); 23andMe; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The UK Medical Research Council and the Wellcome Trust (grant number: 102215/2/13/2) and the University of Bristol provide core support for ALSPAC. When conducting this research MT was supported by a Wellcome Trust PhD Studentship (grant number: 097088/Z/11/Z). LZ was funded by a UK MRC Population Health Scientist fellowship (grant number G0902144). AJS is funded by a UK Medical Research Council grant (grant number: MR/L011824/1). PH is supported by CRUK Population Research Postdoctoral Fellowship (grant number: C52724/A20138). MT, AS, PH and LZ work within the UK Medical Research Council Integrative Epidemiology Unit at the University of Bristol (grant number: MC_UU_12013/1). FD receives funding from the UK MRC (grant number: K006215).; We are extremely grateful to all the families who took part in this study, the midwives for their help in recruiting them, and the whole ALSPAC team, which includes interviewers, computer and laboratory technicians, clerical workers, research scientists, volunteers, managers, receptionists and nurses. The UK Medical Research Council and the Wellcome Trust and the University of Bristol provide core support for ALSPAC. This publication is the work of the authors and all authors will serve as guarantors for the contents of this paper. GWAS data was generated by Sample Logistics and Genotyping Facilities at the Wellcome Trust Sanger Institute and LabCorp (Laboratory Corporation of American using support from 23andMe.	Achur RN, 2010, J NEUROIMMUNE PHARM, V5, P83, DOI 10.1007/s11481-009-9185-z; Bergen SE, 2007, TWIN RES HUM GENET, V10, P423, DOI 10.1375/twin.10.3.423; Bevilacqua L, 2009, CLIN PHARMACOL THER, V85, P359, DOI 10.1038/clpt.2009.6; BHF, 2015, CARD DIS STAT 2015 B; Bierut LJ, 2010, P NATL ACAD SCI USA, V107, P5082, DOI 10.1073/pnas.0911109107; Birley AJ, 2009, HUM MOL GENET, V18, P1533, DOI 10.1093/hmg/ddp060; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Brion MJA, 2013, INT J EPIDEMIOL, V42, P1497, DOI 10.1093/ije/dyt179; Burgess S, 2016, J CLIN EPIDEMIOL, V69, P208, DOI 10.1016/j.jclinepi.2015.08.001; Burgess S, 2013, INT J EPIDEMIOL, V42, P1134, DOI 10.1093/ije/dyt093; Clarke TK, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.83; Davey Smith G, 2014, HUM MOL GENET, V23, pR89, DOI 10.1093/hmg/ddu328; Dick DM, 2003, ALCOHOL CLIN EXP RES, V27, P868, DOI 10.1097/01.ALC.0000065436.24221.63; Dudbridge F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003348; Edenberg HJ, 2007, ALCOHOL RES HEALTH, V30, P5; Edwards AL, 1957, SOCIAL DESIRABILITY, Ve1003348, DOI [10.1371/journal.pgen.1003348, DOI 10.1371/JOURNAL.PGEN.1003348]; Fraser A, 2013, INT J EPIDEMIOL, V42, P97, DOI 10.1093/ije/dys066; Gelernter J, 2014, MOL PSYCHIATR, V19, P41, DOI 10.1038/mp.2013.145; Glymour MM, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4334; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; Heath AC, 2011, BIOL PSYCHIAT, V70, P513, DOI 10.1016/j.biopsych.2011.02.028; Heron J, 2012, ALCOHOL ALCOHOLISM, V47, P169, DOI 10.1093/alcalc/agr156; Holmes MV, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4164; Hung CF, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0334-3; Irons DE, 2007, DEV PSYCHOPATHOL, V19, P1181, DOI 10.1017/S0954579407000612; Kapoor M, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.27; Koppes LLJ, 2005, DIABETES CARE, V28, P719, DOI 10.2337/diacare.28.3.719; Lawlor DA, 2008, STAT MED, V27, P1133, DOI 10.1002/sim.3034; Lees R, 2012, ALCOHOL ALCOHOLISM, V47, P267, DOI 10.1093/alcalc/ags010; Li MD, 2009, NAT REV GENET, V10, P225, DOI 10.1038/nrg2536; MacArthur GJ, 2012, J PUBLIC HEALTH-UK, V34, pI20, DOI 10.1093/pubmed/fds006; Melotti R, 2011, PEDIATRICS, V127, pE948, DOI 10.1542/peds.2009-3450; MIDANIK L, 1982, BRIT J ADDICT, V77, P357; Palla L, 2015, AM J HUM GENET, V97, P250, DOI 10.1016/j.ajhg.2015.06.005; Park BL, 2013, HUM GENET, V132, P657, DOI 10.1007/s00439-013-1281-8; Peterson K, 2004, ALCOHOL RES HEALTH, V28, P30; Prescott CA, 2006, MOL PSYCHIATR, V11, P603, DOI 10.1038/sj.mp.4001811; Rehm J, 2008, AM J EPIDEMIOL, V168, P866, DOI 10.1093/aje/kwn093; Rehm J., 2012, ALCOHOL CONSUMPTION; Ronksley PE, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d671; Shen L, 2016, AM J EPIDEMIOL, V183, P147, DOI 10.1093/aje/kwv204; Smith GD, 2007, PLOS MED, V4, P1985, DOI 10.1371/journal.pmed.0040352; StataCorp, 2013, STATA STAT SOFTW REL; Stockwell T, 2004, ADDICTION, V99, P1024, DOI 10.1111/j.1360-0443.2004.00815.x; Swan G E, 1990, J Subst Abuse, V2, P39; Taylor AE, 2015, SCI REPORTS, P5; Taylor AE, 2016, SCI REP-UK, V6, DOI 10.1038/srep26496; Treutlein J, 2011, CURR PSYCHIAT REP, V13, P147, DOI 10.1007/s11920-011-0176-4; Treutlein J, 2009, ARCH GEN PSYCHIAT, V66, P773, DOI 10.1001/archgenpsychiatry.2009.83; Verhulst B, 2015, PSYCHOL MED, V45, P1061, DOI 10.1017/S0033291714002165; Vink JM, 2014, ADDICTION, V109, P1141, DOI 10.1111/add.12491; Walter S, 2015, AM J MED GENET B, V168, P108, DOI 10.1002/ajmg.b.32286; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Yeung SLA, 2013, INT J EPIDEMIOL, V42, P318, DOI 10.1093/ije/dys221	55	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2016	11	11							e0167360	10.1371/journal.pone.0167360	http://dx.doi.org/10.1371/journal.pone.0167360			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FV	27902751	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000389474100077
